PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Liu, W; Guo, TF; Jing, ZT; Yang, Z; Liu, L; Yang, YP; Lin, X; Tong, QY				Liu, Wei; Guo, Teng-Fei; Jing, Zhen-Tang; Yang, Zhi; Liu, Lei; Yang, Yuan-Ping; Lin, Xu; Tong, Qiao-Yun			Hepatitis B virus core protein promotes hepatocarcinogenesis by enhancing Src expression and activating the Src/PI3K/Akt pathway	FASEB JOURNAL			English	Article						proliferation; cell cycle; Csk; Sp1; survival signaling	HEPATOCELLULAR-CARCINOMA; C-SRC; NUCLEAR-LOCALIZATION; BINDING PROTEIN; FAMILY KINASES; HBX PROTEIN; ANTIGEN; TRANSCRIPTION; GENE; MECHANISMS	Hepatitis B virus core protein (HBc) is expressed preferentially in hepatitis B virus (HBV)-associated hepatocellular carcinoma (HCC). HBc can function as an oncogene arising from its gene regulatory properties, but how it contributes functionally to hepatocarcinogenesis remains unclear. In this study, we determined the molecular and functional roles of HBc during HBV-associated hepatocellular tumorigenesis. HBc increased tumor formation of hepatoma cells. Moreover, expression of HBc specifically promoted proliferation of hepatoma cells in vitro. Mechanistic investigations revealed that these effects were caused by activation of the Src/PI3K/Akt pathway through proximal switch from inactive Src to the active form of the kinase by HBc. HBc-mediated sarcoma (Src) kinase activation was associated with down-regulation of C-terminal Src kinase (Csk). In addition, HBc enhances Src expression by activation of alternative Src 1A promoter in an Sp1 transcription factor-dependent manner. Proliferation induced by stable HBc expression was associated with increased G(1) -S cell cycle progression mediated by Src kinase activation. HBc-induced cellular proliferation and tumor formation were reversed by administration of the Src inhibitor saracatinib. Together, our findings suggest that HBc promotes tumorigenesis of hepatoma cells by enhancing the expression of total Src and the active form of the kinase and subsequently activates Src/PI3K/Akt signaling pathway, revealing novel insights into the underlying mechanisms of HBV-associated hepatocarcinogenesis.				liuwei@ctgu.edu.cn	Liu, Wei/ABX-2014-2022	Liu, Wei/0000-0001-7118-815X	National Natural Science Foundation of China [31600134]; Key Laboratory of Tumor Microbiology, Fujian Medical University [FMUTM-201704]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Tumor Microbiology, Fujian Medical University	This work was supported by National Natural Science Foundation of China Grant 31600134, Key Laboratory of Tumor Microbiology, Fujian Medical University (Open Research Fund, Grant FMUTM-201704). The authors declare no conflicts of interest.	Aravalli RN, 2008, HEPATOLOGY, V48, P2047, DOI 10.1002/hep.22580; Bonham K, 2000, J BIOL CHEM, V275, P37604, DOI 10.1074/jbc.M004882200; Bouchard M, 2001, J VIROL, V75, P4247, DOI 10.1128/JVI.75.9.4247-4257.2001; Brechot C, 2004, GASTROENTEROLOGY, V127, pS56, DOI 10.1053/j.gastro.2004.09.016; Chen JY, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-282; Chen ML, 2011, DIS MARKERS, V30, P325, DOI [10.1155/2011/946295, 10.3233/DMA-2011-0792]; Chen XC, 2004, VACCINE, V22, P439, DOI 10.1016/j.vaccine.2003.07.014; Du J, 2009, CELL DEATH DIFFER, V16, P219, DOI 10.1038/cdd.2008.144; ECKHARDT SG, 1991, J VIROL, V65, P575, DOI 10.1128/JVI.65.2.575-582.1991; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Gai XX, 2013, INT J BIOCHEM CELL B, V45, P1174, DOI 10.1016/j.biocel.2013.03.015; Guo YH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-563; HATTON T, 1992, J VIROL, V66, P5232, DOI 10.1128/JVI.66.9.5232-5241.1992; Ito Y, 2001, J HEPATOL, V35, P68, DOI 10.1016/S0168-8278(01)00077-0; Jeong H, 2014, FEBS LETT, V588, P851, DOI 10.1016/j.febslet.2014.01.020; Kew MC, 2010, PATHOL BIOL, V58, P273, DOI 10.1016/j.patbio.2010.01.005; Klein NP, 1997, MOL CELL BIOL, V17, P6427, DOI 10.1128/MCB.17.11.6427; Kwon JA, 2003, BIOL CHEM, V384, P203, DOI 10.1515/BC.2003.022; Lau GM, 2009, DIGEST DIS SCI, V54, P1465, DOI 10.1007/s10620-008-0519-0; Levinson NM, 2008, CELL, V134, P124, DOI 10.1016/j.cell.2008.05.051; Li HC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001162; LIAO W, 1995, J VIROL, V69, P1025, DOI 10.1128/JVI.69.2.1025-1029.1995; Lin YJ, 2010, P NATL ACAD SCI USA, V107, P9340, DOI 10.1073/pnas.1004762107; Liu HO, 2011, CANCER RES, V71, P7547, DOI 10.1158/0008-5472.CAN-11-2260; Liu W, 2015, FASEB J, V29, P1113, DOI 10.1096/fj.14-263822; Lok AS, 2001, GASTROENTEROLOGY, V120, P1828, DOI 10.1053/gast.2001.24839; Masaki T, 1999, HEPATOLOGY, V29, P379, DOI 10.1002/hep.510290239; Masaki T, 1998, HEPATOLOGY, V27, P1257, DOI 10.1002/hep.510270511; MILICH DR, 1986, SCIENCE, V234, P1398, DOI 10.1126/science.3491425; Neuveut C, 2010, J HEPATOL, V52, P594, DOI 10.1016/j.jhep.2009.10.033; Nicolas M, 2001, J BIOL CHEM, V276, P22126, DOI 10.1074/jbc.M010740200; Ritchie S, 2000, J BIOL CHEM, V275, P847, DOI 10.1074/jbc.275.2.847; Ritchie SA, 2003, NUCLEIC ACIDS RES, V31, P1502, DOI 10.1093/nar/gkg246; Shim HY, 2011, VIROLOGY, V410, P161, DOI 10.1016/j.virol.2010.11.005; Wheeler DL, 2009, ONCOLOGIST, V14, P667, DOI 10.1634/theoncologist.2009-0009; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Wu YL, 2016, J VIROL, V90, P1729, DOI 10.1128/JVI.02604-15; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yin Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022524; Zhang SY, 2012, TRENDS PHARMACOL SCI, V33, P122, DOI 10.1016/j.tips.2011.11.002	40	18	20	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3033	3046		10.1096/fj.201701144R	http://dx.doi.org/10.1096/fj.201701144R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401603				2022-12-28	WOS:000432546000012
J	Chand, KK; Lee, KM; Lee, JD; Qiu, H; Willis, EF; Lavidis, NA; Hilliard, MA; Noakes, PG				Chand, Kirat K.; Lee, Kah Meng; Lee, John D.; Qiu, Hao; Willis, Emily F.; Lavidis, Nickolas A.; Hilliard, Massimo A.; Noakes, Peter G.			Defects in synaptic transmission at the neuromuscular junction precede motor deficits in a TDP-43(Q331K) transgenic mouse model of amyotrophic lateral sclerosis	FASEB JOURNAL			English	Article						neurotransmission; motor neuron disease; ALS; TARDBP; transmitter release	FRONTOTEMPORAL LOBAR DEGENERATION; TARDBP MUTATIONS; VESICLE POOLS; ACTIVE ZONES; NEURON DEATH; CALCIUM-IONS; TDP-43; ALS; MICE; SYNAPSES	Transactive response DNA-binding protein-43 (TDP-43) is involved in gene regulation via the control of RNA transcription, splicing, and transport. TDP-43 is a major protein component of ubiquinated inclusions that are found in amyotrophic lateral sclerosis (ALS); however, the function of TDP-43 at the neuromuscular junction (NMJ) and its role in ALS pathogenesis is largely unknown. Here, we show that TDP-43(Q)(331K) mutation in mice resulted in impaired neurotransmission by age 3 mo, preceding deficits in motor function and motor neuron loss, which were observed from age 10 mo. These defects were in the effective fusion and release of synaptic vesicles within the motor nerve terminal and manifested in decreased quantal content and reduced probability of quantal release. We observed morphologic alterations that were associated with the TDP-43(Q331K) mutation, such as aberrant innervation patterns and the distribution of synaptic vesicle-related proteins, which is indicative of a failing NMJ undergoing synaptic remodeling. These findings support a growing acceptance that dysregulation of the NMJ function is a key early event in the pathology of ALS.	[Chand, Kirat K.; Lee, Kah Meng; Lee, John D.; Qiu, Hao; Willis, Emily F.; Lavidis, Nickolas A.; Noakes, Peter G.] Univ Queensland, Sch Biomed Sci, Res Rd, Brisbane, Qld QLD 4072, Australia; [Chand, Kirat K.; Lee, John D.] Univ Queensland, Ctr Clin Res, Brisbane, Qld, Australia; [Hilliard, Massimo A.] Univ Queensland, Clem Jones Ctr Ageing Dementia Res, Brisbane, Qld, Australia; [Noakes, Peter G.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland; University of Queensland	Noakes, PG (corresponding author), Univ Queensland, Sch Biomed Sci, Res Rd, Brisbane, Qld QLD 4072, Australia.	p.noakes@uq.edu.au	Noakes, Peter/X-9825-2019; Willis, Emily/ABF-7570-2020; Lee, John/Y-2066-2018	Noakes, Peter/0000-0001-9821-8478; Lee, John/0000-0002-9976-7396; Lee, Kah Meng/0000-0002-1659-0178; Hilliard, Massimo A/0000-0001-7458-5812; Chand, Kirat/0000-0001-7739-2098; Willis, Emily/0000-0002-3756-5318	Motor Neuron Disease Research Institute of Australia (MNDRIA) Postdoctoral fellowship; National Health and Medical Research Council (NHMRC) Senior Research Fellowship; NHMRC [APP1067461]; MNDRIA [GIA1429, GIA1547]	Motor Neuron Disease Research Institute of Australia (MNDRIA) Postdoctoral fellowship; National Health and Medical Research Council (NHMRC) Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); MNDRIA	The authors thank William D. Phillips (Bosch Institute, The University of Sydney, NSW, Australia) for carefully going through the manuscript and giving us feedback to improve our manuscript. Supported by a Motor Neuron Disease Research Institute of Australia (MNDRIA) Postdoctoral fellowship (to J.D.L.) and a National Health and Medical Research Council (NHMRC) Senior Research Fellowship (to M.A.H.), and funded by the NHMRC (Project Grant APP1067461; to M.A.H. and P.G.N.) and MNDRIA (Grants GIA1429 and GIA1547; to P.G.N.). The authors declare no conflicts of interest.	Alami NH, 2014, NEURON, V81, P536, DOI 10.1016/j.neuron.2013.12.018; [Anonymous], 2009, THE SPINAL CORD; Arbour D, 2015, J NEUROSCI, V35, P688, DOI 10.1523/JNEUROSCI.1379-14.2015; Armstrong GAB, 2013, J NEUROSCI, V33, P1741, DOI 10.1523/JNEUROSCI.4003-12.2013; Arnold ES, 2013, P NATL ACAD SCI USA, V110, pE736, DOI 10.1073/pnas.1222809110; Atwood HL, 2002, NAT REV NEUROSCI, V3, P497, DOI 10.1038/nrn876; Banks GB, 2001, J COMP NEUROL, V429, P156, DOI 10.1002/1096-9861(20000101)429:1<156::AID-CNE12>3.0.CO;2-3; BENNETT MR, 1986, J PHYSIOL-LONDON, V379, P257, DOI 10.1113/jphysiol.1986.sp016252; BENNETT MR, 1977, J PHYSIOL-LONDON, V271, P641, DOI 10.1113/jphysiol.1977.sp012019; BENNETT MR, 1974, J PHYSIOL-LONDON, V238, P93, DOI 10.1113/jphysiol.1974.sp010512; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Caillol G, 2012, EUR J NEUROSCI, V36, P2400, DOI 10.1111/j.1460-9568.2012.08164.x; Chand KK, 2017, FASEB J, V31, P1323, DOI 10.1096/fj.201600899R; Chand KK, 2016, SCI REP-UK, V6, DOI 10.1038/srep29446; Chand KK, 2015, J PHYSIOL-LONDON, V593, P245, DOI 10.1113/jphysiol.2014.284133; Chiang PM, 2010, P NATL ACAD SCI USA, V107, P16320, DOI 10.1073/pnas.1002176107; Chung T, 2017, MUSCLE NERVE, V55, P894, DOI 10.1002/mus.25267; CLARKE PGH, 1995, METHOD CELL BIOL, V46, P277; Cozzolino M, 2008, ANTIOXID REDOX SIGN, V10, P405, DOI 10.1089/ars.2007.1760; Darabid H, 2014, NAT REV NEUROSCI, V15, P703, DOI 10.1038/nrn3821; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Fogarty MJ, 2015, BRAIN STRUCT FUNCT, V220, P525, DOI 10.1007/s00429-013-0673-9; Fogarty MJ, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00153; Fogarty MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056257; Frey D, 2000, J NEUROSCI, V20, P2534; Gitcho MA, 2009, ACTA NEUROPATHOL, V118, P633, DOI 10.1007/s00401-009-0571-7; Gould TW, 2006, J NEUROSCI, V26, P8774, DOI 10.1523/JNEUROSCI.2315-06.2006; HANLEY T, 1991, BIOTECHNIQUES, V10, P56; Hegedus J, 2008, J PHYSIOL-LONDON, V586, P3337, DOI 10.1113/jphysiol.2007.149286; Hida Y, 2010, J BIOCHEM, V148, P131, DOI 10.1093/jb/mvq065; Ibata K, 2008, NEURON, V57, P819, DOI 10.1016/j.neuron.2008.02.031; Igaz LM, 2011, J CLIN INVEST, V121, P726, DOI 10.1172/JCI44867; Itoh A, 2011, J NEUROSCI, V31, P7223, DOI 10.1523/JNEUROSCI.5947-10.2011; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Knight D, 2003, J PHYSIOL-LONDON, V546, P789, DOI 10.1113/jphysiol.2002.030924; Kopp DM, 2000, J NEUROSCI, V20, P8771; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; LANCEJONES C, 1982, DEV BRAIN RES, V4, P473, DOI 10.1016/0165-3806(82)90192-4; Lee JY, 2013, J ASIA TEFL, V10, P1; Lee JY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0310-z; Lee JD, 2017, BRIT J PHARMACOL, V174, P689, DOI 10.1111/bph.13730; Lee KM, 2017, AGING-US, V9, P880, DOI 10.18632/aging.101198; Lobsiger CS, 2013, P NATL ACAD SCI USA, V110, pE4385, DOI 10.1073/pnas.1318309110; Mahoney RE, 2014, J NEUROSCI, V34, P2111, DOI 10.1523/JNEUROSCI.3556-13.2014; Mantilla CB, 2007, NEUROSCIENCE, V146, P178, DOI 10.1016/j.neuroscience.2007.01.048; Mantilla CB, 2009, RESP PHYSIOL NEUROBI, V169, P133, DOI 10.1016/j.resp.2009.09.002; Murray LM, 2008, HUM MOL GENET, V17, P949, DOI 10.1093/hmg/ddm367; Narayanan RK, 2013, AMYOTROPH LAT SCL FR, V14, P252, DOI 10.3109/21678421.2012.734520; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishimune H, 2004, NATURE, V432, P580, DOI 10.1038/nature03112; Nishimune H, 2016, SCI REP-UK, V6, DOI 10.1038/srep27935; Nishimune H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038029; Nishimune H, 2012, MOL NEUROBIOL, V45, P1, DOI 10.1007/s12035-011-8216-y; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Rocha MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073846; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; Shahidullah M, 2013, J NEUROSCI, V33, P19590, DOI 10.1523/JNEUROSCI.3396-13.2013; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Stallings NR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071793; Swarup V, 2011, BRAIN, V134, P2610, DOI 10.1093/brain/awr159; Swinnen B, 2014, NAT REV NEUROL, V10, P661, DOI 10.1038/nrneurol.2014.184; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Turrigiano G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005736; Valdez G, 2010, P NATL ACAD SCI USA, V107, P14863, DOI 10.1073/pnas.1002220107; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Williams K. L., 2012, NEUROBIOL AGING, V33, pe3, DOI [DOI 10.1016/J.NEUR0BI0LAGING.2012.05.008, 10.1016/j.neurobiolaging.2012.05.008]; Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010; Zhang T., 2014, INT J PHOTO ENERGY, V2014, P10, DOI DOI 10.1016/J.FOODHYD.2014.05.008; Zhou JS, 2010, J BIOL CHEM, V285, P705, DOI 10.1074/jbc.M109.041319	74	31	31	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2676	2689		10.1096/fj.201700835R	http://dx.doi.org/10.1096/fj.201700835R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29295857				2022-12-28	WOS:000432528000029
J	Lecoutre, S; Pourpe, C; Butruille, L; Marousez, L; Laborie, C; Guinez, C; Lesage, J; Vieau, D; Eeckhoute, J; Gabory, A; Oger, F; Eberle, D; Breton, C				Lecoutre, Simon; Pourpe, Charlene; Butruille, Laura; Marousez, Lucie; Laborie, Christine; Guinez, Celine; Lesage, Jean; Vieau, Didier; Eeckhoute, Jerome; Gabory, Anne; Oger, Frederik; Eberle, Delphine; Breton, Christophe			Reduced PPAR gamma 2 expression in adipose tissue of male rat offspring from obese dams is associated with epigenetic modifications	FASEB JOURNAL			English	Article						perinatal programming; DOHaD; gene regulation; fat expansion	ACTIVATED-RECEPTOR-GAMMA; HIGH-FAT DIET; MATERNAL OBESITY; DNA METHYLATION; PPAR-GAMMA; NUTRITIONAL MANIPULATIONS; INSULIN-RESISTANCE; CELL; DIFFERENTIATION; ADIPOGENESIS	According to the Developmental Origin of Health and Disease (DOHaD) concept, maternal obesity and accelerated growth in neonates program obesity later in life. White adipose tissue (WAT) has been the focus of developmental programming events, although underlying mechanisms remain elusive. In rodents, WAT development primarily occurs during lactation. We previously reported that adult rat offspring from dams fed a high-fat (HF) diet exhibited fat accumulation and decreased peroxisome proliferator-activated receptor gamma (PPAR gamma) mRNA levels in WAT. We hypothesized that PPAR gamma down-regulation occurs via epigenetic malprogramming which takes place during adipogenesis. We therefore examined epigenetic modifications in the PPAR gamma 1 and PPAR gamma 2 promoters in perirenal (pWAT) and inguinal fat pads of HF offspring at weaning (postnatal d 21) and in adulthood. Postnatal d 21 is a period characterized by active epigenomic remodeling in the PPAR gamma 2 promoter (DNA hypermethylation and depletion in active histone modification H3ac and H3K4me3) in pWAT, consistent with increased DNA methyltransferase and DNA methylation activities. Adult HF offspring exhibited sustained hypermethylation and histone modification H3ac of the PPAR gamma 2 promoter in both deposits, correlated with persistent decreased PPAR gamma 2 mRNA levels. Consistent with the DOHaD hypothesis, retained epigenetic marks provide a mechanistic basis for the cellular memory linking maternal obesity to a predisposition for later adiposity.	[Lecoutre, Simon; Pourpe, Charlene; Butruille, Laura; Marousez, Lucie; Laborie, Christine; Guinez, Celine; Lesage, Jean; Vieau, Didier; Oger, Frederik; Eberle, Delphine; Breton, Christophe] Univ Lille, CHU Lille, Equipe Accueil EA4489, Equipe Malnutr Maternelle & Programmat Malad Meta, Lille, France; [Eeckhoute, Jerome] Univ Lille, CHU Lille, Inst Pasteur Lille, EGID,INSERM,Unite 1011, Lille, France; [Gabory, Anne] Univ Paris Saclay, ENVA, INRA, UMR,BDR, Jouy En Josas, France	Universite de Lille - ISITE; CHU Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; UDICE-French Research Universities; Universite Paris Saclay	Breton, C (corresponding author), Univ Lille, Equipe Malnutr Maternelle & Programmat Malad Meta, EA4489, F-59000 Lille, France.	christophe.breton@univ-lille1.fr	EBERLE, Delphine/R-5551-2018; lesage, jean/R-5019-2018; Eeckhoute, Jerome/AAN-8219-2021	EBERLE, Delphine/0000-0003-2211-6146; lesage, jean/0000-0002-6329-1613; Eeckhoute, Jerome/0000-0002-7222-9264; Gabory, Anne/0000-0002-0059-7375; BUTRUILLE, Laura/0000-0001-5760-1489; vieau, didier/0000-0002-3254-3662; Oger, Frederik/0000-0003-0006-5835	French Heart and Arteries Foundation; French Ministry of Education; Fondation pour la Recherche Medicale (Equipe Labellisee) [DEQ20150331724]; European Genomic Institute for Diabetes (EGID) [ANR-10-LABX-46]	French Heart and Arteries Foundation; French Ministry of Education; Fondation pour la Recherche Medicale (Equipe Labellisee)(Fondation pour la Recherche Medicale); European Genomic Institute for Diabetes (EGID)	The authors thank Capucine Besenguez, Anne Dickes-Coopman, and Valerie Montel (Universite de Lille) for technical assistance during euthanization. This study was supported by grants from the French Heart and Arteries Foundation and grants from the French Ministry of Education. Work at INSERM Unite 1011 was supported by grants from the Fondation pour la Recherche Medicale (Equipe Labellisee, DEQ20150331724) and the European Genomic Institute for Diabetes (EGID; ANR-10-LABX-46). The authors declare no conflicts of interest.	Berry DC, 2013, DEVELOPMENT, V140, P3939, DOI 10.1242/dev.080549; Birsoy K, 2011, DEVELOPMENT, V138, P4709, DOI 10.1242/dev.067710; Borengasser SJ, 2013, ENDOCRINOLOGY, V154, P4113, DOI 10.1210/en.2012-2255; Cho YW, 2009, CELL METAB, V10, P27, DOI 10.1016/j.cmet.2009.05.010; DESAI M, 2014, AM J OBSTET GYNECOL, V237, pE1, DOI DOI 10.1016/J.AJ0G.2014.03.025; Fujiki K, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-38; Gentile TL, 2013, MOL CELL BIOL, V33, P3864, DOI 10.1128/MCB.01495-12; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; GREENWOOMR, 1974, J LIPID RES, V15, P474; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Han J, 2011, DEVELOPMENT, V138, P5027, DOI 10.1242/dev.067686; Hepler C, 2017, MOL CELL ENDOCRINOL, V445, P95, DOI 10.1016/j.mce.2016.10.011; Jiao F, 2016, J NUTR BIOCHEM, V34, P42, DOI 10.1016/j.jnutbio.2016.04.005; Joe AWB, 2009, STEM CELLS, V27, P2563, DOI 10.1002/stem.190; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Kosaka K, 2016, AM J PHYSIOL-CELL PH, V311, pC322, DOI 10.1152/ajpcell.00301.2015; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lecoutre S, 2017, MOL METAB, V6, P922, DOI 10.1016/j.molmet.2017.05.010; Lecoutre S, 2016, J ENDOCRINOL, V230, P39, DOI 10.1530/JOE-16-0037; Lecoutre S, 2014, ADIPOCYTE, V3, P256, DOI 10.4161/adip.29806; Lecoutre S, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00158; Liang XW, 2016, J PHYSIOL-LONDON, V594, P4453, DOI 10.1113/JP272123; Lu C, 2012, CELL METAB, V16, P9, DOI 10.1016/j.cmet.2012.06.001; Lukaszewski MA, 2013, AM J PHYSIOL-ENDOC M, V305, pE1195, DOI 10.1152/ajpendo.00231.2013; Medvedeva YA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-119; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Modi N, 2011, PEDIATR RES, V70, P287, DOI 10.1203/PDR.0b013e318225f9b1; Oestreich AK, 2017, TRENDS GENET, V33, P399, DOI 10.1016/j.tig.2017.03.008; Oger F, 2014, J BIOL CHEM, V289, P708, DOI 10.1074/jbc.M113.526996; Ortega FJ, 2010, OBESITY, V18, P13, DOI 10.1038/oby.2009.202; Ost A, 2015, CURR OPIN CELL BIOL, V33, P88, DOI 10.1016/j.ceb.2014.12.005; Salma N, 2004, MOL CELL BIOL, V24, P4651, DOI 10.1128/MCB.24.11.4651-4663.2004; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Shankar K, 2008, AM J PHYSIOL-REG I, V294, pR528, DOI 10.1152/ajpregu.00316.2007; Soccio RE, 2017, J CLIN INVEST, V127, P1451, DOI 10.1172/JCI91211; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Sun B, 2012, DIABETES, V61, P2833, DOI 10.2337/db11-0957; Sun YN, 2014, J ANIM SCI, V92, P48, DOI 10.2527/jas.2013-6962; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Vogt MC, 2014, CELL, V156, P495, DOI 10.1016/j.cell.2014.01.008; Yan ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110706; Yang QY, 2013, DIABETES, V62, P3727, DOI 10.2337/db13-0433; Zambrano E, 2010, J PHYSIOL-LONDON, V588, P1791, DOI 10.1113/jphysiol.2010.190033; Zhang B, 1996, MOL ENDOCRINOL, V10, P1457, DOI 10.1210/me.10.11.1457; Zwamborn RAJ, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep43261	47	15	15	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2768	2778		10.1096/fj.201700997R	http://dx.doi.org/10.1096/fj.201700997R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29295860	Green Submitted			2022-12-28	WOS:000432528000036
J	Uekawa, A; Yamanaka, H; Lieben, L; Kimira, Y; Uehara, M; Yamamoto, Y; Kato, S; Ito, K; Carmeliet, G; Masuyama, R				Uekawa, Atsushi; Yamanaka, Hitoki; Lieben, Liesbet; Kimira, Yoshifumi; Uehara, Mariko; Yamamoto, Yoko; Kato, Shigeaki; Ito, Kosei; Carmeliet, Geert; Masuyama, Ritsuko			Phosphate-dependent luminal ATP metabolism regulates transcellular calcium transport in intestinal epithelial cells	FASEB JOURNAL			English	Article						extracellular phosphate; Cx43; ENPP1	VITAMIN-D-RECEPTOR; BONE MINERALIZATION; KNOCKOUT MICE; INORGANIC-PHOSPHATE; RAF/MEK/ERK PATHWAY; PHOSPHORUS INTAKE; DIETARY CALCIUM; ABSORPTION; ACTIVATION; RELEASE	Extracellular low phosphate strongly enhances intestinal calcium absorption independently of active vitamin D [1,25(OH)(2)D-3] signaling, but the underlying mechanisms remain poorly characterized. To elucidate the phosphate-dependent regulation of calcium transport, we investigated part of the enteral environment that is involved in 1,25(OH)(2)D-3-independent calcium absorption, which responds to dietary phosphate levels in mice that lack intestinal vitamin D receptor (Vdr) activity. Impaired calcium absorption in intestinal Vdr-null mice was improved by dietary phosphate restriction. Accordingly, calcium transport in cultured intestinal epithelial cells was increased when the apical side was exposed to low phosphate levels (0.5 mM) compared with normal or high phosphate levels (1.0 or 5.0 mM, respectively). Mechanistically, low phosphate increased ATP in the apical side medium and allowed calcium entry into epithelial cells via the P2X7 purinoreceptor, which results in increased calcium transport. We found that luminal ATP was regulated by the release and degradation of ATP at the epithelium, and phosphate restriction increased ATP release from epithelial cells via connexin-43 hemichannels. Furthermore, ATP degradation by ectonucleotide pyrophosphatase-1 was reduced, which was caused by the reduction of the MAPK cascade. These findings indicate that luminal ATP metabolism regulates transcellular calcium transport in the intestine by an 1,25(OH)(2)D-3-independent mechanism in response to dietary phosphate levels.	[Uekawa, Atsushi; Ito, Kosei; Masuyama, Ritsuko] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Bone Biol, 1-7-1 Sakamoto, Nagasaki 8528588, Japan; [Yamanaka, Hitoki] Nagasaki Univ, Ctr Frontier Life Sci, Nagasaki, Japan; [Lieben, Liesbet; Carmeliet, Geert] Katholieke Univ Leuven, Clin & Expt Endocrinol, Leuven, Belgium; [Kimira, Yoshifumi; Uehara, Mariko] Tokyo Univ Agr, Dept Nutr Sci, Tokyo, Japan; [Yamamoto, Yoko] Univ Tokyo, Surg Oncol & Vasc Surg, Tokyo, Japan; [Kato, Shigeaki] Tokiwa Fdn, Res Inst Innovat Med, Iwaki, Fukushima, Japan	Nagasaki University; Nagasaki University; KU Leuven; Tokyo University of Agriculture; University of Tokyo	Masuyama, R (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Bone Biol, 1-7-1 Sakamoto, Nagasaki 8528588, Japan.	ritsuko@nagasaki-u.ac.jp			Takeda Science Foundation; Japan Society for the Promotion of Science [26462816, 17H01967]	Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The authors thank Dr. Haruka Kohara (Graduate School of Biochemical Sciences, Nagasaki University, Nagasaki, Japan) for technical assistance. This work was supported by the Japan Society for the Promotion of Science (Grants 26462816 and 17H01967; to R.M.), and by research grants from the Takeda Science Foundation (to R.M.). The authors declare no conflicts of interest.	Addison WN, 2007, J BIOL CHEM, V282, P15872, DOI 10.1074/jbc.M701116200; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Alvarez A, 2016, BBA-MOL CELL RES, V1863, P2175, DOI 10.1016/j.bbamcr.2016.05.018; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Beck GR, 2003, J BIOL CHEM, V278, P41921, DOI 10.1074/jbc.M304470200; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Buzzi N, 2009, BBA-GEN SUBJECTS, V1790, P1651, DOI 10.1016/j.bbagen.2009.10.005; Calvo MS, 2013, SEMIN DIALYSIS, V26, P54, DOI 10.1111/sdi.12042; Coco S, 2003, J BIOL CHEM, V278, P1354, DOI 10.1074/jbc.M209454200; Dong X, 2009, AM J PHYSIOL-GASTR L, V296, pG424, DOI 10.1152/ajpgi.90314.2008; Farahbakhsh NA, 2003, INVEST OPHTH VIS SCI, V44, P3952, DOI 10.1167/iovs.02-1213; Garre JM, 2010, P NATL ACAD SCI USA, V107, P22659, DOI 10.1073/pnas.1013793107; Goding JW, 2003, BBA-MOL BASIS DIS, V1638, P1, DOI 10.1016/S0925-4439(03)00058-9; Ito K, 2008, CANCER CELL, V14, P226, DOI 10.1016/j.ccr.2008.08.004; Jones S, 2014, MOL PHARMACOL, V86, P243, DOI 10.1124/mol.114.092528; Kang J, 2008, J NEUROSCI, V28, P4702, DOI 10.1523/JNEUROSCI.5048-07.2008; Karpuk N, 2011, J NEUROSCI, V31, P414, DOI 10.1523/JNEUROSCI.5247-10.2011; Kemi VE, 2008, BRIT J NUTR, V99, P832, DOI 10.1017/S0007114507831783; Kimata M, 2010, BONE, V47, P938, DOI 10.1016/j.bone.2010.08.006; Kornak U, 2011, JOINT BONE SPINE, V78, P561, DOI 10.1016/j.jbspin.2011.03.020; Koshihara M, 2004, BIOFACTORS, V22, P39, DOI 10.1002/biof.5520220107; Kusu T, 2013, J IMMUNOL, V190, P774, DOI 10.4049/jimmunol.1103067; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; Li YC, 1998, ENDOCRINOLOGY, V139, P4391, DOI 10.1210/en.139.10.4391; Lieben L, 2015, BONE, V81, P502, DOI 10.1016/j.bone.2015.08.023; Lieben L, 2012, J CLIN INVEST, V122, P1803, DOI 10.1172/JCI45890; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Masuyama R, 2001, ENDOCRINOLOGY, V142, P494, DOI 10.1210/en.142.1.494; Masuyama R, 2003, J BONE MINER RES, V18, P1217, DOI 10.1359/jbmr.2003.18.7.1217; Masuyama R, 2008, CELL METAB, V8, P257, DOI 10.1016/j.cmet.2008.08.002; Masuyama R, 2006, J CLIN INVEST, V116, P3150, DOI 10.1172/JCI29463; Masuyama R, 2012, J BONE MINER RES, V27, P1708, DOI 10.1002/jbmr.1629; McGaraughty S, 2007, NEUROSCIENCE, V146, P1817, DOI 10.1016/j.neuroscience.2007.03.035; Meyer MB, 2006, MOL ENDOCRINOL, V20, P1447, DOI 10.1210/me.2006-0031; Minns MS, 2016, AM J PATHOL, V186, P285, DOI 10.1016/j.ajpath.2015.10.006; Naishiro Y, 2005, ONCOGENE, V24, P3141, DOI 10.1038/sj.onc.1208517; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Ritz E, 2012, DTSCH ARZTEBL INT, V109, P49, DOI 10.3238/arztebl.2012.0049; Saab JB, 2014, FEBS LETT, V588, P1288, DOI 10.1016/j.febslet.2014.02.059; Sahu G, 2014, SCI REP-UK, V4, DOI 10.1038/srep04955; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Suzuki T, 2004, J NUTR, V134, P1935, DOI 10.1093/jn/134.8.1935; Takai E, 2012, J CELL SCI, V125, P5051, DOI 10.1242/jcs.104976; Uribarri J, 2013, ADV NUTR, V4, P542, DOI 10.3945/an.113.004234; Van Cromphaut SJ, 2001, P NATL ACAD SCI USA, V98, P13324, DOI 10.1073/pnas.231474698; Xue YB, 2009, GASTROENTEROLOGY, V136, P1317, DOI 10.1053/j.gastro.2008.12.051; Yamamoto Y, 2013, ENDOCRINOLOGY, V154, P1008, DOI 10.1210/en.2012-1542; Yamazaki M, 2010, J CELL BIOCHEM, V111, P1210, DOI 10.1002/jcb.22842; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391; Zsembery A, 2003, J BIOL CHEM, V278, P13398, DOI 10.1074/jbc.M212277200	50	6	7	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1903	1915		10.1096/fj.201700631R	http://dx.doi.org/10.1096/fj.201700631R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29282249				2022-12-28	WOS:000429051400014
J	Zhang, Y; Cui, P; Li, YH; Feng, GH; Tong, M; Guo, L; Li, TD; Liu, L; Li, W; Zhou, Q				Zhang, Ying; Cui, Peng; Li, Yuhuan; Feng, Guihai; Tong, Man; Guo, Lu; Li, Tianda; Liu, Lei; Li, Wei; Zhou, Qi			Mitochondrially produced ATP affects stem cell pluripotency via ActI6a-mediated histone acetylation	FASEB JOURNAL			English	Article						mitochondria; oxidative phosphorylation; developmental ability; epigenetics; regenerative medicine	CHROMATIN REMODELING COMPLEX; GLYCOLYTIC METABOLISM; NEURAL DEVELOPMENT; SELF-RENEWAL; IPS CELLS; DIFFERENTIATION; SUBUNIT; ACTIVATION; ENZYMES; SWITCH	ATP is mainly generated by glycolysis in pluripotent stem cells (PSCs) and is consumed to maintain cell viability. Differences in mitochondrial activity among induced (i) PSCs with different degrees of pluripotency are poorly understood. In this study, by comparing gene expression and mitochondrial activity among iPSCs with different degrees of pluripotency, we found that mitochondrial complex I gene expression, complex I activity, and cellular ATP levels were much higher in fully pluripotent stem cell lines than in partially pluripotent stem cell lines. Actin-like protein 6a (Actl6a), a component of ATP-dependent chromatin remodeling and histone acetylation complexes, was more highly expressed in fully pluripotent stem cell lines. ATP promoted Actl6a expression and histone acetylation. Actl6a knockdown reduced the pluripotency of embryonic stem cells (ESCs), and this reduction could not be rescued by the addition of ATP. Furthermore, inhibiting ATP formation by treatment with rotenone reduced the pluripotency of ESCs. These data suggest that the abundance of mitochondrially produced ATP affects stem cell pluripotency via Actl6a-mediated histone acetylation.	[Zhang, Ying; Cui, Peng; Li, Yuhuan; Feng, Guihai; Guo, Lu; Li, Tianda; Liu, Lei; Li, Wei; Zhou, Qi] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing, Peoples R China; [Tong, Man] Chinese Acad Sci, Inst Genet & Dev Biol, Collaborat Ctr Genet & Dev, Key Lab Genet Network Biol, Beijing, Peoples R China; [Cui, Peng; Li, Yuhuan] Univ Chinese Acad Sci, Savaid Med Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhou, Q (corresponding author), Chinese Acad Sci, Inst Zool, 1 Beichen West Rd, Beijing 100101, Peoples R China.	zhouqi@ioz.ac.cn	Feng, Guihai/A-5105-2019	Feng, Guihai/0000-0002-8726-1734	National Basic Research Program of China [2014CB964903]; National Natural Science Foundation of China [31621004, 31471395]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grants 31621004 and 31471395 to Q.Z.), and the National Basic Research Program of China (Grant 2014CB964903). The authors declare no conflicts of interest.	Bao XM, 2013, CELL STEM CELL, V12, P193, DOI 10.1016/j.stem.2012.12.014; BUTTGEREIT F, 1995, BIOCHEM J, V312, P163, DOI 10.1042/bj3120163; Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; Chung S, 2010, J MOL CELL CARDIOL, V48, P725, DOI 10.1016/j.yjmcc.2009.12.014; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; Facucho-Oliveira JM, 2007, J CELL SCI, V120, P4025, DOI 10.1242/jcs.016972; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Gu W, 2016, CELL STEM CELL, V19, P476, DOI 10.1016/j.stem.2016.08.008; HEINEMAN FW, 1990, ANNU REV PHYSIOL, V52, P523; Hezroni H, 2011, NUCLEUS-PHILA, V2, P300, DOI 10.4161/nucl.2.4.16767; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Kaeser MD, 2008, J BIOL CHEM, V283, P32254, DOI 10.1074/jbc.M806061200; Keenen B, 2009, J CELL PHYSIOL, V219, P1, DOI 10.1002/jcp.21654; Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467; Krasteva V, 2012, BLOOD, V120, P4720, DOI 10.1182/blood-2012-04-427047; Landry J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000241; Lee JH, 2004, GENESIS, V38, P32, DOI 10.1002/gene.10250; Lee JH, 2003, MOL CELLS, V16, P78; Lee K, 2007, MOL BIOL CELL, V18, P4013, DOI 10.1091/mbc.E07-05-0437; Lee K, 2011, BIOCHEM BIOPH RES CO, V412, P328, DOI 10.1016/j.bbrc.2011.07.098; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Lessard JA, 2010, ANNU REV CELL DEV BI, V26, P503, DOI 10.1146/annurev-cellbio-051809-102012; Li XZ, 2012, CELL STEM CELL, V11, P163, DOI 10.1016/j.stem.2012.04.023; Lu WS, 2015, STEM CELLS, V33, P1782, DOI 10.1002/stem.2000; Mandal S, 2011, STEM CELLS, V29, P486, DOI 10.1002/stem.590; Mattout A, 2011, J MOL CELL BIOL, V3, P341, DOI 10.1093/jmcb/mjr028; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Mu XP, 2015, CELL REPROGRAM, V17, P259, DOI 10.1089/cell.2014.0102; Novershtern N, 2011, NAT CELL BIOL, V13, P886, DOI 10.1038/ncb2311; Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404; Saladi SV, 2010, STEM CELL REV REP, V6, P62, DOI 10.1007/s12015-010-9120-y; Sawan C, 2013, STEM CELLS, V31, P979, DOI 10.1002/stem.1341; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Tea JS, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-5; WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Zhang J, 2016, CELL STEM CELL, V19, P66, DOI 10.1016/j.stem.2016.05.009; Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401; Zhang Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150454; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zhou WY, 2012, EMBO J, V31, P2103, DOI 10.1038/emboj.2012.71	43	16	16	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1891	1902		10.1096/fj.201700626RR	http://dx.doi.org/10.1096/fj.201700626RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29222327				2022-12-28	WOS:000429051400013
J	Jung, Y; Park, J; Kim, HL; Sim, JE; Youn, DH; Kang, J; Lim, S; Jeong, MY; Yang, WM; Lee, SG; Ahn, KS; Um, JY				Jung, Yunu; Park, Jinbong; Kim, Hye-Lin; Sim, Jung-Eun; Youn, Dong-Hyun; Kang, JongWook; Lim, Seona; Jeong, Mi-Young; Yang, Woong Mo; Lee, Seok-Geun; Ahn, Kwang Seok; Um, Jae-Young			Vanillic acid attenuates obesity via activation of the AMPK pathway and thermogenic factors in vivo and in vitro	FASEB JOURNAL			English	Article						brown adipose tissue; adipogenesis; thermogenesis; lipogenesis; mitochondria	BROWN ADIPOSE-TISSUE; NF-KAPPA-B; PROTEIN-KINASE; ENERGY-EXPENDITURE; HEPATIC STEATOSIS; UPSTREAM KINASE; GLUCOSE-UPTAKE; UNITED-STATES; 3T3-L1 CELLS; PLATYCODIN D	Energy expenditure is a target gaining recent interest for obesity treatment. The antiobesity effect of vanillic acid (VA), a well-known flavoring agent, was investigated in vivo and in vitro. High-fat diet (HFD)-induced obese mice and genetically obese db/db mice showed significantly decreased body weights after VA administration. Two major adipogenic markers, peroxisome proliferator activated receptor gamma (PPAR gamma) and CCAAT/enhancer-binding protein alpha (C/EBP alpha), were reduced while the key factor of energy metabolism, AMPK alpha, was increased in the white adipose tissue and liver tissue of VA-treated mice. Furthermore, VA inhibited lipid accumulation and reduced hepatotoxic/inflammatory markers in liver tissues of mice and HepG2 hepatocytes. VA treatment also decreased differentiation of 3T3-L1 adipocytes by regulating adipogenic factors including PPAR gamma and C/EBP alpha. AMPK alpha small interfering RNA was used to examine whether AMPK was associated with the actions of VA. In AMPK alpha-nulled 3T3-L1 cells, the inhibitory action of VA on PPAR gamma and C/EBP alpha was attenuated. Furthermore, in brown adipose tissues of mice and primary cultured brown adipocytes, VA increased mitochondria- and thermogenesis-related factors such as uncoupling protein 1 and PPAR gamma-coactivator 1-alpha. Taken together, our results suggest that VA has potential as an AMPK alpha- and thermogenesis-activating antiobesity agent.	[Jung, Yunu; Park, Jinbong; Kim, Hye-Lin; Youn, Dong-Hyun; Kang, JongWook; Jeong, Mi-Young; Yang, Woong Mo; Lee, Seok-Geun; Ahn, Kwang Seok; Um, Jae-Young] Kyung Hee Univ, Coll Korean Med, Seoul, South Korea; [Jung, Yunu; Park, Jinbong; Kim, Hye-Lin; Youn, Dong-Hyun; Kang, JongWook; Jeong, Mi-Young; Yang, Woong Mo; Lee, Seok-Geun; Ahn, Kwang Seok; Um, Jae-Young] Kyung Hee Univ, Basic Res Lab Comorbid Regulat, Seoul, South Korea; [Jung, Yunu; Youn, Dong-Hyun; Kang, JongWook; Lim, Seona] Kyung Hee Univ, Dept Sci Korean Med, Seoul, South Korea; [Sim, Jung-Eun] Kyung Hee Univ, Grad Sch, Dept Biol Sci Korean Med, Seoul, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University; Kyung Hee University	Um, JY (corresponding author), Kyung Hee Univ, Dept Pharmacol, Coll Korean Med, 26 Kyungheedae Ro, Seoul 02447, South Korea.	jyum@khu.ac.kr	Yang, Woong Mo/AAH-9185-2020; jung, yunu/HGC-7295-2022; Lee, Seok-Geun/B-3408-2011; Park, Jinbong/AAU-5204-2020	Lee, Seok-Geun/0000-0002-0060-5777; Park, Jinbong/0000-0002-5984-5855; Yang, Woong Mo/0000-0001-5308-2386	National Research Foundation of Korea (NRF) grant - Korean government (MSIP) [NRF-2015R1A4A1042399]	National Research Foundation of Korea (NRF) grant - Korean government (MSIP)	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP; NRF-2015R1A4A1042399). The authors declare no conflicts of interest.	Aljada A, 2001, J CLIN ENDOCR METAB, V86, P3250, DOI 10.1210/jc.86.7.3250; Andreelli F, 2006, ENDOCRINOLOGY, V147, P2432, DOI 10.1210/en.2005-0898; Assifi MM, 2005, AM J PHYSIOL-ENDOC M, V289, pE794, DOI 10.1152/ajpendo.00144.2005; Baumruk F, 1999, FEBS LETT, V444, P206, DOI 10.1016/S0014-5793(99)00053-8; Brix J, 1997, J BIOL CHEM, V272, P20730, DOI 10.1074/jbc.272.33.20730; Brondani LD, 2012, ARQ BRAS ENDOCRINOL, V56, P215, DOI 10.1590/S0004-27302012000400001; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Calixto-Campos C, 2015, J NAT PROD, V78, P1799, DOI 10.1021/acs.jnatprod.5b00246; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chakrabarti P, 2010, ENDOCRINOLOGY, V151, P2408, DOI 10.1210/en.2010-0316; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Crowley VEE, 2002, NAT REV DRUG DISCOV, V1, P276, DOI 10.1038/nrd770; Djouder N, 2010, EMBO J, V29, P469, DOI 10.1038/emboj.2009.339; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Feldstein AE, 2010, SEMIN LIVER DIS, V30, P391, DOI 10.1055/s-0030-1267539; Fenzl A, 2014, HORM MOL BIOL CLIN I, V19, P25, DOI 10.1515/hmbci-2014-0022; Foretz M, 1998, J BIOL CHEM, V273, P14767, DOI 10.1074/jbc.273.24.14767; GALVEZ MC, 1994, Z LEBENSM UNTERS FOR, V199, P29, DOI 10.1007/BF01192948; Gomez-Lechon MJ, 2007, CHEM-BIOL INTERACT, V165, P106, DOI 10.1016/j.cbi.2006.11.004; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Grishko V, 2005, FREE RADICAL BIO MED, V38, P755, DOI 10.1016/j.freeradbiomed.2004.11.023; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hsu CL, 2007, J AGR FOOD CHEM, V55, P8404, DOI 10.1021/jf071695r; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Hwang JT, 2005, BIOCHEM BIOPH RES CO, V338, P694, DOI 10.1016/j.bbrc.2005.09.195; Itoh A, 2009, BIOL PHARM BULL, V32, P1215, DOI 10.1248/bpb.32.1215; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jeong MY, 2015, INT J OBESITY, V39, P456, DOI 10.1038/ijo.2014.155; Kim HL, 2015, J AGR FOOD CHEM, V63, P7721, DOI 10.1021/acs.jafc.5b01908; Kim HL, 2014, FOOD FUNCT, V5, P2961, DOI 10.1039/c4fo00470a; Kim HL, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/423741; Kim SJ, 2010, MOLECULES, V15, P7208, DOI 10.3390/molecules15107208; Klein J, 1999, J BIOL CHEM, V274, P34795, DOI 10.1074/jbc.274.49.34795; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Lee H, 2011, LIFE SCI, V89, P388, DOI 10.1016/j.lfs.2011.07.006; Lee H, 2010, PHYTOTHER RES, V24, pS161, DOI 10.1002/ptr.3054; Lee JN, 2017, MOL CELL TOXICOL, V13, P125, DOI 10.1007/s13273-017-0013-x; Leesnitzer LM, 2002, BIOCHEMISTRY-US, V41, P6640, DOI 10.1021/bi0159581; Lemieux I, 2001, ARTERIOSCL THROM VAS, V21, P961, DOI 10.1161/01.ATV.21.6.961; LIN FT, 1994, P NATL ACAD SCI USA, V91, P8757, DOI 10.1073/pnas.91.19.8757; Lopez-Velazquez JA, 2012, J LIPIDS, V2012, DOI 10.1155/2012/139875; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; Martin-Sanz P, 2010, WORLD J GASTROENTERO, V16, P1430, DOI 10.3748/wjg.v16.i12.1430; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Palou A, 1998, INT J BIOCHEM CELL B, V30, P7, DOI 10.1016/S1357-2725(97)00065-4; Park J, 2017, MOL CELL TOXICOL, V13, P1, DOI 10.1007/s13273-017-0001-1; Paton CM, 2009, AM J PHYSIOL-ENDOC M, V297, pE28, DOI 10.1152/ajpendo.90897.2008; Polvani S, 2016, WORLD J GASTROENTERO, V22, P2441, DOI 10.3748/wjg.v22.i8.2441; Riek U, 2008, J BIOL CHEM, V283, P18331, DOI 10.1074/jbc.M708379200; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Sindhu G, 2015, ENVIRON TOXICOL PHAR, V39, P392, DOI 10.1016/j.etap.2014.12.008; Sinha AK, 2008, INT J FOOD SCI NUTR, V59, P299, DOI 10.1080/09687630701539350; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Tateya Sanshiro, 2013, Front Endocrinol (Lausanne), V4, P93, DOI 10.3389/fendo.2013.00093; Tessari P, 2009, NUTR METAB CARDIOVAS, V19, P291, DOI 10.1016/j.numecd.2008.12.015; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Wright SK, 2017, MOL CARCINOGEN, V56, P149, DOI 10.1002/mc.22479; Xing YF, 2010, BIOCHEM BIOPH RES CO, V396, P691, DOI 10.1016/j.bbrc.2010.04.163; Yao HR, 2011, AM J TRANSL RES, V3, P284; Youn DH, 2017, ONCOTARGET, V8, P9500, DOI 10.18632/oncotarget.13430; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhang CF, 2016, MOL CELL TOXICOL, V12, P45, DOI 10.1007/s13273-016-0007-0; Zhang ZG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6493; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	73	42	44	1	29	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1388	1402		10.1096/fj.201700231RR	http://dx.doi.org/10.1096/fj.201700231RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29141998				2022-12-28	WOS:000427246000022
J	Du, XY; Zhou, Y; Song, LL; Wang, X; Zhang, SC				Du, Xiaoyuan; Zhou, Yang; Song, Lili; Wang, Xia; Zhang, Shicui			Zinc finger protein 365 is a new maternal LPS-binding protein that defends zebrafish embryos against gram-negative bacterial infections	FASEB JOURNAL			English	Article						embryonic immunity; transcriptional factor; antibacterial activity	GENOME-WIDE ASSOCIATION; NF-KAPPA-B; SUSCEPTIBILITY LOCI; ATOPIC-DERMATITIS; RECOGNITION; IMMUNITY; RECEPTOR; POPULATION; EFFECTOR; RNA	Zinc finger protein 365 (ZNF365) is widespread in animals, but its function and mechanism remains poorly defined. Here we clearly demonstrate that zebrafish ZNF365 is a newly identified LPS-binding protein capable of interacting with the gram-negative bacteria Escherichia coli, Vibrio anguillarum, and Aeromonas hydrophila, and functions as an antibacterial effector molecule capable of directly killing the bacteria. We also reveal that N-terminal residues 30-55 consisting of the ZnF_C2H2 domain are indispensable for ZNF365 antimicrobial activity. Importantly, microinjection of recombinant ZNF365 into early embryos significantly enhanced the resistance of the embryos against pathogenic A. hydrophila challenge, whereas down-regulation of ZNF365 by injection of znf365 morpholino into embryos considerably lowered their resistance against A. hydrophila challenge. Furthermore, the N-terminal peptide Z(30-55) with in vitro antibacterial activity also promoted the resistance of embryos against A. hydrophila, but the peptide Z(56-345) without in vitro antibacterial activity did not. Collectively, these results indicate that ZNF365 is a maternal LPS-binding protein that can protect the early embryos of zebrafish against pathogenic attacks, a novel role to be assigned to ZNF365 proteins. This work also provides new insights into the immunologic function of the zinc finger proteins that are widely distributed in various animals.	[Du, Xiaoyuan; Zhou, Yang; Song, Lili; Wang, Xia; Zhang, Shicui] Ocean Univ China, Inst Evolut & Marine Biodivers, Dept Marine Biol, Qingdao, Peoples R China; [Du, Xiaoyuan; Zhou, Yang; Song, Lili; Wang, Xia; Zhang, Shicui] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China	Ocean University of China; Qingdao National Laboratory for Marine Science & Technology	Wang, X (corresponding author), Ocean Univ China, Dept Marine Biol, 5 Yushan Rd, Qingdao 266003, Peoples R China.; Zhang, SC (corresponding author), Ocean Univ China, Dept Marine Biol Evolut & Marine Biodivers, 5 Yushan Rd, Qingdao 266003, Peoples R China.	wx_fajiao163@163.com; sczhang@ouc.edu.cn			National Natural Science Foundation of China [31372505, U1401211]; Fundamental Research Funds for Central Universities [201762003]; Laboratory for Marine Biology and Biotechnology, Qingdao National Laboratory for Marine Science and Technology, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities); Laboratory for Marine Biology and Biotechnology, Qingdao National Laboratory for Marine Science and Technology, China	The authors thank M. Zhu (Institute of Evolution & Marine Biodiversity, Ocean University of China) for technical aid in flow cytometry and D. Feng (Institute of Evolution & Marine Biodiversity, Ocean University of China) for help with immunohistochemistry. This work was supported by the National Natural Science Foundation of China (31372505 and U1401211), by the Fundamental Research Funds for Central Universities (201762003), and by the Laboratory for Marine Biology and Biotechnology, Qingdao National Laboratory for Marine Science and Technology, China. The authors declare no conflicts of interest.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Brown RS, 2005, CURR OPIN STRUC BIOL, V15, P94, DOI 10.1016/j.sbi.2005.01.006; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Gao Z, 2014, EUR J IMMUNOL, V44, P3680, DOI 10.1002/eji.201444734; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; Hirota T, 2012, NAT GENET, V44, P1222, DOI 10.1038/ng.2438; KLUG A, 1987, COLD SPRING HARB SYM, V52, P473, DOI 10.1101/SQB.1987.052.01.054; Klug A, 1999, J MOL BIOL, V293, P215, DOI 10.1006/jmbi.1999.3007; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lee H, 2015, BBA-BIOMEMBRANES, V1848, P634, DOI 10.1016/j.bbamem.2014.11.016; Li ZJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001940; Liang YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004234; Liu B, 2013, J SURG RES, V185, P717, DOI 10.1016/j.jss.2013.06.031; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; Nagase T, 1998, DNA Res, V5, P277, DOI 10.1093/dnares/5.5.277; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; Pino-Yanes M, 2015, J ALLERGY CLIN IMMUN, V135, P1502, DOI 10.1016/j.jaci.2014.10.033; Sharif-Askari E, 2010, MOL CELL BIOL, V30, P3929, DOI 10.1128/MCB.00087-10; Sun LD, 2011, NAT GENET, V43, P690, DOI 10.1038/ng.851; Sun RL, 2011, GENET MOL RES, V10, P3712, DOI 10.4238/2011.December.8.6; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011; Wang CM, 2013, J BIOL CHEM, V288, P24600, DOI 10.1074/jbc.M113.473397; Wang SH, 2011, J BIOL CHEM, V286, P22653, DOI 10.1074/jbc.M111.247635; Wang X, 2016, J BIOL CHEM, V291, P4019, DOI 10.1074/jbc.M115.679167; Wang ZP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004498; Zhang HJ, 2016, PLANT CELL PHYSIOL, V57, P2472, DOI 10.1093/pcp/pcw160; Zhang YC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044465, 10.1155/2012/583417]; Zhang YQ, 2013, CELL CYCLE, V12, P2817, DOI 10.4161/cc.25882	32	7	7	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					979	994		10.1096/fj.201700694R	http://dx.doi.org/10.1096/fj.201700694R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29042450	Bronze			2022-12-28	WOS:000425146900038
J	Ma, LQ; Hu, JB; Li, JY; Yang, Y; Zhang, LK; Zou, LY; Gao, RF; Peng, C; Wang, Y; Luo, T; Xiang, XJ; Qing, H; Xiao, XQ; Wu, CD; Wang, ZH; He, JC; Li, QF; Yang, SM				Ma, Linqiang; Hu, Jinbo; Li, Jiayu; Yang, Yi; Zhang, Linkun; Zou, Lingyun; Gao, Rufei; Peng, Chuan; Wang, Yue; Luo, Ting; Xiang, Xiaojiao; Qing, Hua; Xiao, Xiaoqiu; Wu, Chaodong; Wang, Zhihong; He, John Cijiang; Li, Qifu; Yang, Shumin			Bisphenol A promotes hyperuricemia via activating xanthine oxidase	FASEB JOURNAL			English	Article						uric acid; synthesis; direct binding; enzyme; liver	URIC-ACID; OXIDATIVE STRESS; GENE-EXPRESSION; ESTROGEN; MECHANISM; EXPOSURE; DOCKING; DISEASE; HEALTH; SERUM	The prevalence of hyperuricemia has increased rapidly over the past decades. Bisphenol A (BPA) is an environmental endocrine disruptor. We investigated the effects of BPA on uric acid metabolism and its potential mechanisms. Experiments were performed in different animal models, cell cultures, and humans. In 3 different animal models, BPA exposure increased serum and hepatic uric acid with enhanced activity of xanthine oxidase (XO) in liver, whereas the excretion of uric acid was unchanged. Both in vivo and in vitro, BPA-induced uric acid production was decreased after treatment with allopurinol, which is a XO inhibitor. XO led to the accumulation of uric acid after xanthine was added, with the enzyme-catalyzed reaction, which was enhanced by BPA. Altered secondary structures of XO were found by circular dichroism analysis in the conditions of different BPA concentrations. Molecular docking portrayed Asp360 and Lys422 of XO to be the preferred binding sites for BPA. Mutation of both sites significantly blocked the effect of BPA on XO activity. In humans, patients with hyperuricemia exhibited higher levels of serum BPA than subjects without hyperuricemia. These findings demonstrate BPA promotes hyperuricemia by increasing hepatic uric acid synthesis via the activation of XO, probably through direct binding.	[Ma, Linqiang; Hu, Jinbo; Yang, Yi; Zhang, Linkun; Gao, Rufei; Wang, Yue; Luo, Ting; Xiang, Xiaojiao; Qing, Hua; Xiao, Xiaoqiu; Wang, Zhihong; Li, Qifu; Yang, Shumin] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrinol, 1 Youyi St, Chongqing 400016, Peoples R China; [Li, Jiayu; Peng, Chuan; Xiao, Xiaoqiu] Chongqing Med Univ, Affiliated Hosp 1, Lab Lipid & Glucose Metab, Chongqing, Peoples R China; [Zhang, Linkun] Third Mil Med Univ, Bioinformat Ctr, Dept Microbiol, Chongqing, Peoples R China; [Wu, Chaodong] Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX USA; [Wang, Zhihong; He, John Cijiang] Icahn Sch Med Mt Sinai, Dept Med, Div Nephrol, New York, NY 10029 USA; [Wang, Zhihong] Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA	Chongqing Medical University; Chongqing Medical University; Army Medical University; Texas A&M University System; Texas A&M University College Station; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Li, QF; Yang, SM (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrinol, 1 Youyi St, Chongqing 400016, Peoples R China.	liqifu@yeah.net; 443068494@qq.com	Xiao, Xiaoqiu/AAA-3869-2022; Xiao, Xiaoqiu/K-7672-2019; Hu, Jinbo/AAB-7109-2021	Xiao, Xiaoqiu/0000-0002-4568-8772; Hu, Jinbo/0000-0003-2925-0583	National Key Clinical Specialties Construction Program of China; National Natural Science Foundation of China [81370954, 81670785]; Fundamental Science and Advanced Technology Research of Chongqing Major Project [cstc2015jcyjBX0096]; Chongqing Science and Technology Committee Innovation Project, Technology Development and Application of Precision Medicine [cstc2016shms-ztzx1003]	National Key Clinical Specialties Construction Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Science and Advanced Technology Research of Chongqing Major Project; Chongqing Science and Technology Committee Innovation Project, Technology Development and Application of Precision Medicine	The authors thank the Endocrinology Laboratory and the Laboratory of Lipid and Glucose Metabolism, First Affiliated Hospital of Chongqing Medical University. Support was provided by the National Key Clinical Specialties Construction Program of China to the Department of Endocrinology, the First Affiliated Hospital of Chongqing Medical University; National Natural Science Foundation of China Grants 81370954, 81670785 (to Q.L.); Fundamental Science and Advanced Technology Research of Chongqing Major Project, cstc2015jcyjBX0096 (to Q.L.); Chongqing Science and Technology Committee Innovation Project, Technology Development and Application of Precision Medicine, cstc2016shms-ztzx1003 (to Q.L.) L. Ma and J. Hu are co-first authors. The authors declare no conflicts of interest.	Alonso-Magdalena P, 2012, MOL CELL ENDOCRINOL, V355, P201, DOI 10.1016/j.mce.2011.12.012; Amaral GP, 2012, TOXICOL IN VITRO, V26, P125, DOI 10.1016/j.tiv.2011.10.006; Arden C, 2011, DIABETES, V60, P3110, DOI 10.2337/db11-0061; Attia AM, 2011, INDIAN J BIOCHEM BIO, V48, P184; Bae S, 2015, HYPERTENSION, V65, P313, DOI 10.1161/HYPERTENSIONAHA.114.04261; Bellanti F, 2013, REDOX BIOL, V1, P340, DOI 10.1016/j.redox.2013.05.003; Budhiraja R, 2003, ANTIOXID REDOX SIGN, V5, P705, DOI 10.1089/152308603770380007; Cao HN, 2010, J BIOL CHEM, V285, P28044, DOI 10.1074/jbc.M110.128561; Duda M, 2007, J MOL CELL CARDIOL, V42, P400, DOI 10.1016/j.yjmcc.2006.10.014; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Gassman NR, 2016, ENVIRON HEALTH PERSP, V124, P1241, DOI 10.1289/EHP237; Hadizadeh M, 2009, ACTA BIOCH BIOPH SIN, V41, P603, DOI 10.1093/abbs/gmp048; Hassan ZK, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/194829; Hu JB, 2016, J HYPERTENS, V34, P332, DOI 10.1097/HJH.0000000000000780; Hu JB, 2015, ACTA DIABETOL, V52, P1135, DOI 10.1007/s00592-015-0801-5; Kataria A, 2015, NAT REV NEPHROL, V11, P610, DOI 10.1038/nrneph.2015.94; Kaur K, 2014, FREE RADICAL BIO MED, V76, P25, DOI 10.1016/j.freeradbiomed.2014.07.030; Kuo CC, 2015, ENVIRON INT, V76, P32, DOI 10.1016/j.envint.2014.11.015; Lee CI, 2000, J BIOL CHEM, V275, P9369, DOI 10.1074/jbc.275.13.9369; Lee YM, 2013, ATHEROSCLEROSIS, V230, P1, DOI 10.1016/j.atherosclerosis.2013.06.012; Liang Q, 2014, ENVIRON HEALTH PERSP, V122, P601, DOI 10.1289/ehp.1307491; Liu R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/762820; Liu X, 2007, FEBS J, V274, P6340, DOI 10.1111/j.1742-4658.2007.06152.x; Macczak A, 2017, TOXICOL IN VITRO, V41, P143, DOI 10.1016/j.tiv.2017.02.018; Mandal AK, 2015, ANNU REV PHYSIOL, V77, P323, DOI 10.1146/annurev-physiol-021113-170343; Marmugi A, 2012, HEPATOLOGY, V55, P395, DOI 10.1002/hep.24685; Melzer D, 2012, CIRCULATION, V125, P1482, DOI 10.1161/CIRCULATIONAHA.111.069153; Ning G, 2011, ANN INTERN MED, V155, P368, DOI 10.7326/0003-4819-155-6-201109200-00005; Nipic D, 2010, HEPATOLOGY, V51, P2140, DOI 10.1002/hep.23598; Ohtsubo T, 2004, CIRC RES, V95, P1118, DOI 10.1161/01.RES.0000149571.96304.36; Olea-Herrero N, 2014, J CELL PHYSIOL, V229, P2057, DOI 10.1002/jcp.24665; Petrie JL, 2013, AM J PHYSIOL-ENDOC M, V305, pE1255, DOI 10.1152/ajpendo.00214.2013; RIESELBACH RE, 1974, AM J MED, V56, P665, DOI 10.1016/0002-9343(74)90633-0; Sakuma S, 2010, FOOD CHEM TOXICOL, V48, P2217, DOI 10.1016/j.fct.2010.05.051; Shankar A, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/481641; Strasak A, 2008, CLIN CHEM, V54, P273, DOI 10.1373/clinchem.2007.094425; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Xu CF, 2015, J HEPATOL, V62, P1412, DOI 10.1016/j.jhep.2015.01.019; Yan JK, 2013, FOOD CHEM, V141, P3766, DOI 10.1016/j.foodchem.2013.06.092; Zhu YY, 2011, ARTHRITIS RHEUM-US, V63, P3136, DOI 10.1002/art.30520	40	19	20	7	41	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					1007	1016		10.1096/fj.201700755R	http://dx.doi.org/10.1096/fj.201700755R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29042453				2022-12-28	WOS:000425146900040
J	Vaur, P; Brugg, B; Mericskay, M; Li, ZL; Schmidt, MS; Vivien, D; Orset, C; Jacotot, E; Brenner, C; Duplus, E				Vaur, Pauline; Brugg, Bernard; Mericskay, Mathias; Li, Zhenlin; Schmidt, Mark S.; Vivien, Denis; Orset, Cyrille; Jacotot, Etienne; Brenner, Charles; Duplus, Eric			Nicotinamide riboside, a form of vitamin B-3, protects against excitotoxicity-induced axonal degeneration	FASEB JOURNAL			English	Article						NAD(+); NMDA; FK866; cortical neurons; NR	NAD(+) PRECURSOR; EXTRACELLULAR-PRECURSORS; ACTIVATION; MONONUCLEOTIDE; NEURONS; BIOSYNTHESIS; METABOLISM; ALZHEIMERS; EXPRESSION; PATHWAYS	NAD(+) depletion is a common phenomenon in neurodegenerative pathologies. Excitotoxicity occurs in multiple neurologic disorders and NAD(+) was shown to prevent neuronal degeneration in this process through mechanisms that remained to be determined. The activity of nicotinamide riboside (NR) in neuroprotective models and the recent description of extracellular conversion of NAD(+) to NR prompted us to probe the effects of NAD(+) and NR in protection against excitotoxicity. Here, we show that intracortical administration of NR but not NAD(+) reduces brain damage induced by NMDA injection. Using cortical neurons, we found that provision of extracellular NR delays NMDA-induced axonal degeneration (AxD) much more strongly than extracellular NAD(+). Moreover, the stronger effect of NR compared to NAD(+) depends of axonal stress since in AxD induced by pharmacological inhibition of nicotinamide salvage, both NAD(+) and NR prevent neuronal death and AxD in a manner that depends on internalization of NR. Taken together, our findings demonstrate that NR is a better neuroprotective agent than NAD(+) in excitotoxicity-induced AxD and that axonal protection involves defending intracellular NAD(+) homeostasis.	[Vaur, Pauline; Brugg, Bernard; Mericskay, Mathias; Li, Zhenlin; Jacotot, Etienne; Duplus, Eric] Univ Paris 06, CNRS, INSERM,Sorbonne Univ, UMR Adaptat Biol & Vieillissement,UMR 8256,Inst B, Paris, France; [Li, Zhenlin] Univ Paris Sud, Univ Paris Saclay, INSERM, ERL U1164, Chatenay Malabry, France; [Mericskay, Mathias] Univ Paris Sud, Univ Paris Saclay, INSERM, Unite Signalisat & Physiopathol Cardiovasc, Chatenay Malabry, France; [Schmidt, Mark S.; Brenner, Charles] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA; [Vivien, Denis; Orset, Cyrille] Univ Caen Normandie, CHU Caen, Unite INSERM 1237, GIP Cyceron, Caen, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Iowa; CHU de Caen NORMANDIE; Universite de Caen Normandie	Duplus, E (corresponding author), Univ Paris 06, CNRS, Lab Adaptat Biol & Vieillissement, UMR 8256,Neuronal Stress & Aging Team, Case Courrier 12,9 Quai St Bernard, F-75005 Paris, France.	eric.duplus@upmc.fr	orset, cyrille/A-3540-2010; Brenner, Charles/D-6339-2014; DUPLUS, Eric/F-2969-2013; MERICSKAY, Mathias/M-3477-2018	orset, cyrille/0000-0002-9139-3430; VIVIEN, DENIS/0000-0002-7636-2185; LI, Zhenlin/0000-0002-3706-4505; Brenner, Charles/0000-0002-4955-3226; Schmidt, Mark/0000-0003-4593-4096; DUPLUS, Eric/0000-0003-1954-4836; /0000-0002-5301-1569; MERICSKAY, Mathias/0000-0002-6779-092X	Ile-de-France Region DIM Cerveau et Pensee fellowship; Agence Nationale pour la Recherche (ANR) [2011-RPIB-008-001 2012-17]; Roy J. Carver Trust	Ile-de-France Region DIM Cerveau et Pensee fellowship; Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); Roy J. Carver Trust	The authors thank ChromaDex (Irvine, CA, USA) for kindly providing NR, and MicroBrain Biotech (Paris, France) for technical advice and microfluidic chips. Funding was provided by Ile-de-France Region DIM Cerveau et Pensee fellowship (to P.V.); by Agence Nationale pour la Recherche (ANR) Grant Neuroscreen: 2011-RPIB-008-001 2012-17 (to B.B.); and by the Roy J. Carver Trust (to C.B.). C.B. serves as a member of the scientific advisory board of ChromaDex and is cofounder of ProHealthspan, which respectively developed NR for commercialization and sells NR to consumers. The remaining authors declare no conflicts of interest.	Antenor-Dorsey JAV, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-5; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Benarroch EE, 2015, NEUROLOGY, V84, P2076, DOI 10.1212/WNL.0000000000001601; Bi J, 2012, J NEUROCHEM, V120, P334, DOI 10.1111/j.1471-4159.2011.07566.x; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Brown KD, 2014, CELL METAB, V20, P1059, DOI 10.1016/j.cmet.2014.11.003; Burke RE, 2013, EXP NEUROL, V246, P72, DOI 10.1016/j.expneurol.2012.01.011; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; CHOI DW, 1987, J NEUROSCI, V7, P369; Chung RS, 2005, EXP NEUROL, V193, P481, DOI 10.1016/j.expneurol.2005.01.005; Cohen MS, 2012, CHEM BIOL, V19, P179, DOI 10.1016/j.chembiol.2012.01.012; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Deleglise B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071103; Di Stefano M, 2015, CELL DEATH DIFFER, V22, P731, DOI 10.1038/cdd.2014.164; Fletcher RS, 2017, MOL METAB, V6, P819, DOI 10.1016/j.molmet.2017.05.011; Gerdts J, 2016, NEURON, V89, P449, DOI 10.1016/j.neuron.2015.12.023; Gerdts J, 2015, SCIENCE, V348, P453, DOI 10.1126/science.1258366; Gerdts J, 2013, J NEUROSCI, V33, P13569, DOI 10.1523/JNEUROSCI.1197-13.2013; Ghosh D, 2012, J NEUROSCI, V32, P5821, DOI 10.1523/JNEUROSCI.6192-11.2012; Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300; Gong B, 2013, NEUROBIOL AGING, V34, P1581, DOI 10.1016/j.neurobiolaging.2012.12.005; Griffith DA, 1996, BBA-REV BIOMEMBRANES, V1286, P153, DOI 10.1016/S0304-4157(96)00008-1; Grozio A, 2013, J BIOL CHEM, V288, P25938, DOI 10.1074/jbc.M113.470435; Hamity MV, 2017, PAIN, V158, P962, DOI 10.1097/j.pain.0000000000000862; Hasmann M, 2003, CANCER RES, V63, P7436; Hosie KA, 2012, ASN NEURO, V4, P47, DOI 10.1042/AN20110031; Jullienne A, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-68; Kandan NM, 2013, EXP NEUROL, V246, P44, DOI 10.1016/j.expneurol.2012.06.003; Kim SH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014731, 10.1371/journal.pone.0026214]; Liu D, 2009, NEUROMOL MED, V11, P28, DOI 10.1007/s12017-009-8058-1; Liu D, 2008, ANN NY ACAD SCI, V1147, P275, DOI 10.1196/annals.1427.028; LYON MF, 1993, P NATL ACAD SCI USA, V90, P9717, DOI 10.1073/pnas.90.20.9717; Magnifico S, 2013, FASEB J, V27, P4712, DOI 10.1096/fj.13-229781; Martire S, 2015, MECH AGEING DEV, V146, P53, DOI 10.1016/j.mad.2015.04.001; Milde S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001539; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; Paxinos G, 2012, PAXINOS FRANKLINS MO; Ratajczak J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13103; Sasaki Y, 2006, J NEUROSCI, V26, P8484, DOI 10.1523/JNEUROSCI.2320-06.2006; Sasaki Y, 2016, ELIFE, V5, DOI 10.7554/eLife.19749; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Trammell SAJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12948; Trammell SAJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26933; Trammell SAJ, 2016, J NUTR, V146, P957, DOI 10.3945/jn.116.230078; Trammell SAJ, 2013, COMPUT STRUCT BIOTEC, V4, DOI 10.5936/csbj.201301012; Verghese PB, 2011, P NATL ACAD SCI USA, V108, P19054, DOI 10.1073/pnas.1107325108; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Wang XW, 2014, INT J MOL SCI, V15, P20449, DOI 10.3390/ijms151120449; Yahata N, 2009, J NEUROSCI, V29, P6276, DOI 10.1523/JNEUROSCI.4304-08.2009; Young JD, 2016, BIOCHEM SOC T, V44, P869, DOI 10.1042/BST20160038; Zhang WP, 2010, J CEREBR BLOOD F MET, V30, P1962, DOI 10.1038/jcbfm.2010.71; Zhou B, 2016, J CELL BIOL, V214, P103, DOI 10.1083/jcb.201605101; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309	56	52	54	3	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5440	5452		10.1096/fj.201700221RR	http://dx.doi.org/10.1096/fj.201700221RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28842432				2022-12-28	WOS:000416588300027
J	Goodson, JM; Weldy, CS; MacDonald, JW; Liu, YG; Bammler, TK; Chien, WM; Chin, MT				Goodson, Jamie M.; Weldy, Chad S.; MacDonald, James W.; Liu, Yonggang; Bammler, Theo K.; Chien, Wei-Ming; Chin, Michael T.			In utero exposure to diesel exhaust particulates is associated with an altered cardiac transcriptional response to transverse aortic constriction and altered DNA methylation	FASEB JOURNAL			English	Article						PM2.5; heart failure; miR133a-2; Ptprf; Pamr1	PROTEIN-TYROSINE-PHOSPHATASE; SHORT-TERM EXPOSURE; AIR-POLLUTION; CARDIOVASCULAR-DISEASE; SIGNAL-TRANSDUCTION; VASCULAR-RESPONSES; INSULIN-RECEPTOR; BLOOD-PRESSURE; HEART-FAILURE; HYPERTROPHY	In utero exposure to diesel exhaust air pollution has been associated with increased adult susceptibility to heart failure in mice, but the mechanisms by which this exposure promotes susceptibility to heart failure are poorly understood. To identify the potential transcriptional effects that mediate this susceptibility, we have performed RNA sequencing analysis on adult hearts from mice that were exposed to diesel exhaust in utero and that have subsequently undergone transverse aortic constriction. We identified 3 target genes, Mir133a-2, Ptprf, and Pamr1, which demonstrate dysregulation after exposure and aortic constriction. Examination of expression patterns in human heart tissues indicates a correlation between expression and heart failure. We subsequently assessed DNA methylation modifications at these candidate loci in neonatal cultured cardiac myocytes after in utero exposure to diesel exhaust and found that the promoter for Mir133a-2 is differentially methylated. These target genes in the heart are the first genes to be identified that likely play an important role inmediating adult sensitivity to heart failure. We have also shown a change in DNA methylation within cardiomyocytes as a result of in utero exposure to diesel exhaust.-Goodson, J. M., Weldy, C. S., MacDonald, J. W., Liu, Y., Bammler, T. K., Chien, W.-M., Chin, M. T. In utero exposure to diesel exhaust particulates is associated with an altered cardiac transcriptional response to transverse aortic constriction and altered DNA methylation.	[Goodson, Jamie M.; Weldy, Chad S.; Chin, Michael T.] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Weldy, Chad S.; Liu, Yonggang; Chien, Wei-Ming; Chin, Michael T.] Univ Washington, Sch Med, Dept Med, Div Cardiol, Seattle, WA 98195 USA; [MacDonald, James W.; Bammler, Theo K.] Univ Washington, Sch Publ Hlth, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Chin, MT (corresponding author), Univ Washington, Sch Med, Ctr Cardiovasc Biol, Brotman 353,Box 358050,850 Republican St, Seattle, WA 98109 USA.	mtchin@u.washington.edu		Weldy, Chad/0000-0003-4652-6422; Goodson, Jamie/0000-0002-9091-8362	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences (NIEHS) Training Grant [T32 ES007032]; NIH National Heart, Lung, and Blood Institute Training Grant [T32 HL007312]; NIH NIEHS Grant [P30ES07033, ES023015]; American Heart Association [15GRNT25390012]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033, T32ES007032] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences (NIEHS) Training Grant; NIH National Heart, Lung, and Blood Institute Training Grant; NIH NIEHS Grant; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank James Stewart (University of Washington) for expert technical assistance with diesel exhaust exposures. J.M.G. was supported by U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences (NIEHS) Training Grant T32 ES007032. C.S.W. was supported by NIH National Heart, Lung, and Blood Institute Training Grant T32 HL007312. J.W.M. and T.K.B. were supported by NIH NIEHS Grant P30ES07033 to the University of Washington Center for Exposures, Diseases, Genomics and Environment (EDGE). M.T.C. was supported by NIH NIEHS Grant ES023015 and American Heart Association Grant 15GRNT25390012.	Ahmad F, 1997, J BIOL CHEM, V272, P448; Baccarelli A, 2009, AM J RESP CRIT CARE, V179, P572, DOI 10.1164/rccm.200807-1097OC; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brauer M, 2016, ENVIRON SCI TECHNOL, V50, P79, DOI 10.1021/acs.est.5b03709; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chagnon MJ, 2004, BIOCHEM CELL BIOL, V82, P664, DOI 10.1139/O04-120; Chen WS, 2012, ONCOL REP, V28, P1069, DOI 10.3892/or.2012.1899; Dakhlallah D, 2015, J CARDIOVASC PHARM, V65, P241, DOI 10.1097/FJC.0000000000000183; Drawnel FM, 2012, J CELL BIOL, V199, P783, DOI 10.1083/jcb.201111095; Feng H, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku154; Garcia R, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000211; Gilsbach R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6288; Gould T, 2008, INHAL TOXICOL, V20, P49, DOI [10.1080/08958370701758478, 10.1080/08958370701758478 ]; Greco S, 2012, DIABETES, V61, P1633, DOI 10.2337/db11-0952; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Hansen KD, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r83, 10.1186/gb-2012-13-10-R83]; He B, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-22; Huang LX, 2016, SCI REP-UK, V6, DOI 10.1038/srep20105; Janssen BG, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-22; Krishnan RM, 2012, J AM COLL CARDIOL, V60, P2158, DOI 10.1016/j.jacc.2012.08.973; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; KULAS DT, 1995, J BIOL CHEM, V270, P2435, DOI 10.1074/jbc.270.6.2435; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lewne M, 2007, ANN OCCUP HYG, V51, P693, DOI 10.1093/annhyg/mem046; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Liu N, 2011, J CLIN INVEST, V121, P3258, DOI 10.1172/JCI46267; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; LIU YG, 2013, PART FIBRE TOXICOL, V10; Liu YG, 2010, AM J PHYSIOL-HEART C, V298, pH2082, DOI 10.1152/ajpheart.00747.2009; Lo PHY, 2015, ONCOL REP, V33, P267, DOI 10.3892/or.2014.3581; Matkovich SJ, 2010, CIRC RES, V106, P166, DOI 10.1161/CIRCRESAHA.109.202176; Menzaghi C, 2008, J INTERN MED, V263, P653, DOI 10.1111/j.1365-2796.2008.01924.x; Nakayama Y, 2004, AM J PATHOL, V164, P1773, DOI 10.1016/S0002-9440(10)63735-2; Ni L, 2015, FRONT PHYSIOL, V6, DOI [10.3339/fphys.2015.00294, 10.3389/fphys.2015.00294]; Pope CA, 2006, CIRCULATION, V114, P2443, DOI 10.1161/CIRCULATIONAHA.106.636977; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Saenen ND, 2016, AM J EPIDEMIOL, V184, P442, DOI 10.1093/aje/kww007; Sharma PR, 2015, ENDOCRINOLOGY, V156, P3147, DOI 10.1210/en.2015-1203; Tarantini L, 2009, ENVIRON HEALTH PERSP, V117, P217, DOI 10.1289/ehp.11898; Tonks NK, 2013, FEBS J, V280, P346, DOI 10.1111/febs.12077; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; van den Hooven EH, 2012, ENVIRON HEALTH PERSP, V120, P150, DOI 10.1289/ehp.1003316; van Rossem L, 2015, ENVIRON HEALTH PERSP, V123, P353, DOI 10.1289/ehp.1307419; Wang Y, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000983; Wauters A, 2013, HYPERTENSION, V62, P352, DOI 10.1161/HYPERTENSIONAHA.111.00991; Weldy CS, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-59; Weldy CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088582; Weldy CS, 2013, INHAL TOXICOL, V25, P444, DOI 10.3109/08958378.2013.801004; Westerholm R, 2001, ENVIRON SCI TECHNOL, V35, P1748, DOI 10.1021/es000113i; Xiang F, 2006, AM J PHYSIOL-HEART C, V290, pH1997, DOI 10.1152/ajpheart.01106.2005; Yin F, 2013, ARTERIOSCL THROM VAS, V33, P1153, DOI 10.1161/ATVBAHA.112.300552; Zabolotny JM, 2001, P NATL ACAD SCI USA, V98, P5187, DOI 10.1073/pnas.071050398; Zhang WR, 1996, MOL ENDOCRINOL, V10, P575, DOI 10.1210/me.10.5.575; Zuo L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023116	58	15	17	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4935	4945		10.1096/fj.201700032R	http://dx.doi.org/10.1096/fj.201700032R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28751527	Green Published			2022-12-28	WOS:000413398500024
J	Berkowitz, BA; Lenning, J; Khetarpal, N; Tran, C; Wu, JY; Berri, AM; Dernay, K; Haacke, EM; Shafie-Khorassani, F; Podolsky, RH; Gant, JC; Maimaiti, S; Thibault, O; Murphy, GG; Bennett, BM; Roberts, R				Berkowitz, Bruce A.; Lenning, Jacob; Khetarpal, Nikita; Tran, Catherine; Wu, Johnny Y.; Berri, Ali M.; Dernay, Kristin; Haacke, E. Mark; Shafie-Khorassani, Fatema; Podolsky, Robert H.; Gant, John C.; Maimaiti, Shaniya; Thibault, Olivier; Murphy, Geoffrey G.; Bennett, Brian M.; Roberts, Robin			In vivo imaging of prodromal hippocampus CA1 subfield oxidative stress in models of Alzheimer disease and Angelman syndrome	FASEB JOURNAL			English	Article						reactive oxygen species; MRI; dorsoventral CA1; neurodegenerative disease; neurodevelopment disorders	TRANSGENIC MOUSE MODEL; FREE-RADICAL PRODUCTION; MANGANESE-ENHANCED MRI; MILD COGNITIVE IMPAIRMENT; LIPID-PEROXIDATION; MEMORY DEFICITS; HYDROGEN-PEROXIDE; PYRAMIDAL NEURONS; XANTHINE-OXIDASE; CALCIUM-CHANNEL	Hippocampus oxidative stress is considered pathogenic in neurodegenerative diseases, such as Alzheimer disease (AD), and in neurodevelopmental disorders, such as Angelman syndrome (AS). Yet clinical benefits of antioxidant treatment for these diseases remain unclear because conventional imaging methods are unable to guide management of therapies in specific hippocampus subfields in vivo that underlie abnormal behavior. Excessive production of paramagnetic free radicals in nonhippocampus brain tissue can be measured in vivo as a greater-than-normal 1/T-1 that is quenchable with antioxidant as measured by quench-assisted (Quest) MRI. Here, we further test this approach in phantoms, and we present proof-of-concept data in models of AD-like and AS hippocampus oxidative stress that also exhibit impaired spatial learning and memory. AD-like models showed an abnormal gradient along the CA1 dorsal-ventral axis of excessive free radical production as measured by Quest MRI, and redox-sensitive calcium dysregulation as measured by manganese-enhanced MRI and electrophysiology. In the AS model, abnormally high free radical levels were observed in dorsal and ventral CA1. Quest MRI is a promising in vivo paradigm for bridging brain sub-field oxidative stress and behavior in animal models and in human patients to better manage antioxidant therapy in devastating neurodegenerative and neurodevelopmental diseases.	[Berkowitz, Bruce A.; Lenning, Jacob; Khetarpal, Nikita; Tran, Catherine; Wu, Johnny Y.; Berri, Ali M.; Dernay, Kristin; Roberts, Robin] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, 540 E Canfield, Detroit, MI 48201 USA; [Berkowitz, Bruce A.] Wayne State Univ, Sch Med, Dept Ophthalmol, Detroit, MI USA; [Haacke, E. Mark] Wayne State Univ, Dept Radiol, Detroit, MI USA; [Shafie-Khorassani, Fatema; Podolsky, Robert H.] Wayne State Univ, Dept Family Med & Publ Hlth Sci, Detroit, MI USA; [Gant, John C.; Maimaiti, Shaniya; Thibault, Olivier] Univ Kentucky, Med Ctr, Dept Pharmacol & Nutr Sci, Lexington, KY USA; [Murphy, Geoffrey G.] Univ Michigan, Sch Med, Mol Behav Neurosci Inst, Dept Mol & Integrat Physiol, Ann Arbor, MI USA; [Bennett, Brian M.] Queens Univ, Ctr Neurosci Studies, Dept Biomed & Mol Sci, Fac Hlth Sci, Kingston, ON, Canada	Wayne State University; Wayne State University; Wayne State University; Wayne State University; University of Kentucky; University of Michigan System; University of Michigan; Queens University - Canada	Berkowitz, BA (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, 540 E Canfield, Detroit, MI 48201 USA.	baberko@med.wayne.edu	Lenning, Jacob/GXG-7868-2022; Thibault, Olivier/AAY-7614-2020; Podolsky, Robert/GRY-0740-2022	Thibault, Olivier/0000-0002-3548-3466; Shafie Khorassani, Fatema/0000-0001-7445-322X	U.S. National Institutes of Health (NIH)/National Eye Institute (NEI) [R21EY021619, R01EY026584]; NIH/National Institute on Aging [R01 AG033649, R01 AG028488]; Alzheimer's Society Research Program; Canadian Vascular Network; University of Michigan Protein Folding Disease Initiative; NIH/NEI Core Grant [P30 EY04068]; Research to Prevent Blindness (Kresge Eye Institute, Detroit, MI, USA); NATIONAL EYE INSTITUTE [R21EY021619, R01EY026584, P30EY004068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG058171, R01AG028488, R01AG052934, R01AG033649] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)/National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimer's Society Research Program; Canadian Vascular Network; University of Michigan Protein Folding Disease Initiative; NIH/NEI Core Grant; Research to Prevent Blindness (Kresge Eye Institute, Detroit, MI, USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in part, by the U.S. National Institutes of Health (NIH)/National Eye Institute (NEI) (Grants R21EY021619 and R01EY026584 to B.A.B.), NIH/National Institute on Aging (Grants R01 AG033649 to O.T. and R01 AG028488 to G.G.M.), Alzheimer's Society Research Program (B.M.B.), the Canadian Vascular Network (B.M.B.), University of Michigan Protein Folding Disease Initiative (G.G.M.), NIH/NEI Core Grant P30 EY04068, and an unrestricted grant from Research to Prevent Blindness (Kresge Eye Institute, Detroit, MI, USA).	Arimon M, 2015, NEUROBIOL DIS, V84, P109, DOI 10.1016/j.nbd.2015.06.013; ASHTON D, 1989, BRAIN RES, V487, P368, DOI 10.1016/0006-8993(89)90842-1; Bakalova R, 2015, ACS CHEM NEUROSCI, V6, P1922, DOI 10.1021/acschemneuro.5b00220; Beeman SC, 2016, MAGN RESON MED, V75, P2442, DOI 10.1002/mrm.25821; BENNETT HF, 1987, MAGNET RESON MED, V4, P93, DOI 10.1002/mrm.1910040202; BERKOWITZ BA, 2015, INVEST OPHTH VIS SCI, V56; Berkowitz BA, 2016, INVEST OPHTH VIS SCI, V57, P577, DOI 10.1167/iovs.15-18972; Berkowitz BA, 2016, PROG RETIN EYE RES, V51, P90, DOI 10.1016/j.preteyeres.2015.09.001; Berkowitz BA, 2015, INVEST OPHTH VIS SCI, V56, P7931, DOI 10.1167/iovs.15-18420; Berkowitz BA, 2012, MOL VIS, V18, P372; Bissig D, 2014, NEUROBIOL AGING, V35, P1453, DOI 10.1016/j.neurobiolaging.2013.12.019; Bissig D, 2011, NEUROIMAGE, V58, P749, DOI 10.1016/j.neuroimage.2011.06.062; Bissig D, 2009, NEUROIMAGE, V44, P627, DOI 10.1016/j.neuroimage.2008.10.013; Blalock EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010405; Butterfield DA, 2006, NEUROSCI LETT, V397, P170, DOI 10.1016/j.neulet.2005.12.017; Chen LJ, 2014, NEUROBIOL AGING, V35, P2552, DOI 10.1016/j.neurobiolaging.2014.05.007; Crystal GJ, 2012, ACTA ANAESTH SCAND, V56, P39, DOI 10.1111/j.1399-6576.2011.02583.x; D'Souza Y, 2011, BRIT J PHARMACOL, V164, P632, DOI 10.1111/j.1476-5381.2011.01448.x; D'Souza Y, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0117-y; de Carvalho JER, 2014, SURV OPHTHALMOL, V59, P393, DOI 10.1016/j.survophthal.2013.09.005; Di Domenico F, 2017, FREE RADICAL BIO MED, V111, P253, DOI 10.1016/j.freeradbiomed.2016.10.490; Du Y, 2013, P NATL ACAD SCI USA, V110, P16586, DOI 10.1073/pnas.1314575110; Durak I, 1999, CAN J ANAESTH, V46, P797, DOI 10.1007/BF03013919; Ekanger LA, 2015, METALLOMICS, V7, P405, DOI 10.1039/c4mt00289j; Fanelli F, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-8; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; FREEMAN R, 1971, J CHEM PHYS, V54, P3367, DOI 10.1063/1.1675352; FRIDOVICH I, 1970, J BIOL CHEM, V245, P4053; Furman R, 2016, ACS CHEM NEUROSCI, V7, P367, DOI 10.1021/acschemneuro.5b00316; Gorlach A, 2015, REDOX BIOL, V6, P260, DOI 10.1016/j.redox.2015.08.010; Gomes MB, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-80; Grinan-Ferre C, 2016, AGING-US, V8, P664, DOI 10.18632/aging.100906; Grivas I, 2003, BRAIN RES, V971, P245, DOI 10.1016/S0006-8993(03)02475-2; Haacke E. M., 1999, J MAGN RESON; Han BH, 2015, P NATL ACAD SCI USA, V112, pE881, DOI 10.1073/pnas.1414930112; Hardas SS, 2013, REDOX BIOL, V1, P80, DOI 10.1016/j.redox.2013.01.002; Holt AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014260; Hsu JJ, 2009, MAGN RESON MED, V62, P1202, DOI 10.1002/mrm.22111; Hu Q, 2011, STROKE, V42, P1750, DOI 10.1161/STROKEAHA.110.603142; Hyodo F, 2008, J PHARM PHARMACOL, V60, P1049, DOI 10.1211/jpp.60.8.0011; Hyodo F, 2008, J CEREBR BLOOD F MET, V28, P1165, DOI 10.1038/jcbfm.2008.5; Hyodo F, 2008, J MAGN RESON, V190, P105, DOI 10.1016/j.jmr.2007.10.013; Ilangovan G, 2004, METHOD ENZYMOL, V381, P747; Kanamaru T, 2015, NEUROSCI LETT, V587, P126, DOI 10.1016/j.neulet.2014.12.033; Kelley EE, 2010, FREE RADICAL BIO MED, V48, P493, DOI 10.1016/j.freeradbiomed.2009.11.012; Kudo M, 2001, ANESTHESIOLOGY, V94, P303, DOI 10.1097/00000542-200102000-00021; KUPPUSAMY P, 1989, J BIOL CHEM, V264, P9880; Lin BW, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003154; Malik R, 2016, HIPPOCAMPUS, V26, P341, DOI 10.1002/hipo.22526; Mason RP, 2016, REDOX BIOL, V8, P422, DOI 10.1016/j.redox.2016.04.003; Massaad CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010561; Massaad CA, 2009, P NATL ACAD SCI USA, V106, P13576, DOI 10.1073/pnas.0902714106; Matsumura A, 2015, FREE RADICAL BIO MED, V85, P165, DOI 10.1016/j.freeradbiomed.2015.04.013; McManus MJ, 2011, J NEUROSCI, V31, P15703, DOI 10.1523/JNEUROSCI.0552-11.2011; Modi KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130398; MOSER E, 1993, J NEUROSCI, V13, P3916; Muralidharan P, 2016, SCI REP-UK, V6, DOI 10.1038/srep19067; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Nunomura A, 2012, J NEUROPATH EXP NEUR, V71, P233, DOI 10.1097/NEN.0b013e318248e614; Pancani T, 2013, NEUROBIOL AGING, V34, P1977, DOI 10.1016/j.neurobiolaging.2013.02.019; Pratico D, 2001, J NEUROSCI, V21, P4183, DOI 10.1523/JNEUROSCI.21-12-04183.2001; Prunty MC, 2015, INVEST OPHTH VIS SCI, V56, P5862, DOI 10.1167/iovs.15-16810; Rayner CL, 2016, NEUROCHEM INT, V92, P1, DOI 10.1016/j.neuint.2015.11.003; Rocha TLA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/264971; Santini E, 2015, J NEUROSCI, V35, P16213, DOI 10.1523/JNEUROSCI.2246-15.2015; Sarracanie M, 2014, MAGN RESON MED, V71, P735, DOI 10.1002/mrm.24705; Schallner N, 2014, ANESTH ANALG, V119, P1429, DOI 10.1213/ANE.0000000000000488; Shimohama S, 2000, BIOCHEM BIOPH RES CO, V273, P5, DOI 10.1006/bbrc.2000.2897; Stinnett G., 2015, ISMRM M; Strange BA, 2014, NAT REV NEUROSCI, V15, P655, DOI 10.1038/nrn3785; Surmeier DJ, 2011, ANTIOXID REDOX SIGN, V14, P1289, DOI 10.1089/ars.2010.3521; SUZUKI YJ, 1991, FREE RADICAL RES COM, V15, P255, DOI 10.3109/10715769109105221; Tamagnini F, 2015, HIPPOCAMPUS, V25, P786, DOI 10.1002/hipo.22403; Thibault O, 1996, SCIENCE, V272, P1017, DOI 10.1126/science.272.5264.1017; Thibault O, 2012, BBA-MOL BASIS DIS, V1822, P546, DOI 10.1016/j.bbadis.2012.01.004; Towner RA, 2012, DIABETES, V61, P2405, DOI 10.2337/db11-1540; van Woerden GM, 2007, NAT NEUROSCI, V10, P280, DOI 10.1038/nn1845; Vlcek K, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00089; Wang Q, 2014, DIS MODEL MECH, V7, P1385, DOI 10.1242/dmm.018218; Wen Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208447; Yang L, 2013, J PHYSIOL SCI, V63, P419, DOI 10.1007/s12576-013-0279-2; Yiu AP, 2011, NEUROPSYCHOPHARMACOL, V36, P2169, DOI 10.1038/npp.2011.107; Zhelev Z, 2013, ACS CHEM NEUROSCI, V4, P1439, DOI 10.1021/cn400159h	83	25	25	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					4179	4186		10.1096/fj.201700229R	http://dx.doi.org/10.1096/fj.201700229R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28592637	Green Published, Green Submitted			2022-12-28	WOS:000408713300039
J	Ying, F; Cai, Y; Cai, Y; Wang, Y; Tang, EHC				Ying, Fan; Cai, Yin; Cai, Yu; Wang, Yu; Tang, Eva Hoi Ching			Prostaglandin E receptor subtype 4 regulates lipid droplet size and mitochondrial activity in murine subcutaneous white adipose tissue	FASEB JOURNAL			English	Article						CL316243; WAT remodeling; mitochondrial biogenesis; FSP27; phosphorylation AMPK	FAT-SPECIFIC PROTEIN-27; DE-NOVO LIPOGENESIS; BROWN ADIPOCYTES; EP4 RECEPTOR; METABOLISM; THERMOGENESIS; CONTRIBUTES; ACTIVATION; LIPOLYSIS; STORAGE	The purpose of this study was to investigate whether genetic ablation of prostaglandin E receptor subtype 4 (EP4) affects white adipose tissue (WAT) remodeling mediated by beta(3)-adrenergic stimulation. The selective b3-adrenergic agonist, CL316243 (1mg/kg/d, i.p.) caused a greater increase in metabolic rate in EP4-knockout mice. CL316243 fragmented the unilocular lipid droplet into multilocular lipid vacuoles and increased mitochondrial biogenesis and its activity. These changes were amplified in mice with EP4 deficiency and were selectively seen in subcutaneous WAT. The expression of fat-specific protein (FSP)-27, a protein that promotes fusion of triglycerides and formation of unilocular lipid droplets were diminished, whereas the expression of phosphorylated AMPK, the upstream regulator of FSP27, was enhanced in EP4-deficient mice. The present study showed that EP4 acts as a negative regulator of WAT remodeling, it tightly coordinates rates of triglyceride storage in lipid droplets and mitochondrial respiratory function in subcutaneous white adipocytes through the phosphorylated AMPK-FSP27 signaling axis. Thus, deletion of EP4 increases mitochondrial biogenesis and oxidative capacity in WAT, and fat mass loss ensues in mice.	[Ying, Fan; Cai, Yu; Wang, Yu; Tang, Eva Hoi Ching] Univ Hong Kong, State Key Lab Pharmaceut Biotechnol, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Cai, Yin] Univ Hong Kong, Dept Anesthesiol, Hong Kong, Hong Kong, Peoples R China; [Tang, Eva Hoi Ching] Univ Hong Kong, Li Ka Shing Fac Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Tang, EHC (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Pharmacol & Pharm, L2-26C,2-F Lab Block,21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.	evatang1@hku.hk		wang, yu/0000-0001-8697-2940; Cai, Yin/0000-0002-7763-0612	Research Grant Council of Hong Kong Special Administrative Region (SAR) [27101314]	Research Grant Council of Hong Kong Special Administrative Region (SAR)	The authors thank Prof. Paul M. Vanhoutte (University of Hong Kong), for language editing and proofreading the manuscript. This work was supported, in part, by grants from the Research Grant Council of Hong Kong Special Administrative Region (SAR) under the General Research Fund (27101314 to E.H.C.T.). The authors declare no conflicts of interest.	Astrup A., 2014, HDB OBESITY CLIN APP, P315; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Billot X, 2003, BIOORG MED CHEM LETT, V13, P1129, DOI 10.1016/S0960-894X(03)00042-8; Bugge A, 2014, METHOD ENZYMOL, V538, P233, DOI 10.1016/B978-0-12-800280-3.00013-X; Cai Y, 2015, CELL CYCLE, V14, P3580, DOI 10.1080/15384101.2015.1100771; Cai Y, 2015, FASEB J, V29, P4924, DOI 10.1096/fj.15-274597; Chazotte Brad, 2011, Cold Spring Harb Protoc, V2011, P990, DOI 10.1101/pdb.prot5648; Contreras GA, 2014, AM J PHYSIOL-ENDOC M, V307, pE793, DOI 10.1152/ajpendo.00033.2014; Costford SR, 2006, AM J PHYSIOL-ENDOC M, V290, pE1304, DOI 10.1152/ajpendo.00401.2005; De Pauw A, 2009, AM J PATHOL, V175, P927, DOI 10.2353/ajpath.2009.081155; Dunham-Snary KJ, 2014, REDOX BIOL, V2, P656, DOI 10.1016/j.redox.2014.04.005; Facemire CS, 2011, AM J PHYSIOL-RENAL, V301, pF1035, DOI 10.1152/ajprenal.00054.2011; Gaidhu MP, 2011, J LIPID RES, V52, P1702, DOI 10.1194/jlr.M015354; Gaidhu MP, 2009, J LIPID RES, V50, P704, DOI 10.1194/jlr.M800480-JLR200; Ghorbani Masoud, 2015, Drug Des Devel Ther, V9, P669, DOI 10.2147/DDDT.S73891; Gong JY, 2011, J CELL BIOL, V195, P953, DOI 10.1083/jcb.201104142; Granneman JG, 2003, AM J PHYSIOL-ENDOC M, V285, pE1230, DOI 10.1152/ajpendo.00197.2003; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Harper ME, 2004, PHARMACOTHERAPY OF OBESITY: OPTIONS AND ALTERNATIVES, P363; Herms A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8176; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Lo KA, 2013, BIOSCIENCE REP, V33, P711, DOI 10.1042/BSR20130046; Machwate M, 2001, MOL PHARMACOL, V60, P36, DOI 10.1124/mol.60.1.36; Madsen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011391; Meyer CW, 2010, AM J PHYSIOL-REG I, V299, pR1396, DOI 10.1152/ajpregu.00021.2009; Mottillo EP, 2014, J LIPID RES, V55, P2276, DOI 10.1194/jlr.M050005; Musa CV, 2012, INT J OBESITY, V36, P207, DOI 10.1038/ijo.2011.81; Nedergaard J, 2014, CELL METAB, V20, P396, DOI 10.1016/j.cmet.2014.07.005; Nguyen MT, 1997, NATURE, V390, P78, DOI 10.1038/36342; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Riordan NH, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-29; Rosell M, 2014, AM J PHYSIOL-ENDOC M, V306, pE945, DOI 10.1152/ajpendo.00473.2013; Schulz TJ, 2013, NATURE, V495, P379, DOI 10.1038/nature11943; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Strable MS, 2010, CRIT REV BIOCHEM MOL, V45, P199, DOI 10.3109/10409231003667500; Tang EHC, 2015, J LIPID RES, V56, P358, DOI 10.1194/jlr.M054817; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Ukropec J, 2006, J BIOL CHEM, V281, P31894, DOI 10.1074/jbc.M606114200; Wu W, 2015, EURASIP J WIREL COMM, DOI 10.1186/s13638-015-0378-2; Yokoyama U, 2013, PHARMACOL REV, V65, P1010, DOI 10.1124/pr.112.007195; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zhang XD, 2014, AM J PHYSIOL-ENDOC M, V307, pE1047, DOI 10.1152/ajpendo.00125.2014	46	10	11	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					4023	4036		10.1096/fj.201700191R	http://dx.doi.org/10.1096/fj.201700191R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28533326				2022-12-28	WOS:000408713300027
J	Song, C; Tan, P; Zhang, Z; Wu, W; Dong, YH; Zhao, LM; Liu, HY; Guan, HF; Li, F				Song, Chao; Tan, Peng; Zhang, Zheng; Wu, Wei; Dong, Yonghui; Zhao, Liming; Liu, Huiyong; Guan, Hanfeng; Li, Feng			REV-ERB agonism suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss partially via FABP4 upregulation	FASEB JOURNAL			English	Article						transcription factors; osteoclasts; osteoporosis	NUCLEAR-FACTOR; GENE-EXPRESSION; NADPH OXIDASE; RANK LIGAND; OSTEOPOROSIS; ALPHA; HOMEOSTASIS; MICE; DIFFERENTIATION; TRANSCRIPTION	REV-ERBs (REV-ERB alpha and REV-ERB beta) are transcription repressors and circadian regulators. Previous investigations have shown that REV-ERB s repress the expression of target genes, including MMP9 and CX3CR1, in macrophages. Because MMP9 and CX3CR1 reportedly participate in receptor activator of nuclear factor-kappa B ligand (RANKL)-induced osteoclastogenesis, we inferred that REV-ERBs might play a role in osteoclastogenesis. In the present study, we found that the REV-ERBa level decreased significantly during RANKL-induced osteoclast differentiation from primary bone marrow-derived macrophages (BMMs). REV-ERB alpha knockdown by small interfering RNA in BMMs resulted in the enhanced formation of osteoclasts, whereas REV-ERB beta knockdown showed no effect on osteoclast differentiation. Moreover, the REV-ERB agonist SR9009 inhibited osteoclast differentiation and bone resorption. Intraperitoneal SR9009 administration prevented ovariectomy-induced bone loss; this effect was accompanied by decreased serum RANKL and C-terminal telopeptide of type I collagen levels and increased osteoprotegerin levels. Further investigation revealed that NF-kappa B and MAPK activation and nuclear factor of activated T cells, cytoplasmic 1, and c-fos expression were suppressed by SR9009. The level of reactive oxygen species was also decreased by SR9009, with NADPH oxidase subunits also being down-regulated. In addition, an expression microarray showed that FABP4, an intracellular lipid-binding protein, was up-regulated by REV-ERB agonism. BMS309403, an inhibitor of FABP4, partially prevented the suppression of osteoclastogenesis by SR9009 through stabilizing phosphorylation of p65. To summarize, our results proved that the REV-ERB agonism inhibited osteoclastogenesis partially via FABP4 up-regulation.	[Song, Chao; Tan, Peng; Zhang, Zheng; Wu, Wei; Dong, Yonghui; Zhao, Liming; Liu, Huiyong; Guan, Hanfeng; Li, Feng] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Orthopaed Surg, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China; [Guan, Hanfeng; Li, Feng] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Biol Engn & Regenerat Med Ctr, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Guan, HF; Li, F (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Orthopaed Surg, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China.	hguan@hust.edu.cn; lifengmd@hust.edu.cn	Tan, Peng/HGD-6812-2022	Li, Feng/0000-0002-7961-3728; Zhang, Zheng/0000-0002-3242-5738; CHAO, SONG/0000-0002-1209-1056	National Natural Science Foundation of China [81401762, 81101788, 81572857, 81271934, 81472133]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Dr. Yuting Wang (Huazhong University of Science and Technology) for preparation of the graphical abstract (Fig. 9D). This work was supported by the National Natural Science Foundation of China (81401762 to W.W., 81101788 and 81572857 to H.G., and 81271934 and 81472133 to F.L.). The authors declare no conflicts of interest.	Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Balkan W, 2009, GENE, V446, P90, DOI 10.1016/j.gene.2009.06.013; Carrier Y, 2011, J INVEST DERMATOL, V131, P2428, DOI 10.1038/jid.2011.234; Chen Y, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad0295; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Duarte Joao H, 2016, Nat Rev Rheumatol, V12, P69, DOI 10.1038/nrrheum.2015.177; Guan HF, 2015, FASEB J, V29, P1092, DOI 10.1096/fj.14-262055; Hawse JR, 2008, BONE, V42, P1025, DOI 10.1016/j.bone.2008.02.004; Hofbauer L. C., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P268; Hoo RLC, 2013, J HEPATOL, V58, P358, DOI 10.1016/j.jhep.2012.10.022; Hoshino A, 2013, J CELL SCI, V126, P1032, DOI 10.1242/jcs.113910; Joo JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep22389; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; Karsenty G, 2016, CELL, V164, P1248, DOI 10.1016/j.cell.2016.02.043; Kim JY, 2014, J BONE MINER RES, V29, P1541, DOI 10.1002/jbmr.2183; Kurinna S, 2016, J IMMUNOL, V196, P4663, DOI 10.4049/jimmunol.1501447; Kwak HB, 2005, BLOOD, V105, P2963, DOI 10.1182/blood-2004-07-2534; Lakkakorpi PT, 1996, MICROSC RES TECHNIQ, V33, P171, DOI 10.1002/(SICI)1097-0029(19960201)33:2<171::AID-JEMT7>3.0.CO;2-W; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Lee JH, 2012, CANCER RES, V72, P3175, DOI 10.1158/0008-5472.CAN-12-0481; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Medina-Contreras O, 2016, J IMMUNOL, V196, P34, DOI 10.4049/jimmunol.1501312; Mercer KE, 2014, ALCOHOL CLIN EXP RES, V38, P672, DOI 10.1111/acer.12305; Muxel SM, 2016, J PINEAL RES, V60, P394, DOI 10.1111/jpi.12321; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Roscher Anne, 2016, Bone Rep, V5, P214, DOI 10.1016/j.bonr.2016.07.002; Sato S., 2014, THESCIENTIFICWORLDJO, V2014, P685854, DOI [10.1155/2014/685854, DOI 10.1155/2014/685854]; Schroder K, 2015, CELL MOL LIFE SCI, V72, P25, DOI 10.1007/s00018-014-1712-2; Sengupta S, 2016, FREE RADICAL BIO MED, V93, P177, DOI 10.1016/j.freeradbiomed.2016.02.004; Sitaula S, 2015, BIOCHEM BIOPH RES CO, V460, P566, DOI 10.1016/j.bbrc.2015.03.070; Sundaram K, 2007, EXP CELL RES, V313, P168, DOI 10.1016/j.yexcr.2006.10.001; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Takeya R, 2006, ANTIOXID REDOX SIGN, V8, P1523, DOI 10.1089/ars.2006.8.1523; Van Raemdonck K, 2015, CYTOKINE GROWTH F R, V26, P311, DOI 10.1016/j.cytogfr.2014.11.009; Wang L, 2015, CELL DEATH DIFFER, V22, P1654, DOI 10.1038/cdd.2015.14; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213; Xu HL, 2016, MOL ENDOCRINOL, V30, P325, DOI 10.1210/me.2015-1301; Yin L, 2005, MOL ENDOCRINOL, V19, P1452, DOI 10.1210/me.2005-0057; Zhang CC, 2014, J CELL PHYSIOL, V229, P1330, DOI 10.1002/jcp.24553; Zhang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep13575	42	25	27	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3215	3228		10.1096/fj.201600825RRR	http://dx.doi.org/10.1096/fj.201600825RRR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401617				2022-12-28	WOS:000432546000026
J	Takahashi, M; Takahashi, E; Joudeh, LI; Marini, M; Das, G; Elshenawy, MM; Akal, A; Sakashita, K; Alam, I; Tehseen, M; Sobhy, MA; Stingl, U; Merzaban, JS; Di Fabrizio, E; Hamdan, SM				Takahashi, Masateru; Takahashi, Etsuko; Joudeh, Luay I.; Marini, Monica; Das, Gobind; Elshenawy, Mohamed M.; Akal, Anastassja; Sakashita, Kosuke; Alam, Intikhab; Tehseen, Muhammad; Sobhy, Mohamed A.; Stingl, Ulrich; Merzaban, Jasmeen S.; Di Fabrizio, Enzo; Hamdan, Samir M.			Dynamic structure mediates halophilic adaptation of a DNA polymerase from the deep-sea brines of the Red Sea	FASEB JOURNAL			English	Article						DNA polymerase engineering; halophilic enzymes; thermophilic enzymes; structure dynamism; structural adaptation	CRYSTAL-STRUCTURE; REPLICATION TERMINATION; MALATE-DEHYDROGENASE; PROTEINS; SALTS; AMINOACYLATION; ENVIRONMENT; MECHANISMS; STABILITY; INSIGHTS	The deep-sea brines of the Red Sea are remote and unexplored environments characterized by high temperatures, anoxic water, and elevated concentrations of salt and heavy metals. This environment provides a rare system to study the interplay between halophilic and thermophilic adaptation in biologic macromolecules. The present article reports the first DNA polymerase with halophilic and thermophilic features. Biochemical and structural analysis by Raman and circular dichroism spectroscopy showed that the charge distribution on the protein's surface mediates the structural balance between stability for thermal adaptation and flexibility for counteracting the salt-induced rigid and nonfunctional hydrophobic packing. Salt bridge interactions via increased negative and positive charges contribute to structural stability. Salt tolerance, conversely, is mediated by a dynamic structure that becomes more fixed and functional with increasing salt concentration. We propose that repulsive forces among excess negative charges, in addition to a high percentage of negatively charged random coils, mediate this structural dynamism. This knowledge enabled us to engineer a halophilic version of Thermococcus kodakarensis DNA polymerase.	[Takahashi, Masateru; Takahashi, Etsuko; Joudeh, Luay I.; Elshenawy, Mohamed M.; Sakashita, Kosuke; Tehseen, Muhammad; Sobhy, Mohamed A.; Stingl, Ulrich; Merzaban, Jasmeen S.; Hamdan, Samir M.] King Abdullah Univ Sci & Technol, Biol & Environm Sci & Engn Div, Bldg 2-4221, Jeddah, Saudi Arabia; [Marini, Monica; Das, Gobind; Akal, Anastassja; Di Fabrizio, Enzo] King Abdullah Univ Sci & Technol, Phys Sci & Engn Div, Jeddah, Saudi Arabia; [Akal, Anastassja] King Abdullah Univ Sci & Technol, KAUST Catalysis Ctr, Jeddah, Saudi Arabia; [Alam, Intikhab] King Abdullah Univ Sci & Technol, Computat Biosci Res Ctr, Jeddah, Saudi Arabia; [Stingl, Ulrich] Univ Florida, Ft Lauderdale Res & Educ Ctr, Davie, FL USA	King Abdullah University of Science & Technology; King Abdullah University of Science & Technology; King Abdullah University of Science & Technology; King Abdullah University of Science & Technology; State University System of Florida; University of Florida	Hamdan, SM (corresponding author), King Abdullah Univ Sci & Technol, Biol & Environm Sci & Engn Div, Bldg 2-4221, Jeddah, Saudi Arabia.	samir.hamdan@kaust.edu.sa	Merzaban, Jasmeen/V-3147-2018; Das, Gobind/N-7405-2013; Joudeh, Luay/O-8929-2018; Elshenawy, Mohamed/AAA-6812-2020; Marini, Monica/AAX-1145-2020; Stingl, Uli/H-1191-2014	Merzaban, Jasmeen/0000-0002-7276-2907; Das, Gobind/0000-0003-0942-681X; Joudeh, Luay/0000-0001-9338-205X; Elshenawy, Mohamed/0000-0002-8599-8388; Gespers, Anastassja/0000-0002-7172-3199; Hamdan, Samir/0000-0001-5192-1852; Marini, Monica/0000-0001-8182-5239; Stingl, Uli/0000-0002-0684-2597; Tehseen, Muhammad/0000-0001-9834-2372; Alam, Intikhab/0000-0001-5306-847X	Saudi Economic and Development Company (SEDCO) Research Excellence Project; baseline funding from KAUST	Saudi Economic and Development Company (SEDCO) Research Excellence Project; baseline funding from KAUST	The authors thank the King Abdullah University of Science and Technology (KAUST) BioScience Core Laboratory for providing Pfu polymerase. This research was funded by the Saudi Economic and Development Company (SEDCO) Research Excellence Project and baseline funding from KAUST to S.M.H. The authors declare no conflicts of interest.	Alam I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082210; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Antunes A, 2011, ENV MICROBIOL REP, V3, P416, DOI 10.1111/j.1758-2229.2011.00264.x; Antunes A, 2011, J BACTERIOL, V193, P4553, DOI 10.1128/JB.05462-11; ARAKAWA T, 1984, BIOCHEMISTRY-US, V23, P5912, DOI 10.1021/bi00320a004; ARAKAWA T, 1982, BIOCHEMISTRY-US, V21, P6545, DOI 10.1021/bi00268a034; BACKER H, 1972, NATURE-PHYS SCI, V240, P153, DOI 10.1038/physci240153a0; Bergen K, 2013, CHEMBIOCHEM, V14, P1058, DOI 10.1002/cbic.201300175; Bergqvist S, 2003, BIOCHEM SOC T, V31, P677, DOI 10.1042/bst0310677; Bredenberg JH, 2008, BIOPHYS J, V94, P4634, DOI 10.1529/biophysj.107.125609; Cacciapuoti G, 2012, BBA-PROTEINS PROTEOM, V1824, P1136, DOI 10.1016/j.bbapap.2012.06.014; Chan CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021624; Costantini S, 2006, BIOCHEM BIOPH RES CO, V342, P441, DOI 10.1016/j.bbrc.2006.01.159; Das G, 2011, J MOL STRUCT, V993, P500, DOI 10.1016/j.molstruc.2010.12.044; Das G, 2009, BIOSENS BIOELECTRON, V24, P1693, DOI 10.1016/j.bios.2008.08.050; DYM O, 1995, SCIENCE, V267, P1344, DOI 10.1126/science.267.5202.1344; Elcock AH, 1998, J MOL BIOL, V280, P731, DOI 10.1006/jmbi.1998.1904; Elshenawy MM, 2015, NATURE, V525, P394, DOI 10.1038/nature14866; Evilia C, 2003, RNA, V9, P794, DOI 10.1261/rna.5320603; Evilia C, 2006, BIOCHEMISTRY-US, V45, P6835, DOI 10.1021/bi0521386; FIALA G, 1986, ARCH MICROBIOL, V145, P56, DOI 10.1007/BF00413027; Frege Telma, 2015, Biochem Biophys Rep, V1, P33, DOI 10.1016/j.bbrep.2015.03.003; Frolow F, 1996, NAT STRUCT BIOL, V3, P452, DOI 10.1038/nsb0596-452; Fukuchi S, 2003, J MOL BIOL, V327, P347, DOI 10.1016/S0022-2836(03)00150-5; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Grotzinger SW, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00134; Hamdan SM, 2009, NATURE, V457, P336, DOI 10.1038/nature07512; Hartmann M, 1998, MAR GEOL, V144, P311, DOI 10.1016/S0025-3227(97)00055-8; Hashimoto H, 2001, J MOL BIOL, V306, P469, DOI 10.1006/jmbi.2000.4403; HECHT K, 1989, EUR J BIOCHEM, V183, P69, DOI 10.1111/j.1432-1033.1989.tb14897.x; HUYGHUESDESPOINTES BMP, 1993, PROTEIN SCI, V2, P1604, DOI 10.1002/pro.5560021006; Jergic S, 2013, EMBO J, V32, P1322, DOI 10.1038/emboj.2012.347; Karan Ram, 2012, Aquat Biosyst, V8, P4, DOI 10.1186/2046-9063-8-4; Karlin S, 2002, P NATL ACAD SCI USA, V99, P333, DOI 10.1073/pnas.012608599; Karshikoff A, 2001, TRENDS BIOCHEM SCI, V26, P550, DOI 10.1016/S0968-0004(01)01918-1; Kastritis PL, 2007, INT J BIOL MACROMOL, V41, P447, DOI 10.1016/j.ijbiomac.2007.06.005; Kennedy SP, 2001, GENOME RES, V11, P1641, DOI 10.1101/gr.190201; Kim SW, 2008, INT J BIOL MACROMOL, V42, P356, DOI 10.1016/j.ijbiomac.2008.01.010; LANYI JK, 1974, BACTERIOL REV, V38, P272, DOI 10.1128/MMBR.38.3.272-290.1974; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Li-Chan E., 1994, RAMAN SPECTROSCOPY P; Lieutaud P, 2016, METHODS MOL BIOL, V1415, P265, DOI 10.1007/978-1-4939-3572-7_14; LUNDBERG KS, 1991, GENE, V108, P1, DOI 10.1016/0378-1119(91)90480-Y; Madern D, 2004, EXTREMOPHILES, V8, P377, DOI 10.1007/s00792-004-0398-z; Madern D, 2000, EXTREMOPHILES, V4, P91, DOI 10.1007/s007920050142; Mevarech M, 2000, BIOPHYS CHEM, V86, P155, DOI 10.1016/S0301-4622(00)00126-5; MORIKAWA M, 1994, APPL ENVIRON MICROB, V60, P4559, DOI 10.1128/AEM.60.12.4559-4566.1994; Nayek A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093862; Pandey M, 2015, NUCLEIC ACIDS RES, V43, P5924, DOI 10.1093/nar/gkv527; Reed CJ, 2013, ARCHAEA, V2013, DOI 10.1155/2013/373275; Ruckenstein E, 2006, ADV COLLOID INTERFAC, V123, P97, DOI 10.1016/j.cis.2006.05.018; Santos H, 2002, ENVIRON MICROBIOL, V4, P501, DOI 10.1046/j.1462-2920.2002.00335.x; SIAMWIZA MN, 1975, BIOCHEMISTRY-US, V14, P4870, DOI 10.1021/bi00693a014; Sinha R, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00165; TABOR S, 1989, P NATL ACAD SCI USA, V86, P4076, DOI 10.1073/pnas.86.11.4076; Tadeo X, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000257; Taupin CMJ, 1997, EUR J BIOCHEM, V243, P141, DOI 10.1111/j.1432-1033.1997.0141a.x; Terpe K, 2013, APPL MICROBIOL BIOT, V97, P10243, DOI 10.1007/s00253-013-5290-2; TUMA R, 1995, BIOCHEMISTRY-US, V34, P15150, DOI 10.1021/bi00046a022; van Oijen AM, 2003, SCIENCE, V301, P1235, DOI 10.1126/science.1084387; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; WU FYH, 1987, ANNU REV NUTR, V7, P251, DOI 10.1146/annurev.nu.07.070187.001343; Xue B, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S1-S1; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016	66	12	12	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3346	3360		10.1096/fj.201700862RR	http://dx.doi.org/10.1096/fj.201700862RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401622	Green Published			2022-12-28	WOS:000432546000036
J	Li, ST; Wang, N; Xu, XX; Fujita, M; Nakanishi, H; Kitajima, T; Dean, N; Gao, XD				Li, Sheng-Tao; Wang, Ning; Xu, Xin-Xin; Fujita, Morihisa; Nakanishi, Hideki; Kitajima, Toshihiko; Dean, Neta; Gao, Xiao-Dong			Alternative routes for synthesis of N-linked glycans by Alg2 mannosyltransferase	FASEB JOURNAL			English	Article						N-glycosylation; lipid-linked oligosaccharide; LC-MS	2 ACTIVE-SITES; SACCHAROMYCES-CEREVISIAE; BIOCHEMICAL-CHARACTERIZATION; CONFORMATIONAL-CHANGES; HYALURONAN SYNTHASE; LIPID-COMPOSITION; AMINO-ACIDS; IDENTIFICATION; GLYCOSYLATION; MUTATIONS	Asparagine (N)-linked glycosylation requires the ordered, stepwise synthesis of lipid-linked oligosaccharide (LLO) precursor Glc(3)Man(9)GlcNAc(2)-pyrophosphate-dolichol (G1c(3)Man(9)Gn(2)-PDol) on the endoplasmic reticulum. The fourth and fifth steps of LLO synthesis are catalyzed by Alg2, an unusual mannosyltransferase (MTase) with two different MTase activities; Alg2 adds both an alpha 1,3- and alpha 1,6-mannose onto ManG1cNAc(2)-PDol to form the trimannosyl core Man(3)G1cNAc(2)-PDol. The biochemical properties of Alg2 are controversial and remain undefined. In this study, a liquid chromatography/mass spectrometry-based quantitative assay was established and used to analyze the MTase activities of purified yeast Alg2. Alg2-dependent Man(3)G1cNAc(2)-PDol production relied on net-neutral lipids with a propensity to form bilayers. We further showed addition of the alpha 1,3- and alpha 1,6-mannose can occur independently in either order but at differing rates. The conserved C-terminal EX7E motif, N-terminal cytosolic tail, and 3 G-rich loop motifs in Alg2 play crucial roles for these activities, both in vitro and in vivo. These findings provide insight into the unique bifunctionality of Alg2 during LLO synthesis and lead to a new model in which alternative, independent routes exist for Alg2 catalysis of the trimannosyl core oligosaccharide.	[Li, Sheng-Tao; Wang, Ning; Xu, Xin-Xin; Fujita, Morihisa; Nakanishi, Hideki; Kitajima, Toshihiko; Gao, Xiao-Dong] Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Carbohydrate Chem & Biotechnol, Wuxi, Peoples R China; [Dean, Neta] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	Jiangnan University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Dean, N (corresponding author), SUNY Stony Brook, Stony Brook, NY 11794 USA.; Gao, XD (corresponding author), Jiangnan Univ, 1800 Lihu Ave, Wuxi 214122, Peoples R China.	neta.dean@stonybrook.edu; xdgao@jiangnan.edu.cn	Kitajima, Toshihiko/D-2463-2016; Fujita, Morihisa/AAM-4142-2020	Kitajima, Toshihiko/0000-0001-9677-5086; Wang, Ning/0000-0001-5287-5755	National Natural Science Foundation of China [21778023, 21576118, 31770853, 31400693]; Natural Science Foundation of Jiangsu Province [BK20170174]; Fundamental Research Funds for the Central Universities [JUSRP51629B, JUSRP11727]; Program of Introducing Talents of Discipline to Universities [111-2-06]; Young Thousand Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); Young Thousand Program	This work was supported by grants-in-aid from the National Natural Science Foundation of China (21778023, 21576118, 31770853, 31400693), Natural Science Foundation of Jiangsu Province (BK20170174), Fundamental Research Funds for the Central Universities (JUSRP51629B, JUSRP11727), Program of Introducing Talents of Discipline to Universities (111-2-06), and Young Thousand Program (to M.F.). The authors declare no conflicts of interest.	Abdian PL, 2000, J BIOL CHEM, V275, P40568, DOI 10.1074/jbc.M007496200; Absmanner B, 2010, BIOCHEM J, V426, P205, DOI 10.1042/BJ20091121; Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Agasoster AV, 2003, J BIOL CHEM, V278, P21790, DOI 10.1074/jbc.M211466200; Albesa-Jove D, 2014, GLYCOBIOLOGY, V24, P108, DOI 10.1093/glycob/cwt101; Baenziger JE, 2000, J BIOL CHEM, V275, P777, DOI 10.1074/jbc.275.2.777; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; CHIRALA SS, 1987, J BIOL CHEM, V262, P4231; Cid E, 2000, J BIOL CHEM, V275, P33614, DOI 10.1074/jbc.M005358200; Cossins J, 2013, BRAIN, V136, P944, DOI 10.1093/brain/awt010; Dowhan W, 2012, BBA-BIOMEMBRANES, V1818, P1097, DOI 10.1016/j.bbamem.2011.09.013; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; Geremia RA, 1996, BIOCHEM J, V318, P133, DOI 10.1042/bj3180133; Giganti D, 2013, J BIOL CHEM, V288, P29797, DOI 10.1074/jbc.M113.462705; Guthrie C., 2002, GUIDE YEAST GENETICS; Harada Y, 2013, P NATL ACAD SCI USA, V110, P19366, DOI 10.1073/pnas.1312187110; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Huang YC, 2016, PLANT MOL BIOL, V90, P127, DOI 10.1007/s11103-015-0401-3; HUFFAKER TC, 1983, P NATL ACAD SCI-BIOL, V80, P7466, DOI 10.1073/pnas.80.24.7466; Hwang HY, 2003, NATURE, V423, P439, DOI 10.1038/nature01634; JACKSON BJ, 1993, GLYCOBIOLOGY, V3, P357, DOI 10.1093/glycob/3.4.357; JACKSON BJ, 1989, ARCH BIOCHEM BIOPHYS, V272, P203, DOI 10.1016/0003-9861(89)90211-7; Jing W, 2000, GLYCOBIOLOGY, V10, P883, DOI 10.1093/glycob/10.9.883; Jing W, 2003, GLYCOBIOLOGY, V13, P661, DOI 10.1093/glycob/cwg085; Kampf M, 2009, J BIOL CHEM, V284, P11900, DOI 10.1074/jbc.M806416200; Kapitonov D, 1999, GLYCOBIOLOGY, V9, P961, DOI 10.1093/glycob/9.10.961; Kirsch T, 1997, BIOCHEMISTRY-US, V36, P3359, DOI 10.1021/bi9626867; Kostova Z, 2003, EUR J BIOCHEM, V270, P4507, DOI 10.1046/j.1432-1033.2003.03844.x; Li ST, 2017, BBA-GEN SUBJECTS, V1861, P2934, DOI 10.1016/j.bbagen.2016.09.023; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lu JS, 2012, GLYCOBIOLOGY, V22, P504, DOI 10.1093/glycob/cwr162; O'Reilly MK, 2006, BIOCHEMISTRY-US, V45, P9593, DOI 10.1021/bi060878o; Pabst M, 2008, ANAL CHEM, V80, P7534, DOI 10.1021/ac801024r; PRAKASH C, 1982, BIOCHEMISTRY-US, V21, P4810, DOI 10.1021/bi00262a045; Qasba PK, 2005, TRENDS BIOCHEM SCI, V30, P53, DOI 10.1016/j.tibs.2004.11.005; QURESHI AA, 1994, J CLIN INVEST, V93, P1812, DOI 10.1172/JCI117166; Ramirez AS, 2017, GLYCOBIOLOGY, V27, P726, DOI 10.1093/glycob/cwx045; Satoh T, 2015, MOLECULES, V20, P2475, DOI 10.3390/molecules20022475; Schmaltz RM, 2011, CHEM REV, V111, P4259, DOI 10.1021/cr200113w; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Seelig J, 2004, BBA-BIOMEMBRANES, V1666, P40, DOI 10.1016/j.bbamem.2004.08.004; Sheng F, 2009, J BIOL CHEM, V284, P17796, DOI 10.1074/jbc.M809804200; Takeuchi K, 1999, GLYCOBIOLOGY, V9, P1287, DOI 10.1093/glycob/9.12.1287; Thiel C, 2003, J BIOL CHEM, V278, P22498, DOI 10.1074/jbc.M302850200; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; van der Wel H, 2002, J BIOL CHEM, V277, P46527, DOI 10.1074/jbc.M208824200; Vitrac H, 2013, J BIOL CHEM, V288, P5873, DOI 10.1074/jbc.M112.442988; Wu R, 2015, J BACTERIOL, V197, P2734, DOI 10.1128/JB.00110-15	51	11	14	1	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2492	2506		10.1096/fj.201701267R	http://dx.doi.org/10.1096/fj.201701267R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29273674				2022-12-28	WOS:000432528000015
J	Nikonova, AS; Deneka, AY; Kiseleva, AA; Korobeynikov, V; Gaponova, A; Serebriiskii, IG; Kopp, MC; Hensley, HH; Seeger-Nukpezah, TN; Somlo, S; Proia, DA; Golemis, EA				Nikonova, Anna S.; Deneka, Alexander Y.; Kiseleva, Anna A.; Korobeynikov, Vladislav; Gaponova, Anna; Serebriiskii, Ilya G.; Kopp, Meghan C.; Hensley, Harvey H.; Seeger-Nukpezah, Tamina N.; Somlo, Stefan; Proia, David A.; Golemis, Erica A.			Ganetespib limits ciliation and cystogenesis in autosomal-dominant polycystic kidney disease (ADPKD)	FASEB JOURNAL			English	Article						PKD1; heat shock protein 90; polycystins; renal cyst; cilia	CYST GROWTH; RENAL CYSTOGENESIS; PROTEIN-KINASE; MOUSE MODEL; CELL-CYCLE; AURORA-A; CILIOGENESIS; INHIBITION; ACTIVATION; CANCER	Autosomal-dominant polycystic kidney disease (ADPKD) is associated with progressive formation of renal cysts, kidney enlargement, hypertension, and typically end-stage renal disease. In ADPKD, inherited mutations disrupt function of the polycystins (encoded by PKD1 and PKD2), thus causing loss of a cyst-repressive signal emanating from the renal cilium. Genetic studies have suggested ciliary maintenance is essential for ADPKD pathogenesis. Heat shock protein 90 (HSP90) clients include multiple proteins linked to ciliary maintenance. We determined that ganetespib, a clinical HSP90 inhibitor, inhibited proteasomal repression of NEK8 and the Aurora-A activator trichoplein, rapidly activating Aurora-A kinase and causing ciliary loss in vitro. Using conditional mouse models for ADPKD, we performed long-term (10 or 50 wk) dosing experiments that demonstrated HSP90 inhibition caused durable in vivo loss of cilia, controlled cystic growth, and ameliorated symptoms induced by loss of Pkd1 or Pkd2. Ganetespib efficacy was not increased by combination with 2-deoxy-n-glucose, a glycolysis inhibitor showing some promise for ADPKD. These studies identify a new biologic activity for HSP90 and support a cilia-based mechanism for cyst repression.	[Nikonova, Anna S.; Deneka, Alexander Y.; Kiseleva, Anna A.; Korobeynikov, Vladislav; Gaponova, Anna; Serebriiskii, Ilya G.; Kopp, Meghan C.; Hensley, Harvey H.; Seeger-Nukpezah, Tamina N.; Golemis, Erica A.] Fox Chase Canc Ctr, Inst Canc Res, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Deneka, Alexander Y.; Kiseleva, Anna A.; Serebriiskii, Ilya G.] Kazan Fed Univ, Kazan, Russia; [Korobeynikov, Vladislav] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Gaponova, Anna] Moscow Inst Phys & Technol, Lab Genome Engn, Dolgoprudnyi, Russia; [Gaponova, Anna] Immanuel Kant Balt Fed Univ, Konigsberg, Russia; [Kopp, Meghan C.] Drexel Univ, Coll Med, Canc Biol, Philadelphia, PA 19104 USA; [Seeger-Nukpezah, Tamina N.] Univ Cologne, Dept Internal Med 1, Cologne, Germany; [Seeger-Nukpezah, Tamina N.] Univ Cologne, Ctr Integrated Oncol, Cologne, Germany; [Somlo, Stefan] Yale Sch Med, Dept Internal Med, New Haven, CT USA; [Somlo, Stefan] Yale Sch Med, Dept Genet, New Haven, CT USA; [Proia, David A.] Synta Pharmaceut Corp, Lexington, MA USA	Fox Chase Cancer Center; Kazan Federal University; Columbia University; Moscow Institute of Physics & Technology; Immanuel Kant Baltic Federal University; Drexel University; University of Cologne; University of Cologne; Yale University; Yale University	Golemis, EA (corresponding author), Fox Chase Canc Ctr, W406,333 Cottman Ave, Philadelphia, PA 19111 USA.	erica.golemis@fccc.edu	Kiseleva, Anna/C-3046-2019; Deneka, Alexander/AAE-9202-2020; Kiseleva, Anna/AAE-9747-2020; Korobeynikov, Vlad/H-9541-2019	Kiseleva, Anna/0000-0002-8720-5062; Korobeynikov, Vlad/0000-0002-9127-292X; Golemis, Erica/0000-0003-3618-3673	NIH [NIDDK R01 DK108195]; DOD PRMRP [W81XWH-12-1-0437/PR110518]; PKD Foundation; Russian Government Program for Competitive Growth of Kazan Federal University; NIH National Cancer Institute Core Grant [CA006927]; NATIONAL CANCER INSTITUTE [T32CA009035, P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK108195, P30DK079310] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD PRMRP; PKD Foundation; Russian Government Program for Competitive Growth of Kazan Federal University; NIH National Cancer Institute Core Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors express sincere gratitude to J. Calvet (University of Kansas Cancer Center, Kansas City, KS, USA) and J. Grantham (Kansas University Medical Center, Kansas City, KS, USA) for helpful conversations and encouragement. The authors thank G. Germino [National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)] for providing the Pkd1 mutant mouse strains, S. Tarpinian and A. Lerro (Fox Chase Laboratory Animal Facility, Institute for Cancer Research, Fox Chase Cancer Center) for help with mice, and B. Egleston (Fox Chase Cancer Center Biostatistics Facility) for consultation on analysis. This work was supported by NIH, NIDDK R01 DK108195, by DOD PRMRP W81XWH-12-1-0437/PR110518, and by an award from the PKD Foundation (to E.A.G.); the Russian Government Program for Competitive Growth of Kazan Federal University (to A.Y.D. and A.A.K.); and by NIH National Cancer Institute Core Grant CA006927 (to Fox Chase Cancer Center). The authors declare no conflicts of interest.	Chang MY, 2012, NEPHRON CLIN PRACT, V120, pC25, DOI 10.1159/000334166; Chapman AB, 2010, CLIN J AM SOC NEPHRO, V5, P102, DOI 10.2215/CJN.04310709; Chiaravalli M, 2016, J AM SOC NEPHROL, V27, P1958, DOI 10.1681/ASN.2015030231; Cizmecioglu O, 2012, J CELL SCI, V125, P981, DOI 10.1242/jcs.095075; Ding XF, 2015, J BIOL CHEM, V290, P1389, DOI 10.1074/jbc.M114.589226; Echeverria PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026044; Erickson KF, 2013, ANN INTERN MED, V159, P382, DOI 10.7326/0003-4819-159-6-201309170-00004; Grantham JJ, 2016, NAT REV NEPHROL, V12, P667, DOI 10.1038/nrneph.2016.135; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Inoko A, 2012, J CELL BIOL, V197, P391, DOI 10.1083/jcb.201106101; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jhaveri K, 2015, ONCOTARGETS THER, V8, DOI 10.2147/OTT.S65804; Kasahara K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6081; Kim JH, 2016, BBA-MOL CELL RES, V1863, P1307, DOI 10.1016/j.bbamcr.2016.03.021; Kim S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9087; Lee JE, 2011, GENOME MED, V3, DOI 10.1186/gm275; Lee YR, 2006, NEPHRON CLIN PRACT, V103, pC173, DOI 10.1159/000092915; Lilja A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114975; Ma M, 2013, NAT GENET, V45, P1004, DOI 10.1038/ng.2715; Majumder S, 2013, CELL CYCLE, V12, P849, DOI 10.4161/cc.23824; Nicholls David G, 2010, J Vis Exp, DOI 10.3791/2511; Nikonova AS, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00228; Nikonova AS, 2014, P NATL ACAD SCI USA, V111, P12859, DOI 10.1073/pnas.1405362111; Nikonova AS, 2013, CELL MOL LIFE SCI, V70, P661, DOI 10.1007/s00018-012-1073-7; Outeda P, 2014, CELL REP, V7, P634, DOI 10.1016/j.celrep.2014.03.064; Pan JM, 2013, CELL MOL LIFE SCI, V70, P1849, DOI 10.1007/s00018-012-1052-z; Perrone RD, 2015, NAT REV NEPHROL, V11, P589, DOI 10.1038/nrneph.2015.128; Piontek KB, 2004, J AM SOC NEPHROL, V15, P3035, DOI 10.1097/01.ASN.0000144204.01352.86; Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675; Plotnikova OV, 2012, MOL BIOL CELL, V23, P2658, DOI 10.1091/mbc.E11-12-1056; Plotnikova OV, 2011, J CELL BIOL, V193, P1021, DOI 10.1083/jcb.201012061; Plotnikova OV, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1061; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Rasband W., 2006, IMAGEJ; Reichardt W, 2009, MAGN RESON MATER PHY, V22, P143, DOI 10.1007/s10334-008-0158-7; Rowe I, 2013, NAT MED, V19, P488, DOI 10.1038/nm.3092; Schrier RW, 2014, NEW ENGL J MED, V371, P2255, DOI 10.1056/NEJMoa1402685; Seeger-Nukpezah T, 2015, NAT REV NEPHROL, V11, P515, DOI 10.1038/nrneph.2015.46; Seeger-Nukpezah T, 2013, P NATL ACAD SCI USA, V110, P12786, DOI 10.1073/pnas.1301904110; Seeger-Nukpezah T, 2012, CURR OPIN CELL BIOL, V24, P652, DOI 10.1016/j.ceb.2012.06.002; Serra AL, 2010, NEW ENGL J MED, V363, P820, DOI 10.1056/NEJMoa0907419; Shaheen R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1099-5; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Shults J, 2007, STATA J, V7, P147, DOI 10.1177/1536867X0700700201; Smithline ZB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114403; Socinski MA, 2013, CLIN CANCER RES, V19, P3068, DOI 10.1158/1078-0432.CCR-12-3381; Spirli C, 2010, HEPATOLOGY, V51, P1778, DOI 10.1002/hep.23511; Spirli C, 2010, GASTROENTEROLOGY, V138, P360, DOI 10.1053/j.gastro.2009.09.005; Sweeney WE, 2008, J AM SOC NEPHROL, V19, P1331, DOI 10.1681/ASN.2007060665; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Takiar V, 2011, P NATL ACAD SCI USA, V108, P2462, DOI 10.1073/pnas.1011498108; Torres VE, 2003, KIDNEY INT, V64, P1573, DOI 10.1046/j.1523-1755.2003.00256.x; Torres VE, 2014, NEW ENGL J MED, V371, P2267, DOI 10.1056/NEJMoa1402686; Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511; Torres VE, 2009, KIDNEY INT, V76, P149, DOI 10.1038/ki.2009.128; van Dam Teunis Jp, 2013, Cilia, V2, P7, DOI 10.1186/2046-2530-2-7; WATSON ML, 1992, KIDNEY INT, V41, P206, DOI 10.1038/ki.1992.28; Wheway G, 2015, NAT CELL BIOL, V17, P1074, DOI 10.1038/ncb3201; Wu ZX, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.016675; Wuthrich RP, 2014, EXPERT OPIN PHARMACO, V15, P1085, DOI 10.1517/14656566.2014.903923; Zalli D, 2012, HUM MOL GENET, V21, P1155, DOI 10.1093/hmg/ddr544	61	23	23	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2735	2746		10.1096/fj.201700909R	http://dx.doi.org/10.1096/fj.201700909R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29401581	Green Published			2022-12-28	WOS:000432528000033
J	Sones, JL; Merriam, AA; Seffens, A; Brown-Grant, DA; Butler, SD; Zhao, AM; Xu, XJ; Shawber, CJ; Grenier, JK; Douglas, NC				Sones, Jennifer L.; Merriam, Audrey A.; Seffens, Angelina; Brown-Grant, Dex-Ann; Butler, Scott D.; Zhao, Anna M.; Xu, Xinjing; Shawber, Carrie J.; Grenier, Jennifer K.; Douglas, Nataki C.			Angiogenic factor imbalance precedes complement deposition in placentae of the BPH/5 model of preeclampsia	FASEB JOURNAL			English	Article						decidual vasculature; VEGF; sFlt-1; RGC32; implantation; trophoblast	SYSTEMS ACTIVATION FACTORS; GROWTH-FACTOR; MOUSE MODEL; TYROSINE KINASE-1; PREGNANCY LOSS; EXPRESSION; ONSET; HYPERTENSION; TROPHOBLAST; PROTEINURIA	Preeclampsia (PE), a hypertensive disorder of pregnancy, is a leading cause of maternal and fetal morbidity and mortality. Although the etiology is unknown, PE is thought to be caused by defective implantation and decidualization in pregnancy. Pregnant blood pressure high (BPH)/5 mice spontaneously develop placentopathies and maternal features of human PE. We hypothesized that BPH/5 implantation sites have transcriptomic alterations. Next-generation RNA sequencing of implantation sites at peak decidualization, embryonic day (E)7.5, revealed complement gene up-regulation in BPH/5 vs. controls. In BPH/5, expression of complement factor 3 was increased around the decidual vasculature of E7.5 implantation sites and in the trophoblast giant cell layer of E10.5 placentae. Altered expression of VEGF pathway genes in E5.5 BPH/5 implantation sites preceded complement dysregulation, which correlated with abnormal vasculature and increased placental growth factor mRNA and VEGF(164) expression at E7.5. By E10.5, proangiogenic genes were down-regulated, whereas antiangiogenic sFlt-1 was up-regulated in BPH/5 placentae. We found that early local misexpression of VEGF genes and abnormal decidual vasculature preceded sFlt-1 overexpression and increased complement deposition in BPH/5 placentae. Our findings suggest that abnormal decidual angiogenesis precedes complement activation, which in turn contributes to the aberrant trophoblast invasion and poor placentation that underlie PE.	[Sones, Jennifer L.] Louisiana State Univ, Sch Vet Med, Vet Clin Sci, Baton Rouge, LA 70803 USA; [Merriam, Audrey A.; Seffens, Angelina; Brown-Grant, Dex-Ann; Zhao, Anna M.; Xu, Xinjing; Shawber, Carrie J.; Douglas, Nataki C.] Columbia Univ Coll Phys & Surg, Dept Obstet & Gynecol, Div Reprod Sci, 622 West 168th St,P&S 16-440, New York, NY 10032 USA; [Butler, Scott D.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Grenier, Jennifer K.] Cornell Univ, Coll Vet Med, RNA Sequencing Core, Ctr Reprod Gen,Dept Biomed Sci, Ithaca, NY 14853 USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; Columbia University; Cornell University; Cornell University	Douglas, NC (corresponding author), Columbia Univ Coll Phys & Surg, Dept Obstet & Gynecol, Div Reprod Sci, 622 West 168th St,P&S 16-440, New York, NY 10032 USA.	nd2058@cumc.columbia.edu		Douglas, Nataki/0000-0001-8443-8875	U.S. National Institutes of Health (NIH) National Heart Lung and Blood Institute Grant [1R01HL127013-01A1]; NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant [P50-HD076210]; NIH National Cancer Institute Grant [P30 CA013696]; NIH National Center for Research Resources Grant [S10 RR025686]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD076210] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA013696] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025686] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127013] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart Lung and Blood Institute Grant; NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant; NIH National Cancer Institute Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Center for Research Resources Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Robin L. Davisson for the generous gift of BPH/5 mice and additional support; Michelle A. Hoch for assistance with data analysis; Jan K. Kitajewski and Virginia E. Papaioannou for in-depth discussions and assistance with manuscript editing; and Theresa Swayne and Emilia Laura Munteanu for technical assistance with confocal microscopy. This work was supported by U.S. National Institutes of Health (NIH) National Heart Lung and Blood Institute Grant 1R01HL127013-01A1 (to N.C.D) and NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant P50-HD076210 (to J.L.S. and J.K.G.). Immunofluorescence images were collected in the Confocal and Specialized Microscopy Shared Resource of the Herbert Irving Comprehensive Cancer Center at Columbia University (New York, NY, USA), supported by NIH National Cancer Institute Grant P30 CA013696. The confocal microscope was purchased with NIH National Center for Research Resources Grant S10 RR025686. The authors declare no conflicts of interest.	Burwick RM, 2013, PLACENTA, V34, P201, DOI 10.1016/j.placenta.2012.11.014; Burwick RM, 2013, HYPERTENSION, V62, P1040, DOI 10.1161/HYPERTENSIONAHA.113.01420; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Chang YS, 2017, PEDIATR NEONATOL, V58, P529, DOI 10.1016/j.pedneo.2016.10.005; Chen CW, 2014, CARDIOVASC RES, V101, P579, DOI 10.1093/cvr/cvu018; Chu A, 2016, NUTR RES, V36, P1055, DOI 10.1016/j.nutres.2016.08.001; Cui XB, 2013, CARDIOVASC RES, V99, P632, DOI 10.1093/cvr/cvt121; Daikoku T, 2003, J BIOL CHEM, V278, P7683, DOI 10.1074/jbc.M211390200; Davisson RL, 2002, HYPERTENSION, V39, P337, DOI 10.1161/hy02t2.102904; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Dokras A, 2006, BIOL REPROD, V75, P899, DOI 10.1095/biolreprod.106.053603; Douglas NC, 2014, VASC CELL, V6, DOI 10.1186/2045-824X-6-16; Douglas NC, 2009, REPROD BIOMED ONLINE, V19, P257, DOI 10.1016/S1472-6483(10)60082-X; Douglas NC, 2009, ENDOCRINOLOGY, V150, P3845, DOI 10.1210/en.2008-1207; Droge LA, 2017, PREGNANCY HYPERTENS, V8, P31, DOI 10.1016/j.preghy.2017.02.005; Fan XJ, 2014, J CLIN INVEST, V124, P4941, DOI 10.1172/JCI76864; Gelber SE, 2015, J IMMUNOL, V195, P1129, DOI 10.4049/jimmunol.1402220; Ghulmiyyah L, 2012, SEMIN PERINATOL, V36, P56, DOI 10.1053/j.semperi.2011.09.011; Halder JB, 2000, GENESIS, V26, P213, DOI 10.1002/(SICI)1526-968X(200003)26:3<213::AID-GENE7>3.0.CO;2-M; Hazarika S, 2007, CIRC RES, V101, P948, DOI 10.1161/CIRCRESAHA.107.160630; He YD, 2016, HYPERTENS PREGNANCY, V35, P499, DOI 10.1080/10641955.2016.1190845; He YD, 2016, AM J REPROD IMMUNOL, V76, P205, DOI 10.1111/aji.12541; Heyward CY, 2017, J REPROD IMMUNOL, V120, P27, DOI 10.1016/j.jri.2017.04.002; Hoffmann DS, 2008, HYPERTENSION, V51, P1058, DOI 10.1161/HYPERTENSIONAHA.107.107219; Huckle WR, 2004, J CELL BIOCHEM, V93, P120, DOI 10.1002/jcb.20142; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim M, 2013, EMBO MOL MED, V5, P1415, DOI 10.1002/emmm.201302618; Lacko LA, 2014, MECH DEVELOP, V133, P163, DOI 10.1016/j.mod.2014.04.001; Levin HI, 2017, PLACENTA, V55, P5, DOI 10.1016/j.placenta.2017.04.014; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Lokki AI, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00312; Lynch AM, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.02.035; Lynch AM, 2011, OBSTET GYNECOL, V117, P75, DOI 10.1097/AOG.0b013e3181fc3afa; Lynch AM, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.07.044; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Oatley MJ, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.139832; Qing XP, 2011, KIDNEY INT, V79, P331, DOI 10.1038/ki.2010.393; Rampersad R, 2008, PLACENTA, V29, P855, DOI 10.1016/j.placenta.2008.07.008; Redman CWG, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.08.003; Regal JF, 2015, MOL IMMUNOL, V67, P56, DOI 10.1016/j.molimm.2015.02.030; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Rupprecht TA, 2007, J IMMUNOL, V178, P1861, DOI 10.4049/jimmunol.178.3.1861; SCHLAGER G, 1974, GENETICS, V76, P537; Singh J, 2011, HYPERTENSION, V58, P716, DOI 10.1161/HYPERTENSIONAHA.111.175919; Sones JL, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.75351; Sones JL, 2014, AM J PHYSIOL-REG I, V307, pR490, DOI 10.1152/ajpregu.00176.2014; Sovio U, 2017, HYPERTENSION, V69, P731, DOI 10.1161/HYPERTENSIONAHA.116.08620; Spradley FT, 2015, AM J PHYSIOL-REG I, V309, pR1326, DOI 10.1152/ajpregu.00178.2015; Spradley FT, 2015, BIOMOLECULES, V5, P3142, DOI 10.3390/biom5043142; Sutton EF, 2017, AM J PHYSIOL-REG I, V312, pR485, DOI 10.1152/ajpregu.00512.2016; Szalai G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110867; Taylor RN, 2003, AM J OBSTET GYNECOL, V188, P177, DOI 10.1067/mob.2003.111; Thadhani R, 2004, J CLIN ENDOCR METAB, V89, P770, DOI 10.1210/jc.2003-031244; Thurman JM, 2005, MOL IMMUNOL, V42, P87, DOI 10.1016/j.molimm.2004.07.043; Tidwell SC, 2001, AM J OBSTET GYNECOL, V184, P1267, DOI 10.1067/mob.2001.113129; Tomimatsu T, 2017, HYPERTENS RES, V40, P305, DOI 10.1038/hr.2016.152; Tranquilli AL, 2014, PREGNANCY HYPERTENS, V4, P97, DOI [10.1016/j.preghy.2014.02.001, 10.1016/j.preghy.2014.04.007, 10.1016/j.preghy.2014.04.017]; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Triunfo S, 2016, PLACENTA, V42, P44, DOI 10.1016/j.placenta.2016.04.005; Vlaicu SI, 2008, ARCH IMMUNOL THER EX, V56, P115, DOI 10.1007/s00005-008-0016-3; Vorontchikhina MA, 2005, GENE EXPR PATTERNS, V5, P701, DOI 10.1016/j.modgep.2005.02.001; Vrachnis N, 2013, J MATERN-FETAL NEO M, V26, P995, DOI 10.3109/14767058.2013.766694; Wang QJ, 2015, PLACENTA, V36, P350, DOI 10.1016/j.placenta.2014.12.012; Wang W, 2012, HYPERTENSION, V60, P712, DOI 10.1161/HYPERTENSIONAHA.112.191817; Woods AK, 2011, HYPERTENSION, V57, P94, DOI 10.1161/HYPERTENSIONAHA.110.160242; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; Young CN, 2012, J CLIN INVEST, V122, P3960, DOI 10.1172/JCI64583; Zou L, 2016, J IMMUNOL, V196, P2788, DOI 10.4049/jimmunol.1502106	70	28	29	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2574	2586		10.1096/fj.201701008R	http://dx.doi.org/10.1096/fj.201701008R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29279353	Green Published			2022-12-28	WOS:000432528000022
J	Val, S; Krueger, A; Poley, M; Cohen, A; Brown, K; Panigrahi, A; Preciado, D				Val, Stephanie; Krueger, Anna; Poley, Marian; Cohen, Ariella; Brown, Kristy; Panigrahi, Aswini; Preciado, Diego			Nontypeable Haemophilus influenzae lysates increase heterogeneous nuclear ribonucleoprotein secretion and exosome release in human middle-ear epithelial cells	FASEB JOURNAL			English	Article						otitis media; quantitative proteomic; infection; innate immunity; vesicle	ACUTE OTITIS-MEDIA; PHOSPHATASE-1-DEPENDENT INHIBITION; EXTRACELLULAR VESICLES; P38 MAPK; EXPRESSION; RNA; MICRORNAS; MUC5AC; IDENTIFICATION; BIOMARKERS	Nontypeable Haemophilus influenzae (NTHi), one of the most common acute otitis media (OM) pathogens, is postulated to promote middle-ear epithelial remodeling in the progression of OM from acute to chronic. The goal of this study was to examine early quantitative proteomic secretome effects of NTHi lysate exposure in a human middle-ear epithelial cell (HMEEC) line. NTHi lysates were used to stimulate HMEEC, and conditional quantitative stable isotope labeling with amino acids in cell culture of cell secretions was performed. Mass spectrometry analysis identified 766 proteins across samples. Of interest, several heterogeneous nuclear ribonucleoproteins (hnRNPs) were regulated by NTHi lysate treatment, especially hnRNP A2B1 and hnRNP Q, known to be implicated in microRNA (miRNA) packaging in exosomes. After purification, the presence of exosomes in HMEEC secretions was characterized by dynamic light scattering (<100 nm), transmission electron microscopy, and CD63/heat shock protein 70 positivity. hnRNP A2B1 and hnRNP Q were confirmed to be found in exosomes by Western blot and proteomic analysis. Finally, exosomal miRNA content comprised 110 unique miRNAs, with 5 found to be statistically induced by NTHi lysate (miR-378a-3p + miR-378i, miR-200a-3p, miR-378g, miR30d-5p, and miR-222-3p), all known to target innate immunity genes. This study demonstrates that NTHi lysates promote release of miRNA-laden exosomes from middle-ear epithelium in vitro.	[Val, Stephanie; Krueger, Anna; Poley, Marian; Cohen, Ariella; Preciado, Diego] Childrens Natl Hlth Syst, Sheikh Zayed Inst Pediat Surg Innovat, 111 Michigan Ave NW, Washington, DC 20010 USA; [Brown, Kristy; Panigrahi, Aswini] Childrens Natl Hlth Syst, Ctr Genet Med Res, Washington, DC 20010 USA; [Preciado, Diego] Childrens Natl Hlth Syst, Div Pediat Otolaryngol, Washington, DC 20010 USA	Children's National Health System; Children's National Health System; Children's National Health System	Val, S (corresponding author), Childrens Natl Hlth Syst, Sheikh Zayed Inst Pediat Surg Innovat, 111 Michigan Ave NW, Washington, DC 20010 USA.	sval@cnmc.org			U.S. National Institutes of Health (NIH) [2R24HD050846-06]; National Institute of Child Health and Human Development [5P30HD040677, UL1TR000075]; NIH, District of Columbia Intellectual and Developmental Disabilities Research Center Award (DC-IDDRC) Program [1U54HD090257-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050846, P30HD040677, U54HD090257] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012377] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH, District of Columbia Intellectual and Developmental Disabilities Research Center Award (DC-IDDRC) Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors thank Drs. Mary C. Rose and Colberg-Poley (Center for Genetic Medicine) for their kind advice. This work was partially supported by U.S. National Institutes of Health (NIH) Core Grants 2R24HD050846-06 (National Center for Medical Rehabilitation Research), National Institute of Child Health and Human Development 5P30HD040677 (Intellectual and Developmental Disabilities Research Center), and UL1TR000075 (NIH National Center for Advancing Translational Sciences), and for the proteomics analysis supported by Award Number 1U54HD090257-01 from NIH, District of Columbia Intellectual and Developmental Disabilities Research Center Award (DC-IDDRC) Program. The EM analysis was carried out at the George Washington University Nanofabrication and Imaging Center (GWNIC) with the help of Christine Brantner and Anastas Popratiloff. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Center for Advancing Translational Sciences or the NIH.	Ahmed S, 2014, LARYNGOSCOPE, V124, P301, DOI 10.1002/lary.24190; Bracken CP, 2014, EMBO J, V33, P2040, DOI 10.15252/embj.201488641; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brown KJ, 2013, BBA-PROTEINS PROTEOM, V1834, P2454, DOI 10.1016/j.bbapap.2013.04.007; Casey JR, 2004, PEDIATR INFECT DIS J, V23, P824, DOI 10.1097/01.inf.0000136871.51792.19; Cherry Donald K, 2002, Adv Data, P1; Chun YM, 2002, ANN OTO RHINOL LARYN, V111, P507, DOI 10.1177/000348940211100606; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Grubb MS, 2010, CLIN PEDIATR, V49, P970, DOI 10.1177/0009922810370363; Hathout Y, 2005, J PROTEOME RES, V4, P620, DOI 10.1021/pr049749p; Inamura K, 2016, J CLIN MED, V5, DOI 10.3390/jcm5030036; Janas T, 2015, FEBS LETT, V589, P1391, DOI 10.1016/j.febslet.2015.04.036; Jono H, 2003, J BIOL CHEM, V278, P27811, DOI 10.1074/jbc.M301773200; Jorgensen M, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20920; Juhn SK, 2008, CLIN EXP OTORHINOLAR, V1, P117, DOI 10.3342/ceo.2008.1.3.117; Keller S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-86; Kesimer M, 2015, METHODS, V87, P59, DOI 10.1016/j.ymeth.2015.03.013; Kesimer M, 2009, FASEB J, V23, P1858, DOI 10.1096/fj.08-119131; Klein JO, 2002, AM J MANAG CARE, V8, pS345; Komatsu K, 2008, BIOCHEM BIOPH RES CO, V377, P763, DOI 10.1016/j.bbrc.2008.10.091; Krishn Shiv Ram, 2015, Curr Pharmacol Rep, V1, P355; Lasser C, 2012, EXPERT OPIN BIOL TH, V12, pS189, DOI 10.1517/14712598.2012.680018; Lee HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-87; Li HG, 2014, EUR REV MED PHARMACO, V18, P2048; Lieberthal AS, 2013, PEDIATRICS, V131, pE964, DOI 10.1542/peds.2012-3488; LIM DJ, 1971, ANN OTO RHINOL LARYN, V80, P838, DOI 10.1177/000348947108000611; Lin J, 2016, TUMOR BIOL, V37, P15835, DOI 10.1007/s13277-016-5410-6; Lin JZ, 2003, JARO-J ASSOC RES OTO, V4, P384, DOI 10.1007/s10162-002-3023-9; Liu J, 2009, INT REV IMMUNOL, V28, P139, DOI 10.1080/08830180902943058; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mobergslien A, 2014, J INNATE IMMUN, V6, P105, DOI 10.1159/000351460; Moon SK, 2006, ACTA OTO-LARYNGOL, V126, P564, DOI 10.1080/00016480500452525; Pellatt DF, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2016.11; Preciado D, 2016, INT J PEDIATR OTORHI, V80, P8, DOI 10.1016/j.ijporl.2015.11.016; Preciado D, 2013, LARYNGOSCOPE, V123, pE66, DOI 10.1002/lary.24097; Preciado D, 2010, PEDIATR RES, V68, P231, DOI 10.1203/00006450-201011001-00451; Rosenfeld RM, 2016, OTOLARYNG HEAD NECK, V154, P201, DOI 10.1177/0194599815624407; Ryan AF, 2005, ANN OTO RHINOL LARYN, V114, P42, DOI 10.1177/00034894051140S106; Samuels TL, 2016, INT J PEDIATR OTORHI, V88, P104, DOI 10.1016/j.ijporl.2016.06.056; Santangelo L, 2016, CELL REP, V17, P799, DOI 10.1016/j.celrep.2016.09.031; Sato-Kuwabara Y, 2015, INT J ONCOL, V46, P17, DOI 10.3892/ijo.2014.2712; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Song JJ, 2011, INT J PEDIATR OTORHI, V75, P648, DOI 10.1016/j.ijporl.2011.02.001; Staedel C, 2013, CELL MICROBIOL, V15, P1496, DOI 10.1111/cmi.12159; Val S, 2017, PEDIATR RES, V81, P911, DOI 10.1038/pr.2017.25; Val S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152865; Val S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148612; Val S, 2015, JAMA OTOLARYNGOL, V141, P997, DOI 10.1001/jamaoto.2015.2338; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Watanabe T, 2004, P NATL ACAD SCI USA, V101, P3563, DOI 10.1073/pnas.0400557101; Whitby PW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-925; Wu XF, 2011, AM J RESP CELL MOL, V45, P525, DOI 10.1165/rcmb.2010-0133OC; Wu YT, 2015, ANALYST, V140, P6631, DOI 10.1039/c5an00688k; Yang J, 2013, ACTA BIOCH BIOPH SIN, V45, P938, DOI 10.1093/abbs/gmt100	54	7	7	0	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1855	1867		10.1096/fj.201700248RR	http://dx.doi.org/10.1096/fj.201700248RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29191962	Green Published			2022-12-28	WOS:000429051400010
J	Marneros, AG				Marneros, Alexander G.			Effects of chronically increased VEGF-A on the aging heart	FASEB JOURNAL			English	Article						myocardial hypertrophy; angiogenesis; NLRP3; cardiac failure	INDUCED CARDIAC-HYPERTROPHY; GROWTH-FACTOR; PRESSURE-OVERLOAD; ANGIOTENSIN-II; IN-VIVO; MICE; FAILURE; ANGIOGENESIS; ACTIVATION; INFLAMMASOME	Whether approaches to chronically increase VEGF-A in the heart may have beneficial effects and prevent the development of heart failure, in part by improving cardiac perfusion, or whether this increase could have detrimental effects on cardiac performance in the aging heart, has not been tested yet. In this study, a genetic mouse model with a chronic increase in VEGF-A in the heart is shown to have increased cardiac angiogenesis and develop cardiac hypertrophy with enhanced basal cardiac performance with age progression. However, in aged hearts, this increase in VEGF-A was associated with higher expression of fetal cardiac genes and reduced cardiac performance after beta-agonistic stress, features consistent with pathologic cardiac hypertrophy. Expression of Nod-like receptor protein (NLRP)-3 was increased in the hearts of the mice, and its genetic inactivation prevented increased fetal cardiac gene expression and partially rescued the impaired cardiac performance after beta-agonistic stimulation in aged hearts without reducing cardiac angiogenesis or hypertrophy. Thus, although a chronic increase in cardiac VEGF-A may improve cardiac perfusion, long-term upregulation of VEGF-A leads to reduced cardiac performance under stress, an effect that can be partially inhibited by NLRP3 inactivation. Targeting NLRP3 shifts the VEGF-A-induced cardiac hypertrophy from a pathologic toward a more physiologic hypertrophy.	[Marneros, Alexander G.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Boston, MA 02114 USA; [Marneros, Alexander G.] Harvard Med Sch, Dept Dermatol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Marneros, AG (corresponding author), Massachusetts Gen Hosp, CNY-149,13th St, Charlestown, MA 02129 USA.	amarneros@mgh.harvard.edu		Marneros, Alexander/0000-0003-3866-020X	Massachusetts General Hospital	Massachusetts General Hospital(General Electric)	The author thanks Karin Strittmatter, and Peter Kang and Qingen Ke (Beth Israel Deaconess Medical Center Cardiac Physiology Core Facility) for technical help, and Dr. Peter Kang for helpful discussions of the findings. This study was supported by institutional funds from Massachusetts General Hospital (to A.G.M.). The author declares no conflicts of interest.	Abid MR, 2001, FASEB J, V15, P2548, DOI 10.1096/fj.01-0338fje; Abid MR, 2000, FEBS LETT, V486, P252, DOI 10.1016/S0014-5793(00)02305-X; Abraham D, 2000, CIRC RES, V87, P644, DOI 10.1161/01.RES.87.8.644; Bracey NA, 2014, J BIOL CHEM, V289, P19571, DOI 10.1074/jbc.M114.550624; Bry M, 2010, CIRCULATION, V122, P1725, DOI 10.1161/CIRCULATIONAHA.110.957332; Brydges SD, 2009, IMMUNITY, V30, P875, DOI 10.1016/j.immuni.2009.05.005; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Byrne JA, 2003, CIRC RES, V93, P802, DOI 10.1161/01.RES.0000099504.30207.F5; Colavitti R, 2002, J BIOL CHEM, V277, P3101, DOI 10.1074/jbc.M107711200; Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399; Dor Y, 2002, EMBO J, V21, P1939, DOI 10.1093/emboj/21.8.1939; Fares E, 2010, CLIN EXP PHARMACOL P, V37, P1, DOI 10.1111/j.1440-1681.2009.05276.x; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Giordano FJ, 2001, P NATL ACAD SCI USA, V98, P5780, DOI 10.1073/pnas.091415198; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Helmlinger G, 2000, NATURE, V405, P139, DOI 10.1038/35012132; Jaba IM, 2013, J CLIN INVEST, V123, P1718, DOI 10.1172/JCI65112; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kivela R, 2014, EMBO MOL MED, V6, P307, DOI 10.1002/emmm.201303147; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Manukyan I, 2010, J CELL MOL MED, V14, P1707, DOI 10.1111/j.1582-4934.2009.00804.x; Marneros AG, 2016, EMBO MOL MED, V8, P208, DOI 10.15252/emmm.201505613; Marneros AG, 2013, CELL REP, V4, P945, DOI 10.1016/j.celrep.2013.08.002; Miquerol L, 1999, DEV BIOL, V212, P307, DOI 10.1006/dbio.1999.9355; Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021; Monaghan-Benson E, 2009, J BIOL CHEM, V284, P25602, DOI 10.1074/jbc.M109.009894; Nakagami H, 2003, J MOL CELL CARDIOL, V35, P851, DOI 10.1016/S0022-2828(03)00145-7; Ohtsuka T, 2005, EUR J HEART FAIL, V7, P689, DOI 10.1016/j.ejheart.2004.09.011; Pacher P, 2004, AM J PHYSIOL-HEART C, V287, pH2132, DOI 10.1152/ajpheart.00405.2004; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Satoh M, 2006, P NATL ACAD SCI USA, V103, P7432, DOI 10.1073/pnas.0510444103; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Shiojima I, 2006, GENE DEV, V20, P3347, DOI 10.1101/gad.1492806; Simons M, 2016, NAT REV MOL CELL BIO, V17, P611, DOI 10.1038/nrm.2016.87; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; Tirziu D, 2007, J CLIN INVEST, V117, P3188, DOI 10.1172/JCI32024; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Xu XH, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-54; Zentilin L, 2010, FASEB J, V24, P1467, DOI 10.1096/fj.09-143180; Zolk O, 2008, BIOCHEM BIOPH RES CO, V376, P315, DOI 10.1016/j.bbrc.2008.08.152	45	14	17	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1550	1565		10.1096/fj.201700761RR	http://dx.doi.org/10.1096/fj.201700761RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29146733				2022-12-28	WOS:000427246000034
J	Prodanovic, D; Keenan, CR; Langenbach, S; Li, MN; Chen, QY; Lew, MJ; Stewart, AG				Prodanovic, Danica; Keenan, Christine R.; Langenbach, Shenna; Li, Meina; Chen, Qianyu; Lew, Michael J.; Stewart, Alastair G.			Cortisol limits selected actions of synthetic glucocorticoids in the airway epithelium	FASEB JOURNAL			English	Article						partial agonist; steroid resistance; asthma; stress; inhaled corticosteroids	PERIPHERAL-BLOOD NEUTROPHILS; FINGER PROTEIN PLZF; GM-CSF; INDUCED APOPTOSIS; CELL LINE; INHALED CORTICOSTEROIDS; FLUTICASONE PROPIONATE; SODIUM-CHANNEL; SMOOTH-MUSCLE; IN-VITRO	Cortisol, a physiologic glucocorticoid (GC), is essential for growth and differentiation of the airway epithelium. Epithelial function influences inflammation in chronic respiratory diseases. Synthetic GCs, including inhaled corticosteroids, exert anti-inflammatory effects in airway epithelium by transactivation of genes and by inhibition of proinflammatory cytokine release. We examined the effect of cortisol on the actions of synthetic GCs in the airway epithelium, demonstrating that cortisol acts like a partial agonist at the GC receptor (GR), limiting GC-induced GR-dependent transcription in the BEAS-2B human bronchial epithelial cell line. Cortisol also limited the inhibition of granulocyte macrophage colony-stimulating factor release by synthetic GCs in TNF-alpha-activated BEAS-2B cells. The relevance of these findings is supported by observations on tracheal epithelium obtained from mice treated for 5 d with systemic GC, showing limitations in selected GC effects, including inhibition of IL-6. Moreover, gene transactivation by synthetic GCs was compromised by standard air-liquid interface (ALI) growth medium cortisol concentration (1.4 mu M) in the ALI-differentiated organotypic culture of primary human airway epithelial cells. These findings suggest that endogenous corticosteroids may limit certain actions of synthetic pharmacological GCs and contribute to GC insensitivity, particularly when corticosteroid levels are elevated by stress.	[Prodanovic, Danica; Keenan, Christine R.; Langenbach, Shenna; Li, Meina; Chen, Qianyu; Lew, Michael J.; Stewart, Alastair G.] Univ Melbourne, Dept Pharmacol & Therapeut, Lung Hlth Res Ctr, Parkville, Vic, Australia; [Stewart, Alastair G.] Univ Melbourne, Australian Res Council ARC Ctr Personalised Thera, Parkville, Vic, Australia	University of Melbourne; University of Melbourne	Stewart, AG (corresponding author), Univ Melbourne, 181 Grattan St,Med Bldg, Parkville, Vic 3010, Australia.	astew@unimelb.edu.au		Lew, Michael/0000-0002-2523-7990; stewart, alastair/0000-0002-2271-5942; Keenan, Christine/0000-0002-6057-1855	Asthma Australia; National Health and Medical Research Council (NHMRC) [1059665]	Asthma Australia; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Asthma Australia and the National Health and Medical Research Council (NHMRC) Grant 1059665. The authors declare no conflicts of interest.	Chambers ES, 2015, J ALLERGY CLIN IMMUN, V136, P628, DOI 10.1016/j.jaci.2015.01.026; Chen E, 2007, BRAIN BEHAV IMMUN, V21, P993, DOI 10.1016/j.bbi.2007.03.009; COECK C, 1991, NEW ENGL J MED, V325, P738; COX G, 1992, AM J RESP CELL MOL, V7, P507, DOI 10.1165/ajrcmb/7.5.507; Daley-Yates PT, 2015, BRIT J CLIN PHARMACO, V80, P372, DOI 10.1111/bcp.12637; DeBosscher K, 1997, P NATL ACAD SCI USA, V94, P13504, DOI 10.1073/pnas.94.25.13504; deCastro M, 1996, MOL MED, V2, P597, DOI 10.1007/BF03401643; Dorscheid DR, 2006, AM J PHYSIOL-LUNG C, V291, pL794, DOI 10.1152/ajplung.00322.2005; Eddleston J, 2007, J ALLERGY CLIN IMMUN, V119, P115, DOI 10.1016/j.jaci.2006.08.027; Erle DJ, 2014, J CELL BIOL, V205, P621, DOI 10.1083/jcb.201401050; Fahnenstich J, 2003, MOL HUM REPROD, V9, P611, DOI 10.1093/molehr/gag080; Fossati G, 1998, INT J MOL MED, V1, P943; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Funder JW, 2005, HEART FAIL REV, V10, P15, DOI 10.1007/s10741-005-2344-2; Goleva E, 2008, J ALLERGY CLIN IMMUN, V122, P550, DOI 10.1016/j.jaci.2008.07.007; Gruver-Yates Amanda L, 2013, Cells, V2, P202, DOI 10.3390/cells2020202; HARDING SM, 1990, RESP MED, V84, P25, DOI 10.1016/S0954-6111(08)80004-2; Heijink IH, 2016, RESP RES, V17, DOI 10.1186/s12931-015-0318-z; Henley D, 2016, PHARMACOL THERAPEUT, V166, P128, DOI 10.1016/j.pharmthera.2016.06.020; Holliday MA, 1999, PEDIATR NEPHROL, V13, P989, DOI 10.1007/s004670050741; Joshi T, 2015, BRIT J PHARMACOL, V172, P1360, DOI 10.1111/bph.13014; Jung C, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-91; Kapoor Upender, 2003, Indian Journal of Pediatrics, V70, P965, DOI 10.1007/BF02723822; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; Keenan CR, 2015, PHARMACOL THERAPEUT, V150, P81, DOI 10.1016/j.pharmthera.2015.01.006; Keenan CR, 2015, CAN J PHYSIOL PHARM, V93, P203, DOI 10.1139/cjpp-2014-0391; Keenan CR, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-55; Korn SH, 2001, EUR RESPIR J, V17, P1070, DOI 10.1183/09031936.01.00073301; Kozyrskyj AL, 2008, AM J RESP CRIT CARE, V177, P142, DOI 10.1164/rccm.200703-381OC; Kudielka BM, 2004, PSYCHONEUROENDOCRINO, V29, P983, DOI 10.1016/j.psyneuen.2003.08.009; Laan M, 2003, EUR RESPIR J, V21, P387, DOI 10.1183/09031936.03.00303503; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Landstra AM, 2002, AM J RESP CRIT CARE, V165, P708, DOI 10.1164/ajrccm.165.5.2102115; Laube BL, 2002, RESP MED, V96, P823, DOI 10.1053/rmed.2002.1366; Leigh R, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.243; LeVan TD, 1997, AM J PHYSIOL-LUNG C, V272, pL838, DOI 10.1152/ajplung.1997.272.5.L838; LEVINE SJ, 1993, AM J PHYSIOL, V265, pL360, DOI 10.1152/ajplung.1993.265.4.L360; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Menshanov PN, 2013, PHYSIOL RES, V62, P205, DOI 10.33549/physiolres.932339; Morjaria JB, 2011, THORAX, V66, P537, DOI 10.1136/thx.2010.136523; Neveu WA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-28; Newton R, 2014, EUR J PHARMACOL, V724, P231, DOI 10.1016/j.ejphar.2013.05.035; Oelkers W, 1996, NEW ENGL J MED, V335, P1206, DOI 10.1056/NEJM199610173351607; Orsida BE, 2002, AM J RESP CRIT CARE, V165, P1010, DOI 10.1164/ajrccm.165.7.2105003; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; Pelaia G, 2003, AM J RESP CELL MOL, V29, P12, DOI 10.1165/rcmb.2002-0074OC; Perogamvros I, 2012, NAT REV ENDOCRINOL, V8, P717, DOI 10.1038/nrendo.2012.134; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Rider CF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116773; Rincon M, 2012, INT J BIOL SCI, V8, P1281, DOI 10.7150/ijbs.4874; Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; Sadler AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7795; Samuelsson MKR, 1999, MOL ENDOCRINOL, V13, P1811, DOI 10.1210/me.13.11.1811; Sayegh R, 1999, J BIOL CHEM, V274, P12431, DOI 10.1074/jbc.274.18.12431; Seckl JR, 2004, CURR OPIN PHARMACOL, V4, P597, DOI 10.1016/j.coph.2004.09.001; Smoak KA, 2004, MECH AGEING DEV, V125, P697, DOI 10.1016/j.mad.2004.06.010; SOUSA AR, 1993, AM REV RESPIR DIS, V147, P1557, DOI 10.1164/ajrccm/147.6_Pt_1.1557; Stellato C, 2007, J ALLERGY CLIN IMMUN, V120, P1247, DOI 10.1016/j.jaci.2007.10.041; Strandberg K, 2008, J ASTHMA, V45, P201, DOI 10.1080/02770900801890372; Suliman Bandar Ali, 2012, Front Oncol, V2, P74, DOI 10.3389/fonc.2012.00074; Sutherland ER, 2003, J ALLERGY CLIN IMMUN, V112, P52, DOI 10.1067/mai.2003.1608; Thanawala VJ, 2013, AM J RESP CELL MOL, V48, P220, DOI 10.1165/rcmb.2012-0364OC; TRAPP T, 1994, NEURON, V13, P1457, DOI 10.1016/0896-6273(94)90431-6; Trevor JL, 2014, ALLERGY, V69, P817, DOI 10.1111/all.12412; Turpeinen T, 2010, J PHARMACOL EXP THER, V333, P310, DOI 10.1124/jpet.109.157438; Viengchareun Say, 2007, Nucl Recept Signal, V5, pe012, DOI 10.1621/nrs.05012; Vink NM, 2013, EUR RESPIR J, V41, P846, DOI 10.1183/09031936.00021212; Wasim M, 2012, PAK J PHARM SCI, V25, P617; Wasim M, 2010, J STEROID BIOCHEM, V120, P218, DOI 10.1016/j.jsbmb.2010.04.019; Wen LP, 1997, AM J PHYSIOL-LUNG C, V273, pL921, DOI 10.1152/ajplung.1997.273.5.L921; White SR, 2005, AM J RESP CELL MOL, V32, P301, DOI 10.1165/rcmb.2004-0118OC; Wine E, 2013, J CROHNS COLITIS, V7, P916, DOI 10.1016/j.crohns.2012.12.012; Xia YXC, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006138	76	6	7	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1692	1704		10.1096/fj.201700730R	http://dx.doi.org/10.1096/fj.201700730R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29167235				2022-12-28	WOS:000427246000045
J	Qu, RZ; Chen, XM; Wang, WH; Qiu, C; Ban, MM; Guo, LL; Vasilev, K; Chen, JY; Li, WW; Zhao, YP				Qu, Ruize; Chen, Xiaomin; Wang, Wenhan; Qiu, Cheng; Ban, Miaomiao; Guo, Linlin; Vasilev, Krasimir; Chen, Jianying; Li, Weiwei; Zhao, Yunpeng			Ghrelin protects against osteoarthritis through interplay with Akt and NF-kappa B signaling pathways	FASEB JOURNAL			English	Article						inflammatory cytokines; IL-1 beta; TNF-alpha; cartilage; chondrocyte	VITREOUS CYTOKINE LEVELS; TNF-ALPHA; CARTILAGE DEGRADATION; ARTICULAR-CARTILAGE; CATABOLIC EVENTS; GENE-EXPRESSION; INFLAMMATION; INHIBITION; APOPTOSIS; OVEREXPRESSION	Osteoarthritis (OA) is a common chronic degenerative disease characterized by degeneration in the joints and subsequent destruction of cartilage and bone, yet much remains to be elucidated regarding its molecular mechanism. Ghrelin is a recently discovered neuropeptide with anti-inflammatory actions, but it is unknown whether ghrelin is involved in OA. Human primary chondrocyte and cartilage samples were collected from patients with OA, and the expression pattern of ghrelin was assessed. Human chondrocyte and cartilage samples were stimulated with IL-1 beta and TNF-alpha, and exogenous ghrelin-alleviated disorganization of catabolism and anabolism were mediated by IL-1 beta and TNF-alpha. Destabilization of the medial meniscus and anterior cruciate ligament transection models were established in wild-type mice that were administered ghrelin or PBS. Severity of inflammation and degeneration in the joints were determined by measuring the levels of various inflammatory cytokines and degeneration-associated molecules. Ghrelin down-regulated the production of various inflammatory cytokines, inhibited apoptosis of chondrocytes, decreased the levels of metalloproteinases (including matrix metalloproteinase-13 and a disintegrin and metalloproteinase with thrombospondin motif-5), and maintained the expression of critical matrix components, such as aggrecan and collagen 2. Moreover, suppression of the Akt signaling pathway and activation of NF-kappa B signaling in chondrocytes during OA development was antagonized by ghrelin administration. This supports the assessment of ghrelin as a potential therapeutic approach to treat degenerative cartilage diseases, including OA.	[Qu, Ruize; Chen, Xiaomin; Li, Weiwei] Shandong Univ, Dept Pathol, Qilu Hosp, 107 Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China; [Wang, Wenhan; Zhao, Yunpeng] Shandong Univ, Dept Orthoped, Qilu Hosp, Jinan, Shandong, Peoples R China; [Qu, Ruize; Chen, Xiaomin; Wang, Wenhan; Qiu, Cheng; Ban, Miaomiao; Guo, Linlin] Shandong Univ, Med Sch, Jinan, Shandong, Peoples R China; [Vasilev, Krasimir] Univ South Australia, Sch Engn, Mawson Lakes, SA, Australia; [Chen, Jianying] Inst Biopharmaceut Shandong Prov, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; University of South Australia	Li, WW (corresponding author), Shandong Univ, Dept Pathol, Qilu Hosp, 107 Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China.; Zhao, YP (corresponding author), Shandong Univ, Qilu Hosp, Dept Orthopaed Surg, 107 Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China.	miraculously2008@163.com; liweiweizhao@163.com	Vasilev, Krasimir/C-5248-2008; chen, xia/GXM-5435-2022; chen, xia/GYR-3948-2022; chen, xi/GXH-3653-2022	Qu, Ruize/0000-0002-6280-3322; Vasilev, Krasimir/0000-0003-3534-4754	Key Research and Development Projects of Shandong Province [2015GSF118115]; Natural Science Foundation of Shandong Province [BS2014YY048, BS2015SW028]; National Natural Science Foundation of China [81501880, 26010105131643]	Key Research and Development Projects of Shandong Province; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Key Research and Development Projects of Shandong Province (Grant 2015GSF118115), the Natural Science Foundation of Shandong Province (Grants BS2014YY048 and BS2015SW028), and the National Natural Science Foundation of China (Grants 81501880 and 26010105131643). The authors declare no conflicts of interest.	Akamizu T, 2008, J AM GERIATR SOC, V56, P2363, DOI 10.1111/j.1532-5415.2008.02031.x; Ansari M. Y., 2017, OSTEOARTHRITIS CARTI; Barboza E, 2017, ARTHRITIS RHEUMATOL, V69, P1221, DOI 10.1002/art.40056; Bayliss JA, 2016, NEURAL REGEN RES, V11, P1228, DOI 10.4103/1673-5374.189171; Bianchi E, 2016, J SURG RES, V201, P226, DOI 10.1016/j.jss.2015.10.044; Bonior J., 2017, INT J MOL SCI, V18; Bouaziz W, 2016, P NATL ACAD SCI USA, V113, P5453, DOI 10.1073/pnas.1514854113; Caminos JE, 2005, ENDOCRINOLOGY, V146, P1285, DOI 10.1210/en.2004-1379; Campbell KA, 2013, ARTHRITIS RHEUM-US, V65, P3120, DOI 10.1002/art.38182; Chen WH, 2014, BIOMATERIALS, V35, P9599, DOI 10.1016/j.biomaterials.2014.07.058; Chen YX, 2017, ONCOTARGET, V8, P31065, DOI 10.18632/oncotarget.16075; Chung H, 2016, J ENDOCRINOL, V230, P239, DOI 10.1530/JOE-16-0126; Conaghan PG, 2014, ANN RHEUM DIS, V73, P1442, DOI 10.1136/annrheumdis-2013-204660; Cui X, 2016, SCI REP-UK, V6, DOI 10.1038/srep23117; Cui Z, 2016, ANN RHEUM DIS, V75, P1714, DOI 10.1136/annrheumdis-2015-207923; da Costa BR, 2016, LANCET, V387, P2093, DOI 10.1016/S0140-6736(16)30002-2; Feng ZY, 2015, CELL TISSUE RES, V362, P187, DOI 10.1007/s00441-015-2194-8; Fortier LA, 2014, AM J SPORT MED, V42, pNP31, DOI 10.1177/0363546514537991; Genre F, 2014, CLIN EXP RHEUMATOL, V32, P218; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Glyn-Jones S, 2015, LANCET, V386, P376, DOI 10.1016/S0140-6736(14)60802-3; Gul FC, 2013, GRAEF ARCH CLIN EXP, V251, P1235, DOI 10.1007/s00417-013-2259-x; Heard BJ, 2013, OSTEOARTHR CARTILAGE, V21, P1942, DOI 10.1016/j.joca.2013.08.019; Hou CH, 2015, CELL PHYSIOL BIOCHEM, V36, P1753, DOI 10.1159/000430148; Hu JQ, 2017, AM J TRANSL RES, V9, P79; Iezaki T, 2016, J PATHOL, V239, P426, DOI 10.1002/path.4739; Ismail HM, 2015, ARTHRITIS RHEUMATOL, V67, P1826, DOI 10.1002/art.39099; Jia HR, 2016, P NATL ACAD SCI USA, V113, P14360, DOI 10.1073/pnas.1608938113; Kalunian KC, 2016, CURR OPIN RHEUMATOL, V28, P246, DOI 10.1097/BOR.0000000000000273; Karagiozoglou-Lampoudi T, 2011, METABOLISM, V60, P1359, DOI 10.1016/j.metabol.2011.03.006; Kassebaum NJ, 2016, LANCET, V388, P1603, DOI [10.1016/S0140-6736(16)31460-X, 10.1016/S0140-6736(16)31470-2]; Katsara O., 2016, ARTHRITIS RHEUMATOL; Klooster AR, 2005, ARTHRITIS RES THER, V7, pR127, DOI 10.1186/ar1464; Kuroda K, 2015, ENDOCRINOLOGY, V156, P4437, DOI 10.1210/en.2015-1561; Lai YJ, 2014, ANN RHEUM DIS, V73, P1575, DOI 10.1136/annrheumdis-2013-203561; Legrand R, 2016, EUR NEUROPSYCHOPHARM, V26, P948, DOI 10.1016/j.euroneuro.2016.03.010; Li W, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.223; Li WW, 2015, FEBS J, V282, P2317, DOI 10.1111/febs.13278; Li X, 2009, ARTHRITIS RHEUM-US, V60, P513, DOI 10.1002/art.24258; Lin YG, 2017, EUR J PHARMACOL, V811, P260, DOI 10.1016/j.ejphar.2017.06.032; Liu CC, 2016, 2016 6TH INTERNATIONAL CONFERENCE ON INFORMATION TECHNOLOGY FOR MANUFACTURING SYSTEMS (ITMS 2016), P6; Lorenz J, 2014, METHODS MOL BIOL, V1194, P401, DOI 10.1007/978-1-4939-1215-5_23; Luan Y, 2008, OSTEOARTHR CARTILAGE, V16, P1413, DOI 10.1016/j.joca.2008.03.017; Manfredi AA, 2016, ANN RHEUM DIS, V75, P1511, DOI 10.1136/annrheumdis-2015-208442; Mao YQ, 2015, INT J MOL SCI, V16, P21911, DOI 10.3390/ijms160921911; Matuszyk A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/718314; Mevel E, 2016, SCI REP-UK, V6, DOI 10.1038/srep33527; Minashima T, 2014, OSTEOARTHR CARTILAGE, V22, P852, DOI 10.1016/j.joca.2014.04.008; Minashima T, 2014, ARTHRITIS RHEUMATOL, V66, P1228, DOI 10.1002/art.38373; Mobasheri A, 2017, OSTEOARTHR CARTILAGE, V25, P199, DOI 10.1016/j.joca.2016.12.016; Pearson MJ, 2016, ARTHRITIS RHEUMATOL, V68, P845, DOI 10.1002/art.39520; Raghu H., 2016, ANN RHEUM DIS, V76; Ratneswaran A, 2017, J MOL MED, V95, P431, DOI 10.1007/s00109-016-1501-5; Ruozi G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8388; Sasazawa F, 2014, OSTEOARTHR CARTILAGE, V22, P313, DOI 10.1016/j.joca.2013.11.015; Sherwood J, 2015, ANN RHEUM DIS, V74, P2207, DOI 10.1136/annrheumdis-2014-205546; Stock M, 2017, ARTHRITIS RHEUMATOL, V69, P1233, DOI 10.1002/art.40042; Tian X., 2017, LIFE SCI; Toegel S, 2016, J IMMUNOL, V196, P1910, DOI 10.4049/jimmunol.1501165; Turgut B, 2013, DRUG DES DEV THER, V7, P19, DOI 10.2147/DDDT.S39453; Wang H, 2017, MOL THER, V25, P715, DOI 10.1016/j.ymthe.2016.12.020; Wang LF, 2017, MOL BIOL REP, V44, P219, DOI 10.1007/s11033-017-4098-z; Whirledge SD, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.123570; Wu YS, 2015, SCI REP-UK, V5, DOI 10.1038/srep17602; Yamamoto K, 2016, MATRIX BIOL, V56, P57, DOI 10.1016/j.matbio.2016.03.007; Yan DY, 2013, J BIOL CHEM, V288, P31655, DOI 10.1074/jbc.M112.440420; Yan DY, 2013, GENE, V517, P12, DOI 10.1016/j.gene.2013.01.001; Yuan MJ, 2009, EUR J PHARMACOL, V618, P52, DOI 10.1016/j.ejphar.2009.07.015; Zhang HW, 2013, INT J MOL MED, V32, P851, DOI 10.3892/ijmm.2013.1452; Zhao Y, 2014, JOVE-J VIS EXP, V84, DOI DOI 10.3791/50924; Zhao YP, 2015, ANN RHEUM DIS, V74, P2244, DOI 10.1136/annrheumdis-2014-205779; Zhao YP, 2016, INFLAMMATION, V39, P385, DOI 10.1007/s10753-015-0260-8; Zhen GH, 2013, NAT MED, V19, P704, DOI 10.1038/nm.3143; Zhou S, 2016, OSTEOARTHR CARTILAGE, V24, P2181, DOI 10.1016/j.joca.2016.07.005	74	33	34	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					1044	1058		10.1096/fj.201700265R	http://dx.doi.org/10.1096/fj.201700265R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29070587	Bronze			2022-12-28	WOS:000425146900043
J	Zheng, LF; Meng, X; Li, XM; Zhang, Y; Li, C; Xiang, CX; Xing, YY; Xia, YF; Xi, T				Zheng, Lufeng; Meng, Xia; Li, Xiaoman; Zhang, Yan; Li, Cheng; Xiang, Chenxi; Xing, Yingying; Xia, Yufeng; Xi, Tao			miR-125a-3p inhibits ER alpha transactivation and overrides tamoxifen resistance by targeting CDK3 in estrogen receptor-positive breast cancer	FASEB JOURNAL			English	Article						TFF1; c-myc; estrogen response elements	CELL-PROLIFERATION; CROSS-TALK; PHOSPHORYLATION; MECHANISMS; MICRORNA-125A; MIGRATION; MUTATION; GROWTH	Tamoxifen (TAM) is a major adjuvant therapy for patients who are diagnosed with estrogen receptor-alpha (ER)-positive breast cancer; however, TAM resistance occurs often during treatment and the underlying mechanism is unclear. Here, we report that miR-125a-3p inhibits ER alpha transcriptional activity and, thus, ER+ breast cancer cell proliferation, which causes cell-cycle arrest at the G(1)/S stage, inducing apoptosis and suppressing tumor growth by targeting cyclin-dependent kinase 3 (CDK3) in vitro and in vivo. In addition, CDK3 and miR-125a-3p expression levels were measured in 37 cancerous tissues paired with noncancerous samples, and their expression levels were negatively associated with miR-125a-3p level. Of interest, miR-125a-3p level is down-regulated in MCF-7 TAM resistant (TamR) cells. Of more importance, up-regulation of miR-125a-3p resensitizes MCF-7 TamR cells to TAM, which is dependent on CDK3 expression. These results suggest that miR-125a-3p can function as a novel tumor suppressor in ER+ breast cancerby targeting CDK3, which may be a potential therapeutic approach for TamR breast cancer therapy.	[Zheng, Lufeng; Meng, Xia; Zhang, Yan; Li, Cheng; Xiang, Chenxi; Xing, Yingying; Xi, Tao] China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Zheng, Lufeng; Meng, Xia; Zhang, Yan; Li, Cheng; Xiang, Chenxi; Xing, Yingying; Xi, Tao] China Pharmaceut Univ, Jiangsu Key Lab Carcinogenesis & Intervent, Nanjing, Jiangsu, Peoples R China; [Zheng, Lufeng; Xia, Yufeng] China Pharmaceut Univ, Dept Pharmacol Chinese Mat Med, Jiangsu Key Lab Drug Discovery Metab Dis, Nanjing, Jiangsu, Peoples R China; [Li, Xiaoman] Nanjing Univ Chinese Med, Sch Pharm, Jiangsu Key Lab Pharmacol & Safety Evaluat Chines, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University; China Pharmaceutical University; China Pharmaceutical University; Nanjing University of Chinese Medicine	Xia, YF; Xi, T (corresponding author), China Pharmaceut Univ, Tongjia Xiang 24, Nanjing 210009, Jiangsu, Peoples R China.	yfxiacpu@126.com; xitao18@hotmail.com		Zheng, Lufeng/0000-0002-2183-4974; Xi, Tao/0000-0001-8065-2639	National Major Special Program of New Drug Research and Development [2013ZX09301303-005]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Qing Lan Project; National Natural Science Foundation of China [81372331]; Fundamental Research Funds for the Central Universities [2015ZD004]	National Major Special Program of New Drug Research and Development; Priority Academic Program Development of Jiangsu Higher Education Institutions; Qing Lan Project(Jiangsu Polytech Institute); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Major Special Program of New Drug Research and Development (Grant 2013ZX09301303-005), the Priority Academic Program Development of Jiangsu Higher Education Institutions, the Qing Lan Project, the National Natural Science Foundation of China (Grant 81372331), and the Fundamental Research Funds for the Central Universities (Grant 2015ZD004). The authors declare no conflicts of interest.	Ahmad A, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1561-x; Berrondo C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147236; Cho YY, 2009, CANCER RES, V69, P272, DOI 10.1158/0008-5472.CAN-08-3125; Cui J, 2015, ONCOGENE, V34, P4018, DOI 10.1038/onc.2015.201; Cui JJ, 2012, CANCER RES, V72, P5625, DOI 10.1158/0008-5472.CAN-12-1305; Cuzick J, 2011, LANCET ONCOL, V12, P21, DOI 10.1016/S1470-2045(10)70266-7; de Leeuw R, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/232435; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Green KA, 2007, NAT REV CANCER, V7, P713, DOI 10.1038/nrc2211; Guo X, 2009, RNA BIOL, V6, P575, DOI 10.4161/rna.6.5.10079; Hashiguchi Y, 2012, INT J ONCOL, V40, P1477, DOI 10.3892/ijo.2012.1363; Herynk MH, 2007, CLIN CANCER RES, V13, P3235, DOI 10.1158/1078-0432.CCR-06-2608; Hui R, 2002, CANCER RES, V62, P6916; Jiang LL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-318; Klinge CM, 2012, TRENDS ENDOCRIN MET, V23, P223, DOI 10.1016/j.tem.2012.03.002; Li W, 2009, J MED GENET, V46, P358, DOI 10.1136/jmg.2008.063123; Lu JP, 2016, ONCOTARGET, V7, P7012, DOI 10.18632/oncotarget.6875; Lu MR, 2015, SCI REP-UK, V5, DOI 10.1038/srep08735; Mandlekar S, 2001, APOPTOSIS, V6, P469, DOI 10.1023/A:1012437607881; McCartan D, 2012, CANCER RES, V72, P220, DOI 10.1158/0008-5472.CAN-11-1976; Mulrane L, 2013, CANCER RES, V73, P6554, DOI 10.1158/0008-5472.CAN-13-1841; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Nana-Sinkam SP, 2013, CLIN PHARMACOL THER, V93, P98, DOI 10.1038/clpt.2012.192; Ninio-Many Lihi, 2014, Oncoscience, V1, P250; Ninio-Many L, 2013, J CELL SCI, V126, P2867, DOI 10.1242/jcs.123414; Nishida N, 2011, CLIN CANCER RES, V17, P2725, DOI 10.1158/1078-0432.CCR-10-2132; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Pillai MM, 2014, BREAST CANCER RES TR, V146, P85, DOI 10.1007/s10549-014-3004-9; Qadir MA, 2008, BREAST CANCER RES TR, V112, P389, DOI 10.1007/s10549-007-9873-4; Sarwar N, 2006, ENDOCR-RELAT CANCER, V13, P851, DOI 10.1677/erc.1.01123; Shen R, 2015, AM J TRANSL RES, V7, P2115; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Vargo-Gogola T, 2007, NAT REV CANCER, V7, P659, DOI 10.1038/nrc2193; Vrtacnik P, 2014, BIOCHEM MEDICA, V24, P329, DOI 10.11613/BM.2014.035; Wang GF, 2009, FEBS J, V276, P5571, DOI 10.1111/j.1742-4658.2009.07238.x; Ward A, 2014, J PATHOL, V233, P368, DOI 10.1002/path.4363; Wesierska-Gadek J, 2011, J CELL BIOCHEM, V112, P761, DOI 10.1002/jcb.23004; Yadav V, 2011, MOL CARCINOGEN, V50, P346, DOI 10.1002/mc.20716; Yin F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116759; Yu XF, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0480-4; Yuan J, 2015, BIOCHEM BIOPH RES CO, V457, P171, DOI 10.1016/j.bbrc.2014.12.078; Zhang H, 2015, ACTA BIOCH BIOPH SIN, V47, P496, DOI 10.1093/abbs/gmv039; Zhao M, 2014, WORLD J CLIN ONCOL, V5, P248, DOI 10.5306/wjco.v5.i3.248; Zheng LF, 2016, MOL CELL ENDOCRINOL, V427, P133, DOI 10.1016/j.mce.2016.03.012; Zheng LF, 2015, BREAST CANCER RES TR, V150, P105, DOI 10.1007/s10549-015-3298-2	48	40	41	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					588	600		10.1096/fj.201700461RR	http://dx.doi.org/10.1096/fj.201700461RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	28939591	Bronze			2022-12-28	WOS:000425146900006
J	Li, M; Hong, WX; Hao, CZ; Li, LY; Wu, DM; Shen, AG; Lu, J; Zheng, YL; Li, P; Xu, Y				Li, Min; Hong, Wenxuan; Hao, Chenzhi; Li, Luyang; Wu, Dongmei; Shen, Aiguo; Lu, Jun; Zheng, Yuanlin; Li, Ping; Xu, Yong			SIRT1 antagonizes liver fibrosis by blocking hepatic stellate cell activation in mice	FASEB JOURNAL			English	Article						transcriptional regulation; epigenetics; myofibroblast	TO-MESENCHYMAL TRANSITION; TISSUE GROWTH-FACTOR; NONALCOHOLIC STEATOHEPATITIS; TRANSCRIPTIONAL REPRESSION; ENERGY-EXPENDITURE; CANCER METASTASIS; GENE-EXPRESSION; FIBROTIC LIVER; FATTY LIVER; MOUSE MODEL	Hepatic stellate cells (HSCs) are a major source of fibrogenesis in the liver, contributing to cirrhosis. When activated, HSCs transdifferentiate into myofibroblasts and undergo profound functional alterations paralleling an overhaul of the transcriptome, the mechanism of which remains largely undefined. We investigated the involvement of the class III deacetylase sirtuin [silent information regulator 1 (SIRT1)] in HSC activation and liver fibrosis. SIRT1 levels were down-regulated in the livers inmouse models of liver fibrosis, in patients with cirrhosis, and in activated HSCs as opposed to quiescent HSCs. SIRT1 activation halted, whereas SIRT1 inhibition promoted, HSC transdifferentiation into myofibroblasts. Liver fibrosis was exacerbated in mice with HSC-specific deletion of SIRT1 [conditional knockout (cKO)], receiving CCl4 (1 mg/kg) injection or subjected to bile duct ligation, compared to wild-type littermates. SIRT1 regulated peroxisome proliferator activated receptor gamma (PPAR gamma) transcription by deacetylating enhancer of zeste homolog 2 (EZH2) in quiescentHSCs. Finally, EZH2 inhibition or PPARg activation ameliorated fibrogenesis in cKO mice. In summary, our data suggest that SIRT1 plays an essential role guiding the transition of HSC phenotypes.	[Li, Min; Hong, Wenxuan; Hao, Chenzhi; Li, Luyang; Li, Ping; Xu, Yong] Nanjing Med Univ, Dept Pathophysiol, Key Lab Targeted Intervent Cardiovasc Dis, Nanjing, Jiangsu, Peoples R China; [Li, Min; Hong, Wenxuan; Hao, Chenzhi; Li, Luyang; Li, Ping; Xu, Yong] Nanjing Med Univ, Innovat Collaborat Ctr Cardiovasc Translat Med, Nanjing, Jiangsu, Peoples R China; [Wu, Dongmei; Lu, Jun; Zheng, Yuanlin] Jiangsu Normal Univ, Sch Life Sci, Key Lab Biotechnol Med Plants Jiangsu Prov, Xuzhou, Peoples R China; [Shen, Aiguo] Nantong Univ, Coll Med, Key Lab Inflammat & Mol Targets, Nantong, Peoples R China	Nanjing Medical University; Nanjing Medical University; Jiangsu Normal University; Nantong University	Lu, J (corresponding author), Jiangsu Normal Univ, 101 Shanghai Rd, Xuzhou 221116, Jiangsu, Peoples R China.; Xu, Y (corresponding author), Nanjing Med Univ, 101 Longmian Ave, Nanjing 211166, Jiangsu, Peoples R China.	lu-jun75@163.com; yjxu@njmu.edu.cn	Lu, Jun/N-6109-2019	Lu, Jun/0000-0002-2801-5330	Jiangsu Province [2016 333]; Qinglan Project of the Young and Middle-Aged Academic Leader of Jiangsu College and University; Natural Science Foundation of China [81670223, 81500426, 81570420, 81571055, 81400902, 81271225, 31201039, 81171012, 30950031]; Major Fundamental Research Program of the Natural Science Foundation of the Jiangsu Higher Education Institutions of China [13KJA180001]; Cultivate National Science Fund for Distinguished Young Scholars of Jiangsu Normal University; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Jiangsu Province; Qinglan Project of the Young and Middle-Aged Academic Leader of Jiangsu College and University; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Fundamental Research Program of the Natural Science Foundation of the Jiangsu Higher Education Institutions of China; Cultivate National Science Fund for Distinguished Young Scholars of Jiangsu Normal University; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported, in part, by grants from the 2016 333 Project Award of Jiangsu Province, the 2013 Qinglan Project of the Young and Middle-Aged Academic Leader of Jiangsu College and University, the Natural Science Foundation of China (81670223, 81500426, 81570420, 81571055, 81400902, 81271225, 31201039, 81171012, and 30950031), the Major Fundamental Research Program of the Natural Science Foundation of the Jiangsu Higher Education Institutions of China (13KJA180001), the Cultivate National Science Fund for Distinguished Young Scholars of Jiangsu Normal University, and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). Y.X. is a fellow at the Collaborative Innovative Center for Cardiovascular Translational Medicine. The authors declare no conflicts of interest.	Chavez E, 2008, J APPL TOXICOL, V28, P35, DOI 10.1002/jat.1249; Chen Y, 2012, MOL CELL PROTEOMICS, V11, P1048, DOI 10.1074/mcp.M112.019547; Elsharkawy AM, 2007, HEPATOLOGY, V46, P590, DOI 10.1002/hep.21802; Fan ZW, 2017, HEPATOLOGY, V65, P1904, DOI 10.1002/hep.29127; Fan ZW, 2015, BBA-GENE REGUL MECH, V1849, P1219, DOI 10.1016/j.bbagrm.2015.07.013; Fang F, 2013, CIRC RES, V113, P986, DOI 10.1161/CIRCRESAHA.113.301296; Fang F, 2011, CIRC RES, V108, P797, DOI 10.1161/CIRCRESAHA.111.240655; Fang MM, 2016, BBA-GENE REGUL MECH, V1859, P294, DOI 10.1016/j.bbagrm.2015.11.010; Fang MM, 2015, J BIOMED RES, V29, P308, DOI 10.7555/JBR.29.20150055; Gariani K, 2017, J HEPATOL, V66, P132, DOI 10.1016/j.jhep.2016.08.024; Iwaisako K, 2014, P NATL ACAD SCI USA, V111, pE3297, DOI 10.1073/pnas.1400062111; Kanzler S, 1999, AM J PHYSIOL-GASTR L, V276, pG1059, DOI 10.1152/ajpgi.1999.276.4.G1059; Kessoku T, 2016, SCI REP-UK, V6, DOI 10.1038/srep22251; Kisseleva T, 2017, HEPATOLOGY, V65, P1039, DOI 10.1002/hep.28948; Kitao A, 2009, AM J PATHOL, V175, P616, DOI 10.2353/ajpath.2009.081061; Kong XC, 2009, J MOL CELL CARDIOL, V46, P748, DOI 10.1016/j.yjmcc.2009.01.011; Li P, 2012, NUCLEIC ACIDS RES, V40, P1609, DOI 10.1093/nar/gkr984; Lu Lu, 2011, Chinese Medical Sciences Journal, V26, P77; Maizel J, 2014, AM J PHYSIOL-HEART C, V307, pH1691, DOI 10.1152/ajpheart.00281.2014; Mann J, 2010, GASTROENTEROLOGY, V138, P705, DOI 10.1053/j.gastro.2009.10.002; Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823; Moran-Salvador E, 2013, J HEPATOL, V59, P1045, DOI 10.1016/j.jhep.2013.06.023; Mukhopadhyay P, 2017, J HEPATOL, V66, P589, DOI 10.1016/j.jhep.2016.10.023; Popov Y, 2009, HEPATOLOGY, V50, P1294, DOI 10.1002/hep.23123; Puche JE, 2013, COMPR PHYSIOL, V3, P1473, DOI 10.1002/cphy.c120035; Purushotham A, 2012, MOL CELL BIOL, V32, P1226, DOI 10.1128/MCB.05988-11; Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027; Ramirez T, 2017, J HEPATOL, V66, P601, DOI 10.1016/j.jhep.2016.11.004; Robertson H, 2007, HEPATOLOGY, V45, P977, DOI 10.1002/hep.21624; Sakai K, 2014, AM J PATHOL, V184, P2611, DOI 10.1016/j.ajpath.2014.06.009; Schnabl B, 2001, HEPATOLOGY, V34, P89, DOI 10.1053/jhep.2001.25349; Simic P, 2013, CELL REP, V3, P1175, DOI 10.1016/j.celrep.2013.03.019; Sun LN, 2013, J CELL SCI, V126, P3939, DOI 10.1242/jcs.127381; Sun LN, 2013, JNCI-J NATL CANCER I, V105, P887, DOI 10.1093/jnci/djt118; Tian WF, 2016, INT J BIOCHEM CELL B, V71, P35, DOI 10.1016/j.biocel.2015.12.005; Tian WF, 2013, HEPATOLOGY, V58, P576, DOI 10.1002/hep.26207; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Weng HL, 2007, HEPATOLOGY, V46, P1257, DOI 10.1002/hep.21806; Wu XY, 2011, NUCLEIC ACIDS RES, V39, P9549, DOI 10.1093/nar/gkr651; Wu YT, 2015, TUMOR BIOL, V36, P4063, DOI 10.1007/s13277-015-3488-x; Yang G, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14941; Yang L, 2013, GASTROENTEROLOGY, V144, P1042, DOI 10.1053/j.gastro.2013.01.056; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yin HQ, 2014, GASTROENTEROLOGY, V146, P801, DOI 10.1053/j.gastro.2013.11.008; Zhou YQ, 2015, GASTROENT RES PRACT, V2015, DOI 10.1155/2015/506390	45	48	52	1	34	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					500	511		10.1096/fj.201700612R	http://dx.doi.org/10.1096/fj.201700612R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28970250				2022-12-28	WOS:000419172700044
J	Giacoppo, S; Thangavelu, SR; Diomede, F; Bramanti, P; Conti, P; Trubiani, O; Mazzon, E				Giacoppo, Sabrina; Thangavelu, Soundara Rajan; Diomede, Francesca; Bramanti, Placido; Conti, Pio; Trubiani, Oriana; Mazzon, Emanuela			Anti-inflammatory effects of hypoxia-preconditioned human periodontal ligament cell secretome in an experimental model of multiple sclerosis: a key role of IL-37	FASEB JOURNAL			English	Article						inflammation; EAE; hPDLSC secretome; eperimental autoimmune ensephalomyelitis	MESENCHYMAL STEM-CELL; TRAUMATIC BRAIN-INJURY; IN-VITRO; CORTICAL-NEURONS; OXIDATIVE STRESS; MOUSE MODEL; AUTOPHAGY; APOPTOSIS; FAMILY; INTERLEUKIN-37	Recent research has widely investigated the anti-inflammatory effects of mesenchymal stem cells and their secretory products, termed the secretome, in the treatment of multiple sclerosis (MS). The present study examined the capacity of the conditioned medium (CM) from human periodontal ligament stem cells (hPLSCs) under hypoxia (H-hPDLSCs-CM) to suppress experimental autoimmune encephalomyelitis (EAE), a murine model of MS. To induce EAE, female C57BL/6 mice were immunized with myelin oligodendroglial glycoprotein peptide35-55. At the onset of symptoms, H-hPDLSCs-CM was infused via the tail vein of mice. Our results demonstrate the efficacy of H-hPDLSCs-CM treatment in diminishing clinical and histologic disease score. A key finding from this study is the marked expression of anti-inflammatory cytokine IL-37, paralleledby the suppression of proinflammatory cytokines in mice with EAE that were treated with H-hPDLSCs-CM. In addition, a consequent modulation of oxidative stress, autophagic, and apoptotic markers was observed in mice with EAE after hPDLSCsCM administration. In addition, to provide additional evidence of the molecular mechanisms that underlie H-hPDLSCs-CM, we investigated its therapeutic action in scratch injury-exposed NSC-34 neurons, an in vitro model of injury. This model reproduces severe inflammation and oxidative stress conditions as observed after EAE damage. In vitro results corroborate the ability of hPDLSCs-CM to modulate inflammatory, oxidative stress, and apoptotic pathways. Taken together, our findings suggest H-hPDLSCs-CM as a new pharmacologic opportunity for the management of MS.	[Giacoppo, Sabrina; Thangavelu, Soundara Rajan; Bramanti, Placido; Mazzon, Emanuela] IRCCS, Ctr Neurolesi Bonino Pulejo, Via Prov Palermo, I-98124 Messina, Italy; [Diomede, Francesca; Trubiani, Oriana] Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, Stem Cells & Regenerat Med Lab, Chieti, Italy; [Conti, Pio] Univ G dAnnunzio, Immunol Div, Postgrad Med Sch, Chieti, Italy	IRCCS Bonino Pulejo; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Mazzon, E (corresponding author), IRCCS, Ctr Neurolesi Bonino Pulejo, Via Prov Palermo, I-98124 Messina, Italy.	emazzon.irccs@gmail.com	Diomede, Francesca/AAL-6840-2020; Gao, Jing/M-8264-2018; Mazzon, Emanuela/AAL-4334-2020; Rajan, Thangavelu Soundara/J-9840-2016; Bramanti, Placido/K-5117-2016	Diomede, Francesca/0000-0002-0384-6509; Rajan, Thangavelu Soundara/0000-0001-8728-6176; mazzon, emanuela/0000-0002-5073-717X				Ahmed NEB, 2016, SCI REP-UK, V6, DOI 10.1038/srep35476; Biancone L, 2012, NEPHROL DIAL TRANSPL, V27, P3037, DOI 10.1093/ndt/gfs168; Bruck W, 2005, J NEUROL, V252, pV3, DOI 10.1007/s00415-005-5002-7; Bulau AM, 2014, P NATL ACAD SCI USA, V111, P2650, DOI 10.1073/pnas.1324140111; Cai Zhiyou, 2013, J Biochem Pharmacol Res, V1, P84; Carinci F, 2016, J BIOL REG HOMEOS AG, V30, P945; Chang CP, 2013, CLIN SCI, V124, P165, DOI 10.1042/CS20120226; Dinarello CA, 2002, CLIN EXP RHEUMATOL, V20, pS1; DINARELLO CA, 1986, YALE J BIOL MED, V59, P97; Dulamea A, 2015, J Med Life, V8, P24; Farrokhi M, 2015, ACTA NEUROL BELG, V115, P609, DOI 10.1007/s13760-015-0491-3; Feng XD, 2017, BOSNIAN J BASIC MED, V17, P95, DOI 10.17305/bjbms.2017.1696; Filomeni G, 2015, CELL DEATH DIFFER, V22, P377, DOI 10.1038/cdd.2014.150; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Giacoppo S, 2017, ARCH IMMUNOL THER EX, V65, P363, DOI 10.1007/s00005-017-0460-z; Giacoppo S, 2017, FITOTERAPIA, V116, P77, DOI 10.1016/j.fitote.2016.11.010; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; Haque N, 2013, SCI WORLD J, DOI 10.1155/2013/632972; Imaeda H, 2013, CLIN EXP IMMUNOL, V172, P410, DOI 10.1111/cei.12061; Jarmalaviciute A, 2016, NEURAL REGEN RES, V11, P904, DOI 10.4103/1673-5374.184480; Khwanraj K, 2016, PARKINSONS DIS-US, V2016, DOI 10.1155/2016/8716016; Kumar S, 2013, NEUROBIOL DIS, V56, P131, DOI 10.1016/j.nbd.2013.04.005; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li JH, 2008, J ENDOCRINOL INVEST, V31, P103, DOI 10.1007/BF03345575; Li SZ, 2015, P NATL ACAD SCI USA, V112, P2497, DOI 10.1073/pnas.1424626112; Li TT, 2017, MOL IMMUNOL, V87, P132, DOI 10.1016/j.molimm.2017.04.010; Liu JJ, 2015, STEM CELLS, V33, P627, DOI 10.1002/stem.1909; Lovett-Racke AE, 2011, BBA-MOL BASIS DIS, V1812, P246, DOI 10.1016/j.bbadis.2010.05.012; Ma YH, 2012, NEUROSCI LETT, V510, P14, DOI 10.1016/j.neulet.2011.12.061; Madrigal M, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0260-8; McNamee EN, 2011, P NATL ACAD SCI USA, V108, P16711, DOI 10.1073/pnas.1111982108; Meamar Rokhsareh, 2016, Adv Biomed Res, V5, P46, DOI 10.4103/2277-9175.178791; Menzies FM, 2017, NEURON, V93, P1015, DOI 10.1016/j.neuron.2017.01.022; Merino-Gonzalez C, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00024; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Nold MF, 2010, NAT IMMUNOL, V11, P1014, DOI 10.1038/ni.1944; Paschalidis N, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-33; Payette DJ, 2008, INT J CLIN EXP PATHO, V1, P44; Rajan TS, 2017, J CELL BIOCHEM, V118, P1531, DOI 10.1002/jcb.25815; Rajan TS, 2017, J CELL BIOCHEM, V118, P819, DOI 10.1002/jcb.25757; Rajan TS, 2016, SCI REP-UK, V6, DOI 10.1038/srep38743; Rajan TS, 2016, EXP CELL RES, V349, P152, DOI 10.1016/j.yexcr.2016.10.008; Rodrigues DH, 2010, J NEUROIMMUNOL, V222, P90, DOI 10.1016/j.jneuroim.2010.02.016; Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Sarvar DP, 2016, ADV PHARM BULL, V6, P293, DOI 10.15171/apb.2016.041; Sharma S, 2008, J IMMUNOL, V180, P5477, DOI 10.4049/jimmunol.180.8.5477; Sharpe PT, 2016, DEVELOPMENT, V143, P2273, DOI 10.1242/dev.134189; Song LJ, 2013, J CLIN IMMUNOL, V33, P111, DOI 10.1007/s10875-012-9791-z; Sweeney P, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0077-5; Teng X, 2014, J IMMUNOL, V192, P1815, DOI 10.4049/jimmunol.1300047; Tete S, 2012, INT J IMMUNOPATH PH, V25, P31, DOI 10.1177/039463201202500105; Thorburn A, 2008, APOPTOSIS, V13, P1, DOI 10.1007/s10495-007-0154-9; Ullah I, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150025; Vertelov G, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt153; Wahl SE, 2014, J NEUROSCI, V34, P4453, DOI 10.1523/JNEUROSCI.4311-13.2014; Weber MS, 2012, CURR PHARM DESIGN, V18, P209; Wu TT, 2016, INT J BIOL SCI, V12, P884, DOI 10.7150/ijbs.15194; Wyrsch P, 2012, MOL CELL BIOL, V32, P3541, DOI 10.1128/MCB.00437-12; Yang LB, 2015, APMIS, V123, P1025, DOI 10.1111/apm.12467; Yeo RWY, 2013, ADV DRUG DELIVER REV, V65, P336, DOI 10.1016/j.addr.2012.07.001; Yu J, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt234; Zhao YB, 2012, EXP NEUROL, V237, P489, DOI 10.1016/j.expneurol.2012.07.004; Zhuang XY, 2017, IMMUN INFLAMM DIS, V5, P373, DOI 10.1002/iid3.159	64	63	64	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5592	5608		10.1096/fj.201700524R	http://dx.doi.org/10.1096/fj.201700524R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28842429	Green Published			2022-12-28	WOS:000416588300039
J	Silvander, JSG; Kvarnstrom, SM; Kumari-Ilieva, A; Shrestha, A; Alam, CM; Toivola, DM				Silvander, Jonas S. G.; Kvarnstrom, Sofie M.; Kumari-Ilieva, Angeli; Shrestha, Anup; Alam, Catharina M.; Toivola, Diana M.			Keratins regulate beta-cell mitochondrial morphology, motility, and homeostasis	FASEB JOURNAL			English	Article						TEM; insulin secretion; islets; K8-null mice; fusion	SIMPLE EPITHELIAL KERATINS; INTERMEDIATE-FILAMENTS; ENDOPLASMIC-RETICULUM; CYTOCHROME-C; MITOFUSIN 2; DYSFUNCTION; DIFFERENTIATION; CYTOKERATINS; DISRUPTION; METABOLISM	Loss of the epithelial intermediate filament protein keratin 8 (K8) in murine beta cells leads to irregular insulin vesicles and decreased insulin levels. Because mitochondria are central in glucose-stimulated insulin secretion, the relationship between keratins and beta-cell mitochondrial function and morphology was investigated. beta cells in murine K8-knockout (K8(-/-)) islets of Langerhans have increased numbers of mitochondria, which are rounder and have diffuse cristae, as seen by electron microscopy. The mitochondrial network in primary cultured K8(-/-) beta cells is more fragmented compared with K8(+/+) mitochondria, correlating with decreased levels of mitofusin 2 and the mitofusin 2- and keratin-binding protein trichoplein. K8(-/-) beta-cell mitochondria have decreased levels of total and mitochondrial cytochrome c, which correlates with a reduction in electron transport complexes I and IV. This provokes loss of mitochondrial membrane potential and reduction of ATP and insulin amount, as seen in K8(-/-) beta cells. Mitochondria in K8 wild-type cells and MIN6 insulinoma cells overexpressing K8 and 18 are more stationary compared with mitochondria in keratin-deficient cells. In conclusion, keratins, likely through trichoplein-mitofusin interactions, regulate both structural and dynamic functions of -cell mitochondria, which could have implications for downstream insulin secretion.-Silvander, J. S. G., Kvarnstrom, S. M., Kumari-Ilieva, A., Shrestha, A., Alam, C. M., Toivola, D. M. Keratins regulate beta-cell mitochondrial morphology, motility, and homeostasis.	[Silvander, Jonas S. G.; Kvarnstrom, Sofie M.; Kumari-Ilieva, Angeli; Shrestha, Anup; Alam, Catharina M.; Toivola, Diana M.] Abo Akad Univ, Fac Sci & Engn, Cell Biol, Tykistokatu 6A, FIN-20520 Turku, Finland	Abo Akademi University	Toivola, DM (corresponding author), Abo Akad Univ, Fac Sci & Engn, Cell Biol, Tykistokatu 6A, FIN-20520 Turku, Finland.	dtoivola@abo.fi		Toivola, Diana M./0000-0001-7165-9839	Swedish Cultural Foundation and Doctoral Network in Molecular Biosciences at AAU; Novo Nordisk Foundation; Finnish Diabetes Research Foundation; Diabetes Wellness; Sigrid Juselius Foundation; Academy of Finland; Novo Nordisk Fonden [NNF15OC0016524, NNF16OC0021344] Funding Source: researchfish	Swedish Cultural Foundation and Doctoral Network in Molecular Biosciences at AAU; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Finnish Diabetes Research Foundation; Diabetes Wellness; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Novo Nordisk Fonden(Novo Nordisk Foundation)	The authors thank Helena Saarento, Terhi Helenius, Aruna Ghimire, Carl-Gustaf Stenvall [Abo Akademi University (AAU)], and the personnel at the Cell Imaging Core (Turku Centre for Biotechnology) and the Central Animal Laboratory (University of Turku, UTU) for skillful technical assistance; the D.M.T. laboratory members for joint maintenance of the mouse colony; and Helen Cooper, John Eriksson (AAU), Rudolf Leube [Rheinisch-Westfalische Technische Hochschule (RWTH) Aachen University, Aachen, Germany), M. Bishr Omary (University of Michigan, Ann Arbor, MI, USA), and Kid Tornqvist (AAU) for providing reagents and for fruitful discussions. This work was funded by the Swedish Cultural Foundation and Doctoral Network in Molecular Biosciences at AAU (to J.S.G.S.) and The Novo Nordisk Foundation, The Finnish Diabetes Research Foundation, Diabetes Wellness, The Sigrid Juselius Foundation, and The Academy of Finland (to D.M.T.). The authors declare no conflicts of interest.	Ahmed M, 2005, DIABETOLOGIA, V48, P477, DOI 10.1007/s00125-004-1661-7; Alam CM, 2013, J CELL SCI, V126, P5635, DOI 10.1242/jcs.132795; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; BARIBAULT H, 1994, GENE DEV, V8, P2964, DOI 10.1101/gad.8.24.2964; BLESSING M, 1993, J CELL BIOL, V120, P743, DOI 10.1083/jcb.120.3.743; Bouwens L, 1998, J PATHOL, V184, P234; Cerqua C, 2010, EMBO REP, V11, P854, DOI 10.1038/embor.2010.151; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chernoivanenko IS, 2015, FASEB J, V29, P820, DOI 10.1096/fj.14-259903; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Gentil BJ, 2012, FASEB J, V26, P1194, DOI 10.1096/fj.11-196345; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Hoppins S, 2014, CURR OPIN CELL BIOL, V29, P46, DOI 10.1016/j.ceb.2014.03.005; Jheng HF, 2012, MOL CELL BIOL, V32, P309, DOI 10.1128/MCB.05603-11; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Ku NO, 2004, METHOD CELL BIOL, V78, P489; Kumemura H, 2008, BIOCHEM BIOPH RES CO, V367, P33, DOI 10.1016/j.bbrc.2007.12.116; Lahdeniemi IA, 2017, CELL DEATH DIFFER, V24, P984, DOI 10.1038/cdd.2017.28; Liew CW, 2010, J CLIN INVEST, V120, P2876, DOI 10.1172/JCI36849; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103; Maechler P, 2013, MOL CELL ENDOCRINOL, V379, P12, DOI 10.1016/j.mce.2013.06.019; Milner DJ, 2000, J CELL BIOL, V150, P1283, DOI 10.1083/jcb.150.6.1283; Molina AJA, 2009, DIABETES, V58, P2303, DOI 10.2337/db07-1781; MORRIS RL, 1995, J CELL BIOL, V131, P1315, DOI 10.1083/jcb.131.5.1315; Mourier A, 2015, J CELL BIOL, V208, P429, DOI 10.1083/jcb.201411100; Nekrasova OE, 2011, MOL BIOL CELL, V22, P2282, DOI 10.1091/mbc.E10-09-0766; Nishizawa M, 2005, J CELL SCI, V118, P1081, DOI 10.1242/jcs.01667; Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762; Oriolo AS, 2007, EXP CELL RES, V313, P2255, DOI 10.1016/j.yexcr.2007.02.030; Overly CC, 1996, J CELL SCI, V109, P971; Pan XO, 2013, CURR OPIN CELL BIOL, V25, P47, DOI 10.1016/j.ceb.2012.10.018; Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Schwarz N, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5030030; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Sheng ZH, 2014, J CELL BIOL, V204, P1087, DOI 10.1083/jcb.201312123; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; StoneO MR, 2007, J CELL SCI, V120, P3999, DOI 10.1242/jcs.009241; Supale S, 2012, TRENDS ENDOCRIN MET, V23, P477, DOI 10.1016/j.tem.2012.06.002; Tao GZ, 2009, J CELL SCI, V122, P3851, DOI 10.1242/jcs.051862; Toivola DM, 2010, TRENDS CELL BIOL, V20, P79, DOI 10.1016/j.tcb.2009.11.004; Toivola DM, 2015, CURR OPIN CELL BIOL, V32, P73, DOI 10.1016/j.ceb.2014.12.008; Toivola DM, 2005, TRENDS CELL BIOL, V15, P608, DOI 10.1016/j.tcb.2005.09.004; Vecchione A, 2009, ONCOGENE, V28, P257, DOI 10.1038/onc.2008.381; Vempati UD, 2009, J BIOL CHEM, V284, P4383, DOI 10.1074/jbc.M805972200; Winter L, 2008, J CELL BIOL, V181, P903, DOI 10.1083/jcb.200710151; Zmuda EJ, 2011, JOVE-J VIS EXP, DOI 10.3791/2096	51	10	10	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4578	4587		10.1096/fj.201700095R	http://dx.doi.org/10.1096/fj.201700095R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28666985				2022-12-28	WOS:000413397400033
J	Ka, SO; Bang, IH; Bae, EJ; Park, BH				Ka, Sun-O; Bang, In Hyuk; Bae, Eun Ju; Park, Byung-Hyun			Hepatocyte-specific sirtuin 6 deletion predisposes to nonalcoholic steatohepatitis by up-regulation of Bach1, an Nrf2 repressor	FASEB JOURNAL			English	Article						inflammation; fibrosis; oxidative stress; liver	FATTY LIVER-DISEASE; OXIDATIVE STRESS; HEPATOCELLULAR-CARCINOMA; HEPATIC STEATOSIS; GENE-EXPRESSION; NRF2-NULL MICE; INFLAMMATION; PROGRESSION; DEACETYLATION; CIRRHOSIS	Sirtuin (Sirt)6 has been implicated in negative regulation of inflammation and lipid metabolism, although its function in the progression from simple steatosis to nonalcoholic steatohepatitis (NASH) remains to be defined. To explore the role of hepatocyte Sirt6 in NASH development, we generated hepatocyte-specific Sirt6-knockout (KO) mice that were fed a high-fat and high-fructose (HFHF) diet for 16 wk. HFHF-fed KO mice had increased hepatic steatosis and inflammation and aggravated glucose intolerance and insulin resistance compared with wild-type mice. HFHF-induced liver fibrosis and oxidative stress and related gene expression were significantly elevated in KO mice. In the livers of KO mice, nuclear factor erythroid 2-related factor 2 (Nrf2) was down-regulated; conversely, BTB domain and CNC homolog 1 (Bach1), a nuclear repressor of Nrf2, were up-regulated. We discovered that Sirt6, which interacts with Bach1 under basal condition, induces its detachment from the antioxidant response element (ARE) region of heme oxygenase 1 promoter. Furthermore, we found that Sirt6 promotes Nrf2 binding to ARE in response to oxidative stimuli, which leads to the expression of phase II/antioxidant enzymes. Finally, we showed that HFHF-induced steatosis, inflammation, and fibrosis were ameliorated by adenoviral Sirt6 overexpression. Sirt6 may be a useful therapeutic target for amelioration of NASH by curbing inflammation and oxidative stress.	[Ka, Sun-O; Bang, In Hyuk; Park, Byung-Hyun] Chonbuk Natl Univ, Dept Biochem, Sch Med, Jeonju, South Korea; [Bae, Eun Ju] Woosuk Univ, Coll Pharm, 443 Samnye Ro, Wonju 55338, Jeonbuk, South Korea	Jeonbuk National University; Woosuk University	Bae, EJ (corresponding author), Woosuk Univ, Coll Pharm, 443 Samnye Ro, Wonju 55338, Jeonbuk, South Korea.; Park, BH (corresponding author), Chonbuk Natl Univ, Sch Med, 567 Baekje Daero, Jeonju 54896, Jeonbuk, South Korea.	bhpark@jbnu.ac.kr			Basic Science Research Program through the Korean National Research Foundation (Ministry of Science, Information and Communication Technology and Future Planning) [2015R1D1A1A01058502, 2017R1A2B2005730, 2017R1A2B4008593]; Medical Research Center Program through the Korean National Research Foundation (Ministry of Science, Information and Communication Technology and Future Planning) [2008-0062279]	Basic Science Research Program through the Korean National Research Foundation (Ministry of Science, Information and Communication Technology and Future Planning); Medical Research Center Program through the Korean National Research Foundation (Ministry of Science, Information and Communication Technology and Future Planning)	This work was supported by the Basic Science Research Program (Grants 2015R1D1A1A01058502, 2017R1A2B2005730, and 2017R1A2B4008593), and by the Medical Research Center Program (Grant 2008-0062279) through the Korean National Research Foundation (Ministry of Science, Information and Communication Technology and Future Planning). The authors declare no conflicts of interest.	Anderson JG, 2015, MOL METAB, V4, P846, DOI 10.1016/j.molmet.2015.09.003; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Dominy JE, 2012, MOL CELL, V48, P900, DOI 10.1016/j.molcel.2012.09.030; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Gracia-Sancho J, 2008, HEPATOLOGY, V47, P1248, DOI 10.1002/hep.22166; Hoebe KHN, 2001, AM J PHYSIOL-GASTR L, V280, pG720, DOI 10.1152/ajpgi.2001.280.4.G720; Jang HY, 2016, J ALLERGY CLIN IMMUN, V138, P1452, DOI 10.1016/j.jaci.2016.05.019; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049; Kanfi Y, 2010, AGING CELL, V9, P162, DOI 10.1111/j.1474-9726.2009.00544.x; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Lappas M, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/597514; Lee HS, 2013, ARTHRITIS RHEUM-US, V65, P1776, DOI 10.1002/art.37963; Lee JM, 2003, J BIOL CHEM, V278, P12029, DOI 10.1074/jbc.M211558200; Li Y, 2014, GASTROENTEROLOGY, V146, P539, DOI 10.1053/j.gastro.2013.10.059; Liu F, 2010, TOXICOL SCI, V115, P596, DOI 10.1093/toxsci/kfq075; Marquardt JU, 2013, HEPATOLOGY, V58, P1054, DOI 10.1002/hep.26413; Meakin PJ, 2014, MOL CELL BIOL, V34, P3305, DOI [10.1128/MCB.00677-1, 10.1128/MCB.00677-14]; Niture SK, 2014, FREE RADICAL BIO MED, V66, P36, DOI 10.1016/j.freeradbiomed.2013.02.008; Okita Y, 2013, J BIOL CHEM, V288, P20658, DOI 10.1074/jbc.M113.450478; Palekar NA, 2006, LIVER INT, V26, P151, DOI 10.1111/j.1478-3231.2005.01209.x; Pan HZ, 2016, CELL RES, V26, P190, DOI 10.1038/cr.2016.4; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Radak Z, 2013, FREE RADICAL BIO MED, V58, P87, DOI 10.1016/j.freeradbiomed.2013.01.004; Ramadori P, 2016, FREE RADICAL BIO MED, V91, P114, DOI 10.1016/j.freeradbiomed.2015.12.014; Ryan MC, 2005, DIABETES CARE, V28, P1222, DOI 10.2337/diacare.28.5.1222; Shima T, 2015, HEPATOL RES, V45, P548, DOI 10.1111/hepr.12384; Shimozono R, 2013, MOL PHARMACOL, V84, P62, DOI 10.1124/mol.112.084269; Song MY, 2016, SCI REP-UK, V6, DOI 10.1038/srep30321; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Thandavarayan RA, 2015, EXP DERMATOL, V24, P773, DOI 10.1111/exd.12762; Wang J, 2017, HEPATOLOGY, V65, P225, DOI 10.1002/hep.28777; Xiao CY, 2012, J BIOL CHEM, V287, P41903, DOI 10.1074/jbc.M112.415182; Yin HQ, 2014, GASTROENTEROLOGY, V146, P801, DOI 10.1053/j.gastro.2013.11.008; Zhang ZG, 2014, MOL MED REP, V9, P882, DOI 10.3892/mmr.2013.1879	42	59	60	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3999	4010		10.1096/fj.201700098RR	http://dx.doi.org/10.1096/fj.201700098RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28536120				2022-12-28	WOS:000408713300025
J	van Dijk, IA; Ferrando, ML; van der Wijk, AE; Hoebe, RA; Nazmi, K; de Jonge, WJ; Krawczyk, PM; Bolscher, JGM; Veerman, ECI; Stap, J				van Dijk, Irene A.; Ferrando, Maria Laura; van der Wijk, Anne-Eva; Hoebe, Ron A.; Nazmi, Kamran; de Jonge, Wouter J.; Krawczyk, Przemek M.; Bolscher, Jan G. M.; Veerman, Enno C. I.; Stap, Jan			Human salivary peptide histatin-1 stimulates epithelial and endothelial cell adhesion and barrier function	FASEB JOURNAL			English	Article						adherens junctions; tight junctions; oral cavity	HISTIDINE-RICH POLYPEPTIDES; SMALL G-PROTEINS; E-CADHERIN; MESENCHYMAL TRANSITION; ACTIN CYTOSKELETON; STREPTOCOCCUS-SUIS; CARCINOMA-CELLS; BETA-CATENIN; INTESTINAL-MUCOSA; GENE-EXPRESSION	Histatins are multifunctional histidine-rich peptides secreted by the salivary glands and exclusively present in the saliva of higher primates, where they play a fundamental role in the protection of the oral cavity. Our previously published results demonstrated that histatin-1 (Hst1) promotes cell-substrate adhesion in various cell types and hinted that it could also be involved in cell-cell adhesion, a process of fundamental importance to epithelial and endothelial barriers. Here we explore the effects of Hst1 on cellular barrier function. We show that Hst1 improved endothelial barrier integrity, decreased its permeability for large molecules, and prevented translocation of bacteria across epithelial cell layers. These effects are mediated by the adherens junction protein E-cadherin (E-cad) and by the tight junction protein zonula occludens 1, as Hst1 increases the levels of zonula occludens 1 and of active E-cad. Hst1 may also promote epithelial differentiation as Hst1 induced transcription of the epithelial cell differentiation marker apolipoprotein A-IV (a downstream E-cad target). In addition, Hst1 counteracted the effects of epithelial-mesenchymal transition inducers on the outgrowth of oral cancer cell spheroids, suggesting that Hst1 affects processes that are implicated in cancer progression.	[van Dijk, Irene A.; Hoebe, Ron A.; Krawczyk, Przemek M.; Stap, Jan] Univ Amsterdam, Acad Med Ctr LCAM AMC, Dept Med Biol & Core Facil Cellular Imaging, Van Leeuwenhoek Ctr Adv Microscopy, Amsterdam, Netherlands; [Ferrando, Maria Laura] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Amsterdam, Netherlands; [van der Wijk, Anne-Eva] Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands; [van der Wijk, Anne-Eva] Univ Amsterdam, Acad Med Ctr, Dept Med Biol, Ocular Angiogenesis Grp, Amsterdam, Netherlands; [de Jonge, Wouter J.] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, Amsterdam, Netherlands; [van Dijk, Irene A.; Nazmi, Kamran; Bolscher, Jan G. M.; Veerman, Enno C. I.] Univ Amsterdam, Dept Oral Biochem, Amsterdam, Netherlands; [van Dijk, Irene A.; Nazmi, Kamran; Bolscher, Jan G. M.; Veerman, Enno C. I.] Vrije Univ VU Amsterdam, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam	van Dijk, IA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biol & Core Facil Cellular Imaging LCAM, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	i.a.vandijk@amc.uva.nl	Bolscher, Jan/ABF-6102-2021; Ferrando, Maria Laura/M-3026-2018	Bolscher, Jan/0000-0001-5669-6164; Ferrando, Maria Laura/0000-0002-1398-8244; van der Wijk, Anne-Eva/0000-0002-7436-5323	Dutch Organization for Scientific Research (NWO) [ALW2PJ/09070]; International Team for Implantology (Basel, Switzerland) (ITI) [1091_2015]; Academic Proof-of-Concept fund of the municipality of Amsterdam; University of Amsterdam	Dutch Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); International Team for Implantology (Basel, Switzerland) (ITI); Academic Proof-of-Concept fund of the municipality of Amsterdam; University of Amsterdam	The authors thank K. Kurakula [Academic Medical Center (AMC)] for help with the inhibitor studies, C. de Vries (AMC) for use of equipment and helpful discussions, A. Jansen (AMC) and W. Kamphuis (Netherlands Institute for Neuroscience) for help with qPCR, I. Klaassen (AMC) for use of equipment and designing primers for qPCR, K. Wolthers and C. Schultsz (AMC) for providing the Caco-2 cell line and S. suis strains, respectively, B. Arik-Yetkin (AMC) for providing the HUVECs for cell spreading experiments, E. Verver (AMC) for providing the EGF, and E. Reits for valuable comments on the article. This work was supported by the Dutch Organization for Scientific Research (NWO; Grant ALW2PJ/09070), the International Team for Implantology (Basel, Switzerland) (ITI; Grant 1091_2015), the Academic Proof-of-Concept fund of the municipality of Amsterdam, and a grant from the University of Amsterdam for research into the focal point of oral infections and inflammation.	Auersperg N, 1999, P NATL ACAD SCI USA, V96, P6249, DOI 10.1073/pnas.96.11.6249; Boink MA, 2016, WOUND REPAIR REGEN, V24, P100, DOI 10.1111/wrr.12380; Bolscher JGM, 2011, FASEB J, V25, P2650, DOI 10.1096/fj.11-182212; Chartier NT, 2006, J CELL SCI, V119, P31, DOI 10.1242/jcs.02698; Dardousis K, 2007, MOL THER, V15, P94, DOI 10.1038/sj.mt.6300003; DELI MA, 1995, EXP PHYSIOL, V80, P675, DOI 10.1113/expphysiol.1995.sp003877; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Ferrando ML, 2016, GUT MICROBES, V7, P154, DOI 10.1080/19490976.2016.1144008; Ferrando ML, 2015, J INFECT DIS, V212, P95, DOI 10.1093/infdis/jiu813; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hashimoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047899; Hazan RB, 1998, J BIOL CHEM, V273, P9078, DOI 10.1074/jbc.273.15.9078; HERMISTON ML, 1995, J CELL BIOL, V129, P489, DOI 10.1083/jcb.129.2.489; HILGERS AR, 1990, PHARMACEUT RES, V7, P902, DOI 10.1023/A:1015937605100; Huber AH, 2001, J BIOL CHEM, V276, P12301, DOI 10.1074/jbc.M010377200; Johnson DA, 2000, ARCH ORAL BIOL, V45, P731, DOI 10.1016/S0003-9969(00)00047-9; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kamei T, 1999, ONCOGENE, V18, P6776, DOI 10.1038/sj.onc.1203114; Klaassen I, 2009, EXP EYE RES, V89, P4, DOI 10.1016/j.exer.2009.01.006; Krisanaprakornkit S., 2012, ISRN ONCOL, DOI DOI 10.5402/2012/681469; Kudo Y, 2004, CLIN CANCER RES, V10, P5455, DOI 10.1158/1078-0432.CCR-04-0372; Lawson DA, 2015, NATURE, V526, P131, DOI 10.1038/nature15260; LeBeyec J, 1997, EXP CELL RES, V236, P311; Leckband D, 2006, ANNU REV BIOMED ENG, V8, P259, DOI 10.1146/annurev.bioeng.8.061505.095753; MACKAY BJ, 1984, INFECT IMMUN, V44, P695, DOI 10.1128/IAI.44.3.695-701.1984; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Muhamed I, 2016, J CELL SCI, V129, P1843, DOI 10.1242/jcs.185447; Mullin JM, 2005, DRUG DISCOV TODAY, V10, P395, DOI 10.1016/S1359-6446(05)03379-9; Nanci A., 2013, 10 CATES ORAL HISTOL, DOI DOI 10.1016/B978-0-323-07846-7.00001-X; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Oft M, 1998, CURR BIOL, V8, P1243, DOI 10.1016/S0960-9822(07)00533-7; Oudhoff MJ, 2009, J DENT RES, V88, P846, DOI 10.1177/0022034509342951; Oudhoff MJ, 2008, FASEB J, V22, P3805, DOI 10.1096/fj.08-112003; Oudhoff MJ, 2009, FASEB J, V23, P3928, DOI 10.1096/fj.09-137588; Pal S, 2014, NEW J CHEM, V38, P3889, DOI 10.1039/c4nj00160e; Peignon G, 2006, J BIOL CHEM, V281, P3560, DOI 10.1074/jbc.M506360200; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; POLLOCK JJ, 1984, INFECT IMMUN, V44, P702, DOI 10.1128/IAI.44.3.702-707.1984; Ratheesh A, 2012, NAT REV MOL CELL BIO, V13, P673, DOI 10.1038/nrm3431; Ruijter JM, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-2; Sako Y, 1998, J CELL BIOL, V140, P1227, DOI 10.1083/jcb.140.5.1227; Schreider C, 2002, J CELL SCI, V115, P543; Schubert W, 2001, J BIOL CHEM, V276, P48619, DOI 10.1074/jbc.C100613200; Scrace S, 2013, METHODS MOL BIOL, V1046, P295, DOI 10.1007/978-1-62703-538-5_17; Siemerink MJ, 2012, ANGIOGENESIS, V15, P151, DOI 10.1007/s10456-011-9251-z; Smith HE, 1999, INFECT IMMUN, V67, P1750; Sume SS, 2010, AM J PATHOL, V177, P208, DOI 10.2353/ajpath.2010.090952; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; Tarin D, 2005, CANCER RES, V65, P5996, DOI 10.1158/0008-5472.CAN-05-0699; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; van Dijk IA, 2017, J DENT RES, V96, P423, DOI 10.1177/0022034516681761; van Dijk IA, 2015, FASEB J, V29, P3124, DOI 10.1096/fj.14-266825; Vicente-Manzanares M, 2008, J CELL BIOL, V183, P543, DOI 10.1083/jcb.200806030; Vincent-Salomon A, 2003, BREAST CANCER RES, V5, P101, DOI 10.1186/bcr578; Weber GF, 2011, J CELL SCI, V124, P1183, DOI 10.1242/jcs.064618; Wells A, 2011, FRONT BIOSCI-LANDMRK, V16, P815, DOI 10.2741/3722; Wisniewska-Kruk J, 2015, EXP EYE RES, V138, P167, DOI 10.1016/j.exer.2015.07.006; Woichansky I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10834; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yaguchi T., 2012, Patent, Patent No. [WO/ 2012/ 023588, 2012023588]; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; YAN QY, 1995, BIOCHEM J, V311, P341, DOI 10.1042/bj3110341; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yin A, 2003, ARCH ORAL BIOL, V48, P361, DOI 10.1016/S0003-9969(03)00012-8; Yokoyama K, 2001, ORAL ONCOL, V37, P65, DOI 10.1016/S1368-8375(00)00059-2; Zheng XY, 2006, BIOTECHNOL PROGR, V22, P1294, DOI 10.1021/bp060121o	71	27	27	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3922	3933		10.1096/fj.201700180R	http://dx.doi.org/10.1096/fj.201700180R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28522595				2022-12-28	WOS:000408713300019
J	Tan, T; Zhang, Y; Luo, WH; Lv, JH; Han, CS; Hamlin, JNR; Luo, HJ; Li, H; Wan, Y; Yang, X; Song, WH; Tong, ZQ				Tan, Tao; Zhang, Yun; Luo, Wenhong; Lv, Jihui; Han, Chanshuai; Hamlin, Jason N. R.; Luo, Hongjun; Li, Hui; Wan, You; Yang, Xu; Song, Weihong; Tong, Zhiqian			Formaldehyde induces diabetes-associated cognitive impairments	FASEB JOURNAL			English	Article						ALDH2; hyperglycemia; dementia; Alzheimer	MITOCHONDRIAL ALDEHYDE DEHYDROGENASE; ALZHEIMERS-DISEASE; INSULIN-RESISTANCE; OXIDATIVE STRESS; MEMORY DECLINE; IN-VITRO; MELLITUS; MICE; DEFICIENCY; RATS	Patients with type 2 diabetes mellitus (T2DM) often develop cognitive impairments and have an increased risk of developing Alzheimer's disease. Hyperglycemia is a major characteristic of T2DM, but how elevated glucose levels lead to cognitive decline remains elusive. Here, we report that patients with T2DM and mutations in the formaldehyde (FA)-degrading enzyme aldehyde dehydrogenase 2 (ALDH2) gene had higher levels of FA and more severe dementia. Injection of FA induced hyperglycemia and cognitive deficits in rats. Ablation of gene expression of ALDH2, the main enzyme to oxidize FA, resulted in abnormally high levels of hippocampal FA, leading to hyperglycemia and cognitive impairments as well as potentiating streptozotocin-induced diabetes development in ALDH2 knockout mice. We found that FA interacts with insulin to form FA-insulin adducts, and these FA-insulin adducts caused insulin deficiency, contributing to memory decline in diabetic rodent models. Reduction of FA by transgenic overexpression of human ALDH2 attenuates hyperglycemia and alleviates cognitive deficits in diabetic mouse models. These findings suggest that excess FA plays a critical role in mediating diabetes-related dementia. Targeting FA and its metabolizing enzyme ALDH2 may be a valid approach for preventing and treating dementia in diabetes mellitus.Tan, T., Zhang, Y., Luo, W., Lv, J., Han, C., Hamlin, J. N. R., Luo, H., Li, H., Wan, Y., Yang, X., Song, W., Tong, Z. Formaldehyde induces diabetes-associated cognitive impairments.	[Tan, Tao; Tong, Zhiqian] Capital Med Univ, Beijing Inst Brain Disorders, Alzheimers Dis Ctr, Beijing 100069, Peoples R China; [Tan, Tao] Sichuan Prov Hosp Women & Children, Chengdu, Sichuan, Peoples R China; [Zhang, Yun; Song, Weihong] Univ British Columbia, Dept Psychiat, Townsend Family Labs, Vancouver, BC, Canada; [Luo, Wenhong; Luo, Hongjun; Li, Hui] Shantou Univ, Cent Lab, Med Coll, Shantou, Guangdong, Peoples R China; [Lv, Jihui] Beijing Geriatr Hosp, Beijing, Peoples R China; [Han, Chanshuai; Hamlin, Jason N. R.] McGill Univ, Montreal Neurol Inst, Quebec City, PQ, Canada; [Wan, You] Peking Univ, Neurosci Res Inst, Sch Basic Med Sci, Dept Neurobiol, Beijing, Peoples R China; [Yang, Xu] Cent China Normal Univ, Sect Environm Biomed, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Hubei, Peoples R China	Capital Medical University; University of British Columbia; Shantou University; McGill University; Peking University; Central China Normal University	Tong, ZQ (corresponding author), Capital Med Univ, Beijing Inst Brain Disorders, Alzheimers Dis Ctr, Beijing 100069, Peoples R China.; Song, WH (corresponding author), Univ British Columbia, 2255 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	weihong@mail.ubc.ca; tzqbeida@163.com	Wan, You/M-5279-2019; han, chanshuai/GXG-6801-2022; Tan, Tao/F-5535-2010; Song, Weihong/O-7623-2017	Wan, You/0000-0001-6110-7192; Tan, Tao/0000-0002-4571-3296; Song, Weihong/0000-0001-9928-889X; /0000-0003-1035-6943	Natural Science Foundation of China (NSFC) [81400874, 31171080, 51136002]; Scientific Research Common Program of the Beijing Municipal Commission of Education [KM201510025014]; Natural Scientific Foundation of Capital Medical University (CCMU) [2015ZR31]; Beijing Institute for Brain Disorders [0000040103, ZD2015-08]; Michael Smith Foundation for Health Research/The Pacific Alzheimer Research Foundation Post-Doctoral Fellowship Award	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Scientific Research Common Program of the Beijing Municipal Commission of Education; Natural Scientific Foundation of Capital Medical University (CCMU); Beijing Institute for Brain Disorders; Michael Smith Foundation for Health Research/The Pacific Alzheimer Research Foundation Post-Doctoral Fellowship Award	This work was supported by grants from the Natural Science Foundation of China (NSFC; 81400874, 31171080, and 51136002), the Scientific Research Common Program of the Beijing Municipal Commission of Education (KM201510025014), the Natural Scientific Foundation of Capital Medical University (CCMU; 2015ZR31), and the Beijing Institute for Brain Disorders (0000040103 and ZD2015-08). W.S. is the holder of the Tier 1 Canada Research Chair in Alzheimer's Disease. Y.Z. is the recipient of the Michael Smith Foundation for Health Research/The Pacific Alzheimer Research Foundation Post-Doctoral Fellowship Award. The authors declare no conflicts of interest.	Arvanitakis Z, 2004, ARCH NEUROL-CHICAGO, V61, P661, DOI 10.1001/archneur.61.5.661; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Chen YX, 2014, EXP NEUROL, V261, P610, DOI 10.1016/j.expneurol.2014.06.004; D'Souza Y, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0117-y; de la Monte SM, 2012, CURR ALZHEIMER RES, V9, P35; DICKER E, 1986, BIOCHEM J, V240, P821, DOI 10.1042/bj2400821; Duarte AI, 2006, DIABETES, V55, P2863, DOI 10.2337/db06-0030; Frolich L, 1999, ANN NY ACAD SCI, V893, P290, DOI 10.1111/j.1749-6632.1999.tb07839.x; Grinan-Ferre C, 2016, EXP GERONTOL, V80, P57, DOI 10.1016/j.exger.2016.03.014; Grinan-Ferre C, 2016, AGING-US, V8, P664, DOI 10.18632/aging.100906; Harris C, 2003, REPROD TOXICOL, V17, P349, DOI 10.1016/S0890-6238(03)00013-3; Hong M, 1997, J BIOL CHEM, V272, P19547, DOI 10.1074/jbc.272.31.19547; Ito M, 1999, BIOL PHARM BULL, V22, P988; Izumi Y, 2003, DIABETOLOGIA, V46, P1007, DOI 10.1007/s00125-003-1144-2; Jaganjac M, 2013, FREE RADICAL RES, V47, P39, DOI 10.3109/10715762.2013.789136; Kamino K, 2000, BIOCHEM BIOPH RES CO, V273, P192, DOI 10.1006/bbrc.2000.2923; Kang Y, 2017, CURR ALZHEIMER RES, V14, P841, DOI 10.2174/1567205014666170425112331; Kim TE, 2015, INT J GERIATR PSYCH, V30, P551, DOI 10.1002/gps.4181; Koekkoek PS, 2015, LANCET NEUROL, V14, P329, DOI 10.1016/S1474-4422(14)70249-2; Lu J, 2013, BBA-GEN SUBJECTS, V1830, P4102, DOI 10.1016/j.bbagen.2013.04.028; Lu Z, 2008, INDOOR AIR, V18, P77, DOI 10.1111/j.1600-0668.2008.00524.x; Ly PTT, 2013, J CLIN INVEST, V123, P224, DOI 10.1172/JCI64516; Malek FA, 2003, ANN ANAT, V185, P277, DOI 10.1016/S0940-9602(03)80040-7; Mei YF, 2015, AGING CELL, V14, P659, DOI 10.1111/acel.12345; Olson AL, 1996, ANNU REV NUTR, V16, P235, DOI 10.1146/annurev.nu.16.070196.001315; Patra SK, 2008, CANCER METAST REV, V27, P315, DOI 10.1007/s10555-008-9118-y; Pitcher H, 2006, LANCET NEUROL, V5, P388, DOI 10.1016/S1474-4422(06)70434-3; Pitten FA, 2000, PATHOL RES PRACT, V196, P193, DOI 10.1016/S0344-0338(00)80100-4; Qiang M, 2014, J ALZHEIMERS DIS, V40, P1039, DOI 10.3233/JAD-131595; Qing H, 2008, J EXP MED, V205, P2781, DOI 10.1084/jem.20081588; Quillen EE, 2014, AM J MED GENET B, V165, P103, DOI 10.1002/ajmg.b.32213; Roberts RO, 2008, ARCH NEUROL-CHICAGO, V65, P1066, DOI 10.1001/archneur.65.8.1066; Ryan CM, 2006, DIABETES CARE, V29, P345, DOI 10.2337/diacare.29.02.06.dc05-1626; Sim YB, 2012, ANIM CELLS SYST, V16, P385, DOI 10.1080/19768354.2012.696554; Stenbit AE, 1997, NAT MED, V3, P1096, DOI 10.1038/nm1097-1096; STRUBELT O, 1989, J TOXICOL ENV HEALTH, V27, P351, DOI 10.1080/15287398909531306; Sun X, 2006, P NATL ACAD SCI USA, V103, P18727, DOI 10.1073/pnas.0606298103; Teng S, 2001, CHEM-BIOL INTERACT, V130, P285, DOI 10.1016/S0009-2797(00)00272-6; Tong ZQ, 2015, NEUROBIOL AGING, V36, P100, DOI 10.1016/j.neurobiolaging.2014.07.018; Tong ZQ, 2013, SCI REP-UK, V3, DOI 10.1038/srep01807; Tong ZQ, 2013, AGE, V35, P583, DOI 10.1007/s11357-012-9388-8; Tong ZQ, 2011, NEUROBIOL AGING, V32, P31, DOI 10.1016/j.neurobiolaging.2009.07.013; Tulpule K, 2013, J NEUROCHEM, V127, P7, DOI 10.1111/jnc.12356; Uemura E, 2006, EXP NEUROL, V198, P48, DOI 10.1016/j.expneurol.2005.10.035; Wang JL, 2011, MOL MED, V17, P172, DOI 10.2119/molmed.2010.00114; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Xu F, 2010, HYPERTENS RES, V33, P49, DOI 10.1038/hr.2009.178; Xu WL, 2010, DIABETES, V59, P2928, DOI 10.2337/db10-0539; Yang HY, 2013, MOL MED REP, V7, P431, DOI 10.3892/mmr.2012.1227; Yang Y, 2013, NEUROSCIENCE, V250, P140, DOI 10.1016/j.neuroscience.2013.07.009; Yang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069824; Yu PH, 2003, BBA-PROTEINS PROTEOM, V1647, P193, DOI 10.1016/S1570-9639(03)00101-8; Zeng JY, 2017, ACTA NEUROPATHOL, V133, P967, DOI 10.1007/s00401-017-1669-y; Zhang Y, 2017, PROG NEUROBIOL, V153, P100, DOI 10.1016/j.pneurobio.2017.03.001	54	20	23	4	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3669	3679		10.1096/fj.201701239R	http://dx.doi.org/10.1096/fj.201701239R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29401634				2022-12-28	WOS:000435104500015
J	Tomasi, ML; Ramani, K; Ryoo, M; Cossu, C; Floris, A; Murray, B; Iglesias-Ara, A; Spissu, Y; Mavila, N				Tomasi, Maria Lauda; Ramani, Komal; Ryoo, Minjung; Cossu, Carla; Floris, Andrea; Murray, Ben J.; Iglesias-Ara, Ainhoa; Spissu, Ylenia; Mavila, Nirmala			SUMOylation regulates cytochrome P450 2E1 expression and activity in alcoholic liver disease	FASEB JOURNAL			English	Article						alcohol; CYP2E1; small ubiquitin-like modifier	OXIDATIVE STRESS; CANCER CELLS; S-ADENOSYLMETHIONINE; OXIDANT STRESS; FATTY LIVER; HUMAN COLON; PROTEIN; ETHANOL; UBIQUITIN; SUMO	Alcohol acts through numerous pathways leading to alcoholic liver disease (ALD). Cytochrome P450 (CYP2E1), an ethanol-inducible enzyme, metabolizes ethanol-producing toxic reactive oxygen species (ROS) and is regulated at the posttranslational level. Small ubiquitin-like modifier (SUMO)ylation is a posttranslational modification that involves the addition of SUMOs, which modulate protein stability, activity, and localization. We demonstrated that ubiquitin-conjugation enzyme 9, the SUMO-conjugating enzyme, is induced in the livers of an intragastric ethanol mouse model. Our aim is to examine whether SUMOylation could regulate ethanol-induced CYP2E1 expression in ALD and to elucidate the molecular mechanism(s). CYP2E1 and UBC9 expression in vitro and in vivo was detected by real-time PCR and immunoblotting/immunostaining. SUMOylation was assayed by mass spectrometry and coimmunoprecipitation. Ubc9 expression was induced in ethanol-fed mouse livers, and silencing inhibited ethanol-mediated CYP2E1 microsomal retention and enzymatic activity. CYP2E1 SUMOylation was found to be induced by ethanol in vitro and in vivo. Ubc9 silencing prevents ethanol-induced lipid accumulation and ROS production. UBC9 was highly expressed in human ALD livers. Finally, we found that lysine 410 is a key SUMOylated residue contributing to CYP2E1 protein stability and activity preventing CYP2E1 SUMOylation. Ethanol-mediated up-regulation of CYP2E1 via SUMOylation enhancing its protein stability and activity and may have important implications in ALD.	[Tomasi, Maria Lauda; Ramani, Komal; Ryoo, Minjung; Cossu, Carla; Floris, Andrea; Murray, Ben J.; Spissu, Ylenia; Mavila, Nirmala] Cedars Sinai Med Ctr, Dept Med, DAVIS Res Bldg 3096A,8700 Beverly Blvd, Los Angeles, CA 90048 USA; [Cossu, Carla; Spissu, Ylenia] Univ Sassari, Dept Clin & Expt Med, Sassari, Italy; [Floris, Andrea] Univ Cagliari, Dept Med Sci, Cagliari, Italy; [Iglesias-Ara, Ainhoa] Univ Basque Country, UPV EHU, Dept Genet Phys Anthropol & Anim Physiol, Bilbao, Spain	Cedars Sinai Medical Center; University of Sassari; University of Cagliari; University of Basque Country	Tomasi, ML; Ramani, K (corresponding author), Cedars Sinai Med Ctr, Dept Med, DAVIS Res Bldg 3096A,8700 Beverly Blvd, Los Angeles, CA 90048 USA.	marialauda.tomasi@cshs.org; komal.ramani@cshs.org	Ramani, Komal/AAH-5913-2021; Iglesias, Ainhoa/H-3021-2015; Spissu, Ylenia/AGQ-3624-2022; tomasi, maria lauda/AAI-1819-2021; Mavila, Nirmala/AAH-6140-2021; Spissu, Ylenia/AAY-3011-2020; Iglesias, Ainhoa/AAB-8731-2022	Iglesias, Ainhoa/0000-0002-2056-8213; Spissu, Ylenia/0000-0003-1551-8817; Iglesias, Ainhoa/0000-0002-2056-8213	Dr. Bin Gao [U.S. National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism]; NIH/NIAAA [K01AA022372]; NIH/NIAAA Grant [K01AA022372]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K01AA022372] Funding Source: NIH RePORTER	Dr. Bin Gao [U.S. National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism]; NIH/NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIH/NIAAA Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The authors thank Dr. Shelly Lu (Cedars-Sinai Medical Center) for mentoring support, Dr. Bin Gao [U.S. National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism (NIH/NIAAA)] for material support, and all current and previous laboratory members for technical support and helpful discussions. This work was supported by NIH/NIAAA Grant K01AA022372 (to M.L.T.). The authors declare no conflicts of interest.	Bardag-Gorce F, 2000, BIOCHEM BIOPH RES CO, V279, P23, DOI 10.1006/bbrc.2000.3889; Becker J, 2013, NAT STRUCT MOL BIOL, V20, P525, DOI 10.1038/nsmb.2526; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032; Carter S, 2008, CELL CYCLE, V7, P2519, DOI 10.4161/cc.7.16.6422; Cederbaum AI, 2001, FREE RADICAL BIO MED, V31, P1539, DOI 10.1016/S0891-5849(01)00743-2; Cederbaum AI, 2014, REDOX BIOL, V2, P1048, DOI 10.1016/j.redox.2014.09.007; Chen H, 2007, GASTROENTEROLOGY, V133, P207, DOI 10.1053/j.gastro.2007.03.114; Chen JY, 1997, DRUG METAB DISPOS, V25, P1165; Dasso M, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-5; Davis RL, 2004, ALCOHOL, V32, P195, DOI 10.1016/j.alcohol.2004.01.006; Elmore ZC, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-74; Garcia-Trevijano ER, 2000, FASEB J, V14, P2511, DOI 10.1096/fj.00-0121com; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; GUENGERICH FP, 1987, J BIOL CHEM, V262, P8459; He L, 2002, J BIOL CHEM, V277, P43572, DOI 10.1074/jbc.M204535200; Ingelman-Sundberg M, 1994, Alcohol Alcohol Suppl, V2, P131; Ingelman-Sundberg M, 2004, N-S ARCH PHARMACOL, V369, P89, DOI 10.1007/s00210-003-0819-z; Klenk C, 2006, J BIOL CHEM, V281, P8357, DOI 10.1074/jbc.M513703200; Leung TM, 2013, J HEPATOL, V58, P395, DOI 10.1016/j.jhep.2012.08.018; Lieber CS, 1999, ALCOHOL CLIN EXP RES, V23, P991, DOI 10.1111/j.1530-0277.1999.tb04217.x; Lieber CS, 1997, PHYSIOL REV, V77, P517, DOI 10.1152/physrev.1997.77.2.517; Lu YK, 2008, HEPATOLOGY, V47, P1483, DOI 10.1002/hep.22222; Lu YK, 2010, FREE RADICAL BIO MED, V49, P1406, DOI 10.1016/j.freeradbiomed.2010.07.026; Macauley MS, 2006, J BIOL CHEM, V281, P4164, DOI 10.1074/jbc.M510488200; MURRAY M, 1986, BIOCHEM PHARMACOL, V35, P1817, DOI 10.1016/0006-2952(86)90298-4; Pandey D, 2011, ARTERIOSCL THROM VAS, V31, P1634, DOI 10.1161/ATVBAHA.111.226621; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Pascale RM, 2002, HEPATOLOGY, V35, P1341, DOI 10.1053/jhep.2002.33682; Pichler A, 2005, NAT STRUCT MOL BIOL, V12, P264, DOI 10.1038/nsmb903; Porubsky PR, 2010, J BIOL CHEM, V285, P22282, DOI 10.1074/jbc.M110.109017; Ramani K, 2008, HEPATOLOGY, V47, P521, DOI 10.1002/hep.22064; Romanenko AM, 2006, J UROLOGY, V175, P739, DOI 10.1016/S0022-5347(05)00172-2; Sahin U, 2014, NUCLEUS-PHILA, V5, P499, DOI 10.4161/19491034.2014.970104; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Schattenberg JM, 2014, REDOX BIOL, V3, P7, DOI 10.1016/j.redox.2014.09.004; SONG BJ, 1989, J BIOL CHEM, V264, P3568; Stielow C, 2014, NUCLEIC ACIDS RES, V42, P3044, DOI 10.1093/nar/gkt1317; Tomasi ML, 2015, ONCOTARGET, V6, P37706, DOI 10.18632/oncotarget.5342; Tomasi ML, 2012, HEPATOLOGY, V56, P982, DOI 10.1002/hep.25701; Tsukamoto H, 2001, FASEB J, V15, P1335, DOI 10.1096/fj.00-0650rev; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Yang HP, 2008, GASTROENTEROLOGY, V134, P281, DOI 10.1053/j.gastro.2007.10.027; Zanelli U, 2000, TOXICOL IN VITRO, V14, P69, DOI 10.1016/S0887-2333(99)00085-5; Zhao Q, 2014, NUCLEIC ACIDS RES, V42, pW325, DOI 10.1093/nar/gku383	46	9	9	0	30	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3278	3288		10.1096/fj.201701124R	http://dx.doi.org/10.1096/fj.201701124R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401608	Green Published			2022-12-28	WOS:000432546000031
J	Monickaraj, F; McGuire, P; Das, A				Monickaraj, Finny; McGuire, Paul; Das, Arup			Cathepsin D plays a role in endothelial-pericyte interactions during alteration of the blood-retinal barrier in diabetic retinopathy	FASEB JOURNAL			English	Article						DPP4 inhibitor; endothelium; CI-MPR/IGF2R; CaMKII; PKC-alpha	MANNOSE 6-PHOSPHATE RECEPTOR; PEPTIDASE IV INHIBITOR; II BINDING-SITE; N-CADHERIN; VE-CADHERIN; IGF-II; INFLAMMATION; CELLS; NEPHROPATHY; RECOGNITION	Inflammation plays an important role in the pathogenesis of diabetic retinopathy. We have previously demonstrated the effect of cathepsin D (CD) on the mechanical disruption of retinal endothelial cell junctions and increased vasopermeability, as well as increased levels of CD in retinas of diabetic mice. Here, we have also examined the effect of CD on endothelial-pericyte interactions, as well as the effect of dipeptidyl peptidase-4 (DPP4) inhibitor on CD in endothelial-pericyte interactions in vitro and in vivo. Cocultured cells that were treated with pro-CD demonstrated a significant decrease in the expression of platelet-derived growth factor receptor-beta, a tyrosine kinase receptor that is required for pericyte cell survival; N-cadherin, the key adherens junction protein between endothelium and pericytes; and increases in the vessel destabilizing agent, angiopoietin-2. The effect was reversed in cells that were treated with DPP4 inhibitor along with pro-CD. With pro-CD treatment, there was a significant increase in the phosphorylation of the downstream signaling protein, PKC-alpha, and Ca2+/calmodulin-dependent protein kinase II in endothelial cells and pericytes, which disrupts adherens junction structure and function, and this was significantly reduced with DPP4 inhibitor treatment. Increased CD levels, vasopermeability, and alteration in junctional-related proteins were observed in the retinas of diabetic rats, which were significantly changed with DPP4 inhibitor treatment. Thus, DPP4 inhibitors may be used as potential adjuvant therapeutic agents to treat increased vascular leakage observed in patients with diabetic macular edema.	[Monickaraj, Finny; Das, Arup] Univ New Mexico, Sch Med, Dept Surg, Albuquerque, NM 87131 USA; [Monickaraj, Finny; McGuire, Paul; Das, Arup] Univ New Mexico, Sch Med, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA; [Monickaraj, Finny; Das, Arup] New Mexico Vet Affairs Hlth Care Syst, Albuquerque, NM USA	University of New Mexico; University of New Mexico	Das, A (corresponding author), Univ New Mexico, Dept Surg, Ophthalmol, 1 Univ New Mexico,MSC10-5610, Albuquerque, NM 87131 USA.	adas@unm.edu			U.S. National Institutes of Health (NIH) National Eye Institute Grant [R01-EY022327]; Veterans Affairs (VA) Merit Review Award [IO 1BX001801]; NATIONAL EYE INSTITUTE [R01EY022327] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Eye Institute Grant; Veterans Affairs (VA) Merit Review Award(US Department of Veterans Affairs); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by U.S. National Institutes of Health (NIH) National Eye Institute Grant R01-EY022327, and Veterans Affairs (VA) Merit Review Award IO 1BX001801. The authors thank Alison Wagner and Susan Baca (New Mexico VA Animal Facility) for their help in the animal study, and Tamara Howard (New Mexico Health Sciences Centre, University of New Mexico) for her technical assistance in confocal microscopy and immunofluorescence. The authors declare no conflicts of interest.	Abu El-Asrar AM, 2012, MIDDLE EAST AFR J OP, V19, P70, DOI 10.4103/0974-9233.92118; Adamis AP, 2002, BRIT J OPHTHALMOL, V86, P363, DOI 10.1136/bjo.86.4.363; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Beltramo E, 2013, CURR MED CHEM, V20, P3218, DOI 10.2174/09298673113209990022; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Bianchi R, 2012, J PHARMACOL EXP THER, V340, P64, DOI 10.1124/jpet.111.181529; Chu CH, 2008, J ENDOCRINOL, V197, P381, DOI 10.1677/JOE-07-0619; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Dietrich N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167853; Dreymueller D, 2012, EUR J CELL BIOL, V91, P472, DOI 10.1016/j.ejcb.2011.09.003; FRANK RN, 1990, INVEST OPHTH VIS SCI, V31, P999; Garmroudi F, 1996, MOL ENDOCRINOL, V10, P642, DOI 10.1210/me.10.6.642; Gerhardt H, 2000, DEV DYNAM, V218, P472, DOI 10.1002/1097-0177(200007)218:3<472::AID-DVDY1008>3.0.CO;2-#; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Goncalves A, 2012, DIABETES OBES METAB, V14, P454, DOI 10.1111/j.1463-1326.2011.01548.x; Goncalves A, 2014, BBA-MOL BASIS DIS, V1842, P1454, DOI 10.1016/j.bbadis.2014.04.013; Hancock MK, 2002, J BIOL CHEM, V277, P11255, DOI 10.1074/jbc.M109855200; Ikushima H, 2000, P NATL ACAD SCI USA, V97, P8439, DOI 10.1073/pnas.97.15.8439; Ikushima H, 2002, CELL IMMUNOL, V215, P106, DOI 10.1016/S0008-8749(02)00010-2; Keskin D, 2015, CELL REP, V10, P1066, DOI 10.1016/j.celrep.2015.01.035; Kim YH, 2011, MOL CELLS, V31, P289, DOI 10.1007/s10059-011-0038-2; Kirino Y, 2009, J ENDOCRINOL, V200, P53, DOI 10.1677/JOE-08-0424; Looker HC, 2014, BRIT J OPHTHALMOL, V98, P790, DOI 10.1136/bjophthalmol-2013-303948; Maeda S, 2013, OPHTHALMIC RES, V50, P221, DOI 10.1159/000354116; Marques C, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/538737; Marron-Terada PG, 2000, BIOCHEMISTRY-US, V39, P2243, DOI 10.1021/bi992226o; MATHIEU M, 1990, MOL ENDOCRINOL, V4, P1327, DOI 10.1210/mend-4-9-1327; McGuire PG, 2011, ARTERIOSCL THROM VAS, V31, pE107, DOI 10.1161/ATVBAHA.111.235408; Mega C, 2011, EXP DIABETES RES, DOI 10.1155/2011/162092; Monickaraj F, 2016, FASEB J, V30, P1670, DOI 10.1096/fj.15-279802; Nakashima Toshihisa, 2012, Gan To Kagaku Ryoho, V39, P1443; Navaratna D, 2007, DIABETES, V56, P2380, DOI 10.2337/db06-1694; Okabe T, 2003, J BIOL CHEM, V278, P9920, DOI 10.1074/jbc.M208872200; Olivares AM, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0913-0; Ozerdem U, 2001, DEV DYNAM, V222, P218, DOI 10.1002/dvdy.1200; Panchapakesan U, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00443; Panchapakesan U, 2013, CLIN SCI, V124, P17, DOI 10.1042/CS20120167; Rangasamy S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108508; Rangasamy S, 2011, INVEST OPHTH VIS SCI, V52, P3784, DOI 10.1167/iovs.10-6386; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Robinson R, 2012, DIS MODEL MECH, V5, P444, DOI 10.1242/dmm.009597; Romero-Aroca P, 2017, BRIT J OPHTHALMOL, V101, P1346, DOI 10.1136/bjophthalmol-2016-310063; Scharpfenecker M, 2005, J CELL SCI, V118, P771, DOI 10.1242/jcs.01653; SCHMIDT B, 1995, J BIOL CHEM, V270, P14975, DOI 10.1074/jbc.270.25.14975; Schurmann C, 2012, J PHARMACOL EXP THER, V342, P71, DOI 10.1124/jpet.111.191098; Sharma AK, 2012, J BIOMED RES, V26, P200, DOI 10.7555/JBR.26.20110054; Shiba Y, 2013, CURR BIOL, V23, P1945, DOI 10.1016/j.cub.2013.07.087; Takashima T, 2002, EUR J PHARMACOL, V451, P265, DOI 10.1016/S0014-2999(02)02296-3; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Thomas M, 2009, ANGIOGENESIS, V12, P125, DOI 10.1007/s10456-009-9147-3; Vaghasiya J, 2011, REGUL PEPTIDES, V166, P48, DOI 10.1016/j.regpep.2010.08.007; Wong MG, 2011, AM J PHYSIOL-RENAL, V301, pF84, DOI 10.1152/ajprenal.00287.2010; Zhang CH, 2014, DISCOV MED, V18, P105; Zhou HJ, 2016, NAT MED, V22, P1033, DOI 10.1038/nm.4169; Zhu T, 2006, ARTERIOSCL THROM VAS, V26, P744, DOI 10.1161/01.ATV.0000205591.88522.d4	58	15	15	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2539	2548		10.1096/fj.201700781RR	http://dx.doi.org/10.1096/fj.201700781RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29263022	Green Published			2022-12-28	WOS:000432528000019
J	Tsai, CY; Chi, HC; Chi, LM; Yang, HY; Tsai, MM; Lee, KF; Huang, HW; Chou, LF; Cheng, AJ; Yang, CW; Wang, CS; Lin, KH				Tsai, Chung-Ying; Chi, Hsiang-Cheng; Chi, Lang-Ming; Yang, Huang-Yu; Tsai, Ming-Ming; Lee, Kam-Fai; Huang, Hsiang-Wei; Chou, Li-Fang; Cheng, Ann-Joy; Yang, Chih-Wei; Wang, Chia-Siu; Lin, Kwang-Huei			Argininosuccinate synthetase 1 contributes to gastric cancer invasion and progression by modulating autophagy	FASEB JOURNAL			English	Article						autolysosome; iTRAQ; pMTOR	GENE-EXPRESSION; OVARIAN-CANCER; ARGININE; PROTEIN; METASTASIS; BIOMARKERS; MIGRATION; CELLS; LC3	Argininosuccinate synthetase 1 (ASS1) is a rate-limited enzyme in arginine biosynthesis. The oncogenic potential of ASS1 in terms of prognosis and cancer metastasis in arginine prototrophic gastric cancer (GC) remains unclear at present. We identify differentially expressed proteins in microdissected GC tumor cells relative to adjacent nontumor epithelia by isobaric mass tag for relative and absolute quantitation proteomics analysis. GC cells with stable expression or depletion of ASS1 were further analyzed to identify downstream molecules. We investigated their effects on chemoresistance and cell invasion in the presence or absence of arginine. ASS1 was highly expressed in GC and positively correlated with GC aggressiveness and poor outcome. Depletion of ASS1 led to inhibition of tumor growth and decreased cell invasion via induction of autophagy-lysosome machinery, resulting in degradation of active beta-catenin, Snail, and Twist. Ectopic expression of ASS1 in GC cells reversed these effects and protected cancer cells from chemotherapy drug-induced apoptosis via activation of the AKT-mammalian target of rapamycin signaling pathway. ASS1 contributes to GC progression by enhancing aggressive potential resulting from active beta-catenin, Snail, and Twist accumulation. Our results propose that ASS1 might contribute to GC metastasis and support its utility as a prognostic predictor of GC.	[Tsai, Chung-Ying; Chi, Hsiang-Cheng; Huang, Hsiang-Wei; Lin, Kwang-Huei] Chang Gung Univ, Dept Biochem, 259 Wen Hwa 1st Rd,Kwei San 333, Taoyuan, Taiwan; [Tsai, Chung-Ying; Yang, Huang-Yu; Chou, Li-Fang; Yang, Chih-Wei] Chang Gung Univ, Kidney Res Ctr, Dept Nephrol, Taoyuan, Taiwan; [Cheng, Ann-Joy] Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan; [Chi, Lang-Ming] Chang Gung Univ, Mol Med Res Ctr, Taoyuan, Taiwan; [Chi, Hsiang-Cheng] Chang Gung Mem Hosp, Radiat Biol Res Ctr, Inst Radiol Res, Taoyuan, Taiwan; [Chi, Lang-Ming; Tsai, Ming-Ming] Chang Gung Mem Hosp, Clin Prote Core Lab, Taoyuan, Taiwan; [Cheng, Ann-Joy] Chang Gung Mem Hosp, Dept Radiat Oncol, Taoyuan, Taiwan; [Lin, Kwang-Huei] Chang Gung Mem Hosp, Liver Res Ctr, Taoyuan, Taiwan; [Tsai, Ming-Ming] Chang Gung Univ Sci & Technol, Dept Nursing, Taoyuan, Taiwan; [Lin, Kwang-Huei] Chang Gung Univ Sci & Technol, Coll Human Ecol, Res Ctr Chinese Herbal Med, Taoyuan, Taiwan; [Lee, Kam-Fai] Chang Gung Mem Hosp, Dept Pathol, Chiayi, Taiwan; [Wang, Chia-Siu] Chang Gung Mem Hosp, Dept Gen Surg, Chiayi, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University of Science & Technology; Chang Gung University of Science & Technology; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Lin, KH (corresponding author), Chang Gung Univ, Dept Biochem, 259 Wen Hwa 1st Rd,Kwei San 333, Taoyuan, Taiwan.; Wang, CS (corresponding author), Chang Gung Mem Hosp, Dept Gen Surg, Chiayi, Taiwan.	wangcs@adm.cgmh.org.tw; khlin@mail.cgu.edu.tw	Cheng, Ann-Joy/AAI-4374-2020	Tsai, Chung-Ying/0000-0002-1444-5647; YANG, HUANG-YU/0000-0001-6826-9717; Cheng, Ann-Joy/0000-0002-1317-0725	Chang Gung Memorial Hospital [CMRPG6D0011, CMRPG6D0012, CMRPG6D0013, CIRPG3D0142-3, CORPG3F0131-2, CLRPD190017]; Ministry of Science and Technology of the Republic of China [MOST 100-2314-B-182A-074, 101-2314-B-182A-030, 102-2314-B-182A-074, 101-2623-B-182-001-MY3, 105-2321-B-182-002-MY3]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan)	The authors thank Dr. Ying Liang (Chang Gung University) for immunohistochemistry and pathological comments. This work was supported by grants from Chang Gung Memorial Hospital (CMRPG6D0011, CMRPG6D0012, CMRPG6D0013, CIRPG3D0142-3, CORPG3F0131-2, and CLRPD190017) and the Ministry of Science and Technology of the Republic of China (MOST 100-2314-B-182A-074, 101-2314-B-182A-030, 102-2314-B-182A-074, 101-2623-B-182-001-MY3, 105-2321-B-182-002-MY3). The authors declare no conflicts of interest.	Allen MD, 2014, CANCER RES, V74, P896, DOI 10.1158/0008-5472.CAN-13-1702; Amaravadi RK, 2007, CLIN CANCER RES, V13, P7271, DOI 10.1158/1078-0432.CCR-07-1595; Brasse-Lagnel C, 2007, FEBS J, V274, P5250, DOI 10.1111/j.1742-4658.2007.06047.x; Catalano M, 2015, MOL ONCOL, V9, P1612, DOI 10.1016/j.molonc.2015.04.016; Chen YT, 2010, J PROTEOME RES, V9, P5803, DOI 10.1021/pr100576x; Cho JY, 2011, CLIN CANCER RES, V17, P1850, DOI 10.1158/1078-0432.CCR-10-2180; D'Errico M, 2009, EUR J CANCER, V45, P461, DOI 10.1016/j.ejca.2008.10.032; Delage B, 2010, INT J CANCER, V126, P2762, DOI 10.1002/ijc.25202; Huang HY, 2013, CLIN CANCER RES, V19, P2861, DOI 10.1158/1078-0432.CCR-12-2641; Japanese Gastric Cancer Association, 1998, GASTRIC CANCER, V1, P10, DOI [DOI 10.1007/PL00011681, DOI 10.1007/S101209800016]]; Kim RH, 2009, AUTOPHAGY, V5, P567, DOI 10.4161/auto.5.4.8252; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kobayashi E, 2010, MOL CANCER THER, V9, P535, DOI 10.1158/1535-7163.MCT-09-0774; Liang Y, 2006, EXP MOL PATHOL, V81, P176, DOI 10.1016/j.yexmp.2006.04.008; Lin YH, 2015, J HEPATOL, V62, P1328, DOI 10.1016/j.jhep.2014.12.035; Marrelli D, 1999, ONCOLOGY-BASEL, V57, P55, DOI 10.1159/000012001; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; McAlpine JA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-621; Monari M, 2007, BIOMARK MED, V1, P209, DOI 10.2217/17520363.1.1.209; Morris SM, 2006, AM J CLIN NUTR, V83, p508S; Nagini S, 2012, WORLD J GASTRO ONCOL, V4, P156, DOI 10.4251/wjgo.v4.i7.156; Nicholson LJ, 2009, INT J CANCER, V125, P1454, DOI 10.1002/ijc.24546; Nikolsky Y, 2005, TOXICOL LETT, V158, P20, DOI 10.1016/j.toxlet.2005.02.004; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; Qiang L, 2014, AUTOPHAGY, V10, P1864, DOI 10.4161/auto.32171; Qiu FM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004761; Ren H, 2006, WORLD J GASTROENTERO, V12, P2789, DOI 10.3748/wjg.v12.i17.2789; Rho JH, 2008, J PROTEOME RES, V7, P2959, DOI 10.1021/pr8000892; Shan YS, 2015, ONCOL REP, V33, P49, DOI 10.3892/or.2014.3556; Shih CH, 2004, ENDOCRINOLOGY, V145, P2804, DOI 10.1210/en.2003-1372; Syed N, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.197; Szlosarek PW, 2007, INT J CANCER, V121, P6, DOI 10.1002/ijc.22666; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Tsai CY, 2014, CLIN CANCER RES, V20, P2276, DOI 10.1158/1078-0432.CCR-13-1221; Tsai MM, 2014, CANCER LETT, V351, P222, DOI 10.1016/j.canlet.2014.06.004; Tuloup-Minguez V, 2013, CELL CYCLE, V12, P3317, DOI 10.4161/cc.26298; Wang Chia-Siu, 2002, Chang Gung Med J, V25, P216; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60; Zois CE, 2009, AUTOPHAGY, V5, P442, DOI 10.4161/auto.5.4.7667	39	34	34	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2601	2614		10.1096/fj.201700094R	http://dx.doi.org/10.1096/fj.201700094R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29401583				2022-12-28	WOS:000432528000024
J	Liao, L; Yu, Y; Shao, BY; Su, XX; Wang, H; Kuang, HJ; Jing, H; Shuai, Y; Yang, DQ; Jin, Y				Liao, Li; Yu, Yang; Shao, Bingyi; Su, Xiaoxia; Wang, Han; Kuang, Huijuan; Jing, Huan; Shuai, Yi; Yang, Deqin; Jin, Yan			Redundant let-7a suppresses the immunomodulatory properties of BMSCs by inhibiting the Fas/FasL system in osteoporosis	FASEB JOURNAL			English	Article						immunosuppression; miRNA; T cells	MESENCHYMAL STEM-CELLS; TNF-ALPHA; BONE LOSS; ESTROGEN DEFICIENCY; T-CELLS; MICRORNA; OSTEOBLASTOGENESIS; IMMUNOSUPPRESSION; TRANSPLANTATION; STIMULATION	Bone marrow-derived mesenchymal stem cell (BMSC) cytotherapy has emerged as a promising treatment strategy for refractory immune diseases; however, the influence of the pathologic conditions of donors on the immunomodulatory properties of BMSCs is still poorly understand. Here, we found that BMSCs that were derived from donors with osteoporosis were ineffective as cytotherapy for patients with experimental colitis and graft-vs.-host disease (GVHD). In vivo and in vitro assays revealed that the capacity of osteoporotic BMSCs to induce T-cell apoptosis declined as a result of decreased Fas and FasL protein. Additional analysis revealed that let-7a, a microRNA induced by TNF-alpha in osteoporosis, inhibited the expression of the Fas/FasL system via post-transcriptional regulation. By knocking down let-7a expression, we successfully recovered the immunosuppressive capacity of osteoporotic BMSCs and improved their therapy for experimental colitis and GVHD. Taken together, our study demonstrates that the immunomodulatory properties of BMSCs are suppressed in osteoporosis and illustrates the molecular mechanism that underlies this suppression. These findings might have important implications for the development of targeted strategies to improve BMSC cytotherapy.	[Liao, Li; Kuang, Huijuan; Jing, Huan; Shuai, Yi; Jin, Yan] Fourth Mil Med Univ, Shaanxi Int Joint Res Ctr Oral Dis, Natl Clin Res Ctr Oral Dis, State Key Lab Mil Stomatol,Ctr Tissue Engn,Sch St, Xian, Shaanxi, Peoples R China; [Liao, Li; Kuang, Huijuan; Jing, Huan; Jin, Yan] Xian Inst Tissue Engn & Regenerat Med, Xian, Shaanxi, Peoples R China; [Yu, Yang; Shao, Bingyi; Yang, Deqin] Chongqing Med Univ, Stomatol Hosp, Dept Endodont, Chongqing, Peoples R China; [Yu, Yang; Shao, Bingyi; Yang, Deqin] Chongqing Key Lab Oral Dis & Biomed Sci, Chongqing, Peoples R China; [Yu, Yang; Shao, Bingyi; Yang, Deqin] Chongqing Municipal Key Lab Oral Biomed Engn High, Chongqing, Peoples R China; [Su, Xiaoxia] Xi An Jiao Tong Univ, Coll Stomatol, Key Lab Shaanxi Prov Craniofacial Precis Med Res, Xian, Shaanxi, Peoples R China; [Wang, Han] Guangzhou Med Univ, Affiliated Hosp 1, Dept Stomatol, Guangzhou, Guangdong, Peoples R China; [Shuai, Yi] Peoples Liberat Army, Nanjing Gen Hosp Nanjing Mil Command, Dept Stomatol, Nanjing, Jiangsu, Peoples R China	Air Force Military Medical University; Chongqing Medical University; Xi'an Jiaotong University; Guangzhou Medical University; Nanjing General Hospital	Yang, DQ (corresponding author), Chongqing Med Univ, Stomatol Hosp, 426 Songshibei Rd, Chongqing 401147, Peoples R China.; Jin, Y (corresponding author), Fourth Mil Med Univ, Sch Stomatol, Ctr Tissue Engn, State Key Lab Mil Stomatol, 145 West Changle Rd, Xian 710032, Shaanxi, Peoples R China.	yangde-qin@gmail.com; yanjin@fmmu.edu.cn	Liao, Li/U-6866-2017	Liao, Li/0000-0003-0030-1009; Yang, Deqin/0000-0002-2579-8384	Nature Science Foundation of China [31601113, 31030033, 81600912, 81470710]; National Key Research and Development Program of China [2017YFA0104900]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This work was supported by the National Key Research and Development Program of China (Grant 2017YFA0104900) and the Nature Science Foundation of China (Grants 31601113, 81600912, 31030033, and 81470710). The authors declare no conflicts of interest.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Akiyama K, 2012, CELL STEM CELL, V10, P544, DOI 10.1016/j.stem.2012.03.007; Ammann P, 1997, J CLIN INVEST, V99, P1699, DOI 10.1172/JCI119333; Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006; Bianco P, 2011, ENDOCR DEV, V21, P91, DOI 10.1159/000328138; Cenci S, 2000, J CLIN INVEST, V106, P1229, DOI 10.1172/JCI11066; Choi SW, 2014, NAT REV CLIN ONCOL, V11, P536, DOI 10.1038/nrclinonc.2014.102; Clark EA, 2014, STEM CELLS, V32, P1074, DOI 10.1002/stem.1623; Fan M, 2010, REJUV RES, V13, P429, DOI 10.1089/rej.2009.0986; Gebler A, 2012, TRENDS MOL MED, V18, P128, DOI 10.1016/j.molmed.2011.10.004; Geng LY, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/169082; Gu F, 2012, CLIN IMMUNOL, V145, P142, DOI 10.1016/j.clim.2012.08.012; Han X, 2014, CELL DEATH DIFFER, V21, P1758, DOI 10.1038/cdd.2014.85; He XW, 2012, DIGEST DIS SCI, V57, P3136, DOI 10.1007/s10620-012-2290-5; Kimble RB, 1997, J BONE MINER RES, V12, P935, DOI 10.1359/jbmr.1997.12.6.935; Kotake S, 2014, BBA-GEN SUBJECTS, V1840, P1209, DOI 10.1016/j.bbagen.2013.12.013; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lepperdinger G, 2011, CURR OPIN IMMUNOL, V23, P518, DOI 10.1016/j.coi.2011.05.007; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; Liao L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.130; Liao L, 2016, STEM CELLS, V34, P1054, DOI 10.1002/stem.2274; Lim JY, 2014, CELL TRANSPLANT, V23, P703, DOI 10.3727/096368913X664577; Lysaght T, 2013, CELL STEM CELL, V13, P647, DOI 10.1016/j.stem.2013.11.013; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Nemoto Y, 2013, GUT, V62, P1142, DOI 10.1136/gutjnl-2012-302029; Papantonis A, 2012, EMBO J, V31, P4404, DOI 10.1038/emboj.2012.288; Parekkadan B, 2011, GASTROENTEROLOGY, V140, P966, DOI 10.1053/j.gastro.2010.10.013; Parekkadan B, 2010, ANNU REV BIOMED ENG, V12, P87, DOI 10.1146/annurev-bioeng-070909-105309; Pfeilschifter J, 2002, ENDOCR REV, V23, P90, DOI 10.1210/er.23.1.90; Plumas J, 2005, LEUKEMIA, V19, P1597, DOI 10.1038/sj.leu.2403871; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ren GW, 2010, J IMMUNOL, V184, P2321, DOI 10.4049/jimmunol.0902023; Shao BY, 2015, FASEB J, V29, P3935, DOI 10.1096/fj.15-272823; Shi YF, 2012, TRENDS IMMUNOL, V33, P136, DOI 10.1016/j.it.2011.11.004; Sui BD, 2016, SCI REP-UK, V6, DOI 10.1038/srep30186; Sun Y, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/284215; Teitelbaum SL, 2004, P NATL ACAD SCI USA, V101, P16711, DOI 10.1073/pnas.0407335101; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Trenkmann M, 2013, ARTHRITIS RHEUM-US, V65, P916, DOI 10.1002/art.37834; Wahl EC, 2010, J BONE MINER RES, V25, P114, DOI 10.1359/jbmr.090708; Wang L, 2013, STEM CELLS, V31, P1383, DOI 10.1002/stem.1388; Wang Y, 2014, NAT IMMUNOL, V15, P1009, DOI 10.1038/ni.3002; Weitzmann MN, 2006, J CLIN INVEST, V116, P1186, DOI 10.1172/JCI28550; Xu LL, 2014, CELL BIOCHEM BIOPHYS, V70, P771, DOI 10.1007/s12013-014-9980-x; Yang N, 2013, J BONE MINER RES, V28, P559, DOI 10.1002/jbmr.1798; Yao J, 2012, REJUV RES, V15, P495, DOI 10.1089/rej.2012.1325; Yu B, 2016, TRENDS MOL MED, V22, P641, DOI 10.1016/j.molmed.2016.06.002; Yu Y, 2017, MOL THER, V25, P480, DOI 10.1016/j.ymthe.2016.11.015	49	7	8	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1982	1992		10.1096/fj.201700885R	http://dx.doi.org/10.1096/fj.201700885R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29203591				2022-12-28	WOS:000429051400020
J	Raz, V; Riaz, M; Tatum, Z; Kielbasa, SM; 't Hoen, PAC				Raz, Vered; Riaz, Muhammad; Tatum, Zuotian; Kielbasa, Szymon M.; 't Hoen, Peter A. C.			The distinct transcriptomes of slow and fast adult muscles are delineated by noncoding RNAs	FASEB JOURNAL			English	Article						skeletal muscles; fiber type; mRNA processing; RNAseq; noncoding RNA	FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; TARGET GENES; FIBER TYPES; PROTEIN; DIFFERENTIATION; MECHANISMS; EXPRESSION; COOPERATION; HOMEOSTASIS	Adult muscles have a vast adaptation capacity, enabling function switches in response to altered conditions. During intensive physical activity, disease, or aging, adult skeletal muscles change and adjust their functions. The competence to adjust varies among muscles. Muscle-specific molecular mechanisms in healthy and normal conditions could designate changes in physiologic and pathologic conditions. We generated deep mRNA-sequencing data in adult fast and slow mouse muscles, and applying paired analysis, we identified that the muscle specific signatures are composed of half of the muscle transcriptome. The fast muscles showed a more compact gene network that is concordant with homogenous myofiber typing, compared with the pattern in the slow muscle. The muscle-specific mRNA landscape did not correlate with alternative spicing, alternative polyadenylation, or the expression of muscle transcription factor gene networks. However, we found significant correlation between the differentially expressed noncoding RNAs, microRNAs (miRNAs) and long noncoding RNAs (lncRNAs) and their target genes. More than 25% of the genes expressed in amuscle-specific fashion were found to be targets of muscle specific miRNAs and lncRNAs. We suggest that muscle-specific miRNAs and lncRNAs contribute to the establishment of muscle-specific transcriptomes in adult muscles.	[Raz, Vered; Riaz, Muhammad; Tatum, Zuotian; 't Hoen, Peter A. C.] Leiden Univ, Med Ctr, Dept Human Genet, Einthovenweg 20, NL-2333 ZC Leiden, Netherlands; [Kielbasa, Szymon M.] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Bioinformat Ctr Expertise, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Raz, V (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, Einthovenweg 20, NL-2333 ZC Leiden, Netherlands.	v.raz@lumc.nl	Kiełbasa, Szymon M./K-2792-2019; Kiełbasa, Szymon/G-1636-2018; Hoen, Peter A 't/D-3950-2018	Kiełbasa, Szymon/0000-0003-2805-6535; Hoen, Peter A 't/0000-0003-4450-3112; raz, vered/0000-0003-3152-1952	AFM-Telethon [21160]	AFM-Telethon(Association Francaise contre les Myopathies)	The authors thank Raz Yotam (Leiden University Medical Centre) for muscle histology staining and image quantification advice, and Maaike van Putten (Leiden University Medical Centre) for advice on muscle myofiber staining. The authors thank the Leiden Genome Technology Center and the Sequencing Analysis Support Core (Leiden University Medical Center) for RNAseq and quality control assessment of the RNAseq. The study was partly funded by AFM-Telethon 21160. The authors declare no conflicts of interest.	Abbassi-Daloii T, 2017, NPJ AGING MECH DIS, V3, DOI 10.1038/s41514-017-0007-x; Aoi W, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00290; Bajan Sarah, 2014, Microrna, V3, P10; Barber TD, 2002, GENOMICS, V79, P278, DOI 10.1006/geno.2002.6703; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Buckingham M, 2014, DEV CELL, V28, P225, DOI 10.1016/j.devcel.2013.12.020; Chalkiadaki A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004490; Cheng AW, 2014, BLOOD, V124, P598, DOI 10.1182/blood-2013-12-542209; Conerly ML, 2016, DEV CELL, V36, P375, DOI 10.1016/j.devcel.2016.01.021; Danckwardt S, 2008, EMBO J, V27, P482, DOI 10.1038/sj.emboj.7601932; de Klerk E, 2015, TRENDS GENET, V31, P128, DOI 10.1016/j.tig.2015.01.001; de Klerk E, 2012, NUCLEIC ACIDS RES, V40, P9089, DOI 10.1093/nar/gks655; Flynn JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013535; Fu LN, 2014, CELL RES, V24, P141, DOI 10.1038/cr.2013.165; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; GAUTHIER GF, 1966, J CELL BIOL, V28, P333, DOI 10.1083/jcb.28.2.333; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Horak M, 2016, DEV BIOL, V410, P1, DOI 10.1016/j.ydbio.2015.12.013; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hughes SM, 1997, MECH DEVELOP, V61, P151, DOI 10.1016/S0925-4773(96)00631-4; Jelier R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-291; Jenal M, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.022; Katz Y, 2015, BIOINFORMATICS, V31, P2400, DOI 10.1093/bioinformatics/btv034; Koebis M, 2011, GENES CELLS, V16, P961, DOI 10.1111/j.1365-2443.2011.01542.x; Larsen M, 2015, EUR J HUM GENET, V23, P808, DOI 10.1038/ejhg.2014.191; Lemmers RJLF, 2012, NAT GENET, V44, P1370, DOI 10.1038/ng.2454; Li N, 2013, NAT PROTOC, V8, P1155, DOI 10.1038/nprot.2013.065; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Liu YB, 2010, NUCLEIC ACIDS RES, V38, P6857, DOI 10.1093/nar/gkq585; Mankodi A, 2003, ANN NEUROL, V54, P760, DOI 10.1002/ana.10763; Martinet C, 2016, DEVELOPMENT, V143, P962, DOI 10.1242/dev.131771; Merrell AJ, 2016, NAT REV MOL CELL BIO, V17, P413, DOI 10.1038/nrm.2016.24; Mondal T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8743; Neguembor MV, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-8; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Porter JD, 2001, P NATL ACAD SCI USA, V98, P12062, DOI 10.1073/pnas.211257298; Purves-Smith FM, 2014, EXERC SPORT SCI REV, V42, P45, DOI 10.1249/JES.0000000000000012; Rahimov F, 2012, P NATL ACAD SCI USA, V109, P16234, DOI 10.1073/pnas.1209508109; Raz Y, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00236; Riaz M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006031; Riaz M, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0064-4; ROBINSON MD, 2010, GENOME BIOL, V11; Romanello V, 2016, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00422; Sakakibara I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004386; Sanchez AMJ, 2014, CELL MOL LIFE SCI, V71, P1657, DOI 10.1007/s00018-013-1513-z; Schiaffino S, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0046-6; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trollet C, 2010, HUM MOL GENET, V19, P2191, DOI 10.1093/hmg/ddq098; Wang B, 2017, J AM SOC NEPHROL, V28, P2632, DOI 10.1681/ASN.2016111213; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Xia Z., 2014, NAT COMMUN, V5	58	16	17	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1579	1590		10.1096/fj.201700861R	http://dx.doi.org/10.1096/fj.201700861R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29141996				2022-12-28	WOS:000427246000036
J	Schwartz, NU; Linzer, RW; Truman, JP; Gurevich, M; Hannun, YA; Senkal, CE; Obeid, LM				Schwartz, Nicholas U.; Linzer, Ryan W.; Truman, Jean-Philip; Gurevich, Mikhail; Hannun, Yusuf A.; Senkal, Can E.; Obeid, Lina M.			Decreased ceramide underlies mitochondrial dysfunction in Charcot-Marie-Tooth 2F	FASEB JOURNAL			English	Article						sphingolipid; CerS; mitochondria; neuropathy; CMT2F	LONGEVITY ASSURANCE GENES; OXIDATIVE STRESS; ANIMAL-MODELS; DISEASE; CELL; AUTOPHAGY; MOTOR; HEAT-SHOCK-PROTEIN-27; SPHINGOLIPIDS; SYNTHASES	Charcot-Marie-Tooth (CMT) disease is the most commonly inherited neurologic disorder, but its molecular mechanisms remain unclear. One variant of CMT, 2F, is characterized by mutations in heat shock protein 27 (Hsp27). As bioactive sphingolipids have been implicated in neurodegenerative diseases, we sought to determine if their dysregulation is involved in CMT. Here, we show that Hsp27 knockout mice demonstrated decreases in ceramide in peripheral nerve tissue and that the disease-associated Hsp27 S135F mutant demonstrated decreases in mitochondrial ceramide. Given that Hsp27 is a chaperone protein, we examined its role in regulating ceramide synthases (CerSs), an enzyme family responsible for catalyzing generation of the sphingolipid ceramide. We determined that CerSs colocalized with Hsp27, and upon the presence of S135F mutants, CerS1 lost its colocalization with mitochondria suggesting that decreased mitochondrial ceramides result from reduced mitochondrial CerS localization rather than decreased CerS activity. Mitochondria in mutant cells appeared larger with increased interconnectivity. Furthermore, mutant cell lines demonstrated decreased mitochondrial respiratory function and increased autophagic flux. Mitochondrial structural and functional changes were recapitulated by blocking ceramide generation pharmacologically. These results suggest that mutant Hsp27 decreases mitochondrial ceramide levels, producing structural and functional changes in mitochondria leading to neuronal degeneration.	[Schwartz, Nicholas U.] SUNY Stony Brook, Dept Neurobiol & Behav, Sch Med, Stony Brook, NY 11794 USA; [Linzer, Ryan W.; Truman, Jean-Philip; Hannun, Yusuf A.; Senkal, Can E.; Obeid, Lina M.] SUNY Stony Brook, Dept Med, Sch Med, Stony Brook, NY 11794 USA; [Gurevich, Mikhail] SUNY Stony Brook, Dept Pharmacol, Sch Med, Stony Brook, NY 11794 USA; [Gurevich, Mikhail] SUNY Stony Brook, Sch Med, Dept Orthopaed, Stony Brook, NY 11794 USA; [Obeid, Lina M.] Northport Vet Affairs Med Ctr, Northport, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Obeid, LM (corresponding author), SUNY Stony Brook, Med Ctr, Hlth Sci Ctr, L-4,179, Stony Brook, NY 11794 USA.	lina.obeid@stonybrookmedicine.edu	Gurevich, Mikhail/AAO-2831-2020	Gurevich, Mikhail/0000-0002-4928-9939	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences [GM062887]; Veterans Affairs Merit Award [5I01BX000156-08]; NIH National Cancer Institute [P01CA097132]; NATIONAL CANCER INSTITUTE [P01CA097132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062887, R01GM097741] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000156] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences; Veterans Affairs Merit Award(US Department of Veterans Affairs); NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank Dr. Chiara Luberto (Stony Brook University) for overall advice. The authors also thank the Stony Brook Lipidomics Core for measurement and analysis of sphingolipids, the Stony Brook Proteomics Core for proteomic measurement and analysis of samples, and Dr. Ashley Snider (Stony Brook University) for assistance in managing mice. Peter Dong (University of Pennsylvania, Philadelphia, PA, USA) and Dr. Tanvir Khan (Stony Brook University) assisted in training for DRG dissection. The research in this manuscript was supported by the U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences Grant GM062887 and Veterans Affairs Merit Award 5I01BX000156-08 (to L.M.O.), NIH National Cancer Institute Grant P01CA097132 (to Y.A.H. and L.M.O.). The authors declare no conflicts of interest.	Akbar MT, 2003, J BIOL CHEM, V278, P19956, DOI 10.1074/jbc.M207073200; Almeida-Souza L, 2011, J NEUROSCI, V31, P15320, DOI 10.1523/JNEUROSCI.3266-11.2011; Angelin A, 2007, P NATL ACAD SCI USA, V104, P991, DOI 10.1073/pnas.0610270104; Atkinson D, 2017, NEUROLOGY, V88, P533, DOI 10.1212/WNL.0000000000003595; Bagneris C, 2009, J MOL BIOL, V392, P1242, DOI 10.1016/j.jmb.2009.07.069; Bakthisaran R, 2015, BBA-PROTEINS PROTEOM, V1854, P291, DOI 10.1016/j.bbapap.2014.12.019; Benn SC, 2002, NEURON, V36, P45, DOI 10.1016/S0896-6273(02)00941-8; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Bionda C, 2004, BIOCHEM J, V382, P527, DOI 10.1042/BJ20031819; Bouhy D, 2013, ANN NEUROL, V74, P391, DOI 10.1002/ana.23987; Chen R, 2011, FOLIA BIOL-PRAGUE, V57, P87; Crowe J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077383; d'Ydewalle C, 2011, NAT MED, V17, P968, DOI 10.1038/nm.2396; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; DYCK PJ, 1968, ARCH NEUROL-CHICAGO, V18, P603, DOI 10.1001/archneur.1968.00470360025002; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Fleming MS, 2015, ELIFE, V4, DOI 10.7554/eLife.06828; Haidar M, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00143; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Harel T, 2014, CLIN GENET, V86, P422, DOI 10.1111/cge.12393; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Henriques A, 2015, HUM MOL GENET, V24, P7390, DOI 10.1093/hmg/ddv439; Hernandez-Corbacho MJ, 2015, J BIOL CHEM, V290, P25356, DOI 10.1074/jbc.M115.658658; HIRSCHBERG K, 1993, BIOCHEM J, V290, P751, DOI 10.1042/bj2900751; Jiang JC, 1998, GENOME RES, V8, P1259, DOI 10.1101/gr.8.12.1259; Kim JY, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/9475981; Laviad EL, 2012, J BIOL CHEM, V287, P21025, DOI 10.1074/jbc.M112.363580; Lee H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019783; Lee J, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0154-y; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Lee SM, 2011, J CELL SCI, V124, P3319, DOI 10.1242/jcs.087114; Liu J, 2009, LIFE SCI, V84, P267, DOI 10.1016/j.lfs.2008.12.008; Luigetti M, 2010, J NEUROL SCI, V298, P114, DOI 10.1016/j.jns.2010.09.008; MACMILLAN JC, 1994, CLIN GENET, V45, P128; Matsumoto T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126229; Mesika A, 2007, J BIOL CHEM, V282, P27366, DOI 10.1074/jbc.M703487200; Mielke MM, 2012, NEUROLOGY, V79, P633, DOI 10.1212/WNL.0b013e318264e380; Min JX, 2007, MOL CANCER RES, V5, P801, DOI 10.1158/1541-7786.MCR-07-0100; MORELL P, 1970, J BIOL CHEM, V245, P342; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Neusch C, 2007, EUR J NEUROL, V14, P575, DOI 10.1111/j.1468-1331.2006.01688.x; Novgorodov SA, 2008, J BIOL CHEM, V283, P24707, DOI 10.1074/jbc.M801810200; Patwardhan GA, 2016, J BIOENERG BIOMEMBR, V48, P153, DOI 10.1007/s10863-015-9602-3; Penno A, 2010, J BIOL CHEM, V285, P11178, DOI 10.1074/jbc.M109.092973; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Piccinini M, 2010, MOL NEUROBIOL, V41, P314, DOI 10.1007/s12035-009-8096-6; Rodriguez GE, 2012, ARQ NEURO-PSIQUIAT, V70, P45, DOI 10.1590/S0004-282X2012000100010; Sanderson TH, 2015, MOL CELL NEUROSCI, V64, P116, DOI 10.1016/j.mcn.2014.12.007; Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059; Sharp PS, 2008, NEUROBIOL DIS, V30, P42, DOI 10.1016/j.nbd.2007.12.002; Shen L, 2016, CELL SIGNAL, V28, P1086, DOI 10.1016/j.cellsig.2016.05.008; Smith HL, 2015, SEMIN CELL DEV BIOL, V40, P142, DOI 10.1016/j.semcdb.2015.03.003; Sridevi P, 2010, EXP CELL RES, V316, P78, DOI 10.1016/j.yexcr.2009.09.027; Srivastava AK, 2012, NEUROBIOL DIS, V47, P163, DOI 10.1016/j.nbd.2012.03.035; Sundaram K, 2016, BIOCHEM J, V473, P743, DOI 10.1042/BJ20150586; Tang BS, 2005, ARCH NEUROL-CHICAGO, V62, P1201, DOI 10.1001/archneur.62.8.1201; Teramoto S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066001; Timmerman V, 2014, GENES-BASEL, V5, P13, DOI 10.3390/genes5010013; Tirodkar TS, 2015, J BIOL CHEM, V290, P13157, DOI 10.1074/jbc.M114.631325; Toth ME, 2013, CELL STRESS CHAPERON, V18, P759, DOI 10.1007/s12192-013-0428-9; Venkataraman K, 2002, FEBS LETT, V528, P3, DOI 10.1016/S0014-5793(02)03248-9; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Xie WL, 2012, J NEUROCHEM, V122, P404, DOI 10.1111/j.1471-4159.2012.07769.x; Xu HB, 2014, EUR J CLIN MICROBIOL, V33, P347, DOI 10.1007/s10096-013-1962-1; Zhao LH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002063; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	66	15	17	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1716	1728		10.1096/fj.201701067R	http://dx.doi.org/10.1096/fj.201701067R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29133339	Green Published			2022-12-28	WOS:000427246000047
J	Lee, EJ; Jan, AT; Baig, MH; Ahmad, K; Malik, A; Rabbani, G; Kim, T; Lee, IK; Lee, YH; Park, SY; Choi, I				Lee, Eun Ju; Jan, Arif Tasleem; Baig, Mohammad Hassan; Ahmad, Khurshid; Malik, Adeel; Rabbani, Gulam; Kim, Taeyeon; Lee, In-Kyu; Lee, Yong Ho; Park, So-Young; Choi, Inho			Fibromodulin and regulation of the intricate balance between myoblast differentiation to myocytes or adipocyte-like cells	FASEB JOURNAL			English	Article						extracellular matrix; adipogenesis; myogenesis; muscle disease	MATRIX GLA PROTEIN; SKELETAL-MUSCLE REGENERATION; SATELLITE CELLS; STEM-CELLS; MEMBRANE-PROTEIN; SELF-RENEWAL; MYOSTATIN; EXPRESSION; CLUSTERIN; NETWORKS	Interactions between myoblasts and the surrounding microenvironment led us to explore the role of fibromodulin (FMOD), an extracellular matrix protein, in the maintenance of myoblast stemness and function. Microarray analysis of FMODkd myoblasts and in silico studies were used to identify the top most differentially expressed genes in FMODkd, and helped establish that FMOD-based regulations of integral membrane protein 2a and clusterin are essential components of the myogenic program. Studies in knockout, obese, and diabetic mouse models helped characterize the operation of a novel FMOD-based regulatory circuit that controls myoblast switching from a myogenic to a lipid accumulation fate. FMOD regulation of myoblasts is an essential part of the myogenic program, and it offers opportunities for the development of therapeutics for the treatment of different muscle diseases.	[Lee, Eun Ju; Jan, Arif Tasleem; Baig, Mohammad Hassan; Ahmad, Khurshid; Rabbani, Gulam; Kim, Taeyeon; Choi, Inho] Yeungnam Univ, Dept Med Biotechnol, 280 Daehak Ro, Gyongsan 38541, South Korea; [Malik, Adeel] Chungnam Natl Univ, Dept Microbiol & Mol Biol, Daejeon, South Korea; [Lee, In-Kyu] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea; [Lee, Yong Ho] Catholic Univ Daegu, Dept Biomed Sci, Gyongsan, South Korea; [Park, So-Young] Yeungnam Univ, Coll Med, Dept Physiol, Daegu, South Korea	Yeungnam University; Chungnam National University; Kyungpook National University; Catholic University of Daegu; Yeungnam University	Choi, I (corresponding author), Yeungnam Univ, Dept Med Biotechnol, 280 Daehak Ro, Gyongsan 38541, South Korea.	inhochoi@ynu.ac.kr	Lee, In-Kyu/AAR-6374-2021; Ahmad, Khurshid/M-4676-2014; Rabbani, Gulam/AAE-5629-2022; Park, So-Young/AAC-5528-2022; Malik, Adeel/ABD-4831-2020; Jan, Arif Tasleem/AAX-6531-2020	Ahmad, Khurshid/0000-0002-1095-8445; Rabbani, Gulam/0000-0002-5293-8231; Park, So-Young/0000-0002-6018-0440; Malik, Adeel/0000-0002-3453-6001; Jan, Arif Tasleem/0000-0002-3607-543X; Baig, Mohd Hassan/0000-0001-8227-4838	National Research Foundation (NRF) of Korea - Ministry of Education [2016R1C1B1011478]; Gyeongsangbuk-Do and Gyeongbuk Science & Technology Promotion Center of Korea [SF316001A]	National Research Foundation (NRF) of Korea - Ministry of Education; Gyeongsangbuk-Do and Gyeongbuk Science & Technology Promotion Center of Korea	This work was supported, in part, by the Basic Science Research Program through the National Research Foundation (NRF) of Korea funded by the Ministry of Education (2016R1C1B1011478), and by the Creative Economy Leading Technology Development Program through the Gyeongsangbuk-Do and Gyeongbuk Science & Technology Promotion Center of Korea (SF316001A). The authors declare no conflicts of interest.	Afanasyeva MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098349; Ahmad S, 2017, LIFE SCI, V172, P55, DOI 10.1016/j.lfs.2016.12.011; Baig MH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06067-5; Bentzinger CF, 2013, EMBO REP, V14, P1062, DOI 10.1038/embor.2013.182; Bi PP, 2016, ELIFE, V5, DOI 10.7554/eLife.17355; Chang NC, 2014, CURR TOP DEV BIOL, V107, P161, DOI 10.1016/B978-0-12-416022-4.00006-8; Corda D, 2009, J BIOL CHEM, V284, P24848, DOI 10.1074/jbc.M109.035444; Deleersnijder W, 1996, J BIOL CHEM, V271, P19475, DOI 10.1074/jbc.271.32.19475; Doncheva NT, 2012, NAT PROTOC, V7, P670, DOI 10.1038/nprot.2012.004; Dumon NA, 2015, DEVELOPMENT, V142, P1572, DOI 10.1242/dev.114223; Gonzalez-Freire M, 2017, J CACHEXIA SARCOPENI, V8, P5, DOI 10.1002/jcsm.12121; Hsueh W, 2007, CIRC RES, V100, P1415, DOI 10.1161/01.RES.0000266449.37396.1f; Jan AT, 2016, INT J BIOCHEM CELL B, V80, P66, DOI 10.1016/j.biocel.2016.09.023; Kalamajski S, 2007, J BIOL CHEM, V282, P26740, DOI 10.1074/jbc.M704026200; Kalamajski S, 2016, J BIOL CHEM, V291, P7951, DOI 10.1074/jbc.M115.693408; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Kim DS, 2015, BIOCHEM BIOPH RES CO, V459, P534, DOI 10.1016/j.bbrc.2015.02.144; Kuang S, 2008, TRENDS MOL MED, V14, P82, DOI 10.1016/j.molmed.2007.12.004; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Le Grand F, 2007, DEVELOPMENT, V134, P3953, DOI 10.1242/dev.005934; Lee EJ, 2016, FASEB J, V30, P2708, DOI 10.1096/fj.201500133R; Lee EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079780; Lee EJ, 2012, GENES GENOM, V34, P133, DOI 10.1007/s13258-011-0096-z; Matukumalli SR, 2017, SCI REP-UK, V7, DOI 10.1038/srep41235; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Namkoong S, 2015, AUTOPHAGY, V11, P756, DOI 10.1080/15548627.2015.1034412; Pasut A, 2016, CELL REP, V16, P333, DOI 10.1016/j.celrep.2016.06.001; Relaix F, 2012, DEVELOPMENT, V139, P2845, DOI 10.1242/dev.069088; Rudnicki MA, 2008, COLD SH Q B, V73, P323, DOI 10.1101/sqb.2008.73.064; Scime A, 2010, MECH AGEING DEV, V131, P9, DOI 10.1016/j.mad.2009.11.001; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Su G, 2010, BIOINFORMATICS, V26, P3135, DOI 10.1093/bioinformatics/btq596; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Wallin R, 2000, THROMB HAEMOSTASIS, V84, P1039; Wang YX, 2014, J CELL SCI, V127, P4543, DOI 10.1242/jcs.151209; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wilson MR, 2017, EXPERT OPIN THER TAR, V21, P201, DOI 10.1080/14728222.2017.1267142; Yanaka N, 2003, J BIOL CHEM, V278, P43595, DOI 10.1074/jbc.M302867200; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Zebboudj AF, 2002, J BIOL CHEM, V277, P4388, DOI 10.1074/jbc.M109683200; Zhang F, 2015, BIOCHEM BIOPH RES CO, V458, P375, DOI 10.1016/j.bbrc.2015.01.120; Zheng Z, 2015, J AM COLL SURGEONS, V221, pE35, DOI 10.1016/j.jamcollsurg.2015.08.391; Zheng Z, 2016, AM J PATHOL, V186, P2824, DOI 10.1016/j.ajpath.2016.07.023; Zheng Z, 2012, BIOMATERIALS, V33, P5821, DOI 10.1016/j.biomaterials.2012.04.049	47	30	30	3	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					768	781		10.1096/fj.201700665R	http://dx.doi.org/10.1096/fj.201700665R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	28974563	Green Submitted			2022-12-28	WOS:000425146900020
J	Choi, S; Cui, CC; Luo, YH; Kim, SH; Ko, JK; Huo, XF; Ma, JJ; Fu, LW; Souza, RF; Korichneva, I; Pan, Z				Choi, Sangyong; Cui, Chaochu; Luo, Yanhong; Kim, Sun-Hee; Ko, Jae-Kyun; Huo, Xiaofang; Ma, Jianjie; Fu, Li-Wu; Souza, Rhonda F.; Korichneva, Irina; Pan, Zui			Selective inhibitory effects of zinc on cell proliferation in esophageal squamous cell carcinoma through Orai1	FASEB JOURNAL			English	Article						intracellular Ca2+ oscillations; cancer prevention; histidine; redox sensor	INTRACELLULAR CA2+; CRAC CHANNELS; ION CHANNELS; CANCER; RECEPTOR; PERMEATION; EXPRESSION; BINDING; DOMAIN; DAMAGE	Zinc, an essential micronutrient, has a cancer preventive role. Zinc deficiency has been shown to contribute to the progression of esophageal cancer. Orai1, a store-operated Ca2+ entry (SOCE) channel, was previously reported to be highly expressed in tumor tissues removed from patients with esophageal squamous cell carcinoma (ESCC) with poor prognosis, and elevation of its expression contributes to both hyperactive intracellular Ca2+ oscillations and fast cell proliferation in human ESCC cells. However, the molecular basis of cancer preventive functions of zinc and its association with Orai1-mediated cell proliferation remains unknown. The present study shows that zinc supplementation significantly inhibits proliferation of ESCC cell lines and that the effect of zinc is reversible with N,N,N', N'-tetrakis (2-pyridylmethyl) ethylenediamine, a specific Zn2+ chelator, whereas non-tumorigenic esophageal epithelial cells are significantly less sensitive to zinc treatment. Fluorescence live cell imaging revealed that extracellular Zn2+ exerted rapid inhibitory effects on Orai1-mediated SOCE and on intracellular Ca2+ oscillations in the ESCC cells. Knockdown of Orai1 or expression of Orai1 mutants with compromised zinc binding significantly diminished sensitivity of the cancer cells to zinc treatment in both SOCE and cell proliferation analyses. These data suggest that zinc may inhibit cell proliferation of esophageal cancer cells through Orai1-mediated intracellular Ca2+ oscillations and reveal a possible molecular basis for zinc-induced cancer prevention and Orai1-SOCE signaling pathway in cancer cells.	[Choi, Sangyong; Cui, Chaochu; Pan, Zui] Univ Texas Arlington, Coll Nursing & Hlth Innovat, 501 S Nedderman Dr,Life Sci Bldg 241, Arlington, TX 76019 USA; [Choi, Sangyong; Cui, Chaochu; Luo, Yanhong; Kim, Sun-Hee; Ma, Jianjie; Pan, Zui] Ohio State Univ, Davis Heart & Lung Res Inst, Wexner Med Ctr, Columbus, OH 43210 USA; [Ma, Jianjie] Ohio State Univ, Dept Surg, Wexner Med Ctr, Columbus, OH 43210 USA; [Cui, Chaochu; Fu, Li-Wu] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Canc Ctr, Guangzhou, Guangdong, Peoples R China; [Luo, Yanhong] Chongqing Med Univ, Dept Endocrinol, Childrens Hosp, Chongqing, Peoples R China; [Ko, Jae-Kyun] Mutagenex, Suwanee, GA USA; [Huo, Xiaofang; Souza, Rhonda F.] Baylor Univ, Med Ctr, Ctr Esophageal Dis, Dallas, TX USA; [Huo, Xiaofang; Souza, Rhonda F.] Baylor Scott & White Res Inst, Ctr Esophageal Res, Dallas, TX USA; [Korichneva, Irina] Univ Picardie Jules Verne, Dept Pharmacol, Amiens, France	University of Texas System; University of Texas Arlington; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; State Key Lab Oncology South China; Sun Yat Sen University; Chongqing Medical University; Baylor University; Baylor University Medical Center; Baylor Health Care System; Baylor University Medical Center; Picardie Universites; Universite de Picardie Jules Verne (UPJV)	Pan, Z (corresponding author), Univ Texas Arlington, Coll Nursing & Hlth Innovat, 501 S Nedderman Dr,Life Sci Bldg 241, Arlington, TX 76019 USA.	zui.pan@uta.edu	Kim, Sun/GSN-4867-2022; cui, cui/HHM-4146-2022; Fu, Liwu/AAE-8835-2020	Pan, Zui/0000-0003-4105-901X; Cui, Chaochu/0000-0003-0907-9766	U.S. National Institutes of Health (NIH) National Cancer Institute [R01-CA185055]; Pelotonia (Columbus, OH, USA); NIH National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK106394]; NATIONAL CANCER INSTITUTE [R01CA185055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK106394] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pelotonia (Columbus, OH, USA); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health (NIH) National Cancer Institute Grant R01-CA185055 and funds from Pelotonia (Columbus, OH, USA) (to Z.P.), and by NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant R01-DK106394 (to J.M.). The authors declare no conflicts of interest.	Abnet CC, 2005, JNCI-J NATL CANCER I, V97, P301, DOI 10.1093/jnci/dji042; Alansary D, 2016, SCI REP-UK, V6, DOI 10.1038/srep33347; Peralta FA, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071059; Bogeski I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000672; Bozym RA, 2010, EXP BIOL MED, V235, P741, DOI 10.1258/ebm.2010.009258; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Fong LYY, 1999, CANCER LETT, V143, P63, DOI 10.1016/S0304-3835(99)00191-3; Gore A, 2004, J BIOL CHEM, V279, P11106, DOI 10.1074/jbc.M400005200; Ho E, 2002, P NATL ACAD SCI USA, V99, P16770, DOI 10.1073/pnas.222679399; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Hu HZ, 2009, NAT CHEM BIOL, V5, P183, DOI 10.1038/nchembio.146; Huo XF, 2010, GASTROENTEROLOGY, V139, P194, DOI 10.1053/j.gastro.2010.03.035; Inoue K, 2015, CURR MED CHEM, V22, P1248, DOI 10.2174/0929867322666150209153750; Karakas E, 2009, EMBO J, V28, P3910, DOI 10.1038/emboj.2009.338; Ko JK, 2011, FASEB J, V25, P2638, DOI 10.1096/fj.11-181560; MASUOKA J, 1994, J BIOL CHEM, V269, P25557; McNally BA, 2012, J PHYSIOL-LONDON, V590, P4179, DOI 10.1113/jphysiol.2012.233098; McNally BA, 2009, P NATL ACAD SCI USA, V106, P22516, DOI 10.1073/pnas.0909574106; Mikata Y, 2005, DALTON T, P545, DOI 10.1039/b411924j; National Cancer Institute Division of Cancer Control and Population Sciences, 2016, SEER STAT FACT SHEET; Pan Z, 2000, J BIOL CHEM, V275, P19978, DOI 10.1074/jbc.M908329199; Pan Z, 2017, FRONT BIOSCI-LANDMRK, V22, P623, DOI 10.2741/4507; Pan Zui, 2012, J Vis Exp, DOI 10.3791/3415; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; ROGERS MAM, 1993, CANCER EPIDEM BIOMAR, V2, P305; Taccioli C, 2012, ONCOGENE, V31, P4550, DOI 10.1038/onc.2011.592; Uchida K, 2013, J BIOL CHEM, V288, P25950, DOI 10.1074/jbc.M113.470138; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Zhu H, 2014, ONCOTARGET, V5, P3455, DOI 10.18632/oncotarget.1903; Zhu L, 2014, RSC ADV, V4, P20398, DOI 10.1039/c4ra00354c	31	41	41	2	34	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					404	+		10.1096/fj.201700227RRR	http://dx.doi.org/10.1096/fj.201700227RRR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28928244	Green Published			2022-12-28	WOS:000419172700036
J	Nakao, S; Zandi, S; Sun, DW; Hafezi-Moghadam, A				Nakao, Shintaro; Zandi, Souska; Sun, Dawei; Hafezi-Moghadam, Ali			Cathepsin B-mediated CD18 shedding regulates leukocyte recruitment from angiogenic vessels	FASEB JOURNAL			English	Article						cornea; CD31; molecular imaging; ICAM-1; IL-1 beta	IN-VIVO; INFLAMMATORY ANGIOGENESIS; RETINAL MICROCIRCULATION; CYSTEINE PROTEASES; ENDOTHELIAL INJURY; EXPRESSION; INFILTRATION; CELLS; LYMPHANGIOGENESIS; ADHESION	Cathepsin B (CtsB) contributes to atherosclerosis and cancer progression by processing the extracellular matrix and promoting angiogenesis. Although CtsB was reported to promote and reduce angiogenesis, there is no mechanistic explanation that reconciles this apparent discrepancy. CtsB cleaves CD18 from the surface of immune cells, but its contribution to angiogenesis has not been studied. We developed an in vivo technique for visualization of immune cell transmigration from corneal vessels toward implanted cytokines. Wild-type (WT) leukocytes extravasated from limbal vessels, angiogenic stalks, and growing tip vessels and migrated toward the cytokines, indicating immune competence of angiogenic vessels. Compared to WT leukocytes, CtsB(-/-) leukocytes accumulated in a higher number in angiogenic vessels, but extravasated less toward the implanted cytokine. The accumulated CtsB(-/-) leukocytes in angiogenic vessels expressed more CD18. CD18(-/-) leukocytes extravasated later than WT leukocytes. However, once extravasated, CD18(-/-) leukocytes transmigrated more rapidly than their WT counterparts. These results suggest that, although CD18 facilitates efficient extravasation, outside of the vessel CD18 interaction with the extracellular matrix, it reduced transmigration velocity. Our results reveal an unexpected role for CtsB in leukocyte extravasation and transmigration, which advances our understanding of the complex contribution of CtsB to angiogenesis.	[Nakao, Shintaro; Zandi, Souska; Sun, Dawei; Hafezi-Moghadam, Ali] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Mol Biomarkers Nanoimaging Lab, Boston, MA 02115 USA; [Nakao, Shintaro] Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka, Japan	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Kyushu University	Hafezi-Moghadam, A (corresponding author), Harvard Med Sch, Brigham Womens Hosp, MBNI Lab, 75 Francis St,Thorn Res Bldg, Boston, MA 02115 USA.	ahm@bwh.harvard.edu		Zandi, Souska/0000-0001-9351-4278	U.S. National Institutes of Health (NIH) Impact Award, National Institute of Diabetes and Digestive and Kidney Diseases [DK108238-01]; Juvenile Diabetes Research Fund (JDRF) Innovation award; overseas Research Fellowship Award from Bausch Lomb; Japan Eye Bank Association and Tear Film and Ocular Surface Society; Young Investigator Fellowship; Japan Society for the Promotion of Science (JSPS) KAKENHI [25713057, 17K11456]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK108238] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) Impact Award, National Institute of Diabetes and Digestive and Kidney Diseases; Juvenile Diabetes Research Fund (JDRF) Innovation award; overseas Research Fellowship Award from Bausch Lomb; Japan Eye Bank Association and Tear Film and Ocular Surface Society; Young Investigator Fellowship; Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Rebecca Garland and Aliaa Barakat (Molecular Biomarkers Nano-Imaging Laboratory, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School) for preparation of the manuscript. Rebecca Garland passed away on August 11, 2017. The authors are deeply saddened by her departure and she will be much missed. This work was supported by the U.S. National Institutes of Health (NIH) Impact Award, National Institute of Diabetes and Digestive and Kidney Diseases Grant DK108238-01 (to A.H.-M.); Juvenile Diabetes Research Fund (JDRF) Innovation award (to A.H.-M.); an overseas Research Fellowship Award from Bausch & Lomb; a Fellowship Award from the Japan Eye Bank Association and Tear Film and Ocular Surface Society; a Young Investigator Fellowship (to S.N., under the mentorship of A.H.-M.); and grants from the Japan Society for the Promotion of Science (JSPS) KAKENHI, Grant-in-Aid for Young Scientists (A) 25713057 (to S.N.) and Grant-in-Aid for Scientific Research (C) 17K11456 (to S.N.). The authors declare no conflicts of interest.	Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Berquin IM, 1996, ADV EXP MED BIOL, V389, P281; Coffelt SB, 2010, CANCER RES, V70, P5270, DOI 10.1158/0008-5472.CAN-10-0012; Detmar M, 1998, J INVEST DERMATOL, V111, P1, DOI 10.1046/j.1523-1747.1998.00262.x; DIAMOND MS, 1993, J CELL BIOL, V120, P545, DOI 10.1083/jcb.120.2.545; Fukuda S, 2003, P NATL ACAD SCI USA, V100, P13152, DOI 10.1073/pnas.2336130100; Garland RC, 2011, FASEB J, V25, P1284, DOI 10.1096/fj.10-160051; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Hafezi-Moghadam A, 2004, AM J PHYSIOL-CELL PH, V286, pC876, DOI 10.1152/ajpcell.00500.2003; Hafezi-Moghadam A, 2001, J EXP MED, V193, P863, DOI 10.1084/jem.193.7.863; Hafezi-Moghadam A, 1999, J EXP MED, V189, P939, DOI 10.1084/jem.189.6.939; Im E, 2005, MOL BIOL CELL, V16, P3488, DOI 10.1091/mbc.E04-11-1029; Ishida S, 2003, NAT MED, V9, P781, DOI 10.1038/nm877; Joyce JA, 2004, CANCER CELL, V5, P443, DOI 10.1016/S1535-6108(04)00111-4; Lutgens SPM, 2007, FASEB J, V21, P3029, DOI 10.1096/fj.06-7924com; Miyahara S, 2004, INVEST OPHTH VIS SCI, V45, P4197, DOI 10.1167/iovs.04-0192; Miyahara S, 2008, FASEB J, V22, P1973, DOI 10.1096/fj.07-096891; Mizgerd JP, 1997, J EXP MED, V186, P1357, DOI 10.1084/jem.186.8.1357; Nakao S, 2005, J CLIN INVEST, V115, P2979, DOI 10.1172/JCI23298; Nakao S, 2007, AM J PATHOL, V171, P1058, DOI 10.2353/ajpath.2007.070172; Nakao S, 2016, METHODS MOL BIOL, V1430, P311, DOI 10.1007/978-1-4939-3628-1_21; Nakao S, 2012, INVEST OPHTH VIS SCI, V53, P4323, DOI 10.1167/iovs.11-9119; Nakao S, 2012, INVEST OPHTH VIS SCI, V53, P3296, DOI 10.1167/iovs.11-8114; Nakao S, 2012, FASEB J, V26, P808, DOI 10.1096/fj.11-183897; Nakao S, 2011, AM J PATHOL, V178, P1913, DOI 10.1016/j.ajpath.2011.01.011; Nakao S, 2011, BLOOD, V117, P1081, DOI 10.1182/blood-2010-02-267427; NISHIWAKI H, 1995, INVEST OPHTH VIS SCI, V36, P123; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Rogers MS, 2007, NAT PROTOC, V2, P2545, DOI 10.1038/nprot.2007.368; RUGGERI ZM, 1993, THROMB HAEMOSTASIS, V70, P119; Shree T, 2011, GENE DEV, V25, P2465, DOI 10.1101/gad.180331.111; SINHA AA, 1995, ANAT REC, V241, P353, DOI 10.1002/ar.1092410309; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; Strojnik T, 1999, CLIN CANCER RES, V5, P559; Sun DW, 2014, FASEB J, V28, P3942, DOI 10.1096/fj.14-251934; Sun DW, 2010, FASEB J, V24, P1532, DOI 10.1096/fj.09-148981; Wels J, 2008, GENE DEV, V22, P559, DOI 10.1101/gad.1636908; Xie F, 2010, AM J PATHOL, V177, P39, DOI 10.2353/ajpath.2010.100007; Yamaguchi M, 2016, INVEST OPHTH VIS SCI, V57, P2264, DOI 10.1167/iovs.15-17411	39	10	11	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					143	154		10.1096/fj.201601229R	http://dx.doi.org/10.1096/fj.201601229R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28904019	Green Published			2022-12-28	WOS:000419172700015
J	Fattahi, F; Kalbitz, M; Malan, EA; Abe, E; Jajou, L; Huber-Lang, MS; Bosmann, M; Russell, MW; Zetoune, FS; Ward, PA				Fattahi, Fatemeh; Kalbitz, Miriam; Malan, Elizabeth A.; Abe, Elizabeth; Jajou, Lawrence; Huber-Lang, Markus S.; Bosmann, Markus; Russell, Mark W.; Zetoune, Firas S.; Ward, Peter A.			Complement-induced activation of MAPKs and Akt during sepsis: role in cardiac dysfunction	FASEB JOURNAL			English	Article						CLP; cardiomyocyte; C5a receptor	MYOCARDIAL ISCHEMIA/REPERFUSION INJURY; PROTEIN-KINASE; EXTRACELLULAR HISTONES; NLRP3 INFLAMMASOME; SEPTIC SHOCK; C5A; HEART; CARDIOPROTECTION; LOCALIZATION; INHIBITION	Polymicrobial sepsis in mice causes myocardial dysfunction after generation of the complement anaphylatoxin, complement component 5a (C5a). C5a interacts with its receptors on cardiomyocytes (CMs), resulting in redox imbalance and cardiac dysfunction that can be functionally measured and quantitated using Doppler echocardiography. In this report we have evaluated activation of MAPKs and Akt in CMs exposed to C5a in vitro and after cecal ligation and puncture (CLP) in vivo. In both cases, C5a in vitro caused activation (phosphorylation) of MAPKs and Akt in CMs, which required availability of both C5a receptors. Using immunofluorescence technology, activation of MAPKs and Akt occurred in left ventricular (LV) CMs, requiring both C5a receptors, C5aR1 and -2. Use of a water-soluble p38 inhibitor curtailed activation in vivo of MAPKs and Akt in LVCMs as well as the appearance of cytokines and histones in plasma from CLP mice. When mouse macrophages were exposed in vitro to LPS, activation of MAPKs and Akt also occurred. The copresence of the p38 inhibitor blocked these activation responses. Finally, the presence of the p38 inhibitor in CLP mice reduced the development of cardiac dysfunction. These data suggest that polymicrobial sepsis causes cardiac dysfunction that appears to be linked to activation of MAPKs and Akt in heart.	[Fattahi, Fatemeh; Malan, Elizabeth A.; Abe, Elizabeth; Jajou, Lawrence; Zetoune, Firas S.; Ward, Peter A.] Univ Michigan, Sch Med, Dept Pathol, 1301 Catherine Rd,7520 MSRB I,Box 5602, Ann Arbor, MI 48109 USA; [Russell, Mark W.] Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Ann Arbor, MI USA; [Kalbitz, Miriam; Huber-Lang, Markus S.] Univ Hosp Ulm, Dept Orthopaed Trauma Hand Plast & Reconstruct Su, Ulm, Germany; [Bosmann, Markus] Univ Med Ctr, Ctr Thrombosis & Hemostasis, Mainz, Germany	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Ulm University; Johannes Gutenberg University of Mainz	Ward, PA (corresponding author), Univ Michigan, Sch Med, Dept Pathol, 1301 Catherine Rd,7520 MSRB I,Box 5602, Ann Arbor, MI 48109 USA.	pward@umich.edu	Huber-Lang, Markus/AAJ-2209-2020	Bosmann, Markus/0000-0003-2773-1033	U.S. National Institutes of Health (NIH) National Cancer Institute; O'Brien Renal Center; UM Medical School; Endowment for the Basic Sciences (EBS); UM Department of Cell and Developmental Biology; NIH [GM-29507, GM-61656]; Deutsche Forschungsgemeinschaft [KA 3740, BO 3482/3-1]; Federal Ministry of Education and Research [01EO1003, HU823/302]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061656, R01GM029507, R37GM029507] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); O'Brien Renal Center; UM Medical School; Endowment for the Basic Sciences (EBS); UM Department of Cell and Developmental Biology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the Microscopy and Image Analysis Laboratory (MIL), University of Michigan (UM) Medical School, a multiuser imaging facility supported by a grant from the U.S. National Institutes of Health (NIH) National Cancer Institute; the O'Brien Renal Center, the UM Medical School, the Endowment for the Basic Sciences (EBS), and the UM Department of Cell and Developmental Biology; Kimber Converso-Baran, research sonographer and echocardiographic specialist, for excellent services provided; and Sue Scott, Melissa Rennells, and Michelle Possley (all from UM) for excellent assistance in the preparation of the manuscript. This study was supported by NIH, General Medicine Grants GM-29507 and GM-61656 (to P.A.W.), the Deutsche Forschungsgemeinschaft Fellowship Project KA 3740 (to M.K.); Deutsche Forschungsgemeinschaft Grant BO 3482/3-1 (to M.B.), Federal Ministry of Education and Research Grant 01EO1003 (to M.B.) and HU823/302 (to M.S.H.-L.). F.F. and M.K. are cofirst authors. The authors declare no conflicts of interest.	Abraham E, 2001, CRIT CARE MED, V29, P503, DOI 10.1097/00003246-200103000-00006; Armstrong SC, 2004, CARDIOVASC RES, V61, P427, DOI 10.1016/j.cardiores.2003.09.031; Asaduzzaman M, 2008, CRIT CARE MED, V36, P482, DOI 10.1097/01.CCM.0B013E31816204FA; Badger AM, 2000, ARTHRITIS RHEUM, V43, P175, DOI 10.1002/1529-0131(200001)43:1<175::AID-ANR22>3.0.CO;2-S; Behr TM, 2001, CIRCULATION, V104, P1292, DOI 10.1161/hc3601.094275; Bell JR, 2008, CLIN EXP PHARMACOL P, V35, P126, DOI 10.1111/j.1440-1681.2007.04794.x; Ben-Levy R, 1998, CURR BIOL, V8, P1049, DOI 10.1016/S0960-9822(98)70442-7; Blanco J, 2008, CRIT CARE, V12, DOI 10.1186/cc7157; Bosmann M, 2013, FASEB J, V27, P5010, DOI 10.1096/fj.13-236380; Bosmann M, 2012, FASEB J, V26, P1640, DOI 10.1096/fj.11-199216; Bosmann M, 2011, FASEB J, V25, P4222, DOI 10.1096/fj.11-191205; Cain BS, 1999, CRIT CARE MED, V27, P1309, DOI 10.1097/00003246-199907000-00018; Cattin ME, 2013, CURR OPIN CARDIOL, V28, P297, DOI 10.1097/HCO.0b013e32835f0c79; Chen NJ, 2007, NATURE, V446, P203, DOI 10.1038/nature05559; Chen YP, 2017, EUR J PHARMACOL, V796, P90, DOI 10.1016/j.ejphar.2016.11.053; Cook SA, 1999, J MOL CELL CARDIOL, V31, P1429, DOI 10.1006/jmcc.1999.0979; Court NW, 2002, J MOL CELL CARDIOL, V34, P413, DOI 10.1006/jmcc.2001.1523; Du JF, 2016, AM J PHYSIOL-CELL PH, V310, pC270, DOI 10.1152/ajpcell.00194.2015; Fattahi F, 2017, J INNATE IMMUN, V9, P300, DOI 10.1159/000452951; Fattahi F, 2017, MOL IMMUNOL, V84, P57, DOI 10.1016/j.molimm.2016.11.012; Fernandes CJ, 1999, INTENS CARE MED, V25, P1165, DOI 10.1007/s001340051030; Fisher CJ, 1996, NEW ENGL J MED, V334, P1697, DOI 10.1056/NEJM199606273342603; Gerard NP, 2005, J BIOL CHEM, V280, P39677, DOI 10.1074/jbc.C500287200; Grailer JJ, 2014, J IMMUNOL, V192, P5974, DOI 10.4049/jimmunol.1400368; Haudek SB, 2001, AM J PHYSIOL-HEART C, V280, pH962, DOI 10.1152/ajpheart.2001.280.3.H962; Haynes MP, 2003, J BIOL CHEM, V278, P2118, DOI 10.1074/jbc.M210828200; Hopken UE, 1996, NATURE, V383, P86, DOI 10.1038/383086a0; Hsu WC, 2014, CELL SIGNAL, V26, P1409, DOI 10.1016/j.cellsig.2014.02.021; Huber-Lang M, 2001, J IMMUNOL, V166, P1193, DOI 10.4049/jimmunol.166.2.1193; Huber-Lang MS, 2001, FASEB J, V15, P568; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kalbitz M, 2016, FASEB J, V30, P3997, DOI 10.1096/fj.201600728R; Kalbitz M, 2016, J IMMUNOL, V197, P2353, DOI 10.4049/jimmunol.1600091; Kalbitz M, 2015, FASEB J, V29, P2185, DOI 10.1096/fj.14-268730; Kato K, 2003, AM J PHYSIOL-HEART C, V285, pH1506, DOI 10.1152/ajpheart.00270.2003; Klintman D, 2005, ANN SURG, V242, P830, DOI 10.1097/01.sla.0000189132.86878.f7; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Lim NR, 2013, BIOCHEM J, V456, P149, DOI 10.1042/BJ20121538; Liu XR, 2016, ADV MATER SCI ENG, V2016, DOI 10.1155/2016/7013032; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Mockridge JW, 2000, BIOCHEM BIOPH RES CO, V270, P947, DOI 10.1006/bbrc.2000.2522; NAKAE H, 1994, RES COMMUN CHEM PATH, V84, P189; Niederbichler AD, 2006, J EXP MED, V203, P53, DOI 10.1084/jem.20051207; Pinsetta FR, 2014, J BIOMOL STRUCT DYN, V32, P1047, DOI 10.1080/07391102.2013.803441; Riedemann NC, 2003, FASEB J, V17, P370, DOI 10.1096/fj.03-0708fje; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Romero-Bermejo FJ, 2011, CURR CARDIOL REV, V7, P163, DOI 10.2174/157340311798220494; Rubinfeld H, 1999, J BIOL CHEM, V274, P30349, DOI 10.1074/jbc.274.43.30349; Sarma JV, 2012, CELL HEALTH CYTOSKEL, V4, P73, DOI 10.2147/CHC.S27233; Song LN, 2014, APOPTOSIS, V19, P567, DOI 10.1007/s10495-013-0946-z; Sun LL, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0420-2; Toledo-Pereyra LH, 2004, J INVEST SURG, V17, P303, DOI 10.1080/08941930490884706; Trunzer K, 2013, J CLIN ONCOL, V31, P1767, DOI 10.1200/JCO.2012.44.7888; Ward PA, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/427607; Wrann CD, 2007, J IMMUNOL, V178, P5940, DOI 10.4049/jimmunol.178.9.5940; Zetoune FS, 2007, FASEB J, V21, pA1150; ZHENG CF, 1994, J BIOL CHEM, V269, P19947	58	35	37	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					4129	4139		10.1096/fj.201700140R	http://dx.doi.org/10.1096/fj.201700140R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28572445	Green Published, Green Submitted			2022-12-28	WOS:000408713300035
J	Leclaire, C; Lecointe, K; Gunning, PA; Tribolo, S; Kavanaugh, DW; Wittmann, A; Latousakis, D; MacKenzie, DA; Kawasaki, N; Juge, N				Leclaire, Charlotte; Lecointe, Karine; Gunning, Patrick A.; Tribolo, Sandra; Kavanaugh, Devon W.; Wittmann, Alexandra; Latousakis, Dimitrios; MacKenzie, Donald A.; Kawasaki, Norihito; Juge, Nathalie			Molecular basis for intestinal mucin recognition by galectin-3 and C-type lectins	FASEB JOURNAL			English	Article						mucus; O-glycosylation; N-glycosylation; immune system	N-LINKED OLIGOSACCHARIDES; BETA-GLUCAN RECEPTOR; 3-DERIVED O-GLYCANS; HUMAN DC-SIGN; GOBLET CELL; DENDRITIC CELLS; SPONTANEOUS COLITIS; EPITHELIAL BARRIER; ENDOTHELIAL-CELLS; IMMUNE-RESPONSES	Intestinal mucins trigger immune responses upon recognition by dendritic cells via protein-carbohydrate interactions. We used a combination of structural, biochemical, biophysical, and cell-based approaches to decipher the specificity of the interaction between mucin glycans and mammalian lectins expressed in the gut, including galectin (Gal)-3 and C-type lectin receptors. Gal-3 differentially recognized intestinal mucins with different O-glycosylation profiles, as determined by mass spectrometry (MS). Modification of mucin glycosylation, via chemical treatment leading to a loss of terminal glycans, promoted the interaction of Gal-3 to poly-N-acetyllactosamine. Specific interactions were observed between mucins and mouse dendritic cell-associated lectin (mDectin)-2 or specific intercellular adhesion molecule-grabbing nonintegrin-related-1 (SIGN-R1), but not mDectin-1, using a cell-reporter assay, as also confirmed by atomic force spectroscopy. We characterized the N-glycosylation profile of mouse colonic mucin (Muc)-2 by MS and showed that the interaction with mDectin-2 was mediated by high-mannose N-glycans. Furthermore, we observed Gal-3 binding to the 3 C-type lectins by force spectroscopy. We showed that mDectin-1, mDectin-2, and SIGN-R1 are decorated by N-glycan structures that can be recognized by the carbohydrate recognition domain of Gal-3. These findings provide a structural basis for the role of mucins in mediating immune responses and new insights into the structure and function of major mammalian lectins.	[Leclaire, Charlotte; Lecointe, Karine; Gunning, Patrick A.; Tribolo, Sandra; Kavanaugh, Devon W.; Wittmann, Alexandra; Latousakis, Dimitrios; MacKenzie, Donald A.; Kawasaki, Norihito; Juge, Nathalie] Quadram Inst Biosci, Norwich Res Pk, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute	Juge, N (corresponding author), Quadram Inst Biosci, Gut Hlth & Food Safety Inst, Strateg Programme, Norwich Res Pk, Norwich NR4 7UA, Norfolk, England.	nathalie.juge@quadram.ac.uk	Latousakis, Dimitrios M/K-6269-2017	Latousakis, Dimitrios M/0000-0002-2472-9328; Juge, Nathalie/0000-0001-8515-1315; Lecointe, Karine/0000-0002-9916-5088; Kavanaugh, Devon/0000-0001-8831-8248; TRIBOLO, Sandra/0000-0002-2664-7553	Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC Institute Strategic Programme for The Gut Health and Food Safety [BB/J004529/1]; Institute of Food Research (IFR) Strategy Fund Grant; BBSRC Responsive Mode Grant [BB/K019554/1]; BBSRC [BBS/E/F/00044452, BBS/E/F/000PR10353, BB/K019554/1, BBS/E/F/000PR10355, BBS/E/F/000PR10356, BBS/E/F/00044504, BBS/E/F/00042548] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/F/000PR10353, BBS/E/F/000PR10356, BBS/E/F/00042548, BBS/E/F/00044452, BBS/E/F/000PR10355, BB/K019554/1, BBS/E/F/00044504] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Institute Strategic Programme for The Gut Health and Food Safety(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Institute of Food Research (IFR) Strategy Fund Grant; BBSRC Responsive Mode Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank Dimitra Lamprinaki [Quadram Institute Bioscience (QIB, Norwich, United Kingdom)] for help with manuscript revisions. The work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) and was funded in part by a grant from the BBSRC Institute Strategic Programme for The Gut Health and Food Safety (BB/J004529/1) and the BB/K019554/1 BBSRC Responsive Mode Grant (to N.J.), and the Institute of Food Research (IFR) Strategy Fund Grant (to N.J. and N.K.). C.L. and K.L. are joint first authors. The authors declare no conflicts of interest.	An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Argueso P, 2009, J BIOL CHEM, V284, P23037, DOI 10.1074/jbc.M109.033332; Ariizumi K, 2000, J BIOL CHEM, V275, P11957, DOI 10.1074/jbc.275.16.11957; Asker N, 1998, J BIOL CHEM, V273, P18857, DOI 10.1074/jbc.273.30.18857; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; Bell SL, 2003, BIOCHEM J, V373, P893, DOI 10.1042/BJ20030096; Bene KP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00321; Bergstrom JH, 2016, P NATL ACAD SCI USA, V113, P13833, DOI 10.1073/pnas.1611400113; Bergstrom K, 2017, MUCOSAL IMMUNOL, V10, P91, DOI 10.1038/mi.2016.45; Bergstrom K, 2016, GASTROENTEROLOGY, V151, P152, DOI 10.1053/j.gastro.2016.03.039; Bergstrom KSB, 2013, GLYCOBIOLOGY, V23, P1026, DOI 10.1093/glycob/cwt045; Bian CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025007; Birchenough GMH, 2015, MUCOSAL IMMUNOL, V8, P712, DOI 10.1038/mi.2015.32; Birchenough GMH, 2016, SCIENCE, V352, P1535, DOI 10.1126/science.aaf7419; Bresalier RS, 1996, CANCER RES, V56, P4354; Capon C, 1997, J BIOL CHEM, V272, P31957, DOI 10.1074/jbc.272.51.31957; Chik JHL, 2014, J PROTEOMICS, V108, P146, DOI 10.1016/j.jprot.2014.05.002; Crost EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076341; Dambuza IM, 2015, CURR OPIN IMMUNOL, V32, P21, DOI 10.1016/j.coi.2014.12.002; Davies JR, 2012, METHODS MOL BIOL, V842, P27, DOI 10.1007/978-1-61779-513-8_2; Ermund A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083688; Garcia-Vallejo JJ, 2008, MOL IMMUNOL, V45, P2359, DOI 10.1016/j.molimm.2007.11.001; Geijtenbeek TBH, 2004, ANNU REV IMMUNOL, V22, P33, DOI 10.1146/annurev.immunol.22.012703.104558; Geijtenbeek TBH, 2016, NAT REV IMMUNOL, V16, P433, DOI 10.1038/nri.2016.55; Gunning AP, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111854; Gunning AP, 2013, FASEB J, V27, P2342, DOI 10.1096/fj.12-221416; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Hanisch FG, 2009, PROTEOMICS, V9, P710, DOI 10.1002/pmic.200800492; Herre J, 2004, MOL IMMUNOL, V40, P869, DOI 10.1016/j.molimm.2003.10.007; Hinterdorfer P, 2002, COLLOID SURFACE B, V23, P115, DOI 10.1016/S0927-7765(01)00256-9; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Hollmig ST, 2009, GLYCOBIOLOGY, V19, P568, DOI 10.1093/glycob/cwp032; Larsson JMH, 2013, AM J PHYSIOL-GASTR L, V305, pG357, DOI 10.1152/ajpgi.00048.2013; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Ismail MN, 2011, GLYCOBIOLOGY, V21, P82, DOI 10.1093/glycob/cwq134; Jensen PH, 2010, FEBS J, V277, P81, DOI 10.1111/j.1742-4658.2009.07429.x; Johansson MEV, 2014, CELL HOST MICROBE, V15, P251, DOI 10.1016/j.chom.2014.02.014; Johansson MEV, 2013, DIGEST DIS, V31, P305, DOI 10.1159/000354683; Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35; Johansson MEV, 2011, CELL MOL LIFE SCI, V68, P3635, DOI 10.1007/s00018-011-0822-3; Karlsson NG, 1997, BIOCHEM J, V326, P911, DOI 10.1042/bj3260911; Kataoka H, 2000, J BIOL CHEM, V275, P6573, DOI 10.1074/jbc.275.9.6573; Kato Y, 2006, BIOL PHARM BULL, V29, P1580, DOI 10.1248/bpb.29.1580; Kerscher B, 2013, INT IMMUNOL, V25, P271, DOI 10.1093/intimm/dxt006; Knoop KA, 2015, MUCOSAL IMMUNOL, V8, P198, DOI 10.1038/mi.2014.58; Koning N, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00112; Larsson JMH, 2009, GLYCOBIOLOGY, V19, P756, DOI 10.1093/glycob/cwp048; Lee RT, 2011, GLYCOBIOLOGY, V21, P512, DOI 10.1093/glycob/cwq193; Mason LH, 2003, J IMMUNOL, V171, P4235, DOI 10.4049/jimmunol.171.8.4235; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; McGreal EP, 2006, GLYCOBIOLOGY, V16, P422, DOI 10.1093/glycob/cwj077; Miller MJ, 2014, MUCOSAL IMMUNOL, V7, P452, DOI 10.1038/mi.2014.4; Noll AJ, 2016, BIOCHEM J, V473, P1343, DOI 10.1042/BCJ20160046; Noll AJ, 2016, GLYCOBIOLOGY, V26, P655, DOI 10.1093/glycob/cww002; PAHLSSON P, 1995, EUR J IMMUNOL, V25, P2452, DOI 10.1002/eji.1830250907; Parent SA, 2002, GENE, V293, P33, DOI 10.1016/S0378-1119(02)00722-9; Pelaseyed T, 2014, IMMUNOL REV, V260, P8, DOI 10.1111/imr.12182; Plato A, 2013, INT REV IMMUNOL, V32, P134, DOI 10.3109/08830185.2013.777065; Robbe C, 2004, BIOCHEM J, V384, P307, DOI 10.1042/BJ20040605; Robbe C, 2003, J BIOL CHEM, V278, P46337, DOI 10.1074/jbc.M302529200; Rodriguez-Pineiro AM, 2013, AM J PHYSIOL-GASTR L, V305, pG348, DOI 10.1152/ajpgi.00047.2013; Saijo S, 2011, INT IMMUNOL, V23, P467, DOI 10.1093/intimm/dxr046; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Ng SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052785; Shan MM, 2013, SCIENCE, V342, P447, DOI 10.1126/science.1237910; Silva-Martin N, 2014, STRUCTURE, V22, P1595, DOI 10.1016/j.str.2014.09.001; Soilleux EJ, 2003, CLIN SCI, V104, P437, DOI 10.1042/CS20020092; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Taylor PR, 2004, J IMMUNOL, V172, P1157, DOI 10.4049/jimmunol.172.2.1157; Thomsson KA, 2012, GLYCOBIOLOGY, V22, P1128, DOI 10.1093/glycob/cws083; Tsuboi S, 2011, EMBO J, V30, P3173, DOI 10.1038/emboj.2011.215; Van den Steen P, 1998, CRIT REV BIOCHEM MOL, V33, P151; van der Post S, 2014, J PROTEOME RES, V13, P6013, DOI 10.1021/pr500874f; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; van Liempt E, 2006, FEBS LETT, V580, P6123, DOI 10.1016/j.febslet.2006.10.009; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Warren CM, 2003, ELECTROPHORESIS, V24, P1695, DOI 10.1002/elps.200305392; Wittmann A, 2016, J BIOL CHEM, V291, P17629, DOI 10.1074/jbc.M116.741256; Yu LG, 2007, J BIOL CHEM, V282, P773, DOI 10.1074/jbc.M606862200	81	15	15	2	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3301	3320		10.1096/fj.201700619R	http://dx.doi.org/10.1096/fj.201700619R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401627	Green Published, Green Accepted			2022-12-28	WOS:000432546000033
J	Garwain, O; Valla, K; Scarlata, S				Garwain, Osama; Valla, Kaitlyn; Scarlata, Suzanne			Phospholipase C beta 1 regulates proliferation of neuronal cells	FASEB JOURNAL			English	Article						G protein signaling; cell proliferation; cyclin-dependent kinases	RNA INTERFERENCE; PC12 CELL; SIGNALING PATHWAY; NERVOUS-SYSTEM; LIVING CELLS; C ISOZYMES; CYCLIN Y; FACTOR-X; DIFFERENTIATION; ASSOCIATION	Cells have developed lineage-specific mechanisms to control proliferation and drive morphologic changes upon differentiation. A hallmark of differentiation is the assembly of signaling molecules that transduce extracellular signals, such as the production of the G protein-regulated enzyme phospholipase C beta 1 (PLC beta), which generates calcium signals from sensory stimuli. We found that in most cancerous cell lines there is positive correlation between PLC beta 1 levels and cell proliferation. In cells of neuronal lineage, however, reducing PLC beta 1 levels increases the rate of proliferation. Using a combination of biochemical and biophysical methods, we find that, in the G(1) phase, a cytosolic population of PLC beta 1 associates with cyclin-dependent kinase 16 (CDK16), a neuron-specific enzyme that is activated by cyclin Y to inactivate the antioncogenic protein p27(Ki)(p1). Binding of PLC beta 1 directly inhibits CDK16 activity and in turn reduces the ability of cells to enter the S phase. Activation of G alpha(q) by carbachol causes movement of PLC beta from the cytosol to the plasma membrane, reducing its association with CDK16. Similarly, the overexpression of activated G alpha(q) moves PLC beta 1 to the membrane, reverses G(1) arrest, and promotes proliferation, thereby connecting external stimuli with cell proliferation. Our results present a model in which the transient high expression of PLC beta 1 that occurs at the onset of differentiation arrests cells in the G(1) phase through its association with CDK16 and allows CDK16 to transition to its postmitotic function of neurite outgrowth and trafficking of synaptic vesicles. The novel role of PLC beta 1 in neuronal cell proliferation offers a unique interaction that can be manipulated to guide cells into a neuronal phenotype or to develop therapies for neuroblastomas.	[Garwain, Osama; Valla, Kaitlyn; Scarlata, Suzanne] Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA; [Scarlata, Suzanne] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	Worcester Polytechnic Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Scarlata, S (corresponding author), Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA.	sfscarlata@wpi.edu			U.S. National Institutes of Health [GM116187]; Richard Whitcomb Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116178] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Richard Whitcomb Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Elizabeth Bavaro (Worcester Polytechnic Institute) for her help in cloning mCherry-CDK16. The authors are grateful for the support of U.S. National Institutes of Health Grant GM116187. O.G. is supported by a Richard Whitcomb Fellowship (to S.S.). The authors declare no conflicts of interest.	Aisiku OR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015001; Albasanz JL, 2005, NEUROBIOL DIS, V20, P685, DOI 10.1016/j.nbd.2005.05.001; AOKI K, 1995, NAT GENET, V10, P167, DOI 10.1038/ng0695-167; Cwiek P, 2015, ONCOTARGET, V6, P116; Das KP, 2004, NEUROTOXICOL TERATOL, V26, P397, DOI 10.1016/j.ntt.2004.02.006; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Dowal L, 2006, J BIOL CHEM, V281, P23999, DOI 10.1074/jbc.M512330200; Dwivedi Y, 2002, NEUROPHARMACOLOGY, V43, P1269, DOI 10.1016/S0028-3908(02)00253-8; Follo MY, 2009, J CLIN ONCOL, V27, P782, DOI 10.1200/JCO.2008.19.3748; Garwain O, 2016, J BIOL CHEM, V291, P22970, DOI 10.1074/jbc.M116.744953; Graeser R, 2002, J CELL SCI, V115, P3479; Han W., 2004, ANTIOXID REDOX SIGN, V3, P1065; Hannan AJ, 1998, NEUROPHARMACOLOGY, V37, P593, DOI 10.1016/S0028-3908(98)00056-2; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Hughes TE, 2001, J BIOL CHEM, V276, P4227, DOI 10.1074/jbc.M007608200; Jaendling A, 2010, BIOCHEM J, V429, P225, DOI 10.1042/BJ20100273; Li Z, 2008, BBA-GENE REGUL MECH, V1779, P479, DOI 10.1016/j.bbagrm.2008.03.008; Liu DM, 2010, FLY, V4, P278, DOI 10.4161/fly.4.4.12881; Liu Y, 2009, SCIENCE, V325, P750, DOI 10.1126/science.1176325; Manning EE, 2012, HIPPOCAMPUS, V22, P309, DOI 10.1002/hipo.20900; Mikolcevic P, 2012, MOL CELL BIOL, V32, P868, DOI 10.1128/MCB.06261-11; Narayanan V, 2005, BIOCHEMISTRY-US, V44, P462, DOI 10.1021/bi0487140; OKUDA T, 1992, ONCOGENE, V7, P2249; Ou CY, 2010, CELL, V141, P846, DOI 10.1016/j.cell.2010.04.011; Palmer KJ, 2005, J CELL SCI, V118, P3839, DOI 10.1242/jcs.02496; Philip F, 2016, FASEB J, V30, P1958, DOI 10.1096/fj.201500140; Philip F, 2012, FASEB J, V26, P4903, DOI 10.1096/fj.12-213934; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Scarlata Suzanne, 2016, Advances in Biological Regulation, V61, P51, DOI 10.1016/j.jbior.2015.11.006; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Wang XS, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-30; Westerink RHS, 2008, ACTA PHYSIOL, V192, P273, DOI 10.1111/j.1748-1716.2007.01805.x; YAMADA M, 1991, DEV BRAIN RES, V59, P7, DOI 10.1016/0165-3806(91)90023-C; Yanagi T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119404; Yanagi T, 2015, CELL CYCLE, V14, P463, DOI 10.1080/15384101.2015.1006539	35	9	10	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2891	2898		10.1096/fj.201701284R	http://dx.doi.org/10.1096/fj.201701284R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29401590	Green Published			2022-12-28	WOS:000432528000046
J	Jena, PK; Sheng, L; Di Lucente, J; Jin, LW; Maezawa, I; Wan, YJY				Jena, Prasant Kumar; Sheng, Lili; Di Lucente, Jacopo; Jin, Lee-Way; Maezawa, Izumi; Wan, Yu-Jui Yvonne			Dysregulated bile acid synthesis and dysbiosis are implicated in Western diet-induced systemic inflammation, microglial activation, and reduced neuroplasticity	FASEB JOURNAL			English	Article						gut microbiota; FXR; TGR5; cognition; Alzheimer's disease	RETINOIC ACID; ALZHEIMERS-DISEASE; LIPID-METABOLISM; CHOLESTEROL ACCUMULATION; HEPATIC INFLAMMATION; FECAL MICROBIOTA; GUT MICROBIOTA; ADIPOSE-TISSUE; RECEPTOR TGR5; PEPTIDE-YY	The goal of this study was to identify the intrinsic links that explain the effect of a Western diet (WD) on cognitive dysfunction. Specific pathogen-free, wild-type mice were fed either a control diet (CD) or a high-fat, high-sucrose WD after weaning and were euthanized at 10 mo of age to study the pathways that affect cognitive health. The results showed that long-term WD intake reduced hippocampal synaptic plasticity and the level of brain-derived neurotrophic factor mRNA in the brain and isolated microglia. A WD also activated ERK1/2 and reduced postsynaptic density-95 in the brain, suggesting postsynaptic damage. Moreover, WD-fed mice had increased inflammatory signaling in the brain, ileum, liver, adipose tissue, and spleen, which was accompanied by microglia activation. In the brain, as well as in the digestive tract, a WD reduced signaling regulated by retinoic acid and bile acids (BAs), whose receptors form heterodimers to control metabolism and inflammation. Furthermore, a WD intake caused dysbiosis and dysregulated BA synthesis with reduced endogenous ligands for BA receptors, i.e., farnesoid X receptor and G-protein-coupled bile acid receptor in the liver and brain. Together, dysregulated BA synthesis and dysbiosis were accompanied by systemic inflammation, microglial activation, and reduced neuroplasticity induced by WD.	[Jena, Prasant Kumar; Sheng, Lili; Di Lucente, Jacopo; Jin, Lee-Way; Maezawa, Izumi; Wan, Yu-Jui Yvonne] Univ Calif Davis, Dept Med Pathol & Lab Med, Sacramento, CA 95817 USA; [Di Lucente, Jacopo; Jin, Lee-Way; Maezawa, Izumi] Univ Calif Davis, Med Invest Neurodev Disorders Inst, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis	Wan, YJY (corresponding author), Univ Calif Davis, Davis Hlth Syst, Dept Med Pathol & Lab Med, Room 3400B,Res Bldg 3,4645 2nd Ave 3400STE, Sacramento, CA 95817 USA.	yjywan@ucdavis.edu	Jena, Prasant Kumar/L-4339-2017	Jena, Prasant Kumar/0000-0002-6729-5881	U.S. National Institutes of Health (NIH) National Cancer Institute [U01CA179582]; NIH National Institute on Aging [P30AG010129, R01AG043788]; NATIONAL CANCER INSTITUTE [U01CA179582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010129, R01AG043788] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. Betty P. Guo for extensive review and editing of this manuscript, and Niki Taylor DeGeorge for editing (both from the University of California, Davis). This study was supported by U.S. National Institutes of Health (NIH) National Cancer Institute Grant U01CA179582, and NIH National Institute on Aging Grants P30AG010129 and R01AG043788. The authors declare no conflicts of interest.	Ali AH, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2014.12.06; Allen K, 2011, AM J PATHOL, V178, P175, DOI 10.1016/j.ajpath.2010.11.026; Attene-Ramos MS, 2006, MOL CANCER RES, V4, P9, DOI 10.1158/1541-7786.MCR-05-0126; Ayciriex S, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00211; Bala V, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00420; Barger SW, 2001, J NEUROCHEM, V76, P846, DOI 10.1046/j.1471-4159.2001.00075.x; Berti V, 2015, J NUTR HEALTH AGING, V19, P413, DOI 10.1007/s12603-014-0534-0; Bettcher BM, 2014, CLIN PHARMACOL THER, V96, P464, DOI 10.1038/clpt.2014.147; Blanco LP, 2012, TRENDS MICROBIOL, V20, P66, DOI 10.1016/j.tim.2011.11.005; Bonfili L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02587-2; Brown J, 2004, J BIOL CHEM, V279, P34674, DOI 10.1074/jbc.M402324200; CALI JJ, 1991, J BIOL CHEM, V266, P7779; Cassiman D, 2001, HEPATOLOGY, V33, P148, DOI 10.1053/jhep.2001.20793; Chiang JYL, 2013, COMPR PHYSIOL, V3, P1191, DOI 10.1002/cphy.c120023; Chong YH, 2006, J BIOL CHEM, V281, P20315, DOI 10.1074/jbc.M601016200; CHRISTOPHERHENNING, 1995, IN VIVO, V9, P415; Cyphert HA, 2012, J BIOL CHEM, V287, P25123, DOI 10.1074/jbc.M112.375907; Cyster JG, 2014, NAT REV IMMUNOL, V14, P731, DOI 10.1038/nri3755; De Silva A, 2012, GUT LIVER, V6, P10, DOI 10.5009/gnl.2012.6.1.10; DELAFUENTE M, 1993, IMMUNOLOGY, V80, P259; Ding Y, 2008, J NEUROSCI, V28, P11622, DOI 10.1523/JNEUROSCI.3153-08.2008; Djelti F, 2015, BRAIN, V138, P2383, DOI 10.1093/brain/awv166; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Duboc H, 2014, DIGEST LIVER DIS, V46, P302, DOI 10.1016/j.dld.2013.10.021; Fader KA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05656-8; Friedland RP, 2015, J ALZHEIMERS DIS, V45, P349, DOI 10.3233/JAD-142841; Garcia-Canaveras JC, 2012, J LIPID RES, V53, P2231, DOI 10.1194/jlr.D028803; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Glinghammar B, 2002, CARCINOGENESIS, V23, P839, DOI 10.1093/carcin/23.5.839; Gong YS, 2010, AM J ALZHEIMERS DIS, V25, P547, DOI 10.1177/1533317510382893; Guay V, 2012, METABOLISM, V61, P76, DOI 10.1016/j.metabol.2011.06.002; Guo CS, 2016, IMMUNITY, V45, P944, DOI 10.1016/j.immuni.2016.10.009; HE YH, 2013, MATH PROBL ENG, V2013, P14, DOI DOI 10.1186/1471-2164-14-575; He YQ, 2014, AM J PHYSIOL-GASTR L, V307, pG205, DOI 10.1152/ajpgi.00105.2014; HEUMAN DM, 1989, J LIPID RES, V30, P719; Holland AM, 2016, AM J PHYSIOL-REG I, V311, pR337, DOI 10.1152/ajpregu.00156.2016; Hu N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/524820; Huang F, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00070; Jacobs S, 2006, P NATL ACAD SCI USA, V103, P3902, DOI 10.1073/pnas.0511294103; Jayaraman A, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0476-2; Jeffery IB, 2012, GUT, V61, P997, DOI 10.1136/gutjnl-2011-301501; Jena PK, 2017, AM J PATHOL, V187, P1800, DOI 10.1016/j.ajpath.2017.04.019; Jiang CM, 2017, J ALZHEIMERS DIS, V58, P1, DOI 10.3233/JAD-161141; Jiang HY, 2015, BRAIN BEHAV IMMUN, V48, P186, DOI 10.1016/j.bbi.2015.03.016; Jin LW, 2015, J NEUROSCI, V35, P2516, DOI 10.1523/JNEUROSCI.2778-14.2015; Jolly AJ, 2009, FREE RADICAL RES, V43, P234, DOI 10.1080/10715760802684211; Kappe C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-276; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Keitel V, 2010, GLIA, V58, P1794, DOI 10.1002/glia.21049; Keshava HB, 2017, MED HYPOTHESES, V104, P4, DOI 10.1016/j.mehy.2017.05.002; Kindy Mark S., 1999, J Alzheimers Dis, V1, P155; Kinzig KP, 2010, ENDOCRINOLOGY, V151, P3105, DOI 10.1210/en.2010-0175; Lavrnja I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02638-8; Li TG, 2012, J BIOL CHEM, V287, P1861, DOI 10.1074/jbc.M111.305789; Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005; Lorbek G, 2012, FEBS J, V279, P1516, DOI 10.1111/j.1742-4658.2011.08432.x; Lu B, 2013, NAT REV NEUROSCI, V14, P401, DOI 10.1038/nrn3505; Bonet ML, 2012, BBA-MOL CELL BIOL L, V1821, P177, DOI 10.1016/j.bbalip.2011.06.001; Maezawa Izumi, 2012, Int J Alzheimers Dis, V2012, P868972, DOI 10.1155/2012/868972; Maezawa I, 2009, J NEUROSCI, V29, P5051, DOI 10.1523/JNEUROSCI.0324-09.2009; Mahony S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r2; Mamoon A, 2014, GENE, V550, P165, DOI 10.1016/j.gene.2014.07.017; Matsuzaki T, 2011, NEUROLOGY, V77, P1068, DOI 10.1212/WNL.0b013e31822e145d; McMillin M, 2015, J NEUROCHEM, V135, P565, DOI 10.1111/jnc.13243; Naseribafrouei A, 2014, NEUROGASTROENT MOTIL, V26, P1155, DOI 10.1111/nmo.12378; Nguyen HM, 2017, GLIA, V65, P106, DOI 10.1002/glia.23078; O'Brien KM, 2013, AM J PATHOL, V183, P1498, DOI 10.1016/j.ajpath.2013.07.019; Olazaran J, 2015, J ALZHEIMERS DIS, V45, P1157, DOI 10.3233/JAD-142925; Olson CR, 2010, MOL NUTR FOOD RES, V54, P489, DOI 10.1002/mnfr.200900246; Parracho HMRT, 2005, J MED MICROBIOL, V54, P987, DOI 10.1099/jmm.0.46101-0; Pathak P, 2017, J BIOL CHEM, V292, P11055, DOI 10.1074/jbc.M117.784322; Pinto-Sanchez MI, 2017, GASTROENTEROLOGY, V153, P448, DOI 10.1053/j.gastro.2017.05.003; Pistollato F, 2016, NUTR REV, V74, P624, DOI 10.1093/nutrit/nuw023; Posa M, 2017, MOL PHARMACEUT, V14, P3343, DOI 10.1021/acs.molpharmaceut.7b00375; Puig KL, 2017, SCI REP-UK, V7, DOI 10.1038/srep43725; Ramirez DMO, 2008, J COMP NEUROL, V507, P1676, DOI 10.1002/cne.21605; Sa-nguanmoo P, 2016, HORM BEHAV, V85, P86, DOI 10.1016/j.yhbeh.2016.08.006; Salehi M, 2010, DIABETES, V59, P1330, DOI 10.2337/db09-1253; Schilderink R, 2016, AM J PHYSIOL-GASTR L, V310, pG1138, DOI 10.1152/ajpgi.00411.2015; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schubring SR, 2012, NEUROSCI LETT, V506, P322, DOI 10.1016/j.neulet.2011.11.036; Shao CY, 2011, ACTA NEUROPATHOL, V122, P285, DOI 10.1007/s00401-011-0843-x; Sheng LL, 2017, J PATHOL, V243, P431, DOI 10.1002/path.4983; Sheng LL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01576-9; Shihabudeen MS, 2015, MOL CELL ENDOCRINOL, V414, P19, DOI 10.1016/j.mce.2015.07.012; Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011; Swann JR, 2011, P NATL ACAD SCI USA, V108, P4523, DOI 10.1073/pnas.1006734107; Swerdlow RH, 2011, BBA-MOL BASIS DIS, V1812, P1630, DOI 10.1016/j.bbadis.2011.08.012; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Trapp S, 2013, CURR OPIN PHARMACOL, V13, P964, DOI 10.1016/j.coph.2013.09.006; Trauner M, 2003, PHYSIOL REV, V83, P633, DOI 10.1152/physrev.00027.2002; Tsuei J, 2014, EXP BIOL MED, V239, P1489, DOI 10.1177/1535370214538743; Ukropec Jozef, 2008, Archives of Physiology and Biochemistry, V114, P357, DOI 10.1080/13813450802535812 ; Vavassori P, 2009, J IMMUNOL, V183, P6251, DOI 10.4049/jimmunol.0803978; Wang K, 2008, EXP BIOL MED, V233, P496, DOI 10.3181/0708-MR-231; Wang Q, 2017, MOL NEUROBIOL; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang YJ, 2010, J BIOL CHEM, V285, P15668, DOI 10.1074/jbc.M110.102160; Waszkielewicz AM, 2013, CURR MED CHEM, V20, P1241; Williams JE, 2017, J NUTR, V147, P1739, DOI 10.3945/jn.117.248864; Xie GX, 2016, INT J CANCER, V139, P1764, DOI 10.1002/ijc.30219; Xu HH, 2006, J NEUROIMMUNOL, V171, P135, DOI 10.1016/j.jneuroim.2005.10.004; Yang F, 2007, CANCER RES, V67, P863, DOI 10.1158/0008-5472.CAN-06-1078; Yang F, 2014, BIOCHEM PHARMACOL, V91, P483, DOI 10.1016/j.bcp.2014.08.018; Yanguas-Casas N, 2017, J CELL PHYSIOL, V232, P2231, DOI 10.1002/jcp.25742; Yanovsky Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042512; Yau JLW, 2003, NEUROSCIENCE, V121, P307, DOI 10.1016/S0306-4522(03)00438-X; Yu Y, 2014, J ALZHEIMERS DIS, V38, P133, DOI 10.3233/JAD-130818; Yui S, 2009, NUTR CANCER, V61, P374, DOI 10.1080/01635580802582744; Zhan L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105930; Zhou J, 2006, OBESITY, V14, P683, DOI 10.1038/oby.2006.77	111	57	59	0	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2866	2877		10.1096/fj.201700984RR	http://dx.doi.org/10.1096/fj.201700984RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29401580	Green Published			2022-12-28	WOS:000432528000044
J	Miran, T; Vogg, ATJ; Drude, N; Mottaghy, FM; Morgenroth, A				Miran, Tara; Vogg, Andreas T. J.; Drude, Natascha; Mottaghy, Felix M.; Morgenroth, Agnieszka			Modulation of glutathione promotes apoptosis in triple-negative breast cancer cells	FASEB JOURNAL			English	Article						endogenous radiotherapy; Auger electron emitter; nucleoside analogs	OXIDATIVE STRESS; GLUCOSE-METABOLISM; BUTHIONINE SULFOXIMINE; STEM-CELLS; HYPOXIA; MTOR; RADIORESISTANCE; INHIBITION; GLYCOLYSIS; MECHANISMS	Triple-negative breast cancer has an extremely high rate of relapse. This is particularly due to the existence and survival of cancer stem cells (CSCs) characterized by increased amounts of glutathione (GSH). In this study, we evaluated the potential of pharmacological GSH depletion to sensitize CSCs to ionizing radiotherapy with an I-125-labeled nucleoside analog, 5-iodo-4'-thio-2'-deoxyuridine (ITdU). CSCs were isolated using CD24(-) and CD44(+)-specific microbeads. GSH and reactive oxygen species (ROS) were evaluated by fluorescence-activated cell sorting. GSH synthesis was inhibited with buthionine sulfoximine (BSO). Apoptotic cells were identified with propidium iodide and double-strand DNA breaks were detected by gamma-H2AX staining. For therapy study, BSO treated and untreated mice xenografted with breast CSCs received weekly I-125-ITdU. Therapy efficiency was monitored by fluorodeoxyglucose-18-mu-positron emission tomography. We showed that GSH modulation sensitizes CD24(-) and CD44(+) breast cancer cells to endogenous nanoradiotherapy. BSO synergistically affects ROS generation induced by I-125-ITdU. In an in vivo study, we demonstrated a complete tumor regression as a consequence of preconditioning with a GSH-synthesis inhibitor prior to treatment with I-125-ITdU. GSH modulation in combination with an oxidative stress-generating treatment such as endogenous radiotherapy using an Auger emitter offers an extraordinary opportunity for selective and efficient eradication of drug-resistant CSCs.	[Miran, Tara; Vogg, Andreas T. J.; Drude, Natascha; Mottaghy, Felix M.; Morgenroth, Agnieszka] Univ Aachen, RWTH, Univ Hosp Aachen, Dept Nucl Med, Pauwelsstr 30, D-52074 Aachen, Germany; [Mottaghy, Felix M.] Maastricht Univ, Med Ctr, Dept Nucl Med, Maastricht, Netherlands	RWTH Aachen University; RWTH Aachen University Hospital; Maastricht University	Morgenroth, A (corresponding author), Univ Aachen, RWTH, Univ Hosp Aachen, Dept Nucl Med, Pauwelsstr 30, D-52074 Aachen, Germany.	amorgenroth@ukaachen.de	Mottaghy, Felix/AAU-2673-2020	Mottaghy, Felix/0000-0002-7212-6521; Drude, Natascha/0000-0002-7153-2894				Anderson CP, 1999, EXP CELL RES, V246, P183, DOI 10.1006/excr.1998.4303; Astley SB, 2004, BRIT J NUTR, V91, P63, DOI 10.1079/BJN20031001; Avril S, 2016, J NUCL MED, V57, p34S, DOI 10.2967/jnumed.115.157875; Baccelli I, 2012, J CELL BIOL, V198, P281, DOI 10.1083/jcb.201202014; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bernardi R, 2006, NATURE, V442, P779, DOI 10.1038/nature05029; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bigarella CL, 2014, DEVELOPMENT, V141, P4206, DOI 10.1242/dev.107086; Boivin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014558; Ciavardelli D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.285; CONWAY JG, 1987, CARCINOGENESIS, V8, P999, DOI 10.1093/carcin/8.7.999; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Ding SJ, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/750798; Dong CF, 2013, CANCER CELL, V23, P316, DOI 10.1016/j.ccr.2013.01.022; EBERT BL, 1995, J BIOL CHEM, V270, P29083, DOI 10.1074/jbc.270.49.29083; Falzone N, 2015, J NUCL MED, V56, P1441, DOI 10.2967/jnumed.114.153502; Feng WG, 2014, STEM CELLS, V32, P1734, DOI 10.1002/stem.1662; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Kassis AI, 2004, INT J RADIAT BIOL, V80, P789, DOI 10.1080/09553000400017663; Kondoh H, 2007, HISTOL HISTOPATHOL, V22, P85, DOI 10.14670/HH-22.85; Krause M, 2017, ADV DRUG DELIVER REV, V109, P63, DOI 10.1016/j.addr.2016.02.002; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li L, 2015, REDOX BIOL, V4, P127, DOI 10.1016/j.redox.2014.12.001; Macapinlac HA, 1996, J NUCL MED, V37, pS25; Mah LJ, 2011, CURR RADIOPHARM, V4, P59, DOI 10.2174/1874471011104010059; Miran T, 2017, CANCER MED-US, V6, P1639, DOI 10.1002/cam4.1113; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Morgenroth A, 2008, CLIN CANCER RES, V14, P7311, DOI 10.1158/1078-0432.CCR-08-0907; Morgenroth A, 2011, METHODS, V55, P203, DOI 10.1016/j.ymeth.2011.06.009; Nagano O, 2013, ONCOGENE, V32, P5191, DOI 10.1038/onc.2012.638; Nogueira V, 2013, CLIN CANCER RES, V19, P4309, DOI 10.1158/1078-0432.CCR-12-1424; Paillas S, 2016, ANTIOXID REDOX SIGN, V25, P467, DOI 10.1089/ars.2015.6309; Razumienko EJ, 2016, J NUCL MED, V57, P444, DOI 10.2967/jnumed.115.162339; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; RUSSO A, 1986, CANCER RES, V46, P2845; Schieber MS, 2013, CANCER CELL, V23, P265, DOI 10.1016/j.ccr.2013.02.021; Shields AF, 2003, J NUCL MED, V44, P1432; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Shutt DC, 2010, CANCER BIOL THER, V9, P853, DOI 10.4161/cbt.9.11.11632; SUTHANTHIRAN M, 1990, P NATL ACAD SCI USA, V87, P3343, DOI 10.1073/pnas.87.9.3343; Tamada M, 2012, CANCER RES, V72, P1438, DOI 10.1158/0008-5472.CAN-11-3024; TERRADEZ P, 1993, BIOCHEM J, V292, P477, DOI 10.1042/bj2920477; Toyohara J, 2003, J NUCL MED, V44, P1671; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Walicka MA, 1998, RADIAT RES, V149, P142, DOI 10.2307/3579923; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501	50	26	27	1	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2803	2813		10.1096/fj.201701157R	http://dx.doi.org/10.1096/fj.201701157R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29301945				2022-12-28	WOS:000432528000039
J	Yue, ZY; Yuan, ZJ; Zeng, L; Wang, Y; Lai, L; Li, J; Sun, P; Xue, XW; Qi, JY; Yang, ZF; Zheng, YS; Fang, YZ; Li, DL; Siwko, S; Li, Y; Luo, J; Liu, MY				Yue, Zhiying; Yuan, Zengjin; Zeng, Li; Wang, Ying; Lai, Li; Li, Jing; Sun, Peng; Xue, Xiwen; Qi, Junyi; Yang, Zhengfeng; Zheng, Yansen; Fang, Yuanzhang; Li, Dali; Siwko, Stefan; Li, Yi; Luo, Jian; Liu, Mingyao			LGR4 modulates breast cancer initiation, metastasis, and cancer stem cells	FASEB JOURNAL			English	Article						mammary tumorigenesis; tumor progression; epithelial-mesenchymal transition; Wnt	EPITHELIAL-MESENCHYMAL TRANSITION; R-SPONDIN 1; DOWN-REGULATION; POSTNATAL-DEVELOPMENT; MAMMARY-GLAND; UP-REGULATION; RECEPTOR; GENE; PROMOTES; EXPRESSION	The fourth member of the leucine-rich repeat-containing GPCR family (LGR4, frequently referred to as GPR48) and its cognate ligands, R-spondins (RSPOs) play crucial roles in the development of multiple organs as well as the survival of adult stem cells by activation of canonical Wnt signaling. Wnt/beta-catenin signaling acts to regulate breast cancer; however, the molecular mechanisms determining its spatiotemporal regulation are largely unknown. In this study, we identified LGR4 as a master controller of Wnt/beta-catenin signaling-mediated breast cancer tumorigenesis, metastasis, and cancer stem cell (CSC) maintenance. LGR4 expression in breast tumors correlated with poor prognosis. Either Lgr4 haploinsufficiency or mammary-specific deletion inhibited mouse mammary tumor virus (MMTV)-PyMT- and MMTV-Wnt1-driven mammary tumorigenesis and metastasis. Moreover, LGR4 down-regulation decreased in vitro migration and in vivo xenograft tumor growth and lung metastasis. Furthermore, Lgr4 deletion in MMTV-Wnt1 tumor cells or knockdown in human breast cancer cells decreased the number of functional CSCs by similar to 90%. Canonical Wnt signaling was impaired in LGR4-deficient breast cancer cells, and LGR4 knockdown resulted in increased E-cadherin and decreased expression of N-cadherin and snail transcription factor -2 (SNAI2) (also called SLUG), implicating LGR4 in regulation of epithelial-mesenchymal transition. Our findings support a crucial role of the Wnt signaling component LGR4 in breast cancer initiation, metastasis, and breast CSCs.	[Yue, Zhiying; Yuan, Zengjin; Zeng, Li; Sun, Peng; Xue, Xiwen; Qi, Junyi; Yang, Zhengfeng; Zheng, Yansen; Li, Dali; Luo, Jian; Liu, Mingyao] East China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai, Peoples R China; [Yue, Zhiying; Yuan, Zengjin; Zeng, Li; Sun, Peng; Xue, Xiwen; Qi, Junyi; Yang, Zhengfeng; Zheng, Yansen; Li, Dali; Luo, Jian; Liu, Mingyao] East China Normal Univ, Sch Life Sci, Shanghai, Peoples R China; [Zeng, Li; Wang, Ying; Lai, Li; Siwko, Stefan; Liu, Mingyao] Texas A&M Univ, Hlth Sci Ctr, Dept Mol & Cellular Med, Inst Biosci & Technol, Houston, TX USA; [Li, Jing] East China Normal Univ, Shanghai Fengxian Dist Cent Hosp, Joint Ctr Translat Med, Shanghai, Peoples R China; [Fang, Yuanzhang; Li, Yi] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA	East China Normal University; East China Normal University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; East China Normal University; Baylor College of Medicine	Luo, J; Liu, MY (corresponding author), East China Normal Univ, Sch Life Sci, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, 500 Dongchuan Rd, Shanghai 200241, Peoples R China.	jluo@bio.ecnu.edu.cn; myliu@bio.ecnu.edu.cn	Fang, Yuanzhang/H-3047-2019; Yang, Zhengfeng/AAA-7014-2020; Li, Yi/A-7635-2009	Siwko, Stefan/0000-0003-4260-2985; Fang, Yuanzhang/0000-0002-6985-9388; Sun, Peng/0000-0002-0615-2510; Li, Yi/0000-0002-9976-518X; Lai, Li/0000-0002-5731-2705	National Key Research and Development Program of China [2016YFC0902102]; National Natural Science Foundation of China [81722020, 81472048, 81272911, 81330049]; Innovation Program of Shanghai Municipal Education Commission [14ZZ051, 2017-01-07-00-05-E00011]; Science and Technology Commission of Shanghai Municipality [12ZR1447900]; U.S. National Institutes of Health, National Cancer Institute [R01CA204926]; U.S. Department of Defense-Congressionally Directory Medical Research Program (DOD-CDMRP) [BC160240]; Fundamental Research Funds for the Central Universities; NATIONAL CANCER INSTITUTE [R01CA204926] Funding Source: NIH RePORTER	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Defense-Congressionally Directory Medical Research Program (DOD-CDMRP); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Dihua Yu [M. D. Anderson Cancer Center (MDACC), Houston, TX, USA] for the gift of the MCF10A-ErbB2-14,3,3 cells; Hans Clevers (Hubrecht Institute for Developmental Biology and Stem Cell Research, Utrecht, The Netherlands) for the gift of the LGR4 expression plasmid; Qingyun (Jim) Liu (University of Texas Health Science Center, Houston, TX, USA) for the gift of the anti-LGR4 antibody; Hong Zhang (MDACC) for pathological consultation; and Yanqing Huang (Methodist Research Institute, Houston, TX, USA) for technical advice and assistance. This work was supported by National Key Research and Development Program of China Grant 2016YFC0902102 (to J.L.); the National Natural Science Foundation of China Grants 81722020, 81472048, and 81272911 (to J.L.), and 81330049 (to M.L.); the Innovation Program of Shanghai Municipal Education Commission Grant 14ZZ051 (to J.L.) and 2017-01-07-00-05-E00011 (to M.L.); Science and Technology Commission of Shanghai Municipality Grant 12ZR1447900 (to J.L.); U.S. National Institutes of Health, National Cancer Institute Grant R01CA204926 (to Y.L.); U.S. Department of Defense-Congressionally Directory Medical Research Program (DOD-CDMRP) Grant BC160240 (to Y.L. and M.L.); and the Fundamental Research Funds for the Central Universities (to J.L.). The authors declare no conflicts of interest.	Carmon KS, 2014, P NATL ACAD SCI USA, V111, pE1221, DOI 10.1073/pnas.1323106111; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chalcrabarti R, 2014, NAT CELL BIOL, V16, P1004, DOI 10.1038/ncb3040; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Cho SG, 2011, CANCER RES, V71, P6535, DOI 10.1158/0008-5472.CAN-11-0329; Dang YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089835; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; De Wever O, 2008, HISTOCHEM CELL BIOL, V130, P481, DOI 10.1007/s00418-008-0464-1; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; DeSantis CE, 2016, CA-CANCER J CLIN, V66, P31, DOI 10.3322/caac.21320; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Du B, 2013, J BIOL CHEM, V288, P15131, DOI 10.1074/jbc.M113.455535; Gao Y, 2006, CANCER RES, V66, P11623, DOI 10.1158/0008-5472.CAN-06-2629; Gao Yun, 2009, Ai Zheng, V28, P104; Gong X, 2015, ONCOGENE, V34, P4692, DOI 10.1038/onc.2014.417; Govindaraj V, 2014, HORM CANCER-US, V5, P1, DOI 10.1007/s12672-013-0164-8; Green JL, 2013, P NATL ACAD SCI USA, V110, P6991, DOI 10.1073/pnas.1303671110; Guan X, 2014, J BIOL CHEM, V289, P26492, DOI 10.1074/jbc.M114.564138; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Hoshii T, 2007, BIOL REPROD, V76, P303, DOI 10.1095/biolreprod.106.054619; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Huang S, 2017, FASEB J, V31; Jin C, 2008, INVEST OPHTH VIS SCI, V49, P4245, DOI 10.1167/iovs.08-1860; Kato S, 2007, FEBS LETT, V581, P4685, DOI 10.1016/j.febslet.2007.08.064; Kato S, 2006, NEPHRON EXP NEPHROL, V104, pE63, DOI 10.1159/000093999; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; Kida T, 2014, BIOSCI BIOTECH BIOCH, V78, P1813, DOI 10.1080/09168451.2014.936353; Kinzel B, 2014, DEV BIOL, V390, P181, DOI 10.1016/j.ydbio.2014.03.009; Koizumi M, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.114.123638; Lanczky A, 2016, BREAST CANCER RES TR, V160, P439, DOI 10.1007/s10549-016-4013-7; LEE FS, 1995, P NATL ACAD SCI USA, V92, P2268, DOI 10.1073/pnas.92.6.2268; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Li JY, 2014, ENDOCRINOLOGY, V155, P429, DOI 10.1210/en.2013-1550; Liang F, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0486-1; Liu SJ, 2013, J BIOL CHEM, V288, P8794, DOI 10.1074/jbc.M112.436204; Liu T, 2013, J SURG ONCOL, V107, P188, DOI 10.1002/jso.23240; Liu YF, 2016, CANCER CELL, V30, P243, DOI 10.1016/j.ccell.2016.06.021; Lu J, 2009, CANCER CELL, V16, P195, DOI 10.1016/j.ccr.2009.08.010; Luo J, 2016, NAT MED, V22, P539, DOI 10.1038/nm.4076; Luo J, 2009, DEVELOPMENT, V136, P2747, DOI 10.1242/dev.033571; Luo WJ, 2017, J BIOL CHEM, V292, P15525, DOI 10.1074/jbc.M116.771931; Luo WJ, 2013, STEM CELLS, V31, P2492, DOI 10.1002/stem.1484; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P2241, DOI 10.1210/me.2004-0133; Mendive F, 2006, DEV BIOL, V290, P421, DOI 10.1016/j.ydbio.2005.11.043; Mohri Y, 2012, BIOSCI BIOTECH BIOCH, V76, P888, DOI 10.1271/bbb.110834; Mohri Y, 2010, FERTIL STERIL, V94, P2878, DOI 10.1016/j.fertnstert.2010.05.050; Monteiro J, 2014, CARCINOGENESIS, V35, P2, DOI 10.1093/carcin/bgt279; Mustata RC, 2011, EMBO REP, V12, P558, DOI 10.1038/embor.2011.52; Nagahata T, 2003, CANCER SCI, V94, P515, DOI 10.1111/j.1349-7006.2003.tb01475.x; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Oyama K, 2011, SEX DEV, V5, P205, DOI 10.1159/000329476; Pan HJ, 2014, ENDOCRINOLOGY, V155, P3624, DOI 10.1210/en.2013-2183; Planas-Paz L, 2016, NAT CELL BIOL, V18, P467, DOI 10.1038/ncb3337; Qian Y, 2013, DEVELOPMENT, V140, P1751, DOI 10.1242/dev.093641; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shi GX, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030564; Snyder JC, 2015, J CELL SCI, V128, P1230, DOI 10.1242/jcs.166322; Sone M, 2013, FASEB J, V27, P4917, DOI 10.1096/fj.13-232215; Song HP, 2008, J BIOL CHEM, V283, P36687, DOI 10.1074/jbc.M800721200; Styrkarsdottir U, 2013, NATURE, V497, P517, DOI 10.1038/nature12124; Sun YK, 2015, BIOCHEM BIOPH RES CO, V464, P396, DOI 10.1016/j.bbrc.2015.06.066; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Wang DS, 2015, NATURE, V517, P81, DOI 10.1038/nature13851; Wang F, 2014, J MOL ENDOCRINOL, V52, P133, DOI 10.1530/JME-13-0042; Wang JQ, 2013, NAT CELL BIOL, V15, P1455, DOI 10.1038/ncb2867; Wang J, 2012, J AM SOC NEPHROL, V23, P281, DOI 10.1681/ASN.2011040351; Weng JS, 2008, P NATL ACAD SCI USA, V105, P6081, DOI 10.1073/pnas.0708257105; Wu JH, 2013, CARCINOGENESIS, V34, P2861, DOI 10.1093/carcin/bgt229; Wu ZQ, 2012, P NATL ACAD SCI USA, V109, P16654, DOI 10.1073/pnas.1205822109; Xu P, 2016, CANCER LETT, V383, P161, DOI 10.1016/j.canlet.2016.09.005; Yamakami Yukiko, 2016, Biochem Biophys Rep, V8, P174, DOI 10.1016/j.bbrep.2016.08.018; Yamashita R, 2009, DEV DYNAM, V238, P993, DOI 10.1002/dvdy.21900; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang L, 2015, STEM CELLS, V33, P2913, DOI 10.1002/stem.2083; Yi TF, 2014, J BIOL CHEM, V289, P8767, DOI 10.1074/jbc.M113.530816; Yi ZF, 2009, INT J CANCER, V124, P843, DOI 10.1002/ijc.24027; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Yu CY, 2013, ASIAN PAC J CANCER P, V14, P4907, DOI 10.7314/APJCP.2013.14.8.4907; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Zhang ZY, 2014, STEM CELLS INT, V2014, DOI 10.1155/2014/125683; Zhou J, 2013, ONCOL LETT, V6, P1128, DOI 10.3892/ol.2013.1516; Zhu C, 2016, CELL SIGNAL, V28, P989, DOI 10.1016/j.cellsig.2016.04.010; Zou YY, 2017, OBESITY, V25, P252, DOI 10.1002/oby.21704	84	37	41	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2422	2437		10.1096/fj.201700897R	http://dx.doi.org/10.1096/fj.201700897R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29269400	Green Published			2022-12-28	WOS:000432528000010
J	Val-Laillet, D; Guerin, S; Coquery, N; Nogret, I; Formal, M; Rome, V; Le Normand, L; Meurice, P; Randuineau, G; Guilloteau, P; Malbert, CH; Parnet, P; Lalles, JP; Segain, JP				Val-Laillet, David; Guerin, Sylvie; Coquery, Nicolas; Nogret, Isabelle; Formal, Michele; Rome, Veronique; Le Normand, Laurence; Meurice, Paul; Randuineau, Gwenaelle; Guilloteau, Paul; Malbert, Charles-Henri; Parnet, Patricia; Lalles, Jean-Paul; Segain, Jean-Pierre			Oral sodium butyrate impacts brain metabolism and hippocampal neurogenesis, with limited effects on gut anatomy and function in pigs	FASEB JOURNAL			English	Article						pancreas; cognition; hippocampus	REGULATES MEMORY FORMATION; VENTRAL HIPPOCAMPUS; MILK REPLACER; WEANED PIGS; FEED-INTAKE; RAT-BRAIN; DIET; PIGLETS; GLUCOSE; MODEL	Butyrate can improve gut functions, whereas histone deacetylase inhibitors might alleviate neurocognitive alterations. Our aim was to assess whether oral butyrate could modulate brain metabolism and plasticity and if this would relate to gut function. Sixteen pigs were subjected to sodium butyrate (SB) supplementation via beverage water or water only [control (C)]. All pigs had blood sampled after 2 and 3 wk of treatment, and were subjected to a brain positron emission tomography after 3 wk. Animals were euthanized after 4 wk to sample pancreas, intestine, and brain for gut physiology and anatomy measurements, as well as hippocampal histology, Ki67, and doublecortin (DCX) immunohistochemistry. SB compared with C treatment triggered basal brain glucose metabolism changes in the nucleus accumbens and hippocampus (P = 0.003), increased hippocampal granular cell layer volume (P = 0.006), and neurogenesis (Ki67: P = 0.026; DCX: P = 0.029). After 2 wk of treatment, plasma levels of glucose, insulin, lactate, glucagon-like peptide 1, and peptide tyrosine tyrosine remained unchanged. After 3 wk, plasma levels of lactate were lower in SB compared with C animals (P = 0.028), with no difference for glucose and insulin. Butyrate intake impacted very little gut anatomy and function. These results demonstrate that oral SB impacted brain functions with little effects on the gut.	[Val-Laillet, David; Guerin, Sylvie; Coquery, Nicolas; Nogret, Isabelle; Formal, Michele; Rome, Veronique; Le Normand, Laurence; Meurice, Paul; Randuineau, Gwenaelle; Guilloteau, Paul; Lalles, Jean-Paul] UBL, Univ Rennes, INSERM, Nutr Metab & Canc NuMeCan,INRA, Rennes, France; [Val-Laillet, David; Parnet, Patricia; Lalles, Jean-Paul; Segain, Jean-Pierre] Ctr Rech Nutr Humaine Ouest CRNH Ouest, Nantes, France; [Malbert, Charles-Henri] INRA, Unite Serv Ani Scans 1395, St Gilles, France; [Parnet, Patricia; Segain, Jean-Pierre] Univ Nantes, INRA, Unite Mixte Rech UMR 1280, Physiol Adaptat Nutr PhAN, Nantes, France; [Parnet, Patricia; Segain, Jean-Pierre] Ctr Hosp Univ CHU Hotel Dieu, Inst Malad Appareil Digestif, Nantes, France	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; INRAE; INRAE; Nantes Universite; Nantes Universite; CHU de Nantes	Val-Laillet, D (corresponding author), INRA, 1341 NuMeCan, F-35590 St Gilles, France.	david.val-laillet@inra.fr	Parnet, Patricia/GOH-1209-2022; coquery, nicolas/N-9206-2019; Parnet, Patricia/AAW-5064-2021; coquery, nicolas/GQP-5662-2022; VAL-LAILLET, David/AAH-6454-2021	coquery, nicolas/0000-0002-4687-5924; coquery, nicolas/0000-0002-4687-5924; Lalles, Jean-Paul/0000-0003-2732-5350; Malbert, Charles-Henri/0000-0002-0665-4545	Region Pays de la Loire	Region Pays de la Loire(Region Pays de la Loire)	The authors gratefully acknowledge the efforts and cooperation of the technical staff, and especially Alain Chauvin and Francis Legouevec (INRA, Unite Experimentale Porcs de Rennes, France) for participating in this study and taking care of the animals. This study was part of a research project (EPIMEMO, Impact of butyrate on the consolidation of memory processes), funded by Region Pays de la Loire and coordinated by J.-P.S. and P.P. The authors declare no conflicts of interest.	Arnal ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118092; Arnal ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087967; Arvans DL, 2005, AM J PHYSIOL-GASTR L, V288, pG696, DOI 10.1152/ajpgi.00206.2004; Bagot RC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8062; Barros LF, 2010, BRAIN RES REV, V63, P149, DOI 10.1016/j.brainresrev.2009.10.002; Boubaker J, 2012, J NEUROENDOCRINOL, V24, P1096, DOI 10.1111/j.1365-2826.2012.02326.x; Bourassa MW, 2016, NEUROSCI LETT, V625, P56, DOI 10.1016/j.neulet.2016.02.009; Canfora EE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02546-x; Castanon N, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00229; Chatelais L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019594; Clouard C, 2014, J ANIM SCI, V92, P2133, DOI 10.2527/jas.2013-6809; Clouard C, 2012, ANIMAL, V6, P118, DOI 10.1017/S1751731111001315; Clouard C, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00861; Clouard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037968; Courchesne-Loyer A, 2017, J CEREBR BLOOD F MET, V37, P2485, DOI 10.1177/0271678X16669366; Dienel GA, 2001, J NEUROSCI RES, V66, P812, DOI 10.1002/jnr.10063; Dienel GA, 2012, J CEREBR BLOOD F MET, V32, P1107, DOI 10.1038/jcbfm.2011.175; Donohoe DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046589; During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Gagliano H, 2014, NEUROPHARMACOLOGY, V79, P75, DOI 10.1016/j.neuropharm.2013.10.031; Gieling ET, 2011, ANIM COGN, V14, P151, DOI 10.1007/s10071-010-0364-3; GJEDDE A, 1975, AM J PHYSIOL, V229, P1165, DOI 10.1152/ajplegacy.1975.229.5.1165; Gorka P, 2009, J PHYSIOL PHARMACOL, V60, P47; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; GUILLOTEAU P, 1981, REPROD NUTR DEV, V21, P885, DOI 10.1051/rnd:19810702; Guilloteau P, 2010, NUTR RES REV, V23, P366, DOI 10.1017/S0954422410000247; Guilloteau P, 2009, J DAIRY SCI, V92, P1038, DOI 10.3168/jds.2008-1213; Guilloteau P, 2010, NUTR RES REV, V23, P4, DOI 10.1017/S0954422410000077; Gupta S, 2010, J NEUROSCI, V30, P3589, DOI 10.1523/JNEUROSCI.3732-09.2010; Han A, 2014, NEUROPHARMACOLOGY, V81, P292, DOI 10.1016/j.neuropharm.2014.02.017; Khan S, 2016, CHEM-BIOL INTERACT, V254, P124, DOI 10.1016/j.cbi.2016.06.007; Kisielinski K, 2002, CLIN EXP MED, V2, P131, DOI 10.1007/s102380200018; Lalles JP, 2006, BRIT J NUTR, V95, P488, DOI 10.1079/BJN20051673; Le Gall M, 2009, BRIT J NUTR, V102, P1285, DOI 10.1017/S0007114509990213; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Mairesse J, 2015, PSYCHONEUROENDOCRINO, V62, P36, DOI 10.1016/j.psyneuen.2015.07.005; Manzanilla EG, 2006, J ANIM SCI, V84, P2743, DOI 10.2527/jas.2005-509; Marion J, 2003, J NUTR, V133, P362, DOI 10.1093/jn/133.2.362; Mazzoni M, 2008, J NUTR, V138, P1426, DOI 10.1093/jn/138.8.1426; Moretti M, 2011, BEHAV PHARMACOL, V22, P766, DOI 10.1097/FBP.0b013e32834d0f1b; Morris AAM, 2005, J INHERIT METAB DIS, V28, P109, DOI 10.1007/s10545-005-5518-0; Paille V., 2014, J DEV ORIG HLTH DIS, V6, pS39; Partanen KH, 1999, NUTR RES REV, V12, P117, DOI 10.1079/095442299108728884; Pothuizen HHJ, 2004, EUR J NEUROSCI, V19, P705, DOI 10.1111/j.0953-816X.2004.03170.x; REDIES C, 1989, AM J PHYSIOL, V256, pE805, DOI 10.1152/ajpendo.1989.256.6.E805; Roura E, 2016, NUTR RES REV, V29, P60, DOI 10.1017/S0954422416000020; Saikali S, 2010, J NEUROSCI METH, V192, P102, DOI 10.1016/j.jneumeth.2010.07.041; Sauleau P, 2009, ANIMAL, V3, P1138, DOI 10.1017/S1751731109004649; Sharma S, 2015, BEHAV BRAIN RES, V291, P306, DOI 10.1016/j.bbr.2015.05.052; Stefanko DP, 2009, P NATL ACAD SCI USA, V106, P9447, DOI 10.1073/pnas.0903964106; Val-Laillet D, 2015, NEUROIMAGE-CLIN, V8, P1, DOI 10.1016/j.nicl.2015.03.016; Val-Laillet D, 2017, FASEB J, V31, P2037, DOI 10.1096/fj.201601015R; Valvassori SS, 2014, CURR NEUROVASC RES, V11, P359, DOI 10.2174/1567202611666140829162158; Vanhoutvin SALW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006759; Yadav H, 2013, J BIOL CHEM, V288, P25088, DOI 10.1074/jbc.M113.452516; Zabielski R, 1998, BRIT J NUTR, V79, P287, DOI 10.1079/BJN19980046; Zhang J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/727542; Zhang YF, 2015, J NEUROCHEM, V132, P301, DOI 10.1111/jnc.12965; Zhang YF, 2013, J CEREBR BLOOD F MET, V33, P1307, DOI 10.1038/jcbfm.2013.87	60	39	39	3	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2160	2171		10.1096/fj.201700547RR	http://dx.doi.org/10.1096/fj.201700547RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29242276	Green Submitted			2022-12-28	WOS:000429051400035
J	Sato, Y; Ohtsubo, H; Nihei, N; Kaneko, T; Sato, Y; Adachi, SI; Kondo, S; Nakamura, M; Mizunoya, W; Iida, H; Tatsumi, R; Rada, C; Yoshizawa, F				Sato, Yusuke; Ohtsubo, Hideaki; Nihei, Naohiro; Kaneko, Takane; Sato, Yoriko; Adachi, Shin-Ichi; Kondo, Shinji; Nakamura, Mako; Mizunoya, Wataru; Iida, Hiroshi; Tatsumi, Ryuichi; Rada, Cristina; Yoshizawa, Fumiaki			Apobec2 deficiency causes mitochondrial defects and mitophagy in skeletal muscle	FASEB JOURNAL			English	Article						mitochondria; myopathy; APOBEC	RNA-EDITING ENZYME; CYTIDINE DEAMINASE AID; POLYPEPTIDE 2 APOBEC2; MESSENGER-RNA; MUSCULAR-DYSTROPHIES; RETINA REGENERATION; DNA DEMETHYLATION; MULLER GLIA; FIBER-TYPE; AUTOPHAGY	Apobec2 is a member of the activation-induced deaminase/apolipoprotein B mRNA editing enzyme catalytic polypeptide cytidine deaminase family expressed in differentiated skeletal and cardiac muscle. We previously reported that Apobec2 deficiency in mice leads to a shift in muscle fiber type, myopathy, and diminished muscle mass. However, the mechanisms of myopathy caused by Apobec2 deficiency and its physiologic functions are unclear. Here we show that, although Apobec2 localizes to the sarcomeric Z-lines in mouse tissue and cultured myotubes, the sarcomeric structure is not affected in Apobec2-deficient muscle. In contrast, electron microscopy reveals enlarged mitochondria and mitochondria engulfed by autophagic vacuoles, suggesting that Apobec2 deficiency causes mitochondrial defects leading to increased mitophagy in skeletal muscle. Indeed, Apobec2 deficiency results in increased reactive oxygen species generation and depolarized mitochondria, leading to mitophagy as a defensive response. Furthermore, the exercise capacity of Apobec2(-/-) mice is impaired, implying Apobec2 deficiency results in ongoing muscle dysfunction. The presence of rimmed vacuoles in myofibers from 10-mo-old mice suggests that the chronic muscle damage impairs normal autophagy. We conclude that Apobec2 deficiency causes mitochondrial defects that increase muscle mitophagy, leading to myopathy and atrophy. Our findings demonstrate that Apobec2 is required for mitochondrial homeostasis to maintain normal skeletal muscle function.	[Sato, Yusuke; Nihei, Naohiro; Adachi, Shin-Ichi; Kondo, Shinji; Yoshizawa, Fumiaki] Utsunomiya Univ, Dept Agrobiol & Bioresources, 350 Minemachi, Utsunomiya, Tochigi 3218505, Japan; [Ohtsubo, Hideaki; Kaneko, Takane; Nakamura, Mako; Mizunoya, Wataru; Iida, Hiroshi; Tatsumi, Ryuichi] Kyushu Univ, Dept Anim & Marine Bioresource Sci, Fukuoka, Japan; [Sato, Yoriko; Yoshizawa, Fumiaki] Tokyo Univ Agr & Technol, United Grad Sch Agr Sci, Tokyo, Japan; [Rada, Cristina] MRC, Lab Mol Biol, Cambridge, England	Utsunomiya University; Kyushu University; Tokyo University of Agriculture & Technology; MRC Laboratory Molecular Biology	Sato, Y (corresponding author), Utsunomiya Univ, Dept Agrobiol & Bioresources, 350 Minemachi, Utsunomiya, Tochigi 3218505, Japan.	ysato@cc.utsunomiya-u.ac.jp	Mizunoya, Wataru/W-1674-2019	Mizunoya, Wataru/0000-0002-2258-1964; Nakamura, Mako/0000-0002-6129-7560; Kondo, Shinji/0000-0002-9097-6394	Ministry of Education, Science, Sports and Culture of Japan [25850218]; Morinaga Hoshikai; Nakatomi Foundation; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [17H03908] Funding Source: KAKEN; Medical Research Council [MC_U105178806] Funding Source: researchfish; MRC [MC_U105178806] Funding Source: UKRI	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Morinaga Hoshikai; Nakatomi Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Dr. Ichizo Nishino (National Center of Neurology Psychiatry, Tokyo, Japan) and Dr. Tomotake Kanki (Niigata University, Niigata, Japan) for technical advice and helpful discussions on mitophagy and myopathy, and Yuhei Fujita, Dr. Kunio Sugahara (Utsunomiya University), and Dr. Yoshihide Ikeuchi (Kyushu University) for their kind support and helpful suggestions. The authors acknowledge the original contribution of their late colleague Michael Neuberger. This work was supported by Grants-in-Aid for Scientific Research (Grant 25850218) from the Ministry of Education, Science, Sports and Culture of Japan; Morinaga Hoshikai; Nakatomi Foundation; and The Uehara Memorial Foundation. The authors declare no conflicts of interest.	Anant S, 2001, AM J PHYSIOL-CELL PH, V281, pC1904, DOI 10.1152/ajpcell.2001.281.6.C1904; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; De Palma C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.159; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Dodson S, 2011, ANNU REV MED, V62, P265, DOI 10.1146/annurev-med-061509-131248; Duran RV, 2012, CELL CYCLE, V11, P4107, DOI 10.4161/cc.22632; Etard C, 2010, J CELL BIOL, V189, P527, DOI 10.1083/jcb.200912125; Evans WJ, 2010, AM J CLIN NUTR, V91, p1123S, DOI 10.3945/ajcn.2010.28608A; Frank D, 2006, J MOL MED, V84, P446, DOI 10.1007/s00109-005-0033-1; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; JOST JP, 1993, P NATL ACAD SCI USA, V90, P4684, DOI 10.1073/pnas.90.10.4684; Krzysiak TC, 2012, BIOCHEMISTRY-US, V51, P2008, DOI 10.1021/bi300021s; Lada AG, 2011, BIOCHEMISTRY-MOSCOW+, V76, P131, DOI 10.1134/S0006297911010135; Landes T, 2010, EMBO REP, V11, P459, DOI 10.1038/embor.2010.50; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li J, 2014, GENE, V539, P263, DOI 10.1016/j.gene.2014.01.003; Liao W, 1999, BIOCHEM BIOPH RES CO, V260, P398, DOI 10.1006/bbrc.1999.0925; Lokireddy S, 2012, CELL METAB, V16, P613, DOI 10.1016/j.cmet.2012.10.005; Malicdan MC, 2008, NEUROMUSCULAR DISORD, V18, P521, DOI 10.1016/j.nmd.2008.04.010; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Marino G, 2014, MOL CELL, V53, P710, DOI 10.1016/j.molcel.2014.01.016; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Mikl MC, 2005, MOL CELL BIOL, V25, P7270, DOI 10.1128/MCB.25.16.7270-7277.2005; Mitsuhashi S, 2011, HUM MOL GENET, V20, P3841, DOI 10.1093/hmg/ddr305; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; NAVARATNAM N, 1993, J BIOL CHEM, V268, P20709; Neel BA, 2013, TRENDS ENDOCRIN MET, V24, P635, DOI 10.1016/j.tem.2013.09.004; Nishino Ichizo, 2003, Curr Neurol Neurosci Rep, V3, P64, DOI 10.1007/s11910-003-0040-y; Okuyama S, 2012, INT J CANCER, V130, P1294, DOI 10.1002/ijc.26114; Pernas L, 2016, ANNU REV PHYSIOL, V78, P505, DOI 10.1146/annurev-physiol-021115-105011; Powell C, 2014, J BIOL CHEM, V289, P28924, DOI 10.1074/jbc.M114.603043; Powell C, 2013, P NATL ACAD SCI USA, V110, P19814, DOI 10.1073/pnas.1312009110; Powell C, 2012, J NEUROSCI, V32, P1096, DOI 10.1523/JNEUROSCI.5603-11.2012; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Ramos FJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003802; Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60; Rowe GC, 2013, CELL REP, V3, P1449, DOI 10.1016/j.celrep.2013.04.023; Sandri M, 2013, J CELL SCI, V126, P5325, DOI 10.1242/jcs.114041; Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056; Sato Y, 2010, J BIOL CHEM, V285, P7111, DOI 10.1074/jbc.M109.052977; Sato Y, 2009, BIOSCI BIOTECH BIOCH, V73, P1748, DOI 10.1271/bbb.90085; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Suzuki T, 2002, J BIOCHEM, V131, P647, DOI 10.1093/oxfordjournals.jbchem.a003147; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779; Vonica A, 2011, DEV BIOL, V350, P13, DOI 10.1016/j.ydbio.2010.09.016; Wang YQ, 2012, AUTOPHAGY, V8, P1462, DOI 10.4161/auto.21211; Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008; Zhang TM, 2016, J BIOL CHEM, V291, P21616, DOI 10.1074/jbc.M116.733410	61	15	17	2	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1428	1439		10.1096/fj.201700493R	http://dx.doi.org/10.1096/fj.201700493R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29127187	Green Published, hybrid			2022-12-28	WOS:000427246000025
J	Kong, SY; Kim, W; Lee, HR; Kim, HJ				Kong, Sun-Young; Kim, Woosuk; Lee, Ha-Rim; Kim, Hyun-Jung			The histone demethylase KDM5A is required for the repression of astrocytogenesis and regulated by the translational machinery in neural progenitor cells	FASEB JOURNAL			English	Article						epigenetics; H3K4 demethylase; NSC differentiation; eIF-4E; MAPK-interacting kinase	INITIATION-FACTOR 4E; MESSENGER-RNA; STEM-CELLS; BINDING; CANCER; EXPRESSION; DIFFERENTIATION; ACTIVATION; INHIBITION; EIF4E	Histone demethylases are known to play important roles in the determination of the fate of stem cells and in cancer progression. In this study, we show that the lysine 4 of histone H3 (H3K4), lysine-specific demethylase 5A (KDM5A) is essential for the repression of astrocyte differentiation in neural progenitor cells (NPCs), and its expression is regulated by translational machinery. Knockdown of KDM5A in NPCs increased astrocytogenesis, and conversely, KDM5A overexpression reduced the transcriptional activity of the Gfap promoter. Induction of astrocytogenesis by ciliary neurotrophic factor (CNTF) or small interfering RNA-induced knockdown of KDM5A decreased KDM5A recruitment to the Gfap promoter and increased H3K4 methylation. The transcript level of Kdm5a was high, whereas KDM5A protein level was low in CNTF induced astrocytes. During astroglial differentiation, translational activity indicated by the phosphorylation of eukaryotic translation initiation factor (eIF)4E was decreased. Treatment of NPCs with the cercosporamide, a MAPK-interacting kinases inhibitor, reduced eIF4E phosphorylation and KDM5A protein expression, increased GFAP levels, and enhanced astrocytogenesis. These data suggest that KDM5A is a key regulator that maintains NPCs in an undifferentiated state by repressing astrocytogenesis and that its expression is translationally controlled during astrocyte differentiation. Thus, KDM5A is a promising target for the modulation of NPC fate.	[Kong, Sun-Young; Kim, Woosuk; Lee, Ha-Rim; Kim, Hyun-Jung] Chung Ang Univ, Coll Pharm, Lab Mol & Stem Cell Pharmacol, 221 Heukseok Dong, Seoul 156756, South Korea	Chung Ang University	Kim, HJ (corresponding author), Chung Ang Univ, Coll Pharm, Lab Mol & Stem Cell Pharmacol, 221 Heukseok Dong, Seoul 156756, South Korea.	hyunjungkim@cau.ac.kr			Chung-Ang University Excellent Student Scholarship; National Research Foundation of Korea - South Korean government [NRF2017R1A1A1A05000876]; U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke [NS39055, NS057098]	Chung-Ang University Excellent Student Scholarship; National Research Foundation of Korea - South Korean government; U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the Chung-Ang University Excellent Student Scholarship and the National Research Foundation of Korea Grant NRF2017R1A1A1A05000876 (to H.J.K.), funded by the South Korean government. The Alabama Neuroscience Blueprint Core was supported by the U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke Grants NS39055 and NS057098. The authors declare no conflicts of interest.	Araujo PR, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/475731; Benevolenskaya EV, 2005, MOL CELL, V18, P623, DOI 10.1016/j.molcel.2005.05.012; Bhat M, 2015, NAT REV DRUG DISCOV, V14, P261, DOI 10.1038/nrd4505; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; FATTAEY AR, 1993, ONCOGENE, V8, P3149; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Genheden M, 2015, J NEUROSCI, V35, P972, DOI 10.1523/JNEUROSCI.2641-14.2015; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gkogkas CG, 2014, CELL REP, V9, P1742, DOI 10.1016/j.celrep.2014.10.064; Graff JR, 2008, CANCER RES, V68, P631, DOI 10.1158/0008-5472.CAN-07-5635; Graff JR, 1997, BIOCHEM BIOPH RES CO, V240, P15, DOI 10.1006/bbrc.1997.7592; Hirano K, 2016, STEM CELLS, V34, P1872, DOI 10.1002/stem.2362; Horton JR, 2016, CELL CHEM BIOL, V23, P769, DOI 10.1016/j.chembiol.2016.06.006; Hsieh J, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018911; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Jin H, 2009, MOL CELL BIOL, V29, P5789, DOI 10.1128/MCB.00653-09; Kim HJ, 2009, STEM CELLS, V27, P390, DOI 10.1634/stemcells.2007-1047; KIM YW, 1994, MOL CELL BIOL, V14, P7256, DOI 10.1128/MCB.14.11.7256; Kong J, 2012, NAT REV GENET, V13, P383, DOI 10.1038/nrg3184; Kong SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118188; Konicek BW, 2011, CANCER RES, V71, P1849, DOI 10.1158/0008-5472.CAN-10-3298; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; Lambrot R, 2015, FASEB J, V29, P4402, DOI 10.1096/fj.14-267328; Lee HS, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8040312; Lopez-Bigas N, 2008, MOL CELL, V31, P520, DOI 10.1016/j.molcel.2008.08.004; Mao SF, 1997, ONCOGENE, V14, P1531, DOI 10.1038/sj.onc.1200988; Marcotrigiano J, 1997, Nucleic Acids Symp Ser, P8; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Naruse C, 2017, FASEB J, V31, P2252, DOI 10.1096/fj.201600642R; Proud CG, 2015, BBA-GENE REGUL MECH, V1849, P766, DOI 10.1016/j.bbagrm.2014.10.003; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; ROSENWALD IB, 1995, J BIOL CHEM, V270, P21176, DOI 10.1074/jbc.270.36.21176; SAITO H, 1983, P NATL ACAD SCI-BIOL, V80, P7476, DOI 10.1073/pnas.80.24.7476; Scheper GC, 2002, EUR J BIOCHEM, V269, P5350, DOI 10.1046/j.1432-1033.2002.03291.x; Schmitz SU, 2011, EMBO J, V30, P4586, DOI 10.1038/emboj.2011.383; Scott PAE, 1998, BRIT J CANCER, V77, P2120, DOI 10.1038/bjc.1998.356; Secombe J, 2007, CELL CYCLE, V6, P1324, DOI 10.4161/cc.6.11.4269; SHANTZ LM, 1994, CANCER RES, V54, P2313; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Siddiqui N, 2015, BIOCHEM SOC T, V43, P763, DOI 10.1042/BST20150126; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; Takei N, 2001, J BIOL CHEM, V276, P42818, DOI 10.1074/jbc.M103237200; Tu SJ, 2008, NAT STRUCT MOL BIOL, V15, P419, DOI 10.1038/nsmb.1400; Varaljai R, 2015, GENE DEV, V29, P1817, DOI 10.1101/gad.264036.115; Vinogradova M, 2016, NAT CHEM BIOL, V12, P531, DOI 10.1038/nchembio.2085; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59; Wang CD, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.238; Yoffe Y, 2016, GENE DEV, V30, P1991, DOI 10.1101/gad.285239.116; Yoon HJ, 2014, BIOORGAN MED CHEM, V22, P927, DOI 10.1016/j.bmc.2013.12.018; Yoon HJ, 2013, BIOORGAN MED CHEM, V21, P7165, DOI 10.1016/j.bmc.2013.08.066; Zhang F., 2014, INT J DISTRIB SENS N, V2014, P1, DOI DOI 10.3969/J.ISSN.1000-2324.2014.02.01; Zhao DZ, 2016, CELL REP, V15, P288, DOI 10.1016/j.celrep.2016.03.035; Zhou Q, 2016, MOL BIOL CELL, V27, P627, DOI 10.1091/mbc.E15-07-0513	56	24	24	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					1108	1119		10.1096/fj.201700780R	http://dx.doi.org/10.1096/fj.201700780R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29212818	Green Published			2022-12-28	WOS:000425146900048
J	Stark, RJ; Koch, SR; Choi, H; Mace, EH; Dikalov, SI; Sherwood, ER; Lamb, FS				Stark, Ryan J.; Koch, Stephen R.; Choi, Hyehun; Mace, Eric H.; Dikalov, Sergey I.; Sherwood, Edward R.; Lamb, Fred S.			Endothelial nitric oxide synthase modulates Toll-like receptor 4-mediated IL-6 production and permeability via nitric oxide-independent signaling	FASEB JOURNAL			English	Article						inflammation; eNOS; endothelial cells; TLR-4; p38	MICROVASCULAR PERMEABILITY; GENE-EXPRESSION; SEVERE SEPSIS; IN-VITRO; CYTOKINE; DYSFUNCTION; CELLS; ACTIVATION; GENERATION; ENDOTOXIN	Endothelial dysfunction, characterized by changes in eNOS, is a common finding in chronic inflammatory vascular diseases. These states are associated with increased infectious complications. We hypothesized that alterations in eNOS would enhance the response to LPS-mediated TLR4 inflammation. Human microvascular endothelial cells were treated with sepiapterin or N-nitro-L-arginine methylester (L-NAME) to alter endogenous NO production, and small interfering RNA to knockdown eNOS. Alterations of endogenous NO by sepiapterin, and L-NAME provided no significant changes to LPS inflammation. In contrast, eNOS knockdown greatly enhanced endothelial IL-6 production and permeability in response to LPS. Knockdown of eNOS enhanced LPS-induced p38. Inhibition of p38 with SB203580 prevented IL-6 production, without altering permeability. Knockdown of p38 impaired NF-kappa B activation. Physical interaction between p38 and eNOS was demonstrated by immunoprecipitation, suggesting a novel, NO-independent mechanism for eNOS regulation of TLR4. In correlation, biopsy samples in patients with systemic lupus erythematous showed reduced eNOS expression with associated elevations in TLR4 and p38, suggesting an in vivo link. Thus, reduced expression of eNOS, as seen in chronic inflammatory disease, was associated with enhanced TLR4 signaling through p38. This may enhance the response to infection in patients with chronic inflammatory conditions.	[Stark, Ryan J.; Koch, Stephen R.; Choi, Hyehun; Mace, Eric H.; Lamb, Fred S.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; [Dikalov, Sergey I.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Sherwood, Edward R.] Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Stark, RJ (corresponding author), Vanderbilt Univ, Sch Med, 2200 Childrens Way,5121 Doctors Off Tower, Nashville, TN 37232 USA.	ryan.stark@vanderbilt.edu	Stark, Ryan/O-1862-2019; Stark, Ryan/GZL-7445-2022	Stark, Ryan/0000-0001-6142-5502; Stark, Ryan/0000-0001-6142-5502; Dikalov, Sergey/0000-0003-2976-6184; Lamb, Fred/0000-0003-2955-5133	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences [K08-GM117367, R01-GM104306]; NIH National Heart, Lung, and Blood Institute [R01-HL128386]; American Heart Association [16SDG30610002]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124116, R01HL128386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM117367, R01GM119197, R01GM104306] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021630] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences; NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences Grants K08-GM117367 (to R.J.S.) and R01-GM104306 (to E.R.S.) and NIH National Heart, Lung, and Blood Institute Grant R01-HL128386 (to F.S.L.), and by American Heart Association Grant 16SDG30610002 (to H.C.). The authors declare no conflicts of interest.	Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; AlFadhli S, 2013, DIS MARKERS, V34, P349, DOI [10.3233/DMA-130983, 10.1155/2013/613978]; Balk RA, 2014, VIRULENCE, V5, P20, DOI 10.4161/viru.27135; Brandes RP, 2014, HYPERTENSION, V64, P924, DOI 10.1161/HYPERTENSIONAHA.114.03575; Cardaropoli S, 2003, J HYPERTENS, V21, P2103, DOI 10.1097/00004872-200311000-00020; Castellon X, 2016, AGING DIS, V7, DOI 10.14336/AD.2015.0803; Chrestensen CA, 2012, FEBS OPEN BIO, V2, P51, DOI 10.1016/j.fob.2012.02.002; Craig R, 2000, J BIOL CHEM, V275, P23814, DOI 10.1074/jbc.M909695199; De Cruz Sharon J, 2009, Expert Rev Respir Med, V3, P511, DOI 10.1586/ers.09.39; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074; DeVries HE, 1996, J PHARMACOL EXP THER, V277, P1418; Di Lorenzo A, 2013, J CELL SCI, V126, P5541, DOI 10.1242/jcs.115972; Dreger H, 2016, GENOMICS, V107, P145, DOI 10.1016/j.ygeno.2016.02.002; Duran WN, 2010, CARDIOVASC RES, V87, P254, DOI 10.1093/cvr/cvq139; Flaherty MP, 2007, CARDIOVASC TOXICOL, V7, P165, DOI 10.1007/s12012-007-0028-y; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; GROSS SS, 1992, J BIOL CHEM, V267, P25722; Hauser B, 2005, ANESTH ANALG, V101, P488, DOI 10.1213/01.ANE.0000177117.80058.4D; Kirkeboen KA, 1999, ACTA ANAESTH SCAND, V43, P275; Kobayashi Y, 2010, J LEUKOCYTE BIOL, V88, P1157, DOI 10.1189/jlb.0310149; Kolluru GK, 2010, BIOCHIMIE, V92, P1186, DOI 10.1016/j.biochi.2010.03.020; KUBES P, 1992, AM J PHYSIOL, V262, pH611, DOI 10.1152/ajpheart.1992.262.2.H611; Li LZ, 2015, PROCEEDINGS 2015 SIXTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS DESIGN AND ENGINEERING APPLICATIONS ISDEA 2015, P5, DOI 10.1109/ISDEA.2015.12; Liu B, 2006, J IMMUNOL, V177, P6880, DOI 10.4049/jimmunol.177.10.6880; Liu Q, 2016, IMMUNOL CELL BIOL, V94, P538, DOI 10.1038/icb.2016.18; Mayr FB, 2014, VIRULENCE, V5, P4, DOI 10.4161/viru.27372; RAMIREZ MM, 1995, MICROVASC RES, V50, P223, DOI 10.1006/mvre.1995.1055; Santos MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044668; Shi LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093846; Stark R, 2015, INNATE IMMUN-LONDON, V21, P565, DOI 10.1177/1753425914564172; Steyers CM, 2014, INT J MOL SCI, V15, P11324, DOI 10.3390/ijms150711324; Toukap AN, 2007, ARTHRITIS RHEUM-US, V56, P1579, DOI 10.1002/art.22578; Tsujimoto H, 2008, SHOCK, V29, P315, DOI [10.1097/shk.0b013e318157ee55, 10.1097/SHK.0b013e318157ee55]; Varma S, 2002, MICROVASC RES, V63, P172, DOI 10.1006/mvre.2001.2381; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Woods ME, 2005, ANN NY ACAD SCI, V1063, P239, DOI 10.1196/annals.1355.037; Yamashita T, 2000, CIRCULATION, V101, P931, DOI 10.1161/01.CIR.101.8.931; Yang BL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127931; Yazji I, 2013, P NATL ACAD SCI USA, V110, P9451, DOI 10.1073/pnas.1219997110	40	13	13	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					945	956		10.1096/fj.201700410R	http://dx.doi.org/10.1096/fj.201700410R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29061842	Green Published, Bronze			2022-12-28	WOS:000425146900035
J	Li, H; Yang, DX; Ning, SL; Xu, YH; Yang, F; Yin, RS; Feng, TH; Han, SQ; Guo, L; Zhang, PJ; Qu, WJ; Guo, RB; Song, C; Xiao, P; Zhou, CJ; Xu, ZG; Sun, JP; Yu, X				Li, Hui; Yang, Duxiao; Ning, Shanglei; Xu, Yinghui; Yang, Fan; Yin, Rusha; Feng, Taihu; Han, Shouqing; Guo, Lu; Zhang, Pengju; Qu, Wenjie; Guo, Renbo; Song, Chen; Xiao, Peng; Zhou, Chengjun; Xu, Zhigang; Sun, Jin-Peng; Yu, Xiao			Switching of the substrate specificity of protein tyrosine phosphatase N12 by cyclin-dependent kinase 2 phosphorylation orchestrating 2 oncogenic pathways	FASEB JOURNAL			English	Article						HER2; PAK1; breast cancer; migration; therapy	NONRECEPTOR TYPE 12; CELL LUNG-CANCER; BREAST-CANCER; PTP-PEST; VHR PHOSPHATASE; GROWTH-FACTOR; MIGRATION; ACTIVATION; DEPHOSPHORYLATION; AUTOIMMUNITY	The protein tyrosine phosphatase nonreceptor type 12 (PTPN12) is a multifunctional protein and has elicited much research attention because its decreased protein level has been associated with poor prognosis of several types of cancers. Recently, we have solved the crystal structure of the phosphatase domain of PTPN12, which disclosed a specific PTPN12-insert-loop harboring a cyclin-dependent kinase 2 (CDK2) phosphorylation site. However, the functional significance of this phosphorylation is undefined. In the present study, we found that S19 site phosphorylation of PTPN12 by CDK2 discharged its antitumor activity by down-regulation of its inhibitory role in cell migration, but not affecting its other regulatory functions. Phosphorylation of PTPN12 at the S19 site changed its substrate interface, and by doing so, selectively decreased its activity toward the human epidermal growth factor receptor 2 (HER2)-pY(1196) site, but not otherHER2 phosphorylation sites or other known PTPN12 substrates. Afurther in-depth mechanism study revealed that the phosphorylation of PTPN12 byCDK2 impaired recruitment of the serine/threonine-protein kinase 1 (PAK1) to HER2, resulted in the blockade of the HER2-pY(1196)-PAK1-T-423 signaling pathway, thus increased tumor cell motility. Taken together, our results identified a new phosphorylation-based substrate recognition mechanism of PTPN12 by CDK2, which orchestrated signaling crosstalk between the oncogenic CDK2 and HER2 pathways. The newly identified governing mechanism of the substrate selectivity of a particular phosphatase was previously unappreciated and exemplifies howa phospho-network is precisely controlled in different cellular contexts.	[Li, Hui; Yang, Fan; Yin, Rusha; Feng, Taihu; Han, Shouqing; Qu, Wenjie; Guo, Renbo; Yu, Xiao] Shandong Univ, Sch Med, Key Lab Expt Teratol, Minist Educ, Jinan, Shandong, Peoples R China; [Li, Hui; Yang, Fan; Yin, Rusha; Feng, Taihu; Han, Shouqing; Qu, Wenjie; Guo, Renbo; Yu, Xiao] Shandong Univ, Sch Med, Dept Physiol, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China; [Yang, Duxiao; Zhang, Pengju; Xiao, Peng; Sun, Jin-Peng] Shandong Univ, Sch Med, Dept Mol Biol & Biochem, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China; [Li, Hui; Zhou, Chengjun] Shangdong Univ, Hosp 2, Jinan, Shandong, Peoples R China; [Ning, Shanglei] Shangdong Univ, Qilu Hosp, Jinan, Shandong, Peoples R China; [Ning, Shanglei] Shangdong Univ, Sch Life Sci, Jinan, Shandong, Peoples R China; [Xu, Yinghui] Jilin Univ, Hosp 1, Canc Ctr, Jilin, Jilin, Peoples R China; [Ning, Shanglei] Peking Univ, Ctr Quantitat Biol, Beijing, Peoples R China; [Sun, Jin-Peng] Duke Univ, Sch Med, Durham, NC USA	Shandong University; Shandong University; Shandong University; Shandong University; Shandong University; Shandong University; Jilin University; Peking University; Duke University	Yu, X (corresponding author), Shandong Univ, Sch Med, Dept Physiol, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.; Sun, JP (corresponding author), Shandong Univ, Sch Med, Dept Mol Biol & Biochem, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.	sunjinpeng@sdu.edu.cn; yuxiao@sdu.edu.cn	sun, Jinpeng/AAR-9196-2020		National Key Basic Research Program of China [2013CB967700]; National Natural Science Foundation of China [31270857, 31471102, 31470789]; Shandong Natural Science Fund for Distinguished Young Scholars [JQ201320, JQ201517]; Fundamental Research Funds of Shandong University [2014JC029]; China Postdoctoral Science Foundation [2015M582082]; Shandong Natural Science Fund [ZR2016CQ07, ZR2015HM036]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Natural Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Fundamental Research Funds of Shandong University; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shandong Natural Science Fund	The authors thank Dr. Debo Zou (Shangdon Provincial Qianofoshan Hospital, Jinan, China) for help in GST pull-down experiments. This work was supported by Grant 2013CB967700 from the National Key Basic Research Program of China (to X.Y.); Grants 31270857 and 31471102 (to X.Y) and 31470789 (to J.-P.S.) from the National Natural Science Foundation of China; Grants JQ201320 (to X.Y.) and JQ201517 (to J.-P.) from the Shandong Natural Science Fund for Distinguished Young Scholars; Grant 2014JC029 (to X.Y. and Z.X.) from the Fundamental Research Funds of Shandong University, Grant 2015M582082 (to P.X.) from the China Postdoctoral Science Foundation; Grant ZR2016CQ07 (to P.X.) from the Shandong Natural Science Fund; and Grant ZR2015HM036 (to C.Z.) from the Shandong Natural Science Fund. The authors declare no conflicts of interest.	Afshari FT, 2010, J NEUROSCI, V30, P4246, DOI 10.1523/JNEUROSCI.3351-09.2010; Alonso A, 2003, NAT IMMUNOL, V4, P44, DOI 10.1038/ni856; Cao X, 2015, ONCOTARGET, V6, P11704, DOI 10.18632/oncotarget.3588; Chellaiah MA, 2009, J CELL PHYSIOL, V220, P382, DOI 10.1002/jcp.21777; Chen KE, 2015, STRUCTURE, V23, P653, DOI 10.1016/j.str.2015.01.017; Cong F, 2000, MOL CELL, V6, P1413, DOI 10.1016/S1097-2765(00)00138-6; Cote JF, 2002, J BIOL CHEM, V277, P2973, DOI 10.1074/jbc.M106428200; Dai XZ, 2013, J CLIN INVEST, V123, P2024, DOI 10.1172/JCI66963; Dankort D, 2001, J BIOL CHEM, V276, P38921, DOI 10.1074/jbc.M106239200; De Robertis M, 2017, CLIN CANCER RES, V23, P159, DOI 10.1158/1078-0432.CCR-16-0709; GARTON AJ, 1994, EMBO J, V13, P3763, DOI 10.1002/j.1460-2075.1994.tb06687.x; Grace EA, 2003, J NEUROSCI, V23, P493, DOI 10.1523/JNEUROSCI.23-02-00493.2003; Gu LQ, 2010, CLIN ENDOCRINOL, V72, P248, DOI 10.1111/j.1365-2265.2009.03617.x; Harris IS, 2014, ONCOGENE, V33, P1047, DOI 10.1038/onc.2013.24; Hu SH, 2015, CANCER RES, V75, P2029, DOI 10.1158/0008-5472.CAN-14-1494; Kang TH, 2006, NAT CELL BIOL, V8, P863, DOI 10.1038/ncb1447; Karakas C, 2016, AM J PATHOL, V186, P1900, DOI 10.1016/j.ajpath.2016.02.024; Kim SJ, 2012, ANN ONCOL, V23, P891, DOI 10.1093/annonc/mdr340; Kim SJ, 2014, CANCER LETT, V355, P217, DOI 10.1016/j.canlet.2014.08.042; Kumar SK, 2015, BLOOD, V125, P443, DOI 10.1182/blood-2014-05-573741; Lane HA, 2001, ANN ONCOL, V12, P21, DOI 10.1023/A:1011155606333; Li H, 2016, CELL REP, V15, P1345, DOI 10.1016/j.celrep.2016.04.016; Li J, 2015, MOL CELL BIOL, V35, P4069, DOI 10.1128/MCB.00741-15; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Liu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043631; Maine CJ, 2016, P NATL ACAD SCI USA, V113, pE7231, DOI 10.1073/pnas.1603738113; Mendoza N, 2003, CANCER RES, V63, P1020; Parry D, 2010, MOL CANCER THER, V9, P2344, DOI 10.1158/1535-7163.MCT-10-0324; Qu XH, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0666-y; Rhee I, 2014, MOL CELL BIOL, V34, P888, DOI 10.1128/MCB.01369-13; Rhee I, 2012, NAT IMMUNOL, V13, P439, DOI 10.1038/ni.2246; Rojas M, 2014, P NATL ACAD SCI USA, V111, pE1344, DOI 10.1073/pnas.1400129111; Salmeen A, 2000, MOL CELL, V6, P1401, DOI 10.1016/S1097-2765(00)00137-4; Shanley TP, 2001, J IMMUNOL, V166, P966, DOI 10.4049/jimmunol.166.2.966; Shen CH, 2008, CANCER RES, V68, P7779, DOI 10.1158/0008-5472.CAN-08-0997; Sieg DJ, 1999, J CELL SCI, V112, P2677; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Sood S, 2016, J IMMUNOL, V197, P429, DOI 10.4049/jimmunol.1502656; Souza CM, 2012, J BIOL CHEM, V287, P43180, DOI 10.1074/jbc.M112.387456; Streit S, 2006, CANCER GENET CYTOGEN, V170, P48, DOI 10.1016/j.cancergencyto.2006.05.013; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Veillette A, 2009, IMMUNOL REV, V228, P312, DOI 10.1111/j.1600-065X.2008.00747.x; Wang HM, 2014, CELL RES, V24, P1067, DOI 10.1038/cr.2014.99; Wang SZE, 2006, CANCER RES, V66, P9591, DOI 10.1158/0008-5472.CAN-06-2071; Wu MQ, 2013, ASIAN PAC J CANCER P, V14, P287, DOI 10.7314/APJCP.2013.14.1.287; Yamasaki F, 2007, MOL CANCER THER, V6, P2168, DOI 10.1158/1535-7163.MCT-06-0514; Yu X, 2007, P NATL ACAD SCI USA, V104, P19767, DOI 10.1073/pnas.0706233104; Zheng YH, 2011, MOL CELL BIOL, V31, P4258, DOI 10.1128/MCB.05547-11; Zheng Y, 2013, NATURE, V499, P166, DOI 10.1038/nature12308	49	6	6	2	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					73	82		10.1096/fj.201700418R	http://dx.doi.org/10.1096/fj.201700418R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28842430				2022-12-28	WOS:000419172700009
J	Ma, D; Gilbert, T; Pignanelli, C; Tarade, D; Noel, M; Mansour, F; Gupta, M; Ma, S; Ropat, J; Curran, C; Vshyvenko, S; Hudlicky, T; Pandey, S				Ma, Dennis; Gilbert, Tyler; Pignanelli, Christopher; Tarade, Daniel; Noel, Megan; Mansour, Fadi; Gupta, Manika; Ma, Sabrina; Ropat, Jesse; Curran, Colin; Vshyvenko, Sergey; Hudlicky, Tomas; Pandey, Siyaram			Exploiting mitochondrial and oxidative vulnerabilities with a synthetic analog of pancratistatin in combination with piperlongumine for cancer therapy	FASEB JOURNAL			English	Article						combination therapy; apoptosis; mitochondria; oxidative stress	BIOLOGICAL EVALUATION; TUMOR-CELLS; APOPTOSIS; GROWTH; PROLIFERATION; DYSFUNCTION; HEXOKINASE; STRESS; DEATH; ROS	Harsh adverse effects as a result of nonspecific targeting of chemotherapeutics currently pose obstacles in cancer therapy; thus, it would be invaluable to devise novel approaches to specifically target cancer cells. The natural compound pancratistatin (PST) has been shown to preferentially induce apoptosis in a variety of cancer cell types. Recently, several analogs of PST were shown to be efficacious in inducing apoptosis in a variety of aggressive cancer cell types via cancer cell mitochondrial targeting; it caused dissipation of mitochondrial membrane potential and decreased oxygen consumption, and with isolated mitochondria, it induced the release of apoptogenic factors. The natural compound piperlongumine has been shown to target the stress response to reactive oxygen species in cancer cells. We explored the combinatorial potential of two small molecules (SVTH-6 and piperlongumine) that target these vulnerabilities in cancer cells. Interestingly, when combined with the PST analog, SVTH-6, an increase in mitochondrial dysfunction was observed, leading to an enhanced cytotoxic effect against several human cancer cell types. Additionally, this combination treatment was effective in reducing cancer cell growth in physiologically more relevant 3-dimensional spheroid cell cultures. This enhanced effect was found to be dependent on reactive oxygen species generation because an antioxidant could rescue cancer cells from this combination treatment. Importantly, noncancerous cells were markedly less sensitive to this combination treatment. Thus, targeting mitochondrial and oxidative stress vulnerabilities of cancer cells could be an effective strategy for cancer therapy.	[Ma, Dennis; Gilbert, Tyler; Pignanelli, Christopher; Tarade, Daniel; Noel, Megan; Mansour, Fadi; Gupta, Manika; Ma, Sabrina; Ropat, Jesse; Curran, Colin; Pandey, Siyaram] Univ Windsor, Dept Chem & Biochem, 401 Sunset Ave, Windsor, ON N9B 3P4, Canada; [Vshyvenko, Sergey; Hudlicky, Tomas] Brock Univ, Chem Dept, St Catharines, ON, Canada; [Vshyvenko, Sergey; Hudlicky, Tomas] Brock Univ, Ctr Biotechnol, St Catharines, ON, Canada	University of Windsor; Brock University; Brock University	Pandey, S (corresponding author), Univ Windsor, Dept Chem & Biochem, 401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	spandey@uwindsor.ca	Pandey, Siyaram/AAI-5491-2020; Pignanelli, Christopher/N-7183-2019	Pignanelli, Christopher/0000-0001-7120-4818	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research Frederick Banting and Charles Best Canada Graduate Scholarship; Ontario Graduate Scholarship; Vanier Canada Graduate Scholarship	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research Frederick Banting and Charles Best Canada Graduate Scholarship(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Vanier Canada Graduate Scholarship	The authors gratefully acknowledge A. Dowhayko, P. Tremblay, S. Adams, P. Akbari-Asl, J. Cheema, J. Church, and S. Joshi (all from the University of Windsor) for their initial assistance on this project and their continued support and encouragement. This work was supported, in part, by generous donations by the Knights of Columbus Chapter 9671 (Windsor, ON, Canada), the Windsor Mold Group, and D. and D. Couvillon (in memory of K. Couvillon). Funding from the Natural Sciences and Engineering Research Council of Canada to S.P. and T.H. is gratefully acknowledged. This work was also supported by a Canadian Institutes of Health Research Frederick Banting and Charles Best Canada Graduate Scholarship, an Ontario Graduate Scholarship, and a Vanier Canada Graduate Scholarship awarded to D.M. The authors declare no conflicts of interest.	Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Casellas P, 2002, NEUROCHEM INT, V40, P475, DOI 10.1016/S0197-0186(01)00118-8; Chen G, 2010, MITOCHONDRION, V10, P614, DOI 10.1016/j.mito.2010.08.001; Chen YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007033; Cocheme HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200; Collins J, 2010, J ORG CHEM, V75, P3069, DOI 10.1021/jo1003136; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Earnshaw WC, 1999, NATURE, V397, P387, DOI 10.1038/17015; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; Gogvadze V, 2010, MOL ASPECTS MED, V31, P60, DOI 10.1016/j.mam.2009.12.004; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Griffin C, 2011, INT J ONCOL, V38, P1549, DOI 10.3892/ijo.2011.977; Griffin C, 2011, MOL CANCER THER, V10, P57, DOI 10.1158/1535-7163.MCT-10-0735; Heerdt BG, 2006, CANCER RES, V66, P1591, DOI 10.1158/0008-5472.CAN-05-2717; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Kekre N, 2005, CANCER CHEMOTH PHARM, V56, P29, DOI 10.1007/s00280-004-0941-8; Kumar B, 2008, CANCER RES, V68, P1777, DOI 10.1158/0008-5472.CAN-07-5259; Ma D., 2012, JOVE-J VIS EXP, V63, P3586; Ma D, 2017, SCI REP-UK, V7, DOI 10.1038/srep42957; Ma D, 2012, INVEST NEW DRUG, V30, P1012, DOI 10.1007/s10637-011-9668-7; Mathupala SP, 1997, J BIOENERG BIOMEMBR, V29, P339, DOI 10.1023/A:1022494613613; McLachlan A, 2005, APOPTOSIS, V10, P619, DOI 10.1007/s10495-005-1896-x; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Plas DR, 2002, TRENDS ENDOCRIN MET, V13, P74; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Ryu HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017343; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Siedlakowski P, 2008, CANCER BIOL THER, V7, P376, DOI 10.4161/cbt.7.3.5364; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Vshyvenko S, 2011, BIOORG MED CHEM LETT, V21, P4750, DOI 10.1016/j.bmcl.2011.06.068; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309	35	7	7	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					417	430		10.1096/fj.201700275R	http://dx.doi.org/10.1096/fj.201700275R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28928246				2022-12-28	WOS:000419172700037
J	Mi, YS; Qi, GY; Fan, R; Qiao, QL; Sun, YL; Gao, YQ; Liu, XB				Mi, Yashi; Qi, Guoyuan; Fan, Rong; Qiao, Qinglian; Sun, Yali; Gao, Yuqi; Liu, Xuebo			EGCG ameliorates high-fat- and high-fructose-induced cognitive defects by regulating the IRS/AKT and ERK/CREB/BDNF signaling pathways in the CNS	FASEB JOURNAL			English	Article						insulin resistance; cognitive disorder; appetite; circadian clock	HIPPOCAMPAL SYNAPTIC PLASTICITY; INDUCED INSULIN-RESISTANCE; CIRCADIAN-RHYTHMS; NEUROTROPHIC FACTOR; ADULT NEUROGENESIS; TEA POLYPHENOL; DIET; OBESITY; BDNF; EXPRESSION	Obesity, which is caused by an energy imbalance between calorie intake and consumption, has become a major international health burden. Obesity increases the risk of insulin resistance and age-related cognitive decline, accompanied by peripheral inflammation. (-)-Epigallocatechin-3-gallate (EGCG), the major polyphenol in green tea, possesses antioxidant, anti-inflammatory, and cardioprotective activities; however, few reports have focused on its potential effect on cognitive disorders. In this study, our goal was to investigate the protective effects of EGCG treatment on insulin resistance and memory impairment induced by a high-fat and high-fructose diet (HFFD). We randomly assigned 3-mo-old C57BL/6Jmice to 3 groups with different diets: control group, HFFD group, and HFFD plus EGCG group. Memory loss was assessed by using the Morris water maze test, during which EGCG was observed to prevent HFFD-elicited memory impairment and neuronal loss. Consistent with these results, EGCG attenuated HFFD-induced neuronal damage. Of note, EGCG significantly ameliorated insulin resistance and cognitive disorder by up-regulating the insulin receptor substrate-1 (IRS-1)/AKT and ERK/cAMP response element binding protein (CREB)/brain-derived neurotrophic factor (BDNF) signaling pathways. Long-term HFFD-triggered neuroinflammation was restored by EGCG supplementation by inhibiting the MAPK and NF-kB pathways, as well as the expression of inflammatory mediators, such as TNF-alpha. EGCG also reversed high glucose and glucosamine-induced insulin resistance in SH-SY5Y neuronal cells by improving the oxidized cellular status and mitochondrial function. To our knowledge, this study is the first to provide compelling evidence that the nutritional compound EGCG has the potential to ameliorate HFFD-triggered learning and memory loss.-Mi, Y., Qi, G., Fan, R., Qiao, Q., Sun, Y., Gao, Y., Liu, X. EGCG ameliorates high-fat- and high-fructose-induced cognitive defects by regulating the IRS/AKT and ERK/CREB/BDNF signaling pathways in the CNS.	[Mi, Yashi; Qi, Guoyuan; Fan, Rong; Qiao, Qinglian; Sun, Yali; Gao, Yuqi; Liu, Xuebo] Northwest A&F Univ, Coll Food Sci & Engn, Lab Funct Chem & Nutr Food, Yangling, Peoples R China	Northwest A&F University - China	Liu, XB (corresponding author), Northwest A&F Univ, Coll Food Sci & Engn, 28 Xi Nong Rd, Yangling 712100, Peoples R China.	xueboliu@aliyun.com	Qi, Guoyuan/ABN-1711-2022; Qi, Guoyuan/AAZ-9695-2020		National Natural Science Foundation of China [31571842]; National Key Research and Development Program of China [2016YFD0400601]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	The authors thank Elsevier Language Editing Services for its linguistic assistance during the preparation of this manuscript. This work was supported by the National Natural Science Foundation of China (Grant 31571842) and the National Key Research and Development Program of China (Grant 2016YFD0400601). The authors declare no conflicts of interest.	Air EL, 2002, NAT MED, V8, P179, DOI 10.1038/nm0202-179; Allen SJ, 2013, PHARMACOL THERAPEUT, V138, P155, DOI 10.1016/j.pharmthera.2013.01.004; Arnold SE, 2014, NEUROBIOL DIS, V67, P79, DOI 10.1016/j.nbd.2014.03.011; Asante-Appiah E, 2003, AM J PHYSIOL-ENDOC M, V284, pE663, DOI 10.1152/ajpendo.00462.2002; Asher G, 2015, CELL, V161, P84, DOI 10.1016/j.cell.2015.03.015; Bailey SM, 2014, J ENDOCRINOL, V222, pR75, DOI 10.1530/JOE-14-0200; Bake T, 2014, APPETITE, V77, P60, DOI 10.1016/j.appet.2014.02.020; Baker LD, 2011, ARCH NEUROL-CHICAGO, V68, P51, DOI 10.1001/archneurol.2010.225; Bekinschtein P, 2014, NEUROPHARMACOLOGY, V76, P677, DOI 10.1016/j.neuropharm.2013.04.024; Bhagwat S., 2014, USDA DATABASE FLAVON; Blesa J., 2016, PARKINSONS DIS CELL; Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677; Branecky KL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137970; Catuara-Solarz S, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0103-16.2016; Chakrabarti SK, 2009, OBESITY, V17, P1657, DOI 10.1038/oby.2009.192; Cisternas P, 2015, BBA-MOL BASIS DIS, V1852, P2379, DOI 10.1016/j.bbadis.2015.08.016; Craft S, 2004, LANCET NEUROL, V3, P169, DOI 10.1016/S1474-4422(04)00681-7; de la Monte SM, 2012, CURR ALZHEIMER RES, V9, P35; Eckel-Mahan KL, 2013, CELL, V155, P1464, DOI 10.1016/j.cell.2013.11.034; Franco-Robles E, 2016, MOLECULES, V21, DOI 10.3390/molecules21080998; Fujimoto M, 2005, DIABETES, V54, P1340, DOI 10.2337/diabetes.54.5.1340; Genzer Y, 2016, MOL CELL ENDOCRINOL, V430, P49, DOI 10.1016/j.mce.2016.04.015; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; He BK, 2016, CELL METAB, V23, P610, DOI 10.1016/j.cmet.2016.03.007; Kalupahana NS, 2012, MOL ASPECTS MED, V33, P26, DOI 10.1016/j.mam.2011.10.011; Kanoski SE, 2007, BEHAV BRAIN RES, V182, P57, DOI 10.1016/j.bbr.2007.05.004; Kao Y, 2000, AM J CLIN NUTR, V72, P1232; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; Klaus S, 2005, INT J OBESITY, V29, P615, DOI 10.1038/sj.ijo.0802926; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Lau P, 2004, J BIOL CHEM, V279, P36828, DOI 10.1074/jbc.M404927200; Lee J, 2002, J NEUROCHEM, V80, P539, DOI 10.1046/j.0022-3042.2001.00747.x; Li HY, 2016, MOL NUTR FOOD RES, V60, P2565, DOI 10.1002/mnfr.201600162; Li Q, 2009, NEUROSCIENCE, V163, P741, DOI 10.1016/j.neuroscience.2009.07.014; Liang FX, 2009, NAT REV ENDOCRINOL, V5, P367, DOI 10.1038/nrendo.2009.101; Lindqvist A, 2006, EUR J NEUROL, V13, P1385, DOI 10.1111/j.1468-1331.2006.01500.x; Liu ZG, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600734; Liu ZG, 2017, FOOD FUNCT, V8, P710, DOI 10.1039/c6fo01562j; Liu ZG, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0140839, 10.1371/journal.pone.0128274]; Mongiat LA, 2011, EUR J NEUROSCI, V33, P1055, DOI 10.1111/j.1460-9568.2011.07603.x; Nagao T, 2005, AM J CLIN NUTR, V81, P122; Pinto NB, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/161092; Pipatpiboon N, 2012, ENDOCRINOLOGY, V153, P329, DOI 10.1210/en.2011-1502; Plum L, 2005, TRENDS ENDOCRIN MET, V16, P59, DOI 10.1016/j.tem.2005.01.008; Qiu YY, 2017, BBA-MOL BASIS DIS, V1863, P978, DOI 10.1016/j.bbadis.2017.01.026; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Rios M, 2013, TRENDS NEUROSCI, V36, P83, DOI 10.1016/j.tins.2012.12.009; Roopchand DE, 2015, DIABETES, V64, P2847, DOI 10.2337/db14-1916; Ropelle ER, 2006, J PHYSIOL-LONDON, V577, P997, DOI 10.1113/jphysiol.2006.120006; Sadacca LA, 2011, DIABETOLOGIA, V54, P120, DOI 10.1007/s00125-010-1920-8; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Stranahan AM, 2008, HIPPOCAMPUS, V18, P1085, DOI 10.1002/hipo.20470; Suganuma M, 1998, CARCINOGENESIS, V19, P1771, DOI 10.1093/carcin/19.10.1771; Sukumaran S, 2010, ADV DRUG DELIVER REV, V62, P904, DOI 10.1016/j.addr.2010.05.009; Tanti JF, 2009, CURR OPIN PHARMACOL, V9, P753, DOI 10.1016/j.coph.2009.07.004; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Walker JM, 2015, J ALZHEIMERS DIS, V44, P561, DOI 10.3233/JAD-140981; Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142; Yoshizaki T, 2009, MOL CELL BIOL, V29, P1363, DOI 10.1128/MCB.00705-08; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zhu D, 2015, J AGR FOOD CHEM, V63, P10903, DOI 10.1021/acs.jafc.5b04533; Zhu SM, 2011, MOL CELL BIOCHEM, V353, P305, DOI 10.1007/s11010-011-0799-0; Ziegler AN, 2015, NAT REV ENDOCRINOL, V11, P161, DOI 10.1038/nrendo.2014.208	67	81	82	4	72	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4998	5011		10.1096/fj.201700400RR	http://dx.doi.org/10.1096/fj.201700400RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28739640				2022-12-28	WOS:000413398500029
J	Preston, S; Korhonen, PK; Mouchiroud, L; Cornaglia, M; McGee, SL; Young, ND; Davis, RA; Crawford, S; Nowell, C; Ansell, BRE; Fisher, GM; Andrews, KT; Chang, BCH; Gijs, MAM; Sternberg, PW; Auwerx, J; Baell, J; Hofmann, A; Jabbar, A; Gasser, RB				Preston, Sarah; Korhonen, Pasi K.; Mouchiroud, Laurent; Cornaglia, Matteo; McGee, Sean L.; Young, Neil D.; Davis, Rohan A.; Crawford, Simon; Nowell, Cameron; Ansell, Brendan R. E.; Fisher, Gillian M.; Andrews, Katherine T.; Chang, Bill C. H.; Gijs, Martin A. M.; Sternberg, Paul W.; Auwerx, Johan; Baell, Jonathan; Hofmann, Andreas; Jabbar, Abdul; Gasser, Robin B.			Deguelin exerts potent nematocidal activity via the mitochondrial respiratory chain	FASEB JOURNAL			English	Article						natural product; anthelmintic activity; transcriptomics; oxidative phosphorylation; nematode	NATURAL-PRODUCTS; COMPLEX-I; CYSTEINE PROTEINASES; HAEMONCHUS-CONTORTUS; FUMARATE REDUCTASE; CATHEPSIN-L; INHIBITORS; NEMATODE; ELEGANS; PATHWAY	As a result of limited classes of anthelmintics and an over-reliance on chemical control, there is a great need to discover new compounds to combat drug resistance in parasitic nematodes. Here, we show that deguelin, a plant-derived rotenoid, selectively and potently inhibits the motility and development of nematodes, which supports its potential as a lead candidate for drug development. Furthermore, we demonstrate that deguelin treatment significantly increases gene transcription that is associated with energy metabolism, particularly oxidative phosphorylation and mitoribosomal protein production before inhibiting motility. Mitochondrial tracking confirmed enhanced oxidative phosphorylation. In accordance, real-time measurements of oxidative phosphorylation in response to deguelin treatment demonstrated an immediate decrease in oxygen consumption in both parasitic (Haemonchus contortus) and free-living (Caenorhabditis elegans) nematodes. Consequently, we hypothesize that deguelin is exerting its toxic effect on nematodes as a modulator of oxidative phosphorylation. This study highlights the dynamic biologic response of multicellular organisms to deguelin perturbation.-Preston, S., Korhonen, P. K., Mouchiroud, L., Cornaglia, M., McGee, S. L., Young, N. D., Davis, R. A., Crawford, S., Nowell, C., Ansell, B. R. E., Fisher, G. M., Andrews, K. T., Chang, B. C. H., Gijs, M. A. M., Sternberg, P. W., Auwerx, J., Baell, J., Hofmann, A., Jabbar, A., Gasser, R. B. Deguelin exerts potent nematocidal activity via the mitochondrial respiratory chain.	[Preston, Sarah; Korhonen, Pasi K.; Young, Neil D.; Ansell, Brendan R. E.; Chang, Bill C. H.; Hofmann, Andreas; Jabbar, Abdul; Gasser, Robin B.] Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic 3010, Australia; [Preston, Sarah] Federat Univ, Fac Sci & Technol, Ballarat, Vic, Australia; [Mouchiroud, Laurent; Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, Lausanne, Switzerland; [Cornaglia, Matteo; Gijs, Martin A. M.] Ecole Polytech Fed Lausanne, Lab Microsyst, Lausanne, Switzerland; [McGee, Sean L.] Deakin Univ, Sch Med, Fac Hlth, Metab Res Unit,Metab Reprogramming Lab, Waurn Ponds, Vic, Australia; [Davis, Rohan A.; Fisher, Gillian M.; Andrews, Katherine T.; Hofmann, Andreas] Griffith Univ, Griffith Inst Drug Discovery, Nathan, Qld, Australia; [Crawford, Simon] Univ Melbourne, Sch Biosci, Parkville, Vic, Australia; [Nowell, Cameron] Monash Univ, Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic, Australia; [Baell, Jonathan] Monash Univ, Inst Pharmaceut Sci, Med Chem, Parkville, Vic, Australia; [Chang, Bill C. H.] Yourgene Biosci, Taipei, Taiwan; [Sternberg, Paul W.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	University of Melbourne; Federation University Australia; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Deakin University; Griffith University; University of Melbourne; Monash University; Monash University; California Institute of Technology	Gasser, RB (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic 3010, Australia.	robinbg@unimelb.edu.au	Ansell, Brendan/O-4150-2014; Young, Neil David/AAU-4572-2020; Fisher, Gillian M/B-7539-2017; Auwerx, Johan/ABE-9307-2021; Gasser, Robin/ABH-6185-2020; Andrews, Katherine/F-9586-2011; Hofmann, Andreas/M-9870-2019; Davis, Rohan A/B-1689-2008; Jabbar, Abdul/F-8584-2013	Ansell, Brendan/0000-0003-0297-897X; Young, Neil David/0000-0001-8756-229X; Fisher, Gillian M/0000-0001-8560-3406; Gasser, Robin/0000-0002-4423-1690; Andrews, Katherine/0000-0002-1591-8979; Hofmann, Andreas/0000-0003-4408-5467; Davis, Rohan A/0000-0003-4291-7573; Jabbar, Abdul/0000-0001-8888-0046; Auwerx, Johan/0000-0002-5065-5393; Chang, Bill Chia-Han/0000-0001-5313-4852; Preston, Sarah/0000-0002-4227-1664; Korhonen, Pasi/0000-0002-9957-4674	Australian Research Council; National Health and Medical Research Council (NHMRC) of Australia; Medicines for Malaria Venture, Yourgene Bioscience, the University of Melbourne; Ecole Polytechnique Federale de Lausanne; Gebert Ruf Stiftung [GRS-025/16]; AgingX program of the Swiss Initiative for Systems Biology; EU Ideas Program [ERC-2012-AdG-320404]; Griffith University; NHMRC	Australian Research Council(Australian Research Council); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Medicines for Malaria Venture, Yourgene Bioscience, the University of Melbourne; Ecole Polytechnique Federale de Lausanne; Gebert Ruf Stiftung; AgingX program of the Swiss Initiative for Systems Biology; EU Ideas Program; Griffith University(Griffith University); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the Australian Research Council and the National Health and Medical Research Council (NHMRC) of Australia, as well as by the Medicines for Malaria Venture, Yourgene Bioscience, the University of Melbourne (to R.B.G. S.P., A.J., J.B., B.C.H.C., and A.H.), the Ecole Polytechnique Federale de Lausanne, and the Gebert Ruf Stiftung (GRS-025/16) and the AgingX program of the Swiss Initiative for Systems Biology (to J.A. and L.M.). Some work was supported by the EU Ideas Program (ERC-2012-AdG-320404; to M.A.M.G and M.C.). G.M.F. was supported by a postdoctoral fellowship and a new researcher grant from Griffith University. P.K.K. was supported by an early career research fellowship, and N.D.Y. by a career development fellowship (CDF1) from NHMRC. Funding bodies played no role in the design of the study or collection, analysis, or interpretation of data, or in the writing of the manuscript. The authors thank Compounds Australia (http://www.griffith.edu.au/science-aviation/compounds-australia) for access to the Davis open-access natural product library, which forms part of the Open Access Compound Collection. The authors declare no conflicts of interest.	Agrawal RK, 2012, CURR OPIN STRUC BIOL, V22, P797, DOI 10.1016/j.sbi.2012.08.003; Andreux PA, 2014, SCI REP-UK, V4, DOI 10.1038/srep05285; Andreux PA, 2013, NAT REV DRUG DISCOV, V12, P465, DOI 10.1038/nrd4023; Arulampalam V, 2011, EXP CELL RES, V317, P9, DOI 10.1016/j.yexcr.2010.10.002; ASHACK RJ, 1980, J MED CHEM, V23, P1022, DOI 10.1021/jm00183a011; Atanasov AG, 2015, BIOTECHNOL ADV, V33, P1582, DOI 10.1016/j.biotechadv.2015.08.001; Baell JB, 2016, J NAT PROD, V79, P616, DOI 10.1021/acs.jnatprod.5b00947; Barnes EC, 2016, NAT PROD REP, V33, P372, DOI 10.1039/c5np00121h; Barnes EC, 2010, TETRAHEDRON, V66, P283, DOI 10.1016/j.tet.2009.10.109; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boreddy SR, 2013, ONCOGENE, V32, P3980, DOI 10.1038/onc.2012.413; Bortul R, 2005, BRIT J HAEMATOL, V129, P677, DOI 10.1111/j.1365-2141.2005.05504.x; Cabizza M, 2004, J AGR FOOD CHEM, V52, P288, DOI 10.1021/jf034987a; Caboni P, 2004, CHEM RES TOXICOL, V17, P1540, DOI 10.1021/tx049867r; Cerniglia GJ, 2015, MOL CANCER THER, V14, P1928, DOI 10.1158/1535-7163.MCT-14-0888; Chang DJ, 2012, J MED CHEM, V55, P10863, DOI 10.1021/jm301488q; Chen CS, 2014, ONCOTARGET, V5, P693, DOI 10.18632/oncotarget.1328; Chen JM, 1998, FEBS LETT, V441, P361, DOI 10.1016/S0014-5793(98)01574-9; Cornaglia M, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0083-6; COX GN, 1981, J CELL BIOL, V90, P7, DOI 10.1083/jcb.90.1.7; Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008; Dalton JP, 1995, PARASITOLOGY, V111, P575, DOI 10.1017/S0031182000077052; Dalton JP, 1996, PARASITOL TODAY, V12, P125, DOI 10.1016/0169-4758(96)80676-4; Davis RA, 2005, J NAT PROD, V68, P769, DOI 10.1021/np050025h; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Eder J, 2014, NAT REV DRUG DISCOV, V13, P577, DOI 10.1038/nrd4336; Embeya VO, 2014, J ETHNOPHARMACOL, V153, P686, DOI 10.1016/j.jep.2014.03.027; Epe C, 2013, TRENDS PARASITOL, V29, P129, DOI 10.1016/j.pt.2013.01.001; Fang NB, 1998, P NATL ACAD SCI USA, V95, P3380, DOI 10.1073/pnas.95.7.3380; Farmer RL, 2013, CHEM SCI, V4, P3304, DOI 10.1039/c3sc50424g; Fisher GM, 2014, CHEM BIOL DRUG DES, V84, P462, DOI 10.1111/cbdd.12335; Frand AR, 2005, PLOS BIOL, V3, P1719, DOI 10.1371/journal.pbio.0030312; Fritz JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005117; Garcia J, 2012, BIOORGAN MED CHEM, V20, P672, DOI 10.1016/j.bmc.2011.09.064; Gerhauser C, 1997, CANCER RES, V57, P3429; Guiliano DB, 2004, MOL BIOCHEM PARASIT, V136, P227, DOI 10.1016/j.molbiopara.2004.03.015; Harder A, 2016, ADV PARASIT, V93, P69, DOI 10.1016/bs.apar.2016.02.010; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; HOLLINGWORTH RM, 1994, BIOCHEM SOC T, V22, P230, DOI 10.1042/bst0220230; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Jian Wenjie, 2009, International Journal of Agricultural and Biological Engineering, V2, P98, DOI 10.3965/j.issn.1934-6344.2009.04.098-103; Jovaisaite V, 2014, J EXP BIOL, V217, P137, DOI 10.1242/jeb.090738; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kim WY, 2008, CANCER PREV RES, V1, P577, DOI 10.1158/1940-6207.CAPR-08-0184; Kita K, 2003, CURR MED CHEM, V10, P2535, DOI 10.2174/0929867033456549; Kita K, 2002, ADV PARASIT, V51, P95, DOI 10.1016/S0065-308X(02)51004-6; Knox DP, 2007, PARASITE IMMUNOL, V29, P57, DOI 10.1111/j.1365-3024.2006.00913.x; Korhonen PK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10513; Lee HY, 2005, J NATL CANCER I, V97, P1695, DOI 10.1093/jnci/dji377; Lee HY, 2004, BIOCHEM PHARMACOL, V68, P1119, DOI 10.1016/j.bcp.2004.05.033; Lee SC, 2016, CANCER RES, V76, P686, DOI 10.1158/0008-5472.CAN-15-1492; Lee SC, 2015, MOL PHARMACOL, V88, P245, DOI 10.1124/mol.114.096883; Leon-Felix J, 2004, GENE, V335, P25, DOI 10.1016/j.gene.2004.03.002; Levrier C, 2013, PHYTOCHEMISTRY, V86, P121, DOI 10.1016/j.phytochem.2012.09.019; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu YP, 2016, HEAD NECK-J SCI SPEC, V38, pE524, DOI 10.1002/hed.24034; Lummen P, 1998, BBA-BIOENERGETICS, V1364, P287, DOI 10.1016/S0005-2728(98)00034-6; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Lustigmana S, 2004, MOL BIOCHEM PARASIT, V138, P165, DOI 10.1016/j.molbiopara.2004.08.003; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Matsumoto J, 2008, ANTIMICROB AGENTS CH, V52, P164, DOI 10.1128/AAC.00378-07; Mehta R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065113; Mouchiroud L., 2016, CURR PROTOC NEUROSCI, V77; Mount David W, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.top17; Murillo G, 2002, EUR J CANCER, V38, P2446, DOI 10.1016/S0959-8049(02)00192-2; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oliver EM, 2006, PARASITOLOGY, V133, P237, DOI 10.1017/S0031182006000229; Omura S, 2001, P NATL ACAD SCI USA, V98, P60, DOI 10.1073/pnas.011524698; Ondrovics M, 2016, ADV PARASIT, V91, P233, DOI 10.1016/bs.apar.2015.09.001; Page AP, 2007, WORMBOOK, P1, DOI DOI 10.1895/WORMBOOK.1.138.1; Paulus P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039265; Preston S, 2016, INT J PARASITOL-DRUG, V6, P329, DOI 10.1016/j.ijpddr.2016.07.004; Preston S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1612-4; Preston S, 2016, MOL CELL PROBE, V30, P13, DOI 10.1016/j.mcp.2015.08.005; Preston S, 2015, INT J PARASITOL, V45, P333, DOI 10.1016/j.ijpara.2015.01.007; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Rascon AA, 2013, CURR MED CHEM, V20, P3078; Redmond DL, 2006, PARASITE IMMUNOL, V28, P213, DOI 10.1111/j.1365-3024.2006.00823.x; Rhoads ML, 1998, J PARASITOL, V84, P686, DOI 10.2307/3284570; Rhoads ML, 2001, J PARASITOL, V87, P1144, DOI 10.1645/0022-3395(2001)087[1144:CCSBAS]2.0.CO;2; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sakai C, 2012, BBA-GEN SUBJECTS, V1820, P643, DOI 10.1016/j.bbagen.2011.12.013; Sankowsky N. A., 1936, Patent, Patent No. [US2058832, 2058832]; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Schwarz EM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r89; Shang HS, 2014, MOLECULES, V19, P16588, DOI 10.3390/molecules191016588; Shen B, 2015, CELL, V163, P1297, DOI 10.1016/j.cell.2015.11.031; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Skinner-Adams TS, 2016, DRUG DISCOV TODAY, V21, P725, DOI 10.1016/j.drudis.2016.01.002; Skuce PJ, 1999, PARASITOLOGY, V119, P405, DOI 10.1017/S0031182099004813; Sojka D, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-7; Suh YA, 2013, CANCER LETT, V332, P102, DOI 10.1016/j.canlet.2013.01.022; Thamilselvan V, 2011, INT J CANCER, V129, P2916, DOI 10.1002/ijc.25949; Tort J, 1999, ADV PARASIT, V43, P161, DOI 10.1016/S0065-308X(08)60243-2; Tsang WY, 2002, BIOCHEM BIOPH RES CO, V291, P8, DOI 10.1006/bbrc.2002.6394; Udeani GO, 1997, CANCER RES, V57, P3424; Udeani GO, 2001, CANCER CHEMOTH PHARM, V47, P263, DOI 10.1007/s002800000187; Vats S, 2014, PLANT CELL TISS ORG, V116, P403, DOI 10.1007/s11240-013-0409-9; Vrana JA, 2013, TOXICON, V74, P83, DOI 10.1016/j.toxicon.2013.07.028; Wu W, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.212; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	104	15	15	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4515	4532		10.1096/fj.201700288R	http://dx.doi.org/10.1096/fj.201700288R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28687609				2022-12-28	WOS:000413397400028
J	Li, FH; Liu, ZW; Tang, CY; Cai, J; Dong, Z				Li, Fanghua; Liu, Zhiwen; Tang, Chengyuan; Cai, Juan; Dong, Zheng			FGF21 is induced in cisplatin nephrotoxicity to protect against kidney tubular cell injury	FASEB JOURNAL			English	Article						acute kidney injury; apoptosis; P53	CHEMICALLY-INDUCED HEPATOCARCINOGENESIS; FIBROBLAST GROWTH FACTOR-21; SERUM-LEVELS; P53; APOPTOSIS; MICE; ACTIVATION; AKI; MECHANISMS; SIGNAL	Cisplatin, a widely used cancer therapy drug, induces nephrotoxicity or acute kidney injury (AKI), but the underlying mechanism remains unclear, and renal protective approaches are not available. Fibroblast growth factor (FGF)21 is an endocrine factor that regulates glucose uptake, metabolism, and energy expenditure. However, recent work has also implicated FGF21 in cellular stress response under pathogenic conditions. The role and regulation of FGF21 in AKI are unclear. Here, we show that FGF21 was dramatically induced during cisplatin treatment of renal tubular cells in vitro and mouse kidneys in vivo. The inductive response was suppressed by pifithrin (a pharmacological inhibitor of P53), suggesting a role of P53 in FGF21 induction. In cultured renal tubular cells, knockdown of FGF21 aggravated cisplatin-induced apoptosis, whereas supplementation of recombinant FGF21 was protective. Consistently, recombinant FGF21 alleviated cisplatin-induced kidney dysfunction, tissue damage, and tubular apoptosis in mice. Mechanistically, FGF21 suppressed P53 induction and activation during cisplatin treatment. Together, these results indicate that FGF21 is induced during cisplatin nephrotoxicity to protect renal tubules, and recombinant FGF21 may have therapeutic potential.	[Li, Fanghua; Liu, Zhiwen; Tang, Chengyuan; Cai, Juan; Dong, Zheng] Cent S Univ, Xiangya Hosp 2, Dept Nephrol, Changsha 410011, Hunan, Peoples R China; [Dong, Zheng] Augusta Univ, Med Coll Georgia, Dept Cellular Biol & Anat, 1459 Laney Walker Blvd, Augusta, GA 30912 USA; [Dong, Zheng] Charlie Norwood Vet Affairs Med Ctr, 1459 Laney Walker Blvd, Augusta, GA 30912 USA	Central South University; University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Tang, CY (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Nephrol, Changsha 410011, Hunan, Peoples R China.; Dong, Z (corresponding author), Augusta Univ, Med Coll Georgia, Dept Cellular Biol & Anat, 1459 Laney Walker Blvd, Augusta, GA 30912 USA.; Dong, Z (corresponding author), Charlie Norwood Vet Affairs Med Ctr, 1459 Laney Walker Blvd, Augusta, GA 30912 USA.	tangchengyuan@csu.edu.cn; zdong@augusta.edu			National Natural Science Foundation of China [81720108008, 81430017]; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [DK58831, DK87843]; U.S. Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058831, R01DK087843] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); U.S. Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Jinke Cheng (Shanghai Jiao Tong University School of Medicine, Shanghai, China) for providing the FGF21 shRNA plasmids. This work was supported by the National Natural Science Foundation of China (Grants 81720108008 and 81430017), by the U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (Grants DK58831, DK87843), and by the U.S. Department of Veterans Affairs. The authors declare no conflicts of interest.	Adams AC, 2012, CURR DIABETES REV, V8, P285, DOI 10.2174/157339912800840505; Agarwal A, 2016, J AM SOC NEPHROL, V27, P1288, DOI 10.1681/ASN.2015070740; Basile DP, 2016, J AM SOC NEPHROL, V27, P687, DOI 10.1681/ASN.2015030309; Bhatt K, 2010, MOL MED, V16, P409, DOI 10.2119/molmed.2010.00002; Chen JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep38868; Feingold KR, 2012, ENDOCRINOLOGY, V153, P2689, DOI 10.1210/en.2011-1496; Fisher FM, 2016, ANNU REV PHYSIOL, V78, P223, DOI 10.1146/annurev-physiol-021115-105339; Han SH, 2010, METABOLISM, V59, P1656, DOI 10.1016/j.metabol.2010.03.018; Hao JL, 2017, KIDNEY INT, V91, P106, DOI 10.1016/j.kint.2016.07.017; Hindricks J, 2014, CLIN ENDOCRINOL, V80, P918, DOI 10.1111/cen.12380; Huang XQ, 2006, MOL CARCINOGEN, V45, P934, DOI 10.1002/mc.20241; Jiang M, 2006, ONCOGENE, V25, P4056, DOI 10.1038/sj.onc.1209440; Jiang M, 2004, AM J PHYSIOL-RENAL, V287, pF1140, DOI 10.1152/ajprenal.00262.2004; Jiang M, 2008, J PHARMACOL EXP THER, V327, P300, DOI 10.1124/jpet.108.139162; Kim HW, 2013, ENDOCRINOLOGY, V154, P3366, DOI 10.1210/en.2012-2276; Laeger T, 2014, J CLIN INVEST, V124, P3913, DOI 10.1172/JCI74915; Lin ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018398; Linkermann A, 2014, J AM SOC NEPHROL, V25, P2689, DOI 10.1681/ASN.2014030262; Livingston MJ, 2016, AUTOPHAGY, V12, P976, DOI 10.1080/15548627.2016.1166317; Loeffler I, 2011, J AM SOC NEPHROL, V22, P649, DOI 10.1681/ASN.2010010098; Miller RP, 2010, TOXINS, V2, P2490, DOI 10.3390/toxins2112490; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; Pabla N, 2011, J CLIN INVEST, V121, P2709, DOI 10.1172/JCI45586; Planavila A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3019; Rusu CC, 2017, INT UROL NEPHROL, V49, P517, DOI 10.1007/s11255-016-1474-x; Seth R, 2005, J BIOL CHEM, V280, P31230, DOI 10.1074/jbc.M503305200; Sharp CN, 2016, AM J PHYSIOL-RENAL, V310, pF560, DOI 10.1152/ajprenal.00512.2015; Stein S, 2009, DIABETES CARE, V32, P126, DOI 10.2337/dc08-1054; Torres R, 2016, J AM SOC NEPHROL, V27, P1102, DOI 10.1681/ASN.2015010079; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wei QQ, 2007, AM J PHYSIOL-RENAL, V293, pF1282, DOI 10.1152/ajprenal.00230.2007; Wente W, 2006, DIABETES, V55, P2470, DOI 10.2337/db05-1435; Xu PF, 2015, DIGEST DIS SCI, V60, P3032, DOI 10.1007/s10620-015-3711-z; Yan MJ, 2016, TOXICOL APPL PHARM, V313, P104, DOI 10.1016/j.taap.2016.10.022; Yang CF, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-67; Ye DW, 2014, HEPATOLOGY, V60, P977, DOI 10.1002/hep.27060; Yu YH, 2015, MOL CELL BIOCHEM, V403, P287, DOI 10.1007/s11010-015-2358-6; Zhang C, 2015, DIABETOLOGIA, V58, P1937, DOI 10.1007/s00125-015-3630-8; Zhang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082275; Zhang DS, 2014, J AM SOC NEPHROL, V25, P2278, DOI 10.1681/ASN.2013080902	40	21	22	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3423	3433		10.1096/fj.201701316R	http://dx.doi.org/10.1096/fj.201701316R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401620	Green Published			2022-12-28	WOS:000432546000042
J	Li, Y; Cui, T; Kong, XD; Yi, XL; Kong, DX; Zhang, JN; Liu, CX; Gong, M				Li, Ying; Cui, Tao; Kong, Xiaodong; Yi, Xiulin; Kong, Dexin; Zhang, Jianning; Liu, Changxiao; Gong, Min			Nanoparticles induced by embedding self-assembling cassette into glucagon-like peptide 1 for improving in vivo stability	FASEB JOURNAL			English	Article						GLP-1; self-assembling peptide; type 2 diabetes mellitus; self-assembling GLP-1	AMINO-ACID-SEQUENCE; SIRNA DELIVERY; MECHANICAL-PROPERTIES; SYSTEMATIC VARIATION; OLIGOPEPTIDE MATRIX; CELL-PROLIFERATION; INSULIN-SECRETION; 7-36 AMIDE; GLP-1; PANCREAS	The multiple physiologic characteristics of glucagon-like peptide 1 (GLP-1) make it a promising drug candidate for treating type 2 diabetes mellitus. However, the half-life of GLP-1 is short as a result of degradation by dipeptidyl peptidase IV and renal clearance. Stabilizing GLP-1 is therefore critical for its use in drug development. Self-assembling peptides are a class of peptides that undergo spontaneous assembly into ordered nanostructures. Recently, studies of self-assembling peptides as drug carriers have increased because of their enhanced stability. In the present study, GLP-1 was modified to incorporate the structural characteristics of self-assembling peptides aiming to generate a self-assembling GLP-1 derivative. Receptor binding capacity and insulinotropic effects were measured to investigate the physiologic functions of GLP-1, along with morphologic approaches to observe supramolecular formation on self-assembly at the nano scale. Finally, blood glucose regulation and body weight were monitored after administration of selected derivatives. Our findings revealed that cadyglple and cadyglp1m both exhibited improved stability even though different nanoshapes were observed for these two self-assembling peptides. Both cadyglple and cadyglp1m retained glucoregulatory activity after insulin stimulation and were potent drug candidates for long-acting GLP-1 derivatives to treat type 2 diabetes mellitus. Our findings support the feasibility of introducing self-assembly functions into peptides with poor stabilities, such as GLP-1.	[Li, Ying; Kong, Xiaodong; Zhang, Jianning] Tianjin Med Univ Gen Hosp, Tianjin Neurol Inst, Tianjin, Peoples R China; [Cui, Tao; Liu, Changxiao] Tianjin Univ Tradit Chinese Med, Tianjin, Peoples R China; [Yi, Xiulin] Tianjin Inst Pharmaceut Res, State Key Lab Drug Delivery Technol & Pharmacokin, Tianjin, Peoples R China; [Kong, Dexin; Gong, Min] Tianjin Med Univ, Tianjin Key Lab Technol Enabling Dev Clin Therape, Tianjin, Peoples R China	Tianjin Medical University; Tianjin University of Traditional Chinese Medicine; Tianjin Medical University	Zhang, JN (corresponding author), Tianjin Med Univ Gen Hosp, Tianjin Neurol Inst, Tianjin, Peoples R China.; Gong, M (corresponding author), Tianjin Med Univ, Tianjin Inst Pharmaceut Res, 22 Qixiangtai Rd, Tianjin 300060, Peoples R China.	kahongmg@163.com; gongmin@tmu.edu.cn			National Science and Technology Major Project of the Ministry of Science and Technology of China [2014ZX09507005-003]; National Natural Science Funding [81400932, 81771221]; Major Project of Science and Technology of Tianjin [13RCGFSY19700]; Natural Science Foundation of Tianjin [12JCYBJC31500]; Science and Technology of Tianjin [15JCBJC50500]	National Science and Technology Major Project of the Ministry of Science and Technology of China; National Natural Science Funding(National Natural Science Foundation of China (NSFC)); Major Project of Science and Technology of Tianjin; Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin); Science and Technology of Tianjin	The authors thank Newman Gong (Tianjun Medical University) for his kind support in the data storage. This study was supported by the National Science and Technology Major Project of the Ministry of Science and Technology of China (2014ZX09507005-003), the National Natural Science Funding (81400932 and 81771221), the Major Project of Science and Technology of Tianjin (13RCGFSY19700), the Natural Science Foundation of Tianjin (12JCYBJC31500), and Science and Technology of Tianjin (15JCBJC50500). The authors declare no conflicts of interest.	ADELHORST K, 1994, J BIOL CHEM, V269, P6275; Al-Sabah S, 2003, BRIT J PHARMACOL, V140, P339, DOI 10.1038/sj.bjp.0705453; Brubaker PL, 2004, ENDOCRINOLOGY, V145, P2653, DOI 10.1210/en.2004-0015; Caplan MR, 2002, J BIOMAT SCI-POLYM E, V13, P225, DOI 10.1163/156856202320176493; Caplan MR, 2002, BIOMATERIALS, V23, P219, DOI 10.1016/S0142-9612(01)00099-0; Crombez L, 2011, METHODS MOL BIOL, V683, P349, DOI [10.1007/978-1-60751-919-2_25, 10.1007/978-1-60761-919-2_25]; Crombez L, 2009, MOL THER, V17, P95, DOI 10.1038/mt.2008.215; Davidson Jaime A, 2009, Cleve Clin J Med, V76 Suppl 5, pS28, DOI 10.3949/ccjm.76.s5.05; Deshayes S, 2012, SMALL, V8, P2184, DOI 10.1002/smll.201102413; Dhadwar SS, 2003, BIOTECHNOL ADV, V21, P395, DOI 10.1016/S0734-9750(03)00056-9; Drucker DJ, 2003, MOL ENDOCRINOL, V17, P161, DOI 10.1210/me.2002-0306; Fernandez-Carneado J, 2004, BIOPOLYMERS, V76, P196, DOI 10.1002/bip.10585; Galdiero M, 2012, CURR DRUG METAB, V13, P2, DOI 10.2174/138920012798356925; GALLWITZ B, 1994, EUR J BIOCHEM, V225, P1151, DOI 10.1111/j.1432-1033.1994.1151b.x; Graziano MP, 1996, RECEPTOR CHANNEL, V4, P9; Hui HX, 2005, DIABETES-METAB RES, V21, P313, DOI 10.1002/dmrr.553; KIEFFER TJ, 1995, ENDOCRINOLOGY, V136, P3585, DOI 10.1210/en.136.8.3585; KREYMANN B, 1987, LANCET, V2, P1300; Kurzawa L, 2010, BBA-BIOMEMBRANES, V1798, P2274, DOI 10.1016/j.bbamem.2010.02.027; Leon EJ, 1998, J BIOMAT SCI-POLYM E, V9, P297, DOI 10.1163/156856298X00668; Li Y, 2012, INT J PHARMACEUT, V434, P209, DOI 10.1016/j.ijpharm.2012.06.003; Liang J, 2014, COLLOID SURFACE B, V114, P398, DOI 10.1016/j.colsurfb.2013.10.037; Lugari R, 2000, HORM METAB RES, V32, P424, DOI 10.1055/s-2007-978665; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Nauck MA, 1997, EXP CLIN ENDOCR DIAB, V105, P187, DOI 10.1055/s-0029-1211750; OHNEDA A, 1991, TOHOKU J EXP MED, V165, P209, DOI 10.1620/tjem.165.209; Okerson T, 2012, CARDIOVASC THER, V30, pe146, DOI 10.1111/j.1755-5922.2010.00256.x; Parhofer Klaus G, 2007, MMW Fortschr Med, V149, P41; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; RUIZGRANDE C, 1990, CAN J PHYSIOL PHARM, V68, P1568, DOI 10.1139/y90-239; Runge S, 2003, BRIT J PHARMACOL, V138, P787, DOI 10.1038/sj.bjp.0705120; Schneider JP, 2002, J AM CHEM SOC, V124, P15030, DOI 10.1021/ja027993g; SHIMA K, 1988, REGUL PEPTIDES, V22, P245, DOI 10.1016/0167-0115(88)90037-7; Sloop KW, 2010, DIABETES, V59, P3099, DOI 10.2337/db10-0689; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Villanueva-Penacarrillo ML, 2001, ENDOCRINE, V15, P241, DOI 10.1385/ENDO:15:2:241; Wassenaar TA, 2014, J CHEM THEORY COMPUT, V10, P676, DOI 10.1021/ct400617g; WEIR GC, 1989, DIABETES, V38, P338, DOI 10.2337/diabetes.38.3.338; YAMATO E, 1990, BIOCHEM BIOPH RES CO, V167, P431, DOI 10.1016/0006-291X(90)92041-W; Yang X, 2014, MOL PHARMACEUT, V11, P4092, DOI 10.1021/mp5002685; Zhang SG, 1997, P NATL ACAD SCI USA, V94, P23, DOI 10.1073/pnas.94.1.23	41	9	10	5	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					2992	3004		10.1096/fj.201701033RRR	http://dx.doi.org/10.1096/fj.201701033RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401602				2022-12-28	WOS:000432546000009
J	Yang, YX; Qi, Q; Wang, Y; Shi, YR; Yang, WL; Cen, YZ; Zhu, ED; Li, XX; Chen, D; Wang, BL				Yang, Yongxu; Qi, Qi; Wang, Yi; Shi, Yaru; Yang, Weili; Cen, Yunzhu; Zhu, Endong; Li, Xiaoxia; Chen, Di; Wang, Baoli			Cysteine-rich protein 61 regulates adipocyte differentiation from mesenchymal stem cells through mammalian target of rapamycin complex 1 and canonical Wnt signaling	FASEB JOURNAL			English	Article						adipogenesis; Wnt/beta-catenin; ribosomal protein S6	IMMEDIATE-EARLY GENE; ADIPOGENIC DIFFERENTIATION; OSTEOBLAST DIFFERENTIATION; WNT/BETA-CATENIN; ADIPOSE-TISSUE; CCN FAMILY; IN-VITRO; EXPRESSION; CYR61; GROWTH	Emerging evidence suggests that cysteine-rich protein 61 (CYR61) plays a role in the differentiation and development of chondrocytes, osteoblasts, and osteoclasts; however, little is known about its role in adipogenesis. The current study indicates that the expression level of Cyr61 was altered in primary cultured marrow stromal cells and the established mesenchymal cell line, C3H10T1/2, after adipogenic treatment. Overexpressing Cyr61 repressed C3H10T1/2 and primary marrow stromal cells to differentiate into mature adipocytes. Conversely, inhibition of endogenous Cyr61 induced C3H10T1/2 and primary marrow stromal cells to fully differentiate. Mechanism investigations reveal that knockdown of Cyr61 inhibited the nuclear translocation of beta-catenin and decreased nuclear protein levels of beta-catenin and transcription factor 7-like 2. Moreover, the silencing of Cyr61 increased protein levels of phosphorylated ribosomal protein S6 kinase B1, mammalian target of rapamycin, eukaryotic translation initiation factor 4E-binding protein 1, and ribosomal protein S6-the major components of mammalian target of rapamycin complex 1 (mTORC1) signaling-in C3H10T1/2 cells. Additional investigations demonstrated that treatment with rapamycin significantly attenuated adipocyte formation that was induced by Cyr61 small interfering RNA (siRNA) transfection. Moreover, Cyr61 siRNA also lost its ability to stimulate adipocyte formation under the background of beta-catenin overexpression. Taken together, our study provides evidence that CYR61 regulates adipocyte differentiation via multiple signaling pathways that involve at least the inactivation of mTORC1 signaling and the activation of canonical Wnt signaling.				blwang@tmu.edu.cn			Natural Science Foundation of China [81672116, 81472040, 81772297, 81501846]; Tianjin Municipal Natural Science Foundation [14JCZDJC33700]; Science and Technology Development Fund of the Tianjin Education Commission for Higher Education [2017KJ213]; Key Laboratory of Hormones and Development, Ministry of Health [2015DX03]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Natural Science Foundation(Natural Science Foundation of Tianjin); Science and Technology Development Fund of the Tianjin Education Commission for Higher Education; Key Laboratory of Hormones and Development, Ministry of Health	This work was supported by the Natural Science Foundation of China Grants 81672116 and 81472040 (to B.W.), Grant 81772297 (to X.L.), and Grant 81501846 (to E.Z.). This work was also supported, in part, by Grant 14JCZDJC33700 from the Tianjin Municipal Natural Science Foundation, Grant 2017KJ213 from the Science and Technology Development Fund of the Tianjin Education Commission for Higher Education, and Grant 2015DX03 from the Key Laboratory of Hormones and Development, Ministry of Health. The authors declare no conflicts of interest.	Carnevalli LS, 2010, DEV CELL, V18, P763, DOI 10.1016/j.devcel.2010.02.018; Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Chang GR, 2009, BASIC CLIN PHARMACOL, V105, P188, DOI 10.1111/j.1742-7843.2009.00427.x; Chang GR, 2009, J PHARMACOL SCI, V109, P496, DOI 10.1254/jphs.08215FP; Croci S, 2004, CANCER RES, V64, P1730, DOI 10.1158/0008-5472.CAN-3502-02; Crockett JC, 2007, ENDOCRINOLOGY, V148, P5761, DOI 10.1210/en.2007-0473; French DM, 2004, AM J PATHOL, V165, P855, DOI 10.1016/S0002-9440(10)63348-2; Fujishita T, 2008, P NATL ACAD SCI USA, V105, P13544, DOI 10.1073/pnas.0800041105; Gagnon A, 2001, J CELL PHYSIOL, V189, P14, DOI 10.1002/jcp.1132; Ge CX, 2016, J CELL PHYSIOL, V231, P587, DOI 10.1002/jcp.25102; Grafe I., 2017, COLD SPRING HARB PER; Han Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep35655; Hirasaki S, 2001, HEPATOL RES, V19, P294, DOI 10.1016/S1386-6346(00)00101-7; Houde VP, 2010, DIABETES, V59, P1338, DOI 10.2337/db09-1324; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Kim JE, 2004, DIABETES, V53, P2748, DOI 10.2337/diabetes.53.11.2748; Kireeva ML, 1996, MOL CELL BIOL, V16, P1326; Laudes M, 2011, J MOL ENDOCRINOL, V46, pR65, DOI 10.1530/JME-10-0169; Lechner A, 2000, BONE, V27, P53, DOI 10.1016/S8756-3282(00)00294-5; Leng E, 2002, J BIOMED SCI, V9, P59, DOI 10.1007/BF02256579; Li J, 2015, INT J MOL MED, V36, P1451, DOI 10.3892/ijmm.2015.2390; Li ZY, 2012, COMPUT ENG APPL, V2012, P1, DOI DOI 10.1371/J0URNAL.P0NE.0040132; Liu H, 2017, INT J ONCOL, V50, P631, DOI 10.3892/ijo.2016.3815; Liu WZ, 2012, J BIOL CHEM, V287, P7213, DOI 10.1074/jbc.M111.286724; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu WY, 2014, J CELL BIOCHEM, V115, P1799, DOI 10.1002/jcb.24850; Luo LP, 2016, J ENDOCRINOL, V231, pR77, DOI 10.1530/JOE-16-0211; Malik AR, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00237; Matsushita K, 2017, LAB INVEST, V97, P1158, DOI 10.1038/labinvest.2017.42; Menendez JA, 2003, ENDOCR-RELAT CANCER, V10, P141, DOI 10.1677/erc.0.0100141; Moseti D, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010124; Okamura M, 2009, P NATL ACAD SCI USA, V106, P5819, DOI 10.1073/pnas.0901676106; Owen JL, 2012, P NATL ACAD SCI USA, V109, P16184, DOI 10.1073/pnas.1213343109; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Rendina-Ruedy E, 2017, ENDOCRIN METAB CLIN, V46, P41, DOI 10.1016/j.ecl.2016.09.004; Ricoult SJH, 2013, EMBO REP, V14, P242, DOI 10.1038/embor.2013.5; Schutze N, 2005, PROTEIN EXPRES PURIF, V42, P219, DOI 10.1016/j.pep.2005.03.031; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; Sisakhtnezhad S, 2017, EUR J CELL BIOL, V96, P13, DOI 10.1016/j.ejcb.2016.11.003; Song HI, 2016, SCI REP-UK, V6, DOI 10.1038/srep36968; Su JL, 2010, J BIOL CHEM, V285, P31325, DOI 10.1074/jbc.M109.087122; Wang J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.356; Wong M, 1997, DEV BIOL, V192, P492, DOI 10.1006/dbio.1997.8766; Zhang HH, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006189, 10.1371/journal.pone.0007826]; Zhang YC, 2016, J BONE MINER RES, V31, P549, DOI 10.1002/jbmr.2712; Zhang YY, 2012, MOL ENDOCRINOL, V26, P798, DOI 10.1210/me.2011-1287	46	11	11	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3096	3107		10.1096/fj.201700830RR	http://dx.doi.org/10.1096/fj.201700830RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401606				2022-12-28	WOS:000432546000017
J	Johnson, AM; Roach, JP; Hu, A; Stamatovic, SM; Zochowski, MR; Keep, RF; Andjelkovic, AV				Johnson, Allison M.; Roach, James P.; Hu, Anna; Stamatovic, Svetlana M.; Zochowski, Michal R.; Keep, Richard F.; Andjelkovic, Anuska V.			Connexin 43 gap junctions contribute to brain endothelial barrier hyperpermeability in familial cerebral cavernous malformations type III by modulating tight junction structure	FASEB JOURNAL			English	Article						permeability; PDCD10; cell-cell interaction; zonula occludens-1	ZONULA OCCLUDENS-1; INTERCELLULAR COMMUNICATION; 2-HIT MECHANISM; BINDING DOMAIN; PERMEABILITY; PHOSPHORYLATION; INTEGRITY; CCM3; IDENTIFICATION; CALMODULIN	Familial cerebral cavernous malformations type III (fCCM3) is a disease of the cerebrovascular system caused by loss-of-function mutations in ccm3 that result in dilated capillary beds that are susceptible to hemorrhage. Before hemorrhage, fCCM3 lesions are characterized by a hyperpermeable blood-brain barrier (BBB), the key pathologic feature of fCCM3. We demonstrate that connexin 43 (Cx43), a gap junction (GJ) protein that is incorporated into the BBB junction complex, is up-regulated in lesions of a murine model of fCCM3. Small interfering RNA-mediated ccm3 knockdown (CCM3KD) in brain endothelial cells in vitro increased Cx43 protein expression, GJ plaque size, GJ intracellular communication (GJIC), and barrier permeability. CCM3KD hyperpermeability was rescued by GAP27, a peptide gap junction and hemichannel inhibitor of Cx43 GJIC. Tight junction (TJ) protein, zonula occludens 1 (ZO-1), accumulated at Cx43 GJs in CCM3KD cells and displayed fragmented staining at TJs. The GAP27-mediated inhibition of Cx43 GJs in CCM3KD cells restored ZO-1 to TJ structures and reduced plaque accumulation at Cx43 GJs. The TJ protein, Claudin-5, was also fragmented at TJs in CCM3KD cells, and GAP27 treatment lengthened TJ-associated fragments and increased Claudin 5-Claudin 5 transinteraction. Overall, we demonstrate that Cx43 GJs are aberrantly increased in fCCM3 and regulate barrier permeability by a TJ-dependent mechanism.	[Johnson, Allison M.; Hu, Anna; Stamatovic, Svetlana M.; Andjelkovic, Anuska V.] Univ Michigan, Med Sch, Dept Pathol, 7520A MSRB 1,1150 Med Ctr Dr, Ann Arbor, MI 48109 USA; [Keep, Richard F.; Andjelkovic, Anuska V.] Univ Michigan, Med Sch, Dept Neurosurg, Ann Arbor, MI 48109 USA; [Roach, James P.] Univ Michigan, Med Sch, Neurosci Grad Program, Ann Arbor, MI 48109 USA; [Keep, Richard F.] Univ Michigan, Med Sch, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Zochowski, Michal R.] Univ Michigan, Dept Phys & Biophys, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Andjelkovic, AV (corresponding author), Univ Michigan, Med Sch, Dept Pathol, 7520A MSRB 1,1150 Med Ctr Dr, Ann Arbor, MI 48109 USA.	anuskaa@med.umich.edu		Zochowski, Michal/0000-0002-1722-986X	Public Health Service Grant from the National Institute of Neurological Disorders [R21NS-098066]; Comprehensive Cancer Center U.S. National Institutes of Health (NIH) [P30-CA046592]; National Science Foundation MRI-R2-ID award [DBI-0959823]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS098066] Funding Source: NIH RePORTER	Public Health Service Grant from the National Institute of Neurological Disorders; Comprehensive Cancer Center U.S. National Institutes of Health (NIH); National Science Foundation MRI-R2-ID award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Public Health Service Grant R21NS-098066 from the National Institute of Neurological Disorders (to A.V.A.). The authors thank the Department of Radiology at The University of Michigan for the use of The Center for Molecular Imaging and the Tumor Imaging Core, which are supported, in part, by Comprehensive Cancer Center U.S. National Institutes of Health (NIH) Grant P30-CA046592. The authors also thank the Single Molecule Analysis in Real-Time Center of the University of Michigan, seeded by National Science Foundation MRI-R2-ID award DBI-0959823 to Nils G. Walter, as well as J. Damon Hoff for training, technical advice, and the use of the Olympus STORM-capable microscope. Histology slide scanning was performed at the Department of Pathology Core Flow Cytometry Laboratory and Slide Scanning Services. The authors declare no conflicts of interest.	Aasen T, 2015, CELL TISSUE RES, V360, P685, DOI 10.1007/s00441-014-2078-3; Akers AL, 2009, HUM MOL GENET, V18, P919, DOI 10.1093/hmg/ddn430; BRUZZONE R, 1993, MOL BIOL CELL, V4, P7, DOI 10.1091/mbc.4.1.7; Chaytor AT, 1998, J PHYSIOL-LONDON, V508, P561, DOI 10.1111/j.1469-7793.1998.561bq.x; Clatterbuck RE, 2001, J NEUROL NEUROSUR PS, V71, P188, DOI 10.1136/jnnp.71.2.188; De Bock M, 2011, J CEREBR BLOOD F MET, V31, P1942, DOI 10.1038/jcbfm.2011.86; Dimitrijevic OB, 2006, J CEREBR BLOOD F MET, V26, P797, DOI 10.1038/sj.jcbfm.9600229; Fanning AS, 2009, ANN NY ACAD SCI, V1165, P113, DOI 10.1111/j.1749-6632.2009.04440.x; Gabriels JE, 1998, CIRC RES, V83, P636, DOI 10.1161/01.RES.83.6.636; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; He Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000722; Hilder TL, 2007, J PROTEOME RES, V6, P4343, DOI 10.1021/pr0704276; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Hwang JY, 2014, INT J BIOCHEM CELL B, V47, P118, DOI 10.1016/j.biocel.2013.11.021; Jin CS, 2004, CELL COMMUN ADHES, V11, P67, DOI 10.1080/15419060490951781; Kandasamy K, 2015, AM J PHYSIOL-LUNG C, V309, pL584, DOI 10.1152/ajplung.00211.2014; Kazakoff PW, 1995, IN VITRO CELL DEV-AN, V31, P846; Krause G, 2008, BBA-BIOMEMBRANES, V1778, P631, DOI 10.1016/j.bbamem.2007.10.018; Leithe E, 2018, BBA-BIOMEMBRANES, V1860, P48, DOI 10.1016/j.bbamem.2017.05.008; Lin JHC, 1998, NAT NEUROSCI, V1, P494, DOI 10.1038/2210; Louvi A, 2011, P NATL ACAD SCI USA, V108, P3737, DOI 10.1073/pnas.1012617108; Martinez AD, 2002, CIRC RES, V90, P1100, DOI 10.1161/01.RES.0000019580.64013.31; McDonald DA, 2011, HUM MOL GENET, V20, P211, DOI 10.1093/hmg/ddq433; Mikati AG, 2015, J CEREBR BLOOD F MET, V35, P1632, DOI 10.1038/jcbfm.2015.98; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; O'Donnell JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100931; Olk S, 2009, CELL MOTIL CYTOSKEL, V66, P1000, DOI 10.1002/cm.20404; Pagenstecher A, 2009, HUM MOL GENET, V18, P911, DOI 10.1093/hmg/ddn420; Rhett JM, 2011, MOL BIOL CELL, V22, P1516, DOI 10.1091/mbc.E10-06-0548; Riquelme MA, 2015, J BIOL CHEM, V290, P28321, DOI 10.1074/jbc.M115.683417; Ruch RJ, 2001, J CELL BIOCHEM, V83, P163, DOI 10.1002/jcb.1227; Segretain D, 2004, BIOCHIMIE, V86, P241, DOI 10.1016/j.biochi.2004.05.003; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Stamatovic SM, 2015, ACTA NEUROPATHOL, V130, P731, DOI 10.1007/s00401-015-1479-z; Stockton RA, 2010, J EXP MED, V207, P881, DOI 10.1084/jem.20091258; Tanriover G, 2013, CLIN NEUROL NEUROSUR, V115, P438, DOI 10.1016/j.clineuro.2012.06.023; Tu J, 2005, J NEUROSURG, V103, P903, DOI 10.3171/jns.2005.103.5.0903; Vitale ML, 2009, MICROSC RES TECHNIQ, V72, P856, DOI 10.1002/jemt.20771; Wang N, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0309-x; Wu JJ, 2013, J CELL PHYSIOL, V228, P903, DOI 10.1002/jcp.24241; Zhang J, 2015, AM J PHYSIOL-LUNG C, V309, pL1323, DOI 10.1152/ajplung.00016.2015; Zhou YB, 2007, J BIOL CHEM, V282, P35005, DOI 10.1074/jbc.M707728200; Zou J, 2014, FEBS LETT, V588, P1430, DOI 10.1016/j.febslet.2014.01.003	44	39	42	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2615	2629		10.1096/fj.201700699R	http://dx.doi.org/10.1096/fj.201700699R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29295866	Green Published, Green Submitted			2022-12-28	WOS:000432528000025
J	Olivares-Gonzalez, L; de la Camara, CMF; Hervas, D; Millan, JM; Rodrigo, R				Olivares-Gonzalez, Lorena; Martinez-Fernandez de la Camara, Cristina; Hervas, David; Maria Millan, Jose; Rodrigo, Regina			HIF-1 alpha stabilization reduces retinal degeneration in a mouse model of retinitis pigmentosa	FASEB JOURNAL			English	Article						hyperoxia; DMOG; oxidative damage; inflammation; reactive gliosis	HYPOXIA-INDUCIBLE FACTOR-1; VESSEL OXYGEN-SATURATION; PHOTORECEPTOR CELL-DEATH; PROLYL HYDROXYLASE INHIBITION; OXIDATIVE STRESS; BRAIN-INJURY; EXPRESSION; CULTURES; MULLER; HIF-1	Retinitis pigmentosa (RP) is a group of inherited retinal dystrophies characterized by progressive and irreversible loss of vision due to rod and cone degeneration. Evidence suggests that an inappropriate oxygen level could contribute to its pathogenesis. Rod cell death could increase oxygen concentration, reduce hypoxia-inducible factor 1 (HIF-1 alpha) and contribute to cone cell death. The purposes of this study were: 1) to analyze the temporal profile of HIF-1 alpha, its downstream effectors VEGF, endothelin-1 (ET-1), iNOS, and glucose transporter 1 (GLUT1), and neuroinflammation in retinas of the murine model of rd10 (retinal degeneration 10) mice with RP; 2) to study oxygen bioavailability in these retinas; and 3) to investigate how stabilizing HIF-1 alpha proteins with dimethyloxaloglycine (DMOG), a prolyl hydroxylase inhibitor, affects retinal degeneration, neuroinflammation, and antioxidant response in rd10 mice. A generalized down-regulation of HIF-la and its downstream targets was detected in parallel with reactive gliosis, suggesting high oxygen levels during retinal degeneration. At postnatal d 18, DMOG treatment reduced photoreceptor cell death and glial activation. In summary, retinas of rd10 mice seem to be exposed to a hyperoxic environment even at early stages of degeneration. HIF-1 alpha stabilization could have a temporal neuroprotective effect on photoreceptor cell survival, glial activation, and antioxidant response at early stages of RP.	[Olivares-Gonzalez, Lorena; Martinez-Fernandez de la Camara, Cristina; Maria Millan, Jose; Rodrigo, Regina] Inst Invest Sanitaria La Fe, Grp Invest Biomed Mol Celular & Genom, Valencia, Spain; [Hervas, David] Inst Invest Sanitaria La Fe, Unidad Data Sci Bioestadist & Bioinform, Valencia, Spain; [Olivares-Gonzalez, Lorena; Maria Millan, Jose; Rodrigo, Regina] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain; [Maria Millan, Jose] Hosp Univ & Politecn La Fe, Unidad Genet, Valencia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitari i Politecnic La Fe	Rodrigo, R (corresponding author), Hlth Res Inst Hosp La Fe, Res Grp Mol Cellular & Genom Biomed, Ave Fernando Abril Martorell 106, Valencia 46026, Spain.	regina.rodrigo@iislafe.es	Hervas, David/L-1322-2016; Olivares-González, Lorena/ABG-8737-2020; Martinez, Cristina/ABH-7295-2020; Rodrigo, Regina/I-1868-2015	Hervas, David/0000-0003-0635-4961; Olivares-González, Lorena/0000-0001-8180-1229; Martinez, Cristina/0000-0002-6612-6162; Rodrigo, Regina/0000-0001-5875-986X	European Regional Development Fund; Spanish Ministry of Economy, Industry, and Competitiveness (MINECO) Carlos III Health Institute (ISCIII) [PI12/0481, PI15/0052]; ISCIII CIBERER [CB06/07/1030]; ISCIII Spanish National Health System (SNS) Miguel Servet-Type II research contract [CP15/00019]	European Regional Development Fund(European Commission); Spanish Ministry of Economy, Industry, and Competitiveness (MINECO) Carlos III Health Institute (ISCIII); ISCIII CIBERER; ISCIII Spanish National Health System (SNS) Miguel Servet-Type II research contract	The authors thank the Central Unit for Research in Medicine (UCIM; Valencia University, Valencia, Spain), and its staff for providing animal facilities; Dr. Pilar Marin (Microscopy Unit, IIS-La Fe, Valencia, Spain) for her kind help; and Dr. Rafael Vazquez (Grupo de Biomedicina Molecular, Celular y Genomica, IIS-La Fe) for his advice. This work was supported by the European Regional Development Fund; Spanish Ministry of Economy, Industry, and Competitiveness (MINECO) Carlos III Health Institute (ISCIII) Grants PI12/0481 and PI15/0052; ISCIII CIBERER research contract CB06/07/1030 (L.O.-G.); and ISCIII Spanish National Health System (SNS) Miguel Servet-Type II research contract CP15/00019 (R.R.). The authors declare no conflicts of interest.	Arjamaa O, 2006, EXP EYE RES, V83, P473, DOI 10.1016/j.exer.2006.01.016; Ashok BS, 2017, CLIN EXP PHARMACOL P, V44, P327, DOI 10.1111/1440-1681.12717; BIGNAMI A, 1979, EXP EYE RES, V28, P63; Bramall AN, 2010, ANNU REV NEUROSCI, V33, P441, DOI 10.1146/annurev-neuro-060909-153227; Campochiaro PA, 2015, ANTIOXID REDOX SIGN, V23, P643, DOI 10.1089/ars.2015.6327; Cellini M, 1997, J FR OPHTALMOL, V20, P659; Chen WQ, 2008, NEUROBIOL DIS, V31, P433, DOI 10.1016/j.nbd.2008.05.020; Cheng L, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00020; Choudhury S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.34; Correia SC, 2010, J NEUROCHEM, V112, P1, DOI 10.1111/j.1471-4159.2009.06443.x; Daiger S. P., 2013, RETINAL INFORM NETWO; DELAPAZ MA, 1992, INVEST OPHTH VIS SCI, V33, P2091; Eysteinsson T, 2014, ACTA OPHTHALMOL, V92, P449, DOI 10.1111/aos.12359; GLICKMAN RD, 1992, PHOTOCHEM PHOTOBIOL, V55, P191, DOI 10.1111/j.1751-1097.1992.tb04227.x; Gupta N, 2003, EXP EYE RES, V76, P463, DOI 10.1016/S0014-4835(02)00332-9; Harten SK, 2010, ANTIOXID REDOX SIGN, V12, P459, DOI 10.1089/ars.2009.2870; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hoppe G, 2016, P NATL ACAD SCI USA, V113, pE2516, DOI 10.1073/pnas.1523005113; Hoppe G, 2014, AM J PATHOL, V184, P1890, DOI 10.1016/j.ajpath.2014.02.017; Hughes EH, 2004, EXP EYE RES, V78, P1077, DOI 10.1016/j.exer.2004.02.002; Hughes JM, 2010, J HISTOCHEM CYTOCHEM, V58, P247, DOI 10.1369/jhc.2009.953786; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyalomhe O, 2017, CELL MOL NEUROBIOL, V37, P969, DOI 10.1007/s10571-016-0440-6; Jeong JK, 2013, PHYTOTHER RES, V27, P1185, DOI 10.1002/ptr.4842; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Khan M, 2017, NEURAL REGEN RES, V12, P696, DOI 10.4103/1673-5374.206632; Komeima K, 2007, J CELL PHYSIOL, V213, P809, DOI 10.1002/jcp.21152; Komeima K, 2006, P NATL ACAD SCI USA, V103, P11300, DOI 10.1073/pnas.0604056103; Lee SY, 2011, J CELL PHYSIOL, V226, P1843, DOI 10.1002/jcp.22508; Linsenmeier RA, 2000, INVEST OPHTH VIS SCI, V41, P3117; Lupien C, 2004, EXP EYE RES, V79, P423, DOI 10.1016/j.exer.2004.05.008; Ma CY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050677; Ma YL, 2012, INVEST OPHTH VIS SCI, V53, P4306, DOI 10.1167/iovs.11-8596; de la Camara CMF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11764; de la Camara CMF, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0172-9; de la Camara CMF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074223; de la Camara CMF, 2013, EXP EYE RES, V111, P122, DOI 10.1016/j.exer.2013.03.015; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; MERIN S, 1976, Survey of Ophthalmology, V20, P303, DOI 10.1016/S0039-6257(96)90001-6; Moravej FG, 2016, CELL BIOL INT, V40, P619, DOI 10.1002/cbin.10605; Ogle ME, 2012, NEUROBIOL DIS, V45, P733, DOI 10.1016/j.nbd.2011.10.020; Oveson BC, 2011, J NEUROCHEM, V116, P144, DOI 10.1111/j.1471-4159.2010.07092.x; Padnick-Silver L, 2006, INVEST OPHTH VIS SCI, V47, P3683, DOI 10.1167/iovs.05-1284; Peng B, 2014, J NEUROSCI, V34, P8139, DOI 10.1523/JNEUROSCI.5200-13.2014; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Ren H, 2011, INVEST OPHTH VIS SCI, V52, P3112, DOI 10.1167/iovs.10-5605; Rivas MA, 2009, HISTOL HISTOPATHOL, V24, P1295, DOI 10.14670/HH-24.1295; Ryou MG, 2012, STROKE, V43, P1101, DOI 10.1161/STROKEAHA.111.620088; Ryou MG, 2009, AM J PHYSIOL-HEART C, V297, pH1914, DOI 10.1152/ajpheart.01213.2008; Sears JE, 2008, P NATL ACAD SCI USA, V105, P19898, DOI 10.1073/pnas.0805817105; Semenza GL, 2004, PHYSIOLOGY, V19, P176, DOI 10.1152/physiol.00001.2004; Sen T, 2016, NEUROPHARMACOLOGY, V107, P79, DOI 10.1016/j.neuropharm.2016.03.009; Shen JK, 2005, J CELL PHYSIOL, V203, P457, DOI 10.1002/jcp.20346; Stone J, 1999, PROG RETIN EYE RES, V18, P689, DOI 10.1016/S1350-9462(98)00032-9; Todorova MG, 2016, ACTA OPHTHALMOL, V94, pE231, DOI 10.1111/aos.12846; Trichonas G, 2013, INVEST OPHTH VIS SCI, V54, P4919, DOI 10.1167/iovs.13-12171; Turksever C, 2014, ACTA OPHTHALMOL, V92, P454, DOI 10.1111/aos.12379; Ueda-Consolvo T, 2015, ACTA OPHTHALMOL, V93, pE446, DOI 10.1111/aos.12597; Uren PJ, 2014, MOL VIS, V20, P1612; Usui S, 2009, MOL THER, V17, P778, DOI 10.1038/mt.2009.47; Vadlapatla RK, 2013, CURR DRUG TARGETS, V14, P919, DOI 10.2174/13894501113149990015; WAKAKURA M, 1989, EXP EYE RES, V48, P337, DOI 10.1016/S0014-4835(89)80003-X; Wang K, 2014, SCI REP-UK, V4, DOI 10.1038/srep07601; Wei YC, 2017, INFLAMMATION, V40, P1297, DOI 10.1007/s10753-017-0573-x; Wright WS, 2010, EXP EYE RES, V90, P405, DOI 10.1016/j.exer.2009.12.002; Yu DY, 2000, INVEST OPHTH VIS SCI, V41, P3999; Yu DY, 2006, INVEST OPHTH VIS SCI, V47, P1109, DOI 10.1167/iovs.05-1118; Yu DY, 2005, EXP EYE RES, V80, P745, DOI 10.1016/j.exer.2005.01.018; Yu DY, 2004, INVEST OPHTH VIS SCI, V45, P2013, DOI 10.1167/iovs.03-0845; Zong Y, 2016, GRAEF ARCH CLIN EXP, V254, P243, DOI 10.1007/s00417-015-3039-6	71	17	17	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2438	2451		10.1096/fj.201700985R	http://dx.doi.org/10.1096/fj.201700985R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29295858				2022-12-28	WOS:000432528000011
J	Trogden, KP; Battaglia, RA; Kabiraj, P; Madden, VJ; Herrmann, H; Snider, NT				Trogden, Kathryn P.; Battaglia, Rachel A.; Kabiraj, Parijat; Madden, Victoria J.; Herrmann, Harald; Snider, Natasha T.			An image-based small-molecule screen identifies vimentin as a pharmacologically relevant target of simvastatin in cancer cells	FASEB JOURNAL			English	Article						statin; intermediate filaments; cytoskeleton; drug screen	INTERMEDIATE-FILAMENT PROTEIN; STATIN THERAPY; MUSCLE INJURY; LUNG-CANCER; IN-VITRO; DYNAMICS; EXPRESSION; MANAGEMENT; WITHAFERIN; INHIBITOR	Vimentin is a cytoskeletal intermediate filament protein that is expressed in mesenchymal cells and cancer cells during the epithelial-mesenchymal transition. The goal of this study was to identify vimentin-targeting small molecules by using the Tocriscreen library of 1120 biochemically active compounds. We monitored vimentin filament reorganization and bundling in adrenal carcinoma SW13 vimentin-positive (SW13-vim(+) cells via indirect immunofluorescence. The screen identified 18 pharmacologically diverse hits that included 2 statins-simvastatin and mevastatin. Simvastatin induced vimentin reorganization within 15-30 min and significant perinuclear bundling within 60 min (IC50 = 6.7 nM). Early filament reorganization coincided with increased vimentin solubility. Mevastatin produced similar effects at >1 mu M, whereas the structurally related pravastatin and lovastatin did not affect vimentin. In vitro vimentin filament assembly assays revealed a direct targeting mechanism, as determined biochemically and by electron microscopy. In SW13-vim(+) cells, simvastatin, but not pravastatin, reduced total cell numbers (IC50 = 48.1 nM) and promoted apoptosis after 24 h. In contrast, SW13-vim(-) cell viability was unaffected by simvastatin, unless vimentin was ectopically expressed. Simvastatin similarly targeted vimentin filaments and induced cell death in MDA-MB-231 (vim(+)), but lacked effect in MCF7 (vim(-)) breast cancer cells. In conclusion, this study identified vimentin as a direct molecular target that mediates simvastatin-induced cell death in 2 different cancer cell lines.	[Trogden, Kathryn P.; Battaglia, Rachel A.; Kabiraj, Parijat; Snider, Natasha T.] Univ North Carolina Chapel Hill, Dept Cell Biol & Physiol, 5340C MBRB,111 Mason Farm Rd, Chapel Hill, NC 27516 USA; [Madden, Victoria J.] Univ North Carolina Chapel Hill, Dept Pathol & Lab Med, Chapel Hill, NC 27516 USA; [Herrmann, Harald] German Canc Res Ctr, Div Mol Genet, Heidelberg, Germany; [Herrmann, Harald] Univ Hosp Erlangen, Inst Neuropathol, Erlangen, Germany	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Helmholtz Association; German Cancer Research Center (DKFZ); University of Erlangen Nuremberg	Snider, NT (corresponding author), Univ North Carolina Chapel Hill, Dept Cell Biol & Physiol, 5340C MBRB,111 Mason Farm Rd, Chapel Hill, NC 27516 USA.	ntsnider@med.unc.edu	Ariel, Pablo/AGJ-4118-2022; Kabiraj, Parijat/AAE-9797-2020	, Parijat/0000-0003-3936-3143; Battaglia, Rachel/0000-0003-3187-6964; Trogden, Kathryn/0000-0003-3288-3859	Department of Cell Biology and Physiology at the University of North Carolina-Chapel Hill; National Science Foundation Graduate Research Fellowship; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant [R01-DK110355]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK110355] Funding Source: NIH RePORTER	Department of Cell Biology and Physiology at the University of North Carolina-Chapel Hill; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Helen Willcockson and Deekshita Ramanarayanan (University of North Carolina-Chapel Hill) for technical assistance, and Dr. Susan J. Henning (University of North Carolina-Chapel Hill) for critical reading and helpful discussions of the manuscript. This work was supported by the Department of Cell Biology and Physiology at the University of North Carolina-Chapel Hill, The National Science Foundation Graduate Research Fellowship (to R.A.B), and by U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant R01-DK110355 (to N.T.S.). The authors declare no conflicts of interest.	Ahern TP, 2014, LANCET ONCOL, V15, pE461, DOI 10.1016/S1470-2045(14)70119-6; Alexander JP, 2006, J AM CHEM SOC, V128, P9699, DOI 10.1021/ja062999h; Atilano-Roque A, 2017, TOXICOL IN VITRO, V45, P158, DOI 10.1016/j.tiv.2017.09.002; Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010; Battaglia R. A., 2017, JOVE-J VIS EXP, V123, P1; Bjorkhem-Bergman L, 2011, BRIT J CLIN PHARMACO, V72, P164, DOI 10.1111/j.1365-2125.2011.03907.x; Brown J.H., 2001, GOODMAN GILMANS PHAR, V10th ed., P10; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Bryant AE, 2006, J INFECT DIS, V193, P1685, DOI 10.1086/504261; Cardwell CR, 2015, CANCER EPIDEM BIOMAR, V24, P833, DOI 10.1158/1055-9965.EPI-15-0052; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Chernoivanenko IS, 2015, FASEB J, V29, P820, DOI 10.1096/fj.14-259903; Chernyatina AA, 2015, CURR OPIN CELL BIOL, V32, P65, DOI 10.1016/j.ceb.2014.12.007; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; Fitchett DH, 2015, CIRCULATION, V131, pE389, DOI 10.1161/CIRCULATIONAHA.114.013189; Gan Z, 2016, CELL SYST, V3, P252, DOI 10.1016/j.cels.2016.08.007; Gao X, 2009, CHEM BIOL, V16, P1064, DOI 10.1016/j.chembiol.2009.09.017; Gazzerro P, 2012, PHARMACOL REV, V64, P102, DOI 10.1124/pr.111.004994; Gluba-Brzozka A, 2016, ARCH MED SCI, V12, P645, DOI 10.5114/aoms.2016.59938; GOLDMAN RD, 1971, J CELL BIOL, V51, P752, DOI 10.1083/jcb.51.3.752; Goldman RD, 2008, CURR OPIN CELL BIOL, V20, P28, DOI 10.1016/j.ceb.2007.11.003; Grin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039065; Hamilton SM, 2008, J INFECT DIS, V198, P1692, DOI 10.1086/593016; Herrmann H, 2004, METHOD CELL BIOL, V78, P3; Herrmann H, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018242; Hookway C, 2015, MOL BIOL CELL, V26, P1675, DOI 10.1091/mbc.E14-09-1398; Ioannidis JPA, 2014, JAMA-J AM MED ASSOC, V311, P463, DOI 10.1001/jama.2013.284657; Jiang P, 2014, BRIT J CANCER, V111, P1562, DOI 10.1038/bjc.2014.431; Jimenez-Oses G, 2014, NAT CHEM BIOL, V10, P431, DOI 10.1038/nchembio.1503; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kidd ME, 2014, AM J RESP CELL MOL, V50, P1, DOI 10.1165/rcmb.2013-0314TR; Kou R, 2009, J BIOL CHEM, V284, P14734, DOI 10.1074/jbc.M808664200; Kreplak L, 2008, METHOD CELL BIOL, V88, P273, DOI 10.1016/S0091-679X(08)00415-9; Lowery J, 2015, J BIOL CHEM, V290, P17145, DOI 10.1074/jbc.R115.640359; Matveeva EA, 2015, BIOL OPEN, V4, P1290, DOI 10.1242/bio.011874; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; SARRIA AJ, 1994, J CELL SCI, V107, P1593; Saxon DR, 2016, PROG CARDIOVASC DIS, V59, P153, DOI 10.1016/j.pcad.2016.07.009; Schick BA, 2007, CLIN PHARMACOL THER, V81, P650, DOI 10.1038/sj.clpt.6100124; Schwarz N, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5030030; Seckl MJ, 2017, J CLIN ONCOL, V35, P1506, DOI 10.1200/JCO.2016.69.7391; Snider NT, 2013, J CELL BIOL, V200, P241, DOI 10.1083/jcb.201209028; SOELLNER P, 1985, P NATL ACAD SCI USA, V82, P7929, DOI 10.1073/pnas.82.23.7929; Stroes ES, 2015, EUR HEART J, V36, P1012, DOI 10.1093/eurheartj/ehv043; Tang HL, 2008, BIOCHEM J, V410, P141, DOI 10.1042/BJ20071072; TRAUB P, 1985, FEBS LETT, V193, P217, DOI 10.1016/0014-5793(85)80155-1; Vanden Berghe W, 2012, BIOCHEM PHARMACOL, V84, P1282, DOI 10.1016/j.bcp.2012.08.027; Warita K, 2014, SCI REP-UK, V4, DOI 10.1038/srep07593; Zhu Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.103	52	27	27	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2841	2854		10.1096/fj.201700663R	http://dx.doi.org/10.1096/fj.201700663R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29401610	Green Published			2022-12-28	WOS:000432528000042
J	Vrljicak, P; Lucas, ES; Lansdowne, L; Lucciola, R; Muter, J; Dyer, NP; Brosens, JJ; Ott, S				Vrljicak, Pavle; Lucas, Emma S.; Lansdowne, Lauren; Lucciola, Raffaella; Muter, Joanne; Dyer, Nigel P.; Brosens, Jan J.; Ott, Sascha			Analysis of chromatin accessibility in decidualizing human endometrial stromal cells	FASEB JOURNAL			English	Article						endometrium; decidualization; gene regulation; open chromatin; transposable elements	BINDING-PROTEIN-BETA; PROGESTERONE-RECEPTOR; PROLACTIN EXPRESSION; EVOLUTION; IDENTIFICATION; TRANSCRIPTOME; LANDSCAPE; PREGNANCY; ALIGNMENT; ISOFORMS	Spontaneous decidualization of the endometrium in response to progesterone signaling is confined to menstruating species, including humans and other higher primates. During this process, endometrial stromal cells (EnSCs) differentiate into specialized decidual cells that control embryo implantation. We subjected undifferentiated and decidualizing human EnSCs to an assay for transposase accessible chromatin with sequencing (ATAC-seq) to map the underlying chromatin changes. A total of 185,084 open DNA loci were mapped accurately in EnSCs. Altered chromatin accessibility upon decidualization was strongly associated with differential gene expression. Analysis of 1533 opening and closing chromatin regions revealed over-representation of DNA binding motifs for known decidual transcription factors (TFs) and identified putative new regulators. ATAC-seq footprint analysis provided evidence of TF binding at specific motifs. One of the largest footprints involved the most enriched motif-basic leucine zipper-as part of a triple motif that also comprised the estrogen receptor and Pax domain binding sites. Without exception, triple motifs were located within Alu elements, which suggests a role for this primate-specific transposable element (TE) in the evolution of decidual genes. Although other TEs were generally under-represented in open chromatin of undifferentiated EnSCs, several classes contributed to the regulatory DNA landscape that underpins decidual gene expression.	[Vrljicak, Pavle; Lucas, Emma S.; Brosens, Jan J.; Ott, Sascha] Univ Warwick, Univ Hosp Coventry & Warwickshire Natl Hlth Serv, Tommys Natl Ctr Miscarriage Res, Coventry, W Midlands, England; [Vrljicak, Pavle; Lucas, Emma S.; Lucciola, Raffaella; Muter, Joanne; Brosens, Jan J.] Univ Warwick, Warwick Med Sch, Div Biomed Sci, Coventry, W Midlands, England; [Lansdowne, Lauren; Dyer, Nigel P.; Ott, Sascha] Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick; University of Warwick; University of Warwick	Ott, S (corresponding author), Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England.	s.ott@warwick.ac.uk	Lucas, Emma S/I-2719-2013; Ott, Sascha/A-1180-2011	Lucas, Emma S/0000-0002-8571-8921; Brosens, Jan/0000-0003-0116-9329	Biomedical Research Unit in Reproductive Health; University Hospitals Coventry; Warwickshire National Health Service (NHS) Trust; Warwick Medical School; Tommy's National Centre for Miscarriage Research; Midlands Integrative Biosciences Training Partnership; BBSRC [1791041] Funding Source: UKRI	Biomedical Research Unit in Reproductive Health; University Hospitals Coventry; Warwickshire National Health Service (NHS) Trust; Warwick Medical School; Tommy's National Centre for Miscarriage Research; Midlands Integrative Biosciences Training Partnership; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank Angela Oliveira Pisco (King's College London, London, United Kingdom) for technical advice. The authors also thank patients attending the Implantation Clinic for contributing their endometrial tissue to research. This work was supported by the Biomedical Research Unit in Reproductive Health, a joint initiative between University Hospitals Coventry and Warwickshire National Health Service (NHS) Trust and Warwick Medical School. E.S.L., P.V., and J.J.B. are funded by Tommy's National Centre for Miscarriage Research. L.L. was funded by the Midlands Integrative Biosciences Training Partnership. The authors declare no conflicts of interest.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barros F. S. V., 2016, BIOPROTOCOL, V6; Batzer MA, 1996, J MOL EVOL, V42, P3, DOI 10.1007/BF00163204; Bellofiore N, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.07.041; Brosens JJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep03894; Brosens JJ, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.11.037; Brosens JJ, 1999, ENDOCRINOLOGY, V140, P4809, DOI 10.1210/en.140.10.4809; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Christian M, 2002, J BIOL CHEM, V277, P20825, DOI 10.1074/jbc.M201018200; Christian M, 2002, MOL ENDOCRINOL, V16, P141, DOI 10.1210/me.16.1.141; Cloke B, 2008, ENDOCRINOLOGY, V149, P4462, DOI 10.1210/en.2008-0356; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deininger P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-236; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Emera D, 2012, BIOESSAYS, V34, P26, DOI 10.1002/bies.201100099; Erlebacher A, 2013, ANNU REV IMMUNOL, V31, P387, DOI 10.1146/annurev-immunol-032712-100003; Evans J, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.108175; Evans J, 2012, REV ENDOCR METAB DIS, V13, P277, DOI 10.1007/s11154-012-9223-7; GELLERSEN B, 1989, MOL CELL ENDOCRINOL, V64, P127, DOI 10.1016/0303-7207(89)90073-7; Gellersen B, 2014, ENDOCR REV, V35, P851, DOI 10.1210/er.2014-1045; Gonzalez D, 2012, J CLIN ENDOCR METAB, V97, P957, DOI 10.1210/jc.2011-2366; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Jiang YL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13735; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kaya HS, 2015, MOL ENDOCRINOL, V29, P882, DOI 10.1210/me.2014-1363; Kessler CA, 2008, MOL CELL ENDOCRINOL, V295, P32, DOI 10.1016/j.mce.2008.08.007; Kim MR, 2005, MOL HUM REPROD, V11, P801, DOI 10.1093/molehr/gah240; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Leitao B, 2010, FASEB J, V24, P1541, DOI 10.1096/fj.09-149153; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lucas ES, 2016, REPRODUCTION, V152, pR159, DOI 10.1530/REP-16-0306; Lucas ES, 2016, STEM CELLS, V34, P346, DOI 10.1002/stem.2222; Lynch VJ, 2015, CELL REP, V10, P551, DOI 10.1016/j.celrep.2014.12.052; Lynch VJ, 2011, NAT GENET, V43, P1154, DOI 10.1038/ng.917; Lynch VJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006845; Macdonald LJ, 2011, MOL HUM REPROD, V17, P626, DOI 10.1093/molehr/gar031; Martin RD, 2007, YEARB PHYS ANTHROPOL, V50, P59, DOI 10.1002/ajpa.20734; Mason CE, 2010, NUCLEIC ACIDS RES, V38, P2355, DOI 10.1093/nar/gkp1188; Mazur EC, 2015, ENDOCRINOLOGY, V156, P2239, DOI 10.1210/en.2014-1566; Muter J, 2016, ENDOCRINOLOGY, V157, P2883, DOI 10.1210/en.2015-1914; NORRIS J, 1995, J BIOL CHEM, V270, P22777, DOI 10.1074/jbc.270.39.22777; Piper J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt850; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; RAMSEY EM, 1976, AM J OBSTET GYNECOL, V124, P647, DOI 10.1016/0002-9378(76)90068-5; Salker MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052252; Salker MS, 2011, NAT MED, V17, P1509, DOI 10.1038/nm.2498; Strassmann BI, 1996, Q REV BIOL, V71, P181, DOI 10.1086/419369; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Vasquez YM, 2015, MOL ENDOCRINOL, V29, P421, DOI 10.1210/me.2014-1292; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	55	13	13	2	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2467	2477		10.1096/fj.201701098R	http://dx.doi.org/10.1096/fj.201701098R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29259032	Green Published, hybrid			2022-12-28	WOS:000432528000013
J	Lee, J; Rodero, MP; Patel, J; Moi, D; Mazzieri, R; Khosrotehrani, K				Lee, James; Rodero, Mathieu Paul; Patel, Jatin; Moi, Davide; Mazzieri, Roberta; Khosrotehrani, Kiarash			Interleukin-23 regulates interleukin-17 expression in wounds, and its inhibition accelerates diabetic wound healing through the alteration of macrophage polarization	FASEB JOURNAL			English	Article						chronic wound healing; antibody therapy; inflammation	NECROSIS-FACTOR-ALPHA; OB/OB MICE; SKIN; INFLAMMATION; REPAIR; IL-17	Inflammation is a critical phase in the healing of skin wounds. Excessive inflammation and inflammatory macrophages are known to cause impaired wound closure and outcome. This prompted us to test the role of IL-23 in IL-17 expression and in modulating wound inflammation and macrophage polarization. Full-thickness wounds (4 x 6 mm) were created on the dorsal surface of multiple genetically modified mouse models. Obese diabetic mouse wounds were treated with anti-IL-17A, anti-IL-23, or isotype-matched antibodies. We found IL-23- but not IL-12-deficient mice displayed significantly reduced IL-17 expression in wounds. This was rescued by delivery of recombinant IL-23. IL-23- and IL-17-deficient mice showed a significant increase in noninflammatory macrophages. Obese diabetic mice treated with anti-IL-17A and anti-IL-23p19 blocking antibodies had significantly improved wound reepithelialization. Similarly, IL-17(-/-) obese mice had accelerated wound closure, resulting in reduced iNOS expression and inflammatory macrophages while maintaining prohealing CD206 and lymphatic vessel endothelial hyaluronic acid receptor 1 (LYVE1)-expressing macrophages. This study highlights the importance of the IL-17 pathway in wound closure offering new possibilities of therapeutic intervention in chronic wounds.	[Lee, James; Rodero, Mathieu Paul; Patel, Jatin; Khosrotehrani, Kiarash] Univ Queensland, Ctr Clin Res, Woolloongabba, Qld, Australia; [Moi, Davide; Mazzieri, Roberta; Khosrotehrani, Kiarash] Univ Queensland, Translat Res Inst, Diamantina Inst, 37 Kent St, Woolloongabba, Qld, Australia	University of Queensland; University of Queensland	Khosrotehrani, K (corresponding author), Univ Queensland, Translat Res Inst, Diamantina Inst, 37 Kent St, Woolloongabba, Qld, Australia.	k.khosrotehrani@uq.edu.au	Khosrotehrani, Kiarash/M-8025-2015; rodero, mathieu/C-8083-2011; Patel, Jatin/P-2668-2016; Mazzieri, Roberta/C-9773-2015	Khosrotehrani, Kiarash/0000-0002-6406-4076; rodero, mathieu/0000-0002-1300-0187; Patel, Jatin/0000-0002-3511-0029; Patel, Jatin/0000-0002-6731-0009; Mazzieri, Roberta/0000-0002-5172-0927; Moi, Davide/0000-0002-1198-5146	National Health and Medical Research Council; Australian Research Council [1048385]; Diabetes Australia [Y14G-KHOK]; National Health and Medical Research Council fellowship; Australian postgraduate award scholarship	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Diabetes Australia; National Health and Medical Research Council fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian postgraduate award scholarship	The authors thank the Herston Medical Research Centre (The University of Queensland) for the animal facilities and carers. This work was funded by the National Health and Medical Research Council and the Australian Research Council Project Grant 1048385 and Diabetes Australia Grant Y14G-KHOK. K.K. was supported by a National Health and Medical Research Council fellowship. J.L. was supported by an Australian postgraduate award scholarship. The authors declare no conflict of interest.	Delavary BM, 2011, IMMUNOBIOLOGY, V216, P753, DOI 10.1016/j.imbio.2011.01.001; Dovi JV, 2003, J LEUKOCYTE BIOL, V73, P448, DOI 10.1189/jlb.0802406; Goren I, 2006, AM J PATHOL, V168, P765, DOI 10.2353/ajpath.2006.050293; Goren I, 2007, J INVEST DERMATOL, V127, P2259, DOI 10.1038/sj.jid.5700842; Goren I, 2009, AM J PATHOL, V175, P132, DOI 10.2353/ajpath.2009.081002; Jetten N, 2014, ANGIOGENESIS, V17, P109, DOI 10.1007/s10456-013-9381-6; Keijsers RRMC, 2014, J INVEST DERMATOL, V134, P1276, DOI 10.1038/jid.2013.526; Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943; Lin AM, 2011, J IMMUNOL, V187, P490, DOI 10.4049/jimmunol.1100123; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Madsen DH, 2013, J CELL BIOL, V202, P951, DOI 10.1083/jcb.201301081; Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248; Mirza RE, 2015, J PATHOL, V236, P433, DOI 10.1002/path.4548; Mirza RE, 2015, CYTOKINE, V71, P409, DOI 10.1016/j.cyto.2014.09.005; Nassar D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037084; Rodero MP, 2013, J INVEST DERMATOL, V133, P783, DOI 10.1038/jid.2012.368; Rodero MP, 2013, EXP DERMATOL, V22, P143, DOI 10.1111/exd.12068; Rodero MP, 2010, INT J CLIN EXP PATHO, V3, P643; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Takagi N, 2017, EXP DERMATOL, V26, P137, DOI 10.1111/exd.13115; Willenborg S, 2012, BLOOD, V120, P613, DOI 10.1182/blood-2012-01-403386; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Yan CL, 2010, AM J PATHOL, V176, P2247, DOI 10.2353/ajpath.2010.090048	23	29	34	3	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2086	2094		10.1096/fj.201700773R	http://dx.doi.org/10.1096/fj.201700773R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29208701	Green Submitted			2022-12-28	WOS:000429051400029
J	Yang, QH; Fujii, W; Kaji, N; Kakuta, S; Kada, K; Kuwahara, M; Tsubone, H; Ozaki, H; Hori, M				Yang, Qunhui; Fujii, Wataru; Kaji, Noriyuki; Kakuta, Shigeru; Kada, Kodai; Kuwahara, Masayoshi; Tsubone, Hirokazu; Ozaki, Hiroshi; Hori, Masatoshi			The essential role of phospho-T38 CPI-17 in the maintenance of physiological blood pressure using genetically modified mice	FASEB JOURNAL			English	Article						CRISPR/Cas9; aorta; radio telemetry; PKC; MYPT1	VASCULAR SMOOTH-MUSCLE; RHO-ASSOCIATED KINASE; MYOSIN LIGHT-CHAIN; TARGETING SUBUNIT-1 PHOSPHORYLATION; CONTRACTILE CA2+ SENSITIZATION; 3-KINASE ALPHA-ISOFORM; PROTEIN PHOSPHATASE-1; PHORBOL ESTER; UP-REGULATION; MYOSIN/MOESIN PHOSPHATASE	PKC-potentiated phosphorylation-dependent inhibitory protein of protein phosphatase 1 (CPI-17), an endogenous myosin phosphatase inhibitory protein, is considered a key molecule for Ca2+ sensitization of the contractile apparatus. Here, we have used clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 to generate CPI-17-deficient [knockout (KO)] and threonine 38 (T38)-phospho-resistant mice [threonine mutant into alanine (TA)], and then effects of CPI-17 on vascular contractility in vitro and mean blood pressure (MBP) in vivo were investigated. In isolated thoracic aorta, phorbol 12, 13-dibutyrate induced a sustained contraction of wild-type (WT) mice, whereas no contraction showed from TA or KO mice. A high concentration of KCl solution-induced contraction was not different between transgenic and WT mice. In contrast, phenylephrine (PE)-induced contractions in both mutant strains were significantly smaller than those of WT mice in association with a low level of myosin phosphorylation, suggesting that at least part of PE-induced contraction is regulated by phosphorylation of CPI-17 at T38. Finally, the physiologic role of CPI-17 in the regulation of blood pressure was investigated using radio telemetry. MBP was decreased significantly in both transgenic mice, even with a compensatory increase in heart rate. In summary, we generated KO and constitutively phospho-resistant mouse models of CPI-17 for the first time. p-CPI-17 at T38, possibly by PKC, could be important to maintain vascular contractility and blood pressure in vivo.	[Yang, Qunhui; Kaji, Noriyuki; Kada, Kodai; Ozaki, Hiroshi; Hori, Masatoshi] Univ Tokyo, Dept Vet Pharmacol, Grad Sch Agr & Life Sci, Tokyo, Japan; [Fujii, Wataru] Univ Tokyo, Lab Appl Genet, Grad Sch Agr & Life Sci, Tokyo, Japan; [Kakuta, Shigeru] Univ Tokyo, Dept Biomed Sci, Grad Sch Agr & Life Sci, Tokyo, Japan; [Kuwahara, Masayoshi] Univ Tokyo, Dept Vet Pathophysiol & Anim Hlth, Grad Sch Agr & Life Sci, Tokyo, Japan; [Tsubone, Hirokazu] Univ Tokyo, Res Ctr Food Safety, Grad Sch Agr & Life Sci, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo	Hori, M (corresponding author), Univ Tokyo, Dept Vet Pharmacol, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	ahori@mail.ecc.u-tokyo.ac.jp	Kakuta, Shigeru/L-2241-2018	Kakuta, Shigeru/0000-0002-5900-1425; Kaji, Noriyuki/0000-0001-7423-5679; Fujii, Wataru/0000-0002-6438-7350	Ministry of Education, Japan [24248050, 25221205, 26712025]; Salt Science Research Foundation [1645]; Grant for Joint Research Project of the Institute of Medical Science, The University of Tokyo [235]	Ministry of Education, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Salt Science Research Foundation; Grant for Joint Research Project of the Institute of Medical Science, The University of Tokyo	The authors thank Yoshiharu Tsuru (Primetech Corporation, Tokyo, Japan), for giving great technical support in regard to the telemetry system used to measure blood pressure. The authors thank Kosuke Takeya (Department of Physiology, Asahikawa Medical College) for technical support of protein extraction and Western blot from mouse thoracic aorta. This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Japan (24248050 to M.H.; 25221205 to H.O.; and 26712025 to W.F.), and partly supported by the Salt Science Research Foundation (No. 1645 to M.H.) and Grant for Joint Research Project of the Institute of Medical Science, The University of Tokyo (No. 235 to S.K.). The authors declare no conflicts of interest.	Baek I, 2009, CLIN EXP PHARMACOL P, V36, P256, DOI 10.1111/j.1440-1681.2008.05045.x; Chang SH, 2006, AM J PHYSIOL-RENAL, V290, pF650, DOI 10.1152/ajprenal.00235.2005; Chen CP, 2015, J PHYSIOL-LONDON, V593, P681, DOI 10.1113/jphysiol.2014.283853; Dakshinamurti S, 2005, PEDIATR PULM, V40, P398, DOI 10.1002/ppul.20290; Deng JT, 2002, BIOCHEM J, V367, P517, DOI 10.1042/BJ20020522; Dimopoulos GJ, 2007, CIRC RES, V100, P121, DOI 10.1161/01.RES.0000253902.90489.df; Dubois T, 2003, BIOCHEM BIOPH RES CO, V302, P186, DOI 10.1016/S0006-291X(03)00130-X; Eto M, 2004, P NATL ACAD SCI USA, V101, P8888, DOI 10.1073/pnas.0307812101; Eto M, 1997, FEBS LETT, V410, P356, DOI 10.1016/S0014-5793(97)00657-1; Eto M, 2002, NEURON, V36, P1145, DOI 10.1016/S0896-6273(02)01107-8; ETO M, 1995, J BIOCHEM, V118, P1104, DOI 10.1093/oxfordjournals.jbchem.a124993; Eto M, 2000, CELL MOTIL CYTOSKEL, V46, P222, DOI 10.1002/1097-0169(200007)46:3<222::AID-CM6>3.3.CO;2-2; Eto Masumi, 2017, J Smooth Muscle Res, V53, P1, DOI 10.1540/jsmr.53.1; Eto M, 2013, BIOCHEM BIOPH RES CO, V434, P137, DOI 10.1016/j.bbrc.2013.03.055; Eto M, 2012, IUBMB LIFE, V64, P732, DOI 10.1002/iub.1067; Eto M, 2009, J BIOL CHEM, V284, P35273, DOI 10.1074/jbc.R109.059972; Fujii W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt772; Gao N, 2017, J PHYSIOL-LONDON, V595, P6231, DOI 10.1113/JP274715; Gao N, 2016, J PHYSIOL-LONDON, V594, P3209, DOI 10.1113/JP271703; Grassie ME, 2012, J BIOL CHEM, V287, P36356, DOI 10.1074/jbc.M112.398479; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; HORI M, 1992, J PHARMACOL EXP THER, V261, P506; Iizuka M, 2011, AM J PHYSIOL-GASTR L, V300, pG1010, DOI 10.1152/ajpgi.00350.2010; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; Karaki H, 1997, PHARMACOL REV, V49, P157; Kasa A, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.974448; Kida T, 2011, ATHEROSCLEROSIS, V214, P288, DOI 10.1016/j.atherosclerosis.2010.11.001; Kim JI, 2017, KOREAN J PHYSIOL PHA, V21, P99, DOI 10.4196/kjpp.2017.21.1.99; Kimura K, 1998, J BIOL CHEM, V273, P5542, DOI 10.1074/jbc.273.10.5542; Kitazawa T, 2004, J PHYSIOL-LONDON, V557, P515, DOI 10.1113/jphysiol.2004.064543; Kitazawa T, 1999, J PHYSIOL-LONDON, V520, P139, DOI 10.1111/j.1469-7793.1999.00139.x; Kitazawa T, 2012, J PHYSIOL-LONDON, V590, P5401, DOI 10.1113/jphysiol.2012.241315; KUWAHARA M, 1991, EXP ANIM TOKYO, V40, P331, DOI 10.1538/expanim1978.40.3_331; MITSUI M, 1993, BRIT J PHARMACOL, V109, P229, DOI 10.1111/j.1476-5381.1993.tb13558.x; Miura M, 1997, PFLUG ARCH EUR J PHY, V434, P685, DOI 10.1007/s004240050452; Mori D, 2011, NEUROGASTROENT MOTIL, V23, P1111, DOI 10.1111/j.1365-2982.2011.01799.x; Ohama T, 2003, J BIOL CHEM, V278, P48794, DOI 10.1074/jbc.M310166200; Ohama T, 2008, J GASTROENTEROL, V43, P858, DOI 10.1007/s00535-008-2241-2; Ohama T, 2007, AM J PHYSIOL-GASTR L, V292, pG1429, DOI 10.1152/ajpgi.00315.2006; Ozaki J, 2003, BRIT J PHARMACOL, V140, P1303, DOI 10.1038/sj.bjp.0705552; Pagiatakis C, 2012, J BIOL CHEM, V287, P8361, DOI 10.1074/jbc.M111.286203; Pang HA, 2005, AM J PHYSIOL-CELL PH, V289, pC352, DOI 10.1152/ajpcell.00111.2005; Qiao YN, 2014, J BIOL CHEM, V289, P22512, DOI 10.1074/jbc.M113.525444; Ringvold H C, 2017, Adv Pharmacol, V78, P203, DOI 10.1016/bs.apha.2016.06.002; Saito T, 2013, CIRCULATION, V127, P104, DOI 10.1161/CIRCULATIONAHA.112.135608; Sakai H, 2005, MOL PHARMACOL, V68, P145, DOI 10.1124/mol.104.004325; Sakamoto K, 2003, J PHARMACOL SCI, V92, P56; SATO K, 1992, J PHARMACOL EXP THER, V261, P497; Seko T, 2003, CIRC RES, V92, P411, DOI 10.1161/01.RES.0000059987.90200.44; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Su W, 2008, AM J PHYSIOL-HEART C, V295, pH1634, DOI 10.1152/ajpheart.00257.2008; Su W, 2013, AM J PHYSIOL-HEART C, V305, pH104, DOI 10.1152/ajpheart.00597.2012; Tajimi M, 1997, JPN J PHARMACOL, V74, P195, DOI 10.1254/jjp.74.195; Wang FY, 2016, TRENDS CELL BIOL, V26, P875, DOI 10.1016/j.tcb.2016.08.004; Wang Y, 2006, BIOCHEM J, V394, P581, DOI 10.1042/BJ20051471; Watanabe Y, 2001, BLOOD, V97, P3798, DOI 10.1182/blood.V97.12.3798; Wei XN, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-112; Xie ZW, 2006, CARDIOVASC RES, V69, P491, DOI 10.1016/j.cardiores.2005.11.002; Yamazaki D, 2011, CELL METAB, V14, P231, DOI 10.1016/j.cmet.2011.05.011; Yoshimoto R, 2000, JPN J PHARMACOL, V84, P474, DOI 10.1254/jjp.84.474; Yoshioka K, 2007, MOL PHARMACOL, V71, P912, DOI 10.1124/mol.106.032599	61	13	13	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2095	2109		10.1096/fj.201700794R	http://dx.doi.org/10.1096/fj.201700794R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29229685				2022-12-28	WOS:000429051400030
J	Williams, B; Correnti, J; Oranu, A; Lin, A; Scott, V; Annoh, M; Beck, J; Furth, E; Mitchell, V; Senkal, CE; Obeid, L; Carr, RM				Williams, Bianca; Correnti, Jason; Oranu, Amanke; Lin, Annie; Scott, Victoria; Annoh, Maxine; Beck, James; Furth, Emma; Mitchell, Victoria; Senkal, Can E.; Obeid, Lina; Carr, Rotonya M.			A novel role for ceramide synthase 6 in mouse and human alcoholic steatosis	FASEB JOURNAL			English	Article						PLIN2; glucose tolerance; CerS6; lipid droplet; alcohol; liver	DIFFERENTIATION-RELATED PROTEIN; COLON-CANCER CELLS; HEPATIC STEATOSIS; INSULIN-RESISTANCE; LIVER-DISEASE; INHIBITOR MYRIOCIN; FATTY LIVER; ETHANOL; MICE; STEATOHEPATITIS	Perilipin 2 (PLIN2) is a lipid-droplet protein that is up-regulated in alcoholic steatosis and associated with hepatic accumulation of ceramides, bioactive lipids implicated in alcoholic liver disease pathogenesis. The specific role of ceramide synthetic enzymes in the regulation of PLIN2 and promotion of hepatocellular lipid accumulation is not well understood. We examined the effects of pharmacologic ceramide synthesis inhibition on hepatic PLIN2 expression, steatosis, and glucose and lipid homeostasis in mice with alcoholic steatosis and in ethanol-incubated human hepatoma VL17A cells. In cells, pharmacologic inhibition of ceramide synthase reduced lipid accumulation by reducing PLIN2 RNA stability. The subtype ceramide synthase (CerS)6 was specifically up-regulated in experimental alcoholic steatosis in vivo and in vitro and was up-regulated in zone 3 hepatocytes in human alcoholic steatosis. In vivo ceramide reduction by inhibition of de novo ceramide synthesis reduced PLIN2 and hepatic steatosis in alcohol-fed mice, but only de novo synthesis inhibition, not sphingomyelin hydrolysis, improved glucose tolerance and dyslipidemia. These findings implicate CerS6 as a novel regulator of PLIN2 and suggest that ceramide synthetic enzymes may promote the earliest stage of alcoholic liver disease, alcoholic steatosis.	[Williams, Bianca; Correnti, Jason; Oranu, Amanke; Lin, Annie; Scott, Victoria; Annoh, Maxine; Beck, James; Mitchell, Victoria; Carr, Rotonya M.] Univ Penn, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA; [Furth, Emma] Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA; [Senkal, Can E.; Obeid, Lina] SUNY Stony Brook, Sch Med, Dept Med, Stony Brook, NY 11794 USA; [Obeid, Lina] Northport Vet Affairs Med Ctr, Northport, NY USA	University of Pennsylvania; University of Pennsylvania; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Carr, RM (corresponding author), Univ Penn, Div Gastroenterol, 907 Biomed Res Bldg,421 Curie Blvd, Philadelphia, PA 19104 USA.	rotonya.carr@uphs.upenn.edu			U.S. National Institutes of Health (NIH) National Institute on Alcohol Abuse and Alcoholism [K08-AA021424]; Robert Wood Johnson Foundation; Harold Amos Medical Faculty Development Award [7158]; Institute for Diabetes, Obesity and Metabolism Diabetes Research Center Pilot Award [P30 DK019525]; Health Resources and Services Administration Grant, Center of Excellence for Diversity in Health Education and Research [D34HP24459]; NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [T32 DK007066]; NIH National Institute of General Medical Sciences Grant [R01 GM062887]; NIH/NIDDK [P30-DK050306]; NIH National Cancer Institute [P01-CA97132]; NATIONAL CANCER INSTITUTE [P01CA097132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525, T32DK007066, P30DK050306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K08AA021424, F32AA024347, R01AA026302] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute on Alcohol Abuse and Alcoholism; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Harold Amos Medical Faculty Development Award; Institute for Diabetes, Obesity and Metabolism Diabetes Research Center Pilot Award; Health Resources and Services Administration Grant, Center of Excellence for Diversity in Health Education and Research; NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute of General Medical Sciences Grant; NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The authors thank the Lipidomics Core facility at the State University of New York (SUNY; Stony Brook, NY, USA), the Michael J. Palmieri Metabolic Laboratory (Philadelphia, PA, USA) for lipid analyses; the University of Pennsylvania Molecular Pathology/Imaging, Molecular Biology, and Mouse Phenotyping Cores (Philadelphia, PA, USA); and Dr. Dahn Clemens (University of Nebraska, Omaha, NE, USA) for VL17A cells. The authors acknowledge Amy Praestgaard (Biostatistics Analysis Center, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania), for her biostatistical analysis and support. This work was supported by the U.S. National Institutes of Health (NIH) National Institute on Alcohol Abuse and Alcoholism Grant K08-AA021424; the Robert Wood Johnson Foundation; Harold Amos Medical Faculty Development Award (Grant 7158); the Institute for Diabetes, Obesity and Metabolism Diabetes Research Center Pilot Award P30 DK019525 (to R.M.C.); Health Resources and Services Administration Grant D34HP24459, Center of Excellence for Diversity in Health Education and Research; NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant T32 DK007066 (to A.O.), NIH National Institute of General Medical Sciences Grant R01 GM062887 (to L.M.O.), and, in part, by NIH/NIDDK Grant P30-DK050306; its core facilities (University of Pennsylvania Molecular Pathology and Imaging Core, Molecular Biology/Gene Expression Core, Transgenic and Chimeric Mouse Core, and Cell Culture Core) and its pilot grant program; and NIH National Cancer Institute Grant P01-CA97132 (SUNY Stony Brook Lipidomics Core). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflicts of interest.	Beckmann N, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00331; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Carr RM, 2017, CLIN GASTROENTEROL H, V15, P145, DOI 10.1016/j.cgh.2016.08.023; Carr RM, 2016, EXP CELL RES, V340, P187, DOI 10.1016/j.yexcr.2015.10.021; Carr RM, 2015, ANN NY ACAD SCI, V1353, P1, DOI 10.1111/nyas.12787; Carr RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097118; Carr RM, 2013, ALCOHOL CLIN EXP RES, V37, P1091, DOI 10.1111/acer.12075; Carr RM, 2012, AM J PHYSIOL-REG I, V302, pR996, DOI 10.1152/ajpregu.00177.2011; Chen CYA, 2008, METHOD ENZYMOL, V448, P335, DOI 10.1016/S0076-6879(08)02617-7; Correnti JM, 2014, AM J PHYSIOL-GASTR L, V306, pG959, DOI 10.1152/ajpgi.00395.2013; Donohue TM, 2006, INT J BIOCHEM CELL B, V38, P92, DOI 10.1016/j.biocel.2005.07.010; Ghaeli P, 2004, J CLIN PSYCHOPHARM, V24, P386, DOI 10.1097/01.jcp.0000132441.27854.0d; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Kasumov T, 2015, OBESITY, V23, P1414, DOI 10.1002/oby.21117; Kaushik S, 2015, NAT CELL BIOL, V17, P759, DOI 10.1038/ncb3166; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Liangpunsakul S, 2012, AM J PHYSIOL-GASTR L, V302, pG515, DOI 10.1152/ajpgi.00455.2011; Liangpunsakul S, 2010, AM J PHYSIOL-GASTR L, V298, pG1004, DOI 10.1152/ajpgi.00482.2009; Lizarazo D, 2013, J GASTROEN HEPATOL, V28, P1660, DOI 10.1111/jgh.12291; Longato L, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/479348; Macdonald GA, 2001, J GASTROEN HEPATOL, V16, P599, DOI 10.1046/j.1440-1746.2001.02445.x; Magne J, 2013, FASEB J, V27, P3090, DOI 10.1096/fj.13-228759; Mak KM, 2008, ALCOHOL CLIN EXP RES, V32, P683, DOI 10.1111/j.1530-0277.2008.00624.x; Masuda Y, 2006, J LIPID RES, V47, P87, DOI 10.1194/jlr.M500170-JLR200; McManaman JL, 2013, J LIPID RES, V54, P1346, DOI 10.1194/jlr.M035063; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Mullen TD, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230870; Najt CP, 2016, AM J PHYSIOL-GASTR L, V310, pG726, DOI 10.1152/ajpgi.00436.2015; Osawa Y, 2011, FASEB J, V25, P1133, DOI 10.1096/fj.10-168351; Osna NA, 2005, HEPATOLOGY, V42, P1109, DOI 10.1002/hep.20909; Ramirez T, 2013, ALCOHOL ALCOHOLISM, V48, P39, DOI 10.1093/alcalc/ags106; Raynard B, 2002, HEPATOLOGY, V35, P635, DOI 10.1053/jhep.2002.31782; Rehm J, 2013, J HEPATOL, V59, P160, DOI 10.1016/j.jhep.2013.03.007; Senkal CE, 2017, CELL METAB, V25, P686, DOI 10.1016/j.cmet.2017.02.010; Senthivinayagam S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073696; Tachibana Keisuke, 2005, Nucl Recept, V3, P3, DOI 10.1186/1478-1336-3-3; Tong M, 2014, INT J EXP PATHOL, V95, P49, DOI 10.1111/iep.12052; Turpin SM, 2014, CELL METAB, V20, P678, DOI 10.1016/j.cmet.2014.08.002; Varela GM, 2008, AM J PHYSIOL-GASTR L, V295, pG621, DOI 10.1152/ajpgi.90204.2008; Walker T, 2009, MOL PHARMACOL, V76, P342, DOI 10.1124/mol.109.056523; White-Gilbertson S, 2009, ONCOGENE, V28, P1132, DOI 10.1038/onc.2008.468; Xu GH, 2005, J BIOL CHEM, V280, P42841, DOI 10.1074/jbc.M506569200	45	17	18	2	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					130	142		10.1096/fj.201601142R	http://dx.doi.org/10.1096/fj.201601142R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28864659	Green Published			2022-12-28	WOS:000419172700014
J	Crossland, H; Timmons, JA; Atherton, PJ				Crossland, Hannah; Timmons, James A.; Atherton, Philip J.			A dynamic ribosomal biogenesis response is not required for IGF-1-mediated hypertrophy of human primary myotubes	FASEB JOURNAL			English	Article						RNA; skeletal muscle; mTOR	SKELETAL-MUSCLE HYPERTROPHY; RNA-POLYMERASE-I; C-MYC; RESISTANCE EXERCISE; RDNA TRANSCRIPTION; PROTEIN-SYNTHESIS; UBIQUITIN LIGASES; EXPRESSION; GROWTH; CELLS	Increased ribosomal DNA transcription has been proposed to limit muscle protein synthesis, making ribosome biogenesis central to skeletal muscle hypertrophy. We examined the relationship between ribosomal RNA (rRNA) production and IGF-n/1-n/mediated myotube hypertrophy in vitro. Primary skeletal myotubes were treated with IGF-n/1 (50 ng/ml) with or without 0.5 mu MCX-n/5461 (CX), an inhibitor of RNA polymerase I. Myotube diameter, total protein, and RNA and DNA levels were measured along with markers of RNA polymerase I regulatory factors and regulators of protein synthesis. CX treatment reduced 45S pre-n/rRNA expression (-64 +/- 5% vs. IGF-n/1; P < 0.001) and total RNA content (-16 +/- 2% vs. IGF-n/1; P < 0.001) in IGF-n/1-n/treated myotubes. IGF-n/1-n/mediated increases in myotube diameter (1.27 +/- 0.09-n/fold, P < 0.05 vs. control) and total protein (+20 +/- 2%; P < 0.001 vs. control) were not prevented by CX treatment. Suppression of rRNAsynthesis during IGF-n/1 treatment did not prevent early increases in AKT (+203 +/- 39% vs. CX; P < 0.001) and p70 S6K1 (269 +/- 41% vs. CX; P < 0.001) phosphorylation. Despite robust inhibition of the dynamic ribosomal biogenesis response to IGF-n/1, myotube diameter and protein accretion were sustained. Thus, while ribosome biogenesis represents a potential site for the regulation of skeletal muscle protein synthesis and muscle mass, it does not appear to be a prerequisite for IGF-n/1-n/induced myotube hypertrophy in vitro.-n/Crossland, H., Timmons, J. A., Atherton, P. J. A dynamic ribosomal biogenesis response is not required for IGF-n/1-n/mediated hypertrophy of human primary myotubes.	[Crossland, Hannah; Timmons, James A.] Kings Coll London, Guys Hosp, Div Genet & Mol Med, London, England; [Crossland, Hannah; Atherton, Philip J.] Univ Nottingham, Royal Derby Hosp, Sch Med, Derby, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Nottingham	Atherton, PJ (corresponding author), Univ Nottingham, Clin Metab & Mol Physiol, Med Sch, Royal Derby Hosp, Uttoxeter Rd, Derby DE22 3DT, England.	philip.atherton@nottingham.ac.uk	Crossland, Hannah/GMW-8128-2022; Timmons, James A/J-4698-2014; Timmons, James A/M-6350-2019	Timmons, James A/0000-0002-2255-1220; Timmons, James A/0000-0002-2255-1220; Atherton, Philip/0000-0002-7286-046X	UK Medical Research Council (MRC) [G1100015]; MRC-Arthritis Research UK (ARUK) Centre for Musculoskeletal Ageing Research [MR/K00414X/1, 19891]; Medical Research Council [G1100015] Funding Source: researchfish; MRC [G1100015] Funding Source: UKRI	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC-Arthritis Research UK (ARUK) Centre for Musculoskeletal Ageing Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in part, by the UK Medical Research Council (MRC; Grant G1100015). The MRC-Arthritis Research UK (ARUK) Centre for Musculoskeletal Ageing Research was funded through MRC Grant MR/K00414X/1 and ARUK Grant 19891 awarded to the Universities of Nottingham and Birmingham. The primary cells used were provided by T. Gustafsson (Karolinska Institutet, Solna, Sweden). The authors declare no conflicts of interest.	Adams GR, 1999, J APPL PHYSIOL, V87, P1705, DOI 10.1152/jappl.1999.87.5.1705; Albert B, 2012, GENET RES INT, V2012, DOI 10.1155/2012/276948; Baar K, 1999, AM J PHYSIOL-CELL PH, V276, pC120, DOI 10.1152/ajpcell.1999.276.1.C120; Beckouet F, 2008, MOL CELL BIOL, V28, P1596, DOI 10.1128/MCB.01464-07; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Boon K, 2001, EMBO J, V20, P1383, DOI 10.1093/emboj/20.6.1383; Brook MS, 2016, J PHYSIOL-LONDON, V594, P7399, DOI 10.1113/JP272857; Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; Campbell KJ, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a018408; Chen YW, 2002, J PHYSIOL-LONDON, V545, P27, DOI 10.1113/jphysiol.2002.021220; Crossland H, 2013, AM J PHYSIOL-ENDOC M, V305, pE183, DOI 10.1152/ajpendo.00541.2012; ENDO T, 1986, MOL CELL BIOL, V6, P1412, DOI 10.1128/MCB.6.5.1412; Figueiredo VC, 2015, AM J PHYSIOL-ENDOC M, V309, pE72, DOI 10.1152/ajpendo.00050.2015; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Hannan KM, 2003, MOL CELL BIOL, V23, P8862, DOI 10.1128/MCB.23.23.8862-8877.2003; HANZLIKOVA V, 1975, CELL TISSUE RES, V160, P411; Kim S, 2000, P NATL ACAD SCI USA, V97, P11198, DOI 10.1073/pnas.200372597; Kuhn CD, 2007, CELL, V131, P1260, DOI 10.1016/j.cell.2007.10.051; Kusnadi EP, 2015, GENE, V556, P27, DOI 10.1016/j.gene.2014.11.010; Li LM, 2016, ONCOTARGETS THER, V9, P5985, DOI 10.2147/OTT.S104513; Mammucari C, 2008, AUTOPHAGY, V4, P524, DOI 10.4161/auto.5905; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504; Milan G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7670; Nader GA, 2005, AM J PHYSIOL-CELL PH, V289, pC1457, DOI 10.1152/ajpcell.00165.2005; Nakada S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147284; Olsson K, 2016, ENDOCRINOLOGY, V157, P98, DOI 10.1210/en.2015-1685; Poortinga G, 2004, EMBO J, V23, P3325, DOI 10.1038/sj.emboj.7600335; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Stec MJ, 2016, AM J PHYSIOL-ENDOC M, V310, pE652, DOI 10.1152/ajpendo.00486.2015; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Tamaki T, 2009, HISTOCHEM CELL BIOL, V132, P71, DOI 10.1007/s00418-009-0584-2; von Walden F, 2016, AM J PHYSIOL-CELL PH, V311, pC663, DOI 10.1152/ajpcell.00144.2016; von Walden F, 2012, AM J PHYSIOL-CELL PH, V302, pC1523, DOI 10.1152/ajpcell.00460.2011; Wen Y, 2016, EXERC SPORT SCI REV, V44, P110, DOI 10.1249/JES.0000000000000082; West DWD, 2016, J PHYSIOL-LONDON, V594, P453, DOI 10.1113/JP271365; Xu H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14432	42	8	8	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5196	5207		10.1096/fj.201700329R	http://dx.doi.org/10.1096/fj.201700329R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28774889	Green Published			2022-12-28	WOS:000416588300007
J	Wei, J; Ding, DX; Wang, T; Liu, Q; Lin, Y				Wei, Jie; Ding, Dongxiao; Wang, Tao; Liu, Qiong; Lin, Yi			MiR-338 controls BPA-triggered pancreatic islet insulin secretory dysfunction from compensation to decompensation by targeting Pdx-1	FASEB JOURNAL			English	Article						glucose homeostasis; estrogen receptor; Gpr30; Glp1; diabetes	ENDOCRINE-DISRUPTING CHEMICALS; GLUCAGON-LIKE PEPTIDE-1; BETA-CELL FUNCTION; HIGH-FAT DIET; BREAST-CANCER CELLS; COUPLED RECEPTOR 30; BISPHENOL-A; DIABETES-MELLITUS; GENE-EXPRESSION; DOWN-REGULATION	Bisphenol A (BPA) can disrupt glucose homeostasis and impair pancreatic islet function; however, the mechanisms behind these effects are poorly understood. Malemice (4wk old) were treated with BPA(50 or 500mg/kg/d) for 8 wk. Whole-body glucose homeostasis, pancreatic islet morphology and function, and miR-338-mediated molecular signal transduction analyses were examined. We showed that BPA treatment ledto a disruption of glucose tolerance and a compensatory increase of pancreatic islets insulin secretion and pancreatic and duodenal homeobox 1 (Pdx1) expression in mice. Inhibition of Pdx1 reduced glucose-stimulated insulin secretion and ATP production in the islets of BPA-exposed mice. Based on primary pancreatic islets, we also confirmed that miR-338 regulated Pdx1 and thus contributed to BPA-induced insulin secretory dysfunction from compensation to decompensation. Shortterm BPA exposure downregulated miR-338 through activation of G-protein-coupled estrogen receptor 1 (Gpr30), whereas long-term BPA exposure upregulated miR-338 through suppression of glucagon-like peptide 1 receptor (Glp1r). Taken together, our results reveal a molecular mechanism, whereby BPA regulates Gpr30/Glp1r to mediate the expression of miR-338, which acts to control Pdx1-dependent insulin secretion. The Gpr30/Glp1r-miR-338-Pdx1 axis should be represented as a novel mechanismby which BPA induces insulin secretory dysfunction in pancreatic islets.-Wei, J., Ding, D., Wang, T., Liu, Q., Lin, Y. MiR-338 controls BPA-triggered pancreatic islet insulin secretory dysfunction from compensation to decompensation by targeting Pdx-1.	[Wei, Jie; Liu, Qiong] Xiamen Univ, Med Coll, Dept Basic Med Sci, Xiamen, Peoples R China; [Wang, Tao] Xiamen Univ, State Key Lab Cellular Stress Biol, Xiamen, Peoples R China; [Wang, Tao] Xiamen Univ, Dept Biomed Sci, Sch Life Sci, Xiamen, Peoples R China; [Ding, Dongxiao; Lin, Yi] Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Environm & Hlth, Xiamen 361021, Peoples R China	Xiamen University; Xiamen University; Xiamen University; Chinese Academy of Sciences; Institute of Urban Environment, CAS	Lin, Y (corresponding author), Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Environm & Hlth, Xiamen 361021, Peoples R China.; Wei, J (corresponding author), Xiamen Univ, Dept Basic Med Sci, Med Coll, Xiamen Na 361102, Fujian, Peoples R China.	jiewei@xmu.edu.cn; ylin@iue.ac.cn	CAS, KLUEH/T-5743-2019		National Natural Science Foundation of China [81502782, 21677140]; Natural Science Foundation of Fujian [2015J01351, 2017J01028]; Fundamental Research Funds for the Central Universities [20720150113]; Youth Innovation Promotion Association, Chinese Academy of Sciences [217349]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian(Natural Science Foundation of Fujian Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Youth Innovation Promotion Association, Chinese Academy of Sciences	The authors thank the Xiamen University Laboratory Animal Center for providing animal management and care and Shaopeng Yu of the Center for helping to perform the animal experiments. This work was supported by Grants 81502782 and 21677140 from the National Natural Science Foundation of China; Grants 2015J01351 and 2017J01028 from the Natural Science Foundation of Fujian; Grant 20720150113 from the Fundamental Research Funds for the Central Universities; and Grant 217349 from the Youth Innovation Promotion Association, Chinese Academy of Sciences. The authors declare no conflicts of interest.	Ahren J, 2010, ISLETS, V2, P353, DOI 10.4161.islets.2.6.13619; Alonso-Magdalena P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002069; Alonso-Magdalena P, 2011, NAT REV ENDOCRINOL, V7, P346, DOI 10.1038/nrendo.2011.56; Aschrafi A, 2012, CELL MOL LIFE SCI, V69, P4017, DOI 10.1007/s00018-012-1064-8; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Carchia E, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.319; D'Cruz SC, 2012, FOOD CHEM TOXICOL, V50, P1124, DOI 10.1016/j.fct.2011.11.041; Damsch S, 2011, TOXICOL PATHOL, V39, P348, DOI 10.1177/0192623310388431; Dong S, 2011, ENVIRON POLLUT, V159, P212, DOI 10.1016/j.envpol.2010.09.004; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; El Ouaamari A, 2008, DIABETES, V57, P2708, DOI 10.2337/db07-1614; Farilla L, 2002, ENDOCRINOLOGY, V143, P4397, DOI 10.1210/en.2002-220405; Filios SR, 2015, DIABETES, V64, P3631, DOI 10.2337/db15-0831; Garofano A, 1998, DIABETOLOGIA, V41, P1114, DOI 10.1007/s001250051038; Gauthier BR, 2004, J BIOL CHEM, V279, P31121, DOI 10.1074/jbc.M405030200; Ge LC, 2014, TOXICOL LETT, V226, P81, DOI 10.1016/j.toxlet.2014.01.035; Gifford R, 2015, LANCET DIABETES ENDO, V3, P925, DOI 10.1016/S2213-8587(15)00423-4; Holst JJ, 2004, AM J PHYSIOL-ENDOC M, V287, pE199, DOI 10.1152/ajpendo.00545.2003; Huygh J, 2015, ENVIRON INT, V81, P64, DOI 10.1016/j.envint.2015.04.008; Jacovetti C, 2012, J CLIN INVEST, V122, P3541, DOI 10.1172/JCI64151; Kang HS, 2014, J PHYSIOL PHARMACOL, V65, P273; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Latreille M, 2014, J CLIN INVEST, V124, P2722, DOI 10.1172/JCI73066; Lin Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.206; Lin Y, 2017, BBA-MOL CELL BIOL L, V1862, P869, DOI 10.1016/j.bbalip.2017.05.001; Marmugi A, 2014, TOXICOLOGY, V325, P133, DOI 10.1016/j.tox.2014.08.006; Moon MK, 2015, J ENDOCRINOL, V226, P35, DOI 10.1530/JOE-14-0714; Nadal A, 2018, J STEROID BIOCHEM, V176, P16, DOI 10.1016/j.jsbmb.2017.01.014; Nesca V, 2013, DIABETOLOGIA, V56, P2203, DOI 10.1007/s00125-013-2993-y; Perreault L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069991; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Pupo M, 2012, ENVIRON HEALTH PERSP, V120, P1177, DOI 10.1289/ehp.1104526; Quesada I, 2002, FASEB J, V16, P1671, DOI 10.1096/fj.02-0313fje; Saura M, 2014, FASEB J, V28, P4719, DOI 10.1096/fj.14-252460; Schneyer A, 2011, ENDOCRINOLOGY, V152, P3301, DOI 10.1210/en.2011-1301; Sharma G, 2011, ENDOCRINOLOGY, V152, P3030, DOI 10.1210/en.2011-0091; Sheng ZG, 2011, ENVIRON HEALTH PERSP, V119, P1775, DOI 10.1289/ehp.1103781; Sieli PT, 2011, ENVIRON HEALTH PERSP, V119, P1260, DOI 10.1289/ehp.1003385; Silver MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026868; Smith EP, 2014, CELL METAB, V19, P1050, DOI 10.1016/j.cmet.2014.04.005; Song LQ, 2012, J ENDOCRINOL, V215, P303, DOI 10.1530/JOE-12-0219; Song Y, 2016, J DIABETES, V8, P516, DOI 10.1111/1753-0407.12325; Soriano S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031109; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; Tao SF, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0489-x; Taylor JA, 2011, ENVIRON HEALTH PERSP, V119, P422, DOI 10.1289/ehp.1002514; Teng Y, 2015, J BIOL CHEM, V290, P15799, DOI 10.1074/jbc.M115.641167; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; Thomas P, 2006, J STEROID BIOCHEM, V102, P175, DOI 10.1016/j.jsbmb.2006.09.017; Tiano JP, 2012, NAT REV ENDOCRINOL, V8, P342, DOI 10.1038/nrendo.2011.242; Vandenberg LN, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-46; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Veiga-Lopez A, 2013, ENDOCRINOLOGY, V154, P1873, DOI 10.1210/en.2012-2129; Walker MK, 2012, TOXICOL APPL PHARM, V260, P65, DOI 10.1016/j.taap.2012.01.025; Wei J, 2014, FREE RADICAL BIO MED, V67, P91, DOI 10.1016/j.freeradbiomed.2013.10.811; Wei J, 2011, ENDOCRINOLOGY, V152, P3049, DOI 10.1210/en.2011-0045; Welshons WV, 2006, ENDOCRINOLOGY, V147, pS56, DOI 10.1210/en.2005-1159; Wetherill YB, 2007, REPROD TOXICOL, V24, P178, DOI 10.1016/j.reprotox.2007.05.010; Xu G, 2007, DIABETES, V56, P1551, DOI 10.2337/db06-1033	59	28	28	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5184	5195		10.1096/fj.201700282R	http://dx.doi.org/10.1096/fj.201700282R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28774890				2022-12-28	WOS:000416588300006
J	Galuppo, P; Vettorazzi, S; Hovelmann, J; Scholz, CJ; Tuckermann, JP; Bauersachs, J; Fraccarollo, D				Galuppo, Paolo; Vettorazzi, Sabine; Hoevelmann, Julian; Scholz, Claus-Juergen; Tuckermann, Jan Peter; Bauersachs, Johann; Fraccarollo, Daniela			The glucocorticoid receptor in monocyte-derived macrophages is critical for cardiac infarct repair and remodeling	FASEB JOURNAL			English	Article						fibroblast; myeloid cells; myocardial infarction; wound healing	ACUTE MYOCARDIAL-INFARCTION; INFLAMMATORY RESPONSE; CELLULAR COMPOSITION; SUPPRESSION; ANGIOGENESIS; FIBROBLASTS; ACTIVATION; EXPRESSION	Cell-and tissue-specific actions of glucocorticoids are mediated by the glucocorticoid receptor. Here, we demonstrate that the glucocorticoid receptor (GR) in macrophages is essential for cardiac healing after myocardial infarction. Compared with GR(flox) (wild-type controls), GR(LysMCre) mice that lacked GR in myeloid cells showed increased acute mortality as a result of cardiac rupture. Seven days after left coronary artery ligation, GRLysMCre mice exhibited worse cardiac function and adverse remodeling associated with impaired scar formation and angiogenic response to ischemic injury. Inactivation of GR altered the functional differentiation/maturation of monocyte-derived macrophages in the infarcted myocardium. Mechanistically, CD45(+)/CD11b(+)/Ly6G(-)/F4/80(+) macrophages isolated from GRLysMCre infarcts showed deregulation of factors that control inflammation, neovascularization, collagen degradation, and scar tissue formation. Moreover, we demonstrate that cardiac fibroblasts sorted from the ischemic myocardium of GR(LysMCre) mice compared with cells isolated from injured GRflox hearts displayed higher matrix metalloproteinase 2 expression, and we provide evidence that the macrophage GR regulates myofibroblast differentiation in the infarct microenvironment during the early phase of wound healing. In summary, GR signaling in macrophages, playing a crucial role in tissue-repairing mechanisms, could be a potential therapeutic target during wound healing after ischemic myocardial injury.-Galuppo, P., Vettorazzi, S., Hovelmann, J., Scholz, C.-J., Tuckermann, J. P., Bauersachs, J., Fraccarollo, D. The glucocorticoid receptor in monocyte-derived macrophages is critical for cardiac infarct repair and remodeling.	[Galuppo, Paolo; Hoevelmann, Julian; Bauersachs, Johann; Fraccarollo, Daniela] Hannover Med Sch, Dept Cardiol & Angiol, Carl Neuberg St 1, D-30625 Hannover, Germany; [Vettorazzi, Sabine; Tuckermann, Jan Peter] Univ Ulm, Inst Comparat Mol Endocrinol, Ulm, Germany; [Scholz, Claus-Juergen] Univ Bonn, Life & Med Sci Inst LIMES, Bonn, Germany	Hannover Medical School; Ulm University; University of Bonn	Fraccarollo, D (corresponding author), Hannover Med Sch, Dept Cardiol & Angiol, Carl Neuberg St 1, D-30625 Hannover, Germany.	fraccarollo.daniela@mh-hannover.de	Scholz, Claus Jürgen/H-3202-2019; Hoevelmann, Julian/AAP-3995-2021	Scholz, Claus Jürgen/0000-0002-6406-7859; Hoevelmann, Julian/0000-0002-2023-3026; Vettorazzi, Dr. Sabine/0000-0001-8667-9488	German Cardiac Society	German Cardiac Society	The authors thank Margarete Gobel from the Core Unit Systems Medicine (University of Wurzburg) for excellent technical assistance. J.H. was supported by a research grant from the German Cardiac Society. The authors declare no conflicts of interest.	Bujak M, 2008, AM J PATHOL, V173, P57, DOI 10.2353/ajpath.2008.070974; Cain DW, 2017, NAT REV IMMUNOL, V17, P233, DOI 10.1038/nri.2017.1; Cao J, 2015, MACROMOL RES, V23, P485, DOI 10.1007/s13233-015-3065-6; Chen BJ, 2017, MICROCIRCULATION, V24, DOI 10.1111/micc.12305; Desmet SJ, 2017, J CLIN INVEST, V127, P1136, DOI 10.1172/JCI88886; Dutta P, 2015, ARTERIOSCL THROM VAS, V35, P1066, DOI 10.1161/ATVBAHA.114.304652; Fraccarollo D., 2017, METHODS MOL BIOL FIB; Fraccarollo D, 2008, HYPERTENSION, V51, P905, DOI 10.1161/HYPERTENSIONAHA.107.100941; Fraccarollo D, 2015, ESC HEART FAIL, V2, P150, DOI 10.1002/ehf2.12053; Fraccarollo D, 2012, CARDIOVASC RES, V94, P293, DOI 10.1093/cvr/cvs109; Fraccarollo D, 2011, CIRCULATION, V123, P400, DOI 10.1161/CIRCULATIONAHA.110.983023; Frangogiannis NG, 2001, FASEB J, V15, P1428, DOI 10.1096/fj.00-0745fje; Frangogiannis NG, 2016, CIRC RES, V119, P1049, DOI 10.1161/CIRCRESAHA.116.309926; Frantz S, 2013, FASEB J, V27, P871, DOI 10.1096/fj.12-214049; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Giugliano GR, 2003, AM J CARDIOL, V91, P1055, DOI 10.1016/S0002-9149(03)00148-6; Gray GA, 2017, J MOL ENDOCRINOL, V58, pR1, DOI 10.1530/JME-16-0128; Hafezi-Moghadam A, 2002, NAT MED, V8, P473, DOI 10.1038/nm0502-473; Hilgendorf I, 2014, CIRC RES, V114, P1611, DOI 10.1161/CIRCRESAHA.114.303204; Hubner S, 2015, BIOL CHEM, V396, P1223, DOI 10.1515/hsz-2015-0106; MANNISI JA, 1987, J CLIN INVEST, V79, P1431, DOI 10.1172/JCI112971; Minutti CM, 2017, SEMIN CELL DEV BIOL, V61, P3, DOI 10.1016/j.semcdb.2016.08.006; Montecucco F, 2012, EUR HEART J, V33, P1964, DOI 10.1093/eurheartj/ehr127; Pentecost A. E., 2016, MICROSCALE TECHNOLOG, P292; Pinto AR, 2016, CIRC RES, V118, P400, DOI 10.1161/CIRCRESAHA.115.307778; Prabhu SD, 2016, CIRC RES, V119, P91, DOI 10.1161/CIRCRESAHA.116.303577; Ridiandries A, 2017, FASEB J, V31, P1179, DOI 10.1096/fj.201600540R; Ridiandries A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111856; Sanchez-Martin L, 2011, BLOOD, V117, P88, DOI 10.1182/blood-2009-12-258186; Saxena A, 2013, J IMMUNOL, V191, P4838, DOI 10.4049/jimmunol.1300725; Seropian IM, 2014, J AM COLL CARDIOL, V63, P1593, DOI 10.1016/j.jacc.2014.01.014; Snyder RJ, 2016, WOUND REPAIR REGEN, V24, P613, DOI 10.1111/wrr.12444; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Tillmanns J, 2015, J MOL CELL CARDIOL, V87, P194, DOI 10.1016/j.yjmcc.2015.08.016; Tuckermann JP, 2007, J CLIN INVEST, V117, P1381, DOI 10.1172/JCI28034; Vettorazzi S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8796; Weinberger T, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00107; Zhou PZ, 2016, CIRC RES, V118, P368, DOI 10.1161/CIRCRESAHA.116.308139	38	21	21	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					5122	5132		10.1096/fj.201700317R	http://dx.doi.org/10.1096/fj.201700317R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28768721	Green Published			2022-12-28	WOS:000413398500039
J	Torres, P; Diaz, J; Arce, M; Silva, P; Mendoza, P; Lois, P; Molina-Berrios, A; Owen, GI; Palma, V; Torres, VA				Torres, Pedro; Diaz, Jorge; Arce, Maximiliano; Silva, Patricio; Mendoza, Pablo; Lois, Pablo; Molina-Berrios, Alfredo; Owen, Gareth I.; Palma, Veronica; Torres, Vicente A.			The salivary peptide histatin-1 promotes endothelial cell adhesion, migration, and angiogenesis	FASEB JOURNAL			English	Article						signaling; GTPase; saliva; Rab5; wound healing	WOUND-CLOSURE; RICH PROTEINS; GROWTH-FACTOR; RAC; MORPHOGENESIS; MUCOSAL; RAB5	Saliva is a key factor that contributes to the high efficiency of wound healing in the oral mucosa. This is not only attributed to physical cues but also to the presence of specific peptides in the saliva, such as histatins. Histatin-1 is a 38 aa antimicrobial peptide, highly enriched in human saliva, which has been previously reported to promote the migration of oral keratinocytes and fibroblasts in vitro. However, the participation of histatin-1 in other crucial events required for wound healing, such as angiogenesis, is unknown. Here we demonstrate that histatin-1 promotes angiogenesis, as shown in vivo, using the chick chorioallantoic membrane model, and by an in vitro tube formation assay, using both human primary cultured endothelial cells (HUVECs) and the EA. hy926 cell line. Specifically, histatin-1 promoted endothelial cell adhesion and spreading onto fibronectin, as well as endothelial cell migration in the wound closure and Boyden chamber assays. These actions required the activation of the Ras and Rab interactor 2 (RIN2)/Rab5/Rac1 signaling axis, as histatin-1 increased the recruitment of RIN2, a Rab5-guanine nucleotide exchange factor (GEF) to early endosomes, leading to sequential Rab5/Rac1 activation. Accordingly, interfering with either Rab5 or Rac1 activities prevented histatin-1-dependent endothelial cell migration. Finally, by immunodepletion assays, we showed that salivary histatin-1 is required for the promigratory effects of saliva on endothelial cells. In conclusion, we report that salivary histatin-1 is a novel proangiogenic factor that may contribute to oral wound healing.-Torres, P., Diaz, J., Arce, M., Silva, P., Mendoza, P., Lois, P., Molina-Berrios, A., Owen, G. I., Palma, V., Torres, V. A. The salivary peptide histatin-1 promotes endothelial cell adhesion, migration, and angiogenesis.	[Torres, Pedro; Silva, Patricio; Mendoza, Pablo; Molina-Berrios, Alfredo; Torres, Vicente A.] Univ Chile, Fac Dent, Inst Res Dent Sci, Calle Sergio Livingstone 943, Santiago 8380492, Chile; [Diaz, Jorge; Arce, Maximiliano; Owen, Gareth I.; Torres, Vicente A.] Univ Chile, Adv Ctr Chron Dis ACCDiS, Santiago, Chile; [Lois, Pablo; Palma, Veronica] Univ Chile, Fac Sci, Lab Stem Cells & Dev Biol, Santiago, Chile; [Arce, Maximiliano; Owen, Gareth I.] Pontificia Univ Catolica Chile, Fac Biol Sci, Santiago, Chile; [Arce, Maximiliano; Owen, Gareth I.] Pontificia Univ Catolica Chile, Fac Med, Santiago, Chile; [Owen, Gareth I.] Pontificia Univ Catolica Chile, Millennium Inst Immunol & Immunotherapy, Santiago, Chile; [Silva, Patricio] Univ Cent Chile, Fac Hlth Sci, Santiago, Chile	Universidad de Chile; Universidad de Chile; Universidad de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Universidad Central de Chile	Torres, VA (corresponding author), Univ Chile, Fac Dent, Inst Res Dent Sci, Calle Sergio Livingstone 943, Santiago 8380492, Chile.	vatorres@med.uchile.cl		Torres, Vicente A/0000-0002-5973-7248; Molina-Berrios, Alfredo/0000-0001-8351-3239; Palma, Veronica/0000-0002-4320-7525	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1140907, 1140970, 1140697, 11140227]; Comision Nacional de Investigacion Cientifica y Tecnologica-Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias (CONICYT-FONDAP) [15130011]; Fondo de Fomento al Desarrollo Cientifico y Tecnologico (Fondef) [D09E1047]; Biomedical Research Consortium of Chile (BMRC) [13CTI-21526-P6]; Instituto Milenio en Inmunologia e Inmunoterapia (IMII) [P09/016-F]	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Comision Nacional de Investigacion Cientifica y Tecnologica-Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias (CONICYT-FONDAP); Fondo de Fomento al Desarrollo Cientifico y Tecnologico (Fondef)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDEF); Biomedical Research Consortium of Chile (BMRC); Instituto Milenio en Inmunologia e Inmunoterapia (IMII)	The authors acknowledge C. Pizarro (Faculty of Sciences, Universidad de Chile) for help with the chick CAM analysis. This work was supported, in part, by Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) Grants 1140907 (to V.A.T.), 1140970 (to G.I.O.), 1140697 (to V.P.), and 11140227 (to A.M.-B.); Comision Nacional de Investigacion Cientifica y Tecnologica-Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias (CONICYT-FONDAP) 15130011 (to V.A.T. and G.I.O.); Fondo de Fomento al Desarrollo Cientifico y Tecnologico (Fondef) D09E1047; and Biomedical Research Consortium of Chile (BMRC) 13CTI-21526-P6 and Instituto Milenio en Inmunologia e Inmunoterapia (IMII) P09/016-F (to G.I.O.). The authors declare no conflicts of interest.	Ahmad M, 2004, J HISTOCHEM CYTOCHEM, V52, P361, DOI 10.1177/002215540405200307; Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; Barbieri MA, 2004, EUR J CELL BIOL, V83, P305, DOI 10.1078/0171-9335-00381; Bid HK, 2013, MOL CANCER THER, V12, P1925, DOI 10.1158/1535-7163.MCT-13-0164; Boink MA, 2016, WOUND REPAIR REGEN, V24, P100, DOI 10.1111/wrr.12380; Brand HS, 2013, CHIN J DENT RES, V16, P7; Campese M, 2009, ARCH ORAL BIOL, V54, P345, DOI 10.1016/j.archoralbio.2008.11.010; Connolly JO, 2002, MOL BIOL CELL, V13, P2474, DOI 10.1091/mbc.E02-01-0006; Fernandez-Borja M, 2012, CELL RES, V22, P1426, DOI 10.1038/cr.2012.118; Glim JE, 2013, WOUND REPAIR REGEN, V21, P648, DOI 10.1111/wrr.12072; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Gusman H, 2004, ARCH ORAL BIOL, V49, P11, DOI 10.1016/S0003-9969(03)00182-1; Keswani SG, 2013, WOUND REPAIR REGEN, V21, P554, DOI 10.1111/wrr.12065; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lange S, 2014, J CELL PHYSIOL, V229, P1673, DOI 10.1002/jcp.24612; MACARAK EJ, 1983, J CELL PHYSIOL, V116, P76, DOI 10.1002/jcp.1041160112; Melino S, 2014, FEBS J, V281, P657, DOI 10.1111/febs.12612; Mendoza P, 2013, J CELL SCI, V126, P3835, DOI 10.1242/jcs.119727; OPPENHEIM FG, 1988, J BIOL CHEM, V263, P7472; OPPENHEIM FG, 1986, J BIOL CHEM, V261, P1177; Oudhoff MJ, 2009, J DENT RES, V88, P846, DOI 10.1177/0022034509342951; Oudhoff MJ, 2008, FASEB J, V22, P3805, DOI 10.1096/fj.08-112003; Oudhoff MJ, 2009, FASEB J, V23, P3928, DOI 10.1096/fj.09-137588; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Sandri C, 2012, CELL RES, V22, P1479, DOI 10.1038/cr.2012.110; Silva P, 2016, ONCOTARGET, V7, P29548, DOI 10.18632/oncotarget.8794; Storgard Chris, 2004, V294, P123; Sun XL, 2009, FASEB J, V23, P2691, DOI 10.1096/fj.09-131045; Szpaderska AM, 2003, J DENT RES, V82, P621, DOI 10.1177/154405910308200810; van Dijk IA, 2017, J DENT RES, V96, P423, DOI 10.1177/0022034516681761; van Dijk IA, 2017, FASEB J, V31, P3922, DOI 10.1096/fj.201700180R; van Dijk IA, 2015, FASEB J, V29, P3124, DOI 10.1096/fj.14-266825; VANSETTEN GB, 1995, LARYNGOSCOPE, V105, P610, DOI 10.1288/00005537-199506000-00009; XU T, 1991, INFECT IMMUN, V59, P2549, DOI 10.1128/IAI.59.8.2549-2554.1991	34	42	45	1	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4946	4958		10.1096/fj.201700085R	http://dx.doi.org/10.1096/fj.201700085R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28751526				2022-12-28	WOS:000413398500025
J	Galan, M; Varona, S; Guadall, A; Orriols, M; Navas, M; Aguilo, S; de Diego, A; Navarro, MA; Garcia-Dorado, D; Rodriguez-Sinovas, A; Martinez-Gonzalez, J; Rodriguez, C				Galan, Maria; Varona, Saray; Guadall, Anna; Orriols, Mar; Navas, Miquel; Aguilo, Silvia; de Diego, Alicia; Navarro, Maria A.; Garcia-Dorado, David; Rodriguez-Sinovas, Antonio; Martinez-Gonzalez, Jose; Rodriguez, Cristina			Lysyl oxidase overexpression accelerates cardiac remodeling and aggravates angiotensin II-induced hypertrophy	FASEB JOURNAL			English	Article						reactive oxygen species; extracellular matrix; reactive oxygen species	COLLAGEN CROSS-LINKING; NF-KAPPA-B; HEART-FAILURE; MYOCARDIAL HYPERTROPHY; FIBROSIS; EXPRESSION; FIBROBLASTS; PATHWAYS; MICE; CELL	Lysyl oxidase (LOX) controls matrix remodeling, a key process that underlies cardiovascular diseases and heart failure; however, a lack of suitable animal models has limited our knowledge with regard to the contribution of LOX to cardiac dysfunction. Here, we assessed the impact of LOX overexpression on ventricular function and cardiac hypertrophy in a transgenic LOX (TgLOX) mouse model with a strong cardiac expression of human LOX. TgLOX mice exhibited high expression of the transgene in cardiomyocytes and cardiofibroblasts, which are associated with enhanced LOX activity and H2O2 production and with cardiofibroblast reprogramming. LOX overexpression promoted an age-associated concentric remodeling of the left ventricle and impaired diastolic function. Furthermore, LOX transgenesis aggravated angiotensin II (Ang II)-induced cardiac hypertrophy and dysfunction, which triggered a greater fibrotic response that was characterized by stronger collagen deposition and cross-linking and high expression of fibrotic markers. In addition, LOX transgenesis increased the Ang II-induced myocardial inflammatory infiltrate, exacerbated expression of proinflammatory markers, and decreased that of cardioprotective factors. Mechanistically, LOX over-expression enhanced oxidative stress and potentiated the Ang II-mediated cardiac activation of p38 MAPK while reducing AMPK activation. Our findings suggest that LOX induces an age-dependent disturbance of diastolic function and aggravates Ang II-induced hypertrophy, which provides novel insights into the role of LOX in cardiac performance.	[Galan, Maria; Varona, Saray; Guadall, Anna; Orriols, Mar; Aguilo, Silvia; Rodriguez, Cristina] Inst Catala Ciencies Cardiovasc, Barcelona, Spain; [Galan, Maria; Navas, Miquel] Hosp Santa Creu & Sant Pau, Lab Angiol Biol Vasc & Inflamac, Barcelona, Spain; [Galan, Maria; Navas, Miquel] Hosp Santa Creu & Sant Pau, Serv Cirugia Vasc, Barcelona, Spain; [Galan, Maria; Varona, Saray; Guadall, Anna; Orriols, Mar; Navas, Miquel; Aguilo, Silvia; Martinez-Gonzalez, Jose; Rodriguez, Cristina] Inst Invest Biomed IIB St Pau, Barcelona, Spain; [Galan, Maria; Varona, Saray; Orriols, Mar; Garcia-Dorado, David; Rodriguez-Sinovas, Antonio; Martinez-Gonzalez, Jose; Rodriguez, Cristina] Ctr Invest Biomed Red Enfermedades Cardiovasc, Madrid, Spain; [de Diego, Alicia] Inst Aragones Ciencias Salud, Unidad Transgenesis, Zaragoza, Spain; [Navarro, Maria A.] Univ Zaragoza, Fac Vet, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Zaragoza, Spain; [Garcia-Dorado, David; Rodriguez-Sinovas, Antonio] Univ Autonoma Barcelona, Cardiovasc Dis Res Grp, Dept Cardiol, Vall dHebron Univ Hosp, Barcelona, Spain; [Garcia-Dorado, David; Rodriguez-Sinovas, Antonio] Univ Autonoma Barcelona, Res Inst, Barcelona, Spain; [Martinez-Gonzalez, Jose] Inst Invest Biomed Barcelona, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC); Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Zaragoza; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona	Martinez-Gonzalez, J; Rodriguez, C (corresponding author), Hosp Santa Creu & Sant Pau, Pabellon Inst Catala Ciencies Cardiovasc, C Antoni Maria Claret 167, Barcelona 08025, Spain.	jose.martinez@iibb.csic.es; crodriguezs@csic-iccc.org	Guadall, Anna/I-1709-2014; Rodriguez, Cristina/D-3099-2011; Arroyo, Maria Galán/S-3173-2018; Guadall, Anna/AAG-1691-2019; Navarro, Ángeles/AAG-6089-2019; Rodriguez-Sinovas, Antonio/A-8259-2010	Guadall, Anna/0000-0002-7821-8582; Rodriguez, Cristina/0000-0002-6472-5647; Arroyo, Maria Galán/0000-0002-4758-8388; Guadall, Anna/0000-0002-7821-8582; Rodriguez-Sinovas, Antonio/0000-0003-2930-8773; Navas Madronal, Miquel/0000-0003-2984-1471; de Diego, Alicia/0000-0001-7018-4018; Martinez-Gonzalez, Jose/0000-0002-3894-7166; alvarez, saray/0000-0002-7375-313X	Spanish Ministerio de Economia y Competitividad (MINECO)-Instituto de Salud Carlos III (ISCIII) [PI15/01016, SAF2015-64767-R, RD12/0042/0021, RD12/0042/0053]; Fundacio La Marato de TV3 [20152330, 20153610]; Fondo Europeo de Desarrollo Regional, a way to build Europe; Miguel Servet Program (ISCIII) [CP15/00126]	Spanish Ministerio de Economia y Competitividad (MINECO)-Instituto de Salud Carlos III (ISCIII); Fundacio La Marato de TV3; Fondo Europeo de Desarrollo Regional, a way to build Europe; Miguel Servet Program (ISCIII)	This work was cofunded by the Spanish Ministerio de Economia y Competitividad (MINECO)-Instituto de Salud Carlos III (ISCIII) (Grants PI15/01016, SAF2015-64767-R, RD12/0042/0021 and RD12/0042/0053), Fundacio La Marato de TV3 (20152330 and 20153610), and the Fondo Europeo de Desarrollo Regional, a way to build Europe. Centros de Investigacion Biomedica en Red de Enfermedades Cardiovasculares is an initiative of ISCIII. M.G. was supported by the Miguel Servet Program (ISCIII; CP15/00126). The authors thank Iris Rodriguez (Institut de Recerca Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau) for technical assistance.	Adam O, 2011, J MOL CELL CARDIOL, V50, P678, DOI 10.1016/j.yjmcc.2010.12.019; Aguado A, 2013, TOXICOL APPL PHARM, V268, P188, DOI 10.1016/j.taap.2013.01.030; Badenhorst D, 2003, CARDIOVASC RES, V57, P632, DOI 10.1016/S0008-6363(02)00733-2; Baicu CF, 2003, AM J PHYSIOL-HEART C, V284, pH122, DOI 10.1152/ajpheart.00233.2002; Barry SP, 2010, INT REV CEL MOL BIO, V284, P113, DOI 10.1016/S1937-6448(10)84003-1; Bendall JK, 2002, CIRCULATION, V105, P293, DOI 10.1161/hc0302.103712; Biernacka A, 2011, AGING DIS, V2, P158; Chou DK, 2007, TOXICOL SCI, V99, P267, DOI 10.1093/toxsci/kfm158; Fischer P, 2007, BASIC RES CARDIOL, V102, P279, DOI 10.1007/s00395-007-0658-z; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Frieler RA, 2015, CIRCULATION, V131, P1019, DOI 10.1161/CIRCULATIONAHA.114.008788; Galan M, 2016, DIS MODEL MECH, V9, P541, DOI 10.1242/dmm.024513; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; HIROTA H, 1995, P NATL ACAD SCI USA, V92, P4862, DOI 10.1073/pnas.92.11.4862; Kasner M, 2011, J AM COLL CARDIOL, V57, P977, DOI 10.1016/j.jacc.2010.10.024; Kawano S, 2005, CARDIOVASC RES, V67, P689, DOI 10.1016/j.cardiores.2005.04.030; Koshy SKG, 2003, CARDIOVASC RES, V57, P594, DOI 10.1016/S0008-6363(02)00877-5; Kurdi M, 2011, HYPERTENSION, V57, P1034, DOI 10.1161/HYPERTENSIONAHA.111.172700; Lopez BA, 2013, CARDIOVASC RES, V99, P111, DOI 10.1093/cvr/cvt100; Lopez B, 2012, HYPERTENSION, V60, P677, DOI 10.1161/HYPERTENSIONAHA.112.196113; Lopez B, 2010, AM J PHYSIOL-HEART C, V299, pH1, DOI 10.1152/ajpheart.00335.2010; Luo YX, 2017, EUR HEART J, V38, P1389, DOI 10.1093/eurheartj/ehw138; Maki JM, 2002, CIRCULATION, V106, P2503, DOI 10.1161/01.CIR.0000038109.84500.1E; Manabe I, 2002, CIRC RES, V91, P1103, DOI 10.1161/01.RES.0000046452.67724.B8; Martinez-Martinez E, 2016, J MOL CELL CARDIOL, V92, P96, DOI 10.1016/j.yjmcc.2016.01.012; Moore-Morris T, 2014, J CLIN INVEST, V124, P2921, DOI 10.1172/JCI74783; Murdoch CE, 2014, J AM COLL CARDIOL, V63, P2734, DOI 10.1016/j.jacc.2014.02.572; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Nave AH, 2014, ARTERIOSCL THROM VAS, V34, P1446, DOI 10.1161/ATVBAHA.114.303534; Orriols M, 2014, THROMB HAEMOSTASIS, V112, P812, DOI 10.1160/TH14-01-0024; Planavila A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3019; Qi D, 2015, TRENDS ENDOCRIN MET, V26, P422, DOI 10.1016/j.tem.2015.05.010; Rodriguez C, 2008, CARDIOVASC RES, V79, P7, DOI 10.1093/cvr/cvn102; Rodriguez C, 2008, DRUG NEWS PERSPECT, V21, P218, DOI 10.1358/dnp.2008.21.4.1213351; Rodriguez-Calvo R, 2013, HUM MOL GENET, V22, P1949, DOI 10.1093/hmg/ddt042; Sano M, 2001, CIRC RES, V89, P661, DOI 10.1161/hh2001.098873; Shimizu I, 2016, J MOL CELL CARDIOL, V97, P245, DOI 10.1016/j.yjmcc.2016.06.001; Tanajak P, 2015, J ENDOCRINOL, V227, pR13, DOI 10.1530/JOE-15-0289; Toyoda M, 2003, DEV CELL, V5, P85, DOI 10.1016/S1534-5807(03)00189-8; Tsutamoto T, 1998, J AM COLL CARDIOL, V31, P391, DOI 10.1016/S0735-1097(97)00494-4; Yang J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13710	41	34	36	2	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3787	3799		10.1096/fj.201601157RR	http://dx.doi.org/10.1096/fj.201601157RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28522596				2022-12-28	WOS:000408713300008
J	Fajuyigbe, D; Lwin, SM; Diffey, BL; Baker, R; Tobin, DJ; Sarkany, RPE; Young, AR				Fajuyigbe, Damilola; Lwin, Su M.; Diffey, Brian L.; Baker, Richard; Tobin, Desmond J.; Sarkany, Robert P. E.; Young, Antony R.			Melanin distribution in human epidermis affords localized protection against DNA photodamage and concurs with skin cancer incidence difference in extreme phototypes	FASEB JOURNAL			English	Article						skin phototype; solar-simulated radiation; cyclobutane pyrimidine dimer; minimal erythema dose	SQUAMOUS-CELL CARCINOMA; ULTRAVIOLET-RADIATION; UV EXPOSURE; STEM-CELLS; DAMAGE; COLOR; SUNSCREEN; RESPONSES; ERYTHEMA; SUNLIGHT	Epidermal DNA damage, especially to the basal layer, is an established cause of keratinocyte cancers (KCs). Large differences in KC incidence (20- to 60-fold) between white and black populations are largely attributable to epidermal melanin photoprotection in the latter. The cyclobutane pyrimidine dimer (CPD) is the most mutagenic DNA photolesion; however, most studies suggest that melanin photoprotection against CPD is modest and cannot explain the considerable skin color-based differences in KC incidence. Along with melanin quantity, solar-simulated radiation-induced CPD assessed immediately postexposure in the overall epidermis and within 3 epidermal zones was compared in black West Africans and fair Europeans. Melanin in black skin protected against CPD by 8.0-fold in the overall epidermis and by 59.0-, 16.5-, and 5.0-fold in the basal, middle, and upper epidermis, respectively. Protection was related to the distribution of melanin, which was most concentrated in the basal layer of black skin. These results may explain, at least in part, the considerable skin color differences in KC incidence. These data suggest that a DNA protection factor of at least 60 is necessary in sunscreens to reduce white skin KC incidence to a level that is comparable with that of black skin.Fajuyigbe, D., Lwin, S. M., Diffey, B. L., Baker, R., Tobin, D. J., Sarkany, R. P. E., Young, A. R. Melanin distribution in human epidermis affords localized protection against DNA photodamage and concurs with skin cancer incidence difference in extreme phototypes.	[Fajuyigbe, Damilola; Lwin, Su M.; Sarkany, Robert P. E.; Young, Antony R.] Kings Coll London, St Johns Inst Dermatol, London, England; [Diffey, Brian L.] Newcastle Univ, Inst Cellular Med, Dermatol Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Baker, Richard; Tobin, Desmond J.] Univ Bradford, Ctr Skin Sci, Fac Life Sci, Bradford, W Yorkshire, England	University of London; King's College London; Newcastle University - UK; University of Bradford	Fajuyigbe, D (corresponding author), Kings Coll London, Guys Hosp, 9th Floor,Tower Wing, London SE1 9RT, England.	damilola.fajuyigbe@kcl.ac.uk	Young, Antony/AAI-6723-2020; Tobin, Desmond/A-5228-2009	Young, Antony/0000-0002-4163-6772; Tobin, Desmond/0000-0003-4566-9392	Walgreens Boots Alliance (Weybridge, United Kingdom); National Institute for Health Research (NIHR) Clinical Research Facility at Guy's and St. Thomas' National Health Service (NHS) Foundation Trust; NIHR Biomedical Research Centre based at Guy's and St. Thomas' NHS Foundation Trust and King's College London	Walgreens Boots Alliance (Weybridge, United Kingdom); National Institute for Health Research (NIHR) Clinical Research Facility at Guy's and St. Thomas' National Health Service (NHS) Foundation Trust; NIHR Biomedical Research Centre based at Guy's and St. Thomas' NHS Foundation Trust and King's College London	The authors thank the volunteers for their participation. D.F. is supported by a Ph.D. Studentship from Walgreens Boots Alliance (Weybridge, United Kingdom). This work was also supported by the National Institute for Health Research (NIHR) Clinical Research Facility at Guy's and St. Thomas' National Health Service (NHS) Foundation Trust, and the NIHR Biomedical Research Centre based at Guy's and St. Thomas' NHS Foundation Trust and King's College London. The views expressed here are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. The authors declare no conflicts of interest.	Blanpain C, 2013, NAT CELL BIOL, V15, P126, DOI 10.1038/ncb2657; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; Brenner M, 2008, PHOTOCHEM PHOTOBIOL, V84, P539, DOI 10.1111/j.1751-1097.2007.00226.x; Cestari T, 2017, J AM ACAD DERMATOL, V76, pS110, DOI 10.1016/j.jaad.2016.09.039; Coelho SG, 2013, EXP DERMATOL, V22, P266, DOI 10.1111/exd.12116; Cole C, 2014, PHOTODERMATOL PHOTO, V30, P212, DOI 10.1111/phpp.12124; Dadzie OE, 2013, BRIT J DERMATOL, V169, pIII, DOI 10.1111/bjd.12528; Del Bino S, 2006, PIGM CELL RES, V19, P606, DOI 10.1111/j.1600-0749.2006.00338.x; Del Bino S, 2013, BRIT J DERMATOL, V169, P33, DOI 10.1111/bjd.12529; Del Bino S, 2015, PIGM CELL MELANOMA R, V28, P707, DOI 10.1111/pcmr.12410; Douki T., 2016, SKIN STRESS RESPONSE, P49, DOI [DOI 10.1007/978-3-319-43157-4_3, 10.1007/978-3-319-43157-4_3]; Droste M. S., 2006, THESIS; Fajuyigbe D, 2016, PIGM CELL MELANOMA R, V29, P607, DOI 10.1111/pcmr.12511; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; FREEMAN SE, 1986, J INVEST DERMATOL, V86, P34, DOI 10.1111/1523-1747.ep12283768; Ghiasvand R, 2016, J CLIN ONCOL, V34, P3976, DOI 10.1200/JCO.2016.67.5934; Gloster HM, 2006, J AM ACAD DERMATOL, V55, P741, DOI 10.1016/j.jaad.2005.08.063; Green AC, 2011, J CLIN ONCOL, V29, P257, DOI 10.1200/JCO.2010.28.7078; Harrison GI, 2002, METHODS, V28, P14, DOI 10.1016/S1046-2023(02)00205-0; Hu W., 2015, ENV SYST RES, V4, P4, DOI [10.1186/s40068-015-0031-4, DOI 10.1186/S40068-015-0031-4]; Joly-Tonetti N, 2016, EXP DERMATOL, V25, P501, DOI 10.1111/exd.13016; KAIDBEY KH, 1979, J AM ACAD DERMATOL, V1, P249, DOI 10.1016/S0190-9622(79)70018-1; Khavari PA, 2006, NAT REV CANCER, V6, P270, DOI 10.1038/nrc1838; Leiter U, 2008, ADV EXP MED BIOL, V624, P89, DOI 10.1007/978-0-387-77574-6_8; Martin MT, 2016, MUTAT RES-REV MUTAT, V770, P349, DOI 10.1016/j.mrrev.2016.08.004; MOAN J, 1989, CANCER RES, V49, P4247; Norval M, 2014, PHOTODERMATOL PHOTO, V30, P262, DOI 10.1111/phpp.12106; Owens DM, 2003, NAT REV CANCER, V3, P444, DOI 10.1038/nrc1096; Petersen B, 2014, PHOTODERMATOL PHOTO, V30, P96, DOI 10.1111/phpp.12099; Pfeifer GP, 2012, PHOTOCH PHOTOBIO SCI, V11, P90, DOI 10.1039/c1pp05144j; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Premi S, 2015, SCIENCE, V347, P842, DOI 10.1126/science.1256022; Rijken F, 2004, J INVEST DERMATOL, V122, P1448, DOI 10.1111/j.0022-202X.2004.22609.x; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; Sheehan JM, 2002, J INVEST DERMATOL, V118, P825, DOI 10.1046/j.1523-1747.2002.01681.x; Tadokoro T, 2003, FASEB J, V17, P1177, DOI 10.1096/fj.02-0865fje; Tewari A, 2012, J INVEST DERMATOL, V132, P394, DOI 10.1038/jid.2011.283; van der Pols JC, 2006, CANCER EPIDEM BIOMAR, V15, P2546, DOI 10.1158/1055-9965.EPI-06-0352; Yamaguchi Y, 2006, FASEB J, V20, P1486, DOI 10.1096/fj.06-5725fje; Young AR, 2017, J AM ACAD DERMATOL, V76, pS100, DOI 10.1016/j.jaad.2016.09.038; Young AR, 1998, J INVEST DERMATOL, V111, P982, DOI 10.1046/j.1523-1747.1998.00436.x; Young AR, 2000, J INVEST DERMATOL, V115, P37, DOI 10.1046/j.1523-1747.2000.00012.x	42	60	60	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3700	3706		10.1096/fj.201701472R	http://dx.doi.org/10.1096/fj.201701472R			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29394104				2022-12-28	WOS:000435104500018
J	Kumei, S; Yuhki, KI; Kojima, F; Kashiwagi, H; Imamichi, Y; Okumura, T; Narumiya, S; Ushikubi, F				Kumei, Shima; Yuhki, Koh-Ichi; Kojima, Fumiaki; Kashiwagi, Hitoshi; Imamichi, Yoshitaka; Okumura, Toshikatsu; Narumiya, Shuh; Ushikubi, Fumitaka			Prostaglandin I-2 suppresses the development of diet-induced nonalcoholic steatohepatitis in mice	FASEB JOURNAL			English	Article						Kupffer cell; NASH; oxidative stress	FATTY LIVER-DISEASE; SINUSOIDAL ENDOTHELIAL-CELLS; PROSTANOID RECEPTORS; OXIDATIVE STRESS; COX-2 INDUCTION; KUPFFER CELLS; MOUSE MODEL; PROSTACYCLIN; LACKING; IRON	Nonalcoholic steatohepatitis (NASH) is a hepatic manifestation of metabolic syndrome. Although the prostaglandin (PG)I2 receptor IP is expressed broadly in the liver, the role of PGI2-IP signaling in the development of NASH remains to be determined. Here, we investigated the role of the PGI2-IP system in the development of steatohepatitis using mice lacking the PGI2 receptor IP [IP-knockout (IP-KO) mice] and beraprost (BPS), a specific IP agonist. IP-KO and wild-type (WT) mice were fed a methionine-and choline-deficient diet (MCDD) for 2, 5, or 10 wk. BPS was administered orally to mice every day during the experimental periods. The effect of BPS on the expression of chemokine and inflammatory cytokines was examined also in cultured Kupffer cells. WT mice fed MCDD developed steatohepatitis at 10 wk. IP-KO mice developed steatohepatitis at 5 wk with augmented histologic derangements accompanied by increased hepatic monocyte chemoattractant protein-1 (MCP-1) and TNF-a concentrations. After 10 wk of MCDD, IP-KO mice had greater hepatic iron deposition with prominent oxidative stress, resulting in hepatocyte damage. In WT mice, BPS improved histologic and biochemical parameters of steatohe-patitis, accompanied by reduced hepatic concentration of MCP-1 and TNF-alpha. Accordingly, BPS suppressed the LPS-stimulated Mcp-1 and Tnf-a mRNA expression in cultured Kupffer cells prepared from WT mice. PGI2-IP signaling plays a crucial role in the development and progression of steatohepatitis by modulating the inflammatory response, leading to augmented oxidative stress. We suggest that the PGI2-IP system is an attractive therapeutic target for treating patients with NASH.	[Kumei, Shima; Yuhki, Koh-Ichi; Kojima, Fumiaki; Kashiwagi, Hitoshi; Imamichi, Yoshitaka; Ushikubi, Fumitaka] Asahikawa Med Univ, Dept Pharmacol, Asahikawa, Hokkaido, Japan; [Kumei, Shima; Okumura, Toshikatsu] Asahikawa Med Univ, Dept Gen Med, Asahikawa, Hokkaido, Japan; [Narumiya, Shuh] Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto, Japan	Asahikawa Medical College; Asahikawa Medical College; Kyoto University	Ushikubi, F (corresponding author), Asahikawa Med Univ, Midorigaoka Higashi 2-1-1-1, Asahikawa, Hokkaido 0788510, Japan.	ushikubi@asahikawa-med.ac.jp		Kashiwagi, Hitoshi/0000-0001-6385-9988; Okumura, Toshikatsu/0000-0003-1810-007X	Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Agency [15gm0410006h0106]; Smoking Research Foundation	Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Smoking Research Foundation	The authors thank Y. Watanabe and T. Yokoyama for help in breeding and maintenance of mice; Y. Tomonari, T. Ohkubo, N. Niizeki, and T. Ito for assistance with the experiments; and Y. Takashima for secretarial help (all from Asahikawa Medical University). This work was supported by the Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Agency (Grant 15gm0410006h0106), and by a grant from the Smoking Research Foundation. The authors declare no conflicts of interest.	AKIBA T, 1986, BRIT J PHARMACOL, V89, P703, DOI 10.1111/j.1476-5381.1986.tb11174.x; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; BIRMELIN M, 1984, EUR J BIOCHEM, V142, P219, DOI 10.1111/j.1432-1033.1984.tb08274.x; BUNTING S, 1976, PROSTAG OTH LIPID M, V12, P897, DOI 10.1016/0090-6980(76)90125-8; Corbin KD, 2012, CURR OPIN GASTROEN, V28, P159, DOI 10.1097/MOG.0b013e32834e7b4b; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; dela Pena A, 2007, J HEPATOL, V46, P304, DOI 10.1016/j.jhep.2006.08.025; Dorris SL, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/926968; EYHORN S, 1988, J HEPATOL, V6, P23, DOI 10.1016/S0168-8278(88)80459-8; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Fennekohl A, 1999, J HEPATOL, V30, P38, DOI 10.1016/S0168-8278(99)80006-3; Fujino T, 2004, J CLIN INVEST, V114, P805, DOI 10.1172/JCI200421382; Giannitrapani L, 2009, ANN NY ACAD SCI, V1155, P293, DOI 10.1111/j.1749-6632.2009.03698.x; GRUNDMANN HJ, 1992, J INFECT DIS, V165, P501, DOI 10.1093/infdis/165.3.501; Hara A, 2005, CIRCULATION, V112, P84, DOI 10.1161/CIRCULATIONAHA.104.527077; Haukeland JW, 2006, J HEPATOL, V44, P1167, DOI 10.1016/j.jhep.2006.02.011; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291; Johnston DE, 1996, HEPATOLOGY, V24, P677, DOI 10.1002/hep.510240334; KAWADA N, 1993, EUR J BIOCHEM, V213, P815, DOI 10.1111/j.1432-1033.1993.tb17824.x; Kimura M, 2009, J PHARMACOL SCI, V109, P618, DOI 10.1254/jphs.08338FP; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Koek GH, 2011, CLIN CHIM ACTA, V412, P1297, DOI 10.1016/j.cca.2011.04.013; Leclercq IA, 2004, J HEPATOL, V41, P926, DOI 10.1016/j.jhep.2004.08.010; Lee FP, 2010, J CELL PHYSIOL, V224, P837, DOI 10.1002/jcp.22192; LEE SH, 1985, J EXP MED, V161, P475, DOI 10.1084/jem.161.3.475; Lima-Cabello E, 2011, CLIN SCI, V120, P239, DOI 10.1042/CS20100387; Marra F, 2014, GASTROENTEROLOGY, V147, P577, DOI 10.1053/j.gastro.2014.06.043; Mato JM, 2002, FASEB J, V16, P15, DOI 10.1096/fj.01-0401rev; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Miura K, 2012, AM J PHYSIOL-GASTR L, V302, pG1310, DOI 10.1152/ajpgi.00365.2011; MONCADA S, 1977, LANCET, V1, P18; Murata T, 1997, NATURE, V388, P678, DOI 10.1038/41780; Nakagawa N, 2012, KIDNEY INT, V82, P158, DOI 10.1038/ki.2012.115; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Nelson J, 2011, BBA-BIOMEMBRANES, V1808, P1913, DOI 10.1016/j.bbamem.2011.04.003; Perez S, 2004, MOL CELL BIOCHEM, V266, P183, DOI 10.1023/B:MCBI.0000049159.09349.02; Pietrangelo A, 2009, J HEPATOL, V50, P249, DOI 10.1016/j.jhep.2008.11.011; Requena JR, 1996, NEPHROL DIAL TRANSPL, V11, P48; Rizki G, 2006, J LIPID RES, V47, P2280, DOI 10.1194/jlr.M600198-JLR200; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Sumida Y, 2006, HEPATOL RES, V36, P315, DOI 10.1016/j.hepres.2006.08.003; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; TOMASI V, 1978, NATURE, V273, P670, DOI 10.1038/273670a0; Tomita K, 2006, GUT, V55, P415, DOI 10.1136/gut.2005.071118; Torres DM, 2008, GASTROENTEROLOGY, V134, P1682, DOI 10.1053/j.gastro.2008.02.077; Tosello-Trampont AC, 2012, J BIOL CHEM, V287, P40161, DOI 10.1074/jbc.M112.417014; Valenti L, 2010, GASTROENTEROLOGY, V138, P905, DOI 10.1053/j.gastro.2009.11.013; Velayudham A, 2009, HEPATOLOGY, V49, P989, DOI 10.1002/hep.22711; VICTOROV AV, 1995, BIOCHEM BIOPH RES CO, V215, P691, DOI 10.1006/bbrc.1995.2519; WALKER RJ, 1971, GUT, V12, P1011, DOI 10.1136/gut.12.12.1011; Xiao CY, 2001, CIRCULATION, V104, P2210, DOI 10.1161/hc4301.098058; Yeh CH, 2011, J INVEST MED, V59, P1109, DOI 10.2310/JIM.0b013e3182281f62; Yin H, 2007, HEPATOLOGY, V45, P159, DOI 10.1002/hep.21493; Yoneda M, 2010, DIGEST DIS SCI, V55, P808, DOI 10.1007/s10620-009-0771-y; Yu J, 2006, HEPATOLOGY, V43, P826, DOI 10.1002/hep.21108	56	6	6	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2354	2365		10.1096/fj.20170059OR	http://dx.doi.org/10.1096/fj.20170059OR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29247122				2022-12-28	WOS:000432528000005
J	Gao, JJ; Yao, LC; Xia, TT; Liao, XB; Zhu, DY; Xiang, Y				Gao, Jingjing; Yao, Licheng; Xia, Tingting; Liao, Xuebin; Zhu, Deyu; Xiang, Ye			Biochemistry and structural studies of kynurenine 3-monooxygenase reveal allosteric inhibition by Ro 61-8048	FASEB JOURNAL			English	Article						neurodegeneration diseases; neurologic disorders; therapeutic target	3-HYDROXYLASE INHIBITION; BRAIN; MODEL; PATHWAY; SYSTEM; LEVODOPA	The human kynurenine 3-monooxygenase (hKMO) is a potential therapeutic target for neurodegenerative and neurologic disorders. Inhibition of KMO by Ro 61-8048, a potent, selective, and the most widely used inhibitor of KMO, was shown effective in various models of neurodegenerative or neurologic disorders. However, the molecular basis of hKMO inhibition by Ro 61-8048 is not clearly understood. Here, we report biochemistry studies on hKMO and crystal structures of an hKMO homolog, pfKMO from Pseudomonas fluorescens, in complex with the substrate L-kynurenine and Ro 61-8048. We found that the C-terminal similar to 110 aa are essential for the enzymatic activity of hKMO and the homologous C-terminal region of pfKMO folds into a distinct, all-alpha-helical domain, which associates with the N-terminal catalytic domain to form a unique tunnel in proximity to the substrate-binding pocket. The tunnel binds the Ro 61-8048 molecule, which fills most of the tunnel, and Ro 61-8048 is hydrogen bonded with several completely conserved residues, including an essential catalytic residue. Modification of Ro 61-8048 and biochemical studies of the modified Ro 61-8048 derivatives suggested that Ro 61-8048 inhibits the enzyme in an allosteric manner by affecting the conformation of the essential catalytic residue and by blocking entry of the substrate or product release. The unique binding sites distinguish Ro 61-8048 as a noncompetitive and highly selective inhibitor from other competitive inhibitors, which should facilitate further optimization of Ro 61-8048 and the development of new inhibitory drugs to hKMO.	[Gao, Jingjing; Xiang, Ye] Tsinghua Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Ctr Infect Dis Res, Sch Med,Beijing Adv Innovat Ctr Struct Biol, Beijing, Peoples R China; [Yao, Licheng; Xia, Tingting; Liao, Xuebin] Tsinghua Univ, Sch Pharmaceut Sci, Collaborat Innovat Ctr Diag & Treatment Infect Di, Beijing, Peoples R China; [Zhu, Deyu] Shandong Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Jinan 250012, Shandong, Peoples R China	Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Tsinghua University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Tsinghua University; Shandong University	Zhu, DY (corresponding author), Shandong Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Jinan 250012, Shandong, Peoples R China.; Xiang, Y (corresponding author), Tsinghua Univ, B308,Med Sci Bldg, Beijing 100084, Peoples R China.	zhudeyu@sdu.edu.cn; yxiang@mail.tsinghua.edu.cn		Xiang, Ye/0000-0003-0230-9522	973 Program [2015CB910102]; Beijing Municipal Science and Technology Commission [Z161100000116032]; National Natural Science Foundation of China [31470721]; Junior Thousand Talents Program of China; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases; Beijing Advanced Innovation Center for Structural Biology; Shandong Province Natural Science Foundation [ZR2015CM001]	973 Program(National Basic Research Program of China); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Junior Thousand Talents Program of China; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases; Beijing Advanced Innovation Center for Structural Biology; Shandong Province Natural Science Foundation(Natural Science Foundation of Shandong Province)	The authors thank Haitao Li, Shilong Fan, Haiteng Deng, and Jin Li (Tsinghua University) and Jing Zhu (Shandong University) for their support. The authors thank the Tsinghua University Branch of the China National Center for Protein Sciences, and the Center of Biomedical Analysis of Tsinghua University for providing facility support. The authors thank the staff at the Shanghai Synchrotron Research Facility beam line BL17U for assistance with data collection. This work was supported by funds from the 973 Program (Grant 2015CB910102), the Beijing Municipal Science and Technology Commission (Grant Z161100000116032), the National Natural Science Foundation of China (Grant 31470721), the Junior Thousand Talents Program of China, the Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, and the Beijing Advanced Innovation Center for Structural Biology (to Y.X.), and the Shandong Province Natural Science Foundation (Grant ZR2015CM001; to D.Z.). The coordinates and structure factor files have been deposited into the Protein Data Bank (http://www.pdb.org) under accession numbers 5Y7A, 5Y77, and 5Y66. The authors declare no conflicts of interest.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amaral M, 2013, NATURE, V496, P382, DOI 10.1038/nature12039; Beaumont V, 2016, EXP NEUROL, V282, P99, DOI 10.1016/j.expneurol.2016.05.005; Campbell BM, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00012; Campesan S, 2011, CURR BIOL, V21, P961, DOI 10.1016/j.cub.2011.04.028; Clark CJ, 2005, INFECT IMMUN, V73, P5249, DOI 10.1128/IAI.73.8.5249-5251.2005; Cozzi A, 1999, J CEREBR BLOOD F MET, V19, P771, DOI 10.1097/00004647-199907000-00007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gregoire L, 2008, BEHAV BRAIN RES, V186, P161, DOI 10.1016/j.bbr.2007.08.007; Hutchinson JP, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15827; Justinova Z, 2013, NAT NEUROSCI, V16, P1652, DOI 10.1038/nn.3540; Lovelace MD, 2017, NEUROPHARMACOLOGY, V112, P373, DOI 10.1016/j.neuropharm.2016.03.024; Maddison DC, 2015, SEMIN CELL DEV BIOL, V40, P134, DOI 10.1016/j.semcdb.2015.03.002; Mole DJ, 2016, NAT MED, V22, P202, DOI 10.1038/nm.4020; Moroni F, 1999, EUR J PHARMACOL, V375, P87, DOI 10.1016/S0014-2999(99)00196-X; Moroni F, 1999, ADV EXP MED BIOL, V467, P199; Olucha J, 2011, J BIOL CHEM, V286, P31789, DOI 10.1074/jbc.M111.265876; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Richter A, 2003, EUR J PHARMACOL, V478, P47, DOI 10.1016/j.ejphar.2003.08.038; Rodgers J, 2009, BRAIN, V132, P1259, DOI 10.1093/brain/awp074; Rojewska E, 2016, NEUROPHARMACOLOGY, V102, P80, DOI 10.1016/j.neuropharm.2015.10.040; Rover S, 1997, J MED CHEM, V40, P4378, DOI 10.1021/jm970467t; Samadi P, 2005, MOVEMENT DISORD, V20, P792, DOI 10.1002/mds.20596; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vamos E, 2009, J NEUROL SCI, V283, P21, DOI 10.1016/j.jns.2009.02.326; Walker AL, 2017, J MED CHEM, V60, P3383, DOI 10.1021/acs.jmedchem.7b00055; Wilson K, 2014, PROTEIN EXPRES PURIF, V95, P96, DOI 10.1016/j.pep.2013.11.015; Zadori D, 2009, J NEURAL TRANSM, V116, P1403, DOI 10.1007/s00702-009-0263-4; Zwilling D, 2011, CELL, V145, P863, DOI 10.1016/j.cell.2011.05.020	31	14	16	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2036	2045		10.1096/fj.201700397RR	http://dx.doi.org/10.1096/fj.201700397RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29208702				2022-12-28	WOS:000429051400025
J	van der Zwaard, S; van der Laarse, WJ; Weide, G; Bloemers, FW; Hofmijster, MJ; Levels, K; Noordhof, DA; de Koning, JJ; de Ruiter, CJ; Jaspers, RT				van der Zwaard, Stephan; van der Laarse, Willem J.; Weide, Guido; Bloemers, Frank W.; Hofmijster, Mathijs J.; Levels, Koen; Noordhof, Dionne A.; de Koning, Jos J.; de Ruiter, Cornelis J.; Jaspers, Richard T.			Critical determinants of combined sprint and endurance performance: an integrative analysis from muscle fiber to the human body	FASEB JOURNAL			English	Article						skeletal muscle; oxidative capacity; oxygen transport; muscle architecture; muscle biopsy	HUMAN SKELETAL-MUSCLE; QUADRICEPS FEMORIS MUSCLE; HEART-FAILURE PATIENTS; CALIBRATED HISTOCHEMISTRY; MYOGLOBIN CONCENTRATION; VELOCITY RELATIONSHIPS; CONTRACTILE PROPERTIES; EXERCISE PERFORMANCE; ANAEROBIC THRESHOLD; OXIDATIVE CAPACITY	Optimizing physical performance is a major goal in current physiology. However, basic understanding of combining high sprint and endurance performance is currently lacking. This study identifies critical determinants of combined sprint and endurance performance using multiple regression analyses of physiologic determinants at different biologic levels. Cyclists, including 6 international sprint, 8 team pursuit, and 14 road cyclists, completed a Wingate test and 15-km time trial to obtain sprint and endurance performance results, respectively. Performance was normalized to lean body mass(2/3) to eliminate the influence of body size. Performance determinants were obtained from whole-body oxygen consumption, blood sampling, knee-extensor maximal force, muscle oxygenation, whole-muscle morphology, and muscle fiber histochemistry of musculus vastus lateralis. Normalized sprint performance was explained by percentage of fast-type fibers and muscle volume (R-2 = 0.65; P < 0.001) and normalized endurance performance by performance oxygen consumption (V.o(2)), mean corpuscular hemoglobin concentration, and muscle oxygenation (R-2 = 0.92; P < 0.001). Combined sprint and endurance performance was explained by gross efficiency, performance V.o(2), and likely by muscle volume and fascicle length (P = 0.056; P = 0.059). High performance V.o(2) related to a high oxidative capacity, high capillarization x myoglobin, and small physiologic cross-sectional area (R-2 = 0.67; P < 0.001). Results suggest that fascicle length and capillarization are important targets for training to optimize sprint and endurance performance simultaneously.	[van der Zwaard, Stephan; Weide, Guido; Jaspers, Richard T.] VU Univ Med Ctr Amsterdam, Fac Behav & Movement Sci, Dept Human Movement Sci, Amsterdam, Netherlands; [van der Zwaard, Stephan; Weide, Guido; Hofmijster, Mathijs J.; Levels, Koen; Noordhof, Dionne A.; de Koning, Jos J.; de Ruiter, Cornelis J.; Jaspers, Richard T.] VU Univ Med Ctr Amsterdam, Fac Behav & Movement Sci, Lab Myol, Amsterdam, Netherlands; [Bloemers, Frank W.] VU Univ Med Ctr Amsterdam, Amsterdam Movement Sci, Dept Trauma Surg, Amsterdam, Netherlands; [van der Laarse, Willem J.] VU Univ Med Ctr Amsterdam, Inst Cardiovasc Res, Dept Physiol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Jaspers, RT (corresponding author), Vrije Univ, Fac Behav & Movement Sci, Dept Human Movement Sci, Amsterdam Movement Sci, De Boelelaan 1108,van der Boechorststr 9, NL-1081 BT Amsterdam, Netherlands.	r.t.jaspers@vu.nl	van der Zwaard, Stephan/J-9622-2019; Bloemers, Frank/P-5436-2019; Noordhof, Dionne/AFR-6657-2022	van der Zwaard, Stephan/0000-0002-8296-828X; Bloemers, Frank/0000-0002-8393-4946; Jaspers, Richard/0000-0002-6951-0952; van der Laarse, Willem J/0000-0002-8391-0354; de Koning, Jos J/0000-0002-5596-0282	Dutch Olympic Committee-Dutch Sports Federation (NOC*NSF); Royal Dutch Cycling Federation (KNSB); Royal Dutch Rowing Federation (KNRB); Center for Elite Sports and Education (CTO) Amsterdam; TulipMed; Artinis Medical Systems; SporterOnline; b-Cat High Altitude; Foundation for Technical Sciences (STW) of the Netherlands Organization for Scientific Research (NWO) [12891]	Dutch Olympic Committee-Dutch Sports Federation (NOC*NSF); Royal Dutch Cycling Federation (KNSB); Royal Dutch Rowing Federation (KNRB); Center for Elite Sports and Education (CTO) Amsterdam; TulipMed; Artinis Medical Systems; SporterOnline; b-Cat High Altitude; Foundation for Technical Sciences (STW) of the Netherlands Organization for Scientific Research (NWO)	The authors thank Wendy Noort, David Comerford, Wouter Ruchtie, Jelmer Nuijten, Victor Vane, Niels Daems, Niels Waterval, Nienke de Jong, Isabelle van Dongen and Myriam Sillevis Smitt (Vrije Universiteit Amsterdam) for their excellent assistance with the data collection. The authors thank the Dutch Olympic Committee-Dutch Sports Federation (NOC*NSF), The Royal Dutch Cycling Federation (KNSB), the Royal Dutch Rowing Federation (KNRB), the Center for Elite Sports and Education (CTO) Amsterdam, TulipMed, Artinis Medical Systems, SporterOnline, and b-Cat High Altitude for their support. This work was supported by the Foundation for Technical Sciences (STW) of the Netherlands Organization for Scientific Research (NWO) under Grant 12891. The authors declare no conflicts of interest.	Abe T, 2000, MED SCI SPORT EXER, V32, P1125, DOI 10.1097/00005768-200006000-00014; Andersen JL, 2010, SCAND J MED SCI SPOR, V20, P32, DOI 10.1111/j.1600-0838.2010.01196.x; Andersen JL, 2000, SCI AM, V283, P48, DOI 10.1038/scientificamerican0900-48; ANDERSEN P, 1977, J PHYSIOL-LONDON, V270, P677, DOI 10.1113/jphysiol.1977.sp011975; Atkinson G, 2003, J SPORT SCI, V21, P767, DOI 10.1080/0264041031000102097; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Bekedam MA, 2003, CLIN PHYSIOL FUNCT I, V23, P337, DOI 10.1046/j.1475-0961.2003.00517.x; Beneke R, 2002, EUR J APPL PHYSIOL, V87, P388, DOI 10.1007/s00421-002-0622-4; Blazevich AJ, 2003, MED SCI SPORT EXER, V35, P2013, DOI 10.1249/01.MSS.0000099092.83611.20; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Bottinelli R, 1996, J PHYSIOL-LONDON, V495, P573, DOI 10.1113/jphysiol.1996.sp021617; Calbet JAL, 2003, J APPL PHYSIOL, V94, P668, DOI 10.1152/japplphysiol.00128.2002; Coffey VG, 2017, J PHYSIOL-LONDON, V595, P2883, DOI 10.1113/JP272270; CONSOLI A, 1990, AM J PHYSIOL, V259, pE677, DOI 10.1152/ajpendo.1990.259.5.E677; COSTILL DL, 1976, J APPL PHYSIOL, V40, P149, DOI 10.1152/jappl.1976.40.2.149; COYLE EF, 1988, J APPL PHYSIOL, V64, P2622, DOI 10.1152/jappl.1988.64.6.2622; COYLE EF, 1991, MED SCI SPORT EXER, V23, P93; COYLE EF, 1992, MED SCI SPORT EXER, V24, P782; COYLE EF, 1986, J APPL PHYSIOL, V60, P95, DOI 10.1152/jappl.1986.60.1.95; Craig NP, 2001, SPORTS MED, V31, P457, DOI 10.2165/00007256-200131070-00001; de Koning JJ, 2012, INT J SPORTS MED, V33, P880, DOI 10.1055/s-0032-1306285; Des Tombe AL, 2002, MICROSC RES TECHNIQ, V58, P412, DOI 10.1002/jemt.10153; Dorel S, 2005, INT J SPORTS MED, V26, P739, DOI 10.1055/s-2004-830493; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Ema R, 2016, SCAND J MED SCI SPOR, V26, P782, DOI 10.1111/sms.12511; Erskine RM, 2010, ACTA PHYSIOL, V199, P83, DOI 10.1111/j.1748-1716.2010.02085.x; Erskine RM, 2009, EUR J APPL PHYSIOL, V106, P827, DOI 10.1007/s00421-009-1085-7; Faria EW, 2005, SPORTS MED, V35, P313, DOI 10.2165/00007256-200535040-00003; Folland JP, 2007, SPORTS MED, V37, P145, DOI 10.2165/00007256-200737020-00004; Franchi MV, 2014, ACTA PHYSIOL, V210, P642, DOI 10.1111/apha.12225; Gardner SA., 2005, INT J PERFORM ANAL S, V5, P149, DOI [10.1080/24748668.2005.11868345, DOI 10.1080/24748668.2005.11868345]; Harridge SDR, 1996, PFLUG ARCH EUR J PHY, V432, P913, DOI 10.1007/s004240050215; Hautier CA, 1996, EUR J APPL PHYSIOL, V74, P114, DOI 10.1007/BF00376503; He ZH, 2000, BIOPHYS J, V79, P945, DOI 10.1016/S0006-3495(00)76349-1; Hill AV., 1965, TRAILS TRIALS PHYSL; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Hoppeler H, 2001, J EXP BIOL, V204, P3133; HOPPELER H, 1973, PFLUG ARCH EUR J PHY, V344, P217, DOI 10.1007/BF00588462; Huijing PA, 1998, J ELECTROMYOGR KINES, V8, P61, DOI 10.1016/S1050-6411(97)00023-0; JACOBS I, 1983, J APPL PHYSIOL, V55, P365, DOI 10.1152/jappl.1983.55.2.365; Jacobs RA, 2011, J APPL PHYSIOL, V111, P1422, DOI 10.1152/japplphysiol.00625.2011; Jeukendrup A E, 2000, J Sci Med Sport, V3, P414, DOI 10.1016/S1440-2440(00)80008-0; Joyner MJ, 2008, J PHYSIOL-LONDON, V586, P35, DOI 10.1113/jphysiol.2007.143834; KINDERMANN W, 1979, EUR J APPL PHYSIOL O, V42, P25, DOI 10.1007/BF00421101; Korhonen MT, 2006, J APPL PHYSIOL, V101, P906, DOI 10.1152/japplphysiol.00299.2006; Kumagai K, 2000, J APPL PHYSIOL, V88, P811, DOI 10.1152/jappl.2000.88.3.811; Lee-de Groot MBE, 1998, J HISTOCHEM CYTOCHEM, V46, P1077; Lucia A, 2001, SPORTS MED, V31, P325, DOI 10.2165/00007256-200131050-00004; Martin JC, 2007, INT J SPORT PHYSIOL, V2, P5, DOI 10.1123/ijspp.2.1.5; Martin JC, 2000, J GERONTOL A-BIOL, V55, pM311, DOI 10.1093/gerona/55.6.M311; Martin JC, 1997, MED SCI SPORT EXER, V29, P1505, DOI 10.1097/00005768-199711000-00018; Mujika I, 2001, SPORTS MED, V31, P479, DOI 10.2165/00007256-200131070-00003; Nader GA, 2006, MED SCI SPORT EXER, V38, P1965, DOI 10.1249/01.mss.0000233795.39282.33; Pearson SJ, 2006, MED SCI SPORT EXER, V38, P1601, DOI 10.1249/01.mss.0000227638.75983.9d; Perez-Gomez J, 2008, EUR J APPL PHYSIOL, V102, P685, DOI 10.1007/s00421-007-0648-8; Peters EL, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091889; Plas RLC, 2015, J EXP BIOL, V218, P2166, DOI 10.1242/jeb.117655; POOL CW, 1979, HISTOCHEMISTRY, V64, P251, DOI 10.1007/BF00495025; Prior BM, 2004, J APPL PHYSIOL, V97, P1119, DOI 10.1152/japplphysiol.00035.2004; Qu ZQ, 1997, HISTOCHEM CELL BIOL, V107, P169, DOI 10.1007/s004180050101; Ronnestad BR, 2014, SCAND J MED SCI SPOR, V24, P603, DOI 10.1111/sms.12104; Saltin B, 1977, Ann N Y Acad Sci, V301, P3, DOI 10.1111/j.1749-6632.1977.tb38182.x; Saltin B, 2010, COMPREHENSIVE PHYSL; Santalla A, 2012, INT J SPORT PHYSIOL, V7, P200, DOI 10.1123/ijspp.7.3.200; SCHENAU GJV, 1994, SPORTS MED, V17, P259, DOI 10.2165/00007256-199417040-00006; SIECK GC, 1995, J APPL PHYSIOL, V79, P1629, DOI 10.1152/jappl.1995.79.5.1629; Trappe S, 2015, J APPL PHYSIOL, V118, P1460, DOI 10.1152/japplphysiol.00037.2015; van Beek-Harmsen BJ, 2004, HISTOCHEM CELL BIOL, V121, P335, DOI 10.1007/s00418-004-0641-9; van der Laarse WJ, 2005, J APPL PHYSIOL, V99, P2173, DOI 10.1152/japplphysiol.00470.2005; van der Zwaard S, 2017, MED SCI SPORT EXER, V49, P768, DOI 10.1249/01.mss.0000519047.24644.bc; van der Zwaard S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162914; van der Zwaard S, 2016, J APPL PHYSIOL, V121, P636, DOI 10.1152/japplphysiol.00355.2016; van Wessel T, 2010, EUR J APPL PHYSIOL, V110, P665, DOI 10.1007/s00421-010-1545-0; Verdijk LB, 2009, J GERONTOL A-BIOL, V64, P332, DOI 10.1093/gerona/gln050; Vogt M, 2001, J APPL PHYSIOL, V91, P173, DOI 10.1152/jappl.2001.91.1.173; VONDOBELN W, 1956, ACTA PHYSIOL SCAND, V38, P193; WASSERMAN K, 1987, CIRCULATION, V76, P29; Weibel ER, 2005, J EXP BIOL, V208, P1635, DOI 10.1242/jeb.01548; Weide G, 2017, JOVE-J VIS EXP, DOI 10.3791/55943; WICKIEWICZ TL, 1984, J APPL PHYSIOL, V57, P435, DOI 10.1152/jappl.1984.57.2.435	81	28	28	1	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2110	2123		10.1096/fj.201700827R	http://dx.doi.org/10.1096/fj.201700827R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29217665	Green Submitted			2022-12-28	WOS:000429051400031
J	Inata, Y; Kikuchi, S; Samraj, RS; Hake, PW; O'Connor, M; Ledford, JR; O'Connor, J; Lahni, P; Wolfe, V; Piraino, G; Zingarelli, B				Inata, Yu; Kikuchi, Satoshi; Samraj, Ravi S.; Hake, Paul W.; O'Connor, Michael; Ledford, John R.; O'Connor, James; Lahni, Patrick; Wolfe, Vivian; Piraino, Giovanna; Zingarelli, Basilia			Autophagy and mitochondrial biogenesis impairment contribute to age-dependent liver injury in experimental sepsis: dysregulation of AMP-activated protein kinase pathway	FASEB JOURNAL			English	Article						AICAR; cecal ligation and puncture; MODS; PGC-1 alpha	PHOSPHORYLATION; INHIBITION; KNOCKOUT	Age is an independent risk factor of multiple organ failure in patients with sepsis. However, the age-related mechanisms of injury are not known. AMPK is a crucial regulator of energy homeostasis, which controls mitochondrial biogenesis by activation of peroxisome proliferator-activated receptor-gamma coactivator-alpha (PGC-1 alpha) and disposal of defective organelles by autophagy. We investigated whether AMPK dysregulation might contribute to age-dependent liver injury in young (2-3 mo) and mature male mice (11-13 mo) subjected to sepsis. Liver damage was higher in mature mice than in young mice and was associated with impairment of hepatocyte mitochondrial function, structure, and biogenesis and reduced autophagy. At molecular analysis, there was a time-dependent nuclear translocation of the active phosphorylated catalytic subunits AMPK alpha 1/alpha 2 and PGC-1 alpha in young, but not in mature, mice after sepsis. Treatment with the AMPK activator 5-amino-4-imidazolecarboxamide riboside-1-beta-D-ribofuranoside (AICAR) improved liver mitochondrial structure in both age groups compared with vehicle. In loss-of-function studies, young knockout mice with systemic deficiency of AMPK alpha 1 exhibited greater liver injury than did wild-type mice after sepsis. Our study suggests that AMPK is important for liver metabolic recovery during sepsis. Although its function may diminish with age, pharmacological activation of AMPK may be of therapeutic benefit.	[Inata, Yu; Kikuchi, Satoshi; Samraj, Ravi S.; Hake, Paul W.; O'Connor, Michael; Ledford, John R.; O'Connor, James; Lahni, Patrick; Wolfe, Vivian; Piraino, Giovanna; Zingarelli, Basilia] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati Childrens Hosp Med Ctr,Div Crit Care M, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Zingarelli, B (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Crit Care Med, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	basilia.zingarelli@cchmc.org	, Basilia/AAV-7582-2021; Inata, Yu/H-7572-2019	Inata, Yu/0000-0002-2180-9517	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences [R01 GM-067202]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [P30 DK-078392]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067202] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences; NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Benoit Viollet (INSERM and Cochin Institute, University Paris Descartes, Paris, France) for providing AMPK-alpha 1 WT and KO mice. This work was supported by the U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences Grant R01 GM-067202 (to B.Z.) and, in part, by NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant P30 DK-078392 to the Digestive Research Core Center (Integrative Morphology Core). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflicts of interest.	Angele MK, 2014, VIRULENCE, V5, P12, DOI 10.4161/viru.26982; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Bettinger BT, 2004, NAT REV MOL CELL BIO, V5, P410, DOI 10.1038/nrm1370; Botez G, 2015, INNATE IMMUN-LONDON, V21, P609, DOI 10.1177/1753425915569367; Botros Mona, 2013, Clin Biochem Rev, V34, P117; Brealey D, 2002, LANCET, V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Brownsey RW, 2006, BIOCHEM SOC T, V34, P223, DOI 10.1042/BST0340223; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; Chien WS, 2011, SHOCK, V35, P506, DOI 10.1097/SHK.0b013e31820b2f05; Collier J, 2002, CLIN MED, V2, P406, DOI 10.7861/clinmedicine.2-5-406; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Donnino MW, 2011, CRIT CARE, V15, DOI 10.1186/cc10343; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Guigas B, 2007, BIOCHEM J, V404, P499, DOI 10.1042/BJ20070105; Gustafsson AB, 2008, J MOL CELL CARDIOL, V44, P654, DOI 10.1016/j.yjmcc.2008.01.010; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Kale S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013852; Kramer KA, 2005, CLIN CHEM, V51, P2110, DOI 10.1373/clinchem.2005.050146; Liu AD, 2013, LIVER TRANSPLANT, V19, P762, DOI 10.1002/lt.23666; Martin GS, 2006, CRIT CARE MED, V34, P15, DOI 10.1097/01.CCM.0000194535.82812.BA; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Milbrandt EB, 2010, AM J RESP CRIT CARE, V182, P995, DOI 10.1164/rccm.200904-0630CP; MULLANE KM, 1985, J PHARMACOL METHOD, V14, P157, DOI 10.1016/0160-5402(85)90029-4; Mulligan JD, 2005, J GERONTOL A-BIOL, V60, P21, DOI 10.1093/gerona/60.1.21; Nguyen-Lefebvre Anh Thu, 2015, J Enzymol Metab, V1; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Parajuli N, 2013, AM J PHYSIOL-RENAL, V304, pF257, DOI 10.1152/ajprenal.00435.2012; Protzer U, 2012, NAT REV IMMUNOL, V12, P201, DOI 10.1038/nri3169; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Rohas LM, 2007, P NATL ACAD SCI USA, V104, P7933, DOI 10.1073/pnas.0702683104; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; Stapleton D, 1997, FEBS LETT, V409, P452, DOI 10.1016/S0014-5793(97)00569-3; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Sun K, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-26; Vincent JL, 2011, CRIT CARE MED, V39, P1050, DOI 10.1097/CCM.0b013e31820eda29; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P19, DOI 10.2741/3229; Watanabe E, 2009, LAB INVEST, V89, P549, DOI 10.1038/labinvest.2009.8	42	35	38	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					728	741		10.1096/fj.201700576R	http://dx.doi.org/10.1096/fj.201700576R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	28974562	Green Published, Bronze			2022-12-28	WOS:000425146900017
J	Pertile, RAN; Cui, XY; Hammond, L; Eyles, DW				Pertile, Renata A. N.; Cui, Xiaoying; Hammond, Luke; Eyles, Darryl W.			Vitamin D regulation of GDNF/Ret signaling in dopaminergic neurons	FASEB JOURNAL			English	Article						VDR; C-Ret; SH-SY5Y; GFR alpha 1; DVD-deficiency	D DEFICIENCY ALTERS; BIOLOGICAL-IMAGE-ANALYSIS; C-RET PROTOONCOGENE; NEUROTROPHIC FACTOR; D-RECEPTOR; 1,25-DIHYDROXYVITAMIN D-3; BRAIN-DEVELOPMENT; NIGROSTRIATAL SYSTEM; SUBSTANTIA-NIGRA; MESSENGER-RNAS	1,25(OH)(2)D-3 (vitamin D) appears essential for the normal development of dopaminergic neurons. Vitamin D affects dopamine synthesis and metabolism as well as expression of glial cell line-derived neurotrophic factor (GDNF), which is crucial for the survival of dopaminergic neurons. We investigated the role of vitamin D on GDNF and its receptors protooncogene tyrosine-protein kinase receptor Ret (C-Ret) and GDNF family receptor alpha 1 (GFR alpha 1) signaling. To this end, we used a developmental vitamin D-deficient rat model and SH-SY5Y cells transfected with vitamin D receptor (VDR). The absence of vitamin D ligand in gestation reduces C-Ret expression, but not GDNF and GFRa1, in embryo forebrains. Overexpression of VDR in SH-SY5Y in the absence of ligand (mimicking in vivo developmental vitamin D deficiency) also suppressed C-Ret mRNA levels. In the presence of vitamin D, C-Ret mRNA and protein expression were increased. The chromatin immunoprecipitation results suggested that C-Ret is directly regulated by vitamin D via VDR. GDNF was also increased by vitamin D in these cells. Our small interfering RNA studies showed that knocking down VDR leads to an increase in C-Ret in the absence of ligand. Finally, we confirmed the inverse relationship between GFRa1 and C-Ret, as knocking down C-Ret led to increases in GFRa1 expression. These data extend our knowledge of the diverse and important roles played by vitamin D in dopamine physiology.	[Pertile, Renata A. N.; Cui, Xiaoying; Eyles, Darryl W.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Hammond, Luke] Columbia Univ, Zuckerman Mind Brain Behav Inst, New York, NY USA; [Eyles, Darryl W.] Queensland Ctr Mental Hlth Res, Wacol, Qld, Australia	University of Queensland; Columbia University; Queensland Centre for Mental Health Research	Eyles, DW (corresponding author), Univ Queensland, Queensland Brain Inst, Neurobiol Lab, Brisbane, Qld 4072, Australia.	eyles@uq.edu.au	Eyles, Darryl W/X-3386-2018; Hammond, Luke/AAG-2364-2019	Eyles, Darryl W/0000-0002-5023-7095; Hammond, Luke/0000-0002-4065-7619; Pertile, Renata/0000-0003-4699-8817	National Health and Medical Research Council of Australia [APP1057883]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia (APP1057883). Imaging was performed at the Queensland Brain Institute's Advanced Microscopy Facility. The authors declare no conflicts of interest.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Burazin TCD, 1999, MOL BRAIN RES, V73, P151, DOI 10.1016/S0169-328X(99)00217-X; Burke RE, 2006, J NEURAL TRANSM-SUPP, P41; CHESKIS B, 1994, MOL CELL BIOL, V14, P3329, DOI 10.1128/MCB.14.5.3329; CHOILUNDBERG DL, 1995, DEV BRAIN RES, V85, P80, DOI 10.1016/0165-3806(94)00197-8; Cui X, 2015, NEUROSCIENCE, V304, P90, DOI 10.1016/j.neuroscience.2015.07.048; Cui X, 2013, NEUROSCIENCE, V236, P77, DOI 10.1016/j.neuroscience.2013.01.035; Cui XY, 2010, NEUROSCI LETT, V486, P220, DOI 10.1016/j.neulet.2010.09.057; Esposito CL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001643; Eyles D, 2003, NEUROSCIENCE, V118, P641, DOI 10.1016/S0306-4522(03)00040-X; Eyles D W, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS247, DOI 10.1016/j.psyneuen.2009.04.015; Eyles DW, 2013, FRONT NEUROENDOCRIN, V34, P47, DOI 10.1016/j.yfrne.2012.07.001; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Galleguillos D, 2010, J NEUROCHEM, V114, P1158, DOI 10.1111/j.1471-4159.2010.06841.x; Hawes JE, 2015, BEHAV BRAIN RES, V286, P192, DOI 10.1016/j.bbr.2015.03.008; He DY, 2006, FASEB J, V20, P2420, DOI 10.1096/fj.06-6394fje; Kesby JP, 2009, NEUROSCI LETT, V461, P155, DOI 10.1016/j.neulet.2009.05.070; Kim JY, 2009, MOL ENDOCRINOL, V23, P251, DOI 10.1210/me.2008-0426; Kowsky S, 2007, P NATL ACAD SCI USA, V104, P20049, DOI 10.1073/pnas.0706177104; Kramer ER, 2007, PLOS BIOL, V5, P616, DOI 10.1371/journal.pbio.0050039; Kramer ER, 2015, NEURAL REGEN RES, V10, P1752, DOI 10.4103/1673-5374.165295; Kramer ER, 2015, FEBS LETT, V589, P3760, DOI 10.1016/j.febslet.2015.11.006; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Li L, 2006, NEUROSCIENCE, V142, P391, DOI 10.1016/j.neuroscience.2006.06.018; Li L, 2009, NEUROL RES, V31, P534, DOI 10.1179/174313209X380810; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Luan W., MOL NEUROBI IN PRESS; Marcos C, 1996, Int J Dev Biol, VSuppl 1, p137S; Marinescu VD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-79; MATKOVITS T, 1995, MOL ENDOCRINOL, V9, P232, DOI 10.1210/me.9.2.232; Meyer MB, 2010, J STEROID BIOCHEM, V121, P136, DOI 10.1016/j.jsbmb.2010.02.011; Naveilhan P, 1996, NEUROREPORT, V7, P2171, DOI 10.1097/00001756-199609020-00023; Nosrat CA, 1997, EXP BRAIN RES, V115, P410, DOI 10.1007/PL00005711; Orme RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062040; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; Paratcha G, 2008, TRENDS NEUROSCI, V31, P384, DOI 10.1016/j.tins.2008.05.003; Peng CG, 2007, FEBS LETT, V581, P1357, DOI 10.1016/j.febslet.2007.02.054; Pertile RAN, 2016, NEUROSCIENCE, V333, P193, DOI 10.1016/j.neuroscience.2016.07.020; Prufer K, 1999, J CHEM NEUROANAT, V16, P135, DOI 10.1016/S0891-0618(99)00002-2; Sanchez B, 2002, MOL BRAIN RES, V108, P143, DOI 10.1016/S0169-328X(02)00545-4; Satoh J, 2013, MULT SCLER J, V19, P1035, DOI 10.1177/1352458512471873; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sillivan SE, 2011, NEUROSCIENCE, V199, P501, DOI 10.1016/j.neuroscience.2011.10.004; STROMBERG I, 1993, EXP NEUROL, V124, P401, DOI 10.1006/exnr.1993.1214; STUMPF WE, 1982, SCIENCE, V215, P1403, DOI 10.1126/science.6977846; TOMAC A, 1995, P NATL ACAD SCI USA, V92, P8274, DOI 10.1073/pnas.92.18.8274; Towers TL, 1998, J BIOL CHEM, V273, P10338, DOI 10.1074/jbc.273.17.10338; Trinko JR, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0122-15.2016; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; van Heesbeen HJ, 2013, DEVELOPMENT, V140, P1159, DOI 10.1242/dev.089359; Wallen A, 2001, MOL CELL NEUROSCI, V18, P649, DOI 10.1006/mcne.2001.1057; Wang Y, 2000, NEUROPHARMACOLOGY, V39, P873, DOI 10.1016/S0028-3908(99)00255-5; Yen PM, 1996, J BIOL CHEM, V271, P10910, DOI 10.1074/jbc.271.18.10910; Zella LA, 2007, J STEROID BIOCHEM, V103, P435, DOI 10.1016/j.jsbmb.2006.12.019; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	56	36	40	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					819	828		10.1096/fj.201700713R	http://dx.doi.org/10.1096/fj.201700713R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29018141				2022-12-28	WOS:000425146900024
J	Rebholz, SL; Melchior, JT; Davidson, WS; Jones, HN; Welge, JA; Prentice, AM; Moore, SE; Woollett, LA				Rebholz, Sandra L.; Melchior, John T.; Davidson, W. Sean; Jones, Helen N.; Welge, Jeffrey A.; Prentice, Andrew M.; Moore, Sophie E.; Woollett, Laura A.			Studies in genetically modified mice implicate maternal HDL as a mediator of fetal growth	FASEB JOURNAL			English	Article						apolipoprotein A-I; cholesterol; placenta; pregnancy; fetus	LOW-BIRTH-WEIGHT; PLACENTAL NUTRIENT TRANSPORT; ADVERSE PREGNANCY OUTCOMES; HIGH-DENSITY-LIPOPROTEINS; LIPID-METABOLISM; SERUM-LIPIDS; CHOLESTEROL; RISK; RESTRICTION; CHILDHOOD	Studies in humans have shown a direct association between maternal plasma cholesterol concentrations and infant birthweight. Similarly, previous studies in our laboratory have shown that chow-fed mice lacking apolipoprotein (apo) A-I, the major protein in HDL, have low HDL-cholesterol (HDL-C) concentrations and smaller fetuses in midgestation. In the current study, we measured fetal weights in mice with varying levels of apoA-I gene dose (knockout, wild-type, and transgenic) and examined metabolic pathways known to affect fetal growth. As expected, we found the differences in apoA-I expression led to changes in HDL particle size and protein cargo as well as plasma cholesterol concentrations. Fetal masses correlated directly with maternal plasma cholesterol and apoA-I concentrations, but placental masses and histology did not differ between groups of mice. There was no significant difference in glucose or amino acid transport to the fetus or in expression levels of the glucose (glucose transporter 1 and 2) or amino acid (sodium-coupled neutral amino acid transporter 1 and 2) transporters in whole placentas, although there was a trend for greater uptake of both nutrients in the whole fetal unit (fetus + placenta) of mice with greater apoA-I levels; significant differences in transport rates occurred when mice without apoA-I (knockout) vs. mice with apoA-I (wild-type and transgenic) were compared. Glucose tolerance tests were improved in the mice with the highest level of apoA-I, suggesting increased insulin-induced uptake of glucose by tissues of apoA-I transgenic mice. Thus, maternal HDL is associated with fetal growth, an effect that is likely mediated by plasma cholesterol or other HDL-cargo, including apolipoproteins or complement system proteins. A direct role of enhanced glucose and/or amino acid transport cannot be excluded.	[Rebholz, Sandra L.; Melchior, John T.; Davidson, W. Sean; Woollett, Laura A.] Univ Cincinnati, Sch Med, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA; [Welge, Jeffrey A.] Univ Cincinnati, Sch Med, Dept Psychiat & Behav Neurosci, Cincinnati, OH 45267 USA; [Jones, Helen N.] Cincinnati Childrens Hosp Med Ctr, Div Gen & Thorac Surg & Reprod Sci, Cincinnati, OH 45229 USA; [Prentice, Andrew M.; Moore, Sophie E.] Med Res Council MRC Unit, Serekunda, Gambia; [Prentice, Andrew M.] LSHTM, MCR Int Nutr Grp, London, England; [Moore, Sophie E.] Kings Coll London, Div Womens Hlth, London, England	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; King's College London	Woollett, LA (corresponding author), Univ Cincinnati, 2180 East Galbreith Rd,Reading Campus, Cincinnati, OH 45267 USA.	laura.woollett@uc.edu	Prentice, Andrew/AAG-1961-2019	Davidson, William/0000-0003-2756-2989; Moore, Sophie/0000-0003-1650-3238	Bill and Melinda Gates Foundation [OPP1110668]; Medical Research Council [MC_UU_00026/3, MC_U123292701, MC_UP_1005/1, MR/P012019/1] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U2CDK059630] Funding Source: NIH RePORTER; MRC [MC_UU_00026/3, MC_UP_1005/1, MR/P012019/1, MC_U123292701] Funding Source: UKRI	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Dr. Debi Swertfeger (Cincinnati Children's Hospital Medical Center) and Dr. Philip Howells (University of Cincinnati) for critical review of the manuscript, and Kathryn Owens (Cincinnati Children's Hospital Medical Center) for technical assistance. This work was supported by the Bill and Melinda Gates Foundation (OPP1110668 to L.A.W.). The University of Cincinnati Mouse Metabolic Phenotype Center measured the fatty acid composition of the samples (U2C DK059630). The authors declare no conflicts of interest.	Baardman ME, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.003; Barker DJP, 2006, CLIN OBSTET GYNECOL, V49, P270, DOI 10.1097/00003081-200606000-00009; Barker DJP, 2013, ACTA PAEDIATR, V102, P732, DOI 10.1111/apa.12257; Barker DJP, 2005, HORM RES, V64, P2, DOI 10.1159/000089311; BOERSMA ER, 1980, ACTA PAEDIATR SCAND, V69, P747, DOI 10.1111/j.1651-2227.1980.tb07144.x; Brett KE, 2014, INT J MOL SCI, V15, P16153, DOI 10.3390/ijms150916153; Burillo E, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-116; CHAMBAZ J, 1985, BIOL NEONATE, V47, P136, DOI 10.1159/000242104; Clausen T, 2005, EUR J ENDOCRINOL, V153, P887, DOI 10.1530/eje.1.02034; Crume TL, 2015, J CLIN ENDOCR METAB, V100, P1672, DOI 10.1210/jc.2014-2949; de Bernabe JV, 2004, EUR J OBSTET GYN R B, V116, P3, DOI 10.1016/j.ejogrb.2004.03.007; Edison RJ, 2007, PEDIATRICS, V120, P723, DOI 10.1542/peds.2006-1939; Fernandez-Nino SMG, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00044; Fielding CJ, 2004, BIOCHEM SOC T, V32, P65, DOI 10.1042/BST0320065; Friis CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057467; Gordon SM, 2011, TRENDS ENDOCRIN MET, V22, P9, DOI 10.1016/j.tem.2010.10.001; Gordon SM, 2010, J PROTEOME RES, V9, P5239, DOI 10.1021/pr100520x; Haghiac M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137309; He S, 2016, J MATERN-FETAL NEO M, V29, P1999, DOI 10.3109/14767058.2015.1072159; Heinecke JW, 2010, J CLIN LIPIDOL, V4, P371, DOI 10.1016/j.jacl.2010.08.005; Herrera E, 2014, CURR PHARM BIOTECHNO, V15, P24, DOI 10.2174/1389201015666140330192345; Hviid A, 2007, AM J EPIDEMIOL, V165, P756, DOI 10.1093/aje/kwk064; Jansson T, 2012, PLACENTA, V33, pE23, DOI 10.1016/j.placenta.2012.05.010; Jones HN, 2007, PLACENTA, V28, P763, DOI 10.1016/j.placenta.2007.05.002; Jones HN, 2009, FASEB J, V23, P271, DOI 10.1096/fj.08-116889; Knopp R H, 1985, Diabetes, V34 Suppl 2, P71; Kohler Iliana V., 2012, Genus, V68, P1; Kontush A., 2012, HIGH DENSITY LIPOPRO; Kramer MS, 2013, J PEDIATR-US, V163, P983, DOI 10.1016/j.jpeds.2013.05.014; Kramer MS, 2003, J NUTR, V133, p1592S, DOI 10.1093/jn/133.5.1592S; Kulkarni SR, 2013, DIABETES CARE, V36, P2706, DOI 10.2337/dc12-2445; Lager S, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/179827; Mark PJ, 2006, PLACENTA, V27, P208, DOI 10.1016/j.placenta.2005.01.004; Martin Joyce A, 2015, Natl Vital Stat Rep, V64, P1; McConihay JA, 2000, J LIPID RES, V41, P424; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; McNamara RK, 2009, LIPIDS, V44, P1, DOI 10.1007/s11745-008-3244-8; Melchior JT, 2017, J LIPID RES, V58, P1374, DOI 10.1194/jlr.M075382; Misra VK, 2011, OBESITY, V19, P1476, DOI 10.1038/oby.2011.43; Mitra Subarna, 2012, Indian J Endocrinol Metab, V16, P754, DOI 10.4103/2230-8210.100669; Moore SE, 2001, DIABETIC MED, V18, P646, DOI 10.1046/j.1464-5491.2001.00565.x; Morgan TK, 2016, AM J PERINAT, V33, P258, DOI 10.1055/s-0035-1570379; Mudd LM, 2015, ACTA OBSTET GYN SCAN, V94, P852, DOI 10.1111/aogs.12665; Naksen W, 2015, ENVIRON RES, V142, P288, DOI 10.1016/j.envres.2015.06.035; Napoli C, 1997, J CLIN INVEST, V100, P2680, DOI 10.1172/JCI119813; Pecks U, 2012, J PERINAT MED, V40, P287, DOI [10.1515/jpm.2011.135, 10.1515/JPM.2011.135]; Prentice AM, 2005, ARCH DIS CHILD, V90, P429, DOI 10.1136/adc.2004.059030; Raqib R, 2007, AM J CLIN NUTR, V85, P845, DOI 10.1093/ajcn/85.3.845; Regal JF, 2015, MOL IMMUNOL, V67, P56, DOI 10.1016/j.molimm.2015.02.030; Retnakaran R, 2012, CAN MED ASSOC J, V184, P1353, DOI 10.1503/cmaj.111154; RichEdwards JW, 1997, BRIT MED J, V315, P396, DOI 10.1136/bmj.315.7105.396; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Sattar N, 1999, J CLIN ENDOCR METAB, V84, P128, DOI 10.1210/jc.84.1.128; Shah AS, 2013, J LIPID RES, V54, P2575, DOI 10.1194/jlr.R035725; Stein REK, 2006, PEDIATRICS, V118, P217, DOI 10.1542/peds.2005-2836; Tofail F, 2012, EUR J CLIN NUTR, V66, P237, DOI 10.1038/ejcn.2011.165; Udoh A. E., 1994, Acta Medica Hungarica, V50, P75; Wadsack C, 2007, AM J PHYSIOL-ENDOC M, V292, pE476, DOI 10.1152/ajpendo.00547.2005; WARNICK GR, 1978, J LIPID RES, V19, P65; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; WHO, 2014, GLOBAL NUTRITION TAR; Woollett LA, 2008, ANNU REV NUTR, V28, P97, DOI 10.1146/annurev.nutr.26.061505.111311; Wu LZ, 2003, NATURE, V421, P942, DOI 10.1038/nature01417	63	4	4	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					717	727		10.1096/fj.201700528R	http://dx.doi.org/10.1096/fj.201700528R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	28982731	Bronze, Green Published			2022-12-28	WOS:000425146900016
J	Horvath, TD; Dagan, S; Lorenzi, PL; Hawke, DH; Scaraffia, PY				Horvath, Thomas D.; Dagan, Shai; Lorenzi, Philip L.; Hawke, David H.; Scaraffia, Patricia Y.			Positional stable isotope tracer analysis reveals carbon routes during ammonia metabolism of Aedes aegypti mosquitoes	FASEB JOURNAL			English	Article						mass spectrometry; nitrogen waste; metabolomics	PROTEIN CATABOLISM; ISOBUTYL ESTER; MEAL PROTEIN; AMINO-ACIDS; SERINE; FRAGMENTATION; PATHWAY; FATE	In Aedes aegypti females, the ammonia released during blood meal digestion is partiallymetabolized to facilitate the disposal of excess nitrogen. In this study, we used low- and high-resolution liquid chromatography-mass spectrometry (LC/MS) techniques to investigate the role of glucose during ammonia detoxification. Mosquitoes were fed a blood meal supplemented with [1,2-C-13(2)] glucose, and downstream metabolites were measured for 24 h. Quantification of [C-13] amino acids in the entire mosquito body was conducted without sample derivatization using selected reaction monitoring of mass transitions that are indicative of the structural position of [C-13] atomincorporation. Identification of unlabeled and [C-13] isotopologs of 43 compounds, including amino acids, amino acid derivatives, and organic acids, was performed by high-resolution LC/MS techniques. Blood-fed mosquitoes synthesized [C-13] metabolites in mainly 2 carbon positions from [1,2-C-13(2)] glucose. [C-13(2)] Ala and [C-13(2)] Pro were themost abundant andrapidly labeledamino acids synthesized. Additional [C-13] amino acids, [C-13] amino acid derivatives, and [C-13] organic acids in 1 or 2 carbon positionswere also identified. Two kinetic routeswere proposed based on the incorporation of a [C-13] atom at position 1 in specific amino acids. Our findings provide evidence that glucose is used for ammonia detoxification and [C-13] uric acid synthesis through multiple metabolic pathways, uncovering a metabolic link at the carbon atomic level in ammonia metabolism of A. aegypti.	[Horvath, Thomas D.; Lorenzi, Philip L.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Hawke, David H.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol Prote & Metabol Core Facil, Houston, TX 77030 USA; [Dagan, Shai] Israel Inst Biol Res, Ness Ziona, Israel; [Scaraffia, Patricia Y.] Tulane Univ, Sch Publ Hlth & Trop Med, Vector Borne Infect Dis Res Ctr, Dept Trop Med, New Orleans, LA 70118 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Tulane University	Scaraffia, PY (corresponding author), Tulane Univ, Dept Trop Med, Vector Borne Infect Dis Res Ctr, 1430 Tulane Ave,SL 17,J Bennett Johnston Bldg, New Orleans, LA 70112 USA.	pscaraff@tulane.edu	Horvath, Thomas Donald/AAI-2216-2019	Horvath, Thomas Donald/0000-0001-9761-3484	Corine Adams Baines Professorship Award; U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases [R01AI088092]; NIH [1S10OD012304-01]; Cancer Prevention Research Institute of Texas (CPRIT) [RP130397]; University of Texas M.D. Anderson National Cancer Institute Cancer Center [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088092] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012304] Funding Source: NIH RePORTER	Corine Adams Baines Professorship Award; U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas (CPRIT); University of Texas M.D. Anderson National Cancer Institute Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Dr. Lin Tan and Dr. Di Du (Proteomics and Metabolomics Core Facility, University of Texas MD Anderson Cancer Center) for technical assistance. The authors also thank Dr. Robert Swaim, Ken Miller, and Jamie Humphries (Thermo Fisher Scientific, Waltham, MA, USA) for assistance with training and use of TraceFinder software. This work was supported financially by the Corine Adams Baines Professorship Award, the U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (Grant R01AI088092 to P.Y.S.), NIH 1S10OD012304-01, Cancer Prevention Research Institute of Texas (CPRIT; Grant RP130397), and The University of Texas M.D. Anderson National Cancer Institute Cancer Center (Grant CA016672). The authors declare no conflicts of interest.	Alabaster A, 2011, INSECT BIOCHEM MOLEC, V41, P946, DOI 10.1016/j.ibmb.2011.09.004; Ali S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005135; Armstrong Najealicka, 2017, World J Virol, V6, P1, DOI 10.5501/wjv.v6.i1.1; Attar N., 2016, NAT REV MICROBIOL, V14, P62, DOI DOI 10.1038/NRMICR0.2015.28; Belloni V, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-373; Briegel H, 2002, J INSECT PHYSIOL, V48, P547, DOI 10.1016/S0022-1910(02)00072-0; BRIEGEL H, 1985, J INSECT PHYSIOL, V31, P15, DOI 10.1016/0022-1910(85)90036-8; Bush DR, 2012, J MASS SPECTROM, V47, P1364, DOI 10.1002/jms.3063; Chang J, 2016, SCI REP-UK, V6, DOI 10.1038/srep37350; Soares JBRC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120600; Dong W, 2017, METAB ENG, V43, P113, DOI 10.1016/j.ymben.2017.02.002; FELL DA, 1988, BIOCHEM J, V256, P97, DOI 10.1042/bj2560097; FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303; Goldstrohm DA, 2003, J INSECT PHYSIOL, V49, P629, DOI 10.1016/S0022-1910(03)00072-6; Hou Y, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005309; Isoe J, 2017, FASEB J, V31, P2276, DOI 10.1096/fj.201601185R; Isoe J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065393; Li SZ, 2007, MAGN RESON MED, V57, P265, DOI 10.1002/mrm.21148; Ma X, 2013, J AM SOC MASS SPECTR, V24, P622, DOI 10.1007/s13361-012-0574-9; Martin CA, 2014, NEUROCHEM INT, V73, P71, DOI 10.1016/j.neuint.2014.03.015; Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020; Mazzalupo S, 2016, FASEB J, V30, P111, DOI 10.1096/fj.15-277087; Pacold ME, 2016, NAT CHEM BIOL, V12, P452, DOI [10.1038/NCHEMBIO.2070, 10.1038/nchembio.2070]; Scaraffia PY, 2008, P NATL ACAD SCI USA, V105, P518, DOI 10.1073/pnas.0708098105; Scaraffia PY, 2006, INSECT BIOCHEM MOLEC, V36, P614, DOI 10.1016/j.ibmb.2006.05.003; Scaraffia PY, 2010, J INSECT PHYSIOL, V56, P1040, DOI 10.1016/j.jinsphys.2010.02.016; Scaraffia PY, 2005, INSECT BIOCHEM MOLEC, V35, P491, DOI 10.1016/j.ibmb.2005.01.012; Scaraffia PY, 2003, J INSECT PHYSIOL, V49, P591, DOI 10.1016/S0022-1910(03)00031-3; von Dungern P, 2001, J INSECT PHYSIOL, V47, P73, DOI 10.1016/S0022-1910(00)00095-0; von Dungern P, 2001, J INSECT PHYSIOL, V47, P131, DOI 10.1016/S0022-1910(00)00096-2; Yang M, 2016, NAT REV CANCER, V16, P650, DOI 10.1038/nrc.2016.81; Zhang QF, 2005, J AM SOC MASS SPECTR, V16, P1192, DOI 10.1016/j.jasms.2005.03.052; Zhou GL, 2004, INSECT BIOCHEM MOLEC, V34, P919, DOI 10.1016/j.ibmb.2004.05.009; Zhou GL, 2004, J INSECT PHYSIOL, V50, P337, DOI 10.1016/j.jinsphys.2004.02.003	34	8	8	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					466	477		10.1096/fj.201700657R	http://dx.doi.org/10.1096/fj.201700657R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28970248	Green Published			2022-12-28	WOS:000419172700041
J	Jammal, J; Zaknoon, F; Mor, A				Jammal, Joanna; Zaknoon, Fadia; Mor, Amram			Eliciting improved antibacterial efficacy of host proteins in the presence of antibiotics	FASEB JOURNAL			English	Article						innate immunity; antibiotic resistance; peptidomimetics; synergism	GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; MOLECULAR-MECHANISMS; PEPTIDE ANTIBIOTICS; OUTER-MEMBRANE; RESISTANCE; INFECTIONS; RIFAMPIN; PERMEABILIZATION; SENSITIZATION	We recently reported the aptitude of a membrane-active lipopeptide (C(10)OOc(12)O) to sensitize gram-negative bacilli (GNB) to host antibacterial proteins. Here we explored the potential of harnessing such capacity in the presence of antibiotics. For this purpose, we compared Escherichia coli sensitization to antibiotics in broth and plasma; assessed inner and outer membrane damages using scanning electron microscopy, dyes, and mutant strains; and assessed the ability to affect disease course using the mouse peritonitis-sepsis model for mono-and combination therapies. We found that by altering permeability of both outer and inner membranes, subinhibitory concentrations of C(10)OOc(12)O can transiently sensitize GNB to diverse cytoplasm-targeting antibiotics in simple media. Sensitization was maintained in plasma, where C(10)OOc(12)O instigated greater bactericidal activities, including in the presence of a bacteriostatic antibiotic (erythromycin). Single-dose administrations of rifampin and C(10)OOc(12)O to E. coli-infectedmice resulted in 55% vs. 0, and 36% viability, respectively, for combined and individual treatments. Combining C(10)OOc(12)O and erythromycin has similarly improved mice protection from developing fatal sepsis. Consequently, the data confirmed that C(10)OOc(12)O renders GNB sensitive to both endogenous and exogenous antibacterials, and suggested that the tripartite concomitant presence increases therapeutic efficacy synergistically. This approach might expand the available treatment options to comprise antimicrobials with lowpermeability and/or efflux issues.	[Jammal, Joanna; Zaknoon, Fadia; Mor, Amram] Technion Israel Inst Technol, Dept Biotechnol & Food Engn, IL-32000 Haifa, Israel	Technion Israel Institute of Technology	Mor, A (corresponding author), Technion Israel Inst Technol, Dept Biotechnol & Food Engn, IL-32000 Haifa, Israel.	amor@tx.technion.ac.il			Israel Science Foundation [909/12]; Russell Berrie Nanotechnology Institute (Technion-Israel Institute of Technology)	Israel Science Foundation(Israel Science Foundation); Russell Berrie Nanotechnology Institute (Technion-Israel Institute of Technology)	This work was supported, in part, by the Israel Science Foundation (Grant 909/12), and the Russell Berrie Nanotechnology Institute (Technion-Israel Institute of Technology). The authors declare no conflicts of interest.	Allen RC, 2014, NAT REV MICROBIOL, V12, P300, DOI 10.1038/nrmicro3232; Baym M, 2016, SCIENCE, V351, DOI 10.1126/science.aad3292; Blair JMA, 2015, NAT REV MICROBIOL, V13, P42, DOI 10.1038/nrmicro3380; Brown ED, 2016, NATURE, V529, P336, DOI 10.1038/nature17042; Czaplewski L, 2016, LANCET INFECT DIS, V16, P239, DOI 10.1016/S1473-3099(15)00466-1; Daly SM, 2015, ANTIMICROB AGENTS CH, V59, P2223, DOI 10.1128/AAC.04564-14; Daugelavicius R, 2000, ANTIMICROB AGENTS CH, V44, P2969, DOI 10.1128/AAC.44.11.2969-2978.2000; ELLARD GA, 1986, AM REV RESPIR DIS, V133, P1076; Epand RM, 2008, J AM CHEM SOC, V130, P14346, DOI 10.1021/ja8062327; Epand RM, 2016, BBA-BIOMEMBRANES, V1858, P980, DOI 10.1016/j.bbamem.2015.10.018; FERNANDES PB, 1989, ANTIMICROB AGENTS CH, V33, P1531, DOI 10.1128/AAC.33.9.1531; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Goldberg K, 2013, FASEB J, V27, P3818, DOI 10.1096/fj.13-227942; Gordin F, 2000, JAMA-J AM MED ASSOC, V283, P1445, DOI 10.1001/jama.283.11.1445; Hancock REW, 1999, ANTIMICROB AGENTS CH, V43, P1317, DOI 10.1128/AAC.43.6.1317; HANCOCK REW, 1984, ANNU REV MICROBIOL, V38, P237, DOI 10.1146/annurev.mi.38.100184.001321; HANCOCK REW, 1991, ANTIMICROB AGENTS CH, V35, P1309, DOI 10.1128/AAC.35.7.1309; Helander IM, 2000, J APPL MICROBIOL, V88, P213, DOI 10.1046/j.1365-2672.2000.00971.x; Hurdle JG, 2011, NAT REV MICROBIOL, V9, P62, DOI 10.1038/nrmicro2474; Jammal J, 2017, J INFECT DIS, V215, P1599, DOI 10.1093/infdis/jix119; Jammal J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09216; Kaneti G, 2016, BBA-BIOMEMBRANES, V1858, P995, DOI 10.1016/j.bbamem.2015.10.022; Kaneti G, 2013, FASEB J, V27, P4834, DOI 10.1096/fj.13-237610; Kinch MS, 2014, DRUG DISCOV TODAY, V19, P1033, DOI 10.1016/j.drudis.2014.03.018; LEHRER RI, 1988, J IMMUNOL METHODS, V108, P153, DOI 10.1016/0022-1759(88)90414-0; Meir O, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02373-0; Mensa B, 2011, ANTIMICROB AGENTS CH, V55, P5043, DOI 10.1128/AAC.05009-11; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; Porter EA, 2000, NATURE, V404, P565, DOI 10.1038/35007145; Radzishevsky IS, 2007, NAT BIOTECHNOL, V25, P657, DOI 10.1038/nbt1309; Rotem S, 2008, FASEB J, V22, P2652, DOI 10.1096/fj.07-105015; Rotem S, 2009, BBA-BIOMEMBRANES, V1788, P1582, DOI 10.1016/j.bbamem.2008.10.020; Schaberle TF, 2014, TRENDS MICROBIOL, V22, P165, DOI 10.1016/j.tim.2013.12.007; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; STORM DR, 1977, ANNU REV BIOCHEM, V46, P723, DOI 10.1146/annurev.bi.46.070177.003451; Strahl H, 2010, P NATL ACAD SCI USA, V107, P12281, DOI 10.1073/pnas.1005485107; Ude C, 2016, APPL MICROBIOL BIOT, V100, P4147, DOI 10.1007/s00253-016-7403-1; VAARA M, 1992, MICROBIOL REV, V56, P395, DOI 10.1128/MMBR.56.3.395-411.1992; Vaara M, 2010, CURR OPIN MICROBIOL, V13, P574, DOI 10.1016/j.mib.2010.09.002; Vaara M, 2009, CURR OPIN PHARMACOL, V9, P571, DOI 10.1016/j.coph.2009.08.002; Velkov T, 2010, J MED CHEM, V53, P1898, DOI 10.1021/jm900999h; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Wenzel M, 2014, P NATL ACAD SCI USA, V111, pE1409, DOI 10.1073/pnas.1319900111; Zabawa TP, 2016, CURR OPIN MICROBIOL, V33, P7, DOI 10.1016/j.mib.2016.05.005; Zgurskaya HI, 1999, P NATL ACAD SCI USA, V96, P7190, DOI 10.1073/pnas.96.13.7190; Zhang LJ, 2000, ANTIMICROB AGENTS CH, V44, P3317, DOI 10.1128/AAC.44.12.3317-3321.2000; Zuluaga AF, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-55	47	3	3	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					369	376		10.1096/fj.201700652R	http://dx.doi.org/10.1096/fj.201700652R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28904017				2022-12-28	WOS:000419172700033
J	Sabharwal, S; Verhulst, S; Guirguis, G; Kark, JD; Labat, C; Roche, NE; Martimucci, K; Patel, K; Heller, DS; Kimura, M; Chuang, D; Chuang, A; Benetos, A; Aviv, A				Sabharwal, Sanjeev; Verhulst, Simon; Guirguis, George; Kark, Jeremy D.; Labat, Carlos; Roche, Natalie E.; Martimucci, Kristina; Patel, Krunal; Heller, Debra S.; Kimura, Masayuki; Chuang, Donald; Chuang, Anne; Benetos, Athanase; Aviv, Abraham			Telomere length dynamics in early life: the blood-and-muscle model	FASEB JOURNAL			English	Article						fetus; children; leukocytes	METAANALYSIS; ASSOCIATION; CANCER; RISK; TISSUES; DISEASE	Telomere length (TL) trajectories in somatic tissues during human growth and development are poorly understood. We examined a blood-and-muscle model during early life, focusing on TL trajectories in leukocytes, representing the highly proliferative hematopoietic system, and skeletal muscle, a minimally proliferative tissue. Leukocyte TL (LTL) and skeletal muscle TL (MTL) were measured in 28 fetuses and 73 children. LTL and MTL were highly variable across individuals (SD: fetal LTL = 0.72 kb, MTL = 0.72 kb; children LTL = 0.81 kb, MTL = 0.82 kb) but were highly correlated within individuals (fetuses, r = 0.76, P < 0.0001; children, r = 0.87, P < 0.0001). LTL was shorter than MTL in fetuses (10.63 vs. 11.01 kb; P = 0.0004) and children (8.46 vs. 9.40 kb; < 0.0001). The LTL-MTL gap was smaller in fetuses than children. TL in children was inversely correlated with body mass index (BMI) (LTL: 20.047 6 0.016 kb/BMI, P < 0.005; MTL: -0.037 +/- 0.017 kb/BMI, P = 0.03). We conclude that variations in TL across adults and differences in TL between somatic tissues are largely established in early life. Because TL plays a significant role in aging-related diseases, insight into the factors that fashion TL in somatic tissues during early development should contribute to an understanding of the relationship of TL with these disease and longevity in humans.	[Sabharwal, Sanjeev] State Univ New Jersey, Rutgers New Jersey Med Sch, Dept Orthoped, Newark, NJ USA; [Guirguis, George; Roche, Natalie E.; Martimucci, Kristina; Patel, Krunal] State Univ New Jersey, Rutgers New Jersey Med Sch, Dept Obstet Gynecol & Womens Hlth, Newark, NJ USA; [Heller, Debra S.] State Univ New Jersey, Rutgers New Jersey Med Sch, Dept Pathol, Newark, NJ USA; [Kimura, Masayuki; Chuang, Donald; Chuang, Anne; Aviv, Abraham] State Univ New Jersey, Rutgers New Jersey Med Sch, Ctr Human Dev & Aging, Newark, NJ USA; [Verhulst, Simon] Univ Groningen, Groningen Inst Evolutionary Life Sci, Groningen, Netherlands; [Kark, Jeremy D.] Hebrew Univ Jerusalem, Hadassah Sch Publ Hlth & Community Med, Jerusalem, Israel; [Benetos, Athanase] INSERM, UMR S1116, Paris, France; [Benetos, Athanase] Univ Lorraine, CHRU Nancy, Dept Geriatr Med, Nancy, France	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Groningen; Hebrew University of Jerusalem; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; CHU de Nancy; Universite de Lorraine	Aviv, A (corresponding author), Rutgers New Jersey Med Sch, Ctr Human Dev & Aging, Room F-464 MSB,185 South Orange Ave, Newark, NJ 07103 USA.	avivab@njms.rutgers.edu	Verhulst, Simon/B-1613-2009; Labat, Carlos/F-7492-2010; Verhulst, Simon/S-3404-2019	Verhulst, Simon/0000-0002-1143-6868; Labat, Carlos/0000-0002-5275-3405; Verhulst, Simon/0000-0002-1143-6868	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) [R01HL116446]; NHLBI [R01HL13840]; NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01HD071180]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD071180] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116446] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in part, by the U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) Grant R01HL116446 (Leukocyte Telomere Length and Cardiovascular Disease in the Jackson Heart Study), NHLBI Grant R01HL13840 (Telomeres and Female Fecundity), and NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant R01HD071180 (Determinants of Leukocyte Telomere Length at Birth) (all to A. A.) The authors declare no conflicts of interest.	Anic GM, 2013, CANCER EPIDEMIOL, V37, P434, DOI 10.1016/j.canep.2013.02.010; Aubert G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002696; Aviv A, 2015, EPIDEMIOLOGY, V26, P295, DOI 10.1097/EDE.0000000000000280; Aviv A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr634; Benetos A, 2013, AGING CELL, V12, P615, DOI 10.1111/acel.12086; Benetos A, 2011, AGING CELL, V10, P991, DOI 10.1111/j.1474-9726.2011.00744.x; Buxton JL, 2011, J CLIN ENDOCR METAB, V96, P1500, DOI 10.1210/jc.2010-2924; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; D'Mello MJJ, 2015, CIRC-CARDIOVASC GENE, V8, P82, DOI 10.1161/CIRCGENETICS.113.000485; Daniali L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2602; Factor-Litvak P, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3927; Fyhrquist F, 2013, NAT REV CARDIOL, V10, P274, DOI 10.1038/nrcardio.2013.30; Gardner M, 2014, EXP GERONTOL, V51, P15, DOI 10.1016/j.exger.2013.12.004; Haycock PC, 2017, JAMA ONCOL, V3, P636, DOI 10.1001/jamaoncol.2016.5945; Haycock PC, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4227; Hjelmborg JB, 2015, J MED GENET, V52, P297, DOI 10.1136/jmedgenet-2014-102736; Hunt SC, 2008, AGING CELL, V7, P451, DOI 10.1111/j.1474-9726.2008.00397.x; Iles MM, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju267; Julin B, 2015, BRIT J CANCER, V112, P769, DOI 10.1038/bjc.2014.640; Kimura M, 2010, NAT PROTOC, V5, P1596, DOI 10.1038/nprot.2010.124; Muezzinler A, 2014, OBES REV, V15, P192, DOI 10.1111/obr.12126; Okuda K, 2002, PEDIATR RES, V52, P377, DOI 10.1203/01.PDR.0000022341.72856.72; Seow WJ, 2014, CANCER RES, V74, P4090, DOI 10.1158/0008-5472.CAN-14-0459; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Stone RC, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006144; Twig G, 2016, NEW ENGL J MED, V374, P2430, DOI 10.1056/NEJMoa1503840; Ulaner GA, 1997, MOL HUM REPROD, V3, P769, DOI 10.1093/molehr/3.9.769; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Verhulst S, 2015, INT J EPIDEMIOL, V44, P1683, DOI 10.1093/ije/dyv166; Walsh KM, 2015, NEURO-ONCOLOGY, V17, P1445, DOI 10.1093/neuonc/nov082; Wright WE, 1996, DEV GENET, V18, P173	31	36	36	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					529	534		10.1096/fj.201700630R	http://dx.doi.org/10.1096/fj.201700630R			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28855279	Green Published, Green Submitted			2022-12-28	WOS:000419172700046
J	Lim, H; Yu, CY; Jou, TS				Lim, HooiCheng; Yu, Chun-Ying; Jou, Tzuu-Shuh			Galectin-8 regulates targeting of Gp135/podocalyxin and lumen formation at the apical surface of renal epithelial cells	FASEB JOURNAL			English	Article						apical sorting; cell polarity; lateral lumens	MAJOR SIALOPROTEIN; BASAL POLARITY; MDCK CELLS; PODOCALYXIN; TRAFFICKING; MEMBRANE; DOMAIN; IDENTIFICATION; POLARIZATION; ORIENTATION	Establishment of apical-basal polarity, through correct targeting of polarity determinants to distinct domains of the plasma membrane, is a fundamental process for the development of functioning epithelial tubules. Here we report that galectin (Gal)-8 regulates apical-basal polarity of Madin-Darby canine kidney (MDCK) cells via apical targeting of 135-kDa glycoprotein (Gp135). Gal-8 interacts with newly synthesized Gp135 in a glycandependent manner. Gal-8 knockdown induces aberrant lumens at the lateral domain and mistargeting of Gp135 to this structure, thus disrupting the kidney epithelial polarity of MDCK cells, which organize lumens at the apical surface. The O-glycosylation deletionmutant of Gp135 phenocopies the effect of Gal-8 knockdown, which suggests that Gal-8 is the decoding machinery for the apical sorting signals of Gp135 residing at its O-glycosylation-rich region. Collectively, our results reveal a new role of Gal-8 in the development of luminal organs by regulating targeting of apical polarity protein Gp135.-Lim, H., Yu, C.-Y., Jou, T.-S. Galectin-8 regulates targeting of Gp135/podocalyxin and lumen formation at the apical surface of renal epithelial cells.	[Lim, HooiCheng; Yu, Chun-Ying] Natl Taiwan Univ, Grad Inst Mol Med, Taipei, Taiwan; [Jou, Tzuu-Shuh] Natl Taiwan Univ, Grad Inst Clin Med, 7 Chung Shan S Rd, Taipei 10002, Taiwan; [Yu, Chun-Ying] Acad Sinica, Inst Cellular & Organism Biol, Taipei, Taiwan	National Taiwan University; National Taiwan University; Academia Sinica - Taiwan	Jou, TS (corresponding author), Natl Taiwan Univ, Grad Inst Clin Med, 7 Chung Shan S Rd, Taipei 10002, Taiwan.	jouts@ntu.edu.tw	Yu, Chun-ying/AAE-8368-2020; yu, chun ying/ABB-3212-2020	Yu, Chun-ying/0000-0002-7320-7876; yu, chun ying/0000-0002-7320-7876; JOU, TZUU-SHUH/0000-0003-4341-5137	Taiwan Ministry of Science and Technology (MOST) [103-2320-B-002-049-MY3]; Taiwan MOST Postdoctoral Fellowship [104-2811-B-002-092, 105-2811-B-002-028]	Taiwan Ministry of Science and Technology (MOST); Taiwan MOST Postdoctoral Fellowship	The authors thank the staff of the imaging core at the First Core Laboratories (National Taiwan University College of Medicine) for technical assistance. This work was supported by the Taiwan Ministry of Science and Technology (MOST; to T-S.J.). H.L. was supported by the Taiwan MOST Postdoctoral Fellowship (104-2811-B-002-092 and 105-2811-B-002-028). The authors declare no conflicts of interest.	Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; Bryant DM, 2014, DEV CELL, V31, P171, DOI 10.1016/j.devcel.2014.08.027; Cheng HY, 2005, J AM SOC NEPHROL, V16, P1612, DOI 10.1681/ASN.2004121145; Cohen D, 2007, MOL BIOL CELL, V18, P2203, DOI 10.1091/mbc.E07-02-0095; DEKAN G, 1991, P NATL ACAD SCI USA, V88, P5398, DOI 10.1073/pnas.88.12.5398; Delacour D, 2006, CURR BIOL, V16, P408, DOI 10.1016/j.cub.2005.12.046; Delacour D, 2007, TRAFFIC, V8, P379, DOI 10.1111/j.1600-0854.2007.00539.x; Delacour D, 2009, TRAFFIC, V10, P1405, DOI 10.1111/j.1600-0854.2009.00960.x; Doyonnas R, 2001, J EXP MED, V194, P13, DOI 10.1084/jem.194.1.13; Earl LA, 2011, GLYCOBIOLOGY, V21, P6, DOI 10.1093/glycob/cwq144; KERJASCHKI D, 1985, AM J PATHOL, V118, P343; KERJASCHKI D, 1984, J CELL BIOL, V98, P1591, DOI 10.1083/jcb.98.4.1591; Klinkert K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11166; Koh W, 2008, J CELL SCI, V121, P989, DOI 10.1242/jcs.020693; Lin WL, 2007, HISTOCHEM CELL BIOL, V127, P399, DOI 10.1007/s00418-006-0252-8; Lu RF, 2014, MOL BIOL CELL, V25, P1744, DOI 10.1091/mbc.E13-12-0724; Meder D, 2005, J CELL BIOL, V168, P303, DOI 10.1083/jcb.200407072; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Mishra R, 2010, P NATL ACAD SCI USA, V107, P17633, DOI 10.1073/pnas.1012424107; Mrozowska PS, 2016, J CELL BIOL, V213, P355, DOI 10.1083/jcb.201512024; Nabi IR, 2015, J CELL SCI, V128, P2213, DOI 10.1242/jcs.151159; O'Brien LE, 2001, NAT CELL BIOL, V3, P831, DOI 10.1038/ncb0901-831; Overeem AW, 2015, TRENDS CELL BIOL, V25, P476, DOI 10.1016/j.tcb.2015.04.002; Poland PA, 2011, J BIOL CHEM, V286, P6780, DOI 10.1074/jbc.M110.179002; Richards M, 2015, CURR BIOL, V25, P2325, DOI 10.1016/j.cub.2015.07.045; Roman-Fernandez A, 2016, TRAFFIC, V17, P1244, DOI 10.1111/tra.12417; Stechly L, 2009, TRAFFIC, V10, P438, DOI 10.1111/j.1600-0854.2009.00882.x; Stowell SR, 2008, J BIOL CHEM, V283, P20547, DOI 10.1074/jbc.M802495200; Takeda T, 2001, J CLIN INVEST, V108, P289, DOI 10.1172/JCI12539; Yagi S, 2012, EMBO REP, V13, P237, DOI 10.1038/embor.2011.249; Yu CY, 2007, MOL BIOL CELL, V18, P1710, DOI 10.1091/mbc.E06-07-0629	31	8	8	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4917	4927		10.1096/fj.201601386R	http://dx.doi.org/10.1096/fj.201601386R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28747404				2022-12-28	WOS:000413398500022
J	Phillips, R				Phillips, Rob			Musings on mechanism: quest for a quark theory of proteins?	FASEB JOURNAL			English	Article						physics; toy model; quantitative biology	GROWTH; EVOLUTION; ORIGINS; PHYSICS; SIZE	The give and take between biology and physics is an important part of the history of modern science, with this partnership perhaps now more intimate than ever. In this essay, I explore the ways in which these different fields can strengthen each other through their distinct outlooks on some of the most important questions being asked about the living world. In particular, I highlight three areas where the perspective from physics might lead to deeper insights into the workings of cells. First, I consider what it means for two ostensibly unrelated problems to be the same, and how such sameness can provide unexpected insights into apparently unrelated phenomena. Second, I consider different conceptions of what constitutes a mechanistic understanding of a given phenomenon with an emphasis on nonmolecular notions of mechanism. The third idea is the importance of "toy problems" as a way of providing foundational insights into the real problems. Though my focus here is primarily on ways in which physics approaches might prove interesting in biology, I close with an example of how biology might substantially alter physics by providing a forum and the tools to uncover a fundamental understanding of nonequilibrium phenomena.-Phillips, R. Musings on mechanism: quest for a quark theory of proteins?	[Phillips, Rob] CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; [Phillips, Rob] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Phillips, R (corresponding author), CALTECH, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	phillips@pboc.caltech.edu			U.S. National Institutes of Health [DP1 OD000217]; National Institute of General Medical Sciences [R01 GM085286]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085286] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000217] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The author is grateful to Stephanie Barnes, Cliff Brangwynne, Griffin Chure, Hernan Garcia, Stephan Grill, Jeremy Gunawardena, Christina Hueschen, Jane Kondev, Michael Lassig, Jennifer Lippincott-Schwartz, Ron Milo, Thoru Pederson, Manuel Razo, Mike Rosen, Clarissa Scholes and Julie Theriot for useful discussions and/or commenting on the manuscript, though the views expressed here should not be blamed on them. The author is also grateful to the U.S. National Institutes of Health for support through Directors Pioneer Award DP1 OD000217 and National Institute of General Medical Sciences Grant R01 GM085286. It is a pleasure to acknowledge the Kavli Institute for Theoretical Physics (Santa Barbara, CA, USA) where much of this essay was written. Finally, the referencing provided here is cursory and intended to guide the reader to the literature, and does not attempt to provide a scholarly assessment of the many excellent contributions to the case studies described in this essay and not cited here.	ACKERS GK, 1982, P NATL ACAD SCI-BIOL, V79, P1129, DOI 10.1073/pnas.79.4.1129; ANDERSON PW, 1972, SCIENCE, V177, P393, DOI 10.1126/science.177.4047.393; Atchison DA, 2010, J VISION, V10, DOI 10.1167/10.12.16; Audoly B., 2010, ELASTICITY GEOMETRY; Banani SF, 2016, CELL, V166, P651, DOI 10.1016/j.cell.2016.06.010; Bassler BL, 2014, PHYS BIOL, V11, DOI 10.1088/1478-3975/11/5/053010; Berg J, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-42; Bevilacqua F., 1993, H VONHELMHOLTZ FDN 1; Bialek W., 2012, BIOPHYSICS SEARCHING; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Boal D., 2012, MECH CELL; Bottomley G. A., 1956, T R SOC NZ, V83, P579; Brangwynne CP, 2015, NAT PHYS, V11, P899, DOI [10.1038/NPHYS3532, 10.1038/nphys3532]; Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Brewster RC, 2014, CELL, V156, P1312, DOI 10.1016/j.cell.2014.02.022; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Callen H. B, 1985, THERMODYNAMICS INTRO, V2nd; Carroll Sean., 2016, SERENGETI RULES QUES; Cartwright DE, 2003, NOTES REC ROY SOC, V57, P135, DOI 10.1098/rsnr.2003.0201; CROMMIE MF, 1993, SCIENCE, V262, P218, DOI 10.1126/science.262.5131.218; Cross M, 2009, PATTERN FORMATION DY, DOI 10.1017/CBO9780511627200; DELBRUCK M., 1949, TRANS CONNECTICUT ACAD ARTS SCI, V38, P173; Freund B, 2006, THIN FILM MAT STRESS; Gerland U, 2002, J MOL EVOL, V55, P386, DOI 10.1007/s00239-002-2335-z; Goldenfeld N., 2019, LECT PHASE TRANSITIO, DOI [https://doi.org/10.1201/9780429493492, DOI 10.1201/9780429493492]; HILL TL, 1982, INT REV CYTOL, V78, P1, DOI 10.1016/S0074-7696(08)60105-9; Howard J, 2001, MECH MOTOR PROTEINS; Hui S, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145697; Hyman AA, 2011, DEV CELL, V21, P14, DOI 10.1016/j.devcel.2011.06.013; Kalodimos C, 2013, J MOL BIOL, V425, P2277, DOI 10.1016/j.jmb.2013.04.021; Kirschner M, 2000, CELL, V100, P79, DOI 10.1016/S0092-8674(00)81685-2; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Lassig M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S7; Land M, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0308; Laughlin RB, 2000, P NATL ACAD SCI USA, V97, P28, DOI 10.1073/pnas.97.1.28; Lynch M, 2015, P NATL ACAD SCI USA, V112, pE30, DOI 10.1073/pnas.1421641112; Martins BMC, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002261; Marzen S, 2013, J MOL BIOL, V425, P1433, DOI 10.1016/j.jmb.2013.03.013; Mayr E., 1997, THIS IS BIOL SCI LIV; Mollon JD, 2002, PHILOS T ROY SOC A, V360, P807, DOI 10.1098/rsta.2001.0968; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Pederson T, 2016, FASEB J, V30, P3269, DOI 10.1096/fj.161001ufm; Phillips R, 2013, PHYS BIOL CELL, V2nd ed; Prost J, 2015, NAT PHYS, V11, P111, DOI [10.1038/nphys3224, 10.1038/NPHYS3224]; Ramaswamy S, 2010, ANNU REV CONDEN MA P, V1, P323, DOI 10.1146/annurev-conmatphys-070909-104101; Rao V, 2011, J HIST BIOL, V44, P233, DOI 10.1007/s10739-010-9229-5; Robinson Andrew, 2006, LAST MAN WHO KNEW EV; Savin T, 2011, NATURE, V476, P57, DOI 10.1038/nature10277; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; Schmidt A, 2016, NAT BIOTECHNOL, V34, P104, DOI 10.1038/nbt.3418; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Takatori SC, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.028103; Vilar JMG, 2003, J MOL BIOL, V331, P981, DOI 10.1016/S0022-2836(03)00764-2; Viollet-le-Duc M., 1868, DICT RAISONNE ARCHIT; Weinert FM, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.258101; White A. D., 1932, HIST WARFARE SCI THE; Yong E, 2013, NATURE, V493, P286, DOI 10.1038/493286a; Young T., 1801, PHILOS T ROYAL SOC L, V91, P23, DOI DOI 10.1098/RSTL.1801.0004	61	2	2	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4207	4215		10.1096/fj.201700594	http://dx.doi.org/10.1096/fj.201700594			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28963318	Green Published			2022-12-28	WOS:000413397400002
J	Tai, HR; Wang, XB; Zhou, J; Han, XJ; Fang, TT; Gong, H; Huang, N; Chen, HH; Qin, JQ; Yang, M; Wei, XW; Yang, L; Xiao, HY				Tai, Haoran; Wang, Xiaobo; Zhou, Jiao; Han, Xiaojuan; Fang, Tingting; Gong, Hui; Huang, Ning; Chen, Honghan; Qin, Jianqiong; Yang, Ming; Wei, Xiawei; Yang, Li; Xiao, Hengyi			Protein kinase C beta activates fat mass and obesity-associated protein by influencing its ubiquitin/proteasome degradation	FASEB JOURNAL			English	Article						FTO; mTOR; phosphorylation; adipogenesis	FTO GENE; PKC-BETA; DIABETIC COMPLICATIONS; ADULT OBESITY; PROLIFERATION; DIFFERENTIATION; OVEREXPRESSION; CHILDHOOD; CANCER; CELLS	Protein kinase C beta (PKC beta) is a serine-threonine kinase associated with obesity and diabetic complications; its activation contributes to weight gain, and deletion of its gene results in resistance to genetic- and diet-induced obesity. Fat mass and obesity-associated (FTO) protein is a recently identified RNA demethylase, and its overexpression in mice leads to increased body weight as well as fat mass. Although sharing some features in anabolism regulation, PKC beta and FTO have not been investigated together; therefore, their relationship has not been established. We report that PKC beta positively regulates FTO on the posttranslation level, evidenced by the facts that PKC beta activation contributes to high-glucose-induced FTO up-regulation, and overexpression of PKC beta suppresses ubiquitin-proteasome degradation of FTO, whereas PKC beta inactivation acts in the opposite manner. It was also found that PKC beta can phosphorylate FTO on threonine, and this phosphorylation requires both catalytic and regulatory domains of PKC beta. Moreover, PKC beta inhibition can suppress 3T3-L1 cell differentiation in normal and FTO-overexpressing cells but not in FTO-silenced or -inhibited cells. We propose that PKC beta acts to suppress the degradation of FTO protein and reveals the associated role of PKC beta and FTO in adipogenesis, suggesting a new pathway that affects the development of obesity and metabolic diseases.-Tai, H., Wang, X., Zhou, J., Han, X., Fang, T., Gong, H., Huang, N., Chen, H., Qin, J., Yang, M., Wei, X., Yang, L., Xiao, H. Protein kinase C beta activates fat mass and obesity-associated protein by influencing its ubiquitin/proteasome degradation.	[Tai, Haoran; Wang, Xiaobo; Zhou, Jiao; Han, Xiaojuan; Fang, Tingting; Gong, Hui; Huang, Ning; Chen, Honghan; Qin, Jianqiong; Yang, Ming; Wei, Xiawei; Yang, Li; Xiao, Hengyi] Sichuan Univ, State Key Lab Biotherapy, Collaborat Innovat Ctr Biotherapy, Lab Aging Res,Ctr Gerontol & Geriatr,West China H, Chengdu, Sichuan, Peoples R China	Sichuan University	Xiao, HY (corresponding author), West China Hosp, 1 Keyuan 4 Rd,Gaopneg Ave, Chengdu 610041, Sichuan, Peoples R China.	hengyix@scu.edu.cn	Tai, Haoran/S-2807-2018		National Key Research and Development Program [2016YFC1200203]; National Natural Science Foundation of China [81273224]; National 973 Basic Research Programs of China [2013CB967204]	National Key Research and Development Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Basic Research Programs of China	The authors thank Noel G. Morgan and Dr. Mark A. Russell (University of Exeter, Exeter, United Kingdom) for providing the FTO-HA plasmid, Caiguang Yang (Chinese Academy of Sciences, Shanghai, China) for providing the recombinant FTO protein, and Yuquan Wei, Canhua Huang, and Jie Zhang (Sichuan University) for continuous support. This work was supported by National Key Research and Development Program Grant 2016YFC1200203 (to H.X.), National Natural Science Foundation of China Grant 81273224 (to H.X.), and National 973 Basic Research Programs of China Grant 2013CB967204 (to H.X). The authors declare no conflicts of interest.	Aguiari P, 2008, P NATL ACAD SCI USA, V105, P1226, DOI 10.1073/pnas.0711402105; Basson MD, 2015, MOL ONCOL, V9, P513, DOI 10.1016/j.molonc.2014.10.008; Chen BE, 2012, J AM CHEM SOC, V134, P17963, DOI 10.1021/ja3064149; Chen XL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151056; Cheung MK, 2013, INT J OBESITY, V37, P744, DOI 10.1038/ijo.2012.77; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; El Osta M, 2014, FASEB J, V28, P495, DOI 10.1096/fj.13-230557; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gao X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014005; Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117; Gulati P, 2013, P NATL ACAD SCI USA, V110, P2557, DOI 10.1073/pnas.1222796110; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Huang W, 2012, J LIPID RES, V53, P368, DOI 10.1194/jlr.M019687; Huang W, 2009, HEPATOLOGY, V49, P1525, DOI 10.1002/hep.22815; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Jiao Y, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020102; Koya D, 1998, DIABETES, V47, P859, DOI 10.2337/diabetes.47.6.859; Lei SQ, 2013, DIABETES, V62, P2318, DOI 10.2337/db12-1391; Leonard TA, 2011, CELL, V144, P55, DOI 10.1016/j.cell.2010.12.013; Loraine YC, 2015, MOL METAB, V4, P287, DOI 10.1016/j.molmet.2015.01.011; Lutzny G, 2013, CANCER CELL, V23, P77, DOI 10.1016/j.ccr.2012.12.003; McMurray F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003166; Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055; Mehta NK, 2014, BBA-MOL CELL BIOL L, V1841, P1491, DOI 10.1016/j.bbalip.2014.07.011; Merkestein M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7792; Merkestein M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097162; Pavan C, 2010, PHARMACOGENOMICS J, V10, P408, DOI 10.1038/tpj.2009.67; Poritsanos NJ, 2011, NUTR DIABETES, V1, DOI 10.1038/nutd.2011.15; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Russell MA, 2011, CLIN SCI, V120, P403, DOI 10.1042/CS20100416; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Tan AH, 2015, INT J CLIN EXP PATHO, V8, P13405; Zhang MZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133788; Zhang ZB, 2012, CANCER LETT, V319, P89, DOI 10.1016/j.canlet.2011.12.033; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151; Zhu YP, 2016, ONCOL REP, V35, P2391, DOI 10.3892/or.2016.4613	39	16	16	1	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4396	4406		10.1096/fj.201601159RR	http://dx.doi.org/10.1096/fj.201601159RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28626026				2022-12-28	WOS:000413397400018
J	Yu, ZX; Ruter, DL; Kushner, EJ; Bautch, VL				Yu, Zhixian; Ruter, Dana L.; Kushner, Erich J.; Bautch, Victoria L.			Excess centrosomes induce p53-dependent senescence without DNA damage in endothelial cells	FASEB JOURNAL			English	Article						vasculature; tumor microenvironment; proliferation; blood vessel sprouting	BLOOD-VESSEL FORMATION; CENTRIOLE DUPLICATION; CANCER-CELLS; CELLULAR SENESCENCE; EXTRA CENTROSOMES; IN-VIVO; CYCLE; INSTABILITY; PATHWAY; P53	Tumor blood vessels support tumor growth and progression. Centrosomes are microtubule organization centers in cells, and often up to 30% of tumor endothelial cells (ECs) acquire excess (>2) centrosomes. Although excess centrosomes can lead to aneuploidy and chromosome instability in tumor cells, how untransformed ECs respond to excess centrosomes is poorly understood. We found that the frequency of primary human ECs with excess centrosomes was quickly reduced in a p53-dependent manner. Excess centrosomes in ECs were associated with p53 phosphorylation at Ser33, increased p21 levels, and decreased cell proliferation and expression of senescence markers, but independent of DNA damage and apoptosis. Aspects of the senescence-associated phenotype were also observed in mouse ECs that were isolated from tumors with excess centrosomes. Primary ECs with excess centrosomes in vascular sprouts also had elevated Ser33 p53 phosphorylation and expressed senescence markers. Our work demonstrates that nontransformed ECs respond differently to excess centrosomes than do most tumor cellsthey undergo senescence in vascular sprouts and vessels, which suggests that pathologic outcomes of centrosome overduplication depend on the transformation status of cells.-Yu, Z., Ruter, D. L., Kushner, E. J., Bautch, V. L. Excess centrosomes induce p53-dependent senescence without DNA damage in endothelial cells.	[Yu, Zhixian; Ruter, Dana L.; Kushner, Erich J.; Bautch, Victoria L.] Univ North Carolina Chapel Hill, Dept Biol, 503 Fordham Hall,CB 3280, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Bautch, VL (corresponding author), Univ North Carolina Chapel Hill, Dept Biol, 503 Fordham Hall,CB 3280, Chapel Hill, NC 27599 USA.	bautch@med.unc.edu			U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL43174, HL116719]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043174, R01HL116719] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grants HL43174 and HL116719 (to V.L.B.). The authors thank members of the V.L.B. laboratory for constructive discussions and for comments on the manuscript. Z.Y. and V.L.B. are members of the Curriculum in Genetics and Molecular Biology at the University of North Carolina at Chapel Hill. The authors declare no conflicts of interest.	Aird Katherine M, 2013, Methods Mol Biol, V965, P185, DOI 10.1007/978-1-62703-239-1_12; Anderhub SJ, 2012, CANCER LETT, V322, P8, DOI 10.1016/j.canlet.2012.02.006; Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; Arquint C, 2016, BIOCHEM SOC T, V44, P1253, DOI 10.1042/BST20160116; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130; Cuomo ME, 2008, NAT CELL BIOL, V10, P723, DOI 10.1038/ncb1735; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ganem NJ, 2014, CELL, V158, P833, DOI 10.1016/j.cell.2014.06.029; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gao R, 2015, J GERONTOL A-BIOL, V70, P701, DOI 10.1093/gerona/glu019; GARFINKEL S, 1994, P NATL ACAD SCI USA, V91, P1559, DOI 10.1073/pnas.91.4.1559; Godinho S, 2009, CANCER METAST REV, V28, P85, DOI 10.1007/s10555-008-9163-6; Guderian G, 2010, J CELL SCI, V123, P2163, DOI 10.1242/jcs.068502; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hida K, 2004, CANCER RES, V64, P8249, DOI 10.1158/0008-5472.CAN-04-1567; Holland AJ, 2012, GENE DEV, V26, P2684, DOI 10.1101/gad.207027.112; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Kawabe T, 2004, MOL CANCER THER, V3, P513; Kuo LJ, 2008, IN VIVO, V22, P305; Kushner EJ, 2016, MOL BIOL CELL, V27, P1911, DOI 10.1091/mbc.E15-09-0645; Kushner EJ, 2014, J CELL BIOL, V206, P257, DOI 10.1083/jcb.201311013; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; Loncarek J, 2009, MOL CELLS, V27, P135, DOI 10.1007/s10059-009-0017-z; Mariotti Massimo, 2006, Immun Ageing, V3, P4, DOI 10.1186/1742-4933-3-4; McDonald DM, 2003, NAT MED, V9, P713, DOI 10.1038/nm0603-713; Mikule K, 2007, NAT CELL BIOL, V9, P160, DOI 10.1038/ncb1529; Nagy JA, 2009, BRIT J CANCER, V100, P865, DOI 10.1038/sj.bjc.6604929; Nakatsu Martin N, 2007, J Vis Exp, P186, DOI 10.3791/186; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003; Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345; RING D, 1982, J CELL BIOL, V94, P549, DOI 10.1083/jcb.94.3.549; Roberts DM, 2004, AM J PATHOL, V164, P1531, DOI 10.1016/S0002-9440(10)63711-X; Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640; Salama R, 2014, GENE DEV, V28, P99, DOI 10.1101/gad.235184.113; Salmon ED, 2005, PHILOS T R SOC B, V360, P553, DOI 10.1098/rstb.2004.1610; Sluder G, 1997, J CELL SCI, V110, P421; Srsen V, 2006, J CELL BIOL, V174, P625, DOI 10.1083/jcb.200606051; Taylor SM, 2010, BLOOD, V116, P3108, DOI 10.1182/blood-2010-01-266197; te Poele RH, 2002, CANCER RES, V62, P1876; Terzi MY, 2016, MOL BIOL REP, V43, P1213, DOI 10.1007/s11033-016-4065-0; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Warboys CM, 2014, ARTERIOSCL THROM VAS, V34, P985, DOI 10.1161/ATVBAHA.114.303415; Wolf BB, 1999, J BIOL CHEM, V274, P30651, DOI 10.1074/jbc.274.43.30651; Wong C, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-6; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yasutis KM, 2013, CELL CYCLE, V12, P1501, DOI 10.4161/cc.24637; Yeo EJ, 2000, EXP GERONTOL, V35, P553, DOI 10.1016/S0531-5565(00)00108-X; Yu ZX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168334	53	5	5	2	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4295	4304		10.1096/fj.201601320R	http://dx.doi.org/10.1096/fj.201601320R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28626028	Green Published, Green Submitted			2022-12-28	WOS:000413397400010
J	Lei, S; Huang, FJ; Zhao, AH; Chen, TL; Chen, WL; Xie, GX; Zheng, XJ; Zhang, YJ; Yu, HY; Zhang, P; Rajani, C; Bao, YQ; Jia, WP; Jia, W				Lei, Sha; Huang, Fengjie; Zhao, Aihua; Chen, Tianlu; Chen, Wenlian; Xie, Guoxiang; Zheng, Xiaojiao; Zhang, Yunjing; Yu, Haoyong; Zhang, Pin; Rajani, Cynthia; Bao, Yuqian; Jia, Weiping; Jia, Wei			The ratio of dihomo-gamma-linolenic acid to deoxycholic acid species is a potential biomarker for the metabolic abnormalities in obesity	FASEB JOURNAL			English	Article						bile acid; free fatty acid; targeted metabolomics; type 2 diabetes	Y GASTRIC BYPASS; POLYUNSATURATED FATTY-ACIDS; SERUM BILE-ACIDS; GROWTH-FACTOR 19; BODY-MASS INDEX; GLUCOSE-METABOLISM; DIABETES REMISSION; ENERGY-EXPENDITURE; BARIATRIC SURGERY; FOOD-INTAKE	Bile acid (BA) signaling regulates fatty acid metabolism. BA dysregulation plays an important role in the development of metabolic disease. However, BAs in relation to fatty acids have not been fully investigated in obesity-related metabolic disorders. A targeted metabolomic measurement of serum BA and free fatty acid profiles was applied to sera of 381 individuals in 2 independent studies. The results showed that the ratio of dihomo-gamma-linolenic acid (DGLA) to deoxycholic acid (DCA) species (DCAS) was significantly increased in obese individuals with type 2 diabetes (T2DM) from a case-control study and decreased in the remission group of obese subjects with T2DM after metabolic surgery. The changes were closely associated with their metabolic status. These results were consistently confirmed in both serum and liver of mice with diet-induced obesity, implying that such a metabolic alteration in circulation reflects changes occurring in the liver. In vitro studies of human liver L-02 cell lines under BA treatment revealed that DCA and its conjugated form, TDCA, significantly inhibited mRNA expression of fatty acid transport protein 5 in the presence of DGLA, which was involved in hepatocyte DGLA uptake. Thus, the DGLA: DCAS ratio may be a promising biomarker for metabolic abnormalities in obesity.	[Lei, Sha; Huang, Fengjie; Zhao, Aihua; Chen, Tianlu; Zheng, Xiaojiao; Zhang, Yunjing; Jia, Weiping; Jia, Wei] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Key Lab Diabet Mellitus, Shanghai, Peoples R China; [Lei, Sha; Huang, Fengjie; Zhao, Aihua; Chen, Tianlu; Zheng, Xiaojiao; Zhang, Yunjing; Jia, Weiping; Jia, Wei] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Ctr Translat Med, Shanghai, Peoples R China; [Yu, Haoyong; Bao, Yuqian; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol & Metab, Shanghai, Peoples R China; [Yu, Haoyong; Bao, Yuqian; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Diabet Inst, Shanghai Clin Ctr Diabet, Shanghai, Peoples R China; [Yu, Haoyong; Bao, Yuqian; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Key Clin Ctr Metab Dis, Shanghai, Peoples R China; [Zhang, Pin] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Gen Surg, Shanghai, Peoples R China; [Chen, Wenlian; Xie, Guoxiang; Rajani, Cynthia; Jia, Wei] Univ Hawaii, Ctr Canc, 701 Ilalo St, Honolulu, HI 96813 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Cancer Research Center of Hawaii; University of Hawaii System	Jia, W (corresponding author), Univ Hawaii, Ctr Canc, 701 Ilalo St, Honolulu, HI 96813 USA.	wjia@cc.hawaii.edu	Jia, Wei/AAN-5102-2020; Xie, Guoxiang/F-3022-2016	Jia, Wei/0000-0002-3739-8994; Xie, Guoxiang/0000-0002-0951-4150	International Science and Technology Cooperation Program of China [2014DFA31870]; NATIONAL CANCER INSTITUTE [P30CA071789] Funding Source: NIH RePORTER	International Science and Technology Cooperation Program of China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the International Science and Technology Cooperation Program of China (Grant 2014DFA31870). The authors declare no conflicts of interest.	Albaugh VL, 2015, J CLIN ENDOCR METAB, V100, pE1225, DOI 10.1210/jc.2015-2467; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Alhazmi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097001; Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; Buse JB, 2009, DIABETES CARE, V32, P2133, DOI 10.2337/dc09-9036; Chen WL, 2014, BLOOD, V124, P1645, DOI 10.1182/blood-2014-02-554204; Cho JS, 2014, NUTR RES, V34, P733, DOI 10.1016/j.nutres.2014.08.005; Decara J, 2016, BIOFACTORS, V42, P600, DOI 10.1002/biof.1295; Doege H, 2006, GASTROENTEROLOGY, V130, P1245, DOI 10.1053/j.gastro.2006.02.006; Forouhi NG, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002094; Gerhard GS, 2013, DIABETES CARE, V36, P1859, DOI 10.2337/dc12-2255; Guo CS, 2016, IMMUNITY, V45, P802, DOI 10.1016/j.immuni.2016.09.008; Hao Z, 2016, OBES SURG, V26, P2173, DOI 10.1007/s11695-016-2062-y; Hao Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052922; Hubbard B, 2006, GASTROENTEROLOGY, V130, P1259, DOI 10.1053/j.gastro.2006.02.012; Jorgensen NB, 2015, J CLIN ENDOCR METAB, V100, pE396, DOI 10.1210/jc.2014-1658; Jump DB, 2002, J BIOL CHEM, V277, P8755, DOI 10.1074/jbc.R100062200; Kashihara H, 2015, J GASTROEN HEPATOL, V30, P308, DOI 10.1111/jgh.12690; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Kohli R, 2013, J CLIN ENDOCR METAB, V98, pE708, DOI 10.1210/jc.2012-3736; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Li TG, 2014, PHARMACOL REV, V66, P948, DOI 10.1124/pr.113.008201; Ma HJ, 2014, BEST PRACT RES CL GA, V28, P573, DOI 10.1016/j.bpg.2014.07.004; Matsuda M, 2017, OBES RES CLIN PRACT, V11, P34, DOI 10.1016/j.orcp.2016.02.004; Molendi-Coste O, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/364040; Nausheen S, 2013, AM J PHYSIOL-ENDOC M, V305, pE507, DOI 10.1152/ajpendo.00130.2013; Netto BD, 2015, OBES SURG, V25, P1010, DOI 10.1007/s11695-014-1484-7; Ni Y, 2015, EBIOMEDICINE, V2, P1513, DOI 10.1016/j.ebiom.2015.09.004; Nie B, 2012, HEPATOLOGY, V56, P1300, DOI 10.1002/hep.25797; Park WH, 2011, EXP MOL MED, V43, P571, DOI 10.3858/emm.2011.43.10.064; Patti ME, 2009, OBESITY, V17, P1671, DOI 10.1038/oby.2009.102; Penney NC, 2015, INT J OBESITY, V39, P1565, DOI 10.1038/ijo.2015.115; Shao YM, 2015, DRUG DES DEV THER, V9, P1177, DOI 10.2147/DDDT.S79175; Simonen M, 2012, OBES SURG, V22, P1473, DOI 10.1007/s11695-012-0673-5; Steffen BT, 2012, INT J OBESITY, V36, P797, DOI 10.1038/ijo.2011.157; Steinert RE, 2013, OBESITY, V21, pE660, DOI 10.1002/oby.20522; Wall R, 2010, NUTR REV, V68, P280, DOI 10.1111/j.1753-4887.2010.00287.x; Wang XN, 2016, J PROTEOME RES, V15, P1126, DOI 10.1021/acs.jproteome.5b00217; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Xie GX, 2016, INT J CANCER, V139, P1764, DOI 10.1002/ijc.30219; Xie GX, 2015, J PROTEOME RES, V14, P850, DOI 10.1021/pr500920q; Xie GX, 2013, FASEB J, V27, P3583, DOI 10.1096/fj.13-231860; Yabe D, 2011, PROG BIOPHYS MOL BIO, V107, P248, DOI 10.1016/j.pbiomolbio.2011.07.010; Yary T, 2016, AM J CLIN NUTR, V103, P1337, DOI 10.3945/ajcn.115.128629; Yu HY, 2015, SURG OBES RELAT DIS, V11, P6, DOI 10.1016/j.soard.2014.06.019; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P245; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037	47	15	18	3	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3904	3912		10.1096/fj.201700055R	http://dx.doi.org/10.1096/fj.201700055R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28490483	Green Published			2022-12-28	WOS:000408713300017
J	Norton, JN; Reynolds, RP; Chan, C; Valdivia, RH; Staats, HF				Norton, John N.; Reynolds, Randall P.; Chan, Cliburn; Valdivia, Raphael H.; Staats, Herman F.			Assessing the satisfaction and burden within an academic animal care and use program	FASEB JOURNAL			English	Article						compliance; oversight; policies; standards	HARM-BENEFIT ANALYSIS; IMPOSED REGULATORY BURDEN; SELF-ASSESSMENT SURVEY; FELASA WORKING GROUP; USE COMMITTEE; PART 1; OVERSIGHT; IACUC	Although animal research requires adherence to various regulations and standards, the manner in which compliance is maintained and the degree of additional constraints varies between institutions. Regulatory burden, particularly if institutionally imposed, has become a concern for institutions as increased regulatory expectations result in decreased resources available for research efforts. Faculty, research staff, and support staff engaged in animal research were surveyed to determine what institutional animal care and use committee (IACUC) processes were considered burdensome, the perceived value of some suggested modifications, and satisfaction with the IACUC administrative office and the animal resource unit. Although the results revealed overwhelming satisfaction with the IACUC administrative office and the animal resource unit, several IACUC processes were deemed burdensome, and therefore there would be value in modifying IACUC processes. When comparing the value of modifying IACUC processes, different groups within the animal care and use program (ACUP) tended to have different responses on many of the topics. This survey identified several perceived burdensome IACUC processes that would likely benefit individuals if modified. In today's environment of shrinking budgets for biomedical research, minimizing regulatory burden-particularly unnecessary, self-imposed burden-in the ACUP is particularly important to ensure that costs, time, and effort are appropriate to achieve animal welfare and quality of research endeavors.	[Norton, John N.; Reynolds, Randall P.] Duke Univ, Med Ctr, Div Lab Anim Resources, 103 Res Dr,DUMC 3180, Durham, NC 27710 USA; [Norton, John N.; Staats, Herman F.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Chan, Cliburn] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27710 USA; [Valdivia, Raphael H.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Norton, JN (corresponding author), Duke Univ, Med Ctr, Div Lab Anim Resources, 103 Res Dr,DUMC 3180, Durham, NC 27710 USA.	john.norton@duke.edu	Valdivia, Raphael/R-5377-2019	Valdivia, Raphael/0000-0003-0961-073X				Animal Welfare Regulations, 9 CFR AN AN PROD 1; Banks RE, 2008, ILAR J, V49, P402, DOI 10.1093/ilar.49.4.402; Bronstad A, 2016, LAB ANIM-UK, V50, P1, DOI 10.1177/0023677216642398; Collins JG, 2008, ILAR J, V49, P388, DOI 10.1093/ilar.49.4.388; Committee on Federal Research Regulations and Reporting Re-quirements, 2016, OPT NAT INV AC RES N; Cummings SR., 2013, DESIGNING CLIN RES, V4th, P223; Dale WE, 2008, ILAR J, V49, P393, DOI 10.1093/ilar.49.4.393; Decker RS, 2007, PROFILE FEDERAL GRAN; Federation of American Societies for Experimental Biology, 2013, FIND FASEB SURV ADM; Geetter J. S., 2016, 21 CENTURY CURES MOD; Graham ML, 2015, EUR J PHARMACOL, V759, P19, DOI 10.1016/j.ejphar.2015.03.040; Haywood JR, 2008, ILAR J, V49, P426, DOI 10.1093/ilar.49.4.426; Ingham KM, 2000, CONTEMP TOP LAB ANIM, V39, P28; Laber K, 2016, LAB ANIM-UK, V50, P21, DOI 10.1177/0023677216642397; Levine AS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5200; National Research Council, 2011, GUIDE CARE USE LAB A; National Science Board (NSB), 2014, NSB1418 NAT SCI FDN; Plante A, 2008, ILAR J, V49, P419, DOI 10.1093/ilar.49.4.419; Pritt S, 2016, LAB ANIMAL, V45, P297, DOI 10.1038/laban.1067; PublicHealth Service, 1986, POL HUM CAR US LAB A; Schneider Sandra, 2014, 2012 FACULTY WORKLOA; Silverman J, 2012, LAB ANIMAL, V41, P289, DOI 10.1038/laban1012-289; Silverman J, 2012, LAB ANIMAL, V41, P230, DOI 10.1038/laban0812-230; Thulin JD, 2014, FASEB J, V28, P3297, DOI 10.1096/fj.14-254094; Vanderford DA, 2015, LAB ANIMAL, V44, P395, DOI 10.1038/laban.856	25	4	4	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3913	3921		10.1096/fj.201700072RR	http://dx.doi.org/10.1096/fj.201700072RR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28515151				2022-12-28	WOS:000408713300018
J	Sassa, T; Tadaki, M; Kiyonari, H; Kihara, A				Sassa, Takayuki; Tadaki, Masato; Kiyonari, Hiroshi; Kihara, Akio			Very long-chain tear film lipids produced by fatty acid elongase ELOVL1 prevent dry eye disease in mice	FASEB JOURNAL			English	Article						meibomian gland; wax ester; cholesteryl ester	LIQUID-CHROMATOGRAPHY; PERMEABILITY BARRIER; MASS-SPECTROMETRY; MEIBOMIAN GLAND; WAX ESTERS; SKIN; PATHOPHYSIOLOGY; ACYLCERAMIDES; EXPRESSION; PHYSIOLOGY	Lipids secreted from the meibomian gland (meibum) form the superficial layer of the tear film and prevent water evaporation from the ocular surface and infection. Here, we identified the fatty acid (FA) elongases responsible for the synthesis of very long-chain FAs (VLCFAs) that constitute the meibum lipids. Elongation of VLCFAs (ELOVL)1 is primarily responsible for the production of saturated VLCFAs, whereas ELOVL1, ELOVL3, and ELOVL4 redundantly participate in the synthesis of monounsaturated VLCFAs. Gene disruption of Elov11 in mice shortened acyl moieties in the 2 major meibum lipids: cholesteryl esters and wax esters. These changes were associated with dry eye phenotypes, including increases in eye blink frequency and water evaporation from the ocular surface at younger ages. Aged Elov11 mutant mice developed corneal opacity with vascular invasion, accompanied by epidermalization of the cornea. Thus, in addition to the well-known VLC ceramides (acylceramides) in the epidermis, VLC meibum lipids are barrier-forming lipids.	[Sassa, Takayuki; Tadaki, Masato; Kihara, Akio] Hokkaido Univ, Fac Pharmaceut Sci, Lab Biochem, Sapporo, Hokkaido, Japan; [Kiyonari, Hiroshi] RIKEN, Ctr Life Sci Technol, Kobe, Hyogo, Japan	Hokkaido University; RIKEN	Kihara, A (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Lab Biochem, Kita Ku, Kita 12-Jo,Nishi 6 Chome, Sapporo, Hokkaido 0600812, Japan.	kihara@pharm.hokudai.ac.jp	KIHARA, AKIO/A-3802-2012; SASSA, Takayuki/B-2519-2012	KIHARA, AKIO/0000-0001-5889-0788; SASSA, Takayuki/0000-0003-3145-9829	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan under the Support Program for Implementation of a New Equipment Sharing System; Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from MEXT; Advanced Research and Development Programs for Medical Innovation (AMED-CREST) from AMED [JP17gm0910002]; Japan Society for the Promotion of Science (JSPS) [26251010]; JSPS [16K08220]; Grants-in-Aid for Scientific Research [26251010] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan under the Support Program for Implementation of a New Equipment Sharing System; Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from MEXT; Advanced Research and Development Programs for Medical Innovation (AMED-CREST) from AMED; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Dr. S. Ghazizadeh (State University of New York at Stony Brook, Stony Brook, NY, USA) for providing the human IVL promoter. The authors also thank T. Kashiwagi and T. Hirayama (both from Hokkaido University) for assistance with animal preparation. The authors acknowledge assistance received from Hokkaido University; Global Facility Center (GFC); Pharma Science Open Unit (PSOU), which is funded by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan under the Support Program for Implementation of a New Equipment Sharing System; and Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from MEXT; and Japan Agency for Medical Research and Development (AMED) for use of mass spectrometer. This work was supported by funding from the Advanced Research and Development Programs for Medical Innovation (AMED-CREST; Grant JP17gm0910002 to A.K.) from AMED, by a Grant-in-Aid for Scientific Research (A) (Grant 26251010 to A.K.) from the Japan Society for the Promotion of Science (JSPS), and by a Grant-in-Aid for Scientific Research (C) (Grant 16K08220 to T.S.) from JSPS. The authors declare no conflicts of interest.	Adhikary G, 2005, INVEST OPHTH VIS SCI, V46, P3109, DOI 10.1167/iovs.05-0053; BANKSSCHLEGEL S, 1981, J CELL BIOL, V90, P732, DOI 10.1083/jcb.90.3.732; Bron A J, 2004, Ocul Surf, V2, P149; Bron AJ, 2014, OCUL SURF, V12, pS1, DOI 10.1016/j.jtos.2014.02.002; Butovich IA, 2013, EXP EYE RES, V117, P4, DOI 10.1016/j.exer.2013.05.010; Butovich IA, 2012, INVEST OPHTH VIS SCI, V53, P3766, DOI 10.1167/iovs.11-9333; Camera E, 2010, J LIPID RES, V51, P3377, DOI 10.1194/jlr.D008391; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; CARROLL JM, 1993, P NATL ACAD SCI USA, V90, P10270, DOI 10.1073/pnas.90.21.10270; Cheng JB, 2004, J BIOL CHEM, V279, P37789, DOI 10.1074/jbc.M406225200; Cwiklik L, 2016, BBA-BIOMEMBRANES, V1858, P2421, DOI 10.1016/j.bbamem.2016.02.020; Gayton JL, 2009, CLIN OPHTHALMOL, V3, P405; Gipson IK, 2004, EXP EYE RES, V78, P379, DOI 10.1016/S0014-4835(03)00204-5; IYENGAR BTR, 1969, LIPIDS, V4, P28, DOI 10.1007/BF02531790; Kashima T, 2014, CLIN OPHTHALMOL, V8, P1003, DOI 10.2147/OPTH.S40798; Keating GM, 2015, DRUGS, V75, P911, DOI 10.1007/s40265-015-0409-7; Kihara A, 2016, PROG LIPID RES, V63, P50, DOI 10.1016/j.plipres.2016.04.001; Kihara A, 2012, J BIOCHEM, V152, P387, DOI 10.1093/jb/mvs105; Kitamura T, 2015, BIOCHEM J, V465, P79, DOI 10.1042/BJ20140624; Knop E, 2011, INVEST OPHTH VIS SCI, V52, P1938, DOI 10.1167/iovs.10-6997c; Lam SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024339; Lee HS, 2014, CORNEA, V33, P946, DOI 10.1097/ICO.0000000000000165; MAHADEVAN V, 1962, J LIPID RES, V3, P106; McMahon A, 2014, INVEST OPHTH VIS SCI, V55, P2832, DOI 10.1167/iovs.13-13335; Nien CJ, 2010, MOL VIS, V16, P1132; Ohashi Y, 2006, CLIN CHIM ACTA, V369, P17, DOI 10.1016/j.cca.2005.12.035; Ohno Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14610; Ohno Y, 2015, P NATL ACAD SCI USA, V112, P7707, DOI 10.1073/pnas.1503491112; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P18439, DOI 10.1073/pnas.1005572107; Okuda A, 2010, MOL VIS, V16, P2438; Poli M, 2011, INVEST OPHTH VIS SCI, V52, P9411, DOI 10.1167/iovs.10-7049; Sassa T, 2014, BIOMOL THER, V22, P83, DOI 10.4062/biomolther.2014.017; Sassa T, 2013, MOL CELL BIOL, V33, P2787, DOI 10.1128/MCB.00192-13; Vasireddy V, 2007, HUM MOL GENET, V16, P471, DOI 10.1093/hmg/ddl480	34	37	40	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					2966	2978		10.1096/fj.201700947R	http://dx.doi.org/10.1096/fj.201700947R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401594				2022-12-28	WOS:000432546000007
J	Garciarena, CD; Malik, A; Swietach, P; Moreno, AP; Vaughan-Jones, RD				Garciarena, Carolina D.; Malik, Akif; Swietach, Pawel; Moreno, Alonso P.; Vaughan-Jones, Richard D.			Distinct moieties underlie biphasic H+ gating of connexin43 channels, producing a pH optimum for intercellular communication	FASEB JOURNAL			English	Article						gap junctions; acid-base; heart; brain; electrical synapse	GAP-JUNCTION PROTEIN; INTRACELLULAR PH; DEPENDENT MODULATION; GUINEA-PIG; VENTRICULAR MYOCYTES; CELLS; CALCIUM; PHOSPHORYLATION; PROTON; RAT	Most mammalian cells can intercommunicate via connexin-assembled, gap-junctional channels. To regulate signal transmission, connexin (Cx) channel permeability must respond dynamically to physiological and pathophysiological stimuli. One key stimulus is intracellular pH (pH(i)), which is modulated by a tissue's metabolic and perfusion status. Our understanding of the molecular mechanism of H+ gating of Cx43 channels-the major isoform in the heart and brain-is incomplete. To interrogate the effects of acidic and alkaline pH(i) on Cx43 channels, we combined voltage-clamp electrophysiology with pH(i) imaging and photolytic H+ uncaging, performed over a range of pH(i) values. We demonstrate that Cx43 channels expressed in HeLa or N2a cell pairs are gated biphasically by pHi via a process that consists of activation by H+ ions at alkaline pH(i) and inhibition at more acidic pH(i). For Cx43 channel-mediated solute/ion transmission, the ensemble of these effects produces a pH(i) optimum, near resting pH(i). By using Cx43 mutants, we demonstrate that alkaline gating involves cysteine residues of the C terminus and is independent of motifs previously implicated in acidic gating. Thus, we present a molecular mechanism by which cytoplasmic acid-base chemistry fine tunes intercellular communication and establishes conditions for the optimal transmission of solutes and signals in tissues, such as the heart and brain.	[Garciarena, Carolina D.; Malik, Akif; Swietach, Pawel; Vaughan-Jones, Richard D.] Univ Oxford, Burdon Sanderson Cardiac Sci Ctr, Dept Physiol Anat & Genet, Oxford, England; [Garciarena, Carolina D.] Royal Coll Surgeons Ireland, Irish Ctr Vasc Biol, Dublin, Ireland; [Moreno, Alonso P.] Univ Utah, Nora Eccles Harrison Cardiovasc Res & Training In, 95 South 2000 East, Salt Lake City, UT 84112 USA	University of Oxford; Royal College of Surgeons - Ireland; Utah System of Higher Education; University of Utah	Moreno, AP (corresponding author), Univ Utah, Nora Eccles Harrison Cardiovasc Res & Training In, 95 South 2000 East, Salt Lake City, UT 84112 USA.	alonso.moreno@utah.edu	Swietach, Pawel/AAK-4169-2020	Swietach, Pawel/0000-0002-9945-9473	British Heart Foundation [RG/08/016, RG/15/9/31534]; E.P. Abraham Cephalosporin Fund; Nora Eccles Harrison Treadwell Foundation; U.S. Natiional Institutes of Health, National Heart, Lung, and Blood Institute [R01 HL63969]; Royal Society Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063969] Funding Source: NIH RePORTER; British Heart Foundation [RG/15/9/31534, RG/08/016/26423] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); E.P. Abraham Cephalosporin Fund; Nora Eccles Harrison Treadwell Foundation; U.S. Natiional Institutes of Health, National Heart, Lung, and Blood Institute; Royal Society Fellowship(Royal Society of London); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); British Heart Foundation(British Heart Foundation)	The authors thank Dr. Ningning Zhuang [Cardiovascular Research and Training Institute (CVRTI)] for contributions to the electrophysiologic data set. The authors appreciate the encouragement and reviews from Dr. Kenneth Spitzer (CVRTI). This work was supported by British Heart Foundation Programme Grants RG/08/016 (to R.D.V.-J.), and RG/15/9/31534 (to R.D.V.-J. and P.S.), the E.P. Abraham Cephalosporin Fund (to R.D.V.-J and C.D.G), the Nora Eccles Harrison Treadwell Foundation, and U.S. Natiional Institutes of Health, National Heart, Lung, and Blood Institute Grant R01 HL63969 (to A.P.M.), and the Royal Society Fellowship (to P.S.). The authors declare no conflicts of interest.	Boassa D, 2010, TRAFFIC, V11, P1471, DOI 10.1111/j.1600-0854.2010.01109.x; Bukauskas FF, 2001, BIOPHYS J, V81, P137, DOI 10.1016/S0006-3495(01)75687-1; DAHL G, 1991, EUR J BIOCHEM, V197, P141, DOI 10.1111/j.1432-1033.1991.tb15892.x; DARROW BJ, 1995, CIRC RES, V76, P381, DOI 10.1161/01.RES.76.3.381; Dovmark TH, 2017, ONCOGENE, V36, P4538, DOI 10.1038/onc.2017.71; Duffy HS, 2002, J BIOL CHEM, V277, P36706, DOI 10.1074/jbc.M207016200; EK JF, 1994, CIRC RES, V74, P1058, DOI 10.1161/01.RES.74.6.1058; EkVitorin JF, 1996, BIOPHYS J, V71, P1273, DOI 10.1016/S0006-3495(96)79328-1; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Gilleron J, 2011, INT J BIOCHEM CELL B, V43, P1208, DOI 10.1016/j.biocel.2011.04.014; GIMLICH RL, 1988, J CELL BIOL, V107, P1065, DOI 10.1083/jcb.107.3.1065; Gonzalez-Nieto D, 2008, P NATL ACAD SCI USA, V105, P17169, DOI 10.1073/pnas.0804189105; Hull C, 2004, NEURON, V44, P469, DOI 10.1016/j.neuron.2004.10.010; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; LAIRD DW, 1991, BIOCHEM J, V273, P67, DOI 10.1042/bj2730067; Lampe PD, 2000, J CELL BIOL, V149, P1503, DOI 10.1083/jcb.149.7.1503; LAZRAK A, 1993, BIOPHYS J, V65, P2002, DOI 10.1016/S0006-3495(93)81242-6; Leem CH, 1999, J PHYSIOL-LONDON, V517, P159, DOI 10.1111/j.1469-7793.1999.0159z.x; Lin JHC, 1998, NAT NEUROSCI, V1, P494, DOI 10.1038/2210; LIU SG, 1993, BIOPHYS J, V64, P1422, DOI 10.1016/S0006-3495(93)81508-X; Lurtz MM, 2007, AM J PHYSIOL-CELL PH, V293, pC1806, DOI 10.1152/ajpcell.00630.2006; Moreno AP, 2002, CIRC RES, V90, P450, DOI 10.1161/hh0402.105667; Morley GE, 1996, BIOPHYS J, V70, P1294, DOI 10.1016/S0006-3495(96)79686-8; NOMA A, 1987, J PHYSIOL-LONDON, V382, P193, DOI 10.1113/jphysiol.1987.sp016363; Palacios-Prado N, 2010, P NATL ACAD SCI USA, V107, P9897, DOI 10.1073/pnas.1004552107; Palacios-Prado N, 2009, J PHYSIOL-LONDON, V587, P3251, DOI 10.1113/jphysiol.2009.171496; Peters NS, 1997, CIRCULATION, V95, P988; Pogoda K, 2016, BMC CELL BIOL, V17, DOI 10.1186/s12860-016-0099-3; Skeberdis VA, 2011, J PHYSIOL-LONDON, V589, P3495, DOI 10.1113/jphysiol.2011.209072; Smyth JW, 2014, TRAFFIC, V15, P684, DOI 10.1111/tra.12169; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Sorgen PL, 2002, J BIOMOL NMR, V23, P245, DOI 10.1023/A:1019892719979; SPRAY DC, 1981, SCIENCE, V211, P712, DOI 10.1126/science.6779379; Straub AC, 2011, ARTERIOSCL THROM VAS, V31, P399, DOI 10.1161/ATVBAHA.110.215939; Swietach P, 2005, J PHYSIOL-LONDON, V566, P793, DOI 10.1113/jphysiol.2005.086165; Swietach P, 2007, CIRC RES, V100, P1045, DOI 10.1161/01.RES.0000264071.11619.47; Swietach P, 2007, BIOPHYS J, V92, P641, DOI 10.1529/biophysj.106.096560; Swietach P, 2013, P NATL ACAD SCI USA, V110, pE2064, DOI 10.1073/pnas.1222433110; Thevenin AF, 2013, PHYSIOLOGY, V28, P93, DOI 10.1152/physiol.00038.2012; Trexler EB, 1999, J GEN PHYSIOL, V113, P721; TURIN L, 1977, NATURE, V270, P56, DOI 10.1038/270056a0; Vaughan-Jones RD, 2009, J MOL CELL CARDIOL, V46, P318, DOI 10.1016/j.yjmcc.2008.10.024; Willoughby D, 2001, J PHYSIOL-LONDON, V530, P405, DOI 10.1111/j.1469-7793.2001.0405k.x; Xie H, 2017, BIOMED RES INT, V2017; Zaniboni M, 2003, CIRC RES, V93, P726, DOI 10.1161/01.RES.0000093986.47383.CE	46	5	5	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1969	1981		10.1096/fj.201700876R	http://dx.doi.org/10.1096/fj.201700876R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29183963	Green Published			2022-12-28	WOS:000429051400019
J	Li, LY; Wang, P; Hu, KQ; Wang, XY; Cai, WP; Ai, C; Liu, SF; Wang, Z				Li, Liyuan; Wang, Pan; Hu, Kaiqiang; Wang, Xiaoyan; Cai, Wenping; Ai, Chao; Liu, Shangfeng; Wang, Zhao			PFMG1 promotes osteoblast differentiation and prevents osteoporotic bone loss	FASEB JOURNAL			English	Article						nacre; remodeling; osteoporosis	PINCTADA-MAXIMA; NACRE; PEARL; MARROW; CELL; IMPLANTS; PATHWAY; MATRIX; MANTLE; MINERALIZATION	Nacre is a widely used mineral medicine that has been reported to have beneficial effects in bone remodeling without an increase in inflammation. Water-soluble nacre matrix has been demonstrated to be responsible for the effect, yet core active ingredients are unknown. Pinctada fucata mantle gene 1 (PFMG1) was first discovered in the mantle tissue of Pinctada fucata. The protein has 2 EF-hands, a calcium-binding domain. PFMG1 protein can affect the growth of calcium carbonate crystals in vitro. Here, we demonstrate that PFMG1 affects cell-cycle distribution and promotes preosteoblast proliferation. PFMG1 accelerates preosteoblast differentiation and extracellular matrix mineralization. During the differentiation process, PFMG1 increases the expression level of osteoblastic marker genes and activates the Erk signaling pathway. PFMG1 also accelerates calcium crystal aggregation in culture medium and suppresses osteoclast formation. Moreover, PFMG1 prevents bone loss caused by ovariectomy. RNA sequencing analysis demonstrated that PFMG1 stimulates genes that are associated with tissue development and ossification, which indicated new genes that function in bone remodeling. Our findings demonstrate the therapeutic potential of PFMG1 from nacre as a novel medicine for osteoporosis.	[Li, Liyuan; Wang, Pan; Hu, Kaiqiang; Wang, Xiaoyan; Ai, Chao; Wang, Zhao] Tsinghua Univ, Sch Pharmaceut Sci, Prot Sci Key Lab, Minist Educ, Beijing, Peoples R China; [Wang, Xiaoyan] Natl Univ Def Technol, Dept Biol & Chem, Coll Sci, Changsha, Hunan, Peoples R China; [Cai, Wenping; Liu, Shangfeng] Fudan Univ, Huashan Hosp, Dept Stomatol, Shanghai 200040, Peoples R China; [Ai, Chao] Tsinghua Univ, Med Ctr, Beijing Tsinghua Changgung Hosp, Dept Pharm, Beijing, Peoples R China	Tsinghua University; National University of Defense Technology - China; Fudan University; Tsinghua University	Liu, SF (corresponding author), Fudan Univ, Huashan Hosp, Dept Stomatol, Shanghai 200040, Peoples R China.; Wang, Z (corresponding author), Tsinghua Univ, Dept Pharmacol, Sch Pharmaceut Sci, Room C116, Beijing 100084, Peoples R China.	shangfengliufudan@163.com; zwang@tsinghua.edu.cn			Tsinghua University Initiative Scientific Research Program [2011THZ0]; National Natural Science Foundation of China [81270425]	Tsinghua University Initiative Scientific Research Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Tsinghua University Initiative Scientific Research Program (2011THZ0) and the National Natural Science Foundation of China (81270425). The authors thank the J. Zhou laboratory (Yale University, New Haven, CT, USA) for offering the lentivector with lgk-chain leader sequence built on the basis of the plasmid pCDH-CMV-MCS-T2A. The authors thank Leto Laboratories (Beijing, China) for providing protein purification services. The prediction of the PFMG1 protein structure was completed by X. Lyu and T. Wang (Tsinghua University). The authors declare no conflicts of interest.	Aksay IA, 1996, SCIENCE, V273, P892, DOI 10.1126/science.273.5277.892; Almqvist N, 1999, MAT SCI ENG C-BIO S, V7, P37, DOI 10.1016/S0928-4931(98)00072-1; Amos FF, 2010, CRYST GROWTH DES, V10, P4211, DOI 10.1021/cg100363m; Atlan G, 1997, CR ACAD SCI III-VIE, V320, P253, DOI 10.1016/S0764-4469(97)86933-8; Atlan G, 1999, BIOMATERIALS, V20, P1017, DOI 10.1016/S0142-9612(98)90212-5; Berland S, 2005, BIOMATERIALS, V26, P2767, DOI 10.1016/j.biomaterials.2004.07.019; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Chaturvedi R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084584; Chen JX, 2014, CELL SIGNAL, V26, P1068, DOI 10.1016/j.cellsig.2013.12.020; De A, 2011, ACTA BIOCH BIOPH SIN, V43, P745, DOI 10.1093/abbs/gmr079; DeLano W.L., 2002, PYMOL OPEN SOURCE MO; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Duplat D, 2007, BIOMATERIALS, V28, P4769, DOI 10.1016/j.biomaterials.2007.07.036; Evans JS, 2012, BIOINFORMATICS, V28, P3182, DOI 10.1093/bioinformatics/bts604; Falini G, 2011, J STRUCT BIOL, V173, P128, DOI 10.1016/j.jsb.2010.08.002; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; GEORGE A, 1993, J BIOL CHEM, V268, P12624; Golob AL, 2015, MED CLIN N AM, V99, P587, DOI 10.1016/j.mcna.2015.01.010; Guo J, 2008, BONE, V43, P961, DOI 10.1016/j.bone.2008.06.011; Harborne SPD, 2015, BBA-BIOENERGETICS, V1847, P1245, DOI 10.1016/j.bbabio.2015.07.002; HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253; JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056; Kartsogiannis V, 2004, MOL CELL ENDOCRINOL, V228, P79, DOI 10.1016/j.mce.2003.06.002; Kim H, 2012, BIOMATERIALS, V33, P7489, DOI 10.1016/j.biomaterials.2012.06.098; Komori T, 2003, J BONE MINER METAB, V21, P193, DOI 10.1007/s00774-002-0408-0; Kono M, 2000, BIOCHEM BIOPH RES CO, V269, P213, DOI 10.1006/bbrc.2000.2274; Lamghari M, 2001, BIOMATERIALS, V22, P555, DOI 10.1016/S0142-9612(00)00213-1; Lamghari M, 1999, BONE, V25, p91S, DOI 10.1016/S8756-3282(99)00141-6; Lamghari M, 2001, J BONE MINER RES, V16, P2232, DOI 10.1359/jbmr.2001.16.12.2232; Liang P, 2009, J BIOL CHEM, V284, P4960, DOI 10.1074/jbc.M807704200; Liao HH, 2000, BIOMATERIALS, V21, P457, DOI 10.1016/S0142-9612(99)00184-2; Liu HL, 2007, BIOCHEMISTRY-US, V46, P844, DOI 10.1021/bi061881a; LOPEZ E, 1992, TISSUE CELL, V24, P667, DOI 10.1016/0040-8166(92)90037-8; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; Mouries LP, 2002, COMP BIOCHEM PHYS B, V132, P217; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Perovic I, 2013, BIOCHEMISTRY-US, V52, P5696, DOI 10.1021/bi400808j; Rousseau M, 2003, COMP BIOCHEM PHYS B, V135, P1, DOI 10.1016/S1096-4959(03)00032-0; Rousseau M, 2008, J BIOMED MATER RES A, V85A, P487, DOI 10.1002/jbm.a.31553; Sakai A, 1998, BONE, V23, P443, DOI 10.1016/S8756-3282(98)00121-5; Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Sshrodinger LLC., 2010, PYMOL MOL GRAPHICS S; Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906; Wang W, 2015, GENET MOL RES, V14, P10507, DOI 10.4238/2015.September.8.12; Wang XY, 2015, BIOSCI BIOTECH BIOCH, V79, P558, DOI 10.1080/09168451.2014.987206; Wang XY, 2011, J BONE MINER RES, V26, P1964, DOI 10.1002/jbmr.394; Wang XY, 2011, BIOSCI BIOTECH BIOCH, V75, P991, DOI 10.1271/bbb.100821; Wang XY, 2011, COMP BIOCHEM PHYS B, V158, P173, DOI 10.1016/j.cbpb.2010.11.004; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Westbroek P, 1998, NATURE, V392, P861, DOI 10.1038/31798; Worthley DL, 2015, CELL, V160, P269, DOI 10.1016/j.cell.2014.11.042; Xu HB, 2001, PHARMACOL RES, V44, P1, DOI 10.1006/phrs.2000.0780; Yamamoto T, 2014, FEBS OPEN BIO, V4, P387, DOI 10.1016/j.fob.2014.04.003; Yu B, 2014, NAT MED, V20, P1009, DOI 10.1038/nm.3586; Zhang JX, 2016, J ETHNOPHARMACOL, V181, P229, DOI 10.1016/j.jep.2016.01.039; Zhang NN, 2016, CELL CYCLE, V15, P1009, DOI 10.1080/15384101.2016.1152427	57	7	7	5	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					838	849		10.1096/fj.201700422R	http://dx.doi.org/10.1096/fj.201700422R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29021211	Bronze			2022-12-28	WOS:000425146900026
J	Aoyama, K; Bhadhprasit, W; Watabe, M; Wang, F; Matsumura, N; Nakaki, T				Aoyama, Koji; Bhadhprasit, Wattanaporn; Watabe, Masahiko; Wang, Fan; Matsumura, Nobuko; Nakaki, Toshio			GTRAP3-18 regulates food intake and body weight by interacting with pro-opiomelanocortin	FASEB JOURNAL			English	Article						appetite; obesity; diabetes; hypothalamus; neuron	NERVOUS-SYSTEM CONTROL; INSULIN-RESISTANCE; ALPHA-MSH; NEUROPEPTIDE-Y; GLUTAMATE TRANSPORTER; NEURONAL GLUTATHIONE; ENERGY HOMEOSTASIS; POMC NEURONS; AMP-KINASE; MICE	Pro-opiomelanocortin (POMC)-expressing neurons provide alpha-melanocyte-stimulating hormone (alpha-MSH), which stimulates melanocortin 4 receptor to induce hypophagia by AMPK inhibition in the hypothalamus. alpha-MSH is produced by POMC cleavage in secretory granules and released. However, it is not known yet whether any posttranscriptional regulatory mechanism of POMC signaling exists upstream of the secretory granules in neurons. Here we show that glutamate transporter-associated protein 3-18 (GTRAP3-18), an anchor protein that retains interacting proteins in the endoplasmic reticulum, is a critical regulator of food intake and body weight by interacting with POMC. GTRAP3-18-deficient mice showed hypophagia, lean bodies, and lower blood glucose, insulin, and leptin levels with increased serum and brain alpha-MSH levels, leading to AMPK inhibition. Intraperitoneal glucose tolerance tests revealed significantly decreased blood glucose levels and areas under the curve in GTRAP3-18-deficient mice compared to wild-type mice. An intracerebroventricular infusion of a selective melanocortin 4 receptor antagonist to GTRAP3-18-deficient mice significantly increased their food intake and body weight. A fluorescence resonance energy transfer study showed an interaction between GTRAP3-18 and POMC in vitro. These findings suggest that activation of the melanocortin pathway by modulating GTRAP3-18/POMC interaction could be an alternative strategy for obesity and/or type 2 diabetes.	[Aoyama, Koji; Bhadhprasit, Wattanaporn; Wang, Fan; Matsumura, Nobuko; Nakaki, Toshio] Teikyo Univ, Sch Med, Dept Pharmacol, Tokyo, Japan; [Watabe, Masahiko] Teikyo Univ, Sch Med, G MEC, Tokyo, Japan	Teikyo University; Teikyo University	Nakaki, T (corresponding author), Teikyo Univ, Sch Med, Dept Pharmacol, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	nakaki@med.teikyo-u.ac.jp		Aoyama, Koji/0000-0003-4752-9262	Japan Society for the Promotion of Science [JP23500454, JP24590333]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported, in part, by Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research Grant JP23500454 (to K.A.) and Grant JP24590333 (to T.N. and K.A.). The authors declare no conflicts of interest.	Abdul-Ghani M, 2001, J BIOL CHEM, V276, P6225, DOI 10.1074/jbc.M009073200; Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Anderson EJP, 2016, J MOL ENDOCRINOL, V56, pT157, DOI 10.1530/JME-16-0014; Aoyama K, 2006, NAT NEUROSCI, V9, P119, DOI 10.1038/nn1609; Aoyama K, 2012, NEUROBIOL DIS, V45, P973, DOI 10.1016/j.nbd.2011.12.016; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Cakir I, 2013, J BIOL CHEM, V288, P17675, DOI 10.1074/jbc.M113.475343; Challis BG, 2004, P NATL ACAD SCI USA, V101, P4695, DOI 10.1073/pnas.0306931101; Chaput JP, 2009, INT J OBESITY, V33, P46, DOI 10.1038/ijo.2008.221; Chretien M, 2016, J MOL ENDOCRINOL, V56, pT49, DOI 10.1530/JME-15-0261; Cone RD, 2006, ENDOCR REV, V27, P736, DOI 10.1210/er.2006-0034; DagogoJack S, 1996, DIABETES, V45, P695, DOI 10.2337/diabetes.45.5.695; Damm E, 2012, MOL ENDOCRINOL, V26, P643, DOI 10.1210/me.2011-1218; DEROTTE AA, 1980, BRAIN RES BULL, V5, P375, DOI 10.1016/S0361-9230(80)80007-4; Enriori PJ, 2016, MOL METAB, V5, P807, DOI 10.1016/j.molmet.2016.07.009; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hentges ST, 2009, J NEUROSCI, V29, P13684, DOI 10.1523/JNEUROSCI.3770-09.2009; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Ikemoto MJ, 2002, NEUROREPORT, V13, P2079, DOI 10.1097/00001756-200211150-00018; Inoue K, 2005, NEUROSCI LETT, V386, P184, DOI 10.1016/j.neulet.2005.06.013; Ioffe E, 1998, P NATL ACAD SCI USA, V95, P11852, DOI 10.1073/pnas.95.20.11852; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; King C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017049; Kinoshita C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4823; Lin CLG, 2001, NATURE, V410, P84, DOI 10.1038/35065084; Lippincott-Schwartz J, 2000, ANNU REV CELL DEV BI, V16, P557, DOI 10.1146/annurev.cellbio.16.1.557; Maier S, 2009, J CELL MOL MED, V13, P114, DOI 10.1111/j.1582-4934.2008.00303.x; Marie LS, 2005, P NATL ACAD SCI USA, V102, P18632, DOI 10.1073/pnas.0509240102; MARTIN BC, 1992, LANCET, V340, P925, DOI 10.1016/0140-6736(92)92814-V; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meister B, 2006, EUR J NEUROSCI, V24, P2731, DOI 10.1111/j.1460-9568.2006.05157.x; Mercer AJ, 2014, AM J PHYSIOL-ENDOC M, V306, pE904, DOI 10.1152/ajpendo.00540.2013; Mercer AJ, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00019; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Minokoshi Y, 2008, NUTRITION, V24, P786, DOI 10.1016/j.nut.2008.06.002; Mizuno TM, 2003, DIABETES, V52, P2675, DOI 10.2337/diabetes.52.11.2675; Moller CL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161047; Moller CL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157027; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Pritchard LE, 2007, ENDOCRINOLOGY, V148, P4201, DOI 10.1210/en.2006-1686; Qian S, 2002, MOL CELL BIOL, V22, P5027, DOI 10.1128/MCB.22.14.5027-5035.2002; Ronnett GV, 2009, J NEUROCHEM, V109, P17, DOI 10.1111/j.1471-4159.2009.05916.x; Ruggiero AM, 2008, J BIOL CHEM, V283, P6175, DOI 10.1074/jbc.M701008200; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sanchez VC, 2004, J CLIN INVEST, V114, P357, DOI 10.1172/jci200421620; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Crespo CS, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00058; Stenbit AE, 1997, NAT MED, V3, P1096, DOI 10.1038/nm1097-1096; USATEGUI R, 1976, ENDOCRINOLOGY, V98, P189, DOI 10.1210/endo-98-1-189; Wardlaw SL, 2011, EUR J PHARMACOL, V660, P213, DOI 10.1016/j.ejphar.2010.10.107; Watabe M, 2011, J CELL SCI, V124, P1519, DOI 10.1242/jcs.081778; WILSON JF, 1984, PEPTIDES, V5, P681, DOI 10.1016/0196-9781(84)90006-8; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	59	1	3	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					330	341		10.1096/fj.201700421R	http://dx.doi.org/10.1096/fj.201700421R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28904020				2022-12-28	WOS:000419172700030
J	Esakky, P; Hansen, DA; Drury, AM; Felder, P; Cusumano, A; Moley, KH				Esakky, Prabagaran; Hansen, Deborah A.; Drury, Andrea M.; Felder, Paul; Cusumano, Andrew; Moley, Kelle H.			Testicular cells exhibit similar molecular responses to cigarette smoke condensate ex vivo and in vivo	FASEB JOURNAL			English	Article						germ cells; explant; neonatal; offspring; marker proteins	MOUSE FETAL TESTIS; SPERM FERTILIZING-CAPACITY; GENE-EXPRESSION; NUCLEAR ANTIGEN; SERTOLI-CELLS; SEMEN QUALITY; LEYDIG-CELLS; GERM; EXPOSURE; NICOTINE	Male exposure to cigarette smoke is associated with seminal defects and with congenital anomalies and childhood cancers in offspring. In mice, paternal exposure to cigarette smoke condensate (CSC) causes molecular defects in germcells and phenotypic effects in their offspring. Hereweused an ex vivo testicular explantmodel and in vivo exposure to determine the concentration atwhichCSCimpairs spermatogenesis and offspring development. We explanted testis tissue at postnatal day (P) 5.5 and cultured it until P11.5. Assessment of growth parameters by analyzing expression of cell-specificmarkers revealed that the explant systemmaintained structural and functional integrity. We exposed the P5.5 to -11.5 explants to various concentrations (40-160 mu g/ml) of CSC and confirmed that nicotine intheCSCwasmetabolizedto cotinine. We assessedvarious growthanddifferentiationparameters, aswell as testosterone production, and observed thatmany spermatogenesis featureswere impaired at 160 mu g/ml CSC. The same parameters were impaired by a similar CSC concentration in vivo. Finally, females mated to males that were exposed to 160 mu g/mlCSCneonatally had increased rates of pup resorption. Weconclude thatmale exposure toCSC impairs offspring development and that the concentration atwhich CSC impairs spermatogenesis is similar in vivo andex vivo. Given that the concentrations of CSC we used contained similardoses ofnicotine as human smokers are exposed to, we argue that our modelmimics human male reproductive effects of smoking.	[Esakky, Prabagaran; Hansen, Deborah A.; Drury, Andrea M.] US Dept Vet Affairs Med Ctr, Reasearch & Dev, St Louis, MO USA; [Esakky, Prabagaran; Drury, Andrea M.; Felder, Paul; Cusumano, Andrew; Moley, Kelle H.] Washington Univ, Sch Med, Dept Obstet & Gynecol, 660 South Euclid Ave,Campus Box 8064, St Louis, MO 63110 USA	Washington University (WUSTL)	Esakky, P; Moley, KH (corresponding author), Washington Univ, Sch Med, Dept Obstet & Gynecol, 660 South Euclid Ave,Campus Box 8064, St Louis, MO 63110 USA.	prabagaran.esakky@wustl.edu; moleyk@wustl.edu			U.S. Department of Veterans Affairs, Veterans Health Administration, Biomedical Laboratory Research and Development [I01BX007080]	U.S. Department of Veterans Affairs, Veterans Health Administration, Biomedical Laboratory Research and Development	The authors thank Dr. Deborah Frank (Washington University School of Medicine) for comments. This work was supported, in part, by the U.S. Department of Veterans Affairs, Veterans Health Administration, Biomedical Laboratory Research and Development (Award I01BX007080 to D.A.H.). The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the U.S. government. The authors declare no conflicts of interest.	Aydos K, 2001, BJU INT, V88, P622, DOI 10.1046/j.1464-4096.2001.02384.x; Baker PJ, 1999, EUR J BIOCHEM, V260, P911, DOI 10.1046/j.1432-1327.1999.00245.x; BELLVE AR, 1977, J HISTOCHEM CYTOCHEM, V25, P480, DOI 10.1177/25.7.893996; Benowitz NL, 2013, TOB CONTROL, V22, P14, DOI 10.1136/tobaccocontrol-2012-050860; Bruin JE, 2010, TOXICOL SCI, V116, P364, DOI 10.1093/toxsci/kfq103; Chauvigne F, 2009, ENVIRON HEALTH PERSP, V117, P515, DOI 10.1289/ehp.11870; Choi AMK, 1996, AM J RESP CELL MOL, V15, P9, DOI 10.1165/ajrcmb.15.1.8679227; De Rooij DG, 2000, J ANDROL, V21, P776; ENDERS GC, 1994, DEV BIOL, V163, P331, DOI 10.1006/dbio.1994.1152; Esakky P, 2016, REPROD TOXICOL, V65, P283, DOI 10.1016/j.reprotox.2016.08.017; Esakky P, 2013, REPROD SCI, V20, P238, DOI 10.1177/1933719112452939; Esakky P, 2012, REPROD TOXICOL, V34, P665, DOI 10.1016/j.reprotox.2012.10.005; Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203; Hallmark N, 2007, ENVIRON HEALTH PERSP, V115, P390, DOI 10.1289/ehp.9490; Han ES, 2008, PHYSIOL GENOMICS, V34, P112, DOI 10.1152/physiolgenomics.00239.2007; Hansen DA, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.108845; Harkema JR, 2006, TOXICOL PATHOL, V34, P252, DOI 10.1080/01926230600713475; Holloway AC, 2006, ENDOCRINE, V30, P213, DOI 10.1385/ENDO:30:2:213; Jana K, 2010, TOXICOL SCI, V116, P647, DOI 10.1093/toxsci/kfq149; Jarvis S, 2005, HUM REPROD, V20, P108, DOI 10.1093/humrep/deh565; Kapawa A, 2004, ANDROLOGIA, V36, P57, DOI 10.1111/j.1439-0272.2004.00605.x; KLONOFFCOHEN HS, 1995, JAMA-J AM MED ASSOC, V273, P795, DOI 10.1001/jama.273.10.795; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Kyronlahti A, 2011, MOL CELL ENDOCRINOL, V333, P85, DOI 10.1016/j.mce.2010.12.019; Lambrot R, 2006, BIOCHIMIE, V88, P1831, DOI 10.1016/j.biochi.2006.09.022; LAZUTKA F A, 1969, Gigiena i Sanitariya, V34, P30; Lee JW, 1997, ENDOCRINOLOGY, V138, P2081, DOI 10.1210/en.138.5.2081; Livera G, 2000, BIOL REPROD, V62, P1303, DOI 10.1095/biolreprod62.5.1303; Livera G, 2006, CELL TISSUE RES, V324, P507, DOI 10.1007/s00441-006-0167-7; Mayer B, 2014, ARCH TOXICOL, V88, P5, DOI 10.1007/s00204-013-1127-0; Meeker JD, 2007, AM J EPIDEMIOL, V166, P571, DOI 10.1093/aje/kwm128; Mostafa T, 2010, J ADV RES, V1, P179, DOI 10.1016/j.jare.2010.05.002; Muczynski V, 2012, TOXICOL APPL PHARM, V261, P97, DOI 10.1016/j.taap.2012.03.016; Nagano R, 2000, ANAT REC, V258, P210; Neal MS, 2005, HUM REPROD, V20, P2531, DOI 10.1093/humrep/dei080; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Olaso R, 2000, J ANDROL, V21, P497, DOI 10.1002/j.1939-4640.2000.tb02114.x; PACIFICI R, 1993, THER DRUG MONIT, V15, P358, DOI 10.1097/00007691-199310000-00002; PATTERSON TR, 1990, LIFE SCI, V46, P265, DOI 10.1016/0024-3205(90)90032-M; Pourimand G, 2004, BJU INT, V94, P1310, DOI 10.1111/j.1464-410X.2004.05162.x; Practice Comm Amer Soc Reprod Med, 2012, FERTIL STERIL, V98, P1400, DOI 10.1016/j.fertnstert.2012.07.1146; Ramlau-Hansen CH, 2007, HUM REPROD, V22, P188, DOI 10.1093/humrep/del364; Rodgman A., 2013, CHEM COMPONENTS TOBA, V2nd; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Sato T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130171; Sato T, 2013, NAT PROTOC, V8, P2098, DOI 10.1038/nprot.2013.138; Schane RE, 2010, CIRCULATION, V121, P1518, DOI 10.1161/CIRCULATIONAHA.109.904235; Seccareccia F, 2003, EUR J EPIDEMIOL, V18, P487, DOI 10.1023/A:1024672522802; SOFIKITIS N, 1995, J UROLOGY, V154, P1030, DOI 10.1016/S0022-5347(01)66968-4; Stanley JL, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.096198; Staub C, 2001, J ANDROL, V22, P911; Steger K, 1998, MOL HUM REPROD, V4, P227, DOI 10.1093/molehr/4.3.227; Substance Abuse and Mental Health Services Administration (US) and Office of the Surgeon General (US), 2020, SMOK CESS REP SURG G; VERGOUWEN RPFA, 1991, J REPROD FERTIL, V93, P233, DOI 10.1530/jrf.0.0930233; VICIAN M, 1968, EXPERIENTIA, V24, P511; Vine MF, 1996, INT J ANDROL, V19, P323, DOI 10.1111/j.1365-2605.1996.tb00523.x; Yauk CL, 2007, CANCER RES, V67, P5103, DOI 10.1158/0008-5472.CAN-07-0279; ZHANG J, 1992, INT J EPIDEMIOL, V21, P273, DOI 10.1093/ije/21.2.273; Zheng K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-38; Zhou Q, 2008, BIOL REPROD, V78, P537, DOI 10.1095/biolreprod.107.064337	60	5	5	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					63	72		10.1096/fj.201700405R	http://dx.doi.org/10.1096/fj.201700405R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28842431				2022-12-28	WOS:000419172700008
J	Huang, S; Ge, XT; Yu, JW; Han, ZL; Yin, ZY; Li, Y; Chen, FL; Wang, HC; Zhang, JN; Lei, P				Huang, Shan; Ge, Xintong; Yu, Jinwen; Han, Zhaoli; Yin, Zhenyu; Li, Ying; Chen, Fanglian; Wang, Haichen; Zhang, Jianning; Lei, Ping			Increased miR-124-3p in microglial exosomes following traumatic brain injury inhibits neuronal inflammation and contributes to neurite outgrowth via their transfer into neurons	FASEB JOURNAL			English	Article						extracellular vesicles; glia cells; polarization; PDE4B; mTOR signaling	MESENCHYMAL STROMAL CELLS; EXTRACELLULAR VESICLES; PHOSPHODIESTERASE 4B; IN-VITRO; PATHWAY; POLARIZATION; APOPTOSIS; DISEASE; AKT; NEUROINFLAMMATION	Neuronal inflammation is the characteristic pathologic change of acute neurologic impairment and chronic traumatic encephalopathy after traumatic brain injury (TBI). Inhibiting the excessive inflammatory response is essential for improving the neurologic outcome. To clarify the regulatory mechanism of microglial exosomes on neuronal inflammation in TBI, we focused on studying the impact of microglial exosomal miRNAs on injured neurons in this research. We used a repetitive (r) TBI mousemodel and harvested the injured brain extracts from the acute to the chronic phase of TBI to treat cultured BV2 microglia in vitro. The microglial exosomes were collected for miRNA microarray analysis, which showed that the expression level of miR-124-3p increased most apparently in the miRNAs. We found that miR-124-3p promoted the anti-inflamed M2 polarization in microglia, and microglial exosomal miR-124-3p inhibited neuronal inflammation in scratch-injured neurons. Further, the mammalian target of rapamycin (mTOR) signaling was implicated as being involved in the regulation of miR-124-3p by Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses. Using the mTOR activator MHY1485 we confirmed that the inhibitory effect of exosomalmiR-124-3p on neuronal inflammation was exerted by suppressing the activity of mTOR signaling. PDE4B was predicted to be the target gene of miR-124-3p by pathway analysis. We proved that it was directly targeted by miR-124-3p with a luciferase reporter assay. Using a PDE4B overexpressed lentivirus transfection system, we suggested that miR-124-3p suppressed the activity of m TOR signaling mainly through inhibiting the expression of PDE4B. In addition, exosomal miR-124-3p promoted neurite outgrowth after scratch injury, characterized by an increase on the number of neurite branches and total neurite length, and a decreased expression on RhoA and neurodegenerative proteins [A beta-peptide and p-Tau]. It also improved the neurologic outcome and inhibited neuro-inflammation in mice with rTBI. Taken together, increased miR-124-3p in microglial exosomes after TBI can inhibit neuronal inflammation and contribute to neurite outgrowth via their transfer into neurons. miR-124-3p exerted these effects by targeting PDE4B, thus inhibiting the activity of mTOR signaling. Therefore, miR-124-3p could be a promising therapeutic target for interventions of neuronal inflammation after TBI. miRNAs manipulated microglial exosomes may provide a novel therapy for TBI and other neurologic diseases.	[Huang, Shan; Ge, Xintong; Yu, Jinwen; Yin, Zhenyu; Lei, Ping] Tianjin Geriatr Inst, Lab Neurotrauma & Neurodegenerat Disorders, Tianjin, Peoples R China; [Huang, Shan; Ge, Xintong; Yu, Jinwen; Han, Zhaoli; Yin, Zhenyu; Li, Ying; Chen, Fanglian; Zhang, Jianning] Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin, Peoples R China; [Huang, Shan; Yu, Jinwen; Yin, Zhenyu; Li, Ying; Chen, Fanglian; Zhang, Jianning] Tianjin Neurol Inst, Key Lab Injuries Variat & Regenerat Nervous Syst, Tianjin, Peoples R China; [Ge, Xintong; Zhang, Jianning] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China; [Han, Zhaoli; Lei, Ping] Tianjin Med Univ, Gen Hosp, Dept Geriatr, Anshan Rd, Tianjin 300054, Peoples R China; [Wang, Haichen] Duke Univ, Med Ctr, Dept Neurol, Durham, NC USA	Tianjin Medical University; Tianjin Medical University; Duke University	Lei, P (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Geriatr, Anshan Rd, Tianjin 300054, Peoples R China.	leiping1974@163.com	Ge, Xintong/X-4889-2019	Ge, Xintong/0000-0001-7153-952X	National Natural Science Foundation of China [81501055, 81471252, 81772060]; Tianjin Municipal Science and Technology Commission Natural Fund Project [13JCYBJC23700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Science and Technology Commission Natural Fund Project	This work was supported by Grants 81501055, 81471252, and 81772060 from the National Natural Science Foundation of China, and Grant 13JCYBJC23700 from the Tianjin Municipal Science and Technology Commission Natural Fund Project. The authors appreciate Chunsheng Kang, Lei Han, Anling Zhang, Li Liu, Weiyun Cui, and Lei Zhou (Tianjin Neurological Institute) for their technical support. The authors declare no conflicts of interest.	Asai H, 2015, NAT NEUROSCI, V18, P1584, DOI 10.1038/nn.4132; Bai R., 2017, NEUROCHEM RES; Bai RJ, 2017, MED SCI MONITOR, V23, P1707, DOI 10.12659/MSM.901124; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Budnik V, 2016, NAT REV NEUROSCI, V17, P160, DOI 10.1038/nrn.2015.29; Byles V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3834; Chen ZQ, 2014, CANCER LETT, V350, P43, DOI 10.1016/j.canlet.2014.04.010; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Chopp M, 2015, EXPERT OPIN EMERG DR, V20, P523, DOI 10.1517/14728214.2015.1061993; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Cunha C, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6986175; Dadsetan S, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00106; Edwards P, 2005, LANCET, V365, P1957; Ejlerskov P, 2015, CELL, V163, P324, DOI 10.1016/j.cell.2015.08.069; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gao C, 2017, MOL NEUROBIOL, V54, P8348, DOI 10.1007/s12035-016-0318-0; Gao HB, 2017, BRAIN RES, V1657, P1, DOI 10.1016/j.brainres.2016.11.028; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Ge XT, 2016, BRAIN RES, V1650, P31, DOI 10.1016/j.brainres.2016.07.015; Ge XT, 2015, BRAIN RES, V1603, P150, DOI 10.1016/j.brainres.2015.01.009; Glebov K, 2015, GLIA, V63, P626, DOI 10.1002/glia.22772; Gong X, 2016, AM J TRANSL RES, V8, P2127; Goto T, 2013, BIOORG MED CHEM LETT, V23, P3325, DOI 10.1016/j.bmcl.2013.03.104; Gurney ME, 2015, NEUROTHERAPEUTICS, V12, P49, DOI 10.1007/s13311-014-0309-7; Han RR, 2016, EXP NEUROL, V280, P106, DOI 10.1016/j.expneurol.2016.04.005; Han ZL, 2015, DNA CELL BIOL, V34, P703, DOI 10.1089/dna.2015.2800; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; Harry GJ, 2013, PHARMACOL THERAPEUT, V139, P313, DOI 10.1016/j.pharmthera.2013.04.013; Hartmann H, 2015, CELL TISSUE RES, V362, P9, DOI 10.1007/s00441-015-2183-y; Hooper C, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-144; Hu XK, 2016, MOL MED REP, V14, P3662, DOI 10.3892/mmr.2016.5729; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kim DK, 2016, P NATL ACAD SCI USA, V113, P170, DOI 10.1073/pnas.1522297113; Kim J, 2015, GENE, V558, P173, DOI 10.1016/j.gene.2015.01.001; Kim SW, 2011, CLIN CANCER RES, V17, P6723, DOI 10.1158/1078-0432.CCR-11-0770; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Li DJ, 2016, FASEB J, V30, P3388, DOI 10.1096/fj.201600495R; Mantovani A, 2004, SEMIN CANCER BIOL, V14, P155, DOI 10.1016/j.semcancer.2003.10.001; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Naganuma K, 2009, BIOORG MED CHEM LETT, V19, P3174, DOI 10.1016/j.bmcl.2009.04.121; Ponomarev ED, 2011, NAT MED, V17, P64, DOI 10.1038/nm.2266; Potolicchio A, 2005, J IMMUNOL, V175, P2237, DOI 10.4049/jimmunol.175.4.2237; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Takano T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00044-2; Thompson AG, 2016, NAT REV NEUROL, V12, P346, DOI 10.1038/nrneurol.2016.68; Wang YJ, 2016, ONCOTARGET, V7, P13328, DOI 10.18632/oncotarget.7798; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Xin HQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009027; Xiong Y, 2015, EXPERT OPIN INV DRUG, V24, P743, DOI 10.1517/13543784.2015.1021919; Yu AY, 2017, IMMUNOL LETT, V182, P1, DOI 10.1016/j.imlet.2016.12.003; Zanier ER, 2014, NEUROTHERAPEUTICS, V11, P679, DOI 10.1007/s13311-014-0277-y; Zhang H, 2016, BIOCHEM RES INT, V2016, DOI 10.1155/2016/7498706; Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770; Zhang YQ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-253; Zhang Y, 2017, MOL NEUROBIOL, V54, P2659, DOI 10.1007/s12035-016-9851-0; Zhou X, 2010, LAB INVEST, V90, P144, DOI 10.1038/labinvest.2009.126; Zhu H, 2013, BRAIN RES, V1541, P69, DOI 10.1016/j.brainres.2013.10.002; Zhu LN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5696; Zhu XX, 2014, J CEREBR BLOOD F MET, V34, P1531, DOI 10.1038/jcbfm.2014.113	64	170	177	10	100	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					512	528		10.1096/fj.201700673R	http://dx.doi.org/10.1096/fj.201700673R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28935818				2022-12-28	WOS:000419172700045
J	Liang, TT; Zhou, B; Shi, L; Wang, H; Chu, QP; Xu, FL; Li, Y; Chen, RN; Shen, CY; Schinckel, AP				Liang, Tingting; Zhou, Bo; Shi, Lei; Wang, Han; Chu, Qingpo; Xu, Feilong; Li, Yuan; Chen, Ruonan; Shen, Chunyan; Schinckel, Allan P.			lncRNA AK017368 promotes proliferation and suppresses differentiation of myoblasts in skeletal muscle development by attenuating the function of miR-30c	FASEB JOURNAL			English	Article						myogenesis; ceRNA; C2C12 cells; TNRC6A	LONG NONCODING RNA; REGENERATION; EXPRESSION; LINCRNAS; MECHANISMS; MICRORNAS; EVOLUTION; SEQUENCE; TISSUE; DOMAIN	Long noncoding RNAs (lncRNAs) have been reported to play diverse roles in biologic and pathologic processes, including myogenesis. We found that lncRNA AK017368 is highly expressed in skeletal muscle cells. Functional analyses showed that overexpression of AK017368 promoted proliferation and restrained differentiation of myoblasts; whereas inhibition of AK017368 had completely opposite effects in vitro. In mice, knockdown of AK017368 promoted muscle hypertrophy in vivo. RNA molecules of AK017368 acted mechanistically as competing endogenous RNAs to target micro-RNA (miR)-30c, which was supported by the results of bioinformatics analyses and dual-luciferase reporter assays. It has been shown that lncRNA AK017368 competes with trinucleotide repeat containing-6A (Tnrc6a) for miR-30c. Tnrc6a was previously reported to promote proliferation and inhibit differentiation of myoblast cells, whereas miR-30c targets the 39-UTR of Tnrc6a mRNA to weaken its function. Taken together, lncRNA AK017368 promotes proliferation and inhibits differentiation of myoblast cells by attenuating function ofmiR-30c.	[Liang, Tingting; Zhou, Bo; Shi, Lei; Wang, Han; Chu, Qingpo; Xu, Feilong; Li, Yuan; Chen, Ruonan; Shen, Chunyan] Nanjing Agr Univ, Coll Anim Sci & Technol, Weigang 1, Nanjing 210095, Jiangsu, Peoples R China; [Schinckel, Allan P.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA	Nanjing Agricultural University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Zhou, B (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Weigang 1, Nanjing 210095, Jiangsu, Peoples R China.	zhoubo@njau.edu.cn	Zhou, Bo/AFL-8720-2022	Zhou, Bo/0000-0003-2857-8536	National Natural Science Foundation of China [31672465]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grant 31672465 (to B.Z.). The authors declare no conflicts of interest.	Bergmann JH, 2014, CURR OPIN CELL BIOL, V26, P10, DOI 10.1016/j.ceb.2013.08.005; Butchart LC, 2016, DIFFERENTIATION, V92, P237, DOI 10.1016/j.diff.2016.05.003; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Dey BK, 2014, GENE DEV, V28, P491, DOI 10.1101/gad.234419.113; Dey BK, 2012, GENE DEV, V26, P2180, DOI 10.1101/gad.198085.112; Dey BK, 2011, MOL CELL BIOL, V31, P1329, DOI 10.1128/MCB.05013-11; Dey BK, 2011, MOL CELL BIOL, V31, P203, DOI 10.1128/MCB.01009-10; Diniz GP, 2016, COMPR PHYSIOL, V6, P1279, DOI 10.1002/cphy.c150041; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Gong CG, 2015, DEV CELL, V34, P181, DOI 10.1016/j.devcel.2015.05.009; Grote P, 2015, TRENDS GENET, V31, P329, DOI 10.1016/j.tig.2015.02.002; Grote P, 2013, DEV CELL, V24, P206, DOI 10.1016/j.devcel.2012.12.012; Guess M. G., 2014, CHARACTERIZATION MIC; Guess MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118229; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Hand NJ, 2009, GASTROENTEROLOGY, V136, P1081, DOI 10.1053/j.gastro.2008.12.006; Hiramuki Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130436; Izaurralde E, 2012, EMBO REP, V13, P662, DOI 10.1038/embor.2012.91; Jiang YQ, 2013, BBA-REV CANCER, V1835, P155, DOI 10.1016/j.bbcan.2012.12.003; Kanduri C, 2008, RNA BIOL, V5, P208, DOI 10.4161/rna.7113; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Le Guen Claire L, 2013, F1000Res, V2, P197, DOI 10.12688/f1000research.2-197.v1; Liu J., 2005, NAT CELL BIOL, V8, P100; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Lu W, 2016, SCI REP-UK, V6, DOI 10.1038/srep21620; Nishi K, 2015, NUCLEIC ACIDS RES, V43, P9856, DOI 10.1093/nar/gkv1026; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Shi L, 2015, CELL SIGNAL, V27, P1895, DOI 10.1016/j.cellsig.2015.05.001; Simionescu-Bankston A, 2016, J MOL MED, V94, P853, DOI 10.1007/s00109-016-1443-y; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Till S, 2007, NAT STRUCT MOL BIOL, V14, P897, DOI 10.1038/nsmb1302; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wang G, 2016, SCI PROGRAMMING-NETH, V2016, DOI 10.1155/2016/3676149; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang LJ, 2015, CELL RES, V25, P335, DOI 10.1038/cr.2015.21; Wei W, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.184; Xia T, 2014, SCI REP-UK, V4, DOI 10.1038/srep06088; Zaragosi LE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r64; Zhang J, 2014, BIOCHEM BIOPH RES CO, V443, P1028, DOI 10.1016/j.bbrc.2013.12.092	41	41	44	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					377	389		10.1096/fj.201700560RR	http://dx.doi.org/10.1096/fj.201700560RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28904016				2022-12-28	WOS:000419172700034
J	Tu, JW; Stoner, S; Fromm, PD; Wang, TY; Chen, D; Tuckermann, J; Cooper, MS; Seibel, MJ; Zhou, H				Tu, Jinwen; Stoner, Shihani; Fromm, Phillip D.; Wang, Tingyu; Chen, Di; Tuckermann, Jan; Cooper, Mark S.; Seibel, Markus J.; Zhou, Hong			Endogenous glucocorticoid signaling in chondrocytes attenuates joint inflammation and damage	FASEB JOURNAL			English	Article						glucocorticoid receptor; arthritis; AIA mode; STIA model	RHEUMATOID-ARTHRITIS; ARTICULAR CHONDROCYTES; TRANSGENIC DISRUPTION; RECEPTOR; OSTEOARTHRITIS; CHEMOKINES; CARTILAGE; MICE; OSTEOBLASTS; NEUTROPHILS	Previous studies demonstrated that endogenous glucocorticoid signaling in osteoblasts promotes inflammation in murine immune arthritis. The current study determined whether disruption of endogenous glucocorticoid signaling in chondrocytes also modulates the course and severity of arthritis. Tamoxifen-inducible chondrocyte-targetedglucocorticoidreceptor- knockout (chGRKO) mice were generated by breeding GR(flox)/(flox) mice with tamoxifen-inducible collagen 2a1 Cre (Col2a1-CreER(T2)) mice. Antigen-induced arthritis (AIA) and K/BxN serum transfer-induced arthritis (STIA) were induced in both chGRKO mice and their Cre-negative GR(flox)/(flox) littermates [wild type (WT)]. Arthritis was assessed by measurement of joint swelling and histology of joints collected at d 14. Neutrophil activity and gene expression patterns associated with cartilage damage were also evaluated. In both arthritis models clinical (joint swelling) and histologic indices of inflammatory activity were significantly greater in chGRKO than in WT mice. The STIA model was characterized by early up-regulation of CXCR2/CXCR2 ligand gene expression in ankle tissues, and significant and selective expansion of splenic CXCR2(+) neutrophils in chGRKO arthritic compared to WT arthritic mice. At later stages, gene expression of enzymes involved in cartilage degradation was up-regulatedin chGRKO but not WT arthritic mice. Therefore, we summarize that chondrocytes actively mitigate local joint inflammation, cartilage degradation and systemic neutrophil activity via a glucocorticoid-dependent pathway.	[Tu, Jinwen; Stoner, Shihani; Wang, Tingyu; Seibel, Markus J.; Zhou, Hong] ANZAC Res Inst, Bone Res Program, Sydney, NSW, Australia; [Tu, Jinwen; Cooper, Mark S.] ANZAC Res Inst, Adrenal Steroid Lab, Sydney, NSW, Australia; [Fromm, Phillip D.] ANZAC Res Inst, Dendrit Cell Res, Sydney, NSW, Australia; [Tu, Jinwen; Cooper, Mark S.; Seibel, Markus J.; Zhou, Hong] Univ Sydney, Concord Clin Sch, Sydney, NSW, Australia; [Wang, Tingyu] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Pharm, Shanghai, Peoples R China; [Chen, Di] Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA; [Tuckermann, Jan] Univ Ulm, Inst Comparat Mol Endocrinol, Ulm, Germany; [Cooper, Mark S.; Seibel, Markus J.; Zhou, Hong] Concord Hosp, Dept Endocrinol & Metab, Sydney, NSW, Australia	University of Sydney; ANZAC Research Institute; University of Sydney; ANZAC Research Institute; University of Sydney; ANZAC Research Institute; University of Sydney; Shanghai Jiao Tong University; Rush University; Ulm University; Concord Repatriation General Hospital	Tu, JW; Zhou, H (corresponding author), Univ Sydney, Bone Res Program, ANZAC Res Inst, Gate 3 Hosp Rd, Sydney, NSW 2139, Australia.	jinwen.tu@sydney.edu.au; h.zhou@sydney.edu.au	Research Institute, ANZAC/CAE-9030-2022; Chen, Di/AAJ-3665-2021	Cooper, Mark/0000-0003-3112-7728; Zhou, Hong/0000-0001-5899-9660; Seibel, Markus J/0000-0002-2701-378X	National Health and Medical Research Council (NHMRC) of Australia [APP1087271]; Rebecca L. Cooper Medical Research Foundation/Equipment; Deutsche Forschungsgemeinschaft [SFB 1149, INST 40/492-1, TU 220/6-2]; Natural Science Foundation of China [81572104]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Rebecca L. Cooper Medical Research Foundation/Equipment; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank M. Khalil and the staff of the Molecular Physiology Unit at Australian and New Zealand Army Corps (ANZAC) Research Institute for their excellent animal care. The authors acknowledge the facilities and the scientific and technical assistance of the Australian Microscopy and Microanalysis Research Facility (Australian Centre for Microscopy and Microanalysis, University of Sydney). A. Vu (Dendritic Cell Research, ANZAC Research Institute) is also acknowledged for flow cytometry support. This work was supported by the National Health and Medical Research Council (NHMRC) of Australia (Project Grant APP1087271 to H.Z., M.J.S., and M.S.C).; a Rebecca L. Cooper Medical Research Foundation/Equipment grant to H.Z. and M.J.S.; Deutsche Forschungsgemeinschaft (SFB 1149 Trauma INST 40/492-1 and Priority Program Osteoimmunology TU 220/6-2) to J.T., and Natural Science Foundation of China Grant 81572104 to T.W. The authors declare no conflicts of interest.	Baschant U, 2011, P NATL ACAD SCI USA, V108, P19317, DOI 10.1073/pnas.1105857108; Bendele A, 1999, ARTHRITIS RHEUM, V42, P498, DOI 10.1002/1529-0131(199904)42:3<498::AID-ANR15>3.0.CO;2-A; Bottini N, 2013, NAT REV RHEUMATOL, V9, P24, DOI 10.1038/nrrheum.2012.190; Buttgereit F, 2011, ARTHRITIS RHEUM-US, V63, P1, DOI 10.1002/art.30070; Buttgereit F, 2009, ARTHRITIS RHEUM-US, V60, P1998, DOI 10.1002/art.24619; Dean RA, 2008, BLOOD, V112, P3455, DOI 10.1182/blood-2007-12-129080; DIBATTISTA JA, 1993, J CLIN ENDOCR METAB, V76, P1128, DOI 10.1210/jc.76.5.1128; Dimitrova P, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3926; Fromm PD, 2012, J IMMUNOL, V188, P6258, DOI 10.4049/jimmunol.1100977; Goldring MB, 2011, CURR OPIN RHEUMATOL, V23, P471, DOI 10.1097/BOR.0b013e328349c2b1; Hardy RS, 2014, ANN NY ACAD SCI, V1318, P18, DOI 10.1111/nyas.12389; Henneicke H, 2011, BONE, V49, P733, DOI 10.1016/j.bone.2011.06.013; Hubner S, 2015, BIOL CHEM, V396, P1223, DOI 10.1515/hsz-2015-0106; Huh YH, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.88; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; Lee H, 2006, NAT BIOTECHNOL, V24, P1279, DOI 10.1038/nbt1248; McColl SR, 2002, IMMUNOL CELL BIOL, V80, P489, DOI 10.1046/j.1440-1711.2002.01113.x; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Niedermeier M, 2010, BEST PRACT RES CL RH, V24, P527, DOI 10.1016/j.berh.2010.02.002; Pap T, 2015, NAT REV RHEUMATOL, V11, P606, DOI 10.1038/nrrheum.2015.95; PECCOUD J, 1990, EMBO J, V9, P4215, DOI 10.1002/j.1460-2075.1990.tb07869.x; Sherwood J, 2015, ANN RHEUM DIS, V74, P2207, DOI 10.1136/annrheumdis-2014-205546; Spies CM, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-31; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; Talbot J, 2015, ARTHRITIS RHEUMATOL, V67, P1751, DOI 10.1002/art.39117; Tu JW, 2016, AM J PATHOL, V186, P1293, DOI 10.1016/j.ajpath.2015.12.025; Tu JW, 2014, BONE, V69, P12, DOI 10.1016/j.bone.2014.08.016; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; Zhou H, 2013, BONE RES, V1, DOI 10.4248/BR201302001; Zhu M, 2008, OSTEOARTHR CARTILAGE, V16, P129, DOI 10.1016/j.joca.2007.08.001; Zhu M, 2009, J BONE MINER RES, V24, P12, DOI 10.1359/JBMR.080901	31	13	14	2	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					478	487		10.1096/fj.201700659R	http://dx.doi.org/10.1096/fj.201700659R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28928247				2022-12-28	WOS:000419172700042
J	Tserga, A; Binder, AM; Michels, KB				Tserga, Aggeliki; Binder, Alexandra M.; Michels, Karin B.			Impact of folic acid intake during pregnancy on genomic imprinting of IGF2/H19 and 1-carbon metabolism	FASEB JOURNAL			English	Article						folate; epigenetics; DNA methylation; MTHFR; placenta	NEURAL-TUBE DEFECTS; S-ADENOSYLHOMOCYSTEINE; DNA HYPOMETHYLATION; METHYLENETETRAHYDROFOLATE-REDUCTASE; COLORECTAL-CANCER; HOMOCYSTEINE LEVELS; METHYLATED REGIONS; BIRTH-WEIGHT; FOLATE; GENE	Folic acid is an essential component of 1-carbon metabolism, which generates methyl groups for DNA methylation. Disruption of genomic imprinting leads to biallelic expressionwhichmay affect disease susceptibility possibly reflected in high levels of S-adenosyl-homocysteine (SAH) and low levels of S-adenosyl-methionine (SAM). We investigated the association between folic acid supplementation during pregnancy and loss of imprinting (LOI) of IGF2 and H19 genes in placentas and cord blood of 90mother-child dyads in associationwith the methylenetetrahydrofolate reductase (MTHFR) genotype. Pyrosequencing was used to evaluate deviation from monoallelic expression among 47 placentas heterozygous for H19 and 37 placentas and cord blood tissues heterozygous for IGF2 and H19methylation levels of 48 placentas. We detected relaxation of imprinting (ROI) and LOI of H19 inplacentasnot associatedwithdifferences inmethylationlevels of theH19ICR. Placentas retainedmonoallelic allele-specific gene expression of IGF2, but 32.4% of cord blood samples displayed LOI of IGF2 and 10.8% showed ROI. High SAH levels were significantly associated with low H19 methylation. An interesting positive association between SAM/SAHratio and high H19methylation levelswasdetected among infantswith lowB(12) levels. Our data suggest profound differences in regulation of imprinting in placenta and cord blood; a lack of correlation of the methylome, transcriptome, and proteome; and a complex regulatory feedback network between free methyl groups and genomic imprinting at birth.-Tserga, A., Binder, A. M., Michels, K. B. Impact of folic acid intake during pregnancy on genomic imprinting of IGF2/H19 and 1-carbon metabolism.	[Tserga, Aggeliki; Michels, Karin B.] Univ Freiburg, Fac Med, Inst Prevent & Canc Epidemiol, Freiburg, Germany; [Tserga, Aggeliki; Michels, Karin B.] Univ Freiburg, Med Ctr, Freiburg, Germany; [Binder, Alexandra M.; Michels, Karin B.] Harvard Med Sch, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Obstet & Gynecol Epidemiol Ctr, Boston, MA USA; [Binder, Alexandra M.; Michels, Karin B.] Harvard Sch Publ Hlth, Dept Epidemiol, 677 Longwood Ave, Boston, MA 02115 USA	University of Freiburg; University of Freiburg; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Michels, KB (corresponding author), Harvard Sch Publ Hlth, Dept Epidemiol, 677 Longwood Ave, Boston, MA 02115 USA.	kmichels@hsph.harvard.edu		Tserga, Aggeliki/0000-0002-5531-2111	U.S. National Institutes of Health (NIH), National Cancer Institute Research [R21CA128382]; NIH National Institute of Child Health and Human Development Training Grant [T32HD060454]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060454] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R21CA128382] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Cancer Institute Research; NIH National Institute of Child Health and Human Development Training Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Harvard Epigenetic Birth Cohort was funded by U.S. National Institutes of Health (NIH), National Cancer Institute Research Grant R21CA128382 (to K.B.M.). A.M.B. was supported by NIH National Institute of Child Health and Human Development Training Grant T32HD060454 in Reproductive, Perinatal and Pediatric Epidemiology. The authors declare no conflicts of interest.	Allis C.D., 2008, EPIGENETICS; Azzi S, 2014, CURR OPIN ENDOCRINOL, V21, P30, DOI 10.1097/MED.0000000000000037; Badcock C, 2006, J EVOLUTION BIOL, V19, P1007, DOI 10.1111/j.1420-9101.2006.01091.x; Bailey LB, 1999, J NUTR, V129, P919, DOI 10.1093/jn/129.5.919; Bailey LB, 2015, J NUTR, V145, P1636, DOI 10.3945/jn.114.206599; Blom HJ, 2006, NAT REV NEUROSCI, V7, P724, DOI 10.1038/nrn1986; Cassidy SB, 2012, GENET MED, V14, P10, DOI 10.1038/gim.0b013e31822bead0; Caudill MA, 2001, J NUTR, V131, P2811, DOI 10.1093/jn/131.11.2811; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Crider KS, 2012, ADV NUTR, V3, P21, DOI 10.3945/an.111.000992; Cui HM, 1998, NAT MED, V4, P1276, DOI 10.1038/3260; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; DEKKER GA, 1995, AM J OBSTET GYNECOL, V173, P1042, DOI 10.1016/0002-9378(95)91324-6; Dominguez-Salas P, 2012, P NUTR SOC, V71, P154, DOI 10.1017/S0029665111003338; Eichholzer M, 2006, LANCET, V367, P1352, DOI 10.1016/S0140-6736(06)68582-6; Ferguson-Smith A. C, 2009, EPIGENOMICS; Food and Drug Administration, 1996, FED REGISTER, V61, P8781; Forman HJ, 2009, MOL ASPECTS MED, V30, P1, DOI 10.1016/j.mam.2008.08.006; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; Frost JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013556; Gao RF, 2012, BIOL RES, V45, P351, DOI 10.4067/S0716-97602012000400004; Guo L, 2008, DEV BIOL, V320, P79, DOI 10.1016/j.ydbio.2008.04.025; Haberg SE, 2009, ARCH DIS CHILD, V94, P180, DOI 10.1136/adc.2008.142448; Haggarty P, 2013, AM J CLIN NUTR, V97, P94, DOI 10.3945/ajcn.112.042572; HIBBARD B M, 1969, Journal of Obstetrics and Gynaecology of the British Commonwealth, V76, P1003; HOFFMAN DR, 1980, J BIOL CHEM, V255, P822; Hoyo C, 2011, EPIGENETICS-US, V6, P928, DOI 10.4161/epi.6.7.16263; Ito Y, 2008, HUM MOL GENET, V17, P2633, DOI 10.1093/hmg/ddn163; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; James SJ, 2002, J NUTR, V132, p2361S, DOI 10.1093/jn/132.8.2361S; James SJ, 2004, AM J CLIN NUTR, V80, P1611, DOI 10.1093/ajcn/80.6.1611; Kalish JM, 2014, INT J DEV BIOL, V58, P291, DOI 10.1387/ijdb.140077mb; Krumsiek J, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-21; Laanpere M, 2010, NUTR REV, V68, P99, DOI 10.1111/j.1753-4887.2009.00266.x; Lindblad B, 2005, ACTA OBSTET GYN SCAN, V84, P1055, DOI 10.1111/j.0001-6349.2005.00876.x; Mabb AM, 2011, TRENDS NEUROSCI, V34, P293, DOI 10.1016/j.tins.2011.04.001; Martinez-Frias ML, 2006, AM J MED GENET A, V140A, P987, DOI 10.1002/ajmg.a.31203; Mason JB, 2012, FOOD NUTR BULL, V33, pS104, DOI 10.1177/15648265120332S107; Michels KB, 2006, INT J CANCER, V119, P2007, DOI 10.1002/ijc.22004; Michels KB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025254; Monk D, 2006, P NATL ACAD SCI USA, V103, P6623, DOI 10.1073/pnas.0511031103; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Olsen IE, 2010, PEDIATRICS, V125, pE214, DOI 10.1542/peds.2009-0913; Parle-McDermott A, 2011, ADV NUTR, V2, P463, DOI 10.3945/an.111.001008; Pfeiffer CM, 2005, AM J CLIN NUTR, V82, P442, DOI 10.1093/ajcn/82.2.442; Rancourt RC, 2013, FASEB J, V27, P3335, DOI 10.1096/fj.12-225284; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Rondo PHC, 2000, ANN TROP PAEDIATR, V20, P253, DOI 10.1080/02724936.2000.11748144; Shaw GM, 2004, PUBLIC HEALTH REP, V119, P170, DOI 10.1177/003335490411900210; Stern LL, 2000, CANCER EPIDEM BIOMAR, V9, P849; Sullivan MJ, 1999, ONCOGENE, V18, P7527, DOI 10.1038/sj.onc.1203096; Vanhees K, 2014, CELL MOL LIFE SCI, V71, P271, DOI 10.1007/s00018-013-1427-9; Wang WH, 1996, J BIOL CHEM, V271, P27863, DOI 10.1074/jbc.271.44.27863; Whitrow MJ, 2009, AM J EPIDEMIOL, V170, P1486, DOI 10.1093/aje/kwp315; WOUTERS MGAJ, 1993, FERTIL STERIL, V60, P820; Yamada K, 2001, P NATL ACAD SCI USA, V98, P14853, DOI 10.1073/pnas.261469998; Yi P, 2000, J BIOL CHEM, V275, P29318, DOI 10.1074/jbc.M002725200	58	14	16	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5149	5158		10.1096/fj.201601214RR	http://dx.doi.org/10.1096/fj.201601214RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28778973	Green Published			2022-12-28	WOS:000416588300003
J	Yamaleyeva, LM; Sun, Y; Bledsoe, T; Hoke, A; Gurley, SB; Brosnihan, KB				Yamaleyeva, Liliya M.; Sun, Yao; Bledsoe, Tiffaney; Hoke, Asia; Gurley, Susan B.; Brosnihan, K. Bridget			Photoacoustic imaging for in vivo quantification of placental oxygenation in mice	FASEB JOURNAL			English	Article						placental hypoxia; oxygen saturation; hypertensive pregnancy; HIF-1 alpha; fetal growth restriction	PREGNANCY; HYPOXIA; RATS; BIOMEDICINE; CIRCULATION; TOMOGRAPHY; MICROSCOPY; ARTERY; ACE2	Accurate analysis of placental and fetal oxygenation is critical during pregnancy. Photoacoustic imaging (PAI) combines laser technology with ultrasound in real time. We tested the sensitivity and accuracy of PAI for analysis of placental and fetal oxygen saturation (sO(2)) inmice. The placental labyrinth (L) had a higher sO(2) than the junctional zone plus decidua region (JZ+D) inC57Bl/6mice. ChangingmaternalO(2) from 100 to 20% inC57Bl/6mice lowered sO(2) in these regions. C57Bl/6 mice were treated with the NO synthase inhibitor L-N-G-nitroarginine methyl ester (L-NAME) from gestational day (GD) 11 to GD18 to induce hypertension. L-NAME decreased sO2 in L and JZ+DatGD14 and GD18 in associationwith fetal growth restriction and higher blood pressure. Hypoxia-inducible factor 1 alpha immunostaining was higher in L-NAME vs. control mice at GD14. Fetal sO(2) levels were similar between L-NAME and controlmice atGD14 and GD18. In contrast to untreated C57Bl/6, L-NAMEdecreased placental sO(2) at GD14 and GD18 vs. GD10 or GD12. Placental sO(2) was lower in fetal growth restriction in an angiotensin-converting enzyme 2 knockout mouse model characterized by placental hypoxia. On phantom studies, patterns of sO(2) measured directly correlated with those measured by PAI. In summary, PAI enables the detection of placental and fetal oxygenation during normal and pathologic pregnancies in mice.	[Yamaleyeva, Liliya M.; Bledsoe, Tiffaney; Hoke, Asia; Brosnihan, K. Bridget] Wake Forest Sch Med, Dept Surg Hypertens & Vasc Res, Med Ctr Blvd, Winston Salem, NC 27157 USA; [Sun, Yao] Wake Forest Sch Med, Dept Radiol, Winston Salem, NC 27157 USA; [Gurley, Susan B.] Durham Vet Affairs Med Ctr, Dept Med, Div Nephrol, Durham, NC USA; [Gurley, Susan B.] Duke Univ, Med Ctr, Durham, NC USA	Wake Forest University; Wake Forest University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University	Yamaleyeva, LM (corresponding author), Wake Forest Sch Med, Dept Surg Hypertens & Vasc Res, Med Ctr Blvd, Winston Salem, NC 27157 USA.	lyamaley@wakehealth.edu			U.S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant [R21 HD086357]; American Heart Association [13SDG17390009]; NIH Office of Research Infrustructure Programs (ORIP) /OD-High End Instrumentation Grant [S10 OD012330]; NIH Excellence in Cardiovascular Sciences Summer Research Program Grant [5R25HL092618]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD086357] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL092618] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012330] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant; American Heart Association(American Heart Association); NIH Office of Research Infrustructure Programs (ORIP) /OD-High End Instrumentation Grant; NIH Excellence in Cardiovascular Sciences Summer Research Program Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors acknowledge the assistance of the Preclinical Ultrasound and Photoacoustics Imaging Core and Virtual Microscopy Core of the Wake Forest School of Medicine. The authors also acknowledge the editorial assistance of Karen Klein (Wake Forest Clinical and Translational Science Institute). This work was supported by U.S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant R21 HD086357 (to L.M.Y.), American Heart Association Grant 13SDG17390009 (to L.M.Y.), in part by NIH Office of Research Infrustructure Programs (ORIP) /OD-High End Instrumentation Grant S10 OD012330 (to K.B.B.), and by NIH Excellence in Cardiovascular Sciences Summer Research Program Grant 5R25HL092618. The authors declare no conflicts of interest.	Adamson SL, 2002, DEV BIOL, V250, P358, DOI 10.1006/dbio.2002.0773; Arthuis CJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169850; Bharadwaj MS, 2011, HYPERTENSION, V58, P852, DOI 10.1161/HYPERTENSIONAHA.111.179358; Chalouhi GE, 2011, SEMIN FETAL NEONAT M, V16, P22, DOI 10.1016/j.siny.2010.09.001; Chung E, 2013, CARDIOVASC RES, V100, P402, DOI 10.1093/cvr/cvt208; Cuffe JSM, 2014, J PHYSIOL-LONDON, V592, P3127, DOI 10.1113/jphysiol.2014.272856; Heazell AEP, 2015, PLACENTA, V36, pS20, DOI 10.1016/j.placenta.2014.12.017; KAUR J, 2012, ANN BIOL RES, V3, P4845; Laufer J, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.6.061220; Li CH, 2009, PHYS MED BIOL, V54, pR59, DOI 10.1088/0031-9155/54/19/R01; LI H, 2015, SCI REP UK, V5; Lindsey SH, 2013, AM J PHYSIOL-ENDOC M, V305, pE113, DOI 10.1152/ajpendo.00649.2012; Maslov K, 2008, OPT LETT, V33, P929, DOI 10.1364/OL.33.000929; Nguyen DH, 2013, CANCERINCYTES, V2, DOI DOI 10.1038/PROTEX.2013.097; Osol G, 2009, PHYSIOLOGY, V24, P58, DOI 10.1152/physiol.00033.2008; Rich LJ, 2015, RADIOLOGY, V275, P110, DOI 10.1148/radiol.14140654; Smith LM, 2016, SHOCK, V46, P527, DOI 10.1097/SHK.0000000000000644; Tiboni GM, 2003, PEDIATR RES, V54, P69, DOI 10.1203/01.PDR.0000069840.78984.76; Tsukimori K, 2008, AM J HYPERTENS, V21, P477, DOI 10.1038/ajh.2007.80; Valdes G, 2011, INTEGR BLOOD PRESS C, V4, P45, DOI 10.2147/IBPC.S8393; VisualSonics Inc, 2011, APPL NOT PLANC IM VE; World Health Organization, 2016, ORLD HLTH STAT 2016; Xia WF, 2015, LECT NOTES COMPUT SC, V9349, P371, DOI 10.1007/978-3-319-24553-9_46; Xu MH, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2195024; Yamaleyeva LM, 2015, AM J PHYSIOL-ENDOC M, V309, pE84, DOI 10.1152/ajpendo.00596.2014; Yamaleyeva LM, 2012, J CARDIOVASC PHARM, V59, P529, DOI 10.1097/FJC.0b013e31824dd15b; Yamaleyeva LM, 2012, AM J PHYSIOL-RENAL, V302, pF1374, DOI 10.1152/ajprenal.00656.2011; Yao JJ, 2014, PHOTOACOUSTICS, V2, P87, DOI 10.1016/j.pacs.2014.04.002; Yao JJ, 2011, CONTRAST MEDIA MOL I, V6, P332, DOI 10.1002/cmmi.443; YIN FCP, 1982, AM J PHYSIOL, V243, pH941, DOI 10.1152/ajpheart.1982.243.6.H941	30	18	19	4	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5520	5529		10.1096/fj.201700047RR	http://dx.doi.org/10.1096/fj.201700047RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28842425	Green Published			2022-12-28	WOS:000416588300033
J	Chen, X; Zhi, X; Pan, PP; Cui, J; Cao, LH; Weng, WZ; Zhou, QR; Wang, L; Zhai, X; Zhao, Q; Hu, HG; Huang, BT; Su, JC				Chen, Xiao; Zhi, Xin; Pan, Panpan; Cui, Jin; Cao, Liehu; Weng, Weizong; Zhou, Qirong; Wang, Lin; Zhai, Xiao; Zhao, Qingiie; Hu, Honggang; Huang, Biaotong; Su, Jiacan			Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL-induced osteoclastogenesis	FASEB JOURNAL			English	Article						postmenopausal osteoporosis; NFATc1; osteoclasts	NF-KAPPA-B; DEFICIENCY-INDUCED OSTEOPOROSIS; RECEPTOR ACTIVATOR; ESTROGEN DEFICIENCY; SIGNALING PATHWAYS; POSTMENOPAUSAL OSTEOPOROSIS; PROINFLAMMATORY CYTOKINES; DIFFERENTIATION; INFLAMMATION; LIGAND	Osteoporosis is a metabolic bone disease characterized by decreased bone density and strength due to excessive loss of bone protein and mineral content. The imbalance between osteogenesis by osteoblasts and osteoclastogenesis by osteoclasts contributes to the pathogenesis of postmenopausal osteoporosis. Estrogen withdrawal leads to increased levels of proinflammatory cytokines. Overactivated osteoclasts by inflammation play a vital role in the imbalance. Matrine is an alkaloid found in plants from the Sophora genus with various pharmacological effects, including anti-inflammatory activity. Here we demonstrate that matrine significantly prevented ovariectomy-induced bone loss and inhibited osteoclastogenesis in vivo with decreased serum levels of TRAcp5b, TNF-alpha, and IL-6. In vitro matrine significantly inhibited osteoclast differentiation induced by receptor activator for NF-kappa B ligand (RANKL) and M-CSF in bone marrow monocytes and RAW264.7 cells as demonstrated by tartrate-resistant acid phosphatase (TRAP) staining and actin-ring formation as well as bone resorption through pit formation assays. For molecular mechanisms, matrine abrogated RANKL-induced activation of NF-kappa B, AKT, and MAPK pathways and suppressed osteoclastogenesis-related marker expression, including matrix metalloproteinase 9, NFATc1, TRAP, C-Src, and cathepsin K. Our study demonstrates that matrine inhibits osteoclastogenesis through modulation of multiple pathways and that matrine is a promising agent in the treatment of osteoclast-related diseases such as osteoporosis.	[Chen, Xiao; Pan, Panpan; Cao, Liehu; Weng, Weizong; Zhou, Qirong; Wang, Lin; Zhai, Xiao; Su, Jiacan] Second Mil Med Univ, Dept Orthoped Trauma, Shanghai Changhai Hosp, Shanghai, Peoples R China; [Zhi, Xin; Cui, Jin] Second Mil Med Univ, Shanghai Changhai Hosp, Grad Management Unit, Shanghai, Peoples R China; [Zhao, Qingiie; Hu, Honggang] Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China; [Chen, Xiao; Pan, Panpan; Cao, Liehu; Weng, Weizong; Zhou, Qirong; Wang, Lin; Zhao, Qingiie; Hu, Honggang; Huang, Biaotong; Su, Jiacan] China South Korea Bioengn Ctr, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University	Su, JC (corresponding author), Second Mil Med Univ, Dept Orthoped, Changhai Hosp, Changhai Rd, Shanghai 200433, Peoples R China.	drsujiacan@163.com	Jiacan, Su/N-7068-2019	Jiacan, Su/0000-0001-7080-263X	Shanghai Municipal Science and Technology Commission [15411950600]	Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM))	The authors thank the Clear-Med-Trans Studio (Shanghai, China) for language polishing, Shanghai GeekBiotech (Shanghai, China) for technical support, Dr. J. Wang (Fudan University, Shanghai, China) for technical guidance, and Sir C. Liu for providing matrine. This work was supported by Shanghai Municipal Science and Technology Commission Key Program (15411950600). The authors declare no conflicts of interest.	Abu-Amer Y, 2013, OSTEOPOROSIS INT, V24, P2377, DOI 10.1007/s00198-013-2313-x; Andreopoulou P, 2015, ANNU REV MED, V66, P329, DOI 10.1146/annurev-med-070313-022841; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Barlow DH, 2010, HUM REPROD UPDATE, V16, P761, DOI 10.1093/humupd/dmq008; Bharti AC, 2004, J BIOL CHEM, V279, P6065, DOI 10.1074/jbc.M308062200; Bord S, 2003, BONE, V32, P136, DOI 10.1016/S8756-3282(02)00953-5; Del Fattore A, 2008, ARCH BIOCHEM BIOPHYS, V473, P147, DOI 10.1016/j.abb.2008.01.011; Del Puente A, 2015, J BIOL REG HOMEOS AG, V29, P527; Dou C, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.69; Eghbali-Fatourechi G, 2003, J CLIN INVEST, V111, P1221, DOI 10.1172/JCI200317215; Guan HF, 2015, FASEB J, V29, P1092, DOI 10.1096/fj.14-262055; Jakob F, 2015, UNFALLCHIRURG, V118, P925, DOI 10.1007/s00113-015-0085-9; Janas A, 2017, N-S ARCH PHARMACOL, V390, P175, DOI 10.1007/s00210-016-1295-6; Jia M, 2015, BEST PRACT RES CL EN, V29, P557, DOI 10.1016/j.beem.2015.04.008; Kadono Y, 2005, EMBO REP, V6, P171, DOI 10.1038/sj.embor.7400345; Kameda Y, 2013, J BONE MINER RES, V28, P2463, DOI 10.1002/jbmr.1989; Kearns AE, 2008, ENDOCR REV, V29, P155, DOI 10.1210/er.2007-0014; Koide M, 2009, J BONE MINER RES, V24, P1469, DOI [10.1359/JBMR.090302, 10.1359/jbmr.090302]; Lee EJ, 2014, PHYTOMEDICINE, V21, P1208, DOI 10.1016/j.phymed.2014.04.002; Lewiecki EM, 2011, NAT REV RHEUMATOL, V7, P631, DOI 10.1038/nrrheum.2011.130; Li CH, 2011, J BONE MINER RES, V26, P644, DOI 10.1002/jbmr.242; Li MJ, 2015, INT J MOL MED, V36, P1335, DOI 10.3892/ijmm.2015.2330; Ma J, 2015, J AM COLL CARDIOL, V66, pC23, DOI 10.1016/j.jacc.2015.06.1115; Pino AM, 2010, J BONE MINER RES, V25, P492, DOI 10.1359/jbmr.090802; Mizukami J, 2002, MOL CELL BIOL, V22, P992, DOI 10.1128/MCB.22.4.992-1000.2002; Moriwaki S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097177; Mundy GR, 2007, NUTR REV, V65, pS147, DOI 10.1301/nr.2007.dec.S147-S151; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Novella S, 2012, ARTERIOSCL THROM VAS, V32, P2035, DOI 10.1161/ATVBAHA.112.250308; Pfeilschifter J, 2002, ENDOCR REV, V23, P90, DOI 10.1210/er.23.1.90; Quach JM, 2015, J BONE MINER RES, V30, P886, DOI 10.1002/jbmr.2415; Shao HM, 2013, ONCOL LETT, V6, P517, DOI 10.3892/ol.2013.1399; Shukla P, 2017, J BIOL CHEM, V292, P4686, DOI 10.1074/jbc.M116.764779; Sun DQ, 2016, BIOCHEM BIOPH RES CO, V477, P83, DOI 10.1016/j.bbrc.2016.06.024; Tyagi AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044552; Vegeto E, 2008, FRONT NEUROENDOCRIN, V29, P507, DOI 10.1016/j.yfrne.2008.04.001; Walsh MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00511; Warren JT, 2015, J CELL BIOCHEM, V116, P2476, DOI 10.1002/jcb.25191; Wu X, 2012, J BONE MINER RES, V27, P1298, DOI 10.1002/jbmr.1576; Xu M, 2012, BRAIN RES, V1454, P48, DOI 10.1016/j.brainres.2012.03.020; Xu WH, 2014, HEPATOLOGY, V60, P648, DOI 10.1002/hep.27138; Yao ZQ, 2009, J CLIN INVEST, V119, P3024, DOI 10.1172/JCI38716; Yu B, 2014, NAT MED, V20, P1009, DOI 10.1038/nm.3586; Yuan FL, 2015, BONE, V75, P128, DOI 10.1016/j.bone.2015.02.017; Zeng XZ, 2017, BIOCHEM PHARMACOL, V124, P57, DOI 10.1016/j.bcp.2016.10.007; Zeng XY, 2015, BRIT J PHARMACOL, V172, P4303, DOI 10.1111/bph.13209; Zhang B, 2011, EUR J PHARM SCI, V44, P573, DOI 10.1016/j.ejps.2011.09.020; Zhang PP, 2016, CANCER LETT, V376, P95, DOI 10.1016/j.canlet.2016.01.011; Zhou Y, 2009, MED HYPOTHESES, V73, P83, DOI 10.1016/j.mehy.2009.01.029	49	62	67	4	44	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4855	4865		10.1096/fj.201700316R	http://dx.doi.org/10.1096/fj.201700316R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28739641	Green Published			2022-12-28	WOS:000413398500017
J	Zhao, ZY; Liang, YJ; Liu, Y; Xu, P; Flamme-Wiese, MJ; Sun, DM; Sun, JE; Mullins, RF; Chen, Y; Cai, JY				Zhao, Zhenyang; Liang, Yuejin; Liu, Yin; Xu, Pei; Flamme-Wiese, Miles J.; Sun, Deming; Sun, Jiaren; Mullins, Robert F.; Chen, Yan; Cai, Jiyang			Choroidal gamma delta T cells in protection against retinal pigment epithelium and retinal injury	FASEB JOURNAL			English	Article						inflammation; choriocapillaris drop out; immune modulation; AhR	ARYL-HYDROCARBON RECEPTOR; MACULAR DEGENERATION; IMMUNE PRIVILEGE; SODIUM IODATE; RPE; ACTIVATION; INNATE; NLRP3; NEOVASCULARIZATION; INFLAMMATION	gamma delta T cells located near the epithelial barrier are integral components of local inflammatory and innate immune responses. We have previously reported the presence of choroidal gd T cells in a model of chronic degeneration of the retinal pigment epithelium (RPE). The goals of the current study were to further define the functions of choroidal gd T cells and to explore the underlying mechanisms of their action. Our data demonstrate that choroidal gamma delta Tcells are activated by RPE injury in response to NaIO3 treatment, and that they express genes that encode immunosuppressive cytokines, such as IL-4 and IL-10. gd-T-cell-deficient mice developed profound RPE and retinal damage at doses that caused minimal effects in wild-type mice, and adoptive transfer of gd T cells prevented sensitization. Intravitreal injection of IL-4 and IL-10 ameliorated RPE toxicity that was inducedbyNaIO(3). Ex vivo coculture of gamma delta Tcells with RPE explants activated the production of anti-inflammatory cytokines via an aryl hydrocarbon receptor (AhR)-dependent mechanism. AhR deficiency abolished the protective effects of gd T cells after adoptive transfer. Collectively, these findings define important roles for choroid gd T cells in maintaining tissue homeostasis in the outer retina.-Zhao, Z., Liang, Y., Liu, Y., Xu, P., Flamme-Wiese, M. J., Sun, D., Sun, J., Mullins, R. F., Chen, Y., Cai, J. Choroidal gd T cells in protection against retinal pigment epithelium and retinal injury.	[Zhao, Zhenyang; Xu, Pei; Chen, Yan; Cai, Jiyang] Univ Texas Med Branch, Dept Ophthalmol & Visual Sci, 301 Univ Blvd, Galveston, TX 77555 USA; [Liang, Yuejin; Sun, Jiaren] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Liu, Yin] Univ Texas Hlth Sci Ctr Houston, Dept Neurobiol & Anat, Houston, TX 77030 USA; [Flamme-Wiese, Miles J.; Mullins, Robert F.] Univ Iowa, Stephen A Wynn Inst Vis Res, Iowa City, IA USA; [Sun, Deming] Univ Calif Los Angeles, David Geffen Sch Med, Doheny Eye Inst, Los Angeles, CA 90095 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Health Science Center Houston; University of Iowa; Doheny Eye Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Cai, JY (corresponding author), Univ Texas Med Branch, Dept Ophthalmol & Visual Sci, 301 Univ Blvd, Galveston, TX 77555 USA.	jicai@utmb.edu	Liang, Yuejin/X-5250-2019; Mullins, Robert F/I-6717-2013; Xu, Pei/B-1680-2016	Xu, Pei/0000-0002-9480-8021; Liang, Yuejin/0000-0002-9557-1847; Mullins, Robert/0000-0002-5006-0891	U.S. National Institutes of Health, National Eye Institute [EY021937, EY026999, EY022403, EY024605]; Ted Nash Long Life Foundation; Carl Marshall Reeves and Mildred Almen Reeves Foundation; BrightFocus Foundation; International Retina Research Foundation; NATIONAL EYE INSTITUTE [R01EY026999, R01EY018827, R01EY022403, R01EY024605, R01EY021937] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Ted Nash Long Life Foundation; Carl Marshall Reeves and Mildred Almen Reeves Foundation; BrightFocus Foundation(BrightFocus Foundation); International Retina Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by U.S. National Institutes of Health, National Eye Institute Grants EY021937, EY026999, EY022403, and EY024605; the Ted Nash Long Life Foundation; Carl Marshall Reeves and Mildred Almen Reeves Foundation; BrightFocus Foundation; and International Retina Research Foundation. The authors declare no conflicts of interest.	Akitsu A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8464; Ambati J, 2013, NAT REV IMMUNOL, V13, P438, DOI 10.1038/nri3459; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Apte RS, 2006, PLOS MED, V3, P1371, DOI 10.1371/journal.pmed.0030310; Ashour HM, 2006, J IMMUNOL, V177, P8331, DOI 10.4049/jimmunol.177.12.8331; Balmer J, 2015, INT J MOL SCI, V16, P15086, DOI 10.3390/ijms160715086; Born W K, 2000, Respir Res, V1, P151, DOI 10.1186/rr26; Camelo S, 2016, OPHTHALMOLOGICA, V236, P53, DOI 10.1159/000446587; Carido M, 2014, INVEST OPHTH VIS SCI, V55, P5431, DOI 10.1167/iovs.14-14325; Chen SD, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/369312; Chen Y, 2002, J BIOL CHEM, V277, P33242, DOI 10.1074/jbc.M202026200; Chen YP, 2002, P NATL ACAD SCI USA, V99, P14338, DOI 10.1073/pnas.212290499; Cheruvu NPS, 2006, INVEST OPHTH VIS SCI, V47, P4513, DOI 10.1167/iovs.06-0404; Chien YH, 2014, ANNU REV IMMUNOL, V32, P121, DOI 10.1146/annurev-immunol-032713-120216; Chirco KR, 2016, EXP EYE RES, V146, P393, DOI 10.1016/j.exer.2015.09.003; Choudhary M, 2015, J PATHOL, V235, P101, DOI 10.1002/path.4433; Clemson CM, 2017, OCUL IMMUNOL INFLAMM, V25, P179, DOI 10.3109/09273948.2015.1092560; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Coughlin B, 2016, SCI REP-UK, V6, DOI 10.1038/srep23794; Dace DS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003381; Detrick B, 2010, IMMUNOL RES, V47, P153, DOI 10.1007/s12026-009-8146-1; Doyle SL, 2012, NAT MED, V18, P791, DOI 10.1038/nm.2717; Gay D, 2013, NAT MED, V19, P916, DOI 10.1038/nm.3181; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Green DR, 2001, NAT REV MOL CELL BIO, V2, P917, DOI 10.1038/35103104; Gregerson DS, 2007, INVEST OPHTH VIS SCI, V48, P4654, DOI 10.1167/iovs.07-0286; Haas JD, 2012, IMMUNITY, V37, P48, DOI 10.1016/j.immuni.2012.06.003; Haas JD, 2009, EUR J IMMUNOL, V39, P3488, DOI 10.1002/eji.200939922; Han H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11432; Hasegawa E, 2013, J IMMUNOL, V190, P1778, DOI 10.4049/jimmunol.1202495; HAVRAN WL, 1991, SCIENCE, V252, P1430, DOI 10.1126/science.1828619; Hayday A, 2003, NAT REV IMMUNOL, V3, P233, DOI 10.1038/nri1030; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Hu P, 2013, P NATL ACAD SCI USA, V110, pE4069, DOI 10.1073/pnas.1307574110; Imai A, 2012, INVEST OPHTH VIS SCI, V53, P7299, DOI 10.1167/iovs.12-10182; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Kaestel CG, 2005, CURR EYE RES, V30, P375, DOI 10.1080/02713680590934120; Kannan R, 2014, NEURAL REGEN RES, V9, P2044, DOI 10.4103/1673-5374.147927; Kauppinen A, 2012, IMMUNOL LETT, V147, P29, DOI 10.1016/j.imlet.2012.05.005; Kawazoe Y, 2012, EXP EYE RES, V94, P32, DOI 10.1016/j.exer.2011.11.002; Kelly J, 2007, J CLIN INVEST, V117, P3421, DOI 10.1172/JCI32430; Keyes BE, 2016, CELL, V167, P1323, DOI 10.1016/j.cell.2016.10.052; Kim SY, 2014, INVEST OPHTH VIS SCI, V55, P6031, DOI 10.1167/iovs.14-15091; Kuhl AA, 2007, J LEUKOCYTE BIOL, V81, P168, DOI 10.1189/jlb.1105696; Li YW, 2008, NAT PROTOC, V3, P1703, DOI 10.1038/nprot.2008.172; Liang DC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150078; Liang DC, 2013, J IMMUNOL, V191, P1118, DOI 10.4049/jimmunol.1300626; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Maxwell JR, 2015, IMMUNITY, V43, P739, DOI 10.1016/j.immuni.2015.08.019; McLeod DS, 2009, INVEST OPHTH VIS SCI, V50, P4982, DOI 10.1167/iovs.09-3639; Misiak A, 2017, J IMMUNOL, V198, P363, DOI 10.4049/jimmunol.1601024; Mullins RE, 2011, INVEST OPHTH VIS SCI, V52, P1606, DOI 10.1167/iovs.10-6476; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Nian H, 2011, INVEST OPHTH VIS SCI, V52, P5920, DOI 10.1167/iovs.10-6758; Nowarski R, 2017, CELL, V168, P362, DOI 10.1016/j.cell.2016.11.040; O'Brien RL, 2010, SEMIN IMMUNOL, V22, P193, DOI 10.1016/j.smim.2010.03.006; Park CY, 2010, OCUL IMMUNOL INFLAMM, V18, P24, DOI 10.3109/09273940903326203; Patel M, 2008, SEMIN IMMUNOPATHOL, V30, P97, DOI 10.1007/s00281-008-0112-9; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; ROSENBAUM JT, 1995, J IMMUNOL, V155, P4090; SIM GK, 1994, INT IMMUNOL, V6, P1287, DOI 10.1093/intimm/6.9.1287; Skelsey ME, 2001, J IMMUNOL, V166, P4327, DOI 10.4049/jimmunol.166.7.4327; Song XY, 2015, IMMUNITY, V43, P488, DOI 10.1016/j.immuni.2015.06.024; Stange J, 2013, SEMIN IMMUNOPATHOL, V35, P645, DOI 10.1007/s00281-013-0389-1; Sumaria N, 2011, J EXP MED, V208, P505, DOI 10.1084/jem.20101824; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Tseng WA, 2013, INVEST OPHTH VIS SCI, V54, P110, DOI 10.1167/iovs.12-10655; Wallace CA, 2013, INVEST OPHTH VIS SCI, V54, P722, DOI 10.1167/iovs.12-10602; Wang W, 2011, OPHTHALMOL EYE DIS, V3, DOI 10.4137/OED.S7797; Wenkel H, 2000, INVEST OPHTH VIS SCI, V41, P3467; Wohl SG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022408; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; Yu B, 2014, INVEST OPHTH VIS SCI, V55, P8638, DOI 10.1167/iovs.14-14758; Zhang SJ, 2016, INVEST OPHTH VIS SCI, V57, P312, DOI 10.1167/iovs.15-17578; ZHAO ZY, 2014, INVEST OPHTH VIS SCI, V55; Zhou R, 2012, J IMMUNOL, V188, P1742, DOI 10.4049/jimmunol.1102415; Zhu YJ, 2016, IMMUNOLOGY, V147, P414, DOI 10.1111/imm.12571	80	13	13	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4903	4916		10.1096/fj.201700533R	http://dx.doi.org/10.1096/fj.201700533R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28729290	Green Published, Green Submitted			2022-12-28	WOS:000413398500021
J	Gao, XP; Zhao, L; Zhuang, JG; Zang, N; Xu, FD				Gao, Xiuping; Zhao, Lei; Zhuang, Jianguo; Zang, Na; Xu, Fadi			Prenatal nicotinic exposure prolongs superior laryngeal C-fiber-mediated apnea and bradycardia through enhancing neuronal TRPV1 expression and excitation	FASEB JOURNAL			English	Article						SIDS; cardiorespiratory activity; I-Ks	SUDDEN-INFANT-DEATH; SENSORY NEURONS; CIGARETTE-SMOKE; NEONATAL-RATS; REFLEX APNEA; DECEREBRATE PIGLETS; RESPIRATORY CONTROL; POTASSIUM CURRENTS; BREATHING PATTERN; HYPOXIA	Maternal cigarette smoke, including prenatal nicotinic exposure (PNE), is responsible for sudden infant death syndrome (SIDS). The fatal events of SIDS are characterized by severe bradycardia and life-threatening apneas. Although activation of transient receptor potential vanilloid 1 (TRPV1) of superior laryngeal C fibers (SLCFs) could induce bradycardia and apnea and has been implicated in SIDS pathogenesis, how PNE affects the SLCF-mediated cardiorespiratory responses remains unexplored. Here, we tested the hypothesis that PNE would aggravate the SLCF-mediated apnea and bradycardia via up-regulating TRPV1 expression and excitation of laryngeal C neurons in the nodose/jugular (N/J) ganglia. To this end, we compared the following outcomes between control and PNE rat pups at postnatal days 11-14: 1) the cardiorespiratory responses to intralaryngeal application of capsaicin (10 mu g/ml, 50 mu l), a selective stimulant for TRPV1 receptors, in anesthetized preparation; 2) immunoreactivity and mRNA of TRPV1 receptors of laryngeal sensory C neurons in the N/J ganglia retrogradely traced by 1,1-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate; and 3) TRPV1 currents and electrophysiological characteristics of these neurons by using whole-cell patch-clamp technique in vitro. Our results showed that PNE markedly prolonged the apneic response and exacerbated the bradycardic response to intralaryngeal perfusion of capsaicin, which was associated with up-regulation of TRPV1 expression in laryngeal C neurons. In addition, PNE increased the TRPV1 currents, depressed the slow delayed rectifier potassium currents, and increased the resting membrane potential of these neurons. Our results suggest that PNE is capable of aggravating the SLCF-mediated apnea and bradycardia through TRPV1 sensitization and neuronal excitation, which may contribute to the pathogenesis of SIDS.-Gao, X., Zhao, L., Zhuang, J., Zang, N., Xu, F. Prenatal nicotinic exposure prolongs superior laryngeal C-fiber-mediated apnea and bradycardia through enhancing neuronal TRPV1 expression and excitation.	[Gao, Xiuping; Zhao, Lei; Zhuang, Jianguo; Zang, Na; Xu, Fadi] Lovelace Resp Res Inst, 2425 Ridgecrest Dr SE, Albuquerque, NM 87108 USA	Lovelace Respiratory Research Institute	Xu, FD (corresponding author), Lovelace Resp Res Inst, 2425 Ridgecrest Dr SE, Albuquerque, NM 87108 USA.	fxu@lrri.org			U.S. National Institutes of Health, National Heart, Lung and Blood Institute [HL-107462, HL-119683]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119683, R01HL107462] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Ellen Blake (Lovelace Respiratory Research Institute) for editing the manuscript. This study was supported by U.S. National Institutes of Health, National Heart, Lung and Blood Institute Grants HL-107462 and HL-119683. The authors declare no conflicts of interest.	Abu-Shaweesh JM, 2001, J APPL PHYSIOL, V90, P1570, DOI 10.1152/jappl.2001.90.4.1570; Adams EJ, 1998, PEDIATRICS, V102, P1445, DOI 10.1542/peds.102.6.1445; Anand U, 2006, NEUROSCI LETT, V399, P51, DOI 10.1016/j.neulet.2006.01.046; Ballanyi Klaus, 2004, Current Neuropharmacology, V2, P221, DOI 10.2174/1570159043476828; BENOWITZ NL, 1984, CLIN PHARMACOL THER, V35, P499, DOI 10.1038/clpt.1984.67; BOGGS DF, 1982, J APPL PHYSIOL, V53, P455, DOI 10.1152/jappl.1982.53.2.455; Campos M, 2009, CLIN EXP PHARMACOL P, V36, P1205, DOI 10.1111/j.1440-1681.2009.05214.x; Chen H, 2005, EUR J NEUROSCI, V22, P380, DOI 10.1111/j.1460-9568.2005.04229.x; Cheng JH, 2004, ACTA PHARMACOL SIN, V25, P137; Daley KC, 2004, CURR OPIN PEDIATR, V16, P227; DOWNING SE, 1975, PEDIATRICS, V55, P640; Duy PM, 2010, EXP PHYSIOL, V95, P774, DOI 10.1113/expphysiol.2010.052647; Evans AR, 1999, J PHYSIOL-LONDON, V516, P163, DOI 10.1111/j.1469-7793.1999.163aa.x; FAGENHOLZ SA, 1979, AM J PHYSIOL, V237, pR10, DOI 10.1152/ajpregu.1979.237.1.R10; Fregosi RF, 2008, RESP PHYSIOL NEUROBI, V164, P80, DOI 10.1016/j.resp.2008.05.008; Gu QH, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00065; Guntheroth WG, 2001, PEDIATRICS, V107, P693, DOI 10.1542/peds.107.4.693; GUNTHEROTH WG, 1975, J CLIN INVEST, V56, P1371, DOI 10.1172/JCI108217; Hafstrom O, 2002, AM J RESP CRIT CARE, V166, P1544, DOI 10.1164/rccm.200204-289OC; Hafstrom O, 2002, AM J RESP CRIT CARE, V166, P92, DOI 10.1164/rccm.2107082; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Harper RM, 2000, RESP PHYSIOL, V119, P123, DOI 10.1016/S0034-5687(99)00107-3; Hayakawa T, 2014, J CHEM NEUROANAT, V55, P18, DOI 10.1016/j.jchemneu.2013.11.001; Hishida N, 1997, J VET MED SCI, V59, P499, DOI 10.1292/jvms.59.499; Hu YM, 2010, AM J PHYSIOL-LUNG C, V299, pL483, DOI 10.1152/ajplung.00111.2010; Huang YH, 2004, RESP PHYSIOL NEUROBI, V143, P1, DOI 10.1016/j.resp.2004.07.002; Iyer SM, 2014, NAT BIOTECHNOL, V32, P274, DOI 10.1038/nbt.2834; JIANG C, 1994, EXP BRAIN RES, V100, P407, DOI 10.1007/BF02738401; Jost N, 2007, ANN NONINVAS ELECTRO, V12, P64, DOI 10.1111/j.1542-474X.2007.00140.x; Kalra R, 2002, J PHARMACOL EXP THER, V302, P935, DOI 10.1124/jpet.302.3.935; KASHIBA H, 1995, MOL BRAIN RES, V30, P158, DOI 10.1016/0169-328X(94)00249-E; Kinney HC, 2009, NEW ENGL J MED, V361, P795, DOI 10.1056/NEJMra0803836; LANIER B, 1983, OTOLARYNG HEAD NECK, V91, P597, DOI 10.1177/019459988309100602; LEE JC, 1977, AM J PHYSIOL, V233, pR30, DOI 10.1152/ajpregu.1977.233.1.R30; Lee LY, 2013, PULM PHARMACOL THER, V26, P491, DOI 10.1016/j.pupt.2013.03.010; Lee LY, 2009, CURR OPIN PHARMACOL, V9, P243, DOI 10.1016/j.coph.2009.02.002; Leiter JC, 2007, RESP PHYSIOL NEUROBI, V159, P127, DOI 10.1016/j.resp.2007.05.014; Lin YJ, 2013, J APPL PHYSIOL, V114, P361, DOI 10.1152/japplphysiol.00977.2012; Liu BY, 2015, J APPL PHYSIOL, V118, P635, DOI 10.1152/japplphysiol.00717.2014; Liu BY, 2013, PULM PHARMACOL THER, V26, P364, DOI 10.1016/j.pupt.2013.01.010; LUCK W, 1985, DEV PHARMACOL THERAP, V8, P384, DOI 10.1159/000457063; MU XJ, 1993, J NEUROSCI, V13, P4029; Mutoh T, 2000, J VET MED SCI, V62, P665, DOI 10.1292/jvms.62.665; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; NISENBAUM ES, 1995, J NEUROSCI, V15, P4449; Pendlebury JD, 2008, AM J RESP CRIT CARE, V177, P1255, DOI 10.1164/rccm.200711-1739OC; Potenzieri C, 2012, J PHYSIOL-LONDON, V590, P5449, DOI 10.1113/jphysiol.2012.237115; Saareks V, 2000, J PHYSIOL PHARMACOL, V51, P631; SANTAMBROGIO G, 1995, RESP PHYSIOL, V102, P1, DOI 10.1016/0034-5687(95)00048-I; Shea AK, 2008, NICOTINE TOB RES, V10, P267, DOI 10.1080/14622200701825908; St-Hilaire M, 2007, J APPL PHYSIOL, V102, P1429, DOI 10.1152/japplphysiol.00977.2006; St-John WM, 1999, NEUROSCI LETT, V267, P206, DOI 10.1016/S0304-3940(99)00364-X; Stephan-Blanchard E, 2013, RESP PHYSIOL NEUROBI, V185, P110, DOI 10.1016/j.resp.2012.06.023; Stephenson R, 2001, J PHYSIOL-LONDON, V536, P225, DOI 10.1111/j.1469-7793.2001.00225.x; Varro A, 2000, J PHYSIOL-LONDON, V523, P67, DOI 10.1111/j.1469-7793.2000.00067.x; Wang RR, 2008, J PERINAT MED, V36, P161, DOI 10.1515/JPM.2008.022; WENNERGREN G, 1989, ACTA PAEDIATR SCAND, V78, P11, DOI 10.1111/j.1651-2227.1989.tb10879.x; Wong-Riley MTT, 2013, RESP PHYSIOL NEUROBI, V185, P156, DOI 10.1016/j.resp.2012.05.026; Xia L, 2013, RESP PHYSIOL NEUROBI, V186, P109, DOI 10.1016/j.resp.2013.01.004; Xia LX, 2008, J APPL PHYSIOL, V104, P269, DOI 10.1152/japplphysiol.00721.2007; Xia LX, 2008, RESP PHYSIOL NEUROBI, V164, P358, DOI 10.1016/j.resp.2008.08.002; Xu F, 2003, J APPL PHYSIOL, V94, P1446, DOI 10.1152/japplphysiol.00767.2002; Yoshida Yoshikazu, 2000, American Journal of Medicine, V108, p51S, DOI 10.1016/S0002-9343(99)00342-3; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893; Zhang ZX, 2013, RESP PHYSIOL NEUROBI, V186, P164, DOI 10.1016/j.resp.2013.01.006; Zhao L, 2016, TOXICOL SCI, V153, P103, DOI 10.1093/toxsci/kfw108; Zhao L, 2016, TOXICOL APPL PHARM, V303, P58, DOI 10.1016/j.taap.2016.05.008; Zhao L, 2016, TOXICOL APPL PHARM, V290, P107, DOI 10.1016/j.taap.2015.10.023; Zhuang JG, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12023; Zhuang JG, 2015, AM J PHYSIOL-LUNG C, V308, pL922, DOI 10.1152/ajplung.00241.2014	70	8	8	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4325	4334		10.1096/fj.201700163R	http://dx.doi.org/10.1096/fj.201700163R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28615326	Green Published			2022-12-28	WOS:000413397400012
J	Oskolkova, O; Gawlak, G; Tian, YF; Ke, YB; Sarich, N; Son, S; Andreasson, K; Bochkov, VN; Birukova, AA; Birukov, KG				Oskolkova, Olga; Gawlak, Grzegorz; Tian, Yufeng; Ke, Yunbo; Sarich, Nicolene; Son, Sophia; Andreasson, Katrin; Bochkov, Valery N.; Birukova, Anna A.; Birukov, Konstantin G.			Prostaglandin E receptor-4 receptor mediates endothelial barrier-enhancing and anti-inflammatory effects of oxidized phospholipids	FASEB JOURNAL			English	Article						acute lung injury; vascular permeability; cytoskeleton	LUNG VASCULAR-PERMEABILITY; SIGNALING PATHWAY; DIFFERENTIAL REGULATION; STAPHYLOCOCCUS-AUREUS; PROTECTIVE RESPONSE; OXIDATION-PRODUCTS; GENE-EXPRESSION; S1P(1) RECEPTOR; EP4 RECEPTORS; KNOCKOUT MICE	Unlike other agonists that cause transient endothelial cell (EC) response, the products of 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine (PAPC) oxidation that contain cyclopenthenone groups, which recapitulate prostaglandin-like structure, cause sustained enhancement of the pulmonary EC barrier. The mechanisms that drive the sustained effects by oxidized PAPC (OxPAPC) remain unexplored. On the basis of the structural similarity of iso-prostanoid moieties that are present in full-length oxygenated PAPC species, we used an inhibitory approach to perform the screening of prostanoid receptors as potential candidates that mediate OxPAPC effects. Results show that only prostaglandin E receptor-4 (EP4) was involved and mediated the sustained phase of the barrier-enhancing effects of OxPAPC that are associated with the activation of Rac GTPase and its cytoskeletal targets. EC incubation with OxPAPC also induced EP4 mRNA expression in pulmonary ECs and lung tissue. EP4 knockdown using gene-specific small interfering RNA did not affect the rapid phase of OxPAPC-induced EC barrier enhancement or the protective effects against thrombin-induced EC permeability, but abolished the advanced barrier enhancement phase and suppressed the protective effects of OxPAPC against more sustained EC barrier dysfunction and cell inflammatory response caused by TNF-alpha. Endothelial-specific knockout of the EP4 receptor in mice attenuated the protective effect of intravenous OxPAPC administration in the model of acute lung injury caused by intratracheal injection of LPS. Taken together, these results demonstrate a novel role for prostaglandin receptor EP4 in the mediation of barrier-enhancing and anti-inflammatory effects caused by oxidized phospholipids.	[Oskolkova, Olga; Gawlak, Grzegorz; Tian, Yufeng; Ke, Yunbo; Sarich, Nicolene; Son, Sophia; Birukova, Anna A.; Birukov, Konstantin G.] Univ Chicago, Dept Med, Sect Pulm & Crit Med, Lung Injury Ctr, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Andreasson, Katrin] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Bochkov, Valery N.] Karl Franzens Univ Graz, Dept Pharmaceut Chem, Graz, Austria; [Ke, Yunbo; Birukova, Anna A.] Univ Maryland, Dept Med, Baltimore, MD 21201 USA; [Birukov, Konstantin G.] Univ Maryland, Dept Anesthesiol, Baltimore, MD 21201 USA	University of Chicago; Stanford University; University of Graz; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Birukov, KG (corresponding author), Univ Maryland, Dept Anesthesiol, Baltimore, MD 21201 USA.; Birukov, KG (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol, UMSOM Lung Biol Program, 20 Penn St,HSF 2,Room S145, Baltimore, MD 21201 USA.	kbirukov@anes.umm.edu	Birukov, Konstantin/FJB-5755-2022	Oskolkova, Olga/0000-0001-9443-8705	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [HL076259, HL087823, HL107920, HL130431]; NIH National Institute of General Medical Sciences [GM114171]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL107920, R01HL076259, R01HL107920, R01HL130431, R01HL087823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114171, R01GM122940] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grants HL076259, HL087823, HL107920, and HL130431 and NIH National Institute of General Medical Sciences Grant GM114171. The authors thank Mohan Tulapurkar (University of Maryland, Baltimore, MD, USA), for superior technical assistance and analysis of EP4 expression in lung tissue samples.	Alfranca A, 2006, CARDIOVASC RES, V70, P446, DOI 10.1016/j.cardiores.2005.12.020; Bauer J, 2014, BRIT J PHARMACOL, V171, P3115, DOI 10.1111/bph.12677; Birukov KG, 2004, CIRC RES, V95, P892, DOI 10.1161/01.RES.0000147310.18962.06; Birukova AA, 2006, AM J PATHOL, V168, P1749, DOI 10.2353/ajpath.2006.050431; Birukova AA, 2004, FASEB J, V18, P1879, DOI 10.1096/fj.04-2328com; Birukova AA, 2007, FASEB J, V21, P2776, DOI 10.1096/fj.06-7660com; Birukova AA, 2007, EXP CELL RES, V313, P2504, DOI 10.1016/j.yexcr.2007.03.036; Birukova AA, 2007, AM J PHYSIOL-LUNG C, V293, pL199, DOI 10.1152/ajplung.00020.2007; Birukova AA, 2015, BBA-MOL BASIS DIS, V1852, P778, DOI 10.1016/j.bbadis.2014.12.016; Birukova AA, 2014, MOL BIOL CELL, V25, P2006, DOI 10.1091/mbc.E13-12-0743; Birukova AA, 2013, MOL BIOL CELL, V24, P2678, DOI 10.1091/mbc.E13-02-0098; Birukova AA, 2013, TRANSL RES, V161, P495, DOI 10.1016/j.trsl.2012.12.008; Birukova AA, 2011, EXP CELL RES, V317, P859, DOI 10.1016/j.yexcr.2010.11.011; Birukova AA, 2011, J CELL PHYSIOL, V226, P2052, DOI 10.1002/jcp.22543; Birukova AA, 2009, AM J RESP CELL MOL, V40, P99, DOI 10.1165/rcmb.2008-0099OC; Bochkov VN, 2002, NATURE, V419, P77, DOI 10.1038/nature01023; Bochkov VN, 2002, BLOOD, V99, P199, DOI 10.1182/blood.V99.1.199; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Boniface K, 2009, J EXP MED, V206, P535, DOI 10.1084/jem.20082293; Breyer RM, 2001, ANNU REV PHARMACOL, V41, P661, DOI 10.1146/annurev.pharmtox.41.1.661; Bustos RI, 2008, CURR BIOL, V18, P1606, DOI 10.1016/j.cub.2008.09.019; BUTLER BD, 1989, AM J PHYSIOL, V257, pH1466, DOI 10.1152/ajpheart.1989.257.5.H1466; Cole AL, 2003, ARTERIOSCL THROM VAS, V23, P1384, DOI 10.1161/01.ATV.0000081215.45714.71; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Dejana E, 2009, CELL TISSUE RES, V335, P17, DOI 10.1007/s00441-008-0694-5; Dudek SM, 2004, J BIOL CHEM, V279, P24692, DOI 10.1074/jbc.M313969200; Erridge C, 2008, J BIOL CHEM, V283, P24748, DOI 10.1074/jbc.M800352200; Fu P, 2009, EUR RESPIR J, V33, P612, DOI 10.1183/09031936.00014808; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Goolaerts A, 2011, THORAX, V66, P788, DOI 10.1136/thx.2010.155788; Guo F, 2012, MOL IMMUNOL, V50, P98, DOI 10.1016/j.molimm.2011.12.009; Harding P, 2010, AM J PHYSIOL-HEART C, V298, pH623, DOI 10.1152/ajpheart.00746.2009; Harris ES, 2010, CURR OPIN CELL BIOL, V22, P651, DOI 10.1016/j.ceb.2010.07.006; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Head JA, 2003, MOL BIOL CELL, V14, P3216, DOI 10.1091/mbc.e02-11-0753; HOCKING DC, 1990, CIRC RES, V67, P68, DOI 10.1161/01.RES.67.1.68; Jacobson JR, 2006, AM J PHYSIOL-LUNG C, V291, pL289, DOI 10.1152/ajplung.00343.2005; Kakiashvili E, 2009, J BIOL CHEM, V284, P11454, DOI 10.1074/jbc.M805933200; Khakpour S, 2015, INNATE IMMUN-LONDON, V21, P827, DOI 10.1177/1753425915606525; Kiemer AK, 2002, CIRC RES, V90, P874, DOI 10.1161/01.RES.0000017068.58856.F3; Konya V, 2015, BRIT J PHARMACOL, V172, P4454, DOI 10.1111/bph.13229; Konya V, 2013, PHARMACOL THERAPEUT, V138, P485, DOI 10.1016/j.pharmthera.2013.03.006; Legler DF, 2006, J IMMUNOL, V176, P966, DOI 10.4049/jimmunol.176.2.966; Leitinger N, 1999, P NATL ACAD SCI USA, V96, P12010, DOI 10.1073/pnas.96.21.12010; Li M, 2005, BONE, V37, P46, DOI 10.1016/j.bone.2005.03.016; Li RS, 2006, CIRC RES, V98, P642, DOI 10.1161/01.RES.0000207394.39249.fc; Liang XB, 2011, J CLIN INVEST, V121, P4362, DOI 10.1172/JCI46279; Lorenowicz MJ, 2008, EUR J CELL BIOL, V87, P779, DOI 10.1016/j.ejcb.2008.05.004; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Ma Z, 2004, AM J PHYSIOL-LUNG C, V286, pL808, DOI 10.1152/ajplung.00220.2003; Mammoto T, 2007, J BIOL CHEM, V282, P23910, DOI 10.1074/jbc.M702169200; Meliton AY, 2015, AM J PHYSIOL-LUNG C, V308, pL550, DOI 10.1152/ajplung.00248.2014; Metrich M, 2010, PFLUG ARCH EUR J PHY, V459, P535, DOI 10.1007/s00424-009-0747-y; Minami M, 2008, J BIOL CHEM, V283, P9692, DOI 10.1074/jbc.M709663200; Monvoisin A, 2006, DEV DYNAM, V235, P3413, DOI 10.1002/dvdy.20982; Munoz Nilda M, 2012, Pulm Circ, V2, P182, DOI 10.4103/2045-8932.97604; Nonas S, 2006, AM J RESP CRIT CARE, V173, P1130, DOI 10.1164/rccm.200511-1737OC; Noren NK, 2003, J BIOL CHEM, V278, P13615, DOI 10.1074/jbc.C200657200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ratcliffe MJ, 2007, EUR RESPIR J, V29, P986, DOI 10.1183/09031936.00131606; REGAN JW, 1994, MOL PHARMACOL, V46, P213; Scandella E, 2002, BLOOD, V100, P1354, DOI 10.1182/blood-2001-11-0017; Singleton PA, 2005, FASEB J, V19, P1646, DOI 10.1096/fj.05-3928com; Singleton PA, 2007, J BIOL CHEM, V282, P30643, DOI 10.1074/jbc.M702573200; Singleton PA, 2009, CIRC RES, V104, P978, DOI 10.1161/CIRCRESAHA.108.193367; Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086; Tauseef M, 2008, CIRC RES, V103, P1164, DOI 10.1161/01.RES.0000338501.84810.51; Tian YF, 2015, J BIOL CHEM, V290, P4097, DOI 10.1074/jbc.M114.620377; Vallerie SN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158316; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; Wu TH, 2013, TRANSL RES, V162, P45, DOI 10.1016/j.trsl.2013.03.005; Yagami T, 2016, MOL NEUROBIOL, V53, P4754, DOI 10.1007/s12035-015-9355-3; Yokoyama U, 2013, PHARMACOL REV, V65, P1010, DOI 10.1124/pr.112.007195	74	10	11	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					4187	4202		10.1096/fj.201601232RR	http://dx.doi.org/10.1096/fj.201601232RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28572443	Green Published			2022-12-28	WOS:000408713300040
J	Xiong, MN; Zhu, ZP; Tian, SW; Zhu, RP; Bai, S; Fu, KQ; Davis, JG; Sun, Z; Baur, JA; Zheng, K; Ye, L				Xiong, Mengneng; Zhu, Zhiping; Tian, Suwen; Zhu, Ruping; Bai, Shun; Fu, Kaiqiang; Davis, James G.; Sun, Zheng; Baur, Joseph A.; Zheng, Ke; Ye, Lan			Conditional ablation of Raptor in the male germline causes infertility due to meiotic arrest and impaired inactivation of sex chromosomes	FASEB JOURNAL			English	Article						germ cells; meiosis; sex chromosome silencing; mTOR	DNA-DAMAGE RESPONSE; SYNAPTONEMAL COMPLEX; MAMMALIAN MEIOSIS; MALE-FERTILITY; MOUSE; RAPAMYCIN; MTOR; SYNAPSIS; CELLS; MICE	Rapamycin is a clinically important drug that is used in transplantation and cancer therapy but which causes a number of side effects, including male infertility. Its canonical target, mammalian target of rapamycin complex 1 (mTORC1), plays a key role in metabolism and binds chromatin; however, its precise role in the male germline has not been elucidated. Here, we inactivate the core component, Raptor, to show that mTORC1 function is critical for male meiosis and the inactivation of sex chromosomes. Disruption of the Raptor gene impairs chromosomal synapsis and prevents the efficient spreading of silencing factors into the XY chromatin. Accordingly, mRNA for XY-linked genes remains inappropriately expressed in Raptor-deficient mice. Molecularly, the failure to suppress gene expression corresponded with deficiencies in 2 repressive chromatin markers, H3K9 dimethylation and H3K9 trimethylation, in the XY body. Together, these results demonstrate that mTORC1 has an essential role in the meiotic progression and silencing of sex chromosomes in the male germline, which may explain the infertility that has been associated with such inhibitors as rapamycin.	[Xiong, Mengneng; Zhu, Zhiping; Tian, Suwen; Zhu, Ruping; Bai, Shun; Fu, Kaiqiang; Zheng, Ke; Ye, Lan] Nanjing Med Univ, State Key Lab Reprod Med, 101 Longmian Ave, Nanjing 211166, Jiangsu, Peoples R China; [Davis, James G.; Baur, Joseph A.] Univ Penn, Dept Physiol, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Sun, Zheng] Baylor Coll Med, Houston, TX 77030 USA	Nanjing Medical University; University of Pennsylvania; Pennsylvania Medicine; Baylor College of Medicine	Ye, L (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, 101 Longmian Ave, Nanjing 211166, Jiangsu, Peoples R China.	lanye@njmu.edu.cn			National Natural Science Foundation of China [81471502]; Nanjing Medical University Startup Grant [2013RC03]; Innovative and Entrepreneurial Program of Jiangsu Province; Natural Science Foundation of Jiangsu Province [15KJA180006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nanjing Medical University Startup Grant; Innovative and Entrepreneurial Program of Jiangsu Province; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	The authors thank Jeremy Wang (University of Pennsylvania) for critical reading of this manuscript. The authors also thank David M. Sabatini (Massachusetts Institute of Technology, Boston, MA, USA) and Jeremy Wang for providing RaptorFlox/Flox mice and Neurog3-Cre mice, respectively. The authors thank Fang Yang (University of Pennsylvania) for anti-SYCP2 Abs and technique support for chromosome spread. The authors thank Zhenyi Qiao (Shanghai Biotechnology, Shanghai, China) for analyzing RNA-seq data. This work was funded by the National Natural Science Foundation of China (Grant 81471502), a Nanjing Medical University Startup Grant (2013RC03), the Innovative and Entrepreneurial Program of Jiangsu Province, and the Natural Science Foundation of Jiangsu Province (15KJA180006).	Baarends WM, 2005, MOL CELL BIOL, V25, P1041, DOI 10.1128/MCB.25.3.1041-1053.2005; Bailis JM, 1998, GENE DEV, V12, P3551, DOI 10.1101/gad.12.22.3551; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Bandhakavi S, 2010, MOL CELL PROTEOMICS, V9, P403, DOI 10.1074/mcp.M900326-MCP200; Barchi M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000076; BELLVE AR, 1993, METHOD ENZYMOL, V225, P84; Beuvink I, 2005, CELL, V120, P747, DOI 10.1016/j.cell.2004.12.040; Blattler SM, 2012, CELL METAB, V15, P505, DOI 10.1016/j.cmet.2012.03.008; Broering TJ, 2014, J CELL BIOL, V205, P663, DOI 10.1083/jcb.201311050; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Burgoyne PS, 2009, NAT REV GENET, V10, P207, DOI 10.1038/nrg2505; Busada Jonathan T, 2015, Dev Biol, V407, P90, DOI 10.1016/j.ydbio.2015.08.004; Chaveroux C, 2013, CELL METAB, V17, P586, DOI 10.1016/j.cmet.2013.03.003; Chow JC, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000604; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; de Vries FAT, 2005, GENE DEV, V19, P1376, DOI 10.1101/gad.329705; Dominick G, 2017, AGING CELL, V16, P52, DOI 10.1111/acel.12525; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; FAWCETT DW, 1956, J BIOPHYS BIOCHEM CY, V2, P403, DOI 10.1083/jcb.2.4.403; Feng LX, 2000, J BIOL CHEM, V275, P25572, DOI 10.1074/jbc.M002218200; Fernandez-Capetillo O, 2003, DEV CELL, V4, P497, DOI 10.1016/S1534-5807(03)00093-5; Fraenkel M, 2008, DIABETES, V57, P945, DOI 10.2337/db07-0922; Guo F, 2013, LEUKEMIA, V27, P2040, DOI 10.1038/leu.2013.93; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Hobbs RM, 2015, EMBO REP, V16, P467, DOI 10.15252/embr.201439379; Hobbs RM, 2010, CELL, V142, P468, DOI 10.1016/j.cell.2010.06.041; HOLLINGSWORTH NM, 1990, CELL, V61, P73, DOI 10.1016/0092-8674(90)90216-2; Huyghe E, 2007, TRANSPL INT, V20, P305, DOI 10.1111/j.1432-2277.2006.00423.x; Ichijima Y, 2011, GENE DEV, V25, P959, DOI 10.1101/gad.2030811; Khalil AM, 2004, P NATL ACAD SCI USA, V101, P16583, DOI 10.1073/pnas.0406325101; Kofman AE, 2012, AGING-US, V4, P279, DOI 10.18632/aging.100451; Kolas NK, 2005, CHROMOSOMA, V114, P92, DOI 10.1007/s00412-005-0334-8; Korhonen HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024821; Kouznetsova A, 2009, J CELL SCI, V122, P2446, DOI 10.1242/jcs.049353; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Mahadevaiah SK, 2008, J CELL BIOL, V182, P263, DOI 10.1083/jcb.200710195; Mahadevaiah SK, 1998, HUM MOL GENET, V7, P715, DOI 10.1093/hmg/7.4.715; MCKEE BD, 1993, CHROMOSOMA, V102, P71, DOI 10.1007/BF00356023; Modzelewski AJ, 2012, DEV CELL, V23, P251, DOI 10.1016/j.devcel.2012.07.003; MOSES MJ, 1956, J BIOPHYS BIOCHEM CY, V2, P215, DOI 10.1083/jcb.2.2.215; Odorisio T, 1996, DEV BIOL, V180, P336, DOI 10.1006/dbio.1996.0305; Page SL, 2004, ANNU REV CELL DEV BI, V20, P525, DOI 10.1146/annurev.cellbio.19.111301.155141; Pelttari J, 2001, MOL CELL BIOL, V21, P5667, DOI 10.1128/MCB.21.16.5667-5677.2001; Perry J, 2001, GENOME RES, V11, P1826, DOI 10.1101/gr.203001; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Petukhova GV, 2005, NAT STRUCT MOL BIOL, V12, P449, DOI 10.1038/nsmb923; Royo H, 2013, GENE DEV, V27, P1484, DOI 10.1101/gad.219477.113; Royo H, 2010, CURR BIOL, V20, P2117, DOI 10.1016/j.cub.2010.11.010; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Schalk JAC, 1998, CHROMOSOMA, V107, P540, DOI 10.1007/s004120050340; Schell C, 2016, AM J PATHOL, V186, P324, DOI 10.1016/j.ajpath.2015.10.012; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Shiu PKT, 2001, CELL, V107, P905, DOI 10.1016/S0092-8674(01)00609-2; Shor B, 2010, J BIOL CHEM, V285, P15380, DOI 10.1074/jbc.M109.071639; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; Tanwar PS, 2012, HUM MOL GENET, V21, P4394, DOI 10.1093/hmg/dds272; Tsubouchi T, 2008, GENE DEV, V22, P3217, DOI 10.1101/gad.1709408; Turner JMA, 2015, ANNU REV GENET, V49, P395, DOI 10.1146/annurev-genet-112414-055145; Turner JMA, 2005, NAT GENET, V37, P41, DOI 10.1038/ng1484; Turner JMA, 2004, CURR BIOL, V14, P2135, DOI 10.1016/j.cub.2004.11.032; Wang PJ, 2005, HUM MOL GENET, V14, P2911, DOI 10.1093/hmg/ddi322; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yan W, 2009, EPIGENETICS-US, V4, P452, DOI 10.4161/epi.4.7.9923; Yang F, 2008, GENE DEV, V22, P682, DOI 10.1101/gad.1613608; Yang F, 2008, J CELL BIOL, V180, P673, DOI 10.1083/jcb.200709057; Yang F, 2006, J CELL BIOL, V173, P497, DOI 10.1083/jcb.200603063; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; Zheng K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003038; Zheng K, 2010, P NATL ACAD SCI USA, V107, P11841, DOI 10.1073/pnas.1003953107; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	71	12	12	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3934	3949		10.1096/fj.201700251R	http://dx.doi.org/10.1096/fj.201700251R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28490482				2022-12-28	WOS:000408713300020
J	Flier, JS; Loscalzo, J				Flier, Jeffrey S.; Loscalzo, Joseph			Categorizing biomedical research: the basics of translation	FASEB JOURNAL			English	Article						research classification; research quality; disease research	IMPACT	As biomedical research has evolved over the past century, the terminology employed to categorize it has failed to evolve in parallel to accommodate the implications of these changes. In particular, the terms basic research and translational research as used today in biomedicine seem especially problematic. Here we review the origins of these terms, analyze some of the conceptual confusions attendant to their current use, and assess some of the deleterious consequences of these confusions. We summarize that the distinction between basic and translational biomedical research is an anachronism. Elimination of this often contentious distinction would improve both the culture and the effectiveness of the scientific process, and its potential benefits to society.	[Flier, Jeffrey S.] Harvard Med Sch, Dept Neurobiol, 200 Longwood Ave,Goldenson 542, Boston, MA 02115 USA; [Flier, Jeffrey S.; Loscalzo, Joseph] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Flier, Jeffrey S.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Loscalzo, Joseph] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital	Flier, JS (corresponding author), Harvard Med Sch, Dept Neurobiol, 200 Longwood Ave,Goldenson 542, Boston, MA 02115 USA.; Loscalzo, J (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	jeffrey_flier@hms.harvard.edu; jloscalzo@rics.bwh.harvard.edu	Flier, jeffrey/AAG-6223-2019; Loscalzo, Joseph/ABD-8980-2021		U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [HL61795, HL119145]; NIH National Institute of General Medical Sciences [GM 107618]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL061795, U54HL119145, R01HL061795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107618] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in part, by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grants HL61795, HL119145, and NIH National Institute of General Medical Sciences Grant GM 107618 (to J.L.). The authors thank Stephanie Tribuna (Brigham and Women's Hospital) for expert secretarial assistance.	Alberts B, 2014, P NATL ACAD SCI USA, V111, P5773, DOI 10.1073/pnas.1404402111; Birks J. B., 1962, RUTHERFORD MANCHESTE, P108; Cohrs RJ, 2015, NEW HORIZ TRANSL MED, V2, P86, DOI 10.1016/j.nhtm.2014.12.002; COMROE JH, 1978, SCIENCE, V200, P931, DOI 10.1126/science.644335; Fang FC, 2010, INFECT IMMUN, V78, P563, DOI 10.1128/IAI.01318-09; Kirschner M, 2013, SCIENCE, V340, P1265, DOI 10.1126/science.1240456; Levenson T., 2016, THEBOSTONGLOBE; Loscalzo J, 2014, NEW ENGL J MED, V370, P1756, DOI 10.1056/NEJMcibr1402199; Loscalzo J, 2012, NEW ENGL J MED, V367, P1954, DOI 10.1056/NEJMcibr1205363; Loscalzo J, 2011, CIRCULATION, V123, P947, DOI 10.1161/CIRCULATIONAHA.111.020529; Ridley M., 2015, WALL STREET J; Rowlett P, 2011, NATURE, V475, P166, DOI 10.1038/475166a; Zoghbi HY, 2013, SCIENCE, V339, P250, DOI 10.1126/science.1234799	13	4	4	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3210	3215		10.1096/fj.201700303R	http://dx.doi.org/10.1096/fj.201700303R			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28765169	Green Published			2022-12-28	WOS:000405932400002
J	Adam, M; Heikela, H; Sobolewski, C; Portius, D; Maki-Jouppila, J; Mehmood, A; Adhikari, P; Esposito, I; Elo, LL; Zhang, FP; Ruohonen, ST; Strauss, L; Foti, M; Poutanen, M				Adam, Marion; Heikelae, Hanna; Sobolewski, Cyril; Portius, Dorothea; Maki-Jouppila, Jenni; Mehmood, Arfa; Adhikari, Prem; Esposito, Irene; Elo, Laura L.; Zhang, Fu-Ping; Ruohonen, Suvi T.; Strauss, Leena; Foti, Michelangelo; Poutanen, Matti			Hydroxysteroid (17 beta) dehydrogenase 13 deficiency triggers hepatic steatosis and inflammation in mice	FASEB JOURNAL			English	Article						liver; steatohepatitis; lipid droplet	FATTY LIVER-DISEASE; GENOME-WIDE ASSOCIATION; LIPID DROPLET PROTEINS; MICROVESICULAR STEATOSIS; EXPRESSION ANALYSIS; GENE; BIOLOGY; BIOCONDUCTOR; DIVERSITY; HORMONE	Hydroxysteroid (17(3) dehydrogenases (HSD17Bs) form an enzyme family characterized by their ability to catalyze reactions in steroid and lipid metabolism. In the present study, we characterized the phenotype of HSD17B13-knockout (HSD17B13KO) mice deficient in Hsd1 7b13. In these studies, hepatic steatosis was detected in HSD17B13KO male mice, indicated by histologic analysis and by the increased triglyceride concentration in the liver, whereas reproductive performance and serum steroid concentrations were normal in HSD17B13KO mice. In line with these changes, the expression of key proteins in fatty acid synthesis, such as FAS, acetyl-CoA carboxylase 1, and SCD1, was increased in the HSD17B13KO liver. Furthermore, the knockout liver showed an increase in 2 acylcamitines, suggesting impaired mitochondrial beta-oxidation in the presence of unaltered malonyl CoA and AMPK expression. The glucose tolerance did not differ between wild-type and HSD17B13KO mice in the presence of lower levels of glucose 6-phosphatase in HSD17B13KO liver compared with wild-type liver. Furthermore, microgranulomas and increased portal inflammation together with up-regulation of immune response genes were observed in HSD17B13KO mice. Our data indicate that disruption of Hsdl7b13 impairs hepatic-lipid metabolism in mice, resulting in liver steatosis and inflammation, but the enzyme does not play a major role in the regulation of reproductive functions.	[Adam, Marion; Heikelae, Hanna; Maki-Jouppila, Jenni; Mehmood, Arfa; Adhikari, Prem; Zhang, Fu-Ping; Ruohonen, Suvi T.; Strauss, Leena; Poutanen, Matti] Univ Turku, Inst Biomed, Res Ctr Integrat Physiol & Pharmacol, Turku Ctr Dis Modeling, Turku, Finland; [Sobolewski, Cyril; Portius, Dorothea; Foti, Michelangelo] Ctr Med Univ Geneva, Dept Cell Physiol & Metab, Fac Med, Off C05-2138-A,Rue Michel Servet 1, CH-1211 Geneva 4, Switzerland; [Mehmood, Arfa; Elo, Laura L.] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Mehmood, Arfa; Elo, Laura L.] Abo Akad Univ, Turku, Finland; [Esposito, Irene] Tech Univ Munich, Inst Pathol, Munich, Germany; [Poutanen, Matti] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Internal Med, Gothenburg, Sweden	University of Turku; University of Geneva; University of Turku; Abo Akademi University; Technical University of Munich; University of Gothenburg	Foti, M (corresponding author), Ctr Med Univ Geneva, Dept Cell Physiol & Metab, Fac Med, Off C05-2138-A,Rue Michel Servet 1, CH-1211 Geneva 4, Switzerland.; Poutanen, M (corresponding author), Univ Turku, Res Ctr Integrat Physiol & Pharmacol, Inst Biomed, Kiinamyllynkatu 10, FIN-20520 Turku, Finland.	michelangevlo.foti@unige.ch; matti.poutanen@utu.fi	Poutanen, Matti/I-1700-2018; Strauss, Leena/AAY-8824-2021; Sobolewski, Cyril/ABA-8197-2021; Elo, Laura/A-9449-2015	Poutanen, Matti/0000-0002-8953-1734; Sobolewski, Cyril/0000-0002-9404-6290; Elo, Laura/0000-0001-5648-4532; Foti, Michelangelo/0000-0001-7199-4135	German Academic Exchange Service; Academy of Finland; Novo Nordisk Foundation; Sigrid Juselius Foundation; Swiss National Science Foundation [310030_172862]	German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Academy of Finland(Academy of Finland); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The authors thank Gilles Mithieux and Fabienne Rajas (University of Lyon, INSERM U1213 Lyon, France) for providing G6pase antibody for this study and N. Messner, H. Niittymaki, K. Hovirinta, H. Liljenback, A. Junnila, A. Hakkarainen, T. Kirjonen, J. Palmu, M. Niiranen, E. Nyman, M.-R. Kajaala, K. Asp, and M. Leppiaho (all from the University of Turku) for technical assistance. The study was supported by a fellowship within the Postdoctoral-Programme of the German Academic Exchange Service (to M. A.); the Academy of Finland, Novo Nordisk Foundation, and the Sigrid Juselius Foundation (to M.P.); and Swiss National Science Foundation Grant 310030_172862 (to M.F.). The authors declare no conflicts of interest.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; Cao JS, 2014, AM J PHYSIOL-ENDOC M, V306, pE1176, DOI 10.1152/ajpendo.00666.2013; Carr RM, 2016, EXP CELL RES, V340, P187, DOI 10.1016/j.yexcr.2015.10.021; Carter-Kent C, 2011, J PEDIATR GASTR NUTR, V52, P190, DOI 10.1097/MPG.0b013e3181fb47d3; Chai ZL, 2003, ENDOCRINOLOGY, V144, P2084, DOI 10.1210/en.2002-221030; Crunk AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067631; DiStefano MT, 2015, J BIOL CHEM, V290, P15175, DOI 10.1074/jbc.M115.650184; Edelman D, 2015, MOL GENET GENOM MED, V3, P558, DOI 10.1002/mgg3.168; Ellis PJI, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-49; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fotbolcu H, 2016, WORLD J GASTROENTERO, V22, P4079, DOI 10.3748/wjg.v22.i16.4079; Gai ZB, 2016, J BIOL CHEM, V291, P2397, DOI 10.1074/jbc.M115.694323; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goh GBB, 2015, BBA CLIN, V3, P141, DOI 10.1016/j.bbacli.2014.09.001; HAAVISTO AM, 1993, ENDOCRINOLOGY, V132, P1687, DOI 10.1210/en.132.4.1687; Hijmans BS, 2017, HEPATOLOGY, V66, P2042, DOI 10.1002/hep.29389; Horiguchi Y, 2008, BIOCHEM BIOPH RES CO, V370, P235, DOI 10.1016/j.bbrc.2008.03.063; HUHTANIEMI I, 1985, J CLIN ENDOCR METAB, V61, P698, DOI 10.1210/jcem-61-4-698; Ibrahim SH, 2016, DIGEST DIS SCI, V61, P1325, DOI 10.1007/s10620-015-3977-1; Jokela H, 2010, ENDOCRINOLOGY, V151, P1884, DOI 10.1210/en.2009-0928; Jolly Robert A, 2004, Toxicol Pathol, V32 Suppl 2, P19, DOI 10.1080/01926230490451699; Kahali B, 2015, SEMIN LIVER DIS, V35, P375, DOI 10.1055/s-0035-1567870; Kainuma M, 2006, J GASTROENTEROL, V41, P971, DOI 10.1007/s00535-006-1883-1; Kanth VVR, 2016, WORLD J HEPATOL, V8, P827, DOI 10.4254/wjh.v8.i20.827; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Liu S, 2007, ACTA BIOCHIM POL, V54, P213, DOI 10.18388/abp.2007_3289; Ma SZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep07633; Mashek DG, 2015, HEPATOLOGY, V62, P964, DOI 10.1002/hep.27839; Meli R, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00177; Mikolasevic I, 2016, WORLD J GASTROENTERO, V22, P9488, DOI 10.3748/wjg.v22.i43.9488; Mindnich J, 2009, MOL CELL ENDOCRINOL, V301, P20, DOI 10.1016/j.mce.2008.12.002; Mindnich R, 2004, MOL CELL ENDOCRINOL, V218, P7, DOI 10.1016/j.mce.2003.12.006; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Mutel E, 2011, J HEPATOL, V54, P529, DOI 10.1016/j.jhep.2010.08.014; Natarajan SK, 2006, J GASTROEN HEPATOL, V21, P1240, DOI 10.1111/j.1440-1746.2006.04313.x; Neuschwander-Tetri BA, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0806-8; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Park Tae-Joon, 2013, Genomics & Informatics, V11, P149, DOI 10.5808/GI.2013.11.3.149; R Development Core Team, 2016, R LANG ENV STAT COMP; Rantakari P, 2010, ENDOCRINOLOGY, V151, P1893, DOI 10.1210/en.2009-0929; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saloniemi T, 2012, J ENDOCRINOL, V212, P27, DOI 10.1530/JOE-11-0315; Schleicher J, 2015, BBA-MOL CELL BIOL L, V1851, P641, DOI 10.1016/j.bbalip.2015.02.004; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Sookoian S, 2015, WORLD J GASTROENTERO, V21, P711, DOI 10.3748/wjg.v21.i3.711; Strable MS, 2010, CRIT REV BIOCHEM MOL, V45, P199, DOI 10.3109/10409231003667500; Su W, 2017, AM J PHYSIOL-ENDOC M, V312, DOI 10.1152/ajpendo.00310.2016; Su W, 2014, P NATL ACAD SCI USA, V111, P11437, DOI 10.1073/pnas.1410741111; Tan JSY, 2014, J GENET GENOMICS, V41, P251, DOI 10.1016/j.jgg.2014.03.003; Tandra S, 2011, J HEPATOL, V55, P654, DOI 10.1016/j.jhep.2010.11.021; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; van Casteren JIJ, 2000, BIOL REPROD, V62, P886, DOI 10.1095/biolreprod62.4.886; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Zhang XL, 2017, PROTEIN CELL, V8, P4, DOI 10.1007/s13238-016-0327-9	58	31	32	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3434	3447		10.1096/fj.201700914R	http://dx.doi.org/10.1096/fj.201700914R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401633				2022-12-28	WOS:000432546000043
J	Smith, HK; Omura, S; Vital, SA; Becker, F; Senchenkova, EY; Kaur, G; Tsunoda, I; Peirce, SM; Gavins, FNE				Smith, Helen K.; Omura, Seiichi; Vital, Shantel A.; Becker, Felix; Senchenkova, Elena Y.; Kaur, Gaganpreet; Tsunoda, Ikuo; Peirce, Shayn M.; Gavins, Felicity N. E.			Metallothionein I as a direct link between therapeutic hematopoietic stem/progenitor cells and cerebral protection in stroke	FASEB JOURNAL			English	Article						brain; cerebrovascular disease; neuroprotectants; ischemia-reperfusion injury	MESENCHYMAL STEM-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; COLONY-STIMULATING FACTOR; INTRAARTERIAL DELIVERY; FUNCTIONAL RECOVERY; IMPROVE RECOVERY; ISCHEMIC-STROKE; CD34(+) CELLS; BRAIN; EXPRESSION	Stroke continues to be a leading cause of death and disability worldwide, yet effective treatments are lacking. Previous studies have indicated that stem-cell transplantation could be an effective treatment. However, little is known about the direct impact of transplanted cells on injured brain tissue. We wanted to help fill this knowledge gap and investigated effects of hematopoietic stem/progenitor cells (HSPCs) on the cerebral microcirculation after ischemia-reperfusion injury (I/RI). Treatment of HSPCs in I/RI for up to 2 wk after cerebral I/RI led to decreased mortality rate, decreased infarct volume, improved functional outcome, reduced microglial activation, and reduced cerebral leukocyte adhesion. Confocal microscopy and fluorescence-activated cell sorting analyses showed transplanted HSPCs emigrate preferentially into ischemic cortex brain parenchyma. We isolated migrated HSPCs from the brain; using RNA sequencing to investigate the transcriptome, we found metallothionein (MT, particularly MT-I) transcripts were dramatically up-regulated. Finally, to confirm the significance of MT, we exogenously administered MT-I after cerebral I/RI and found that it produced neuroprotection in a manner similar to HSPC treatment. These findings provide novel evidence that the mechanism through which HSPCs promote repair after stroke maybe via direct action of HSPC-derived MT-I and could therefore be exploited as a useful therapeutic strategy for stroke.	[Smith, Helen K.; Vital, Shantel A.; Becker, Felix; Senchenkova, Elena Y.; Kaur, Gaganpreet; Gavins, Felicity N. E.] Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Mol & Cellular Physiol, 1501 Kings Highway, Shreveport, LA 71105 USA; [Omura, Seiichi; Tsunoda, Ikuo] Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Microbiol & Immunol, Shreveport, LA 71105 USA; [Tsunoda, Ikuo; Gavins, Felicity N. E.] Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Neurol, Shreveport, LA 71105 USA; [Smith, Helen K.] Weill Cornell Med Coll, Pathol & Lab Med, New York, NY USA; [Omura, Seiichi; Tsunoda, Ikuo] Kindai Univ, Fac Med, Dept Microbiol, Osakasayama, Osaka, Japan; [Becker, Felix] Univ Hosp Muenster, Dept Gen & Visceral Surg, Munster, Germany; [Peirce, Shayn M.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Cornell University; University of Munster; University of Virginia	Gavins, FNE (corresponding author), Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Mol & Cellular Physiol, 1501 Kings Highway, Shreveport, LA 71105 USA.	fgavin@lsuhsc.edu	Gavins, Felicity N. E./AAU-6010-2020; Omura, Seiichi/J-7793-2018; Tsunoda, Ikuo/B-4722-2008	Gavins, Felicity N. E./0000-0001-7008-5423; Omura, Seiichi/0000-0003-4619-9345; Tsunoda, Ikuo/0000-0003-1798-714X; Kaur, Gaganpreet/0000-0003-4633-7218; Peirce, Shayn/0000-0001-5857-5606	U.S. National Institutes of Health/National Heart, Lung, and Blood Institute [HL125572-01A1]; Malcolm Feist Cardiovascular Fellowship program; NIH/National Institute of General Medical Sciences Centers of Biomedical Research Excellence (COBRE) [P30-GM110703]; Japan Society for the Promotion of Science [16H07356]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL125572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110703] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Malcolm Feist Cardiovascular Fellowship program; NIH/National Institute of General Medical Sciences Centers of Biomedical Research Excellence (COBRE); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank R. Jin (Louisiana State University Health Sciences Center-Shreveport) for his help with immunofluorescence staining, U. Cvek (Louisiana State University) for her help with statistical analysis, and P. Kubes (University of Calgary, Calgary, AB, Canada) for the LyZM mice. F.N.E.G. acknowledges the financial support of the U.S. National Institutes of Health/National Heart, Lung, and Blood Institute (HL125572-01A1). H.K.S. and S.O. acknowledge the financial support of the Malcolm Feist Cardiovascular Fellowship program. I.T. was supported by a NIH/National Institute of General Medical Sciences Centers of Biomedical Research Excellence (COBRE) grant (P30-GM110703), and the Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (KAKENHI; 16H07356). The authors declare no conflicts of interest.	[Anonymous], 2011, PRINCIPAL COMPONENT; Banerjee S, 2014, STEM CELL TRANSL MED, V3, P1322, DOI 10.5966/sctm.2013-0178; Chaitanya GV, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-125; Chen JL, 2005, J CEREBR BLOOD F MET, V25, P281, DOI 10.1038/sj.jcbfm.9600034; Chung RS, 2008, J BIOL CHEM, V283, P15349, DOI 10.1074/jbc.M708446200; Cui LL, 2015, STEM CELL RES THER, V6, DOI 10.1186/scrt544; Detante O, 2009, CELL TRANSPLANT, V18, P1369, DOI 10.3727/096368909X474230; Eidizadeh A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144035; England TJ, 2012, STROKE, V43, P405, DOI 10.1161/STROKEAHA.111.636449; Gavins FNE, 2015, J CEREBR BLOOD F MET, V35, P1090, DOI 10.1038/jcbfm.2015.93; Gavins FNE, 2012, FASEB J, V26, P4977, DOI 10.1096/fj.12-205971; Giralt M, 2002, EXP NEUROL, V173, P114, DOI 10.1006/exnr.2001.7772; Goldmacher GV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060049; Gutierrez-Fernandez M, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt159; Hao L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/468748; Honmou O, 2011, BRAIN, V134, P1790, DOI 10.1093/brain/awr063; Horie N, 2011, STEM CELLS, V29, P274, DOI 10.1002/stem.584; Imai Y, 2010, INT J HEMATOL, V91, P569, DOI 10.1007/s12185-010-0555-3; Ito Y, 2013, CURR PHARM BIOTECHNO, V14, P400, DOI 10.2174/1389201011314040003; Janowski M, 2015, STROKE, V46, P2354, DOI 10.1161/STROKEAHA.114.007803; Lee SJ, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-30; Levivier E, 2001, BIOCHEM BIOPH RES CO, V287, P688, DOI 10.1006/bbrc.2001.5652; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; Ma XL, 2013, CURR NEUROVASC RES, V10, P103, DOI 10.2174/1567202611310020003; Mitkari B, 2014, BEHAV BRAIN RES, V259, P50, DOI 10.1016/j.bbr.2013.10.030; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ogawa M, 2001, ANN NY ACAD SCI, V938, P139; Oki K, 2012, STEM CELLS, V30, P1120, DOI 10.1002/stem.1104; Omura S, 2014, CIRC-CARDIOVASC GENE, V7, DOI 10.1161/CIRCGENETICS.114.000505; Paczkowska E, 2005, EUR J HAEMATOL, V75, P461, DOI 10.1111/j.1600-0609.2005.00536.x; Pedersen MO, 2009, BIOFACTORS, V35, P315, DOI 10.1002/biof.44; Prasad K, 2014, STROKE, V45, P3618, DOI 10.1161/STROKEAHA.114.007028; Santos CRA, 2012, IUBMB LIFE, V64, P126, DOI 10.1002/iub.585; Sato F, 2014, CELL IMMUNOL, V292, P85, DOI 10.1016/j.cellimm.2014.10.004; Schwarting S, 2008, STROKE, V39, P2867, DOI 10.1161/STROKEAHA.108.513978; Shyu WC, 2004, CIRCULATION, V110, P1847, DOI 10.1161/01.CIR.0000142616.07367.66; Smith HK, 2015, J NEUROSCI METH, V249, P99, DOI 10.1016/j.jneumeth.2015.04.008; Smith HK, 2015, FASEB J, V29, P2161, DOI 10.1096/fj.14-263160; Smith HK, 2012, FASEB J, V26, P2239, DOI 10.1096/fj.11-195719; Stroemer P, 2009, NEUROREHAB NEURAL RE, V23, P895, DOI 10.1177/1545968309335978; Sun JQ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-219; Swamydas M., 2013, JOVE-J VIS EXP, V77, P50586, DOI DOI 10.3791/50586; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Tatarishvili J, 2014, RESTOR NEUROL NEUROS, V32, P547, DOI 10.3233/RNN-140404; Tornero D, 2013, BRAIN, V136, P3561, DOI 10.1093/brain/awt278; Trendelenburg G, 2002, J NEUROSCI, V22, P5879; Tsunoda I, 2007, BRAIN PATHOL, V17, P45, DOI 10.1111/j.1750-3639.2006.00042.x; Ulyanova T, 2005, BLOOD, V106, P86, DOI 10.1182/blood-2004-09-3417; Vasconcelos-dos-Santos A, 2012, STEM CELL RES, V9, P1, DOI 10.1016/j.scr.2012.02.002; Vital SA, 2016, CIRCULATION, V133, P2169, DOI 10.1161/CIRCULATIONAHA.115.020633; Wei X, 2013, ACTA PHARMACOL SIN, V34, P747, DOI 10.1038/aps.2013.50; WITT PL, 1990, J INTERFERON RES, V10, P393, DOI 10.1089/jir.1990.10.393; Yanagida K, 2017, P NATL ACAD SCI USA, V114, P4531, DOI 10.1073/pnas.1618659114; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Yilmaz G, 2011, STROKE, V42, P806, DOI 10.1161/STROKEAHA.110.597088	55	6	6	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2381	2394		10.1096/fj.201700746R	http://dx.doi.org/10.1096/fj.201700746R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29269399	Green Published, Green Submitted			2022-12-28	WOS:000432528000007
J	Bain, AR; Ainslie, PN; Hoiland, RL; Barak, OF; Drvis, I; Stembridge, M; MacLeod, DM; McEneny, J; Stacey, BS; Tuaillon, E; Marchi, N; De Maudave, AF; Dujic, Z; MacLeod, DB; Bailey, DM				Bain, Anthony R.; Ainslie, Philip N.; Hoiland, Ryan L.; Barak, Otto F.; Drvis, Ivan; Stembridge, Mike; MacLeod, Douglas M.; McEneny, Jane; Stacey, Benjamin S.; Tuaillon, Eduoard; Marchi, Nicola; De Maudave, Alexis Fayd'Herbe; Dujic, Zeljko; MacLeod, David B.; Bailey, Damian M.			Competitive apnea and its effect on the human brain: focus on the redox regulation of blood-brain barrier permeability and neuronal-parenchymal integrity	FASEB JOURNAL			English	Article						hypoxia; hypercapnea; hypertension; cerebral perfusion; free radicals	BREATH-HOLD DIVERS; CEREBRAL OXIDATIVE-METABOLISM; INDUCED ATP RELEASE; NITRIC-OXIDE; S-NITROSOHEMOGLOBIN; EXTREME APNEA; FREE-RADICALS; VITAMIN-C; ALPHA-TOCOPHEROL; HYPOXIA	Static apnea provides a unique model that combines transient hypertension, hypercapnia, and severe hypoxemia. With apnea durations exceeding 5 min, the purpose of the present study was to determine how that affects cerebral free-radical formation and the corresponding implications for brain structure and function. Measurements were obtained before and following a maximal apnea in 14 divers with transcerebral exchange kinetics, measured as the product of global cerebral blood flow (duplex ultrasound) and radial arterial to internal jugular venous concentration differences (a-v(D)). Apnea increased the systemic (arterial) and, to a greater extent, the regional (jugular venous) concentration of the ascorbate free radical, resulting in a shift from net cerebral uptake to output (P < 0.05). Peroxidation (lipid hydroperoxides, LDL oxidation), NO bioactivity, and S100 beta were correspondingly enhanced (P < 0.05), the latter interpreted as minor and not a pathologic disruption of the blood-brain barrier. However, those changes were insufficient to cause neuronal-parenchymal damage confirmed by the lack of change in the a-v(D) of neuron-specific enolase and human myelin basic protein (P > 0.05). Collectively, these observations suggest that increased cerebral oxidative stress following prolonged apnea in trained divers may reflect a functional physiologic response, rather than a purely maladaptive phenomenon.	[Bain, Anthony R.; Ainslie, Philip N.; Hoiland, Ryan L.] Univ British Columbia, Sch Hlth & Exercise Sci, Ctr Heart Lung & Vasc Hlth, Kelowna, BC, Canada; [Bain, Anthony R.] Univ Colorado, Integrat Physiol, Boulder, CO 80309 USA; [Barak, Otto F.; Dujic, Zeljko] Univ Split, Sch Med, Split, Croatia; [Barak, Otto F.] Univ Novi Sad, Fac Med, Novi Sad, Serbia; [Drvis, Ivan] Univ Zagreb, Sch Kinesiol, Zagreb, Croatia; [Stembridge, Mike] Cardiff Metropolitan Univ, Cardiff Ctr Exercise & Hlth, Cardiff, S Glam, Wales; [MacLeod, Douglas M.] Emory Univ, Goizueta Business Sch, Atlanta, GA 30322 USA; [McEneny, Jane] Queens Univ Belfast, Ctr Publ Hlth, Belfast, Antrim, North Ireland; [Stacey, Benjamin S.; Bailey, Damian M.] Univ South Wales, Fac Life Sci & Educ, Neurovasc Res Lab, Glyntaff Campus,Cemetery Rd, Pontypridd CF37 4AT, Glam, Wales; [Tuaillon, Eduoard] Univ Montpellier I, UMR, INSERM, EFS, Montpellier, France; [Marchi, Nicola; De Maudave, Alexis Fayd'Herbe] CNRS, INSERM, Lab Cerebrovasc Mech Brain Disorders, UMR,Dept Neurosci,Inst Funct Genom, Montpellier, France; [MacLeod, David B.] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA	University of British Columbia; University of Colorado System; University of Colorado Boulder; University of Split; University of Novi Sad; University of Zagreb; University of Zagreb, Faculty of Kinesiology; Cardiff Metropolitan University; Emory University; Queens University Belfast; University of South Wales; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Duke University	Bailey, DM (corresponding author), Univ South Wales, Fac Life Sci & Educ, Neurovasc Res Lab, Glyntaff Campus,Cemetery Rd, Pontypridd CF37 4AT, Glam, Wales.	damian.bailey@southwales.ac.uk	Barak, Otto F/E-3771-2016; Bailey, Damian Miles/AAQ-1840-2020; Marchi, Nicola/J-8607-2016	Barak, Otto F/0000-0001-6727-8304; Marchi, Nicola/0000-0001-9124-0226; Fayd'herbe de Maudave, Alexis/0000-0002-0903-1108; Stembridge, Mike/0000-0003-0818-6420; Tuaillon, Edouard/0000-0001-5866-9530; Dujic, Zeljko/0000-0002-6450-0130	Royal Society Wolfson Research Fellow [WM170007]; Higher Education Funding Council of Wales; Physiological Society; Canada Research Chair (CRC); Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant; NSERC postdoctoral fellowship; Autonomic Province of Vojvodina, Serbia [142-451- 2541]; Croatian Science Foundation Grant [IP-2014-09-1937]	Royal Society Wolfson Research Fellow; Higher Education Funding Council of Wales(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Physiological Society; Canada Research Chair (CRC)(Canada Research Chairs); Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC postdoctoral fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Autonomic Province of Vojvodina, Serbia; Croatian Science Foundation Grant	The authors acknowledge the valued technical input/scientific discussions with P. E. James and N. Jones (Cardiff Metropolitan University) and the cheerful cooperation of all participants. D.M.B. is a Royal Society Wolfson Research Fellow (WM170007). This study was funded in part by the Higher Education Funding Council of Wales and The Physiological Society (to D.M.B.). P.N.A. was funded by a Canada Research Chair (CRC) and Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant. A.R.B. was funded through a NSERC postdoctoral fellowship. O.F.B. was also funded by the Autonomic Province of Vojvodina, Serbia (142-451- 2541). D.J., I.D., O.F.B., and P.N.A. were also funded by a Croatian Science Foundation Grant (IP-2014-09-1937). The authors declare no conflicts of interest.	Almutairi MMA, 2016, CELL MOL LIFE SCI, V73, P57, DOI 10.1007/s00018-015-2050-8; Anand N, 2005, CEREBROVASC DIS, V20, P213, DOI 10.1159/000087701; Andersson JPA, 2009, J APPL PHYSIOL, V107, P809, DOI 10.1152/japplphysiol.91434.2008; Bailey DM, 2014, ACTA PHYSIOL, V212, P175, DOI 10.1111/apha.12313; Bailey DM, 2007, FREE RADICAL RES, V41, P182, DOI 10.1080/10715760601028867; Bailey DM, 2017, HIGH ALT MED BIOL, V18, P73, DOI 10.1089/ham.2016.0081; Bailey DM, 2017, CIRCULATION, V135, P166, DOI 10.1161/CIRCULATIONAHA.116.024226; Bailey DM, 2011, J CEREBR BLOOD F MET, V31, P1020, DOI 10.1038/jcbfm.2011.2; Bailey DM, 2009, AM J PHYSIOL-REG I, V297, pR1283, DOI 10.1152/ajpregu.00366.2009; Bailey DM, 2006, FREE RADICAL BIO MED, V40, P591, DOI 10.1016/j.freeradbiomed.2005.09.024; Bain AR, 2017, J CEREBR BLOOD F MET, V37, P3231, DOI 10.1177/0271678X16686093; Bain AR, 2016, J PHYSIOL-LONDON, V594, P5317, DOI 10.1113/JP272404; BARONE FC, 1993, BRAIN RES, V623, P77, DOI 10.1016/0006-8993(93)90012-C; BERGFELD GR, 1992, CARDIOVASC RES, V26, P40, DOI 10.1093/cvr/26.1.40; Bolanos JP, 1999, BBA-BIOENERGETICS, V1411, P415, DOI 10.1016/S0005-2728(99)00030-4; Carassiti D, 2017, NEUROPATHOL APPL NEU; CATIGNANI GL, 1983, CLIN CHEM, V29, P708; Cheng F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106680; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Dadas A, 2016, FLUIDS BARRIERS CNS, V13, DOI 10.1186/s12987-016-0045-y; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dugan L. L, 1999, BASIC NEUROCHEMISTRY; Dunn JF, 1997, ADV EXP MED BIOL, V428, P645; Ellsworth ML, 1995, AM J PHYSIOL-HEART C, V269, pH2155, DOI 10.1152/ajpheart.1995.269.6.H2155; Ewing JF, 1998, FREE RADICAL BIO MED, V25, P621, DOI 10.1016/S0891-5849(98)00083-5; Ezraty B, 2011, EMBO REP, V12, P321, DOI 10.1038/embor.2011.7; Gladwin MT, 2000, P NATL ACAD SCI USA, V97, P11482, DOI 10.1073/pnas.97.21.11482; Gladwin MT, 2004, CIRC RES, V94, P851, DOI 10.1161/01.RES.0000126697.64381.37; Gren M, 2016, BRAIN INJURY, V30, P1226, DOI 10.1080/02699052.2016.1179792; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Heusser K, 2009, HYPERTENSION, V53, P719, DOI 10.1161/HYPERTENSIONAHA.108.127530; Ivancev V, 2007, J PHYSIOL-LONDON, V582, P723, DOI 10.1113/jphysiol.2007.128991; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; Joulia F, 2003, RESP PHYSIOL NEUROBI, V137, P19, DOI 10.1016/S1569-9048(03)00110-1; Kanner AA, 2003, CANCER, V97, P2806, DOI 10.1002/cncr.11409; Kjeld T, 2015, SCAND J MED SCI SPOR, V25, pe253, DOI 10.1111/sms.12309; Kohshi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105006; Lochhead JJ, 2010, J CEREBR BLOOD F MET, V30, P1625, DOI 10.1038/jcbfm.2010.29; MADSEN PL, 1993, J CEREBR BLOOD F MET, V13, P646, DOI 10.1038/jcbfm.1993.83; Matsuo R, 2014, CASE REP NEUROL, V6, P23, DOI 10.1159/000357169; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; MCDOWELL IFW, 1995, ANN CLIN BIOCHEM, V32, P167, DOI 10.1177/000456329503200206; McMahon TJ, 2002, NAT MED, V8, P711, DOI 10.1038/nm718; NEMOTO EM, 1979, STROKE, V10, P44, DOI 10.1161/01.STR.10.1.44; NOUROOZZADEH J, 1994, ANAL BIOCHEM, V220, P403, DOI 10.1006/abio.1994.1357; Pardridge William M, 2005, NeuroRx, V2, P3; Pawloski JR, 2001, NATURE, V409, P622, DOI 10.1038/35054560; Poss WB, 1996, AM J PHYSIOL-LUNG C, V270, pL941, DOI 10.1152/ajplung.1996.270.6.L941; Sorci Guglielmo, 2010, Cardiovasc Psychiatry Neurol, V2010, DOI 10.1155/2010/656481; Sprague RS, 1998, AM J PHYSIOL-HEART C, V275, pH1726, DOI 10.1152/ajpheart.1998.275.5.H1726; Stamler JS, 1997, SCIENCE, V276, P2034, DOI 10.1126/science.276.5321.2034; Steinback CD, 2010, AUTON NEUROSCI-BASIC, V156, P138, DOI 10.1016/j.autneu.2010.05.002; Stembridge M, 2017, EXP PHYSIOL, V102, P1288, DOI 10.1113/EP086429; Sureda A, 2004, FREE RADICAL BIO MED, V37, P1744, DOI 10.1016/j.freeradbiomed.2004.07.033; Theunissen S, 2013, DIVING HYPERB MED, V43, P63; Thiel VE, 2001, ANTIOXID REDOX SIGN, V3, P273, DOI 10.1089/152308601300185223; THURNHAM DI, 1988, CLIN CHEM, V34, P377; VUILLEUMIER JP, 1989, J MICRONUTR ANAL, V5, P25; Wan JD, 2008, P NATL ACAD SCI USA, V105, P16432, DOI 10.1073/pnas.0805779105; Waypa GB, 2010, CIRC RES, V106, P526, DOI 10.1161/CIRCRESAHA.109.206334; Willie CK, 2015, J CEREBR BLOOD F MET, V35, P66, DOI 10.1038/jcbfm.2014.170; Winklewski PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135429; Wolff S. P., 1994, METHOD ENZYMOL, V233, P183; Woodman RJ, 2001, J APPL PHYSIOL, V91, P929, DOI 10.1152/jappl.2001.91.2.929	64	16	16	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2305	2314		10.1096/fj.201701031R	http://dx.doi.org/10.1096/fj.201701031R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29191963				2022-12-28	WOS:000429051400047
J	Hwang, YS; Seo, M; Bang, S; Kim, H; Han, JY				Hwang, Young Sun; Seo, Minseok; Bang, Sohyun; Kim, Heebal; Han, Jae Yong			Transcriptional and translational dynamics during maternal-to-zygotic transition in early chicken development	FASEB JOURNAL			English	Article						aves; early embryo; RNA-seq; intrauterine development	PRIMORDIAL GERM-CELLS; PRIMITIVE STREAK FORMATION; COMPLEMENTARY NORMAL TABLE; GENE-EXPRESSION DATA; PREIMPLANTATION EMBRYOS; GENOME ACTIVATION; XENOPUS-EMBRYOS; MOUSE EMBRYO; 1ST STAGES; CLEAVAGE	Maternal-to-zygotic transition (MZT) is the critical process for the establishment of embryonic identity across vertebrates. During this period, the massive transcriptional activation, called zygotic genome activation (ZGA), is mediated by maternally stored factors, and maternal mRNA clearance by conserved zygotic microRNAs (miRNAs) occurs; however, the important transition in avian species was identified by morphologic perspectives only. In this study, we performed transcriptome analysis to examine the molecular transitions of intrauterine development in chickens. On the basis of coexpression analyses on RNA sequencing data, 2 waves of ZGA-mediated MZT were observed across the early embryonic stages and were associated with transcriptional and translational dynamics. Furthermore, definite transitions were observed according to the distinct developmental characteristics between cleavage and the area pellucida formation period in the functional analysis. Finally, epigenetic modification and the evolutionarily conserved miRNA expression suggest that certain MZT proceeds from Eyal-Giladi and Kochav stage VIII in early chicken development. We expect our study to provide an evolutionary link among vertebrates from the perspective of MZT regulation.	[Hwang, Young Sun; Kim, Heebal; Han, Jae Yong] Seoul Natl Univ, Res Inst Agr & Life Sci, Dept Agr Biotechnol, Seoul, South Korea; [Seo, Minseok; Bang, Sohyun; Kim, Heebal] Seoul Natl Univ, C&K Genom, SNU Res Pk, Seoul, South Korea; [Seo, Minseok] Harvard Med Sch, Channing Div Network Med, Boston, MA USA; [Seo, Minseok] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Kim, Heebal; Han, Jae Yong] Shinshu Univ, Inst Biomed Sci, Minamiminowa, Japan	Seoul National University (SNU); Seoul National University (SNU); Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Shinshu University	Han, JY (corresponding author), Seoul Natl Univ, Res Inst Agr & Life Sci, 1 Gwanak Ro, Seoul 08826, South Korea.	jaehan@snu.ac.kr	Kim, Heebal/A-8889-2016	Kim, Heebal/0000-0003-3064-1303; Hwang, Young Sun/0000-0002-6443-9579	National Research Foundation of Korea - South Korean government [NRF-2015R1A3A2033826]	National Research Foundation of Korea - South Korean government	This work was supported by a National Research Foundation of Korea grant funded by the South Korean government (Grant NRF-2015R1A3A2033826). The authors declare no conflicts of interest.	Akkers RC, 2009, DEV CELL, V17, P425, DOI 10.1016/j.devcel.2009.08.005; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Aoki F, 1997, DEV BIOL, V181, P296, DOI 10.1006/dbio.1996.8466; Aoshima K, 2015, EMBO REP, V16, P803, DOI 10.15252/embr.201439700; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BOUNIOL C, 1995, EXP CELL RES, V218, P57, DOI 10.1006/excr.1995.1130; Dahl JA, 2016, NATURE, V537, P548, DOI 10.1038/nature19360; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; Gilbert I, 2009, MOL REPROD DEV, V76, P762, DOI 10.1002/mrd.21030; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Ihara M, 2011, BIOL REPROD, V84, P944, DOI 10.1095/biolreprod.110.089680; Kendall M.G., 1968, ADV THEORY STAT, V3; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; KOCHAV S, 1980, DEV BIOL, V79, P296, DOI 10.1016/0012-1606(80)90117-7; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee HC, 2016, STEM CELLS DEV, V25, P68, DOI 10.1089/scd.2015.0208; Lee MT, 2014, ANNU REV CELL DEV BI, V30, P581, DOI 10.1146/annurev-cellbio-100913-013027; Lee MT, 2013, NATURE, V503, P360, DOI 10.1038/nature12632; Lee SI, 2011, P NATL ACAD SCI USA, V108, P10426, DOI 10.1073/pnas.1106141108; Lindeman LC, 2011, DEV CELL, V21, P993, DOI 10.1016/j.devcel.2011.10.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lund E, 2009, RNA, V15, P2351, DOI 10.1261/rna.1882009; Mak SS, 2015, ELIFE, V4, DOI 10.7554/eLife.07178; Nagai H, 2015, DEVELOPMENT, V142, P1279, DOI 10.1242/dev.118604; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; Park HJ, 2006, MOL REPROD DEV, V73, P452, DOI 10.1002/mrd.20441; Rengaraj D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-757; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Svoboda P, 2010, EMBO REP, V11, P590, DOI 10.1038/embor.2010.102; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Wu JY, 2016, NATURE, V534, P652, DOI 10.1038/nature18606; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yartseva V, 2015, CURR TOP DEV BIOL, V113, P191, DOI 10.1016/bs.ctdb.2015.07.020	37	9	9	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2004	2011		10.1096/fj.201700955R	http://dx.doi.org/10.1096/fj.201700955R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29212819				2022-12-28	WOS:000429051400022
J	Ampomah, PB; Moraes, LA; Lukman, HM; Lim, LHK				Ampomah, Patrick B.; Moraes, Leonardo A.; Lukman, Hakim M.; Lim, Lina H. K.			Formyl peptide receptor 2 is regulated by RNA mimics and viruses through an IFN-beta-STAT3-dependent pathway	FASEB JOURNAL			English	Article						FPR2; IRF3; innate immunity; IFN signaling	TOLL-LIKE RECEPTORS; DOUBLE-STRANDED-RNA; INFLUENZA-A VIRUS; EPITHELIAL-CELLS; INNATE IMMUNITY; LIPOXIN A(4); IFN-BETA; INFLAMMATION; REPLICATION; RECOGNITION	The regulation of host factors is a key strategy employed by viruses to suppress host defense systems and enhance their propagation; however, the mechanisms that underlie this regulation is still unclear. Formyl peptide receptor 2 (FPR2) recognizes numerous proinflammatory and anti-inflammatory stimuli, and emerging reports indicate elevated levels of FPR2 in several disease conditions. Although studies have implicated FPR2 in a myriad of inflammatory conditions, how viruses exploit this cell-surface receptor to facilitate disease progression remains unknown. In this study, we show that the activation of TLR3 and TLR7 induces the up-regulation of FPR2. We provide evidence that signal transducer and activator of transcription 3 (STAT3) phosphorylation is critical for the induction of FPR2 by double-stranded RNA, but not single-stranded RNA viral mimetics. Use of bone marrow-derived macrophages (BMDMs) from IFN-alpha beta receptor-deficient mice revealed that signaling via the type I IFN-STAT3 pathway is essential for FPR2 induction. We demonstrate that virus infection with enterovirus 71 and H1N1 PR8 influenza virus results in increased FPR2 expression. Inhibition of STAT3 phosphorylation in virus-infected cells repressed the induction of FPR2, which led to a reduction in viral loads. Finally, the absence of FPR2 in murine BMDMs resulted in lower viral loads, which suggests that FPR2 may be important for virus replication. Altogether, our study provides novel insights into how RNA viruses may hijack the immune system to facilitate their replication and survival. Identification of these regulatory elements may be useful in designing therapeutics for inflammatory disease conditions that are associated with elevated levels of FPR2.	[Ampomah, Patrick B.; Moraes, Leonardo A.; Lukman, Hakim M.; Lim, Lina H. K.] Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Physiol, Singapore, Singapore; [Ampomah, Patrick B.; Moraes, Leonardo A.; Lukman, Hakim M.; Lim, Lina H. K.] Natl Univ Singapore, Immunol Program, Life Sci Inst, Singapore, Singapore	National University of Singapore; National University of Singapore	Lim, LHK (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Ctr Life Sci,NUS Immunol Program, Level 3,28 Med Dr 03-06J, Singapore 117456, Singapore.	linalim@nus.edu.sg			Singapore National Medical Research Council [NMRC/CBRG/056/2014]; NUS-SINGA graduate scholarship	Singapore National Medical Research Council(National Medical Research Council, Singapore); NUS-SINGA graduate scholarship	The authors thank Dr. Mauro Perretti (William Harvey Research Institute, London, United Kingdom) and Dr. Magnus Back (Karolinska Institutet, Solna, Sweden) for kindly providing FPR2-deficient mice. The authors thank Dr. Sylvie Alonso and Pei Xuan Lee of the National University of Singapore (NUS) Immunology Program for IFN-alpha b receptordeficient mice. The authors also thank Dr. Esther Koh and Dr. Paul Hutchinson (Life Sciences Institute) for their help and assistance. This study was supported by the Singapore National Medical Research Council (Grant NMRC/CBRG/056/2014; to L.H.K.L.). P.B.A. was supported by a NUS-SINGA graduate scholarship. The authors declare no conflicts of interest.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; [Anonymous], 2013, PAND INFL PREP RESP; Arora S, 2016, CELL DEATH DIFFER, V23, P1243, DOI 10.1038/cdd.2016.19; Bist P, 2013, J IMMUNOL, V191, P4375, DOI 10.4049/jimmunol.1301504; Boehme KW, 2004, J VIROL, V78, P7867, DOI 10.1128/JVI.78.15.7867-7873.2004; BOULAY F, 1990, BIOCHEM BIOPH RES CO, V168, P1103, DOI 10.1016/0006-291X(90)91143-G; Bozinovski S, 2014, J THORAC DIS, V6, P1548, DOI 10.3978/j.issn.2072-1439.2014.08.08; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cattaneo F, 2013, INT J MOL SCI, V14, P7193, DOI 10.3390/ijms14047193; Chen KQ, 2006, J BIOL CHEM, V281, P3651, DOI 10.1074/jbc.M508125200; Courtin N, 2017, ANTIVIR RES, V143, P252, DOI 10.1016/j.antiviral.2017.05.001; Davidson S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4864; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dufton N, 2010, J IMMUNOL, V184, P2611, DOI 10.4049/jimmunol.0903526; Fierro IM, 2003, J IMMUNOL, V170, P2688, DOI 10.4049/jimmunol.170.5.2688; FIORE S, 1992, J BIOL CHEM, V267, P16168; Fitzgerald DC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-130; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gobbetti T, 2014, P NATL ACAD SCI USA, V111, P18685, DOI 10.1073/pnas.1410938111; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Hinkle P. M., 2010, J NEUROIMMUNOL, V300, P25; Hsiao HM, 2014, J IMMUNOL, V193, P4980, DOI 10.4049/jimmunol.1400313; Iribarren P, 2005, FASEB J, V19, P2032, DOI 10.1096/fj.05-4578fje; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Iwasaki A., 2012, NAT REV IMMUNOL, V100, P130; Jensen S, 2012, J VIROL, V86, P2900, DOI 10.1128/JVI.05738-11; Jeon SG, 2007, J ALLERGY CLIN IMMUN, V120, P803, DOI 10.1016/j.jaci.2007.05.030; Kanzler H, 2007, NAT MED, V13, P552, DOI 10.1038/nm1589; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Koltsida O, 2013, EMBO MOL MED, V5, P762, DOI 10.1002/emmm.201201891; Li L, 2015, CELL REP, V10, P654, DOI 10.1016/j.celrep.2015.01.011; Liang TS, 2000, BIOCHEM BIOPH RES CO, V270, P331, DOI 10.1006/bbrc.2000.2416; Liu WC, 2009, J BIOL CHEM, V284, P24006, DOI 10.1074/jbc.M109.025528; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Morita M, 2013, CELL, V153, P112, DOI 10.1016/j.cell.2013.02.027; Nacionales DC, 2007, ARTHRITIS RHEUM, V56, P3770, DOI 10.1002/art.23023; Okemoto K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071932; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Reuter S, 2012, J IMMUNOL, V188, P5123, DOI 10.4049/jimmunol.1101618; Sen N, 2012, P NATL ACAD SCI USA, V109, P600, DOI 10.1073/pnas.1114232109; Sheikh F, 2014, J LEUKOCYTE BIOL, V96, P591, DOI 10.1189/jlb.2A0414-191R; Son KN, 2015, J VIROL, V89, P9383, DOI 10.1128/JVI.01299-15; Sordi R, 2013, INT IMMUNOPHARMACOL, V17, P283, DOI 10.1016/j.intimp.2013.06.010; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tcherniuk S, 2016, J INFECT DIS, V214, P237, DOI 10.1093/infdis/jiw127; Torres D, 2010, J IMMUNOL, V185, P451, DOI 10.4049/jimmunol.0902833; UNAIDS, UNAIDS WORLD AIDS DA; Walther A, 2000, MOL CELL, V5, P831, DOI 10.1016/S1097-2765(00)80323-8; Waris G, 2005, J VIROL, V79, P1569, DOI 10.1128/JVI.79.3.1569-1580.2005; Waris G, 2002, J VIROL, V76, P2721, DOI 10.1128/JVI.76.6.2721-2729.2002; Xiang Y, 2016, AM J CANCER RES, V6, P2599; Yang L, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00138	54	18	18	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1468	1478		10.1096/fj.201700584RR	http://dx.doi.org/10.1096/fj.201700584RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29127186				2022-12-28	WOS:000427246000028
J	Miao, YL; Zhou, CY; Cui, ZK; Zhang, MQ; ShiYang, XY; Lu, YJ; Xiong, B				Miao, Yilong; Zhou, Changyin; Cui, Zhaokang; Zhang, Mianqun; ShiYang, Xiayan; Lu, Yajuan; Xiong, Bo			Postovulatory aging causes the deterioration of porcine oocytes via induction of oxidative stress	FASEB JOURNAL			English	Article						oocyte quality; fertilization capacity; organelle arrangement; cortical granule; ovastacin	LYSOZYME-LIKE PROTEIN; MOUSE EGGS; MEIOTIC MATURATION; CORTICAL GRANULES; HUMAN SPERMATOZOA; MEIOSIS; FERTILIZATION; ACTIVATION; OVASTACIN; DYNAMICS	Negative effects of postovulatory aging on fertilization ability and subsequent embryo development have been reported in rodents; however, the molecular and cellular changes during this process have not been fully defined. Here, we used porcine oocytes, a model that is physiologically and developmentally similar to humans, to explore the molecular mechanisms that underlie how postovulatory aging affects oocyte quality and fertilization capacity. We found that postovulatory aging caused the morphologic change of porcine oocytes by exhibiting the incompact expansion of cumulus cells and an increased occurrence of fragmentation. Aging also impaired oocyte quality by disrupting organelle structures, including the spindle assembly, actin polymerization, and mitochondrial integrity. Moreover, postovulatory aging led to the abnormal distribution of cortical granules and ovastacin, which, in turn, resulted in defective sperm binding and consequently compromised fertilization potential. Of note, we observed that postovulatory aging induced oxidative stress with a high level of reactive oxygen species and apoptotic rate in oocytes, thereby resulting in the deterioration of critical factors in the maintenance of oocyte quality and fertilization capacity. Taken together, our findings demonstrate that postovulatory aging perturbs a variety of molecular and cellular changes in porcine oocytes by inducing oxidative stress.-Miao, Y., Zhou, C., Cui, Z., Zhang, M., ShiYang, X., Lu, Y., Xiong, B. Postovulatory aging causes the deterioration of porcine oocytes via induction of oxidative stress.	[Miao, Yilong; Zhou, Changyin; Cui, Zhaokang; Zhang, Mianqun; ShiYang, Xiayan; Lu, Yajuan; Xiong, Bo] Nanjing Agr Univ, Coll Anim Sci & Technol, 1 Weigang, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Xiong, B (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, 1 Weigang, Nanjing, Jiangsu, Peoples R China.	xiongbo@njau.edu.cn			National Natural Science Foundation of China [31571545]; Natural Science Foundation of Jiangsu Province [BK20150677]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	The authors thank Dr. Jurrien Dean (National Institute of Diabetes and Digestive and Kidney Diseases, U.S. National Institutes of Health, Bethesda, MD, USA) for providing Abs. This work was supported by the National Natural Science Foundation of China (Grant 31571545) and the Natural Science Foundation of Jiangsu Province (Grant BK20150677). The authors declare no conflicts of interest.	Burkart AD, 2012, J CELL BIOL, V197, P37, DOI 10.1083/jcb.201112094; Dai XX, 2017, HUM REPROD, V32, P598, DOI 10.1093/humrep/dew362; Dai XX, 2016, BBA-MOL CELL RES, V1863, P2934, DOI 10.1016/j.bbamcr.2016.09.017; Diaz H, 2004, ZYGOTE, V12, P95, DOI 10.1017/S0967199404002680; Diaz H., 2004, Journal of Submicroscopic Cytology and Pathology, V36, P211; DODSON MG, 1989, J IN VITRO FERTIL EM, V6, P101, DOI 10.1007/BF01130735; DUCIBELLA T, 1990, BIOL REPROD, V43, P870, DOI 10.1095/biolreprod43.5.870; Dumollard R, 2007, CURR TOP DEV BIOL, V77, P21, DOI 10.1016/S0070-2153(06)77002-8; Field CM, 2011, CURR BIOL, V21, pR825, DOI 10.1016/j.cub.2011.07.043; GAO Y, 2016, SCI REP UK, V6; Goud PT, 1999, MOL HUM REPROD, V5, P227, DOI 10.1093/molehr/5.3.227; Herrero MB, 2005, DEV BIOL, V284, P126, DOI 10.1016/j.ydbio.2005.05.008; LONGO FJ, 1981, BIOL REPROD, V25, P399, DOI 10.1095/biolreprod25.2.399; Lord T, 2013, REPRODUCTION, V146, pR217, DOI 10.1530/REP-13-0111; Lord T, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.106450; Lu YJ, 2017, NUCLEIC ACIDS RES, V45, P9388, DOI 10.1093/nar/gkx563; Mandal A, 2003, BIOL REPROD, V68, P1525, DOI 10.1095/biolreprod.102.010108; Miao YL, 2009, HUM REPROD UPDATE, V15, P573, DOI 10.1093/humupd/dmp014; Miao YL, 2017, CELL CYCLE, V16, P536, DOI 10.1080/15384101.2017.1282583; ROTSZTEJN DA, 1991, SEMIN REPROD ENDOCR, V9, P272, DOI 10.1055/s-2007-1019419; SAITO H, 1993, HORM RES, V39, P28, DOI 10.1159/000182754; SATHANATHAN AH, 1994, MICROSC RES TECHNIQ, V27, P145, DOI 10.1002/jemt.1070270208; Schatten H, 2009, ENVIRON MOL MUTAGEN, V50, P620, DOI 10.1002/em.20493; Sun QY, 2009, CELL CYCLE, V8, P2741, DOI 10.4161/cc.8.17.9471; Swann K, 2008, INT J DEV BIOL, V52, P585, DOI 10.1387/ijdb.072530ks; SZOLLOSI D, 1971, AM J ANAT, V130, P209, DOI 10.1002/aja.1001300207; Tarin JJ, 1999, BIOL REPROD, V61, P1347, DOI 10.1095/biolreprod61.5.1347; Wang H, 2017, ONCOTARGET, V8, P38631, DOI 10.18632/oncotarget.16219; Wang T, 2017, AGING-US, V9, P1552, DOI 10.18632/aging.101252; Xiong B, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006580; Xu Z, 1997, BIOL REPROD, V57, P743, DOI 10.1095/biolreprod57.4.743; Zhang MQ, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12396; Zhang MQ, 2017, ONCOTARGET, V8, P1593, DOI 10.18632/oncotarget.13684; Zhang T, 2016, AGING-US, V8, P685, DOI 10.18632/aging.100911	34	44	45	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1328	1337		10.1096/fj.201700908R	http://dx.doi.org/10.1096/fj.201700908R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29109171	Green Published			2022-12-28	WOS:000427246000017
J	Page, MM; Skovso, S; Cen, HN; Chiu, AP; Dionne, DA; Hutchinson, DF; Lim, GE; Szabat, M; Flibotte, S; Sinha, S; Nislow, C; Rodrigues, B; Johnson, JD				Page, Melissa M.; Skovso, Sos; Cen, Haoning; Chiu, Amy P.; Dionne, Derek A.; Hutchinson, Daria F.; Lim, Gareth E.; Szabat, Marta; Flibotte, Stephane; Sinha, Sunita; Nislow, Corey; Rodrigues, Brian; Johnson, James D.			Reducing insulin via conditional partial gene ablation in adults reverses diet-induced weight gain	FASEB JOURNAL			English	Article						obesity; adipose tissue; Ptrf/Cavin; high-fat diet; innate immunity	ADIPOSE-TISSUE; CAVEOLIN-1 EXPRESSION; INDUCED OBESITY; MICE LACKING; RECEPTOR; HYPERINSULINEMIA; RESISTANCE; CONTRIBUTES; RESTRICTION; SENSITIVITY	Excess circulating insulin is associated with obesity in humans and in animal models. However, the physiologic causality of hyperinsulinemia in adult obesity has rightfully been questioned because of the absence of clear evidence that weight loss can be induced by acutely reversing diet-induced hyperinsulinemia. Herein, we describe the consequences of inducible, partial insulin gene deletion in a mouse model in which animals have already been made obese by consuming a high-fat diet. A modest reduction in insulin production/secretion was sufficient to cause significant weight loss within 5 wk, with a specific effect on visceral adipose tissue. This result was associated with a reduction in the protein abundance of the lipodystrophy gene polymerase I and transcript release factor (Ptrf; Cavin) in gonadal adipose tissue. RNAseq analysis showed that reduced insulin and weight loss also associated with a signature of reduced innate immunity. This study demonstrates that changes in circulating insulin that are too fine to adversely affect glucose homeostasis nonetheless exert control over adiposity.	[Page, Melissa M.; Skovso, Sos; Cen, Haoning; Dionne, Derek A.; Hutchinson, Daria F.; Lim, Gareth E.; Szabat, Marta; Johnson, James D.] Univ British Columbia, Life Sci Inst, Diabet Res Grp, Dept Cellular & Physiol Sci, Vancouver, BC, Canada; [Chiu, Amy P.; Flibotte, Stephane; Sinha, Sunita; Nislow, Corey; Rodrigues, Brian] Univ British Columbia, Pharmaceut Sci, Vancouver, BC, Canada; [Page, Melissa M.] Catholic Univ Louvain, Inst Sci Vie, Louvain La Neuve, Belgium; [Lim, Gareth E.] Univ Montreal, CRCHUM, Montreal, PQ, Canada	University of British Columbia; University of British Columbia; Universite Catholique Louvain; Universite de Montreal	Johnson, JD (corresponding author), Univ British Columbia, Vancouver, BC V6T 1Z3, Canada.	james.d.johnson@ubc.ca	Cen, Haoning Howard/GSN-3597-2022; Lim, Gareth/G-9143-2017	Cen, Haoning Howard/0000-0001-8045-1335; Rodrigues, Brian/0000-0002-0129-4261; Page, Melissa/0000-0001-5750-8962; Lim, Gareth/0000-0003-3850-3757; Flibotte, Stephane/0000-0001-9613-7666	Canadian Foundation for Innovation; British Columbia Knowledge Development Foundation; UBC Faculty of Dentistry; Canadian Institutes of Health Research; Canadian Diabetes Association; Canadian Diabetes Association Doctoral Student Research Award; Benzon Foundation Fellowship; Juvenile Diabetes Research Foundation; Michael Smith Foundation for Health Research Postdoctoral Fellowship Awards	Canadian Foundation for Innovation(Canada Foundation for Innovation); British Columbia Knowledge Development Foundation; UBC Faculty of Dentistry; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association; Canadian Diabetes Association Doctoral Student Research Award; Benzon Foundation Fellowship; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Michael Smith Foundation for Health Research Postdoctoral Fellowship Awards	The authors thank Farnaz Taghizadeh and Xiaoke (Betty) Hu [both with the University of British Columbia (UBC)] for assistance with islet isolations, perifusions, and animal work; the UBC Sequencing and Bioinformatics Consortium for RNA sequencing; the UBC Centre for High-Throughput Phenogenomics for micro-CT imaging; and John Schipilow and Dr. Nancy Ford (UBC) for technical support and assistance. The Centre is supported by the Canadian Foundation for Innovation, British Columbia Knowledge Development Foundation, and the UBC Faculty of Dentistry. Financial support was provided by an operating grant from the Canadian Institutes of Health Research; Canadian Diabetes Association postdoctoral fellowship awards (to M.M.P. and M.S.); a Canadian Diabetes Association Doctoral Student Research Award (to A.P.C.); a Benzon Foundation Fellowship (to S.S.); and the Juvenile Diabetes Research Foundation and Michael Smith Foundation for Health Research Postdoctoral Fellowship Awards (to G.E.L.). The authors declare no conflicts of interest.	Alemzadeh R, 1998, J CLIN ENDOCR METAB, V83, P1911, DOI 10.1210/jc.83.6.1911; Alemzadeh R, 2008, METABOLISM, V57, P1597, DOI 10.1016/j.metabol.2008.06.017; Azizi PM, 2015, MOL BIOL CELL, V26, P740, DOI 10.1091/mbc.E14-08-1307; Bartness TJ, 2014, FRONT NEUROENDOCRIN, V35, P473, DOI 10.1016/j.yfrne.2014.04.001; BJORNTORP P, 1978, J LIPID RES, V19, P316; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Boothe T, 2016, MOL METAB, V5, P366, DOI 10.1016/j.molmet.2016.01.009; Boucher J, 2016, DIABETES, V65, P2201, DOI 10.2337/db16-0212; Boucher J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1905; Briand N, 2014, DIABETES, V63, P4032, DOI 10.2337/db13-1961; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; Cheverud JM, 2011, OBESITY, V19, P160, DOI 10.1038/oby.2010.141; Christian M, 2015, ADIPOCYTE, V4, P50, DOI 10.4161/adip.29853; Cohen AW, 2005, DIABETES, V54, P679, DOI 10.2337/diabetes.54.3.679; Czech MP, 2013, DIABETOLOGIA, V56, P949, DOI 10.1007/s00125-013-2869-1; Dror V, 2007, DIABETOLOGIA, V50, P2504, DOI 10.1007/s00125-007-0835-5; Duvillie B, 1997, P NATL ACAD SCI USA, V94, P5137, DOI 10.1073/pnas.94.10.5137; Ebana Y, 2007, J HUM GENET, V52, P220, DOI 10.1007/s10038-006-0102-5; Gray SL, 2010, ENDOCRINOLOGY, V151, P4178, DOI 10.1210/en.2010-0102; Haemmerle G, 2002, J BIOL CHEM, V277, P12946, DOI 10.1074/jbc.M108640200; Harvie MN, 2011, INT J OBESITY, V35, P714, DOI 10.1038/ijo.2010.171; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Jaworski K, 2007, AM J PHYSIOL-GASTR L, V293, pG1, DOI 10.1152/ajpgi.00554.2006; Kang L, 2013, DIABETES, V62, P1888, DOI 10.2337/db12-1502; Kitamura T, 2003, ANNU REV PHYSIOL, V65, P313, DOI 10.1146/annurev.physiol.65.092101.142540; Klemm DJ, 2001, J BIOL CHEM, V276, P28430, DOI 10.1074/jbc.M103382200; Lawson HA, 2011, MAMM GENOME, V22, P197, DOI 10.1007/s00335-010-9313-3; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Lustig RH, 2006, INT J OBESITY, V30, P331, DOI 10.1038/sj.ijo.0803074; Lustig RH, 2016, OBESITY, V24, P453, DOI 10.1002/oby.21371; Ma YJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26242; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Nasteska D, 2014, DIABETES, V63, P2332, DOI 10.2337/db13-1563; Nolan CJ, 2015, DIABETES, V64, P673, DOI 10.2337/db14-0694; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Pocai A, 2005, NATURE, V434, P1026, DOI 10.1038/nature03439; Rosell M, 2014, AM J PHYSIOL-ENDOC M, V306, pE945, DOI 10.1152/ajpendo.00473.2013; Schwingshackl L, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-130; Softic S, 2016, DIABETES, V65, P2187, DOI 10.2337/db16-0213; Svensson Marcus, 2006, Expert Rev Clin Immunol, V2, P759, DOI 10.1586/1744666X.2.5.759; Szabat M, 2010, DIABETOLOGIA, V53, P1680, DOI 10.1007/s00125-010-1758-0; Szabat M, 2016, CELL METAB, V23, P179, DOI 10.1016/j.cmet.2015.10.016; Templeman NM, 2017, CELL REP, V20, P451, DOI 10.1016/j.celrep.2017.06.048; Templeman NM, 2017, J ENDOCRINOL, V232, pR173, DOI [10.1530/JOE-16-0449, 10.1530/joe-16-0449]; Templeman NM, 2015, DIABETOLOGIA, V58, P2392, DOI 10.1007/s00125-015-3676-7; Vetterli L, 2016, J BIOL CHEM, V291, P13063, DOI 10.1074/jbc.M115.707448; Wharton S, 2016, CAN J DIABETES, V40, P184, DOI 10.1016/j.jcjd.2015.07.005; World Health Organization, 2000, WHO TECHN REP SER, V894; Xue B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017386; Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001; Zhu Y, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad6793	53	23	23	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1196	1206		10.1096/fj.201700518R	http://dx.doi.org/10.1096/fj.201700518R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29122848	hybrid, Green Published			2022-12-28	WOS:000427246000008
J	Cooke, D; Ouattara, A; Ables, GP				Cooke, Diana; Ouattara, Amadou; Ables, Gene P.			Dietary methionine restriction modulates renal response and attenuates kidney injury in mice	FASEB JOURNAL			English	Article						5/6 nephrectomy; osmotic homeostasis; ion transport; inflammation; fibrosis	GLOMERULAR-FILTRATION-RATE; SODIUM-CHANNEL ENAC; SERUM CYSTATIN C; URINARY CLUSTERIN; PROTEIN; ALBUMINURIA; DISEASE; TISSUE; MODEL; NEPHROPATHY	Methionine restriction (MR) extends the lifespan across several species, such as rodents, fruit flies, roundworms, and yeast. MR studies have been conducted on various rodent organs, such as liver, adipose tissue, heart, bones, and skeletal muscle, to elucidate its benefits to the healthspan; however, studies of the direct effect of MR on kidneys are lacking. To investigate the renal effects of MR, we used young and aged unilateral nephrectomized and 5/6 nephrectomized (5/6Nx) mice. Our studies indicated that MR mice experienced polydipsia and polyuria compared with control-fed counterparts. Urine albumin, creatinine, albumin-to-creatinine ratio, sulfur amino acids, and electrolytes were reduced in MR mice. Kidneys of MR mice up-regulated genes that are involved in ion transport, such as Aqp2, Scnn1a, and Slc6a19, which indicated a response to maintain osmotic balance. In addition, we identified renoprotective biomarkers that are affected by MR, such as clusterin and cystatin C. Of importance, MR attenuated kidney injury in 5/6Nx mice by down-regulating inflammation and fibrosis mechanisms. Thus, our studies in mice show the important role of kidneys during MR in maintaining osmotic homeostasis. Moreover, our studies also show that the MR diet delays the progression of kidney disease.	[Cooke, Diana; Ouattara, Amadou; Ables, Gene P.] Orentreich Fdn Adv Sci, 855 Route 301, Cold Spring on Hudson, NY 10516 USA		Ables, GP (corresponding author), Orentreich Fdn Adv Sci, 855 Route 301, Cold Spring on Hudson, NY 10516 USA.	gables@orentreich.org			Orentreich Foundation for the Advancement of Science	Orentreich Foundation for the Advancement of Science	This work was funded by the Orentreich Foundation for the Advancement of Science. The authors thank Dr. Arthur Cooper (New York Medical College, Valhalla, NY, USA) and Angela Tremain (Orentreich Foundation for the Advancement of Science) for help in editing the manuscript. The authors declare no conflicts of interest.	Ables GP, 2017, EXP GERONTOL, V94, P83, DOI 10.1016/j.exger.2017.01.012; Ables GP, 2015, SCI REP-UK, V5, DOI 10.1038/srep08886; Andrukhova O, 2014, EMBO J, V33, P229, DOI 10.1002/embj.201284188; Bohmer C, 2005, BIOCHEM J, V389, P745; Brown-Borg Holly M, 2014, Longev Healthspan, V3, P10, DOI 10.1186/2046-2395-3-10; Butterworth MB, 2010, BBA-MOL BASIS DIS, V1802, P1166, DOI 10.1016/j.bbadis.2010.03.010; Cabreiro F, 2013, CELL, V153, P228, DOI 10.1016/j.cell.2013.02.035; Caro P, 2009, REJUV RES, V12, P421, DOI 10.1089/rej.2009.0902; Cheng Q, 2017, BRIT J PHARMACOL, V174, P468, DOI 10.1111/bph.13711; Collins A, 2014, AM J KIDNEY DIS, V63, pE1; Dieterle F, 2010, NAT BIOTECHNOL, V28, P463, DOI 10.1038/nbt.1622; DULLAART RPF, 1993, DIABETES CARE, V16, P483, DOI 10.2337/diacare.16.2.483; Elshorbagy AK, 2010, NUTRITION, V26, P1201, DOI 10.1016/j.nut.2009.09.017; Ferlizza E, 2015, VET J, V204, P73, DOI 10.1016/j.tvjl.2015.01.023; Forney LA, 2017, OBESITY, V25, P730, DOI 10.1002/oby.21806; Gao XA, 2011, KIDNEY INT, V79, P987, DOI 10.1038/ki.2010.539; Gava Agata L, 2012, Int J Physiol Pathophysiol Pharmacol, V4, P167; Ge SW, 2013, CIRC RES, V113, P965, DOI 10.1161/CIRCRESAHA.113.301934; Grant L, 2016, MECH AGEING DEV, V157, P35, DOI 10.1016/j.mad.2016.07.003; Hanukoglu I, 2016, GENE, V579, P95, DOI 10.1016/j.gene.2015.12.061; Hine C, 2015, CELL, V160, P132, DOI 10.1016/j.cell.2014.11.048; Hoerger TJ, 2015, AM J KIDNEY DIS, V65, P403, DOI 10.1053/j.ajkd.2014.09.023; Jheng HF, 2015, DIS MODEL MECH, V8, P1311, DOI 10.1242/dmm.019398; Johnson JI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106014; Kaucsar T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148043; Kujal P, 2008, Cesk Fysiol, V57, P104; Lee BC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4592; Leelahavanichkul A, 2014, AM J PHYSIOL-RENAL, V307, pF939, DOI 10.1152/ajprenal.00025.2013; Maddineni S, 2013, EXP BIOL MED, V238, P392, DOI 10.1177/1535370213477988; Mallipattu SK, 2014, AM J PHYSIOL-RENAL, V306, pF1008, DOI 10.1152/ajprenal.00597.2013; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; Nagasu H, 2012, AM J PHYSIOL-RENAL, V302, pF1402, DOI 10.1152/ajprenal.00459.2011; Ninomiya T, 2009, J AM SOC NEPHROL, V20, P1813, DOI 10.1681/ASN.2008121270; ORENTREICH N, 1993, J NUTR, V123, P269; Ouattara Amadou, 2016, Bone Rep, V5, P33, DOI 10.1016/j.bonr.2016.02.002; Ozcan A, 2012, AM J NEPHROL, V35, P356, DOI 10.1159/000337918; Perrone CE, 2013, EXP GERONTOL, V48, P654, DOI 10.1016/j.exger.2012.07.005; Perrone CE, 2012, J NUTRIGENET NUTRIGE, V5, P132, DOI 10.1159/000339347; Ramalingam A, 2010, AM J PHYSIOL-CELL PH, V299, pC1028, DOI 10.1152/ajpcell.00482.2009; RICHIE JP, 1994, FASEB J, V8, P1302, DOI 10.1096/fasebj.8.15.8001743; Rizzetto F, 2017, RENAL FAILURE, V39, P357, DOI 10.1080/0886022X.2017.1282374; Skrovanek S, 2007, AM J PHYSIOL-REG I, V293, pR1046, DOI 10.1152/ajpregu.00072.2007; Song S, 2009, NEPHROL DIAL TRANSPL, V24, P1157, DOI 10.1093/ndt/gfn626; Tang BQ, 2010, NUTRITION, V26, P1170, DOI 10.1016/j.nut.2009.10.006; Vinken P, 2012, TOXICOL PATHOL, V40, P1049, DOI 10.1177/0192623312444765; Watanabe S, 2017, P JPN ACAD B-PHYS, V93, P1, DOI 10.2183/pjab.93.001; Wolf MTF, 2014, J BIOL CHEM, V289, P35849, DOI 10.1074/jbc.M114.616649; Wolfgram DF, 2017, AM J NEPHROL, V45, P172, DOI 10.1159/000455388; Xiang DJ, 2014, INT J CLIN EXP PATHO, V7, P7172; Zhao LW, 2017, BMC BIOTECHNOL, V17, DOI 10.1186/s12896-017-0368-z	51	21	21	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					693	702		10.1096/fj.201700419R	http://dx.doi.org/10.1096/fj.201700419R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	28970255				2022-12-28	WOS:000425146900014
J	Zhang, BL; Xu, D; She, LL; Wang, ZX; Yang, N; Sun, RB; Zhang, YR; Yan, CX; Wei, QL; Aa, JY; Liu, BL; Wang, GJ; Xie, Y				Zhang, Bangling; Xu, Dan; She, Linlin; Wang, Zixia; Yang, Na; Sun, Runbin; Zhang, Yirui; Yan, Caixia; Wei, Qingli; Aa, Jiye; Liu, Baolin; Wang, Guangji; Xie, Yuan			Silybin inhibits NLRP3 inflammasome assembly through the NAD(+)/SIRT2 pathway in mice with nonalcoholic fatty liver disease	FASEB JOURNAL			English	Article						cytokine; microtubule; alpha-tubulin; ER stress	ACTIVATION; MITOCHONDRIA; SILYMARIN; CELLS; HEPATITIS; SILIBININ; CIRRHOSIS; MARIANUM; TISSUE; MODEL	Silybin is one of the effective, traditional Chinese medicines used as a hepatoprotective agent in nonalcoholic fatty liver disease (NAFLD) therapy worldwide, and the NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome has been recognized as an important factor involved in NAFLD development. However, little is known about the mechanisms of silybin in the regulation of high-fat diet (HFD)-induced liver inflammation. In our study, we found that silybin inhibited endoplasmic reticulum stress and NLRP3 inflammasome activation in the livers of HFD-fed mice and in cultured hepatocytes. Phosphorylation of inositol-requiring enzyme (IRE)1 alpha and eIF2 alpha, expression of thioredoxin-interacting protein and cleaved caspase-1, and release of IL-1 beta were reduced by silybin. In addition, silybin inhibited the approach of calreticulin and translocase of outer membrane 20 (Tom20), prevented assembly of the NLRP3 inflammasome complex, and suppressed the accumulation of acetylated alpha-tubulin in the perinuclear region. Both MEC-17 and sirtuin 2 (SIRT2) were influenced by palmitate and silybin, whereas histone deacetylase 6 was not affected. In addition, supplementing NAD(+) directly or increasing NAD(+) concentration with silybin could maintain the activity of SIRT2. The anti-inflammatory effect of silybin was blocked by SIRT2 silencing or by the SIRT2 inhibitor AGK2, as evidenced by NLRP3/ASC colocalization, AC-alpha-tubulin expression, and IL-1 beta release. These findings indicate that the NAD(+)/SIRT2 pathway is an important mediator through which silybin prevents NLRP3 inflammasome activation during NAFLD.	[Zhang, Bangling; Yang, Na; Sun, Runbin; Zhang, Yirui; Yan, Caixia; Wei, Qingli; Aa, Jiye; Wang, Guangji; Xie, Yuan] China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, State Key Lab Nat Med, Tongjia Xiang 24, Nanjing 210009, Jiangsu, Peoples R China; [She, Linlin; Wang, Zixia; Liu, Baolin] China Pharmaceut Univ, Dept Pharmacol Chinese Mat Med, Jiangsu Key Lab Tradit Chinese Med TCM Evaluat &, Nanjing, Jiangsu, Peoples R China; [Xu, Dan] Nanjing Chia Tai Tianqing Pharmaceut, Res & Dev Ctr, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University; China Pharmaceutical University	Wang, GJ (corresponding author), China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, State Key Lab Nat Med, Tongjia Xiang 24, Nanjing 210009, Jiangsu, Peoples R China.; Xie, Y (corresponding author), China Pharmaceut Univ, Tongjia Xiang 24, Nanjing 210009, Jiangsu, Peoples R China.	guangjiwang@hotmail.com; yuanxie58@yahoo.com		Wang, Guangji/0000-0002-0777-3896	National Natural Science Foundation of China [81673679, 81202590]; Natural Science Foundation of Jiangsu Province of China [BK2012350]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province)	The authors thank the Cellular and Molecular Biology Center of China Pharmaceutical University for assistance with confocal microscopy work and are grateful to Xiao-Nan Ma (China Pharmaceutical University) for her technical help. This work was supported by the National Natural Science Foundation of China (Grants 81673679, 81202590) and the Natural Science Foundation of Jiangsu Province of China (Grant BK2012350). The authors declare no conflicts of interest.	Benetti E, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/678627; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; Csak T, 2011, HEPATOLOGY, V54, P133, DOI 10.1002/hep.24341; Davis-Searles PR, 2005, CANCER RES, V65, P4448, DOI 10.1158/0008-5472.CAN-04-4662; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Dulai PS, 2017, HEPATOLOGY, V65, P1557, DOI 10.1002/hep.29085; Elliott EI, 2015, IMMUNOL REV, V265, P35, DOI 10.1111/imr.12286; FERENCI P, 1989, J HEPATOL, V9, P105, DOI 10.1016/0168-8278(89)90083-4; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Gurung P, 2015, TRENDS MOL MED, V21, P193, DOI 10.1016/j.molmed.2014.11.008; Hawke RL, 2010, J CLIN PHARMACOL, V50, P434, DOI 10.1177/0091270009347475; Huseini HF, 2006, PHYTOTHER RES, V20, P1036, DOI 10.1002/ptr.1988; Jangra A, 2015, BIOL TRACE ELEM RES, V168, P462, DOI 10.1007/s12011-015-0375-7; Li L, 2015, CELL MOL LIFE SCI, V72, P4237, DOI 10.1007/s00018-015-2000-5; Liu HY, 2016, ONCOTARGET, V7, P62503, DOI 10.18632/oncotarget.11526; Lu A, 2015, FEBS J, V282, P435, DOI 10.1111/febs.13133; Man SM, 2015, IMMUNOL REV, V265, P6, DOI 10.1111/imr.12296; Matsuzaka T, 2012, HEPATOLOGY, V56, P2199, DOI 10.1002/hep.25932; Merkwirth C, 2008, CELL, V135, P1165, DOI 10.1016/j.cell.2008.12.005; Mesquita I, 2016, CELL MOL LIFE SCI, V73, P1225, DOI 10.1007/s00018-015-2119-4; MIGUEZ MP, 1994, CHEM-BIOL INTERACT, V91, P51, DOI 10.1016/0009-2797(94)90006-X; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Miyake Y, 2016, NAT CHEM BIOL, V12, P748, DOI 10.1038/nchembio.2140; Mohamed IN, 2014, DIABETOLOGIA, V57, P413, DOI 10.1007/s00125-013-3101-z; OLMSTED JB, 1973, ANNU REV BIOCHEM, V42, P507, DOI 10.1146/annurev.bi.42.070173.002451; Oufi HG, 2014, EUR J PHARMACOL, V730, P36, DOI 10.1016/j.ejphar.2014.02.010; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Serviddio G, 2014, FREE RADICAL BIO MED, V73, P117, DOI 10.1016/j.freeradbiomed.2014.05.002; Sodhi RK, 2010, VASC PHARMACOL, V53, P77, DOI 10.1016/j.vph.2010.06.003; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Szabo G, 2012, J HEPATOL, V57, P642, DOI 10.1016/j.jhep.2012.03.035; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Trappoliere M, 2005, Eur Rev Med Pharmacol Sci, V9, P299; Wan XY, 2016, CAN J GASTROENTEROL, V2016, DOI 10.1155/2016/6489012; Wang LL, 2016, J LIPID RES, V57, P1243, DOI 10.1194/jlr.M067397; Wree A, 2014, J MOL MED, V92, P1069, DOI 10.1007/s00109-014-1170-1; Wu XX, 2012, BIOCHEM PHARMACOL, V84, P1164, DOI 10.1016/j.bcp.2012.08.006; Yang G, 2016, SCI REP-UK, V6, DOI 10.1038/srep24399; Yuan Q, 2015, EUR J PHARMACOL, V764, P554, DOI 10.1016/j.ejphar.2015.07.045; Zhou CC, 2016, BRIT J PHARMACOL, V173, P2352, DOI 10.1111/bph.13513	42	57	64	3	48	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					757	767		10.1096/fj.201700602R	http://dx.doi.org/10.1096/fj.201700602R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	28970254	Bronze			2022-12-28	WOS:000425146900019
J	Chen, J; Xue, J; Ruan, JS; Zhao, J; Tang, BS; Duan, RH				Chen, Jia; Xue, Jin; Ruan, Jingsong; Zhao, Juan; Tang, Beisha; Duan, Ranhui			Drosophila CHIP protects against mitochondrial dysfunction by acting downstream of Pink1 in parallel with Parkin	FASEB JOURNAL			English	Article						Parkinson disease; E3 ubiquitin ligase; CRISPR	E3 UBIQUITIN LIGASE; AUTOPHAGIC CLEARANCE; OXIDATIVE STRESS; ALPHA-SYNUCLEIN; IN-VITRO; DISEASE; MITOPHAGY; DEGRADATION; DEGENERATION; PROTEASOME	Mitochondrial kinase PTEN-induced putative kinase 1 (PINK1) and E3 ubiquitin ligase Parkin function in a common pathway to regulate mitochondrial homeostasis contributing to the pathogenesis of Parkinson disease. The carboxyl terminus of Hsc70-interacting protein (CHIP) acts as a heat shock protein 70/heat shock protein 90 cochaperone to mediate protein folding or as an E3 ubiquitin ligase to target proteins for degradation. In this study, overexpression of Drosophila CHIP suppressed a range of Pink1 mutant phenotypes in flies, including abnormal wing posture, thoracic indentation, locomotion defects, muscle degeneration, and loss of dopaminergic neurons. Mitochondrial defects of Pink1 mutant, such as excessive fusion, reduced ATP content, and crista disorganization, were rescued by CHIP but not its ligase-dead mutants. Similar phenotypes and mitochondrial impairment were ameliorated in Parkin mutant flies by wild-type CHIP. Inactivation of CHIP with null fly mutants resulted in mitochondrial defects, such as reduced thoracic ATP content at 3 d old, decreased thoracic mitochondrial DNA content, and defective mitochondrial morphology at 60 d old. CHIP mutants did not exacerbate the phenotypes of Pink1 mutant flies but markedly shortened the life span of Parkin mutant flies. These results indicate that CHIP is involved in mitochondrial integrity and may act downstream of Pink1 in parallel with Parkin.-Chen, J., Xue, J., Ruan, J., Zhao, J., Tang, B., Duan, R. Drosophila CHIP protects against mitochondrial dysfunction by acting downstream of Pink1 in parallel with Parkin.	[Chen, Jia; Xue, Jin; Ruan, Jingsong; Zhao, Juan; Tang, Beisha; Duan, Ranhui] Cent S Univ, Xiangya Hosp, Sch Life Sci, State Key Lab Med Genet, Changsha, Hunan, Peoples R China; [Tang, Beisha] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha 410008, Hunan, Peoples R China	Central South University; Central South University	Tang, BS (corresponding author), Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha 410008, Hunan, Peoples R China.; Duan, RH (corresponding author), State Key Lab Med Genet, 110 Xiangya Rd, Changsha 410008, Hunan, Peoples R China.	bstang7398@163.com; duanranhui@sklmg.edu.cn			National Natural Science Foundation of China [81571253, 81172513, 81071028]; Doctoral Student Autonomous Exploration Project of Central South University [2015zzts091]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Student Autonomous Exploration Project of Central South University	The authors thank Z. Zhang, K. Xia, C. Tang, T. Zhang, and R. Wang (State Key Laboratory of Medical Genetics) for technical support and valuable comments. The authors thank the Drosophila Stock Center (Indiana University, Bloomington, IN, USA) and the Tsinghua Fly Center (Tsinghua University, Beijing Shi, China) for fly stocks. This work was supported by National Natural Science Foundation of China (Grants 81571253, 81172513, and 81071028) and the Doctoral Student Autonomous Exploration Project of Central South University (Grant 2015zzts091). The authors declare no conflicts of interest.	Arun S, 2016, CURR NEUROPHARMACOL, V14, P143, DOI 10.2174/1570159X13666150703154541; Bras J, 2015, CELL, V160, P570, DOI 10.1016/j.cell.2015.01.019; Cha GH, 2005, P NATL ACAD SCI USA, V102, P10345, DOI 10.1073/pnas.0500346102; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cunningham CN, 2015, NAT CELL BIOL, V17, P160, DOI 10.1038/ncb3097; de Castro IP, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001456; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Duan RH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149039; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Hauser DN, 2013, NEUROBIOL DIS, V51, P35, DOI 10.1016/j.nbd.2012.10.011; Hofmann RM, 2001, J BIOL CHEM, V276, P27936, DOI 10.1074/jbc.M103378200; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Ko HS, 2009, P NATL ACAD SCI USA, V106, P2897, DOI 10.1073/pnas.0810123106; Kumar P, 2007, HUM MOL GENET, V16, P848, DOI 10.1093/hmg/ddm030; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Li HM, 2005, FREE RADICAL RES, V39, P1091, DOI 10.1080/10715760500260348; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Miller VM, 2005, J NEUROSCI, V25, P9152, DOI 10.1523/JNEUROSCI.3001-05.2005; Morishima Y, 2008, HUM MOL GENET, V17, P3942, DOI 10.1093/hmg/ddn296; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Narendra D, 2009, AUTOPHAGY, V5, P706, DOI 10.4161/auto.5.5.8505; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Palubinsky AM, 2015, ANTIOXID REDOX SIGN, V23, P535, DOI 10.1089/ars.2014.6102; Park J, 2009, BIOCHEM BIOPH RES CO, V378, P518, DOI 10.1016/j.bbrc.2008.11.086; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Paul I, 2015, INT J BIOCHEM CELL B, V58, P37, DOI 10.1016/j.biocel.2014.10.027; Paul I, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/918183; Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Ren XJ, 2013, P NATL ACAD SCI USA, V110, P19012, DOI 10.1073/pnas.1318481110; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Singleton A, 2016, NEURON, V90, P1154, DOI 10.1016/j.neuron.2016.05.040; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; Takahashi R, 2003, J NEUROL, V250, P25, DOI 10.1007/s00415-003-1305-8; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Tetzlaff JE, 2008, J BIOL CHEM, V283, P17962, DOI 10.1074/jbc.M802283200; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Urushitani M, 2004, J NEUROCHEM, V90, P231, DOI 10.1111/j.1471-4159.2004.02486.x; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Whitworth AJ, 2011, ADV GENET, V73, P1, DOI 10.1016/B978-0-12-380860-8.00001-X; Wu K, 2014, FASEB J, V28, P5111, DOI 10.1096/fj.14-255802; Xu Z, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-26; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Yung C, 2016, MOL NEUROBIOL, V53, P6270, DOI 10.1007/s12035-015-9537-z; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zhang TM, 2016, J BIOL CHEM, V291, P21616, DOI 10.1074/jbc.M116.733410; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	64	13	13	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5234	5245		10.1096/fj.201700011R	http://dx.doi.org/10.1096/fj.201700011R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28778978				2022-12-28	WOS:000416588300010
J	Yan, MP; Zhang, XH; Chen, A; Gu, W; Liu, J; Ren, XJ; Zhang, JP; Wu, XX; Place, AT; Minshall, RD; Liu, GQ				Yan, Meiping; Zhang, Xinhua; Chen, Ao; Gu, Wei; Liu, Jie; Ren, Xiaojiao; Zhang, Jianping; Wu, Xiaoxiong; Place, Aaron T.; Minshall, Richard D.; Liu, Guoquan			Endothelial cell SHP-2 negatively regulates neutrophil adhesion and promotes transmigration by enhancing ICAM-1-VE-cadherin interaction	FASEB JOURNAL			English	Article						inflammation; lung injury; leukocyte; LPS	TYROSINE-PHOSPHATASE SHP2; CADHERIN-CATENIN COMPLEX; VE-CADHERIN; BARRIER FUNCTION; ADHERENS JUNCTIONS; VASCULAR-PERMEABILITY; IN-VIVO; TRANSENDOTHELIAL MIGRATION; LEUKOCYTE EXTRAVASATION; PULMONARY ENDOTHELIUM	Intercellular adhesion molecule-1 (ICAM-1) mediates the firm adhesion of leukocytes to endothelial cells and initiates subsequent signaling that promotes their transendothelial migration (TEM). Vascular endothelial (VE)-cadherin plays a critical role in endothelial cell-cell adhesion, thereby controlling endothelial permeability and leukocyte transmigration. This study aimed to determine the molecular signaling events that originate from the ICAM-1-mediated firm adhesion of neutrophils that regulate VE-cadherin's role as a negative regulator of leukocyte transmigration. We observed that ICAM-1 interacts with Src homology domain 2-containing phosphatase-2 (SHP-2), and SHP-2 down-regulation via silencing of small interfering RNA in endothelial cells enhanced neutrophil adhesion to endothelial cells but inhibited neutrophil transmigration. We also found that VE-cadherin associated with the ICAM-1-SHP-2 complex. Moreover, whereas the activation of ICAM-1 leads to VE-cadherin dissociation from ICAM-1 and VE-cadherin association with actin, SHP-2 down-regulation prevented ICAM-1-VE-cadherin association and promoted VE-cadherin-actin association. Furthermore, SHP-2 down-regulation in vivo promoted LPS-induced neutrophil recruitment in mouse lung but delayed neutrophil extravasation. These results suggest that SHP-2-via association with ICAM-1-mediates ICAM-1-induced Src activation and modulates VE-cadherin switching association with ICAM-1 or actin, thereby negatively regulating neutrophil adhesion to endothelial cells and enhancing their TEM.	[Yan, Meiping; Zhang, Xinhua; Chen, Ao; Gu, Wei; Liu, Jie; Ren, Xiaojiao; Zhang, Jianping; Wu, Xiaoxiong; Liu, Guoquan] Huazhong Agr Univ, Dept Basic Vet Med, Coll Anim Sci & Vet Med, Wuhan, Hubei, Peoples R China; [Place, Aaron T.; Minshall, Richard D.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL USA; [Minshall, Richard D.] Univ Illinois, Coll Med, Dept Anesthesiol, Chicago, IL 60680 USA	Huazhong Agricultural University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Liu, GQ (corresponding author), Huazhong Agr Univ, Anim Sci & Vet Med, 1 Shizishan St, Wuhan 430070, Hubei, Peoples R China.	liuguoquan@mail.hzau.edu.cn		Wei, Gu/0000-0002-4421-2326; yan, meiping/0000-0002-6851-082X	National Natural Science Foundation of China [31372418]; Huazhong Agricultural University Scientific and Technology Self-innovation Foundation [2012RC011]; Fundamental Research Funds for Central University [2662013PY054]; 948 Project of Chinese Ministry of Agriculture [2015-Z33]; U.S. National Institutes of Health National Heart, Lung, and Blood Institute [R01-HL71626, P01-HL60678]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125356, R01HL071626, P01HL060678] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Huazhong Agricultural University Scientific and Technology Self-innovation Foundation; Fundamental Research Funds for Central University; 948 Project of Chinese Ministry of Agriculture; U.S. National Institutes of Health National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Natural Science Foundation of China (Grant 31372418; to G.L.), the Huazhong Agricultural University Scientific and Technology Self-innovation Foundation (program no. 2012RC011; to G.L.), the Fundamental Research Funds for the Central University (project no. 2662013PY054; to G.L.), the 948 Project of Chinese Ministry of Agriculture (Grant 2015-Z33; to G.L.), and U.S. National Institutes of Health National Heart, Lung, and Blood Institute Grants R01-HL71626 and P01-HL60678 (to R.D.M.). The authors thank Maricela Castellon (University of Illinois at Chicago) for excellent technical assistance. The authors declare no conflicts of interest.	Adamson P, 1999, J IMMUNOL, V162, P2964; Allingham MJ, 2007, J IMMUNOL, V179, P4053, DOI 10.4049/jimmunol.179.6.4053; Angelini DJ, 2006, AM J PHYSIOL-LUNG C, V291, pL1232, DOI 10.1152/ajplung.00109.2006; Bannerman DD, 1998, J BIOL CHEM, V273, P35371, DOI 10.1074/jbc.273.52.35371; Birukova AA, 2012, J CELL PHYSIOL, V227, P3405, DOI 10.1002/jcp.24041; Bixel MG, 2007, BLOOD, V109, P5327, DOI 10.1182/blood-2006-08-043109; Castillo R L, 2015, Open Respir Med J, V9, P83, DOI 10.2174/1874306401509010083; Chichger H, 2015, AM J RESP CELL MOL, V52, P695, DOI 10.1165/rcmb.2013-0489OC; Chichger H, 2015, FASEB J, V29, P868, DOI 10.1096/fj.14-257212; Di Lorenzo A, 2013, J CELL SCI, V126, P5541, DOI 10.1242/jcs.115972; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Giannotta M, 2013, DEV CELL, V26, P441, DOI 10.1016/j.devcel.2013.08.020; Golovkine G, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003939; Gong HX, 2014, J EXP MED, V211, P579, DOI 10.1084/jem.20131190; Gooding JM, 2004, BIOESSAYS, V26, P497, DOI 10.1002/bies.20033; Grinnell KL, 2010, AM J PHYSIOL-LUNG C, V298, pL361, DOI 10.1152/ajplung.00374.2009; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Hamborg M, 2013, PHARM RES-DORDR, V30, P140, DOI 10.1007/s11095-012-0856-8; Hatanaka K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037600; HEIMARK RL, 1990, J CELL BIOL, V110, P1745, DOI 10.1083/jcb.110.5.1745; Hermant B, 2003, J BIOL CHEM, V278, P14002, DOI 10.1074/jbc.M300351200; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Ishiyama N, 2010, CELL, V141, P117, DOI 10.1016/j.cell.2010.01.017; Kustermann S, 2014, TOXICOL SCI, V138, P333, DOI 10.1093/toxsci/kft336; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Liu GQ, 2012, BLOOD, V120, P1942, DOI 10.1182/blood-2011-12-397430; Liu GQ, 2011, ARTERIOSCL THROM VAS, V31, P1342, DOI 10.1161/ATVBAHA.110.222208; Ludwig A, 2011, METHODS MOL BIOL, V763, P319, DOI 10.1007/978-1-61779-191-8_22; Mege RM, 2006, CURR OPIN CELL BIOL, V18, P541, DOI 10.1016/j.ceb.2006.08.004; Miller I, 2002, BLOOD, V99, P2662, DOI 10.1182/blood.V99.8.2662; Muller WA, 2015, CARDIOVASC RES, V107, P310, DOI 10.1093/cvr/cvv145; Oas RG, 2010, CIRC RES, V106, P941, DOI 10.1161/CIRCRESAHA.109.207753; Pluskota E, 2000, J BIOL CHEM, V275, P30029, DOI 10.1074/jbc.M000240200; Purswani MU, 2002, J ANTIMICROB CHEMOTH, V50, P51, DOI 10.1093/jac/dkf091; Qian LW, 2008, J VIROL, V82, P11902, DOI 10.1128/JVI.01042-08; Qu CK, 2000, CELL RES, V10, P279, DOI 10.1038/sj.cr.7290055; Rabiet MJP, 1996, ARTERIOSCL THROM VAS, V16, P488, DOI 10.1161/01.ATV.16.3.488; Roebuck KA, 1999, J LEUKOCYTE BIOL, V66, P876, DOI 10.1002/jlb.66.6.876; Sano H, 1998, BIOCHEM BIOPH RES CO, V250, P694, DOI 10.1006/bbrc.1998.9385; Schulte D, 2011, EMBO J, V30, P4157, DOI 10.1038/emboj.2011.304; Sidibe A, 2014, AM J PHYSIOL-HEART C, V307, pH455, DOI 10.1152/ajpheart.00774.2013; Spindel ON, 2014, CIRC RES, V114, P1125, DOI 10.1161/CIRCRESAHA.114.301315; Su WH, 2002, BLOOD, V100, P3597, DOI 10.1182/blood-2002-01-0303; Timmerman I, 2012, MOL BIOL CELL, V23, P4212, DOI 10.1091/mbc.E12-01-0038; Ukropec JA, 2000, J BIOL CHEM, V275, P5983, DOI 10.1074/jbc.275.8.5983; Wallez Y, 2007, ONCOGENE, V26, P1067, DOI 10.1038/sj.onc.1209855; Wang Q, 2003, J BIOL CHEM, V278, P47731, DOI 10.1074/jbc.M308466200; Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yang JJ, 2015, CELL MOL LIFE SCI, V72, P4849, DOI 10.1007/s00018-015-1973-4; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4	52	11	11	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4759	4769		10.1096/fj.201700280R	http://dx.doi.org/10.1096/fj.201700280R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28701303	Green Published			2022-12-28	WOS:000413398500009
J	Pein, H; Koeberle, SC; Voelkel, M; Schneider, F; Rossi, A; Thurmer, M; Loeser, K; Sautebin, L; Morrison, H; Werz, O; Koeberle, A				Pein, Helmut; Koeberle, Solveigh C.; Voelkel, Maria; Schneider, Freya; Rossi, Antonietta; Thuermer, Maria; Loeser, Konstantin; Sautebin, Lidia; Morrison, Helen; Werz, Oliver; Koeberle, Andreas			Vitamin A regulates Akt signaling through the phospholipid fatty acid composition	FASEB JOURNAL			English	Article						bioactive lipid; lipidomics; phosphatidylcholine; kinase; retinoic acid	TRANS-RETINOIC ACID; PHOSPHOINOSITIDE 3-KINASE/AKT PATHWAY; INDUCED DIFFERENTIATION; ACYLTRANSFERASE 3; DEFICIENT RATS; LINOLEIC-ACID; CELLS; METABOLISM; GROWTH; IDENTIFICATION	Protein kinases, including the serine/threonine kinase Akt, mediate manifold bioactivities of vitamin A, although the mechanisms behind the sustained kinase activation are diffuse. To investigate the role of cellular lipids as targetable factors in Akt signaling, we combined mass spectrometry-based lipidomics with immunologic detection of Akt (Ser473) phosphorylation. A screening campaign revealed retinol (vitamin A alcohol) and all-trans retinoic acid (vitamin A acid) (RA) as hits that time-dependently (>= 24 h) deplete phosphatidylcholine-bound polyunsaturated fatty acids (PUFA-PCs) from NIH-3T3 mouse fibroblasts while inducing Akt activation (EC50 approximate to 0.1-1 mu M). Other mitogenic and stress-regulated kinases were hardly affected. Organized in a coregulated phospholipid subcluster, PUFA-PCs compensated for the RA-induced loss of cellular PUFA-PCs and diminished Akt activation when supplemented. The counter-regulation of phospholipids and Akt by RA was mimicked by knockdown of lysophosphatidylcholine acyltransferase-3 or the selective retinoid X receptor (RXR) agonist bexarotene and prevented by the selective RXR antagonist Hx531. Treatment of mice with retinol decreased the tissue ratio of PUFA-PC and enhanced basal Akt activation preferentially in brain, which was attributed to astrocytes in dissociated cortical cultures. Together, our findings show that RA regulates the long-term activation of Akt by changes in the phospholipid composition.Pein, H., Koeberle, S. C., Voelkel, M., Schneider, F., Rossi, A., Thurmer, M., Loeser, K., Sautebin, L., Morrison, H., Werz, O., Koeberle, A. Vitamin A regulates Akt signaling through the phospholipid fatty acid composition.	[Pein, Helmut; Voelkel, Maria; Schneider, Freya; Thuermer, Maria; Loeser, Konstantin; Werz, Oliver; Koeberle, Andreas] Friedrich Schiller Univ, Inst Pharm, Philosophenweg 14, D-07743 Jena, Germany; [Koeberle, Solveigh C.; Morrison, Helen] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Rossi, Antonietta; Sautebin, Lidia] Univ Naples Federico II, Sch Med, Dept Pharm, Naples, Italy	Friedrich Schiller University of Jena; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Naples Federico II	Koeberle, A (corresponding author), Friedrich Schiller Univ, Inst Pharm, Philosophenweg 14, D-07743 Jena, Germany.	andreas.koeberle@uni-jena.de	Morrison, Helen/F-9748-2014; Koeberle, Andreas/ABB-2356-2020	Morrison, Helen/0000-0003-4938-1409; Koeberle, Andreas/0000-0001-6269-5088; Koeberle, Solveigh/0000-0002-8008-494X; Antonietta, Rossi/0000-0002-3237-2584	German Research Council [GRK 1715, KO 4589/4-1]; Phospholipid Research Center Heidelberg (Heidelberg, Germany)	German Research Council(German Research Foundation (DFG)); Phospholipid Research Center Heidelberg (Heidelberg, Germany)	This work was supported by the German Research Council (GRK 1715; KO 4589/4-1) and the Phospholipid Research Center Heidelberg (Heidelberg, Germany). The authors declare no conflicts of interest.	Bastien J, 2006, ONCOGENE, V25, P2040, DOI 10.1038/sj.onc.1209241; Bavelloni A, 2014, FASEB J, V28, P2009, DOI 10.1096/fj.13-244368; Beaudoin GMJ, 2012, NAT PROTOC, V7, P1741, DOI 10.1038/nprot.2012.099; Ben-Sasson H, 2011, FERTIL STERIL, V95, P2080, DOI 10.1016/j.fertnstert.2011.01.155; Carta G, 2014, NUTRIENTS, V6, P1262, DOI 10.3390/nu6031262; Chidester E., 1930, ANAT REC, V47, P304; Chidester F E, 1932, Science, V76, P436, DOI 10.1126/science.76.1976.436; Conaway HH, 2013, ENDOCR REV, V34, P766, DOI 10.1210/er.2012-1071; Dal Col J, 2012, CANCER RES, V72, P1825, DOI 10.1158/0008-5472.CAN-11-2505; del Rincon SV, 2003, ONCOGENE, V22, P3353, DOI 10.1038/sj.onc.1206485; di Masi A, 2015, MOL ASPECTS MED, V41, P1, DOI 10.1016/j.mam.2014.12.003; ECKHOFF C, 1991, J NUTR, V121, P1016, DOI 10.1093/jn/121.7.1016; Endersby R, 2011, CANCER RES, V71, P4106, DOI 10.1158/0008-5472.CAN-10-3597; Finsterwald C, 2015, CURR PHARM DESIGN, V21, P3570, DOI 10.2174/1381612821666150710144502; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; Huang PX, 2014, CHEM REV, V114, P233, DOI 10.1021/cr400161b; HUNT TK, 1986, J AM ACAD DERMATOL, V15, P817, DOI 10.1016/S0190-9622(86)70238-7; Ishida S, 2004, BIOCHEM PHARMACOL, V68, P2177, DOI 10.1016/j.bcp.2004.08.017; Janssen CIF, 2014, PROG LIPID RES, V53, P1, DOI 10.1016/j.plipres.2013.10.002; Koeberle A, 2016, FUTURE MED CHEM, V8, P2169, DOI 10.4155/fmc-2016-0182; Koeberle A, 2015, FASEB J, V29, P2439, DOI 10.1096/fj.14-268474; Koeberle A, 2013, P NATL ACAD SCI USA, V110, P2546, DOI 10.1073/pnas.1216182110; Koeberle A, 2012, FASEB J, V26, P169, DOI 10.1096/fj.11-184879; Koeberle A, 2010, FASEB J, V24, P4929, DOI 10.1096/fj.10-162818; Koberlin MS, 2015, CELL, V162, P170, DOI 10.1016/j.cell.2015.05.051; KRAUSE RF, 1974, J NUTR, V104, P629, DOI 10.1093/jn/104.5.629; KRAUSE RF, 1971, J NUTR, V101, P161, DOI 10.1093/jn/101.2.161; Lopez-Carballo G, 2002, J BIOL CHEM, V277, P25297, DOI 10.1074/jbc.M201869200; Bonet ML, 2012, BBA-MOL CELL BIOL L, V1821, P177, DOI 10.1016/j.bbalip.2011.06.001; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matkovic K, 2006, LEUKEMIA, V20, P941, DOI 10.1038/sj.leu.2404204; Miranda MB, 2007, MOL CANCER THER, V6, P3081, DOI 10.1158/1535-7163.MCT-07-0514; Qiao JB, 2012, BIOCHEM BIOPH RES CO, V424, P421, DOI 10.1016/j.bbrc.2012.06.125; Read DE, 2009, CELL MOL LIFE SCI, V66, P2975, DOI 10.1007/s00018-009-0057-8; Reed LL, 1932, SCIENCE, V76, P300, DOI 10.1126/science.76.1970.300; Shearer KD, 2012, TRENDS NEUROSCI, V35, P733, DOI 10.1016/j.tins.2012.08.005; Uruno A, 2005, CIRCULATION, V112, P727, DOI 10.1161/CIRCULATIONAHA.104.500959; Yamasaki D, 2011, EUR J CELL BIOL, V90, P657, DOI 10.1016/j.ejcb.2011.02.005; Zhang R, 2007, NEUROCHEM RES, V32, P2194, DOI 10.1007/s11064-007-9417-7; Zhao KN, 2013, CELL CALCIUM, V54, P151, DOI 10.1016/j.ceca.2013.05.009	41	4	4	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4566	4577		10.1096/fj.201700078R	http://dx.doi.org/10.1096/fj.201700078R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28687611				2022-12-28	WOS:000413397400032
J	Branco, RCS; Camargo, RL; Batista, TM; Vettorazzi, JF; Borck, PC; dos Santos-Silva, JCR; Boschero, AC; Zoppi, CC; Carneiro, EM				Souto Branco, Renato Chaves; Camargo, Rafael Ludemann; Batista, Thiago Martins; Vettorazzi, Jean Franciesco; Borck, Patricia Cristine; Rebelo dos Santos-Silva, Junia Carolina; Boschero, Antonio Carlos; Zoppi, Claudio Cesar; Carneiro, Everardo Magalhaes			Protein malnutrition blunts the increment of taurine transporter expression by a high-fat diet and impairs taurine reestablishment of insulin secretion	FASEB JOURNAL			English	Article						undernutrition; obesity; NADP; pyruvate carboxylase; interleukin-6	PYRUVATE-CARBOXYLASE; MALNOURISHED MICE; ANTIOXIDANT ACTIVITY; DIABETES-MELLITUS; LEPTIN RECEPTOR; GENE-EXPRESSION; DOWN-REGULATION; GLUCOSE; ISLETS; CELLS	Taurine (Tau) restores beta-cell function in obesity; however, its action is lost in malnourished obese rodents. Here, we investigated the mechanisms involved in the lack of effects of Tau in this model. C57BL/6 mice were fed a control diet (CD) (14% protein) or a protein-restricted diet (RD) (6% protein) for 6 wk. Afterward, mice received a high-fat diet (HFD) for 8 wk [CD + HFD (CH) and RD + HFD (RH)] with or without 5% Tau supplementation after weaning on their drinking water [CH + Tau (CHT) and RH + Tau (RHT)]. The HFD increased insulin secretion through mitochondrial metabolism in CH and RH. Tau prevented all those alterations in CHT only. The expression of the taurine transporter (Tau-T), as well as Tau content in pancreatic islets, was increased in CH but had no effect on RH. Protein malnutrition programs beta cells and impairs Tau-induced restoration of mitochondrial metabolism and biogenesis. This may be associated with modulation of the expression of Tau-T in pancreatic islets, which may be responsible for the absence of effect of Tau in protein-malnourished obese mice.	[Souto Branco, Renato Chaves; Camargo, Rafael Ludemann; Batista, Thiago Martins; Vettorazzi, Jean Franciesco; Borck, Patricia Cristine; Rebelo dos Santos-Silva, Junia Carolina; Boschero, Antonio Carlos; Zoppi, Claudio Cesar; Carneiro, Everardo Magalhaes] Univ Campinas UNICAMP, Dept Struct & Funct Biol, Inst Biol, BR-13083970 Campinas, SP, Brazil	Universidade Estadual de Campinas	Branco, RCS (corresponding author), Univ Campinas UNICAMP, Dept Struct & Funct Biol, Inst Biol, BR-13083970 Campinas, SP, Brazil.	renatocsb@gmail.com	Batista, Thiago M/C-9816-2014; Carneiro, Everardo/D-4758-2012; Silva, Junia C Santos/E-5052-2015	Batista, Thiago M/0000-0001-6971-1191; Silva, Junia C Santos/0000-0002-8667-8140; VETTORAZZI, JEAN/0000-0002-6411-2947	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Sao Paulo, Brazil); Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico (Brasilia, Brazil); Instituto Nacional de Ciencia e Tecnologia (Brasilia, Brazil)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Sao Paulo, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico (Brasilia, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia (Brasilia, Brazil)	This study was supported by grants from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Sao Paulo, Brazil); the Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico (Brasilia, Brazil); and the Instituto Nacional de Ciencia e Tecnologia (Brasilia, Brazil). C.C.Z. and M.C. share senior authorship. The authors declare no conflicts of interest.	Batista TM, 2013, MOL NUTR FOOD RES, V57, P423, DOI 10.1002/mnfr.201200345; Batista TM, 2012, J NUTR BIOCHEM, V23, P306, DOI 10.1016/j.jnutbio.2010.12.012; Baumann H, 1996, P NATL ACAD SCI USA, V93, P8374, DOI 10.1073/pnas.93.16.8374; Besseiche A, 2018, DIABETES METAB, V44, P45, DOI 10.1016/j.diabet.2017.01.007; BORDIN S, 1995, J MEMBRANE BIOL, V148, P177; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bridges CC, 2001, AM J PHYSIOL-CELL PH, V281, pC1825, DOI 10.1152/ajpcell.2001.281.6.C1825; Cappelli AP, 2014, LIVER INT, V34, P771, DOI 10.1111/liv.12291; Duque-Guimaraes DE, 2013, TRENDS ENDOCRIN MET, V24, P525, DOI 10.1016/j.tem.2013.05.006; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Fransson U, 2006, DIABETOLOGIA, V49, P1578, DOI 10.1007/s00125-006-0263-y; Ghilardi N, 1996, P NATL ACAD SCI USA, V93, P6231, DOI 10.1073/pnas.93.13.6231; Guay C, 2007, J BIOL CHEM, V282, P35657, DOI 10.1074/jbc.M707294200; Haan C, 2002, BIOCHEM J, V361, P105, DOI 10.1042/0264-6021:3610105; Hales CN, 2013, INT J EPIDEMIOL, V42, P1215, DOI 10.1093/ije/dyt133; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Han J, 2010, J ENDOCRINOL, V204, P143, DOI 10.1677/JOE-09-0391; Hansen DB, 2012, J MEMBRANE BIOL, V245, P77, DOI 10.1007/s00232-012-9416-8; Hansen SH, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S23; Hasan NM, 2008, J BIOL CHEM, V283, P28048, DOI 10.1074/jbc.M804170200; Hasnain SZ, 2016, J MOL ENDOCRINOL, V56, pR33, DOI 10.1530/JME-15-0232; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; HOFFMANN EK, 1983, J PHYSIOL-LONDON, V338, P613, DOI 10.1113/jphysiol.1983.sp014692; JACOBSEN JG, 1968, PHYSIOL REV, V48, P424, DOI 10.1152/physrev.1968.48.2.424; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Jong CJ, 2012, AMINO ACIDS, V42, P2223, DOI 10.1007/s00726-011-0962-7; Kang YS, 2002, J NEUROCHEM, V83, P1188, DOI 10.1046/j.1471-4159.2002.01223.x; Kim KS, 2012, EXP MOL MED, V44, P665, DOI 10.3858/emm.2012.44.11.075; Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101; Krause MD, 2012, J ENDOCRINOL, V214, P301, DOI 10.1530/JOE-12-0223; Lambert IH, 2014, AM J PHYSIOL-CELL PH, V306, pC1028, DOI 10.1152/ajpcell.00005.2014; LAMBERT IH, 1993, J MEMBRANE BIOL, V131, P67, DOI 10.1007/BF02258535; Leite NC, 2016, SCI REP-UK, V6, DOI 10.1038/srep33464; Leloup C, 2009, DIABETES, V58, P673, DOI 10.2337/db07-1056; Lenzen S, 2008, BIOCHEM SOC T, V36, P343, DOI 10.1042/BST0360343; Ling C, 2008, DIABETOLOGIA, V51, P615, DOI 10.1007/s00125-007-0916-5; MacDonald MJ, 2008, AM J PHYSIOL-CELL PH, V294, pC442, DOI 10.1152/ajpcell.00368.2007; Maechler P, 2012, BEST PRACT RES CL EN, V26, P739, DOI 10.1016/j.beem.2012.07.003; Mayeur S, 2013, AM J PHYSIOL-ENDOC M, V304, pE14, DOI 10.1152/ajpendo.00332.2012; Mochizuki T, 2002, FEBS LETT, V517, P92, DOI 10.1016/S0014-5793(02)02584-X; Mollerup J, 1998, BBA-BIOMEMBRANES, V1371, P335, DOI 10.1016/S0005-2736(98)00033-9; Mollerup J, 1996, J MEMBRANE BIOL, V150, P73, DOI 10.1007/s002329900031; Oropeza D, 2015, MOL METAB, V4, P811, DOI 10.1016/j.molmet.2015.08.001; Park HK, 2004, ANN NY ACAD SCI, V1011, P205, DOI 10.1196/annals.1293.021; Parvez S, 2008, BASIC CLIN PHARMACOL, V102, P382, DOI 10.1111/j.1742-7843.2008.00208.x; Peterside IE, 2003, AM J PHYSIOL-ENDOC M, V285, pE1258, DOI 10.1152/ajpendo.00437.2002; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; QUINLAN TR, 1995, AM J PATHOL, V147, P728; da Silva PMR, 2012, METABOLISM, V61, P721, DOI 10.1016/j.metabol.2011.09.012; da Silva PMR, 2010, METABOLISM, V59, P911, DOI 10.1016/j.metabol.2009.10.014; Ribeiro RA, 2012, AMINO ACIDS, V43, P1791, DOI 10.1007/s00726-012-1263-5; Santos GJ, 2011, CELL SIGNAL, V23, P1669, DOI 10.1016/j.cellsig.2011.06.001; Schaffer SW, 2009, CAN J PHYSIOL PHARM, V87, P91, DOI 10.1139/Y08-110; Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649; Soriano S, 2010, ENDOCRINOLOGY, V151, P3543, DOI 10.1210/en.2010-0008; Sugden MC, 2011, ISLETS, V3, P302, DOI 10.4161/isl.3.6.17806; Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656; Theys N, 2009, AM J PHYSIOL-REG I, V297, pR1516, DOI 10.1152/ajpregu.00280.2009; Vettorazzi JF, 2014, AMINO ACIDS, V46, P2123, DOI 10.1007/s00726-014-1763-6; Voss JW, 2004, EUR J BIOCHEM, V271, P4646, DOI 10.1111/j.1432-1033.2004.04420.x; Wiederkehr A, 2012, MOL CELL ENDOCRINOL, V353, P128, DOI 10.1016/j.mce.2011.07.016; Xu J, 2008, DIABETOLOGIA, V51, P2022, DOI 10.1007/s00125-008-1130-9; Yoon JC, 2003, DEV CELL, V5, P73, DOI 10.1016/S1534-5807(03)00170-9	65	7	7	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					4078	4087		10.1096/fj.201600326RRR	http://dx.doi.org/10.1096/fj.201600326RRR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28572444				2022-12-28	WOS:000408713300031
J	Nixon, RA				Nixon, Ralph A.			Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer's disease: inseparable partners in a multifactorial disease	FASEB JOURNAL			English	Review						autophagy; cholinergic neurodegeneration; presenilin; apoliprotein E; Down Syndrome	C-TERMINAL FRAGMENT; GAMMA-SECRETASE ACTIVITY; A-BETA; MOUSE MODEL; BASAL FOREBRAIN; APOLIPOPROTEIN E4; DOWN-SYNDROME; CELL-DEATH; PH DOMAIN; PRESENILIN MUTATIONS	Abnormalities of the endosomal-lysosomal network (ELN) are a signature feature of Alzheimer's disease (AD). These include the earliest known cytopathology that is specific to AD and that affects endosomes and induces the progressive failure of lysosomes, each of which are directly linked by distinct mechanisms to neurodegeneration. The origins of ELN dysfunction and beta-amyloidogenesis closely overlap, which reflects their common genetic basis, the established early involvement of endosomes and lysosomes in amyloid precursor protein (APP) processing and clearance, and the pathologic effect of certain APP metabolites on ELN functions. Genes that promote beta-amyloidogenesis in AD (APP, PSEN1/2, and APOE4) have primary effects on ELN function. The importance of primary ELN dysfunction to pathogenesis is underscored by the mutations in more than 35 ELN-related genes that, thus far, are known to cause familial neurodegenerative diseases even though different pathogenic proteins may be involved. In this article, I discuss growing evidence that implicates AD gene-driven ELN disruptions as not only the antecedent pathobiology that underlies beta-amyloidogenesis but also as the essential partner with APP and its metabolites that drive the development of AD, including tauopathy, synaptic dysfunction, and neurodegeneration. The striking amelioration of diverse deficits in animal AD models by remediating ELN dysfunction further supports a need to integrate APP and ELN relationships, including the role of amyloid-beta, into a broader conceptual framework of how AD arises, progresses, and may be effectively therapeutically targeted.-Nixon, R. A. Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer's disease: inseparable partners in a multifactorial disease.	[Nixon, Ralph A.] Nathan S Kline Inst, Ctr Dementia Res, Orangeburg, NY USA; [Nixon, Ralph A.] NYU, Dept Psychiat, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Nixon, Ralph A.] NYU, Dept Cell Biol, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA	Nathan Kline Institute for Psychiatric Research; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Nixon, RA (corresponding author), NYU, Sch Med, New York, NY 10016 USA.	ralph.nixon@nki.rfmh.org		Nixon, Ralph A/0000-0001-5124-1021	U.S. National Institutes of Health, National Institute on Aging; NATIONAL INSTITUTE ON AGING [P01AG017617] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research from R.A.N. laboratories is supported by the U.S. National Institutes of Health, National Institute on Aging. Contributions of Martin Berg (Center for Dementia Research, Nathan S. Kline Institute) to manuscript preparation are gratefully acknowledged.	Aits S, 2013, J CELL SCI, V126, P1905, DOI 10.1242/jcs.091181; Araki W, 2016, BRAIN RES BULL, V126, P170, DOI 10.1016/j.brainresbull.2016.04.009; Bagshaw RD, 2003, BIOCHEM BIOPH RES CO, V300, P615, DOI 10.1016/S0006-291X(02)02865-6; Bahr BA, 2002, J NEUROCHEM, V83, P481, DOI 10.1046/j.1471-4159.2002.01192.x; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Basurto-Islas G, 2013, J BIOL CHEM, V288, P17495, DOI 10.1074/jbc.M112.446070; Beel AJ, 2008, BIOCHEMISTRY-US, V47, P9428, DOI 10.1021/bi800993c; Beel AJ, 2010, BBA-MOL CELL BIOL L, V1801, P975, DOI 10.1016/j.bbalip.2010.03.008; Belinson H, 2008, J NEUROSCI, V28, P4690, DOI 10.1523/JNEUROSCI.5633-07.2008; Bellettato CM, 2010, J INHERIT METAB DIS, V33, P347, DOI 10.1007/s10545-010-9075-9; Berger Z, 2006, HUM MOL GENET, V15, P433, DOI 10.1093/hmg/ddi458; Bissig C, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016816; Bohdanowicz M, 2012, MOL BIOL CELL, V23, P176, DOI 10.1091/mbc.E11-06-0489; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Bordi M, 2016, AUTOPHAGY, V12, P2467, DOI 10.1080/15548627.2016.1239003; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Brendza RP, 2005, J CLIN INVEST, V115, P428, DOI 10.1172/JCI200523269; Bright NA, 2016, CURR BIOL, V26, P2233, DOI 10.1016/j.cub.2016.06.046; Brown TC, 2005, NEURON, V45, P81, DOI 10.1016/j.neuron.2004.12.023; Bustamante HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083096; Butler D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020501; Cabeza C, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-11; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Cai Y, 2012, NEUROTOX RES, V21, P160, DOI 10.1007/s12640-011-9256-9; Calafate S, 2016, CELL REP, V17, P931, DOI 10.1016/j.celrep.2016.09.063; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Cataldo AM, 2004, J NEUROPATH EXP NEUR, V63, P821, DOI 10.1093/jnen/63.8.821; Cataldo AM, 1997, J NEUROSCI, V17, P6142; Cataldo AM, 1996, J NEUROSCI, V16, P186; CATALDO AM, 1995, NEURON, V14, P671, DOI 10.1016/0896-6273(95)90324-0; Cataldo AM, 2008, AM J PATHOL, V173, P370, DOI 10.2353/ajpath.2008.071053; Chen B, 2000, J BIOL CHEM, V275, P19275, DOI 10.1074/jbc.M908994199; Chen YM, 2012, J NEUROSCI, V32, P11390, DOI 10.1523/JNEUROSCI.0757-12.2012; Cheng F, 2014, J BIOL CHEM, V289, P20871, DOI 10.1074/jbc.M114.552810; Cheng XP, 2015, SEMIN CELL DEV BIOL, V45, P24, DOI 10.1016/j.semcdb.2015.10.031; Cherra SJ, 2010, NEUROPATH APPL NEURO, V36, P125, DOI [10.1111/j.1365-2990.2009.01062.x, 10.1111/j.1365-2990.2010.01062.x]; Choi JHK, 2013, J ALZHEIMERS DIS, V34, P691, DOI 10.3233/JAD-122143; Choi SH, 2001, FASEB J, V15, P1816, DOI 10.1096/fj.00-0859fje; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Colacurcio DJ, 2016, AGEING RES REV, V32, P75, DOI 10.1016/j.arr.2016.05.004; Cosker KE, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020669; Cossec JC, 2010, BBA-MOL CELL BIOL L, V1801, P839, DOI 10.1016/j.bbalip.2010.03.010; Danson C, 2013, J CELL SCI, V126, P4885, DOI 10.1242/jcs.125732; Das U, 2016, NAT NEUROSCI, V19, P55, DOI 10.1038/nn.4188; De Jonghe C, 2001, HUM MOL GENET, V10, P1665, DOI 10.1093/hmg/10.16.1665; Devi L, 2014, NEUROBIOL AGING, V35, P2272, DOI 10.1016/j.neurobiolaging.2014.04.031; Dhaka A, 2003, J NEUROSCI, V23, P748; Di Fiore PP, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016865; Dolan PJ, 2010, J BIOL CHEM, V285, P21978, DOI 10.1074/jbc.M110.110940; Duggan SP, 2016, CELL SIGNAL, V28, P1, DOI 10.1016/j.cellsig.2015.10.006; Eckman EA, 2005, BIOCHEM SOC T, V33, P1101, DOI 10.1042/BST0331101; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Eitan E, 2016, AGEING RES REV, V32, P65, DOI 10.1016/j.arr.2016.05.001; Felbor U, 2002, P NATL ACAD SCI USA, V99, P7883, DOI 10.1073/pnas.112632299; Fernandez-Monreal M, 2016, J CELL SCI, V129, P2793, DOI 10.1242/jcs.183475; Flores-Rodriguez N, 2015, J CELL SCI, V128, P755, DOI 10.1242/jcs.161786; Florez-McClure ML, 2007, AUTOPHAGY, V3, P569, DOI 10.4161/auto.4776; Fraldi A, 2016, ANNU REV NEUROSCI, V39, P277, DOI 10.1146/annurev-neuro-070815-014031; Frautschy SA, 1996, NEUROBIOL AGING, V17, P311, DOI 10.1016/0197-4580(95)02073-X; Frautschy SA, 1998, J NEUROSCI, V18, P8311; Fu R, 2012, AM J MED GENET A, V158A, P2775, DOI 10.1002/ajmg.a.35395; Fu XP, 2011, MOL BIOL CELL, V22, P3684, DOI 10.1091/mbc.E11-04-0308; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Funmilayo E, 2016, J BIOL CHEM, V291, P15753, DOI 10.1074/jbc.M116.718023; Gamba P, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00119; Garcia-Arencibia M, 2010, SEMIN CELL DEV BIOL, V21, P691, DOI 10.1016/j.semcdb.2010.02.008; Ginsberg SD, 2010, BIOL PSYCHIAT, V68, P885, DOI 10.1016/j.biopsych.2010.05.030; Giudetti AM, 2016, CURR ALZHEIMER RES, V13, P198, DOI 10.2174/1567205012666150921103426; Gomez-Sintes R, 2016, AGEING RES REV, V32, P150, DOI 10.1016/j.arr.2016.02.009; Gout I, 2000, EMBO J, V19, P4015, DOI 10.1093/emboj/19.15.4015; Granholm ACE, 2000, EXP NEUROL, V161, P647, DOI 10.1006/exnr.1999.7289; Grothe M, 2012, BIOL PSYCHIAT, V71, P805, DOI 10.1016/j.biopsych.2011.06.019; Guenette SY, 2003, NEUROMOL MED, V4, P147, DOI 10.1385/NMM:4:3:147; Hamano T, 2008, EUR J NEUROSCI, V27, P1119, DOI 10.1111/j.1460-9568.2008.06084.x; Hamm V. B., 2014, NEUR 2014 44 ANN NEU; He XY, 2007, J NEUROSCI, V27, P4052, DOI 10.1523/JNEUROSCI.3993-06.2007; He XY, 2005, J BIOL CHEM, V280, P11696, DOI 10.1074/jbc.M411296200; Heeren J, 2004, J BIOL CHEM, V279, P55483, DOI 10.1074/jbc.M409324200; Heinrich M, 1999, EMBO J, V18, P5252, DOI 10.1093/emboj/18.19.5252; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; HOLTZMAN DM, 1992, NEURON, V9, P465, DOI 10.1016/0896-6273(92)90184-F; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Huang YD, 2010, TRENDS MOL MED, V16, P287, DOI 10.1016/j.molmed.2010.04.004; Hughes AL, 2012, NATURE, V492, P261, DOI 10.1038/nature11654; Hupalowska A, 2012, J CELL SCI, V125, P4090, DOI 10.1242/jcs.105171; Imbimbo BP, 2011, CURR TOP MED CHEM, V11, P1555; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Ivy G. O., 1989, ADV EXP MED BIOL, V266, P45; IVY GO, 1989, ADV EXP MED BIOL, V266, P31; Jayne T, 2016, J ALZHEIMERS DIS, V52, P781, DOI 10.3233/JAD-151186; Ji ZS, 2006, J BIOL CHEM, V281, P2683, DOI 10.1074/jbc.M506646200; Ji ZS, 2002, J BIOL CHEM, V277, P21821, DOI 10.1074/jbc.M112109200; Jiang Y, 2010, P NATL ACAD SCI USA, V107, P1630, DOI 10.1073/pnas.0908953107; Kalaidzidis I, 2015, J CELL BIOL, V211, P123, DOI 10.1083/jcb.201311117; Karch CM, 2015, BIOL PSYCHIAT, V77, P43, DOI 10.1016/j.biopsych.2014.05.006; Kavcic N, 2017, BIOL CHEM, V398, P289, DOI 10.1515/hsz-2016-0252; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Khurana V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001026; Kim HS, 2004, J NEUROSCI RES, V75, P117, DOI 10.1002/jnr.10845; Kim S, 2016, MOL PSYCHIATR, V21, P707, DOI 10.1038/mp.2015.97; Koffie RM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-63; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Kumar-Singh S, 2006, HUM MUTAT, V27, P686, DOI 10.1002/humu.20336; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Laifenfeld D, 2007, J NEUROSCI, V27, P7141, DOI 10.1523/JNEUROSCI.4599-06.2007; Lane-Donovan C, 2014, NEURON, V83, P771, DOI 10.1016/j.neuron.2014.08.005; Larsen KE, 2002, HISTOL HISTOPATHOL, V17, P897, DOI 10.14670/HH-17.897; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lauritzen I, 2016, ACTA NEUROPATHOL, V132, P257, DOI 10.1007/s00401-016-1577-6; Lauritzen I, 2012, J NEUROSCI, V32, P16243, DOI 10.1523/JNEUROSCI.2775-12.2012; LeBlanc AC, 1999, J NEUROCHEM, V72, P1832, DOI 10.1046/j.1471-4159.1999.0721832.x; Lee JR, 2011, BIOCHEM BIOPH RES CO, V415, P206, DOI 10.1016/j.bbrc.2011.10.064; Lee JH, 2015, CELL REP, V12, P1430, DOI 10.1016/j.celrep.2015.07.050; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Lee S, 2011, J NEUROSCI, V31, P7817, DOI 10.1523/JNEUROSCI.6412-10.2011; Liang B, 2010, J BIOL CHEM, V285, P27737, DOI 10.1074/jbc.M110.117960; Lin DC, 2006, MOL CELL BIOL, V26, P8928, DOI 10.1128/MCB.00228-06; Ling DJ, 2014, ASN NEURO, V6, DOI 10.1042/AN20130044; Majumdar D, 2011, MOL CELL NEUROSCI, V46, P633, DOI 10.1016/j.mcn.2011.01.003; Maloney JA, 2014, J BIOL CHEM, V289, P30990, DOI 10.1074/jbc.M114.589069; Martini-Stoica H, 2016, TRENDS NEUROSCI, V39, P221, DOI 10.1016/j.tins.2016.02.002; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; McBrayer M, 2013, BIOCHEM SOC T, V41, P1495, DOI 10.1042/BST20130201; McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200; McCray BA, 2008, NEUROSIGNALS, V16, P75, DOI 10.1159/000109761; McPhie DL, 2003, J NEUROSCI, V23, P6914; Merkulova M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14827; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Missotten M, 1999, CELL DEATH DIFFER, V6, P124, DOI 10.1038/sj.cdd.4400456; Molin Mikael, 2014, Int J Cell Biol, V2014, P913071, DOI 10.1155/2014/913071; Mondragon-Rodriguez S. M., 2014, NEUR 2014 44 ANN NEU; Mony VK, 2016, AUTOPHAGY, V12, P619, DOI 10.1080/15548627.2016.1147671; Mueller-Steiner S, 2006, NEURON, V51, P703, DOI 10.1016/j.neuron.2006.07.027; Mufson EJ, 2002, J COMP NEUROL, V443, P136, DOI 10.1002/cne.10122; MUFSON EJ, 1989, EXP NEUROL, V105, P221, DOI 10.1016/0014-4886(89)90124-6; Muhammad A, 2008, P NATL ACAD SCI USA, V105, P7327, DOI 10.1073/pnas.0802545105; Mullins C, 2001, BIOESSAYS, V23, P333, DOI 10.1002/bies.1048; Muth K, 2010, BIOL PSYCHIAT, V67, P588, DOI 10.1016/j.biopsych.2009.02.026; Napolitano G, 2016, J CELL SCI, V129, P2475, DOI 10.1242/jcs.146365; Natunen T, 2016, NEUROBIOL DIS, V85, P187, DOI 10.1016/j.nbd.2015.11.005; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Nguyen K, 2016, J PHYS CHEM B, V120, P2187, DOI 10.1021/acs.jpcb.5b12235; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Nishitomi K, 2006, J NEUROCHEM, V99, P1555, DOI 10.1111/j.1471-4159.2006.04178.x; Nistor A, 2007, NEUROBIOL AGING, V28, P1493, DOI 10.1016/j.neurobiolaging.2006.06.023; Nixon R. A., 2017, AD PD 2017 13 INT C; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2008, AUTOPHAGY, V4, P590, DOI 10.4161/auto.6259; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Nixon RA, 2006, J ALZHEIMERS DIS, V9, P277; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Novotny R, 2016, J NEUROSCI, V36, P5084, DOI 10.1523/JNEUROSCI.0258-16.2016; Ogawa A, 2013, BRAIN RES, V1494, P118, DOI 10.1016/j.brainres.2012.12.010; Ohmi K, 2009, P NATL ACAD SCI USA, V106, P8332, DOI 10.1073/pnas.0903223106; Okada H, 2010, FASEB J, V24, P2783, DOI 10.1096/fj.09-146357; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Pasternak SH, 2003, J BIOL CHEM, V278, P26687, DOI 10.1074/jbc.M304009200; Perez-Gonzalez R, 2012, J BIOL CHEM, V287, P43108, DOI 10.1074/jbc.M112.404467; Pitsi D, 2004, J BIOL CHEM, V279, P25333, DOI 10.1074/jbc.M312710200; Polito VA, 2014, EMBO MOL MED, V6, P1142, DOI 10.15252/emmm.201303671; Rao MV, 2014, J NEUROSCI, V34, P9222, DOI 10.1523/JNEUROSCI.1132-14.2014; Rellin L, 2008, BBA-MOL CELL BIOL L, V1781, P232, DOI 10.1016/j.bbalip.2008.02.001; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Rhinn H, 2013, NATURE, V500, P45, DOI 10.1038/nature12415; Ruckenstuhl C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004347; Ryazantsev S, 2007, MOL GENET METAB, V90, P393, DOI 10.1016/j.ymgme.2006.11.006; Ryu JY, 2014, CELL REP, V7, P1227, DOI 10.1016/j.celrep.2014.04.006; Salehi A, 2006, NEURON, V51, P29, DOI 10.1016/j.neuron.2006.05.022; Sannerud R, 2016, CELL, V166, P193, DOI 10.1016/j.cell.2016.05.020; Schmitz TW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13249; Schnoder L, 2016, J BIOL CHEM, V291, P2067, DOI 10.1074/jbc.M115.695916; Schroder B, 2016, AGEING RES REV, V32, P51, DOI 10.1016/j.arr.2016.04.012; Settembre C, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016907; SIMAN R, 1993, J BIOL CHEM, V268, P16602; Simon AM, 2009, NEUROBIOL DIS, V33, P369, DOI 10.1016/j.nbd.2008.11.005; Small SA, 2015, NAT REV NEUROSCI, V16, P126, DOI 10.1038/nrn3896; SOFRONIEW MV, 1990, SCIENCE, V247, P338, DOI 10.1126/science.1688664; Song WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136950; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Sun BG, 2008, NEURON, V60, P247, DOI 10.1016/j.neuron.2008.10.001; Sun LF, 2017, P NATL ACAD SCI USA, V114, pE476, DOI 10.1073/pnas.1618657114; Syntichaki P, 2003, NAT REV NEUROSCI, V4, P672, DOI 10.1038/nrn1174; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Tamayev R, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-19; Tamayev R, 2012, EMBO MOL MED, V4, P171, DOI 10.1002/emmm.201100195; Tamayev R, 2011, EMBO J, V30, P2501, DOI 10.1038/emboj.2011.161; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Thomas RS, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0288-1; Tian Y, 2014, AUTOPHAGY, V10, P694, DOI 10.4161/auto.27802; Tian Y, 2013, P NATL ACAD SCI USA, V110, P17071, DOI 10.1073/pnas.1315110110; Tian Y, 2011, FASEB J, V25, P1934, DOI 10.1096/fj.10-175158; Urwin H, 2009, BIOCHEM SOC T, V37, P208, DOI 10.1042/BST0370208; Villasenor R, 2016, CURR OPIN CELL BIOL, V39, P53, DOI 10.1016/j.ceb.2016.02.002; Vito P, 1999, J BIOL CHEM, V274, P1533, DOI 10.1074/jbc.274.3.1533; Vito P, 1996, SCIENCE, V271, P521, DOI 10.1126/science.271.5248.521; Wang HB, 2013, TRENDS PHARMACOL SCI, V34, P215, DOI 10.1016/j.tips.2013.01.008; Wang JJ, 2016, NEUROSCI BULL, V32, P323, DOI 10.1007/s12264-016-0042-9; Wang YP, 2009, HUM MOL GENET, V18, P4153, DOI 10.1093/hmg/ddp367; Williamson W Ryan, 2010, Commun Integr Biol, V3, P604, DOI 10.4161/cib.3.6.13364; Woodruff G, 2016, CELL REP, V17, P759, DOI 10.1016/j.celrep.2016.09.034; Xu HX, 2015, ANNU REV PHYSIOL, V77, P57, DOI 10.1146/annurev-physiol-021014-071649; Xu W, 2016, J CLIN INVEST, V126, P1815, DOI 10.1172/JCI82409; Xu W, 2015, EXP NEUROL, V264, P82, DOI 10.1016/j.expneurol.2014.12.008; Xue X, 2014, NANO LETT, V14, P5110, DOI 10.1021/nl501839q; Yamashima T, 2016, AGEING RES REV, V32, P169, DOI 10.1016/j.arr.2016.05.008; Yamashita N, 2016, CURR OPIN NEUROBIOL, V39, P139, DOI 10.1016/j.conb.2016.06.004; Yan X.-X. C., 2011, 41 ANN NEUR M; Yang DS, 2008, AM J PATHOL, V173, P665, DOI 10.2353/ajpath.2008.071176; Yang DS, 2017, HUM MOL GENET, V26, P843, DOI 10.1093/hmg/ddx001; Yang DS, 2014, BRAIN, V137, P3300, DOI 10.1093/brain/awu278; Yang DS, 2011, AUTOPHAGY, V7, P788, DOI 10.4161/auto.7.7.15596; Yang DS, 2011, BRAIN, V134, P258, DOI 10.1093/brain/awq341; Yang T, 2017, J NEUROSCI, V37, P152, DOI 10.1523/JNEUROSCI.1698-16.2016; Yoon SY, 2006, NEUROBIOL DIS, V22, P435, DOI 10.1016/j.nbd.2005.12.013; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Zhang ZT, 2014, NAT MED, V20, P1254, DOI 10.1038/nm.3700; Zhu GY, 2007, EMBO J, V26, P3484, DOI 10.1038/sj.emboj.7601771	218	173	176	1	44	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					2729	2743		10.1096/fj.201700359	http://dx.doi.org/10.1096/fj.201700359			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28663518	Green Published			2022-12-28	WOS:000405931000003
J	Yang, XY; Wang, J; Zhou, ZW; Jiang, R; Huang, J; Chen, LL; Cao, ZL; Chu, H; Han, B; Cheng, YS; Chao, J				Yang, Xiyue; Wang, Jing; Zhou, Zewei; Jiang, Rong; Huang, Jie; Chen, Lulu; Cao, Zhouli; Chu, Han; Han, Bing; Cheng, Yusi; Chao, Jie			Silica-induced initiation of circular ZC3H4 RNA/ZC3H4 pathway promotes the pulmonary macrophage activation	FASEB JOURNAL			English	Article						miR-212; migration; silicosis; inflammation; circRNA	ZINC-FINGER PROTEIN; FIBROSIS; MCPIP1; RNAS; TRANSPLANTATION; INHIBITION; REVEALS; CANCER	Phagocytosis of silicon dioxide (SiO2) into lung cells causes an inflammatory cascade that results in fibroblast proliferation and migration, followed by fibrosis. Circular RNAs (circRNAs) are a subclass of noncoding RNAs that are present within mammalian cells; however, researchers have not determined whether circRNAs are involved in the pathophysiologic process of silicosis. To elucidate the role of these RNAs in SiO2 induced inflammation in pulmonary macrophages, we investigated the upstream molecular mechanisms and functional effects of circRNAs on cell apoptosis, proliferation, and migration. Primary cultures of alveolar macrophages from healthy donors and from patients and the RAW264.7 macrophage cell line were used to explore the functions of circZC3H4 RNA in macrophage activation. The experimental results indicated the following: 1) SiO2 concomitantly increased circZC3H4 RNA expression and increased ZC3H4 protein levels; 2) circular ZC3H4 (circZC3H4) RNA and ZC3H4 protein participated in SiO2 -induced macrophage activation; and 3) SiO2-activated macrophages promoted fibroblast proliferation and migration via the circZC3H4 RNA/ZC3H4 pathway. The up-regulation of the ZC3H4 protein was confirmed in tissue samples from patients with silicosis. Our study elucidates a link between SiO2 -induced macrophage activation and the circZC3H4 RNA/ZC3H4 pathway, thereby providing novel insight into the potential use of ZC3H4 to develop novel therapeutic strategies for silicosis.	[Yang, Xiyue; Wang, Jing; Zhou, Zewei; Jiang, Rong; Huang, Jie; Chen, Lulu; Cao, Zhouli; Chu, Han; Cheng, Yusi; Chao, Jie] Southeast Univ, Dept Physiol, Nanjing, Jiangsu, Peoples R China; [Yang, Xiyue; Zhou, Zewei; Jiang, Rong; Chao, Jie] Southeast Univ, Zhongda Hosp, Dept Respirat, Nanjing, Jiangsu, Peoples R China; [Yang, Xiyue; Zhou, Zewei; Han, Bing] Southeast Univ, Sch Med, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China; [Yang, Xiyue; Zhou, Zewei; Jiang, Rong; Chen, Lulu; Chu, Han; Chao, Jie] Southeast Univ, Key Lab Dev Genes & Human Dis, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China; Southeast University - China; Southeast University - China	Chao, J (corresponding author), Southeast Univ, Sch Med, Dept Physiol, 87 Dingjiaqiao Rd, Nanjing 210009, Jiangsu, Peoples R China.	chaojie@seu.edu.cn	Jie, Chao/J-1004-2019	Jie, Chao/0000-0002-7800-3557	National Natural Science Foundation of China [81773796]; National Key R&D Program of China [2017YFA0104303]; Natural Science Foundation of Jiangsu Province [BK20141347]; Postgraduate Research and Practice Innovation Program of Jiangsu Province [KYCX17-0165]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Postgraduate Research and Practice Innovation Program of Jiangsu Province	This work was supported by the National Natural Science Foundation of China (Grant 81773796) and the National Key R&D Program of China (Grant 2017YFA0104303), the Natural Science Foundation of Jiangsu Province (Grant BK20141347), and the Postgraduate Research and Practice Innovation Program of Jiangsu Province (Grant KYCX17-0165). The authors declare no conflicts of interest.	Adegunsoye A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/510105; Armakola M, 2012, NAT GENET, V44, P1302, DOI 10.1038/ng.2434; Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; Boeckel JN, 2015, CIRC RES, V117, P884, DOI 10.1161/CIRCRESAHA.115.306319; Cao ZL, 2017, CELL DEATH DIS, V8, DOI 10.1038/s41419-017-0017-4; Carneiro PJ, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00159; Chao J, 2015, J INVEST DERMATOL, V135, P2944, DOI 10.1038/jid.2015.334; Cortes-Lopez Mariela, 2016, Yale Journal of Biology and Medicine, V89, P527; Cui XL, 2016, BIOMARK MED, V10, P943, DOI 10.2217/bmm-2016-0130; Daskalova E, 2006, EVOL BIOINFORM, V2, P103; Dong R, 2017, RNA BIOL, V14, P1064, DOI 10.1080/15476286.2016.1269999; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Gordon S, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0392-4; Guarnerio J, 2016, CELL, V165, P289, DOI 10.1016/j.cell.2016.03.020; Gungen AC, 2016, RESPIR MED CASE REP, V18, P93, DOI 10.1016/j.rmcr.2016.04.011; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Impellizzeri D, 2015, BRIT J NUTR, V114, P853, DOI 10.1017/S0007114515002597; Jin X, 2016, ONCOTARGET, V7, P66455, DOI 10.18632/oncotarget.12186; Jura J, 2012, BBA-MOL CELL RES, V1823, P1905, DOI 10.1016/j.bbamcr.2012.06.029; Lasda E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148407; Li ZY, 2017, NAT STRUCT MOL BIOL, V24, P194, DOI 10.1038/nsmb0217-194a; Liang J, 2008, J BIOL CHEM, V283, P6337, DOI 10.1074/jbc.M707861200; Liang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002880; Liu H, 2016, J BIORESOURCES BIOPR, V1, P55; Liu Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep22572; Mackay JP, 1998, TRENDS BIOCHEM SCI, V23, P1, DOI 10.1016/S0968-0004(97)01168-7; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Miao RM, 2016, J THORAC DIS, V8, P329, DOI 10.21037/jtd.2016.02.46; Mosser D. M., 2008, CURR PROTOC IMMUNOL, V83; Murthy S, 2015, FASEB J, V29, P3527, DOI 10.1096/fj.15-271304; Pollard KM, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00097; Rosengarten D, 2017, AM J IND MED, V60, P248, DOI 10.1002/ajim.22687; Stumpo DJ, 2004, MOL CELL BIOL, V24, P6445, DOI 10.1128/MCB.24.14.6445-6455.2004; Sziksz E, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/764641; Talhouarne GJS, 2014, RNA, V20, P1476, DOI 10.1261/rna.045781.114; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Wang K, 2016, EUR HEART J, V37, P2602, DOI 10.1093/eurheartj/ehv713; Wang XG, 2016, TOXICOL SCI, V151, P126, DOI 10.1093/toxsci/kfw029; Westholm JO, 2014, CELL REP, V9, P1966, DOI 10.1016/j.celrep.2014.10.062; Xie HJ, 2016, ONCOTARGET, V7, P26680, DOI 10.18632/oncotarget.8589; Yang CB, 2015, CRIT REV EUKAR GENE, V25, P77, DOI 10.1615/CritRevEukaryotGeneExpr.2015013022; Zhang Y, 2013, MOL CELL, V51, P792, DOI 10.1016/j.molcel.2013.08.017; Zhao MM, 2013, MOL MED REP, V8, P741, DOI 10.3892/mmr.2013.1580; Zheng QP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11215; Zhou ZW, 2018, THERANOSTICS, V8, P575, DOI 10.7150/thno.21648	46	64	68	2	45	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3264	3277		10.1096/fj.201701118R	http://dx.doi.org/10.1096/fj.201701118R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401612				2022-12-28	WOS:000432546000030
J	Neumann, V; Knies, R; Seidinger, A; Simon, A; Lorenz, K; Matthey, M; Breuer, J; Wenzel, D				Neumann, Vanessa; Knies, Ralf; Seidinger, Alexander; Simon, Annika; Lorenz, Kristina; Matthey, Michaela; Breuer, Johannes; Wenzel, Daniela			The beta(2) agonist terbutaline specifically decreases pulmonary arterial pressure under normoxia and hypoxia via alpha adrenoceptor antagonism	FASEB JOURNAL			English	Article						pulmonary vasorelaxation; lung physiology; pulmonary circulation; drug research	RAT INTRAPULMONARY ARTERY; NITRIC-OXIDE; HYPERTENSION; RECEPTOR; RELAXATION; AORTA; CONTRACTION; NEBIVOLOL; ALPHA(1)-ADRENOCEPTOR; 5-HYDROXYTRYPTAMINE	Pulmonary hypertension is a severe, incurable disease with a poor prognosis. Although treatment regimens have improved during the last 2 decades, current pharmacologic strategies are limited and focus on the modulation of only a few pathways related to endothelin, NO, and prostacyclin signaling. Therefore, the identification of novel molecular targets is urgently needed. We found that the beta(2) adrenoceptor (AR) agonists terbutaline (TER) and salbutamol induced a dose-dependent vasorelaxation in large pulmonary arteries but not aortas of mouse. This effect was found to be independent of beta ARs and the endothelium but was determined by the type of the preconstrictor. Vasodilation by beta(2) AR agonists occurred after pretreatment of pulmonary arteries with phenylephrine and serotonin, both agonists of alpha(1) ARs, but was absent after preconstriction with the thromboxane analog U46619. These data indicated alpha-adrenolytic activity of beta(2) AR agonists, which was confirmed by a right shift of the phenylephrine dose-response curve by TER. This effect was physiologically relevant because TER also relaxed small intrapulmonary arteries in lung slices and diminished pulmonary arterial pressure in an isolated perfused lung model under normoxia and hypoxia. Finally, TER applied as an aerosol also selectively decreased pulmonary arterial pressure without effects on systemic blood pressure and heart rate in mouse in vivo. Thus, beta(2) AR agonists display alpha-adrenolytic activity in pulmonary arteries ex vivo and in vivo, and may provide a novel option to reduce pulmonary arterial pressure in pulmonary hypertension.	[Neumann, Vanessa; Seidinger, Alexander; Simon, Annika; Matthey, Michaela; Wenzel, Daniela] Univ Bonn, Med Fac, Inst Physiol 1, Life & Brain Ctr, Bonn, Germany; [Neumann, Vanessa; Knies, Ralf; Breuer, Johannes] Univ Clin Bonn, Pediat Heart Ctr, Dept Pediat Cardiol, Bonn, Germany; [Lorenz, Kristina] Leibniz Inst Analyt Wissensch ISAS, Dortmund, Germany; [Lorenz, Kristina] West German Heart & Vasc Ctr, Essen, Germany	University of Bonn; University of Bonn; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS)	Wenzel, D (corresponding author), Univ Bonn, Med Fac, Inst Physiol 1, Sigmund Freud St 25, D-53127 Bonn, Germany.	dwenzel@uni-bonn.de	Wenzel, Daniela/B-7613-2014; Lorenz, Kristina/F-3522-2016	Wenzel, Daniela/0000-0003-1100-6363; Matthey, Michaela/0000-0002-1841-2906; Seidinger, Alexander/0000-0001-5086-0605; Lorenz, Kristina/0000-0002-5747-2207; Simon, Annika/0000-0003-2907-2684	Deutsche Forschungsgemeinschaft (DFG) [WE 4461/1-1]; Deutsche Gesellschaft fur Padiatrische Kardiologie	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Gesellschaft fur Padiatrische Kardiologie	The authors thank T. von Einem (University of Bonn) for technical assistance. This study was supported by the Deutsche Forschungsgemeinschaft (DFG) (WE 4461/1-1 to D.W.) and the Deutsche Gesellschaft fur Padiatrische Kardiologie (to R.K.). The authors declare no conflicts of interest.	Albouaini Khaled, 2007, Int J Chron Obstruct Pulmon Dis, V2, P535; ALPERT MA, 1994, ANGIOLOGY, V45, P667, DOI 10.1177/000331979404500801; ARUNLAKSHANA O, 1959, BRIT J PHARM CHEMOTH, V14, P48, DOI 10.1111/j.1476-5381.1959.tb00928.x; BALUK P, 1994, AM J PHYSIOL, V266, pL461, DOI 10.1152/ajplung.1994.266.4.L461; Bogaard HJ, 2010, AM J RESP CRIT CARE, V182, P652, DOI 10.1164/rccm.201003-0335OC; Brahmadevara N, 2004, BRIT J PHARMACOL, V142, P781, DOI 10.1038/sj.bjp.0705840; Brahmadevara N, 2003, BRIT J PHARMACOL, V138, P99, DOI 10.1038/sj.bjp.0705017; Broeders MAW, 2000, CIRCULATION, V102, P677, DOI 10.1161/01.CIR.102.6.677; de Man FS, 2013, AM J RESP CRIT CARE, V187, P14, DOI 10.1164/rccm.201209-1663PP; de Man FS, 2012, CIRC-HEART FAIL, V5, P97, DOI 10.1161/CIRCHEARTFAILURE.111.964494; Delavoie F, 2009, AM J RESP CELL MOL, V40, P388, DOI 10.1165/rcmb.2008-0037OC; Dessy C, 2005, CIRCULATION, V112, P1198, DOI 10.1161/CIRCULATIONAHA.104.532960; ELIASEN K, 1991, CLIN PHYSIOL, V11, P231, DOI 10.1111/j.1475-097X.1991.tb00454.x; Elwing Jean, 2008, Int J Chron Obstruct Pulmon Dis, V3, P55; Faber JE, 2007, AM J PHYSIOL-HEART C, V292, pH2316, DOI 10.1152/ajpheart.00792.2006; Goncharova EA, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-109; Hanania Nicola A., 2004, Current Drug Targets - Inflammation and Allergy, V3, P271, DOI 10.2174/1568010043343598; Holverda S, 2006, J AM COLL CARDIOL, V47, P1732, DOI 10.1016/j.jacc.2006.01.048; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029; JONES RM, 1982, THORAX, V37, P746, DOI 10.1136/thx.37.10.746; KILLAM AL, 1995, EUR J PHARMACOL, V273, P7, DOI 10.1016/0014-2999(94)00613-C; Koola MM, 2014, THER ADV PSYCHOPHARM, V4, P43, DOI 10.1177/2045125313500982; Kozlowska H, 2005, J CARDIOVASC PHARM, V46, P76; Kozlowska H, 2003, BRIT J PHARMACOL, V140, P3, DOI 10.1038/sj.bjp.0705421; Leblais V, 2004, J PHARMACOL EXP THER, V309, P137, DOI 10.1124/jpet.103.061192; Leblais Veronique, 2005, Naunyn Schmiedebergs Arch Pharmacol, V371, P535, DOI 10.1007/s00210-005-1067-1; Leblais V, 2008, CARDIOVASC RES, V77, P202, DOI 10.1093/cvr/cvm008; MARIN J, 1981, J PHARM PHARMACOL, V33, P715, DOI 10.1111/j.2042-7158.1981.tb13911.x; Matthey M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag2288; Narayan Perinchery, 2005, Rev Urol, V7 Suppl 4, pS42; OGAWA Y, 1995, JPN CIRC J, V59, P89, DOI 10.1253/jcj.59.89; ORIOWO MA, 1994, BRIT J PHARMACOL, V113, P699, DOI 10.1111/j.1476-5381.1994.tb17049.x; Perros F, 2015, J AM COLL CARDIOL, V65, P668, DOI 10.1016/j.jacc.2014.11.050; Pourageaud F, 2005, N-S ARCH PHARMACOL, V372, P14, DOI 10.1007/s00210-005-1082-2; PURDY RE, 1987, J PHARMACOL EXP THER, V240, P535; RIBEIRO CAF, 1991, PHARMACOLOGY, V43, P264; Salvi SS, 1999, CHEST, V115, P1708, DOI 10.1378/chest.115.6.1708; Schmid E, 2015, NAT MED, V21, P1298, DOI 10.1038/nm.3972; SEMPLICINI A, 1981, CLIN EXP PHARMACOL P, V8, P1, DOI 10.1111/j.1440-1681.1981.tb00127.x; Shaw AM, 2000, PULM PHARMACOL THER, V13, P277, DOI 10.1006/pupt.2000.0255; STARKE K, 1975, N-S ARCH PHARMACOL, V291, P55, DOI 10.1007/BF00510821; Velez-Roa S, 2004, CIRCULATION, V110, P1308, DOI 10.1161/01.CIR.0000140724.90898.D3; Vosen S, 2016, J CONTROL RELEASE, V241, P164, DOI 10.1016/j.jconrel.2016.09.024; Vosen S, 2016, ACS NANO, V10, P369, DOI 10.1021/acsnano.5b04996; Wee S, 2008, EUR NEUROPSYCHOPHARM, V18, P303, DOI 10.1016/j.euroneuro.2007.08.003; Welschoff J, 2014, FASEB J, V28, P2281, DOI 10.1096/fj.13-246348; Wenzel D, 2013, P NATL ACAD SCI USA, V110, P18710, DOI 10.1073/pnas.1308130110; Wenzel D, 2012, HYPERTENSION, V59, P1256, DOI 10.1161/HYPERTENSIONAHA.111.188367; Wenzel D, 2012, PHARM RES-DORDR, V29, P1242, DOI 10.1007/s11095-011-0657-5; Wenzel D, 2009, HYPERTENSION, V54, P157, DOI 10.1161/HYPERTENSIONAHA.109.130468	50	3	4	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2519	2530		10.1096/fj.201700684RR	http://dx.doi.org/10.1096/fj.201700684RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29295855				2022-12-28	WOS:000432528000017
J	Abiraman, K; Tzingounis, AV; Lykotrafitis, G				Abiraman, Krithika; Tzingounis, Anastasios V.; Lykotrafitis, George			K(Ca)2 channel localization and regulation in the axon initial segment	FASEB JOURNAL			English	Article						potassium channels; atomic force microscopy; cAMP; PKA; endocytosis	CA2+-ACTIVATED K+ CHANNEL; FUNCTIONAL EXPRESSION; POTASSIUM CHANNEL; SK2 CHANNELS; APAMIN; PLASTICITY; MEMBRANE; TRAFFICKING; SUBUNITS; ISOFORM	Small conductance calcium-activated potassium (K(Ca)2) channels are expressed throughout the CNS and play a critical role in synaptic and neuronal excitability. K(Ca)2 channels have a somatodendritic distribution with their highest expression in distal dendrites. It is unclear whether K(Ca)2 channels are specifically present on the axon initial segment (AIS), the site at which action potentials are initiated in neurons. Through a powerful combination of toxin pharmacology, single-molecule atomic force microscopy, and dual-color fluorescence microscopy, we report here that K(Ca)2 channels-predominantly the K(Ca)2.3 subtype-are indeed present on the AIS. We also report that cAMP-PKA controls the axonal K(Ca)2 channel surface expression. Surprisingly, and in contrast to K(Ca)2 channels that were observed in the soma and dendrites, the inhibition of cAMP-PKA increased the surface expression of K(Ca)2 channels without promoting nanoclustering. Lastly, we found that axonal K(Ca)2 channels seem to undergo endocytosis in a dynamin-independent manner, unlike K(Ca)2 channels in the soma and dendrites. Together, these novel results demonstrate that the distribution and membrane recycling of K(Ca)2 channels differs among various neuronal subcompartments.	[Abiraman, Krithika; Tzingounis, Anastasios V.; Lykotrafitis, George] Univ Connecticut, Dept Biomed Engn, Storrs, CT 06269 USA; [Tzingounis, Anastasios V.] Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA; [Lykotrafitis, George] Univ Connecticut, Dept Mech Engn, 191 Auditorium Rd,Unit 3139, Storrs, CT 06269 USA	University of Connecticut; University of Connecticut; University of Connecticut	Lykotrafitis, G (corresponding author), Univ Connecticut, Dept Mech Engn, 191 Auditorium Rd,Unit 3139, Storrs, CT 06269 USA.; Tzingounis, AV (corresponding author), Physiol & Neurobiol, 75 North Eagleville Rd,Unit 3156, Storrs, CT 06269 USA.	anastasios.tzingounis@uconn.edu; gelyko@engr.uconn.edu			National Science Foundation Civil, Mechanical and Manufacturing Innovation (CMMI) Career Award [1354363]; U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke [NS073981, MH110887]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH110887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073981, R56NS073981] Funding Source: NIH RePORTER; Div Of Civil, Mechanical, & Manufact Inn [1351363] Funding Source: National Science Foundation	National Science Foundation Civil, Mechanical and Manufacturing Innovation (CMMI) Career Award; U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by the National Science Foundation Civil, Mechanical and Manufacturing Innovation (CMMI) Career Award (1354363; to G.L.), and the U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke (Grants NS073981 and MH110887; to A.V.T.). The authors declare no conflicts of interest.	Abiraman K, 2016, J MOL BIOL, V428, P2521, DOI 10.1016/j.jmb.2016.04.014; Allen D, 2011, NAT NEUROSCI, V14, P744, DOI 10.1038/nn.2832; Ballesteros-Merino C, 2014, EUR J NEUROSCI, V39, P883, DOI 10.1111/ejn.12474; Ballesteros-Merino C, 2012, HIPPOCAMPUS, V22, P1467, DOI 10.1002/hipo.20986; Bhushan B, 2004, SPRINGER HANDBOOK OF NANOTECHNOLOGY, P475; Bowden SEH, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-20-j0006.2001; Carrodus NL, 2014, JOVE-J VIS EXP, DOI 10.3791/51139; Cueni L, 2008, NAT NEUROSCI, V11, P683, DOI 10.1038/nn.2124; D'hoedt D, 2004, J BIOL CHEM, V279, P12088, DOI 10.1074/jbc.C300382200; Deschaux O, 2005, NEUROSCI LETT, V386, P5, DOI 10.1016/j.neulet.2005.05.050; Deschaux O, 1997, NEUROSCI LETT, V222, P159, DOI 10.1016/S0304-3940(97)13367-5; Dupres V, 2005, NAT METHODS, V2, P515, DOI 10.1038/NMETH769; Faber ESL, 2008, J NEUROSCI, V28, P10803, DOI 10.1523/JNEUROSCI.1796-08.2008; Ishii TM, 1997, J BIOL CHEM, V272, P23195, DOI 10.1074/jbc.272.37.23195; Leterrier C, 2015, CELL REP, V13, P2781, DOI 10.1016/j.celrep.2015.11.051; Lin MT, 2008, NAT NEUROSCI, V11, P170, DOI 10.1038/nn2041; Lin MT, 2010, J NEUROSCI, V30, P11726, DOI 10.1523/JNEUROSCI.1411-10.2010; Lu L, 2009, P NATL ACAD SCI USA, V106, P18402, DOI 10.1073/pnas.0908207106; Maciaszek JL, 2012, J NEUROSCI, V32, P11435, DOI 10.1523/JNEUROSCI.1785-12.2012; MESSIER C, 1991, BRAIN RES, V551, P322, DOI 10.1016/0006-8993(91)90950-Z; MOY VT, 1994, SCIENCE, V266, P257, DOI 10.1126/science.7939660; Obermair GJ, 2003, EUR J NEUROSCI, V17, P721, DOI 10.1046/j.1460-9568.2003.02488.x; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; Partola KR, 2016, J BIOMECH, V49, P1221, DOI 10.1016/j.jbiomech.2016.02.035; Rafizadeh S, 2014, P NATL ACAD SCI USA, V111, P9989, DOI 10.1073/pnas.1323541111; Ren YJ, 2006, J BIOL CHEM, V281, P11769, DOI 10.1074/jbc.M513125200; Sailer CA, 2002, J NEUROSCI, V22, P9698; Stackman RW, 2002, J NEUROSCI, V22, P10163; Stocker M, 2000, MOL CELL NEUROSCI, V15, P476, DOI 10.1006/mcne.2000.0842; Strassmaier T, 2005, J BIOL CHEM, V280, P21231, DOI 10.1074/jbc.M413125200; van Weert AWM, 2000, EUR J CELL BIOL, V79, P394, DOI 10.1078/0171-9335-00062; Voos P, 2017, EUR BIOPHYS J BIOPHY, V46, P517, DOI 10.1007/s00249-016-1196-0; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Yu YG, 2010, J NEUROSCI, V30, P11858, DOI 10.1523/JNEUROSCI.2651-10.2010; Zhang J, 2017, BIOPHYS J, V112, P143, DOI 10.1016/j.bpj.2016.11.3204; Zhang Y, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005567; Zhong GS, 2014, ELIFE, V3, DOI 10.7554/eLife.04581	37	6	6	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1794	1805		10.1096/fj.201700605R	http://dx.doi.org/10.1096/fj.201700605R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29180442	Green Published			2022-12-28	WOS:000429051400005
J	Wu, MR; Liu, HM; Lu, CW; Shen, WH; Lin, IJ; Liao, LW; Huang, YY; Shieh, MJ; Hsiao, JK				Wu, Menq-Rong; Liu, Hon-Man; Lu, Chen-Wen; Shen, Way-Hone; Lin, I-Jou; Liao, Li-Wen; Huang, Yi-You; Shieh, Ming-Jium; Hsiao, Jong-Kai			Organic anion-transporting polypeptide 1B3 as a dual reporter gene for fluorescence and magnetic resonance imaging	FASEB JOURNAL			English	Article						IVIS; cell tracking; ICG; Gd-EOB-DTPA; near-infrared	GD-EOB-DTPA; HEPATIC-UPTAKE; CONTRAST; MRI; AGENT; RECEPTOR; LIGHT; OATPS	Reporter proteins have broad applications in visualizing molecular events at the cellular, tissue and whole-body levels. Transmembrane transporters recognizing specific molecular domains are of particular interest because they enable the migration of signal-source molecules from the extracellular space to the cytoplasm for subsequent application in multimodality imaging. Organic anion-transporting polypeptides (OATPs) have demonstrated their MRI reporter efficacy. We further expanded their use as a dual-modality reporter in MRI and noninvasive in vivo imaging system (IVIS). We overexpressed OATP1B3 in the HT-1080 sarcoma cell line. Both Gd-EOB-DTPA, an MRI contrast agent, and indocyanine green (ICG), a near-infrared fluorescent dye that provides better deep-tissue detection because of its long wave length, could be delivered to the intracellular space and imaged in a tumor-bearing nude mouse model. Our in vivo dual-imaging reporter system achieved high sensitivity in MRI and observation periods lasting as long as 96 h in IVIS. Because of the superior temporal and spatial resolutions and the clinical availability of both ICG and Gd-EOB-DTPA, this dual-imaging OATP1B3 system will find biomedical use in tumor biology, stem cell trafficking, and tissue engineering.	[Wu, Menq-Rong; Huang, Yi-You; Shieh, Ming-Jium] Natl Taiwan Univ, Inst Biomed Engn, Taipei, Taiwan; [Liu, Hon-Man] Natl Taiwan Univ, Dept Med Imaging, Natl Taiwan Univ Hosp, Taipei, Taiwan; [Liu, Hon-Man] Natl Taiwan Univ, Dept Radiol, Coll Med, Taipei, Taiwan; [Wu, Menq-Rong; Lu, Chen-Wen; Shen, Way-Hone; Lin, I-Jou; Liao, Li-Wen; Hsiao, Jong-Kai] Taipei TzuChi Gen Hosp, Buddhist Tzu Chi Med Fdn, Dept Med Imaging, New Taipei, Taiwan; [Liu, Hon-Man] Fu Jen Catholic Univ & Hosp, Dept Radiol & Med Imaging, New Taipei, Taiwan; [Lu, Chen-Wen] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Hsiao, Jong-Kai] Tzu Chi Univ, Sch Med, Hualien, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Fu Jen Catholic University; Fu Jen Catholic University Hospital; National Taiwan Normal University; Tzu Chi University	Hsiao, JK (corresponding author), Taipei Tzu Chi Hosp, Dept Med Imaging, 289 Jianguo Rd, New Taipei 23142, Taiwan.	jongkai@gmail.com		LIU, HON-MAN/0000-0001-6715-6366; Wu, Menq-Rong/0000-0002-6139-8062	National Research Program for Biopharmaceuticals (Ministry of Science and Technology of Taiwan) [MOST 105-2325-B-001-010]; Core Laboratory of the Taipei Tzu Chi Hospital (Buddhist Tzu Chi Medical Foundation); National Science Council [NSC 99-2314-B-303-012-MY3, 102-2628-B-303-001-MY3, 103-2314-B-303-001-MY3]; Taiwan Ministry of Science and Technology	National Research Program for Biopharmaceuticals (Ministry of Science and Technology of Taiwan); Core Laboratory of the Taipei Tzu Chi Hospital (Buddhist Tzu Chi Medical Foundation); National Science Council(Ministry of Science and Technology, Taiwan); Taiwan Ministry of Science and Technology	The authors thank the 7-T Animal MRI Core Lab of the Molecular Imaging Center (National Taiwan University) for providing technical and facility support; the Taiwan Mouse Clinic, which is funded by the National Research Program for Biopharmaceuticals (Ministry of Science and Technology of Taiwan; Grant MOST 105-2325-B-001-010) for providing technical support for the IVIS experiment, and the staff of the Core Labs Department of Medical Research (National Taiwan University Hospital) for providing technical support. Financial support was provided by The Core Laboratory of the Taipei Tzu Chi Hospital (Buddhist Tzu Chi Medical Foundation); and by Grant NSC 99-2314-B-303-012-MY3, 102-2628-B-303-001-MY3 and 103-2314-B-303-001-MY3 from the National Science Council, and the Taiwan Ministry of Science and Technology to J.H. The authors declare no conflicts of interest.	Alander JT, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/940585; Alford R, 2009, MOL IMAGING, V8, P341, DOI 10.2310/7290.2009.00031; Cui Y, 2001, J BIOL CHEM, V276, P9626, DOI 10.1074/jbc.M004968200; de Graaf W, 2011, J HEPATOL, V54, P738, DOI 10.1016/j.jhep.2010.07.047; Deans AE, 2006, MAGN RESON MED, V56, P51, DOI 10.1002/mrm.20914; Gilad AA, 2008, J NUCL MED, V49, P1905, DOI 10.2967/jnumed.108.053520; Hagenbuch B, 2003, BBA-BIOMEMBRANES, V1609, P1, DOI 10.1016/S0005-2736(02)00633-8; Hogemann-Savellano D, 2003, NEOPLASIA, V5, P495; Hoogstins CES, 2016, CLIN CANCER RES, V22, P2929, DOI 10.1158/1078-0432.CCR-15-2640; Ito A, 2014, GASTRIC CANCER, V17, P497, DOI 10.1007/s10120-013-0316-0; Judy RP, 2015, SCI REP-UK, V5, DOI 10.1038/srep16208; LANDSMAN MLJ, 1976, J APPL PHYSIOL, V40, P575, DOI 10.1152/jappl.1976.40.4.575; Laufer J, 2013, BIOMED OPT EXPRESS, V4, P2477, DOI 10.1364/BOE.4.002477; Laufer J, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.5.056016; Leonhardt M, 2010, DRUG METAB DISPOS, V38, P1024, DOI 10.1124/dmd.110.032862; Maruyama T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122849; Muhler A., 1993, MAGMA MAGN RESON MAT, V1, P134; Murata M, 2014, EUR J PHARM BIOPHARM, V86, P115, DOI 10.1016/j.ejpb.2013.09.006; Patrick PS, 2014, MOL IMAGING BIOL, V16, P626, DOI 10.1007/s11307-014-0741-4; Patrick PS, 2014, P NATL ACAD SCI USA, V111, P415, DOI 10.1073/pnas.1319000111; Qin CX, 2013, SCI REP-UK, V3, DOI 10.1038/srep01490; Sabapathy V, 2015, STEM CELLS INT, V2015; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schonitzer V, 2014, J NUCL MED, V55, P1342, DOI 10.2967/jnumed.113.134775; Serganova I, 2012, NUCL MED REV, V15, pC20; Svoboda M, 2011, CURR DRUG METAB, V12, P139, DOI 10.2174/138920011795016863; Thakkar N, 2015, AAPS J, V17, P535, DOI 10.1208/s12248-015-9740-x; Thorne N, 2010, CHEM BIOL, V17, P646, DOI 10.1016/j.chembiol.2010.05.012; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Van Beers BE, 2012, J HEPATOL, V57, P421, DOI 10.1016/j.jhep.2012.01.031; Vandsburger MH, 2013, NMR BIOMED, V26, P872, DOI 10.1002/nbm.2869; Weber J, 2016, NAT METHODS, V13, P639, DOI [10.1038/nmeth.3929, 10.1038/NMETH.3929]; Weissleder Ralph, 2000, Nature Medicine, V6, P351, DOI 10.1038/73219; Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123; Zhang HF, 2006, NAT BIOTECHNOL, V24, P848, DOI 10.1038/nbt1220	35	23	24	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1705	1715		10.1096/fj.201700767R	http://dx.doi.org/10.1096/fj.201700767R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29146731	Green Published, hybrid			2022-12-28	WOS:000427246000046
J	Peng, LQ; Zhao, H; Liu, S; Yuan, YP; Yuan, CY; Mwamunyi, MJ; Pearce, D; Yao, LJ				Peng, Li-Qin; Zhao, Hong; Liu, Song; Yuan, Ya-Pei; Yuan, Cheng-Yan; Mwamunyi, Mercy-Julian; Pearce, David; Yao, Li-Jun			Lack of serum- and glucocorticoid-inducible kinase 3 leads to podocyte dysfunction	FASEB JOURNAL			English	Article						cell viability; podocin; proteinuria	PKB/SGK-RESISTANT GSK3; TARGETED MICE LACKING; PUROMYCIN AMINONUCLEOSIDE; UP-REGULATION; DIABETIC CONDITIONS; ISOFORM SGK3; IN-VITRO; INJURY; ACTIVATION; KIDNEY	Serum- and glucocorticoid-inducible kinase 3 (SGK3) is a downstream mediator of PI3K, which is essential for maintaining the functional integrity of podocytes. However, little is known about the role of SGK3 in podocyte function. Herein, we demonstrated that SGK3 contributes to the maintenance of podocyte integrity. Conditionally immortalized mouse podocyte cells (MPCs) were treated with puromycin aminonucleoside (PAN). PAN treatment inhibited the activity of SGK3 and the expression of podocin. Short hairpin RNA (shRNA)-mediated knockdown of SGK3 also reduced podocin expression in the absence of PAN. Adriamycin (ADR)-treated mice developed proteinuria and had decreased renal glomerular SGK3 expression in comparison to control mice. Consistent with a role for SGK3 in the ADR effect, SGK3 knockout (KO) mice had markedly reduced kidney podocin expression and significantly elevated proteinuria compared with wild-type mice. Electron microscopy revealed that SGK3 KO mice displayed partial effacement of podocyte foot processes. Further, a SGK3 target protein, glycogen synthase kinase-3 (GSK3), was discovered to be dramatically activated in PAN and SGK3 shRNA-treated MPCs and in SGK3 KO mice. Taken together, these data strongly suggest that SGK3 plays a significant role in regulating podocyte function, likely by controlling the expression and activity of GSK3.	[Peng, Li-Qin; Liu, Song; Yuan, Ya-Pei; Yuan, Cheng-Yan; Mwamunyi, Mercy-Julian; Yao, Li-Jun] Huazhong Univ Sci & Technol, Union Hosp, Dept Nephrol, Tongji Med Coll, Jiefang Rd 1277, Wuhan 430022, Hubei, Peoples R China; [Zhao, Hong] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Trauma Surg, Wuhan, Hubei, Peoples R China; [Pearce, David] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Pearce, David] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Yao, LJ (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Dept Nephrol, Tongji Med Coll, Jiefang Rd 1277, Wuhan 430022, Hubei, Peoples R China.	drylj@hotmail.com			National Nature Science foundation of China [81370818]	National Nature Science foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Zi-Fang Li (Union Hospital, Tongji Medical College, Huazhong University of Science and Technology) for help in revising the manuscript. This work was supported by the National Nature Science foundation of China (Grant 81370818). The authors declare no conflicts of interest.	Ahmed M, 2016, CELL PHYSIOL BIOCHEM, V38, P359, DOI 10.1159/000438636; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Bhandaru M, 2011, KIDNEY INT, V80, P61, DOI 10.1038/ki.2011.67; Boehmer C, 2007, FEBS LETT, V581, P5586, DOI 10.1016/j.febslet.2007.11.006; Boehmer C, 2006, J NEUROCHEM, V97, P911, DOI 10.1111/j.1471-4159.2006.03629.x; Bohmer C, 2010, CELL PHYSIOL BIOCHEM, V25, P723, DOI 10.1159/000315092; Boini KM, 2009, AM J PHYSIOL-RENAL, V296, pF153, DOI 10.1152/ajprenal.90398.2008; Canaud G, 2013, NAT MED, V19, P1288, DOI 10.1038/nm.3313; Dai FY, 2002, BIOCHEM BIOPH RES CO, V293, P1191, DOI 10.1016/S0006-291X(02)00349-2; Dong N, 2017, INT UROL NEPHROL, V49, P1489, DOI 10.1007/s11255-017-1622-y; Fejes-Toth G, 2008, AM J PHYSIOL-RENAL, V294, pF1298, DOI 10.1152/ajprenal.00579.2007; Foller M, 2011, J AM SOC NEPHROL, V22, P873, DOI 10.1681/ASN.2010070757; Fogo AB, 2003, SEMIN NEPHROL, V23, P161, DOI 10.1053/snep.2003.50015; Fogo AB, 2015, NAT REV NEPHROL, V11, P76, DOI 10.1038/nrneph.2014.216; Friedrich B, 2002, KIDNEY BLOOD PRESS R, V25, P303, DOI 10.1159/000066794; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Grahammer F, 2006, AM J PHYSIOL-REG I, V290, pR945, DOI 10.1152/ajpregu.00484.2005; Ha TS, 2015, DIABETES-METAB RES, V31, P50, DOI 10.1002/dmrr.2562; Henke G, 2002, KIDNEY BLOOD PRESS R, V25, P370, DOI 10.1159/000068699; Huang DY, 2006, AM J PHYSIOL-RENAL, V291, pF1264, DOI 10.1152/ajprenal.00299.2005; Huang DY, 2004, J AM SOC NEPHROL, V15, P885, DOI 10.1097/01.ASN.0000120368.59693.A8; Huber TB, 2003, MOL CELL BIOL, V23, P4917, DOI 10.1128/MCB.23.14.4917-4928.2003; Kang HG, 2010, NEPHRON EXP NEPHROL, V115, pE1, DOI 10.1159/000286518; Kobayashi T, 1999, BIOCHEM J, V344, P189, DOI 10.1042/0264-6021:3440189; Kumar JM, 1999, J AM SOC NEPHROL, V10, P2488; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Li CB, 2016, J PATHOL, V239, P23, DOI 10.1002/path.4692; Li XZ, 2015, J AM SOC NEPHROL, V26, P2361, DOI 10.1681/ASN.2014040405; Liang YX, 2015, BIOCHEM BIOPH RES CO, V463, P70, DOI 10.1016/j.bbrc.2015.05.020; Liu GY, 2015, PHARMACOLOGY, V95, P193, DOI 10.1159/000381314; Maier G, 2006, CELL PHYSIOL BIOCHEM, V18, P177, DOI 10.1159/000097666; Mariappan MM, 2014, J BIOL CHEM, V289, P35363, DOI 10.1074/jbc.M114.587840; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Nasir O, 2009, IUBMB LIFE, V61, P768, DOI 10.1002/iub.209; Paeng J, 2014, APOPTOSIS, V19, P1678, DOI 10.1007/s10495-014-1037-5; Pasham V, 2011, J GASTROENTEROL, V46, P305, DOI 10.1007/s00535-010-0348-8; Pippin JW, 2009, AM J PHYSIOL-RENAL, V296, pF213, DOI 10.1152/ajprenal.90421.2008; Ren Q, 2016, J RECEPT SIG TRANSD, V36, P288, DOI 10.3109/10799893.2015.1101137; Sandu C, 2005, PFLUG ARCH EUR J PHY, V451, P437, DOI 10.1007/s00424-005-1474-7; Schmid E, 2012, CELL PHYSIOL BIOCHEM, V30, P1423, DOI 10.1159/000343330; Sobiesiak M, 2009, J IMMUNOL, V183, P4395, DOI 10.4049/jimmunol.0803017; Strutz-Seebohm N, 2006, PFLUG ARCH EUR J PHY, V452, P276, DOI 10.1007/s00424-005-0032-7; Tessier M, 2006, J BIOL CHEM, V281, P23978, DOI 10.1074/jbc.M604333200; Trepiccione F, 2011, KIDNEY INT, V80, P13, DOI 10.1038/ki.2011.60; Wang Y, 2000, KIDNEY INT, V58, P1797, DOI 10.1046/j.1523-1755.2000.00342.x; Yaddanapudi S, 2011, J CLIN INVEST, V121, P3965, DOI 10.1172/JCI58552; Yang SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074871; Yao LJ, 2011, MOL ENDOCRINOL, V25, P2106, DOI 10.1210/me.2010-0329; Zheng CX, 2008, KIDNEY INT, V74, P596, DOI 10.1038/ki.2008.203; Zou J, 2006, VIRCHOWS ARCH, V448, P485, DOI 10.1007/s00428-005-0134-9	50	4	4	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					576	587		10.1096/fj.201700393RR	http://dx.doi.org/10.1096/fj.201700393RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	28935820	Bronze, Green Published			2022-12-28	WOS:000425146900005
J	Hagmann, H; Mangold, N; Rinschen, MM; Koenig, T; Kunzelmann, K; Schermer, B; Benzing, T; Brinkkoetter, PT				Hagmann, Henning; Mangold, Nicole; Rinschen, Markus M.; Koenig, Tim; Kunzelmann, Karl; Schermer, Bernhard; Benzing, Thomas; Brinkkoetter, Paul T.			Proline-dependent and basophilic kinases phosphorylate human TRPC6 at serine 14 to control channel activity through increased membrane expression	FASEB JOURNAL			English	Article						MAPK; cyclin-dependent kinase 5; proteinuria; podocyte; glomerular disease	FOCAL SEGMENTAL GLOMERULOSCLEROSIS; PODOCYTE INJURY; ANGIOTENSIN-II; PHOSPHOPROTEOMIC ANALYSIS; TYROSINE PHOSPHORYLATION; DIABETIC-NEPHROPATHY; CARDIAC-HYPERTROPHY; NEPHROTIC SYNDROME; CATION CHANNELS; ACTIVATION	Signaling via the transient receptor potential (TRP) ion channel C6 plays a pivotal role in hereditary and sporadic glomerular kidney disease. Several studies have identified gain-of-function mutations of TRPC6 and report induced expression and enhanced channel activity of TRPC6 in association with glomerular diseases. Interfering with TRPC6 activity may open novel therapeutic pathways. TRPC6 channel activity is controlled by protein expression and stability as well as intracellular trafficking. Identification of regulatory phosphorylation sites in TRPC6 and corresponding protein kinases is essential to understand the regulation of TRPC6 activity and may result in future therapeutic strategies. In this study, an unbiased phosphoproteomic screen of human TRPC6 identified several novel serine phosphorylation sites. The phosphorylation site at serine 14 of TRPC6 is embedded in a basophilic kinase motif that is highly conserved across species. We confirmed serine 14 as a target of MAPKs and proline-directed kinases like cyclin-dependent kinase 5 (Cdk5) in cell-based as well as in vitro kinase assays and quantitative phosphoproteomic analysis of TRPC6. Phosphorylation of TRPC6 at serine 14 enhances channel conductance by boosting membrane expression of TRPC6, whereas protein stability and multimerization of TRPC6 are not altered, making serine 14 phosphorylation a potential drug target to interfere with TRPC6 channel activity.	[Hagmann, Henning; Mangold, Nicole; Rinschen, Markus M.; Schermer, Bernhard; Benzing, Thomas; Brinkkoetter, Paul T.] Univ Cologne, Ctr Mol Med Cologne, Dept Internal Med 2, Cologne, Germany; [Rinschen, Markus M.; Koenig, Tim; Schermer, Bernhard; Benzing, Thomas] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Rinschen, Markus M.; Schermer, Bernhard; Benzing, Thomas] Univ Cologne, Syst Biol Ageing Cologne Sybacol, Cologne, Germany; [Koenig, Tim] Univ Cologne, Inst Genet, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Kunzelmann, Karl] Univ Regensburg, Dept Physiol, Regensburg, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Regensburg	Brinkkoetter, PT (corresponding author), Univ Hosp Cologne, Ctr Mol Med Cologne, Robert Koch St 21, D-50931 Cologne, Germany.	paul.brinkkoetter@uk-koeln.de	Rinschen, Markus/N-7283-2019; Benzing, Thomas/X-5476-2019; Schermer, Bernhard/E-9972-2014	Rinschen, Markus/0000-0002-9252-1342; Schermer, Bernhard/0000-0002-5194-9000; Konig, Tim/0000-0002-3484-1196	Koln Fortune Program of the University of Cologne; Deutsche Forschungsgemeinschaft [SFB699A7, SCHE1562/2, 1562/6, SFB635, SFB829, BR2955/4-1]	Koln Fortune Program of the University of Cologne; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank A. Koser for technical support. This study was funded by the Koln Fortune Program of the University of Cologne to H.H. K.K. was supported by the Deutsche Forschungsgemeinschaft (SFB699A7). B.S. obtained funding from the Deutsche Forschungsgemeinschaft (SCHE1562/2 and 1562/6). T.B. received funding from the Deutsche Forschungsgemeinschaft (SFB635 and SFB829). P.T.B. received funding from the Deutsche Forschungsgemeinschaft (BR2955/4-1) and the Koln Fortune Program, University of Cologne. The authors declare no conflicts of interest.	Abramowitz J, 2009, FASEB J, V23, P297, DOI 10.1096/fj.08-119495; Ambrus L, 2015, J CELL MOL MED, V19, P2771, DOI 10.1111/jcmm.12660; Bokemeyer D, 1998, KIDNEY INT, V54, pS189, DOI 10.1046/j.1523-1755.1998.06743.x; Bousquet SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018121; Bousquet SM, 2010, J BIOL CHEM, V285, P40534, DOI 10.1074/jbc.M110.160051; Brinkkoetter PT, 2010, KIDNEY INT, V77, P690, DOI 10.1038/ki.2009.548; Brinkkoetter PT, 2009, J CLIN INVEST, V119, P3089, DOI 10.1172/JCI37978; Brinkkoetter PT, 2013, NAT REV NEPHROL, V9, P328, DOI 10.1038/nrneph.2013.78; Chen Z, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.300; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dryer SE, 2010, AM J PHYSIOL-RENAL, V299, pF689, DOI 10.1152/ajprenal.00298.2010; Du JY, 2009, BIOPHYS J, V96, p264A, DOI 10.1016/j.bpj.2008.12.1306; Eckel J, 2011, J AM SOC NEPHROL, V22, P526, DOI 10.1681/ASN.2010050522; Elger M, 1998, NEPHROL DIAL TRANSPL, V13, P1368, DOI 10.1093/ndt/13.6.1368; Heeringa SF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007771; Hisatsune C, 2004, J BIOL CHEM, V279, P18887, DOI 10.1074/jbc.M311274200; Huang HT, 2017, CELL PHYSIOL BIOCHEM, V41, P163, DOI 10.1159/000455985; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Ilatovskaya D., 2015, FASEB J, V29; Ilatovskaya DV, 2015, SCI REP-UK, V5, DOI 10.1038/srep17637; Ilatovskaya DV, 2015, AM J PHYSIOL-RENAL, V309, pF393, DOI 10.1152/ajprenal.00186.2015; Kanda S, 2011, MOL BIOL CELL, V22, P1824, DOI 10.1091/mbc.E10-12-0929; Kim EY, 2012, AM J PHYSIOL-RENAL, V302, pF298, DOI 10.1152/ajprenal.00423.2011; Kohli P, 2014, AM J PHYSIOL-CELL PH, V306, pC805, DOI 10.1152/ajpcell.00339.2013; Koshikawa M, 2005, J AM SOC NEPHROL, V16, P2690, DOI 10.1681/ASN.2004121084; Krall P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012859; Kriz W, 2013, AM J PHYSIOL-RENAL, V304, pF333, DOI 10.1152/ajprenal.00478.2012; Kuwahara K, 2006, J CLIN INVEST, V116, P3114, DOI 10.1172/JCI27702; Lepage PK, 2006, J BIOL CHEM, V281, P30356, DOI 10.1074/jbc.M603930200; Leuner K, 2007, FASEB J, V21, P4101, DOI 10.1096/fj.07-8110com; Liu BC, 2013, BBA-MOL CELL RES, V1833, P1434, DOI 10.1016/j.bbamcr.2013.02.031; Liu SF, 2010, MOL BIOL REP, V37, P2477, DOI 10.1007/s11033-009-9761-6; Liu Y, 2015, BEHAV BRAIN RES, V294, P186, DOI 10.1016/j.bbr.2015.07.062; Maier T, 2015, BRIT J PHARMACOL, V172, P3650, DOI 10.1111/bph.13151; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Moeller CC, 2007, J AM SOC NEPHROL, V18, P29, DOI 10.1681/ASN.2006091010; Mottl AK, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-104; Nijenhuis T, 2011, AM J PATHOL, V179, P1719, DOI 10.1016/j.ajpath.2011.06.033; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Nishida M, 2010, J BIOL CHEM, V285, P13244, DOI 10.1074/jbc.M109.074104; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Rinschen MM, 2016, HUM MOL GENET, V25, P1328, DOI 10.1093/hmg/ddw016; Rinschen MM, 2015, PROTEOMICS, V15, P1326, DOI 10.1002/pmic.201400235; Rinschen MM, 2014, J AM SOC NEPHROL, V25, P1509, DOI 10.1681/ASN.2013070760; Sakai N, 2005, AM J KIDNEY DIS, V45, P54, DOI 10.1053/j.ajkd.2004.08.039; Schindl R, 2008, CELL CALCIUM, V43, P260, DOI 10.1016/j.ceca.2007.05.015; Seo K, 2014, P NATL ACAD SCI USA, V111, P6115, DOI 10.1073/pnas.1405263111; Seo K, 2014, P NATL ACAD SCI USA, V111, P1551, DOI 10.1073/pnas.1308963111; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Shi J, 2010, J PHYSIOL-LONDON, V588, P3671, DOI 10.1113/jphysiol.2010.194621; Sonneveld R, 2014, AM J PATHOL, V184, P1715, DOI 10.1016/j.ajpath.2014.02.008; Stambe C, 2003, KIDNEY INT, V64, P2121, DOI 10.1046/j.1523-1755.2003.00324.x; Taniguchi Y, 2012, AM J PHYSIOL-RENAL, V302, pF1161, DOI 10.1152/ajprenal.00614.2011; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang LM, 2015, J CLIN INVEST, V125, P1913, DOI 10.1172/JCI76767; Washburn DG, 2013, BIOORG MED CHEM LETT, V23, P4979, DOI 10.1016/j.bmcl.2013.06.047; Wedel BJ, 2003, J BIOL CHEM, V278, P25758, DOI 10.1074/jbc.M303890200; Winn MP, 2006, J AM SOC NEPHROL, V17, P378, DOI 10.1681/ASN.2005090962; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Zhang H, 2009, EXP BIOL MED, V234, P1029, DOI 10.3181/0901-RM-11	67	3	4	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					208	+		10.1096/fj.201700309R	http://dx.doi.org/10.1096/fj.201700309R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28877958	Green Published			2022-12-28	WOS:000419172700020
J	Dyari, HRE; Rawling, T; Chen, YJ; Sudarmana, W; Bourget, K; Dwyer, JM; Allison, SE; Murray, M				Dyari, Herryawan Ryadi Eziwar; Rawling, Tristan; Chen, Yongjuan; Sudarmana, William; Bourget, Kirsi; Dwyer, Julie M.; Allison, Sarah E.; Murray, Michael			A novel synthetic analogue of omega-3 17,18-epoxyeicosatetraenoic acid activates TNF receptor-1/ASK1/JNK signaling to promote apoptosis in human breast cancer cells	FASEB JOURNAL			English	Article						epoxyfatty acids; apoptotic signaling; death receptor	POLYUNSATURATED FATTY-ACIDS; PROTEIN-KINASE; EPOXYEICOSATRIENOIC ACIDS; LIPID RAFTS; INHIBITION; NECROSIS; ANGIOGENESIS; N-3; PROLIFERATION; RECRUITMENT	A saturated analog of the cytochrome P450-mediated omega-3-17,18-epoxide of omega-3-eicosapentaenoic acid (C20E) activated apoptosis in human triple-negative MDA-MB-231 breast cancer cells. This study evaluated the apoptotic mechanism of C20E. Increased cytosolic cytochrome c expression and altered expression of pro- and antiapoptotic B-cell lymphoma-2 proteins indicated activation of the mitochondrial pathway. Caspase-3 activation by C20E was prevented by pharmacological inhibition and silencing of the JNK and p38 MAP kinases (MAPK), upstream MAPK kinases MKK4 and MKK7, and the upstream MAPK kinase kinase apoptosis signal-regulating kinase 1 (ASK1). Silencing of the death receptorTNF receptor 1 (TNFR1), but not Fas, DR4, orDR5, and the adapters TRADD and TNF receptor-associated factor 2, but not Fas-associated death domain, prevented C20E-mediated apoptosis. B-cell lymphoma-2 homology 3-interacting domain death agonist (Bid) cleavage by JNK/p38 MAPK linked the extrinsic and mitochondrial pathways of apoptosis. In further studies, an antibody against the extracellular domain of TNFR1 prevented apoptosis by TNF-alpha but not C20E. These findings suggest that C20E acts intracellularly at TNFR1 to activate ASK1-MKK4/7-JNK/p38 MAPK signaling and to promote Bid-dependent mitochondrial disruption and apoptosis. In in vivo studies, tumors isolated from C20E-treated nu/nu mice carrying MDA-MB-231 xenografts showed increased TUNEL staining and decreased Ki67 staining, reflecting increased apoptosis and decreased proliferation, respectively. omega-3-Epoxy fatty acids like C20E could be incorporated into treatments for triple-negative breast cancers.	[Dyari, Herryawan Ryadi Eziwar; Chen, Yongjuan; Sudarmana, William; Bourget, Kirsi; Dwyer, Julie M.; Allison, Sarah E.; Murray, Michael] Univ Sydney, Sydney Med Sch, Sch Med Sci, Discipline Pharmacol, Sydney, NSW 2006, Australia; [Dyari, Herryawan Ryadi Eziwar] Univ Kebangsaan Malaysia, Sch Biosci & Biotechnol, Fac Sci & Technol, Bangi, Malaysia; [Rawling, Tristan] Univ Technol Sydney, Sch Math & Phys Sci, Fac Sci, Ultimo, NSW, Australia	University of Sydney; Universiti Kebangsaan Malaysia; University of Technology Sydney	Murray, M (corresponding author), Univ Sydney, Sydney Med Sch, Sch Med Sci, Discipline Pharmacol, Sydney, NSW 2006, Australia.	michael.murray@sydney.edu.au	Dyari, Herryawan Ryadi Eziwar/M-6776-2015	Rawling, Tristan/0000-0002-6624-6586; Eziwar Dyari, Herryawan Ryadi/0000-0002-4327-1180	Australian National Health and Medical Research Council [570933, 1031686]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the Australian National Health and Medical Research Council (570933 and 1031686). Supply of the dominant-negative mutant plasmids of p38 MAPK, JNK, MKK3, MKK6, and MKK7 by Dr. R. J. Davis (Howard Hughes Medical Institute, University of Massachusetts Medical School, Worcester, MA, USA) through Addgene (Cambridge, MA, USA) is gratefully acknowledged. The authors declare no conflicts of interest.	Altenburg JD, 2009, MOL CANCER RES, V7, P1013, DOI 10.1158/1541-7786.MCR-08-0385; Brenner D, 2009, CURR OPIN CELL BIOL, V21, P871, DOI 10.1016/j.ceb.2009.09.004; Chajes V, 2012, CANCER EPIDEM BIOMAR, V21, P319, DOI 10.1158/1055-9965.EPI-11-0896; Chang SH, 2004, P NATL ACAD SCI USA, V101, P591, DOI 10.1073/pnas.2535911100; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chen JK, 2001, MOL CELL BIOL, V21, P6322, DOI 10.1128/MCB.21.18.6322-6331.2001; Chen JK, 1998, J BIOL CHEM, V273, P29254, DOI 10.1074/jbc.273.44.29254; Cui PH, 2011, BRIT J PHARMACOL, V162, P1143, DOI 10.1111/j.1476-5381.2010.01113.x; Dulin NO, 1998, P NATL ACAD SCI USA, V95, P8098, DOI 10.1073/pnas.95.14.8098; Dyari HRE, 2014, J MED CHEM, V57, P7459, DOI 10.1021/jm501083y; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Greene ER, 2011, PROSTAG OTH LIPID M, V96, P27, DOI 10.1016/j.prostaglandins.2011.08.004; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Harper N, 2003, J BIOL CHEM, V278, P25534, DOI 10.1074/jbc.M303399200; Jiang JG, 2005, CANCER RES, V65, P4707, DOI 10.1158/0008-5472.CAN-04-4173; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Liu YM, 2013, MOL PHARMACOL, V84, P925, DOI 10.1124/mol.113.088302; Los M, 2002, MOL BIOL CELL, V13, P978, DOI 10.1091/mbc.01-05-0272; MADHUN ZT, 1991, J CLIN INVEST, V88, P456, DOI 10.1172/JCI115325; Maillard V, 2002, INT J CANCER, V98, P78, DOI 10.1002/ijc.10130; McIlwain DR, 2015, CSH PERSPECT BIOL, V7; MURRAY M, 1991, ARCH BIOCHEM BIOPHYS, V286, P618, DOI 10.1016/0003-9861(91)90089-2; Nebot N, 2010, BRIT J PHARMACOL, V161, P1059, DOI 10.1111/j.1476-5381.2010.00946.x; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Noguchi T, 2005, J BIOL CHEM, V280, P37033, DOI 10.1074/jbc.M506771200; Potente M, 2002, J BIOL CHEM, V277, P15671, DOI 10.1074/jbc.M110806200; Quilley J, 1997, BIOCHEM PHARMACOL, V54, P1059, DOI 10.1016/S0006-2952(97)00039-7; RIBEIRO CMP, 1994, AM J PHYSIOL, V266, pF497, DOI 10.1152/ajprenal.1994.266.3.F497; Rompe F, 2010, HYPERTENSION, V55, P924, DOI 10.1161/HYPERTENSIONAHA.109.147843; Rose DP, 2000, NUTR CANCER, V37, P119, DOI 10.1207/S15327914NC372_1; Schley PD, 2007, J NUTR, V137, P548, DOI 10.1093/jn/137.3.548; Shaikh SR, 2012, J NUTR BIOCHEM, V23, P101, DOI 10.1016/j.jnutbio.2011.07.001; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Spector AA, 2009, J LIPID RES, V50, pS52, DOI 10.1194/jlr.R800038-JLR200; Szymczak M, 2008, BLOOD, V111, P3514, DOI 10.1182/blood-2007-08-109934; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Whitmarsh AJ, 2007, ONCOGENE, V26, P3172, DOI 10.1038/sj.onc.1210410; Yang SL, 2007, AM J PHYSIOL-HEART C, V293, pH142, DOI 10.1152/ajpheart.00783.2006; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang GD, 2013, P NATL ACAD SCI USA, V110, P6530, DOI 10.1073/pnas.1304321110	42	23	23	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5246	+		10.1096/fj.201700033R	http://dx.doi.org/10.1096/fj.201700033R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28798154				2022-12-28	WOS:000416588300011
J	Miotti, S; Gulino, A; Ferri, R; Parenza, M; Chronowska, A; Lecis, D; Sangaletti, S; Tagliabue, E; Tripodo, C; Colombo, MP				Miotti, Silvia; Gulino, Alessandro; Ferri, Renata; Parenza, Mariella; Chronowska, Agnieszka; Lecis, Daniele; Sangaletti, Sabina; Tagliabue, Elda; Tripodo, Claudio; Colombo, Mario P.			Antibody-mediated blockade of JMJD6 interaction with collagen I exerts antifibrotic and antimetastatic activities	FASEB JOURNAL			English	Article						JmjC family; extracellular matrix; monoclonal antibody; in vivo treatment; peptide library	CONTAINING PROTEIN 6; PHOSPHATIDYLSERINE RECEPTOR; APOPTOTIC CELLS; BINDING-SITE; METASTASIS; FIBROSIS; SPARC; HYDROXYLATION; LOCALIZATION; FIBRONECTIN	JMJD6 is known to localize in the nucleus, exerting histone arginine demethylase and lysyl hydroxylase activities. A novel localization of JMJD6 in the extracellular matrix, resulting from its secretion as a soluble protein, was unveiled by a new anti-JMJD6 mAb called P4E11, which was developed to identify new targets in the stroma. Recombinant JMJD6 binds with collagen type I (Coll-I), and distinct JMJD6 peptides interfere with collagen fibrillogenesis, collagen-fibronectin interaction, and adhesion of human tumor cells to the collagen substrate. P4E11 and collagen binding to JMJD6 are mutually exclusive because the amino acid sequences of JMJD6 necessary for the interaction with Coll-I are part of the conformational epitope recognized by P4E11. In mice injected with mouse 4T1 breast carcinoma cells, treatment with P4E11 reduced fibrosis at the primary tumor and prevented lung metastases. Reduction of fibrosis has also been documented in human breast and ovarian tumors (MDA-MB-231 and IGROV1, respectively) xenotransplanted into immunodeficient mice treated with P4E11. In summary, this study uncovers a new localization and function for JMJD6 that is most likely independent from its canonical enzymatic activities, and demonstrates that JMJD6 can functionally interact with Coll-I. P4E11 mAb, inhibiting JMJD6/Coll-I interaction, represents a new opportunity to target fibrotic and tumor diseases.	[Miotti, Silvia; Ferri, Renata; Parenza, Mariella; Chronowska, Agnieszka; Lecis, Daniele; Sangaletti, Sabina; Colombo, Mario P.] Ist Nazl Tumori, Fdn Ist Ricovero & Cura Carattere Sci IRCCS, Dept Expt Oncol & Mol Med, Mol Immunol Unit, Milan, Italy; [Tagliabue, Elda] Ist Nazl Tumori, Fdn Ist Ricovero & Cura Carattere Sci IRCCS, Dept Expt Oncol & Mol Med, Mol Targeting Unit, Milan, Italy; [Gulino, Alessandro; Tripodo, Claudio] Univ Palermo, Dept Hlth Sci, Tumor Immunol Unit, Palermo, Italy; [Chronowska, Agnieszka] Univ Calif San Diego, La Jolla, CA 92093 USA	Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Palermo; University of California System; University of California San Diego	Colombo, MP (corresponding author), Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Mol Immunol Unit, Via Amadeo 42 St, I-20133 Milan, Italy.	mariopaolo.colombo@istitutotumori.mi.it	Sangaletti, Sabina/AAB-5873-2019; Lecis, Daniele/C-2113-2017; Tripodo, Claudio/AAB-6004-2022; Tagliabue, Elda/B-9377-2017; Colombo, Mario P./V-7166-2017	Sangaletti, Sabina/0000-0001-7047-287X; Lecis, Daniele/0000-0002-0564-0563; Tripodo, Claudio/0000-0002-0821-6231; Tagliabue, Elda/0000-0001-9877-2903; Colombo, Mario P./0000-0003-0042-7955	Associazione Italiana per la Ricerca sul Cancro [IG 10137]	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	The authors thank C. Melani (Fondazione IRCCS Istituto Nazionale dei Tumori) for initial characterization of P4E11 mAb; A. Andolfo and D. Drago (Protein Microsequencing Facility, San Raffaele Scientific Institute) for P4E11 epitope mapping; and I. Facetti (Fondazione IRCCS Istituto Nazionale dei Tumori) for technical support. The authors also thank the Associazione Italiana per la Ricerca sul Cancro for financial support (Grant IG 10137 to M.P.C.). The authors declare no conflicts of interest.	Bergamaschi A, 2008, J PATHOL, V214, P357, DOI 10.1002/path.2278; Bottger A, 2015, BIOCHEM J, V468, P191, DOI 10.1042/BJ20150278; Bose Jens, 2004, J Biol, V3, P15, DOI 10.1186/jbiol10; Bradshaw AD, 2009, J CELL COMMUN SIGNAL, V3, P239, DOI 10.1007/s12079-009-0062-6; Cellot S, 2013, BLOOD, V122, P1545, DOI 10.1182/blood-2013-04-496281; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Cikala M, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-26; Cox TR, 2014, CLIN CANCER RES, V20, P3637, DOI 10.1158/1078-0432.CCR-13-1059; Cox TR, 2013, CANCER RES, V73, P1721, DOI 10.1158/0008-5472.CAN-12-2233; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; Cui P, 2004, EXP CELL RES, V293, P154, DOI 10.1016/j.yexcr.2003.09.023; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Gao WW, 2015, P NATL ACAD SCI USA, V112, pE3327, DOI 10.1073/pnas.1509658112; Giridharan SSP, 2013, MOL BIOL CELL, V24, P1776, DOI 10.1091/mbc.E13-01-0026; Hankins HM, 2015, MOL BIOL CELL, V26, P4674, DOI 10.1091/mbc.E15-07-0487; Hehnly H, 2012, CURR BIOL, V22, P1944, DOI 10.1016/j.cub.2012.08.022; Heim A, 2014, NUCLEIC ACIDS RES, V42, P7833, DOI 10.1093/nar/gku488; Hong X, 2010, P NATL ACAD SCI USA, V107, P14568, DOI 10.1073/pnas.1008832107; Hu YJ, 2015, NUCLEIC ACIDS RES, V43, P7790, DOI 10.1093/nar/gkv645; Hullin-Matsuda F, 2014, SEMIN CELL DEV BIOL, V31, P48, DOI 10.1016/j.semcdb.2014.04.010; Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008; KLEINMAN HK, 1978, J BIOL CHEM, V253, P5642; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kottakis F, 2014, CANCER RES, V74, P3935, DOI 10.1158/0008-5472.CAN-13-2733; Lee YF, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3200; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Loenarz C, 2011, TRENDS BIOCHEM SCI, V36, P7, DOI 10.1016/j.tibs.2010.07.002; Mantri M, 2011, CHEMBIOCHEM, V12, P531, DOI 10.1002/cbic.201000641; Markolovic S, 2015, J BIOL CHEM, V290, P20712, DOI 10.1074/jbc.R115.662627; Miotti S, 2005, AM J PATHOL, V167, P1411, DOI 10.1016/S0002-9440(10)61228-X; Mouw JK, 2014, NAT REV MOL CELL BIO, V15, P771, DOI 10.1038/nrm3902; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Poulard C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126181; Poulard C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087982; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Rogasevskaia TP, 2015, J BIOL CHEM, V290, P28683, DOI 10.1074/jbc.M115.681429; RUOSLAHTI E, 1979, J BIOL CHEM, V254, P6054; Sangaletti S, 2003, J EXP MED, V198, P1475, DOI 10.1084/jem.20030202; Sangaletti S, 2008, CANCER RES, V68, P9050, DOI 10.1158/0008-5472.CAN-08-1327; Sangaletti S, 2014, CANCER RES, V74, P4706, DOI 10.1158/0008-5472.CAN-13-3334; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Unoki M, 2013, J BIOL CHEM, V288, P6053, DOI 10.1074/jbc.M112.433284; Wang F, 2014, CHIN J POPUL RESOUR, V12, P6, DOI 10.1080/10042857.2014.886802; Webby CJ, 2009, SCIENCE, V325, P90, DOI 10.1126/science.1175865; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yang HW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6717; Zemskov EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019414; Zhang J, 2013, TUMOR BIOL, V34, P2397, DOI 10.1007/s13277-013-0789-9	50	7	7	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5356	5370		10.1096/fj.201700377R	http://dx.doi.org/10.1096/fj.201700377R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28790175				2022-12-28	WOS:000416588300020
J	Xie, N; Khabbazi, S; Nassar, ZD; Gregory, K; Vithanage, T; Anand-Apte, B; Cabot, PJ; Sturgess, D; Shaw, PN; Parat, MO				Xie, Nan; Khabbazi, Samira; Nassar, Zeyad D.; Gregory, Kye; Vithanage, Tharindu; Anand-Apte, Bela; Cabot, Peter J.; Sturgess, David; Shaw, Paul N.; Parat, Marie-Odile			Morphine alters the circulating proteolytic profile in mice: functional consequences on cellular migration and invasion	FASEB JOURNAL			English	Article						MMP-9; TIMPs; endothelial cells; 4T1 cell line; opioids	LYMPHATIC ENDOTHELIAL-CELLS; NITRIC-OXIDE; OPIOID RECEPTOR; NODE METASTASIS; TUMOR-GROWTH; P38 MAPK; KAPPA-B; MATRIX-METALLOPROTEINASE-9; CANCER; MACROPHAGES	Opioids modulate the tumor microenvironment with potential functional consequences for tumor growth and metastasis. We evaluated the effects of morphine administration on the circulating proteolytic profile of tumor-freemice. Serum from morphine-treated (1 or 10mg/kg, i.p. every 12 h) or saline-treated mice was collected at different time points and tested ex vivo in endothelial, lymphatic endothelial, and breast cancer cell migration assays. Serum from mice that were treated with 10mg/kg morphine for 3 d displayed reduced chemotactic potential for endothelial and breast cancer cells, and elicited reduced cancer cell invasion through reconstituted basement membrane compared with serum from saline controls. This was associated with decreased circulating matrix metalloproteinase 9 (MMP-9) and increased circulating tissue inhibitor of metalloproteinase 1 (TIMP-1) and TIMP3/4 as assessed by zymography and reverse zymography. By using quantitative RT-PCR, we confirmed morphine induced alterations in MMP-9 and TIMP expression and identified organs, including the liver and spleen, in which these changes originated. Pharmacologic inhibition of MMP-9 abrogated the difference in chemotactic attraction between serum from saline-treated and morphine-treated mice, which indicated that reduced proteolytic ability mediated the decreased migration toward serum from morphine-treated mice. This novel mechanism may enable morphine administration to promote an environment that is less conducive to tumor growth, invasion, and metastasis.-Xie, N., Khabbazi, S., Nassar, Z. D., Gregory, K., Vithanage, T., Anand-Apte, B., Cabot, P. J., Sturgess, D., Shaw, P. N., Parat, M.-O. Morphine alters the circulating proteolytic profile inmice: functional consequences on cellular migration and invasion.	[Xie, Nan; Khabbazi, Samira; Nassar, Zeyad D.; Cabot, Peter J.; Shaw, Paul N.; Parat, Marie-Odile] Univ Queensland, Sch Pharm, St Lucia, Qld, Australia; [Gregory, Kye; Vithanage, Tharindu; Sturgess, David] Univ Queensland, Mater Res Inst MRI UQ, St Lucia, Qld, Australia; [Anand-Apte, Bela] Case Western Reserve Univ, Cleveland Clin, Dept Ophthalmol, Cole Eye Inst,Lerner Coll Med, Cleveland, OH 44106 USA; [Parat, Marie-Odile] Outcome Res Consortium, Cleveland, OH USA; [Nassar, Zeyad D.] Univ Adelaide, South Australian Hlth & Med Res Inst, North Terrace, Adelaide, SA 5000, Australia	University of Queensland; Mater Research; University of Queensland; Case Western Reserve University; Cleveland Clinic Foundation; South Australian Health & Medical Research Institute (SAHMRI); University of Adelaide	Parat, MO (corresponding author), Univ Queensland, 20 Cornwall St, Brisbane, Qld 4072, Australia.	m.parat@uq.edu.au	Sturgess, David/G-2965-2011; Parat, Marie-Odile/G-4410-2010; Shaw, Paul/Q-8454-2019; Shaw, Paul N/G-4418-2010; Cabot, Peter John/B-2424-2013; Nassar, Zeyad/B-1621-2012	Sturgess, David/0000-0002-4364-0038; Parat, Marie-Odile/0000-0003-4895-7381; Shaw, Paul/0000-0001-7154-592X; Shaw, Paul N/0000-0001-7154-592X; Cabot, Peter John/0000-0003-1778-3753; Nassar, Zeyad/0000-0002-7779-2697; Khabbazi, Samira/0000-0002-5410-795X	Pfizer - Anaesthesia and Pain Medicine Foundation, Australian and New Zealand College of Anaesthetists [14/020]; U.S. National Institutes of Health, National Eye Institute [EY027083, EY026181, P30EY025585]; Research to Prevent Blindness Challenge Grant; Foundation Fighting Blindness Center Grant; NATIONAL EYE INSTITUTE [P30EY025585, R01EY027083, R01EY026181] Funding Source: NIH RePORTER	Pfizer - Anaesthesia and Pain Medicine Foundation, Australian and New Zealand College of Anaesthetists; U.S. National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness Challenge Grant(Research to Prevent Blindness (RPB)); Foundation Fighting Blindness Center Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported, in part, by Pfizer funds granted by the Anaesthesia and Pain Medicine Foundation, Australian and New Zealand College of Anaesthetists (Project Grant 14/020). The sponsor had no involvement in study design, in collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. B.A.-A. is supported by U.S. National Institutes of Health, National Eye Institute Grants EY027083, EY026181, P30EY025585; a Research to Prevent Blindness Challenge Grant; and a Foundation Fighting Blindness Center Grant. The authors declare no conflicts of interest.	Afsharimani B, 2015, BRIT J PHARMACOL, V172, P251, DOI 10.1111/bph.12589; Afsharimani B, 2014, CLIN EXP METASTAS, V31, P149, DOI 10.1007/s10585-013-9616-3; Afsharimani B, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00046; Borner C, 2012, MOL PHARMACOL, V81, P587, DOI 10.1124/mol.111.076620; Cao MH, 2013, BEHAV BRAIN RES, V237, P249, DOI 10.1016/j.bbr.2012.09.040; Duraffourd C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110230; Eberhardt W, 2000, KIDNEY INT, V57, P59, DOI 10.1046/j.1523-1755.2000.00808.x; Gach K, 2011, MOL BIOL REP, V38, P1231, DOI 10.1007/s11033-010-0222-z; Harimaya Y, 2002, CANCER LETT, V187, P121, DOI 10.1016/S0304-3835(02)00360-9; Hosaka K, 2016, P NATL ACAD SCI USA, V113, pE5618, DOI 10.1073/pnas.1608384113; Khabbazi S., 2016, MRS 2016 16 WORLD U; Khabbazi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep31572; Khabbazi S, 2015, SCI REP-UK, V5, DOI 10.1038/srep11389; LEZA JC, 1995, EUR J PHARMACOL, V285, P95, DOI 10.1016/0014-2999(95)00474-Y; Liu C., 2017, ZEBRAFISH MODEL DISC, DOI [10.1158/1078-0432.CCR-17-0101, DOI 10.1158/1078-0432.CCR-17-0101]; Liu WT, 2010, J NEUROSCI, V30, P7613, DOI 10.1523/JNEUROSCI.1358-10.2010; Liu YC, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-19; Liu Y, 2017, ONCOTARGET, V8, P16988, DOI 10.18632/oncotarget.15217; Meschiari CA, 2013, MOL CELL BIOCHEM, V378, P127, DOI 10.1007/s11010-013-1602-1; Nakamoto K, 2012, EUR J PHARMACOL, V683, P86, DOI 10.1016/j.ejphar.2012.03.006; Nakamura ES, 2004, CANCER SCI, V95, P25, DOI 10.1111/j.1349-7006.2004.tb03166.x; Ninkovic J, 2012, AM J PATHOL, V180, P1068, DOI 10.1016/j.ajpath.2011.11.034; Plein LM, 2018, BRIT J PHARMACOL, V175, P2717, DOI 10.1111/bph.13750; Qiu SW, 2015, J IMMUNOL, V194, P1021, DOI 10.4049/jimmunol.1400106; Rebhun RB, 2006, NEOPLASIA, V8, P747, DOI 10.1593/neo.06322; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sinha I, 2006, ANN VASC SURG, V20, P92, DOI 10.1007/s10016-005-9429-1; Takeba Y, 2001, J RHEUMATOL, V28, P2176; Toda N, 2009, ANESTHESIOLOGY, V110, P166, DOI 10.1097/ALN.0b013e31819146a9; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; Wang JH, 2003, J BIOL CHEM, V278, P37622, DOI 10.1074/jbc.M301224200; Welters ID, 2007, EUR J ANAESTH, V24, P958, DOI 10.1017/S026502150700083X; Xie N, 2017, BRAIN BEHAV IMMUN, V61, P244, DOI 10.1016/j.bbi.2016.12.002; Yang YL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11385	34	13	13	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5208	+		10.1096/fj.201700546R	http://dx.doi.org/10.1096/fj.201700546R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28784632	Green Published			2022-12-28	WOS:000416588300008
J	Eriksen, KG; Radford, EJ; Silver, MJ; Fulford, AJC; Wegmuller, R; Prentice, AM				Eriksen, Kamilla G.; Radford, Elizabeth J.; Silver, Matt J.; Fulford, Anthony J. C.; Wegmueller, Rita; Prentice, Andrew M.			Influence of intergenerational in utero parental energy and nutrient restriction on offspring growth in rural Gambia	FASEB JOURNAL			English	Article						epigenetics; birth season; parental influences; fetal and postnatal growth	TRANSGENERATIONAL EPIGENETIC INHERITANCE; LOW-BIRTH-WEIGHT; DUTCH FAMINE; PRENATAL EXPOSURE; AFRICAN WOMEN; NUTRITION; LIFE; SEASONALITY; MORTALITY; HEALTH	The prenatal environment can alter an individual's developmental trajectory with long-lasting effects on health. Animal models demonstrate that the impact of the early life environment extends to subsequent generations, but there is a paucity of data from human populations on intergenerational transmission of environmentally induced phenotypes. Here we investigated the association of parental exposure to energy and nutrient restriction in utero on their children's growth in rural Gambia. In a Gambian cohortwith infants born between 1972 and 2011, we used multiple regression to test whether parental season of birth predicted offspring birth weight (n=2097) or length (n=1172), height-for-age z score (HAZ), weight-for-height z score (WHZ), and weight-for-age z score (WAZ) at 2yr of age (n = 923). We found that maternal exposure to seasonal energy restriction in utero was associated with reduced offspring birth length (crude: -4.2 mm, P = 0.005; adjusted: -4.0 mm, P = 0.02). In contrast, paternal birth season predicted offspring HAZ at 24mo (crude: -0.21, P = 0.005; adjusted: -0.22, P = 0.004) but had no discernible impact at birth. Our results indicate that periods of nutritional restriction in a parent's fetal life can have intergenerational consequences in human populations. Fetal growth appears to be under matriline influence, and postnatal growth appears to be under patriline intergenerational influences.-Eriksen, K. G., Radford, E. J., Silver, M. J., Fulford, A. J. C., Wegmuller, R., Prentice, A. M. Influence of intergenerational in utero parental energy and nutrient restriction on offspring growth in rural Gambia.	[Eriksen, Kamilla G.] MRC Elsie Widdowson Lab, Cambridge, England; [Radford, Elizabeth J.] Cambridge Univ Hosp Natl Hlth Serv NHS Fdn Trust, Cambridge, England; [Radford, Elizabeth J.] Univ Cambridge, Dept Genet, Cambridge, England; [Silver, Matt J.; Fulford, Anthony J. C.; Wegmueller, Rita; Prentice, Andrew M.] Gambia, MRC Unit, Atlantic Blvd,POB 273, Banjul, Gambia; [Silver, Matt J.; Fulford, Anthony J. C.; Prentice, Andrew M.] London Sch Hyg & Trop Med, MRC Int Nutr Grp, London, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Cambridge; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Prentice, AM (corresponding author), Gambia, MRC Unit, Atlantic Blvd,POB 273, Banjul, Gambia.	andrew.prentice@lshtm.ac.uk	Eriksen, Kamilla Gehrt/P-6734-2019; Prentice, Andrew/AAG-1961-2019	Eriksen, Kamilla Gehrt/0000-0001-8909-061X; Silver, Matt/0000-0002-3852-9677; Radford, Elizabeth/0000-0002-7829-5422	Medical Research Council [MC_EX_MR/M01424X/1, MC_U123292701] Funding Source: Medline; National Institute for Health Research [ACF-2015-14-007] Funding Source: researchfish; MRC [MC_EX_MR/M01424X/1, MC_U123292701] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BANTJE H, 1983, J TROP PEDIATRICS, V29, P50, DOI 10.1093/tropej/29.1.50; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Ceesay SM, 1997, BMJ-BRIT MED J, V315, P786, DOI 10.1136/bmj.315.7111.786; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; Dominguez-Salas P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4746; Dominguez-Salas P, 2013, AM J CLIN NUTR, V97, P1217, DOI 10.3945/ajcn.112.048462; Drake AJ, 2004, J ENDOCRINOL, V180, P1, DOI 10.1677/joe.0.1800001; Fulford AJC, 2006, PAEDIATR PERINAT EP, V20, P251, DOI 10.1111/j.1365-3016.2006.00714.x; Gapp K, 2014, NAT NEUROSCI, V17, P667, DOI 10.1038/nn.3695; Gkountela S, 2015, CELL, V161, P1425, DOI 10.1016/j.cell.2015.05.012; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Grossniklaus U, 2013, NAT REV GENET, V14, P228, DOI 10.1038/nrg3435; Guo F, 2015, CELL, V161, P1437, DOI 10.1016/j.cell.2015.05.015; Jimenez-Chillaron JC, 2009, DIABETES, V58, P460, DOI 10.2337/db08-0490; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Kaati G, 2007, EUR J HUM GENET, V15, P784, DOI 10.1038/sj.ejhg.5201832; Kuzawa CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040905; Li Q, 2015, ECON HUM BIOL, V18, P27, DOI 10.1016/j.ehb.2015.03.003; Lumey LH, 1995, EUR J OBSTET GYN R B, V63, P197, DOI 10.1016/0301-2115(95)02240-6; Lumey LH, 1997, AM J EPIDEMIOL, V146, P810, DOI 10.1093/oxfordjournals.aje.a009198; Magnus P, 2001, J EPIDEMIOL COMMUN H, V55, P873, DOI 10.1136/jech.55.12.873; Moore SE, 1997, NATURE, V388, P434, DOI 10.1038/41245; Moore SE, 1999, INT J EPIDEMIOL, V28, P1088, DOI 10.1093/ije/28.6.1088; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Painter RC, 2008, BJOG-INT J OBSTET GY, V115, P1243, DOI 10.1111/j.1471-0528.2008.01822.x; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; PRENTICE AM, 1987, AM J CLIN NUTR, V46, P912, DOI 10.1093/ajcn/46.6.912; PRENTICE AM, 1981, AM J CLIN NUTR, V34, P2790, DOI 10.1093/ajcn/34.12.2790; Radford EJ, 2014, SCIENCE, V345, P785, DOI 10.1126/science.1255903; Rao S, 2009, INT J EPIDEMIOL, V38, P1094, DOI 10.1093/ije/dyp223; Rickard IJ, 2012, P ROY SOC B-BIOL SCI, V279, P4253, DOI 10.1098/rspb.2012.1363; Roland MCP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039324; Rousham EK, 1998, AUST NZ J PUBL HEAL, V22, P669, DOI 10.1111/j.1467-842X.1998.tb01467.x; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Senn S, 2006, EUR J HUM GENET, V14, P1149, DOI 10.1038/sj.ejhg.5201683; Silver MJ, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0660-y; SINGH J, 1989, BRIT J NUTR, V62, P315, DOI 10.1079/BJN19890033; Stein AD, 2000, HUM BIOL, V72, P641; Tang WWC, 2015, CELL, V161, P1453, DOI 10.1016/j.cell.2015.04.053; Veenendaal MVE, 2013, BJOG-INT J OBSTET GY, V120, P548, DOI 10.1111/1471-0528.12136; Walton A, 1938, PROC R SOC SER B-BIO, V125, P311, DOI 10.1098/rspb.1938.0029; Wei YC, 2015, HUM REPROD UPDATE, V21, P194, DOI 10.1093/humupd/dmu061	43	14	14	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4928	4934		10.1096/fj.201700017R	http://dx.doi.org/10.1096/fj.201700017R			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28778976	Green Published, Green Accepted			2022-12-28	WOS:000413398500023
J	Maier, A; Wu, H; Cordasic, N; Oefner, P; Dietel, B; Thiele, C; Weidemann, A; Eckardt, KU; Warnecke, C				Maier, Anja; Wu, Hao; Cordasic, Nada; Oefner, Peter; Dietel, Barbara; Thiele, Christoph; Weidemann, Alexander; Eckardt, Kai-Uwe; Warnecke, Christina			Hypoxia-inducible protein 2 Hig2/Hilpda mediates neutral lipid accumulation in macrophages and contributes to atherosclerosis in apolipoprotein E-deficient mice	FASEB JOURNAL			English	Article						foam cell; lipid droplets; hypoxia-inducible factor-1	DROPLET PROTEIN; CELLS; GENE; LIPOLYSIS; TARGET; CANCER; CYCLOOXYGENASE-2; MICROENVIRONMENT; OVEREXPRESSION; INFLAMMATION	Recently we identified hypoxia-inducible protein 2 (HIG2)/hypoxia-inducible lipid droplet-associated (HILPDA) as lipid droplet (LD) protein. Because HILPDA is highly expressed in atherosclerotic plaques, we examined its regulation and function in murine macrophages, compared it to the LD adipose differentiation-related protein (Adrp)/perilipin 2 (Plin2), and investigated its effects on atherogenesis in apolipoprotein E-deficient (ApoE(-/-)) mice. Tie2-Cre-driven Hilpda conditional knockout (cKO) did not affect viability, proliferation, and ATP levels in macrophages. Hilpda proved to be a target of hypoxia-inducible factor 1 (Hif-1) andperoxisomeproliferator-activated receptors. In contrast, Adrp/Plin2 was not induced by Hif-1. Hilpda localized to the endoplasmic reticulum-LD interface, the site of LD formation. Hypoxic lipid accumulation and storage of oxidized LDL, cholesteryl esters and triglycerides were abolished in Hilpda cKO macrophages, independent of the glycolytic switch, fatty acid or lipoprotein uptake. Hilpda depletion reduced resistance against lipid overload and increased production of reactive oxygen species after reoxygenation. LPS-stimulated prostaglandin-E2 production was dysregulated in macrophages, demonstrating the substrate buffer and reservoir function of LDs for eicosanoid production. In ApoE(-/-) Hilpda cKO mice, total aortic plaque area, plaque macrophages and vascular Vegf expression were reduced. Thus, macrophage Hilpda is crucial to foam-cell formation and lipid deposition, and to controlled prostaglandin-E2 production. By these means Hilpda promotes lesion formation and progression of atherosclerosis.-Maier, A., Wu, H., Cordasic, N., Oefner, P., Dietel, B., Thiele, C., Weidemann, A., Eckardt, K.-U., Warnecke, C. Hypoxia-inducible protein 2 Hig2/Hilpda mediates neutral lipid accumulation in macrophages and contributes to atherosclerosis in apolipoprotein E-deficient mice.	[Maier, Anja; Cordasic, Nada; Weidemann, Alexander; Eckardt, Kai-Uwe; Warnecke, Christina] Friedrich Alexander Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, Erlangen, Germany; [Dietel, Barbara] Friedrich Alexander Univ Erlangen Nurnberg, Dept Mol Cardiol & Angiol, Erlangen, Germany; [Wu, Hao] Johns Hopkins Univ Sch Med, Dept Mol Biol & Genet, Baltimore, MD USA; [Wu, Hao] Johns Hopkins Univ Sch Med, Howard Hughes Med Inst, Baltimore, MD USA; [Oefner, Peter] Univ Regensburg, Inst Funct Genom, Regensburg, Germany; [Thiele, Christoph] Univ Bonn, Life & Med Sci LIMES Inst, Bonn, Germany; [Weidemann, Alexander] Univ Witten Herdecke, Med Ctr Cologne Merheim, Dept Med Nephrol Transplantat & Med Intens Care 1, Cologne, Germany; [Wu, Hao] MIT, Whitehead Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; University of Regensburg; University of Bonn; Witten Herdecke University; Massachusetts Institute of Technology (MIT); Whitehead Institute	Warnecke, C (corresponding author), Univ Hosp Erlangen, Translat Res Ctr, Labs Med Clin 4, Schwabachanlage 12, D-91054 Erlangen, Germany.	christina.warnecke@uk-erlangen.de			Interdisciplinary Center for Clinical Research (IZKF) Erlangen [A56]; Doktor-Robert-Pfleger Foundation, Bamberg; Human Frontier Science Program fellowship [LT000125/2009-L]; National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator award fellowship [22950]	Interdisciplinary Center for Clinical Research (IZKF) Erlangen; Doktor-Robert-Pfleger Foundation, Bamberg; Human Frontier Science Program fellowship(Human Frontier Science Program); National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator award fellowship	The authors thank E. Schefler and J. Baumgartl (both from Friedrich-Alexander-University Erlangen-Nurnberg) for excellent technical assistance. C.W. was supported by the Interdisciplinary Center for Clinical Research (IZKF) Erlangen (Project A56) and the Doktor-Robert-Pfleger Foundation, Bamberg. H.W. was supported by a Human Frontier Science Program fellowship (LT000125/2009-L) and a National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator award fellowship (Grant 22950). The authors declare no conflicts of interest.	Accioly MT, 2008, CANCER RES, V68, P1732, DOI 10.1158/0008-5472.CAN-07-1999; Bensaad K, 2014, CELL REP, V9, P349, DOI 10.1016/j.celrep.2014.08.056; Bozza PT, 2009, BBA-MOL CELL BIOL L, V1791, P540, DOI 10.1016/j.bbalip.2009.01.005; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Chaudhari SM, 2015, ARTERIOSCL THROM VAS, V35, P2316, DOI 10.1161/ATVBAHA.115.306171; Cipollone F, 2001, CIRCULATION, V104, P921, DOI 10.1161/hc3401.093152; Crucet M, 2013, ATHEROSCLEROSIS, V229, P110, DOI 10.1016/j.atherosclerosis.2013.04.034; Dehne N, 2009, EXP CELL RES, V315, P1791, DOI 10.1016/j.yexcr.2009.03.019; Dietel B, 2013, ATHEROSCLEROSIS, V230, P92, DOI 10.1016/j.atherosclerosis.2013.06.014; DiStefano MT, 2016, MOL METAB, V5, P1149, DOI 10.1016/j.molmet.2016.09.009; DiStefano MT, 2015, J BIOL CHEM, V290, P15175, DOI 10.1074/jbc.M115.650184; Gimm T, 2010, FASEB J, V24, P4443, DOI 10.1096/fj.10-159806; Gomez I, 2013, PROSTAG LEUKOTR ESS, V89, P55, DOI 10.1016/j.plefa.2013.04.004; GORDON GB, 1977, AM J PATHOL, V88, P663; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Hulbert AJ, 2005, BIOL REV, V80, P155, DOI 10.1017/S1464793104006578; Jacobi J, 2010, AM J PATHOL, V176, P2559, DOI 10.2353/ajpath.2010.090614; Kaushik S, 2015, NAT CELL BIOL, V17, P759, DOI 10.1038/ncb3166; Kim SH, 2013, CANCER LETT, V341, P159, DOI 10.1016/j.canlet.2013.07.028; Lee K, 2013, ATHEROSCLEROSIS, V226, P74, DOI 10.1016/j.atherosclerosis.2012.09.037; Marsch E, 2013, CURR OPIN LIPIDOL, V24, P393, DOI 10.1097/MOL.0b013e32836484a4; Mattijssen F, 2014, J BIOL CHEM, V289, P19279, DOI 10.1074/jbc.M114.570044; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Parathath S, 2013, TRENDS CARDIOVAS MED, V23, P80, DOI 10.1016/j.tcm.2012.09.004; Richard D, 2008, PHARMACOL RES, V57, P451, DOI 10.1016/j.phrs.2008.05.002; Sankaranarayanan S, 2011, J LIPID RES, V52, P2332, DOI 10.1194/jlr.D018051; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen GM, 2015, MOL MED REP, V12, P8055, DOI 10.3892/mmr.2015.4488; Spandl J, 2009, TRAFFIC, V10, P1579, DOI 10.1111/j.1600-0854.2009.00980.x; Takeda N, 2010, GENE DEV, V24, P491, DOI 10.1101/gad.1881410; Thiele C, 2012, ACS CHEM BIOL, V7, P2004, DOI 10.1021/cb300414v; Togashi A, 2005, CANCER RES, V65, P4817, DOI 10.1158/0008-5472.CAN-05-0120; Warnecke C, 2003, FASEB J, V17, P1186, DOI 10.1096/fj.02-1062fje; Weller Peter F, 2016, Trans Am Clin Climatol Assoc, V127, P328; Xu SW, 2010, CYTOTECHNOLOGY, V62, P473, DOI 10.1007/s10616-010-9290-0	36	34	35	3	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4971	4984		10.1096/fj.201700235R	http://dx.doi.org/10.1096/fj.201700235R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28760743				2022-12-28	WOS:000413398500027
J	Zeng, SC; Liu, LJ; Sun, Y; Lu, GX; Lin, G				Zeng, Sicong; Liu, Lvjun; Sun, Yi; Lu, Guangxiu; Lin, Ge			Role of telomeric repeat-containing RNA in telomeric chromatin remodeling during the early expansion of human embryonic stem cells	FASEB JOURNAL			English	Article						histone demethylation; telomere length; TERRA; TRF1	HUMAN BLASTOCYSTS; SELF-RENEWAL; IN-VITRO; LENGTH; TERRA; ELONGATION; DIFFERENTIATION; TRANSCRIPTION; PLURIPOTENCY; ASSOCIATION	This study aimed to explore the role of telomeric repeat-containing RNA (TERRA) in telomeric chromatin remodeling during the early expansion of human embryonic stem cells (hESCs). During the derivation of hESCs, histone demethylation in the telomeric region facilitates telomerase-mediated telomere elongation. An adequate telomere repeat is essential for hESCs to acquire and/or maintain the unlimited symmetric division, which suggests that there is a link between pluripotency and telomere maintenance. The present study found that the gradual decrease in TERRA levels and related TERRA foci were correlated with telomeric length elongation in the early expansion of hESCs. In addition, TERRA participated in telomeric chromatin remodeling by cooperating with SUV39H1 (suppressor of variegation 3-9 homolog 1/2) to propagate telomeric heterochromatin marker, histone H3 trimethylation of lysine 9. Moreover, the fibroblast growth factor signaling pathway, which is activated in hESCs, could suppress TERRA levels via telomeric repeat factor 1, which results in reduced SUV39H1 recruitment by TERRA at the telomere. Taken together, these results highlight the role of TERRA in hESC telomere elongation and homeostasis in the acquisition and/or maintenance of stem cell pluripotency.	[Zeng, Sicong; Liu, Lvjun; Sun, Yi; Lin, Ge] Cent S Univ, Inst Reprod & Stem Cell Engn, Sch Basic Med Sci, 110 Xiangya St, Changsha 410001, Hunan, Peoples R China; [Zeng, Sicong; Liu, Lvjun; Sun, Yi; Lu, Guangxiu; Lin, Ge] Natl Engn & Res Ctr Human Stem Cell, Changsha, Hunan, Peoples R China	Central South University	Lin, G (corresponding author), Cent S Univ, Inst Reprod & Stem Cell Engn, Sch Basic Med Sci, 110 Xiangya St, Changsha 410001, Hunan, Peoples R China.	2670162908@qq.com		Sun, Yi/0000-0001-9238-976X	postdoctoral research station of Central South University - China Postdoctoral Science Foundation [2014M560650]; National Natural Science Foundation of China [31401248]; Natural Science Foundation of Hunan Province [14JJ2004, 2014SK3066]	postdoctoral research station of Central South University - China Postdoctoral Science Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province)	The authors thank Dr. Pingyuan Xie for data analysis and Dr. Di Zhou and Lamei Cheng for proofreading. This work was supported by the postdoctoral research station of Central South University and funded by the China Postdoctoral Science Foundation (2014M560650; to S.Z.), the National Natural Science Foundation of China (Grant 31401248; to S.Z.), and the Natural Science Foundation of Hunan Province (Grants 14JJ2004 and 2014SK3066; to Y.S.). The authors declare no conflicts of interest.	Agarwal S, 2010, NATURE, V464, P292, DOI 10.1038/nature08792; Arnoult N, 2012, NAT STRUCT MOL BIOL, V19, P948, DOI 10.1038/nsmb.2364; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Bartman CM, 2015, EXP CELL RES, V330, P178, DOI 10.1016/j.yexcr.2014.07.020; Benetti R, 2007, J CELL BIOL, V178, P925, DOI 10.1083/jcb.200703081; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 2005, EMBO J, V24, P1095, DOI 10.1038/sj.emboj.7600598; Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38; Cusanelli E, 2013, MOL CELL, V51, P780, DOI 10.1016/j.molcel.2013.08.029; Dai C, 2015, J BIOL CHEM, V290, P22423, DOI 10.1074/jbc.M115.642710; Deng Z, 2009, MOL CELL, V35, P403, DOI 10.1016/j.molcel.2009.06.025; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Garcia-Cao M, 2004, NAT GENET, V36, P94, DOI 10.1038/ng1278; Gil ME, 2004, MOL BIOTECHNOL, V27, P169, DOI 10.1385/MB:27:2:169; Ginis I, 2004, DEV BIOL, V269, P360, DOI 10.1016/j.ydbio.2003.12.034; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Hiyama E, 2007, BRIT J CANCER, V96, P1020, DOI 10.1038/sj.bjc.6603671; Huang JJ, 2011, CELL RES, V21, P779, DOI 10.1038/cr.2011.16; Le RR, 2014, CELL STEM CELL, V14, P27, DOI 10.1016/j.stem.2013.11.005; Lin G, 2009, CELL STEM CELL, V5, P461, DOI 10.1016/j.stem.2009.10.009; Liu L, 2017, TRENDS GENET, V33, P16, DOI 10.1016/j.tig.2016.10.007; Marion RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025680; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; Moravec M, 2016, EMBO REP, V17, P999, DOI 10.15252/embr.201541708; Niida H, 1998, NAT GENET, V19, P203, DOI 10.1038/580; Nishikawa T, 2001, STRUCTURE, V9, P1237, DOI 10.1016/S0969-2126(01)00688-8; Porro A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6379; Porro A, 2014, CELL REP, V6, P765, DOI 10.1016/j.celrep.2014.01.022; Porro A, 2010, MOL CELL BIOL, V30, P4808, DOI 10.1128/MCB.00460-10; Pucci F, 2013, CELL STEM CELL, V12, P479, DOI 10.1016/j.stem.2013.01.018; Scheibe M, 2013, GENOME RES, V23, P2149, DOI 10.1101/gr.151878.112; Schneider RP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2946; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Song XP, 2015, ONCOTARGET, V6, P5263, DOI 10.18632/oncotarget.3029; Dang-Nguyen TQ, 2013, J REPROD DEVELOP, V59, P27; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Varela E, 2011, P NATL ACAD SCI USA, V108, P15207, DOI 10.1073/pnas.1105414108; Xie CQ, 2003, CHINESE SCI BULL, V48, P354, DOI 10.1360/03tb9075; Xie PY, 2014, STEM CELLS, V32, P391, DOI 10.1002/stem.1558; Yang CB, 2008, STEM CELLS, V26, P850, DOI 10.1634/stemcells.2007-0677; Zeng SC, 2014, J CELL SCI, V127, P752, DOI 10.1242/jcs.131433; Zhang LF, 2009, GENETICS, V182, P685, DOI 10.1534/genetics.109.103093	44	5	6	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4783	4795		10.1096/fj.201600939RR	http://dx.doi.org/10.1096/fj.201600939RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28765174				2022-12-28	WOS:000413398500011
J	Feng, SF; Shi, TY; Qiu, JX; Yang, HH; Wu, Y; Zhou, WX; Wang, W; Wu, HT				Feng, Shufang; Shi, Tianyao; Qiu, Jiangxia; Yang, Haihong; Wu, Yan; Zhou, Wenxia; Wang, Wei; Wu, Haitao			Notch1 deficiency in postnatal neural progenitor cells in the dentate gyrus leads to emotional and cognitive impairment	FASEB JOURNAL			English	Article						adult neurogenesis; anxiety; synaptic transmission; pCREB	ADULT HIPPOCAMPAL NEUROGENESIS; ELEMENT-BINDING PROTEIN; PATTERN SEPARATION; SYNAPTIC PLASTICITY; STEM-CELLS; FATE SPECIFICATION; NEURONS; CA3; MAINTENANCE; BRAIN	It is well known that Notch1 signaling plays a crucial role in embryonic neural development and adult neurogenesis. The latest evidence shows that Notch1 also plays a critical role in synaptic plasticity in mature hippocampal neurons. So far, deeper insights into the function of Notch1 signaling during the different steps of adult neurogenesis are still lacking, and the mechanisms by which Notch1 dysfunction is associated with brain disorders are also poorly understood. In the current study, we found that Notch1 was highly expressed in the adult-born immature neurons in the hippocampal dentate gyrus. Using a genetic approach to selectively ablate Notch1 signaling in late immature precursors in the postnatal hippocampus by cross-breeding doublecortin (DCX)(+) neuron-specific proopiomelanocortin (POMC)-alpha Cre mice with floxed Notch1 mice, we demonstrated a previously unreported pivotal role of Notch1 signaling in survival and function of adult newborn neurons in the dentate gyrus. Moreover, behavioral and functional studies demonstrated that POMC-Notch1(-/-) mutant mice showed anxiety and depressive-like behavior with impaired synaptic transmission properties in the dentate gyrus. Finally, our mechanistic study showed significantly compromised phosphorylation of cAMP response element-binding protein (CREB) in Notch1 mutants, suggesting that the dysfunction of Notch1 mutants is associated with the disrupted pCREB signaling in postnatally generated immature neurons in the dentate gyrus.-Feng, S., Shi, T., Qiu, J., Yang, H., Wu, Y., Zhou, W., Wang, W., Wu, H. Notch1 deficiency in postnatal neural progenitor cells in the dentate gyrus leads to emotional and cognitive impairment.	[Feng, Shufang; Qiu, Jiangxia; Yang, Haihong; Wu, Yan; Wu, Haitao] Beijing Inst Basic Med Sci, Dept Neurobiol, Taiping Rd 27, Beijing 100850, Peoples R China; [Shi, Tianyao; Zhou, Wenxia] Beijing Inst Pharmacol & Toxicol, Dept Tradit Chinese Med TCM & Neuroimmunopharmaco, Beijing, Peoples R China; [Wang, Wei] Jinzhou Med Univ, Affiliated Hosp 1, Dept Orthoped, Res Inst, Jinzhou, Peoples R China; [Wu, Haitao] Nantong Univ, Coinnovat Ctr Neuroregenerat, Key Lab Neuroregenerat, Nantong, Peoples R China	Academy of Military Medical Sciences - China; Academy of Military Medical Sciences - China; Jinzhou Medical University; Nantong University	Wu, HT (corresponding author), Beijing Inst Basic Med Sci, Dept Neurobiol, Taiping Rd 27, Beijing 100850, Peoples R China.	wuht@bmi.ac.cn	Wu, Haitao/AAK-4389-2020	Wu, Haitao/0000-0001-8437-3194; Zhou, Wenxia/0000-0002-6175-4821	Program 973, from State Key Development Program for Basic Research of China [2014CB542203]; National Natural Science Foundation of China [31371149, 31522029]; Beijing Municipal Science and Technology Commission [Z161100000216154]	Program 973, from State Key Development Program for Basic Research of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission)	The authors thank all of the members of the H.W. laboratory for their encouragement and discussions. This work was supported, in part, by Program 973, Grant 2014CB542203, from the State Key Development Program for Basic Research of China (to H.W.), National Natural Science Foundation of China Grants 31371149 and 31522029 (to H.W.), and Grant Z161100000216154 Beijing Municipal Science and Technology Commission (to H.W.) The authors declare no conflicts of interest.	Ables JL, 2011, NAT REV NEUROSCI, V12, P269, DOI 10.1038/nrn3024; Aguilar-Arredondo A, 2015, REV NEUROSCIENCE, V26, P269, DOI 10.1515/revneuro-2014-0071; Aimone JB, 2011, NEURON, V70, P589, DOI 10.1016/j.neuron.2011.05.010; Alberi L, 2011, NEURON, V69, P437, DOI 10.1016/j.neuron.2011.01.004; ALTMAN J, 1966, J COMP NEUROL, V126, P337, DOI 10.1002/cne.901260302; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Andreu-Agullo C, 2009, NAT NEUROSCI, V12, P1514, DOI 10.1038/nn.2437; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Aujla PK, 2013, DEVELOPMENT, V140, P3511, DOI 10.1242/dev.098681; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Bazelot M, 2012, EUR J NEUROSCI, V35, P244, DOI 10.1111/j.1460-9568.2011.07962.x; Brandt MD, 2010, EUR J NEUROSCI, V32, P1256, DOI 10.1111/j.1460-9568.2010.07410.x; Breunig JJ, 2007, P NATL ACAD SCI USA, V104, P20558, DOI 10.1073/pnas.0710156104; Bruel-Jungerman E, 2006, J NEUROSCI, V26, P5888, DOI 10.1523/JNEUROSCI.0782-06.2006; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; CHITNIS AB, 1995, MOL CELL NEUROSCI, V6, P311, DOI 10.1006/mcne.1995.1024; Corbo JC, 2002, J NEUROSCI, V22, P7548; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; Ehm O, 2010, J NEUROSCI, V30, P13794, DOI 10.1523/JNEUROSCI.1567-10.2010; Eisch AJ, 2002, PROG BRAIN RES, V138, P315, DOI 10.1016/S0079-6123(02)38085-3; Eisch AJ, 2008, J NEUROSCI, V28, P11785, DOI 10.1523/JNEUROSCI.3798-08.2008; Feng SF, 2012, BEHAV BRAIN RES, V232, P245, DOI 10.1016/j.bbr.2012.04.019; Ferrari-Toninelli G, 2009, DEV NEUROBIOL, V69, P378, DOI 10.1002/dneu.20710; Gao X, 2007, J NEUROSCI, V27, P14317, DOI 10.1523/JNEUROSCI.3206-07.2007; Gao X, 2009, EXP NEUROL, V215, P178, DOI 10.1016/j.expneurol.2008.10.009; Germain J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074992; Givogri MI, 2006, DEV NEUROSCI-BASEL, V28, P81, DOI 10.1159/000090755; Henrique D, 1997, CURR BIOL, V7, P661, DOI 10.1016/S0960-9822(06)00293-4; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Jagasia R, 2009, J NEUROSCI, V29, P7966, DOI 10.1523/JNEUROSCI.1054-09.2009; Kappeler C, 2007, J COMP NEUROL, V500, P239, DOI 10.1002/cne.21170; Kempermann G, 2008, CURR OPIN PSYCHIATR, V21, P290, DOI 10.1097/YCO.0b013e3282fad375; Kesner RP, 2007, LEARN MEMORY, V14, P771, DOI 10.1101/lm.688207; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Leutgeb S, 2007, LEARN MEMORY, V14, P745, DOI 10.1101/lm.703907; Levy WB, 1996, HIPPOCAMPUS, V6, P579, DOI 10.1002/(SICI)1098-1063(1996)6:6<579::AID-HIPO3>3.0.CO;2-C; Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; MCNAUGHTON BL, 1980, BRAIN RES, V199, P1, DOI 10.1016/0006-8993(80)90226-7; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Nakagawa S, 2002, J NEUROSCI, V22, P9868; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; OKA C, 1995, DEVELOPMENT, V121, P3291; Ortega-Perez I, 2007, J MOL HISTOL, V38, P555, DOI 10.1007/s10735-007-9114-5; Piatti VC, 2011, J NEUROSCI, V31, P7715, DOI 10.1523/JNEUROSCI.1380-11.2011; Platel JC, 2010, BRAIN RES REV, V63, P60, DOI 10.1016/j.brainresrev.2010.02.004; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Sahay A, 2011, NEURON, V70, P582, DOI 10.1016/j.neuron.2011.05.012; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Spampanato J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041029; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Tronel S, 2012, HIPPOCAMPUS, V22, P292, DOI 10.1002/hipo.20895; Wang Y, 2004, P NATL ACAD SCI USA, V101, P9458, DOI 10.1073/pnas.0308126101; Wu HT, 2012, NEURON, V75, P94, DOI 10.1016/j.neuron.2012.04.033; Zhang JB, 2013, J NEUROSCI, V33, P12825, DOI 10.1523/JNEUROSCI.0783-13.2013; Zhang K, 2014, NEUROBIOL DIS, V64, P66, DOI 10.1016/j.nbd.2013.12.010; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	64	9	9	3	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4347	4358		10.1096/fj.201700216RR	http://dx.doi.org/10.1096/fj.201700216RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28611114				2022-12-28	WOS:000413397400014
J	Hansen, BC; Gografe, S; Pritt, S; Jen, KLC; McWhirter, CA; Barman, SM; Comuzzie, A; Greene, M; McNulty, JA; Michele, DE; Moaddab, N; Nelson, RJ; Norris, K; Uray, KD; Banks, R; Westlund, KN; Yates, BJ; Silverman, J; Hansen, KD; Redman, B				Hansen, Barbara C.; Gografe, Sylvia; Pritt, Stacy; Jen, Kai-lin Catherine; McWhirter, Camille A.; Barman, Susan M.; Comuzzie, Anthony; Greene, Molly; McNulty, Justin A.; Michele, Daniel Eugene; Moaddab, Naz; Nelson, Randall J.; Norris, Karen; Uray, Karen D.; Banks, Ron; Westlund, Karin N.; Yates, Bill J.; Silverman, Jerald; Hansen, Kenneth D.; Redman, Barbara			Ensuring due process in the IACUC and animal welfare setting: considerations in developing noncompliance policies and procedures for institutional animal care and use committees and institutional officials	FASEB JOURNAL			English	Review						humane animal care; AWA; OLAW; PHS		Every institution that is involved in research with animals is expected to have in place policies and procedures for the management of allegations of noncompliance with the Animal Welfare Act and the U.S. Public Health Service Policy on the Humane Care and Use of Laboratory Animals. We present here a model set of recommendations for institutional animal care and use committees and institutional officials to ensure appropriate consideration of allegations of noncompliance with federal Animal Welfare Act regulations that carry a significant risk or specific threat to animal welfare. This guidance has 3 overarching aims: 1) protecting the welfare of research animals; 2) according fair treatment and due process to an individual accused of noncompliance; and 3) ensuring compliance with federal regulations. Through this guidance, the present work seeks to advance the cause of scientific integrity, animal welfare, and the public trust while recognizing and supporting the critical importance of animal research for the betterment of the health of both humans and animals.-Hansen, B. C., Gografe, S., Pritt, S., Jen, K.-L. C., McWhirter, C. A., Barman, S. M., Comuzzie, A., Greene, M., McNulty, J. A., Michele, D. E., Moaddab, N., Nelson, R. J., Norris, K., Uray, K. D., Banks, R., Westlund, K. N., Yates, B. J., Silverman, J., Hansen, K. D., Redman, B. Ensuring due process in the IACUC and animal welfare setting: considerations in developing noncompliance policies and procedures for institutional animal care and use committees and institutional officials.	[Hansen, Barbara C.] Univ S Florida, Dept Internal Med & Pediat, Morsani Coll Med, Tampa, FL 33612 USA; [McWhirter, Camille A.] Univ S Florida, Off Clin Res, Morsani Coll Med, Tampa, FL 33612 USA; [Gografe, Sylvia] Florida Atlantic Univ, Div Comparat Med, Boca Raton, FL 33431 USA; [Pritt, Stacy] Univ Texas Southwestern, Div Inst Anim Care & Use, Dallas, TX USA; [Jen, Kai-lin Catherine] Wayne State Univ, Dept Nutr & Food Sci, Detroit, MI 48202 USA; [Barman, Susan M.] Michigan State Univ, Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA; [Greene, Molly] Michigan State Univ, Off Vice President Res, E Lansing, MI 48824 USA; [Comuzzie, Anthony] Texas Fdn Biomed Res, Div Genet, San Antonio, TX USA; [McNulty, Justin A.] LabDog Consulting, Austin, TX USA; [Michele, Daniel Eugene] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Moaddab, Naz] Univ Maryland, Dept Neurol, Baltimore, MD 21201 USA; [Nelson, Randall J.] Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [Norris, Karen] Univ Georgia, Dept Infect Dis, Ctr Vaccines & Immunol, Coll Vet Med, Athens, GA 30602 USA; [Uray, Karen D.] Univ Debrecen, Dept Med Chem, Fac Med, Debrecen, Hungary; [Banks, Ron] Univ Oklahoma Hlth Sci, Div Comparat Med, Oklahoma City, OK USA; [Westlund, Karin N.] Univ New Mexico, Sch Med, Dept Anesthesiol & Crit Care Med, Albuquerque, NM 87131 USA; [Yates, Bill J.] Univ Pittsburgh, Inst Eye & Ear, Dept Otolaryngol, Pittsburgh, PA 15213 USA; [Silverman, Jerald] Univ Massachusetts, Sch Med, Dept Anim Med & Pathol, Worcester, MA USA; [Hansen, Kenneth D.] Int Hlth Fdn, St Petersburg, FL USA; [Redman, Barbara] NYU, Div Med Eth, New York, NY USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; Florida Atlantic University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Wayne State University; Michigan State University; Michigan State University; University of Michigan System; University of Michigan; University System of Maryland; University of Maryland Baltimore; University of Tennessee System; University of Tennessee Health Science Center; University System of Georgia; University of Georgia; University of Debrecen; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of New Mexico; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Massachusetts System; University of Massachusetts Worcester	Hansen, BC (corresponding author), Univ S Florida, Morsani Coll Med, Dept Internal Med, 12901 Bruce B Downs Blvd MDC19, Tampa, FL 33612 USA.	bhansen@health.usf.edu	Barman, Susan/P-7641-2019; Westlund, Karin/R-6960-2019; Yates, Bill/D-5602-2009	Pritt, Stacy/0000-0001-8887-6186; Westlund High, Karin/0000-0002-7388-4834; Yates, Bill/0000-0001-6819-097X; Uray, Karen/0000-0001-6997-459X	NIH; NSF; DoD; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K26OD016502] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002695] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); DoD(United States Department of Defense); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	The AWA is as found in the United States Code, Title 7-Agriculture-Chapter 54-Transportation Sale, and Handling of Certain Animals, Sections 2131-2159 (https://www.gpo.gov/fdsys/browse/collectionUScode.action?collectionCode=USCODE). The AWRs are as found in the Code of Federal Regulations, Title 9-Animals and Animal Products-Chapter 1-Animal and Plant Health Inspection Service, Department of Agriculture-Subchapter A-Animal Welfare-Parts 1-4 (https://www.gpo.gov/fdsys/browse/collectionCfr.action?collectionCode=CFR). The AWA and AWRs have been reprinted together for ease of access in the "Blue Book" (3). The AWA, passed by Congress originally in 1966, was the first federal legislation to protect the welfare of laboratory animals and is the only federal law in the United States that regulates the treatment of animals in research and exhibition. It does not apply to birds, rats of the genus Rattus, or mice of the genus Mus, nor any cold-blooded animals. Where federal funds through the NIH or NSF are involved, OLAW provides oversight and an assurance process to assist institutions in meeting these obligations, while leaving specific policies and procedures to the research institutions. While DoD programs may have an assurance on file with OLAW(as do most research institutions in the United States), there is not currently a specific memorandum of understanding that places all oversight of DoD-funded research-at least outside of DoD facilities-under OLAW's authority as there is with NSF-funded research. Institutional assurances must currently state that the terms cover all PHS- and NSF-funded research conducted under the authority of the institution. DoD-funded projects are handled under a separate contractual agreement, and any noncompliance would be managed through DoD rather than directly through OLAW.	HANSEN BC, 1989, SRA-J SOC RES ADMIN, V20, P5; HANSEN BC, 1988, GRANTS MAG, V11, P65; Haywood JR, 2008, ILAR J, V49, P426, DOI 10.1093/ilar.49.4.426; National Academies of Sciences Engineering and Medicine, 2015, OPT NAT INV AC RES N; National Institutes of Health (U. S.) Office of Laboratory Animal Welfare United States. Public Health Service, 2002, PUBL HLTH SERV POL H; National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals Institute for Laboratory Animal Research (US) and National Academies Press (US), 2011, GUIDE CARE USE LAB A; Office of Laboratory Animal Welfare, 2015, PHS POL HUM CAR US L; [Office of Laboratory Animal Welfare U. S. National Institutes of Health], 2005, GUID PROMPT REP OLAW; Policies of General Applicability, 1989, HANDL MISC REG SUBP; Redman BK, 2017, SCI ENG ETHICS, V23, P555, DOI 10.1007/s11948-016-9753-6; Silverman J., 2015, RES REGULATORY COMPL, P41, DOI [10.1016/B978-0-12-420058-6.00003-4, DOI 10.1016/B978-0-12-420058-6.00003-4]; Silverman J., 2014, THE IACUC HDB, VThird; U.S. National Institute of Health, 2002, I AN CAR US COMM GUI; United States Department of Agriculture, 2013, AN WELF ACT AN WELF; *US DEP HHS, 1995, INT MISC RES REP COM	15	11	11	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4216	4225		10.1096/fj.201601250R	http://dx.doi.org/10.1096/fj.201601250R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28821637	Green Published, Green Submitted			2022-12-28	WOS:000413397400003
J	Zhang, D; Lee, H; Haspel, JA; Jin, Y				Zhang, Duo; Lee, Heedoo; Haspel, Jeffrey A.; Jin, Yang			Long noncoding RNA FOXD3-AS1 regulates oxidative stress-induced apoptosis via sponging microRNA-150	FASEB JOURNAL			English	Article						epithelial cell; hyperoxia; lncRNA array; lung injury; epigenetic regulation	IN-VITRO; INFLAMMATION; HOMEOSTASIS	The function of most human long noncoding RNAs (lncRNAs) remains unclear. Our studies identified a highly up-regulated mammalian lncRNA, FOXD3-AS1, known as linc1623 in mice, in the setting of hyperoxia/reactive oxygen species (ROS)-induced lung injury. We found that ROS induced a robust expression of FOXD3-AS1 in mouse lung tissue. Functionally, FOXD3-AS1 promoted oxidative stress-induced lung epithelial cell death. In human lung epithelial cells, the microRNA-150 (miR-150) was identified to interact with FOXD3-AS1; this finding was confirmed using the luciferase reporter assays. Consistently, mutation on the miR-150 pairing sequence in FOXD3-AS1 abolished the interactions between FOXD3-AS1 and miR-150. Additionally, miR-150 mimics suppressed the level of FOXD3-AS1. The antisense oligos of FOXD3-AS1 significantly augmented the intracellular level of miR-150, supporting the theory of sponging effects of FOXD3-AS1 on miR-150. We further investigated the cellular function of miR-150 in our lung injury models. MiR-150 conferred a cytoprotective role in lung epithelial cells after oxidative stress, whereas FOXD3-AS1 promoted cell death. Taken together, our studies indicated that FOXD3-AS1 serves as a sponge or as a competing endogenous noncoding RNA for miR-150, restricting its capability to promote cell growth and thereby exaggerating hyperoxia-induced lung epithelial cell death.-Zhang, D., Lee, H., Haspel, J. A., Jin, Y. Long noncoding RNA FOXD3-AS1 regulates oxidative stress-induced apoptosis via sponging microRNA-150.	[Zhang, Duo; Lee, Heedoo; Jin, Yang] Boston Univ, Dept Med, Div Pulm & Crit Care Med, Boston, MA USA; [Haspel, Jeffrey A.] Washington Univ, Sch Med, Div Pulm & Crit Care Med, St Louis, MO USA	Boston University; Washington University (WUSTL)	Jin, Y (corresponding author), Boston Univ, Div Pulm & Crit Care Med, Dept Med, 72 E Concord St, N Andover, MA 02118 USA.	yjin1@bu.edu	Haspel, J./K-3563-2019; Zhang, Duo/U-6203-2019; Zhang, Duo/GYU-8678-2022; Zhang, Duo/S-2034-2016	Lee, Heedoo/0000-0001-7652-3930; Zhang, Duo/0000-0003-0361-4174	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [R01HL102076]; NIH National Institute of Allergy and Infectious Diseases [R21AI121644]; NIH National Institute of General Medical Sciences [R01GM111313]; NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI121644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111313] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant R01HL102076 (to Y.J.), NIH National Institute of Allergy and Infectious Diseases Grant R21AI121644 (to Y.J.), and NIH National Institute of General Medical Sciences Grant R01GM111313 (to Y.J.). Funding for open access is from the NIH.	Cabili MN, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0586-4; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cao MH, 2014, EUR J CANCER, V50, P1013, DOI 10.1016/j.ejca.2013.12.024; Chen WN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132734; Chuquimia OD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032125; Dalessandri T, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00347; Fang ZH, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.256; Gomes AQ, 2013, INT J MOL SCI, V14, P16010, DOI 10.3390/ijms140816010; Groppera MA, 2008, CURR OPIN CRIT CARE, V14, P11, DOI 10.1097/MCC.0b013e3282f417a0; Guillot L, 2013, INT J BIOCHEM CELL B, V45, P2568, DOI 10.1016/j.biocel.2013.08.009; Isakov O, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks228; Johnson ER, 2010, J AEROSOL MED PULM D, V23, P243, DOI 10.1089/jamp.2009.0775; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kung JTY, 2013, GENETICS, V193, P651, DOI 10.1534/genetics.112.146704; Lee HD, 2016, SCI REP-UK, V6, DOI 10.1038/srep35250; Lennox KA, 2016, NUCLEIC ACIDS RES, V44, P863, DOI 10.1093/nar/gkv1206; Li J, 2015, BMC MOL BIOL, V16, DOI 10.1186/s12867-015-0052-6; Liu SJ, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0932-1; Mach WJ, 2011, NURS RES PRACT, V2011, DOI 10.1155/2011/260482; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Rahal A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/761264; Rajput C, 2016, ARTERIOSCL THROM VAS, V36, P380, DOI 10.1161/ATVBAHA.115.306997; THOMPSON AB, 1995, EUR RESPIR J, V8, P127, DOI 10.1183/09031936.95.08010127; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Vir P, 2014, APMIS, V122, P268, DOI 10.1111/apm.12141; Wahid F, 2010, BBA-MOL CELL RES, V1803, P1231, DOI 10.1016/j.bbamcr.2010.06.013; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yin QW, 2015, INT J CLIN EXP PATHO, V8, P842; Zaher TE, 2007, FREE RADICAL BIO MED, V42, P897, DOI 10.1016/j.freeradbiomed.2007.01.021; Zhang D, 2017, AM J PHYSIOL-LUNG C, V312, pL110, DOI 10.1152/ajplung.00423.2016; Zhang D, 2016, CELL REP, V16, P757, DOI 10.1016/j.celrep.2016.06.040; Zhang D, 2016, AM J PHYSIOL-LUNG C, V310, pL700, DOI 10.1152/ajplung.00392.2015	33	47	50	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4472	4481		10.1096/fj.201700091R	http://dx.doi.org/10.1096/fj.201700091R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28655711	Green Published			2022-12-28	WOS:000413397400024
J	Kakuta, S; Yamaguchi, J; Suzuki, C; Sasaki, M; Kazuno, S; Uchiyama, Y				Kakuta, Soichiro; Yamaguchi, Junji; Suzuki, Chigure; Sasaki, Mitsuho; Kazuno, Saiko; Uchiyama, Yasuo			Small GTPase Rab1B is associated with ATG9A vesicles and regulates autophagosome formation	FASEB JOURNAL			English	Article						autophagy; electron microscopy; mass spectrometry	ENDOPLASMIC-RETICULUM; FORMATION SITE; RECYCLING ENDOSOMES; ISOLATION MEMBRANE; EARLY STEPS; PROTEIN; BIOGENESIS; COMPLEX; CELLS; MACROAUTOPHAGY	ATG9 is a membrane protein that is essential for autophagy and is considered to be directly involved in the early steps of autophagosome formation. Yeast Atg9 is mainly localized to small vesicles (Atg9 vesicles), whereas mammalian ATG9A is reportedly localized to the trans-Golgi network, the endosomal compartment, and other unidentified membrane structures. To dissect the ATG9A-containing membranes, we examined the subcellular localization of ATG9A and performed immunoisolation of those membranes. ATG9A-green fluorescent protein in human culture cells was observed as numerous puncta that move rapidly throughout the cytoplasm. We isolated these cytoplasmic membranes and found that they were small vesicles that resemble the yeast Atg9 vesicle. One of the proteins obtained via proteomic analyses of the mammalian ATG9A vesicle was Rab1, a small GTPase that is essential in endoplasmic reticulum-to-Golgi vesicle trafficking. Knockdown studies of Rab1B showed a suppression of autophagy. In these Rab1B-depleted cells, ATG9A accumulated in intermediate membrane structures at autophagosome formation sites. These results indicate that Rab1B is involved in regulating the proper development of autophagosomes.	[Kakuta, Soichiro; Yamaguchi, Junji; Suzuki, Chigure; Uchiyama, Yasuo] Juntendo Univ, Grad Sch Med, Dept Cellular & Mol Neuropathol, Tokyo 1138421, Japan; [Kakuta, Soichiro] Juntendo Univ, Grad Sch Med, Lab Morphol & Image Anal, Res Support Ctr, Tokyo, Japan; [Suzuki, Chigure] Juntendo Univ, Grad Sch Med, Dept Cellular & Mol Pharmacol, Tokyo, Japan; [Kazuno, Saiko] Juntendo Univ, Grad Sch Med, Lab Prote & Biomol Sci, Res Support Ctr, Tokyo, Japan; [Sasaki, Mitsuho] Natl Inst Biomed Innovat Hlth & Nutr, Lab Anim Models Human Dis, Osaka, Japan	Juntendo University; Juntendo University; Juntendo University; Juntendo University	Uchiyama, Y (corresponding author), Juntendo Univ, Grad Sch Med, Dept Cellular & Mol Neuropathol, Tokyo 1138421, Japan.	y-uchi@juntendo.ac.jp			Ministry of Education, Science, Sports and Culture, Japan (MEXT); MEXT-supported Program for the Strategic Research Foundation at Private Universities;  [25860149];  [16GS0315];  [23111004];  [23110517];  [10049091]	Ministry of Education, Science, Sports and Culture, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT-supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; ; ; 	The authors thank Tomohisa Nanao (Tokyo University of Science) for providing a plasmid and technical assistance and members of the Laboratory of Proteomics and Biomedical Science, Research Support Center, Juntendo University Graduate School of Medicine for their help in mass spectrometric analyses. This work was supported by a Grant-in-Aid for Young Scientists (B) 25860149 (to S.K.), Grant-in-Aid for Creative Scientific Research 16GS0315 (to Y.U.), Scientific Researches on Innovative Area, Grants-in-Aids for Scientific Research (B) 23111004 and 23110517 (to Y.U.), Grant-in-Aid for challenging Exploratory Research 10049091 (to Y.U.), the Ministry of Education, Science, Sports and Culture, Japan (MEXT), and the MEXT-supported Program for the Strategic Research Foundation at Private Universities (to Y.U.). The authors declare no conflicts of interest.	Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Ao X, 2014, CELL DEATH DIFFER, V21, P348, DOI 10.1038/cdd.2013.187; Carlsson SR, 2015, J CELL SCI, V128, P193, DOI 10.1242/jcs.141036; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Ge L, 2014, CURR OPIN CELL BIOL, V29, P18, DOI 10.1016/j.ceb.2014.02.005; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; Huang J, 2011, AUTOPHAGY, V7, P17, DOI 10.4161/auto.7.1.13840; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Imai K, 2016, J CELL SCI, V129, P3781, DOI 10.1242/jcs.196196; Itakura E, 2012, J CELL SCI, V125, P1488, DOI 10.1242/jcs.094110; Itakura E, 2011, J CELL BIOL, V192, P17, DOI 10.1083/jcb.201009067; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Jiang PD, 2014, CELL RES, V24, P69, DOI 10.1038/cr.2013.161; Kageyama S, 2011, MOL BIOL CELL, V22, P2290, DOI 10.1091/mbc.E10-11-0893; Kakuta S, 2012, J BIOL CHEM, V287, P44261, DOI 10.1074/jbc.M112.411454; Kishi-Itakura C, 2014, J CELL SCI, V127, P4089, DOI 10.1242/jcs.156034; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; Lang T, 2000, J BACTERIOL, V182, P2125, DOI 10.1128/JB.182.8.2125-2133.2000; Lipatova Z, 2013, MOL BIOL CELL, V24, P3133, DOI 10.1091/mbc.E13-05-0269; Lynch-Day MA, 2010, P NATL ACAD SCI USA, V107, P7811, DOI 10.1073/pnas.1000063107; Mannack LVJC, 2015, RES REP BIOCHEM, V5, P39, DOI 10.2147/RRBC.S57405; Mari M, 2010, J CELL BIOL, V190, P1005, DOI 10.1083/jcb.200912089; Zoppino FCM, 2010, TRAFFIC, V11, P1246, DOI 10.1111/j.1600-0854.2010.01086.x; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mochizuki Y, 2013, J BIOL CHEM, V288, P1009, DOI 10.1074/jbc.M112.395087; Moyer BD, 2001, TRAFFIC, V2, P268, DOI 10.1034/j.1600-0854.2001.1o007.x; Noda T, 2000, J CELL BIOL, V148, P465, DOI 10.1083/jcb.148.3.465; Orsi A, 2012, MOL BIOL CELL, V23, P1860, DOI 10.1091/mbc.E11-09-0746; Pozuelo-Rubio Mercedes, 2012, Cells, V1, P754, DOI 10.3390/cells1040754; Puri C, 2014, AUTOPHAGY, V10, P182, DOI 10.4161/auto.27174; Sekito T, 2009, GENES CELLS, V14, P525, DOI 10.1111/j.1365-2443.2009.01299.x; Shibutani ST, 2014, CELL RES, V24, P58, DOI 10.1038/cr.2013.159; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Suzuki K, 2010, FEBS LETT, V584, P1280, DOI 10.1016/j.febslet.2010.02.001; Takahashi Y, 2016, ONCOTARGET, V7, P20855, DOI 10.18632/oncotarget.8028; Takahashi Y, 2011, AUTOPHAGY, V7, P61, DOI 10.4161/auto.7.1.14015; Uemura T, 2014, MOL CELL BIOL, V34, P1695, DOI 10.1128/MCB.01327-13; Wang J, 2015, J CELL BIOL, V210, P273, DOI 10.1083/jcb.201408075; Wang J, 2013, P NATL ACAD SCI USA, V110, P9800, DOI 10.1073/pnas.1302337110; Weerasekara VK, 2014, MOL CELL BIOL, V34, P4379, DOI 10.1128/MCB.00740-14; Wesselborg S, 2015, CELL MOL LIFE SCI, V72, P4721, DOI 10.1007/s00018-015-2034-8; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Yamada T, 2005, J BIOL CHEM, V280, P18283, DOI 10.1074/jbc.M413957200; Yamamoto H, 2012, J CELL BIOL, V198, P219, DOI 10.1083/jcb.201202061; Young ARJ, 2006, J CELL SCI, V119, P3888, DOI 10.1242/jcs.03172	50	32	33	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3757	3773		10.1096/fj.201601052R	http://dx.doi.org/10.1096/fj.201601052R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28522593	Bronze			2022-12-28	WOS:000408713300006
J	Itzhaki, RF				Itzhaki, Ruth F.			Herpes simplex virus type 1 and Alzheimer's disease: possible mechanisms and signposts	FASEB JOURNAL			English	Article						reactivation; encephalitis; epidemiology; interferon; DNA repair	TEMPORAL-LOBE EPILEPSY; MILD COGNITIVE IMPAIRMENT; CENTRAL-NERVOUS-SYSTEM; GAMMA-INTERFERON SYNERGIZE; DEPENDENT PROTEIN-KINASE; BASE EXCISION-REPAIR; DOUBLE-STRAND BREAKS; DNA DAMAGE RESPONSE; BRAIN-TISSUE; INFECTIOUS BURDEN	Support for the concept that herpes simplex virus type 1 (HSV1), when present in the brains of apolipoprotein-E-epsilon 4 carriers, is a major risk for Alzheimer's disease (AD) is increasing steadily, with over 120 publications providing direct or indirect evidence relevant to the hypothesis. No articles have contested the concept, apart from 3 published 13-18 yr ago. This review describes very recent studies on the role of HSV1 but refers also to older studies that provide background for some lesser-known related topics not covered in other recent reviews; these include the relevance of herpes simplex encephalitis and of epilepsy to AD, the action of IFN, and the possible relevance of the different types of DNA damage to AD-in particular, those caused by HSV1- and mechanisms of repair of damage. New epidemiologic data supporting previous studies on mild cognitive impairment and progression to AD are reviewed, as are those examining the relationship between total infectious burden(additive seropositivity to various microbes) and cognition/AD. The latter indicates the involvement of HSV1 and cytomegalovirus (and the necessity of taking into account any marked differences in sensitivity of antibody detection). Recent studies that provide further support for the occurrence of repeated reactivation of latent HSV1 in the brain in AD pathogenesis are also discussed.	[Itzhaki, Ruth F.] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England	University of Oxford	Itzhaki, RF (corresponding author), Univ Oxford, Nuffield Dept Clin Neurosci, John Radcliffe Hosp, Level 6,West Wing, Oxford OX3 9DU, England.	ruth.itzhaki@manchester.ac.uk						Aboud O, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-41; Agostini S, 2016, BRAIN BEHAV IMMUN, V58, P254, DOI 10.1016/j.bbi.2016.07.153; Aiello AE, 2006, J AM GERIATR SOC, V54, P1046, DOI 10.1111/j.1532-5415.2006.00796.x; Alvarez G, 2012, J NEUROSCI RES, V90, P1020, DOI 10.1002/jnr.23003; ARANDAANZALDO A, 1992, ARCH VIROL, V122, P317, DOI 10.1007/BF01317193; ARANDAANZALDO A, 1992, ARCH VIROL, V124, P245, DOI 10.1007/BF01309806; BARINGER JR, 1994, ANN NEUROL, V36, P823, DOI 10.1002/ana.410360605; Barnes LL, 2015, J INFECT DIS, V211, P230, DOI 10.1093/infdis/jiu437; Bertrand P., 1993, NEURODEGENERATION, V2, P201; Bien CG, 2007, NEUROLOGY, V69, P1236, DOI 10.1212/01.wnl.0000276946.08412.ef; Bourgade K, 2015, BIOGERONTOLOGY, V16, P85, DOI 10.1007/s10522-014-9538-8; Bourgeois M, 1999, NEUROSURGERY, V44, P633, DOI 10.1097/00006123-199903000-00106; Braak H, 2015, BRAIN, V138, P2814, DOI 10.1093/brain/awv236; Briellmann RS, 2000, NEUROLOGY, V55, P435, DOI 10.1212/WNL.55.3.435; Brown JC, 2014, GENOMICS, V104, P287, DOI 10.1016/j.ygeno.2014.08.005; Bu XL, 2015, EUR J NEUROL, V22, P1519, DOI 10.1111/ene.12477; CABRERA CV, 1980, NATURE, V288, P288, DOI 10.1038/288288a0; Carr DJJ, 2009, J NEUROIMMUNOL, V206, P39, DOI 10.1016/j.jneuroim.2008.10.008; Carr DJJ, 2003, J NEUROIMMUNOL, V141, P40, DOI 10.1016/S0165-5728(03)00216-9; Chen SH, 2006, J VIROL, V80, P12387, DOI 10.1128/JVI.01232-06; Chin J, 2013, EPILEPSY BEHAV, V26, P343, DOI 10.1016/j.yebeh.2012.11.040; Cliffe AR, 2015, CELL HOST MICROBE, V18, P649, DOI 10.1016/j.chom.2015.11.007; De Chiara G, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00242; De Chiara G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013989; DeBiasi RL, 2002, J CLIN VIROL, V25, pS5, DOI 10.1016/S1386-6532(02)00028-8; Deng Z, 2014, CELL REP, V9, P2263, DOI 10.1016/j.celrep.2014.11.019; Ferrer I, 2007, BRAIN PATHOL, V17, P297, DOI 10.1111/j.1750-3639.2007.00073.x; Forero DA, 2016, J GERONTOL A-BIOL, V71, P1069, DOI 10.1093/gerona/glw053; Fortunato EA, 2003, REV MED VIROL, V13, P21, DOI 10.1002/rmv.368; Fotheringham J, 2007, PLOS MED, V4, P848, DOI 10.1371/journal.pmed.0040180; Frost B, 2016, NUCLEUS-PHILA, V7, P275, DOI 10.1080/19491034.2016.1183859; GANNICLIFFE A, 1985, LANCET, V1, P214; Gouras GK, 1997, ANN NEUROL, V41, P402, DOI 10.1002/ana.410410317; Grimaldi LME, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-30; Hou YJ, 2017, MECH AGEING DEV, V161, P83, DOI 10.1016/j.mad.2016.04.005; Huang C, 2015, NEUROSCI LETT, V593, P29, DOI 10.1016/j.neulet.2014.12.063; Huang WY, 2010, J GEN VIROL, V91, P591, DOI 10.1099/vir.0.016964-0; Ill-Raga G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021456; Ittner A, 2016, SCIENCE, V354, P904, DOI 10.1126/science.aah6205; Itzhaki RF, 1997, LANCET, V349, P241, DOI 10.1016/S0140-6736(96)10149-5; Itzhaki RF, 2016, J ALZHEIMERS DIS, V54, P1273, DOI 10.3233/JAD-160607; Itzhaki RF, 2015, J INFECT DIS, V211, P2023, DOI 10.1093/infdis/jiv051; Itzhaki RF, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00202; Itzhaki RF, 2012, FUTURE MICROBIOL, V7, P307, DOI [10.2217/FMB.12.10, 10.2217/fmb.12.10]; Itzhaki RF, 2009, APOPROTEIN RESEARCH, P99; JAMIESON GA, 1991, J MED VIROL, V33, P224, DOI 10.1002/jmv.1890330403; JAMIESON GA, 1992, J PATHOL, V167, P365, DOI 10.1002/path.1711670403; Jay V., CHILDS NERV SYST, V14, P15; Jiang YC, 2016, INT J ORAL SCI, V8, P1, DOI 10.1038/ijos.2016.3; Kanungo Jyotshna, 2016, J Neurol Neuromedicine, V1, P17; Katan M, 2013, NEUROLOGY, V80, P1209, DOI 10.1212/WNL.0b013e3182896e79; Kim Shin Hye, 2013, J Epilepsy Res, V3, P28, DOI 10.14581/jer.13005; KINSELLA TJ, 1987, BIOCHEM BIOPH RES CO, V149, P355, DOI 10.1016/0006-291X(87)90374-3; KLAPPER PE, 1984, J NEUROL NEUROSUR PS, V47, P1247, DOI 10.1136/jnnp.47.11.1247; Koch R, 1893, Z HYG INFEKTIONSKR, V14, P319, DOI [10.1007/bf02284324., DOI 10.1007/BF02284324, 10.1007/BF02284324]; Kristen H, 2015, NEUROBIOL AGING, V36, P2737, DOI 10.1016/j.neurobiolaging.2015.06.014; Kumar DKV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1059; Lam MMW, 2016, CYTOKINE, V88, P251, DOI 10.1016/j.cyto.2016.09.002; LeesMiller SP, 1996, J VIROL, V70, P7471, DOI 10.1128/JVI.70.11.7471-7477.1996; Lerchundi R, 2011, J ALZHEIMERS DIS, V23, P513, DOI 10.3233/JAD-2010-101386; LI JC, 1985, BIOCHEM BIOPH RES CO, V129, P733, DOI 10.1016/0006-291X(85)91953-9; Li LH, 2016, J NEUROVIROL, V22, P293, DOI 10.1007/s13365-015-0393-4; Lieberman PM, 2016, CELL HOST MICROBE, V19, P619, DOI 10.1016/j.chom.2016.04.008; Lillenes MS, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0237-z; Lilley CE, 2005, P NATL ACAD SCI USA, V102, P5844, DOI 10.1073/pnas.0501916102; Lin WR, 2002, J PATHOL, V197, P395, DOI 10.1002/path.1127; LIU J, 2016, COCHRANE DB SYST REV, V11, DOI DOI 10.1002/14651858.CD011922.PUB2; Lovell MA, 2011, MECH AGEING DEV, V132, P443, DOI 10.1016/j.mad.2011.08.003; MACKENZIE IRA, 1994, ACTA NEUROPATHOL, V87, P504; Mancuso R, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00285; Martin C, 2014, J ALZHEIMERS DIS, V39, P849, DOI 10.3233/JAD-131706; Merlo D, 2016, CURR ALZHEIMER RES, V13, P1208, DOI 10.2174/1567205013666160401114915; Michael BD, 2012, EPILEPSIA, V53, P63, DOI 10.1111/j.1528-1167.2012.03615.x; Miller MA, 2010, BRAIN INJURY, V24, P1468, DOI 10.3109/02699052.2010.520299; Niehusmann P, 2010, EPILEPSIA, V51, P2478, DOI 10.1111/j.1528-1167.2010.02741.x; Olsson J, 2016, DIS MODEL MECH, V9, P1349, DOI 10.1242/dmm.026674; Otth C, 2017, ADV ALZH DIS, V5, P209, DOI 10.3233/978-1-61499-706-209; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; Parkinson J, 1999, J VIROL, V73, P650, DOI 10.1128/JVI.73.1.650-657.1999; Peng T, 2008, J VIROL, V82, P1934, DOI 10.1128/JVI.01649-07; Peter JB, 2001, MOL CELL PROBE, V15, P177, DOI 10.1006/mcpr.2001.0356; Piacentini R, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.06.009; Pierce AT, 2005, J GEN VIROL, V86, P2421, DOI 10.1099/vir.0.80979-0; Pouplin T, 2011, ANTIMICROB AGENTS CH, V55, P3624, DOI 10.1128/AAC.01023-10; PUCHHAMMERSTOCKL E, 1990, J MED VIROL, V32, P77, DOI 10.1002/jmv.1890320202; Ramakrishna C, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004730; ROBBINS JH, 1985, J NEUROL NEUROSUR PS, V48, P916, DOI 10.1136/jnnp.48.9.916; Robinson SR, 2002, NEUROBIOL AGING, V23, P1051, DOI 10.1016/S0197-4580(01)00342-6; ROBISON SH, 1987, ANN NEUROL, V21, P250, DOI 10.1002/ana.410210306; Sainz B, 2002, J VIROL, V76, P11541, DOI 10.1128/JVI.76.22.11541-11550.2002; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Santana S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.12.010; Scarmeas N, 2009, ARCH NEUROL-CHICAGO, V66, P992, DOI 10.1001/archneurol.2009.130; SCUDIERO DA, 1986, MUTAT RES, V159, P125, DOI 10.1016/0027-5107(86)90121-1; Shim SM, 2017, J ALZHEIMERS DIS, V55, P293, DOI 10.3233/JAD-160563; Simpson-Holley M, 2005, J VIROL, V79, P12840, DOI 10.1128/JVI.79.20.12840-12851.2005; Smith S, 2015, FUTURE VIROL, V10, P383, DOI 10.2217/FVL.15.18; Smith S, 2014, J VIROL, V88, P10146, DOI 10.1128/JVI.01723-14; SMITH TAD, 1991, GERONTOLOGY, V37, P193; Spiegel R, 2008, J CHILD NEUROL, V23, P344, DOI 10.1177/0883073807309243; Stowe RP, 2012, J MED VIROL, V84, P1797, DOI 10.1002/jmv.23397; Strandberg TE, 2004, ARCH GERONTOL GERIAT, P419; Suberbielle E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9897; TOBI SE, 1990, J MED GENET, V27, P437, DOI 10.1136/jmg.27.7.437; TOBI SE, 1993, GERONTOLOGY, V39, P241; TOBI SE, 1993, INT J RADIAT BIOL, V63, P617, DOI 10.1080/09553009314450801; Valyi-Nagy T, 2005, HISTOL HISTOPATHOL, V20, P957, DOI 10.14670/HH-20.957; Van Meter M, 2016, CELL REP, V16, P2641, DOI 10.1016/j.celrep.2016.08.006; Vossel KA, 2016, ANN NEUROL, V80, P858, DOI 10.1002/ana.24794; Vossel KA, 2013, JAMA NEUROL, V70, P1158, DOI 10.1001/jamaneurol.2013.136; Wang HB, 2017, MECH AGEING DEV, V161, P163, DOI 10.1016/j.mad.2016.09.005; Wang JH, 2013, NEUROSCI BULL, V29, P649, DOI 10.1007/s12264-013-1379-y; Weissman L, 2007, NUCLEIC ACIDS RES, V35, P5545, DOI 10.1093/nar/gkm605; White MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101364; Whitley Richard J, 2015, Continuum (Minneap Minn), V21, P1704, DOI 10.1212/CON.0000000000000243; Wozniak MA, 2009, J PATHOL, V217, P131, DOI 10.1002/path.2449; Wozniak MA, 2005, J MED VIROL, V75, P300, DOI 10.1002/jmv.20271; Wozniak MA, 2007, NEUROSCI LETT, V429, P95, DOI 10.1016/j.neulet.2007.09.077; Wozniak MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025152; Wozniak MA, 2009, J ALZHEIMERS DIS, V16, P341, DOI 10.3233/JAD-2009-0963; Wright CB, 2015, J AM GERIATR SOC, V63, P1540, DOI 10.1111/jgs.13557; Wu HM, 2004, EXP NEUROL, V189, P66, DOI 10.1016/j.expneurol.2004.05.010; Yamada S, 2003, J NEUROL NEUROSUR PS, V74, P262, DOI 10.1136/jnnp.74.2.262; Yan XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048782; Yao HW, 2014, J VIROL, V88, P11264, DOI 10.1128/JVI.01616-14; Zambrano A, 2008, J ALZHEIMERS DIS, V14, P259	126	64	67	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3216	3226		10.1096/fj.201700360	http://dx.doi.org/10.1096/fj.201700360			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28765170				2022-12-28	WOS:000405932400003
J	WHELAN, WJ				WHELAN, WJ			PUBLISH AND PERISH	FASEB JOURNAL			English	Editorial Material											WHELAN, WJ (corresponding author), UNIV MIAMI,SCH MED,MIAMI,FL 33101, USA.							WHELAN WJ, 1993, FASEB J, V7, P1423, DOI 10.1096/fasebj.7.15.8262325	1	0	0	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998	0892-6638			FASEB J	Faseb J.	NOV	1995	9	14					1389	1389		10.1096/fasebj.9.14.1389	http://dx.doi.org/10.1096/fasebj.9.14.1389			1	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TF678	29397765				2022-12-28	WOS:A1995TF67800001
J	Wan, Y; Jin, HJ; Zhu, YY; Fang, Z; Mao, L; He, QW; Xia, YP; Li, M; Li, YN; Chen, XQ; Hu, B				Wan, Yan; Jin, Hui-Juan; Zhu, Yi-Yi; Fang, Zhi; Mao, Ling; He, Quanwei; Xia, Yuan-Peng; Li, Man; Li, Yanan; Chen, Xiaoqian; Hu, Bo			MicroRNA-149-5p regulates blood-brain barrier permeability after transient middle cerebral artery occlusion in rats by targeting S1PR2 of pericytes	FASEB JOURNAL			English	Article						pericyte migration; N-cadherin; NF-kappa B p65; stroke	SPHINGOSINE 1-PHOSPHATE; ISCHEMIC-STROKE; TIGHT JUNCTION; MIGRATION; SPHINGOSINE-1-PHOSPHATE; RECEPTOR; MIR-149; EXPRESSION; PROTEINS; CELLS	Blood-brain barrier (BBB) disruption caused by reperfusion injury after ischemic stroke is an intractable event conducive to further injury. Brain pericytes play a vital role in maintaining BBB integrity by interacting with other components of the BBB. In this study, we found that sphingosine-1-phosphate receptor (S1PR)2 expressed in pericytes was significantly up-regulated after ischemia in vivo and in vitro. By using a S1PR2 antagonist (JTE-013), we showed that S1PR2 plays a critical role in the induction of BBB permeability of transient middle cerebral artery occlusion (tMCAO) rats and the in vitro BBB model. Furthermore, we discovered that S1PR2 may decrease N-cadherin expression and increase pericyte migration via NF-kappa B p65 signal and found that S1PR2 could be regulated by miR-149-5p negatively, which was decreased in the ischemic boundary zone and cultured pericytes after ischemia. Overexpression of miR-149-5p in cultured pericytes substantially increased N-cadherin expression and decreased pericyte migration, which decreased BBB leakage in the in vitro model. Up-regulating miR-149-5p by intracerebroventricular injection of agomir-149-5p attenuated BBB permeability and improved the outcomes of tMCAO rats significantly. Thus, our data suggest that miR-149-5p may serve as a potential target for treatment of BBB disruption after ischemic stroke.				hubo@mail.hust.edu.cn	Fang, Zhi/AGE-7582-2022; xia, yuanpeng/S-7988-2019	Fang, Zhi/0000-0002-9495-4467	National Natural Science Foundation of China [81571119, 81371311, 81671147]; National Key Research and Development Program of China [2016YFC1300600]; New Century Excellent Talents in University [NCET-10-0406]; Integrated Innovative Team for Major Human Disease Program of Tongji Medical College (HUST) [5001530026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Integrated Innovative Team for Major Human Disease Program of Tongji Medical College (HUST)	This work was supported by the National Natural Science Foundation of China (Grants 81571119 and 81371311 to B.H.; Grant 81671147 to H.J.), the National Key Research and Development Program of China Grant 2016YFC1300600), the New Century Excellent Talents in University Grant NCET-10-0406 to B.H.), and Integrated Innovative Team for Major Human Disease Program of Tongji Medical College (HUST) (Grant 5001530026). The authors declare no conflicts of interest.	[Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Brait VH, 2016, STROKE, V47, P3053, DOI 10.1161/STROKEAHA.116.015371; Braun A, 2007, J NEUROSCI, V27, P12012, DOI 10.1523/JNEUROSCI.3281-07.2007; Dore-Duffy P, 2000, MICROVASC RES, V60, P55, DOI 10.1006/mvre.2000.2244; Duan HY, 2014, CANCER RES, V74, P5782, DOI 10.1158/0008-5472.CAN-14-0650; Dusaban SS, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0882-x; Duz B, 2007, CRYOBIOLOGY, V55, P279, DOI 10.1016/j.cryobiol.2007.08.009; Fang Z, 2016, FASEB J, V30, P2097, DOI 10.1096/fj.201500126; Fayyaz S, 2014, DIABETOLOGIA, V57, P373, DOI 10.1007/s00125-013-3123-6; Gaire B. P., 2017, MOL NEUROBIOL; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Gonul E, 2002, MICROVASC RES, V64, P116, DOI 10.1006/mvre.2002.2413; He QW, 2013, MOL NEUROBIOL, V47, P976, DOI 10.1007/s12035-013-8396-8; Hsieh MJ, 2014, BRIT J PHARMACOL, V171, P3037, DOI 10.1111/bph.12626; Jeon YJ, 2013, ARTERIOSCL THROM VAS, V33, P420, DOI 10.1161/ATVBAHA.112.300251; Jin L, 2016, MOL MED REP, V13, P5386, DOI 10.3892/mmr.2016.5205; Kim GS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8893; Kim JH, 2009, J NEUROSCI RES, V87, P653, DOI 10.1002/jnr.21884; Kimura A, 2008, STROKE, V39, P3411, DOI 10.1161/STROKEAHA.108.514612; Li L, 2015, INT J CLIN EXP MED, V8, P15351; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Luo G, 2015, ONCOTARGET, V6, P37808, DOI 10.18632/oncotarget.5676; McGuire PG, 2011, ARTERIOSCL THROM VAS, V31, pE107, DOI 10.1161/ATVBAHA.111.235408; Molina CA, 2009, CEREBROVASC DIS, V27, P162, DOI 10.1159/000200455; Nakagawa S, 2007, CELL MOL NEUROBIOL, V27, P687, DOI 10.1007/s10571-007-9195-4; Ozen I, 2014, ACTA NEUROPATHOL, V128, P381, DOI 10.1007/s00401-014-1295-x; Paik JH, 2004, GENE DEV, V18, P2392, DOI 10.1101/gad.1227804; Pfister F, 2008, DIABETES, V57, pA234, DOI 10.2337/db08-0325; Pillai DR, 2009, J CEREBR BLOOD F MET, V29, P1846, DOI 10.1038/jcbfm.2009.106; Proia RL, 2015, J CLIN INVEST, V125, P1379, DOI 10.1172/JCI76369; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rosen H, 2013, ANNU REV BIOCHEM, V82, P637, DOI 10.1146/annurev-biochem-062411-130916; Sa-Pereira I, 2012, MOL NEUROBIOL, V45, P327, DOI 10.1007/s12035-012-8244-2; Sanchez T, 2007, ARTERIOSCL THROM VAS, V27, P1312, DOI 10.1161/ATVBAHA.107.143735; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Santini P, 2014, RHEUMATOL INT, V34, P711, DOI 10.1007/s00296-013-2754-8; Saver JL, 2011, J THROMB HAEMOST, V9, P333, DOI 10.1111/j.1538-7836.2011.04371.x; Sayed ASM, 2015, CLINICS, V70, P257, DOI 10.6061/clinics/2015(04)07; Sheikh MSA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/740301; Shen LH, 2006, NEUROSCIENCE, V137, P393, DOI 10.1016/j.neuroscience.2005.08.092; Song L, 2007, BLOOD, V109, P1515, DOI 10.1182/blood-2006-07-034009; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Srinivasan B, 2015, JALA-J LAB AUTOM, V20, P107, DOI 10.1177/2211068214561025; Testai FD, 2014, J NEUROCHEM, V131, P530, DOI 10.1111/jnc.12836; Thomsen LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134765; Underly RG, 2017, J NEUROSCI, V37, P129, DOI 10.1523/JNEUROSCI.2891-16.2016; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Wang MD, 2016, MOL NEUROBIOL, V53, P1310, DOI 10.1007/s12035-015-9099-0; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Xu GX, 2014, J CELL BIOCHEM, V115, P919, DOI 10.1002/jcb.24734; Zachariah MA, 2010, SCIENCE, V328, P1129, DOI 10.1126/science.1188222; Zhang WL, 2013, PROSTAG OTH LIPID M, V106, P62, DOI 10.1016/j.prostaglandins.2013.06.001; Zhu DH, 2010, BLOOD, V115, P4963, DOI 10.1182/blood-2010-01-262386; Zhu JL, 2017, NEOPLASIA, V19, P672, DOI 10.1016/j.neo.2017.06.002	56	50	56	2	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3133	3148		10.1096/fj.201701121R	http://dx.doi.org/10.1096/fj.201701121R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401609				2022-12-28	WOS:000432546000020
J	Khan, SI; Andrews, KL; Jackson, KL; Memon, B; Jefferis, AM; Lee, MKS; Diep, H; Wei, ZH; Drummond, GR; Head, GA; Jennings, GL; Murphy, AJ; Vinh, A; Sampson, AK; Chin-Dusting, JPF				Khan, Shanzana I.; Andrews, Karen L.; Jackson, Kristy L.; Memon, Basimah; Jefferis, Ann-Maree; Lee, Man K. S.; Diep, Henry; Wei, Zihui; Drummond, Grant R.; Head, Geoffrey A.; Jennings, Garry L.; Murphy, Andrew J.; Vinh, Antony; Sampson, Amanda K.; Chin-Dusting, Jaye P. F.			Y-chromosome lineage determines cardiovascular organ T-cell infiltration in the stroke-prone spontaneously hypertensive rat	FASEB JOURNAL			English	Article						inflammation; genetics; vascular biology; endothelium	ENDOTHELIUM-DEPENDENT CONTRACTIONS; II-INDUCED HYPERTENSION; VASCULAR DYSFUNCTION; AUTOIMMUNE-DISEASE; BLOOD-PRESSURE; AORTA; PROSTACYCLIN; KIDNEY; CYCLOOXYGENASE; ACETYLCHOLINE	The essential role of the Y chromosome in male sex determination has largely overshadowed the possibility that it may exert other biologic roles. Here, we show that Y-chromosome lineage is a strong determinant of perivascular and renal T-cell infiltration in the stroke-prone spontaneously hypertensive rat, which, in turn, may influence vascular function and blood pressure (BP). We also show, for the first time to our knowledge, that augmented perivascular T-cell levels can directly instigate vascular dysfunction, and that the production of reactive oxygen species that stimulate cyclo-oxygenase underlies this. We thus provide strong evidence for the consideration of Y-chromosome lineage in the diagnosis and treatment of male hypertension, and point to the modulation of cardiovascular organ T-cell infiltration as a possible mechanism that underpins Y- chromosome regulation of BP.	[Khan, Shanzana I.; Andrews, Karen L.; Jefferis, Ann-Maree; Diep, Henry; Wei, Zihui; Chin-Dusting, Jaye P. F.] Monash Univ, Biomed Discovery Inst, Dept Pharmacol, Clayton, Vic, Australia; [Khan, Shanzana I.; Chin-Dusting, Jaye P. F.] Monash Univ, Dept Med, Melbourne, Vic, Australia; [Khan, Shanzana I.; Andrews, Karen L.; Jackson, Kristy L.; Memon, Basimah; Jefferis, Ann-Maree; Lee, Man K. S.; Head, Geoffrey A.; Jennings, Garry L.; Murphy, Andrew J.; Sampson, Amanda K.; Chin-Dusting, Jaye P. F.] Baker Heart & Diabet Inst, Melbourne, Vic, Australia; [Drummond, Grant R.; Vinh, Antony] La Trobe Univ, Dept Physiol Anat & Microbiol, Bundoora, Vic, Australia; [Jennings, Garry L.] Univ Sydney, Sydney Med Sch, Camperdown, NSW, Australia	Monash University; Monash University; Baker Heart and Diabetes Institute; La Trobe University; University of Sydney	Khan, SI (corresponding author), Monash Univ, Dept Pharmacol, 9 Ancora Imparo Way, Melbourne, Vic 3800, Australia.	shanzana.khan@monash.edu	Jennings, Garry/B-3914-2009; Head, Geoffrey/B-2177-2010; Vinh, Antony/I-1563-2014	Murphy, Andrew/0000-0001-7039-7777; Head, Geoffrey/0000-0002-7623-137X; Vinh, Antony/0000-0001-8367-6134	National Health and Medical Research Council of Australia Program [APP10363652]; Victorian Government's Infrastructure Support Program	National Health and Medical Research Council of Australia Program(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Infrastructure Support Program	The authors thank Prof. A. Dominiczak and Dr. D. Graham (both from the University of Glasgow, Glasgow, United Kingdom) for the generation of the consomic rat colonies. This work was supported by a National Health and Medical Research Council of Australia Program grant (APP10363652 to J.C.D.) and, in part, by the Victorian Government's Infrastructure Support Program. S.I.K., K.L.A., A.-M.J. and J.P.F.C.-D. are members of the Cardiovascular Program at Monash University. The authors declare no conflicts of interest.	Bellott DW, 2014, NATURE, V508, P494, DOI 10.1038/nature13206; Case LK, 2013, GENOME RES, V23, P1474, DOI 10.1101/gr.156703.113; Chan CT, 2015, HYPERTENSION, V66, P1023, DOI 10.1161/HYPERTENSIONAHA.115.05779; Charchar FJ, 2012, LANCET, V379, P915, DOI 10.1016/S0140-6736(11)61453-0; Cook KD, 2015, IMMUNITY, V43, P703, DOI 10.1016/j.immuni.2015.09.002; CURTIS JJ, 1983, NEW ENGL J MED, V309, P1009, DOI 10.1056/NEJM198310273091702; Drummond GR, 2014, TRENDS ENDOCRIN MET, V25, P452, DOI 10.1016/j.tem.2014.06.012; ELY DL, 1990, HYPERTENSION, V16, P277, DOI 10.1161/01.HYP.16.3.277; Feletou M, 2006, AM J PHYSIOL-HEART C, V291, pH985, DOI 10.1152/ajpheart.00292.2006; Fu HM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4436; Gluais P, 2005, BRIT J PHARMACOL, V146, P834, DOI 10.1038/sj.bjp.0706390; Gomez E, 2008, AM J PHYSIOL-HEART C, V295, pH2198, DOI 10.1152/ajpheart.00507.2008; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; HALL JE, 1990, HYPERTENSION, V15, P547, DOI 10.1161/01.HYP.15.6.547; Hernanz R, 2014, CLIN SCI, V126, P111, DOI 10.1042/CS20120651; Ji H, 2014, HYPERTENSION, V64, P573, DOI 10.1161/HYPERTENSIONAHA.114.03663; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; LUSCHER TF, 1986, HYPERTENSION, V8, P344, DOI 10.1161/01.HYP.8.4.344; Maan AA, 2017, EUR J HUM GENET, V25, P1181, DOI 10.1038/ejhg.2017.128; Madhur MS, 2010, HYPERTENSION, V55, P500, DOI 10.1161/HYPERTENSIONAHA.109.145094; Mattson DL, 2014, AM J PHYSIOL-RENAL, V307, pF499, DOI 10.1152/ajprenal.00258.2014; McMaster WG, 2015, CIRC RES, V116, P1022, DOI 10.1161/CIRCRESAHA.116.303697; Merhi-Soussi F, 2000, J LEUKOCYTE BIOL, V68, P881; Mikolajczyk TP, 2016, FASEB J, V30, P1987, DOI 10.1096/fj.201500088R; Monaco C, 2002, J LEUKOCYTE BIOL, V71, P659; Negrin CD, 2001, HYPERTENSION, V37, P391, DOI 10.1161/01.HYP.37.2.391; Pollow DP, 2014, HYPERTENSION, V64, P384, DOI 10.1161/HYPERTENSIONAHA.114.03581; Prokop JW, 2016, BIOL SEX DIFFER, V7, DOI 10.1186/s13293-016-0064-z; Qi ZH, 2006, HYPERTENSION, V48, P323, DOI 10.1161/01.HYP.0000231934.67549.b7; Reckelhoff JF, 2001, HYPERTENSION, V37, P1199, DOI 10.1161/01.HYP.37.5.1199; Sampson AK, 2014, HYPERTENSION, V64, P1376, DOI 10.1161/HYPERTENSIONAHA.114.03756; Sezgin E, 2009, HUM GENET, V125, P281, DOI 10.1007/s00439-008-0620-7; Shao J, 2003, HYPERTENSION, V42, P31, DOI 10.1161/01.HYP.0000075082.06183.4E; Strahorn P, 2005, J HYPERTENS, V23, P2179, DOI 10.1097/01.hjh.0000191904.26853.b8; Teuschert C, 2006, P NATL ACAD SCI USA, V103, P8024, DOI 10.1073/pnas.0600536103; Tipton AJ, 2014, HYPERTENSION, V64, P557, DOI 10.1161/HYPERTENSIONAHA.114.03512; Trott DW, 2014, HYPERTENSION, V64, P1108, DOI 10.1161/HYPERTENSIONAHA.114.04147; Vinh A, 2010, CIRCULATION, V122, P2529, DOI 10.1161/CIRCULATIONAHA.109.930446; Vogt MHJ, 2000, BLOOD, V96, P3126, DOI 10.1182/blood.V96.9.3126.h8003126_3126_3132; Wallace K, 2011, HYPERTENSION, V57, P949, DOI 10.1161/HYPERTENSIONAHA.110.168344; Wei ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114895	41	4	4	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2747	2756		10.1096/fj.201700933RR	http://dx.doi.org/10.1096/fj.201700933RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29301944				2022-12-28	WOS:000432528000034
J	Kim, CS; Ahmad, S; Wu, TD; Walton, WG; Redinbo, MR; Tarran, R				Kim, Christine Seulki; Ahmad, Saira; Wu, Tongde; Walton, William G.; Redinbo, Matthew R.; Tarran, Robert			SPLUNC1 is an allosteric modulator of the epithelial sodium channel	FASEB JOURNAL			English	Article						BPIFA1; CFTR; airway surface liquid; Na+ transport	TRANSMEMBRANE CONDUCTANCE REGULATOR; NA+ CHANNEL; PROTEOLYTIC CLEAVAGE; LIDDLES-SYNDROME; ENAC; LUNG; TRAFFICKING; EXPRESSION; TRANSPORT; PROTEIN	Cystic fibrosis (CF) is a common genetic disease with significantly increased mortality. CF airways exhibit ion transport abnormalities, including hyperactivity of the epithelial Na+ channel (ENaC). Short-palate lung and nasal epithelial clone 1 (SPLUNC1) is a multifunctional innate defense protein that is secreted into the airway lumen. We have previously demonstrated that SPLUNC1 binds to and inhibits ENaC to maintain fluid homeostasis in airway epithelia and that this process fails in CF airways. Despite this, how SPLUNC1 actually regulates ENaC is unknown. Here, we found that SPLUNC1 caused alpha gamma-ENaC to internalize, whereas SPLUNC1 and beta-ENaC remained at the plasma membrane. Additional studies revealed that SPLUNC1 increased neural precursor cell-expressed developmentally down-regulated protein 4-2-dependent ubiquitination of alpha- but not beta- or gamma-ENaC. We also labeled intracellular ENaC termini with green fluorescent protein and mCherry, and found that extracellular SPLUNC1 altered intracellular ENaC Forster resonance energy transfer. Taken together, our data indicate that SPLUNC1 is an allosteric regulator of ENaC that dissociates alpha beta gamma-ENaC to generate a new SPLUNC1-beta-ENaC complex. These data indicate a novel mode for regulating ENaC at the plasma membrane.	[Kim, Christine Seulki; Ahmad, Saira; Wu, Tongde; Tarran, Robert] Univ N Carolina, Cyst Fibrosis Ctr, Marsico Lung Inst, Chapel Hill, NC 27515 USA; [Walton, William G.; Redinbo, Matthew R.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27515 USA; [Tarran, Robert] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Tarran, R (corresponding author), Univ N Carolina, 7102 Marsico Hall,124 Mason Farm Rd,CB7118, Chapel Hill, NC 27599 USA.	robert_tarran@med.unc.edu	, PEP-MX Core/AGV-4051-2022	Kim, Christine/0000-0001-7512-7960; Ahmad, Saira/0000-0002-5339-7211; Wu, Tongde/0000-0002-3689-0872	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [R01-HL108927]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [P30-DK065988]; UK Cystic Fibrosis Trust (INOVCF) [SRC003]; Cystic Fibrosis Foundation [R026-CR11, TARRAN17G0]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK065988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; Cystic Fibrosis Trust [SRC003] Funding Source: researchfish	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); UK Cystic Fibrosis Trust (INOVCF); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Cystic Fibrosis Trust	The authors thank the University of North Carolina (UNC) CF Center Tissue and Molecular Cores for providing cells and constructs, Douglas Cyr (UNC) for providing the HA-ubiquitin construct, Colin Bingle (University of Sheffield, Sheffield, United Kingdom) for providing the SPLUNC1 construct, Dmitri Firsov (University of Lausanne, Lausanne, Switzerland) for providing the alpha beta gamma-ENaC concatemer, Peter Snyder (University of Iowa) for providing the Nedd4-2 dominantnegative construct, Debbie Baines (St. George's, University of London, London, United Kingdom) for providing the alpha- and beta-ENaC-GFP constructs, and Thomas Kleyman (University of Pittsburgh, Pittsburgh, PA, USA) and M. Jackson Stutts (UNC) for the epitope-tagged alpha-, beta-, and gamma-ENaC constructs. The authors thank M. Flori Sassano and Eric Davies (UNC) for critical reading of this manuscript. This study was funded by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant R01-HL108927, NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant P30-DK065988, the UK Cystic Fibrosis Trust (INOVCF, SRC003), and Cystic Fibrosis Foundation Grants R026-CR11 and TARRAN17G0. R.T. is a founder of and has equity in Spyryx Bioscience. The remaining authors declare no conflicts of interest.	Boase NA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1284; Boucher RC, 2007, J INTERN MED, V261, P5, DOI 10.1111/j.1365-2796.2006.01744.x; Boulkroun S, 2008, AM J PHYSIOL-RENAL, V295, pF889, DOI 10.1152/ajprenal.00001.2008; Buck TM, 2017, BIOCHEM J, V474, P357, DOI 10.1042/BCJ20160760; Buck TM, 2010, MOL BIOL CELL, V21, P1047, DOI 10.1091/mbc.E09-11-0944; Butterworth MB, 2007, J BIOL CHEM, V282, P37885, DOI 10.1074/jbc.M707989200; Butterworth MB, 2010, BBA-MOL BASIS DIS, V1802, P1166, DOI 10.1016/j.bbadis.2010.03.010; Butterworth MB, 2009, AM J PHYSIOL-RENAL, V296, pF10, DOI 10.1152/ajprenal.90248.2008; Chanoux RA, 2013, AM J PHYSIOL-CELL PH, V305, pC776, DOI 10.1152/ajpcell.00059.2013; Di YP, 2011, BIOCHEM SOC T, V39, P1051, DOI 10.1042/BST0391051; Elborn JS, 2016, LANCET, V388, P2519, DOI 10.1016/S0140-6736(16)00576-6; Firsov D, 1998, EMBO J, V17, P344, DOI 10.1093/emboj/17.2.344; Flores SY, 2003, PFLUG ARCH EUR J PHY, V446, P334, DOI 10.1007/s00424-003-1027-x; Fulcher M Leslie, 2013, Methods Mol Biol, V945, P109, DOI 10.1007/978-1-62703-125-7_8; Gakhar L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009098; Garcia-Caballero A, 2009, P NATL ACAD SCI USA, V106, P11412, DOI 10.1073/pnas.0903609106; Garland AL, 2013, P NATL ACAD SCI USA, V110, P15973, DOI 10.1073/pnas.1311999110; Grumbach Y, 2014, AM J PHYSIOL-CELL PH, V307, pC701, DOI 10.1152/ajpcell.00134.2014; Harris M, 2008, J BIOL CHEM, V283, P7455, DOI 10.1074/jbc.M707399200; Hobbs CA, 2013, AM J PHYSIOL-LUNG C, V305, pL990, DOI 10.1152/ajplung.00103.2013; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Kamynina E, 2001, KIDNEY INT, V60, P466, DOI 10.1046/j.1523-1755.2001.060002466.x; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kimura T, 2011, P NATL ACAD SCI USA, V108, P3216, DOI 10.1073/pnas.1010334108; Knight KK, 2006, P NATL ACAD SCI USA, V103, P2805, DOI 10.1073/pnas.0511184103; Lebowitz J, 2003, AM J PHYSIOL-RENAL, V285, pF524, DOI 10.1152/ajprenal.00366.2001; Liu YY, 2013, J IMMUNOL, V191, P4259, DOI 10.4049/jimmunol.1202340; Matalon S, 2015, AM J PHYSIOL-LUNG C, V309, pL1229, DOI 10.1152/ajplung.00319.2015; McGillivary G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013224; Peters DM, 2014, P NATL ACAD SCI USA, V111, pE374, DOI 10.1073/pnas.1306798111; POULSEN JH, 1994, P NATL ACAD SCI USA, V91, P5340, DOI 10.1073/pnas.91.12.5340; Rollins BM, 2010, CHANNELS, V4, P255, DOI 10.4161/chan.4.4.12255; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Rotin D, 2001, AM J PHYSIOL-RENAL, V281, pF391, DOI 10.1152/ajprenal.2001.281.3.F391; Schild L, 2010, BBA-MOL BASIS DIS, V1802, P1159, DOI 10.1016/j.bbadis.2010.06.014; Sheng SH, 2001, J BIOL CHEM, V276, P1326, DOI 10.1074/jbc.M008117200; Sheridan JT, 2013, J BIOL CHEM, V288, P33509, DOI 10.1074/jbc.M113.486662; Sheridan JT, 2011, J BIOL CHEM, V286, P1381, DOI 10.1074/jbc.M110.174847; Shi PP, 2008, AM J PHYSIOL-RENAL, V295, pF462, DOI 10.1152/ajprenal.90300.2008; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; Staruschenko A, 2005, BIOPHYS J, V88, P3966, DOI 10.1529/biophysj.104.056804; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Staub O, 2000, KIDNEY INT, V57, P809, DOI 10.1046/j.1523-1755.2000.00919.x; STUTTS MJ, 1986, PEDIATR RES, V20, P1316, DOI 10.1203/00006450-198612000-00026; Tarran R, 2014, INT J BIOCHEM CELL B, V52, P130, DOI 10.1016/j.biocel.2014.03.002; Walton WG, 2016, BIOCHEMISTRY-US, V55, P2979, DOI 10.1021/acs.biochem.6b00271; Watson MJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep27390; Weisz OA, 2003, AM J PHYSIOL-RENAL, V285, pF833, DOI 10.1152/ajprenal.00088.2003; Woollhead AM, 2006, J BIOL CHEM, V281, P5158, DOI 10.1074/jbc.M509947200; Wu T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14118	51	22	25	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2478	2491		10.1096/fj.201701126R	http://dx.doi.org/10.1096/fj.201701126R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29295861	Green Published			2022-12-28	WOS:000432528000014
J	Takemoto, Y; Slough, DP; Meinke, G; Katnik, C; Graziano, ZA; Chidipi, B; Reiser, M; Alhadidy, MM; Ramirez, R; Salvador-Montanes, O; Ennis, S; Guerrero-Serna, G; Haburcak, M; Diehl, C; Cuevas, J; Jalife, J; Bohm, A; Lin, YS; Noujaim, SF				Takemoto, Yoshio; Slough, Diana P.; Meinke, Gretchen; Katnik, Christopher; Graziano, Zachary A.; Chidipi, Bojjibabu; Reiser, Michelle; Alhadidy, Mohammed M.; Ramirez, Rafael; Salvador-Montanes, Oscar; Ennis, Steven; Guerrero-Serna, Guadalupe; Haburcak, Marian; Diehl, Carl; Cuevas, Javier; Jalife, Jose; Bohm, Andrew; Lin, Yu-Shan; Noujaim, Sami F.			Structural basis for the antiarrhythmic blockade of a potassium channel with a small molecule	FASEB JOURNAL			English	Article						potassium inward rectifier; atrial fibrillation; I-KACh	ATRIAL-FIBRILLATION; CRYSTAL-STRUCTURE; PROTEIN; CHLOROQUINE; PATHOPHYSIOLOGY; INHIBITION; PREDICTION; RESIDUES; BINDING; SYSTEM	The acetylcholine-activated inward rectifier potassium current (I-KACh) is constitutively active in persistent atrial fibrillation (AF). We tested the hypothesis that the blocking of I-KACh with the small molecule chloroquine terminates persistent AF. We used a sheep model of tachypacing-induced, persistent AF, molecular modeling, electrophysiology, and structural biology approaches. The 50% inhibition/inhibitory concentration of I-KACh block with chloroquine, measured by patch clamp, was 1 mu M. In optical mapping of sheep hearts with persistent AF, 1 mu M chloroquine restored sinus rhythm. Molecular modeling suggested that chloroquine blocked the passage of a hydrated potassium ion through the intracellular domain of Kir3.1 (a molecular correlate of I-KACh) by interacting with residues D260 and F255, in proximity to I228, Q227, and L299. H-1 N-15 heteronuclear single-quantum correlation of purified Kir3.1 intracellular domain confirmed the modeling results. F255, I228, Q227, and L299 underwent significant chemical-shift perturbations upon drug binding. We then crystallized and solved a 2.5 angstrom X-ray structure of Kir3.1 with F255A mutation. Modeling of chloroquine binding to the mutant channel suggested that the drug's binding to the pore becomes off centered, reducing its ability to block a hydrated potassium ion. Patch clamp validated the structural and modeling data, where the F255A and D260A mutations significantly reduced I-KACh block by chloroquine. With the use of numerical and structural biology approaches, we elucidated the details of how a small molecule could block an ion channel and exert antiarrhythmic effects. Chloroquine binds the I-KACh channel at a site formed by specific amino acids in the ion-permeation pathway, leading to decreased I-KACh and the subsequent termination of AF.	[Takemoto, Yoshio] Nagoya Univ, Res Inst Environm Med, Dept Cardiovasc Res, Nagoya, Aichi, Japan; [Takemoto, Yoshio; Ramirez, Rafael; Salvador-Montanes, Oscar; Ennis, Steven; Guerrero-Serna, Guadalupe; Jalife, Jose] Univ Michigan, Ctr Arrhythmia Res, Ann Arbor, MI 48109 USA; [Slough, Diana P.; Graziano, Zachary A.; Lin, Yu-Shan] Tufts Univ, Dept Chem, Medford, MA USA; [Meinke, Gretchen; Bohm, Andrew] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA; [Katnik, Christopher; Chidipi, Bojjibabu; Reiser, Michelle; Alhadidy, Mohammed M.; Cuevas, Javier; Noujaim, Sami F.] Univ S Florida, Mol Pharmacol & Physiol Dept, 12901 Bruce B Downs Blvd, Tampa, FL 33612 USA; [Haburcak, Marian] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; [Diehl, Carl] Sarom Biostruct, Copenhagen, Denmark; [Jalife, Jose] Ctr Nacl Invest Cardiovasc Carlos III, Madrid, Spain; [Jalife, Jose] Ctr Invest Biomed Red Enfermedades Cardiovasc, Madrid, Spain	Nagoya University; University of Michigan System; University of Michigan; Tufts University; Tufts University; State University System of Florida; University of South Florida; Brandeis University; Centro Nacional de Investigaciones Cardiovasculares (CNIC); CIBER - Centro de Investigacion Biomedica en Red; CIBERCV	Noujaim, SF (corresponding author), Univ S Florida, Mol Pharmacol & Physiol Dept, 12901 Bruce B Downs Blvd, Tampa, FL 33612 USA.	snoujaim@health.usf.edu	Ramirez, Rafael J./AAI-7712-2020; Jalife, Jose/A-8781-2019; Jalife, Jose/AAJ-9156-2021; CHIDIPI, BOJJI BABU/AAZ-8681-2021; Jalife, Jose/L-4833-2015; Salvador Montanes, Oscar/GQZ-7546-2022	Jalife, Jose/0000-0003-0080-3500; Jalife, Jose/0000-0003-0080-3500; CHIDIPI, BOJJI BABU/0000-0003-4107-1668; Jalife, Jose/0000-0003-0080-3500; Salvador Montanes, Oscar/0000-0002-3201-1316; Sanford, Diana/0000-0002-3777-8292; Haburcak, Marian/0000-0003-0662-0756	American Heart Association; U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) [R21 HL138064, R01HL129136]; Tufts start-up Fund; Knez Family Investment Fund; NIH NHLBI [R01HL122352]; Leducq Foundation: Transatlantic Network of Excellence Program on Structural Alterations in the Myocardium; Substrate for Cardiac Fibrillation; University of Michigan Health System-Peking University Health Science Center Joint Institute for Translational and Clinical Research [HEK293]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL138064, R01HL122352, R01HL129136] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Tufts start-up Fund; Knez Family Investment Fund; NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Leducq Foundation: Transatlantic Network of Excellence Program on Structural Alterations in the Myocardium(Leducq Foundation); Substrate for Cardiac Fibrillation; University of Michigan Health System-Peking University Health Science Center Joint Institute for Translational and Clinical Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Kevin Nash (University of South Florida) for his help with creation of mutant constructs. This work was supported, in part, by an American Heart Association postdoctoral fellowship to Y.T.; U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI), R21 HL138064 and R01HL129136 to S.F.N.; Tufts start-up and the Knez Family Investment Funds for Y-S.L.; and NIH NHLBI R01HL122352, the Leducq Foundation: Transatlantic Network of Excellence Program on Structural Alterations in the Myocardium and the Substrate for Cardiac Fibrillation, and University of Michigan Health System-Peking University Health Science Center Joint Institute for Translational and Clinical Research to J.J. HEK293 cells, stably transfected with Kir3.1 and Kir3.4, were a kind gift from the laboratory of Dr. Douglas Bayliss (University of Virginia Charlottesville, VA, USA). The authors declare no conflicts of interest.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Atienza F, 2006, CIRCULATION, V114, P2434, DOI 10.1161/CIRCULATIONAHA.106.633735; BURRELL ZL, 1958, NEW ENGL J MED, V258, P798, DOI 10.1056/NEJM195804172581608; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dobrev D, 2005, CIRCULATION, V112, P3697, DOI 10.1161/circulationaha.105.575332; Dobrev D, 2012, NAT REV DRUG DISCOV, V11, P275, DOI 10.1038/nrd3682; Dobrev D, 2011, CARDIOVASC RES, V89, P689, DOI 10.1093/cvr/cvr021; Dobrev D, 2010, LANCET, V375, P1212, DOI 10.1016/S0140-6736(10)60096-7; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferrari R, 2016, INT J CARDIOL, V203, P22, DOI 10.1016/j.ijcard.2015.10.089; Greenwood JR, 2010, J COMPUT AID MOL DES, V24, P591, DOI 10.1007/s10822-010-9349-1; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IIJIMA H, 1987, PROTEINS, V2, P330, DOI 10.1002/prot.340020408; Ivanina T, 2003, J BIOL CHEM, V278, P29174, DOI 10.1074/jbc.M304518200; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kurachi Y, 2004, J PHYSIOL-LONDON, V554, P285, DOI 10.1113/jphysiol.2003.048439; Li DX, 2016, BIOPHYS CHEM, V219, P43, DOI 10.1016/j.bpc.2016.09.010; Logothetis DE, 2007, J PHYSIOL-LONDON, V582, P953, DOI 10.1113/jphysiol.2007.133157; Mahler J, 2012, INORG CHEM, V51, P425, DOI 10.1021/ic2018693; Makary S, 2011, CIRC RES, V109, P1031, DOI 10.1161/CIRCRESAHA.111.253120; Martins RP, 2014, CIRCULATION, V129, P1472, DOI 10.1161/CIRCULATIONAHA.113.004742; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nattel S, 2016, NAT REV CARDIOL, V13, P575, DOI 10.1038/nrcardio.2016.118; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Noujaim SF, 2007, J PHYSIOL-LONDON, V578, P315, DOI 10.1113/jphysiol.2006.121475; Noujaim SF, 2011, CARDIOVASC RES, V89, P862, DOI 10.1093/cvr/cvr008; Noujaim SF, 2010, FASEB J, V24, P4302, DOI 10.1096/fj.10-163246; Olshansky B, 2004, J AM COLL CARDIOL, V43, P2063, DOI 10.1016/j.jacc.2004.03.020; Osawa M, 2009, J BIOL CHEM, V284, P26117, DOI 10.1074/jbc.M109.029355; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Podd SJ, 2016, EUROPACE, V18, P340, DOI 10.1093/europace/euv263; Ramu Y, 2004, BIOCHEMISTRY-US, V43, P10701, DOI 10.1021/bi049125x; Rodriguez-Menchaca AA, 2008, P NATL ACAD SCI USA, V105, P1364, DOI 10.1073/pnas.0708153105; Sanchez-Capula JA, 2001, J PHARMACOL EXP THER, V297, P437; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; Shivakumar D, 2010, J CHEM THEORY COMPUT, V6, P1509, DOI 10.1021/ct900587b; Takemoto Yoshio, 2016, JACC Basic Transl Sci, V1, P143; Voigt N, 2007, CARDIOVASC RES, V74, P426, DOI 10.1016/j.cardiores.2007.02.009; Voigt N, 2010, CIRC-ARRHYTHMIA ELEC, V3, P472, DOI 10.1161/CIRCEP.110.954636; Voigt N, 2010, N-S ARCH PHARMACOL, V381, P251, DOI 10.1007/s00210-009-0452-6; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wakili R, 2011, J CLIN INVEST, V121, P2955, DOI 10.1172/JCI46315; Walfridsson H, 2015, EUROPACE, V17, P473, DOI 10.1093/europace/euu192; WALKER O, 1983, BRIT J CLIN PHARMACO, V16, P701, DOI 10.1111/j.1365-2125.1983.tb02244.x; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Yokogawa M, 2009, BIOMOL NMR ASSIGN, V3, P125, DOI 10.1007/s12104-009-9156-6	54	15	16	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1778	1793		10.1096/fj.201700349R	http://dx.doi.org/10.1096/fj.201700349R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29162702	Green Published, Green Submitted			2022-12-28	WOS:000429051400004
J	Shen, ZF; Jiang, X; Yan, LL; Chen, Y; Wang, WW; Shi, Y; Shi, LE; Liu, DX; Zhou, NM				Shen, Zhangfei; Jiang, Xue; Yan, Lili; Chen, Yu; Wang, Weiwei; Shi, Ying; Shi, Liangen; Liu, Dongxiang; Zhou, Naiming			Structural basis for the interaction of diapause hormone with its receptor in the silkworm, Bombyx mori	FASEB JOURNAL			English	Article						GPCR; neuropeptide; signaling; structure-activity relationship	PROTEIN-COUPLED RECEPTOR; NEUROPEPTIDE FAMILY; BIOLOGICAL-ACTIVITY; EMBRYONIC DIAPAUSE; IDENTIFICATION; INSECT; COEVOLUTION; ACTIVATION; INDUCTION; PEPTIDES	Diapause hormone (DH) is a 24-aa amidated neuropeptide that elicits the embryonic diapause of the silkworm, Bombyx mori (Bommo), via sensitive and selective interaction with its receptor, Bommo DH receptor (Bommo-DHR). Previous studies of the structure-activity relationship of Bommo-DH were all based on an in vivo diapause-induction bioassay, which has provided little information on the structure of Bommo-DHR or its iteration with DH. Here, to unveil the interaction of Bommo-DH with its receptor, N-terminally truncated analogs and alanine-scanning mutants of Bommo-DH were chemically synthesized and functionally evaluated by using a Cy5.5-labeled Bommo-DH competitive binding assay and Bommo-DHR-based functional assays, including cAMP assay and Ca2+ mobilization assay. Our study demonstrates that the C-terminal residues of Arg23 and Leu24 of Bommo-DH are essential for the binding and activation of Bommo-DHR, and that Trp19 and Phe20 also contribute to the functional activity of Bommo-DH. In contrast, when Gly21 or Pro22 were replaced with alanine, both mutants exhibited binding and signaling activities that were indistinguishable from the wild-type peptide. Furthermore, our homology modeling and molecular dynamics simulations, together with experimental validations, have identified the residues of Glu89, Phe172, Phe194, and Tyr299 in Bommo-DHR that are critically involved in the interaction with Bommo-DH. These results may deepen our understanding of the interactions of class-AGPCRs with their peptidic ligands, particularly those between pheromone biosynthesis-activating neuropeptide/DH family neuropeptides and their cognate receptors.-Shen, Z., Jiang, X., Yan, L., Chen, Y., Wang, W., Shi, Y., Shi, L., Liu, D., Zhou, N. Structural basis for the interaction of diapause hormone with its receptor in the silkworm, Bombyx mori.	[Shen, Zhangfei; Jiang, Xue; Shi, Liangen] Zhejiang Univ, Coll Anim Sci, Dept Econ Zool, Hangzhou, Zhejiang, Peoples R China; [Yan, Lili; Chen, Yu; Wang, Weiwei; Shi, Ying; Zhou, Naiming] Zhejiang Univ, Coll Life Sci, Inst Biochem, Zijingang Campus, Hangzhou 310058, Zhejiang, Peoples R China; [Liu, Dongxiang] Chinese Acad Sci, Shanghai Inst Mat Med, Dept Pharmacol 3, Shanghai 201203, Peoples R China	Zhejiang University; Zhejiang University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Zhou, NM (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Biochem, Zijingang Campus, Hangzhou 310058, Zhejiang, Peoples R China.; Liu, DX (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Dept Pharmacol 3, Shanghai 201203, Peoples R China.	dxl@mail.shcnc.ac.cn; zhounaiming@zju.edu.cn	Zhou, Naiming/AHC-1121-2022; Chen, Yi/HIR-2608-2022; Chen, Yu/Y-3292-2019	shen, zhangfei/0000-0002-3707-2265	National Natural Science Foundation of China [31272375, 31572462, 21472206, 21672233]; Science and Technology Project of Zhejiang, China [2016C32079]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Zhejiang, China	This work was supported by the National Natural Science Foundation of China (Grants 31272375, 31572462, 21472206, and 21672233) and the Science and Technology Project of Zhejiang, China (Grant 2016C32079). The authors declare no conflicts of interest.	Choi MY, 2007, INSECT BIOCHEM MOLEC, V37, P296, DOI 10.1016/j.ibmb.2006.12.004; Cvejic S, 2004, NAT CELL BIOL, V6, P540, DOI 10.1038/ncb1133; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Darlison MG, 1999, TRENDS NEUROSCI, V22, P81, DOI 10.1016/S0166-2236(98)01333-2; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Fukuda S., 1951, Proceedings of the Japan Academy, V27, P672; Hasegawa K., 1951, Proceedings of the Japan Academy, V27, P667; Homma T, 2006, BIOCHEM BIOPH RES CO, V344, P386, DOI 10.1016/j.bbrc.2006.03.085; Huang HS, 2010, BIOCHEMISTRY-US, V49, P10862, DOI 10.1021/bi1014425; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IKEDA M, 1993, J INSECT PHYSIOL, V39, P889, DOI 10.1016/0022-1910(93)90122-8; IMAI K, 1991, P JPN ACAD B-PHYS, V67, P98, DOI 10.2183/pjab.67.98; Imai K, 1998, BIOSCI BIOTECH BIOCH, V62, P1875, DOI 10.1271/bbb.62.1875; Jiang HB, 2014, SCI REP-UK, V4, DOI 10.1038/srep06800; Jiang X, 2016, INSECT BIOCHEM MOLEC, V75, P78, DOI 10.1016/j.ibmb.2016.06.005; Kawai T, 2014, J BIOL CHEM, V289, P19150, DOI 10.1074/jbc.M113.488999; KITAMURA A, 1989, BIOCHEM BIOPH RES CO, V163, P520, DOI 10.1016/0006-291X(89)92168-2; KUNIYOSHI H, 1992, INSECT BIOCHEM MOLEC, V22, P399, DOI 10.1016/0965-1748(92)90078-S; Li G, 2010, J BIOL CHEM, V285, P22605, DOI 10.1074/jbc.M109.087213; Morita A, 2003, J INSECT PHYSIOL, V49, P1093, DOI 10.1016/j.jinsphys.2003.08.009; NACHMAN RJ, 1993, PEPTIDES, V14, P1043, DOI 10.1016/0196-9781(93)90084-T; NACHMAN RJ, 1991, P NATL ACAD SCI USA, V88, P4518, DOI 10.1073/pnas.88.10.4518; Nusawardani T, 2013, INSECT MOL BIOL, V22, P331, DOI 10.1111/imb.12025; Park Y, 2002, P NATL ACAD SCI USA, V99, P11423, DOI 10.1073/pnas.162276199; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Predel R, 2006, HANDBOOK OF BIOLOGICALLY ACTIVE PEPTIDES, P207, DOI 10.1016/B978-012369442-3/50035-0; SAITO H, 1994, PEPTIDES, V15, P1173, DOI 10.1016/0196-9781(94)90139-2; SATO Y, 1993, P NATL ACAD SCI USA, V90, P3251, DOI 10.1073/pnas.90.8.3251; Sato Y., 2006, P JPN ACAD, V68, P75; Shalev AH, 2015, PEPTIDES, V63, P81, DOI 10.1016/j.peptides.2014.10.014; SHIMIZU I, 1991, JPN J APPL ENTOMOL Z, V35, P83; Shiomi K, 2015, SCI REP-UK, V5, DOI 10.1038/srep15566; SUWAN S, 1994, INSECT BIOCHEM MOLEC, V24, P1001, DOI 10.1016/0965-1748(94)90137-6; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Watanabe K, 2007, MOL CELL ENDOCRINOL, V273, P51, DOI 10.1016/j.mce.2007.05.008; Yamashita O, 1996, J INSECT PHYSIOL, V42, P669, DOI 10.1016/0022-1910(96)00003-0; Yang HP, 2013, INSECT BIOCHEM MOLEC, V43, P1028, DOI 10.1016/j.ibmb.2013.08.011; Yang JW, 2013, J BIOL CHEM, V288, P11662, DOI 10.1074/jbc.M112.441675	39	7	8	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1338	1353		10.1096/fj.201700931R	http://dx.doi.org/10.1096/fj.201700931R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29101222	Bronze			2022-12-28	WOS:000427246000018
J	Yang, W; Hosford, SR; Traphagen, NA; Shee, K; Demidenko, E; Liu, S; Miller, TW				Yang, Wei; Hosford, Sarah R.; Traphagen, Nicole A.; Shee, Kevin; Demidenko, Eugene; Liu, Stephanie; Miller, Todd W.			Autophagy promotes escape from phosphatidylinositol 3-kinase inhibition in estrogen receptor-positive breast cancer	FASEB JOURNAL			English	Article						PI3K; GDC-0941; chloroquine; ER; BH3-only proteins	ADVANCED SOLID TUMORS; PHASE-I TRIAL; MONITORING AUTOPHAGY; BH3-ONLY PROTEINS; FEEDBACK LOOP; HYDROXYCHLOROQUINE; PUMA; RESISTANT; APOPTOSIS; CELLS	Hyperactivation of the PI3K pathway has been implicated in resistance to antiestrogen therapies in estrogen receptor a (ER)-positive breast cancer, prompting the development of therapeutic strategies to inhibit this pathway. Autophagy has tumor-promoting and -suppressing roles and has been broadly implicated in resistance to anticancer therapies, including antiestrogens. Chloroquine (CQ) is an antimalarial and amebicidal drug that inhibits autophagy in mammalian cells and human tumors. Herein, we observed that CQ inhibited proliferation and autophagy in ER+ breast cancer cells. PI3K inhibition with GDC-0941 (pictilisib) induced autophagy. Inhibition of autophagy using CQ or RNA interference potentiated PI3K inhibitor-induced apoptosis. Combined inhibition of PI3K and autophagy effectively induced mitochondrial membrane depolarization, which required the BH3-only proapoptotic proteins Bim and PUMA. Treatment with GDC-0941, CQ, or the combination, significantly suppressed the growth of ER+ breast cancer xenografts in mice. In an antiestrogen-resistant xenograft model, GDC-0941 synergized with CQ to provide partial, but durable, tumor regression. These findings warrant clinical evaluation of therapeutic strategies to target ER, PI3K, and autophagy for the treatment of ER+ breast cancer.	[Yang, Wei; Hosford, Sarah R.; Traphagen, Nicole A.; Shee, Kevin; Liu, Stephanie; Miller, Todd W.] Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Dept Mol & Syst Biol, One Med Ctr Dr,HB 7936, Lebanon, NH 03756 USA; [Demidenko, Eugene] Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Community & Family Med, Lebanon, NH 03756 USA; [Miller, Todd W.] Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Comprehens Breast Program, Lebanon, NH 03756 USA	Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; Norris Cotton Cancer Center	Miller, TW (corresponding author), Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Dept Mol & Syst Biol, One Med Ctr Dr,HB 7936, Lebanon, NH 03756 USA.	todd.w.miller@dartmouth.edu	Shee, Kevin/V-6803-2019	Shee, Kevin/0000-0001-5378-7650	American Cancer Society [RSG-13-292-01-TBE]; U.S. National Institutes of Health, National Cancer Institute [P30CA023108]; NATIONAL CANCER INSTITUTE [R01CA200994, R01CA211869, P30CA023108, F30CA216966] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank the following Norris Cotton Cancer Center Shared Resources for assistance: Flow Cytometry, Microscopy, Pathology, and the Center for Comparative Medicine and Research. This work was supported by the American Cancer Society (Grant RSG-13-292-01-TBE to T.W.M.) and U.S. National Institutes of Health, National Cancer Institute (Grant P30CA023108 to Dartmouth College, Norris Cotton Cancer Center Support). The authors declare no conflicts of interest.	Amente S, 2011, NUCLEIC ACIDS RES, V39, P9498, DOI 10.1093/nar/gkr638; Barnard RA, 2014, AUTOPHAGY, V10, P1415, DOI 10.4161/auto.29165; Baselga J, 2016, CANC RES S, V76; Bean GR, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003483; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Chude CI, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061279; Cook KL, 2014, CLIN CANCER RES, V20, P3222, DOI 10.1158/1078-0432.CCR-13-3227; Cook KL, 2012, CANCER RES, V72, P3337, DOI 10.1158/0008-5472.CAN-12-0269; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Demidenko E., 2013, MIXED MODELS THEORY; Demidenko E, 2006, J R STAT SOC C-APPL, V55, P365, DOI 10.1111/j.1467-9876.2006.00541.x; Demidenko E, 2010, INT J RADIAT BIOL, V86, P164, DOI 10.3109/09553000903419304; Dillon LM, 2015, ONCOGENE, V34, P3968, DOI 10.1038/onc.2014.328; Ebi H, 2013, P NATL ACAD SCI USA, V110, P21124, DOI 10.1073/pnas.1314124110; Echeverry N, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.124; Faber AC, 2011, CANCER DISCOV, V1, P352, DOI 10.1158/2159-8290.CD-11-0106; Garner F, 2016, CANC RES, V76; Green DR, 2014, CELL, V157, P65, DOI 10.1016/j.cell.2014.02.049; Guo JYX, 2016, COLD SH Q B, V81, P73, DOI 10.1101/sqb.2016.81.030981; Happo L, 2012, J CELL SCI, V125, P1081, DOI 10.1242/jcs.090514; Hosford SR, 2017, CLIN CANCER RES, V23, P2795, DOI 10.1158/1078-0432.CCR-15-2764; Ji YH, 2015, CLIN LAB, V61, P1043, DOI 10.7754/Clin.Lab.2015.150144; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kimura S, 2009, METHOD ENZYMOL, V452, P1, DOI 10.1016/S0076-6879(08)03601-X; Kimura T, 2013, CANCER RES, V73, P3, DOI 10.1158/0008-5472.CAN-12-2464; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kreuzaler P, 2012, NAT REV CANCER, V12, P411, DOI 10.1038/nrc3264; Krop IE, 2016, LANCET ONCOL, V17, P811, DOI 10.1016/S1470-2045(16)00106-6; Lamoureux F, 2013, CLIN CANCER RES, V19, P833, DOI 10.1158/1078-0432.CCR-12-3114; Lewis Matthew D, 2011, BMC Res Notes, V4, P262, DOI 10.1186/1756-0500-4-262; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Lui A, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2490-z; Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653; Mayer IA, 2017, CLIN CANCER RES, V23, P26, DOI 10.1158/1078-0432.CCR-16-0134; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Miller TW, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3039; Miller TW, 2011, J CLIN ONCOL, V29, P4452, DOI 10.1200/JCO.2010.34.4879; Miller TW, 2010, J CLIN INVEST, V120, P2406, DOI 10.1172/JCI41680; Miller TW, 2009, CLIN CANCER RES, V15, P7266, DOI 10.1158/1078-0432.CCR-09-1665; Molenaar RJ, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014961; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Ni J, 2012, CANCER DISCOV, V2, P425, DOI 10.1158/2159-8290.CD-12-0003; O'Brien C, 2010, CLIN CANCER RES, V16, P3670, DOI 10.1158/1078-0432.CCR-09-2828; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Rangwala R, 2014, AUTOPHAGY, V10, P1391, DOI 10.4161/auto.29119; Rangwala R, 2014, AUTOPHAGY, V10, P1369, DOI 10.4161/auto.29118; Rosenfeld MR, 2014, AUTOPHAGY, V10, P1359, DOI 10.4161/auto.28984; Schoenlein PV, 2009, AUTOPHAGY, V5, P400, DOI 10.4161/auto.5.3.7784; Tartarone A, 2012, NEW ENGL J MED, V366, P1739, DOI 10.1056/NEJMc1202719; Team RC., 2014, R LANGUAGE ENV STAT; Vaillant F, 2013, CANCER CELL, V24, P120, DOI 10.1016/j.ccr.2013.06.002; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Wang C, 2016, PHARMACOL RES, V105, P164, DOI 10.1016/j.phrs.2016.01.028; Wang YC, 2016, ONCOTARGET, V7, P19897, DOI 10.18632/oncotarget.7658; White E, 2015, J CLIN INVEST, V125, P42, DOI 10.1172/JCI73941; Wolpin BM, 2014, ONCOLOGIST, V19, P637, DOI 10.1634/theoncologist.2014-0086; Yang W, 2016, CLIN CANCER RES, V22, P2250, DOI 10.1158/1078-0432.CCR-15-2276; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353	60	18	18	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1222	1235		10.1096/fj.201700477R	http://dx.doi.org/10.1096/fj.201700477R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29127189	Green Published			2022-12-28	WOS:000427246000010
J	Keeley, TP; Siow, RCM; Jacob, R; Mann, GE				Keeley, Thomas P.; Siow, Richard C. M.; Jacob, Ron; Mann, Giovanni E.			A PP2A-mediated feedback mechanism controls Ca2+-dependent NO synthesis under physiological oxygen	FASEB JOURNAL			English	Article						endothelial cells; normoxia; hypoxia	ENDOTHELIAL NITRIC-OXIDE; PROTEIN PHOSPHATASE 2A; NEURAL PRECURSOR CELLS; FLUID SHEAR-STRESS; DOWN-REGULATION; STEM-CELLS; SYNTHASE; PHOSPHORYLATION; HYPOXIA; O-2	Intracellular O-2 is a key regulator of NO signaling, yet most in vitro studies are conducted in atmospheric O-2 levels, hyperoxic with respect to the physiologic milieu. We investigated NO signaling in endothelial cells cultured in physiologic (5%) O-2 and stimulated with histamine or shear stress. Culture of cells in 5% O-2 (> 5 d) decreased histamine but not shear stress-stimulated endothelial (e) NOSactivity. Unlike cells adapted to a hypoxic environment(1% O-2), those cultured in 5% O-2 still mobilized sufficient Ca2+ to activate AMPK. Enhanced expression and membrane targeting of PP2A-C was observed in 5% O-2, resulting in greater interaction with eNOS in response to histamine. Moreover, increased dephosphorylation of eNOS in 5% O-2 was Ca2+-sensitive and reversed by okadaic acid or PP2A-C siRNA. The present findings establish that Ca2+ mobilization stimulates both NO synthesis and PP2A-mediated eNOS dephosphorylation, thus constituting a novel negative feedback mechanism regulating eNOS activity not present in response to shear stress. This, coupled with enhanced NO bioavailability, underpins differences in NO signaling induced by inflammatory and physiologic stimuli that are apparent only in physiologic O-2 levels. Furthermore, an explicit delineation between physiologic normoxia and genuine hypoxia is defined here, with implications for our understanding of pathophysiological hypoxia.-Keeley, T. P., Siow, R. C. M., Jacob, R., Mann, G. E. A PP2A-mediated feedback mechanism controls Ca2+-dependent NO synthesis under physiological oxygen.	[Keeley, Thomas P.; Siow, Richard C. M.; Jacob, Ron; Mann, Giovanni E.] Kings Coll London, Fac Life Sci & Med, Cardiovasc Div, Kings British Heart Fdn,Ctr Res Excellence, 150 Stamford St,Franklin Wilkins Bldg,Room 3-01, London SE1 9NH, England	University of London; King's College London	Mann, GE (corresponding author), Kings Coll London, Fac Life Sci & Med, Cardiovasc Div, Kings British Heart Fdn,Ctr Res Excellence, 150 Stamford St,Franklin Wilkins Bldg,Room 3-01, London SE1 9NH, England.	giovanni.mann@kcl.ac.uk		Mann, Giovanni/0000-0001-7311-2044; Keeley, Thomas/0000-0002-0334-7144	British Heart Foundation [FS/13/66/30445]; Heart Research UK [NET01/13]	British Heart Foundation(British Heart Foundation); Heart Research UK	The authors thank Dr. Kalwant Authi for assistance with ultracentrifugation, Paraskevi-Maria Psefteli for experimental assistance, and Prof. Jeremy Pearson and Dr. Sarah J. Chapple (all from King's College) for helpful discussions, and the midwives of St. Thomas' Hospital (London, United Kingdom) for assistance in the collection of umbilical cords. This work was supported by Grant FS/13/66/30445 from the British Heart Foundation and NET01/13 from Heart Research UK. The authors declare no conflicts of interest.	ANDO J, 1988, IN VITRO CELL DEV B, V24, P871; Atkuri KR, 2007, P NATL ACAD SCI USA, V104, P4547, DOI 10.1073/pnas.0611732104; Atkuri KR, 2005, P NATL ACAD SCI USA, V102, P3756, DOI 10.1073/pnas.0409910102; Ayajiki K, 1996, CIRC RES, V78, P750, DOI 10.1161/01.RES.78.5.750; Baharians Z, 1998, J BIOL CHEM, V273, P19019, DOI 10.1074/jbc.273.30.19019; BALIN AK, 1977, J CELL BIOL, V74, P58, DOI 10.1083/jcb.74.1.58; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BOKKALA S, 1995, BIOCHEM J, V306, P837, DOI 10.1042/bj3060837; BUSSE R, 1990, FEBS LETT, V265, P133, DOI 10.1016/0014-5793(90)80902-U; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chapple SJ, 2016, FREE RADICAL BIO MED, V92, P152, DOI 10.1016/j.freeradbiomed.2015.12.013; Davis AJ, 2008, J BIOL CHEM, V283, P16104, DOI 10.1074/jbc.M710313200; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; El Alami M, 2014, STEM CELL REP, V3, P566, DOI 10.1016/j.stemcr.2014.08.002; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Fleming I, 1998, CIRC RES, V82, P686, DOI 10.1161/01.RES.82.6.686; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Fulton D, 2002, J BIOL CHEM, V277, P4277, DOI 10.1074/jbc.M106302200; Garcia C, 2008, J CLIN INVEST, V118, P2291, DOI [10.1172/JC134508, 10.1172/JCI34508]; Grallert A, 2015, NATURE, V517, P94, DOI 10.1038/nature14019; Harris MB, 2001, J BIOL CHEM, V276, P16587, DOI 10.1074/jbc.M100229200; Janssens V, 2003, J BIOL CHEM, V278, P10697, DOI 10.1074/jbc.M211717200; Kou RQ, 2002, J BIOL CHEM, V277, P29669, DOI 10.1074/jbc.M204519200; KOUREMBANAS S, 1993, J CLIN INVEST, V92, P99, DOI 10.1172/JCI116604; Lantoine F, 1998, BIOCHEM J, V330, P695, DOI 10.1042/bj3300695; Li TS, 2011, CARDIOVASC RES, V89, P157, DOI 10.1093/cvr/cvq251; Liu XP, 1998, P NATL ACAD SCI USA, V95, P2175, DOI 10.1073/pnas.95.5.2175; Lorenz M, 2015, ATHEROSCLEROSIS, V240, P61, DOI 10.1016/j.atherosclerosis.2015.02.018; MCQUILLAN LP, 1994, AM J PHYSIOL-HEART C, V267, pH1921; Moreno CS, 2000, J BIOL CHEM, V275, P5257, DOI 10.1074/jbc.275.8.5257; Murata T, 2002, J BIOL CHEM, V277, P44085, DOI 10.1074/jbc.M205934200; Olszewska-Pazdrak B, 2009, AM J PHYSIOL-CELL PH, V296, pC1162, DOI 10.1152/ajpcell.00533.2008; Ostergaard L, 2007, AM J PHYSIOL-HEART C, V293, pH2894, DOI 10.1152/ajpheart.01230.2006; Ostergaard L, 2009, PROTEOMICS, V9, P4457, DOI 10.1002/pmic.200800130; Palacios-Callender M, 2007, P NATL ACAD SCI USA, V104, P18508, DOI 10.1073/pnas.0709440104; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Persechini A, 2002, TRENDS CARDIOVAS MED, V12, P32, DOI 10.1016/S1050-1738(01)00144-X; Qing L, 2004, P NATL ACAD SCI USA, V101, P17126, DOI 10.1073/pnas.0407492101; RILEY RJ, 1993, CLIN OBSTET GYNECOL, V36, P13, DOI 10.1097/00003081-199303000-00005; Rowlands DJ, 2011, HYPERTENSION, V57, P833, DOI 10.1161/HYPERTENSIONAHA.110.162198; SANDERS SP, 1993, J CLIN INVEST, V91, P46, DOI 10.1172/JCI116198; Schmidt K, 1998, METH MOL B, V100, P281; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stacpoole SRL, 2011, CELL DEATH DIFFER, V18, P1016, DOI 10.1038/cdd.2010.171; Stacpoole SRL, 2013, STEM CELL TRANSL MED, V2, P464, DOI 10.5966/sctm.2012-0144; Takemoto M, 2002, CIRCULATION, V106, P57, DOI 10.1161/01.CIR.0000020682.73694.AB; Thomas DD, 2001, P NATL ACAD SCI USA, V98, P355, DOI 10.1073/pnas.98.1.355; Thors B, 2003, ATHEROSCLEROSIS, V168, P245, DOI 10.1016/S0021-9150(03)00127-8; Tiede LM, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.128; Toporsian M, 2000, CIRC RES, V86, P671, DOI 10.1161/01.RES.86.6.671; Tsai AG, 2003, PHYSIOL REV, V83, P933, DOI 10.1152/physrev.00034.2002; Urbich C, 2002, FASEB J, V16, P706, DOI 10.1096/fj.01-0637fje; Victor VM, 2009, CIRC RES, V104, P1178, DOI 10.1161/CIRCRESAHA.109.197228; Wei Q, 2006, J BIOL CHEM, V281, P21652, DOI 10.1074/jbc.M602105200; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Yamamoto K, 2000, AM J PHYSIOL-HEART C, V279, pH285, DOI 10.1152/ajpheart.2000.279.1.H285; Zhang QJ, 2012, DIABETES, V61, P1848, DOI 10.2337/db11-1399	59	14	15	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5172	+		10.1096/fj.201700211R	http://dx.doi.org/10.1096/fj.201700211R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28760745	Green Published			2022-12-28	WOS:000416588300005
J	Zhao, Q; Zhou, D; You, HJ; Lou, BW; Zhang, Y; Tian, YL; Guo, N; Chen, XL; Liu, Y; Wu, Y; Yuan, ZY; Zhou, J				Zhao, Qiang; Zhou, Dong; You, Hongjun; Lou, Bowen; Zhang, Yan; Tian, Yuling; Guo, Ning; Chen, Xiaoli; Liu, Yan; Wu, Yue; Yuan, Zuyi; Zhou, Juan			IFN-gamma aggravates neointimal hyperplasia by inducing endoplasmic reticulum stress and apoptosis in macrophages by promoting ubiquitin-dependent liver X receptor-alpha degradation	FASEB JOURNAL			English	Article						inflammation; ER stress; restenosis	MUSCLE-CELL PROLIFERATION; INTERFERON-GAMMA; LXR-ALPHA; RESTENOSIS; INJURY; INFLAMMATION; ARTERY; PREDICTORS; MECHANISMS	Neointimal hyperplasia is the main cause of restenosis after percutaneous coronary interventions (PCIs). Both IFN-gamma and macrophages play nonredundant roles in the pathogenesis of vascular intimal hyperplasia; however, the underlying mechanisms remain elusive and must be further investigated. In mouse peritoneal macrophages, IFN-gamma significantly accelerated degradation and up-regulated polyubiquitination of liver X receptor (LXR)-alpha. Signal transducer and activator of transcription 1 (STAT1) inhibitor, fludarabine, and PIAS1 knockdown reduced ubiquitination and increased the expression of LXR-alpha in IFN-gamma-treated macrophages. IFN-gamma also increased the expression of endoplasmic reticulum (ER) stress-related proteins, including p-PERK, p-eIIF2 alpha, and CCAAT-enhancer-binding protein homologous protein (CHOP), as well as apoptosis of macrophages. Treatment with ER stress inhibitor, 4-phenylbutyric acid (4-PBA), and LXR agonist, T0901317 (T0), alleviated IFN-gamma-induced apoptosis in macrophages. Neointimal hyperplasia was significant after carotid ligation for 4 wk in ApoE(-/-) mice. IFN-gamma mAb, T0, and 4-PBA treatment not only significantly attenuated neointimal hyperplasia but also decreased CD68(+)TUNEL(+) double-positive macrophages in the hyperplastic neointima. Moreover, after 4-PBA or T0 administration, the number of CD68(+)p-eIIF2 alpha(+) and CD68(+)CHOP(+) double-positive cells in neointimal was also apparently decreased. Taken together, these results defined an unexpected role of IFN-gamma and LXR-alpha in the development of neointimal hyperplasia. The PIAS1/STAT1-dependent LXR-alpha degradation induced by IFN-gamma promoted ER stress and apoptosis in macrophages, which leads to aggravated neointimal hyperplasia. LXR agonist efficiently improved neointimal hyperplasia, which may be a promising new strategy to ameliorate restenosis and vascular remodeling after PCI.	[Zhao, Qiang; Zhou, Dong; You, Hongjun; Lou, Bowen; Zhang, Yan; Tian, Yuling; Guo, Ning; Chen, Xiaoli; Liu, Yan; Wu, Yue; Yuan, Zuyi; Zhou, Juan] Xi An Jiao Tong Univ, Minist Educ, Dept Cardiovasc Med, Med Sch,Affiliated Hosp 1, Xian, Shaanxi, Peoples R China; [Yuan, Zuyi] Xi An Jiao Tong Univ, Minist Educ, Key Lab Environm & Genes Related Dis, Xian, Shaanxi, Peoples R China; [Zhou, Juan] Key Lab Mol Cardiol Shanxi Prov, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Yuan, ZY; Zhou, J (corresponding author), Xi An Jiao Tong Univ, Dept Cardiovasc Med, Affiliated Hosp 1, 277 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China.	zuyiyuan@mail.xjtu.edu.cn; 1306899042@qq.com	Zhao, Qiang/AAS-9878-2020	Zhao, Qiang/0000-0003-0080-7210; Yuan, Zuyi/0000-0002-4141-0298	National Natural Science Foundation of China [91639301, 91339116, 81300226]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The author expresses heartfelt gratitude to her husband for valuable encouragement and spiritual support during the study. This work was supported by the National Natural Science Foundation of China (Grants 91639301, 91339116, and 81300226). The authors declare no conflicts of interest.	Alfonso F, 2014, J AM COLL CARDIOL, V63, P2659, DOI 10.1016/j.jacc.2014.02.545; Bayes-Genis A, 2002, ATHEROSCLEROSIS, V163, P89, DOI 10.1016/S0021-9150(01)00771-7; Blaschke F, 2004, CIRC RES, V95, pE110, DOI 10.1161/01.RES.0000150368.56660.4f; Cassese S, 2014, HEART, V100, P153, DOI 10.1136/heartjnl-2013-304933; Costa MA, 2005, CIRCULATION, V111, P2257, DOI 10.1161/01.CIR.0000163587.36485.A7; Dai XY, 2016, CIRC RES, V119, P1089, DOI 10.1161/CIRCRESAHA.116.309463; Danenberg HD, 2002, CIRCULATION, V106, P599, DOI 10.1161/01.CIR.0000023532.98469.48; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Guzeloglu M, 2012, J CARDIOTHORAC SURG, V7, DOI 10.1186/1749-8090-7-57; Hong C, 2014, NAT REV DRUG DISCOV, V13, P433, DOI 10.1038/nrd4280; Hui DY, 2008, CURR DRUG TARGETS, V9, P251, DOI 10.2174/138945008783755601; Ishimura S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06943; Kim KH, 2009, MOL ENDOCRINOL, V23, P466, DOI 10.1210/me.2008-0295; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; Lee JH, 2009, MOL CELL, V35, P806, DOI 10.1016/j.molcel.2009.07.021; Lee JY, 2011, J AM COLL CARDIOL, V57, P1349, DOI 10.1016/j.jacc.2010.10.041; Noda T, 2015, ARTERIOSCL THROM VAS, V35, P1246, DOI 10.1161/ATVBAHA.114.304923; Park SJ, 2012, J AM COLL CARDIOL, V59, P2051, DOI 10.1016/j.jacc.2011.10.909; Rong X, 2013, CELL METAB, V18, P685, DOI 10.1016/j.cmet.2013.10.002; Rose ML, 2007, CIRC RES, V101, P542, DOI 10.1161/CIRCRESAHA.107.160911; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shah PK, 2003, CIRCULATION, V107, P2175, DOI 10.1161/01.CIR.0000069943.41206.BD; Sun XW, 2016, J BIOL CHEM, V291, P1115, DOI 10.1074/jbc.M115.668269; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tavakoli NN, 2012, INT J MOL MED, V30, P545, DOI 10.3892/ijmm.2012.1034; Tellides G, 2007, CIRC RES, V100, P622, DOI 10.1161/01.RES.0000258861.72279.29; Toutouzas K, 2004, EUR HEART J, V25, P1679, DOI 10.1016/j.ehj.2004.06.011; Wang QX, 2014, CIRC RES, V114, P480, DOI 10.1161/CIRCRESAHA.114.302113; Wang YN, 2007, CIRC RES, V101, P560, DOI 10.1161/CIRCRESAHA.107.151068; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	31	10	11	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5321	+		10.1096/fj.201700327R	http://dx.doi.org/10.1096/fj.201700327R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28798155				2022-12-28	WOS:000416588300017
J	Funken, D; Ishikawa-Ankerhold, H; Uhl, B; Lerchenberger, M; Rentsch, M; Mayr, D; Massberg, S; Werner, J; Khandoga, A				Funken, Dominik; Ishikawa-Ankerhold, Hellen; Uhl, Bernd; Lerchenberger, Maximilian; Rentsch, Markus; Mayr, Doris; Massberg, Steffen; Werner, Jens; Khandoga, Andrej			In situ targeting of dendritic cells sets tolerogenic environment and ameliorates CD4(+) T-cell response in the postischemic liver	FASEB JOURNAL			English	Article						hepatic ischemia/reperfusion; transplantation; T lymphocytes; immunological tolerance; microvascular injury	HEPATIC STELLATE CELLS; MOUSE-LIVER; INJURY; ACTIVATION; MICE; PARICALCITOL; INFLAMMATION; INDUCTION; PROMOTE	CD4(+) T cells recruited to the liver play a key role in the pathogenesis of ischemia/reperfusion (I/R) injury. The mechanism of their activation during alloantigen-independent I/R is not completely understood. We hypothesized that liver-resident dendritic cells (DCs) interact with CD4(+) T cells in the postischemic liver and that modulation of DCs or T-cell-DC interactions attenuates liver inflammation. In mice, warm hepatic I/R (90/120-240 min) was induced. Tolerogenic DCs were generated in situ by pretreatment of animals with the vitamin D analog paricalcitol. A mAb-CD44 was used for blockade of CD4(+) T-cell-DC interactions. As shown by 2-photon in vivo microscopy as well as confocal microscopy, CD4(+) T cells were closely colocalized with DCs in the postischemic liver. Pretreatment with paricalcitol attenuated I/R-induced maturation of DCs (flow cytometry), CD4(+) T-cell recruitment into the liver (intravital microscopy), and hepatocellular/microvascular damage (intravital microscopy, alanine aminotransferase/aspartate aminotransferase, histology). However, interruption of T-cell-DC interaction increased proinflammatory DC maturation and even enhanced tissue damage. Simultaneous treatment with an anti-CD44mAb completely abolished the beneficial effect of paricalcitol on T-cell migration and tissue injury. Our study demonstrates for the first time that hepatic DCs interact with CD4(+) T cells in the postischemic liver in vivo; modulation of DCs and/or generation of tolerogenic DCs attenuates intrahepatic CD4(+) T-cell recruitment and reduces I/R injury; and interruption of CD44-dependent CD4(+) T-cell-DC interactions enhances tissue injury by preventing the modulatory effect of hepatic DCs on T cells, especially type 1 T helper effector cells. Thus, hepatic DCs are strongly involved in the promotion of CD4(+) T-cell-dependent postischemic liver inflammation.	[Funken, Dominik; Lerchenberger, Maximilian; Rentsch, Markus; Werner, Jens; Khandoga, Andrej] Univ Munich, Dept Gen Visceral & Transplant Surg, Marchioninistr 15, D-81377 Munich, Germany; [Ishikawa-Ankerhold, Hellen; Massberg, Steffen] Univ Munich, Dept Cardiol, Munich, Germany; [Mayr, Doris] Univ Munich, Dept Pathol, Munich, Germany; [Ishikawa-Ankerhold, Hellen; Uhl, Bernd] Walter Brendel Ctr Expt Med, Munich, Germany	University of Munich; University of Munich; University of Munich; University of Munich	Khandoga, A (corresponding author), Univ Munich, Dept Gen Visceral & Transplant Surg, Marchioninistr 15, D-81377 Munich, Germany.	Andrej.Khandoga@med.uni-muenchen.de	Massberg, Steffen/AAN-6054-2021		Deutsche Forschungsgemeinschaft [KH92-3/1];  [SFB914]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 	The authors thank R. Haas (Max von Pettenkofer Institute, University of Munich) for providing the C57BL/6 CD11c-eYFP mice. This work was supported, in part, by the Deutsche Forschungsgemeinschaft (KH92-3/1), and by the SFB914, Project Z01 (to S.M., A.K., and H.I.-A.). The authors declare no conflicts of interest.	Adorini Luciano, 2002, Curr Opin Investig Drugs, V3, P1458; Bakdash G, 2014, VACCINE, V32, P6294, DOI 10.1016/j.vaccine.2014.08.075; Bamboat ZM, 2010, J CLIN INVEST, V120, P559, DOI 10.1172/JCI40008; Castellaneta A, 2014, HEPATOLOGY, V60, P267, DOI 10.1002/hep.27037; Ferreira GB, 2014, J IMMUNOL, V192, P4210, DOI 10.4049/jimmunol.1302350; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Gonzalez-Mateo GT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108477; Hanschen M, 2008, TRANSPLANTATION, V86, P710, DOI 10.1097/TP.0b013e3181821aa7; Henrickson SE, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.112pt2; Herz J, 2012, MICROSC MICROANAL, V18, P730, DOI 10.1017/S1431927612000281; Heymann F, 2015, HEPATOLOGY, V62, P279, DOI 10.1002/hep.27793; Khandoga A, 2006, HEPATOLOGY, V43, P306, DOI 10.1002/hep.21017; Khandoga A, 2002, TRANSPLANTATION, V74, P681, DOI 10.1097/00007890-200209150-00016; Lee JW, 2014, BIOCHEM BIOPH RES CO, V444, P121, DOI 10.1016/j.bbrc.2014.01.005; Lian ZX, 2003, J IMMUNOL, V170, P2323, DOI 10.4049/jimmunol.170.5.2323; Liu T, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-40; Liu Y, 2015, AM J TRANSPLANT, V15, P954, DOI 10.1111/ajt.13067; Martin M, 2010, J GASTROINTEST SURG, V14, P511, DOI 10.1007/s11605-009-1104-3; Mathieu C, 2002, TRENDS MOL MED, V8, P174, DOI 10.1016/S1471-4914(02)02294-3; Nikolic T, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00113; Pommey S, 2013, HEPATOLOGY, V57, P1597, DOI 10.1002/hep.25985; Reifart J, 2015, TRANSPLANTATION, V99, P41, DOI 10.1097/TP.0000000000000461; Segura E, 2013, TRENDS IMMUNOL, V34, P440, DOI 10.1016/j.it.2013.06.001; Selzner N, 2003, GASTROENTEROLOGY, V125, P917, DOI 10.1016/S0016-5085(03)01048-5; Shen XD, 2009, HEPATOLOGY, V50, P1537, DOI 10.1002/hep.23153; Singh-Jasuja H, 2013, IMMUNOBIOLOGY, V218, P28, DOI 10.1016/j.imbio.2012.01.021; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Strauss O, 2015, J HEPATOL, V62, P458, DOI 10.1016/j.jhep.2014.10.006; Suarez-Martinez Edu, 2014, Ther Adv Cardiovasc Dis, V8, P224, DOI 10.1177/1753944714542593; Teng M, 2003, NEW ENGL J MED, V349, P446, DOI 10.1056/NEJMoa022536; Termeer C, 2003, IMMUNOLOGY, V109, P32, DOI 10.1046/j.1365-2567.2003.01617.x; Tiegs G, 2010, J AUTOIMMUN, V34, P1, DOI 10.1016/j.jaut.2009.08.008; von Bruhl ML, 2012, J EXP MED, V209, P819, DOI 10.1084/jem.20112322; Yang JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106892; Zhang M, 2013, HEPATOLOGY, V57, P1585, DOI 10.1002/hep.26129	35	7	9	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4796	4808		10.1096/fj.201601358R	http://dx.doi.org/10.1096/fj.201601358R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28720647				2022-12-28	WOS:000413398500012
J	Tynan, A; Mawhinney, L; Armstrong, ME; O'Reilly, C; Kennedy, S; Caraher, E; Julicher, K; O'Dwyer, D; Maher, L; Schaffer, K; Fabre, A; McKone, EF; Leng, L; Bucala, R; Bernhagen, J; Cooke, G; Donnelly, SC				Tynan, Aisling; Mawhinney, Leona; Armstrong, Michelle E.; O'Reilly, Ciaran; Kennedy, Sarah; Caraher, Emma; Julicher, Karen; O'Dwyer, David; Maher, Lewena; Schaffer, Kirsten; Fabre, Aurelie; McKone, Edward F.; Leng, Lin; Bucala, Richard; Bernhagen, Juergen; Cooke, Gordon; Donnelly, Seamas C.			Macrophage migration inhibitory factor enhances Pseudomonas aeruginosa biofilm formation, potentially contributing to cystic fibrosis pathogenesis	FASEB JOURNAL			English	Article						cytokine; bacteria; respiratory infections	TAUTOMERASE ACTIVE-SITE; FACTOR MIF; ENZYMATIC-ACTIVITY; DISEASE SEVERITY; INFLAMMATION; MODULATOR	Macrophage migration inhibitory factor (MIF) is a key proinflammatory mediator that we have previously shown to be associated with an aggressive clinical phenotype in cystic fibrosis. It possesses unique tautomerase enzymatic activity. However, todate, nohuman-derived substrate has been identified that has the capacity to interact with this cytokine's unique tautomerase activity. This led us to hypothesize that MIF may have the capacity to interact with external substrates. We describe for the first time how Pseudomonas aeruginosa can utilize human recombinant MIF (rMIF) to significantly (P < 0.01) enhance its endogenous biofilm formation. Our in vivo studies demonstrate that utilizing a small-molecular-weight inhibitor targeting MIF's tautomerase activity (SCD-19) significantly reduces the inflammatory response in a murine pulmonary chronic P. aeruginosa model. In addition, we show that in in vitro experiments, pretreatment of P. aeruginosa with rMIF is associated with reduced bacterial killing by tobramycin. Our novel findings support the concept of an anti-MIF strategy that targets this enzymatic activity as a potential future antibacterial therapeutic approach.-Tynan, A., Mawhinney, L., Armstrong, M. E., O'Reilly, C., Kennedy, S., Caraher, E., Julicher, K., O'Dwyer, D., Maher, L., Schaffer, K., Fabre, A., McKone, E. F., Leng, L., Bucala, R., Bernhagen, J., Cooke, G., Donnelly, S. C. Macrophage migration inhibitory factor enhances Pseudomonas aeruginosa biofilm formation, potentially contributing to cystic fibrosis pathogenesis.	[Tynan, Aisling; Mawhinney, Leona; Armstrong, Michelle E.; O'Reilly, Ciaran; Julicher, Karen; Donnelly, Seamas C.] Trinity Coll Dublin, Tallaght Hosp, Dept Med, Dublin, Ireland; [Kennedy, Sarah; Caraher, Emma; Cooke, Gordon] Inst Technol Tallaght, Dept Sci, Ctr Microbial Host Interact, Dublin, Ireland; [O'Dwyer, David; Maher, Lewena; Schaffer, Kirsten; Fabre, Aurelie; McKone, Edward F.] Univ Coll Dublin, St Vincents Univ Hosp, Dublin, Ireland; [O'Dwyer, David; Maher, Lewena; Schaffer, Kirsten; Fabre, Aurelie; McKone, Edward F.] Univ Coll Dublin, Sch Med, Dublin, Ireland; [O'Dwyer, David; Maher, Lewena; Schaffer, Kirsten; Fabre, Aurelie; McKone, Edward F.] Univ Coll Dublin, UCD Conway Inst Biomol & Biomed Res, Dublin, Ireland; [Leng, Lin; Bucala, Richard] Yale Sch Med, Internal Med, New Haven, CT USA; [Bernhagen, Juergen] Rhein Westfal TH Aachen, Inst Biochem & Mol Cell Biol, Aachen, Germany; [Bernhagen, Juergen] Ludwig Maximilians Univ Munchen, Klinikum Univ Munchen, Inst Stroke & Dementia Res, Vasc Biol, Munich, Germany	Trinity College Dublin; Technological University Dublin; University College Dublin; Saint Vincent's University Hospital; University College Dublin; University College Dublin; Yale University; RWTH Aachen University; University of Munich	Donnelly, SC (corresponding author), Trinity Coll Dublin, Trinity Ctr, Trinity Biomed Sci Inst, Dept Clin Med,Sch Med, 152-160 Pearse St, Dublin 24, Ireland.	seamas.donnelly@tcd.ie	Cooke, Gordon/E-3743-2010	Cooke, Gordon/0000-0003-0366-3603; fabre, aurelie/0000-0001-8176-1386; Leng, Lin/0000-0002-0605-358X; Tynan, Aisling/0000-0002-6856-2259; Donnelly, Seamas/0000-0001-7145-1843; O'Reilly, Ciaran/0000-0001-8926-1853; Armstrong, Michelle E./0000-0001-7729-755X	Science Foundation Ireland (SFI); Health Research Board (HRB); Irish Lung Foundation (ILF); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130669] Funding Source: NIH RePORTER	Science Foundation Ireland (SFI)(Science Foundation Ireland); Health Research Board (HRB); Irish Lung Foundation (ILF); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	S.C.D. was supported by grants from Science Foundation Ireland (SFI), the Health Research Board (HRB), and the Irish Lung Foundation (ILF). The authors thank G.A. O'Toole (Dartmouth School of Medicine, Hanover, NH, USA) for his kind donation of PA14-and GFP-tagged PA01. G.C. and S.C.D. share senior authorship. The authors declare no conflicts of interest.	Adamali H, 2012, AM J RESP CRIT CARE, V186, P162, DOI 10.1164/rccm.201110-1864OC; Al-Abed Y, 2005, J BIOL CHEM, V280, P36541, DOI 10.1074/jbc.C500243200; Baugh JA, 2002, GENES IMMUN, V3, P170, DOI 10.1038/sj.gene.6363867; Bendrat K, 1997, BIOCHEMISTRY-US, V36, P15356, DOI 10.1021/bi971153a; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Deschaght P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-244; Donnelly SC, 1997, NAT MED, V3, P320, DOI 10.1038/nm0397-320; Gadjeva M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000826; Ghafoor A, 2011, APPL ENVIRON MICROB, V77, P5238, DOI 10.1128/AEM.00637-11; Gregory JL, 2004, ARTHRITIS RHEUM-US, V50, P3023, DOI 10.1002/art.20470; Gregory JL, 2006, J IMMUNOL, V177, P8072, DOI 10.4049/jimmunol.177.11.8072; Hopkins N, 2001, J APPL PHYSIOL, V91, P919, DOI 10.1152/jappl.2001.91.2.919; KRUGER TF, 1987, ARCH ANDROLOGY, V18, P275, DOI 10.3109/01485018708988493; Leigh R, 2002, AM J RESP CELL MOL, V27, P526, DOI 10.1165/rcmb.2002-0048OC; Lobo J, 2012, CLIN CHEST MED, V33, P307, DOI 10.1016/j.ccm.2012.02.006; Lubetsky JB, 2002, J BIOL CHEM, V277, P24976, DOI 10.1074/jbc.M203220200; Mawhinney L, 2014, MOL MED, V20, P729, DOI 10.2119/molmed.2014.00136; Merritt Judith H, 2005, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b01s00; Moreau-Marquis S, 2008, PULM PHARMACOL THER, V21, P595, DOI 10.1016/j.pupt.2007.12.001; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nielsen MW, 2011, JOVE-J VIS EXP, DOI 10.3791/2383; Parks QM, 2009, J MED MICROBIOL, V58, P492, DOI 10.1099/jmm.0.005728-0; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Plant BJ, 2005, AM J RESP CRIT CARE, V172, P1412, DOI 10.1164/rccm.200412-1714OC; Reber LL, 2012, J IMMUNOL, V188, P3478, DOI 10.4049/jimmunol.1004227; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; Rossi AG, 1998, J CLIN INVEST, V101, P2869, DOI 10.1172/JCI1524; Santos LL, 2011, ARTHRITIS RHEUM-US, V63, P960, DOI 10.1002/art.30203; Song XJ, 2014, LIFE SCI, V119, P9, DOI 10.1016/j.lfs.2014.10.006; Sugimoto H, 1996, FEBS LETT, V389, P145, DOI 10.1016/0014-5793(96)00553-4; Zaidi T, 2011, SCI REP-UK, V1, DOI 10.1038/srep00058; Zhou L, 2012, CLIN VACCINE IMMUNOL, V19, P1065, DOI 10.1128/CVI.05715-11	36	8	9	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					5102	5110		10.1096/fj.201700463R	http://dx.doi.org/10.1096/fj.201700463R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28768722	Green Published, Green Submitted			2022-12-28	WOS:000413398500037
J	Olivera-Perez, HM; Lam, L; Dang, J; Jiang, WL; Rodriguez, F; Rigali, E; Weitzman, S; Porter, V; Rubbi, L; Morselli, M; Pellegrini, M; Fiala, M				Olivera-Perez, Henry M.; Lam, Larry; Dang, Johnny; Jiang, Weilan; Rodriguez, Fabian; Rigali, Elizabeth; Weitzman, Sarah; Porter, Verna; Rubbi, Liudmilla; Morselli, Marco; Pellegrini, Matteo; Fiala, Milan			Omega-3 fatty acids increase the unfolded protein response and improve amyloid-beta phagocytosis by macrophages of patients with mild cognitive impairment	FASEB JOURNAL			English	Article							ENDOPLASMIC-RETICULUM STRESS; ALZHEIMERS-DISEASE PATIENTS; ER STRESS; NEURODEGENERATIVE DISORDERS; OMEGA-3 SUPPLEMENTATION; ALLOSTERIC INHIBITION; RESOLVIN D1; A-BETA; INFLAMMATION; TRANSCRIPTION	Macrophages (M phi s) of patients with Alzheimer's disease and mild cognitive impairment (MCI) are defective in amyloid-beta(1-42) (A beta) phagocytosis and have low resistance to apoptosis by A beta. Omega-3 fatty acids (omega-3s) in vitro and in vivo and the omega-3 mediator, resolvin D1, in vitro increase A beta phagocytosis by M phi s of patients with MCI. We have investigated the unfolded protein response (UPR) to endoplasmic reticulum (ER) stress by M phi s in a longitudinal study of fish-derived, omega-3-supplemented patients with MCI. Patients in the apolipoprotein E (ApoE)e3/e3 subgroup over time exhibited an increase of protein kinase RNA-like ER kinase (PERK) expression, A beta phagocytosis, intermediate M1-M2 M phi type, and a Mini-Mental State Examination (MMSE) rate of change of +1.8 points per year, whereas patients in the ApoEe3/e4 subgroup showed individually divergent results with an MMSE rate of change of -3.2 points per year. In vitro treatment of M phi s by fish-derived omega-3 emulsion increased A beta phagocytosis, PERK expression, and UPR RNA signature, and decreased ER stress signature. Augmented genes in the UPR signature included chaperones, lectins, foldases, and N-linked glycosylation enzymes. In summary, fish-derived omega-3s increase cytoprotective genes and decrease proapoptotic genes, improve immune clearance of A beta, and are associated with an improved MMSE rate of change in ApoEe3/e3 vs. ApoEe3/e4 patients.-Olivera-Perez, H. M., Lam, L., Dang, J., Jiang, W., Rodriguez, F., Rigali, E., Weitzman, S., Porter, V., Rubbi, L., Morselli, M., Pellegrini, M., Fiala, M. Omega-3 fatty acids increase the unfolded protein response and improve amyloid-beta phagocytosis by macrophages of patients with mild cognitive impairment.	[Olivera-Perez, Henry M.; Lam, Larry; Dang, Johnny; Jiang, Weilan; Rodriguez, Fabian; Rigali, Elizabeth; Weitzman, Sarah; Rubbi, Liudmilla; Morselli, Marco; Pellegrini, Matteo; Fiala, Milan] Univ Calif Los Angeles, Sch Med, Dept Cell Mol & Dev Biol, Life Sci, Los Angeles, CA 90095 USA; [Porter, Verna] Univ Calif Los Angeles, Dept Neurol, Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Fiala, M (corresponding author), Univ Calif Los Angeles, Sch Med, 100 UCLA Med Plaza,Suite 150, Los Angeles, CA 90095 USA.	mfiala@ucla.edu	Morselli, Marco/AAF-3182-2019	Morselli, Marco/0000-0003-3351-5791; Fiala, Milan/0000-0001-8023-6053; Pellegrini, Matteo/0000-0001-9355-9564	U.S. National Institutes of Health, National Institute of General Medical Sciences [5P01GM099134-03]; Smartfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099134] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Smartfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health, National Institute of General Medical Sciences Grant 5P01GM099134-03 (to M.P.) and a donation from Smartfish AS (to M.F.). Smartfish AS supplied the drink to the patients who requested it. The authors thank Leonard Haller, Angela Kim, Janteshpreet Sandhu, Jessica Xu, Gigi Arnone, Sheila Hou, Peter Cho, and Yasmine Alhoch (all from University of California, Los Angeles, Los Angeles, CA, USA) for assistance with data collection. The authors thank R. Rao (the Buck Institute, Novato, CA, USA) for testing the APOE genotype of study patients. The authors are grateful to Fawaz George Haj and Bruce Hammock (both from University of California, Davis, Davis, CA, USA) for helpful discussions of lipid mediators and ER stress. Smartfish was not involved in the design, analysis, interpretation of the data, or the decision to submit the manuscript for publication. M.F. received paid travel to meetings and honoraria from Smartfish.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Begum G, 2013, TRANSL STROKE RES, V4, P635, DOI 10.1007/s12975-013-0282-1; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Cai Y, 2016, AUTOPHAGY, V12, P225, DOI 10.1080/15548627.2015.1121360; Casas-Tinto S, 2011, HUM MOL GENET, V20, P2144, DOI 10.1093/hmg/ddr100; Chow CY, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004924; Doyle KM, 2011, J CELL MOL MED, V15, P2025, DOI 10.1111/j.1582-4934.2011.01374.x; Duara R, 2011, AM J GERIAT PSYCHIAT, V19, P951, DOI 10.1097/JGP.0b013e3182107c69; Duran-Aniotz C, 2017, ACTA NEUROPATHOL, V134, P489, DOI 10.1007/s00401-017-1694-x; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Famenini S, 2017, FASEB J, V31, P148, DOI 10.1096/fj.201600677RR; Feldman HC, 2016, ACS CHEM BIOL, V11, P2195, DOI 10.1021/acschembio.5b00940; Fiala M, 2007, P NATL ACAD SCI USA, V104, P12849, DOI 10.1073/pnas.0701267104; Fiala M, 2015, J ALZHEIMERS DIS, V48, P293, DOI 10.3233/JAD-150367; Fiala M, 2015, FASEB J, V29, P2681, DOI 10.1096/fj.14-264218; Galehdar Z, 2010, J NEUROSCI, V30, P16938, DOI 10.1523/JNEUROSCI.1598-10.2010; Ghosh R, 2014, CELL, V158, P534, DOI 10.1016/j.cell.2014.07.002; Hong Y, 2016, INT IMMUNOPHARMACOL, V33, P83, DOI 10.1016/j.intimp.2016.02.002; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Lam L, 2016, FASEB J, V30, P3461, DOI 10.1096/fj.201600259RR; Li MQ, 2000, MOL CELL BIOL, V20, P5096, DOI 10.1128/MCB.20.14.5096-5106.2000; Liu Guanghao, 2012, Am J Neurodegener Dis, V1, P60; Maly DJ, 2014, NAT CHEM BIOL, V10, P892, DOI 10.1038/nchembio.1664; Meyerovich K, 2016, J MOL ENDOCRINOL, V57, pR1, DOI 10.1530/JME-15-0306; Mizwicki MT, 2013, J ALZHEIMERS DIS, V34, P155, DOI 10.3233/JAD-121735; Pereira DM, 2015, NAT PROD REP, V32, P705, DOI 10.1039/c4np00102h; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Pham TV, 2010, BIOINFORMATICS, V26, P363, DOI 10.1093/bioinformatics/btp677; Scheper W, 2015, ACTA NEUROPATHOL, V130, P315, DOI 10.1007/s00401-015-1462-8; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Walker AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081170; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Yassine HN, 2017, JAMA NEUROL, V74, P337, DOI 10.1001/jamaneurol.2016.4899; Yassine HN, 2016, JAMA NEUROL, V73, P1208, DOI 10.1001/jamaneurol.2016.1924; Zaghi J, 2009, ACTA NEUROPATHOL, V117, P111, DOI 10.1007/s00401-008-0481-0	38	13	14	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4359	4369		10.1096/fj.201700290R	http://dx.doi.org/10.1096/fj.201700290R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28634213	Green Published			2022-12-28	WOS:000413397400015
J	Wu, N; Meng, FY; Zhou, TH; Han, YY; Kennedy, L; Venter, J; Francis, H; DeMorrow, S; Onori, P; Invernizzi, P; Bernuzzi, F; Mancinelli, R; Gaudio, E; Franchitto, A; Glaser, S; Alpini, G				Wu, Nan; Meng, Fanyin; Zhou, Tianhao; Han, Yuyan; Kennedy, Lindsey; Venter, Julie; Francis, Heather; DeMorrow, Sharon; Onori, Paolo; Invernizzi, Pietro; Bernuzzi, Francesca; Mancinelli, Romina; Gaudio, Eugenio; Franchitto, Antonio; Glaser, Shannon; Alpini, Gianfranco			Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation	FASEB JOURNAL			English	Article						angiogenesis; biliary epithelium; cholangiopathy; cholestasis; miRNA	ENDOTHELIAL GROWTH-FACTOR; BILE-DUCT LIGATION; CHOLESTATIC RATS; UP-REGULATION; CANCER CELLS; MELATONIN; EXPRESSION; MICE; PROLIFERATION; CHOLANGIOCYTES	Melatonin therapy or prolonged exposure to complete darkness reduces biliary hyperplasia and liver fibrosis in bile-duct-ligated (BDL) rats; however, no information exists in primary sclerosing cholangitis (PSC). Thus, we aimed to determine the therapeutic effects of prolonged dark therapy or melatonin administration on hepatic fibrosis in the multidrug resistance gene 2-knockout (Mdr2(-/-)) mouse model of PSC. Melatonin levels, biliary mass, liver fibrosis, angiogenesis and miR-200b expression were evaluated in wild-type and Mdr2(-/-) mice exposed to darkness or melatonin treatment or in male patients with PSC and healthy controls. Mdr2(-/-) mice were also treated with miR-200b inhibitor or control before evaluating biliary mass, liver fibrosis, and angiogenesis. After overexpression of arylalkylamine N-acetyltransferase (AANAT; the enzyme regulating melatonin synthesis) or inhibition of miR-200b in cholangiocytes and hepatic stellate cells in vitro, we evaluated angiogenesis and fibrosis gene expression. After exposure to darkness or administration of melatonin, Mdr2(-/-) mice show elevated serum melatonin levels and inhibition of biliary mass, along with reduction of liver fibrosis and angiogenesis. MicroRNA PCR analysis demonstrated that miR-200b expression increased in Mdr2(-/-) mice and patients with PSC compared with controls and decreased in Mdr2(-/-) mice subjected to dark exposure or melatonin treatment. Inhibition of miR-200b in Mdr2(-/-) ablates biliary proliferation, liver fibrosis, and angiogenesis. In vitro, overexpression of AANAT or inhibition of miR-200b in cholangiocytes and hepatic stellate cells decreased the expression of miR-200b, angiogenesis, and fibrosis genes. Dark therapy or targeting melatonin/miR-200b axis may be important in the management of biliary damage and liver fibrosis in cholangiopathies including PSC.-Wu, N., Meng, F., Zhou, T., Han, Y., Kennedy, L., Venter, J., Francis, H., DeMorrow, S., Onori, P., Invernizzi, P., Bernuzzi, F., Mancinelli, R., Gaudio, E., Franchitto, A., Glaser, S., Alpini G. Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation.	[Wu, Nan; Meng, Fanyin; Zhou, Tianhao; Han, Yuyan; Kennedy, Lindsey; Venter, Julie; Francis, Heather; DeMorrow, Sharon; Glaser, Shannon; Alpini, Gianfranco] Texas A&M Univ, Hlth Sci Ctr, Dept Med, Div Gastroenterol, Temple, TX USA; [Meng, Fanyin; Francis, Heather; DeMorrow, Sharon; Glaser, Shannon; Alpini, Gianfranco] Baylor Scott & White, Digest Res Ctr, Temple, TX USA; [Meng, Fanyin; Francis, Heather; DeMorrow, Sharon; Glaser, Shannon; Alpini, Gianfranco] Cent Texas Vet Hlth Care Syst, Res Serv, Temple, TX USA; [Onori, Paolo; Mancinelli, Romina; Gaudio, Eugenio] La Sapienza, Dept Anat Histol & Forens Med & Orthoped Sci, Rome, Italy; [Invernizzi, Pietro; Bernuzzi, Francesca] Humanitas Clin & Res Ctr, Ctr Autoimmune Liver Dis, Rozzano, Italy; [Franchitto, Antonio] Eleonora Lorillard Spencer Cenci Fdn, Rome, Italy; [Invernizzi, Pietro; Bernuzzi, Francesca] Bicocca Univ, Dept Med & Surg, Monza, Italy	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Baylor Health Care System; Sapienza University Rome; IRCCS Humanitas Research Hospital; University of Milano-Bicocca	Glaser, S; Alpini, G (corresponding author), Cent Texas Vet Univ Hlth Care Syst, Texas A&M Hlth Sci Ctr, Olin E Teague Med Ctr, 1901 South 1st St,Bldg 205,1R60, Temple, TX 76504 USA.	sglaser@medicine.tamhsc.edu; galpini@tamu.edu	Onori, Paolo/J-9394-2013; bernuzzi, francesca/AAQ-7073-2020; Zhou, Tianhao/AAO-3542-2021; Franchitto, Antonio/C-8095-2009; Invernizzi, Pietro/AAB-8367-2022; Mancinelli, Romina/Y-4540-2018	Onori, Paolo/0000-0002-7195-3760; Zhou, Tianhao/0000-0002-5722-6954; Invernizzi, Pietro/0000-0003-3262-1998; Mancinelli, Romina/0000-0003-2040-0581	Dr. Nicholas C. Hightower Centennial Chair of Gastroenterology (Baylor Scott & White), a Translational Genomics Research Institute (TGEN); Veterans Affairs (VA); VA [5I01BX000574, 5I01BX002192, 1I01BX001724, 1I01BX003031, 1IO1BX002638]; University of Rome "La Sapienza,"; Fondo per gli Investimenti della Ricerca di Base (FIRB) Accordi di Programma [2010-RBAP10Z7FS]; U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases [DK054811, DK076898, DK107310, DK110035, DK062975, DK108959, DK082435]; Central Texas Veterans Health Care System; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK107310, R01DK082435, R01DK054811, R01DK062975, R01DK108959, R01DK115184, R01DK110035, R01DK076898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA025997, R21AA025157] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000574, I01BX002638, I01BX003031, I01BX001724, I01BX002192] Funding Source: NIH RePORTER	Dr. Nicholas C. Hightower Centennial Chair of Gastroenterology (Baylor Scott & White), a Translational Genomics Research Institute (TGEN); Veterans Affairs (VA)(US Department of Veterans Affairs); VA(US Department of Veterans Affairs); University of Rome "La Sapienza,"; Fondo per gli Investimenti della Ricerca di Base (FIRB) Accordi di Programma(Ministry of Education, Universities and Research (MIUR)); U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Central Texas Veterans Health Care System; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Dr. Nicholas C. Hightower Centennial Chair of Gastroenterology (Baylor Scott & White), a Translational Genomics Research Institute (TGEN) seed grant, and a Veterans Affairs (VA) Research Career Scientist Award (to G.A.); and VA Merit Awards 5I01BX000574 (to G.A.) 5I01BX002192 (to S.G.), 1I01BX001724 (to F.M.), 1I01BX003031 (to H.F.), and 1IO1BX002638 (to S.D.); University of Rome "La Sapienza," and Fondo per gli Investimenti della Ricerca di Base (FIRB) Accordi di Programma 2010-RBAP10Z7FS (to E.G.); U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases Grants DK054811, DK076898, DK107310, DK110035, and DK062975 (to G.A., F.M., and S.G.), DK108959 (to H.F.), and DK082435 to (S.D., N.W., and F.M.). This publication is the result of work supported by resources at the Central Texas Veterans Health Care System. The content is the responsibility of the authors alone, and does not necessarily reflect the views or policies of the Department of Veterans Affairs or the U.S. Government. G.A., A.F., and S.G. share senior authorship. The authors declare no conflicts of interest.	Alpini G, 1996, GASTROENTEROLOGY, V110, P1636, DOI 10.1053/gast.1996.v110.pm8613073; Aron JH, 2009, SEMIN IMMUNOPATHOL, V31, P383, DOI 10.1007/s00281-009-0154-7; Calderone V, 2016, GASTROENTEROLOGY, V150, P982, DOI 10.1053/j.gastro.2015.11.038; Chaparro M, 2007, ANN HEPATOL, V6, P208, DOI 10.1016/S1665-2681(19)31900-3; Delis S, 2009, DIGEST LIVER DIS, V41, P72, DOI 10.1016/j.dld.2007.11.016; Eaton JE, 2013, GASTROENTEROLOGY, V145, P521, DOI 10.1053/j.gastro.2013.06.052; Fava G, 2005, CANCER RES, V65, P11437, DOI 10.1158/0008-5472.CAN-05-1470; Fickert P, 2004, GASTROENTEROLOGY, V127, P261, DOI 10.1053/j.gastro.2004.04.009; Franchitto Antonio, 2013, Hepatobiliary Surg Nutr, V2, P68, DOI 10.3978/j.issn.2304-3881.2012.10.11; Gaudio E, 2006, GASTROENTEROLOGY, V130, P1270, DOI 10.1053/j.gastro.2005.12.034; Glaser S., 2014, GASTROENTEROLOGY, V146; Han YY, 2014, AM J PHYSIOL-GASTR L, V307, pG894, DOI 10.1152/ajpgi.00288.2014; Huang LT, 2009, PEDIATR RES, V65, P176, DOI 10.1203/PDR.0b013e31818d5bc7; Jardim-Perassi BV, 2016, ANTI-CANCER AGENT ME, V16, P347, DOI 10.2174/1871520615666150511094201; Jones H, 2016, HEPATOLOGY, V64, P1202, DOI 10.1002/hep.28704; Kim SJ, 2015, BIOCHEM BIOPH RES CO, V458, P462, DOI 10.1016/j.bbrc.2015.01.117; Kim YD, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12386; Lewczuk B, 2000, NEUROENDOCRINOL LETT, V21, P293; Li L, 2014, HEPATOLOGY, V60, P896, DOI 10.1002/hep.27050; Lissoni P, 2001, NEUROENDOCRINOL LETT, V22, P45; Lv D, 2012, CHINESE J CANCER RES, V24, P310, DOI [10.3978/j.issn.1000-9604.2012.09.03, 10.1007/s11670-012-0269-6]; Maroni L, 2015, CELL MOL GASTROENTER, V1, P368, DOI 10.1016/j.jcmgh.2015.05.005; Melum E, 2011, NAT GENET, V43, P17, DOI 10.1038/ng.728; Montagnese S, 2013, LIVER INT, V33, P203, DOI 10.1111/liv.12026; Murakami Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016081; Padgett KA, 2009, J AUTOIMMUN, V32, P246, DOI 10.1016/j.jaut.2009.02.022; Popov Y, 2005, J HEPATOL, V43, P1045, DOI 10.1016/j.jhep.2005.06.025; Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005; Renzi A, 2013, HEPATOLOGY, V57, P1130, DOI 10.1002/hep.26105; Renzi A, 2011, AM J PHYSIOL-GASTR L, V301, pG634, DOI 10.1152/ajpgi.00206.2011; Sezer A, 2010, CURR THER RES CLIN E, V71, P118, DOI 10.1016/j.curtheres.2010.03.004; Sohn EJ, 2015, J CANCER, V6, P19, DOI 10.7150/jca.9591; Tahan G, 2010, CAN J SURG, V53, P313; Velissaris D, 2008, WORLD J GASTROENTERO, V14, P4190, DOI 10.3748/wjg.14.4190; Wu N, 2016, HEPATOLOGY, V64, P865, DOI 10.1002/hep.28622; Xia JL, 2006, AM J PATHOL, V168, P1500, DOI 10.2353/ajpath.2006.050747; Xiao YT, 2014, CELL SIGNAL, V26, P925, DOI 10.1016/j.cellsig.2014.01.003; Xiong MX, 2012, AM J PHYSIOL-RENAL, V302, pF369, DOI 10.1152/ajprenal.00268.2011; Zhang JJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040673; ZHOU P, 2014, SCI REP UK, V4	40	35	37	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4305	4324		10.1096/fj.201700097R	http://dx.doi.org/10.1096/fj.201700097R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28634212	Green Published			2022-12-28	WOS:000413397400011
J	Li, JJ; Li, TY; Lu, YY; Shen, GF; Guo, H; Wu, J; Lei, C; Du, F; Zhou, FL; Zhao, XD; Nie, YZ; Fan, DM				Li, Jinjing; Li, Tingyu; Lu, Yuanyuan; Shen, Gaofei; Guo, Hao; Wu, Jian; Lei, Chao; Du, Feng; Zhou, Fenli; Zhao, Xiaodi; Nie, Yongzhan; Fan, Daiming			MiR-2392 suppresses metastasis and epithelial- mesenchymal transition by targeting MAML3 and WHSC1 in gastric cancer	FASEB JOURNAL			English	Article						microRNA; migration; invasion; EMT	MASTERMIND-LIKE 3; E-CADHERIN; PANCREATIC-CANCER; TUMOR-GROWTH; MICRORNA; CELLS; EXPRESSION; PATHWAY; TRANSCRIPTION; CARCINOMA	MicroRNAs have emerged as essential regulators of various cellular processes. We identified the role and underlying mechanisms of miR-2392 in gastric cancer (GC) metastasis. MiR-2392 was down-regulated in GC cell lines and tissues, and overexpression of miR-2392 significantly inhibited GC invasion and metastasis in vitro and in vivo. We identified MAML3 and WHSC1 as novel targets of miR-2392, and knockdown of MAML3 and WHSC1 had the same antimetastatic effect as that of miR-2392 in GC cells. These effects were clinically relevant, as low miR-2392 expression was correlated with high MAML3 and WHSC1 expression and poor survival in patients with GC. Furthermore, forced expression of miR-2392 substantially suppressed Slug and Twist1, transcriptional repressors of E-cadherin, by targeting MAML3 and WHSC1, respectively, resulting in inhibition of the epithelial-mesenchymal transition. These findings indicate that the miR-2392-MAML3/WHSC1-Slug/Twist1 regulatory axis plays a critical role in GC metastasis. Restoration of miR-2392 may be a therapeutic approach for blocking GC metastasis.	[Li, Jinjing; Li, Tingyu; Lu, Yuanyuan; Shen, Gaofei; Guo, Hao; Wu, Jian; Lei, Chao; Du, Feng; Zhou, Fenli; Zhao, Xiaodi; Nie, Yongzhan; Fan, Daiming] Fourth Mil Med Univ, Xijing Hosp Digest Dis, State Key Lab Canc Biol, Xian, Peoples R China	Air Force Military Medical University	Zhao, XD; Nie, YZ (corresponding author), Xijing Hosp Digest Dis, State Key Lab Canc Biol, 127 Chang Le West Rd, Xian 710032, Shaanxi, Peoples R China.	leedyzhao@fmmu.edu.cn; yongznie@fmmu.edu.cn		Wu, Jian/0000-0003-4953-8330	National Natural Science Foundation of China [81430072, 81120108005, 81602641, 81572929]; National Key Basic Research Program of China [2014CBA02002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China)	This work was supported, in part, by the National Natural Science Foundation of China (81430072, 81120108005, 81602641, 81572929) and the National Key Basic Research Program of China (2014CBA02002).	Ahn SM, 2012, ONCOGENE, V31, P3051, DOI 10.1038/onc.2011.484; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen JY, 2013, INT J MOL MED, V32, P557, DOI 10.3892/ijmm.2013.1424; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Ezponda T, 2013, ONCOGENE, V32, P2882, DOI 10.1038/onc.2012.297; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Hudlebusch HR, 2011, CANCER RES, V71, P4226, DOI 10.1158/0008-5472.CAN-10-3810; Hudlebusch HR, 2011, CLIN CANCER RES, V17, P2919, DOI 10.1158/1078-0432.CCR-10-1302; Hurst DR, 2009, CANCER RES, V69, P7495, DOI 10.1158/0008-5472.CAN-09-2111; Jia B, 2014, CANCER LETT, V342, P104, DOI 10.1016/j.canlet.2013.08.040; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Lin QS, 2014, CANCER LETT, V345, P85, DOI 10.1016/j.canlet.2013.11.014; Min DJ, 2013, LEUKEMIA, V27, P686, DOI 10.1038/leu.2012.269; Onishi H, 2016, CANCER LETT, V371, P143, DOI 10.1016/j.canlet.2015.11.012; Oyama T, 2011, DEVELOPMENT, V138, P5235, DOI 10.1242/dev.062802; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Sethi N, 2011, CANCER CELL, V19, P192, DOI 10.1016/j.ccr.2010.12.022; Sonoshita M, 2011, CANCER CELL, V19, P125, DOI 10.1016/j.ccr.2010.11.008; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tian Y, 2015, MOL CELL ENDOCRINOL, V403, P30, DOI 10.1016/j.mce.2015.01.015; Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Van Cutsem E, 2016, LANCET, V388, P2654, DOI 10.1016/S0140-6736(16)30354-3; Vasko V, 2007, P NATL ACAD SCI USA, V104, P2803, DOI 10.1073/pnas.0610733104; Wang XQ, 2012, INT J CANCER, V131, pE163, DOI 10.1002/ijc.27336; Wu L, 2002, MOL CELL BIOL, V22, P7688, DOI 10.1128/MCB.22.21.7688-7700.2002; Yang P, 2012, MOL CELL BIOL, V32, P3121, DOI 10.1128/MCB.00204-12; Zhao X, 2014, CELL DEATH DIFFER, V21, P1900, DOI 10.1038/cdd.2014.109; Zhao X, 2013, ONCOGENE, V32, P1363, DOI 10.1038/onc.2012.156; Zhou JN, 2015, HEPATOLOGY, V62, P801, DOI 10.1002/hep.27887; Zhou L, 2013, FASEB J, V27, P4929, DOI 10.1096/fj.13-233387; Zuo QF, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.297	38	21	24	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3774	3786		10.1096/fj.201601140RR	http://dx.doi.org/10.1096/fj.201601140RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28512191				2022-12-28	WOS:000408713300007
J	Pessentheiner, AR; Huber, K; Pelzmann, HJ; Prokesch, A; Radner, FPW; Wolinski, H; Lindroos-Christensen, J; Hoefler, G; Rulicke, T; Birner-Gruenberger, R; Bilban, M; Bogner-Strauss, JG				Pessentheiner, Ariane R.; Huber, Katharina; Pelzmann, Helmut J.; Prokesch, Andreas; Radner, Franz P. W.; Wolinski, Heimo; Lindroos-Christensen, Josefine; Hoefler, Gerald; Ruelicke, Thomas; Birner-Gruenberger, Ruth; Bilban, Martin; Bogner-Strauss, Juliane G.			APMAP interacts with lysyl oxidase-like proteins, and disruption of Apmap leads to beneficial visceral adipose tissue expansion	FASEB JOURNAL			English	Article						obesity; extracellular matrix; insulin resistance	DIET-INDUCED OBESITY; ADIPOCYTE DIFFERENTIATION; EXTRACELLULAR-MATRIX; INSULIN-RESISTANCE; PPAR-GAMMA; METABOLICALLY HEALTHY; MAMMALIAN GENOMES; GENE-EXPRESSION; FAT; ADIPOGENESIS	Adipocyte plasma membrane-associated protein (APMAP) has been described as an adipogenic factor in 3T3-L1 cells with unknown biochemical function; we therefore aimed to investigate the physiologic function of APMAP in vivo. We generated Apmap-knockout mice and challenged them with an obesogenic diet to investigate their metabolic phenotype. We identified a novel truncated adipocyte-specific isoform of APMAP in mice that is produced by alternative transcription. Mice lacking the full-length APMAP protein, the only isoform that is expressed in humans, have an improved metabolic phenotype upon diet-induced obesity, indicated by enhanced insulin sensitivity, preserved glucose tolerance, increased respiratory exchange ratio, decreased inflammatory marker gene expression, and reduced adipocyte size. At the molecular level, APMAP interacts with the extracellular collagen cross-linking matrix proteins lysyl oxidase-like 1 and 3. On a high-fat diet, the expression of lysyl oxidase-like 1 and 3 is strongly decreased in Apmap-knockout mice, paralleled by reduced expression of profibrotic collagens and total collagen content in epididymal white adipose tissue, indicating decreased fibrotic potential. Together, our data suggest that APMAP is a novel regulator of extracellular matrix components, and establish that APMAP is a potential target to mitigate obesity-associated insulin resistance.	[Pessentheiner, Ariane R.; Huber, Katharina; Pelzmann, Helmut J.; Bogner-Strauss, Juliane G.] Graz Univ Technol, Inst Biochem, Humboldtstr 46-3, A-8010 Graz, Austria; [Prokesch, Andreas] Med Univ Graz, Inst Cell Biol Histol & Embryol, Graz, Austria; [Hoefler, Gerald] Med Univ Graz, Inst Pathol, Graz, Austria; [Radner, Franz P. W.; Wolinski, Heimo] Karl Franzens Univ Graz, Inst Mol Biosci, Graz, Austria; [Wolinski, Heimo] Karl Franzens Univ Graz, BioTechMed Graz, Graz, Austria; [Lindroos-Christensen, Josefine; Bilban, Martin] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Ruelicke, Thomas] Univ Vet Med Vienna, Inst Lab Anim Sci, Vienna, Austria; [Birner-Gruenberger, Ruth] Omics Ctr Graz, BioTechMed Graz, Graz, Austria	Graz University of Technology; Medical University of Graz; Medical University of Graz; University of Graz; University of Graz; Medical University of Vienna; University of Veterinary Medicine Vienna	Bogner-Strauss, JG (corresponding author), Graz Univ Technol, Inst Biochem, Humboldtstr 46-3, A-8010 Graz, Austria.	juliane.bogner-strauss@tugraz.at	Birner-Gruenberger, Ruth/E-8623-2010; Birner-Gruenberger, Ruth/X-9433-2019; Hoefler, Gerald/H-1796-2016; PROKESCH, ANDREAS/B-6786-2019	Birner-Gruenberger, Ruth/0000-0003-3950-0312; Birner-Gruenberger, Ruth/0000-0003-3950-0312; Hoefler, Gerald/0000-0002-9056-3063; Huber, Katharina/0000-0002-4072-4877; Pessentheiner, Ariane/0000-0002-5010-9528; Wolinski, Heimo/0000-0002-1583-6092; PROKESCH, ANDREAS/0000-0002-8487-7103; Radner, Franz/0000-0003-3466-0181	Austrian Science Fund (FWF) [P24103, 27108]; Doctoral Program-Metabolic and Cardiovascular Disease [W1226]; NAWI Graz; BioTechMed Graz	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Doctoral Program-Metabolic and Cardiovascular Disease; NAWI Graz; BioTechMed Graz	This work was supported, in part, by the Austrian Science Fund (FWF; P24103, 27108), and the Doctoral Program-Metabolic and Cardiovascular Disease (DK-MCD; W1226). The authors gratefully acknowledge support from NAWI Graz and BioTechMed Graz, and the important technical assistance of T. Schreiner, W. Krispel, F. Stoeger, C. Gaug, B. Gadermaier, K. Leets (all from Graz University of Technology), L. Liesinger, and S. Schauer (both from the Medical University of Graz).	Albrektsen T, 2001, BIOCHEM J, V359, P393, DOI 10.1042/0264-6021:3590393; Badoud F, 2015, FASEB J, V29, P748, DOI 10.1096/fj.14-263913; Bluher M, 2010, CURR OPIN LIPIDOL, V21, P38, DOI 10.1097/MOL.0b013e3283346ccc; Bogner-Strauss JG, 2010, CELL MOL LIFE SCI, V67, P4049, DOI 10.1007/s00018-010-0424-5; Buechler C, 2015, WORLD J DIABETES, V6, P548, DOI 10.4239/wjd.v6.i4.548; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; DIMACULANGAN DD, 1994, DIFFERENTIATION, V58, P47, DOI 10.1046/j.1432-0436.1994.5810047.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ghosh S, 2014, FASEB J, V28, P2577, DOI 10.1096/fj.14-249458; Grandl G, 2016, MOL METAB, V5, P937, DOI 10.1016/j.molmet.2016.07.008; Hageman RS, 2010, PHYSIOL GENOMICS, V42, P55, DOI 10.1152/physiolgenomics.00072.2009; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; Hoffstedt J, 2010, DIABETOLOGIA, V53, P2496, DOI 10.1007/s00125-010-1889-3; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Huang GR, 2012, TRENDS ENDOCRIN MET, V23, P16, DOI 10.1016/j.tem.2011.09.006; Huang HY, 2013, STEM CELL RES, V10, P278, DOI 10.1016/j.scr.2012.12.005; Huang HY, 2009, P NATL ACAD SCI USA, V106, P12670, DOI 10.1073/pnas.0906266106; Ilhan A, 2008, BIOCHEM J, V414, P485, DOI 10.1042/BJ20080503; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Kersey PJ, 2016, NUCLEIC ACIDS RES, V44, pD574, DOI 10.1093/nar/gkv1209; Koppen A, 2010, FEBS LETT, V584, P3250, DOI 10.1016/j.febslet.2010.06.035; Landry JR, 2003, TRENDS GENET, V19, P640, DOI 10.1016/j.tig.2003.09.014; Lin S, 2000, INT J OBESITY, V24, P639, DOI 10.1038/sj.ijo.0801209; Lindroos J, 2013, CELL METAB, V18, P62, DOI 10.1016/j.cmet.2013.05.020; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Mariman ECM, 2010, CELL MOL LIFE SCI, V67, P1277, DOI 10.1007/s00018-010-0263-4; Miana M, 2015, DIS MODEL MECH, V8, P543, DOI 10.1242/dmm.020107; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Mosser S, 2015, HUM MOL GENET, V24, P371, DOI 10.1093/hmg/ddu449; Muir LA, 2016, OBESITY, V24, P597, DOI 10.1002/oby.21377; Nadler ST, 2000, P NATL ACAD SCI USA, V97, P11371, DOI 10.1073/pnas.97.21.11371; Nakajima I, 1998, DIFFERENTIATION, V63, P193, DOI 10.1111/j.1432-0436.1998.00193.x; Nedergaard J, 2005, BBA-MOL BASIS DIS, V1740, P293, DOI 10.1016/j.bbadis.2005.02.003; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Pessentheiner AR, 2013, J BIOL CHEM, V288, P36040, DOI 10.1074/jbc.M113.491324; Rosell M, 2014, AM J PHYSIOL-ENDOC M, V306, pE945, DOI 10.1152/ajpendo.00473.2013; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Rutkowski JM, 2015, J CELL BIOL, V208, P501, DOI 10.1083/jcb.201409063; Ryden M, 2016, CELL REP, V16, P2317, DOI 10.1016/j.celrep.2016.07.070; Sauvola J, 2000, PATTERN RECOGN, V33, P225, DOI 10.1016/S0031-3203(99)00055-2; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Senol-Cosar O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10686; Steger DJ, 2010, GENE DEV, V24, P1035, DOI 10.1101/gad.1907110; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Su H, 2002, GENESIS, V32, P187, DOI 10.1002/gene.10043; Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Thorleifsson G, 2007, SCIENCE, V317, P1397, DOI 10.1126/science.1146554; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324	51	9	9	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					4088	4103		10.1096/fj.201601337R	http://dx.doi.org/10.1096/fj.201601337R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28559441	Green Published, hybrid			2022-12-28	WOS:000408713300032
J	Zheng, KZ; Lu, P; Delpapa, E; Bellve, K; Deng, RT; Condon, JC; Fogarty, K; Lifshitz, LM; Simas, TAM; Shi, FX; ZhuGe, RH				Zheng, Kaizhi; Lu, Ping; Delpapa, Ellen; Bellve, Karl; Deng, Ruitang; Condon, Jennifer C.; Fogarty, Kevin; Lifshitz, Lawrence M.; Simas, Tiffany A. Moore; Shi, Fangxiong; ZhuGe, Ronghua			Bitter taste receptors as targets for tocolytics in preterm labor therapy	FASEB JOURNAL			English	Article						uterine smooth muscle; relaxation; chloroquine; G-protein coupled receptor	SALIVARY PROGESTERONE; ALPHA-GUSTDUCIN; ANIMAL-MODELS; CA2+ SPARKS; BIRTH; CONTRACTION; MECHANISMS; CALCIUM; CELLS; PREVENTION	Preterm birth (PTB) is the leading cause of neonatal mortality and morbidity, with few prevention and treatment options. Uterine contraction is a central feature of PTB, so gaining new insights into the mechanisms of this contraction and consequently identifying novel targets for tocolytics are essential for more successful management of PTB. Here we report that myometrial cells from human and mouse express bitter taste receptors (TAS2Rs) and their canonical signaling components (i.e., G-protein gustducin and phospholipase C beta 2). Bitter tastants can completely relax myometrium precontracted by different uterotonics. In isolated single mouse myometrial cells, a phenotypical bitter tastant (chloroquine, ChQ) reverses the rise in intracellular Ca2+ concentration ([Ca2+](i)) and cell shortening induced by uterotonics, and this reversal effect is inhibited by pertussis toxin and by genetic deletion of a-gustducin. In human myometrial cells, knockdown of TAS2R14 but not TAS2R10 inhibits ChQ's reversal effect on an oxytocin-induced rise in [Ca2+](i). Finally, ChQpreventsmouse PTBs induced by bacterial endotoxin LPS or progesterone receptor antagonist mifepristone more often than current commonly used tocolytics, and this prevention is largely lost in alpha-gustducin-knockout mice. Collectively, our results reveal that activation of the canonical TAS2R signaling system in myometrial cells produces profound relaxation of myometrium precontracted by a broad spectrum of contractile agonists, and that targeting TAS2Rs is an attractive approach to developing effective tocolytics for PTB management.	[Zheng, Kaizhi; Shi, Fangxiong] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing 210095, Jiangsu, Peoples R China; [Zheng, Kaizhi; Lu, Ping; ZhuGe, Ronghua] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA USA; [Delpapa, Ellen; Simas, Tiffany A. Moore] Univ Massachusetts, Sch Med, Dept Obstet & Gynecol, Worcester, MA USA; [Simas, Tiffany A. Moore] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA USA; [Bellve, Karl; Fogarty, Kevin; Lifshitz, Lawrence M.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Deng, Ruitang] Univ Rhode Isl, Coll Pharm, Kingston, RI USA; [Condon, Jennifer C.] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA	Nanjing Agricultural University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Rhode Island; Wayne State University	Shi, FX (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing 210095, Jiangsu, Peoples R China.; ZhuGe, RH (corresponding author), Univ Massachusetts, Sch Med, Biomed Imaging Grp, Dept Microbiol & Physiol Syst, 368 Plantat St,ASC8-1045, Worcester, MA 01605 USA.	fxshi@njau.edu.cn; ronghua.zhuge@umassmed.edu		Lu, Ping/0000-0002-8953-1494	National Natural Science Foundation of China [31172206, 31572403]; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [NIDDK098586]; NIH National Heart, Lung, and Blood Institute [HL117104]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117104] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank R. F. Margolskee (Monell Chemical Senses Center, Philadelphia, PA, USA) for providing Gnat3<SUP>-/-</SUP> mice. This study was supported, in part, by the National Natural Science Foundation of China (31172206 and 31572403 to F.S.), and by the U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grant NIDDK098586, and NIH National Heart, Lung, and Blood Institute Grant HL117104 (both to R.Z.G.). The authors declare no conflicts of interest.	Aguilar HN, 2010, HUM REPROD UPDATE, V16, P725, DOI 10.1093/humupd/dmq016; Avau B, 2015, SCI REP-UK, V5, DOI 10.1038/srep15985; Behrens M, 2011, PHYSIOL BEHAV, V105, P4, DOI 10.1016/j.physbeh.2011.02.010; Behrman R. E., 2007, PRETERM BIRTH CAUSES, P259; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; Caicedo A, 2003, J NEUROSCI, V23, P9947; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chaudhari N, 2010, J CELL BIOL, V191, P429, DOI 10.1083/jcb.20100314420100927c; Clapp TR, 2008, FEBS LETT, V582, P3783, DOI 10.1016/j.febslet.2008.10.007; DARNE J, 1987, BRIT MED J, V294, P270, DOI 10.1136/bmj.294.6567.270; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Dudley DJ, 1996, BIOL REPROD, V55, P992, DOI 10.1095/biolreprod55.5.992; Ehn NL, 2007, PEDIATR RES, V62, P630, DOI 10.1203/PDR.0b013e3181567bfc; Elovitz MA, 2004, TRENDS ENDOCRIN MET, V15, P479, DOI 10.1016/j.tem.2004.10.009; Erdei C, 2014, PERSPECT BIOL MED, V57, P470, DOI 10.1353/pbm.2014.0036; Garner P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000169.pub2; Gupta S, 2012, WOMENS HEALTH, V8, P21, DOI [10.2217/WHE.11.78, 10.2217/whe.11.78]; Huang LQ, 1999, NAT NEUROSCI, V2, P1055, DOI 10.1038/15981; Illanes SE, 2014, EXPERT OPIN INV DRUG, V23, P759, DOI 10.1517/13543784.2014.905541; Janssen S, 2011, P NATL ACAD SCI USA, V108, P2094, DOI 10.1073/pnas.1011508108; Jarde A, 2017, BJOG-INT J OBSTET GY, V124, P1176, DOI 10.1111/1471-0528.14624; Kaga N, 1996, AM J OBSTET GYNECOL, V174, P754, DOI 10.1016/S0002-9378(96)70460-X; Krishna U, 2001, PREGNANCY RISK CURRE; Lachelin GCL, 2009, BJOG-INT J OBSTET GY, V116, P1515, DOI 10.1111/j.1471-0528.2009.02293.x; Maged AM, 2015, J MATERN-FETAL NEO M, V28, P1147, DOI 10.3109/14767058.2014.947474; Manuck TA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.048; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Mitchell BF, 2013, FACTS VIEWS VIS OBGY, V5, P72; Mitchell BF, 2009, AM J PHYSIOL-REG I, V297, pR525, DOI 10.1152/ajpregu.00153.2009; Morrey C, 2008, J PHARMACOL EXP THER, V326, P871, DOI 10.1124/jpet.108.137919; Moynihan AT, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.08.074; Ngassa C, 2000, AFRICAN J REPROD HLT, V4, P53; Orr AW, 2002, J BIOL CHEM, V277, P20453, DOI 10.1074/jbc.M112091200; Ortinau C, 2015, CLIN ANAT, V28, P168, DOI 10.1002/ca.22430; Priya B, 2013, BJOG-INT J OBSTET GY, V120, P1003, DOI 10.1111/1471-0528.12217; Radeva-Petrova D, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000169.pub3; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Romero R, 2014, SEMIN FETAL NEONAT M, V19, P15, DOI 10.1016/j.siny.2013.10.004; Rozengurt N, 2006, AM J PHYSIOL-GASTR L, V291, pG792, DOI 10.1152/ajpgi.00074.2006; RUIZAVILA L, 1995, NATURE, V376, P80, DOI 10.1038/376080a0; Sai WB, 2014, CLIN EXP PHARMACOL P, V41, P301, DOI 10.1111/1440-1681.12217; Sakai H, 2016, BIOL PHARM BULL, V39, P33, DOI 10.1248/bpb.b15-00426; Sanborn BM, 2005, J SOC GYNECOL INVEST, V12, P479, DOI 10.1016/j.jsgi.2005.07.002; Shmygol A, 2007, ANN NY ACAD SCI, V1101, P97, DOI 10.1196/annals.1389.031; Simmons LE, 2010, SEMIN PERINATOL, V34, P408, DOI 10.1053/j.semperi.2010.09.005; Smith R, 2007, NEW ENGL J MED, V356, P271, DOI 10.1056/NEJMra061360; Stamatelou F, 2009, ANN ACAD MED SINGAP, V38, P1011; Swaggart KA, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a023127; Tan XH, 2014, BRIT J PHARMACOL, V171, P646, DOI 10.1111/bph.12460; Ueda T, 2003, J NEUROSCI, V23, P7376; Upadhyaya JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110373; van Vliet EOG, 2014, EXPERT OPIN PHARMACO, V15, P787, DOI 10.1517/14656566.2014.889684; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Zhang CH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001501; Zhang T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101578; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; ZhuGe RH, 1999, J GEN PHYSIOL, V113, P215, DOI 10.1085/jgp.113.2.215; Zhuge R, 2010, J BIOL CHEM, V285, P2203, DOI 10.1074/jbc.M109.067546	59	28	29	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					4037	4052		10.1096/fj.201601323RR	http://dx.doi.org/10.1096/fj.201601323RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28559440	Green Published			2022-12-28	WOS:000408713300028
J	Chen, KH; Zuo, DC; Wang, SY; Chen, HJ				Chen, Kuihao; Zuo, Dongchuan; Wang, Sho-Ya; Chen, Haijun			Kir2 inward rectification-controlled precise and dynamic balances between Kir2 and HCN currents initiate pacemaking activity	FASEB JOURNAL			English	Article						pacemaker cells; Kir2.1 channels; HCN channels; spontaneous rhythmic action potential	PACE-MAKER CURRENT; FUNNY CURRENT; SODIUM-CHANNELS; BIOLOGICAL PACEMAKER; CARDIAC PACEMAKING; K+ CURRENT; SINOATRIAL; NODE; CELLS; HEART	Spontaneous rhythmic action potential or pacemaking activity of pacemaker cells controls rhythmic signaling such as heartbeat. The mechanism underlying the origin of pacemaking activity is not well understood. In this study, we created human embryonic kidney (HEK) 293 cells that show pacemaking activity through heterologous expression of strong inward rectifier IC subfamily 2 isoform 1 (Kir2.1) channels, hyperpolarization-activated cyclic nucleotide-gated isoform 2 (HCN2) nonselective cation channels, and voltage-gated Na + subfamily 1 isoform 5 or Ca2+ subfamily 3 isoform 1 (Na(v)1.5 or Ca(v)3.1) channels. A range of relative levels of Kir2.1 and HCN2 currents dynamically counterbalance, generating spontaneous rhythmic oscillation of resting membrane potential between -64 and -34 mV and determining oscillation rates. Each oscillation cycle begins with an autodepolarization phase, which slowly proceeds to the threshold potential that activates Na(v)1.5 or Ca(v)3.1 channels and triggers action potential, causing engineered HEK293 cells to exhibit pacemaking activity at a rate of <= 67 beats/min. Engineered HEK293 cells with Kir2.1 and either HCN3 or HCN4 also show the oscillation. Engineered HEK293 cells expressing HCN2 and other Kir2 channels, which lack Kir2.1-like complete inward rectification, do not show the oscillation. Therefore, Kir2.1-like inward rectification-controlled precise and dynamic balances between Kir2 and HCN currents initiate spontaneous rhythmic action potential and form an origin of pacemaking activity; Kir2 and HCN channels play essential roles in pacemaking activity.				hchen01@albany.edu			U.S. National Institutes of Health, National Institute of General Medical Sciences Award [R01GM102943]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102943] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of General Medical Sciences Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Toshinori Hoshi (Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA) for providing Ca<INF>v</INF>1 and Ca<INF>v</INF>3 plasmids and sharing information of functional expression of Ca<INF>v</INF>1 and Ca<INF>v</INF>3 channels, Edward Perez-Reyes (University of Virginia School of Medicine, Charlottesville, VA, USA) for providing HEK293-Ca<INF>v</INF>3.1 cells, and Steven A. Siegelbaum (Columbia University Medical Center, New York, NY, USA), Juliane Stieber (University of Erlangen-Nuremberg, Erlangen, Germany), and Catherine Proenza (University of Colorado School of Medicine, Denver, CO, USA) for providing HCN plasmids. H.C. was supported by the U.S. National Institutes of Health, National Institute of General Medical Sciences Award R01GM102943. The authors declare no conflicts of interest.	Accorsi-Mendonca D, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00424; Anumonwo JMB, 2010, J MOL CELL CARDIOL, V48, P45, DOI 10.1016/j.yjmcc.2009.08.013; Baruscotti M, 2005, PHARMACOL THERAPEUT, V107, P59, DOI 10.1016/j.pharmthera.2005.01.005; Berridge MJ, 2008, J PHYSIOL-LONDON, V586, P5047, DOI 10.1113/jphysiol.2008.160440; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; BOSMITH RE, 1993, BRIT J PHARMACOL, V110, P343, DOI 10.1111/j.1476-5381.1993.tb13815.x; Capel RA, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00080; Chan YC, 2009, J CARDIOVASC ELECTR, V20, P1048, DOI 10.1111/j.1540-8167.2009.01475.x; Cho HS, 2003, J PHYSIOL-LONDON, V550, P169, DOI 10.1113/jphysiol.2003.040501; DENYER JC, 1990, J PHYSIOL-LONDON, V428, P405, DOI 10.1113/jphysiol.1990.sp018219; DIFRANCESCO D, 1981, J PHYSIOL-LONDON, V314, P377, DOI 10.1113/jphysiol.1981.sp013714; DIFRANCESCO D, 1981, J PHYSIOL-LONDON, V314, P359, DOI 10.1113/jphysiol.1981.sp013713; DiFrancesco D, 2012, HEART RHYTHM, V9, P299, DOI 10.1016/j.hrthm.2011.09.021; DiFrancesco D, 2010, CIRC RES, V106, P434, DOI 10.1161/CIRCRESAHA.109.208041; Findeisen F, 2010, CHANNELS, V4, P459, DOI 10.4161/chan.4.6.12867; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; IRISAWA H, 1993, PHYSIOL REV, V73, P197, DOI 10.1152/physrev.1993.73.1.197; Kubo Y, 2001, J PHYSIOL-LONDON, V531, P645, DOI 10.1111/j.1469-7793.2001.0645h.x; Kuhlman SJ, 2006, J BIOL RHYTHM, V21, P470, DOI 10.1177/0748730406294316; Lakatta EG, 2010, CIRC RES, V106, P659, DOI 10.1161/CIRCRESAHA.109.206078; Lakatta EG, 2009, J MOL CELL CARDIOL, V47, P157, DOI 10.1016/j.yjmcc.2009.03.022; Lee JH, 1999, J NEUROSCI, V19, P1912; Lei M, 2004, J PHYSIOL-LONDON, V559, P835, DOI 10.1113/jphysiol.2004.068643; Lopatin AN, 2001, J MOL CELL CARDIOL, V33, P625, DOI 10.1006/jmcc.2001.1344; LU Z, 1994, NATURE, V371, P243, DOI 10.1038/371243a0; Ma LQ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001726; Maier SKG, 2003, P NATL ACAD SCI USA, V100, P3507, DOI 10.1073/pnas.2627986100; Maltsev VA, 2012, HEART RHYTHM, V9, P302, DOI 10.1016/j.hrthm.2011.09.022; Maltsev VA, 2010, J MOL CELL CARDIOL, V48, P804, DOI 10.1016/j.yjmcc.2009.12.009; Mangoni ME, 2008, PHYSIOL REV, V88, P919, DOI 10.1152/physrev.00018.2007; Mangoni ME, 2006, CIRC RES, V98, P1422, DOI 10.1161/01.RES.0000225862.14314.49; Mesirca P, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00019; Mesirca P, 2014, PFLUG ARCH EUR J PHY, V466, P791, DOI 10.1007/s00424-014-1482-6; Miake J, 2002, NATURE, V419, P132, DOI 10.1038/419132b; Miake J, 2003, J CLIN INVEST, V111, P1529, DOI 10.1172/JCI200317959; NOBLE D, 1968, J PHYSIOL-LONDON, V195, P185, DOI 10.1113/jphysiol.1968.sp008454; Noble D, 2010, CIRC RES, V106, P1791, DOI 10.1161/CIRCRESAHA.110.218875; Qu JH, 2003, CIRCULATION, V107, P1106, DOI 10.1161/01.CIR.0000059939.97249.2C; Rosen MR, 2011, NAT REV CARDIOL, V8, P656, DOI 10.1038/nrcardio.2011.120; SHAH AK, 1987, BIOPHYS J, V52, P519, DOI 10.1016/S0006-3495(87)83241-1; Shinagawa Y, 2000, J PHYSIOL-LONDON, V523, P593, DOI 10.1111/j.1469-7793.2000.t01-2-00593.x; Sun Y, 2017, STEM CELL REV REP, V13, P631, DOI 10.1007/s12015-017-9745-1; Tse HF, 2006, CIRCULATION, V114, P1000, DOI 10.1161/CIRCULATIONAHA.106.615385; Verkerk AO, 2007, EUR HEART J, V28, P2472, DOI 10.1093/eurheartj/ehm339; Verkerk AO, 2009, INT J BIOL SCI, V5, P201; Wang GK, 2014, MOL PHARMACOL, V85, P692, DOI 10.1124/mol.113.091173; WIBLE BA, 1994, NATURE, V371, P246, DOI 10.1038/371246a0; Xie LH, 2003, J PHYSIOL-LONDON, V550, P67, DOI 10.1113/jphysiol.2003.043117; Xie LH, 2002, J GEN PHYSIOL, V120, P53, DOI 10.1085/jgp.20028576; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7; Yuill KH, 2002, PFLUG ARCH EUR J PHY, V445, P311, DOI 10.1007/s00424-002-0932-8; Zuo DC, 2017, J PHYSIOL-LONDON, V595, P5129, DOI 10.1113/JP274268	52	8	8	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3047	3057		10.1096/fj.201701260R	http://dx.doi.org/10.1096/fj.201701260R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401592	Green Published			2022-12-28	WOS:000432546000013
J	Woodman, AG; Mah, R; Keddie, D; Noble, RMN; Panahi, S; Gragasin, FS; Lemieux, H; Bourque, SL				Woodman, Andrew G.; Mah, Richard; Keddie, Danae; Noble, Ronan M. N.; Panahi, Sareh; Gragasin, Ferrante S.; Lemieux, Helene; Bourque, Stephane L.			Prenatal iron deficiency causes sex-dependent mitochondria! dysfunction and oxidative stress in fetal rat kidneys and liver	FASEB JOURNAL			English	Article						pregnancy; development; nutrition; metabolism; programming	CYTOCHROME-C-OXIDASE; RENAL DEVELOPMENT; PREGNANT RATS; WISTAR RATS; COMPLEX-II; ANEMIA; HYPOXIA; TESTOSTERONE; HYPERTENSION; RESTRICTION	Prenatal iron deficiency alters fetal developmental trajectories, which results in persistent changes in organ function. Here, we studied the effects of prenatal iron deficiency on fetal kidney and liver mitochondrial function. Pregnant Sprague-Dawley rats were fed partially or fully iron-restricted diets to induce a state of moderate or severe iron deficiency alongside iron-replete control rats. We assessed mitochondrial function via high-resolution respirometry and reactive oxygen species generation via fluorescence microscopy on gestational d 21. Hemoglobin levels were reduced in dams in the moderate (-31%) and severe groups (-54%) compared with controls, which was accompanied by 55% reductions in fetal hemoglobin levels in both moderate and severe groups versus controls. Male iron-deficient kidneys exhibited globally reduced mitochondrial content and respiration, as well as increased cytosolic superoxide and decreased NO. Female iron-deficient kidneys exhibited complex II down-regulation and increased mitochondrial oxidative stress. Male iron-deficient livers exhibited reduced complex IV respiration and increased cytosolic superoxide, whereas female liver tissues exhibited no alteration in oxidant levels or mitochondrial function. These findings indicate that prenatal iron deficiency causes changes in mitochondrial content and function as well as oxidant status in a sex- and organ-dependent manner, which may be an important mechanism that underlies the programming of cardiovascular disease.	[Woodman, Andrew G.; Bourque, Stephane L.] Univ Alberta, Dept Pharmacol, Edmonton, AB, Canada; [Woodman, Andrew G.; Mah, Richard; Keddie, Danae; Noble, Ronan M. N.; Panahi, Sareh; Gragasin, Ferrante S.; Bourque, Stephane L.] Univ Alberta, Women & Childrens Hlth Res Inst, Edmonton, AB, Canada; [Mah, Richard; Keddie, Danae; Noble, Ronan M. N.; Panahi, Sareh; Gragasin, Ferrante S.; Bourque, Stephane L.] Univ Alberta, Dept Anesthesiol & Pain Med, Edmonton, AB, Canada; [Lemieux, Helene] Univ Alberta, Fac St Jean, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta	Bourque, SL (corresponding author), Univ Alberta, Katz Grp Ctr, 3-020H, Edmonton, AB T6G 2E1, Canada.	sbourque@ualberta.ca		Mah, Richard/0000-0002-1172-5088; lemieux, Helene/0000-0002-8864-6062; Woodman, Andrew/0000-0002-1476-1850	Canadian Institutes of Health Research (CIHR) [MOP142396]; Women and Children's Health Research Institute; Discovery Grant from the National Sciences and Engineering Research Council [RGPIN 402636]; CIHR; Alberta Innovates-Health Solutions; CIHR New Investigator Salary Award; Alberta Innovates [201600255] Funding Source: researchfish	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Women and Children's Health Research Institute; Discovery Grant from the National Sciences and Engineering Research Council; CIHR(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions; CIHR New Investigator Salary Award(Canadian Institutes of Health Research (CIHR)); Alberta Innovates	This work was supported by grants from the Canadian Institutes of Health Research (CIHR; MOP142396) and the Women and Children's Health Research Institute (to S.L.B.), and a Discovery Grant from the National Sciences and Engineering Research Council (RGPIN 402636; to H.L.). A.G.W. holds studentships from CIHR and Alberta Innovates-Health Solutions. S.L.B. holds a CIHR New Investigator Salary Award. The authors declare no conflicts of interest.	Bourque SL, 2008, J NUTR, V138, P931, DOI 10.1093/jn/138.5.931; Bourque SL, 2008, HYPERTENSION, V51, P154, DOI 10.1161/HYPERTENSIONAHA.107.100446; Bourque SL, 2012, ENDOCRINOLOGY, V153, P1174, DOI 10.1210/en.2011-1700; Breymann C, 2015, SEMIN HEMATOL, V52, P339, DOI 10.1053/j.seminhematol.2015.07.003; DALLMAN PR, 1986, ANNU REV NUTR, V6, P13, DOI 10.1146/annurev.nu.06.070186.000305; Danson MJ, 2001, METHOD ENZYMOL, V331, P3; DAVIS LE, 1991, AM J PHYSIOL, V261, pR1542, DOI 10.1152/ajpregu.1991.261.6.R1542; Drake KA, 2009, PEDIATR RES, V66, P619, DOI 10.1203/PDR.0b013e3181be79c2; Gnaiger E, 1998, J EXP BIOL, V201, P1129; Gnaiger E., 2014, MITOCHONDRIAL PATHWA, V4th ed., P81, DOI DOI 10.26124/BEC:2020-0002; Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013; Haase VH, 2010, AM J PHYSIOL-RENAL, V299, pF1, DOI 10.1152/ajprenal.00174.2010; HABERT R, 1984, J STEROID BIOCHEM, V21, P193, DOI 10.1016/0022-4731(84)90383-2; Iverson TM, 2012, J BIOL CHEM, V287, P35430, DOI 10.1074/jbc.R112.408419; Komolova M, 2008, INT J OBESITY, V32, P1441, DOI 10.1038/ijo.2008.97; Lewis RM, 2002, BRIT J NUTR, V88, P283, DOI 10.1079/BJN2002656; Lisle SJM, 2003, BRIT J NUTR, V90, P33, DOI 10.1079/BJN2003881; Lopez A, 2016, LANCET, V387, P907, DOI 10.1016/S0140-6736(15)60865-0; Luo SX, 2014, CURR PHARM DESIGN, V20, P3548, DOI 10.2174/13816128113196660746; MACKLER B, 1983, TERATOLOGY, V28, P103, DOI 10.1002/tera.1420280113; Maduwegedera D, 2007, AM J PHYSIOL-REG I, V292, pR706, DOI 10.1152/ajpregu.00458.2006; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Ortiz LA, 2003, HYPERTENSION, V41, P328, DOI 10.1161/01.HYP.0000049763.51269.51; Ozcay F, 2003, PEDIATR NEPHROL, V18, P254, DOI 10.1007/s00467-002-1054-4; Paddenberg R, 2003, AM J PHYSIOL-LUNG C, V284, pL710, DOI 10.1152/ajplung.00149.2002; Pereira SP, 2015, AM J PHYSIOL-RENAL, V308, pF1217, DOI 10.1152/ajprenal.00419.2014; Pesta D, 2011, AM J PHYSIOL-REG I, V301, pR1078, DOI 10.1152/ajpregu.00285.2011; Ralph SJ, 2011, PHARM RES-DORDR, V28, P2695, DOI 10.1007/s11095-011-0566-7; Rensvold JW, 2016, J BIOL CHEM, V291, P20827, DOI 10.1074/jbc.M116.727701; Rensvold JW, 2013, CELL REP, V3, P237, DOI 10.1016/j.celrep.2012.11.029; Srinivasan S, 2012, FREE RADICAL BIO MED, V53, P1252, DOI 10.1016/j.freeradbiomed.2012.07.021; Stangenberg S, 2015, INT J BIOCHEM CELL B, V64, P81, DOI 10.1016/j.biocel.2015.03.017; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; Toblli JE, 2012, PLACENTA, V33, P81, DOI 10.1016/j.placenta.2011.11.017; Tower J, 2006, MECH AGEING DEV, V127, P705, DOI 10.1016/j.mad.2006.05.001; Unger EL, 2012, J NUTR, V142, P2040, DOI 10.3945/jn.112.162198; Ventura-Clapier R, 2017, CLIN SCI, V131, P803, DOI 10.1042/CS20160485; Vieyra-Reyes P, 2017, J PHYSIOL BIOCHEM, V73, P99, DOI 10.1007/s13105-016-0529-x; WEISZ J, 1980, ENDOCRINOLOGY, V106, P306, DOI 10.1210/endo-106-1-306; Woodman AG, 2017, SCI REP-UK, V7, DOI 10.1038/srep46573	40	22	22	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3254	3263		10.1096/fj.201701080R	http://dx.doi.org/10.1096/fj.201701080R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401611				2022-12-28	WOS:000432546000029
J	Mashahreh, B; Hassouna, F; Soudah, N; Cohen-Kfir, E; Strulovich, R; Haitin, Y; Wiener, R				Mashahreh, Bayan; Hassouna, Fouad; Soudah, Nadine; Cohen-Kfir, Einav; Strulovich, Roi; Haitin, Yoni; Wiener, Reuven			Trans-binding of UFM1 to UBA5 stimulates UBA5 homodimerization and ATP binding	FASEB JOURNAL			English	Article						ubiquitin-like protein; activating enzyme E1; ufmylation	UBIQUITIN-ACTIVATING ENZYME; PROTEIN-ACTIVATION; CRYSTAL-STRUCTURE; CONJUGATION; MECHANISM; INSIGHTS; E1; CASCADE; SYSTEM; ATG7	All ubiquitin-like proteins (UBLs) undergo an activation process before their conjugation to target proteins. Although the steps required for the activation of UBLs are conserved and common to all UBLs, we have previously shown that the activation of the UBL, ubiquitin fold modifier 1 (UFM1) by the E1, Ufm1 modifier-activating enzyme 5 (UBA5) is executed in a trans-binding mechanism, not observed in any other E1. In this study, we explored the necessity of that mechanism for UFM1 activation and found that it is needed not only for UFM1 binding to UBA5 but also for stabilizing the UBA5 homodimer. Although UBA5 functions as a dimer, in solution it behaves as a weak dimer. Dimerization of UBA5 is required for ATP binding; therefore, stabilization of the dimer by UFM1 enhances ATP binding. Our results make a connection between the binding of UFM1 to UBA5 and the latter's affinity to ATP, so we propose a novel mechanism for the regulation of ATP's binding to E1.	[Mashahreh, Bayan; Hassouna, Fouad; Soudah, Nadine; Cohen-Kfir, Einav; Wiener, Reuven] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Biochem & Mol Biol, POB 12272, IL-9112102 Jerusalem, Israel; [Strulovich, Roi; Haitin, Yoni] Tel Aviv Univ, Fac Med, Dept Physiol & Pharmacol, Tel Aviv, Israel	Hebrew University of Jerusalem; Tel Aviv University	Wiener, R (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Biochem & Mol Biol, POB 12272, IL-9112102 Jerusalem, Israel.	reuvenw@ekmd.huji.ac.il	Haitin, Yoni/AAQ-4571-2021	Haitin, Yoni/0000-0002-1648-6792	United States-Israel Binational Science Foundation [2013261]; Marie Curie Career Integration [PCIG13-GA-2013-630755]; Israel Science Foundation [1383/17]	United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Marie Curie Career Integration; Israel Science Foundation(Israel Science Foundation)	This work was supported by United States-Israel Binational Science Foundation (Grant 2013261), the Marie Curie Career Integration (Grant PCIG13-GA-2013-630755), and the Israel Science Foundation (Grant 1383/17). The authors declare no conflicts of interest.	Azfer A, 2006, AM J PHYSIOL-HEART C, V291, pH1411, DOI 10.1152/ajpheart.01378.2005; Bacik JP, 2010, J BIOL CHEM, V285, P20273, DOI 10.1074/jbc.M110.102921; Bae JY, 2010, J MICROBIOL BIOTECHN, V20, P1647, DOI 10.4014/jmb.1007.07061; Cai YF, 2016, EXP HEMATOL, V44, P442, DOI 10.1016/j.exphem.2016.03.007; Cai YF, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005643; Capili AD, 2007, CURR OPIN STRUC BIOL, V17, P726, DOI 10.1016/j.sbi.2007.08.018; Cappadocia L, 2018, CHEM REV, V118, P889, DOI 10.1021/acs.chemrev.6b00737; Colin E, 2016, AM J HUM GENET, V99, P695, DOI 10.1016/j.ajhg.2016.06.030; Daniel J, 2014, CELLS-BASEL, V3, P627, DOI 10.3390/cells3020627; Gavin JM, 2014, J BIOL CHEM, V289, P22648, DOI 10.1074/jbc.M114.573972; Ha BH, 2011, J BIOL CHEM, V286, P10248, DOI 10.1074/jbc.M110.172171; Habisov S, 2016, J BIOL CHEM, V291, P9025, DOI 10.1074/jbc.M116.715474; Hertel P, 2013, J BIOL CHEM, V288, P10661, DOI 10.1074/jbc.M113.458000; Hong SB, 2011, NAT STRUCT MOL BIOL, V18, P1323, DOI 10.1038/nsmb.2165; Kang SH, 2007, J BIOL CHEM, V282, P5256, DOI 10.1074/jbc.M610590200; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; Kumeta H, 2010, J BIOMOL NMR, V47, P237, DOI 10.1007/s10858-010-9420-1; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; Lemaire K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018517; Mizushima T, 2007, BIOCHEM BIOPH RES CO, V362, P1079, DOI 10.1016/j.bbrc.2007.08.129; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Noda NN, 2011, MOL CELL, V44, P462, DOI 10.1016/j.molcel.2011.08.035; Oweis W, 2016, CELL REP, V16, P3113, DOI 10.1016/j.celrep.2016.08.067; Padala P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00610-0; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pirone L, 2017, SCI REP-UK, V7, DOI 10.1038/srep40756; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Taherbhoy AM, 2011, MOL CELL, V44, P451, DOI 10.1016/j.molcel.2011.08.034; Tatsumi K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1182; Tatsumi K, 2010, J BIOL CHEM, V285, P5417, DOI 10.1074/jbc.M109.036814; Yoo HM, 2014, MOL CELL, V56, P261, DOI 10.1016/j.molcel.2014.08.007; Zhang M, 2015, CELL DEATH DIFFER, V22, P1922, DOI 10.1038/cdd.2015.51; Zheng M, 2008, J CELL BIOCHEM, V104, P2324, DOI 10.1002/jcb.21791	33	9	10	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2794	2802		10.1096/fj.201701057R	http://dx.doi.org/10.1096/fj.201701057R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29295865				2022-12-28	WOS:000432528000038
J	Bohrer, RC; Dicks, N; Gutierrez, K; Duggavathi, R; Bordignon, V				Bohrer, Rodrigo C.; Dicks, Naomi; Gutierrez, Karina; Duggavathi, Raj; Bordignon, Vilceu			Double-strand DNA breaks are mainly repaired by the homologous recombination pathway in early developing swine embryos	FASEB JOURNAL			English	Article						DNA damage; DNA repair; ATM; ATR; DNA-PK	DEPENDENT PROTEIN-KINASE; CELL-CYCLE; GENOME STABILITY; MAMMALIAN-CELLS; DAMAGE RESPONSE; HISTONE H2AX; IN-VIVO; ATM; MOUSE; INTEGRITY	DNA double-strand breaks (DSBs) are less frequent than single-strand breaks but have more harmful consequences on cell survival and physiology. Homologous recombination (HR) and nonhomologous end-joining (NHEJ) are the two main pathways that are responsible for DSB repair in eukaryotic cells, but their importance for the preservation of genome stability in totipotent blastomeres of early developing embryos has not been determined. In this study, we observed that the chemical inhibition of HR or both pathways, but not NHEJ alone, increased the number of DSBs, reduced embryo development to the blastocyst stage, and resulted in embryos with higher proportions of apoptotic cells. Targeted knockdown of ATM (ataxia telangiectasia mutated) and ATR (ataxia telangiectasia and Rad3 related; HR regulators) and DNA-dependent protein kinase (NHEJ regulator) mRNAs revealed that the attenuation of HR or both HR and NHEJ regulators severely impaired blastocyst formation and quality. Attenuation of ATM alone resulted in a higher incidence of DSBs, lower development and embryo quality, and increased mRNA abundance of genes that are involved in either repair pathway. These findings indicate that HR is the main pathway responsible for the promotion of DSB repair in early developing embryos, and that ATM seems to be more important than ATR in the regulation of the HR pathway in mammalian embryos.	[Bohrer, Rodrigo C.; Dicks, Naomi; Gutierrez, Karina; Duggavathi, Raj; Bordignon, Vilceu] McGill Univ, Dept Anim Sci, Montreal, PQ, Canada	McGill University	Bordignon, V (corresponding author), McGill Univ, Dept Anim Sci, MS1-089,21,111 Lakeshore Rd, Ste Anne De Bellevue, PQ H9X 3V9, Canada.	vilceu.bordignon@mcgill.ca	Duggavathi, Raj/GSJ-3503-2022; Bohrer, Rodrigo/I-7725-2013	Bohrer, Rodrigo/0000-0002-0726-7643; Gutierrez, Karina/0000-0001-9112-1542; Bordignon, Vilceu/0000-0001-7076-7707	Natural Sciences and Engineering Research Council (NSERC) of Canada [2016-04910]; Science Without Borders Program of the Brazilian Council of Scientific and Technological Development; NSERC Alexander Graham Bell Canada Graduate Scholarship	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Science Without Borders Program of the Brazilian Council of Scientific and Technological Development; NSERC Alexander Graham Bell Canada Graduate Scholarship	The authors thank Olymel S.E.C./L.P. (Saint Esprit, QC, Canada) for providing porcine ovaries for use in these experiments. This work was supported by the Natural Sciences and Engineering Research Council (NSERC) of Canada (Grant 2016-04910; to V.B.). R.C.B. and K.G. were supported by scholarships from the Science Without Borders Program of the Brazilian Council of Scientific and Technological Development. N.D. is supported by an NSERC Alexander Graham Bell Canada Graduate Scholarship. The authors declare no conflicts of interest.	Abeydeera LR, 1997, BIOL REPROD, V57, P729, DOI 10.1095/biolreprod57.4.729; Adiga SK, 2010, FERTIL STERIL, V93, P2486, DOI 10.1016/j.fertnstert.2009.06.015; Barber RC, 2006, ONCOGENE, V25, P7336, DOI 10.1038/sj.onc.1209723; Barreta MH, 2012, EXP CELL RES, V318, P2049, DOI 10.1016/j.yexcr.2012.06.003; Bohrer RC, 2013, REPRODUCTION, V146, P325, DOI 10.1530/REP-13-0271; Bohrer RC, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.130542; Bohrer RC, 2014, CELL CYCLE, V13, P2138, DOI 10.4161/cc.29215; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Couedel C, 2004, GENE DEV, V18, P1293, DOI 10.1101/gad.1209204; De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025; Delacote F, 2008, CELL CYCLE, V7, P33, DOI 10.4161/cc.7.1.5149; Derijck A, 2008, HUM MOL GENET, V17, P1922, DOI 10.1093/hmg/ddn090; Essers J, 2000, EMBO J, V19, P1703, DOI 10.1093/emboj/19.7.1703; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Furgason JM, 2013, PHARMACOL THERAPEUT, V137, P298, DOI 10.1016/j.pharmthera.2012.10.009; Grigaravicius P, 2009, MUTAGENESIS, V24, P191, DOI 10.1093/mutage/gen071; Hammarsten O, 1998, P NATL ACAD SCI USA, V95, P525, DOI 10.1073/pnas.95.2.525; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Juan HC, 2016, CELL DEATH DIFFER, V23, P1038, DOI 10.1038/cdd.2015.157; Karran P, 2000, CURR OPIN GENET DEV, V10, P144, DOI 10.1016/S0959-437X(00)00069-1; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kujjo LL, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092064; Kujjo LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009204; Leahy JJJ, 2004, BIOORG MED CHEM LETT, V14, P6083, DOI 10.1016/j.bmcl.2004.09.060; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Mari PO, 2006, P NATL ACAD SCI USA, V103, P18597, DOI 10.1073/pnas.0609061103; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Marshall GM, 2014, NAT REV CANCER, V14, P277, DOI 10.1038/nrc3679; McManus KJ, 2005, MOL BIOL CELL, V16, P5013, DOI 10.1091/mbc.E05-01-0065; Mu XF, 2011, BIOL REPROD, V85, P524, DOI 10.1095/biolreprod.110.089334; MUKHERJEE AB, 1976, P NATL ACAD SCI USA, V73, P1608, DOI 10.1073/pnas.73.5.1608; Ocampo A, 2016, CELL, V167, P1719, DOI 10.1016/j.cell.2016.11.052; PAPAIOANNOU VE, 1982, J EMBRYOL EXP MORPH, V68, P199; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Perez GI, 2007, CELL DEATH DIFFER, V14, P524, DOI 10.1038/sj.cdd.4402050; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; Reaper PM, 2011, NAT CHEM BIOL, V7, P428, DOI [10.1038/NCHEMBIO.573, 10.1038/nchembio.573]; Rich T, 2000, NATURE, V407, P777, DOI 10.1038/35037717; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; SCHOENBECK RA, 1992, BIOL REPROD, V47, P1118, DOI 10.1095/biolreprod47.6.1118; Simon L, 2014, HUM REPROD, V29, P2402, DOI 10.1093/humrep/deu228; SMITH RKW, 1986, J REPROD FERTIL, V76, P393, DOI 10.1530/jrf.0.0760393; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Wang B, 2013, SCI WORLD J, DOI 10.1155/2013/405645; Wang H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142561; Wang ZW, 2013, CELL CYCLE, V12, P3336, DOI 10.4161/cc.26327; Yang YG, 2004, ONCOGENE, V23, P3872, DOI 10.1038/sj.onc.1207491; Yin XJ, 2002, BIOL REPROD, V67, P442, DOI 10.1095/biolreprod67.2.442; Yoshioka K, 2002, BIOL REPROD, V66, P112, DOI 10.1095/biolreprod66.1.112; Zha S, 2008, P NATL ACAD SCI USA, V105, P9302, DOI 10.1073/pnas.0803520105	56	10	10	2	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1818	1829		10.1096/fj.201700800R	http://dx.doi.org/10.1096/fj.201700800R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29162700				2022-12-28	WOS:000429051400007
J	Derouiche, S; Takayama, Y; Murakami, M; Tominaga, M				Derouiche, Sandra; Takayama, Yasunori; Murakami, Masataka; Tominaga, Makoto			TRPV4 heats up ANO1-dependent exocrine gland fluid secretion	FASEB JOURNAL			English	Article						calcium; ion channels; saliva; tears	CA2+-ACTIVATED CL-CHANNEL; CATION CHANNEL; EVOKED ACTIVATION; SALIVARY; TEMPERATURE; MODULATION; MECHANISM; PATHWAY; ENTRY; AQP5	Several ion channels and transporters regulate fluid secretion in salivary and lacrimal glands. In salivary glands, the major anion channel involved in fluid secretion is the calcium-activated chloride channel anoctamin 1 (ANO1). Several members of the transient receptor potential (TRP) channel superfamily regulate ANO1 activity. Here, we report a functional interaction between thermosensitive TRP vanilloid (TRPV)4 and ANO1 in acinar cells isolated from mouse salivary and lacrimal glands. TRPV4 activation induced chloride currents and shrinkage of acinar cells by increasing intracellular calcium concentrations. The chloride currents evoked by a TRPV4-specific activator (GSK1016790A) were identified as ANO1-mediated currents. Moreover, TRPV4 activation by an inositol 1,4,5-trisphosphate (IP3)-dependent mechanism was found to contribute to the muscarinic pathway of fluid secretion. Muscarinic stimulation of saliva and tear secretion was down-regulated in both TRPV4-deficient mice and in acinar cells treated with a TRPV4-specific antagonist (HC-067047). Furthermore, the temperature dependence of muscarinic salivation was shown to depend mainly on TRPV4. Our results suggest that TRPV4 interacts with IP3 receptors and ANO1 to regulate the muscarinic pathway that mediates salivation and lacrimation.	[Derouiche, Sandra; Takayama, Yasunori; Tominaga, Makoto] Natl Inst Physiol Sci, Okazaki Inst Integrat Biosci, Div Cell Signaling, Okazaki, Aichi, Japan; [Takayama, Yasunori; Murakami, Masataka; Tominaga, Makoto] Grad Univ Adv Studies SOKENDAI, Dept Physiol Sci, Okazaki, Aichi, Japan; [Murakami, Masataka] Natl Inst Physiol Sci, Okazaki, Aichi, Japan; [Tominaga, Makoto] Juntendo Univ, Inst Environm & Gender Specif Med, Urayasu, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Juntendo University	Derouiche, S; Tominaga, M (corresponding author), Natl Inst Nat Sci, Natl Inst Physiol Sci, Okazaki Inst Integrat Biosci, Div Cell Signaling, Higashiyama 5-1, Okazaki, Aichi 4448787, Japan.	derosand@nips.ac.jp; tominaga@nips.ac.jp	Takayama, Yasunori/AAG-1133-2021		Japanese Society for the Promotion of Science; Japanese National Institute for Physiological Sciences in Japan; Ministry of Education, Culture, Sports, Science and Technology [15H02501, 15H05928]	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese National Institute for Physiological Sciences in Japan; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors thank K. Mikoshiba (RIKEN Brain Science Institute, Saitama, Japan) and K. Shibasaki (Gunma University, Maebashi, Japan) for the generous gifts of the IP<INF>3</INF> receptor and TRPV4 antibodies, respectively. This work was supported by grants from the Japanese Society for the Promotion of Science and the Japanese National Institute for Physiological Sciences in Japan (to S.D.) and by Grants 15H02501 and 15H05928 from Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (to M.T.). The authors declare no conflict of interest.	Ambudkar IS, 2012, CURR MED CHEM, V19, P5774; Arniges M, 2004, J BIOL CHEM, V279, P54062, DOI 10.1074/jbc.M409708200; Cao DS, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-5; Catalan MA, 2015, P NATL ACAD SCI USA, V112, P2263, DOI 10.1073/pnas.1415739112; COMPTON J, 1981, ARCH ORAL BIOL, V26, P555, DOI 10.1016/0003-9969(81)90017-0; Cuajungco MP, 2006, J BIOL CHEM, V281, P18753, DOI 10.1074/jbc.M602452200; D'hoedt D, 2008, J BIOL CHEM, V283, P6272, DOI 10.1074/jbc.M706386200; Earley S, 2005, CIRC RES, V97, P1270, DOI 10.1161/01.RES.0000194321.60300.d6; Edlund A, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-87; Fernandes J, 2008, J GEN PHYSIOL, V131, pi2, DOI DOI 10.1085/JGP1315OIA2; Fujita-Yoshigaki J, 2005, CELL TISSUE RES, V320, P455, DOI 10.1007/s00441-005-1076-x; Garcia-Elias A, 2008, J BIOL CHEM, V283, P31284, DOI 10.1074/jbc.C800184200; Guler AD, 2002, J NEUROSCI, V22, P6408; Hosoi K, 2016, PFLUG ARCH EUR J PHY, V468, P519, DOI 10.1007/s00424-015-1749-6; Jin X, 2016, J PHYSIOL-LONDON, V594, P19, DOI 10.1113/jphysiol.2014.275107; Jin X, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004184; Lee MG, 2012, PHYSIOL REV, V92, P39, DOI 10.1152/physrev.00011.2011; Lee RJ, 2010, AM J PHYSIOL-LUNG C, V298, pL210, DOI 10.1152/ajplung.00342.2009; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liu XB, 2007, P NATL ACAD SCI USA, V104, P17542, DOI 10.1073/pnas.0701254104; Liu XB, 2006, J BIOL CHEM, V281, P15485, DOI 10.1074/jbc.M600549200; MARTY A, 1984, J PHYSIOL-LONDON, V357, P293, DOI 10.1113/jphysiol.1984.sp015501; Mizuno A, 2003, AM J PHYSIOL-CELL PH, V285, pC96, DOI 10.1152/ajpcell.00559.2002; Mukaibo K., 2013, OPEN J STOMATOLOGY, V3, P83; MURAKAMI M, 1990, J PHYSIOL-LONDON, V426, P127, DOI 10.1113/jphysiol.1990.sp018130; Nakahari T, 1998, J MEMBRANE BIOL, V161, P287, DOI 10.1007/s002329900335; Nakamura T, 2004, J PHYSIOL-LONDON, V558, P561, DOI 10.1113/jphysiol.2004.064626; Norman LL, 2010, BIOPHYS J, V99, P1726, DOI 10.1016/j.bpj.2010.07.031; Novak I, 2010, J PHYSIOL-LONDON, V588, P3615, DOI 10.1113/jphysiol.2010.190017; Pani B, 2013, J CELL SCI, V126, P667, DOI 10.1242/jcs.118943; Putney JW, 2014, CELL CALCIUM, V55, P290, DOI 10.1016/j.ceca.2014.01.001; Romanenko VG, 2010, J BIOL CHEM, V285, P12990, DOI 10.1074/jbc.M109.068544; Shibasaki K, 2007, J NEUROSCI, V27, P1566, DOI 10.1523/JNEUROSCI.4284-06.2007; Sobhan U, 2013, CELL TISSUE RES, V354, P507, DOI 10.1007/s00441-013-1691-x; Sokabe Takaaki, 2010, Commun Integr Biol, V3, P619, DOI 10.4161/cib.3.6.13461; Sokabe T, 2010, J BIOL CHEM, V285, P18749, DOI 10.1074/jbc.M110.103606; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Takayama Y, 2015, P NATL ACAD SCI USA, V112, P5213, DOI 10.1073/pnas.1421507112; Takayama Y, 2014, FASEB J, V28, P2238, DOI 10.1096/fj.13-243436; Tominaga M, 2014, CHANNELS, V8, DOI 10.4161/chan.29001; Wang Y, 2007, J BIOL CHEM, V282, P36561, DOI 10.1074/jbc.M703903200; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Xing J, 2014, J PHYSIOL-LONDON, V592, P927, DOI 10.1113/jphysiol.2013.267740; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Ye L, 2012, CELL, V151, P96, DOI 10.1016/j.cell.2012.08.034; Yu DF, 2012, AM J PHYSIOL-CELL PH, V303, pC767, DOI 10.1152/ajpcell.00195.2012; Zhang Y, 2012, AM J PHYSIOL-GASTR L, V303, pG1365, DOI 10.1152/ajpgi.00366.2012	49	20	21	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1841	1854		10.1096/fj.201700954R	http://dx.doi.org/10.1096/fj.201700954R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29187363				2022-12-28	WOS:000429051400009
J	Mizumura, K; Justice, MJ; Schweitzer, KS; Krishnan, S; Bronova, I; Berdyshev, EV; Hubbard, WC; Pewzner-Jung, Y; Futerman, AH; Choi, AMK; Petrache, I				Mizumura, Kenji; Justice, Matthew J.; Schweitzer, Kelly S.; Krishnan, Sheila; Bronova, Irina; Berdyshev, Evgeny V.; Hubbard, Walter C.; Pewzner-Jung, Yael; Futerman, Anthony H.; Choi, Augustine M. K.; Petrache, Irina			Sphingolipid regulation of lung epithelial cell mitophagy and necroptosis during cigarette smoke exposure	FASEB JOURNAL			English	Article						ceramide; sphingosine; cell death; cell survival; inflammation	OBSTRUCTIVE PULMONARY-DISEASE; CERAMIDE SYNTHASE 2; SELECTIVE AUTOPHAGY; INDUCED EMPHYSEMA; PROTEIN; APOPTOSIS; STRESS; DEATH; MICE; PATHOGENESIS	The mechanisms by which lung structural cells survive toxic exposures to cigarette smoke (CS) are not well defined but may involve proper disposal of damaged mitochondria by macro-autophagy (mitophagy), processes that may be influenced by pro-apoptotic ceramide (Cer) or its precursor dihydroceramide (DHC). Human lung epithelial and endothelial cells exposed to CS exhibited mitochondrial damage, signaled by phosphatase and tensin homolog-induced putative kinase 1 (PINK1) phosphorylation, autophagy, and necroptosis. Although cells responded to CS by rapid inhibition of DHC desaturase, which elevated DHC levels, palmitoyl (C16)-Cer also increased in CS-exposed cells. Where as DHC augmentation triggered autophagy without cell death, the exogenous administration of C16-Cer was sufficient to trigger necroptosis. Inhibition of Cer-generating acid sphingomyelinase reduced both CS-induced PINK1 phosphorylation and necroptosis. When exposed to CS, Pink1-deficient (Pink1(-/-)) mice, which are protected from airspace enlargement compared with wild-type littermates, had blunted C16-Cer elevations and less lung necroptosis. CS-exposed Pink1(-/-) mice also exhibited significantly increased levels of lignoceroyl (C24)-DHC, along with increased expression of Cer synthase 2 (CerS2), the enzyme responsible for its production. This suggested that a combination of high C24-DHC and low C16-Cer levels might protect against CS-induced necroptosis. Indeed, CerS2(-/-) mice, which lack C24-DHC at the expense of increased C16-Cer, were more susceptible to CS, developing airspace enlargement following only 1 month of exposure. These results implicate DHCs, in particular, C24-DHC, as protective against CS toxicity by enhancing autophagy, where as C16-Cer accumulation contributes to mitochondrial damage and PINK1-mediated necroptosis, which may be amplified by the inhibition of C24-DHC-producing CerS2.	[Mizumura, Kenji; Choi, Augustine M. K.] New York Presbyterian Hosp, Weill Cornell Med Coll, Joan & Sanford I Weill Dept Med, New York, NY USA; [Mizumura, Kenji] Nihon Univ, Sch Med, Div Resp Med, Tokyo, Japan; [Justice, Matthew J.; Schweitzer, Kelly S.; Krishnan, Sheila; Petrache, Irina] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Justice, Matthew J.; Schweitzer, Kelly S.; Krishnan, Sheila; Petrache, Irina] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Justice, Matthew J.; Schweitzer, Kelly S.; Bronova, Irina; Berdyshev, Evgeny V.; Petrache, Irina] Natl Jewish Hlth, Denver, CO USA; [Bronova, Irina; Berdyshev, Evgeny V.] Univ Illinois, Dept Med, Chicago, IL USA; [Hubbard, Walter C.] Johns Hopkins Univ, Dept Clin Pharmacol, Baltimore, MD USA; [Pewzner-Jung, Yael; Futerman, Anthony H.] Weizmann Inst Sci, Dept Biomol Sci, Rehovot, Israel	Cornell University; NewYork-Presbyterian Hospital; Nihon University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; National Jewish Health; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Johns Hopkins University; Weizmann Institute of Science	Petrache, I (corresponding author), Natl Jewish Hlth, Div Pulm Crit Care & Sleep Med, 1400 Jackson St,J203, Denver, CO 80206 USA.	petrachei@njhealth.org	Petrache, Irina/AAZ-9648-2020; Pewzner, Faivish/I-6225-2017	Pewzner, Faivish/0000-0002-7490-8121; Futerman, Anthony/0000-0003-0013-0115; Mizumura, Kenji/0000-0001-8532-9670	U.S. National Institute of Health, National Heart, Lung, and Blood Institute [RO1HL077328, F31HL126459, P01HL114501, R01HL132198]; Binational Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077328, F31HL126459, R01HL132198, P01HL114501] Funding Source: NIH RePORTER	U.S. National Institute of Health, National Heart, Lung, and Blood Institute; Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors acknowledge the support from U.S. National Institute of Health, National Heart, Lung, and Blood Institute Grants RO1HL077328 (to I.P.), F31HL126459 (to M.J.J.), and P01HL114501 and R01HL132198 (to A.M.K.C.); and support from the Binational Science Foundation (to I.P. and A.H.F.). K.M. and M.J.J. are cofirst authors on this manuscript. The authors declare no conflicts of interest.	Ahmad T, 2015, FASEB J, V29, P2912, DOI 10.1096/fj.14-268276; Arena G, 2017, J PATHOL, V241, P251, DOI 10.1002/path.4815; Chen ZH, 2010, P NATL ACAD SCI USA, V107, P18880, DOI 10.1073/pnas.1005574107; Chen ZH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003316; Clauss M, 2011, J CLIN INVEST, V121, P2470, DOI 10.1172/JCI43881; Devlin CM, 2011, J BIOL CHEM, V286, P38069, DOI 10.1074/jbc.M111.297994; Dorn GW, 2015, CIRC RES, V116, P167, DOI 10.1161/CIRCRESAHA.116.303554; Elias JA, 2005, NAT MED, V11, P471, DOI 10.1038/nm0505-471; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Jiang WH, 2014, BBA-MOL CELL BIOL L, V1841, P783, DOI 10.1016/j.bbalip.2013.09.005; Kamocki K, 2013, AM J RESP CELL MOL, V48, P87, DOI 10.1165/rcmb.2012-0254OC; Kitada T, 2007, P NATL ACAD SCI USA, V104, P11441, DOI 10.1073/pnas.0702717104; Lam HC, 2013, J CLIN INVEST, V123, P5212, DOI 10.1172/JCI69636; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050; Medler TR, 2008, AM J RESP CELL MOL, V38, P639, DOI 10.1165/rcmb.2007-0274OC; Mizumura K, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00244; Mizumura K, 2014, J CLIN INVEST, V124, P3987, DOI 10.1172/JCI74985; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Petrache I, 2016, ANNU REV PHYSIOL, V78, P463, DOI 10.1146/annurev-physiol-021115-105221; Petrache I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062968; Petrusca DN, 2014, AM J RESP CELL MOL, V50, P513, DOI 10.1165/rcmb.2013-0023OC; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059; Spassieva SD, 2009, BIOCHEM J, V424, P273, DOI 10.1042/BJ20090699; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Tuder RM, 2012, J CLIN INVEST, V122, P2749, DOI 10.1172/JCI60324; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zigdon H, 2013, J BIOL CHEM, V288, P4947, DOI 10.1074/jbc.M112.402719	33	39	39	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1880	1890		10.1096/fj.201700571R	http://dx.doi.org/10.1096/fj.201700571R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29196503	Green Published			2022-12-28	WOS:000429051400012
J	Li, XY; Zhang, Y; Wang, XX; Jin, C; Wang, YQ; Sun, TC; Li, J; Tang, JX; Batool, A; Deng, SL; Chen, SR; Cheng, CY; Liu, YX				Li, Xiao-Yu; Zhang, Yan; Wang, Xiu-Xia; Jin, Cheng; Wang, Yu-Qian; Sun, Tie-Cheng; Li, Jian; Tang, Ji-Xin; Batool, Alia; Deng, Shou-Long; Chen, Su-Ren; Cheng, C. Yan; Liu, Yi-Xun			Regulation of blood-testis barrier assembly in vivo by germ cells	FASEB JOURNAL			English	Article						tight junction; testosterone; claudin 3	SPERMATOGONIAL STEM-CELLS; C-KIT; SERTOLI; PROLIFERATION; EXPRESSION; ANDROGENS; RAT	The assembly of the blood-testis barrier (BTB) during postnatal development is crucial to support meiosis. However, the role of germcells in BTB assembly remains unclear. Herein, Kit(W)/Kit(WV) micewere used as a study model. These mice were infertile, failing to establish a functional BTB to support meiosis due to c-Kit mutation. Tra nsplantation of undifferentiated spermatogonia derived from normal mice into the testis of Kit(W)/Kit(WV) mice triggered functional BTB assembly, displaying cyclic remodeling during the epithelial cycle. Also, transplanted germ cells were capable of inducing Leydig cell testosterone production, which could enhance the expression of integral membrane protein claudin 3 in Sertoli cells. Early spermatocytes were shown to play a vital role in directing BTB assembly by expressing claudin 3, which likely created a transient adhesion structure to mediate BTB and cytoskeleton assembly in adjacent Sertoli cells. In summary, the positive modulation of germcells on somatic cell function provides useful information regarding somatic-germ cell interactions.	[Li, Xiao-Yu; Zhang, Yan; Wang, Xiu-Xia; Jin, Cheng; Wang, Yu-Qian; Sun, Tie-Cheng; Li, Jian; Tang, Ji-Xin; Batool, Alia; Deng, Shou-Long; Chen, Su-Ren; Liu, Yi-Xun] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing, Peoples R China; [Li, Xiao-Yu; Sun, Tie-Cheng; Li, Jian; Tang, Ji-Xin; Batool, Alia] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhang, Yan] Changsha Reprod Med Hosp, Changsha, Hunan, Peoples R China; [Cheng, C. Yan] Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, New York, NY 10065 USA	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Population Council	Cheng, CY (corresponding author), Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, New York, NY 10065 USA.; Liu, YX (corresponding author), Chinese Acad Sci, Inst Zool, 1 Beichen West Rd, Beijing 100101, Peoples R China.	liuyx@ioz.ac.cn	Deng, Shou-Long/GWV-0452-2022; deng, shoulong/GWV-0293-2022; Chen, Su-Ren/S-1025-2017	Chen, Su-Ren/0000-0002-9337-5412; Cheng, C Yan/0000-0003-3117-3791; deng, shou-long/0000-0003-1187-3037; Li, Xiaoyu/0000-0002-0241-6152	Major Research Plan 973 Project [2012CB944702]; Natural Science Foundation of China [31501161, 31501953, 31471352, 31471400, 81270662, 31171380]; Clinical Capability Construction Project for Liaoning Provincial Hospitals [LNCCC-C09-2015, LNCCC-D50-2015]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056034] Funding Source: NIH RePORTER	Major Research Plan 973 Project; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Clinical Capability Construction Project for Liaoning Provincial Hospitals; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from Major Research Plan 973 Project (2012CB944702), Natural Science Foundation of China (31501161, 31501953, 31471352, 31471400, 81270662, and 31171380), Clinical Capability Construction Project for Liaoning Provincial Hospitals (LNCCC-C09-2015, LNCCC-D50-2015), and Academician Workstation Support (Shenyang, Changsha, and Shandong). The authors declare no conflicts of interest.	BERGMANN M, 1983, ANAT EMBRYOL, V168, P269, DOI 10.1007/BF00315821; BESMER P, 1993, DEVELOPMENT, P125; BYERS S, 1991, AM J ANAT, V191, P35, DOI 10.1002/aja.1001910104; Chakraborty P, 2014, MOL ENDOCRINOL, V28, P1055, DOI 10.1210/me.2013-1134; Chihara M, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.107847; DYM M, 1977, BIOL REPROD, V17, P390, DOI 10.1095/biolreprod17.3.390; Kaitu'u-Lino TJ, 2007, REPRODUCTION, V133, P1169, DOI 10.1530/REP-06-0385; Kubota H, 2009, BIOL REPROD, V81, P293, DOI 10.1095/biolreprod.109.075960; Meng J, 2005, P NATL ACAD SCI USA, V102, P16696, DOI 10.1073/pnas.0506084102; Mitic LL, 2000, AM J PHYSIOL-GASTR L, V279, pG250, DOI 10.1152/ajpgi.2000.279.2.G250; Morrow CMK, 2009, BIOL REPROD, V81, P871, DOI 10.1095/biolreprod.109.077040; Mruk DD, 2004, ENDOCR REV, V25, P747, DOI 10.1210/er.2003-0022; Mruk DD, 2015, ENDOCR REV, V36, P681, DOI [10.1210/er.2015-1127, 10.1210/er.2014-1101]; Nagano M, 1999, BIOL REPROD, V60, P1429, DOI 10.1095/biolreprod60.6.1429; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; Ohta H, 2003, BIOL REPROD, V69, P1815, DOI 10.1095/biolreprod.103.019323; Schrans-Stassen BHGJ, 1999, ENDOCRINOLOGY, V140, P5894, DOI 10.1210/en.140.12.5894; Smith BE, 2012, SCIENCE, V338, P798, DOI 10.1126/science.1219969; SU L, 2014, SPERMATOGENESIS, V3, DOI DOI 10.4161/SPMG.26460; Su LL, 2010, EXP CELL RES, V316, P2945, DOI 10.1016/j.yexcr.2010.07.018; Takashima S, 2011, CELL STEM CELL, V9, P463, DOI 10.1016/j.stem.2011.08.011; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Wang SY, 2016, INT J DISTRIB SENS N, DOI 10.1155/2016/3159805; WEBER JE, 1987, AM J ANAT, V180, P1, DOI 10.1002/aja.1001800102; Wen Q, 2014, AM J PHYSIOL-ENDOC M, V307, pE1131, DOI 10.1152/ajpendo.00425.2014; Zhang Y, 2012, CELL RES, V22, P773, DOI 10.1038/cr.2012.17	26	21	23	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1653	1664		10.1096/fj.201700681R	http://dx.doi.org/10.1096/fj.201700681R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29183964	Green Published			2022-12-28	WOS:000427246000042
J	Andressen, KW; Ulsund, AH; Krobert, KA; Lohse, MJ; Bunemann, M; Levy, FO				Andressen, Kjetil Wessel; Ulsund, Andrea Hembre; Krobert, Kurt A.; Lohse, Martin J.; Buenemann, Moritz; Levy, Finn Olav			Related GPCRs couple differently to G(s): preassociation between G protein and 5-HT7 serotonin receptor reveals movement of Gas upon receptor activation	FASEB JOURNAL			English	Article						Gnas; precoupling; collision coupling; FRET; FRAP	HETEROTRIMERIC G-PROTEINS; ADRENERGIC-RECEPTOR; ADENYLATE-CYCLASE; SPLICE VARIANTS; ASSOCIATION; PHARMACOLOGY; DYNAMICS; CELL	How GPCRs and G proteins interact is important for their biologic functions and their functions as pharmacologic targets. It is still an open question whether receptors and G proteins are preassembled in a complex or interact only after receptor activation. We compared the propensity of the two G(s)-coupled serotonin (5-HT) receptors 5-HT4 and 5-HT7 to associate with G protein prior to agonist activation. Combining receptor-immobilized fluorescence recovery after photobleaching and fluorescence resonance energy transfer methodologies, we observed that 5-HT7 receptors markedly reduced the diffusion of both G alpha and G beta gamma at the cell surface, which indicated 5-HT7 receptor preassociation with G(s). This is in sharp contrast to the 5-HT4 receptor for which the diffusion of Ga beta gamma was not modified, and agonist activation brought together the receptor and G gamma, which is consistent with interaction by collision coupling. Agonist activation of 5-HT7 dissociated G gamma from the receptor, whereas Gas underwent a rapid conformational change with respect to both G gamma and the receptor, followed by a slower dissociation of G gamma from both G alpha(s) and the receptor. Taken together, these data demonstrate a different propensity among receptors to preassociate with G protein in the absence of ligand and reveals a rapid conformational change in G alpha(s) upon activation by the receptor.	[Andressen, Kjetil Wessel; Ulsund, Andrea Hembre; Krobert, Kurt A.; Levy, Finn Olav] Univ Oslo, Dept Pharmacol, Inst Clin Med, Oslo, Norway; [Andressen, Kjetil Wessel; Ulsund, Andrea Hembre; Krobert, Kurt A.; Levy, Finn Olav] Univ Oslo, Ctr Heart Failure Res, Fac Med, Oslo, Norway; [Andressen, Kjetil Wessel; Ulsund, Andrea Hembre; Krobert, Kurt A.; Levy, Finn Olav] Oslo Univ Hosp, Oslo, Norway; [Lohse, Martin J.] Univ Wurzburg, Inst Pharmacol & Toxicol, Wurzburg, Germany; [Lohse, Martin J.] Univ Wurzburg, Rudolf Virchow Ctr, Wurzburg, Germany; [Buenemann, Moritz] Univ Wurzburg, Comprehens Heart Failure Ctr, Wurzburg, Germany; [Lohse, Martin J.] Max Delbruck Ctr, Berlin, Germany; [Buenemann, Moritz] Philipps Univ Marburg, Inst Pharmacol & Clin Pharm, Marburg, Germany	University of Oslo; University of Oslo; University of Oslo; University of Wurzburg; University of Wurzburg; University of Wurzburg; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Philipps University Marburg	Levy, FO (corresponding author), Univ Oslo, Dept Pharmacol, Fac Med, Sognsvannsveien 20,POB 1057, N-0316 Oslo, Norway.	f.o.levy@medisin.uio.no	Lohse, Martin J/A-7160-2012	Lohse, Martin J/0000-0002-0599-3510; Andressen, Kjetil Wessel/0000-0003-1094-1501	Norwegian Council on Cardiovascular Diseases; Research Council of Norway; Kristian Gerhard Jebsen Foundation; Norwegian Cancer Society; Anders Jahre Foundation for the Promotion of Science; Novo Nordisk Foundation; Family Blix Foundation; University of Oslo; Deutsche Forschungsgemeinschaft [SFB487, TR166, 593]; European Research Council Advanced grant "Topas"; Bundesministerium fur Bildung und Forschung grant "OptiMAR"; COST Action CM1207 (GLISTEN)	Norwegian Council on Cardiovascular Diseases; Research Council of Norway(Research Council of Norway); Kristian Gerhard Jebsen Foundation; Norwegian Cancer Society(Norwegian Cancer Society); Anders Jahre Foundation for the Promotion of Science; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Family Blix Foundation; University of Oslo; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council Advanced grant "Topas"; Bundesministerium fur Bildung und Forschung grant "OptiMAR"(Federal Ministry of Education & Research (BMBF)); COST Action CM1207 (GLISTEN)(European Cooperation in Science and Technology (COST))	The authors thank C. H. Berlot for providing the G alpha<INF>s</INF>-CFP plasmid (20) and N. A. Lambert for providing the G beta gamma-Venus plasmid (21). This work was supported by the Norwegian Council on Cardiovascular Diseases, the Research Council of Norway, the Kristian Gerhard Jebsen Foundation, the Norwegian Cancer Society, the Anders Jahre Foundation for the Promotion of Science, the Novo Nordisk Foundation, the Family Blix Foundation, grants from the University of Oslo, Deutsche Forschungsgemeinschaft (Grants SFB487, 593, and TR166), the European Research Council Advanced grant "Topas," and the Bundesministerium fur Bildung und Forschung grant "OptiMAR" and the COST Action CM1207 (GLISTEN; http://www.glisten-gpcr.eu). The authors declare no conflicts of interest.	Andressen KW, 2015, BRIT J PHARMACOL, V172, P3846, DOI 10.1111/bph.13169; Andressen KW, 2006, MOL PHARMACOL, V69, P207, DOI 10.1124/mol.105.015396; Ayoub MA, 2010, FASEB J, V24, P3522, DOI 10.1096/fj.10-154997; Azpiazu I, 2004, J BIOL CHEM, V279, P27709, DOI 10.1074/jbc.M403712200; Bach T, 2001, N-S ARCH PHARMACOL, V363, P146, DOI 10.1007/s002100000299; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Bockaert J, 2004, CNS NEUROL DISORD-DR, V3, P39, DOI 10.2174/1568007043482615; Bruheim S, 2003, RECEPTOR CHANNEL, V9, P107, DOI 10.1080/10606820308245; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; Damian M, 2015, P NATL ACAD SCI USA, V112, P1601, DOI 10.1073/pnas.1414618112; Dorsch S, 2009, NAT METHODS, V6, P225, DOI [10.1038/NMETH.1304, 10.1038/nmeth.1304]; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; Hynes TR, 2004, J BIOL CHEM, V279, P44101, DOI 10.1074/jbc.M405151200; Kilander MBC, 2014, FASEB J, V28, P2293, DOI 10.1096/fj.13-246363; Krobert KA, 2001, N-S ARCH PHARMACOL, V363, P620, DOI 10.1007/s002100000369; Krobert KA, 2002, BRIT J PHARMACOL, V135, P1563, DOI 10.1038/sj.bjp.0704588; Kvachnina E, 2005, J NEUROSCI, V25, P7821, DOI 10.1523/JNEUROSCI.1790-05.2005; Lohse MJ, 2015, MOL PHARMACOL, V88, P572, DOI 10.1124/mol.115.100248; Matthys A, 2011, MOL NEUROBIOL, V43, P228, DOI 10.1007/s12035-011-8175-3; Nobles M, 2005, P NATL ACAD SCI USA, V102, P18706, DOI 10.1073/pnas.0504778102; ORLY J, 1976, P NATL ACAD SCI USA, V73, P4410, DOI 10.1073/pnas.73.12.4410; Piscitelli CL, 2015, MOL PHARMACOL, V88, P536, DOI 10.1124/mol.115.099663; Qin K, 2008, FASEB J, V22, P2920, DOI 10.1096/fj.08-105775; Qin K, 2011, NAT CHEM BIOL, V7, P740, DOI [10.1038/nchembio.642, 10.1038/NCHEMBIO.642]; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Roka F, 1999, MOL PHARMACOL, V56, P1014, DOI 10.1124/mol.56.5.1014; SKOMEDAL T, 1980, ACTA PHARMACOL TOX, V46, P200; TOLKOVSKY AM, 1978, BIOCHEMISTRY-US, V17, P3795, DOI 10.1021/bi00611a020; Vasquez C, 1999, J NEUROSCI, V19, P9271	33	16	16	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					1059	1069		10.1096/fj.201700486R	http://dx.doi.org/10.1096/fj.201700486R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29079700	Green Submitted			2022-12-28	WOS:000425146900044
J	Angelova, DM; Jones, HBL; Brown, DR				Angelova, Dafina M.; Jones, Hannah B. L.; Brown, David R.			Levels of alpha- and beta-synuclein regulate cellular susceptibility to toxicity from alpha-synuclein oligomers	FASEB JOURNAL			English	Article						FoxO3a; iron; Parkinson disease	FOXO TRANSCRIPTION FACTORS; NIGRAL IRON CONTENT; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASES; IN-VIVO; PHOSPHATIDYLINOSITOL 3-KINASE; FERRIREDUCTASE ACTIVITY; DOPAMINERGIC-NEURONS; PRESYNAPTIC PROTEIN	alpha-Synuclein (alpha-syn) is associated with a range of diseases, including Parkinson disease. In disease, alpha-syn is known to aggregate and has the potential to be neurotoxic. The association between copper and alpha-syn results in the formation of stellate toxic oligomers that are highly toxic to cultured neurons. We further investigated the mechanism of toxicity of alpha-syn oligomers. Cells that overexpress alpha-syn showed increased susceptibility to the toxicity of the oligomers, while those that overexpressed beta-syn showed increased resistance to the toxic oligomers. Elevated alpha-syn expression caused an increase in expression of the transcription factor Forkhead box O3a (FoxO3a). Inhibition of FoxO3a activity by the overexpression of DNA binding domain of FoxO3a resulted in significant protection from a-syn oligomer toxicity. Increased FoxO3a expression in cells was shown to be caused by increased ferrireductase activity and Fe(II) levels. These results suggest that alpha-syn increases FoxO3a expression as a result of its intrinsic ferrireductase activity. The results also suggest that FoxO3a plays a pivotal role in the toxicity of both Fe(II) and toxic alpha-syn species to neuronal cells.	[Angelova, Dafina M.; Jones, Hannah B. L.; Brown, David R.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Bath	Brown, DR (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	bssdrb@bath.ac.uk		Jones, Hannah/0000-0002-7834-0625				Ackerman D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002498; Albani D, 2004, FASEB J, V18, P1713, DOI 10.1096/fj.04-1621fje; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Binolfi A, 2006, J AM CHEM SOC, V128, P9893, DOI 10.1021/ja0618649; Bodles AM, 2000, EUR J BIOCHEM, V267, P2186, DOI 10.1046/j.1432-1327.2000.01219.x; Brown JWP, 2016, SCI REP-UK, V6, DOI 10.1038/srep36010; Carboni E, 2015, METALLOMICS, V7, P395, DOI 10.1039/c4mt00339j; Chen L, 2007, J BIOL CHEM, V282, P5582, DOI 10.1074/jbc.M609273200; Chiba-Falek O, 2006, MOVEMENT DISORD, V21, P1703, DOI 10.1002/mds.21007; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Davies P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015814; Davies P, 2011, BIOCHEMISTRY-US, V50, P37, DOI 10.1021/bi101582p; Dettmer U, 2013, J BIOL CHEM, V288, P6371, DOI 10.1074/jbc.M112.403311; Dexter DT, 2011, J NEURAL TRANSM, V118, P223, DOI 10.1007/s00702-010-0531-3; DEXTER DT, 1987, LANCET, V2, P1219; DEXTER DT, 1992, ANN NEUROL, V32, pS94, DOI 10.1002/ana.410320716; DEXTER DT, 1990, J NEUROCHEM, V55, P16, DOI 10.1111/j.1471-4159.1990.tb08814.x; DEXTER DT, 1989, J NEUROCHEM, V52, P1830, DOI 10.1111/j.1471-4159.1989.tb07264.x; DEXTER DT, 1991, BRAIN, V114, P1953, DOI 10.1093/brain/114.4.1953; DEXTER DT, 1993, ADV NEUROL, V60, P273; Du HN, 2003, BIOCHEMISTRY-US, V42, P8870, DOI 10.1021/bi034028+; Duda JE, 2000, J NEUROSCI RES, V61, P121, DOI 10.1002/1097-4547(20000715)61:2<121::AID-JNR1>3.0.CO;2-4; El-Agnaf OMA, 2000, J STRUCT BIOL, V130, P300, DOI 10.1006/jsbi.2000.4262; El-Agnaf OMA, 1998, FEBS LETT, V440, P71, DOI 10.1016/S0014-5793(98)01418-5; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Febbraro F, 2013, EXP NEUROL, V247, P45, DOI 10.1016/j.expneurol.2013.03.017; Forloni G, 2000, ANN NEUROL, V47, P632, DOI 10.1002/1531-8249(200005)47:5<632::AID-ANA11>3.3.CO;2-E; Gaugler MN, 2012, ACTA NEUROPATHOL, V123, P653, DOI 10.1007/s00401-012-0963-y; Golts N, 2002, J BIOL CHEM, V277, P16116, DOI 10.1074/jbc.M107866200; Haigh CL, 2006, J NEUROCHEM, V98, P677, DOI 10.1111/j.1471-4159.2006.03906.x; Hashimoto M, 2004, J BIOL CHEM, V279, P23622, DOI 10.1074/jbc.M313784200; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; Hayashita-Kinoh H, 2006, BIOCHEM BIOPH RES CO, V341, P1088, DOI 10.1016/j.bbrc.2006.01.057; He Q, 2011, J NEURAL TRANSM, V118, P397, DOI 10.1007/s00702-010-0453-0; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Janowska MK, 2015, SCI REP-UK, V5, DOI 10.1038/srep15164; Klotz LO, 2015, REDOX BIOL, V6, P51, DOI 10.1016/j.redox.2015.06.019; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lee EN, 2003, J NEUROCHEM, V84, P1128, DOI 10.1046/j.1471-4159.2003.01612.x; Lee EN, 2004, BIOCHEMISTRY-US, V43, P3704, DOI 10.1021/bi0356707; Li WX, 2004, J NEUROSCI, V24, P7400, DOI 10.1523/JNEUROSCI.1370-04.2004; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Maiese Kenneth, 2016, J Transl Sci, V2, P241; Uranga RM, 2013, J BIOL CHEM, V288, P19773, DOI 10.1074/jbc.M113.457622; Uranga RM, 2009, TOXICOL SCI, V111, P331, DOI 10.1093/toxsci/kfp152; Martins R, 2016, AGING CELL, V15, P196, DOI 10.1111/acel.12427; Masliah E, 1996, AM J PATHOL, V148, P201; Mateos MV, 2008, NEUROCHEM INT, V53, P199, DOI 10.1016/j.neuint.2008.07.005; McDowall JS, 2017, MOL CELL NEUROSCI, V85, P1, DOI 10.1016/j.mcn.2017.08.001; McDowall JS, 2017, BIOCHEMISTRY-US, V56, P2497, DOI 10.1021/acs.biochem.7b00257; Ostrerova-Golts N, 2000, J NEUROSCI, V20, P6048, DOI 10.1523/JNEUROSCI.20-16-06048.2000; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; PALL HS, 1987, LANCET, V2, P238; Park JY, 2003, BIOCHEMISTRY-US, V42, P3696, DOI 10.1021/bi020604a; Pino E, 2014, HUM MOL GENET, V23, P1435, DOI 10.1093/hmg/ddt530; Puukila S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122852; Rasia RM, 2005, P NATL ACAD SCI USA, V102, P4294, DOI 10.1073/pnas.0407881102; Roberts HL, 2015, BIOMOLECULES, V5, P282, DOI 10.3390/biom5020282; Rockenstein E, 2001, BRAIN RES, V914, P48, DOI 10.1016/S0006-8993(01)02772-X; Roostaee A, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-5; Sendamarai AK, 2008, P NATL ACAD SCI USA, V105, P7410, DOI 10.1073/pnas.0801318105; Seo JH, 2002, FASEB J, V16, P1826, DOI 10.1096/fj.02-0041fje; Shaltiel-Karyo R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013863; Sidhu A, 2004, FASEB J, V18, P637, DOI 10.1096/fj.03-1112rev; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Snyder H, 2005, J BIOL CHEM, V280, P7562, DOI 10.1074/jbc.M412887200; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Su B, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-32; Sung JY, 2001, J BIOL CHEM, V276, P27441, DOI 10.1074/jbc.M101318200; Tsigelny IF, 2007, FEBS J, V274, P1862, DOI 10.1111/j.1742-4658.2007.05733.x; Tsigelny IF, 2012, FEBS J, V279, P1000, DOI 10.1111/j.1742-4658.2012.08489.x; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200; Volles MJ, 2003, BIOCHEMISTRY-US, V42, P7871, DOI 10.1021/bi030086j; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Wang XY, 2010, J NEUROCHEM, V113, P704, DOI 10.1111/j.1471-4159.2010.06638.x; Windisch M, 2004, J MOL NEUROSCI, V24, P155, DOI 10.1385/JMN:24:1:155; Wright JA, 2013, MOL CELL NEUROSCI, V57, P33, DOI 10.1016/j.mcn.2013.09.002; Wright JA, 2009, FASEB J, V23, P2384, DOI 10.1096/fj.09-130039; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	84	5	5	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					995	1006		10.1096/fj.201700675R	http://dx.doi.org/10.1096/fj.201700675R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29054856	Green Submitted, Bronze			2022-12-28	WOS:000425146900039
J	Karasik, A; Ledwitch, KV; Aranyi, T; Varadi, A; Roberts, A; Szeri, F				Karasik, Agnes; Ledwitch, Kaitlyn Victoria; Aranyi, Tamas; Varadi, Andras; Roberts, Arthur; Szeri, Flora			Boosted coupling of ATP hydrolysis to substrate transport upon cooperative estradiol-17-beta-D-glucuronide binding in a Drosophila ATP binding cassette type-C transporter	FASEB JOURNAL			English	Article						E(2)G transport; kinetic modeling; COPASI; allosteric cooperativity; Drosophila MRP	MULTIDRUG-RESISTANCE PROTEIN; ABC TRANSPORTER; STRUCTURAL BASIS; ORGANIC-ANIONS; P-GLYCOPROTEIN; HUMAN LIVER; 2ND DOMAIN; MRP1; GENE; EXPRESSION	ATP binding cassette type-C (ABCC) transporters move molecules across cell membranes upon hydrolysis of ATP; however, their coupling of ATP hydrolysis to substrate transport remains elusive. Drosophila multidrug resistance-associated protein (DMRP) is the functional ortholog of human long ABCC transporters, with similar substrate and inhibitor specificity, but higher activity. Exploiting its high activity, we kinetically dissected the catalytic mechanism of DMRP by using E-2-D-glucuronide (E(2)G), the physiologic substrate of human ABCC. We examined the DMRP-mediated interdependence of ATP and E(2)G in biochemical assays. We observed E(2)G-dependent ATPase activity to be biphasic at subsaturating ATP concentrations, which implies at least 2 E(2)G binding sites on DMRP. Furthermore, transport measurements indicated strong nonreciprocal cooperativity between ATP and E(2)G. In addition to confirming these findings, our kinetic modeling with the Complex Pathway Simulator indicated a 10-fold decrease in the E(2)G-mediated activation of ATP hydrolysis upon saturation of the second E(2)G binding site. Surprisingly, the binding of the second E(2)G allowed for substrate transport with a constant rate, which tightly coupled ATP hydrolysis to transport. In summary, we show that the second E(2)G binding-similar to human ABCC2-allosterically stimulates transport activity of DMRP. Our data suggest that this is achieved by a significant increase in the coupling of ATP hydrolysis to transport.	[Karasik, Agnes; Aranyi, Tamas; Varadi, Andras; Szeri, Flora] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary; [Ledwitch, Kaitlyn Victoria; Roberts, Arthur] Univ Georgia, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA; [Szeri, Flora] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA	Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; University System of Georgia; University of Georgia; Jefferson University	Szeri, F (corresponding author), Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Act Transport Prot Res Grp, Magyar Tudosok Korutja 2, H-1117 Budapest, Hungary.; Szeri, F (corresponding author), Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA.	szeri.flora@ttk.mta.hu	Szeri, Flóra/L-6162-2019; Aranyi, Tamas/AAJ-9629-2021; Szeri, Flora/AAD-3907-2021	Szeri, Flóra/0000-0003-2572-6820; Aranyi, Tamas/0000-0002-2087-6275; Szeri, Flora/0000-0003-2572-6820; Ledwitch, Kaitlyn/0000-0003-3791-7392	Hungarian Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA) [104227, 114336]; Hungarian National Research, Development, and Innovation Office [VKSz14-1-2015-0155]; Fulbright Research Scholar by the J. William Fulbright Foreign Scholarship Board; U.S. National Institutes of Health, National Cancer Institute [R01-CA204846-01A1]; NATIONAL CANCER INSTITUTE [R01CA204846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007491] Funding Source: NIH RePORTER	Hungarian Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian National Research, Development, and Innovation Office; Fulbright Research Scholar by the J. William Fulbright Foreign Scholarship Board; U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Steven Robinow (University of Hawaii, Honolulu, HI, USA) for sharing the plasmid with the wild-type DMRP sequence, and for the primary Ab against DMRP. The authors also thank Karoly Liliom (Semmelweis University, Budapest, Hungary) and Gergely Szakacs (Hungarian Academy of Sciences) for their insightful comments. The assistance of Gyorgyi Demeter (Hungarian Academy of Sciences) is greatly acknowledged. This work was supported by the Hungarian Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA) (Grants 104227 and 114336), Grant VKSz14-1-2015-0155 from the Hungarian National Research, Development, and Innovation Office, a grant from the Fulbright Research Scholar by the J. William Fulbright Foreign Scholarship Board, and U.S. National Institutes of Health, National Cancer Institute Grant R01-CA204846-01A1. The authors declare no conflicts of interest.	Al-Shawi MK, 2003, J BIOL CHEM, V278, P52629, DOI 10.1074/jbc.M308175200; Bakos E, 2000, MOL PHARMACOL, V57, P760, DOI 10.1124/mol.57.4.760; Bakos E, 2007, PFLUG ARCH EUR J PHY, V453, P621, DOI 10.1007/s00424-006-0160-8; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; Bodo A, 2003, TOXICOL LETT, V140, P133, DOI 10.1016/S0378-4274(02)00497-6; Bodo A, 2003, J BIOL CHEM, V278, P23529, DOI 10.1074/jbc.M303515200; Bridges CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073559; Chahine S, 2012, ARCH INSECT BIOCHEM, V81, P228, DOI 10.1002/arch.21066; Chen ZS, 2003, MOL PHARMACOL, V63, P351, DOI 10.1124/mol.63.2.351; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Cui YH, 1999, MOL PHARMACOL, V55, P929; Davydov DR, 2005, BIOPHYS J, V89, P418, DOI 10.1529/biophysj.104.058479; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; Dermauw W, 2014, INSECT BIOCHEM MOLEC, V45, P89, DOI 10.1016/j.ibmb.2013.11.001; Donner MG, 2001, HEPATOLOGY, V34, P351, DOI 10.1053/jhep.2001.26213; Ernst R, 2008, P NATL ACAD SCI USA, V105, P5069, DOI 10.1073/pnas.0800191105; Gao M, 2000, J BIOL CHEM, V275, P13098, DOI 10.1074/jbc.275.17.13098; Gerk PM, 2004, DRUG METAB DISPOS, V32, P1139, DOI 10.1124/dmd.104.000372; Grailles M, 2003, GENE, V307, P41, DOI 10.1016/S0378-1119(03)00455-4; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hitzl M, 2003, J PHARMACOL EXP THER, V304, P524, DOI 10.1124/jpet.102.043547; Hohl M, 2014, P NATL ACAD SCI USA, V111, P11025, DOI 10.1073/pnas.1400485111; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hopper-Borge EA, 2011, CANCER RES, V71, P3649, DOI 10.1158/0008-5472.CAN-10-3623; Hou YX, 2000, J BIOL CHEM, V275, P20280, DOI 10.1074/jbc.M001109200; Hou YX, 2003, J BIOL CHEM, V278, P3599, DOI 10.1074/jbc.M210480200; Hou YX, 2002, J BIOL CHEM, V277, P5110, DOI 10.1074/jbc.M107133200; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; Jansen RS, 2014, ARTERIOSCL THROM VAS, V34, P1985, DOI 10.1161/ATVBAHA.114.304017; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Jones PM, 1999, FEMS MICROBIOL LETT, V179, P187, DOI 10.1111/j.1574-6968.1999.tb08727.x; Keppler D, 1997, BIOL CHEM, V378, P787; Ledwitch KV, 2016, BIOCHEM PHARMACOL, V118, P96, DOI 10.1016/j.bcp.2016.08.013; Ledwitch KV, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20150317; Li QL, 2016, J INVEST DERMATOL, V136, P550, DOI 10.1016/j.jid.2015.10.065; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Loe DW, 1996, J BIOL CHEM, V271, P9683, DOI 10.1074/jbc.271.16.9683; Matsuo M, 1999, J BIOL CHEM, V274, P37479, DOI 10.1074/jbc.274.52.37479; MAYER R, 1995, J CELL BIOL, V131, P137, DOI 10.1083/jcb.131.1.137; Nagata K, 2000, J BIOL CHEM, V275, P17626, DOI 10.1074/jbc.M000792200; Paulusma CC, 1996, SCIENCE, V271, P1126, DOI 10.1126/science.271.5252.1126; Payen LF, 2003, J BIOL CHEM, V278, P38537, DOI 10.1074/jbc.M305786200; Perez C, 2017, SCI REP-UK, V7, DOI 10.1038/srep46641; Prince L, 2014, TOXICOL SCI, V140, P425, DOI 10.1093/toxsci/kfu095; Procko E, 2006, MOL CELL, V24, P51, DOI 10.1016/j.molcel.2006.07.034; Roberts AG, 2011, BIOCHEMISTRY-US, V50, P10804, DOI 10.1021/bi200924t; SARKADI B, 1992, J BIOL CHEM, V267, P4854; Scheffer GL, 2002, LAB INVEST, V82, P193, DOI 10.1038/labinvest.3780411; Segel IH., 1993, ENZYME KINETICS BEHA; Shapiro AB, 1998, ACTA PHYSIOL SCAND, V163, P227; Slot AJ, 2011, ESSAYS BIOCHEM, V50, P179, DOI [10.1042/BSE0500179, 10.1042/bse0500179]; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Szakacs G, 2001, BIOCHEM J, V356, P71, DOI 10.1042/0264-6021:3560071; Szeri F, 2009, BBA-BIOMEMBRANES, V1788, P402, DOI 10.1016/j.bbamem.2008.11.007; Takikawa H, 1996, HEPATOLOGY, V23, P607; Tarnay JN, 2004, INSECT MOL BIOL, V13, P539, DOI 10.1111/j.0962-1075.2004.00512.x; Timachi MH, 2017, ELIFE, V6, DOI 10.7554/eLife.20236; Tusnady GE, 1997, FEBS LETT, V402, P1, DOI 10.1016/S0014-5793(96)01478-0; Vore M, 1997, DRUG METAB REV, V29, P183, DOI 10.3109/03602539709037580; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Yang RY, 2003, J BIOL CHEM, V278, P30764, DOI 10.1074/jbc.M304118200; Zeng H, 2000, CANCER RES, V60, P4779; Zhang XJC, 2016, PROTEIN CELL, V7, P17, DOI 10.1007/s13238-015-0211-z	65	1	1	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					669	680		10.1096/fj.201700606R	http://dx.doi.org/10.1096/fj.201700606R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	28939593	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000425146900012
J	Miranda, BH; Charlesworth, MR; Tobin, DJ; Sharpe, DT; Randall, VA				Miranda, Benjamin H.; Charlesworth, Matthew R.; Tobin, Desmond J.; Sharpe, David T.; Randall, Valerie A.			Androgens trigger different growth responses in genetically identical human hair follicles in organ culture that reflect their epigenetic diversity in life	FASEB JOURNAL			English	Article						alopecia; balding; hirsutism; model system; intermediate hair follicles	DERMAL PAPILLA CELLS; NON-GENOMIC ACTIONS; PUBERTAL CHANGES; STEM-CELLS; IN-VITRO; RECEPTORS; REGENERATION; CONTAIN; INDUCE; NICHE	Male sex hormones-androgens-regulate male physique development. Without androgen signaling, genetic males appear female. During puberty, increasing androgens harness the hair follicle's unique regenerative ability to replace many tiny vellus hairs with larger, darker terminal hairs (e.g., beard). Follicle response is epigenetically varied: some remain unaffected (e.g., eyelashes) or are inhibited, causing balding. How sex steroid hormones alter such developmental processes is unclear, despite high incidences of hormone-driven cancer, hirsutism, and alopecia. Unfortunately, existing development models are not androgen sensitive. Here, we use hair follicles to establish an androgen-responsive human organ culture model. We show that women's intermediate facial follicles respond to men's higher androgen levels by synthesizing more hair over several days, unlike donor-matched, androgen-insensitive, terminal follicles. We demonstrate that androgen receptors-androgen-activated gene transcription regulators-are required and are present in vivo within these follicles. This is the first human organ that involves multiple cell types that responds appropriately to hormones in prolonged culture, in a way which mirrors its natural behavior. Thus, intermediate hair follicles offer a hormone-switchable human model with exceptional, unique availability of genetically identical, but epigenetically hormone-insensitive, terminal follicles. This should enable advances in understanding sex steroid hormone signaling, gene regulation, and developmental and regenerative systems and facilitate better therapies for hormone-dependent disorders.	[Miranda, Benjamin H.; Charlesworth, Matthew R.; Tobin, Desmond J.; Sharpe, David T.; Randall, Valerie A.] Univ Bradford, Ctr Skin Sci, Bradford, W Yorkshire, England; [Miranda, Benjamin H.; Sharpe, David T.] Univ Bradford, Plast Surg & Burns Res Unit, Bradford, W Yorkshire, England	University of Bradford; University of Bradford	Randall, VA (corresponding author), Univ Bradford, Ctr Skin Sci, Fac Life Sci, Richmond Rd, Bradford BD7 1DP, W Yorkshire, England.	v.a.randall@bradford.ac.uk	Miranda, BEN/AAV-3434-2020; Tobin, Desmond/A-5228-2009	Miranda, BEN/0000-0002-6403-546X; Tobin, Desmond/0000-0003-4566-9392	Plastic Surgery and Burns Research Unit; Faculty of Life Sciences at the University of Bradford (Bradford, United Kingdom)	Plastic Surgery and Burns Research Unit; Faculty of Life Sciences at the University of Bradford (Bradford, United Kingdom)	The authors thank the Plastic Surgery and Burns Research Unit and the Faculty of Life Sciences at the University of Bradford (Bradford, United Kingdom) for financial support for B.H.M. and M.R.C., respectively. The authors declare no conflicts of interest.	Adam RC, 2015, NATURE, V521, P366, DOI 10.1038/nature14289; Ando Y, 1999, BRIT J DERMATOL, V141, P840, DOI 10.1046/j.1365-2133.1999.03156.x; AUBER L., 1952, TRANS ROY SOC EDINBURGH, V62, P191; Bieche I, 2001, CARCINOGENESIS, V22, P1521, DOI 10.1093/carcin/22.9.1521; Bunagan MJK, 2013, DERMATOL CLIN, V31, P141, DOI 10.1016/j.det.2012.08.012; Cash TF, 2001, CLIN DERMATOL, V19, P161, DOI 10.1016/S0738-081X(00)00127-9; Castoria G, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.497; Chen CC, 2016, J MOL BIOL, V428, P1423, DOI 10.1016/j.jmb.2015.07.009; Chi W, 2015, EXP DERMATOL, V24, P265, DOI 10.1111/exd.12608; Chuong CM, 2012, PHYSIOLOGY, V27, P61, DOI 10.1152/physiol.00028.2011; CROFT NJ, 2003, HAIR SCI TECHNOLOGY, P69; Cunha GR, 2011, DIFFERENTIATION, V82, P168, DOI 10.1016/j.diff.2011.04.002; Driskell RR, 2012, J INVEST DERMATOL, V132, P1084, DOI 10.1038/jid.2011.428; Foradori CD, 2008, FRONT NEUROENDOCRIN, V29, P169, DOI 10.1016/j.yfrne.2007.10.005; Girman CJ, 1998, DERMATOLOGY, V197, P223, DOI 10.1159/000018001; HAMILTON JB, 1951, ANN NY ACAD SCI, V53, P708, DOI 10.1111/j.1749-6632.1951.tb31971.x; HAMILTON JB, 1958, BIOL HAIR GROWTH, P399, DOI DOI 10.1016/B978-1-4832-3287-4.50022-2; Handesman D., 2001, ENDOCRINOLOGY, P2232; Hibberts NA, 1998, J ENDOCRINOL, V156, P59, DOI 10.1677/joe.0.1560059; Higgins CA, 2013, P NATL ACAD SCI USA, V110, P19679, DOI 10.1073/pnas.1309970110; Higgins CA, 2009, J INVEST DERMATOL, V129, P2100, DOI 10.1038/jid.2009.66; Hughes IA, 2012, SEMIN REPROD MED, V30, P432, DOI [10.1055/s-0032-1324728, 10.1016/S0140-6736(12)60071-3]; ITAMI S, 1995, BRIT J DERMATOL, V132, P527; Jansen VAA, 2006, NATURE, V440, P663, DOI 10.1038/nature04387; Khidhir KG, 2013, FASEB J, V27, P557, DOI 10.1096/fj.12-218156; Lay K, 2016, P NATL ACAD SCI USA, V113, pE1506, DOI 10.1073/pnas.1601569113; Leach DA, 2015, ONCOTARGET, V6, P16135, DOI 10.18632/oncotarget.3873; Lee SH, 2015, STEM CELLS, V33, P3356, DOI 10.1002/stem.2096; Lei MX, 2016, SCIENCE, V351, P559, DOI 10.1126/science.aaf1635; Lien WH, 2014, NAT CELL BIOL, V16, P179, DOI 10.1038/ncb2903; Lin SJ, 2013, SCIENCE, V340, P1442, DOI 10.1126/science.1230374; Linke T, 2011, METHODS MOL BIOL, V776, P225, DOI 10.1007/978-1-61779-243-4_14; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Martin KA, 2008, J CLIN ENDOCR METAB, V93, P1105, DOI 10.1210/jc.2007-2437; McElwee KJ, 2003, J INVEST DERMATOL, V121, P1267, DOI 10.1111/j.1523-1747.2003.12568.x; Miranda BH, 2010, BRIT J DERMATOL, V163, P287, DOI 10.1111/j.1365-2133.2010.09867.x; Morgan B. A., 2014, PERSPECT MED, V4; Randall V. A., 2012, TESTOSTERONE ACTION, P154; RANDALL VA, 1992, J ENDOCRINOL, V133, P141, DOI 10.1677/joe.0.1330141; Randall VA, 2005, ENDOCRINOLOGY, P3295; Randall VA, 2008, DERMATOL THER, V21, P314, DOI 10.1111/j.1529-8019.2008.00214.x; Randall VA, 2007, SEMIN CELL DEV BIOL, V18, P274, DOI 10.1016/j.semcdb.2007.02.004; Reynolds AJ, 1999, NATURE, V402, P33, DOI 10.1038/46938; Ricke EA, 2012, CARCINOGENESIS, V33, P1391, DOI 10.1093/carcin/bgs153; SAITOH M, 1970, J INVEST DERMATOL, V54, P65, DOI 10.1111/1523-1747.ep12551679; Sanders TA, 2013, NATURE, V497, P628, DOI 10.1038/nature12157; Shorter K, 2008, FASEB J, V22, P1725, DOI 10.1096/fj.07-099424; Thornton MJ, 2001, J ENDOCRINOL, V168, P401, DOI 10.1677/joe.0.1680401; Walker WH, 2009, STEROIDS, V74, P602, DOI 10.1016/j.steroids.2008.11.017; Wang C, 2014, INT J MOL SCI, V15, P15412, DOI 10.3390/ijms150915412; Wang XJ, 2014, J INVEST DERMATOL, V134, P736, DOI 10.1038/jid.2013.368	52	12	12	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					795	806		10.1096/fj.201700260RR	http://dx.doi.org/10.1096/fj.201700260RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29046359	Green Published, hybrid			2022-12-28	WOS:000425146900022
J	Maherally, Z; Fillmore, HL; Tan, SL; Tan, SF; Jassam, SA; Quack, FI; Hatherell, KE; Pilkington, GJ				Maherally, Zaynah; Fillmore, Helen L.; Tan, Sim Ling; Tan, Suk Fei; Jassam, Samah A.; Quack, Friederike I.; Hatherell, Kathryn E.; Pilkington, Geoffrey J.			Real-time acquisition of transendothelial electrical resistance in an all-human, in vitro, 3-dimensional, blood-brain barrier model exemplifies tight-junction integrity	FASEB JOURNAL			English	Article						neurovascular unit; extracellular matrix; central nervous system	CENTRAL-NERVOUS-SYSTEM; ASTROCYTE-ENDOTHELIAL INTERACTIONS; HEPARAN-SULFATE PROTEOGLYCAN; EXTRACELLULAR-MATRIX; CELL-LINE; FUNCTIONAL-CHARACTERIZATION; GROWTH-FACTOR; BASAL LAMINA; BBB MODEL; PERICYTES	The blood-brain barrier (BBB) consists of endothelial cells, astrocytes, and pericytes embedded in basal lamina (BL). Most in vitro models use nonhuman, monolayer cultures for therapeutic-delivery studies, relying on transendothelial electrical resistance (TEER) measurements without other tight-junction (TJ) formation parameters. We aimed to develop reliable, reproducible, in vitro 3-dimensional (3D) models incorporating relevant human, in vivo cell types and BL proteins. The 3D BBB models were constructed with human brain endothelial cells, human astrocytes, and human brain pericytes in mono-, co-, and tricultures. TEER was measured in 3D models using a volt/ohmmeter and cellZscope. Influence of BL proteins-laminin, fibronectin, collagen type IV, agrin, and perlecan-on adhesion and TEER was assessed using an electric cell-substrate impedance-sensing system. TJ protein expression was assessed by Western blotting (WB) and immunocytochemistry (ICC). Perlecan (10mg/ml) evoked unreportedly high, in vitro TEER values (1200 Omega) and the strongest adhesion. Coculturing endothelial cells with astrocytes yielded the greatest resistance over time. ICC and WB results correlated with resistance levels, with evidence of prominent occludin expression in cocultures. BL proteins exerted differential effects on TEER, whereas astrocytes in contact yielded higher TEER values and TJ expression.	[Maherally, Zaynah; Fillmore, Helen L.; Jassam, Samah A.; Quack, Friederike I.; Hatherell, Kathryn E.; Pilkington, Geoffrey J.] Univ Portsmouth, Sch Pharm & Biomed Sci, Inst Biomed & Biomol Sci, Brain Tumour Res Ctr, St Michaels Bldg,White Swan Rd, Portsmouth PO1 2DT, Hants, England; [Tan, Sim Ling; Tan, Suk Fei] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Med, Serdang, Selangor, Malaysia	University of Portsmouth; Universiti Putra Malaysia	Pilkington, GJ (corresponding author), Univ Portsmouth, Sch Pharm & Biomed Sci, Inst Biomed & Biomol Sci, Brain Tumour Res Ctr, St Michaels Bldg,White Swan Rd, Portsmouth PO1 2DT, Hants, England.	zaynah.maherally@port.ac.uk	Tan, Suk Fei/AAU-4358-2020	Tan, Suk Fei/0000-0001-7777-5961; Fillmore, Helen/0000-0003-4131-579X; Lamburne, Samah A/0000-0002-5000-0493	Brain Tumour Research and the Dr. Hadwen Trust; Lord Dowding Fund; Research Management Centre, University Putra Malaysia; Higher Committee of Education Development in Iraq	Brain Tumour Research and the Dr. Hadwen Trust; Lord Dowding Fund; Research Management Centre, University Putra Malaysia; Higher Committee of Education Development in Iraq	The authors thank Dr. Pierre-Olivier Couraud (Institut Cochin, Paris, France) for the hCMEC/D3 cells. G.J.P. received grants from Brain Tumour Research and the Dr. Hadwen Trust (which supported H.L.F. and Z.M.), and a grant from the Lord Dowding Fund (which supported K.E.H.). S.L. T. and S.F.T. were visiting doctoral students supported by Research Management Centre, University Putra Malaysia. F.I.Q. was an Erasmus research internship student from Saarland University (Saarbrucken, Germany), and S.A.J. was a doctoral student supported by the Higher Committee of Education Development in Iraq. The authors declare no conflicts of interest.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x; An Q, 2014, NEURO-ONCOLOGY, V16, P265, DOI 10.1093/neuonc/not202; Arikawa-Hirasawa E, 1999, NAT GENET, V23, P354, DOI 10.1038/15537; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; AUMAILLEY M, 1986, J CELL BIOL, V103, P1569, DOI 10.1083/jcb.103.4.1569; Baeten KM, 2011, DEV NEUROBIOL, V71, P1018, DOI 10.1002/dneu.20954; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Barber AJ, 1997, DEV DYNAM, V208, P62, DOI 10.1002/(SICI)1097-0177(199701)208:1<62::AID-AJA6>3.0.CO;2-#; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Berzin TM, 2000, NEUROBIOL AGING, V21, P349, DOI 10.1016/S0197-4580(00)00121-4; Chen Y, 2012, ADV DRUG DELIVER REV, V64, P640, DOI 10.1016/j.addr.2011.11.010; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Deguchi Y, 2002, J NEUROCHEM, V83, P381, DOI 10.1046/j.1471-4159.2002.01129.x; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Diaz-Flores L, 2009, HISTOL HISTOPATHOL, V24, P909, DOI 10.14670/HH-24.909; Dohgu S, 2005, BRAIN RES, V1038, P208, DOI 10.1016/j.brainres.2005.01.027; Engelhardt B, 2009, SEMIN IMMUNOPATHOL, V31, P497, DOI 10.1007/s00281-009-0177-0; Fricker G., 2014, TOPICS MED CHEM, P1; Gaillard PJ, 2001, EUR J PHARM SCI, V12, P215, DOI 10.1016/S0928-0987(00)00123-8; Garcia CM, 2004, DEV BRAIN RES, V152, P25, DOI 10.1016/j.devbrainres.2004.05.008; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Gesemann M, 1998, J BIOL CHEM, V273, P600, DOI 10.1074/jbc.273.1.600; Hartmann C, 2007, EXP CELL RES, V313, P1318, DOI 10.1016/j.yexcr.2007.01.024; Hatherell K, 2011, J NEUROSCI METH, V199, P223, DOI 10.1016/j.jneumeth.2011.05.012; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hayashi K, 2004, REGUL PEPTIDES, V123, P77, DOI 10.1016/j.regpep.2004.05.023; Hayashi Y, 1997, GLIA, V19, P13, DOI 10.1002/(SICI)1098-1136(199701)19:1<13::AID-GLIA2>3.3.CO;2-E; Hori S, 2004, J NEUROCHEM, V89, P503, DOI 10.1111/j.1471-4159.2004.02343.x; Isobe I, 1996, NEUROCHEM INT, V28, P523, DOI 10.1016/0197-0186(95)00142-5; Kacem K, 1998, GLIA, V23, P1; Kroger S, 1996, EUR J NEUROSCI, V8, P500, DOI 10.1111/j.1460-9568.1996.tb01234.x; Lai CH, 2005, BRAIN RES REV, V50, P258, DOI 10.1016/j.brainresrev.2005.07.004; Lee DS, 2006, LIFE SCI, V80, P154, DOI 10.1016/j.lfs.2006.08.039; Maherally Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030691; Malina KCK, 2009, BRAIN RES, V1284, P12, DOI 10.1016/j.brainres.2009.05.072; Muramatsu R, 2014, NEUROSCI RES, V81-82, P38, DOI 10.1016/j.neures.2014.01.007; Nakagawa S, 2007, CELL MOL NEUROBIOL, V27, P687, DOI 10.1007/s10571-007-9195-4; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Rascher G, 2002, ACTA NEUROPATHOL, V104, P85, DOI 10.1007/s00401-002-0524-x; Roberts J, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00155; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Siddharthan V, 2007, BRAIN RES, V1147, P39, DOI 10.1016/j.brainres.2007.02.029; Sims DE, 2000, CLIN EXP PHARMACOL P, V27, P842, DOI 10.1046/j.1440-1681.2000.03343.x; Sixt M, 2001, J CELL BIOL, V153, P933, DOI 10.1083/jcb.153.5.933; Steiner E, 2014, CELL TISSUE RES, V358, P465, DOI 10.1007/s00441-014-1969-7; Takata F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-106; Tilling T, 1998, J NEUROCHEM, V71, P1151; Weksler B, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-16; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Wilhelm I, 2013, INT J MOL SCI, V14, P1383, DOI 10.3390/ijms14011383; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Winkler S, 2002, J NEUROSCI RES, V69, P477, DOI 10.1002/jnr.10311; Wolburg H, 2002, VASC PHARMACOL, V38, P323, DOI 10.1016/S1537-1891(02)00200-8; Wolburg H, 2009, NEUROSCIENTIST, V15, P180, DOI 10.1177/1073858408329509; Yamamizu K, 2017, STEM CELL REP, V8, P634, DOI 10.1016/j.stemcr.2017.01.023; YUNG WKA, 1985, J NEURO-ONCOL, V3, P35	59	25	26	3	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					168	182		10.1096/fj.201700162R	http://dx.doi.org/10.1096/fj.201700162R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28883042	Green Published			2022-12-28	WOS:000419172700017
J	Lyons, JD; Klingensmith, NJ; Otani, S; Mittal, R; Liang, Z; Ford, ML; Coopersmith, CM				Lyons, John D.; Klingensmith, Nathan J.; Otani, Shunsuke; Mittal, Rohit; Liang, Zhe; Ford, Mandy L.; Coopersmith, Craig M.			Sepsis reveals compartment-specific responses in intestinal proliferation and apoptosis in transgenic mice whose enterocytes re-enter the cell cycle	FASEB JOURNAL			English	Article						gut; critical illness; stress; cyclin; barrier	PSEUDOMONAS-AERUGINOSA PNEUMONIA; CRITICAL ILLNESS; T-ANTIGEN; EPITHELIAL APOPTOSIS; BARRIER DYSFUNCTION; IMPROVES SURVIVAL; MURINE MODEL; GUT; MECHANISMS; MORTALITY	Cellproductionanddeathare tightly regulatedinthe rapidly renewing gut epithelium, with proliferation confined to crypts and apoptosis occurring in villi and crypts. This study sought to determine how stress alters these compartmentalized processes. Wild-type mice made septic via cecal ligation and puncture had decreased crypt proliferation and increased crypt and villus apoptosis. Fabpi-TAg mice expressing large T-antigen solely in villi had ectopic enterocyte proliferation with increased villus apoptosis in unmanipulated animals. Septic fabpi-TAg mice had an unexpected increase in villus proliferation compared with unmanipulated littermates, whereas crypt proliferation was decreased. Cell cycle regulators cyclin D1 and cyclin D2 were decreased in jejunal tissue in septic transgenic mice. In contrast, villus and crypt apoptosis were increased in septic fabpi-TAg mice. To examine the relationship between apoptosis and proliferation in a compartment-specific manner, fabpi-TAg mice were crossed with fabpl-Bcl-2 mice, resulting in expression of both genes in the villus but Bcl-2 alone in the crypt. Septic bitransgenic animals had decreased crypt apoptosis but had a paradoxical increase in villus apoptosis comparedwith septic fabpi-TAg mice, associated with decreased proliferation in both compartments. Thus, sepsis unmasks compartment-specific proliferative and apoptotic regulation that is not present under homeostatic conditions.	[Lyons, John D.; Klingensmith, Nathan J.; Otani, Shunsuke; Mittal, Rohit; Liang, Zhe; Ford, Mandy L.; Coopersmith, Craig M.] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA; [Lyons, John D.; Klingensmith, Nathan J.; Otani, Shunsuke; Mittal, Rohit; Liang, Zhe; Coopersmith, Craig M.] Emory Univ, Sch Med, Emory Crit Care Ctr, Atlanta, GA 30322 USA; [Ford, Mandy L.] Emory Univ, Sch Med, Emory Transplant Ctr, Atlanta, GA 30322 USA; [Otani, Shunsuke] Chiba Univ, Grad Sch Med, Dept Emergency & Crit Care Med, Chiba, Japan	Emory University; Emory University; Emory University; Chiba University	Coopersmith, CM (corresponding author), Emory Univ, 101 Woodruff Circle,Suite WMB 5105, Atlanta, GA 30322 USA.	cmcoop3@emory.edu			U.S. National Institutes of Health, National Institute of General Medical Sciences Grants [GM072808, GM095442, GM104323, GM109779, GM113228, GM117895]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072808, T32GM095442, R01GM113228, R01GM109779, F32GM117895, R01GM104323] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of General Medical Sciences Grants; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health, National Institute of General Medical Sciences Grants GM072808, GM095442, GM104323, GM109779, GM113228, and GM117895. The authors declare no conflicts of interest.	Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Alverdy JC, 2017, CRIT CARE MED, V45, P337, DOI [10.1097/CCM.0000000000002172, 10.1097/ccm.0000000000002172]; Ban KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076790; Blachier F, 2017, AM J PATHOL, V187, P476, DOI 10.1016/j.ajpath.2016.11.015; Butin-Israeli V, 2010, J VIROL, V84, P3431, DOI 10.1128/JVI.01735-09; Chandrasekaran C, 1996, J BIOL CHEM, V271, P28414, DOI 10.1074/jbc.271.45.28414; Clark JA, 2008, SHOCK, V30, P36, DOI 10.1097/SHK.0b013e31815D0820; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.0b013e31805569df; Clark JA, 2009, AM J PHYSIOL-GASTR L, V297, pG471, DOI 10.1152/ajpgi.00012.2009; Coopersmith CM, 2003, CRIT CARE MED, V31, P1630, DOI 10.1097/01.CCM.0000055385.29232.11; Coopersmith CM, 2002, CRIT CARE MED, V30, P195, DOI 10.1097/00003246-200201000-00028; Coopersmith CM, 2002, JAMA-J AM MED ASSOC, V287, P1716, DOI 10.1001/jama.287.13.1716; Coopersmith CM, 1999, AM J PHYSIOL-GASTR L, V276, pG677, DOI 10.1152/ajpgi.1999.276.3.G677; Coopersmith CM, 1997, ONCOGENE, V15, P131, DOI 10.1038/sj.onc.1201176; Darzynkiewicz Z, 2015, ONCOTARGET, V6, P11735, DOI 10.18632/oncotarget.4149; Dominguez JA, 2011, SHOCK, V36, P381, DOI 10.1097/SHK.0b013e31822793c4; Drayman N, 2016, ONCOTARGET, V7, P52643, DOI 10.18632/oncotarget.10769; Duronio RJ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008904; Fan Y, 2008, TRENDS CELL BIOL, V18, P467, DOI 10.1016/j.tcb.2008.08.001; Fay KT, 2017, BBA-MOL BASIS DIS, V1863, P2574, DOI 10.1016/j.bbadis.2017.03.005; Gaieski DF, 2013, CRIT CARE MED, V41, P1167, DOI 10.1097/CCM.0b013e31827c09f8; Gerbe F, 2012, CELL MOL LIFE SCI, V69, P2907, DOI 10.1007/s00018-012-0984-7; HALL PA, 1994, J CELL SCI, V107, P3569; HAUFT SM, 1992, J CELL BIOL, V117, P825, DOI 10.1083/jcb.117.4.825; Hayakawa M, 2011, DIGEST DIS SCI, V56, P2361, DOI 10.1007/s10620-011-1649-3; Helander HF, 2014, SCAND J GASTROENTERO, V49, P681, DOI 10.3109/00365521.2014.898326; Klingensmith NJ, 2017, SHOCK, V47, P184, DOI 10.1097/SHK.0000000000000709; Klingensmith NJ, 2016, CRIT CARE CLIN, V32, P203, DOI 10.1016/j.ccc.2015.11.004; Li QR, 2009, J PATHOL, V218, P210, DOI 10.1002/path.2525; Lyons JD, 2017, PEDIATR CRIT CARE ME, V18, pS46, DOI 10.1097/PCC.0000000000001046; McDonald D, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00199-16; Meng M, 2017, CURR OPIN CRIT CARE, V23, P143, DOI 10.1097/MCC.0000000000000386; Mittal R, 2014, TRENDS MOL MED, V20, P214, DOI 10.1016/j.molmed.2013.08.004; Mollereau B, 2013, CELL DEATH DIFFER, V20, P181, DOI 10.1038/cdd.2012.82; Neal MD, 2013, J IMMUNOL, V190, P3541, DOI 10.4049/jimmunol.1202264; Nyangale EP, 2012, J PROTEOME RES, V11, P5573, DOI 10.1021/pr300637d; Odenwald MA, 2017, NAT REV GASTRO HEPAT, V14, P9, DOI 10.1038/nrgastro.2016.169; Perrone EE, 2012, SHOCK, V38, P68, DOI 10.1097/SHK.0b013e318259abdb; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Robles MTS, 2009, SEMIN CANCER BIOL, V19, P229, DOI 10.1016/j.semcancer.2009.02.002; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Sender R, 2016, CELL, V164, P337, DOI 10.1016/j.cell.2016.01.013; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Taylor SC, 2013, MOL BIOTECHNOL, V55, P217, DOI 10.1007/s12033-013-9672-6; Tsai SC, 2000, J BIOL CHEM, V275, P3239, DOI 10.1074/jbc.275.5.3239; Vyas D, 2007, HISTOL HISTOPATHOL, V22, P623, DOI 10.14670/HH-22.623; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Yoseph BP, 2016, SHOCK, V46, P52, DOI 10.1097/SHK.0000000000000565	50	3	4	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5507	5519		10.1096/fj.201700015RR	http://dx.doi.org/10.1096/fj.201700015RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28842422	Green Published			2022-12-28	WOS:000416588300032
J	Benn, A; Hiepen, C; Osterland, M; Schutte, C; Zwijsen, A; Knaus, P				Benn, Andreas; Hiepen, Christian; Osterland, Marc; Schuette, Christof; Zwijsen, An; Knaus, Petra			Role of bone morphogenetic proteins in sprouting angiogenesis: differential BMP receptor-dependent signaling pathways balance stalk vs. tip cell competence	FASEB JOURNAL			English	Article						ALK2; ALK3; SMAD1/5; p38 MAPK; cell migration	ENDOTHELIAL-CELLS; TGF-BETA; ALK1; KINASE; ACTIVATION; NOTCH; MIGRATION; VEGF; EXPRESSION; BINDING	Before the onset of sprouting angiogenesis, the endothelium is prepatterned for the positioning of tip and stalk cells. Both cell identities are not static, as endothelial cells (ECs) constantly compete for the tip cell position in a dynamic fashion. Here, we show that both bone morphogenetic protein 2 (BMP2) and BMP6 are proangiogenic in vitro and ex vivo and that the BMP type I receptors, activin receptor-like kinase 3 (ALK3) and ALK2, play crucial and distinct roles in this process. BMP2 activates the expression of tip cell-associated genes, such as delta-like ligand 4 (DLL4) and kinase insert domain receptor (KDR), and p38-heat shock protein 27 (HSP27)-dependent cell migration, thereby generating tip cell competence. Whereas BMP6 also triggers collective cell migration via the p38-HSP27 signaling axis, BMP6 induces in addition SMAD1/5 signaling, thereby promoting the expression of stalk cell-associated genes, such as hairy and enhancer of split 1 (HES1) and fms-like tyrosine kinase 1 (FLT1). Specifically, ALK3 is required for sprouting from HUVEC spheroids, whereas ALK2 represses sprout formation. We demonstrate that expression levels and respective complex formation of BMP type I receptors in ECs determine stalk vs. tip cell identity, thus contributing to endothelial plasticity during sprouting angiogenesis. As antiangiogenic monotherapies that target the VEGF or ALK1 pathways have not fulfilled efficacy objectives in clinical trials, the selective targeting of the ALK2/3 pathways may be an attractive new approach.	[Benn, Andreas; Hiepen, Christian; Knaus, Petra] Free Univ Berlin, Inst Chem & Biochem, Thielallee 63, D-14195 Berlin, Germany; [Osterland, Marc; Schuette, Christof] Free Univ Berlin, Inst Math, Berlin, Germany; [Benn, Andreas; Knaus, Petra] Berlin Sch Integrat Oncol, Deutsch Forsch Gemeinschaft DFG Grad Sch 1093, Berlin, Germany; [Benn, Andreas; Hiepen, Christian; Knaus, Petra] Berlin Brandenburg Sch Regenerat Therapies, DFG Grad Sch 203, Berlin, Germany; [Benn, Andreas; Zwijsen, An] VIB, Ctr Brain & Dis Res, Leuven, Belgium; [Benn, Andreas; Zwijsen, An] Katholieke Univ KU Leuven, Dept Human Genet, Leuven, Belgium; [Osterland, Marc; Schuette, Christof] Zuse Inst Berlin, Berlin, Germany	Free University of Berlin; Free University of Berlin; Flanders Institute for Biotechnology (VIB); KU Leuven; Zuse Institute Berlin	Knaus, P (corresponding author), Free Univ Berlin, Inst Chem & Biochem, Thielallee 63, D-14195 Berlin, Germany.	knaus@chemie.fu-berlin.de	Zwijsen, An/AAK-2897-2020; Hiepen, Christian/AAI-3685-2021; Hiepen, Christian/AAY-3399-2020	Hiepen, Christian/0000-0001-7345-6496; Zwijsen, An/0000-0002-8583-1721	Berlin School of Integrative Oncology [Deutsche Forschungsgemeinschaft (DFG) Graduate School [1093]; Berlin School for Regenerative Therapies (DFG Graduate School) [203]; European Molecular Biology Organization; Flanders Research Foundation [FWO G.0542.13]; German Research Foundation DFG [SFB958]	Berlin School of Integrative Oncology [Deutsche Forschungsgemeinschaft (DFG) Graduate School; Berlin School for Regenerative Therapies (DFG Graduate School); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Flanders Research Foundation(FWO); German Research Foundation DFG(German Research Foundation (DFG))	The authors thank Karen Beets, Isabel Casanova, Alexander Hron, Patrizia Weigell, and Johanna Scholz for experimental technical assistance; Steffen Prohaska (Berlin, Germany) for technical and analytical assistance on chemotaxis analyses; Mario Lorenz, Verena Stangl, and Axel Pries (Berlin, Germany) for kindly providing HUVECs and HAECs; James Kirkpatrick (Mainz, Germany) for providing HPMECs; Walter Sebald (Wurzburg, Germany) for providing recombinant BMP2; Slobodan Vukicevic (Zagreb, Croatia) for providing recombinant BMP6; and Alex Bullock (Oxford University, Oxford, United Kingdom) for providing K02288. This work was supported by the Berlin School of Integrative Oncology [Deutsche Forschungsgemeinschaft (DFG) Graduate School 1093, fellowship to A.B.], the Berlin School for Regenerative Therapies (DFG Graduate School 203, fellowship to A.B.), the European Molecular Biology Organization (fellowship to A.B.), the Flanders Research Foundation FWO G.0542.13 (to A.Z.), and the German Research Foundation DFG SFB958 (to P.K.). The authors thank all lab members for vivid discussions and valuable comments. The authors declare no conflicts of interest.	Akiyama I, 2014, REPROD SCI, V21, P477, DOI 10.1177/1933719113503411; Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103; Arai H, 2002, BIOCHEM BIOPH RES CO, V299, P116, DOI 10.1016/S0006-291X(02)02588-3; Aspalter IM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8264; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Benn A, 2016, J CELL SCI, V129, P206, DOI 10.1242/jcs.179960; Bongrazio M, 2000, CARDIOVASC RES, V47, P384, DOI 10.1016/S0008-6363(00)00111-5; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Crowe J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077383; Cunha SI, 2015, CANCER RES, V75, P2445, DOI 10.1158/0008-5472.CAN-14-3706; Cunha SI, 2011, BLOOD, V117, P6999, DOI 10.1182/blood-2011-01-330142; De Smet F, 2009, ARTERIOSCL THROM VAS, V29, P639, DOI 10.1161/ATVBAHA.109.185165; de Vinuesa AG, 2016, CYTOKINE GROWTH F R, V27, P65, DOI 10.1016/j.cytogfr.2015.12.005; Deckers MML, 2002, ENDOCRINOLOGY, V143, P1545, DOI 10.1210/en.143.4.1545; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Ebisawa T, 1999, J CELL SCI, V112, P3519; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Finkenzeller G, 2012, MICROVASC RES, V84, P81, DOI 10.1016/j.mvr.2012.03.010; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gamell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016477; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gilboa L, 2000, MOL BIOL CELL, V11, P1023, DOI 10.1091/mbc.11.3.1023; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Guzman A, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.387639; Hartung A, 2006, MOL CELL BIOL, V26, P7791, DOI 10.1128/MCB.00022-06; Hawinkels LJAC, 2016, CLIN CANCER RES, V22, P96, DOI 10.1158/1078-0432.CCR-15-0743; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hiepen C, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-43; Hill CS, 2009, CELL RES, V19, P36, DOI 10.1038/cr.2008.325; Holderfield MT, 2006, BIOCHEM BIOPH RES CO, V346, P637, DOI 10.1016/j.bbrc.2006.05.177; Huth J, 2011, COMPUT METH PROG BIO, V104, P227, DOI 10.1016/j.cmpb.2011.06.002; Itoh F, 2004, EMBO J, V23, P541, DOI 10.1038/sj.emboj.7600065; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Jimeno A, 2016, CANCER-AM CANCER SOC, V122, P3641, DOI 10.1002/cncr.30317; Jonker L, 2014, MICROCIRCULATION, V21, P93, DOI 10.1111/micc.12099; Jung SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3562; Kerr G, 2015, ANGIOGENESIS, V18, P209, DOI 10.1007/s10456-014-9457-y; Kieran MW, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006593; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Korff T, 1999, J CELL SCI, V112, P3249; Krump-Konvalinkova V, 2001, LAB INVEST, V81, P1717, DOI 10.1038/labinvest.3780385; Kumar S, 1999, BIOCHEM BIOPH RES CO, V263, P825, DOI 10.1006/bbrc.1999.1454; Langenfeld EM, 2004, MOL CANCER RES, V2, P141; Larrivee B, 2012, DEV CELL, V22, P489, DOI 10.1016/j.devcel.2012.02.005; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Lorenz M, 2015, ATHEROSCLEROSIS, V240, P61, DOI 10.1016/j.atherosclerosis.2015.02.018; Makker V, 2015, GYNECOL ONCOL, V138, P24, DOI 10.1016/j.ygyno.2015.04.006; Metzner P, 2009, MULTISCALE MODEL SIM, V7, P1192, DOI 10.1137/070699500; Mitchell D, 2010, MOL CANCER THER, V9, P379, DOI 10.1158/1535-7163.MCT-09-0650; Mouillesseaux KP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13247; Mountzios G, 2014, PHARMACOL THERAPEUT, V141, P117, DOI 10.1016/j.pharmthera.2013.09.003; Moya IM, 2012, DEV CELL, V22, P501, DOI 10.1016/j.devcel.2012.01.007; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Mudgett JS, 2000, P NATL ACAD SCI USA, V97, P10454, DOI 10.1073/pnas.180316397; Mueller TD, 2012, FEBS LETT, V586, P1846, DOI 10.1016/j.febslet.2012.02.043; Nickel J, 2009, CYTOKINE GROWTH F R, V20, P367, DOI 10.1016/j.cytogfr.2009.10.022; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Park C, 2006, DEVELOPMENT, V133, P3473, DOI 10.1242/dev.02499; Perez VADJ, 2009, J CELL BIOL, V184, P83, DOI 10.1083/jcb.200806049; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Pi XC, 2007, J CELL BIOL, V179, P1569, DOI 10.1083/jcb.200704010; Prinz JH, 2011, MULTISCALE MODEL SIM, V9, P545, DOI 10.1137/100789191; Raida M, 2005, J CANCER RES CLIN, V131, P741, DOI 10.1007/s00432-005-0024-1; Ren RQ, 2007, BLOOD, V109, P2847, DOI 10.1182/blood-2006-08-039743; Roukens MG, 2010, NAT CELL BIOL, V12, P933, DOI 10.1038/ncb2096; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x; Sanvitale CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062721; Saremba S, 2008, FEBS J, V275, P172, DOI 10.1111/j.1742-4658.2007.06187.x; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Simic P, 2006, J BIOL CHEM, V281, P25509, DOI 10.1074/jbc.M513276200; Suzuki Y, 2008, J BIOCHEM, V143, P199, DOI 10.1093/jb/mvm215; Taylor KL, 2002, MICROVASC RES, V64, P372, DOI 10.1006/mvre.2002.2443; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; Tillet E, 2015, FRONT GENET, V5, DOI 10.3389/fgene.2014.00456; Valdimarsdottir G, 2002, CIRCULATION, V106, P2263, DOI 10.1161/01.CIR.0000033830.36431.46; van Meeteren LA, 2012, J BIOL CHEM, V287, P18551, DOI 10.1074/jbc.M111.338103; Vitorino P, 2011, MOL CELL BIOL, V31, P342, DOI 10.1128/MCB.00800-10; Wakayama Y, 2015, DEV CELL, V32, P109, DOI 10.1016/j.devcel.2014.11.024; Wang JK, 2005, DEV BIOL, V286, P299, DOI 10.1016/j.ydbio.2005.07.035; Wiley DM, 2011, NAT CELL BIOL, V13, P686, DOI 10.1038/ncb2232; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116	83	45	48	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4720	4733		10.1096/fj.201700193RR	http://dx.doi.org/10.1096/fj.201700193RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28733457	Green Published			2022-12-28	WOS:000413398500006
J	Meng, GM; Tang, XY; Yang, ZL; Benesch, MGK; Marshall, A; Murray, D; Hemmings, DG; Wuest, F; McMullen, TPW; Brindley, DN				Meng, Guanmin; Tang, Xiaoyun; Yang, Zelei; Benesch, Matthew G. K.; Marshall, Alison; Murray, David; Hemmings, Denise G.; Wuest, Frank; McMullen, Todd P. W.; Brindley, David N.			Implications for breast cancer treatment from increased autotaxin production in adipose tissue after radiotherapy	FASEB JOURNAL			English	Article						lysophosphatidate signaling; wound healing; inflammatory mediators; NF-kappa B; radioresistance	NF-KAPPA-B; LYSOPHOSPHATIDIC ACID; TNF-ALPHA; LYSOPHOSPHOLIPASE-D; LUNG FIBROSIS; TUMOR-GROWTH; DNA-DAMAGE; ACTIVATION; EXPRESSION; RADIATION	We have previously established that adipose tissue adjacent to breast tumors becomes inflamed by tumor-derived cytokines. This stimulates autotaxin (ATX) secretion from adipocytes, whereas breast cancer cells produce insignificant ATX. Lysophosphatidate produced by ATX promotes inflammatory cytokine secretion in a vicious inflammatory cycle, which increases tumor growth and metastasis and decreases response to chemotherapy. We hypothesized that damage to adipose tissue during radiotherapy for breast cancer should promote lysophosphatidic acid (LPA) signaling and further inflammatory signaling, which could potentially protect cancer cells from subsequent fractions of radiation therapy. To test this hypothesis, we exposed rat and human adipose tissue to radiation doses (0.25-5 Gy) that were expected during radiotherapy. This exposure increased mRNA levels for ATX, cyclooxygenase-2, IL-1 beta, IL-6, IL-10, TNF-alpha, and LPA(1) and LPA(2) receptors by 1.8- to 5.1-fold after 4 to 48 h. There were also 1.5- to 2.5-fold increases in the secretion of ATX and 14 inflammatory mediators after irradiating at 1 Gy. Inhibition of the radiation-induced activation of NF-kappa B, cyclooxygenase-2, poly (ADP-ribose) polymerase-1, or ataxia telangiectasia and Rad3-related protein blocked inflammatory responses to gamma-radiation. Consequently, collateral damage to adipose tissue during radiotherapy could establish a comprehensive wound-healing response that involves increased signaling by LPA, cyclooxygenase-2, and other inflammatory mediators that could decrease the efficacy of further radiotherapy or chemotherapy.	[Meng, Guanmin; Tang, Xiaoyun; Yang, Zelei; Benesch, Matthew G. K.; Brindley, David N.] Univ Alberta, Signal Transduct Res Grp, Dept Biochem, Edmonton, AB, Canada; [Marshall, Alison; Murray, David; Wuest, Frank] Univ Alberta, Cross Canc Inst, Dept Oncol, Edmonton, AB, Canada; [Hemmings, Denise G.] Univ Alberta, Dept Obstet & Gynecol, Edmonton, AB, Canada; [Hemmings, Denise G.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [McMullen, Todd P. W.] Univ Alberta, Dept Surg, Edmonton, AB, Canada; [Meng, Guanmin] Tongde Hosp Zhejiang Prov, Dept Clin Lab, Hangzhou, Zhejiang, Peoples R China	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta	Brindley, DN (corresponding author), Univ Alberta, Dept Biochem, Heritage Med Res Ctr 357, Edmonton, AB T6G 2S2, Canada.	david.brindley@ualberta.ca	Benesch, Matthew/GRF-0677-2022	Meng, Guanmin/0000-0002-6701-8980	Canadian Cancer Society Research Institute; Canadian Breast Cancer Foundation (CBCF); Tongde Hospital of Zhejiang Province; National Natural Science Foundation of China [81602822]; 75th Anniversary Graduate Studentship from the University of Alberta; Canadian Breast Cancer Foundation; Government of Canada; Canadian Institutes of Health Research; Alberta Innovates-Health Solutions; Killam Trust Award; CBCF	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Breast Cancer Foundation (CBCF); Tongde Hospital of Zhejiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 75th Anniversary Graduate Studentship from the University of Alberta; Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Government of Canada(CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions; Killam Trust Award; CBCF	This work was supported by grants from the Canadian Cancer Society Research Institute and the Canadian Breast Cancer Foundation (CBCF). G.M. received financial supports from Tongde Hospital of Zhejiang Province and the National Natural Science Foundation of China (Grant 81602822). Z.Y. received a 75th Anniversary Graduate Studentship from the University of Alberta and a salary through a grant from the Canadian Breast Cancer Foundation. M.G.K.B. received a Vanier Canada Graduate Scholarship (Government of Canada), a Canadian Institutes of Health Research M.D./Ph.D. Studentship, an M.D./Ph.D. Studentship from Alberta Innovates-Health Solutions, and a Killam Trust Award. X.T. held a research fellowship from CBCF. The authors thank Drs. M. Hendzel and M. Weinfeld (both from the Cross Cancer Institute, University of Alberta) for excellent advice.	Bai ZB, 2013, J IMMUNOL, V190, P2036, DOI 10.4049/jimmunol.1202025; Balogh A, 2015, CELL SIGNAL, V27, P1751, DOI 10.1016/j.cellsig.2015.05.015; Bekele RT, 2016, SCI REP-UK, V6, DOI 10.1038/srep21164; Benesch MGK, 2015, FASEB J, V29, P3990, DOI 10.1096/fj.15-274480; Benesch MGK, 2015, J LIPID RES, V56, P1134, DOI 10.1194/jlr.M057661; Benesch MGK, 2014, FEBS LETT, V588, P2712, DOI 10.1016/j.febslet.2014.02.009; Benesch MGK, 2014, FASEB J, V28, P2655, DOI 10.1096/fj.13-248641; Bhave SR, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00236; Bower JE, 2009, CLIN CANCER RES, V15, P5534, DOI 10.1158/1078-0432.CCR-08-2584; Brindley D.N., 2015, AUTOTAXIN ENZYMATIC; Brindley DN, 2013, BBA-MOL CELL BIOL L, V1831, P74, DOI 10.1016/j.bbalip.2012.08.015; Brindley DN, 2004, J CELL BIOCHEM, V92, P900, DOI 10.1002/jcb.20126; Budd DC, 2013, FUTURE MED CHEM, V5, P1935, DOI [10.4155/FMC.13.154, 10.4155/fmc.13.154]; Carswell KA, 2012, METHODS MOL BIOL, V806, P203, DOI 10.1007/978-1-61779-367-7_14; Castelino FV, 2016, ARTHRITIS RHEUMATOL, V68, P2964, DOI 10.1002/art.39797; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Dusaulcy R, 2011, J LIPID RES, V52, P1247, DOI 10.1194/jlr.M014985; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Esquivel-Velazquez M, 2015, J INTERF CYTOK RES, V35, P1, DOI 10.1089/jir.2014.0026; Euer N, 2002, ANTICANCER RES, V22, P733; FISHER B, 1995, NEW ENGL J MED, V333, P1456, DOI 10.1056/NEJM199511303332203; Fotopoulou S, 2010, DEV BIOL, V339, P451, DOI 10.1016/j.ydbio.2010.01.007; Funakoshi-Tago M, 2008, BIOCHEM PHARMACOL, V76, P662, DOI 10.1016/j.bcp.2008.06.015; Gaetano CG, 2009, MOL CARCINOGEN, V48, P801, DOI 10.1002/mc.20524; Gamper AM, 2013, NUCLEIC ACIDS RES, V41, P10334, DOI 10.1093/nar/gkt833; Gan L, 2011, BIOCHEM BIOPH RES CO, V409, P7, DOI 10.1016/j.bbrc.2011.04.084; Gry M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-365; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harbort CJ, 2015, BLOOD, V126, P2842, DOI 10.1182/blood-2015-05-645424; Harris Jay R, 2014, Am Soc Clin Oncol Educ Book, P21, DOI 10.14694/EdBook_AM.2014.34.21; Jayakumar S, 2015, MUTAT RES-FUND MOL M, V779, P33, DOI 10.1016/j.mrfmmm.2015.06.007; Koike S, 2010, BIOCHEM BIOPH RES CO, V400, P66, DOI 10.1016/j.bbrc.2010.08.008; Koike S, 2009, J BIOL CHEM, V284, P33561, DOI 10.1074/jbc.M109.012716; Lauw FN, 2000, J IMMUNOL, V165, P2783, DOI 10.4049/jimmunol.165.5.2783; Lin FT, 2007, J BIOL CHEM, V282, P37759, DOI 10.1074/jbc.M705025200; Little D, 2007, J VET INTERN MED, V21, P367, DOI 10.1892/0891-6640(2007)21[367:CCIATI]2.0.CO;2; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Mazereeuw-Hautier J, 2005, J INVEST DERMATOL, V125, P421, DOI 10.1111/j.0022-202X.2005.23855.x; McDonald JT, 2010, CANCER RES, V70, P8886, DOI 10.1158/0008-5472.CAN-10-0171; Mitchell MD, 2004, J CLIN ENDOCR METAB, V89, P4149, DOI 10.1210/jc.2004-0373; Nakasaki T, 2008, AM J PATHOL, V173, P1566, DOI 10.2353/ajpath.2008.071153; Nochi H, 2008, J IMMUNOL, V181, P5111, DOI 10.4049/jimmunol.181.7.5111; Perez CER, 2011, AM J PHYSIOL-GASTR L, V300, pG637, DOI 10.1152/ajpgi.00381.2010; Popnikolov NK, 2012, TUMOR BIOL, V33, P2237, DOI 10.1007/s13277-012-0485-1; Rancoule C, 2011, EXPERT OPIN INV DRUG, V20, P657, DOI 10.1517/13543784.2011.566864; Ray R, 2017, BLOOD, V129, P1177, DOI 10.1182/blood-2016-10-743757; Rocha S, 2005, EMBO J, V24, P1157, DOI 10.1038/sj.emboj.7600608; Samadi N, 2009, ONCOGENE, V28, P1028, DOI 10.1038/onc.2008.442; Samadi N, 2011, BIOCHIMIE, V93, P61, DOI 10.1016/j.biochi.2010.08.002; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Schaue D, 2015, SEMIN RADIAT ONCOL, V25, P4, DOI 10.1016/j.semradonc.2014.07.007; Schaue D, 2012, RADIAT RES, V178, P505, DOI 10.1667/RR3031.1; Schleicher SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022182; Sekhar KR, 2015, FREE RADICAL BIO MED, V88, P268, DOI 10.1016/j.freeradbiomed.2015.04.035; Shishodia S, 2004, J IMMUNOL, V173, P2011, DOI 10.4049/jimmunol.173.3.2011; Sloan EK, 2010, CANCER RES, V70, P7042, DOI 10.1158/0008-5472.CAN-10-0522; So J, 2005, GYNECOL ONCOL, V97, P870, DOI 10.1016/j.ygyno.2005.03.004; St-Coeur PD, 2013, ARCH PHARM, V346, P91, DOI 10.1002/ardp.201200395; Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X; Swaney JS, 2010, BRIT J PHARMACOL, V160, P1699, DOI 10.1111/j.1476-5381.2010.00828.x; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Tang XY, 2014, J LIPID RES, V55, P2389, DOI 10.1194/jlr.M053462; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Venkatraman G, 2015, FASEB J, V29, P772, DOI 10.1096/fj.14-262659; Veuger SJ, 2009, ONCOGENE, V28, P832, DOI 10.1038/onc.2008.439; Vidot S, 2010, CELL SIGNAL, V22, P926, DOI 10.1016/j.cellsig.2010.01.017; Wang Y, 2004, CANCER RES, V64, P6240, DOI 10.1158/0008-5472.CAN-04-0591; Wu JM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-71; Yoo J, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-90; Zhang YF, 2012, J IMMUNOL, V189, P3914, DOI 10.4049/jimmunol.1201604; Zhao YT, 2005, BIOCHEM J, V385, P493, DOI 10.1042/BJ20041160; Zhou SN, 2013, CRIT REV ONCOL HEMAT, V88, P706, DOI 10.1016/j.critrevonc.2013.09.001	74	30	30	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					4064	4077		10.1096/fj.201700159R	http://dx.doi.org/10.1096/fj.201700159R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28539367				2022-12-28	WOS:000408713300030
J	Pang, ZD; Kushiyama, A; Sun, J; Kikuchi, T; Yamazaki, H; Iwamoto, Y; Koriyama, H; Yoshida, S; Shimamura, M; Higuchi, M; Kawano, T; Takami, Y; Rakugi, H; Morishita, R; Nakagami, H				Pang, Zhengda; Kushiyama, Akifumi; Sun, Jiao; Kikuchi, Takako; Yamazaki, Hiroki; Iwamoto, Yasuhiko; Koriyama, Hiroshi; Yoshida, Shota; Shimamura, Munehisa; Higuchi, Masayoshi; Kawano, Tomohiro; Takami, Yoichi; Rakugi, Hiromi; Morishita, Ryuichi; Nakagami, Hironori			Glial fibrillary acidic protein (GFAP) is a novel biomarker for the prediction of autoimmune diabetes	FASEB JOURNAL			English	Article						type 1 diabetes; GAD65; autoantibody; nonobese diabetic; type 2 diabetes	ISLET-CELL ANTIBODIES; ADULTS LADA; NOD MICE; INSULIN; DECARBOXYLASE; AUTOANTIGEN; MELLITUS; AUTOANTIBODIES; IDENTIFICATION; PROGRESSION	Glial fibrillary acidic protein (GFAP) is expressed in peri-islet Schwann cells, as well as in glia cells, and has been reported to be an autoantigen candidate for type 1 diabetes mellitus (T1DM). We confirmed that the production of the autoantibodies GFAP and glutamic acid decarboxylase 65 (GAD65) was increased and inversely correlated with the concentration of secreted C peptide in female nonobese diabetic mice (T1DM model). Importantly, the development of T1DM in female nonobese diabetic mice at 30 wk of age was predicted by the positive GFAP autoantibody titer at 17 wk. The production of GFAP and GAD65 autoantibodies was also increasedinKK-Ay mice [type 2 diabetes mellitus (T2DM) model]. In patients with diabetes mellitus, GFAP autoantibody levels were increased in patients with either T1DM or T2DM, and were significantly associated with GAD65 autoantibodies but not zinc transporter 8 autoantibodies. Furthermore, we identified a B-cell epitope of GFAP corresponding to the GFAP autoantibody in both mice and patients with diabetes. Thus, these results indicate that autoantibodies against GFAP could serve as apredictive marker for the development of overt autoimmunediabetes.	[Pang, Zhengda] Xi An Jiao Tong Univ, Sch Med, Dept Physiol & Pathophysiol, Xian, Peoples R China; [Pang, Zhengda; Yoshida, Shota; Higuchi, Masayoshi; Takami, Yoichi; Rakugi, Hiromi] Osaka Univ, Grad Sch Med, Dept Geriatr Med, Osaka, Japan; [Kushiyama, Akifumi; Kikuchi, Takako; Yamazaki, Hiroki; Iwamoto, Yasuhiko] Asahi Life Fdn, Inst Adult Dis, Div Diabet & Metab, Tokyo, Japan; [Sun, Jiao; Koriyama, Hiroshi; Shimamura, Munehisa; Nakagami, Hironori] Osaka Univ, Grad Sch Med, Dept Hlth Dev & Med, 2-1 Yamada Oka, Suita, Osaka, Japan; [Kawano, Tomohiro] Osaka Univ, Grad Sch Med, Dept Neurol, Osaka, Japan; [Morishita, Ryuichi] Osaka Univ, Grad Sch Med, Dept Clin Gene Therapy, 2-1 Yamada Oka, Suita, Osaka, Japan	Xi'an Jiaotong University; Osaka University; Asahi Life Foundation; Osaka University; Osaka University; Osaka University	Nakagami, H (corresponding author), Osaka Univ, Grad Sch Med, Dept Hlth Dev & Med, 2-1 Yamada Oka, Suita, Osaka, Japan.; Morishita, R (corresponding author), Osaka Univ, Grad Sch Med, Dept Clin Gene Therapy, 2-1 Yamada Oka, Suita, Osaka, Japan.	morishit@cgt.med.osaka-u.ac.jp; nakagami@gts.med.osaka-u.ac.jp	Kushiyama, Akifumi/A-6386-2011; Kushiyama, Akifumi/W-5988-2019; Nakagami, Hironori/GLU-0570-2022	Kushiyama, Akifumi/0000-0003-1385-7487; Kushiyama, Akifumi/0000-0003-1385-7487; Nakagami, Hironori/0000-0003-4494-3601; Rakugi, Hiromi/0000-0001-6508-4338; Takami, Yoichi/0000-0001-9018-6707; Yoshida, Shota/0000-0002-6830-7063	Japan Insulin-Dependent Diabetes Mellitis (IDDM) Network	Japan Insulin-Dependent Diabetes Mellitis (IDDM) Network	The authors thank all members in Department of Health Development and Medicine (Osaka University Graduate School of Medicine) for supporting this project. This work was supported, in part, by a grant from the Japan Insulin-Dependent Diabetes Mellitis (IDDM) Network.	BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; Brooks-Worrell B, 2013, DIABETES OBES METAB, V15, P137, DOI 10.1111/dom.12167; Bush TG, 1998, CELL, V93, P189, DOI 10.1016/S0092-8674(00)81571-8; Carrillo J, 2005, DIABETES, V54, P69, DOI 10.2337/diabetes.54.1.69; Daneman D, 2006, LANCET, V367, P847, DOI 10.1016/S0140-6736(06)68341-4; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Fischbach F.T., 2009, MANUAL LAB DIAGNOSTI, V8th; Gomez-Tourino I, 2010, DIABETIC MED, V27, P247, DOI 10.1111/j.1464-5491.2009.02911.x; GROOP LC, 1986, DIABETES, V35, P237, DOI 10.2337/diabetes.35.2.237; Guan YY, 2012, DIABETES RES CLIN PR, V95, P93, DOI 10.1016/j.diabres.2011.09.019; IRVINE WJ, 1977, LANCET, V1, P1025; Itariu BK, 2014, GERONTOLOGY, V60, P189, DOI 10.1159/000356747; Juneja R, 2001, METABOLISM, V50, P1008, DOI 10.1053/meta.2001.25654; LAN MS, 1994, DNA CELL BIOL, V13, P505, DOI 10.1089/dna.1994.13.505; Lohmann T, 1997, DIABETES CARE, V20, P524, DOI 10.2337/diacare.20.4.524; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Moroki T, 2013, IN VIVO, V27, P465; Mueller R, 1996, J EXP MED, V184, P1093, DOI 10.1084/jem.184.3.1093; Naik RG, 2009, J CLIN ENDOCR METAB, V94, P4635, DOI 10.1210/jc.2009-1120; Overbergh L, 2000, DIABETES, V49, P1301, DOI 10.2337/diabetes.49.8.1301; PALMER JP, 1983, SCIENCE, V222, P1337, DOI 10.1126/science.6362005; Pang ZD, 2017, FEBS LETT, V591, P129, DOI 10.1002/1873-3468.12511; RABIN DU, 1994, J IMMUNOL, V152, P3183; Regoli M, 2000, J HISTOCHEM CYTOCHEM, V48, P259, DOI 10.1177/002215540004800211; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Towns R, 2011, DRUG FUTURE, V36, P847, DOI 10.1358/dof.2011.036.11.1710754; TUOMI T, 1993, DIABETES, V42, P359, DOI 10.2337/diabetes.42.2.359; Turner R, 1997, LANCET, V350, P1288, DOI 10.1016/S0140-6736(97)03062-6; Vuilleumier N, 2014, WORLD J CARDIOL, V6, P314, DOI 10.4330/wjc.v6.i5.314; Weaver DJ, 2001, J IMMUNOL, V167, P586, DOI 10.4049/jimmunol.167.1.586; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Winer S, 2003, NAT MED, V9, P198, DOI 10.1038/nm818; ZIMMET PZ, 1994, DIABETIC MED, V11, P299, DOI 10.1111/j.1464-5491.1994.tb00275.x	33	13	13	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					4053	4063		10.1096/fj.201700110R	http://dx.doi.org/10.1096/fj.201700110R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28546444				2022-12-28	WOS:000408713300029
J	Paine, A; Woeller, CF; Zhang, HW; Garcia-Hernandez, MD; Huertas, N; Xing, LP; Phipps, RP; Ritchlin, CT				Paine, Ananta; Woeller, Collynn F.; Zhang, Hengwei; de la Luz Garcia-Hernandez, Maria; Huertas, Nelson; Xing, Lianping; Phipps, Richard P.; Ritchlin, Christopher T.			Thyl is a positive regulator of osteoblast differentiation and modulates bone homeostasis in obese mice	FASEB JOURNAL			English	Article						adipocytes; CD90; mesenchymal stem cells; osteoblastogenesis; trabecular bone volume	STEM-CELLS; IN-VITRO; MARROW; OSTEOPOROSIS; EXPRESSION; TISSUE; ADIPOGENESIS; FIBROBLASTS; ADHESION; WOMEN	Thy1 (CD90), a glycosylated, glycophosphatidylinositol-anchored membrane protein highly expressed by subsets of mesenchymal stem cells and fibroblasts, inhibits adipogenesis. The role of Thy1 on bone structure and function has been poorly studied and represents a major knowledge gap. Therefore, we analyzed the long bones of wild-type (WT) and Thy1 knockout (KO) mice with micro-computed tomography (micro-CT) and histomorphometry to compare changes in bone architecture and overall bone structure. micro-CT analysis of long bones revealed Thy1 KO and WT mice fed a high-fat diet demonstrated bone structural parameters at 4 mo that differed significantly between WT and KO mice. A significant reduction in trabecular bone volume was noted in Thy1 KO mice. The most prominent differences were observed in trabecular bone volume ratio and trabecular bone connectivity density. Consistent with micro-CT measurements, histomorphometric analysis also showed decreased bone volume in the obese Thy1 KO mice compared to obese WT mice. In vitro assays revealed that osteogenic conditions increased Thy1 expression during OB differentiation and absence of Thy1 attenuated osteoblastogenesis. Together, these findings support the concept that Thy1 serves as a major mechanistic link to regulate bone formation and negatively regulate adipogenesis.	[Paine, Ananta; de la Luz Garcia-Hernandez, Maria; Huertas, Nelson; Ritchlin, Christopher T.] Univ Rochester, Med Ctr, Div Allergy Immunol & Rheumatol, 601 Elmwood Ave,Room 56216,Box 695, Rochester, NY 14642 USA; [Woeller, Collynn F.; Phipps, Richard P.] Univ Rochester, Med Ctr, Dept Environm Med, Rochester, NY USA; [Zhang, Hengwei; Xing, Lianping] Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Rochester, NY USA; [Zhang, Hengwei; Xing, Lianping] Univ Rochester, Sch Med & Dent, Dept Pathol & Lab Med, Rochester, NY USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester	Paine, A (corresponding author), Univ Rochester, Med Ctr, Div Allergy Immunol & Rheumatol, 601 Elmwood Ave,Room 56216,Box 695, Rochester, NY 14642 USA.	ananta_paine@urmc.rochester.edu		ritchlin, christopher/0000-0002-2602-1219; Garcia-Hernandez, Maria de la luz/0000-0001-9268-2464; Woeller, Collynn/0000-0001-7197-5057	Lung Biology Strategic Plan High Risk Project Pilot Research Award; Health Sciences Research Using High Performance Computational Resources (HSCCI) Pilot Grant; Department of Medicine Research Pilot Projects Award from University of Rochester; U.S. National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR0169000, AR063650, P30AR069655]; National Institute for Translational Sciences [5UL1TR000042-09]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR069000, R01AR063650, P30AR069655] Funding Source: NIH RePORTER	Lung Biology Strategic Plan High Risk Project Pilot Research Award; Health Sciences Research Using High Performance Computational Resources (HSCCI) Pilot Grant; Department of Medicine Research Pilot Projects Award from University of Rochester; U.S. National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute for Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Michael Thullen, Sarah Mack, and Christopher Dean (all from the University of Rochester) for excellent technical assistance with micro-CT and histological analysis; and Cheryl Ackert-Bicknell, Edward M. Schwarz, Michael John Zuscik, Jennifer Jonason, and Thomas J. Mariani (all from the University of Rochester) for assistance and helpful scientific discussions. This study was supported by funds from the Lung Biology Strategic Plan High Risk Project Pilot Research Award, a Health Sciences Research Using High Performance Computational Resources (HSCCI) Pilot Grant and a Department of Medicine Research Pilot Projects Award from University of Rochester; and from U.S. National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases Grants AR0169000, AR063650, and P30AR069655, and National Institute for Translational Sciences Grant 5UL1TR000042-09. The authors declare no conflicts of interest.	Albala C, 1996, INT J OBESITY, V20, P1027; Bar-Shavit Z, 2007, J CELL BIOCHEM, V102, P1130, DOI 10.1002/jcb.21553; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Chen HY, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/213234; Chen Q, 2016, CELL DEATH DIFFER, V23, P1128, DOI 10.1038/cdd.2015.168; Chen XD, 1999, J BONE MINER RES, V14, P362, DOI 10.1359/jbmr.1999.14.3.362; Chung MT, 2013, TISSUE ENG PT A, V19, P989, DOI [10.1089/ten.tea.2012.0370, 10.1089/ten.TEA.2012.0370]; Compston JE, 2014, J BONE MINER RES, V29, P487, DOI 10.1002/jbmr.2051; Doucette CR, 2015, J CELL PHYSIOL, V230, P2032, DOI 10.1002/jcp.24954; Garreta E, 2006, TISSUE ENG, V12, P2215, DOI 10.1089/ten.2006.12.2215; Genant HK, 2006, ANN NY ACAD SCI, V1068, P410, DOI 10.1196/annals.1346.038; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Hosoya A, 2012, HISTOCHEM CELL BIOL, V137, P733, DOI 10.1007/s00418-012-0928-1; Issever AS, 2009, J BONE MINER RES, V24, P1628, DOI [10.1359/JBMR.090311, 10.1359/jbmr.090311]; Justesen J, 2001, BIOGERONTOLOGY, V2, P165, DOI 10.1023/A:1011513223894; Kim YK, 2016, STEM CELL TRANSL MED, V5, P227, DOI 10.5966/sctm.2015-0013; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Koumas L, 2003, AM J PATHOL, V163, P1291, DOI 10.1016/S0002-9440(10)63488-8; Lehmann GM, 2010, AM J PHYSIOL-CELL PH, V299, pC672, DOI 10.1152/ajpcell.00451.2009; Pino AM, 2012, BIOL RES, V45, P279, DOI 10.4067/S0716-97602012000300009; McNiece I, 2000, EXP HEMATOL, V28, P1312, DOI 10.1016/S0301-472X(00)00609-3; MEUNIER P, 1971, CLIN ORTHOP RELAT R, P147, DOI 10.1097/00003086-197110000-00021; Paine A, 2012, J IMMUNOL, V188, P1620, DOI 10.4049/jimmunol.1100181; PHIPPS RP, 1989, AM J RESP CELL MOL, V1, P65, DOI 10.1165/ajrcmb/1.1.65; QUARLES LD, 1992, J BONE MINER RES, V7, P683; Rege TA, 2006, BBA-MOL CELL RES, V1763, P991, DOI 10.1016/j.bbamcr.2006.08.008; Rege TA, 2006, FASEB J, V20, P1045, DOI 10.1096/fj.05-5460rev; REIF AE, 1964, NATURE, V203, P886, DOI 10.1038/203886a0; RIBOT C, 1994, ADV NUTR RES, V9, P257; Rodan GA, 1998, P NATL ACAD SCI USA, V95, P13361, DOI 10.1073/pnas.95.23.13361; Shi JX, 2014, ARTHRITIS RHEUMATOL, V66, P657, DOI 10.1002/art.38278; Sogaard AJ, 2015, J INTERN MED, V277, P306, DOI 10.1111/joim.12230; Takahashi T, 2011, CALCIFIED TISSUE INT, V88, P336, DOI 10.1007/s00223-011-9461-9; Watts NB, 2014, NAT REV ENDOCRINOL, V10, P412, DOI 10.1038/nrendo.2014.55; Woeller CF, 2017, TOXICOL SCI, V157, P305, DOI 10.1093/toxsci/kfx046; Woeller CF, 2015, FASEB J, V29, P920, DOI 10.1096/fj.14-257121; Yeung DKW, 2005, J MAGN RESON IMAGING, V22, P279, DOI 10.1002/jmri.20367; Zhang LZ, 2016, BONE RES, V4, DOI 10.1038/boneres.2015.37	39	20	21	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3174	3183		10.1096/fj.201701379R	http://dx.doi.org/10.1096/fj.201701379R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401595	Green Published			2022-12-28	WOS:000432546000023
J	Shoemark, DK; Sessions, RB; Brancaccio, A; Bigotti, MG				Shoemark, Deborah K.; Sessions, Richard B.; Brancaccio, Andrea; Bigotti, Maria Giulia			Intraring allostery controls the function and assembly of a hetero-oligomeric class II chaperonin	FASEB JOURNAL			English	Article						molecular chaperones; protein folding; molecular dynamics	TRANSIENT KINETIC-ANALYSIS; CRYO-EM STRUCTURE; EUKARYOTIC CHAPERONIN; ATP HYDROLYSIS; CRYSTAL-STRUCTURE; CCT; COOPERATIVITY; MECHANISM; THERMOSOME; REVEALS	Class II chaperonins are essential multisubunit complexes that aid the folding of nonnative proteins in the cytosol of archaea and eukarya. They use energy derived from ATP to drive a series of structural rearrangements that enable polypeptides to fold within their central cavity. These events are regulated by an elaborate allosteric mechanism in need of elucidation. We employed mutagenesis and experimental analysis in concert with in silico molecular dynamics simulations and interface-binding energy calculations to investigate the class II chaperonin from Thermoplasma acidophilum. Here we describe the effects on the asymmetric allosteric mechanism and on hetero-oligomeric complex formation in a panel of mutants in the ATP-binding pocket of the alpha and beta subunits. Our observations reveal a potential model for a nonconcerted folding mechanism optimized for protecting and refolding a range of nonnative substrates under different environmental conditions, starting to unravel the role of subunit heterogeneity in this folding machine and establishing important links with the behavior of the most complex eukaryotic chaperonins..	[Shoemark, Deborah K.; Sessions, Richard B.; Brancaccio, Andrea; Bigotti, Maria Giulia] Univ Bristol, Dept Biochem, Univ Walk, Bristol BS8 1TD, Avon, England; [Brancaccio, Andrea] Univ Cattolica Sacro Cuore, CNR, Ist Chim Riconoscimento Mol, Rome, Italy	University of Bristol; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR)	Bigotti, MG (corresponding author), Univ Bristol, Dept Biochem, Univ Walk, Bristol BS8 1TD, Avon, England.	g.bigotti@bristol.ac.uk	Brancaccio, Andrea/C-5876-2009; Shoemark, Deborah K/S-6236-2018	Brancaccio, Andrea/0000-0003-4690-8826; Sessions, Richard/0000-0003-0320-0895; /0000-0002-1240-8463; Bigotti, Giulia/0000-0001-9595-3338	Wellcome Trust Research Career Reentry Fellowship [097350/Z/11/Z]; BBSRC [BB/L01386X/1, BB/K004050/1] Funding Source: UKRI; EPSRC [EP/L000253/1, EP/M022609/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K004050/1, BB/L01386X/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/M022609/1, EP/L000253/1] Funding Source: researchfish	Wellcome Trust Research Career Reentry Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors thank the Advanced Computing Research Centre at Bristol University (BlueCrystal) for access to computational resources and High-End Computing (HEC)Bioism for allocating time on Archer, the UK Supercomputer. This work was supported by Wellcome Trust Research Career Reentry Fellowship (097350/Z/11/Z to M.G.B). The authors declare no conflicts of interest.	Amit M, 2010, J MOL BIOL, V401, P532, DOI 10.1016/j.jmb.2010.06.037; Bigotti MG, 2006, J MOL BIOL, V362, P835, DOI 10.1016/j.jmb.2006.07.064; Bigotti MG, 2005, J MOL BIOL, V348, P13, DOI 10.1016/j.jmb.2005.01.066; Chaston JJ, 2016, STRUCTURE, V24, P364, DOI 10.1016/j.str.2015.12.016; Clare DK, 2008, STRUCTURE, V16, P528, DOI 10.1016/j.str.2008.01.016; Cong Y, 2010, P NATL ACAD SCI USA, V107, P4967, DOI 10.1073/pnas.0913774107; de Macario EC, 2017, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00084; Dekker C, 2011, EMBO J, V30, P3078, DOI 10.1038/emboj.2011.208; Ditzel L, 1998, CELL, V93, P125, DOI 10.1016/S0092-8674(00)81152-6; Douglas NR, 2011, CELL, V144, P240, DOI 10.1016/j.cell.2010.12.017; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gruber R, 2017, P NATL ACAD SCI USA, V114, P5189, DOI 10.1073/pnas.1617746114; Gutsche I, 2000, J MOL BIOL, V300, P187, DOI 10.1006/jmbi.2000.3833; HARDER KW, 1994, BIOCHEM J, V298, P395, DOI 10.1042/bj2980395; Huo YW, 2010, STRUCTURE, V18, P1270, DOI 10.1016/j.str.2010.07.009; Jiang Y, 2011, P NATL ACAD SCI USA, V108, P16962, DOI 10.1073/pnas.1112244108; Joachimiak LA, 2014, CELL, V159, P1042, DOI 10.1016/j.cell.2014.10.042; Kafri G, 2003, J MOL BIOL, V326, P981, DOI 10.1016/S0022-2836(03)00046-9; Kalisman N, 2013, STRUCTURE, V21, P540, DOI 10.1016/j.str.2013.01.017; Kapatai G, 2006, MOL MICROBIOL, V61, P1583, DOI 10.1111/j.1365-2958.2006.05324.x; Korobko I, 2016, J MOL BIOL, V428, P4520, DOI 10.1016/j.jmb.2016.09.017; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Lin P, 1997, GENETICS, V147, P1609; Lin P, 1997, P NATL ACAD SCI USA, V94, P10780, DOI 10.1073/pnas.94.20.10780; Lopez T, 2017, NAT STRUCT MOL BIOL, V24, P726, DOI 10.1038/nsmb.3440; Lopez T, 2015, J MOL BIOL, V427, P2919, DOI 10.1016/j.jmb.2015.04.013; McIntosh-Smith S, 2015, INT J HIGH PERFORM C, V29, P119, DOI 10.1177/1094342014528252; MONERA OD, 1994, PROTEIN SCI, V3, P1984, DOI 10.1002/pro.5560031110; Nitsch M, 1998, NAT STRUCT BIOL, V5, P855, DOI 10.1038/2296; Paul DM, 2016, SCI REP-UK, V6, DOI 10.1038/srep20696; Pereira JH, 2010, J BIOL CHEM, V285, P27958, DOI 10.1074/jbc.M110.125344; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reissmann S, 2012, CELL REP, V2, P866, DOI 10.1016/j.celrep.2012.08.036; Rivenzon-Segal D, 2005, NAT STRUCT MOL BIOL, V12, P233, DOI 10.1038/nsmb901; Schoehn G, 2000, J MOL BIOL, V301, P323, DOI 10.1006/jmbi.2000.3952; Shimon L, 2008, J MOL BIOL, V377, P469, DOI 10.1016/j.jmb.2008.01.011; Skjaerven L, 2015, FEBS LETT, V589, P2522, DOI 10.1016/j.febslet.2015.06.019; Staniforth RA, 1998, J MOL BIOL, V275, P133, DOI 10.1006/jmbi.1997.1409; Tordai H, 2005, FEBS J, V272, P5064, DOI 10.1111/j.1742-4658.2005.04917.x; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; WEISS C, 1995, J BIOL CHEM, V270, P13956, DOI 10.1074/jbc.270.23.13956; Wood CW, 2017, BIOINFORMATICS, V33, P3043, DOI 10.1093/bioinformatics/btx352; Wood CW, 2014, BIOINFORMATICS, V30, P3029, DOI 10.1093/bioinformatics/btu502; Yamamoto YY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176054; Zang YX, 2016, NAT STRUCT MOL BIOL, V23, P1083, DOI 10.1038/nsmb.3309; Zhang JJ, 2011, STRUCTURE, V19, P633, DOI 10.1016/j.str.2011.03.005; Zhang JJ, 2010, NATURE, V463, P379, DOI 10.1038/nature08701	47	0	0	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2223	2234		10.1096/fj.201701061R	http://dx.doi.org/10.1096/fj.201701061R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29233859	Green Published, Green Submitted			2022-12-28	WOS:000429051400040
J	Yang, WL; Mei, FC; Cheng, XD				Yang, Wenli; Mei, Fang C.; Cheng, Xiaodong			EPAC1 regulates endothelial annexin A2 cell surface translocation and plasminogen activation	FASEB JOURNAL			English	Article						fibrinolysis; PLC; plasmin; cAMP; PKC	PROTEIN-KINASE-C; PHOSPHOLIPASE-C; CYCLIC-AMP; CAMP EPAC; PHOSPHORYLATION; RECEPTOR; P36; FIBRINOLYSIS; SUBSTRATE; PATHWAY	Annexins, a family of highly conserved calcium- and phospholipid-binding proteins, play important roles in a wide range of physiologic functions. Among the 12 known annexins in humans, annexin A2 (AnxA2) is one of the most extensively studied and has been implicated in various human diseases. AnxA2 can exist as a monomer or a heterotetrameric complex with S100A10 (P11) and plays a critical role in many cellular processes, including exocytosis, endocytosis, and membrane organization. At the endothelial cell surface, the (AnxA2P11)(2) tetrameracting as a coreceptor for plasminogen and tissue plasminogen activator (tPA)-accelerates tPA-dependent activation of the fibrinolytic protease, plasmin, the enzyme that is responsible for thrombus dissolution and the degradation of fibrin. This study demonstrates that EPAC1 (exchange proteins directly activated by cAMP isoform 1) interacts with AnxA2 and regulates its biologic functions by modulating its membrane translocation in endothelial cells. By using genetic and pharmacologic approaches, we demonstrate that EPAC1acting via the PLC epsilon-PKC pathwayinhibits AnxA2 surface translocation and plasminogen activation. These results suggest that EPAC1 plays a role in the regulation of fibrinolysis in endothelial cells and may represent a novel therapeutic target for disorders of fibrinolysis.	[Yang, Wenli; Mei, Fang C.; Cheng, Xiaodong] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Texas Therapeut Inst, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Cheng, XD (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, 6431 Fannin St, Houston, TX 77030 USA.	xiaodong.cheng@uth.tmc.edu	Cheng, Xiaodong/O-8176-2019	Cheng, Xiaodong/0000-0002-3479-1694	U.S. National Institutes of Health [R01-GM066170, R35-GM122536, R01-AI111464]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI111464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066170, R35GM122536] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Pei Luo (University of Texas Health Science Center) for helping designing the real-time PCR primers. The authors are indebted to Dr. Alan V. Smrcka's laboratory (University of Michigan, Ann Arbor, MI, USA) for generous gifts of anti-PLC epsilon Ab and other related reagents for this study. This work was supported by U.S. National Institutes of Health Grants R01-GM066170, R35-GM122536 (National Institute of General Medical Sciences), and R01-AI111464 (National Institute of Allergy and Infectious Diseases). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest.	Almahariq M, 2013, MOL PHARMACOL, V83, P122, DOI 10.1124/mol.112.080689; Brandherm I, 2013, BLOOD, V122, P1042, DOI 10.1182/blood-2012-12-475251; Canas F, 2015, THROMB RES, V135, P226, DOI 10.1016/j.thromres.2014.11.034; Cesarman-Maus G, 2005, BRIT J HAEMATOL, V129, P307, DOI 10.1111/j.1365-2141.2005.05444.x; Chen HJ, 2013, TETRAHEDRON LETT, V54, P1546, DOI 10.1016/j.tetlet.2013.01.024; Cheng XD, 2008, ACTA BIOCH BIOPH SIN, V40, P651, DOI 10.1111/j.1745-7270.2008.00438.x; Deora AB, 2004, J BIOL CHEM, V279, P43411, DOI 10.1074/jbc.M408078200; Fang Y, 2007, J PHARMACOL EXP THER, V322, P1189, DOI 10.1124/jpet.107.119933; Foley JH, 2017, SEMIN THROMB HEMOST, V43, P135, DOI 10.1055/s-0036-1592302; GLENNEY JR, 1985, P NATL ACAD SCI USA, V82, P7884, DOI 10.1073/pnas.82.23.7884; GOULD KL, 1986, MOL CELL BIOL, V6, P2738, DOI 10.1128/MCB.6.7.2738; Grindheim AK, 2017, BBA-GEN SUBJECTS, V1861, P2515, DOI 10.1016/j.bbagen.2017.08.024; Hajjar KA, 1999, TRENDS CARDIOVAS MED, V9, P128, DOI 10.1016/S1050-1738(99)00020-1; Hajjar KA, 1996, J BIOL CHEM, V271, P21652, DOI 10.1074/jbc.271.35.21652; Hajjar Katherine A, 2015, Trans Am Clin Climatol Assoc, V126, P144; He KL, 2011, J BIOL CHEM, V286, P15428, DOI 10.1074/jbc.M110.185058; He KL, 2008, J BIOL CHEM, V283, P19192, DOI 10.1074/jbc.M800100200; Huang BH, 2011, BLOOD, V118, P2918, DOI 10.1182/blood-2011-03-341214; ISACKE CM, 1986, MOL CELL BIOL, V6, P2745, DOI 10.1128/MCB.6.7.2745; JOHNSSON N, 1986, EMBO J, V5, P3455, DOI 10.1002/j.1460-2075.1986.tb04669.x; Jost M, 1996, BBA-MOL CELL RES, V1313, P283, DOI 10.1016/0167-4889(96)00101-2; KHANNNA NC, 1986, BIOCHEM BIOPH RES CO, V137, P397, DOI 10.1016/0006-291X(86)91223-4; Ling Q, 2004, J CLIN INVEST, V113, P38, DOI 10.1172/JCI200419684; Luo M, 2017, J EXP MED, V214, P2535, DOI 10.1084/jem.20160652; Luo W, 2008, MOL CARCINOGEN, V47, P934, DOI 10.1002/mc.20445; Madureira PA, 2011, BLOOD, V118, P4789, DOI 10.1182/blood-2011-06-334672; Mei FC, 2005, MOL BIOSYST, V1, P325, DOI 10.1039/b511267b; Menell JS, 1999, NEW ENGL J MED, V340, P994, DOI 10.1056/NEJM199904013401303; Nygaard G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08975-y; Oestreich EA, 2009, J BIOL CHEM, V284, P1514, DOI 10.1074/jbc.M806994200; Parnell E, 2014, BIOCHEM SOC T, V42, P274, DOI 10.1042/BST20130271; Parnell E, 2012, BRIT J PHARMACOL, V166, P434, DOI 10.1111/j.1476-5381.2011.01808.x; Peterson EA, 2003, J CELL SCI, V116, P2399, DOI 10.1242/jcs.00434; RADKE K, 1979, P NATL ACAD SCI USA, V76, P5212, DOI 10.1073/pnas.76.10.5212; REGNOUF F, 1995, J BIOL CHEM, V270, P27143, DOI 10.1074/jbc.270.45.27143; Sands WA, 2005, BIOCHEM SOC T, V33, P1126, DOI 10.1042/BST0331126; Schlegel N, 2014, CELL TISSUE RES, V355, P587, DOI 10.1007/s00441-013-1755-y; Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020; THIEL C, 1992, J CELL SCI, V103, P733; Vliem MJ, 2008, CHEMBIOCHEM, V9, P2052, DOI 10.1002/cbic.200800216; Wang H, 2005, CIRC RES, V97, P1305, DOI 10.1161/01.RES.0000196578.15385.bb; Welling TH, 1996, J SURG RES, V66, P36, DOI 10.1006/jsre.1996.0369; Ye N, 2015, J MED CHEM, V58, P6033, DOI 10.1021/acs.jmedchem.5b00635	43	11	12	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2212	2222		10.1096/fj.201701027R	http://dx.doi.org/10.1096/fj.201701027R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29217666	Green Submitted, Green Published			2022-12-28	WOS:000429051400039
J	Marchbank, T; Playford, RJ				Marchbank, Tania; Playford, Raymond J.			Trefoil factor family peptides enhance cell migration by increasing cellular osmotic permeability and aquaporin 3 levels	FASEB JOURNAL			English	Article						repair; gastrointestinal; regulatory peptides; growth factors; pathophysiology	EPIDERMAL-GROWTH-FACTOR; SECRETORY TRYPSIN-INHIBITOR; INFLAMMATORY-BOWEL-DISEASE; WATER PERMEABILITY; EPITHELIAL BARRIER; IN-VITRO; MICE; PS2; ADENOCARCINOMA; PROLIFERATION	Trefoil factor family (TFF) peptides are produced rapidly at sites of injury, stimulating epithelial migration, a process involving rapid changes in cell shape and volume, requiring rapid flow of water into and out of the cell. We examined the effect of TFFs on fluidity of cells by measuring their sensitivity to osmotic challenges and cell migration, and determined whether those results were mediated through altering the levels of aquaporins (AQPs), a family of transmembrane water channels involved in cellular water homeostasis. Gastric (AGS) and colonic (Caco-2) cell lines had intrinsic TFF levels determined and the predominant TFF peptide knocked down (RNA interference). Knockdown caused lessened responsiveness to changes in external osmotic challenge (by 51 and 69% in AGS and Caco-2 cells, respectively) and reduced cell migration and transepithelial permeability but did not influence proliferation. Exogenous TFF increased several AQPs, particularly AQP3, and those were reciprocally reduced in knockdown cells. TFF-induced, but not fetal calf serum-induced, cell migration was inhibited by the presence of AQP3 blocker (CuSO4). We summarize that TFF peptides promptly produced at sites of injury increase AQP levels, most notably AQP3, thereby enhancing the cells' ability to rapidly change their shape as part of the restitutive process. TFF peptides also require functioning AQP3 channels to induce cell migration.	[Marchbank, Tania; Playford, Raymond J.] Plymouth Univ Peninsula Sch Med & Dent, John Bull Bldg,Tamar Sci Pk,Res Way, Plymouth PL6 8BU, Devon, England		Playford, RJ (corresponding author), Plymouth Univ Peninsula Sch Med & Dent, John Bull Bldg,Tamar Sci Pk,Res Way, Plymouth PL6 8BU, Devon, England.	raymond.playford@plymouth.ac.uk		Playford, Raymond/0000-0003-1235-8504				BARRANCO SC, 1983, CANCER RES, V43, P1703; CHINERY R, 1995, CLIN SCI, V88, P401, DOI 10.1042/cs0880401; Fenton RA, 2010, AM J PHYSIOL-RENAL, V298, pF224, DOI 10.1152/ajprenal.00463.2009; FitzGerald AJ, 2004, PEPTIDES, V25, P793, DOI 10.1016/j.peptides.2003.12.022; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Graness A, 2002, J BIOL CHEM, V277, P18440, DOI 10.1074/jbc.M200468200; Hara-Chikuma M, 2008, J MOL MED-JMM, V86, P221, DOI 10.1007/s00109-007-0272-4; Huang YM, 2010, CANCER BIOL THER, V9, P1000, DOI 10.4161/cbt.9.12.11705; Jaeger M, 1999, BIOPHYS J, V77, P1257, DOI 10.1016/S0006-3495(99)76977-8; Kjellev S, 2009, CELL MOL LIFE SCI, V66, P1350, DOI 10.1007/s00018-008-8646-5; Lin N, 2013, BIOCHEM BIOPH RES CO, V440, P143, DOI 10.1016/j.bbrc.2013.09.049; Marchbank T, 1998, J PATHOL, V185, P153; Marchbank T, 2013, AM J PHYSIOL-RENAL, V305, pF382, DOI 10.1152/ajprenal.00357.2012; Marchbank T, 2009, AM J PHYSIOL-GASTR L, V296, pG697, DOI 10.1152/ajpgi.90565.2008; Martini E, 2017, CELL MOL GASTROENTER, V4, P33, DOI 10.1016/j.jcmgh.2017.03.007; Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262; Matsuzaki Toshiyuki, 2004, Medical Electron Microscopy, V37, P71; Meir M, 2015, AM J PHYSIOL-GASTR L, V309, pG613, DOI 10.1152/ajpgi.00357.2014; Murphy MS, 1998, NUTRITION, V14, P771, DOI 10.1016/S0899-9007(98)00081-1; NUNEZ AM, 1989, EMBO J, V8, P823, DOI 10.1002/j.1460-2075.1989.tb03443.x; Papadopoulos MC, 2008, PFLUG ARCH EUR J PHY, V456, P693, DOI 10.1007/s00424-007-0357-5; PLAYFORD RJ, 1995, GUT, V37, P595, DOI 10.1136/gut.37.5.595; PLAYFORD RJ, 1995, GASTROENTEROLOGY, V108, P108, DOI 10.1016/0016-5085(95)90014-4; Playford RJ, 1996, P NATL ACAD SCI USA, V93, P2137, DOI 10.1073/pnas.93.5.2137; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680; Solenov E, 2004, AM J PHYSIOL-CELL PH, V286, pC426, DOI 10.1152/ajpcell.00298.2003; Sturm A, 2008, WORLD J GASTROENTERO, V14, P348, DOI 10.3748/wjg.14.348; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Thiagarajah JR, 2017, P NATL ACAD SCI USA, V114, P568, DOI 10.1073/pnas.1612921114; Verkman AS, 2011, J CELL SCI, V124, P2107, DOI 10.1242/jcs.079467; Wang JP, 2012, CANCER LETT, V319, P109, DOI 10.1016/j.canlet.2011.12.040; Yang PC, 2007, J GASTROEN HEPATOL, V22, P1823, DOI 10.1111/j.1440-1746.2006.04710.x; Zelenina M, 2004, J BIOL CHEM, V279, P51939, DOI 10.1074/jbc.M407645200; Zhu C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091399	35	7	7	2	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					1017	1024		10.1096/fj.201700799R	http://dx.doi.org/10.1096/fj.201700799R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29046361	Green Submitted			2022-12-28	WOS:000425146900041
J	Rahman, SS; Moffitt, AEJ; Trease, AJ; Foster, KW; Storck, MD; Band, H; Boesen, EI				Rahman, Shamma S.; Moffitt, Alexandra E. J.; Trease, Andrew J.; Foster, Kirk W.; Storck, Matthew D.; Band, Hamid; Boesen, Erika I.			EHD4 is a novel regulator of urinary water homeostasis	FASEB JOURNAL			English	Article						endocytic recycling; arginine vasopressin; aquaporin-2; aquaporin-4	KIDNEY COLLECTING DUCT; SHORT-TERM STIMULATION; THICK ASCENDING LIMB; AQP2 TRAFFICKING; SUBCELLULAR-LOCALIZATION; AQUAPORIN-2 TRAFFICKING; DIFFERENTIAL REGULATION; MEMBRANE TRANSLOCATION; CL-COTRANSPORTER; PLASMA-MEMBRANE	The Eps15-homology domain-containing (EHD) protein family comprises 4 members that regulate endocytic recycling. Although the kidney expresses all 4 EHD proteins, their physiologic roles are largely unknown. This study focused on EHD4, which we found to be expressed differentially across nephron segments with the highest expression in the innermedullary collecting duct. Under baseline conditions, Ehd42/2 [EHD4-knockout (KO)] mice on a C57Bl/6 background excreted a higher volume of more dilute urine than control C57Bl/6 wild-type (WT) mice while maintaining a similar plasma osmolality. Urine excretion after an acute intraperitoneal water load was significantly increased in EHD4-KO mice compared to WT mice, and although EHD4-KO mice concentrated their urine during 24-h water restriction, urinary osmolality remained significantly lower than in WT mice, suggesting that EHD4 plays a role in renal water handling. Total aquaporin 2 (AQP2) and phospho-S256-AQP2 (pAQP2) protein expression in the inner medulla was similar in the two groups in baseline conditions. However, localization of both AQP2 and pAQP2 in the renal innermedullary principal cells appeared more dispersed, and the intensity of apical membrane staining for AQP2 was reduced significantly (by similar to 20%) in EHD4-KO mice compared to WT mice in baseline conditions, suggesting an important role of EHD4 in trafficking of AQP2. Together, these data indicate that EHD4 play important roles in the regulation of water homeostasis.-Rahman, S. S., Moffitt, A. E. J., Trease, A. J., Foster, K. W., Storck, M. D., Band, H., Boesen, E. I. EHD4 is a novel regulator of urinary water homeostasis.	[Rahman, Shamma S.; Boesen, Erika I.] Univ Nebraska Med Ctr, Dept Cellular & Integrat Physiol, 985850 Nebraska Med Ctr,Room DRC1-5005, Omaha, NE 68198 USA; [Moffitt, Alexandra E. J.; Storck, Matthew D.; Band, Hamid] Univ Nebraska Med Ctr, Eppley Inst Res Canc, Omaha, NE 68198 USA; [Trease, Andrew J.; Band, Hamid] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Foster, Kirk W.; Band, Hamid] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Band, Hamid] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA; [Band, Hamid] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA; [Band, Hamid] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Boesen, EI (corresponding author), Univ Nebraska Med Ctr, Dept Cellular & Integrat Physiol, 985850 Nebraska Med Ctr,Room DRC1-5005, Omaha, NE 68198 USA.; Band, H (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, 985950 Nebraska Med Ctr, Omaha, NE 68198 USA.	hband@unmc.edu; erika.boesen@unmc.edu	Rahman, Shamma/L-6142-2018; Band, Hamid/AAF-4701-2020	Rahman, Shamma/0000-0003-2588-4466; Storck, Matthew/0000-0002-4029-8943; Boesen, Erika/0000-0002-5672-9197; Trease, Andrew/0000-0003-4912-6926	American Heart Association [15PRE25580003]; U.S. National Institutes of Health (NIH) Institutional Development Award (IDeA); NIH National Institute of General Medical Sciences [P30 GM106397]; NIH National Cancer Institute (NCI) [CA105489]; NCI Core Support Grant; NATIONAL CANCER INSTITUTE [R01CA105489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106397] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); U.S. National Institutes of Health (NIH) Institutional Development Award (IDeA); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI Core Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the following people of the University of Nebraska Medical Center for technical assistance: Eileen Marks for collection of IMCD and cortical proximal and distal tubular cells; Bangchen Wang for collection of mTAL; Timothy Bielecki for transfection of mpkCCD cells with shRNA; and Kaushik Patel and Xuefei Liu for collection of hypothalamic tissue. This work was supported by Predoctoral Fellowship 15PRE25580003 from the American Heart Association (to S.S.R.); a U.S. National Institutes of Health (NIH) Institutional Development Award (IDeA); NIH National Institute of General Medical Sciences Grant P30 GM106397 (to E.B. and H.B.); NIH National Cancer Institute (NCI) Grant CA105489 (to H.B.); and an NCI Core Support Grant to the Fred and Pamela Buffett Cancer Center. The authors declare no conflicts of interest.	Adrogue HJ, 2000, NEW ENGL J MED, V342, P1493, DOI 10.1056/NEJM200005183422006; Arnspang EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073977; Bouley R, 2006, BIOL CELL, V98, P215, DOI 10.1042/BC20040054; Braun A, 2005, MOL BIOL CELL, V16, P3642, DOI 10.1091/mbc.E05-01-0076; Brown D, 2003, AM J PHYSIOL-RENAL, V284, pF893, DOI 10.1152/ajprenal.00387.2002; Bugaj V, 2009, AM J PHYSIOL-RENAL, V297, pF1411, DOI 10.1152/ajprenal.00371.2009; Butterworth MB, 2009, AM J PHYSIOL-RENAL, V296, pF10, DOI 10.1152/ajprenal.90248.2008; Chou CL, 1998, AM J PHYSIOL-CELL PH, V274, pC549, DOI 10.1152/ajpcell.1998.274.2.C549; Chukkapalli S, 2014, CARCINOGENESIS, V35, P877, DOI 10.1093/carcin/bgt399; Curran J, 2014, CIRC RES, V115, P68, DOI 10.1161/CIRCRESAHA.115.304149; Gao Y, 2016, AM J PHYSIOL-RENAL, V311, pF1074, DOI 10.1152/ajprenal.00494.2016; George M, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-3; George M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017838; George M, 2010, GENESIS, V48, P328, DOI 10.1002/dvg.20620; Gimenez I, 2003, J BIOL CHEM, V278, P26946, DOI 10.1074/jbc.M303435200; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Grant BD, 2008, TRAFFIC, V9, P2043, DOI 10.1111/j.1600-0854.2008.00834.x; Gudmundsson H, 2012, J MOL CELL CARDIOL, V52, P1183, DOI 10.1016/j.yjmcc.2012.02.008; Gudmundsson H, 2010, CIRC RES, V107, P84, DOI 10.1161/CIRCRESAHA.110.216713; Gunaratne R, 2010, P NATL ACAD SCI USA, V107, P15653, DOI 10.1073/pnas.1007424107; Hasler U, 2002, J BIOL CHEM, V277, P10379, DOI 10.1074/jbc.M111880200; Hendriks G, 2004, J BIOL CHEM, V279, P2975, DOI 10.1074/jbc.M310767200; Ho HTB, 2000, MOL CELL BIOL, V20, P5840, DOI 10.1128/MCB.20.16.5840-5846.2000; Knepper MA, 2015, NEW ENGL J MED, V372, P1349, DOI 10.1056/NEJMra1404726; KOHAN DE, 1993, AM J PHYSIOL, V265, pF670, DOI 10.1152/ajprenal.1993.265.5.F670; Lee JW, 2015, J AM SOC NEPHROL, V26, P2669, DOI 10.1681/ASN.2014111067; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mutig K, 2010, AM J PHYSIOL-RENAL, V298, pF502, DOI 10.1152/ajprenal.00476.2009; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Naslavsky N, 2011, TRENDS CELL BIOL, V21, P122, DOI 10.1016/j.tcb.2010.10.003; Nedvetsky PI, 2007, TRAFFIC, V8, P110, DOI 10.1111/j.1600-0854.2006.00508.x; Nejsum LN, 2005, AM J PHYSIOL-RENAL, V288, pF930, DOI 10.1152/ajprenal.00291.2004; Nielsen S, 1996, P NATL ACAD SCI USA, V93, P5495, DOI 10.1073/pnas.93.11.5495; NIELSEN S, 1995, P NATL ACAD SCI USA, V92, P1013, DOI 10.1073/pnas.92.4.1013; Noda Y, 2006, BBA-BIOMEMBRANES, V1758, P1117, DOI 10.1016/j.bbamem.2006.03.004; Norregaard R, 2011, AM J PHYSIOL-RENAL, V301, pF1303, DOI 10.1152/ajprenal.00665.2010; Park EJ, 2013, AM J PHYSIOL-RENAL, V304, pF958, DOI 10.1152/ajprenal.00469.2012; Rapaport D, 2006, TRAFFIC, V7, P52, DOI 10.1111/j.1600-0854.2005.00359.x; Rieg T, 2013, AM J PATHOL, V182, P96, DOI 10.1016/j.ajpath.2012.09.014; Russo LM, 2006, AM J PHYSIOL-RENAL, V291, pF246, DOI 10.1152/ajprenal.00437.2005; Sauter D, 2006, KIDNEY INT, V69, P1024, DOI 10.1038/sj.ki.5000211; Simone LC, 2014, HISTOL HISTOPATHOL, V29, P285, DOI 10.14670/HH-29.285; Tajika Y, 2005, HISTOCHEM CELL BIOL, V124, P1, DOI 10.1007/s00418-005-0010-3; Tamma G, 2005, J CELL SCI, V118, P3623, DOI 10.1242/jcs.02495; U.S. National Institutes of Health National Heart Lung and Blood Institute, KIDN SYST BIOL PROJ; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; Vesey David A., 2009, V466, P19, DOI 10.1007/978-1-59745-352-3_2; VINAY P, 1981, AM J PHYSIOL, V241, pF403, DOI 10.1152/ajprenal.1981.241.4.F403; Welling PA, 2010, PHYSIOLOGY, V25, P280, DOI 10.1152/physiol.00022.2010; Yang J, 2009, AM J PHYSIOL-RENAL, V297, pF1220, DOI 10.1152/ajprenal.00314.2009	50	2	2	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5217	5233		10.1096/fj.201601182RR	http://dx.doi.org/10.1096/fj.201601182RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28778975	Green Published			2022-12-28	WOS:000416588300009
J	Ruegsegger, GN; Grigsby, KB; Kelty, TJ; Zidon, TM; Childs, TE; Vieira-Potter, VJ; Klinkebiel, DL; Matheny, M; Scarpace, PJ; Booth, FW				Ruegsegger, Gregory N.; Grigsby, Kolter B.; Kelty, Taylor J.; Zidon, Terese M.; Childs, Thomas E.; Vieira-Potter, Victoria J.; Klinkebiel, David L.; Matheny, Michael; Scarpace, Phillip J.; Booth, Frank W.			Maternal Western diet age-specifically alters female offspring voluntary physical activity and dopamine- and leptin-related gene expression	FASEB JOURNAL			English	Article						obesity; nucleus accumbens; VTA; in utero reprogramming	HIGH-FAT DIET; MU-OPIOID RECEPTOR; ENERGY-EXPENDITURE; OBESITY; INACTIVITY; EXERCISE; SENSITIVITY; MODULATION; PREGNANCY; TERM	Prenatal overnutrition affects development into adulthood and influences risk of obesity. We assessed the transgenerational effect of maternal Western diet (WD) consumption on offspring physical activity. Voluntary wheel running was increased in juvenile (4-7 wk of age), but decreased in adult (16-19 wk of age), F-1 female WD offspring. In contrast, no wheel-running differences in F-1 male offspring were observed. Increased wheel running in juvenile female WD offspring was associated with up-regulated dopamine receptor (DRD)-1 and -2 in the nucleus accumbens (NAc) and with down-regulated Lepr in the ventral tegmental area (VTA). Conversely, decreased wheel running by adult female WD offspring was associated with down-regulated DRD1 in the NAc and with up-regulated Lepr in the VTA. Body fat, leptin, and insulin were increased in male, but not in female, F-1 WD offspring. Recombinant virus (rAAV) leptin antagonism in the VTA decreased wheel running in standard diet but not in WD F1 female offspring. Analysis of F-2 offspring found no differences in wheel running or adiposity in male or female offspring, suggesting that changes in the F1 generation were related to in uterosomatic reprogramming. Our findings indicate prenatal WD exposure leads to age-specific changes in voluntary physical activity in female offspring that are differentially influenced by VTA leptin antagonism.	[Ruegsegger, Gregory N.; Grigsby, Kolter B.; Kelty, Taylor J.; Childs, Thomas E.; Booth, Frank W.] Univ Missouri, Dept Biomed Sci, E102 Vet Med Bldg,1600 E Rollins St, Columbia, MO 65211 USA; [Zidon, Terese M.; Vieira-Potter, Victoria J.; Booth, Frank W.] Univ Missouri, Dept Nutr & Exercise Physiol, Columbia, MO 65211 USA; [Booth, Frank W.] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO 65211 USA; [Booth, Frank W.] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA; [Klinkebiel, David L.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA; [Matheny, Michael; Scarpace, Phillip J.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Nebraska System; University of Nebraska Medical Center; State University System of Florida; University of Florida	Booth, FW (corresponding author), Univ Missouri, Dept Biomed Sci, E102 Vet Med Bldg,1600 E Rollins St, Columbia, MO 65211 USA.	boothf@missouri.edu		Ruegsegger, Gregory/0000-0002-8018-0456	College of Veterinary Medicine at the University of Missouri; American Heart Association [AHA 16PRE2715005]; University of Missouri Life Sciences Program	College of Veterinary Medicine at the University of Missouri; American Heart Association(American Heart Association); University of Missouri Life Sciences Program	This work was supported by grants from the College of Veterinary Medicine at the University of Missouri (to G.N.R. and F.W.B), American Heart Association Grant AHA 16PRE2715005 (to G.N.R.), and funding from the University of Missouri Life Sciences Program (to G.N.R.). The authors declare no conflicts of interest.	Baker MS, 2015, INT J OBESITY, V39, P98, DOI 10.1038/ijo.2013.146; Beeler JA, 2016, BIOL PSYCHIAT, V79, P887, DOI 10.1016/j.biopsych.2015.07.009; Booth FW, 2012, COMPR PHYSIOL, V2, P1143, DOI 10.1002/cphy.c110025; Catalano PM, 2006, BJOG-INT J OBSTET GY, V113, P1126, DOI 10.1111/j.1471-0528.2006.00989.x; Cunha FD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118586; Dearden L, 2014, ENDOCRINOLOGY, V155, P2144, DOI 10.1210/en.2014-1131; Desai M, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.025; Domingos AI, 2011, NAT NEUROSCI, V14, P1562, DOI 10.1038/nn.2977; Dunn GA, 2011, ENDOCRINOLOGY, V152, P2228, DOI 10.1210/en.2010-1461; Dunn GA, 2011, HORM BEHAV, V59, P290, DOI 10.1016/j.yhbeh.2010.05.004; Eclarinal JD, 2016, FASEB J, V30, P2541, DOI 10.1096/fj.201500018R; Ferezou-Viala J, 2007, AM J PHYSIOL-REG I, V293, pR1056, DOI 10.1152/ajpregu.00117.2007; Fernandes MFA, 2015, CELL METAB, V22, P741, DOI 10.1016/j.cmet.2015.08.003; Friend DM, 2017, CELL METAB, V25, P312, DOI 10.1016/j.cmet.2016.12.001; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Garland T, 2011, J EXP BIOL, V214, P206, DOI 10.1242/jeb.048397; Giraudo SQ, 2010, PHARMACOL BIOCHEM BE, V97, P121, DOI 10.1016/j.pbb.2010.04.017; Heerwagen MJR, 2010, AM J PHYSIOL-REG I, V299, pR711, DOI 10.1152/ajpregu.00310.2010; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; Johnson SA, 2017, J DEV ORIG HLTH DIS, V8, P75, DOI 10.1017/S2040174416000490; Khan LY, 2003, HYPERTENSION, V41, P168, DOI 10.1161/01.HYP.0000047511.97879.FC; Knab AM, 2010, INT J BIOL SCI, V6, P133; Kohl HW, 2012, LANCET, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Lawlor DA, 2011, CIRCULATION, V123, P258, DOI 10.1161/CIRCULATIONAHA.110.980169; Lecoutre S, 2016, J ENDOCRINOL, V230, P39, DOI 10.1530/JOE-16-0037; Li G, 2013, DIABETES, V62, P2773, DOI 10.2337/db12-1306; Matheny M, 2009, AM J PHYSIOL-REG I, V297, pR1254, DOI 10.1152/ajpregu.90449.2008; Meek TH, 2012, PHYSIOL BEHAV, V106, P252, DOI 10.1016/j.physbeh.2012.02.012; Mehta SH, 2012, J MATERN-FETAL NEO M, V25, P41, DOI 10.3109/14767058.2012.626927; Ong ZY, 2011, FASEB J, V25, P2167, DOI 10.1096/fj.10-178392; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Rhodes JS, 2005, INTEGR COMP BIOL, V45, P438, DOI 10.1093/icb/45.3.438; Rhodes JS, 2003, PSYCHOPHARMACOLOGY, V167, P242, DOI 10.1007/s00213-003-1399-9; Roberts MD, 2014, J PHYSIOL-LONDON, V592, P2119, DOI 10.1113/jphysiol.2013.268805; Roberts MD, 2013, AM J PHYSIOL-REG I, V304, pR1024, DOI 10.1152/ajpregu.00581.2012; Roberts MD, 2012, PHYSIOL BEHAV, V105, P661, DOI 10.1016/j.physbeh.2011.09.024; Rowland TW, 1998, MED SCI SPORT EXER, V30, P392, DOI 10.1097/00005768-199803000-00009; Ruegsegger GN, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00109; Ruegsegger GN, 2015, PHYSIOL BEHAV, V152, P47, DOI 10.1016/j.physbeh.2015.09.004; Ruegsegger GN, 2015, NEUROPHARMACOLOGY, V97, P171, DOI 10.1016/j.neuropharm.2015.05.022; Vickers MH, 2003, AM J PHYSIOL-REG I, V285, pR271, DOI 10.1152/ajpregu.00051.2003; Vucetic Z, 2012, J NEUROCHEM, V120, P891, DOI 10.1111/j.1471-4159.2012.07649.x; Vucetic Z, 2011, NEUROPSYCHOPHARMACOL, V36, P1199, DOI 10.1038/npp.2011.4; Vucetic Z, 2010, ENDOCRINOLOGY, V151, P4756, DOI 10.1210/en.2010-0505; White CL, 2009, AM J PHYSIOL-REG I, V296, pR1464, DOI 10.1152/ajpregu.91015.2008; Yogev Y, 2009, OBSTET GYN CLIN N AM, V36, pviii; Yogev Y, 2009, OBSTET GYN CLIN N AM, V36, P285, DOI 10.1016/j.ogc.2009.03.003	48	12	12	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5371	5383		10.1096/fj.201700389R	http://dx.doi.org/10.1096/fj.201700389R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28794174				2022-12-28	WOS:000416588300021
J	Horii, N; Uchida, M; Hasegawa, N; Fujie, S; Oyanagi, E; Yano, H; Hashimoto, T; Iemitsu, M				Horii, Naoki; Uchida, Masataka; Hasegawa, Natsuki; Fujie, Shumpei; Oyanagi, Eri; Yano, Hiromi; Hashimoto, Takeshi; Iemitsu, Motoyuki			Resistance training prevents muscle fibrosis and atrophy via down-regulation of C1q-induced Wnt signaling in senescent mice	FASEB JOURNAL			English	Article						aging; sarcopenia; muscle regeneration	DIFFERENT FIBER TYPES; STEM-CELL FATE; SKELETAL-MUSCLE; BODY-COMPOSITION; EXERCISE; SARCOPENIA; HYPERTROPHY; RATS; C1Q; ACTIVATION	Increased complement component 1q (C1q) secretion with aging leads to muscle fibrosis and atrophy whereas resistance training attenuates circulating C1q levels. This study aimed to clarify whether resistance exercise-induced reduction of C1q secretion contributes to the inhibition of fibrosis and atrophy in aged muscles. Young (13-wk-old) and aged (38-wk-old) senescence-accelerated mouse prone 1 mice were randomly assigned to one of 4 groups: a young or aged sedentary control group, or a young or aged resistance training (climbing a ladder 3 d/wk for 12 wk) group. We found that resistance training ameliorated muscle fibrosis and atrophy in aged mice, concomitant with decreased circulating and muscle C1q levels and attenuated activation of muscle Wnt signaling (glycogen synthase kinase beta/beta-catenin), including beta-catenin in satellite (Pax7(+)/DAPI(+)) and fibroblast (vimentin(+)/DAPI(+)) cells. Furthermore, during muscle regeneration after mice were injured by cardiotoxin injection, we observed a reduction in circulating C1q levels, the inhibition of muscle fibrosis and repair, and decreased in the activation of muscle cytoplasmic and nuclear beta-catenin in aged mice from the resistance training group, but these effects were cancelled by a single preadministration of exogenous recombinant C1q. In addition, resistance training attenuated aging-related muscle loss concomitant with decreased expression of both muscle ring-finger protein 1 and muscle atrophy F-box in the muscle. Thus, resistance training-induced changes in circulating C1q levels may contribute to the prevention of muscle fibrosis and atrophy via muscle Wnt signaling in senescent mice.-Horii, N., Uchida, M., Hasegawa, N., Fujie, S., Oyanagi, E., Yano, H., Hashimoto, T., Iemitsu, M. Resistance training prevents muscle fibrosis and atrophy via down-regulation of C1q-induced Wnt signaling in senescent mice.	[Horii, Naoki; Uchida, Masataka; Hasegawa, Natsuki; Fujie, Shumpei; Hashimoto, Takeshi; Iemitsu, Motoyuki] Ritsumeikan Univ, Fac Sport & Hlth Sci, 1-1-1 Nojihigashi, Shiga 5258577, Japan; [Hasegawa, Natsuki; Fujie, Shumpei] Japan Soc Promot Sci, Tokyo, Japan; [Oyanagi, Eri; Yano, Hiromi] Kawasaki Univ Med Welf, Dept Hlth & Sports Sci, Okayama, Japan	Ritsumeikan University; Japan Society for the Promotion of Science	Iemitsu, M (corresponding author), Ritsumeikan Univ, Fac Sport & Hlth Sci, 1-1-1 Nojihigashi, Shiga 5258577, Japan.	iemitsu@fc.ritsumei.ac.jp			Japan Science Society [29-628]; Japanese Ministry of Education, Culture, Sports, Science, and Technology (KAKENHI) [16K13059, 17H02182]; Grants-in-Aid for Scientific Research [15H03091, 17H02182] Funding Source: KAKEN	Japan Science Society; Japanese Ministry of Education, Culture, Sports, Science, and Technology (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (KAKENHI; 17H02182 and 16K13059 to M.I.), and the Sasakawa Scientific Research Grant from the Japan Science Society (29-628 to N.H.). The authors declare no conflicts of interest.	Armstrong DD, 2005, AM J PHYSIOL-CELL PH, V289, pC853, DOI 10.1152/ajpcell.00093.2005; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Bazgir B, 2017, CELL J, V18, P473; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; EVANS WJ, 1993, J NUTR, V123, P465, DOI 10.1093/jn/123.suppl_2.465; Gale CR, 2007, INT J EPIDEMIOL, V36, P228, DOI 10.1093/ije/dyl224; Gasier HG, 2011, ACTA PHYSIOL, V201, P381, DOI 10.1111/j.1748-1716.2010.02183.x; Haramizu S, 2011, J APPL PHYSIOL, V111, P1654, DOI 10.1152/japplphysiol.01434.2010; Horii N, 2016, HORM METAB RES, V48, P207, DOI 10.1055/s-0035-1564132; Horii N, 2017, AM J PHYSIOL-REG I, V312, pR520, DOI 10.1152/ajpregu.00383.2016; Hornberger TA, 2004, CAN J APPL PHYSIOL, V29, P16, DOI 10.1139/h04-002; Iemitsu M, 2002, AM J PHYSIOL-HEART C, V283, pH1750, DOI 10.1152/ajpheart.01051.2001; Iemitsu M, 2006, J APPL PHYSIOL, V101, P151, DOI 10.1152/japplphysiol.00392.2005; Kim JM, 2012, AGE, V34, P11, DOI 10.1007/s11357-011-9207-7; LEXELL J, 1983, MUSCLE NERVE, V6, P588, DOI 10.1002/mus.880060809; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; Matheny W, 2009, EXP BIOL MED, V234, P164, DOI 10.3181/0808-RM-251; Montero-Fernandez N, 2013, EUR J PHYS REHAB MED, V49, P131; Naito AT, 2012, CELL, V149, P1298, DOI 10.1016/j.cell.2012.03.047; Okada K, 2015, CIRC-HEART FAIL, V8, P799, DOI 10.1161/CIRCHEARTFAILURE.114.001958; Ono Y, 2015, CELL REP, V10, P1135, DOI 10.1016/j.celrep.2015.01.045; Rosenberg IH, 1997, J NUTR, V127, pS990, DOI 10.1093/jn/127.5.990S; Roubenoff R, 2000, J GERONTOL A-BIOL, V55, pM716, DOI 10.1093/gerona/55.12.M716; Sakakima H, 2004, J GERONTOL A-BIOL, V59, P1015; Sato K, 2017, FASEB J, V31, P793, DOI 10.1096/fj.201600874R; Sayer AA, 2005, DIABETES CARE, V28, P2541, DOI 10.2337/diacare.28.10.2541; Uchida M, 2014, IMMUNOL LETT, V158, P151, DOI 10.1016/j.imlet.2013.12.021; Verschueren S, 2013, OSTEOPOROSIS INT, V24, P87, DOI 10.1007/s00198-012-2057-z; Watanabe S, 2015, FASEB J, V29, P1003, DOI 10.1096/fj.14-262154; Yabumoto C, 2015, SCI REP-UK, V5, DOI 10.1038/srep14453; Zanchi NE, 2009, EUR J APPL PHYSIOL, V106, P415, DOI 10.1007/s00421-009-1033-6	31	30	31	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3547	3559		10.1096/fj.201700772RRR	http://dx.doi.org/10.1096/fj.201700772RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29401629				2022-12-28	WOS:000435104500006
J	Tian, HY; Huang, JJ; Golzio, C; Gao, X; Hector-Greene, M; Katsanis, N; Blobe, GC				Tian, Hongyu; Huang, Jennifer J.; Golzio, Christelle; Gao, Xia; Hector-Greene, Melissa; Katsanis, Nicholas; Blobe, Gerard C.			Endoglin interacts with VEGFR2 to promote angiogenesis	FASEB JOURNAL			English	Article						endothelial; sprouting; VEGF; signaling cancer	HEREDITARY HEMORRHAGIC TELANGIECTASIA; ENDOTHELIAL-CELLS; KINASE-ACTIVITY; PHASE-I; SU5416; TRC105; GROWTH; INHIBITOR; ANTIBODY; TRAFFICKING	Endoglin, a TGF-beta coreceptor predominantly expressed in endothelial cells, plays an important role in vascular development and tumor-associated angiogenesis. However, the mechanism by which endoglin regulates angiogenesis, especially during tip cell formation, remains largely unknown. In this study, we report that endoglin promoted VEGF-induced tip cell formation. Mechanistically, endoglin interacted with VEGF receptor (VEGFR)-2 in a VEGF-dependent manner, which sustained VEGFR2 on the cell surface and prevented its degradation. Endoglin mutants deficient in the ability to interact with VEGFR2 failed to sustain VEGFR2 on the cell surface and to promote VEGF-induced tip cell formation. Further, an endoglin-targeting monoclonal antibody (mAb), TRC105, cooperated with a VEGF-A targeting mAb, bevacizumab, to inhibit VEGF signaling and tip cell formation in vitro and to inhibit tumor growth, metastasis, and tumor-associated angiogenesis in a murine tumor model. This study demonstrate a novel mechanism by which endoglin initiates and regulates VEGF-driven angiogenesis while providing a rationale for combining anti-VEGF and anti-endoglin therapy in patients with cancer.	[Tian, Hongyu; Blobe, Gerard C.] Duke Univ, Med Ctr, Dept Med, Div Med Oncol, Durham, NC 27708 USA; [Huang, Jennifer J.; Hector-Greene, Melissa; Blobe, Gerard C.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA; [Golzio, Christelle; Katsanis, Nicholas] Duke Univ, Med Ctr, Ctr Human Dis Modeling, Durham, NC 27708 USA; [Gao, Xia] Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27708 USA	Duke University; Duke University; Duke University; Duke University	Tian, HY; Blobe, GC (corresponding author), Duke Univ, Med Ctr, Dept Med, B354 LSRC,Box 91004 DUMC,Res Dr, Durham, NC 27708 USA.	hongyu.tian@duke.edu; gerard.blobe@duke.edu	Blobe, Gerard/AAJ-5945-2020	Blobe, Gerard/0000-0002-4274-8901; Golzio, Christelle/0000-0002-4420-3921; Hector-Greene, Melissa/0000-0001-7263-1440	Susan G. Komen for the Cure [CCR15333124, SAC10002]; HHT Young Scholar Award	Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); HHT Young Scholar Award	The authors thank Dr. Elisabetta Dejana [Italian Foundation for Cancer Research (FIRC) Institute of Molecular Oncology, European Institute of Oncology, Milan, Italy] for providing mouse embryonic endothelial cells; Dr. Christopher D. Kontos (Duke University) for providing the VEGFR2 construct; Tracon Pharma, Inc. (San Diego, CA, USA) for providing TRC105 antibody; and Genentech, Inc. for providing bevacizumab and B20-4.1 antibodies. This work was supported, in part, by Susan G. Komen for the Cure Grants CCR15333124 (to H.T.) and SAC10002 (to G.C.B.), and an HHT Young Scholar Award (to H.T.). The authors declare no conflicts of interest.	Alajati A, 2008, NAT METHODS, V5, P439, DOI [10.1038/nmeth.1198, 10.1038/NMETH.1198]; Anderberg C, 2013, J EXP MED, V210, P563, DOI 10.1084/jem.20120662; Apolo AB, 2017, CLIN GENITOURIN CANC, V15, P77, DOI 10.1016/j.clgc.2016.05.010; Ardelean DS, 2014, ANGIOGENESIS, V17, P129, DOI 10.1007/s10456-013-9383-4; Ballmer-Hofer K, 2011, BLOOD, V118, P816, DOI 10.1182/blood-2011-01-328773; Bruns AF, 2010, TRAFFIC, V11, P161, DOI 10.1111/j.1600-0854.2009.01001.x; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Deng T, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0752-z; Dorff TB, 2017, CANCER-AM CANCER SOC, V123, P4566, DOI 10.1002/cncr.30942; Duffy AG, 2015, UNITED EUR GASTROENT, V3, P453, DOI 10.1177/2050640615583587; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Fong TAT, 1999, CANCER RES, V59, P99; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gordon MS, 2014, CLIN CANCER RES, V20, P5918, DOI 10.1158/1078-0432.CCR-14-1143; Goumans MJ, 2009, CELL RES, V19, P116, DOI 10.1038/cr.2008.326; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, TRENDS CARDIOVAS MED, V13, P301, DOI 10.1016/S1050-1738(03)00142-7; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hendriksen EM, 2009, MICROVASC RES, V77, P96, DOI 10.1016/j.mvr.2008.11.002; Jin Y, 2017, NAT CELL BIOL, V19, P639, DOI 10.1038/ncb3534; Karzai FH, 2015, BJU INT, V116, P546, DOI 10.1111/bju.12986; Keskin U, 2012, OPHTHALMIC RES, V47, P13, DOI 10.1159/000324994; Koleva RI, 2006, J BIOL CHEM, V281, P25110, DOI 10.1074/jbc.M601288200; Lanahan AA, 2010, DEV CELL, V18, P713, DOI 10.1016/j.devcel.2010.02.016; Larrivee B, 2012, DEV CELL, V22, P489, DOI 10.1016/j.devcel.2012.02.005; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lee NY, 2012, MOL BIOL CELL, V23, P2412, DOI 10.1091/mbc.E11-12-0993; Li CG, 2003, J CELL SCI, V116, P2677, DOI 10.1242/jcs.00470; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Liu Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086273; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Mahmoud M, 2010, CIRC RES, V106, P1425, DOI 10.1161/CIRCRESAHA.109.211037; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; McDonald J, 2011, GENET MED, V13, P607, DOI 10.1097/GIM.0b013e3182136d32; Mendel DB, 2000, ANTI-CANCER DRUG DES, V15, P29; Minhajat R, 2006, VIRCHOWS ARCH, V448, P127, DOI 10.1007/s00428-005-0062-8; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Nagy JA, 2007, ANNU REV PATHOL-MECH, V2, P251, DOI 10.1146/annurev.pathol.2.010506.134925; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Paauwe M, 2016, ONCOGENE, V35, P4069, DOI 10.1038/onc.2015.509; Pardali E, 2009, FRONT BIOSCI-LANDMRK, V14, P4848, DOI 10.2741/3573; Pece-Barbara N, 2005, J BIOL CHEM, V280, P27800, DOI 10.1074/jbc.M503471200; Ray BN, 2010, CARCINOGENESIS, V31, P435, DOI 10.1093/carcin/bgp327; Ricard N, 2012, BLOOD, V119, P6162, DOI 10.1182/blood-2012-01-407593; Rosen LS, 2012, CLIN CANCER RES, V18, P4820, DOI 10.1158/1078-0432.CCR-12-0098; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Simonds J, 2009, LARYNGOSCOPE, V119, P988, DOI 10.1002/lary.20159; Smolich BD, 2001, BLOOD, V97, P1413, DOI 10.1182/blood.V97.5.1413; Sugden WW, 2017, NAT CELL BIOL, V19, P653, DOI 10.1038/ncb3528; Tian H, 2015, ONCOGENE, V34, P5635, DOI 10.1038/onc.2015.13; Tian HY, 2017, ARTERIOSCL THROM VAS, V37, P1115, DOI 10.1161/ATVBAHA.116.308859; Tian HY, 2012, EMBO J, V31, P3885, DOI 10.1038/emboj.2012.246; WILSON IA, 1985, P NATL ACAD SCI USA, V82, P5255, DOI 10.1073/pnas.82.16.5255; Yee KWH, 2002, BLOOD, V100, P2941, DOI 10.1182/blood-2002-02-0531; Zhu YH, 2003, STROKE, V34, P2483, DOI 10.1161/01.STR.0000088644.60368.ED	58	39	42	1	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					2934	2949		10.1096/fj.201700867RR	http://dx.doi.org/10.1096/fj.201700867RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401587				2022-12-28	WOS:000432546000005
J	Yang, XX; Ren, HL; Wood, K; Li, MS; Qiu, SF; Shi, FD; Ma, CG; Liu, Q				Yang, Xiaoxia; Ren, Honglei; Wood, Kristofer; Li, Minshu; Qiu, Shenfeng; Shi, Fu-Dong; Ma, Cungen; Liu, Qiang			Depletion of microglia augments the dopaminergic neurotoxicity of MPTP	FASEB JOURNAL			English	Article						MPTP; Parkinson's disease; neuroprotection	PARKINSONS-DISEASE; NEURODEGENERATIVE DISEASE; MOUSE MODEL; NEUROTROPHIC FACTOR; PROGENITOR-CELL; BRAIN-INJURY; IN-VIVO; INFLAMMATION; ACTIVATION; NEURONS	The activation of microglia and the various substances they produce have been linked to the pathologic development of Parkinson's disease (PD), but the precise role of microglia in PD remains to be defined. The survival of microglia depends on colony-stimulating factor 1 receptor (CSF1R) signaling, and CSF1R inhibition results in rapid elimination of microglia in the central nervous system. Using a mouse PD model induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment, we showed that the depletion of microglia via the CSF1R inhibitor PLX3397 exacerbated the impairment of locomotor activities and the loss of dopaminergic neurons. Further, depletion of microglia augmented the production of inflammatory mediators and infiltration of leukocytes in the brain after MPTP exposure. Microglia depletion-induced aggravation of MPTP neurotoxicity was also seen in lymphocyte-deficient mice. In addition, the depletion of microglia did not affect the production of brain-derived neurotrophic factor, but it dramatically augmented the production of inflammatory mediators by astrocytes after MPTP treatment. Our findings suggest microglia play a protective role against MPTP-induced neuroinflammation and dopaminergic neurotoxicity.	[Yang, Xiaoxia; Ren, Honglei; Li, Minshu; Shi, Fu-Dong; Liu, Qiang] Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurol, Tianjin, Peoples R China; [Yang, Xiaoxia; Wood, Kristofer; Shi, Fu-Dong; Liu, Qiang] St Josephs Hosp, Barrow Neurol Inst, Dept Neurol, Phoenix, AZ USA; [Qiu, Shenfeng] Univ Arizona, Coll Med Phoenix, Dept Basic Med Sci, Phoenix, AZ USA; [Ma, Cungen] Shanxi Datong Univ, Sch Med, Inst Brain Sci, Datong, Peoples R China	Tianjin Medical University; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; University of Arizona; Shanxi Datong University	Liu, Q (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurol, Tianjin, Peoples R China.	qliu.asu@gmail.com	Liu, Qiang/HHZ-3181-2022		U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke Grant [R01NS092713]; American Heart Association [16SDG27250236]; National Multiple Sclerosis Society Grant [RG-1507-05318]; Arizona Alzheimer's Research Consortium grant; Valley Research Partnership grant; National Science Foundation of China Grant [81471535]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS092713] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke Grant; American Heart Association(American Heart Association); National Multiple Sclerosis Society Grant(National Multiple Sclerosis Society); Arizona Alzheimer's Research Consortium grant; Valley Research Partnership grant; National Science Foundation of China Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported in part by the U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke Grant R01NS092713; American Heart Association Grant 16SDG27250236; National Multiple Sclerosis Society Grant RG-1507-05318; an Arizona Alzheimer's Research Consortium grant; a Valley Research Partnership grant; and National Science Foundation of China Grant 81471535. The authors declare no conflicts of interest.	Athauda D, 2015, NAT REV NEUROL, V11, P25, DOI 10.1038/nrneurol.2014.226; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Bruttger J, 2015, IMMUNITY, V43, P92, DOI 10.1016/j.immuni.2015.06.012; Cheng YX, 2008, NEUROSCI LETT, V441, P16, DOI 10.1016/j.neulet.2008.05.116; Colombo E, 2014, ANN NEUROL, V76, P325, DOI 10.1002/ana.24217; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; De I, 2014, GLIA, V62, P1955, DOI 10.1002/glia.22717; Depboylu C, 2012, EXP NEUROL, V238, P183, DOI 10.1016/j.expneurol.2012.08.020; Ding YM, 2004, J NEUROCHEM, V89, P776, DOI 10.1111/j.1471-4159.2004.02415.x; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Gomes C, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-16; Gonzalez H, 2013, J IMMUNOL, V190, P5048, DOI 10.4049/jimmunol.1203121; Hauser DN, 2011, J NEUROCHEM, V117, P357, DOI 10.1111/j.1471-4159.2011.07217.x; Heneka MT, 2014, NAT REV IMMUNOL, V14, P463, DOI 10.1038/nri3705; Hirsch EC, 1998, ANN NEUROL, V44, pS115, DOI 10.1002/ana.410440717; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; Jin WN, 2017, J CEREBR BLOOD F MET, V37, P2224, DOI 10.1177/0271678X17694185; Kordower JH, 2003, ANN NEUROL, V53, pS120, DOI 10.1002/ana.10485; Li MS, 2017, J CEREBR BLOOD F MET, V37, P2383, DOI 10.1177/0271678X16666551; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Liu L, 2015, BEHAV BRAIN RES, V281, P215, DOI 10.1016/j.bbr.2014.12.035; Liu Q, 2017, IMMUNITY, V46, P474, DOI 10.1016/j.immuni.2017.02.015; Liu Q, 2016, NAT NEUROSCI, V19, P243, DOI 10.1038/nn.4211; Liu Z, 2017, MOL NEUROBIOL, V54, P7762, DOI 10.1007/s12035-016-0249-9; Moriguchi S, 2012, J NEUROCHEM, V120, P541, DOI 10.1111/j.1471-4159.2011.07608.x; Nam JH, 2015, MOL NEUROBIOL, V51, P487, DOI 10.1007/s12035-014-8729-2; Nandi S, 2012, DEV BIOL, V367, P100, DOI 10.1016/j.ydbio.2012.03.026; Olanow CW, 2013, ANN NEUROL, V74, P337, DOI 10.1002/ana.24011; Ouchi Y, 2005, ANN NEUROL, V57, P168, DOI 10.1002/ana.20338; Patterson SL, 2015, NEUROPHARMACOLOGY, V96, P11, DOI 10.1016/j.neuropharm.2014.12.020; Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Rice RA, 2017, GLIA, V65, P931, DOI 10.1002/glia.23135; Schapira AHV, 2014, LANCET, V384, P545, DOI 10.1016/S0140-6736(14)61010-2; Schapira AHV, 2010, NAT REV NEUROL, V6, P309, DOI 10.1038/nrneurol.2010.52; Schwartz M, 2004, TRENDS PHARMACOL SCI, V25, P407, DOI 10.1016/j.tips.2004.06.010; Shao W, 2013, NATURE, V494, P90, DOI 10.1038/nature11748; Szalay G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11499; Zhang C, 2013, P NATL ACAD SCI USA, V110, P5689, DOI 10.1073/pnas.1219457110; Zhao P, 2017, FASEB J, V31, P172, DOI 10.1096/fj.201600751R	42	54	55	2	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3336	3345		10.1096/fj.201700833RR	http://dx.doi.org/10.1096/fj.201700833RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401614	Green Published			2022-12-28	WOS:000432546000035
J	Vinik, Y; Shatz-Azoulay, H; Hiram-Bab, S; Kandel, L; Gabet, Y; Rivkin, G; Zick, Y				Vinik, Yaron; Shatz-Azoulay, Hadas; Hiram-Bab, Sahar; Kandel, Leonid; Gabet, Yankel; Rivkin, Gurion; Zick, Yehiel			Ablation of the mammalian lectin galectin-8 induces bone defects in mice	FASEB JOURNAL			English	Article						glycan-binding protiens; osteoblast differentiation; bone remodeling; estrogen receptor	ESTROGEN-RECEPTOR-ALPHA; OSTEOBLAST DIFFERENTIATION; POSTMENOPAUSAL OSTEOPOROSIS; ANIMAL-MODELS; STEM-CELLS; IN-VITRO; EXPRESSION; TURNOVER; OSTEOCLASTS; MECHANISMS	Mice overexpressing galectin-8 [gal-8 transgenic (Tg)], a secreted mammalian lectin, exhibit enhanced bone turnover and reduced bone mass, similar to cases of postmenopausal osteoporosis. Here, we show that gal-8 knockout (KO) mice have increased bone mass accrual at a young age but exhibit accelerated bone loss during adulthood. These phenotypes can be attributed to a gal-8-mediated increase in receptor activator of NF-kappa B ligand (RANKL) expression that promotes osteoclastogenesis, combined with direct inhibition of osteoblast differentiation, evident by reduced bone morphogenetic protein (BMP) signaling, reduced phosphorylation of receptor regulated mothers against decapentaplegic homolog (R-SMAD) and reduced expression of osteoblast differentiation markers osterix, osteocalcin, runt-related transcription factor 2 (RUNX2), dentin matrix acidic phosphoprotein-1 (DMP1), and alkaline phosphatase. At the same time, gal-8 promotes expression of estrogen receptor alpha (ESR1). Accordingly, the rate of bone loss is accelerated in ovariectomized, estrogen-deficient gal-8 Tg mice, whereas gal-8 KO mice, having low levels of ESR1, are refractory to ovariectomy. Finally, gal-8 mRNA positively correlates with the mRNA levels of osteoclastogenic markers RANKL, tartrate-resistant acid phosphatase, and cathepsin K in human femurs. Collectively, these findings identify gal-8 as a new physiologic player in the regulation of bone mass.	[Vinik, Yaron; Shatz-Azoulay, Hadas; Zick, Yehiel] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Hiram-Bab, Sahar; Gabet, Yankel] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, Tel Aviv, Israel; [Kandel, Leonid; Rivkin, Gurion] Hadassah Hebrew Univ, Med Ctr, Dept Orthoped Surg, Jerusalem, Israel	Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem; Hadassah University Medical Center	Zick, Y (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	yehiel.zick@weizmann.ac.il	Gabet, Yankel/I-6244-2019; Zick, Yehiel/K-1479-2012	Gabet, Yankel/0000-0002-7494-0631; 	Minerva Foundation [711425]; Israel Science Foundation [776/13]	Minerva Foundation; Israel Science Foundation(Israel Science Foundation)	Insightful discussions with Dr. Sanford Sampson (Bar Ilan University, Ramat Gan, Israel) and Dr. Eytan Elhanany (Israel Institute for Biological Research, Ness Ziona, Israel) are greatly acknowledged. This work was supported by The Minerva Foundation (711425) and The Israel Science Foundation (776/13; to Y.Z.). The authors declare no conflicts of interest.	Almeida M, 2013, J CLIN INVEST, V123, P394, DOI 10.1172/JCI65910; Arlot M E, 1990, Osteoporos Int, V1, P41, DOI 10.1007/BF01880415; Bakker A, 2003, METH MOLEC MED, V80, P19; Bhat R, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-6; Bonucci E, 2014, TOXICOL PATHOL, V42, P957, DOI 10.1177/0192623313512428; Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; Bourguignon LYW, 2005, J BIOL CHEM, V280, P11961, DOI 10.1074/jbc.M411985200; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Cheung AM, 2016, INT J WOMENS HEALTH, V8, P537, DOI 10.2147/IJWH.S112621; Chim SM, 2013, CYTOKINE GROWTH F R, V24, P297, DOI 10.1016/j.cytogfr.2013.03.008; de Jong DS, 2004, J BONE MINER RES, V19, P947, DOI 10.1359/JBMR.040216; Di Lella S, 2011, BIOCHEMISTRY-US, V50, P7842, DOI 10.1021/bi201121m; Ebeling PR, 1996, J CLIN ENDOCR METAB, V81, P3366, DOI 10.1210/jc.81.9.3366; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eghbali-Fatourechi G, 2003, J CLIN INVEST, V111, P1221, DOI 10.1172/JCI200317215; Elola MT, 2007, CELL MOL LIFE SCI, V64, P1679, DOI 10.1007/s00018-007-7044-8; Eriksen EF, 2010, REV ENDOCR METAB DIS, V11, P219, DOI 10.1007/s11154-010-9153-1; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Garimella R, 2008, J HISTOCHEM CYTOCHEM, V56, P569, DOI 10.1369/jhc.2008.950394; Garnero P, 1996, J BONE MINER RES, V11, P337, DOI 10.1002/jbmr.5650110307; Idris AI, 2012, METHODS MOL BIOL, V816, P545, DOI 10.1007/978-1-61779-415-5_34; Katagiri T, 2002, ORAL DIS, V8, P147, DOI 10.1034/j.1601-0825.2002.01829.x; Khosla S, 2012, TRENDS ENDOCRIN MET, V23, P576, DOI 10.1016/j.tem.2012.03.008; Komori T, 2015, EUR J PHARMACOL, V759, P287, DOI 10.1016/j.ejphar.2015.03.028; Komori T, 2010, ADV EXP MED BIOL, V658, P43, DOI 10.1007/978-1-4419-1050-9_5; Kruger MC, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060376; Ledeen RW, 2012, ANN NY ACAD SCI, V1253, P206, DOI 10.1111/j.1749-6632.2012.06479.x; Li XF, 2005, NAT GENET, V37, P945, DOI 10.1038/ng1614; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Maeda Y, 2004, J CELL BIOCHEM, V93, P337, DOI 10.1002/jcb.20154; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; Manolagas SC, 2013, NAT REV ENDOCRINOL, V9, P699, DOI 10.1038/nrendo.2013.179; Mathieu PS, 2012, TISSUE ENG PART B-RE, V18, P436, DOI [10.1089/ten.teb.2012.0014, 10.1089/ten.TEB.2012.0014]; Matsumoto Y, 2013, STEROIDS, V78, P513, DOI 10.1016/j.steroids.2013.02.011; McNamara LM, 2010, J R SOC INTERFACE, V7, P353, DOI 10.1098/rsif.2009.0282; Melville KM, 2014, J BONE MINER RES, V29, P370, DOI 10.1002/jbmr.2082; Miyazawa K, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022095; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Nagy V, 2015, GERONTOLOGY, V61, P534, DOI 10.1159/000371845; Nakajima K, 2014, NEOPLASIA, V16, P939, DOI 10.1016/j.neo.2014.09.005; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Ota K, 2013, J CELL BIOCHEM, V114, P1901, DOI 10.1002/jcb.24537; Oya K, 2017, HISTOCHEM CELL BIOL, V147, P341, DOI 10.1007/s00418-016-1490-z; Paic F, 2009, BONE, V45, P682, DOI 10.1016/j.bone.2009.06.010; Rabinovich GA, 2011, CURR OPIN HEMATOL, V18, P443, DOI 10.1097/MOH.0b013e32834bab18; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Rowe PSN, 2012, CRIT REV EUKAR GENE, V22, P61, DOI 10.1615/CritRevEukarGeneExpr.v22.i1.50; Sebban LE, 2007, J IMMUNOL, V179, P1225, DOI 10.4049/jimmunol.179.2.1225; Song I, 2011, BIOCHEM BIOPH RES CO, V408, P126, DOI 10.1016/j.bbrc.2011.03.135; Takarada T, 2013, J BONE MINER RES, V28, P2064, DOI 10.1002/jbmr.1945; Takeshita S, 2013, J CLIN INVEST, V123, P3914, DOI 10.1172/JCI69493; Tanikawa R, 2010, BIOCHEM BIOPH RES CO, V394, P317, DOI 10.1016/j.bbrc.2010.02.175; Tanizawa T, 1999, BONE, V25, P493, DOI 10.1016/S8756-3282(99)00183-0; Thiemann S, 2011, J CLIN IMMUNOL, V31, P2, DOI 10.1007/s10875-010-9460-z; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Toegel S, 2014, HISTOCHEM CELL BIOL, V142, P373, DOI 10.1007/s00418-014-1234-x; Troncoso MF, 2014, GLYCOBIOLOGY, V24, P907, DOI 10.1093/glycob/cwu054; Vinik Y, 2015, ELIFE, V4, DOI 10.7554/eLife.05914; Zoch ML, 2016, BONE, V82, P42, DOI 10.1016/j.bone.2015.05.046; zur Nieden NI, 2003, DIFFERENTIATION, V71, P18, DOI 10.1046/j.1432-0436.2003.700602.x	63	9	9	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2366	2380		10.1096/fj.201700716R	http://dx.doi.org/10.1096/fj.201700716R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29259034				2022-12-28	WOS:000432528000006
J	Trefier, A; Musnier, A; Landomiel, F; Bourquard, T; Boulo, T; Ayoub, MA; Leon, K; Bruneau, G; Chevalier, M; Durand, G; Blache, MC; Inoue, A; Fontaine, J; Gauthier, C; Tesseraud, S; Reiter, E; Poupon, A; Crepieux, P				Trefier, Aurelie; Musnier, Astrid; Landomiel, Flavie; Bourquard, Thomas; Boulo, Thomas; Ayoub, Mohammed Akli; Leon, Kelly; Bruneau, Gilles; Chevalier, Manon; Durand, Guillaume; Blache, Marie-Claire; Inoue, Asuka; Fontaine, Joel; Gauthier, Christophe; Tesseraud, Sophie; Reiter, Eric; Poupon, Anne; Crepieux, Pascale			G protein-dependent signaling triggers a beta-arrestin-scaffolded p70S6K/rpS6 module that controls 5 ' TOP mRNA translation	FASEB JOURNAL			English	Article						GPCR; FSHR; gene regulation	FOLLICLE-STIMULATING-HORMONE; COUPLED RECEPTOR KINASES; TESTIS BARRIER DYNAMICS; CRYSTAL-STRUCTURE; S6 PHOSPHORYLATION; PHOSPHATASE 2A; ACTIVATION; MTOR; RPS6; ERK	Many interaction partners of beta-arrestins intervene in the control of mRNA translation. However, how b-arrestins regulate this cellular process has been poorly explored. In this study, we show that beta-arrestins constitutively assemble a p70S6K/ribosomal protein S6 (rpS6) complex in HEK293 cells and in primary Sertoli cells of the testis. We demonstrate that this interaction is direct, and experimentally validate the interaction interface between beta-arrestin 1 and p70S6K predicted by our docking algorithm. Like most GPCRs, the biological function of follicle-stimulating hormone receptor (FSHR) is transduced by G proteins and beta-arrestins. Upon follicle-stimulating hormone (FSH) stimulation, activation of G protein-dependent signaling enhances p70S6K activity within the beta-arrestin/p70S6K/rpS6 preassembled complex, which is not recruited to the FSHR. In agreement, FSH-induced rpS6 phosphorylation within the beta-arrestin scaffold was decreased in cells depleted of Gas. Integration of the cooperative action of beta-arrestin and G proteins led to the translation of 59 oligopyrimidine track mRNA with high efficacy within minutes of FSH input. Hence, this work highlights new relationships between G proteins and beta-arrestins when acting cooperatively on a common signaling pathway, contrasting with their previously shown parallel action on the ERK MAP kinase pathway. In addition, this study provides insights into how GPCR can exert trophic effects in the cell.	[Trefier, Aurelie; Musnier, Astrid; Landomiel, Flavie; Bourquard, Thomas; Boulo, Thomas; Ayoub, Mohammed Akli; Leon, Kelly; Bruneau, Gilles; Chevalier, Manon; Durand, Guillaume; Fontaine, Joel; Gauthier, Christophe; Reiter, Eric; Poupon, Anne; Crepieux, Pascale] INRA, Biol & Bioinformat Signaling Syst BIOS Grp, Nouzilly, France; [Blache, Marie-Claire] INRA, Unite Physiol Reprod & Comportements, Unite Mixte Rech 85, PIC, Nouzilly, France; [Tesseraud, Sophie] INRA, Unite Rech Avicoles, Unite Rech 83, Metab Birds Qual & Adaptat MOQA Grp, Nouzilly, France; [Trefier, Aurelie; Musnier, Astrid; Landomiel, Flavie; Bourquard, Thomas; Boulo, Thomas; Ayoub, Mohammed Akli; Leon, Kelly; Bruneau, Gilles; Chevalier, Manon; Durand, Guillaume; Blache, Marie-Claire; Fontaine, Joel; Gauthier, Christophe; Reiter, Eric; Poupon, Anne; Crepieux, Pascale] CNRS, Unite Mixte Rech 7247, Nouzilly, France; [Trefier, Aurelie; Musnier, Astrid; Landomiel, Flavie; Bourquard, Thomas; Boulo, Thomas; Ayoub, Mohammed Akli; Leon, Kelly; Bruneau, Gilles; Chevalier, Manon; Durand, Guillaume; Blache, Marie-Claire; Fontaine, Joel; Gauthier, Christophe; Reiter, Eric; Poupon, Anne; Crepieux, Pascale] Univ Tours, Tours, France; [Trefier, Aurelie; Musnier, Astrid; Landomiel, Flavie; Bourquard, Thomas; Boulo, Thomas; Ayoub, Mohammed Akli; Leon, Kelly; Bruneau, Gilles; Chevalier, Manon; Durand, Guillaume; Blache, Marie-Claire; Fontaine, Joel; Gauthier, Christophe; Reiter, Eric; Poupon, Anne; Crepieux, Pascale] IFCE, Nouzilly, France; [Inoue, Asuka] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi, Japan; [Ayoub, Mohammed Akli] United Arab Emirates Univ, Coll Sci, Biol Dept, Al Ain, U Arab Emirates	INRAE; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; INRAE; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; Tohoku University; United Arab Emirates University	Crepieux, P (corresponding author), CNRS, Ctr Rech Val de Loire, UMR7247, F-37380 Nouzilly, France.	Pascale.Crepieux@inra.fr	Crepieux, Pascale/X-3217-2019; Durand, Guillaume/K-6352-2019	Durand, Guillaume/0000-0001-6655-5904; AYOUB, Mohammed Akli/0000-0003-0022-578X; musnier, astrid/0000-0002-9994-3724	Institut National de la Recherche Agronomique PHASE Department; Centre National de la Recherche Scientifique; ANR program GPCRnet; Region Centre	Institut National de la Recherche Agronomique PHASE Department; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); ANR program GPCRnet(French National Research Agency (ANR)); Region Centre(Region Centre-Val de Loire)	The authors thank Professor Robert J. Lefkowitz (Duke University, Durham, NC, USA) for the kind gift of beta-arrestin 1,2 knockout MEFs, Dr. George R. Bousfield (Wichita State University, KS, USA) for the generous gift of highly purified porcine FSH, Professor Jean-Claude Lacaille (Universite de Montreal, QC, Canada) for the gift of the 5 ' TOP-YFP reporter, Dr. Jerome A.J. Becker (UMR PRC, Nouzilly, France) for critical and helpful reading of the manuscript, Isaline Bolard (UMR PRC, Nouzilly, France) for excellent technical assistance, and the staff of UEPAO (Domaine de l'Orfrasiere, Nouzilly, France). This work has benefited from the facilities and expertise of the Plateforme d'imagerie Cellulaire (PIC) of the UMR-PRC. This work was funded by the Institut National de la Recherche Agronomique PHASE Department, by the Centre National de la Recherche Scientifique, by the ANR program GPCRnet and by the Region Centre. The authors declare no conflicts of interest.	Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Alam H, 2004, J BIOL CHEM, V279, P19431, DOI 10.1074/jbc.M401235200; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Biever A, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00075; Biever A, 2015, J NEUROSCI, V35, P4113, DOI 10.1523/JNEUROSCI.3288-14.2015; Boularan C, 2007, P NATL ACAD SCI USA, V104, P18061, DOI 10.1073/pnas.0705550104; Bourquard T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10760; Crepieux P, 2001, ONCOGENE, V20, P4696, DOI 10.1038/sj.onc.1204632; Crepieux P, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00032; CSIBI A, 2010, PLOS ONE, V5; Dennis PB, 1998, J BIOL CHEM, V273, P14845, DOI 10.1074/jbc.273.24.14845; Dewire SM, 2008, J BIOL CHEM, V283, P10611, DOI 10.1074/jbc.M710515200; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Freedman NJ, 1996, RECENT PROG HORM RES, V51, P319; Fritz I B, 1975, Curr Top Mol Endocrinol, V2, P367; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Gloaguen Pauline, 2011, Front Endocrinol (Lausanne), V2, P45, DOI 10.3389/fendo.2011.00045; Gobert D, 2008, J NEUROCHEM, V106, P1160, DOI 10.1111/j.1471-4159.2008.05470.x; GUILLOU F, 1986, BIOCHIM BIOPHYS ACTA, V887, P196, DOI 10.1016/0167-4889(86)90055-8; Hahn K, 2010, CELL METAB, V11, P438, DOI 10.1016/j.cmet.2010.03.015; Han K, 2014, NAT METHODS, V11, P86, DOI [10.1038/NMETH.2729, 10.1038/nmeth.2729]; Heitzler D, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.22; Hohenegger M, 1998, P NATL ACAD SCI USA, V95, P346, DOI 10.1073/pnas.95.1.346; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hou XY, 2010, ENDOCRINOLOGY, V151, P2846, DOI 10.1210/en.2009-1032; Huynh J, 2009, MOL CELL ENDOCRINOL, V302, P118, DOI 10.1016/j.mce.2009.01.002; JEFFERIES HBJ, 1994, P NATL ACAD SCI USA, V91, P4441, DOI 10.1073/pnas.91.10.4441; Johnston H, 2004, ENDOCRINOLOGY, V145, P318, DOI 10.1210/en.2003-1055; Kang DS, 2014, CURR OPIN CELL BIOL, V27, P63, DOI 10.1016/j.ceb.2013.11.005; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Kara E, 2006, MOL ENDOCRINOL, V20, P3014, DOI 10.1210/me.2006-0098; Kendall RT, 2014, J BIOL CHEM, V289, P26155, DOI 10.1074/jbc.M114.595728; Kim YK, 2014, J BIOL CHEM, V289, P3901, DOI 10.1074/jbc.M113.515015; Kitano H, 2005, NAT BIOTECHNOL, V23, P961, DOI 10.1038/nbt1111; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Kristensen AR, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.47; Kruger T, 2007, J CELL BIOL, V177, P573, DOI 10.1083/jcb.200612048; Lecureuil C, 2005, MOL ENDOCRINOL, V19, P1812, DOI 10.1210/me.2004-0289; Lee MH, 2016, NATURE, V531, P665, DOI 10.1038/nature17154; Lefkowitz RJ, 2004, CURR OPIN CELL BIOL, V16, P162, DOI 10.1016/j.ceb.2004.01.001; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Leon K, 2014, J MOL ENDOCRINOL, V52, P373, DOI 10.1530/JME-14-0009; Li B, 2013, FEBS LETT, V587, P410, DOI 10.1016/j.febslet.2013.01.027; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Marion S, 2002, BIOL REPROD, V66, P70, DOI 10.1095/biolreprod66.1.70; Marion S, 2006, J ENDOCRINOL, V190, P341, DOI 10.1677/joe.1.06857; Meyuhas O, 2015, BBA-GENE REGUL MECH, V1849, P801, DOI 10.1016/j.bbagrm.2014.08.015; Meyuhas Oded, 1996, V30, P363; Milano SK, 2006, J BIOL CHEM, V281, P9812, DOI 10.1074/jbc.M512703200; Miller WE, 2001, CURR OPIN CELL BIOL, V13, P139, DOI 10.1016/S0955-0674(00)00190-3; Mok KW, 2015, ENDOCRINOLOGY, V156, P1900, DOI 10.1210/en.2014-1791; Mok KW, 2014, J CELL SCI, V127, P4870, DOI 10.1242/jcs.152231; Mok KW, 2012, ENDOCRINOLOGY, V153, P5036, DOI 10.1210/en.2012-1665; Musnier A, 2012, MOL ENDOCRINOL, V26, P669, DOI 10.1210/me.2011-1267; Musnier A, 2010, CELL SIGNAL, V22, P707, DOI 10.1016/j.cellsig.2009.10.012; Musnier A, 2009, CELL MOL LIFE SCI, V66, P3487, DOI 10.1007/s00018-009-0134-z; Nakamura K, 1998, J BIOL CHEM, V273, P24346, DOI 10.1074/jbc.273.38.24346; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; Reiter E, 2001, BIOCHEM BIOPH RES CO, V282, P71, DOI 10.1006/bbrc.2001.4534; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Rosner M, 2011, ONCOGENE, V30, P4509, DOI 10.1038/onc.2011.165; Rosner M, 2011, AMINO ACIDS, V40, P595, DOI 10.1007/s00726-010-0684-2; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shiina T, 2000, J BIOL CHEM, V275, P29082, DOI 10.1074/jbc.M909757199; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; Son O, 2015, BIOCHEM BIOPH RES CO, V465, P200, DOI 10.1016/j.bbrc.2015.07.150; Stallaert W, 2017, MOL PHARMACOL, V91, P533, DOI 10.1124/mol.116.106419; Sunami T, 2010, J BIOL CHEM, V285, P4587, DOI 10.1074/jbc.M109.040667; Thomsen ARB, 2016, CELL, V166, P907, DOI 10.1016/j.cell.2016.07.004; Tian Xufan, 2014, Handb Exp Pharmacol, V219, P173, DOI 10.1007/978-3-642-41199-1_9; Troispoux C, 1999, MOL ENDOCRINOL, V13, P1599, DOI 10.1210/me.13.9.1599; Wehbi V, 2010, MOL ENDOCRINOL, V24, P561, DOI 10.1210/me.2009-0347; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Wiedemann A, 2016, FASEB J, V30, P4180, DOI 10.1096/fj.201600701R; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Yang M, 2009, BIOCHEM J, V417, P287, DOI 10.1042/BJ20081561; Yu UY, 2010, BMB REP, V43, P263, DOI 10.5483/BMBRep.2010.43.4.263; Zhan XZ, 2011, J MOL BIOL, V406, P467, DOI 10.1016/j.jmb.2010.12.034; Zhang X, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13223	89	19	21	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1154	1169		10.1096/fj.201700763R	http://dx.doi.org/10.1096/fj.201700763R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29084767				2022-12-28	WOS:000427246000005
J	Zheng, J; Chen, YP; Li, ZR; Cao, SN; Zhang, ZX; Jia, HL				Zheng, Jun; Chen, Yaping; Li, Zhaoran; Cao, Shinuo; Zhang, Zhaoxia; Jia, Honglin			Translationally controlled tumor protein is required for the fast growth of Toxoplasma gondii and maintenance of its intracellular development	FASEB JOURNAL			English	Article						TCTP; knockout; invasion; replication; egress	HISTAMINE-RELEASING FACTOR; TRYPANOSOMA-BRUCEI; CALCIUM-BINDING; BRUGIA-MALAYI; IN-VITRO; TCTP; HOMOLOG; TARGET; OVEREXPRESSION; AMINOPEPTIDASE	Translationally controlled tumor protein (TCTP) is a highly conserved, multifunctional protein that has been implicated in a range of cell physiologic processes, especially cell growth and development. ATCTP-like gene has been identified in the Toxoplasma genome [Toxoplasma gondii TCTP (TgTCTP)], although its function remains unknown. The sequence analysis of TgTCTP indicated that it is a highly conserved protein in eukaryotes. We found that the expression level of TgTCTP in the virulent RH strain was significantly higher than that in the avirulent PLK strain. Indirect immunofluorescence showed that TgTCTP was expressed in the parasite cytoplasm. The localization of TgTCTP was unchanged during the replication of the parasite. We expressed a functional recombinant TgTCTP (rTgTCTP) protein in Escherichia coli and found that the recombinant protein could form a multimer. We then evaluated the function of TgTCTP using the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 knockout (KO) system. Phenotypic analysis of the KO strain (Delta TgTCTP) revealed that TgTCTP is required for the robust growth of the parasites. TgTCTP deficiency also led to early egress of the parasites and subsequent impairment in their invasion and attachment abilities. We subsequently found that the multimer formof TgTCTP might not be necessary for the growth and replication of the parasite. Then the expression profiling of genes in the Delta TgTCTP and complement strains were analyzed. The results revealed that 988 genes were regulated in Delta TgTCTP compared with the complement strain. Overall, although not essential, TgTCTP is required for the fast growth of Tg and maintenance of its intracellular development.	[Zheng, Jun; Chen, Yaping; Li, Zhaoran; Cao, Shinuo; Zhang, Zhaoxia; Jia, Honglin] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, 678 Haping St, Harbin 150069, Heilongjiang, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Jia, HL (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, 678 Haping St, Harbin 150069, Heilongjiang, Peoples R China.	jiahonglin@caas.cn	洪林, 贾/AAN-3442-2020; Cao, Shinuo/ABH-3244-2021; Cao, Shinuo/AAD-1027-2020	洪林, 贾/0000-0001-7458-9565; 	National Natural Science Foundation of China [31402184]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Dr. K. A. Joiner (Yale University, New Haven, CT, USA) for providing the pHXNTPHA plasmids, generated by Dr. X. Xuan (Obihiro University of Agriculture and Veterinary Medicine, Hokkaido, Japan). This work was supported by a grant awarded to J.Z. by the National Natural Science Foundation of China (Grant 31402184). The authors have no conflicts of interest to declare.	Acunzo J, 2014, CANCER TREAT REV, V40, P760, DOI 10.1016/j.ctrv.2014.02.007; Ajzenberg D, 2002, J INFECT DIS, V186, P684, DOI 10.1086/342663; Amson R, 2013, TRENDS CELL BIOL, V23, P37, DOI 10.1016/j.tcb.2012.10.002; Amson R, 2012, NAT MED, V18, P91, DOI 10.1038/nm.2546; Bae SY, 2017, AUTOPHAGY, V13, P820, DOI 10.1080/15548627.2017.1287650; Bhisutthibhan J, 1999, EUR J CELL BIOL, V78, P665, DOI 10.1016/S0171-9335(99)80052-1; Bhisutthibhan J, 2001, ANTIMICROB AGENTS CH, V45, P2397, DOI 10.1128/AAC.45.8.2397-2399.2001; Bommer UA, 2004, INT J BIOCHEM CELL B, V36, P379, DOI 10.1016/S1357-2725(03)00213-9; Caldas LA, 2007, VET PARASITOL, V147, P210, DOI 10.1016/j.vetpar.2007.05.012; Chen K, 2014, MOL BIOL EVOL, V31, P2194, DOI 10.1093/molbev/msu181; Chen SH, 2007, MOL BIOL CELL, V18, P2525, DOI 10.1091/mbc.E07-02-0188; Dong XC, 2009, J BIOL CHEM, V284, P23754, DOI 10.1074/jbc.M109.012823; Gardiner DL, 2006, J BIOL CHEM, V281, P1741, DOI 10.1074/jbc.M508955200; Gnanasekar M, 2002, MOL BIOCHEM PARASIT, V121, P107, DOI 10.1016/S0166-6851(02)00027-0; Gnanasekar M, 2007, PARASITOL RES, V101, P1533, DOI 10.1007/s00436-007-0671-z; GROSS B, 1989, NUCLEIC ACIDS RES, V17, P8367, DOI 10.1093/nar/17.20.8367; Heaslip AT, 2016, MOL BIOL CELL, V27, P2080, DOI 10.1091/mbc.E15-12-0824; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Huynh MH, 2003, EMBO J, V22, P2082, DOI 10.1093/emboj/cdg217; Jia HL, 2010, MOL BIOCHEM PARASIT, V170, P1, DOI 10.1016/j.molbiopara.2009.11.005; Kim M, 2013, BIOCHIMIE, V95, P659, DOI 10.1016/j.biochi.2012.10.007; Kim M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006464; Lun ZR, 2015, P NATL ACAD SCI USA, V112, P8835, DOI 10.1073/pnas.1502599112; MACDONALD SM, 1995, SCIENCE, V269, P688, DOI 10.1126/science.7542803; MacDonald SM, 2001, P NATL ACAD SCI USA, V98, P10829, DOI 10.1073/pnas.201191498; Matthews KR, 2005, J CELL SCI, V118, P283, DOI 10.1242/jcs.01649; Miao X, 2013, TUMOR BIOL, V34, P3357, DOI 10.1007/s13277-013-0906-9; Morrissette N, 2015, EUKARYOT CELL, V14, P2, DOI 10.1128/EC.00225-14; Nagano-Ito M, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/204960; Pszenny V, 2016, J BIOL CHEM, V291, P3725, DOI 10.1074/jbc.M115.671974; Qureshi BM, 2013, FASEB J, V27, P1034, DOI 10.1096/fj.11-180992; Reynolds MG, 2001, ANTIMICROB AGENTS CH, V45, P1271, DOI 10.1128/AAC.45.4.1271-1277.2001; Rho SB, 2011, FEBS LETT, V585, P29, DOI 10.1016/j.febslet.2010.11.014; Schagger H, 2001, METHOD CELL BIOL, V65, P231, DOI 10.1016/S0091-679X(01)65014-3; Shen B, 2014, P NATL ACAD SCI USA, V111, P3567, DOI 10.1073/pnas.1315156111; Sibley LD, 2002, PHILOS T R SOC B, V357, P81, DOI 10.1098/rstb.2001.1017; Sidik SM, 2016, CELL, V166, P1423, DOI 10.1016/j.cell.2016.08.019; SOLDATI D, 1993, SCIENCE, V260, P349, DOI 10.1126/science.8469986; THOMAS G, 1981, P NATL ACAD SCI-BIOL, V78, P5712, DOI 10.1073/pnas.78.9.5712; Tuynder M, 2004, P NATL ACAD SCI USA, V101, P15364, DOI 10.1073/pnas.0406776101; Wang YB, 2009, J BIOL CHEM, V284, P1694, DOI 10.1074/jbc.M807890200; Yarm FR, 2002, MOL CELL BIOL, V22, P6209, DOI 10.1128/MCB.22.17.6209-6221.2002; Yoon T, 2000, ARCH BIOCHEM BIOPHYS, V384, P379, DOI 10.1006/abbi.2000.2108	44	8	9	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					906	919		10.1096/fj.201700994R	http://dx.doi.org/10.1096/fj.201700994R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29046358	Bronze			2022-12-28	WOS:000425146900032
J	Aittomaki, S; Valanne, S; Lehtinen, T; Matikainen, S; Nyman, TA; Ramet, M; Pesu, M				Aittomaki, Saara; Valanne, Susanna; Lehtinen, Tapio; Matikainen, Sampsa; Nyman, Tuula A.; Ramet, Mika; Pesu, Marko			Proprotein convertase Furin1 expression in the Drosophila fat body is essential for a normal antimicrobial peptide response and bacterial host defense	FASEB JOURNAL			English	Article						innate immunity; stress; Toll pathway; IMD pathway; JAK/STAT pathway	PEPTIDOGLYCAN RECOGNITION PROTEIN; TOLL SIGNALING PATHWAY; GENOME-WIDE ANALYSIS; IMMUNE-RESPONSE; GENE-EXPRESSION; NEGATIVE REGULATOR; PROCESSING ENZYME; IMD PATHWAY; MELANOGASTER; CELLS	Invading pathogens provoke robust innate immune responses in Dipteran insects, such as Drosophila melanogaster. In a systemic bacterial infection, a humoral response is induced in the fat body. Gram-positive bacteria trigger the Toll signaling pathway, whereas gram-negative bacterial infections are signaled via the immune deficiency (IMD) pathway. We show here that the RNA interference-mediated silencing of Furin1-a member of the proprotein convertase enzyme family-specifically in the fat body, results in a reduction in the expression of antimicrobial peptides. This, in turn, compromises the survival of adult fruit flies in systemic infections that are caused by both gram-positive and -negative bacteria. Furin1 plays a nonredundant role in the regulation of immune responses, as silencing of Furin2, the other member of the enzyme family, had no effect on survival or the expression of antimicrobial peptides upon a systemic infection. Furin1 does not directly affect the Toll or IMD signaling pathways, but the reduced expression of Furin1 up-regulates stress response factors in the fat body. We also demonstrate that Furin1 is a negative regulator of the Janus kinase/signal transducer and activator of transcription signaling pathway, which is implicated in stress responses in the fly. In summary, our data identify Furin1 as a novel regulator of humoral immunity and cellular stress responses in Drosophila.	[Aittomaki, Saara; Lehtinen, Tapio; Pesu, Marko] Univ Tampere, Immunoregulat Grp, Tampere, Finland; [Aittomaki, Saara; Valanne, Susanna; Lehtinen, Tapio; Ramet, Mika; Pesu, Marko] Univ Tampere, BioMediTech Inst, Arvo Ylpon Katu 34, FI-33520 Tampere, Finland; [Valanne, Susanna; Ramet, Mika] Univ Tampere, Fac Med & Life Sci, Expt Immunol Grp, Tampere, Finland; [Matikainen, Sampsa] Helsinki Univ Hosp, Dept Rheumatol, Helsinki, Finland; [Nyman, Tuula A.] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Ramet, Mika] Univ Oulu, PEDEGO Res Unit, Med Res Ctr Oulu, Oulu Univ Hosp, Oulu, Finland; [Ramet, Mika] Univ Oulu, Oulu Univ Hosp, Dept Children & Adolescents, Oulu, Finland; [Pesu, Marko] Tampere Univ Hosp, Dept Dermatol, Tampere, Finland; [Nyman, Tuula A.] Univ Oslo, Dept Immunol, Oslo, Norway; [Nyman, Tuula A.] Oslo Univ Hosp, Oslo, Norway	Tampere University; Tampere University; Tampere University; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Oulu; University of Oulu; Tampere University; Tampere University Hospital; University of Oslo; University of Oslo	Pesu, M (corresponding author), Univ Tampere, BioMediTech Inst, Arvo Ylpon Katu 34, FI-33520 Tampere, Finland.	marko.pesu@uta.fi	Valanne, Susanna/GZK-2381-2022; Pesu, Marko/L-6344-2013; Matikainen, Sampsa/AAH-8654-2021	Valanne, Susanna/0000-0003-0898-8423; Pesu, Marko/0000-0002-7541-3921; 	Sigrid Juselius Foundation; Academy of Finland [295814, 286477]; Finnish Cultural Foundation Pirkanmaa Regional fund; Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital; Cancer Society of Finland; Tampere Tuberculosis Foundation; Cancer Foundation Finland sr [150117] Funding Source: researchfish	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Finnish Cultural Foundation Pirkanmaa Regional fund; Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital; Cancer Society of Finland; Tampere Tuberculosis Foundation; Cancer Foundation Finland sr	This work was supported by the Sigrid Juselius Foundation, the Academy of Finland (Grants 295814 and 286477), Finnish Cultural Foundation Pirkanmaa Regional fund, the Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital, Cancer Society of Finland, and Tampere Tuberculosis Foundation. The authors thank Tuula Myllymaki and Sanna Hamalainen (University of Tampere) for technical assistance and all the members of the Immuno-regulation Group for scientific discussions. Tampere Drosophila Core Facility is acknowledged for providing resources for fly husbandry. The authors declare no conflicts of interest.	Akiyama T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002549; Artenstein AW, 2011, NEW ENGL J MED, V365, P2507, DOI 10.1056/NEJMra1106700; Attrill H, 2016, NUCLEIC ACIDS RES, V44, pD786, DOI 10.1093/nar/gkv1046; Ballard SL, 2010, DEV BIOL, V337, P375, DOI 10.1016/j.ydbio.2009.11.011; Bhadra R, 2014, J CLIN INVEST, V124, P2441, DOI 10.1172/JCI70522; BRAND AH, 1993, DEVELOPMENT, V118, P401; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; Clark RI, 2011, CURR BIOL, V21, P1672, DOI 10.1016/j.cub.2011.08.048; Cordova ZM, 2016, ONCOTARGET, V7, P54392, DOI 10.18632/oncotarget.11106; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; DEBIE I, 1995, J BIOL CHEM, V270, P1020, DOI 10.1074/jbc.270.3.1020; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Dushay MS, 1996, P NATL ACAD SCI USA, V93, P10343, DOI 10.1073/pnas.93.19.10343; Ekengren S, 2001, BIOCHEM BIOPH RES CO, V284, P998, DOI 10.1006/bbrc.2001.5067; Eleftherianos I, 2016, IMMUNOBIOLOGY, V221, P1362, DOI 10.1016/j.imbio.2016.07.011; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; GEISLER R, 1992, CELL, V71, P613, DOI 10.1016/0092-8674(92)90595-4; Ghosh AC, 2014, P NATL ACAD SCI USA, V111, P5729, DOI 10.1073/pnas.1319116111; Girardot F, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-74; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Gronke S, 2003, CURR BIOL, V13, P603, DOI 10.1016/S0960-9822(03)00175-1; GUNNE H, 1993, EUR J BIOCHEM, V214, P287, DOI 10.1111/j.1432-1033.1993.tb17923.x; HARRISON DA, 1995, EMBO J, V14, P2857, DOI 10.1002/j.1460-2075.1995.tb07285.x; Hedengren M, 2000, BIOCHEM BIOPH RES CO, V279, P574, DOI 10.1006/bbrc.2000.3988; Honti V, 2014, DEV COMP IMMUNOL, V42, P47, DOI 10.1016/j.dci.2013.06.005; Horng T, 2001, P NATL ACAD SCI USA, V98, P12654, DOI 10.1073/pnas.231471798; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Hwang SO, 2008, J BIOL CHEM, V283, P13063, DOI 10.1074/jbc.M709656200; Jain A, 2015, J BIOL CHEM, V290, P14945, DOI 10.1074/jbc.M115.656116; Johnson TK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9759; Kallio J, 2005, MICROBES INFECT, V7, P811, DOI 10.1016/j.micinf.2005.03.014; Kallio J, 2010, FASEB J, V24, P4467, DOI 10.1096/fj.10-162784; Kleino A, 2005, EMBO J, V24, P3423, DOI 10.1038/sj.emboj.7600807; Kleino A, 2008, J IMMUNOL, V180, P5413, DOI 10.4049/jimmunol.180.8.5413; Kunnapuu J, 2009, P NATL ACAD SCI USA, V106, P8501, DOI 10.1073/pnas.0809885106; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leulier F, 2002, CURR BIOL, V12, P996, DOI 10.1016/S0960-9822(02)00873-4; Lin P, 2015, HISTOCHEM CELL BIOL, V144, P543, DOI 10.1007/s00418-015-1359-6; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.0.CO;2-L; Maxton-Kuchenmeister J, 1999, MECH DEVELOP, V83, P107, DOI 10.1016/S0925-4773(99)00041-6; Meister M, 2003, CELL MICROBIOL, V5, P573, DOI 10.1046/j.1462-5822.2003.00302.x; Myllymaki H, 2014, SCAND J IMMUNOL, V79, P377, DOI 10.1111/sji.12170; Myllymaki H, 2014, J IMMUNOL, V192, P3455, DOI 10.4049/jimmunol.1303309; Naitza S, 2002, IMMUNITY, V17, P575, DOI 10.1016/S1074-7613(02)00454-5; Ojanen MJT, 2015, INFECT IMMUN, V83, P1431, DOI 10.1128/IAI.03135-14; Oksanen A, 2014, J IMMUNOL, V193, P5470, DOI 10.4049/jimmunol.1401629; Ortutay Z, 2015, J LEUKOCYTE BIOL, V98, P73, DOI 10.1189/jlb.2A0514-257RR; Pesu M, 2008, NATURE, V455, P246, DOI 10.1038/nature07210; Pesu M, 2006, BLOOD, V108, P983, DOI 10.1182/blood-2005-09-3824; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Ramet M, 2012, ACTA PAEDIATR, V101, P900, DOI 10.1111/j.1651-2227.2012.02740.x; Robinson SW, 2013, NUCLEIC ACIDS RES, V41, pD744, DOI 10.1093/nar/gks1141; ROEBROEK AJM, 1992, J BIOL CHEM, V267, P17208; ROEBROEK AJM, 1993, EMBO J, V12, P1853, DOI 10.1002/j.1460-2075.1993.tb05834.x; ROEBROEK AJM, 1991, FEBS LETT, V289, P133, DOI 10.1016/0014-5793(91)81052-A; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; ROEBROEK AJM, 1995, DNA CELL BIOL, V14, P223, DOI 10.1089/dna.1995.14.223; Savijoki K, 2011, J PROTEOME RES, V10, P3460, DOI 10.1021/pr2000896; Schmid MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102568; Seegmiller AC, 2002, DEV CELL, V2, P229, DOI 10.1016/S1534-5807(01)00119-8; Seidah NG, 2013, J BIOL CHEM, V288, P21473, DOI 10.1074/jbc.R113.481549; Siekhaus DE, 1999, J NEUROSCI, V19, P6942, DOI 10.1523/JNEUROSCI.19-16-06942.1999; Sopory S, 2010, DEV BIOL, V346, P102, DOI 10.1016/j.ydbio.2010.07.019; Turpeinen H, 2013, CURR GENOMICS, V14, P453, DOI 10.2174/1389202911314050010; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Valanne S, 2010, J IMMUNOL, V184, P6188, DOI 10.4049/jimmunol.1000261; Vanha-aho LM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004895; Wharton KA, 1999, GENETICS, V152, P629; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Zhang P, 2016, SCI REP-UK, V6, DOI 10.1038/srep19418; Zhang YC, 2016, INT J FUTUR GENER CO, V9, P1, DOI 10.14257/ijfgcn.2016.9.10.01; Zhou A, 1999, J BIOL CHEM, V274, P20745, DOI 10.1074/jbc.274.30.20745; Zhou J, 2015, DEV BIOL, V399, P189, DOI 10.1016/j.ydbio.2014.12.017	75	5	6	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4770	4782		10.1096/fj.201700296R	http://dx.doi.org/10.1096/fj.201700296R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28705811				2022-12-28	WOS:000413398500010
J	Wen, L; Fu, LZ; Shi, YB				Wen, Luan; Fu, Liezhen; Shi, Yun-Bo			Histone methyltransferase Dot1L is a coactivator for thyroid hormone receptor during Xenopus development	FASEB JOURNAL			English	Article						epigenetics; histone modification; activation mark; organogenesis	IN-VIVO ANALYSIS; AMPHIBIAN METAMORPHOSIS; POSTEMBRYONIC DEVELOPMENT; TRANSCRIPTIONAL ACTIVATION; LAEVIS METAMORPHOSIS; COREPRESSOR COMPLEX; GENE REPRESSION; MEDIATED TRANSCRIPTION; HUMAN GENOME; SET-DOMAIN	Histone modifications are associated with transcriptional regulation by diverse transcription factors. Genome-wide correlation studies have revealed that histone activation marks and repression marks are associated with activated and repressed gene expression, respectively. Among the histone activation marks is histone H3 K79 methylation, which is carried out by only a single methyltransferase, disruptor of telomeric silencing-1-like (DOT1L). We have been studying thyroid hormone (T3)-dependent amphibian metamorphosis in two highly related species, the pseudo-tetraploid Xenopus laevis and diploid Xenopus tropicalis, as a model for postembryonic development, a period around birth in mammals that is difficult to study. We previously showed that H3K79 methylation levels are induced at T3 target genes during natural and T3-induced metamorphosis and that Dot1L is itself a T3 target gene. These suggest that T3 induces Dot1L expression, and Dot1L in turn functions as a T3 receptor (TR) coactivator to promote vertebrate development. We show here that in cotransfection studies or in the reconstituted frog oocyte in vivo transcription system, overexpression of Dot1L enhances gene activation by TR in the presence of T3. Furthermore, making use of the ability to carry out transgenesis in X. laevis and gene knockdown in X. tropicalis, we demonstrate that endogenous Dot1L is critical for T3-induced activation of endogenous TR target genes while transgenic Dot1L enhances endogenous TR function in premetamorphic tadpoles in the presence of T3. Our studies thus for the first time provide complementary gain- and loss-of functional evidence in vivo for a cofactor, Dot1L, in gene activation by TR during vertebrate development.	[Wen, Luan; Fu, Liezhen; Shi, Yun-Bo] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Morphogenesis, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Shi, YB (corresponding author), NICHHD, NIH, Bldg 49,Room 6A82,18 Lib Dr,MSC 5431, Bethesda, MD 20892 USA.	shi@helix.nih.gov	Wen, Luan/ABH-3991-2020	Wen, Luan/0000-0001-9408-8709; Shi, Yun-Bo/0000-0002-6330-0639	U.S. National Institutes of Health, National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008858, ZIAHD001901] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in part, by the Intramural Research Program of the U.S. National Institutes of Health, National Institute of Child Health and Human Development. The authors declare no conflicts of interest.	Amaya E, 1998, TRENDS GENET, V14, P253, DOI 10.1016/S0168-9525(98)01506-6; Nguyen AT, 2011, GENE DEV, V25, P1345, DOI 10.1101/gad.2057811; ATKINSON BG, 1994, DEV GENET, V15, P313, DOI 10.1002/dvg.1020150402; Bagamasbad PD, 2015, MOL ENDOCRINOL, V29, P856, DOI 10.1210/me.2014-1349; Barry ER, 2010, EXPERT OPIN THER TAR, V14, P405, DOI 10.1517/14728221003623241; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Barth TK, 2010, TRENDS BIOCHEM SCI, V35, P618, DOI 10.1016/j.tibs.2010.05.006; Bilesimo P, 2011, MOL ENDOCRINOL, V25, P225, DOI 10.1210/me.2010-0269; Blitz IL, 2013, GENESIS, V51, P827, DOI 10.1002/dvg.22719; Buchholz DR, 2003, MOL CELL BIOL, V23, P6750, DOI 10.1128/MCB.23.19.6750-6758.2003; Buchholz DR, 2006, GEN COMP ENDOCR, V145, P1, DOI 10.1016/j.ygcen.2005.07.009; Buchholz DR, 2004, MOL CELL BIOL, V24, P9026, DOI 10.1128/MCB.24.20.9026-9037.2004; Burke LJ, 2000, FASEB J, V14, P1876, DOI 10.1096/fj.99-0943rev; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Choi JY, 2015, ENDOCRINOLOGY, V156, P735, DOI 10.1210/en.2014-1554; Das B, 2009, J BIOL CHEM, V284, P34167, DOI 10.1074/jbc.M109.066084; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Dodd M.H.I., 1976, P467; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Fu LZ, 2006, J BIOL CHEM, V281, P16870, DOI 10.1074/jbc.M603041200; Fu LZ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-81; Fu LZ, 2002, MOL REPROD DEV, V62, P470, DOI 10.1002/mrd.10137; Fujimoto K, 2012, ENDOCRINOLOGY, V153, P5082, DOI 10.1210/en.2012-1308; Furlow JD, 1999, MOL ENDOCRINOL, V13, P2076, DOI 10.1210/me.13.12.2076; Furlow JD, 2002, ENDOCRINOLOGY, V143, P3295, DOI 10.1210/en.2002-220126; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Guo XG, 2014, DEVELOPMENT, V141, P707, DOI 10.1242/dev.099853; Havis E, 2003, EMBO REP, V4, P883, DOI 10.1038/sj.embor.embor908; Heimeier RA, 2008, MOL ENDOCRINOL, V22, P1065, DOI 10.1210/me.2007-0492; Huang ZQ, 2003, EMBO J, V22, P2146, DOI 10.1093/emboj/cdg219; Ishizuka T, 2003, MOL CELL BIOL, V23, P5122, DOI 10.1128/MCB.23.15.5122-5131.2003; Jones B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000190; Jones PL, 2003, CURR TOP MICROBIOL, V274, P237; Jones PL, 2001, J BIOL CHEM, V276, P8807, DOI 10.1074/jbc.C000879200; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Lei Y, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-21; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Li JW, 2000, MOL CELL BIOL, V20, P2031, DOI 10.1128/MCB.20.6.2031-2042.2000; Li JW, 2002, GENE DEV, V16, P687, DOI 10.1101/gad.962502; Matsuda H, 2007, MOL ENDOCRINOL, V21, P1082, DOI 10.1210/me.2006-0448; Matsuda H, 2010, STEM CELLS, V28, P2073, DOI 10.1002/stem.529; Matsuda H, 2009, MOL CELL BIOL, V29, P745, DOI 10.1128/MCB.00827-08; Matsuura K, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-25; Matsuura K, 2012, ENDOCRINOLOGY, V153, P961, DOI 10.1210/en.2011-1736; Maunakea AK, 2010, CIRC RES, V107, P327, DOI 10.1161/CIRCRESAHA.110.222463; McKenna NJ, 2001, ANN NY ACAD SCI, V949, P3; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Nakajima K, 2003, DEV DYNAM, V227, P246, DOI 10.1002/dvdy.10300; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; Nieuwkoop P.D., 1965, NORMAL TABLE XENOPUS; Paul BD, 2005, J BIOL CHEM, V280, P27165, DOI 10.1074/jbc.M503999200; Paul BD, 2005, MOL CELL BIOL, V25, P5712, DOI 10.1128/MCB.25.13.5712-5724.2005; Paul BD, 2007, J BIOL CHEM, V282, P7472, DOI 10.1074/jbc.M607589200; Paul DB, 2003, CELL RES, V13, P459, DOI 10.1038/sj.cr.7290188; RANJAN M, 1994, J BIOL CHEM, V269, P24699; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Sachs LM, 2002, MOL CELL BIOL, V22, P8527, DOI 10.1128/MCB.22.24.8527-8538.2002; Sato Y, 2007, MECH DEVELOP, V124, P476, DOI 10.1016/j.mod.2007.03.006; Schreiber AM, 2001, P NATL ACAD SCI USA, V98, P10739, DOI 10.1073/pnas.191361698; Shanower GA, 2005, GENETICS, V169, P173, DOI 10.1534/genetics.104.033191; Shi Y.-B., 1999, AMPHIBIAN METAMORPHO; Shi YB, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-42; Shi ZY, 2015, FASEB J, V29, P4914, DOI 10.1096/fj.15-273425; Singer MS, 1998, GENETICS, V150, P613; Sterling J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047407; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; TATA JR, 1993, BIOESSAYS, V15, P239, DOI 10.1002/bies.950150404; Tomita A, 2004, MOL CELL BIOL, V24, P3337, DOI 10.1128/MCB.24.8.3337-3346.2004; Tomita A, 2003, J BIOL CHEM, V278, P30788, DOI 10.1074/jbc.M303309200; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Wang FQ, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0006-1; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wang XD, 2008, ENDOCRINOLOGY, V149, P5610, DOI 10.1210/en.2008-0751; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wang ZB, 2009, CURR OPIN GENET DEV, V19, P127, DOI 10.1016/j.gde.2009.02.001; Wen L, 2015, FASEB J, V29, P385, DOI 10.1096/fj.14-252171; Wen L, 2015, ENDOCRINOLOGY, V156, P721, DOI 10.1210/en.2014-1439; Wen LA, 2010, DEV DYNAM, V239, P2198, DOI 10.1002/dvdy.22356; WONG JM, 1995, J BIOL CHEM, V270, P18479, DOI 10.1074/jbc.270.31.18479; WONG JM, 1995, GENE DEV, V9, P2696, DOI 10.1101/gad.9.21.2696; Wong JM, 1997, EMBO J, V16, P3158, DOI 10.1093/emboj/16.11.3158; Yen PM, 2015, CELL BIOSCI, V5, DOI 10.1186/2045-3701-5-8; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9	88	11	11	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4821	4831		10.1096/fj.201700131R	http://dx.doi.org/10.1096/fj.201700131R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28739643	Green Published			2022-12-28	WOS:000413398500014
J	Losfeld, ME; Scibona, E; Lin, CW; Villiger, TK; Gauss, R; Morbidelli, M; Aebi, M				Losfeld, Marie-Estelle; Scibona, Ernesto; Lin, Chia-Wei; Villiger, Thomas K.; Gauss, Robert; Morbidelli, Massimo; Aebi, Markus			Influence of protein/glycan interaction on site-specific glycan heterogeneity	FASEB JOURNAL			English	Article						glycoengineering; glycobiology; glycoprotein maturation; Golgi processing; enzymatic flux	N-LINKED GLYCOSYLATION; ENHANCED AROMATIC SEQUONS; HAMSTER OVARY CELLS; THERAPEUTIC PROTEINS; HIGH-MANNOSE; HOST; ANTIBODY; MICROHETEROGENEITY; OLIGOSACCHARIDES; GLYCOBIOLOGY	To study how the interaction between N-linked glycans and the surrounding amino acids influences oligosaccharide processing, we used protein disulfide isomerase (PDI), a glycoprotein bearing 5 N-glycosylation sites, as a model system and expressed it transiently in a Chinese hamster ovary (CHO)-S cell line. PDI was produced as both secreted Sec-PDI and endoplasmic reticulum-retained glycoprotein (ER)-PDI, to study glycan processing by ER and Golgi resident enzymes. Quantitative site-specific glycosylation profiles were obtained, and flux analysis enabled modeling site-specific glycan processing. By altering the primary sequence of PDI, we changed the glycan/protein interaction and thus the site-specific glycoprofile because of the improved enzymatic fluxes at enzymatic bottlenecks. Our results highlight the importance of direct interactions between N-glycans and surface-exposed amino acids of glycoproteins on processing in the ER and the Golgi and the possibility of changing a site-specific N-glycan profile by modulating such interactions and thus the associated enzymatic fluxes. Altering the primary protein sequence can therefore be used to glycoengineer recombinant proteins.-Losfeld, M.-E., Scibona, E., Lin, C.-W., Villiger, T. K., Gauss, R., Morbidelli, M., Aebi, M. Influence of protein/glycan interaction on site-specific glycan heterogeneity.	[Losfeld, Marie-Estelle; Lin, Chia-Wei; Gauss, Robert; Aebi, Markus] Swiss Fed Inst Technol, Inst Microbiol, Dept Biol, Swiss Fed Inst Technol, Zurich, Switzerland; [Scibona, Ernesto; Villiger, Thomas K.; Morbidelli, Massimo] Swiss Fed Inst Technol, Inst Chem & Bioengn, Dept Chem & Appl Biosci, Swiss Fed Inst Technol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Aebi, M (corresponding author), Inst Microbiol HCI F407, Vladimir Prelog Weg 1-5-10, CH-8093 Zurich, Switzerland.	markus.aebi@micro.biol.ethz.ch	Lin, Chia-wei/ABA-6065-2021; Villiger, Thomas/AAE-8499-2020	Lin, Chia-wei/0000-0003-4777-2916; Villiger, Thomas/0000-0003-0036-2522; Morbidelli, Massimo/0000-0002-0112-414X; Scibona, Ernesto/0000-0002-2012-5674	European Union Seventh Framework Programme [627197]	European Union Seventh Framework Programme(European Commission)	The authors thank the Functional Genomics Center, Zurich, for help with the mass spectrometry analyses. The research leading to these results received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under Grant 627197 to M.-E.L. The authors declare no conflict of interest.	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Breitling J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013359; Butler M, 2014, CURR OPIN BIOTECH, V30, P107, DOI 10.1016/j.copbio.2014.06.010; Chen W, 2016, ACS CHEM BIOL, V11, P1852, DOI 10.1021/acschembio.5b01035; Cherepanova N, 2016, CURR OPIN CELL BIOL, V41, P57, DOI 10.1016/j.ceb.2016.03.021; del Val IJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28547; del Val IJ, 2016, BIOTECHNOL J, V11, P610, DOI 10.1002/biot.201400663; del Val IJ, 2011, BIOTECHNOL PROGR, V27, P1730, DOI 10.1002/btpr.688; Dell Anne, 2010, Int J Microbiol, V2010, P148178, DOI 10.1155/2010/148178; Doores KJ, 2015, J VIROL, V89, P1105, DOI 10.1128/JVI.02905-14; Durocher Y, 2009, CURR OPIN BIOTECH, V20, P700, DOI 10.1016/j.copbio.2009.10.008; Faid V, 2006, GLYCOBIOLOGY, V16, P440, DOI 10.1093/glycob/cwj081; GLEESON PA, 1985, BIOCHEMISTRY-US, V24, P493, DOI 10.1021/bi00323a037; Grabenhorst E, 1999, GLYCOCONJUGATE J, V16, P81, DOI 10.1023/A:1026466408042; Gu J, 2009, J PROTEOME RES, V8, P431, DOI 10.1021/pr800674g; Hall MK, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060925; Hang I, 2015, GLYCOBIOLOGY, V25, P1335, DOI 10.1093/glycob/cwv058; Hossler P, 2009, GLYCOBIOLOGY, V19, P936, DOI 10.1093/glycob/cwp079; HSIEH P, 1983, J BIOL CHEM, V258, P2548; Hsu CH, 2016, J AM CHEM SOC, V138, P7636, DOI 10.1021/jacs.6b02879; Hua S, 2012, ANAL BIOANAL CHEM, V403, P1291, DOI 10.1007/s00216-011-5109-x; HUBBARD SC, 1988, J BIOL CHEM, V263, P19303; Khatri K, 2016, MOL CELL PROTEOMICS, V15, P1895, DOI 10.1074/mcp.M116.058016; Lin N, 2015, BIOTECHNOL PROGR, V31, P334, DOI 10.1002/btpr.2038; Mast SW, 2006, METHOD ENZYMOL, V415, P31, DOI 10.1016/S0076-6879(06)15003-X; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Murray AN, 2015, CHEM BIOL, V22, P1052, DOI 10.1016/j.chembiol.2015.06.017; Niwa R, 2004, CANCER RES, V64, P2127, DOI 10.1158/0008-5472.CAN-03-2068; North SJ, 2010, J BIOL CHEM, V285, P5759, DOI 10.1074/jbc.M109.068353; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; Price JL, 2012, BIOPOLYMERS, V98, P195, DOI 10.1002/bip.22030; Price JL, 2011, P NATL ACAD SCI USA, V108, P14127, DOI 10.1073/pnas.1105880108; Raju TS, 2014, CURR OPIN BIOTECH, V30, P147, DOI 10.1016/j.copbio.2014.06.014; Ryczko MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23043; Scallon BJ, 2007, MOL IMMUNOL, V44, P1524, DOI 10.1016/j.molimm.2006.09.005; SCHACHTER H, 1991, Glycobiology, V1, P453, DOI 10.1093/glycob/1.5.453; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; Shah N, 2008, P NATL ACAD SCI USA, V105, P9570, DOI 10.1073/pnas.0802206105; Stanley Pamela, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a005199; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; TRIMBLE RB, 1983, J BIOL CHEM, V258, P2562; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; Varki A, 1998, TRENDS CELL BIOL, V8, P34, DOI 10.1016/S0962-8924(97)01198-7; Villiger TK, 2016, BIOTECHNOL PROGR, V32, P1135, DOI 10.1002/btpr.2315; Wang LX, 2012, ACS CHEM BIOL, V7, P110, DOI 10.1021/cb200429n; Wang Q, 2015, METHODS MOL BIOL, V1321, P287, DOI 10.1007/978-1-4939-2760-9_20; Werner RG, 2007, ACTA PAEDIATR, V96, P17, DOI 10.1111/j.1651-2227.2007.00199.x; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Wright RD, 2014, GLYCOBIOLOGY, V24, P1242, DOI 10.1093/glycob/cwu101; Yamane-Ohnuki N, 2004, BIOTECHNOL BIOENG, V87, P614, DOI 10.1002/bit.20151; Yin BJ, 2015, BIOTECHNOL BIOENG, V112, P2343, DOI 10.1002/bit.25650; Yu XJ, 2013, J AM CHEM SOC, V135, P9723, DOI 10.1021/ja4014375; Zacchi LF, 2016, GLYCOCONJUGATE J, V33, P359, DOI 10.1007/s10719-015-9641-3; Zhang PQ, 2013, ADV BIOCHEM ENG BIOT, V131, P63, DOI 10.1007/10_2012_163; Zhou Q, 2008, BIOTECHNOL BIOENG, V99, P652, DOI 10.1002/bit.21598; Zielinska DF, 2012, MOL CELL, V46, P542, DOI 10.1016/j.molcel.2012.04.031	56	23	23	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4623	4635		10.1096/fj.201700403R	http://dx.doi.org/10.1096/fj.201700403R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28679530				2022-12-28	WOS:000413397400037
J	Oortveld, MAW; van Vlijmen-Willems, IMJJ; Kersten, FFJ; Cheng, T; Verdoes, M; van Erp, PEJ; Verbeek, S; Reinheckel, T; Hendriks, WJAJ; Schalkwijk, J; Zeeuwen, PLJM				Oortveld, Merel A. W.; van Vlijmen-Willems, Ivonne M. J. J.; Kersten, Ferry F. J.; Cheng, Tsing; Verdoes, Martijn; van Erp, Piet E. J.; Verbeek, Sjef; Reinheckel, Thomas; Hendriks, Wiljan J. A. J.; Schalkwijk, Joost; Zeeuwen, Patrick L. J. M.			Cathepsin B as a potential cystatin M/E target in the mouse hair follicle	FASEB JOURNAL			English	Article						proteases; cysteine protease inhibitor; epidermis; alopecia; activity-based probes	CYSTEINE PROTEINASE-INHIBITOR; EPIDERMAL CORNIFICATION; CORNEAL EPITHELIUM; DEFICIENT MICE; CROSS-LINKING; PROTEASES; CELLS; DIFFERENTIATION; MUTATION; COLOCALIZATION	Deficiency of the cysteine protease inhibitor cystatin M/E (Cst6) in mice leads to disturbed epidermal cornification, impaired barrier function, and neonatal lethality. We report the rescue of the lethal skin phenotype of ichq (Cst6-deficient; Cst6(-/-)) mice by transgenic, epidermis-specific, reexpression of Cst6 under control of the human involucrin (INV) promoter. Rescued Tg(INV-Cst6)Cst6(ichq/ichq) mice survive the neonatal phase, but display severe eye pathology and alopecia after 4 mo. We observed keratitis and squamous metaplasia of the corneal epithelium, comparable to Cst6(-/-)Ctsl(+/-) mice, as we have reported in other studies. We found the INV promoter to be active in the hair follicle infundibulum; however, we did not observe Cst6 protein expression in the lower regions of the hair follicle in Tg(INV-Cst6)Cst6(ichq/ichq) mice. This result suggests that unrestricted activity of proteases is involved in disturbance of hair follicle biology, eventually leading to baldness. Using quenched activity-based probes, we identified mouse cathepsin B (CtsB), which is expressed in the lower regions of the hair follicle, as an additional target of mouse Cst6. These data suggest that Cst6 is necessary to control CtsB activity in hair follicle morphogenesis and highlight Cst6-controlled proteolytic pathways as targets for preventing hair loss.-Oortveld, M. A. W., van Vlijmen-Willems, I. M. J. J., Kersten, F. F. J., Cheng, T., Verdoes, M., van Erp, P. E. J., Verbeek, S., Reinheckel, T., Hendriks, W. J. A. J., Schalkwijk, J., Zeeuwen, P. L. J. M. Cathepsin B as a potential cystatin M/E target in the mouse hair follicle.	[Oortveld, Merel A. W.; van Vlijmen-Willems, Ivonne M. J. J.; Kersten, Ferry F. J.; Cheng, Tsing; van Erp, Piet E. J.; Schalkwijk, Joost; Zeeuwen, Patrick L. J. M.] Radboud Univ Nijmegen, Med Ctr, Dept Dermatol, Radboud Inst Mol Life Sci, Nijmegen, Netherlands; [Verdoes, Martijn] Radboud Univ Nijmegen, Med Ctr, Dept Tumor Immunol, Radboud Inst Mol Life Sci, Nijmegen, Netherlands; [Hendriks, Wiljan J. A. J.] Radboud Univ Nijmegen, Med Ctr, Dept Cell Biol, Radboud Inst Mol Life Sci, Nijmegen, Netherlands; [Verbeek, Sjef] Leiden Univ, Dept Human Genet, Med Ctr, Leiden, Netherlands; [Reinheckel, Thomas] Albert Ludwigs Univ, Inst Mol Med & Cell Res, Freiburg, Germany; [Reinheckel, Thomas] Albert Ludwigs Univ, BIOSS Ctr Biol Signaling Studies, Freiburg, Germany	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Freiburg; University of Freiburg	Schalkwijk, J; Zeeuwen, PLJM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Dermatol, POB 9101, NL-6500 HB Nijmegen, Netherlands.	joost.schalkwijk@radboudumc.nl; patrick.zeeuwen@radboudumc.nl	van Vlijmen-Willems, Ivonne MJJ/P-5336-2015; van Erp, Piet/B-4061-2008; Hendriks, Wiljan J.A.J./A-5214-2013; Kersten, Ferry F.J./ABC-7666-2020; Zeeuwen, Patrick/N-1779-2013; Verdoes, Martijn/A-4911-2015; Schalkwijk, Joost/N-1774-2013; Reinheckel, Thomas/AAL-9761-2021; Verdoes, Martijn/AAD-5239-2022; Schalkwijk, Joost/R-7509-2019	van Vlijmen-Willems, Ivonne MJJ/0000-0002-3522-2573; van Erp, Piet/0000-0002-6955-8817; Hendriks, Wiljan J.A.J./0000-0001-9481-8281; Zeeuwen, Patrick/0000-0002-6878-2438; Verdoes, Martijn/0000-0001-8753-3528; Reinheckel, Thomas/0000-0001-9866-9105; Verdoes, Martijn/0000-0001-8753-3528; Schalkwijk, Joost/0000-0002-1308-1319; Cheng, Tsing/0000-0001-5191-3289	Earth and Life Sciences (ALW) from the Netherlands Organization for Health Research and Development (ZonMW) [821.02.013]; Deutsche Forschungsgemeinschaft [SFB 850]	Earth and Life Sciences (ALW) from the Netherlands Organization for Health Research and Development (ZonMW); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank Daphne Reijnen (Central Animal Laboratory, Radboud University Nijmegen Medical Center) for assistance with the animal experiments. This work was supported by Earth and Life Sciences (ALW) Grant 821.02.013 (to J.S. and P.L.J.M.Z.) from the Netherlands Organization for Health Research and Development (ZonMW), and Deutsche Forschungsgemeinschaft SFB 850 Project B7 (to T.R.). The authors declare no conflicts of interest.	de Andrade FA, 2014, IMMUNOL RES, V60, P356, DOI 10.1007/s12026-014-8602-4; Barrett A. J., 1998, HDB PROTEOLYTIC ENZY; Behringer R., 2014, MANIPULATING MOUSE E, P298; Berardi S, 2001, ARTHRITIS RHEUM, V44, P1819, DOI 10.1002/1529-0131(200108)44:8<1819::AID-ART319>3.0.CO;2-4; Blum G, 2007, NAT CHEM BIOL, V3, P668, DOI 10.1038/nchembio.2007.26; Cheng T, 2006, J BIOL CHEM, V281, P15893, DOI 10.1074/jbc.M600694200; Cheng T, 2009, J INVEST DERMATOL, V129, P1232, DOI 10.1038/jid.2008.353; De Paiva CS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1625, DOI 10.1001/archophthalmol.2009.316; Deussing J, 1998, P NATL ACAD SCI USA, V95, P4516, DOI 10.1073/pnas.95.8.4516; Edgington-Mitchell LE, 2017, METHODS MOL BIOL, V1491, P145, DOI 10.1007/978-1-4939-6439-0_11; FIDLER IJ, 1975, CANCER RES, V35, P218; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; Hashimoto Y, 2001, BIOCHEM BIOPH RES CO, V283, P334, DOI 10.1006/bbrc.2001.4787; Hook V, 2005, BIOL CHEM, V386, P931, DOI 10.1515/BC.2005.108; Kos J, 2014, FUTURE MED CHEM, V6, P1355, DOI [10.4155/FMC.14.73, 10.4155/fmc.14.73]; Morioka K, 2001, ACTA HISTOCHEM CYTOC, V34, P337, DOI 10.1267/ahc.34.337; Ni J, 1997, J BIOL CHEM, V272, P10853; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; Okada Y, 2008, JPN J OPHTHALMOL, V52, P1, DOI 10.1007/s10384-007-0499-1; Pavlova A, 2000, FEBS LETT, V487, P156, DOI 10.1016/S0014-5793(00)02337-1; Pennacchio LA, 1998, NAT GENET, V20, P251, DOI 10.1038/3059; RALPH P, 1977, J IMMUNOL, V119, P950; Reinheckel T, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00133; RICE RH, 1979, CELL, V18, P681, DOI 10.1016/0092-8674(79)90123-5; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; Sotiropoulou G, 1997, J BIOL CHEM, V272, P903, DOI 10.1074/jbc.272.2.903; Sundberg JP, 1997, AM J PATHOL, V151, P293; Tholen S, 2013, MOL CELL PROTEOMICS, V12, P611, DOI 10.1074/mcp.M112.017962; Tong L, 2006, INVEST OPHTH VIS SCI, V47, P1938, DOI 10.1167/iovs.05-1129; Tong XM, 2003, TRENDS MOL MED, V9, P79, DOI 10.1016/S1471-4914(02)00025-4; Turk B, 2002, BIOL CHEM, V383, P1035, DOI 10.1515/BC.2002.112; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; vanRuissen F, 1996, J CELL PHYSIOL, V168, P442; Verdoes M, 2013, J AM CHEM SOC, V135, P14726, DOI 10.1021/ja4056068; Zeeuwen PLJM, 2007, J INVEST DERMATOL, V127, P120, DOI 10.1038/sj.jid.5700480; Zeeuwen PLJM, 2010, FASEB J, V24, P3744, DOI 10.1096/fj.10-155879; Zeeuwen PLJM, 2009, J INVEST DERMATOL, V129, P1327, DOI 10.1038/jid.2009.40; Zeeuwen PLJM, 2004, HUM MOL GENET, V13, P1069, DOI 10.1093/hmg/ddh115; Zeeuwen PLJM, 2002, HUM MOL GENET, V11, P2867, DOI 10.1093/hmg/11.23.2867; Zeeuwen PLJM, 2001, J INVEST DERMATOL, V116, P693, DOI 10.1046/j.1523-1747.2001.01309.x	41	5	7	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4286	4294		10.1096/fj.201700267R	http://dx.doi.org/10.1096/fj.201700267R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28596234	Green Published, hybrid			2022-12-28	WOS:000413397400009
J	Munoz-Castaneda, JR; Herencia, C; de Mier, MVPR; Rodriguez-Ortiz, ME; Diaz-Tocados, JM; Vergara, N; Martinez-Moreno, JM; Salmeron, MD; Richards, WG; Felsenfeld, A; Kuro-O, M; Almaden, Y; Rodriguez, M				Munoz-Castaneda, Juan R.; Herencia, Carmen; Victoria Pendon-Ruiz de Mier, Maria; Encarnacion Rodriguez-Ortiz, Maria; Diaz-Tocados, Juan M.; Vergara, Noemi; Martinez-Moreno, Julio M.; Dolores Salmeron, Maria; Richards, William G.; Felsenfeld, Arnold; Kuro-O, Makoto; Almaden, Yolanda; Rodriguez, Mariano			Differential regulation of renal Klotho and FGFR1 in normal and uremic rats	FASEB JOURNAL			English	Article						phosphaturia; FGF23; mineral metabolism; chronic kidney disease	GROWTH-FACTOR 23; CHRONIC KIDNEY-DISEASE; VITAMIN-D; FGF23; PHOSPHATE; EXPRESSION; CALCIFICATION; CALCIUM; INJURY; GENE	In renal failure, hyperphosphatemia occurs despite a marked elevation in serum fibroblast growth factor (FGF)-23. Abnormal regulation of the FGFR1-Klotho receptor complex may cause a resistance to the phosphaturic action of FGF23. The purpose of the present study was to investigate the regulation of renal Klotho and FGF receptor (FEFR)-1 in healthy and uremic rats induced by 5/6 nephrectomy. In normal rats, the infusion of rat recombinant FGF23 enhanced phosphaturia and increased renal FGFR1 expression; however, Klotho expression was reduced. Uremic rats on a high-phosphate (HP) diet presented hyperphosphatemia with marked elevation of FGF23 and an increased fractional excretion of phosphate (P) that was associated with a marked reduction of Klotho expression and an increase in FGFR1. After neutralization of FGF23 by anti-FGF23 administration, phosphaturia was still abundant, Klotho expression remained low, and the FGFR1 level was reduced. These results suggest that the expression of renal Klotho is modulated by phosphaturia, whereas the FGFR1 expression is regulated by FGF23. Calcitriol (CTR) administration prevented a decrease in renal Klotho expression. In HEK293 cells HP produced nuclear translocation of beta-catenin, together with a reduction in Klotho. Wnt/beta-catenin inhibition with Dkk-1 prevented the P-induced down-regulation of Klotho. The addition of CTR to HP medium was able to recover Klotho expression. In summary, high FGF23 levels increase FGFR1, whereas phosphaturia decreases Klotho expression through the activation of Wnt/beta-catenin pathway.	[Munoz-Castaneda, Juan R.; Herencia, Carmen; Victoria Pendon-Ruiz de Mier, Maria; Diaz-Tocados, Juan M.; Vergara, Noemi; Martinez-Moreno, Julio M.; Dolores Salmeron, Maria; Almaden, Yolanda; Rodriguez, Mariano] Inst Maimonides Invest Biomed Cordoba IMIBIC, Cordoba, Spain; [Munoz-Castaneda, Juan R.; Rodriguez, Mariano] Hosp Univ Reina Sofia, Unidad Gest Clin UGC Nefrol, Cordoba, Spain; [Munoz-Castaneda, Juan R.; Herencia, Carmen; Victoria Pendon-Ruiz de Mier, Maria; Diaz-Tocados, Juan M.; Vergara, Noemi; Martinez-Moreno, Julio M.; Dolores Salmeron, Maria; Almaden, Yolanda; Rodriguez, Mariano] Univ Cordoba, Dept Med, Cordoba, Spain; [Munoz-Castaneda, Juan R.; Rodriguez, Mariano] Red Nacl Invest Nefrol REDinREN, Cordoba, Spain; [Almaden, Yolanda] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Cordoba, Spain; [Herencia, Carmen; Victoria Pendon-Ruiz de Mier, Maria; Diaz-Tocados, Juan M.; Vergara, Noemi; Martinez-Moreno, Julio M.; Dolores Salmeron, Maria] Hosp Univ Reina Sofia, Cordoba, Spain; [Encarnacion Rodriguez-Ortiz, Maria] Fdn Jimenez Diaz, Inst Invest Sanitaria, REDinREN, Lab Nefrol, Madrid, Spain; [Richards, William G.] Amgen Inc, Thousand Oaks, CA 91320 USA; [Felsenfeld, Arnold] Vet Affairs Greater Los Angeles Healthcare Syst, Dept Med, Los Angeles, CA USA; [Felsenfeld, Arnold] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Kuro-O, Makoto] Jichi Med Univ, Ctr Mol Med, Div Antiaging Med, Shimotsuke, Japan; [Almaden, Yolanda] Hosp Univ Reina Sofia, UGC Med Interna, Cordoba, Spain	Universidad de Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Hospital Universitario Reina Sofia - Cordoba; Fundacion Jimenez Diaz; Amgen; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Jichi Medical University	Rodriguez, M (corresponding author), Univ Cordoba, Serv Nefrol REDinREN, Inst Maimonides Invest Biomed Cordoba, Hosp Univ Reina Sofia, Avd Menendez Pidal S-N, E-14004 Cordoba, Spain.	marianorodriguezportillo@gmail.com	Muñoz-Castañeda, Juan R./AFQ-3443-2022; Tocados, Juan Miguel Díaz/I-8254-2018; Martínez, Julio Manuel/AAA-6724-2020; Herencia, Carmen/AAA-6843-2020	Martínez, Julio Manuel/0000-0002-1945-5078; Rodriguez, Mariano/0000-0002-9380-6614; Munoz-Castaneda, Juan R/0000-0002-9341-0724; Diaz Tocados, Juan Miguel/0000-0001-5192-5212	Spanish government from the Programa Nacional I+D+I; Instituto de Salud Carlos III (ISCIII) - European Funds (FEDER) [PI14/00638, PI14/00467]; Consejeria de Economia, Innovacion, Ciencia y Empleo from the Junta de Andalucia [CVI-7925]; Framework Programme 7 Syskid UE Grant [FP7-241544]; EUTOX from the ISCIII; REDinREN from the ISCIII; Consejeria de Economia, Innovacion Grant from the Junta de Andalucia [CVI-7925]; ISCIII; Nicolas Monardes Programme, Consejeria de Salud-SAS (Junta de Andalucia); Laboratorios Rubio SA research award	Spanish government from the Programa Nacional I+D+I; Instituto de Salud Carlos III (ISCIII) - European Funds (FEDER); Consejeria de Economia, Innovacion, Ciencia y Empleo from the Junta de Andalucia; Framework Programme 7 Syskid UE Grant; EUTOX from the ISCIII; REDinREN from the ISCIII; Consejeria de Economia, Innovacion Grant from the Junta de Andalucia(Junta de Andalucia); ISCIII(Instituto de Salud Carlos III); Nicolas Monardes Programme, Consejeria de Salud-SAS (Junta de Andalucia)(Junta de Andalucia); Laboratorios Rubio SA research award	The authors thank Ignacio Lopez (Universidad de Cordoba) for criticism of the study and participation in the correction of the manuscript. This work was partially supported by a Spanish government grant from the Programa Nacional I+D+I 2008-2011 and Instituto de Salud Carlos III (ISCIII) Grants PI14/00638 and PI14/00467, cofinancing from European Funds (FEDER), Consejeria de Economia, Innovacion, Ciencia y Empleo (Grant CVI-7925) from the Junta de Andalucia, Framework Programme 7 Syskid UE Grant FP7-241544, and EUTOX and REDinREN from the ISCIII. N.V. and J.M.D.-T. were supported by Consejeria de Economia, Innovacion Grant CVI-7925 Ciencia y Empleo from the Junta de Andalucia. M.E.R.-O. is the recipient of a "Sara Borrell" research contract from the ISCIII. Y.A. and J.R.M.-C. are senior researchers supported by the Nicolas Monardes Programme, Consejeria de Salud-SAS (Junta de Andalucia). M.D.S. is supported by a Laboratorios Rubio SA research award. W.G.R. is employed by Amgen, Inc., and M.R. has received honorarium for lectures from Abbott, Amgen, Inc., Fresenius, and Shire. The remaining authors declare no conflicts of interest.	Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409; Canalejo R, 2010, J AM SOC NEPHROL, V21, P1125, DOI 10.1681/ASN.2009040427; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Faverman L, 2008, FEBS LETT, V582, P1552, DOI 10.1016/j.febslet.2008.03.053; Fliser D, 2007, J AM SOC NEPHROL, V18, P2600, DOI 10.1681/ASN.2006080936; Forster RE, 2011, BIOCHEM BIOPH RES CO, V414, P557, DOI 10.1016/j.bbrc.2011.09.117; Gattineni J, 2014, AM J PHYSIOL-RENAL, V306, pF351, DOI 10.1152/ajprenal.00232.2013; Goetz R, 2013, NAT REV MOL CELL BIO, V14, P166, DOI 10.1038/nrm3528; Guerrero F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089179; Hassan A, 2016, AM J PHYSIOL-RENAL, V310, pF217, DOI 10.1152/ajprenal.00332.2015; Haussler MR, 2012, REV ENDOCR METAB DIS, V13, P57, DOI 10.1007/s11154-011-9199-8; HAUT LL, 1980, KIDNEY INT, V17, P722, DOI 10.1038/ki.1980.85; Hiyama A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3830; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Isakova T, 2010, KIDNEY INT, V78, P947, DOI 10.1038/ki.2010.281; Kuro-o M, 2013, KIDNEY INT SUPPL, V3, P420, DOI 10.1038/kisup.2013.88; Liu JY, 2016, INT UROL NEPHROL, V48, P1313, DOI 10.1007/s11255-016-1291-2; Liu SG, 2008, J AM SOC NEPHROL, V19, P2342, DOI 10.1681/ASN.2007121301; Martinez-Moreno JM, 2012, AM J PHYSIOL-RENAL, V303, pF1136, DOI 10.1152/ajprenal.00684.2011; de Oca AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089525; Moreno JA, 2011, J AM SOC NEPHROL, V22, P1315, DOI 10.1681/ASN.2010101073; Olauson H, 2013, CURR OPIN NEPHROL HY, V22, P397, DOI 10.1097/MNH.0b013e32836213ee; Quinn SJ, 2013, AM J PHYSIOL-ENDOC M, V304, pE310, DOI 10.1152/ajpendo.00460.2012; Rodriguez-Ortiz ME, 2012, J AM SOC NEPHROL, V23, P1190, DOI 10.1681/ASN.2011101006; Sastre C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083713; Shalhoub V, 2012, J CLIN INVEST, V122, P2543, DOI 10.1172/JCI61405; Shao JS, 2005, J CLIN INVEST, V115, P1210, DOI 10.1172/JCI200524140; Sugiura H, 2010, NEPHROL DIAL TRANSPL, V25, P60, DOI 10.1093/ndt/gfp451; Sun CY, 2012, KIDNEY INT, V81, P640, DOI 10.1038/ki.2011.445; Tsujikawa H, 2003, MOL ENDOCRINOL, V17, P2393, DOI 10.1210/me.2003-0048; Wolf M, 2012, KIDNEY INT, V82, P737, DOI 10.1038/ki.2012.176; Wolf M, 2011, J AM SOC NEPHROL, V22, P956, DOI 10.1681/ASN.2010080894; Wu AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057322; Zhou LL, 2013, J AM SOC NEPHROL, V24, P771, DOI 10.1681/ASN.2012080865	34	25	27	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3858	3867		10.1096/fj.201700006R	http://dx.doi.org/10.1096/fj.201700006R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28515153				2022-12-28	WOS:000408713300013
J	Royce, SG; Rele, S; Broughton, BRS; Kelly, K; Samuel, CS				Royce, Simon G.; Rele, Siddharth; Broughton, Brad R. S.; Kelly, Kilian; Samuel, Chrishan S.			Intranasal administration of mesenchymoangioblast-derived mesenchymal stem cells abrogates airway fibrosis and airway hyperresponsiveness associated with chronic allergic airways disease	FASEB JOURNAL			English	Article						asthma; airway remodeling; therapies; pulmonary delivery	STROMAL CELLS; COMBINATION THERAPY; EXPERIMENTAL-MODEL; EPITHELIAL-CELLS; MOUSE MODEL; ASTHMA; INFLAMMATION; SERELAXIN; MICE; PROLIFERATION	Structural changes known as airway remodeling (AWR) characterize chronic/severe asthma and contribute to lung dysfunction. Thus, we assessed the in vivo efficacy of induced pluripotent stem cell and mesenchymoangioblast-derived mesenchymal stem cells (MCA-MSCs) on AWR in a murine model of chronic allergic airways disease (AAD)/asthma. Female Balb/c mice were subjected to a 9-wk model of ovalbumin (Ova)induced chronic AAD and treated intravenously or intranasally with MCA-MSCs from weeks 9 to 11. Changes in airway inflammation (AI), AWR, and airway hyperresponsiveness (AHR) were assessed. Ova-injured mice presented with AI, goblet cell metaplasia, epithelial thickening, increased airway TGF-beta 1 levels, subepithelial myofibroblast and collagen accumulation, total lung collagen concentration, and AHR (all P < 0.001 vs. uninjured control group). Apart from epithelial thickness, all other parameters measured were significantly, although not totally, decreased by intravenous delivery of MCA-MSCs to Ova-injured mice. In comparison, intranasal delivery of MCA-MSCs to Ova-injured mice significantly decreased all parameters measured (all P < 0.05 vs. Ova group) and, most notably, normalized aberrant airway TGF-b1 levels, airway/lung fibrosis, and AHR to values measured in uninjured animals. MCA-MSCs also increased collagen-degrading gelatinase levels. Hence, direct delivery of MCA-MSCs offers great therapeutic benefit for the AWR and AHR associated with chronic AAD.	[Royce, Simon G.; Rele, Siddharth; Samuel, Chrishan S.] Monash Univ, Fibrosis Lab, Clayton, Vic, Australia; [Broughton, Brad R. S.] Monash Univ, Cardiovasc & Pulm Pharmacol Grp, Cardiovasc Dis Program, Biomed Discovery Inst, Clayton, Vic, Australia; Monash Univ, Dept Pharmacol, Clayton, Vic, Australia; [Royce, Simon G.] Monash Univ, Dept Med, Cent Clin Sch, Prahran, Vic, Australia; [Kelly, Kilian] Cynata Therapeut, Armadale, Vic, Australia	Monash University; Monash University; Monash University; Monash University	Royce, SG; Samuel, CS (corresponding author), Monash Univ, Fibrosis Lab, Dept Pharmacol, Clayton, Vic 3800, Australia.	simon.royce@monash.edu; chrishan.samuel@monash.edu		/0000-0001-8844-974X; Rele, Siddharth/0000-0003-2778-2893	National Health and Medical Research Council (NHMRC) of Australia [GNT1041766]; Cynata Therapeutics	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cynata Therapeutics	The authors acknowledge the facilities and technical assistance of Monash Histology Platform (Department of Anatomy and Developmental Biology, Monash University). This work was supported by a National Health and Medical Research Council (NHMRC) of Australia Senior Research Fellowship (GNT1041766) to C.S.S., and by Cynata Therapeutics funding to C.S.S. and S.G.R. S.G.R., S.R., B.R.S.B., and C.S.S. are with the Cardiovascular Disease Program, Biomedicine Discovery Institute and Department of Pharmacology, Monash University. S.G.R. is also affiliated with the Central Clinical School, Monash University. K.K. is an employee and shareholder of Cynata Therapeutics Ltd., but was not involved with performing the experiments or analysis of data.	Abreu SC, 2013, RESP PHYSIOL NEUROBI, V185, P615, DOI 10.1016/j.resp.2012.11.005; Adams N. P., 2008, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD3534.PUB3; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Broide DH, 2008, J ALLERGY CLIN IMMUN, V121, P560, DOI 10.1016/j.jaci.2008.01.031; Carsin A, 2016, EUR RESPIR REV, V25, P158, DOI 10.1183/16000617.0101-2015; Cates CJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006922.pub3; Cates CJ, 2013, COCHRANE DB SYST REV, V6; Cho KS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165661; Cohen L, 2007, AM J RESP CRIT CARE, V176, P138, DOI 10.1164/rccm.200607-1062OC; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; Curran DR, 2010, AM J RESP CELL MOL, V42, P268, DOI 10.1165/rcmb.2009-0151TR; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Formigli L, 2007, J CELL MOL MED, V11, P1087, DOI 10.1111/j.1582-4934.2007.00111.x; GALLOP PM, 1975, PHYSIOL REV, V55, P418, DOI 10.1152/physrev.1975.55.3.418; GAO F, 2016, CELL DEATH DIS, V7; Goodwin M, 2011, STEM CELLS, V29, P1137, DOI 10.1002/stem.656; Hastie AT, 2002, AM J RESP CRIT CARE, V165, P266, DOI 10.1164/ajrccm.165.2.2101069; Holgate ST, 2000, CLIN EXP ALLERGY, V30, P37; Holgate ST, 2008, CLIN EXP ALLERGY, V38, P872, DOI 10.1111/j.1365-2222.2008.02971.x; Holgate ST, 2010, CLIN SCI, V118, P439, DOI 10.1042/CS20090474; Holgate ST, 2009, IMMUNITY, V31, P362, DOI 10.1016/j.immuni.2009.08.013; Huuskes BM, 2015, FASEB J, V29, P540, DOI 10.1096/fj.14-254789; Inamdar AC, 2013, EXP LUNG RES, V39, P315, DOI 10.3109/01902148.2013.816803; Kapoor S, 2012, J ALLERGY CLIN IMMUN, V129, P1094, DOI 10.1016/j.jaci.2011.10.048; Knight Darryl A, 2010, Expert Rev Respir Med, V4, P747, DOI 10.1586/ers.10.72; Koch JM, 2016, CYTOTHERAPY, V18, P219, DOI 10.1016/j.jcyt.2015.10.013; Lim R, 2013, RESPIRATION, V85, P332, DOI 10.1159/000343078; Mancheno-Corvo P, 2015, STEM CELLS DEV, V24, P2158, DOI 10.1089/scd.2014.0508; Martinez-Gonzalez I, 2014, STEM CELLS DEV, V23, P2352, DOI 10.1089/scd.2013.0616; Mathias LJ, 2013, J IMMUNOL, V191, P5914, DOI 10.4049/jimmunol.1300667; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; Ogulur I, 2014, INT IMMUNOPHARMACOL, V20, P101, DOI 10.1016/j.intimp.2014.02.028; Ou-Yang HF, 2011, EXP BIOL MED, V236, P1461, DOI 10.1258/ebm.2011.011221; Patel KP, 2016, BRIT J PHARMACOL, V173, P2016, DOI 10.1111/bph.13494; Pitchford S, 2003, BRIT J PHARMACOL, V138, P1181, DOI 10.1038/sj.bjp.0705136; Reddel HK, 2000, EUR RESPIR J, V16, P226, DOI 10.1034/j.1399-3003.2000.16b08.x; Rolfe K J, 2012, ISRN Dermatol, V2012, P698034, DOI 10.5402/2012/698034; Royce SG, 2016, CLIN SCI, V130, P2151, DOI 10.1042/CS20160328; Royce SG, 2015, STEM CELL RES, V15, P495, DOI 10.1016/j.scr.2015.09.007; Royce SG, 2014, PHARMACOL THERAPEUT, V141, P250, DOI 10.1016/j.pharmthera.2013.10.008; Royce SG, 2013, AM J RESP CELL MOL, V48, P135, DOI 10.1165/rcmb.2011-0320OC; Royce SG, 2013, CLIN SCI, V124, P41, DOI 10.1042/CS20120024; Samuel CS, 2016, TRENDS PHARMACOL SCI, V37, P485, DOI 10.1016/j.tips.2016.02.007; Shifren Adrian, 2012, J Allergy (Cairo), V2012, P316049, DOI 10.1155/2012/316049; Sueblinvong V, 2010, TRANSL RES, V156, P188, DOI 10.1016/j.trsl.2010.06.007; Sun YQ, 2012, STEM CELLS, V30, P2692, DOI 10.1002/stem.1241; Urbanek K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158746; Vodyanik MA, 2010, CELL STEM CELL, V7, P718, DOI 10.1016/j.stem.2010.11.011; Weiss DJ, 2014, STEM CELLS, V32, P16, DOI 10.1002/stem.1506; Wener RRL, 2013, EUR RESPIR REV, V22, P227, DOI 10.1183/09059180.00001913; WOESSNER JF, 1995, METHOD ENZYMOL, V248, P510; Zeng SL, 2015, MOL MED REP, V12, P2511, DOI 10.3892/mmr.2015.3706	52	19	21	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					4168	4178		10.1096/fj.201700178R	http://dx.doi.org/10.1096/fj.201700178R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28626025				2022-12-28	WOS:000408713300038
J	Shi, JX; Wang, YF; He, J; Li, PP; Jin, R; Wang, K; Xu, X; Hao, J; Zhang, Y; Liu, HJ; Chen, XP; Wu, HN; Ge, Q				Shi, Junxiu; Wang, Yifan; He, Jian; Li, Pingping; Jin, Rong; Wang, Ke; Xu, Xi; Hao, Jie; Zhang, Yan; Liu, Hongju; Chen, Xiaoping; Wu, Hounan; Ge, Qing			Intestinal microbiota contributes to colonic epithelial changes in simulated microgravity mouse model	FASEB JOURNAL			English	Article						intestinal epithelial cells; homeostasis; colitis	SEGMENTED FILAMENTOUS BACTERIA; GERM-FREE; BARRIER FUNCTION; GUT MICROBIOTA; CELL-DEATH; VIRULENCE; MUCOSAL; MUCUS; HOMEOSTASIS; MICE	Exposure to microgravity leads to alterations in multiple systems, but microgravity-related changes in the gastrointestinal tract and its clinical significance have not been well studied. We used the hindlimb unloading (HU) mouse model to simulate a microgravity condition and investigated the changes in intestinal microbiota and colonic epithelial cells. Compared with ground-based controls (Ctrls), HU affected fecal microbiota composition with a profile that was characterized by the expansion of Firmicutes and decrease of Bacteroidetes. The colon epithelium of HU mice showed decreased goblet cell numbers, reduced epithelial cell turnover, and decreased expression of genes that are involved in defense and inflammatory responses. As a result, increased susceptibility to dextran sulfate sodium-induced epithelial injury was observed in HU mice. Cohousing of Ctrl mice with HU mice resulted in HU like epithelial changes in Ctrl mice. Transplantation of feces from Ctrl to HU mice alleviated these epithelial changes in HU mice. Results indicate that HU changes intestinal microbiota, which leads to altered colonic epithelial cell homeostasis, impaired barrier function, and increased susceptibility to colitis. We further demonstrate that alteration in gastrointestinal motility may contribute to HU-associated dysbiosis. These animal results emphasize the necessity of evaluating astronauts' intestinal homeostasis during distant space travel.	[Shi, Junxiu; Wang, Yifan; Jin, Rong; Wang, Ke; Hao, Jie; Zhang, Yan; Ge, Qing] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Key Lab Med Immunol,Minist Hlth,Dept Immunol, Beijing, Peoples R China; [Wu, Hounan] Peking Univ, Hlth Sci Ctr, Med & Hlth Analyt Ctr, Beijing, Peoples R China; [He, Jian] Chinese Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, Beijing, Peoples R China; [Li, Pingping; Liu, Hongju; Chen, Xiaoping] China Med Univ, Shengjing Hosp, Shenyang, Peoples R China; [Xu, Xi] Nanjing Univ Sci & Technol, Ctr Mol Metab, Nanjing, Jiangsu, Peoples R China	Peking University; Peking University; China Medical University; Nanjing University of Science & Technology	Wu, HN; Ge, Q (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Immunol, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	wuhounan@bjmu.edu.cn; qingge@bjmu.edu.cn	Shi, Junxiu/M-1393-2019; Li, Ping/GYV-4914-2022; Shi, Junxiu/GXH-8588-2022	he, jian/0000-0002-8632-4924	National Natural Science Foundation of China [31671244, 81471525, 31270935]; Foundation for Innovative Research Groups of the National Natural Science Foundation of China [81621001]; Beijing Natural Science Foundation [5152010]; Natural Basic Research Program of China [2011CB711000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Innovative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Natural Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China (31671244, 81471525, and 31270935 to Q.G.), the Foundation for Innovative Research Groups of the National Natural Science Foundation of China (81621001 to Q.G.), Beijing Natural Science Foundation (5152010 to Q.G.), and the Natural Basic Research Program of China (2011CB711000 to Q.G.). The authors thank Professors Xiaohuan Guo (Qinghua University, Beijing, China), Zhihua Liu (Institute of Biophysics, Chinese Academy of Sciences, Beijing, China), Kunshan Zhang (Tongji University, Shanghai, China), Xiaoyan Qiu, and Pingzhang Wang (Peking University Health Science Center) for data analysis and helpful discussions. The authors declare no conflicts of interest.	ABRAMS GD, 1963, LAB INVEST, V12, P355; Al-Asmakh M, 2015, J MICROBIOL BIOTECHN, V25, P1583, DOI 10.4014/jmb.1501.01039; Allen CA, 2008, ENVIRON MICROBIOL, V10, P1512, DOI 10.1111/j.1462-2920.2008.01567.x; AMIDON GL, 1991, J CLIN PHARMACOL, V31, P968, DOI 10.1002/j.1552-4604.1991.tb03658.x; Atiakshin D A, 2011, Aviakosm Ekolog Med, V45, P25; Backhed F, 2007, P NATL ACAD SCI USA, V104, P606, DOI 10.1073/pnas.0605957104; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Barzegari A, 2012, FUTURE MICROBIOL, V7, P571, DOI [10.2217/FMB.12.37, 10.2217/fmb.12.37]; Bergstrom KSB, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005108; Birchenough GMH, 2016, SCIENCE, V352, P1535, DOI 10.1126/science.aaf7419; BROWN LR, 1976, J AM DENT ASSOC, V93, P357, DOI 10.14219/jada.archive.1976.0502; Cervantes JL, 2016, INT REV IMMUNOL, V35, P67, DOI 10.3109/08830185.2015.1027821; CHAPES SK, 1993, J LEUKOCYTE BIOL, V54, P227, DOI 10.1002/jlb.54.3.227; Chopra V, 2006, J TOXICOL ENV HEAL A, V69, P1345, DOI 10.1080/15287390500361792; Coskun M, 2013, PHARMACOL RES, V76, P1, DOI 10.1016/j.phrs.2013.06.007; Crawford PA, 2005, P NATL ACAD SCI USA, V102, P13254, DOI 10.1073/pnas.0504830102; DECELLE JG, 1976, APPL ENVIRON MICROB, V32, P659, DOI 10.1128/AEM.32.5.659-665.1976; Delgado ME, 2016, FEBS J, V283, P2701, DOI 10.1111/febs.13575; Drossman DA, 2016, GASTROENTEROLOGY, V150, P1262, DOI 10.1053/j.gastro.2016.02.032; Giogha C, 2014, CYTOKINE GROWTH F R, V25, P235, DOI 10.1016/j.cytogfr.2013.12.012; Hansen CHF, 2013, GUT MICROBES, V4, P241, DOI 10.4161/gmic.23999; Harm DL, 2002, DIGEST DIS SCI, V47, P1737, DOI 10.1023/A:1016480109272; Higginson EE, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw095; Hudson LE, 2017, CLIN MICROBIOL REV, V30, P191, DOI 10.1128/CMR.00049-16; Ilyin VK, 2005, ACTA ASTRONAUT, V56, P839, DOI 10.1016/j.actaastro.2005.01.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iwai H, 2007, CELL, V130, P611, DOI 10.1016/j.cell.2007.06.043; Johansson MEV, 2013, DIGEST DIS, V31, P305, DOI 10.1159/000354683; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kabat AM, 2014, TRENDS IMMUNOL, V35, P507, DOI 10.1016/j.it.2014.07.010; Klaus DM, 2006, TRENDS BIOTECHNOL, V24, P131, DOI 10.1016/j.tibtech.2006.01.008; Kriegel MA, 2011, P NATL ACAD SCI USA, V108, P11548, DOI 10.1073/pnas.1108924108; Kubinak JL, 2015, CELL HOST MICROBE, V17, P153, DOI 10.1016/j.chom.2014.12.009; Kuwahara T, 2011, DNA RES, V18, P291, DOI 10.1093/dnares/dsr022; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li PP, 2015, FASEB J, V29, P3263, DOI 10.1096/fj.15-271700; LIZKO NN, 1991, ACTA ASTRONAUT, V23, P163, DOI 10.1016/0094-5765(91)90115-L; Lopez-Posadas R, 2017, CELL MOL LIFE SCI, V74, P803, DOI 10.1007/s00018-016-2363-2; Lung TWF, 2014, CELL MICROBIOL, V16, P1736, DOI 10.1111/cmi.12371; McCarville JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068961; McCauley HA, 2015, TRENDS MOL MED, V21, P492, DOI 10.1016/j.molmed.2015.06.003; Mori T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076941; Nefedov Y G, 1971, Life Sci Space Res, V9, P11; Negroni A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/250762; Nickerson CA, 2004, MICROBIOL MOL BIOL R, V68, P345, DOI 10.1128/MMBR.68.2.345-361.2004; Nickerson CA, 2000, INFECT IMMUN, V68, P3147, DOI 10.1128/IAI.68.6.3147-3152.2000; Nowarski R, 2015, CELL, V163, P1444, DOI 10.1016/j.cell.2015.10.072; Pearson JS, 2013, NATURE, V501, P247, DOI 10.1038/nature12524; Pelaseyed T, 2014, IMMUNOL REV, V260, P8, DOI 10.1111/imr.12182; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Reading NC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00148; Ritchie LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125792; SAVAGE DC, 1981, APPL ENVIRON MICROB, V42, P996, DOI 10.1128/AEM.42.6.996-1001.1981; SAWYER HR, 1992, J APPL PHYSIOL, V73, pS148, DOI 10.1152/jappl.1992.73.2.S148; Seedorf H, 2014, CELL, V159, P253, DOI 10.1016/j.cell.2014.09.008; Shan MM, 2013, SCIENCE, V342, P447, DOI 10.1126/science.1237910; Shih VFS, 2014, P NATL ACAD SCI USA, V111, P13942, DOI 10.1073/pnas.1323852111; SHUBICH MG, 1977, KOSM BIOL AVIAK MED+, V11, P40; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Somova LA, 2005, ADV SPACE RES-SERIES, V35, P1621, DOI 10.1016/j.asr.2004.12.046; Stepankova R, 2007, INFLAMM BOWEL DIS, V13, P1202, DOI 10.1002/ibd.20221; Stowe RP, 1999, J LEUKOCYTE BIOL, V65, P179, DOI 10.1002/jlb.65.2.179; Tanoue T, 2012, SEMIN IMMUNOL, V24, P50, DOI 10.1016/j.smim.2011.11.009; Thelemann C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086844; Tomas J, 2016, P NATL ACAD SCI USA, V113, pE5934, DOI 10.1073/pnas.1612559113; Vandeputte D, 2016, GUT, V65, P57, DOI 10.1136/gutjnl-2015-309618; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Versari S, 2013, FASEB J, V27, P4466, DOI 10.1096/fj.13-229195; Wallace KL, 2014, WORLD J GASTROENTERO, V20, P6, DOI 10.3748/wjg.v20.i1.6; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Wilson JW, 2007, P NATL ACAD SCI USA, V104, P16299, DOI 10.1073/pnas.0707155104; Wilson JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003923; Zhang KY, 2015, CELL MICROBIOL, V17, P1561, DOI 10.1111/cmi.12501; Zhou Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044329; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	75	33	36	2	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3695	3709		10.1096/fj.201700034R	http://dx.doi.org/10.1096/fj.201700034R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28495755				2022-12-28	WOS:000405932400040
J	Martinez-Chacon, G; Brown, KA; Docanto, MM; Kumar, H; Salminen, S; Saarinen, N; Makela, S				Martinez-Chacon, Gabriela; Brown, Kristy A.; Docanto, Maria M.; Kumar, Himanshu; Salminen, Seppo; Saarinen, Niina; Makela, Sari			IL-10 suppresses TNF-alpha-induced expression of human aromatase gene in mammary adipose tissue	FASEB JOURNAL			English	Article						weight gain; anti-inflammatory cytokine; ovariectomy; CYP19A1 regulation	NECROSIS-FACTOR-ALPHA; STROMAL CELLS; METABOLIC SYNDROME; BREAST AROMATASE; GUT MICROBIOTA; HUMAN OBESITY; BODY-WEIGHT; INFLAMMATION; INTERLEUKIN-10; WOMEN	White adipose tissue inflammation is linked with increased aromatase gene expression and estrogen production, a major risk factor for breast cancer in obese postmenopausal women. TNF-alpha, a proinflammatory cytokine, is a key driver of aromatase promoter I.4-mediated expression in adipose tissue. In this study, we have shown that IL-10, an anti-inflammatory cytokine, suppressed both TNF-alpha-stimulated human aromatase reporter-luciferase (hARO-Luc) expression in mouse bone marrow mesenchymal stromal cells and aromatase gene expression in human breast adipose stromal cells (ASCs). IL-10 blocked TNF-alpha-stimulated ERK 1 / 2 activation in ASCs, suggesting an inhibitory effect through the MAPK signaling pathway. The links among obesity, IL-10, and aromatase were confirmed in ovariectomized (OVX) hARO-Luc mice, where increased adiposity was associated with upregulation of aromatase reporter activity and reduced IL-10 level in the mammary fat pad. OVX mice also exhibited changes in gut microbiota, similar to that in obese women, indicating altered immune function. In summary, our results suggest that increased adiposity, induced by the lack of ovarian hormones, results in enhanced expression of aromatase in mammary adipose tissue, mediated by reduction in local IL-10. These findings may bring new insights into the mechanisms involved in the development of postmenopausal breast cancer, as well as novel approaches for prevention.	[Martinez-Chacon, Gabriela; Kumar, Himanshu; Salminen, Seppo; Makela, Sari] Univ Turku, Funct Foods Forum, Turku, Finland; [Martinez-Chacon, Gabriela; Saarinen, Niina; Makela, Sari] Univ Turku, Inst Biomed, Turku 20014, Finland; [Saarinen, Niina; Makela, Sari] Univ Turku, Turku Ctr Dis Modeling, Turku, Finland; [Brown, Kristy A.; Docanto, Maria M.] Hudson Inst Med Res, Ctr Canc Res, Metab & Canc Lab, Clayton, Vic, Australia; [Brown, Kristy A.; Docanto, Maria M.] Monash Univ, Dept Physiol, Clayton, Vic, Australia	University of Turku; University of Turku; University of Turku; Hudson Institute of Medical Research; Monash University	Makela, S (corresponding author), Univ Turku, Inst Biomed, Turku 20014, Finland.	sari.makela@utu.fi	kumar, Himanshu/ABE-7982-2020	kumar, Himanshu/0000-0002-9749-8620; Makela, Sari/0000-0002-8698-4076; Martinez-Chacon, Gabriela/0000-0002-1387-8715; Saarinen, Niina/0000-0003-3531-378X	University of Turku Graduate School; Academy of Finland [264153]; Finnish Cultural Foundation [0116947-3]; Victorian Government Operational Infrastructure Support Program; Mavis Robertson Fellowship from the National Breast Cancer Foundation [ECF-16-004]; National Health and Medical Research Council [GNT1061800]	University of Turku Graduate School; Academy of Finland(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Victorian Government Operational Infrastructure Support Program; Mavis Robertson Fellowship from the National Breast Cancer Foundation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by the University of Turku Graduate School, and by grants from the Academy of Finland (264153) and the Finnish Cultural Foundation (0116947-3; to G.M.-C., N.S., and S.M.). K.A.B. was supported by the Victorian Government Operational Infrastructure Support Program, and by the Mavis Robertson Fellowship from the National Breast Cancer Foundation (ECF-16-004), and the National Health and Medical Research Council Project Grant GNT1061800. The authors declare no conflicts of interest.	ACKERMAN GE, 1981, J CLIN ENDOCR METAB, V53, P412, DOI 10.1210/jcem-53-2-412; Agarwal VR, 1996, J CLIN ENDOCR METAB, V81, P3843, DOI 10.1210/jc.81.11.3843; Asarian L, 2002, HORM BEHAV, V42, P461, DOI 10.1006/hbeh.2002.1835; Avdiushko R, 2001, J LEUKOCYTE BIOL, V70, P624; Brown KA, 2017, J CLIN ENDOCR METAB, V102, P1692, DOI 10.1210/jc.2016-3606; BULUN SE, 1994, BREAST CANCER RES TR, V30, P19, DOI 10.1007/BF00682738; BULUN SE, 1994, J CLIN ENDOCR METAB, V78, P428, DOI 10.1210/jc.78.2.428; Chen D, 2012, MOL CELL ENDOCRINOL, V355, P114, DOI 10.1016/j.mce.2012.01.027; Chen Z, 2005, AM J CLIN NUTR, V82, P651, DOI 10.1093/ajcn/82.3.651; Cox AJ, 2015, LANCET DIABETES ENDO, V3, P207, DOI 10.1016/S2213-8587(14)70134-2; Daniel H, 2014, ISME J, V8, P295, DOI 10.1038/ismej.2013.155; Docanto MM, 2014, BREAST CANCER RES TR, V147, P193, DOI 10.1007/s10549-014-3060-1; Esposito K, 2003, J CLIN ENDOCR METAB, V88, P1055, DOI 10.1210/jc.2002-021437; GRODIN JM, 1973, J CLIN ENDOCR METAB, V36, P207, DOI 10.1210/jcem-36-2-207; Hamidullah, 2012, BREAST CANCER RES TR, V133, P11, DOI 10.1007/s10549-011-1855-x; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Iyengar NM, 2017, CANCER PREV RES, V10, P235, DOI 10.1158/1940-6207.CAPR-16-0314; Iyengar NM, 2016, CLIN CANCER RES, V22, P2283, DOI 10.1158/1078-0432.CCR-15-2239; Iyengar NM, 2015, CANCER PREV RES, V8, P349, DOI 10.1158/1940-6207.CAPR-14-0243; Juge-Aubry CE, 2005, CYTOKINE, V29, P270, DOI 10.1016/j.cyto.2004.10.017; Jung SH, 2008, J NUTR BIOCHEM, V19, P371, DOI 10.1016/j.jnutbio.2007.05.007; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Leon-Cabrera S, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/493409; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lira FS, 2011, METABOLISM, V60, P359, DOI 10.1016/j.metabol.2010.02.017; Liu TW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136150; Lizcano F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/757461; Makki Kassem, 2013, ISRN Inflamm, V2013, P139239, DOI 10.1155/2013/139239; MINELLI EB, 1993, MICROB ECOL HEALTH D, V6, P43, DOI 10.3109/08910609309141561; Mocellin S, 2003, TRENDS IMMUNOL, V24, P36, DOI 10.1016/S1471-4906(02)00009-1; Morris PG, 2011, CANCER PREV RES, V4, P1021, DOI 10.1158/1940-6207.CAPR-11-0110; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Musso G, 2010, DIABETES CARE, V33, P2277, DOI 10.2337/dc10-0556; Nishida M, 2007, CIRC J, V71, P1234, DOI 10.1253/circj.71.1234; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Schmidt FM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121971; Simpson ER, 2001, ENDOCRINOLOGY, V142, P4589, DOI 10.1210/endo.142.11.8547; Simpson ER, 2013, J MOL ENDOCRINOL, V51, pT51, DOI 10.1530/JME-13-0217; Strauss L, 2013, FASEB J, V27, P1342, DOI 10.1096/fj.12-219048; Subbaramaiah K, 2012, CANCER DISCOV, V2, P356, DOI 10.1158/2159-8290.CD-11-0241; Subbaramaiah K, 2011, CANCER PREV RES, V4, P329, DOI 10.1158/1940-6207.CAPR-10-0381; To SQ, 2013, BIOCHEM BIOPH RES CO, V433, P96, DOI 10.1016/j.bbrc.2013.02.058; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; van Exel E, 2002, DIABETES, V51, P1088, DOI 10.2337/diabetes.51.4.1088; WADE GN, 1975, J COMP PHYSIOL PSYCH, V88, P183, DOI 10.1037/h0076186; Wang XY, 2015, J STEROID BIOCHEM, V153, P35, DOI 10.1016/j.jsbmb.2015.07.008; Williams LM, 2004, IMMUNOLOGY, V113, P281, DOI 10.1111/j.1365-2567.2004.01988.x; ZHAO Y, 1995, J BIOL CHEM, V270, P16449, DOI 10.1074/jbc.270.27.16449; Zhao Y, 1996, MOL ENDOCRINOL, V10, P1350, DOI 10.1210/me.10.11.1350	52	18	19	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3361	3370		10.1096/fj.201700938RRR	http://dx.doi.org/10.1096/fj.201700938RRR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401621				2022-12-28	WOS:000432546000037
J	Wang, Q; Delcorde, J; Tang, T; Downey, GP; McCulloch, CA				Wang, Qin; Delcorde, Julie; Tang, Tracy; Downey, Gregory P.; McCulloch, Christopher A.			Regulation of IL-1 signaling through control of focal adhesion assembly	FASEB JOURNAL			English	Article						fibroblasts; cell spreading; integrins; cytokine signaling	TYROSINE PHOSPHATASE-ALPHA; ENDOPLASMIC-RETICULUM; GENE-EXPRESSION; ACTIN DYNAMICS; CELL-ADHESION; KINASE IRAK; KAPPA-B; INTERLEUKIN-1; INTEGRIN; ACTIVATION	IL-1 signaling is adhesion-restricted in many cell types, but the mechanism that drives it is not defined. We screened for proteins recruited to nascent adhesions in IL-1-treated human fibroblasts with tandem mass tag-mass spectrometry. We used fibronectin bead preparations to enrich 10 actin-associated proteins. There was a 1.2 times log 2-fold enrichment of actin capping protein (ACP) at 30 min after IL-1 stimulation. Knockdown (KD) of ACP by siRNA reduced IL-1-induced ERK activation(by 56%, matrix metalloproteinase-3 (MMP-3) expression by 48%, and MMP-9 expression by 62% (in all reductions, P < 0.01). Confocal or structured illumination microscopy showed that ACP was diffused throughout the cytosol but strongly accumulated at the ruffled border of spreading cells. ACP colocalized with nascent paxillin- and vinculin-containing adhesions at the ruffled border, but not with mature adhesions in the center. ACP KD promoted the formation of large, stable adhesions. Immunoprecipitation and proximity ligation analysis showed that ACP was associated with the IL-1 signal transduction proteins myeloid differentiation factor 88 (MyD88) and IL-1 receptor-associated kinase (IRAK) at the ruffled border of the leading edge. IL-1-induced phospho-ERK and MyD88 or IRAK colocalized at the leading edge. We concluded that ACP is required for recruitment and function of IL-1 signaling complexes in nascent adhesions at the leading edge of the cell.				christopher.mcculloch@utoronto.ca		Downey, Gregory P/0000-0003-3253-5862	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grant [HL132950]; Canadian Institutes of Health Research (CIHR) [MOP-483461]; Canada Research Chair (Tier 1) in Matrix Dynamics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132950] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grant; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair (Tier 1) in Matrix Dynamics(Canada Research Chairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Jonathan Krieger (SPARC BioCentre, Hospital for Sick Children Toronto, ON, Canada) for performing MS. This work was supported by U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grant HL132950, and by Canadian Institutes of Health Research (CIHR) Grant MOP-483461. C.A.M. is supported by a Canada Research Chair (Tier 1) in Matrix Dynamics. The authors declare no conflicts of interest.	Abreu MTH, 2006, J CELL PHYSIOL, V207, P132, DOI 10.1002/jcp.20544; ARORA PD, 1995, J BIOL CHEM, V270, P6042, DOI 10.1074/jbc.270.11.6042; Blanchoin L, 2014, PHYSIOL REV, V94, P235, DOI 10.1152/physrev.00018.2013; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011; Chiu CL, 2013, MICROSC RES TECHNIQ, V76, P1070, DOI 10.1002/jemt.22267; Cooper JA, 2008, INT REV CEL MOL BIO, V267, P183, DOI 10.1016/S1937-6448(08)00604-7; CURTIS BM, 1989, P NATL ACAD SCI USA, V86, P3045, DOI 10.1073/pnas.86.9.3045; Dolat L, 2014, J CELL BIOL, V207, P225, DOI 10.1083/jcb.201405050; Edwards M, 2014, NAT REV MOL CELL BIO, V15, P677, DOI 10.1038/nrm3869; Franz CM, 2005, J CELL SCI, V118, P5315, DOI 10.1242/jcs.02653; Gallegos L, 2011, NAT CELL BIOL, V13, P344, DOI [10.1038/ncb0411-344, 10.1038/ncb2230]; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Geiger T, 2012, CURR OPIN CELL BIOL, V24, P562, DOI 10.1016/j.ceb.2012.05.004; GREENFEDER SA, 1995, J BIOL CHEM, V270, P13757, DOI 10.1074/jbc.270.23.13757; HONIG J, 1989, J PERIODONTAL RES, V24, P362, DOI 10.1111/j.1600-0765.1989.tb00883.x; Horton ER, 2015, NAT CELL BIOL, V17, P1577, DOI 10.1038/ncb3257; Iskratsch T, 2013, DEV CELL, V27, P545, DOI 10.1016/j.devcel.2013.11.003; Kai F, 2015, ONCOTARGET, V6, P11162, DOI 10.18632/oncotarget.3578; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Lanier MH, 2016, J BIOL CHEM, V291, P1076, DOI 10.1074/jbc.M115.676882; Livne A, 2016, J CELL SCI, V129, P1293, DOI 10.1242/jcs.180927; Lo YYC, 1998, J BIOL CHEM, V273, P7059, DOI 10.1074/jbc.273.12.7059; Luo L, 1997, BIOCHEM J, V324, P653, DOI 10.1042/bj3240653; MacGillivray MK, 2000, J BIOL CHEM, V275, P23509, DOI 10.1074/jbc.M003186200; Manninen A, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600022; McCulloch CA, 2006, NAT REV DRUG DISCOV, V5, P864, DOI 10.1038/nrd2109; McDermott EP, 2002, J BIOL CHEM, V277, P7808, DOI 10.1074/jbc.M108133200; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Morimatsu M, 2015, NANO LETT, V15, P2220, DOI 10.1021/nl5047335; Murphy-Ullrich JE, 2001, J CLIN INVEST, V107, P785, DOI 10.1172/JCI12609; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; PLOPPER GE, 1995, MOL BIOL CELL, V6, P1349, DOI 10.1091/mbc.6.10.1349; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; QWARNSTROM EE, 1991, P NATL ACAD SCI USA, V88, P1232, DOI 10.1073/pnas.88.4.1232; Rajshankar D, 2012, FASEB J, V26, P4429, DOI 10.1096/fj.12-207381; Reunanen N, 1998, J BIOL CHEM, V273, P5137, DOI 10.1074/jbc.273.9.5137; Shekhar S, 2016, J CELL SCI, V129, P1085, DOI 10.1242/jcs.179994; SIMS JE, 1993, P NATL ACAD SCI USA, V90, P6155, DOI 10.1073/pnas.90.13.6155; SLACK J, 1993, J BIOL CHEM, V268, P2513; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Sun ZQ, 2016, J CELL BIOL, V215, P445, DOI 10.1083/jcb.201609037; Wang Q, 2016, MOB INF SYST, V2016, DOI [10.1155/2016/8765874, 10.1155/2016/2159703]; Wang Q, 2006, J BIOL CHEM, V281, P31093, DOI 10.1074/jbc.M606392200; Wang Qin, 2003, FASEB Journal, V17, P1898; Wang Q, 2014, J BIOL CHEM, V289, P18427, DOI 10.1074/jbc.M113.540294; Wang Q, 2013, BIOCHEM J, V449, P771, DOI 10.1042/BJ20121170; Wang Q, 2010, J BIOL CHEM, V285, P22308, DOI 10.1074/jbc.M110.102426; Wang Q, 2009, J BIOL CHEM, V284, P20763, DOI 10.1074/jbc.M808828200; Wang Yu-li, 2007, Sci STKE, V2007, ppe10; Wehrle-Haller B, 2002, TRENDS CELL BIOL, V12, P382, DOI 10.1016/S0962-8924(02)02321-8; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Wesche H, 1997, J BIOL CHEM, V272, P7727, DOI 10.1074/jbc.272.12.7727; Zamir E, 2001, J CELL SCI, V114, P3577; Zhu P, 1998, BIOCHEM J, V330, P975, DOI 10.1042/bj3300975	59	9	9	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3119	3132		10.1096/fj.201700966R	http://dx.doi.org/10.1096/fj.201700966R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401618	Green Published			2022-12-28	WOS:000432546000019
J	Zhang, HK; Yu, F; Qin, FX; Shao, Y; Chong, W; Guo, ZF; Liu, XL; Fu, L; Gu, F; Ma, YJ				Zhang, Huikun; Yu, Feng; Qin, Fengxia; Shao, Ying; Chong, Wei; Guo, Zhifang; Liu, Xiaoli; Fu, Li; Gu, Feng; Ma, Yongjie			Combination of cytoplasmic and nuclear girdin expression is an independent prognosis factor of breast cancer	FASEB JOURNAL			English	Article						subcellular distribution; topoisomerase-II alpha; survival; recurrence; metastasis	ACTIN-BINDING PROTEIN; CLINICAL-IMPLICATIONS; CELL MOTILITY; RECURRENCE; GIV/GIRDIN; MIGRATION; INVASION; SURVIVAL; PROLIFERATION; ACTIVATION	Girdin is an actin-binding protein playing key roles in the development of various carcinomas. Although online tools have predicted nuclear localization of girdin with a high probability, convincing proof has rarely been provided until now. The purpose of this study was to discover girdin's precise subcellular distribution and the potential prognostic value corresponding to its localization. The subcellular distribution of girdin was detected in a human breast cancer cell line and in >800 samples of human breast tissue by clinical pathologic analysis. In this study, we discovered for the first time that girdin could attach to chromatin and interact with topoisomerase-II alpha in nucleus. Cytoplasmic and nuclear girdin exhibited different roles in prognosis of breast cancer cytoplasmic girdin expression was an independent prognostic factor for progression-free survival (PFS), whereas nuclear girdin expression was an independent prognostic factor for overall survival (OS). More important, combination cytoplasmic and nuclear girdin was an independent prognosis factor of both OS and PFS. In conclusion, our research results strongly recommend combination analysis of cytoplasmic and nuclear girdin for a precise prognostic prediction in breast cancer.	[Zhang, Huikun; Qin, Fengxia; Shao, Ying; Chong, Wei; Fu, Li; Gu, Feng] Tianjin Med Univ, Canc Inst & Hosp, Natl Clin Res Ctr Canc, Dept Breast Canc Pathol, Tianjin, Peoples R China; [Yu, Feng; Guo, Zhifang; Liu, Xiaoli; Ma, Yongjie] Tianjin Med Univ, Canc Inst & Hosp, Natl Clin Res Ctr Canc, Res Lab, Tianjin, Peoples R China; [Yu, Feng; Ma, Yongjie] Tianjin Med Univ, Canc Inst & Hosp, Natl Clin Res Ctr Canc, Dept Tumor Cell Biol, Tianjin, Peoples R China; [Yu, Feng; Ma, Yongjie] Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China; [Yu, Feng; Ma, Yongjie] Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China; [Yu, Feng; Ma, Yongjie] Tianjin Med Univ, Minist Educ, Key Lab Breast Canc Prevent & Therapy, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Ma, YJ (corresponding author), Tianjin Med Univ, Canc Inst & Hosp, Huanhu West Rd, Tianjin 300060, Peoples R China.	mayongjie@tjmuch.com	Liu, Xiaoli/HGE-7614-2022	Chong, Wei/0000-0002-1074-8595	National Scientific Foundation of China [81572851, 81672636]	National Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grants 81572851 (to Y.M.) and 81672636 (to F.G.) from the National Scientific Foundation of China. The authors declare no conflicts of interest.	Bednarski JJ, 2016, J EXP MED, V213, P209, DOI 10.1084/jem.20151048; Cao K, 2014, MOL MED REP, V10, P848, DOI 10.3892/mmr.2014.2268; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Christensen MO, 2002, J CELL BIOL, V157, P31, DOI 10.1083/jcb.200112023; Cossetti RJD, 2015, J CLIN ONCOL, V33, P65, DOI 10.1200/JCO.2014.57.2461; Dai XF, 2016, J CANCER, V7, P1281, DOI 10.7150/jca.13141; Dunkel Y, 2016, FASEB J, V30, P3702, DOI 10.1096/fj.201600500; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Enomoto A, 2009, NEURON, V63, P774, DOI 10.1016/j.neuron.2009.08.015; Fulcoli FG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11688; Garcia-Marcos M, 2015, J BIOL CHEM, V290, P6697, DOI 10.1074/jbc.R114.613414; Garcia-Marcos M, 2011, FASEB J, V25, P590, DOI 10.1096/fj.10-167304; Garcia-Marcos M, 2010, J BIOL CHEM, V285, P12765, DOI 10.1074/jbc.M109.045161; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Ghosh P, 2008, J CELL BIOL, V182, P381, DOI 10.1083/jcb.200712066; Ghosh P, 2016, CLIN CANCER RES, V22, P3488, DOI 10.1158/1078-0432.CCR-15-2290; Ghosh P, 2015, CELL CYCLE, V14, P2561, DOI 10.1080/15384101.2015.1066538; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Gu F, 2014, J NEUROCHEM, V131, P457, DOI 10.1111/jnc.12831; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, P907, DOI [10.1043/1543-2165-134.6.907, 10.1200/JCO.2009.25.6529, 10.1200/JOP.777003]; Hasan UA, 2013, J EXP MED, V210, P1369, DOI 10.1084/jem.20122394; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Jiang P, 2008, CANCER RES, V68, P1310, DOI 10.1158/0008-5472.CAN-07-5111; Jiang P, 2013, TUMORI J, V99, P530, DOI 10.1700/1361.15106; Jin F, 2013, ONCOL LETT, V5, P1549, DOI 10.3892/ol.2013.1249; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Khoshnoud MR, 2008, BREAST CANCER RES TR, V107, P71, DOI 10.1007/s10549-007-9520-0; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Ling Y, 2011, CANCER INVEST, V29, P405, DOI 10.3109/07357907.2011.568568; Liu CG, 2012, MED ONCOL, V29, P1554, DOI 10.1007/s12032-011-0087-6; Lopez-Sanchez I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5451; Lopez-Sanchez I, 2013, P NATL ACAD SCI USA, V110, P5510, DOI 10.1073/pnas.1303392110; Nishimae K, 2015, BREAST CANCER-TOKYO, V22, P445, DOI 10.1007/s12282-013-0501-3; Ohara K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036681; Pegram M D, 2000, Cancer Treat Res, V103, P57; Peng WT, 2014, ANN SURG ONCOL, V21, pS648, DOI 10.1245/s10434-014-3746-y; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Shibata T, 2013, ONCOL REP, V29, P2127, DOI 10.3892/or.2013.2406; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Song JY, 2014, ONCOL LETT, V7, P337, DOI 10.3892/ol.2013.1745; Tomiyama L, 2015, ONCOGENE, V34, P1141, DOI 10.1038/onc.2014.31; Wang CH, 2014, MOL CLIN ONCOL, V2, P425, DOI 10.3892/mco.2014.265; Wang YF, 2015, MOBILE SOCIAL NETWORKING AND COMPUTING: A MULTIDISCIPLINARY INTEGRATED PERSPECTIVE, P3; WOESSNER RD, 1991, CELL GROWTH DIFFER, V2, P209; Wolff AC, 2014, ARCH PATHOL LAB MED, V138, P241, DOI 10.5858/arpa.2013-0953-SA	46	4	4	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2395	2410		10.1096/fj.201700825RR	http://dx.doi.org/10.1096/fj.201700825RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29259035				2022-12-28	WOS:000432528000008
J	Zhao, SS; Adebiyi, MG; Zhang, YJ; Couturier, JP; Fan, XG; Zhang, HQ; Kellems, RE; Lewis, DE; Xia, Y				Zhao, Shushan; Adebiyi, Morayo G.; Zhang, Yujin; Couturier, Jacob P.; Fan, Xuegong; Zhang, Hongqi; Kellems, Rodney E.; Lewis, Dorothy E.; Xia, Yang			Sphingosine-1-phosphate receptor 1 mediates elevated IL-6 signaling to promote chronic inflammation and multitissue damage in sickle cell disease	FASEB JOURNAL			English	Article						S1PR1; JAK2; macrophage	PERSISTENT STAT3 ACTIVATION; SPHINGOSINE 1-PHOSPHATE; ERYTHROCYTES; ADENOSINE; KINASE; ARTHRITIS; EFFICACY; FTY720; EGRESS; CANCER	Sphingosine-1-phosphate (S1P) is a biolipid involved in chronic inflammation in several inflammatory disorders. Recent studies revealed that elevated S1P contributes to sickling in sickle cell disease (SCD), a devastating hemolytic, genetic disorder associated with severe chronic inflammation and tissue damage. We evaluated the effect of elevated S1P in chronic inflammation and tissue damage in SCD and underlying mechanisms. First, we demonstrated that interfering with S1P receptor signaling by FTY720, a U.S. Food and Drug Administration-approved drug, significantly reduced systemic, local inflammation and tissue damage without antisickling effects. These findings led us to discover that S1P receptor activation leads to substantial elevated local and systemic IL-6 levels in SCD mice. Genetic deletion of IL-6 in SCD mice significantly reduced local and systemic inflammation, tissue damage, and kidney dysfunction. At the cellular level, we determined that elevated IL-6 is a key cytokine functioning downstream of elevated S1P, which contributes to increased S1P receptor 1 (S1pr1) gene expression in the macrophages of several tissues in SCD mice. Mechanistically, we revealed that S1P-S1PR1 signaling reciprocally upregulated IL-6 gene expression in primary mouse macrophages in a JAK2-dependent manner. Altogether, we revealed that elevated S1P, coupled with macrophage S1PR1 reciprocally inducing IL-6 expression, is a key signaling network functioning as a malicious, positive, feed-forward loop to sustain inflammation and promote tissue damage in SCD. Our findings immediately highlight novel therapeutic possibilities.	[Zhao, Shushan; Fan, Xuegong; Zhang, Hongqi] Cent S Univ, Xiangya Hosp, Dept Orthoped, Changsha, Hunan, Peoples R China; [Xia, Yang] Cent S Univ, Xiangya Hosp, Dept Nephrol, Changsha, Hunan, Peoples R China; [Zhao, Shushan; Adebiyi, Morayo G.; Zhang, Yujin; Kellems, Rodney E.; Xia, Yang] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, 6431 Fannin St,MSB 6-200, Houston, TX 77030 USA; [Couturier, Jacob P.; Lewis, Dorothy E.] Univ Texas Houston, Sch Med, Dept Internal Med, Houston, TX 77030 USA; [Adebiyi, Morayo G.; Kellems, Rodney E.; Xia, Yang] MD Anderson Univ Texas Hlth Grad Sch UTHlth, Houston, TX USA	Central South University; Central South University; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Xia, Y (corresponding author), Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, 6431 Fannin St,MSB 6-200, Houston, TX 77030 USA.	yang.xia@uth.tmc.edu	赵, 树山/F-1536-2011		U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL113574, HL114457, HL136969, HL137990]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL137990, P01HL114457, R01HL136969, R01HL113574] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grants HL113574, HL114457, HL136969, and HL137990 (to Y.X.). The authors declare no conflicts of interest.	Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Amenabar Jose M, 2006, J Oral Sci, V48, P139, DOI 10.2334/josnusd.48.139; An SZ, 2000, J BIOL CHEM, V275, P288, DOI 10.1074/jbc.275.1.288; Awojoodu AO, 2014, BLOOD, V124, P1941, DOI 10.1182/blood-2014-01-543652; Bode C, 2010, J CELL BIOCHEM, V109, P1232, DOI 10.1002/jcb.22507; Florey O, 2009, J IMMUNOL, V183, P2330, DOI 10.4049/jimmunol.0901019; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Goyal P, 2013, MOL HUM REPROD, V19, P528, DOI 10.1093/molehr/gat023; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hu X, 2016, CELL REP, V16, P106, DOI 10.1016/j.celrep.2016.05.080; Ito K, 2007, BIOCHEM BIOPH RES CO, V357, P212, DOI 10.1016/j.bbrc.2007.03.123; Jin BR, 2017, SCI REP-UK, V7, DOI 10.1038/srep46252; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Kaul DK, 2000, J CLIN INVEST, V106, P411, DOI 10.1172/JCI9225; Keikhaei B, 2013, EUR CYTOKINE NETW, V24, P45, DOI 10.1684/ecn.2013.0328; Keul P, 2011, CIRC RES, V108, P314, DOI 10.1161/CIRCRESAHA.110.235028; Kikuta J, 2011, RHEUMATOL INT, V31, P967, DOI 10.1007/s00296-010-1634-8; Kunkel GT, 2013, NAT REV DRUG DISCOV, V12, P688, DOI 10.1038/nrd4099; Lai Wen-Qi, 2010, World J Biol Chem, V1, P321, DOI 10.4331/wjbc.v1.i11.321; Lan YY, 2005, AM J TRANSPLANT, V5, P2649, DOI 10.1111/j.1600-6143.2005.01085.x; Lee H, 2010, NAT MED, V16, P1421, DOI 10.1038/nm.2250; Lee OH, 1999, BIOCHEM BIOPH RES CO, V264, P743, DOI 10.1006/bbrc.1999.1586; Lewis ND, 2013, J IMMUNOL, V190, P3533, DOI 10.4049/jimmunol.1201810; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Madigan Catherine, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010659; Maines Lynn W., 2010, Inflammopharmacology, V18, P73, DOI 10.1007/s10787-010-0032-x; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Pathare A, 2004, AM J HEMATOL, V77, P323, DOI 10.1002/ajh.20196; Platt OS, 2000, J CLIN INVEST, V106, P337, DOI 10.1172/JCI10726; Ranjbaran Mina, 2017, J Nephropathol, V6, P69, DOI 10.15171/jnp.2017.12; Ratajczak MZ, 2010, LEUKEMIA, V24, P976, DOI 10.1038/leu.2010.53; Sun KQ, 2015, BLOOD, V125, P1643, DOI 10.1182/blood-2014-08-595751; Takasugi N, 2011, J NEUROSCI, V31, P6850, DOI 10.1523/JNEUROSCI.6467-10.2011; Weinblatt ME, 2015, ARTHRITIS RHEUMATOL, V67, P2591, DOI 10.1002/art.39249; Weischenfeldt J, 2008, CSH PROTOC, V2008, P5080; Xiang YQ, 2014, J CLIN INVEST, V124, P4823, DOI 10.1172/JCI77685; Yokota S, 2014, J RHEUMATOL, V41, P759, DOI 10.3899/jrheum.130690; Zhang YJ, 2014, J CLIN INVEST, V124, P2750, DOI 10.1172/JCI74604; Zhang YJ, 2011, NAT MED, V17, P79, DOI 10.1038/nm.2280	41	25	26	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2855	2865		10.1096/fj.201600788RR	http://dx.doi.org/10.1096/fj.201600788RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29401601	Green Published			2022-12-28	WOS:000432528000043
J	Zhou, YF; Li, YN; Jin, HJ; Wu, JH; He, QW; Wang, XX; Lei, H; Hu, B				Zhou, Yi-Fan; Li, Ya-Nan; Jin, Hui-Juan; Wu, Jie-Hong; He, Quan-Wei; Wang, Xu-Xia; Lei, Hao; Hu, Bo			Sema4D/PlexinB1 inhibition ameliorates blood-brain barrier damage and improves outcome after stroke in rats	FASEB JOURNAL			English	Article						ischemic stroke; pericytes; inflammatory response; BBB permeability; brain	CEREBRAL-ARTERY OCCLUSION; SEMAPHORIN 4D; SEMA4D; PERICYTES; PERMEABILITY; MICROGLIA; ISCHEMIA; INFLAMMATION; ANGIOGENESIS; DISEASE	The inflammatory process in stroke is the major contributor to blood-brain barrier (BBB) breakdown. Previous studies indicated that semaphorin 4D (Sema4D), an axon guidance molecule, initiated inflammatory microglial activation and disrupted endothelial function in the CNS. However, whether Sema4D disrupts BBB integrity after stroke remains unclear. To study the effect of Sema4D on BBB disruption in stroke, rats were subjected to transient middle cerebral artery occlusion and targeted injection of lentivirus-mediated clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 gene disruption of PlexinB1. We found that Sema4D synchronously increased with BBB permeability and accumulated in the perivascular area after stroke. Suppressing Sema4D/PlexinB1 signaling in the periinfarct cortex significantly decreased BBB permeability as detected by MRI and fibrin deposition, and thereby improved stroke outcome. In vitro, we confirmed that Sema4D disrupted BBB integrity and endothelial tight junctions. Moreover, we found that Sema4D induced pericytes to acquire a CD11b-positive phenotype and express proinflammatory cytokines. In addition, Sema4D inhibited AUF1-induced proinflammatory mRNA decay effect. Taken together, our data provides evidence that Sema4D disrupts BBB integrity and promotes an inflammatory response by binding to PlexinB1 in pericytes after transient middle cerebral artery occlusion. Our study indicates that Sema4D may be a novel therapeutic target for treatment in the acute phase of stroke.	[Zhou, Yi-Fan; Li, Ya-Nan; Jin, Hui-Juan; Wu, Jie-Hong; He, Quan-Wei; Hu, Bo] Huazhong Univ Sci & Technol, Union Hosp, Dept Neurol, Tongji Med Coll, 1277 Jiefang Dadao, Wuhan 430022, Hubei, Peoples R China; [Wang, Xu-Xia; Lei, Hao] Chinese Acad Sci, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan Inst Phys & Math, Natl Ctr Magnet Resonance Wuhan, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS	Hu, B (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Dept Neurol, Tongji Med Coll, 1277 Jiefang Dadao, Wuhan 430022, Hubei, Peoples R China.	hubo@mail.hust.edu.cn	Lei, Hao/A-7004-2008	Lei, Hao/0000-0003-3412-1241	Integrated Innovative Team for Major Human Diseases Program of Tongji Medical College, HUST [5001530026]; New Century Excellent Talents in University [NCET-10-0406]; National Natural Science Foundation of China [81571119, 81301002, 81601027, 81571139, 81301001, 81371311, 81400969, 81400970]; National Research Foundation for the Doctoral Program of Higher Education of China [20120142110068]; National Key Research and Development Program of China [2016YFC1300600]	Integrated Innovative Team for Major Human Diseases Program of Tongji Medical College, HUST; New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Research Foundation for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Key Research and Development Program of China	This work was supported by National Natural Science Foundation of China (Grants 81571119 and 81371311 to B.H., 81601027 to Y.-N.L., 81400969 to Q.-W.H., 81571139, 81301002, 81400970, and 81301001); Integrated Innovative Team for Major Human Diseases Program of Tongji Medical College, HUST (5001530026); National Research Foundation for the Doctoral Program of Higher Education of China (Grant 20120142110068 to B.H.); New Century Excellent Talents in University (NCET-10-0406 to B.H.); and National Key Research and Development Program of China (Grant 2016YFC1300600). The authors declare no conflicts of interest.	Alvarez-Sabin J, 2013, LANCET NEUROL, V12, P689, DOI 10.1016/S1474-4422(13)70055-3; Babu SS, 2015, TRENDS CARDIOVAS MED, V25, P676, DOI 10.1016/j.tcm.2015.02.006; Basile JR, 2006, P NATL ACAD SCI USA, V103, P9017, DOI 10.1073/pnas.0508825103; Basile JR, 2004, CANCER RES, V64, P5212, DOI 10.1158/0008-5472.CAN-04-0126; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bohara M, 2014, J CEREBR BLOOD F MET, V34, P589, DOI 10.1038/jcbfm.2013.234; Ch'ng ES, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-251; Chen CYA, 2004, RNA, V10, P669, DOI 10.1261/rna.5269304; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Chenette DM, 2016, CELL REP, V16, P1379, DOI 10.1016/j.celrep.2016.06.095; Conrotto P, 2005, BLOOD, V105, P4321, DOI 10.1182/blood-2004-07-2885; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Desilles JP, 2013, NEUROLOGY, V80, P844, DOI 10.1212/WNL.0b013e31828406de; Dimitrijevic OB, 2006, J CEREBR BLOOD F MET, V26, P797, DOI 10.1038/sj.jcbfm.9600229; Dimitrijevic OB, 2007, STROKE, V38, P1345, DOI 10.1161/01.STR.0000259709.16654.8f; Dohgu S, 2005, BRAIN RES, V1038, P208, DOI 10.1016/j.brainres.2005.01.027; Evans EE, 2015, CANCER IMMUNOL RES, V3, P689, DOI 10.1158/2326-6066.CIR-14-0171; Fang Z, 2016, FASEB J, V30, P2097, DOI 10.1096/fj.201500126; Fazzari P, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-55; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Fernandez-Klett F, 2013, J CEREBR BLOOD F MET, V33, P428, DOI 10.1038/jcbfm.2012.187; FRANK JI, 1995, NEUROLOGY, V45, P1286, DOI 10.1212/WNL.45.7.1286; Gerriets T, 2004, STROKE, V35, P566, DOI 10.1161/01.STR.0000113692.38574.57; Gong HX, 2017, SCI REP-UK, V7, DOI 10.1038/srep42127; Hasegawa Y, 2013, TRANSL STROKE RES, V4, P524, DOI 10.1007/s12975-013-0260-7; Hsieh CH, 2017, J PATHOL, V241, P337, DOI 10.1002/path.4838; Hu XM, 2017, CIRC RES, V120, P449, DOI 10.1161/CIRCRESAHA.116.308427; Jander S, 2007, STROKE, V38, P642, DOI 10.1161/01.STR.0000250048.42916.ad; Jolivel V, 2015, ACTA NEUROPATHOL, V129, P279, DOI 10.1007/s00401-014-1372-1; Lambertsen KL, 2011, J NEUROPATH EXP NEUR, V70, P481, DOI 10.1097/NEN.0b013e31821db3aa; Li YA, 2015, SCI REP-UK, V5, DOI 10.1038/srep13316; Liu KH, 2005, FREE RADICAL BIO MED, V39, P71, DOI 10.1016/j.freeadbiomed.2005.03.033; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Lu JY, 2006, GENE DEV, V20, P3174, DOI 10.1101/gad.1467606; Mao L, 2014, CNS NEUROSCI THER, V20, P460, DOI 10.1111/cns.12238; Moreau-Fauvarque C, 2003, J NEUROSCI, V23, P9229; Mou PP, 2013, BLOOD, V121, P4221, DOI 10.1182/blood-2012-11-470609; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Okuno T, 2010, J IMMUNOL, V184, P1499, DOI 10.4049/jimmunol.0903302; Ozen I, 2014, ACTA NEUROPATHOL, V128, P381, DOI 10.1007/s00401-014-1295-x; Paradis S, 2007, NEURON, V53, P217, DOI 10.1016/j.neuron.2006.12.012; Perego C, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-174; Pillai DR, 2009, J CEREBR BLOOD F MET, V29, P1846, DOI 10.1038/jcbfm.2009.106; Prakash R, 2015, CURR OPIN NEUROL, V28, P556, DOI 10.1097/WCO.0000000000000248; Rustenhoven J, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0503-0; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Sawano T, 2015, GLIA, V63, P2249, DOI 10.1002/glia.22890; Siniscalchi A, 2016, CURR VASC PHARMACOL, V14, P98, DOI 10.2174/1570161113666150923111329; Sladojevic N, 2014, NEUROBIOL DIS, V67, P57, DOI 10.1016/j.nbd.2014.03.010; Smith ES, 2015, NEUROBIOL DIS, V73, P254, DOI 10.1016/j.nbd.2014.10.008; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Song L, 2007, BLOOD, V109, P1515, DOI 10.1182/blood-2006-07-034009; Suzuki K, 2008, NAT IMMUNOL, V9, P17, DOI 10.1038/ni1553; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Taniguchi Y, 2009, J NEUROSCI RES, V87, P2833, DOI 10.1002/jnr.22124; Terpolilli NA, 2012, CIRC RES, V110, P727, DOI 10.1161/CIRCRESAHA.111.253419; Toguchi M, 2009, NEUROCHEM INT, V55, P573, DOI 10.1016/j.neuint.2009.05.013; Tuttolomondo A, 2009, CURR TOP MED CHEM, V9, P1240, DOI 10.2174/156802609789869619; Underly RG, 2017, J NEUROSCI, V37, P129, DOI 10.1523/JNEUROSCI.2891-16.2016; Voloshanenko O, 2017, FASEB J, V31, P4832, DOI 10.1096/fj.201700144R; Wang MD, 2016, MOL NEUROBIOL, V53, P1310, DOI 10.1007/s12035-015-9099-0; White EJF, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1393; Yang Y, 2011, STROKE, V42, P3323, DOI 10.1161/STROKEAHA.110.608257; Zhou H, 2014, ANGIOGENESIS, V17, P261, DOI 10.1007/s10456-013-9395-0; Zhu L, 2007, P NATL ACAD SCI USA, V104, P1621, DOI 10.1073/pnas.0606344104; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	66	29	31	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2181	2196		10.1096/fj.201700786RR	http://dx.doi.org/10.1096/fj.201700786RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29242274				2022-12-28	WOS:000429051400037
J	Paula, FMM; Leite, NC; Borck, PC; Freitas-Dias, R; Cnop, M; Chacon-Mikahil, MPT; Cavaglieri, CR; Marchetti, P; Boschero, AC; Zoppi, CC; Eizirik, DL				Paula, Flavia M. M.; Leite, Nayara C.; Borck, Patricia C.; Freitas-Dias, Ricardo; Cnop, Miriam; Chacon-Mikahil, Mara P. T.; Cavaglieri, Claudia R.; Marchetti, Piero; Boschero, Antonio C.; Zoppi, Claudio C.; Eizirik, Decio L.			Exercise training protects human and rodent beta cells against endoplasmic reticulum stress and apoptosis	FASEB JOURNAL			English	Article						T1D; STAT3; pancreatic islets; myokine; IL6	SKELETAL-MUSCLE; INSULIN-SECRETION; CANDIDATE GENE; GLUCOSE-UPTAKE; TYPE-1; MECHANISMS; ACTIVATION; RAT; IDENTIFICATION; INTERLEUKIN-6	Prolonged exercise has positive metabolic effects in obese or diabetic individuals. These effects are usually ascribed to improvements in insulin sensitivity. We evaluated whether exercise also generates circulating signals that protect human and rodent beta cells against endoplasmic reticulum (ER) stress and apoptosis. For this purpose, we obtained serum from humans or mice before and after an 8 wk training period. Exposure of human islets or mouse or rat b cells to human or rodent sera, respectively, obtained from trained individuals reduced cytokine (IL-1 beta+IFN-gamma)- or chemical ER stressor-induced beta-cell ER stress and apoptosis, at least in part via activation of the transcription factor STAT3. These findings indicate that exercise training improves human and rodent beta-cell survival under diabetogenic conditions and support lifestyle interventions as a protective approach for both type 1 and 2 diabetes.	[Paula, Flavia M. M.; Cnop, Miriam; Eizirik, Decio L.] ULB, Erasmus Hosp, Ctr Diabet Res, Brussels, Belgium; [Cnop, Miriam] ULB, Erasmus Hosp, Div Endocrinol, Brussels, Belgium; [Leite, Nayara C.; Borck, Patricia C.; Freitas-Dias, Ricardo; Boschero, Antonio C.; Zoppi, Claudio C.] Univ Campinas UNICAMP, Obes & Comorbid Res Ctr, Inst Biol, Dept Struct & Funct Biol, Campinas, Brazil; [Chacon-Mikahil, Mara P. T.; Cavaglieri, Claudia R.] Univ Campinas UNICAMP, Fac Phys Educ, Exercise Physiol Lab FISEX, Campinas, Brazil; [Freitas-Dias, Ricardo] Univ Pernambuco, Dept Phys Therapy, Petrolina, Brazil; [Marchetti, Piero] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade de Pernambuco (UPE); University of Pisa	Paula, FMM (corresponding author), ULB, Erasmus Hosp, Ctr Diabet Res, Brussels, Belgium.; Paula, FMM (corresponding author), ULB, Ctr Diabet Res, Med Fac, Route Lennik 808, B-1070 Brussels, Belgium.	flaviammdepaula@gmail.com	Cavaglieri, Cláudia Regina/C-4291-2012; Dias, Ricardo Freitas/E-1657-2013	Cavaglieri, Cláudia Regina/0000-0002-7795-6575; Cnop, Miriam/0000-0002-5112-1692; Leite, Nayara/0000-0003-4436-6947; Chacon-Mikahil, Mara Patricia Traina/0000-0002-6109-5141	Sao Paulo Research Foundation (FAPESP) [2015/12611-0]; CNPq [310398/2015]; Faepex [850/2015]; European Union's Horizon 2020 Research and Innovation Programme; project T2DSystems [667191]; Innovative Medicines Initiative 2 [115797]; Union's Horizon 2020 research and innovation program; European Federation of Pharmaceutical Industries and Associations (EFPIA); Juvenile Diabetes Reach Foundation; Leona M. and Harry B. Helmsley Charitable Trust	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Faepex; European Union's Horizon 2020 Research and Innovation Programme; project T2DSystems; Innovative Medicines Initiative 2; Union's Horizon 2020 research and innovation program; European Federation of Pharmaceutical Industries and Associations (EFPIA); Juvenile Diabetes Reach Foundation; Leona M. and Harry B. Helmsley Charitable Trust	The authors thank A. Musuaya, M. Pangerl, and I. Millard for excellent technical support. The work was supported by Sao Paulo Research Foundation (FAPESP) Grant 2015/12611-0 (to A.C.B. and C.C.Z.), CNPq Grant 310398/2015, and Faepex Grant 850/2015 (to M.P.T.C.-M. and C.R.C.). D.L.E., M.C., and P.M. received funding from the European Union's Horizon 2020 Research and Innovation Programme, project T2DSystems, under Grant Agreement 667191, and the Innovative Medicines Initiative 2 Joint Undertaking under Grant Agreement 115797 (INNODIA). This joint undertaking received support from the Union's Horizon 2020 research and innovation program and the European Federation of Pharmaceutical Industries and Associations (EFPIA), the Juvenile Diabetes Reach Foundation and The Leona M. and Harry B. Helmsley Charitable Trust. C.C.Z. and D.L.E. are co-senior authors. The authors declare no conflicts of interest.	BORDIN S, 1995, J MEMBRANE BIOL, V148, P177; Brozzi F, 2015, DIABETOLOGIA, V58, P2307, DOI 10.1007/s00125-015-3669-6; Calegari VC, 2012, J APPL PHYSIOL, V112, P711, DOI 10.1152/japplphysiol.00318.2011; Carpenter RL, 2014, CANCERS, V6, P897, DOI 10.3390/cancers6020897; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Catoire M, 2014, PHYSIOL GENOMICS, V46, P256, DOI 10.1152/physiolgenomics.00174.2013; Christensen CS, 2015, J CLIN ENDOCR METAB, V100, pE1289, DOI 10.1210/jc.2014-4506; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Cnop M, 2014, DIABETES, V63, P1978, DOI 10.2337/db13-1383; Conceicao MS, 2016, MED SCI SPORT EXER, V48, P1699, DOI 10.1249/MSS.0000000000000970; Coskun O, 2004, TOHOKU J EXP MED, V203, P145, DOI 10.1620/tjem.203.145; Czepluch FS, 2011, THROMB HAEMOSTASIS, V105, P122, DOI 10.1160/TH10-06-0363; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Darling NJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184907; De Groef S, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.171; Eizirik DL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002552; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Gurzov EN, 2009, CELL DEATH DIFFER, V16, P1539, DOI 10.1038/cdd.2009.99; Gurzov EN, 2011, TRENDS CELL BIOL, V21, P424, DOI 10.1016/j.tcb.2011.03.001; Gurzov EN, 2010, J BIOL CHEM, V285, P19910, DOI 10.1074/jbc.M110.122374; HAMMACHER A, 1994, PROTEIN SCI, V3, P2280, DOI 10.1002/pro.5560031213; Huang HW, 2011, EXP DIABETES RES, DOI 10.1155/2011/465910; Hung CC, 2003, J BIOL CHEM, V278, P29317, DOI 10.1074/jbc.M302368200; Igoillo-Esteve M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003888; International Diabetes Federation (IDF), 2015, IDF DIAB ATL; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Karstoft K, 2016, IMMUNOL CELL BIOL, V94, P146, DOI 10.1038/icb.2015.101; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Kolb H, 2012, NAT REV ENDOCRINOL, V8, P183, DOI 10.1038/nrendo.2011.158; Krolopp JE, 2016, FRONT PHYSIOL, V7, DOI [10.3339/fphys.2016.00626, 10.3389/fphys.2016.00626]; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li JM, 2011, J BIOL CHEM, V286, P4912, DOI 10.1074/jbc.M110.199729; Lindholm ME, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006294; Liu DB, 2001, ENDOCRINOLOGY, V142, P2593, DOI 10.1210/en.142.6.2593; Liu SW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175498; Marchetti P, 2007, DIABETOLOGIA, V50, P2486, DOI 10.1007/s00125-007-0816-8; Marroqui L, 2015, EBIOMEDICINE, V2, P378, DOI 10.1016/j.ebiom.2015.03.012; Marroqui L, 2014, DIABETES, V63, P2516, DOI 10.2337/db13-1443; Miani M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.236; Mitsuyama K, 2006, CYTOKINE GROWTH F R, V17, P451, DOI 10.1016/j.cytogfr.2006.09.003; Moore F, 2012, METHODS MOL BIOL, V820, P179, DOI 10.1007/978-1-61779-439-1_11; Moore F, 2009, DIABETES, V58, P1283, DOI 10.2337/db08-1510; Narendran P, 2015, DIABETOLOGIA, V58, P10, DOI 10.1007/s00125-014-3412-8; Nogueira TC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003532; Paula FMM, 2015, FASEB J, V29, P1805, DOI 10.1096/fj.14-264820; Peake JM, 2015, J APPL PHYSIOL, V119, P172, DOI 10.1152/japplphysiol.01055.2014; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; Rezende EL, 2006, J EXP BIOL, V209, P115, DOI 10.1242/jeb.01883; Stanford KI, 2014, ADV PHYSIOL EDUC, V38, P308, DOI 10.1152/advan.00080.2014; Supale S, 2012, TRENDS ENDOCRIN MET, V23, P477, DOI 10.1016/j.tem.2012.06.002; Toth KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017392; Wang SW, 2014, INT J ONCOL, V44, P1032, DOI 10.3892/ijo.2014.2259; Weigert C, 2014, PROTEOM CLIN APPL, V8, P5, DOI 10.1002/prca.201300094	53	18	20	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1524	1536		10.1096/fj.201700710R	http://dx.doi.org/10.1096/fj.201700710R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29133342				2022-12-28	WOS:000427246000032
J	Binnemars-Postma, K; Bansal, R; Storm, G; Prakash, J				Binnemars-Postma, Karin; Bansal, Ruchi; Storm, Gert; Prakash, Jai			Targeting the Stat6 pathway in tumor-associated macrophages reduces tumor growth and metastatic niche formation in breast cancer	FASEB JOURNAL			English	Article						TAMs; AS1517499; M2 macrophages; liver metastasis	STIMULATING FACTOR; POLARIZATION; MECHANISMS; RECRUITMENT; POPULATION; MIGRATION; RECEPTOR	Tumor-associated macrophages (TAMs) are the key effector cells in the tumor microenvironment and induce neoangiogenesis, matrix remodeling, and metastasis while suppressing the tumor immune system. These protumoral macrophages display an M2 phenotype induced by IL-4 and IL-13 cytokines. In this study, we hypothesized that the inhibition of the signal transducer and activator of transcription 6 (Stat6) pathway, a common downstream signaling pathway of IL-4 and IL-13, may be an interesting strategy by which to inhibit TAM differentiation and, thus, their protumorigenic activities. In vitro inhibition of the Stat6 pathway by using small interfering RNA or the pharmacologic inhibitor, AS1517499, inhibited the differentiation of mouse RAW264.7 macrophages into the M2 phenotype, as demonstrated by the reduction of Arg-1 (arginase-1) and Mrc-1 (mannose receptor 1) expression and arginase activity. In vivo, AS1517499 significantly attenuated tumor growth and early liver metastasis in an orthotopic 4T1 mammary carcinoma mouse model. Furthermore, in another experiment, we observed an increase in the intrahepatic mRNA expression of F4/80 (EGF-like module-containing mucin-like hormone receptor-like 1; total macrophages) and M2 macrophage markers [Ym-1 (chitinase 3-like protein 3) and Mrc-1] and metastatic niche markers [Mmp-2 (matrix metalloproteinase-2), Postn (periostin), and Cd34] in mice with increasing growth of primary tumors. Of interest, these markers were found to be reduced after treatment with AS1517499. In summary, inhibition of the Stat6 pathway in TAMs is a vital therapeutic approach to attenuate tumor growth and metastasis by inhibiting TAM-induced protumorigenic and prometastatic activities.	[Binnemars-Postma, Karin; Bansal, Ruchi; Storm, Gert; Prakash, Jai] Univ Twente, Inst Biomed Technol & Tech Med MIRA, Targeted Therapeut Biomat Sci & Technol, Enschede, Netherlands; [Storm, Gert] Univ Utrecht, Dept Pharmaceut, Utrecht, Netherlands	University of Twente; Utrecht University	Prakash, J (corresponding author), Univ Twente, Drienerlolaan 5, NL-7522 NB Enschede, Netherlands.	j.prakash@utwente.nl	Prakash, Jai/C-8015-2014; Bansal, Ruchi/D-4796-2016	Prakash, Jai/0000-0003-1050-650X; Bansal, Ruchi/0000-0003-2470-5876	Phospholipid Research Centre Heidelberg [30926319]; MIRA Institute, University of Twente	Phospholipid Research Centre Heidelberg; MIRA Institute, University of Twente	The authors thank Dr. Joop van Baarlen (LabPON, Hengelo, The Netherlands) for providing human breast tumor tissue. This study was supported by the Phospholipid Research Centre Heidelberg (Grant 30926319 to J.P.) and the MIRA Institute, University of Twente. The authors declare no conflicts of interest.	Allavena P, 2012, CLIN EXP IMMUNOL, V167, P195, DOI 10.1111/j.1365-2249.2011.04515.x; Biswas SK, 2013, SEMIN IMMUNOPATHOL, V35, P585, DOI 10.1007/s00281-013-0367-7; Brown HK, 2009, CURR CANCER DRUG TAR, V9, P807, DOI 10.2174/156800909789760339; Chiba Y, 2009, AM J RESP CELL MOL, V41, P516, DOI 10.1165/rcmb.2008-0163OC; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Ding T, 2009, HUM PATHOL, V40, P381, DOI 10.1016/j.humpath.2008.08.011; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Guo QJ, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/9720912; Hume DA, 2012, BLOOD, V119, P1810, DOI 10.1182/blood-2011-09-379214; International Agency for Research on Cancer, BREAST CANC; Jia XM, 2014, BREAST CANCER RES TR, V148, P291, DOI 10.1007/s10549-014-3164-7; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Mantovani A, 2004, EUR J CANCER, V40, P1660, DOI 10.1016/j.ejca.2004.03.016; Mantovani A, 2017, NAT REV CLIN ONCOL, V14, P399, DOI 10.1038/nrclinonc.2016.217; Nagashima S, 2007, BIOORGAN MED CHEM, V15, P1044, DOI 10.1016/j.bmc.2006.10.015; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Ngambenjawong C, 2017, ADV DRUG DELIVER REV, V114, P206, DOI 10.1016/j.addr.2017.04.010; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Oishi K, 2015, SURG TODAY, V45, P715, DOI 10.1007/s00595-014-0989-y; Ostrand-Rosenberg S, 2000, J IMMUNOL, V165, P6015, DOI 10.4049/jimmunol.165.11.6015; Pauleau AL, 2004, J IMMUNOL, V172, P7565, DOI 10.4049/jimmunol.172.12.7565; Peinado H, 2017, NAT REV CANCER, V17, P302, DOI 10.1038/nrc.2017.6; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Quail DF, 2016, SCIENCE, V352, DOI 10.1126/science.aad3018; Sakurai M, 2003, J ANTIBIOT, V56, P513, DOI 10.7164/antibiotics.56.513; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Sica A, 2008, CANCER LETT, V267, P204, DOI 10.1016/j.canlet.2008.03.028; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Solinas G, 2010, J IMMUNOL, V185, P642, DOI 10.4049/jimmunol.1000413; Tang XQ, 2013, CANCER LETT, V332, P3, DOI 10.1016/j.canlet.2013.01.024; Wang N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00614; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240; Zhou WC, 2015, NAT CELL BIOL, V17, P170, DOI 10.1038/ncb3090	35	96	106	5	26	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					969	978		10.1096/fj.201700629R	http://dx.doi.org/10.1096/fj.201700629R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29066614	Green Submitted, Bronze			2022-12-28	WOS:000425146900037
J	Huang, Q; Voloudakis, G; Ren, YM; Yoon, Y; Zhang, E; Kajiwara, Y; Shao, ZP; Xuan, Z; Lebedev, D; Georgakopoulos, A; Robakis, NK				Huang, Qian; Voloudakis, Georgios; Ren, Yimin; Yoon, Yonejung; Zhang, Emily; Kajiwara, Yuji; Shao, Zhiping; Xuan, Zhao; Lebedev, Denis; Georgakopoulos, Anastasios; Robakis, Nikolaos K.			Presenilin1/gamma-secretase protects neurons from glucose deprivation-induced death by regulating miR-212 and PEA15	FASEB JOURNAL			English	Article						CREB; microRNA; NMDAR	POSITRON-EMISSION-TOMOGRAPHY; ALZHEIMERS-DISEASE; GAMMA-SECRETASE; METABOLISM; EXPRESSION; APOPTOSIS; LIGAND; DEGENERATION; INHIBITORS; IMPAIRMENT	Reduced cerebral glucose utilization is found in aged individuals and often is an early sign of neuro-degeneration. Here, we show that under glucose deprivation (GD) conditions, decreased expression of presenilin 1(PS1) results in decreased neuronal survival, whereas increased PS1 increases neuronal survival. Inhibition of g-secretase also decreases neuronal survival under GD conditions, which suggests the PS1/gamma-secretase system protects neurons from GD-induced death. We also show that neuronal levels of the survival protein, phosphoprotein enriched in astrocytes at similar to 15 kDa (PEA15), and its mRNA are regulated by PS1/gamma-secretase. Furthermore, down-regulation of PEA15 decreases neuronal survival under reduced glucose conditions, whereas exogenous PEA15 increases neuronal survival even in the absence of PS1, which indicates that PEA15 promotes neuronal survival under GD conditions. The absence or reduction of PS1, as well asg-secretase inhibitors, increases neuronal miR-212, which targets PEA15 mRNA. PS1/gamma-secretase activates the transcription factor, cAMP response element-binding protein, regulating miR-212, which targets PEA15 mRNA. Taken together, our data show that under conditions of reduced glucose, the PS1/gamma-secretase system decreases neuronal losses by suppressing miR-212 and increasing its target survival factor, PEA15. These observations have implications for mechanisms of neuronal death under conditions of reduced glucose and may provide targets for intervention in neurodegenerative disorders.	[Huang, Qian; Voloudakis, Georgios; Ren, Yimin; Yoon, Yonejung; Zhang, Emily; Kajiwara, Yuji; Shao, Zhiping; Xuan, Zhao; Lebedev, Denis; Georgakopoulos, Anastasios; Robakis, Nikolaos K.] Icahn Sch Med Mt Sinai, Ctr Mol Biol & Genet Neurodegenerat, Dept Psychiat, One Gustave Levy Pl, New York, NY 10029 USA; [Huang, Qian; Voloudakis, Georgios; Ren, Yimin; Yoon, Yonejung; Zhang, Emily; Kajiwara, Yuji; Shao, Zhiping; Xuan, Zhao; Lebedev, Denis; Georgakopoulos, Anastasios; Robakis, Nikolaos K.] Icahn Sch Med Mt Sinai, Ctr Mol Biol & Genet Neurodegenerat, Dept Neurosci, One Gustave Levy Pl, New York, NY 10029 USA; [Voloudakis, Georgios] Univ Crete, Sch Med, Iraklion, Crete, Greece	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Crete	Robakis, NK (corresponding author), Icahn Sch Med Mt Sinai, Ctr Mol Biol & Genet Neurodegenerat, Dept Psychiat, One Gustave Levy Pl, New York, NY 10029 USA.; Robakis, NK (corresponding author), Icahn Sch Med Mt Sinai, Ctr Mol Biol & Genet Neurodegenerat, Dept Neurosci, One Gustave Levy Pl, New York, NY 10029 USA.	nikos.robakis@mssm.edu	Voloudakis, Georgios/B-8858-2019; Robakis, Nikolaos/AAA-1838-2021	Voloudakis, Georgios/0000-0002-5729-632X; Xuan, Zhao/0000-0002-8254-2887; Georgakopoulos, Anastasios/0000-0001-8241-6306; kajiwara, yuji/0000-0002-9307-8215; Yoon, YoneJung/0000-0002-1608-2122	U.S. National Institutes of Health (NIH) National Institute on Aging [AG17926, AG08200, AG05138]; NIH National Institute of Neurological Disorders and Stroke [NS047229]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG008200, P50AG005138, R01AG017926, R37AG017926, RF1AG008200] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute on Aging; NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by U.S. National Institutes of Health (NIH) National Institute on Aging Grants AG17926, AG08200, and AG05138; and NIH National Institute of Neurological Disorders and Stroke Grant NS047229. The authors declare no conflicts of interest.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Auffret A, 2010, J ALZHEIMERS DIS, V19, P1021, DOI 10.3233/JAD-2010-1302; Baki L, 2004, EMBO J, V23, P2586, DOI 10.1038/sj.emboj.7600251; Baki L, 2008, J NEUROSCI, V28, P483, DOI 10.1523/JNEUROSCI.4067-07.2008; Barthet G, 2013, NEUROBIOL AGING, V34, P499, DOI 10.1016/j.neurobiolaging.2012.02.024; Barthet G, 2011, FASEB J, V25, P2937, DOI 10.1096/fj.11-183806; BlumDegen D, 1995, J NEURAL TRANSM-SUPP, P139; Bruban J, 2015, FASEB J, V29, P3702, DOI 10.1096/fj.15-270645; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Costantini LC, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S16; Dai C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015008; de la Torre JC, 2000, ANN NY ACAD SCI, V924, P136; DELEON MJ, 1993, AM J NEURORADIOL, V14, P897; Eckert A, 2008, ONCOGENE, V27, P1155, DOI 10.1038/sj.onc.1210732; Estelles A, 1999, DEV BIOL, V216, P16, DOI 10.1006/dbio.1999.9510; Fiory F, 2009, AM J PHYSIOL-ENDOC M, V297, pE592, DOI 10.1152/ajpendo.00228.2009; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Giannakopoulos P, 1997, AM J PATHOL, V150, P429; Goussakov I, 2010, J NEUROSCI, V30, P12128, DOI 10.1523/JNEUROSCI.2474-10.2010; Hardingham GE, 2002, BBA-PROTEINS PROTEOM, V1600, P148, DOI 10.1016/S1570-9639(02)00455-7; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hernandez-Rapp J, 2017, PROG NEURO-PSYCHOPH, V73, P79, DOI 10.1016/j.pnpbp.2016.04.011; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Incoronato M, 2010, CANCER RES, V70, P3638, DOI 10.1158/0008-5472.CAN-09-3341; KENNEDY AM, 1995, ALZ DIS ASSOC DIS, V9, P17, DOI 10.1097/00002093-199505000-00005; KENNEDY AM, 1995, NEUROSCI LETT, V186, P17, DOI 10.1016/0304-3940(95)11270-7; Killiany RJ, 2000, ANN NEUROL, V47, P430, DOI 10.1002/1531-8249(200004)47:4<430::AID-ANA5>3.0.CO;2-I; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Leissring MA, 2000, J CELL BIOL, V149, P793, DOI 10.1083/jcb.149.4.793; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Magill ST, 2010, P NATL ACAD SCI USA, V107, P20382, DOI 10.1073/pnas.1015691107; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Mattson MP, 2000, J NEUROSCI, V20, P1358; Mergenthaler P, 2012, P NATL ACAD SCI USA, V109, P1518, DOI 10.1073/pnas.1108225109; Mosconi L, 2008, ANN NY ACAD SCI, V1147, P180, DOI 10.1196/annals.1427.007; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Ramos JW, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-134; Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202; Reiman EM, 2001, P NATL ACAD SCI USA, V98, P3334, DOI 10.1073/pnas.061509598; Saugstad JA, 2010, J CEREBR BLOOD F MET, V30, P1564, DOI 10.1038/jcbfm.2010.101; Schaefer A, 2007, J EXP MED, V204, P1553, DOI 10.1084/jem.20070823; Scholl M, 2011, J ALZHEIMERS DIS, V24, P495, DOI 10.3233/JAD-2011-101563; Shioya M, 2010, NEUROPATH APPL NEURO, V36, P320, DOI 10.1111/j.1365-2990.2010.01076.x; Smith GS, 2012, ARCH NEUROL-CHICAGO, V69, P1141, DOI 10.1001/archneurol.2012.590; Smith PY, 2015, HUM MOL GENET, V24, P6721, DOI 10.1093/hmg/ddv377; Song JH, 2006, J NEUROSCI, V26, P3299, DOI 10.1523/JNEUROSCI.5572-05.2006; Sonntag KC, 2010, BRAIN RES, V1338, P48, DOI 10.1016/j.brainres.2010.03.106; Suh SW, 2007, J PHARMACOL EXP THER, V321, P45, DOI 10.1124/jpet.106.115550; Suh SW, 2003, J NEUROSCI, V23, P10681; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Visser PJ, 1999, J NEUROL, V246, P477, DOI 10.1007/s004150050387; Wanet A, 2012, NUCLEIC ACIDS RES, V40, P4742, DOI 10.1093/nar/gks151; Wang Y, 2009, NEUROBIOL AGING, V30, P1061, DOI 10.1016/j.neurobiolaging.2007.10.009; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xu JD, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.06.017; Xu JD, 2009, J BIOL CHEM, V284, P27220, DOI 10.1074/jbc.M109.048728; Xuan Z, 2013, J BIOL CHEM, V288, P30495, DOI 10.1074/jbc.M113.499004; Zhang C, 2009, NATURE, V460, P632, DOI 10.1038/nature08177; Zovoilis A, 2011, EMBO J, V30, P4299, DOI 10.1038/emboj.2011.327	60	7	7	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					243	+		10.1096/fj.201700447RR	http://dx.doi.org/10.1096/fj.201700447RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28855274	Green Published			2022-12-28	WOS:000419172700023
J	Gullmets, J; Torvaldson, E; Lindqvist, J; Imanishi, SY; Taimen, P; Meinander, A; Eriksson, JE				Gullmets, Josef; Torvaldson, Elin; Lindqvist, Julia; Imanishi, Susumu Y.; Taimen, Pekka; Meinander, Annika; Eriksson, John E.			Internal epithelia in Drosophila display rudimentary competence to form cytoplasmic networks of transgenic human vimentin	FASEB JOURNAL			English	Article						intermediate filaments; lamin; tropomyosin; arthropod; evolution	INTERMEDIATE-FILAMENT PROTEINS; EPIDERMOLYSIS-BULLOSA SIMPLEX; MICE LACKING VIMENTIN; NUCLEAR LAMINS; EVOLUTION; DIFFERENTIATION; INVERTEBRATES; MELANOGASTER; ORGANIZATION; ARCHITECTURE	Cytoplasmic intermediate filaments (cIFs) are found in all eumetazoans, except arthropods. To investigate the compatibility of cIFs in arthropods, we expressed human vimentin(h Vim), a cIF with filament-forming capacity in vertebrate cells and tissues, transgenically in Drosophila. Transgenic hVim could be recovered from whole-fly lysates by using a standard procedure for intermediate filament (IF) extraction. When this procedure was used to test for the possible presence of IF-like proteins in flies, only lamins and tropomyosin were observed in IF-enriched extracts, thereby providing biochemical reinforcement to the paradigm that arthropods lack cIFs. In Drosophila, transgenic hVim was unable to form filament networks in S2 cells and mesenchymal tissues; however, cage-like vimentin structures could be observed around the nuclei in internal epithelia, which suggests that Drosophila retains selective competence for filament formation. Taken together, our results imply that although the filament network formation competence is partially lost in Drosophila, a rudimentary filament network formation ability remains in epithelial cells. As a result of the observed selective competence for cIF assembly in Drosophila, we hypothesize that internal epithelial cIFs were the last cIFs to disappear from arthropods.	[Gullmets, Josef; Torvaldson, Elin; Lindqvist, Julia; Meinander, Annika; Eriksson, John E.] Abo Akad Univ, Cell Biol, Fac Sci & Engn, Turku, Finland; [Gullmets, Josef; Torvaldson, Elin; Lindqvist, Julia; Imanishi, Susumu Y.; Eriksson, John E.] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Gullmets, Josef; Torvaldson, Elin; Lindqvist, Julia; Imanishi, Susumu Y.; Eriksson, John E.] Abo Akad Univ, Turku, Finland; [Gullmets, Josef; Taimen, Pekka] Univ Turku, Dept Pathol, Turku, Finland; [Gullmets, Josef; Taimen, Pekka] Turku Univ Hosp, Turku, Finland; [Gullmets, Josef; Taimen, Pekka] MediCity Res Lab, Turku, Finland	Abo Akademi University; University of Turku; Abo Akademi University; University of Turku; University of Turku; University of Turku	Eriksson, JE (corresponding author), Abo Akad Univ, Fac Sci & Engn, Tykistokatu 6,2nd Floor, FIN-20520 Turku, Finland.; Eriksson, JE (corresponding author), Univ Turku, Tykistokatu 6,2nd Floor, FIN-20520 Turku, Finland.	john.eriksson@abo.fi	Imanishi, Susumu/B-8697-2014; Meinander, Annika/E-9260-2017	Imanishi, Susumu/0000-0002-3641-4390; Meinander, Annika/0000-0002-3878-2293; Torvaldson, Elin/0000-0002-7175-6396; Gullmets, Josef/0000-0003-2466-7574	Academy of Finland; Sigrid Juselius Foundation; Magnus Ehrnrooth Foundation; Svenska Kulturfonden; Svensk-Osterbottniska Samfundet; Waldemar von Frenckell's Foundation; K. Albin Johansson's Foundation; Medicinska Understodsforening Liv och Halsa r.f.; Finsk-Norska Medicinska Stiftelsen; Finnish Medical Foundation; Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse; Maud Kuistila Memorial Foundation; Turku Doctoral Network in Molecular Biosciences; Turku Graduate School for Biomedical Sciences	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Magnus Ehrnrooth Foundation; Svenska Kulturfonden; Svensk-Osterbottniska Samfundet; Waldemar von Frenckell's Foundation; K. Albin Johansson's Foundation; Medicinska Understodsforening Liv och Halsa r.f.; Finsk-Norska Medicinska Stiftelsen; Finnish Medical Foundation; Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse; Maud Kuistila Memorial Foundation; Turku Doctoral Network in Molecular Biosciences; Turku Graduate School for Biomedical Sciences	This work was supported by the Academy of Finland, the Sigrid Juselius Foundation, the Magnus Ehrnrooth Foundation, Svenska Kulturfonden, Svensk-Osterbottniska Samfundet, Waldemar von Frenckell's Foundation, K. Albin Johansson's Foundation, Medicinska Understodsforening Liv och Halsa r.f., Finsk-Norska Medicinska Stiftelsen, The Finnish Medical Foundation, Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse, and the Maud Kuistila Memorial Foundation. The authors thank Dr. Gregory Edgecombe (The Natural History Museum, London, United Kingdom) for valuable comments on the manuscript. The authors also thank Prof. Konrad Basler (University of Zurich, Zurich, Switzerland) for the pUAS-attB plasmid. The authors thank Karolina Ost and Fanny Orn for technical assistance, and Markku Saari and Jouko Sandholm (Imaging Core at Turku Center for Biotechnology) for assistance with imaging. Biocenter Finland and the Turku Proteomics Facility are acknowledged for assistance with mass spectrometry. Sinikka Collanus and the histology personnel at Pathology/Tyks are acknowledged for assistance in histological applications. Turku Doctoral Network in Molecular Biosciences and Turku Graduate School for Biomedical Sciences are acknowledged for their support. J. E. E. was the principal, and A. M. the coprincipal investigator in this project. The authors declare no conflicts of interest.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; BARTNIK E, 1989, EUR J CELL BIOL, V50, P17; Bischof J, 2014, NAT PROTOC, V9, P1607, DOI 10.1038/nprot.2014.105; BLUMENBERG M, 1989, MOL BIOL EVOL, V6, P53; Bohnekamp J, 2015, J INVEST DERMATOL, V135, P2031, DOI 10.1038/jid.2015.129; Boraas LC, 2016, SCI REP-UK, V6, DOI 10.1038/srep30814; Broers JLV, 1997, HISTOCHEM CELL BIOL, V107, P505, DOI 10.1007/s004180050138; Carberry K, 2009, CELL MOTIL CYTOSKEL, V66, P852, DOI 10.1002/cm.20372; Cheng F, 2016, P NATL ACAD SCI USA, V113, pE4320, DOI 10.1073/pnas.1519197113; Cho A, 2016, CELL REP, V16, P928, DOI 10.1016/j.celrep.2016.06.054; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Dunn CW, 2014, ANNU REV ECOL EVOL S, V45, P371, DOI 10.1146/annurev-ecolsys-120213-091627; Eckes B, 2000, J CELL SCI, V113, P2455; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; Fedorchak GR, 2014, PROG BIOPHYS MOL BIO, V115, P76, DOI 10.1016/j.pbiomolbio.2014.06.009; Ganot P, 2015, MOL BIOL EVOL, V32, P44, DOI 10.1093/molbev/msu265; Gregory SL, 1998, J CELL BIOL, V143, P1271, DOI 10.1083/jcb.143.5.1271; Hering L, 2016, ELIFE, V5, DOI [10.7554/eLife.11117, 10.7554/eLife.1117]; Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214; Hwang JS, 2008, MOL BIOL EVOL, V25, P2009, DOI 10.1093/molbev/msn154; Imanishi SY, 2007, PROTEOMICS, V7, P174, DOI 10.1002/pmic.200600571; Li ZL, 1996, DEV BIOL, V175, P362, DOI 10.1006/dbio.1996.0122; LLOYD C, 1995, J CELL BIOL, V129, P1329, DOI 10.1083/jcb.129.5.1329; MARCHUK D, 1984, CELL, V39, P491, DOI 10.1016/0092-8674(84)90456-2; Matsuyama M, 2013, J BIOL CHEM, V288, P35626, DOI 10.1074/jbc.M113.514737; Mencarelli C, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-17; Milner DJ, 1996, J CELL BIOL, V134, P1255, DOI 10.1083/jcb.134.5.1255; Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762; Omary MB, 2009, J CLIN INVEST, V119, P1756, DOI 10.1172/JCI39894; Peter A, 2015, CURR OPIN CELL BIOL, V32, P48, DOI 10.1016/j.ceb.2014.12.009; Peter A, 2012, NUCLEUS-PHILA, V3, P44, DOI 10.4161/nucl.18927; Peters B, 2001, MOL BIOL CELL, V12, P1775, DOI 10.1091/mbc.12.6.1775; Sahlgren CM, 2003, MOL CELL BIOL, V23, P5090, DOI 10.1128/MCB.23.14.5090-5106.2003; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Virtakoivu R, 2015, CANCER RES, V75, P2349, DOI 10.1158/0008-5472.CAN-14-2842; WEBER K, 1989, EMBO J, V8, P3221, DOI 10.1002/j.1460-2075.1989.tb08481.x; ZACKROFF RV, 1980, SCIENCE, V208, P1152, DOI 10.1126/science.7189605; Zhang HY, 2013, AGING CELL, V12, P2, DOI 10.1111/acel.12021	39	1	1	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5332	+		10.1096/fj.201700332R	http://dx.doi.org/10.1096/fj.201700332R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28778974				2022-12-28	WOS:000416588300018
J	Majtan, T; Hulkova, H; Park, I; Krijt, J; Kozich, V; Bublil, EM; Kraus, JP				Majtan, Tomas; Hulkova, Helena; Park, Insun; Krijt, Jakub; Kozich, Viktor; Bublil, Erez M.; Kraus, Jan P.			Enzyme replacement prevents neonatal death, liver damage, and osteoporosis in murine homocystinuria	FASEB JOURNAL			English	Article						cystathionine beta-synthase; homocysteine; PEGylation; preclinical drug development; rare inherited disease	CYSTATHIONINE BETA-SYNTHASE; DEFICIENCY; HOMOCYSTEINE; GUIDELINES; THERAPY; MODEL	Classical homocystinuria (HCU) is an inborn error of sulfur amino acidmetabolism caused by deficient activity of cystathionine beta-synthase (CBS), resulting in an accumulation of homocysteine and a concomitant decrease of cystathionine and cysteine in blood and tissues. In mice, the complete lack of CBS is neonatally lethal. In this study, newborn CBS-knockout (KO) mice were treated with recombinant polyethyleneglycolylated human truncatedCBS (PEG-CBS). Full survival of the treatedKOmice, along with a positive impact on metabolite levels in plasma, liver, brain, and kidneys, was observed. The PEG-CBS treatment prevented an otherwise fatal liver disease characterized by steatosis, death of hepatocytes, and ultrastructural abnormalities of endoplasmic reticulum andmitochondria. Furthermore, treatment of the KO mice for 5mo maintained the plasma metabolite balance and completely prevented osteoporosis and changes in body composition that characterize both the KO model and human patients. These findings argue that early treatment of patients with HCU with PEG-CBSmay prevent clinical symptoms of the disease possibly without the need of dietary protein restriction.	[Majtan, Tomas; Park, Insun; Kraus, Jan P.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Hulkova, Helena; Krijt, Jakub; Kozich, Viktor] Charles Univ Prague, Fac Med 1, Inst Inherited Metab Disorders, Prague, Czech Republic; [Hulkova, Helena] Charles Univ Prague, Fac Med 1, Inst Pathol, Prague, Czech Republic; [Hulkova, Helena] Gen Univ Hosp, Prague, Czech Republic; [Bublil, Erez M.] Orphan Technol Ltd, Rapperswil, Switzerland	University of Colorado System; University of Colorado Anschutz Medical Campus; Charles University Prague; Charles University Prague; General University Hospital Prague	Majtan, T; Kraus, JP (corresponding author), Univ Colorado, Sch Med, 12800 E 19th Ave,Mail Stop 8313, Aurora, CO 80045 USA.	tomas.majtan@ucdenver.edu; jan.kraus@ucdenver.edu	Kozich, Viktor/A-7672-2008; Majtan, Tomas/AAE-8426-2021; Krijt, Jakub/F-4861-2017	Kozich, Viktor/0000-0001-5820-5277; Majtan, Tomas/0000-0002-2751-2124; Krijt, Jakub/0000-0002-1738-654X	Orphan Technologies; Colorado Clinical and Translational Sciences Institute; Colorado Clinical and Translational Science from U.S. National Institutes of Health, National Center for Advancing Translational Sciences [UL1 TR001082]; American Heart Association Scientist Development Grant [16SDG30040000]; project RVO-VFN [64165]; project PROGRES [Q26]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER	Orphan Technologies; Colorado Clinical and Translational Sciences Institute; Colorado Clinical and Translational Science from U.S. National Institutes of Health, National Center for Advancing Translational Sciences; American Heart Association Scientist Development Grant(American Heart Association); project RVO-VFN; project PROGRES; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The authors thank Richard Carrillo (University of Colorado) for htCBS C15S purification and assistance in the preparation of various PEG-CBS conjugates; Carla Ray, Linda Farb, Sally Stabler, and Robert Allen (University of Colorado) for determination of plasma sulfur amino acid metabolites; Jitka Sokolova (Institute of Inherited Metabolic Disorders, Charles University-First Faculty of Medicine and General University Hospital) for help with tissue metabolite analyses; and Hong Wang (University of Colorado) for access to the DXA scanner. This work was supported by a research grant from Orphan Technologies (to J.P.K.), and by the Colorado Clinical and Translational Sciences Institute, funded, in part, by Colorado Clinical and Translational Science Awards Grant UL1 TR001082 from the U.S. National Institutes of Health, National Center for Advancing Translational Sciences. T.M. is a recipient of the American Heart Association Scientist Development Grant (16SDG30040000). V.K. and J.K. received institutional support from projects RVO-VFN 64165 and PROGRES Q26. Charles University-First Faculty of Medicine received a partial reimbursement for analyses of tissues from Orphan Technologies. T.M., E.M.B., and J.P.K. are inventors on patents related to the processes and products referred to herein (U.S. patents 9,034,318 and 9,243,239). T.M. provides consulting services to Orphan Technologies. The remaining authors declare no conflicts of interest.	ALLEN RH, 1993, METABOLISM, V42, P1448, DOI 10.1016/0026-0495(93)90198-W; BARBER GW, 1967, LANCET, V1, P337; Bublil EM, 2016, J CLIN INVEST, V126, P2372, DOI 10.1172/JCI85396; Dickinson DA, 2002, ANN NY ACAD SCI, V973, P488, DOI 10.1111/j.1749-6632.2002.tb04690.x; GAULL G, 1974, J PEDIATR-US, V84, P381, DOI 10.1016/S0022-3476(74)80721-3; GAULL GE, 1971, PEDIATR RES, V5, P23, DOI 10.1203/00006450-197101000-00005; Huemer M, 2015, J INHERIT METAB DIS, V38, P1007, DOI 10.1007/s10545-015-9830-z; KOMROWER GM, 1966, ARCH DIS CHILD, V41, P666, DOI 10.1136/adc.41.220.666; Kozich V, 2016, BIOCHIMIE, V126, P14, DOI 10.1016/j.biochi.2016.01.001; Kraus JP, 2009, MOL GENET METAB, V97, P250, DOI 10.1016/j.ymgme.2009.04.001; Krijt J, 2009, J CHROMATOGR B, V877, P2061, DOI 10.1016/j.jchromb.2009.05.039; Mack CL, 2001, J PEDIATR GASTR NUTR, V33, P221, DOI 10.1097/00005176-200108000-00026; Maclean KN, 2010, MOL GENET METAB, V101, P163, DOI 10.1016/j.ymgme.2010.06.007; Majtan T, 2017, BIOMACROMOLECULES, V18, P1747, DOI 10.1021/acs.biomac.7b00154; Majtan T, 2016, CURR DRUG TARGETS, V17, P1455, DOI 10.2174/1389450117666160302094910; Moorthie S, 2014, J INHERIT METAB DIS, V37, P889, DOI 10.1007/s10545-014-9729-0; Morris AAM, 2017, J INHERIT METAB DIS, V40, P49, DOI 10.1007/s10545-016-9979-0; Mudd S., 2001, METABOLIC MOL BASES, P2007; Parrot F, 2000, J INHERIT METAB DIS, V23, P338, DOI 10.1023/A:1005618927729; Robert K, 2005, GASTROENTEROLOGY, V128, P1405, DOI 10.1053/j.gastro.2005.02.034; Schedewie H, 1973, Pediatr Radiol, V1, P12, DOI 10.1007/BF00972819; SMOLIN LA, 1981, J PEDIATR-US, V99, P467, DOI 10.1016/S0022-3476(81)80352-6; Vitvitsky V, 2004, AM J PHYSIOL-REG I, V287, pR39, DOI 10.1152/ajpregu.00036.2004; Walter JH, 1998, EUR J PEDIATR, V157, pS71, DOI 10.1007/PL00014308; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; Wilcken DEL, 1997, J INHERIT METAB DIS, V20, P295, DOI 10.1023/A:1005373209964	26	17	19	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5495	5506		10.1096/fj.201700565R	http://dx.doi.org/10.1096/fj.201700565R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28821635	Green Submitted, Green Published			2022-12-28	WOS:000416588300031
J	Montane, J; de Pablo, S; Castano, C; Rodriguez-Comas, J; Cadavez, L; Obach, M; Visa, M; Alcarraz-Vizan, G; Sanchez-Martinez, M; Nonell-Canals, A; Parrizas, M; Servitja, JM; Novials, A				Montane, Joel; de Pablo, Sara; Castano, Carlos; Rodriguez-Comas, Julia; Cadavez, Lisa; Obach, Merce; Visa, Montse; Alcarraz-Vizan, Gema; Sanchez-Martinez, Melchor; Nonell-Canals, Alfons; Parrizas, Marcelina; Servitja, Joan-Marc; Novials, Anna			Amyloid-induced beta-cell dysfunction and islet inflammation are ameliorated by 4-phenylbutyrate (PBA) treatment	FASEB JOURNAL			English	Article						diabetes; IAPP; insulin; pancreatic islets	PANCREATIC-ISLETS; POLYPEPTIDE; TYPE-2; IAPP; STRESS; APOPTOSIS; MODEL; ACID; EXPRESSION; FIBRILS	Human islet amyloid polypeptide (hIAPP) aggregation is associated with beta-cell dysfunction and death in type 2 diabetes (T2D). we aimed to determine whether in vivo treatment with chemical chaperone 4-phenylbutyrate (PBA) ameliorates hIAPP-induced beta-cell dysfunction and islet amyloid formation. Oral administration of PBA in hIAPP transgenic (hIAPP Tg) mice expressing hIAPP in pancreatic beta cells counteracted impaired glucose homeostasis and restored glucose-stimulated insulin secretion. Moreover, PBA treatment almost completely prevented the transcriptomic alterations observed in hIAPP Tg islets, including the induction of genes related to inflammation. PBA also increased beta-cell viability and improved insulin secretion in hIAPP Tg islets cultured under glucolipotoxic conditions. Strikingly, PBA not only prevented but even reversed islet amyloid deposition, pointing to a direct effect of PBA on hIAPP. This was supported by in silico calculations uncovering potential binding sites of PBA to monomeric, dimeric, and pentameric fibrillar structures, and by in vitro assays showing inhibition of hIAPP fibril formation by PBA. Collectively, these results uncover a novel beneficial effect of PBA on glucose homeostasis by restoring b-cell function and preventing amyloid formation in mice expressing hIAPP in b cells, highlighting the therapeutic potential of PBA for the treatment of T2D.	[Montane, Joel; de Pablo, Sara; Castano, Carlos; Rodriguez-Comas, Julia; Cadavez, Lisa; Obach, Merce; Visa, Montse; Alcarraz-Vizan, Gema; Parrizas, Marcelina; Servitja, Joan-Marc; Novials, Anna] Hosp Clin Barcelona, Inst Invest Biomed August Pi i Sunyer IDIBAPS, Diabet & Obes Res Lab, Barcelona, Spain; [Montane, Joel; de Pablo, Sara; Castano, Carlos; Rodriguez-Comas, Julia; Cadavez, Lisa; Obach, Merce; Visa, Montse; Alcarraz-Vizan, Gema; Parrizas, Marcelina; Servitja, Joan-Marc; Novials, Anna] Ctr Invest Biomed Red Diabet & Enfermed Metab Aso, Madrid, Spain; [Sanchez-Martinez, Melchor; Nonell-Canals, Alfons] Mind Byte, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Montane, J; Novials, A (corresponding author), Hosp Clin Barcelona, Inst Invest Biomed August Pi i Sunyer IDIBAPS, Diabet & Obes Res Lab, Barcelona, Spain.	joelmontane@gmail.com; anovials@clinic.ub.es	Visa, Montse/AAQ-8529-2021; Rodríguez-Comas, Júlia/AAC-4131-2021; Montane, Joel/ABE-6021-2021; Castaño, Carlos/AAS-3591-2021; Sanchez-Martinez, Melchor/A-3392-2014; Parrizas, Marcelina/AAS-3629-2021	Rodríguez-Comas, Júlia/0000-0002-4788-6668; Castaño, Carlos/0000-0003-1671-7826; Sanchez-Martinez, Melchor/0000-0002-3674-8577; Alcarraz-Vizan, Gema/0000-0002-2429-0597; SERVITJA, JOAN-MARC/0000-0002-1241-8004; Obach, Merce/0000-0002-2756-6181; Novials, Anna/0000-0003-0465-2949; Montane, Joel/0000-0001-9531-9580; Parrizas, Marcelina/0000-0003-1296-8302	IDIBAPS Postdoctoral Fellowship-BioTrack - European Community's Seventh Framework Programme (ECFP7) [229673]; Fundacao da Cieencia e Tecnologia (FCT-PhD) fellowship - POPH-QREN [SFRH/BD/65645/2009]; Ministerio de Economia y Competitividad [PI11/00679, PI14/00447]; ISCIII-Subdireccion General de Evaluacion y Fomento de la investigacion, Fondo Europeo de Desarrollo Regional (FEDER); Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM); CERCA Programme (Generalitat de Catalunya); Department of Universities, Research and Information Society of the Government of Catalonia [2014_SGR_520]	IDIBAPS Postdoctoral Fellowship-BioTrack - European Community's Seventh Framework Programme (ECFP7); Fundacao da Cieencia e Tecnologia (FCT-PhD) fellowship - POPH-QREN; Ministerio de Economia y Competitividad(Spanish Government); ISCIII-Subdireccion General de Evaluacion y Fomento de la investigacion, Fondo Europeo de Desarrollo Regional (FEDER); Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM); CERCA Programme (Generalitat de Catalunya); Department of Universities, Research and Information Society of the Government of Catalonia	The authors thank M. T. Bowers (University of California, Santa Barbara, Santa Barbara, CA, USA) and R. Tycko (National Institutes of Health, Bethesda, MD, USA) for kindly providing the crystal structures of hIAPP. The authors also thank L. Llorach-Pares (Mind the Byte) for assistance in the computational analysis of hIAPP-PBA complexes. The authors acknowledge K. Katte (CIBERDEM) for editorial work. J.M. is a recipient of an IDIBAPS Postdoctoral Fellowship-BioTrack, supported by the European Community's Seventh Framework Programme (ECFP7/2007-2013) under Grant 229673. L.C. is a recipient of Fundacao da Cieencia e Tecnologia (FCT-PhD) fellowship SFRH/BD/65645/2009, financed by POPH-QREN. This work was supported by Grants PI11/00679 and PI14/00447, integrated in the Plan Estatal I + D + I 2013-2016 from the Ministerio de Economia y Competitividad and cofinanced by the ISCIII-Subdireccion General de Evaluacion y Fomento de la investigacion, Fondo Europeo de Desarrollo Regional (FEDER), the Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM), and the CERCA Programme (Generalitat de Catalunya), as well as with the support of Project 2014_SGR_520 of the Department of Universities, Research and Information Society of the Government of Catalonia. J.-M.S. and A.N. are joint senior authors. The authors declare no conflicts of interest.	Almaca J, 2014, P NATL ACAD SCI USA, V111, P17612, DOI 10.1073/pnas.1414053111; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cadavez L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101797; Casas S, 2007, DIABETES, V56, P2284, DOI 10.2337/db07-0178; Case D. A., 2015, AMBER15; Chen WY, 1997, P NATL ACAD SCI USA, V94, P5798, DOI 10.1073/pnas.94.11.5798; Couce M, 1996, DIABETES, V45, P1094, DOI 10.2337/diabetes.45.8.1094; Dupuis NF, 2011, J AM CHEM SOC, V133, P7240, DOI 10.1021/ja1081537; Felix E., CLOUD BASED APPROACH; Gotz J, 2009, CELL MOL LIFE SCI, V66, P1321, DOI 10.1007/s00018-009-9070-1; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Henson MS, 2006, AMYLOID, V13, P250, DOI 10.1080/13506120600960734; Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976; Homo-Delarche F, 2006, DIABETES, V55, P1625, DOI 10.2337/db05-1526; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; Hull RL, 2009, DIABETOLOGIA, V52, P1102, DOI 10.1007/s00125-009-1329-4; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang P, 2011, BIOPHYS J, V100, P1550, DOI 10.1016/j.bpj.2011.02.010; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jurgens CA, 2011, AM J PATHOL, V178, P2632, DOI 10.1016/j.ajpath.2011.02.036; Kars M, 2010, DIABETES, V59, P1899, DOI 10.2337/db10-0308; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; Maestri NE, 1996, NEW ENGL J MED, V335, P855, DOI 10.1056/NEJM199609193351204; Meng FL, 2010, BIOCHEMISTRY-US, V49, P8127, DOI 10.1021/bi100939a; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Montane J, 2012, DIABETES OBES METAB, V14, P68, DOI 10.1111/j.1463-1326.2012.01657.x; Montane J, 2016, MOL CELL ENDOCRINOL, V420, P57, DOI 10.1016/j.mce.2015.11.018; Montane J, 2014, DIABET METAB SYND OB, V7, P25, DOI 10.2147/DMSO.S37649; Moreno-Asso A, 2013, DIABETOLOGIA, V56, P1761, DOI 10.1007/s00125-013-2930-0; Nanga RPR, 2011, BBA-BIOMEMBRANES, V1808, P2337, DOI 10.1016/j.bbamem.2011.06.012; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Patil SM, 2009, J BIOL CHEM, V284, P11982, DOI 10.1074/jbc.M809085200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Potter KJ, 2010, P NATL ACAD SCI USA, V107, P4305, DOI 10.1073/pnas.0909024107; Ricobaraza Ana, 2011, Front Biosci (Elite Ed), V3, P1375; Soty M, 2011, J BIOL CHEM, V286, P40857, DOI 10.1074/jbc.M111.232801; Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367; Verchere CB, 1996, P NATL ACAD SCI USA, V93, P3492, DOI 10.1073/pnas.93.8.3492; Visa M, 2015, FASEB J, V29, P2970, DOI 10.1096/fj.15-270553; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036; Westwell-Roper C, 2011, J IMMUNOL, V187, P2755, DOI 10.4049/jimmunol.1002854; Westwell-Roper CY, 2015, DIABETOLOGIA, V58, P575, DOI 10.1007/s00125-014-3447-x; Westwell-Roper CY, 2014, DIABETES, V63, P1698, DOI 10.2337/db13-0863; Wijesekara N, 2015, DIABETES OBES METAB, V17, DOI 10.1111/dom.12529; Wiley JC, 2011, AGING CELL, V10, P418, DOI 10.1111/j.1474-9726.2011.00680.x; Xiao CT, 2011, DIABETES, V60, P918, DOI 10.2337/db10-1433; Zraika S, 2010, DIABETOLOGIA, V53, P1046, DOI 10.1007/s00125-010-1671-6; Zraika S, 2010, J BIOL CHEM, V285, P18177, DOI 10.1074/jbc.M109.082032	50	23	23	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5296	+		10.1096/fj.201700236R	http://dx.doi.org/10.1096/fj.201700236R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28821639	Green Published			2022-12-28	WOS:000416588300015
J	Zhang, XH; Yuan, D; Sun, Q; Xu, L; Lee, E; Lewis, AJ; Zuckerbraun, BS; Rosengart, MR				Zhang, Xianghong; Yuan, Du; Sun, Qian; Xu, Li; Lee, Emma; Lewis, Anthony J.; Zuckerbraun, Brian S.; Rosengart, Matthew R.			Calcium/calmodulin-dependent protein kinase regulates the PINK1/Parkin and DJ-1 pathways of mitophagy during sepsis	FASEB JOURNAL			English	Article						mitochondria; macrophage; autophagy; mitochondrial membrane potential	ISCHEMIA-REPERFUSION INJURY; MITOCHONDRIAL-FUNCTION; PARKINSONS-DISEASE; OXIDATIVE-PHOSPHORYLATION; AUTOPHAGY PROTECTS; ORGAN FAILURE; CALCIUM; MECHANISMS; ACTIVATION; PINK1	During sepsis and shock states, mitochondrial dysfunction occurs. Consequently, adaptive mechanisms, such as fission, fusion, and mitophagy, are induced to eliminate damaged portions or entire dysfunctional mitochondria. The regulatory PINK1/Parkin and DJ-1 pathways are strongly induced by mitochondrial depolarization, although a direct link between loss of mitochondrial membrane potential (Delta(Psi)) and mitophagy has not been identified. Mitochondria also buffer Ca2+, and their buffering capacity is dependent on Delta(Psi). Here, we characterize a role for calcium/calmodulin-dependent protein kinase (CaMK) I in the regulation of these mechanisms. Loss of Delta(Psi) with either pharmacologic depolarization or LPS leads to Ca2+-dependent mitochondrial recruitment and activation of CaMKI that precedes the colocalization of PINK1/Parkin and DJ-1. CaMKI is required and serves as both a PINK1 and Parkin kinase. The mechanisms operate in both immune and nonimmune cells and are induced in in vivo models of endotoxemia, sepsis, and hemorrhagic shock. These data support the idea that CaMKI links mitochondrial stress with the PINK1/Parkin and DJ-1 mechanisms of mitophagy.-Zhang, X., Yuan, D., Sun, Q., Xu, L., Lee, E., Lewis, A. J., Zuckerbraun, B. S., Rosengart, M. R. Calcium/calmodulin-dependent protein kinase regulates the PINK1/Parkin and DJ-1 pathways of mitophagy during sepsis.	[Zhang, Xianghong; Yuan, Du; Sun, Qian; Xu, Li; Lee, Emma; Lewis, Anthony J.; Zuckerbraun, Brian S.; Rosengart, Matthew R.] Univ Pittsburgh, Dept Surg, 200 Lothrop St,Suite F1266-1, Pittsburgh, PA 15213 USA; [Yuan, Du] Cent S Univ, Dept Med, Third Xiangya Hosp, Changsha, Hunan, Peoples R China; [Xu, Li] Huazhong Univ Sci & Technol, Union Hosp, Dept Emergency Surg, Tongji Med Coll, Wuhan, Hubei, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Central South University; Huazhong University of Science & Technology	Rosengart, MR (corresponding author), Univ Pittsburgh, Dept Surg, 200 Lothrop St,Suite F1266-1, Pittsburgh, PA 15213 USA.	rosengartmr@upmc.edu		Lewis, Anthony/0000-0002-7986-0956	U.S. National Institutes of Health, National Institute of General Medical Sciences [R01-GM082852]; Surgical Infection Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082852, T32GM008516] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Surgical Infection Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Kevin P. Mollen and John E. Griepentrog (both from the University of Pittsburgh) for their assistance in interpreting the final collective data and reviewing the final manuscript. This work was supported by the U.S. National Institutes of Health, National Institute of General Medical Sciences Grant R01-GM082852 (to M.R.R.), and the Surgical Infection Society Junior Faculty Fellowship Award (to X.Z.). The authors declare no conflicts of interest.	Aerts L, 2015, J BIOL CHEM, V290, P2798, DOI 10.1074/jbc.M114.620906; Bauerfeld CP, 2012, J IMMUNOL, V188, P2847, DOI 10.4049/jimmunol.1102157; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Carchman EH, 2013, FASEB J, V27, P4703, DOI 10.1096/fj.13-229476; Carchman EH, 2011, HEPATOLOGY, V53, P2053, DOI 10.1002/hep.24324; Cardenes N, 2014, BLOOD, V123, P2864, DOI 10.1182/blood-2013-09-529420; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Collage RD, 2013, CRIT CARE MED, V41, pE352, DOI 10.1097/CCM.0b013e31828cf436; Crouser ED, 2004, MITOCHONDRION, V4, P729, DOI 10.1016/j.mito.2004.07.023; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Durcan TM, 2015, GENE DEV, V29, P989, DOI 10.1101/gad.262758.115; Eid N, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00100; Eiyama A, 2015, CURR OPIN CELL BIOL, V33, P95, DOI 10.1016/j.ceb.2015.01.002; Evankovich J, 2012, AM J PHYSIOL-GASTR L, V303, pG189, DOI 10.1152/ajpgi.00051.2012; Gomez H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135032; Guo LP, 2013, J IMMUNOL, V190, P3620, DOI 10.4049/jimmunol.1102975; Hao LY, 2010, P NATL ACAD SCI USA, V107, P9747, DOI 10.1073/pnas.0911175107; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Howe CJ, 2002, J BIOL CHEM, V277, P30469, DOI 10.1074/jbc.M205036200; Howe CJ, 2004, J BIOL CHEM, V279, P44573, DOI 10.1074/jbc.M404175200; Howell GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069520; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Huang J, 2007, CELL CYCLE, V6, P1837, DOI 10.4161/cc.6.15.4511; Huang WP, 2002, CELL STRUCT FUNCT, V27, P409, DOI 10.1247/csf.27.409; Huber TB, 2012, AUTOPHAGY, V8, P1009, DOI 10.4161/auto.19821; Iguchi M, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.467530; Irrcher I, 2010, HUM MOL GENET, V19, P3734, DOI 10.1093/hmg/ddq288; Ji J, 2015, J CEREBR BLOOD F MET, V35, P319, DOI 10.1038/jcbfm.2014.204; Kaftan EJ, 2000, J BIOL CHEM, V275, P25465, DOI 10.1074/jbc.M000903200; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Kimura T, 2011, J AM SOC NEPHROL, V22, P902, DOI 10.1681/ASN.2010070705; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Klionsky DJ, 2005, CURR BIOL, V15, pR282, DOI 10.1016/j.cub.2005.04.013; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Loughran PA, 2013, NITRIC OXIDE-BIOL CH, V31, P9, DOI 10.1016/j.niox.2013.02.084; Luo Y, 1997, P NATL ACAD SCI USA, V94, P9705, DOI 10.1073/pnas.94.18.9705; McCoy MK, 2012, ANTIOXID REDOX SIGN, V16, P869, DOI [10.1089/ars.2011.4019, 10.1089/ars.2011.4074]; Mccoy MK, 2011, AUTOPHAGY, V7, P531, DOI 10.4161/auto.7.5.14684; Means AR, 2008, MOL ENDOCRINOL, V22, P2759, DOI 10.1210/me.2008-0312; Nace GW, 2013, HEPATOLOGY, V58, P374, DOI 10.1002/hep.26346; Nakayama Y, 2010, J BIOCHEM, V147, P471, DOI 10.1093/jb/mvp189; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Pendergrass W, 2004, CYTOM PART A, V61A, P162, DOI 10.1002/cyto.a.20033; Puleston Daniel, 2015, Cold Spring Harb Protoc, V2015, DOI 10.1101/pdb.prot086298; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Rosengart MR, 2000, SHOCK, V13, P183, DOI 10.1097/00024382-200003000-00003; Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005; Schmitt JM, 2004, J BIOL CHEM, V279, P24064, DOI 10.1074/jbc.M401501200; Shi SY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8415; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002; Shimizu Y, 2016, J MOL CELL CARDIOL, V97, P56, DOI 10.1016/j.yjmcc.2016.04.008; Singer M, 2005, CRIT CARE MED, V33, pS539, DOI 10.1097/01.CCM.0000186080.13402.96; Singer M, 1999, BIOCHEM SOC SYMP, V66, P149, DOI 10.1042/bss0660149; Singer M, 2007, CRIT CARE MED, V35, pS441, DOI 10.1097/01.CCM.0000278049.48333.78; Solaini G, 2007, BIOSCIENCE REP, V27, P11, DOI 10.1007/s10540-007-9033-4; Springer W, 2011, AUTOPHAGY, V7, P266, DOI 10.4161/auto.7.3.14348; Stedman DR, 2004, FEBS LETT, V566, P275, DOI 10.1016/j.febslet.2004.04.042; Takahashi-Niki K, 2016, BIOCHEM BIOPH RES CO, V474, P131, DOI 10.1016/j.bbrc.2016.04.084; Thomas KJ, 2011, HUM MOL GENET, V20, P40, DOI 10.1093/hmg/ddq430; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; Tucsek Z, 2011, J LEUKOCYTE BIOL, V89, P105, DOI 10.1189/jlb.0610355; van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011072; Vasseur S, 2009, P NATL ACAD SCI USA, V106, P1111, DOI 10.1073/pnas.0812745106; Walsh C, 2009, BBA-BIOENERGETICS, V1787, P1374, DOI 10.1016/j.bbabio.2009.01.007; Wang XL, 2012, J NEUROCHEM, V121, P830, DOI 10.1111/j.1471-4159.2012.07734.x; Wang YQ, 2012, AUTOPHAGY, V8, P1462, DOI 10.4161/auto.21211; Weinberg SE, 2015, IMMUNITY, V42, P406, DOI 10.1016/j.immuni.2015.02.002; Whelan SP, 2014, J SURG RES, V186, P297, DOI 10.1016/j.jss.2013.08.007; Williams JA, 2015, AM J PHYSIOL-GASTR L, V309, pG324, DOI 10.1152/ajpgi.00108.2015; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; YOKOKURA H, 1995, J BIOL CHEM, V270, P23851, DOI 10.1074/jbc.270.40.23851; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhang XH, 2008, J IMMUNOL, V181, P5015, DOI 10.4049/jimmunol.181.7.5015; Zhang XH, 2014, J IMMUNOL, V193, P2405, DOI 10.4049/jimmunol.1302798; Zhang XH, 2011, J LEUKOCYTE BIOL, V90, P249, DOI 10.1189/jlb.0510286	79	25	26	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4382	4395		10.1096/fj.201601096RRR	http://dx.doi.org/10.1096/fj.201601096RRR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28615325	Green Published			2022-12-28	WOS:000413397400017
J	Bai, RL; Kusama, K; Nakamura, K; Sakurai, T; Kimura, K; Ideta, A; Aoyagi, Y; Imakawa, K				Bai, Rulan; Kusama, Kazuya; Nakamura, Keigo; Sakurai, Toshihiro; Kimura, Koji; Ideta, Atsushi; Aoyagi, Yoshito; Imakawa, Kazuhiko			Down-regulation of transcription factor OVOL2 contributes to epithelial-mesenchymal transition in a noninvasive type of trophoblast implantation to the maternal endometrium	FASEB JOURNAL			English	Article						bovine; TEAD; YAP; NOTCH	NOTCH SIGNALING PATHWAY; HIPPO PATHWAY; CONCEPTUS ATTACHMENT; BOVINE CONCEPTUSES; CELL FATE; EXPRESSION; GENE; TROPHECTODERM; MECHANISMS; PROTEIN	Embryo implantation into the uterine endometrium is required for pregnancy establishment in most mammals. By using global expression analysis, we investigated the molecules that are related to epithelial- mesenchymal transition (EMT) in noninvasive bovine trophoblasts and found that the transcription factor, ovo-like zinc finger 2 (OVOL2), which is essential for mesenchymal-epithelial transition in various cancers, was down-regulated after trophoblast attachment to the endometrial epithelium in utero. In cultured bovine trophoblast cells, OVOL2 down-regulation occurred only when cells were allowed to attach to bovine endometrial epithelial cells via the TEAD3/YAP signaling pathway. This resulted in the up-regulation of the EMT-associated transcription factors, ZEB1 and SNAI2, and the mesenchymal cell markers, N-cadherin (CDH2) and vimentin (VIM), whereas epithelial cell marker, E-cadherin (CDH1), was down-regulated. In contrast, OVOL2 overexpression in bovine trophoblast cells exhibited a decrease in ZEB1 transcripts and an increase in E-cadherin. These observations revealed that ovo-like protein (OVOL)2 down-regulation occurred concurrently with conceptus implantation into the uterine endometrium via the YAP/TEAD3 signaling pathway, and suggest that the down-regulation of OVOL2 expression contributes to the up-regulation of EMT-related transcription factor expression, which enables EMT progression in the noninvasive bovine trophectoderm postimplantation.	[Bai, Rulan; Kusama, Kazuya; Nakamura, Keigo; Imakawa, Kazuhiko] Univ Tokyo, Anim Resource Sci Ctr, Grad Sch Agr & Life Sci, 3145 Ago, Kasama, Ibaraki 3190206, Japan; [Sakurai, Toshihiro] Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Occupat & Environm Hlth, Noda, Chiba, Japan; [Kimura, Koji] Okayama Univ, Grad Sch Environm & Life Sci, Okayama, Japan; [Ideta, Atsushi; Aoyagi, Yoshito] Zennoh Embryo Transfer Ctr, Kamishihoro, Hokkaido, Japan	University of Tokyo; Tokyo University of Science; Okayama University	Imakawa, K (corresponding author), Univ Tokyo, Anim Resource Sci Ctr, Grad Sch Agr & Life Sci, 3145 Ago, Kasama, Ibaraki 3190206, Japan.	akaz@mail.ecc.u-tokyo.ac.jp	Imakawa, Kazuhiko/AAD-3211-2022; Kusama, Kazuya/K-9716-2018	Kusama, Kazuya/0000-0002-9120-0475; Imakawa, Kazuhiko/0000-0002-3798-3560	Livestock Promotional Funds of Japan Racing Association; Japan Society for the Promotion of Science [16H02584, 16F16403, 15K18767]	Livestock Promotional Funds of Japan Racing Association; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The authors thank Dr. Alan Ealy (Virginia Polytechnic Institute and State University, Blacksburg, VA, USA) for the generous gift of bovine trophoblast CT-1 cells, and Prof. Christiane Pfarrer (University of Veterinary Medicine Hannover, Hannover, Germany) for kindly providing us with bovine trophoblast F3 cells. The authors also thank Robert Moriarty (Berlitz Japan, Tokyo, Japan) for his editorial assistance throughout the manuscript preparation. This work was supported by Livestock Promotional Funds of Japan Racing Association (to K.I.), a Grant-in-Aid for Scientific Research (16H02584) from the Japan Society for the Promotion of Science (to K.I.), a Grant-in-Aid for International Research Fellow (16F16403) from the Japan Society for the Promotion of Science (to R.B.), and a Grant-in-Aid for Young Scientists (B) (15K18767) from the Japan Society for the Promotion of Science (to K.K.). The authors declare no conflicts of interest.	Ayyanathan K, 2007, CANCER RES, V67, P9097, DOI 10.1158/0008-5472.CAN-07-2987; Bai H, 2009, MOL REPROD DEV, V76, P1143, DOI 10.1002/mrd.21082; Bai RL, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.128652; Bai R, 2014, REPRODUCTION, V148, P119, DOI 10.1530/REP-13-0655; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Cuman C, 2014, REPRODUCTION, V147, pR75, DOI 10.1530/REP-13-0474; Dufraine J, 2008, ONCOGENE, V27, P5132, DOI 10.1038/onc.2008.227; Hambruch N, 2010, PLACENTA, V31, P67, DOI 10.1016/j.placenta.2009.10.011; Hong AW, 2016, NAT REV GASTRO HEPAT, V13, P324, DOI 10.1038/nrgastro.2016.59; Ideta A, 2007, CLONING STEM CELLS, V9, P571, DOI 10.1089/clo.2007.0017; IMAKAWA K, 1987, NATURE, V330, P377, DOI 10.1038/330377a0; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kumar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039399; Kusama K, 2016, DOMEST ANIM ENDOCRIN, V57, P21, DOI 10.1016/j.domaniend.2016.05.002; Kusama K, 2016, MOL CELL ENDOCRINOL, V434, P81, DOI 10.1016/j.mce.2016.06.017; Langer EM, 2008, DEV CELL, V14, P424, DOI 10.1016/j.devcel.2008.01.005; Lee B, 2014, DEV CELL, V29, P47, DOI 10.1016/j.devcel.2014.03.005; Li B, 2002, GENOMICS, V80, P319, DOI 10.1006/geno.2002.6831; Li S, 2014, DEV CELL, V29, P1, DOI 10.1016/j.devcel.2014.04.002; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Miele L, 2006, CURR MOL MED, V6, P905, DOI 10.2174/156652406779010830; Mitoma Chikage, 2014, Fukuoka Acta Medica, V105, P166; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Renaud SJ, 2015, P NATL ACAD SCI USA, V112, pE6175, DOI 10.1073/pnas.1507397112; Roca H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076773; Sakurai T, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100180; Sakurai T, 2010, ENDOCRINOLOGY, V151, P5873, DOI 10.1210/en.2010-0458; Senfter Daniel, 2016, BioMolecular Concepts, V7, P311, DOI 10.1515/bmc-2016-0020; Shin SH, 2014, J INVEST DERMATOL, V134, P838, DOI 10.1038/jid.2013.421; Skarzynski DJ, 2000, BIOL REPROD, V62, P1116, DOI 10.1095/biolreprod62.5.1116; Talbot NC, 2000, BIOL REPROD, V62, P235, DOI 10.1095/biolreprod62.2.235; Wang ZW, 2010, CURR DRUG TARGETS, V11, P745, DOI 10.2174/138945010791170860; Watanabe K, 2014, DEV CELL, V29, P59, DOI 10.1016/j.devcel.2014.03.006; Wu CL, 2016, ONCOTARGET, V7, P26593, DOI 10.18632/oncotarget.8557; Yamakoshi S, 2012, REPRODUCTION, V143, P377, DOI 10.1530/REP-11-0364; Yimlamai D, 2014, CELL, V157, P1324, DOI 10.1016/j.cell.2014.03.060; Yu OM, 2016, MOL CELL BIOL, V36, P39, DOI 10.1128/MCB.00772-15; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11459	39	23	24	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3371	3384		10.1096/fj.201701131RR	http://dx.doi.org/10.1096/fj.201701131RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29394105				2022-12-28	WOS:000432546000038
J	Espaillat, MP; Snider, AJ; Qiu, ZJ; Channer, B; Coant, N; Schuchman, EH; Kew, RR; Sheridan, BS; Hannun, YA; Obeid, LM				Espaillat, Mel Pilar; Snider, Ashley J.; Qiu, Zhijuan; Channer, Breana; Coant, Nicolas; Schuchman, Edward H.; Kew, Richard R.; Sheridan, Brian S.; Hannun, Yusuf A.; Obeid, Lina M.			Loss of acid ceramidase in myeloid cells suppresses intestinal neutrophil recruitment	FASEB JOURNAL			English	Article						sphingolipids; IBD; ulcerative colitis; colitis-associated cancer; MDSC	INFLAMMATORY-BOWEL-DISEASE; SPHINGOSINE KINASE 1; ULCERATIVE-COLITIS; IMMUNE-SYSTEM; UP-REGULATION; MECHANISMS; CANCER; PATHOGENESIS; DEFICIENCY; GENE	Bioactive sphingolipids are modulators of immune processes and their metabolism is often dysregulated in ulcerative colitis, a major category of inflammatory bowel disease (IBD). While multiple axes of sphingolipid metabolism have been investigated to delineate mechanisms regulating ulcerative colitis, the role of acid ceramidase (AC) in intestinal inflammation is yet to be characterized. Here we demonstrate that AC expression is elevated selectively in the inflammatory infiltrate in human and murine colitis. To probe for mechanistic insight into how AC up-regulation can impact intestinal inflammation, we investigated the selective loss of AC expression in the myeloid population. Using a model of intestinal epithelial injury, we demonstrate that myeloid AC conditional knockout mice exhibit impairment of neutrophil recruitment to the colon mucosa as a result of defective cytokine and chemokine production. Furthermore, the loss of myeloid AC protects from tumor incidence in colitis-associated cancer (CAC) and inhibits the expansion of neutrophils and granulocytic myeloid-derived suppressor cells in the tumor microenvironment. Collectively, our results demonstrate a tissue-specific role for AC in regulating neutrophilic inflammation and cytokine production. We demonstrate novel mechanisms of how granulocytes are recruited to the colon that may have therapeutic potential in intestinal inflammation, IBD, and CAC.	[Espaillat, Mel Pilar; Qiu, Zhijuan; Sheridan, Brian S.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY USA; [Espaillat, Mel Pilar; Snider, Ashley J.; Channer, Breana; Coant, Nicolas; Hannun, Yusuf A.; Obeid, Lina M.] SUNY Stony Brook, Dept Med, Stony Brook, NY USA; [Snider, Ashley J.; Hannun, Yusuf A.; Obeid, Lina M.] SUNY Stony Brook, Stony Brook Canc Ctr, Stony Brook, NY USA; [Channer, Breana] SUNY Stony Brook, Dept Biol, Stony Brook, NY USA; [Kew, Richard R.] SUNY Stony Brook, Dept Pathol, Stony Brook, NY USA; [Snider, Ashley J.; Obeid, Lina M.] Northport Vet Affairs Med Ctr, Northport, NY USA; [Schuchman, Edward H.] Plexcera Therapeut, New York, NY USA; [Schuchman, Edward H.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Icahn School of Medicine at Mount Sinai	Snider, AJ; Obeid, LM (corresponding author), SUNY Stony Brook, Hlth Sci Ctr, Dept Med, L-4 179, Stony Brook, NY 11794 USA.	ashley.snider@stonybrookmedicine.edu; lina.obeid@stonybrookmedicine.edu		COANT, Nicolas/0000-0001-9237-2132	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [F31 DK105711-01]; U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences [9R01GM097741-13A1]; Research Supplement to Promote Diversity in Health-Related Research; NIH National Cancer Institute [P01 CA097132]; Stony Brook University W. Burghardt Turner Graduate Fellowship Award; Undergraduate IMSD-MERGE Program; U.S. Department of Veterans Affairs Biomedical Laboratory Research and Development Service [2 I01 BX000156]; NATIONAL CANCER INSTITUTE [P01CA097132, R01CA172517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK105711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097741] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000156] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences; Research Supplement to Promote Diversity in Health-Related Research; NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stony Brook University W. Burghardt Turner Graduate Fellowship Award; Undergraduate IMSD-MERGE Program; U.S. Department of Veterans Affairs Biomedical Laboratory Research and Development Service; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank Dr. Vincent W. Yang for his expert advice in clinical gastroenterology and colorectal cancer, and Dr. James B. Bliska for his expert advice in BMDM differentiation and culturing (both from the Stony Brook University School of Medicine). The authors also thank the Sphingolipid Animal Cancer Pathobiology Shared Resource Core (P01 CA097132) for the genetically modified models; the Lipidomics, Research Histology, and Flow Cytometry facilities at Stony Brook University for the technical and analytical work carried out in support of this manuscript; the Lipidomics Shared Resource at Hollings Cancer Center, Medical University of South Carolina (MUSC; Charleston, SC, USA); and the Lipidomics Core in the MUSC Center of Biomedical Research Excellence in Lipidomics and Pathobiology for providing lipid analyses and LCL385. This work was supported, in part, by a Merit Review Award 2 I01 BX000156 from the U.S. Department of Veterans Affairs Biomedical Laboratory Research and Development Service (to L.M.O.); U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant F31 DK105711-01 (to M.P.E.); U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences Grant 9R01GM097741-13A1 (to L.M.O.); and a Research Supplement to Promote Diversity in Health-Related Research (to M.P.E.); NIH National Cancer Institute Grant P01 CA097132 (to Y.A.H., L.M.O., and A.J.S.); Stony Brook University W. Burghardt Turner Graduate Fellowship Award (to M.P.E.) and Undergraduate IMSD-MERGE Program (to B.C.). Edward H. Schuchman is an equity holder and consultant for Plexcera Therapeutics LLC, a company founded to develop acid ceramidase therapies for ceramide diseases. He is also named as an inventor on several acid ceramidase-related patents that have been licensed to Plexcera, and will derive royalty income from them should they be commercialized. The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government. All other authors declare no conflicts of interest.	Adada MM, 2013, J BIOL CHEM, V288, P27667, DOI 10.1074/jbc.M113.489443; Ahn GO, 2010, P NATL ACAD SCI USA, V107, P8363, DOI 10.1073/pnas.0911378107; Alayoubi AM, 2013, EMBO MOL MED, V5, P827, DOI 10.1002/emmm.201202301; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Bar J, 2001, HUM MUTAT, V17, P199, DOI 10.1002/humu.5; Beckham TH, 2012, INT J CANCER, V131, P2034, DOI 10.1002/ijc.27480; Begagne E, 2014, J CLIN INVEST, V124, P5368, DOI 10.1172/JCI74188; Bielawski J, 2010, ADV EXP MED BIOL, V688, P46; Bilsborough J., 2016, AM J GASTROENTEROL S, V3, P27, DOI [10.1038/ajgsup.2016.18, DOI 10.1038/ajgsup.2016.18]; Carrigan SO, 2007, J LEUKOCYTE BIOL, V82, P1575, DOI 10.1189/jlb.0806528; Chung LK, 2016, CELL HOST MICROBE, V20, P296, DOI 10.1016/j.chom.2016.07.018; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Coffelt SB, 2016, NAT REV CANCER, V16, P431, DOI 10.1038/nrc.2016.52; CROSS M, 1988, P NATL ACAD SCI USA, V85, P6232, DOI 10.1073/pnas.85.17.6232; Danese S, 2011, NEW ENGL J MED, V365, P1713, DOI 10.1056/NEJMra1102942; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Dworski S, 2017, BBA-MOL BASIS DIS, V1863, P386, DOI 10.1016/j.bbadis.2016.11.031; Dworski S, 2015, HAEMATOLOGICA, V100, DOI 10.3324/haematol.2014.108530; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Eliyahu E, 2007, FASEB J, V21, P1403, DOI 10.1096/fj.06-7016com; Eliyahu E, 2012, CELL PHYSIOL BIOCHEM, V30, P735, DOI 10.1159/000341453; Elson CO, 2005, IMMUNOL REV, V206, P260, DOI 10.1111/j.0105-2896.2005.00291.x; Espaillat Mel Pilar, 2017, Advances in Biological Regulation, V63, P140, DOI 10.1016/j.jbior.2016.11.001; Fournier BM, 2012, MUCOSAL IMMUNOL, V5, P354, DOI 10.1038/mi.2012.24; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gonzalez-Cabrera Pedro J, 2014, F1000Prime Rep, V6, P109, DOI 10.12703/P6-109; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; HO MK, 1983, J BIOL CHEM, V258, P636; Holtmann MH, 2006, ADV EXP MED BIOL, V579, P227; Hu XL, 2011, CANCER RES, V71, P2882, DOI 10.1158/0008-5472.CAN-10-2493; Huang WC, 2016, FASEB J, V30, P2945, DOI 10.1096/fj.201600394R; Jenkins RW, 2011, J BIOL CHEM, V286, P13292, DOI 10.1074/jbc.M110.163378; Kaplan GG, 2015, NAT REV GASTRO HEPAT, V12, P720, DOI 10.1038/nrgastro.2015.150; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kim ND, 2015, TRENDS IMMUNOL, V36, P547, DOI 10.1016/j.it.2015.07.007; Knoop KA, 2016, GUT, V65, P1100, DOI 10.1136/gutjnl-2014-309059; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kuhl AA, 2007, GASTROENTEROLOGY, V133, P1882, DOI 10.1053/j.gastro.2007.08.073; Kumar V, 2016, TRENDS IMMUNOL, V37, P208, DOI 10.1016/j.it.2016.01.004; Kunkel GT, 2013, NAT REV DRUG DISCOV, V12, P688, DOI 10.1038/nrd4099; Lee PY, 2013, J LEUKOCYTE BIOL, V94, P585, DOI 10.1189/jlb.0113014; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li CM, 2002, GENOMICS, V79, P218, DOI 10.1006/geno.2002.6686; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Liu TC, 2016, ANNU REV PATHOL-MECH, V11, P127, DOI 10.1146/annurev-pathol-012615-044152; MacDonald TT, 2012, INFLAMM BOWEL DIS, V18, P2180, DOI 10.1002/ibd.22967; MacDonald TT, 2011, GASTROENTEROLOGY, V140, P1768, DOI 10.1053/j.gastro.2011.02.047; MacDonald TT, 2006, ADV EXP MED BIOL, V579, P98; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Morad SAF, 2016, CANCER LETT, V376, P199, DOI 10.1016/j.canlet.2016.03.049; Morad SAF, 2015, BBA-MOL CELL BIOL L, V1851, P1134, DOI 10.1016/j.bbalip.2015.05.001; Muthas D, 2017, SCAND J GASTROENTERO, V52, P125, DOI 10.1080/00365521.2016.1235224; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Ordas I, 2012, LANCET, V380, P1606, DOI 10.1016/S0140-6736(12)60150-0; PARKOS CA, 1991, J CLIN INVEST, V88, P1605, DOI 10.1172/JCI115473; Peloquin JM, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87899; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; de Mattos BRR, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/493012; Sagiv JY, 2015, CELL REP, V10, P562, DOI 10.1016/j.celrep.2014.12.039; Schmid MC, 2010, J ONCOL, V2010, DOI 10.1155/2010/201026; Shang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051848; Sheridan Brian S, 2012, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0319s99; Snider AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113998; Snider AJ, 2012, PROSTAG OTH LIPID M, V99, P124, DOI 10.1016/j.prostaglandins.2012.08.003; Snider AJ, 2010, BIOCHIMIE, V92, P707, DOI 10.1016/j.biochi.2010.02.008; Snider AJ, 2009, FASEB J, V23, P143, DOI 10.1096/fj.08-118109; Sun W, 2008, J INVEST DERMATOL, V128, P389, DOI 10.1038/sj.jid.5701025; Tan SF, 2016, ONCOTARGET, V7, P83208, DOI 10.18632/oncotarget.13079; Trujillo G, 2011, MOL IMMUNOL, V49, P495, DOI 10.1016/j.molimm.2011.09.024; Wang K, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.36; Wang Y, 2014, MUCOSAL IMMUNOL, V7, P1106, DOI 10.1038/mi.2013.126; Williams IR, 2007, GASTROENTEROLOGY, V133, P2049, DOI 10.1053/j.gastro.2007.10.031; Wu D, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/436307; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Zeidan YH, 2006, J BIOL CHEM, V281, P24695, DOI 10.1074/jbc.M604713200; Zeng MY, 2017, MUCOSAL IMMUNOL, V10, P18, DOI 10.1038/mi.2016.75; Zhang QQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep15948; ZIGMOND SH, 1973, J EXP MED, V137, P387, DOI 10.1084/jem.137.2.387; Zilio S, 2016, VACCINES-BASEL, V4, DOI 10.3390/vaccines4030031	81	15	16	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2339	2353		10.1096/fj.201700585R	http://dx.doi.org/10.1096/fj.201700585R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29259036	Green Published			2022-12-28	WOS:000432528000004
J	Tsachaki, M; Mladenovic, N; Stambergova, H; Birk, J; Odermatt, A				Tsachaki, Maria; Mladenovic, Natasa; Stambergova, Hana; Birk, Julia; Odermatt, Alex			Hexose-6-phosphate dehydrogenase controls cancer cell proliferation and migration through pleiotropic effects on the unfolded-protein response, calcium homeostasis, and redox balance	FASEB JOURNAL			English	Article						endoplasmic reticulum; NADPH; signaling	ENDOPLASMIC-RETICULUM STRESS; GENE-EXPRESSION; BREAST-CANCER; TRANSCRIPTION FACTOR; MESSENGER-RNA; ER STRESS; PATHWAY; AUTOPHAGY; XBP1; TRANSLATION	Hexose-6-phosphate dehydrogenase (H6PD) produces reduced NADPH in the endoplasmic reticulum (ER) lumen. NADPH constitutes a cofactor for many reducing enzymes, and its inability to traverse biologic membranes makes in situ synthesis of NADPH in the ER lumen indispensable. The H6PD gene is amplified in several types of malignancies, and earlier work pointed toward a potential involvement of the enzyme in cancer cell growth. In the present study, we demonstrated a pivotal role of H6PD in proliferation and migratory potential of 3 human breast cancer cell lines. Knockdown of H6PD decreased proliferation and migration in SUM159, MCF7, and MDA-MB-453 cells. To understand the mechanism through which H6PD exerts its effects, we investigated the cellular changes after H6PD silencing in SUM159 cells. Knockdown of H6PD resulted in an increase in ER lumen oxidation, and down-regulation of many components of the unfolded protein response, including the transcription factors activating transcription factor-4, activating transcription factor-6, split X-box binding protein-1, and CCAAT/enhancer binding protein homologous protein. This effect was accompanied by an increase in sarco/endoplasmic reticulum Ca2+-ATPase-2 pump expression and an decrease in inositol trisphosphate receptor-III, which led to augmented levels of calcium in the ER. Further characterization of the molecular pathways involving H6PD could greatly broaden our understanding of how the ER microenvironment sustains malignant cell growth.	[Tsachaki, Maria; Mladenovic, Natasa; Stambergova, Hana; Birk, Julia; Odermatt, Alex] Univ Basel, Div Mol & Syst Toxicol, Dept Pharmaceut Sci, Klingelbergstr 50, CH-4056 Basel, Switzerland; [Birk, Julia; Odermatt, Alex] Charles Univ Prague, Fac Pharm, Hradec Kralove, Czech Republic	University of Basel; Charles University Prague	Odermatt, A (corresponding author), Charles Univ Prague, Fac Pharm, Hradec Kralove, Czech Republic.	alex.odermatt@unibas.ch	; Navratilova, Hana/S-5560-2017	Odermatt, Alex/0000-0002-6820-2712; Navratilova, Hana/0000-0002-7831-3811; Winter, denise V./0000-0002-3764-1747	Swiss National Science Foundation [31003A-159454, 316030-133859]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The authors thank Prof. Christoph Handschin and Dr. Svenia Schnyder (Biozentrum, University of Basel) for support with the Seahorse measurements, and Dr. Dominik Witzigmann and Dr. Denise Kratschmar (Pharmazentrum, University of Basel) for technical help with the FACS and MitoSox Red measurements, respectively. This work was supported by Swiss National Science Foundation Grants 31003A-159454 and 316030-133859. The authors declare no conflicts of interest.	AMELUNG D, 1953, J CLIN ENDOCR METAB, V13, P1125, DOI 10.1210/jcem-13-9-1125; Atanasov AG, 2004, FEBS LETT, V571, P129, DOI 10.1016/j.febslet.2004.06.065; Atkins C, 2013, CANCER RES, V73, P1993, DOI 10.1158/0008-5472.CAN-12-3109; Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; B'chir W, 2014, CELL SIGNAL, V26, P1385, DOI 10.1016/j.cellsig.2014.03.009; B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Baker-LePain JC, 2002, J EXP MED, V196, P1447, DOI 10.1084/jem.20020436; Banhegyi G, 2004, J BIOL CHEM, V279, P27017, DOI 10.1074/jbc.M404159200; Birk Julia, 2013, Frontiers in Genetics, V4, P108, DOI 10.3389/fgene.2013.00108; Birk J, 2013, J CELL SCI, V126, P1604, DOI 10.1242/jcs.117218; BUBLITZ C, 1981, BIOCHEM BIOPH RES CO, V98, P588, DOI 10.1016/0006-291X(81)91155-4; BUBLITZ C, 1988, J BIOL CHEM, V263, P12849; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Clarke JL, 2003, ARCH BIOCHEM BIOPHYS, V415, P229, DOI 10.1016/S0003-9861(03)00229-7; Conley SJ, 2012, P NATL ACAD SCI USA, V109, P2784, DOI 10.1073/pnas.1018866109; Corazzari M, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00078; Doghman-Bouguerra M, 2017, MOL CELL ENDOCRINOL, V441, P176, DOI 10.1016/j.mce.2016.08.050; Eletto D, 2014, J CELL SCI, V127, P3649, DOI 10.1242/jcs.153643; Endo Y, 2004, INT J CANCER, V110, P225, DOI 10.1002/ijc.20118; Engeli RT, 2016, J STEROID BIOCHEM, V155, P147, DOI 10.1016/j.jsbmb.2015.10.023; Etienne-Manneville S, 2013, ANNU REV CELL DEV BI, V29, P471, DOI 10.1146/annurev-cellbio-101011-155711; Feng Yanhong, 2014, Comput Intell Neurosci, V2014, P970456, DOI 10.1155/2014/970456; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Flanagan L, 1999, BREAST CANCER RES TR, V58, P193, DOI 10.1023/A:1006331716981; Gutierrez T, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00291; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; He Y, 2010, GENE EXPRESSION, V15, P13, DOI 10.3727/105221610X12819686555051; Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976; Hetz C, 2009, GENE DEV, V23, P2294, DOI 10.1101/gad.1830709; Kato H, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00093; Knezevic CE, 2016, CELL CHEM BIOL, V23, P1490, DOI 10.1016/j.chembiol.2016.10.011; Kozlov G, 2010, J MOL BIOL, V401, P618, DOI 10.1016/j.jmb.2010.06.045; Lavery GG, 2008, J BIOL CHEM, V283, P8453, DOI 10.1074/jbc.M710067200; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Crisosto C, 2015, BBA-MOL BASIS DIS, V1852, P2096, DOI 10.1016/j.bbadis.2015.07.011; Majumder M, 2012, MOL CELL BIOL, V32, P992, DOI 10.1128/MCB.06665-11; Marini C, 2016, SCI REP-UK, V6, DOI 10.1038/srep25092; Mason PJ, 1999, BLOOD CELL MOL DIS, V25, P30, DOI 10.1006/bcmd.1999.0224; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; Mimura N, 2012, BLOOD, V119, P5772, DOI 10.1182/blood-2011-07-366633; Monteith GR, 2017, NAT REV CANCER, V17, P367, DOI 10.1038/nrc.2017.18; Montero D, 2013, REDOX BIOL, V1, P508, DOI 10.1016/j.redox.2013.10.005; Nagelkerke A, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3373; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Odermatt A, 2015, J STEROID BIOCHEM, V151, P85, DOI 10.1016/j.jsbmb.2014.08.011; Ou Y, 2016, J BIOL CHEM, V291, P15388, DOI 10.1074/jbc.M116.721241; Pacifico F, 2003, J MOL ENDOCRINOL, V30, P399, DOI 10.1677/jme.0.0300399; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Papandreou I, 2011, BLOOD, V117, P1311, DOI 10.1182/blood-2010-08-303099; Pehar M, 2012, J BIOL CHEM, V287, P29921, DOI 10.1074/jbc.M112.363911; Pereira ER, 2014, J BIOL CHEM, V289, P3352, DOI 10.1074/jbc.M113.507194; Piccirella S, 2006, J BIOL CHEM, V281, P4671, DOI 10.1074/jbc.M509406200; Radisky ES, 2017, J CELL BIOCHEM, V118, P3531, DOI 10.1002/jcb.26185; Ramming T, 2015, FREE RADICAL BIO MED, V83, P361, DOI 10.1016/j.freeradbiomed.2015.02.011; Raturi A, 2014, HISTOL HISTOPATHOL, V29, P543, DOI 10.14670/HH-29.10.543; Semjonous NM, 2011, ENDOCRINOLOGY, V152, P93, DOI 10.1210/en.2010-0957; Singleton DC, 2012, EXPERT OPIN THER TAR, V16, P1189, DOI 10.1517/14728222.2012.728207; Takahashi M, 2002, ONCOGENE, V21, P5861, DOI 10.1038/sj.onc.1205755; Tsachaki M, 2015, BBA-MOL CELL RES, V1853, P1672, DOI 10.1016/j.bbamcr.2015.04.002; Vandewynckel YP, 2013, ANTICANCER RES, V33, P4683; Wakida NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015462; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Yadav Raj Kumar, 2014, J Cancer Prev, V19, P75, DOI 10.15430/JCP.2014.19.2.75; Yang CM, 2017, ONCOTARGETS THER, V10, P711, DOI 10.2147/OTT.S117933; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang YH, 2017, BIOMED PHARMACOTHER, V92, P972, DOI 10.1016/j.biopha.2017.05.132	68	19	19	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2690	2705		10.1096/fj.201700870RR	http://dx.doi.org/10.1096/fj.201700870RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29295867	Green Accepted, Green Published			2022-12-28	WOS:000432528000030
J	Chen, SY; Li, X; Liu, L; Liu, C; Han, X				Chen, Siyu; Li, Xiao; Liu, Li; Liu, Chang; Han, Xiao			Ophiopogonin D alleviates high-fat diet-induced metabolic syndrome and changes the structure of gut microbiota in mice	FASEB JOURNAL			English	Article						saponin compound; obesity; intestinal bacteria; transplantation; pyrosequence	GLUCAGON-LIKE PEPTIDE-1; AQUEOUS EXTRACT; COMPOUND K; OBESITY; HEALTH; HOST; INFLAMMATION; JAPONICUS; POLYSACCHARIDE; EPIDEMIOLOGY	Gut dysbiosis is believed to play a critical role in the pathogenesis of metabolic diseases, including obesity. Ophiopogonin D (OP-D), a steroidal glycoside and an active component extracted from the root of the plant Ophiopogon japonicus (also known as radix ophiopogonis), can regulate multiple physiologic processes. Here we show that OP-D administration reduces body weight, hyperglycemia, hyperlipidemia, and insulin resistance in male mice fed a high-fat diet (HFD). Pyrosequencing of the V4 regions of 16S rRNA genes in mouse feces revealed a deviation of the gut microbiota in response to OP-D treatment. In particular, the decreased Firmicutes-to-Bacteroidetes ratios and endotoxin-bearing Proteobacteria levels indicated that OP-D reversed HFD-induced gut dysbiosis. More importantly, the effects of OP-D on modulation of obesity and microbiota were transferable via horizontal feces transfer from OP-D-treated mice to HFD-fed mice. Taken together, our results suggest that OP-D may be used as a prebiotic agent to treat obesity-associated gut dysbiosis and metabolic syndrome.	[Chen, Siyu; Han, Xiao] Nanjing Med Univ, Key Lab Human Funct Genom Jiangsu Prov, Dept Biochem & Mol Biol, 101 Longmian Ave, Nanjing 211166, Jiangsu, Peoples R China; [Chen, Siyu; Liu, Chang] China Pharmaceut Univ, Sch Life Sci, 639 Longmian Ave, Nanjing 211198, Jiangsu, Peoples R China; [Li, Xiao] Nanjing Med Univ, Affiliated Hosp 1, Dept Pathol, Nanjing, Jiangsu, Peoples R China; [Liu, Li] Nanjing Med Univ, Affiliated Hosp 1, Dept Geriatr, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; China Pharmaceutical University; Nanjing Medical University; Nanjing Medical University	Han, X (corresponding author), Nanjing Med Univ, Key Lab Human Funct Genom Jiangsu Prov, Dept Biochem & Mol Biol, 101 Longmian Ave, Nanjing 211166, Jiangsu, Peoples R China.; Liu, C (corresponding author), China Pharmaceut Univ, Sch Life Sci, 639 Longmian Ave, Nanjing 211198, Jiangsu, Peoples R China.	changliu@cpu.edu.cn; hanxiao@njmu.edu.cn		Chen, Siyu/0000-0002-3809-1062	National Natural Science Foundation of China (NSF) [81420108007, 31422028]; National Key Research and Development Program of China [2016YFC1304804]; NSF of Jiangsu Province of China [BK20140041]; Jiangsu Postdoctoral Research Funding Plan [1601020A]	National Natural Science Foundation of China (NSF)(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; NSF of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Jiangsu Postdoctoral Research Funding Plan	This work was supported by research grants from the National Natural Science Foundation of China (NSF; 81420108007 to X.H., 31422028 to C.L.) and the National Key Research and Development Program of China (2016YFC1304804 to X.H.), NSF of Jiangsu Province of China (BK20140041 to C.L.), and the Jiangsu Postdoctoral Research Funding Plan (1601020A to S.C.). X.H. and C.L. are fellows at the Collaborative Innovation Center for Cardiovascular Disease Translational Medicine and Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The authors have declared that no competing interests exist.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Borody Thomas J, 2013, Curr Gastroenterol Rep, V15, P337, DOI 10.1007/s11894-013-0337-1; Campos P, 2006, INT J EPIDEMIOL, V35, P55, DOI 10.1093/ije/dyi254; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cartwright TH, 2002, J CLIN ONCOL, V20, P160, DOI 10.1200/JCO.20.1.160; CHEN M, 1990, ACTA PHARM SINIC, V11, P161; Chen SY, 2014, DIABETES, V63, P2073, DOI 10.2337/db13-0788; Chen XM, 2013, CARBOHYD POLYM, V94, P378, DOI 10.1016/j.carbpol.2013.01.037; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; DeMinicis S, 2014, HEPATOLOGY, V59, P1738, DOI 10.1002/hep.26695; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ge X, 2015, INT J MOL SCI, V16, P28180, DOI 10.3390/ijms161226093; Guo JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24197; LeBlanc JG, 2013, CURR OPIN BIOTECH, V24, P160, DOI 10.1016/j.copbio.2012.08.005; Hernandez JB, 2015, NAT COMMUN, V6, DOI [10.1038/ncomms8216, 10.1038/ncomms8489]; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Huang Q, 2015, BONE, V74, P18, DOI 10.1016/j.bone.2015.01.002; Hur KY, 2015, DIABETES METAB J, V39, P198, DOI 10.4093/dmj.2015.39.3.198; Hwang I, 2015, FASEB J, V29, P2397, DOI 10.1096/fj.14-265983; Ichikawa H, 2003, AM J CHINESE MED, V31, P509, DOI 10.1142/S0192415X03001193; Ishibashi H, 2001, BRIT J PHARMACOL, V132, P461, DOI 10.1038/sj.bjp.0703818; Jia W, 2008, NAT REV DRUG DISCOV, V7, P123, DOI 10.1038/nrd2505; Jia WP, 2010, BIOMED ENVIRON SCI, V23, P4, DOI 10.1016/S0895-3988(10)60025-6; Jiang MM, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-350; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Kameyama K, 2014, MICROBES ENVIRON, V29, P427, DOI 10.1264/jsme2.ME14054; Kang KA, 2013, INT J ONCOL, V43, P1907, DOI 10.3892/ijo.2013.2129; Kim KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062409; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Kou JP, 2005, BIOL PHARM BULL, V28, P1234, DOI 10.1248/bpb.28.1234; Kou J, 2006, BIOL PHARM BULL, V29, P1267, DOI 10.1248/bpb.29.1267; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Liu C, 2013, J ENDOCRINOL, V217, P185, DOI 10.1530/JOE-12-0502; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; McChesney James D, 2002, P R Health Sci J, V21, P91; Million M, 2013, CLIN MICROBIOL INFEC, V19, P305, DOI 10.1111/1469-0691.12172; Moayyedi P, 2008, DIGEST DIS SCI, V53, P2293, DOI 10.1007/s10620-008-0410-z; Neyrinck AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020944; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Pachikian BD, 2013, MOL NUTR FOOD RES, V57, P347, DOI 10.1002/mnfr.201200364; Qian JC, 2010, J ETHNOPHARMACOL, V128, P438, DOI 10.1016/j.jep.2010.01.031; Raman M, 2013, CLIN GASTROENTEROL H, V11, P868, DOI 10.1016/j.cgh.2013.02.015; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Smith KB, 2016, PRIMARY CARE, V43, P121, DOI 10.1016/j.pop.2015.10.001; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Ueyama J, 2005, EUR J PHARMACOL, V510, P127, DOI 10.1016/j.ejphar.2005.01.025; Villanueva-Millan MJ, 2015, J PHYSIOL BIOCHEM, V71, P509, DOI 10.1007/s13105-015-0390-3; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952; Yang Z, 2012, DRUG METAB DISPOS, V40, P1538, DOI 10.1124/dmd.111.044008; Zang QQ, 2016, J INTEGR MED-JIM, V14, P51, DOI 10.1016/S2095-4964(16)60238-8; Zhan S.Y., 2014, ARCH PHARM RES; Zhang S, 2017, ANAEROBE, V48, P184, DOI 10.1016/j.anaerobe.2017.08.017; Zhang W, 2017, EUR J DRUG METAB PH, V42, P669, DOI 10.1007/s13318-016-0384-8; Zhang X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040320, 10.1371/journal.pone.0042529]; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071108; Zhang YY, 2015, J PHARMACOL EXP THER, V352, P166, DOI 10.1124/jpet.114.219261; Zhao LP, 2013, NAT REV MICROBIOL, V11, P639, DOI 10.1038/nrmicro3089; Zhao LP, 2010, J BIOTECHNOL, V149, P183, DOI 10.1016/j.jbiotec.2010.02.008	70	27	34	5	42	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1139	1153		10.1096/fj.201700741RR	http://dx.doi.org/10.1096/fj.201700741RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29084766				2022-12-28	WOS:000427246000004
J	Dou, XW; Menkari, C; Mitsuyama, R; Foroud, T; Wetherill, L; Hammond, P; Suttie, M; Chen, XP; Chen, SY; Charness, ME				Dou, Xiaowei; Menkari, Carrie; Mitsuyama, Rei; Foroud, Tatiana; Wetherill, Leah; Hammond, Peter; Suttie, Michael; Chen, Xiaopan; Chen, Shao-Yu; Charness, Michael E.		Collaborative Initiative Fetal Alc	L1 coupling to ankyrin and the spectrin-actin cytoskeleton modulates ethanol inhibition of L1 adhesion and ethanol teratogenesis	FASEB JOURNAL			English	Article						FASD; alcohol; phosphorylation; susceptibility	FETAL ALCOHOL SPECTRUM; CELL-ADHESION; MOLECULE L1; NEURITE OUTGROWTH; STRUCTURAL REQUIREMENTS; BINDING-ACTIVITY; BRAIN STRUCTURES; CRASH SYNDROME; OUTSIDE-IN; MUTATIONS	Ethanol causes fetal alcohol spectrum disorders (FASDs) partly by inhibiting cell adhesion mediated by the L1 neural cell adhesion molecule. Ethanol interacts with an alcohol binding pocket in the L1 extracellular domain (ECD), and dephosphorylation of S1248 in the L1 cytoplasmic domain (CD) renders L1 adhesion insensitive to inhibition by ethanol (L1 insensitive). The mechanism underlying this inside-out signaling is unknown. Here we show that phosphorylation of the human L1-CD at S1152, Y1176, S1181, and S1248 renders L1 sensitive to ethanol by promoting L1 coupling with ankyrin-G and the spectrin-actin cytoskeleton. Knockdown of ankyrin-G or L1 mutations that uncouple L1 from ankyrin reduce L1 sensitivity to ethanol, but not methanol, consistent with a small conformational change in the extracellular alcohol binding pocket. Phosphorylation of Y1176 and ankyrin-G coupling with L1 are higher in NIH/3T3 clonal cell lines in which ethanol inhibits L1 adhesion than in ethanol-resistant NIH/3T3 clonal cell lines. Similarly, phosphorylation of Y1176 is higher in C57BL/6J mice that are sensitive to ethanol teratogenesis than in ethanol resistant C57BL/6N mice. Finally, poly-morphisms in genes that encode ankyrin-G and p90rsk, a kinase that phosphorylates S1152, are linked to facial dysmorphology in children with heavy prenatal ethanol exposure. These findings indicate that genes that regulate L1 coupling to ankyrin may influence susceptibility to FASD.-Dou, X., Menkari, C., Mitsuyama, R., Foroud, T., Wetherill, L., Hammond, P., Suttie, M., Chen, X., Chen, S.-Y., Charness, M. E., Collaborative Initiative on Fetal Alcohol Spectrum Disorders. L1 coupling to ankyrin and the spectrin-actin cytoskeleton modulates ethanol inhibition of L1 adhesion and ethanol teratogenesis.	[Dou, Xiaowei; Menkari, Carrie; Mitsuyama, Rei; Charness, Michael E.] Harvard Med Sch, Vet Affairs Boston Healthcare Syst, Dept Neurol, West Roxbury, MA 02132 USA; [Foroud, Tatiana; Wetherill, Leah] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Hammond, Peter; Suttie, Michael] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England; [Chen, Xiaopan] Zhejiang Prov Peoples Hosp, Dept Reprod Endocrinol, Hangzhou, Zhejiang, Peoples R China; [Chen, Shao-Yu] Univ Louisville, Hlth Sci Ctr, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [Charness, Michael E.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Indiana University System; Indiana University Bloomington; University of Oxford; Zhejiang Provincial People's Hospital; University of Louisville; Boston University	Charness, ME (corresponding author), Harvard Med Sch, VA Boston Healthcare Syst, 1400 VFW Pkwy, West Roxbury, MA 02132 USA.	mcharness@hms.harvard.edu	Dou, Xiaowei/ABC-8814-2021; Wetherill, Leah/AAJ-2791-2020	Wetherill, Leah/0000-0003-2888-9051; Chen, Xiaopan/0000-0003-4289-7541; Suttie, Michael/0000-0002-5538-8431; Charness, Michael/0000-0002-3301-8966	U.S. National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism (NIAAA); NIAAA [R01AA012974, U24AA014811, U01AA014809, R01AA020265, R01AA021434, P50AA024337]; Medical Research Service and Veterans Affairs Merit Review [5I01BX002374]; Department of Defense [W81XWH-12- 2-0048, 8742sc]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012974, P50AA024337, R01AA020265, U24AA014811, R01AA021434, U01AA014809, U01AA026103] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002374] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism (NIAAA); NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Medical Research Service and Veterans Affairs Merit Review; Department of Defense(United States Department of Defense); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank Valerie Novakovic and Jerry Lee (Veterans Affairs Boston Healthcare System; Harvard Medical School) for assistance with FACS measurements and critical review of the manuscript. Part of this work was done in conjunction with the Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), which is funded by grants from the U.S. National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism (NIAAA). Additional information about CIFASD can be found at www.cifasd.org. This work was supported by NIAAA Grant R01AA012974 (to M.E.C.), NIAAA U24AA014811 as a component of CIFASD (to M.E.C.); The Medical Research Service and Veterans Affairs Merit Review 5I01BX002374 (to M.E.C.); Department of Defense Grant W81XWH-12- 2-0048 Subaward 8742sc (to M.E.C.); NIAAA U01AA014809 (to T.F. and P.H.); NIAAA R01AA020265 (to S.-Y.C), NIAAA R01AA021434 ( to S.-Y.C) and NIAAA P50AA024337 (to S.-Y.C). The authors declare no conflicts of interest.	Arevalo E, 2008, P NATL ACAD SCI USA, V105, P371, DOI 10.1073/pnas.0707815105; Bearer CF, 1999, J BIOL CHEM, V274, P13264, DOI 10.1074/jbc.274.19.13264; Bennett V, 1999, J NEUROCYTOL, V28, P303, DOI 10.1023/A:1007005528505; Bi C, 2012, HUM MUTAT, V33, P1635, DOI 10.1002/humu.22174; Blankenship J, 2016, PEDIATRICS, V138; BONTHIUS DJ, 1988, ALCOHOL, V5, P209, DOI 10.1016/0741-8329(88)90054-7; Buhusi M, 2003, J BIOL CHEM, V278, P25024, DOI 10.1074/jbc.M303084200; Chen MM, 2010, MOL BIOL CELL, V21, P1671, DOI 10.1091/mbc.E09-10-0900; Chen SZ, 2008, P NATL ACAD SCI USA, V105, P19962, DOI 10.1073/pnas.0807758105; Chen SY, 2005, DEV NEUROSCI-BASEL, V27, P13, DOI 10.1159/000084528; Chen SY, 2001, FASEB J, V15, P1649, DOI 10.1096/fj.00-0862fje; Dai JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073000; Dai JX, 2012, MOL CELL NEUROSCI, V50, P201, DOI 10.1016/j.mcn.2012.05.001; DAVIS JQ, 1994, J BIOL CHEM, V269, P27163; De Angelis E, 2002, HUM MOL GENET, V11, P1, DOI 10.1093/hmg/11.1.1; Dou XW, 2014, ALCOHOL CLIN EXP RES, V38, P2707, DOI 10.1111/acer.12556; Dou XW, 2013, P NATL ACAD SCI USA, V110, P5683, DOI 10.1073/pnas.1221386110; Dou XW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.209254; Eberhart JK, 2016, ALCOHOL CLIN EXP RES, V40, P1154, DOI 10.1111/acer.13066; Floyd RL, 1999, AM J PREV MED, V17, P101, DOI 10.1016/S0749-3797(99)00059-8; FRANSEN E, 1995, EUR J HUM GENET, V3, P273; Fransen E, 1998, J MED GENET, V35, P399, DOI 10.1136/jmg.35.5.399; Garver TD, 1997, J CELL BIOL, V137, P703, DOI 10.1083/jcb.137.3.703; Haspel J, 2003, FRONT BIOSCI-LANDMRK, V8, pS1210, DOI 10.2741/1108; Hoffman EJ, 2008, NEUROSCIENCE, V157, P556, DOI 10.1016/j.neuroscience.2008.08.071; Hortsch M, 1998, J CELL BIOL, V142, P251, DOI 10.1083/jcb.142.1.251; IGNELZI MA, 1994, NEURON, V12, P873, DOI 10.1016/0896-6273(94)90339-5; Iqbal Z, 2013, HUM MOL GENET, V22, P1960, DOI 10.1093/hmg/ddt043; Jenkins PM, 2015, P NATL ACAD SCI USA, V112, P957, DOI 10.1073/pnas.1416544112; Kietzman HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089448; Kizhatil K, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703158200; Lipinski RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043067; May PA, 2014, PEDIATRICS, V134, P855, DOI 10.1542/peds.2013-3319; McCarthy N, 2013, DEVELOPMENT, V140, P3254, DOI 10.1242/dev.094938; Needham LK, 2001, J NEUROSCI, V21, P1490, DOI 10.1523/JNEUROSCI.21-05-01490.2001; Ota M, 2016, PSYCHIAT CLIN NEUROS, V70, P498, DOI 10.1111/pcn.12431; Ramanathan R, 1996, J CELL BIOL, V133, P381, DOI 10.1083/jcb.133.2.381; Schaefer AW, 2002, J CELL BIOL, V157, P1223, DOI 10.1083/jcb.200203024; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; STREISSGUTH AP, 1993, AM J MED GENET, V47, P857, DOI 10.1002/ajmg.1320470612; Suttie M, 2013, PEDIATRICS, V131, pE779, DOI 10.1542/peds.2012-1371; Tuvia S, 1997, P NATL ACAD SCI USA, V94, P12957, DOI 10.1073/pnas.94.24.12957; Vallejo Y, 1997, J BIOL CHEM, V272, P12244, DOI 10.1074/jbc.272.18.12244; Wilkemeyer MF, 1999, ALCOHOL CLIN EXP RES, V23, P1711, DOI 10.1097/00000374-199911000-00002; Wilkemeyer MF, 2003, P NATL ACAD SCI USA, V100, P8543, DOI 10.1073/pnas.1331636100; Wilkemeyer MF, 1998, J NEUROCHEM, V71, P2382; Wong EV, 1996, J NEUROCHEM, V66, P779; Wong EV, 1996, J BIOL CHEM, V271, P18217, DOI 10.1074/jbc.271.30.18217; Yamasaki M, 1997, NEUROPEDIATRICS, V28, P175, DOI 10.1055/s-2007-973696; Zeniou M, 2002, HUM MOL GENET, V11, P2929, DOI 10.1093/hmg/11.23.2929; Zhang X, 1998, J BIOL CHEM, V273, P30785, DOI 10.1074/jbc.273.46.30785; Zhao X, 1996, J BIOL CHEM, V271, P6563, DOI 10.1074/jbc.271.12.6563	52	9	9	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1364	1374		10.1096/fj.201700970	http://dx.doi.org/10.1096/fj.201700970			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29109170	Green Published			2022-12-28	WOS:000427246000020
J	Maclean, KN; Jiang, H; Aivazidis, S; Kim, E; Shearn, CT; Harris, PS; Petersen, DR; Allen, RH; Stabler, SP; Roede, JR				Maclean, Kenneth N.; Jiang, Hua; Aivazidis, Stefanos; Kim, Eugene; Shearn, Colin T.; Harris, Peter S.; Petersen, Dennis R.; Allen, Robert H.; Stabler, Sally P.; Roede, James R.			Taurine treatment prevents derangement of the hepatic gamma-glutamyl cycle and methylglyoxal metabolism in a mouse model of classical homocystinuria: regulatory crosstalk between thiol and sulfinic acid metabolism	FASEB JOURNAL			English	Article						cystathionine; beta-synthase; glutathione; ophthalmate	SYNTHASE-DEFICIENT HOMOCYSTINURIA; GLUTATHIONE-RELATED ENZYMES; TRANSCRIPTION FACTOR NRF2; INDUCED OXIDATIVE STRESS; SUBUNIT GENE-EXPRESSION; NECROSIS-FACTOR-ALPHA; APOPTOTIC CELL-DEATH; GLYOXALASE-I; ENDOTHELIAL DYSFUNCTION; ANTIOXIDATIVE ENZYMES	Cystathionine beta-synthase-deficient homocystinuria (HCU) is a poorly understood, life-threatening inborn error of sulfur metabolism. Analysis of hepatic glutathione (GSH) metabolism in a mouse model of HCU demonstrated significant depletion of cysteine, GSH, and GSH disulfide independent of the block in trans-sulfuration compared with wild-type controls. HCU induced the expression of the catalytic and regulatory subunits of gamma-glutamyl ligase, GSH synthase (GS), gamma-glutamyl transpeptidase 1, 5-oxoprolinase (OPLAH), and the GSH-dependent methylglyoxal detoxification enzyme, glyoxalase-1. Multiple components of the transcription factor nuclear factor (erythroid-derived 2)-like 2 (Nrf2)-mediated antioxidant-response regulatory axis were induced without any detectable activation of Nrf2. Metabolomic analysis revealed the accumulation of multiple gamma-glutamyl amino acids and that plasma ophthalmate levels could serve as a noninvasive marker for hepatic redox stress. Neither cysteine, nor betaine treatment was able to reverse the observed enzyme inductions. Taurine treatment normalized the expression levels of gamma-glutamyl ligase C/M, GS, OPLAH, and glyoxalase-1, and reversed HCU-induced deficits in protein glutathionylation by acting to double GSH levels relative to controls. Collectively, our data indicate that the perturbation of the gamma-glutamyl cycle could contribute to multiple sequelae in HCU and that taurine has significant therapeutic potential for both HCU and other diseases for which GSH depletion is a critical pathogenic factor.-Maclean, K.N., Jiang, H., Aivazidis, S., Kim, E., Shearn, C.T., Harris, P.S., Petersen, D.R., Allen, R.H., Stabler, S. P., Roede, J. R. Taurine treatment prevents derangement of the hepatic gamma-glutamyl cycle and methylglyoxal metabolism in a mouse model of classical homocystinuria: regulatory crosstalk between thiol and sulfinic acid metabolism.	[Maclean, Kenneth N.; Jiang, Hua; Kim, Eugene] Univ Colorado, Hlth Sci Ctr, Dept Pediat, Aurora, CO 80045 USA; [Aivazidis, Stefanos; Shearn, Colin T.; Harris, Peter S.; Petersen, Dennis R.; Roede, James R.] Univ Colorado, Hlth Sci Ctr, Dept Pharmaceut Sci, Aurora, CO 80045 USA; [Allen, Robert H.; Stabler, Sally P.] Univ Colorado, Hlth Sci Ctr, Dept Med, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Maclean, KN (corresponding author), Univ Colorado, Sch Med, Dept Pediat, UCHSC, Mail Stop 8313,POB 6511, Aurora, CO 80045 USA.	ken.maclean@UCdenver.edu		Aivazids, Stefanos/0000-0003-0421-1473; Kim, Eugene/0000-0003-3409-4124	William R. Hummel Homocystinuria Research Fund; Ehst-Hummel-Kaufmann Family Endowed Chair in Inherited Metabolic Disease; Skaggs School of Pharmacy and Pharmaceutical Sciences (Aurora, CO, USA); Children's Hospital of Colorado (Aurora, CO, USA) Summer Child Health Research Internship	William R. Hummel Homocystinuria Research Fund; Ehst-Hummel-Kaufmann Family Endowed Chair in Inherited Metabolic Disease; Skaggs School of Pharmacy and Pharmaceutical Sciences (Aurora, CO, USA); Children's Hospital of Colorado (Aurora, CO, USA) Summer Child Health Research Internship	K.N.M. gratefully acknowledges financial support from the William R. Hummel Homocystinuria Research Fund and holds the Ehst-Hummel-Kaufmann Family Endowed Chair in Inherited Metabolic Disease. Additional funding for this work was provided by a faculty start-up package from the Skaggs School of Pharmacy and Pharmaceutical Sciences (Aurora, CO, USA; to J.R.R.). E.K. gratefully acknowledges support from a Children's Hospital of Colorado (Aurora, CO, USA) Summer Child Health Research Internship. The authors declare no conflicts of interest.	Akhand AA, 2001, FREE RADICAL BIO MED, V31, P20, DOI 10.1016/S0891-5849(01)00550-0; Aquilano Katia, 2011, Commun Integr Biol, V4, P477, DOI 10.4161/cib.4.4.15654; Aquilano K, 2011, J CELL SCI, V124, P1043, DOI 10.1242/jcs.077149; Arai RJ, 2008, TOXICOL APPL PHARM, V233, P227, DOI 10.1016/j.taap.2008.07.023; Bachhawat AK, 2013, BBA-GEN SUBJECTS, V1830, P3154, DOI 10.1016/j.bbagen.2012.11.018; BALLATORI N, 1994, J BIOL CHEM, V269, P19731; Bardag-Gorce F, 2011, EXP MOL PATHOL, V90, P123, DOI 10.1016/j.yexmp.2010.10.013; Briviba K, 1999, METHOD ENZYMOL, V301, P301; Broadhead GK, 2011, J BIOL CHEM, V286, P8786, DOI 10.1074/jbc.M110.149724; Brouwers O, 2014, DIABETOLOGIA, V57, P224, DOI 10.1007/s00125-013-3088-5; BUHL R, 1989, LANCET, V2, P1294; Cacciatore I, 2010, MOLECULES, V15, P1242, DOI 10.3390/molecules15031242; Cai JX, 1997, BIOCHEM J, V326, P167, DOI 10.1042/bj3260167; Chun HJ, 2016, NEUROTOX RES, V29, P419, DOI 10.1007/s12640-015-9588-y; CLIFFE EE, 1961, BIOCHEM J, V79, P475, DOI 10.1042/bj0790475; DEQUAY B, 1992, AIDS, V6, P815, DOI 10.1097/00002030-199208000-00008; DIILIO C, 1995, CANCER LETT, V96, P189, DOI 10.1016/0304-3835(95)03928-P; Forman HJ, 2009, MOL ASPECTS MED, V30, P1, DOI 10.1016/j.mam.2008.08.006; Garcia-Ruiz C, 2007, J GASTROEN HEPATOL, V22, pS38, DOI 10.1111/j.1440-1746.2006.04644.x; Go YM, 2005, CIRCULATION, V111, P2973, DOI 10.1161/CIRCULATIONAHA.104.515155; Griffith OW, 1999, ADV ENZYMOL RAMB, V73, P209, DOI 10.1002/9780470123195.ch7; GRIFFITH OW, 1979, P NATL ACAD SCI USA, V76, P5606, DOI 10.1073/pnas.76.11.5606; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; Gu F, 2013, FREE RADICAL BIO MED, V65, P488, DOI 10.1016/j.freeradbiomed.2013.07.021; Gupta S, 2014, FASEB J, V28, P781, DOI 10.1096/fj.13-240770; Habib GM, 2000, HEPATOLOGY, V32, P556, DOI 10.1053/jhep.2000.9715; Hanssen NMJ, 2014, EUR HEART J, V35, P1137, DOI 10.1093/eurheartj/eht402; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Helbling B, 1996, EUR J CLIN INVEST, V26, P38, DOI 10.1046/j.1365-2362.1996.88237.x; HUANG CS, 1993, J BIOL CHEM, V268, P19675; HUANG CS, 1993, J BIOL CHEM, V268, P20578; Huang ZZ, 1998, HEPATOLOGY, V27, P147, DOI 10.1002/hep.510270123; Huseby NE, 2016, FREE RADICAL RES, V50, P1, DOI 10.3109/10715762.2015.1100730; Jacob C, 2012, CHEM RES TOXICOL, V25, P588, DOI 10.1021/tx200342b; Janaky R, 2000, NEUROSCIENCE, V95, P617; Jiang H, 2015, BIOL OPEN, V4, P1154, DOI 10.1242/bio.013433; Jiang H, 2014, FASEB J, V28, P4044, DOI 10.1096/fj.14-253633; Jiang H, 2012, MOL GENET METAB, V107, P55, DOI 10.1016/j.ymgme.2012.04.025; Jones DP, 2006, ANTIOXID REDOX SIGN, V8, P1865, DOI 10.1089/ars.2006.8.1865; Jones DP, 1998, CLIN CHIM ACTA, V275, P175, DOI 10.1016/S0009-8981(98)00089-8; Kalish BT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059653; Kanaoka Y, 1997, CELL, V90, P1085, DOI 10.1016/S0092-8674(00)80374-8; Keating AK, 2011, MOL GENET METAB, V103, P330, DOI 10.1016/j.ymgme.2011.04.012; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kwak MK, 2001, MOL MED, V7, P135, DOI 10.1007/BF03401947; Lee TD, 2005, BIOCHEM J, V390, P521, DOI 10.1042/BJ20050439; Lieberman MW, 1996, P NATL ACAD SCI USA, V93, P7923, DOI 10.1073/pnas.93.15.7923; LU SC, 1992, J CLIN INVEST, V90, P524, DOI 10.1172/JCI115890; LU SC, 1992, AM J PHYSIOL, V263, pC1181, DOI 10.1152/ajpcell.1992.263.6.C1181; Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Luo JL, 1998, AM J PHYSIOL-ENDOC M, V275, pE359, DOI 10.1152/ajpendo.1998.275.2.E359; Luperchio S, 1996, FREE RADICAL BIO MED, V21, P513, DOI 10.1016/0891-5849(96)00219-5; Maclean KN, 2012, J BIOL CHEM, V287, P31994, DOI 10.1074/jbc.M112.355172; Maclean KN, 2012, MOL GENET METAB, V105, P395, DOI 10.1016/j.ymgme.2011.11.190; Maclean KN, 2010, MOL GENET METAB, V101, P153, DOI 10.1016/j.ymgme.2010.06.010; Maclean KN, 2010, MOL GENET METAB, V101, P163, DOI 10.1016/j.ymgme.2010.06.007; Maclean KN, 2002, HUM MUTAT, V19, P641, DOI 10.1002/humu.10089; Mannervik B, 1981, Methods Enzymol, V77, P297; Martin JA, 2001, JAMA-J AM MED ASSOC, V285, P1444, DOI 10.1001/jama.285.11.1444; Maynard L. A., 1962, ANIMAL NUTRITION, P283; MEISTER A, 1988, J BIOL CHEM, V263, P17205; MEISTER A, 1974, LIFE SCI, V15, P177, DOI 10.1016/0024-3205(74)90206-9; Moinova HR, 1999, BIOCHEM BIOPH RES CO, V261, P661, DOI 10.1006/bbrc.1999.1109; Mosharov E, 2000, BIOCHEMISTRY-US, V39, P13005, DOI 10.1021/bi001088w; MUDD SH, 1985, AM J HUM GENET, V37, P1; ORLOWSKI M, 1970, P NATL ACAD SCI USA, V67, P1248, DOI 10.1073/pnas.67.3.1248; ORLOWSKI M, 1971, J BIOL CHEM, V246, P7095; Pompella A, 2007, CURR OPIN PHARMACOL, V7, P360, DOI 10.1016/j.coph.2007.04.004; Pullin CH, 2002, J INHERIT METAB DIS, V25, P107, DOI 10.1023/A:1015672625913; RACKER E, 1951, J BIOL CHEM, V190, P685; Rahman I, 1998, FEBS LETT, V427, P129, DOI 10.1016/S0014-5793(98)00410-4; Rahman I, 1996, FEBS LETT, V396, P21, DOI 10.1016/0014-5793(96)01027-7; Sengupta R, 2013, ANTIOXID REDOX SIGN, V18, P259, DOI 10.1089/ars.2012.4716; Siitonen T, 1999, ANN ONCOL, V10, P1361, DOI 10.1023/A:1008382912096; SILBER PM, 1986, ANAL BIOCHEM, V158, P68, DOI 10.1016/0003-2697(86)90590-7; SNOKE JE, 1953, J BIOL CHEM, V201, P573; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; STABLER SP, 1993, BLOOD, V81, P3404; Steullet P, 2006, NEUROSCIENCE, V137, P807, DOI 10.1016/j.neuroscience.2005.10.014; Stiborova M, 2008, TOXICOLOGY, V247, P11, DOI 10.1016/j.tox.2008.01.018; Stipanuk MH, 2011, J INHERIT METAB DIS, V34, P17, DOI 10.1007/s10545-009-9006-9; Sun WM, 1996, BIOCHEM J, V320, P321, DOI 10.1042/bj3200321; TATEISHI N, 1974, J BIOCHEM, V75, P93, DOI 10.1093/oxfordjournals.jbchem.a130387; TESHIGAWARA M, 1995, RES EXP MED, V195, P55, DOI 10.1007/BF02576774; Thornalley Paul J., 2008, Drug Metabolism and Drug Interactions, V23, P125; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; Urata Y, 1996, J BIOL CHEM, V271, P15146, DOI 10.1074/jbc.271.25.15146; URSINI F, 1995, METHOD ENZYMOL, V252, P38; VANDERWE.P, 1973, P NATL ACAD SCI USA, V70, P759; Wild AC, 1999, J BIOL CHEM, V274, P33627, DOI 10.1074/jbc.274.47.33627; Yan CC, 1996, BIOCHEM PHARMACOL, V51, P375, DOI 10.1016/0006-2952(95)02189-2; Yang G, 2016, CELL REP, V17, P1022, DOI 10.1016/j.celrep.2016.09.067; Yang HP, 2005, BIOCHEM J, V391, P399, DOI 10.1042/BJ20050795; Zhang HQ, 2006, FREE RADICAL BIO MED, V40, P1281, DOI 10.1016/j.freeradbiomed.2005.11.005	95	13	13	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1265	1280		10.1096/fj.201700586R	http://dx.doi.org/10.1096/fj.201700586R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29101223				2022-12-28	WOS:000427246000013
J	Wiley, SZ; Sriram, K; Liang, WJ; Chang, SE; French, R; McCann, T; Sicklick, J; Nishihara, H; Lowy, AM; Insel, PA				Wiley, Shu Z.; Sriram, Krishna; Liang, Wenjing; Chang, Sarah E.; French, Randall; McCann, Thalia; Sicklick, Jason; Nishihara, Hiroshi; Lowy, Andrew M.; Insel, Paul A.			GPR68, a proton-sensing GPCR, mediates interaction of cancer-associated fibroblasts and cancer cells	FASEB JOURNAL			English	Article						GPCR signaling pathway; pancreatic cancer; cyclic AMP; tumor microenvironment	PROTEIN-COUPLED RECEPTORS; PANCREATIC STELLATE CELLS; GENE-EXPRESSION; IN-VIVO; INHIBITOR; CYTOKINES; PH; MYOFIBROBLASTS; ANGIOGENESIS; REPERTOIRE	The microenvironment of pancreatic ductal adenocarcinoma (PDAC) is characterized by a dense fibrotic stroma (desmoplasia) generated by pancreatic cancer-associated fibroblasts (CAFs) derived from pancreatic stellate cells (PSCs) and pancreatic fibroblasts (PFs). Using an unbiased GPCRomic array approach, we identified 82 G-protein-coupled receptors (GPCRs) commonly expressed by CAFs derived from 5 primary PDAC tumors. Compared with PSCs and PFs, CAFs have increased expression of GPR68 (a proton-sensing GPCR), with the results confirmed by immunoblotting, The Cancer Genome Atlas data, and immunohistochemistry of PDAC tumors. Coculture of PSCs with PDAC cells, or incubation with TNF-alpha, induced GPR68 expression. GPR68 activation (by decreasing the extracellular pH) enhanced IL-6 expression via a cAMP/PKA/cAMP response element binding protein signaling pathway. Knockdown of GPR68 by short interfering RNA diminished low pH-induced production of IL-6 and enhancement of PDAC cell proliferation by CAF conditioned media. CAFs from other gastrointestinal cancers also express GPR68. PDAC cells thus induce expression by CAFs of GPR68, which senses the acidic microenvironment, thereby increasing production of fibrotic markers and IL-6 and promoting PDAC cell proliferation. CAF-expressed GPR68 is a mediator of low-pH-promoted regulation of the tumor microenvironments, in particular to PDAC cell-CAF interaction and may be a novel therapeutic target for pancreatic and perhaps other types of cancers.	[Wiley, Shu Z.; Sriram, Krishna; Liang, Wenjing; Chang, Sarah E.; McCann, Thalia; Insel, Paul A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Insel, Paul A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [French, Randall; Sicklick, Jason; Lowy, Andrew M.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Sicklick, Jason; Lowy, Andrew M.] Univ Calif San Diego, Div Surg Oncol, Dept Surg, La Jolla, CA 92093 USA; [Liang, Wenjing] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Jinan, Shandong, Peoples R China; [Nishihara, Hiroshi] Hokkaido Canc Ctr, Div Clin Canc Genom, Shiroishi Ku, Sapporo, Hokkaido, Japan	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Shandong University	Insel, PA (corresponding author), Univ Calif San Diego, 9500 Gilman Dr,BSB 3076,MC 0636, La Jolla, CA 92093 USA.	pinsel@ucsd.edu	Liang, Wenjing/AAC-1434-2020		National Cancer Institute (NCI) Therapeutic Training Grant [5T32CA121938]; NIH/NCI [R21 CA189477, R01 CA155620]; NIH/NCI; American Society for Pharmacology and Experimental Therapeutics (ASPET)-David Lehr Research Award; U.S. National Institutes of Health (NIH); NATIONAL CANCER INSTITUTE [R01CA155620, K08CA168999, T32CA121938, R21CA189477] Funding Source: NIH RePORTER	National Cancer Institute (NCI) Therapeutic Training Grant; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Society for Pharmacology and Experimental Therapeutics (ASPET)-David Lehr Research Award; U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Jing Zhang (University of California, San Diego) for assisting us with statistical analysis. This work was supported by U.S. National Institutes of Health (NIH), National Cancer Institute (NCI) Therapeutic Training Grant 5T32CA121938, NIH/NCI Research Grants R21 CA189477, R01 CA155620, and Padres Pedal the Cause PTC2017, and by an American Society for Pharmacology and Experimental Therapeutics (ASPET)-David Lehr Research Award. The authors declare no conflicts of interest.	[Anonymous], 2017, CANC FACTS FIG 2017, P1; Apte MV, 2013, GASTROENTEROLOGY, V144, P1210, DOI 10.1053/j.gastro.2012.11.037; Apte MV, 1999, GUT, V44, P534, DOI 10.1136/gut.44.4.534; ARAFAT HA, 2007, J AM COLL SURGEONS, V204, P1005; Arafat HA, 2007, J AM COLL SURGEONS, V204, P996, DOI 10.1016/j.jamcollsurg.2007.01.067; Bellone G, 2006, J IMMUNOL, V177, P3448, DOI 10.4049/jimmunol.177.5.3448; Bjarnadottir TK, 2006, GENOMICS, V88, P263, DOI 10.1016/j.ygeno.2006.04.001; Damaghi M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00370; de Valliere C, 2016, CELL MOL GASTROENTER, V2, P796, DOI 10.1016/j.jcmgh.2016.06.003; de Valliere C, 2015, INFLAMM BOWEL DIS, V21, P1269, DOI 10.1097/MIB.0000000000000375; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Duluc C, 2015, EMBO MOL MED, V7, P735, DOI 10.15252/emmm.201404346; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Erkan M, 2008, CLIN GASTROENTEROL H, V6, P1155, DOI 10.1016/j.cgh.2008.05.006; Erkan M, 2012, NAT REV GASTRO HEPAT, V9, P454, DOI 10.1038/nrgastro.2012.115; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; GILLIES RJ, 1994, AM J PHYSIOL, V267, pC195, DOI 10.1152/ajpcell.1994.267.1.C195; Guha S, 2005, CANCER RES, V65, P2738, DOI 10.1158/0008-5472.CAN-04-3197; Haqq J, 2014, EUR J CANCER, V50, P2570, DOI 10.1016/j.ejca.2014.06.021; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Huang XP, 2015, NATURE, V527, P477, DOI 10.1038/nature15699; Huang Y, 2008, MOL CELL BIOCHEM, V308, P133, DOI 10.1007/s11010-007-9621-4; Insel PA, 2015, MOL PHARMACOL, V88, P181, DOI 10.1124/mol.115.098129; Ke N, 2007, MOL CANCER THER, V6, P1840, DOI 10.1158/1535-7163.MCT-07-0066; Kleger A, 2014, ANN ONCOL, V25, P1260, DOI 10.1093/annonc/mdu013; Kordes C, 2005, PANCREAS, V31, P156, DOI 10.1097/01.mpa.0000168222.05591.a0; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Li BBX, 2009, CHEMBIOCHEM, V10, P2721, DOI 10.1002/cbic.200900552; Li Jing, 2013, J Mol Signal, V8, P6, DOI 10.1186/1750-2187-8-6; Li M., 2010, CANCER SCI, V99, P2218; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lu D, 2013, MOL PHARMACOL, V84, P787, DOI 10.1124/mol.113.087742; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Matsuo Y, 2009, INT J CANCER, V125, P1027, DOI 10.1002/ijc.24383; Mogi C, 2005, J PHARMACOL SCI, V99, P160, DOI 10.1254/jphs.FP0050599; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; Ozdemir BC, 2015, CANCER CELL, V28, P831, DOI 10.1016/j.ccell.2015.11.002; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Ohlund D, 2017, J EXP MED, V214, P579, DOI 10.1084/jem.20162024; Okada S, 1998, JPN J CLIN ONCOL, V28, P12, DOI 10.1093/jjco/28.1.12; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pilon-Thomas S, 2017, CANCER RES, V77, P2552, DOI 10.1158/0008-5472.CAN-17-0559; Pilon-Thomas S, 2016, CANCER RES, V76, P1381, DOI 10.1158/0008-5472.CAN-15-1743; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roshani R, 2014, CANCER LETT, V345, P157, DOI 10.1016/j.canlet.2013.07.014; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Ryder NM, 2001, J CELL PHYSIOL, V186, P53, DOI 10.1002/1097-4652(200101)186:1<53::AID-JCP1004>3.0.CO;2-Q; Segerstolpe A, 2016, CELL METAB, V24, P593, DOI 10.1016/j.cmet.2016.08.020; Sherman MH, 2014, CELL, V159, P80, DOI 10.1016/j.cell.2014.08.007; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Singh LS, 2007, JNCI-J NATL CANCER I, V99, P1313, DOI 10.1093/jnci/djm107; Snead AN, 2012, FASEB J, V26, P4540, DOI 10.1096/fj.12-213496; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; van Sluis R, 1999, MAGN RESON MED, V41, P743, DOI 10.1002/(SICI)1522-2594(199904)41:4<743::AID-MRM13>3.0.CO;2-Z; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Walter K, 2008, CANCER BIOL THER, V7, P882, DOI 10.4161/cbt.7.6.5869; Wehr AY, 2011, PANCREAS, V40, P557, DOI 10.1097/MPA.0b013e318214efaf; Xie FC, 2015, J MED CHEM, V58, P5075, DOI 10.1021/acs.jmedchem.5b00468; Zhou Honglei, 2014, Oncoscience, V1, P765	65	54	55	2	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1170	1183		10.1096/fj.201700834R	http://dx.doi.org/10.1096/fj.201700834R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29092903	Green Published			2022-12-28	WOS:000427246000006
J	Capogrosso, RF; Mantuano, P; Uaesoontrachoon, K; Cozzoli, A; Giustino, A; Dow, T; Srinivassane, S; Filipovic, M; Bell, C; Vandermeulen, J; Massari, AM; De Bellis, M; Conte, E; Pierno, S; Camerino, GM; Liantonio, A; Nagaraju, K; De Luca, A				Capogrosso, Roberta Francesca; Mantuano, Paola; Uaesoontrachoon, Kitipong; Cozzoli, Anna; Giustino, Arcangela; Dow, Todd; Srinivassane, Sadish; Filipovic, Marina; Bell, Christina; Vandermeulen, Jack; Massari, Ada Maria; De Bellis, Michela; Conte, Elena; Pierno, Sabata; Camerino, Giulia Maria; Liantonio, Antonella; Nagaraju, Kanneboyina; De Luca, Annamaria			Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy	FASEB JOURNAL			English	Article						skeletal muscle; Duchenne muscular dystrophy; preclinical drug testing; murine model; rycals	DUCHENNE MUSCULAR-DYSTROPHY; STANDARD OPERATING PROCEDURES; SKELETAL-MUSCLE; MOUSE MODEL; IN-VIVO; CALCIUM HOMEOSTASIS; ENZYME-RELEASE; KATP CHANNELS; EXERCISE; REGENERATION	Muscle fibers lacking dystrophin undergo a long-term alteration of Ca2+ homeostasis, partially caused by a leaky Ca2+ release ryanodine (RyR) channel. S48168/ARM210, an RyR calcium release channel stabilizer (a Rycal compound), is expected to enhance the rebinding of calstabin to the RyR channel complex and possibly alleviate the pathologic Ca2+ leakage in dystrophin-deficient skeletal and cardiac muscle. This study systematically investigated the effect of S48168/ARM210 on the phenotype of mdx mice by means of a first proof-of-concept, short (4 wk), phase 1 treatment, followed by a 12-wk treatment (phase 2) performed in parallel by 2 independent laboratories. The mdx mice were treated with S48168/ARM210 at two different concentrations (50 or 10 mg/kg/d) in their drinking water for 4 and 12 wk, respectively. The mice were subjected to treadmill sessions twice per week (12 m/min for 30 min) to unmask the mild disease. This testing was followed by in vivo forelimb and hindlimb grip strength and fatigability measurement, ex vivo extensor digitorum longus (EDL) and diaphragm (DIA) force contraction measurement and histologic and biochemical analysis. The treatments resulted in functional (grip strength, ex vivo force production in DIA and EDL muscles) as well as histologic improvement after 4 and 12 wk, with no adverse effects. Furthermore, levels of cellular biomarkers of calcium homeostasis increased. Therefore, these data suggest that S48168/ARM210 may be a safe therapeutic option, at the dose levels tested, for the treatment of Duchenne muscular dystrophy (DMD).	[Capogrosso, Roberta Francesca; Mantuano, Paola; Cozzoli, Anna; Giustino, Arcangela; Massari, Ada Maria; De Bellis, Michela; Conte, Elena; Pierno, Sabata; Camerino, Giulia Maria; Liantonio, Antonella; De Luca, Annamaria] Univ Bari, Dept Pharm Drug Sci, Pharmacol Unit, Bari, Italy; [Uaesoontrachoon, Kitipong; Dow, Todd; Srinivassane, Sadish; Filipovic, Marina; Bell, Christina; Vandermeulen, Jack; Nagaraju, Kanneboyina] Agada Biosci Inc, Halifax, NS, Canada; [Nagaraju, Kanneboyina] SUNY Binghamton, Sch Pharm & Pharmaceut Sci, Binghamton, NY 13902 USA	Universita degli Studi di Bari Aldo Moro; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Nagaraju, K (corresponding author), SUNY Binghamton, Dept Pharmaceut Sci, Sch Pharm & Pharmaceut Sci, AB-G34,POB 6000, Binghamton, NY 13902 USA.; De Luca, A (corresponding author), Univ Bari Aldo Moro, Dept Pharm Drug Sci, Sect Pharmacol, Orabona 4 Campus, I-70125 Bari, Italy.	nagaraju@binghamton.edu; annamaria.deluca@uniba.it	Conte, Elena/AAV-3153-2020; Nagaraju, Kanneboyina/ABA-6525-2021; Conte, Elena/AAF-4055-2019; Nagaraju, Kanneboyina/AAV-7684-2021; Mantuano, Paola/AAG-9696-2019; De Bellis, Michela/ABE-2595-2020	Conte, Elena/0000-0001-8571-5125; Mantuano, Paola/0000-0001-6339-2222; Camerino, Giulia Maria/0000-0003-1410-6327; Dow, Todd/0000-0001-9607-5071	Muscular Dystrophy Association [228338]; U.S. National Institutes of Health [K26OD011171]; Dutch Duchenne Parent Project (NL-DPP); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K26OD011171] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Duchenne Parent Project (NL-DPP); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Dr. Deborah McClellan for editing the manuscript. The compound used for this study was provided by Servier (Suresnes, France) and Armgo Pharma (Tarrytown, NY, USA), who are jointly developing S48168/ARM210 for indications including DMD. This study was supported in part by funds from Muscular Dystrophy Association Grant 228338 (Chicago, IL, USA); by U.S. National Institutes of Health Grant K26OD011171 (to K.N.); and by funds from the Dutch Duchenne Parent Project (NL-DPP) (to A.D.L.). K.N. and A.D.L. are senior coauthors. K.N. is a cofounder of Reveragen Biopharma, which is engaged in the development of therapeutic products for DMD. The remaining authors declare no conflicts of interest.	ARMSTRONG RB, 1990, MED SCI SPORT EXER, V22, P429; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; Burdi R, 2006, NEUROMUSCULAR DISORD, V16, P237, DOI 10.1016/j.nmd.2006.01.013; Burdi R, 2009, J APPL PHYSIOL, V106, P1311, DOI 10.1152/japplphysiol.90985.2008; Camerino GM, 2014, HUM MOL GENET, V23, P5720, DOI 10.1093/hmg/ddu287; Capogrosso RF, 2017, J APPL PHYSIOL, V122, P828, DOI 10.1152/japplphysiol.00776.2015; Capogrosso RF, 2016, PHARMACOL RES, V106, P101, DOI 10.1016/j.phrs.2016.02.016; CARLSON BM, 1973, AM J ANAT, V137, P119, DOI 10.1002/aja.1001370202; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Cozzoli A, 2014, AM J PHYSIOL-CELL PH, V307, pC634, DOI 10.1152/ajpcell.00372.2013; Dahlqvist JR, 2014, MUSCLE NERVE, V49, P261, DOI 10.1002/mus.23909; De Luca A, 2005, AM J PATHOL, V166, P477, DOI 10.1016/S0002-9440(10)62270-5; De Luca A, 2003, J PHARMACOL EXP THER, V304, P453, DOI 10.1124/jpet.102.041343; De Luca A, 2008, NEUROBIOL DIS, V32, P243, DOI 10.1016/j.nbd.2008.07.009; Deconinck N, 2007, PEDIATR NEUROL, V36, P1, DOI 10.1016/j.pediatrneurol.2006.09.016; Duan DS, 2016, J CARDIOVASC TRANSL, V9, P85, DOI 10.1007/s12265-015-9669-6; EMERY AEH, 1980, BRIT MED J, V280, P355, DOI 10.1136/bmj.280.6211.355; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; Fauconnier J, 2010, P NATL ACAD SCI USA, V107, P1559, DOI 10.1073/pnas.0908540107; FONG P, 1990, SCIENCE, V250, P673, DOI 10.1126/science.2173137; Fraysse B, 2004, NEUROBIOL DIS, V17, P144, DOI 10.1016/j.nbd.2004.06.002; Friden J, 2001, SCAND J MED SCI SPOR, V11, P126, DOI 10.1034/j.1600-0838.2001.011002126.x; Gailly P, 2002, BBA-PROTEINS PROTEOM, V1600, P38, DOI 10.1016/S1570-9639(02)00442-9; Goonasekera SA, 2011, J CLIN INVEST, V121, P1044, DOI 10.1172/JCI43844; Grange RW, 2002, AM J PHYSIOL-CELL PH, V283, pC1090, DOI 10.1152/ajpcell.00450.2001; Grefte S, 2007, STEM CELLS DEV, V16, P857, DOI 10.1089/scd.2007.0058; Grounds MD, 2008, NEUROBIOL DIS, V31, P1, DOI 10.1016/j.nbd.2008.03.008; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1991, MOL ASPECTS MED, V12, P175, DOI 10.1016/0098-2997(91)90001-3; HUTTER OF, 1991, J MUSCLE RES CELL M, V12, P585, DOI 10.1007/BF01738447; KOMULAINEN J, 1994, PFLUG ARCH EUR J PHY, V428, P346, DOI 10.1007/BF00724517; Malerba A, 2011, MOL THER, V19, P345, DOI 10.1038/mt.2010.261; Mele A, 2014, BIOCHEM PHARMACOL, V91, P266, DOI 10.1016/j.bcp.2014.06.023; MENKE A, 1991, NATURE, V349, P69, DOI 10.1038/349069a0; MENKE A, 1995, J CELL SCI, V108, P727; OHLENDIECK K, 1991, J CELL BIOL, V115, P1685, DOI 10.1083/jcb.115.6.1685; Pal R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5425; PASTERNAK C, 1995, J CELL BIOL, V128, P355, DOI 10.1083/jcb.128.3.355; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Pierno S, 2014, AGE, V36, P73, DOI 10.1007/s11357-013-9544-9; Pierno S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065167; Robert V, 2001, J BIOL CHEM, V276, P4647, DOI 10.1074/jbc.M006337200; Rolland JF, 2006, NEUROBIOL DIS, V24, P466, DOI 10.1016/j.nbd.2006.08.010; ROSES AD, 1975, NATURE, V254, P350, DOI 10.1038/254350a0; Sali A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034204; Sharp PS, 2011, MOL THER, V19, P165, DOI 10.1038/mt.2010.213; SPENCER MJ, 1995, J BIOL CHEM, V270, P10909, DOI 10.1074/jbc.270.18.10909; Spurney CF, 2009, MUSCLE NERVE, V39, P591, DOI 10.1002/mus.21211; Terrill JR, 2012, NEUROMUSCULAR DISORD, V22, P427, DOI 10.1016/j.nmd.2011.11.007; Tricarico D, 2012, J PHARMACOL EXP THER, V340, P266, DOI 10.1124/jpet.111.185835; TURNER PR, 1988, NATURE, V335, P735, DOI 10.1038/335735a0; TURNER PR, 1991, J CELL BIOL, V115, P1701, DOI 10.1083/jcb.115.6.1701; Uaesoontrachoon K, 2014, HUM MOL GENET, V23, P3239, DOI 10.1093/hmg/ddu033; VANDERMEULEN JH, 1991, J APPL PHYSIOL, V71, P999, DOI 10.1152/jappl.1991.71.3.999; Wacker SJ, 2012, CHEMMEDCHEM, V7, P1775, DOI 10.1002/cmdc.201100600; Wang QL, 2015, J MOL CELL CARDIOL, V89, P177, DOI 10.1016/j.yjmcc.2015.11.009; Wang X, 2005, NAT CELL BIOL, V7, P525, DOI 10.1038/ncb1254; Waning DL, 2015, NAT MED, V21, P1262, DOI 10.1038/nm.3961; Whitehead NP, 2008, J PHYSIOL-LONDON, V586, P2003, DOI 10.1113/jphysiol.2007.148338; Whitehead NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015354; Willmann Raffaella, 2015, J Neuromuscul Dis, V2, P113; Willmann R, 2012, NEUROMUSCULAR DISORD, V22, P43, DOI 10.1016/j.nmd.2011.04.012; Willmann R, 2009, NEUROMUSCULAR DISORD, V19, P241, DOI 10.1016/j.nmd.2008.11.015	63	32	33	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					1025	1043		10.1096/fj.201700182RRR	http://dx.doi.org/10.1096/fj.201700182RRR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29097503	Green Published, hybrid			2022-12-28	WOS:000425146900042
J	Mummler, C; Burgy, O; Hermann, S; Mutze, K; Gunther, A; Konigshoff, M				Muemmler, Carlo; Burgy, Olivier; Hermann, Sarah; Mutze, Kathrin; Guenther, Andreas; Koenigshoff, Melanie			Cell-specific expression of runt-related transcription factor 2 contributes to pulmonary fibrosis	FASEB JOURNAL			English	Article						RUNX2; IPF; alveolar epithelial cells; fibroblast	ALVEOLAR EPITHELIAL-CELLS; HUMAN LUNG FIBROBLASTS; MESENCHYMAL TRANSITION; SIGNALING PATHWAY; OSTEOBLAST DIFFERENTIATION; MOLECULAR-MECHANISMS; GENE-EXPRESSION; BREAST-CANCER; BETA; PROLIFERATION	Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease with limited therapeutic options and unknown etiology. IPF is characterized by epithelial cell injury, impaired cellular crosstalk between epithelial cells and fibroblasts, and the formation of fibroblast foci with increased extracellular matrix deposition (ECM). We investigated the role of runt-related transcription factor 2 (RUNX2), a master regulator of bone development that has been linked to profibrotic signaling. RUNX2 expression was up-regulated in lung homogenates from patients with IPF and in experimental bleomycin-induced lung fibrosis. The RUNX2 level correlated with disease severity as measured by decreased diffusing capacity and increased levels of the IPF biomarker, matrix metalloproteinase 7. Nuclear RUNX2 was observed in prosurfactant protein C-positive hyperplastic epithelial cells and was rarely found in myofibroblasts. We discovered an up-regulation of RUNX2 in fibrotic alveolar epithelial type II (ATII) cells as well as an increase of RUNX2-negative fibroblasts in experimental and human pulmonary fibrosis. Functionally, small interfering RNA-mediated RUNX2 knockdown decreased profibrotic ATII cell function, such as proliferation and migration, whereas fibroblasts displayed activation markers and increased ECM expression after RUNX2 knockdown. This study reveals that RUNX2 is differentially expressed in ATII cells vs. fibroblasts in lung fibrosis, which contributes to profibrotic cell function. Cell-specific targeting of RUNX2 pathways may represent a therapeutic approach for IPF.	[Muemmler, Carlo; Hermann, Sarah; Mutze, Kathrin; Koenigshoff, Melanie] Ludwig Maximilians Univ Munchen, Univ Hosp Grosshadern, Helmholtz Ctr Munich, Comprehens Pneumol Ctr, Munich, Germany; [Burgy, Olivier; Koenigshoff, Melanie] Univ Colorado, Dept Med, Div Pulm Sci & Crit Care Med, Denver, CO 80045 USA; [Guenther, Andreas] Univ Giessen, Lung Ctr, Dept Internal Med, Giessen, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Justus Liebig University Giessen	Konigshoff, M (corresponding author), Univ Colorado, Dept Med, Div Pulm Sci & Crit Care Med, AMC, Res 2,9th Floor,12700 East 19th Ave, Denver, CO 80045 USA.	melanie.koenigshoff@ucdenver.edu	Burgy, Olivier/V-8709-2018	Mutze, Kathrin/0000-0002-5577-4500	German Center of Lung Research; Helmholtz Association; European Respiratory Society; European Molecular Biology Organization [ERS LTRF 2016-7481]	German Center of Lung Research; Helmholtz Association(Helmholtz Association); European Respiratory Society; European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	The authors are grateful to all members of the M.G. Laboratory for stimulating discussions. The authors thank Darcy E. Wagner for helping with dataset analysis, Nadine Adam, Anastasia van den Berg, Julia Kipp and Marlene Stein (all of the Comprehensive Pneumology Center Munich, Ludwig Maximillians University) for excellent technical assistance and Nicole Manning (University of Colorado) for proofreading the manuscript. This work was funded by grants from the German Center of Lung Research and the Helmholtz Association. Helmholtz Center Munich and University of Giessen Lung Center are members of the German Center for Lung Research. O.B. is supported by a postdoctoral fellowship from the European Respiratory Society and the European Molecular Biology Organization (Fellowship ERS LTRF 2016-7481). The authors declare no conflicts of interest.	Baarsma HA, 2017, THORAX, V72, P746, DOI 10.1136/thoraxjnl-2016-209753; Baarsma HA, 2017, J EXP MED, V214, P143, DOI 10.1084/jem.20160675; Baarsma HA, 2013, PHARMACOL THERAPEUT, V138, P66, DOI 10.1016/j.pharmthera.2013.01.002; Baniwal SK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-258; Bellaye PS, 2015, AM J RESP CELL MOL, V52, P244, DOI 10.1165/rcmb.2014-0011OC; Blackwell TS, 2014, AM J RESP CRIT CARE, V189, P214, DOI 10.1164/rccm.201306-1141WS; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Bridges RS, 2009, AM J PATHOL, V175, P2351, DOI 10.2353/ajpath.2009.080954; Burgy O, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0475-8; Chang CH, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0257-3; Chimge NO, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3073; Chuang LSH, 2013, INT J CANCER, V132, P1260, DOI 10.1002/ijc.27964; Emblom-Callahan MC, 2010, GENOMICS, V96, P134, DOI 10.1016/j.ygeno.2010.04.005; Fernandez IE, 2012, LANCET, V380, P680, DOI 10.1016/S0140-6736(12)61144-1; Ferrari N, 2015, SCI REP-UK, V5, DOI 10.1038/srep15658; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Horowitz JC, 2016, EUR RESPIR J, V47, P1842, DOI 10.1183/13993003.01201-2015; Hsu YL, 2011, J BIOL CHEM, V286, P37335, DOI 10.1074/jbc.M111.256156; Huang XM, 1999, NAT STRUCT BIOL, V6, P624; Ito Y, 2003, CURR OPIN GENET DEV, V13, P43, DOI 10.1016/S0959-437X(03)00007-8; Ito Y, 2015, NAT REV CANCER, V15, P81, DOI 10.1038/nrc3877; Jenkins RG, 2017, AM J RESP CELL MOL, V56, P667, DOI 10.1165/rcmb.2017-0096ST; Ji CH, 1998, J CELL BIOCHEM, V69, P353, DOI 10.1002/(SICI)1097-4644(19980601)69:3<353::AID-JCB12>3.3.CO;2-W; Kim JI, 2013, BBA-MOL BASIS DIS, V1832, P1520, DOI 10.1016/j.bbadis.2013.04.021; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kim W, 2014, P NATL ACAD SCI USA, V111, P16389, DOI 10.1073/pnas.1407097111; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Klee S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20547; Konigshoff M, 2014, AM J RESP CRIT CARE, V190, P1339, DOI 10.1164/rccm.201411-2030ED; Konigshoff M, 2011, RESPIRATION, V81, P353, DOI 10.1159/000326299; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Lansley SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep36349; Lawson WE, 2005, AM J RESP CRIT CARE, V171, P899, DOI 10.1164/rccm.200311-1535OC; Lee KS, 2010, ONCOGENE, V29, P3349, DOI 10.1038/onc.2010.79; Li H, 2013, TUMOR BIOL, V34, P1807, DOI 10.1007/s13277-013-0720-4; Lomas NJ, 2012, INT J CLIN EXP PATHO, V5, P58; Marmai C, 2011, AM J PHYSIOL-LUNG C, V301, pL71, DOI 10.1152/ajplung.00212.2010; McCarthy TL, 2010, MOL ENDOCRINOL, V24, P587, DOI 10.1210/me.2009-0379; Mutze K, 2015, DIS MODEL MECH, V8, P877, DOI 10.1242/dmm.019117; Nasreen N, 2009, AM J PHYSIOL-LUNG C, V297, pL115, DOI 10.1152/ajplung.90587.2008; Niu DF, 2012, LAB INVEST, V92, P1181, DOI 10.1038/labinvest.2012.84; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Onodera Y, 2010, CANCER SCI, V101, P2670, DOI 10.1111/j.1349-7006.2010.01742.x; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Owens TW, 2014, CANCER RES, V74, P5277, DOI 10.1158/0008-5472.CAN-14-0053; Pozharskaya V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007559; Pratap J, 2006, CANCER METAST REV, V25, P589, DOI 10.1007/s10555-006-9032-0; Pullamsetti SS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001725; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Ruffenach G, 2016, AM J RESP CRIT CARE, V194, P1273, DOI 10.1164/rccm.201512-2380OC; Sally ML, 2011, J CELL MOL MED, V15, P2095, DOI 10.1111/j.1582-4934.2010.01212.x; Selman Moises, 2006, Proc Am Thorac Soc, V3, P364, DOI 10.1513/pats.200601-003TK; Shi N, 2017, FASEB J, V31, P412, DOI [10.1096/fj.201600954R, 10.1096/fj.201600954r]; Tahirov TH, 2001, CELL, V104, P755, DOI 10.1016/S0092-8674(01)00271-9; Tanjore H, 2009, AM J RESP CRIT CARE, V180, P657, DOI 10.1164/rccm.200903-0322OC; Tsuji K, 1998, BONE, V22, P87, DOI 10.1016/S8756-3282(97)00267-6; van Dijk EM, 2016, AM J PHYSIOL-LUNG C, V310, pL1166, DOI 10.1152/ajplung.00226.2015; Weng TT, 2014, AM J RESP CRIT CARE, V190, P1402, DOI 10.1164/rccm.201404-0744OC; White ES, 2016, AM J RESP CRIT CARE, V194, P1242, DOI 10.1164/rccm.201505-0862OC; Xia H, 2017, J CLIN INVEST, V127, P2586, DOI 10.1172/JCI90832; Yang DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027324; Yang DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023965; Yang J, 2013, AM J PATHOL, V183, P1559, DOI 10.1016/j.ajpath.2013.07.016	65	16	16	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					703	716		10.1096/fj.201700482R	http://dx.doi.org/10.1096/fj.201700482R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	28986417	Bronze, Green Submitted			2022-12-28	WOS:000425146900015
J	Wei, PC; Song, GJ; Shi, MY; Zhou, YF; Liu, Y; Lei, J; Chen, P; Yin, L				Wei, Pengcheng; Song, Guangji; Shi, Mengyang; Zhou, Yafei; Liu, Yang; Lei, Jun; Chen, Peng; Yin, Lei			Substrate analog interaction with MCR-1 offers insight into the rising threat of the plasmid-mediated transferable colistin resistance	FASEB JOURNAL			English	Article						X-ray crystallography; antibiotic resistance; template for drug design	PHOSPHOETHANOLAMINE TRANSFERASE; GENE MCR-1; ANTIBIOTIC-RESISTANCE; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; POLYMYXIN; MECHANISMS; SOFTWARE; TOOLS	Colistin is considered a last-resort antibiotic against most gram-negative bacteria. Recent discoveries of a plasmid-mediated, transferable mobilized colistin-resistance gene (mcr-1) on all continents have heralded the imminent emergence of pan-drug-resistant superbacteria. The inner-membrane protein MCR-1 can catalyze the transfer of phosphoethanolamine (PEA) to lipid A, resulting in colistin resistance. However, little is known about the mechanism, and few drugs exist to address this issue. We present crystal structures revealing the MCR-1 catalytic domain (cMCR-1) as a monozinc metalloprotein with ethanolamine (ETA) and d-glucose, respectively, thus highlighting 2 possible substrate-binding pockets in the MCR-1-catalyzed PEA transfer reaction. Mutation of the residues involved in ETA and d-glucose binding impairs colistin resistance in recombinant Escherichia coli containing full-length MCR-1. Partial analogs of the substrate are used for cocrystallization with cMCR-1, providing valuable information about the family of PEA transferases. One of the analogs, ETA, causes clear inhibition of polymyxin B resistance, highlighting its potential for drug development. These data demonstrate the crucial role of the PEA- and lipid A-binding pockets and provide novel insights into the structure-based mechanisms, important drug-target hot spots, and a drug template for further drug development to combat the urgent, rising threat of MCR-1-mediated antibiotic resistance.	[Wei, Pengcheng; Song, Guangji; Shi, Mengyang; Zhou, Yafei; Liu, Yang; Lei, Jun; Chen, Peng; Yin, Lei] Wuhan Univ, Dept Biochem & Mol Biol, Coll Life Sci, State Key Lab Virol,Hubei Key Lab Cell Homeostasi, Luojia Hill, Wuhan 430072, Hubei, Peoples R China	Wuhan University	Yin, L (corresponding author), Wuhan Univ, Dept Biochem & Mol Biol, Coll Life Sci, State Key Lab Virol,Hubei Key Lab Cell Homeostasi, Luojia Hill, Wuhan 430072, Hubei, Peoples R China.	yinlei@whu.edu.cn	Wei, Pengcheng/ABH-2631-2020	Liu, Yang/0000-0002-2420-2606; yin, lei/0000-0001-5203-2766; Wei, Pengcheng/0000-0003-0002-9439	National Basic Research Program of China [2014CB910103]; National Natural Science Foundation of China [31470738]; National Thousand (Young) Talents Program from the Office of Global Experts Recruitment in China	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Thousand (Young) Talents Program from the Office of Global Experts Recruitment in China	The authors thank Na Yang and the staff of the Protein Research Core Facility at the Institute of Biophysics, Chinese Academy of Sciences; and Hengjiang Cong and the X-ray facility at the College of Chemistry and Molecular Sciences, Wuhan University, for their technical support during crystals testing. The authors also thank the staff from BL17U1/BL19U1 Beamline of the National Center for Protein Sciences Shanghai at the Shanghai Synchrotron Radiation Facility, for assistance during data collection. This work was supported by the National Basic Research Program of China (Grant 2014CB910103 to L.Y.) and the National Natural Science Foundation of China (Grant 31470738 to L.Y.). L.Y. received scholarships from the National Thousand (Young) Talents Program from the Office of Global Experts Recruitment in China. The authors declare no conflicts of interest.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Anandan A, 2017, P NATL ACAD SCI USA, V114, P2218, DOI 10.1073/pnas.1612927114; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biswas S, 2012, EXPERT REV ANTI-INFE, V10, P917, DOI [10.1586/eri.12.78, 10.1586/ERI.12.78]; Blair JMA, 2015, NAT REV MICROBIOL, V13, P42, DOI 10.1038/nrmicro3380; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Fage CD, 2014, ACTA CRYSTALLOGR D, V70, P2730, DOI 10.1107/S1399004714017623; Falgenhauer L, 2016, LANCET INFECT DIS, V16, P282, DOI 10.1016/S1473-3099(16)00009-8; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Gao RS, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005957; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hinchliffe P, 2017, SCI REP-UK, V7, DOI 10.1038/srep39392; Hu ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep38793; Hu YF, 2016, LANCET INFECT DIS, V16, P146, DOI 10.1016/S1473-3099(15)00533-2; Jiang XL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15784; Kelesidis T, 2015, EXPERT OPIN DRUG SAF, V14, P1687, DOI 10.1517/14740338.2015.1088520; Kieffer N, 2017, ANTIMICROB AGENTS CH, V61; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Liu T, 2017, P NATL ACAD SCI USA, V114, P7683, DOI 10.1073/pnas.1621486114; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; Ma GX, 2016, SCI REP-UK, V6, DOI 10.1038/srep39540; Malhotra-Kumar S, 2016, LANCET INFECT DIS, V16, P283, DOI 10.1016/S1473-3099(16)00012-8; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGann P, 2016, ANTIMICROB AGENTS CH, V60, P4420, DOI 10.1128/AAC.01103-16; Mulvey MR, 2016, LANCET INFECT DIS, V16, P289, DOI [10.1016/S1473-3099(16)00067-0, 10.1016/S1473-3099(15)00540-X]; Needham BD, 2013, NAT REV MICROBIOL, V11, P467, DOI 10.1038/nrmicro3047; Nei M., 2000, MOL EVOLUTION PHYLOG, P352; Norimatsu Y, 2017, NATURE, V545, P193, DOI 10.1038/nature22357; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Palmer AC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5296; Poirel L, 2017, CLIN MICROBIOL REV, V30, P557, DOI 10.1128/CMR.00064-16; Rosay T, 2015, MBIO, V6, DOI 10.1128/mBio.01033-15; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schwarz S, 2016, J ANTIMICROB CHEMOTH, V71, P2066, DOI 10.1093/jac/dkw274; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sprenger M, 2016, SCIENCE, V351, P1264, DOI 10.1126/science.aad9450; Stojanoski V, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0303-0; STORM DR, 1977, ANNU REV BIOCHEM, V46, P723, DOI 10.1146/annurev.bi.46.070177.003451; Sun J, 2017, MBIO, V8, DOI 10.1128/mBio.00625-17; Suzuki S, 2016, LANCET INFECT DIS, V16, P284, DOI 10.1016/S1473-3099(16)00008-6; Trimble M. J., 2016, COLD SPRING HARB PER, V6; Velkov T, 2013, FUTURE MICROBIOL, V8, P711, DOI [10.2217/FMB.13.39, 10.2217/fmb.13.39]; Wanty C, 2013, J MOL BIOL, V425, P3389, DOI 10.1016/j.jmb.2013.06.029; WESTERHOFF HV, 1989, P NATL ACAD SCI USA, V86, P6597, DOI 10.1073/pnas.86.17.6597; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wright GD, 2011, CHEM COMMUN, V47, P4055, DOI 10.1039/c0cc05111j; Xavier B. B., 2016, EURO SURVEILL, V21; Yang L, 2000, BIOPHYS J, V79, P2002, DOI 10.1016/S0006-3495(00)76448-4; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	58	23	25	0	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					1085	1098		10.1096/fj.201700705R	http://dx.doi.org/10.1096/fj.201700705R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29079699	Bronze			2022-12-28	WOS:000425146900046
J	Dehn, S; Thorp, EB				Dehn, Shirley; Thorp, Edward B.			Myeloid receptor CD36 is required for early phagocytosis of myocardial infarcts and induction of Nr4a1-dependent mechanisms of cardiac repair	FASEB JOURNAL			English	Article						myocardial infarction; inflammation; monocyte	APOPTOTIC CELLS; TYROSINE KINASE; HEART-DISEASE; FATTY-ACID; CARDIOVASCULAR-DISEASE; NUCLEAR RECEPTORS; IN-VITRO; MACROPHAGES; MONOCYTES; INFLAMMATION	Phagocytosis after myocardial infarction (MI) is a prerequisite to cardiac repair. Recruited monocytes clear necrotic cardiomyocytes and differentiate into cardiac macrophages. Some studies have linked apoptotic cell receptors on cardiac macrophages to tissue repair; however, the contribution of precursor monocyte phagocytic receptors, which are the first to interact with the cardiac parenchyma, is unclear. The scavenger receptor cluster of differentiation (CD) 36 protein was detected on cardiac Ly6cHI monocytes, and bone marrow-derived Cd36 was essential for both early phagocytosis of dying cardiomyocytes and for smaller infarct sizes in female and male mice after permanent coronary ligation. Cd36 deficiency led to reduced expression of phagocytosis receptor Mertk and nuclear receptor Nr4a1 in cardiac macrophages, the latter previously shown to be required for phagocyte survival. Nr4a1 was required for phagocytosis-induced Mertk expression, and Nr4a1 protein directly bound to Mertk gene regulatory elements. To test the overall contribution of the Cd36-Mertk axis, MI was induced in Cd36(-/-) Mertk(-/-) double-knockout mice and led to increases in myocardial rupture. These data implicate monocyte CD36 in the mitigation of early infarct size and transition to Mertk-dependent macrophage function. Increased myocardial rupture in the absence of both Cd36 and Mertk underscore the physiologic significance of phagocytosis during tissue injury.	[Dehn, Shirley; Thorp, Edward B.] Northwestern Univ, Feinberg Sch Med, Dept Pathol, 300 East Super St, Chicago, IL 60611 USA; [Dehn, Shirley; Thorp, Edward B.] Northwestern Univ, Feinberg Sch Med, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Thorp, EB (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pathol, 300 East Super St, Chicago, IL 60611 USA.	ebthorp@northwestern.edu			Collaborative Learning and Integrated Mentoring in the Biosciences, Cellular, and Molecular Basis of Disease Program [U.S. National Institutes of Health (NIH), National Institute of General Medicine Sciences] [T32GM08061]; NIH National Heart, Lung, and Blood Institute Diversity Supplements [R01HL122309]; Sidney and Bess Eisenberg Memorial Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008061, R25GM079300] Funding Source: NIH RePORTER	Collaborative Learning and Integrated Mentoring in the Biosciences, Cellular, and Molecular Basis of Disease Program [U.S. National Institutes of Health (NIH), National Institute of General Medicine Sciences]; NIH National Heart, Lung, and Blood Institute Diversity Supplements; Sidney and Bess Eisenberg Memorial Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Matthew DeBerge, Kristofor Glinton (both from Northwestern University), and Terry Means (Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA) for their intellectual contributions. This work was supported by Collaborative Learning and Integrated Mentoring in the Biosciences, Cellular, and Molecular Basis of Disease Program [U.S. National Institutes of Health (NIH), National Institute of General Medicine Sciences Grant T32GM08061], and NIH National Heart, Lung, and Blood Institute Diversity Supplements R01HL122309 (to S.D.) and R01HL122309 (to E.B.T.). Publication of this research was supported by the Sidney and Bess Eisenberg Memorial Fund. The authors declare no conflicts of interest.	Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; Bessi VL, 2012, CARDIOVASC RES, V96, P99, DOI 10.1093/cvr/cvs225; Bonen A, 1998, AM J PHYSIOL-ENDOC M, V275, pE471, DOI 10.1152/ajpendo.1998.275.3.E471; Bonta PI, 2006, ARTERIOSCL THROM VAS, V26, P2288, DOI 10.1161/01.ATV.0000238346.84458.5d; Bottcher A, 2006, ARTHRITIS RHEUM-US, V54, P927, DOI 10.1002/art.21660; Cai BS, 2016, P NATL ACAD SCI USA, V113, P6526, DOI 10.1073/pnas.1524292113; Chang J, 2013, DIAGN HISTOPATHOL, V19, P7, DOI DOI 10.1016/J.MPDHP.2012.11.001; Cho S, 2005, J NEUROSCI, V25, P2504, DOI 10.1523/JNEUROSCI.0035-05.2005; CLEMETSON KJ, 1977, BIOCHIM BIOPHYS ACTA, V464, P493, DOI 10.1016/0005-2736(77)90025-6; Dehn S, 2016, J IMMUNOL, V197, P3639, DOI 10.4049/jimmunol.1600402; DeLeon-Pennell KY, 2016, CIRC-CARDIOVASC GENE, V9, P14, DOI 10.1161/CIRCGENETICS.115.001249; Driscoll WS, 2013, CIRC RES, V113, P52, DOI 10.1161/CIRCRESAHA.112.300683; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Febbraio M, 2007, INT J BIOCHEM CELL B, V39, P2012, DOI 10.1016/j.biocel.2007.03.012; Frangogiannis NG, 2008, PHARMACOL RES, V58, P88, DOI 10.1016/j.phrs.2008.06.007; Getts DR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007563; Grisanti LA, 2016, CIRCULATION, V134, P153, DOI 10.1161/CIRCULATIONAHA.116.022304; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Heather LC, 2006, CARDIOVASC RES, V72, P430, DOI 10.1016/j.cardiores.2006.08.020; Heidt T, 2014, CIRC RES, V115, P284, DOI 10.1161/CIRCRESAHA.115.303567; Helming L, 2009, J CELL SCI, V122, P453, DOI 10.1242/jcs.037200; Hilgendorf I, 2014, CIRC RES, V114, P1611, DOI 10.1161/CIRCRESAHA.114.303204; Howangyin KY, 2016, CIRCULATION, V133, P826, DOI 10.1161/CIRCULATIONAHA.115.020857; Huang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep32660; Ipseiz N, 2014, J IMMUNOL, V192, P4852, DOI 10.4049/jimmunol.1303377; Jesty SA, 2012, P NATL ACAD SCI USA, V109, P13380, DOI 10.1073/pnas.1208114109; Kaikita K, 2004, AM J PATHOL, V165, P439, DOI 10.1016/S0002-9440(10)63309-3; Kim E, 2012, ANN NEUROL, V71, P753, DOI 10.1002/ana.23569; Kiss RS, 2006, CURR BIOL, V16, P2252, DOI 10.1016/j.cub.2006.09.043; Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021; Lagasse HAD, 2016, J LEUKOCYTE BIOL, V99, P659, DOI 10.1189/jlb.4HI0315-130RRR; Larson SR, 2016, CELL DEATH DIFFER, V23, P997, DOI 10.1038/cdd.2016.24; Lavine KJ, 2014, P NATL ACAD SCI USA, V111, P16029, DOI 10.1073/pnas.1406508111; Lee PY, 2009, AM J PATHOL, V175, P2023, DOI 10.2353/ajpath.2009.090328; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009; Leuschner F, 2011, NAT BIOTECHNOL, V29, P1005, DOI 10.1038/nbt.1989; Libby P, 2016, J AM COLL CARDIOL, V67, P1091, DOI 10.1016/j.jacc.2015.12.048; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Maira M, 1999, MOL CELL BIOL, V19, P7549; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; Mukundan L, 2009, NAT MED, V15, P1266, DOI 10.1038/nm.2048; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nakano Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep29601; Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa; Nicholls HT, 2011, DIABETES, V60, P1100, DOI 10.2337/db10-1353; Panizzi P, 2010, J AM COLL CARDIOL, V55, P1629, DOI 10.1016/j.jacc.2009.08.089; Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535; Piechota M, 2012, PROTEIN J, V31, P511, DOI 10.1007/s10930-012-9431-8; Sager HB, 2016, CIRC RES, V119, P853, DOI 10.1161/CIRCRESAHA.116.309001; Santamaria MH, 2014, MICROVASC RES, V95, P131, DOI 10.1016/j.mvr.2014.08.004; Sather S, 2007, BLOOD, V109, P1026, DOI 10.1182/blood-2006-05-021634; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Shiraishi M, 2016, J CLIN INVEST, V126, P2151, DOI 10.1172/JCI85782; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; SWERLICK RA, 1992, J IMMUNOL, V148, P78; Teupser D, 2008, CLIN EXP PHARMACOL P, V35, P552, DOI 10.1111/j.1440-1681.2007.04836.x; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Wan E, 2013, CIRC RES, V113, P1004, DOI 10.1161/CIRCRESAHA.113.301198; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; Woo MS, 2016, J BIOL CHEM, V291, P23654, DOI 10.1074/jbc.M116.750018; Xiong WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072772; Zhan YP, 2008, NAT CHEM BIOL, V4, P548, DOI 10.1038/nchembio.106; Zhou P, 2011, NEUROBIOL DIS, V42, P292, DOI 10.1016/j.nbd.2011.01.019	66	33	34	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					254	+		10.1096/fj.201700450R	http://dx.doi.org/10.1096/fj.201700450R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28860151	Green Published			2022-12-28	WOS:000419172700024
J	Wang, L; Wang, XJ; Wang, LF; Yousaf, M; Li, J; Zuo, MX; Yang, ZC; Gou, DZ; Bao, BH; Li, L; Xiang, N; Jia, HB; Xu, CQ; Chen, QY; Wang, QK				Wang, Li; Wang, Xiaojing; Wang, Longfei; Yousaf, Muhammad; Li, Jia; Zuo, Mengxia; Yang, Zhongcheng; Gou, Dongzhi; Bao, Binghao; Li, Lei; Xiang, Ning; Jia, Haibo; Xu, Chengqi; Chen, Qiuyun; Wang, Qing Kenneth			Identification of a new adtrp1-tfpi regulatory axis for the specification of primitive myelopoiesis and definitive hematopoiesis	FASEB JOURNAL			English	Article						hemangioblasts; vascular development; aggf1; coagulation	COLONY-STIMULATING FACTOR; CORONARY-ARTERY-DISEASE; ATHEROSCLEROSIS; PATHWAY; ENDOTHELIUM; INHIBITION; BLOOD; CELLS; TFPI; POLYMORPHISMS	A genomic variant in the human ADTRP [androgen-dependent tissue factor (TF) pathway inhibitor (TFPI) regulating protein] gene increases the risk of coronary artery disease, the leading cause of death worldwide. TFPI is the TF pathway inhibitor that is involved in coagulation. Here, we report that adtrp and tfpi forma regulatory axis that specifies primitive myelopoiesis and definitive hematopoiesis, but not primitive erythropoiesis or vasculogenesis. In zebrafish, there are 2 paralogues for adtrp (i.e., adtrp1 and adtrp2). Knockdown of adtrp1 expression inhibits the specification of hemangioblasts, as shown by decreased expression of the hemangioblast markers, etsrp, fli1a, and scl; blocks primitive hematopoiesis, as shown by decreased expression of pu. 1, mpo, and l-plastin; and disrupts the specification of hematopoietic stem cells (definitive hematopoiesis), as shown by decreased expression of runx1 and c-myb. However, adtrp1 knockdown does not affect erythropoiesis during primitive hematopoiesis (no effect on gata1 or h-bae1) or vasculogenesis (no effect on kdrl, ephb2a, notch3, dab2, or flt4). Knockdown of adtrp2 expression does not have apparent effects on all markers tested. Knockdown of adtrp1 reduced the expression of tfpi, and hematopoietic defects in adtrp1 morphants were rescued by tfpi overexpression. These data suggest that the regulation of tfpi expression is one potential mechanism by which adtrp1 regulates primitive myelopoiesis and definitive hematopoiesis.	[Wang, Li; Wang, Xiaojing; Wang, Longfei; Yousaf, Muhammad; Li, Jia; Zuo, Mengxia; Yang, Zhongcheng; Gou, Dongzhi; Bao, Binghao; Li, Lei; Jia, Haibo; Xu, Chengqi; Wang, Qing Kenneth] Huazhong Univ Sci & Technol, Ctr Human Genome Res, Coll Life Sci & Technol, Key Lab Mol Biophys,Minist Educ,Cardio X Ctr, Wuhan, Hubei, Peoples R China; [Xiang, Ning] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Chen, Qiuyun; Wang, Qing Kenneth] Cleveland Clin, Lerner Coll Med, Ctr Cardiovasc Genet, Lerner Res Inst,Dept Mol Cardiol, Cleveland, OH 44106 USA; [Chen, Qiuyun; Wang, Qing Kenneth] Cleveland Clin, Dept Mol Med, Lerner Coll Med, Cleveland, OH 44106 USA; [Chen, Qiuyun; Wang, Qing Kenneth] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University	Chen, QY (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA.; Wang, QK (corresponding author), Huazhong Univ Sci & Technol, Ctr Human Genome Res, 1037 Luoyu Rd, Wuhan 430074, Hubei, Peoples R China.; Wang, QK (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, 1037 Luoyu Rd, Wuhan 430074, Hubei, Peoples R China.	qkwang@mail.hust.edu.cn	Wang, Li/AAM-2454-2021	Wang, Li/0000-0002-8969-7427; Li, Jia/0000-0001-7132-2574; Li, Lei/0000-0002-2822-4482; Xu, Chengqi/0000-0002-4269-6830; Wang, Qing/0000-0002-5639-8519	China National Natural Science Foundation [31430047, 81630003, 91439129]; Chinese National Basic Research (973 Programs) [2013CB531101, 2012CB517801]; Hubei Province's Outstanding Medical Academic Leader Program, Hubei Province Natural Science Programs [2016CFB224, 2014CFA074]; U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute [R01-HL121358, R01-HL126729]; Bayer Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126729, R01HL121358] Funding Source: NIH RePORTER	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese National Basic Research (973 Programs)(National Basic Research Program of China); Hubei Province's Outstanding Medical Academic Leader Program, Hubei Province Natural Science Programs; U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Bayer Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the China National Natural Science Foundation (Grants 31430047, 81630003, and 91439129), Chinese National Basic Research (973 Programs 2013CB531101 and 2012CB517801), Hubei Province's Outstanding Medical Academic Leader Program, Hubei Province Natural Science Programs (2016CFB224 and 2014CFA074), and the U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (Grants R01-HL121358 and R01-HL126729). Other related research projects on ADTRP in the Q.K.W. Laboratory received funding from Bayer Health.	Aitsebaomo J, 2008, CIRC RES, V103, P929, DOI 10.1161/CIRCRESAHA.108.184937; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Broxmeyer HE, 2012, NAT MED, V18, P1786, DOI 10.1038/nm.2991; Bukrinsky A, 2009, BLOOD, V113, P2038, DOI 10.1182/blood-2008-06-162495; Burns CE, 2009, BLOOD, V113, P5776, DOI 10.1182/blood-2008-12-193607; Butko E, 2015, DEVELOPMENT, V142, P1050, DOI 10.1242/dev.119180; Chen D, 2013, HUM MOL GENET, V22, P963, DOI 10.1093/hmg/dds501; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Chinetti-Gbaguidi G, 2015, FEBS LETT, V589, P461, DOI 10.1016/j.febslet.2015.01.002; Clements WK, 2013, NAT REV IMMUNOL, V13, P336, DOI 10.1038/nri3443; Cornejo MG, 2011, BLOOD, V118, P1264, DOI 10.1182/blood-2011-01-328567; Dechamethakun S, 2014, J ATHEROSCLER THROMB, V21, P680; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Gao L. N., 2015, EVID-BASED COMPL ALT, V2015, P1; Gore A. V., 2012, VASCULAR DEV ZEBRAFI; Groves JA, 2005, DEVELOPMENT, V132, P4211, DOI 10.1242/dev.01958; Guo CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043732; Haghighat A, 2007, CIRCULATION, V115, P2049, DOI 10.1161/CIRCULATIONAHA.106.665570; Hasegawa H, 2006, BIOCHEM BIOPH RES CO, V344, P370, DOI 10.1016/j.bbrc.2006.03.081; Hsu CH, 2015, SCI REP-UK, V5, DOI 10.1038/srep10673; Hu ZH, 2013, INT J MOL SCI, V14, P4805, DOI 10.3390/ijms14034805; Huang EW, 2016, J HUM GENET, V61, P389, DOI 10.1038/jhg.2015.158; Jagannathan-Bogdan M, 2013, DEVELOPMENT, V140, P2463, DOI 10.1242/dev.083147; Juntilla MM, 2010, BLOOD, V115, P4030, DOI 10.1182/blood-2009-09-241000; Khurana S, 2013, BLOOD, V121, P2587, DOI 10.1182/blood-2012-09-456715; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Larson JD, 2004, DEV DYNAM, V231, P204, DOI 10.1002/dvdy.20102; Li L, 2014, BLOOD, V123, P501, DOI 10.1182/blood-2013-07-514612; Liu F, 2008, CURR BIOL, V18, P1234, DOI 10.1016/j.cub.2008.07.048; Lu QL, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002529; Lupu C, 2011, BLOOD, V118, P4463, DOI 10.1182/blood-2011-05-355370; Maroney SA, 2015, J THROMB HAEMOST, V13, pS200, DOI 10.1111/jth.12897; Notta F, 2016, SCIENCE, V351, P139, DOI 10.1126/science.aab2116; Paffett-Lugassy NN, 2004, METH MOLEC MED, V105, P171; Paik EJ, 2010, INT J DEV BIOL, V54, P1127, DOI 10.1387/ijdb.093042ep; Peraramelli S, 2014, J THROMB HAEMOST, V12, P1826, DOI 10.1111/jth.12713; Ren X, 2010, BLOOD, V115, P5338, DOI 10.1182/blood-2009-09-244640; Stachura DL, 2013, BLOOD, V122, P3918, DOI 10.1182/blood-2012-12-475392; Su ZH, 2014, INT J BIOCHEM CELL B, V49, P53, DOI 10.1016/j.biocel.2014.01.005; Takai H, 2008, J VET MED SCI, V70, P943, DOI 10.1292/jvms.70.943; Tayebi N, 2013, CLIN BIOCHEM, V46, P755, DOI 10.1016/j.clinbiochem.2013.01.004; Thomassen MCLGD, 2015, J THROMB HAEMOST, V13, P92, DOI 10.1111/jth.12766; Uribe RA, 2015, MOL BIOL CELL, V26, P3728, DOI 10.1091/mbc.E15-02-0112; Wang F, 2011, NAT GENET, V43, P345, DOI 10.1038/ng.783; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Warga RM, 2009, DEV CELL, V16, P744, DOI 10.1016/j.devcel.2009.04.007; Wood JP, 2014, BLOOD, V123, P2934, DOI 10.1182/blood-2013-11-512764; Ye J, 2016, SCI REP-UK, V6, DOI 10.1038/srep34034; Zhang T, 2016, HUM MOL GENET, V25, P5094, DOI 10.1093/hmg/ddw273; Zhou JY, 2016, SCI REP-UK, V6, DOI 10.1038/srep25088	50	12	12	2	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					183	194		10.1096/fj.201700166RR	http://dx.doi.org/10.1096/fj.201700166RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28877957	Green Published			2022-12-28	WOS:000419172700018
J	Csoka, B; Toro, G; Vindeirinho, J; Varga, ZV; Koscso, B; Nemeth, ZH; Kokai, E; Antonioli, L; Suleiman, M; Marchetti, P; Cseri, K; Deak, A; Virag, L; Pacher, P; Bai, P; Hasko, G				Csoka, Balazs; Toro, Gabor; Vindeirinho, Joana; Varga, Zoltan V.; Koscso, Balazs; Nemeth, Zoltan H.; Kokai, Endre; Antonioli, Luca; Suleiman, Mara; Marchetti, Piero; Cseri, Karolina; Deak, Adam; Virag, Laszlo; Pacher, Pal; Bai, Peter; Hasko, Gyorgy			A(2A) adenosine receptors control pancreatic dysfunction in high-fat-diet-induced obesity	FASEB JOURNAL			English	Article						diabetes; islet; beta-cell; beta-cell dedifferentiation	BETA-CELL DEDIFFERENTIATION; ENDOPLASMIC-RETICULUM STRESS; CHRONIC OXIDATIVE STRESS; INSULIN-SECRETION; ADIPOSE-TISSUE; GLUCOSE TOXICITY; MACROPHAGES; INFLAMMATION; SURVIVAL; MICE	Adenosine, a key extracellular signaling mediator, regulates several aspects of metabolism by activating 4 G-protein-coupled receptors, the A(1), A(2A), A(2B), and A(3) adenosine receptors (ARs). The role of A(2A)ARs in regulating high-fat-diet (HFD)-induced metabolic derangements is unknown. To evaluate the role of A(2A)ARs in regulating glucose and insulin homeostasis in obesity, we fed A(2A)AR-knockout (KO) and control mice an HFD for 16 wk to initiate HFD-induced metabolic disorder. We found that genetic deletion of A(2A)ARs caused impaired glucose tolerance in mice fed an HFD. This impaired glucose tolerance was caused by a decrease in insulin secretion but not in insulin sensitivity. Islet size and insulin content in pancreata of A(2A)AR-deficient micewere decreased compared with control mice after consuming an HFD. A(2A)AR-KO mice had decreased expression of the beta-cell-specific markers pdx1, glut2, mafA, and nkx6.1 and increased expression of the dedifferentiation markers sox2 and hes1. Ex vivo islet experiments confirmed the role of A(2A)ARs in protecting against decreased insulin content and release caused by HFD. Other experiments with bone marrow chimeras revealed that inflammation was not the primary cause of decreased insulin secretion in A(2A)AR-KO mice. Altogether, our data showed that A(2A)ARs control pancreatic dysfunction in HFD-induced obesity.-Csoka, B., Toro, G., Vindeirinho, J., Varga, Z. V., Koscso, B., Nemeth, Z. H., Kokai, E., Antonioli, L., Suleiman, M., Marchetti, P., Cseri, K., Deak, A., Virag, L., Pacher, P., Bai, P., Hasko ', G. A(2A) adenosine receptors control pancreatic dysfunction in high- fat-diet-induced obesity.	[Csoka, Balazs; Toro, Gabor; Vindeirinho, Joana; Nemeth, Zoltan H.; Hasko, Gyorgy] Rutgers New Jersey Med Sch, Dept Surg, Newark, NJ USA; [Csoka, Balazs; Toro, Gabor; Hasko, Gyorgy] Rutgers New Jersey Med Sch, Ctr Immun & Inflammat, Newark, NJ USA; [Varga, Zoltan V.; Pacher, Pal] NIAAA, NIH, Bethesda, MD USA; [Koscso, Balazs] Penn State Univ Coll Med, Dept Microbiol & Immunol, Hershey, PA USA; [Nemeth, Zoltan H.] Morristown Mem Med Ctr, Dept Surg, Morristown, NJ USA; [Kokai, Endre; Cseri, Karolina; Virag, Laszlo; Bai, Peter; Hasko, Gyorgy] Univ Debrecen, Dept Med Chem, Fac Med, Debrecen, Hungary; [Deak, Adam] Univ Debrecen, Dept Operat Tech & Surg Res, Inst Surg, Debrecen, Hungary; [Antonioli, Luca; Suleiman, Mara; Marchetti, Piero] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy; [Virag, Laszlo; Bai, Peter] Hungarian Acad Sci, Cell Biol & Signalling Res Grp, Debrecen, Hungary	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Debrecen; University of Debrecen; University of Pisa; Hungarian Academy of Sciences	Csoka, B; Hasko, G (corresponding author), Rutgers New Jersey Med Sch, Dept Surg, Ctr Immun & Inflammat, 185 South Orange Ave, Newark, NJ 07103 USA.	csokaba@njms.rutgers.edu; haskoge@njms.rutgers.edu	Suleiman, Mara/AAB-9841-2019; Varga, Zoltan V/J-9264-2017; Pacher, Pal/B-6378-2008	Suleiman, Mara/0000-0002-2478-8782; Varga, Zoltan V/0000-0002-2758-0784; Pacher, Pal/0000-0001-7036-8108; Koscso, Balazs/0000-0001-9676-2066; Virag, Laszlo/0000-0002-7099-6718	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences [R01GM66189]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [R01DK113790]; U.S. Army Medical Research and Materiel Command [09065004]; Hungarian Scientific Research Fund (OTKA) [CK 78275, PD83473]; Intramural Research Program of the NIH National Institute on Alcohol Abuse and Alcoholism; Bolyai fellowship; Hungarian National Innovation Office (Baross Program Seahorse) [TeT_09-2010-0023, TAMOP-4.2.2.A-11/1/KONV-2012-0025, TAMOP4.2.1./B-09/KONV-2010-0007, TAMOP-4.2.2/B-10/1-2010-0024]; Medical and Health Science Center [Mec-8/2011]; National Research, Development and Innovation Office [GINOP-2.3.2-15-201600020 TUMORDNS, GINOP-2.3.2-15-2016-00048-STAYALIVE, OTKA K112336]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK113790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066189] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences; NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Intramural Research Program of the NIH National Institute on Alcohol Abuse and Alcoholism; Bolyai fellowship(Hungarian Academy of Sciences); Hungarian National Innovation Office (Baross Program Seahorse); Medical and Health Science Center; National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Katalin Erdelyi (University of Debrecen) for technical assistance. This work was supported by U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences Grant R01GM66189 (to G.H.), NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant R01DK113790, U.S. Army Medical Research and Materiel Command Grant 09065004 (to G.H.), Hungarian Scientific Research Fund (OTKA) Grants CK 78275 (to G.H.) and PD83473 (to P.B.), the Intramural Research Program of the NIH National Institute on Alcohol Abuse and Alcoholism (to P.P.), a Bolyai fellowship (to P.B.), the Hungarian National Innovation Office (Baross Program Seahorse Grants TeT_09-2010-0023), TAMOP-4.2.2.A-11/1/KONV-2012-0025, TAMOP4.2.1./B-09/KONV-2010-0007, TAMOP-4.2.2/B-10/1-2010-0024), and the Medical and Health Science Center (Mecenatura Mec-8/2011). L.V. is supported by National Research, Development and Innovation Office Grants GINOP-2.3.2-15-201600020 TUMORDNS, GINOP-2.3.2-15-2016-00048-STAYALIVE, and OTKA K112336. The authors declare no conflicts of Interest.	Ahren B, 2005, CURR MOL MED, V5, P275, DOI 10.2174/1566524053766004; ANAND BK, 1951, P SOC EXP BIOL MED, V77, P323, DOI 10.3181/00379727-77-18766; Andersson O, 2014, EXP CELL RES, V321, P3, DOI 10.1016/j.yexcr.2013.11.019; Andersson O, 2012, CELL METAB, V15, P885, DOI 10.1016/j.cmet.2012.04.018; Antonioli L, 2015, NAT REV ENDOCRINOL, V11, P228, DOI 10.1038/nrendo.2015.10; Antonioli L, 2013, NAT REV CANCER, V13, P842, DOI 10.1038/nrc3613; Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Bai P, 2011, CELL METAB, V13, P450, DOI 10.1016/j.cmet.2011.03.013; Bensellam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029807; Burkart V, 1999, NAT MED, V5, P314, DOI 10.1038/6535; Butler AE, 2003, DIABETES, V52, P2304, DOI 10.2337/diabetes.52.9.2304; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Centers for Disease Control and Prevention, 2014, NATIONAL DIABETES ST; Chen JF, 2014, INT REV NEUROBIOL, V119, P257, DOI 10.1016/B978-0-12-801022-8.00012-X; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Csoka B, 2007, BLOOD, V110, P2685, DOI 10.1182/blood-2007-01-065870; Csoka B, 2015, FASEB J, V29, P25, DOI 10.1096/fj.14-253567; Csoka B, 2014, DIABETES, V63, P850, DOI 10.2337/db13-0573; Csoka B, 2012, FASEB J, V26, P376, DOI 10.1096/fj.11-190934; Csoka B, 2010, J IMMUNOL, V185, P542, DOI 10.4049/jimmunol.0901295; Eckle T, 2014, J IMMUNOL, V192, P1249, DOI 10.4049/jimmunol.1100593; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Eisenstein A, 2014, J CELL PHYSIOL, V229, P414, DOI 10.1002/jcp.24473; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Eltzschig HK, 2009, EXPERT OPIN THER TAR, V13, P1267, DOI 10.1517/14728220903241666; Fiori JL, 2013, DIABETES, V62, P3500, DOI 10.2337/db13-0266; Fredholm BB, 2000, N-S ARCH PHARMACOL, V362, P364, DOI 10.1007/s002100000313; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Gao T, 2014, CELL METAB, V19, P259, DOI 10.1016/j.cmet.2013.12.002; Gehl Z, 2012, HISTOL HISTOPATHOL, V27, P651, DOI 10.14670/HH-27.651; Girgis CM, 2012, TRENDS ENDOCRIN MET, V23, P372, DOI 10.1016/j.tem.2012.05.003; Gnad T, 2014, NATURE, V516, P395, DOI 10.1038/nature13816; Grden M, 2007, EXP MOL PATHOL, V83, P392, DOI 10.1016/j.yexmp.2007.03.005; Grenz A, 2012, CURR OPIN CRIT CARE, V18, P178, DOI 10.1097/MCC.0b013e3283514bd0; Guo SL, 2013, J CLIN INVEST, V123, P3305, DOI 10.1172/JCI65390; Hart ML, 2011, J IMMUNOL, V186, P4367, DOI 10.4049/jimmunol.0903617; Hasko G, 2000, FASEB J, V14, P2065, DOI 10.1096/fj.99-0508com; Hasko G, 2008, J LEUKOCYTE BIOL, V83, P447, DOI 10.1189/jlb.0607359; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Hull R, 2005, DIABETOLOGIA, V48, P1350, DOI 10.1007/s00125-005-1772-9; Johnston-Cox H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098775; Jourdan T, 2013, NAT MED, V19, P1132, DOI 10.1038/nm.3265; Kaneto H, 2005, INT J BIOCHEM CELL B, V37, P1595, DOI 10.1016/j.biocel.2005.04.003; Koupenova Milka, 2013, J Cell Physiol, DOI 10.1002/jcp.24352; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Linnemann AK, 2014, ADV NUTR, V5, P278, DOI 10.3945/an.113.005488; Masini M, 2009, DIABETOLOGIA, V52, P1083, DOI 10.1007/s00125-009-1347-2; Nemeth ZH, 2006, J IMMUNOL, V176, P5616, DOI 10.4049/jimmunol.176.9.5616; Ohtani M, 2013, GEN COMP ENDOCR, V187, P86, DOI 10.1016/j.ygcen.2013.02.011; Peng Z, 2009, J CLIN INVEST, V119, P582, DOI 10.1172/JCI37409; Pinhal-Enfield G, 2003, AM J PATHOL, V163, P711, DOI 10.1016/S0002-9440(10)63698-X; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Puri S, 2013, GENE DEV, V27, P2563, DOI 10.1101/gad.227785.113; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Robertson RP, 2004, J BIOL CHEM, V279, P42351, DOI 10.1074/jbc.R400019200; Sitkovsky MV, 2014, CANCER IMMUNOL RES, V2, P598, DOI 10.1158/2326-6066.CIR-14-0075; Sitkovsky MV, 2009, TRENDS IMMUNOL, V30, P102, DOI 10.1016/j.it.2008.12.002; Stull ND, 2012, JOVE-J VIS EXP, DOI 10.3791/4137; Szot G. L., 2007, J VIS EXP, V25; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Wang ZY, 2014, CELL METAB, V19, P872, DOI 10.1016/j.cmet.2014.03.010; Weinberg N, 2007, DIABETES, V56, P1299, DOI 10.2337/db06-1654; Zehetner J, 2008, GENE DEV, V22, P3135, DOI 10.1101/gad.496908	65	21	21	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4985	4997		10.1096/fj.201700398R	http://dx.doi.org/10.1096/fj.201700398R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28765173	Green Published			2022-12-28	WOS:000413398500028
J	Gupta, AK; Ghosh, K; Palit, S; Barua, J; Das, PK; Ukil, A				Gupta, Anand Kumar; Ghosh, Kuntal; Palit, Shreyasi; Barua, Jayita; Das, Pijush K.; Ukil, Anindita			Leishmania donovani inhibits inflammasome-dependent macrophage activation by exploiting the negative regulatory proteins A20 and UCP2	FASEB JOURNAL			English	Article						IL-1 beta; caspase-1; NF-kappa B; ROS	EXPERIMENTAL VISCERAL LEISHMANIASIS; HOST IMMUNE-RESPONSE; NLRP3 INFLAMMASOME; UNCOUPLING PROTEIN-2; PATTERN-RECOGNITION; MYCOBACTERIUM-TUBERCULOSIS; MURINE MACROPHAGES; ENZYME A20; GENE; EXPRESSION	In visceral leishmaniasis, we found that the antileishmanial drug Amp B produces a higher level of IL-1 beta over the infected control. Moreover, administering anti-IL-1 beta antibody to infected Amp B-treated mice showed significantly less parasite clearance. Investigation revealed that Leishmania inhibits stimuli-induced expression of a multiprotein signaling platform, NLRP3 inflammasome, which in turn inhibits caspase-1 activation mediated maturation of IL-1 beta from its pro form. Attenuation of NLRP3 and pro-IL-1 beta in infection was found to result from decreased NF-kappa B activity. Transfecting infected cells with constitutively active NF-kappa B plasmid increased NLRP3 and pro-IL-1 beta expression but did not increase mature IL-1 beta, suggesting that IL-1 beta maturation requires a second signal, which was found to be reactive oxygen species (ROS). Decreased NF-kappa B was attributed to increased expression of A20, a negative regulator of NF-kappa B signaling. Silencing A20 in infected cells restored NLRP3 and pro-IL-1 beta expression, but also increased matured IL-1 beta, implying an NF-kappa B-independent A20-modulated IL-1 beta maturation. Macrophage ROS is primarily regulated by mitochondrial uncoupling protein 2 (UCP2), and UCP2-silencedinfected cells showed an increased IL-1 beta level. Shorthairpin RNA-mediated knockdown of A20 and UCP2 in infected mice independently documented decreased liver and spleen parasite burden and increased IL-1 beta production. These results suggest that Leishmania exploits A20 and UCP2 to impair inflammasome activation for disease propagation.-Gupta, A. K., Ghosh, K., Palit, S., Barua, J., Das, P. K., Ukil, A. Leishmania donovani inhibits inflammasome-dependent macrophage activation by exploiting the negative regulatory proteins A20 and UCP2.	[Gupta, Anand Kumar; Palit, Shreyasi; Das, Pijush K.] Indian Inst Chem Biol, CSIR, Infect Dis & Immunol Div, 4 Raja SC Mullick Rd, Kolkata 700032, India; [Ghosh, Kuntal; Barua, Jayita; Ukil, Anindita] Univ Calcutta, Dept Biochem, 35 Ballygunge Circular Rd, Kolkata 700019, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); University of Calcutta	Das, PK (corresponding author), Indian Inst Chem Biol, CSIR, Infect Dis & Immunol Div, 4 Raja SC Mullick Rd, Kolkata 700032, India.; Ukil, A (corresponding author), Univ Calcutta, Dept Biochem, 35 Ballygunge Circular Rd, Kolkata 700019, India.	pijushdas@iicb.res.in; aninditau@yahoo.com		Gupta, Anand/0000-0001-7917-9194; Gupta, Purnima/0000-0003-4389-3024	Government of West Bengal, Department of Biotechnology [221/BT(Estt)/RD-40/2014]; Indo Israel Grant [F.6-10/2016(IC)]; University Grants Commission, University with Potential for Excellence II Grant [UGC/148/UPE/ST1]; Department of Science and Technology [EMR/2014/000287]; Department of Biotechnology Grant [BT/PR10289/BRB/10/1257/2013]; National Academy of Sciences, India (NASI) Senior Scientist Fellowship; University Grants Commission; Council of Scientific and Industrial Research	Government of West Bengal, Department of Biotechnology; Indo Israel Grant; University Grants Commission, University with Potential for Excellence II Grant(University Grants Commission, India); Department of Science and Technology(Department of Science & Technology (India)); Department of Biotechnology Grant; National Academy of Sciences, India (NASI) Senior Scientist Fellowship; University Grants Commission(University Grants Commission, India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Government of West Bengal, Department of Biotechnology Grant 221/BT(Estt)/RD-40/2014, Indo Israel Grant F.6-10/2016(IC), University Grants Commission, University with Potential for Excellence II Grant UGC/148/UPE/ST1, Department of Science and Technology Grant EMR/2014/000287, Department of Biotechnology Grant BT/PR10289/BRB/10/1257/2013, a National Academy of Sciences, India (NASI) Senior Scientist Fellowship, University Grants Commission, and the Council of Scientific and Industrial Research. The authors declare no conflicts of interest.	Abais JM, 2015, ANTIOXID REDOX SIGN, V22, P1111, DOI 10.1089/ars.2014.5994; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Apte RN, 2002, SEMIN CANCER BIOL, V12, P277, DOI 10.1016/S1044-579X(02)00014-7; Arsenescu R, 2005, J IMMUNOL, V174, P3906, DOI 10.4049/jimmunol.174.7.3906; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Ball WB, 2011, J IMMUNOL, V187, P1322, DOI 10.4049/jimmunol.1004237; Bauernfeind F, 2013, EMBO MOL MED, V5, P814, DOI 10.1002/emmm.201201771; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; CHANG KP, 1976, SCIENCE, V193, P678, DOI 10.1126/science.948742; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Darisipudi MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019588; Delbridge LM, 2007, CURR OPIN IMMUNOL, V19, P10, DOI 10.1016/j.coi.2006.11.005; Dowling JK, 2012, CRIT REV BIOCHEM MOL, V47, P424, DOI 10.3109/10409238.2012.694844; Duong BH, 2015, IMMUNITY, V42, P55, DOI 10.1016/j.immuni.2014.12.031; Eder C, 2009, IMMUNOBIOLOGY, V214, P543, DOI 10.1016/j.imbio.2008.11.007; Eklund D, 2014, J INFECT DIS, V209, P749, DOI 10.1093/infdis/jit572; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Gavrilin MA, 2009, J IMMUNOL, V182, P7982, DOI 10.4049/jimmunol.0803073; Ghosh K, 2013, J INFECT DIS, V207, P1016, DOI 10.1093/infdis/jis771; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Gurung P, 2015, J CLIN INVEST, V125, P1329, DOI 10.1172/JCI79526; Gurung P, 2014, J IMMUNOL, V192, P1835, DOI 10.4049/jimmunol.1302839; Heyninck K, 1999, J CELL BIOL, V145, P1471, DOI 10.1083/jcb.145.7.1471; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Hu ZZ, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.363; Jin CC, 2010, J CLIN IMMUNOL, V30, P628, DOI 10.1007/s10875-010-9440-3; Kankkunen P, 2010, J IMMUNOL, V184, P6335, DOI 10.4049/jimmunol.0903019; Kanneganti TD, 2010, NAT REV IMMUNOL, V10, P688, DOI 10.1038/nri2851; Kar S, 2010, J LEUKOCYTE BIOL, V88, P9, DOI 10.1189/jlb.0909644; Kedzierski L, 2010, J GLOB INFECT DIS, V2, P177, DOI 10.4103/0974-777X.62881; Kole L, 1999, J INFECT DIS, V180, P811, DOI 10.1086/314929; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Lima DS, 2013, NAT MED, V19, P909, DOI 10.1038/nm.3221; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; Nishitsuji H, 2004, MICROBES INFECT, V6, P76, DOI 10.1016/j.micinf.2003.10.009; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; Ozoren N, 2006, J IMMUNOL, V176, P4337, DOI 10.4049/jimmunol.176.7.4337; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pei Y, 2006, NAT METHODS, V3, P670, DOI 10.1038/NMETH911; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Rahman MM, 2011, J VIROL, V85, P12505, DOI 10.1128/JVI.00410-11; Santhosh CV, 2008, BIOCHEM BIOPH RES CO, V371, P546, DOI 10.1016/j.bbrc.2008.04.106; Shio MT, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003868; Shio MT, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/819512; Shio MT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000559; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; Srivastav S, 2012, J IMMUNOL, V189, P924, DOI 10.4049/jimmunol.1102845; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; van de Veerdonk Frank L, 2011, Trends Immunol, V32, P110, DOI 10.1016/j.it.2011.01.003; Vande Walle L, 2014, NATURE, V512, P69, DOI 10.1038/nature13322; Vela JM, 2002, MOL CELL NEUROSCI, V20, P489, DOI 10.1006/mcne.2002.1127; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; Yeon SH, 2017, J LEUKOCYTE BIOL, V101, P205, DOI 10.1189/jlb.3VMA1215-579RR; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305	65	36	36	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					5087	5101		10.1096/fj.201700407R	http://dx.doi.org/10.1096/fj.201700407R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28765172				2022-12-28	WOS:000413398500036
J	Voloshanenko, O; Gmach, P; Winter, J; Kranz, D; Boutros, M				Voloshanenko, Oksana; Gmach, Philipp; Winter, Jan; Kranz, Dominique; Boutros, Michael			Mapping of Wnt-Frizzled interactions by multiplex CRISPR targeting of receptor gene families	FASEB JOURNAL			English	Article						multiplex sgRNA; canonical Wnt signaling; FZD receptors; Cas9	CHROMOSOMAL REARRANGEMENTS; PROTEIN; POLARITY; CELLS; MEMBRANE; WINGLESS; PATHWAY; CANCER; GROWTH; RECOGNITION	Signaling pathway modules are often encoded by several closely related paralogous genes that can have redundant roles and are therefore difficult to analyze by loss-of-function analysis. A typical example is the Wnt signaling pathway, which in mammals is mediated by 19 Wnt ligands that can bind to 10 Frizzled (FZD) receptors. Although significant progress in understanding Wnt-FZD receptor interactions has been made in recent years, tools to generate systematic interaction maps have been largely lacking. Here we generated cell lines with multiplex mutant alleles of FZD1, FZD2, and FZD7 and demonstrate that these cells are unresponsive to canonical Wnt ligands. Subsequently, we performed genetic rescue experiments with combinations of FZDs and canonical Wnts to create a functional ligand-receptor interaction map. These experiments showed that whereas several Wnt ligands, such as Wnt3a, induce signaling through a broad spectrum of FZD receptors, others, such as Wnt8a, act through a restricted set of FZD genes. Together, our results map functional interactions of FZDs and 10 Wnt ligands and demonstrate how multiplex targeting by clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 can be used to systematically elucidate the functions of multigene families.	German Canc Res Ctr, Div Signaling & Funct Genom, Heidelberg, Germany; Heidelberg Univ, Dept Cell & Mol Biol, Med Fac Mannheim, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Voloshanenko, O; Boutros, M (corresponding author), German Canc Res Ctr, Neuenheimer Feld 580, D-69120 Heidelberg, Germany.	o.voloshanenko@dkfz.de; m.boutros@dkfz.de	Boutros, Michael/C-3566-2008	Boutros, Michael/0000-0002-9458-817X; Kranz, Dominique/0000-0003-3604-7647; Gmach, Philipp/0000-0002-5258-0321	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	The authors thank members of the M.B. group for helpful discussions and F. Reuter [German Cancer Research Center (DKFZ)] for help with experiments. The authors are particularly grateful to B. Rauscher for help with computational analysis and F. Heigwer (both from the DKFZ) for the help with E-CRISP and the design of sgRNAs. The authors thank M. Waterman (University of California, Irvine, Irvine, CA USA), D. Virshup (Duke-National University of Singapore Medical School, Singapore), and F. Zhang (Broad Institute, Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts, USA.) for plasmids received through Addgene. Work in the laboratory of M.B. was in part supported by the German Research Foundation (DFG). The authors declare no conflicts of interest.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bhat KM, 1998, CELL, V95, P1027, DOI 10.1016/S0092-8674(00)81726-2; Blasco RB, 2014, CELL REP, V9, P1219, DOI 10.1016/j.celrep.2014.10.051; Bylund L, 2004, CYTOGENET GENOME RES, V106, P28, DOI 10.1159/000078556; Carmon KS, 2008, BIOCHEM BIOPH RES CO, V368, P285, DOI 10.1016/j.bbrc.2008.01.088; Carmon KS, 2010, ANAL BIOCHEM, V401, P288, DOI 10.1016/j.ab.2010.03.009; Chang H, 2013, P NATL ACAD SCI USA, V110, pE908, DOI 10.1073/pnas.1301430110; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Choi PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4728; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cong L, 2015, METHODS MOL BIOL, V1239, P197, DOI 10.1007/978-1-4939-1862-1_10; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Demir K, 2013, CELL REP, V4, P1224, DOI 10.1016/j.celrep.2013.08.008; Dijksterhuis JP, 2014, BRIT J PHARMACOL, V171, P1195, DOI 10.1111/bph.12364; Dijksterhuis JP, 2015, J BIOL CHEM, V290, P6789, DOI 10.1074/jbc.M114.612648; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gao XX, 2014, NAT CHEM BIOL, V10, P61, DOI [10.1038/NCHEMBIO.1392, 10.1038/nchembio.1392]; Gao XX, 2011, FEBS LETT, V585, P2501, DOI 10.1016/j.febslet.2011.06.033; Gazit A, 1999, ONCOGENE, V18, P5959, DOI 10.1038/sj.onc.1202985; Ghezraoui H, 2014, MOL CELL, V55, P829, DOI 10.1016/j.molcel.2014.08.002; Gross JC, 2012, NAT CELL BIOL, V14, P1036, DOI 10.1038/ncb2574; Guo N, 2004, P NATL ACAD SCI USA, V101, P9277, DOI 10.1073/pnas.0402802101; He ZY, 2015, BIOTECHNOL BIOENG, V112, P1060, DOI 10.1002/bit.25490; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Herr P, 2012, DEV BIOL, V361, P392, DOI 10.1016/j.ydbio.2011.11.003; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hua ZL, 2014, DEVELOPMENT, V141, P3944, DOI 10.1242/dev.110189; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233; Kemp CR, 2007, DEV DYNAM, V236, P2011, DOI 10.1002/dvdy.21198; Kim M, 2008, J HEPATOL, V48, P780, DOI 10.1016/j.jhep.2007.12.020; Koval A, 2011, BIOCHEM J, V433, P435, DOI 10.1042/BJ20101878; Lin YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5767; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Najdi R, 2012, DIFFERENTIATION, V84, P203, DOI 10.1016/j.diff.2012.06.004; Nickles D, 2012, MOL CELL BIOL, V32, P3372, DOI 10.1128/MCB.06739-11; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Nile AH, 2016, NAT CHEM BIOL, V12, P60, DOI [10.1038/NCHEMBIO.2005, 10.1038/nchembio.2005]; Ouedraogo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050653; Proffitt KD, 2013, CANCER RES, V73, P502, DOI 10.1158/0008-5472.CAN-12-2258; Schulte G, 2010, PHARMACOL REV, V62, P632, DOI 10.1124/pr.110.002931; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Spanjer AIR, 2016, FASEB J, V30, P1823, DOI 10.1096/fj.201500129; Stanganello E, 2016, J CELL SCI, V129, P665, DOI 10.1242/jcs.182469; Steinhart Z, 2017, NAT MED, V23, P60, DOI 10.1038/nm.4219; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Voloshanenko O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3610; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Wang Y, 2012, CELL SIGNAL, V24, P2389, DOI 10.1016/j.cellsig.2012.08.009; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464; Yu HM, 2012, DEVELOPMENT, V139, P4383, DOI 10.1242/dev.083352; Zhan T, 2017, ONCOGENE, V36, P1461, DOI 10.1038/onc.2016.304	60	62	62	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4832	4844		10.1096/fj.201700144R	http://dx.doi.org/10.1096/fj.201700144R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28733458	Green Published			2022-12-28	WOS:000413398500015
J	Armani, A; Berry, A; Cirulli, F; Caprio, M				Armani, Andrea; Berry, Alessandra; Cirulli, Francesca; Caprio, Massimiliano			Molecular mechanisms underlying metabolic syndrome: the expanding role of the adipocyte	FASEB JOURNAL			English	Review						adipose tissue; browning; aging; caloric restriction; obesity	BROWN ADIPOSE-TISSUE; HIGH-FAT-DIET; ACTIVATED PROTEIN-KINASE; WHOLE-BODY GLUCOSE; INSULIN-RESISTANCE; MINERALOCORTICOID RECEPTOR; LIFE-SPAN; CALORIE RESTRICTION; OXIDATIVE STRESS; VISCERAL FAT	The metabolic syndrome (MetS) is defined as a cluster of 3 or more metabolic and cardiovascular risk factors and represents a serious problem for public health. Altered function of adipose tissue has a significant impact on whole-body metabolism and represents a key driver for the development of these metabolic derangements, collectively referred as to MetS. In particular, increased visceral and ectopic fat deposition play a major role in the development of insulin resistance and MetS. A large body of evidence demonstrates that aging and MetS share several metabolic alterations. Of importance, molecular pathways that regulate lifespan affect key processes of adipose tissue physiology, and transgenic mouse models with adipose-specific alterations in these pathways show derangements of adipose tissue and other metabolic features of MetS, which highlights a causal link between dysfunctional adipose tissue and deleterious effects on whole-body homeostasis. This review analyzes adipose tissue-specific dysfunctions, including metabolic alterations that are related to aging, that have a significant impact on the development of MetS.-Armani, A., Berry, A., Cirulli, F., Caprio, M. Molecular mechanisms underlying metabolic syndrome: the expanding role of the adipocyte.	[Armani, Andrea; Caprio, Massimiliano] Ist Ricovero & Cura Carattere Sci San Raffaele Pi, Lab Cardiovasc Endocrinol, Via Val Cannuta 247, I-00166 Rome, Italy; [Berry, Alessandra; Cirulli, Francesca] Ist Super Sanita, Ctr Behav Sci & Mental Hlth, Rome, Italy; [Caprio, Massimiliano] San Raffaele Roma Open Univ, Dept Human Sci & Promot Qual Life, Rome, Italy	Istituto Superiore di Sanita (ISS)	Caprio, M (corresponding author), Ist Ricovero & Cura Carattere Sci San Raffaele Pi, Lab Cardiovasc Endocrinol, Via Val Cannuta 247, I-00166 Rome, Italy.	massimiliano.caprio@sanraffaele.it	Cirulli, Francesca/B-1581-2013; Armani, Andrea/AAC-2071-2022; Caprio, Massimiliano/J-3020-2012; cirulli, francesca/H-5992-2019; Berry, Alessandra/N-9280-2017	Cirulli, Francesca/0000-0001-9440-1873; Armani, Andrea/0000-0002-2130-1596; Caprio, Massimiliano/0000-0003-0722-7163; cirulli, francesca/0000-0001-9440-1873; Berry, Alessandra/0000-0001-6562-9043	Ministero della Salute (Progetti Collaborazione Ricercatori Italiani all'Estero) [PE-2011-02347070]; Ministero della Salute (Project H2020 AwE) [633589]	Ministero della Salute (Progetti Collaborazione Ricercatori Italiani all'Estero); Ministero della Salute (Project H2020 AwE)	This work was supported by the Ministero della Salute (Bando 2011-2012,Progetti Collaborazione Ricercatori Italiani all'Estero; Project Grant PE-2011-02347070 to M.C., and Project H2020 AwE, Grant Agreement 633589 to F.C.). The authors acknowledge networking support by the European Cooperation in Science and Technology (COST) Action Aldosterone and Mineralocorticoid Receptor (ADMIRE) BM1301. The authors thank Uberto Pagotto (Alma Mater University of Bologna, Bologna, Italy) and Elisa Fabbrini (The Janssen Pharmaceutical Companies of Johnson & Johnson) for critical review of the manuscript, and Morag J. Young (Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, VIC, Australia) for English editing. The authors declare no conflicts of interest.	Adamiak Paulina, 2016, Pol Merkur Lekarski, V40, P122; Aguirre GA, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-015-0762-z; Al-Regaiey KA, 2016, EUR REV MED PHARMACO, V20, P2468; An KO, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2016.07.005; Armani A, 2015, J MOL ENDOCRINOL, V55, pR1, DOI 10.1530/JME-15-0122; Armani A, 2014, FASEB J, V28, P3745, DOI 10.1096/fj.13-245415; Armani A, 2011, TRENDS ENDOCRIN MET, V22, P404, DOI 10.1016/j.tem.2011.05.004; Baerga R, 2009, AUTOPHAGY, V5, P1118, DOI 10.4161/auto.5.8.9991; Bain J, 2010, MATURITAS, V66, P16, DOI 10.1016/j.maturitas.2010.01.009; Ballestri S, 2015, EXPERT REV GASTROENT, V9, P603, DOI 10.1586/17474124.2015.1007955; Barbato DL, 2016, AGEING RES REV, V28, P85, DOI 10.1016/j.arr.2016.05.007; Barbato DL, 2015, AGING-US, V7, P869, DOI 10.18632/aging.100832; Barzilai N, 2012, DIABETES, V61, P1315, DOI 10.2337/db11-1300; Berbee JFP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7356; Bergeron R, 2001, DIABETES, V50, P1076, DOI 10.2337/diabetes.50.5.1076; Berniakovich I, 2008, J BIOL CHEM, V283, P34283, DOI 10.1074/jbc.M804362200; Berry A, 2013, NEUROSCI BIOBEHAV R, V37, P790, DOI 10.1016/j.neubiorev.2013.03.005; Bhasin S, 2006, NAT CLIN PRACT ENDOC, V2, P146, DOI 10.1038/ncpendmet0120; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Bonomini F, 2015, AGING DIS, V6, P109, DOI 10.14336/AD.2014.0305; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Britton KA, 2011, CIRCULATION, V124, pE837, DOI 10.1161/CIRCULATIONAHA.111.077602; Butera PC, 2010, PHYSIOL BEHAV, V99, P175, DOI 10.1016/j.physbeh.2009.06.010; Byrne CD, 2013, P NUTR SOC, V72, P412, DOI 10.1017/S0029665113001249; Canto C, 2012, PHARMACOL REV, V64, P166, DOI 10.1124/pr.110.003905; Caprio M, 1999, ENDOCRINOLOGY, V140, P4939, DOI 10.1210/en.140.11.4939; Caprio M, 2011, ENDOCRINOLOGY, V152, P113, DOI 10.1210/en.2010-0674; Cava E, 2013, AGING-US, V5, P507, DOI 10.18632/aging.100581; Chakrabarti P, 2011, J LIPID RES, V52, P1693, DOI 10.1194/jlr.M014647; Chalkiadaki A, 2012, CELL METAB, V16, P180, DOI 10.1016/j.cmet.2012.07.003; Chang GR, 2009, BASIC CLIN PHARMACOL, V105, P188, DOI 10.1111/j.1742-7843.2009.00427.x; Chang GR, 2009, J PHARMACOL SCI, V109, P496, DOI 10.1254/jphs.08215FP; Chau MDL, 2010, P NATL ACAD SCI USA, V107, P12553, DOI 10.1073/pnas.1006962107; Chondronikola M, 2014, DIABETES, V63, P4089, DOI 10.2337/db14-0746; Ciciliot S, 2015, DIABETOLOGIA, V58, P2352, DOI 10.1007/s00125-015-3667-8; Cinti S, 2012, DIS MODEL MECH, V5, P588, DOI 10.1242/dmm.009662; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Costantino S, 2016, J PHYSIOL-LONDON, V594, P2061, DOI 10.1113/JP270538; Cree MG, 2004, J CLIN ENDOCR METAB, V89, P3864, DOI 10.1210/jc.2003-031986; Curtis JM, 2010, DIABETES, V59, P1132, DOI 10.2337/db09-1105; Cybulski N, 2009, P NATL ACAD SCI USA, V106, P9902, DOI 10.1073/pnas.0811321106; Cypess AM, 2015, CELL METAB, V21, P33, DOI 10.1016/j.cmet.2014.12.009; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Daval M, 2005, J BIOL CHEM, V280, P25250, DOI 10.1074/jbc.M414222200; del Rincon JP, 2007, DIABETES, V56, P1638, DOI 10.2337/db06-0299; Demozay D, 2008, DIABETES, V57, P1216, DOI 10.2337/db07-0389; Ding JZ, 2009, AM J CLIN NUTR, V90, P499, DOI 10.3945/ajcn.2008.27358; Dong M, 2013, CELL METAB, V18, P118, DOI 10.1016/j.cmet.2013.06.003; Fabbrini E, 2015, J CLIN INVEST, V125, P787, DOI 10.1172/JCI78425; Fabbrini E, 2009, P NATL ACAD SCI USA, V106, P15430, DOI 10.1073/pnas.0904944106; Fadini GP, 2011, AGING CELL, V10, P10, DOI 10.1111/j.1474-9726.2010.00642.x; Fallo F, 2006, J CLIN ENDOCR METAB, V91, P454, DOI 10.1210/jc.2005-1733; Fan HQ, 2007, ACTA PHARMACOL SIN, V28, P410, DOI 10.1111/j.1745-7254.2007.00523.x; Fedarko NS, 2011, CLIN GERIATR MED, V27, P27, DOI 10.1016/j.cger.2010.08.006; Feraco A, 2013, J STEROID BIOCHEM, V137, P99, DOI 10.1016/j.jsbmb.2013.02.012; Ferguson JE, 2013, ARAB J UROL, V11, P222, DOI 10.1016/j.aju.2013.07.009; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]; Gagnon A, 2001, J CELL PHYSIOL, V189, P14, DOI 10.1002/jcp.1132; Ghosh AK, 2016, AGING-US, V8, P2525, DOI 10.18632/aging.101083; Giordano A, 2016, NAT REV DRUG DISCOV, V15, P405, DOI 10.1038/nrd.2016.31; Giorgio M, 2012, AGING CELL, V11, P162, DOI 10.1111/j.1474-9726.2011.00770.x; Gong H, 2014, MOL MED REP, V10, P3296, DOI 10.3892/mmr.2014.2648; Graja A, 2015, GERONTOLOGY, V61, P211, DOI 10.1159/000366557; Greenstein AS, 2009, CIRCULATION, V119, P1661, DOI 10.1161/CIRCULATIONAHA.108.821181; Grundy SM, 2015, EUR J CLIN INVEST, V45, P1209, DOI 10.1111/eci.12519; Guo C, 2008, CIRCULATION, V117, P2253, DOI 10.1161/CIRCULATIONAHA.107.748640; Habinowski SA, 2001, BIOCHEM BIOPH RES CO, V286, P852, DOI 10.1006/bbrc.2001.5484; Haffner SM, 2000, INT J OBESITY, V24, pS56, DOI 10.1038/sj.ijo.0801279; Haigis MC, 2010, MOL CELL, V40, P333, DOI 10.1016/j.molcel.2010.10.002; Haim Y, 2015, AUTOPHAGY, V11, P2074, DOI 10.1080/15548627.2015.1094597; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hirata A, 2009, CARDIOVASC RES, V84, P164, DOI 10.1093/cvr/cvp191; Hondares E, 2010, CELL METAB, V11, P206, DOI 10.1016/j.cmet.2010.02.001; Hotta Y, 2009, ENDOCRINOLOGY, V150, P4625, DOI 10.1210/en.2009-0119; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Iacobellis G, 2005, NAT CLIN PRACT CARD, V2, P134, DOI 10.1038/ncpcardio0132; Irving BA, 2014, CURR OBES REP, V3, P235, DOI 10.1007/s13679-014-0091-1; Ishii S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112718; Isidori AM, 1999, J CLIN ENDOCR METAB, V84, P3673, DOI 10.1210/jc.84.10.3673; Jura M, 2016, AGE, V38, DOI 10.1007/s11357-016-9884-3; Kalinkovich A, 2017, AGEING RES REV, V35, P200, DOI 10.1016/j.arr.2016.09.008; Katz LEL, 2002, J CLIN ENDOCR METAB, V87, P2978, DOI 10.1210/jc.87.6.2978; Kawano Jordan, 2009, J Cardiometab Syndr, V4, P44, DOI 10.1111/j.1559-4572.2008.00030.x; Kelekar A, 2005, ANN NY ACAD SCI, V1066, P259, DOI 10.1196/annals.1363.015; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Khan UI, 2014, OBESITY, V22, P786, DOI 10.1002/oby.20139; Kim JH, 2014, ENDOCR J, V61, P1055, DOI 10.1507/endocrj.EJ14-0262; Kovsan J, 2011, J CLIN ENDOCR METAB, V96, pE268, DOI 10.1210/jc.2010-1681; Kumar A, 2010, DIABETES, V59, P1397, DOI 10.2337/db09-1061; Kusminski CM, 2012, TRENDS ENDOCRIN MET, V23, P435, DOI 10.1016/j.tem.2012.06.004; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee P, 2014, DIABETES, V63, P3686, DOI 10.2337/db14-0513; Lizcano F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/757461; Luyten W, 2016, BIOGERONTOLOGY, V17, P771, DOI 10.1007/s10522-016-9644-x; Lymperopoulos A, 2013, CIRC RES, V113, P739, DOI 10.1161/CIRCRESAHA.113.300308; Ma XR, 2014, P NATL ACAD SCI USA, V111, P14289, DOI 10.1073/pnas.1407640111; Maixner N, 2012, OBESITY FACTS, V5, P710, DOI 10.1159/000343983; Mammi C, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/789653; Maneschi E, 2016, MOL CELL ENDOCRINOL, V424, P50, DOI 10.1016/j.mce.2016.01.015; Martinez-Lopez N, 2013, EMBO REP, V14, P795, DOI 10.1038/embor.2013.111; Marzolla V, 2014, STEROIDS, V91, P46, DOI 10.1016/j.steroids.2014.05.001; Mathis AS, 2004, AM J HEALTH-SYST PH, V61, P565, DOI 10.1093/ajhp/61.6.565; Matsushita M, 2014, INT J OBESITY, V38, P812, DOI 10.1038/ijo.2013.206; Mattison JA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14063; Mauvais-Jarvis F, 2013, ENDOCR REV, V34, P309, DOI 10.1210/er.2012-1055; McDonald RB, 1999, J BIOENERG BIOMEMBR, V31, P507, DOI 10.1023/A:1005404708710; McGavock JM, 2007, CIRCULATION, V116, P1170, DOI 10.1161/CIRCULATIONAHA.106.645614; Mennes E, 2014, J GERONTOL A-BIOL, V69, P1060, DOI 10.1093/gerona/glt156; Michalakis K, 2013, METABOLISM, V62, P1341, DOI 10.1016/j.metabol.2013.05.019; Migliaccio E, 2006, ANTIOXID REDOX SIGN, V8, P600, DOI 10.1089/ars.2006.8.600; Miljkovic I, 2016, OBESITY, V24, P476, DOI 10.1002/oby.21328; Miljkovic N, 2015, ANN REHABIL MED-ARM, V39, P155, DOI 10.5535/arm.2015.39.2.155; Mitschke MM, 2013, FASEB J, V27, P1621, DOI 10.1096/fj.12-221580; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mueller E, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00019; Murata Y, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/981315; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Natalicchio A, 2015, DIABETOLOGIA, V58, P1260, DOI 10.1007/s00125-015-3563-2; Nedergaard J, 2010, CELL METAB, V11, P268, DOI 10.1016/j.cmet.2010.03.007; Newgard CB, 2014, J GERONTOL A-BIOL, V69, pS21, DOI 10.1093/gerona/glu058; Nisoli E, 2000, P NATL ACAD SCI USA, V97, P8033, DOI 10.1073/pnas.97.14.8033; O'Neill S, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12229; Ogorodnikova AD, 2013, OBESITY, V21, P1726, DOI 10.1002/oby.20200; Andrade JMO, 2014, NUTRITION, V30, P915, DOI 10.1016/j.nut.2013.11.016; Palmer AK, 2016, EXP GERONTOL, V86, P97, DOI 10.1016/j.exger.2016.02.013; Palmer BF, 2015, MOL CELL ENDOCRINOL, V402, P113, DOI 10.1016/j.mce.2014.11.029; Palmieri VO, 2006, J NUTR, V136, P3022, DOI 10.1093/jn/136.12.3022; Paneni F, 2014, ATHEROSCLEROSIS, V236, P426, DOI 10.1016/j.atherosclerosis.2014.07.027; Paneni F, 2012, CIRC RES, V111, P278, DOI 10.1161/CIRCRESAHA.112.266593; Parisi V, 2016, CIRC RES, V118, P1244, DOI 10.1161/CIRCRESAHA.115.307765; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Polager S, 2008, ONCOGENE, V27, P4860, DOI 10.1038/onc.2008.117; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Poulsen MM, 2013, DIABETES, V62, P1186, DOI 10.2337/db12-0975; Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027; Qiao LP, 2006, J BIOL CHEM, V281, P39915, DOI 10.1074/jbc.M607215200; Ramsey JJ, 2014, J GERONTOL A-BIOL, V69, P1177, DOI 10.1093/gerona/glt198; Ranieri SC, 2013, VITAM HORM, V91, P219, DOI 10.1016/B978-0-12-407766-9.00009-2; Ranieri SC, 2010, P NATL ACAD SCI USA, V107, P13420, DOI 10.1073/pnas.1008647107; Rao PM, 2013, NAT REV ENDOCRINOL, V9, P479, DOI 10.1038/nrendo.2013.122; Reilly SM, 2013, NAT MED, V19, P313, DOI 10.1038/nm.3082; Reuben A, 2001, LIVER TRANSPLANT, V7, pS13, DOI 10.1053/jlts.2001.29167; Riera CE, 2016, ANNU REV BIOCHEM, V85, P35, DOI 10.1146/annurev-biochem-060815-014451; Rogers NH, 2012, AGING CELL, V11, P1074, DOI 10.1111/acel.12010; Rolland Y, 2008, J NUTR HEALTH AGING, V12, P433, DOI 10.1007/BF02982704; Ryter SW, 2014, CURR OPIN CLIN NUTR, V17, P329, DOI 10.1097/MCO.0000000000000068; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Salminen A, 2012, AGEING RES REV, V11, P230, DOI 10.1016/j.arr.2011.12.005; Sanada K, 2012, EUR J CLIN NUTR, V66, P1093, DOI 10.1038/ejcn.2012.43; Sattler FR, 2013, BEST PRACT RES CL EN, V27, P541, DOI 10.1016/j.beem.2013.05.003; Schrauwen P, 2007, P NUTR SOC, V66, P33, DOI 10.1017/S0029665107005277; Seals DR, 2004, DIABETES, V53, P276, DOI 10.2337/diabetes.53.2.276; Sidossis L, 2015, J CLIN INVEST, V125, P478, DOI 10.1172/JCI78362; Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228; Slutsky N, 2016, INT J OBESITY, V40, P912, DOI 10.1038/ijo.2016.5; Smith TJ, 2010, PHARMACOL REV, V62, P199, DOI 10.1124/pr.109.002469; Snel M, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/983814; Song XM, 2002, DIABETOLOGIA, V45, P56, DOI 10.1007/s125-002-8245-8; Soussi H, 2015, DIABETES, V64, P3452, DOI 10.2337/db14-1933; Stefanska A, 2015, ADV CLIN CHEM, V72, P1, DOI 10.1016/bs.acc.2015.07.001; Stenholm S, 2008, CURR OPIN CLIN NUTR, V11, P693, DOI 10.1097/MCO.0b013e328312c37d; Suba Z, 2012, PATHOL ONCOL RES, V18, P123, DOI 10.1007/s12253-011-9466-8; Tamori Y, 2002, DIABETES, V51, P2045, DOI 10.2337/diabetes.51.7.2045; Tazearslan C, 2011, AGING CELL, V10, P551, DOI 10.1111/j.1474-9726.2011.00697.x; Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; Tormos KV, 2011, CELL METAB, V14, P537, DOI 10.1016/j.cmet.2011.08.007; Traish AM, 2015, REV ENDOCR METAB DIS, V16, P249, DOI 10.1007/s11154-015-9323-2; Trayhurn Paul, 2011, Archives of Physiology and Biochemistry, V117, P47, DOI 10.3109/13813455.2010.535835; Urfer SR, 2017, GEROSCIENCE, V39, P117, DOI 10.1007/s11357-017-9972-z; Valle A, 2010, AGING CELL, V9, P882, DOI 10.1111/j.1474-9726.2010.00613.x; van Heemst D, 2010, AGING DIS, V1, P147; Veniant MM, 2015, CELL METAB, V21, P731, DOI 10.1016/j.cmet.2015.04.019; Villarroya F, 2013, CELL METAB, V17, P638, DOI 10.1016/j.cmet.2013.02.020; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Wang S, 2015, INT J OBESITY, V39, P967, DOI 10.1038/ijo.2015.23; Wannamethee SG, 2015, P NUTR SOC, V74, P405, DOI 10.1017/S002966511500169X; Xie QH, 2015, J CELL MOL MED, V19, P986, DOI 10.1111/jcmm.12487; Xu SH, 2014, AGING DIS, V5, P263, DOI 10.14336/AD.2014.0500263; Yakar S, 2001, DIABETES, V50, P1110, DOI 10.2337/diabetes.50.5.1110; Yanovski SZ, 2002, NEW ENGL J MED, V346, P591, DOI 10.1056/NEJMra012586; Yao YX, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003295; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; Zhang CB, 2013, AM J PHYSIOL-ENDOC M, V305, pE530, DOI 10.1152/ajpendo.00640.2012; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19860, DOI 10.1073/pnas.0906048106; Zhou S, 2011, CIRC RES, V109, P639, DOI 10.1161/CIRCRESAHA.111.243592; Zhu M, 2007, EXP GERONTOL, V42, P733, DOI 10.1016/j.exger.2007.05.011; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	196	47	47	0	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4240	4255		10.1096/fj.201601125RRR	http://dx.doi.org/10.1096/fj.201601125RRR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28705812				2022-12-28	WOS:000413397400005
J	Jian, W; Yan, BW; Huang, SM; Qiu, Y				Jian, Wei; Yan, Bowen; Huang, Suming; Qiu, Yi			Histone deacetylase 1 activates PU.1 gene transcription through regulating TAF9 deacetylation and transcription factor IID assembly	FASEB JOURNAL			English	Article						TFIID; downstream promoter element; HDAC1; HDACi; acetylation	ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; MURINE ERYTHROLEUKEMIA-CELLS; PROMOTER ELEMENT; TERMINAL DIFFERENTIATION; ERYTHROID-CELLS; GAMMA-GLOBIN; TATA-BOX; GATA-1; ERYTHROPOIESIS	Histone acetyltransferases and histone deacetylases (HDACs) are important epigenetic coregulators. It has been thought that HDACs associate with corepressor complexes and repress gene transcription; however, in this study, we have found that PU.1-a key master regulator for hematopoietic self-renewal and lineage specification-requires HDAC activity for gene activation. Deregulated PU.1 gene expression is linked to dysregulated hematopoiesis and the development of leukemia. In this study, we used erythroid differentiation as a model to analyze how the PU.1 gene is regulated. We found that active HDAC1 is directly recruited to active PU.1 promoter in progenitor cells, whereas acetylated HDAC1, which is inactive, is on the silenced PU.1 promoter in differentiated erythroid cells. We then studied the mechanism of HDAC1-mediated activation. We discovered that HDAC1 activates PU.1 gene transcription via deacetylation of TATA-binding protein-associated factor 9 (TAF9), a component in the transcription factor IID (TFIID) complex. Treatment with HDAC inhibitor results in an increase in TAF9 acetylation. Acetylated TAF9 does not bind to the PU.1 gene promoter and subsequently leads to the disassociation of the TFIID complex and transcription repression. Thus, these results demonstrate a key role for HDAC1 in PU.1 gene transcription and, more importantly, uncover a novel mechanism of TFIID recruitment and gene activation.	[Jian, Wei; Yan, Bowen; Qiu, Yi] Univ Florida, Coll Med, Dept Anat & Cell Biol, 2033 Mowry Rd, Gainesville, FL 32610 USA; [Huang, Suming] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Huang, Suming] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Macau Inst Appl Res Med & Hlth, Taipa, Macau, Peoples R China	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Macau University of Science & Technology	Qiu, Y (corresponding author), Univ Florida, Coll Med, Dept Anat & Cell Biol, 2033 Mowry Rd, Gainesville, FL 32610 USA.	qiuy@ufl.edu		, Yi/0000-0002-3282-6072	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [R01-HL095674]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK110108]; American Heart Association [AHA16GRNT31020032]; Florida Bankhead Coley Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095674] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK110108] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association(American Heart Association); Florida Bankhead Coley Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant R01-HL095674 (to Y.Q.), NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant R01-DK110108 (to S.H.), American Heart Association Grant AHA16GRNT31020032 (to S.H.), and the Florida Bankhead Coley Research Foundation (to Y.Q.). The authors thank Dr. Jim Bieker (Icahn School of Medicine at Mount Sinai, New York, NY, USA) for TAF9 plasmids and Dr. Robert Roeder (The Rockefeller University, New York, NY, USA) for discussion and constructive suggestions. The authors declare no conflicts of interest.	Amaravadi L, 1999, DNA CELL BIOL, V18, P875, DOI 10.1089/104454999314737; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; Atar O, 2005, BIOCHEM BIOPH RES CO, V329, P1288, DOI 10.1016/j.bbrc.2005.02.109; Back J, 2005, EXP HEMATOL, V33, P395, DOI 10.1016/j.exphem.2004.12.010; Back J, 2004, BLOOD, V103, P3615, DOI 10.1182/blood-2003-11-4089; Bieniossek C, 2013, NATURE, V493, P699, DOI 10.1038/nature11791; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Burke TW, 1996, GENE DEV, V10, P711, DOI 10.1101/gad.10.6.711; Chen HM, 1996, J BIOL CHEM, V271, P15743, DOI 10.1074/jbc.271.26.15743; Chen XY, 2004, MOL CELL BIOL, V24, P10416, DOI 10.1128/MCB.24.23.10416-10424.2004; Chen Z, 2003, MOL CELL BIOL, V23, P7350, DOI 10.1128/MCB.23.20.7350-7362.2003; Chen Z, 2003, J BIOL CHEM, V278, P35172, DOI 10.1074/jbc.M304241200; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cler E, 2009, CELL MOL LIFE SCI, V66, P2123, DOI 10.1007/s00018-009-0009-3; Dobbin MM, 2013, NAT NEUROSCI, V16, P1008, DOI 10.1038/nn.3460; Drummond DC, 2005, ANNU REV PHARMACOL, V45, P495, DOI 10.1146/annurev.pharmtox.45.120403.095825; Fathallah H, 2007, BLOOD, V110, P3391, DOI 10.1182/blood-2007-02-076091; Ferrara FF, 2001, CANCER RES, V61, P2; Frontini M, 2005, MOL CELL BIOL, V25, P4638, DOI 10.1128/MCB.25.11.4638-4649.2005; Hattangadi SM, 2011, BLOOD, V118, P6258, DOI 10.1182/blood-2011-07-356006; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Huang S, 2000, MOL CELL BIOL, V20, P2248, DOI 10.1128/MCB.20.6.2248-2259.2000; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Kastner P, 2008, INT J BIOCHEM CELL B, V40, P22, DOI 10.1016/j.biocel.2007.01.026; Kerenyi MA, 2010, J EXP MED, V207, P2537, DOI 10.1084/jem.20102260; KISTLER B, 1995, ONCOGENE, V11, P1095; Koschmieder S, 2005, INT J HEMATOL, V81, P368, DOI 10.1532/IJH97.05051; Kueh HY, 2013, SCIENCE, V341, P670, DOI 10.1126/science.1240831; Kutach AK, 2000, MOL CELL BIOL, V20, P4754, DOI 10.1128/MCB.20.13.4754-4764.2000; Laribee RN, 2001, J IMMUNOL, V167, P5160, DOI 10.4049/jimmunol.167.9.5160; LOZZIO CB, 1979, NATURE, V281, P709, DOI 10.1038/281709b0; Luo Y, 2009, J BIOL CHEM, V284, P34901, DOI 10.1074/jbc.M109.038356; Mak Ka Sin, 2011, Int J Cell Biol, V2011, P808524, DOI 10.1155/2011/808524; McCaffrey PG, 1997, BLOOD, V90, P2075, DOI 10.1182/blood.V90.5.2075; Minucci S, 2001, ONCOGENE, V20, P3110, DOI 10.1038/sj.onc.1204336; MoreauGachelin F, 1996, MOL CELL BIOL, V16, P2453; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; Oikawa T, 1999, CELL DEATH DIFFER, V6, P599, DOI 10.1038/sj.cdd.4400534; Pace BS, 2000, EXP HEMATOL, V28, P283, DOI 10.1016/S0301-472X(99)00153-8; Palis J, 1998, BLOOD REV, V12, P106, DOI 10.1016/S0268-960X(98)90022-4; Qiu Y, 2006, MOL CELL, V22, P669, DOI 10.1016/j.molcel.2006.04.019; Qiu Y, 2011, J BIOL CHEM, V286, P7641, DOI 10.1074/jbc.M110.185488; Rao G, 1997, ONCOGENE, V14, P123, DOI 10.1038/sj.onc.1200807; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Richardson CL, 2013, J CLIN INVEST, V123, P3614, DOI 10.1172/JCI68487; Rodriguez P, 2005, EMBO J, V24, P2354, DOI 10.1038/sj.emboj.7600702; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; Shao HS, 2005, MOL CELL BIOL, V25, P206, DOI 10.1128/MCB.25.1.206-219.2005; Shen WC, 2003, EMBO J, V22, P3395, DOI 10.1093/emboj/cdg336; Staber PB, 2013, MOL CELL, V49, P934, DOI 10.1016/j.molcel.2013.01.007; Steidl U, 2007, J CLIN INVEST, V117, P2611, DOI 10.1172/JCI30525; Verbiest T, 2015, CARCINOGENESIS, V36, P413, DOI 10.1093/carcin/bgv016; Wagner JM, 2010, CLIN EPIGENETICS, V1, DOI 10.1007/s13148-010-0012-4; Walker AK, 2001, EMBO J, V20, P5269, DOI 10.1093/emboj/20.18.5269; Walker D, 1999, METHODS, V19, P386, DOI 10.1006/meth.1999.0874; Wang Q, 2007, LEUKEMIA, V21, P1015, DOI 10.1038/sj.leu.2404644; Will B, 2015, NAT MED, V21, P1172, DOI 10.1038/nm.3936; Wolff L, 2013, STEM CELLS, V31, P1237, DOI 10.1002/stem.1379; Wong P, 2011, BLOOD, V118, pE128, DOI 10.1182/blood-2011-03-341404; WORKMAN JL, 1991, METHOD CELL BIOL, V35, P419; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Yamada T, 1997, BLOOD, V89, P1383, DOI 10.1182/blood.V89.4.1383; Yamada T, 2001, BLOOD, V97, P2300, DOI 10.1182/blood.V97.8.2300; Yang T, 2012, J BIOL CHEM, V287, P40279, DOI 10.1074/jbc.M112.349704; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yu YT, 2013, J BIOL CHEM, V288, P8805, DOI 10.1074/jbc.M112.423756; Zhang P, 2000, BLOOD, V96, P2641; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705	70	16	17	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					4104	4116		10.1096/fj.201700022R	http://dx.doi.org/10.1096/fj.201700022R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28572446	Green Published			2022-12-28	WOS:000408713300033
J	Kazazian, HH				Kazazian, Haig H. Jr			Fifty years in human genetics-a career retrospective	FASEB JOURNAL			English	Article							BETA-THALASSEMIA MUTATIONS; L1 RETROTRANSPOSITION; GAMMA-GLOBIN; CLONED BETA; SEQUENCE; POLYMORPHISMS; GENES; CELLS; HYBRIDIZATION; TRANSDUCTION		[Kazazian, Haig H. Jr] Johns Hopkins Sch Med, Inst Med Genet, 733 N Broadway, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Kazazian, HH (corresponding author), Johns Hopkins Sch Med, Inst Med Genet, 733 N Broadway, Baltimore, MD 21205 USA.	hkazazi1@jhmi.edu			U.S. National Institutes of Health, National Institute of General Medical Sciences [P50GM107632, 1R01GM099875]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107632, R01GM099875] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The author thanks his wonderful students and postdocs, named and unnamed, for outstanding contributions; his wife, Lilli, for her continued support and love; and Barbara Migeon and John Goodier, for helpful comments on the manuscript. The author expresses his appreciation to the many investigators and collaborators who helped our research over the years by providing important information or materials but were not mentioned as a result of space considerations. This study was supported by Grants P50GM107632 and 1R01GM099875 from the U.S. National Institutes of Health, National Institute of General Medical Sciences.	ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P137, DOI 10.1073/pnas.79.1.137; ANTONARAKIS SE, 1984, P NATL ACAD SCI-BIOL, V81, P1154, DOI 10.1073/pnas.81.4.1154; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; CHENG TC, 1984, P NATL ACAD SCI-BIOL, V81, P2821, DOI 10.1073/pnas.81.9.2821; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; CURCIO MJ, 1991, P NATL ACAD SCI USA, V88, P936, DOI 10.1073/pnas.88.3.936; DAVIDSON RG, 1963, P NATL ACAD SCI USA, V50, P481, DOI 10.1073/pnas.50.3.481; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; Doucet-O'Hare TT, 2015, P NATL ACAD SCI USA, V112, pE4894, DOI 10.1073/pnas.1502474112; Erwin JA, 2016, NAT NEUROSCI, V19, P1583, DOI 10.1038/nn.4388; Evrony GD, 2012, CELL, V151, P483, DOI 10.1016/j.cell.2012.09.035; Ewing AD, 2015, GENOME RES, V25, P1536, DOI 10.1101/gr.196238.115; Ewing AD, 2010, GENOME RES, V20, P1262, DOI 10.1101/gr.106419.110; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; FREEMAN JD, 1994, BIOTECHNIQUES, V17, P46; GABRIEL A, 1991, P NATL ACAD SCI USA, V88, P9794, DOI 10.1073/pnas.88.21.9794; GITSCHIER J, 1984, NATURE, V312, P326, DOI 10.1038/312326a0; Goodier JL, 2000, HUM MOL GENET, V9, P653, DOI 10.1093/hmg/9.4.653; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; HARRIS H, 1966, PROC R SOC SER B-BIO, V164, P298, DOI 10.1098/rspb.1966.0032; HEIDMANN T, 1988, P NATL ACAD SCI USA, V85, P2219, DOI 10.1073/pnas.85.7.2219; HOLLENBE.MD, 1971, SCIENCE, V174, P698, DOI 10.1126/science.174.4010.698; HOLMES SE, 1994, NAT GENET, V7, P143, DOI 10.1038/ng0694-143; Huang CRL, 2010, CELL, V141, P1171, DOI 10.1016/j.cell.2010.05.026; HUBBY JL, 1966, GENETICS, V54, P577; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; JEFFREYS AJ, 1979, CELL, V18, P1, DOI 10.1016/0092-8674(79)90348-9; KABACK MM, 1974, PROG MED GENET, V10, P103; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; KAZAZIAN HH, 1968, J BIOL CHEM, V243, P6446; KAZAZIAN HH, 1984, NATURE, V310, P152, DOI 10.1038/310152a0; KAZAZIAN HH, 1965, SCIENCE, V150, P1601, DOI 10.1126/science.150.3703.1601; KAZAZIAN HH, 1984, EMBO J, V3, P593, DOI 10.1002/j.1460-2075.1984.tb01853.x; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; KAZAZIAN HH, 1968, J BIOL CHEM, V243, P2048; KELLY TJ, 1970, J MOL BIOL, V51, P393, DOI 10.1016/0022-2836(70)90150-6; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; MATHIAS SL, 1991, SCIENCE, V254, P1808, DOI 10.1126/science.1722352; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; ORKIN SH, 1982, NATURE, V296, P627, DOI 10.1038/296627a0; Ostertag EM, 2003, AM J HUM GENET, V73, P1444, DOI 10.1086/380207; Ostertag EM, 2002, NAT GENET, V32, P655, DOI 10.1038/ng1022; PERGOLIZZI R, 1981, NUCLEIC ACIDS RES, V9, P7065, DOI 10.1093/nar/9.24.7065; PHILLIPS JA, 1980, P NATL ACAD SCI-BIOL, V77, P2853, DOI 10.1073/pnas.77.5.2853; Pickeral OK, 2000, GENOME RES, V10, P411, DOI 10.1101/gr.10.4.411; RABINOVITZ M, 1969, COLD SPRING HARB SYM, V34, P567, DOI 10.1101/SQB.1969.034.01.064; RUND D, 1991, P NATL ACAD SCI USA, V88, P310, DOI 10.1073/pnas.88.1.310; SCOTT A F, 1987, Genomics, V1, P113, DOI 10.1016/0888-7543(87)90003-6; SINGER MF, 1982, CELL, V28, P433, DOI 10.1016/0092-8674(82)90194-5; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPRITZ RA, 1981, P NATL ACAD SCI-BIOL, V78, P2455, DOI 10.1073/pnas.78.4.2455; TOOLE JJ, 1984, NATURE, V312, P342, DOI 10.1038/312342a0; Upton KR, 2015, CELL, V161, P228, DOI 10.1016/j.cell.2015.03.026; WAIKAN Y, 1978, P NATL ACAD SCI USA, V75, P5631, DOI 10.1073/pnas.75.11.5631; WALLACE RB, 1981, NUCLEIC ACIDS RES, V9, P879, DOI 10.1093/nar/9.4.879; WESTAWAY D, 1981, NUCLEIC ACIDS RES, V9, P1777, DOI 10.1093/nar/9.8.1777; WONG C, 1987, NATURE, V330, P384, DOI 10.1038/330384a0	60	2	2	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3712	3718		10.1096/fj.201700502RR	http://dx.doi.org/10.1096/fj.201700502RR			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28860307	Green Published			2022-12-28	WOS:000408713300002
J	Sakai, E; Morita, M; Ohuchi, M; Kido, MA; Fukuma, Y; Nishishita, K; Okamoto, K; Itoh, K; Yamamoto, M; Tsukuba, T				Sakai, Eiko; Morita, Masanobu; Ohuchi, Masahiro; Kido, Mizuho A.; Fukuma, Yutaka; Nishishita, Kazuhisa; Okamoto, Kuniaki; Itoh, Ken; Yamamoto, Masayuki; Tsukuba, Takayuki			Effects of deficiency of Kelch-like ECH-associated protein 1 on skeletal organization: a mechanism for diminished nuclear factor of activated T cells cytoplasmic 1 during osteoclastogenesis	FASEB JOURNAL			English	Article						Blimp1; IRF-8; Nrf2; oxidative stress; MafB	PROMOTES OSTEOBLAST DIFFERENTIATION; NF-KAPPA-B; BONE HOMEOSTASIS; OXIDATIVE STRESS; DC-STAMP; NRF2; RANKL; PATHWAYS; EXPRESSION; TRANSCRIPTION	Kelch-like ECH-associated protein 1 (Keap1) binds to nuclear factor E2 p45-related factor 2 (Nrf2), a transcription factor for antioxidant enzymes, to suppress Nrf2 activation. The role of oxidative stress in many diseases supports the possibility that processes that are associated with Nrf2 activation might offer therapeutic potential. Nrf2 deficiency induces osteoclastogenesis, which is responsible for bone loss, by activating receptor activator of NF-kappa B ligand (RANKL)-mediated signaling; however, the effects of Keap1 deficiency remain unclear. By using Keap1-deficient newborn mice, we observed that talus and calcaneus bone formation was partially retarded and that osteoclast number was reduced in vivo without severe gross abnormalities. In addition, Keap1-deficient macrophages were unable to differentiate into osteoclasts in vitro via attenuation of RANKL-mediated signaling and expression of nuclear factor of activated T cells cytoplasmic 1 (NFATc1), a key transcription factor that is involved in osteoclastogenesis. Furthermore, Keap1 deficiency up-regulated the expression of Mafb, a negative regulator of NFATc1. RANKL-induced mitochondrial gene expression is required for down-regulation of IFN regulatory factor 8 (IRF-8), a negative transcriptional regulator of NFATc1. Our results indicate that Keap1 deficiency down-regulated peroxisome proliferator-activated receptor-gamma coactivator 1 beta and mitochondrial gene expression and up-regulated Irf8 expression. These results suggest that the Keap1/Nrf2 axis plays a critical role in NFATc1 expression and osteoclastogenic progression.	[Sakai, Eiko; Fukuma, Yutaka; Nishishita, Kazuhisa; Okamoto, Kuniaki; Tsukuba, Takayuki] Nagasaki Univ, Div Dent Pharmacol, Dept Dev & Reconstruct Med, Grad Sch Biomed Sci, 1-7-1 Sakamoto, Nagasaki 8528588, Japan; [Morita, Masanobu; Yamamoto, Masayuki] Tohoku Univ, Dept Med Biochem, Grad Sch Med, Sendai, Miyagi, Japan; [Morita, Masanobu] Tohoku Univ, Dept Environm Hlth Sci & Mol Toxicol, Grad Sch Med, Sendai, Miyagi, Japan; [Ohuchi, Masahiro] Kyushu Univ, Dept Orthodont, Grad Dent Sci, Fukuoka, Japan; [Kido, Mizuho A.] Saga Univ, Dept Anat & Physiol, Fac Med, Saga, Japan; [Itoh, Ken] Hirosaki Univ, Dept Stress Response Sci, Grad Sch Med, Hirosaki, Aomori, Japan	Nagasaki University; Tohoku University; Tohoku University; Kyushu University; Saga University; Hirosaki University	Sakai, E (corresponding author), Nagasaki Univ, Div Dent Pharmacol, Dept Dev & Reconstruct Med, Grad Sch Biomed Sci, 1-7-1 Sakamoto, Nagasaki 8528588, Japan.	eiko-s@nagasaki-u.ac.jp	Tsukuba, Takayuki/I-9542-2018; Itoh, Ken/B-9506-2013; Yamamoto, Masayuki/A-4873-2010	Tsukuba, Takayuki/0000-0003-3322-1339; Itoh, Ken/0000-0002-5518-0729; Yamamoto, Masayuki/0000-0002-9073-9436; sakai, eiko/0000-0002-6776-6540	Japan Society for the Promotion of Science [25462892, 16K11480, 25293383, 26670906, 15H05298]; Grants-in-Aid for Scientific Research [26111002] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partly supported by Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (KAKENHI) (25462892 and 16K11480 to E.S.; and 25293383, 26670906, and 15H05298 to T.T.). The authors thank Drs. Takeshi Moriishi, Mariko Naito, and Hideaki Hayashida (all from Nagasaki University) for their technical support and helpful discussions.	Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chuvpilo S, 2002, IMMUNITY, V16, P881, DOI 10.1016/S1074-7613(02)00329-1; Dinkova-Kostova AT, 2005, P NATL ACAD SCI USA, V102, P4584, DOI 10.1073/pnas.0500815102; Fukuma Y, 2015, BIOFACTORS, V41, P222, DOI 10.1002/biof.1218; Hinoi E, 2007, BONE, V40, P337, DOI 10.1016/j.bone.2006.08.016; Hinoi E, 2006, J BIOL CHEM, V281, P18015, DOI 10.1074/jbc.M600603200; Hotokezaka H, 2002, J BIOL CHEM, V277, P47366, DOI 10.1074/jbc.M208284200; Hu JP, 2008, EUR J PHARMACOL, V580, P70, DOI 10.1016/j.ejphar.2007.11.013; Hyeon S, 2013, FREE RADICAL BIO MED, V65, P789, DOI 10.1016/j.freeradbiomed.2013.08.005; Ishii K, 2009, NAT MED, V15, P259, DOI 10.1038/nm.1910; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Itoh N, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00154; Iwaki F, 2016, EUR J PHARMACOL, V793, P14, DOI 10.1016/j.ejphar.2016.10.034; Kamiya T, 1998, J BIOCHEM-TOKYO, V123, P752; Karsenty G, 2003, NATURE, V423, P316, DOI 10.1038/nature01654; Khan NM, 2017, FREE RADICAL BIO MED, V106, P288, DOI 10.1016/j.freeradbiomed.2017.02.041; Kim BR, 2018, BIOCHEM BIOPH RES CO, V497, P1149, DOI 10.1016/j.bbrc.2017.01.107; Kim H, 2006, FEBS LETT, V580, P5661, DOI 10.1016/j.febslet.2006.09.015; Kim K, 2008, MOL ENDOCRINOL, V22, P176, DOI 10.1210/me.2007-0237; Kim K, 2007, BLOOD, V109, P3253, DOI 10.1182/blood-2006-09-048249; Kim YR, 2010, J PATHOL, V220, P446, DOI 10.1002/path.2653; Kobayashi EH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11624; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kukita T, 2004, J EXP MED, V200, P941, DOI 10.1084/jem.20040518; Lee JH, 2010, MOL PHARMACOL, V77, P17, DOI 10.1124/mol.109.057877; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Monteiro HP, 1996, FREE RADICAL BIO MED, V21, P323, DOI 10.1016/0891-5849(96)00051-2; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Nishikaw K, 2010, P NATL ACAD SCI USA, V107, P3117, DOI 10.1073/pnas.0912779107; Nishikawa K, 2015, NAT MED, V21, P281, DOI 10.1038/nm.3774; Nishikawa K, 2010, J CLIN INVEST, V120, P3455, DOI 10.1172/JCI42528; Park CK, 2014, BONE, V63, P36, DOI 10.1016/j.bone.2014.01.025; Sakai E, 2016, PHYTOMEDICINE, V23, P828, DOI 10.1016/j.phymed.2016.04.002; Sakai E, 2012, J CELL BIOCHEM, V113, P486, DOI 10.1002/jcb.23372; Solis LM, 2010, CLIN CANCER RES, V16, P3743, DOI 10.1158/1078-0432.CCR-09-3352; Sun YX, 2015, BONE, V74, P1, DOI 10.1016/j.bone.2014.12.066; Takahashi N, 1999, BIOCHEM BIOPH RES CO, V256, P449, DOI 10.1006/bbrc.1999.0252; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Thaler R, 2016, J BIOL CHEM, V291, P6754, DOI 10.1074/jbc.M115.678235; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Wei W, 2012, P NATL ACAD SCI USA, V109, P3143, DOI 10.1073/pnas.1200797109; Wruck CJ, 2011, ANN RHEUM DIS, V70, P844, DOI 10.1136/ard.2010.132720; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476; Zhao BH, 2009, NAT MED, V15, P1066, DOI 10.1038/nm.2007; Zheng H, 2006, J BIOL CHEM, V281, P15809, DOI 10.1074/jbc.M513225200	52	11	12	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					4011	4022		10.1096/fj.201700177R	http://dx.doi.org/10.1096/fj.201700177R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28515152				2022-12-28	WOS:000408713300026
J	Hakkarainen, J; Zhang, FP; Jokela, H; Mayerhofer, A; Behr, R; Cisneros-Montalvo, S; Nurmio, M; Toppari, J; Ohlsson, C; Kotaja, N; Sipila, P; Poutanen, M				Hakkarainen, Janne; Zhang, Fu-Ping; Jokela, Heli; Mayerhofer, Artur; Behr, Ruediger; Cisneros-Montalvo, Sheyla; Nurmio, Mirja; Toppari, Jorma; Ohlsson, Claes; Kotaja, Noora; Sipilae, Petra; Poutanen, Matti			Hydroxysteroid (17 beta) dehydrogenase 1 expressed by Sertoli cells contributes to steroid synthesis and is required for male fertility	FASEB JOURNAL			English	Article						HSD17B1; infertility; spermatogenesis; cell junctions	MULLERIAN-INHIBITING SUBSTANCE; FOLLICLE-STIMULATING-HORMONE; 17-BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE-1; LUTEINIZING-HORMONE; ECTOPLASMIC SPECIALIZATION; MALE-INFERTILITY; SPERMATOGENESIS; AROMATASE; KNOCKOUT; PROLIFERATION	The pituitary gonadotrophins and testosterone are the main hormonal regulators of spermatogenesis, but estradiol is also known to play a role in the process. The hormonal responses in the testis are partially mediated by somatic Sertoli cells that provide nutritional and physical support for differentiating male germ cells. Hydroxysteroid (17 beta) dehydrogenase 1 (HSD17B1) is a steroidogenic enzyme that especially catalyzes the conversion of low potent 17keto-steroids to highly potent 17 beta-hydroxysteroids. In this study, we show that Hsd17b1 is highly expressed in Sertoli cells of fetal and newborn mice, and HSD17B1 knockout males present with disrupted spermatogenesis with major defects, particularly in the head shape of elongating spermatids. The cell-cell junctions between Sertoli cells and germ cells were disrupted in the HSD17B1 knockout mice. This resulted in complications in the orientation of elongating spermatids in the seminiferous epithelium, reduced sperm production, and morphologically abnormal spermatozoa. We also showed that the Sertoli cell-expressed HSD17B1 participates in testicular steroid synthesis, evidenced by a compensatory up-regulation of HSD17B3 in Leydig cells. These results revealed a novel role for HSD17B1 in the control of spermatogenesis and male fertility, and that Sertoli cells significantly contribute to steroid synthesis in the testis.	[Hakkarainen, Janne; Zhang, Fu-Ping; Jokela, Heli; Cisneros-Montalvo, Sheyla; Nurmio, Mirja; Toppari, Jorma; Kotaja, Noora; Sipilae, Petra; Poutanen, Matti] Univ Turku, Res Ctr Integrat Physiol & Pharmacol, Inst Biomed, Turku, Finland; [Zhang, Fu-Ping; Poutanen, Matti] Univ Turku, Turku Ctr Dis Modeling, Turku, Finland; [Mayerhofer, Artur] Ludwig Maximilians Univ Munchen, Biomed Ctr BMC, Cell Biol Anat 3, Martinsried, Germany; [Behr, Ruediger] German Primate Ctr, Leibniz Inst Primate Res, Platform Degenerat Dis, Gottingen, Germany; [Behr, Ruediger] German Ctr Cardiovasc Res DZHK, Partner Site Gottingen, Gottingen, Germany; [Nurmio, Mirja; Toppari, Jorma] Turku Univ Hosp, Dept Pediat, Turku, Finland; [Ohlsson, Claes; Poutanen, Matti] Gothenburg Univ, Sahlgrenska Acad, Inst Med, Gothenburg, Sweden	University of Turku; University of Turku; University of Munich; Deutsches Primatenzentrum (DPZ); German Centre for Cardiovascular Research; University of Turku; University of Gothenburg	Poutanen, M (corresponding author), Univ Turku, Turku Ctr Dis Modeling, Res Ctr Integrat Physiol & Pharmacol, Inst Biomed, Kiinamyllynkatu 10, FIN-20520 Turku, Finland.	matti.poutanen@utu.fi	Sipilä, Petra/GYE-3323-2022; Ohlsson, Claes/AGP-3544-2022; Ohlsson, Claes/HIR-6959-2022; Poutanen, Matti/I-1700-2018	Ohlsson, Claes/0000-0002-9633-2805; Ohlsson, Claes/0000-0002-9633-2805; Poutanen, Matti/0000-0002-8953-1734; Kotaja, Noora/0000-0003-1503-9170; Nurmio, Mirja/0000-0002-3278-639X; Mayerhofer, Artur/0000-0002-9388-4639; Jokela, Heli/0000-0003-1839-7870; Sipila, Petra/0000-0001-8187-7143; Cisneros Montalvo, Sheyla/0000-0001-5667-4846	Academy of Finland; Sigrid Juselius Foundation; Swedish Research Council; IngaBritt and Arne Lundberg Foundation (LUA-ALF) research grant from the Salhgrenska University Hospital; Novo Nordisk Foundation; Deutscher Akademischer Austauschdienst (DAAD)	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); IngaBritt and Arne Lundberg Foundation (LUA-ALF) research grant from the Salhgrenska University Hospital; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	The authors thank N. Messner, H. Niittymaki, K. Hovirinta, A. Mantyla, A. Hakkarainen, T. Kirjonen, J. Jarvi, J. Palmu, M. Niiranen, E. Nyman, M.-R. Kaajala, K. Asp (all from the University of Turku), and A. Tiefenbacher (Ludwig-Maximilians-Universitat Munchen) for technical assistance, and the Electron Microscopy Core Unit of the University of Turku for services regarding electron microscopy. The authors are grateful to F.-M. Kohn (Andrologicum Munchen, Munchen, Germany) and J. U. Schwarzer (Andrologie Centrum Munchen, Munchen, Germany) for providing human samples. For funding, the authors thank the Academy of Finland, the Sigrid Juselius Foundation, the Swedish Research Council, the IngaBritt and Arne Lundberg Foundation (LUA-ALF) research grant from the Salhgrenska University Hospital, and the Novo Nordisk Foundation, as well as Deutscher Akademischer Austauschdienst (DAAD). The authors declare no conflicts of interest.	Aka JA, 2010, MOL ENDOCRINOL, V24, P832, DOI 10.1210/me.2009-0468; AlAttar L, 1997, J CLIN INVEST, V100, P1335, DOI 10.1172/JCI119653; Allan CM, 2004, ENDOCRINOLOGY, V145, P1587, DOI 10.1210/en.2003-1164; Andersson S, 1997, STEROIDS, V62, P143, DOI 10.1016/S0039-128X(96)00173-0; Arango NA, 1999, CELL, V99, P409, DOI 10.1016/S0092-8674(00)81527-5; Bartles JR, 1996, J CELL SCI, V109, P1229; De Santa Barbara P, 1998, MOL CELL BIOL, V18, P6653, DOI 10.1128/MCB.18.11.6653; FOURNETDULGUEROV N, 1987, J CLIN ENDOCR METAB, V65, P757, DOI 10.1210/jcem-65-4-757; GEISSLER WM, 1994, NAT GENET, V7, P34, DOI 10.1038/ng0594-34; GHERSEVICH SA, 1994, J ENDOCRINOL, V143, P139, DOI 10.1677/joe.0.1430139; Giuili G, 1997, DEVELOPMENT, V124, P1799; HAAVISTO AM, 1993, ENDOCRINOLOGY, V132, P1687, DOI 10.1210/en.132.4.1687; Hakkarainen J, 2015, FASEB J, V29, P3806, DOI 10.1096/fj.14-269035; Hara K, 2014, CELL STEM CELL, V14, P658, DOI 10.1016/j.stem.2014.01.019; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Jokela H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16618-5; Kotaja N, 2004, NAT METHODS, V1, P249, DOI 10.1038/nmeth1204-249; Lasala C, 2011, AM J PHYSIOL-ENDOC M, V301, pE539, DOI 10.1152/ajpendo.00187.2011; Lin SX, 2006, MOL CELL ENDOCRINOL, V248, P38, DOI 10.1016/j.mce.2005.11.035; Manno FAM, 2008, PHYSIOL BEHAV, V93, P364, DOI 10.1016/j.physbeh.2007.09.011; Mayer C, 2016, SCI REP-UK, V6, DOI 10.1038/srep37128; McLachlan RI, 2002, RECENT PROG HORM RES, V57, P149, DOI 10.1210/rp.57.1.149; Miettinen MM, 1996, BIOCHEM J, V314, P839, DOI 10.1042/bj3140839; Mruk DD, 2004, ENDOCR REV, V25, P747, DOI 10.1210/er.2003-0022; Mruk DD, 2004, TRENDS ENDOCRIN MET, V15, P439, DOI 10.1016/j.tem.2004.09.009; Mruk DD, 2008, PHARMACOL REV, V60, P146, DOI 10.1124/pr.107.07105; Mueller S, 2003, BIOL REPROD, V69, P1330, DOI 10.1095/biolreprod.102.014670; Nilsson ME, 2015, ENDOCRINOLOGY, V156, P2492, DOI 10.1210/en.2014-1890; Nokelainen P, 1996, EUR J BIOCHEM, V236, P482, DOI 10.1111/j.1432-1033.1996.00482.x; O'Donnell L, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1017; O'Shaughnessy PJ, 2000, ENDOCRINOLOGY, V141, P2631, DOI 10.1210/en.141.7.2631; ODonnell L, 1996, BIOL REPROD, V55, P895, DOI 10.1095/biolreprod55.4.895; Pakarainen T, 2005, ENDOCRINOLOGY, V146, P596, DOI 10.1210/en.2004-0913; Pelletier G, 2004, J MOL ENDOCRINOL, V33, P459, DOI 10.1677/jme.1.01567; POUTANEN M, 1993, ENDOCRINOLOGY, V133, P2639, DOI 10.1210/en.133.6.2639; Puranen T, 1997, ENDOCRINOLOGY, V138, P3532, DOI 10.1210/en.138.8.3532; Robertson KM, 1999, P NATL ACAD SCI USA, V96, P7986, DOI 10.1073/pnas.96.14.7986; Rotgers E, 2015, ANDROLOGY-US, V3, P947, DOI 10.1111/andr.12066; Saloniemi T, 2012, J ENDOCRINOL, V212, P27, DOI 10.1530/JOE-11-0315; Schimenti KJ, 2013, GENETICS, V194, P447, DOI 10.1534/genetics.113.150789; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; Shima Y, 2013, MOL ENDOCRINOL, V27, P63, DOI 10.1210/me.2012-1256; Sinkevicius KW, 2009, ENDOCRINOLOGY, V150, P2898, DOI 10.1210/en.2008-1016; Sridharan S, 2007, BIOL REPROD, V76, P804, DOI 10.1095/biolreprod.106.059212; Toyama Y, 2001, MOL CELL ENDOCRINOL, V178, P161, DOI 10.1016/S0303-7207(01)00419-1; van Casteren JIJ, 2000, BIOL REPROD, V62, P886, DOI 10.1095/biolreprod62.4.886; Viger RS, 1998, DEVELOPMENT, V125, P2665; Walker WH, 2005, REPRODUCTION, V130, P15, DOI 10.1530/rep.1.00358; Walker William H, 2011, Spermatogenesis, V1, P116; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wong EWP, 2008, BBA-BIOMEMBRANES, V1778, P692, DOI 10.1016/j.bbamem.2007.11.006; Yan HHN, 2007, BIOESSAYS, V29, P36, DOI 10.1002/bies.20513; Yeh SY, 2002, P NATL ACAD SCI USA, V99, P13498, DOI 10.1073/pnas.212474399; Zhang FP, 2001, MOL ENDOCRINOL, V15, P172, DOI 10.1210/me.15.1.172; Zhu SJ, 2002, J ENDOCRINOL, V172, P31, DOI 10.1677/joe.0.1720031	55	10	10	3	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3229	3241		10.1096/fj.201700921R	http://dx.doi.org/10.1096/fj.201700921R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401623				2022-12-28	WOS:000432546000027
J	Sparkes, A; De Baetselier, P; Brys, L; Cabrito, I; Sterckx, YGJ; Schoonooghe, S; Muyldermans, S; Raes, G; Bucala, R; Vanlandschoot, P; Van Ginderachter, JA; Stijlemans, B				Sparkes, Amanda; De Baetselier, Patrick; Brys, Lea; Cabrito, Ines; Sterckx, Yann G. -J.; Schoonooghe, Steve; Muyldermans, Serge; Raes, Geert; Bucala, Richard; Vanlandschoot, Peter; Van Ginderachter, Jo A.; Stijlemans, Benoit			Novel half-life extended anti-MIF nanobodies protect against endotoxic shock	FASEB JOURNAL			English	Article						Nbs; MIF antagonist; LPS	MIGRATION-INHIBITORY-FACTOR; SINGLE-DOMAIN ANTIBODIES; TOLL-LIKE RECEPTOR-4; SEVERE SEPSIS; SEPTIC SHOCK; MONOCLONAL-ANTIBODIES; TAUTOMERASE ACTIVITY; LETHAL ENDOTOXEMIA; CYTOKINE; BINDING	Sepsis-leading to septic shock-is the leading cause of death in intensive care units. The systemic inflammatory response to infection, which is initiated by activated myeloid cells, plays a key role in the lethal outcome. Macrophage migration inhibitory factor (MIF) is an upstream immunoregulatory mediator, released by myeloid cells, that underlies a common genetic susceptibility to different infections and septic shock. Accordingly, strategies that are aimed at inhibiting the action of MIF have therapeutic potential. Here, we report the isolation and characterization of tailorable, small, affinity-matured nanobodies (Nbs; single-domain antigen-binding fragments derived from camelid heavy-chain Abs) directed against MIF. Of importance, these bioengineered Nbs bind both human and mouse MIFs with nanomolar affinity. NbE5 and NbE10 inhibit key MIF functions that can exacerbate septic shock, such as the tautomerase activity of MIF (by blocking catalytic pocket residues that are critical for MIF's conformation and receptor binding), the TNF-inducing potential, and the ability of MIF to antagonize glucocorticoid action. A lead NbE10, tailored to be a multivalent, half-life extended construct (NbE10-NbAlb8-NbE10), attenuated lethality in murine endotoxemia when administered via single injection, either prophylactically or therapeutically. Hence, Nbs, with their structural and pharmacologic advantages over currently available inhibitors, may be an effective, novel approach to interfere with the action of MIF in septic shock and other conditions of inflammatory end-organ damage.	[Sparkes, Amanda; De Baetselier, Patrick; Brys, Lea; Sterckx, Yann G. -J.; Schoonooghe, Steve; Muyldermans, Serge; Raes, Geert; Van Ginderachter, Jo A.; Stijlemans, Benoit] Vrije Univ Brussels, Lab Cellular & Mol Immunol, Brussels, Belgium; [Sparkes, Amanda; De Baetselier, Patrick; Brys, Lea; Schoonooghe, Steve; Raes, Geert; Van Ginderachter, Jo A.; Stijlemans, Benoit] Flanders Inst Biotechnol VIB, Myeloid Cell Immunol Lab, Ctr Inflammat Res, Brussels, Belgium; [Cabrito, Ines] Good Mfg Practices GMP Lab, Dept Biopharmaceut, Pharmaceut Prod Dev PPD Labs, Athlone, Ireland; [Cabrito, Ines; Vanlandschoot, Peter] Ablynx NV, Zwijnaarde, Belgium; [Bucala, Richard] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Vanlandschoot, Peter] N Spired, Aalter, Belgium	Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Yale University	Stijlemans, B (corresponding author), Vrije Univ Brussel VIB, Pl Laan 2, B-1050 Brussels, Belgium.	benoit.stijlemans@vub.be	Sterckx, Yann G.-J./F-2269-2017; Van Ginderachter, Jo A/H-5473-2013; Muyldermans, Serge/AAC-7374-2019; Raes, Geert M/H-5185-2013; Stijlemans, Benoit/AAD-9122-2021	Sterckx, Yann G.-J./0000-0002-7420-0983; Van Ginderachter, Jo A/0000-0002-4442-7474; Muyldermans, Serge/0000-0002-3678-3575; Raes, Geert M/0000-0002-9065-1549; Stijlemans, Benoit/0000-0003-0082-9751; Schoonooghe, Steve/0000-0001-8824-0452	Interuniversity Attraction Pole Program (PAI-IAP) [P7/41]; Research Foundation-Flanders (FWO) [KaN 1515813N]; starting budget from Ablynx; Strategic Research Program (Vrije Universiteit Brussels) [SRP3]; U.S. National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110452] Funding Source: NIH RePORTER	Interuniversity Attraction Pole Program (PAI-IAP); Research Foundation-Flanders (FWO)(FWO); starting budget from Ablynx(Ablynx); Strategic Research Program (Vrije Universiteit Brussels); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Yvon Elkrim, Ella Omasta, Marie-Therese Detobel, Maria Slazak, Victor Orimoloye, Natalia Smiejkowska, Shahid Hussain, and Nadia Abou for technical and administrative assistance, as well as Dr. Alain Beschin for constructive discussions [all from the Vrije Universiteit Brussel (VUB) and the Flanders Institute for Biotechnology (VIB) Center for Inflammation Research]. This work, performed in the frame of an Interuniversity Attraction Pole Program (PAI-IAP N. P7/41; http://www.belspo.be/belspo/iap/index_en.stm), was supported by a grant from the Research Foundation-Flanders (FWO; KaN 1515813N), and a starting budget from Ablynx. B.S. was supported by the Strategic Research Program (SRP3; Vrije Universiteit Brussels). R.B. was supported by the U.S. National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest.	Abraham E, 1999, INTENS CARE MED, V25, P556, DOI 10.1007/s001340050903; Al-Abed Y, 2005, J BIOL CHEM, V280, P36541, DOI 10.1074/jbc.C500243200; Al-Abed Y, 2011, FUTURE MED CHEM, V3, P45, DOI 10.4155/FMC.10.281; Alampour-Rajabi S, 2015, FASEB J, V29, P4497, DOI 10.1096/fj.15-273904; Beishuizen A., 2009, J CLIN ENDOCR METAB, V86, P2811; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bozza FA, 2004, SHOCK, V22, P309, DOI 10.1097/01.shk.0000140305.01641.c8; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Bozza Marcelo T, 2012, J Parasitol Res, V2012, P413052, DOI 10.1155/2012/413052; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Caljon G, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001902; Chagnon F, 2005, CIRC RES, V96, P1095, DOI 10.1161/01.RES.0000168327.22888.4d; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; Coppieters K, 2006, ARTHRITIS RHEUM-US, V54, P1856, DOI 10.1002/art.21827; De Groeve K, 2010, J NUCL MED, V51, P782, DOI 10.2967/jnumed.109.070078; Dios A, 2002, J MED CHEM, V45, P2410, DOI 10.1021/jm010534q; Emonts M, 2007, CLIN INFECT DIS, V44, P1321, DOI 10.1086/514344; Esposito S, 2017, J GLOB ANTIMICROB RE, V10, P204, DOI 10.1016/j.jgar.2017.06.013; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Fingerle-Rowson G, 2009, MOL CELL BIOL, V29, P1922, DOI 10.1128/MCB.01907-08; Flaster H, 2007, MOL ENDOCRINOL, V21, P1267, DOI 10.1210/me.2007-0065; Gao XM, 2011, J MOL CELL CARDIOL, V50, P991, DOI 10.1016/j.yjmcc.2010.12.022; Grieb G, 2010, DRUG NEWS PERSPECT, V23, P257, DOI 10.1358/dnp.2010.23.4.1453629; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Hassanzadeh-Ghassabeh G, 2013, NANOMEDICINE-UK, V8, P1013, DOI [10.2217/nnm.13.86, 10.2217/NNM.13.86]; Hoefman S, 2015, ANTIBODIES, V4, P141, DOI 10.3390/antib4030141; Jing LA, 2011, ANN CLIN LAB SCI, V41, P14; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Kerschbaumer RJ, 2012, J BIOL CHEM, V287, P7446, DOI 10.1074/jbc.M111.329664; Kudrin A, 2006, J BIOL CHEM, V281, P29641, DOI 10.1074/jbc.M601103200; Lai KN, 2003, J PATHOL, V199, P496, DOI 10.1002/path.1291; Le Roy D, 1999, J IMMUNOL, V162, P7454; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Leng L, 2011, J IMMUNOL, V186, P527, DOI 10.4049/jimmunol.1001767; Luan YY, 2014, J INTERF CYTOK RES, V34, P2, DOI 10.1089/jir.2013.0042; Martin ACR, 1996, PROTEINS, V25, P130, DOI 10.1002/(SICI)1097-0134(199605)25:1<130::AID-PROT11>3.3.CO;2-Y; Martin P, 2015, LEUKEMIA LYMPHOMA, V56, P3065, DOI 10.3109/10428194.2015.1028052; Maussang D, 2013, J BIOL CHEM, V288, P29562, DOI 10.1074/jbc.M113.498436; Merk M, 2011, P NATL ACAD SCI USA, V108, pE577, DOI 10.1073/pnas.1102941108; Merk M, 2009, J IMMUNOL, V182, P6896, DOI 10.4049/jimmunol.0803710; Meza-Romero R, 2016, METAB BRAIN DIS, V31, P249, DOI 10.1007/s11011-016-9798-x; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Muyldermans S, 2009, VET IMMUNOL IMMUNOP, V128, P178, DOI 10.1016/j.vetimm.2008.10.299; Nee PA, 2006, EMERG MED J, V23, P713, DOI 10.1136/emj.2005.029934; Orr BA, 2003, BIOTECHNOL PROGR, V19, P631, DOI 10.1021/bp0200797; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Rajasekaran D, 2016, J BIOL CHEM, V291, P15881, DOI 10.1074/jbc.M116.717751; Renner P, 2012, FASEB J, V26, P907, DOI 10.1096/fj.11-195065; Rex S, 2014, MINI-REV MED CHEM, V14, P1116; Riechmann L, 1999, J IMMUNOL METHODS, V231, P25, DOI 10.1016/S0022-1759(99)00138-6; Roger T, 2003, J ENDOTOXIN RES, V9, P119, DOI 10.1179/096805103125001513; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Saerens D, 2004, J BIOL CHEM, V279, P51965, DOI 10.1074/jbc.M409292200; Savva A, 2016, P NATL ACAD SCI USA, V113, P3597, DOI 10.1073/pnas.1520727113; Steeland S, 2015, J BIOL CHEM, V290, P4022, DOI 10.1074/jbc.M114.617787; Stijlemans B, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005862; Stijlemans B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004414; Sun HW, 1996, P NATL ACAD SCI USA, V93, P5191, DOI 10.1073/pnas.93.11.5191; Tarasuk M, 2014, INT J MOL MED, V33, P515, DOI 10.3892/ijmm.2014.1622; Tilstam PV, 2017, EXPERT OPIN THER TAR, V21, P671, DOI 10.1080/14728222.2017.1336227; Tohyama S, 2008, GENE THER, V15, P1513, DOI 10.1038/gt.2008.112; Tsai TL, 2014, J BIOMOL SCREEN, V19, P1116, DOI 10.1177/1087057114523317; Van Bockstaele F, 2009, CURR OPIN INVEST DR, V10, P1212; Vandenbroucke K, 2010, MUCOSAL IMMUNOL, V3, P49, DOI 10.1038/mi.2009.116; Vincke C, 2009, J BIOL CHEM, V284, P3273, DOI 10.1074/jbc.M806889200; Vosjan MJWD, 2012, MOL CANCER THER, V11, P1017, DOI 10.1158/1535-7163.MCT-11-0891; Vujicic M, 2014, EUR J PHARMACOL, V740, P683, DOI 10.1016/j.ejphar.2014.06.009; Worn A, 2001, J MOL BIOL, V305, P989, DOI 10.1006/jmbi.2000.4265; Zhang JB, 2004, J MOL BIOL, V335, P49, DOI 10.1016/j.jmb.2003.09.034; Zhang Y, 2011, INT IMMUNOPHARMACOL, V11, P1333, DOI 10.1016/j.intimp.2011.04.017; Zhou JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107181	74	22	23	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3411	3422		10.1096/fj.201701189R	http://dx.doi.org/10.1096/fj.201701189R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401625	Green Submitted, Green Published			2022-12-28	WOS:000432546000041
J	Xin, YL; Zhao, Y; Zheng, JG; Zhou, HZ; Zhang, XJC; Tian, CL; Huang, YH				Xin, Yanlong; Zhao, Yan; Zheng, Jiangge; Zhou, Haizhen; Zhang, Xuejun Cai; Tian, Changlin; Huang, Yihua			Structure of YidC from Thermotoga maritima and its implications for YidC-mediated membrane protein insertion	FASEB JOURNAL			English	Article						X-ray crystallography; YidC/Oxa1/Alb3; membrane protein insertase; membrane protein biogenesis	ESCHERICHIA-COLI YIDC; PERIPLASMIC DOMAIN; CRYSTAL-STRUCTURE; BACTERIAL; REGIONS; SECYEG; TRANSLOCON; RIBOSOMES; COMPLEX	The evolutionarily conserved YidC/Oxa1/Alb3 family of proteins represents a unique membrane protein family that facilitates the insertion, folding, and assembly of a cohort of alpha-helical membrane proteins in all kingdoms of life, yet its underlying mechanisms remain elusive. We report the crystal structures of the full-length Thermotoga maritima YidC (TmYidC) and the TmYidC periplasmic domain (TmPD) at a resolution of 3.8 and 2.5 angstrom, respectively. The crystal structure of TmPD reveals a beta-supersandwich fold but with apparently shortened beta strands and different connectivity, as compared to the Escherichia coli YidC (EcYidC) periplasmic domain (EcPD). TmYidC in a detergent-solubilized state also adopts a monomeric form and its conserved core domain, which consists of 2 loosely associated alpha-helical bundles, assemble a fold similar to that of the other YidC homologues, yet distinct from that of the archaeal YidC-like DUF106 protein. Functional analysis using in vivo photo-crosslinking experiments demonstrates that Pf3 coat protein, a Sec-independent YidC substrate, exits to the lipid bilayer laterally via one of the 2 alpha-helical bundle interfaces: TM3-TM5. Engineered intramolecular disulfide bonds in TmYidC, in combination with complementation assays, suggest that significant rearrangement of the 2 a-helical bundles at the top of the hydrophilic groove is critical for TmYidC function. These experiments provide a more detailed mechanical insight into YidC-mediated membrane protein biogenesis.	[Xin, Yanlong; Tian, Changlin] Univ Sci & Technol China, Sch Life Sci, Natl Lab Phys Sci Microscale, Hefei, Anhui, Peoples R China; [Xin, Yanlong; Zhao, Yan; Zheng, Jiangge; Zhou, Haizhen; Zhang, Xuejun Cai; Huang, Yihua] Chinese Acad Sci, Ctr Excellence Biomacromoll, Inst Biophys, Natl Lab Biomacromol, Beijing, Peoples R China; [Zhang, Xuejun Cai; Huang, Yihua] Univ Chinese Acad Sci, Beijing, Peoples R China; [Tian, Changlin] Chinese Acad Sci, High Field Magnet Lab, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS	Tian, CL (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei, Anhui, Peoples R China.; Huang, YH (corresponding author), Chinese Acad Sci, Ctr Excellence Biomacromol, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.	cltian@ustc.edu.cn; yihuahuang@sun5.ibp.ac.cn			Ministry of Science and Technology [2016YFA0500404, 2013CB910603]; National Natural Science Foundation of China [31625009, 31470743]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB080203]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	The authors thank all Y.H. laboratory staff members for valuable discussions and critically reading the manuscript. The diffraction data were collected at the Shanghai Synchrotron Radiation Facility (SSRF). This work was supported by Grants 2016YFA0500404 and 2013CB910603 from the Ministry of Science and Technology (to Y.H.); Grants 31625009 and 31470743 from the National Natural Science Foundation of China (to Y.H.), and Grant XDB080203 from the Strategic Priority Research Program of the Chinese Academy of Sciences (to Y.H.). The coordinates and diffraction data of TmPD and TmYidC crystal structures have been deposited in the Research Collaboratory for Structural Bioinformatics Protein Data Bank (RCSB PDB; http://rcsb.org; 5Y82 and 5Y83). The authors declare no conflicts of interests.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Borowska MT, 2015, STRUCTURE, V23, P1715, DOI 10.1016/j.str.2015.06.025; Dalbey RE, 2014, BBA-MOL CELL RES, V1843, P1489, DOI 10.1016/j.bbamcr.2013.12.022; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Funes S, 2011, BIOL CHEM, V392, P13, DOI 10.1515/BC.2011.013; Herrmann JM, 2013, J MOL BIOL, V425, P4071, DOI 10.1016/j.jmb.2013.08.003; Jiang FL, 2003, J BIOL CHEM, V278, P48965, DOI 10.1074/jbc.M307362200; Jiang FL, 2002, J BIOL CHEM, V277, P19281, DOI 10.1074/jbc.M110857200; Kedrov A, 2013, J MOL BIOL, V425, P4112, DOI 10.1016/j.jmb.2013.07.042; Klenner C, 2012, J BIOL CHEM, V287, P3769, DOI 10.1074/jbc.M111.307223; Kohler R, 2009, MOL CELL, V34, P344, DOI 10.1016/j.molcel.2009.04.019; Kuhn A, 2017, MOL MICROBIOL, V103, P590, DOI 10.1111/mmi.13586; Kumazaki K, 2014, SCI REP-UK, V4, DOI 10.1038/srep07299; Kumazaki K, 2014, NATURE, V509, P516, DOI 10.1038/nature13167; Oliver DC, 2008, J BIOL CHEM, V283, P5208, DOI 10.1074/jbc.M708936200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ravaud S, 2008, J BIOL CHEM, V283, P9350, DOI 10.1074/jbc.M710493200; Sachelaru I, 2013, J BIOL CHEM, V288, P16295, DOI 10.1074/jbc.M112.446583; Saller MJ, 2012, BIOL CHEM, V393, P1279, DOI 10.1515/hsz-2012-0199; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Schulze RJ, 2014, P NATL ACAD SCI USA, V111, P4844, DOI 10.1073/pnas.1315901111; Seitl I, 2014, MOL MICROBIOL, V91, P408, DOI 10.1111/mmi.12465; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shimokawa-Chiba N, 2015, P NATL ACAD SCI USA, V112, P5063, DOI 10.1073/pnas.1423817112; Veenendaal AKJ, 2004, BBA-MOL CELL RES, V1694, P81, DOI 10.1016/j.bbamcr.2004.02.009; Wang P, 2011, BBA-BIOMEMBRANES, V1808, P866, DOI 10.1016/j.bbamem.2010.08.014; Winterfeld S, 2009, BIOCHEMISTRY-US, V48, P6684, DOI 10.1021/bi9003809; Xie K, 2006, BIOCHEMISTRY-US, V45, P13401, DOI 10.1021/bi060826z	30	15	15	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2411	2421		10.1096/fj.201700893RR	http://dx.doi.org/10.1096/fj.201700893RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29295859				2022-12-28	WOS:000432528000009
J	Wei, C; Stock, L; Valanejad, L; Zalewski, ZA; Karns, R; Puymirat, J; Nelson, D; Witte, D; Woodgett, J; Timchenko, NA; Timchenko, L				Wei, Christina; Stock, Lauren; Valanejad, Leila; Zalewski, Zachary A.; Karns, Rebekah; Puymirat, Jack; Nelson, David; Witte, David; Woodgett, Jim; Timchenko, Nikolai A.; Timchenko, Lubov			Correction of GSK3 beta at young age prevents muscle pathology in mice with myotonic dystrophy type 1	FASEB JOURNAL			English	Article						CUG repeats; CUGBP1; glycogen synthase kinase 3 beta	RNA-BINDING PROTEIN; SKELETAL-MUSCLE; CUG REPEATS; NEUROMUSCULAR-JUNCTION; HELICASE P68/DDX5; MESSENGER-RNA; OVEREXPRESSION; MECHANISMS; EXPRESSION; MOUSE	Myotonic dystrophy type 1 (DM1) is a progressive neuromuscular disease caused by expanded CUG repeats, which misregulate RNA metabolism through several RNA-binding proteins, including CUG-binding protein/CUGBP1 elav-like factor 1 (CUGBP1/CELF1) and muscleblind 1 protein. Mutant CUG repeats elevate CUGBP1 and alter CUGBP1 activity via a glycogen synthase kinase 3 beta (GSK3 beta)-cyclin D3-cyclin D-dependent kinase 4 (CDK4) signaling pathway. Inhibition of GSK3 corrects abnormal activity of CUGBP1 in DM1 mice [human skeletal actin mRNA, containing long repeats (HSA(LR)) model]. Here, we show that the inhibition of GSK3 beta in young HSA(LR) mice prevents development of DM1 muscle pathology. Skeletal muscle in 1-yr-old HSA(LR) mice, treated at 1.5 mo for 6 wk with the inhibitors of GSK3, exhibits high fiber density, corrected atrophy, normal fiber size, with reduced central nuclei and normalized grip strength. Because CUG-GSK3 beta-cyclin D3-CDK4 converts the active form of CUGBP1 into a form of translational repressor, we examined the contribution of CUGBP1 in myogenesis using Celf1 knockout mice. We found that a loss of CUGBP1 disrupts myogenesis, affecting genes that regulate differentiation and the extracellular matrix. Proteins of those pathways are also misregulated in young HSA(LR) mice and in muscle biopsies of patients with congenital DM1. These findings suggest that the correction of GSK3-CUGBP1 pathway in young HSA(LR) mice might have a positive effect on the myogenesis over time.	[Wei, Christina; Stock, Lauren; Timchenko, Lubov] Cincinnati Childrens Hosp, Div Neurol, Cincinnati, OH USA; [Valanejad, Leila; Timchenko, Nikolai A.] Cincinnati Childrens Hosp, Dept Surg, Cincinnati, OH USA; [Karns, Rebekah] Cincinnati Childrens Hosp, Dept Bioinformat, Cincinnati, OH USA; [Witte, David] Cincinnati Childrens Hosp, Dept Pathol, Cincinnati, OH USA; [Zalewski, Zachary A.; Nelson, David] Baylor Coll Med, Dept Mol Genet, Houston, TX 77030 USA; [Puymirat, Jack] CHU Laval, Res Ctr, Quebec City, PQ, Canada; [Woodgett, Jim] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Baylor College of Medicine; Laval University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Timchenko, L (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Neurol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	tubov.timchenko@cchmc.org	Woodgett, Jim/F-1087-2010	Woodgett, Jim/0000-0003-3731-5797	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR044387, AR052791, AR064488]; NIH National Cancer Institute [CA159942]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [DK102597]; Internal Development Funds from Cincinnati Children's Hospital Medical Center; NATIONAL CANCER INSTITUTE [R01CA159942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044387, R01AR052791, R21AR064488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008307] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Internal Development Funds from Cincinnati Children's Hospital Medical Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Mei Wang (Cincinnati Children's Hospital Medical Center) for the help with RT-PCR analysis. This work was supported by U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases Grants AR044387 and AR052791, AR064488 (to L.T.), NIH National Cancer Institute Grant CA159942, NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant DK102597 (to N.A.T.), and by Internal Development Funds from Cincinnati Children's Hospital Medical Center (to L.T. and N.A.T.). The authors declare no conflicts of interest.	Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; Berger DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019274; Bourgeois F, 2015, NEUROMUSCULAR DISORD, V25, P461, DOI 10.1016/j.nmd.2015.01.012; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Chopra P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014305; Giudice J, 2016, SCI REP-UK, V6, DOI 10.1038/srep35550; Gunthorpe D, 1999, DEV BIOL, V215, P130, DOI 10.1006/dbio.1999.9449; Harper PS, 2001, MYOTONIC DYSTROPHY; Ho TH, 2005, HUM MOL GENET, V14, P1539, DOI 10.1093/hmg/ddi162; Huichalaf C, 2010, FASEB J, V24, P3706, DOI 10.1096/fj.09-151159; Jones K, 2015, P NATL ACAD SCI USA, V112, P8041, DOI 10.1073/pnas.1422273112; Jones K, 2012, J CLIN INVEST, V122, P4461, DOI 10.1172/JCI64081; Kim YK, 2014, HUM MOL GENET, V23, P293, DOI 10.1093/hmg/ddt419; Koshelev M, 2010, HUM MOL GENET, V19, P1066, DOI 10.1093/hmg/ddp570; Kress C, 2007, MOL CELL BIOL, V27, P1146, DOI 10.1128/MCB.01009-06; Kuyumcu-Martinez NM, 2007, MOL CELL, V28, P68, DOI 10.1016/j.molcel.2007.07.027; Latvanlehto A, 2010, J NEUROSCI, V30, P12230, DOI 10.1523/JNEUROSCI.5518-09.2010; Laurent FX, 2012, NUCLEIC ACIDS RES, V40, P3159, DOI 10.1093/nar/gkr1228; Lu TJ, 2013, P NATL ACAD SCI USA, V110, P19131, DOI 10.1073/pnas.1303687110; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Ogawa R, 2015, DEVELOPMENT, V142, P51, DOI 10.1242/dev.112557; Pettersson OJ, 2014, NUCLEIC ACIDS RES, V42, P7186, DOI 10.1093/nar/gku352; Ravel-Chapuis A, 2012, J CELL BIOL, V196, P699, DOI 10.1083/jcb.201108113; Salisbury E, 2008, EXP CELL RES, V314, P2266, DOI 10.1016/j.yexcr.2008.04.018; Schoser B, 2010, CURR GENOMICS, V11, P77, DOI 10.2174/138920210790886844; Tamada H, 2002, BIOCHEM BIOPH RES CO, V297, P96, DOI 10.1016/S0006-291X(02)02132-0; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Timchenko LT, 1996, HUM MOL GENET, V5, P115, DOI 10.1093/hmg/5.1.115; Timchenko LT, 1999, AM J HUM GENET, V64, P360, DOI 10.1086/302268; Timchenko L, 2013, INT J BIOCHEM CELL B, V45, P2280, DOI 10.1016/j.biocel.2013.06.010; Timchenko NA, 2004, J BIOL CHEM, V279, P13129, DOI 10.1074/jbc.M312923200; Timchenko NA, 2001, J BIOL CHEM, V276, P7820, DOI 10.1074/jbc.M005960200; Vivian JL, 1999, DEV BIOL, V208, P44, DOI 10.1006/dbio.1998.9182; Wagatsuma A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/121254; Ward AJ, 2010, HUM MOL GENET, V19, P3614, DOI 10.1093/hmg/ddq277; Yurchenco PD, 2009, CURR PHARM DESIGN, V15, P1277, DOI 10.2174/138161209787846766	37	18	18	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2073	2085		10.1096/fj.201700700R	http://dx.doi.org/10.1096/fj.201700700R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29203592	Green Published			2022-12-28	WOS:000429051400028
J	Feng, YF; Wang, J; Yuan, YZ; Zhang, X; Shen, MQ; Yuan, F				Feng, Yifan; Wang, Jing; Yuan, Yuanzhi; Zhang, Xi; Shen, Minqian; Yuan, Fei			miR-539-5p inhibits experimental choroidal neovascularization by targeting CXCR7	FASEB JOURNAL			English	Article						microRNA; SDF-1; endothelial cells; angiogenesis	RETINAL ENDOTHELIAL-CELLS; MACULAR DEGENERATION; OCULAR NEOVASCULARIZATION; CHEMOKINE RECEPTOR; PROGENITOR CELLS; PROSTATE-CANCER; TUBE FORMATION; TUMOR-GROWTH; IN-VIVO; EXPRESSION	Stromal cell-derived factor-1 (SDF-1) has been previously confirmed to participate in the formation of choroidal neovascularization (CNV) via its receptor, CXC chemokine receptor (CXCR) 4; CXCR7 is a recently identified receptor for SDF-1. The molecular mechanisms and therapeutic value of CXCR7 in CNV remain undefined. In this study, experimental CNV was induced by laser photocoagulation in Brown-Norway pigmented rats, and aberrant CXCR7 overexpression was detected in the retinal pigment epithelial/choroid/sclera tissues of laser-injured eyes. Blockade of CXCR7 activation via CXCR7 knockdown or neutralizing Ab administration inhibited SDF-1-induced cell survival and the tubular formation of human retinal microvascular endothelial cells (HRMECs) in vitro and reduced CNV leakage and lesion size in vivo. By using microRNA array screening and bioinformatic analyses, we identified miR-539-5p as a regulator of CXCR7. Transfection of HRMECs and choroid-retinal endothelial (RF/6A) cells with the miR-539-5p mimic inhibited their survival and tube formation, whereas CXCR7 overexpression rescued the suppressive effect of miR-539-5p. The antiangiogenic activities of the miR-539-5p mimic were additionally demonstrated in vivo by intravitreal injection. ERK1/2 and AKT signaling downstream of CXCR7 is involved in the miR-539-5p regulation of endothelial cell behaviors. These findings suggest that the manipulation of miR-539-5p/CXCR7 levels may have important therapeutic implications in CNV-associated diseases.	[Feng, Yifan; Wang, Jing; Yuan, Yuanzhi; Zhang, Xi; Shen, Minqian; Yuan, Fei] Fudan Univ, Zhongshan Hosp, Dept Ophthalmol, 180 Fenglin Rd, Shanghai 200032, Peoples R China	Fudan University	Yuan, F (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Ophthalmol, 180 Fenglin Rd, Shanghai 200032, Peoples R China.	yuanfeiyk@163.com		wang, jing/0000-0003-3904-488X	National Nature Science Foundation of China [81641157, 81470637, 81600735]; Young Foundation of Zhongshan Hospital [2016ZSQN38]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Foundation of Zhongshan Hospital	This study was supported by grants from the National Nature Science Foundation of China (Grants 81641157, 81470637, and 81600735) and the Young Foundation of Zhongshan Hospital (Grant 2016ZSQN38). The authors declare no conflicts of interest.	Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berber P, 2017, MOL DIAGN THER, V21, P31, DOI 10.1007/s40291-016-0234-z; Bullard LE, 2003, INVEST OPHTH VIS SCI, V44, P1722, DOI 10.1167/iovs.01-1193; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cai JJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-88; Chang SH, 2014, P NATL ACAD SCI USA, V111, P18309, DOI 10.1073/pnas.1412172111; Chen Q, 2015, STEM CELLS, V33, P2574, DOI 10.1002/stem.2022; Chen XF, 2016, BIOMED PHARMACOTHER, V81, P379, DOI [10.1016/j.biopha.2016.04.023, 10.1016/j.biopha.2016.09.038]; Dufourcq P, 2008, AM J PATHOL, V172, P37, DOI 10.2353/ajpath.2008.070130; Feng YF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136175; Feng YF, 2014, MOL CELL BIOCHEM, V397, P131, DOI 10.1007/s11010-014-2180-6; Garrett KL, 2001, J GENE MED, V3, P373, DOI 10.1002/jgm.197; Gracia A, 2016, FOOD FUNCT, V7, P1680, DOI [10.1039/c5fo01090j, 10.1039/C5FO01090J]; Guerin E, 2008, MICROVASC RES, V75, P302, DOI 10.1016/j.mvr.2007.12.001; Hao HF, 2017, CIRCULATION, V135, P1253, DOI 10.1161/CIRCULATIONAHA.116.023027; Hu Y, 2013, INVEST OPHTH VIS SCI, V54, P141, DOI 10.1167/iovs.12-10281; Jin J, 2013, OPHTHALMIC RES, V50, P6, DOI 10.1159/000348532; Kumar R, 2012, CELL IMMUNOL, V272, P230, DOI 10.1016/j.cellimm.2011.09.015; Lee E, 2010, INVEST OPHTH VIS SCI, V51, P3666, DOI 10.1167/iovs.09-3802; Liu CH, 2015, P NATL ACAD SCI USA, V112, P12163, DOI 10.1073/pnas.1508426112; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maksym RB, 2009, EUR J PHARMACOL, V625, P31, DOI 10.1016/j.ejphar.2009.04.071; Mazzinghi B, 2008, J EXP MED, V205, P479, DOI 10.1084/jem.20071903; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Muthusamy S, 2014, J BIOL CHEM, V289, P29665, DOI 10.1074/jbc.M114.578682; Nagai N, 2014, J NUTR BIOCHEM, V25, P1218, DOI 10.1016/j.jnutbio.2014.05.015; Neelam K, 2012, PROG RETIN EYE RES, V31, P495, DOI 10.1016/j.preteyeres.2012.04.001; Pawig L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00429; Peghaire C, 2016, ARTERIOSCL THROM VAS, V36, P2369, DOI 10.1161/ATVBAHA.116.307926; Ren CD, 2017, CELL PHYSIOL BIOCHEM, V41, P1413, DOI 10.1159/000467941; RHOADS RE, 1988, TRENDS BIOCHEM SCI, V13, P52, DOI 10.1016/0968-0004(88)90028-X; SanGiovanni JP, 2017, CLIN CHEM LAB MED, V55, P763, DOI 10.1515/cclm-2016-0898; Sengupta N, 2010, INVEST OPHTH VIS SCI, V51, P2697, DOI 10.1167/iovs.09-4137; Shen JK, 2008, MOL THER, V16, P1208, DOI 10.1038/mt.2008.104; Sheu SJ, 2013, INVEST OPHTH VIS SCI, V54, P6426, DOI 10.1167/iovs.13-12024; Silva RLE, 2007, FASEB J, V21, P3219, DOI 10.1096/fj.06-7359com; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Suzuki M, 2014, BRIT J OPHTHALMOL, V98, P1186, DOI 10.1136/bjophthalmol-2013-304670; Totonchy JE, 2014, CELL ADHES MIGR, V8, P165, DOI 10.4161/cam.28495; Tranos P, 2013, DRUG DES DEV THER, V7, P485, DOI 10.2147/DDDT.S43470; Tripathi V, 2014, CELL COMMUN ADHES, V21, P221, DOI 10.3109/15419061.2013.876013; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; WANG K, 2014, NAT COMMUN, V5; Wang L, 2016, J PHYSIOL BIOCHEM, V72, P583, DOI 10.1007/s13105-016-0496-2; Wang LY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050626; Wong CW, 2016, PROG RETIN EYE RES, V53, P107, DOI 10.1016/j.preteyeres.2016.04.002; Yamada K, 2015, INT J CANCER, V137, P2825, DOI 10.1002/ijc.29655; Yang XM, 2009, INVEST OPHTH VIS SCI, V50, P1873, DOI 10.1167/iovs.08-2591; Zhang HT, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0337-8; Zhang ZX, 2011, CURR EYE RES, V36, P838, DOI 10.3109/02713683.2011.593107; Zhang ZL, 2009, EXP EYE RES, V89, P522, DOI 10.1016/j.exer.2009.05.012; Zhou QB, 2014, MOL THER, V22, P378, DOI 10.1038/mt.2013.243; Zhou QB, 2011, P NATL ACAD SCI USA, V108, P8287, DOI 10.1073/pnas.1105254108; Zhu CY, 2016, LIFE SCI, V166, P34, DOI 10.1016/j.lfs.2016.10.002	56	25	26	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1626	1639		10.1096/fj.201700640R	http://dx.doi.org/10.1096/fj.201700640R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29146732				2022-12-28	WOS:000427246000040
J	Cui, GH; Wu, J; Mou, FF; Xie, WH; Wang, FB; Wang, QL; Fang, J; Xu, YW; Dong, YR; Liu, JR; Guo, HD				Cui, Guo-Hong; Wu, Jing; Mou, Fang-Fang; Xie, Wei-Hua; Wang, Fu-Bo; Wang, Qiang-Li; Fang, Jie; Xu, Yan-Wu; Dong, You-Rong; Liu, Jian-Ren; Guo, Hai-Dong			Exosomes derived from hypoxia-preconditioned mesenchymal stromal cells ameliorate cognitive decline by rescuing synaptic dysfunction and regulating inflammatory responses in APP/PS1 mice	FASEB JOURNAL			English	Article						Alzheimer disease; microRNA; inflammatory cytokine	NF-KAPPA-B; ALZHEIMERS-DISEASE; STEM-CELLS; DELIVERY; BRAIN; DIFFERENTIATION; TRANSPLANTATION; CONTRIBUTES; MICRORNA-21; SUPPRESSION	Administration of exosomes derived from mesenchymal stromal cells (MSCs) could improve some neurologic conditions by transferring functional biomolecules to recipient cells. Furthermore, exosomes from hypoxic progenitor cells exerted better therapeutic effects in organ injury through specific cargoes. However, there are no related reports about whether exosomes derived from MSCs or hypoxia-preconditioned MSCs (PC-MSCs) could prevent memory deficits in Alzheimer disease (AD). In this study, the exosomes derived from MSCs or PC-MSCs were systemically administered to transgenic APP/PS1 mice. The expression of miR-21 in MSCs was significantly increased after hypoxic treatment. Injection of exosomes from normoxic MSCs could rescue cognition and memory impairment according to results of the Morris water maze test, reduced plaque deposition, and Ab levels in the brain; could decrease the activation of astrocytes and microglia; could down-regulate proinflammatory cytokines (TNF-alpha and IL-1 beta); and could up-regulate anti-inflammatory cytokines (IL-4 and -10) in AD mice, as well as reduce the activation of signal transducer and activator of transcription 3 (STAT3) and NF-kappa B. Compared to the group administered exosomes from normoxic MSCs, in the group administered exosomes from PC-MSCs, learning and memory capabilities were significantly improved; the plaque deposition and Ab levels were lower, and expression of growth-associated protein 43, synapsin 1, and IL-10 was increased; and the levels of glial fibrillary acidic protein, ionized calcium-binding adaptor molecule 1, TNF-alpha, IL-1 beta, and activation of STAT3 and NF-kappa B were sharply decreased. More importantly, exosomes from PC-MSCs effectively increased the level of miR-21 in the brain of AD mice. Additionally, replenishment of miR-21 restored the cognitive deficits in APP/PS1 mice and prevented pathologic features. Taken together, these findings suggest that exosomes from PC-MSCs could improve the learning and memory capabilities of APP/PS1 mice, and that the underlying mechanism may lie in the restoration of synaptic dysfunction and regulation of inflammatory responses through regulation of miR-21.	[Cui, Guo-Hong; Wu, Jing; Fang, Jie; Dong, You-Rong; Liu, Jian-Ren] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Neurol, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China; [Mou, Fang-Fang; Wang, Fu-Bo; Wang, Qiang-Li; Xu, Yan-Wu; Guo, Hai-Dong] Shanghai Univ Tradit Chinese Med, Sch Basic Med, Dept Anat, 1200 Cailun Rd, Shanghai 201203, Peoples R China; [Xie, Wei-Hua] Hosp Anhui Prov, Dept Constipat Acupuncture & Moxibust, Hefei, Anhui, Peoples R China	Shanghai Jiao Tong University; Shanghai University of Traditional Chinese Medicine	Liu, JR (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Neurol, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.; Guo, HD (corresponding author), Shanghai Univ Tradit Chinese Med, Sch Basic Med, Dept Anat, 1200 Cailun Rd, Shanghai 201203, Peoples R China.	liujr021@vip.163.com; hdguo8@hotmail.com	wang, qiangli/GVU-4045-2022; wang, fubo/GPF-4834-2022; Xu, Yanwu/AAK-6357-2020	Xu, Yanwu/0000-0002-9253-7790	National Natural Science Foundation of China [31400838, 81102670]; Shanghai People's Hospital [2013A05, 9]; Shanghai Jiaotong University Biomedical Engineering Crossover Project [YG2011MS12]; Research Fund for the Doctoral Program Construction of Shanghai [B201706]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai People's Hospital; Shanghai Jiaotong University Biomedical Engineering Crossover Project; Research Fund for the Doctoral Program Construction of Shanghai	This work was supported, in part, by grants from the National Natural Science Foundation of China (31400838 and 81102670), the Program of No. 9 Shanghai People's Hospital (2013A05), the Shanghai Jiaotong University Biomedical Engineering Crossover Project (YG2011MS12), and the Research Fund for the Doctoral Program Construction of Shanghai (B201706). The authors declare no conflicts of interest.	Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Carlson C, 2011, ALZHEIMERS DEMENT, V7, P396, DOI 10.1016/j.jalz.2011.05.2353; Carta MG, 2002, PSYCHOTHER PSYCHOSOM, V71, P233, DOI 10.1159/000063649; Chatterjee N, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.83; Chever O, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0596; Choi DS, 2015, MASS SPECTROM REV, V34, P474, DOI 10.1002/mas.21420; Cui GH, 2016, MOL NEUROBIOL, V53, P1108, DOI 10.1007/s12035-014-9069-y; Das A, 2014, J IMMUNOL, V192, P1120, DOI 10.4049/jimmunol.1300613; Dong LY, 2014, J CELL MOL MED, V18, P2213, DOI 10.1111/jcmm.12353; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Garo LP, 2016, CELL MOL LIFE SCI, V73, P2041, DOI 10.1007/s00018-016-2167-4; Granic I, 2009, J ALZHEIMERS DIS, V16, P809, DOI 10.3233/JAD-2009-0976; Gray WD, 2015, CIRC RES, V116, P255, DOI 10.1161/CIRCRESAHA.116.304360; Haney MJ, 2015, J CONTROL RELEASE, V207, P18, DOI 10.1016/j.jconrel.2015.03.033; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Kamphuis W, 2016, BBA-MOL BASIS DIS, V1862, P1847, DOI 10.1016/j.bbadis.2016.07.007; Katsuda T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01197; Kim EA, 2014, J NEUROIMMUNE PHARM, V9, P461, DOI 10.1007/s11481-014-9542-4; Kim S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045757; Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004; Lee JK, 2010, STEM CELLS, V28, P329, DOI 10.1002/stem.277; Lee SY, 2005, MOL BRAIN RES, V140, P45, DOI 10.1016/j.molbrainres.2005.07.009; Lee YJ, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-132; Li X, 2016, EBIOMEDICINE, V8, P72, DOI 10.1016/j.ebiom.2016.04.030; Liu YC, 2015, SCI REP-UK, V5, DOI 10.1038/srep17543; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Paris D, 2013, EUR J PHARMACOL, V698, P145, DOI 10.1016/j.ejphar.2012.11.017; Peng J, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt73; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Sandhir R, 2014, NEUROCHEM INT, V78, P117, DOI 10.1016/j.neuint.2014.09.009; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; SELKOE DJ, 1989, ANN MED, V21, P73, DOI 10.3109/07853898909149187; Theriault P, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0125-2; Verma M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128224; Wang F, 2014, MOL NEUROBIOL, V50, P305, DOI 10.1007/s12035-013-8609-1; Wen Y, 2008, NEURON, V57, P680, DOI 10.1016/j.neuron.2008.02.024; Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346; Xiao SH, 2016, BIOMATERIALS, V106, P98, DOI 10.1016/j.biomaterials.2016.08.021; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Yu J, 2016, EXP THER MED, V12, P1822, DOI 10.3892/etm.2016.3535; Zhou HM, 2016, J NEUROL SCI, V367, P3, DOI 10.1016/j.jns.2016.05.038	41	174	184	11	49	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					654	668		10.1096/fj.201700600R	http://dx.doi.org/10.1096/fj.201700600R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	28970251	Bronze			2022-12-28	WOS:000425146900011
J	Goetzl, EJ; Abner, EL; Jicha, GA; Kapogiannis, D; Schwartz, JB				Goetzl, Edward J.; Abner, Erin L.; Jicha, Gregory A.; Kapogiannis, Dimitrios; Schwartz, Janice B.			Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer's disease	FASEB JOURNAL			English	Article						dementia; neurodegeneration; biomarkers	COGNITIVE IMPAIRMENT; EXCITATORY SYNAPSES; NEUROLIGINS; OLIGOMERS; NARP	Interactions of the presynaptic proteins, neuronal pentraxin 2 (NPTX2) and neurexin 2 alpha (NRXN2 alpha), with their respective postsynaptic functional partners, GluA4-containing glutamate (AMPA4) receptor and neuroligin 1 (NLGN1), enhance excitatory synaptic activity in some areas of the hippocampus and cerebral cortex. As early damage of such excitatory circuits in the brain tissues of participants with Alzheimer's disease (AD) correlates with cognitive losses, plasma neuron-derived exosome (NDE) levels of these 2 pairs of specialized synaptic proteins were quantified to assess their biomarker characteristics. The NDE contents of all 4 proteins were decreased significantly in AD dementia (n=46), and diminished levels of AMPA4 and NLGN1 correlated with the extent of cognitive loss. In a preclinical period, 6-11 yr before the onset of dementia, the NDE levels of all but NPTX2 were significantly lower than those of matched controls, and levels of all proteins declined significantly with the development of dementia. Reductions in NDE levels of these specialized excitatory synaptic proteins may therefore be indicative of the extent of cognitive loss and may reflect progression of the severity of AD.	[Goetzl, Edward J.; Schwartz, Janice B.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Schwartz, Janice B.] Univ Calif San Francisco, Dept Bioengn, San Francisco, CA USA; [Goetzl, Edward J.; Schwartz, Janice B.] Jewish Home San Francisco, San Francisco, CA USA; [Abner, Erin L.; Jicha, Gregory A.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Kapogiannis, Dimitrios] NIA, Lab Neurosci, Baltimore, MD 21224 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Kentucky; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Goetzl, EJ (corresponding author), Geriatr Res Ctr, 1719 Broderick St, San Francisco, CA 94115 USA.	edward.goetzl@ucsf.edu	Kapogiannis, Dimitrios/AAW-4934-2020; Schwartz, Janice/K-6354-2019	Kapogiannis, Dimitrios/0000-0003-2181-3118; 	Biomarkers Across Neurodegenerative Diseases 2 (BAND2) program of the Michael J. Fox Foundation for Parkinson's Research; Alzheimer's Association, Alzheimer's Research United Kingdom; Weston Brain Institute; U.S. National Institutes of Health (NIH) National Institute on Aging (NIA) [P30028383]; Intramural Research Program of the NIH NIA; NATIONAL INSTITUTE ON AGING [ZIAAG000975, P30AG028383] Funding Source: NIH RePORTER	Biomarkers Across Neurodegenerative Diseases 2 (BAND2) program of the Michael J. Fox Foundation for Parkinson's Research; Alzheimer's Association, Alzheimer's Research United Kingdom; Weston Brain Institute; U.S. National Institutes of Health (NIH) National Institute on Aging (NIA); Intramural Research Program of the NIH NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Judith H. Goetzl (Jewish Home of San Francisco) for expert preparation of the illustrations. This work was supported by a grant from the Biomarkers Across Neurodegenerative Diseases 2 (BAND2) program of the Michael J. Fox Foundation for Parkinson's Research, the Alzheimer's Association, Alzheimer's Research United Kingdom, and the Weston Brain Institute (to E.J.G.); and by the U.S. National Institutes of Health (NIH) National Institute on Aging (NIA) (Grant P30028383; to G.A.J.). D.K. was supported by the Intramural Research Program of the NIH NIA. E.J.G. has filed an application with the U.S. Patent Office for the platform and methodologies described in this report. The remaining authors declare no conflicts of interest.	Bie BH, 2014, NAT NEUROSCI, V17, P223, DOI 10.1038/nn.3618; Brito-Moreira J, 2017, J BIOL CHEM, V292, P7327, DOI 10.1074/jbc.M116.761189; Cano SJ, 2010, J NEUROL NEUROSUR PS, V81, P1363, DOI 10.1136/jnnp.2009.204008; Chang MC, 2010, NAT NEUROSCI, V13, P1090, DOI 10.1038/nn.2621; Clare R, 2010, J NEUROSCI RES, V88, P2083, DOI 10.1002/jnr.22392; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Dinamarca MC, 2015, BIOCHEM BIOPH RES CO, V466, P66, DOI 10.1016/j.bbrc.2015.08.107; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Goetzl EJ, 2016, FASEB J, V30, P4141, DOI 10.1096/fj.201600816R; Goetzl EJ, 2016, FASEB J, V30, P3853, DOI 10.1096/fj.201600756R; Kapogiannis D, 2015, FASEB J, V29, P589, DOI 10.1096/fj.14-262048; Lee SJ, 2017, J NEUROSCI, V37, P1062, DOI 10.1523/JNEUROSCI.2768-16.2016; Mustapic M, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00278; Pelkey KA, 2016, NEURON, V90, P661, DOI 10.1016/j.neuron.2016.04.024; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Soler-Llavina GJ, 2011, P NATL ACAD SCI USA, V108, P16502, DOI 10.1073/pnas.1114028108; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tristan-Clavijo E, 2015, NEUROBIOL AGING, V36, P3171, DOI 10.1016/j.neurobiolaging.2015.09.004; Weiner Michael W, 2015, Alzheimers Dement, V11, pe1, DOI 10.1016/j.jalz.2014.11.001; Xiao MF, 2017, ELIFE, V6, DOI 10.7554/eLife.23798; Xu DS, 2003, NEURON, V39, P513, DOI 10.1016/S0896-6273(03)00463-X	25	112	114	1	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					888	893		10.1096/fj.201700731R	http://dx.doi.org/10.1096/fj.201700731R			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29025866	Green Published, Bronze			2022-12-28	WOS:000425146900030
J	O'Leime, CS; Kozareva, DA; Hoban, AE; Long-Smith, CM; Cryan, JF; Nolan, YM				O'Leime, Ciaran S.; Kozareva, Danka A.; Hoban, Alan E.; Long-Smith, Caitriona M.; Cryan, John F.; Nolan, Yvonne M.			TLX is an intrinsic regulator of the negative effects of IL-1 beta on proliferating hippocampal neural progenitor cells	FASEB JOURNAL			English	Article						neurogenesis; nuclear receptor; inflammation; Nr2e1	NF-KAPPA-B; NUCLEAR RECEPTOR TLX; LONG-TERM POTENTIATION; SPATIAL-PATTERN SEPARATION; STEM-CELLS; INTERLEUKIN-1 RECEPTORS; ADULT NEUROGENESIS; PRECURSOR CELLS; DENTATE GYRUS; TAILLESS GENE	Hippocampal neurogenesis is a lifelong process whereby new neurons are produced and integrate into the host circuitry within the hippocampus. It is regulated by a multitude of extrinsic and intrinsic regulators and is believed to contribute to certain hippocampal-dependent cognitive tasks. Hippocampal neurogenesis and associated cognition have been demonstrated to be impaired after increases in the levels of proinflammatory cytokine IL-1 beta in the hippocampus, such as that which occurs in various neurodegenerative and psychiatric disorders. IL-1 beta also suppresses the expression of TLX(orphan nuclear receptor tailless homolog), which is an orphan nuclear receptor that functions to promote neural progenitor cell (NPC) proliferation and suppress neuronal differentiation; therefore, manipulation of TLX represents a potential strategy with which to prevent the antiproliferative effects of IL-1 beta. In this study, we assessed the mechanism that underlies IL-1 beta-induced changes in TLX expression and determined the protective capacity of TLX to mitigate the effects of IL-1 beta on embryonic rat hippocampal neurosphere expansion. We demonstrate that IL-1 beta activated the NF-kappa B pathway in proliferating NPCs and that this activation was responsible for IL-1 beta-induced changes in TLX expression. In addition, we report that enhancing TLX expression prevented the IL-1 beta-induced suppression of neurosphere expansion. Thus, we highlight TLX as a potential protective regulator of the antiproliferative effects of IL-1 beta on hippocampal neurogenesis.	[O'Leime, Ciaran S.; Kozareva, Danka A.; Hoban, Alan E.; Long-Smith, Caitriona M.; Cryan, John F.; Nolan, Yvonne M.] Univ Coll Cork, Dept Anat & Neurosci, Western Gate Bldg,Western Rd, Cork T12 YN60, Ireland; [Long-Smith, Caitriona M.; Cryan, John F.; Nolan, Yvonne M.] Univ Coll Cork, Alimentary Pharmabiot Ctr, Microbiome Inst, Cork, Ireland	University College Cork; University College Cork	Nolan, YM (corresponding author), Univ Coll Cork, Dept Anat & Neurosci, Western Gate Bldg,Western Rd, Cork T12 YN60, Ireland.	y.nolan@ucc.ie	Cryan, John F./A-6950-2013; Long-Smith, Caitriona/AAD-1936-2022	Cryan, John F./0000-0001-5887-2723; Nolan, Yvonne/0000-0003-2426-234X; Kozareva, Danka/0000-0001-7627-0312; Leime, Ciaran/0000-0002-7420-4159	Science Foundation Ireland [12/IA/1537]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by the Science Foundation Ireland (Grant 12/IA/1537). The authors declare no conflicts of interest.	Arias-Salvatierra D, 2011, CELL SIGNAL, V23, P425, DOI 10.1016/j.cellsig.2010.10.017; Bekinschtein P, 2011, SEMIN CELL DEV BIOL, V22, P536, DOI 10.1016/j.semcdb.2011.07.002; Benod C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099440; Chen F, 2006, J BIOL CHEM, V281, P37142, DOI 10.1074/jbc.M603631200; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Creer DJ, 2010, P NATL ACAD SCI USA, V107, P2367, DOI 10.1073/pnas.0911725107; de Vries EM, 2014, ENDOCRINOLOGY, V155, P2000, DOI 10.1210/en.2013-2018; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Drapeau E, 2007, J NEUROSCI, V27, P6037, DOI 10.1523/JNEUROSCI.1031-07.2007; FARRAR WL, 1987, J IMMUNOL, V139, P459; Godbout JP, 2009, IMMUNOL ALLERGY CLIN, V29, P321, DOI 10.1016/j.iac.2009.02.007; Goshen I, 2008, MOL PSYCHIATR, V13, P717, DOI 10.1038/sj.mp.4002055; Green HF, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.117; Green HF, 2012, NEUROCHEM INT, V61, P666, DOI 10.1016/j.neuint.2012.07.003; Green HF, 2012, MOL CELL NEUROSCI, V49, P311, DOI 10.1016/j.mcn.2012.01.001; Griffin BD, 2006, J BIOL CHEM, V281, P10316, DOI 10.1074/jbc.M509973200; Hodge RD, 2011, DEV NEUROBIOL, V71, P680, DOI 10.1002/dneu.20882; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Keohane A, 2010, MOL CELL NEUROSCI, V43, P127, DOI 10.1016/j.mcn.2009.10.003; Kesanakurti D, 2013, ONCOGENE, V32, P5144, DOI 10.1038/onc.2012.546; Kettenmann H, 2013, NEURON, V77, P10, DOI 10.1016/j.neuron.2012.12.023; Kohman RA, 2013, BRAIN BEHAV IMMUN, V27, P22, DOI 10.1016/j.bbi.2012.09.003; Koo JW, 2008, P NATL ACAD SCI USA, V105, P751, DOI 10.1073/pnas.0708092105; Koo JW, 2010, P NATL ACAD SCI USA, V107, P2669, DOI 10.1073/pnas.0910658107; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kumar A, 2011, DIABETES OBES METAB, V13, P750, DOI 10.1111/j.1463-1326.2011.01402.x; Lazarov O, 2010, TRENDS NEUROSCI, V33, P569, DOI 10.1016/j.tins.2010.09.003; Leonard BE, 2007, NEUROCHEM RES, V32, P1749, DOI 10.1007/s11064-007-9385-y; Li WW, 2008, MOL ENDOCRINOL, V22, P56, DOI 10.1210/me.2007-0290; Liu CM, 2009, NEUROMOL MED, V11, P141, DOI 10.1007/s12017-009-8077-y; Liu HK, 2010, GENE DEV, V24, P683, DOI 10.1101/gad.560310; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Maes M, 2012, EXPERT OPIN THER TAR, V16, P1097, DOI 10.1517/14728222.2012.718331; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; MONAGHAN AP, 1995, DEVELOPMENT, V121, P839; Monaghan AP, 1997, NATURE, V390, P515, DOI 10.1038/37364; Murai K, 2014, P NATL ACAD SCI USA, V111, P9115, DOI 10.1073/pnas.1406779111; Na KS, 2014, PROG NEURO-PSYCHOPH, V48, P277, DOI 10.1016/j.pnpbp.2012.10.022; Nolan YM, 2013, TRENDS MOL MED, V19, P187, DOI 10.1016/j.molmed.2012.12.003; O'Leary JD, 2018, GENES BRAIN BEHAV, V17, DOI 10.1111/gbb.12357; O'Leary JD, 2016, BEHAV BRAIN RES, V306, P36, DOI 10.1016/j.bbr.2016.03.022; O'Leime CS, 2017, BRAIN BEHAV IMMUN, V66, P394, DOI 10.1016/j.bbi.2017.07.153; Park HJ, 2010, MOL CELLS, V30, P403, DOI 10.1007/s10059-010-0122-z; PARNET P, 1994, MOL BRAIN RES, V27, P63, DOI 10.1016/0169-328X(94)90185-6; Pechnick RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027290; Pugh CR, 1999, BEHAV BRAIN RES, V106, P109, DOI 10.1016/S0166-4328(99)00098-4; Qu QH, 2009, J CELL PHYSIOL, V221, P5, DOI 10.1002/jcp.21862; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Rothwell NJ, 1996, PHARMACOL THERAPEUT, V69, P85, DOI 10.1016/0163-7258(95)02033-0; Roy K, 2002, PHYSIOL BEHAV, V77, P595, DOI 10.1016/S0031-9384(02)00902-2; Ryan SM, 2013, BRAIN BEHAV IMMUN, V33, P7, DOI 10.1016/j.bbi.2013.03.005; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Seitz CS, 2000, CANCER RES, V60, P4085; Sharpless NE, 2004, J CLIN INVEST, V113, P160, DOI 10.1172/JCI200420761; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Shin HM, 2004, FEBS LETT, V571, P50, DOI 10.1016/j.febslet.2004.06.056; SIMS JE, 1993, P NATL ACAD SCI USA, V90, P6155, DOI 10.1073/pnas.90.13.6155; Song Juhyun, 2013, Exp Neurobiol, V22, P268, DOI 10.5607/en.2013.22.4.268; Sun GQ, 2007, P NATL ACAD SCI USA, V104, P15282, DOI 10.1073/pnas.0704089104; Tanti A, 2013, CELL TISSUE RES, V354, P203, DOI 10.1007/s00441-013-1612-z; Tong LQ, 2012, J NEUROSCI, V32, P17714, DOI 10.1523/JNEUROSCI.1253-12.2012; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Vereker E, 2000, J NEUROSCI, V20, P6811, DOI 10.1523/JNEUROSCI.20-18-06811.2000; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Wang XF, 2007, MOL CELL NEUROSCI, V36, P343, DOI 10.1016/j.mcn.2007.07.005; Widera D, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-64; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Xie ZX, 2016, CELL MOL NEUROBIOL, V36, P1343, DOI 10.1007/s10571-016-0333-8; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao C, 2010, P NATL ACAD SCI USA, V107, P1876, DOI 10.1073/pnas.0908750107; Zhu JX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131782; Zonis S, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0281-0; Zunszain PA, 2012, NEUROPSYCHOPHARMACOL, V37, P939, DOI 10.1038/npp.2011.277	82	10	10	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					613	624		10.1096/fj.201700495R	http://dx.doi.org/10.1096/fj.201700495R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	28970252				2022-12-28	WOS:000425146900008
J	Breasson, L; Sardi, C; Becattini, B; Zani, F; Solinas, G				Breasson, Ludovic; Sardi, Claudia; Becattini, Barbara; Zani, Fabio; Solinas, Giovanni			PI3K gamma ablation does not promote diabetes in db/db mice, but improves insulin sensitivity and reduces pancreatic beta-cell apoptosis	FASEB JOURNAL			English	Article						phosphoinositide 3-kinase; macrophage activation; neutrophils	3-KINASE GAMMA; SECRETION; INFLAMMATION; OBESITY; PHOSPHORYLATION; INHIBITION; P110-GAMMA; RESISTANCE; ELEVATION; BLOCKADE	PI3K gamma has emerged as a promising target for the treatment of obesity and insulin resistance; however, previous studies have indicated that PI3K gamma activity in pancreatic beta cells is required for normal insulin secretion in response to glucose. Hence, a possible deterioration of insulin secretion capacity in patients who are predisposed to the failure of pancreatic beta-cell function is a major concern for the pharmacologic inhibition of PI3K gamma. To address this issue, we investigated the effects of PI3K gamma ablation in db/db diabetic mice, a genetic model of obesity-driven beta-cell failure and diabetes. Mice that lacked PI3K gamma were backcrossed into db/+ mice C57BL/KS (>10 generations) to obtain db/db-PI3K gamma(-/-) mice. db/db-PI3K gamma(-/-) mice and control db/db mice were phenotyped for glucose homeostasis, insulin sensitivity, insulin secretion, steatosis, metabolic inflammation, pancreatic islet morphometry, islet cellular composition, and inflammation. Pancreatic beta-cell apoptosis and proliferation were also evaluated. db/db-PI3K gamma(-/-) mice and control db/db mice developed similar body weight, steatosis, glycemia, and insulin levels after a glucose load; however, db/db-PI3K gamma(-/-) mice displayed improved insulin tolerance, higher levels of fasting seruminsulin, and lower pancreatic insulin content. In db/db-PI3K gamma(-/-) mice, the number of adipose tissue macrophages was similar to control, but displayed reduced adipose tissue neutrophils and M2-polarized adipose tissue gene expression. Finally, db/db-PI3K gamma(-/-) mice have more pancreatic beta cells and larger islets than db/db mice, despite displaying similar islet inflammation. This phenotype could be explained by reduced beta-cell apoptosis in db/db-PI3K gamma(-/-) mice compared with control db/db mice. Our results are consistent with the concept that the beneficial action of PI3K gamma ablation in obesity-driven glucose intolerance is largely a result of its leptin-dependent effects on adiposity and, to a lesser extent, the promotion of adipose tissue neutrophil recruitment and M1 polarization of gene expression. Of importance, our data challenge the concept that PI3K gamma is required for insulin secretion in response to glucose in vivo, and indicate that PI3K gamma ablation protects db/db mice from beta-cell apoptosis and improves fasting insulin levels. We conclude that PI3K gamma inhibition in obese patients who are predisposed to beta-cell failure is not expected to produce adverse effects on insulin secretion.	[Breasson, Ludovic; Sardi, Claudia; Becattini, Barbara; Solinas, Giovanni] Univ Gothenburg, Dept Mol & Clin Med, Wallenberg Lab, Bruna Straket 16, S-41345 Gothenburg, Sweden; [Zani, Fabio] Canc Res UK Beatson Inst, Glasgow, Lanark, Scotland	University of Gothenburg; Beatson Institute	Solinas, G (corresponding author), Univ Gothenburg, Dept Mol & Clin Med, Wallenberg Lab, Bruna Straket 16, S-41345 Gothenburg, Sweden.	giovanni.solinas@wlab.gu.se	Solinas, Giovanni/R-4777-2019	Solinas, Giovanni/0000-0002-0140-2621; Breasson, Ludovic/0000-0003-2168-976X; Becattini, Barbara/0000-0002-1002-6891	Swedish Research Council [2014-3019]; Swedish Diabetes Foundation [DIA2014-069]; Novo Nordisk Foundation [NNF14OC0010919]; University of Gothenburg; European Foundation for the Study of Diabetes Diabetes and Cancer Research Programme; Swiss National Science Foundation [152998]; Swiss National Science Foundation Sinergia [154499]; Novo Nordisk Fonden [NNF14OC0010919] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); University of Gothenburg; European Foundation for the Study of Diabetes Diabetes and Cancer Research Programme; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Science Foundation Sinergia(Swiss National Science Foundation (SNSF)); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Swedish Research Council (Grant 2014-3019), the Swedish Diabetes Foundation (Grant DIA2014-069), the Novo Nordisk Foundation (Grant NNF14OC0010919), a startup fund from the University of Gothenburg, the European Foundation for the Study of Diabetes Diabetes and Cancer Research Programme, the Swiss National Science Foundation project (Grant 152998), and the Swiss National Science Foundation Sinergia (Grant 154499; to G.S.). The authors declare no conflicts of interest.	Andreozzi F, 2004, CIRC RES, V94, P1211, DOI 10.1161/01.RES.0000126501.34994.96; Becattini B, 2011, P NATL ACAD SCI USA, V108, pE854, DOI 10.1073/pnas.1106698108; Breasson L, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aaf2969; Burke JE, 2015, TRENDS BIOCHEM SCI, V40, P88, DOI 10.1016/j.tibs.2014.12.003; De Henau O, 2016, NATURE, V539, P443, DOI 10.1038/nature20554; Donath MY, 2014, NAT REV DRUG DISCOV, V13, P465, DOI 10.1038/nrd4275; Eto K, 2002, DIABETES, V51, P87, DOI 10.2337/diabetes.51.1.87; Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030; Kaneda MM, 2016, NATURE, V539, P437, DOI 10.1038/nature19834; Kaneda MM, 2016, CANCER DISCOV, V6, P870, DOI 10.1158/2159-8290.CD-15-1346; Kobayashi N, 2011, P NATL ACAD SCI USA, V108, P5753, DOI 10.1073/pnas.1016430108; Kolic J, 2016, MOL METAB, V5, P459, DOI 10.1016/j.molmet.2016.05.003; Kolic J, 2014, J BIOL CHEM, V289, P32109, DOI 10.1074/jbc.M114.577510; Lanuza-Masdeu J, 2013, DIABETES, V62, P2308, DOI 10.2337/db12-1097; Li LX, 2006, ENDOCRINOLOGY, V147, P3318, DOI 10.1210/en.2006-0155; Lopez-Guadamillas E, 2016, AGING-US, V8, P2747, DOI 10.18632/aging.101075; Luo L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5407; MacDonald PE, 2004, ENDOCRINOLOGY, V145, P4078, DOI 10.1210/en.2004-0028; Ortega-Molina A, 2015, CELL METAB, V21, P558, DOI 10.1016/j.cmet.2015.02.017; Ortega-Molina A, 2012, CELL METAB, V15, P382, DOI 10.1016/j.cmet.2012.02.001; Perino A, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005485; Pigeau GM, 2009, DIABETES, V58, P2084, DOI 10.2337/db08-1371; Solinas G, 2006, P NATL ACAD SCI USA, V103, P16454, DOI 10.1073/pnas.0607626103; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Wymann MP, 2013, ANN NY ACAD SCI, V1280, P44, DOI 10.1111/nyas.12037	25	10	10	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					319	+		10.1096/fj.201700372RR	http://dx.doi.org/10.1096/fj.201700372RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28904022				2022-12-28	WOS:000419172700029
J	Rius, B; Duran-Guell, M; Flores-Costa, R; Lopez-Vicario, C; Lopategi, A; Alcaraz-Quiles, J; Casulleras, M; Lozano, JJ; Titos, E; Claria, J				Rius, Bibiana; Duran-Guell, Marta; Flores-Costa, Roger; Lopez-Vicario, Cristina; Lopategi, Aritz; Alcaraz-Quiles, Jose; Casulleras, Mireia; Jose Lozano, Juan; Titos, Esther; Claria, Joan			The specialized proresolving lipid mediator maresin 1 protects hepatocytes from lipotoxic and hypoxia-induced endoplasmic reticulum stress	FASEB JOURNAL			English	Article						NAFLD; UPR; miRNA; liver cells	FATTY LIVER; CELL-DEATH; ER STRESS; ACUTE-INFLAMMATION; ADIPOSE-TISSUE; RESOLVIN D1; RESOLUTION; DISEASE; ROLES; AUTOPHAGY	Endoplasmic reticulum(ER) stress and activation of the unfolded protein response (UPR) are hallmarks of nonalcoholic fatty liver disease (NAFLD), which is the hepatic manifestation of the metabolic syndrome associated with obesity. The specialized proresolving lipid mediator maresin 1 (MaR1) preserves tissue homeostasis by exerting cytoprotective actions, dampening inflammation, and expediting its timely resolution. Here, we explored whether MaR1 protects liver cells from lipotoxic and hypoxia-induced ER stress. Mice were rendered obese by high fat diet feeding, and experiments were performed in primary hepatocytes, Kupffer cells, and precision-cut liver slices (PCLSs). Palmitate-induced lipotoxicity increased ER stress and altered autophagy in hepatocytes, effects that were prevented by MaR1. MaR1 protected hepatocytes against lipotoxicity-induced apoptosis by activating the UPR prosurvival mechanisms and preventing the excessive up-regulation of proapoptotic pathways. Protective MaR1 effects were also seen in hepatocytes challenged with hypoxia and TNF-alpha-induced cell death. High-throughput microRNA (miRNA) sequencing revealed that MaR1 actions were associated with specific miRNA signatures targeting both protein folding and apoptosis. MaR1 also prevented lipotoxic-triggered ER stress and hypoxia-induced inflammation in PCLSs and enhanced Kupffer cell phagocytic capacity. Together, these findings describe the ability of MaR1 to oppose ER stress in liver cells under conditions frequently encountered in NAFLD.	[Rius, Bibiana; Duran-Guell, Marta; Flores-Costa, Roger; Lopez-Vicario, Cristina; Lopategi, Aritz; Alcaraz-Quiles, Jose; Casulleras, Mireia; Titos, Esther; Claria, Joan] IDIBAPS, Hosp Clin, Dept Biochem & Mol Genet, Barcelona, Spain; [Lopez-Vicario, Cristina; Jose Lozano, Juan; Titos, Esther; Claria, Joan] CIBERehd, Barcelona, Spain; [Claria, Joan] European Fdn Study Chron Liver Failure EF CLIF, Barcelona, Spain; [Claria, Joan] Univ Barcelona, Dept Biomed Sci, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona	Claria, J (corresponding author), Hosp Clin Barcelona, Dept Biochem & Mol Genet, Villarroel 170, E-08036 Barcelona, Spain.	jclaria@clinic.ub.es	Claria, Joan/M-7772-2019; Titos, Esther/AAA-5394-2019	Titos, Esther/0000-0002-2543-2243; Duran, Marta/0000-0002-3265-395X; Lopez-Vicario, Cristina/0000-0002-6609-8501; Lozano, Juan Jose/0000-0001-7613-3908; Casulleras, Mireia/0000-0002-2899-5826	Spanish Ministerio de Economia y Competitividad (MEC) under European Regional Development Funds [SAF15-63674-R, PIE14/00045]; Instituto de Salud Carlos III; MEC [BES-2013-063705]; Agaur/BFU (FI-DGR); Marie Curie Action	Spanish Ministerio de Economia y Competitividad (MEC) under European Regional Development Funds; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); MEC(European Commission); Agaur/BFU (FI-DGR); Marie Curie Action(European Commission)	The authors thank Ana Isabel Martinez-Puchol [Institut d'Investigacions Biomediques, August Pi i Sunyer (IDIBAPS)] for technical assistance. This work was supported by grants from the Spanish Ministerio de Economia y Competitividad (MEC) (SAF15-63674-R and PIE14/00045) under European Regional Development Funds. CIBERehd is funded by the Instituto de Salud Carlos III. This study was carried out at the Center Esther Koplowitz (IDIBAPs), which is a member of the Centres de Recerca de Catalunya (CERCA) Programme/Generalitat de Catalunya. B.R. is a recipient of a MEC fellowship (BES-2013-063705). J.A.-Q. is a recipient of an Agaur/BFU fellowship (FI-DGR 2015). A.L. was funded by a Marie Curie Action. The authors declare no conflicts of interest.	Abdulnour REE, 2014, P NATL ACAD SCI USA, V111, P16526, DOI 10.1073/pnas.1407123111; Airley RE, 2003, INT J CANCER, V104, P85, DOI 10.1002/ijc.10904; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Boden Guenther, 1998, Frontiers in Bioscience, V3, pD169; Borgeson E, 2015, CELL METAB, V22, P125, DOI 10.1016/j.cmet.2015.05.003; Buckley CD, 2013, NAT REV IMMUNOL, V13, P59, DOI 10.1038/nri3362; Carabelli J, 2011, J CELL MOL MED, V15, P1329, DOI 10.1111/j.1582-4934.2010.01128.x; Dalli J, 2013, FASEB J, V27, P2573, DOI 10.1096/fj.13-227728; Dalli J, 2013, CHEM BIOL, V20, P188, DOI 10.1016/j.chembiol.2012.11.010; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gidalevitz T, 2013, BBA-MOL CELL RES, V1833, P2410, DOI 10.1016/j.bbamcr.2013.03.007; Grootjans J, 2016, NAT REV IMMUNOL, V16, P469, DOI 10.1038/nri.2016.62; Han J, 2013, DIABETOLOGIA, V56, P911, DOI 10.1007/s00125-012-2809-5; Han J, 2016, J LIPID RES, V57, P1329, DOI 10.1194/jlr.R067595; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Jewell UR, 2001, FASEB J, V15, P1312, DOI 10.1096/fj.00-0732fje; Jungermann K, 2000, HEPATOLOGY, V31, P255, DOI 10.1002/hep.510310201; Kaluz S, 2009, BBA-REV CANCER, V1795, P162, DOI 10.1016/j.bbcan.2009.01.001; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Klassen LW, 2008, BIOCHEM PHARMACOL, V76, P426, DOI 10.1016/j.bcp.2008.05.012; Li J, 2008, CELL DEATH DIFFER, V15, P1460, DOI 10.1038/cdd.2008.81; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lopez-Vicario C, 2015, P NATL ACAD SCI USA, V112, P536, DOI 10.1073/pnas.1422590112; Lopez-Vicario C, 2014, GUT, V63, P344, DOI 10.1136/gutjnl-2012-303179; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Mantena SK, 2009, BIOCHEM J, V417, P183, DOI 10.1042/BJ20080868; Marcon R, 2013, J IMMUNOL, V191, P4288, DOI 10.4049/jimmunol.1202743; Muller S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/948408; Nath B, 2012, HEPATOLOGY, V55, P622, DOI 10.1002/hep.25497; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Pastorekova S, 2006, ADV CLIN CHEM, V42, P167, DOI 10.1016/S0065-2423(06)42005-9; Pfaffenbach KT, 2010, AM J PHYSIOL-ENDOC M, V298, pE1027, DOI 10.1152/ajpendo.00642.2009; Recchiuti A, 2011, FASEB J, V25, P544, DOI 10.1096/fj.10-169599; Rius B, 2014, FASEB J, V28, P836, DOI 10.1096/fj.13-235614; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rubinstein AD, 2011, MOL CELL, V44, P698, DOI 10.1016/j.molcel.2011.10.014; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Sanyal AJ, 2005, NAT CLIN PRACT GASTR, V2, P46, DOI 10.1038/ncpgasthep0084; Savransky V, 2007, HEPATOLOGY, V45, P1007, DOI 10.1002/hep.21593; Serhan CN, 2015, SEMIN IMMUNOL, V27, P200, DOI 10.1016/j.smim.2015.03.004; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2012, FASEB J, V26, P1755, DOI 10.1096/fj.11-201442; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Spite M, 2014, CELL METAB, V19, P21, DOI 10.1016/j.cmet.2013.10.006; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; Trauner M, 2010, BBA-MOL CELL BIOL L, V1801, P299, DOI 10.1016/j.bbalip.2009.10.007; Upton JP, 2012, SCIENCE, V338, P818, DOI 10.1126/science.1226191; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wenger RH, 1997, KIDNEY INT, V51, P560, DOI 10.1038/ki.1997.79; Willy JA, 2015, MOL BIOL CELL, V26, P2190, DOI 10.1091/mbc.E15-01-0036; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yang Z., 2014, PLOS ONE, V9, P1, DOI [10.1371/journal.pone.011598925551561, DOI 10.1371/JOURNAL.PONE.011598925551561, DOI 10.1371/J0URNAL.P0NE.0115989]	60	40	41	3	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5384	+		10.1096/fj.201700394R	http://dx.doi.org/10.1096/fj.201700394R			25	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28768719	Green Submitted			2022-12-28	WOS:000416588300022
J	Hsu, K; Lee, TY; Periasamy, A; Kao, FJ; Li, LT; Lin, CY; Lin, HJ; Lin, M				Hsu, Kate; Lee, Ting-Ying; Periasamy, Ammasi; Kao, Fu-Jen; Li, Li-Tzu; Lin, Chuang-Yu; Lin, Hui-Ju; Lin, Marie			Adaptable interaction between aquaporin-1 and band 3 reveals a potential role of water channel in blood CO2 transport	FASEB JOURNAL			English	Article						anion exchanger-1; erythrocyte; FLIM-FRET; Miltenberger subtype III	CARBONIC-ANHYDRASE-II; CELL; MEMBRANE; PROTEIN; MI.III; LOCALIZATION; EXPRESSION; METABOLON; COMPLEX; DOMAIN	Human CO2 respiration requires rapid conversion between CO2 and HCO3-. Carbonic anhydrase II facilitates this reversible reaction inside red blood cells, and band 3 [anion exchanger 1 (AE1)] provides a passage for HCO3- flux across the cell membrane. These 2 proteins are core components of the CO2 transport metabolon. Intracellular H2O is necessary for CO2/HCO3- conversion. However, abundantly expressed aquaporin 1 (AQP1) in erythrocytes is thought not to be part of band 3 complexes or the CO2 transport metabolon. To solve this conundrum, we used Forster resonance energy transfer (FRET) measured by fluorescence lifetime imaging (FLIM-FRET) and identified interaction between aquaporin-1 and band 3 at a distance of 8 nm, within the range of dipole-dipole interaction. Notably, their interaction was adaptable to membrane tonicity changes. This suggests that the function of AQP1 in tonicity response could be coupled or correlated to its function in band 3-mediated CO2/HCO3- exchange. By demonstrating AQP1 as a mobile component of the CO2 transport metabolon, our results uncover a potential role of water channel in blood CO2 transport and respiration.-Hsu, K., Lee, T.-Y., Periasamy, A., Kao, F.-J., Li, L.-T., Lin, C.-Y., Lin, H.-J., Lin, M. Adaptable interaction between aquaporin-1 and band 3 reveals a potential role of water channel in blood CO2 transport.	[Hsu, Kate; Lee, Ting-Ying; Lin, Hui-Ju; Lin, Marie] Mackay Mem Hosp, Transfus Med Lab, 45 Min Sheng Rd,Res Bldg 616, Tamsui 251, Taiwan; [Periasamy, Ammasi] Univ Virginia, WM Keck Ctr Cellular Imaging, Charlottesville, VA USA; [Kao, Fu-Jen] Natl Yang Ming Univ, Inst Biophoton, Taipei, Taiwan; [Li, Li-Tzu] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Lin, Chuang-Yu] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto, Japan	Mackay Memorial Hospital; University of Virginia; National Yang Ming Chiao Tung University; National Defense Medical Center; Kyoto University	Hsu, K (corresponding author), Mackay Mem Hosp, Transfus Med Lab, 45 Min Sheng Rd,Res Bldg 616, Tamsui 251, Taiwan.	khsu1@mmh.org.tw	Kao, Fu-Jen/C-8269-2012; Kao, Fu-Jen/GYQ-6902-2022	Hsu, Kate/0000-0003-1009-0997; Kao, Fu-Jen/0000-0001-8361-3942	National Health Research Institute (NHRI) of Taiwan [EX103-10122SI]; Taiwan Ministry of Science & Technology (MOST) [103-2320-B-195-001-MY3]; Mackay Memorial Hospital [104-49, 105-52, 106-23]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016446] Funding Source: NIH RePORTER	National Health Research Institute (NHRI) of Taiwan(National Health Research Institutes - Taiwan); Taiwan Ministry of Science & Technology (MOST); Mackay Memorial Hospital; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Dr. John Yu (Chang Gung University, Taoyuan City, Taiwan and Academia Sinica-Taiwan, Taipei, Taiwan) and Dr. Hsin-Hung Lin (University of California, San Diego, San Diego, CA, USA and Academia Sinica-Taiwan) for support with the FLIM instrumentation, Dr. Yu-Jun Lai (MMH) for support with the MetaMorph software. This work was supported by Grant EX103-10122SI from National Health Research Institute (NHRI) of Taiwan; Grant 103-2320-B-195-001-MY3 from the Taiwan Ministry of Science & Technology (MOST); and Mackay Memorial Hospital Grants 104-49, 105-52, and 106-23 (to K.H.). K. H. and T.-Y.L. share equal first authorship. The authors declare no conflicts of interest.	Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; AGRE P, 1993, AM J PHYSIOL, V265, pF463; Arakawa T, 2015, SCIENCE, V350, P680, DOI 10.1126/science.aaa4335; Beachey W., 2013, RESP CARE ANATOMY PH, Vthird; BENNETT V, 1983, METHOD ENZYMOL, V96, P313; Bruce LJ, 2003, BLOOD, V101, P4180, DOI 10.1182/blood-2002-09-2824; Cabral PD, 2012, AM J PHYSIOL-RENAL, V303, pF621, DOI 10.1152/ajprenal.00268.2012; Cho MR, 1999, BIOPHYS J, V76, P1136, DOI 10.1016/S0006-3495(99)77278-4; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Endeward V, 2006, FASEB J, V20, P1974, DOI 10.1096/fj.04-3300com; Endeward V, 2008, FASEB J, V22, P64, DOI 10.1096/fj.07-9097com; FORSTER RE, 1975, J APPL PHYSIOL, V38, P710, DOI 10.1152/jappl.1975.38.4.710; Geers C, 2000, PHYSIOL REV, V80, P681, DOI 10.1152/physrev.2000.80.2.681; Hall J. E., 2011, GUYTON HALL TXB MED; Heckwolf M, 2011, PLANT J, V67, P795, DOI 10.1111/j.1365-313X.2011.04634.x; Hsu K, 2015, VOX SANG, V108, P403, DOI 10.1111/vox.12236; Hsu K, 2012, VOX SANG, V102, P221, DOI 10.1111/j.1423-0410.2011.01535.x; Hsu K, 2011, VOX SANG, V100, P389, DOI 10.1111/j.1423-0410.2010.01436.x; Hsu K., 2011, ISBT SCI SERIES, V6, P302, DOI DOI 10.1111/J.1751-2824.2011; Hsu K, 2015, SCI REP-UK, V5, DOI 10.1038/srep10327; Hsu K, 2013, TRANSFUS APHER SCI, V49, P370, DOI 10.1016/j.transci.2013.05.011; Hsu K, 2013, TRANSFUSION, V53, P962, DOI 10.1111/j.1537-2995.2012.03861.x; Hsu K, 2009, BLOOD, V114, P1919, DOI 10.1182/blood-2008-12-195180; HUANG CH, 1991, J BIOL CHEM, V266, P7248; Issitt PD, 1985, APPL BLOOD GROUP SER; Jiang JR, 2013, INT J DISTRIB SENS N, DOI 10.1155/2013/529489; Kuchel PW, 2005, BIOSYSTEMS, V82, P189, DOI 10.1016/j.biosystems.2005.07.002; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lodish H, 2000, MOL CELL BIOL; MA TH, 1993, J BIOL CHEM, V268, P22756; MARCHESI VT, 1967, J CELL BIOL, V35, P385, DOI 10.1083/jcb.35.2.385; Miles EW, 1999, J BIOL CHEM, V274, P12193, DOI 10.1074/jbc.274.18.12193; Musa-Aziz R, 2009, P NATL ACAD SCI USA, V106, P5406, DOI 10.1073/pnas.0813231106; Nakhoul NL, 1998, AM J PHYSIOL-CELL PH, V274, pC543, DOI 10.1152/ajpcell.1998.274.2.C543; NIIZEKI K, 1983, JPN J PHYSIOL, V33, P635, DOI 10.2170/jjphysiol.33.635; Periasamy A., 2010, FLIM MICROSCOPY BIOL; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; Reithmeier RAF, 2001, BLOOD CELL MOL DIS, V27, P85, DOI 10.1006/bcmd.2000.0353; Reithmeier RAF, 2016, BBA-BIOMEMBRANES, V1858, P1507, DOI 10.1016/j.bbamem.2016.03.030; Rhoades R.A., 2017, MED PHYSL PRINCIPLES; Sinanoglu O., 1965, MODERN QUANTUM CHEM; SMITH BL, 1991, J BIOL CHEM, V266, P6407; Spence M.T.Z., 2010, MOL PROBES HDB GUIDE; STECK TL, 1978, J SUPRAMOL STR CELL, V8, P311, DOI 10.1002/jss.400080309; Sterling D, 2001, JOP, V2, P165; Sterling D, 2001, J BIOL CHEM, V276, P47886, DOI 10.1074/jbc.M105959200; Sun YS, 2011, NAT PROTOC, V6, P1324, DOI 10.1038/nprot.2011.364; Tani K, 2014, BBA-GEN SUBJECTS, V1840, P1605, DOI 10.1016/j.bbagen.2013.10.007; Verkman AS, 2013, CURR BIOL, V23, pR52, DOI 10.1016/j.cub.2012.11.025; Vilas G, 2015, MOL BIOL CELL, V26, P1106, DOI 10.1091/mbc.E14-03-0812; Vince JW, 1998, J BIOL CHEM, V273, P28430, DOI 10.1074/jbc.273.43.28430; Zhang DC, 2000, BLOOD, V96, P2925	52	10	10	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4256	4264		10.1096/fj.201601282R	http://dx.doi.org/10.1096/fj.201601282R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28596233	Green Published			2022-12-28	WOS:000413397400006
J	Tourki, B; Halade, G				Tourki, Bochra; Halade, Ganesh			Leukocyte diversity in resolving and nonresolving mechanisms of cardiac remodeling	FASEB JOURNAL			English	Review						heart failure; inflammation; myocardial infarction; resolution of inflammation	ACUTE MYOCARDIAL-INFARCTION; ISCHEMIA-REPERFUSION INJURY; RECEPTOR TYROSINE KINASE; CHRONIC HEART-FAILURE; ST-SEGMENT ELEVATION; HUMAN IMMUNE-SYSTEM; INFLAMMATORY RESPONSE; LIPID MEDIATORS; BONE-MARROW; TGF-BETA	In response to myocardial infarction (MI), time-dependent leukocyte infiltration is critical to program the acute inflammatory response. Post-MI leukocyte density, residence time in the infarcted area, and exit from the infarcted injury predict resolving or nonresolving inflammation. Overactive or unresolved inflammation is the primary determinant in heart failure pathology post-MI. Here, our review describes supporting evidence that the acute inflammatory response also guides the generation of healing and regenerative mediators after cardiac damage. Time-dependent leukocyte density and diversity and the magnitude of myocardial injury is responsible for the resolving and nonresolving pathway in myocardial healing. Post MI, the diversity of leukocytes, such as neutrophils, macrophages, and lymphocytes, has been explored that regulate the clearance of deceased cardiomyocytes by using the classic and reparative pathways. Among the innovative factors and intermediates that have been recognized as essential in acute the self-healing and clearance mechanism, we highlight specialized proresolving mediators as the emerging factor for post-MI reparative mechanismstranslational leukocyte modifiers, such as aging, the source of leukocytes, and the milieu around the leukocytes. In the clinical setting, it is possible that leukocyte diversity is more prominent as a result of risk factors, such as obesity, diabetes, and hypertension. Pharmacologic agents are critical modifiers of leukocyte diversity in healing mechanisms that may impair or stimulate the clearance mechanism. Future research is needed, with a focused approach to understand the molecular targets, cellular effectors, and receptors. A clear understanding of resolving and nonresolving inflammation in myocardial healing will help to develop novel targets with major emphasis on the resolution of inflammation in heart failure pathology.-Tourki, B., Halade, G. Leukocyte diversity in resolving and nonresolving mechanisms of cardiac remodeling.	[Tourki, Bochra] Univ Carthage Tunis, Inst Pasteur Tunis, Lab Venins & Biomol Therapeut & Plateforme Physio, Carthage, Tunisia; [Halade, Ganesh] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, 703 19th St South,MC 7755, Birmingham, AL 35233 USA	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Carthage; University of Alabama System; University of Alabama Birmingham	Halade, G (corresponding author), Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, 703 19th St South,MC 7755, Birmingham, AL 35233 USA.	ganeshhalade@uabmc.edu			U.S. National Institutes of Health [AT006704, HL132989]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [K99AT006704] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R00AT006704] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132989] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. National Institutes of Health Grants AT006704 (National Center for Complementary and Integrative Health) and HL132989 (National Heart, Lung, and Blood Institute) (to G.H.). The authors declare no conflicts of interest.	Al-Ahmad RS, 2004, SAUDI MED J, V25, P923; Alibhai FJ, 2014, CIRC RES, V114, P1713, DOI 10.1161/CIRCRESAHA.114.302995; Amantea D, 2016, NEURAL REGEN RES, V11, P81, DOI 10.4103/1673-5374.169633; Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Arumugam TV, 2006, CLIN CHIM ACTA, V374, P33, DOI 10.1016/j.cca.2006.06.010; Assmus B, 2012, EUR HEART J, V33, P1911, DOI 10.1093/eurheartj/ehr388; Aurora AB, 2014, J CLIN INVEST, V124, P1382, DOI 10.1172/JCI72181; Backteman K, 2014, CLIN EXP IMMUNOL, V175, P104, DOI 10.1111/cei.12210; Baylis Daniel, 2013, Longev Healthspan, V2, P8, DOI 10.1186/2046-2395-2-8; Blum Arnon, 2003, Eur J Intern Med, V14, P407, DOI 10.1016/j.ejim.2003.09.002; Bolli R, 2015, CIRC RES, V117, P665, DOI 10.1161/CIRCRESAHA.115.307496; Braga FAV, 2016, HUM MOL GENET, V25, pR141, DOI 10.1093/hmg/ddw192; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Camenisch TD, 1999, J IMMUNOL, V162, P3498; Carr EJ, 2016, NAT IMMUNOL, V17, P461, DOI 10.1038/ni.3371; Chow A, 2013, NAT MED, V19, P429, DOI 10.1038/nm.3057; Cochain C, 2012, ARTERIOSCL THROM VAS, V32, P2206, DOI 10.1161/ATVBAHA.112.254409; de Haan JJ, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/206039; De Jager PL, 2015, SEMIN IMMUNOL, V27, P51, DOI 10.1016/j.smim.2015.03.003; Dewald O, 2005, CIRC RES, V96, P881, DOI 10.1161/01.RES.0000163017.13772.3a; Dobaczewski M, 2010, AM J PATHOL, V176, P2177, DOI 10.2353/ajpath.2010.090759; Dutta P, 2015, ARTERIOSCL THROM VAS, V35, P1066, DOI 10.1161/ATVBAHA.114.304652; Ehninger A, 2011, J EXP MED, V208, P421, DOI 10.1084/jem.20110132; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Epelman S, 2012, J CARDIOVASC TRANSL, V5, P827, DOI 10.1007/s12265-012-9410-7; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; FAN K, 1992, BLOOD, V79, P1679; Fang L, 2015, J GERIATR CARDIOL, V12, P305, DOI 10.11909/j.issn.1671-5411.2015.03.020; Faxon DP, 2002, J AM COLL CARDIOL, V40, P1199, DOI 10.1016/S0735-1097(02)02136-8; Fleming SD, 2003, CLIN IMMUNOL, V108, P263, DOI 10.1016/S1521-6616(03)00160-8; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Frangogiannis NG, 2003, AM J PHYSIOL-HEART C, V285, pH483, DOI 10.1152/ajpheart.01016.2002; Frangogiannis NG, 2012, CIRC RES, V110, P159, DOI 10.1161/CIRCRESAHA.111.243162; Frantz S, 2014, CARDIOVASC RES, V102, P240, DOI 10.1093/cvr/cvu025; Frantz S, 2013, FASEB J, V27, P871, DOI 10.1096/fj.12-214049; Freire MO, 2013, PERIODONTOL 2000, V63, P149, DOI 10.1111/prd.12034; Fuijkschot WW, 2017, J CARDIOL, V69, P394, DOI 10.1016/j.jjcc.2016.10.003; Fujiu K, 2014, CARDIOVASC RES, V102, P232, DOI 10.1093/cvr/cvu059; Funk CD, 2007, J CARDIOVASC PHARM, V50, P470, DOI 10.1097/FJC.0b013e318157f72d; Glezeva N, 2015, J MOL CELL CARDIOL, V89, P136, DOI 10.1016/j.yjmcc.2015.10.029; Gong KZ, 2006, AM HEART J, V151, P62, DOI 10.1016/j.ahj.2005.02.040; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Granger DN, 1995, PHYSL PATHOPHYSIOLOG; Halade GV, 2016, AGING-US, V8, P2611, DOI 10.18632/aging.101077; Halade GV, 2016, J MOL CELL CARDIOL, V97, P44, DOI 10.1016/j.yjmcc.2016.04.016; Halade GV, 2011, EXP GERONTOL, V46, P43, DOI 10.1016/j.exger.2010.09.014; Haubner BJ, 2016, CIRC RES, V118, P216, DOI 10.1161/CIRCRESAHA.115.307017; Heilker R, 2009, DRUG DISCOV TODAY, V14, P231, DOI 10.1016/j.drudis.2008.11.011; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; Hirayasu K, 2015, J HUM GENET, V60, P703, DOI 10.1038/jhg.2015.64; Hofmann U, 2015, CIRC RES, V116, P354, DOI 10.1161/CIRCRESAHA.116.304072; Hofmann U, 2012, CIRCULATION, V125, P1652, DOI 10.1161/CIRCULATIONAHA.111.044164; Horckmans M, 2017, EUR HEART J, V38, P187, DOI 10.1093/eurheartj/ehw002; Ismahil MA, 2014, CIRC RES, V114, P266, DOI 10.1161/CIRCRESAHA.113.301720; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Iyer RP, 2015, INT J CARDIOL, V185, P198, DOI 10.1016/j.ijcard.2015.03.054; Jung K, 2013, CIRC RES, V112, P891, DOI 10.1161/CIRCRESAHA.111.300484; Kaikita K, 2004, AM J PATHOL, V165, P439, DOI 10.1016/S0002-9440(10)63309-3; Kain V, 2015, J MOL CELL CARDIOL, V84, P24, DOI 10.1016/j.yjmcc.2015.04.003; Kain V, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0444-7; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; Keyes KT, 2010, AM J PHYSIOL-HEART C, V299, pH153, DOI 10.1152/ajpheart.01057.2009; Kim ND, 2013, NAT MED, V19, P1208, DOI 10.1038/nm.3367; Kimmel SE, 2005, ANN INTERN MED, V142, P157, DOI 10.7326/0003-4819-142-3-200502010-00005; Koeppen M, 2012, ANESTHESIOLOGY, V116, P1245, DOI 10.1097/ALN.0b013e318255793c; Kreisel D, 2010, P NATL ACAD SCI USA, V107, P18073, DOI 10.1073/pnas.1008737107; Lavine KJ, 2014, P NATL ACAD SCI USA, V111, P16029, DOI 10.1073/pnas.1406508111; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009; Li K, 2009, CIRC RES, V105, P353, DOI 10.1161/CIRCRESAHA.109.195230; Li SZ, 2009, CIRC RES, V105, P1072, DOI 10.1161/CIRCRESAHA.109.199570; Lin GM, 2012, AM HEART J, V164, pE19, DOI 10.1016/j.ahj.2012.09.012; Linfert Douglas, 2009, Transplant Rev (Orlando), V23, P1, DOI 10.1016/j.trre.2008.08.003; Liu LL, 2011, INT IMMUNOPHARMACOL, V11, P480, DOI 10.1016/j.intimp.2010.12.019; Liu S., 2016, F1000 RES, V5; Lo Celso C, 2011, J CELL SCI, V124, P3529, DOI 10.1242/jcs.074112; Lopez EF, 2015, AM J PHYSIOL-HEART C, V308, pH269, DOI 10.1152/ajpheart.00604.2014; LUCCHESI BR, 1989, J MOL CELL CARDIOL, V21, P1241, DOI 10.1016/0022-2828(89)90670-6; Ma YG, 2016, CARDIOVASC RES, V110, P51, DOI 10.1093/cvr/cvw024; Ma YG, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-11; Mann DL, 2004, CIRCULATION, V109, P1594, DOI 10.1161/01.CIR.0000124490.27666.B2; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martin F, 2006, ANNU REV IMMUNOL, V24, P467, DOI 10.1146/annurev.immunol.24.021605.090517; Massa M, 2005, BLOOD, V105, P199, DOI 10.1182/blood-2004-05-1831; McMurray JJV, 2009, CIRCULATION, V120, P2188, DOI 10.1161/CIRCULATIONAHA.109.849117; MEHTA J, 1989, CIRCULATION, V79, P549, DOI 10.1161/01.CIR.79.3.549; Micera A, 2016, J CELL PHYSIOL, V231, P531, DOI 10.1002/jcp.25124; Moore KJ, 2002, J BIOL CHEM, V277, P47373, DOI 10.1074/jbc.M208788200; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Neely CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085623; Nunez J, 2008, AM J CARDIOL, V101, P747, DOI 10.1016/j.amjcard.2007.11.004; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Ortega-Gomez A, 2013, EMBO MOL MED, V5, P661, DOI 10.1002/emmm.201202382; Peart JN, 2007, PHARMACOL THERAPEUT, V114, P208, DOI 10.1016/j.pharmthera.2007.02.004; Pechkovsky DV, 2010, CLIN IMMUNOL, V137, P89, DOI 10.1016/j.clim.2010.06.017; Pepys MB, 2006, NATURE, V440, P1217, DOI 10.1038/nature04672; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Prince LR, 2011, CURR OPIN PHARMACOL, V11, P397, DOI 10.1016/j.coph.2011.06.007; Ramasubbu K, 2008, J AM COLL CARDIOL, V51, P415, DOI 10.1016/j.jacc.2007.10.009; Reiter R, 2012, CIRC RES, V110, P105, DOI 10.1161/CIRCRESAHA.111.254284; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Ross EA, 2006, BLOOD, V107, P1178, DOI 10.1182/blood-2005-07-2692; Saito T, 2004, J MOL CELL CARDIOL, V37, P71, DOI 10.1016/j.yjmcc.2004.04.002; Salio M, 2008, CIRCULATION, V117, P1055, DOI 10.1161/CIRCULATIONAHA.107.749234; Sather S, 2007, BLOOD, V109, P1026, DOI 10.1182/blood-2006-05-021634; Saxena A, 2016, TRANSL RES, V167, P152, DOI 10.1016/j.trsl.2015.07.002; Saxena A, 2013, J IMMUNOL, V191, P4838, DOI 10.4049/jimmunol.1300725; Schif-Zuck S, 2011, EUR J IMMUNOL, V41, P366, DOI 10.1002/eji.201040801; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2010, AM J PATHOL, V177, P1576, DOI 10.2353/ajpath.2010.100322; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; SILVERMAN HS, 1987, AM J CARDIOL, V59, P363, DOI 10.1016/0002-9149(87)90817-4; Stahl GL, 2003, AM J PATHOL, V162, P449, DOI 10.1016/S0002-9440(10)63839-4; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Suzuki K, 2001, CIRCULATION, V104, pI308; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; TANAKA M, 1993, CIRCULATION, V87, P526, DOI 10.1161/01.CIR.87.2.526; Thorp E, 2009, J LEUKOCYTE BIOL, V86, P1089, DOI 10.1189/jlb.0209115; Troidl C, 2009, J CELL MOL MED, V13, P3485, DOI 10.1111/j.1582-4934.2009.00707.x; Tsiantoulas D, 2015, ARTERIOSCL THROM VAS, V35, P296, DOI 10.1161/ATVBAHA.114.303569; Tsujioka H, 2009, J AM COLL CARDIOL, V54, P130, DOI 10.1016/j.jacc.2009.04.021; van der Laan AM, 2014, EUR HEART J, V35, P376, DOI 10.1093/eurheartj/eht331; Van Dyke TE, 2008, J PERIODONTOL, V79, P1503, DOI 10.1902/jop.2008.080239; Vinten-Johansen J, 2004, CARDIOVASC RES, V61, P481, DOI 10.1016/j.cardiores.2003.10.011; WAHL SM, 1987, P NATL ACAD SCI USA, V84, P5788, DOI 10.1073/pnas.84.16.5788; Wan E, 2013, CIRC RES, V113, P1004, DOI 10.1161/CIRCRESAHA.113.301198; Werner F, 2000, J BIOL CHEM, V275, P36653, DOI 10.1074/jbc.M004536200; Wilensky RL, 2009, CURR OPIN LIPIDOL, V20, P415, DOI 10.1097/MOL.0b013e3283307c16; Yan WW, 2015, INT J CLIN EXP PATHO, V8, P14667; Yan XX, 2013, J MOL CELL CARDIOL, V62, P24, DOI 10.1016/j.yjmcc.2013.04.023; Yanaba K, 2008, IMMUNOL REV, V223, P284, DOI 10.1111/j.1600-065X.2008.00646.x; Yancy CW, 2013, CIRCULATION, V128, pE240, DOI 10.1161/CIR.0b013e31829e8776; Yoshimura A, 2010, J BIOCHEM, V147, P781, DOI 10.1093/jb/mvq043; Zouggari Y, 2013, NAT MED, V19, P1273, DOI 10.1038/nm.3284	141	37	38	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4226	4239		10.1096/fj.201700109R	http://dx.doi.org/10.1096/fj.201700109R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28642328	Green Published			2022-12-28	WOS:000413397400004
J	Wang, B; Wang, ZX; de Avila, JM; Zhu, MJ; Zhang, FY; Gomez, NA; Zhao, L; Tian, QY; Zhao, JX; Maricelli, J; Zhang, H; Rodgers, BD; Du, M				Wang, Bo; Wang, Zhixiu; de Avila, Jeanene M.; Zhu, Mei-Jun; Zhang, Faya; Gomez, Noe Alberto; Zhao, Liang; Tian, Qiyu; Zhao, Junxing; Maricelli, Joseph; Zhang, Hui; Rodgers, Buel D.; Du, Min			Moderate alcohol intake induces thermogenic brown/beige adipocyte formation via elevating retinoic acid signaling	FASEB JOURNAL			English	Article						beige adipocyte; glucose; fatty acids; thermogenesis; obesity	BROWN ADIPOSE-TISSUE; DIET-INDUCED OBESITY; BODY-WEIGHT; VITAMIN-A; IN-VIVO; BEIGE ADIPOGENESIS; LIVER-DISEASE; FATTY LIVER; CONSUMPTION; METABOLISM	Clinically, low and moderate alcohol intake improves human health with protection against metabolic syndromes, including type 2 diabetes; however, mechanisms that are associated with these effects remain to be elucidated. The aims of this study were to investigate the effects of moderate alcohol intake on thermogenic brown/beige adipocyte formation and glucose and lipid homeostasis, as well as the involvement of retinoic acid (RA) signaling in the entire process. C57BL6 male mice were supplemented with 8% (w/v) alcohol in water for 1 or 4 mo. Alcohol intake prevented body weight gain, induced the formation of uncoupling protein 1-positive beige adipocytes in white adipose tissue, and increased thermogenesis in mice, which is associated with decreased serum glucose and triacylglycerol levels. Mechanistically, alcohol intake increased RA levels in serum and adipose tissue, which was associated with increased expression of aldehyde dehydrogenase family 1 subfamily A1 (Aldh1a1). When RA receptor-alpha signaling was conditionally blocked in platelet-derived growth factor receptor-alpha-positive adipose progenitors, the effects of alcohol on beige adipogenesis were largely abolished. Finally, moderate alcohol prevented high-fat diet-induced obesity and metabolic dysfunction. In conclusion, moderate alcohol intake induces thermogenic brown/beige adipocyte formation and promotes glucose and lipid oxidation via elevation of RA signaling.-Wang, B., Wang, Z., de Avila, J. M., Zhu, M.-J., Zhang, F., Gomez, N. A., Zhao, L., Tian, Q., Zhao, J., Maricelli, J., Zhang, H., Rodgers, B. D., Du, M. Moderate alcohol intake induces thermogenic brown/beige adipocyte formation via elevating retinoic acid signaling.	[Wang, Bo; Du, Min] China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing, Peoples R China; [Wang, Bo; Wang, Zhixiu; de Avila, Jeanene M.; Gomez, Noe Alberto; Zhao, Liang; Tian, Qiyu; Rodgers, Buel D.; Du, Min] Washington State Univ, Dept Anim Sci, Clark Hall 116,100 Dairy Rd, Pullman, WA 99164 USA; [Zhu, Mei-Jun] Washington State Univ, Sch Food Sci, Pullman, WA 99164 USA; [Zhang, Faya; Zhang, Hui] Washington State Univ, Dept Pharmaceut Sci, Coll Pharm, Pullman, WA 99164 USA; [Maricelli, Joseph] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Zhao, Junxing; Du, Min] Shanxi Agr Univ, Coll Anim Sci & Vet Med, Jinzhong, Shanxi, Peoples R China	China Agricultural University; Washington State University; Washington State University; Washington State University; Washington State University; Shanxi Agricultural University	Du, M (corresponding author), Washington State Univ, Dept Anim Sci, Clark Hall 116,100 Dairy Rd, Pullman, WA 99164 USA.	min.du@wsu.edu	Zhang, Faya/Y-4122-2019; Gomez, Noe/ABC-8916-2021; Rodgers, Dan/AAA-5343-2020; Du, Min/H-4311-2011	Zhang, Faya/0000-0001-5311-4667; Gomez, Noe/0000-0002-5959-9367; Du, Min/0000-0002-7232-072X; Rodgers, Buel/0000-0003-0751-1105; Wang, Bo/0000-0003-0604-1607	U.S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01-HD067449]; NIH National Institute on Aging [R21-AG049976]; U.S. Department of Agriculture, National Institute of Food and Agriculture [2015-67015-23219]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD067449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG049976] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development; NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); U.S. Department of Agriculture, National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by U.S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant R01-HD067449, NIH National Institute on Aging Grant R21-AG049976, and U.S. Department of Agriculture, National Institute of Food and Agriculture Award 2015-67015-23219). The authors thank Dr. Cathy Mendelsohn (Columbia University, New York, NY, USA) for providing ROSA26-RAR alpha DN mice. The authors declare no conflicts of interest.	Arif AA, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-126; Avogaro A, 2004, DIABETES CARE, V27, P1369, DOI 10.2337/diacare.27.6.1369; Berry DC, 2012, DIABETES, V61, P1112, DOI 10.2337/db11-1620; Berry R, 2013, NAT CELL BIOL, V15, P302, DOI 10.1038/ncb2696; Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032; Blaner WS, 2017, SCI REP-UK, V7, DOI 10.1038/srep43474; Bonet ML, 2003, CELL MOL LIFE SCI, V60, P1311, DOI 10.1007/s00018-003-2290-x; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Clugston RD, 2012, NUTRIENTS, V4, P356, DOI 10.3390/nu4050356; Cordain L, 1997, J AM COLL NUTR, V16, P134; Dani C, 1997, J CELL SCI, V110, P1279; DECASTRO JM, 1990, AM J CLIN NUTR, V52, P246, DOI 10.1093/ajcn/52.2.246; Ekblom B., 2001, INT TXB OBESITY; Fan F, 2014, ACTA PHARMACOL SIN, V35, P1015, DOI 10.1038/aps.2014.46; Ferrieres J, 2004, HEART, V90, P107, DOI 10.1136/heart.90.1.107; Halsted CH, 2004, SEMIN LIVER DIS, V24, P289, DOI 10.1055/s-2004-832941; Jequier E, 1999, AM J CLIN NUTR, V69, P173; Joosten MM, 2010, APPETITE, V55, P124, DOI 10.1016/j.appet.2010.04.217; Kane MA, 2010, FASEB J, V24, P823, DOI 10.1096/fj.09-141572; Kiefer FW, 2012, NAT MED, V18, P918, DOI 10.1038/nm.2757; Kim YK, 2010, METHODS MOL BIOL, V652, P263, DOI 10.1007/978-1-60327-325-1_15; King BM, 2013, AM PSYCHOL, V68, P88, DOI 10.1037/a0030684; Koppes LLJ, 2005, DIABETES CARE, V28, P719, DOI 10.2337/diacare.28.3.719; Lee P, 2014, INT J OBESITY, V38, P170, DOI 10.1038/ijo.2013.82; Lee YH, 2013, CELL METAB, V18, P355, DOI 10.1016/j.cmet.2013.08.003; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; LEO MA, 1982, NEW ENGL J MED, V307, P597, DOI 10.1056/NEJM198209023071006; Lind Penelope A., 2008, Human Genomics, V3, P24; LIU SM, 1994, AM J EPIDEMIOL, V140, P912, DOI 10.1093/oxfordjournals.aje.a117179; Lowe CE, 2011, J CELL SCI, V124, P2681, DOI 10.1242/jcs.079699; McCaffery P, 2004, DEV BRAIN RES, V153, P233, DOI 10.1016/j.devbrainres.2004.09.003; Mercader J, 2006, ENDOCRINOLOGY, V147, P5325, DOI 10.1210/en.2006-0760; Moriya A, 2011, ALIMENT PHARM THER, V33, P378, DOI 10.1111/j.1365-2036.2010.04520.x; Moriya A, 2013, HEPATOL INT, V7, P859, DOI 10.1007/s12072-013-9449-9; Noy N, 2013, ADIPOCYTE, V2, P184, DOI 10.4161/adip.23489; Pereira SE, 2012, OBES SURG, V22, P602, DOI 10.1007/s11695-011-0522-y; Peschechera A, 2013, ARCH PHYSIOL BIOCHEM, V119, P151, DOI 10.3109/13813455.2013.796995; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 1996, BIOCHEM J, V317, P827, DOI 10.1042/bj3170827; Purohit V, 2009, ALCOHOL CLIN EXP RES, V33, P191, DOI 10.1111/j.1530-0277.2008.00827.x; Reichert B, 2011, MOL ENDOCRINOL, V25, P799, DOI 10.1210/me.2010-0465; Rosselot C, 2010, DEVELOPMENT, V137, P283, DOI 10.1242/dev.040287; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Shao M, 2017, MOL METAB, V6, P111, DOI 10.1016/j.molmet.2016.11.009; Shelton NJ, 2014, AM J PUBLIC HEALTH, V104, P629, DOI 10.2105/AJPH.2013.301643; Tian LP, 2016, INT J BIOL SCI, V12, P1052, DOI 10.7150/ijbs.15811; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Da Silva LDV, 2007, NUTRITION, V23, P392, DOI 10.1016/j.nut.2007.02.009; Villarroya F, 1999, INT J OBESITY, V23, P1, DOI 10.1038/sj.ijo.0800799; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang B., 2017, J MOL CELL IN PRESS; Wang B, 2017, EBIOMEDICINE, V18, P288, DOI 10.1016/j.ebiom.2017.03.041; Wang B, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-162; Wang FF, 2013, P NATL ACAD SCI USA, V110, P18656, DOI 10.1073/pnas.1314863110; Wang S, 2015, INT J OBESITY, V39, P967, DOI 10.1038/ijo.2015.23; Wannamethee SG, 2003, AM J CLIN NUTR, V77, P1312, DOI 10.1093/ajcn/77.5.1312; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yeomans MR, 2010, PHYSIOL BEHAV, V100, P82, DOI 10.1016/j.physbeh.2010.01.012; Zhang M, 2015, J PHARMACOL SCI, V127, P430, DOI 10.1016/j.jphs.2015.03.001; Zhou HZ, 2002, AM J PHYSIOL-HEART C, V283, pH165, DOI 10.1152/ajpheart.00408.2001; Zhou ZX, 2005, AM J PATHOL, V166, P1681, DOI 10.1016/S0002-9440(10)62478-9; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587	62	9	9	1	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4612	4622		10.1096/fj.201700396R	http://dx.doi.org/10.1096/fj.201700396R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28679528	Green Published			2022-12-28	WOS:000413397400036
J	Zhang, F; Gannon, M; Chen, YJ; Zhou, LF; Jiao, K; Wang, Q				Zhang, Fang; Gannon, Mary; Chen, Yunjia; Zhou, Lufang; Jiao, Kai; Wang, Qin			The amyloid precursor protein modulates alpha(2A)-adrenergic receptor endocytosis and signaling through disrupting arrestin 3 recruitment	FASEB JOURNAL			English	Article						internalization; desensitization; interactions; cell surface receptor	ALPHA(2A) ADRENERGIC-RECEPTOR; CULTURED SYMPATHETIC NEURONS; INTERACTING PROTEINS; COUPLED RECEPTORS; DENDRITIC SPINES; DEFICIENT MICE; KINASE-A; IN-VITRO; SPINOPHILIN; APP	The amyloid precursor protein (APP) has long been appreciated for its role in Alzheimer's disease (AD) pathology. However, less is known about the physiologic function of APP outside of AD. Particularly, whether and how APP may regulate functions of cell surface receptors, including GPCRs, remains largely unclear. In this study, we identified a novel direct interaction between APP and the alpha(2A)-adrenergic receptor (alpha(2A)AR) that occurs at the intracellular domains of both proteins. The APP interaction with alpha(2A)AR is promoted by agonist stimulation and competes with arrestin 3 binding to the receptor. Consequently, the presence of APP attenuates alpha(2A)AR internalization and desensitization, which are arrestin-dependent processes. Furthermore, in neuroblastoma neuro-2A cells and primary superior cervical ganglion neurons, where APP is highly expressed, the lack of APP leads to a dramatic increase in plasma membrane recruitment of endogenous arrestin 3 following alpha(2A)AR activation. Concomitantly, agonist-induced internalization of alpha(2A)AR is significantly enhanced in these neuronal cells. Our study provided the first evidence that APP fine tunes GPCR signaling and trafficking. Given the important role of alpha(2A)AR in controlling norepinephrine release and response, this novel regulation of alpha(2A)AR by APP may have an impact on modulation of noradrenergic activity and sympathetic tone.-Zhang, F., Gannon, M., Chen, Y., Zhou, L., Jiao, K., Wang, Q. The amyloid precursor protein modulates alpha(2A)-adrenergic receptor endocytosis and signaling through disrupting arrestin 3 recruitment.	[Zhang, Fang; Gannon, Mary; Chen, Yunjia; Wang, Qin] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, 1918 Univ Blvd,986 MCLM, Birmingham, AL 35294 USA; [Zhou, Lufang] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Jiao, Kai] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Wang, Q (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, 1918 Univ Blvd,986 MCLM, Birmingham, AL 35294 USA.	qinwang@uab.edu	Zhang, Fang/AAT-5087-2020	Zhang, Fang/0000-0001-6403-9009; Zhou, Lufang/0000-0002-1321-8442; jiao, kai/0000-0002-1901-8329; Wang, Qin/0000-0002-1079-5914; Jiao, Kai/0000-0002-5415-9020	U.S. National Institutes of Health, National Institute of Mental Health [MH081917]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL121206, R21HL127599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081917] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank Dr. Jeffrey Benovic (Thomas Jefferson University, Philadelphia PA, USA) for generously providing the anti-arrestin 3 Ab. This work was supported by U.S. National Institutes of Health, National Institute of Mental Health Grant MH081917 (to Q.W.). The authors declare no conflicts of interest.	ALLINQUANT B, 1994, J NEUROSCI, V14, P6842; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Bockaert J, 2004, PHARMACOL THERAPEUT, V103, P203, DOI 10.1016/j.pharmthera.2004.06.004; Bockaert J, 2010, ANNU REV PHARMACOL, V50, P89, DOI 10.1146/annurev.pharmtox.010909.105705; Brum PC, 2006, NEUROPHARMACOLOGY, V51, P397, DOI 10.1016/j.neuropharm.2006.03.032; Chen YJ, 2014, P NATL ACAD SCI USA, V111, P17296, DOI 10.1073/pnas.1409513111; Chen YJ, 2012, J NEUROSCI, V32, P2683, DOI 10.1523/JNEUROSCI.4125-11.2011; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; Cottingham C, 2013, J BIOL CHEM, V288, P29193, DOI 10.1074/jbc.M113.469494; Cottingham C, 2012, NEUROPHARMACOLOGY, V62, P2354, DOI 10.1016/j.neuropharm.2012.02.011; Cottingham C, 2011, J BIOL CHEM, V286, P36063, DOI 10.1074/jbc.M111.261578; Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2; DeGraff JL, 1999, J BIOL CHEM, V274, P11253, DOI 10.1074/jbc.274.16.11253; Deyts C, 2016, TRENDS PHARMACOL SCI, V37, P390, DOI 10.1016/j.tips.2016.01.005; Duce JA, 2013, MOL PSYCHIATR, V18, P245, DOI 10.1038/mp.2011.168; Edwards SW, 1999, J BIOL CHEM, V274, P16331, DOI 10.1074/jbc.274.23.16331; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Gilsbach R, 2012, BRIT J PHARMACOL, V165, P90, DOI 10.1111/j.1476-5381.2011.01533.x; Giovannitti Joseph A Jr, 2015, Anesth Prog, V62, P31, DOI 10.2344/0003-3006-62.1.31; Gyires K, 2009, NEUROCHEM INT, V55, P447, DOI 10.1016/j.neuint.2009.05.014; Hein L, 1999, NATURE, V402, P181, DOI 10.1038/46040; Hein L, 2006, CELL TISSUE RES, V326, P541, DOI 10.1007/s00441-006-0285-2; Klevanski M, 2014, MOL CELL NEUROSCI, V61, P201, DOI 10.1016/j.mcn.2014.06.004; Lefkowitz RJ, 2013, PROG MOL BIOL TRANSL, V118, P3, DOI 10.1016/B978-0-12-394440-5.00001-2; Lohse Martin J, 2014, Handb Exp Pharmacol, V219, P15, DOI 10.1007/978-3-642-41199-1_2; Lu R, 2010, MOL PHARMACOL, V78, P279, DOI 10.1124/mol.110.065300; Lu RJ, 2009, J BIOL CHEM, V284, P13233, DOI 10.1074/jbc.M807535200; Ma L, 2007, J CELL SCI, V120, P213, DOI 10.1242/jcs.03338; MacMillan LB, 1996, SCIENCE, V273, P801, DOI 10.1126/science.273.5276.801; Masse F, 2006, PSYCHOPHARMACOLOGY, V183, P471, DOI 10.1007/s00213-005-0220-3; Matrone C, 2011, J NEUROSCI, V31, P11756, DOI 10.1523/JNEUROSCI.1960-11.2011; Muly EC, 2004, J COMP NEUROL, V469, P185, DOI 10.1002/cne.11001; Nelson CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074680; Nicolas M, 2014, DEVELOPMENT, V141, P2543, DOI 10.1242/dev.108712; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Russo C, 2005, BRAIN RES REV, V48, P257, DOI 10.1016/j.brainresrev.2004.12.016; Schlicker E, 1998, BRAIN RES BULL, V47, P129, DOI 10.1016/S0361-9230(98)00068-9; SCHUBERT W, 1991, BRAIN RES, V563, P184, DOI 10.1016/0006-8993(91)91532-6; STARKE K, 1989, PHYSIOL REV, V69, P864, DOI 10.1152/physrev.1989.69.3.864; Steinbach JP, 1998, CELL DEATH DIFFER, V5, P858, DOI 10.1038/sj.cdd.4400391; Trendelenburg AU, 2001, N-S ARCH PHARMACOL, V363, P110; van der Kant R, 2015, DEV CELL, V32, P502, DOI 10.1016/j.devcel.2015.01.022; Wang B, 2007, P NATL ACAD SCI USA, V104, P14140, DOI 10.1073/pnas.0704070104; Wang Q, 2004, SCIENCE, V304, P1940, DOI 10.1126/science.1098274; Wang Q, 2002, J BIOL CHEM, V277, P50589, DOI 10.1074/jbc.M208503200; Wang Q, 2007, BIOCHEM PHARMACOL, V73, P1135, DOI 10.1016/j.bcp.2006.12.024; Wang Q, 2006, J BIOL CHEM, V281, P25948, DOI 10.1074/jbc.M605415200; Xu JM, 2008, J BIOL CHEM, V283, P14516, DOI 10.1074/jbc.M710340200; Zhang Q, 2014, J ALZHEIMERS DIS, V40, P605, DOI 10.3233/JAD-130017; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	52	17	17	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4434	4446		10.1096/fj.201700346R	http://dx.doi.org/10.1096/fj.201700346R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28646018	Green Published			2022-12-28	WOS:000413397400021
J	Evankovich, J; Lear, T; Mckelvey, A; Dunn, S; Londino, J; Liu, Y; Chen, BB; Mallampalli, RK				Evankovich, John; Lear, Travis; Mckelvey, Alison; Dunn, Sarah; Londino, James; Liu, Yuan; Chen, Bill B.; Mallampalli, Rama K.			Receptor for advanced glycation end products is targeted by FBXO10 for ubiquitination and degradation	FASEB JOURNAL			English	Article						ubiquitin; acute lung injury; F-box proteins	LUNG INJURY; CELL-DEATH; RAGE; PROTEOLYSIS; PROTEASOME; STABILITY; DAMPS	The receptor for advanced glycation end products (RAGE) is a highly expressed cell membrane receptor serving to anchor lung epithelia to matrix components, and it also amplifies inflammatory signaling during acute lung injury. However, mechanisms that regulate its protein concentrations in cells remain largely unknown. Here we show that RAGE exhibits an extended life span in lung epithelia (t(1/2) 6 h), is monoubiquitinated at K374, and is degraded in lysosomes. The RAGE ligand ODN2006, a synthetic oligodeoxynucleotide resembling pathogenic hypomethylated CpG DNA, promotes rapid lysosomal RAGE degradation through activation of protein kinase C zeta (PKC zeta), which phosphorylates RAGE. PKC zeta overexpression enhances RAGE degradation, while PKC zeta knockdown stabilizes RAGE protein levels and prevents ODN2006-mediated degradation. We identify that RAGE is targeted by the ubiquitin E3 ligase subunit F-box protein O10 (FBXO10), which associates with RAGE to mediate its ubiquitination and degradation. FBXO10 depletion in cells stabilizes RAGE and is required for ODN2006-mediated degradation. These data suggest that modulation of regulators involved in ubiquitin-mediated disposal of RAGE might serve as unique molecular inputs directing RAGE cellular concentrations and downstream responses, which are critical in an array of inflammatory disorders, including acute lung injury.	[Evankovich, John; Londino, James; Liu, Yuan; Chen, Bill B.; Mallampalli, Rama K.] Univ Pittsburgh, Acute Lung Injury Ctr Excellence, Pittsburgh, PA 15213 USA; [Evankovich, John; Liu, Yuan; Chen, Bill B.; Mallampalli, Rama K.] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15213 USA; [Lear, Travis; Mckelvey, Alison; Dunn, Sarah] Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15213 USA; [Mallampalli, Rama K.] Vet Affairs Pittsburgh Healthcare Syst, Med Specialty Serv Line, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Mallampalli, RK (corresponding author), Univ Pittsburgh, UPMC Montefiore, Div Pulm Allergy & Crit Care Med, Dept Med, NW 628 Montefiore,3459 Fifth Ave, Pittsburgh, PA 15213 USA.	mallampalirk@upmc.edu	Londino, James/GXH-4404-2022; Londino, James/GXH-2306-2022	Londino, James/0000-0001-7647-6927; Lear, Travis/0000-0001-9156-0844	U.S. National Institutes of Health, National Heart Lung, and Blood [HL096376, HL097376, HL098174, 5T32HL007563-28, P01 HL114453, HL116472, HL132862]; U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Bio-medical Laboratory Research and Development; Merit Review Award from the U.S. Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098174, F32HL137258, R01HL116472, R01HL096376, P01HL114453, T32HL007563, R01HL132862, R01HL097376, R01HL081784, UH3HL123502] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002200] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart Lung, and Blood; U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Bio-medical Laboratory Research and Development(US Department of Veterans Affairs); Merit Review Award from the U.S. Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in part, by U.S. National Institutes of Health, National Heart Lung, and Blood Grants HL096376, HL097376, HL098174, 5T32HL007563-28, and P01 HL114453 (to R.K.M.), and HL116472 and HL132862 (to B.B.C.); and by the U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Bio-medical Laboratory Research and Development, as well as a Merit Review Award from the U.S. Department of Veterans Affairs (to R.K.M.). B.B.C. and R.K.M are co-senior authors.	Calfee CS, 2008, THORAX, V63, P1083, DOI 10.1136/thx.2008.095588; CARDON LR, 1994, P NATL ACAD SCI USA, V91, P3799, DOI 10.1073/pnas.91.9.3799; Chen BB, 2014, CELL REP, V7, P476, DOI 10.1016/j.celrep.2014.02.048; Chen BB, 2013, NAT IMMUNOL, V14, P470, DOI 10.1038/ni.2565; Chiorazzi M, 2013, P NATL ACAD SCI USA, V110, P3943, DOI 10.1073/pnas.1217271110; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Coon TA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3881; Franz J, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/912713; Guo WA, 2012, INTENS CARE MED, V38, P1588, DOI 10.1007/s00134-012-2624-y; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hu YB, 2015, TRANSL NEURODEGENER, V4, DOI 10.1186/s40035-015-0041-1; Jabaudon M, 2015, AM J RESP CRIT CARE, V192, P191, DOI 10.1164/rccm.201501-0020OC; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Lear T, 2016, J EXP MED, V213, P1029, DOI 10.1084/jem.20151229; Liu YW, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.150; Milutinovic PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088259; Mrozek S, 2016, CHEST, V150, P998, DOI 10.1016/j.chest.2016.03.016; Nakahira K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001577; Nakamura T, 2011, CLIN BIOCHEM, V44, P601, DOI 10.1016/j.clinbiochem.2010.12.014; Pradella A., 2010, CRIT CARE, V14, P194; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Ramsgaard L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020132; Raucci A, 2008, FASEB J, V22, P3716, DOI 10.1096/fj.08-109033; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Sakaguchi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023132; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI200114002; Sessa L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086903; Shirasawa M, 2004, GENES CELLS, V9, P165, DOI 10.1111/j.1356-9597.2004.00712.x; Simmons JD, 2013, ANN SURG, V258, P591, DOI 10.1097/SLA.0b013e3182a4ea46; Sirois CM, 2014, J EXP MED, V211; Skaar JR, 2014, NAT REV DRUG DISCOV, V13, P889, DOI 10.1038/nrd4432; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Vadasz I, 2012, CHEST, V141, P763, DOI 10.1378/chest.11-1660; van Zoelen MAD, 2009, J IMMUNOL, V182, P4349, DOI 10.4049/jimmunol.0801199; Weathington NM, 2013, AM J RESP CRIT CARE, V188, P530, DOI 10.1164/rccm.201304-0754PP; Wittkowski H, 2007, CRIT CARE MED, V35, P1369, DOI 10.1097/01.CCM.0000262386.32287.29; Zhang L, 2008, J BIOL CHEM, V283, P35507, DOI 10.1074/jbc.M806948200; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhao J, 2012, NAT IMMUNOL, V13, P651, DOI 10.1038/ni.2341; Zou CB, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7793	40	14	14	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3894	3903		10.1096/fj.201700031R	http://dx.doi.org/10.1096/fj.201700031R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28515150	Green Published			2022-12-28	WOS:000408713300016
J	de los Rios, EA; Ruiz-Herrera, X; Tinoco-Pantoja, V; Lopez-Barrera, F; de la Escalera, GM; Clapp, C; Macotela, Y				de los Rios, Ericka A.; Ruiz-Herrera, Xarubet; Tinoco-Pantoja, Viridiana; Lopez-Barrera, Fernando; Martinez de la Escalera, Gonzalo; Clapp, Carmen; Macotela, Yazmin			Impaired prolactin actions mediate altered offspring metabolism induced by maternal high-fat feeding during lactation	FASEB JOURNAL			English	Article						nursing pups; metabolic programming; insulin resistance	RECOMBINANT HUMAN PROLACTIN; LONG-TERM CONSEQUENCES; DIET-INDUCED OBESITY; HUMAN BREAST-MILK; INSULIN SENSITIVITY; SIGNALING PATHWAYS; LEPTIN SENSITIVITY; LIPID BIOSYNTHESIS; PREVENTS OBESITY; GROWTH-HORMONE	Maternal diet during lactation affects offspring metabolic health throughout life. Prolactin (PRL) is present in high quantities in maternal milk; however, the effects of milk PRL on the offspring remain poorly characterized. In this study, we evaluated whether feeding a high-fat diet (HFD) to rats during lactation alters PRL, both in the mother's serum and in milk, and whether this factor contributes to HFD-induced metabolic dysfunction in the offspring. Maternal HFD resulted in decreased PRL levels in milk (but not in serum), reduced mammary gland (MG) PRL receptor expression, and altered MG structure and function. Offspring from HFD-fed dams had increased body weight and adiposity, and developed fatty liver, hyperinsulinemia, and insulin resistance at weaning. Increasing PRL levels in the HFD-fed mothers by subcutaneous osmotic minipumps releasing PRL normalized MG function and PRL levels in milk. Moreover, PRL treatment in HFD-fed mothers, or directly in their pups via oral PRL administration, increased liver STAT5 phosphorylation, reduced visceral adiposity, ameliorated fatty liver, and improved insulin sensitivity in offspring. Our results show that HFD impairs PRL actions during lactation to negatively affect MG physiology and directly impair offspring metabolism.	[de los Rios, Ericka A.; Ruiz-Herrera, Xarubet; Tinoco-Pantoja, Viridiana; Lopez-Barrera, Fernando; Martinez de la Escalera, Gonzalo; Clapp, Carmen; Macotela, Yazmin] Univ Nacl Autonoma Mexico, Inst Neurobiol, Campus UNAM, Juriquilla 76230, Queretaro, Mexico	Universidad Nacional Autonoma de Mexico	Macotela, Y (corresponding author), Univ Nacl Autonoma Mexico, Inst Neurobiol, Campus UNAM, Juriquilla 76230, Queretaro, Mexico.	macotelag@unam.mx			UNAM grant UNAM-DGAPA-PAPIIT [IN203915]; Programa de Doctorado en Ciencias Biomedicas, UNAM; Consejo Nacional de Ciencia y Tecnologia (CONACYT) Fellowship [230452]	UNAM grant UNAM-DGAPA-PAPIIT; Programa de Doctorado en Ciencias Biomedicas, UNAM; Consejo Nacional de Ciencia y Tecnologia (CONACYT) Fellowship(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors thank Daniel Mondragon, Maarten Werdler, Gabriel Nava, Martin Garcia-Servin, Alejandra Castilla, and Antonio Prado [all from the Instituto de Neurobiologia, Universidad Nacional Autonoma de Mexico (UNAM)] for excellent technical assistance. The authors thank Jessica Gonzalez Norris (UNAM) for critically editing the manuscript. This study was supported by UNAM grant UNAM-DGAPA-PAPIIT IN203915 (to Y.M.) E.A.D.L.R. is a doctoral student from Programa de Doctorado en Ciencias Biomedicas, UNAM and received a Consejo Nacional de Ciencia y Tecnologia (CONACYT) Fellowship 230452. The authors declare no conflicts of interest.	Badillo-Suarez PA, 2017, J MAMMARY GLAND BIOL, V22, P171, DOI 10.1007/s10911-017-9382-y; Andreas NJ, 2015, EARLY HUM DEV, V91, P629, DOI 10.1016/j.earlhumdev.2015.08.013; Aydin S, 2008, NUTRITION, V24, P689, DOI 10.1016/j.nut.2008.03.020; Bautista CJ, 2016, BRIT J NUTR, V115, P538, DOI 10.1017/S0007114515004547; Ben-Jonathan N, 2015, ADV EXP MED BIOL, V846, P1, DOI 10.1007/978-3-319-12114-7_1; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Bonomo IT, 2008, J ENDOCRINOL, V198, P331, DOI 10.1677/JOE-07-0505; Bonomo IT, 2007, J ENDOCRINOL, V192, P339, DOI 10.1677/joe.1.06952; Brisken C, 1999, DEV BIOL, V210, P96, DOI 10.1006/dbio.1999.9271; Buonfiglio DC, 2016, SCI REP-UK, V6, DOI 10.1038/srep22421; Catli G, 2014, J CLIN RES PEDIATR E, V6, P192, DOI [10.4274/Jcrpe.1531, 10.4274/jcrpe.1531]; Chirico V, 2013, CLIN ENDOCRINOL, V79, P537, DOI 10.1111/cen.12183; Clinton SK, 1997, J NUTR, V127, P225, DOI 10.1093/jn/127.2.225; COLLET C, 1991, J MOL ENDOCRINOL, V6, P9, DOI 10.1677/jme.0.0060009; Czech MP, 2017, NAT MED, V23, P804, DOI 10.1038/nm.4350; De Luca A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168568; de Moura EG, 2009, J PHYSIOL-LONDON, V587, P4919, DOI 10.1113/jphysiol.2009.176289; DePeters EJ, 2009, J MAMMARY GLAND BIOL, V14, P397, DOI 10.1007/s10911-009-9158-0; Diau GY, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-11; Du QW, 2015, PEPTIDES, V70, P23, DOI 10.1016/j.peptides.2015.05.003; Du Y, 2012, GENE DEV, V26, P1306, DOI 10.1101/gad.191031.112; ELLIS LA, 1995, ENDOCRINOLOGY, V136, P2711, DOI 10.1210/en.136.6.2711; Ellis LA, 1996, J MAMMARY GLAND BIOL, V1, P259, DOI 10.1007/BF02018079; Ferezou-Viala J, 2007, AM J PHYSIOL-REG I, V293, pR1056, DOI 10.1152/ajpregu.00117.2007; Flint DJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1179, DOI 10.1152/ajpendo.00433.2004; Ganapathy S, 2009, INDIAN PEDIATR, V46, P785; Gavalda-Navarro A, 2015, SCI REP-UK, V5, DOI 10.1038/srep13717; Gillam MP, 2011, PITUITARY, 3RD EDITION, P119, DOI 10.1016/B978-0-12-380926-1.10005-7; GONNELLA PA, 1989, J CELL PHYSIOL, V140, P138, DOI 10.1002/jcp.1041400117; GROSVENOR CE, 1993, ENDOCR REV, V14, P710, DOI 10.1210/edrv-14-6-710; GROSVENOR CE, 1976, J ENDOCRINOL, V70, P1, DOI 10.1677/joe.0.0700001; GROVE D S, 1991, Endocrine Regulations, V25, P111; Guillou A, 2015, ENDOCRINOLOGY, V156, P1924, DOI 10.1210/en.2014-1571; GUYETTE WA, 1979, CELL, V17, P1013, DOI 10.1016/0092-8674(79)90340-4; Haeusler RA, 2018, NAT REV MOL CELL BIO, V19, P31, DOI 10.1038/nrm.2017.89; Hara M, 1998, ANAT REC, V251, P37, DOI 10.1002/(SICI)1097-0185(199805)251:1<37::AID-AR7>3.0.CO;2-B; Heird WC, 2005, ANNU REV NUTR, V25, P549, DOI 10.1146/annurev.nutr.24.012003.132254; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Hennighausen L, 1991, Biotechnology, V16, P65; Hernandez LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032598; Horta BL, 2015, ACTA PAEDIATR, V104, P30, DOI 10.1111/apa.13133; Hurley WL, 2011, NUTRIENTS, V3, P442, DOI 10.3390/nu3040442; JAGODA CA, 1991, P SOC EXP BIOL MED, V197, P431; KACSOH B, 1993, J ENDOCRINOL, V138, P243, DOI 10.1677/joe.0.1380243; Laitinen K, 2006, PEDIATR RES, V59, P723, DOI 10.1203/01.pdr.0000203158.31452.9e; Lemas DJ, 2016, AM J CLIN NUTR, V103, P1291, DOI 10.3945/ajcn.115.126375; Lemini M, 2015, AM J PHYSIOL-REG I, V308, pR792, DOI 10.1152/ajpregu.00327.2014; Liang XW, 2016, SCI REP-UK, V6, DOI 10.1038/srep34345; Masuyama H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092805; Melo AI, 2009, HORM BEHAV, V56, P281, DOI 10.1016/j.yhbeh.2009.06.005; Moretto Vera L, 2011, ISRN Obstet Gynecol, V2011, P876502, DOI 10.5402/2011/876502; Munzberg H, 2010, FORUM NUTR, V63, P123, DOI 10.1159/000264400; Musilova S, 2014, BENEF MICROBES, V5, P273, DOI 10.3920/BM2013.0080; NAGANO M, 1994, J BIOL CHEM, V269, P13337; Neville MC, 2002, J MAMMARY GLAND BIOL, V7, P49, DOI 10.1023/A:1015770423167; Nguyen DAD, 1998, J MAMMARY GLAND BIOL, V3, P233, DOI 10.1023/A:1018707309361; O'Sullivan EJ, 2015, J NUTR, V145, P2369, DOI 10.3945/jn.115.214619; Oben JA, 2010, J HEPATOL, V52, P913, DOI 10.1016/j.jhep.2009.12.042; Ollivier-Bousquet M, 1993, Endocr Regul, V27, P115; OPPAT CA, 1988, P SOC EXP BIOL MED, V188, P342; Pai VP, 2008, J BIOL CHEM, V283, P30901, DOI 10.1074/jbc.M802476200; Palou A, 2009, APPETITE, V52, P249, DOI 10.1016/j.appet.2008.09.013; Park S, 2011, DIABETES-METAB RES, V27, P564, DOI 10.1002/dmrr.1215; Pico C, 2007, INT J OBESITY, V31, P1199, DOI 10.1038/sj.ijo.0803585; Powe CE, 2011, PEDIATRICS, V127, pE359, DOI 10.1542/peds.2010-1627; Powe CE, 2010, CLIN ENDOCRINOL, V73, P645, DOI 10.1111/j.1365-2265.2010.03850.x; Rasmussen KM, 2007, ANNU REV NUTR, V27, P103, DOI 10.1146/annurev.nutr.27.061406.093738; Rasmussen KM, 2004, PEDIATRICS, V113, pE465, DOI 10.1542/peds.113.5.e465; ROLLS BA, 1986, PHYSIOL BEHAV, V38, P185, DOI 10.1016/0031-9384(86)90153-8; ROLLS BJ, 1980, P NUTR SOC, V39, pA51; Rudolph MC, 2011, AM J PHYSIOL-ENDOC M, V300, pE1059, DOI 10.1152/ajpendo.00083.2011; Ruiz-Herrera X, 2017, ENDOCRINOLOGY, V158, P56, DOI 10.1210/en.2016-1444; SAMPSON DA, 1984, J PEDIATR GASTR NUTR, V3, P613, DOI 10.1097/00005176-198409000-00023; Sanchez J, 2005, ENDOCRINOLOGY, V146, P2575, DOI 10.1210/en.2005-0112; Savino F, 2009, INT J PEDIATR ENDOCR, DOI 10.1155/2009/327505; Seddiki T, 2002, BIOL CELL, V94, P173, DOI 10.1016/S0248-4900(02)01188-7; SHAH GV, 1988, ENDOCRINOLOGY, V122, P1883, DOI 10.1210/endo-122-5-1883; SHYR SW, 1986, ENDOCRINOLOGY, V119, P1217, DOI 10.1210/endo-119-3-1217; Stull MA, 2007, P NATL ACAD SCI USA, V104, P16708, DOI 10.1073/pnas.0708136104; Sun B, 2012, DIABETES, V61, P2833, DOI 10.2337/db11-0957; TANAKA T, 1980, J CLIN ENDOCR METAB, V51, P1058, DOI 10.1210/jcem-51-5-1058; Turcksin R, 2014, MATERN CHILD NUTR, V10, P166, DOI 10.1111/j.1740-8709.2012.00439.x; Velazquez-Villegas LA, 2015, BBA-BIOMEMBRANES, V1848, P1157, DOI 10.1016/j.bbamem.2015.02.011; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; VILLALBA M, 1991, ENDOCRINOLOGY, V129, P2857, DOI 10.1210/endo-129-6-2857; Vogt MC, 2014, CELL, V156, P495, DOI 10.1016/j.cell.2014.01.008; WATERS SB, 1988, AM J PHYSIOL, V255, pE567, DOI 10.1152/ajpendo.1988.255.4.E567; WHITWORTH NS, 1978, J ENDOCRINOL, V79, P191, DOI 10.1677/joe.0.0790191; Yore MM, 2014, CELL, V159, P318, DOI 10.1016/j.cell.2014.09.035; Young BE, 2017, EUR J CLIN NUTR, V71, P1094, DOI 10.1038/ejcn.2017.75; Yu JJ, 2013, DIABETES, V62, P3103, DOI 10.2337/db13-0182	91	12	12	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3457	3470		10.1096/fj.201701154R	http://dx.doi.org/10.1096/fj.201701154R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401632				2022-12-28	WOS:000432546000045
J	Li, ZL; Yang, AJ; Yin, XL; Dong, SW; Luo, F; Dou, C; Lan, X; Xie, Z; Hou, TY; Xu, JZ; Xing, JC				Li, Zhilin; Yang, Aijun; Yin, Xiaolong; Dong, Shiwu; Luo, Fei; Dou, Ce; Lan, Xu; Xie, Zhao; Hou, Tianyong; Xu, Jianzhong; Xing, Junchao			Mesenchymal stem cells promote endothelial progenitor cell migration, vascularization, and bone repair in tissue-engineered constructs via activating CXCR2-Src-PKL/Vav2-Rac1	FASEB JOURNAL			English	Article						bone tissue engineering; signal pathway; vasculogenesis	FOCAL ADHESION KINASE; FUNCTIONAL-PROPERTIES; SIGNALING PATHWAYS; GROWTH-FACTOR; LINKER PKL; RECEPTOR 2; CXCR2; MOBILIZATION; CANCER; OSTEOGENESIS	Tissue-engineered constructs (TECs) hold great promise for treating large bone defects. Incorporated mesenchymal stem cells (MSCs) can facilitate the vascularization of TECs. Nevertheless, the underlying mechanism remains ambiguous. Here we analyzed the roles of C-X-C chemokine receptor 2 (CXCR2) and its downstream signal pathways in MSC-induced endothelial progenitor cell (EPC) migration. Transwell assays and immunofluorescence staining were performed for cell migration analysis in vitro and in vivo, respectively. A series of signal inhibitors and short hairpin RNA was used for screening essential signaling molecules. We found that blockade of CXCR2 abolished the migration of EPCs toward MSCs as well as subsequent vascularization and bone repair in TECs. Moreover, screening results suggested that steroid receptor coactivator (Src) acted as a predominant downstream effector of CXCR2. Further molecular biologic and histomorphological experiments revealed that the action of Src required the phosphorylation of ras-related C3 botulinum toxin substrate 1 (Rac1), which was pivotal for the development of lamellipodia and filopodia. The phosphorylation and colocalization of paxillin kinase linker (PKL) and vav guanine nucleotide exchange factor 2 (Vav2) were essential for the activation of Rac1. Therefore, we demonstrated that MSCs promoted EPC migration via activating CXCR2 and its downstream Src-PKL/Vav2-Rac1 signaling pathway. These findings unveiled the molecular mechanism in the vascularization of TECs and were expected to provide novel targets for efficacy improvement.	[Li, Zhilin; Yang, Aijun; Yin, Xiaolong; Dong, Shiwu; Luo, Fei; Dou, Ce; Xie, Zhao; Hou, Tianyong; Xu, Jianzhong; Xing, Junchao] Southwest Hosp, Dept Orthoped, Natl & Reg United Engn Lab Tissue Engn, Chongqing, Peoples R China; [Dong, Shiwu] Third Mil Med Univ, Dept Biomed Mat Sci, Coll Biomed Engn, Chongqing, Peoples R China; [Li, Zhilin; Yang, Aijun; Yin, Xiaolong; Luo, Fei; Dou, Ce; Xie, Zhao; Hou, Tianyong; Xu, Jianzhong; Xing, Junchao] Ctr Regenerat & Reconstruct Engn Technol Chongqin, Chongqing, Peoples R China; [Li, Zhilin; Yang, Aijun; Yin, Xiaolong; Luo, Fei; Dou, Ce; Xie, Zhao; Hou, Tianyong; Xu, Jianzhong; Xing, Junchao] Tissue Engn Lab Chongqing City, Chongqing, Peoples R China; [Li, Zhilin; Lan, Xu] Chinese Peoples Liberat Army, Lanzhou Command, Lanzhou Gen Hosp, Dept Spine, Lanzhou, Gansu, Peoples R China	Army Medical University; Army Medical University	Xu, JZ; Xing, JC (corresponding author), Third Mil Med Univ, Southwest Hosp, 29 Gaotanyan St, Chongqing 400038, Peoples R China.	prof_jianzhongxu@163.com; 46327289@qq.com	Xing, Junchao/GWN-0403-2022; Dou, Ce/B-8841-2012	Dou, Ce/0000-0002-6983-6354	National High Technology Research and Development Program of China (863 Program) [2015AA020315]; Natural Science Foundation of China [81471802]; Foundation of Southwest Hospital [SWH2015QN05]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Southwest Hospital	This work was supported by the National High Technology Research and Development Program of China (863 Program, 2015AA020315), the Natural Science Foundation of China (81471802), and the Foundation of Southwest Hospital (SWH2015QN05). The authors declare no conflicts of interest.	Addison CL, 2000, J IMMUNOL, V165, P5269, DOI 10.4049/jimmunol.165.9.5269; Almeida CR, 2016, STEM CELL REP, V6, P466, DOI 10.1016/j.stemcr.2016.02.012; Atesok K, 2012, KNEE SURG SPORT TR A, V20, P1366, DOI 10.1007/s00167-012-1940-7; Bolland BJRF, 2008, BONE, V43, P195, DOI 10.1016/j.bone.2008.02.013; Bose S, 2012, TRENDS BIOTECHNOL, V30, P546, DOI 10.1016/j.tibtech.2012.07.005; Chen QA, 2010, CYTOTHERAPY, V12, P831, DOI 10.3109/14653249.2010.495980; Dang I, 2013, NATURE, V503, P281, DOI 10.1038/nature12611; Di Cioccio V, 2004, IMMUNOLOGY, V111, P407, DOI 10.1111/j.1365-2567.2004.01822.x; Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649; Fedorovich NE, 2010, TISSUE ENG PT A, V16, P2355, DOI [10.1089/ten.tea.2009.0603, 10.1089/ten.TEA.2009.0603]; Frank SR, 2006, EMBO J, V25, P1848, DOI 10.1038/sj.emboj.7601092; Gao XQ, 2014, FASEB J, V28, P3792, DOI 10.1096/fj.13-247965; Garrett TA, 2007, EXP CELL RES, V313, P3285, DOI 10.1016/j.yexcr.2007.05.027; Gavard J, 2009, MOL CELL BIOL, V29, P2469, DOI 10.1128/MCB.01304-08; Goligorsky MS, 2014, SEMIN NEPHROL, V34, P365, DOI 10.1016/j.semnephrol.2014.06.003; Gray EJ, 2014, J BIOL CHEM, V289, P35397, DOI 10.1074/jbc.M114.615112; Ha H, 2017, THERANOSTICS, V7, P1543, DOI 10.7150/thno.15625; Ha J, 2011, CYTOKINE, V55, P48, DOI 10.1016/j.cyto.2011.03.026; Hauck CR, 2000, J BIOL CHEM, V275, P41092, DOI 10.1074/jbc.M005450200; Herrmann M, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00079; Hou YN, 2015, STEM CELL RES, V14, P133, DOI 10.1016/j.scr.2014.12.001; Hristov M, 2007, CIRC RES, V100, P590, DOI 10.1161/01.RES.0000259043.42571.68; Hu MM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005171; Jones MC, 2013, MOL BIOL CELL, V24, P1882, DOI 10.1091/mbc.E12-09-0654; Ju L, 2017, CELL PHYSIOL BIOCHEM, V41, P1346, DOI 10.1159/000465389; Kamprom W, 2016, EUR J CELL BIOL, V95, P153, DOI 10.1016/j.ejcb.2016.02.001; Kasashima H, 2016, AM J PATHOL, V186, P3028, DOI 10.1016/j.ajpath.2016.07.024; Kawakatsu T, 2005, J BIOL CHEM, V280, P4940, DOI 10.1074/jbc.M408710200; Kimura H, 2013, CELL PHYSIOL BIOCHEM, V32, P899, DOI 10.1159/000354493; Kurtagic E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145115; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Laing AJ, 2007, J ORTHOP RES, V25, P44, DOI 10.1002/jor.20228; Lee DY, 2008, BONE, V42, P932, DOI 10.1016/j.bone.2008.01.007; Li AH, 2011, TRANSL ONCOL, V4, P20, DOI 10.1593/tlo.10184; Li Z, 2014, CYTOKINE, V69, P6, DOI 10.1016/j.cyto.2014.05.004; Matsumoto T, 2008, J CELL PHYSIOL, V215, P234, DOI 10.1002/jcp.21309; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Miyake M, 2013, LAB INVEST, V93, P768, DOI 10.1038/labinvest.2013.71; Pang H, 2013, INT ORTHOP, V37, P753, DOI 10.1007/s00264-012-1751-y; Pelus LM, 2006, EXP HEMATOL, V34, P1010, DOI 10.1016/j.exphem.2006.04.004; Schroder K, 2011, ANTIOXID REDOX SIGN, V15, P915, DOI 10.1089/ars.2010.3533; Seebach C, 2010, TISSUE ENG PT A, V16, P1961, DOI 10.1089/ten.TEA.2009.0715; Sobolik T, 2014, MOL BIOL CELL, V25, P566, DOI 10.1091/mbc.E13-07-0360; Spiller KL, 2015, BIOMATERIALS, V37, P194, DOI 10.1016/j.biomaterials.2014.10.017; Tang YB, 2011, EUR CELLS MATER, V21, P459, DOI 10.22203/eCM.v021a34; Tilghman RW, 2005, J CELL SCI, V118, P2613, DOI 10.1242/jcs.02380; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; West KA, 2001, J CELL BIOL, V154, P161, DOI 10.1083/jcb.200101039; Wu FJ, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0316-6; Wu XH, 2013, TISSUE ENG PT A, V19, P2486, DOI [10.1089/ten.TEA.2013.0124, 10.1089/ten.tea.2013.0124]; Xing JC, 2017, ACTA BIOMATER, V53, P470, DOI 10.1016/j.actbio.2017.02.016; Xing JC, 2014, J SURG RES, V192, P454, DOI 10.1016/j.jss.2014.05.037; Xing JC, 2014, CELL PHYSIOL BIOCHEM, V33, P905, DOI 10.1159/000358663; Yamauchi J, 2004, P NATL ACAD SCI USA, V101, P8774, DOI 10.1073/pnas.0402795101; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Ye DW, 2016, J HEPATOL, V65, P988, DOI 10.1016/j.jhep.2016.05.041; Yu BQ, 2016, STEM CELLS, V34, P2368, DOI 10.1002/stem.2410	57	29	31	3	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2197	2211		10.1096/fj.201700895R	http://dx.doi.org/10.1096/fj.201700895R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29229683				2022-12-28	WOS:000429051400038
J	Gromnitza, S; Lepa, C; Weide, T; Schwab, A; Pavenstadt, H; George, B				Gromnitza, Sascha; Lepa, Carolin; Weide, Thomas; Schwab, Albrecht; Pavenstaedt, Hermann; George, Britta			Tropomyosin-related kinase C (TrkC) enhances podocyte migration by ERK-mediated WAVE2 activation	FASEB JOURNAL			English	Article						actin cytoskeleton; signaling; tyrosine kinase; neurotrophin-3	TYROSINE KINASE; ARP2/3 COMPLEX; PHOSPHATIDYLINOSITOL 3-KINASE; SUBCELLULAR-DISTRIBUTION; ACTIN POLYMERIZATION; REGULATORY COMPLEX; CELL-MIGRATION; FOOT PROCESSES; RECEPTORS; PHOSPHORYLATION	Podocyte malfunction is central to glomerular diseases and is marked by defective podocyte intercellular junctions and actin cytoskeletal dynamics. Podocytes share many morphologic features with neurons, so that similar sets of proteins appear to regulate cell process formation. One such protein is the tropomyosin-related kinase C (TrkC). TrkC deficiency inmice leads to proteinuria as a surrogate of defective kidney filter function. Activation of endogenous TrkC by its ligand neurotrophin-3 resulted in increased podocyte migration-a surrogate of podocyte actin dynamics in vivo. Employing a mutagenesis approach, we found that the Src homologous and collagen-like (Shc) binding site Tyr(516) within the TrkC cytoplasmic domain was necessary for TrkC-induced migration of podocytes. TrkC activation led to a mobility shift of Wiskott-Aldrich syndrome family verprolin-homologous protein (WAVE)-2which is knownto orchestrate Arp2/3 activation and actin polymerization. Chemical inactivation of Erk ormutagenesis of 2 of 4 knownErk target siteswithinWAVE2, Thr(346) and Ser(351), abolishedthe TrkC-induced WAVE2 mobility shift. Knockdown of WAVE2 by shRNA abolished TrkC-induced podocyte migration. In summary, TrkC signals to the podocyte actin cytoskeleton to induce migration by phosphorylating WAVE2 Erk dependently. This signaling mechanism may be important for TrkC-mediated cytoskeletal dynamics in podocyte disease.	[Gromnitza, Sascha; Lepa, Carolin; Weide, Thomas; Pavenstaedt, Hermann; George, Britta] Univ Klinikum Munster, Med Klin D, Albert Schweitzer Campus 1, D-48149 Munster, Germany; [Schwab, Albrecht] Westfal Wilhelms Univ Munster, Inst Physiol 2, Munster, Germany	University of Munster; University of Munster	George, B (corresponding author), Univ Klinikum Munster, Med Klin D, Albert Schweitzer Campus 1, D-48149 Munster, Germany.	britta.george@ukmuenster.de	George, Britta/AAL-2031-2021	Hoppe, Sascha/0000-0001-9246-3747; George, Britta/0000-0001-5430-5086	Deutsche Nierenstiftung; Zentrum fur Klinische Forschung [Geo2/003/16]; Deutsche Forschungsgemeinschaft [GE 2158/3-1, SCHW 407/17]; Cells-in-Motion Cluster of Excellence (University of Munster) [EXC 1003-CiM]	Deutsche Nierenstiftung; Zentrum fur Klinische Forschung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cells-in-Motion Cluster of Excellence (University of Munster)	The authors thank Moses Chao (New York University School of Medicine, New York, NY, USA) for providing TrkC plasmids. This work was supported by grants from Deutsche Nierenstiftung (to B.G.), Zentrum fur Klinische Forschung Grant Geo2/003/16 (to B.G.), Deutsche Forschungsgemeinschaft Grants GE 2158/3-1 (to B.G.) and SCHW 407/17 (to A.S.), and Cells-in-Motion Cluster of Excellence (University of Munster) Grant EXC 1003-CiM (to A.S.). The authors declare no conflicts of interest. This article contains parts of the PhD. thesis of S.G., and the M.Sc. thesis of C.L.	Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chen ZC, 2010, NATURE, V468, P533, DOI 10.1038/nature09623; Cunningham ME, 1997, J BIOL CHEM, V272, P10957; Danson CM, 2007, J CELL SCI, V120, P4144, DOI 10.1242/jcs.013714; Dudanova I, 2013, TRENDS NEUROSCI, V36, P295, DOI 10.1016/j.tins.2013.01.007; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; George B, 2014, KIDNEY INT, V85, P1382, DOI 10.1038/ki.2013.556; George B, 2012, SEMIN NEPHROL, V32, P307, DOI 10.1016/j.semnephrol.2012.06.002; George B, 2012, J CLIN INVEST, V122, P674, DOI 10.1172/JCI60070; Gloy J, 2000, AM J PHYSIOL-RENAL, V278, pF999, DOI 10.1152/ajprenal.2000.278.6.F999; GUITON M, 1995, J BIOL CHEM, V270, P20384, DOI 10.1074/jbc.270.35.20384; Jin W, 2008, J BIOL CHEM, V283, P1391, DOI 10.1074/jbc.M705052200; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Kobayashi Naoto, 2004, Anatomical Science International, V79, P1, DOI 10.1111/j.1447-073x.2004.00066.x; Korobova F, 2008, MOL BIOL CELL, V19, P1561, DOI 10.1091/mbc.E07-09-0964; Kurisu S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-226; Lebensohn AM, 2009, MOL CELL, V36, P512, DOI 10.1016/j.molcel.2009.10.024; Lefevre GM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001142; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; Mendoza MC, 2013, SEMIN CELL DEV BIOL, V24, P272, DOI 10.1016/j.semcdb.2013.01.007; Mendoza MC, 2011, MOL CELL, V41, P661, DOI 10.1016/j.molcel.2011.02.031; Mojallal M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5557; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Nakanishi O, 2007, J BIOCHEM, V141, P319, DOI 10.1093/jb/mvm034; OBERMEIER A, 1993, EMBO J, V12, P933, DOI 10.1002/j.1460-2075.1993.tb05734.x; Patrakka J, 2007, J AM SOC NEPHROL, V18, P689, DOI 10.1681/ASN.2006060675; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Pereira DB, 2007, J NEUROSCI, V27, P4859, DOI 10.1523/JNEUROSCI.4587-06.2007; PHILO J, 1994, J BIOL CHEM, V269, P27840; Sainath R, 2015, CELL TISSUE RES, V359, P267, DOI 10.1007/s00441-014-1955-0; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Schell C, 2013, J AM SOC NEPHROL, V24, P713, DOI 10.1681/ASN.2012080844; Schulze U, 2014, MOL CELL PROTEOMICS, V13, P1397, DOI 10.1074/mcp.M113.034108; Schwab A, 2006, J CELL PHYSIOL, V206, P86, DOI 10.1002/jcp.20434; Scott RP, 2012, J AM SOC NEPHROL, V23, P1149, DOI 10.1681/ASN.2011121206; Segal RA, 1996, J BIOL CHEM, V271, P20175, DOI 10.1074/jbc.271.33.20175; Sitek B, 2005, MOL CELL PROTEOMICS, V4, P291, DOI 10.1074/mcp.M400188-MCP200; SOLTOFF SP, 1992, J BIOL CHEM, V267, P17472; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Tapia R, 2008, KIDNEY INT, V73, P733, DOI 10.1038/sj.ki.5002726; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; VETTER ML, 1991, P NATL ACAD SCI USA, V88, P5650, DOI 10.1073/pnas.88.13.5650; Vignjevic D, 2006, METHOD ENZYMOL, V406, P727, DOI 10.1016/S0076-6879(06)06057-5; Weide T, 2009, J AM SOC NEPHROL, V20, P1862, DOI 10.1681/ASN.2009070691; Wennmann DO, 2014, MOL BIOL EVOL, V31, P1710, DOI 10.1093/molbev/msu115; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Yamauchi J, 2003, P NATL ACAD SCI USA, V100, P14421, DOI 10.1073/pnas.2336152100; Zonta Barbara, 2013, Front Synaptic Neurosci, V5, P9, DOI 10.3389/fnsyn.2013.00009	49	6	6	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1665	1676		10.1096/fj.201700703R	http://dx.doi.org/10.1096/fj.201700703R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29162704				2022-12-28	WOS:000427246000043
J	Jayatilaka, H; Giri, A; Karl, M; Aifuwa, I; Trenton, NJ; Phillip, JM; Khatau, S; Wirtz, D				Jayatilaka, Hasini; Giri, Anjil; Karl, Michelle; Aifuwa, Ivie; Trenton, Nicholaus J.; Phillip, Jude M.; Khatau, Shyam; Wirtz, Denis			EB1 and cytoplasmic dynein mediate protrusion dynamics for efficient 3-dimensional cell migration	FASEB JOURNAL			English	Article						RhoA; paclitaxel; microtubule	MICROTUBULE PLUS ENDS; EXTRACELLULAR-MATRIX; PERICELLULAR PROTEOLYSIS; RHO-GTPASES; CANCER; ACTIVATION; PROTEINS; COLLAGEN; MOTILITY; RAC1	Microtubules have long been implicated to play an integral role in metastatic disease, for which a critical step is the local invasion of tumor cells into the 3-dimensional (3D) collagen-rich stromal matrix. Here we show that cell migration of human cancer cells uses the dynamic formation of highly branched protrusions that are composed of a microtubule core surrounded by cortical actin, a cytoskeletal organization that is absent in cells on 2-dimensional (2D) substrates. Microtubule plus-end tracking protein End-binding 1 and motor protein dynein subunits light intermediate chain 2 and heavy chain 1, which do not regulate 2D migration, critically modulate 3D migration by affecting RhoA and thus regulate protrusion branching through differential assembly dynamics of microtubules. An important consequence of this observation is that the commonly used cancer drug paclitaxel is 100-fold more effective at blocking migration in a 3D matrix than on a 2D matrix. This work reveals the central role that microtubule dynamics plays in powering cell migration in a more pathologically relevant setting and suggests further testing of therapeutics targeting microtubules to mitigate migration.	[Jayatilaka, Hasini; Giri, Anjil; Karl, Michelle; Aifuwa, Ivie; Khatau, Shyam; Wirtz, Denis] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Jayatilaka, Hasini; Giri, Anjil; Karl, Michelle; Aifuwa, Ivie; Wirtz, Denis] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD 21218 USA; [Trenton, Nicholaus J.] Rice Univ, Dept Bioengn, Houston, TX USA; [Wirtz, Denis] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD USA; [Wirtz, Denis] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD USA; [Wirtz, Denis] Johns Hopkins Sch Med, Sydney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Phillip, Jude M.] Weill Cornell Med, Dept Med, Div Hematol & Oncol, New York, NY USA	Johns Hopkins University; Johns Hopkins University; Rice University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Cornell University	Wirtz, D (corresponding author), Johns Hopkins Univ, 3400 North Charles St,Maryland Hall 221, Baltimore, MD 21218 USA.	wirtz@jhu.edu	Phillip, Jude/AAR-6240-2020	Karl, Michelle/0000-0003-3306-701X	U.S. National Institutes of Health, National Cancer Institute [U54CA143868, R01CA174388]; NATIONAL CANCER INSTITUTE [R01CA174388, U54CA143868] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by U.S. National Institutes of Health, National Cancer Institute Grants U54CA143868 and R01CA174388. The authors declare no conflicts of interest.	Applegate KT, 2011, J STRUCT BIOL, V176, P168, DOI 10.1016/j.jsb.2011.07.009; ASOKAN R, 1993, MOL CELL BIOCHEM, V120, P25, DOI 10.1007/BF00925981; Buey RM, 2011, MOL BIOL CELL, V22, P2912, DOI 10.1091/mbc.E11-01-0017; Chang YC, 2008, MOL BIOL CELL, V19, P2147, DOI 10.1091/mbc.E07-12-1269; Chitaley K, 2001, MED HYPOTHESES, V56, P381, DOI 10.1054/mehy.2000.1207; Courtheoux T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13487; Duellberg C, 2013, TRENDS CELL BIOL, V23, P54, DOI 10.1016/j.tcb.2012.10.003; Dujardin DL, 2003, J CELL BIOL, V163, P1205, DOI 10.1083/jcb.200310097; Fraley SI, 2015, SCI REP-UK, V5, DOI 10.1038/srep14580; Fraley SI, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1711; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Gierke S, 2012, CURR BIOL, V22, P753, DOI 10.1016/j.cub.2012.02.069; Giri A, 2013, FASEB J, V27, P4089, DOI 10.1096/fj.12-224352; HALL J, 1985, HUM PATHOL, V16, P439, DOI 10.1016/S0046-8177(85)80080-0; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; Jayatilaka H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15584; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Katoh H, 2006, J CELL SCI, V119, P56, DOI 10.1242/jcs.02720; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Kutys ML, 2014, NAT CELL BIOL, V16, P909, DOI 10.1038/ncb3026; Machesky LM, 1998, NATURE, V394, P125, DOI 10.1038/28039; Matov A, 2010, NAT METHODS, V7, P761, DOI 10.1038/nmeth.1493; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Nalbant P, 2004, SCIENCE, V305, P1615, DOI 10.1126/science.1100367; Netti PA, 2000, CANCER RES, V60, P2497; Pluen A, 2001, P NATL ACAD SCI USA, V98, P4628, DOI 10.1073/pnas.081626898; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ridley AJ, 2001, J CELL SCI, V114, P2713; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Roberts AJ, 2013, NAT REV MOL CELL BIO, V14, P713, DOI 10.1038/nrm3667; Rogers SL, 2004, CURR BIOL, V14, P1827, DOI 10.1016/j.cub.2004.09.078; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Schober JM, 2012, BIOCHEM BIOPH RES CO, V417, P67, DOI 10.1016/j.bbrc.2011.11.056; Shields MA, 2012, BIOCHEM J, V441, P541, DOI 10.1042/BJ20111240; Slattum G, 2009, J CELL BIOL, V186, P693, DOI 10.1083/jcb.200903079; Takesono A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008774; Tirnauer JS, 2000, J CELL BIOL, V149, P761, DOI 10.1083/jcb.149.4.761; Vaughan KT, 2005, J CELL BIOL, V171, P197, DOI 10.1083/jcb.200509150; Vladar EK, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002964; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Worthylake RA, 2003, J BIOL CHEM, V278, P13578, DOI 10.1074/jbc.M211584200; Wu PH, 2015, NAT PROTOC, V10, DOI 10.1038/nprot.2015.030; Wu PH, 2014, P NATL ACAD SCI USA, V111, P3949, DOI 10.1073/pnas.1318967111; Zaoui K, 2008, J CELL BIOL, V183, P401, DOI 10.1083/jcb.200805107; Zhang G, 2014, J BIOL CHEM, V289, P23112, DOI 10.1074/jbc.M114.549550; Zhou XM, 2008, GENE DEV, V22, P1231, DOI 10.1101/gad.1643308	55	15	15	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1207	1221		10.1096/fj.201700444RR	http://dx.doi.org/10.1096/fj.201700444RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29097501	hybrid, Green Published			2022-12-28	WOS:000427246000009
J	Yang, HQ; Jana, K; Rindler, MJ; Coetzee, WA				Yang, Hua Qian; Jana, Kundan; Rindler, Michael J.; Coetzee, William A.			The trafficking protein, EHD2, positively regulates cardiac sarcolemmal K-ATP channel surface expression: role in cardioprotection	FASEB JOURNAL			English	Article						caveolae; endocytosis; ischemic preconditioning; endocytic recycling	SENSITIVE POTASSIUM CHANNELS; PLASMA-MEMBRANE; KINASE-C; ENDOCYTIC TRAFFICKING; PROTEOMIC ANALYSIS; CAVEOLAE; ADENOSINE; MICRODOMAINS; ASSOCIATION; ADIPOCYTES	ATP-sensitive K+ (K-ATP) channels uniquely link cellular energy metabolism to membrane excitability and are expressed in diverse cell types that range from the endocrine pancreas to neurons and smooth, skeletal, and cardiac muscle. A decrease in the surface expression of K-ATP channels has been linked to various disorders, including dysregulated insulin secretion, abnormal blood pressure, and impaired resistance to cardiac injury. In contrast, up-regulation of K-ATP channel surface expression may be protective, for example, by mediating the beneficial effect of ischemic preconditioning. Molecular mechanisms that regulate K-ATP channel trafficking are poorly understood. Here, we used cellular assays with immunofluorescence, surface biotinylation, and patch clamping to demonstrate that Eps15 homology domain-containing protein 2 (EHD2) is a novel positive regulator of K-ATP channel trafficking to increase surface K-ATP channel density. EHD2 had no effect on cardiac Na+ channels (Nav1.5). The effect is specific to EHD2 as other members of the EHD family-EHD1, EHD3, and EHD4-had no effect on K-ATP channel surface expression. EHD2 did not directly affect K-ATP channel properties as unitary conductance and ATP sensitivity were unchanged. Instead, we observed that the mechanism by which EHD2 increases surface expression is by stabilizing K-ATP channel-containing caveolar structures, which results in a reduced rate of endocytosis. EHD2 also regulated K-ATP channel trafficking in isolated cardiomyocytes, which validated the physiologic relevance of these observations. Pathophysiologically, EHD2 may be cardioprotective as a dominant-negative EHD2 mutant sensitized cardiomyocytes to ischemic damage. Our findings highlight EHD2 as a potential pharmacologic target in the treatment of diseases with K-ATP channel trafficking defects.	[Yang, Hua Qian; Jana, Kundan; Coetzee, William A.] NYU, Sch Med, Dept Pediat, New York, NY USA; [Rindler, Michael J.] NYU, Sch Med, Dept Cell Biol, New York, NY USA; [Coetzee, William A.] NYU, Sch Med, Dept Physiol & Neurosci, New York, NY USA; [Coetzee, William A.] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY USA	New York University; New York University; New York University; New York University	Coetzee, WA (corresponding author), NYU, Sch Med, 450 E 29th St,ACLS 824, New York, NY 10016 USA.	william.coetzee@med.nyu.edu	Yang, Hua-Qian/ABE-8167-2021	Yang, Hua-Qian/0000-0002-9402-6222; Jana, Kundan/0000-0002-7804-9344; Coetzee, William/0000-0003-1522-8326	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL126905]; American Heart Association Postdoctoral Fellowship Award [17POST33370050]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126905] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association Postdoctoral Fellowship Award(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the U.S. National Institutes of Health, National Heart, Lung, and Blood Institute (Grant HL126905; to W.A.C.) and an American Heart Association Postdoctoral Fellowship Award (17POST33370050; to H.Q.Y.).	Bao L, 2011, AM J PHYSIOL-HEART C, V300, pH262, DOI 10.1152/ajpheart.00857.2010; Benjamin S, 2011, BIOCHEM J, V439, P433, DOI 10.1042/BJ20111010; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Bruederle CE, 2011, TRAFFIC, V12, P1242, DOI 10.1111/j.1600-0854.2011.01227.x; Curran J, 2015, J BIOL CHEM, V290, P12210, DOI 10.1074/jbc.M115.646893; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; Foster MN, 2016, PHYSIOL REV, V96, P177, DOI 10.1152/physrev.00003.2015; Garg V, 2009, CARDIOVASC RES, V82, P51, DOI 10.1093/cvr/cvp039; George M, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-3; Gudmundsson H, 2010, CIRC RES, V107, P84, DOI 10.1161/CIRCRESAHA.110.216713; Guilherme A, 2004, J BIOL CHEM, V279, P10593, DOI 10.1074/jbc.M307702200; Hansen CG, 2011, J CELL SCI, V124, P2777, DOI 10.1242/jcs.084319; Hong MY, 2011, FASEB J, V25, P2456, DOI 10.1096/fj.10-176669; Hu KL, 2003, NEURON, V38, P417, DOI 10.1016/S0896-6273(03)00256-3; Jakobsson J, 2011, J NEUROSCI, V31, P13972, DOI 10.1523/JNEUROSCI.1289-11.2011; Jiao JD, 2008, HYPERTENSION, V52, P499, DOI 10.1161/HYPERTENSIONAHA.108.110817; Kefaloyianni E, 2013, PROTEOMICS, V13, P368, DOI 10.1002/pmic.201200324; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; Ludwig A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001640; Mankouri J, 2006, EMBO J, V25, P4142, DOI 10.1038/sj.emboj.7601275; Manna PT, 2010, J BIOL CHEM, V285, P5963, DOI 10.1074/jbc.M109.066902; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Miller SL, 2005, MOL ENDOCRINOL, V19, P939, DOI 10.1210/me.2004-0443; Moore RH, 2004, J CELL SCI, V117, P3107, DOI 10.1242/jcs.01168; Moren B, 2012, MOL BIOL CELL, V23, P1316, DOI 10.1091/mbc.E11-09-0787; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Naslavsky N, 2009, J CELL SCI, V122, P389, DOI 10.1242/jcs.037051; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Park SH, 2013, P NATL ACAD SCI USA, V110, P12673, DOI 10.1073/pnas.1216351110; Park SY, 2004, BIOCHEMISTRY-US, V43, P7552, DOI 10.1021/bi049970f; Sampson LJ, 2004, CIRC RES, V95, P1012, DOI 10.1161/01.RES.0000148634.47095.ab; Sierra A, 2013, J BIOL CHEM, V288, P1568, DOI 10.1074/jbc.M112.429548; Sorvina A, 2016, BIOL OPEN, V5, P678, DOI 10.1242/bio.016642; Stoeber M, 2012, EMBO J, V31, P2350, DOI 10.1038/emboj.2012.98; Thomsen P, 2002, MOL BIOL CELL, V13, P238, DOI 10.1091/mbc.01-06-0317; TSUCHIDA A, 1994, CIRC RES, V75, P576, DOI 10.1161/01.RES.75.3.576; Turrell HE, 2011, J MOL CELL CARDIOL, V51, P370, DOI 10.1016/j.yjmcc.2011.06.015; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Yang HQ, 2016, AM J PHYSIOL-HEART C, V310, pH1558, DOI 10.1152/ajpheart.00158.2016; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zingman LV, 2002, P NATL ACAD SCI USA, V99, P13278, DOI 10.1073/pnas.212315199	41	11	12	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1613	1625		10.1096/fj.201700027R	http://dx.doi.org/10.1096/fj.201700027R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29133341	Green Published			2022-12-28	WOS:000427246000039
J	Kwon, W; Kim, HS; Jeong, J; Sung, Y; Choi, M; Park, S; Lee, J; Jang, S; Kim, SH; Lee, S; Kim, MO; Ryoo, ZY				Kwon, Wookbong; Kim, Hyeng-Soo; Jeong, Jain; Sung, Yonghun; Choi, Minjee; Park, Song; Lee, Jinhee; Jang, Soyoung; Kim, Sung Hyun; Lee, Sanggyu; Kim, Myoung Ok; Ryoo, Zae Young			Tet1 overexpression leads to anxiety-like behavior and enhanced fear memories via the activation of calcium-dependent cascade through Egr1 expression in mice	FASEB JOURNAL			English	Article						excitatory neurons; immediate early genes; stress-related behavior; transgenic mouse	ADULT HIPPOCAMPAL NEUROGENESIS; ACTIVE DNA DEMETHYLATION; GENE-EXPRESSION; PREFRONTAL CORTEX; SYNAPTIC PLASTICITY; NEURONAL CIRCUITS; CONTEXTUAL FEAR; C-FOS; TRANSCRIPTION; STRESS	Ten-eleven translocation methylcytosine dioxygenase 1 (Tet1) initiates DNA demethylation by converting 5-methylcytosine (5-mC) to 5-hydroxymethylcytosine (5-hmC) at CpG-rich regions of genes, which have key roles in adult neurogenesis and memory. In addition, the overexpression of Tet1 with 5-hmC alteration in patients with psychosis has also been reported, for instance in schizophrenia and bipolar disorders. The mechanism underlying Tet1 overexpression in the brain; however, is still elusive. In the present study, we found that Tet1-transgenic (Tet1-TG) mice displayed abnormal behaviors involving elevated anxiety and enhanced fear memories. We confirmed that Tet1 overexpression affected adult neurogenesis with oligodendrocyte differentiation in the hippocampal dentate gyrus of Tet1-TG mice. In addition, Tet1 overexpression induced the elevated expression of immediate early genes, such as Egr1, c-fos, Arc, and Bdnf, followed by the activation of intracellular calcium signals (i.e., CamKII, ERK, and CREB) in prefrontal and hippocampal neurons. The expression of GABA receptor subunits (Gabra2 and Gabra4) fluctuated in the prefrontal cortex and hippocampus. We evaluated the effects of Tet1 over-expression on intracellular calcium-dependent cascades by activating the Egr1 promoter in vitro. Tet1 enhanced Egr1 expression, which may have led to alterations in Gabra2 and Gabra4 expression in neurons. Taken together, we suggest that the Tet1 overexpression in our Tet1-TG mice can be applied as an effective model for studying various stress-related diseases that show hyperactivation of intracellular calcium-dependent cascades in the brain.	[Kwon, Wookbong; Kim, Hyeng-Soo; Jeong, Jain; Sung, Yonghun; Choi, Minjee; Park, Song; Lee, Jinhee; Jang, Soyoung; Lee, Sanggyu; Ryoo, Zae Young] Kyungpook Natl Univ, Sch Life Sci, Plus KNU Creat BioRes Grp BK21, 80 Daehakro, Daegu 41566, South Korea; [Kim, Hyeng-Soo; Kim, Sung Hyun] Kyungpook Natl Univ, Inst Life Sci & Biotechnol, Daegu, South Korea; [Kim, Myoung Ok] Kyungpook Natl Univ, Sch Anim Biotechnol BT Sci, 2559 Gyeongsang Daero, Sangju Si 37224, Gyeongsangbuk D, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University	Ryoo, ZY (corresponding author), Kyungpook Natl Univ, Sch Life Sci, Plus KNU Creat BioRes Grp BK21, 80 Daehakro, Daegu 41566, South Korea.; Kim, MO (corresponding author), Kyungpook Natl Univ, Sch Anim Biotechnol BT Sci, 2559 Gyeongsang Daero, Sangju Si 37224, Gyeongsangbuk D, South Korea.	ok4325@knu.ac.kr; jaewoong64@knu.ac.kr	RYOO, ZAEYOUNG/AAQ-1573-2020	Jang, Soyoung/0000-0003-2673-4259; Kwon, Wookbong/0000-0002-0655-6531	Korean Ministry of Science, Information and Communications Technology; Future Planning (MSIP) National Research Foundation of Korea (NRF) [2016R1A2B4014686]	Korean Ministry of Science, Information and Communications Technology; Future Planning (MSIP) National Research Foundation of Korea (NRF)	This work was supported by the Korean Ministry of Science, Information and Communications Technology, and Future Planning (MSIP) National Research Foundation of Korea (NRF) (Grant 2016R1A2B4014686). The authors declare no conflicts of interest.	AKBARIAN S, 1995, CEREB CORTEX, V5, P550, DOI 10.1093/cercor/5.6.550; AKBARIAN S, 1995, ARCH GEN PSYCHIAT, V52, P258, DOI 10.1001/archpsyc.1995.03950160008002; Ambigapathy G, 2015, EPIGENETICS-US, V10, P981, DOI 10.1080/15592294.2015.1090072; ARNOLD FJL, 1992, NEUROSCIENCE, V51, P377, DOI 10.1016/0306-4522(92)90322-S; Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Chakraborty T, 2016, BEHAV BRAIN RES, V302, P122, DOI 10.1016/j.bbr.2016.01.018; CHENG B, 1994, BRAIN RES, V640, P56, DOI 10.1016/0006-8993(94)91857-0; Chuang HC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00280; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Dong E, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2015.191; Dong E, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.86; Edgar N, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.34; Elliott E, 2016, J NEUROSCI, V36, P730, DOI 10.1523/JNEUROSCI.0971-15.2016; Fath T, 2009, NAT PROTOC, V4, P78, DOI 10.1038/nprot.2008.199; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Frank CA, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00040; Gaiarsa JL, 2002, TRENDS NEUROSCI, V25, P564, DOI 10.1016/S0166-2236(02)02269-5; Gerrow K, 2010, CURR OPIN NEUROBIOL, V20, P631, DOI 10.1016/j.conb.2010.06.010; Grayson DR, 2013, NEUROPSYCHOPHARMACOL, V38, P138, DOI 10.1038/npp.2012.125; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hashimoto T, 2003, J NEUROSCI, V23, P6315; Hogan B, 1994, MANIPULATING MOUSE E; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Je HS, 2012, P NATL ACAD SCI USA, V109, P15924, DOI 10.1073/pnas.1207767109; Kaas GA, 2013, NEURON, V79, P1086, DOI 10.1016/j.neuron.2013.08.032; Kim H, 2016, BIOCHEM BIOPH RES CO, V471, P437, DOI 10.1016/j.bbrc.2016.02.060; Ko Shanelle W., 2005, Shengli Xuebao, V57, P421; Leaderbrand K, 2014, NEUROBIOL LEARN MEM, V113, P35, DOI 10.1016/j.nlm.2013.09.005; Lewis DA, 2000, BRAIN RES REV, V31, P270, DOI 10.1016/S0165-0173(99)00042-9; Li L, 2005, MOL CELL BIOL, V25, P10286, DOI 10.1128/MCB.25.23.10286-10300.2005; Li L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6469; Liu J, 2008, SCI SIGNAL, V1, DOI [10.1126/stke.114re1, 10.1126/scisignal.123tr3]; Matsuda S, 1996, NEUROSCI RES, V26, P157, DOI 10.1016/S0168-0102(96)01088-7; Mifsud KR, 2011, BRAIN BEHAV IMMUN, V25, P1305, DOI 10.1016/j.bbi.2011.06.005; Mo J, 2015, J NEUROCHEM, V133, P489, DOI 10.1111/jnc.13077; Nakayama D, 2015, J NEUROSCI, V35, P819, DOI 10.1523/JNEUROSCI.2525-14.2015; Pagel JI, 2011, INDIAN J BIOCHEM BIO, V48, P226; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Papale LA, 2017, EPIGENETICS-US, V12, P264, DOI 10.1080/15592294.2017.1285986; Penke Z, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0159; Pierri JN, 1999, AM J PSYCHIAT, V156, P1709; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Qin XK, 2015, J BIOL CHEM, V290, P29603, DOI 10.1074/jbc.M115.668889; Radecki DT, 2005, HIPPOCAMPUS, V15, P246, DOI 10.1002/hipo.20048; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rudenko A, 2013, NEURON, V79, P1109, DOI 10.1016/j.neuron.2013.08.003; Saunderson EA, 2016, P NATL ACAD SCI USA, V113, P4830, DOI 10.1073/pnas.1524857113; Swiss VA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018088; Tovote P, 2015, NAT REV NEUROSCI, V16, P317, DOI 10.1038/nrn3945; Tronson NC, 2009, J NEUROSCI, V29, P3387, DOI 10.1523/JNEUROSCI.5619-08.2009; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Tzingounis AV, 2006, NEURON, V52, P403, DOI 10.1016/j.neuron.2006.10.016; Veyrac A, 2013, P NATL ACAD SCI USA, V110, P7062, DOI 10.1073/pnas.1220558110; Vieira PA, 2015, NEUROBIOL LEARN MEM, V119, P52, DOI 10.1016/j.nlm.2014.12.012; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Wu LJ, 2008, NEUROCHEM RES, V33, P1925, DOI 10.1007/s11064-008-9679-8; Yang JM, 2009, NAT NEUROSCI, V12, P113, DOI 10.1038/nn.2244; Zhang RR, 2013, CELL STEM CELL, V13, P237, DOI 10.1016/j.stem.2013.05.006; Zhang XH, 2015, DEPRESS ANXIETY, V32, P720, DOI 10.1002/da.22394; Zhao XH, 2014, GLIA, V62, P914, DOI 10.1002/glia.22649; Zimmerman G, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.4	64	12	12	3	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					390	403		10.1096/fj.201601340RR	http://dx.doi.org/10.1096/fj.201601340RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28899881				2022-12-28	WOS:000419172700035
J	Li, S; Wang, D; Zhao, J; Weathington, NM; Shang, D; Zhao, YT				Li, Shuang; Wang, Dan; Zhao, Jing; Weathington, Nathaniel M.; Shang, Dong; Zhao, Yutong			The deubiquitinating enzyme USP48 stabilizes TRAF2 and reduces E-cadherin-mediated adherens junctions	FASEB JOURNAL			English	Article						deubiquitination; phosphorylation; signal pathway; epithelial barrier integrity	NF-KAPPA-B; GLYCOGEN-SYNTHASE KINASE-3; MESENCHYMAL TRANSITION; EPITHELIAL-CELLS; TARGETS TRAF2; ACTIVATION; ALPHA; UBIQUITINATION; DEGRADATION; RECEPTOR	The tumor necrosis factor receptor-associated factor 2 (TRAF2) is a second messenger adaptor protein that plays an essential role in propagating TNF-alpha-mediated signaling pathways. Modulation of TRAF2 activity by ubiquitination is well studied; however, the deubiquitinating enzyme (DUB), which regulates TRAF2 stability, has not been identified. Here we reveal USP48 as the first identified DUB to deubiquitinate and stabilize TRAF2 in epithelial cells. Down-regulation of USP48 increases K48-linked polyubiquitination of TRAF2 and reduces TRAF2 protein levels. Interestingly, USP48 only targets the TRAF2 related to JNK pathway, not the TRAF2 related to NF-kappa B and p38 pathways. USP48 is serine phosphorylated in response to TNF-alpha. The phosphorylation is catalyzed by glycogen synthase kinase 3 beta (GSK3 beta), ultimately resulting in increases in USP48 DUB activity. Furthermore, we reveal a new biologic function of TRAF2 that contributes to epithelial barrier dysfunction, which is attenuated by knockdown of USP48. Inhibition of TRAF2/JNK pathway increases E (epithelial)-cadherin expression and enhances epithelial barrier integrity, while knockdown of USP48 attenuates TNF-a/JNK pathway and increases E-cadherin expression and cell-cell junction in epithelial cells. These data, taken together, indicate that USP48 stabilizes TRAF2, which is promoted by GSK3 beta-mediated phosphorylation. Further, down-regulation of USP48 increases E-cadherin expression and epithelial barrier integrity through reducing TRAF2 stability.	[Li, Shuang; Shang, Dong] Dalian Med Univ, Dept Gen Surg, Affiliated Hosp 1, Dalian, Peoples R China; [Li, Shuang; Wang, Dan; Zhao, Jing; Weathington, Nathaniel M.; Zhao, Yutong] Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Acute Lung Injury Ctr Excellence, 930 Scaife Hall, Pittsburgh, PA 15213 USA; [Wang, Dan] Jilin Univ, Affiliated Hosp 1, Dept Anesthesia, Changchun, Jilin, Peoples R China	Dalian Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Jilin University	Zhao, YT (corresponding author), Univ Pittsburgh, Dept Med, 3459 Fifth Ave,MUH NW628, Pittsburgh, PA 15213 USA.	zhaoy3@upmc.edu			U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [R01 HL112791, HL131665]; NIH National Institute of General Medical Sciences [R01GM115389]; American Lung Association Biomedical Research [RG350146]; American Heart Association [16GRNT30660001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131665, R01HL091916, R01HL112791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115389] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Lung Association Biomedical Research; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in part, by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grants R01 HL112791 and HL131665 (to Y.Z.), NIH National Institute of General Medical Sciences Grant R01GM115389 (to J.Z.), American Lung Association Biomedical Research Grant RG350146 (to J.Z.), and American Heart Association Grant 16GRNT30660001 (to Y.Z.). The authors declare no conflicts of interest.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Amasheh M, 2010, J CELL SCI, V123, P4145, DOI 10.1242/jcs.070896; Armando I, 2014, FASEB J, V28, P1422, DOI 10.1096/fj.13-243840; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Borghi A, 2016, BIOCHEM PHARMACOL, V116, P1, DOI 10.1016/j.bcp.2016.03.009; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Capaldo CT, 2007, MOL BIOL CELL, V18, P189, DOI 10.1091/mbc.E06-05-0471; Carayol N, 2002, AM J RESP CELL MOL, V26, P341, DOI 10.1165/ajrcmb.26.3.4684; Chen BB, 2013, NAT IMMUNOL, V14, P470, DOI 10.1038/ni.2565; Cortes-Vieyra R, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-23; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dong S, 2014, AM J PHYSIOL-CELL PH, V307, pC893, DOI 10.1152/ajpcell.00132.2014; Dupoux A, 2009, BLOOD, V113, P175, DOI 10.1182/blood-2008-02-137919; Fraile JM, 2012, ONCOGENE, V31, P2373, DOI 10.1038/onc.2011.443; Habelhah H, 2004, EMBO J, V23, P322, DOI 10.1038/sj.emboj.7600044; Habelhah H, 2002, EMBO J, V21, P5756, DOI 10.1093/emboj/cdf576; He DH, 2009, J BIOL CHEM, V284, P24123, DOI 10.1074/jbc.M109.007393; Hulpiau P, 2009, INT J BIOCHEM CELL B, V41, P349, DOI 10.1016/j.biocel.2008.09.027; Jin J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6930; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kessler BM, 2011, CELL BIOCHEM BIOPHYS, V60, P21, DOI 10.1007/s12013-011-9176-6; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lee MH, 2011, FASEB J, V25, P613, DOI 10.1096/fj.10-161380; Lee MH, 2009, FASEB J, V23, P3874, DOI 10.1096/fj.08-117804; Leng SH, 2010, J ENDOCRINOL, V206, P171, DOI 10.1677/JOE-09-0456; Li LY, 2009, BBA-MOL CELL RES, V1793, P346, DOI 10.1016/j.bbamcr.2008.09.013; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Li Y, 2010, J DERMATOL SCI, V60, P105, DOI 10.1016/j.jdermsci.2010.08.003; Liu J, 2012, P NATL ACAD SCI USA, V109, P191, DOI 10.1073/pnas.1105176108; Lockhart PJ, 2004, DNA SEQUENCE, V15, P9, DOI 10.1080/10855660310001638197; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Nawijn MC, 2011, TRENDS IMMUNOL, V32, P248, DOI 10.1016/j.it.2011.03.004; Niu WB, 2016, DEVELOPMENT, V143, P1778, DOI 10.1242/dev.132175; Prieto-Garcia E, 2017, MED ONCOL, V34, DOI 10.1007/s12032-017-0980-8; Ramirez SH, 2010, AM J PATHOL, V176, P881, DOI 10.2353/ajpath.2010.090671; Reiley W, 2005, MOL CELL BIOL, V25, P3886, DOI 10.1128/MCB.25.10.3886-3895.2005; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Schurch C, 2012, J CLIN INVEST, V122, P624, DOI 10.1172/JCI45977; Schwabe RF, 2002, AM J PHYSIOL-GASTR L, V283, pG204, DOI 10.1152/ajpgi.00016.2002; Schweitzer K, 2015, BBA-MOL CELL RES, V1853, P453, DOI 10.1016/j.bbamcr.2014.11.028; Shi CS, 2003, J BIOL CHEM, V278, P15429, DOI 10.1074/jbc.M211796200; Shkoda A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001376; Tada K, 2001, J BIOL CHEM, V276, P36530, DOI 10.1074/jbc.M104837200; ter Haar E, 2001, NAT STRUCT BIOL, V8, P593, DOI 10.1038/89624; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Tzimas C, 2006, CELL SIGNAL, V18, P83, DOI 10.1016/j.cellsig.2005.03.017; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Van den Bossche J, 2012, BLOOD, V119, P1623, DOI 10.1182/blood-2011-10-384289; Wang HZ, 2011, CYTOKINE, V53, P130, DOI 10.1016/j.cyto.2010.10.009; Wu CJ, 2005, EMBO J, V24, P1886, DOI 10.1038/sj.emboj.7600649; Xiao N, 2012, BIOCHEM J, V441, P979, DOI 10.1042/BJ20111358; Xie Ping, 2013, J Mol Signal, V8, P7, DOI 10.1186/1750-2187-8-7; Xu D, 2015, ELIFE, V4, DOI 10.7554/eLife.10510; Zhao J, 2012, NAT IMMUNOL, V13, P651, DOI 10.1038/ni.2341; Zhong HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080976	57	21	21	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					230	242		10.1096/fj.201700415RR	http://dx.doi.org/10.1096/fj.201700415RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28874458	Green Published			2022-12-28	WOS:000419172700022
J	Stewart, AJ; Leong, DTK; Farquharson, C				Stewart, Alan J.; Leong, Darren T. K.; Farquharson, Colin			PLA(2) and ENPP6 may act in concert to generate phosphocholine from the matrix vesicle membrane during skeletal mineralization	FASEB JOURNAL			English	Article						bone; hydroxyapatite; PHOSPHO1; phosphodiesterase; phospholipase	SECRETORY PHOSPHOLIPASE A(2); GROWTH-PLATE CHONDROCYTES; ALKALINE-PHOSPHATASE; BONE MINERALIZATION; GLYCEROPHOSPHODIESTER-PHOSPHODIESTERASE; PRIMARY CULTURES; CARTILAGE; CELLS; CALCIFICATION; MOUSE	Mineralization is a key process in the formation of bone and cartilage in vertebrates, involving the deposition of calcium-and phosphate-containing hydroxyapatite (HA) mineral within a collagenous matrix. Inorganic phosphate (Pi) accumulation within matrix vesicles (MVs) is a fundamental stage in the precipitation of HA, with PHOSPHO1 being identified as the principal enzyme acting to produce Pi. PHOSPHO1 is a dual-specific phosphocholine/phosphoethanolamine phosphatase enriched in mineralizing cells and within MVs. However, the source and mechanism by which PHOSPHO1 substrates are formed before mineralization have not been determined. Here, we propose that 2 enzymes-phospholipase A2 (PLA(2)) and ectonucleotide pyrophophatase/phosphodiesterase 6 (ENPP6)-act in sequence upon phosphatidylcholine found in MV membranes to produce phosphocholine, which PHOSPHO1 can hydrolyze to liberate P-i. This hypothesis is supported by evidence that both enzymes are expressed in mineralizing cells and data showing that phosphatidylcholine is broken down in MVs during mineralization. Therefore, PLA2 and ENPP6 activities may represent a key step in the mineralization process. Further functional studies are urgently required to examine their specific roles in the initiation of skeletal mineralization.	[Stewart, Alan J.; Leong, Darren T. K.] Univ St Andrews, Sch Med, St Andrews KY16 9TF, Fife, Scotland; [Farquharson, Colin] Univ Edinburgh, Roslin Inst, Edinburgh EH25 9RG, Midlothian, Scotland; [Farquharson, Colin] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland	University of St Andrews; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Stewart, AJ (corresponding author), Univ St Andrews, Sch Med, St Andrews KY16 9TF, Fife, Scotland.; Farquharson, C (corresponding author), Univ Edinburgh, Roslin Inst, Edinburgh EH25 9RG, Midlothian, Scotland.; Farquharson, C (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland.	ajs21@st-andrews.ac.uk; colin.farquharson@roslin.ac.uk	farquharson, colin/C-2956-2011; Leong, Darren/HIR-7304-2022; Stewart, Alan J/B-6569-2008	farquharson, colin/0000-0002-4970-4039; Stewart, Alan J/0000-0003-4580-1840	Biotechnology and Biological Sciences Research Council (BBSRC) in the form of an Institute Strategic Programme Grant [BB/J004316/1, BBS/E/D/20221657]; BBSRC [BBS/E/D/10002071] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/10002071] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) in the form of an Institute Strategic Programme Grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors are grateful for the technical assistance of Elaine Seawright (University of Edinburgh) for the Western blot and immunohistochemistry. The authors are also grateful to the Biotechnology and Biological Sciences Research Council (BBSRC) in the form of an Institute Strategic Programme Grant (BB/J004316/1; BBS/E/D/20221657; to C.F.).	Anderson HC, 1997, AM J PATHOL, V151, P1555; ANDERSON HC, 1995, CLIN ORTHOP RELAT R, P266; ANDERSON HC, 1990, AM J PATHOL, V136, P391; CECIL RNA, 1978, METAB BONE DIS RELAT, V1, P89, DOI 10.1016/0221-8747(78)90043-7; Chen Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156686; Dinkins MB, 2016, J NEUROSCI, V36, P8653, DOI 10.1523/JNEUROSCI.1429-16.2016; Edgar R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066629; Eriksson S, 2009, BRIT J NUTR, V102, P407, DOI 10.1017/S0007114508190286; Fedde KN, 1999, J BONE MINER RES, V14, P2015, DOI 10.1359/jbmr.1999.14.12.2015; FONTEH AN, 1994, J IMMUNOL, V152, P5438; Garcia C, 1996, J BONE MINER RES, V11, P521; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; Higashi S, 2000, INFLAMM RES, V49, P102, DOI 10.1007/s000110050566; Ho AM, 2000, SCIENCE, V289, P265, DOI 10.1126/science.289.5477.265; Houston B, 2004, BONE, V34, P629, DOI 10.1016/j.bone.2003.12.023; Houston DA, 2016, CALCIFIED TISSUE INT, V99, P510, DOI 10.1007/s00223-016-0176-9; Huesa C, 2011, BONE, V48, P1066, DOI 10.1016/j.bone.2011.01.010; Kawaguchi M, 2011, J AM CHEM SOC, V133, P12021, DOI 10.1021/ja201028t; Khavandgar Z, 2011, J CELL BIOL, V194, P277, DOI 10.1083/jcb.201102051; KVAM BJ, 1992, MAGNET RESON MED, V25, P355, DOI 10.1002/mrm.1910250215; Lang JK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165926; Lutter AH, 2016, PROSTAG LEUKOTR ESS, V111, P1, DOI 10.1016/j.plefa.2016.03.017; MacRae VE, 2010, BONE, V46, P1146, DOI 10.1016/j.bone.2009.12.018; Mallat Z, 2010, CIRCULATION, V122, P2183, DOI 10.1161/CIRCULATIONAHA.110.936393; Mebarek S, 2013, INT J MOL SCI, V14, P5036, DOI 10.3390/ijms14035036; Morita J, 2016, SCI REP-UK, V6, DOI 10.1038/srep20995; Nakamura Y, 2017, J BIOCHEM, V161, P315, DOI 10.1093/jb/mvw094; Nakano Y, 2003, CONNECT TISSUE RES, V44, P219, DOI 10.1080/03008200390181690; Ramanadham S, 2008, AM J PATHOL, V172, P868, DOI 10.2353/ajpath.2008.070756; Roach HI, 1999, HISTOCHEM J, V31, P53, DOI 10.1023/A:1003519104980; Roberts S, 2007, J BONE MINER RES, V22, P617, DOI 10.1359/JBMR.070108; Roberts SJ, 2004, BIOCHEM J, V382, P59, DOI 10.1042/BJ20040511; Rodriguez-Florez N, 2015, J BONE MINER RES, V30, P786, DOI 10.1002/jbmr.2414; Sakagami H, 2005, J BIOL CHEM, V280, P23084, DOI 10.1074/jbc.M413438200; Silvestrini G, 1996, BONE, V18, P559, DOI 10.1016/8756-3282(96)00088-9; Stewart AJ, 2006, BONE, V39, P1000, DOI 10.1016/j.bone.2006.05.014; Stoffel W, 2007, AM J PATHOL, V171, P153, DOI 10.2353/ajpath.2007.061285; Terkeltaub RA, 2001, AM J PHYSIOL-CELL PH, V281, pC1, DOI 10.1152/ajpcell.2001.281.1.C1; WHYTE MP, 1994, ENDOCR REV, V15, P439, DOI 10.1210/er.15.4.439; Wu LNY, 2002, J BIOL CHEM, V277, P5126, DOI 10.1074/jbc.M107899200; WU LNY, 1995, J CELL BIOCHEM, V57, P218, DOI 10.1002/jcb.240570206; WU LNY, 1989, J BIOL CHEM, V264, P21346; WUTHIER RE, 1968, J LIPID RES, V9, P68; Yadav MC, 2016, J BONE MINER RES, V31, P1275, DOI 10.1002/jbmr.2790; Yadav MC, 2011, J BONE MINER RES, V26, P286, DOI 10.1002/jbmr.195	45	17	17	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					20	25		10.1096/fj.201700521R	http://dx.doi.org/10.1096/fj.201700521R			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28864658				2022-12-28	WOS:000419172700004
J	Cipolla, E; Fisher, AJ; Gu, HM; Mickler, EA; Agarwal, M; Wilke, CA; Kim, KK; Moore, BB; Vittal, R				Cipolla, Ellyse; Fisher, Amanda J.; Gu, Hongmei; Mickler, Elizabeth A.; Agarwal, Manisha; Wilke, Carol A.; Kim, Kevin K.; Moore, Bethany B.; Vittal, Ragini			IL-17A deficiency mitigates bleomycin-induced complement activation during lung fibrosis	FASEB JOURNAL			English	Article						DAF; ER stress; C5b-9; C3a; C5a	IDIOPATHIC PULMONARY-FIBROSIS; ENDOPLASMIC-RETICULUM STRESS; EPITHELIAL-CELLS; OBLITERATIVE BRONCHIOLITIS; CIRCULATING KL-6; ACUTE EXACERBATION; TRANSPLANTATION; INJURY; INTERLEUKIN-17; INFECTION	Interleukin 17A (IL-17A) and complement (C') activation have each been implicated in the pathogenesis of idiopathic pulmonary fibrosis (IPF). We have reported that IL-17Ainduces epithelial injury via TGF-beta inmurine bronchiolitis obliterans; that TGF-b and the C' cascade present signaling interactions inmediating epithelial injury; and that the blockade of C' receptorsmitigates lung fibrosis. In the present study, we investigated the role of IL-17A in regulating C' in lung fibrosis. Microarray analyses of mRNA isolated from primary normal human small airway epithelial cells indicated that IL-17A(100 ng/ml; 24 h; n = 5 donor lungs) induces C' components (C' factor B, C3, and GPCR kinase isoform 5), cytokines (IL8, -6, and -1B), and cytokine ligands (CXCL1, -2, -3, -5, -6, and -16). IL-17A induces protein and mRNA regulation of C' components and the synthesis of active C' 3a (C3a) in normal primary human alveolar type II epithelial cells (AECs). Wild-type mice subjected to IL-17A neutralization and IL-17A knockout (il17a(-/-)) mice were protected against bleomycin (BLEO)-induced fibrosis and collagen deposition. Further, BLEO-injured il17a(-/-) mice had diminished levels of circulating Krebs Von Den Lungen 6 (alveolar epithelial injurymarker), local caspase-3/7, andlocalendoplasmic reticular stress-relatedgenes. BLEO-induced local C' activation [C3a, C5a, and terminal C' complex (C5b-9)] was attenuated in il17a(-/-) mice, and IL-17Aneutralization prevented the loss of epithelial C' inhibitors (C' receptor-1 related isoform Y and decay accelerating factor), and an increase in local TUNEL levels. RNAi-mediated gene silencing of il17a in fibroticmice arrested the progression of lung fibrosis, attenuated cellular apoptosis (caspase-3/7) and lung deposition of collagen and C' (C5b-9). Compared tonormals, plasma fromIPF patients showed significantlyhigher hemolytic activity. Our findings demonstrate that limiting complement activation by neutralizing IL-17A is a potential mechanism in ameliorating lung fibrosis.	[Cipolla, Ellyse; Agarwal, Manisha; Wilke, Carol A.; Kim, Kevin K.; Moore, Bethany B.; Vittal, Ragini] Univ Michigan, Div Pulm & Crit Care Med, 4065 BSRB,Zina Pitcher Pl, Ann Arbor, MI 48109 USA; [Fisher, Amanda J.; Gu, Hongmei; Mickler, Elizabeth A.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Moore, Bethany B.] Indiana Univ Sch Med, Dept Med, Div Pulm & Crit Care Med, Indianapolis, IN 46202 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Indiana University System; Indiana University Bloomington	Vittal, R (corresponding author), Univ Michigan, Div Pulm & Crit Care Med, 4065 BSRB,Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	rvittal@med.umich.edu	Agarwal, Manisha/GXH-6695-2022; VITTAL, RAGINI/AAE-9052-2020	Agarwal, Manisha/0000-0002-9621-0875; Cipolla, Ellyse/0000-0001-7637-228X; Moore, Bethany/0000-0003-3051-745X	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) [R01-HL119682, R01-HL109288]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109288, R01HL108904, R01HL115618, R01HL119682] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056097] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) Grants R01-HL119682 (to B.B.M.) and R01-HL109288 (to R.V.). The authors declare no conflict of interest.	Addis-Lieser E, 2005, J IMMUNOL, V175, P1894, DOI 10.4049/jimmunol.175.3.1894; Braun RK, 2010, J HEART LUNG TRANSPL, V29, P873, DOI 10.1016/j.healun.2010.03.012; Campos IB, 2017, VACCINE, V35, P1306, DOI 10.1016/j.vaccine.2017.01.030; Choi JE, 2009, AM J RESP CRIT CARE, V179, P212, DOI 10.1164/rccm.200802-228OC; Collard HR, 2010, AM J PHYSIOL-LUNG C, V299, pL3, DOI 10.1152/ajplung.90637.2008; Dong C, 2008, IMMUNOL REV, V226, P80, DOI 10.1111/j.1600-065X.2008.00709.x; Fan L, 2011, AM J TRANSPLANT, V11, P911, DOI 10.1111/j.1600-6143.2011.03482.x; Faria D, 2012, PFLUG ARCH EUR J PHY, V463, P819, DOI 10.1007/s00424-012-1091-1; Ge LY, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.90301; Ghali JR, 2017, NEPHRON, V135, P207, DOI 10.1159/000453059; Gu HM, 2016, FASEB J, V30, P2336, DOI 10.1096/fj.201500044; Gu HM, 2014, FASEB J, V28, P4223, DOI 10.1096/fj.13-247650; Hackett TL, 2009, AM J RESP CRIT CARE, V180, P122, DOI 10.1164/rccm.200811-1730OC; Hofmann S, 2013, EUR RESPIR J, V41, P888, DOI 10.1183/09031936.00033812; Inglis JE, 2008, ADV PHYSIOL EDUC, V32, P317, DOI 10.1152/advan.00061.2007; Jiang X, 2015, AM J TRANSPLANT, V15, P1768, DOI 10.1111/ajt.13189; Katz Y, 2000, CLIN EXP IMMUNOL, V120, P22, DOI 10.1046/j.1365-2249.2000.01199.x; Kim SR, 2015, THERANOSTICS, V5, P1343, DOI 10.7150/thno.11685; Korfei M, 2008, AM J RESP CRIT CARE, V178, P838, DOI 10.1164/rccm.200802-313OC; Lajoie S, 2010, NAT IMMUNOL, V11, P928, DOI 10.1038/ni.1926; LAMBRE CR, 1986, AM REV RESPIR DIS, V134, P238; Lawson WE, 2008, AM J PHYSIOL-LUNG C, V294, pL1119, DOI 10.1152/ajplung.00382.2007; Lederer DJ, 2009, EUR RESPIR J, V33, P793, DOI 10.1183/09031936.00150708; Luo FY, 2016, FASEB J, V30, P874, DOI 10.1096/fj.15-274845; Luzina IG, 2008, J LEUKOCYTE BIOL, V83, P237, DOI 10.1189/jlb.0707504; McAllister F, 2005, J IMMUNOL, V175, P404, DOI 10.4049/jimmunol.175.1.404; Ohshimo S, 2014, RESP MED, V108, P1031, DOI 10.1016/j.rmed.2014.04.009; Pacello F, 2016, SCI REP-UK, V6, DOI 10.1038/srep21140; Parra ER, 2008, INT J EXP PATHOL, V89, P350, DOI 10.1111/j.1365-2613.2008.00600.x; Reed M, 2015, MUCOSAL IMMUNOL, V8, P1118, DOI 10.1038/mi.2015.3; Seaayfan E, 2016, J BIOL CHEM, V291, P4487, DOI 10.1074/jbc.M115.702514; Selman Moises, 2006, Proc Am Thorac Soc, V3, P364, DOI 10.1513/pats.200601-003TK; Silasi-Mansat R, 2015, J CELL MOL MED, V19, P2549, DOI 10.1111/jcmm.12667; Simonian PL, 2009, J IMMUNOL, V182, P657, DOI 10.4049/jimmunol.182.1.657; STRUNK RC, 1988, J CLIN INVEST, V81, P1419, DOI 10.1172/JCI113472; Sugihara T, 2010, CLIN EXP IMMUNOL, V160, P386, DOI 10.1111/j.1365-2249.2010.04093.x; Suzuki H, 2013, J IMMUNOL, V191, P4431, DOI 10.4049/jimmunol.1202242; Tanjore H, 2012, AM J PHYSIOL-LUNG C, V302, pL721, DOI 10.1152/ajplung.00410.2011; Tavernier SJ, 2017, NAT CELL BIOL, V19, P698, DOI 10.1038/ncb3518; Van Kooten C, 1998, J AM SOC NEPHROL, V9, P1526; Vittal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076451; Vittal R, 2013, AM J RESP CELL MOL, V49, P47, DOI 10.1165/rcmb.2012-0389OC; Vittal R, 2013, AM J PHYSIOL-LUNG C, V304, pL401, DOI 10.1152/ajplung.00080.2012; Wheaton AK, 2017, AM J PHYSIOL-LUNG C, V312, P1722, DOI 10.1152/ajplung.00478.2016; Wilson MS, 2010, J EXP MED, V207, P535, DOI 10.1084/jem.20092121; Witt CA, 2013, J HEART LUNG TRANSPL, V32, P1034, DOI 10.1016/j.healun.2013.07.004; Xu Y, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.90558; Yokoyama A, 1998, AM J RESP CRIT CARE, V158, P1680, DOI 10.1164/ajrccm.158.5.9803115; Yokoyama A, 2006, RESPIROLOGY, V11, P164, DOI 10.1111/j.1440-1843.2006.00834.x; Yuan T, 2012, ARCH MED RES, V43, P522, DOI 10.1016/j.arcmed.2012.10.002; Zhang YZ, 2012, CURR OPIN PULM MED, V18, P441, DOI 10.1097/MCP.0b013e328356d03c; Zhang Z, 2006, INFLAMM BOWEL DIS, V12, P382, DOI 10.1097/01.MIB.0000218764.06959.91; Zhou X, 2016, MUCOSAL IMMUNOL, V9, P610, DOI 10.1038/mi.2015.85	53	35	39	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5543	+		10.1096/fj.201700289R	http://dx.doi.org/10.1096/fj.201700289R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28821630	Green Published, Green Submitted			2022-12-28	WOS:000416588300035
J	Dang, VD; Jella, KK; Ragheb, RRT; Denslow, ND; Alli, AA				Dang, Viet D.; Jella, Kishore Kumar; Ragheb, Ragy R. T.; Denslow, Nancy D.; Alli, Abdel A.			Lipidomic and proteomic analysis of exosomes from mouse cortical collecting duct cells	FASEB JOURNAL			English	Article						sphingomyelin; cardiolipin; mpkCCD; exosomal; NanoSight	EPITHELIAL NA+ CHANNELS; ENAC ACTIVITY; AQUAPORIN-2 EXPRESSION; SODIUM-CHANNEL; APICAL MEMBRANE; PRINCIPAL CELLS; MPKCCD CELLS; TRAFFICKING; PROTEIN; ACTIN	Exosomes are endosome-derived nanovesicles that are involved in cellular communication and signaling. Exosomes are produced by epithelial cells and are found in biologic fluids including blood and urine. The packaged material within exosomes includes proteins and lipids, but the molecular comparison within exosome subtypes is largely unknown. The purpose of this study was to investigate differences between exosomes derived from the apical plasma membrane and basolateral plasma membrane of polarized murine cortical collecting duct principal cells. Nanoparticle tracking analysis showed that the size and concentration of apical and basolateral exosomes remained relatively stable across 3 different temperatures (23, 37, and 42 degrees C). Liquid chromatography-tandem mass spectrometry analysis revealed marked differences between the proteins packaged within the two types of exosomes from the same cells. Several proteins expressed at the inner leaflet of the plasma membrane, including alpha-actinin-1, moesin, 14-3-3 protein zeta/delta, annexin A1/A3/A4/A5/A6, clathrin heavy chain 1, glyceraldehyde-3-phosphate dehydrogenase, a-enolase, filamin-A, and heat shock protein 90, were identified in samples of apical plasma membrane-derived exosomes, but not in basolateral plasma membrane exosomes from mouse cortical collecting duct cells. In addition to differences at the protein level, mass spectrometry-based shotgun lipidomics analysis showed significant differences in the lipid classes and fatty acid composition of the two types of exosomes. We found higher levels of sphingomyelin and lower levels of cardiolipin, among other phospholipids in the apical plasma membrane compared to the basolateral plasma membrane exosomes. The molecular analyses of exosome subtypes presented herein will contribute to our understanding of exosome biogenesis, and the results may have potential implications for biomarker discovery.	[Dang, Viet D.; Denslow, Nancy D.] Univ Florida, Dept Physiol Sci, Gainesville, FL 32610 USA; [Dang, Viet D.; Denslow, Nancy D.] Univ Florida, Ctr Environm & Human Toxicol, Gainesville, FL 32610 USA; [Dang, Viet D.] Iowa State Univ, Dept Vet Diagnost & Prod Anim Prod, Ames, IA USA; [Jella, Kishore Kumar] Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA USA; [Ragheb, Ragy R. T.] Malvern Instruments, Westborough, MA USA; [Alli, Abdel A.] Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL 32610 USA; [Alli, Abdel A.] Univ Florida, Coll Med, Dept Med, Div Nephrol Hypertens & Renal Transplantat, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Iowa State University; Emory University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Alli, AA (corresponding author), Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL 32610 USA.; Alli, AA (corresponding author), Univ Florida, Coll Med, Dept Med, Div Nephrol Hypertens & Renal Transplantat, Gainesville, FL 32610 USA.	aalli@ufl.edu			U.S. National Institutes of Health (NIH) [1S10OD018141-01A1]; NIH, National Institute of Diabetes and Digestive and Kidney Diseases [K01 DK099617]; NIH, National Cancer Institute designated Comprehensive Cancer Center [P30-CA076292]; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK099617] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018141] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH, National Cancer Institute designated Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Wei Guan and Bin Fang, Ph.D., (both from Proteomics Core Facility, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA) for assistance with proteomics. This project was made possible by U.S. National Institutes of Health (NIH) Shared Instrumentation (Grant 1S10OD018141-01A1); NIH, National Institute of Diabetes and Digestive and Kidney Diseases (Grant K01 DK099617; to A.A.A.); the University of Florida College of Medicine; in part, by the Proteomics Core Facility at the H. Lee Moffitt Cancer Center and Research Institute; and by the NIH, National Cancer Institute designated Comprehensive Cancer Center (Grant P30-CA076292). The authors declare no conflicts of interest.	Alli AA, 2015, AM J PHYSIOL-RENAL, V309, pF456, DOI 10.1152/ajprenal.00631.2014; Alli AA, 2012, AM J PHYSIOL-RENAL, V303, pF800, DOI 10.1152/ajprenal.00703.2011; Berdiev BK, 2001, BIOPHYS J, V80, P2176, DOI 10.1016/S0006-3495(01)76190-5; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chassin C, 2007, CELL BIOL TOXICOL, V23, P257, DOI 10.1007/s10565-006-0169-y; Cheema MU, 2015, AM J PHYSIOL-RENAL, V309, pF305, DOI 10.1152/ajprenal.00685.2014; Chou CL, 2000, J BIOL CHEM, V275, P36839, DOI 10.1074/jbc.M005552200; ECELBARGER CA, 1995, AM J PHYSIOL-RENAL, V269, pF663, DOI 10.1152/ajprenal.1995.269.5.F663; Fenton RA, 2013, CURR OPIN NEPHROL HY, V22, P551, DOI 10.1097/MNH.0b013e328364000d; Fenton RA, 2008, PROG BRAIN RES, V170, P571, DOI 10.1016/S0079-6123(08)00444-5; Feraille E, 2003, ANN NY ACAD SCI, V986, P570, DOI 10.1111/j.1749-6632.2003.tb07255.x; Ferguson SW, 2016, J CONTROL RELEASE, V228, P179, DOI 10.1016/j.jconrel.2016.02.037; Hasler U, 2005, J AM SOC NEPHROL, V16, P1571, DOI 10.1681/ASN.2004110930; Hasler U, 2009, AM J PHYSIOL-CELL PH, V296, pC641, DOI 10.1152/ajpcell.00655.2008; Hill WG, 2007, J BIOL CHEM, V282, P37402, DOI 10.1074/jbc.M704084200; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Ilatovskaia D V, 2011, Tsitologiia, V53, P903; Ilatovskaya DV, 2011, FASEB J, V25, P2688, DOI 10.1096/fj.10-167262; Jella KK, 2014, RADIAT RES, V181, P138, DOI 10.1667/RR13337.1; Jella KK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165763; Jovov B, 1999, J BIOL CHEM, V274, P37845, DOI 10.1074/jbc.274.53.37845; Klussmann E, 2000, REV PHYSIOL BIOCH P, V141, P33, DOI 10.1007/BFb0119577; Kortenoeven MLA, 2012, AM J PHYSIOL-RENAL, V302, pF1395, DOI 10.1152/ajprenal.00376.2011; Laulagnier K, 2004, BIOCHEM J, V380, P161, DOI 10.1042/BJ20031594; Lee Byung-Heon, 2007, Electrolyte Blood Press, V5, P15, DOI 10.5049/EBP.2007.5.1.15; Lee Min-Jae, 2016, Ann Pediatr Endocrinol Metab, V21, P119; Li CL, 2011, AM J PHYSIOL-RENAL, V300, pF1255, DOI 10.1152/ajprenal.00469.2010; Liang XB, 2006, J BIOL CHEM, V281, P16323, DOI 10.1074/jbc.M601360200; Mazzochi C, 2006, J BIOL CHEM, V281, P6528, DOI 10.1074/jbc.M509386200; Montgomery DS, 2017, AM J PHYSIOL-CELL PH, V313, pC42, DOI 10.1152/ajpcell.00244.2016; Nagaki K, 2006, BIOCHEMISTRY-US, V45, P6733, DOI 10.1021/bi052640q; Nedvetsky Pavel I, 2009, Handb Exp Pharmacol, P133, DOI 10.1007/978-3-540-79885-9_6; Pathan M, 2015, PROTEOMICS, V15, P2597, DOI 10.1002/pmic.201400515; Pearce D, 2015, CLIN J AM SOC NEPHRO, V10, P135, DOI 10.2215/CJN.05760513; Perez-Hernandez J, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/613536; Procino G, 2010, AM J PHYSIOL-RENAL, V298, pF266, DOI 10.1152/ajprenal.00359.2009; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Reifenberger MS, 2014, AM J PHYSIOL-RENAL, V307, pF86, DOI 10.1152/ajprenal.00251.2013; Schlame M, 2005, CHEM PHYS LIPIDS, V138, P38, DOI 10.1016/j.chemphyslip.2005.08.002; Sokolova V, 2011, COLLOID SURFACE B, V87, P146, DOI 10.1016/j.colsurfb.2011.05.013; Stoops EH, 2014, J AM SOC NEPHROL, V25, P1375, DOI 10.1681/ASN.2013080883; Suzuki KGN, 2012, BIOTECHNOL J, V7, P753, DOI 10.1002/biot.201100360; Svensson KJ, 2013, J BIOL CHEM, V288, P17713, DOI 10.1074/jbc.M112.445403; Tan SS, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.22614; Terris J, 1995, AM J PHYSIOL-RENAL, V269, pF775, DOI 10.1152/ajprenal.1995.269.6.F775; Verrey F, 2003, ANN NY ACAD SCI, V986, P554, DOI 10.1111/j.1749-6632.2003.tb07253.x; Wang Q, 2013, J BIOL CHEM, V288, P264, DOI 10.1074/jbc.M112.396408; Wang WH, 2009, PFLUG ARCH EUR J PHY, V458, P157, DOI 10.1007/s00424-008-0593-3; Xie LK, 2010, AM J PHYSIOL-RENAL, V298, pF1018, DOI 10.1152/ajprenal.00580.2009; Xing L, 2014, WORLD J PEDIATR, V10, P306, DOI 10.1007/s12519-014-0508-7; Yip KP, 2015, CELL PHYSIOL BIOCHEM, V36, P670, DOI 10.1159/000430129; Yu MJ, 2008, AM J PHYSIOL-CELL PH, V295, pC661, DOI 10.1152/ajpcell.90650.2007; Zeringer Emily, 2015, Cold Spring Harb Protoc, V2015, P319, DOI 10.1101/pdb.top074476	53	48	48	0	51	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5399	5408		10.1096/fj.201700417R	http://dx.doi.org/10.1096/fj.201700417R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28821634	Green Published			2022-12-28	WOS:000416588300023
J	Wang, JP; Tang, C; Wang, Q; Su, J; Ni, T; Yang, WJ; Wang, YS; Chen, W; Liu, XQ; Wang, S; Zhang, JJ; Song, HL; Zhu, J; Wang, Y				Wang, Junpeng; Tang, Chao; Wang, Qian; Su, Jun; Ni, Ting; Yang, Wenjing; Wang, Yongsheng; Chen, Wei; Liu, Xiqiang; Wang, Shuai; Zhang, Jingjing; Song, Huili; Zhu, Jun; Wang, Yuan			NRF1 coordinates with DNA methylation to regulate spermatogenesis	FASEB JOURNAL			English	Article						ASZ1; germline gene regulation; mitochondria	GERM-CELL DEVELOPMENT; EMBRYONIC STEM-CELLS; MITOCHONDRIAL BIOGENESIS; HUMAN GENOME; DAZL GENE; PROMOTER; PROTEIN; MICE; GASZ; SPECIFICATION	Spermatogenesis is a highly coordinated process that requires tightly regulated gene expression programmed by transcription factors and epigenetic modifiers. In this study, we found that nuclear respiratory factor (NRF)-1, a key transcription factor for mitochondrial biogenesis, cooperated with DNA methylation to directly regulate the expression of multiple germ cell-specific genes, including Asz1. In addition, conditional ablation of NRF1 in gonocytes dramatically down-regulated these germline genes, blocked germ cell proliferation, and subsequently ledtomale infertility in mice. Our data highlight a precise crosstalk between transcriptional regulation by NRF1 and epigenetic modulation during germ cell development and unequivocally demonstrate a novel role of NRF1 in spermatogenesis.-Wang, J., Tang, C., Wang, Q., Su, J., Ni, T., Yang, W., Wang, Y., Chen, W., Liu, X., Wang, S., Zhang, J., Song, H., Zhu, J., Wang, Y. NRF1 coordinates with DNA methylation to regulate spermatogenesis.	[Wang, Junpeng; Tang, Chao; Wang, Qian; Su, Jun; Wang, Yongsheng; Chen, Wei; Liu, Xiqiang; Wang, Shuai; Zhang, Jingjing; Song, Huili; Wang, Yuan] East China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai, Peoples R China; [Wang, Junpeng; Tang, Chao; Wang, Qian; Su, Jun; Wang, Yongsheng; Chen, Wei; Liu, Xiqiang; Wang, Shuai; Zhang, Jingjing; Song, Huili; Wang, Yuan] East China Normal Univ, Sch Life Sci, 500 Dongchuan Rd, Shanghai 200241, Peoples R China; [Ni, Ting] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Minist Educ MOE, Shanghai, Peoples R China; [Ni, Ting] Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Collaborat Innovat Ctr Genet & Dev, Shanghai, Peoples R China; [Yang, Wenjing; Zhu, Jun] NHLBI, Syst Biol Ctr, NIH, Bethesda, MD USA; [Wang, Yuan] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA	East China Normal University; East China Normal University; Fudan University; Fudan University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Michigan State University	Wang, Y (corresponding author), East China Normal Univ, Sch Life Sci, 500 Dongchuan Rd, Shanghai 200241, Peoples R China.	ywang@bio.ecnu.edu.cn		wang, Yuan/0000-0002-0939-1269; Tang, Chao/0000-0002-2091-3355; Zhang, Jingjing/0000-0002-7953-1159	Ministry of Science and Technology of China [2016YFA0100300, 2014CB964800]; National Natural Science Foundation of China [31471347, 31271589, 16JC1404200, 11DZ2260300]; Science and Technology Commission of Shanghai Municipality, China [1ZICHL006058]; Intramural Research Program of the U.S. National Institutes of Health, National Heart Lung Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006230, ZICHL006058] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality, China(Science & Technology Commission of Shanghai Municipality (STCSM)); Intramural Research Program of the U.S. National Institutes of Health, National Heart Lung Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Richard Mailman from Penn State College of Medicine (State College, PA, USA) for help in manuscript preparation. This work was supported by Grants 2016YFA0100300 and 2014CB964800 (to Yu.W.) from the Ministry of Science and Technology of China, Grants 31471347 and 31271589 (to Yu.W.) from the National Natural Science Foundation of China, Grants 16JC1404200 (to Yu.W.) and 11DZ2260300 from the Science and Technology Commission of Shanghai Municipality, China, and Grant 1ZICHL006058 (to J.Z.) from the Intramural Research Program of the U.S. National Institutes of Health, National Heart Lung Blood Institute. The authors declare no conflicts of interest.	Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Azhikina TL, 2005, BIOCHEMISTRY-MOSCOW+, V70, P596, DOI 10.1007/s10541-005-0153-9; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Domcke S, 2015, NATURE, V528, P575, DOI 10.1038/nature16462; EVANS MJ, 1989, J BIOL CHEM, V264, P14361; Ewen KA, 2010, MOL CELL ENDOCRINOL, V323, P76, DOI 10.1016/j.mce.2009.12.013; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Hammoud SS, 2014, CELL STEM CELL, V15, P239, DOI 10.1016/j.stem.2014.04.006; Hayashi K, 2007, SCIENCE, V316, P394, DOI 10.1126/science.1137545; HOFMANN MC, 1992, EXP CELL RES, V201, P417, DOI 10.1016/0014-4827(92)90291-F; Huo L, 2001, MOL CELL BIOL, V21, P644, DOI 10.1128/MCB.21.2.644-654.2001; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Linher K, 2009, DIFFERENTIATION, V77, P335, DOI 10.1016/j.diff.2008.08.001; Ma L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000635; Maatouk DM, 2006, DEVELOPMENT, V133, P3411, DOI 10.1242/dev.02500; Miranda TB, 2007, J CELL PHYSIOL, V213, P384, DOI 10.1002/jcp.21224; Qiu LL, 2016, J REPROD DEVELOP, V62, P367, DOI 10.1262/jrd.2016-003; Ramalho-Santos J, 2009, HUM REPROD UPDATE, V15, P553, DOI 10.1093/humupd/dmp016; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Sada A, 2009, SCIENCE, V325, P1394, DOI 10.1126/science.1172645; Saga Y, 2008, CURR OPIN GENET DEV, V18, P337, DOI 10.1016/j.gde.2008.06.003; Saitou M, 2009, CURR OPIN GENET DEV, V19, P386, DOI 10.1016/j.gde.2009.06.003; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Shen L, 2007, PLOS GENET, V3, P2023, DOI 10.1371/journal.pgen.0030181; Song HW, 2014, SEMIN CELL DEV BIOL, V30, P14, DOI 10.1016/j.semcdb.2014.02.005; Teng YN, 2012, HUM REPROD, V27, P2857, DOI 10.1093/humrep/des227; Tsai-Morris CH, 2004, P NATL ACAD SCI USA, V101, P6373, DOI 10.1073/pnas.0401855101; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Wang Q, 2013, STEM CELL RES, V11, P845, DOI 10.1016/j.scr.2013.05.012; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wylie C, 1999, CELL, V96, P165, DOI 10.1016/S0092-8674(00)80557-7; Yan W, 2002, MOL ENDOCRINOL, V16, P1168, DOI 10.1210/me.16.6.1168; Zhang JJ, 2016, EMBO REP, V17, P220, DOI 10.15252/embr.201540846; Zhang XL, 2014, STEM CELL REP, V3, P460, DOI 10.1016/j.stemcr.2014.07.004	41	28	28	1	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4959	4970		10.1096/fj.201700093R	http://dx.doi.org/10.1096/fj.201700093R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28754714	Green Published			2022-12-28	WOS:000413398500026
J	Linnemann, AK; Blumer, J; Marasco, MR; Battiola, TJ; Umhoefer, HM; Han, JY; Lamming, DW; Davis, DB				Linnemann, Amelia K.; Blumer, Joseph; Marasco, Michelle R.; Battiola, Therese J.; Umhoefer, Heidi M.; Han, Jee Young; Lamming, Dudley W.; Davis, Dawn Belt			Interleukin 6 protects pancreatic beta cells from apoptosis by stimulation of autophagy	FASEB JOURNAL			English	Article						pancreas; islet; diabetes	CHAPERONE-MEDIATED AUTOPHAGY; INFLAMMATORY CYTOKINES; SERINE PHOSPHORYLATION; MAXIMAL ACTIVATION; ADIPOSE-TISSUE; IN-VITRO; STAT3; MICE; MTOR; MECHANISMS	IL-6 is a pleiotropic cytokinewith complex roles in inflammation and metabolic disease. The role of IL-6 as a pro-or anti-inflammatory cytokine is still unclear. Within the pancreatic islet, IL-6 stimulates secretion of the prosurvival incretin hormone glucagon-like peptide 1 (GLP-1) by a cells and acts directly on beta cells to stimulate insulin secretion in vitro. Uncovering physiologic mechanisms promoting beta-cell survival under conditions of inflammation and stress can identify important pathways for diabetes prevention and treatment. Given the established role of GLP-1 in promoting beta-cell survival, we hypothesized that IL-6 may also directly protect beta cells from apoptosis. Herein, we show that IL-6 robustly activates signal transducer and activator of transcription 3 (STAT3), a transcription factor that is involved in autophagy. IL-6 stimulates LC3 conversion and autophagosome formation in cultured beta cells. In vivo IL-6 infusion stimulates a robust increase in lysosomes in the pancreas that is restricted to the islet. Autophagy is critical for beta-cell homeostasis, particularly under conditions of stress and increased insulin demand. The stimulation of autophagy by IL-6 is regulated via multiple complementary mechanisms including inhibition of mammalian target of rapamycin complex 1 (mTORC1) and activation of Akt, ultimately leading to increases in autophagy enzyme production. Pretreatment with IL-6 renders beta cells resistant to apoptosis induced by proinflammatory cytokines, and inhibition of autophagy with chloroquine prevents the ability of IL-6 to protect from apoptosis. Importantly, we find that IL-6 can activate STAT3 and the autophagy enzyme GABARAPL1 in human islets. We also see evidence of decreased IL-6 pathway signaling in islets from donors with type 2 diabetes. On the basis of our results, we propose direct stimulation of autophagy as a novel mechanism for IL-6-mediated protection of beta cells from stress-induced apoptosis.	[Linnemann, Amelia K.; Blumer, Joseph; Battiola, Therese J.; Umhoefer, Heidi M.; Han, Jee Young; Lamming, Dudley W.; Davis, Dawn Belt] Univ Wisconsin Madison, Div Endocrinol Diabet & Metab, Dept Med, Madison, WI USA; [Linnemann, Amelia K.; Marasco, Michelle R.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Lamming, Dudley W.; Davis, Dawn Belt] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital	Linnemann, AK (corresponding author), Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, 635 Barnhill Dr,MS 2051, Indianapolis, IN 46202 USA.	aklinnem@iu.edu	Lamming, Dudley/O-7191-2015; Davis, Dawn/B-1624-2013	Lamming, Dudley/0000-0002-0079-4467; Davis, Dawn/0000-0002-0239-4715; Han, Jee Young/0000-0002-1306-6899	U.S. National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [K01DK102492]; Herman B. Wells Center for Pediatric Research at Indiana University School of Medicine; Pilot and Feasibility Award within the Indiana University CDMD NIH/NIDDK Grant [P30 DK097512]; NIH National Institute on Aging [AG041765, AG050135]; Glenn Foundation Award for Research in the Biological Mechanisms of Aging; UW-Madison Department of Medicine; American Federation for Aging Research (AFAR); Department of Veterans Affairs [I01BX001880]; NIH/NIDDK [R01DK110324]; University of Wisconsin-Madison Department of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK097512, K01DK102492, R01DK110324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG041765, R21AG050135, K99AG041765] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001880] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Herman B. Wells Center for Pediatric Research at Indiana University School of Medicine; Pilot and Feasibility Award within the Indiana University CDMD NIH/NIDDK Grant; NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Glenn Foundation Award for Research in the Biological Mechanisms of Aging; UW-Madison Department of Medicine; American Federation for Aging Research (AFAR); Department of Veterans Affairs(US Department of Veterans Affairs); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Wisconsin-Madison Department of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank M. Kimple and M. Merrins (both from the University of Wisconsin), as well as all the members of the Davis, Lamming, Kimple, and Merrins laboratories, for their assistance and insight. The authors thank A. Strohecker (The Ohio State University, Columbus, OH, USA), B. Layden, and M. Priyadarshini (both from Northwestern University, Evanston, IL, USA) for helpful comments and assistance with data interpretation. The authors thank M. Kimple for providing some human islet samples from donors with type 2 diabetes. A.K.L. is supported by a Research Scientist Development Award from the U.S. National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK; K01DK102492), the Herman B. Wells Center for Pediatric Research at Indiana University School of Medicine, and a Pilot and Feasibility Award within the Indiana University CDMD NIH/NIDDK Grant P30 DK097512. The Lamming lab is supported by grants from the NIH National Institute on Aging (AG041765 and AG050135), a Glenn Foundation Award for Research in the Biological Mechanisms of Aging, and the UW-Madison Department of Medicine. This research was conducted while D.W.L. was an American Federation for Aging Research (AFAR) grant recipient. D.B.D. is supported by a merit award from the Department of Veterans Affairs (I01BX001880), NIH/NIDDK (R01DK110324), and the University of Wisconsin-Madison Department of Medicine. This work was supported using facilities and resources from the William S. Middleton Memorial Veterans Hospital, and does not represent the views of the Department of Veterans Affairs or the United States Government. The authors declare no conflicts of interest.	Ardestani A, 2014, NAT MED, V20, P385, DOI 10.1038/nm.3482; Arias E, 2015, MOL CELL, V59, P270, DOI 10.1016/j.molcel.2015.05.030; Bachar-Wikstrom E, 2013, DIABETES, V62, P1227, DOI 10.2337/db12-1474; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Centers for Disease Control and Prevention, 2014, NAT DIAB STAT REP ES; Cho Yoon Ju, 2011, Lab Anim Res, V27, P197, DOI 10.5625/lar.2011.27.3.197; Choi SE, 2004, TRANSPL IMMUNOL, V13, P43, DOI 10.1016/j.trim.2004.04.001; Daily K, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-495; Dimberg LY, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-318; Donath MY, 2005, DIABETES, V54, pS108, DOI 10.2337/diabetes.54.suppl_2.S108; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Efeyan A, 2015, NATURE, V517, P302, DOI 10.1038/nature14190; Efeyan A, 2014, DEV CELL, V29, P321, DOI 10.1016/j.devcel.2014.03.017; Ellingsgaard H, 2008, P NATL ACAD SCI USA, V105, P13163, DOI 10.1073/pnas.0801059105; Febbraio MA, 2003, J PHYSIOL-LONDON, V549, P607, DOI 10.1113/jphysiol.2003.042374; Febbraio MA, 2002, FASEB J, V16, P1335, DOI 10.1096/fj.01-0876rev; Gorogawa S, 2004, BIOCHEM BIOPH RES CO, V319, P1159, DOI 10.1016/j.bbrc.2004.05.095; Grumati P, 2011, AUTOPHAGY, V7, P1415, DOI 10.4161/auto.7.12.17877; Gu YY, 2011, DIABETES, V60, P827, DOI 10.2337/db10-1194; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Herder C, 2005, DIABETES, V54, pS11, DOI 10.2337/diabetes.54.suppl_2.S11; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kamimura D, 2004, REV PHYSIOL BIOCH P, V149, P1, DOI 10.1007/s10254-003-0012-2; Kennedy BK, 2016, CELL METAB, V23, P990, DOI 10.1016/j.cmet.2016.05.009; Kim HK, 1997, J BIOL CHEM, V272, P14571, DOI 10.1074/jbc.272.23.14571; Krause MD, 2012, J ENDOCRINOL, V214, P301, DOI 10.1530/JOE-12-0223; Liu Y, 2013, AGE, V35, P1531, DOI 10.1007/s11357-012-9456-0; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Ost A, 2010, MOL MED, V16, P235, DOI 10.2119/molmed.2010.00023; Parzych KR, 2014, ANTIOXID REDOX SIGN, V20, P460, DOI 10.1089/ars.2013.5371; Qin BB, 2015, SCI REP-UK, V5, DOI 10.1038/srep15701; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schuringa JJ, 2000, BIOCHEM J, V347, P89, DOI 10.1042/0264-6021:3470089; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shen SS, 2012, MOL CELL, V48, P667, DOI 10.1016/j.molcel.2012.09.013; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Sultan A, 2009, CIRC RES, V104, P961, DOI 10.1161/CIRCRESAHA.108.190280; Suzuki T, 2011, DIABETES, V60, P537, DOI 10.2337/db10-0796; Timper K, 2017, CELL REP, V19, P267, DOI 10.1016/j.celrep.2017.03.043; Vgontzas AN, 1999, J CLIN ENDOCR METAB, V84, P2603, DOI 10.1210/jc.84.8.2603; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; You LK, 2015, AUTOPHAGY, V11, P729, DOI 10.1080/15548627.2015.1017192; Yuan T, 2017, DIABETOLOGIA, V60, P668, DOI 10.1007/s00125-016-4188-9; Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851	50	55	56	1	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					4140	4152		10.1096/fj.201700061RR	http://dx.doi.org/10.1096/fj.201700061RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28592636	Green Published			2022-12-28	WOS:000408713300036
J	Wu, Q; Gao, K; Zheng, SZ; Zhu, X; Liang, YW; Pan, JM				Wu, Qiong; Gao, Kang; Zheng, Shuzhi; Zhu, Xin; Liang, Yinwen; Pan, Junmin			Calmodulin regulates a TRP channel (ADF1) and phospholipase C (PLC) to mediate elevation of cytosolic calcium during acidic stress that induces deflagellation in Chlamydomonas	FASEB JOURNAL			English	Article						cilia and flagella; NBBC; cilia motility; cilia assembly; intraflagellar transport	FLAGELLAR EXCISION; PRIMARY CILIA; 2 DISTINCT; PROTEIN; REINHARDTII; REGENERATION; BINDING; LOCALIZATION; DECILIATION; RESISTANCE	Calcium has been implicated in the motility, assembly, disassembly, and deflagellation of the eukaryotic flagellum or cilium (exchangeable terms). Calmodulin (CaM) is known to be critical for flagellar motility; however, it is unknown whether and how CaM is involved in other flagella-related activities. We have studied CaM in Chlamydomonas, a widely used organism for ciliary studies. CaM is present in the cell body and the flagellum, with enrichment in the basal body region. Loss of CaM causes shortening of the nucleus basal body connector and impairs flagellar motility and assembly but not flagellar disassembly. Moreover, the cam mutant is defective in pH shock-induced deflagellation. The mutant deflagellates, however, upon mechanical shearing and treatment with mastoparan or detergent undergo permeabilization in the presence of calcium, indicating the cam mutant is defective in elevations of cytosolic calcium induced by pH shock, rather than by the deflagellation machinery. Indeed, the cam mutant fails to produce inositol 1,4,5-trisphosphate. Biochemical and genetic analysis showed that CaM does not directly activate PLC. Furthermore, CaM interacts with ADF1, a transient receptor channel that functions in acid-induced calcium entry. Thus, CaM is a critical regulator of flagellar activities especially those involved in modulating calcium homeostasis during acidic stress.Wu, Q., Gao, K., Zheng, S., Zhu, X., Liang, Y., Pan, J. Calmodulin regulates a TRP channel (ADF1) and phospholipase C (PLC) to mediate elevation of cytosolic calcium during acidic stress that induces deflagellation in Chlamydomonas.	[Wu, Qiong; Zhu, Xin; Liang, Yinwen; Pan, Junmin] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, Minist Educ,Key Lab Prot Sci, Beijing, Peoples R China; [Wu, Qiong; Pan, Junmin] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China; [Gao, Kang; Zheng, Shuzhi] Hebei Normal Univ, Coll Life Sci, Hebei Key Lab Mol & Cellular Biol, Shijiazhuang, Hebei, Peoples R China	Tsinghua University; Qingdao National Laboratory for Marine Science & Technology; Hebei Normal University	Pan, JM (corresponding author), Tsinghua Univ, 1 Qinghuayuan,Renhuanlou 413, Beijing 100084, Peoples R China.	panjunmin@tsinghua.edu.cn	Liang, Yinwen/U-2734-2019; wu, qiong/GRY-4672-2022		Blue Life Breakthrough Program of the Laboratory for Marine Biology and Biotechnology [MS2017NO05]; Qingdao National Laboratory for Marine Science and Technology; National Natural Science Foundation of China [31330044, 31671387]; Sino-Germany Science Center [GZ990]	Blue Life Breakthrough Program of the Laboratory for Marine Biology and Biotechnology; Qingdao National Laboratory for Marine Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sino-Germany Science Center	The authors are indebted to Dr. Roger Sloboda (Dartmouth College, Hanover, NH, USA) for his critical reading and editing of this manuscript. This work was supported by the Blue Life Breakthrough Program of the Laboratory for Marine Biology and Biotechnology (Grant MS2017NO05), the Qingdao National Laboratory for Marine Science and Technology; the National Natural Science Foundation of China (Grants 31330044 and 31671387), and the Sino-Germany Science Center (Grant GZ990) to J.P.. The authors declare no conflicts of interest.	Awasthi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039258; Berthold P, 2002, PROTIST, V153, P401, DOI 10.1078/14344610260450136; Braun FJ, 1999, EUR J CELL BIOL, V78, P199, DOI 10.1016/S0171-9335(99)80099-5; BROKAW CJ, 1987, J CELL BIOCHEM, V35, P175, DOI 10.1002/jcb.240350302; CHESHIRE JL, 1994, J CELL SCI, V107, P2491; CHESHIRE JL, 1991, J CELL BIOL, V115, P1651, DOI 10.1083/jcb.115.6.1651; CHEUNG WY, 1980, SCIENCE, V207, P19, DOI 10.1126/science.6243188; Craige Branch, 2013, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0341s59; DiPetrillo C, 2009, METHOD CELL BIOL, V92, P163, DOI 10.1016/S0091-679X(08)92011-2; DiPetrillo CG, 2013, METHOD ENZYMOL, V524, P37, DOI 10.1016/B978-0-12-397945-2.00003-2; Dymek EE, 2006, J CELL SCI, V119, P3107, DOI 10.1242/jcs.03028; Friedberg F, 2001, IUBMB LIFE, V51, P215; Gaillard AR, 2006, MOL BIOL CELL, V17, P2626, DOI 10.1091/mbc.E06-02-0095; Geimer S, 2005, EUKARYOT CELL, V4, P1253, DOI 10.1128/EC.4.7.1253-1263.2005; GITELMAN SE, 1980, J CELL BIOL, V87, P764, DOI 10.1083/jcb.87.3.764; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gonzalez-Ballester D, 2005, ANAL BIOCHEM, V340, P330, DOI 10.1016/j.ab.2005.01.031; Gonzalez- Ballester D., 2005, ANAL BIOCHEM, V340, P353; Heuser T, 2012, MOL BIOL CELL, V23, P3143, DOI 10.1091/mbc.E12-05-0357; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Hilton LK, 2016, G3-GENES GENOM GENET, V6, P3409, DOI 10.1534/g3.116.034264; Hu ZF, 2015, CELL REP, V10, P1803, DOI 10.1016/j.celrep.2015.02.044; Iomini C, 2004, J CELL BIOL, V164, P811, DOI 10.1083/jcb.200312133; Ishii M, 2003, LIFE SCI, V74, P163, DOI 10.1016/j.lfs.2003.09.004; Ishikawa H, 2012, CURR BIOL, V22, P414, DOI 10.1016/j.cub.2012.01.031; JAMIESON GA, 1979, P NATL ACAD SCI USA, V76, P6471, DOI 10.1073/pnas.76.12.6471; JONES HP, 1980, P NATL ACAD SCI-BIOL, V77, P2772, DOI 10.1073/pnas.77.5.2772; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Kader MA, 2010, PLANT SIGNAL BEHAV, V5, P233, DOI 10.4161/psb.5.3.10740; Kuin H, 2000, PLANTA, V210, P286, DOI 10.1007/PL00008136; LEFEBVRE PA, 1978, J CELL BIOL, V78, P8, DOI 10.1083/jcb.78.1.8; Leng TD, 2014, PROG NEUROBIOL, V115, P189, DOI 10.1016/j.pneurobio.2013.12.008; Levin LR, 2015, ANNU REV PHYSIOL, V77, P347, DOI 10.1146/annurev-physiol-021014-071821; Liang YW, 2016, CELL MOL LIFE SCI, V73, P1787, DOI 10.1007/s00018-016-2148-7; Liang YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069902; Meng D, 2014, J CELL SCI, V127, P281, DOI 10.1242/jcs.140723; Munnik T, 1998, BBA-LIPID LIPID MET, V1389, P222, DOI 10.1016/S0005-2760(97)00158-6; NAKAMURA S, 1987, CELL STRUCT FUNCT, V12, P369, DOI 10.1247/csf.12.369; Nakamura Y, 2017, J BIOCHEM, V161, P315, DOI 10.1093/jb/mvw094; Overgaard CE, 2009, MOL BIOL CELL, V20, P102, DOI 10.1091/mbc.E08-07-0741; Perochon A, 2011, BIOCHIMIE, V93, P2048, DOI 10.1016/j.biochi.2011.07.012; Plotnikova OV, 2012, MOL BIOL CELL, V23, P2658, DOI 10.1091/mbc.E11-12-1056; Pokotylo I, 2014, BIOCHIMIE, V96, P144, DOI 10.1016/j.biochi.2013.07.004; QUARMBY LM, 1994, J CELL BIOL, V124, P807, DOI 10.1083/jcb.124.5.807; QUARMBY LM, 1992, J CELL BIOL, V116, P737, DOI 10.1083/jcb.116.3.737; Quarmby LM, 2004, INT REV CYTOL, V233, P47, DOI 10.1016/S0074-7696(04)33002-0; RANNESTA.J, 1974, J CELL BIOL, V63, P1009, DOI 10.1083/jcb.63.3.1009; Reiter JF, 2017, NAT REV MOL CELL BIO, V18, P533, DOI 10.1038/nrm.2017.60; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; ROSENBAU.JL, 1969, J CELL BIOL, V41, P600, DOI 10.1083/jcb.41.2.600; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; SALISBURY JL, 1987, J CELL BIOL, V105, P1799, DOI 10.1083/jcb.105.4.1799; SALISBURY JL, 1988, J CELL BIOL, V107, P635, DOI 10.1083/jcb.107.2.635; SANDERS MA, 1989, J CELL BIOL, V108, P1751, DOI 10.1083/jcb.108.5.1751; Sizova I, 2001, GENE, V277, P221, DOI 10.1016/S0378-1119(01)00616-3; Spassky N, 2017, NAT REV MOL CELL BIO, V18, P423, DOI 10.1038/nrm.2017.21; Takao D, 2016, CELL MOL LIFE SCI, V73, P119, DOI 10.1007/s00018-015-2058-0; Thompson CL, 2016, FASEB J, V30, P716, DOI 10.1096/fj.15-274944; TUCKER RW, 1979, CELL, V18, P1065, DOI 10.1016/0092-8674(79)90219-8; Tuxhorn J, 1998, CELL MOTIL CYTOSKEL, V40, P133, DOI 10.1016/j.semcdb.2008.07.005; Van Eldik L J, 1980, Ann N Y Acad Sci, V356, P36; Verhey KJ, 2009, NAT REV MOL CELL BIO, V10, P765, DOI 10.1038/nrm2782; Vinogradova MV, 2008, J STRUCT BIOL, V163, P76, DOI 10.1016/j.jsb.2008.04.004; Wagstaff KM, 2009, TRAFFIC, V10, P1188, DOI 10.1111/j.1600-0854.2009.00937.x; WALTER MF, 1981, EUR J CELL BIOL, V24, P97; Wheeler GL, 2008, PLANT J, V53, P401, DOI 10.1111/j.1365-313X.2007.03349.x; Wilson NF, 2004, EUKARYOT CELL, V3, P1307, DOI 10.1128/EC.3.5.1307-1319.2004; WRIGHT RL, 1985, J CELL BIOL, V101, P1903, DOI 10.1083/jcb.101.5.1903; Yang PF, 2001, J CELL BIOL, V153, P1315, DOI 10.1083/jcb.153.6.1315; YUEH YG, 1993, J CELL BIOL, V123, P869, DOI 10.1083/jcb.123.4.869; Zheng SZ, 2012, PLANT J, V69, P689, DOI 10.1111/j.1365-313X.2011.04823.x; Zhou F, 2015, CELL, V162, DOI 10.1016/j.cell.2015.06.048; Zhu X, 2017, CELL MOL LIFE SCI, V74, P3425, DOI 10.1007/s00018-017-2525-x; Zielinski RE, 1998, ANNU REV PLANT PHYS, V49, P697, DOI 10.1146/annurev.arplant.49.1.697; ZIMMER WE, 1988, J BIOL CHEM, V263, P19370	76	7	7	1	24	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3689	3699		10.1096/fj.201701396RR	http://dx.doi.org/10.1096/fj.201701396RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29401628				2022-12-28	WOS:000435104500017
J	Yamazaki, M; Yamada, H; Munetsuna, E; Ishikawa, H; Mizuno, G; Mukuda, T; Mouri, A; Nabeshima, T; Saito, K; Suzuki, K; Hashimoto, S; Ohashi, K				Yamazaki, Mirai; Yamada, Hiroya; Munetsuna, Eiji; Ishikawa, Hiroaki; Mizuno, Genki; Mukuda, Takao; Mouri, Akihiro; Nabeshima, Toshitaka; Saito, Kuniaki; Suzuki, Koji; Hashimoto, Shuji; Ohashi, Koji			Excess maternal fructose consumption impairs hippocampal function in offspring via epigenetic modification of BDNF promoter	FASEB JOURNAL			English	Article						maternal nutrition; early-life adversity; DOHaD; cognitive function	DEPRESSIVE-LIKE BEHAVIOR; DNA METHYLATION; CARDIOVASCULAR-DISEASE; NEUROGENESIS; EXPRESSION; STRESS; BRAIN; GENE; AGE; PREGNANCY	Recent increases in fructose consumption have raised concerns about the potential adverse intergenerational effects of excess fructose intake. In the present study, we investigated whether excess maternal fructose intake affects hippocampal function in offspring. Female Sprague-Dawley rats were divided into 3 experimental groups: one group received distilled water, one group received 20% fructose water, and one group received 20% glucose water in addition to standard chow during gestation and lactation. Hippocampal function of offspring was evaluated by using novel object recognition and fear conditioning tests. Impaired cognitive performance was observed in the offspring of fructose-fed dams at postnatal d 60, potentially a result of decreased hippocampal neurogenesis. Real-time PCR analysis demonstrated that offspring from fructose-fed dams exhibited decreased brain-derived neurotrophic factor (BDNF) gene expression, whereas pyrosequencing assays revealed increased DNA methylation at the BDNF promoter. The potential association between BDNF transcription and levels of DNA methylation was confirmed on the basis of luciferase activity. Furthermore, longitudinal analysis revealed that increased methylation of the BDNF promoter region was maintained at least until rats reached maturity. These results indicate that epigenetic changes associated with BDNF may underlie hippocampal dysfunction that is induced by early-life exposure to excess maternal fructose consumption.	[Yamazaki, Mirai; Ishikawa, Hiroaki; Mizuno, Genki; Suzuki, Koji] Fujita Hlth Univ, Dept Clin Biochem, Toyoake, Aichi, Japan; [Mouri, Akihiro; Nabeshima, Toshitaka] Fujita Hlth Univ, Adv Diagnost Syst Res Lab, Toyoake, Aichi, Japan; [Saito, Kuniaki] Fujita Hlth Univ, Dept Dis Control & Prevent, Toyoake, Aichi, Japan; [Suzuki, Koji] Fujita Hlth Univ, Dept Prevent Med Sci, Sch Hlth Sci, Toyoake, Aichi, Japan; [Yamada, Hiroya; Hashimoto, Shuji] Fujita Hlth Univ, Sch Med, Dept Hyg, 1-98 Dengakugakubo,Kutsukake Cho, Toyoake, Aichi, Japan; [Munetsuna, Eiji] Fujita Hlth Univ, Dept Biochem, Sch Med, Toyoake, Aichi, Japan; [Mukuda, Takao] Tottori Univ, Fac Med, Dept Anat, Yonago, Tottori, Japan	Fujita Health University; Fujita Health University; Fujita Health University; Fujita Health University; Fujita Health University; Fujita Health University; Tottori University	Yamada, H (corresponding author), Fujita Hlth Univ, Sch Med, Dept Hyg, 1-98 Dengakugakubo,Kutsukake Cho, Toyoake, Aichi, Japan.	hyamada@fujita-hu.ac.jp		Mizuno, Genki/0000-0001-8052-5146; Suzuki, Koji/0000-0002-3235-9558	Japan Society for the Promotion of Science [JP17K07805, JP17H04252]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research (JP17K07805 and JP17H04252). The authors declare no conflicts of interest.	Asghar ZA, 2016, SCI REP-UK, V6, DOI 10.1038/srep25091; Bideskan AE, 2017, EXP TOXICOL PATHOL, V69, P329, DOI 10.1016/j.etp.2017.02.006; Cantone I, 2013, NAT STRUCT MOL BIOL, V20, P282, DOI 10.1038/nsmb.2489; Chen YJ, 2013, ADV MECH ENG, DOI 10.1155/2013/175347; Chesnokova V, 2016, BRAIN BEHAV IMMUN, V58, P1, DOI 10.1016/j.bbi.2016.01.017; Christie LA, 2012, CLIN CANCER RES, V18, P1954, DOI 10.1158/1078-0432.CCR-11-2000; Dennis KE, 2005, MOL BRAIN RES, V140, P1, DOI 10.1016/j.molbrainres.2005.06.014; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Fan CN, 2016, NUTR RES, V36, P1013, DOI 10.1016/j.nutres.2016.06.005; Ghezzi AC, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-3; Goran MI, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020146; HAGERMAN DD, 1952, J CLIN INVEST, V31, P911, DOI 10.1172/JCI102679; Han H, 2016, BRAIN RES BULL, V124, P269, DOI 10.1016/j.brainresbull.2016.05.011; Harrell CS, 2015, PSYCHONEUROENDOCRINO, V62, P252, DOI 10.1016/j.psyneuen.2015.08.025; Hoeijmakers L, 2015, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00103; Ibanez G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135849; Lajud N, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00003; Lajud N, 2013, HORM BEHAV, V64, P781, DOI 10.1016/j.yhbeh.2013.10.005; Laker RC, 2014, DIABETES, V63, P1605, DOI [10.2337/db14-0135, 10.2337/db13-1614]; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Mizuno G, 2017, ENDOCR RES, V42, P71, DOI 10.1080/07435800.2016.1182186; Narain A, 2016, INT J CLIN PRACT, V70, P791, DOI 10.1111/ijcp.12841; Ogden Cynthia L, 2011, NCHS Data Brief, P1; Ohashi K, 2015, BIOCHEM BIOPH RES CO, V468, P185, DOI 10.1016/j.bbrc.2015.10.134; Ohashi K, 2015, NUTR RES, V35, P259, DOI 10.1016/j.nutres.2014.11.001; OSMOND C, 1993, BRIT MED J, V307, P1519, DOI 10.1136/bmj.307.6918.1519; Painter RC, 2006, AM J CLIN NUTR, V84, P322; Park JH, 2008, J CLIN INVEST, V118, P2316, DOI [10.1172/JC133655, 10.1172/JCI33655]; Ravelli ACJ, 1999, AM J CLIN NUTR, V70, P811; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rodrigo S, 2016, MOL NUTR FOOD RES, V60, P2700, DOI 10.1002/mnfr.201600193; Rutledge AC, 2007, NUTR REV, V65, pS13, DOI [10.1111/j.1753-4887.2007.tb00322.x, 10.1301/nr.2007.jun.S13-S23]; Shepherd PR, 1997, BRIT J NUTR, V78, P121, DOI 10.1079/BJN19970124; Shih YH, 2016, NEUROSCIENCE, V322, P346, DOI 10.1016/j.neuroscience.2016.02.045; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Stephan BCM, 2010, J GERONTOL A-BIOL, V65, P809, DOI 10.1093/gerona/glq079; Susser E, 1998, AM J EPIDEMIOL, V147, P213; Talens RP, 2010, FASEB J, V24, P3135, DOI 10.1096/fj.09-150490; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Tozuka Y, 2010, NEUROCHEM INT, V57, P235, DOI 10.1016/j.neuint.2010.05.015; van der Borght K, 2011, REGUL PEPTIDES, V167, P26, DOI 10.1016/j.regpep.2010.11.002; Vickers MH, 2011, ENDOCRINOLOGY, V152, P1378, DOI 10.1210/en.2010-1093; Vos Miriam B, 2008, Medscape J Med, V10, P160; Wu KLH, 2016, NEUROBIOL LEARN MEM, V130, P105, DOI 10.1016/j.nlm.2016.02.004; Yamada L, 2017, J DEV ORIG HLTH DIS, V8, P30, DOI 10.1017/S2040174416000507; Yamazaki M, 2016, LIFE SCI, V149, P146, DOI 10.1016/j.lfs.2016.02.020	48	34	32	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2549	2562		10.1096/fj.201700783RR	http://dx.doi.org/10.1096/fj.201700783RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29401579				2022-12-28	WOS:000432528000020
J	Li, YN; Li, XP; He, KY; Li, B; Liu, K; Qi, JS; Wang, H; Wang, Y; Luo, WG				Li, Yanning; Li, Xiaoping; He, Kunyu; Li, Bin; Liu, Kun; Qi, Jinsheng; Wang, Hui; Wang, Yu; Luo, Weigang			C-peptide prevents NF-kappa B from recruiting p300 and binding to the inos promoter in diabetic nephropathy	FASEB JOURNAL			English	Article						transcriptional regulation; oxidative stress; peptide; high glucose	GENE-TRANSCRIPTION; OXIDATIVE STRESS; ACETYLATION; INHIBITION; INJURY; MEMORY; RATS	C-peptide (CP) has demonstrated unique beneficial effects in diabetic nephropathy (DN), but whether and how CP regulates NF-kappa B and its coactivator, p300, to suppress inducible iNOS and antagonize DN are unknown. iNOS expression, NF-kappa B nuclear translocation, colocalization and binding of NF-kappa B to p300, binding of NF-kappa B to the inos promoter, and the bound NF-kappa B, p300, and histone 3 lysine 9 acetylation (H3K9ac) at binding sites were measured in high glucose-stimulated mesangial cells. We evaluated pathologic changes, iNOS expression, NF-kappa B, and p300 contents in diabetic rats. We found that CP inhibited iNOS expression and notably prevented colocalization and binding of NF-kappa B and p300. CP prevented NF-kappa B from binding to the inos promoter, especially at the distal site, and reduced bound NF-kappa B, p300, and H3K9ac. N-terminal plus middle fragment could mostly mimic the antagonizing effects of CP against the pathologic changes of DN and equally suppresses renal iNOS expression as CP. In conclusion, CP prevented NF-kappa B from recruiting p300 and binding to the inos promoter, and decreased H3K9ac at the binding sites to suppress iNOS expression and antagonize DN, with the effect region identified as N-terminal plus middle fragment.	[Li, Yanning; Wang, Yu; Luo, Weigang] Hebei Med Univ, Dept Biochem, Hebei Key Lab Med Biotechnol, 361 East Zhongshan Rd, Shijiazhuang 050017, Hebei, Peoples R China; [Li, Xiaoping; He, Kunyu; Li, Bin; Liu, Kun; Qi, Jinsheng] Hebei Med Univ, Dept Mol Biol, Hebei Key Lab Lab Anim, Shijiazhuang, Hebei, Peoples R China; [Wang, Hui] Hebei Med Univ, Dept Pathol, Shijiazhuang, Hebei, Peoples R China	Hebei Medical University; Hebei Medical University; Hebei Medical University	Qi, JS (corresponding author), Hebei Med Univ, Dept Biochem, Hebei Key Lab Med Biotechnol, 361 East Zhongshan Rd, Shijiazhuang 050017, Hebei, Peoples R China.	qijinsheng777@163.com			Hebei Natural Science Foundation [H2015206101]; National Natural Science Foundation of China [81070658, 81470595]	Hebei Natural Science Foundation(Natural Science Foundation of Hebei Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grants 81070658 and 81470595) and the Hebei Natural Science Foundation (Grant H2015206101). The authors declare no conflicts of interest.	Al-Waili N, 2017, REDOX REP, V22, P99, DOI 10.1080/13510002.2017.1297885; Ansley DM, 2013, J PATHOL, V229, P232, DOI 10.1002/path.4113; Bhatt MP, 2016, J ENDOCRINOL, V231, P97, DOI 10.1530/JOE-16-0349; Bhatt MP, 2013, DIABETES, V62, P243, DOI 10.2337/db12-0293; Brunskill NJ, 2017, J INTERN MED, V281, P41, DOI 10.1111/joim.12548; Castellano JM, 2013, DIABETES, V62, P1791, DOI 10.2337/db12-1215; Fineberg D, 2013, NAT REV ENDOCRINOL, V9, P713, DOI 10.1038/nrendo.2013.184; Ganster RW, 2001, P NATL ACAD SCI USA, V98, P8638, DOI 10.1073/pnas.151239498; Garcia-Serrano S, 2015, OBESITY, V23, P1607, DOI 10.1002/oby.21137; Guo Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146640; Hills CE, 2010, AM J NEPHROL, V31, P389, DOI 10.1159/000289864; Ho HJ, 2012, CELL SIGNAL, V24, P2166, DOI 10.1016/j.cellsig.2012.07.018; Ido Y, 1997, SCIENCE, V277, P563, DOI 10.1126/science.277.5325.563; Inagi R, 2006, DIABETES, V55, P356, DOI 10.2337/diabetes.55.02.06.db05-0702; Ishii T, 2012, J BIOCHEM, V152, P53, DOI 10.1093/jb/mvs052; Kato M, 2014, NAT REV NEPHROL, V10, P517, DOI 10.1038/nrneph.2014.116; Kim SW, 2013, IEEE ICCE, P65, DOI 10.1109/ICCE.2013.6486797; Landreh M, 2014, BIOCHEM BIOPH RES CO, V450, P1433, DOI 10.1016/j.bbrc.2014.07.012; Li YN, 2013, MOL CELL ENDOCRINOL, V381, P255, DOI 10.1016/j.mce.2013.08.007; Li YN, 2013, MOL CELL ENDOCRINOL, V370, P78, DOI 10.1016/j.mce.2013.02.015; Li YN, 2010, MOL MED, V16, P335, DOI 10.2119/molmed.2010.00034; Lim YC, 2014, CARDIOVASC RES, V101, P155, DOI 10.1093/cvr/cvt238; Lin CL, 2014, J AM SOC NEPHROL, V25, P1698, DOI 10.1681/ASN.2013050527; Lindahl E, 2010, J BIOL CHEM, V285, P3462, DOI 10.1074/jbc.M109.053587; Liu RJ, 2014, DIABETES, V63, P2440, DOI 10.2337/db13-1810; Luppi P, 2017, J INTERN MED, V281, P7, DOI 10.1111/joim.12522; Luppi P, 2009, DIABETOLOGIA, V52, P2218, DOI 10.1007/s00125-009-1476-7; Miao F, 2014, DIABETES, V63, P1748, DOI 10.2337/db13-1251; Rahangdale S, 2009, FRONT BIOSCI-LANDMRK, V14, P192, DOI 10.2741/3240; Reddy MA, 2014, KIDNEY INT, V85, P362, DOI 10.1038/ki.2013.387; Shaw JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127439; Sun W, 2010, ACTA BIOCH BIOPH SIN, V42, P893, DOI 10.1093/abbs/gmq100; Tavafi Majid, 2013, J Nephropathol, V2, P20, DOI 10.5812/nephropathol.9093; Wahren J, 2016, DIABETES CARE, V39, P596, DOI 10.2337/dc15-2068; Wahren J, 2015, DIABETES RES CLIN PR, V107, P309, DOI 10.1016/j.diabres.2015.01.016; Wahren J, 2012, DIABETES, V61, P761, DOI 10.2337/db11-1423; Wang YT, 2015, 2ND INTERNATIONAL CONFERENCE ON SIMULATION AND MODELING METHODOLOGIES, TECHNOLOGIES AND APPLICATIONS (SMTA 2015), P34; Xu SQ, 2015, BIOCHEM BIOPH RES CO, V458, P674, DOI 10.1016/j.bbrc.2015.02.022; Yuan H, 2013, AM J PHYSIOL-RENAL, V304, pF601, DOI 10.1152/ajprenal.00523.2012; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	41	15	17	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2269	2279		10.1096/fj.201700891R	http://dx.doi.org/10.1096/fj.201700891R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29229684				2022-12-28	WOS:000429051400044
J	Mangat, R; Borthwick, F; Haase, T; Jacome, M; Nelson, R; Kontush, A; Vine, DF; Proctor, SD				Mangat, Rabban; Borthwick, Faye; Haase, Tina; Jacome, Miriam; Nelson, Randy; Kontush, Anatol; Vine, Donna F.; Proctor, Spencer D.			Intestinal lymphatic HDL miR-223 and ApoA-I are reduced during insulin resistance and restored with niacin	FASEB JOURNAL			English	Article						niacin/nicotinic acid; lipid metabolism; ApoB48; chylomicrons; lipoproteins	HIGH-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-A-I; ACTIVATED RECEPTOR-ALPHA; ESTER TRANSFER PROTEIN; REVERSE CHOLESTEROL TRANSPORT; ISCHEMIC-HEART-DISEASE; POSTPRANDIAL DYSLIPIDEMIA; REMNANT CHOLESTEROL; GENE-EXPRESSION; INCREASES HDL	The intestine is involved in whole-body lipid and cholesterol homeostasis and secretes lipoproteins containing apolipoprotein(Apo) B48 and discrete ApoA-I into the mesenteric lymph. The lymphatic system has been proposed to have a significant role in the reverse cholesterol transport pathway associated with HDL-ApoA-I. In conditions of insulin resistance (IR), there is intestinal overproduction of chylomicrons containing ApoB48; however, there is limited data on the intestinal synthesis and secretion of HDL-ApoA-I. microRNA (miR)-223 has been shown to regulate peripheral HDL metabolism and may impact intestinal-derived HDL. Niacin (nicotinic acid; vitamin B3) is known to regulate lipid metabolism, but the role of niacin in modulating intestinal lipid and lipoprotein (ApoB48 and ApoA-I) metabolism is unknown. The aim of this study was to determine the secretion of intestinal lymphatic HDL-ApoA-I and the effect of dietary intervention with niacin on these pathways in a rodent model of IR. HDL was isolated from intestinal mesenteric lymph by density ultracentrifugation, and subsequent HDL miR analysis was developed in collaboration with Exiqon Services. Insulin-resistant rodents were fed chow or chow with niacin (1% w/w) for 6wk. Intestinal lymph HDL-ApoA-I and miR-223 expression were lower by at least 45 and 60%, respectively, and lymph HDL was associated with 85% higher triglyceride (TG) content in IR compared to non-IR control group. Niacin was found to increase secretion of lymph HDL and miR-223 by at least 50-60% and to deplete the TGs associated with HDL compared with the nontreated IR group. Niacin significantly increased peroxisome proliferator-activating nuclear receptor a and carnitine palmitoyltransferase I a mRNA and annulled Tnf-alpha mRNA expression in intestinal (jejunal) explants. Altered intestinal lymphatic HDL-ApoA-I and miR-223 metabolism in IR and modulation by niacin may provide insight into the intestinal-mediated regulation of the reverse cholesterol transport pathway.	[Mangat, Rabban; Borthwick, Faye; Haase, Tina; Jacome, Miriam; Nelson, Randy; Vine, Donna F.; Proctor, Spencer D.] Univ Alberta, Grp Mol Cell Biol Lipids, Metab & Cardiovasc Dis Lab, Edmonton, AB, Canada; [Mangat, Rabban; Borthwick, Faye; Haase, Tina; Jacome, Miriam; Nelson, Randy; Vine, Donna F.; Proctor, Spencer D.] Univ Alberta, Alberta Diabet Inst, Edmonton, AB, Canada; [Mangat, Rabban; Borthwick, Faye; Haase, Tina; Jacome, Miriam; Nelson, Randy; Vine, Donna F.; Proctor, Spencer D.] Univ Alberta, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada; [Kontush, Anatol] Univ Paris 06, Salpetriere Univ Hosp, Natl Inst Hlth & Med Res, Paris, France	University of Alberta; University of Alberta; University of Alberta; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Proctor, SD (corresponding author), Univ Alberta, Metab & Cardiovasc Dis Lab, Alberta Diabet & Mazankowski Heart Inst, Grp Mol Cell Biol Lipids,J Li Ka Shing Ctr Hlth I, Edmonton, AB T6G 2P5, Canada.	spencer.proctor@ualberta.ca			investigator-initiated studies grant - Merck; University of Alberta Vitamin Fund; Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant	investigator-initiated studies grant - Merck; University of Alberta Vitamin Fund; Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	The authors thank Sandra Kelly, Sharon Sokolik, and Kendra Chow (University of Alberta) for their excellent technical assistance in the study. This work was supported, in part, by an investigator-initiated studies grant sponsored by Merck (to S.D.P.). Seed funds were also provided by a University of Alberta Vitamin Fund (to D.F.V.) and a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (to S.D.P. and D.F.V.). The authors declare no conflicts of interest.	Agerholm-Larsen B, 2000, CIRCULATION, V102, P2197; Avramoglu RK, 2003, FRONT BIOSCI, V8, pD464, DOI 10.2741/1022; BISGAIER CL, 1983, ANNU REV PHYSIOL, V45, P625, DOI 10.1146/annurev.ph.45.030183.003205; Blenkiron C, 2014, ANN SURG, V260, P341, DOI 10.1097/SLA.0000000000000447; BLUM CB, 1977, J CLIN INVEST, V60, P795, DOI 10.1172/JCI108833; Borthwick F, 2014, ATHEROSCLEROSIS, V232, P141, DOI 10.1016/j.atherosclerosis.2013.10.031; Brunham LR, 2015, PROG LIPID RES, V58, P14, DOI 10.1016/j.plipres.2015.01.001; Brunham LR, 2006, J CLIN INVEST, V116, P1052, DOI 10.1172/JCI27352; Bunger M, 2007, PHYSIOL GENOMICS, V30, P192, DOI 10.1152/physiolgenomics.00198.2006; CHUNG BH, 1980, J LIPID RES, V21, P284; Colin S, 2013, EUR HEART J, V34, P2566, DOI 10.1093/eurheartj/ehs227; Dash S, 2015, ANNU REV NUTR, V35, P265, DOI 10.1146/annurev-nutr-071714-034338; FORESTER GP, 1983, J BIOL CHEM, V258, P5938; GLICKMAN RM, 1977, P NATL ACAD SCI USA, V74, P2569, DOI 10.1073/pnas.74.6.2569; Goldberg IJ, 2001, J CLIN ENDOCR METAB, V86, P965, DOI 10.1210/jc.86.3.965; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Haas MJ, 2003, BBA-GEN SUBJECTS, V1623, P120, DOI 10.1016/j.bbagen.2003.08.004; Hernandez M, 2007, BIOCHEM BIOPH RES CO, V355, P1075, DOI 10.1016/j.bbrc.2007.02.079; Hogue JC, 2007, J LIPID RES, V48, P1336, DOI 10.1194/jlr.M600548-JLR200; Hsieh J, 2008, ATHEROSCLEROSIS SUPP, V9, P7, DOI 10.1016/j.atherosclerosissup.2008.05.011; Huang LH, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00182; Hussain MM, 2014, CURR OPIN LIPIDOL, V25, P200, DOI 10.1097/MOL.0000000000000084; Hutchins PM, 2015, CURR OPIN LIPIDOL, V26, P388, DOI 10.1097/MOL.0000000000000209; Iqbal J, 2014, J LIPID RES, V55, P2261, DOI 10.1194/jlr.M047951; Jacome-Sosa MM, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-60; Kimura R, 2011, BIOCHEM BIOPH RES CO, V410, P1, DOI 10.1016/j.bbrc.2011.05.057; Kruit JK, 2006, WORLD J GASTROENTERO, V12, P6429, DOI 10.3748/wjg.v12.i40.6429; Lamon-Fava S, 2008, ARTERIOSCL THROM VAS, V28, P1672, DOI 10.1161/ATVBAHA.108.164541; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; Lu J, 2011, BRIT J NUTR, V105, P1572, DOI 10.1017/S0007114510005453; Martel C, 2013, J CLIN INVEST, V123, P1571, DOI 10.1172/JCI63685; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mooradian AD, 2004, DIABETES, V53, P513, DOI 10.2337/diabetes.53.3.513; Mooradian AD, 2009, NAT CLIN PRACT ENDOC, V5, P150, DOI 10.1038/ncpendmet1066; Pang J, 2012, CURR OPIN LIPIDOL, V23, P303, DOI 10.1097/MOL.0b013e328354c790; Pont F, 2002, INT J OBESITY, V26, P1151, DOI 10.1038/sj.ijo.0802070; Qin BL, 2007, DIABETES, V56, P450, DOI 10.2337/db06-0518; SHEPHERD J, 1979, J CLIN INVEST, V63, P858, DOI 10.1172/JCI109385; SHIAU YF, 1985, AM J PHYSIOL, V248, pG164, DOI 10.1152/ajpgi.1985.248.2.G164; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Siripurkpong P, 2009, J NUTR BIOCHEM, V20, P261, DOI 10.1016/j.jnutbio.2008.02.010; Smith D, 1997, ANN CLIN BIOCHEM, V34, P185, DOI 10.1177/000456329703400210; van der Hoorn JWA, 2008, ARTERIOSCL THROM VAS, V28, P2016, DOI 10.1161/ATVBAHA.108.171363; Varbo A, 2014, PHARMACOL THERAPEUT, V141, P358, DOI 10.1016/j.pharmthera.2013.11.008; Varbo A, 2013, J AM COLL CARDIOL, V61, P427, DOI 10.1016/j.jacc.2012.08.1026; Vickers KC, 2014, P NATL ACAD SCI USA, V111, P14518, DOI 10.1073/pnas.1215767111; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Vine DF, 2007, ATHEROSCLEROSIS, V190, P282, DOI 10.1016/j.atherosclerosis.2006.03.013; Vu-Dac N, 1998, J BIOL CHEM, V273, P25713, DOI 10.1074/jbc.273.40.25713; Wang Y, 2012, MOL NUTR FOOD RES, V56, P1234, DOI 10.1002/mnfr.201100517; Wang Y, 2009, J NUTR, V139, P2049, DOI 10.3945/jn.109.109488; Watt MJ, 2004, J MOL ENDOCRINOL, V33, P533, DOI 10.1677/jme.1.01499; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; WEISER MM, 1973, J BIOL CHEM, V248, P2536; Xiao CT, 2012, BBA-MOL CELL BIOL L, V1821, P736, DOI 10.1016/j.bbalip.2011.09.019; Yuana Y, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23262; Zhang LH, 2012, J LIPID RES, V53, P941, DOI 10.1194/jlr.M020917; Zhuang GQ, 2012, CIRCULATION, V125, P2892, DOI 10.1161/CIRCULATIONAHA.111.087817	58	3	5	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1602	1612		10.1096/fj.201600298RR	http://dx.doi.org/10.1096/fj.201600298RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29183962				2022-12-28	WOS:000427246000038
J	Lee, SH; Joo, K; Jung, EJ; Hong, H; Seo, J; Kim, J				Lee, Si-Hyung; Joo, Kwangsic; Jung, Eun Ji; Hong, Hyowon; Seo, Jimyung; Kim, Joon			Export of membrane proteins from the Golgi complex to the primary cilium requires the kinesin motor, KIFC1	FASEB JOURNAL			English	Article						ciliogenesis; ASAP1; TTBK2; dynein	RAB11 EFFECTOR FIP3; INTRACELLULAR-TRANSPORT; CYTOPLASMIC DYNEIN; SUPERFAMILY MOTOR; CILIARY MEMBRANE; MITOTIC SPINDLE; CANCER-CELLS; TRAFFICKING; RECEPTOR; HSET	Microtubule-based motors contribute to the efficiency and selectivity of Golgi exit and post-Golgi transport of membrane proteins that are targeted to distinct compartments. Cytoplasmic dynein moves post-Golgi vesicles that carry rhodopsin toward the base of the connecting cilium in photoreceptor cells; however, the identity of the motors that are involved in the vesicular trafficking of ciliary membrane proteins in nonphotoreceptor cells remains unclear. Here, we demonstrate that the minus end-directed kinesin KIFC1 (kinesin family member C1) is required for both ciliary membrane protein transport and serum starvation-induced ciliogenesis in retinal pigmented epithelial 1 cells. Although KIFC1 is known as a mitotic motor that is sequestered in the nucleus during interphase, KIFC1 immunoreactivity appeared in the Golgi region after serum starvation. Knockdown of KIFC1 inhibited the export of ciliary receptors from the Golgi complex. KIFC1 overexpression affected the Golgi localization of GMAP210 (Golgi microtubule-associated protein 210) and IFT20 (intraflagellar transport 20), which are involved in membrane protein transport to cilia. Moreover, KIFC1 physically interacted with ASAP1 (ADP-ribosylation factor GTPase-activating protein with SH3 domain, ankyrin repeat and PH domain 1), which regulates the budding of rhodopsin transport carriers from the Golgi complex, and KIFC1 depletion caused Golgi accumulation of ASAP1. A decrease in the centrosomal levels of IFT20 and TTBK2 (tau-tubulin kinase 2) was associated with ciliogenesis defects in KIFC1-depleted cells. Our results suggest that KIFC1 plays roles in the Golgi exit of ciliary receptors and in the recruitment of ciliogenesis regulators.	[Lee, Si-Hyung; Joo, Kwangsic; Jung, Eun Ji; Hong, Hyowon; Seo, Jimyung; Kim, Joon] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea; [Lee, Si-Hyung] Yonsei Univ, Coll Med, Dept Dermatol, Seoul, South Korea; [Joo, Kwangsic] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Seongnam, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Yonsei University; Yonsei University Health System; Seoul National University (SNU)	Kim, J (corresponding author), Korea Adv Inst Sci & Technol, Biomed Res Ctr 5109, 291 Daehak Ro, Daejeon 34141, South Korea.	joonkim@kaist.ac.kr	Kim, Joon/C-1833-2011	Hong, Hyowon/0000-0002-3272-7859; Seo, Jimyung/0000-0003-3416-9990	National Research Foundation - Korean Ministry of Science and ICT [1711049553]; Health Industry Development Institute - Korean Ministry of Health Welfare [1465023644]	National Research Foundation - Korean Ministry of Science and ICT; Health Industry Development Institute - Korean Ministry of Health Welfare	The authors thank Dr. Erich Nigg (University of Basel, Basel, Switzerland) for the Cep164 Ab and Dr. Gregory Pazour (University of Massachusetts Medical School, Worcester, MA, USA) for the IFT20-Flag plasmid. Supported by an National Research Foundation grant funded by the Korean Ministry of Science and ICT (1711049553), and a Health Technology R&D Project through the Health Industry Development Institute funded by the Korean Ministry of Health & Welfare (1465023644).	Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; Braun M, 2013, CYTOSKELETON, V70, P515, DOI 10.1002/cm.21133; Cai S, 2009, MOL BIOL CELL, V20, P1348, DOI 10.1091/mbc.E08-09-0971; Chavali PL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11005; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Delevoye C, 2014, CELL REP, V6, P445, DOI 10.1016/j.celrep.2014.01.002; Deretic D, 2005, P NATL ACAD SCI USA, V102, P3301, DOI 10.1073/pnas.0500095102; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Follit JA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000315; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Hanlon DW, 1997, NEURON, V18, P439, DOI 10.1016/S0896-6273(00)81244-1; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Incardona JP, 2002, CURR BIOL, V12, P983, DOI 10.1016/S0960-9822(02)00895-3; Inoue H, 2008, MOL BIOL CELL, V19, P4224, DOI 10.1091/mbc.E08-03-0290; Ishikawa H, 2005, NAT CELL BIOL, V7, P517, DOI 10.1038/ncb1251; Jackson PK, 2012, CELL, V151, P697, DOI 10.1016/j.cell.2012.10.027; Jaulin F, 2007, DEV CELL, V13, P511, DOI 10.1016/j.devcel.2007.08.001; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Joo K, 2013, P NATL ACAD SCI USA, V110, P5987, DOI 10.1073/pnas.1220927110; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Kim N, 2013, CELL STRUCT FUNCT, V38, P21, DOI 10.1247/csf.12014; Kleylein-Sohn J, 2012, J CELL SCI, V125, P5391, DOI 10.1242/jcs.107474; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; Lecland N, 2014, NAT CELL BIOL, V16, P770, DOI 10.1038/ncb2996; Lim YS, 2011, BIOL CELL, V103, P209, DOI 10.1042/BC20100150; Liu SJ, 2012, CELL MOL LIFE SCI, V69, P4093, DOI 10.1007/s00018-012-1021-6; Ma DD, 2017, ONCOTARGET, V8, P36082, DOI [10.18632/oncotarget.16429, 10.18632/oncotarget.8553]; Malicki JJ, 2017, TRENDS CELL BIOL, V27, P126, DOI 10.1016/j.tcb.2016.08.002; Mountain V, 1999, J CELL BIOL, V147, P351, DOI 10.1083/jcb.147.2.351; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Nath S, 2007, MOL BIOL CELL, V18, P1839, DOI 10.1091/mbc.E06-06-0524; Noda Y, 2001, J CELL BIOL, V155, P77, DOI 10.1083/jcb.200108042; Ogden A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42289; Pannu V, 2015, ONCOTARGET, V6, P6076, DOI 10.18632/oncotarget.3475; Rios RM, 2004, CELL, V118, P323; Roberts AJ, 2013, NAT REV MOL CELL BIO, V14, P713, DOI 10.1038/nrm3667; Rohatgi R, 2010, CURR OPIN CELL BIOL, V22, P541, DOI 10.1016/j.ceb.2010.03.010; Saito N, 1997, NEURON, V18, P425, DOI 10.1016/S0896-6273(00)81243-X; Scholey JM, 2013, ANNU REV CELL DEV BI, V29, P443, DOI 10.1146/annurev-cellbio-101512-122335; She ZY, 2017, ONCOTARGET, V8, P36469, DOI 10.18632/oncotarget.16863; Singh SA, 2014, EMBO J, V33, P385, DOI 10.1002/embj.201385876; SOROKIN S, 1962, J CELL BIOL, V15, P363, DOI 10.1083/jcb.15.2.363; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Sung CH, 2013, NAT CELL BIOL, V15, P1387, DOI 10.1038/ncb2888; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Verhey KJ, 2009, NAT REV MOL CELL BIO, V10, P765, DOI 10.1038/nrm2782; Wang J, 2015, J CELL SCI, V128, P1375, DOI 10.1242/jcs.162925; Wang J, 2012, EMBO J, V31, P4057, DOI 10.1038/emboj.2012.253; Watanabe T, 2015, J CELL BIOL, V210, P737, DOI 10.1083/jcb.201412075; Xu Y, 2002, J CELL BIOL, V158, P293, DOI 10.1083/jcb.200202058; Yang WX, 2003, BIOL REPROD, V69, P1719, DOI 10.1095/biolreprod.102.014878; Yu KM, 2009, CELL TISSUE RES, V337, P113, DOI 10.1007/s00441-009-0800-3; Zimmerman W, 2000, TRAFFIC, V1, P927, DOI 10.1034/j.1600-0854.2000.011202.x	59	16	18	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					957	968		10.1096/fj.201700563R	http://dx.doi.org/10.1096/fj.201700563R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29042452	Bronze			2022-12-28	WOS:000425146900036
J	Marchesi, VT				Marchesi, Vincent T.			De novo digenic mutations of telomere-associated proteins and inflammasomes initiate many chronic human diseases: a hypothesis	FASEB JOURNAL			English	Article						inflammation; TERT; NLRP3	DOUBLE-STRAND BREAKS; AUTOINFLAMMATORY DISEASES; CELL-PROLIFERATION; HEMATOPOIETIC STEM; HYPERCHOLESTEROLEMIA; RECRUITMENT; GENETICS	Many age-related human diseases have inflammatory components of uncertain causes. It has been proposed that some may be initiated or sustained by doublymutated immune cells that have both inappropriately activated inflammasomes and enhanced replicative potential. Genes of cells that expressmutant TERT and NLRP3 proteins are presumed to be at increased risk for mutagenesis because they reside in subtelomeric regions of chromatin that are deficient in DNA repair mechanisms. Expanded clones of proinflammatory cells can occur throughout one's lifetime and could represent an alternative explanation for some forms of pathologic scarring that are now attributed to truncated telomeres.	[Marchesi, Vincent T.] Yale Univ, Dept Pathol, 295 Congress Ave, New Haven, CT 06536 USA	Yale University	Marchesi, VT (corresponding author), Yale Univ, Dept Pathol, 295 Congress Ave, New Haven, CT 06536 USA.	vincent.marchesi@yale.edu			Anthony N. Brady Professorship of Yale University	Anthony N. Brady Professorship of Yale University	This work was supported by the Anthony N. Brady Professorship of Yale University.	Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Bell RJA, 2016, MOL CANCER RES, V14, P315, DOI 10.1158/1541-7786.MCR-16-0003; Hrdlickova R, 2012, MOL CELL BIOL, V32, P4283, DOI 10.1128/MCB.00550-12; Kulkarni A, 2010, MOL CELL BIOL, V30, P578, DOI 10.1128/MCB.01137-09; Leroy C, 2013, EUR J HUM GENET, V21, P602, DOI 10.1038/ejhg.2012.230; Podlevsky JD, 2008, NUCLEIC ACIDS RES, V36, pD339, DOI 10.1093/nar/gkm700; Robin JD, 2014, GENE DEV, V28, P2464, DOI 10.1101/gad.251041.114; Schaffer AA, 2013, J MED GENET, V50, P641, DOI 10.1136/jmedgenet-2013-101713; Schmidt JC, 2016, CELL, V166, P1188, DOI 10.1016/j.cell.2016.07.033; Seijkens T, 2014, FASEB J, V28, P2202, DOI 10.1096/fj.13-243105; Shao L, 2008, AM J MED GENET A, V146A, P2242, DOI 10.1002/ajmg.a.32399; Silva BA, 2017, DNA REPAIR, V49, P1, DOI 10.1016/j.dnarep.2016.10.008; Stojanov S, 2005, CURR OPIN RHEUMATOL, V17, P586, DOI 10.1097/bor.0000174210.78449.6b; Tolani S, 2013, ATHEROSCLEROSIS, V229, P79, DOI 10.1016/j.atherosclerosis.2013.03.031	15	0	0	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					16	19		10.1096/fj.201700388RR	http://dx.doi.org/10.1096/fj.201700388RR			4	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28864660				2022-12-28	WOS:000419172700003
J	Zhang, MQ; Miao, YL; Chen, Q; Cai, M; Dong, WK; Dai, XX; Lu, YJ; Zhou, CY; Cui, ZK; Xiong, B				Zhang, Mianqun; Miao, Yilong; Chen, Qian; Cai, Meng; Dong, Wenkang; Dai, Xiaoxin; Lu, Yajuan; Zhou, Changyin; Cui, Zhaokang; Xiong, Bo			BaP exposure causes oocyte meiotic arrest and fertilization failure to weaken female fertility	FASEB JOURNAL			English	Article						environmental pollutant; oocyte quality; meiotic progression; fertilization ability; oxidative stress	POLYCYCLIC AROMATIC-HYDROCARBONS; SPINDLE ASSEMBLY CHECKPOINT; LYSOZYME-LIKE PROTEIN; IN-VITRO; ZONA-PELLUCIDA; HYDROXYLASE-ACTIVITY; GAMETE RECOGNITION; OXIDATIVE STRESS; SPERM BINDING; MOUSE OOCYTES	Benzo[a] pyrene (BaP) is a ubiquitous environmental pollutant and carcinogen that is frequently found in particulate matter, with a diameter of <= 2.5 mu m (PM2.5). It has been reported to interrupt the normal reproductive system, but the exact molecular basis has not been clearly defined. To understand the underlying mechanisms regarding how BaP exposure disrupts female fertility, we evaluated oocyte quality by assessing the critical regulators and events during oocyte meiotic maturation and fertilization. We found that BaP exposure compromised the mouse oocyte meiotic progression by disrupting normal spindle assembly, chromosome alignment, and kinetochore-microtubule attachment, consequently leading to the generation of aneuploid eggs. In addition, BaP administration significantly decreased the fertilization rate of mouse eggs by reducing the number of sperm binding to the zona pellucida, which was consistent with the premature cleavage of N terminus of zona pellucida sperm-binding protein 2 and precocious exocytosis of ovastacin. Furthermore, BaP exposure interfered with the gamete fusion process by perturbing the localization and protein level of Juno. Notably, we found that BaP exposure induced oxidative stress with an increased level of reactive oxygen species and apoptosis in oocytes and thereby led to the deterioration of critical regulators and events during oocyte meiotic progression and fertilization. Our data document that BaP exposure reduces female fertility via impairing oocyte maturation and fertilization ability induced by oxidative stress and early apoptosis in murine models.	[Zhang, Mianqun; Miao, Yilong; Chen, Qian; Cai, Meng; Dong, Wenkang; Dai, Xiaoxin; Lu, Yajuan; Zhou, Changyin; Cui, Zhaokang; Xiong, Bo] Nanjing Agr Univ, Coll Anim Sci & Technol, 1 Weigang, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Xiong, B (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, 1 Weigang, Nanjing 210095, Jiangsu, Peoples R China.	xiongbo@njau.edu.cn			National Natural Science Foundation [31571545]; Natural Science Foundation of Jiangsu Province [BK20150677]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	The authors thank Dr. Shaochen Sun (Nanjing Agricultural University) for critical comments on the manuscript. This work was supported by National Natural Science Foundation Grant 31571545 (to B.X.) and Natural Science Foundation of Jiangsu Province Grant BK20150677(to B.X). The authors declare no conflicts of interest.	Agrawal M., 2017, REV ENV CONTAM TOXIC; Aravamudhan P, 2015, NAT CELL BIOL, V17, P868, DOI 10.1038/ncb3179; Avella MA, 2013, MOL HUM REPROD, V19, P279, DOI 10.1093/molehr/gat004; Aydin H, 2016, NATURE, V534, P562, DOI 10.1038/nature18595; Beal MA, 2015, MUTAT RES-FUND MOL M, V775, P26, DOI 10.1016/j.mrfmmm.2015.03.010; BERWALD Y, 1965, J NATL CANCER I, V35, P641; Bianchi E, 2014, NATURE, V508, P483, DOI 10.1038/nature13203; BINNEMANN PH, 1979, Z LEBENSM UNTERS FOR, V169, P447, DOI 10.1007/BF01126748; BLEIL JD, 1980, DEV BIOL, V76, P185, DOI 10.1016/0012-1606(80)90371-1; BLEIL JD, 1981, DEV BIOL, V86, P189, DOI 10.1016/0012-1606(81)90329-8; BLEIL JD, 1980, CELL, V20, P873, DOI 10.1016/0092-8674(80)90334-7; Bolden AL, 2017, REPROD TOXICOL, V73, P61, DOI 10.1016/j.reprotox.2017.07.012; Borman SM, 2000, TOXICOL APPL PHARM, V167, P191, DOI 10.1006/taap.2000.9006; Brunsch D, 1978, Krankenpflege (Frankf), V32, P6; Burkart AD, 2012, J CELL BIOL, V197, P37, DOI 10.1083/jcb.201112094; Chang WA, 2016, ONCOL LETT, V11, P1783, DOI 10.3892/ol.2016.4153; Chatkin J. M., 2014, PLOS ONE, V9; CHORAZY M, 1994, ENVIRON HEALTH PERSP, V102, P61, DOI 10.2307/3431932; CSABA G, 1993, J DEV PHYSIOL, V19, P217; Dai XX, 2017, HUM REPROD, V32, P598, DOI 10.1093/humrep/dew362; Dai X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126653; DIAMOND L, 1967, CANCER RES, V27, P890; Esengen S, 2000, J Am Med Dir Assoc, V1, P197; Ewa B, 2017, J APPL GENET, V58, P321, DOI 10.1007/s13353-016-0380-3; Fu PB, 2017, ENVIRON SCI TECHNOL, V51, P1587, DOI 10.1021/acs.est.6b04418; Gahlay G, 2010, SCIENCE, V329, P216, DOI 10.1126/science.1188178; Gimenez-Abian JF, 2005, CELL CYCLE, V4, P1561, DOI 10.4161/cc.4.11.2146; Grayson P, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150296; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; HEIDELBERGER C, 1975, ANNU REV BIOCHEM, V44, P79, DOI 10.1146/annurev.bi.44.070175.000455; Herrero MB, 2005, DEV BIOL, V284, P126, DOI 10.1016/j.ydbio.2005.05.008; HUBERMAN E, 1974, INT J CANCER, V13, P326, DOI 10.1002/ijc.2910130308; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Jin YT, 2016, CANCER INVEST, V34, P173, DOI 10.3109/07357907.2016.1156689; Kalthoff S, 2017, FREE RADICAL BIO MED, V108, P66, DOI 10.1016/j.freeradbiomed.2017.03.006; Klinovska K, 2014, INT J MOL SCI, V15, P10652, DOI 10.3390/ijms150610652; Kummer V, 2013, J APPL TOXICOL, V33, P90, DOI 10.1002/jat.1714; Liang Jing, 2016, Zhongguo Zhong Xi Yi Jie He Za Zhi, V36, P234; Liu B, 2017, ENVIRON POLLUT, V220, P1171, DOI 10.1016/j.envpol.2016.11.018; Liu H, 2016, TRANSCR-AUSTIN, V7, P21, DOI 10.1080/21541264.2015.1127315; Luderer U, 2017, ENVIRON INT, V100, P110, DOI 10.1016/j.envint.2016.12.021; Lumpe D, 1979, US MED, V15, P11; Lybarger JA, 1999, RENAL FAILURE, V21, P263, DOI 10.3109/08860229909085088; MACKENZIE KM, 1981, BIOL REPROD, V24, P183, DOI 10.1095/biolreprod24.1.183; Madeen EP, 2017, REV ENVIRON HEALTH, V32, P73, DOI 10.1515/reveh-2016-0045; Mandal A, 2003, BIOL REPROD, V68, P1525, DOI 10.1095/biolreprod.102.010108; MATTISON DR, 1989, TOXICOL PATHOL, V17, P364, DOI 10.1177/019262338901700213; MATTISON DR, 1980, TOXICOL APPL PHARM, V56, P399, DOI 10.1016/0041-008X(80)90074-5; MATTISON DR, 1979, CANCER RES, V39, P3471; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Neal MS, 2008, REPROD TOXICOL, V25, P100, DOI 10.1016/j.reprotox.2007.10.012; Nijenhuis W, 2014, NAT CELL BIOL, V16, P1257, DOI 10.1038/ncb3065; Radford SJ, 2017, CHROMOSOMA, V126, P351, DOI 10.1007/s00412-016-0618-1; Ramathal CY, 2010, SEMIN REPROD MED, V28, P17, DOI 10.1055/s-0029-1242989; Ramesh A, 2002, POLYCYCL AROMAT COMP, V22, P969, DOI 10.1080/10406630290104121; Rekhadevi PV, 2014, HUM EXP TOXICOL, V33, P196, DOI 10.1177/0960327113489050; Rogula-Kozlowska W, 2016, AIR QUAL ATMOS HLTH, V9, P533, DOI 10.1007/s11869-015-0359-y; Rogula-Kozlowska W, 2013, B ENVIRON CONTAM TOX, V91, P349, DOI 10.1007/s00128-013-1060-1; Sachdev M, 2012, DEV BIOL, V363, P40, DOI 10.1016/j.ydbio.2011.12.021; Sadeu JC, 2011, REPROD TOXICOL, V31, P402, DOI 10.1016/j.reprotox.2010.12.006; Sadeu JC, 2011, FERTIL STERIL, V95, P2410, DOI 10.1016/j.fertnstert.2011.03.072; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Schmitt EE, 2017, MOL PHARMACOL, V91, P178, DOI 10.1124/mol.116.106740; Shomper M, 2014, CELL CYCLE, V13, P1171, DOI 10.4161/cc.28046; Sikdar S, 2014, ENVIRON TOXICOL PHAR, V37, P300, DOI 10.1016/j.etap.2013.12.004; Sikdar S, 2015, J PHARMACOPUNCT, V18, P86, DOI 10.3831/KPI.2015.18.019; Smith JN, 2017, TOXICOL LETT, V269, P23, DOI 10.1016/j.toxlet.2017.01.008; Sobinoff AP, 2012, TOXICOL APPL PHARM, V260, P70, DOI 10.1016/j.taap.2012.01.028; STEDMAN RL, 1968, CHEM IND-LONDON, P394; SULLIVAN JL, 1982, GERONTOLOGY, V28, P242, DOI 10.1159/000212539; Tatemoto H, 2000, BIOL REPROD, V63, P805, DOI 10.1095/biolreprod63.3.805; Valentovic MA, 2006, TOXICOL LETT, V164, P214, DOI 10.1016/j.toxlet.2005.12.009; Viau C, 2000, INT ARCH OCC ENV HEA, V73, P331, DOI 10.1007/s004209900112; WASSARMAN PM, 1990, DEVELOPMENT, V108, P1; Wassarman PM, 2001, NAT CELL BIOL, V3, pE59, DOI 10.1038/35055178; WEATHERSBEE PS, 1980, J REPROD MED, V25, P315; Wu ZW, 2014, EXP DERMATOL, V23, P260, DOI 10.1111/exd.12360; Wynne DJ, 2015, J CELL BIOL, V210, P899, DOI 10.1083/jcb.201506020; Xiong B, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006580; Yu NX, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01769; Zenzes MT, 2000, HUM REPROD UPDATE, V6, P122, DOI 10.1093/humupd/6.2.122; Zhang B, 2017, NATURE, V542, P31, DOI 10.1038/542031a; Zhang MQ, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12396	84	42	42	3	89	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					342	352		10.1096/fj.201700514R	http://dx.doi.org/10.1096/fj.201700514R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28904021				2022-12-28	WOS:000419172700031
J	Mihailidou, C; Papavassiliou, AG; Kiaris, H				Mihailidou, Chrysovalantou; Papavassiliou, Athanasios G.; Kiaris, Hippokratis			Cell-autonomous cytotoxicity of type I interferon response via induction of endoplasmic reticulum stress	FASEB JOURNAL			English	Article						unfolded protein response; tauroursodeoxycholate; 4-phenylbutyrate; ciclopirox; cellullar death	UNFOLDED PROTEIN RESPONSE; DIABETES-MELLITUS; ER STRESS; CANCER; MICE; MECHANISMS; DEATH; GAMMA; P21	The interaction of IFN with specific membrane receptors that transduce death-inducing signals is considered to be the principle mechanism of IFN-induced cytotoxicity. In this study, the classic non-cell-autonomous cytotoxicity of IFN was augmented by cell-autonomous mechanisms that operated independently of the interaction of IFN with its receptors. Cells primed to produce IFN by 5-azacytidine (5-aza) underwent endoplasmic reticulum (ER) stress. The chemical chaperones tauroursodeoxycholate (TUDCA) and 4-phenylbutyrate (4-PBA), as well as the iron chelator ciclopirox (CPX), which reduces ER stress, alleviated the cytotoxicity of 5-aza. Ablation of CCAAT-enhancer-binding protein homologous protein (CHOP), the major ER stress-associated proapoptotic transcription factor, protected fibroblasts from 5-aza only when the cytotoxicity was examined cell autonomously. In a medium transfer experiment in which the cell-autonomous effects of 5-aza was dissociated, CHOP ablation was incapable of modulating cytotoxicity; however, neutralization of IFN receptor was highly effective. Also the levels of caspase activation showed a distinct profile between the cell-autonomous and themedium-transfer experiments. We suggest that besides the classic paracrinemechanism, cell-autonomous mechanisms that involve induction of ER stress also participate. These results have implications in the development of anti-IFN-based therapies and expand the class of pathologic states that are viewed as protein-misfolding diseases.	[Mihailidou, Chrysovalantou; Papavassiliou, Athanasios G.; Kiaris, Hippokratis] Univ Athens, Med Sch, Dept Biol Chem, Athens, Greece; [Kiaris, Hippokratis] Univ South Carolina, Dept Drug Discovery & Biomed Sci, CLS 713,715 Sumter St, Columbia, SC 29208 USA	National & Kapodistrian University of Athens; University of South Carolina System; University of South Carolina Columbia	Kiaris, H (corresponding author), Univ South Carolina, Dept Drug Discovery & Biomed Sci, CLS 713,715 Sumter St, Columbia, SC 29208 USA.	kiarish@sccp.sc.edu	Karamouzis, Michalis/AAD-2860-2020		U.S. National Institutes of Health, National Institute on Aging [RAG051976A]; NATIONAL INSTITUTE ON AGING [R03AG051976] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Grant RAG051976A from the U.S. National Institutes of Health, National Institute on Aging. The authors declare no conflicts of interest.	Antonelli A, 2014, WORLD J DIABETES, V5, P586, DOI 10.4239/wjd.v5.i5.586; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Bohnert KR, 2016, FASEB J, V30, P3053, DOI 10.1096/fj.201600250RR; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Cao SS, 2014, ANTIOXID REDOX SIGN, V21, P396, DOI 10.1089/ars.2014.5851; Dioufa N, 2012, EXP BIOL MED, V237, P1173, DOI 10.1258/ebm.2012.012140; Fensterl V, 2009, BIOFACTORS, V35, P14, DOI 10.1002/biof.6; FOULIS AK, 1987, LANCET, V2, P1423; Gade P, 2012, P NATL ACAD SCI USA, V109, P10316, DOI 10.1073/pnas.1119273109; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Leonova KI, 2013, P NATL ACAD SCI USA, V110, pE89, DOI 10.1073/pnas.1216922110; Li Q, 2008, P NATL ACAD SCI USA, V105, P12439, DOI 10.1073/pnas.0806439105; Liu YP, 2012, J IMMUNOL, V189, P4630, DOI 10.4049/jimmunol.1102737; Mihailidou C, 2017, ANTIOXID REDOX SIGN, V27, P185, DOI 10.1089/ars.2016.6671; Mihailidou C, 2016, PFLUG ARCH EUR J PHY, V468, P1957, DOI 10.1007/s00424-016-1887-5; Mihailidou C, 2015, ENDOCR-RELAT CANCER, V22, P217, DOI 10.1530/ERC-15-0018; Mihailidou C, 2015, ENDOCR-RELAT CANCER, V22, P229, DOI 10.1530/ERC-15-0019; Papa FR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007666; Parker BS, 2016, NAT REV CANCER, V16, P131, DOI 10.1038/nrc.2016.14; Pavitt GD, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012278; Razaghi A, 2016, J BIOTECHNOL, V240, P48, DOI 10.1016/j.jbiotec.2016.10.022; Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Smith JA, 2008, EUR J IMMUNOL, V38, P1194, DOI 10.1002/eji.200737882; Tanaka S, 2013, ENDOCR J, V60, P837, DOI 10.1507/endocrj.EJ13-0222; Vendramini-Costa DB, 2012, CURR PHARM DESIGN, V18, P3831; Yie Q, 2002, HEPATOLOGY, V36, P592, DOI 10.1053/jhep.2002.35441; Yoon YM, 2016, SCI REP-UK, V6, DOI 10.1038/srep39838; Zheng PL, 2016, AM J PHYSIOL-RENAL, V311, pF763, DOI 10.1152/ajprenal.00225.2016; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	32	5	5	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5432	5439		10.1096/fj.201700152R	http://dx.doi.org/10.1096/fj.201700152R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28821633	Green Published			2022-12-28	WOS:000416588300026
J	Sun, Y; Liu, CH; Wang, ZX; Meng, SS; Burnim, SB; SanGiovanni, JP; Kamenecka, TM; Solt, LA; Chen, J				Sun, Ye; Liu, Chi-Hsiu; Wang, Zhongxiao; Meng, Steven S.; Burnim, Samuel B.; SanGiovanni, John Paul; Kamenecka, Theodore M.; Solt, Laura A.; Chen, Jing			ROR alpha modulates semaphorin 3E transcription and neurovascular interaction in pathological retinal angiogenesis	FASEB JOURNAL			English	Article						retinopathy; SEMA3E; nuclear receptor; neovascularization	ORPHAN RECEPTOR-ALPHA; OXYGEN-INDUCED RETINOPATHY; MURINE MODEL; MOUSE MODEL; FACTOR-I; EXPRESSION; ACTIVATION; VASCULATURE; SUPPRESSION; INHIBITION	Pathological proliferation of retinal blood vessels commonly causes vision impairment in proliferative retinopathies, including retinopathy of prematurity. Dysregulated crosstalk between the vasculature and retinal neurons is increasingly recognized as a major factor contributing to the pathogenesis of vascular diseases. Class 3 semaphorins (SEMA3s), a group of neuron-secreted axonal and vascular guidance factors, suppress pathological vascular growth in retinopathy. However, the upstream transcriptional regulators that mediate the function of SEMA3s in vascular growth are poorly understood. Here we showed that retinoic acid receptor-related orphan receptor (ROR alpha), a nuclear receptor and transcription factor, is a novel transcriptional regulator of SEMA3E-mediated neurovascular coupling in a mouse model of oxygen-induced proliferative retinopathy. We found that genetic deficiency of ROR alpha substantially induced Sema3e expression in retinopathy. Both ROR alpha and SEMA3E were expressed in retinal ganglion cells. ROR alpha directly bound to a specific ROR alpha response element on the promoter of Sema3e and negatively regulated Sema3e promoter-driven luciferase expression. Suppression of Sema3e using adeno-associated virus 2 carrying short hairpin RNA targeting Sema3e promoted disoriented pathological neovascularization and partially abolished the inhibitory vascular effects of ROR alpha deficiency in retinopathy. Our findings suggest that ROR alpha is a novel transcriptional regulator of SEMA3E-mediated neurovascular coupling in pathological retinal angiogenesis.Sun, Y., Liu, C.-H., Wang, Z., Meng, S. S., Burnim, S. B., SanGiovanni, J. P., Kamenecka, T. M., Solt, L. A., Chen, J. ROR modulates semaphorin 3E transcription and neurovascular interaction in pathological retinal angiogenesis.	[Sun, Ye; Liu, Chi-Hsiu; Wang, Zhongxiao; Meng, Steven S.; Burnim, Samuel B.; Chen, Jing] Harvard Med Sch, Boston Childrens Hosp, Dept Ophthalmol, Boston, MA USA; [SanGiovanni, John Paul] NIAAA, Sect Nutr Neurosci, NIH, Bethesda, MD USA; [SanGiovanni, John Paul] Georgetown Sch Med, Dept Biochem & Mol & Cellular Biol, Washington, DC USA; [Kamenecka, Theodore M.] Scripps Res Inst, Dept Mol Med, Jupiter, FL USA; [Solt, Laura A.] Scripps Res Inst, Dept Immunol & Microbiol, Jupiter, FL USA	Harvard University; Boston Children's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Scripps Research Institute; Scripps Research Institute	Chen, J (corresponding author), Boston Childrens Hosp, Dept Ophthalmol, 300 Longwood Ave, Boston, MA 02115 USA.	jing.chen@childrens.harvard.edu	SanGiovanni, John Paul/AAU-3895-2020	Sun, Ye/0000-0002-7674-9056	U.S. National Institutes of Health (NIH) National Eye Institute [R01 EY024963]; BrightFocus Foundation; Boston Children's Hospital Career Development Award; Boston Children's Hospital Ophthalmology Foundation; Massachusetts Lions Eye Research Fund; NIH National Institute of Allergy and Infectious Diseases [1R01 AI116885-01A1]; Margaret Q. Landenberger Research Foundation; NATIONAL EYE INSTITUTE [R01EY024963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI116885] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); BrightFocus Foundation(BrightFocus Foundation); Boston Children's Hospital Career Development Award; Boston Children's Hospital Ophthalmology Foundation; Massachusetts Lions Eye Research Fund; NIH National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Margaret Q. Landenberger Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Drs. Lois Smith, Zhongjie Fu, and Yan Gong (all from Boston Children's Hospital) for helpful discussions and Peyton Morss, Thomas Fredrick, and Nicholas Saba (all from Boston Children's Hospital) for excellent technical assistance. This work was supported by U.S. National Institutes of Health (NIH) National Eye Institute Grant R01 EY024963; the BrightFocus Foundation; a Boston Children's Hospital Career Development Award; the Boston Children's Hospital Ophthalmology Foundation and Massachusetts Lions Eye Research Fund (to J.C.), NIH National Institute of Allergy and Infectious Diseases Grant 1R01 AI116885-01A1 (to L.A.S.); and funds from the Margaret Q. Landenberger Research Foundation (to L.A.S.). The authors declare no conflicts of interest.	Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Besnard S, 2002, FEBS LETT, V511, P36, DOI 10.1016/S0014-5793(01)03275-6; Buehler A, 2013, FEBS LETT, V587, P1650, DOI 10.1016/j.febslet.2013.04.008; Chen Jing, 2007, Angiogenesis, V10, P133, DOI 10.1007/s10456-007-9066-0; Chen J, 2013, ANGIOGENESIS, V16, P985, DOI 10.1007/s10456-013-9374-5; Chen J, 2009, INVEST OPHTH VIS SCI, V50, P1329, DOI 10.1167/iovs.08-2521; Chenoweth JM, 2016, FLA MUS NAT HIST-RIP, P1; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Fujieda H, 2009, J NEUROCHEM, V108, P91, DOI 10.1111/j.1471-4159.2008.05739.x; Fukushima Y, 2011, J CLIN INVEST, V121, P1974, DOI 10.1172/JCI44900; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; Grieger JC, 2006, NAT PROTOC, V1, P1412, DOI 10.1038/nprot.2006.207; Guo SZ, 2008, P NATL ACAD SCI USA, V105, P7582, DOI 10.1073/pnas.0801105105; Hamilton BA, 1996, NATURE, V379, P736, DOI 10.1038/379736a0; HIROSE T, 1994, BIOCHEM BIOPH RES CO, V205, P1976, DOI 10.1006/bbrc.1994.2902; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Ino H, 2004, J HISTOCHEM CYTOCHEM, V52, P311, DOI 10.1177/002215540405200302; Jetten AM, 2001, PROG NUCLEIC ACID RE, V69, P205, DOI 10.1016/S0079-6603(01)69048-2; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Joyal JS, 2011, BLOOD, V117, P6024, DOI 10.1182/blood-2010-10-311589; Kallen J, 2004, J BIOL CHEM, V279, P14033, DOI 10.1074/jbc.M400302200; Kamata Y, 2015, J DERMATOL SCI, V79, P84, DOI 10.1016/j.jdermsci.2015.03.015; Kern TS, 2014, DIABETES METAB J, V38, P163, DOI 10.4093/dmj.2014.38.3.163; Kim EJ, 2008, ARTERIOSCL THROM VAS, V28, P1796, DOI 10.1161/ATVBAHA.108.171546; Kim J, 2011, GENE DEV, V25, P1399, DOI 10.1101/gad.2042011; Kojetin DJ, 2014, NAT REV DRUG DISCOV, V13, P197, DOI 10.1038/nrd4100; Kwon SH, 2015, OPHTHALMOLOGY, V122, P968, DOI 10.1016/j.ophtha.2015.01.007; Lechtken A, 2006, PROTEIN EXPRES PURIF, V49, P114, DOI 10.1016/j.pep.2006.03.012; Li J, 2014, INVEST OPHTH VIS SCI, V55, P8267, DOI 10.1167/iovs.14-15623; Liu CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep33947; Michan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085031; Migita H, 2004, FEBS LETT, V557, P269, DOI 10.1016/S0014-5793(03)01502-3; Miki N, 2004, J BIOL CHEM, V279, P15025, DOI 10.1074/jbc.M313186200; Moriya J, 2010, CIRC RES, V106, P391, DOI 10.1161/CIRCRESAHA.109.210815; Nakahara T, 2013, J PHARMACOL SCI, V123, P79, DOI 10.1254/jphs.13R03CP; Nasarre P, 2014, ONCOTARGETS THER, V7, P1663, DOI 10.2147/OTT.S37744; Nishijima T, 2010, NEURON, V67, P834, DOI 10.1016/j.neuron.2010.08.007; Ochsenbein AM, 2016, DEVELOPMENT, V143, P589, DOI 10.1242/dev.127670; Park YK, 2008, NUCLEIC ACIDS RES, V36, pW97, DOI 10.1093/nar/gkn280; Qian HH, 2011, EXP DIABETES RES, DOI 10.1155/2011/693426; Rao RC, 2013, NEW ENGL J MED, V368, P1161, DOI 10.1056/NEJMc1301021; Sapieha P, 2008, NAT MED, V14, P1067, DOI 10.1038/nm.1873; Serini G, 2013, J INTERN MED, V273, P138, DOI 10.1111/joim.12017; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Solt LA, 2015, ENDOCRINOLOGY, V156, P869, DOI 10.1210/en.2014-1677; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Stahl A, 2009, ANGIOGENESIS, V12, P297, DOI 10.1007/s10456-009-9155-3; Stahl A, 2010, AM J PATHOL, V177, P2715, DOI 10.2353/ajpath.2010.100526; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Steinmayr M, 1998, P NATL ACAD SCI USA, V95, P3960, DOI 10.1073/pnas.95.7.3960; Sun Y, 2015, P NATL ACAD SCI USA, V112, P10401, DOI 10.1073/pnas.1504387112; Sun Y, 2015, ARCHAEA, V2015, DOI 10.1155/2015/397924; Talia DM, 2016, ARTERIOSCL THROM VAS, V36, P1186, DOI 10.1161/ATVBAHA.115.307080; Tosini G, 2007, FASEB J, V21, P3866, DOI 10.1096/fj.07-8371com; Ueda K, 2013, EUR J PHARMACOL, V699, P188, DOI 10.1016/j.ejphar.2012.11.054; Ueda K, 2010, NEUROSCI LETT, V485, P55, DOI 10.1016/j.neulet.2010.08.061; Vandenberghe LH, 2010, HUM GENE THER, V21, P1251, DOI 10.1089/hum.2010.107; Wang ZX, 2016, AM J PATHOL, V186, P2588, DOI 10.1016/j.ajpath.2016.06.015; Worzfeld T, 2014, NAT REV DRUG DISCOV, V13, P603, DOI 10.1038/nrd4337; Xiong GF, 2012, CANCER RES, V72, P1728, DOI 10.1158/0008-5472.CAN-11-2762; Yang WJ, 2015, EMBO MOL MED, V7, P1267, DOI 10.15252/emmm.201404922; Zheng L, 2007, INVEST OPHTH VIS SCI, V48, P361, DOI 10.1167/iovs.06-0510	62	14	14	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4492	4502		10.1096/fj.201700172R	http://dx.doi.org/10.1096/fj.201700172R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28646017	Green Published			2022-12-28	WOS:000413397400026
J	Liu, Y; Xu, J; Xu, LL; Wu, TY; Sun, YX; Lee, YW; Wang, B; Chan, HC; Jiang, XH; Zhang, JF; Li, G				Liu, Yang; Xu, Jia; Xu, Liangliang; Wu, Tianyi; Sun, Yuxin; Lee, Yuk-Wai; Wang, Bin; Chan, Hsiao-Chang; Jiang, Xiaohua; Zhang, Jinfang; Li, Gang			Cystic fibrosis transmembrane conductance regulator mediates tenogenic differentiation of tendon-derived stem cells and tendon repair: accelerating tendon injury healing by intervening in its downstream signaling	FASEB JOURNAL			English	Article						CFTR; beta-catenin; ERK1/2	INHIBITOR U0126; GROWTH-FACTORS; CFTR; INFLAMMATION; TENDINOPATHY; BIOLOGY; INVOLVEMENT; ACTIVATION; DECORIN; TISSUE	Tendons are a mechanosensitive tissue, which enables them to transmit to bone forces that are derived from muscle. Patients with tendon injuries, such as tendinopathy or tendon rupture, were often observed with matrix degeneration, and the healing of tendon injuries remains a challenge as a result of the limited understanding of tendon biology. Our study demonstrates that the stretch-mediated activation channel, cystic fibrosis transmembrane conductance regulator (CFTR), was up-regulated intendon-derived stem cells (TDSCs) during tenogenic differentiation under mechanical stretching. Tendon tissues in CFTR-dysfunctional DF508 mice exhibited irregular cell arrangement, uneven fibril diameter distribution, weak mechanical properties, and less matrix formation in a tendon defect model. Moreover, both tendon tissues and TDSCs isolated from DF508 mice showed significantly decreased levels of tendon markers, such as scleraxis, tenomodulin, Col1A1 (collagen type I a 1 chain), and decorin. Furthermore, by RNA sequencing analysis, we demonstrated that Wnt/beta-catenin signaling was abnormally activated in TDSCs from DF508 mice, thereby further activating the pERK1/2 signaling pathway. Of most importance, we found that intervention in pERK1/2 signaling could promote tenogenic differentiation and tendon regeneration both in vitro and in vivo. Taken together, our study demonstrates that CFTR plays an important role in tenogenic differentiation and tendon regeneration by inhibiting the beta-catinin/pERK1/2 signaling pathway. The therapeutic strategy of intervening in the CFTR/beta-catenin/pERK1/2 regulatory axis may be helpful for accelerating tendon injury healing, which has implications for tendon injury management.	[Liu, Yang; Xu, Liangliang; Wu, Tianyi; Sun, Yuxin; Lee, Yuk-Wai; Wang, Bin; Zhang, Jinfang; Li, Gang] Chinese Univ Hong Kong, Prince Wales Hosp, Fac Med, Dept Orthopaed & Traumatol, Shatin, Hong Kong, Peoples R China; [Zhang, Jinfang; Li, Gang] Chinese Univ Hong Kong, Lui Che Woo Inst Innovat Med, Stem Cells & Regenerat Med Lab, Li Ka Shing Inst Hlth Sci,Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [Xu, Jia; Wu, Tianyi] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Orthopaed Surg, Shanghai, Peoples R China; [Xu, Liangliang] Guangzhou Univ Chinese Med, Key Lab Orthopaed & Traumatol, Affiliated Hosp 1, Clin Med Coll 1, Guangzhou, Guangdong, Peoples R China; [Chan, Hsiao-Chang; Jiang, Xiaohua] Chinese Univ Hong Kong, Sch Biomed Sci, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Li, Gang] Chinese Univ Hong Kong, Minist Educ, Key Lab Regenerat Med, Sch Biomed Sci,Fac Med, Hong Kong, Hong Kong, Peoples R China; [Li, Gang] Chinese Univ Hong Kong, Shenzhen Res Inst, Chinese Univ Hong Kong China Astronaut Res & Trai, Shenzhen, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Shanghai Jiao Tong University; Guangzhou University of Chinese Medicine; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen	Zhang, JF; Li, G (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Orthopaed & Traumatol, Shatin, Hong Kong, Peoples R China.; Li, G (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China.	zhangjf06@gmail.com; gangli@cuhk.edu.hk	Li, Gang/J-7830-2018; jiang, cynthia xiaohua/F-7580-2017; Chan, Hsiao Chang/E-1507-2016; WANG, BIN/O-2346-2019; Liangliang, XU/K-9185-2019; Lee, Wayne YW/H-8298-2013	Li, Gang/0000-0002-3981-2239; jiang, cynthia xiaohua/0000-0002-7372-4961; WANG, BIN/0000-0002-1348-1494; Liangliang, XU/0000-0002-5249-7480; Lee, Wayne YW/0000-0002-0486-360X	National Natural Science Foundation of China [81371946, 81374568]; Hong Kong Government Research Grant Council, General Research Fund [470813, 14119115, 9054014]; China Shenzhen City Science and Technology Bureau [GJHZ20140419120051680, JCYJ20150630165236960]; Sports Medicine And Regenerative Technology (SMART; Chinese University of Hong Kong) program; Lui Che Woo Institute of Innovation Medicine, The Chinese University of Hong Kong	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hong Kong Government Research Grant Council, General Research Fund; China Shenzhen City Science and Technology Bureau; Sports Medicine And Regenerative Technology (SMART; Chinese University of Hong Kong) program; Lui Che Woo Institute of Innovation Medicine, The Chinese University of Hong Kong	This work was supported, in part, by grants from National Natural Science Foundation of China (81371946 and 81374568); the Hong Kong Government Research Grant Council, General Research Fund (470813, 14119115 and 9054014); and the China Shenzhen City Science and Technology Bureau (GJHZ20140419120051680 and JCYJ20150630165236960) to G. L.; as well as by a grant from Sports Medicine And Regenerative Technology (SMART; Chinese University of Hong Kong) program and Lui Che Woo Institute of Innovation Medicine, The Chinese University of Hong Kong. The authors thank Dr. Xiaohu Zhang for the breeding of DF508 and WT mice and Josie Lai and Jean Kung for help with the transmembrane electron microscope at The Chinese University of Hong Kong. The authors also thank Yuk-Wa Lee for the technique support of tendon mechanical testing at The Chinese University of Hong Kong. The authors thank Prof. Dong Sun and Dr. Ran Wang for help with the examination with confocal laser scanning microscopy at The City University of Hong Kong. The authors declare no conflicts of interest.	Andres BM, 2008, CLIN ORTHOP RELAT R, V466, P1539, DOI 10.1007/s11999-008-0260-1; Berger AL, 2005, J BIOL CHEM, V280, P5221, DOI 10.1074/jbc.M412972200; Bestwick CS, 2004, BRIT J SPORT MED, V38, P672, DOI 10.1136/bjsm.2004.012351; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Bikkavilli Rama Kamesh, 2009, Commun Integr Biol, V2, P46; Bonvin E, 2008, J PHYSIOL-LONDON, V586, P3231, DOI 10.1113/jphysiol.2008.150763; Buhrmann C, 2011, J BIOL CHEM, V286, P28556, DOI 10.1074/jbc.M111.256180; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Chiodo CP, 2006, FOOT ANKLE INT, V27, P305, DOI 10.1177/107110070602700415; Cohen JC, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-70; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; Dakin SG, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4269; de Jong JP, 2014, CLIN ORTHOP SURG, V6, P196, DOI 10.4055/cios.2014.6.2.196; Divangahi M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000586; Dong ZW, 2015, SCI REP-UK, V5, DOI 10.1038/srep15946; Duan W, 2004, J IMMUNOL, V172, P7053, DOI 10.4049/jimmunol.172.11.7053; Dunkman AA, 2014, ANN BIOMED ENG, V42, P619, DOI 10.1007/s10439-013-0915-2; Guardavaccaro D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002921; Havis E, 2014, DEVELOPMENT, V141, P3683, DOI 10.1242/dev.108654; Heijerman Harry, 2005, J Cyst Fibros, V4 Suppl 2, P3, DOI 10.1016/j.jcf.2005.05.005; Ito Y, 2010, P NATL ACAD SCI USA, V107, P10538, DOI 10.1073/pnas.1000525107; James R, 2008, J HAND SURG-AM, V33A, P102, DOI 10.1016/j.jhsa.2007.09.007; Jiang DP, 2016, CONNECT TISSUE RES, V57, P20, DOI 10.3109/03008207.2015.1087517; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu HH, 2015, STEM CELLS, V33, P443, DOI 10.1002/stem.1866; Longo UG, 2008, DISABIL REHABIL, V30, P1563, DOI 10.1080/09638280701785643; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Lui PPY, 2013, RHEUMATOLOGY, V52, P1609, DOI 10.1093/rheumatology/ket214; Mohammad G, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/658548; Moyer BD, 1999, J CLIN INVEST, V104, P1353, DOI 10.1172/JCI7453; Ni M, 2013, BIOMATERIALS, V34, P2024, DOI 10.1016/j.biomaterials.2012.11.046; Ni M, 2012, J ORTHOP RES, V30, P613, DOI 10.1002/jor.21559; Nourissat G, 2015, NAT REV RHEUMATOL, V11, P223, DOI 10.1038/nrrheum.2015.26; Pouzaud F, 2004, J PHARMACOL EXP THER, V308, P394, DOI 10.1124/jpet.103.057984; Prasadam I, 2013, J MOL MED, V91, P369, DOI 10.1007/s00109-012-0953-5; Ruan YC, 2014, J CELL SCI, V127, P4396, DOI 10.1242/jcs.148098; Rui YF, 2010, TISSUE ENG PT A, V16, P1549, DOI 10.1089/ten.TEA.2009.0529; Sharma P., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P181; Shead EF, 2007, THORAX, V62, P650, DOI 10.1136/thx.2006.075887; Skutek M, 2001, EUR J APPL PHYSIOL, V86, P48, DOI 10.1007/s004210100502; Stalvey MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080098; Wang JHC, 2005, ANN BIOMED ENG, V33, P337, DOI 10.1007/s10439-005-1736-8; Yuan J, 2003, BBA-MOL CELL RES, V1641, P35, DOI 10.1016/S0167-4889(03)00047-8; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776; Zhang WK, 2010, NAT CELL BIOL, V12, P507, DOI 10.1038/ncb2053	45	26	27	0	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3800	3815		10.1096/fj.201601181R	http://dx.doi.org/10.1096/fj.201601181R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28495756				2022-12-28	WOS:000408713300009
J	Cannizzo, CM; Adonopulos, AA; Solly, EL; Ridiandries, A; Vanags, LZ; Mulangala, J; Yuen, SCG; Tsatralis, T; Henriquez, R; Robertson, S; Nicholls, SJ; Di Bartolo, BA; Ng, MKC; Lam, YT; Bursill, CA; Tan, JTM				Cannizzo, Carla M.; Adonopulos, Aaron A.; Solly, Emma L.; Ridiandries, Anisyah; Vanags, Laura Z.; Mulangala, Jocelyne; Yuen, Sui Ching G.; Tsatralis, Tania; Henriquez, Rodney; Robertson, Stacy; Nicholls, Stephen J.; Di Bartolo, Belinda A.; Ng, Martin K. C.; Lam, Yuen Ting; Bursill, Christina A.; Tan, Joanne T. M.			VEGFR2 is activated by high-density lipoproteins and plays a key role in the proangiogenic action of HDL in ischemia	FASEB JOURNAL			English	Article						angiogenesis; hypoxia; apoA-I	ENDOTHELIAL GROWTH-FACTOR; CORONARY HEART-DISEASE; B TYPE-I; PROGENITOR CELLS; INDUCED ANGIOGENESIS; SIGNAL PATHWAY; PROTEIN-KINASE; HYPOXIA; CHOLESTEROL; RECRUITMENT	High-density lipoproteins augment hypoxia-induced angiogenesis by inducing the key angiogenic vascular endothelial growth factor A (VEGFA) and total protein levels of its receptor 2 (VEGFR2). The activation/phosphorylation of VEGFR2 is critical for mediating downstream, angiogenic signaling events. This study aimed to determine whether reconstituted high-density lipoprotein (rHDL) activates VEGFR2 phosphorylation and the downstream signaling events and the importance of VEGFR2 in the proangiogenic effects of rHDL in hypoxia. In vitro, rHDL increased VEGFR2 activation and enhanced phosphorylation of downstream, angiogenic signaling proteins ERK1/2 and p38 MAPK in hypoxia. Incubation with a VEGFR2-neutralizing antibody attenuated rHDL-induced phosphorylation of VEGFR2, ERK1/2, p38 MAPK, and tubule formation. In a murine model of ischemia-driven neovascularization, rHDL infusions enhanced blood perfusion and augmented capillary and arteriolar density. Infusion of a VEGFR2-neutralizing antibody ablated those proangiogenic effects of rHDL. Circulating Sca1(+)/CXCR4(+) angiogenic progenitor cell levels, important for neovascularization in response to ischemia, were higher in rHDL-infused mice 3 d after ischemic induction, but that did not occur in mice that also received the VEGFR2-neutralizing antibody. In summary, VEGFR2 has a key role in the proangiogenic effects of rHDL in hypoxia/ischemia. These findings have therapeutic implications for angiogenic diseases associated with an impaired response to tissue ischemia.	[Cannizzo, Carla M.; Adonopulos, Aaron A.; Ridiandries, Anisyah; Vanags, Laura Z.; Yuen, Sui Ching G.; Tsatralis, Tania; Henriquez, Rodney; Robertson, Stacy; Ng, Martin K. C.; Lam, Yuen Ting; Bursill, Christina A.; Tan, Joanne T. M.] Heart Res Inst, Newtown, NSW, Australia; [Cannizzo, Carla M.; Adonopulos, Aaron A.; Ridiandries, Anisyah; Vanags, Laura Z.; Yuen, Sui Ching G.; Robertson, Stacy; Ng, Martin K. C.; Lam, Yuen Ting; Bursill, Christina A.; Tan, Joanne T. M.] Univ Sydney, Sydney Med Sch, Camperdown, NSW, Australia; [Solly, Emma L.; Mulangala, Jocelyne; Nicholls, Stephen J.; Di Bartolo, Belinda A.; Bursill, Christina A.; Tan, Joanne T. M.] South Australian Hlth & Med Res Inst, Heart Hlth Theme, North Terrace, Adelaide, SA 5000, Australia; [Mulangala, Jocelyne; Nicholls, Stephen J.; Di Bartolo, Belinda A.; Bursill, Christina A.; Tan, Joanne T. M.] Univ Adelaide, Fac Hlth & Med Sci, Adelaide Med Sch, Adelaide, SA, Australia; [Ng, Martin K. C.] Royal Prince Alfred Hosp, Dept Cardiol, Camperdown, NSW, Australia	University of Sydney; Heart Research Institute; University of Sydney; South Australian Health & Medical Research Institute (SAHMRI); University of Adelaide; University of Sydney	Bursill, CA; Tan, JTM (corresponding author), South Australian Hlth & Med Res Inst, Heart Hlth Theme, North Terrace, Adelaide, SA 5000, Australia.	christina.bursill@sahmri.com; joanne.tan@sahmri.com	Di Bartolo, Belinda/AAF-5153-2021; Ridiandries, Anisyah/I-4360-2017; Tan, Joanne Tsui Ming/Y-4423-2019; Tan, Ming-Jen/A-3862-2011	Ridiandries, Anisyah/0000-0001-8996-6896; Tan, Joanne Tsui Ming/0000-0003-1875-4882; Henriquez, Rodney/0000-0002-2959-2260; Tan, Ming-Jen/0000-0002-3583-1723; Bursill, Christina/0000-0002-0682-8760; Nicholls, Stephen/0000-0002-9668-4368; Di Bartolo, Belinda/0000-0001-8420-0461	National Health and Medical Research Council of Australia [632512, APP1038394]; National Heart Foundation Career Development Fellowship [CR07S3331, PB12S6959]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation Career Development Fellowship(National Heart Foundation of Australia)	The authors thank Pat Pisansarakit from the Heart Research Institute (Newtown, NSW, Australia) for the maintenance of HCAECs. This work was supported by the National Health and Medical Research Council of Australia (Project Grant 632512 to M.K.C.N. and C.A.B.), and P.h.D. Scholarship (Grant APP1038394 to S.C.G.Y.); the National Heart Foundation Career Development Fellowship (Grant CR07S3331 to C.A.B.), and Ph.D. Scholarship (Grant PB12S6959 to L.Z.V.). The authors declare no conflicts of interest.	Al-Jarallah A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106487; Bocci G, 2004, CANCER RES, V64, P6616, DOI 10.1158/0008-5472.CAN-04-0401; CASTELLI WP, 1977, CIRCULATION, V55, P767, DOI 10.1161/01.CIR.55.5.767; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; DAVIES MJ, 1993, BRIT HEART J, V69, P377; De Falco E, 2004, BLOOD, V104, P3472, DOI 10.1182/blood-2003-12-4423; Drew BG, 2004, P NATL ACAD SCI USA, V101, P6999, DOI 10.1073/pnas.0306266101; Endo A, 2003, J RECEPT SIG TRANSD, V23, P239, DOI 10.1081/RRS-120025567; Fang LH, 2013, NATURE, V498, P118, DOI 10.1038/nature12166; Felton-Edkins ZA, 2003, EMBO J, V22, P2422, DOI 10.1093/emboj/cdg240; Feng Y, 2008, ARTERIOSCL THROM VAS, V28, P278, DOI 10.1161/ATVBAHA.107.158741; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Hattori K, 2001, J EXP MED, V193, P1005, DOI 10.1084/jem.193.9.1005; Ivy SP, 2009, NAT REV CLIN ONCOL, V6, P569, DOI 10.1038/nrclinonc.2009.130; Kimura T, 2010, J BIOL CHEM, V285, P4387, DOI 10.1074/jbc.M109.043869; Lam YT, 2016, ENDOCRINOLOGY, V157, P4853, DOI 10.1210/en.2016-1301; Lee RT, 1997, ARTERIOSCL THROM VAS, V17, P1859, DOI 10.1161/01.ATV.17.10.1859; Li B, 2006, FASEB J, V20, P1495, DOI 10.1096/fj.05-5137fje; Li WL, 2011, EXP BRAIN RES, V214, P503, DOI 10.1007/s00221-011-2849-y; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Minet E, 2000, FEBS LETT, V468, P53, DOI 10.1016/S0014-5793(00)01181-9; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Olszewska-Pazdrak B, 2009, AM J PHYSIOL-CELL PH, V296, pC1162, DOI 10.1152/ajpcell.00533.2008; Pages G, 2000, J BIOL CHEM, V275, P26484, DOI 10.1074/jbc.M002104200; Petoumenos V, 2009, J CELL MOL MED, V13, P4623, DOI 10.1111/j.1582-4934.2008.00472.x; Prosser HCG, 2014, CARDIOVASC RES, V101, P145, DOI 10.1093/cvr/cvt234; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Seetharam D, 2006, CIRC RES, V98, P63, DOI 10.1161/01.RES.0000199272.59432.5b; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Simha V, 2016, DIABETES, V65, P2826, DOI 10.2337/dbi16-0039; Sontheimer DL, 2006, AM FAM PHYSICIAN, V73, P1971; Srinivasan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008283; Sumi M, 2007, ARTERIOSCL THROM VAS, V27, P813, DOI 10.1161/01.ATV.0000259299.38843.64; TAKESHITA S, 1994, J CLIN INVEST, V93, P662, DOI 10.1172/JCI117018; Tan JTM, 2016, DIABETES, V65, P3091, DOI 10.2337/db15-1668; Tan JTM, 2014, FASEB J, V28, P206, DOI 10.1096/fj.13-233874; Tso C, 2006, ARTERIOSCL THROM VAS, V26, P1144, DOI 10.1161/01.ATV.0000216600.37436.cf; van Oostrom O, 2007, ARTERIOSCL THROM VAS, V27, P1864, DOI 10.1161/ATVBAHA.107.143875; WEISWEILER P, 1987, CLIN CHIM ACTA, V169, P249, DOI 10.1016/0009-8981(87)90325-1; Wong C, 2005, J BIOL CHEM, V280, P33262, DOI 10.1074/jbc.M503198200; Yuhanna IS, 2001, NAT MED, V7, P853, DOI 10.1038/89986; Zhang QH, 2010, EXP BIOL MED, V235, P1082, DOI 10.1258/ebm.2010.010060; Zhang XJ, 2011, J MOL MED, V89, P985, DOI 10.1007/s00109-011-0754-2	48	8	8	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					2911	2922		10.1096/fj.201700617R	http://dx.doi.org/10.1096/fj.201700617R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401597				2022-12-28	WOS:000432546000003
J	Garcia, LD; Sebastian-Serrano, A; Hernandez, IH; Pintor, J; Lucas, JJ; Diaz-Hernandez, M				de Diego Garcia, Laura; Sebastian-Serrano, Alvaro; Hernandez, Ivo H.; Pintor, Jesus; Lucas, Jose J.; Diaz-Hernandez, Miguel			The regulation of proteostasis in glial cells by nucleotide receptors is key in acute neuroinflammation	FASEB JOURNAL			English	Article						P2Y(2)R; Up(4)U; LPS; astrocytes; ubiquitin-proteasome system	P2Y(2) RECEPTOR; UP-REGULATION; EXTRACELLULAR NUCLEOTIDES; PROTEASOME ACTIVITY; UBIQUITIN SYSTEM; P2 RECEPTORS; MOUSE MODEL; ACTIVATION; EXPRESSION; PATHOPHYSIOLOGY	The disturbances of cellular proteostasis caused by the alteration in the ubiquitin-proteasome system (UPS) have been proposed as a common mechanism underlying several neural pathologies that involve a neuroinflammatory process. As we have previously reported that the nucleotide receptor P2Y purinoceptor 2 (P2Y(2)R) regulates the proteasomal catalytic activities, we wonder whether this receptor is involved in the UPS disturbances associated with the neuroinflammation process. With the use of mice expressing a UPS reporter [mice expressing the UPS reporter ubiquitin (G76v)-green fluorescent protein (UbGFP mice)], we found that LPS-induced acute neuroinflammation status causes a UPS impairment in astrocytes and microglial cells by a mechanism dependent on P2Y(2)R. In this line, LPS-treated double transgenic UbGFP; P2Y(2)R(-/-) mice did not present a UPS impairment in astrocytes or a social interaction deficit as severe as that observed in LPS-treated UbGFP mice. In vivo administration of selective P2Y(2)R agonist diuridine tetraphosphate reversed the UPS impairment completely in astrocytes and partially in microglial cells, promoting increased expression of the proteasomal beta 5 subunit by a mechanism dependent on the Src/PI3K/ERK pathway. Altogether, our results suggest that LPS induces unbalanced proteostasis in astrocytes by blocking P2Y(2)R. Finally, our findings point to the design of selective P2Y(2)R agonist drugs as a new therapeutic approach to treat the neuroinflammatory status.				migueldiaz@ucm.es	DE DIEGO GARCIA, LAURA/AAD-2806-2022; Lucas, Jose J./U-6543-2019; Sebastian-Serrano, Alvaro/Q-5982-2018; Hernández, Ivó H./AAB-2065-2020	DE DIEGO GARCIA, LAURA/0000-0002-1404-5803; Sebastian Serrano, Alvaro/0000-0002-9810-2165; Hernandez, Ivo H./0000-0001-9656-6508	Spanish Ministry of Science and Education [BFU2012-31195]; European Union [H2020-MSCA-ITN-2017, 766124]; Universidad Complutense of Madrid (UCM)-Santander Central Hispano Bank [911585-670]; UCM; Fundacion Banco Bilbao Vizcaya Argentaria (BBVA) grants from CiberNed-ISCIII [PI2015-2/06-3]; Mineco [SAF2015-65371-R]	Spanish Ministry of Science and Education(Spanish Government); European Union(European Commission); Universidad Complutense of Madrid (UCM)-Santander Central Hispano Bank; UCM; Fundacion Banco Bilbao Vizcaya Argentaria (BBVA) grants from CiberNed-ISCIII(BBVA Foundation); Mineco(Spanish Government)	This work was supported by funding from the Spanish Ministry of Science and Education (BFU2012-31195; European Union Project H2020-MSCA-ITN-2017, No. 766124 to M.D.-H.) and Universidad Complutense of Madrid (UCM)-Santander Central Hispano Bank (911585-670 to M.D.-H.). A.S.-S. was funded by Grant BFU2012-31195; L.D.D.-G. has a UCM pre-doctoral fellowship supervised by M.D.-H, and J.J.L. received Fundacion Banco Bilbao Vizcaya Argentaria (BBVA) grants from CiberNed-ISCIII PI2015-2/06-3 (Collaborative), and from Mineco SAF2015-65371-R. The authors declare no conflicts of interest.	Asehnoune K, 2005, CELL SIGNAL, V17, P385, DOI 10.1016/j.cellsig.2004.08.005; Bi W, 2014, NEUROIMMUNOMODULAT, V21, P331, DOI 10.1159/000357811; Boucsein C, 2003, EUR J NEUROSCI, V17, P2267, DOI 10.1046/j.1460-9568.2003.02663.x; Brehm A, 2015, SEMIN IMMUNOPATHOL, V37, P323, DOI 10.1007/s00281-015-0486-4; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; de Diego-Garcia L, 2017, BBA-MOL BASIS DIS, V1863, P43, DOI 10.1016/j.bbadis.2016.10.012; Degagne E, 2009, J IMMUNOL, V183, P4521, DOI 10.4049/jimmunol.0803977; Diaz-Hernandez M, 2006, J NEUROCHEM, V98, P1585, DOI 10.1111/j.1471-4159.2006.03968.x; Eun SY, 2014, INT IMMUNOPHARMACOL, V18, P270, DOI 10.1016/j.intimp.2013.11.026; Floreani NA, 2010, J NEUROIMMUNE PHARM, V5, P533, DOI 10.1007/s11481-010-9213-z; Garcia-Verdugo I, 2008, AM J PHYSIOL-LUNG C, V295, pL708, DOI 10.1152/ajplung.00536.2007; Glickman MH, 2005, FEBS LETT, V579, P3214, DOI 10.1016/j.febslet.2005.04.048; Godbout JP, 2005, FASEB J, V19, P1329, DOI 10.1096/fj.05-3776fje; Gonzalez FA, 2005, MOL NEUROBIOL, V31, P65, DOI 10.1385/MN:31:1-3:065; Guerra AN, 2003, J ENDOTOXIN RES, V9, P256, DOI 10.1179/096805103225001468; Henry CJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-15; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Homolya L, 1999, J BIOL CHEM, V274, P26454, DOI 10.1074/jbc.274.37.26454; Jamart C, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-166; Kaushik S, 2015, NAT MED, V21, P1406, DOI 10.1038/nm.4001; Kong Q, 2009, J NEUROCHEM, V109, P1300, DOI 10.1111/j.1471-4159.2009.06048.x; Kukulski F, 2010, MOL IMMUNOL, V47, P991, DOI 10.1016/j.molimm.2009.11.020; Lindsten K, 2003, NAT BIOTECHNOL, V21, P897, DOI 10.1038/nbt851; Liu J, 2004, J BIOL CHEM, V279, P8212, DOI 10.1074/jbc.M312230200; Martinon F, 2015, NAT REV RHEUMATOL, V11, P11, DOI 10.1038/nrrheum.2014.158; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Nichols KK, 2004, EXPERT OPIN INV DRUG, V13, P47, DOI 10.1517/13543784.13.1.47; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Pintado C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-87; Pla A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.46; Rodriguez-Zayas AE, 2010, INT J DEV NEUROSCI, V28, P413, DOI 10.1016/j.ijdevneu.2010.07.001; Schrader AM, 2005, ARCH ORAL BIOL, V50, P533, DOI 10.1016/j.archoralbio.2004.11.005; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Shen JZ, 2004, MOL PHARMACOL, V66, P1265, DOI 10.1124/mol.104.002642; Shi JS, 2015, J MOL HISTOL, V46, P457, DOI 10.1007/s10735-015-9637-0; Shin JN, 2013, J BIOL CHEM, V288, P35886, DOI 10.1074/jbc.M113.514919; Sunkaria A, 2016, MOL NEUROBIOL, V53, P944, DOI 10.1007/s12035-014-9064-3; Weisman GA, 2012, MOL NEUROBIOL, V46, P96, DOI 10.1007/s12035-012-8263-z; Xiao ZL, 2012, CELL BIOL INT, V36, P625, DOI 10.1042/CBI20110111; Zhang FF, 2015, BIOCHEM BIOPH RES CO, V464, P1202, DOI 10.1016/j.bbrc.2015.07.105	40	6	6	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3020	3032		10.1096/fj.201701064RR	http://dx.doi.org/10.1096/fj.201701064RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401585				2022-12-28	WOS:000432546000011
J	Pahlavan, S; Tousi, MS; Ayyari, M; Alirezalu, A; Ansari, H; Saric, T; Baharvand, H				Pahlavan, Sara; Tousi, Marziyeh Shalchi; Ayyari, Mahdi; Alirezalu, Abolfazl; Ansari, Hassan; Saric, Tomo; Baharvand, Hossein			Effects of hawthorn (Crataegus pentagyna) leaf extract on electrophysiologic properties of cardiomyocytes derived from human cardiac arrhythmia-specific induced pluripotent stem cells	FASEB JOURNAL			English	Article						nutraceuticals; in vitro drug testing; CPVT1; LQTS2	POLYMORPHIC VENTRICULAR-TACHYCARDIA; HEART-FAILURE; RAT MODEL; OXYACANTHA; PATIENT; DIFFERENTIATION; COMPLEMENTARY; PHARMACOLOGY; PROGRESSION; GENERATION	Cardiac arrhythmias are major life-threatening conditions. The landmark discovery of induced pluripotent stem cells has provided a promising in vitro system for modeling hereditary cardiac arrhythmias as well as drug development and toxicity testing. Nowadays, nutraceuticals are frequently used as supplements for cardiovascular therapy. Here we studied the cardiac effects of hawthorn (Crataegus pentagyna) leaf extract using cardiomyocytes (CMs) differentiated from healthy human embryonic stem cells, long QT syndrome type 2 (LQTS2), and catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) patient-specific induced pluripotent stem cells. The hydroalcoholic extract resulted in a dose-dependent negative chronotropic effect in all CM preparations leading to a significant reduction at 1000 mu g/ml. This was accompanied by prolongation of field potential durations, although with different magnitudes in CMs from different human embryonic stem cell and iPSC lines. Hawthorn further prolonged field potential durations in LQTS2 CMs but reduced the beating frequencies and occurrence of immature field potentials triggered by beta(1)-adrenergic stimulation in CPVT1 CMs at 300 and 1000 mu g/ml. Furthermore, isoquercetin and vitexin flavonoids significantly slowed down isoproterenol (5 mu M)-induced beating frequencies at 3 and 10 mu g/ml. Therefore, C. pentagyna leaf extract and its isoquercetin and vitexin flavonoids may be introduced as a novel nutraceutical with antiarrhythmic potential for CPVT1 patients.	[Pahlavan, Sara; Tousi, Marziyeh Shalchi; Ayyari, Mahdi; Ansari, Hassan; Baharvand, Hossein] Acad Ctr Educ Culture & Res, Royan Inst Stem Cell Biol & Technol, Dept Stem Cells & Dev Biol, Cell Sci Res Ctr, Tehran, Iran; [Ayyari, Mahdi] TMU, Dept Hort Sci, Tehran, Iran; [Alirezalu, Abolfazl] Urmia Univ, Dept Hort Sci, Fac Agr, Orumiyeh, Iran; [Saric, Tomo] Univ Cologne, Inst Neurophysiol, Med Fac, Ctr Physiol & Pathophysiol, Cologne, Germany; [Baharvand, Hossein] Univ Sci & Culture, Dept Dev Biol, Tehran, Iran	Academic Center for Education, Culture & Research (ACECR); Urmia University; University of Cologne	Baharvand, H (corresponding author), Royan Inst, Banihashem Sq,Banihashem St,POB 16635-148, Tehran 1665659911, Iran.	baharvand@royaninstitute.org	Alirezalu, Abolfazl/U-7964-2019	Alirezalu, Abolfazl/0000-0002-5882-8981; Pahlavan, Sara/0000-0002-8854-2626	Royan Institute; Iranian Council of Herbal Medicine; Iran National Science Foundation (INSF) [96001316]; Iran Science Elites Federation; EBiSC project; European Commission	Royan Institute; Iranian Council of Herbal Medicine; Iran National Science Foundation (INSF)(Iran National Science Foundation (INSF)); Iran Science Elites Federation; EBiSC project; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by grants from the Royan Institute, the Iranian Council of Herbal Medicine, the Iran National Science Foundation (INSF; Grant 96001316), and the Iran Science Elites Federation to H.B. The banking of CPVT1 and LQTS2 iPSC lines was supported by the EBiSC project (to T.S. and J.H.). EBiSC is supported as a multinational public-private Innovative Medicines Initiative (http://www.imi.europa.eu/) funded by the European Commission and in-kind contributions from Pfizer Ltd., H. Lundbeck A/S, Janssen Pharmaceutica NV, Novo Nordisk A/S, AstraZeneca A/B, UCB Pharma SA, and Bayer Pharma AG and Lilly (joining after the Hot Start). The authors declare no conflicts of interest.	Al Makdessi S, 1999, BASIC RES CARDIOL, V94, P71, DOI 10.1007/s003950050128; Alp H, 2015, ANATOL J CARDIOL, V15, P970, DOI 10.5152/akd.2014.5869; AMMON HPT, 1981, PLANTA MED, V43, P209, DOI 10.1055/s-2007-971502; Baharvand H, 2006, DEV GROWTH DIFFER, V48, P117, DOI 10.1111/j.1440-169x.2006.00851.x; Brenyo A, 2014, AM J CARDIOL, V113, P897, DOI 10.1016/j.amjcard.2013.11.044; Burridge PW, 2012, CELL STEM CELL, V10, P16, DOI 10.1016/j.stem.2011.12.013; Chang WT, 2005, AM J CHINESE MED, V33, P1, DOI 10.1142/S0192415X05002606; Chen ZY, 1998, LIFE SCI, V63, P1983, DOI 10.1016/S0024-3205(98)00476-7; Dahmer S, 2010, AM FAM PHYSICIAN, V81, P465; Diane A, 2016, FOOD FUNCT, V7, P3943, DOI [10.1039/c6fo01023g, 10.1039/C6FO01023G]; Dong LY, 2008, AM J CHINESE MED, V36, P385, DOI 10.1142/S0192415X08005849; Edwards JE, 2012, PHYTOCHEMISTRY, V79, P5, DOI 10.1016/j.phytochem.2012.04.006; Fatima A, 2016, STEM CELL RES, V16, P304, DOI 10.1016/j.scr.2015.12.039; Fatima A, 2011, CELL PHYSIOL BIOCHEM, V28, P579, DOI 10.1159/000335753; Flattery Maureen, 2008, Prog Cardiovasc Nurs, V23, P187, DOI 10.1111/j.1751-7117.2008.00014.x; Fonoudi H, 2016, JOVE-J VIS EXP, DOI 10.3791/54276; Fonoudi H, 2015, STEM CELL TRANSL MED, V4, P1482, DOI 10.5966/sctm.2014-0275; Ganji F, 2015, CELL J, V16, P426; Garjani A, 2000, PHYTOTHER RES, V14, P428, DOI 10.1002/1099-1573(200009)14:6&lt;428::AID-PTR618&gt;3.0.CO;2-L; Halbach MD, 2003, CELL PHYSIOL BIOCHEM, V13, P271, DOI 10.1159/000074542; Harris K, 2015, CURR PROTOC PHARM, V71, P11181; Harvey RD, 2003, BRIT J PHARMACOL, V139, P1074, DOI 10.1038/sj.bjp.0705338; Herron TJ, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.113.003638; Holubarsch CJF, 2008, EUR J HEART FAIL, V10, P1255, DOI 10.1016/j.ejheart.2008.10.004; Hwang HS, 2009, PHARMACOTHERAPY, V29, P639, DOI 10.1592/phco.29.6.639; Itzhaki I, 2012, J AM COLL CARDIOL, V60, P990, DOI 10.1016/j.jacc.2012.02.066; Jung CB, 2012, EMBO MOL MED, V4, P180, DOI 10.1002/emmm.201100194; Koch E, 2011, PLANTA MED, V77, P1123, DOI 10.1055/s-0030-1270849; Larijani MR, 2011, STEM CELLS DEV, V20, P1911, DOI 10.1089/scd.2010.0517; Li XM, 2015, MOL MED REP, V12, P5423, DOI 10.3892/mmr.2015.4080; Long SR, 2006, PHYTOMEDICINE, V13, P643, DOI 10.1016/j.phymed.2006.01.005; Lu CC, 2013, N-S ARCH PHARMACOL, V386, P747, DOI 10.1007/s00210-013-0873-0; Muller A, 1996, PHYTOMEDICINE, V3, P257, DOI 10.1016/S0944-7113(96)80063-8; Muller A, 1999, PLANTA MED, V65, P335, DOI 10.1055/s-1999-13997; Nishizawa H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007069; Novak A, 2012, J CELL MOL MED, V16, P468, DOI 10.1111/j.1582-4934.2011.01476.x; Pittler MH, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005312.pub2; Rigelsky JM, 2002, AM J HEALTH-SYST PH, V59, P417, DOI 10.1093/ajhp/59.5.417; Salehi S, 2009, J NAT MED-TOKYO, V63, P1, DOI 10.1007/s11418-008-0278-4; SCHUSSLER M, 1995, ARZNEIMITTEL-FORSCH, V45-2, P842; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Veveris M, 2004, LIFE SCI, V74, P1945, DOI 10.1016/j.lfs.2003.09.050; Vijayan NA, 2012, MOL CELL BIOCHEM, V367, P1, DOI 10.1007/s11010-012-1251-9; Vitale AM, 2011, INT J BIOCHEM CELL B, V43, P843, DOI 10.1016/j.biocel.2011.03.013; Zhang XH, 2013, CELL CALCIUM, V54, P57, DOI 10.1016/j.ceca.2013.04.004; Zick SM, 2005, J CARD FAIL, V11, P586, DOI 10.1016/j.cardfail.2005.06.427; Zick SM, 2008, EUR J HEART FAIL, V10, P587, DOI 10.1016/j.ejheart.2008.04.008; Zick SM, 2009, EUR J HEART FAIL, V11, P990, DOI 10.1093/eurjhf/hfp116; Zwi L, 2009, CIRCULATION, V120, P1513, DOI 10.1161/CIRCULATIONAHA.109.868885	49	13	14	3	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1440	1451		10.1096/fj.201700494RR	http://dx.doi.org/10.1096/fj.201700494RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29133340				2022-12-28	WOS:000427246000026
J	Pera, T; Deshpande, DA; Ippolito, M; Wang, B; Gavrila, A; Michael, JV; Nayak, AP; Tompkins, E; Farrell, E; Kroeze, WK; Roth, BL; Panettieri, RA; Benovic, JL; An, SS; Dulin, NO; Penn, RB				Pera, Tonio; Deshpande, Deepak A.; Ippolito, Michael; Wang, Bin; Gavrila, Adelina; Michael, James V.; Nayak, Ajay P.; Tompkins, Eric; Farrell, Eleni; Kroeze, Wesley K.; Roth, Bryan L.; Panettieri, Reynold A., Jr.; Benovic, Jeffrey L.; An, Steven S.; Dulin, Nickolai O.; Penn, Raymond B.			Biased signaling of the proton-sensing receptor OGR1 by benzodiazepines	FASEB JOURNAL			English	Article						airway smooth muscle; asthma; biased agonism; GPR68; qualitative signaling	AIRWAY SMOOTH-MUSCLE; PARATHYROID-HORMONE RECEPTOR; PROTEIN-KINASE-A; EXTRACELLULAR PH; BETA-ARRESTINS; HYPERRESPONSIVENESS; EXPRESSION; AGONISTS; ASTHMA; CELLS	GPCRs have diverse signaling capabilities, based on their ability to assume various conformations. Moreover, it is now appreciated that certain ligands can promote distinct receptor conformations and thereby bias signaling toward a specific pathway to differentially affect cell function. The recently deorphanized G protein-coupled receptor OGR1 [ovarian cancer G protein-coupled receptor 1 (GPR68)] exhibits diverse signaling events when stimulated by reductions in extracellular pH. We recently demonstrated airway smooth muscle cells transduce multiple signaling events, reflecting a diverse capacity to couple to multiple G proteins. Moreover, we recently discovered that the benzodiazepine lorazepam, more commonly recognized as anagonist of the gamma-aminobutyric acid A(GABA(A)) receptor, canfunctionas an allosteric modulator of OGR1 and, similarly, can promote multiple signaling events. In this study, we demonstrated that different benzodiazepines exhibit a range of biases for OGR1, with sulazepam selectively activating the canonical Gs of the G protein signaling pathway, in heterologous expression systems, as well as in several primary cell types. These findings highlight the potential power of biased ligand pharmacology for manipulating receptor signaling qualitatively, to preferentially activate pathways that are therapeutically beneficial.	[Pera, Tonio; Deshpande, Deepak A.; Ippolito, Michael; Wang, Bin; Gavrila, Adelina; Michael, James V.; Nayak, Ajay P.; Tompkins, Eric; Farrell, Eleni; Penn, Raymond B.] Thomas Jefferson Univ, Jane & Leonard Korman Lung Ctr, Div Pulm & Crit Care Med, Dept Med,Ctr Translat Med, Room 543 JAH,1020 Locust St, Philadelphia, PA 19107 USA; [Kroeze, Wesley K.; Roth, Bryan L.] Thomas Jefferson Univ, Dept Biochem, Philadelphia, PA 19107 USA; [Kroeze, Wesley K.; Roth, Bryan L.] Univ N Carolina, Chapel Hill Sch Med, Dept Pharmacol, Chapel Hill, NC USA; [Roth, Bryan L.] Univ N Carolina, Chapel Hill Sch Med, NIMH, Psychoact Drug Screening Program,Sch Med, Chapel Hill, NC USA; [Panettieri, Reynold A., Jr.] Univ N Carolina, Chapel Hill Sch Med, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC USA; [Benovic, Jeffrey L.] Rutgers State Univ, Child Hlth Inst New Jersey, Rutgers Inst Translat Med & Sci, New Brunswick, NJ USA; [An, Steven S.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth & Engn, Baltimore, MD USA; [Dulin, Nickolai O.] Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, 5841 S Maryland Ave, Chicago, IL 60637 USA	Jefferson University; Jefferson University; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Rutgers State University New Brunswick; Rutgers State University Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Chicago	Penn, RB (corresponding author), Thomas Jefferson Univ, Jane & Leonard Korman Lung Ctr, Div Pulm & Crit Care Med, Dept Med,Ctr Translat Med, Room 543 JAH,1020 Locust St, Philadelphia, PA 19107 USA.	raymond.penn@jefferson.edu	panettieri, reynold/AAG-9485-2019; Roth, Bryan/ABE-7032-2020; An, Steven/AAM-3848-2020; Roth, Bryan L/F-3928-2010	Roth, Bryan/0000-0002-0561-6520; An, Steven/0000-0003-4723-1888; Michael, James/0000-0001-8796-5259	U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute [P01 HL114471, HL087560]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL114471, K99HL087560, R00HL087560, R01HL137030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI135082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK116195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH104974] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by the U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (Grant P01 HL114471 to R.B.P., R.A.P., J.L.B., and S.S.A.; and Grant HL087560 to D.A.D.) The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflicts of interest.	An SS, 2006, AM J RESP CELL MOL, V35, P55, DOI 10.1165/rcmb.2005-0453OC; Carr R, 2014, J BIOL CHEM, V289, P35668, DOI 10.1074/jbc.M114.618819; Deshpande DA, 2003, FASEB J, V17, P452, DOI 10.1096/fj.02-0450fje; Deshpande DA, 2008, FASEB J, V22, P2134, DOI 10.1096/fj.07-102459; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Disthabanchong S, 2002, KIDNEY INT, V62, P1171, DOI 10.1111/j.1523-1755.2002.kid568.x; Dogra S, 2016, METHOD CELL BIOL, V132, P233, DOI 10.1016/bs.mcb.2015.11.001; Dong SY, 2010, NAT PROTOC, V5, P561, DOI 10.1038/nprot.2009.239; Erlenbach I, 2001, J NEUROCHEM, V77, P1327, DOI 10.1046/j.1471-4159.2001.00344.x; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Forkuo GS, 2016, AM J RESP CELL MOL, V55, P234, DOI 10.1165/rcmb.2015-0373OC; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Gosens R, 2006, AM J PHYSIOL-LUNG C, V291, pL523, DOI 10.1152/ajplung.00013.2006; Huang XP, 2015, NATURE, V527, P477, DOI 10.1038/nature15699; Ichimonji I, 2010, AM J PHYSIOL-LUNG C, V299, pL567, DOI 10.1152/ajplung.00415.2009; Isom DG, 2013, MOL CELL, V51, P531, DOI 10.1016/j.molcel.2013.07.012; Kong KC, 2008, BIOCHEMISTRY-US, V47, P9279, DOI 10.1021/bi801056w; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Luttrell LM, 2015, MOL PHARMACOL, V88, P579, DOI 10.1124/mol.115.099630; Misior AM, 2008, MOL PHARMACOL, V73, P566, DOI 10.1124/mol.107.040519; Mizuta K, 2011, AM J RESP CELL MOL, V45, P1232, DOI 10.1165/rcmb.2011-0088OC; Morgan SJ, 2014, J BIOL CHEM, V289, P23065, DOI 10.1074/jbc.M114.557652; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Ogata N, 2011, J BIOL CHEM, V286, P13733, DOI 10.1074/jbc.M110.200196; Patel CB, 2010, MOL PHARMACOL, V78, P983, DOI 10.1124/mol.110.067066; Pauwels RA, 1997, AM J RESP CRIT CARE, V156, pS78, DOI 10.1164/ajrccm.156.4.12-tac-1; Penn RB, 1998, AM J RESP CELL MOL, V19, P338, DOI 10.1165/ajrcmb.19.2.3025; Pereverzev A, 2008, BONE, V42, P150, DOI 10.1016/j.bone.2007.08.044; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Sandbo N, 2009, AM J RESP CELL MOL, V41, P332, DOI 10.1165/rcmb.2008-0288OC; Saxena H, 2012, BRIT J PHARMACOL, V166, P981, DOI 10.1111/j.1476-5381.2011.01807.x; Soergel DG, 2014, PAIN, V155, P1829, DOI 10.1016/j.pain.2014.06.011; Tang DD, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0296-1; Tomura H, 2005, J BIOL CHEM, V280, P34458, DOI 10.1074/jbc.M505287200; Walker JKL, 2011, BRIT J PHARMACOL, V163, P18, DOI 10.1111/j.1476-5381.2010.01178.x; Wisler JW, 2014, CURR OPIN CELL BIOL, V27, P18, DOI 10.1016/j.ceb.2013.10.008; Yan HD, 2011, FASEB J, V25, P389, DOI 10.1096/fj.10-164798; Yang MH, 2006, J BIOL CHEM, V281, P23598, DOI 10.1074/jbc.M602191200; Yang YM, 2017, MOL BIOL CELL, V28, P1792, DOI 10.1091/mbc.E17-02-0096	39	29	29	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					862	874		10.1096/fj.201700555R	http://dx.doi.org/10.1096/fj.201700555R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29042451	Bronze, Green Published			2022-12-28	WOS:000425146900028
J	Zapata, RC; Singh, A; Chelikani, PK				Zapata, Rizaldy C.; Singh, Arashdeep; Chelikani, Prasanth K.			Peptide YY mediates the satiety effects of diets enriched with whey protein fractions in male rats	FASEB JOURNAL			English	Article						lactalbumin; lactoferrin; Y2 receptor blockade; energy balance; conditioned taste preference	FOOD-INTAKE; GENE-EXPRESSION; ENERGY-BALANCE; GUT HORMONES; ALPHA-LACTALBUMIN; WEIGHT REGAIN; VISCERAL FAT; BODY-WEIGHT; LACTOFERRIN; RECEPTOR	Dairy proteins-whey protein, in particular-are satiating and often recommended for weight control; however, little is known about the mechanisms by which whey protein and its components promote satiety and weight loss. We used diet-induced obese rats to determine whether the hypophagic effects of diets that are enriched with whey and its fractions, lactalbumin and lactoferrin, are mediated by the gut hormone, peptide YY (PYY). We demonstrate that high protein diets that contain whey, lactalbumin, and lactoferrin decreased food intake and body weight with a concurrent increase in PYY mRNA abundance in the colon and/or plasma PYY concentrations. Of importance, blockade of PYY neuropeptide Y receptor subtype 2 (Y2) receptors with a peripherally restricted antagonist attenuated the hypophagic effects of diets that are enriched with whey protein fractions. Diets that are enriched with whey fractions were less preferred; however, in a modified conditioned taste preference test, PYY Y2 receptor blockade induced hyperphagia of a lactoferrin diet, but caused a reduction in preference for Y2 antagonist-paired flavor, which suggested that PYY signaling is important for lactoferrin-induced satiety, but not essential for preference for lactoferrin-enriched diets. Taken together, these data provide evidence that the satiety of diets that are enriched with whey protein components is mediated, in part, via enhanced PYY secretion and action in obese male rats.	[Zapata, Rizaldy C.; Singh, Arashdeep; Chelikani, Prasanth K.] Univ Calgary, Fac Vet Med, Dept Prod Anim Hlth, HS 1871,3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada; [Chelikani, Prasanth K.] Univ Calgary, Snyder Inst Chron Dis, Gastrointestinal Res Grp, Calgary, AB, Canada	University of Calgary; University of Calgary	Chelikani, PK (corresponding author), Univ Calgary, Fac Vet Med, Dept Prod Anim Hlth, HS 1871,3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	pchelika@ucalgary.ca	Chelikani, Prasanth/N-3462-2019; Chelikani, Prasanth/AAY-2145-2021; Singh, Arashdeep/L-4795-2019	Chelikani, Prasanth/0000-0002-7300-2918; Singh, Arashdeep/0000-0002-2477-1438; Zapata, Rizaldy/0000-0003-4745-8513	Gerald L. (Jerry) Weber Cosmopolitan International Club of Calgary Graduate Scholarship; Natural Sciences and Engineering Research Council of Canada [355993]; Alberta Livestock and Meat Agency [2015P001R]; Koopmans Memorial Research Fund; Canada Foundation for Innovation [18617]; Alberta Advanced Education and Technology [URSI-09-008-SEG]	Gerald L. (Jerry) Weber Cosmopolitan International Club of Calgary Graduate Scholarship; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Livestock and Meat Agency; Koopmans Memorial Research Fund; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Alberta Advanced Education and Technology	The authors thank Dr. Roger Reidelberger (Creighton University, Omaha, NE, USA) for providing the syntax for analyses of meal patterns and Dr. Adel Pezeshki (Oklahoma State University, Stillwater, OK, USA) for help in conducting Experiment 2. Supported by Gerald L. (Jerry) Weber Cosmopolitan International Club of Calgary Graduate Scholarship (to R.C.Z.), and funded by operating grants from the Natural Sciences and Engineering Research Council of Canada (Grant 355993), Alberta Livestock and Meat Agency (Grant 2015P001R), and Koopmans Memorial Research Fund, with infrastructure support from the Canada Foundation for Innovation (Grant 18617) and Alberta Advanced Education and Technology (Grant URSI-09-008-SEG; to P.K.C.).	Abbott CR, 2005, BRAIN RES, V1043, P139, DOI 10.1016/j.brainres.2005.02.065; Abbott CR, 2005, BRAIN RES, V1044, P127, DOI 10.1016/j.brainres.2005.03.011; Adams SH, 2006, J NUTR, V136, P195, DOI 10.1093/jn/136.1.195; Akhavan T, 2014, J NUTR BIOCHEM, V25, P36, DOI 10.1016/j.jnutbio.2013.08.012; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Batterham RL, 2006, CELL METAB, V4, P223, DOI 10.1016/j.cmet.2006.08.001; Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; Bendtsen LQ, 2013, ADV NUTR, V4, P418, DOI 10.3945/an.113.003723; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Betley JN, 2015, NATURE, V521, P180, DOI 10.1038/nature14416; Boey D, 2006, DIABETOLOGIA, V49, P1360, DOI 10.1007/s00125-006-0237-0; Boey D, 2008, NEUROPEPTIDES, V42, P19, DOI 10.1016/j.npep.2007.11.003; Brothers SP, 2010, MOL PHARMACOL, V77, P46, DOI 10.1124/mol.109.058677; Burdyga G, 2008, J NEUROSCI, V28, P11583, DOI 10.1523/JNEUROSCI.2493-08.2008; Chelikani PK, 2005, ENDOCRINOLOGY, V146, P879, DOI 10.1210/en.2004-1138; Chelikani PK, 2006, PEPTIDES, V27, P3193, DOI 10.1016/j.peptides.2006.08.001; Chungchunlam SMS, 2015, EUR J CLIN NUTR, V69, P179, DOI 10.1038/ejcn.2014.266; Dailey MJ, 2010, OBESITY, V18, P904, DOI 10.1038/oby.2010.14; DIBATTISTA D, 1988, PHYSIOL BEHAV, V44, P189, DOI 10.1016/0031-9384(88)90136-9; Diepvens K, 2008, INT J OBESITY, V32, P510, DOI 10.1038/sj.ijo.0803758; Even PC, 2012, AM J PHYSIOL-REG I, V303, pR459, DOI 10.1152/ajpregu.00137.2012; Guo Y, 2006, OBESITY, V14, P1562, DOI 10.1038/oby.2006.180; Hamad EM, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-57; Hassan AM, 2017, SCI REP-UK, V7, DOI 10.1038/srep40968; Hertel A, 2010, PHYSIOL BEHAV, V99, P482, DOI 10.1016/j.physbeh.2009.12.016; Hursel R, 2010, BRIT J NUTR, V103, P775, DOI 10.1017/S0007114509992352; Jensen MD, 2014, CIRCULATION, V129, pS102, DOI 10.1161/01.cir.0000437739.71477.ee; Keire DA, 2002, PEPTIDES, V23, P305, DOI 10.1016/S0196-9781(01)00602-7; Koda S, 2005, ENDOCRINOLOGY, V146, P2369, DOI 10.1210/en.2004-1266; Krissansen GW, 2007, J AM COLL NUTR, V26, p713S, DOI 10.1080/07315724.2007.10719652; La Sala MS, 2013, FASEB J, V27, P5022, DOI 10.1096/fj.13-228064; Leidy HJ, 2015, AM J CLIN NUTR, V101, p1320S, DOI 10.3945/ajcn.114.084038; Li YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111707; Luhovyy BL, 2007, J AM COLL NUTR, V26, p704S, DOI 10.1080/07315724.2007.10719651; Ma J, 2009, DIABETES CARE, V32, P1600, DOI 10.2337/dc09-0723; McManus B, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0049-7; Morishita S, 2013, J OLEO SCI, V62, P97, DOI 10.5650/jos.62.97; Nieuwenhuizen AG, 2009, BRIT J NUTR, V101, P1859, DOI 10.1017/S0007114508131774; Ono T, 2010, BRIT J NUTR, V104, P1688, DOI 10.1017/S0007114510002734; Pal S, 2014, EUR J CLIN NUTR, V68, P980, DOI 10.1038/ejcn.2014.84; Parker LA, 2014, EUR J PHARMACOL, V722, P122, DOI 10.1016/j.ejphar.2013.09.070; Perez C, 1998, PHARMACOL BIOCHEM BE, V59, P451, DOI 10.1016/S0091-3057(97)00439-5; Pezeshki A, 2015, J NUTR, V145, P2236, DOI 10.3945/jn.115.213843; Pilvi TK, 2009, BRIT J NUTR, V102, P337, DOI 10.1017/S0007114508199445; Reidelberger R, 2013, AM J PHYSIOL-ENDOC M, V304, pE944, DOI 10.1152/ajpendo.00075.2013; Reidelberger R, 2011, PEPTIDES, V32, P770, DOI 10.1016/j.peptides.2011.01.005; Shi J, 2012, J FUNCT FOODS, V4, P66, DOI 10.1016/j.jff.2011.08.001; Singh A, 2017, OBESITY, V25, P1050, DOI 10.1002/oby.21840; Singh A, 2016, J NUTR BIOCHEM, V37, P47, DOI 10.1016/j.jnutbio.2016.07.011; Steinert RE, 2017, PHYSIOL REV, V97, P411, DOI 10.1152/physrev.00031.2014; Sukkar SG, 2013, MEDITERR J NUTR META, V6, P259, DOI 10.1007/s12349-013-0121-7; Sun J, 2016, J FUNCT FOODS, V22, P189, DOI 10.1016/j.jff.2016.01.022; Svendsen B, 2015, ENDOCRINOLOGY, V156, P847, DOI 10.1210/en.2014-1710; Tauriainen E, 2011, J NUTRIGENET NUTRIGE, V4, P49, DOI 10.1159/000327132; Tranberg B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071439; Ullrich SS, 2015, AM J PHYSIOL-REG I, V308, pR300, DOI 10.1152/ajpregu.00504.2014; van der Klaauw AA, 2013, OBESITY, V21, P1602, DOI 10.1002/oby.20154; Veldhorst MAB, 2009, CLIN NUTR, V28, P147, DOI 10.1016/j.clnu.2008.12.003; Wang SY, 2015, HORM RES PAEDIAT, V83, P19, DOI 10.1159/000362168; Westerterp-Plantenga MS, 2009, ANNU REV NUTR, V29, P21, DOI 10.1146/annurev-nutr-080508-141056; Wortley KE, 2007, GASTROENTEROLOGY, V133, P1534, DOI 10.1053/j.gastro.2007.08.024; Xiao RJ, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-1; Zapata RC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09781-2; Zhang L, 2010, AM J PHYSIOL-REG I, V299, pR1618, DOI 10.1152/ajpregu.00345.2010; Zhou J, 2011, OBESITY, V19, P1568, DOI 10.1038/oby.2011.14; Zorrilla EP, 2005, AM J PHYSIOL-REG I, V288, pR1450, DOI 10.1152/ajpregu.00175.2004	66	11	11	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					850	861		10.1096/fj.201700519RR	http://dx.doi.org/10.1096/fj.201700519RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29042449	Bronze			2022-12-28	WOS:000425146900027
J	Ohue-Kitano, R; Yasuoka, Y; Goto, T; Kitamura, N; Park, SB; Kishino, S; Kimura, I; Kasubuchi, M; Takahashi, H; Li, YJ; Yeh, YS; Jheng, HF; Iwase, M; Tanaka, M; Masuda, S; Inoue, T; Yamakage, H; Kusakabe, T; Tani, F; Shimatsu, A; Takahashi, N; Ogawa, J; Satoh-Asahara, N; Kawada, T				Ohue-Kitano, Ryuji; Yasuoka, Yumiko; Goto, Tsuyoshi; Kitamura, Nahoko; Park, Si-Bum; Kishino, Shigenobu; Kimura, Ikuo; Kasubuchi, Mayu; Takahashi, Haruya; Li, Yongjia; Yeh, Yu-Sheng; Jheng, Huei-Fen; Iwase, Mari; Tanaka, Masashi; Masuda, Shinya; Inoue, Takayuki; Yamakage, Hajime; Kusakabe, Toru; Tani, Fumito; Shimatsu, Akira; Takahashi, Nobuyuki; Ogawa, Jun; Satoh-Asahara, Noriko; Kawada, Teruo			alpha-Linolenic acid-derived metabolites from gut lactic acid bacteria induce differentiation of anti-inflammatory M2 macrophages through G protein-coupled receptor 40	FASEB JOURNAL			English	Article						omega-3 PUFA; probiotic bacteria; PPAR; intestinal mucosal immunity	SYMPATHETIC-NERVOUS-SYSTEM; WHITE ADIPOSE-TISSUE; CHAIN FATTY-ACIDS; PPAR-GAMMA; MICROBIAL METABOLITE; 10-HYDROXY-CIS-12-OCTADECENOIC ACID; ALTERNATIVE ACTIVATION; SIGNALING PATHWAYS; HEPG2 HEPATOCYTES; GENE-EXPRESSION	Among dietary fatty acids with immunologic effects, omega-3 polyunsaturated fatty acids, such as a-linolenic acid (ALA), have been considered as factors that contribute to the differentiation of M2-type macrophages (M2 macrophages). In this study, we examined the effect of ALA and its gut lactic acid bacteriametabolites 13-hydroxy-9(Z), 15(Z)-octadecadienoic acid (13-OH) and 13-oxo-9(Z), 15(Z)-octadecadienoic acid (13-oxo) on the differentiation of M2 macrophages from bone marrow-derived cells (BMDCs) and investigated the underlying mechanisms. BMDCs were stimulated with ALA, 13-OH, or 13-oxo in the presence of IL-4 or IL-13 for 24 h, and significant increases in M2 macrophage markers CD206 and Arginase-1 (Arg1) were observed. In addition, M2 macrophage phenotypes were less prevalent following cotreatment with GPCR40 antagonists or inhibitors of PLC-beta and MEK under these conditions, suggesting that GPCR40 signaling is involved in the regulation of M2 macrophage differentiation. In further experiments, remarkable M2 macrophage accumulation was observed in the lamina propria of the small intestine of C57BL/6 mice after intragastric treatmentswith ALA, 13-OH, or 13-oxo at 1 g/kg body weight per day for 3 d. These findings suggest a novel mechanism of M2 macrophage differentiation involving fatty acids from gut lactic acid bacteria and GPCR40 signaling.	[Ohue-Kitano, Ryuji; Tanaka, Masashi; Masuda, Shinya; Inoue, Takayuki; Yamakage, Hajime; Kusakabe, Toru; Satoh-Asahara, Noriko] Natl Hosp Org, Kyoto Med Ctr, Dept Endocrinol Metab & Hypertens, Kyoto, Japan; [Shimatsu, Akira] Natl Hosp Org, Kyoto Med Ctr, Clin Res Inst, Kyoto, Japan; [Ohue-Kitano, Ryuji; Yasuoka, Yumiko; Goto, Tsuyoshi; Takahashi, Haruya; Li, Yongjia; Yeh, Yu-Sheng; Jheng, Huei-Fen; Iwase, Mari; Takahashi, Nobuyuki; Kawada, Teruo] Kyoto Univ, Lab Mol Funct Food, Div Food Sci & Biotechnol, Grad Sch Agr, Uji, Kyoto 6110011, Japan; [Tani, Fumito] Kyoto Univ, Div Food Sci & Biotechnol, Lab Food Environm Sci, Grad Sch Agr, Uji, Kyoto, Japan; [Ohue-Kitano, Ryuji; Goto, Tsuyoshi; Takahashi, Nobuyuki; Ogawa, Jun; Kawada, Teruo] Kyoto Univ, Ctr Promot Interdisciplinary Educ & Res, Res Unit Physiol Chem, Kyoto, Japan; [Kitamura, Nahoko; Kishino, Shigenobu; Ogawa, Jun] Kyoto Univ, Div Appl Life Sci, Lab Fermentat Physiol & Appl Microbiol, Kyoto, Japan; [Park, Si-Bum] Kyoto Univ, Lab Ind Microbiol, Grad Sch Agr, Kyoto, Japan; [Kimura, Ikuo] Tokyo Univ Agr & Technol, Grad Sch Agr, Dept Appl Biol Sci, Tokyo, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Tokyo University of Agriculture & Technology	Goto, T (corresponding author), Kyoto Univ, Lab Mol Funct Food, Div Food Sci & Biotechnol, Grad Sch Agr, Uji, Kyoto 6110011, Japan.	tgoto@kais.kyoto-u.ac.jp	Shimatsu, Akira/I-3856-2019; Kimura, Ikuo/B-4193-2015; Yeh, Yu-Sheng/GZH-3004-2022; Takahashi, Nobuyuki/AAX-8671-2021; , Masashi/AAM-9856-2021; Goto, Tsuyoshi/AAY-2344-2020; Iwase, Mari/GZH-2961-2022	Yeh, Yu-Sheng/0000-0002-0099-2690; Takahashi, Nobuyuki/0000-0002-9705-662X; , Masashi/0000-0003-0719-8972; Goto, Tsuyoshi/0000-0003-1283-147X; Iwase, Mari/0000-0002-6494-8787	Ministry of Education, Culture, Sports, Science and Technology of Japan [15H02241, 16H02551, 16K14927, 16K07734]; Bio-Oriented Technology Research Advancement Institution of Japan [26002A]; Advanced Low Carbon Technology Research and Development Program of Japan; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry from the Ministry of Agriculture, Forestry and Fisheries of Japan [26002AB]; New Energy and Industrial Technology Development Organization (NEDO) Innovation Commercialization Venture [151016470]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Bio-Oriented Technology Research Advancement Institution of Japan; Advanced Low Carbon Technology Research and Development Program of Japan; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry from the Ministry of Agriculture, Forestry and Fisheries of Japan; New Energy and Industrial Technology Development Organization (NEDO) Innovation Commercialization Venture	The authors thank M. Komori and S. Shinotoh (Kyoto University) for technical assistance and secretarial support. The authors also thank K. Muranaka and R. Shoda (Kyoto Medical Center) for their technical assistance. This study was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grants 15H02241, 16H02551, 16K14927, and 16K07734); the Bio-Oriented Technology Research Advancement Institution of Japan (Grant 26002A); the Advanced Low Carbon Technology Research and Development Program of Japan; the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry from the Ministry of Agriculture, Forestry and Fisheries of Japan (Grant 26002AB), and the New Energy and Industrial Technology Development Organization (NEDO) Innovation Commercialization Venture Support Project (Grant 151016470). The authors declare no conflicts of interest.	Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Bassaganya-Riera J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031238; Bergamo P, 2014, J FUNCT FOODS, V11, P192, DOI 10.1016/j.jff.2014.10.007; Bosurgi L, 2017, SCIENCE, V356, P1072, DOI 10.1126/science.aai8132; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Camell C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075147; Christoffersen TE, 2014, PROBIOTICS ANTIMICRO, V6, P1, DOI 10.1007/s12602-013-9152-0; Daniel B, 2014, GENE DEV, V28, P1562, DOI 10.1101/gad.242685.114; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Goto T, 2005, BIOCHEM BIOPH RES CO, V337, P440, DOI 10.1016/j.bbrc.2005.09.077; Goto T, 2015, BIOCHEM BIOPH RES CO, V459, P597, DOI 10.1016/j.bbrc.2015.02.154; Goto T, 2012, J NUTR BIOCHEM, V23, P768, DOI 10.1016/j.jnutbio.2011.04.001; Hirata A, 2015, J LIPID RES, V56, P1340, DOI 10.1194/jlr.M059444; Hong C, 2008, CURR OPIN GENET DEV, V18, P461, DOI 10.1016/j.gde.2008.07.016; Houthuijzen JM, 2017, FASEB J, V31, P2195, DOI 10.1096/fj.201601248R; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Im DS, 2016, EUR J PHARMACOL, V785, P36, DOI 10.1016/j.ejphar.2015.03.094; Iyer A, 2015, FASEB J, V29, P3612, DOI 10.1096/fj.15-271155; Jang SE, 2013, J APPL MICROBIOL, V115, P888, DOI 10.1111/jam.12273; Ji J, 2016, SCI REP-UK, V6, DOI 10.1038/srep24838; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kim M, 2015, SCI REP-UK, V5, DOI 10.1038/srep18013; Kim YG, 2014, CELL HOST MICROBE, V15, P95, DOI 10.1016/j.chom.2013.12.010; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Kimura I, 2011, P NATL ACAD SCI USA, V108, P8030, DOI 10.1073/pnas.1016088108; Kishino S, 2013, P NATL ACAD SCI USA, V110, P17808, DOI 10.1073/pnas.1312937110; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; McCarthy C, 2013, FASEB J, V27, P499, DOI 10.1096/fj.12-215442; Miyamoto J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040450; Miyamoto J, 2015, J BIOL CHEM, V290, P2902, DOI 10.1074/jbc.M114.610733; Nagy L, 2012, PHYSIOL REV, V92, P739, DOI 10.1152/physrev.00004.2011; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Ohue R, 2012, CYTOTECHNOLOGY, V64, P221, DOI 10.1007/s10616-011-9351-z; Ohue R, 2011, J INNATE IMMUN, V3, P605, DOI 10.1159/000330786; Pini M, 2016, FASEB J, V30, P241, DOI 10.1096/fj.15-276675; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Song MY, 2016, MOL NUTR FOOD RES, V60, P2481, DOI 10.1002/mnfr.201600014; Sosa-Alvarado C, 2015, EUR J PHARMACOL, V768, P108, DOI 10.1016/j.ejphar.2015.10.038; Suzuki M, 2013, J BIOL CHEM, V288, P10684, DOI 10.1074/jbc.M112.420042; Szanto A, 2010, IMMUNITY, V33, P699, DOI 10.1016/j.immuni.2010.11.009; Takahashi N, 2002, FEBS LETT, V514, P315, DOI 10.1016/S0014-5793(02)02390-6; Tang XL, 2015, MOL CELL ENDOCRINOL, V413, P78, DOI 10.1016/j.mce.2015.06.013; Thaiss CA, 2016, NATURE, V535, P65, DOI 10.1038/nature18847; Vieira WA, 2016, CELL MOL LIFE SCI, V73, P3665, DOI 10.1007/s00018-016-2263-5; Wang JH, 2006, J BIOL CHEM, V281, P34457, DOI 10.1074/jbc.M608019200; Wang SB, 2015, J BIOL CHEM, V290, P19544, DOI 10.1074/jbc.M115.638924; Williams-Bey Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097957; Wills-Karp M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1.51.pe55; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Yan YQ, 2013, IMMUNITY, V38, P1154, DOI 10.1016/j.immuni.2013.05.015; Zhou DX, 2014, CELL SIGNAL, V26, P192, DOI 10.1016/j.cellsig.2013.11.004; Zizzo G, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0081-4	56	49	49	3	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					304	318		10.1096/fj.201700273R	http://dx.doi.org/10.1096/fj.201700273R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28904023				2022-12-28	WOS:000419172700028
J	Shi, C; Uda, Y; Dedic, C; Azab, E; Sun, NY; Hussein, AI; Petty, CA; Fulzele, K; Mitterberger-Vogt, MC; Zwerschke, W; Pereira, R; Wang, KZ; Pajevic, PD				Shi, Chao; Uda, Yuhei; Dedic, Christopher; Azab, Ehab; Sun, Ningyuan; Hussein, Amira I.; Petty, Christopher A.; Fulzele, Keertik; Mitterberger-Vogt, Maria C.; Zwerschke, Werner; Pereira, Renata; Wang, Kunzheng; Pajevic, Paola Divieti			Carbonic anhydrase III protects osteocytes from oxidative stress	FASEB JOURNAL			English	Article						bone homeostasis; sclerostin; PTH	VAN-BUCHEM-DISEASE; PHOSPHATASE-ACTIVITY; SOST GENE; IN-VIVO; OSTEOCLAST DIFFERENTIATION; INHIBITOR SCLEROSTIN; PARATHYROID-HORMONE; BONE-FORMATION; EXPRESSION; ACTIVATION	Osteocytes are master orchestrators of bone remodeling; they control osteoblast and osteoclast activities both directly via cell-to-cell communication and indirectly via secreted factors, and they are the main postnatal source of sclerostin and RANKL(receptor activator of NF-kB ligand), two regulators of osteoblast and osteoclast function. Despite progress in understanding osteocyte biology and function, much remains to be elucidated. Recently developed osteocytic cell lines-together with new genome editing tools-has allowed a closer look at the biology and molecular makeup of these cells. By using single-cell cloning, we identified genes that are associated with high Sost/sclerostin expression and analyzed their regulation and function. Unbiased transcriptome analysis of high-vs. low-Sost/sclerostin-expressing cells identified known and novel genes. Dmp1 (dentin matrix protein 1), Dkk1 (Dickkopf WNT signaling pathway inhibitor 1), and Phex were among the most up-regulated known genes, whereas Srpx2, Cd200, and carbonic anhydrase III (CAIII) were identified as novel markers of differentiated osteocytes. Aspn, Enpp2, Robo2, Nov, and Serpina3g were among the transcripts that were most significantly suppressed in high-Sost cells. Considering that CAII was recently identified as being regulated by Sost/sclerostin and capable of controlling mineral homeostasis, we focused our attention on CAIII. Here, we report that CAIII is highly expressed in osteocytes, is regulated by parathyroid hormone both in vitro and in vivo, and protects osteocytes from oxidative stress.	[Shi, Chao; Wang, Kunzheng] Xi An Jiao Tong Univ, Dept Orthopaed, Affiliated Hosp 2, Xian, Shaanxi, Peoples R China; [Shi, Chao; Uda, Yuhei; Dedic, Christopher; Azab, Ehab; Sun, Ningyuan; Petty, Christopher A.; Fulzele, Keertik; Pajevic, Paola Divieti] Boston Univ, Mol & Cell Biol, Henry M Goldman Sch Dent Med, Boston, MA 02118 USA; [Hussein, Amira I.] Boston Univ, Sch Med, Dept Orthoped, Boston, MA 02118 USA; [Hussein, Amira I.] Univ Innsbruck, Cell Metab & Differentiat Res Grp, Innsbruck, Austria; [Pereira, Renata] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Xi'an Jiaotong University; Boston University; Boston University; University of Innsbruck; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wang, KZ (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Xian 710004, Shaanxi, Peoples R China.; Pajevic, PD (corresponding author), Boston Univ, Henry M Goldman Sch Dent Med, 700 Albany St,W201C, Boston, MA 02118 USA.	wangkunzheng66@163.com; pdivieti@bu.edu	Azab, Ehab/GQH-9122-2022; Uda, Yuhei/AAZ-4978-2021; Azab, Ehab/F-5269-2019; Pajevic, Paola Divieti/M-3236-2019	Uda, Yuhei/0000-0003-4705-6215; Azab, Ehab/0000-0002-1122-3942; Zwerschke, Werner/0000-0003-1137-2953; Petty, Christopher/0000-0001-5219-5776	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR060221, AR059655]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [DK079161]; Center for Skeletal Research Core (NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases) [P30-AR066261]; Boston University Flow Cytometry Core Facility; Boston University Microarray Core Facility [U54-TR001012]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [U54TR001012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [UH2AR059655, P30AR066261, R01AR060221, UH3AR059655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079161, R56DK079161] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Center for Skeletal Research Core (NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases); Boston University Flow Cytometry Core Facility; Boston University Microarray Core Facility; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was partially supported by U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases Grants AR060221, AR059655, and NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant DK079161 (to P.D.P.). The Center for Skeletal Research Core (NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant P30-AR066261) provided primary calvaria osteoblasts and hypoxic chambers and conducted radioimmunoassays for cAMP. This work was also supported by the Boston University Flow Cytometry Core Facility and the Boston University Microarray Core Facility (Clinical & Translational Science Institute Grant U54-TR001012). The authors declare no conflicts of interest.	Balemans W, 1999, AM J HUM GENET, V64, P1661, DOI 10.1086/302416; Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Bezooijen RL, 2005, CYTOKINE GROWTH F R, V16, P319, DOI 10.1016/j.cytogfr.2005.02.005; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Cabiscol E, 1996, P NATL ACAD SCI USA, V93, P4170, DOI 10.1073/pnas.93.9.4170; CABISCOL E, 1995, J BIOL CHEM, V270, P14742, DOI 10.1074/jbc.270.24.14742; Frikha-Benayed D, 2016, BONE, V90, P15, DOI 10.1016/j.bone.2016.05.011; Fulzele K, 2017, J BONE MINER RES, V32, P373, DOI 10.1002/jbmr.3001; Fulzele K, 2013, BLOOD, V121, P930, DOI 10.1182/blood-2012-06-437160; Gailly P, 2008, KIDNEY INT, V74, P52, DOI 10.1038/sj.ki.5002794; Guo DY, 2009, THER ADV MUSCULOSKEL, V1, P87, DOI 10.1177/1759720X09341484; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Huang H, 2014, MOL MED REP, V10, P1887, DOI 10.3892/mmr.2014.2439; Kato K, 2012, P NATL ACAD SCI USA, V109, P16876, DOI 10.1073/pnas.1208017109; Kato K, 2012, ACTA CRYSTALLOGR F, V68, P778, DOI 10.1107/S1744309112019306; Kim CA, 2008, GENET TEST, V12, P475, DOI 10.1089/gte.2008.0036; Kim G, 2004, MOL CELL BIOL, V24, P9942, DOI 10.1128/MCB.24.22.9942-9947.2004; Kogawa M, 2013, J BONE MINER RES, V28, P2436, DOI 10.1002/jbmr.2003; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Mitterberger MC, 2012, EXP CELL RES, V318, P877, DOI 10.1016/j.yexcr.2012.02.011; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Paic F, 2009, BONE, V45, P682, DOI 10.1016/j.bone.2009.06.010; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Roy P, 2010, FEBS J, V277, P441, DOI 10.1111/j.1742-4658.2009.07496.x; Saini V, 2013, J BIOL CHEM, V288, P20122, DOI 10.1074/jbc.M112.441360; Shang XL, 2012, ARCH MED SCI, V8, P711, DOI 10.5114/aoms.2012.30295; Shang XL, 2009, MED HYPOTHESES, V72, P427, DOI 10.1016/j.mehy.2008.10.027; Spatz JM, 2012, J CLIN ENDOCR METAB, V97, pE1736, DOI 10.1210/jc.2012-1579; Spatz JM, 2015, J BIOL CHEM, V290, P16744, DOI 10.1074/jbc.M114.628313; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Sun HL, 2009, CELLS TISSUES ORGANS, V190, P69, DOI 10.1159/000178020; Tang HT, 2016, CELL MOL NEUROBIOL, V36, P1067, DOI 10.1007/s10571-015-0300-9; Wein MN, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13176; Wein Marc N, 2015, J Bone Miner Res, V30, P400, DOI 10.1002/jbmr.2381; Woo SM, 2011, J BONE MINER RES, V26, P2634, DOI 10.1002/jbmr.465; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yang WC, 2009, BONE, V44, P32, DOI 10.1016/j.bone.2008.08.133; Zaman G, 1999, J BONE MINER RES, V14, P1123, DOI 10.1359/jbmr.1999.14.7.1123; Zhang F, 2014, HUM MOL GENET, V23, pR40, DOI 10.1093/hmg/ddu125	45	18	19	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					440	452		10.1096/fj.201700485RR	http://dx.doi.org/10.1096/fj.201700485RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28928248	Green Published			2022-12-28	WOS:000419172700039
J	Nio, Y; Tanaka, M; Hirozane, Y; Muraki, Y; Okawara, M; Hazama, M; Matsuo, T				Nio, Yasunori; Tanaka, Masayuki; Hirozane, Yoshihiko; Muraki, Yo; Okawara, Mitsugi; Hazama, Masatoshi; Matsuo, Takanori			Phosphodiesterase 4 inhibitor and phosphodiesterase 5 inhibitor combination therapy has antifibrotic and anti-inflammatory effects in mdx mice with Duchenne muscular dystrophy	FASEB JOURNAL			English	Article						DMD; piclamilast; sildenafil; muscle fibrosis	OXIDE SYNTHASE TRANSGENE; MOUSE MODEL; NITRIC-OXIDE; TGF-BETA; MUSCLE; RESVERATROL; FIBROSIS; SILDENAFIL; EXPRESSION; CELLS	Duchenne muscular dystrophy (DMD) is the most common inherited muscular dystrophy. Patients experience DMD in their 20s from cardiac or respiratory failure related to progressive muscle wasting. Currently, the only treatments for the symptoms of DMD are available. Muscle fibrosis, a DMD feature, leads to reduced muscle function and muscle mass, and hampers pharmaceutical therapeutic efficacy. Although antifibrotic agents may be useful, none is currently approved. Phosphodiesterase 4 (PDE4) inhibitors have exhibited antifibrotic effects in human and animal models. In this study, we showed beneficial effects of the PDE4 inhibitor piclamilast in the DMD mdx mouse. Piclamilast reduced the mRNA level of profibrotic genes, including collagen 1A1, in the gastrocnemius and diaphragm, in the mdx mouse, and significantly reduced the Sirius red staining area. The PDE5 inhibitors sildenafil and tadalafil ameliorated functional muscle ischemia in boys with DMD, and sildenafil reversed cardiac dysfunction in the mdx mouse. Single-treatment piclamilast or sildenafil showed similar antifibrotic effects on the gastrocnemius; combination therapy showed a potent antifibrotic effect, and piclamilast and combination therapy increased peroxisome proliferator-activated receptor gamma coactivator-1 alpha mRNA in mouse gastrocnemius. In summary, we confirmed that piclamilast has significant antifibrotic effects in mdx mouse muscle and is a potential treatment for muscle fibrosis in DMD.	[Nio, Yasunori; Muraki, Yo; Okawara, Mitsugi; Hazama, Masatoshi; Matsuo, Takanori] Takeda Pharmaceut Co Ltd, Extra Value Generat & Gen Med Drug Discovery Unit, Fujisawa, Kanagawa, Japan; [Tanaka, Masayuki] Takeda Pharmaceut Co Ltd, Inflammat Drug Discovery Unit, Fujisawa, Kanagawa, Japan; [Hirozane, Yoshihiko] Takeda Pharmaceut Co Ltd, Biomol Res Labs, Pharmaceut Res Div, Fujisawa, Kanagawa, Japan	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd	Nio, Y (corresponding author), Takeda Pharmaceut Co Ltd, Pharmaceut Res Div, 26-1 Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan.	yasunori.nio@takeda.com	Nio, Yasunori/AFE-2456-2022	Muraki, Yo/0000-0001-6891-3074	Takeda Exploratory Challenge	Takeda Exploratory Challenge	This work was supported by Takeda Exploratory Challenge. The authors thank Nikam Sham and Atsushi Nakanishi (Takeda Pharmaceutical Co.) for their important advice and comments regarding this study. The authors declare no conflicts of interest.	Abdel-Hamid H, 2012, CURR OPIN NEUROL, V25, P604, DOI 10.1097/WCO.0b013e328357f44c; Adamo CM, 2010, P NATL ACAD SCI USA, V107, P19079, DOI 10.1073/pnas.1013077107; Asai A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000806; Ascah A, 2011, AM J PHYSIOL-HEART C, V300, pH144, DOI 10.1152/ajpheart.00522.2010; Bella AJ, 2007, EUR UROL, V52, P990, DOI 10.1016/j.eururo.2007.06.048; Biressi S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008411; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; CARNWATH JW, 1987, J NEUROL SCI, V80, P39, DOI 10.1016/0022-510X(87)90219-X; Chini CCS, 1997, J BIOL CHEM, V272, P9854; Coley WD, 2016, HUM MOL GENET, V25, P130, DOI 10.1093/hmg/ddv460; DANGAIN J, 1984, MUSCLE NERVE, V7, P700, DOI 10.1002/mus.880070903; Desguerre I, 2009, J NEUROPATH EXP NEUR, V68, P762, DOI 10.1097/NEN.0b013e3181aa31c2; DIMARIO JX, 1991, DEV BIOL, V148, P314, DOI 10.1016/0012-1606(91)90340-9; Fukada S, 2010, AM J PATHOL, V176, P2414, DOI 10.2353/ajpath.2010.090887; Gan ZJ, 2011, GENE DEV, V25, P2619, DOI 10.1101/gad.178434.111; Gong KZ, 2011, MOL ENDOCRINOL, V25, P1794, DOI 10.1210/me.2011-1009; Gordon BS, 2014, CAN J PHYSIOL PHARM, V92, P243, DOI 10.1139/cjpp-2013-0350; Gordon BS, 2013, CLIN NUTR, V32, P104, DOI 10.1016/j.clnu.2012.06.003; Guevel L, 2011, J PROTEOME RES, V10, P2465, DOI 10.1021/pr2001385; Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107; Hori YS, 2011, J PHARMACOL EXP THER, V338, P784, DOI 10.1124/jpet.111.183210; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Kawahara G, 2011, P NATL ACAD SCI USA, V108, P5331, DOI 10.1073/pnas.1102116108; Keravis T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028899; Kolosionek E, 2009, MOL BIOL CELL, V20, P4751, DOI 10.1091/mbc.E09-01-0019; Lai Y, 2009, J CLIN INVEST, V119, P624, DOI 10.1172/JCI36612; Lee EM, 2015, LIFE SCI, V143, P35, DOI 10.1016/j.lfs.2015.10.023; Ljubicic V, 2014, AM J PHYSIOL-CELL PH, V307, pC66, DOI 10.1152/ajpcell.00357.2013; Lynch GS, 2001, J PHYSIOL-LONDON, V535, P591, DOI 10.1111/j.1469-7793.2001.00591.x; Martin EA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004327; McDonald AA, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12391; Mezzano V, 2007, J CELL COMMUN SIGNAL, V1, P205, DOI 10.1007/s12079-008-0018-2; Michelakis E, 2002, CIRCULATION, V105, P2398, DOI 10.1161/01.CIR.0000016641.12984.DC; MUNTONI F, 1993, J NEUROL SCI, V120, P71, DOI 10.1016/0022-510X(93)90027-V; Nelson MD, 2014, NEUROLOGY, V82, P2085, DOI 10.1212/WNL.0000000000000498; Nio Y, 2012, DIABETOLOGIA, V55, P3350, DOI 10.1007/s00125-012-2710-2; Oeckl P, 2012, J NEUROSCI METH, V203, P338, DOI 10.1016/j.jneumeth.2011.09.032; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Percival JM, 2012, J PATHOL, V228, P77, DOI 10.1002/path.4054; Perk H, 2008, J CLIN PHARM THER, V33, P635, DOI 10.1111/j.1365-2710.2008.00962.x; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Schinner E, 2015, INT J MOL SCI, V16, P2320, DOI 10.3390/ijms16022320; Segnani C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144630; Selsby JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030063; Stapleton DI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091514; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Tennen RI, 2012, CELL, V148, P387, DOI 10.1016/j.cell.2012.01.032; Turgeman T, 2008, NEUROMUSCULAR DISORD, V18, P857, DOI 10.1016/j.nmd.2008.06.386; Wehling M, 2001, J CELL BIOL, V155, P123, DOI 10.1083/jcb.200105110; Wehling-Henricks M, 2005, HUM MOL GENET, V14, P1921, DOI 10.1093/hmg/ddi197; Whitehead NP, 2015, P NATL ACAD SCI USA, V112, P12864, DOI 10.1073/pnas.1509536112; Wu B, 2008, P NATL ACAD SCI USA, V105, P14814, DOI 10.1073/pnas.0805676105; Xu W, 2015, CLIN EXP PHARMACOL P, V42, P1075, DOI 10.1111/1440-1681.12459; Zhou L, 2010, J NEUROPATH EXP NEUR, V69, P771, DOI 10.1097/NEN.0b013e3181e9a34b	55	18	19	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5307	5320		10.1096/fj.201700249R	http://dx.doi.org/10.1096/fj.201700249R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28798156				2022-12-28	WOS:000416588300016
J	Pir, GJ; Choudhary, B; Mandelkow, E				Pir, Ghulam Jeelani; Choudhary, Bikash; Mandelkow, Eckhard			Caenorhabditis elegans models of tauopathy	FASEB JOURNAL			English	Review						human tau; pathology; nematodes	MICROTUBULE-ASSOCIATED PROTEIN; PAIRED HELICAL FILAMENTS; TAU-INDUCED NEUROTOXICITY; BETA-AMYLOID PEPTIDE; C-ELEGANS; ALZHEIMERS-DISEASE; ABNORMAL PHOSPHORYLATION; NEUROFIBRILLARY TANGLES; CELL LINEAGES; TUBULIN GENE	One of the hallmarks of the tauopathies, which include the neurodegenerative disorders, such as Alzheimer disease (AD), corticobasal degeneration, frontotemporal dementia, and progressive supranuclear palsy (PSP), is the abnormal accumulation of post-translationally modified, insoluble tau. The result is a loss of neurons, decreased mental function, and complete dependence of patients on others. Aggregation of tau, which under physiologic conditions is a highly soluble protein, is thought to be central to the pathogenesis of these diseases. Indeed one of the strongest lines of evidence is the MAPT gene polymorphisms that lead to the familial forms of tauopathy. Extensive research in animalmodels over the years has contributedsomeof themostimportant findings regarding the pathogenesis of these diseases. Despite this, the precisemolecularmechanismsthat lead to abnormal tau folding, accumulation, and spreading remain unknown. Owing to the fact that most of the biochemical pathways are conserved, Caenorhabditis elegans provides an alternative approach to identify cellular mechanisms and druggable genes that operate in such disorders. Many human genes implicated in neurodegenerative diseases have counterparts in C. elegans, makingitan excellentmodel inwhichto study theirpathogenesis. In this article, we review some of the important findings gained from C. elegans tauopathy models.-Pir, G. J., Choudhary, B., Mandelkow, E. Caenorhabditis elegans models of tauopathy.	[Pir, Ghulam Jeelani; Choudhary, Bikash; Mandelkow, Eckhard] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Pir, Ghulam Jeelani; Choudhary, Bikash; Mandelkow, Eckhard] Max Planck Inst Metab Res Cologne, Hamburg, Germany; [Mandelkow, Eckhard] Caesar Res Ctr, Bonn, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Center of Advanced European Studies & Research (CAESAR)	Pir, GJ (corresponding author), DZNE, Sigmund Freud St 27, D-53127 Bonn Na, Germany.	jeelani.pir@dzne.de		Pir, Ghulam Jeelani/0000-0002-3147-8141	DZNE; Max-Planck-Gesellschaft (MPG)	DZNE; Max-Planck-Gesellschaft (MPG)(Max Planck Society)	The authors thank Dr. Eva-Maria Mandelkow and Dr. Daniele Bano [both from the German Center for Neurodegenerative Diseases (DZNE)] for fruitful discussions. This work was funded by DZNE and Max-Planck-Gesellschaft (MPG). The authors declare no conflicts of interest.	Alexander AG, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00279; Altun-Gultekin Z, 2001, DEVELOPMENT, V128, P1951; Andreadis A, 2006, PROG MOLEC, V44, P89; Arendt T, 2016, BRAIN RES BULL, V126, P238, DOI 10.1016/j.brainresbull.2016.08.018; Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; BERNSTEIN HG, 1994, BRAIN RES, V667, P287, DOI 10.1016/0006-8993(94)91509-1; Boyd WA, 2010, NEUROTOXICOL TERATOL, V32, P68, DOI 10.1016/j.ntt.2008.12.004; Brandt R, 2009, NEUROBIOL AGING, V30, P22, DOI 10.1016/j.neurobiolaging.2007.05.011; BRENNER S, 1974, GENETICS, V77, P71; Burns AR, 2006, NAT PROTOC, V1, P1906, DOI 10.1038/nprot.2006.283; CHEN J, 1992, NATURE, V360, P674, DOI 10.1038/360674a0; Chen X, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0046-3; Chew YL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05185; Chew YL, 2013, J CELL SCI, V126, P2079, DOI 10.1242/jcs.jcs124404; Chung KH, 2008, NAT METHODS, V5, P637, DOI 10.1038/nmeth.1227; Cinar H, 2005, CURR BIOL, V15, P340, DOI 10.1016/j.cub.2005.02.025; Claverie JM, 2001, SCIENCE, V291, P1255, DOI 10.1126/science.1058969; Coppola G, 2012, HUM MOL GENET, V21, P3500, DOI 10.1093/hmg/dds161; CROWTHER RA, 1991, P NATL ACAD SCI USA, V88, P2288, DOI 10.1073/pnas.88.6.2288; David Della C., 2012, Frontiers in Genetics, V3, P247, DOI 10.3389/fgene.2012.00247; Decker JM, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0193-3; Dennissen FJA, 2016, P NATL ACAD SCI USA, V113, P11597, DOI 10.1073/pnas.1603119113; Dickson D, 2011, J MOL NEUROSCI, V45, P384, DOI 10.1007/s12031-011-9589-0; Doi M, 2002, NEURON, V33, P249, DOI 10.1016/S0896-6273(01)00587-6; Dolphin CT, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl352; Duff K, 2000, NEUROBIOL DIS, V7, P87, DOI 10.1006/nbdi.1999.0279; Fatouros C, 2012, HUM MOL GENET, V21, P3587, DOI 10.1093/hmg/dds190; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Fox RM, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-42; Frokjaer-Jensen C, 2013, GENETICS, V195, P635, DOI 10.1534/genetics.113.156521; Fukushige T, 1999, J CELL SCI, V112, P395; Goedert M, 1996, J CELL SCI, V109, P2661; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Gotz J, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00072; Gotz J, 2012, BRIT J PHARMACOL, V165, P1246, DOI 10.1111/j.1476-5381.2011.01713.x; Gordon P, 2008, DEV GENES EVOL, V218, P541, DOI 10.1007/s00427-008-0250-z; Gravato-Nobre MJ, 2008, DEV DYNAM, V237, P3762, DOI 10.1002/dvdy.21792; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Guthrie CR, 2011, HUM MOL GENET, V20, P1989, DOI 10.1093/hmg/ddr079; Guthrie CR, 2009, HUM MOL GENET, V18, P1825, DOI 10.1093/hmg/ddp099; HAMELIN M, 1992, EMBO J, V11, P2885, DOI 10.1002/j.1460-2075.1992.tb05357.x; Hanger DP, 2007, J BIOL CHEM, V282, P23645, DOI 10.1074/jbc.M703269200; Hellstrom-Lindahl E, 1999, MOL BRAIN RES, V66, P94, DOI 10.1016/S0169-328X(99)00030-3; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Iqbal K, 2008, J ALZHEIMERS DIS, V14, P365; Iwasaki K, 1997, NEURON, V18, P613, DOI 10.1016/S0896-6273(00)80302-5; Iwasaki K, 2000, EMBO J, V19, P4806, DOI 10.1093/emboj/19.17.4806; Jones AK, 2004, BIOESSAYS, V26, P39, DOI 10.1002/bies.10377; Kaletta T, 2006, NAT REV DRUG DISCOV, V5, P387, DOI 10.1038/nrd2031; Kara E, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.04.006; Kelly SM, 2007, P NATL ACAD SCI USA, V104, P12306, DOI 10.1073/pnas.0701244104; Khlistunova I, 2006, J BIOL CHEM, V281, P1205, DOI 10.1074/jbc.M507753200; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; KOPKE E, 1993, J BIOL CHEM, V268, P24374; Kovacs GG, 2011, CLIN NEUROPATHOL, V30, P3, DOI 10.5414/NPP30003; Kow RL, 2018, BIOL PSYCHIAT, V83, P438, DOI 10.1016/j.biopsych.2017.06.007; Kraemer BC, 2006, HUM MOL GENET, V15, P1483, DOI 10.1093/hmg/ddl067; Kraemer BC, 2003, P NATL ACAD SCI USA, V100, P9980, DOI 10.1073/pnas.1533448100; Kraemer BC, 2007, HUM MOL GENET, V16, P1959, DOI 10.1093/hmg/ddm143; Krieg M, 2017, ELIFE, V6, DOI [10.7554/eLife.20172, 10.7554/elife.20172]; Kruger L, 2016, CURR OPIN NEUROBIOL, V36, P52, DOI 10.1016/j.conb.2015.09.004; Kwiatkowski AV, 2003, TRENDS CELL BIOL, V13, P386, DOI 10.1016/S0962-8924(03)00130-2; Kwok TCY, 2006, NATURE, V441, P91, DOI 10.1038/nature04657; Labbadia J, 2013, TRENDS BIOCHEM SCI, V38, P378, DOI 10.1016/j.tibs.2013.05.003; Lai CH, 2000, GENOME RES, V10, P703, DOI 10.1101/gr.10.5.703; LEE G, 1988, SCIENCE, V239, P285, DOI 10.1126/science.3122323; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Liu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084849; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; LOER CM, 1993, J NEUROSCI, V13, P5407, DOI 10.1523/JNEUROSCI.13-12-05407.1993; LOPRESTI P, 1995, P NATL ACAD SCI USA, V92, P10369, DOI 10.1073/pnas.92.22.10369; MacMorris M, 2007, RNA, V13, P511, DOI 10.1261/rna.426707; Malone CJ, 2003, CELL, V115, P825, DOI 10.1016/S0092-8674(03)00985-1; Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247; McCormick AV, 2013, BIOL PSYCHIAT, V73, P464, DOI 10.1016/j.biopsych.2012.08.027; McDermott JB, 1996, BIOCHEMISTRY-US, V35, P9415, DOI 10.1021/bi952646n; Miyasaka T, 2005, NEUROBIOL DIS, V20, P372, DOI 10.1016/j.nbd.2005.03.017; Mudher A, 2001, J NEUROSCI, V21, P4987, DOI 10.1523/JNEUROSCI.21-14-04987.2001; NEVE RL, 1986, MOL BRAIN RES, V1, P271, DOI 10.1016/0169-328X(86)90033-1; Nishimura I, 2004, CELL, V116, P671, DOI 10.1016/S0092-8674(04)00170-9; Noble W, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00083; Nonet ML, 1997, J NEUROSCI, V17, P8061; Nonet ML, 1998, J NEUROSCI, V18, P70; Nonet ML, 1999, J NEUROSCI METH, V89, P33, DOI 10.1016/S0165-0270(99)00031-X; Nussbaum-Krammer CI, 2014, DIS MODEL MECH, V7, P31, DOI 10.1242/dmm.013011; O'Brien KP, 2004, HUM MUTAT, V24, P112, DOI 10.1002/humu.20068; Pir GJ, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0096-1; Pulak Rock, 2006, V351, P275; Reed LA, 1997, ANN NEUROL, V42, P564, DOI 10.1002/ana.410420406; Reed LA, 1998, J NEUROPATH EXP NEUR, V57, P588, DOI 10.1097/00005072-199806000-00006; Reynolds CH, 2008, J BIOL CHEM, V283, P18177, DOI 10.1074/jbc.M709715200; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Rohde CB, 2007, P NATL ACAD SCI USA, V104, P13891, DOI 10.1073/pnas.0706513104; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Salazar MA, 2003, J BIOL CHEM, V278, P49031, DOI 10.1074/jbc.M308104200; SAVAGE C, 1989, GENE DEV, V3, P870, DOI 10.1101/gad.3.6.870; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Schneider A, 1999, BIOCHEMISTRY-US, V38, P3549, DOI 10.1021/bi981874p; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Spillantini MG, 1998, BRAIN PATHOL, V8, P387; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; STINCHCOMB DT, 1985, MOL CELL BIOL, V5, P3484, DOI 10.1128/MCB.5.12.3484; SULSTON J, 1975, J COMP NEUROL, V163, P215, DOI 10.1002/cne.901630207; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, COLD SPRING HARB SYM, V48, P443, DOI 10.1101/SQB.1983.048.01.049; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Szebenyi G, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-19; Teaktong T, 2003, GLIA, V41, P207, DOI 10.1002/glia.10132; TERRY RD, 1963, J NEUROPATH EXP NEUR, V22, P629, DOI 10.1097/00005072-196310000-00005; Therrien M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00085; THOMAS JH, 1990, GENETICS, V124, P855; Tien NW, 2011, NEUROBIOL DIS, V43, P495, DOI 10.1016/j.nbd.2011.04.023; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Tomizawa K, 2001, FEBS LETT, V492, P221, DOI 10.1016/S0014-5793(01)02256-6; Voisine C, 2010, NEUROBIOL DIS, V40, P12, DOI 10.1016/j.nbd.2010.05.007; Wang HY, 2003, J BIOL CHEM, V278, P31547, DOI 10.1074/jbc.M212532200; Wang JZ, 1998, FEBS LETT, V436, P28, DOI 10.1016/S0014-5793(98)01090-4; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Wheeler JM, 2010, BIOCHEM SOC T, V38, P973, DOI 10.1042/BST0380973; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; Yeh E, 2005, J NEUROSCI, V25, P3833, DOI 10.1523/JNEUROSCI.4978-04.2005; Yin JA, 2014, J NEUROSCI, V34, P3947, DOI 10.1523/JNEUROSCI.4013-13.2014; Zempell H, 2014, TRENDS NEUROSCI, V37, P721, DOI 10.1016/j.tins.2014.08.004; Zhang SF, 2004, CELL, V119, P137, DOI 10.1016/j.cell.2004.09.012; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886; Zhong Q, 2012, J BIOL CHEM, V287, P20711, DOI 10.1074/jbc.M112.364067; Zhou LJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15295	133	20	20	0	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5137	5148		10.1096/fj.201701007	http://dx.doi.org/10.1096/fj.201701007			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	29191965				2022-12-28	WOS:000416588300002
J	Yang, AZ; Zhou, JS; Wang, B; Dai, JH; Colman, RW; Song, WC; Wu, Y				Yang, Aizhen; Zhou, Junsong; Wang, Bo; Dai, Jihong; Colman, Robert W.; Song, Wenchao; Wu, Yi			A critical role for plasma kallikrein in the pathogenesis of autoantibody-induced arthritis	FASEB JOURNAL			English	Article						kallikrein-kinin system; arthritis; immune complex; cytokine; monocytes	MOLECULAR-WEIGHT KININOGEN; PEPTIDOGLYCAN-INDUCED ARTHRITIS; EARLY RHEUMATOID-ARTHRITIS; ANTI-GLUCOSE-6-PHOSPHATE ISOMERASE; INFLAMMATORY ARTHRITIS; LEWIS RAT; GLUCOSE-6-PHOSPHATE ISOMERASE; ACTIVATED RECEPTORS; PROTEASE INHIBITORS; AUTOIMMUNE-DISEASE	The plasma kallikrein-kinin system (KKS) consists of serine proteases, prekallikrein (pKal) and factor XII (FXII), and a cofactor, high-MW kininogen (HK). Upon activation, activated pKal and FXII cleave HK to release bradykinin. Activation of this system has been noted in patients with rheumatoid arthritis, and its pathogenic role has been characterized in animal arthritic models. In this study, we generated 2 knockout mouse strains that lacked pKal and HK and determined the role of KKS in autoantibody-induced arthritis. In a K/BxN serum transfer-induced arthritis (STIA) model, mice that lacked HK, pKal, or bradykinin receptors displayed protective phenotypes in joint swelling, histologic changes in inflammation, and cytokine production; however, FXII-deficient mice developed normal arthritis. Inhibition of Kal ameliorated arthritis severity and incidence at early stage STIA and reduced the levels of major cytokines in joints. In addition to releasing bradykinin from HK, Kal directly activated monocytes to produce proinflammatory cytokines, up-regulated their C5aR and FcRIII expression, and released C5a. Immune complex increased pKal activity, which led to HK cleavage. The absence of HK is associated with a decrease in joint vasopermeability. Thus, we identify a critical role for Kal in autoantibody-induced arthritis with pleiotropic effects, which suggests that it is a new target for the inhibition of arthritis.	[Yang, Aizhen; Zhou, Junsong; Wang, Bo; Wu, Yi] Soochow Univ, Collaborat Innovat Ctr Hematol, Cyrus Tang Hematol Ctr, Suzhou, Peoples R China; [Zhou, Junsong; Dai, Jihong; Colman, Robert W.; Wu, Yi] Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, 3420 N Broad St, Philadelphia, PA 19140 USA; [Dai, Jihong] Rutgers New Jersey Med Sch, Dept Pathol & Lab Med, Newark, NJ USA; [Song, Wenchao] Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Song, Wenchao] Univ Penn, Inst Translat Med & Therapeut, Perelman Sch Med, Philadelphia, PA 19104 USA	Soochow University - China; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Wu, Y (corresponding author), Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, 3420 N Broad St, Philadelphia, PA 19140 USA.	yiwu@temple.edu			U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR051713, AR057542, AR063290]; National Natural Science Foundation of China [91539122, 81301534, 30971491]; Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR057542, R01AR051713, R03AR063290] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in part, by the U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (Grants AR051713, AR057542, and AR063290) and the National Natural Science Foundation of China (Grants 91539122, 81301534, and 30971491), and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The authors declare no conflicts of interest.	Abdallah RT, 2010, J BIOL CHEM, V285, P35206, DOI 10.1074/jbc.M110.171769; Blais C, 1997, ARTHRITIS RHEUM, V40, P1327, DOI 10.1002/1529-0131(199707)40:7<1327::AID-ART18>3.0.CO;2-B; Castelar-Pinheiro GD, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00320; Christensen AD, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00213; COCHRANE CG, 1972, J CLIN INVEST, V51, P2736, DOI 10.1172/JCI107093; Colman RW, 1997, BLOOD, V90, P3819, DOI 10.1182/blood.V90.10.3819; Cook AD, 1996, ARTHRITIS RHEUM, V39, P1720, DOI 10.1002/art.1780391015; Dai JH, 2012, ARTHRITIS RHEUM-US, V64, P3574, DOI 10.1002/art.34607; DELACADENA RA, 1995, FASEB J, V9, P446, DOI 10.1096/fasebj.9.5.7896018; DELACADENA RA, 1991, AM J PHYSIOL, V260, pG213, DOI 10.1152/ajpgi.1991.260.2.G213; Ditzel HJ, 2004, TRENDS MOL MED, V10, P40, DOI 10.1016/j.molmed.2003.11.004; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; EPSTEIN WV, 1969, ANN NY ACAD SCI, V168, P173, DOI 10.1111/j.1749-6632.1969.tb43106.x; Furuya T, 2008, CLIN EXP RHEUMATOL, V26, P918; Gerlag DM, 2016, RHEUMATOLOGY, V55, P607, DOI 10.1093/rheumatology/kev347; HARGREAVES KM, 1988, CLIN PHARMACOL THER, V44, P613, DOI 10.1038/clpt.1988.202; Hayashi Taichi, 2005, Mod Rheumatol, V15, P258; Ho PP, 2010, J IMMUNOL, V184, P379, DOI 10.4049/jimmunol.0901639; Holmdahl R, 2014, EUR J IMMUNOL, V44, P1593, DOI 10.1002/eji.201444486; Isordia-Salas I, 2003, BLOOD, V102, P2835, DOI 10.1182/blood-2003-02-0661; Iwaki T, 2006, THROMB HAEMOSTASIS, V95, P1003, DOI 10.1160/TH06-03-0128; Iwanami K, 2008, ARTHRITIS RHEUM-US, V58, P754, DOI 10.1002/art.23222; Jilani AA, 2015, INT J RHEUMATOL, V2015, DOI 10.1155/2015/728610; Johnson K, 1998, J IMMUNOL, V160, P5130; Jutley G, 2015, CURR OPIN RHEUMATOL, V27, P249, DOI 10.1097/BOR.0000000000000174; Kirino Y, 2015, NAT REV RHEUMATOL, V11, P401, DOI 10.1038/nrrheum.2015.41; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Lee EDH, 2003, IMMUNOL LETT, V89, P155, DOI 10.1016/S0165-2478(03)00130-5; Majka DS, 2008, ANN RHEUM DIS, V67, P801, DOI 10.1136/ard.2007.076679; Markland W, 1996, BIOCHEMISTRY-US, V35, P8058, DOI 10.1021/bi952629y; Matsumoto I, 2005, INT J MOL MED, V16, P793; Matsumoto I, 2002, NAT IMMUNOL, V3, P360, DOI 10.1038/ni772; Monach Paul, 2007, V136, P269; Oikonomopoulou K, 2006, BIOL CHEM, V387, P677, DOI 10.1515/BC.2006.086; Rose S, 2013, ARTHRITIS RHEUM-US, V65, P2279, DOI 10.1002/art.38030; Sainz IM, 2005, ARTHRITIS RHEUM-US, V52, P2549, DOI 10.1002/art.21202; Sainz IM, 2004, FASEB J, V18, P887, DOI 10.1096/fj.03-0835fje; Sainz IM, 2007, THROMB HAEMOSTASIS, V98, P77, DOI 10.1160/Th07-04-0250; SCOTT CF, 1985, J BIOL CHEM, V260, P856; SCOTT CF, 1982, J CLIN INVEST, V69, P844, DOI 10.1172/JCI110524; Smolen JS, 2016, LANCET, V388, P2023, DOI 10.1016/S0140-6736(16)30173-8; Sokolove J, 2014, ARTHRITIS RHEUMATOL, V66, P813, DOI 10.1002/art.38307; Sokolove J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035296; Suzuki T, 2005, AUTOIMMUN REV, V4, P475, DOI 10.1016/j.autrev.2005.05.005; Uknis AB, 2001, INFLAMM RES, V50, P149, DOI 10.1007/s000110050739; van Gaalen FA, 2004, ARTHRITIS RHEUM-US, V50, P395, DOI 10.1002/art.20028; WIGGINS RC, 1983, J BIOL CHEM, V258, P8963; Wipke BT, 2004, J IMMUNOL, V172, P7694, DOI 10.4049/jimmunol.172.12.7694; Wu Y, 2015, THROMB J, V13, DOI 10.1186/s12959-015-0048-y; Xie ZL, 2014, RHEUMATOLOGY, V53, P1301, DOI 10.1093/rheumatology/keu015; Yang A. X. Z., 2017, J EXP MED IN PRESS; Zhou XD, 2010, PROG MOL BIOL TRANSL, V93, P423, DOI 10.1016/S1877-1173(10)93018-4	53	10	10	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5419	5431		10.1096/fj.201700018R	http://dx.doi.org/10.1096/fj.201700018R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28808141	Green Published			2022-12-28	WOS:000416588300025
J	Pagel, R; Bar, F; Schroder, T; Sunderhauf, A; Kunstner, A; Ibrahim, SM; Autenrieth, SE; Kalies, K; Konig, P; Tsang, AH; Bettenworth, D; Divanovic, S; Lehnert, H; Fellermann, K; Oster, H; Derer, S; Sina, C				Pagel, Rene; Baer, Florian; Schroeder, Torsten; Suenderhauf, Annika; Kuenstner, Axel; Ibrahim, Saleh M.; Autenrieth, Stella E.; Kalies, Kathrin; Koenig, Peter; Tsang, Anthony H.; Bettenworth, Dominik; Divanovic, Senad; Lehnert, Hendrik; Fellermann, Klaus; Oster, Henrik; Derer, Stefanie; Sina, Christian			Circadian rhythm disruption impairs tissue homeostasis and exacerbates chronic inflammation in the intestine	FASEB JOURNAL			English	Article						epithelial cells; necroptosis; inflammatory bowel disease	BOWEL-DISEASE; CELL-DIFFERENTIATION; SLEEP DISTURBANCES; CROHNS-DISEASE; CLOCK; GENES; MPER2; MICE; RISK; PROLIFERATION	Endogenous circadian clocks regulate 24-h rhythms of physiology and behavior. Circadian rhythm disruption (CRD) is suggested as a risk factor for inflammatory bowel disease. However, the underlying molecular mechanisms remain unknown. Intestinal biopsies from Per1/2 mutant and wild-type (WT) mice were investigated by electron microscopy, immunohistochemistry, and bromodeoxyuridine pulse-chase experiments. TNF-alpha was injected intraperitoneally, with or without necrostatin-1, into Per1/2 mice or rhythmic and externally desynchronized WT mice to study intestinal epithelial cell death. Experimental chronic colitis was induced by oral administration of dextran sodium sulfate. In vitro, caspase activity was assayed in Per1/2-specific small interfering RNA-transfected cells. Wee1 was overexpressed to study antiapoptosis and the cell cycle. Genetic ablation of circadian clock function or environmental CRD in mice increased susceptibility to severe intestinal inflammation and epithelial dysregulation, accompanied by excessive necroptotic cell death and a reduced number of secretory epithelial cells. Receptor-interacting serine/threonine-protein kinase (RIP)-3-mediated intestinal necroptosis was linked to increased mitotic cell cycle arrest via Per1/2-controlled Wee1, resulting in increased antiapoptosis via cellular inhibitor of apoptosis-2. Together, our data suggest that circadian rhythm stability is pivotal for the maintenance of mucosal barrier function. CRD increases intestinal necroptosis, thus rendering the gut epithelium more susceptible to inflammatory processes.	[Pagel, Rene; Baer, Florian; Schroeder, Torsten; Tsang, Anthony H.; Lehnert, Hendrik; Fellermann, Klaus; Oster, Henrik; Sina, Christian] Univ Hosp Schleswig Holstein, Dept Med 1, Campus Lubeck,Ratzeburger Allee 160, D-23538 Lubeck, Germany; [Schroeder, Torsten; Suenderhauf, Annika; Derer, Stefanie; Sina, Christian] Univ Hosp Schleswig Holstein, Inst Nutr Med, Campus Lubeck,Ratzeburger Allee 160, D-23538 Lubeck, Germany; [Schroeder, Torsten] Univ Lubeck, Inst Syst Inflammat Res, Lubeck, Germany; [Kuenstner, Axel; Ibrahim, Saleh M.] Univ Lubeck, Lubeck Inst Expt Dermatol, Lubeck, Germany; [Kalies, Kathrin; Koenig, Peter] Univ Lubeck, Inst Anat, Lubeck, Germany; [Kuenstner, Axel] Max Planck Inst Evolutionary Biol, Guest Grp Evolutionary Genom, Plon, Germany; [Autenrieth, Stella E.] Univ Tubingen, Dept Internal Med 2, Tubingen, Germany; [Bettenworth, Dominik] Univ Hosp Munster, Dept Med B, Munster, Germany; [Divanovic, Senad] Univ Cincinnati, Div Immunobiol, Cincinnati Childrens Hosp Res Fdn, Cincinnati, OH USA	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Lubeck; University of Lubeck; University of Lubeck; Max Planck Society; Eberhard Karls University of Tubingen; University of Munster; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati	Sina, C (corresponding author), Univ Hosp Schleswig Holstein, Dept Med 1, Campus Lubeck,Ratzeburger Allee 160, D-23538 Lubeck, Germany.; Sina, C (corresponding author), Univ Hosp Schleswig Holstein, Inst Nutr Med, Campus Lubeck,Ratzeburger Allee 160, D-23538 Lubeck, Germany.	christian.sina@uksh.de	Oster, Henrik/O-4426-2019; Autenrieth, Stella/GOG-8744-2022; König, Peter/AAK-2021-2020; Derer, Stefanie/B-9300-2017; Ibrahim, Saleh/AAO-9541-2020	Oster, Henrik/0000-0002-1414-7068; Sunderhauf, Annika/0000-0003-0591-8809; Kunstner, Axel/0000-0003-0692-2105; Kalies, Kathrin/0000-0002-8929-4249; Ibrahim, Saleh/0000-0001-7827-2290; Tsang, Anthony/0000-0002-3673-6365	Section of Medicine, University of Lubeck [E15-2013]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	Section of Medicine, University of Lubeck; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Petra Langenstrassen, Ann-Kathrin Brethack, and Heidi Schlichting (all from the Institute of Nutritional Medicine, University Hospital Schleswig-Holstein), and Lidija Gutjahr, Harry Manfeldt, and Christo Orun, (all from the Institute of Anatomy, University of Lubeck) for excellent technical support. This work was supported by Grant E15-2013 from the Section of Medicine, University of Lubeck (to F.B.). H.O. is a Lichtenberg fellow of the Volkswagen Foundation. S.D. and C.S. shared senior authorship of this project. The authors declare no conflicts of interest.	Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Ali T, 2013, INFLAMM BOWEL DIS, V19, P2440, DOI 10.1097/MIB.0b013e3182a0ea54; Ananthakrishnan AN, 2013, CLIN GASTROENTEROL H, V11, P965, DOI 10.1016/j.cgh.2013.01.021; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Becker C, 2005, GUT, V54, P950, DOI 10.1136/gut.2004.061283; BUCHI KN, 1991, GASTROENTEROLOGY, V101, P410, DOI 10.1016/0016-5085(91)90019-H; Cermakian N, 2003, BRAIN RES REV, V42, P204, DOI 10.1016/S0165-0173(03)00171-1; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Froy O, 2005, FASEB J, V19, P1920, DOI 10.1096/fj.05-4216fje; Gersemann M, 2009, DIFFERENTIATION, V77, P84, DOI 10.1016/j.diff.2008.09.008; Graff LA, 2011, INFLAMM BOWEL DIS, V17, P1882, DOI 10.1002/ibd.21580; GRIFFITHS G, 1993, FINE STRUCTURE IMMUN; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Hoogerwerf WA, 2010, AM J PHYSIOL-GASTR L, V299, pG549, DOI 10.1152/ajpgi.00147.2010; Hoogerwerf WA, 2010, AM J PHYSIOL-GASTR L, V298, pG143, DOI 10.1152/ajpgi.00402.2009; Jin HS, 2006, BIOCHEM J, V399, P335, DOI 10.1042/BJ20060612; Karpowicz P, 2013, CELL REP, V3, P996, DOI 10.1016/j.celrep.2013.03.016; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Keefer L, 2006, J CLIN SLEEP MED, V2, P409; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Lo Sasso G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102495; MARRA G, 1994, GASTROENTEROLOGY, V106, P982, DOI 10.1016/0016-5085(94)90757-9; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Mazzoccoli G, 2012, CHRONOBIOL INT, V29, P994, DOI 10.3109/07420528.2012.705935; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mukherji A, 2013, CELL, V153, P812, DOI 10.1016/j.cell.2013.04.020; NARDUCCI F, 1987, GUT, V28, P17, DOI 10.1136/gut.28.1.17; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Oh-oka K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098016; Pacha J, 2013, ACTA PHYSIOL, V208, P11, DOI 10.1111/apha.12090; Palmieri O, 2015, CHRONOBIOL INT, V32, P903, DOI 10.3109/07420528.2015.1050726; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Pierdomenico M, 2014, AM J GASTROENTEROL, V109, P279, DOI 10.1038/ajg.2013.403; Preuss F, 2008, AM J PHYSIOL-REG I, V295, pR2034, DOI 10.1152/ajpregu.00118.2008; QIU JM, 1994, EPITHELIAL CELL BIOL, V3, P137; Ranjbaran Z, 2007, J GASTROEN HEPATOL, V22, P1748, DOI 10.1111/j.1440-1746.2006.04820.x; Rogler G, 2015, INFLAMM BOWEL DIS, V21, P400, DOI 10.1097/MIB.0000000000000229; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Saito H, 2008, AM J PHYSIOL-GASTR L, V295, pG395, DOI 10.1152/ajpgi.90317.2008; SCHEVING LE, 1978, ANAT REC, V191, P479, DOI 10.1002/ar.1091910407; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schwerk J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072700; Seidelin JB, 2007, VIRCHOWS ARCH, V451, P1031, DOI 10.1007/s00428-007-0517-1; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Silver AC, 2012, IMMUNITY, V36, P251, DOI 10.1016/j.immuni.2011.12.017; Srinivas G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3462; Steinlechner S, 2002, J BIOL RHYTHM, V17, P202, DOI 10.1177/07430402017003003; STEVENSON NR, 1980, AM J PHYSIOL, V238, pG203, DOI 10.1152/ajpgi.1980.238.3.G203; STEVENSON NR, 1975, BIOCHIM BIOPHYS ACTA, V406, P131, DOI 10.1016/0005-2736(75)90048-6; Swanson GR, 2011, EXPERT REV CLIN IMMU, V7, P29, DOI [10.1586/eci.10.83, 10.1586/ECI.10.83]; Tang YM, 2009, SLEEP MED, V10, P597, DOI 10.1016/j.sleep.2008.12.009; Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048; Watson AJM, 2012, ANN NY ACAD SCI, V1258, P1, DOI 10.1111/j.1749-6632.2012.06523.x; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Wild CP, 2005, CANCER EPIDEM BIOMAR, V14, P1847, DOI 10.1158/1055-9965.EPI-05-0456; Yu XF, 2013, SCIENCE, V342, P727, DOI 10.1126/science.1243884; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	66	47	48	1	30	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4707	4719		10.1096/fj.201700141RR	http://dx.doi.org/10.1096/fj.201700141RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28710114	Green Published			2022-12-28	WOS:000413398500005
J	Pathak, S; Regmi, S; Gupta, B; Pham, TT; Yong, CS; Kim, JO; Yook, S; Kim, JR; Park, MH; Bae, YK; Jeong, JH				Pathak, Shiva; Regmi, Shobha; Gupta, Biki; Tung Thanh Pham; Yong, Chul Soon; Kim, Jong Oh; Yook, Simmyung; Kim, Jae-Ryong; Park, Min Hui; Bae, Young Kyung; Jeong, Jee-Heon			Engineered islet cell clusters transplanted into subcutaneous space are superior to pancreatic islets in diabetes	FASEB JOURNAL			English	Article						pseudoislets; hypoxia; apoptosis; transplantation	BIOARTIFICIAL PANCREAS; RAT ISLETS; DEVICE; REVASCULARIZATION; SURVIVAL; SITE	An alternative route for pancreatic islet transplantation is the subcutaneous space; however, inadequate vascularization in the subcutaneous space limits the availability of oxygen and nutrients to the subcutaneously transplanted islets, which leads to the development of a necrotic core in the islets, thereby causing islet dysfunction. Thus, we aimed to prevent the early apoptosis of pancreatic islets after transplantation into subcutaneous space by preparing islet clusters of appropriate size. We prepared fully functional islet cell clusters (ICCs) by using the hanging-drop technique. We optimized the size of ICCs on the basis of viability and functionality after culture in an hypoxic environment. We transplanted ICCs into the subcutaneous space of diabetic mice and evaluated the viability of the islets at the transplantation site. In an hypoxic environment, ICCs exhibited improved viability and functionality compared with control islets. ICCs, upon transplantation into the hypoxic subcutaneous space of diabetic mice, showed better glycemic control compared with control islets. Live/dead imaging of the islets after retrieval fromthe transplanted area revealed significantly reduced apoptosis in ICCs. Transplantation of ICCsmay be an attractive strategy to prevent islet cell apoptosis that results from nonimmune-mediated physiologic stress at the transplantation site.-Pathak, S., Regmi, S., Gupta, B., Pham, T. T., Yong, C. S., Kim, J. O., Yook, S., Kim, J.-R., Park, M. H., Bae, Y. K., Jeong, J.-H. Engineeredislet cell clusters transplanted into subcutaneous space are superior to pancreatic islets in diabetes.	[Pathak, Shiva; Regmi, Shobha; Gupta, Biki; Tung Thanh Pham; Yong, Chul Soon; Kim, Jong Oh; Jeong, Jee-Heon] Yeungnam Univ, Coll Pharm, Gyongsan, South Korea; [Yook, Simmyung] Keimyung Univ, Coll Pharm, Daegu, South Korea; [Kim, Jae-Ryong] Yeungnam Univ, Coll Med, Dept Biochem & Mol Biol, Daegu, South Korea; [Kim, Jae-Ryong] Yeungnam Univ, Coll Med, Smart Aging Convergence Res Ctr, Daegu, South Korea; [Park, Min Hui; Bae, Young Kyung] Yeungnam Univ, Dept Pathol, Coll Med, Daegu, South Korea	Yeungnam University; Keimyung University; Yeungnam University; Yeungnam University; Yeungnam University	Jeong, JH (corresponding author), Yeungnam Univ, Coll Pharm, 280 Daehak Ro, Gyongsan 38541, Gyeongbuk Do, South Korea.	jeeheon@yu.ac.kr	Gupta, Biki/AAF-6859-2020; Pathak, Shiva/AAY-2052-2021; Pham, Tung/AAC-9514-2020; Pham, Tung/GPT-1655-2022	Bae, Young Kyung/0000-0002-6689-9413; Pham, Tung/0000-0002-3961-8268; Gupta, Biki/0000-0002-2315-1026; Gupta, Biki/0000-0001-8158-6813	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, Information and Communications Technology (ICT), and Future Planning [2015R1A2A2A04005616, 2015R1A5A2009124]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute; Ministry of Health and Welfare [HI16C1767]; Creative Economy Leading Technology Development Program through the Gyeongsangbuk-Do [SF316001A]; Creative Economy Leading Technology Development Program through Gyeongbuk Science and Technology Promotion Center of Korea [SF316001A]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, Information and Communications Technology (ICT), and Future Planning; Korea Health Technology R&D Project through the Korea Health Industry Development Institute; Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Creative Economy Leading Technology Development Program through the Gyeongsangbuk-Do; Creative Economy Leading Technology Development Program through Gyeongbuk Science and Technology Promotion Center of Korea	The authors thank the members of the Department of Pathology (College of Medicine, Yeungnam University) for their assistance during the immunohistochemical studies. The authors also thank the members of laboratory animal center of Yeungnam University for their assistance with animal care. This work was supported by the Basic Science Research Program through the National Research Foundation of Korea, funded by the Ministry of Science, Information and Communications Technology (ICT), and Future Planning (Grants 2015R1A2A2A04005616 and 2015R1A5A2009124), Korea Health Technology R&D Project through the Korea Health Industry Development Institute and the Ministry of Health and Welfare (Grant HI16C1767), and the Creative Economy Leading Technology Development Program through the Gyeongsangbuk-Do and Gyeongbuk Science and Technology Promotion Center of Korea (SF316001A). The authors declare no conflicts of interests.	Balamurugan AN, 2003, PANCREAS, V26, P279, DOI 10.1097/00006676-200304000-00012; Barkai U, 2013, CELL TRANSPLANT, V22, P1463, DOI 10.3727/096368912X657341; Bennet W, 2000, UPSALA J MED SCI, V105, P125, DOI 10.1517/03009734000000059; Bloch K, 2006, TISSUE ENG, V12, P337, DOI 10.1089/ten.2006.12.337; Brissova M, 2006, DIABETES, V55, P2974, DOI 10.2337/db06-0690; Carlsson PO, 2001, DIABETES, V50, P489, DOI 10.2337/diabetes.50.3.489; Cavallari G, 2007, TRANSPL P, V39, P2018, DOI 10.1016/j.transproceed.2007.05.016; CIRULLI V, 1994, J CELL SCI, V107, P1429; Cui W, 2004, TRANSPL P, V36, P1206, DOI 10.1016/j.transproceed.2004.04.059; Evron Y, 2015, HORM METAB RES, V47, P24, DOI 10.1055/s-0034-1394375; Hauge-Evans AC, 1999, DIABETES, V48, P1402, DOI 10.2337/diabetes.48.7.1402; Head WS, 2012, DIABETES, V61, P1700, DOI 10.2337/db11-1312; Henriksnas J, 2012, DIABETES, V61, P665, DOI 10.2337/db10-0895; Kawakami Y, 2001, PANCREAS, V23, P375, DOI 10.1097/00006676-200111000-00007; Kim HJ, 2013, TRANSPL P, V45, P605, DOI 10.1016/j.transproceed.2012.11.014; Lehmann R, 2007, DIABETES, V56, P594, DOI 10.2337/db06-0779; MacGregor RR, 2006, AM J PHYSIOL-ENDOC M, V290, pE771, DOI 10.1152/ajpendo.00097.2005; O'Sullivan ES, 2010, DIABETOLOGIA, V53, P937, DOI 10.1007/s00125-009-1653-8; Olsson R, 2011, DIABETES, V60, P2350, DOI 10.2337/db09-0490; Pathak S, 2016, ACS APPL MATER INTER, V8, P25702, DOI 10.1021/acsami.6b07897; Pedraza E, 2012, P NATL ACAD SCI USA, V109, P4245, DOI 10.1073/pnas.1113560109; Pepper AR, 2015, NAT BIOTECHNOL, V33, P518, DOI 10.1038/nbt.3211; Pileggi A, 2006, TRANSPLANTATION, V81, P1318, DOI 10.1097/01.tp.0000203858.41105.88; Rajab A, 2010, CURR DIABETES REP, V10, P332, DOI 10.1007/s11892-010-0130-6; Regmi S, 2017, INT J PHARMACEUT, V520, P163, DOI 10.1016/j.ijpharm.2017.02.014; Riopel M, 2014, FRONT BIOSCI-LANDMRK, V19, P77, DOI 10.2741/4196; Sakata N, 2010, PEDIATR DIABETES, V11, P471, DOI 10.1111/j.1399-5448.2009.00629.x; SHAPIRO AMJ, 1995, TRANSPLANTATION, V59, P1060, DOI 10.1097/00007890-199504150-00027; Zuellig RA, 2017, J TISSUE ENG REGEN M, V11, P109, DOI 10.1002/term.1891	29	17	17	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					5111	5121		10.1096/fj.201700490R	http://dx.doi.org/10.1096/fj.201700490R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28754712				2022-12-28	WOS:000413398500038
J	Philip, K; Mills, TW; Davies, J; Chen, NY; Karmouty-Quintana, H; Luo, FY; Molina, JG; Amione-Guerra, J; Sinha, N; Guha, A; Eltzschig, HK; Blackburn, MR				Philip, Kemly; Mills, Tingting Weng; Davies, Jonathan; Chen, Ning-Yuan; Karmouty-Quintana, Harry; Luo, Fayong; Molina, Jose G.; Amione-Guerra, Javier; Sinha, Neeraj; Guha, Ashrith; Eltzschig, Holger K.; Blackburn, Michael R.			HIF1A up-regulates the ADORA2B receptor on alternatively activated macrophages and contributes to pulmonary fibrosis	FASEB JOURNAL			English	Article						idiopathic pulmonary fibrosis; hypoxia; adenosine receptors	IDIOPATHIC INTERSTITIAL PNEUMONIA; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; A(2B) ADENOSINE RECEPTOR; A2B RECEPTOR; LUNG INJURY; HYPERTENSION; DISEASE; INFLAMMATION; CELLS; MICE	Idiopathic pulmonary fibrosis (IPF) is a deadly chronic lung disease. Extracellular accumulation of adenosine and subsequent activation of the ADORA2B receptor play important roles in regulating inflammation and fibrosis in IPF. Additionally, alternatively activated macrophages (AAMs) expressing ADORA2B have been implicated in mediating adenosine's effects in IPF. Although hypoxic conditions are present in IPF, hypoxia's role as a direct modulator of macrophage phenotype and identification of factors that regulate ADORA2B expression on AAMs in IPF is not well understood. In this study, an experimental mouse model of pulmonary fibrosis and lung samples from patients with IPF were used to examine the effects and interactions of macrophage differentiation and hypoxia on fibrosis. We demonstrate that hypoxia-inducible factor 1-alpha (HIF1A) inhibition in late stages of bleomycin-induced injury attenuates pulmonary fibrosis in association, with reductions in ADORA2B expression in AAMs. Additionally, ADORA2B deletion or pharmacological antagonism along with HIF1A inhibition disrupts AAM differentiation and subsequent IL-6 production in cultured macrophages. These findings suggest that hypoxia, through HIF1A, contributes to the development and progression of pulmonary fibrosis through its regulation of ADORA2B expression on AAMs, cell differentiation, and production of profibrotic mediators. These studies support a potential role for HIF1A or ADORA2B antagonists in the treatment of IPF.	[Philip, Kemly; Mills, Tingting Weng; Chen, Ning-Yuan; Karmouty-Quintana, Harry; Luo, Fayong; Molina, Jose G.; Blackburn, Michael R.] UTHealth, McGovern Med Sch, Dept Biochem & Mol Biol, 6431 Fannin St, Houston, TX 77030 USA; [Eltzschig, Holger K.] UTHealth, McGovern Med Sch, Dept Anesthesiol, Houston, TX 77030 USA; [Philip, Kemly; Blackburn, Michael R.] Univ Texas MD Anderson Canc Ctr, UTHealth Grad Sch Biomed Sci, Houston, TX 77030 USA; [Davies, Jonathan] Baylor Coll Med, Dept Pediat, Div Neonatal Perinatal Med, Houston, TX 77030 USA; [Amione-Guerra, Javier; Sinha, Neeraj; Guha, Ashrith] Houston Methodist Hosp, JC Walter Jr Transplant Ctr, Houston, TX USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston	Blackburn, MR (corresponding author), UTHealth, McGovern Med Sch, Dept Biochem & Mol Biol, 6431 Fannin St, Houston, TX 77030 USA.	Michael.R.Blackburn@uth.tmc.edu	Karmouty-Quintana, Harry/ABC-9144-2020; Amione, Javier/AAM-3106-2020	Karmouty-Quintana, Harry/0000-0003-4753-9823; Philip, Kemly/0000-0002-7749-9781	U.S. National Institutes of Health National Heart, Lung, and Blood Institute Program [1P01HL114457]; Schissler Foundation Fellowship for Translational Studies of Common Human Diseases; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119837, P01HL114457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097075] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Heart, Lung, and Blood Institute Program; Schissler Foundation Fellowship for Translational Studies of Common Human Diseases; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Kelly A. Volcik (UTHealth) for assisting in manuscript revisions. This work was supported by the U.S. National Institutes of Health National Heart, Lung, and Blood Institute Program Project Grant 1P01HL114457 (to M. R. Blackburn) and the Schissler Foundation Fellowship for Translational Studies of Common Human Diseases (to K. Philip).	Bryant AJ, 2016, AM J PHYSIOL-LUNG C, V310, pL249, DOI 10.1152/ajplung.00258.2015; Chiba Y, 2009, AM J RESP CELL MOL, V41, P516, DOI 10.1165/rcmb.2008-0163OC; Chunn JL, 2005, J IMMUNOL, V175, P1937, DOI 10.4049/jimmunol.175.3.1937; COULTAS DB, 1994, AM J RESP CRIT CARE, V150, P967, DOI 10.1164/ajrccm.150.4.7921471; Csoka B, 2012, FASEB J, V26, P376, DOI 10.1096/fj.11-190934; Eckle T, 2014, J IMMUNOL, V192, P1249, DOI 10.4049/jimmunol.1100593; Eckle T, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001665; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Goenka S, 2011, IMMUNOL RES, V50, P87, DOI 10.1007/s12026-011-8205-2; Hasko G, 2012, ARTERIOSCL THROM VAS, V32, P865, DOI 10.1161/ATVBAHA.111.226852; Hickey MM, 2010, J CLIN INVEST, V120, P827, DOI 10.1172/JCI36362; Jakubzick C, 2004, J CLIN PATHOL, V57, P477, DOI 10.1136/jcp.2003.012799; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Karmouty-Quintana H, 2015, FASEB J, V29, P50, DOI 10.1096/fj.14-260182; Karmouty-Quintana H, 2013, AM J RESP CELL MOL, V49, P1038, DOI 10.1165/rcmb.2013-0089OC; Karmouty-Quintana H, 2013, J MOL MED, V91, P173, DOI 10.1007/s00109-013-0997-1; Karmouty-Quintana H, 2012, FASEB J, V26, P2546, DOI 10.1096/fj.11-200907; Kasuno K, 2004, J BIOL CHEM, V279, P2550, DOI 10.1074/jbc.M308197200; Kaunisto J, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-53; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Kong TQ, 2006, FASEB J, V20, P2242, DOI 10.1096/fj.06-6419com; Le TTT, 2014, J IMMUNOL, V193, P3755, DOI 10.4049/jimmunol.1302470; Li QF, 2006, ANESTHESIOLOGY, V105, P1211, DOI 10.1097/00000542-200612000-00021; Malli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053658; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Morote-Garcia JC, 2009, GASTROENTEROLOGY, V136, P607, DOI 10.1053/j.gastro.2008.10.037; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Park SW, 2009, J KOREAN MED SCI, V24, P614, DOI 10.3346/jkms.2009.24.4.614; Rafii R, 2013, J THORAC DIS, V5, P48, DOI 10.3978/j.issn.2072-1439.2012.12.07; Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC; Rottoli P, 2005, PROTEOMICS, V5, P1423, DOI 10.1002/pmic.200301007; Sun CX, 2006, J CLIN INVEST, V116, P2173, DOI 10.1172/JCI27303; Takeda K, 1996, J IMMUNOL, V157, P3220; Tanaka T, 2010, J ANESTH, V24, P54, DOI 10.1007/s00540-009-0829-1; Tzouvelekis A, 2007, AM J RESP CRIT CARE, V176, P1108, DOI 10.1164/rccm.200705-683OC; Ueno M, 2011, AM J PHYSIOL-LUNG C, V300, pL740, DOI 10.1152/ajplung.00146.2010; Wada H, 1997, SURG TODAY, V27, P1131, DOI 10.1007/BF02385681; Weng TT, 2014, AM J RESP CRIT CARE, V190, P1402, DOI 10.1164/rccm.201404-0744OC; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Zhou QY, 2016, AM J RESP CELL MOL, V54, P728, DOI 10.1165/rcmb.2015-0111OC; Zhou Y, 2011, J IMMUNOL, V186, P1097, DOI 10.4049/jimmunol.1002907; Zhou Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009224	45	38	44	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4745	4758		10.1096/fj.201700219R	http://dx.doi.org/10.1096/fj.201700219R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28701304	Green Published			2022-12-28	WOS:000413398500008
J	Wiedmann, NM; Stefanidis, A; Oldfield, BJ				Wiedmann, Nicole M.; Stefanidis, Aneta; Oldfield, Brian J.			Characterization of the central neural projections to brown, white, and beige adipose tissue	FASEB JOURNAL			English	Article						neurotropic viruses; command neurons; brite fat	SYMPATHETIC-NERVOUS-SYSTEM; NEUROCHEMICAL CHARACTERIZATION; COMMAND NEURONS; PPAR-GAMMA; FAT; ADIPOCYTES; THERMOGENESIS; MOUSE; OUTFLOW; NERVES	The functional recruitment of classic brown adipose tissue (BAT) and inducible brown-like or beige fat is, to a large extent, dependent on intact sympathetic neural input. Whereas the central neural circuits directed specifically to BAT or white adipose tissue (WAT) are well established, there is only a developing insight into the nature of neural inputs common to both fat types. Moreover, there is no clear view of the specific central and peripheral innervation of the browned component of WAT: beige fat. The objective of the present study is to examine the neural input to both BAT and WAT in the same animal and, by exposing different cohorts of rats to either thermoneutral or cold conditions, define changes in central neural organization that will ensure that beige fat is appropriately recruited and modulated after browning of inguinal WAT (iWAT). At thermoneutrality, injection of the neurotropic (pseudorabies) viruses into BAT and WAT demonstrates that there are dedicated axonal projections, as well as collateral axonal branches of command neurons projecting to both types of fat. After cold exposure, central neural circuits directed to iWAT showed evidence of reorganization with a greater representation of command neurons projecting to both brown and beiged WAT in hypothalamic (paraventricular nucleus and lateral hypothalamus) and brainstem (raphe pallidus and locus coeruleus) sites. This shift was driven by a greater number of supraspinal neurons projecting to iWAT under cold conditions. These data provide evidence for a reorganization of the nervous system at the level of neural connectivity following browning of WAT.	[Wiedmann, Nicole M.; Stefanidis, Aneta; Oldfield, Brian J.] Monash Univ, Dept Physiol, 26 Innovat Walk, Clayton, Vic 3800, Australia	Monash University	Oldfield, BJ (corresponding author), Monash Univ, Dept Physiol, 26 Innovat Walk, Clayton, Vic 3800, Australia.	brian.oldfield@monash.edu		Oldfield, Brian/0000-0002-8609-6589; Wiedmann, Nicole/0000-0001-9390-2457	Australia National Health and Medical Research Council (NHMRC) [APP1082599]; NHMRC [APP1022451]	Australia National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a grant from the Australia National Health and Medical Research Council (NHMRC) Grant APP1082599, and an NHMRC Fellowship (APP1022451) (both to B.J.O.). The authors declare no conflicts of interest.	Adler ES, 2012, J NEUROSCI, V32, P15913, DOI 10.1523/JNEUROSCI.2591-12.2012; Bamshad M, 1999, AM J PHYSIOL-REG I, V276, pR1569, DOI 10.1152/ajpregu.1999.276.6.R1569; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; BARON R, 1985, J COMP NEUROL, V238, P158, DOI 10.1002/cne.902380204; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Bartness TJ, 2005, CAN J DIABETES, V29, P420; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Brito NA, 2008, AM J PHYSIOL-REG I, V294, pR1445, DOI 10.1152/ajpregu.00068.2008; Brown LM, 2006, PHYSIOL BEHAV, V89, P687, DOI 10.1016/j.physbeh.2006.08.008; Buettner C, 2008, NAT MED, V14, P667, DOI 10.1038/nm1775; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao L, 2011, CELL METAB, V14, P324, DOI 10.1016/j.cmet.2011.06.020; Contreras GA, 2014, AM J PHYSIOL-ENDOC M, V307, pE793, DOI 10.1152/ajpendo.00033.2014; COUSIN B, 1992, J CELL SCI, V103, P931; Cypess AM, 2010, CURR OPIN ENDOCRINOL, V17, P143, DOI 10.1097/MED.0b013e328337a81f; Dodd GT, 2015, CELL, V160, P88, DOI 10.1016/j.cell.2014.12.022; Douris N, 2015, ENDOCRINOLOGY, V156, P2470, DOI 10.1210/en.2014-2001; Fischer K, 2017, NAT MED, V23, P623, DOI 10.1038/nm.4316; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Frontini A, 2010, CELL METAB, V11, P253, DOI 10.1016/j.cmet.2010.03.004; Gabella G., 2001, ELS; Giordano A, 1996, J NEUROCYTOL, V25, P125, DOI 10.1007/BF02284791; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hettigoda NS, 2015, BRAIN STRUCT FUNCT, V220, P2103, DOI 10.1007/s00429-014-0781-1; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; HIMMSHAGEN J, 1991, FRONT NEUROENDOCRIN, V12, P38; Ishibashi J, 2010, SCIENCE, V328, P1113, DOI 10.1126/science.1190816; JANSEN ASP, 1995, SCIENCE, V270, P644, DOI 10.1126/science.270.5236.644; Jespersen NZ, 2013, CELL METAB, V17, P798, DOI 10.1016/j.cmet.2013.04.011; Kupfermann I, 2001, CURR OPIN NEUROBIOL, V11, P673, DOI 10.1016/S0959-4388(01)00267-7; Langley J.N, 1921, AUTONOMIC NERVOUS SY; LAZZARINI SJ, 1991, AM J PHYSIOL, V260, pR47, DOI 10.1152/ajpregu.1991.260.1.R47; Lee YH, 2015, FASEB J, V29, P286, DOI 10.1096/fj.14-263038; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Liu C, 2014, CELL METAB, V19, P722, DOI 10.1016/j.cmet.2014.01.021; McGlashon JM, 2015, CELL METAB, V21, P692, DOI 10.1016/j.cmet.2015.04.008; Mercader J, 2006, ENDOCRINOLOGY, V147, P5325, DOI 10.1210/en.2006-0760; Morrison SF, 2014, CELL METAB, V19, P741, DOI 10.1016/j.cmet.2014.02.007; Morrison Shaun F, 2012, Front Endocrinol (Lausanne), V3; Mottillo EP, 2014, J LIPID RES, V55, P2276, DOI 10.1194/jlr.M050005; Murano I, 2009, J ANAT, V214, P171, DOI 10.1111/j.1469-7580.2008.01001.x; Nedergaard J, 2014, CELL METAB, V20, P396, DOI 10.1016/j.cmet.2014.07.005; Nguyen NLT, 2017, AM J PHYSIOL-REG I, V312, pR132, DOI 10.1152/ajpregu.00344.2016; Norheim F, 2014, FEBS J, V281, P739, DOI 10.1111/febs.12619; Oldfield BJ, 2007, EUR J NEUROSCI, V25, P2404, DOI 10.1111/j.1460-9568.2007.05429.x; Oldfield BJ, 2002, NEUROSCIENCE, V110, P515, DOI 10.1016/S0306-4522(01)00555-3; OLDFIELD BJ, 1981, J COMP NEUROL, V196, P329, DOI 10.1002/cne.901960211; OLDFIELD BJ, 1980, NEUROSCI LETT, V18, P11, DOI 10.1016/0304-3940(80)90206-2; Patsouris D, 2015, CELL REP, V13, P1538, DOI 10.1016/j.celrep.2015.10.028; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Porter C, 2015, SHOCK, V44, P258, DOI 10.1097/SHK.0000000000000410; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Rao RR, 2014, CELL, V157, P1279, DOI 10.1016/j.cell.2014.03.065; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Ruan HB, 2014, CELL, V159, P306, DOI 10.1016/j.cell.2014.09.010; Schulz TJ, 2013, NATURE, V495, P379, DOI 10.1038/nature11943; Sellayah D, 2011, CELL METAB, V14, P478, DOI 10.1016/j.cmet.2011.08.010; Sidossis LS, 2015, CELL METAB, V22, P219, DOI 10.1016/j.cmet.2015.06.022; Song CK, 2005, VIRUS RES, V111, P235, DOI 10.1016/j.virusres.2005.04.012; Stefanidis A, 2014, BEST PRACT RES CL EN, V28, P685, DOI 10.1016/j.beem.2014.08.001; Villarroya F, 2013, CELL METAB, V17, P638, DOI 10.1016/j.cmet.2013.02.020; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Weiner J, 2016, SCI REP-UK, V6, DOI 10.1038/srep38124; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; YOUNG P, 1984, FEBS LETT, V167, P10, DOI 10.1016/0014-5793(84)80822-4; Zhang Y, 2016, AM J PHYSIOL-ENDOC M, V311, pE530, DOI 10.1152/ajpendo.00094.2016	72	22	22	0	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4879	4890		10.1096/fj.201700433R	http://dx.doi.org/10.1096/fj.201700433R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28798153				2022-12-28	WOS:000413398500019
J	Lall, VK; Bruce, G; Voytenko, L; Drinkhill, M; Wellershaus, K; Willecke, K; Deuchars, J; Deuchars, SA				Lall, Varinder K.; Bruce, Gareth; Voytenko, Larysa; Drinkhill, Mark; Wellershaus, Kerstin; Willecke, Klaus; Deuchars, Jim; Deuchars, Susan A.			Physiologic regulation of heart rate and blood pressure involves connexin 36-containing gap junctions	FASEB JOURNAL			English	Article						sympathetic; cardiovascular; spinal cord; knockout models	SYMPATHETIC PREGANGLIONIC NEURONS; AUTONOMIC NERVOUS-SYSTEM; SPINAL-CORD; ADULT-RAT; IN-VITRO; MOUSE; VARIABILITY; BRAIN; HYPERTENSION; EXPRESSION	Chronically elevated sympathetic nervous activity underlies many cardiovascular diseases. Elucidating the mechanisms contributing to sympathetic nervous system output may reveal new avenues of treatment. The contribution of the gap junctional protein connexin 36 (Cx36) to the regulation of sympathetic activity and thus blood pressure and heart rate was determined using a mouse with specific genetic deletion of Cx36. Ablation of the Cx36 protein was confirmed in sympathetic preganglionic neurons of Cx36-knockout (KO) mice. Telemetric analysis from conscious Cx36 KO mice revealed higher variance in heart rate and blood pressure during rest and activity compared to wild-type (WT) mice, and smaller responses to chemoreceptor activation when anesthetized. In the working heart-brain stem preparation of the Cx36-KO mouse, respiratory-coupled sympathetic nerve discharge was attenuated and responses to chemoreceptor stimulation and noxious stimulation were blunted compared to WT mice. Using whole cell patch recordings, sympathetic preganglionic neurons in spinal cord slices of Cx36-KO mice displayed lower levels of spikelet activity compared to WT mice, indicating reduced gap junction coupling between neurons. Cx36 deletion therefore disrupts normal regulation of sympathetic outflow with effects on cardiovascular parameters.	[Lall, Varinder K.; Bruce, Gareth; Voytenko, Larysa; Deuchars, Jim; Deuchars, Susan A.] Univ Leeds, Sch Biomed Sci, Fac Biol Sci, Leeds, W Yorkshire, England; [Drinkhill, Mark] Univ Leeds, Inst Cardiovasc & Metab Med, Div Cardiovasc & Diabet Res, Leeds, W Yorkshire, England; [Wellershaus, Kerstin; Willecke, Klaus] Univ Bonn, Life & Med Sci Inst LIMES, Bonn, Germany	University of Leeds; University of Leeds; University of Bonn	Deuchars, SA (corresponding author), Univ Leeds, Sch Biomed Sci, Fac Biol Sci, Leeds, W Yorkshire, England.; Deuchars, SA (corresponding author), Univ Leeds, Sch Biomed Sci, Leeds, W Yorkshire, England.	s.a.deuchars@leeds.ac.uk		LAll, Varinder/0000-0003-1989-0130; Deuchars, Susan/0000-0002-1876-3239; Deuchars, Jim/0000-0002-4445-654X	British Heart Foundation [PG/08/120/26338]; Biotechnology and Biological Sciences Research Council [BB/1]; Wellcome Trust [WT093072MA]; BBSRC [BB/E001831/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E001831/1] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank B. Frater (University of Leeds) for expert technical assistance. Research conducted in these studies was supported by the British Heart Foundation (Grant PG/08/120/26338 to S.A.D.), the Biotechnology and Biological Sciences Research Council (Ph.D. studentship to V.K.L., and Grant BB/1 to J.D.), and the Wellcome Trust (Grant WT093072MA to S.A.D.).	Baudry S, 1997, J PHARM PHARMACOL, V49, P1086, DOI 10.1111/j.2042-7158.1997.tb06047.x; Charkoudian N, 2009, MAYO CLIN PROC, V84, P822, DOI 10.1016/S0025-6196(11)60492-8; Condorelli DF, 2000, BRAIN RES REV, V32, P72, DOI 10.1016/S0165-0173(99)00068-5; Cummings DM, 2008, J NEUROSCI RES, V86, P2147, DOI 10.1002/jnr.21674; Deuchars SA, 2001, NEUROSCIENCE, V106, P433, DOI 10.1016/S0306-4522(01)00277-9; Deuchars SA, 2015, COMPR PHYSIOL, V5, P829, DOI 10.1002/cphy.c140020; Ferrari AU, 1996, AM J PHYSIOL-HEART C, V270, pH2143, DOI 10.1152/ajpheart.1996.270.6.H2143; Florea VG, 2014, CIRC RES, V114, P1815, DOI 10.1161/CIRCRESAHA.114.302589; Frank M, 2010, J CELL SCI, V123, P3605, DOI 10.1242/jcs.068668; Frisch C, 2005, BEHAV BRAIN RES, V157, P177, DOI 10.1016/j.bbr.2004.06.023; Head WS, 2012, DIABETES, V61, P1700, DOI 10.2337/db11-1312; Hirose M, 1998, ANESTHESIOLOGY, V89, P666, DOI 10.1097/00000542-199809000-00016; JULIEN C, 1990, AM J PHYSIOL, V259, pH1337, DOI 10.1152/ajpheart.1990.259.5.H1337; Lall VK, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-103; LAOTHAVORN P, 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P51; Lee SC, 2014, J NEUROSCI, V34, P13170, DOI 10.1523/JNEUROSCI.0562-14.2014; Leslie J, 2000, J PHYSIOL-LONDON, V528P, p108P; Logan SD, 1996, J PHYSIOL-LONDON, V495, P491, DOI 10.1113/jphysiol.1996.sp021609; LOW PA, 1978, ANN NEUROL, V4, P511, DOI 10.1002/ana.410040606; Malpas SC, 1998, PROG NEUROBIOL, V56, P65, DOI 10.1016/S0301-0082(98)00030-6; Mancia G, 2014, CIRC RES, V114, P1804, DOI 10.1161/CIRCRESAHA.114.302524; Marina N, 2008, AUTON NEUROSCI-BASIC, V139, P15, DOI 10.1016/j.autneu.2007.12.004; MARSHALL JM, 1994, PHYSIOL REV, V74, P543, DOI 10.1152/physrev.1994.74.3.543; Murray AR, 2016, AUTON NEUROSCI-BASIC, V199, P48, DOI 10.1016/j.autneu.2016.06.004; Ng FL, 2016, CURR HYPERTENS REP, V18, DOI 10.1007/s11906-016-0670-5; Nishie M, 2004, ACTA NEUROPATHOL, V107, P292, DOI 10.1007/s00401-003-0811-1; Paton JFR, 1996, J NEUROSCI METH, V65, P63, DOI 10.1016/0165-0270(95)00147-6; PICKERING AE, 1994, J PHYSIOL-LONDON, V480, P109, DOI 10.1113/jphysiol.1994.sp020345; Pierce ML, 2010, NEUROSCIENCE, V170, P827, DOI 10.1016/j.neuroscience.2010.07.007; Simms AE, 2007, J PHYSIOL-LONDON, V579, P473, DOI 10.1113/jphysiol.2006.124396; Stalbovskiy AO, 2014, J PHYSIOL-LONDON, V592, P2215, DOI 10.1113/jphysiol.2014.270769; Wellershaus K, 2008, EXP CELL RES, V314, P997, DOI 10.1016/j.yexcr.2007.12.024; Zolnik TA, 2016, J PHYSIOL-LONDON, V594, P2579, DOI 10.1113/JP271880	33	5	5	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3966	3977		10.1096/fj.201600919RR	http://dx.doi.org/10.1096/fj.201600919RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28533325	Green Published, hybrid			2022-12-28	WOS:000408713300022
J	Anorga, S; Overstreet, JM; Falke, LL; Tang, JQ; Goldschmeding, RG; Higgins, PJ; Samarakoon, R				Anorga, Sandybell; Overstreet, Jessica M.; Falke, Lucas L.; Tang, Jiaqi; Goldschmeding, Roel G.; Higgins, Paul J.; Samarakoon, Rohan			Deregulation of Hippo-TAZ pathway during renal injury confers a fibrotic maladaptive phenotype	FASEB JOURNAL			English	Article						CTGF; TGF-beta 1; CKD; UUO; AAN	CHRONIC KIDNEY-DISEASE; TGF-BETA; DIABETIC-NEPHROPATHY; TARGET GENES; FIBROSIS; ACTIVATION; TGF-BETA-1; CANCER; MECHANISMS; EXPRESSION	Although yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ), nuclear transducers of the Hippo pathway, are mostly silent in adult organs, aberrant activation of YAP/TAZ promotes tumorigenesis and abnormal tissue repair. The extent of involvement of TAZ in chronic kidney disease (CKD) is unknown. In our study, increased TAZ nuclear accumulation and expression in the tubulointerstitium was readily evident in 3 models of renal injury including obstructive, aristolochic acid (AA), and diabetic nephropathy, correlating with fibrosis progression. Stable TAZ overexpression in human kidney (HK)-2 epithelial cells promoted connective tissue growth factor (CTGF), fibronectin, vimentin, and p21 expression, epithelial dedifferentiation, and growth inhibition, in part, via Sma mothers against decapentaplegic homologue (SMAD)-3-dependent CTGF induction. CTGF secretion by TAZ-overexpressing epithelium also triggered proliferative defects in non engineered HK-2 cells confirming a nonautonomous role of TAZ (via a paracrine mechanism) in orchestrating kidney epithelial cell-cell communication. Renal tubular-specific induction of TGF-beta 1 in mice and TGF-beta 1 stimulation of HK-2 cells resulted in TAZ protein up-regulation. TAZ stable silencing in HK-2 cells abrogated TGF-beta 1-induced expression of target genes without affecting SMAD3 phosphorylation, which is also crucial for fibrotic reprogramming. Thus, TAZ was activated in fibrosis through TGF-beta 1-dependent mechanisms and sustained TAZ signaling promotes epithelial maladaptive repair. TAZ is also a novel non-SMAD downstream effector of renal TGF-beta 1 signaling, establishing TAZ as a new antifibrosis target for treatment of CKD.	[Anorga, Sandybell; Tang, Jiaqi; Higgins, Paul J.; Samarakoon, Rohan] Albany Med Ctr, Dept Regenerat & Canc Cell Biol, MC-165,47 New Scotland Ave, Albany, NY 12208 USA; [Overstreet, Jessica M.] Vanderbilt Univ Sch Med, Div Nephrol & Hypertens, Nashville, TN USA; [Falke, Lucas L.; Goldschmeding, Roel G.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands	Albany Medical College; Vanderbilt University; Utrecht University; Utrecht University Medical Center	Samarakoon, R (corresponding author), Albany Med Ctr, Dept Regenerat & Canc Cell Biol, MC-165,47 New Scotland Ave, Albany, NY 12208 USA.	samarar@mail.amc.edu	Falke, Lucas L/D-5288-2017	Falke, Lucas L/0000-0003-0020-433X; Tang, Jiaqi/0000-0002-3544-3456	U.S. National Institutes of Health (NIH) General Medicine Grant [GM057242]; Capital Region Medical Research Institute grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057242] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) General Medicine Grant; Capital Region Medical Research Institute grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Wilhelm Kriz (University of Heidelberg, Heidelberg, Germany) for generously providing us with kidney tissue from Pax8-rtTA-tet-o-TGF-beta 1 mice for IHC studies. Portions of this study were presented as an abstract at the American Society of Nephrology Annual Meeting in November 3-5, 2015, San Diego, CA, USA. This work was supported by U.S. National Institutes of Health (NIH) General Medicine Grant GM057242 (to P.J.H.), and a Capital Region Medical Research Institute grant (to R.S.). R.G.G. was employed (2008-2009) by, performs contract research for, and receives reagents for CTGF-related research from FibroGen, Inc., a company involved in development of anti-CTGF therapies. The remaining authors declare no conflicts of interest.	Beyer TA, 2013, CELL REP, V5, P1611, DOI 10.1016/j.celrep.2013.11.021; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Chen JC, 2016, J AM SOC NEPHROL, V27, P1689, DOI 10.1681/ASN.2015040415; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Ferenbach DA, 2015, NAT REV NEPHROL, V11, P264, DOI 10.1038/nrneph.2015.3; Friedman SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004700; Fujii M, 2012, J EXP MED, V209, P479, DOI 10.1084/jem.20111653; Genevet A, 2011, BIOCHEM J, V436, P213, DOI 10.1042/BJ20110217; Gokmen MR, 2013, ANN INTERN MED, V158, P469, DOI 10.7326/0003-4819-158-6-201303190-00006; Ito Y, 1998, KIDNEY INT, V53, P853, DOI 10.1046/j.1523-1755.1998.00820.x; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150; Koesters R, 2010, AM J PATHOL, V177, P632, DOI 10.2353/ajpath.2010.091012; Kramann R, 2013, J PATHOL, V231, P273, DOI 10.1002/path.4253; Liang M, 2017, J AM SOC NEPHROL, V28, P3277, DOI 10.1681/ASN.2015121354; Liu F, 2015, AM J PHYSIOL-LUNG C, V308, pL344, DOI 10.1152/ajplung.00300.2014; Macconi D, 2014, KIDNEY INT SUPPL, V4, P58, DOI 10.1038/kisup.2014.11; Mannaerts I, 2015, J HEPATOL, V63, P679, DOI 10.1016/j.jhep.2015.04.011; Mauviel A, 2012, ONCOGENE, V31, P1743, DOI 10.1038/onc.2011.363; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Miranda MZ, 2017, J BIOL CHEM, V292, P14902, DOI 10.1074/jbc.M117.780502; Mitani A, 2009, AM J RESP CRIT CARE, V180, P326, DOI 10.1164/rccm.200812-1827OC; Overstreet JM, 2015, FASEB J, V29, P1258, DOI 10.1096/fj.14-262527; Overstreet JM, 2014, CELL SIGNAL, V26, P1427, DOI 10.1016/j.cellsig.2014.02.017; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Perico N, 2012, NEPHROL DIAL TRANSPL, V27, P19, DOI 10.1093/ndt/gfs284; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Preisser F, 2016, BBA-MOL CELL RES, V1863, P2027, DOI 10.1016/j.bbamcr.2016.05.001; Rohatgi R, 2010, CURR OPIN NEPHROL HY, V19, P65, DOI 10.1097/MNH.0b013e32833327f3; Ruster C, 2011, J AM SOC NEPHROL, V22, P1189, DOI 10.1681/ASN.2010040384; Samarakoon R, 2016, FASEB J, V30, P3308, DOI 10.1096/fj.201500105R; Samarakoon R, 2015, J PATHOL, V236, P421, DOI 10.1002/path.4538; Samarakoon R, 2013, CELL SIGNAL, V25, P2198, DOI 10.1016/j.cellsig.2013.07.007; Samarakoon R, 2013, CELL SIGNAL, V25, P264, DOI 10.1016/j.cellsig.2012.10.003; Samarakoon R, 2012, CELL TISSUE RES, V347, P117, DOI 10.1007/s00441-011-1181-y; Strutz F, 2003, SPRINGER SEMIN IMMUN, V24, P459, DOI 10.1007/s00281-003-0123-5; Szeto SG, 2016, J AM SOC NEPHROL, V27, P3117, DOI 10.1681/ASN.2015050499; Tesch GH, 2006, NEPHRON EXP NEPHROL, V104, pE57, DOI 10.1159/000093998; Tschumperlin DJ, 2013, CURR OPIN RHEUMATOL, V25, P92, DOI 10.1097/BOR.0b013e32835b13cd; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005	48	55	59	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2644	2657		10.1096/fj.201700722R	http://dx.doi.org/10.1096/fj.201700722R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29298862	Green Published			2022-12-28	WOS:000432528000027
J	Jin, WN; Ducruet, AF; Liu, Q; Shi, SXY; Waters, M; Zou, M; Sheth, KN; Gonzales, R; Shi, FD				Jin, Wei-Na; Ducruet, Andrew F.; Liu, Qiang; Shi, Samuel Xiang-Yu; Waters, Michael; Zou, Ming; Sheth, Kevin N.; Gonzales, Rayna; Shi, Fu-Dong			Activation of JAK/STAT3 restores NK-cell function and improves immune defense after brain ischemia	FASEB JOURNAL			English	Article						ischemic stroke; multigene signature; natural killer cell; immune suppression; poststroke infection	NATURAL-KILLER-CELLS; STROKE-INDUCED IMMUNODEPRESSION; MULTIPLE-SCLEROSIS; KYOTO ENCYCLOPEDIA; INFECTION; DEFICIENCY; INJURY; RESPONSES; GENOMES; KEGG	Stroke-induced immune suppression predisposes the host to infections and can contribute to high morbidity and mortality in stroke patients. Because ischemic stroke has a profound effect on the systemic immune response, which may explain the increased susceptibility of stroke patients to infection, an urgent need persists for a better understanding of mechanisms associated with immune suppression; new and effective treatments for stroke can then be identified. NK cells play a key role in early host defense against pathogens by killing infected cells and/or producing cytokines such as IFN-gamma. Because the phenotype and function of peripheral NK cells have been widely investigated in ischemic stroke, nCounter Inflammation Gene Array Analysis was used to build immune-related gene profiles of NK cells to comprehensively analyze the molecular signature of NK cells after ischemic brain injury. We observed distinct gene expression profiles reflecting different splenic NK-cell phenotypes and functional properties across the time course of transient middle cerebral artery occlusion (MCAO). Based on gene expression and pathway-network analysis, lower expression levels of signal transducer and activator of transcription-3 (STAT3) were observed in animals with MCAO compared with sham control animals. Genetic activation of STAT3 through the introduction of STAT3 clustered regularly interspaced short palindromic repeats (CRISPR) plasmid prevented the loss of NK-cell-derived IFN-gamma production after MCAO, together with reduced bacterial burden and mortality. Our data suggest that brain ischemia impairs NK-cell-mediated immune defense in the periphery, at least in part through the JAK-STAT3 pathway, which can be readdressed by modulating STAT3 activation status.	[Jin, Wei-Na; Shi, Fu-Dong] Capital Med Univ, Beijing Tiantan Hosp, Ctr Neuroinflammat, Beijing 100050, Peoples R China; [Jin, Wei-Na; Liu, Qiang; Zou, Ming; Shi, Fu-Dong] Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurol, Tianjin, Peoples R China; [Jin, Wei-Na; Ducruet, Andrew F.; Liu, Qiang; Waters, Michael; Shi, Fu-Dong] St Josephs Hosp, Barrow Neurol Inst, Div Neurol & Neurosurg, Phoenix, AZ USA; [Shi, Samuel Xiang-Yu; Gonzales, Rayna] Univ Arizona, Coll Med, Dept Basic Med Sci, Phoenix, AZ 85004 USA; [Sheth, Kevin N.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA	Capital Medical University; Tianjin Medical University; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; University of Arizona; Yale University	Shi, FD (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Ctr Neuroinflammat, Beijing 100050, Peoples R China.; Gonzales, R (corresponding author), Univ Arizona, Coll Med, Dept Basic Med Sci, Phoenix, AZ 85004 USA.	rjgonzal@email.arizona.edu; fshi66@gmail.com	Liu, Qiang/HHZ-3181-2022	Gonzales, Rayna/0000-0003-1716-8988	National Science Foundation of China [91642205, 81471535, 81771274, 81471220]; U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke [R01NS092713]; American Heart Association [16SDG27250236]; National Multiple Sclerosis Society Grant [RG-1507-05318]; Arizona Alzheimer's Research Center grant; Handley Charitable Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS092713] Funding Source: NIH RePORTER	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association(American Heart Association); National Multiple Sclerosis Society Grant(National Multiple Sclerosis Society); Arizona Alzheimer's Research Center grant; Handley Charitable Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Kristofer Wood (Department of Neurology, Barrow Neurological Institute, Phoenix, AZ, USA) for editorial assistance. This work was supported by National Science Foundation of China Grants 91642205, 81471535, 81771274, 81471220; U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke Grant R01NS092713; American Heart Association Grant 16SDG27250236; National Multiple Sclerosis Society Grant RG-1507-05318; donor-directed funding "Handley Charitable Trust"; and an Arizona Alzheimer's Research Center grant. The authors declare no conflicts of interest.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bielekova B, 2006, P NATL ACAD SCI USA, V103, P5941, DOI 10.1073/pnas.0601335103; Bolen RD, 2015, J NEUROL SCI, V352, P125, DOI 10.1016/j.jns.2015.03.037; Chamorro A, 2006, STROKE, V37, P291, DOI 10.1161/01.STR.0000200561.69611.f8; Davenport RJ, 1996, STROKE, V27, P415, DOI 10.1161/01.STR.27.3.415; Dirnagl U, 2007, STROKE, V38, P770, DOI 10.1161/01.STR.0000251441.89665.bc; Du JL, 2014, MOL BIOSYST, V10, P2441, DOI 10.1039/c4mb00287c; Emsley HC, 2008, LANCET NEUROL, V7, P341, DOI 10.1016/S1474-4422(08)70061-9; Fu Y, 2015, NAT REV NEUROL, V11, P524, DOI 10.1038/nrneurol.2015.144; Gan Y, 2014, P NATL ACAD SCI USA, V111, P2704, DOI 10.1073/pnas.1315943111; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Gross CC, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00606; Hao JW, 2010, J EXP MED, V207, P1907, DOI 10.1084/jem.20092749; Hong KS, 2008, EUR J NEUROL, V15, P1324, DOI 10.1111/j.1468-1331.2008.02310.x; Hsia HC, 2017, J LEUKOCYTE BIOL, V101, P1053, DOI 10.1189/jlb.4A1016-199RR; Hug A, 2009, STROKE, V40, P3226, DOI 10.1161/STROKEAHA.109.557967; Huhn MH, 2008, CELL MICROBIOL, V10, P426, DOI 10.1111/j.1462-5822.2007.01056.x; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Jiang WZ, 2011, J IMMUNOL, V187, P781, DOI 10.4049/jimmunol.1100789; Jin WN, 2017, J CEREBR BLOOD F MET, V37, P2224, DOI 10.1177/0271678X17694185; Jin WN, 2016, J CEREBR BLOOD F MET, V36, P1464, DOI 10.1177/0271678X15611137; Kalra L, 2015, LANCET, V386, P1835, DOI 10.1016/S0140-6736(15)00126-9; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Klehmet J, 2009, NEUROSCIENCE, V158, P1184, DOI 10.1016/j.neuroscience.2008.07.044; Koennecke HC, 2011, NEUROLOGY, V77, P965, DOI 10.1212/WNL.0b013e31822dc795; Lafargue M, 2012, FASEB J, V26, P2919, DOI 10.1096/fj.11-197384; Liu Q, 2014, NEUROSCIENCE, V256, P170, DOI 10.1016/j.neuroscience.2013.10.049; Liu Q, 2017, IMMUNITY, V46, P474, DOI 10.1016/j.immuni.2017.02.015; Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Nguyen S, 2006, J NEUROIMMUNOL, V179, P117, DOI 10.1016/j.jneuroim.2006.05.028; Offner H, 2009, NEUROSCIENCE, V158, P1098, DOI 10.1016/j.neuroscience.2008.05.033; Orange JS, 2013, J ALLERGY CLIN IMMUN, V132, P515, DOI 10.1016/j.jaci.2013.07.020; Peterfalvi A, 2009, CEREBROVASC DIS, V28, P490, DOI 10.1159/000236527; Poli A, 2013, J IMMUNOL, V190, P5355, DOI 10.4049/jimmunol.1203401; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Shi FD, 2006, NAT REV IMMUNOL, V6, P751, DOI 10.1038/nri1935; Shi FD, 2011, NAT REV IMMUNOL, V11, P658, DOI 10.1038/nri3065; Tang ZW, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-26; Urra X, 2009, CURR MOL MED, V9, P195, DOI 10.2174/156652409787581574; van de Beek D, 2009, ARCH NEUROL-CHICAGO, V66, P1076, DOI 10.1001/archneurol.2009.176; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Vogelgesang A, 2008, STROKE, V39, P237, DOI 10.1161/STROKEAHA.107.493635; Wang FY, 2015, EUR J IMMUNOL, V45, P661, DOI 10.1002/eji.201444998; Wartenberg KE, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/830614; Westendorp WF, 2015, LANCET, V385, P1519, DOI 10.1016/S0140-6736(14)62456-9; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301	49	14	17	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2757	2767		10.1096/fj.201700962R	http://dx.doi.org/10.1096/fj.201700962R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29401578	Green Published			2022-12-28	WOS:000432528000035
J	Bernstock, JD; Ye, D; Smith, JA; Lee, YJ; Gessler, FA; Yasgar, A; Kouznetsova, J; Jadhav, A; Wang, ZR; Pluchino, S; Zheng, W; Simeonov, A; Hallenbeck, JM; Yang, W				Bernstock, Joshua D.; Ye, Daniel; Smith, Jayden A.; Lee, Yang-Ja; Gessler, Florian A.; Yasgar, Adam; Kouznetsova, Jennifer; Jadhav, Ajit; Wang, Zhuoran; Pluchino, Stefano; Zheng, Wei; Simeonov, Anton; Hallenbeck, John M.; Yang, Wei			Quantitative high-throughput screening identifies cytoprotective molecules that enhance SUMO conjugation via the inhibition of SUMO-specific protease (SENP)2	FASEB JOURNAL			English	Article						drug repurposing; ischemia; neuroprotection; stroke; SUMOylation	ISCHEMIC-STROKE; ENDOVASCULAR TREATMENT; NEUROPROTECTION; SUMOYLATION; HYPOTHERMIA; MECHANISMS; ACTIVATION; PROTEINS; INCREASE; EBSELEN	The development of novel neuroprotective treatments for acute stroke has been fraught with failures, which supports the view of ischemic brain damage as a highly complex multifactorial process. Post-translational modifications such as small ubiquitin-like modifier (SUMO)ylation have emerged as critical molecular regulatory mechanisms in states of both homeostasis and ischemic stress, as evidenced by our previous work. Accordingly, the clinical significance of the selective control of the global SUMOylation process has become apparent in studies of ischemic pathobiology and pathophysiology. Herein, we describe a process capable of identifying and characterizing small molecules with the potential of targeting the SUMO system through inhibition of SUMO deconjugation in an effort to develop novel stroke therapies.	[Bernstock, Joshua D.; Ye, Daniel; Lee, Yang-Ja; Hallenbeck, John M.] NINDS, Stroke Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Bernstock, Joshua D.; Smith, Jayden A.; Gessler, Florian A.; Pluchino, Stefano] Univ Cambridge, Div Stem Cell Neurobiol, Dept Clin Neurosci, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge, England; [Bernstock, Joshua D.; Smith, Jayden A.; Gessler, Florian A.; Pluchino, Stefano] Univ Cambridge, Natl Inst Hlth Res Biomed Res Ctr, Cambridge, England; [Bernstock, Joshua D.] Univ Alabama Birmingham, UAB Med Sch, Birmingham, AL USA; [Yasgar, Adam; Kouznetsova, Jennifer; Jadhav, Ajit; Zheng, Wei; Simeonov, Anton] NIH, Natl Ctr Adv Translat Sci, Bldg 10, Bethesda, MD 20892 USA; [Wang, Zhuoran; Yang, Wei] Duke Univ, Med Ctr, Dept Anesthesiol, Ctr Perioperat Organ Protect, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Cambridge; University of Cambridge; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Duke University	Bernstock, JD (corresponding author), NINDS, NIH, Bldg 10,Room 5B06, Bethesda, MD 20892 USA.; Yang, W (corresponding author), Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA.	bernstockjd@ninds.nih.gov; wei.yang@duke.edu	Zheng, Wei/J-8889-2014; Yang, Wei/ABE-2905-2021; Zheng, Wei/GQQ-8951-2022; Pluchino, Stefano/AAE-9037-2019; Zheng, Wei/GOE-5990-2022	Zheng, Wei/0000-0003-1034-0757; Pluchino, Stefano/0000-0002-6267-9472; Jadhav, Ajit/0000-0001-7955-1451; Smith, Jayden/0000-0003-2307-8452; Bernstock, Joshua/0000-0002-7814-3867; Yasgar, Adam/0000-0001-7350-1402; Ye, Daniel/0000-0002-5417-3279	NIH/NINDS [R01 NS099590]; National Center for Advancing Translational Sciences; American Heart Association [16GRNT30270003]; NIH/OxCam Fellowship; Medical Research Council [MC_PC_12009] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIATR000018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002856, R01NS099590, ZIANS002924] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); American Heart Association(American Heart Association); NIH/OxCam Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Dr. Gregory K. Friedman (University of Alabama at Birmingham) and Dr. Jorn Karhausen (Duke University Medical Center) for critical reading and editing of the manuscript. The authors also thank Dr. Dragan Maric [Flow Cytometry Core Facility, U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke Sciences (NINDS)]. This research was supported by the Intramural Research Program of the NIH/NINDS; the National Center for Advancing Translational Sciences; NIH/NINDS Grant R01 NS099590 and American Heart Association Grant 16GRNT30270003 (to W.Y.); and an NIH/OxCam Fellowship (to J.D.B.). The authors declare no conflicts of interest.	Almqvist H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11040; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernstock JD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07631-9; Bernstock JD, 2016, J CEREBR BLOOD F MET, V36, P426, DOI 10.1177/0271678X15609939; Chamorro A, 2016, LANCET NEUROL, V15, P869, DOI 10.1016/S1474-4422(16)00114-9; Chang P, 2017, F1000 RES, V6, P484; Datwyler AL, 2011, J CEREBR BLOOD F MET, V31, P2152, DOI 10.1038/jcbfm.2011.112; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Fanis P, 2012, MOL CELL PROTEOMICS, V11, P1263, DOI 10.1074/mcp.M112.017194; Fisher M, 2011, STROKE, V42, pS24, DOI 10.1161/STROKEAHA.110.592394; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Gu JM, 2014, CARDIOVASC RES, V104, P83, DOI 10.1093/cvr/cvu177; Guo C, 2013, EMBO J, V32, P1514, DOI 10.1038/emboj.2013.65; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Henley JM, 2014, PHYSIOL REV, V94, P1249, DOI 10.1152/physrev.00008.2014; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Huang R., 2011, SCI TRANSL MED, V3; Jafari R, 2014, NAT PROTOC, V9, P2100, DOI 10.1038/nprot.2014.138; Kang XL, 2010, MOL CELL, V38, P191, DOI 10.1016/j.molcel.2010.03.005; Kumar A, 2015, COMPUT STRUCT BIOTEC, V13, P204, DOI 10.1016/j.csbj.2015.03.001; Lee Y, 2007, J CEREBR BLOOD F MET, V27, P950, DOI 10.1038/sj.jcbfm.9600395; Lee YJ, 2016, J NEUROCHEM, V138, P101, DOI 10.1111/jnc.13643; Lee YJ, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00416; Lee YJ, 2013, NEUROMOL MED, V15, P771, DOI 10.1007/s12017-013-8239-9; Lee YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047787; Lee YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025852; Lee YJ, 2009, J NEUROCHEM, V109, P257, DOI 10.1111/j.1471-4159.2009.05957.x; Luo J, 2017, J TOXICOL SCI, V42, P529, DOI 10.2131/jts.42.529; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Mendes AV, 2016, BBA-MOL CELL RES, V1863, P139, DOI 10.1016/j.bbamcr.2015.10.020; Mikolajczyk J, 2007, J BIOL CHEM, V282, P26217, DOI 10.1074/jbc.M702444200; Minnerup J, 2012, INT J MOL SCI, V13, P11753, DOI 10.3390/ijms130911753; Moretti A, 2015, PHARMACOL THERAPEUT, V146, P23, DOI 10.1016/j.pharmthera.2014.09.003; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; NELSON JA, 1975, CANCER RES, V35, P2872; Noguchi N, 2016, ARCH BIOCHEM BIOPHYS, V595, P109, DOI 10.1016/j.abb.2015.10.024; Parnham MJ, 2013, BIOCHEM PHARMACOL, V86, P1248, DOI 10.1016/j.bcp.2013.08.028; Peters M, 2017, NEUROCHEM INT, V107, P66, DOI 10.1016/j.neuint.2017.03.011; Reverter D, 2006, NAT STRUCT MOL BIOL, V13, P1060, DOI 10.1038/nsmb1168; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Savitz SI, 2007, ANN NEUROL, V61, P396, DOI 10.1002/ana.21127; Seeler JS, 2017, NAT REV CANCER, V17, P184, DOI 10.1038/nrc.2016.143; Sharma P, 2013, CELL REP, V3, P1640, DOI 10.1016/j.celrep.2013.04.016; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tempe D, 2008, BIOCHEM SOC T, V36, P874, DOI 10.1042/BST0360874; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tymianski M, 2017, STROKE, V48, P1700, DOI 10.1161/STROKEAHA.117.017040; VOLONTE C, 1992, J NEUROCHEM, V58, P700, DOI 10.1111/j.1471-4159.1992.tb09774.x; Wang LL, 2012, J NEUROCHEM, V123, P349, DOI 10.1111/j.1471-4159.2012.07916.x; Yamaguchi T, 1998, STROKE, V29, P12, DOI 10.1161/01.STR.29.1.12; Yang W, 2008, J CEREBR BLOOD F MET, V28, P892, DOI 10.1038/sj.jcbfm.9600601; Yang W, 2008, J CEREBR BLOOD F MET, V28, P269, DOI 10.1038/sj.jcbfm.9600523; Yang W, 2016, STROKE VASC NEUROL, V1, P101, DOI 10.1136/svn-2016-000031; Yang W, 2013, J BIOMOL SCREEN, V18, P621, DOI 10.1177/1087057113479971; Yang W, 2009, J CEREBR BLOOD F MET, V29, P886, DOI 10.1038/jcbfm.2009.16; Yasgar A, 2016, METHODS MOL BIOL, V1439, P77, DOI 10.1007/978-1-4939-3673-1_5; Zhang L, 2017, NEUROSCIENCE, V343, P190, DOI 10.1016/j.neuroscience.2016.11.036	63	23	23	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1677	1691		10.1096/fj.201700711R	http://dx.doi.org/10.1096/fj.201700711R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29146736	Green Published			2022-12-28	WOS:000427246000044
J	Law, BA; Liao, XH; Moore, KS; Southard, A; Roddy, P; Ji, RP; Szulc, Z; Bielawska, A; Schulze, PC; Cowart, LA				Law, Brittany A.; Liao, Xianghai; Moore, Kelsey S.; Southard, Abigail; Roddy, Patrick; Ji, Ruiping; Szulc, Zdzislaw; Bielawska, Ala; Schulze, P. Christian; Cowart, L. Ashley			Lipotoxic very-long-chain ceramides cause mitochondrial dysfunction, oxidative stress, and cell death in cardiomyocytes	FASEB JOURNAL			English	Article						mitophagy; sphingolipid; diabetic cardiomyopathy; cardiovascular disease	IDIOPATHIC DILATED CARDIOMYOPATHY; RADIATION-INDUCED APOPTOSIS; HEART-FAILURE SUBSEQUENT; INSULIN-RESISTANCE; DIABETIC CARDIOMYOPATHY; MYOCARDIAL-INFARCTION; HEMODYNAMIC STRESS; RESPIRATORY-CHAIN; SYNTHASE ACTIVITY; MOUSE MODEL	Accumulating data support a role for bioactive lipids as mediators of lipotixicity in cardiomyocytes. One class of these, the ceramides, constitutes a family of molecules that differ in structure and are synthesized by distinct enzymes, ceramide synthase(CerS) 1-CerS6. Data support that specific ceramides and the enzymes that catalyze their formation play distinct roles in cell function. In a mouse model of diabetic cardiomyopathy, sphingolipid profiling revealed increases in not only the CerS5-derived ceramides but also in very long chain (VLC) ceramides derived from CerS2. Overexpression of CerS2 elevated VLC ceramides caused insulin resistance, oxidative stress, mitochondrial dysfunction, and mitophagy. Palmitate induced CerS2 and oxidative stress, mitophagy, and apoptosis, which were prevented by depletion of CerS2. Neither overexpression nor knockdown of CerS5 had any function in these processes, suggesting a chain-length dependent impact of ceramides on mitochondrial function. This concept was also supported by the observation that synthetic mitochondria-targeted ceramides led to mitophagy in a manner proportional to N-acyl chain length. Finally, blocking mitophagy exacerbated cell death. Taken together, our results support a model by which CerS2 and VLC ceramides have a distinct role in lipotoxicity, leading to mitochondrial damage, which results in subsequent adaptive mitophagy. Our data reveal a novel lipotoxic pathway through CerS2.	[Law, Brittany A.] Duke Univ, Med Ctr, Dept Med Cardiol, Durham, NC USA; [Liao, Xianghai; Ji, Ruiping; Schulze, P. Christian] Columbia Univ, Dept Med, Med Ctr, Div Cardiol, New York, NY USA; [Moore, Kelsey S.; Southard, Abigail; Roddy, Patrick; Szulc, Zdzislaw; Bielawska, Ala; Cowart, L. Ashley] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Schulze, P. Christian] Univ Jena, Friedrich Schiller Univ Jena, Div Cardiol Angiol Pneumol & Intens Med Care, Dept Internal Med 1, Jena, Germany; [Cowart, L. Ashley] Dept Vet Affairs, Charleston, SC USA	Duke University; Columbia University; Medical University of South Carolina; Friedrich Schiller University of Jena	Cowart, LA (corresponding author), MUSC, 173 Ashley Ave,Room BSB 512E, Charleston, SC 29425 USA.	lauren.cowart@vcuhealth.org	Schulze, Christian/AGJ-7744-2022	Schulze, Christian/0000-0001-9442-7141; Elliott, Brittany/0000-0001-5907-1231	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [1R01HL117233]; U.S. Department of Veteran's Affairs; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117233] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000200] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); U.S. Department of Veteran's Affairs(US Department of Veterans Affairs); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the U.S. National Institutes of Health, National Heart, Lung, and Blood Institute (Grant 1R01HL117233), the U.S. Department of Veteran's Affairs, and the American Heart Association. The authors declare no conflicts of interest.	Arora AS, 1997, HEPATOLOGY, V25, P958, DOI 10.1002/hep.510250428; Ashrafian H, 2007, CIRCULATION, V116, P434, DOI 10.1161/CIRCULATIONAHA.107.702795; Banerjee D, 2013, CIRC-HEART FAIL, V6, P364, DOI 10.1161/CIRCHEARTFAILURE.112.000022; Basu R, 2009, AM J PHYSIOL-HEART C, V297, pH2096, DOI 10.1152/ajpheart.00452.2009; BELCH JJF, 1991, BRIT HEART J, V65, P245; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Campolo J, 2007, J CARDIOVASC MED, V8, P1024, DOI 10.2459/JCM.0b013e3281053a63; Canton M, 2011, J AM COLL CARDIOL, V57, P300, DOI 10.1016/j.jacc.2010.06.058; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Chiu HC, 2005, CIRC RES, V96, P225, DOI 10.1161/01.RES.0000154079.20681.B9; Chokshi A, 2012, CIRCULATION, V125, P2844, DOI 10.1161/CIRCULATIONAHA.111.060889; COUGHLIN SS, 1994, EPIDEMIOLOGY, V5, P449, DOI 10.1097/00001648-199407000-00012; Davidson MM, 2005, J MOL CELL CARDIOL, V39, P133, DOI 10.1016/j.yjmcc.2005.03.003; Deng XZ, 2008, SCIENCE, V322, P110, DOI 10.1126/science.1158111; Di Paola M, 2000, BIOCHEMISTRY-US, V39, P6660, DOI 10.1021/bi9924415; Di Paola M, 2004, J BIOENERG BIOMEMBR, V36, P165, DOI 10.1023/B:JOBB.0000023619.97392.0c; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; FranceLanord V, 1997, J NEUROCHEM, V69, P1612; GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369; Ghafourifar P, 1999, J BIOL CHEM, V274, P6080, DOI 10.1074/jbc.274.10.6080; Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154; Hartmann D, 2012, INT J BIOCHEM CELL B, V44, P620, DOI 10.1016/j.biocel.2011.12.019; Hill MF, 1996, AM J PATHOL, V148, P291; Hill MF, 1997, CIRCULATION, V96, P2414; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hoshino A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3308; Jaishy B, 2015, J LIPID RES, V56, P546, DOI 10.1194/jlr.M055152; Kim HJ, 2012, J LIPID RES, V53, P1701, DOI 10.1194/jlr.D025627; Knaapen MWM, 2001, CARDIOVASC RES, V51, P304, DOI 10.1016/S0008-6363(01)00290-5; Kostin S, 2003, CIRC RES, V92, P715, DOI 10.1161/01.RES.0000067471.95890.5C; KUO TH, 1983, DIABETES, V32, P781, DOI 10.2337/diabetes.32.9.781; Laviad EL, 2012, J BIOL CHEM, V287, P21025, DOI 10.1074/jbc.M112.363580; Lee H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019783; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Liu L, 2009, J BIOL CHEM, V284, P36312, DOI 10.1074/jbc.M109.049817; Mallat Z, 1998, CIRCULATION, V97, P1536, DOI 10.1161/01.CIR.97.16.1536; Mesicek J, 2010, CELL SIGNAL, V22, P1300, DOI 10.1016/j.cellsig.2010.04.006; Miyata S, 2006, AM J PATHOL, V168, P386, DOI 10.2353/ajpath.2006.050137; Muriel MP, 2000, J COMP NEUROL, V426, P297, DOI 10.1002/1096-9861(20001016)426:2<297::AID-CNE10>3.0.CO;2-O; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Narula J, 2000, CURR OPIN CARDIOL, V15, P183, DOI 10.1097/00001573-200005000-00011; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; Novgorodov SA, 2016, J LIPID RES, V57, P546, DOI 10.1194/jlr.M060061; Park TS, 2008, J LIPID RES, V49, P2101, DOI 10.1194/jlr.M800147-JLR200; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; QuilletMary A, 1997, J BIOL CHEM, V272, P21388, DOI 10.1074/jbc.272.34.21388; Russell LK, 2005, J MOL CELL CARDIOL, V38, P81, DOI 10.1016/j.yjmcc.2004.10.010; Russo SB, 2013, J BIOL CHEM, V288, P13397, DOI 10.1074/jbc.M112.428185; Russo SB, 2012, J CLIN INVEST, V122, P3919, DOI 10.1172/JCI63888; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; Senkal CE, 2010, FASEB J, V24, P296, DOI 10.1096/fj.09-135087; Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059; Shen X, 2004, AM J PHYSIOL-ENDOC M, V287, pE896, DOI 10.1152/ajpendo.00047.2004; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Shimomura H, 2001, JPN CIRC J, V65, P965, DOI 10.1253/jcj.65.965; Siskind LJ, 2002, J BIOL CHEM, V277, P26796, DOI 10.1074/jbc.M200754200; Son NH, 2007, J CLIN INVEST, V117, P2791, DOI 10.1172/JCI30335; Stratford S, 2001, BIOCHEM J, V354, P359, DOI 10.1042/0264-6021:3540359; Szulc ZM, 2008, BIOORGAN MED CHEM, V16, P1015, DOI 10.1016/j.bmc.2007.08.033; Szulc ZM, 2006, BIOORGAN MED CHEM, V14, P7083, DOI 10.1016/j.bmc.2006.07.016; Watanabe E, 2006, J CARD FAIL, V12, P527, DOI 10.1016/j.cardfail.2006.05.011; Watanabe T, 2014, EXP CELL RES, V323, P314, DOI 10.1016/j.yexcr.2014.02.027; Westermeier F, 2015, BBA-MOL CELL RES, V1853, P1113, DOI 10.1016/j.bbamcr.2015.02.005; Witteles RM, 2004, J AM COLL CARDIOL, V44, P78, DOI 10.1016/j.jacc.2004.03.037; Yagyu H, 2003, J CLIN INVEST, V111, P419, DOI [10.1172/JCI200316751, 10.1172/JCI16751]; Yamamoto S, 2000, J MOL CELL CARDIOL, V32, P161, DOI 10.1006/jmcc.1999.1064; Yaoita H, 2008, HEART FAIL REV, V13, P181, DOI 10.1007/s10741-007-9074-6; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	71	99	105	4	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1403	1416		10.1096/fj.201700300R	http://dx.doi.org/10.1096/fj.201700300R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29127192	Green Published			2022-12-28	WOS:000427246000023
J	Mori, Y; Asakura, S; Yamamoto, A; Odagiri, S; Yamada, D; Sekiguchi, M; Wada, K; Sato, M; Kurabayashi, A; Suzuki, H; Kanamoto, R; Ohinata, K				Mori, Yukiha; Asakura, Saho; Yamamoto, Akane; Odagiri, Saori; Yamada, Daisuke; Sekiguchi, Masayuki; Wada, Keiji; Sato, Masaru; Kurabayashi, Atsushi; Suzuki, Hideyuki; Kanamoto, Ryuhei; Ohinata, Kousaku			Characterization of soy-deprestatin, a novel orally active decapeptide that exerts antidepressant-like effects via gut-brain communication	FASEB JOURNAL			English	Article						vagus nerve; serotonin 5-HT1A; dopamine D-1; GABA(A)	ANXIOLYTIC-LIKE ACTIVITY; D1-D2 RECEPTOR COMPLEX; FORCED SWIMMING TEST; DOPAMINE D-1; FOOD-INTAKE; MAJOR DEPRESSION; BLOOD-PRESSURE; VAGUS NERVE; ARG-PHE; MICE	We found that the orally administered thermolysin digest of beta-conglycinin exhibits antidepressant-like effects in tail suspension and forced swim tests inmice. Acomprehensive peptide analysis of the digest using liquid chromatography/mass spectrometry was performed, and LSSTQAQQSY emerged as a candidate antidepressant-like peptide. Orally administered synthetic LSSTQAQQSY exhibited antidepressant-like effects at a dose of 0.3 mg/kg; therefore, we named the decapeptide soy-deprestatin. In contrast, intraperitoneally administered soy-deprestatin was ineffective. We then hypothesized that it acted on the gut, and its signal was transferred to the brain. Indeed, orally administered soy-deprestatin exhibited antidepressant-like activity in sham-treated, but not vagotomized, mice. Oral administration of soy-deprestatin also increased the c-Fos expression in the nucleus of the solitary tract, which receives inputs from the vagus nerve. These results suggested that the antidepressant-like effects were mediated by the vagus nerve. Thermolysin digest- and soy-deprestatin-induced antidepressant-like effects were also blocked by antagonists of serotonin 5-HT1A, dopamine D-1, or GABA(A) receptors. We also clarified the order of receptor activation as 5-HT1A, D-1, and GABA(A), using selective agonists and antagonists. Taken together, soy-deprestatin may exhibit antidepressant-like effects after oral administration via a novel pathway mediated by 5-HT1A, followed by D-1 and GABA(A) systems. This is the first orally active peptide demonstrating antidepressant-like effects via gut-brain communication.	[Mori, Yukiha; Asakura, Saho; Yamamoto, Akane; Kanamoto, Ryuhei; Ohinata, Kousaku] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto 6110011, Japan; [Odagiri, Saori; Yamada, Daisuke; Sekiguchi, Masayuki; Wada, Keiji] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, Tokyo, Japan; [Sato, Masaru; Kurabayashi, Atsushi; Suzuki, Hideyuki] Kazusa DNA Res Inst, Dept Res & Dev, Kisarazu, Japan	Kyoto University; National Center for Neurology & Psychiatry - Japan; Kazusa DNA Research Institute	Ohinata, K (corresponding author), Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto 6110011, Japan.	ohinata@kais.kyoto-u.ac.jp	Suzuki, Hideyuki/J-7571-2016; Wada, Keiji/AAV-1500-2021	Yamada, Daisuke/0000-0002-6989-6736	Japanese Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food industry; Grants-in-Aid for Scientific Research [15K06730] Funding Source: KAKEN	Japanese Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food industry; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by the Japanese Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food industry. The authors declare no conflicts of interest.	Abbott CR, 2005, BRAIN RES, V1044, P127, DOI 10.1016/j.brainres.2005.03.011; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Dominguez-Lopez S, 2012, REV NEUROSCIENCE, V23, P429, DOI 10.1515/revneuro-2012-0044; Eisch AJ, 2012, SCIENCE, V338, P72, DOI 10.1126/science.1222941; EWART WR, 1983, AM J PHYSIOL, V244, pG613, DOI 10.1152/ajpgi.1983.244.6.G613; Ferres-Coy A, 2013, PSYCHOPHARMACOLOGY, V225, P61, DOI 10.1007/s00213-012-2795-9; Furmaga H, 2011, BIOL PSYCHIAT, V70, P937, DOI 10.1016/j.biopsych.2011.07.020; Hirata H, 2007, PEPTIDES, V28, P1998, DOI 10.1016/j.peptides.2007.07.024; Hou IC, 2011, J NEUROCHEM, V119, P785, DOI 10.1111/j.1471-4159.2011.07472.x; Kagebayashi T, 2012, MOL NUTR FOOD RES, V56, P1456, DOI 10.1002/mnfr.201200168; Kanegawa N, 2010, FEBS LETT, V584, P599, DOI 10.1016/j.febslet.2009.12.008; Kontani N, 2014, MOL NUTR FOOD RES, V58, P359, DOI 10.1002/mnfr.201300334; Mann JJ, 2014, DEPRESS ANXIETY, V31, P814, DOI 10.1002/da.22278; Maruyama Y, 2004, ACTA CRYSTALLOGR D, V60, P289, DOI 10.1107/S0907444903027367; Mizushige T, 2013, FASEB J, V27, P2911, DOI 10.1096/fj.12-225474; Mizushige T, 2013, NEUROSCI LETT, V543, P126, DOI 10.1016/j.neulet.2013.03.043; NIKULINA EM, 1991, PSYCHOPHARMACOLOGY, V105, P525, DOI 10.1007/BF02244374; Oda A, 2012, J NEUROCHEM, V122, P356, DOI 10.1111/j.1471-4159.2012.07777.x; Ohinata K, 2007, BIOSCI BIOTECH BIOCH, V71, P2618, DOI 10.1271/bbb.70516; Ota A, 2017, NEUROCHEM INT, V105, P51, DOI 10.1016/j.neuint.2016.12.020; Papakostas GI, 2009, J CLIN PSYCHIAT, V70, P16, DOI 10.4088/JCP.8133su1c.03; Pehrson AL, 2015, DRUG DES DEV THER, V9, P603, DOI 10.2147/DDDT.S62912; Pei L, 2010, NAT MED, V16, P1393, DOI 10.1038/nm.2263; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Richardson-Jones JW, 2011, J NEUROSCI, V31, P6008, DOI 10.1523/JNEUROSCI.5836-10.2011; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Strader AD, 2005, GASTROENTEROLOGY, V128, P175, DOI 10.1053/j.gastro.2004.10.043; Tanti A, 2010, BRIT J PHARMACOL, V159, P1187, DOI 10.1111/j.1476-5381.2009.00585.x; Thase ME, 2007, AM J PSYCHIAT, V164, P739, DOI 10.1176/appi.ajp.164.5.739; van der Kleij H, 2008, AM J PHYSIOL-REG I, V295, pD1131, DOI 10.1152/ajpregu.90434.2008; Wong AHC, 2012, CLIN PHARMACOL THER, V91, P298, DOI 10.1038/clpt.2011.311; Yamamoto Y, 2015, NEUROPEPTIDES, V51, P25, DOI 10.1016/j.npep.2015.04.002; Zeidan MP, 2007, EUR J PHARMACOL, V565, P125, DOI 10.1016/j.ejphar.2007.03.027; Zhao H, 2008, PEPTIDES, V29, P345, DOI 10.1016/j.peptides.2007.11.011	34	13	14	5	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					568	575		10.1096/fj.201700333RR	http://dx.doi.org/10.1096/fj.201700333RR			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	28970253	Bronze			2022-12-28	WOS:000425146900004
J	Cai, XC; Yuan, YX; Liao, ZR; Xing, KP; Zhu, CJ; Xu, YQ; Yu, LL; Wang, LN; Wang, SB; Zhu, XT; Gao, P; Zhang, YL; Jiang, QY; Xu, PW; Shu, G				Cai, Xingcai; Yuan, Yexian; Liao, Zhengrui; Xing, Kongping; Zhu, Canjun; Xu, Yaqiong; Yu, Lulu; Wang, Lina; Wang, Songbo; Zhu, Xiaotong; Gao, Ping; Zhang, Yongliang; Jiang, Qingyan; Xu, Pingwen; Shu, Gang			alpha-Ketoglutarate prevents skeletal muscle protein degradation and muscle atrophy through PHD3/ADRB2 pathway	FASEB JOURNAL			English	Article						tricarboxylic acid cycle; metabolite; Duchenne muscular dystrophy; metabolism	UBIQUITIN LIGASES; CANCER CACHEXIA; EXPRESSION; HYPERTROPHY; PROTEOLYSIS; CAMP; SUPPRESSES; MECHANISMS; INHIBITION; KINASE	Skeletalmuscle atrophy due to excessive protein degradation is the main cause for muscle dysfunction, fatigue, and weakening of athletic ability. Endurance exercise is effective to attenuate muscle atrophy, but the underlying mechanismhas not been fully investigated. alpha-Ketoglutarate (AKG) is akey intermediate of tricarboxylic acid cycle, which is generated during endurance exercise. Here, we demonstrated that AKG effectively attenuated corticosterone-induced protein degradation and rescued the muscle atrophy and dysfunction in a Duchenne muscular dystrophy mouse model. Interestingly, AKG also inhibited the expression of proline hydroxylase 3 (PHD3), one of the important oxidoreductases expressed under hypoxic conditions. Subsequently, we identified the beta(2) adrenergic receptor (ADRB2) as a downstreamtarget for PHD3. We found AKG inhibited PHD3/ADRB2 interaction and therefore increased the stability of ADRB2. In addition, combining pharmacologic and genetic approaches, we showed that AKG rescues skeletal muscle atrophy and protein degradation through a PHD3/ADRB2 mediated mechanism. Taken together, these data reveal a mechanism for inhibitory effects of AKG on muscle atrophy and protein degradation. These findings not only provide a molecular basis for the potential use of exercise-generated metabolite AKG in muscle atrophy treatment, but also identify PHD3 as a potential target for the development of therapies formusclewasting.	[Cai, Xingcai; Yuan, Yexian; Liao, Zhengrui; Xing, Kongping; Zhu, Canjun; Xu, Yaqiong; Yu, Lulu; Wang, Lina; Wang, Songbo; Zhu, Xiaotong; Gao, Ping; Zhang, Yongliang; Jiang, Qingyan; Shu, Gang] South China Agr Univ, Guangdong Prov Key Lab Anim Nutr Control, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China; [Jiang, Qingyan; Shu, Gang] South China Agr Univ, Natl Engn Res Ctr Breeding Swine Ind, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China; [Xu, Pingwen] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	South China Agricultural University; South China Agricultural University; Baylor College of Medicine	Shu, G (corresponding author), South China Agr Univ, Guangzhou 510640, Guangdong, Peoples R China.	shugang@scau.edu.cn	Xu, Pingwen/GRR-9137-2022		National Basic Research Program of China [2013CB127306]; National Key Point Research and Invention Program [2016YFD0501205]; Training Program for Outstanding Young Teachers in the Universities of Guangdong Province; National Natural Science Foundation of China [31572480, 31472105]; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [K99DK107008]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK107008] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Key Point Research and Invention Program; Training Program for Outstanding Young Teachers in the Universities of Guangdong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Basic Research Program of China (Grant 2013CB127306 to G.S.), National Key Point Research and Invention Program (Grant 2016YFD0501205 to G.S.), Training Program for Outstanding Young Teachers in the Universities of Guangdong Province (G.S.), National Natural Science Foundation of China (Grants 31572480 to G.S. and 31472105 to Q.J.), and the U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (Grant K99DK107008 to P.X.). The authors declare no conflicts of interest.	Anthony TG, 2016, DOMEST ANIM ENDOCRIN, V56, pS23, DOI 10.1016/j.domaniend.2016.02.012; Atherton PJ, 2016, AM J PHYSIOL-ENDOC M, V311, pE594, DOI 10.1152/ajpendo.00257.2016; Bamman MM, 2017, COLD SPRING HARB PER; Barbe C, 2015, AM J PHYSIOL-ENDOC M, V309, pE557, DOI 10.1152/ajpendo.00098.2015; Berdeaux R, 2012, AM J PHYSIOL-ENDOC M, V303, pE1, DOI 10.1152/ajpendo.00555.2011; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Bonifacio A, 2015, BBA-MOL CELL RES, V1853, P1841, DOI 10.1016/j.bbamcr.2015.04.010; Bowman SL, 2016, J CELL BIOL, V214, P797, DOI 10.1083/jcb.201512068; Cai XC, 2016, SCI REP-UK, V6, DOI 10.1038/srep26802; Carbo N, 1997, CANCER LETT, V115, P113, DOI 10.1016/S0304-3835(97)04718-6; Chung YW, 2011, J BIOL CHEM, V286, P29681, DOI 10.1074/jbc.M111.264945; Delghandi MP, 2005, CELL SIGNAL, V17, P1343, DOI 10.1016/j.cellsig.2005.02.003; Dibble CC, 2015, TRENDS CELL BIOL, V25, P545, DOI 10.1016/j.tcb.2015.06.002; Diehl J, 2016, CELL TISSUE RES, V364, P245, DOI 10.1007/s00441-015-2318-1; Duran RV, 2013, ONCOGENE, V32, P4549, DOI 10.1038/onc.2012.465; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Escobar RG, 2017, REV CHIL PEDIATR-CHI, V88, P100, DOI 10.1016/j.rchipe.2016.07.003; Fan JJ, 2017, ONCOTARGET, V8, P17475, DOI [10.18632/oncotarget.15420, 10.18632/oncotarget.15728]; Fujita N, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375964; Fuster G, 2007, CANCER RES, V67, P6512, DOI 10.1158/0008-5472.CAN-07-0231; Garvalov BK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6577; German NJ, 2016, MOL CELL, V63, P1006, DOI 10.1016/j.molcel.2016.08.014; Gianelo MCS, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20154118; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Goncalves DAP, 2012, AM J PHYSIOL-ENDOC M, V302, pE123, DOI 10.1152/ajpendo.00188.2011; Gordon BS, 2013, INT J BIOCHEM CELL B, V45, P2147, DOI 10.1016/j.biocel.2013.05.039; Grosfeld A, 2007, J BIOL CHEM, V282, P13264, DOI 10.1074/jbc.M611648200; Hinkle RT, 2005, MUSCLE NERVE, V32, P775, DOI 10.1002/mus.20416; Hou YQ, 2011, FRONT BIOSCI-LANDMRK, V16, P1186, DOI 10.2741/3783; Kang SH, 2017, AM J PHYSIOL-ENDOC M, V312, pE495, DOI 10.1152/ajpendo.00389.2016; Kornegay JN, 2017, SKELET MUSCLE, V7, DOI 10.1186/s13395-017-0124-z; Kristensen NB, 2002, J ANIM PHYSIOL AN N, V86, P239, DOI 10.1046/j.1439-0396.2002.00380.x; Lee DE, 2017, PHYSIOL GENOMICS, V49, P253, DOI 10.1152/physiolgenomics.00006.2017; Lee SW, 2004, J AM SOC NEPHROL, V15, P1537, DOI 10.1097/01.ASN.0000127211.86206.E1; Leibowitz A, 2012, ACTA NEUROBIOL EXP, V72, P385; LEPEUCH CJ, 1979, BIOCHEMISTRY-US, V18, P5267, DOI 10.1021/bi00591a001; Lieb ME, 2002, BIOCHEM CELL BIOL, V80, P421, DOI 10.1139/O02-115; Lim JY, 2016, INTEGR MED RES, V5, P176, DOI 10.1016/j.imr.2016.06.003; Malicdan MC, 2008, NEUROMUSCULAR DISORD, V18, P521, DOI 10.1016/j.nmd.2008.04.010; Minetti GC, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002038; Navegantes LCC, 2000, AM J PHYSIOL-ENDOC M, V279, pE663, DOI 10.1152/ajpendo.2000.279.3.E663; Ng R, 2012, PROG MOL BIOL TRANSL, V105, P83, DOI 10.1016/B978-0-12-394596-9.00004-4; OHTSUKA A, 1992, J NUTR SCI VITAMINOL, V38, P83, DOI 10.3177/jnsv.38.83; Percival Justin M, 2011, Biophys Rev, V3, P209, DOI 10.1007/s12551-011-0060-9; Polletta L, 2015, AUTOPHAGY, V11, P253, DOI 10.1080/15548627.2015.1009778; ROGERS JE, 1985, J BIOL CHEM, V260, P8002; Rossetti ML, 2017, MOL CELL ENDOCRINOL, V447, P35, DOI 10.1016/j.mce.2017.02.031; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sato T, 2014, MOL CELL BIOCHEM, V391, P37, DOI 10.1007/s11010-014-1984-8; Schoepflin Z. R., 2017, FASEB J; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Silveira WA, 2014, J APPL PHYSIOL, V117, P11, DOI 10.1152/japplphysiol.01055.2013; Singh Y, 2016, MOL IMMUNOL, V76, P7, DOI 10.1016/j.molimm.2016.06.003; Stephens NA, 2010, GENOME MED, V2, DOI 10.1186/gm122; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Taylor MS, 2001, GENE, V275, P125, DOI 10.1016/S0378-1119(01)00633-3; van der Heide LP, 2005, TRENDS BIOCHEM SCI, V30, P81, DOI 10.1016/j.tibs.2004.12.002; Verdijk LB, 2012, MED SCI SPORT EXER, V44, P2322, DOI 10.1249/MSS.0b013e3182667c2e; Voltarelli VA, 2014, J CELL MOL MED, V18, P1087, DOI 10.1111/jcmm.12253; Wannenes F, 2012, WORLD ALLERGY ORGAN, V5, P66, DOI 10.1097/WOX.0b013e31825eff8b; West CM, 2007, DEVELOPMENT, V134, P3349, DOI 10.1242/dev.000893; White JP, 2013, MOL CELL ENDOCRINOL, V365, P174, DOI 10.1016/j.mce.2012.10.019; Xie L, 2015, J CLIN INVEST, V125, P2759, DOI 10.1172/JCI80369; Xie L, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000444; Xue J, 2010, GASTROENTEROLOGY, V138, P606, DOI 10.1053/j.gastro.2009.09.049; Yao K, 2012, AMINO ACIDS, V42, P2491, DOI 10.1007/s00726-011-1060-6; YOUNG VR, 1978, FED PROC, V37, P2291; ZALIN RJ, 1974, CELL, V2, P103, DOI 10.1016/0092-8674(74)90098-1; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102; Zhao JH, 2015, P NATL ACAD SCI USA, V112, P15790, DOI 10.1073/pnas.1521919112	70	25	28	3	36	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					488	499		10.1096/fj.201700670R	http://dx.doi.org/10.1096/fj.201700670R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28939592	Green Published			2022-12-28	WOS:000419172700043
J	Hector, AJ; McGlory, C; Damas, F; Mazara, N; Baker, SK; Phillips, SM				Hector, Amy J.; McGlory, Chris; Damas, Felipe; Mazara, Nicole; Baker, Steven K.; Phillips, Stuart M.			Pronounced energy restriction with elevated protein intake results in no change in proteolysis and reductions in skeletal muscle protein synthesis that are mitigated by resistance exercise	FASEB JOURNAL			English	Article						muscle protein turnover; weight loss; dietary protein	FAT-FREE MASS; WEIGHT-LOSS; IN-VIVO; DIETARY-PROTEIN; AMINO-ACIDS; OLDER MEN; DEFICIT; HUMANS; MYOFIBRILLAR; INGESTION	Preservation of lean body mass (LBM) may be important during dietary energy restriction (ER) and requires equal rates of muscle protein synthesis(MPS) and muscle protein breakdown(MPB). Currently, the relative contribution of MPS and MPB to the loss of LBM during ER in humans is unknown. We aimed to determine the impact of dietary protein intake and resistance exercise on MPS and MPB during a controlled short-term energy deficit. Adult men (body mass index, 28.66 +/- 0.6 kg/m(2); age 22 +/- 1 yr) underwent 10 d of 40%-reduced energy intake while performing unilateral resistance exercise and consuming lower protein (1.2 g/kg/d, n = 12) or higher protein (2.4 g/kg/d, n = 12). Pre- and postintervention testing included dual-energy X-ray absorptiometry, primed constant infusion of ring-[C-13(6)] phenylalanine, and (15)[N] phenylalanine to measure acute postabsorptive MPS and MPB; D2O to measure integrated MPS; and gene and protein expression. There was a decrease in acute MPS after ER (higher protein, 0.059 +/- 0.006 to 0.051 +/- 0.009%/h; lower protein, 0.061 +/- 0.005 to 0.045 +/- 0.006%/h; P < 0.05) that was attenuated with resistance exercise (higher protein, 0.067 +/- 0.01%/h; lower protein, 0.061 +/- 0.006%/hr), and integrated MPS followed a similar pattern. There was no change in MPB (energy balance, 0.080 +/- 0.01%/hr; ER rested legs, 0.078 +/- 0.008%/hr; ER exercised legs, 0.079 +/- 0.006%/hr). We conclude that a reduction in MPS is the main mechanism that underpins LBM loss early in ER in adult men.	[Hector, Amy J.; McGlory, Chris; Mazara, Nicole; Phillips, Stuart M.] McMaster Univ, Dept Kinesiol, 1280 Main St West, Hamilton, ON L8S 4K1, Canada; [Baker, Steven K.] McMaster Univ, Div Phys Med & Rehabil, Dept Med, Hamilton, ON, Canada; [Damas, Felipe] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil	McMaster University; McMaster University; Universidade de Sao Paulo	Phillips, SM (corresponding author), McMaster Univ, Dept Kinesiol, 1280 Main St West, Hamilton, ON L8S 4K1, Canada.	phillis@mcmaster.ca	Damas, Felipe/S-7122-2019; Damas, Felipe/F-1143-2013; Phillips, Stuart/B-2343-2009	Damas, Felipe/0000-0001-9049-3598; Damas, Felipe/0000-0001-9049-3598; Phillips, Stuart/0000-0002-1956-4098; McGlory, Chris/0000-0003-4853-4960	National Science and Engineering Research Council of Canada; Canada Research Chairs Program	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs Program(Canada Research Chairs)	This work was supported by a grant from the National Science and Engineering Research Council of Canada (to S.M.P.). S.M.P. was supported by the Canada Research Chairs Program and greatly acknowledges that funding. The authors thank Todd Prior (McMaster University) for technical assistance during laboratory analyses. The authors declare no conflicts of interest.	Areta JL, 2014, AM J PHYSIOL-ENDOC M, V306, pE989, DOI 10.1152/ajpendo.00590.2013; Bellamy LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109739; BERGSTROM J, 1974, J APPL PHYSIOL, V36, P693, DOI 10.1152/jappl.1974.36.6.693; BIOLO G, 1995, AM J PHYSIOL-ENDOC M, V268, pE75, DOI 10.1152/ajpendo.1995.268.1.E75; Brook MS, 2016, J PHYSIOL-LONDON, V594, P7399, DOI 10.1113/JP272857; Burd NA, 2012, J APPL PHYSIOL, V113, P896, DOI 10.1152/japplphysiol.00513.2012; Burd NA, 2009, J APPL PHYSIOL, V106, P1692, DOI 10.1152/japplphysiol.91351.2008; Burke LM, 2011, J SPORT SCI, V29, pS17, DOI 10.1080/02640414.2011.585473; Canadian Institutes of Health Research Natural Sciences and Engineering Research Council of Canada and Social Sciences and Humanities Research Council of Canada, 2014, TRIC POL STAT ETH CO; Carbone JW, 2014, APPL PHYSIOL NUTR ME, V39, P960, DOI 10.1139/apnm-2013-0433; Carbone JW, 2013, FASEB J, V27, P5104, DOI 10.1096/fj.13-239228; Greenhaff PL, 2008, AM J PHYSIOL-ENDOC M, V295, pE595, DOI 10.1152/ajpendo.90411.2008; Hammond KM, 2016, MED SCI SPORT EXER, V48, P2108, DOI 10.1249/MSS.0000000000001009; Hector AJ, 2015, J NUTR, V145, P246, DOI 10.3945/jn.114.200832; Henry CJK, 2005, PUBLIC HEALTH NUTR, V8, P1133, DOI 10.1079/PHN2005801; Heymsfield SB, 2011, OBES REV, V12, pe348, DOI 10.1111/j.1467-789X.2010.00767.x; Jamart C, 2012, EUR J APPL PHYSIOL, V112, P3173, DOI 10.1007/s00421-011-2287-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longland TM, 2016, AM J CLIN NUTR, V103, P738, DOI 10.3945/ajcn.115.119339; Margolis LM, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00445; Mathis AD, 2017, MOL CELL PROTEOMICS, V16, P243, DOI 10.1074/mcp.M116.063255; Moore DR, 2009, J PHYSIOL-LONDON, V587, P897, DOI 10.1113/jphysiol.2008.164087; Murphy C. J., 2016, THESIS; Murphy CH, 2016, AM J CLIN NUTR, V104, P1594, DOI 10.3945/ajcn.116.136424; Murphy CH, 2015, EUR J SPORT SCI, V15, P21, DOI 10.1080/17461391.2014.936325; Pasiakos SM, 2015, FASEB J, V29, P1136, DOI 10.1096/fj.14-266890; Pasiakos SM, 2013, FASEB J, V27, P3837, DOI 10.1096/fj.13-230227; Pasiakos SM, 2010, J NUTR, V140, P745, DOI 10.3945/jn.109.118372; Paul PK, 2012, MOL CELL BIOL, V32, P1248, DOI 10.1128/MCB.06351-11; Phillips SM, 1997, AM J PHYSIOL-ENDOC M, V273, pE99, DOI 10.1152/ajpendo.1997.273.1.E99; Smiles WJ, 2015, AM J PHYSIOL-REG I, V309, pR603, DOI 10.1152/ajpregu.00413.2014; Stefanetti RJ, 2015, PFLUG ARCH EUR J PHY, V467, P1523, DOI 10.1007/s00424-014-1587-y; Weinheimer EM, 2010, NUTR REV, V68, P375, DOI 10.1111/j.1753-4887.2010.00298.x; Wilkinson DJ, 2014, AM J PHYSIOL-ENDOC M, V306, pE571, DOI 10.1152/ajpendo.00650.2013; Wolfe RR, 2006, AM J CLIN NUTR, V84, P475, DOI 10.1093/ajcn/84.3.475; Zhang XJ, 1996, AM J PHYSIOL-ENDOC M, V270, pE759, DOI 10.1152/ajpendo.1996.270.5.E759	36	50	50	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					265	275		10.1096/fj.201700158RR	http://dx.doi.org/10.1096/fj.201700158RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28899879				2022-12-28	WOS:000419172700025
J	McMahon, DB; Workman, AD; Kohanski, MA; Carey, RM; Freund, JR; Hariri, BM; Chen, B; Doghramji, LJ; Adappa, ND; Palmer, JN; Kennedy, DW; Lee, RJ				McMahon, Derek B.; Workman, Alan D.; Kohanski, Michael A.; Carey, Ryan M.; Freund, Jenna R.; Hariri, Benjamin M.; Chen, Bei; Doghramji, Laurel J.; Adappa, Nithin D.; Palmer, James N.; Kennedy, David W.; Lee, Robert J.			Protease-activated receptor 2 activates airway apical membrane chloride permeability and increases ciliary beating	FASEB JOURNAL			English	Article						trypsin; GPCR; calcium signaling; respiratory epithelial physiology	SEROUS ACINAR-CELLS; DUST MITE EXTRACT; EPITHELIAL-CELLS; FLUID SECRETION; LUNG INFLAMMATION; INNATE IMMUNITY; ION-TRANSPORT; NITRIC-OXIDE; TRYPSIN; RELEASE	Mucociliary clearance, driven by the engine of ciliary beating, is the primary physical airway defense against inhaled pathogens and irritants. Abetter understanding of the regulation of ciliary beating and mucociliary transport is necessary for identifying new receptor targets to stimulate improved clearance in airway diseases, such as cystic fibrosis and chronic rhinosinusitis. In this study, we examined the protease-activated receptor (PAR)-2, a GPCR previously shown to regulate airway cell cytokine and mucus secretion, and transepithelial Cl- current. PAR-2 is activated by proteases secreted by airway neutrophils and pathogens. We cultured various airway cell lines, primary human and mouse sinonasal cells, and human bronchial cells at air-liquid interface and examined them using molecular biology, biochemistry, and live-cell imaging. We found that PAR-2 is expressed basolaterally, where it stimulates both intracellular Ca2+ release and Ca2+ influx, which activates low-levelnitric oxide production, increases apical membrane Cl- permeability similar to 3-5-fold, and increases ciliary beating similar to 20-50%. No molecular or functional evidence of PAR-4 was observed. These data suggest a novel and previously overlooked role of PAR-2 in airway physiology, adding to our understanding of the role of this receptor in airway Ca2+ signaling and innate immunity.	[McMahon, Derek B.; Workman, Alan D.; Kohanski, Michael A.; Carey, Ryan M.; Freund, Jenna R.; Hariri, Benjamin M.; Chen, Bei; Doghramji, Laurel J.; Adappa, Nithin D.; Palmer, James N.; Kennedy, David W.; Lee, Robert J.] Univ Penn, Perelman Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Ravdin Bldg,5th Floor,Suite A,3400 Spruce St, Philadelphia, PA 19104 USA; [Lee, Robert J.] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Lee, RJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Ravdin Bldg,5th Floor,Suite A,3400 Spruce St, Philadelphia, PA 19104 USA.	rjl@mail.med.upenn.edu	Lee, Robert J./L-4397-2017; Carey, Ryan/AAA-8471-2019	Lee, Robert J./0000-0001-5826-6686; Freund, Jenna/0000-0001-8264-8318	U.S. National Institutes of Health, National Institute on Deafness and Other Communication Disorders [R03DC01386]; Cystic Fibrosis Foundation [LEER16G0]; Department of Otorhinolaryngology at the University of Pennsylvania; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC013862] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Department of Otorhinolaryngology at the University of Pennsylvania; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors thank M. Victoria (Perelman School of Medicine) for excellent technical assistance with PCR experiments. This study was supported by grants from U.S. National Institutes of Health, National Institute on Deafness and Other Communication Disorders (Grant R03DC01386), the Cystic Fibrosis Foundation (Grant LEER16G0), and funding from the Department of Otorhinolaryngology at the University of Pennsylvania (to R.J.L). The authors declare no conflicts of interest.	Boitano S, 2011, AM J PHYSIOL-LUNG C, V300, pL605, DOI 10.1152/ajplung.00359.2010; Bunnett NW, 2006, SEMIN THROMB HEMOST, V32, P39, DOI 10.1055/s-2006-939553; Cho HJ, 2012, J ALLERGY CLIN IMMUN, V129, P529, DOI 10.1016/j.jaci.2011.11.024; Cho HJ, 2010, J CELL BIOCHEM, V109, P1254, DOI 10.1002/jcb.22511; Chokki M, 2005, FEBS J, V272, P6387, DOI 10.1111/j.1742-4658.2005.05035.x; Chokki M, 2004, AM J RESP CELL MOL, V30, P470, DOI 10.1165/rcmb.2003-0199OC; Chow JM, 2000, BRIT J PHARMACOL, V131, P1584, DOI 10.1038/sj.bjp.0703738; Cocks TM, 2001, PULM PHARMACOL THER, V14, P183, DOI 10.1006/pupt.2001.0285; Compton SJ, 2000, J BIOL CHEM, V275, P39207, DOI 10.1074/jbc.M007215200; Cottrell GS, 2003, BIOCHEM SOC T, V31, P1191; de Boer JD, 2014, INNATE IMMUN-LONDON, V20, P618, DOI 10.1177/1753425913503387; DONG YJ, 1995, EMBO J, V14, P2700, DOI 10.1002/j.1460-2075.1995.tb07270.x; Dulon S, 2003, AM J RESP CELL MOL, V28, P339, DOI 10.1165/rcmb.4908; Ebert CS, 2014, INT FORUM ALLERGY RH, V4, P266, DOI 10.1002/alr.21295; Fulcher M Leslie, 2013, Methods Mol Biol, V945, P109, DOI 10.1007/978-1-62703-125-7_8; Grimsey N, 2014, METHOD ENZYMOL, V535, P389, DOI 10.1016/B978-0-12-397925-4.00022-5; GRUENERT DC, 1995, AM J PHYSIOL-LUNG C, V268, pL347, DOI 10.1152/ajplung.1995.268.3.L347; Hariri BM, 2017, J BIOL CHEM, V292, P8484, DOI [10.1074/jbc.M116.771949, 10.1074/jbc.m116.771949]; Hariri BM, 2016, AM J RHINOL ALLERGY, V30, P261, DOI 10.2500/ajra.2016.30.4331; Homma T, 2016, AM J RESP CELL MOL, V54, P60, DOI 10.1165/rcmb.2015-0062OC; Jairaman A, 2016, SCI REP-UK, V6, DOI 10.1038/srep32311; Jairaman A, 2015, J IMMUNOL, V195, P2122, DOI 10.4049/jimmunol.1500396; Jung SR, 2016, J GEN PHYSIOL, V147, P255, DOI 10.1085/jgp.201511477; Kunzelmann K, 2005, FASEB J, V19, P969, DOI 10.1096/fj.04-2469fje; Lan RS, 2002, PHARMACOL THERAPEUT, V95, P239, DOI 10.1016/S0163-7258(02)00237-1; Lee HM, 2007, ANN OTO RHINOL LARYN, V116, P554, DOI 10.1177/000348940711600712; Lee HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043188; Lee RJ, 2007, J PHYSIOL-LONDON, V582, P1099, DOI 10.1113/jphysiol.2007.131995; Lee RJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33221; Lee RJ, 2014, INNATE IMMUN-LONDON, V20, P606, DOI 10.1177/1753425913503386; Lee RJ, 2014, CELL CALCIUM, V55, P325, DOI 10.1016/j.ceca.2014.02.001; Lee RJ, 2014, J CLIN INVEST, V124, P1393, DOI 10.1172/JCI72094; Lee RJ, 2013, FASEB J, V27, P5094, DOI 10.1096/fj.13-234476; Lee RJ, 2012, J CLIN INVEST, V122, P4145, DOI 10.1172/JCI64240; Lee RJ, 2010, J CLIN INVEST, V120, P3137, DOI 10.1172/JCI42992; Lee RJ, 2010, AM J PHYSIOL-LUNG C, V298, pL210, DOI 10.1152/ajplung.00342.2009; Lidington EA, 2005, AM J PHYSIOL-CELL PH, V289, pC1437, DOI 10.1152/ajpcell.00502.2004; Liu CY, 2013, ARCH BIOCHEM BIOPHYS, V535, P234, DOI 10.1016/j.abb.2013.02.013; Matsuwaki Y, 2012, INT ARCH ALLERGY IMM, V158, P19, DOI 10.1159/000337756; O'Grady SM, 2013, J PHYSIOL-LONDON, V591, P4595, DOI 10.1113/jphysiol.2013.254649; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Pablo JL, 2017, J GEN PHYSIOL, V149, P37, DOI 10.1085/jgp.201611696; Palmer ML, 2006, AM J PHYSIOL-CELL PH, V290, pC1189, DOI 10.1152/ajpcell.00464.2005; Park MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092726; Peters T, 2009, BRIT J PHARMACOL, V158, P1017, DOI 10.1111/j.1476-5381.2009.00449.x; Reed CE, 2004, J ALLERGY CLIN IMMUN, V114, P997, DOI 10.1016/j.jaci.2004.07.060; Ribeiro CMP, 2005, J BIOL CHEM, V280, P17798, DOI 10.1074/jbc.M410618200; Ribeiro CMP, 2003, J GEN PHYSIOL, V122, P377, DOI 10.1085/jgp.200308893; Rothmeier AS, 2012, SEMIN IMMUNOPATHOL, V34, P133, DOI 10.1007/s00281-011-0289-1; Salathe M, 2007, ANNU REV PHYSIOL, V69, P401, DOI 10.1146/annurev.physiol.69.040705.141253; Sato S, 2005, BRIT J PHARMACOL, V146, P397, DOI 10.1038/sj.bjp.0706330; Sherwood CL, 2014, AM J PHYSIOL-CELL PH, V307, pC718, DOI 10.1152/ajpcell.00257.2014; Sisson JH, 2003, J MICROSC-OXFORD, V211, P103, DOI 10.1046/j.1365-2818.2003.01209.x; Smith Claire M, 2012, Cilia, V1, P14, DOI 10.1186/2046-2530-1-14; Stevens WW, 2015, J ALLERGY CLIN IMMUN, V136, P1442, DOI 10.1016/j.jaci.2015.10.009; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Zhou J, 2013, MOL CELL BIOCHEM, V377, P75, DOI 10.1007/s11010-013-1572-3	57	16	16	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					155	+		10.1096/fj.201700114RRR	http://dx.doi.org/10.1096/fj.201700114RRR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28874459	Green Published			2022-12-28	WOS:000419172700016
J	Weiss, E; Hanzelmann, D; Fehlhaber, B; Klos, A; von Loewenich, FD; Liese, J; Peschel, A; Kretschmer, D				Weiss, Elisabeth; Hanzelmann, Dennis; Fehlhaber, Beate; Klos, Andreas; von Loewenich, Friederike D.; Liese, Jan; Peschel, Andreas; Kretschmer, Dorothee			Formyl-peptide receptor 2 governs leukocyte influx in local Staphylococcus aureus infections	FASEB JOURNAL			English	Article						mFpr2; PSMs; innate immunity; neutrophil; Hoxb8	N-FORMYLPEPTIDE RECEPTOR; COMMUNITY-ASSOCIATED MRSA; VIRULENCE DETERMINANTS; LISTERIA-MONOCYTOGENES; NEUTROPHIL CHEMOTAXIS; BACTERIAL; PROTEIN; FPR2; IDENTIFICATION; MACROPHAGES	Leukocytes express formyl-peptide receptors (FPRs), which sensemicrobe-associated molecular pattern (MAMP) molecules, leading to leukocyte chemotaxis and activation. Werecently demonstrated that phenol-soluble modulin (PSM) peptides from highly pathogenic Staphylococcus aureus are efficient ligands for the human FPR2. HowPSMdetection by FPR2 impacts on the course of S. aureus infections has remained unknown. We characterized the specificity of mouse FPR2 (mFpr2) using a receptor-transfected cell line, homeobox b8 (Hoxb8), and primary neutrophils isolated from wild-type (WT) or mFpr2(-/-) mice. The influx of leukocytes into the peritoneum of WT and mFpr2(-/-) mice was analyzed. We demonstrate that mFpr2 is specifically activated by PSMs in mice, and they represent the first secreted pathogen-derived ligands for the mFpr2. Intraperitoneal infection with S. aureus led to lower numbers of immigrated leukocytes in mFpr2(-/-) compared with WT mice at 3 h after infection, and this difference was not observed when mice were infected with an S. aureus PSM mutant. Our data support the hypothesis that themFpr2 is the functional homolog of the human FPR2 and that amouse infectionmodel represents a suitablemodel for analyzing the role ofPSMs during infection. PSMrecognition bymFpr2 shapes leukocyte influx in local infections, the typical infections caused by S. aureus.	[Weiss, Elisabeth; Hanzelmann, Dennis; Peschel, Andreas; Kretschmer, Dorothee] Univ Tubingen, Interfac Inst Microbiol & Infect Med Tubingen IMI, Infect Biol, Morgenstelle 28, D-72076 Tubingen, Germany; [Liese, Jan] Univ Tubingen, Interfac Inst Microbiol & Infect Med Tubingen IMI, Med Microbiol & Hyg, Tubingen, Germany; [Fehlhaber, Beate; Klos, Andreas] Med Sch Hannover, Inst Med Microbiol & Hosp Epidemiol, Hannover, Germany; [von Loewenich, Friederike D.] Johannes Gutenberg Univ Mainz, Med Ctr, Dept Med Microbiol & Hyg, Mainz, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Hannover Medical School; Johannes Gutenberg University of Mainz	Kretschmer, D (corresponding author), Univ Tubingen, Interfac Inst Microbiol & Infect Med Tubingen IMI, Infect Biol, Morgenstelle 28, D-72076 Tubingen, Germany.	dorothee.kretschmer@uni-tuebingen.de	Loewenich, Friederike/AAL-1587-2020	Peschel, Andreas/0000-0002-3209-8626	German Research Council [SFB685, SFB766, TRR156, PE805/5-1, TRR34, KL 603/10-1]; University of Tubingen Medical Faculty Fortune Program	German Research Council(German Research Foundation (DFG)); University of Tubingen Medical Faculty Fortune Program	The authors thank Cordula Gekeler (University of Tubingen) for technical support, Philip Murphy for providing vectors for mFpr1 and mFpr2 cloning, and Ji Ming Wang (both from the U.S. National Institutes of Health) for providing C57BL/6 mFpr2<SUP>-/-</SUP> mice. This work was supported by grants from the German Research Council (SFB685, SFB766, TRR156, and PE805/5-1 to A.P.; TRR34 to A.P. and D.K.; and KL 603/10-1 to A.K.) and the University of Tubingen Medical Faculty Fortune Program (to D.K.). The authors declare no conflicts of interest.	Belkaid Y, 2016, NAT REV IMMUNOL, V16, P353, DOI 10.1038/nri.2016.48; Bergstrom B, 2015, J IMMUNOL, V195, P1100, DOI 10.4049/jimmunol.1403176; Bloes DA, 2015, NAT REV MICROBIOL, V13, P95, DOI 10.1038/nrmicro3390; Bloes DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039910; Bufe B, 2015, J BIOL CHEM, V290, P7369, DOI 10.1074/jbc.M114.626747; Chen KQ, 2010, J IMMUNOL, V184, P3331, DOI 10.4049/jimmunol.0903022; Correia-de-Sa P, 2013, TOXICON, V61, P16, DOI 10.1016/j.toxicon.2012.10.014; Dahlgren C, 2016, BIOCHEM PHARMACOL, V114, P22, DOI 10.1016/j.bcp.2016.04.014; de Haas CJC, 2004, J EXP MED, V199, P687, DOI 10.1084/jem.20031636; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Durr MC, 2006, CELL MICROBIOL, V8, P207, DOI 10.1111/j.1462-5822.2005.00610.x; Foster TJ, 2004, J CLIN INVEST, V114, P1693, DOI 10.1172/JCI200423825; GAO JL, 1993, J BIOL CHEM, V268, P25395; Gao JL, 1998, GENOMICS, V51, P270, DOI 10.1006/geno.1998.5376; Gao JL, 1999, J EXP MED, V189, P657, DOI 10.1084/jem.189.4.657; Gobbetti T, 2014, P NATL ACAD SCI USA, V111, P18685, DOI 10.1073/pnas.1410938111; Hanzelmann D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12304; Hartt JK, 1999, J EXP MED, V190, P741, DOI 10.1084/jem.190.5.741; Joo HS, 2011, J BIOL CHEM, V286, P8933, DOI 10.1074/jbc.M111.221382; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim HJ, 2012, J HUM GENET, V57, P247, DOI 10.1038/jhg.2012.12; Kretschmer D, 2015, J LEUKOCYTE BIOL, V97, P689, DOI 10.1189/jlb.2A0514-275R; Kretschmer D, 2012, J INNATE IMMUN, V4, P201, DOI 10.1159/000332142; Kretschmer D, 2010, CELL HOST MICROBE, V7, P463, DOI 10.1016/j.chom.2010.05.012; Kruger A, 2015, EMBO REP, V16, P1656, DOI 10.15252/embr.201540861; Liang TS, 2000, BIOCHEM BIOPH RES CO, V270, P331, DOI 10.1006/bbrc.2000.2416; Liu MY, 2012, SCI REP-UK, V2, DOI 10.1038/srep00786; McDonald JU, 2011, FASEB J, V25, P1972, DOI 10.1096/fj.10-178517; Muto Y, 2015, J MOL EVOL, V80, P130, DOI 10.1007/s00239-015-9666-z; Onnheim K, 2008, IMMUNOLOGY, V125, P591, DOI 10.1111/j.1365-2567.2008.02873.x; OSEAS RS, 1980, J LAB CLIN MED, V96, P213; Otto M, 2013, INT J MED MICROBIOL, V303, P324, DOI 10.1016/j.ijmm.2013.02.007; Prat C, 2006, J IMMUNOL, V177, P8017, DOI 10.4049/jimmunol.177.11.8017; Prat C, 2009, J IMMUNOL, V183, P6569, DOI 10.4049/jimmunol.0801523; Rabiet MJ, 2005, EUR J IMMUNOL, V35, P2486, DOI 10.1002/eji.200526338; Rautenberg M, 2011, FASEB J, V25, P1254, DOI 10.1096/fj.10-175208; Rzodkiewicz P, 2010, INFLAMM RES, V59, P187, DOI 10.1007/s00011-009-0124-5; Sharma Ashimav Deb, 2012, Indian J Dermatol, V57, P233, DOI 10.4103/0019-5154.96211; Skovbakke SL, 2016, BIOCHEM PHARMACOL, V119, P56, DOI 10.1016/j.bcp.2016.09.004; SNYDERMAN R, 1980, SCIENCE, V209, P493, DOI 10.1126/science.6248959; Sordi R, 2013, INT IMMUNOPHARMACOL, V17, P283, DOI 10.1016/j.intimp.2013.06.010; Southgate EL, 2008, J IMMUNOL, V181, P1429, DOI 10.4049/jimmunol.181.2.1429; Stempel H, 2016, J BIOL CHEM, V291, P9762, DOI 10.1074/jbc.M116.714493; Swamydas Muthulekha, 2015, Curr Protoc Immunol, V110, DOI 10.1002/0471142735.im0320s110; Thammavongsa V, 2015, NAT REV MICROBIOL, V13, P529, DOI 10.1038/nrmicro3521; Tiffany HL, 2001, J BIOL CHEM, V276, P23645, DOI 10.1074/jbc.M101031200; van Belkum A, 2009, INFECT GENET EVOL, V9, P32, DOI 10.1016/j.meegid.2008.09.012; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Xie XH, 2012, J HUAZHONG U SCI-MED, V32, P317, DOI 10.1007/s11596-012-0055-1; Yang EM, 2010, ANN ALLERG ASTHMA IM, V105, P96, DOI 10.1016/j.anai.2010.05.003; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Zhang Y, 2003, GENES IMMUN, V4, P22, DOI 10.1038/sj.gene.6363900	53	17	18	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					26	36		10.1096/fj.201700441R	http://dx.doi.org/10.1096/fj.201700441R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28855276	Green Published			2022-12-28	WOS:000419172700005
J	Lai, CJ; Cheng, HC; Lin, CY; Huang, SH; Chen, TH; Chung, CJ; Chang, CH; Wang, HD; Chuu, CP				Lai, Chih-Jen; Cheng, Hsu-Chen; Lin, Ching-Yu; Huang, Shih-Han; Chen, Ting-Huan; Chung, Chi-Jung; Chang, Chung-Ho; Wang, Horng-Dar; Chuu, Chih-Pin			Activation of liver X receptor suppresses angiogenesis via induction of ApoD	FASEB JOURNAL			English	Article						T0901317; HUVEC; Akt	ENDOTHELIAL GROWTH-FACTOR; CELL-PROLIFERATION; LIPID-METABOLISM; INHIBITION; EXPRESSION; PATHWAY; LXRS; CHOLESTEROL; MODULATION; AGONIST	LiverXreceptors (LXRs) are important sensors andregulators for cholesterol, fattyacid, andglucose. LXRs play essential roles in the development and progression of cardiovascular diseases. We examined the effects of T0901317, a potent LXR agonist, on angiogenesis of human umbilical vein endothelial cells (HUVECs). Treatment with T0901317 inhibited the tube formation and migration of HUVECs and reduced the in vivo angiogenesis, as determined by chorioallantoic membrane assay. T0901317 stimulated gene and protein expression of LXR target gene apolipoprotein D (ApoD). Overexpression of ApoD suppressed the tube formation of HUVECs. ApoD interacted with scavenger receptor class B member 1 (SR-B1), while knockdown of SR-B1 blocked suppressive effects of T0901317 on HUVEC migration. T0901317 treatment or overexpression of ApoD lessened expression of proteins regulating angiogenesis, including phospho-eNOS S1177, phospho-Akt T308, phospho-Akt S473, eNOS, mammalian target of rapamycin, VEGF-A, VEGF-C, IL-8, RhoB, matrixmetalloproteinase (MMP)-8, -9, and monocyte chemoattractant protein 1. Our study suggested that activation of LXR interferes with angiogenesis through induction of LXR target gene ApoD, which in turn suppresses PI3K-Akt-eNOS signaling, an essential pathway regulating angiogenesis. ApoD may be a potential therapeutic target for tumor angiogenesis.	[Lai, Chih-Jen; Lin, Ching-Yu; Huang, Shih-Han; Chen, Ting-Huan; Chang, Chung-Ho; Chuu, Chih-Pin] Natl Hlth Res Inst, Inst Cellular & Syst Med, 35 Keyan Rd, Miaoli 35053, Taiwan; [Lai, Chih-Jen; Chen, Ting-Huan; Wang, Horng-Dar] Natl Tsing Hua Univ, Inst Biotechnol, 101,Sect 2,Kuang Fu Rd, Hsinchu 30013, Taiwan; [Cheng, Hsu-Chen] Natl Chung Hsing Univ, Dept Life Sci, Taichung, Taiwan; [Chuu, Chih-Pin] Natl Chung Hsing Univ, Biotechnol Ctr, Taichung, Taiwan; [Huang, Shih-Han] Natl Cent Univ, Dept Life Sci, Taoyuan, Taiwan; [Chung, Chi-Jung] China Med Univ, Dept Hlth Risk Management, Taichung, Taiwan; [Chuu, Chih-Pin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Chuu, Chih-Pin] China Med Univ, Grad Program Aging, Taichung, Taiwan; [Chang, Chung-Ho] Changhua Christian Hosp, Dept Internal Med, Changhua, Taiwan	National Health Research Institutes - Taiwan; National Tsing Hua University; National Chung Hsing University; National Chung Hsing University; National Central University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; Changhua Christian Hospital	Chuu, CP (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, 35 Keyan Rd, Miaoli 35053, Taiwan.; Wang, HD (corresponding author), Natl Tsing Hua Univ, Inst Biotechnol, 101,Sect 2,Kuang Fu Rd, Hsinchu 30013, Taiwan.	hdwang@life.nthu.edu.tw; cpchuu@nhri.org.tw	Chuu, Chih-Pin/N-6697-2019; Lin, Ching Yu/AAN-9581-2020	Lin, Ching Yu/0000-0001-9041-5653; Wang, Horng-Dar/0000-0001-9570-3611; Cheng, Hsu-Chen/0000-0002-6586-6425	National Health Research Institutes [CS-105-PP-14]; Ministry of Science and Technology (MOST) [105-2314-B-400-020, 105-2628-B-400-005-MY3, 105-2923-B-400-001-MY3, 105-2633-B-400-001, 02-2311-B-007-008-MY3]; Live Cell Imaging Core Facility of the National Health Research Institutes	National Health Research Institutes(National Health Research Institutes, Japan); Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); Live Cell Imaging Core Facility of the National Health Research Institutes	The authors thank the reviewers and the editor for useful suggestions and advice. This work was supported, in part, by the National Health Research Institutes (Grants CS-105-PP-14) and the Ministry of Science and Technology (MOST; 105-2314-B-400-020, 105-2628-B-400-005-MY3, 105-2923-B-400-001-MY3, and 105-2633-B-400-001; to C.P.C. C.Y.L. is supported by MOST 105-2811-B-400-031, and H.D.W. is supported by MOST 102-2311-B-007-008-MY3. The authors acknowledge support from the Live Cell Imaging Core Facility of the National Health Research Institutes.	Alberti S, 2001, J CLIN INVEST, V107, P565, DOI 10.1172/JCI9794; Birbrair A, 2014, AM J PHYSIOL-CELL PH, V307, pC25, DOI 10.1152/ajpcell.00084.2014; Blaschke F, 2004, CIRC RES, V95, pE110, DOI 10.1161/01.RES.0000150368.56660.4f; Bouloumie A, 1999, CARDIOVASC RES, V41, P773, DOI 10.1016/S0008-6363(98)00228-4; Braesch-Andersen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115180; Cao GQ, 2003, J BIOL CHEM, V278, P1131, DOI 10.1074/jbc.M210208200; Chuu CP, 2007, J BIOMED SCI, V14, P543, DOI 10.1007/s11373-007-9160-8; Collins JL, 2002, J MED CHEM, V45, P1963, DOI 10.1021/jm0255116; Dai J, 2009, ONCOGENE, V28, P3412, DOI 10.1038/onc.2009.189; Edwards PA, 2002, VASC PHARMACOL, V38, P249, DOI 10.1016/S1537-1891(02)00175-1; Efanov AM, 2004, DIABETES, V53, pS75, DOI 10.2337/diabetes.53.suppl_3.S75; Fang LH, 2013, NATURE, V498, P118, DOI 10.1038/nature12166; Hong CC, 2015, MOL IMMUNOL, V66, P340, DOI 10.1016/j.molimm.2015.03.254; Howe GA, 2012, VASC CELL, V4, DOI 10.1186/2045-824X-4-1; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Karkkainen MJ, 2000, ONCOGENE, V19, P5598, DOI 10.1038/sj.onc.1203855; Koldamova T, 2005, J BIOL CHEM, V280, P4079, DOI 10.1074/jbc.M411420200; Kroll J, 1998, BIOCHEM BIOPH RES CO, V252, P743, DOI 10.1006/bbrc.1998.9719; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Lu CW, 2017, CANCER LETT, V388, P130, DOI 10.1016/j.canlet.2016.11.033; Maffucci T, 2005, CANCER RES, V65, P8339, DOI 10.1158/0008-5472.CAN-05-0121; Nagy JA, 2008, ANGIOGENESIS, V11, P109, DOI 10.1007/s10456-008-9099-z; Niu J, 2008, J BIOL CHEM, V283, P14542, DOI 10.1074/jbc.M802139200; Noghero A, 2012, ARTERIOSCL THROM VAS, V32, P2280, DOI 10.1161/ATVBAHA.112.250621; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Pang XF, 2010, CANCER RES, V70, P1951, DOI 10.1158/0008-5472.CAN-09-3201; Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868; Park HJ, 2006, STEM CELL REV, V2, P93, DOI 10.1007/s12015-006-0015-x; Santhekadur PK, 2012, J BIOL CHEM, V287, P3425, DOI 10.1074/jbc.M111.298976; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Verhamme P, 2006, ACTA CLIN BELG, V61, P213, DOI 10.1179/acb.2006.036; Wu BJ, 2015, INT J CARDIOL, V199, P204, DOI 10.1016/j.ijcard.2015.07.014	33	13	13	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5568	5576		10.1096/fj.201700374R	http://dx.doi.org/10.1096/fj.201700374R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28842423				2022-12-28	WOS:000416588300037
J	Liu, YN; Lou, GH; Norton, JT; Wang, C; Kandela, I; Tang, S; Shank, NI; Gupta, P; Huang, M; Avram, MJ; Green, R; Mazar, A; Appella, D; Chen, Z; Huang, S				Liu, Yanning; Lou, Guohua; Norton, John T.; Wang, Chen; Kandela, Irawati; Tang, Shuai; Shank, Nathaniel I.; Gupta, Pankaj; Huang, Min; Avram, Michael J.; Green, Richard; Mazar, Andrew; Appella, Daniel; Chen, Zhi; Huang, Sui			6-Methoxyethylamino-numonafide inhibits hepatocellular carcinoma xenograft growth as a single agent and in combination with sorafenib	FASEB JOURNAL			English	Article						MEAN; HCC therapeutic; combination treatment; C-MYC inhibition	TYROSINE-PHOSPHATASE SHP-1; LIVER-TRANSPLANTATION; MOLECULAR-MECHANISMS; CANCER; TXNIP; AMONAFIDE; SIRT1; MYC; EPIDEMIOLOGY; REGULATOR	Hepatocellular carcinoma (HCC) is the third leading form of cancer worldwide, and its incidence is increasing rapidly in the United States, tripling over the past 3 decades. The current chemotherapeutic strategies against localized and metastatic HCC are ineffective. Here we report that 6-methoxyethylamino-numonafide (MEAN) is a potent growth inhibitor of murine xenografts of 2 human HCC cell lines. At the same dose and with the same treatment strategies, MEAN was more efficacious in inhibiting tumor growth in mice than sorafenib, the only approved drug for HCC. Treatment by MEAN at an effective dose for 6 wk was well toleratedby animals. Combined therapy using both sorafenib and MEAN enhanced tumor growth inhibition over monotherapy with either agent. Additional experiments revealed that MEAN inhibited tumor growth through mechanisms distinct from those of either its parent compound, amonafide, or sorafenib. MEAN suppressed C-MYC expression and increased expression of several tumor suppressor genes, including Src homology region 2 domain-containing phosphatase-1 (SHP-1) andTXNIP (thioredoxin-interacting protein). As an encouraging feature for envisioned clinical application, the IC50 of MEAN was not significantly changed in several drug-resistant cell lines with activated P-glycoprotein drug efflux pumps compared to drug-sensitive parent cells, demonstrating the ability of MEAN to be effective in cells resistant to existing chemotherapy regimens. MEAN is a promising candidate for clinical development as a single-agent therapy or in combination with sorafenib for the management of HCC.	[Liu, Yanning; Lou, Guohua; Chen, Zhi] Zhejiang Univ, Affiliated Hosp 1, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Diag & Treatment,Coll Me, Hangzhou, Zhejiang, Peoples R China; [Norton, John T.; Wang, Chen; Huang, Sui] Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, 303 E Chicago Ave, Chicago, IL 60614 USA; [Avram, Michael J.] Northwestern Univ, Dept Anesthesiol, Feinberg Sch Med, Chicago, IL 60614 USA; [Green, Richard] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60614 USA; [Kandela, Irawati; Mazar, Andrew] Northwestern Univ, Dev Therapeut Core, Chicago, IL 60614 USA; [Tang, Shuai; Huang, Min] Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, State Key Lab Drug Res, Shanghai, Peoples R China; [Shank, Nathaniel I.; Gupta, Pankaj; Appella, Daniel] NIDDK, NIH, Bethesda, MD USA	Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Huang, S (corresponding author), Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, 303 E Chicago Ave, Chicago, IL 60614 USA.; Chen, Z (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, 79 Qingchun Rd,6A-17, Hangzhou 310003, Zhejiang, Peoples R China.	chenzhi@zju.edu.cn; s-huang2@northwestern.edu	Avram, Michael/M-7681-2019		International Science and Technology Cooperation Project (Re-Innovation Industrialization) [2012C14028]; H. Foundation; Rosenberg Foundation of the Robert H. Lurie Comprehensive Cancer Center; U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences [2 R01 GM078555-05]; NIH; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK031143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078555] Funding Source: NIH RePORTER	International Science and Technology Cooperation Project (Re-Innovation Industrialization); H. Foundation; Rosenberg Foundation of the Robert H. Lurie Comprehensive Cancer Center; U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in part, by the International Science and Technology Cooperation Project (Re-Innovation Industrialization; Gramt 2012C14028 to Z.C.); the H. Foundation and the Rosenberg Foundation of the Robert H. Lurie Comprehensive Cancer Center; the U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (Grant 2 R01 GM078555-05 to S.H.); NIH Intramural Research Program funding to D.A.; and intramural funding to M.H. The authors declare no conflicts of interest.	Abdel-Rahman O, 2014, CRIT REV ONCOL HEMAT, V92, P194, DOI 10.1016/j.critrevonc.2014.06.003; American Cancer Society, 2016, CANC FACTS FIG; AmericanCancer Society, 2017, LIV BIL DUCT CANC PA; Avram MJ, 2007, DRUG METAB DISPOS, V35, P262, DOI 10.1124/dmd.106.010652; Bellmunt J, 2011, CRIT REV ONCOL HEMAT, V78, P24, DOI 10.1016/j.critrevonc.2010.03.006; Bergeron S, 2011, ENDOCRINOLOGY, V152, P4581, DOI 10.1210/en.2011-1268; Cao ZW, 2011, CANCER RES, V71, P2286, DOI 10.1158/0008-5472.CAN-10-3367; Centers for Disease Control and Prevention, 2016, VIR HEP LIV CANC; Cervello M, 2012, CELL CYCLE, V11, P2843, DOI 10.4161/cc.21193; Chau M, 2008, LEUKEMIA RES, V32, P465, DOI 10.1016/j.leukres.2007.07.017; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Choi HN, 2011, ONCOL REP, V26, P503, DOI 10.3892/or.2011.1301; Chutkow WA, 2008, J BIOL CHEM, V283, P2397, DOI 10.1074/jbc.M708169200; Clark JM, 2006, J CLIN GASTROENTEROL, V40, pS5; Clavien PA, 2012, LANCET ONCOL, V13, pE11, DOI 10.1016/S1470-2045(11)70175-9; Costanza ME, 1999, J CLIN ONCOL, V17, P1397, DOI 10.1200/JCO.1999.17.5.1397; Delgado JS, 2008, DIGEST DIS SCI, V53, P3055, DOI 10.1007/s10620-008-0294-y; Deng KY, 2014, TUMOR BIOL, V35, P9497, DOI 10.1007/s13277-014-2511-y; Dubois MJ, 2006, NAT MED, V12, P549, DOI 10.1038/nm1397; Dunn LL, 2010, ARTERIOSCL THROM VAS, V30, P2089, DOI 10.1161/ATVBAHA.110.209643; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gabay M, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014241; Gotink KJ, 2010, ANGIOGENESIS, V13, P1, DOI 10.1007/s10456-009-9160-6; Hanish SI, 2011, ONCOLOGY-NY, V25, P752; Ingrassia L, 2009, CURR MED CHEM, V16, P1192, DOI 10.2174/092986709787846659; Innocenti F, 2001, DRUG METAB DISPOS, V29, P596; Iyer R, 2010, EXPERT OPIN PHARMACO, V11, P1943, DOI 10.1517/14656566.2010.496453; Jin HO, 2011, ONCOGENE, V30, P3792, DOI 10.1038/onc.2011.102; Jung H, 2013, CELL METAB, V18, P75, DOI 10.1016/j.cmet.2013.06.002; Kim R, 2011, ONCOLOGY-NY, V25, P283; Knight JRP, 2012, CURR OPIN ONCOL, V24, P68, DOI 10.1097/CCO.0b013e32834d813b; Kuczynski EA, 2015, CANCER RES, V75, P2510, DOI 10.1158/0008-5472.CAN-14-3687; Lane T, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00050; Liou I, 2006, J CLIN GASTROENTEROL, V40, pS11; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Liu Tie Fu, 2013, Genes Cancer, V4, P135, DOI 10.1177/1947601913476948; Liu YN, 2011, NEOPLASIA, V13, P453, DOI 10.1593/neo.101738; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Mao BB, 2011, INT J BIOCHEM CELL B, V43, P1573, DOI 10.1016/j.biocel.2011.07.006; Memon Khairuddin, 2013, Recent Results Cancer Res, V190, P207, DOI 10.1007/978-3-642-16037-0_14; Morrison JA, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-62; Nordenstedt H, 2010, DIGEST LIVER DIS, V42, pS206, DOI 10.1016/S1590-8658(10)60507-5; Norton JT, 2008, ANTI-CANCER DRUG, V19, P23, DOI 10.1097/CAD.0b013e3282f00e17; PAULL KD, 1989, J NATL CANCER I, V81, P1088, DOI 10.1093/jnci/81.14.1088; Peterson CW, 2011, FRONT BIOSCI-LANDMRK, V16, P2206, DOI 10.2741/3848; Razumilava N, 2011, ONCOLOGY-NY, V25, P300; Rhee YH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-28; Riechelmann RP, 2008, AM J CLIN ONCOL-CANC, V31, P182, DOI 10.1097/COC.0b013e3181574084; Santagata S, 2013, SCIENCE, V341, P250, DOI 10.1126/science.1238303; SAVARAJ N, 1989, CANCER INVEST, V7, P117, DOI 10.3109/07357908909038278; Schmitz R, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014282; Sewastianik T, 2014, BBA-REV CANCER, V1846, P457, DOI 10.1016/j.bbcan.2014.08.006; Sheth SS, 2006, ONCOGENE, V25, P3528, DOI 10.1038/sj.onc.1209394; Shiraha H, 2013, INT J ONCOL, V42, P1133, DOI 10.3892/ijo.2013.1829; Simmons GE, 2015, INT J MOL SCI, V16, P950, DOI 10.3390/ijms16010950; Stecklair KP, 2001, CANCER CHEMOTH PHARM, V48, P375, DOI 10.1007/s002800100367; Su JC, 2014, CARCINOGENESIS, V35, P2807, DOI 10.1093/carcin/bgu210; Suh HW, 2013, BIOCHEM BIOPH RES CO, V438, P264, DOI 10.1016/j.bbrc.2013.07.036; Uhlen M., 2015, HUM PROT ATL SIRT1; US Department of Health and Human Services, 2015, PUBL HLTH SERV POL H; Watanabe R, 2011, PHARMACOL THERAPEUT, V129, P239, DOI 10.1016/j.pharmthera.2010.09.001; Worns MA, 2013, DIGEST LIVER DIS, V45, P408, DOI 10.1016/j.dld.2012.10.010; Wu CY, 2003, GENE, V306, P1, DOI 10.1016/S0378-1119(03)00400-1; Wu G, 2014, INT J ONCOL, V45, P351, DOI 10.3892/ijo.2014.2416; Yamaguchi F, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-468; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Zhou JBA, 2011, INT J BIOCHEM CELL B, V43, P1668, DOI 10.1016/j.biocel.2011.09.005	69	8	8	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5453	5465		10.1096/fj.201700306RR	http://dx.doi.org/10.1096/fj.201700306RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28821631	Green Published			2022-12-28	WOS:000416588300028
J	Overstreet, JM; Wang, YQ; Wang, X; Niu, AL; Gewin, LS; Yao, B; Harris, RC; Zhang, MZ				Overstreet, Jessica M.; Wang, Yinqiu; Wang, Xin; Niu, Aolei; Gewin, Leslie S.; Yao, Bing; Harris, Raymond C.; Zhang, Ming-Zhi			Selective activation of epidermal growth factor receptor in renal proximal tubule induces tubulointerstitial fibrosis	FASEB JOURNAL			English	Article						EGFR; HB-EGF; EMT; tubular dysfunction; epithelial dedifferentiation	CHRONIC KIDNEY-DISEASE; ANGIOTENSIN-II; MESENCHYMAL TRANSITION; MOLECULAR-MECHANISMS; URETERAL OBSTRUCTION; INJURY; EGF; PROGRESSION; PATHOPHYSIOLOGY; EXPRESSION	Epidermal growth factor receptor (EGFR) has been implicated in the pathogenesis of diabetic nephropathy and renal fibrosis; however, the causative role of sustained EGFR activation is unclear. Here, we generated a novel kidney fibrotic mouse model of persistent EGFR activation by selectively expressing the EGFR ligand, human heparin-binding EGF-like growth factor (hHB-EGF), in renal proximal tubule epithelium. hHB-EGF expression increased tyrosine kinase phosphorylation of EGFR and the subsequent activation of downstream signaling pathways, including ERK and AKT, as well as the profibrotic TGF-beta 1/SMAD pathway. Epithelial-specific activation of EGFR was sufficient to promote spontaneous and progressive renal tubulointerstitial fibrosis, as characterized by increased collagen deposition, immune cell infiltration, and alpha-smooth muscle actin (alpha-SMA)-positive myofibroblasts. Tubule-specific EGFR activation promoted epithelial dedifferentiation and cell-cycle arrest. Furthermore, EGFR activation in epithelial cells promoted the proliferation of alpha-SMA(+) myofibroblasts in a paracrine manner. Genetic or pharmacologic inhibition of EGFR tyrosine kinase activity or downstream MEK activity attenuated the fibrotic phenotype. This study provides definitive evidence that sustained activation of EGFR in proximal epithelia is sufficient to cause spontaneous, progressive renal tubulointerstitial fibrosis, evident by epithelial dedifferentiation, increased myofibroblasts, immune cell infiltration, and increased matrix deposition.-Overstreet, J. M., Wang, Y., Wang, X., Niu, A., Gewin, L. S., Yao, B., Harris, R. C., Zhang, M.-Z. Selective activation of epidermal growth factor receptor in renal proximal tubule induces tubulointerstitial fibrosis.	[Overstreet, Jessica M.; Wang, Yinqiu; Wang, Xin; Niu, Aolei; Gewin, Leslie S.; Yao, Bing; Harris, Raymond C.; Zhang, Ming-Zhi] Vanderbilt Univ, Div Nephrol, Sch Med, 1161 21st Ave South,C3121 MCN, Nashville, TN 37232 USA; [Harris, Raymond C.; Zhang, Ming-Zhi] Vanderbilt Univ, Vanderbilt Ctr Kidney Dis, Sch Med, Nashville, TN 37232 USA; [Gewin, Leslie S.; Harris, Raymond C.] Nashville Vet Affairs Hosp, Dept Nephrol, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Harris, RC (corresponding author), Vanderbilt Univ, Div Nephrol, Sch Med, 1161 21st Ave South,C3121 MCN, Nashville, TN 37232 USA.	ray.harris@vanderbilt.edu			U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [DK51265, DK95785, DK103067, T32DK07569]; Veterans Affairs Merit Award [00507969]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051265, T32DK007569, R01DK095785, R01DK108968, R24DK103067] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grants DK51265, DK95785, and DK103067 (to R.C.H. and M.-Z.Z.) and T32DK07569 (to J.M.O.); Veterans Affairs Merit Award 00507969 (to R.C.H.). The authors declare no conflicts of interest.	Bollee G, 2011, NAT MED, V17, P1242, DOI 10.1038/nm.2491; Cao Q, 2014, KIDNEY INT SUPPL, V4, P16, DOI 10.1038/kisup.2014.4; Chen JC, 2012, J AM SOC NEPHROL, V23, P215, DOI 10.1681/ASN.2011070645; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; Dick FA, 2013, NAT REV MOL CELL BIO, V14, P297, DOI 10.1038/nrm3567; Ding H, 2012, J AM SOC NEPHROL, V23, P801, DOI 10.1681/ASN.2011060614; Eddy AA, 2005, ADV CHRONIC KIDNEY D, V12, P353, DOI 10.1053/j.ackd.2005.07.011; Endo T, 2015, J PATHOL, V236, P251, DOI 10.1002/path.4514; Friedman SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004700; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Grgic I, 2012, KIDNEY INT, V82, P172, DOI 10.1038/ki.2012.20; Guo JK, 2010, ANNU REV PHYSIOL, V72, P357, DOI 10.1146/annurev.physiol.010908.163245; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kefaloyianni E, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87023; Kim MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143961; Kok HM, 2014, NAT REV NEPHROL, V10, P700, DOI 10.1038/nrneph.2014.184; Lautrette A, 2005, NAT MED, V11, P867, DOI 10.1038/nm1275; Lee DC, 2003, ANN NY ACAD SCI, V995, P22, DOI 10.1111/j.1749-6632.2003.tb03207.x; Liu N, 2012, J AM SOC NEPHROL, V23, P854, DOI 10.1681/ASN.2011050493; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; LUETTEKE NC, 1994, GENE DEV, V8, P399, DOI 10.1101/gad.8.4.399; Maarouf OH, 2016, J AM SOC NEPHROL, V27, P781, DOI 10.1681/ASN.2014121188; Meng XM, 2014, NAT REV NEPHROL, V10, P493, DOI 10.1038/nrneph.2014.114; Meran S, 2011, INT J EXP PATHOL, V92, P158, DOI 10.1111/j.1365-2613.2011.00764.x; Miyazawa T, 2013, KIDNEY INT, V84, P1176, DOI 10.1038/ki.2013.214; Mulder GM, 2010, J PATHOL, V221, P183, DOI 10.1002/path.2698; Overstreet JM, 2015, FASEB J, V29, P1258, DOI 10.1096/fj.14-262527; Ozawa Y, 2007, AM J PHYSIOL-RENAL, V292, pF330, DOI 10.1152/ajprenal.00059.2006; Rayego-Mateos S, 2013, J PATHOL, V231, P480, DOI 10.1002/path.4250; Rayego-Mateos S, 2013, J MOL CELL BIOL, V5, P323, DOI 10.1093/jmcb/mjt030; Rockey DC, 2015, NEW ENGL J MED, V372, P1138, DOI 10.1056/NEJMra1300575; Samarakoon R, 2015, J PATHOL, V236, P421, DOI 10.1002/path.4538; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Tapmeier TT, 2010, KIDNEY INT, V78, P351, DOI 10.1038/ki.2010.177; Grande MT, 2015, NAT MED, V21, P989, DOI 10.1038/nm.3901; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Yang L, 2011, CONTRIB NEPHROL, V174, P149, DOI 10.1159/000329385; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Zeng FH, 2016, AM J PHYSIOL-RENAL, V311, pF695, DOI 10.1152/ajprenal.00377.2015; Zeng FH, 2009, EXP CELL RES, V315, P602, DOI 10.1016/j.yexcr.2008.08.005; Zhang MZ, 2014, DIABETES, V63, P2063, DOI 10.2337/db13-1279; Zhang MZ, 2012, J CLIN INVEST, V122, P4519, DOI 10.1172/JCI60363; Zhuang S, 2008, AM J PHYSIOL-RENAL, V294, pF459, DOI 10.1152/ajprenal.00473.2007	44	36	39	2	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4407	4421		10.1096/fj.201601359RR	http://dx.doi.org/10.1096/fj.201601359RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28626027	Green Published			2022-12-28	WOS:000413397400019
J	Chen, HZ; Bai, JL; Dong, F; Fang, HZ; Zhang, Y; Meng, W; Liu, BL; Luo, Y; Liu, ML; Bai, YD; Abdul-Ghani, MA; Li, RX; Wu, JR; Zeng, R; Zhou, ZG; Dong, LQ; Liu, F				Chen, Hongzhi; Bai, Juli; Dong, Feng; Fang, Hezhi; Zhang, Yun; Meng, Wen; Liu, Bilian; Luo, Yan; Liu, Meilian; Bai, Yidong; Abdul-Ghani, Muhammad A.; Li, Rongxia; Wu, Jiarui; Zeng, Rong; Zhou, Zhiguang; Dong, Lily Q.; Liu, Feng			Hepatic DsbA-L protects mice from diet-induced hepatosteatosis and insulin resistance (vol 31, pg 2314, 2017)	FASEB JOURNAL			English	Correction									Cent S Univ, Natl Clin Res Ctr Metab Dis, Key Lab Diabet Immunol,Minist Educ,Xiangya Hosp 2, Dept Metab & Endocrinol,Metab Syndrome Res Ctr, Changsha, Hunan, Peoples R China; [Chen, Hongzhi; Liu, Feng] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Bai, Juli; Liu, Feng] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Dong, Feng; Abdul-Ghani, Muhammad A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Fang, Hezhi; Bai, Yidong; Dong, Lily Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Liu, Meilian] Univ New Mexico, Hlth Sci Ctr, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA; [Li, Rongxia; Wu, Jiarui; Zeng, Rong] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China	Central South University; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of New Mexico; University of New Mexico's Health Sciences Center; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Liu, F (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Endocrinol & Metab, Changsha 410011, Hunan, Peoples R China.	liuf@uthscsa.edu	Bai, Juli/AAY-1770-2020; Liu, Feng/CAG-8962-2022; Bai, Yidong/A-4959-2012; Bai, Juli/AAR-8235-2020	Bai, Juli/0000-0002-1193-8155				Chen HZ, 2017, FASEB J, V31, P2314, DOI 10.1096/fj.201600985R	1	0	0	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					4203	4203		10.1096/fj.201600985RERR	http://dx.doi.org/10.1096/fj.201600985RERR			1	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28860308	Green Published			2022-12-28	WOS:000408713300042
J	Ohnishi, T; Hashizume, C; Taniguchi, M; Furumoto, H; Han, J; Gao, RF; Kinami, S; Kosaka, T; Okazaki, T				Ohnishi, Toshio; Hashizume, Chieko; Taniguchi, Makoto; Furumoto, Hidehiro; Han, Jia; Gao, Rongfen; Kinami, Shinichi; Kosaka, Takeo; Okazaki, Toshiro			Sphingomyelin synthase 2 deficiency inhibits the induction of murine colitis-associated colon cancer	FASEB JOURNAL			English	Article						SMS2; ceramide; colon inflammation; tumorigenesis	SODIUM-INDUCED COLITIS; COLORECTAL-CANCER; ULCERATIVE-COLITIS; SMS2 DEFICIENCY; CELL APOPTOSIS; MICE; INFLAMMATION; CERAMIDE; ACTIVATION; ATHEROSCLEROSIS	Sphingomyelin synthase 2 (SMS2) is the synthetic enzyme of sphingomyelin (SM), which regulates membrane fluidity and microdomain structure. SMS2 plays a role in LPS-induced lung injury and inflammation; however, its role in inflammation-mediated tumorigenesis is unclear. We investigated the effect of SMS2 deficiency on dextran sodium sulfate (DSS)-induced murine colitis and found inhibition of DSS-induced inflammation in SMS2-deficient (SMS2(-/-)) mice. DSS treatment induced a significant increase in ceramide levels, with a decrease of SM levels in SMS2(-/-) colon tissue, and demonstrated attenuation of the elevation of both inflammation-related gene expression and proinflammatory cytokines and chemokines, leukocyte infiltration, and MAPK and signal transducer and activator of transcription 3 activation. After undergoing transplantation of wild-type bone marrow, SMS2(-/-) mice also exhibited inhibition of DSS-induced inflammation in the colon, which suggested that SMS2 deficiency in bone marrow-derived immune cells was not involved in the inhibition of colitis. Finally, in an azoxymethane/DSS-induced cancer model, SMS2 deficiency significantly decreased tumor incidence in the colon. Our results demonstrate that SMS2 deficiency inhibits DSS-induced colitis and subsequent colitis-associated colon cancer via inhibition of colon epithelial cell-mediated inflammation; therefore, inhibition of SMS2 may be a potential therapeutic target for human colitis and colorectal cancer.	[Ohnishi, Toshio; Kinami, Shinichi; Kosaka, Takeo] Kanazawa Med Univ, Med Res Inst, Div Gen & Digest Surg, Uchinada, Ishikawa, Japan; [Hashizume, Chieko; Furumoto, Hidehiro; Gao, Rongfen; Okazaki, Toshiro] Kanazawa Med Univ, Med Res Inst, Div Hematol Immunol, Uchinada, Ishikawa, Japan; [Han, Jia] Kanazawa Med Univ, Div Med Oncol, Dept Med, Med Res Inst, Uchinada, Ishikawa, Japan; [Taniguchi, Makoto] Kanazawa Med Univ, Med Res Inst, Dept Life Sci, Uchinada, Ishikawa, Japan; [Okazaki, Toshiro] Kanazawa Med Univ, Med Res Inst, Dept Adv Med, Uchinada, Ishikawa, Japan	Kanazawa Medical University; Kanazawa Medical University; Kanazawa Medical University; Kanazawa Medical University; Kanazawa Medical University	Okazaki, T (corresponding author), Kanazawa Med Univ, Div Hematol Immunol, Dept Med, 1-1 Daigaku, Uchinada, Ishikawa, Japan.	toshiroo@kanazawa-med.ac.jp	Taniguchi, Makoto/L-5757-2019	Taniguchi, Makoto/0000-0001-5920-8285	Takeda Science Foundation; Strategic Research Foundation Grant-Aided Project for Private Universities from the Japan Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [S1201004]; Kanazawa Medical University [H2012-15]	Takeda Science Foundation(Takeda Science Foundation (TSF)); Strategic Research Foundation Grant-Aided Project for Private Universities from the Japan Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Kanazawa Medical University	This work was supported, in part, by the Takeda Science Foundation and grants from the Strategic Research Foundation Grant-Aided Project for Private Universities (Grant S1201004) from the Japan Ministry of Education, Culture, Sports, Science, and Technology (MEXT), and from Kanazawa Medical University (H2012-15; 2012-2016). The authors thank Dr. Yoshimichi Ueda (Kanazawa Medical University) for the pathologic assessment of mouse specimens. The authors also thank Dr. Hideo Ogiso (Kanazawa Medical University) for performing liquid chromatography-tandem mass spectrometry analysis.	Asano S, 2012, MOL CELL BIOL, V32, P3242, DOI 10.1128/MCB.00121-12; Bauer J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007197; Begagne E, 2014, J CLIN INVEST, V124, P5368, DOI 10.1172/JCI74188; Braun A, 2009, INFLAMM BOWEL DIS, V15, P1705, DOI 10.1002/ibd.20993; Bromberg J, 2009, CANCER CELL, V15, P79, DOI 10.1016/j.ccr.2009.01.009; Candido J, 2013, J CLIN IMMUNOL, V33, pS79, DOI 10.1007/s10875-012-9847-0; Chen Y, 2015, MOL CANCER THER, V14, P259, DOI 10.1158/1535-7163.MCT-14-0468-T; Clapper ML, 2007, ACTA PHARMACOL SIN, V28, P1450, DOI 10.1111/j.1745-7254.2007.00695.x; Dong LL, 2012, INT IMMUNOL, V24, P327, DOI 10.1093/intimm/dxs008; Fan YF, 2010, ARTERIOSCL THROM VAS, V30, P2114, DOI 10.1161/ATVBAHA.110.213363; Fischbeck A, 2011, GUT, V60, P55, DOI 10.1136/gut.2009.201988; Furuya H, 2011, CANCER METAST REV, V30, P567, DOI 10.1007/s10555-011-9304-1; Galadari S, 2015, APOPTOSIS, V20, P689, DOI 10.1007/s10495-015-1109-1; Garcia-Barros M, 2014, BBA-MOL CELL BIOL L, V1841, P773, DOI 10.1016/j.bbalip.2013.09.007; Gommeaux J, 2007, MOL CELL BIOL, V27, P2215, DOI 10.1128/MCB.01454-06; Gowda S, 2011, AM J PHYSIOL-LUNG C, V300, pL430, DOI 10.1152/ajplung.00208.2010; Grivennikov SI, 2013, SEMIN IMMUNOPATHOL, V35, P229, DOI 10.1007/s00281-012-0352-6; Hailemariam TK, 2008, ARTERIOSCL THROM VAS, V28, P1519, DOI 10.1161/ATVBAHA.108.168682; Hayashi Y, 2014, J BIOL CHEM, V289, P30842, DOI 10.1074/jbc.M114.574285; Heinz LX, 2015, CELL REP, V11, P1919, DOI 10.1016/j.celrep.2015.05.006; Hertervig E, 1997, CANCER, V79, P448, DOI 10.1002/(SICI)1097-0142(19970201)79:3<448::AID-CNCR4>3.0.CO;2-E; Iwai K, 2003, J BIOL CHEM, V278, P9813, DOI 10.1074/jbc.M201867200; Kawamori T, 2009, FASEB J, V23, P405, DOI 10.1096/fj.08-117572; Lakatos PL, 2008, WORLD J GASTROENTERO, V14, P3937, DOI 10.3748/wjg.14.3937; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Liu J, 2009, CIRC RES, V105, P295, DOI 10.1161/CIRCRESAHA.109.194613; Lu MH, 2012, J PHYSIOL-LONDON, V590, P4029, DOI 10.1113/jphysiol.2012.235846; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Mitsutake S, 2011, J BIOL CHEM, V286, P28544, DOI 10.1074/jbc.M111.255646; Nielsen MMB, 2016, SCI REP-UK, V6, DOI 10.1038/srep39571; Risco A, 2012, P NATL ACAD SCI USA, V109, P11200, DOI 10.1073/pnas.1207290109; Sawai H., 2015, BIOACTIVE SPHINGOLIP, P23; Schilling JD, 2013, J BIOL CHEM, V288, P2923, DOI 10.1074/jbc.M112.419978; Shakor ABA, 2011, J BIOL CHEM, V286, P36053, DOI 10.1074/jbc.M111.228593; Sjoqvist U, 2002, INFLAMM BOWEL DIS, V8, P258; Snider AJ, 2009, FASEB J, V23, P143, DOI 10.1096/fj.08-118109; Taniguchi M, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.82; Taniguchi M, 2014, BBA-MOL CELL BIOL L, V1841, P692, DOI 10.1016/j.bbalip.2013.12.003; Taniguchi M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.416552; Tenesa A, 2009, NAT REV GENET, V10, P353, DOI 10.1038/nrg2574; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Venable ME, 1995, J BIOL CHEM, V270, P30701, DOI 10.1074/jbc.270.51.30701; Wang K, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.36; Yamaoka S, 2004, J BIOL CHEM, V279, P18688, DOI 10.1074/jbc.M401205200; Yan GF, 2016, ONCOTARGET, V7, P33429, DOI 10.18632/oncotarget.7960; Zhang Y, 2011, BIOCHEM PHARMACOL, V82, P287, DOI 10.1016/j.bcp.2011.04.009	46	32	33	5	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3816	3830		10.1096/fj.201601225RR	http://dx.doi.org/10.1096/fj.201601225RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28522594				2022-12-28	WOS:000408713300010
J	Roy, J; Galano, JM; Durand, T; Le Guennec, JY; Lee, JCY				Roy, Jerome; Galano, Jean-Marie; Durand, Thierry; Le Guennec, Jean-Yves; Lee, Jetty Chung-Yung			Physiological role of reactive oxygen species as promoters of natural defenses	FASEB JOURNAL			English	Review						oxidative stress; redox pathologies; redox homeostasis; redox signaling	NITRIC-OXIDE SYNTHASE; EXTENDS LIFE-SPAN; OXIDATIVE STRESS; NADPH OXIDASE; HYDROGEN-PEROXIDE; FREE-RADICALS; SUPEROXIDE-DISMUTASE; IN-VIVO; LIPID-PEROXIDATION; NAD(P)H OXIDASE	It has been 60 yr since the discovery of reactive oxygen species (ROS) in biology and the beginning of the scientific community's attempt to understand the impact of the unpaired electron of ROS molecules in biological pathways, which was eventually noted to be toxic. Several studies have shown that the presence of ROS is essential in triggering or acting as a secondary factor for numerous pathologies, including metabolic and genetic diseases; however, it was demonstrated that chronic treatment with antioxidants failed to show efficacy and positive effects in the prevention of diseases or health complications that result from oxidative stress. On the contrary, such treatment has been shown to sometimes even worsen the disease. Because of the permanent presence of ROS in organisms, elaborate mechanisms to adapt with these reactive molecules and to use them without necessarily blocking or preventing their actions have been studied. There is now a large body of evidence that shows that living organisms have conformed to the presence of ROS and, in retrospect, have adapted to the bioactive molecules that are generated by ROS on proteins, lipids, and DNA. In addition, ROS have undergone a shift from being molecules that invoked oxidative damage in regulating signaling pathways that impinged on normal physiological and redox responses. Working in this direction, this review unlocks a new conception about the involvement of cellular oxidants in the maintenance of redox homeostasis in redox regulation of normal physiological functions, and an explanation for its essential role in numerous pathophysiological states is noted.	[Roy, Jerome] Univ Montreal, CRCHUM, 900 Rue St Denis, Montreal, PQ H2X 0A9, Canada; [Roy, Jerome] Univ Montreal, Montreal Diabet Res Ctr, Dept Nutr, 900 Rue St Denis, Montreal, PQ H2X 0A9, Canada; [Roy, Jerome; Le Guennec, Jean-Yves] Univ Montpellier, CNRS, Unite Mixte Rech 9214, Inserm,Unite Physiol & Med Expt Coeur & Muscles, Montpellier, France; [Galano, Jean-Marie; Durand, Thierry] Univ Montpellier, Inst Biomol Max Mousseron, Ecole Natl Super Chim Montpellier, CNRS,Unite Mixte Rech 5247, Montpellier, France; [Lee, Jetty Chung-Yung] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China	Universite de Montreal; Universite de Montreal; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; University of Hong Kong	Roy, J (corresponding author), Univ Montreal, CRCHUM, 900 Rue St Denis, Montreal, PQ H2X 0A9, Canada.; Roy, J (corresponding author), Univ Montreal, Montreal Diabet Res Ctr, Dept Nutr, 900 Rue St Denis, Montreal, PQ H2X 0A9, Canada.	jerome.roy1902@gmail.com	Lee, Jetty Chung-Yung/S-1443-2019; Roy, Jerome/AAX-9842-2021; Lee, Jetty Chung-Yung/E-1475-2011	Lee, Jetty Chung-Yung/0000-0002-8175-7069; Lee, Jetty Chung-Yung/0000-0002-8175-7069; jerome, roy/0000-0002-3007-1585	Fondation pour la Recherche Medicale [FRM 40199]	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	J.R. was supported by the Fondation pour la Recherche Medicale (FRM 40199). The authors declare no conflicts of interest.	ABDALLA DSP, 1986, CLIN CHEM, V32, P805; Aikawa R, 2001, BIOCHEM BIOPH RES CO, V289, P901, DOI 10.1006/bbrc.2001.6068; ALBELDA SM, 1994, FASEB J, V8, P504, DOI 10.1096/fasebj.8.8.8181668; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Babaei S, 2003, AM J PATHOL, V162, P1927, DOI 10.1016/S0002-9440(10)64326-X; BABIOR BM, 1994, ENVIRON HEALTH PERSP, V102, P53, DOI 10.2307/3432214; Babior BM, 2000, AM J MED, V109, P33, DOI 10.1016/S0002-9343(00)00481-2; Bae YS, 2000, J BIOL CHEM, V275, P10527, DOI 10.1074/jbc.275.14.10527; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Banki K, 1999, J IMMUNOL, V162, P1466; Bauerova K, 1999, GEN PHYSIOL BIOPHYS, V18, P15; BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405; BEAUDEUX JL, 2006, IMMUNO-ANAL BIOL SPE, V21, P144, DOI DOI 10.1016/J.IMMBIO.2006.02.001; Beauvillain C., 2012, EMC BIOL MED PARIS, V7, P1; Becker LB, 2004, CARDIOVASC RES, V61, P461, DOI 10.1016/j.cardiores.2003.10.025; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Bell EL, 2007, MOL CELL BIOL, V27, P5737, DOI 10.1128/MCB.02265-06; Berry CE, 2004, J PHYSIOL-LONDON, V555, P589, DOI 10.1113/jphysiol.2003.055913; Blakytny R, 2006, DIABETIC MED, V23, P594, DOI 10.1111/j.1464-5491.2006.01773.x; BRADY PS, 1979, J NUTR, V109, P1103, DOI 10.1093/jn/109.6.1103; Bunn HF, 1996, PHYSIOL REV, V76, P839, DOI 10.1152/physrev.1996.76.3.839; BURTON KP, 1990, J MOL CELL CARDIOL, V22, P1035, DOI 10.1016/0022-2828(90)91043-7; Canbolat O, 1998, RESP PHYSIOL, V114, P175, DOI 10.1016/S0034-5687(98)00080-2; Cao Y, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1219-8; Gomez-Cabrera MC, 2015, FREE RADICAL BIO MED, V86, P37, DOI 10.1016/j.freeradbiomed.2015.04.006; CHANCE B, 1971, BIOCHEM J, V122, P225, DOI 10.1042/bj1220225; Chandrasekaran V, 2015, MOL CELL NEUROSCI, V67, P116, DOI 10.1016/j.mcn.2015.06.007; Chen ZY, 1998, J MOL CELL CARDIOL, V30, P2281, DOI 10.1006/jmcc.1998.0789; COMMONER B, 1954, NATURE, V174, P689, DOI 10.1038/174689a0; Comporti M, 2004, FREE RADICAL BIO MED, V37, P724, DOI 10.1016/j.freeradbiomed.2004.06.007; Cunnane G, 2001, ARTHRITIS RHEUM, V44, P2263, DOI 10.1002/1529-0131(200110)44:10<2263::AID-ART389>3.3.CO;2-T; Date M, 2002, J AM COLL CARDIOL, V39, P907, DOI 10.1016/S0735-1097(01)01826-5; DAVIES KJA, 1987, J BIOL CHEM, V262, P9895; de Medina P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2835; de Medina P, 2009, J MED CHEM, V52, P7765, DOI 10.1021/jm901063e; De Vos K, 1998, J BIOL CHEM, V273, P9673, DOI 10.1074/jbc.273.16.9673; Delbosc S, 2002, HYPERTENSION, V40, P142, DOI 10.1161/01.HYP.0000024348.87637.6F; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; DILLARD CJ, 1978, J APPL PHYSIOL, V45, P927, DOI 10.1152/jappl.1978.45.6.927; DIZDAROGLU M, 1992, MUTAT RES, V275, P331, DOI 10.1016/0921-8734(92)90036-O; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Durand T, 2005, PATHOL BIOL, V53, P349, DOI 10.1016/j.patbio.2004.10.005; ECK HP, 1989, BIOL CHEM H-S, V370, P101, DOI 10.1515/bchm3.1989.370.1.101; ENTMAN ML, 1993, CIRCULATION, V88, P800, DOI 10.1161/01.CIR.88.2.800; Esteve JM, 1999, FASEB J, V13, P1055, DOI 10.1096/fasebj.13.9.1055; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; FANDREY J, 1994, BIOCHEM J, V303, P507, DOI 10.1042/bj3030507; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Frenette PS, 1996, NEW ENGL J MED, V334, P1526, DOI 10.1056/NEJM199606063342308; Genestra M, 2007, CELL SIGNAL, V19, P1807, DOI 10.1016/j.cellsig.2007.04.009; Gonzalez DR, 2007, P NATL ACAD SCI USA, V104, P20612, DOI 10.1073/pnas.0706796104; GONZALEZFLECHA B, 1993, J CLIN INVEST, V91, P456, DOI 10.1172/JCI116223; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Gupte SA, 2006, PULM PHARMACOL THER, V19, P303, DOI 10.1016/j.pupt.2005.08.002; Ha HC, 2000, CLIN CANCER RES, V6, P3783; Halliwell B., 2015, Free radicals in biology and medicine; Hamanaka RB, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003638; Hamuro Junji, 1999, V48, P153; Hanzen S, 2016, CELL, V166, P140, DOI 10.1016/j.cell.2016.05.006; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124; Hehner SP, 2000, J IMMUNOL, V165, P4319, DOI 10.4049/jimmunol.165.8.4319; Higuchi Y, 2002, J MOL CELL CARDIOL, V34, P233, DOI 10.1006/jmcc.2001.1505; Hingtgen SD, 2006, PHYSIOL GENOMICS, V26, P180, DOI 10.1152/physiolgenomics.00029.2005; Hirotani S, 2002, CIRCULATION, V105, P509, DOI 10.1161/hc0402.102863; Hodara R, 2011, ARTERIOSCL THROM VAS, V31, P2203, DOI 10.1161/ATVBAHA.111.233247; Hohn A, 2013, J PROTEOMICS, V92, P132, DOI 10.1016/j.jprot.2013.01.004; Hokayem M, 2013, DIABETES CARE, V36, P1454, DOI 10.2337/dc12-1652; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Irani K, 2000, CIRC RES, V87, P179, DOI 10.1161/01.RES.87.3.179; Jamil J, 2014, NEUROCHEM RES, V39, P2360, DOI 10.1007/s11064-014-1436-6; Johnson TM, 1996, P NATL ACAD SCI USA, V93, P11848, DOI 10.1073/pnas.93.21.11848; Jones DP, 2006, ANTIOXID REDOX SIGN, V8, P1865, DOI 10.1089/ars.2006.8.1865; Jude S, 2003, BRIT J PHARMACOL, V139, P816, DOI 10.1038/sj.bjp.0705308; Juntilla MM, 2010, BLOOD, V115, P4030, DOI 10.1182/blood-2009-09-241000; Kadam DP, 2010, INDIAN J CLIN BIOCHE, V25, P388, DOI 10.1007/s12291-010-0043-9; Kaikkonen JE, 2013, ANN MED, V45, P455, DOI 10.3109/07853890.2013.809915; Kaminski M, 2007, MOL CELL BIOL, V27, P3625, DOI 10.1128/MCB.02295-06; Kasparova S, 2005, NEUROCHEM INT, V46, P601, DOI 10.1016/j.neuint.2005.02.006; Kim H, 2014, SCI WORLD J, DOI 10.1155/2014/683045; Kim YM, 2005, CIRC RES, V97, P629, DOI 10.1161/01.RES.0000183735.09871.61; Kim YM, 2006, CANCER RES, V66, P6167, DOI 10.1158/0008-5472.CAN-05-3640; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; KOREN A, 1983, COMP BIOCHEM PHYS B, V74, P633, DOI 10.1016/0305-0491(83)90241-9; Kraaij MD, 2010, P NATL ACAD SCI USA, V107, P17686, DOI 10.1073/pnas.1012016107; Krijnen PAJ, 2003, J CLIN PATHOL, V56, P194, DOI 10.1136/jcp.56.3.194; KUKREJA RC, 1992, CARDIOVASC RES, V26, P641, DOI 10.1093/cvr/26.7.641; Kumar A, 2005, FASEB J, V19, P443, DOI 10.1096/fj.03-1364fje; Landmesser U, 2003, J CLIN INVEST, V111, P1201, DOI 10.1172/JCI200314172; Lapointe J, 2009, J BIOL CHEM, V284, P20364, DOI 10.1074/jbc.M109.006569; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Le G. J.-Y., 2014, Patent, Patent No. [WO2014086819 A1, 2014086819]; Lee K, 2011, P NATL ACAD SCI USA, V108, P9548, DOI 10.1073/pnas.1012645108; Lee SJ, 2010, CURR BIOL, V20, P2131, DOI 10.1016/j.cub.2010.10.057; Li JM, 2002, HYPERTENSION, V40, P477, DOI 10.1161/01.HYP.0000032031.30374.32; Li L, 2003, HYPERTENSION, V42, P316, DOI 10.1161/01.HYP.0000084853.47326.F2; Li LX, 2003, HYPERTENSION, V41, P663, DOI 10.1161/01.HYP.0000047875.43777.79; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; Liu XX, 2005, GENE DEV, V19, P2424, DOI 10.1101/gad.1352905; Lombardi V, 1998, CELL MOL NEUROBIOL, V18, P399, DOI 10.1023/A:1022597431593; LOS M, 1995, EUR J IMMUNOL, V25, P159, DOI 10.1002/eji.1830250127; Ma Long, 2015, Asian Pac J Cancer Prev, V16, P1637; Malinska D, 2012, MITOCHONDRION, V12, P144, DOI 10.1016/j.mito.2011.06.015; Maneesh M, 2005, INDIAN J CLIN BIOCHE, V20, P62, DOI [10.1007/BF02867402, 10.1007/BF02893057]; Maurice MM, 1997, J IMMUNOL, V158, P1458; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Miggin SM, 2001, BBA-MOL CELL RES, V1539, P147, DOI 10.1016/S0167-4889(01)00103-3; Milne GL, 2015, BBA-MOL CELL BIOL L, V1851, P433, DOI 10.1016/j.bbalip.2014.10.007; Moens AL, 2006, ARTERIOSCL THROM VAS, V26, P2439, DOI 10.1161/01.ATV.0000243924.00970.cb; Morel N, 2006, ANN FR ANESTH, V25, P955, DOI 10.1016/j.annfar.2006.04.013; Morimoto H, 2013, CELL STEM CELL, V12, P774, DOI 10.1016/j.stem.2013.04.001; Muslin AJ, 2008, CLIN SCI, V115, P203, DOI 10.1042/CS20070430; Nakamura K, 1998, CIRCULATION, V98, P794, DOI 10.1161/01.CIR.98.8.794; Nelson R. J., 2005, INTRO BEHAV ENDROCRI; NouroozZadeh J, 1997, BIOCHEM BIOPH RES CO, V236, P467, DOI 10.1006/bbrc.1997.6869; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; PACKER L, 1977, NATURE, V267, P423, DOI 10.1038/267423a0; Peers C, 2010, RESP PHYSIOL NEUROBI, V174, P292, DOI 10.1016/j.resp.2010.08.010; Pham-Huy Lien Ai, 2008, Int J Biomed Sci, V4, P89; Pimentel DR, 2001, CIRC RES, V89, P453, DOI 10.1161/hh1701.096615; Podrez EA, 2000, FREE RADICAL BIO MED, V28, P1717, DOI 10.1016/S0891-5849(00)00229-X; Prosser BL, 2011, SCIENCE, V333, P1440, DOI 10.1126/science.1202768; Rahman M, 2001, EUR J PHARMACOL, V428, P113, DOI 10.1016/S0014-2999(01)01357-7; REID MB, 1993, J APPL PHYSIOL, V75, P1081, DOI 10.1152/jappl.1993.75.3.1081; Reimund J.-M., 2002, NUTR CLIN METAB, V16, P275; Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010; Roberts LJ, 1997, BBA-LIPID LIPID MET, V1345, P121, DOI 10.1016/S0005-2760(96)00162-2; Roe ND, 2012, VASC PHARMACOL, V57, P168, DOI 10.1016/j.vph.2012.02.004; Rogers MS, 2005, CLIN CHEM, V51, P1271, DOI 10.1373/clinchem.2004.047241; Roy J, 2017, FREE RADICAL BIO MED, V102, P229, DOI 10.1016/j.freeradbiomed.2016.12.005; Roy J, 2016, BIOCHIMIE, V120, P56, DOI 10.1016/j.biochi.2015.06.010; Roy J, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0273-z; Roy J, 2015, FREE RADICAL BIO MED, V86, P269, DOI 10.1016/j.freeradbiomed.2015.04.014; Sabri A, 2003, ANTIOXID REDOX SIGN, V5, P731, DOI 10.1089/152308603770380034; Sag CM, 2011, J MOL CELL CARDIOL, V51, P749, DOI 10.1016/j.yjmcc.2011.07.016; SAGGU H, 1989, J NEUROCHEM, V53, P692, DOI 10.1111/j.1471-4159.1989.tb11759.x; Sahiner UM, 2011, WORLD ALLERGY ORGAN, V4, P151, DOI 10.1097/WOX.0b013e318232389e; Salvemini D, 1999, SCIENCE, V286, P304, DOI 10.1126/science.286.5438.304; Sanchez G, 2005, J MOL CELL CARDIOL, V39, P982, DOI 10.1016/j.yjmcc.2005.08.010; Santos CXC, 2011, FREE RADICAL BIO MED, V50, P777, DOI 10.1016/j.freeradbiomed.2011.01.003; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; Schroder K, 2012, CIRC RES, V110, P1217, DOI 10.1161/CIRCRESAHA.112.267054; Schulz R, 2000, AM J RESP CRIT CARE, V162, P566, DOI 10.1164/ajrccm.162.2.9908091; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Sciarretta S, 2015, CLIN SCI, V128, P387, DOI 10.1042/CS20140336; Sedeek MH, 2003, HYPERTENSION, V42, P806, DOI 10.1161/01.HYP.0000084372.91932.BA; SELLAK H, 1994, BLOOD, V83, P2669; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; SEN CK, 1995, J APPL PHYSIOL, V79, P675, DOI 10.1152/jappl.1995.79.3.675; Serrano CV, 1996, BBA-MOL BASIS DIS, V1316, P191, DOI 10.1016/0925-4439(96)00025-7; Sethi S, 1996, J LAB CLIN MED, V128, P27, DOI 10.1016/S0022-2143(96)90111-0; Shi HX, 2015, INT J BIOL SCI, V11, P845, DOI 10.7150/ijbs.11921; Sies H, 1997, EXP PHYSIOL, V82, P291, DOI 10.1113/expphysiol.1997.sp004024; SIES H, 1970, FEBS LETT, V11, P172, DOI 10.1016/0014-5793(70)80521-X; SMITH LL, 1991, FREE RADICAL BIO MED, V11, P47, DOI 10.1016/0891-5849(91)90187-8; SPINA MB, 1989, P NATL ACAD SCI USA, V86, P1398, DOI 10.1073/pnas.86.4.1398; Swaminathan PD, 2011, J CLIN INVEST, V121, P3277, DOI 10.1172/JCI57833; Tak PP, 2000, IMMUNOL TODAY, V21, P78, DOI 10.1016/S0167-5699(99)01552-2; Tanaki K, 2001, J AM COLL CARDIOL, V37, P676, DOI 10.1016/S0735-1097(00)01123-2; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Thiagarajan RR, 1997, THROMB HAEMOSTASIS, V78, P310; Ting HJ, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-24; Tojo T, 2005, CIRCULATION, V111, P2347, DOI 10.1161/01.CIR.0000164261.62586.14; Touyz RM, 2011, HYPERTENS RES, V34, P5, DOI 10.1038/hr.2010.201; Urao N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057618; Valko M, 2004, MOL CELL BIOCHEM, V266, P37, DOI 10.1023/B:MCBI.0000049134.69131.89; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; van de Veerdonk FL, 2010, P NATL ACAD SCI USA, V107, P3030, DOI 10.1073/pnas.0914795107; Van Raamsdonk JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000361; Van Raamsdonk JM, 2010, ANTIOXID REDOX SIGN, V13, P1911, DOI 10.1089/ars.2010.3215; Vinson Joe A, 2006, Pathophysiology, V13, P151, DOI 10.1016/j.pathophys.2006.05.006; Weinberger B, 2006, PEDIATR INT, V48, P479, DOI 10.1111/j.1442-200X.2006.02257.x; Welch WJ, 2001, KIDNEY INT, V59, P1257, DOI 10.1046/j.1523-1755.2001.0590041257.x; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139; Yuan XM, 2003, ANN MED, V35, P578, DOI 10.1080/07853890310016342; Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013; Zazzo J.-F, 2002, NUTR CLIN METAB, V16, P268; Zhang M, 2010, P NATL ACAD SCI USA, V107, P18121, DOI 10.1073/pnas.1009700107; Zheng JS, 2003, CIRCULATION, V108, P1238, DOI 10.1161/01.CIR.0000089082.40285.C3; Zima AV, 2006, CARDIOVASC RES, V71, P310, DOI 10.1016/j.cardiores.2006.02.019; Zweier JL, 2011, ANTIOXID REDOX SIGN, V14, P1769, DOI 10.1089/ars.2011.3904	183	131	136	1	32	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3729	3745		10.1096/fj.201700170R	http://dx.doi.org/10.1096/fj.201700170R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28592639				2022-12-28	WOS:000408713300004
J	Honda, R; Kuwata, K				Honda, Ryo; Kuwata, Kazuo			Evidence for a central role of PrP helix 2 in the nucleation of amyloid fibrils	FASEB JOURNAL			English	Article						prion; protein misfolding; phi-value analysis	MOUSE PRION PROTEIN; AGGREGATION KINETIC-DATA; MAMMALIAN PRIONS; IN-VITRO; HYDROGEN/DEUTERIUM EXCHANGE; AUTOCATALYTIC GROWTH; HYDROGEN-EXCHANGE; ALPHA-HELIX; BETA; MECHANISM	Amyloid fibrils are filamentous protein aggregates associated with the pathogenesis of a wide variety of human diseases. The formation of such aggregates typically follows nucleation-dependent kinetics, wherein the assembly and structural conversion of amyloidogenic proteins into oligomeric aggregates (nuclei) is the rate-limiting step of the overall reaction. In this study, we sought to gain structural insights into the oligomeric nuclei of the human prion protein (PrP) by preparing a series of deletion mutants lacking 14-44 of the C-terminal 107 residues of PrP and examined the kinetics and thermodynamics of these mutants in amyloid formation. An analysis of the experimental data using the concepts of the phi-value analysis indicated that the helix 2 region (residues 168-196) acquires an amyloid-like -sheet during nucleation, whereas the other regions preserves a relatively disordered structure in the nuclei. This finding suggests that the helix 2 region serves as the nucleation site for the assembly of amyloid fibrils.Honda, R., Kuwata, K. Evidence for a central role of PrP helix 2 in the nucleation of amyloid fibrils.	[Honda, Ryo] Gifu Univ, Grad Sch Med, Dept Mol Pathobiochem, Gifu, Japan; [Honda, Ryo; Kuwata, Kazuo] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu, Japan; [Kuwata, Kazuo] Gifu Univ, Grad Sch Med, Dept Gene & Dev, Gifu, Japan	Gifu University; Gifu University; Gifu University	Honda, R (corresponding author), Gifu Univ, Yanagido 1-1, Gifu 5011194, Japan.	ryohonda.rh@gmail.com			Japan Society for the Promotion of Science (JSPS) [16J04145]; Japan Agency for Medical Research and Development (AMED) [17ek0109075h0003]; Japanese Ministry of Health, Labor, and Welfare Research Committee on Surveillance and Infection Control of Prion Disease	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japanese Ministry of Health, Labor, and Welfare Research Committee on Surveillance and Infection Control of Prion Disease	The authors thank Enago (www.enago.jp) for the English language review and Tatsuya Nakayama (Gifu Pharmaceutical University) for helpful discussion about chemical kinetics. This work was supported by Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (KAKENHI) 16J04145 (to R.H.) and funding from the Japan Agency for Medical Research and Development (AMED; 17ek0109075h0003 to K.K.), and from the the Japanese Ministry of Health, Labor, and Welfare Research Committee on Surveillance and Infection Control of Prion Disease (to K.K.). The authors declare no conflicts of interest.	Abskharon R, 2016, SCI REP-UK, V6, DOI 10.1038/srep38877; Adachi M, 2015, J BIOL CHEM, V290, P18134, DOI 10.1074/jbc.M115.648139; Alvarez-Martinez MT, 2011, BBA-PROTEINS PROTEOM, V1814, P1305, DOI 10.1016/j.bbapap.2011.05.016; Anderson M, 2006, J MOL BIOL, V358, P580, DOI 10.1016/j.jmb.2006.02.007; Arosio P, 2015, PHYS CHEM CHEM PHYS, V17, P7606, DOI 10.1039/c4cp05563b; Baskakov IV, 2004, J BIOL CHEM, V279, P7671, DOI 10.1074/jbc.M310594200; Bentea L, 2017, J PHYS CHEM C, V121, P5302, DOI 10.1021/acs.jpcc.6b12021; Bocharova OV, 2005, PROTEIN SCI, V14, P1222, DOI 10.1110/ps.041186605; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Buell AK, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.228101; Chakroun N, 2010, FASEB J, V24, P3222, DOI 10.1096/fj.09-153924; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Choi JK, 2016, P NATL ACAD SCI USA, V113, P13851, DOI 10.1073/pnas.1610716113; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Cobb NJ, 2014, J BIOL CHEM, V289, P2643, DOI 10.1074/jbc.M113.520718; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Cohen SIA, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3608916; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; Colby DW, 2009, P NATL ACAD SCI USA, V106, P20417, DOI 10.1073/pnas.0910350106; Diaz-Espinoza R, 2012, NAT STRUCT MOL BIOL, V19, P370, DOI 10.1038/nsmb.2266; Dogan J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02076; Dutta A, 2013, FEBS LETT, V587, P2918, DOI 10.1016/j.febslet.2013.07.023; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Giehm L, 2010, ANAL BIOCHEM, V400, P270, DOI 10.1016/j.ab.2010.02.001; Groveman BR, 2014, J BIOL CHEM, V289, P24129, DOI 10.1074/jbc.M114.578344; Hellstrand E, 2010, ACS CHEM NEUROSCI, V1, P13, DOI 10.1021/cn900015v; Honda RP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00710-x; Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.3.CO;2-0; Jain S, 2011, BIOCHEMISTRY-US, V50, P1153, DOI 10.1021/bi101757x; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; Kim W, 2006, P NATL ACAD SCI USA, V103, P15824, DOI 10.1073/pnas.0605629103; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Kurt TD, 2014, J NEUROSCI, V34, P1022, DOI 10.1523/JNEUROSCI.4636-13.2014; Kuwata K, 2003, P NATL ACAD SCI USA, V100, P14790, DOI 10.1073/pnas.2433563100; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Li L, 2000, NAT STRUCT BIOL, V7, P336; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; Meisl G, 2017, CHEM SCI, V8, P7087, DOI 10.1039/c7sc01965c; Moran SD, 2014, J PHYS CHEM LETT, V5, P1984, DOI 10.1021/jz500794d; Morillas M, 2001, BIOCHEMISTRY-US, V40, P6982, DOI 10.1021/bi010232q; Morris AM, 2008, BIOCHEMISTRY-US, V47, P2413, DOI 10.1021/bi701899y; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Muramoto T, 1997, NAT MED, V3, P750, DOI 10.1038/nm0797-750; Muramoto T, 1996, P NATL ACAD SCI USA, V93, P15457, DOI 10.1073/pnas.93.26.15457; Naiki H, 1999, METHOD ENZYMOL, V309, P305; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Nakajima K, 2016, SCI REP-UK, V6, DOI 10.1038/srep22015; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Peralvarez-Marin A, 2009, BIOPHYS J, V97, P277, DOI 10.1016/j.bpj.2009.04.017; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Risor MW, 2017, BIOPHYS J, V113, P580, DOI 10.1016/j.bpj.2017.06.030; Sabareesan AT, 2017, BIOCHEMISTRY-US, V56, P5931, DOI 10.1021/acs.biochem.7b00894; Salamat K, 2012, J BIOL CHEM, V287, P18953, DOI 10.1074/jbc.M112.341677; Sanchez IE, 2003, J MOL BIOL, V334, P1077, DOI 10.1016/j.jmb.2003.10.016; Sarell CJ, 2010, J BIOL CHEM, V285, P41533, DOI 10.1074/jbc.M110.171355; Sarroukh R, 2013, BBA-BIOMEMBRANES, V1828, P2328, DOI 10.1016/j.bbamem.2013.04.012; Schreiber G, 2009, CHEM REV, V109, P839, DOI 10.1021/cr800373w; Sievers SA, 2011, NATURE, V475, P96, DOI 10.1038/nature10154; Sigurdson CJ, 2009, P NATL ACAD SCI USA, V106, P304, DOI 10.1073/pnas.0810680105; Singh J, 2016, BIOCHEMISTRY-US, V55, P459, DOI 10.1021/acs.biochem.5b01266; Singh J, 2014, J AM CHEM SOC, V136, P16704, DOI 10.1021/ja510964t; Singh J, 2013, J MOL BIOL, V425, P3510, DOI 10.1016/j.jmb.2013.06.009; Singh J, 2012, J MOL BIOL, V423, P217, DOI 10.1016/j.jmb.2012.06.040; Smirnovas V, 2016, PRION, V10, pS49; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Smirnovas V, 2009, J BIOL CHEM, V284, P24233, DOI 10.1074/jbc.M109.036558; Stohr J, 2008, P NATL ACAD SCI USA, V105, P2409, DOI 10.1073/pnas.0712036105; Sun Y, 2007, J BIOL CHEM, V282, P9090, DOI 10.1074/jbc.M608623200; Szczepankiewicz O, 2015, J AM CHEM SOC, V137, P14673, DOI 10.1021/jacs.5b07849; Taylor JD, 2016, SCI REP-UK, V6, DOI 10.1038/srep24656; Tycko R, 2010, BIOCHEMISTRY-US, V49, P9488, DOI 10.1021/bi1013134; Vanik DL, 2004, MOL CELL, V14, P139, DOI 10.1016/S1097-2765(04)00155-8; Wang GZ, 2015, P NATL ACAD SCI USA, V112, P2437, DOI 10.1073/pnas.1500243112; Watzky MA, 1997, J AM CHEM SOC, V119, P10382, DOI 10.1021/ja9705102; Watzky MA, 2008, BIOCHEMISTRY-US, V47, P10790, DOI 10.1021/bi800726m; Wright CF, 2003, NAT STRUCT BIOL, V10, P658, DOI 10.1038/nsb947; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Yamaguchi K, 2012, PROTEIN SCI, V21, P38, DOI 10.1002/pro.755; Yamaguchi KI, 2008, BIOCHEMISTRY-US, V47, P13242, DOI 10.1021/bi801562w; Yoshimura Y, 2012, P NATL ACAD SCI USA, V109, P14446, DOI 10.1073/pnas.1208228109; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904	84	7	7	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3641	3652		10.1096/fj.201701183RR	http://dx.doi.org/10.1096/fj.201701183RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29401635				2022-12-28	WOS:000435104500013
J	Jia, YG; Miao, YM; Yue, MF; Shu, M; Wei, ZF; Dai, Y				Jia, Yugai; Miao, Yumeng; Yue, Mengfan; Shu, Mei; Wei, Zhifeng; Dai, Yue			Tetrandrine attenuates the bone erosion in collagen-induced arthritis rats by inhibiting osteoclastogenesis via spleen tyrosine kinase	FASEB JOURNAL			English	Article						rheumatoid arthritis; osteoclasts; NF-kappa B; NFATc1	NF-KAPPA-B; RANKL-INDUCED OSTEOCLASTOGENESIS; RECEPTOR ACTIVATOR; MEDIATED COSTIMULATION; RHEUMATOID-ARTHRITIS; SPECTROMETRY METHOD; DIFFERENTIATION; CELLS; PHOSPHORYLATION; DESTRUCTION	Tetrandrine, a bisbenzylisoquinoline alkaloid, was previously demonstrated to attenuate inflammation and cartilage destruction in the ankles of mice with collagen-induced arthritis (CIA). Here, we explored the underlying mechanism by which tetrandrine prevented arthritis-induced bone erosion by focusing on the differentiation and function of osteoclasts. We found that daily administration of tetrandrine (30 mg/kg) markedly reduced the bone damage and decreased the number of osteoclasts in CIA rats. In vitro, tetrandrine inhibited receptor activator of NF-kappa B ligand (RANKL)-induced osteoclastogenesis at the early stage and reduced the expressions of osteoclast-related marker genes. In bone marrow-derived macrophages and RAW264.7 cells, tetrandrine inhibited RANKL-induced translocation of NF-kappa B-p65 and nuclear factor of activated T cell 1 (NFATc1) through suppressing spleen tyrosine kinase (Syk)-Bruton's tyrosine kinase-PLC gamma 2-Ca2+ signaling. Of interest, tetrandrine did not affect the phosphorylation of immunoreceptor tyrosine-based activation motifs, the conventional upstream of Syk, but it inhibited the activity of Syk by enhancing its ubiquitination and degradation. The anti-osteoclastogenesis effect of tetrandrine nearly disappeared when it was used in combination with the Syk inhibitor piceatannol or in constitutively activated Syk-overexpressing cells. Taken together, tetrandrine attenuated CIA-induced bone destruction by inhibiting osteoclastogenesis through hindering the translocation of NF-kappa B-p65 and NFATc1 via reducing the activation of Syk.	[Jia, Yugai; Miao, Yumeng; Yue, Mengfan; Shu, Mei; Wei, Zhifeng; Dai, Yue] China Pharmaceut Univ, Dept Pharmacol Chinese Mat Med, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University	Wei, ZF; Dai, Y (corresponding author), China Pharmaceut Univ, 24 Tong Jia Xiang, Nanjing 210009, Jiangsu, Peoples R China.	zhifeng-wei@hotmail.com; yuedaicpu@126.com			National Natural Science Foundation of China [81373426]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the National Natural Science Foundation of China (81373426) and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The authors declare no conflicts of interest.	Aletaha D, 2006, ARTHRITIS RHEUM-US, V54, P2784, DOI 10.1002/art.22052; Bae JS, 2003, BIOCHEM BIOPH RES CO, V305, P1094, DOI 10.1016/S0006-291X(03)00869-6; Baek JM, 2017, MOL MED REP, V15, P784, DOI 10.3892/mmr.2016.6069; Boyce BF, 2015, ENDOCRINOL METAB, V30, P35, DOI 10.3803/EnM.2015.30.1.35; Breen ME, 2015, ACS CHEM BIOL, V10, P175, DOI 10.1021/cb5008376; Cheon YH, 2016, J BONE MINER RES, V31, P403, DOI 10.1002/jbmr.2612; Chiu YG, 2017, EXPERT OPIN BIOL TH, V17, P119, DOI 10.1080/14712598.2017.1263614; Crotti TN, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/281287; de Castro Rodrigo Orlandini, 2011, J Signal Transduct, V2011, P507291, DOI 10.1155/2011/507291; Engdahl C, 2017, J BONE MINER RES, V32, P1681, DOI 10.1002/jbmr.3158; Geahlen RL, 2014, TRENDS PHARMACOL SCI, V35, P414, DOI 10.1016/j.tips.2014.05.007; Hayer S, 2016, DIS MODEL MECH, V9, P1329, DOI 10.1242/dmm.025460; Huh JE, 2016, SCI REP-UK, V6, DOI 10.1038/srep22511; Justa-Schuch D, 2016, ELIFE, V5, DOI [10.7554/eLife.16370, 10.7554/elife.16370]; Karmakar S, 2010, RHEUM DIS CLIN N AM, V36, P385, DOI 10.1016/j.rdc.2010.03.003; Kato T, 2017, EUR J PHARMACOL, V801, P1, DOI 10.1016/j.ejphar.2017.02.048; Kavitha CV, 2014, MOL CARCINOGEN, V53, P169, DOI 10.1002/mc.21959; Kim HS, 2012, CELL SIGNAL, V24, P1306, DOI 10.1016/j.cellsig.2012.02.014; Kim J, 2013, J BONE MINER RES, V28, P2381, DOI 10.1002/jbmr.1973; Kim JY, 2015, J NAT PROD, V78, P2167, DOI 10.1021/acs.jnatprod.5b00233; Kim Jung Ha, 2016, Chonnam Med J, V52, P12, DOI 10.4068/cmj.2016.52.1.12; Kim KJ, 2015, BONE, V81, P208, DOI 10.1016/j.bone.2015.07.023; Li CH, 2011, J BONE MINER RES, V26, P644, DOI 10.1002/jbmr.242; Li SS, 2014, J CLIN INVEST, V124, P5057, DOI 10.1172/JCI71882; Liu T, 2016, ONCOTARGET, V7, P40800, DOI 10.18632/oncotarget.8315; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Park-Min KH, 2009, J IMMUNOL, V183, P2444, DOI 10.4049/jimmunol.0804165; Schiff Michael, 2015, Curr Treatm Opt Rheumatol, V1, P334, DOI 10.1007/s40674-015-0029-0; Shinohara Masahiro, 2007, Curr Osteoporos Rep, V5, P67; Song NN, 2008, J PHARMACEUT BIOMED, V48, P974, DOI 10.1016/j.jpba.2008.06.002; Takahashi T, 2012, BIOL PHARM BULL, V35, P1765, DOI 10.1248/bpb.b12-00445; Tanaka S, 2018, MOD RHEUMATOL, V28, P9, DOI 10.1080/14397595.2017.1369491; Teitelbaum SL, 2011, ANN NY ACAD SCI, V1240, P14, DOI 10.1111/j.1749-6632.2011.06283.x; Wang XL, 2015, J SEP SCI, V38, P1286, DOI 10.1002/jssc.201401384; Wei ZL, 2013, INT J DISTRIB SENS N, DOI 10.1155/2013/147839; Xu J, 2015, MOL MED REP, V11, P865, DOI 10.3892/mmr.2014.2807; Yokota K, 2014, ARTHRITIS RHEUMATOL, V66, P121, DOI 10.1002/art.38218; Yuan XS, 2016, BIOCHEM PHARMACOL, V101, P87, DOI 10.1016/j.bcp.2015.11.025	39	29	30	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3398	3410		10.1096/fj.201701148RR	http://dx.doi.org/10.1096/fj.201701148RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401630				2022-12-28	WOS:000432546000040
J	Strug, MR; Su, RW; Kim, TH; Mauriello, A; Ticconi, C; Lessey, BA; Young, SL; Lim, JM; Jeong, JW; Fazleabas, AT				Strug, Michael R.; Su, Ren-Wei; Kim, Tae Hoon; Mauriello, Alessandro; Ticconi, Carlo; Lessey, Bruce A.; Young, Steven L.; Lim, Jeong Mook; Jeong, Jae-Wook; Fazleabas, Asgerally T.			RBPJ mediates uterine repair in the mouse and is reduced in women with recurrent pregnancy loss	FASEB JOURNAL			English	Article						Notch; decidualization; embryo implantation; IFN-gamma	ENDOMETRIAL STROMAL CELLS; PROGESTERONE-RECEPTOR; INTERFERON-GAMMA; IFN-GAMMA; T-CELLS; DECIDUALIZATION; PATHWAY; EXPRESSION; UTERUS; NOTCH1	Unexplained recurrent pregnancy loss (uRPL) is associated with repeated embryo loss and endometrial repair with elevated endometrial expression of inflammatory cytokines, including IFN-gamma. Notch signaling through its transcription factor recombination signal binding protein J kappa (RBPJ) regulates mechanisms including the immune response and repair after tissue injury. Initially, null mutation of RBPJ in the mouse uterus (Pgr(cre/+)Rbpj(f/f); Rbpj c-KO) results in subfertility, but we have found that these mice become infertile after pregnancy as a result of dysfunctional postpartum uterine repair, including delayed endometrial epithelial and myometrial regeneration. RNA sequencing of postpartum uterine repair sites revealed global up-regulation of inflammatory pathways, including IFN signaling. Consistent with elevated IFN-gamma, macrophages were recruited and polarized toward an M1-cytotoxic phenotype, which is associated with preventing repair and promoting further tissue injury. Through embryo transfer experiments, we show that dysfunctional postpartum repair directly impairs future embryo implantation in Rbpj c-KO mice. Last, we clinically correlated our findings from the Rbpj c-KO mouse in women diagnosed with uRPL. Reduced RBPJ in women with uRPL was associated with increased levels of IFN-gamma. The data, taken together, indicate that RBPJ regulates inflammation during endometrial repair, which is essential for future pregnancy potential, and its dysregulation may serve as an unidentified contributor to uRPL in women.	[Strug, Michael R.; Su, Ren-Wei; Kim, Tae Hoon; Jeong, Jae-Wook; Fazleabas, Asgerally T.] Michigan State Univ, Dept Obstet Gynecol & Reprod Biol, 333 Bostwick Ave NE,Suite 4027 VAI, Grand Rapids, MI 49503 USA; [Su, Ren-Wei] South China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China; [Mauriello, Alessandro; Ticconi, Carlo] Tor Vergata Univ, Dept Biomed & Prevent, Sect Gynecol & Obstet, Rome, Italy; [Lessey, Bruce A.] Greenville Hlth Syst, Dept Obstet & Gynecol, Greenville, SC USA; [Young, Steven L.] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC 27515 USA; [Lim, Jeong Mook] Seoul Natl Univ, Dept Agr Biotechnol, World Class Univ WCU Biomodulat, Seoul, South Korea	Michigan State University; South China Agricultural University; University of Rome Tor Vergata; Greenville Health System; University of North Carolina; University of North Carolina Chapel Hill; Seoul National University (SNU)	Fazleabas, AT (corresponding author), Michigan State Univ, Dept Obstet Gynecol & Reprod Biol, 333 Bostwick Ave NE,Suite 4027 VAI, Grand Rapids, MI 49503 USA.	asgi@hc.msu.edu	Ticconi, Carlo/AAU-9766-2021; Young, Steven L/G-2304-2014; MAURIELLO, ALESSANDRO/K-4705-2016; Ticconi, Carlo/AAZ-1010-2021	Young, Steven L/0000-0002-5205-4495; MAURIELLO, ALESSANDRO/0000-0002-7351-5676; Ticconi, Carlo/0000-0003-1923-2744	NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01 HD042280, F30 HD082951]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F30HD082951, R01HD067721, R01HD042280] Funding Source: NIH RePORTER	NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors thank F. DeMayo [U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences), N. Carlesso (Beckman Research Institute of the City of Hope, Durate, CA, USA), and T. Honjo (Kyoto University, Kyoto, Japan) for kindly providing the Pgr<SUP>pre/+</SUP> and Rbpj<SUP>flox/flox</SUP> mice. The authors also thank S. Bond, S. Poncil, A. Ochoa, and M. Olson (all from Michigan State University, Grand Rapids, MI, USA) for their excellent technical assistance. The authors thank R. Ergasti for her contribution to collecting and organizing of human tissues. The authors thank the Michigan State University Research Technology Support Facility Genomics Core for their assistance with library preparation and RNA-Seq. The authors also thank M. Winn (Van Andel Research Institute Bioinformatics and Biostatistics Core, Grand Rapids, MI, USA), for performing data analysis of the RNA-Seq results. Funding for this study was provided by the NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development (Grants R01 HD042280 to A.T.F. and F30 HD082951 to M.R.S.). The authors declare no conflicts of interest.	Afshar Y, 2012, ENDOCRINOLOGY, V153, P2884, DOI 10.1210/en.2011-2122; Afshar Y, 2012, FASEB J, V26, P282, DOI 10.1096/fj.11-184663; Amer Soc Reprod Med, 2013, FERTIL STERIL, V99, P63, DOI 10.1016/j.fertnstert.2012.09.023; Amer Soc Reprod Med, 2012, FERTIL STERIL, V98, P1103, DOI 10.1016/j.fertnstert.2012.06.048; Anacker J, 2011, MOL HUM REPROD, V17, P637, DOI 10.1093/molehr/gar033; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Branch DW, 2010, NEW ENGL J MED, V363, P1740, DOI 10.1056/NEJMcp1005330; BRANDON JM, 1994, ANAT RECORD, V240, P233, DOI 10.1002/ar.1092400210; BRANDON JM, 1990, J REPROD FERTIL, V88, P151; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brosens JJ, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.11.037; Chen CP, 2015, REPROD SCI, V22, P1461, DOI 10.1177/1933719115585148; Chen P, 2016, J OBSTET GYNAECOL RE, V42, P669, DOI 10.1111/jog.12957; Chiang CM, 1997, GYNECOL OBSTET INVES, V43, P245, DOI 10.1159/000291866; Christiansen OB, 2005, FERTIL STERIL, V83, P821, DOI 10.1016/j.fertnstert.2004.12.018; Christiansen OB, 2008, GYNECOL OBSTET INVES, V66, P257, DOI 10.1159/000149575; Comba C, 2015, FERTIL STERIL, V104, P1467, DOI 10.1016/j.fertnstert.2015.08.011; Erlebacher A, 2013, ANNU REV IMMUNOL, V31, P387, DOI 10.1146/annurev-immunol-032712-100003; FINN CA, 1971, ADV REPROD PHYSIOL, V5, P1; Franco HL, 2012, FASEB J, V26, P1218, DOI 10.1096/fj.11-193334; Fuhrich DG, 2013, ANAL QUANT CYTOL, V35, P210; Gellersen B, 2014, ENDOCR REV, V35, P851, DOI 10.1210/er.2014-1045; Girardi G, 2003, J CLIN INVEST, V112, P1644, DOI 10.1172/JCI200318817; Goddard LM, 2014, CELL, V156, P549, DOI 10.1016/j.cell.2013.12.025; Grewal S, 2010, BIOL REPROD, V83, P75, DOI 10.1095/biolreprod.109.080630; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Huang CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044285; Ishida Y, 2004, J IMMUNOL, V172, P1848, DOI 10.4049/jimmunol.172.3.1848; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jaiswal MK, 2015, SCI REP-UK, V5, DOI 10.1038/srep15221; Jaslow CR, 2010, FERTIL STERIL, V93, P1234, DOI 10.1016/j.fertnstert.2009.01.166; JAYATILAK PG, 1984, BIOL REPROD, V31, P556, DOI 10.1095/biolreprod31.3.556; Kaitu'u-Lino TJ, 2010, ENDOCRINOLOGY, V151, P3386, DOI 10.1210/en.2009-1334; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kosova G, 2015, HUM REPROD, V30, P519, DOI 10.1093/humrep/deu355; Krieg SA, 2012, MOL HUM REPROD, V18, P442, DOI 10.1093/molehr/gas017; Kwak-Kim JYH, 2003, HUM REPROD, V18, P767, DOI 10.1093/humrep/deg156; LALA PK, 1990, CANCER METAST REV, V9, P369, DOI 10.1007/BF00049525; Lee K, 2006, NAT GENET, V38, P1204, DOI 10.1038/ng1874; Liang PY, 2015, REPROD BIOMED ONLINE, V31, P823, DOI 10.1016/j.rbmo.2015.08.009; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; LUDWIG H, 1991, ANN NY ACAD SCI, V622, P28, DOI 10.1111/j.1749-6632.1991.tb37848.x; Luster AD, 1998, P ASSOC AM PHYSICIAN, V110, P183; Mao DL, 2003, IMMUNITY, V19, P813, DOI 10.1016/S1074-7613(03)00321-2; Nancy P, 2012, SCIENCE, V336, P1317, DOI 10.1126/science.1220030; OKA C, 1995, DEVELOPMENT, V121, P3291; Orent W, 2016, HUM MOL GENET, V25, P404, DOI 10.1093/hmg/ddv474; Palaga T, 2003, J IMMUNOL, V171, P3019, DOI 10.4049/jimmunol.171.6.3019; Patterson AL, 2013, STEM CELLS DEV, V22, P964, DOI 10.1089/scd.2012.0435; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Raghupathy R, 1999, CELL IMMUNOL, V196, P122, DOI 10.1006/cimm.1999.1532; Rai R, 2006, LANCET, V368, P601, DOI 10.1016/S0140-6736(06)69204-0; Rudolph M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032922; Salamonsen LA, 2003, REPRODUCTION, V125, P301, DOI 10.1530/rep.0.1250301; Salker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010287; Salker MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052252; Santos MA, 2007, P NATL ACAD SCI USA, V104, P15454, DOI 10.1073/pnas.0702891104; Sawamiphak S, 2014, DEV CELL, V31, P640, DOI 10.1016/j.devcel.2014.11.007; Shynlova O, 2013, J CELL MOL MED, V17, P311, DOI 10.1111/jcmm.12012; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Soyal SM, 2005, GENESIS, V41, P58, DOI 10.1002/gene.20098; Su RW, 2015, J CLIN ENDOCR METAB, V100, pE433, DOI 10.1210/jc.2014-3720; Ticconi C, 2011, AM J REPROD IMMUNOL, V66, P452, DOI 10.1111/j.1600-0897.2011.01021.x; Weimar CHE, 2013, HUM REPROD UPDATE, V19, P542, DOI 10.1093/humupd/dmt025; Weimar CHE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041424; Wilson AJ, 1997, CLIN SCI, V93, P97, DOI 10.1042/cs0930097; Winter WE, 2014, LABMEDICINE, V45, P92, DOI 10.1309/LMF28S2GIMXNWHMM; Yoshii A, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.117929; Zhang S, 2014, CELL RES, V24, P925, DOI 10.1038/cr.2014.82	74	18	20	2	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2452	2466		10.1096/fj.201701032R	http://dx.doi.org/10.1096/fj.201701032R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29242273	Green Published			2022-12-28	WOS:000432528000012
J	Zang, XJ; Zheng, X; Hou, YL; Hu, MM; Wang, H; Bao, XQ; Zhou, F; Wang, GJ; Hao, HP				Zang, Xiaojie; Zheng, Xiao; Hou, Yuanlong; Hu, Miaomiao; Wang, Hong; Bao, Xiaoqiang; Zhou, Fang; Wang, Guangji; Hao, Haiping			Regulation of proinflammatory monocyte activation by the kynurenine-AhR axis underlies immunometabolic control of depressive behavior in mice	FASEB JOURNAL			English	Article						tryptophan metabolism; neuroimmune interaction; glial activation	ARYL-HYDROCARBON RECEPTOR; LY6C(HI) MONOCYTES; BRAIN; TRYPTOPHAN; CNS; STIMULATION; INHIBITION; MICROBIOTA; PERIPHERY; RESPONSES	Elevated kynurenine (Kyn) production from tryptophan (Trp) metabolism is a biomarker of immune dysregulation in depression, but its mechanistic contributions to the behavioral symptoms are poorly defined. In this study, Kyn was shown to be ametabolic regulator of proinflammatory monocytes that orchestrated peripheral immune activation and neuroinflammation in depressive mice. Kyn-induced depressive behavior was paralleled by brain infiltration of proinflammatory monocytes and astrocytic activation. Kyn enhanced chemokine (C-C motif) ligand-2-mediated chemotaxis of monocytes and their proinflammatory capability on cocultured astrocytes in vitro, which involved the activation of aryl hydrocarbon receptor (AhR) signaling. Kyn augmented, whereas pharmacological AhR blockade rescued, systemic inflammation-induced monocyte trafficking, neuroimmune disturbance, and depressive-like behavior in mice. The behavior-exacerbating effects of the Kyn-AhR axis were dampened with prior depletion of functional monocytes in the periphery. The findings in our study extend understanding of an immunologic effect of Kyn that links Trp metabolism and inflammatory signaling in depression pathology, with potential therapeutic implications for depressive disorders.	[Zang, Xiaojie; Zheng, Xiao; Hou, Yuanlong; Hu, Miaomiao; Wang, Hong; Zhou, Fang; Wang, Guangji; Hao, Haiping] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing 210009, Jiangsu, Peoples R China; [Zang, Xiaojie; Zheng, Xiao; Hou, Yuanlong; Hu, Miaomiao; Wang, Hong; Zhou, Fang; Wang, Guangji; Hao, Haiping] China Pharmaceut Univ, Lab Metab Regulat & Drug Target Discovery, Nanjing, Jiangsu, Peoples R China; [Zang, Xiaojie; Zheng, Xiao; Hou, Yuanlong; Hu, Miaomiao; Wang, Hong; Zhou, Fang; Wang, Guangji; Hao, Haiping] China Pharmaceut Univ, Jiangsu Prov Key Lab Drug Metab, Nanjing, Jiangsu, Peoples R China; [Zheng, Xiao; Hao, Haiping] China Pharmaceut Univ, Sch Pharm, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China; [Bao, Xiaoqiang] China Pharmaceut Univ, Sch Basic Med & Clin Pharm, Anim Expt Ctr, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University; China Pharmaceutical University; China Pharmaceutical University; China Pharmaceutical University; China Pharmaceutical University	Wang, GJ (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, Nanjing 210009, Jiangsu, Peoples R China.; Hao, HP (corresponding author), China Pharmaceut Univ, Sch Pharm, State Key Lab Nat Med, 24 Tongjia Lane, Nanjing 210009, Jiangsu, Peoples R China.	guangjiwang@hotmail.com; hhp_770505@hotmail.com	Zheng, Xiao/GQZ-5063-2022; Hao, Haiping/L-8265-2019	Hao, Haiping/0000-0003-2522-7546; Wang, Hong/0000-0002-6192-3082; Wang, Guangji/0000-0002-0777-3896	National Natural Science Foundation of China [81503142, 81430091, 81325025]; Natural Science Foundation of Jiangsu Province [BK20141035, BK2012026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	The authors thank Dr. An Kang (Nanjing University of Chinese Medicine, Nanjing, China) and Wenxia Bai (Nanjing Technical University, Nanjing, China) for technical support and advice. This work was supported by National Natural Science Foundation of China Grants 81503142 (to X.Z.) and 81430091 and 81325025 (to H.H.), and Natural Science Foundation of Jiangsu Province Grants BK20141035 (to X.Z.) and BK2012026 (to H.H.). The authors declare no conflicts of interest.	Agudelo LZ, 2014, CELL, V159, P33, DOI 10.1016/j.cell.2014.07.051; Alcocer-Gomez E, 2016, MOL NEUROBIOL, V53, P4874, DOI 10.1007/s12035-015-9408-7; Bessede A, 2014, NATURE, V511, P184, DOI 10.1038/nature13323; Breda C, 2016, P NATL ACAD SCI USA, V113, P5435, DOI 10.1073/pnas.1604453113; Corona AW, 2013, BRAIN BEHAV IMMUN, V31, P134, DOI 10.1016/j.bbi.2012.08.008; Cuartero MI, 2014, CIRCULATION, V130, P2040, DOI 10.1161/CIRCULATIONAHA.114.011394; Fuertig R, 2016, BRAIN BEHAV IMMUN, V54, P59, DOI 10.1016/j.bbi.2015.12.020; Fung TC, 2017, NAT NEUROSCI, V20, P145, DOI 10.1038/nn.4476; Hennessy E, 2015, J NEUROSCI, V35, P8411, DOI 10.1523/JNEUROSCI.2745-14.2015; Hoshi M, 2014, INFECT IMMUN, V82, P4487, DOI 10.1128/IAI.02113-14; Hucke S, 2012, BRAIN, V135, P1586, DOI 10.1093/brain/aws058; Kawasaki H, 2014, ALLERGY, V69, P445, DOI 10.1111/all.12346; Kaye J, 2016, P NATL ACAD SCI USA, V113, pE6145, DOI 10.1073/pnas.1607843113; Kim SH, 2006, MOL PHARMACOL, V69, P1871, DOI 10.1124/mol.105.021832; King IL, 2009, BLOOD, V113, P3190, DOI 10.1182/blood-2008-07-168575; Mayo L, 2014, NAT MED, V20, P1147, DOI 10.1038/nm.3681; McKim DB, 2018, MOL PSYCHIATR, V23, P1421, DOI 10.1038/mp.2017.64; McKim DB, 2016, BIOL PSYCHIAT, V79, P803, DOI 10.1016/j.biopsych.2015.07.010; Menard C, 2017, NEUROPSYCHOPHARMACOL, V42, P62, DOI 10.1038/npp.2016.90; Mohle L, 2016, CELL REP, V15, P1945, DOI 10.1016/j.celrep.2016.04.074; Novikov O, 2016, MOL PHARMACOL, V90, P674, DOI 10.1124/mol.116.105361; O'Connor JC, 2009, MOL PSYCHIATR, V14, P511, DOI 10.1038/sj.mp.4002148; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Parrott JM, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.200; Pino Paula A, 2011, J Vis Exp, DOI 10.3791/2348; Qiu J, 2013, IMMUNITY, V39, P386, DOI 10.1016/j.immuni.2013.08.002; Raison CL, 2010, MOL PSYCHIATR, V15, P393, DOI 10.1038/mp.2009.116; Ray Avijit, 2010, J Vis Exp, DOI 10.3791/1488; Rothhammer V, 2016, NAT MED, V22, P586, DOI 10.1038/nm.4106; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Strasser B, 2017, CURR TOP BEHAV NEURO, V31, P95, DOI 10.1007/7854_2016_23; Vogel CFA, 2014, J BIOL CHEM, V289, P1866, DOI 10.1074/jbc.M113.505578; Walker AK, 2013, NEUROPSYCHOPHARMACOL, V38, P1609, DOI 10.1038/npp.2013.71; Weber MD, 2017, NEUROPSYCHOPHARMACOL, V42, P46, DOI 10.1038/npp.2016.102; Wichers MC, 2005, MOL PSYCHIATR, V10, P538, DOI 10.1038/sj.mp.4001600; Wohleb ES, 2016, NAT REV NEUROSCI, V17, P497, DOI 10.1038/nrn.2016.69; Wurfel BE, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.88; Xue J, 2016, GASTROENTEROLOGY, V151, P1206, DOI 10.1053/j.gastro.2016.09.064; Zheng X, 2016, SCI REP-UK, V6, DOI 10.1038/srep19406; Zheng X, 2015, DRUG DISCOV TODAY, V20, P562, DOI 10.1016/j.drudis.2015.03.015; Zhou YF, 2013, BLOOD, V121, P3195, DOI 10.1182/blood-2012-08-453597; Zunszain PA, 2012, NEUROPSYCHOPHARMACOL, V37, P939, DOI 10.1038/npp.2011.277; Zwilling D, 2011, CELL, V145, P863, DOI 10.1016/j.cell.2011.05.020	43	28	29	1	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1944	1956		10.1096/fj.201700853R	http://dx.doi.org/10.1096/fj.201700853R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29183965				2022-12-28	WOS:000429051400017
J	Ewanchuk, BW; Allan, ERO; Warren, AL; Ramachandran, R; Yates, RM				Ewanchuk, Benjamin W.; Allan, Euan R. O.; Warren, Amy L.; Ramachandran, Rithwik; Yates, Robin M.			The cooling compound icilin attenuates autoimmune neuroinflammation through modulation of the T-cell response	FASEB JOURNAL			English	Article						inflammation; T lymphocytes; neuropharmacology; multiple sclerosis	GENE-RELATED PEPTIDE; CYTOKINE GM-CSF; MULTIPLE-SCLEROSIS; TRPM8 ACTIVATION; CALCIUM-CHANNEL; ION-CHANNEL; COLD; MENTHOL; ENCEPHALOMYELITIS; EXPRESSION	The synthetic supercooling drug, icilin, and its primary receptor target, the cation channel transient receptor potential (TRP) melastatin-8 (TRPM8), have been described as potent negative regulators of inflammation in the colon. The aim of this study was to determine whether the anti-inflammatory action of icilin could potentially be used to treat autoimmune neuroinflammatory disorders, such as multiple sclerosis (MS). During experimental autoimmune encephalomyelitis (EAE)-a CD4+ T cell-driven murine model of MS-we found that both wild-type (WT) and TRPM8-deficient EAE mice were protected from disease progression during icilin treatment, as evidenced by delays in clinical onset and reductions in neuroinflammation. In vitro, icilin potently inhibited the proliferation of murine and human CD4+ T cells, with the peripheral expansion of autoantigen-restricted T cells similarly diminished by the administration of icilin in mice. Attenuation of both TRPM8(-/-) and TRP ankyrin-1(-/-) T-cell proliferation by icilin was consistent with the WT phenotype, which suggests a mechanism that is independent of these channels. In addition, icilin treatment altered the expressional profile of activated CD4+ T cells to one that was indicative of restricted effector function and limited neuroinflammatory potential. These findings identify a potent anti-inflammatory role for icilin in lymphocyte-mediated neuroinflammation and highlight clear pleiotropic effects of the compound beyond classic TRP channel activation.-Ewanchuk, B.W., Allan, E.R.O., Warren, A.L., Ramachandran, R., Yates, R. M. The cooling compound icilin attenuates autoimmune neuroinflammation through modulation of the T-cell response.	[Ewanchuk, Benjamin W.; Yates, Robin M.] Univ Calgary, Fac Vet Med, Cumming Sch Med, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Allan, Euan R. O.; Yates, Robin M.] Univ Calgary, Fac Vet Med, Dept Comparat Biol & Expt Med, Calgary, AB, Canada; [Warren, Amy L.] Univ Calgary, Fac Vet Med, Dept Vet Clin & Diagnost Sci, Calgary, AB, Canada; [Ramachandran, Rithwik] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON, Canada	University of Calgary; University of Calgary; University of Calgary; Western University (University of Western Ontario)	Yates, RM (corresponding author), Univ Calgary, Dept Comparat Biol & Expt Med, 3330 Hosp Dr NW,HRIC 4AA10, Calgary, AB T2N 4N1, Canada.	rmyates@ucalgary.ca	Ramachandran, Rithwik/N-7815-2015	Ramachandran, Rithwik/0000-0001-9557-9905; Ewanchuk, Benjamin/0000-0001-6197-9222	Multiple Sclerosis Society of Canada; Canadian Institutes of Health Research	Multiple Sclerosis Society of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Multiple Sclerosis Society of Canada and the Canadian Institutes of Health Research. Graduate student support was generously provided by the endMS Research and Training Network, Alberta Innovates-Health Solutions, and the Snyder Institute for Chronic Diseases (Calgary, AB, Canada). The authors declare no conflicts of interest.	Agrawal SM, 2011, J NEUROSCI, V31, P669, DOI 10.1523/JNEUROSCI.3659-10.2011; Allan ERO, 2014, J IMMUNOL, V192, P4989, DOI 10.4049/jimmunol.1302896; Badou A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00243; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Becher B, 2017, NAT REV IMMUNOL, V17, P49, DOI 10.1038/nri.2016.123; Belmaati MS, 2014, INFLAMM BOWEL DIS, V20, P1004, DOI 10.1097/MIB.0000000000000039; Bertin S, 2017, GUT, V66, P1584, DOI 10.1136/gutjnl-2015-310710; Bielekova B, 2006, P NATL ACAD SCI USA, V103, P5941, DOI 10.1073/pnas.0601335103; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Cohen JA, 2012, LANCET, V380, P1819, DOI 10.1016/S0140-6736(12)61769-3; Croxford AL, 2015, IMMUNITY, V43, P502, DOI 10.1016/j.immuni.2015.08.010; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; de Jong PR, 2015, MUCOSAL IMMUNOL, V8, P491, DOI 10.1038/mi.2014.82; Dendrou CA, 2015, NAT REV IMMUNOL, V15, P545, DOI 10.1038/nri3871; Dhaka A, 2008, J NEUROSCI, V28, P566, DOI 10.1523/JNEUROSCI.3976-07.2008; Du J, 2009, FLUIDS BARRIERS CNS, V6, DOI 10.1186/1743-8454-6-3; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Fonfria E, 2006, J RECEPT SIG TRANSD, V26, P159, DOI 10.1080/10799890600637506; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Hagenacker T, 2014, BRAIN RES, V1557, P171, DOI 10.1016/j.brainres.2014.02.022; Harrington AM, 2011, PAIN, V152, P1459, DOI 10.1016/j.pain.2011.01.027; Hartung HP, 2002, LANCET, V360, P2018, DOI 10.1016/S0140-6736(02)12023-X; Hedrick SM, 2012, NAT REV IMMUNOL, V12, P649, DOI 10.1038/nri3278; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Johnson CD, 2009, AM J PHYSIOL-HEART C, V296, pH1868, DOI 10.1152/ajpheart.01112.2008; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Khalil M, 2016, MUCOSAL IMMUNOL, V9, P1500, DOI 10.1038/mi.2016.16; Kim CS, 2003, CELL SIGNAL, V15, P299, DOI 10.1016/S0898-6568(02)00086-4; Kim SH, 2011, BIOCHEM BIOPH RES CO, V406, P30, DOI 10.1016/j.bbrc.2011.01.094; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lee S, 2013, BIOCHEM BIOPH RES CO, V441, P1005, DOI 10.1016/j.bbrc.2013.11.015; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; Ma ST, 2009, AM J PHYSIOL-HEART C, V297, pH887, DOI 10.1152/ajpheart.00460.2009; Mahieu F, 2007, J BIOL CHEM, V282, P3325, DOI 10.1074/jbc.M605213200; Matusevicius D, 1999, MULT SCLER J, V5, P101, DOI 10.1177/135245859900500206; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Melanaphy D, 2016, AM J PHYSIOL-HEART C, V311, pH1416, DOI 10.1152/ajpheart.00222.2015; Melzer N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047617; Mikami N, 2012, INT IMMUNOL, V24, P681, DOI 10.1093/intimm/dxs075; NORONHA A, 1993, J NEUROIMMUNOL, V46, P145, DOI 10.1016/0165-5728(93)90244-S; Omilusik K, 2011, IMMUNITY, V35, P349, DOI 10.1016/j.immuni.2011.07.011; Paltser G, 2013, MOL MED, V19, P149, DOI 10.2119/molmed.2012.00329; Parenti A, 2016, BRIT J PHARMACOL, V173, P953, DOI 10.1111/bph.13392; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; RACKE MK, 1995, J IMMUNOL, V154, P450; Ramachandran R, 2013, P NATL ACAD SCI USA, V110, P7476, DOI 10.1073/pnas.1217431110; Rangachari M, 2013, J AUTOIMMUN, V45, P31, DOI 10.1016/j.jaut.2013.06.008; Sardi C, 2014, J NEUROIMMUNOL, V271, P18, DOI 10.1016/j.jneuroim.2014.03.008; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Schattling B, 2012, NAT MED, V18, P1805, DOI 10.1038/nm.3015; Shi YF, 2007, NAT IMMUNOL, V8, P817, DOI 10.1038/ni1489; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; TRAUGOTT U, 1983, SCIENCE, V219, P308, DOI 10.1126/science.6217550; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Valero MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029760; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; WEI ET, 1983, J PHARM PHARMACOL, V35, P110, DOI 10.1111/j.2042-7158.1983.tb04279.x; Zhang L, 2016, LUNG, V194, P595, DOI 10.1007/s00408-016-9901-4; ZIEGLER SF, 1994, STEM CELLS, V12, P456, DOI 10.1002/stem.5530120502	64	2	2	3	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1236	1249		10.1096/fj.201700552R	http://dx.doi.org/10.1096/fj.201700552R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29114087				2022-12-28	WOS:000427246000011
J	Patranabis, S; Bhattacharyya, SN				Patranabis, Somi; Bhattacharyya, Suvendra Nath			P-body-induced inactivation of let-7a miRNP prevents the death of growth factor-deprived neuronal cells	FASEB JOURNAL			English	Article						PC12; P-body proteins; neuronal differentiation; apoptosis; sympathetic neurons	CYTOPLASMIC PROCESSING BODIES; ACTIVATED PROTEIN-KINASE; MESSENGER-RNA DECAY; PC12 CELLS; FACTOR WITHDRAWAL; SYMPATHETIC NEURONS; NEURITE OUTGROWTH; GENE-EXPRESSION; DIFFERENTIATION; PHOSPHORYLATION	RNA processing bodies (P-bodies) are cytoplasmic RNA granules in eukaryotic cells that regulate gene expression by executing the translation suppression and degradation of mRNAs that are targeted to these bodies. P-bodies can also serve as storage sites for translationally repressed mRNAs both in mammalian cells and yeast cells. In this report, a unique role of mammalian P-bodies is documented. Depletion of P-body components dedifferentiate nerve growth factor-treated PC12 cells, whereas ectopic expression of P-body components induces the neuronal differentiation of precursor cells. Trophic factor withdrawal from differentiated cells induces a decrease in cellular P-body size and numbers that are coupled with dedifferentiation and cell death. Here, we report how the expression of P-body proteins-by ensuring the phosphorylation of argonaute protein 2 and the subsequent inactivation let-7a miRNPs-prevents the apoptotic death of growth factor-depleted neuronal cells.	[Patranabis, Somi; Bhattacharyya, Suvendra Nath] Indian Inst Chem Biol, CSIR, Mol Genet Div, RNA Biol Res Lab, 4 Raja SC Mullick Rd, Kolkata 700032, India; [Patranabis, Somi] Amity Univ, Amity Inst Biotechnol, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Bhattacharyya, SN (corresponding author), Indian Inst Chem Biol, CSIR, Mol Genet Div, RNA Biol Res Lab, 4 Raja SC Mullick Rd, Kolkata 700032, India.	sb@csiriicb.in			Wellcome Trust International Senior Research Fellowship (ISRF); Council of Scientific and Industrial Research (CSIR); Wellcome Trust ISRF fund [084324/Z/07/A]; CSIR Network Project Fund MinD [BSC0215]; Government of India Department of Science and Technology [HRR/2016/000093]	Wellcome Trust International Senior Research Fellowship (ISRF)(Wellcome Trust); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Wellcome Trust ISRF fund; CSIR Network Project Fund MinD; Government of India Department of Science and Technology(Department of Science & Technology (India))	The authors thank Witold Filipowicz (Friedrich Miescher Institute (FMI), Basel, Switzerland) and Edouard Bertrand (Institut de Genetique Moleculaire de Montpellier, Montpellier, France) for different plasmids constructs and valuable discussions. S.N.B. is supported by The Wellcome Trust International Senior Research Fellowship (ISRF). S.P. received support from the Council of Scientific and Industrial Research (CSIR). The authors are supported by the Wellcome Trust ISRF fund (084324/Z/07/A) and CSIR Network Project Fund MinD (BSC0215) as well as a High-Risk High Reward Project grant (HRR/2016/000093) from the Government of India Department of Science and Technology. The authors declare no conflicts of interest.	Aizer A, 2014, J CELL SCI, V127, P4443, DOI 10.1242/jcs.152975; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Bruno IG, 2011, MOL CELL, V42, P500, DOI 10.1016/j.molcel.2011.04.018; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Cougot N, 2008, J NEUROSCI, V28, P13793, DOI 10.1523/JNEUROSCI.4155-08.2008; DICHTER MA, 1977, NATURE, V268, P501, DOI 10.1038/268501a0; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Fan L, 2002, HUM MOL GENET, V11, P1605, DOI 10.1093/hmg/11.14.1605; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Jeon CY, 2010, SYNAPSE, V64, P765, DOI 10.1002/syn.20789; Jiang H, 2005, J MOL NEUROSCI, V25, P133, DOI 10.1385/JMN:25:2:133; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Lopez-Orozco J, 2015, RNA, V21, P2030, DOI 10.1261/rna.053207.115; Magill ST, 2010, P NATL ACAD SCI USA, V107, P20382, DOI 10.1073/pnas.1015691107; Mathys H, 2014, MOL CELL, V54, P751, DOI 10.1016/j.molcel.2014.03.036; Mazumder A, 2013, EMBO REP, V14, P1008, DOI 10.1038/embor.2013.149; MESNER PW, 1992, J CELL BIOL, V119, P1669, DOI 10.1083/jcb.119.6.1669; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Morooka T, 1998, J BIOL CHEM, V273, P24285, DOI 10.1074/jbc.273.38.24285; Moser JJ, 2010, INT J BIOCHEM CELL B, V42, P828, DOI 10.1016/j.biocel.2009.11.018; Navarro-Tableros V, 2004, DIABETES, V53, P2018, DOI 10.2337/diabetes.53.8.2018; Nicklas S, 2015, NUCLEIC ACIDS RES, V43, P2638, DOI 10.1093/nar/gkv138; Oh JY, 2013, J CELL SCI, V126, P2114, DOI 10.1242/jcs.125690; Patranabis S, 2016, MOL CELL BIOL, V36, P1260, DOI 10.1128/MCB.00054-16; Peng Y, 2008, MOL CANCER RES, V6, P663, DOI 10.1158/1541-7786.MCR-07-0370; Rajasethupathy P, 2009, NEURON, V63, P803, DOI 10.1016/j.neuron.2009.05.029; Rudel S, 2011, NUCLEIC ACIDS RES, V39, P2330, DOI 10.1093/nar/gkq1032; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Sheth U, 2006, CELL, V125, P1095, DOI 10.1016/j.cell.2006.04.037; Torcia M, 1996, CELL, V85, P345, DOI 10.1016/S0092-8674(00)81113-7; Vaghefi H, 2004, J BIOL CHEM, V279, P15604, DOI 10.1074/jbc.M311500200; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Wang J, 2017, NAT REV NEUROL, V13, P612, DOI 10.1038/nrneurol.2017.111; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946; Yao B, 2012, EMBO REP, V13, P1102, DOI 10.1038/embor.2012.160; Yu JY, 2008, EXP CELL RES, V314, P2618, DOI 10.1016/j.yexcr.2008.06.002; Zeitelhofer M, 2008, RNA BIOL, V5, P244, DOI 10.4161/rna.6948; Zipprich JT, 2009, RNA, V15, P781, DOI 10.1261/rna.1448009	42	4	4	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1493	1509		10.1096/fj.201700633R	http://dx.doi.org/10.1096/fj.201700633R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29167236				2022-12-28	WOS:000427246000030
J	Masola, V; Zaza, G; Bellin, G; Dall'Olmo, L; Granata, S; Vischini, G; Secchi, MF; Lupo, A; Gambaro, G; Onisto, M				Masola, Valentina; Zaza, Gianluigi; Bellin, Gloria; Dall'Olmo, Luigi; Granata, Simona; Vischini, Gisella; Secchi, Maria Francesca; Lupo, Antonio; Gambaro, Giovanni; Onisto, Maurizio			Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury	FASEB JOURNAL			English	Article						kidney; inflammation; cytokines; SST0001	ISCHEMIA-REPERFUSION INJURY; TOLL-LIKE RECEPTOR-4; ACUTE KIDNEY INJURY; GROUP BOX-1 PROTEIN; DENDRITIC CELLS; INFLAMMATION; ACTIVATION; EXPRESSION; MONOCYTES; CONTRIBUTE	Heparanase (HPSE) is part of the biologic network triggered by ischemia/reperfusion (I/R) injury, a complication of renal transplantation and acute kidney injury. During this period, the kidney or graft undergoes a process of macrophages recruitment and activation. HPSE may therefore control these biologic effects. We measured the ability of HPSE and its inhibitor, SST0001, to regulate macrophage polarization and the crosstalk between macrophages and HK-2 renal tubular cells during in vitro hypoxia/reoxygenation (H/R). Furthermore, we evaluated in vivo renal inflammation, macrophage polarization, and histologic changes in mice subjected to monolateral I/R and treated with SST0001 for 2 or 7 d. The in vitro experiments showed that HPSE sustained M1 macrophage polarization and modulated apoptosis, the release of damage associated molecular patterns in post-H/R tubular cells, the synthesis of proinflammatory cytokines, and the up-regulation of TLRs on both epithelial cells and macrophages. HPSE also regulated M1 polarization induced by H/R-injured tubular cells and the partial epithelial-mesenchymal transition of these epithelial cells by M1 macrophages. All these effects were prevented by inhibiting HPSE. Furthermore, the inhibition of HPSE in vivo reduced inflammation and M1 polarization in mice undergoing I/R injury, partially restored renal function and normal histology, and reduced apoptosis. These results show for the first time that HPSE regulates macrophage polarization as well as renal damage and repair after I/R. HPSE inhibitors could therefore provide a new pharmacologic approach to minimize acute kidney injury and to prevent the chronic profibrotic damages induced by I/R.	[Masola, Valentina; Zaza, Gianluigi; Bellin, Gloria; Granata, Simona; Lupo, Antonio] Univ Hosp Verona, Dept Med, Renal Unit, Piazzale A Stefani 1, I-37126 Verona, VR, Italy; [Dall'Olmo, Luigi] Osped San Giovanni & Paolo, Azienda Ulss Serenissima 3, Venice, Italy; [Vischini, Gisella; Gambaro, Giovanni] Univ Cattolica Sacro Cuore, Renal Unit, Rome, Italy; [Secchi, Maria Francesca; Onisto, Maurizio] Univ Padua, Dept Biomed Sci Padova, Padua, Italy	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; ULSS 3 Serenissima; Ospedale SS Giovanni Paolo Venezia; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Padua	Zaza, G (corresponding author), Univ Hosp Verona, Dept Med, Renal Unit, Piazzale A Stefani 1, I-37126 Verona, VR, Italy.	gianluigi.zaza@univr.it	Onisto, Maurizio/K-5281-2014; Zaza, Gianluigi/K-3827-2018; Vischini, Gisella/N-9980-2019	Onisto, Maurizio/0000-0002-1191-7418; Vischini, Gisella/0000-0001-5829-4396; Gambaro, Giovanni/0000-0001-5733-2370; Masola, Valentina/0000-0003-2341-2481; Zaza, Gianluigi/0000-0002-6004-6196; dall'olmo, luigi/0000-0003-1564-2594	Leadiant Biosciences; University of Padova [CPDA144519/14]	Leadiant Biosciences; University of Padova	The authors thank A. Noseda (Leadiant Biosciences, Mendrisio, Switzerland) for continuous support. This work was supported by a grant from Leadiant Biosciences, and by a grant provided by the University of Padova (CPDA144519/14).	Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Bergler T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156900; Blich M, 2013, ARTERIOSCL THROM VAS, V33, pE56, DOI 10.1161/ATVBAHA.112.254961; Chadban SJ, 2010, SEMIN NEPHROL, V30, P278, DOI 10.1016/j.semnephrol.2010.03.009; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Garsen M, 2016, AM J PATHOL, V186, P805, DOI 10.1016/j.ajpath.2015.12.008; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Goldberg R, 2014, DIABETES, V63, P4302, DOI 10.2337/db14-0001; Goldberg R, 2013, MATRIX BIOL, V32, P234, DOI 10.1016/j.matbio.2013.02.008; Goode KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109596; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gutter-Kapon L, 2016, P NATL ACAD SCI USA, V113, pE7808, DOI 10.1073/pnas.1611380113; HANCOCK WW, 1983, TRANSPLANTATION, V35, P458, DOI 10.1097/00007890-198305000-00013; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Jo SK, 2006, NEPHROL DIAL TRANSPL, V21, P1231, DOI 10.1093/ndt/gfk047; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lee S, 2011, J AM SOC NEPHROL, V22, P317, DOI 10.1681/ASN.2009060615; Lerner I, 2011, J CLIN INVEST, V121, P1709, DOI 10.1172/JCI43792; Li L, 2010, SEMIN NEPHROL, V30, P268, DOI 10.1016/j.semnephrol.2010.03.005; Liu XJ, 2014, AM J NEPHROL, V39, P337, DOI 10.1159/000360549; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Masola V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175618; Masola V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160074; Masola V, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0538-5; Masola V, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-213; Masola V, 2011, BBA-MOL CELL RES, V1813, P1475, DOI 10.1016/j.bbamcr.2011.05.004; Matsuguchi T, 2000, J IMMUNOL, V165, P5767, DOI 10.4049/jimmunol.165.10.5767; Meirovitz A, 2013, FEBS J, V280, P2307, DOI 10.1111/febs.12184; Minafra L, 2011, LEUKEMIA RES, V35, P226, DOI 10.1016/j.leukres.2010.07.040; Naggi A, 2005, J BIOL CHEM, V280, P12103, DOI 10.1074/jbc.M414217200; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Park JS, 2003, AM J PHYSIOL-CELL PH, V284, pC870, DOI 10.1152/ajpcell.00322.2002; Pedregosa JF, 2011, INT IMMUNOPHARMACOL, V11, P1311, DOI 10.1016/j.intimp.2011.04.014; Ponticelli CE, 2015, KIDNEY INT, V87, P272, DOI 10.1038/ki.2014.359; Rabadi MM, 2012, AM J PHYSIOL-RENAL, V303, pF873, DOI 10.1152/ajprenal.00092.2012; Rabelink TJ, 2017, NAT REV NEPHROL, V13, P201, DOI 10.1038/nrneph.2017.6; Rivara S, 2016, FUTURE MED CHEM, V8, P647, DOI 10.4155/fmc-2016-0012; Sanchez-Nino MD, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/182958; Sedeek M, 2013, J AM SOC NEPHROL, V24, P1512, DOI 10.1681/ASN.2012111112; Taniguchi K, 2015, J CELL BIOCHEM, V116, P2840, DOI 10.1002/jcb.25230; Vesey DA, 2002, J LAB CLIN MED, V140, P342, DOI 10.1067/mlc.2002.128468; Vesey DA, 2002, KIDNEY INT, V62, P31, DOI 10.1046/j.1523-1755.2002.00401.x; Vlodaysky I, 2016, DRUG RESIST UPDATE, V29, P54, DOI 10.1016/j.drup.2016.10.001; Wang N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00614; Wang YQ, 2015, KIDNEY INT, V88, P1274, DOI 10.1038/ki.2015.295; Wilson HM, 2004, CURR OPIN NEPHROL HY, V13, P285, DOI 10.1097/00041552-200405000-00004; Wolfs TGAM, 2002, J IMMUNOL, V168, P1286, DOI 10.4049/jimmunol.168.3.1286; Wyburn KR, 2005, TRANSPLANTATION, V80, P1641, DOI 10.1097/01.tp.0000173903.26886.20; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82; Zaza G, 2015, J NEPHROL, V28, P431, DOI 10.1007/s40620-015-0216-y; Zaza G, 2014, EXP BIOL MED, V239, P52, DOI 10.1177/1535370213506678; Zhang J., 2016, MATH PROBL ENG, V2016, P1, DOI DOI 10.1042/BSR20160076; Zhang J, 2016, AM J TRANSL RES, V8, P4054; Zhang M, 2005, NEPHRON EXP NEPHROL, V99, P68, DOI 10.1159/000083414; Zhao HL, 2014, AM J PHYSIOL-RENAL, V306, pF801, DOI 10.1152/ajprenal.00469.2013; Zuk A, 2016, ANNU REV MED, V67, P293, DOI 10.1146/annurev-med-050214-013407	59	33	34	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					742	756		10.1096/fj.201700597R	http://dx.doi.org/10.1096/fj.201700597R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	28970256	Bronze			2022-12-28	WOS:000425146900018
J	Wang, Y; Wang, MD; Xia, YP; Gao, Y; Zhu, YY; Chen, SC; Mao, L; He, QW; Yue, ZY; Hu, B				Wang, Yong; Wang, Meng-Die; Xia, Yuan-Peng; Gao, Yuan; Zhu, Yi-Yi; Chen, Sheng-Cai; Mao, Ling; He, Quan-Wei; Yue, Zhen-Yu; Hu, Bo			MicroRNA-130a regulates cerebral ischemia-induced blood-brain barrier permeability by targeting Homeobox A5	FASEB JOURNAL			English	Article						ischemic stroke; rats; BMECs; occludin	ARTERY OCCLUSION; ANGIOGENESIS; STROKE; MIR-130A; CANCER; RATS; CELLS	Blood-brain barrier (BBB) disruption plays a critical role in brain injury induced by cerebral ischemia, and preserving BBB integrity during ischemia could alleviate cerebral injury. We examined the role of miR-130a in ischemic BBB disruption by using models of rat middle cerebral artery occlusion and cell oxygen-glucose deprivation. We found that ischemia significantly increased microRNA-130a (miR-130a) level and that miR-130a was predominantly from brain microvascular endothelial cells. Antagomir-130a, an antagonist of miR-130a, could attenuate brain edema, lower BBB permeability, reduce infarct volume, and improve neurologic function. MiR-130a overexpression induced by miR-130a mimic increased monolayer permeability, and intercellular inhibition of miR-130a by a miR-130a inhibitor suppressed oxygen-glucose deprivation-induced increase in monolayer permeability. Moreover, dual luciferase reporter system showed that Homeobox A5 was the direct target of miR-130a. MiR-130a, by inhibiting Homeobox A5 expression, could down-regulate occludin, thereby increasing BBB permeability. Our results suggested that miR-130a might be implicated in ischemia-induced BBB dysfunction and serve as a target for the treatment of ischemic stroke.	[Wang, Yong; Wang, Meng-Die; Xia, Yuan-Peng; Gao, Yuan; Zhu, Yi-Yi; Chen, Sheng-Cai; Mao, Ling; He, Quan-Wei; Hu, Bo] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Neurol, Wuhan, Hubei, Peoples R China; [Gao, Yuan] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Nucl Med, Wuhan, Hubei, Peoples R China; [Yue, Zhen-Yu] Icahn Sch Med Mt Sinai, Friedman Brain Inst, Dept Neurol, New York, NY 10029 USA; [Yue, Zhen-Yu] Icahn Sch Med Mt Sinai, Friedman Brain Inst, Dept Neurosci, New York, NY 10029 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Hu, B (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Neurol, 1277 Jiefang Dadao Ave, Hankou Wuhan 430022, Hubei, Peoples R China.	hubo@mail.hust.edu.cn	xia, yuanpeng/S-7988-2019		National Natural Science Foundation of China [81301001, 81571119, 81371311, 81571139, 81671147, 81301002, 81400969, 81400970, 81601027]; National Key Research and Development Program of China [2016YFC1300600]; National Research Foundation for the Doctoral Program of Higher Education of China [20120142110068]; New Century Excellent Talents in University [NCET-10-0406]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; National Research Foundation for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Natural Science Foundation of China (Grants 81301001 to M.-D.W., 81571119 and 81371311 to B.H., 81571139 to L.M., 81671147 to J.H.J., 81301002 to Y.-P.X., 81400969 to Q.-W.H., 81400970 to M.L., and 81601027 to Y.N.L.), the National Key Research and Development Program of China (Grant 2016YFC1300600), the National Research Foundation for the Doctoral Program of Higher Education of China (Grant 20120142110068 to B.H.), and the New Century Excellent Talents in University (Grant NCET-10-0406 to B.H.). The authors declare no conflicts of interest.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bauer AT, 2010, J CEREBR BLOOD F MET, V30, P837, DOI 10.1038/jcbfm.2009.248; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Fang Z, 2016, FASEB J, V30, P2097, DOI 10.1096/fj.201500126; Feng YQ, 2016, ARCH BIOCHEM BIOPHYS, V598, P57, DOI 10.1016/j.abb.2016.03.019; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Gursoy-Ozdemir Y, 2000, STROKE, V31, P1974, DOI 10.1161/01.STR.31.8.1974; He QW, 2013, MOL NEUROBIOL, V47, P976, DOI 10.1007/s12035-013-8396-8; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Lee SH, 2015, ONCOTARGET, V6, P33269, DOI 10.18632/oncotarget.5037; Li Q, 2016, FEBS J, V283, P1720, DOI 10.1111/febs.13697; Li Q, 2016, AM J TRANSL RES, V8, P955; Li YA, 2015, SCI REP-UK, V5, DOI 10.1038/srep13316; Lin L, 2015, ONCOL REP, V34, P3088, DOI 10.3892/or.2015.4301; Lu C, 2015, J MOL CELL CARDIOL, V89, P87, DOI 10.1016/j.yjmcc.2015.10.011; Pan R, 2017, SCI REP-UK, V7, DOI 10.1038/srep40331; Petrovic-Djergovic D, 2016, CIRC RES, V119, P142, DOI 10.1161/CIRCRESAHA.116.308022; Petty MA, 2002, PROG NEUROBIOL, V68, P311, DOI 10.1016/S0301-0082(02)00128-4; Rhoads Kim, 2005, Lymphatic Research and Biology, V3, P240, DOI 10.1089/lrb.2005.3.240; Saito K, 2011, NUCLEIC ACIDS RES, V39, P6086, DOI 10.1093/nar/gkr194; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Sepramaniam S, 2012, J BIOL CHEM, V287, P12006, DOI 10.1074/jbc.M111.280701; Song CL, 2016, ONCOTARGET, V7, P71922, DOI 10.18632/oncotarget.12431; Tan JR, 2011, CURR MOL MED, V11, P76; Tan KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007689; Wang MD, 2016, MOL NEUROBIOL, V53, P1310, DOI 10.1007/s12035-015-9099-0; Ye M, 2015, CELL PHYSIOL BIOCHEM, V36, P712, DOI 10.1159/000430132	27	42	44	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					935	944		10.1096/fj.201700139RRR	http://dx.doi.org/10.1096/fj.201700139RRR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29070584	Bronze			2022-12-28	WOS:000425146900034
J	Zheng, W; Hu, RK; Cai, RQ; Hofmann, L; Hu, QL; Fatehi, M; Long, WT; Kong, T; Tang, JF; Light, P; Flockerzi, V; Cao, Y; Chen, XZ				Zheng, Wang; Hu, Ruikun; Cai, Ruiqi; Hofmann, Laura; Hu, Qiaolin; Fatehi, Mohammad; Long, Wentong; Kong, Tim; Tang, Jingfeng; Light, Peter; Flockerzi, Veit; Cao, Ying; Chen, Xing-Zhen			Identification and characterization of hydrophobic gate residues in TRP channels	FASEB JOURNAL			English	Article						electrophysiology; Xenopus oocyte; hydrophobicity; hydrophilicity	CRYSTAL-STRUCTURE; RECEPTOR; ACTIVATION; SELECTIVITY; PKD2L1	Transient receptor potential (TRP) channels, subdivided into 6 subfamilies in mammals, have essential roles in sensory physiology. They respond to remarkably diverse stimuli, comprising thermal, chemical, and mechanical modalities, through opening or closing of channel gates. In this study, we systematically substituted the hydrophobic residues within the distal fragment of pore-lining helix S6 with hydrophilic residues and, based on Xenopus oocyte and mammalian cell electrophysiology and a hydrophobic gate theory, identified hydrophobic gates in TRPV6/V5/V4/C4/M8. We found that channel activity drastically increased when TRPV6(Ala616) (or) (Met617) or TRPV5(Ala576) (or Met577), but not any of their adjacent residues, was substituted with hydrophilic residues. Channel activity strongly correlated with the hydrophilicity of the residues at those sites, suggesting that consecutive hydrophobic residues TRPV6(Ala616-Met617) and TRPV5(Ala576-Met577) form a double-residue gate in each channel. By the same strategy, we identified a hydrophobic single-residue gate in TRPV4(Iso715), TRPC4(Iso617), and TRPM8(Val976). In support of the hydrophobic gate theory, hydrophilic substitution at the gate site, which removes the hydrophobic gate seal, substantially increased the activity of TRP channels in low-activity states but had little effect on the function of activated channels. The double-residue gate channels were more sensitive to small changes in the gate's hydrophobicity or size than single-residue gate channels. The unconventional double-reside gating mechanism in TRP channels may have been evolved to respond especially to physiologic stimuli that trigger relatively small gate conformational changes.	[Zheng, Wang; Tang, Jingfeng] Hubei Univ Technol, Coll Bioengn, Inst Biomed & Pharmaceut Sci, Key Lab Fermentat Engn,Minist Educ, Wuhan, Hubei, Peoples R China; [Zheng, Wang; Cai, Ruiqi; Hu, Qiaolin; Kong, Tim; Chen, Xing-Zhen] Univ Alberta, Fac Med & Dent, Dept Physiol, Membrane Prot Dis Res Grp, Edmonton, AB, Canada; [Fatehi, Mohammad; Long, Wentong; Light, Peter] Univ Alberta, Fac Med & Dent, Dept Pharmacol, Edmonton, AB, Canada; [Hu, Ruikun; Cao, Ying] Tongji Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Hofmann, Laura; Flockerzi, Veit] Univ Saarland, Expt & Klin Pharmakol & Toxikol, Homburg, Germany	Hubei University of Technology; University of Alberta; University of Alberta; Tongji University; Saarland University	Tang, JF (corresponding author), Hubei Univ Technol, Wuhan, Hubei, Peoples R China.; Chen, XZ (corresponding author), Univ Alberta, Med Sci 7 29A, Edmonton, AB T6G 2H7, Canada.	jingfeng9930@163.com; xzchen@ualberta.ca		, Tim/0000-0002-3240-8989; Long, Wentong/0000-0003-4650-8064; Tang, jingfeng/0000-0002-5524-4518	Natural Sciences and Engineering Research Council of Canada (NSERC); National Natural Science Foundation of China [81570648, 81602448]; Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich/Transregio 152]; Alberta Innovates-Doctoral Graduate Student Scholarship; NSERC International Research Training Group (IRTG); DFG [IRTG 1830]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Alberta Innovates-Doctoral Graduate Student Scholarship; NSERC International Research Training Group (IRTG); DFG(German Research Foundation (DFG))	The authors are grateful to J. Y. Lapointe (University of Montreal, Montreal, QC, Canada) for valuable comments and X. Liu (University of Alberta) for important contributions to electrophysiology experiments. This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC; to X.-Z.C.), the National Natural Science Foundation of China (Grant 81570648, to X.-Z.C. and 81602448, to J. T.), and by the Deutsche Forschungsgemeinschaft (DFG;, Sonderforschungsbereich/Transregio 152, to V.F.). W.Z. was a recipient of the Alberta Innovates-Doctoral Graduate Student Scholarship. R.C. and Q.H. were recipients of the NSERC International Research Training Group (IRTG) Studentship. L.H. was a recipient of the IRTG 1830 Student Scholarship (DFG). The authors declare no conflicts of interest.	Akbulut Y, 2015, ANGEW CHEM INT EDIT, V54, P3787, DOI 10.1002/anie.201411511; Aryal P, 2015, J MOL BIOL, V427, P121, DOI 10.1016/j.jmb.2014.07.030; Aryal P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5377; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Beck A, 2013, J BIOL CHEM, V288, P19471, DOI 10.1074/jbc.M113.478305; Bharate SS, 2012, ACS CHEM NEUROSCI, V3, P248, DOI 10.1021/cn300006u; Brelidze TI, 2003, P NATL ACAD SCI USA, V100, P9017, DOI 10.1073/pnas.1532257100; Chen J, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-3; Chung MK, 2008, NAT NEUROSCI, V11, P555, DOI 10.1038/nn.2102; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Courjaret R, 2013, J CELL PHYSIOL, V228, P2386, DOI 10.1002/jcp.24411; del Camino D, 2001, NEURON, V32, P649, DOI 10.1016/S0896-6273(01)00487-1; Eijkelkamp N, 2013, ANNU REV NEUROSCI, V36, P519, DOI 10.1146/annurev-neuro-062012-170412; Fecher-Trost C, 2013, J BIOL CHEM, V288, P16629, DOI 10.1074/jbc.M113.469726; Fernandez JA, 2011, J GEN PHYSIOL, V137, P173, DOI 10.1085/jgp.201010498; Freichel M, 2014, HANDB EXP PHARMACOL, V222, P85, DOI 10.1007/978-3-642-54215-2_5; Grieben M, 2017, NAT STRUCT MOL BIOL, V24, P114, DOI 10.1038/nsmb.3343; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Huynh KW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11130; Ishimaru Y, 2009, J DENT RES, V88, P212, DOI 10.1177/0022034508330212; Jeon JP, 2013, CELL CALCIUM, V54, P307, DOI 10.1016/j.ceca.2013.07.006; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Kitaguchi T, 2004, J GEN PHYSIOL, V124, P319, DOI 10.1085/jgp.200409098; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liu C, 2015, BIOCHEM BIOPH RES CO, V460, P22, DOI 10.1016/j.bbrc.2015.02.067; Loukin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019533; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Moran MM, 2011, NAT REV DRUG DISCOV, V10, P601, DOI 10.1038/nrd3456; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Nilius Bernd, 2005, Sci STKE, V2005, pre8, DOI 10.1126/stke.2952005re8; Oelstrom K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11608; Oelstrom K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4420; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Peng JB, 1999, J BIOL CHEM, V274, P22739, DOI 10.1074/jbc.274.32.22739; Peng JB, 2011, ADV EXP MED BIOL, V704, P239, DOI 10.1007/978-94-007-0265-3_14; Salazar H, 2009, NAT STRUCT MOL BIOL, V16, P704, DOI 10.1038/nsmb.1633; Saotome K, 2016, NATURE, V534, P506, DOI 10.1038/nature17975; Shapovalov G, 2016, SEMIN IMMUNOPATHOL, V38, P357, DOI 10.1007/s00281-015-0525-1; Shen PS, 2016, CELL, V167, P763, DOI 10.1016/j.cell.2016.09.048; Sherkheli MA, 2008, PAK J PHARM SCI, V21, P370; Sukhareva M, 2003, J GEN PHYSIOL, V122, P541, DOI 10.1085/jgp.200308905; Teng JF, 2015, P NATL ACAD SCI USA, V112, P3386, DOI 10.1073/pnas.1502366112; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Wang WJ, 2008, SCIENCE, V321, P1179, DOI 10.1126/science.1159262; Wilkes M, 2017, NAT STRUCT MOL BIOL, V24, P123, DOI 10.1038/nsmb.3357; Yang J, 2012, J BIOL CHEM, V287, P6551, DOI 10.1074/jbc.M111.305854; Yeh BI, 2005, EMBO J, V24, P3224, DOI 10.1038/sj.emboj.7600795; Zheng W, 2015, SCI REP-UK, V5, DOI 10.1038/srep09460; Zubcevic L, 2016, NAT STRUCT MOL BIOL, V23, P180, DOI 10.1038/nsmb.3159	50	23	24	2	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					639	653		10.1096/fj.201700599RR	http://dx.doi.org/10.1096/fj.201700599RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	28970257	Bronze			2022-12-28	WOS:000425146900010
J	Wu, XR; Jin, L; Zhang, H; Tong, RN; Ma, M; Chen, YJ				Wu, Xuri; Jin, Liang; Zhang, Hong; Tong, Ruinian; Ma, Min; Chen, Yijun			Identification of truncated form of NosP as a transcription factor to regulate the biosynthesis of nosiheptide	FASEB JOURNAL			English	Article						Streptomyces; antibiotics; SARP family; transcription regulation; secondary metabolism	STREPTOMYCES-COELICOLOR A3(2); GENE-CLUSTER; FAMILY; ANTIBIOTICS; MATURATION; MECHANISM; ACTIVATOR; PROMOTER; SYNTHASE; PEPTIDE	Nosiheptide (NOS), a typical member of the thiopeptides, possesses strong activities against multidrug-resistant, gram-positive bacterial pathogens. Similar to other thiopeptides, the biosynthetic pathway of NOS belongs to a ribosomally synthesized and posttranslationally modified peptide system. Bioinformatics analysis of the NOS gene cluster suggests that nosP gene encodes a homologous protein of the Streptomyces antibiotic regulatory protein (SARP) family. In the present study, the actual initiation codon of nosP was identified by comparison of potential initiation codons GUG and AUG. In contrast to previous predictions of starting with GUG, AUG, corresponding to methionine residue as the 53rd residue in the original sequence, is actually the initiation codon of nosP, indicating that a truncated form of NosP (NosP(53-323)) is a functional protein. For better understanding of the transcriptional regulation for NOS biosynthesis, the binding region was subsequently investigated with NosP(53-323), demonstrating that NosP(53-323) specifically binds the bidirectional nosL-nosM promoter region. Additionally, NosP(53-323) was confirmed to serve as a transcription factor to activate the transcription of all 15 structural genes in the gene cluster. The present study provides new insights into pathway-specific regulation of the biosynthesis of NOS, which would be beneficial to the investigation of the regulatory function of similar SARP proteins in the gene clusters of other thiopeptides.	[Chen, Yijun] China Pharmaceut Univ, State Key Lab Nat Med, 24 Tongjia St, Nanjing 210009, Jiangsu, Peoples R China; [Chen, Yijun] China Pharmaceut Univ, Lab Biol Chem, 24 Tongjia St, Nanjing 210009, Jiangsu, Peoples R China	China Pharmaceutical University; China Pharmaceutical University	Chen, YJ (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, 24 Tongjia St, Nanjing 210009, Jiangsu, Peoples R China.; Chen, YJ (corresponding author), China Pharmaceut Univ, Lab Biol Chem, 24 Tongjia St, Nanjing 210009, Jiangsu, Peoples R China.	yjchen@cpu.edu.cn	Chen, Yijun/H-3209-2019	Chen, Yijun/0000-0002-4920-152X; Wu, Xuri/0000-0002-0933-5902	Ministry of Education of the People's Republic of China 111 Project; State Administration of Foreign Exports Affairs of China [111-2-07]; National Natural Science Foundation of China [81502961]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Ministry of Education of the People's Republic of China 111 Project; State Administration of Foreign Exports Affairs of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the Ministry of Education of the People's Republic of China 111 Project, the State Administration of Foreign Exports Affairs of China (Grant 111-2-07), the National Natural Science Foundation of China (Grant 81502961), and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The authors declare no conflicts of interest.	Aigle B, 2005, J BACTERIOL, V187, P2491, DOI 10.1128/JB.187.7.2491-2500.2005; Badding ED, 2017, J AM CHEM SOC, V139, P5896, DOI 10.1021/jacs.7b01497; Bagley MC, 2005, CHEM REV, V105, P685, DOI 10.1021/cr0300441; BENAZET F, 1980, EXPERIENTIA, V36, P414, DOI 10.1007/BF01975121; BIBB MJ, 1985, GENE, V38, P215, DOI 10.1016/0378-1119(85)90220-3; Chater KF, 2006, PHILOS T R SOC B, V361, P761, DOI 10.1098/rstb.2005.1758; Colombo V, 2001, MICROBIOL-SGM, V147, P3083, DOI 10.1099/00221287-147-11-3083; Procopio RED, 2012, BRAZ J INFECT DIS, V16, P466, DOI 10.1016/j.bjid.2012.08.014; Ding W, 2017, ANGEW CHEM INT EDIT, V56, P3857, DOI 10.1002/anie.201609948; Ding Y, 2010, MOL BIOSYST, V6, P1180, DOI 10.1039/c005121g; GRAMAJO HC, 1993, MOL MICROBIOL, V7, P837, DOI 10.1111/j.1365-2958.1993.tb01174.x; Guthrie EP, 1998, MICROBIOL-SGM, V144, P727, DOI 10.1099/00221287-144-3-727; Hughes RA, 2007, ANGEW CHEM INT EDIT, V46, P7930, DOI 10.1002/anie.200700728; Ji XJ, 2015, ANGEW CHEM INT EDIT, V54, P9021, DOI 10.1002/anie.201503976; Jiang Lei, 2015, Chin J Nat Med, V13, P854, DOI 10.1016/S1875-5364(15)30089-3; Jin L, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.02880-16; Katz L, 2016, J IND MICROBIOL BIOT, V43, P155, DOI 10.1007/s10295-015-1723-5; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kurniawan YN, 2014, APPL MICROBIOL BIOT, V98, P9713, DOI 10.1007/s00253-014-5988-9; Lee PC, 2002, MOL MICROBIOL, V43, P1413, DOI 10.1046/j.1365-2958.2002.02840.x; Liu G, 2013, MICROBIOL MOL BIOL R, V77, P112, DOI 10.1128/MMBR.00054-12; Liu SS, 2015, SCI REP-UK, V5, DOI 10.1038/srep12744; Liu WY, 2013, CHEMBIOCHEM, V14, P1544, DOI 10.1002/cbic.201300427; Liu WY, 2013, CHEMBIOCHEM, V14, P573, DOI 10.1002/cbic.201200681; Ma M, 2014, CHEM COMMUN, V50, P10430, DOI 10.1039/c4cc04974h; MADDURI K, 1995, J BACTERIOL, V177, P3879, DOI 10.1128/jb.177.13.3879-3884.1995; Matsuno K, 2004, ARCH MICROBIOL, V181, P52, DOI 10.1007/s00203-003-0625-5; Nicolet Y, 2014, ANGEW CHEM INT EDIT, V53, P11840, DOI 10.1002/anie.201407320; Romero-Rodriguez A, 2015, BBA-GENE REGUL MECH, V1849, P1017, DOI 10.1016/j.bbagrm.2015.06.007; Sekurova ON, 2004, J BACTERIOL, V186, P1345, DOI 10.1128/JB.186.5.1345-1354.2004; Stratigopoulos G, 2002, CHEM BIOL, V9, P71, DOI 10.1016/S1074-5521(01)00095-3; Strobel GA, 2003, MICROBES INFECT, V5, P535, DOI 10.1016/S1286-4579(03)00073-X; Suzuki T, 2010, BIOSCI BIOTECH BIOCH, V74, P819, DOI 10.1271/bbb.90927; Swiercz JP, 2008, NUCLEIC ACIDS RES, V36, P7240, DOI 10.1093/nar/gkn898; Takano E, 2003, MOL MICROBIOL, V50, P475, DOI 10.1046/j.1365-2958.2003.03728.x; TAKANO E, 1992, MOL MICROBIOL, V6, P2797, DOI 10.1111/j.1365-2958.1992.tb01459.x; Vior NM, 2014, MICROBIOL-SGM, V160, P467, DOI 10.1099/mic.0.075218-0; Wang SF, 2013, CURR OPIN CHEM BIOL, V17, P626, DOI 10.1016/j.cbpa.2013.06.021; Wang SZ, 2016, RSC ADV, V6, P94643, DOI 10.1039/c6ra20302g; Wang Y, 2012, J BACTERIOL, V194, P5237, DOI 10.1128/JB.00989-12; Wietzorrek A, 1997, MOL MICROBIOL, V25, P1181, DOI 10.1046/j.1365-2958.1997.5421903.x; Yu Y, 2010, J AM CHEM SOC, V132, P16324, DOI 10.1021/ja106571g; Yu Y, 2009, ACS CHEM BIOL, V4, P855, DOI 10.1021/cb900133x	43	7	9	3	29	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					453	+		10.1096/fj.201700556R	http://dx.doi.org/10.1096/fj.201700556R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28935819				2022-12-28	WOS:000419172700040
J	Zhang, YQ; Deng, RY; Yang, X; Xu, W; Liu, Y; Li, FY; Zhang, J; Tang, HJ; Ji, XY; Bi, YF; Wang, X; Zhou, LB; Ning, G				Zhang, Yuqing; Deng, Ruyuan; Yang, Xue; Xu, Wan; Liu, Yun; Li, Fengying; Zhang, Juan; Tang, Hongju; Ji, Xueying; Bi, Yufang; Wang, Xiao; Zhou, Libin; Ning, Guang			Glucose potentiates beta-cell function by inducing Tph1 expression in rat islets	FASEB JOURNAL			English	Article						tryptophan hydroxylase 1; islet function; serotonin; diabetes	INSULIN-SECRETION; PANCREATIC-ISLETS; SEROTONIN; GROWTH; PREGNANCY; RELEASE; PROLIFERATION; DYSFUNCTION; GLUCOKINASE; HOMEOSTASIS	Impaired pancreatic beta-cell function is the primary defect in type 2 diabetes. Glucose is an important regulator of b-cell growth and function; however, the mechanisms that are involved in the chronic adaptation of beta cells to hyperglycemia remain largely unknown. In the present study, global gene expression patterns revealed that tryptophan hydroxylase 1 (Tph1) was the most profound of genes that are up-regulated in rat islets exposed to high glucose. Calcium and cAMP signals synergistically mediated glucose-stimulated Tph1 transcription in b cells by activating cAMP-responsive element-binding protein and promoting its binding with a Tph1 promoter. Similar to in vitro results, in vivo infusion of high glucose also strongly induced Tph1 expression and serotonin production in rat islets, along with enhanced islet function. Inhibition or knockdown of Tph1 markedly decreased glucose-potentiated insulin secretion. In contrast, overexpression of Tph1 augmented glucose-stimulated insulin secretion in rat islets by up-regulating the expression of genes that are related to islet function. In addition, the long-acting glucagon-like peptide 1 receptor agonist, exendin-4, stimulated Tph1 expression in a glucose-dependent manner. Knockdown of Tph1 inhibited exendin-4-potentiated insulin secretion in rat islets. These findings suggest that Tph1 mediates the compensation of islet function induced by glucose, and that promoting Tph1 expression in pancreatic b cells will provide a new strategy for the treatment of type 2 diabetes mellitus.	[Zhang, Yuqing; Deng, Ruyuan; Yang, Xue; Xu, Wan; Liu, Yun; Li, Fengying; Zhang, Juan; Tang, Hongju; Ji, Xueying; Bi, Yufang; Wang, Xiao; Zhou, Libin; Ning, Guang] Shanghai Jiao Tong Univ, Dept Endocrine & Metab Dis, Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Inst Endocrine & Metab Dis,Sch Med,Ruiji, 197 Ruijin Rd 2, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University	Wang, X; Zhou, LB (corresponding author), Shanghai Jiao Tong Univ, Dept Endocrine & Metab Dis, Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Inst Endocrine & Metab Dis,Sch Med,Ruiji, 197 Ruijin Rd 2, Shanghai 200025, Peoples R China.	wangxiao1976@hotmail.com; libinzhou99@hotmail.com		Yuqing, Zhang/0000-0002-3485-4202	National Natural Science Foundation of China [81570693, 81400768, 81370876, 81471030, 81270910, 81170720]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (81570693, 81400768, 81370876, 81471030, 81270910, and 81170720). The authors thank Dr. Guangwu Xu (Oregon Health and Science University, Portland, OR, USA) for technical assistance.	Adeghate Ernest, 1999, Neuro Endocrinol Lett, V20, P315; Ahren B, 2005, CURR MOL MED, V5, P275, DOI 10.2174/1566524053766004; Amireault P, 2013, ACS CHEM NEUROSCI, V4, P64, DOI 10.1021/cn300154j; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Berglund ED, 2013, J CLIN INVEST, V123, P5061, DOI 10.1172/JCI70338; Bonner-Weir S, 2000, ENDOCRINOLOGY, V141, P1926, DOI 10.1210/en.141.6.1926; BONNERWEIR S, 1994, TRENDS ENDOCRIN MET, V5, P60, DOI 10.1016/1043-2760(94)90003-5; Brouwers B, 2014, CELL METAB, V20, P979, DOI 10.1016/j.cmet.2014.11.004; Buteau J, 1999, DIABETOLOGIA, V42, P856, DOI 10.1007/s001250051238; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; CHARLES MA, 1973, SCIENCE, V179, P569, DOI 10.1126/science.179.4073.569; Cornu M, 2010, J BIOL CHEM, V285, P10538, DOI 10.1074/jbc.M109.091116; Crane JD, 2015, NAT MED, V21, P166, DOI 10.1038/nm.3766; Deeney JT, 2000, SEMIN CELL DEV BIOL, V11, P267, DOI 10.1006/scdb.2000.0175; Donelan MJ, 2002, J BIOL CHEM, V277, P24232, DOI 10.1074/jbc.M203345200; Drucker DJ, 2015, DIABETES, V64, P317, DOI 10.2337/db14-1514; Filler G, 2000, NEPHROL DIAL TRANSPL, V15, P867, DOI 10.1093/ndt/15.6.867; Franklin IK, 2004, J GEN PHYSIOL, V123, P185, DOI 10.1085/jgp.200409016; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Hinke SA, 2004, J PHYSIOL-LONDON, V558, P369, DOI 10.1113/jphysiol.2004.064881; Holst Jens Juul, 2004, Expert Opin Emerg Drugs, V9, P155, DOI 10.1517/14728214.9.1.155; Hoorens A, 1996, J CLIN INVEST, V98, P1568, DOI 10.1172/JCI118950; Hui HX, 2003, ENDOCRINOLOGY, V144, P1444, DOI 10.1210/en.2002-220897; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Johnson D, 2007, DIABETES, V56, P1694, DOI 10.2337/db07-0026; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; Lingohr MK, 2006, J BIOL CHEM, V281, P15884, DOI 10.1074/jbc.M600356200; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Nesher R, 2002, DIABETES, V51, pS53, DOI 10.2337/diabetes.51.2007.S53; Odagiri H, 1996, J BIOL CHEM, V271, P1909, DOI 10.1074/jbc.271.4.1909; Ohara-Imaizumi M, 2013, P NATL ACAD SCI USA, V110, P19420, DOI 10.1073/pnas.1310953110; Ohta Y, 2011, DIABETES, V60, P3208, DOI 10.2337/db10-1192; Park S, 2006, J BIOL CHEM, V281, P1159, DOI 10.1074/jbc.M508307200; Path G, 2004, DIABETES, V53, pS82, DOI 10.2337/diabetes.53.2007.S82; Paulmann N, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000229; Peschke E, 1997, J PINEAL RES, V23, P156, DOI 10.1111/j.1600-079X.1997.tb00349.x; Poitout V, 2006, J NUTR, V136, P873, DOI 10.1093/jn/136.4.873; Porat S, 2011, CELL METAB, V13, P440, DOI 10.1016/j.cmet.2011.02.012; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Schraenen A, 2010, DIABETOLOGIA, V53, P2589, DOI 10.1007/s00125-010-1913-7; Shi YC, 2015, ENDOCRINOLOGY, V156, P3122, DOI 10.1210/en.2015-1168; Tengholm A, 2012, UPSALA J MED SCI, V117, P355, DOI 10.3109/03009734.2012.724732; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Wang WD, 2009, P NATL ACAD SCI USA, V106, P1427, DOI 10.1073/pnas.0811848106; Wierup N, 2006, DIABETES, V55, P305, DOI 10.2337/diabetes.55.02.06.db04-1383; Wu L, 2012, BBA-MOL BASIS DIS, V1822, P1815, DOI 10.1016/j.bbadis.2012.08.009; Wuttke A, 2015, BASIC CLIN PHARMACOL, V116, P281, DOI 10.1111/bcpt.12369; Zawalich WS, 2001, J BIOL CHEM, V276, P37120, DOI 10.1074/jbc.M105008200; Zhang HL, 2012, ENDOCRINOLOGY, V153, P602, DOI 10.1210/en.2011-1460	53	11	13	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5342	5355		10.1096/fj.201700351R	http://dx.doi.org/10.1096/fj.201700351R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28794173				2022-12-28	WOS:000416588300019
J	Lamothe, SM; Song, W; Guo, J; Li, WT; Yang, TH; Baranchuk, A; Graham, CH; Zhang, ST				Lamothe, Shawn M.; Song, WonJu; Guo, Jun; Li, Wentao; Yang, Tonghua; Baranchuk, Adrian; Graham, Charles H.; Zhang, Shetuan			Hypoxia reduces mature hERG channels through calpain up-regulation	FASEB JOURNAL			English	Article						heart; ion channel regulation; LQTS; proteases	CELL-SURFACE EXPRESSION; HIPPEL-LINDAU PROTEIN; INDUCIBLE FACTOR-I; POTASSIUM CHANNEL; K+ CHANNELS; CARDIAC-ARRHYTHMIA; DIRECT BINDING; SLEEP-APNEA; KR; ISCHEMIA	Human ether-a-go-go-related gene (hERG) encodes the pore-forming subunit of the rapidly activating delayed rectifier potassium current (IKr) potassium channel, which is important for cardiac repolarization. Impairment of hERG function is the primary cause of acquired long QT syndrome, which predisposes individuals to cardiac arrhythmias and sudden death. Patients with hypoxia due to conditions such as cardiac ischemia or obstructive sleep apnea display increased incidence of cardiac arrhythmias and sudden death. We sought to understand the mechanisms that underlie hypoxia-associated cardiac arrhythmias. Using cell biology and electrophysiologic techniques, we found that hypoxic culture of hERG-expressing human embryonic kidney (HEK) cells and neonatal rat cardiomyocytes reduced hERGcurrent/IKr andmature ERGchannel expressionwith a concomitant increase in calpain expression. Calpainwas actively released into the extracellularmilieu and degraded cell-surface hERG. In contrast to hERG, the ether-a-go-go (EAG) channel was not reduced by hypoxic culture. By making chimeric channels between hERG and EAG, we identified that hypoxia-induced calpain degraded hERG by targeting its extracellular S5-pore linker. The scorpion toxin BeKm-1, which is known to selectively bind to the S5-pore linker of hERG, prevented hypoxia-induced hERG reduction. Our data provide novel information about hypoxia-mediated hERG dysfunction and may have biological and clinical implications in hypoxia-associated diseases.-Lamothe, S. M., Song, W., Guo, J., Li, W., Yang, T., Baranchuk, A., Graham, C. H., Zhang, S. Hypoxia reduces mature hERG channels through calpain up-regulation.	[Lamothe, Shawn M.; Song, WonJu; Guo, Jun; Li, Wentao; Yang, Tonghua; Graham, Charles H.; Zhang, Shetuan] Queens Univ, Kingston Gen Hosp, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Baranchuk, Adrian] Queens Univ, Kingston Gen Hosp, Dept Med, Kingston, ON, Canada	Queens University - Canada; Queens University - Canada	Zhang, ST (corresponding author), Queens Univ, Dept Biomed & Mol Sci, 18 Stuart St, Kingston, ON K7L 3N6, Canada.	shetuan.zhang@queensu.ca		Zhang, Shetuan/0000-0002-2297-0193; Lamothe, Shawn/0000-0001-8722-2631	Canadian Institutes of Health Research [MOP 72911]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported, in part, by Canadian Institutes of Health Research Grant MOP 72911 (to S.Z.). The authors declare no conflicts of interest.	ALLSHIRE A, 1987, BIOCHEM J, V244, P381, DOI 10.1042/bj2440381; Ardyanto TD, 2006, INT J ONCOL, V29, P549; Baranchuk A, 2012, J ELECTROCARDIOL, V45, P508, DOI 10.1016/j.jelectrocard.2012.03.003; Ben-Yosef Y, 2002, CIRC RES, V90, P784, DOI 10.1161/01.RES.0000015588.70132.DC; Bradley TD, 2009, LANCET, V373, P82, DOI 10.1016/S0140-6736(08)61622-0; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Culver C, 2010, MOL CELL BIOL, V30, P4901, DOI 10.1128/MCB.00409-10; Fan JS, 1999, BIOPHYS J, V76, P3128, DOI 10.1016/S0006-3495(99)77464-3; Ficker E, 1998, CIRC RES, V82, P386, DOI 10.1161/01.RES.82.3.386; Fontana L, 2001, BIOCHEM BIOPH RES CO, V286, P857, DOI 10.1006/bbrc.2001.5464; Frangie C, 2006, J BIOL CHEM, V281, P26624, DOI 10.1074/jbc.M603007200; Gille T, 2014, AM J RESP CELL MOL, V50, P526, DOI 10.1165/rcmb.2012-0518OC; Gong QM, 2002, AM J PHYSIOL-HEART C, V283, pH77, DOI 10.1152/ajpheart.00008.2002; Guo J, 2007, J PHARMACOL EXP THER, V321, P911, DOI 10.1124/jpet.107.120931; Guo J, 2012, J BIOL CHEM, V287, P33132, DOI 10.1074/jbc.M112.389643; Hamanaka RB, 2009, CURR OPIN CELL BIOL, V21, P894, DOI 10.1016/j.ceb.2009.08.005; Hool LC, 2004, J PHYSIOL-LONDON, V554, P743, DOI 10.1113/jphysiol.2003.055442; JANSE MJ, 1989, PHYSIOL REV, V69, P1049, DOI 10.1152/physrev.1989.69.4.1049; Kenigsberg DN, 2007, J AM COLL CARDIOL, V49, P1299, DOI 10.1016/j.jacc.2006.11.035; Lamothe SM, 2016, J BIOL CHEM, V291, P20387, DOI 10.1074/jbc.M116.743138; Letavernier B, 2012, ARTERIOSCL THROM VAS, V32, P335, DOI 10.1161/ATVBAHA.111.240242; Maurer E, 2012, BIOL CHEM, V393, P535, DOI 10.1515/hsz-2011-0221; Mehra R, 2009, ARCH INTERN MED, V169, P1147, DOI 10.1001/archinternmed.2009.138; Mehta JL, 1999, CARDIOVASC RES, V43, P291, DOI 10.1016/S0008-6363(99)00132-7; Nanduri J, 2008, BIOCHEM BIOPH RES CO, V373, P309, DOI 10.1016/j.bbrc.2008.06.028; Nanduri J, 2009, BIOCHEM BIOPH RES CO, V388, P212, DOI 10.1016/j.bbrc.2009.07.149; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; Perez J, 2016, J IMMUNOL, V196, P168, DOI 10.4049/jimmunol.1500749; Radisky DC, 2009, NAT REV MOL CELL BIO, V10, P228, DOI 10.1038/nrm2633; Rajamani S, 2006, AM J PHYSIOL-HEART C, V290, pH1278, DOI 10.1152/ajpheart.00777.2005; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Shamsuzzaman AS, 2015, SLEEP, V38, P1113, DOI 10.5665/sleep.4824; Shimoda LA, 2011, AM J PHYSIOL-CELL PH, V300, pC951, DOI 10.1152/ajpcell.00512.2010; Svoboda LK, 2012, CIRC RES, V111, P842, DOI 10.1161/CIRCRESAHA.111.263525; Taglialatela M, 1997, P NATL ACAD SCI USA, V94, P11698, DOI 10.1073/pnas.94.21.11698; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Tseng GN, 2007, BIOPHYS J, V92, P3524, DOI 10.1529/biophysj.106.097360; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang N, 2016, AM J PHYSIOL-CELL PH, V310, pC329, DOI 10.1152/ajpcell.00231.2015; Xu LJ, 2004, J BIOL CHEM, V279, P53683, DOI 10.1074/jbc.M409889200; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200; Zeidan-Shwiri T, 2011, HEART RHYTHM, V8, P657, DOI 10.1016/j.hrthm.2010.12.030; Zhang HL, 2013, J MOL CELL CARDIOL, V65, P51, DOI 10.1016/j.yjmcc.2013.09.002; Zhang JL, 1998, AM J PHYSIOL-LUNG C, V275, pL461, DOI 10.1152/ajplung.1998.275.3.L461; Zhang ST, 2006, AM J PHYSIOL-HEART C, V290, pH1038, DOI 10.1152/ajpheart.00679.2005; Zhao Y, 2016, HEART RHYTHM, V13, P2004, DOI 10.1016/j.hrthm.2016.06.019; Zheng XW, 2014, P NATL ACAD SCI USA, V111, P2560, DOI 10.1073/pnas.1320815111; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3	51	12	13	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					5068	5077		10.1096/fj.201700255R	http://dx.doi.org/10.1096/fj.201700255R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28784631				2022-12-28	WOS:000413398500034
J	Nguyen, K; Li, J; Puthenveetil, R; Lin, XC; Poe, MM; Hsiao, CHC; Vinogradova, O; Wiemer, AJ				Nguyen, Khiem; Li, Jin; Puthenveetil, Robbins; Lin, Xiaochen; Poe, Michael M.; Hsiao, Chia-Hung Christine; Vinogradova, Olga; Wiemer, Andrew J.			The butyrophilin 3A1 intracellular domain undergoes a conformational change involving the juxtamembrane region	FASEB JOURNAL			English	Article						phosphoantigen; CD277; B7 family coreceptor; gamma delta T cell; bisphosphonate	DELTA T-CELLS; SMALL-ANGLE SCATTERING; ISOPRENOID METABOLISM; NONPEPTIDE ANTIGENS; CANCER-IMMUNOTHERAPY; BTN3A1 CONTROLS; IN-VIVO; ACTIVATION; RECOGNITION; NMR	Small isoprenoid diphosphates, such as (E)-4-hydroxy-3-methyl-but-2-enyl diphosphate (HMBPP), are ligands of the internal domain of BTN3A1. Ligand binding in target cells promotes activation of V gamma 9V delta 2 T cells. We demonstrate by small-angle X-ray scattering (SAXS) that HMBPP binding to the internal domain of BTN3A1 induces a conformational change in the position of the B30.2 domain relative to the juxtamembrane (JM) region. To better understand the molecular details of this conformational rearrangement, NMR spectroscopy was used to discover that the JM region interacts with HMBPP, specifically at the diphosphate. The spectral location of the affected amide peaks, partial NMR assignments, and JM mutants (ST(296)AA or T(304)A) investigated, confirm that the backbone amide of at least one Thr (Thr(304)), adjacent to conserved Ser, comes close to the HMBPP diphosphate, whereas double mutation of nonconserved residues (Ser/Thr(296/297)) may perturb the local fold. Cellular mutation of either of the identified Thr residues reduces the activation of V gamma 9V delta 2 T cells by HMBPP, zoledronate, and POM2-C-HMBP, but not by a partial agonist BTN3 antibody. Taken together, our results show that ligand binding to BTN3A1 induces a conformational change within the intracellular domain that involves the JM region and is required for full activation.	[Nguyen, Khiem; Li, Jin; Lin, Xiaochen; Poe, Michael M.; Hsiao, Chia-Hung Christine; Vinogradova, Olga; Wiemer, Andrew J.] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT USA; [Puthenveetil, Robbins] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT USA; [Wiemer, Andrew J.] Univ Connecticut, Inst Syst Genom, Storrs, CT USA	University of Connecticut; University of Connecticut; University of Connecticut	Wiemer, AJ (corresponding author), Univ Connecticut, 69 N Eagleville Rd,Unit 3092, Storrs Mansfield, CT 06269 USA.	andrew.wiemer@uconn.edu	Wiemer, Andrew J/C-2257-2009; Vinogradova, Olga/ABE-8367-2020	Wiemer, Andrew J/0000-0002-3029-1780; Vinogradova, Olga/0000-0001-5101-7361; Hsiao, Chia-Hung Christine/0000-0002-9037-027X; Li, Jin/0000-0002-6764-3743; Poe, Michael/0000-0002-8054-2947	U.S. National Institutes of Health (NIH) National Cancer Institute (NCI) [R01CA186935]; NATIONAL CANCER INSTITUTE [R01CA186935] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the U.S. National Institutes of Health (NIH) National Cancer Institute (NCI) Grant R01CA186935 (to A.J.W. and P.I.). A.J.W. owns shares in Terpenoid Therapeutics, Coralville, IA, USA. The current work did not involve Terpenoid Therapeutics. The remaining authors have no conflicts of interest.	Adams EJ, 2015, CELL IMMUNOL, V296, P31, DOI 10.1016/j.cellimm.2015.04.008; Ali Z, 2009, J IMMUNOL, V183, P5407, DOI 10.4049/jimmunol.0901760; Belmant C, 2000, FASEB J, V14, P1669, DOI 10.1096/fj.99-0909fje; Boedec A, 2008, J MED CHEM, V51, P1747, DOI 10.1021/jm701101g; BORN WK, 1991, FASEB J, V5, P2699, DOI 10.1096/fasebj.5.12.1717333; Fournie JJ, 2013, CELL MOL IMMUNOL, V10, P35, DOI 10.1038/cmi.2012.39; Gober HJ, 2003, J EXP MED, V197, P163, DOI 10.1084/jem.20021500; Harly C, 2012, BLOOD, V120, P2269, DOI 10.1182/blood-2012-05-430470; Hsiao CHC, 2014, CHEM BIOL, V21, P945, DOI 10.1016/j.chembiol.2014.06.006; Huang D, 2009, P NATL ACAD SCI USA, V106, P7553, DOI 10.1073/pnas.0811250106; Kilcollins AM, 2016, J IMMUNOL, V197, P419, DOI 10.4049/jimmunol.1501833; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Meraviglia S, 2010, CLIN EXP IMMUNOL, V161, P290, DOI 10.1111/j.1365-2249.2010.04167.x; Morita CT, 2007, IMMUNOL REV, V215, P59, DOI 10.1111/j.1600-065X.2006.00479.x; Nada MH, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0209-6; Palakodeti A, 2012, J BIOL CHEM, V287, P32780, DOI 10.1074/jbc.M112.384354; Peigne CM, 2017, J IMMUNOL, V198, P4228, DOI 10.4049/jimmunol.1601910; Petoukhov MV, 2007, CURR OPIN STRUC BIOL, V17, P562, DOI 10.1016/j.sbi.2007.06.009; Puthenveetil R, 2017, NANOTECHNOL REV, V6, P111, DOI 10.1515/ntrev-2016-0076; Puthenveetil R, 2013, PROTEINS, V81, P1222, DOI 10.1002/prot.24271; Reichenberg A, 2003, BIOORG MED CHEM LETT, V13, P1257, DOI 10.1016/S0960-894X(03)00138-0; Rhodes DA, 2015, J IMMUNOL, V194, P2390, DOI 10.4049/jimmunol.1401064; Riano F, 2014, EUR J IMMUNOL, V44, P2571, DOI 10.1002/eji.201444712; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sandstrom A, 2014, IMMUNITY, V40, P490, DOI 10.1016/j.immuni.2014.03.003; Santolaria T, 2013, J IMMUNOL, V191, P1993, DOI 10.4049/jimmunol.1300255; Sebestyen Z, 2016, CELL REP, V15, P1973, DOI 10.1016/j.celrep.2016.04.081; Seo M, 2016, P NATL ACAD SCI USA, V113, P14390, DOI 10.1073/pnas.1615287113; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shippy RR, 2017, J MED CHEM, V60, P2373, DOI 10.1021/acs.jmedchem.6b00965; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; Tu WW, 2011, J EXP MED, V208, P1511, DOI 10.1084/jem.20110226; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Vinogradova O, 2012, TOP CURR CHEM, V326, P35, DOI 10.1007/128_2011_216; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang H, 2015, J IMMUNOL, V195, P4583, DOI 10.4049/jimmunol.1500314; Wang H, 2011, J IMMUNOL, V187, P5099, DOI 10.4049/jimmunol.1002697; Wiemer AJ, 2010, CURR TOP MED CHEM, V10, P1858; Wiemer AJ, 2009, ANTI-CANCER AGENT ME, V9, P526, DOI 10.2174/187152009788451860; Wiemer DF, 2014, BIOCHEM PHARMACOL, V89, P301, DOI 10.1016/j.bcp.2014.03.009; Wriggers W, 2012, ACTA CRYSTALLOGR D, V68, P344, DOI 10.1107/S0907444911049791; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213	47	33	34	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4697	4706		10.1096/fj.201601370RR	http://dx.doi.org/10.1096/fj.201601370RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28705810	Green Published			2022-12-28	WOS:000413398500004
J	Chen, JF; Wu, QS; Xie, YX; Si, BL; Yang, PP; Wang, WY; Hua, Q; He, Q				Chen, Jun-Feng; Wu, Qi-Shun; Xie, Yu-Xian; Si, Bo-Lin; Yang, Ping-Ping; Wang, Wen-Yan; Hua, Qin; He, Qing			TRAP1 ameliorates renal tubulointerstitial fibrosis in mice with unilateral ureteral obstruction by protecting renal tubular epithelial cell mitochondria	FASEB JOURNAL			English	Article						apoptosis; extracellular matrix; mitochondrial DNA; mitofilin; reactive oxygen species	COLORECTAL-CARCINOMA; METABOLIC SWITCH; OXIDATIVE STRESS; CHAPERONE TRAP1; APOPTOSIS; MITOFILIN; INJURY; PROTEIN; OVEREXPRESSION; CARDIOMYOCYTES	Mitochondrial dysfunction causes renal tubular epithelial cell injury and promotes cell apoptosis and renal tubulointerstitial fibrosis (TIF) progression. TNF receptor-associated protein 1 (TRAP1) is a molecular chaperone protein that is localized in mitochondria. It plays an important role in cell apoptosis; however, its functional mechanism in TIF remains unclear. In this study, we observed the effects of TRAP1 in renal tubular epithelial cell mitochondria in mice with unilateral ureteral obstruction and its function in cell apoptosis and TIF. Results show that TRAP1 could protect the mitochondrial structure in renal tubular epithelial cells; maintain the levels of mitochondrial membrane potential, ATP, and mitochondrial DNA copy number; inhibit reactive oxygen species production; stabilize the expression of the mitochondrial inner membrane protein mitofilin; reduce renal tubular epithelial cell apoptosis; and inhibit TIF. These results provide new theoretical foundations for additional understanding of the antifibrotic mechanism of TRAP1 in the kidney.-Chen, J.-F., Wu, Q.-S., Xie, Y.-X., Si, B.-L., Yang, P.-P., Wang, W.-Y., Hua, Q., He, Q. TRAP1 ameliorates renal tubulointerstitial fibrosis in mice with unilateral ureteral obstruction by protecting renal tubular epithelial cell mitochondria.	[Chen, Jun-Feng; He, Qing] Nanjing Med Univ, Nanjing Hosp 1, Div Hemodialysis, 68 Changle Rd, Nanjing 210006, Jiangsu, Peoples R China; [Wu, Qi-Shun; Si, Bo-Lin; Yang, Ping-Ping; Wang, Wen-Yan; Hua, Qin] Jiangsu Univ, Affiliated Hosp, Div Nephrol, Zhenjiang, Peoples R China; [Xie, Yu-Xian] Jiangsu Univ, Peoples Hosp Suzhou High Tech Dist, Div Nephrol, Suzhou, Peoples R China	Nanjing Medical University; Jiangsu University; Jiangsu University	Chen, JF (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Div Hemodialysis, 68 Changle Rd, Nanjing 210006, Jiangsu, Peoples R China.	njchenjf@sina.com			National Natural Science Foundation of China [81400743]; Medical Science and Technology Development Foundation (Nanjing Department of Health) [JQX16027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Science and Technology Development Foundation (Nanjing Department of Health)	This study was supported by grants from the National Natural Science Foundation of China (81400743) and the Medical Science and Technology Development Foundation (Nanjing Department of Health; JQX16027). The authors declare no conflicts of interest.	Agorreta J, 2014, MOL CANCER RES, V12, P660, DOI 10.1158/1541-7786.MCR-13-0481; Bhreathnach U, 2017, BBA-MOL BASIS DIS, V1863, P896, DOI 10.1016/j.bbadis.2017.01.015; Brezniceanu ML, 2008, DIABETES, V57, P451, DOI 10.2337/db07-0013; Chacko BK, 2010, BIOCHEM J, V432, P9, DOI 10.1042/BJ20100308; Condelli V, 2015, ONCOTARGET, V6, P22298, DOI 10.18632/oncotarget.4263; Docherty NG, 2006, AM J PHYSIOL-RENAL, V290, pF4, DOI 10.1152/ajprenal.00045.2005; Gieffers C, 1997, EXP CELL RES, V232, P395, DOI 10.1006/excr.1997.3539; Hua GQ, 2007, J BIOL CHEM, V282, P20553, DOI 10.1074/jbc.M703196200; Im CN, 2016, CELL STRESS CHAPERON, V21, P553, DOI 10.1007/s12192-016-0687-3; Ix JH, 2015, J AM SOC NEPHROL, V26, P2494, DOI 10.1681/ASN.2014070696; John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.e04-08-0697; Kadye R, 2014, IUBMB LIFE, V66, P42, DOI 10.1002/iub.1234; Kramer S, 2009, AM J PHYSIOL-RENAL, V297, pF218, DOI 10.1152/ajprenal.90617.2008; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; Lambert AJ, 2009, METHODS MOL BIOL, V554, P165, DOI 10.1007/978-1-59745-521-3_11; Lettini G, 2016, CELL DEATH DIFFER, V23, P1792, DOI 10.1038/cdd.2016.67; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Masgras I, 2017, CELL REP, V18, P659, DOI 10.1016/j.celrep.2016.12.056; Mathur A, 2000, CARDIOVASC RES, V46, P126, DOI 10.1016/S0008-6363(00)00002-X; Noh YH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.341; Palladino G, 2016, ENDOCR-RELAT CANCER, V23, P699, DOI 10.1530/ERC-16-0063; Park YU, 2010, P NATL ACAD SCI USA, V107, P17785, DOI 10.1073/pnas.1004361107; Rao M, 2009, J AM SOC NEPHROL, V20, P189, DOI 10.1681/ASN.2007091031; Romanov V, 2011, APOPTOSIS, V16, P1217, DOI 10.1007/s10495-011-0646-5; Rossi MN, 2009, J BIOL CHEM, V284, P31616, DOI 10.1074/jbc.M109.025882; Schaier M, 2009, AM J PHYSIOL-RENAL, V297, pF769, DOI 10.1152/ajprenal.90530.2008; Suzuki T, 2016, J AM SOC NEPHROL, V27, P1925, DOI 10.1681/ASN.2015060623; Szeto HH, 2011, J AM SOC NEPHROL, V22, P1041, DOI 10.1681/ASN.2010080808; Thapa D, 2015, J MOL CELL CARDIOL, V79, P212, DOI 10.1016/j.yjmcc.2014.11.008; Tian X, 2014, FEBS J, V281, P2805, DOI 10.1111/febs.12822; Torres VE, 2014, J AM SOC NEPHROL, V25, P18, DOI 10.1681/ASN.2013040398; Wang C, 2013, FREE RADICAL BIO MED, V65, P1417, DOI 10.1016/j.freeradbiomed.2013.10.005; Wang W, 2013, J IMMUNOL, V190, P1239, DOI 10.4049/jimmunol.1201959; Xiang F, 2010, FEBS J, V277, P1929, DOI 10.1111/j.1742-4658.2010.07615.x; Xu LJ, 2009, J CEREBR BLOOD F MET, V29, P365, DOI 10.1038/jcbfm.2008.125; Yang RF, 2012, BIOCHEM BIOPH RES CO, V428, P93, DOI 10.1016/j.bbrc.2012.10.012; Yoshida S, 2013, P NATL ACAD SCI USA, V110, pE1604, DOI 10.1073/pnas.1220659110; Zhang G, 2016, J CLIN INVEST, V126, P1834, DOI 10.1172/JCI82661; Zhang P, 2015, CELL PHYSIOL BIOCHEM, V36, P2072, DOI 10.1159/000430174	39	18	19	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4503	4514		10.1096/fj.201700283R	http://dx.doi.org/10.1096/fj.201700283R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28710113				2022-12-28	WOS:000413397400027
J	Khanna, S; Stewart, R; Gnyawali, S; Harris, H; Balch, M; Spieldenner, J; Sen, CK; Rink, C				Khanna, Savita; Stewart, Richard; Gnyawali, Surya; Harris, Hallie; Balch, Maria; Spieldenner, James; Sen, Chandan K.; Rink, Cameron			Phytoestrogen isoflavone intervention to engage the neuroprotective effect of glutamate oxaloacetate transaminase against stroke	FASEB JOURNAL			English	Article						phytonutrient; ischemia; brain	LIPOPOLYSACCHARIDE-INDUCED DAMAGE; FOCAL CEREBRAL-ISCHEMIA; PROTECTS DOPAMINERGIC-NEURONS; ESTROGEN-RELATED RECEPTORS; NEURAL CELL-DEATH; VITAMIN-E ACTION; ALPHA-TOCOTRIENOL; DOWN-REGULATION; IN-VITRO; THERAPEUTIC TARGET	In the pathophysiologic setting of cerebral ischemia, excitotoxic levels of glutamate contribute to neuronal cell death. Our previous work demonstrated the ability of glutamate oxaloacetate transaminase (GOT) to metabolize neurotoxic glutamate in the stroke-affected brain. Here, we seek to identify small-molecule inducers of GOT expression to mitigate ischemic stroke injury. From a panel of phytoestrogen isoflavones, biochanin A (BCA) was identified as the most potent inducer of GOT gene expression in neural cells. BCA significantly increased GOT mRNA and protein expression at 24 h and protected against glutamate-induced cell death. Of note, this protection was lost when GOT was knocked down. To validate outcomes in vivo, C57BL/6 mice were intraperitoneally injected with BCA (5 and 10 mg/kg) for 4 wk and subjected to ischemic stroke. BCA levels were significantly increased in plasma and brain of mice. Immunohistochemistry demonstrated increased GOT protein expression in the brain. BCA attenuated stroke lesion volume as measured by 9.4T MRI and improved sensorimotor function-this protection was lost with GOT knockdown. BCA increased luciferase activity in cells that were transfected with the pERRE(3)tk-LUC plasmid, which demonstrated transactivation of GOT. This increase was lost when estrogen-related receptor response element sites were mutated. Taken together, BCA represents a natural phytoestrogen that mitigates stroke-induced injury by inducing GOT expression.-Khanna, S., Stewart, R., Gnyawali, S., Harris, H., Balch, M., Spieldenner, J., Sen, C. K., Rink, C. Phytoestrogen isoflavone intervention to engage the neuroprotective effect of glutamate oxaloacetate transaminase against stroke.	[Khanna, Savita; Stewart, Richard; Gnyawali, Surya; Harris, Hallie; Balch, Maria; Spieldenner, James; Sen, Chandan K.; Rink, Cameron] Ohio State Univ, Dept Surg, Davis Heart & Lung Res Inst, Wexner Med Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Khanna, S; Rink, C (corresponding author), Ohio State Univ, Wexner Med Ctr, 473 W 12th Ave, Columbus, OH 43210 USA.	savita.khanna@osumc.edu; cameron.rink@osumc.edu	Gnyawali, Surya/AAC-3082-2020; Rink, Cameron/AAA-4484-2021; Gnyawali, Surya/AAC-3082-2020	Gnyawali, Surya/0000-0001-8980-4889; Rink, Cameron/0000-0002-3149-3624; Balch, Maria/0000-0003-2011-6345; Gnyawali, Surya/0000-0002-4214-8068	U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) [R01NS085272]; NIH NINDS [R01NS42617]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085272, R01NS042617] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) Grant R01NS085272 (to C.R. and S.K.), and supported, in part, by NIH NINDS Grant R01NS42617 (to C.K.S.).	[Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Aras AB, 2015, INFLAMMATION, V38, P1311, DOI 10.1007/s10753-014-0102-0; Aras AB, 2015, NEURAL REGEN RES, V10, P146, DOI 10.4103/1673-5374.150724; Audet-Walsh E, 2015, ACTA PHARMACOL SIN, V36, P51, DOI 10.1038/aps.2014.121; Burguete MC, 2006, EUR J NEUROSCI, V23, P703, DOI 10.1111/j.1460-9568.2006.04599.x; Castillo J, 2016, J CEREBR BLOOD F MET, V36, P292, DOI 10.1177/0271678X15606721; Chan HY, 2003, BRIT J NUTR, V90, P87, DOI 10.1079/BJN2003868; Chan YC, 2012, J BIOL CHEM, V287, P41032, DOI 10.1074/jbc.M112.413294; Chan YC, 2012, ARTERIOSCL THROM VAS, V32, P1372, DOI 10.1161/ATVBAHA.112.248583; Chan YC, 2011, J BIOL CHEM, V286, P2047, DOI 10.1074/jbc.M110.158790; Chen HQ, 2007, NEUROSCI LETT, V417, P112, DOI 10.1016/j.neulet.2006.11.045; Cornara L, 2016, CRIT REV FOOD SCI, V56, pS149, DOI 10.1080/10408398.2015.1038378; Cortina B, 2013, EUR J PHARMACOL, V708, P88, DOI 10.1016/j.ejphar.2013.02.016; de Rijke E, 2001, J CHROMATOGR A, V932, P55, DOI 10.1016/S0021-9673(01)01231-6; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Eichner LJ, 2011, MITOCHONDRION, V11, P544, DOI 10.1016/j.mito.2011.03.121; Ghatak S, 2016, NANOMED-NANOTECHNOL, V12, P1827, DOI 10.1016/j.nano.2016.03.004; Giguere V, 2002, TRENDS ENDOCRIN MET, V13, P220, DOI 10.1016/S1043-2760(02)00592-1; Harini R, 2012, EUR J PHARMACOL, V676, P89, DOI 10.1016/j.ejphar.2011.11.051; Hubbard WJ, 2015, SHOCK, V44, P3, DOI 10.1097/SHK.0000000000000364; Hurtado O, 2012, NEUROCHEM INT, V61, P119, DOI 10.1016/j.neuint.2012.04.007; Khanna S, 2005, FREE RADICAL BIO MED, V39, P1310, DOI 10.1016/j.freeradbiomed.2005.06.013; Khanna S, 2005, STROKE, V36, pE144, DOI 10.1161/01.STR.0000181082.70763.22; Khanna S, 2003, J BIOL CHEM, V278, P43508, DOI 10.1074/jbc.M307075200; Khanna S, 2007, J BIOL CHEM, V282, P23482, DOI 10.1074/jbc.M611269200; Khanna S, 2006, J NEUROCHEM, V98, P1474, DOI 10.1111/j.1471-4159.2006.04000.x; Khanna S, 2015, FASEB J, V29, P828, DOI 10.1096/fj.14-263723; Khanna S, 2015, ANTIOXID REDOX SIGN, V22, P175, DOI 10.1089/ars.2014.6106; Khanna S, 2013, J CEREBR BLOOD F MET, V33, P1197, DOI 10.1038/jcbfm.2013.68; Khanna S, 2010, J NEUROCHEM, V112, P1249, DOI 10.1111/j.1471-4159.2009.06550.x; Khanna S, 2009, ANTIOXID REDOX SIGN, V11, P449, DOI 10.1089/ARS.2008.2230; Kim E, 2015, J NEUROSCI, V35, P15113, DOI 10.1523/JNEUROSCI.2890-15.2015; Kurzer MS, 1997, ANNU REV NUTR, V17, P353, DOI 10.1146/annurev.nutr.17.1.353; Leibowitz A, 2012, INT J MOL SCI, V13, P10041, DOI 10.3390/ijms130810041; Liang K, 2014, J NEUROL SCI, V344, P100, DOI 10.1016/j.jns.2014.06.033; Moran J, 2017, CELL MOL NEUROBIOL, V37, P405, DOI 10.1007/s10571-016-0372-1; Nestel P, 2004, EUR J CLIN NUTR, V58, P403, DOI 10.1038/sj.ejcn.1601796; Park HA, 2009, CELL DEATH DIFFER, V16, P1167, DOI 10.1038/cdd.2009.37; Park HA, 2011, STROKE, V42, P2308, DOI 10.1161/STROKEAHA.110.608547; Patel V, 2012, J NUTR, V142, P513, DOI 10.3945/jn.111.151902; Qian YS, 2015, PHARM BIOL, V53, P1124, DOI 10.3109/13880209.2014.962057; Qian YS, 2012, NEUROCHEM INT, V60, P759, DOI 10.1016/j.neuint.2012.03.011; Rink C, 2017, FASEB J, V31, P1709, DOI 10.1096/fj.201601033R; Rink C, 2011, ANTIOXID REDOX SIGN, V14, P1777, DOI 10.1089/ars.2011.3930; Rink C, 2011, ANTIOXID REDOX SIGN, V14, P1889, DOI 10.1089/ars.2010.3474; Rink C, 2010, J CEREBR BLOOD F MET, V30, P1275, DOI 10.1038/jcbfm.2010.7; Roy S, 2002, METHOD ENZYMOL, V352, P326; Sen CK, 2017, FASEB J, V31, P927, DOI 10.1096/fj.201600437R; Sen CK, 2000, J BIOL CHEM, V275, P13049, DOI 10.1074/jbc.275.17.13049; Spagnuolo P, 2014, FITOTERAPIA, V94, P62, DOI 10.1016/j.fitote.2014.01.027; Stein RA, 2006, ENDOCR-RELAT CANCER, V13, pS25, DOI 10.1677/erc.1.01292; Stout JM, 2013, BEHAV BRAIN RES, V256, P428, DOI 10.1016/j.bbr.2013.08.027; Suetsugi M, 2003, MOL CANCER RES, V1, P981; Tan JW, 2013, NEUROCHEM RES, V38, P512, DOI 10.1007/s11064-012-0943-6; Teede HJ, 2003, ARTERIOSCL THROM VAS, V23, P1066, DOI 10.1161/01.ATV.0000072967.97296.4A; Turner JV, 2007, J PHARM SCI-US, V96, P1879, DOI 10.1002/jps.20987; Wang J, 2016, NEUROTOX RES, V30, P486, DOI 10.1007/s12640-016-9648-y; Wang J, 2015, PHARMACOL BIOCHEM BE, V138, P96, DOI 10.1016/j.pbb.2015.09.013; Wang SQ, 2014, INT J BIOL SCI, V10, P457, DOI 10.7150/ijbs.7562; Wang WB, 2015, J NEUROL SCI, V348, P121, DOI 10.1016/j.jns.2014.11.018; Zhao YX, 2011, J CEREBR BLOOD F MET, V31, P1412, DOI 10.1038/jcbfm.2010.230; Zhu HB, 2014, PLANTA MED, V80, P262, DOI 10.1055/s-0033-1360340; Zhumadilov A, 2015, EXPERT REV NEUROTHER, V15, P501, DOI 10.1586/14737175.2015.1032259	63	19	19	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4533	4544		10.1096/fj.201700353	http://dx.doi.org/10.1096/fj.201700353			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28655710	Green Published			2022-12-28	WOS:000413397400029
J	Kuo, HY; Liu, FC				Kuo, Hsiao-Ying; Liu, Fu-Chin			Valproic acid induces aberrant development of striatal compartments and corticostriatal pathways in a mouse model of autism spectrum disorder	FASEB JOURNAL			English	Article						striatum; striosome; risperidone; ultrasonic vocalizations	BASAL GANGLIA; CEREBRAL-CORTEX; MATRIX COMPARTMENTS; PRENATAL EXPOSURE; PATTERN-FORMATION; NEURONS; MICE; PATCH; FOXP2; RAT	The striatum comprises two neurochemical compartments: striosomes and the matrix. Striosomal and matrix compartments receive inputs from limbic system-related and sensorimotor cortices, respectively. Here, we investigate the impact on the corticostriosomal pathway in the valproic acid (VPA)-induced autism spectrum disorder mouse model. VPA administration during the neurogenesis time windows of striosomes, but not the matrix, resulted in aberrant compartmentation [i.e., maternal VPA injections at embryonic day (E)12.75 decreased -opioid receptor-positive striosomes, but increased calbindin-positive matrix in the rostral striatum]. VPA(E12.75) treatment also impaired the aggregation of cells pulse labeled with 5-bromo-2'-deoxyuridine at E12.75 into striosomal cell clusters, which suggests defective segregation of striosomal cells from matrix cells. This possibility was supported by our findings that VPA(E12.75) treatment altered the expression of ephrinA5 and EphA4, two molecules that are related to compartmental segregation. In the VPA(E12.75) neocortex, Foxp2-positive neurons were decreased in layer VI, but increased in layer V, which projects to the striosomal compartment. We also investigated VPA effects on the corticostriosomal pathway. VPA(E12.75) treatment decreased the putative corticostriosomal synapses of striosomal neurons and induced an aberrant pattern of isolation stress-induced ultrasonic vocalizations. Of interest, risperidone treatments conjointly improved ultrasonic vocalizations and restored the striosomal compartment in VPA(E12.75) pups. Collectively, dysfunctional corticostriatal pathways, particularly via the aberrant striosomal compartment, may be involved in autism spectrum disorder pathophysiology.-Kuo, H.-Y., Liu, F.-C. Valproic acid induces aberrant development of striatal compartments and corticostriatal pathways in a mouse model of autism spectrum disorder.	[Kuo, Hsiao-Ying; Liu, Fu-Chin] Natl Yang Ming Univ, Inst Neurosci, 155 Sect 2,Li Nong St, Taipei 11221, Taiwan	National Yang Ming Chiao Tung University	Liu, FC (corresponding author), Natl Yang Ming Univ, Inst Neurosci, 155 Sect 2,Li Nong St, Taipei 11221, Taiwan.	fuchin@ym.edu.tw		Kuo, Hsiao-Ying/0000-0003-2571-3755	National Science Council [NSC101-2321-B-010-021, NSC102-2321-B-010-018]; Ministry of Science and Technology [MOST103-2321-B-010-009, MOST104-2321-B-010-022, MOST105-2321-B-010-013, MOST104-2311-B-010-010-MY3, MOST106-2321-B-010-012]; Aiming for Top University grant, Taiwan Ministry of Education;  [MOST 105-2811-B-010-036]	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Aiming for Top University grant, Taiwan Ministry of Education; 	The authors thank Pierre Vanderhaeghen (IRIBHM and ULB Neuroscience Institute, Universite Libre de Bruxelles, Brussels, Belgium) for providing probes for in situ hybridization and Chou P. Hung (U.S. Army Research Lab (ARL), Human Research and Engineering Directorate (HRED), Synergistic Human-Machine Interfaces Branch (SHMI), Aberdeen Proving Ground, Aberdeen, MD) for editing the manuscript. This work was supported by National Science Council Grants NSC101-2321-B-010-021 and NSC102-2321-B-010-018; Ministry of Science and Technology Grants MOST103-2321-B-010-009, MOST104-2321-B-010-022, MOST105-2321-B-010-013, MOST104-2311-B-010-010-MY3, and MOST106-2321-B-010-012; an Aiming for Top University grant, Taiwan Ministry of Education (to F.-C.L.); and Postdoctoral Fellowship Grant MOST 105-2811-B-010-036 (to H.-Y.K.). The authors declare no conflicts of interest.	Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; [Anonymous], 2007, FDA Consum, V41, P4; Arbogast T, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005709; Arndt TL, 2005, INT J DEV NEUROSCI, V23, P189, DOI 10.1016/j.ijdevneu.2004.11.001; Bromley RL, 2008, NEUROLOGY, V71, P1923, DOI 10.1212/01.wnl.0000339399.64213.1a; Chen YC, 2016, NAT NEUROSCI, V19, P1513, DOI 10.1038/nn.4380; Crandall JE, 2007, J NEUROSCI, V27, P3813, DOI 10.1523/JNEUROSCI.5124-06.2007; Crittenden JR, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00059; DONOGHUE JP, 1986, BRAIN RES, V365, P397, DOI 10.1016/0006-8993(86)91658-6; Enard W, 2009, CELL, V137, P961, DOI 10.1016/j.cell.2009.03.041; FISHELL G, 1991, J COMP NEUROL, V312, P33, DOI 10.1002/cne.903120104; Fuccillo MV, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00027; Gandal MJ, 2010, BIOL PSYCHIAT, V68, P1100, DOI 10.1016/j.biopsych.2010.09.031; GERFEN CR, 1984, NATURE, V311, P461, DOI 10.1038/311461a0; GERFEN CR, 1989, SCIENCE, V246, P385, DOI 10.1126/science.2799392; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; Geschwind DH, 2011, TRENDS COGN SCI, V15, P409, DOI 10.1016/j.tics.2011.07.003; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; GRAYBIEL AM, 1990, TRENDS NEUROSCI, V13, P244, DOI 10.1016/0166-2236(90)90104-I; GRAYBIEL AM, 1982, P NATL ACAD SCI-BIOL, V79, P198, DOI 10.1073/pnas.79.1.198; Haber SN, 2016, DIALOGUES CLIN NEURO, V18, P7; Hage SR, 2010, HBK BEHAV NEUROSCI, V19, P339, DOI 10.1016/B978-0-12-374593-4.00032-2; Hara Y, 2015, BEHAV BRAIN RES, V289, P39, DOI 10.1016/j.bbr.2015.04.022; Hisaoka T, 2010, NEUROSCIENCE, V166, P551, DOI 10.1016/j.neuroscience.2009.12.055; Hollander E, 2005, BIOL PSYCHIAT, V58, P226, DOI 10.1016/j.biopsych.2005.03.040; Janis LS, 1999, J NEUROSCI, V19, P4962; JANSSEN PAJ, 1988, J PHARMACOL EXP THER, V244, P685; Kataoka S, 2013, INT J NEUROPSYCHOPH, V16, P91, DOI 10.1017/S1461145711001714; Kim KC, 2011, TOXICOL LETT, V201, P137, DOI 10.1016/j.toxlet.2010.12.018; Kincaid AE, 1996, J COMP NEUROL, V374, P578; Kolozsi E, 2009, NEUROSCIENCE, V163, P1201, DOI 10.1016/j.neuroscience.2009.07.021; KRUSHEL LA, 1995, EUR J NEUROSCI, V7, P1210, DOI 10.1111/j.1460-9568.1995.tb01111.x; Lee PS, 2009, CEREB CORTEX, V19, P1787, DOI 10.1093/cercor/bhn209; Lee SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045512; Liao WL, 2008, P NATL ACAD SCI USA, V105, P6765, DOI 10.1073/pnas.0802109105; Liegeois F, 2003, NAT NEUROSCI, V6, P1230, DOI 10.1038/nn1138; Mason HA, 2005, DEVELOPMENT, V132, P4247, DOI 10.1242/dev.02008; Moles A, 2004, SCIENCE, V304, P1983, DOI 10.1126/science.1095943; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Nickl-Jockschat T, 2012, HUM BRAIN MAPP, V33, P1470, DOI 10.1002/hbm.21299; Passante L, 2008, DEVELOPMENT, V135, P3281, DOI 10.1242/dev.024778; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Pelphrey KA, 2011, J CHILD PSYCHOL PSYC, V52, P631, DOI 10.1111/j.1469-7610.2010.02349.x; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Pennartz CMA, 2009, J NEUROSCI, V29, P12831, DOI 10.1523/JNEUROSCI.3177-09.2009; Qiu AQ, 2010, J AM ACAD CHILD PSY, V49, P539, DOI 10.1016/j.jaac.2010.02.012; Rinaldi T, 2008, CEREB CORTEX, V18, P763, DOI 10.1093/cercor/bhm117; Rinaldi T, 2007, P NATL ACAD SCI USA, V104, P13501, DOI 10.1073/pnas.0704391104; Rojas DC, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-56; Schneider T, 2005, NEUROPSYCHOPHARMACOL, V30, P80, DOI 10.1038/sj.npp.1300518; Smith JB, 2016, NEURON, V91, P1069, DOI 10.1016/j.neuron.2016.07.046; Snow WM, 2008, DEV PSYCHOBIOL, V50, P633, DOI 10.1002/dev.20337; SONG DD, 1994, DEV BRAIN RES, V83, P233, DOI 10.1016/0165-3806(94)00144-8; Stanfield AC, 2008, EUR PSYCHIAT, V23, P289, DOI 10.1016/j.eurpsy.2007.05.006; Takahashi T, 2016, MOL PSYCHIATR, V21, P1208, DOI 10.1038/mp.2015.190; VANDERKOOY D, 1987, BRAIN RES, V401, P155, DOI 10.1016/0006-8993(87)91176-0; Wagner GC, 2006, J AUTISM DEV DISORD, V36, P779, DOI 10.1007/s10803-006-0117-y; Watkins KE, 1999, AM J HUM GENET, V65, P1215, DOI 10.1086/302631; Yi HG, 2016, CEREB CORTEX, V26, P1409, DOI 10.1093/cercor/bhu236; Yochum CL, 2008, BRAIN RES, V1203, P126, DOI 10.1016/j.brainres.2008.01.055; Yoneshima H, 2006, NEUROSCIENCE, V137, P401, DOI 10.1016/j.neuroscience.2005.08.075	62	22	23	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4458	4471		10.1096/fj.201700054R	http://dx.doi.org/10.1096/fj.201700054R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28687613				2022-12-28	WOS:000413397400023
J	Barrios, J; Patel, KR; Aven, L; Achey, R; Minns, MS; Lee, Y; Trinkaus-Randall, VE; Ai, XB				Barrios, Juliana; Patel, Kruti R.; Aven, Linh; Achey, Rebecca; Minns, Martin S.; Lee, Yoonjoo; Trinkaus-Randall, Vickery E.; Ai, Xingbin			Early life allergen-induced mucus overproduction requires augmented neural stimulation of pulmonary neuroendocrine cell secretion	FASEB JOURNAL			English	Article						NT4; innervation; GABA; childhood asthma	MICE LACKING NT4; NEUROEPITHELIAL BODIES; AIRWAY HYPERRESPONSIVENESS; PROXIMAL AIRWAYS; INNERVATION; EPITHELIUM; EXPOSURE; ASTHMA; MUCIN; GABA	Pulmonary neuroendocrine cells (PNECs) are the only innervated airway epithelial cells. To what extent neural innervation regulates PNEC secretion and function is unknown. Here, we discover that neurotrophin 4 (NT4) plays an essential role in mucus overproduction after early life allergen exposure by orchestrating PNEC innervation and secretion of GABA. We found that PNECs were the only cellular source of GABA in airways. In addition, PNECs expressed NT4 as a target-derived mechanism underlying PNEC innervation during development. Early life allergen exposure elevated the level of NT4 and caused PNEC hyperinnervation and nodose neuron hyperactivity. Associated with aberrant PNEC innervation, the authors discovered that GABA hypersecretion was required for the induction of mucin Muc5ac expression. In contrast, NT4(-/-) mice were protected from allergen-induced mucus overproduction and changes along the nerve-PNEC axis without any defects in inflammation. Last, GABA installation restored mucus overproduction in NT4(-/-) mice after early life allergen exposure. Together, our findings provide the first evidence for NT4-dependent neural regulation of PNEC secretion of GABA in a neonatal disease model. Targeting the nerve-PNEC axis may be a valid treatment strategy for mucus overproduction in airway diseases, such as childhood asthma.	[Barrios, Juliana; Patel, Kruti R.; Aven, Linh; Achey, Rebecca] Boston Univ, Sch Med, Dept Med, Ctr Pulm, Boston, MA 02118 USA; [Minns, Martin S.; Lee, Yoonjoo; Trinkaus-Randall, Vickery E.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Ai, Xingbin] Brigham & Womens Hosp, Div Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA	Boston University; Boston University; Harvard University; Brigham & Women's Hospital	Ai, XB (corresponding author), Brigham & Womens Hosp, Pulm & Crit Care Med, Thorn Bldg,Rm 905,75 Francis St, Boston, MA 02115 USA.	xai@partners.org		Patel, Kruti/0000-0002-4303-8717; Minns, Martin/0000-0002-9793-5819	American Asthma Foundation [12-0086]; U.S. National Institutes of Health, National Heart, Lung, and Blood Institute (NIH/NHLBI) [1R01HL116163, 1R01HL132991]; NIH/NHLBI [HL007035]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116163, T32HL007035, F31HL126443, R01HL132991] Funding Source: NIH RePORTER	American Asthma Foundation; U.S. National Institutes of Health, National Heart, Lung, and Blood Institute (NIH/NHLBI); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Y. Bai and K. Trieu (both from Brigham and Women's Hospital) for technical assistance, and K. C. Kim, (University of Arizona, Tucson, AZ, USA) for critical reading. This work is supported by an American Asthma Foundation award (12-0086), U.S. National Institutes of Health, National Heart, Lung, and Blood Institute (NIH/NHLBI) Grants 1R01HL116163 and 1R01HL132991 (to X.A.), and NIH/NHLBI F31 Training Grant HL007035 (to J.B.).	Adriaensen D, 2015, AUTON NEUROSCI-BASIC, V191, P39, DOI 10.1016/j.autneu.2015.04.006; Aven L, 2014, FASEB J, V28, P897, DOI 10.1096/fj.13-238212; Branchfield K, 2016, SCIENCE, V351, P707, DOI 10.1126/science.aad7969; Brouns I, 2000, AM J RESP CELL MOL, V23, P52, DOI 10.1165/ajrcmb.23.1.3936; Chang RB, 2015, CELL, V161, P622, DOI 10.1016/j.cell.2015.03.022; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Chen G, 2009, J CLIN INVEST, V119, P2914, DOI 10.1172/JCI39731; Chen X, 2005, NEURON, V46, P13, DOI 10.1016/j.neuron.2005.03.009; Cockayne DA, 2005, J PHYSIOL-LONDON, V567, P621, DOI 10.1113/jphysiol.2005.088435; Cutz E, 2013, SEMIN CELL DEV BIOL, V24, P40, DOI 10.1016/j.semcdb.2012.09.003; Dakhama A, 2005, AM J PHYSIOL-LUNG C, V288, pL761, DOI 10.1152/ajplung.00143.2004; Erickson JT, 1996, J NEUROSCI, V16, P5361; Evans CM, 2004, AM J RESP CELL MOL, V31, P382, DOI 10.1165/rcmb.2004-0060OC; Fu XW, 2011, AM J RESP CELL MOL, V44, P222, DOI 10.1165/rcmb.2010-0109OC; Guilbert TW, 2006, NEW ENGL J MED, V354, P1985, DOI 10.1056/NEJMoa051378; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; HUNG KS, 1982, ANAT RECORD, V203, P285, DOI 10.1002/ar.1092030210; Ito T, 2000, DEVELOPMENT, V127, P3913; Jarvis MF, 2002, P NATL ACAD SCI USA, V99, P17179, DOI 10.1073/pnas.252537299; Kim EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018472; Larson SD, 2004, TOXICOL APPL PHARM, V194, P211, DOI 10.1016/j.taap.2003.09.025; Lazarowski ER, 2011, SUBCELL BIOCHEM, V55, P1, DOI 10.1007/978-94-007-1217-1_1; Li JF, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00260; Linnoila RI, 2006, LAB INVEST, V86, P425, DOI 10.1038/labinvest.3700412; LIU X, 1995, NATURE, V375, P238, DOI 10.1038/375238a0; Maddox L, 2002, ANNU REV MED, V53, P477, DOI 10.1146/annurev.med.53.082901.103921; Ordonez CL, 2001, AM J RESP CRIT CARE, V163, P517, DOI 10.1164/ajrccm.163.2.2004039; Oswald DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044574; Pardo-Saganta A, 2013, AM J RESP CELL MOL, V48, P364, DOI 10.1165/rcmb.2012-0146OC; Park SW, 2009, AM J RESP CRIT CARE, V180, P603, DOI 10.1164/rccm.200811-1768OC; Patel KR, 2016, MUCOSAL IMMUNOL, V9, P1466, DOI 10.1038/mi.2016.11; Rajavelu P, 2015, J CLIN INVEST, V125, P2021, DOI 10.1172/JCI79422; Saatian B, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24333; Schnorbusch K, 2013, HISTOCHEM CELL BIOL, V140, P549, DOI 10.1007/s00418-013-1093-x; Song H, 2012, P NATL ACAD SCI USA, V109, P17531, DOI 10.1073/pnas.1207238109; Stern DA, 2008, LANCET, V372, P1058, DOI 10.1016/S0140-6736(08)61447-6; Stevens PT, 2008, CLIN EXP ALLERGY, V38, P1901, DOI 10.1111/j.1365-2222.2008.03093.x; Szczepankiewicz A, 2012, EUR RESPIR J, V39, P1035, DOI 10.1183/09031936.00136611; Tortorolo L, 2005, AM J RESP CRIT CARE, V172, P233, DOI 10.1164/rccm.200412-1693OC; VanRossum D, 1997, NEUROSCI BIOBEHAV R, V21, P649, DOI 10.1016/S0149-7634(96)00023-1; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wojcik SM, 2006, NEURON, V50, P575, DOI 10.1016/j.neuron.2006.04.016; Wu ZX, 2016, RESP PHYSIOL NEUROBI, V223, P1, DOI 10.1016/j.resp.2015.11.009; Wu ZX, 2009, ENVIRON HEALTH PERSP, V117, P1434, DOI 10.1289/ehp.0800511; Xiang YY, 2007, NAT MED, V13, P862, DOI 10.1038/nm1604; Yu M, 2008, J ALLERGY CLIN IMMUN, V122, P640, DOI 10.1016/j.jaci.2008.04.038	46	32	34	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					4117	4128		10.1096/fj.201700115R	http://dx.doi.org/10.1096/fj.201700115R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28566470	Green Published			2022-12-28	WOS:000408713300034
J	Quan, NH; Sun, WQ; Wang, L; Chen, X; Bogan, JS; Zhou, XC; Cates, C; Liu, Q; Zheng, Y; Li, J				Quan, Nanhu; Sun, Wanqing; Wang, Lin; Chen, Xu; Bogan, Jonathan S.; Zhou, Xinchun; Cates, Courtney; Liu, Quan; Zheng, Yang; Li, Ji			Sestrin2 prevents age-related intolerance to ischemia and reperfusion injury by modulating substrate metabolism	FASEB JOURNAL			English	Article						aging; AMPK; glucose transport	ACTIVATED PROTEIN-KINASE; MYOCARDIAL-ISCHEMIA; GLUCOSE-UPTAKE; MITOCHONDRIAL BIOGENESIS; SIGNALING PATHWAY; ELDERLY-PATIENTS; SENESCENT HEART; SKELETAL-MUSCLE; IN-VIVO; AMPK	A novel stress-inducible protein, Sestrin2 (Sesn2), declines in the heart with aging. AMPK has emerged as a pertinent stress-activated kinase that has been shown to have cardioprotective capabilities against myocardial ischemic injury. We identified the interaction between Sesn2 and AMPK in the ischemic heart. To determine whether ischemic AMPK activation-modulated by the Sesn2-AMPK complex in the heart-is impaired in aging that sensitizes the heart to ischemic insults, young C57BL/6 mice (age 3-4 mo), middle-aged mice (age 10-12 mo), and aged mice (age 24-26 mo) were subjected to left anterior descending coronary artery occlusion for in vivo regional ischemia. The ex vivo working heart system was used for measuring substrate metabolism. The protein level of Sesn2 in hearts was gradually decreased with aging. Of interest, ischemic AMPK activation was blunted in aged hearts compared with young hearts (P < 0.05); the AMPK downstream glucose uptake and the rate of glucose oxidation were significantly impaired in aged hearts during ischemia and reperfusion (P < 0.05 vs. young hearts). Myocardial infarction size was larger in aged hearts (P < 0.05 vs. young hearts). Immunoprecipitation with Sesn2 Ab revealed that cardiac Sesn2 forms a complex with AMPK and upstream liver kinase B1 (LKB1) during ischemia. Of interest, the binding affinity between Sesn2 and AMPK upstream LKB1 is impaired in aged hearts during ischemia (P < 0.05 vs. young hearts). Furthermore, Sesn2-knockout hearts demonstrate a cardiac phenotype and response to ischemic stress that is similar to wild-type aged hearts (i.e., impaired ischemic AMPK activation and higher sensitivity to ischemia-and reperfusion-induced injury). Adeno-associated virus-Sesn2 was delivered to aged hearts via a coronary delivery approach and significantly rescued the protein level of Sesn2 and the ischemic tolerance of aged hearts; therefore, Sesn2 is a scaffold protein that mediates AMPK activation in the ischemic myocardium via an interaction with AMPK upstream LKB1. Decreased Sesn2 levels in aging lead to a blunted ischemic AMPK activation, alterations in substrate metabolism, and an increased sensitivity to ischemic insults	[Quan, Nanhu; Sun, Wanqing; Wang, Lin; Liu, Quan; Zheng, Yang] Jilin Univ, Hosp 1, Cardiovasc Ctr, Changchun 130000, Jilin, Peoples R China; [Quan, Nanhu; Sun, Wanqing; Wang, Lin; Chen, Xu; Cates, Courtney; Li, Ji] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Mississippi Ctr Heart Res, G559 Guyton Res Bldg,2500 N State St, Jackson, MS 39216 USA; [Zhou, Xinchun] Univ Mississippi, Med Ctr, Dept Pathol, Inst Canc, Jackson, MS 39216 USA; [Bogan, Jonathan S.] Yale Univ, Sch Med, Dept Internal Med, Endocrinol Sect, New Haven, CT 06510 USA; [Bogan, Jonathan S.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA	Jilin University; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; Yale University; Yale University	Zheng, Y (corresponding author), Jilin Univ, Hosp 1, Cardiovasc Ctr, Changchun 130000, Jilin, Peoples R China.; Li, J (corresponding author), Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Mississippi Ctr Heart Res, G559 Guyton Res Bldg,2500 N State St, Jackson, MS 39216 USA.	zhengyang@jlu.edu.cn; jli3@umc.edu	Quan, Nanhu/AAC-8561-2020; Bogan, Jonathan S/A-1575-2010	Bogan, Jonathan S/0000-0001-6463-8466	American Diabetes Association [1-17-IBS-296]; U.S. National Institutes of Health (NIH) National Institute on Aging [R21AG044820, R01AG049835]; NIH National Heart, Lung and Blood Institute [P01HL051971]; NIH National Institute of General Medical Sciences [P20GM104357]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [R01DK092661]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG044820, R01AG049835] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); U.S. National Institutes of Health (NIH) National Institute on Aging; NIH National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Thomas Rousselle (Mississippi Center for Heart Research, University of Mississippi Medical Center) for contributions in performing substrate metabolism measurements and proofreading the manuscript. These studies were supported by American Diabetes Association Grant 1-17-IBS-296, U.S. National Institutes of Health (NIH) National Institute on Aging Grants R21AG044820 and R01AG049835, NIH National Heart, Lung and Blood Institute Grant P01HL051971, NIH National Institute of General Medical Sciences Grant P20GM104357, and NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant R01DK092661. The authors declare no conflicts of interest.	Altarejos JY, 2005, J BIOL CHEM, V280, P183, DOI 10.1074/jbc.M411810200; Bogan JS, 2003, NATURE, V425, P727, DOI 10.1038/nature01989; BRAUNWALD E, 1982, CIRCULATION, V66, P1146, DOI 10.1161/01.CIR.66.6.1146; Budanou AV, 2010, EMBO MOL MED, V2, P388, DOI 10.1002/emmm.201000097; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Budanov AV, 2002, ONCOGENE, V21, P6017, DOI 10.1038/sj.onc.1205877; Costa R, 2012, J THROMB HAEMOST, V10, P1736, DOI 10.1111/j.1538-7836.2012.04833.x; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Essler S, 2009, FEBS LETT, V583, P3531, DOI 10.1016/j.febslet.2009.10.017; Feng ZH, 2007, P NATL ACAD SCI USA, V104, P16633, DOI 10.1073/pnas.0708043104; Gonzalez AA, 2004, AM J PHYSIOL-REG I, V287, pR1270, DOI 10.1152/ajpregu.00409.2004; Holloway GP, 2010, DIABETES, V59, P819, DOI 10.2337/db09-1519; Hue L, 2007, ESSAYS BIOCHEM, V43, P121, DOI 10.1042/bse0430121; JAEGER AA, 1994, J AM COLL CARDIOL, V24, P104, DOI 10.1016/0735-1097(94)90548-7; Kim AS, 2009, ACTA PHYSIOL, V196, P37, DOI 10.1111/j.1748-1716.2009.01978.x; Kim AS, 2011, J MOL CELL CARDIOL, V51, P24, DOI 10.1016/j.yjmcc.2011.03.003; Kim H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10025; KUDO N, 1995, J BIOL CHEM, V270, P17513, DOI 10.1074/jbc.270.29.17513; Lakatta EG, 2002, COMP BIOCHEM PHYS A, V132, P699, DOI 10.1016/S1095-6433(02)00124-1; Lee JH, 2012, CELL METAB, V16, P311, DOI 10.1016/j.cmet.2012.08.004; Lee JH, 2010, SCIENCE, V327, P1223, DOI 10.1126/science.1182228; Li J, 2005, CIRC RES, V97, P872, DOI 10.1161/01.RES.0000187458.77026.10; Li J, 2004, AM J PHYSIOL-ENDOC M, V287, pE834, DOI 10.1152/ajpendo.00234.2004; LINDSAY J, 1994, AM HEART J, V128, P697, DOI 10.1016/0002-8703(94)90267-4; Ma H, 2010, CIRCULATION, V122, P282, DOI 10.1161/CIRCULATIONAHA.110.953208; Ma YN, 2015, COMPR PHYSIOL, V5, P667, DOI 10.1002/cphy.c140041; Ma YN, 2015, THROMB HAEMOSTASIS, V113, P338, DOI 10.1160/TH14-04-0360; Maiuri MC, 2009, CELL CYCLE, V8, P1571, DOI 10.4161/cc.8.10.8498; Mariani J, 2000, J THORAC CARDIOV SUR, V120, P660, DOI 10.1067/mtc.2000.106528; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; McCarty MF, 2004, MED HYPOTHESES, V63, P334, DOI 10.1016/j.mehy.2004.01.043; Miller EJ, 2008, NATURE, V451, P578, DOI 10.1038/nature06504; Miller EJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE1922, DOI 10.1152/ajpendo.00170.2006; Morrison A, 2015, FASEB J, V29, P408, DOI 10.1096/fj.14-258814; Morrison A, 2011, AM J PHYSIOL-HEART C, V301, pH895, DOI 10.1152/ajpheart.00137.2011; Morrison A, 2011, BIOCHEM PHARMACOL, V82, P195, DOI 10.1016/j.bcp.2011.04.004; Moussa A, 2012, ACTA PHARM SIN B, V2, P368, DOI 10.1016/j.apsb.2012.06.001; Olson N, 2011, AM J PHYSIOL-LUNG C, V301, pL993, DOI 10.1152/ajplung.00250.2011; Ommen SR, 2000, CIRCULATION, V102, P1788; Reznick RM, 2007, CELL METAB, V5, P151, DOI 10.1016/j.cmet.2007.01.008; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Russell RR, 1999, AM J PHYSIOL-HEART C, V277, pH643, DOI 10.1152/ajpheart.1999.277.2.H643; Sakamoto K, 2006, AM J PHYSIOL-ENDOC M, V290, pE780, DOI 10.1152/ajpendo.00443.2005; Sanli T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032035; Seo K, 2015, CELL SIGNAL, V27, P1533, DOI 10.1016/j.cellsig.2015.03.003; Shi XD, 2017, J CEREBR BLOOD F MET, V37, P1447, DOI 10.1177/0271678X16656201; Shi XD, 2016, NEUROBIOL DIS, V95, P111, DOI 10.1016/j.nbd.2016.07.016; Starnes JW, 1997, AGING-CLIN EXP RES, V9, P268, DOI 10.1007/BF03341829; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; STONE GW, 1995, J AM COLL CARDIOL, V25, P370, DOI 10.1016/0735-1097(94)00367-Y; SUN DQ, 1994, CIRCULATION, V89, P793, DOI 10.1161/01.CIR.89.2.793; Sun W, 2016, MATH PROBL ENG, V2016, DOI 10.1155/2016/9748378; Tian R, 2001, CIRCULATION, V103, P2961, DOI 10.1161/01.CIR.103.24.2961; Tong C, 2013, FASEB J, V27, P4332, DOI 10.1096/fj.12-216473; Turdi S, 2010, AGING CELL, V9, P592, DOI 10.1111/j.1474-9726.2010.00586.x; Turer AT, 2010, AM J CARDIOL, V106, P360, DOI 10.1016/j.amjcard.2010.03.032; Velasco-Miguel S, 1999, ONCOGENE, V18, P127, DOI 10.1038/sj.onc.1202274; Wang J, 2013, J THROMB HAEMOST, V11, P1020, DOI 10.1111/jth.12243; Wang J, 2011, J THROMB HAEMOST, V9, P1308, DOI 10.1111/j.1538-7836.2011.04331.x; Wang JY, 2013, CIRCULATION, V128, P225, DOI 10.1161/CIRCULATIONAHA.112.000862; Yang H, 2016, BIOCHEM PHARMACOL, V108, P47, DOI 10.1016/j.bcp.2016.03.019; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Young LH, 2008, CIRCULATION, V117, P832, DOI 10.1161/CIRCULATIONAHA.107.713115; Young LH, 1997, CIRCULATION, V95, P415; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	68	81	88	3	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					4153	4167		10.1096/fj.201700063R	http://dx.doi.org/10.1096/fj.201700063R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28592638	Green Published			2022-12-28	WOS:000408713300037
J	Zwart, SR; Gibson, CR; Gregory, JF; Mader, TH; Stover, PJ; Zeisel, SH; Smith, SM				Zwart, Sara R.; Gibson, Charles R.; Gregory, Jesse F.; Mader, Thomas H.; Stover, Patrick J.; Zeisel, Steven H.; Smith, Scott M.			Astronaut ophthalmic syndrome	FASEB JOURNAL			English	Article						B vitamins; cerebrospinal fluid; endothelial dysfunction; oxidative stress; microgravity	DURATION SPACE-FLIGHT; OPTIC DISC EDEMA; DOSE FOLIC-ACID; ENDOTHELIAL DYSFUNCTION; METHYLENETETRAHYDROFOLATE REDUCTASE; INSULIN-RESISTANCE; BLOOD-PRESSURE; FLUID SHIFTS; SIGNIFICANT PREDICTORS; ARTERIAL PERMEABILITY	During and after missions on the International Space Station, some astronauts experience ophthalmic changes, including choroidal folds, optic disc edema, cotton-wool spots, globe flattening, and refraction changes. Astronauts with ophthalmic issues had significantly higher plasma concentrations of metabolites that are associated with the 1-carbon metabolic pathway than those without ophthalmic issues. We hypothesized that genetic differences might explain the metabolite differences. Indeed, genetics and B vitamin status were significant predictors of ophthalmic issues. We now have developed a hypothesis regarding the mechanisms that link 1-carbon pathway genetics and the condition that we suggest calling, "astronaut ophthalmic syndrome." We maintain that this condition is genetically predisposed and is associated with endothelial dysfunction that is induced by oxidative stress. Subsequent edema can hinder cerebrospinal fluid efflux and can lead to locally increased pressures in the subarachnoid space within the orbit, which impinges on the optic nerve and/or eye in affected individuals. Confirming this hypothesis will help characterize the genetics of 1-carbon pathway metabolism, homocysteine, oxidative stress, endothelial dysfunction, and cardiovascular and potentially other diseases.	[Zwart, Sara R.] Univ Texas Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX 77555 USA; [Gibson, Charles R.] Coastal Eye Associates, Webster, TX USA; [Gregory, Jesse F.] Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA; [Stover, Patrick J.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Zeisel, Steven H.] Univ North Carolina Chapel Hill, Inst Nutr Res, Kannapolis, NC USA; [Smith, Scott M.] NASA, Human Hlth & Performance Directorate, Lyndon B Johnson Space Ctr, Houston, TX USA	University of Texas System; University of Texas Medical Branch Galveston; State University System of Florida; University of Florida; Cornell University; University of North Carolina; University of North Carolina Chapel Hill; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Smith, SM (corresponding author), NASA, Lyndon B Johnson Space Ctr, Mail Code SK3,2101 NASA Pkwy, Houston, TX 77058 USA.	scott.m.smith@nasa.gov			National Aeronautics and Space Administration (NASA) Human Research Program's Human Health Countermeasures Element	National Aeronautics and Space Administration (NASA) Human Research Program's Human Health Countermeasures Element	This work was supported by the National Aeronautics and Space Administration (NASA) Human Research Program's Human Health Countermeasures Element. The authors thank Antony Jeevarajan (NASA Johnson Space Center) for helpful discussions, and Jane Krauhs (KBRwyle, Houston, TX, USA) for editorial assistance. The authors declare no conflicts of interest.	Aleyasin A, 2010, IRAN J PUBLIC HEALTH, V39, P53; Alfrey CP, 1996, MED SCI SPORT EXER, V28, pS42; Antoniades C, 2006, CIRCULATION, V114, P1193, DOI 10.1161/CIRCULATIONAHA.106.612325; Antoniades C, 2009, CIRCULATION, V119, P2507, DOI 10.1161/CIRCULATIONAHA.108.808675; Antoniades C, 2009, EUR HEART J, V30, P6, DOI 10.1093/eurheartj/ehn515; Blanc S, 2000, J CLIN ENDOCR METAB, V85, P2223, DOI 10.1210/jc.85.6.2223; Brosnan ME, 2016, ANNU REV NUTR, V36, P369, DOI 10.1146/annurev-nutr-071715-050738; Bueno O, 2016, J NUTR, V146, P1, DOI 10.3945/jn.115.223685; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Chalupsky K, 2015, ANTIOXID REDOX SIGN, V23, P1076, DOI 10.1089/ars.2015.6329; Chancellor Jeffery C., 2014, Life-Basel, V4, P491, DOI 10.3390/life4030491; Cherla DV, 2013, ALLERGY RHINOL, V4, pE49, DOI 10.2500/ar.2013.4.0047; CLAYTON PT, 1986, J NEUROL NEUROSUR PS, V49, P920, DOI 10.1136/jnnp.49.8.920; Clifford AJ, 2012, J NUTR, V142, P1764, DOI 10.3945/jn.112.160333; Colson NJ, 2017, EUR J NUTR, V56, P247, DOI 10.1007/s00394-015-1076-x; Corrigan FE, 2015, INT J CARDIOL, V194, P94, DOI 10.1016/j.ijcard.2015.05.065; Crider KS, 2011, AM J CLIN NUTR, V93, P1365, DOI 10.3945/ajcn.110.004671; Cronyn P. D., 2012, NASATP2012217358; Davis SR, 2005, J NUTR, V135, P1045, DOI 10.1093/jn/135.5.1045; Diedrich A, 2007, AM J MED SCI, V334, P80, DOI 10.1097/MAJ.0b013e318065b89b; Empen K, 2012, ARTERIOSCL THROM VAS, V32, P481, DOI 10.1161/ATVBAHA.111.232876; Flyunt R, 2001, CHEM-EUR J, V7, P796, DOI 10.1002/1521-3765(20010216)7:4<796::AID-CHEM796>3.3.CO;2-A; Friedman AN, 2001, J AM SOC NEPHROL, V12, P2181, DOI 10.1681/ASN.V12102181; Garcia-Minguillan CJ, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0435-1; Gauger G E, 1986, Adv Space Res, V6, P243, DOI 10.1016/0273-1177(86)90298-X; Hadi HAR, 2005, VASC HEALTH RISK MAN, V1, P183; Hargens AR, 2009, RESP PHYSIOL NEUROBI, V169, pS30, DOI 10.1016/j.resp.2009.07.005; Hazra A, 2009, HUM MOL GENET, V18, P4677, DOI 10.1093/hmg/ddp428; HERBERT V, 1973, AM J CLIN NUTR, V26, P77, DOI 10.1093/ajcn/26.1.77; Hladik D, 2016, MUTAT RES-REV MUTAT, V770, P219, DOI 10.1016/j.mrrev.2016.08.003; Hughson RL, 2016, AM J PHYSIOL-HEART C, V310, pH628, DOI 10.1152/ajpheart.00802.2015; JEEVARAJAN AS, 1990, J PHYS CHEM-US, V94, P1372, DOI 10.1021/j100367a033; Katusic ZS, 2001, AM J PHYSIOL-HEART C, V281, pH981, DOI 10.1152/ajpheart.2001.281.3.H981; Kluijtmans LAJ, 2003, BLOOD, V101, P2483, DOI 10.1182/blood.V101.7.2483; Knowles L, 2016, JIMD REP, V29, P103, DOI 10.1007/8904_2016_529; Kramer LA, 2012, RADIOLOGY, V263, P819, DOI 10.1148/radiol.12111986; Kvietys PR, 2012, FREE RADICAL BIO MED, V52, P556, DOI 10.1016/j.freeradbiomed.2011.11.002; Lambrinoudaki I, 2008, EUR J ENDOCRINOL, V159, P233, DOI 10.1530/EJE-07-0848; Lawley JS, 2017, J PHYSIOL-LONDON, V595, P2115, DOI 10.1113/JP273557; Leach CS, 1996, J APPL PHYSIOL, V81, P105, DOI 10.1152/jappl.1996.81.1.105; Lee AG, 2016, J NEURO-OPHTHALMOL, V36, P85, DOI 10.1097/WNO.0000000000000334; Lehmann M, 2003, DEMENT GERIATR COGN, V16, P145, DOI 10.1159/000071002; Li WX, 2015, NUTRIENTS, V7, P6670, DOI 10.3390/nu7085303; Maass H., 1995, P NORD S SCI RES GER, P732; MacFarlane AJ, 2011, CANCER RES, V71, P2098, DOI 10.1158/0008-5472.CAN-10-1886; Mader TH, 2017, J NEURO-OPHTHALMOL, V37, P133, DOI 10.1097/WNO.0000000000000467; Mader TH, 2015, J NEURO-OPHTHALMOL, V35, P226, DOI 10.1097/WNO.0000000000000207; Mader TH, 2013, J NEURO-OPHTHALMOL, V33, P249, DOI 10.1097/WNO.0b013e31829b41a6; Mader TH, 2011, OPHTHALMOLOGY, V118, P2058, DOI 10.1016/j.ophtha.2011.06.021; Marshall-Bowman K, 2013, ACTA ASTRONAUT, V87, P77, DOI 10.1016/j.actaastro.2013.01.014; Marshall-Goebel K, 2017, AEROSP MED HUM PERF, V88, P10, DOI 10.3357/AMHP.4653.2017; McMahon A, 2016, NUTRIENTS, V8, DOI 10.3390/nu8110720; Moat SJ, 2004, AM J PHYSIOL-HEART C, V287, pH1, DOI 10.1152/ajpheart.00952.2003; Moens AL, 2008, AM J PHYSIOL-HEART C, V294, pH1971, DOI 10.1152/ajpheart.91503.2007; Moens AL, 2008, CIRCULATION, V117, P1810, DOI 10.1161/CIRCULATIONAHA.107.725481; Mohammad NS, 2016, PSYCHIAT GENET, V26, P281, DOI 10.1097/YPG.0000000000000152; Molero-Luis M, 2015, EXPERT REV NEUROTHER, V15, P793, DOI 10.1586/14737175.2015.1055322; MOORE TP, 1987, AVIAT SPACE ENVIR MD, V58, pA91; Moreira ES, 2011, FREE RADICAL BIO MED, V51, P876, DOI 10.1016/j.freeradbiomed.2011.05.034; Morrow GP, 2015, J BIOL CHEM, V290, P2244, DOI 10.1074/jbc.M114.600718; Mullick AE, 2006, AM J PHYSIOL-REG I, V291, pR1349, DOI 10.1152/ajpregu.00335.2006; Norsk P, 2006, HYPERTENSION, V47, P69, DOI 10.1161/01.HYP.0000194332.98674.57; Norsk P, 2005, CURR PHARM BIOTECHNO, V6, P325, DOI 10.2174/1389201054553734; Norsk P, 2015, J PHYSIOL-LONDON, V593, P573, DOI 10.1113/jphysiol.2014.284869; Olin JT, 2011, RESP PHYSIOL NEUROBI, V175, P176, DOI 10.1016/j.resp.2010.09.011; Perry JL, 2003, S CHINA MORNING  JAN, P1; Pravenec M, 2013, AM J HYPERTENS, V26, P135, DOI 10.1093/ajh/hps015; PRISK GK, 1993, J APPL PHYSIOL, V75, P15, DOI 10.1152/jappl.1993.75.1.15; Reichenbach A, 2013, GLIA, V61, P651, DOI 10.1002/glia.22477; Shelnutt KP, 2003, J NUTR, V133, P4107, DOI 10.1093/jn/133.12.4107; Shin JH, 2011, OTOLARYNG HEAD NECK, V145, P1040, DOI 10.1177/0194599811418040; Shirodaria C, 2007, CIRCULATION, V115, P2262, DOI 10.1161/CIRCULATIONAHA.106.679084; Smith SM, 2012, J CLIN ENDOCR METAB, V97, P270, DOI 10.1210/jc.2011-2233; Solomon LR, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2015.07.017; Spector R, 2015, EXP NEUROL, V273, P57, DOI 10.1016/j.expneurol.2015.07.027; Stein TP, 1997, ADV EXP MED BIOL, V407, P443; STEIN TP, 1994, AVIAT SPACE ENVIR MD, V65, P1091; Steinberg HO, 1996, J CLIN INVEST, V97, P2601, DOI 10.1172/JCI118709; Stover PJ, 2017, CURR OPIN BIOTECH, V44, P146, DOI 10.1016/j.copbio.2017.01.006; Symons JD, 2006, ARTERIOSCL THROM VAS, V26, P814, DOI 10.1161/01.ATV.0000204408.01416.16; Symons JD, 2006, AM J PHYSIOL-HEART C, V290, pH181, DOI 10.1152/ajpheart.00765.2005; Symons JD, 2002, ARTERIOSCL THROM VAS, V22, P772, DOI 10.1161/01.ATV.0000014588.71807.0A; Taibbi G, 2016, INVEST OPHTH VIS SCI, V57, P495, DOI 10.1167/iovs.15-18530; Taibbi G, 2014, AVIAT SPACE ENVIR MD, V85, P983, DOI 10.3357/ASEM.4055.2014; Taibbi G, 2013, SURV OPHTHALMOL, V58, P155, DOI 10.1016/j.survophthal.2012.04.002; Taibbi G, 2013, AVIAT SPACE ENVIR MD, V84, P148, DOI 10.3357/ASEM.3520.2013; THORNTON WE, 1987, AVIAT SPACE ENVIR MD, V58, pA86; Tousoulis D, 2010, MINERVA MED, V101, P271; Tousoulis D, 2011, AM J HYPERTENS, V24, P936, DOI 10.1038/ajh.2011.65; Traon APL, 2007, EUR J APPL PHYSIOL, V101, P143, DOI 10.1007/s00421-007-0474-z; Verhaar MC, 2002, ARTERIOSCL THROM VAS, V22, P6, DOI 10.1161/hq0102.102190; VERNIKOSDANELLIS J, 1976, AVIAT SPACE ENVIR MD, V47, P583; Virdis A, 2001, J AM COLL CARDIOL, V38, P1106, DOI 10.1016/S0735-1097(01)01492-9; Vitvitsky V, 2007, AM J PHYSIOL-RENAL, V293, pF594, DOI 10.1152/ajprenal.00171.2007; Wang YY, 2016, RADIAT RES, V186, P153, DOI 10.1667/RR14445.1; Werner ER, 2011, BIOCHEM J, V438, P397, DOI 10.1042/BJ20110293; Wilkerson MK, 2005, AM J PHYSIOL-HEART C, V288, pH1652, DOI 10.1152/ajpheart.00925.2004; Wilson CP, 2013, HYPERTENSION, V61, P1302, DOI 10.1161/HYPERTENSIONAHA.111.01047; Zeisel SH, 2011, J NUTR, V141, P531, DOI 10.3945/jn.110.130369; Zinck JWR, 2015, AM J CLIN NUTR, V101, P1295, DOI 10.3945/ajcn.115.107219; Zwart SR, 2014, HANDBOOK OF NUTRITION, DIET, AND THE EYE, P393, DOI 10.1016/B978-0-12-401717-7.00040-X; Zwart SR, 2016, FASEB J, V30, P141, DOI 10.1096/fj.15-278457; Zwart SR, 2012, J NUTR, V142, P427, DOI 10.3945/jn.111.154245	103	25	25	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3746	3756		10.1096/fj.201700294	http://dx.doi.org/10.1096/fj.201700294			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28546443	Green Submitted, Bronze			2022-12-28	WOS:000408713300005
J	Yang, SW; Jang, YH; Kwon, SB; Lee, YJ; Chae, W; Byun, YH; Kim, P; Park, C; Lee, YJ; Kim, CK; Kim, YS; Choi, SI; Seong, BL				Yang, Seung Won; Jang, Yo Han; Kwon, Soon Bin; Lee, Yoon Jae; Chae, Wonil; Byun, Young Ho; Kim, Paul; Park, Chan; Lee, Young Jae; Kim, Choon Kang; Kim, Young Seok; Choi, Seong Il; Seong, Baik Lin			Harnessing an RNA-mediated chaperone for the assembly of influenza hemagglutinin in an immunologically relevant conformation	FASEB JOURNAL			English	Article						protein folding; chaperna; neutralizing antibody; viral infection	MOLECULAR CHAPERONES; ESCHERICHIA-COLI; RIBOSOMAL-RNA; SOLUBILITY; PROTEINS; DOMAIN; PEPTIDE; ORGANIZATION; AGGREGATION; SYNTHETASE	A novel protein-folding function of RNA has been recognized, which can outperform previously known molecular chaperone proteins. The RNA as a molecular chaperone (chaperna) activity is intrinsic to some ribozymes and is operational during viral infections. Our purpose was to test whether influenza hemagglutinin (HA) can be assembled in a soluble, trimeric, and immunologically activating conformation by means of an RNA molecular chaperone (chaperna) activity. An RNA-interacting domain (RID) from the host being immunized was selected as a docking tag for RNA binding, which served as a transducer for the chaperna function for de novo folding and trimeric assembly of RID-HA1. Mutations that affect tRNA binding greatly increased the soluble aggregation defective in trimer assembly, suggesting that RNA interaction critically controls the kinetic network in the folding/assembly pathway. Immunization of mice resulted in strong hemagglutination inhibition and high titers of a neutralizing antibody, providing sterile protection against a lethal challenge and confirming the immunologically relevant HA conformation. The results may be translated into a rapid response to a new influenza pandemic. The harnessing of the novel chaperna described herein with immunologically tailored antigen-folding functions should serve as a robust prophylactic and diagnostic tool for viral infections.	[Yang, Seung Won; Jang, Yo Han; Kwon, Soon Bin; Lee, Yoon Jae; Chae, Wonil; Byun, Young Ho; Kim, Paul; Park, Chan; Lee, Young Jae; Kim, Choon Kang; Kim, Young Seok; Seong, Baik Lin] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biotechnol, Seoul 03722, South Korea; [Seong, Baik Lin] Yonsei Univ, Vaccine Translat Res Ctr, Seoul, South Korea; [Choi, Seong Il] Stockholm Univ, Dept Biochem & Biophys, Stockholm, Sweden	Yonsei University; Yonsei University; Stockholm University	Seong, BL (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biotechnol, Seoul 03722, South Korea.	blseong@yonsei.ac.kr	Lee, Yoon Jae/HGE-5712-2022	Lee, Young Jae/0000-0002-4902-2281	Korean Ministry of Health and Welfare [HI13C0826]; Ministry of Agriculture, Food and Rural Affairs (MAFRA) [716002-7]	Korean Ministry of Health and Welfare(Ministry of Health & Welfare (MOHW), Republic of Korea); Ministry of Agriculture, Food and Rural Affairs (MAFRA)	This work was supported by grants from the Korean Ministry of Health and Welfare (HI13C0826) and the Ministry of Agriculture, Food and Rural Affairs (MAFRA; 716002-7). The authors declare no conflicts of interest.	AGOU F, 1995, BIOCHEMISTRY-US, V34, P569, DOI 10.1021/bi00002a023; Aguilar-Yanes JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011694; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; BACHMANN MF, 1993, SCIENCE, V262, P1448, DOI 10.1126/science.8248784; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Chattopadhyay S, 1996, P NATL ACAD SCI USA, V93, P8284, DOI 10.1073/pnas.93.16.8284; Choi SI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002677; Choi SI, 2009, RNA BIOL, V6, P21, DOI 10.4161/rna.6.1.7441; Clark EDB, 1998, CURR OPIN BIOTECH, V9, P157; Cusack S, 1997, CURR OPIN STRUC BIOL, V7, P881, DOI 10.1016/S0959-440X(97)80161-3; D'Aoust MA, 2010, PLANT BIOTECHNOL J, V8, P607, DOI 10.1111/j.1467-7652.2009.00496.x; Docter BE, 2016, NUCLEIC ACIDS RES, V44, P4835, DOI 10.1093/nar/gkw291; Dormitzer PR, 2015, CURR TOP MICROBIOL, V386, P237, DOI 10.1007/82_2014_399; DuBois RM, 2011, J VIROL, V85, P865, DOI 10.1128/JVI.01412-10; Fineberg HV, 2014, NEW ENGL J MED, V370, P1335, DOI 10.1056/NEJMra1208802; Francin M, 2003, J BIOL CHEM, V278, P1472, DOI 10.1074/jbc.M208802200; Francin M, 2002, J BIOL CHEM, V277, P1762, DOI 10.1074/jbc.M109759200; Giersing BK, 2016, VACCINE, V34, P2863, DOI 10.1016/j.vaccine.2016.04.041; GOULD KG, 1991, J VIROL, V65, P5401, DOI 10.1128/JVI.65.10.5401-5409.1991; GOULD KG, 1987, J EXP MED, V166, P693, DOI 10.1084/jem.166.3.693; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Guthe S, 2004, J MOL BIOL, V337, P905, DOI 10.1016/j.jmb.2004.02.020; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hendrick JP, 1995, FASEB J, V9, P1559, DOI 10.1096/fasebj.9.15.8529835; HERSCHLAG D, 1995, J BIOL CHEM, V270, P20871, DOI 10.1074/jbc.270.36.20871; Horowitz S, 2016, RNA BIOL, V13, P1228, DOI 10.1080/15476286.2016.1247147; Jang YH, 2016, VACCINE, V34, P1343, DOI 10.1016/j.vaccine.2016.01.053; Jang YH, 2014, J VIROL METHODS, V196, P56, DOI 10.1016/j.jviromet.2013.10.035; Kanekiyo M, 2013, NATURE, V499, P102, DOI 10.1038/nature12202; Khurana S, 2011, J VIROL, V85, P1246, DOI 10.1128/JVI.02107-10; Khurana S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011548; Kim CW, 2007, PROTEIN SCI, V16, P635, DOI 10.1110/ps.062330907; Kim JM, 2017, RNA BIOL, V14, P926, DOI 10.1080/15476286.2017.1311455; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Koldewey P, 2016, CELL, V166, P369, DOI 10.1016/j.cell.2016.05.054; Korshun L N, 2011, Mikrobiol Z, V73, P36; Kovachev PS, 2017, J BIOL CHEM, V292, P9345, DOI 10.1074/jbc.M116.762096; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403; Kudlicki W, 1997, FOLD DES, V2, P101, DOI 10.1016/S1359-0278(97)00014-X; Lee KH, 2006, VACCINE, V24, P1966, DOI 10.1016/j.vaccine.2005.10.051; Liu CM, 2010, NATURE, V463, P197, DOI 10.1038/nature08651; Mallajosyula VVA, 2014, P NATL ACAD SCI USA, V111, pE2514, DOI 10.1073/pnas.1402766111; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Raran-Kurussi S, 2015, PROTEIN EXPRES PURIF, V110, P159, DOI 10.1016/j.pep.2015.03.004; Sachdev D, 1998, BIOCHEM BIOPH RES CO, V244, P933, DOI 10.1006/bbrc.1998.8365; Santner AA, 2012, BIOCHEMISTRY-US, V51, P7250, DOI 10.1021/bi300653m; Saschenbrecker S, 2007, CELL, V129, P1189, DOI 10.1016/j.cell.2007.04.025; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Slepenkov SV, 2002, MOL MICROBIOL, V45, P1197, DOI 10.1046/j.1365-2958.2002.03093.x; Son A, 2015, RNA BIOL, V12, P1198, DOI 10.1080/15476286.2015.1096487; Stull F, 2016, NAT STRUCT MOL BIOL, V23, P53, DOI 10.1038/nsmb.3133; Suzuki K, 1998, PROTEIN ENG, V11, P1051, DOI 10.1093/protein/11.11.1051; Thoma J, 2015, NAT STRUCT MOL BIOL, V22, P795, DOI 10.1038/nsmb.3087; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; TOWNSEND ARM, 1986, NATURE, V324, P575, DOI 10.1038/324575a0; Vera A, 2007, BIOTECHNOL BIOENG, V96, P1101, DOI 10.1002/bit.21218; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Weldon WC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012466; Welsh JP, 2012, BIOTECHNOL BIOENG, V109, P2962, DOI 10.1002/bit.24581; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; Yiadom KPAB, 2003, PEPTIDES, V24, P987, DOI 10.1016/S0196-9781(03)00188-8	63	15	17	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2658	2675		10.1096/fj.201700747RR	http://dx.doi.org/10.1096/fj.201700747RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29295864	Green Published			2022-12-28	WOS:000432528000028
J	Collado, MC; Engen, PA; Bandin, C; Cabrera-Rubio, R; Voigt, RM; Green, SJ; Naqib, A; Keshavarzian, A; Scheer, FAJL; Garaulet, M				Carmen Collado, Maria; Engen, Phillip A.; Bandin, Cristina; Cabrera-Rubio, Raul; Voigt, Robin M.; Green, Stefan J.; Naqib, Ankur; Keshavarzian, Ali; Scheer, Frank A. J. L.; Garaulet, Marta			Timing of food intake impacts daily rhythms of human salivary microbiota: a randomized, crossover study	FASEB JOURNAL			English	Article						feces; eating time; diurnal rhythm; alpha diversity; beta diversity	CIRCADIAN CLOCK; FUSOBACTERIUM-NUCLEATUM; SUBGINGIVAL MICROBIOME; GUT MICROBIOME; WEIGHT-LOSS; OBESITY; HEALTH; TIME; DIVERSITY; MODEL	The composition of the diet (what we eat) has been widely related to the microbiota profile. However, whether the timing of food consumption (when we eat) influences microbiota in humans is unknown. A randomized, crossover study was performed in 10 healthy normal-weight young women to test the effect of the timing of food intake on the human microbiota in the saliva and fecal samples. More specifically, to determine whether eating late alters daily rhythms of human salivary microbiota, we interrogated salivary microbiota in samples obtained at 4 specific time points over 24 h, to achieve a better understanding of the relationship between food timing and metabolic alterations in humans. Results revealed significant diurnal rhythms in salivary diversity and bacterial relative abundance (i.e., TM7 and Fusobacteria) across both early and late eating conditions. More importantly, meal timing affected diurnal rhythms in diversity of salivary microbiota toward an inverted rhythm between the eating conditions, and eating late increased the number of putative proinflammatory taxa, showing a diurnal rhythm in the saliva. In a randomized, crossover study, we showed for the first time the impact of the timing of food intake on human salivary microbiota. Eating the main meal late inverts the daily rhythm of salivary microbiota diversity which may have a deleterious effect on the metabolism of the host.	[Carmen Collado, Maria; Cabrera-Rubio, Raul] Spanish Natl Res Council IATA CSIC, Inst Agrochem & Food Technol, Dept Biotechnol, Valencia, Spain; [Engen, Phillip A.; Voigt, Robin M.; Keshavarzian, Ali] Rush Univ, Med Ctr, Dept Internal Med, Div Digest Dis & Nutr, Chicago, IL 60612 USA; [Keshavarzian, Ali] Rush Univ, Med Ctr, Dept Pharmacol, Chicago, IL 60612 USA; [Keshavarzian, Ali] Rush Univ, Med Ctr, Dept Physiol, Chicago, IL 60612 USA; [Bandin, Cristina; Garaulet, Marta] Univ Murcia, Dept Physiol, Campus Espinardo, E-30100 Murcia, Spain; [Bandin, Cristina; Garaulet, Marta] Murcian Inst Biosanit Res IMIB Arrixaca, Murcia, Spain; [Cabrera-Rubio, Raul] Univ Coll Cork, Microbiome Inst, APC, Cork, Ireland; [Cabrera-Rubio, Raul] Moorepk Teagasc Food Res Ctr, Fermoy, Cork, Ireland; [Green, Stefan J.; Naqib, Ankur] Univ Illinois, DNA Serv Facil, Res Resources Ctr, Chicago, IL USA; [Green, Stefan J.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Keshavarzian, Ali] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacol, Utrecht, Netherlands; [Scheer, Frank A. J. L.] Brigham & Womens Hosp, Div Sleep & Circadian Disorders, 75 Francis St, Boston, MA 02115 USA; [Scheer, Frank A. J. L.] Harvard Med Sch, Div Sleep Med, Boston, MA USA	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); Rush University; Rush University; Rush University; University of Murcia; University College Cork; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Utrecht University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Garaulet, M (corresponding author), Univ Murcia, Dept Physiol, Campus Espinardo, E-30100 Murcia, Spain.; Collado, MC (corresponding author), CSIC, IATA, Dept Biotechnol, Ave Agustin Escardino 7, Paterna Valencia 46980, Spain.	mcolam@iata.csic.es; garaulet@um.es	COLLADO, MARIA CARMEN/H-4924-2012; Garaulet, Marta/K-6625-2014; Scheer, Frank A.J.L./C-2795-2012	COLLADO, MARIA CARMEN/0000-0002-6204-4864; Garaulet, Marta/0000-0002-4066-3509; Scheer, Frank A.J.L./0000-0002-2014-7582	Spanish Government of Economy and Competitiveness (MINECO) [AGL2015-707487-P, SAF2014-52480R]; European Regional Development Fund (ERDF); U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [R01DK102696, DK1-R01DK_105072-01A1, R01 DK099512, R01DK105072]; NIH National, Heart, Lung, and Blood Institute [R01 HL094806, R01 HL140574, R01 HL118601]; Bayer Healthcare; Sentara Healthcare; Philips; Kellogg Company; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL140574, R01HL094806, R01HL118601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105072, R01DK099512, R01DK102696] Funding Source: NIH RePORTER	Spanish Government of Economy and Competitiveness (MINECO); European Regional Development Fund (ERDF)(European Commission); U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National, Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Sentara Healthcare; Philips; Kellogg Company; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Spanish Government of Economy and Competitiveness (MINECO) Grants AGL2015-707487-P (to M.C.C.) and SAF2014-52480R; the European Regional Development Fund (ERDF); U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grants R01DK102696 and DK1-R01DK_105072-01A1 (to M.G.), and R01 DK099512 and R01DK105072 (to F.A.J.L.S.); and NIH National, Heart, Lung, and Blood Institute Grants R01 HL094806, R01 HL140574 and R01 HL118601 (to F.A.J.L.S.). F.A.J.L.S. has received speaker fees from Bayer Healthcare, Sentara Healthcare, Philips, and Kellogg Company. The remaining authors declare no conflicts of interest.	Abusleme L, 2013, ISME J, V7, P1016, DOI 10.1038/ismej.2012.174; Arble DM, 2009, OBESITY, V17, P2100, DOI 10.1038/oby.2009.264; Asher G, 2015, CELL, V161, P84, DOI 10.1016/j.cell.2015.03.015; Atarashi K, 2017, SCIENCE, V358, P359, DOI 10.1126/science.aan4526; Azevedo CVM, 2008, MIND BRAIN EDUC, V2, P34, DOI 10.1111/j.1751-228X.2008.00027.x; Bahl MI, 2012, FEMS MICROBIOL LETT, V329, P193, DOI 10.1111/j.1574-6968.2012.02523.x; Bandin C, 2015, INT J OBESITY, V39, P828, DOI 10.1038/ijo.2014.182; Bullon P, 2014, PERIODONTOL 2000, V64, P139, DOI 10.1111/j.1600-0757.2012.00455.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carbonero F, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00448; Chaix A, 2014, CELL METAB, V20, P991, DOI 10.1016/j.cmet.2014.11.001; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Collado MC, 2008, AM J CLIN NUTR, V88, P894, DOI 10.1093/ajcn/88.4.894; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Damms-Machado A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/806248; Dean CB, 2007, LIFETIME DATA ANAL, V13, P497, DOI 10.1007/s10985-007-9065-x; Demmer RT, 2017, J CLIN PERIODONTOL, V44, P255, DOI 10.1111/jcpe.12664; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020; Garaulet M, 2013, INT J OBESITY, V37, P604, DOI 10.1038/ijo.2012.229; Garaulet M, 2016, AM J CLIN NUTR, V104, P1160, DOI 10.3945/ajcn.116.134528; Garaulet M, 2014, PHYSIOL BEHAV, V134, P44, DOI 10.1016/j.physbeh.2014.01.001; Gabarra AG, 2017, NUTR HOSP, V34, P490, DOI 10.20960/nh.937; Genco RJ, 2005, J PERIODONTOL, V76, P2075, DOI 10.1902/jop.2005.76.11-S.2075; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Goodson JM, 2009, J DENT RES, V88, P519, DOI 10.1177/0022034509338353; Goodson JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170437; Green SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128122; Han YPW, 2015, CURR OPIN MICROBIOL, V23, P141, DOI 10.1016/j.mib.2014.11.013; Hansen TH, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0157-z; Jakubowicz D, 2013, OBESITY, V21, P2504, DOI 10.1002/oby.20460; Janem WF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172647; Johnston JD, 2016, ADV NUTR, V7, P399, DOI 10.3945/an.115.010777; Kaczmarek JL, 2017, AM J CLIN NUTR, V106, P1220, DOI 10.3945/ajcn.117.156380; Kalliomaki M, 2008, AM J CLIN NUTR, V87, P534, DOI 10.1093/ajcn/87.3.534; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kolde R., 2013, PHEATMAP PRETTY HEAT; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Langendijk-Genevaux PS, 2001, J CLIN PERIODONTOL, V28, P1151, DOI 10.1034/j.1600-051X.2001.281210.x; Leone V, 2015, CELL HOST MICROBE, V17, P681, DOI 10.1016/j.chom.2015.03.006; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li YH, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2891-z; Longo VD, 2016, CELL METAB, V23, P1048, DOI 10.1016/j.cmet.2016.06.001; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Mataix Verdu J., 1995, TABLA COMPOSICION AL; Mattson MP, 2014, P NATL ACAD SCI USA, V111, P16647, DOI 10.1073/pnas.1413965111; McDonald D, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-7; McHill AW, 2017, AM J CLIN NUTR, V106, P1213, DOI 10.3945/ajcn.117.161588; Morris CJ, 2015, OBESITY, V23, P2053, DOI 10.1002/oby.21189; Mukherji A, 2013, CELL, V153, P812, DOI 10.1016/j.cell.2013.04.020; Murakami M, 2016, EMBO REP, V17, P1292, DOI 10.15252/embr.201642463; Nakajima M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134234; Oksanen J., 2016, R PACKAGE, DOI DOI 10.1016/J.DIB.2020.105500; Perez-Llamas F, 2012, NUTR HOSP, V27, P1576, DOI 10.3305/nh.2012.27.5.5940; Remely M., 2016, ENDOCR METAB IMMUNE; Ruiz-Lozano T, 2016, CLIN NUTR, V35, P1308, DOI 10.1016/j.clnu.2016.02.007; Salgado-Delgado R, 2010, ENDOCRINOLOGY, V151, P1019, DOI 10.1210/en.2009-0864; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Signat B, 2011, CURR ISSUES MOL BIOL, V13, P25; Sinclair L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116955; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Sze MA, 2016, MBIO, V7, DOI 10.1128/mBio.01018-16; Takayasu L, 2017, DNA RES, V24, P261, DOI 10.1093/dnares/dsx001; Takeshita T, 2016, SCI REP-UK, V6, DOI 10.1038/srep22164; Thaiss CA, 2016, CELL, V167, P1495, DOI 10.1016/j.cell.2016.11.003; Thaiss CA, 2015, GUT MICROBES, V6, P137, DOI 10.1080/19490976.2015.1016690; Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Venable EB, 2017, J EQUINE VET SCI, V49, P113, DOI 10.1016/j.jevs.2016.09.010; Voigt RM, 2016, INT REV NEUROBIOL, V131, P193, DOI 10.1016/bs.irn.2016.07.002; Voigt RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097500; Wu G, 2016, BIOINFORMATICS, V32, P3351, DOI 10.1093/bioinformatics/btw405; Zarrinpar A, 2014, CELL METAB, V20, P1006, DOI 10.1016/j.cmet.2014.11.008; Zeigler CC, 2012, OBESITY, V20, P157, DOI 10.1038/oby.2011.305	77	56	58	1	29	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2060	2072		10.1096/fj.201700697RR	http://dx.doi.org/10.1096/fj.201700697RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29233857	Green Published, Green Submitted			2022-12-28	WOS:000429051400027
J	Kim, JH; Lee, E; Friedline, RH; Suk, S; Jung, DY; Dagdeviren, S; Hu, XD; Inashima, K; Noh, HL; Kwon, JY; Nambu, A; Huh, JR; Han, MS; Davis, RJ; Lee, AS; Lee, KW; Kim, JK				Kim, Jong Hun; Lee, Eunjung; Friedline, Randall H.; Suk, Sujin; Jung, Dae Young; Dagdeviren, Sezin; Hu, Xiaodi; Inashima, Kunikazu; Noh, Hye Lim; Kwon, Jung Yeon; Nambu, Aya; Huh, Jun R.; Han, Myoung Sook; Davis, Roger J.; Lee, Amy S.; Lee, Ki Won; Kim, Jason K.			Endoplasmic reticulum chaperone GRP78 regulates macrophage function and insulin resistance in diet-induced obesity	FASEB JOURNAL			English	Article						glucose metabolism; inflammation; unfolded protein response	TRANSCRIPTION FACTOR; ADIPOSE-TISSUE; ALTERNATIVE ACTIVATION; ER STRESS; IKK-BETA; INFLAMMATION; SENSITIVITY; PROTEINS; ATF6; MICE	Obesity-mediated inflammation is a major cause of insulin resistance, and macrophages play an important role in this process. The 78-kDa glucose-regulated protein (GRP78) is a major endoplasmic reticulum chaperone that modulates unfolded protein response (UPR), and mice with GRP78 heterozygosity were resistant to diet-induced obesity. Here, we show that mice with macrophage-selective ablation of GRP78 (Lyz-GRP78(-/-)) are protected from skeletal muscle insulin resistance without changes in obesity compared with wild-type mice after 9 wk of high-fat diet. GRP78-deficient macrophages demonstrated adapted UPR with up-regulation of activating transcription factor (ATF)-4 and M2-polarization markers. Diet-induced adipose tissue inflammation was reduced, and bone marrow-derived macrophages from Lyz-GRP78(-/-) mice demonstrated a selective increase in IL-6 expression. Serum IL-13 levels were elevated by >4-fold in Lyz-GRP78(-/-) mice, and IL-6 stimulated the myocyte expression of IL-13 and IL-13 receptor. Lastly, recombinant IL-13 acutely increased glucose metabolism in Lyz-GRP78(-/-) mice. Taken together, our data indicate that GRP78 deficiency activates UPR by increasing ATF-4, and promotes M2-polarization of macrophages with a selective increase in IL-6 secretion. Macrophage-derived IL-6 stimulates the myocyte expression of IL-13 and regulates muscle glucose metabolism in a paracrine manner. Thus, our findings identify a novel crosstalk between macrophages and skeletal muscle in the modulation of obesity-mediated insulin resistance.	[Kim, Jong Hun; Lee, Eunjung; Friedline, Randall H.; Suk, Sujin; Jung, Dae Young; Dagdeviren, Sezin; Hu, Xiaodi; Inashima, Kunikazu; Noh, Hye Lim; Kwon, Jung Yeon; Han, Myoung Sook; Davis, Roger J.; Kim, Jason K.] Univ Massachusetts, Sch Med, Dept Med, Program Mol Med, Worcester, MA USA; [Nambu, Aya; Huh, Jun R.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA USA; [Kim, Jason K.] Univ Massachusetts, Sch Med, Dept Med, Div Endocrinol Metab & Diabet, Worcester, MA USA; [Kim, Jong Hun; Lee, Eunjung; Suk, Sujin; Lee, Ki Won; Kim, Jason K.] Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotechnol, Seoul, South Korea; [Lee, Ki Won] Seoul Natl Univ, Coll Agr & Life Sci, Res Inst Agr & Life Sci, Seoul, South Korea; [Lee, Amy S.] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA USA; [Lee, Ki Won] Seoul Natl Univ, Adv Inst Convergence Technol, Wellness Emergence Ctr, Suwon, South Korea; [Lee, Eunjung] Korea Food Res Inst, Seongnam, South Korea; [Kwon, Jung Yeon] Oregon State Univ, Astoria, OR USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Seoul National University (SNU); Seoul National University (SNU); University of Southern California; Seoul National University (SNU); Korea Food Research Institute (KFRI); Oregon State University	Lee, KW (corresponding author), Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotechnol, Seoul, South Korea.; Lee, KW (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.; Kim, JK (corresponding author), Univ Massachusetts, Sch Med, Albert Sherman Ctr, Program Mol Med, 368 Plantat St,AS9-1041, Worcester, MA 01605 USA.	kiwon@snu.ac.kr; jason.kim@umassmed.edu	Dagdeviren, Sezin/CAI-5833-2022; Dagdeviren, Sezin/I-9277-2019; Lee, Ki Won/M-4114-2018	Han, Myoung Sook/0000-0002-7226-2590; Davis, Roger/0000-0002-0130-1652; Nambu, Aya/0000-0002-2797-6420; Lee, Amy/0000-0002-0378-5443; Kim, Jason/0000-0002-7185-042X	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK080756, 5U2C-DK093000, R01-DK079999, R24-DK090963]; Mid-Career Researcher Program of the National Research Foundation [2015R1A2A1A10053567]; Korean Ministry of Science, Information and Communications Technology (ICT), and Future Planning; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079999, R01DK080756, U2CDK093000, R24DK090963] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Mid-Career Researcher Program of the National Research Foundation; Korean Ministry of Science, Information and Communications Technology (ICT), and Future Planning; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Payal Patel, Duy Tran, Kevin Hsu, Marilia Loubato, and Sung-Yong Hwang (all from University of Massachusetts Medical School) for technical support. This study was supported by the U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (Grants R01-DK080756 and 5U2C-DK093000 to J.K.K.; R01-DK079999 to A.S.L. and J.K.K.; and R24-DK090963 to R.J.D. and J.K.K.), and the Mid-Career Researcher Program (Grant 2015R1A2A1A10053567 to K.W.L.) of the National Research Foundation, funded by the Korean Ministry of Science, Information and Communications Technology (ICT), and Future Planning. R.J.D. is an investigator of the Howard Hughes Medical Institute. The authors declare no conflicts of interest.	Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Dagdeviren S, 2016, MOL CELL BIOL, V36, P2956, DOI 10.1128/MCB.00181-16; Darkhal P, 2015, INT J OBESITY, V39, P1292, DOI 10.1038/ijo.2015.52; Fu Y, 2008, P NATL ACAD SCI USA, V105, P19444, DOI 10.1073/pnas.0807691105; Garbers C, 2011, J BIOL CHEM, V286, P14804, DOI 10.1074/jbc.M111.229393; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hong EG, 2009, DIABETES, V58, P2525, DOI 10.2337/db08-1261; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2010, NAT MED, V16, P396, DOI 10.1038/nm0410-396; Iwasaki Y, 2014, DIABETES, V63, P152, DOI 10.2337/db13-0757; Jiang LQ, 2013, AM J PHYSIOL-ENDOC M, V305, pE1359, DOI 10.1152/ajpendo.00236.2013; KAHN CR, 1994, DIABETES, V43, P1066, DOI 10.2337/diab.43.8.1066; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Kewalramani G, 2010, CURR OPIN CLIN NUTR, V13, P382, DOI 10.1097/MCO.0b013e32833aabd9; Kim JK, 2009, METHODS MOL BIOL, V560, P221, DOI 10.1007/978-1-59745-448-3_15; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; Kwon H, 2014, CELL REP, V9, P1574, DOI 10.1016/j.celrep.2014.10.068; Lee AS, 2014, NAT REV CANCER, V14, P263, DOI 10.1038/nrc3701; LIOU HC, 1990, SCIENCE, V247, P1581, DOI 10.1126/science.2321018; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Luo B, 2013, ONCOGENE, V32, P805, DOI 10.1038/onc.2012.130; Mauer J, 2014, NAT IMMUNOL, V15, P423, DOI 10.1038/ni.2865; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Park SY, 2005, DIABETES, V54, P3530, DOI 10.2337/diabetes.54.12.3530; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Sabio G, 2010, TRENDS BIOCHEM SCI, V35, P490, DOI 10.1016/j.tibs.2010.04.004; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Shi Y, 2009, TOXICOL SCI, V109, P247, DOI 10.1093/toxsci/kfp060; Stanya KJ, 2013, J CLIN INVEST, V123, P261, DOI 10.1172/JCI64941; Steensberg A, 2003, AM J PHYSIOL-ENDOC M, V285, pE433, DOI 10.1152/ajpendo.00074.2003; Wang Y, 2000, J BIOL CHEM, V275, P27013; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Ye RS, 2010, DIABETES, V59, P6, DOI 10.2337/db09-0755; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	41	21	24	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2292	2304		10.1096/fj.201701017R	http://dx.doi.org/10.1096/fj.201701017R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29242277	Green Published			2022-12-28	WOS:000429051400046
J	Rapp, AE; Hachemi, Y; Kemmler, J; Koenen, M; Tuckermann, J; Ignatius, A				Rapp, Anna E.; Hachemi, Yasmine; Kemmler, Julia; Koenen, Mascha; Tuckermann, Jan; Ignatius, Anita			Induced global deletion of glucocorticoid receptor impairs fracture healing	FASEB JOURNAL			English	Article						inflammation; knockout mice; steroids; bone repair; endochondral ossification	OSTEOBLAST-TARGETED DISRUPTION; T-CELLS; BONE; MICE; DIFFERENTIATION; THERAPY; INFLAMMATION; DIMERIZATION; MACROPHAGES; SUPPRESSION	Although endogenous glucocorticoids (GCs) are important regulators of bone integrity and the immune system, their role in bone repair after fracture-a process highly dependent on inflammation and bone formationis unclear. Because most effects of GCs are mediated by the glucocorticoid receptor (GR), we used an inducible global GR knockout (GR(gtROSACreERT2)) mouse model to eliminate endogenous GC action in all cells contributing to bone repair. The healing process was analyzed by cytokine/chemokine multiplex analysis, flow cytometry, histology, gene-expression analysis, microcomputed tomography, and biomechanical analysis. We observed increased early systemic and local inflammatory responses, as well as a significantly higher number of T cells infiltrating the fracture callus. Later in the healing process, we found impaired endochondral ossification in the absence of the GR, leading to persistent cartilage in the calli of the GR(gtROSACreERT2) mice, decreased bending stiffness, and a significantly lower proportion of healed bones. Collectively, our data show that the absence of the GR significantly impairs fracture healing associated with a defective cartilage-to-bone transition, underscoring an important role of GCs during fracture healing.	[Rapp, Anna E.; Kemmler, Julia; Ignatius, Anita] Ulm Univ, Med Ctr, Ctr Trauma Res Ulm, Inst Orthopaed Res & Biomech, Helmholtzstr 14, D-89081 Ulm, Germany; [Hachemi, Yasmine; Koenen, Mascha; Tuckermann, Jan] Ulm Univ, Inst Comparat Mol Endocrinol, Helmholtzstrasse 8-1,Room 3-34, D-89081 Ulm, Germany	Ulm University; Ulm University	Ignatius, A (corresponding author), Ulm Univ, Med Ctr, Ctr Trauma Res Ulm, Inst Orthopaed Res & Biomech, Helmholtzstr 14, D-89081 Ulm, Germany.; Tuckermann, J (corresponding author), Ulm Univ, Inst Comparat Mol Endocrinol, Helmholtzstrasse 8-1,Room 3-34, D-89081 Ulm, Germany.	jan.tuckermann@uni-ulm.de; anita.ignatius@uni-ulm.de	Ignatius, Anita/M-6012-2013; Koenen, Mascha/GWZ-9700-2022; Rapp, Anna Elise/L-8807-2016	Ignatius, Anita/0000-0002-4782-1979; Koenen, Mascha/0000-0002-1024-4506; Rapp, Anna Elise/0000-0001-5122-765X	German Research Foundation in the Collaborative Research Centre 1149 Study, Danger Response, Disturbance Factors, and Regenerative Potential after Acute Trauma [CRC 1149, C02/INST 40/492-1]	German Research Foundation in the Collaborative Research Centre 1149 Study, Danger Response, Disturbance Factors, and Regenerative Potential after Acute Trauma	The authors thank G. Strauss (Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center) for the use of the fluorescence-activated cell sorting facility and her support. The authors acknowledge the excellent technical assistance of N. Mobius (Institute of Comparative Molecular Endocrinology, Ulm University), I. Baum, S. Schroth, U. Maile, and M. Tomo (Institute of Orthopaedic Research and Biomechanics, Ulm University Medical Centre). This work was financed by the German Research Foundation in the context of the Collaborative Research Centre 1149 Study, Danger Response, Disturbance Factors, and Regenerative Potential after Acute Trauma (CRC 1149, C02/INST 40/492-1). The authors declare no conflicts of interest.	Aslan M, 2005, DENT TRAUMATOL, V21, P222, DOI 10.1111/j.1600-9657.2005.00300.x; Baschant U, 2011, P NATL ACAD SCI USA, V108, P19317, DOI 10.1073/pnas.1105857108; Baschant U, 2010, J STEROID BIOCHEM, V120, P69, DOI 10.1016/j.jsbmb.2010.03.058; Carcamo-Orive I, 2010, J BONE MINER RES, V25, P2115, DOI 10.1002/jbmr.120; Conaway HH, 2016, BONE, V93, P43, DOI 10.1016/j.bone.2016.08.024; Coutinho AE, 2012, ENDOCRINOLOGY, V153, P234, DOI 10.1210/en.2011-1398; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Dunn AJ, 2000, ANN NY ACAD SCI, V917, P608, DOI 10.1111/j.1749-6632.2000.tb05426.x; Frenkel B, 2015, ADV EXP MED BIOL, V872, P179, DOI 10.1007/978-1-4939-2895-8_8; Hartmann K, 2016, PHYSIOL REV, V96, P409, DOI 10.1152/physrev.00011.2015; Hubner Sabine, 2012, Biomol Concepts, V3, P241, DOI 10.1515/bmc-2011-0033; Hubner S, 2015, BIOL CHEM, V396, P1223, DOI 10.1515/hsz-2015-0106; Jia D, 2006, ENDOCRINOLOGY, V147, P5592, DOI 10.1210/en.2006-0459; Kalak R, 2009, BONE, V45, P61, DOI 10.1016/j.bone.2009.03.673; Kleiman A, 2012, FASEB J, V26, P722, DOI 10.1096/fj.11-192112; Koetz KR, 2012, J CLIN ENDOCR METAB, V97, P85, DOI 10.1210/jc.2011-2036; Li J, 2012, INJURY, V43, P1284, DOI 10.1016/j.injury.2012.04.014; Lim HW, 2015, GENOME RES, V25, P836, DOI 10.1101/gr.188581.114; Maes C, 2013, CALCIFIED TISSUE INT, V92, P307, DOI 10.1007/s00223-012-9689-z; Morgan EF, 2009, BONE, V44, P335, DOI 10.1016/j.bone.2008.10.039; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Piemontese M, 2016, AM J PHYSIOL-ENDOC M, V311, pE587, DOI 10.1152/ajpendo.00219.2016; Rauch A, 2010, CELL METAB, V11, P517, DOI 10.1016/j.cmet.2010.05.005; Rontgen V, 2010, J ORTHOP RES, V28, P1456, DOI 10.1002/jor.21148; Sher LB, 2006, CALCIFIED TISSUE INT, V79, P118, DOI 10.1007/s00223-005-0297-z; Sher LB, 2004, ENDOCRINOLOGY, V145, P922, DOI 10.1210/en.2003-0655; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tronche F, 1998, CURR OPIN GENET DEV, V8, P532, DOI 10.1016/S0959-437X(98)80007-5; Tu JW, 2014, BONE, V69, P12, DOI 10.1016/j.bone.2014.08.016; Tuckermann JP, 2007, J CLIN INVEST, V117, P1381, DOI 10.1172/JCI28034; Vandevyver S, 2012, J CLIN INVEST, V122, P2130, DOI 10.1172/JCI60006; Waters RV, 2000, ACTA ORTHOP SCAND, V71, P316, DOI 10.1080/000164700317411951; Weber AJ, 2010, STEROIDS, V75, P282, DOI 10.1016/j.steroids.2010.01.005; Wust S, 2008, J IMMUNOL, V180, P8434, DOI 10.4049/jimmunol.180.12.8434; Zhou H, 2008, J BIOL CHEM, V283, P1936, DOI 10.1074/jbc.M702687200; Zhou H, 2009, DEVELOPMENT, V136, P427, DOI 10.1242/dev.027706	36	18	18	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2235	2245		10.1096/fj.201700459RR	http://dx.doi.org/10.1096/fj.201700459RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29217668	Green Published, hybrid			2022-12-28	WOS:000429051400041
J	Zhang, W; Chen, EM; Chen, M; Ye, CY; Qi, YY; Ding, QH; Li, H; Xue, DT; Gao, X; Pan, ZJ				Zhang, Wei; Chen, Erman; Chen, Mo; Ye, Chenyi; Qi, Yiying; Ding, Qianhai; Li, Hang; Xue, Deting; Gao, Xiang; Pan, Zhijun			IGFBP7 regulates the osteogenic differentiation of bone marrow-derived mesenchymal stem cells via Wnt/beta-catenin signaling pathway	FASEB JOURNAL			English	Article						IGFBP7; BMSCs; osteogenesis	PROTEIN-RELATED PROTEIN-1; FACTOR-BINDING PROTEIN-7; PERIODONTAL-LIGAMENT; IN-VITRO; CULTURED OSTEOBLASTS; STROMAL CELLS; ACTIVIN-A; EXPRESSION; INDUCTION; MARKER	Insulin-like growth factor-binding protein 7 (IGFBP7), a low-affinity IGF binder, may play an important role in bone metabolism. However, its function in osteogenic differentiation of human bone marrow-derived mesenchymal stem cells (BMSCs) remains unclear. Therefore, we investigated its effects on osteogenic differentiation. Overexpression of IGFBP7 enhanced the expression of osteo-specific genes and proteins, and IGFBP7 knockdown decreased osteogenesis-specific markers. More mineral deposits and higher alkaline phosphatase activity were observed after the up-regulation of IGFBP7. Moreover, beta-catenin levels were up-regulated by the overexpression of IGFBP7 or the addition of extracellular IGFBP7 protein and were reduced by the depletion of IGFBP7. The increase in osteogenic differentiation due to the overexpression of IGFBP7 was partially decreased by specific Wnt/beta-catenin signaling inhibitors. Using a rat tibial osteotomy model, a sheet of IGFBP7-overexpressing BMSCs improved bone healing, as demonstrated by imaging, biomechanical, and histologic analyses. Taken together, these findings indicate that IGFBP7 regulates the osteogenic differentiation of BMSCs partly via the Wnt/-catenin signaling pathway.	[Zhang, Wei; Chen, Erman; Ye, Chenyi; Qi, Yiying; Ding, Qianhai; Li, Hang; Xue, Deting; Gao, Xiang; Pan, Zhijun] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Orthoped, Hangzhou 310009, Zhejiang, Peoples R China; [Chen, Mo] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Rheumatol, Hangzhou, Zhejiang, Peoples R China; [Zhang, Wei; Chen, Erman; Ye, Chenyi; Qi, Yiying; Ding, Qianhai; Li, Hang; Xue, Deting; Gao, Xiang; Pan, Zhijun] Zhejiang Univ, Res Inst Orthopaed, Hangzhou, Zhejiang, Peoples R China; [Chen, Mo] Hangzhou Hosp Tradit Chinese Med, Dept Nephrol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Xue, DT; Gao, X (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Orthoped, Hangzhou 310009, Zhejiang, Peoples R China.	blueskine@zju.edu.cn; gaoxiang162@zju.edu.cn		Xue, deting/0000-0001-6388-2862	Zhejiang Medical and Health Science and Technology Plan Project [2014KYA92, 2015KYB182]; Zhejiang Provincial Natural Science Foundation of China [LY16H060003, LY15H060002, LY15H060001, LY13H060002, LY18H060003, LY17H060002]; National Natural Science Foundation of China [81672147, 81501906, 81572124]; Department of Eduction of Zhejiang province [Y201328201]	Zhejiang Medical and Health Science and Technology Plan Project; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Eduction of Zhejiang province	This research was supported by Zhejiang Provincial Natural Science Foundation of China (LY18H060003; LY15H060002; LY15H060001; LY17H060002; LY16H060003; and LY13H060002), National Natural Science Foundation of China (81672147, 81501906 and 81572124), Department of Eduction of Zhejiang province (Y201328201), and Zhejiang Medical and Health Science and Technology Plan Project (2015KYB182, 2014KYA92). The authors declare no conflicts of interest.	Ahmadzadeh A, 2016, CELL TISSUE RES, V363, P321, DOI 10.1007/s00441-015-2300-y; Aisha MD, 2014, EXP CELL RES, V326, P46, DOI 10.1016/j.yexcr.2014.06.003; Akiel M, 2014, J HEPATOCELL CARCINO, V1, P9, DOI 10.2147/JHC.S44460; Al-Kharobi H, 2014, CELL MOL LIFE SCI, V71, P1469, DOI 10.1007/s00018-013-1508-9; Alves RDAM, 2013, MOL CELL PROTEOMICS, V12, P2890, DOI 10.1074/mcp.M112.024927; Balemans W, 2008, CALCIFIED TISSUE INT, V82, P445, DOI 10.1007/s00223-008-9130-9; Bolomsky A, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-014-0105-1; Bosemark P, 2014, J ORTHOP RES, V32, P721, DOI 10.1002/jor.22599; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Chen EM, 2015, FEBS LETT, V589, P4088, DOI 10.1016/j.febslet.2015.11.021; Chen FM, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0288-1; Chen HC, 2010, ARTHRITIS RHEUM-US, V62, P781, DOI 10.1002/art.27288; Conover CA, 2008, AM J PHYSIOL-ENDOC M, V294, pE10, DOI 10.1152/ajpendo.00648.2007; Court-Brown CM, 2016, J BONE JOINT SURG AM, V98, DOI 10.2106/JBJS.15.00793; Dudek H, 2014, MOL THER, V22, P92, DOI 10.1038/mt.2013.233; El-Hoss J, 2014, J BONE JOINT SURG AM, V96A, DOI 10.2106/JBJS.M.00862; Heilmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084232; Hooper AT, 2009, CIRC RES, V105, P201, DOI 10.1161/CIRCRESAHA.109.196790; James MJ, 2004, GENE EXPR PATTERNS, V4, P595, DOI 10.1016/j.modgep.2004.01.013; Jeffries MA, 2016, ARTHRITIS RHEUMATOL, V68, P1403, DOI 10.1002/art.39555; Kang YQ, 2014, ACS APPL MATER INTER, V6, P9622, DOI 10.1021/am502056q; Kutsukake M, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-54; LEBOY PS, 1991, J CELL PHYSIOL, V146, P370, DOI 10.1002/jcp.1041460306; Liao Y, 2016, MOL THER, V24, P1860, DOI 10.1038/mt.2016.140; Liu WJ, 2014, BBA-GEN SUBJECTS, V1840, P1125, DOI 10.1016/j.bbagen.2013.11.003; Liu Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep10227; Ma DD, 2009, J ENDODONT, V35, P1546, DOI 10.1016/j.joen.2009.07.016; MacDonald BT, 2012, COLD SPRING HARB PER, V4; Marsell R, 2011, INJURY, V42, P551, DOI 10.1016/j.injury.2011.03.031; Nakamura A, 2009, TISSUE ENG PART C-ME, V15, P169, DOI 10.1089/ten.tec.2007.0334; Oh YM, 1996, J BIOL CHEM, V271, P30322, DOI 10.1074/jbc.271.48.30322; Park JS, 2010, BIOMATERIALS, V31, P6239, DOI 10.1016/j.biomaterials.2010.05.002; Pereira RC, 1999, ENDOCRINOLOGY, V140, P228, DOI 10.1210/en.140.1.228; Pereira RC, 1999, ENDOCRINOLOGY, V140, P1998, DOI 10.1210/en.140.5.1998; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qi YY, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0256-1; Qi YY, 2014, KNEE SURG SPORT TR A, V22, P1424, DOI 10.1007/s00167-012-2256-3; Qi YY, 2013, CYTOTHERAPY, V15, P44, DOI 10.1016/j.jcyt.2012.10.006; Qi YY, 2012, CELL TRANSPLANT, V21, P693, DOI 10.3727/096368911X623844; Rao C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085340; Regard J. B., 2012, COLD SPRING HARB PER, V4; Rudnicki MA, 2015, BONE, V80, P60, DOI 10.1016/j.bone.2015.02.009; Sugii H, 2014, BONE, V66, P62, DOI 10.1016/j.bone.2014.05.021; Sun HL, 2014, STEM CELLS, V32, P1943, DOI 10.1002/stem.1671; SWISSHELM K, 1995, P NATL ACAD SCI USA, V92, P4472, DOI 10.1073/pnas.92.10.4472; Takahata M, 2012, J BONE MINER RES, V27, P26, DOI 10.1002/jbmr.518; Tan WX, 2015, BIOCHEM BIOPH RES CO, V460, P639, DOI 10.1016/j.bbrc.2015.03.082; Tao K, 2016, TOXICOL LETT, V240, P68, DOI 10.1016/j.toxlet.2015.10.007; Tsai SC, 2012, INT J ONCOL, V41, P2065, DOI 10.3892/ijo.2012.1640; Tsai YH, 2015, FEBS LETT, V589, P2058, DOI 10.1016/j.febslet.2015.06.023; Usui T, 2002, INT IMMUNOL, V14, P1273, DOI 10.1093/intimm/dxf102; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Wajapeyee N, 2010, CELL, V141, P746, DOI 10.1016/j.cell.2010.05.014; Wang ZF, 2015, J BIOMED MATER RES B, V103, P1204, DOI 10.1002/jbm.b.33288; Wei FL, 2012, J CELL PHYSIOL, V227, P3216, DOI 10.1002/jcp.24012; Xu LL, 2015, FASEB J, V29, P1143, DOI 10.1096/fj.14-254169; Xue DT, 2017, ONCOTARGET, V8, P42098, DOI 10.18632/oncotarget.16887; Yamanaka Y, 1997, J BIOL CHEM, V272, P30729, DOI 10.1074/jbc.272.49.30729; Yoon H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6176; Zhang W, 2015, GROWTH FACTORS, V33, P356, DOI 10.3109/08977194.2015.1108313; Zhang W, 2008, J BONE MINER RES, V23, P1118, DOI 10.1359/JBMR.080304; Zhou XP, 2015, GROWTH FACTORS, V33, P23, DOI 10.3109/08977194.2014.969420	62	41	43	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2280	2291		10.1096/fj.201700998RR	http://dx.doi.org/10.1096/fj.201700998RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29242275				2022-12-28	WOS:000429051400045
J	Lee, JH; Wen, XL; Cho, H; Koo, SH				Lee, Ji-Hyun; Wen, Xianlan; Cho, Hana; Koo, Seung-Hoi			CREB/CRTC2 controls GLP-1-dependent regulation of glucose homeostasis	FASEB JOURNAL			English	Article						cAMP signaling; transcriptional activator; glucose metabolism; intestinal L cells	GLUCAGON-LIKE PEPTIDE-1; PROGLUCAGON GENE-EXPRESSION; CREB COACTIVATOR TORC2; INSULIN-SECRETION; INCRETIN HORMONES; KEY REGULATOR; PREPROGLUCAGON; PANCREAS; PROTEIN; CELLS	Glucagon-like peptide 1 (GLP-1) is a major incretin that controls glucose homeostasis. The secretion of mature GLP-1 is regulated via GPCRs, including bile acid receptor G protein-coupled bile acid receptor 1, which uses cAMP signaling to enhance the exocytosis of GLP-1-containing vesicles. However, the role of cAMP-mediated transcription has not been clearly demonstrated to date. In this study, we explored the role of cAMP response element-binding protein/CREB-regulated transcription coactivator 2 (CREB/CRTC2)-dependent transcription on GLP-1 secretion in the L cells. We found that the reduced CREB/CRTC2 activity impaired the cAMP-dependent increase in GLP-1 secretion, whereas expression of constitutively active CRTC2 increased GLP-1 exocytosis from the L cells. Close investigation revealed that expression of not only proglucagon but also PC1/3, an endopeptidase for GLP-1 maturation, is transcriptionally regulated by CREB/CRTC2. Furthermore, expression of peroxisome proliferator-activating receptor coactivator 1 a is also reduced upon depletion of CRTC2, leading to the decreased expression of oxidative phosphorylation (OxPhos) genes, reduced ATP levels, and calcium concentrations in the L cells. Finally, we observed that intestine-specific CRTC2 knockout mice displayed reduced GLP-1 expression, leading to the lower plasma GLP-1 levels, impaired glucose tolerance, and decreased insulin-containing beta cells in pancreatic islets. Our data show that the CREB/CRTC2-dependent transcriptional pathway is critical for regulating glucose homeostasis by controlling production of GLP-1 from the L cells at the level of transcription, maturation, and exocytosis.	[Lee, Ji-Hyun; Koo, Seung-Hoi] Korea Univ, Div Life Sci, 145 Anam Rd, Seoul 02841, South Korea; [Wen, Xianlan; Cho, Hana] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Physiol, Suwon, South Korea	Korea University; Sungkyunkwan University (SKKU)	Koo, SH (corresponding author), Korea Univ, Div Life Sci, 145 Anam Rd, Seoul 02841, South Korea.	koohoi@korea.ac.kr		Cho, Hana/0000-0002-9394-8671	National Research Foundation of Korea [NRF-2015R1A2A1A01006687, NRF-2012M3A9B6055345, NRF-2015R1A5A1009024, NRF-2017M3A9D5A01052447]; Ministry of Science and ICT, Korea; Korea University	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Science and ICT, Korea; Korea University	The authors thank Prof. Daniel Drucker (University of Toronto, Toronto, ON, Canada) and Prof. Toru Hira (Hokkaido University, Sapporo, Hokkaido, Japan) for kindly providing us the GLUTag L cells and Prof. Minsun Kim (Asan Medical Center, Seoul, Korea) for kindly providing us with the villin-Cre transgenic mice. The authors thank members of the Koo Laboratory for critical review of this manuscript. This work was supported by the National Research Foundation of Korea (Grants NRF-2015R1A2A1A01006687, NRF-2012M3A9B6055345, NRF-2015R1A5A1009024, and NRF-2017M3A9D5A01052447), funded by the Ministry of Science and ICT, Korea, and a grant from Korea University. The authors declare no conflicts of interests.	Baggio L, 2000, ENDOCRINOLOGY, V141, P3703, DOI 10.1210/en.141.10.3703; BELL GI, 1983, NATURE, V304, P368, DOI 10.1038/304368a0; Cani PD, 2007, MOL CELL ENDOCRINOL, V276, P18, DOI 10.1016/j.mce.2007.06.003; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Deacon CF, 2006, INT J BIOCHEM CELL B, V38, P831, DOI 10.1016/j.biocel.2005.09.011; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Dyer J, 2003, EUR J BIOCHEM, V270, P3377, DOI 10.1046/j.1432-1033.2003.03721.x; Eberhard CE, 2013, ENDOCRINOLOGY, V154, P2308, DOI 10.1210/en.2012-2088; El-Ouaghlidi A, 2007, J CLIN ENDOCR METAB, V92, P4165, DOI 10.1210/jc.2006-1932; Espinosa VP, 2008, NEUROSCIENCE, V156, P788, DOI 10.1016/j.neuroscience.2008.07.063; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gevrey JC, 2004, DIABETOLOGIA, V47, P926, DOI 10.1007/s00125-004-1380-0; Han JB, 2015, NATURE, V524, P243, DOI 10.1038/nature14557; Harach T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00430; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Henriksen DB, 2003, J BONE MINER RES, V18, P2180, DOI 10.1359/jbmr.2003.18.12.2180; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Holst JJ, 2004, AM J PHYSIOL-ENDOC M, V287, pE199, DOI 10.1152/ajpendo.00545.2003; Katsuma S, 2005, BIOCHEM BIOPH RES CO, V329, P386, DOI 10.1016/j.bbrc.2005.01.139; Kim MJ, 2015, DIABETES, V64, P3189, DOI 10.2337/db14-1240; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lotfi S, 2006, ENDOCRINOLOGY, V147, P3727, DOI 10.1210/en.2006-0056; MOJSOV S, 1986, J BIOL CHEM, V261, P1880; NOVAK U, 1987, EUR J BIOCHEM, V164, P553, DOI 10.1111/j.1432-1033.1987.tb11162.x; Ogata H, 2014, J ENDOCRINOL, V222, P191, DOI 10.1530/JOE-14-0161; ORSKOV C, 1988, ENDOCRINOLOGY, V123, P2009, DOI 10.1210/endo-123-4-2009; Orskov C, 1996, SCAND J GASTROENTERO, V31, P665, DOI 10.3109/00365529609009147; Parker HE, 2012, DIABETOLOGIA, V55, P2445, DOI 10.1007/s00125-012-2585-2; Reimann F, 2002, DIABETES, V51, P2757, DOI 10.2337/diabetes.51.9.2757; Reimann F, 2008, CELL METAB, V8, P532, DOI 10.1016/j.cmet.2008.11.002; ROUILLE Y, 1994, P NATL ACAD SCI USA, V91, P3242, DOI 10.1073/pnas.91.8.3242; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Ugleholdt R, 2004, ENDOCRINOLOGY, V145, P1349, DOI 10.1210/en.2003-0801; Villareal DT, 2010, DIABETES, V59, P479, DOI 10.2337/db09-1169; Wang YG, 2012, NATURE, V485, P128, DOI 10.1038/nature10988; Wang YG, 2010, P NATL ACAD SCI USA, V107, P3087, DOI 10.1073/pnas.0914897107; Wettergren A, 1998, PEPTIDES, V19, P877, DOI 10.1016/S0196-9781(98)00020-5; Whalley NM, 2011, J ENDOCRINOL, V211, P99, DOI 10.1530/JOE-11-0094; Yi FH, 2005, J BIOL CHEM, V280, P1457, DOI 10.1074/jbc.M411487200; Yoon YS, 2010, P NATL ACAD SCI USA, V107, P17704, DOI 10.1073/pnas.1012665107	43	20	21	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1566	1578		10.1096/fj.201700845R	http://dx.doi.org/10.1096/fj.201700845R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29118086				2022-12-28	WOS:000427246000035
J	Pan, I; Roitenberg, N; Cohen, E				Pan, Ieshita; Roitenberg, Noa; Cohen, Ehud			Vesicle-mediated secretion of misfolded prion protein molecules from cyclosporin A-treated cells	FASEB JOURNAL			English	Article						proteotoxicity; neurodegeneration; exosome; PrP	UNCONVENTIONAL SECRETION; NEUROBLASTOMA-CELLS; STRAUSSLER-SYNDROME; CULTURED-CELLS; EXOSOMES; AGGRESOMES; MICROVESICLES; COMPARTMENTS; AGGREGATION; HEPATOCYTES	Loss of protein homeostasis is a hazardous situation that jeopardizes cellular functionality and viability. Cells have developed mechanisms that supervise protein integrity and direct misfolded molecules for degradation. Nevertheless, subsets of aggregation-prone proteins escape degradation and form aggregates that can underlie the development of neurodegenerative disorders. In some cases, cells deposit hazardous protein aggregates in designated sites, like aggresomes, or secrete them with vesicles. The prion protein (PrP) is an aggregation-prone, membrane-anchored glycoprotein, whose aggregation causes familial and sporadic, fatal, neurodegenerative diseases. The proper maturation of PrP is assisted by cyclophilin B, an endoplasmic reticulum-resident foldase. Accordingly, the inhibition of cyclophilins by the drug cyclosporin A (CsA) leads to the accumulation of aggregated PrP and to its deposition in aggresomes. In this study, we asked whether secretion is an alternative strategy that cells adopt to get rid of misfolded PrP molecules and found that, upon treatment with CsA, cells secrete PrP by exosomes, a subtype of secretion vesicles, and by additional types of vesicles. CsA-induced, PrP-containing exosomes originate from the endoplasmic reticulum in a Golgi-independent manner. These findings divulge a new cellular response that is activated upon CsA treatment to secrete misfolded PrP species from the cell and may underlie the spreading of toxic prions among cells and across tissues.	[Pan, Ieshita; Roitenberg, Noa; Cohen, Ehud] Hebrew Univ Jerusalem, Sch Med, Dept Biochem & Mol Biol, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Cohen, E (corresponding author), Hebrew Univ Jerusalem, Sch Med, Dept Biochem & Mol Biol, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel.	ehudc@ekmd.huji.ac.il	Pan, Ieshita/ABD-1807-2021	Cohen, Ehud/0000-0001-5552-7086; PAN, IESHITA/0000-0003-3434-2845	E-Rare Net (The Israeli Ministry of Health and Research) [3-0000-44710]; Israel Science Foundation [ISF 981/16]	E-Rare Net (The Israeli Ministry of Health and Research); Israel Science Foundation(Israel Science Foundation)	The authors thank Tatyana Dubnikov (Hebrew University School of Medicine) for critical reading of the manuscript. This work was generously supported by the E-Rare Net (The Israeli Ministry of Health and Research, Grant 3-0000-44710) and the Israel Science Foundation (Grant ISF 981/16). The authors declare no conflicts of interest.	Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Alais S, 2008, BIOL CELL, V100, P603, DOI 10.1042/BC20080025; Ben-Gedalya T, 2015, EMBO J, V34, P2820, DOI 10.15252/embj.201592042; Ben-Gedalya T, 2011, J CELL SCI, V124, P1891, DOI 10.1242/jcs.077693; CAUGHEY B, 1989, J VIROL, V63, P175, DOI 10.1128/JVI.63.1.175-181.1989; Cohen E, 2003, EMBO J, V22, P404, DOI 10.1093/emboj/cdg045; Drisaldi B, 2003, J BIOL CHEM, V278, P21732, DOI 10.1074/jbc.M213247200; Dubnikov T, 2016, J CELL SCI, V129, P3635, DOI 10.1242/jcs.186981; Falker C, 2016, J NEUROCHEM, V137, P88, DOI 10.1111/jnc.13514; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Hartmann A, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00194; Hosseini-Beheshti E, 2012, MOL CELL PROTEOMICS, V11, P863, DOI 10.1074/mcp.M111.014845; Howitt J, 2016, J BIOL CHEM, V291, P26589, DOI 10.1074/jbc.R116.757955; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kim SJ, 2002, DEV CELL, V2, P207, DOI 10.1016/S1534-5807(01)00120-4; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Laulagnier K, 2017, METHODS MOL BIOL, V1545, P129, DOI 10.1007/978-1-4939-6728-5_9; Lee JG, 2016, NAT CELL BIOL, V18, P765, DOI 10.1038/ncb3372; Lehmann S, 1997, J BIOL CHEM, V272, P21479, DOI 10.1074/jbc.272.34.21479; Lipatova Z, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005390; Marques FC, 2015, ANNU REV PATHOL-MECH, V10, P1, DOI 10.1146/annurev-pathol-012414-040508; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; Momen-Heravi F, 2015, SCI REP-UK, V5, DOI 10.1038/srep09991; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rampelt H, 2012, EMBO J, V31, P4221, DOI 10.1038/emboj.2012.264; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Robertson C, 2006, BLOOD, V107, P3907, DOI 10.1182/blood-2005-02-0802; Ruhlmann A, 1997, IMMUNOBIOLOGY, V198, P192; Sassone J, 2006, EUR J HISTOCHEM, V50, P109; SCOTT MR, 1992, PROTEIN SCI, V1, P986, DOI 10.1002/pro.5560010804; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; Tauro BJ, 2012, METHODS, V56, P293, DOI 10.1016/j.ymeth.2012.01.002; Volkmar N, 2016, NAT CELL BIOL, V18, P724, DOI 10.1038/ncb3381; Walker LC, 2006, TRENDS NEUROSCI, V29, P438, DOI 10.1016/j.tins.2006.06.010; Willms E, 2016, SCI REP-UK, V6, DOI 10.1038/srep22519; Xia D, 2016, GENE, V583, P64, DOI 10.1016/j.gene.2016.02.042; Yamazaki M, 1999, ACTA NEUROPATHOL, V98, P506, DOI 10.1007/s004010051116; Zhang M, 2013, SCIENCE, V340, P559, DOI 10.1126/science.1234740	42	6	6	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1479	1492		10.1096/fj.201700598RRR	http://dx.doi.org/10.1096/fj.201700598RRR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29127190				2022-12-28	WOS:000427246000029
J	Pogribny, IP; Dreval, K; Kindrat, I; Melnyk, S; Jimenez, L; de Conti, A; Tryndyak, V; Pogribna, M; Ortega, JF; James, SJ; Rusyn, I; Beland, FA				Pogribny, Igor P.; Dreval, Kostiantyn; Kindrat, Iryna; Melnyk, Stepan; Jimenez, Leandro; de Conti, Aline; Tryndyak, Volodymyr; Pogribna, Marta; Ortega, Juliana Festa; James, S. Jill; Rusyn, Ivan; Beland, Frederick A.			Epigenetically mediated inhibition of S-adenosylhomocysteine hydrolase and the associated dysregulation of 1-carbon metabolism in nonalcoholic steatohepatitis and hepatocellular carcinoma	FASEB JOURNAL			English	Article						hepatocarcinogenesis; mouse; epigenetics	FATTY LIVER-DISEASE; ONE-CARBON METABOLISM; COULOMETRIC ELECTROCHEMICAL DETECTION; FOLATE-DEFICIENT DIET; HEPATIC ONE-CARBON; LIPID-METABOLISM; BETAINE SUPPLEMENTATION; INTERSTRAIN DIFFERENCES; METHIONINE METABOLISM; PLASMA HOMOCYSTEINE	The substantial rise in the prevalence of nonalcoholic steatohepatitis (NASH), an advanced form of nonalcoholic fatty liver disease, and the strong association between NASH and the development of hepatocellular carcinoma indicate the urgent need for a better understanding of the underlying mechanisms. In the present study, by using the Stelic animal model of NASH and NASH-derived liver carcinogenesis, we investigated the role of the folate-dependent 1-carbon metabolism in the pathogenesis of NASH. We demonstrated that advanced NASH and NASH-related liver carcinogenesis are characterized by a significant dysregulation of 1-carbon homeostasis, with diminished expression of key 1-carbon metabolism genes, especially a marked inhibition of the S-adenosylhomocysteine hydrolase (Ahcy) gene and an increased level of S-adenosyl-L-homocysteine (SAH). The reduction in Ahcy expression was associated with gene-specific cytosine DNA hypermethylation and enrichment of the gene promoter by trimethylated histone H3 lysine 27 and deacetylated histone H4 lysine 16, 2 main transcription-inhibiting markers. These results indicate that epigenetically mediated inhibition of Ahcy expression may be a driving force in causing SAH elevation and subsequent downstream disturbances in transsulfuration and transmethylation pathways during the development and progression of NASH.	[Pogribny, Igor P.; Dreval, Kostiantyn; Kindrat, Iryna; de Conti, Aline; Tryndyak, Volodymyr; Pogribna, Marta; Ortega, Juliana Festa; Beland, Frederick A.] Natl Ctr Toxicol Res, Div Biochem Toxicol, Jefferson, AR 72079 USA; [Melnyk, Stepan; James, S. Jill] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Jimenez, Leandro] Hosp Sirio Libanes, Mol Oncol Ctr, Sao Paulo, Brazil; [Ortega, Juliana Festa] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Food & Expt Nutr, Sao Paulo, Brazil; [Rusyn, Ivan] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77843 USA	US Food & Drug Administration (FDA); University of Arkansas System; University of Arkansas Medical Sciences; Hospital Sirio Libanes; Universidade de Sao Paulo; Texas A&M University System; Texas A&M University College Station	Pogribny, IP (corresponding author), NCTR, Div Biochem Toxicol, 3900 NCTR Rd, Jefferson, AR 72079 USA.	igor.pogribny@fda.hhs.gov	Kindrat, Iryna/AAA-7824-2020	Dreval, Kostiantyn/0000-0002-6214-2843; Rusyn, Ivan/0000-0001-9340-7384; Kindrat, Iryna/0000-0003-3960-0495; Tryndyak, Volodymyr/0000-0002-8319-2954	NIEHS NIH HHS [P30 ES023512] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES023512] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Aissa AF, 2014, MOL NUTR FOOD RES, V58, P1502, DOI 10.1002/mnfr.201300726; Avila MA, 2000, J HEPATOL, V33, P907, DOI 10.1016/S0168-8278(00)80122-1; Baric I, 2004, P NATL ACAD SCI USA, V101, P4234, DOI 10.1073/pnas.0400658101; Barroso M, 2016, BBA-MOL BASIS DIS, V1862, P82, DOI 10.1016/j.bbadis.2015.10.019; Bellentani S, 2017, LIVER INT, V37, P81, DOI 10.1111/liv.13299; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buist NRM, 2006, J INHERIT METAB DIS, V29, P538, DOI 10.1007/s10545-006-0240-0; Cheung O, 2008, SEMIN LIVER DIS, V28, P351, DOI 10.1055/s-0028-1091979; Dai HJ, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0221-6; de Conti A, 2017, MOL CANCER RES, V15, P1163, DOI 10.1158/1541-7786.MCR-17-0109; Deminice R, 2015, AMINO ACIDS, V47, P839, DOI 10.1007/s00726-014-1913-x; Doycheva I, 2017, HEPATOLOGY, V65, P2100, DOI 10.1002/hep.29068; Frau M, 2013, J HEPATOL, V59, P830, DOI 10.1016/j.jhep.2013.04.031; Fujii M, 2013, MED MOL MORPHOL, V46, P141, DOI 10.1007/s00795-013-0016-1; Goldberg D, 2017, GASTROENTEROLOGY, V152, P1090, DOI 10.1053/j.gastro.2017.01.003; Gupta S, 2016, J INHERIT METAB DIS, V39, P39, DOI 10.1007/s10545-015-9883-z; Kakehashi A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020434; Leach NV, 2014, EUR J INTERN MED, V25, P762, DOI 10.1016/j.ejim.2014.09.007; Machado MV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127991; Maher JJ, 2011, ANTIOXID REDOX SIGN, V15, P535, DOI 10.1089/ars.2010.3749; Marengo A, 2016, ANNU REV MED, V67, P103, DOI 10.1146/annurev-med-090514-013832; Matthews RP, 2009, DEVELOPMENT, V136, P865, DOI 10.1242/dev.027565; Medici V, 2010, J HEPATOL, V53, P551, DOI 10.1016/j.jhep.2010.03.029; Melnyk S, 1999, J NUTR BIOCHEM, V10, P490, DOI 10.1016/S0955-2863(99)00033-9; Melnyk S, 2000, CLIN CHEM, V46, P265; Murphy SK, 2013, GASTROENTEROLOGY, V145, P1076, DOI 10.1053/j.gastro.2013.07.047; Neuschwander-Tetri BA, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0806-8; Pacana T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136822; Pastore A, 2014, INT J MOL SCI, V15, P21202, DOI 10.3390/ijms151121202; Pogribny IP, 2013, FASEB J, V27, P2233, DOI 10.1096/fj.12-227116; Pogribny IP, 2009, J HEPATOL, V51, P176, DOI 10.1016/j.jhep.2009.03.021; Ratziu V, 2015, J HEPATOL, V62, pS65, DOI 10.1016/j.jhep.2015.02.041; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rubio-Aliaga I, 2011, PHYSIOL GENOMICS, V43, P408, DOI 10.1152/physiolgenomics.00179.2010; Saito K, 2015, SCI REP-UK, V5, DOI 10.1038/srep12466; Satapathy SK, 2015, SEMIN LIVER DIS, V35, P221, DOI 10.1055/s-0035-1562943; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwahn BC, 2004, BIOCHEM J, V382, P831, DOI 10.1042/BJ20030822; Stender S, 2015, MOL GENET METAB, V116, P269, DOI 10.1016/j.ymgme.2015.10.009; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Teng YW, 2012, J NUTR, V142, P1964, DOI 10.3945/jn.112.166835; Tryndyak V, 2012, FASEB J, V26, P4592, DOI 10.1096/fj.12-209569; Tryndyak VP, 2011, MOL NUTR FOOD RES, V55, P411, DOI 10.1002/mnfr.201000300; Tsuchiya M, 2012, HEPATOLOGY, V56, P130, DOI 10.1002/hep.25641; Turner MA, 2000, CELL BIOCHEM BIOPHYS, V33, P101, DOI 10.1385/CBB:33:2:101; Uehara T, 2013, TOXICOL SCI, V132, P53, DOI 10.1093/toxsci/kfs342; Wong RJ, 2015, GASTROENTEROLOGY, V148, P547, DOI 10.1053/j.gastro.2014.11.039; Yi P, 2000, J BIOL CHEM, V275, P29318, DOI 10.1074/jbc.M002725200; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Younossi ZM, 2015, HEPATOLOGY, V62, P1723, DOI 10.1002/hep.28123; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	51	18	18	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1591	1601		10.1096/fj.201700866R	http://dx.doi.org/10.1096/fj.201700866R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29127188	Green Published, Bronze			2022-12-28	WOS:000427246000037
J	Sukumaran, P; Sun, YY; Antonson, N; Singh, BB				Sukumaran, Pramod; Sun, Yuyang; Antonson, Neil; Singh, Brij B.			Dopaminergic neurotoxins induce cell death by attenuating NF-kappa B-mediated regulation of TRPC1 expression and autophagy	FASEB JOURNAL			English	Article						calcium; SOCE; apoptosis; PD; calcium channels	PROTEIN-KINASE-C; CA2+ ENTRY; ALPHA PHOSPHORYLATES; DISTINCT MECHANISMS; PARKINSONS-DISEASE; SIGNALING PATHWAYS; INDUCED APOPTOSIS; ANIMAL-MODELS; ER STRESS; PKC-DELTA	Alterations in Ca2+ homeostasis affect neuronal survival. However, the identity of Ca2+ channels and the mechanisms underlying neurotoxin-induced neuronal degeneration are not well understood. In this study, the dopaminergic neurotoxins 6-hydroxydopamine (6-OHDA) and 1-methyl-4-phenylpyridiumions (MPP+)/1-methyl4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), which mimic Parkinson's disease (PD), induced neuronal degeneration by decreasing store-mediated Ca2+ entry. The function of the transient receptor potential canonical (TRPC)-1 channel was decreased upon exposure to the neurotoxins, followed by a decrease in TRPC1 expression. Similar to neurotoxins, samples from patients with PD exhibited attenuated TRPC1 expression, which was accompanied by a decrease in autophagic markers and a subsequent increase in apoptosis markers. Furthermore, exposure to neurotoxins attenuated PKC phosphorylation, decreased expression of autophagic markers, and increased apoptosis in SHSY-5Y neuroblastoma cells, which was again dependent on TRPC1. Prolonged neurotoxin treatment attenuated the binding of NF-kappa B to the TRPC1 promoter, which resulted in a decrease in TRPC1 expression, thereby attenuating autophagy and activating cell death. Restoration of TRPC1 expression rescued the effects of the dopaminergic neurotoxins in neuroblastoma cells by increasing Ca2+ entry, restoring NF-kappa B activity, and promoting autophagy. Overall, these results suggest that dopaminergic neurotoxins initially decreased Ca2+ entry, which inhibited the binding of NF-kappa B to the TRPC1 promoter, thereby inhibiting TRPC1 expression and resulting in cell death by preventing autophagy.	[Sukumaran, Pramod; Sun, Yuyang; Antonson, Neil; Singh, Brij B.] Univ North Dakota, Sch Med & Hlth Sci, Dept Biomed Sci, 501 N Columbia Rd, Grand Forks, ND 58202 USA	University of North Dakota Grand Forks	Singh, BB (corresponding author), Univ North Dakota, Sch Med & Hlth Sci, Dept Biomed Sci, 501 N Columbia Rd, Grand Forks, ND 58202 USA.	brij.singh@med.und.edu		Singh, Brij/0000-0003-0535-5997	U.S. National Institutes of Health (NIH) Centers of Biomedical Research Excellence (COBRE) [P30GM103329]; NIH, National Institute of Dental and Craniofacial Research [R01DE017102, R01DE022765, R21DE024300]; NIH National Institute of General Medical Sciences (NIGMS) [P20GM113123]; NIH/NIGMS [P20GM113123, P20GM103442]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022765, R01DE017102, R21DE024300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103329, P20GM113123, P20GM103442] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) Centers of Biomedical Research Excellence (COBRE); NIH, National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the Confocal Facility at the University of North Dakota, which is partially supported by the U.S. National Institutes of Health (NIH) Centers of Biomedical Research Excellence (COBRE; Grant P30GM103329). This work was supported by the NIH, National Institute of Dental and Craniofacial Research (Grants R01DE017102, R01DE022765, and R21DE024300), and the NIH National Institute of General Medical Sciences (NIGMS; Grant P20GM113123 to B.B.S.). The Flow Cytometer Core is supported by NIH/NIGMS Grants P20GM103442 and P20GM113123. The authors declare no conflicts of interest.	Abramowitz J, 2009, FASEB J, V23, P297, DOI 10.1096/fj.08-119495; Ahmmed GU, 2004, J BIOL CHEM, V279, P20941, DOI 10.1074/jbc.M313975200; Badger JL, 2014, NEUROPHARMACOLOGY, V76, P88, DOI 10.1016/j.neuropharm.2013.08.035; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546; Chauhan A, 2015, ASN NEURO, V7, DOI 10.1177/1759091415592126; Cheng KT, 2008, J BIOL CHEM, V283, P12935, DOI 10.1074/jbc.C800008200; Choi WS, 1999, EXP NEUROL, V159, P274, DOI 10.1006/exnr.1999.7133; Choi WS, 1999, J NEUROSCI RES, V57, P86, DOI 10.1002/(SICI)1097-4547(19990701)57:1<86::AID-JNR9>3.0.CO;2-E; Fan Y, 2014, NEUROL RES, V36, P53, DOI 10.1179/1743132813Y.0000000267; Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004; Han BS, 2003, J NEUROSCI, V23, P5069; Hanrott K, 2006, J BIOL CHEM, V281, P5373, DOI 10.1074/jbc.M511560200; Hoyer-Hansen M, 2007, AUTOPHAGY, V3, P381, DOI 10.4161/auto.4240; Kania E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/352794; KITAHAMA K, 1991, NEUROSCIENCE, V44, P185, DOI 10.1016/0306-4522(91)90260-U; Kondo I, 2000, JPN J PHARMACOL, V82, P210, DOI 10.1254/jjp.82.210; Kondratskyi A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00272; Latchoumycandane C, 2011, TOXICOL APPL PHARM, V256, P314, DOI 10.1016/j.taap.2011.07.021; Li Y, 2014, ARCH BIOCHEM BIOPHYS, V558, P79, DOI 10.1016/j.abb.2014.06.023; Lilienbaum A, 2003, MOL CELL BIOL, V23, P2680, DOI 10.1128/MCB.23.8.2680-2698.2003; Lotharius J, 1999, J NEUROSCI, V19, P1284; Marasa BS, 2006, BIOCHEM J, V397, P77, DOI 10.1042/BJ20060124; Marks AR, 1997, AM J PHYSIOL-HEART C, V272, pH597, DOI 10.1152/ajpheart.1997.272.2.H597; Menzies FM, 2017, NEURON, V93, P1015, DOI 10.1016/j.neuron.2017.01.022; Muller J, 2000, NEUROLOGY, V55, P888, DOI 10.1212/WNL.55.6.888; Mut M, 2010, TURK NEUROSURG, V20, P277, DOI 10.5137/1019-5149.JTN.3008-10.1; Pani B, 2013, J CELL SCI, V126, P667, DOI 10.1242/jcs.118943; Parkhitko A, 2011, P NATL ACAD SCI USA, V108, P12455, DOI 10.1073/pnas.1104361108; Partovian C, 2004, CELL SIGNAL, V16, P951, DOI 10.1016/j.cellsig.2004.01.008; Schober A, 2004, CELL TISSUE RES, V318, P215, DOI 10.1007/s00441-004-0938-y; Selvaraj S, 2012, J CLIN INVEST, V122, P1354, DOI 10.1172/JCI61332; Selvaraj S, 2009, CELL CALCIUM, V46, P209, DOI 10.1016/j.ceca.2009.07.008; Shao CY, 2006, J NEUROPATH EXP NEUR, V65, P327, DOI 10.1097/01.jnen.0000218441.00040.82; Shen S, 2011, ONCOGENE, V30, P4544, DOI 10.1038/onc.2011.168; Shen Y, 2015, EXP CELL RES, V334, P207, DOI 10.1016/j.yexcr.2015.04.010; Steichen AL, 2013, J LEUKOCYTE BIOL, V94, P393, DOI 10.1189/jlb.1212622; Su J, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/193461; Sukumaran P, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.7; Sun YY, 2014, BBA-MOL CELL RES, V1843, P1839, DOI 10.1016/j.bbamcr.2014.04.019; Thanan R, 2015, INT J MOL SCI, V16, P193, DOI 10.3390/ijms16010193; Venderova K, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009365; Yang LX, 2009, PEPTIDES, V30, P1368, DOI 10.1016/j.peptides.2009.04.007; Yap YW, 2016, NEUROCHEM RES, V41, P554, DOI 10.1007/s11064-015-1666-2	44	22	24	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1640	1652		10.1096/fj.201700662RR	http://dx.doi.org/10.1096/fj.201700662RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29150520	Green Published			2022-12-28	WOS:000427246000041
J	Smith, AJ; Verkman, AS				Smith, Alex J.; Verkman, Alan S.			The "glymphatic" mechanism for solute clearance in Alzheimer's disease: game changer or unproven speculation?	FASEB JOURNAL			English	Review						aquaporin-4; water transport; brain edema; beta-amyloid; sleep	CEREBRAL AMYLOID ANGIOPATHY; BRAIN EXTRACELLULAR-SPACE; INTERSTITIAL FLUID; RAT-BRAIN; BULK FLOW; IN-VIVO; NEURODEGENERATIVE DISEASES; METABOLITE CLEARANCE; GLUTAMATE DIFFUSION; CEREBROSPINAL-FLUID	How solutes and macromolecules are removed from brain tissue is of central importance in normal brain physiology and in how toxic protein aggregates are cleared in neurodegenerative conditions, including Alzheimer's disease (AD). Conventionally, solute transport in the narrow and tortuous extracellular space in brain parenchyma has been thought to be primarily diffusive and nondirectional. The recently proposed "glymphatic" (gliallymphatic) hypothesis posits that solute clearance is convective and driven by active fluid transport from paraarterial to paravenous spaces though aquaporin-4 water channels in astrocyte endfeet. Glymphatic, convective solute clearance has received much attention because of its broad implications for AD and other brain pathologies and even the function of sleep. However, the theoretical plausibility of glymphatic transport has been questioned, and recent data have challenged its experimental underpinnings. A substantiated mechanism of solute clearance in the brain is of considerable importance because of its implications for pathogenic mechanisms of neurologic diseases and delivery of therapeutics.	[Smith, Alex J.; Verkman, Alan S.] UCSF, Dept Med, 1246 Hlth Sci East Tower,513 Parnassus Ave, San Francisco, CA 94143 USA; [Smith, Alex J.; Verkman, Alan S.] UCSF, Dept Physiol, 1246 Hlth Sci East Tower,513 Parnassus Ave, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Verkman, AS (corresponding author), UCSF, Dept Med, 1246 Hlth Sci East Tower,513 Parnassus Ave, San Francisco, CA 94143 USA.; Verkman, AS (corresponding author), UCSF, Dept Physiol, 1246 Hlth Sci East Tower,513 Parnassus Ave, San Francisco, CA 94143 USA.	alan.verkman@ucsf.edu			U.S. National Institutes of Health (NIH; Bethesda, MD, USA) National Eye Institute [EY13574]; NIH National Institute of Biomedical Imaging and Bioengineering [EB00415]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [DK35124, DK72517]; Guthy-Jackson Charitable Foundation; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000415, R01EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035124, P30DK072517, R37DK035124] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH; Bethesda, MD, USA) National Eye Institute; NIH National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Guthy-Jackson Charitable Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health (NIH; Bethesda, MD, USA) National Eye Institute Grant EY13574, NIH National Institute of Biomedical Imaging and Bioengineering Grant EB00415, NIH National Institute of Diabetes and Digestive and Kidney Diseases Grants DK35124, and DK72517, and a grant from the Guthy-Jackson Charitable Foundation. The authors declare no conflicts of interest.	Abbott NJ, 2004, NEUROCHEM INT, V45, P545, DOI 10.1016/j.neuint.2003.11.006; Adams DL, 2015, CEREB CORTEX, V25, P3673, DOI 10.1093/cercor/bhu221; Alperin NJ, 2000, RADIOLOGY, V217, P877, DOI 10.1148/radiology.217.3.r00dc42877; Asgari M, 2016, SCI REP-UK, V6, DOI 10.1038/srep38635; Asgari M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15024; Bakker ENTP, 2016, CELL MOL NEUROBIOL, V36, P181, DOI 10.1007/s10571-015-0273-8; Ball KK, 2010, J CEREBR BLOOD F MET, V30, P162, DOI 10.1038/jcbfm.2009.206; Bilston Lynne E., 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P235; Binder DK, 2004, J NEUROSCI, V24, P8049, DOI 10.1523/JNEUROSCI.2294-04.2004; Bohm C, 2015, MOL CELL NEUROSCI, V66, P3, DOI 10.1016/j.mcn.2015.02.016; BRADBURY MWB, 1983, J PHYSIOL-LONDON, V339, P519, DOI 10.1113/jphysiol.1983.sp014731; Carare RO, 2013, NEUROPATH APPL NEURO, V39, P593, DOI 10.1111/nan.12042; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Cicognola C, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0130-3; CSERR HF, 1981, AM J PHYSIOL, V240, pF319, DOI 10.1152/ajprenal.1981.240.4.F319; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Dechadilok P, 2009, J COLLOID INTERF SCI, V338, P135, DOI 10.1016/j.jcis.2009.06.018; Dreha-Kulaczewski S, 2017, J NEUROSCI, V37, P2395, DOI 10.1523/JNEUROSCI.2754-16.2017; Eidsvaag VA, 2017, GLIA, V65, P964, DOI 10.1002/glia.23138; Godin AG, 2017, NAT NANOTECHNOL, V12, P238, DOI [10.1038/nnano.2016.248, 10.1038/NNANO.2016.248]; Heller JP, 2017, J NEUROSCI RES, V95, P2159, DOI 10.1002/jnr.24026; Hirsch S, 2012, J CEREBR BLOOD F MET, V32, P952, DOI 10.1038/jcbfm.2012.39; Hladky SB, 2019, HANDB EXP PHARMACOL, V253, P385, DOI 10.1007/164_2017_37; Hladky SB, 2016, FLUIDS BARRIERS CNS, V13, DOI 10.1186/s12987-016-0040-3; Hladky SB, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-26; Holmes BB, 2014, J BIOL CHEM, V289, P19855, DOI 10.1074/jbc.R114.549295; Holter KE, 2017, P NATL ACAD SCI USA, V114, P9894, DOI 10.1073/pnas.1706942114; Holtzman DM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006312; Hong S, 2014, NEURON, V82, P308, DOI 10.1016/j.neuron.2014.02.027; Hui FK, 2015, WORLD NEUROSURG, V83, P715, DOI 10.1016/j.wneu.2015.03.001; ICHIMURA T, 1991, BRAIN RES, V545, P103, DOI 10.1016/0006-8993(91)91275-6; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2013, J NEUROSCI, V33, P18190, DOI 10.1523/JNEUROSCI.1592-13.2013; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Jin BJ, 2016, J GEN PHYSIOL, V148, P489, DOI 10.1085/jgp.201611684; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Kinney JP, 2013, J COMP NEUROL, V521, P448, DOI 10.1002/cne.23181; Kohn D, 2017, WASHINGTON POST; Konnikova M., 2014, NEW YORK TIMES 0602; Korogod N, 2015, ELIFE, V4, DOI 10.7554/eLife.05793; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Kullmann DM, 1999, PHILOS T ROY SOC B, V354, P395, DOI 10.1098/rstb.1999.0392; Lee HD, 2015, J NEUROSCI, V35, P11034, DOI 10.1523/JNEUROSCI.1625-15.2015; MCBAIN CJ, 1990, SCIENCE, V249, P674, DOI 10.1126/science.2382142; Mendelsohn AR, 2013, REJUV RES, V16, P518, DOI 10.1089/rej.2013.1530; Musiek ES, 2016, SCIENCE, V354, P1004, DOI 10.1126/science.aah4968; Nedergaard M, 2013, SCIENCE, V340, P1529, DOI 10.1126/science.1240514; NICHOLSON C, 1993, BIOPHYS J, V65, P2277, DOI 10.1016/S0006-3495(93)81324-9; NICHOLSON C, 1993, J NEUROSCI METH, V48, P199, DOI 10.1016/0165-0270(93)90092-6; Nielsen S, 1997, J NEUROSCI, V17, P171; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Penn RD, 2005, J NEUROSURG, V102, P1069, DOI 10.3171/jns.2005.102.6.1069; Pollak TA, 2018, LANCET PSYCHIAT, V5, P79, DOI 10.1016/S2215-0366(17)30293-6; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Rennels M L, 1990, Adv Neurol, V52, P431; Roh JH, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004291; ROSENBERG GA, 1980, AM J PHYSIOL, V238, pF42, DOI 10.1152/ajprenal.1980.238.1.F42; Sample I., 2013, GUARDIAN; Schley D, 2006, J THEOR BIOL, V238, P962, DOI 10.1016/j.jtbi.2005.07.005; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Smith AJ, 2017, ELIFE, V6, DOI [10.7554/elife.27679, 10.7554/eLife.27679]; Smith AJ, 2015, BIOPHYS J, V109, P2511, DOI 10.1016/j.bpj.2015.10.047; Smith AJ, 2015, TRENDS NEUROSCI, V38, P331, DOI 10.1016/j.tins.2015.04.006; Smith AJ, 2014, J CELL BIOL, V204, P559, DOI 10.1083/jcb.201308118; Sosunov AA, 2014, J NEUROSCI, V34, P2285, DOI 10.1523/JNEUROSCI.4037-13.2014; Spector R, 2015, EXP NEUROL, V273, P57, DOI 10.1016/j.expneurol.2015.07.027; Steiner E, 2012, GLIA, V60, P1646, DOI 10.1002/glia.22383; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; SZENTISTVANYI I, 1984, AM J PHYSIOL, V246, pF835, DOI 10.1152/ajprenal.1984.246.6.F835; Tarasoff-Conway JM, 2015, NAT REV NEUROL, V11, P457, DOI 10.1038/nrneurol.2015.119; VANHARREVELD A, 1965, J CELL BIOL, V25, P117, DOI 10.1083/jcb.25.1.117; Weller RO, 1998, AM J PATHOL, V153, P725, DOI 10.1016/S0002-9440(10)65616-7; Weller RO, 2008, BRAIN PATHOL, V18, P253, DOI 10.1111/j.1750-3639.2008.00133.x; Weller RO, 2009, ACTA NEUROPATHOL, V117, P1, DOI 10.1007/s00401-008-0457-0; Wilcock DM, 2009, NEUROSCIENCE, V159, P1055, DOI 10.1016/j.neuroscience.2009.01.023; Wolak DJ, 2013, MOL PHARMACEUT, V10, P1492, DOI 10.1021/mp300495e; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yao XM, 2008, J NEUROSCI, V28, P5460, DOI 10.1523/JNEUROSCI.0257-08.2008; Yeh FL, 2016, NEURON, V91, P328, DOI 10.1016/j.neuron.2016.06.015; Zador Z, 2008, FASEB J, V22, P870, DOI 10.1096/fj.07-9468com; Zeppenfeld DM, 2017, JAMA NEUROL, V74, P91, DOI 10.1001/jamaneurol.2016.4370; Zhao Z, 2015, NAT NEUROSCI, V18, P978, DOI 10.1038/nn.4025	85	82	84	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					543	551		10.1096/fj.201700999	http://dx.doi.org/10.1096/fj.201700999			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29101220	Bronze, Green Published			2022-12-28	WOS:000425146900002
J	Fisher, AG; Seaborne, RA; Hughes, TM; Gutteridge, A; Stewart, C; Coulson, JM; Sharples, AP; Jarvis, JC				Fisher, Andrew G.; Seaborne, Robert A.; Hughes, Thomas M.; Gutteridge, Alex; Stewart, Claire; Coulson, Judy M.; Sharples, Adam P.; Jarvis, Jonathan C.			Transcriptomic and epigenetic regulation of disuse atrophy and the return to activity in skeletal muscle	FASEB JOURNAL			English	Article							E3 UBIQUITIN LIGASES; PROBE LEVEL DATA; GENE-EXPRESSION; PROTEIN-TURNOVER; DNA METHYLATION; YOUNG MEN; BED REST; DENERVATION; CACHEXIA; IMMOBILIZATION	Physical inactivity and disuse are major contributors to age-related muscle loss. Denervation of skeletal muscle has been previously used as a model with which to investigate muscle atrophy following disuse. Although gene regulatory networks that control skeletal muscle atrophy after denervation have been established, the transcriptome in response to the recovery of muscle after disuse and the associated epigenetic mechanisms that may function to modulate gene expression during skeletal muscle atrophy or recovery have yet to be investigated. We report that silencing the tibialis anterior muscle in rats with tetrodotoxin (TTX)-administered to the common peroneal nerve-resulted in reductions in muscle mass of 7, 29, and 51% with corresponding reductions in muscle fiber cross-sectional area of 18, 42, and 69% after 3, 7, and 14 d of TTX, respectively. Of importance, 7 d of recovery, during which rodents resumed habitual physical activity, restored muscle mass from a reduction of 51% after 14 d TTX to a reduction of only 24% compared with sham control. Returning muscle mass to levels observed at 7 d TTX administration (29% reduction). Transcriptome-wide analysis demonstrated that 3714 genes were differentially expressed across all conditions at a significance of P <= 0.001 after disuse-induced atrophy. Of interest, after 7 d of recovery, the expression of genes that were most changed during TTX had returned to that of the sham control. The 20 most differentially expressed genes after microarray analysis were identified across all conditions and were cross-referenced with the most frequently occurring differentially expressed genes between conditions. This gene subset included myogenin (MyoG), Hdac4, Ampd3, Trim63 (MuRF1), and acetylcholine receptor subunit alpha 1 (Chrna1). Transcript expression of these genes and Fboxo32 (MAFbx), because of its previously identified role in disuse atrophy together with Trim63 (MuRF1), were confirmed by real-time quantitative RT-PCR, and DNA methylation of their promoter regions was analyzed by PCR and pyrosequencing. MyoG, Trim63 (MuRF1), Fbxo32 (MAFbx), and Chrna1 demonstrated significantly decreased DNA methylation at key time points after disuse-induced atrophy that corresponded with significantly increased gene expression. Of importance, after TTX cessation and 7 d of recovery, there was a marked increase in the DNA methylation profiles of Trim63 (MuRF1) and Chrna1 back to control levels. This also corresponded with the return of gene expression in the recovery group back to baseline expression observed in sham-surgery controls. To our knowledge, this is the first study to demonstrate that skeletal muscle atrophy in response to disuse is accompanied by dynamic epigenetic modifications that are associated with alterations in gene expression, and that these epigenetic modifications and gene expression profiles are reversible after skeletal muscle returns to normal activity.	[Fisher, Andrew G.] Univ Liverpool, Inst Ageing & Chron Dis, Liverpool, Merseyside, England; [Coulson, Judy M.] Univ Liverpool, Dept Cellular & Mol Biol, Liverpool, Merseyside, England; [Seaborne, Robert A.; Stewart, Claire; Sharples, Adam P.] Keele Univ, Med Sch, Inst Sci & Technol Med, Keele, Staffs, England; [Seaborne, Robert A.; Sharples, Adam P.; Jarvis, Jonathan C.] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Exercise Metab & Adaptat Res Grp, Stem Cells Ageing & Mol Physiol Res Unit, Liverpool, Merseyside, England; [Hughes, Thomas M.] Univ Valparaiso, Inst Fis & Astron, Valparaiso, Chile; [Gutteridge, Alex] Pfizer, Tadworth, England	University of Liverpool; University of Liverpool; Keele University; Liverpool John Moores University; Universidad de Valparaiso; Pfizer	Sharples, AP (corresponding author), Keele Univ, Inst Sci & Technol Med, Guy Hilton Res Ctr, Thornburrow Dr, Keele ST4 7QB, Staffs, England.; Jarvis, JC (corresponding author), Liverpool John Moores Univ, Res Inst Sport & Exercise, Sci, Byrom St Campus, Liverpool L3 3AF, Merseyside, England.	a.p.sharples@gmail.com; J.C.Jarvis@ljmu.ac.uk	Seaborne, Robert/K-7916-2019; Sharples, Adam P/H-6730-2012; Stewart, Claire E/I-3177-2013	Seaborne, Robert/0000-0003-2491-3747; Sharples, Adam P/0000-0003-1526-9400; Coulson, Judy/0000-0003-2191-2001; Stewart, Claire/0000-0002-8104-4819	UK Medical Research Council; Doctoral Training Alliance funded studentship; GlaxoSmithKline	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Doctoral Training Alliance funded studentship; GlaxoSmithKline(GlaxoSmithKline)	This work was supported by an integrative mammalian biology studentship from the UK Medical Research Council [to A.G.F. (via J.C.J.)], as well as by a Doctoral Training Alliance funded studentship and GlaxoSmithKline [to R.A.S. (via A.P.S.)]. The authors declare no conflicts of interest.	Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174; Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001; Batt J, 2005, FASEB J, V19, P115, DOI 10.1096/fj.04-3640fje; Beker F, 2003, J NEUROPHYSIOL, V90, P1956, DOI 10.1152/jn.01079.2002; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bodine SC, 2014, AM J PHYSIOL-ENDOC M, V307, pE469, DOI 10.1152/ajpendo.00204.2014; Bogdanovic O, 2009, CHROMOSOMA, V118, P549, DOI 10.1007/s00412-009-0221-9; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Buffelli M, 1997, J MUSCLE RES CELL M, V18, P683, DOI 10.1023/A:1018687923929; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Cohen TJ, 2007, J BIOL CHEM, V282, P33752, DOI 10.1074/jbc.M706268200; Colquhoun D, 2004, TRENDS NEUROSCI, V27, P337, DOI 10.1016/j.tins.2004.04.010; Davis P, 2015, FASEB J, V29; de Boer MD, 2007, J PHYSIOL-LONDON, V583, P1079, DOI 10.1113/jphysiol.2007.135392; DEITRICK JE, 1948, B NEW YORK ACAD MED, V24, P364; Dupont AC, 2003, IEEE T NEUR SYS REH, V11, P209, DOI 10.1109/TNSRE.2003.817675; Eddins MJ, 2007, J MOL BIOL, V367, P204, DOI 10.1016/j.jmb.2006.12.065; Ehrlich Kenneth C., 2016, Yale Journal of Biology and Medicine, V89, P441; Ferrando AA, 1996, AM J PHYSIOL-ENDOC M, V270, pE627, DOI 10.1152/ajpendo.1996.270.4.E627; Giangregorio L, 2006, J SPINAL CORD MED, V29, P489, DOI 10.1080/10790268.2006.11753898; GIBSON JNA, 1987, CLIN SCI, V72, P503, DOI 10.1042/cs0720503; Giniatullin R, 2005, TRENDS NEUROSCI, V28, P371, DOI 10.1016/j.tins.2005.04.009; GOLDBERG AL, 1969, J BIOL CHEM, V244, P3223; Hasselgren PO, 1998, WORLD J SURG, V22, P203, DOI 10.1007/s002689900370; Ibebunjo C, 2013, MOL CELL BIOL, V33, P194, DOI 10.1128/MCB.01036-12; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jacobsen SC, 2012, DIABETOLOGIA, V55, P3341, DOI 10.1007/s00125-012-2717-8; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Jarvis JC, 1996, MUSCLE NERVE, V19, P1469, DOI 10.1002/(SICI)1097-4598(199611)19:11<1469::AID-MUS11>3.0.CO;2-O; JARVIS JC, 1991, J MED ENG TECHNOL, V15, P53, DOI 10.3109/03091909109009968; Kalyani RR, 2014, LANCET DIABETES ENDO, V2, P819, DOI 10.1016/S2213-8587(14)70034-8; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; LEBLANC AD, 1992, J APPL PHYSIOL, V73, P2172, DOI 10.1152/jappl.1992.73.5.2172; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Llano-Diez M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-602; Macpherson PCD, 2011, J CELL BIOCHEM, V112, P2149, DOI 10.1002/jcb.23136; Magnusson C, 2005, EUR J NEUROSCI, V21, P577, DOI 10.1111/j.1460-9568.2005.03855.x; MICHEL RN, 1990, MUSCLE NERVE, V13, P646, DOI 10.1002/mus.880130714; Moresi V, 2010, CELL, V143, P35, DOI 10.1016/j.cell.2010.09.004; Nikawa T, 2004, FASEB J, V18, P522, DOI 10.1096/fj.03-0419fje; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sharples AP, 2016, AGING CELL, V15, P603, DOI 10.1111/acel.12486; Sharples AP, 2016, BIOGERONTOLOGY, V17, P603, DOI 10.1007/s10522-015-9604-x; Strassburg S, 2005, INT J BIOCHEM CELL B, V37, P1938, DOI 10.1016/j.biocel.2005.03.013; Tan BHL, 2008, CURR OPIN CLIN NUTR, V11, P400, DOI 10.1097/MCO.0b013e328300ecc1; Tang HB, 2006, P NATL ACAD SCI USA, V103, P16977, DOI 10.1073/pnas.0601565103; Tang HB, 2009, MOL BIOL CELL, V20, P1120, DOI 10.1091/mbc.E08-07-0759; Tang WWC, 2015, CELL, V161, P1453, DOI 10.1016/j.cell.2015.04.053; Trasler J, 2003, CARCINOGENESIS, V24, P39, DOI 10.1093/carcin/24.1.39; YU XM, 1991, NATURE, V352, P64, DOI 10.1038/352064a0	54	28	28	1	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5268	5282		10.1096/fj.201700089RR	http://dx.doi.org/10.1096/fj.201700089RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28821632	Green Accepted			2022-12-28	WOS:000416588300013
J	Isherwood, CM; van der Veen, DR; Johnston, JD; Skene, DJ				Isherwood, Cheryl M.; van der Veen, Daan R.; Johnston, Jonathan D.; Skene, Debra J.			Twenty-four-hour rhythmicity of circulating metabolites: effect of body mass and type 2 diabetes	FASEB JOURNAL			English	Article						metabolomics; human; obesity; biological rhythms; circadian clock	GENE-EXPRESSION; ACID; SLEEP; IDENTIFICATION; CONSEQUENCES; METABOLOMICS; OBESITY; TIME	Metabolic profiling of individuals with type 2 diabetesmellitus (T2DM) has previously been limited to single-time-point samples, ignoring time-of-day variation. Here, we tested our hypothesis that body mass and T2DM affect daily rhythmicity and concentrations of circulating metabolites across a 24-h day in 3 age-matched, male groups-lean, overweight/obese (OW/OB), and OW/OB with T2DM-in controlled laboratory conditions, which were not confounded by large meals. By using targeted liquid chromatography/mass spectrometry metabolomics, we quantified 130 plasma metabolites every 2 h over 24 h, and we show that average metabolite concentrations were significantly altered by increased body mass (90 of 130) and T2DM (56 of 130). Thirty-eight percent of metabolites exhibited daily rhythms in at least 1 study group, and where ametabolite was rhythmic in >1 group, its peak time was comparable. The optimal time of day was assessed to provide discriminating biomarkers. This differed between metabolite classes and study groups-for example, phospholipids showed maximal difference at 5: 00AM(lean vs. OW/OB) and at 5: 00 PM (OW/OB vs. T2DM). Metabolites that were identified with both robust 24-h rhythms and significant concentration differences between study groups emphasize the importance of controlling the time of day fordiagnosis and biomarker discovery, offering a significant improvement over current single sampling.	[Isherwood, Cheryl M.; van der Veen, Daan R.; Johnston, Jonathan D.; Skene, Debra J.] Univ Surrey, Fac Hlth & Med Sci, Chronobiol Sect, Guildford GU2 7XH, Surrey, England	University of Surrey	Skene, DJ (corresponding author), Univ Surrey, Fac Hlth & Med Sci, Chronobiol Sect, Guildford GU2 7XH, Surrey, England.	d.skene@surrey.ac.uk	Johnston, Jonathan/AAS-6969-2021; van der Veen, Daan R/T-1013-2017; Johnston, Jonathan D/H-6363-2011	van der Veen, Daan R/0000-0001-8037-1407; Johnston, Jonathan D/0000-0001-8083-9794; Skene, Debra/0000-0001-8202-6180	Diabetes United Kingdom [08/0003607]; EU FP7-HEALTH EuRhythDia [278397]; Biotechnology and Biological Sciences Research Council [BB/D526853/1, BB/I019405/1]; Stockgrand Ltd. (Guilford, United Kingdom); BBSRC [BB/I019405/1] Funding Source: UKRI; MRC [MR/N006321/1] Funding Source: UKRI; Medical Research Council [MR/N006321/1] Funding Source: researchfish	Diabetes United Kingdom(Diabetes UK); EU FP7-HEALTH EuRhythDia; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Stockgrand Ltd. (Guilford, United Kingdom); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank Dr. Daniella T. Otway for recruitment of participants and for contributing to data collection, and Dr. Denise Robertson for input into study design and sample collection (both from the Faculty of Health and Medical Sciences, University of Surrey). The assistance of Namrata Chowdhury and the staff of the Surrey Clinical Research Centre and the Metabolomics Core Facility at the University of Surrey is acknowledged. The authors also thank Dr. Anne Skeldon (Department of Mathematics, University of Surrey) and Dr. Jeroen Pennings (National Institute for Public Health and the Environment, Bilthoven, The Netherlands, for assistance and writing the analysis scripts for MatLab and R, respectively. This work was funded by Diabetes United Kingdom (Grant 08/0003607), EU FP7-HEALTH-2011 EuRhythDia (Grant 278397), the Biotechnology and Biological Sciences Research Council (Grants BB/D526853/1 and BB/I019405/1), and Stockgrand Ltd. (Guilford, United Kingdom). The authors declare no conflicts of interest.	Ando H, 2005, ENDOCRINOLOGY, V146, P5631, DOI 10.1210/en.2005-0771; Ando H, 2009, DIABETOLOGIA, V52, P329, DOI 10.1007/s00125-008-1194-6; Ang JE, 2012, CHRONOBIOL INT, V29, P868, DOI 10.3109/07420528.2012.699122; Barber MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041456; Chua ECP, 2013, P NATL ACAD SCI USA, V110, P14468, DOI 10.1073/pnas.1222647110; Dallmann R, 2012, P NATL ACAD SCI USA, V109, P2625, DOI 10.1073/pnas.1114410109; Davies SK, 2014, P NATL ACAD SCI USA, V111, P10761, DOI 10.1073/pnas.1402663111; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Guasch-Ferre M, 2016, DIABETES CARE, V39, P833, DOI 10.2337/dc15-2251; Johnston JD, 2016, ADV NUTR, V7, P399, DOI 10.3945/an.115.010777; Kasukawa T, 2012, P NATL ACAD SCI USA, V109, P15036, DOI 10.1073/pnas.1207768109; Krug S, 2012, FASEB J, V26, P2607, DOI 10.1096/fj.11-198093; Mantele S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037123; Mihalik SJ, 2012, DIABETES CARE, V35, P605, DOI [10.2337/DC11-1577, 10.2337/dc11-1577]; Mihalik SJ, 2010, OBESITY, V18, P1695, DOI 10.1038/oby.2009.510; Minami Y, 2009, P NATL ACAD SCI USA, V106, P9890, DOI 10.1073/pnas.0900617106; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Otway DT, 2011, DIABETES, V60, P1577, DOI 10.2337/db10-1098; Potter GDM, 2016, ENDOCR REV, V37, P584, DOI 10.1210/er.2016-1083; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Skene DJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep43030; Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953; VanCauter E, 1997, ENDOCR REV, V18, P716, DOI 10.1210/er.18.5.716; Wang TJ, 2013, J CLIN INVEST, V123, P4309, DOI 10.1172/JCI64801; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380	29	28	28	2	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5557	+		10.1096/fj.201700323R	http://dx.doi.org/10.1096/fj.201700323R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28821636	Green Published			2022-12-28	WOS:000416588300036
J	Shea, DJ; Li, YW; Stebe, KJ; Konstantopoulos, K				Shea, Daniel J.; Li, Yi W.; Stebe, Kathleen J.; Konstantopoulos, Konstantinos			E-selectin-mediated rolling facilitates pancreatic cancer cell adhesion to hyaluronic acid	FASEB JOURNAL			English	Article						PODXL; CD44v; cell rolling	COLON-CARCINOMA CELLS; SHEAR-FLOW; VASCULAR INTERACTIONS; TUMOR-CELLS; P-SELECTIN; MUCIN 16; CD44; BINDING; KINETICS; LIGAND	Tumor cell extravasation is a multistep process preceded by cell rolling and arrest on the vessel wall via the formation of specific receptor-ligand bonds. The strength, availability, and number of receptor-ligand bonds regulate the rate by which tumor cells tether, roll, and adhere to vascular walls. Although the mechanics of selectin mediated rolling have been extensively studied, little is known regarding how tumor cell rolling on selectins facilitates adhesion toa distinct substrate-bound protein with different kinetic properties. By using multicomponent protein patterning and a microfluidic system, we evaluated how E-selectin-dependent rolling modulates hyaluronic acid ( HA) adhesion as a function of fluid shear, contact time, and the spacing between E-selectin and HA regions patterned on the substrate. We show that tumor cells rolling on E-selectinwere similar to 40-fold more likely to bind to HA than nonrolling cells in shear flow. Furthermore, E-selectin-dependent rolling promotes adhesion to HA by both physically slowing cells and enabling them to position proximal to the surface, thereby increasing the on rate of adhesion. Abetter understanding of tumor cell adhesion under physiologic shear would lead to the development of new diagnostic assays and pave the way to clinical approaches aimed ultimately to halt metastasis.-Shea, D. J., Li, Y. W., Stebe, K. J., Konstantopoulos, K. E-selectin-mediated rolling facilitates pancreatic cancer cell adhesion to hyaluronic acid.	[Konstantopoulos, Konstantinos] Johns Hopkins Univ, Johns Hopkins Inst NanoBioTechnol, Baltimore, MD USA; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD USA; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Dept Oncol, Baltimore, MD USA; [Stebe, Kathleen J.] Univ Penn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Pennsylvania	Konstantopoulos, K (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, 3400 N Charles St, Baltimore, MD 21218 USA.	konstant@jhu.edu			National Science Foundation [NSF-CBET-1159823]; U.S. National Institutes of Health, National Cancer Institute [R01CA186286]; NATIONAL CANCER INSTITUTE [R01CA186286] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Science Foundation Grant NSF-CBET-1159823 (to K.K. and K.J.S.) and the U.S. National Institutes of Health, National Cancer Institute Grant R01CA186286 (to K.K.). The authors declare no conflicts of interest.	Alon R, 1998, P NATL ACAD SCI USA, V95, P11631, DOI 10.1073/pnas.95.20.11631; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Burdick MM, 2004, AM J PHYSIOL-CELL PH, V287, pC539, DOI 10.1152/ajpcell.00450.2003; Burdick MM, 2003, AM J PHYSIOL-CELL PH, V284, pC977, DOI 10.1152/ajpcell.00423.2002; Chang KC, 2000, P NATL ACAD SCI USA, V97, P11262, DOI 10.1073/pnas.200240897; Chen SH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01870; Chen SH, 2012, FASEB J, V26, P1349, DOI 10.1096/fj.11-195669; Chesla SE, 1998, BIOPHYS J, V75, P1553, DOI 10.1016/S0006-3495(98)74074-3; Cheung LSL, 2011, BIOPHYS J, V100, P2338, DOI 10.1016/j.bpj.2011.04.013; Cheung LSL, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015013; Christophis C, 2011, BIOPHYS J, V101, P585, DOI 10.1016/j.bpj.2011.05.045; Clark RA, 1996, J CELL BIOL, V134, P1075, DOI 10.1083/jcb.134.4.1075; Dallas MR, 2012, AM J PHYSIOL-CELL PH, V303, pC616, DOI 10.1152/ajpcell.00149.2012; Ghosh M, 2008, LANGMUIR, V24, P8134, DOI 10.1021/la8006525; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; HAMMER DA, 1992, BIOPHYS J, V63, P35, DOI 10.1016/S0006-3495(92)81577-1; Hanley WD, 2004, J CELL SCI, V117, P2503, DOI 10.1242/jcs.01088; Hanley WD, 2006, FASEB J, V20, P337, DOI 10.1096/fj.05-4574fje; Jablonska A, 2018, J CEREBR BLOOD F MET, V38, P835, DOI 10.1177/0271678X17703888; Kim HR, 2004, CANCER RES, V64, P4569, DOI 10.1158/0008-5472.CAN-04-0202; Konstantopoulos K, 2009, ANNU REV BIOMED ENG, V11, P177, DOI 10.1146/annurev-bioeng-061008-124949; Launiere C, 2012, ANAL CHEM, V84, P4022, DOI 10.1021/ac2033408; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; McCarty OJT, 2002, BIOPHYS J, V83, P836, DOI 10.1016/S0006-3495(02)75212-0; Mohamadzadeh M, 1998, J CLIN INVEST, V101, P97, DOI 10.1172/JCI1604; Myung JH, 2014, ANAL CHEM, V86, P6088, DOI 10.1021/ac501243a; Nalayanda DD, 2007, BIOMED MICRODEVICES, V9, P207, DOI 10.1007/s10544-006-9022-6; Nandi A, 2000, J BIOL CHEM, V275, P14939, DOI 10.1074/jbc.275.20.14939; Napier SL, 2007, J BIOL CHEM, V282, P3433, DOI 10.1074/jbc.M607219200; Ogino S, 2010, STRUCTURE, V18, P649, DOI 10.1016/j.str.2010.02.010; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Raman PS, 2012, BIOPHYS J, V103, P415, DOI 10.1016/j.bpj.2012.06.039; Raman PS, 2011, J CELL SCI, V124, P1903, DOI 10.1242/jcs.079814; Schmidt BJ, 2008, ANAL CHEM, V80, P944, DOI 10.1021/ac071529i; Shea DJ, 2015, ONCOTARGET, V6, P24842, DOI 10.18632/oncotarget.4704; Streppel MM, 2012, HUM PATHOL, V43, P1755, DOI 10.1016/j.humpath.2012.01.005; TAKADA M, 1994, PANCREAS, V9, P748, DOI 10.1097/00006676-199411000-00013; Thomas SN, 2009, BIORHEOLOGY, V46, P207, DOI 10.3233/BIR-2009-0534; Tong ZQ, 2012, INTEGR BIOL-UK, V4, P847, DOI 10.1039/c2ib20036h; Wu L, 2007, J BIOL CHEM, V282, P9846, DOI 10.1074/jbc.M609219200; Yago T, 2004, J CELL BIOL, V166, P913, DOI 10.1083/jcb.200403144; Yu Q, 1997, J EXP MED, V186, P1985, DOI 10.1084/jem.186.12.1985; Zhu C, 2000, BIOPHYS J, V79, P1850, DOI 10.1016/S0006-3495(00)76434-4	43	12	12	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					5078	5086		10.1096/fj.201700331R	http://dx.doi.org/10.1096/fj.201700331R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28765175	Green Published			2022-12-28	WOS:000413398500035
J	Patel, KR; Bai, Y; Trieu, KG; Barrios, J; Ai, XB				Patel, Kruti R.; Bai, Yan; Trieu, Kenneth G.; Barrios, Juliana; Ai, Xingbin			Targeting acetylcholine receptor M3 prevents the progression of airway hyperreactivity in a mouse model of childhood asthma	FASEB JOURNAL			English	Article						allergen; neuroplasticity; beta 2AR agonist	SMOOTH-MUSCLE-CELLS; INHALED CORTICOSTEROIDS; MUSCARINIC RECEPTORS; UNCONTROLLED ASTHMA; CA2+ OSCILLATIONS; OZONE EXPOSURE; LUNG-FUNCTION; EARLY-LIFE; CONTRACTION; ALLERGEN	Asthma often progresses into adulthood from early-life episodes of adverse environmental exposures. However, how the injury to developing lungs contributes to the pathophysiology of persistent asthma remains poorly understood. In this study, we identified an age-related mechanism along the cholinergic nerve-airway smooth muscle (ASM) axis that underlies prolonged airway hyperreactivity (AHR) in mice. We showed that ASM continued to mature until similar to 3 wk after birth. Coinciding with postnatal ASM maturation, there was a critical time window for the development of ASM hypercontractility after cholinergic stimulation. We found that allergen exposure in neonatal mice, but not in adult mice, elevated the level and activity of cholinergic nerves (termed neuroplasticity). We demonstrated that cholinergic neuroplasticity is necessary for the induction of persistent AHR after neonatal exposure during rescue assays in mice deficient in neuroplasticity. In addition, early intervention with cholinergic receptor muscarinic (ChRM)-3 blocker reversed the progression of AHR in the neonatal exposure model, whereas beta 2-adrenoceptor agonists had no such effect. Together, our findings demonstrate a functional relationship between cholinergic neuroplasticity and ASM contractile phenotypes that operates uniquely in early life to induce persistent AHR after allergen exposure. Targeting ChRM3 may have disease-modifying benefits in childhood asthma.-Patel, K. R., Bai, Y., Trieu, K. G., Barrios, J., Ai, X. Targeting acetylcholine receptor M3 prevents the progression of airway hyperreactivity in a mouse model of childhood asthma.	[Patel, Kruti R.] Harvard Med Sch, Brigham & Womens Hosp, Div Neurol, Boston, MA 02115 USA; [Bai, Yan; Trieu, Kenneth G.; Ai, Xingbin] Harvard Med Sch, Brigham & Womens Hosp, Div Pulm & Crit Care Med, 75 Francis Ave, Boston, MA 02115 USA; [Barrios, Juliana] Boston Univ, Sch Med, Div Pulm, Boston, MA 02118 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Boston University	Ai, XB (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Pulm & Crit Care Med, 75 Francis Ave, Boston, MA 02115 USA.	xai@partners.org		Patel, Kruti/0000-0002-4303-8717; Trieu, Kenneth/0000-0002-4851-1876	American Asthma Foundation [12-0086]; U.S. National Institutes of Health (NIH) National Heart, Lung and Blood Institute [1R01HL116163, 1R01HL132991]; F31 Training Grant [HL007035]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116163, K08HL135443, R01HL132991, T32HL007035] Funding Source: NIH RePORTER	American Asthma Foundation; U.S. National Institutes of Health (NIH) National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); F31 Training Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by an American Asthma Foundation Award 12-0086, and U.S. National Institutes of Health (NIH) National Heart, Lung and Blood Institute Grants 1R01HL116163 and 1R01HL132991 (to X.A.) and F31 Training Grant HL007035 (to J.B.). The authors declare no conflicts of interest.	Aven L, 2014, FASEB J, V28, P897, DOI 10.1096/fj.13-238212; Balzar S, 2011, AM J RESP CRIT CARE, V183, P299, DOI 10.1164/rccm.201002-0295OC; BERGER J, 1978, J TOXICOL ENV HEALTH, V4, P587, DOI 10.1080/15287397809529682; Boterman M, 2005, EUR J PHARMACOL, V516, P85, DOI 10.1016/j.ejphar.2005.04.029; Bradley SJ, 2016, P NATL ACAD SCI USA, V113, P4524, DOI 10.1073/pnas.1521706113; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Buehring B, 2013, J ALLERGY CLIN IMMUN, V132, P1019, DOI 10.1016/j.jaci.2013.08.040; Canning BJ, 2001, RESP PHYSIOL, V125, P113, DOI 10.1016/S0034-5687(00)00208-5; Carey SA, 2011, AM J PHYSIOL-LUNG C, V300, pL242, DOI 10.1152/ajplung.00177.2010; Chapman KR, 2008, EUR RESPIR J, V31, P320, DOI 10.1183/09031936.00039707; de Kleer IM, 2016, IMMUNITY, V45, P1285, DOI 10.1016/j.immuni.2016.10.031; Grainge CL, 2011, NEW ENGL J MED, V364, P2006, DOI 10.1056/NEJMoa1014350; Guilbert TW, 2006, NEW ENGL J MED, V354, P1985, DOI 10.1056/NEJMoa051378; Hunter DD, 2010, AM J RESP CELL MOL, V43, P750, DOI 10.1165/rcmb.2009-0191OC; Kajekar R, 2007, RESP PHYSIOL NEUROBI, V155, P55, DOI 10.1016/j.resp.2006.03.002; Kerstjens HAM, 2015, LANCET RESP MED, V3, P367, DOI 10.1016/S2213-2600(15)00031-4; Kerstjens HAM, 2011, J ALLERGY CLIN IMMUN, V128, P308, DOI 10.1016/j.jaci.2011.04.039; Kistemaker LEM, 2015, TRENDS PHARMACOL SCI, V36, P164, DOI 10.1016/j.tips.2014.11.005; Kistemaker LEM, 2014, AM J RESP CELL MOL, V50, P690, DOI 10.1165/rcmb.2013-0220OC; Kistemaker LEM, 2013, EUR RESPIR J, V42, P1677, DOI 10.1183/09031936.00112412; LARSEN GL, 1994, AM J PHYSIOL, V266, pL263, DOI 10.1152/ajplung.1994.266.3.L263; Maddox L, 2002, ANNU REV MED, V53, P477, DOI 10.1146/annurev.med.53.082901.103921; McGeachie MJ, 2016, NEW ENGL J MED, V374, P1842, DOI 10.1056/NEJMoa1513737; Morgan SJ, 2014, J BIOL CHEM, V289, P23065, DOI 10.1074/jbc.M114.557652; Oenema TA, 2012, AM J PHYSIOL-LUNG C, V303, pL589, DOI 10.1152/ajplung.00400.2011; Patel KR, 2016, MUCOSAL IMMUNOL, V9, P1466, DOI 10.1038/mi.2016.11; Pera T, 2014, CURR OPIN PHARMACOL, V16, P72, DOI 10.1016/j.coph.2014.03.005; Perez JF, 2005, J GEN PHYSIOL, V125, P535, DOI 10.1085/jgp.200409216; Perez JF, 2005, J GEN PHYSIOL, V125, P555, DOI 10.1085/jgp.200409217; Peters SP, 2010, NEW ENGL J MED, V363, P1715, DOI 10.1056/NEJMoa1008770; Ressmeyer AR, 2010, AM J RESP CELL MOL, V43, P179, DOI 10.1165/rcmb.2009-0222OC; Sanderson Michael J, 2008, Proc Am Thorac Soc, V5, P23, DOI 10.1513/pats.200704-050VS; Schleputz M, 2011, J APPL PHYSIOL, V110, P545, DOI 10.1152/japplphysiol.00409.2010; Scott GD, 2012, CHEM IMMUNOL ALLERGY, V98, P48, DOI 10.1159/000336498; Stern DA, 2008, LANCET, V372, P1058, DOI DOI 10.1016/S0140-6736(08)61447-6; Szczepankiewicz A, 2012, EUR RESPIR J, V39, P1035, DOI 10.1183/09031936.00136611; Thanawala VJ, 2013, AM J RESP CELL MOL, V48, P220, DOI 10.1165/rcmb.2012-0364OC; Tortorolo L, 2005, AM J RESP CRIT CARE, V172, P233, DOI 10.1164/rccm.200412-1693OC; Townley RG, 2010, EXPERT OPIN BIOL TH, V10, P1595, DOI 10.1517/14712598.2010.526103; Vogelberg C, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0175-9; WANG ZW, 1995, AM J RESP CRIT CARE, V151, P830; Wu ZX, 2009, ENVIRON HEALTH PERSP, V117, P1434, DOI 10.1289/ehp.0800511; Yost BL, 1999, J APPL PHYSIOL, V87, P1272, DOI 10.1152/jappl.1999.87.4.1272; Yu M, 2008, J ALLERGY CLIN IMMUN, V122, P640, DOI 10.1016/j.jaci.2008.04.038; Zhang WW, 2015, CAN J PHYSIOL PHARM, V93, P129, DOI 10.1139/cjpp-2014-0388	45	14	16	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4335	4346		10.1096/fj.201700186R	http://dx.doi.org/10.1096/fj.201700186R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28619712	Green Published			2022-12-28	WOS:000413397400013
J	Hennigar, SR; McClung, JP; Pasiakos, SM				Hennigar, Stephen R.; McClung, James P.; Pasiakos, Stefan M.			Nutritional interventions and the IL-6 response to exercise	FASEB JOURNAL			English	Review						adaptation; muscle; myokine; inflammation; hepcidin	VITAMIN-C SUPPLEMENTATION; HUMAN SKELETAL-MUSCLE; POLYUNSATURATED FATTY-ACIDS; PLACEBO-CONTROLLED TRIAL; CYTOKINE MESSENGER-RNA; CARBOHYDRATE INGESTION; PLASMA CYTOKINE; ECCENTRIC EXERCISE; IMMUNE-RESPONSES; IRON STATUS	IL-6 is a pleiotropic cytokine with a wide range of biologic effects. In response to prolonged exercise, IL-6 is synthesized by contracting skeletal muscle and released into circulation. Circulating IL-6 is thought to maintain energy status during exercise by acting as an energy sensor for contracting muscle and stimulating glucose production. If tissue damage occurs, immune cells infiltrate and secrete cytokines, including IL-6, to repair skeletal muscle damage. With adequate rest and nutrition, the IL-6 response to exercise is attenuated as skeletal muscle adapts to training. However, sustained elevations in IL-6 due to repeated bouts of unaccustomed activities or prolonged exercise with limited rest may result in untoward physiologic effects, such as accelerated muscle proteolysis and diminished nutrient absorption, and may impair normal adaptive responses to training. Recent intervention studies have explored the role of mixed meals or carbohydrate, protein, omega-3 fatty acid, or antioxidant supplementation in mitigating exercise-induced increases in IL-6. Emerging evidence suggests that sufficient energy intake before exercise is an important factor in attenuating exercise-induced IL-6 by maintaining muscle glycogen. We detail various nutritional interventions that may affect the IL-6 response to exercise in healthy human adults and provide recommendations for future research exploring the role of IL-6 in the adaptive response to exercise.	[Hennigar, Stephen R.; McClung, James P.; Pasiakos, Stefan M.] US Army Res Inst Environm Med, Mil Nutr Div, Natick, MA 01760 USA; [Hennigar, Stephen R.] Oak Ridge Inst Sci & Educ, Belcamp, MD USA	United States Department of Defense; United States Army; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education	Hennigar, SR (corresponding author), US Army Res Inst Environm Med, 10 Gen Greene Ave, Natick, MA 01760 USA.	stephen.r.hennigar.ctr@mail.mil	Pasiakos, Stefan M/E-6295-2014; McClung, James P/A-1989-2009	Pasiakos, Stefan M/0000-0002-5378-5820; 	U.S. Army Medical Research and Material Command; U.S. Department of Energy	U.S. Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); U.S. Department of Energy(United States Department of Energy (DOE))	The authors acknowledge A. M. Kelley for technical assistance and A. J. Young [both from the U.S. Army Research Institute of Environmental Medicine (USARIEM) and the Oak Ridge Institute for Science and Education] for reviewing the article. This article is approved for public release; distribution is unlimited. The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Army or the Department of Defense. Any citations or commercial organizations and trade names in this report do not constitute an official Department of the Army endorsement of approval of the products or services of these organizations. This work was supported, in part, by the U.S. Army Medical Research and Material Command and appointment to the USARIEM administered by the Oak Ridge Institute for Science and Education (to S.R.H.) through an interagency agreement between the U.S. Department of Energy and the U.S. Army Medical Research and Material Command.	Aguilo A, 2014, J SPORT SCI, V32, P1659, DOI 10.1080/02640414.2014.912759; Aydemir TB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048679; Badenhorst CE, 2015, EUR J APPL PHYSIOL, V115, P2215, DOI 10.1007/s00421-015-3202-0; Badenhorst CE, 2016, EUR J APPL PHYSIOL, V116, P1715, DOI 10.1007/s00421-016-3426-7; Badenhorst CE, 2015, EUR J APPL PHYSIOL, V115, P2521, DOI 10.1007/s00421-015-3252-3; Banzet S, 2012, CYTOKINE, V58, P158, DOI 10.1016/j.cyto.2012.01.006; Beavers KM, 2010, APPL PHYSIOL NUTR ME, V35, P261, DOI 10.1139/H10-015; Bishop NC, 2001, INT J SPORT NUTR EXE, V11, P503, DOI 10.1123/ijsnem.11.4.503; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Castell LM, 1997, EUR J APPL PHYSIOL O, V75, P47; Chan MHS, 2004, FASEB J, V18, P1785, DOI 10.1096/fj.03-1039fje; Chu A, 2017, SPORTS MED, V47, P127, DOI 10.1007/s40279-016-0567-0; Chu A, 2016, MED SCI SPORT EXER, V48, P726, DOI 10.1249/MSS.0000000000000805; Clarkson PM, 2002, AM J PHYS MED REHAB, V81, pS52, DOI [10.1097/00002060-200211001-00007, 10.1097/01.PHM.0000029772.45258.43]; Cox AJ, 2010, INT J SPORTS MED, V31, P207, DOI 10.1055/s-0029-1243645; Cox AJ, 2008, INT J SPORTS MED, V29, P1003, DOI 10.1055/s-2008-1038753; Davison G, 2005, INT J SPORT NUTR EXE, V15, P465, DOI 10.1123/ijsnem.15.5.465; DeCaterina R, 1996, LIPIDS, V31, pS57, DOI 10.1007/BF02637052; Diaz V, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12475; Dilorenzo FM, 2014, J STRENGTH COND RES, V28, P2768, DOI 10.1519/JSC.0000000000000617; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Febbraio MA, 2003, J PHYSIOL-LONDON, V549, P607, DOI 10.1113/jphysiol.2003.042374; Febbraio MA, 2002, FASEB J, V16, P1335, DOI 10.1096/fj.01-0876rev; Febbraio MA, 2004, DIABETES, V53, P1643, DOI 10.2337/diabetes.53.7.1643; Fernandes A, 2009, BLOOD, V114, P437, DOI 10.1182/blood-2008-03-146134; Fischer CP, 2006, EXERC IMMUNOL REV, V12, P6; Fischer CP, 2004, J PHYSIOL-LONDON, V558, P633, DOI 10.1113/jphysiol.2004.066779; Gaetke LM, 1997, AM J PHYSIOL-ENDOC M, V272, pE952, DOI 10.1152/ajpendo.1997.272.6.E952; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Hennigar SR, 2016, J NUTR, V146, P2167, DOI 10.3945/jn.116.237081; Hiscock N, 2003, J APPL PHYSIOL, V95, P145, DOI 10.1152/japplphysiol.00471.2002; Ihalainen JK, 2014, J STRENGTH COND RES, V28, P2786, DOI 10.1519/JSC.0000000000000470; Karl JP, 2010, AM J CLIN NUTR, V92, P93, DOI 10.3945/ajcn.2010.29185; Keller C, 2003, J PHYSIOL-LONDON, V550, P927, DOI 10.1113/jphysiol.2003.044883; Keller C, 2001, FASEB J, V15, P2748, DOI 10.1096/fj.01-0507fje; Kemna E, 2005, BLOOD, V106, P1864, DOI 10.1182/blood-2005-03-1159; Kerasioti E, 2013, FOOD CHEM TOXICOL, V61, P42, DOI 10.1016/j.fct.2013.01.023; Khalfoun B, 1997, ADV EXP MED BIOL, V400, P589; Lancaster GI, 2003, INT J SPORT NUTR EXE, V13, P436, DOI 10.1123/ijsnem.13.4.436; Lenn J, 2002, MED SCI SPORT EXER, V34, P1605, DOI 10.1097/00005768-200210000-00012; Li TL, 2005, EUR J APPL PHYSIOL, V95, P391, DOI 10.1007/s00421-005-0024-5; Liuzzi JP, 2005, P NATL ACAD SCI USA, V102, P6843, DOI 10.1073/pnas.0502257102; Lukaski HC, 2005, AM J CLIN NUTR, V81, P1045; Lyngso D, 2002, J PHYSIOL-LONDON, V543, P373, DOI 10.1113/jphysiol.2002.019380; MacDonald C, 2003, J APPL PHYSIOL, V95, P2273, DOI 10.1152/japplphysiol.00242.2003; Malaguti M, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/825928; Mastaloudis A, 2004, FREE RADICAL BIO MED, V36, P1329, DOI 10.1016/j.freeradbiomed.2004.02.069; McClung JP, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-141; McClung JP, 2009, BRIT J NUTR, V102, P605, DOI 10.1017/S0007114509220873; McClung JP, 2009, AM J CLIN NUTR, V90, P124, DOI 10.3945/ajcn.2009.27774; Meksawan K, 2004, J AM COLL NUTR, V23, P331, DOI 10.1080/07315724.2004.10719376; Miles MP, 2007, INT J SPORT NUTR EXE, V17, P507, DOI 10.1123/ijsnem.17.6.507; Munoz-Canoves P, 2013, FEBS J, V280, P4131, DOI 10.1111/febs.12338; Naclerio F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125188; Naclerio F, 2014, APPL PHYSIOL NUTR ME, V39, P1151, DOI 10.1139/apnm-2013-0556; Nakhostin-Roohi B, 2008, J SPORT MED PHYS FIT, V48, P217; NehlsenCannarella SL, 1997, J APPL PHYSIOL, V82, P1662, DOI 10.1152/jappl.1997.82.5.1662; Nelson AR, 2013, EUR J APPL PHYSIOL, V113, P2211, DOI 10.1007/s00421-013-2650-7; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nielsen HB, 1996, AM J PHYSIOL-REG I, V271, pR222, DOI 10.1152/ajpregu.1996.271.1.R222; Nieman David C, 2015, Front Nutr, V2, P27, DOI 10.3389/fnut.2015.00027; Nieman DC, 2009, INT J SPORT NUTR EXE, V19, P536, DOI 10.1123/ijsnem.19.5.536; Nieman DC, 2005, MED SCI SPORT EXER, V37, P1283, DOI 10.1249/01.mss.0000175054.99588.b1; Nieman DC, 2003, J APPL PHYSIOL, V94, P1917, DOI 10.1152/japplphysiol.01130.2002; Nieman DC, 2002, J APPL PHYSIOL, V92, P1970, DOI 10.1152/japplphysiol.00961.2001; Nieman DC, 1998, MED SCI SPORT EXER, V30, P671, DOI 10.1097/00005768-199805000-00005; Nieman DC, 2000, J INTERF CYTOK RES, V20, P1029, DOI 10.1089/10799900050198480; Nieman DC, 2004, J APPL PHYSIOL, V96, P1292, DOI 10.1152/japplphysiol.01064.2003; Nieman DC, 2001, J APPL PHYSIOL, V91, P109, DOI 10.1152/jappl.2001.91.1.109; Ostrowski K, 1998, J PHYSIOL-LONDON, V513, P889, DOI 10.1111/j.1469-7793.1998.889ba.x; Ostrowski K, 1999, J PHYSIOL-LONDON, V515, P287, DOI 10.1111/j.1469-7793.1999.287ad.x; Pal M, 2014, IMMUNOL CELL BIOL, V92, P331, DOI 10.1038/icb.2014.16; Pasiakos SM, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12820; Pedersen BK, 2000, PHYSIOL REV, V80, P1055, DOI 10.1152/physrev.2000.80.3.1055; Pedersen BK, 2001, J PHYSIOL-LONDON, V536, P329, DOI 10.1111/j.1469-7793.2001.0329c.xd; Peeling P, 2009, INT J SPORT NUTR EXE, V19, P583, DOI 10.1123/ijsnem.19.6.583; Penland JG, 2000, J NUTR, V130, p361S, DOI 10.1093/jn/130.2.361S; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Phillips T, 2003, MED SCI SPORT EXER, V35, P2032, DOI 10.1249/01.MSS.0000099112.32342.10; Preza GC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058934; Qiao B, 2012, CELL METAB, V15, P918, DOI 10.1016/j.cmet.2012.03.018; Robson-Ansley P, 2011, CYTOKINE, V53, P196, DOI 10.1016/j.cyto.2010.10.001; Rohde T, 1997, AM J PHYSIOL-ENDOC M, V273, pE85, DOI 10.1152/ajpendo.1997.273.1.E85; Ronsen O, 2002, J APPL PHYSIOL, V92, P2547, DOI 10.1152/japplphysiol.01263.2001; Rowlands DS, 2008, APPL PHYSIOL NUTR ME, V33, P39, DOI 10.1139/H07-136; Sandstead H. H., 2001, REPLETION ZINC IRON; Scharhag J, 2006, MED SCI SPORT EXER, V38, P286, DOI 10.1249/01.mss.0000191437.69493.d4; Schroer AB, 2014, INT J SPORT NUTR EXE, V24, P507, DOI 10.1123/ijsnem.2013-0173; Sim M, 2012, EUR J APPL PHYSIOL, V112, P1889, DOI 10.1007/s00421-011-2156-0; Starkie R, 2003, FASEB J, V17, P884, DOI 10.1096/fj.02-0670fje; Starkie RL, 2001, J PHYSIOL-LONDON, V533, P585, DOI 10.1111/j.1469-7793.2001.0585a.x; Starkie RL, 2000, J PHYSIOL-LONDON, V528, P647, DOI 10.1111/j.1469-7793.2000.t01-1-00647.x; Steensberg A, 2001, J PHYSIOL-LONDON, V537, P633, DOI 10.1111/j.1469-7793.2001.00633.x; Steensberg A, 2003, AM J PHYSIOL-ENDOC M, V285, pE433, DOI 10.1152/ajpendo.00074.2003; Tartibian B, 2011, CLIN J SPORT MED, V21, P131, DOI 10.1097/JSM.0b013e31820f8c2f; Thompson D, 2003, EUR J APPL PHYSIOL, V89, P393, DOI 10.1007/s00421-003-0816-4; Thompson D, 2001, INT J SPORT NUTR EXE, V11, P466, DOI 10.1123/ijsnem.11.4.466; Thompson D, 2004, EUR J APPL PHYSIOL, V92, P133, DOI 10.1007/s00421-004-1064-y; Timmons BW, 2004, PEDIATR RES, V56, P227, DOI 10.1203/01.PDR.0000132852.29770.C5; Toft AD, 2000, J APPL PHYSIOL, V89, P2401, DOI 10.1152/jappl.2000.89.6.2401; Tsigos C, 1997, J CLIN ENDOCR METAB, V82, P4167, DOI 10.1210/jc.82.12.4167; Vassilakopoulos T, 2003, J APPL PHYSIOL, V94, P1025, DOI 10.1152/japplphysiol.00735.2002; Yfanti C, 2012, J APPL PHYSIOL, V112, P990, DOI 10.1152/japplphysiol.01027.2010	103	74	76	0	31	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3719	3728		10.1096/fj.201700080R	http://dx.doi.org/10.1096/fj.201700080R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28507168				2022-12-28	WOS:000408713300003
J	Guilbert, SM; Lambert, H; Rodrigue, MA; Fuchs, M; Landry, J; Lavoie, JN				Guilbert, Solenn M.; Lambert, Herman; Rodrigue, Marc-Antoine; Fuchs, Margit; Landry, Jacques; Lavoie, Josee N.			HSPB8 and BAG3 cooperate to promote spatial sequestration of ubiquitinated proteins and coordinate the cellular adaptive response to proteasome insufficiency	FASEB JOURNAL			English	Article						molecular chaperones; proteotoxic stress; p62/SQSTM1; aggresome; small HSP	HEAT-SHOCK PROTEINS; TRANSCRIPTION FACTOR NRF2; MISFOLDED PROTEINS; MYOFIBRILLAR MYOPATHY; SELECTIVE AUTOPHAGY; AGGRESOME FORMATION; KEAP1-NRF2 PATHWAY; CHAPERONE ACTIVITY; OXIDATIVE STRESS; QUALITY-CONTROL	BCL2-associated athanogene (BAG)-3 is viewed as a platform that would physically and functionally link distinct classes of molecular chaperones of the heat shock protein (HSP) family for the stabilization and clearance of damaged proteins. In this study, we show that HSPB8, a member of the small heat shock protein subfamily, cooperates with BAG3 to coordinate the sequestration of harmful proteins and the cellular adaptive response upon proteasome inhibition. Silencing of HSPB8, like depletion of BAG3, inhibited targeting of ubiquitinated proteins to the juxtanuclear aggresome, a mammalian system of spatial quality control. However, aggresome targeting was restored in BAG3-depleted cells by a mutant BAG3 defective in HSPB8 binding, uncoupling HSPB8 function from its binding to BAG3. Depletion of HSPB8 impaired formation of ubiquitinated microaggregates in an early phase and interfered with accurate modifications of the stress sensor p62/sequestosome (SQSTM)-1. This impairment correlated with decreased coupling of BAG3 to p62/SQSTM1 in response to stress, hindering Kelch-like ECH-associated protein (KEAP)-1 sequestration and stabilization of nuclear factor E2-related factor (Nrf)-2, an important arm of the antioxidant defense. Notably, the myopathy-associated mutation of BAG3 (P209L), which lies within the HSPB8-binding motif, deregulated the association between BAG3 and p62/SQSTM1 and the KEAP1-Nrf2 signaling axis. Together, our findings support a so-far-unrecognized role for the HSPB8-BAG3 connection in mounting of an efficient stress response, which may be involved in BAG3-related human diseases. -Guilbert, S. M., Lambert, H., Rodrigue, M.-A., Fuchs, M., Landry, J., Lavoie, J. N. HSPB8 and BAG3 cooperate to promote spatial sequestration of ubiquitinated proteins and coordinate the cellular adaptive response to proteasome insufficiency.	[Guilbert, Solenn M.; Lambert, Herman; Rodrigue, Marc-Antoine; Fuchs, Margit; Landry, Jacques; Lavoie, Josee N.] Univ Laval, Ctr Rech Canc, Quebec City, PQ, Canada; [Guilbert, Solenn M.; Lambert, Herman; Rodrigue, Marc-Antoine; Fuchs, Margit; Landry, Jacques; Lavoie, Josee N.] Univ Laval, Ctr Rech, CHU Quebec, Oncol, Quebec City, PQ, Canada; [Landry, Jacques; Lavoie, Josee N.] Univ Laval, Dept Biol Mol Biochim Med & Pathol, Quebec City, PQ, Canada	Laval University; Laval University; Laval University	Lavoie, JN (corresponding author), Univ Laval, St Patrick Local 3724-1,9 Rue McMahon, Quebec City, PQ G1R 3S3, Canada.	josee.lavoie@crchudequebec.ulaval.ca		Lavoie, Josee N/0000-0001-6912-1132	Canadian Institutes of Health Research Grant [7088]; Bellini Foundation; Fondazione Roby [PT67892]	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Bellini Foundation; Fondazione Roby	The authors thank Dr. Arshad Desai (Ludwig Institute for Cancer Research, University of California, San Diego, San Diego, CA, USA) for contributing Flp-In-TREx HeLa cells; Dr. Sabine Elowe (Centre Hospitalier de l'Universite Laval,) for HeLa-RFP-H2B cells; Carl St-Pierre and Anne Loranger (Centre de Recherche sur le Cancer de l'Universite Laval) for assistance in microscopic analyses; and Dr. Ronald Hancock for editing the manuscript. This work was supported by Canadian Institutes of Health Research Grant 7088 to J.N.L. and J.L., and by a grant from the Bellini Foundation and Fondazione Roby (subaward to J.N.L.; PT67892). The authors declare no conflicts of interest.	Arndt V, 2010, CURR BIOL, V20, P143, DOI 10.1016/j.cub.2009.11.022; Bakthisaran R, 2015, BBA-PROTEINS PROTEOM, V1854, P291, DOI 10.1016/j.bbapap.2014.12.019; Behl C, 2016, TRENDS PHARMACOL SCI, V37, P672, DOI 10.1016/j.tips.2016.04.007; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Carra S, 2008, J BIOL CHEM, V283, P1437, DOI 10.1074/jbc.M706304200; Ciuffa R, 2015, CELL REP, V11, P748, DOI 10.1016/j.celrep.2015.03.062; Crippa V, 2016, HUM MOL GENET, V25, P3908, DOI 10.1093/hmg/ddw232; Crippa V, 2016, SCI REP-UK, V6, DOI 10.1038/srep22827; Crippa V, 2010, HUM MOL GENET, V19, P3440, DOI 10.1093/hmg/ddq257; Escusa-Toret S, 2013, NAT CELL BIOL, V15, P1231, DOI 10.1038/ncb2838; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; Fuchs M., 2016, JOVE-J VIS EXP; Fuchs M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005582; Fuchs M, 2010, BIOCHEM J, V425, P245, DOI 10.1042/BJ20090907; Fujita KI, 2011, P NATL ACAD SCI USA, V108, P1427, DOI 10.1073/pnas.1014156108; Fuse Y, 2017, MOLECULES, V22, DOI 10.3390/molecules22030436; Gallina I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7533; Gamerdinger M, 2011, EMBO REP, V12, P149, DOI 10.1038/embor.2010.203; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Ganassi M, 2016, MOL CELL, V63, P796, DOI 10.1016/j.molcel.2016.07.021; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Guilbert S.M., 2015, BIG BOOK SMALL HEAT; Haslbeck M, 2015, J MOL BIOL, V427, P1537, DOI 10.1016/j.jmb.2015.02.002; Hill SM, 2017, EMBO REP, V18, P377, DOI 10.15252/embr.201643458; Horie M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144835; Houslay MD, 2010, AUTOPHAGY, V6, P1198, DOI 10.4161/auto.6.8.13479; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; Itakura E, 2011, J CELL BIOL, V192, P17, DOI 10.1083/jcb.201009067; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; JONES HW, 1971, OBSTET GYNECOL, V38, P945; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kathage B, 2017, BBA-MOL CELL RES, V1864, P62, DOI 10.1016/j.bbamcr.2016.10.007; Katsuragi Y, 2015, FEBS J, V282, P4672, DOI 10.1111/febs.13540; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kim HG, 2016, NUCL ENG TECHNOL, V48, P1, DOI 10.1016/j.net.2015.11.011; Kim MV, 2004, BIOCHEM BIOPH RES CO, V315, P796, DOI 10.1016/j.bbrc.2004.01.130; Klebig C, 2009, J CELL BIOL, V185, P841, DOI 10.1083/jcb.200902128; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Konersman CG, 2015, NEUROMUSCULAR DISORD, V25, P418, DOI 10.1016/j.nmd.2015.01.009; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Lee HC, 2012, CLIN GENET, V81, P394, DOI 10.1111/j.1399-0004.2011.01659.x; Lee Y, 2017, CELL REP, V20, P1994, DOI 10.1016/j.celrep.2017.08.019; Lelouard H, 2004, J CELL BIOL, V164, P667, DOI 10.1083/jcb.200312073; Liu XD, 2012, J BIOL CHEM, V287, P19687, DOI 10.1074/jbc.M112.350934; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; Merabova N, 2015, J CELL PHYSIOL, V230, P831, DOI 10.1002/jcp.24811; Miller SBM, 2015, EMBO J, V34, P778, DOI 10.15252/embj.201489524; Minoia M, 2014, AUTOPHAGY, V10, P1603, DOI 10.4161/auto.29409; Moscat J, 2012, TRENDS BIOCHEM SCI, V37, P230, DOI 10.1016/j.tibs.2012.02.008; Mymrikov EV, 2017, J BIOL CHEM, V292, P672, DOI 10.1074/jbc.M116.760413; Mymrikov EV, 2012, CELL STRESS CHAPERON, V17, P157, DOI 10.1007/s12192-011-0296-0; Naidu SD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11262-5; Odgerel Z, 2010, NEUROMUSCULAR DISORD, V20, P438, DOI 10.1016/j.nmd.2010.05.004; Rantanen K, 2013, J CELL SCI, V126, P1144, DOI 10.1242/jcs.115667; Ravikumar B, 2005, NAT GENET, V37, P771, DOI 10.1038/ng1591; Ruparelia AA, 2014, ACTA NEUROPATHOL, V128, P821, DOI 10.1007/s00401-014-1344-5; Rusmini P, 2013, NEUROBIOL AGING, V34, P2585, DOI 10.1016/j.neurobiolaging.2013.05.026; Sala AJ, 2017, J CELL BIOL, V216, P1231, DOI 10.1083/jcb.201612111; Samarasinghe B, 2014, BIOCHEM PHARMACOL, V87, P445, DOI 10.1016/j.bcp.2013.11.014; Scior A, 2016, ESSAYS BIOCHEM, V60, P153, DOI 10.1042/EBC20160002; Selcen D, 2009, ANN NEUROL, V65, P83, DOI 10.1002/ana.21553; Specht S, 2011, J CELL BIOL, V195, P617, DOI 10.1083/jcb.201106037; Su HB, 2011, TRENDS CARDIOVAS MED, V21, P224, DOI 10.1016/j.tcm.2012.05.015; Taguchi K, 2012, P NATL ACAD SCI USA, V109, P13561, DOI 10.1073/pnas.1121572109; Taniguchi K, 2016, FEBS LETT, V590, P2375, DOI 10.1002/1873-3468.12301; Ulbricht A, 2013, AUTOPHAGY, V9, P920, DOI 10.4161/auto.24213; Ulbricht A, 2013, CURR BIOL, V23, P430, DOI 10.1016/j.cub.2013.01.064; Ungelenk S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13673; Varlet AA, 2017, CELL STRESS CHAPERON, V22, P553, DOI 10.1007/s12192-017-0780-2; Wallace EWJ, 2015, CELL, V162, P1286, DOI 10.1016/j.cell.2015.08.041; Watanabe Y, 2017, AUTOPHAGY, V13, P133, DOI 10.1080/15548627.2016.1248018; Wigley WC, 1999, J CELL BIOL, V145, P481; Wolff S, 2014, CELL, V157, P52, DOI 10.1016/j.cell.2014.03.007; Xu Z, 2013, J CELL SCI, V126, P4173, DOI 10.1242/jcs.126102; Yang XD, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00402; Zhang XQ, 2011, MOL BIOL CELL, V22, P3277, DOI 10.1091/mbc.E11-05-0388	81	36	36	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3518	3535		10.1096/fj.201700558RR	http://dx.doi.org/10.1096/fj.201700558RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29405094				2022-12-28	WOS:000435104500004
J	Kim, SM; Neuendorff, N; Alaniz, RC; Sun, YX; Chapkin, RS; Earnest, DJ				Kim, Sam-Moon; Neuendorff, Nichole; Alaniz, Robert C.; Sun, Yuxiang; Chapkin, Robert S.; Earnest, David J.			Shift work cycle-induced alterations of circadian rhythms potentiate the effects of high-fat diet on inflammation and metabolism	FASEB JOURNAL			English	Article						macrophage; clock gene; cytokines; metabolic disorders; insulin resistance	RECEPTOR-GAMMA ACTIVATION; CHRONIC JET-LAG; REV-ERB-ALPHA; INSULIN-RESISTANCE; ADIPOSE-TISSUE; INDUCIBLE 6-PHOSPHOFRUCTO-2-KINASE; OBESITY; CLOCK; MICE; MACROPHAGES	Based on genetic models with mutation or deletion of core clock genes, circadian disruption has been implicated in the pathophysiology of metabolic disorders. Thus, we examined whether circadian desynchronization in response to shift work-type schedules is sufficient to compromise metabolic homeostasis and whether inflammatory mediators provide a key link in the mechanism by which alterations of circadian timekeeping contribute to diet-induced metabolic dysregulation. In high-fat diet (HFD)-fed mice, exposure to chronic shifts of the light-dark cycle (12 h advance every 5 d): 1) disrupts photoentrainment of circadian behavior and modulates the period of spleen and macrophage clock gene rhythms; 2) potentiates HFD-induced adipose tissue infiltration and activation of proinflammatory M1 macrophages; 3) amplifies macrophage proinflammatory cytokine expression in adipose tissue and bone marrow-derived macrophages; and 4) exacerbates diet-induced increases in body weight, insulin resistance, and glucose intolerance in the absence of changes in total daily food intake. Thus, complete disruption of circadian rhythmicity or clock gene function as transcription factors is not requisite to the link between circadian and metabolic phenotypes. These findings suggest that macrophage proinflammatory activation and inflammatory signaling are key processes in the physiologic cascade by which dysregulation of circadian rhythmicity exacerbates diet-induced systemic insulin resistance and glucose intolerance.				r-chapkin@tamu.edu; dearnest@medicine.tamhsc.edu		Chapkin, Robert/0000-0002-6515-3898; Earnest, David/0000-0003-4433-6481	Center for Translational Environmental Health Research [P30ES02351]; U.S. National Institutes of Health, National Cancer Institute Outstanding Investigator Award [R35CA197707]; NATIONAL CANCER INSTITUTE [R35CA197707] Funding Source: NIH RePORTER	Center for Translational Environmental Health Research; U.S. National Institutes of Health, National Cancer Institute Outstanding Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Yang-Yi Fan (Texas A&M University) for her assistance with the FACS analysis. This study was supported by the Center for Translational Environmental Health Research (P30ES02351) and U.S. National Institutes of Health, National Cancer Institute Outstanding Investigator Award R35CA197707 (to R.S.C.). The authors declare no conflicts of interest.	Arble DM, 2009, OBESITY, V17, P2100, DOI 10.1038/oby.2009.264; Bozek K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004882; Castanon-Cervantes O, 2010, J IMMUNOL, V185, P5796, DOI 10.4049/jimmunol.1001026; Curtis AM, 2014, IMMUNITY, V40, P178, DOI 10.1016/j.immuni.2014.02.002; Dallmann R, 2012, P NATL ACAD SCI USA, V109, P2625, DOI 10.1073/pnas.1114410109; Earnest DJ, 2016, ENDOCRINOLOGY, V157, P2836, DOI 10.1210/en.2016-1130; Farnell YF, 2011, EUR J NEUROSCI, V33, P1533, DOI 10.1111/j.1460-9568.2011.07629.x; FATOUROS M, 1995, BRIT J SURG, V82, P1675, DOI 10.1002/bjs.1800821230; Filipski E, 2004, CANCER RES, V64, P7879, DOI 10.1158/0008-5472.CAN-04-0674; Fontaine C, 2008, MOL ENDOCRINOL, V22, P1797, DOI 10.1210/me.2007-0439; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Guo X, 2010, J BIOL CHEM, V285, P23711, DOI 10.1074/jbc.M110.123174; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Huo YQ, 2010, J BIOL CHEM, V285, P3713, DOI 10.1074/jbc.M109.058446; Iwamoto A, 2014, CHRONOBIOL INT, V31, P189, DOI 10.3109/07420528.2013.837478; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Lange T, 2010, ANN NY ACAD SCI, V1193, P48, DOI 10.1111/j.1749-6632.2009.05300.x; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Nguyen KD, 2013, SCIENCE, V341, P1483, DOI 10.1126/science.1240636; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Oike H, 2015, BIOCHEM BIOPH RES CO, V465, P556, DOI 10.1016/j.bbrc.2015.08.059; Paschos GK, 2012, NAT MED, V18, P1768, DOI 10.1038/nm.2979; Prieur X, 2011, DIABETES, V60, P797, DOI 10.2337/db10-0705; Reddy AB, 2002, J NEUROSCI, V22, P7326; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Silver AC, 2012, IMMUNITY, V36, P251, DOI 10.1016/j.immuni.2011.12.017; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Spengler ML, 2012, P NATL ACAD SCI USA, V109, pE2457, DOI 10.1073/pnas.1206274109; Stienstra R, 2008, J BIOL CHEM, V283, P22620, DOI 10.1074/jbc.M710314200; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Xu H, 2014, J BIOL CHEM, V289, P16374, DOI 10.1074/jbc.M113.539601; Yan L, 2011, NEUROSCIENCE, V183, P99, DOI 10.1016/j.neuroscience.2011.03.041; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	39	39	41	5	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3085	3095		10.1096/fj.201700784R	http://dx.doi.org/10.1096/fj.201700784R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29405095	Green Published			2022-12-28	WOS:000432546000016
J	Yang, H; Yue, HW; He, WT; Hong, JY; Jiang, LL; Hu, HY				Yang, Hui; Yue, Hong-Wei; He, Wen-Tian; Hong, Jun-Ye; Jiang, Lei-Lei; Hu, Hong-Yu			PolyQ-expanded huntingtin and ataxin-3 sequester ubiquitin adaptors hHR23B and UBQLN2 into aggregates via conjugated ubiquitin	FASEB JOURNAL			English	Article						neurodegeneration; inclusions; interaction; pathologic mechanism	PROTEIN-QUALITY CONTROL; GROUP-C PROTEIN; POLYGLUTAMINE DISEASE; ALPHA-SYNUCLEIN; NEURODEGENERATIVE DISEASES; PARKINSONS-DISEASE; NUCLEAR INCLUSIONS; NUCLEOCYTOPLASMIC TRANSPORT; DEUBIQUITINATING FUNCTION; CYTOPLASMIC INCLUSIONS	The components of ubiquitin (Ub)-proteasome system, such as Ub, Ub adaptors, or proteasome subunits, are commonly accumulated with the aggregated proteins in inclusions, but how protein aggregates sequester Ub-related proteins remains elusive. Using N-terminal huntingtin (Htt-N552) and ataxin (Atx)-3 as model proteins, we investigated the molecular mechanism underlying sequestration of Ub adaptors by polyQ-expanded proteins. We found that polyQ-expanded Htt-N552 and Atx-3 sequester endogenous Ub adaptors, human RAD23 homolog B (hHR23B) and ubiquilin (UBQLN)-2, into inclusions. This sequestration effect is dependent on the UBA domains of Ub adaptors and the conjugated Ub of the aggregated proteins. Moreover, polyQ-expanded Htt-N552 and Atx-3 reduce the protein level of xeroderma pigmentosum group C (XPC) by sequestration of hHR23B, suggesting that this process may cut down the available quantity of hHR23B and thus affect its normal function in stabilizing XPC. Our findings demonstrate that polyQ-expanded proteins sequester Ub adaptors or other Ub-related proteins into aggregates or inclusions through ubiquitination of the pathogenic proteins. This study may also provide a common mechanism for the formation of Ub-positive inclusions in cells.-Yang, H., Yue, H.-W., He, W.-T., Hong, J.-Y., Jiang, L.-L., Hu, H.-Y. PolyQ-expanded huntingtin and ataxin-3 sequester ubiquitin adaptors hHR23B and UBQLN2 into aggregates via conjugated ubiquitin.	[Yang, Hui; Yue, Hong-Wei; He, Wen-Tian; Hong, Jun-Ye; Jiang, Lei-Lei; Hu, Hong-Yu] Univ CAS, State Key Lab Mol Biol, CAS, Ctr Excellence Mol Cell Sci,SIBCB, Shanghai, Peoples R China; [Yang, Hui] Fudan Univ, Collaborat Innovat Ctr Genet & Dev, Sch Life Sci, State Key Lab Genet Engn, Shanghai, Peoples R China	Chinese Academy of Sciences; Fudan University	Hu, HY (corresponding author), Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Mol Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	hyhu@sibcb.ac.cn	Hu, Hong-Yu/AAQ-2633-2020		National Basic Research Program of China [2012CB911003]; National Natural Science Foundation of China [31470758, 31670782]; China Postdoctoral Science Foundation [Y649S21022]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The authors thank Drs. J. Y. Chen and R. G. Hu (State Key Laboratory of Molecular Biology, Chinese Academy of Sciences) for technical help and valuable discussion. This work was supported by National Basic Research Program of China Grant 2012CB911003 (to H.-Y.H), National Natural Science Foundation of China Grants 31470758 (to H.-Y.H) and 31670782 (to H.-Y.H), and China Postdoctoral Science Foundation Grant Y649S21022 (to H.Y). The authors declare no conflicts of interest.	Adegbuyiro A, 2017, BIOCHEMISTRY-US, V56, P1199, DOI 10.1021/acs.biochem.6b00936; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Bergink S, 2006, NEUROBIOL DIS, V23, P708, DOI 10.1016/j.nbd.2006.06.005; Blount JR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5638; Chai YH, 2002, P NATL ACAD SCI USA, V99, P9310, DOI 10.1073/pnas.152101299; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; Chang YG, 2006, PROTEIN SCI, V15, P1248, DOI 10.1110/ps.051995006; Che MX, 2015, FEBS LETT, V589, P1920, DOI 10.1016/j.febslet.2015.06.009; Choi YJ, 2012, MOL CELL NEUROSCI, V49, P127, DOI 10.1016/j.mcn.2011.11.003; Dantuma NP, 2009, DNA REPAIR, V8, P449, DOI 10.1016/j.dnarep.2009.01.005; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Donaldson KM, 2003, P NATL ACAD SCI USA, V100, P8892, DOI 10.1073/pnas.1530212100; Dugger BN, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028035; Evers MM, 2014, MOL NEUROBIOL, V49, P1513, DOI 10.1007/s12035-013-8596-2; Fujita K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2828; Haacke A, 2006, HUM MOL GENET, V15, P555, DOI 10.1093/hmg/ddi472; Hjerpe R, 2016, CELL, V166, P935, DOI 10.1016/j.cell.2016.07.001; Hsu TC, 2014, HUM MOL GENET, V23, P6878, DOI 10.1093/hmg/ddu410; Janer A, 2010, HUM MOL GENET, V19, P181, DOI 10.1093/hmg/ddp478; Jiang YJ, 2011, J BIOL CHEM, V286, P25236, DOI 10.1074/jbc.M110.216333; Kumar V, 2016, EUR J MED CHEM, V124, P1105, DOI 10.1016/j.ejmech.2016.07.054; Kuusisto E, 2003, J NEUROPATH EXP NEUR, V62, P1241, DOI 10.1093/jnen/62.12.1241; Kuusisto E, 2001, NEUROREPORT, V12, P2085, DOI 10.1097/00001756-200107200-00009; KUZUHARA S, 1988, ACTA NEUROPATHOL, V75, P345, DOI 10.1007/BF00687787; LENNOX G, 1988, NEUROSCI LETT, V94, P211, DOI 10.1016/0304-3940(88)90297-2; Lindersson E, 2004, J BIOL CHEM, V279, P12924, DOI 10.1074/jbc.M306390200; LOWE J, 1988, J PATHOL, V155, P9, DOI 10.1002/path.1711550105; Mao Y, 2005, P NATL ACAD SCI USA, V102, P12700, DOI 10.1073/pnas.0506344102; Matos CA, 2017, CURR PHARM DESIGN, V23, P753, DOI [10.2174/1381612822666161227, 10.2174/1381612822666161227121912]; McClellan AJ, 2005, NAT CELL BIOL, V7, P736, DOI 10.1038/ncb0805-736; McNaught KSP, 2001, NEUROSCI LETT, V297, P191, DOI 10.1016/S0304-3940(00)01701-8; Meyer H, 2014, J CELL SCI, V127, P3877, DOI 10.1242/jcs.093831; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Mori F, 2012, ACTA NEUROPATHOL, V124, P149, DOI 10.1007/s00401-012-0999-z; Nath SR, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00078; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Ng JMY, 2003, GENE DEV, V17, P1630, DOI 10.1101/gad.260003; Nicastro G, 2005, P NATL ACAD SCI USA, V102, P10493, DOI 10.1073/pnas.0501732102; Ochaba J, 2014, P NATL ACAD SCI USA, V111, P16889, DOI 10.1073/pnas.1420103111; Oh S, 2005, MECH AGEING DEV, V126, P1292, DOI 10.1016/j.mad.2005.07.006; Okuda Y, 2004, DNA REPAIR, V3, P1285, DOI 10.1016/j.dnarep.2004.06.010; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; Pratt WB, 2015, ANNU REV PHARMACOL, V55, P353, DOI 10.1146/annurev-pharmtox-010814-124332; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Rui YN, 2015, NAT CELL BIOL, V17, P262, DOI 10.1038/ncb3101; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Suhr ST, 2001, J CELL BIOL, V153, P283, DOI 10.1083/jcb.153.2.283; Tai HC, 2012, AM J PATHOL, V181, P1426, DOI 10.1016/j.ajpath.2012.06.033; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Teyssou E, 2017, NEUROBIOL AGING, V58, DOI 10.1016/j.neurobiolaging.2017.06.018; Todi SV, 2010, J BIOL CHEM, V285, P39303, DOI 10.1074/jbc.M110.181610; Tofaris GK, 2011, P NATL ACAD SCI USA, V108, P17004, DOI 10.1073/pnas.1109356108; Tsou WL, 2013, J BIOL CHEM, V288, P34460, DOI 10.1074/jbc.M113.513903; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Woerner AC, 2016, SCIENCE, V351, P173, DOI 10.1126/science.aad2033; YANG H, 2014, SCI REP UK, V4; Yang H, 2016, FEBS J, V283, P3705, DOI 10.1111/febs.13722; Yang H, 2015, J BIOL CHEM, V290, P21996, DOI 10.1074/jbc.M114.631663; Yokoi M, 2017, GENE, V597, P1, DOI 10.1016/j.gene.2016.10.027; Yu A, 2014, P NATL ACAD SCI USA, V111, pE1481, DOI 10.1073/pnas.1321811111; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zeng L, 2015, NEUROBIOL DIS, V82, P281, DOI 10.1016/j.nbd.2015.06.017; Zhang YJ, 2016, NAT NEUROSCI, V19, P668, DOI 10.1038/nn.4272; Zheng QY, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00303; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	66	19	19	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					2923	2933		10.1096/fj.201700801RR	http://dx.doi.org/10.1096/fj.201700801RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401586				2022-12-28	WOS:000432546000004
J	Keeley, TP; Siow, RCM; Jacob, R; Mann, GE				Keeley, Thomas P.; Siow, Richard C. M.; Jacob, Ron; Mann, Giovanni E.			Reduced SERCA activity underlies dysregulation of Ca(2)(+ )homeostasis under atmospheric O-2 levels	FASEB JOURNAL			English	Article						Ca2+ signaling; physiological normoxia; oxygen; mitochondria; Ca2+ overload	NITRIC-OXIDE PRODUCTION; ENDOTHELIAL-CELLS; PROTEIN-KINASE; RETICULUM CA2+-ATPASE; ENDOPLASMIC-RETICULUM; CA2+ CONCENTRATION; CALCIUM; MECHANISM; ISOFORM; CULTURE	Unregulated increases in cellular Ca(2+)homeostasis are a hallmark of pathophysiological conditions and a key trigger of cell death. Endothelial cells cultured under physiologic O-2 conditions (5% O-2) exhibit a reduced cytosolic Ca(2+)response to stimulation. The mechanism for reduced plateau [Ca2+](i) upon stimulation was due to increased sarco/endoplasmic reticulum Ca(2+)ATPase (SERCA)-mediated reuptake rather than changes in Ca(2+)influx capacity. Agonist-stimulated phosphorylation of the SERCA regulatory protein phospholamban was increased in cells cultured under 5% O-2. Elevation of cytosolic and mitochondrial [Ca2+] and cell death after prolonged ionomycin treatment, as a model of Ca(2+)overload, were lower when cells were cultured long-term under 5% compared with 18% O-2. This protection was abolished by cotreatment with the SERCA inhibitor cyclopiazonic acid. Taken together, these results demonstrate that culturing cells under hyperoxic conditions reduces their ability to efficiently regulate [Ca2+](i), resulting in greater sensitivity to cytotoxic stimuli.	[Keeley, Thomas P.; Siow, Richard C. M.; Jacob, Ron; Mann, Giovanni E.] Kings Coll London, Fac Life Sci & Med, Sch Cardiovasc Med & Sci, Kings British Heart Fdn,Ctr Res Excellence, London, England	University of London; King's College London	Mann, GE (corresponding author), Kings Coll London, 150 Stamford St,Franklin Wilkins Bldg,Room 3-01, London SE1 9NH, England.	giovanni.mann@kcl.ac.uk		Keeley, Thomas/0000-0002-0334-7144; Mann, Giovanni/0000-0001-7311-2044	British Heart Foundation [FS/13/66/30445]; Heart Research UK [RG2633]	British Heart Foundation(British Heart Foundation); Heart Research UK	The authors thank Kalwant Authi (King's College London) for helpful discussions and SERCA2 and SERCA3 antibodies, and the midwives of St. Thomas' Hospital (London, United Kingdom) for collecting umbilical cords. This study was supported by British Heart Foundation Grant FS/13/66/30445 and Heart Research UK Grant RG2633. The authors declare no conflicts of interest.	Abaci HE, 2014, SCI REP-UK, V4, DOI 10.1038/srep04951; Aley PK, 2005, J BIOL CHEM, V280, P13349, DOI 10.1074/jbc.M413674200; ANGER M, 1993, FEBS LETT, V334, P45, DOI 10.1016/0014-5793(93)81677-R; Atkuri KR, 2005, P NATL ACAD SCI USA, V102, P3756, DOI 10.1073/pnas.0409910102; Berna N, 2002, J CELL BIOCHEM, V84, P115, DOI 10.1002/jcb.1271; Bhosale G, 2015, ANN NY ACAD SCI, V1350, P107, DOI 10.1111/nyas.12885; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Brocard JB, 2001, J PHYSIOL-LONDON, V531, P793, DOI 10.1111/j.1469-7793.2001.0793h.x; Camello P, 1996, J PHYSIOL-LONDON, V490, P585, DOI 10.1113/jphysiol.1996.sp021169; Chami M, 2000, ONCOGENE, V19, P2877, DOI 10.1038/sj.onc.1203605; Chandrasekera PC, 2009, AM J PHYSIOL-CELL PH, V296, pC1105, DOI 10.1152/ajpcell.00650.2008; Chapple SJ, 2016, FREE RADICAL BIO MED, V92, P152, DOI 10.1016/j.freeradbiomed.2015.12.013; CHOI DW, 1985, NEUROSCI LETT, V58, P293, DOI 10.1016/0304-3940(85)90069-2; Cohen RA, 1999, CIRC RES, V84, P210, DOI 10.1161/01.RES.84.2.210; CORNWELL TL, 1991, MOL PHARMACOL, V40, P923; El Alami M, 2014, STEM CELL REP, V3, P566, DOI 10.1016/j.stemcr.2014.08.002; Ferdek PE, 2012, CURR BIOL, V22, P1241, DOI 10.1016/j.cub.2012.05.002; Haas B, 2015, J CELL PHYSIOL, V230, P1128, DOI 10.1002/jcp.24844; Halliwell B, 2003, FEBS LETT, V540, P3, DOI 10.1016/S0014-5793(03)00235-7; Herscher CJ, 1997, ANN NY ACAD SCI, V834, P407, DOI 10.1111/j.1749-6632.1997.tb52284.x; Kanatous SB, 2009, AM J PHYSIOL-CELL PH, V296, pC393, DOI 10.1152/ajpcell.00428.2008; Keeley TP, 2017, FASEB J, V31, P5172, DOI 10.1096/fj.201700211R; Khan I, 2000, MOL CELL BIOCHEM, V203, P11, DOI 10.1023/A:1007093516593; Lantoine F, 1998, BIOCHEM J, V330, P695, DOI 10.1042/bj3300695; Lim WS, 2008, CIRCULATION, V117, P940, DOI 10.1161/CIRCULATIONAHA.107.711275; Morgan AJ, 1998, J PHYSIOL-LONDON, V513, P83, DOI 10.1111/j.1469-7793.1998.083by.x; MORGAN AJ, 1994, BIOCHEM J, V300, P665, DOI 10.1042/bj3000665; Mountian I, 1999, CELL CALCIUM, V25, P371, DOI 10.1054/ceca.1999.0034; Periasamy M, 2007, MUSCLE NERVE, V35, P430, DOI 10.1002/mus.20745; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; Sahai A, 1997, AM J PHYSIOL-RENAL, V273, pF954, DOI 10.1152/ajprenal.1997.273.6.F954; Schneider H, 2015, HYPERTENSION, V66, P108, DOI 10.1161/HYPERTENSIONAHA.115.05514; Scotcher J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13187; Steinert JR, 2002, FASEB J, V16, P721, DOI 10.1096/fj.01-0916fje; Stout AK, 1998, NAT NEUROSCI, V1, P366, DOI 10.1038/1577; Sutliff RL, 1999, CIRC RES, V84, P360, DOI 10.1161/01.RES.84.3.360; TEPIKIN AV, 1992, J BIOL CHEM, V267, P3569; Ward JPT, 2008, BBA-BIOENERGETICS, V1777, P1, DOI 10.1016/j.bbabio.2007.10.010; WEIR EK, 1995, FASEB J, V9, P183, DOI 10.1096/fasebj.9.2.7781921; White R, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-27; Zhu J, 2012, J NEUROSCI RES, V90, P422, DOI 10.1002/jnr.22765	42	6	6	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2531	2538		10.1096/fj.201700685RRR	http://dx.doi.org/10.1096/fj.201700685RRR			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29273673	Green Published			2022-12-28	WOS:000432528000018
J	Jiang, L; Su, HR; Keogh, JM; Chen, Z; Henning, E; Wilkinson, P; Goodyer, I; Farooqi, IS; Rui, LY				Jiang, Lin; Su, Haoran; Keogh, Julia M.; Chen, Zheng; Henning, Elana; Wilkinson, Paul; Goodyer, Ian; Farooqi, I. Sadaf; Rui, Liangyou			Neural deletion of Sh2b1 results in brain growth retardation and reactive aggression	FASEB JOURNAL			English	Article						aggression circuits; brain development; BDNF	NEUROTROPHIC FACTOR; ENERGY-BALANCE; GLUCOSE-METABOLISM; BODY-WEIGHT; MICE; OBESITY; IDENTIFICATION; DIFFERENTIATION; MECHANISMS; BEHAVIORS	Psychiatric disorders are associated with aberrant brain development and/or aggressive behavior and are influenced by genetic factors; however, genes that affect brain aggression circuits remain elusive. Here, we show that neuronal Src-homology-2 (SH2)B adaptor protein-1 (Sh2b1) is indispensable for both brain growth and protection against aggression. Global and brain-specific deletion of Sh2b1 decreased brain weight and increased aggressive behavior. Global and brain-specific Sh2b1 knockout (KO) mice exhibited fatal, intermale aggression. In a resident-intruder paradigm, latency to attack was markedly reduced, whereas the number and the duration of attacks was significantly increased in global and brain-specific Sh2b1 KO mice compared with wild-type littermates. Consistently, core aggression circuits were activated to a higher level in global and brain-specific Sh2b1 KO males, based on c-fos immunoreactivity in the amygdala and periaqueductal gray. Brain-specific restoration of Sh2b1 normalized brain size and reversed pathologic aggression and aberrant activation of core aggression circuits in Sh2b1 KO males. SH2B1 mutations in humans were linked to aberrant brain development and behavior. At the molecular level, Sh2b1 enhanced neurotrophin-stimulated neuronal differentiation and protected against oxidative stress-induced neuronal death. Our data suggest that neuronal Sh2b1 promotes brain development and the integrity of core aggression circuits, likely through enhancing neurotrophin signaling.	[Jiang, Lin; Su, Haoran; Chen, Zheng; Rui, Liangyou] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, 7810 MS 2,1137 E Catherine St, Ann Arbor, MI 48109 USA; [Wilkinson, Paul; Goodyer, Ian; Rui, Liangyou] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Keogh, Julia M.; Henning, Elana; Farooqi, I. Sadaf] Univ Cambridge, Metab Res Labs, Addenbrookes Hosp, Wellcome Trust Med Res Council MRC Inst Metab Sci, Box 289, Cambridge CB2 0QQ, England; [Keogh, Julia M.; Henning, Elana; Farooqi, I. Sadaf] Natl Inst Hlth Res Cambridge Biomed Res Ctr, Cambridge, England; [Wilkinson, Paul; Goodyer, Ian] Dept Psychiat, Cambridge, England; [Wilkinson, Paul; Goodyer, Ian] Cambridgeshire & Peterborough Natl Hlth Serv Fdn, Cambridge, England	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Rui, LY (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, 7810 MS 2,1137 E Catherine St, Ann Arbor, MI 48109 USA.; Farooqi, IS (corresponding author), Univ Cambridge, Metab Res Labs, Addenbrookes Hosp, Wellcome Trust Med Res Council MRC Inst Metab Sci, Box 289, Cambridge CB2 0QQ, England.	isf20@cam.ac.uk; ruily@umich.edu	Farooqi, Ismaa Sadaf/AAZ-3046-2020; O'Rahilly, Stephen/ABF-6509-2020	O'Rahilly, Stephen/0000-0003-2199-4449; Farooqi, Sadaf/0000-0001-7609-3504	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [DK114220, DK094014]; Wellcome Trust; National Institutes for Health Research Cambridge Biomedical Research Centre; Bernard Wolfe Health Neuroscience Fund; Wellcome Trust Strategic Award [095844]; Michigan Diabetes Research Center [DK020572]; Michigan Metabolomics and Obesity Center [DK089503]; University of Michigan Gut Peptide Research Center [DK34933]; MRC [MC_UU_12012/5] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091591, R01DK114220, R01DK094014, P60DK020572, P30DK089503, P30DK034933, P30DK020572] Funding Source: NIH RePORTER; Medical Research Council [MC_UU_12012/5/B, MC_UU_12012/5] Funding Source: researchfish	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes for Health Research Cambridge Biomedical Research Centre; Bernard Wolfe Health Neuroscience Fund; Wellcome Trust Strategic Award(Wellcome Trust); Michigan Diabetes Research Center; Michigan Metabolomics and Obesity Center; University of Michigan Gut Peptide Research Center; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank Dr. Louis F. Reichardt (University of California, San Francisco, San Francisco, CA, USA) for providing rat TrkB cDNA and Dr. Christin Carter-Su for helpful discussions. The authors thank the patients and their families and the physicians who recruited patients to the Genetics of Obesity Study (GOOS). This work was supported by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grants DK114220 and DK094014 (to L.R.), the Wellcome Trust, the National Institutes for Health Research Cambridge Biomedical Research Centre, and the Bernard Wolfe Health Neuroscience Fund (to I.S.F.). I.G. was supported by a Wellcome Trust Strategic Award (Grant 095844). This work used the cores supported by the Michigan Diabetes Research Center (DK020572), Michigan Metabolomics and Obesity Center (DK089503), and the University of Michigan Gut Peptide Research Center (DK34933). The authors declare no conflicts of interest.	Anderson DJ, 2012, BIOL PSYCHIAT, V71, P1081, DOI 10.1016/j.biopsych.2011.11.012; Barr Christina S, 2014, Curr Top Behav Neurosci, V17, P45, DOI 10.1007/7854_2013_267; Bevilacqua L, 2010, NATURE, V468, P1061, DOI 10.1038/nature09629; Blair RJR, 2007, BEHAV SCI LAW, V25, P321, DOI 10.1002/bsl.750; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; Chan JP, 2006, NEUROSCIENCE, V142, P49, DOI 10.1016/j.neuroscience.2006.06.002; Chen Z, 2014, DIABETES, V63, P585, DOI 10.2337/db13-0666; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; Doche ME, 2012, J CLIN INVEST, V122, P4732, DOI 10.1172/JCI62696; Dorfman Hayley M, 2014, Curr Top Behav Neurosci, V17, P297, DOI 10.1007/7854_2013_272; Gregg TR, 2001, PROG NEURO-PSYCHOPH, V25, P91, DOI 10.1016/S0278-5846(00)00150-0; Hegedus B, 2007, CELL STEM CELL, V1, P443, DOI 10.1016/j.stem.2007.07.008; Hong WZ, 2014, CELL, V158, P1348, DOI 10.1016/j.cell.2014.07.049; Ito W, 2011, GENES BRAIN BEHAV, V10, P365, DOI 10.1111/j.1601-183X.2010.00676.x; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; Nelson RJ, 2007, NAT REV NEUROSCI, V8, P536, DOI 10.1038/nrn2174; Niv S., 2013, J CRIM JUSTICE, V41; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Pearce LR, 2014, ENDOCRINOLOGY, V155, P3219, DOI 10.1210/en.2014-1264; Qian XZ, 1998, NEURON, V21, P1017, DOI 10.1016/S0896-6273(00)80620-0; Ren DC, 2005, CELL METAB, V2, P95, DOI 10.1016/j.cmet.2005.07.004; Ren DC, 2007, J CLIN INVEST, V117, P397, DOI 10.1172/JCI29417; Rios M, 2014, Handb Exp Pharmacol, V220, P283, DOI 10.1007/978-3-642-45106-5_11; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Rui L, 2014, WORLD J DIABETES, V5, P511, DOI 10.4239/wjd.v5.i4.511; Rui LY, 1999, J BIOL CHEM, V274, P10590, DOI 10.1074/jbc.274.15.10590; Sclafani AM, 2006, GENESIS, V44, P336, DOI 10.1002/dvg.20220; Shih CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079619; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Stowers L, 2013, CURR OPIN NEUROBIOL, V23, P339, DOI 10.1016/j.conb.2013.01.007; Takahashi Aki, 2014, Curr Top Behav Neurosci, V17, P3, DOI 10.1007/7854_2013_263; Vilar M, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00026; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073	35	12	13	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1830	1840		10.1096/fj.201700831R	http://dx.doi.org/10.1096/fj.201700831R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29180441	Green Submitted, Green Published			2022-12-28	WOS:000429051400008
J	Rimon-Dahari, N; Heinemann-Yerushalmi, L; Hadas, R; Kalich-Philosoph, L; Ketter, D; Nevo, N; Galiani, D; Dekel, N				Rimon-Dahari, Nitzan; Heinemann-Yerushalmi, Lia; Hadas, Ron; Kalich-Philosoph, Lital; Ketter, Dafna; Nevo, Nava; Galiani, Dalia; Dekel, Nava			Vasorin: a newly identified regulator of ovarian folliculogenesis	FASEB JOURNAL			English	Article						ovulation; TGF-beta; ovarian reserve	GROWTH-FACTOR-BETA; ANTI-MULLERIAN HORMONE; TGF-BETA; MOUSE OVARY; IN-VIVO; FOLLICLE DEVELOPMENT; SUPERFAMILY MEMBERS; GENE-EXPRESSION; GRANULOSA-CELLS; MICE	Members of the TGF-beta superfamily take part in the control of folliculogenesis. Vasorin (Vasn) is a newly identified negative regulator of TGF-beta signaling whose possible involvement in ovarian physiology has never been studied. Here, we demonstrate that Vasn is expressed in the ovary by somatic cells of follicles, and that its expression is up-regulated by LH. We established a conditional knockout (cKO) mouse model in which Vasn is deleted specifically in granulosa cells of growing follicles from the secondary stage onwards. Using this model, we show that, upon hormonal stimulation, follicle ovulation size is almost 2-fold higher. This enhanced ovulatory response is associated with overactivation of the TGF-beta signaling pathway and a lower number of atretic antral follicles. Of importance, we demonstrate that the number of primordial follicles is reduced in prepubertal cKO mouse ovaries, which suggests that the production of VASN by growing follicles protects the ovarian reserve. Finally, analysis of systemic KO mice revealed that the ovarian reserve is almost 2.5-fold higher, which implies that Vasn may also play a role in primordial follicle formation. Overall, our findings reveal that Vasn is a new regulator that exerts an effect on several key ovarian functions, including folliculogenesis, maintenance of the ovarian reserve, and ovulation.	[Rimon-Dahari, Nitzan; Heinemann-Yerushalmi, Lia; Hadas, Ron; Kalich-Philosoph, Lital; Ketter, Dafna; Nevo, Nava; Galiani, Dalia; Dekel, Nava] Weizmann Inst Sci, Dept Regulat Biol, 234 Herzl St, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Dekel, N (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, 234 Herzl St, IL-76100 Rehovot, Israel.	nava.dekel@weizmann.ac.il	DEKEL, NAVA/R-8817-2019	Heinemann-Yerushalmi, Lia/0000-0002-2488-9022	Dwek Fund for Biomedical Research; Israel Science Foundation [1115/16]	Dwek Fund for Biomedical Research; Israel Science Foundation(Israel Science Foundation)	The authors thank Calanit Raanan for histologic processing, Oz Yermiahu and Hana Stup for animal care and maintenance (all from the Weizmann Institute of Science), and Elazar Zelzer, Alon Chen, and the entire N.D. laboratory (the Weizmann Institute of Science) for fruitful discussions and insightful comments. This work was supported by the Dwek Fund for Biomedical Research (to N.D.) and the Israel Science Foundation (1115/16). The authors declare no conflicts of interest.	Bristol-Gould SK, 2006, DEV BIOL, V298, P132, DOI 10.1016/j.ydbio.2006.06.025; Chang H, 2002, ENDOCR REV, V23, P787, DOI 10.1210/er.2002-0003; Chen L, 2005, BIOCHEM BIOPH RES CO, V336, P364, DOI 10.1016/j.bbrc.2005.08.071; Choksi S, 2011, MOL CELL, V42, P597, DOI 10.1016/j.molcel.2011.03.030; DODSON WC, 1987, ENDOCRINOLOGY, V120, P512, DOI 10.1210/endo-120-2-512; Durlinger ALL, 2002, ENDOCRINOLOGY, V143, P1076, DOI 10.1210/en.143.3.1076; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; Edson MA, 2009, ENDOCR REV, V30, P624, DOI 10.1210/er.2009-0012; Fortin J, 2014, FASEB J, V28, P1474, DOI 10.1096/fj.13-237818; Harlow CR, 2002, ENDOCRINOLOGY, V143, P3316, DOI 10.1210/en.2001-211389; Huang AX, 2015, INT J BIOL SCI, V11, P961, DOI 10.7150/ijbs.11943; Ikeda Y, 2004, P NATL ACAD SCI USA, V101, P10732, DOI 10.1073/pnas.0404117101; Ingman WV, 2009, CYTOKINE GROWTH F R, V20, P233, DOI 10.1016/j.cytogfr.2009.05.003; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Krautzberger AM, 2012, GENE EXPR PATTERNS, V12, P167, DOI 10.1016/j.gep.2012.02.003; Kuo SW, 2011, J CELL PHYSIOL, V226, P1608, DOI 10.1002/jcp.22491; Li QL, 2008, MOL CELL BIOL, V28, P7001, DOI 10.1128/MCB.00732-08; Li SH, 2015, ONCOTARGET, V6, P10045, DOI 10.18632/oncotarget.6631; Lin SY, 2003, REPRODUCTION, V126, P133, DOI 10.1530/rep.0.1260133; Liu XW, 1999, ENDOCRINOLOGY, V140, P2480, DOI 10.1210/en.140.6.2480; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Malapeira J, 2011, ONCOGENE, V30, P1912, DOI 10.1038/onc.2010.565; Mansouri-Attia N, 2014, MOL ENDOCRINOL, V28, P1887, DOI 10.1210/me.2014-1217; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Myers M, 2009, DEV BIOL, V334, P458, DOI 10.1016/j.ydbio.2009.08.001; Pangas SA, 2004, MOL CELL ENDOCRINOL, V225, P83, DOI 10.1016/j.mce.2004.02.017; Pangas SA, 2006, MOL ENDOCRINOL, V20, P1406, DOI 10.1210/me.2005-0462; Pangas SA, 2012, MOL CELL ENDOCRINOL, V356, P40, DOI 10.1016/j.mce.2011.06.021; Pepling ME, 2012, REPRODUCTION, V143, P139, DOI 10.1530/REP-11-0299; Raja-Khan N, 2014, REPROD SCI, V21, P20, DOI 10.1177/1933719113485294; Reddy P, 2010, TRENDS ENDOCRIN MET, V21, P96, DOI 10.1016/j.tem.2009.10.001; Richards JS, 2010, J CLIN INVEST, V120, P963, DOI 10.1172/JCI41350; Rimon-Dahari N, 2016, RESULTS PROBL CELL D, V58, P167, DOI 10.1007/978-3-319-31973-5_7; ROBERTS VJ, 1993, J CLIN ENDOCR METAB, V77, P1402, DOI 10.1210/jc.77.5.1402; Schindler R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012979; SHIMASAKI S, 1989, MOL ENDOCRINOL, V3, P651, DOI 10.1210/mend-3-4-651; Shwartz Y., 2014, METHODS MOL BIOL SER, V1130; Tal R, 2013, FERTIL STERIL, V100, P538, DOI 10.1016/j.fertnstert.2013.04.022; Tingen CM, 2009, BIOL REPROD, V81, P16, DOI 10.1095/biolreprod.108.074898; Tomic D, 2002, BIOL REPROD, V66, P917, DOI 10.1095/biolreprod66.4.917; Torrents E, 2003, HUM REPROD UPDATE, V9, P471, DOI 10.1093/humupd/dmg036; Trombly DJ, 2009, SEMIN REPROD MED, V27, P14, DOI 10.1055/s-0028-1108006; Wang ZP, 2014, J BIOL CHEM, V289, P8299, DOI 10.1074/jbc.M113.532952; Zamah AM, 2015, CLIN PROTEOM, V12, DOI 10.1186/s12014-015-9077-6	44	10	11	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2124	2136		10.1096/fj.201700057RRR	http://dx.doi.org/10.1096/fj.201700057RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29259033				2022-12-28	WOS:000429051400032
J	Kentala, H; Koponen, A; Kivela, AM; Andrews, R; Li, CH; Zhou, Y; Olkkonen, VM				Kentala, Henriikka; Koponen, Annika; Kivela, Annukka M.; Andrews, Robert; Li, ChunHei; Zhou, You; Olkkonen, Vesa M.			Analysis of ORP2-knockout hepatocytes uncovers a novel function in actin cytoskeletal regulation	FASEB JOURNAL			English	Article						CRISPR-Cas9; F-actin; interactome; OSBPL2; RNA sequencing	OXYSTEROL-BINDING-PROTEIN; OSBP-RELATED PROTEIN-2; HEARING-LOSS; STEROL TRANSPORT; PLASMA-MEMBRANE; LIPID DROPLETS; EXPRESSION; ER; RHOA; GENE	ORP2 is implicated in cholesterol transport, triglyceride metabolism, and adrenocortical steroid hormone production. We addressed ORP2 function in hepatocytes by generating ORP2-knockout (KO) HuH7 cells by CRISPR-Cas9 gene editing, followed by analyses of transcriptome, F-actin morphology, migration, adhesion, and proliferation. RNA sequencing of ORP2-KO cells revealed >2-fold changes in 579 mRNAs. The Ingenuity Pathway Analysis (IPA) uncovered alterations in the following functional categories: cellular movement, cell-cell signaling and interaction, cellular development, cellular function and maintenance, cellular growth and proliferation, and cell morphology. Many pathways in these categories involved actin cytoskeleton, cell migration, adhesion, or proliferation. Analysis of the ORP2 interactome uncovered 109 putative new partners. Their IPA analysis revealed Ras homolog A (RhoA) signaling as the most significant pathway. Interactions of ORP2 with SEPT9, MLC12, and ARHGAP12 were validated by independent assays. ORP2-KO resulted in abnormal F-actin morphology characterized by impaired capacity to form lamellipodia, migration defect, and impaired adhesion and proliferation. Rescue of the migration phenotype and generation of typical cell surface morphology required an intact ORP2 phosphoinositide binding site, suggesting that ORP2 function involves phosphoinositide binding and transport. The results point at a novel function of ORP2 as a lipid-sensing regulator of the actin cytoskeleton, with impacts on hepatocellular migration, adhesion, and proliferation.-Kentala, H., Koponen, A., Kivela, A. M., Andrews, R., Li, C., Zhou, Y., Olkkonen, V. M. Analysis of ORP2-knockout hepatocytes uncovers a novel function in actin cytoskeletal regulation.	[Kentala, Henriikka; Koponen, Annika; Kivela, Annukka M.; Zhou, You; Olkkonen, Vesa M.] Minerva Fdn, Inst Med Res, Helsinki, Finland; [Andrews, Robert; Li, ChunHei; Zhou, You] Cardiff Univ, Sch Med, Syst Immun Res Inst, Cardiff, S Glam, Wales; [Li, ChunHei; Zhou, You] Cardiff Univ, Sch Med, Div Infect & Immun, Cardiff, S Glam, Wales; [Olkkonen, Vesa M.] Univ Helsinki, Fac Med, Dept Anat, Helsinki, Finland; [Olkkonen, Vesa M.] Minerva Fdn, Inst Med Res, Biomed 2U, Tukholmankatu 8, FI-00290 Helsinki, Finland	Cardiff University; Cardiff University; University of Helsinki	Olkkonen, VM (corresponding author), Minerva Fdn, Inst Med Res, Biomed 2U, Tukholmankatu 8, FI-00290 Helsinki, Finland.	vesa.olkkonen@helsinki.fi		Koponen, Annika/0000-0002-3348-9661; ZHOU, YOU/0000-0002-1743-1291; Andrews, Robert/0000-0002-3491-2361	Academy of Finland [285223]; University of Helsinki Doctoral Programme in Biomedicine; Finnish Concordia Fund; Ida Montin Foundation; Finnish Norwegian Medical Foundation; Aarne Koskelo Foundation; Sigrid Juselius Foundation; Magnus Ehrnrooth Foundation; Finnish Foundation for Cardiovascular Research; Systems Immunity Research Institute Seedcorn Fund; Novo Nordisk Fonden [NNF11OC1014724] Funding Source: researchfish	Academy of Finland(Academy of Finland); University of Helsinki Doctoral Programme in Biomedicine; Finnish Concordia Fund; Ida Montin Foundation; Finnish Norwegian Medical Foundation; Aarne Koskelo Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Magnus Ehrnrooth Foundation; Finnish Foundation for Cardiovascular Research; Systems Immunity Research Institute Seedcorn Fund; Novo Nordisk Fonden(Novo Nordisk Foundation)	The authors thank Eeva Jaaskelainen and Riikka Kosonen (Minerva Foundation Institute for Medical Research, Helsinki, Finland) for expert technical assistance; Sarah Edkins and Kevin Ashelford (Wales Gene Park, Cardiff, United Kingdom) for technical support; the Advanced Computing Research Team (Cardiff University) for high-throughput computer support; BioMediTech Protein Technologies core facility, a member of Biocenter Finland and Instruct-FI, the Helsinki University Genome Biology Unit, and the Biomedicum Functional Genomics Unit (HiLIFE Institute, Helsinki, Finland) for the use of the facilities and expertise. Dr. Shiqian Li (University of Helsinki) is thanked for kindly providing the CRISPR-Cas9 vectors. This study was supported by the Academy of Finland (Grant 285223; to V.M.O.); by the University of Helsinki Doctoral Programme in Biomedicine, the Finnish Concordia Fund, the Ida Montin Foundation; the Finnish Norwegian Medical Foundation, and the Aarne Koskelo Foundation (to H.K.); the Sigrid Juselius Foundation, the Magnus Ehrnrooth Foundation, and the Finnish Foundation for Cardiovascular Research (to V.M.O.); and Systems Immunity Research Institute Seedcorn Funding (to Y.Z.). The authors declare no conflicts of interest.	Alfaro G, 2011, TRAFFIC, V12, P1521, DOI 10.1111/j.1600-0854.2011.01265.x; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Anderson GJ, 2002, CELL BIOCHEM BIOPHYS, V36, P137, DOI 10.1385/CBB:36:2-3:137; Aoki K, 2016, P NATL ACAD SCI USA, V113, pE1863, DOI 10.1073/pnas.1600968113; Beaslas O, 2012, EXP CELL RES, V318, P1933, DOI 10.1016/j.yexcr.2012.05.026; Beh CT, 2001, GENETICS, V157, P1117; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Blom AM, 2004, MOL IMMUNOL, V40, P1333, DOI 10.1016/j.molimm.2003.12.002; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Burridge K, 2016, EXP CELL RES, V343, P14, DOI 10.1016/j.yexcr.2015.10.029; Burrows JF, 2003, J PATHOL, V201, P581, DOI 10.1002/path.1484; Castellino FJ, 2005, THROMB HAEMOSTASIS, V93, P647, DOI 10.1160/TH04-12-0842; Charman M, 2014, J BIOL CHEM, V289, P15705, DOI 10.1074/jbc.M114.571216; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Choi SY, 2015, BBA-MOL CELL BIOL L, V1851, P711, DOI 10.1016/j.bbalip.2015.01.009; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Chung J, 2015, SCIENCE, V349, P428, DOI 10.1126/science.aab1370; Chutkow WA, 2008, J BIOL CHEM, V283, P2397, DOI 10.1074/jbc.M708169200; Croft DR, 2006, MOL CELL BIOL, V26, P4612, DOI 10.1128/MCB.02061-05; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Dong R, 2016, CELL, V166, P408, DOI 10.1016/j.cell.2016.06.037; Escajadillo T, 2016, MOL CELL ENDOCRINOL, V427, P73, DOI 10.1016/j.mce.2016.03.006; Faugaret D, 2011, BIOCHEM PHARMACOL, V81, P144, DOI 10.1016/j.bcp.2010.09.014; Gesmann M, 2011, R J, V3, P40; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Hynynen R, 2005, BIOCHEM J, V390, P273, DOI 10.1042/BJ20042082; Hynynen R, 2009, J LIPID RES, V50, P1305, DOI 10.1194/jlr.M800661-JLR200; Jansen M, 2011, TRAFFIC, V12, P218, DOI 10.1111/j.1600-0854.2010.01142.x; Jiang W, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-4; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Kalikin LM, 2000, GENOMICS, V63, P165, DOI 10.1006/geno.1999.6077; Kang TH, 2016, GENES GENET SYST, V91, P289, DOI 10.1266/ggs.16-00041; Kentala H, 2015, STEROIDS, V99, P248, DOI 10.1016/j.steroids.2015.01.027; Kim H, 2010, BBA-MOL CELL RES, V1803, P975, DOI 10.1016/j.bbamcr.2010.04.001; Kozminski KG, 2006, TRAFFIC, V7, P1224, DOI 10.1111/j.1600-0854.2006.00467.x; Kuroda S, 1999, BIOCHEM BIOPH RES CO, V265, P79, DOI 10.1006/bbrc.1999.1638; Laitinen S, 2002, J LIPID RES, V43, P245; Larreaa MD, 2009, P NATL ACAD SCI USA, V106, P9268, DOI 10.1073/pnas.0805057106; Lazarini M, 2013, BBA-MOL BASIS DIS, V1832, P365, DOI 10.1016/j.bbadis.2012.11.010; Lehto M, 2008, J CELL SCI, V121, P695, DOI 10.1242/jcs.016964; Li DH, 2013, MOL BIOL CELL, V24, P848, DOI 10.1091/mbc.E12-08-0597; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McCarty OJT, 2005, J BIOL CHEM, V280, P39474, DOI 10.1074/jbc.M504672200; McGrath J, 2017, SEMIN CELL DEV BIOL, V65, P88, DOI 10.1016/j.semcdb.2016.08.017; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Moh MC, 2005, J HEPATOL, V42, P833, DOI 10.1016/j.jhep.2005.01.025; Morris SM, 2009, BRIT J PHARMACOL, V157, P922, DOI 10.1111/j.1476-5381.2009.00278.x; Nagata KI, 2005, ONCOGENE, V24, P65, DOI 10.1038/sj.onc.1208101; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Neuhaus C, 2017, CLIN GENET, V91, P892, DOI 10.1111/cge.12915; Ngo MH, 2010, BIOCHEM J, V429, P13, DOI 10.1042/BJ20100263; Nissila E, 2012, BBA-MOL CELL BIOL L, V1821, P1472, DOI 10.1016/j.bbalip.2012.08.004; Noma N, 2012, ONCOL REP, V27, P2080, DOI 10.3892/or.2012.1733; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; Olkkonen VM, 2013, PROG LIPID RES, V52, P529, DOI 10.1016/j.plipres.2013.06.004; Pedraza Neus, 2019, Small GTPases, V10, P47, DOI 10.1080/21541248.2016.1268665; Perttila J, 2009, J MOL MED, V87, P825, DOI 10.1007/s00109-009-0490-z; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Raychaudhuri S, 2010, ANNU REV CELL DEV BI, V26, P157, DOI 10.1146/annurev.cellbio.042308.113334; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Sackmann E, 2015, BBA-MOL CELL RES, V1853, P3132, DOI 10.1016/j.bbamcr.2015.06.012; Salo VT, 2016, EMBO J, V35, P2699, DOI 10.15252/embj.201695170; Schurpf T, 2012, FASEB J, V26, P3412, DOI 10.1096/fj.11-202036; Sewer MB, 2013, MOL CELL ENDOCRINOL, V371, P79, DOI 10.1016/j.mce.2012.11.014; Shathasivam P, 2017, BRIT J CANCER, V116, P1065, DOI 10.1038/bjc.2017.51; Stritt S, 2016, BLOOD, V127, P2903, DOI 10.1182/blood-2015-10-675629; Suchanek M, 2007, BIOCHEM J, V405, P473, DOI 10.1042/BJ20070176; Tan J, 2014, CRIT REV BIOCHEM MOL, V49, P33, DOI 10.3109/10409238.2013.853024; TASHIAN RE, 1989, BIOESSAYS, V10, P186, DOI 10.1002/bies.950100603; Thoenes M, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0238-5; von Filseck JM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7671; Wang C, 2002, BIOCHEM J, V361, P461, DOI 10.1042/0264-6021:3610461; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Weber-Boyvat M, 2015, CELL MOL LIFE SCI, V72, P1967, DOI 10.1007/s00018-014-1786-x; Weber-Boyvat M, 2015, EXP CELL RES, V331, P278, DOI 10.1016/j.yexcr.2014.10.019; Wight TN, 2014, BBA-GEN SUBJECTS, V1840, P2441, DOI 10.1016/j.bbagen.2013.12.028; Wilson CA, 2010, NATURE, V465, P373, DOI 10.1038/nature08994; Worthley DL, 2005, INTERN MED J, V35, P548, DOI 10.1111/j.1445-5994.2005.00908.x; Wyles JP, 2007, EXP CELL RES, V313, P1426, DOI 10.1016/j.yexcr.2007.01.018; Xing GQ, 2015, GENET MED, V17, P210, DOI 10.1038/gim.2014.90; Yamanaka H, 2000, BIOCHEM BIOPH RES CO, V271, P796, DOI 10.1006/bbrc.2000.2699; Zhang Li, 2012, Subcell Biochem, V59, P177, DOI 10.1007/978-94-007-3015-1_6; Zhong WB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12702	86	21	21	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1281	1295		10.1096/fj.201700604R	http://dx.doi.org/10.1096/fj.201700604R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29092904	Green Published			2022-12-28	WOS:000427246000014
J	Park, S; Kim, K; Bae, IH; Lee, SH; Jung, J; Lee, TR; Cho, EG				Park, Sunyoung; Kim, Kyuhan; Bae, Il-Hong; Lee, Sung Hoon; Jung, Jiyong; Lee, Tae Ryong; Cho, Eun-Gyung			TIMP3 is a CLOCK-dependent diurnal gene that inhibits the expression of UVB-induced inflammatory cytokines in human keratinocytes	FASEB JOURNAL			English	Article						circadian rhythm; skin inflammation; MMP1; TNF-alpha; chemokine	MAMMALIAN CIRCADIAN CLOCK; INDUCED DNA-DAMAGE; BARRIER FUNCTION; HUMAN SKIN; EPIDERMIS; PROLIFERATION; ALPHA; CELLS; MICE	As the outermost physical barrier of an organism, the skin is diurnally exposed to UV radiation (UVR). Recent studies have revealed that the skin exhibits a circadian rhythm in various functions, and this oscillation is disturbed and reset via a strong environmental cue, the UVR. However, a molecular link between circadian perturbation by UVR and UVR-induced cellular responses has not been investigated. We identified tissue inhibitor of metalloproteinase (TIMP)-3 as a novel circadian locomotor output cycles kaput (CLOCK)-dependent diurnal gene by using a CLOCK-knockdown strategy in human keratinocytes. Among dozens of identified transcripts down-regulated by CLOCK knockdown, TIMP3 displayed a rhythmic expression in a CLOCK-dependent manner, in which the expression of matrix metalloproteinase (MMP)-1 and inflammatory cytokines, such as TNF-alpha, chemokine (C-X-C motif) ligand (CXCL)-1, and IL-8, were inversely regulated. Upon UVB exposure, the expression of CLOCK and TIMP3 was down-regulated, which led to an up-regulation of secretion of MMP1 and TNF-a proteins and in the transcription of CXCL1 and IL-8 via CCAAT-enhancer binding protein (C/EBP)-alpha. UVB-induced TNF-alpha secretion increased further or decreased by knockdown or overexpression of TIMP3, respectively, as well as by CLOCK. As a novel CLOCK-dependent diurnal gene, TIMP3 inhibits the expression of inflammatory cytokines that are up-regulated by UV irradiation inhuman keratinocytes. Thus, our work suggests a molecular link between circadian perturbation by UVR and UVR-induced inflammation.	[Park, Sunyoung; Kim, Kyuhan; Bae, Il-Hong; Lee, Sung Hoon; Jung, Jiyong; Lee, Tae Ryong; Cho, Eun-Gyung] AmorePacific Corp, Basic Res & Innovat Div, Res & Dev Unit, Yongin, South Korea		Lee, TR; Cho, EG (corresponding author), AmorePacific Corp, Basic Res & Innovat Div, R&D Unit, 1920 Yonggu Daero, Yongin, Gyeonggi Do, South Korea.	trlee@amorepacific.com; egcho@amorepacific.com		Bae, Il-Hong/0000-0003-0535-8303	AmorePacific Corp.	AmorePacific Corp.	All authors are employees of AmorePacific Corp. (Seoul, South Korea). AmorePacific Corp. provided all financial support for this study.	Al-Nuaimi Y, 2014, J INVEST DERMATOL, V134, P610, DOI 10.1038/jid.2013.366; Ando N, 2015, J INVEST DERMATOL, V135, P3001, DOI 10.1038/jid.2015.316; Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Banno T, 2004, J BIOL CHEM, V279, P32633, DOI 10.1074/jbc.M400642200; Cornelissen G, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-16; Dakup P, 2017, PHOTOCHEM PHOTOBIOL, V93, P296, DOI 10.1111/php.12662; Denda M, 2000, BRIT J DERMATOL, V142, P881, DOI 10.1046/j.1365-2133.2000.03466.x; Dickmeis T, 2013, MOL CELL ENDOCRINOL, V380, P2, DOI 10.1016/j.mce.2013.05.012; Duffield GE, 2003, J NEUROENDOCRINOL, V15, P991, DOI 10.1046/j.1365-2826.2003.01082.x; Geyfman M, 2012, P NATL ACAD SCI USA, V109, P11758, DOI 10.1073/pnas.1209592109; Geyfman M, 2009, J INVEST DERMATOL, V129, P1063, DOI 10.1038/jid.2008.384; Hardman JA, 2015, J INVEST DERMATOL, V135, P1053, DOI 10.1038/jid.2014.442; Hoffmann J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102238; Kahari VM, 1997, EXP DERMATOL, V6, P199, DOI 10.1111/j.1600-0625.1997.tb00164.x; Kawara S, 2002, J INVEST DERMATOL, V119, P1220, DOI 10.1046/j.1523-1747.2002.19619.x; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsui MS, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060801; Matsunaga N, 2014, J INVEST DERMATOL, V134, P1636, DOI 10.1038/jid.2014.13; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Murphy G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-233; Plikus MV, 2015, J BIOL RHYTHM, V30, P163, DOI 10.1177/0748730414563537; Plikus MV, 2013, P NATL ACAD SCI USA, V110, pE2106, DOI 10.1073/pnas.1215935110; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sandu C, 2012, CELL MOL LIFE SCI, V69, P3329, DOI 10.1007/s00018-012-1026-1; Sesto A, 2002, P NATL ACAD SCI USA, V99, P2965, DOI 10.1073/pnas.052678999; Sporl F, 2012, P NATL ACAD SCI USA, V109, P10903, DOI 10.1073/pnas.1118641109; Sporl F, 2011, J INVEST DERMATOL, V131, P338, DOI 10.1038/jid.2010.315; Steude J, 2002, J INVEST DERMATOL, V119, P1254, DOI 10.1046/j.1523-1747.2002.19616.x; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Takita E, 2013, BRIT J DERMATOL, V168, P39, DOI 10.1111/j.1365-2133.2012.11176.x; Yosipovitch G, 2004, J INVEST DERMATOL, V122, P824, DOI 10.1111/j.0022-202X.2004.22313.x; Yosipovitch G, 1998, J INVEST DERMATOL, V110, P20, DOI 10.1046/j.1523-1747.1998.00069.x	35	21	22	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1510	1523		10.1096/fj.201700693R	http://dx.doi.org/10.1096/fj.201700693R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29180440	Green Published, hybrid			2022-12-28	WOS:000427246000031
J	Camera, DM; Burniston, JG; Pogson, MA; Smiles, WJ; Hawley, JA				Camera, Donny M.; Burniston, Jatin G.; Pogson, Mark A.; Smiles, William J.; Hawley, John A.			Dynamic proteome profiling of individual proteins in human skeletal muscle after a high-fat diet and resistance exercise	FASEB JOURNAL			English	Article						muscle protein synthesis; abundance; metabolism; adaptation; protein degradation	MYOFIBER HYPERTROPHY; OLDER-ADULTS; PHOSPHORYLATION; MYOFIBRILLAR; METABOLISM; EXPRESSION; YOUNG; RATES; MICE; TIME	It is generally accepted that muscle adaptation to resistance exercise (REX) training is underpinned by contraction-induced, increased rates of protein synthesis and dietary protein availability. By using dynamic proteome profiling (DPP), we investigated the contribution of both synthesis and breakdown to changes in abundance on a protein-by-protein basis inhuman skeletal muscle. Age-matched, overweight males consumed 9 d of a high-fat, low-carbohydrate diet during which time they either undertook 3 sessions of REX or performed no exercise. Precursor enrichment and the rate of incorporation of deuterium oxide into newly synthesized muscle proteins were determined by mass spectrometry. Ninety proteins were included in the DPP, with 28 proteins exhibiting significant responses to REX. The most common pattern of response was an increase in turnover, followed by an increase in abundance with no detectable increase in protein synthesis. Here, we provide novel evidence that demonstrates that the contribution of synthesis and breakdown to changes in protein abundance induced by REX differ on a protein by-protein basis. We also highlight the importance of the degradation of individual muscle proteins after exercise in human skeletal muscle.	[Camera, Donny M.; Smiles, William J.; Hawley, John A.] Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Ctr Exercise & Nutr, Fitzroy, Vic, Australia; [Burniston, Jatin G.; Hawley, John A.] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool, Merseyside, England; [Pogson, Mark A.] Liverpool John Moores Univ, Dept Appl Math, Liverpool, Merseyside, England	Australian Catholic University; Liverpool John Moores University; Liverpool John Moores University	Hawley, JA (corresponding author), Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Fitzroy, Vic 3165, Australia.	hawley@acu.edu.au	Camera, Donny/J-1571-2018; Burniston, Jatin G/B-7833-2008; Burniston, Jatin/AAB-8831-2020; Hawley, John A/U-3814-2018; Pogson, Mark/D-9558-2016	Camera, Donny/0000-0002-6494-9472; Burniston, Jatin G/0000-0001-7303-9318; Burniston, Jatin/0000-0001-7303-9318; Hawley, John A/0000-0002-0886-9881; Smiles, William/0000-0002-6846-689X; Pogson, Mark/0000-0002-2116-7200	Australian Catholic University Collaborative Research Network [2013000443]	Australian Catholic University Collaborative Research Network	The authors thank the study participants for their efforts and dedication. This work was supported by an Australian Catholic University Collaborative Research Network Grant to J.A.H. (2013000443). The authors declare no conflicts of interest.	Arndt V, 2010, CURR BIOL, V20, P143, DOI 10.1016/j.cub.2009.11.022; Balagopal P, 2001, AM J PHYSIOL-ENDOC M, V280, pE203, DOI 10.1152/ajpendo.2001.280.2.E203; BENNDORF R, 1994, J BIOL CHEM, V269, P20780; BIOLO G, 1995, AM J PHYSIOL-ENDOC M, V268, pE514; Bloch RJ, 2003, EXERC SPORT SCI REV, V31, P73, DOI 10.1097/00003677-200304000-00004; Brook MS, 2015, FASEB J, V29, P4485, DOI 10.1096/fj.15-273755; Burniston JG, 2014, PROTEOMICS, V14, P2339, DOI 10.1002/pmic.201400118; Camera DM, 2015, MED SCI SPORT EXER, V47, P82, DOI 10.1249/MSS.0000000000000390; Camera DM, 2012, J APPL PHYSIOL, V113, P206, DOI 10.1152/japplphysiol.00395.2012; Camera DM, 2010, MED SCI SPORT EXER, V42, P1843, DOI 10.1249/MSS.0b013e3181d964e4; CHESLEY A, 1992, J APPL PHYSIOL, V73, P1383, DOI 10.1152/jappl.1992.73.4.1383; COMMERFORD SL, 1983, RADIAT RES, V94, P151, DOI 10.2307/3575870; Hawley J. A., 1985, J APPL PHYSIOL, V110, P834; HAWLEY JA, 1992, EUR J APPL PHYSIOL, V65, P79, DOI 10.1007/BF01466278; Hawley JA, 2014, CELL, V159, P738, DOI 10.1016/j.cell.2014.10.029; Hesketh S, 2016, PROTEOMES, V4, DOI 10.3390/proteomes4010012; Hipkiss AR, 2011, AGEING RES REV, V10, P498, DOI 10.1016/j.arr.2011.05.003; Kasumov T, 2013, ARTERIOSCL THROM VAS, V33, P1994, DOI 10.1161/ATVBAHA.113.301700; Koopman R, 2006, EUR J APPL PHYSIOL, V96, P525, DOI 10.1007/s00421-005-0118-0; Kosek DJ, 2006, J APPL PHYSIOL, V101, P531, DOI 10.1152/japplphysiol.01474.2005; Lam MPY, 2014, J CLIN INVEST, V124, P1734, DOI 10.1172/JCI73787; Leber Y, 2016, HUM MOL GENET, V25, P2776, DOI 10.1093/hmg/ddw135; Lehti M, 2009, J APPL PHYSIOL, V106, P1419, DOI 10.1152/japplphysiol.90660.2008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Macrae K, 2013, J LIPID RES, V54, P2366, DOI 10.1194/jlr.M036996; Malik ZA, 2013, PROTEOMES, V1, DOI 10.3390/proteomes1030290; Mayhew DL, 2009, J APPL PHYSIOL, V107, P1655, DOI 10.1152/japplphysiol.91234.2008; McCabe BJ, 2006, ANAL BIOCHEM, V350, P171, DOI 10.1016/j.ab.2006.01.020; Meplan C, 2016, FASEB J, V30, P2812, DOI 10.1096/fj.201600251R; Mertens I, 2006, INT J OBESITY, V30, P1308, DOI 10.1038/sj.ijo.0803189; Mitchell CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089431; Moore DR, 2009, J PHYSIOL-LONDON, V587, P897, DOI 10.1113/jphysiol.2008.164087; Noh HS, 2016, AUTOPHAGY, V12, P2183, DOI 10.1080/15548627.2016.1219013; Paulsen G, 2012, EUR J APPL PHYSIOL, V112, P1773, DOI 10.1007/s00421-011-2132-8; Paulsen G, 2009, J APPL PHYSIOL, V107, P570, DOI 10.1152/japplphysiol.00209.2009; Phillips SM, 2005, J AM COLL NUTR, V24, p134S, DOI 10.1080/07315724.2005.10719454; Phillips SM, 1997, AM J PHYSIOL-ENDOC M, V273, pE99, DOI 10.1152/ajpendo.1997.273.1.E99; Price JC, 2012, MOL CELL PROTEOMICS, V11, P1801, DOI 10.1074/mcp.M112.021204; R Core Team, 2016, LANG ENV STAT COMP; Sanger JW, 2017, HANDB EXP PHARMACOL, V235, P39, DOI 10.1007/164_2016_53; Shankaran M, 2016, AM J PHYSIOL-ENDOC M, V310, pE405, DOI 10.1152/ajpendo.00257.2015; Shankaran M, 2016, J CLIN INVEST, V126, P288, DOI 10.1172/JCI79639; Sollanek KJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171007; Stefanyk LE, 2010, CURR OPIN CLIN NUTR, V13, P255, DOI 10.1097/MCO.0b013e328338236e; Tachtsis B, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00144; TESCH PA, 1986, EUR J APPL PHYSIOL, V55, P362, DOI 10.1007/BF00422734; Ulbricht A, 2015, AUTOPHAGY, V11, P538, DOI 10.1080/15548627.2015.1017186; Volek JS., 2011, ART SCI LOW CARBOHYD; Wagenmakers AJM, 1999, P NUTR SOC, V58, P987, DOI 10.1017/S0029665199001305; Weinheimer EM, 2010, NUTR REV, V68, P375, DOI 10.1111/j.1753-4887.2010.00298.x; Wilkinson DJ, 2017, J PHYSIOL-LONDON, V595, P2873, DOI 10.1113/JP272277; Williamson D, 2003, J PHYSIOL-LONDON, V547, P977, DOI 10.1113/jphysiol.2002.036673; Woolstenhulme MT, 2006, J APPL PHYSIOL, V100, P1876, DOI 10.1152/japplphysiol.01592.2005; Wretman C, 2001, J PHYSIOL-LONDON, V535, P155, DOI 10.1111/j.1469-7793.2001.00155.x; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Yokoyama T, 2007, J CELL BIOL, V177, P781, DOI 10.1083/jcb.200703195	57	29	31	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5478	5494		10.1096/fj.201700531R	http://dx.doi.org/10.1096/fj.201700531R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28855275	Green Accepted			2022-12-28	WOS:000416588300030
J	Matot, I; Nachmansson, N; Duev, O; Schulz, S; Schroeder-Stein, K; Frede, S; Abramovitch, R				Matot, Idit; Nachmansson, Nathalie; Duev, Omri; Schulz, Susanne; Schroeder-Stein, Katrin; Frede, Stilla; Abramovitch, Rinat			Impaired liver regeneration after hepatectomy and bleeding is associated with a shift from hepatocyte proliferation to hypertrophy	FASEB JOURNAL			English	Article						hypoxia-inducible factor; liver failure; mTOR	HYPOXIA-INDUCIBLE FACTOR; HEPATIC RESECTION; HEMORRHAGIC-SHOCK; RADIOFREQUENCY ABLATION; SURGICAL RESECTION; RAT MODEL; TRANSPLANTATION; RESUSCITATION; HYDROXYLASES; REPLICATION	Extensive liver resections are common, and bleeding is frequent in these operations. Impaired regeneration after partial hepatectomy (PHx) may contribute to liver failure. We thus assessed the impact of acute bleeding on the liver regeneration progress after PHx and explored possible contributing molecular mechanisms. In rats, the regeneration progress was delayed and attenuated with PHx and bleeding and was not restored with colloid resuscitation. Livers restored their initial volume by postoperative day (POD) 2 after PHx through hepatocyte proliferation vs. POD 4 in the PHx and bleeding group, primarily by hepatocyte hypertrophy. With bleeding, hepatocyte proliferation was hindered in two mechanisms: by inhibiting cells from starting proliferation and by causing hindrance in G(1)/S progression. Liver hypoxia was prominent, with significant prolonged up-regulation of hypoxia-inducible factors (HIF) and HIF-targeted genes only in the PHx and bleeding group. Gene expression profiling revealed alterations in numerous genes that belong to critical pathways, including cell cycle, DNA replication, PI3K-Akt, purine, and pyrimidine metabolism. Because liver surgery is frequently performed in patients with a predamaged liver, an improper regenerative process after PHx and bleeding might lead to decompensation. The results hint at specific pathways to target in order to improve liver regeneration during PHx and bleeding.	[Matot, Idit] Tel Aviv Univ, Sackler Sch Med, Div Anesthesiol Intens Care & Pain, Tel Aviv Med Ctr, Tel Aviv, Israel; [Nachmansson, Nathalie; Duev, Omri; Abramovitch, Rinat] Hadassah Hebrew Univ, Goldyne Savad Inst Gene Therapy, Med Ctr, POB1200, IL-91120 Jerusalem, Israel; [Schulz, Susanne; Schroeder-Stein, Katrin; Frede, Stilla] Univ Hosp Bonn, Clin Anesthesiol & Intens Care Med, Bonn, Germany	Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Bonn	Abramovitch, R (corresponding author), Hadassah Hebrew Univ, Goldyne Savad Inst Gene Therapy, Med Ctr, POB1200, IL-91120 Jerusalem, Israel.	rinat@hadassah.org.il			Israel Science Foundation [1157/12]; European Society of Anesthesiology; Israeli Health Ministry [3-10999]; German Israel Foundation [I-1318-422.13/2015]	Israel Science Foundation(Israel Science Foundation); European Society of Anesthesiology; Israeli Health Ministry; German Israel Foundation(German-Israeli Foundation for Scientific Research and Development)	The authors thank T. Asraf (Hadassah Hebrew University Medical Center) for performing histologic evaluation for liver samples of rats treated with rapamycin. This research was supported by the Israel Science Foundation (Grant 1157/12; to I.M.), a grant from the European Society of Anesthesiology (to R.A.), the Israeli Health Ministry (Grant 3-10999; to R.A.), and the German Israel Foundation (Grant I-1318-422.13/2015; to R.A., S.F. and I.M.). The authors declare no conflicts of interest.	Barash H, 2007, RADIOLOGY, V243, P727, DOI 10.1148/radiol.2433060433; Barasli H, 2008, HEPATOLOGY, V48, P1232, DOI 10.1002/hep.22394; Benzing C, 2015, CLIN TRANSPLANT, V29, P1081, DOI 10.1111/ctr.12631; Cescon M, 2009, ANN SURG, V249, P995, DOI 10.1097/SLA.0b013e3181a63c74; Clavien P, 2007, NEW ENGL J MED, V356, P1545, DOI 10.1056/NEJMra065156; Cramer T, 2003, CELL CYCLE, V2, P192, DOI 10.4161/cc.2.3.402; Diril MK, 2012, P NATL ACAD SCI USA, V109, P3826, DOI 10.1073/pnas.1115201109; Silva OCE, 2007, DIGEST DIS SCI, V52, P2610, DOI 10.1007/s10620-006-9722-z; Elorza A, 2012, MOL CELL, V48, P681, DOI 10.1016/j.molcel.2012.09.017; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Feng K, 2012, J HEPATOL, V57, P794, DOI 10.1016/j.jhep.2012.05.007; Gielchinsky Y, 2010, GENE DEV, V24, P543, DOI 10.1101/gad.563110; Gilgenkrantz H, 2011, CLIN RES HEPATOL GAS, V35, P623, DOI 10.1016/j.clinre.2011.04.002; Glover TE, 2016, TRANSPLANTATION, V100, P621, DOI 10.1097/TP.0000000000001006; Goodnough LT, 2014, TRANSFUSION, V54, P2753, DOI 10.1111/trf.12723; Haga S, 2005, J HEPATOL, V43, P799, DOI 10.1016/j.jhep.2005.03.027; Hammond JS, 2011, BRIT J SURG, V98, P1188, DOI 10.1002/bjs.7630; Higgins GM, 1931, ARCH PATHOL, V12, P186; Huang JS, 2014, AM J PATHOL, V184, P309, DOI 10.1016/j.ajpath.2013.04.034; Huang JW, 2010, ANN SURG, V252, P903, DOI 10.1097/SLA.0b013e3181efc656; Jaeschke H, 2003, AM J PHYSIOL-GASTR L, V284, pG15, DOI 10.1152/ajpgi.00342.2002; Jamagin WR, 2002, ANN SURG, V236, P397, DOI 10.1097/01.SLA.0000029003.66466.B3; Karhausen J, 2005, CELL CYCLE, V4, P256; Karkampouna S, 2012, CURR PHARM DESIGN, V18, P4103, DOI 10.2174/138161212802430521; Khan Z, 2006, AM J PATHOL, V169, P1251, DOI 10.2353/ajpath.2006.060360; KOBELT F, 1994, SHOCK, V2, P281, DOI 10.1097/00024382-199410000-00009; Kopetz S, 2009, J CLIN ONCOL, V27, P3677, DOI 10.1200/JCO.2008.20.5278; Liu YL, 2014, TOXICOL LETT, V226, P117, DOI 10.1016/j.toxlet.2014.01.033; Lokmic Z, 2012, INT REV CEL MOL BIO, V296, P139, DOI 10.1016/B978-0-12-394307-1.00003-5; Lu H, 2016, HEPATOBIL SURG NUTR, V5, P141, DOI 10.3978/j.issn.2304-3881.2015.10.02; Maeno H, 2005, LIVER INT, V25, P1002, DOI 10.1111/j.1478-3231.2005.01144.x; Matot I, 2008, SHOCK, V29, P16, DOI 10.1097/shk.0b013e3180556964; Matot I, 2013, CRIT CARE MED, V41, P842, DOI 10.1097/CCM.0b013e3182711b38; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Miyaoka Y, 2013, CELL DIV, V8, DOI 10.1186/1747-1028-8-8; Mollenhauer M, 2012, LANGENBECK ARCH SURG, V397, P1313, DOI 10.1007/s00423-012-0998-5; Nath B, 2012, HEPATOLOGY, V55, P622, DOI 10.1002/hep.25497; Rankin EB, 2009, MOL CELL BIOL, V29, P4527, DOI 10.1128/MCB.00200-09; Schadde E, 2017, SURGERY, V161, P666, DOI 10.1016/j.surg.2016.05.018; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Takahashi K, 2016, TOHOKU J EXP MED, V239, P47, DOI 10.1620/tjem.239.47; van den Broek MAJ, 2008, LIVER INT, V28, P767, DOI 10.1111/j.1478-3231.2008.01777.x; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; WANG P, 1990, J SURG RES, V48, P464, DOI 10.1016/0022-4804(90)90014-S; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501	46	13	13	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5283	5295		10.1096/fj.201700153R	http://dx.doi.org/10.1096/fj.201700153R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28790176	Green Published			2022-12-28	WOS:000416588300014
J	Al-Owais, MM; Hettiarachchi, NT; Kirton, HM; Hardy, ME; Boyle, JP; Scragg, JL; Steele, DS; Peers, C				Al-Owais, Moza M.; Hettiarachchi, Nishani T.; Kirton, Hannah M.; Hardy, Matthew E.; Boyle, John P.; Scragg, Jason L.; Steele, Derek S.; Peers, Chris			A key role for peroxynitrite-mediated inhibition of cardiac ERG (Kv11.1) K+ channels in carbon monoxide-induced proarrhythmic early afterdepolarizations	FASEB JOURNAL			English	Article						nitric oxide; arrhythmia; potassium channel	HERG POTASSIUM CHANNELS; LONG-QT SYNDROME; HEME OXYGENASE-1; I-KR; TRANSGENIC MICE; ARRHYTHMIA; RANOLAZINE; RATS; INFARCTION; EXPRESSION	Exposure to CO causes early afterdepolarization arrhythmias. Previous studies in rats have indicated that arrhythmias arose as a result of augmentation of the late Na+ current. The purpose of the present study was to examine the basis for CO-induced arrhythmias in guinea pig myocytes in which action potentials (APs) more closely resemble those of human myocytes. Whole-cell current- and voltage-clamp recordings were made from isolated guinea pig myocytes as well as from human embryonic kidney 293 (HEK293) cells that express wild-type or a C723S mutant form of ether-a-go-go-related gene (ERG; Kv11.1). We also monitored the formation of peroxynitrite (ONOO-) in HEK293 cells fluorimetrically. CO-applied as the CO-releasing molecule, CORM-2-prolonged the APs and induced early afterdepolarizations in guinea pig myocytes. In HEK293 cells, CO inhibited wild-type, but not C723S mutant, Kv11.1 K+ currents. Inhibition was prevented by an antioxidant, mitochondrial inhibitors, or inhibition of NO formation. CO also raised ONOO- levels, an effect that was reversed by the ONOO- scavenger, FeTPPS [5,10,15,20-tetrakis-(4-sulfonatophenyl)-porphyrinato-iron(III)], which also prevented the CO inhibition of Kv11.1 currents and abolished the effects of CO on Kv11.1 tail currents and APs in guinea pig myocytes. Our data suggest that CO induces arrhythmias in guinea pig cardiac myocytes via the ONOO--mediated inhibition of Kv11.1 K+ channels.	[Al-Owais, Moza M.; Hettiarachchi, Nishani T.; Boyle, John P.; Scragg, Jason L.; Peers, Chris] Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Fac Med & Hlth, Div Cardiovasc & Diabet Res, Clarendon Way, Leeds LS2 9JT, W Yorkshire, England; [Kirton, Hannah M.; Hardy, Matthew E.; Steele, Derek S.] Univ Leeds, Fac Biol Sci, Leeds, W Yorkshire, England	University of Leeds; University of Leeds	Peers, C (corresponding author), Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Fac Med & Hlth, Div Cardiovasc & Diabet Res, Clarendon Way, Leeds LS2 9JT, W Yorkshire, England.	c.s.peers@leeds.ac.uk	Hardy, Matt/ABD-1397-2022	Hardy, Matt/0000-0002-3129-9549; Steele, Derek/0000-0002-1339-784X; Al-Owais, Moza/0000-0001-9122-7873; Kirton, Hannah Marie/0000-0001-5179-9770	British Heart Foundation [PG/13/61/30410]; British Heart Foundation [RG/16/6/32233] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by a grant from the British Heart Foundation (PG/13/61/30410; to C.P., J.L.S., and D.S.S.). The authors declare no conflicts of interest.	Andre L, 2010, AM J RESP CRIT CARE, V181, P587, DOI 10.1164/rccm.200905-0794OC; Balijepalli SY, 2012, CIRCULATION, V126, P2809, DOI 10.1161/CIRCULATIONAHA.112.118018; Bell ML, 2009, CIRCULATION, V120, P949, DOI 10.1161/CIRCULATIONAHA.109.851113; Clark JE, 2003, CIRC RES, V93, pE2, DOI 10.1161/01.RES.0000084381.86567.08; COBB N, 1991, JAMA-J AM MED ASSOC, V266, P659, DOI 10.1001/jama.266.5.659; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Dallas ML, 2012, AM J RESP CRIT CARE, V186, P648, DOI 10.1164/rccm.201204-0688OC; Davie C, 2004, J CARDIOVASC ELECTR, V15, P1302, DOI 10.1046/j.1540-8167.2004.04099.x; Du CY, 2014, J MOL CELL CARDIOL, V74, P220, DOI 10.1016/j.yjmcc.2014.05.013; Gandini C, 2001, J TOXICOL-CLIN TOXIC, V39, P35, DOI 10.1081/CLT-100102878; Hancox JC, 2008, PHARMACOL THERAPEUT, V119, P118, DOI 10.1016/j.pharmthera.2008.05.009; Henry CR, 2006, JAMA-J AM MED ASSOC, V295, P398, DOI 10.1001/jama.295.4.398; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Kolbe K, 2010, J PHYSIOL-LONDON, V588, P2999, DOI 10.1113/jphysiol.2010.192468; Lakkisto P, 2002, J MOL CELL CARDIOL, V34, P1357, DOI 10.1006/jmcc.2002.2094; Lee SY, 2004, J CARDIOVASC PHARM, V43, P706, DOI 10.1097/00005344-200405000-00014; Leffler CW, 2011, AM J PHYSIOL-HEART C, V301, pH1, DOI 10.1152/ajpheart.00230.2011; Liang SH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5676; MEREDITH T, 1988, BMJ-BRIT MED J, V296, P77, DOI 10.1136/bmj.296.6615.77; Misko TP, 1998, J BIOL CHEM, V273, P15646, DOI 10.1074/jbc.273.25.15646; Musameh MD, 2006, BRIT J PHARMACOL, V149, P1104, DOI 10.1038/sj.bjp.0706939; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Otterbein LE, 2016, CIRC RES, V118, P1940, DOI 10.1161/CIRCRESAHA.116.306588; Peers C, 2015, BRIT J PHARMACOL, V172, P1546, DOI 10.1111/bph.12760; Peers C, 2012, J MOL CELL CARDIOL, V52, P359, DOI 10.1016/j.yjmcc.2011.05.013; Rajamani S, 2008, J CARDIOVASC PHARM, V51, P581, DOI 10.1097/FJC.0b013e3181799690; Regan CP, 2005, J CARDIOVASC PHARM, V46, P68, DOI 10.1097/01.fjc.0000162774.86780.9d; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Satran D, 2005, J AM COLL CARDIOL, V45, P1513, DOI 10.1016/j.jacc.2005.01.044; Scragg JL, 2008, J BIOL CHEM, V283, P24412, DOI 10.1074/jbc.M803037200; Taglialatela M, 1997, P NATL ACAD SCI USA, V94, P11698, DOI 10.1073/pnas.94.21.11698; Thomas D, 2004, CARDIOVASC RES, V64, P467, DOI 10.1016/j.cardiores.2004.07.023; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Ueda K, 2008, P NATL ACAD SCI USA, V105, P9355, DOI 10.1073/pnas.0801294105; Varon J, 1999, J EMERG MED, V17, P87, DOI 10.1016/S0736-4679(98)00128-0; Von Burg R, 1999, J APPL TOXICOL, V19, P379; Wang GW, 2010, CIRCULATION, V121, P1912, DOI 10.1161/CIRCULATIONAHA.109.905471; Witchel HJ, 2007, EXPERT OPIN THER TAR, V11, P321, DOI 10.1517/14728222.11.3.321; Witchel HJ, 2011, CARDIOVASC THER, V29, P251, DOI 10.1111/j.1755-5922.2010.00154.x; Wu L, 2004, J PHARMACOL EXP THER, V310, P599, DOI 10.1124/jpet.104.066100; Wymore RS, 1997, CIRC RES, V80, P261, DOI 10.1161/01.RES.80.2.261; Yang WX, 2007, NEUROSCI LETT, V426, P128, DOI 10.1016/j.neulet.2007.09.007; Yet SF, 1999, J CLIN INVEST, V103, pR23, DOI 10.1172/JCI6163; Yet SF, 2001, CIRC RES, V89, P168, DOI 10.1161/hh1401.093314; Yoshida T, 2001, CIRCULATION, V103, P1695, DOI 10.1161/01.CIR.103.12.1695	46	9	9	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4845	4854		10.1096/fj.201700259R	http://dx.doi.org/10.1096/fj.201700259R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28743763	Green Published			2022-12-28	WOS:000413398500016
J	Aucagne, R; Girard, S; Mayotte, N; Lehnertz, B; Lopes-Paciencia, S; Gendron, P; Boucher, G; Chagraoui, J; Sauvageau, G				Aucagne, Romain; Girard, Simon; Mayotte, Nadine; Lehnertz, Bernhard; Lopes-Paciencia, Stephane; Gendron, Patrick; Boucher, Genevieve; Chagraoui, Jalila; Sauvageau, Guy			UBAP2L is amplified in a large subset of human lung adenocarcinoma and is critical for epithelial lung cell identity and tumor metastasis	FASEB JOURNAL			English	Article						UBAP2L; EMT-like phenotype; non-small cell lung cancer; metastasis	MESENCHYMAL TRANSITION; PROTEIN 2-LIKE; CANCER GENOMICS; CARCINOMA CELLS; MIGRATION; GROWTH	The ubiquitin-associated protein 2-like (UBAP2L) gene remains poorly studied in human and mouse development. UBAP2L interacts with the Polycomb group protein B lymphoma Mo-MLV insertion region 1 homolog (BMI1) and determines the activity of mouse hematopoietic stem cells in vivo. Here we show that loss of Ubap2l leads to disorganized respiratory epithelium of mutant neonates, which die of respiratory failure. We also show that UBAP2L overexpression leads to epithelial-mesenchymal transition-like phenotype in a non-small cell lung carcinoma (NSCLC) cell line. UBAP2L is amplified in 15% of human primary lung adenocarcinoma specimens. Such patients express higher levels of UBAP2L and show a reduction in survival when compared with those who do not have this gene amplification. Supporting a possible role for UBAP2L in lung tumor progression, NSCLC cells engineered to express low levels of this gene produce much smaller tumors in vivo than wild-type control cells. Together, these results suggest that UBAP2L contributes to epithelial lung cell identity in mice and that it plays an important role in human lung adenocarcinoma.-Aucagne, R., Girard, S., Mayotte, N., Lehnertz, B., Lopes-Paciencia, S., Gendron, P., Boucher, G., Chagraoui, J., Sauvageau, G. UBAP2L is amplified in a large subset of human lung adenocarcinoma and is critical for epithelial lung cell identity and tumor metastasis.	[Aucagne, Romain; Girard, Simon; Mayotte, Nadine; Lehnertz, Bernhard; Lopes-Paciencia, Stephane; Chagraoui, Jalila; Sauvageau, Guy] Univ Montreal, Lab Mol Genet Stem Cells, Montreal, PQ, Canada; [Gendron, Patrick; Boucher, Genevieve] Univ Montreal, IRIC, Bioinformat Platform, Montreal, PQ, Canada; [Sauvageau, Guy] Univ Montreal, Dept Med, Montreal, PQ, Canada; [Sauvageau, Guy] Maisonneuve Rosemont Hosp, Div Hematol, Montreal, PQ, Canada; [Aucagne, Romain] Univ Bourgogne, UFR Sci Sante, UMR 1231, SAPHIHR Lab, Dijon, France	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Sauvageau, G (corresponding author), Univ Montreal, IRIC, Downtown Stn, POB 6128, Montreal, PQ H3C 3J7, Canada.	guy.sauvageau@umontreal.ca		Sauvageau, Guy/0000-0002-4333-7266; Aucagne, Romain/0000-0002-5644-3287; Boucher, Genevieve/0000-0001-6389-9007; Lopes-Paciencia, Stephane/0000-0002-0819-1572; Gendron, Patrick/0000-0001-9829-2600; Lehnertz, Bernhard/0000-0003-1523-1410	Canadian Institutes of Health Research [MOP-15064, FDN-143286]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The authors thank Melanie Frechette and Valerie Blouin-Chagnon [both from the Institute for Research in Immunology and Cancer (IRIC)] for technical assistance, Celine Moison and Camille Simon (IRIC) for scientific comments, and IRIC core facilities staff for flow cytometry (Daniele Gagne and Gael Dulude) and histology (Dr. Louis Gaboury) services. This work was supported by Canadian Institutes of Health Research operating Grant MOP-15064 and foundation Grant FDN-143286 awarded to G.S. G.S. holds a Canada Research Chair in Molecular Genetics of Stem Cells. The authors declare no conflicts of interest.	Baumgartner R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003598; Bordeleau ME, 2014, BLOOD, V124, P2362, DOI 10.1182/blood-2014-01-548651; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chai R, 2016, TUMOR BIOL, V37, P13225, DOI 10.1007/s13277-016-5159-y; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; De Rubeis S, 2010, MOL CELL NEUROSCI, V43, P43, DOI 10.1016/j.mcn.2009.09.013; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kuniyoshi H, 2002, GENETICS, V162, P1775; Kwon SC, 2013, NAT STRUCT MOL BIOL, V20, P1122, DOI 10.1038/nsmb.2638; Lavigne MC, 2004, BIOCHEM BIOPH RES CO, V324, P534, DOI 10.1016/j.bbrc.2004.09.080; Li D, 2014, ONCOL REP, V32, P1578, DOI 10.3892/or.2014.3360; Luca R, 2013, EMBO MOL MED, V5, P1523, DOI 10.1002/emmm.201302847; Maeda M, 2016, FASEB J, V30, P312, DOI 10.1096/fj.14-268987; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Naz RK, 2010, J REPROD IMMUNOL, V84, P24, DOI 10.1016/j.jri.2009.10.006; Qu P, 2009, CANCER RES, V69, P7252, DOI 10.1158/0008-5472.CAN-09-0577; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tirino V, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.144; Torr E., 2016, PHYSL REP, V4; Wilde IB, 2011, J PROTEOME RES, V10, P1062, DOI 10.1021/pr1008543; Ye T, 2017, CELL PHYSIOL BIOCHEM, V41, P1584, DOI 10.1159/000470824; Zhao B, 2015, INT J MOL MED, V36, P1012, DOI 10.3892/ijmm.2015.2323	24	10	10	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					5012	5018		10.1096/fj.201601219RRR	http://dx.doi.org/10.1096/fj.201601219RRR			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28754713				2022-12-28	WOS:000413398500030
J	Lukic, A; Larssen, P; Fauland, A; Samuelsson, B; Wheelock, CE; Gabrielsson, S; Radmark, O				Lukic, Ana; Larssen, Pia; Fauland, Alexander; Samuelsson, Bengt; Wheelock, Craig E.; Gabrielsson, Susanne; Radmark, Olof			GM-CSF- and M-CSF-primed macrophages present similar resolving but distinct inflammatory lipid mediator signatures	FASEB JOURNAL			English	Article						eicosanoid; M1; M2; leukotriene; lipoxin	ALTERNATIVELY ACTIVATED MACROPHAGES; COLONY-STIMULATING FACTORS; LEUKOTRIENE BIOSYNTHESIS; ANTIINFLAMMATORY ACTIONS; CYSTEINYL-LEUKOTRIENES; HUMAN MONOCYTES; RESOLUTION; POLARIZATION; CELLS; 5-LIPOXYGENASE	M1 and M2 activated macrophages (M phi s) have different roles in inflammation. Because pathogens may first encounter resting cells, we investigated lipid mediator profiles prior to full activation. Human monocytes were differentiated with granulocyte M phi colony-stimulating factor (GM-CSF) or M phi colony-stimulating factor (M-CSF), which are known to prime toward M1 or M2 phenotypes, respectively. Lipid mediators released during resting conditions and produced in response to bacterial stimuli (LPS/N-formylmethionyl-leucyl-phenylalanine or peptidoglycan) were quantified by liquid chromatography-mass spectrometry. In resting conditions, both M phi phenotypes released primarily proresolving lipid mediators (prostaglandin E-2 metabolite, lipoxin A(4), and 18-hydroxyeicosapentaenoic acid). A striking shift toward proinflammatory eicosanoids was observed when the same cells were exposed (30 min) to bacterial stimuli: M-CSF M phi s produced considerably more 5-lipoxygenase products, particularly leukotriene C-4, potentially linked to M2 functions in asthma. Prostaglandins were formed by both M phi types. In the M-CSF cells, there was also an enhanced release of arachidonic acid and activation of cytosolic phospholipase A(2). However, GM-CSF cells expressed higher levels of 5-lipoxygenase and 5-lipoxygenase-activating protein, and in ionophore incubations these cells also produced the highest levels of 5-hydroxyeicosatetraenoic acid. In summary, GM-CSF and M-CSF M phi s displayed similar proresolving lipid mediator formation in resting conditions but shifted toward different proinflammatory eicosanoids upon bacterial stimuli. This demonstrates that preference for specific eicosanoid pathways is primed by CSFs before full M1/M2 activation.-Lukic, A., Larssen, P., Fauland, A., Samuelsson, B., Wheelock, C. E., Gabrielsson, S., Radmark, O. GM-CSF- and M-CSF-primed macrophages present similar resolving but distinct inflammatory lipid mediator signatures.	[Lukic, Ana; Fauland, Alexander; Samuelsson, Bengt; Wheelock, Craig E.; Radmark, Olof] Karolinska Inst, Div Physiol Chem 2, Dept Med Biochem & Biophys, Scheeles Vag 2, SE-17177 Stockholm, Sweden; [Larssen, Pia; Gabrielsson, Susanne] Karolinska Inst, Dept Med Solna, Immunol & Allergy Unit, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Radmark, O (corresponding author), Karolinska Inst, Div Physiol Chem 2, Dept Med Biochem & Biophys, Scheeles Vag 2, SE-17177 Stockholm, Sweden.	olof.radmark@ki.se	Gabrielsson, S./E-4145-2014	Gabrielsson, S./0000-0003-1771-1346	Swedish Medical Research Council; Swedish Cancer Foundation; Cancer Research Foundations of Radiumhemmet; Stockholm County Council; Swedish Heart-Lung Foundation; Center for Allergy Research; Cancer and Allergy Foundation; AstraZeneca Joint Research Program in Translational Science (ChAMP); Hesselman Foundation; Karolinska Institute (Stockholm, Sweden); Karin and Sten Mortstedt Initiative on Anaphylaxis (Stockholm, Sweden); Swedish Heart Lung Foundation [HLF 20150640]	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Cancer Foundation; Cancer Research Foundations of Radiumhemmet; Stockholm County Council(Stockholm County Council); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Center for Allergy Research; Cancer and Allergy Foundation; AstraZeneca Joint Research Program in Translational Science (ChAMP); Hesselman Foundation; Karolinska Institute (Stockholm, Sweden)(Karolinska Institutet); Karin and Sten Mortstedt Initiative on Anaphylaxis (Stockholm, Sweden); Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation)	The authors thank Johan Kolmert (Department of Environmental Medicine, Karolinska Institutet) for kind help and discussions. This work was supported by grants from the Swedish Medical Research Council, the Swedish Cancer Foundation, the Cancer Research Foundations of Radiumhemmet, the Stockholm County Council, the Swedish Heart-Lung Foundation, the Center for Allergy Research, the Cancer and Allergy Foundation, the AstraZeneca Joint Research Program in Translational Science (ChAMP), and the Hesselman Foundation, and from the Karolinska Institute (all in Stockholm, Sweden). A.F. was funded by the Karin and Sten Mortstedt Initiative on Anaphylaxis (Stockholm, Sweden). C.E.W. was supported by the Swedish Heart Lung Foundation (HLF 20150640). The authors declare no conflicts of interest.	Allen IC, 2006, AM J PHYSIOL-LUNG C, V290, pL526, DOI 10.1152/ajplung.00340.2005; Balgoma D, 2016, EUR RESPIR J, V47, P1645, DOI 10.1183/13993003.01080-2015; Bosse Y, 2008, CLIN EXP ALLERGY, V38, P113, DOI 10.1111/j.1365-2222.2007.02873.x; Buczynski MW, 2007, J BIOL CHEM, V282, P22834, DOI 10.1074/jbc.M701831200; Cabrero A, 2003, METABOLISM, V52, P652, DOI 10.1053/meta.2003.50100; Dai MY, 2015, J CELL PHYSIOL, V230, P2108, DOI 10.1002/jcp.24939; Dalli J, 2013, FASEB J, V27, P2573, DOI 10.1096/fj.13-227728; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859; Draijer C, 2016, J LEUKOCYTE BIOL, V100, P95, DOI 10.1189/jlb.3MAB1115-505R; Dziarski R, 2003, CELL MOL LIFE SCI, V60, P1793, DOI 10.1007/s00018-003-3019-6; Endo J, 2014, J EXP MED, V211, P1673, DOI 10.1084/jem.20132011; Esser J, 2011, FASEB J, V25, P1417, DOI 10.1096/fj.10-175828; Esser J, 2010, J ALLERGY CLIN IMMUN, V126, P1032, DOI 10.1016/j.jaci.2010.06.039; Fredman G, 2014, P NATL ACAD SCI USA, V111, P14530, DOI 10.1073/pnas.1410851111; FU JY, 1990, J BIOL CHEM, V265, P16737; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hamilton TA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00554; Ivanov I, 2015, GENE, V573, P1, DOI 10.1016/j.gene.2015.07.073; Jiang ZL, 2016, J ASTHMA ALLERGY, V9, P101, DOI 10.2147/JAA.S104508; Kita Y, 2005, BIOCHEM BIOPH RES CO, V330, P898, DOI 10.1016/j.bbrc.2005.03.055; Kolaczkowska E, 2002, INFLAMMATION, V26, P61, DOI 10.1023/A:1014837110735; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Lehmann C, 2015, FASEB J, V29, P5029, DOI 10.1096/fj.15-275487; Luan B, 2015, P NATL ACAD SCI USA, V112, P15642, DOI 10.1073/pnas.1519644112; Lukic A, 2016, J LIPID RES, V57, P1659, DOI 10.1194/jlr.M066910; Lundstrom SL, 2013, J LIPID RES, V54, P116, DOI 10.1194/jlr.M030171; Mandal AK, 2008, P NATL ACAD SCI USA, V105, P20434, DOI 10.1073/pnas.0808211106; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Matsuoka T, 2007, THESCIENTIFICWORLDJO, V7, P1329, DOI 10.1100/tsw.2007.182; Moreira AP, 2011, J INTERF CYTOK RES, V31, P485, DOI 10.1089/jir.2011.0027; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Namgaladze D, 2014, BBA-MOL CELL BIOL L, V1841, P1329, DOI 10.1016/j.bbalip.2014.06.007; Norris PC, 2014, P NATL ACAD SCI USA, V111, P12746, DOI 10.1073/pnas.1404372111; Norris PC, 2012, P NATL ACAD SCI USA, V109, P8517, DOI 10.1073/pnas.1200189109; Poczobutt JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079633; Poulin S, 2011, CLIN EXP ALLERGY, V41, P204, DOI 10.1111/j.1365-2222.2010.03653.x; Radmark O, 2015, BBA-MOL CELL BIOL L, V1851, P331, DOI 10.1016/j.bbalip.2014.08.012; Rossi A, 2014, PHARMACOL RES, V87, P1, DOI 10.1016/j.phrs.2014.05.011; Serhan CN, 2017, FASEB J, V31, P1273, DOI [10.1096/fj.201601222R, 10.1096/fj.201601222r]; Serhan CN, 2002, PROSTAG OTH LIPID M, V68-9, P433, DOI 10.1016/S0090-6980(02)00047-3; Shirey KA, 2014, MUCOSAL IMMUNOL, V7, P549, DOI 10.1038/mi.2013.71; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Sokolowska M, 2014, J BIOL CHEM, V289, P4470, DOI 10.1074/jbc.M113.515106; Surette ME, 1998, FASEB J, V12, P1521, DOI 10.1096/fasebj.12.14.1521; Thompson C, 2008, AM J RESP CELL MOL, V39, P227, DOI 10.1165/rcmb.2007-0293OC; Tjonahen E, 2006, CHEM BIOL, V13, P1193, DOI 10.1016/j.chembiol.2006.09.011; Varin A, 2015, ARTERIOSCL THROM VAS, V35, P1357, DOI 10.1161/ATVBAHA.115.305539; Wei C, 2009, MOL PHARMACOL, V76, P516, DOI 10.1124/mol.109.057489; Werz Oliver, 2002, Current Drug Targets - Inflammation and Allergy, V1, P23, DOI 10.2174/1568010023344959; Zhang YY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157035	54	41	41	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4370	4381		10.1096/fj.201700319R	http://dx.doi.org/10.1096/fj.201700319R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28637652				2022-12-28	WOS:000413397400016
J	Moreno-Navarrete, JM; Moreno, M; Ortega, F; Xifra, G; Hong, SY; Asara, JM; Serrano, JCE; Jove, M; Pissios, P; Bluher, M; Ricart, W; Portero-Otin, M; Fernandez-Real, JM				Maria Moreno-Navarrete, Jose; Moreno, Maria; Ortega, Francisco; Xifra, Gemma; Hong, Shangyu; Asara, John M.; Serrano, Jose C. E.; Jove, Mariona; Pissios, Pavlos; Blueher, Matthias; Ricart, Wifredo; Portero-Otin, Manuel; Manuel Fernandez-Real, Jose			TSHB mRNA is linked to cholesterol metabolism in adipose tissue	FASEB JOURNAL			English	Article						adipocyte; lipidomic; obesity; statins; HMGCR	THYROID-STIMULATING HORMONE; SERUM-LIPID PROFILES; SUBCLINICAL HYPOTHYROIDISM; POPULATION; INFLAMMATION; EXPRESSION; PATHWAY; OBESITY; STRESS; LIVER	Subclinical hypothyroidism is known to be associated with increased serum cholesterol. Since thyroid-stimulating hormone (TSH) exerts an inductor effect on cholesterol biosynthesis, we aimed to investigate the relationship between TSH mRNA and cholesterol metabolism in human adipose tissue (AT). Cross-sectionally, AT TSH-beta (TSHB) mRNA was evaluated in 4 independent cohorts in association with serum total and LDL cholesterol, and AT lipidomics. Longitudinally, the effects of statins and of diet and exercise on AT TSHB mRNA were also examined. The bidirectional relationship between cholesterol and TSHB were studied in isolated human adipocytes. TSHB mRNA was consistently detected in AT from euthyroid subjects, and positively associated with serum total- and LDL-cholesterol, and with AT-specific cholesterol metabolism-associated lipids [arachidonoyl cholesteryl ester, C8-dihydroceramide, N-stearoyl-d-sphingosine, and GlcCer(18:0, 24:1)]. Reduction of cholesterol with statins and with diet and exercise interventions led to decreased TSHB mRNA in human AT, whereas excess cholesterol up-regulated TSHB mRNA in human adipocytes. In addition, recombinant human TSH alpha/beta administration resulted in increased HMGCR mRNA levels in human adipocytes. In mice, subcutaneous AT Tshb expression levels correlated directly with circulating cholesterol levels. In summary, current results provide novel evidence of TSHB as a paracrine factor that is modulated in parallel with cholesterol metabolism in human AT.-Moreno-Navarrete, J. M., Moreno, M., Ortega, F., Xifra, G., Hong, S., Asara, J. M., Serrano, J. C. E., Jove, M., Pissios, P., Bluher, M., Ricart, W., Portero-Otin, M., Fernandez-Real, J. M. TSHB mRNA is linked to cholesterol metabolism in adipose tissue.	[Maria Moreno-Navarrete, Jose; Moreno, Maria; Ortega, Francisco; Xifra, Gemma; Ricart, Wifredo; Manuel Fernandez-Real, Jose] Inst Salud Carlos III ISCIII, Inst Invest Biomed Girona IdIBGi, Dept Diabet Endocrinol & Nutr, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Girona, Spain; [Xifra, Gemma; Ricart, Wifredo; Manuel Fernandez-Real, Jose] Univ Girona, Dept Med, Girona, Spain; [Hong, Shangyu; Pissios, Pavlos] Beth Israel Deaconess Med Ctr, Div Diabet Endocrinol & Metab, Boston, MA 02215 USA; [Asara, John M.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02215 USA; [Serrano, Jose C. E.; Jove, Mariona; Portero-Otin, Manuel] Univ Lleida, Nutr & Envelliment NUTREN Nutrigen, Cient & Tecnol Agroalimentari Lleida PCiTAL, Inst Recerca Biomed Lleida IRBLLEIDA, Lleida, Spain; [Blueher, Matthias] Univ Leipzig, Dept Med, Leipzig, Germany	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Universitat de Girona; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida; Leipzig University	Fernandez-Real, JM (corresponding author), Inst Salud Carlos III ISCIII, Inst Invest Biomed Girona IdIBGi, Dept Diabet Endocrinol & Nutr, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Girona, Spain.; Fernandez-Real, JM (corresponding author), Hosp Girona Dr Josep Trueta, Sect Diabet Endocrinol & Nutr, Carretera Franca S-N, Girona 17007, Spain.	jmfreal@idibgi.org	Moreno-Navarrete, José María/H-9772-2015; Jové, Mariona/M-9104-2016; Serrano, Jose C. E./C-6557-2011; Fernández-Real, Jose Manuel/AGH-3599-2022; Portero-Otin, Manuel/B-7122-2009; Ortega, Francisco José J/F-3883-2016; Moreno-Navarrete, José María/ABG-5548-2021	Moreno-Navarrete, José María/0000-0002-2883-511X; Jové, Mariona/0000-0001-5577-6162; Serrano, Jose C. E./0000-0001-6714-6061; Fernández-Real, Jose Manuel/0000-0002-7442-9323; Portero-Otin, Manuel/0000-0002-1823-0299; Ortega, Francisco José J/0000-0003-2111-769X; Moreno-Navarrete, José María/0000-0002-2883-511X	Instituto de Salud Carlos III from Spain [PI15/01934]; Fondo Europeo de Desarrollo Regional (FEDER); U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [DK083694]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083694] Funding Source: NIH RePORTER	Instituto de Salud Carlos III from Spain(Instituto de Salud Carlos III); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank A. Casane (Institut de Recerca Biomedica de Lleida) and E. Loshuertos and O. Rovira [Endocrinology, Institut d'Investigacio Biomedicade Girona (IdIBGi)] for technical help. We are indebted to the IdiBGi Biobank, integrated in the Spanish National Biobank Network, for the sample and data procurement. This work was partially supported by research grant PI15/01934 from the Instituto de Salud Carlos III from Spain, and was also supported by Fondo Europeo de Desarrollo Regional (FEDER). Centro de Investigacion Biomedica en Red (CIBER), Fisiopatologia de la Obesidad y Nutricion (OBN) is an initiative of the Instituto de Salud Carlos III of Spain. This study was also partially funded by U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant DK083694 (to P.P.). The authors declare no conflicts of interest.	Babenko NA, 1999, BIOCHEMISTRY-MOSCOW+, V64, P912; Bakker SJL, 2001, J CLIN ENDOCR METAB, V86, P1206, DOI 10.1210/jc.86.3.1206; Chakaroun R, 2012, METABOLISM, V61, P706, DOI 10.1016/j.metabol.2011.10.008; Chon Seung Joo, 2016, J Menopausal Med, V22, P146, DOI 10.6118/jmm.2016.22.3.146; Chung S, 2014, ARTERIOSCL THROM VAS, V34, P1880, DOI 10.1161/ATVBAHA.114.303896; Delitala AP, 2017, EUR J INTERN MED, V38, P17, DOI 10.1016/j.ejim.2016.12.015; Draman MS, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00083; Gao N, 2013, ATHEROSCLEROSIS, V227, P18, DOI 10.1016/j.atherosclerosis.2012.10.070; Haluzik M, 2003, J CLIN ENDOCR METAB, V88, P5605, DOI 10.1210/jc.2003-030576; Ittermann T, 2016, EUR RADIOL, V26, P4490, DOI 10.1007/s00330-016-4316-4; Jove M, 2014, FASEB J, V28, P1071, DOI 10.1096/fj.13-234419; Kolak M, 2007, DIABETES, V56, P1960, DOI 10.2337/db07-0111; KOVANEN PT, 1975, J LIPID RES, V16, P211; Lambrinoudaki I, 2012, J HYPERTENS, V30, P592, DOI 10.1097/HJH.0b013e32834f5076; Liu SD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124951; Lu SM, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-17; Menghini R, 2005, CIRCULATION, V111, P1946, DOI 10.1161/01.CIR.0000161814.02942.B2; MIETTINEN TA, 1981, INT J OBESITY, V5, P613; Morton NM, 2016, NAT MED, V22, P771, DOI 10.1038/nm.4115; Ohba K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018667; PORTER NA, 1995, LIPIDS, V30, P277, DOI 10.1007/BF02536034; Santos-Palacios S, 2013, CLIN ENDOCRINOL, V79, P874, DOI 10.1111/cen.12216; Song GH, 2016, SCI REP-UK, V6, DOI 10.1038/srep30889; Tian LM, 2010, HEPATOLOGY, V52, P1401, DOI 10.1002/hep.23800; Wang FR, 2012, J CLIN ENDOCR METAB, V97, P2724, DOI 10.1210/jc.2012-1133; Wang Y, 2015, J IMMUNOL, V195, P126, DOI 10.4049/jimmunol.1403149; Witte T, 2015, J CLIN ENDOCR METAB, V100, P2090, DOI 10.1210/jc.2014-4466; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Yang J, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12369; Zhang XJ, 2015, J LIPID RES, V56, P963, DOI 10.1194/jlr.M047654; Zhao M, 2015, THYROID, V25, P485, DOI 10.1089/thy.2014.0219; Zhou LY, 2016, SCI REP-UK, V6, DOI 10.1038/srep31381	32	9	9	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4482	4491		10.1096/fj.201700161R	http://dx.doi.org/10.1096/fj.201700161R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28646016	Green Published			2022-12-28	WOS:000413397400025
J	Marti-Pamies, I; Canes, L; Alonso, J; Rodriguez, C; Martinez-Gonzalez, J				Marti-Pamies, Ingrid; Canes, Laia; Alonso, Judith; Rodriguez, Cristina; Martinez-Gonzalez, Jose			The nuclear receptor NOR-1/NR4A3 regulates the multifunctional glycoprotein vitronectin in human vascular smooth muscle cells	FASEB JOURNAL			English	Article						atherosclerosis; extracellular matrix; cell migration	PLASMINOGEN-ACTIVATOR INHIBITOR-1; NF-KAPPA-B; TRANSCRIPTIONAL REGULATORS; NEOINTIMAL HYPERPLASIA; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; NOR-1; INJURY; PROLIFERATION; MIGRATION	The nuclear receptor NOR-1 (NR4A3) has recently been involved in the regulation of extracellular matrix (ECM) proteins associated with neointimal thickening and the vascular control of hemostasis. We sought to find as-yet unidentified NOR-1 target genes in human vascular smooth muscle cells (VSMCs). An in silico analysis identified putative NOR-1 response elements in the proximal promoter region of several genes encoding for ECM proteins, including vitronectin (VTN). Lentiviral overexpression of NOR-1 strongly increased VTN mRNA and protein levels, whereas NOR-1 silencing significantly reduced VTN expression. Deletion and site-directed mutagenesis studies, as well as EMSA and chromatin immunoprecipitation, identified the NBRE(-202/-195) site in the VTN promoter as an essential element for NOR-1 responsiveness. Furthermore, NOR-1 and VTN colocalized in VSMCs in human atherosclerotic lesions. VTN levels were increased in cell supernatants from VSMCs that overexpress NOR-1. Cell supernatants from VSMCs overexpressing NOR-1 induced cell migration to a greater extent than supernatants from control cells, and this effect was attenuated when cell supernatants were preincubated with anti-VTN blocking antibodies or VTN was silenced in supernatant-generating cells. These results indicate that VTN is a target of NOR-1 and suggest that this multifunctional glycoprotein may participate in vascular responses mediated by this nuclear receptor.-Marti-Pamies, I., Canes, L., Alonso, J., Rodriguez, C., Martinez-Gonzalez, J. The nuclear receptor NOR-1/NR4A3 regulates the multifunctional glycoprotein vitronectin in human vascular smooth muscle cells.	[Marti-Pamies, Ingrid; Canes, Laia; Alonso, Judith; Martinez-Gonzalez, Jose] CSIC, IIBB, Barcelona, Spain; [Rodriguez, Cristina] St Pau Biomed Res Inst, ICCC, Madrid, Spain; [Marti-Pamies, Ingrid; Alonso, Judith; Rodriguez, Cristina; Martinez-Gonzalez, Jose] Ctr Invest Biomed Red CIBER Enfermedades Cardiova, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); CIBER - Centro de Investigacion Biomedica en Red; CIBERCV	Martinez-Gonzalez, J (corresponding author), Hosp Santa Creu & Sant Pau, Inst Catala Ciencies Cardiovasc, Pabellon 11,Avda St Antoni Maria Claret 167, Barcelona 08025, Spain.	jmartinez@csic-iccc.org	Rodriguez, Cristina/D-3099-2011	Rodriguez, Cristina/0000-0002-6472-5647; Marti-Pamies, Ingrid/0000-0002-6870-2231; Canes Esteve, Laia/0000-0002-9579-1321; Alonso Nieto, Judith/0000-0003-0537-0417	Spanish Ministerio de Economia y Competitividad (MINECO)-Instituto de Salud Carlos III (ISCIII) [PI15/01016, SAF2015-64767-R, RD12/0042/0053]; Fundacio La Marato TV3 [20152330]; Fondo Europeo de Desarrollo Regional (FEDER)	Spanish Ministerio de Economia y Competitividad (MINECO)-Instituto de Salud Carlos III (ISCIII); Fundacio La Marato TV3; Fondo Europeo de Desarrollo Regional (FEDER)(European Commission)	The authors thank Naganari Ohkura (Growth Factor Division, National Cancer Center Research Institute, Tokyo, Japan) and James Hastie (Medical Research Council, University of Dundee, Dundee, United Kingdom) for kindly providing the human NOR-1 cDNA, and the plasmid containing the NOR-1-FLAG, respectively. This work was supported by Spanish Ministerio de Economia y Competitividad (MINECO)-Instituto de Salud Carlos III (ISCIII) Grants PI15/01016, SAF2015-64767-R and RD12/0042/0053 and Fundacio La Marato TV3 Grant 20152330. This study was cofunded by Fondo Europeo de Desarrollo Regional (FEDER). Centro de Investigacion Biomedica en Red (CIBER) de Enfermedades Cardiovasculares is an initiative of ISCIII-MINECO. The authors declare no conflicts of interest.	Alonso J, 2016, SCI REP-UK, V6, DOI 10.1038/srep34056; Bergmeier W, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005132; Bonta PI, 2006, ARTERIOSCL THROM VAS, V26, P2288, DOI 10.1161/01.ATV.0000238346.84458.5d; BROWN SL, 1994, CARDIOVASC RES, V28, P1815, DOI 10.1093/cvr/28.12.1815; Calvayrac O, 2015, J MOL CELL CARDIOL, V80, P34, DOI 10.1016/j.yjmcc.2014.12.015; Calvayrac O, 2011, ARTERIOSCL THROM VAS, V31, P2733, DOI 10.1161/ATVBAHA.111.235721; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chistiakov DA, 2013, CARDIOL REV, V21, P270, DOI 10.1097/CRD.0b013e31828c5ced; Churchman Adrian T., 2009, V467, P127, DOI 10.1007/978-1-59745-241-0_7; Coleman KR, 1999, CIRC RES, V84, P1268, DOI 10.1161/01.RES.84.11.1268; Dufourcq P, 2002, CARDIOVASC RES, V53, P952, DOI 10.1016/S0008-6363(01)00547-8; Dufourcq P, 1998, ARTERIOSCL THROM VAS, V18, P168, DOI 10.1161/01.ATV.18.2.168; Duren RP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150450; Ferran B, 2016, SCI REP-UK, V6, DOI 10.1038/srep25944; Garg N, 2010, J THROMB HAEMOST, V8, P1847, DOI 10.1111/j.1538-7836.2010.03907.x; Gizard F, 2011, J BIOL CHEM, V286, P35485, DOI 10.1074/jbc.M111.295840; Gruber F, 2003, BLOOD, V101, P3042, DOI 10.1182/blood-2002-07-2331; Guadall A, 2011, J BIOL CHEM, V286, P7093, DOI 10.1074/jbc.M110.162917; Halper J, 2014, ADV EXP MED BIOL, V802, P31, DOI 10.1007/978-94-007-7893-1_3; Konstantinides S, 2001, CIRCULATION, V103, P576, DOI 10.1161/01.CIR.103.4.576; Li P, 2013, CARDIOVASC RES, V99, P185, DOI 10.1093/cvr/cvt082; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; Martinez-Gonzalez J, 2005, CARDIOVASC RES, V65, P609, DOI 10.1016/j.cardiores.2004.10.002; Martinez-Gonzalez J, 2003, CIRC RES, V92, P96, DOI 10.1161/01.ES.0000050921.53008.47; Martorell L, 2007, J THROMB HAEMOST, V5, P1766, DOI 10.1111/j.1538-7836.2007.02627.x; Martorell L, 2009, MOL CELL BIOL, V29, P5828, DOI 10.1128/MCB.00945-09; Mullican SE, 2007, NAT MED, V13, P730, DOI 10.1038/nm1579; Nomiyama T, 2006, J BIOL CHEM, V281, P33467, DOI 10.1074/jbc.M603436200; Nomiyama T, 2009, CIRCULATION, V119, P577, DOI 10.1161/CIRCULATIONAHA.108.822056; Ohkura N, 1996, BBA-GENE STRUCT EXPR, V1308, P205, DOI 10.1016/0167-4781(96)00101-7; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Pei LM, 2005, J BIOL CHEM, V280, P29256, DOI 10.1074/jbc.M502606200; Preissner KT, 2011, SEMIN THROMB HEMOST, V37, P408, DOI 10.1055/s-0031-1276590; Preissner KT, 1998, THROMB RES, V89, P1, DOI 10.1016/S0049-3848(97)00298-3; PREISSNER KT, 1989, BLOOD, V74, P1989; Reuning U, 2011, J CELL BIOCHEM, V112, P1909, DOI 10.1002/jcb.23111; Rius J, 2006, ATHEROSCLEROSIS, V184, P276, DOI 10.1016/j.atherosclerosis.2005.04.008; Rius J, 2004, ARTERIOSCL THROM VAS, V24, P697, DOI 10.1161/01.ATV.0000121570.00515.dc; Rodriguez-Calvo R, 2015, THROMB HAEMOSTASIS, V113, P1323, DOI 10.1160/TH14-07-0645; Rodriguez-Calvo R, 2013, HUM MOL GENET, V22, P1949, DOI 10.1093/hmg/ddt042; Sambri I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141932; Sato R, 1994, J Atheroscler Thromb, V1 Suppl 1, pS50; Shimizu S, 2002, BBA-GENE STRUCT EXPR, V1574, P337, DOI 10.1016/S0167-4781(02)00232-4; Thakar RG, 2009, BIOPHYS J, V96, P3423, DOI 10.1016/j.bpj.2008.11.074; Wang YB, 2013, INT J CARDIOL, V168, P163, DOI 10.1016/j.ijcard.2012.09.100; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Wingate AD, 2006, BIOCHEM J, V393, P715, DOI 10.1042/BJ20050967; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Yang P, 2016, ARTERIOSCL THROM VAS, V36, P361, DOI 10.1161/ATVBAHA.115.306891; Zhao Y, 2010, CIRC RES, V107, P501, DOI 10.1161/CIRCRESAHA.110.222083; Zhao Y, 2010, ARTERIOSCL THROM VAS, V30, P1535, DOI 10.1161/ATVBAHA.109.191163	51	14	14	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4588	4599		10.1096/fj.201700136RR	http://dx.doi.org/10.1096/fj.201700136RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28666984				2022-12-28	WOS:000413397400034
J	Dumont, V; Tolvanen, TA; Kuusela, S; Wang, H; Nyman, TA; Lindfors, S; Tienari, J; Nisen, H; Suetsugu, S; Plomann, M; Kawachi, H; Lehtonen, S				Dumont, Vincent; Tolvanen, Tuomas A.; Kuusela, Sara; Wang, Hong; Nyman, Tuula A.; Lindfors, Sonja; Tienari, Jukka; Nisen, Harry; Suetsugu, Shiro; Plomann, Markus; Kawachi, Hiroshi; Lehtonen, Sanna			PACSIN2 accelerates nephrin trafficking and is up-regulated in diabetic kidney disease	FASEB JOURNAL			English	Article						endocytosis; recycling; rabenosyn-5; palmitate; podocyte	SLIT DIAPHRAGM; MEMBRANE-TRAFFICKING; FATTY-ACIDS; PROTEIN; NEPHROPATHY; PODOCYTES; COMPLEX; INJURY; GENE; ORGANIZATION	Nephrin is a core component of podocyte (glomerular epithelial cell) slit diaphragm and is required for kidney ultrafiltration. Down-regulation or mislocalization of nephrin has been observed in diabetic kidney disease (DKD), characterized by albuminuria. Here, we investigate the role of protein kinase C and casein kinase 2 substrate in neurons 2 (PACSIN2), a regulator of endocytosis and recycling, in the trafficking of nephrin and development of DKD. We observe that PACSIN2 is up-regulated and nephrin mislocalized in podocytes of obese Zucker diabetic fatty (ZDF) rats that have altered renal function. In cultured podocytes, PACSIN2 and nephrin colocalize and interact. We show that nephrin is endocytosed in PACSIN2-positive membrane regions and that PACSIN2 overexpression increases both nephrin endocytosis and recycling. We identify rabenosyn-5, which is involved in early endosome maturation and endosomal sorting, as a novel interaction partner of PACSIN2. Interestingly, rabenosyn-5 expression is increased in podocytes in obese ZDF rats, and, in vitro, its overexpression enhances the association of PACSIN2 and nephrin. We also show that palmitate, which is elevated in diabetes, enhances this association. Collectively, PACSIN2 is up-regulated and nephrin is abnormally localized in podocytes of diabetic ZDF rats. In vitro, PACSIN2 enhances nephrin turnover apparently via a mechanism involving rabenosyn-5. The data suggest that elevated PACSIN2 expression accelerates nephrin trafficking and associates with albuminuria.	[Dumont, Vincent; Tolvanen, Tuomas A.; Kuusela, Sara; Wang, Hong; Lindfors, Sonja; Tienari, Jukka; Lehtonen, Sanna] Univ Helsinki, Dept Pathol, Haartmaninkatu 3,B241, FIN-00290 Helsinki, Finland; [Nyman, Tuula A.] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Tienari, Jukka] Helsinki Univ Hosp, Dept Pathol, Hyvinkaa, Finland; [Nisen, Harry] Helsinki Univ Hosp, Dept Urol, Helsinki, Finland; [Suetsugu, Shiro] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma, Japan; [Plomann, Markus] Univ Cologne, Ctr Biochem, Cologne, Germany; [Kawachi, Hiroshi] Niigata Univ, Kidney Res Ctr, Dept Cell Biol, Grad Sch Med & Dent Sci, Niigata, Japan; [Nyman, Tuula A.] Univ Oslo, Dept Immunol, Inst Clin Med, Oslo, Norway; [Nyman, Tuula A.] Natl Hosp Norway, Oslo, Norway	University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Nara Institute of Science & Technology; University of Cologne; Niigata University; University of Oslo; University of Oslo; National Hospital Norway	Lehtonen, S (corresponding author), Univ Helsinki, Dept Pathol, Haartmaninkatu 3,B241, FIN-00290 Helsinki, Finland.	sanna.h.lehtonen@helsinki.fi	Lehtonen, Sanna/AAE-4545-2020; Lehtonen, Sanna/GRJ-3642-2022; Suetsugu, Shiro/ABB-6033-2020; Suetsugu, Shiro/AAF-4427-2019; Wang, Hong/AAW-6913-2020; Lindfors, Sonja/AAP-2050-2021; Suetsugu, Shiro/B-3300-2010	Lehtonen, Sanna/0000-0003-4189-2415; Suetsugu, Shiro/0000-0002-4612-0628; Wang, Hong/0000-0001-5700-6786; Lindfors, Sonja/0000-0002-2024-0760; Suetsugu, Shiro/0000-0002-4612-0628; Dumont, Vincent/0000-0002-2893-5479; Kuusela, Sara/0000-0002-2790-5841; Tolvanen, Tuomas Aleksi/0000-0002-3581-208X	Academy of Finland [121248, 131255, 218021]; Sigrid Juselius Foundation; Paivikki and Sakari Sohlberg Foundation; Diabetes Research Foundation; Faculty of Medicine, University of Helsinki; Research Foundation of the University of Helsinki; Helsinki Biomedical Graduate Program; Finnish Cultural Foundation; Helsinki University Hospital grant; Japan Society for the Promotion of Science (JSPS) [15H05902]; Grants-in-Aid for Scientific Research [17H06006] Funding Source: KAKEN	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Paivikki and Sakari Sohlberg Foundation; Diabetes Research Foundation; Faculty of Medicine, University of Helsinki; Research Foundation of the University of Helsinki; Helsinki Biomedical Graduate Program; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Helsinki University Hospital grant; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Dr. Andrey S. Shaw (Washington University School of Medicine, St. Louis, MO, USA) for the mouse podocyte cell line, and Dr. Silvia Corvera (University of Massachusetts Medical School, Worcester, MA, USA) for providing the rabenosyn-5 IgG; Dr. Yosuke Senju and Dr. Johan Peranen (both from the University of Helsinki) for fruitful discussions; Niina Ruoho and Leena Saikko (both from the University of Helsinki) for skillful technical assistance; and the Biomedicum Imaging Unit and Biochemical Analysis Core for Experimental Research of the University of Helsinki for help in imaging and metabolic measurements, respectively. This work was supported by the Academy of Finland (121248, 131255, 218021; to S.L.); the Sigrid Juselius Foundation (to S.L.); the Paivikki and Sakari Sohlberg Foundation (to S.L.); the Diabetes Research Foundation (to S.L.); the Faculty of Medicine, University of Helsinki (to S.L.); the Research Foundation of the University of Helsinki (to V.D.); the Helsinki Biomedical Graduate Program (to V.D. and T.A.T.); the Finnish Cultural Foundation (to V.D.); the Helsinki University Hospital grant (to J.T.); and the Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (15H05902; to S.S.).	Baynes J, 2009, OXID MED CELL LONGEV, V2, P328, DOI 10.4161/oxim.2.5.9831; Billcliff PG, 2016, MOL BIOL CELL, V27, P90, DOI 10.1091/mbc.E15-06-0329; Bonnet F, 2001, DIABETOLOGIA, V44, P874; Coimbra TM, 2000, KIDNEY INT, V57, P167, DOI 10.1046/j.1523-1755.2000.00836.x; De Renzis S, 2002, NAT CELL BIOL, V4, P124, DOI 10.1038/ncb744; Foley RN, 2013, CLIN J AM SOC NEPHRO, V8, P845, DOI 10.2215/CJN.06840712; FRAZE E, 1985, J CLIN ENDOCR METAB, V61, P807, DOI 10.1210/jcem-61-5-807; Giridharan SSP, 2013, MOL BIOL CELL, V24, P1776, DOI 10.1091/mbc.E13-01-0026; HAGENFEL.L, 1972, J CLIN INVEST, V51, P2324, DOI 10.1172/JCI107043; Heikkila E, 2011, BIOCHEM J, V435, P619, DOI 10.1042/BJ20101599; Hoshi S, 2002, LAB INVEST, V82, P25, DOI 10.1038/labinvest.3780392; HOSTETTER TH, 1981, KIDNEY INT, V19, P410, DOI 10.1038/ki.1981.33; Huber TB, 2003, HUM MOL GENET, V12, P3397, DOI 10.1093/hmg/ddg360; Hyvonen ME, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/102969; Ina K, 2002, J ELECTRON MICROSC, V51, P275, DOI 10.1093/jmicro/51.4.275; Inoki K, 2011, J CLIN INVEST, V121, P2181, DOI 10.1172/JCI44771; Kessels MM, 2004, J CELL SCI, V117, P3077, DOI 10.1242/jcs.01290; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Ku CH, 2008, DIABETES, V57, P2824, DOI 10.2337/db08-0647; Lehtonen S, 2002, AM J PHYSIOL-RENAL, V283, pF734, DOI 10.1152/ajprenal.00312.2001; Lehtonen S, 2004, AM J PATHOL, V165, P923, DOI 10.1016/S0002-9440(10)63354-8; Liu L, 2001, HUM MOL GENET, V10, P2637, DOI 10.1093/hmg/10.23.2637; Menne J, 2006, KIDNEY INT, V70, P1456, DOI 10.1038/sj.ki.5001830; Modregger J, 2000, J CELL SCI, V113, P4511; New LA, 2014, CURR OPIN NEPHROL HY, V23, P420, DOI 10.1097/01.mnh.0000447018.28852.b6; Nielsen E, 2000, J CELL BIOL, V151, P601, DOI 10.1083/jcb.151.3.601; Qin XS, 2009, J AM SOC NEPHROL, V20, P2534, DOI 10.1681/ASN.2009010011; Quack I, 2006, P NATL ACAD SCI USA, V103, P14110, DOI 10.1073/pnas.0602587103; Quack I, 2011, J BIOL CHEM, V286, P12959, DOI 10.1074/jbc.M110.204024; Satoh D, 2014, J BIOCHEM, V156, P115, DOI 10.1093/jb/mvu022; Savijoki K, 2011, J PROTEOME RES, V10, P3460, DOI 10.1021/pr2000896; Senju Y, 2015, J CELL SCI, V128, P2766, DOI 10.1242/jcs.167775; Senju Y, 2011, J CELL SCI, V124, P2032, DOI 10.1242/jcs.086264; Sorensson J, 2002, J AM SOC NEPHROL, V13, P2639, DOI 10.1097/01.ASN.0000033277.32822.23; Stockler S, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0141-5; Subramanian B, 2016, KIDNEY INT, V90, P363, DOI 10.1016/j.kint.2016.04.020; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Tolvanen TA, 2015, J CELL SCI, V128, P4588, DOI 10.1242/jcs.175075; Tossidou I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010185; Wasik AA, 2017, EXP CELL RES, V350, P336, DOI 10.1016/j.yexcr.2016.12.010; Xie SW, 2016, MOL BIOL CELL, V27, P108, DOI 10.1091/mbc.E15-07-0514; Yao G, 2014, HUM MOL GENET, V23, P2769, DOI 10.1093/hmg/ddt672; Yao G, 2013, KIDNEY INT, V83, P426, DOI 10.1038/ki.2012.379; Yasuda M, 2014, BBA-MOL BASIS DIS, V1842, P1097, DOI 10.1016/j.bbadis.2014.04.001	44	23	23	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3978	3990		10.1096/fj.201601265R	http://dx.doi.org/10.1096/fj.201601265R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28550045	Green Published, hybrid			2022-12-28	WOS:000408713300023
J	Bedarida, T; Domingues, A; Baron, S; Ferreira, C; Vibert, F; Cottart, CH; Paul, JL; Escriou, V; Bigey, P; Gaussem, P; Leguillier, T; Nivet-Antoine, V				Bedarida, Tatiana; Domingues, Alison; Baron, Stephanie; Ferreira, Chrystophe; Vibert, Francoise; Cottart, Charles-Henry; Paul, Jean-Louis; Escriou, Virginie; Bigey, Pascal; Gaussem, Pascale; Leguillier, Teddy; Nivet-Antoine, Valerie			Reduced endothelial thioredoxin-interacting protein protects arteries from damage induced by metabolic stress in vivo	FASEB JOURNAL			English	Article						TXNIP; HP-LC diet; arterial damage; endothelial dysfunction; inflammation	SMOOTH-MUSCLE-CELLS; OXIDATIVE STRESS; INFLAMMASOME ACTIVATION; INSULIN-RESISTANCE; DISEASE; MICE; DYSFUNCTION; RESVERATROL; MOUSE; DIET	Although thioredoxin-interacting protein (TXNIP) is involved in a variety of biologic functions, the contribution of endothelial TXNIP has not been well defined. To investigate the endothelial function of TXNIP, we generated a TXNIP knockout mouse on the Cdh5-cre background (TXNIPfl/fl cdh5(cre)). Control (TXNIPfl/fl) and TXNIPfl/fl cdh5(cre) mice were fed a high protein-low carbohydrate (HP-LC) diet for 3 mo to induce metabolic stress. We found that TXNIPfl/fl and TXNIPfl/fl cdh5(cre) mice on an HP-LC diet displayed impaired glucose tolerance and dyslipidemia concretizing the metabolic stress induced. We evaluated the impact of this metabolic stress on mice with reduced endothelial TXNIP expression with regard to arterial structure and function. TXNIPfl/fl cdh5(cre) mice on an HP-LC diet exhibited less endothelial dysfunction than littermate mice on an HP-LC diet. These mice were protected from decreased aortic medial cell content, impaired aortic distensibility, and increased plasminogen activator inhibitor 1 secretion. This protective effect came with lower oxidative stress and lower inflammation, with a reduced NLRP3 inflammasome expression, leading to a decrease in cleaved IL-1 beta. We also show the major role of TXNIP in inflammation with a knockdown model, using a TXNIP-specific, small interfering RNA included in a lipoplex. These findings demonstrate a key role for endothelial TXNIP in arterial impairments induced by metabolic stress, making endothelial TXNIP a potential therapeutic target.				valerie.nivet-antoine@parisdescartes.fr	Nivet-Antoine, Valerie/R-1981-2017; Gaussem, Pascale/AGY-9723-2022; Gaussem, P./ABA-1222-2020; Gaussem, Pascale/ABA-2228-2020; Baron, Stephanie/AAY-5703-2020	Nivet-Antoine, Valerie/0000-0003-2490-0428; Gaussem, P./0000-0002-9139-2147; Baron, Stephanie/0000-0002-0375-6968; Escriou, Virginie/0000-0001-5686-9301; Cottart, Charles-Henry/0000-0003-3776-957X; bigey, pascal/0000-0002-6795-8569; Ferreira, Chrystophe/0000-0002-1990-278X; /0000-0002-5493-455X	French Ministry of Research and Technology; INSERM; Paris Descartes University	French Ministry of Research and Technology; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Paris Descartes University	The authors thank the Cellular and Molecular Imaging Platform (CRP2-UMS3612CNRS-US25 INSERM-IRD) Faculte de Pharmacie, Paris Descartes University, and the Small Animals Platform of the Cochin Institute for Echo-Doppler Assessment. The authors also thank ATT Traduction Technique et Scientifique (Clermont-Ferrand, France) for language editing, Amal Zerrad-Saadi (INSERM, Unite Mixte de Recherche (UMR) S-1139, Paris, France) and Tharmarajan Ramprasath (Madurai Kamaraj University, Madurai, India) for their advice, and Antoine Giraud, Nizar Mahrouk, and Blandine Dizier (INSERM UMR S-1140, Paris, France) for their technical assistance. T.B. and A.D. were supported by funds from the French Ministry of Research and Technology. This work was funded by grants from INSERM and Paris Descartes University. The authors declare no conflicts of interest.	Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; Apostolakis Stavros, 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P150, DOI 10.2174/187152508783955006; Arruda DC, 2016, METHODS MOL BIOL, V1445, P137, DOI 10.1007/978-1-4939-3718-9_8; Baron S, 2014, J GERONTOL A-BIOL, V69, P260, DOI 10.1093/gerona/glt081; Bedarida T, 2016, J GERONTOL A-BIOL, V71, P720, DOI 10.1093/gerona/glv071; Bedarida T, 2014, AM J PHYSIOL-HEART C, V307, pH649, DOI 10.1152/ajpheart.00291.2014; Bousserouel S, 2003, J LIPID RES, V44, P601, DOI 10.1194/jlr.M200092-JLR200; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2009070721, 10.1681/ASN.2004080648]; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Csiszar A, 2002, CIRC RES, V90, P1159, DOI 10.1161/01.RES.0000020401.61826.EA; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; DESILVA HV, 1994, J LIPID RES, V35, P1297; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Foo SY, 2009, P NATL ACAD SCI USA, V106, P15418, DOI 10.1073/pnas.0907995106; Honjo K, 2017, FASEB J, V31, P2625, DOI 10.1096/fj.201600871RR; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Ishrat T, 2015, MOL NEUROBIOL, V51, P766, DOI 10.1007/s12035-014-8766-x; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; LIBBY P, 1988, J CLIN INVEST, V81, P487, DOI 10.1172/JCI113346; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahmood DFD, 2013, ANTIOXID REDOX SIGN, V19, P1266, DOI 10.1089/ars.2012.4757; Mohamed IN, 2014, DIABETOLOGIA, V57, P413, DOI 10.1007/s00125-013-3101-z; Nivet-Antoine V, 2013, ATHEROSCLEROSIS, V227, P100, DOI 10.1016/j.atherosclerosis.2012.12.015; Nivet-Antoine V, 2010, BIOCHIMIE, V92, P1766, DOI 10.1016/j.biochi.2010.07.018; Oslowski CM, 2012, CELL METAB, V16, P265, DOI 10.1016/j.cmet.2012.07.005; Shah A, 2013, J BIOL CHEM, V288, P6835, DOI 10.1074/jbc.M112.419101; Spindel ON, 2012, J CLIN INVEST, V122, P30, DOI 10.1172/JCI61467; Sun D, 2004, AM J PHYSIOL-HEART C, V286, pH2249, DOI 10.1152/ajpheart.00854.2003; Ungvari Z, 2008, CIRC RES, V102, P519, DOI 10.1161/CIRCRESAHA.107.168369; Ungvari Z, 2007, AM J PHYSIOL-HEART C, V293, pH37, DOI 10.1152/ajpheart.01346.2006; Verma S, 2003, CIRCULATION, V108, P2054, DOI 10.1161/01.CIR.0000089191.72957.ED; Wang XQ, 2012, CIRC RES, V110, P560, DOI 10.1161/CIRCRESAHA.111.256362; Wu D, 2017, ARTERIOSCL THROM VAS, V37, P694, DOI 10.1161/ATVBAHA.116.307648; Yoshioka J, 2007, CIRC RES, V101, P1328, DOI 10.1161/CIRCRESAHA.106.160515; Zheng F, 2013, HEART LUNG CIRC, V22, P746, DOI 10.1016/j.hlc.2013.01.012; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831; Zhou RH, 2012, ARTERIOSCL THROM VAS, V32, P745, DOI 10.1161/ATVBAHA.111.243121	38	10	10	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3108	3118		10.1096/fj.201700856RRR	http://dx.doi.org/10.1096/fj.201700856RRR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401599				2022-12-28	WOS:000432546000018
J	Chen, X; Ling, Y; Wei, YP; Tang, J; Ren, YB; Zhang, BH; Jiang, F; Li, HY; Wang, RY; Wen, W; Lv, GS; Wu, MC; Chen, L; Li, L; Wang, HY				Chen, Xin; Ling, Yan; Wei, Yanping; Tang, Jing; Ren, Yibing; Zhang, Baohua; Jiang, Feng; Li, Hengyu; Wang, Ruoyu; Wen, Wen; Lv, Guishuai; Wu, Mengchao; Chen, Lei; Li, Liang; Wang, Hongyang			Dual regulation of HMGB1 by combined JNK1/2-ATF2 axis with miR-200 family in nonalcoholic steatohepatitis in mice	FASEB JOURNAL			English	Article						NAFLD; NASH; HMG1; JNK; microRNA-429	FATTY LIVER-DISEASE; CHROMATIN PROTEIN HMGB1; GROUP BOX-1 PROTEIN; TOLL-LIKE RECEPTORS; HEPATOCELLULAR-CARCINOMA; CLIP-SEQ; CANCER; ACTIVATION; OBESITY; INFLAMMATION	In the context of diabetes, obesity, and metabolic syndrome, the inflammatory signaling has critical roles in the pathogenesis of nonalcoholic fatty liver disease (NAFLD), but the underlying mechanisms remain poorly delineated. Herein, early and persistently elevated, proinflammatory cytokine HMGB1 expression was detected in a high-fat diet (HFD)-induced NAFLD model in C57BL/6 mice. The expression and extracellular release of HMGB1 was rapidly and dramatically induced by saturated palmitic acid in vitro. HFD-induced inflammatory response and liver function impairment were both mitigated after the inhibition of endogenous HMGB1 by neutralizing antibody in vivo. The up-regulation of HMGB1 was thought to be modified by dual channels: in the transcriptional level, it was regulated by JNK1/JNK2-ATF2 axis; post-transcriptionally, it was regulated by the microRNA (miR)-200 family, especially miR-429. miR-429 liver conditional knockout mice (miR-429(Delta hep)), fed either a normal diet or an HFD, showed severe liver inflammation and dysfunction, accompanied by greater expression of HMGB1. Intriguingly, the up-regulation and release of HMGB1 could in turn self-activate TLR4-JNK1/JNK2-ATF2 signaling, thus forming a positive feedback. Our findings reveal a novel mechanism by which HMGB1 expression was regulated by both the JNK1/2 -ATF2 axis and the miR-200 family, which provides a potential new approach for the treatment of NAFLD.	[Chen, Xin; Ling, Yan; Wei, Yanping; Ren, Yibing; Li, Hengyu; Wen, Wen; Lv, Guishuai; Chen, Lei; Li, Liang; Wang, Hongyang] Second Mil Med Univ, Eastern Hepatobiliary Surg Inst, Int Cooperat Lab Signal Transduct, Shanghai, Peoples R China; [Zhang, Baohua; Wang, Ruoyu; Wu, Mengchao] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China; [Li, Hengyu] Second Mil Med Univ, Changhai Hosp, Shanghai, Peoples R China; [Chen, Xin; Ling, Yan; Wei, Yanping; Ren, Yibing; Wen, Wen; Lv, Guishuai; Chen, Lei; Li, Liang; Wang, Hongyang] Natl Ctr Liver Canc, Shanghai, Peoples R China; [Wei, Yanping] Fujian Med Univ, Grad Sch, Fuzhou, Fujian, Peoples R China; [Tang, Jing] Wuhan Gen Hosp Guangzhou Command, Dept Neurosurg, Wuhan, Hubei, Peoples R China; [Jiang, Feng] Canc Hosp Jiangsu Prov, Jiangsu Key Lab Mol & Translat Canc Res, Nanjing, Jiangsu, Peoples R China; [Wang, Hongyang] Shanghai Jiao Tong Univ, RenJi Hosp, Canc Inst, Natl Lab Oncogenes & Related Genes, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; Fujian Medical University; Nanjing Medical University; Shanghai Jiao Tong University	Li, L; Wang, HY (corresponding author), Natl Ctr Liver Canc, Shanghai, Peoples R China.	liliangyuanquan@163.com; hywangk@vip.sina.com	Chen, Lei/AAG-6304-2020; Li, Liang/AAY-9298-2020	Li, Liang/0000-0002-9410-6513	State Key Project for Liver Cancer [2015ZX09J15107]; National Research Program of China [2012CB316503, 2012AA02A201]; National Natural Science Foundation of China [81521091, 81372674, 81672777]; Science Foundation of Shanghai [2017ZZ01007, 17QA1405700, 20154Y0054]	State Key Project for Liver Cancer; National Research Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	The authors thank Dongping Hu, Shanhua Tang, Linna Guo, Liang Chi, Dandan Huang, Dan Cao, Shanna Huang, Huanlin Sun, Shennian Ge, and Congli Hu (all from the National Center for Liver Cancer, Shanghai, China) for technical assistance. H. W. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The authors gratefully acknowledge the support from the State Key Project for Liver Cancer (2015ZX09J15107), the National Research Program of China (2012CB316503, 2012AA02A201), the National Natural Science Foundation of China (81521091, 81372674 and 81672777), and the Science Foundation of Shanghai (2017ZZ01007, 17QA1405700 and 20154Y0054). The authors declare no conflicts of interest.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alisi A, 2011, HEPATOLOGY, V54, P1500, DOI 10.1002/hep.24611; Beg AA, 2002, TRENDS IMMUNOL, V23, P509, DOI 10.1016/S1471-4906(02)02317-7; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Gan LT, 2014, J HEPATOL, V61, P1376, DOI 10.1016/j.jhep.2014.07.024; Hunter JE, 2010, AM J CLIN NUTR, V91, P46, DOI 10.3945/ajcn.2009.27661; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Li L, 2015, GUT, V64, P156, DOI 10.1136/gutjnl-2013-305715; Li L, 2011, HEPATOLOGY, V54, P1620, DOI 10.1002/hep.24552; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; Park JW, 2015, LIVER INT, V35, P2155, DOI 10.1111/liv.12818; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Rivera CA, 2007, J HEPATOL, V47, P571, DOI 10.1016/j.jhep.2007.04.019; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Solinas G, 2010, FASEB J, V24, P2596, DOI 10.1096/fj.09-151340; Spruss A, 2009, HEPATOLOGY, V50, P1094, DOI 10.1002/hep.23122; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Sun BC, 2012, J HEPATOL, V56, P704, DOI 10.1016/j.jhep.2011.09.020; Tu QQ, 2014, ACTA PHARMACOL SIN, V35, P504, DOI 10.1038/aps.2013.170; Wu He-Shui, 2004, Hepatobiliary Pancreat Dis Int, V3, P250; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Youn JH, 2006, J IMMUNOL, V177, P7889, DOI 10.4049/jimmunol.177.11.7889	27	19	21	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2722	2734		10.1096/fj.201700875R	http://dx.doi.org/10.1096/fj.201700875R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29298863				2022-12-28	WOS:000432528000032
J	Choi, HJ; Kim, I; Lee, HJ; Park, YH; Suh, JY; Han, JY				Choi, Hee Jung; Kim, Iktae; Lee, Hong Jo; Park, Young Hyun; Suh, Jeong-Yong; Han, Jae Yong			Chicken NANOG self-associates via a novel folding-upon-binding mechanism	FASEB JOURNAL			English	Article						intrinsically disordered protein; primordial germ cell; blastoderm cells	EMBRYONIC STEM-CELLS; PRIMORDIAL GERM-CELLS; TRANSCRIPTION FACTOR NANOG; UNSTRUCTURED PROTEINS; INTRINSIC DISORDER; IN-VITRO; ES CELLS; PLURIPOTENCY; MOUSE; EXPRESSION	NANOG plays a pivotal role in pluripotency acquisition and lineage specification in higher vertebrates, and its expression is restricted to primordial germ cells (PGCs) during early embryonic development. Mammalian NANOG self-associates via conserved tryptophan-repeat motifs in the C-terminal domain (CTD) to maintain pluripotency. Avian NANOG, however, lacks the conserved motifs, and the molecular mechanism underlying the biologic function is not clearly understood. Here, using spectroscopic and biochemical methods as well as cell-based assays, we report that chicken NANOG (cNANOG) oligomerizes through its CTD via a novel folding-upon-binding mechanism. The CTD of cNANOG is disordered as a monomer and associates into an a-helical multimer driven by intermolecular hydrophobic interactions. Mutation of key aromatic residues in the CTD abrogates the selfassociation, leading to a loss of the proliferation of chicken PGCs and blastoderm cells. Our results demonstrate that the CTD of cNANOG belongs to a novel IDP that switches into a helical oligomer via self-association, enabling the maintenance of PGCs and blastoderm cells.	[Choi, Hee Jung; Kim, Iktae; Lee, Hong Jo; Park, Young Hyun; Suh, Jeong-Yong; Han, Jae Yong] Seoul Natl Univ, Coll Agr & Life Sci, Res Inst Agr & Life Sci, Dept Agr Biotechnol, Seoul, South Korea; [Suh, Jeong-Yong; Han, Jae Yong] Shinshu Univ, Inst Biomed Sci, Minamiminowa, Japan	Seoul National University (SNU); Shinshu University	Suh, JY; Han, JY (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, 1 Gwanak Ro, Seoul 08826, South Korea.	jysuh@snu.ac.kr; jaehan@snu.ac.kr			National Research Foundation of Korea (NRF) [2015R1A3A2033826, 2017004471]; Korean Ministry of Science and Information and Communication Technology (ICT)	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean Ministry of Science and Information and Communication Technology (ICT)	This work was supported by National Research Foundation of Korea (NRF) Grants 2015R1A3A2033826 and 2017004471, funded by the Korean Ministry of Science and Information and Communication Technology (ICT). The authors declare no conflicts of interest.	Canon S, 2006, DEV DYNAM, V235, P2889, DOI 10.1002/dvdy.20927; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chang DF, 2009, STEM CELLS, V27, P812, DOI 10.1634/stemcells.2008-0657; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dixon JE, 2010, DEVELOPMENT, V137, P2973, DOI 10.1242/dev.049262; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; Han M, 2014, P NATL ACAD SCI USA, V111, P18613, DOI 10.1073/pnas.1419525112; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; Hatano S, 2005, MECH DEVELOP, V122, P67, DOI 10.1016/j.mod.2004.08.008; Hayashi Y, 2015, P NATL ACAD SCI USA, V112, P4666, DOI 10.1073/pnas.1502855112; Hwang YS, 2016, SCI REP-UK, V6, DOI 10.1038/srep36704; Jauch R, 2008, J MOL BIOL, V376, P758, DOI 10.1016/j.jmb.2007.11.091; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kim PM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.16; Korasick DA, 2014, P NATL ACAD SCI USA, V111, P5427, DOI 10.1073/pnas.1400074111; Lavial F, 2007, DEVELOPMENT, V134, P3549, DOI 10.1242/dev.006569; Lavial F, 2009, DEV BIOL, V330, P73, DOI 10.1016/j.ydbio.2009.03.012; Lee SI, 2011, P NATL ACAD SCI USA, V108, P10426, DOI 10.1073/pnas.1106141108; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mullin NP, 2008, BIOCHEM J, V411, P227, DOI 10.1042/BJ20080134; Mullins NP, 2017, J MOL BIOL, V429, P1544, DOI 10.1016/j.jmb.2016.12.001; Murakami K, 2016, NATURE, V529, P403, DOI 10.1038/nature16480; Nakanoh S, 2013, ZOOL SCI, V30, P543, DOI 10.2108/zsj.30.543; Nanao MH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4617; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Pain B, 1996, DEVELOPMENT, V122, P2339; Park TS, 2012, P NATL ACAD SCI USA, V109, P9337, DOI 10.1073/pnas.1203823109; Saunders A, 2013, STEM CELLS, V31, P1227, DOI 10.1002/stem.1384; Schuff M, 2012, STEM CELLS DEV, V21, P1225, DOI 10.1089/scd.2011.0285; Siu MKY, 2013, ONCOGENE, V32, P3500, DOI 10.1038/onc.2012.363; Theunissen TW, 2011, DEVELOPMENT, V138, P4853, DOI 10.1242/dev.068775; Tompa P, 2008, PROTEINS, V71, P903, DOI 10.1002/prot.21773; Torres-Padilla ME, 2014, DEVELOPMENT, V141, P2173, DOI 10.1242/dev.102624; Sanchez-Sanchez AV, 2010, STEM CELLS, V28, P1457, DOI 10.1002/stem.469; Wang J, 2008, P NATL ACAD SCI USA, V105, P6326, DOI 10.1073/pnas.0802288105; Yamaguchi S, 2005, GENE EXPR PATTERNS, V5, P639, DOI 10.1016/j.modgep.2005.03.001; Yamaguchi S, 2009, DEVELOPMENT, V136, P4011, DOI 10.1242/dev.041160	41	4	4	2	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2563	2573		10.1096/fj.201700924RR	http://dx.doi.org/10.1096/fj.201700924RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29295863				2022-12-28	WOS:000432528000021
J	Joe, Y; Kim, S; Kim, HJ; Park, J; Chen, Y; Park, HJ; Jekal, SJ; Ryter, SW; Kim, UH; Chung, HT				Joe, Yeonsoo; Kim, Sena; Kim, Hyo Jeong; Park, Jeongmin; Chen, Yingqing; Park, Hyeok-Jun; Jekal, Seung-Joo; Ryter, Stefan W.; Kim, Uh Hyun; Chung, Hun Taeg			FGF21 induced by carbon monoxide mediates metabolic homeostasis via the PERK/ATF4 pathway	FASEB JOURNAL			English	Article						hepatic steatosis; metabolic disease; ER stress; ROS; thermogenic genes	GROWTH-FACTOR 21; ENDOPLASMIC-RETICULUM-STRESS; HEME OXYGENASE-1/CARBON MONOXIDE; ENDOTHELIAL-CELL APOPTOSIS; UNFOLDED PROTEIN RESPONSE; INSULIN SENSITIVITY; HEPATIC STEATOSIS; GLUCOSE-HOMEOSTASIS; PPAR-ALPHA; MICE	The prevalence of metabolic diseases, including type 2 diabetes, obesity, and cardiovascular disease, has rapidly increased, yet the molecular mechanisms underlying the metabolic syndrome, a primary risk factor, remain incompletely understood. The small, gaseous molecule carbon monoxide (CO) has well-known anti-inflammatory, antiproliferative, and antiapoptotic effects in a variety of cellular- and tissue-injury models, whereas its potential effects on the complex pathways of metabolic disease remain unknown. We demonstrate here that CO can alleviate metabolic dysfunction in vivo and in vitro. We show that CO increased the expression and section of the fibroblast growth factor 21 (FGF21) in hepatocytes and liver. CO-stimulated PERK activation and enhanced the levels of FGF21 via the eIF2 alpha-ATF4 signaling pathway. The induction of FGF21 by CO attenuated endoreticulum stress- or diet-induced, obesity-dependent hepatic steatosis. Moreover, CO inhalation lowered blood glucose levels, enhanced insulin sensitivity, and promoted energy expenditure by stimulating the emergence of beige adipose cells from white adipose cells. In conclusion, we suggest that CO acts as a potent inducer of FGF21 expression and that CO critically depends on FGF21 to regulate metabolic homeostasis.	[Joe, Yeonsoo; Kim, Sena; Kim, Hyo Jeong; Park, Jeongmin; Chen, Yingqing; Park, Hyeok-Jun; Chung, Hun Taeg] Univ Ulsan, Sch Biol Sci, Meta Inflammat Res Inst Basic Res, Bldg 35,Room 807, Ulsan, South Korea; [Jekal, Seung-Joo] Wonkwang Hlth Sci Univ, Iksan, Jeonbuk, South Korea; [Ryter, Stefan W.] Weill Cornell Med, Joan & Sanford I Weill Dept Med, Div Pulm & Crit Care Med, New York, NY USA; [Kim, Uh Hyun] Chonbuk Natl Univ, Med Sch, Natl Creat Res Lab Signaling Network Ca2, Jeonju 54896, South Korea	University of Ulsan; Cornell University; Jeonbuk National University	Chung, HT (corresponding author), Univ Ulsan, Sch Biol Sci, Meta Inflammat Res Inst Basic Res, Bldg 35,Room 807, Ulsan, South Korea.; Kim, UH (corresponding author), Chonbuk Natl Univ, Med Sch, Natl Creat Res Lab Signaling Network Ca2, Jeonju 54896, South Korea.	uhkim@chonbuk.ac.kr; chung@ulsan.ac.kr	Chen, Yingqing/AAH-1367-2020	Chen, Yingqing/0000-0003-2326-7587; Kim, Uh-Hyun/0000-0003-3304-7190; Kim, Sena/0000-0002-6930-2416	Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2014R1A6A1030318]; Bio and Medical Technology Development Program of the NRF - Ministry of Science, Information and Communications Technology (ICT), and Future Planning [2012M3A9C3048687, NRF-2012R1A3A2026453]	Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Bio and Medical Technology Development Program of the NRF - Ministry of Science, Information and Communications Technology (ICT), and Future Planning	This work was supported by Priority Research Centers Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education (Grant 2014R1A6A1030318) and the Bio and Medical Technology Development Program of the NRF, funded by the Ministry of Science, Information and Communications Technology (ICT), and Future Planning (Grants 2012M3A9C3048687 to H.T.C., and NRF-2012R1A3A2026453 to U.H.K). The authors declare no conflicts of interest.	Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Chung J, 2011, MOL IMMUNOL, V48, P1793, DOI 10.1016/j.molimm.2011.05.014; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Ejaz A, 2016, DIABETES, V65, P902, DOI 10.2337/db15-1094; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Freire MO, 2017, J IMMUNOL, V198, P718, DOI 10.4049/jimmunol.1601543; Gilardi F, 2014, J BIOL CHEM, V289, P6908, DOI 10.1074/jbc.M113.506394; Gong Q, 2016, HEPATOLOGY, V64, P425, DOI 10.1002/hep.28523; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hosick PA, 2016, ADIPOCYTE, V5, P1, DOI 10.1080/21623945.2015.1038443; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hui XY, 2016, J MOL CELL BIOL, V8, P110, DOI 10.1093/jmcb/mjw013; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Jiang S, 2014, J BIOL CHEM, V289, P29751, DOI 10.1074/jbc.M114.565960; Joe Y, 2015, AM J PATHOL, V185, P2867, DOI 10.1016/j.ajpath.2015.07.002; Joe Y, 2011, ANN NY ACAD SCI, V1229, P156, DOI 10.1111/j.1749-6632.2011.06121.x; Keipert S, 2014, AM J PHYSIOL-ENDOC M, V306, pE469, DOI 10.1152/ajpendo.00330.2013; Kettner NM, 2015, CELL METAB, V22, P448, DOI 10.1016/j.cmet.2015.06.005; Kim CS, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0030-5; Kim KM, 2007, CIRC RES, V101, P919, DOI 10.1161/CIRCRESAHA.107.154781; Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014; Kim SH, 2015, DIABETOLOGIA, V58, P809, DOI 10.1007/s00125-014-3475-6; Kim SK, 2014, ANTIOXID REDOX SIGN, V20, P2589, DOI 10.1089/ars.2012.5138; Lee SJ, 2011, AM J RESP CELL MOL, V45, P867, DOI 10.1165/rcmb.2010-0352OC; Lin ZF, 2015, CIRCULATION, V131, P1861, DOI 10.1161/CIRCULATIONAHA.115.015308; Lin ZF, 2013, CELL METAB, V17, P779, DOI 10.1016/j.cmet.2013.04.005; Lindsay Robert S, 2004, Curr Diab Rep, V4, P63, DOI 10.1007/s11892-004-0013-9; Liu XK, 2016, AM J CANCER RES, V6, P1011; Liu XY, 2017, J CELL PHYSIOL, V232, P1893, DOI 10.1002/jcp.25735; [刘银华 Liu Yinhua], 2016, [中国临床药理学与治疗学, Chinese Journal of Clinical Pharmacology and Therapeutics], V21, P6; De Sousa-Coelho AL, 2012, BIOCHEM J, V443, P165, DOI 10.1042/BJ20111748; Makela J, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-2; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Marino JS, 2016, J BIOL CHEM, V291, P25776, DOI 10.1074/jbc.M116.752311; Maruyama R, 2016, BIOSCI BIOTECH BIOCH, V80, P929, DOI 10.1080/09168451.2015.1135045; Murata Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069330; Panchal SK, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/351982; Ryter SW, 2007, AM J RESP CELL MOL, V36, P175, DOI 10.1165/rcmb.2006-0333TR; Ryter SW, 2018, AM J PHYSIOL-CELL PH, V314, pC211, DOI 10.1152/ajpcell.00022.2017; Ryter SW, 2009, AM J RESP CELL MOL, V41, P251, DOI 10.1165/rcmb.2009-0170TR; Schaap FG, 2013, BIOCHIMIE, V95, P692, DOI 10.1016/j.biochi.2012.10.019; Song RP, 2003, AM J PATHOL, V163, P231, DOI 10.1016/S0002-9440(10)63646-2; Tamashiro KL, 2011, STRESS, V14, P468, DOI 10.3109/10253890.2011.606341; Wan XS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/807874; Wang YJ, 2010, J BIOL CHEM, V285, P15668, DOI 10.1074/jbc.M110.102160; Woo YC, 2013, CLIN ENDOCRINOL, V78, P489, DOI 10.1111/cen.12095; Wu SF, 2012, J BIOL CHEM, V287, P26060, DOI 10.1074/jbc.M112.343707; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Yu YH, 2016, INT IMMUNOPHARMACOL, V38, P144, DOI 10.1016/j.intimp.2016.05.026; Zarei M, 2016, DIABETES, V65, P3185, DOI 10.2337/db16-0155; Zheng M, 2012, FASEB J, V26, P2558, DOI 10.1096/fj.11-199604	53	32	32	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2630	2643		10.1096/fj.201700709RR	http://dx.doi.org/10.1096/fj.201700709RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29295856	Green Published			2022-12-28	WOS:000432528000026
J	Jovanovic, M; Schmidt, FN; Guterman-Ram, G; Khayyeri, H; Hiram-Bab, S; Orenbuch, A; Katchkovsky, S; Aflalo, A; Isaksson, H; Busse, B; Jahn, K; Levaot, N				Jovanovic, Milena; Schmidt, Felix N.; Guterman-Ram, Gali; Khayyeri, Hanifeh; Hiram-Bab, Sahar; Orenbuch, Ayelet; Katchkovsky, Svetlana; Aflalo, Anastasia; Isaksson, Hanna; Busse, Bjorn; Jahn, Katharina; Levaot, Noam			Perturbed bone composition and integrity with disorganized osteoblast function in zinc receptor/Gpr39-deficient mice	FASEB JOURNAL			English	Article						GPCR; collagen deposition; zinc; osteoblast; bone	EHLERS-DANLOS-SYNDROME; ESTROGEN DEFICIENCY; SENSING RECEPTOR; COLLAGEN; CELLS; GPR39; OSTEOPOROSIS; PROTEIN; GROWTH; TISSUE	Changes in bone matrix composition are frequently found with bone diseases and maybe associated with increased fracture risk. Bone is rich in the trace element zinc. Zinc was established to play a significant role in the growth, development, and maintenance of healthy bones; however, the mechanisms underlying zinc effects on the integrity of the skeleton are poorly understood. Here, we show that the zinc receptor (ZnR)/Gpr39 is required for normal bone matrix deposition by osteoblasts. Initial analysis showed that Gpr39-deficient (Gpr39(-/-)) mice had weaker bones as a result of altered bone composition. Fourier transform infrared spectroscopy analysis showed high mineral-to-matrix ratios in the bones of Gpr39(-/-) mice. Histologic analysis showed abnormally high numbers of active osteoblasts but normal osteoclast numbers on the surfaces of bones from Gpr39(-/-) mice. Furthermore, Gpr39(-/-) osteoblasts had disorganized matrix deposition in vitro with cultures exhibiting abnormally low collagen and high mineral contents, findings that demonstrate a cell-intrinsic role for ZnR/Gpr39 in these cells. We show that both collagen synthesis and deposition by Gpr39(-/-) osteoblasts are perturbed. Finally, the expression of the zinc transporter Zip13 and a disintegrin and metalloproteinase with thrombospondin motifs family of zinc-dependent metalloproteases that regulate collagen processing was downregulated in Gpr39(-/-) osteoblasts. Altogether, our results suggest that zinc sensing by ZnR/Gpr39 affects the expression levels of zinc-dependent enzymes in osteoblasts and regulates collagen processing and deposition.	[Jovanovic, Milena; Guterman-Ram, Gali; Orenbuch, Ayelet; Katchkovsky, Svetlana; Aflalo, Anastasia; Levaot, Noam] Ben Gurion Univ Negev, Dept Physiol & Cell Biol, Fac Hlth Sci, Beer Sheva, Israel; [Levaot, Noam] Ben Gurion Univ Negev, Regenerat Med & Stem Cell Res Ctr, Beer Sheva, Israel; [Schmidt, Felix N.; Busse, Bjorn; Jahn, Katharina] Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, Hamburg, Germany; [Khayyeri, Hanifeh; Isaksson, Hanna] Lund Univ, Fac Engn, Dept Biomed Engn, Lund, Sweden; [Hiram-Bab, Sahar] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, Tel Aviv, Israel	Ben Gurion University; Ben Gurion University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Lund University; Tel Aviv University; Sackler Faculty of Medicine	Levaot, N (corresponding author), Ben Gurion Univ Negev, Dept Physiol & Cell Biol, Bldg M6,Room 321, IL-84105 Beer Sheva, Israel.	levaot@bgu.ac.il	Isaksson, Hanna/L-1340-2015; Busse, Björn/AAC-4033-2020; Levaot, Noam/AAA-3052-2022	Isaksson, Hanna/0000-0002-9690-8907; Busse, Björn/0000-0002-3099-8073; Levaot, Noam/0000-0001-7747-3883; Khayyeri, Hanifeh/0000-0001-5751-3737; Jahn-Rickert, Katharina/0000-0002-9338-831X; Guterman-Ram, Gali/0000-0002-8583-3401; Schmidt, Felix/0000-0001-6586-6794; Katchkovsky, Svetlana/0000-0001-8079-7731; Jovanovic, Milena/0000-0001-8797-0031	Joachim Herz Foundation; Partnership for Innovation, Education and Research (PIER); Israel Science Foundation [544/15]	Joachim Herz Foundation; Partnership for Innovation, Education and Research (PIER); Israel Science Foundation(Israel Science Foundation)	F.N.S. acknowledges a doctoral fellowship from the Joachim Herz Foundation in cooperation with Partnership for Innovation, Education and Research (PIER). This study was supported by a grant from the Israel Science Foundation (544/15). The authors declare no conflicts of interest.	Boskey A, 2007, BIOMATERIALS, V28, P2465, DOI 10.1016/j.biomaterials.2006.11.043; Bouxsein ML, 2009, BEST PRACT RES CL RH, V23, P741, DOI 10.1016/j.berh.2009.09.008; Chartrel N, 2007, SCIENCE, V315, DOI 10.1126/science.1135047; Chen F, 2014, J BONE MINER RES, V29, P1412, DOI 10.1002/jbmr.2177; Christensen JO, 1999, OSTEOPOROSIS INT, V10, P307, DOI 10.1007/s001980050232; Cohen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035482; Colige A, 2002, J BIOL CHEM, V277, P5756, DOI 10.1074/jbc.M105601200; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Dubi N, 2008, CARCINOGENESIS, V29, P1692, DOI 10.1093/carcin/bgn027; Egerod KL, 2011, INT J ENDOCRINOL, V2011, DOI 10.1155/2011/401258; FERNANDEZMADRID F, 1973, J LAB CLIN MED, V82, P951; Fukada T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003642; Fukuharu M, 2000, DIABETES RES CLIN PR, V48, P1, DOI 10.1016/S0168-8227(99)00141-2; Giunta C, 2008, AM J HUM GENET, V82, P1290, DOI 10.1016/j.ajhg.2008.05.001; Gourion-Arsiquaud S, 2009, J BONE MINER RES, V24, P1565, DOI [10.1359/JBMR.090414, 10.1359/jbmr.090414]; Graham LV, 2010, J BIOL CHEM, V285, P7067, DOI 10.1074/jbc.M109.006841; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Hadjidakis DJ, 2006, ANN NY ACAD SCI, V1092, P385, DOI 10.1196/annals.1365.035; HAUMONT S, 1961, J HISTOCHEM CYTOCHEM, V9, P141, DOI 10.1177/9.2.141; Hershfinkel M, 2007, MOL MED, V13, P331, DOI 10.2119/2006-00038.Hershfinkel; Holst B, 2007, ENDOCRINOLOGY, V148, P13, DOI 10.1210/en.2006-0933; Holst B, 2009, ENDOCRINOLOGY, V150, P2577, DOI 10.1210/en.2008-1250; Hyun TH, 2004, AM J CLIN NUTR, V80, P715; Isaksson H, 2010, J BONE MINER RES, V25, P1360, DOI 10.1002/jbmr.10; Jepsen KJ, 2011, CLIN ORTHOP RELAT R, V469, P2150, DOI 10.1007/s11999-010-1706-9; Karaaslan F, 2014, CLIN INTERV AGING, V9, P1375, DOI 10.2147/CIA.S66354; Kim SW, 2017, J BONE MINER RES, V32, P892, DOI 10.1002/jbmr.3038; Lauwers E, 2006, BIOCHEM BIOPH RES CO, V351, P21, DOI 10.1016/j.bbrc.2006.09.141; Le Goff C, 2006, DEVELOPMENT, V133, P1587, DOI 10.1242/dev.02308; Lee WC, 2017, ENDOCR REV, V38, P255, DOI 10.1210/er.2017-00064; Li JY, 2016, J CLIN INVEST, V126, P2049, DOI 10.1172/JCI86062; Li XD, 2013, CONNECT TISSUE RES, V54, P290, DOI 10.3109/03008207.2013.813495; Lowenstam HA, 1989, BIOMINERALIZATION; Moechars D, 2006, GASTROENTEROLOGY, V131, P1131, DOI 10.1053/j.gastro.2006.07.009; Ovesen J., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P428; Ovesen J, 2001, BONE, V29, P565, DOI 10.1016/S8756-3282(01)00616-0; Pacheco-Pantoja Elda L., 2011, BMC Physiology, V11, P12, DOI 10.1186/1472-6793-11-12; Paschalis EP, 2001, J BONE MINER RES, V16, P1821, DOI 10.1359/jbmr.2001.16.10.1821; Patsch JM, 2011, ANN NY ACAD SCI, V1240, P77, DOI 10.1111/j.1749-6632.2011.06282.x; Petersen PS, 2011, FASEB J, V25, P3803, DOI 10.1096/fj.11-184531; Popovics P, 2011, CELL MOL LIFE SCI, V68, P85, DOI 10.1007/s00018-010-0517-1; PRASAD AS, 1961, AM J MED, V31, P532, DOI 10.1016/0002-9343(61)90137-1; PRASAD AS, 1983, NUTR REV, V41, P197, DOI 10.1111/j.1753-4887.1983.tb07155.x; Qiao YQ, 2014, BIOMATERIALS, V35, P6882, DOI 10.1016/j.biomaterials.2014.04.101; Raehtz S, 2017, ENDOCRINOLOGY, V158, P2086, DOI 10.1210/en.2016-1821; Rodriguez-Martinez MA, 2002, PHARMACOL THERAPEUT, V93, P37, DOI 10.1016/S0163-7258(02)00164-X; Ruppel ME, 2008, OSTEOPOROSIS INT, V19, P1251, DOI 10.1007/s00198-008-0579-1; Shao YX, 2017, J NUTR, V147, P1282, DOI 10.3945/jn.116.243238; Shapiro Jr, 2014, OSTEOGENESIS IMPERFECTA: A TRANSLATIONAL APPROACH TO BRITTLE BONE DISEASE, P1; Sims NA, 2006, AM J PHYSIOL-ENDOC M, V290, pE456, DOI 10.1152/ajpendo.00311.2005; Sims NA, 2014, ARCH BIOCHEM BIOPHYS, V561, P22, DOI 10.1016/j.abb.2014.05.015; STOCKER W, 1995, PROTEIN SCI, V4, P823; Storjohann L, 2008, FEBS LETT, V582, P2583, DOI 10.1016/j.febslet.2008.06.030; Sunuwar L, 2017, BBA-MOL BASIS DIS, V1863, P947, DOI 10.1016/j.bbadis.2017.01.009; Tullberg-Reinert H, 1999, HISTOCHEM CELL BIOL, V112, P271, DOI 10.1007/s004180050447; Yamaguchi M, 1992, J Nutr Sci Vitaminol (Tokyo), VSpec No, P522; Yamaguchi M, 2010, MOL CELL BIOCHEM, V338, P241, DOI 10.1007/s11010-009-0358-0; Yasuda SI, 2007, J RECEPT SIG TRANSD, V27, P235, DOI 10.1080/10799890701506147; Zheng JM, 2014, BIOL TRACE ELEM RES, V160, P15, DOI 10.1007/s12011-014-0031-7	59	20	22	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2507	2518		10.1096/fj.201700661RR	http://dx.doi.org/10.1096/fj.201700661RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29295862				2022-12-28	WOS:000432528000016
J	Kegelman, CD; Mason, DE; Dawahare, JH; Horan, DJ; Vigil, GD; Howard, SS; Robling, AG; Bellido, TM; Boerckel, JD				Kegelman, Christopher D.; Mason, Devon E.; Dawahare, James H.; Horan, Daniel J.; Vigil, Genevieve D.; Howard, Scott S.; Robling, Alexander G.; Bellido, Teresita M.; Boerckel, Joel D.			Skeletal cell YAP and TAZ combinatorially promote bone development	FASEB JOURNAL			English	Article						osteogenesis; transcriptional regulation; osteoprogenitor cells; osteoblasts	TRANSCRIPTIONAL CONTROL; TARGETED DISRUPTION; PROCOLLAGEN COL1A1; TRANSGENIC MICE; PROTEIN YAP; COMPLEX; GENE; DIFFERENTIATION; COLLAGEN; MODEL	The functions of the paralogous transcriptional coactivators Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) in bone are controversial. Each has been observed to promote or inhibit osteogenesis in vitro, with reports of both equivalent and divergent functions. Their combinatorial roles in bone physiology are unknown. We report that combinatorial YAP/TAZ deletion from skeletal lineage cells, using Osterix-Cre, caused an osteogenesis imperfecta-like phenotype with severity dependent on allele dose and greater phenotypic expressivity with homozygous TAZ vs. YAP ablation. YAP/TAZ deletion decreased bone accrual and reduced intrinsic bone material properties through impaired collagen content and organization. These structural and material defects produced spontaneous fractures, particularly in mice with homozygous TAZ deletion and caused neonatal lethality in dual homozygous knockouts. At the cellular level in vivo, YAP/TAZ ablation reduced osteoblast activity and increased osteoclast activity, in an allele dose-dependent manner, impairing bone accrual and remodeling. Transcriptionally, YAP/TAZ deletion and small-molecule inhibition of YAP/TAZ interaction with the transcriptional coeffector TEAD reduced osteogenic and collagen-related gene expression, both in vivo and in vitro. These data demonstrate that YAP and TAZ combinatorially promote bone development through regulation of osteoblast activity, matrix quality, and osteoclastic remodeling.	[Kegelman, Christopher D.; Mason, Devon E.; Boerckel, Joel D.] Univ Penn, Dept Orthopaed Surg, Philadelphia, PA 19104 USA; [Kegelman, Christopher D.; Boerckel, Joel D.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Kegelman, Christopher D.; Mason, Devon E.; Dawahare, James H.; Boerckel, Joel D.] Univ Notre Dame, Dept Aerosp & Mech Engn, Notre Dame, IN USA; [Vigil, Genevieve D.; Howard, Scott S.] Univ Notre Dame, Dept Elect Engn, Notre Dame, IN USA; [Horan, Daniel J.; Robling, Alexander G.; Bellido, Teresita M.] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA	University of Pennsylvania; University of Pennsylvania; University of Notre Dame; University of Notre Dame; Indiana University System; Indiana University Bloomington	Boerckel, JD (corresponding author), Univ Penn, G10A Stemmler Hall,3450 Hamilton Walk, Philadelphia, PA 19104 USA.	boerckel@pennmedicine.upenn.edu	Howard, Scott S/D-2900-2011	Howard, Scott S/0000-0003-3246-6799; Mason, Devon/0000-0002-0525-6270; Vigil, Genevieve/0000-0002-7219-1526; Kegelman, Christopher/0000-0001-5359-7128	U.S. National Institutes of Health (NIH) National Center for Advancing Translational Sciences [UL1TR001108]; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases [T32-AR007132]; National Science Foundation [1435467]; American Heart Association [16SDG31230034]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007132] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Center for Advancing Translational Sciences; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	YAP<SUP>fl/fl</SUP>; TAZ<SUP>fl/fl</SUP> mice were provided by Eric Olson (University of Texas Southwestern Medical Center, Dallas, TX, USA); mouse husbandry and maintenance were performed by Theresa Sikorski (University of Notre Dame). 8xGTIIC luciferase and Renilla constructs were provided by Dr. Munir Tanas (University of Iowa, Iowa City, IA, USA); and 6xOSE2 and 657 bp osteocalcin promoter luciferase constructs were provided by Dr. Ling Qin (University of Pennsylvania). This project was supported in part by U.S. National Institutes of Health (NIH) National Center for Advancing Translational Sciences Grant UL1TR001108 (to J.D.B.) and NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant T32-AR007132 (to C.D.K.), by National Science Foundation Grant 1435467 (to J.D.B.), and by American Heart Association Grant 16SDG31230034 (to J.D.B.). The authors declare no conflicts of interest.	Afzal F, 2005, J CELL PHYSIOL, V204, P63, DOI 10.1002/jcp.20258; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akens MK, 2007, PHOTOCHEM PHOTOBIOL, V83, P1034, DOI 10.1111/j.1751-1097.2007.00172.x; Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Byun MR, 2014, CELL DEATH DIFFER, V21, P854, DOI 10.1038/cdd.2014.8; Caroti CM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13477-y; Chen JQ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085161, 10.1371/journal.pone.0101277]; Chen XY, 2012, NAT PROTOC, V7, P654, DOI 10.1038/nprot.2012.009; CHIPMAN SD, 1993, P NATL ACAD SCI USA, V90, P1701, DOI 10.1073/pnas.90.5.1701; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; Deng YJ, 2016, CELL REP, V14, P2224, DOI 10.1016/j.celrep.2016.02.021; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Forlino A, 2016, LANCET, V387, P1657, DOI 10.1016/S0140-6736(15)00728-X; Guss JD, 2017, J BONE MINER RES, V32, P1343, DOI 10.1002/jbmr.3114; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Hong JH, 2006, CELL CYCLE, V5, P176, DOI 10.4161/cc.5.2.2362; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Hong WJ, 2012, SEMIN CELL DEV BIOL, V23, P785, DOI 10.1016/j.semcdb.2012.05.004; Hossain Z, 2007, P NATL ACAD SCI USA, V104, P1631, DOI 10.1073/pnas.0605266104; Javed A, 2010, ORAL MAXIL SURG CLIN, V22, P283, DOI 10.1016/j.coms.2010.05.001; Jepsen KJ, 2015, J BONE MINER RES, V30, P951, DOI 10.1002/jbmr.2539; Kaan HYK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02219-9; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Karystinou A, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0639-9; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KHILLAN JS, 1991, J BIOL CHEM, V266, P23373; Kim KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092427; Kim M, 2015, CELL REP, V11, P270, DOI 10.1016/j.celrep.2015.03.015; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kourtis LC, 2014, ANN BIOMED ENG, V42, P1773, DOI 10.1007/s10439-014-1027-3; Li HT, 2010, AM J PATHOL, V176, P2405, DOI 10.2353/ajpath.2010.090704; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Miesfeld JB, 2015, DEVELOPMENT, V142, P3021, DOI 10.1242/dev.119008; Morin-Kensicki EM, 2006, MOL CELL BIOL, V26, P77, DOI 10.1128/MCB.26.1.77-87.2006; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nadiarnykh O, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2799538; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Park HW, 2015, CELL, V162, P780, DOI 10.1016/j.cell.2015.07.013; PEREIRA R, 1993, J CLIN INVEST, V91, P709, DOI 10.1172/JCI116252; Rauch F, 2000, BONE, V26, P581, DOI 10.1016/S8756-3282(00)00269-6; RICHTER AM, 1990, J PHOTOCH PHOTOBIO B, V5, P231, DOI 10.1016/1011-1344(90)80008-L; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Schneider P, 2013, BONE, V53, P120, DOI 10.1016/j.bone.2012.11.024; Seo E, 2013, CELL REP, V3, P2075, DOI 10.1016/j.celrep.2013.05.029; Tanas MR, 2016, ONCOGENE, V35, P929, DOI 10.1038/onc.2015.148; Tang Y, 2013, DEV CELL, V25, P402, DOI 10.1016/j.devcel.2013.04.011; Vanleene M, 2012, BONE, V50, P1317, DOI 10.1016/j.bone.2012.03.007; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Varelas X, 2014, DEVELOPMENT, V141, P1614, DOI 10.1242/dev.102376; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Wang L, 2015, CALCIFIED TISSUE INT, V96, P129, DOI 10.1007/s00223-014-9945-5; Xin M, 2013, P NATL ACAD SCI USA, V110, P13839, DOI 10.1073/pnas.1313192110; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Yang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056585; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zhang HB, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aac5418; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408	62	75	82	1	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2706	2721		10.1096/fj.201700872R	http://dx.doi.org/10.1096/fj.201700872R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29401582	Green Published			2022-12-28	WOS:000432528000031
J	van Kruchten, A; Wilden, JJ; Niemann, S; Peters, G; Loffler, B; Ludwig, S; Ehrhardt, C				van Kruechten, Andre; Wilden, Janine J.; Niemann, Silke; Peters, Georg; Loeffler, Bettina; Ludwig, Stephan; Ehrhardt, Christina			Staphylococcus aureus triggers a shift from influenza virus-induced apoptosis to necrotic cell death	FASEB JOURNAL			English	Article						signaling; superinfection; caspase-8; accessory gene regulator locus	PANTON-VALENTINE LEUKOCIDIN; COMMUNITY-ACQUIRED PNEUMONIA; VIRULENCE DETERMINANT; COINFECTION; CLEAVAGE; INFECTION; NECROSIS; RELEASE; PROTEIN; AGR	Superinfections with Staphylococcus aureus are a major complication of influenza disease, causing excessive inflammation and tissue damage. This enhanced cell-damaging effect is also observed in superinfected tissue cultures, leading to a strong decrease in overall cell viability. In our analysis of the underlying molecular mechanisms, we observed that, despite enhanced cell damage in superinfection, S. aureus did not increase but rather inhibited influenza virus (IV)-induced apoptosis in cells on the level of procaspase-8 activation. This apparent contradiction was solved when we observed that S. aureus mediated a switch from apoptosis to necrotic cell death of IV-infected cells, a mechanism that was dependent on the bacterial accessory gene regulator (agr) locus that promotes bacterial survival and spread. This so far unknown action may be a bacterial strategy to enhance dissemination of intracellular S. aureus and may thereby contribute to increased tissue damage and severity of disease.	[van Kruechten, Andre; Wilden, Janine J.; Ludwig, Stephan; Ehrhardt, Christina] Westfaelische Wilhelms Univ WWU Munster, Inst Virol IVM, Munster, Germany; [Peters, Georg; Ludwig, Stephan; Ehrhardt, Christina] Westfaelische Wilhelms Univ WWU Munster, Cells Mot Interfaculty Ctr, Cluster Excellence EXC 1003, Munster, Germany; [van Kruechten, Andre; Niemann, Silke; Peters, Georg] Univ Hosp Munster, Inst Med Microbiol, Munster, Germany; [Loeffler, Bettina] Jena Univ Hosp, Inst Med Microbiol, Jena, Germany	University of Munster; Friedrich Schiller University of Jena	Ehrhardt, C (corresponding author), Westfaelische Wilhelms Univ, Von Esmarch Str 56, D-48149 Munster, Germany.	ehrhardc@uni-muenster.de		Ludwig, Stephan/0000-0003-4490-3052	Jurgen Manchot Foundation; Deutsche Forschungsgemeinschaft [SFB 1009]; Innovative Medical Research Fund Grant [EH121307]; Interdisziplinares Zentrum fur Klinische Forschung (IZKF; Interdisciplinary Center for Clinical Research) Grant [EhC2/006/15]	Jurgen Manchot Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Innovative Medical Research Fund Grant; Interdisziplinares Zentrum fur Klinische Forschung (IZKF; Interdisciplinary Center for Clinical Research) Grant	This work was supported by the Jurgen Manchot Foundation, Deutsche Forschungsgemeinschaft Grant SFB 1009, Projects B01 and B02; Innovative Medical Research Fund Grant EH121307; and Interdisziplinares Zentrum fur Klinische Forschung (IZKF; Interdisciplinary Center for Clinical Research) Grant EhC2/006/15. The authors declare no conflicts of interest.	Aleandri M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117005; Bischoff M, 2001, J BACTERIOL, V183, P5171, DOI 10.1128/JB.183.17.5171-5179.2001; BREMELL T, 1992, INFECT IMMUN, V60, P2976, DOI 10.1128/IAI.60.7.2976-2985.1992; Burts ML, 2005, P NATL ACAD SCI USA, V102, P1169, DOI 10.1073/pnas.0405620102; Chen KS, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2172-0; Chertow DS, 2013, JAMA-J AM MED ASSOC, V309, P275, DOI 10.1001/jama.2012.194139; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; Chi CY, 2014, J INFECT DIS, V209, P224, DOI 10.1093/infdis/jit445; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Ehrhardt C, 2007, J VIROL, V81, P3058, DOI 10.1128/JVI.02082-06; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; George EA, 2007, CHEMBIOCHEM, V8, P847, DOI 10.1002/cbic.200700023; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Grosz M, 2014, CELL MICROBIOL, V16, P451, DOI 10.1111/cmi.12233; Hacker G, 2000, CELL TISSUE RES, V301, P5, DOI 10.1007/s004410000193; Hageman JC, 2006, EMERG INFECT DIS, V12, P894, DOI 10.3201/eid1206.051141; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hogner K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003188; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Iverson AR, 2011, J INFECT DIS, V203, P880, DOI 10.1093/infdis/jiq113; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kallen AJ, 2009, ANN EMERG MED, V53, P358, DOI 10.1016/j.annemergmed.2008.04.027; Kawahara A, 1998, J CELL BIOL, V143, P1353, DOI 10.1083/jcb.143.5.1353; Kitur K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004820; Kobayashi SD, 2013, VIRULENCE, V4, P707, DOI 10.4161/viru.26572; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Korea CG, 2014, INFECT IMMUN, V82, P4144, DOI 10.1128/IAI.01576-14; Koziel J, 2015, J INNATE IMMUN, V7, P187, DOI 10.1159/000368048; Koziel J, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/427021; Koziel J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005210; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liedmann S, 2014, J INFECT DIS, V209, P532, DOI 10.1093/infdis/jit463; Loffler B, 2013, EXPERT REV ANTI-INFE, V11, P1041, DOI 10.1586/14787210.2013.827891; LOURIA DB, 1959, J CLIN INVEST, V38, P213, DOI 10.1172/JCI103789; Mayank AK, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.360; McDanel JS, 2016, EMERG INFECT DIS, V22, P1253, DOI 10.3201/eid2207.151319; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Moriwaki K, 2013, GENE DEV, V27, P1640, DOI 10.1101/gad.223321.113; Niemann S, 2012, J INFECT DIS, V206, P1138, DOI 10.1093/infdis/jis468; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Oberst A, 2010, J BIOL CHEM, V285, P16632, DOI 10.1074/jbc.M109.095083; Otto M, 2013, INT J MED MICROBIOL, V303, P324, DOI 10.1016/j.ijmm.2013.02.007; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; Rasigade JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063176; Saitoh Y, 2016, LEUKEMIA, V30, P716, DOI 10.1038/leu.2015.267; Segawa K, 2014, SCIENCE, V344, P1164, DOI 10.1126/science.1252809; Siegel SJ, 2014, CELL HOST MICROBE, V16, P55, DOI 10.1016/j.chom.2014.06.005; Sinha B, 2010, INT J MED MICROBIOL, V300, P170, DOI 10.1016/j.ijmm.2009.08.019; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Smith AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003238; Syed AK, 2015, INFECT IMMUN, V83, P3428, DOI 10.1128/IAI.00401-15; Tarquini F, 2014, CELL BIOCHEM FUNCT, V32, P87, DOI 10.1002/cbf.2975; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Tuchscherr L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004870; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Warnking K, 2015, CELL MICROBIOL, V17, P303, DOI 10.1111/cmi.12375; Wilson TR, 2009, CELL DEATH DIFFER, V16, P1352, DOI 10.1038/cdd.2009.76; Wurzer WJ, 2004, J BIOL CHEM, V279, P30931, DOI 10.1074/jbc.M403258200; Wurzer WJ, 2003, EMBO J, V22, P2717, DOI 10.1093/emboj/cdg279; Yao ZJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140604	62	10	10	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2779	2793		10.1096/fj.201701006R	http://dx.doi.org/10.1096/fj.201701006R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29401589				2022-12-28	WOS:000432528000037
J	Huynh, DN; Bessi, VL; Menard, L; Piquereau, J; Proulx, C; Febbraio, M; Lubell, WD; Carpentier, AC; Burelle, Y; Ong, H; Marleau, S				Huynh, David N.; Bessi, Valerie L.; Menard, Liliane; Piquereau, Jerome; Proulx, Caroline; Febbraio, Maria; Lubell, William D.; Carpentier, Andre C.; Burelle, Yan; Ong, Huy; Marleau, Sylvie			Adiponectin has a pivotal role in the cardioprotective effect of CP-3(iv), a selective CD36 azapeptide ligand, after transient coronary artery occlusion in mice	FASEB JOURNAL			English	Article						ischemia/reperfusion; reactive oxygen species; PPAR-gamma; Langendorff; hemodynamics	HORMONE-RELEASING PEPTIDE; SCAVENGER RECEPTOR CD36; ISCHEMIA-REPERFUSION INJURY; FATTY-ACID UPTAKE; MYOCARDIAL-ISCHEMIA; CHOLESTEROL EFFLUX; GENE-EXPRESSION; PROTECTS; ISCHEMIA/REPERFUSION; DIFFERENTIATION	CD36 is a multiligand receptor involved in lipid metabolism. We investigated the mechanisms underlying the cardioprotective effect of CP-3(iv), an azapeptide belonging to a new class of selective CD36 ligands. The role of CP-3(iv) in mediating cardioprotection was investigated because CD36 signaling leads to activation of peroxisome proliferator-activated receptor-gamma, a transcriptional regulator of adiponectin. CP-3(iv) pretreatment reduced infarct size by 54% and preserved hemodynamics in C57BL/6mice subjected to 30min coronary ligation and reperfusion but had no effect in CD36-deficient mice. The effects of CP-3(iv) were associated with an increase in circulating adiponectin levels, epididymal fat adiponectin gene expression, and adiponectin transcriptional regulators (Pparg, Cebpb, Sirt1) after 6 h of reperfusion. Reduced myocardial oxidative stress and apoptosis were observed along with an increase in expression of myocardial adiponectin target proteins, including cyclooxygenase-2, phospho-AMPK, and phospho-Akt. Moreover, CP-3(iv) increased myocardial performance in isolated hearts, whereas blockade of adiponectin with an anti-adiponectin antibody abrogated it. CP-3(iv) exerts cardioprotection against myocardial ischemia and reperfusion (MI/R) injury and dysfunction, at least in part, by increasing circulating and myocardial adiponectin levels. Hence, both paracrine and endocrine effects of adiponectin may contribute to reduced reactive oxygen species generation and apoptosis after MI/R, in a CD36-dependent manner.	[Huynh, David N.; Bessi, Valerie L.; Menard, Liliane; Piquereau, Jerome; Burelle, Yan; Ong, Huy; Marleau, Sylvie] Univ Montreal, Fac Pharm, 2940 CP,PO 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Proulx, Caroline; Lubell, William D.] Univ Montreal, Dept Chem, Montreal, PQ, Canada; [Febbraio, Maria] Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada; [Carpentier, Andre C.] Univ Sherbrooke, Dept Med, Div Endocrinol, Sherbrooke, PQ, Canada; [Piquereau, Jerome] Univ Paris Sud 11, Orsay, France; [Proulx, Caroline] North Carolina State Univ, Raleigh, NC USA; [Burelle, Yan] Univ Ottawa, Ottawa, ON, Canada	Universite de Montreal; Universite de Montreal; University of Alberta; University of Sherbrooke; UDICE-French Research Universities; Universite Paris Saclay; University of North Carolina; North Carolina State University; University of Ottawa	Bessi, VL; Marleau, S (corresponding author), Univ Montreal, Fac Pharm, 2940 CP,PO 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	valerie.lafreniere.bessi@gmail.com; sylvie.marleau@umontreal.ca	Burelle, Yan/AAF-8104-2021	Burelle, Yan/0000-0001-9379-146X; Piquereau, Jerome/0000-0002-6019-8683	Fonds de Recherche du Quebec-Sante; Groupe de Recherche Universitaire sur le Medicament; GSK Chair in Diabetes of the Universite de Sherbrooke; Heart and Stoke Foundation of Quebec; Canadian Institute of Health Research [MOP 97915]	Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); Groupe de Recherche Universitaire sur le Medicament; GSK Chair in Diabetes of the Universite de Sherbrooke; Heart and Stoke Foundation of Quebec; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	V.L.B. and D.N.H. are recipients of the Fonds de Recherche du Quebec-Sante and Groupe de Recherche Universitaire sur le Medicament studentships. A.C.C. is the recipient of the GSK Chair in Diabetes of the Universite de Sherbrooke. This work was supported by grants from the Heart and Stoke Foundation of Quebec and the Canadian Institute of Health Research (Grant MOP 97915). The authors declare no conflicts of interest.	Abraham D, 2015, JOVE-J VIS EXP, DOI 10.3791/52942; Angin Y, 2012, BIOCHEM J, V448, P43, DOI 10.1042/BJ20120060; Ascah A, 2011, AM J PHYSIOL-HEART C, V300, pH144, DOI 10.1152/ajpheart.00522.2010; Avallone R, 2006, MOL ENDOCRINOL, V20, P3165, DOI 10.1210/me.2006-0146; Bessi VL, 2012, CARDIOVASC RES, V96, P99, DOI 10.1093/cvr/cvs225; Braun M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119416; Bujold K, 2009, CARDIOVASC RES, V83, P457, DOI 10.1093/cvr/cvp118; Depre C, 2000, CARDIOVASC RES, V45, P538, DOI 10.1016/S0008-6363(99)00266-7; Fang XP, 2010, AM J PHYSIOL-ENDOC M, V299, pE721, DOI 10.1152/ajpendo.00086.2010; Glatz JFC, 2013, PROSTAG LEUKOTR ESS, V88, P71, DOI 10.1016/j.plefa.2012.04.009; Gonon AT, 2008, CARDIOVASC RES, V78, P116, DOI 10.1093/cvr/cvn017; Hajri T, 2007, DIABETES, V56, P1872, DOI 10.2337/db06-1699; Horowitz JD, 2010, CURR OPIN CARDIOL, V25, P329, DOI 10.1097/HCO.0b013e328339f191; Hui XY, 2012, BRIT J PHARMACOL, V165, P574, DOI 10.1111/j.1476-5381.2011.01395.x; Ibanez B, 2015, J AM COLL CARDIOL, V65, P1455, DOI 10.1016/j.jacc.2015.02.032; Iwaki M, 2003, DIABETES, V52, P1655, DOI 10.2337/diabetes.52.7.1655; Johnson AR, 2016, MOL METAB, V5, P506, DOI 10.1016/j.molmet.2016.04.005; Kintaka T, 2002, CIRC J, V66, P819, DOI 10.1253/circj.66.819; Koentges C, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0495-4; Lauer MS, 2012, CHEST, V141, P500, DOI 10.1378/chest.11-2521; Lopaschuk Gary D, 2004, Curr Opin Investig Drugs, V5, P290; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Marleau Sylvie, 2005, FASEB J, V19, P1869; Nagendran J, 2013, J MOL CELL CARDIOL, V63, P180, DOI 10.1016/j.yjmcc.2013.07.020; Nanayakkara G, 2012, AM J CARDIOVASC DIS, V2, P253; Nichols M, 2014, EUR HEART J, V35, P2950, DOI 10.1093/eurheartj/ehu299; Nulton-Persson AC, 2001, J BIOL CHEM, V276, P23357, DOI 10.1074/jbc.M100320200; Park BH, 2004, MOL CELL BIOL, V24, P8671, DOI 10.1128/MCB.24.19.8671-8680.2004; Pineiro R, 2005, FEBS LETT, V579, P5163, DOI 10.1016/j.febslet.2005.07.098; Proulx C, 2012, J MED CHEM, V55, P6502, DOI 10.1021/jm300557t; Qiao LP, 2011, DIABETES, V60, P1519, DOI 10.2337/db10-1017; Qiao LP, 2006, J BIOL CHEM, V281, P39915, DOI 10.1074/jbc.M607215200; Raedschelders K, 2012, PHARMACOL THERAPEUT, V133, P230, DOI 10.1016/j.pharmthera.2011.11.004; Ramasamy R, 2001, AM J PHYSIOL-HEART C, V281, pH290, DOI 10.1152/ajpheart.2001.281.1.H290; Rodrigue-Way A, 2007, ENDOCRINOLOGY, V148, P1009, DOI 10.1210/en.2006-0975; Rodrigue-Way A, 2014, FASEB J, V28, P1910, DOI 10.1096/fj.13-240168; Sabatino D, 2011, J AM CHEM SOC, V133, P12493, DOI 10.1021/ja203007u; Shetty S, 2009, TRENDS PHARMACOL SCI, V30, P234, DOI 10.1016/j.tips.2009.02.004; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Simons PJ, 2007, J ENDOCRINOL, V192, P289, DOI 10.1677/JOE-06-0047; Tao C, 2014, BEST PRACT RES CL EN, V28, P43, DOI 10.1016/j.beem.2013.11.003; Tao L, 2007, CIRCULATION, V115, P1408, DOI 10.1161/CIRCULATIONAHA.106.666941; Tretter L, 2014, METHOD ENZYMOL, V547, P199, DOI 10.1016/B978-0-12-801415-8.00012-6; Verma S, 2002, CIRCULATION, V105, P2332, DOI 10.1161/01.CIR.0000016602.96363.36; Vroegrijk IOCM, 2013, OBESITY, V21, P2037, DOI 10.1002/oby.20354; Xu AM, 2015, AUTOPHAGY, V11, P723, DOI 10.1080/15548627.2015.1034418; Xue P, 2013, DIABETES, V62, P845, DOI 10.2337/db12-0584; Zhang HR, 2010, ARTERIOSCL THROM VAS, V30, P2156, DOI 10.1161/ATVBAHA.110.214700	49	10	10	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					807	818		10.1096/fj.201700505R	http://dx.doi.org/10.1096/fj.201700505R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29018142	Bronze			2022-12-28	WOS:000425146900023
J	Shen, H; Lim, C; Schwartz, AG; Andreev-Andrievskiy, A; Deymier, AC; Thomopoulos, S				Shen, Hua; Lim, Chanteak; Schwartz, Andrea G.; Andreev-Andrievskiy, Alexander; Deymier, Alix C.; Thomopoulos, Stavros			Effects of spaceflight on the muscles of the murine shoulder	FASEB JOURNAL			English	Article						microgravity; unloading; rotator cuff	ROTATOR CUFF TEARS; SKELETAL-MUSCLE; STATISTICAL-MODEL; STRENGTH; MICROGRAVITY; MOUSE; SUPRASPINATUS; ARCHITECTURE; ADAPTATIONS; GENDER	Mechanical loading is necessary for the development and maintenance of the musculoskeletal system. Removal of loading viamicrogravity, paralysis, or bed rest leads to rapid loss of muscle mass and function; however, the molecular mechanisms that lead to these changes are largely unknown, particularly for the spaceflight (SF) microgravity environment. Furthermore, few studies have explored these effects on the shoulder, a dynamically stabilized joint with a large range of motion; therefore, we examined the effects of microgravity on mouse shoulder muscles for the 15-d Space Transportation System (STS)-131, 13-d STS-135, and 30-d Bion-M1 missions. Mice from STS missions were euthanized within 4 h after landing, whereas mice from the Bion-M1 mission were euthanized within 14 h after landing. The motion-generating deltoid muscle was more sensitive to microgravity than the joint-stabilizing rotator cuff muscles. Mice from the STS-131 mission exhibited reduced myogenic (Myf5 and -6) and adipogenic (Pparg, Cebpa, and Lep) gene expression, whereas either no change or an increased expression of these genes was observed in mice from the Bion-M1 mission. In summary, muscle responses to microgravity were muscle type specific, short-duration SF caused dramatic molecular changes to shoulder muscles and responses to reloading uponlanding were rapid.	[Shen, Hua; Lim, Chanteak; Schwartz, Andrea G.] Washington Univ, Dept Orthopaed Surg, St Louis, MO USA; [Andreev-Andrievskiy, Alexander] Russian Acad Sci, Inst Biomed Problems, Moscow, Russia; [Andreev-Andrievskiy, Alexander] Moscow MV Lomonosov State Univ, Biol Fac, Moscow, Russia; [Deymier, Alix C.; Thomopoulos, Stavros] Columbia Univ, Dept Orthoped Surg, Black Bldg,Room 1408,650 W 168 St, New York, NY 10032 USA; [Thomopoulos, Stavros] Columbia Univ, Dept Biomed Engn, New York, NY USA	Washington University (WUSTL); Russian Academy of Sciences; Institute of Biomedical Problems of the Russian Academy of Sciences; Lomonosov Moscow State University; Columbia University; Columbia University	Thomopoulos, S (corresponding author), Columbia Univ, Dept Orthoped Surg, Black Bldg,Room 1408,650 W 168 St, New York, NY 10032 USA.	sat2@columbia.edu	Andreev-Andrievskiy, Alexander/B-7336-2013; Deymier, Alix/AAY-4762-2021	Andreev-Andrievskiy, Alexander/0000-0002-1173-8153; Deymier, Alix/0000-0001-5187-4427	NASA [NNX09AP05G]; NSBRI [PD13-0019]; Plan for Fundamental Research of the State Research Centre of the Russian Federation (SRC RF) Institute of Biomedical Problems, Russian Academy of Science; U.S. National Institutes of Health (NIH), National Cancer Institute [P30-CA91842]; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER	NASA(National Aeronautics & Space Administration (NASA)); NSBRI; Plan for Fundamental Research of the State Research Centre of the Russian Federation (SRC RF) Institute of Biomedical Problems, Russian Academy of Science; U.S. National Institutes of Health (NIH), National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Grants NASA NNX09AP05G and NSBRI PD13-0019, and the Plan for Fundamental Research of the State Research Centre of the Russian Federation (SRC RF) Institute of Biomedical Problems, Russian Academy of Science. Proteomics analysis was supported by a U.S. National Institutes of Health (NIH), National Cancer Institute Grant P30-CA91842. The authors thank Drs. J. Malone and R. Townsend for their assistance with proteomic analysis. The authors are grateful to A. Popova (Institute for Biomedical Problems, Russian Academy of Sciences, Moscow State University) for help with grip force measurement. The authors declare no conflicts of interest.	Allen DL, 2009, J APPL PHYSIOL, V106, P582, DOI 10.1152/japplphysiol.90780.2008; Andreev-Andrievskiy A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104830; Beeler S, 2013, J SHOULDER ELB SURG, V22, P1537, DOI 10.1016/j.jse.2013.01.028; Clark BC, 2009, ARCH PHYS MED REHAB, V90, P178, DOI 10.1016/j.apmr.2008.06.032; Das R, 2011, J ORTHOP RES, V29, P281, DOI 10.1002/jor.21234; Davis ME, 2013, J APPL PHYSIOL, V115, P884, DOI 10.1152/japplphysiol.00137.2013; Deschenes MR, 2012, MUSCLE NERVE, V46, P210, DOI 10.1002/mus.23289; Dirks ML, 2016, DIABETES, V65, P2862, DOI 10.2337/db15-1661; Fitts RH, 2010, J PHYSIOL-LONDON, V588, P3567, DOI 10.1113/jphysiol.2010.188508; Fitts RH, 2000, J APPL PHYSIOL, V89, P823, DOI 10.1152/jappl.2000.89.2.823; Galatz LM, 2009, J SHOULDER ELB SURG, V18, P669, DOI 10.1016/j.jse.2009.02.016; Gambara G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169314; Harrison BC, 2003, J APPL PHYSIOL, V95, P2462, DOI 10.1152/japplphysiol.00603.2003; Hogendoorn S, 2010, J BONE JOINT SURG AM, V92A, P935, DOI 10.2106/JBJS.I.00193; Ishihara A, 2015, MUSCLE NERVE, V52, P63, DOI 10.1002/mus.24491; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim HM, 2012, J SHOULDER ELB SURG, V21, P847, DOI 10.1016/j.jse.2011.05.004; Kortebein P, 2008, J GERONTOL A-BIOL, V63, P1076, DOI 10.1093/gerona/63.10.1076; Laron D, 2012, J SHOULDER ELB SURG, V21, P164, DOI 10.1016/j.jse.2011.09.027; Lieber RL, 2013, AM J PHYSIOL-CELL PH, V305, pC241, DOI 10.1152/ajpcell.00173.2013; Lynch G S, 2001, Exerc Sport Sci Rev, V29, P141, DOI 10.1097/00003677-200110000-00002; Maurissen JPJ, 2003, NEUROTOXICOL TERATOL, V25, P543, DOI 10.1016/S0892-0362(03)00073-4; Mendias CL, 2015, J SHOULDER ELB SURG, V24, P111, DOI 10.1016/j.jse.2014.06.037; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Ploutz-Snyder L, 2014, J WOMENS HEALTH, V23, P963, DOI 10.1089/jwh.2014.4910; Sandona D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033232; Sato EJ, 2015, J BONE JOINT SURG AM, V97A, P565, DOI 10.2106/JBJS.M.01503; Schwartz AG, 2013, BONE, V55, P44, DOI 10.1016/j.bone.2013.03.010; SHARKEY NA, 1994, J ORTHOPAED RES, V12, P699, DOI 10.1002/jor.1100120513; Shen H, 2015, J BONE MINER RES, V30, P596, DOI 10.1002/jbmr.2389; Shen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077613; Silldorff MD, 2014, J BONE JOINT SURG AM, V96A, DOI 10.2106/JBJS.M.01315; Smith JP, 1995, J NEUROSCI METH, V62, P15, DOI 10.1016/0165-0270(95)00049-6; Tatara AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097375; Ulanova A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/104735; Ward SR, 2006, CLIN ORTHOP RELAT R, P157, DOI 10.1097/01.blo.0000194680.94882.d3	36	15	16	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5466	5477		10.1096/fj.201700320R	http://dx.doi.org/10.1096/fj.201700320R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28821629	Green Published			2022-12-28	WOS:000416588300029
J	Schenk, LK; Moller-Kerutt, A; Klosowski, R; Wolters, D; Schaffner-Reckinger, E; Weide, T; Pavenstadt, H; Vollenbroker, B				Schenk, Laura K.; Moeller-Kerutt, Annika; Klosowski, Rafael; Wolters, Dirk; Schaffner-Reckinger, Elisabeth; Weide, Thomas; Pavenstaedt, Hermann; Vollenbroeker, Beate			Angiotensin II regulates phosphorylation of actin-associated proteins in human podocytes	FASEB JOURNAL			English	Article						kidney; L-plastin; actin turnover; calcium	COLLECTING DUCT CELLS; L-PLASTIN; SIGNALING PATHWAYS; ALDOSTERONE SYSTEM; EPITHELIAL-CELLS; KIDNEY-DISEASE; KINASE-C; IN-VIVO; PROTEOME; DYNAMICS	Within the kidney, angiotensin II (AngII) targets different cell types in the vasculature, tubuli, and glomeruli. An important part of the renal filtration barrier is composed of podocytes with their actin-rich foot processes. In this study, we used stable isotope labeling with amino acids in cell culture coupled to mass spectrometry to characterize relative changes in the phosphoproteome of human podocytes in response to short-term treatment with AngII. In 4 replicates, we identified a total of 17,956 peptides that were traceable to 2081 distinct proteins. Bioinformatic analyses revealed that among the increasingly phosphorylated peptides are predominantly peptides that are related to actin filaments, cytoskeleton, lamellipodia, mammalian target of rapamycin, andMAPK signaling. Among others, this screening approach highlighted the increased phosphorylation of actin-bundling protein, L-plastin (LCP1). AngII-dependent phosphorylation of LCP1 in cultured podocytes was mediated by the kinases ERK, p90 ribosomal S6 kinase, PKA, or PKC. LCP1 phosphorylation increased filopodia formation. In addition, treatmentwith AngII led to LCP1 redistribution to the cell margins, membrane ruffling, and formation of lamellipodia. Our data highlight the importance of AngII-triggered actin cytoskeleton-associated signal transduction inpodocytes.-Schenk, L.K.,Moller-Kerutt, A., Klosowski, R.,Wolters, D.,Schaffner-Reckinger, E.,Weide, T.,Pavenstadt, H., Vollenbroker, B.Angiotensin II regulatesphosphorylation of actin-associatedproteins in human podocytes.	[Schenk, Laura K.; Moeller-Kerutt, Annika; Weide, Thomas; Pavenstaedt, Hermann; Vollenbroeker, Beate] Univ Klinikum Munster, Med Klin & Poliklin D, Munster, Germany; [Klosowski, Rafael; Wolters, Dirk] Ruhr Univ Bochum, Analyt Chem, Biomol Massenspektrometrie, Bochum, Germany; [Schaffner-Reckinger, Elisabeth] Univ Luxembourg, Life Sci Res Unit, Lab Cytoskeleton & Cell Plast, Esch Sur Alzette, Luxembourg	University of Munster; Ruhr University Bochum; University of Luxembourg	Vollenbroker, B (corresponding author), Med Klin & Poliklin D, Albert Schweitzer Campus 1,A14, D-48149 Munster, Germany.	beate.vollenbroeker@ukmuenster.de		Sievers, Laura Katharina/0000-0002-4677-5181	German Research Foundation (DFG) [PA 483/16-1, BU 1214/4-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by grants from the German Research Foundation (DFG; Grants PA 483/16-1 and BU 1214/4-1). The authors declare no conflicts of interest.	Al Tanoury Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009210; Ayoub MA, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00094; Azatov M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28805; Brahler S, 2016, J AM SOC NEPHROL, V27, P3285, DOI 10.1681/ASN.2015121303; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Christensen GL, 2010, MOL CELL PROTEOMICS, V9, P1540, DOI 10.1074/mcp.M900550-MCP200; Courcelles M, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.25; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Delanote V, 2010, FASEB J, V24, P105, DOI 10.1096/fj.09-134304; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Douglass J, 2012, AM J PHYSIOL-CELL PH, V303, pC715, DOI 10.1152/ajpcell.00166.2012; DWORKIN LD, 1983, AM J PHYSIOL, V244, pF95, DOI 10.1152/ajprenal.1983.244.2.F95; Eguchi S, 2003, BIOCHEM SOC T, V31, P1198; Famulski KS, 2013, AM J TRANSPLANT, V13, P634, DOI 10.1111/ajt.12080; Fukuda A, 2012, KIDNEY INT, V81, P40, DOI 10.1038/ki.2011.306; Gloy J, 1997, J CLIN INVEST, V99, P2772, DOI 10.1172/JCI119467; Greka A, 2012, SEMIN NEPHROL, V32, P319, DOI 10.1016/j.semnephrol.2012.06.003; Harding SD, 2011, DEVELOPMENT, V138, P2845, DOI 10.1242/dev.063594; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hsu HH, 2008, J MOL MED, V86, P1379, DOI 10.1007/s00109-008-0399-y; Huling JC, 2012, AM J PHYSIOL-RENAL, V302, pF401, DOI 10.1152/ajprenal.00457.2011; Humphrey SJ, 2015, NAT BIOTECHNOL, V33, P990, DOI 10.1038/nbt.3327; Ishida H, 2017, SCI REP-UK, V7, DOI 10.1038/srep40662; Janji B, 2006, J CELL SCI, V119, P1947, DOI 10.1242/jcs.02874; Khurana S, 2011, CELL ADHES MIGR, V5, P409, DOI 10.4161/cam.5.5.17644; Kobori H, 2013, CURR PHARM DESIGN, V19, P3033; Lommel MJ, 2016, FASEB J, V30, P1218, DOI 10.1096/fj.15-276311; McMahon AP, 2008, J AM SOC NEPHROL, V19, P667, DOI 10.1681/ASN.2007101078; MORGAN AJ, 1994, BIOCHEM J, V300, P665, DOI 10.1042/bj3000665; Morley SC, 2013, IMMUNOL REV, V256, P48, DOI 10.1111/imr.12102; NAMBA Y, 1992, J BIOCHEM-TOKYO, V112, P503, DOI 10.1093/oxfordjournals.jbchem.a123929; Nilufar S, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-66; Poppe H, 2008, NAT METHODS, V5, P277, DOI 10.1038/nmeth0408-277; Reiser J, 2004, J CLIN INVEST, V113, P1390, DOI 10.1172/JCI200420402; Remuzzi Giuseppe, 2005, Kidney Int Suppl, pS57; Rinschen MM, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aaf8165; Rinschen MM, 2016, AM J PHYSIOL-CELL PH, V311, pC404, DOI 10.1152/ajpcell.00121.2016; Rinschen MM, 2010, P NATL ACAD SCI USA, V107, P3882, DOI 10.1073/pnas.0910646107; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Ruster C, 2011, J AM SOC NEPHROL, V22, P1189, DOI 10.1681/ASN.2010040384; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Schenk LK, 2016, CELL PHYSIOL BIOCHEM, V38, P2452, DOI 10.1159/000445596; Schulze U, 2014, MOL CELL PROTEOMICS, V13, P1397, DOI 10.1074/mcp.M113.034108; Schweda F, 2015, PFLUG ARCH EUR J PHY, V467, P565, DOI 10.1007/s00424-014-1668-y; Scott RP, 2015, J CELL BIOL, V209, P199, DOI 10.1083/jcb.201410017; Shin SY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6777; Suzuki Hiroyuki, 2005, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V3, P305, DOI 10.2174/156801605774322355; Tchapyjnikov D, 2010, PHYSIOL GENOMICS, V40, P167, DOI 10.1152/physiolgenomics.00148.2009; Thingholm Tine E., 2009, V527, P57, DOI 10.1007/978-1-60327-834-8_5; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wennmann DO, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.476; Wennmann DO, 2012, SEMIN NEPHROL, V32, P377, DOI 10.1016/j.semnephrol.2012.06.009; Wisniewski JR, 2012, ANAL CHEM, V84, P2631, DOI 10.1021/ac300006b; Xiao KH, 2010, P NATL ACAD SCI USA, V107, P15299, DOI 10.1073/pnas.1008461107; Xie XF, 2016, AM J KIDNEY DIS, V67, P728, DOI 10.1053/j.ajkd.2015.10.011; Yao J, 2004, PLOS BIOL, V2, P787, DOI 10.1371/journal.pbio.0020167	59	14	14	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					5019	5035		10.1096/fj.201700142R	http://dx.doi.org/10.1096/fj.201700142R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28768720	Green Submitted			2022-12-28	WOS:000413398500031
J	Hsu, JY; Chang, JY; Chang, KY; Chang, WC; Chen, BK				Hsu, Jinn-Yuan; Chang, Jang-Yang; Chang, Kwang-Yu; Chang, Wen-Chang; Chen, Ben-Kuen			Epidermal growth factor-induced pyruvate dehydrogenase kinase 1 expression enhances head and neck squamous cell carcinoma metastasis via up-regulation of fibronectin	FASEB JOURNAL			English	Article						EGF; PDK1; HNSCC; MMP	HIGH LACTATE LEVELS; CANCER-CELLS; GLUCOSE-METABOLISM; PATIENT SURVIVAL; HYPOXIA; ACTIVATION; GLYCOLYSIS; RECEPTOR; OVEREXPRESSION; TUMORIGENESIS	Epidermal growth factor receptor (EGFR) activation is a major cause of metastasis in such cancers as head and neck squamous cell carcinoma (HNSCC); however, whether the metabolic enzyme, pyruvate dehydrogenase kinase 1 (PDK1), mediates EGF-enhanced HNSCC metastasis remains unclear. Of interest, we found that EGF induced PDK1 expression in HNSCC. Tumor cell transformation induced by EGF was repressed by PDK1 knockdown, and the down-regulation of PDK1 expression or inhibition of its activity significantly blocked EGF-enhanced cell migration and invasion. In addition, depletion of PDK1 impeded EGF-enhanced binding of HNSCC cells to endothelial cells as well as the metastatic seeding of tumor cells in lungs. PDK1 depletion inhibited EGF-induced matrix metalloproteinase-1 (MMP-1), MMP-2, MMP-3, MMP-9, and fibronectin expression and Rac1/cdc42 activation. Furthermore, PDK1 overexpression induced MMP-1, MMP-2, MMP-3, MMP-9, and fibronectin expression and Rac1/cdc42 activation. Of interest, depletion of fibronectin inhibited PDK1-enhanced MMP-1-3 and MMP-9 expression as well as Rac1/cdc42 activation and tumor invasion. These results demonstrate that EGF-induced PDK1 expression enhances HNSCC metastasis via activation of the fibronectin signaling pathway. Inhibition of PDK1 may be a potential strategy for the treatment of EGFR-mediated HNSCC metastasis.-Hsu, J.-Y., Chang, J.-Y., Chang, K.-Y., Chang, W.-C., Chen B.-K. Epidermal growth factor-induced pyruvate dehydrogenase kinase 1 expression enhances head and neck squamous cell carcinoma metastasis via up-regulation of fibronectin.	[Hsu, Jinn-Yuan] Natl Cheng Kung Univ Hosp, Ctr Infect Dis & Signaling Res, Tainan, Taiwan; [Chang, Jang-Yang] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan, Taiwan; [Chen, Ben-Kuen] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan, Taiwan; [Chang, Kwang-Yu] Natl Cheng Kung Univ, Div Hematol Oncol, Dept Internal Med, Tainan, Taiwan; [Chen, Ben-Kuen] Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Coll Biosci & Biotechnol, Tainan, Taiwan; [Chang, Jang-Yang; Chang, Kwang-Yu] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Chang, Wen-Chang; Chen, Ben-Kuen] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Health Research Institutes - Taiwan; Taipei Medical University	Chang, WC (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan.; Chen, BK (corresponding author), Natl Cheng Kung Univ, Coll Biosci & Biotechnol, 1 Univ Rd, Tainan 701, Taiwan.	wcchang@tmu.edu.tw; bkchen58@mail.ncku.edu.tw		Chen, Ben-Kuen/0000-0002-4720-4364	Ministry of Science and Technology of Taiwan [NSC 102-2628-B-006-011-MY3, 102-2320-B-038-046-MY3]; Headquarters of University Advancement at National Cheng Kung University	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Headquarters of University Advancement at National Cheng Kung University	This work was supported by the Ministry of Science and Technology of Taiwan (Grants NSC 102-2628-B-006-011-MY3 and 102-2320-B-038-046-MY3), and the Headquarters of University Advancement at National Cheng Kung University. The authors declare no conflicts of interest.	Akakura N, 2001, CANCER RES, V61, P6548; Albini A, 2012, NAT REV CLIN ONCOL, V9, P498, DOI 10.1038/nrclinonc.2012.120; Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Blum R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.38; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Boussouar F, 1999, BIOL REPROD, V61, P1139, DOI 10.1095/biolreprod61.4.1139; Carneiro BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116001; Chang KY, 2011, CLIN CANCER RES, V17, P7116, DOI 10.1158/1078-0432.CCR-11-0796; Chang KY, 2009, J BIOL CHEM, V284, P9908, DOI 10.1074/jbc.M806210200; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; GRANDIS JR, 1993, CANCER RES, V53, P3579; Grandis JR, 1998, JNCI-J NATL CANCER I, V90, P824, DOI 10.1093/jnci/90.11.824; Guillaumond F, 2013, P NATL ACAD SCI USA, V110, P3919, DOI 10.1073/pnas.1219555110; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hirschhaeuser F, 2011, CANCER RES, V71, P6921, DOI 10.1158/0008-5472.CAN-11-1457; Hsu JY, 2015, ONCOTARGET, V6, P1723, DOI 10.18632/oncotarget.2783; Huang M, 2012, ONCOGENE, V31, P2783, DOI 10.1038/onc.2011.450; Ishihara H, 1999, J CLIN INVEST, V104, P1621, DOI 10.1172/JCI7515; ISHITOYA J, 1989, BRIT J CANCER, V59, P559, DOI 10.1038/bjc.1989.113; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kalyankrishna S, 2006, J CLIN ONCOL, V24, P2666, DOI 10.1200/JCO.2005.04.8306; Kamarajan P, 2013, CANCER MED-US, V2, P793, DOI 10.1002/cam4.147; KAPLAN O, 1990, J BIOL CHEM, V265, P13641; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Koukourakis MI, 2005, NEOPLASIA, V7, P1, DOI 10.1593/neo.04373; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Lu CW, 2008, J BIOL CHEM, V283, P28106, DOI 10.1074/jbc.M803508200; McFate T, 2008, J BIOL CHEM, V283, P22700, DOI 10.1074/jbc.M801765200; Mikuriya K, 2007, INT J ONCOL, V30, P849; Moore JD, 2014, ONCOTARGET, V5, P12862, DOI 10.18632/oncotarget.2656; Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111; Ota S, 2013, TARGET ONCOL, V8, P145, DOI 10.1007/s11523-013-0273-x; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Porporato PE, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00049; Robey RB, 2002, J BIOL CHEM, V277, P14370, DOI 10.1074/jbc.M111722200; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; STEINSVAG SK, 1991, LARYNGOSCOPE, V101, P1323, DOI 10.1002/lary.5541011212; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; van Houten VMM, 2000, RECENT RESULTS CANC, V157, P90; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Velpula KK, 2013, CANCER RES, V73, P7277, DOI 10.1158/0008-5472.CAN-13-1868; Walenta S, 2000, CANCER RES, V60, P916; Walenta S, 1997, AM J PATHOL, V150, P409; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Yang P, 2014, CELL SIGNAL, V26, P1853, DOI 10.1016/j.cellsig.2014.03.020; Yang WW, 2012, MOL CELL, V48, P771, DOI 10.1016/j.molcel.2012.09.028; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Yeh TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055018; Zhou WD, 2011, J PROTEOME RES, V10, P1944, DOI 10.1021/pr101179t; Ziebart T, 2011, J CANCER RES CLIN, V137, P193, DOI 10.1007/s00432-010-0875-y	53	12	15	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4265	4276		10.1096/fj.201700156R	http://dx.doi.org/10.1096/fj.201700156R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28596235				2022-12-28	WOS:000413397400007
J	Scoville, DK; Botta, D; Galdanes, K; Schmuck, SC; White, CC; Stapleton, PL; Bammler, TK; MacDonald, JW; Altemeier, WA; Hernandez, M; Kleeberger, SR; Chen, LC; Gordon, T; Kavanagh, TJ				Scoville, David K.; Botta, Dianne; Galdanes, Karen; Schmuck, Stefanie C.; White, Collin C.; Stapleton, Patricia L.; Bammler, Theo K.; MacDonald, James W.; Altemeier, William A.; Hernandez, Michelle; Kleeberger, Steven R.; Chen, Lung-Chi; Gordon, Terry; Kavanagh, Terrance J.			Genetic determinants of susceptibility to silver nanoparticle-induced acute lung inflammation in mice	FASEB JOURNAL			English	Article						genome-wide association; nanosilver; Nedd4l; Ano6; Rnf220	GENOME-WIDE ASSOCIATION; COLLABORATIVE CROSS; INTRATRACHEAL INSTILLATION; RAT LUNG; OROPHARYNGEAL ASPIRATION; ALVEOLAR MACROPHAGES; CARBON NANOTUBES; PARTICLE-SIZE; ANOCTAMIN 6; MOUSE	Silver nanoparticles (AgNPs) are employed in a variety of consumer products; however, in vivo rodent studies indicate that AgNPs can cause lung inflammation and toxicity in a strain- and particle type-dependent manner, but mechanisms of susceptibility remain unclear. The aim of this study was to assess the variation in AgNP-induced lung inflammation and toxicity across multiple inbred mouse strains and to use genome-wide association (GWA) mapping to identify potential candidate susceptibility genes. Mice received doses of 0.25 mg/kg of either 20-nm citrate-coated AgNPs or citrate buffer using oropharyngeal aspiration. Neutrophils in bronchoalveolar lavage fluid (BALF) served as markers of inflammation. We found significant strain- and treatment-dependent variation in neutrophils in BALF. GWA mapping identified 10 significant single-nucleotide polymorphisms (false discovery rate, 15%) in 4 quantitative trait loci on mouse chromosomes 1, 4, 15, and 18, and Nedd4l (neural precursor cell expressed developmentally downregulated gene 4-like; chromosome 18), Ano6 (anocatmin 6; chromosome 15), and Rnf220 (Ring finger protein 220; chromosome 4) were considered candidate genes. Quantitative RT-PCR revealed significant inverse associations between mRNA levels of these genes and neutrophil influx. Nedd4l, Ano6, and Rnf220 are candidate susceptibility genes for AgNP-induced lung inflammation that warrant additional exploration in future studies.-Scoville, D. K., Botta, D., Galdanes, K., Schmuck, S. C., White, C. C., Stapleton, P. L., Bammler, T. K., MacDonald, J. W., Altemeier, W. A., Hernandez, M., Kleeberger, S. R., Chen, L.-C., Gordon, T., Kavanagh, T. J. Genetic determinants of susceptibility to silver nanoparticle-induced acute lung inflammation in mice.	[Scoville, David K.; Botta, Dianne; Schmuck, Stefanie C.; White, Collin C.; Stapleton, Patricia L.; Bammler, Theo K.; MacDonald, James W.; Kavanagh, Terrance J.] Univ Washington, Dept Environm & Occupat Hlth Sci, 4225 Roosevelt Way NE Suite 100,Box 354695, Seattle, WA 98195 USA; [Altemeier, William A.] Univ Washington, Dept Med, Seattle, WA USA; [Galdanes, Karen; Hernandez, Michelle; Chen, Lung-Chi] NYU, Dept Environm Med, Tuxedo Pk, NY USA; [Kleeberger, Steven R.] NIEHS, Immun Inflammat & Dis Lab, POB 12233, Res Triangle Pk, NC 27709 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; New York University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Kavanagh, TJ (corresponding author), Univ Washington, Dept Environm & Occupat Hlth Sci, 4225 Roosevelt Way NE Suite 100,Box 354695, Seattle, WA 98195 USA.	tjkav@uw.edu	Kleeberger, Steven R/F-1807-2019	Kleeberger, Steven R/0000-0003-2948-8452; Altemeier, William/0000-0001-8860-405X	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences (NIEHS) [U01-ES019545, U01-ES0200126, T32-ES015459, P30-ES007033, P30-ES000260]; NIH NIEHS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033, U19ES019545, P30ES000260, ZIAES100512, ZIAES100557, T32ES015459] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences (NIEHS) Grants U01-ES019545, U01-ES0200126, T32-ES015459, P30-ES007033, and P30-ES000260. S.R.K. was supported by the NIH NIEHS Intramural Research Program. The silver nanomaterials used in these studies were procured, characterized, and provided by NIEHS Centers for Nanotechnology Health Implications Research Consortium.	Almasy L, 2010, COLD SPRING HARB PRO, V2010; Anderson DS, 2015, NANOTOXICOLOGY, V9, P591, DOI 10.3109/17435390.2014.958116; Anderson DS, 2015, TOXICOL SCI, V144, P366, DOI 10.1093/toxsci/kfv005; [Anonymous], 2014, R LANG ENV STAT COMP; Aylor DL, 2011, GENOME RES, V21, P1213, DOI 10.1101/gr.111310.110; Botelho DJ, 2016, NANOTOXICOLOGY, V10, P118, DOI 10.3109/17435390.2015.1038330; Careau E, 2002, AM J RESP CELL MOL, V26, P579, DOI 10.1165/ajrcmb.26.5.4737; Church RJ, 2014, TOXICOL SCI, V140, P481, DOI 10.1093/toxsci/kfu094; Cohen J., 1988, J AM STAT ASSOC, V2nd, DOI [DOI 10.2307/2290095, 10.1016/B978-0-12-179060-8.50007-4, DOI 10.1016/B978-0-12-179060-8.50007-4]; Colinayo VV, 2003, MAMM GENOME, V14, P464, DOI 10.1007/s00335-002-2187-2; Cui L., 2013, THESIS; Deepayan S., 2008, LATTICE MULTIVARIATE; Driscoll KE, 2000, TOXICOL SCI, V55, P24, DOI 10.1093/toxsci/55.1.24; Durrant C, 2011, GENOME RES, V21, P1239, DOI 10.1101/gr.118786.110; Felix TM, 2012, GENETICS, V191, P989, DOI 10.1534/genetics.112.140640; Gliga AR, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-11; Guo YJ, 2015, BLOOD, V126, P2220, DOI 10.1182/blood-2015-02-622233; Harrill AH, 2009, GENOME RES, V19, P1507, DOI 10.1101/gr.090241.108; HOLTER JF, 1986, J CLIN INVEST, V78, P1513, DOI 10.1172/JCI112743; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kimura T, 2011, P NATL ACAD SCI USA, V108, P3216, DOI 10.1073/pnas.1010334108; Kinaret P, 2017, ACS NANO, V11, P291, DOI 10.1021/acsnano.6b05652; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Korns D, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00057; Labots M, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0411-4; Lakatos HF, 2006, EXP LUNG RES, V32, P181, DOI 10.1080/01902140600817465; Lee JS, 2015, NANOTOXICOLOGY, V9, P802, DOI 10.3109/17435390.2014.978404; Lee YH, 2014, BIOMATERIALS, V35, P4706, DOI 10.1016/j.biomaterials.2014.02.021; Li B, 2015, ENDOCRINOLOGY, V156, P203, DOI 10.1210/en.2014-1539; Liao HY, 2014, NANOTOXICOLOGY, V8, P100, DOI 10.3109/17435390.2013.858793; Liu W, 2010, NANOTOXICOLOGY, V4, P319, DOI 10.3109/17435390.2010.483745; Ma PC, 2014, MOL CELL BIOL, V34, P4355, DOI 10.1128/MCB.00731-14; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Mares CA, 2011, IMMUNOL CELL BIOL, V89, P167, DOI 10.1038/icb.2010.81; Martins JR, 2011, P NATL ACAD SCI USA, V108, P18168, DOI 10.1073/pnas.1108094108; McConnachie LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064165; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Morimoto K, 2012, RESP MED, V106, P1800, DOI 10.1016/j.rmed.2012.08.020; Nichols JL, 2014, FASEB J, V28, P2538, DOI 10.1096/fj.13-247221; Ousingsawat J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7245; Pang CF, 2016, NANOTOXICOLOGY, V10, P129, DOI 10.3109/17435390.2015.1024295; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parks BW, 2013, CELL METAB, V17, P141, DOI 10.1016/j.cmet.2012.12.007; Pedemonte N, 2014, PHYSIOL REV, V94, P419, DOI 10.1152/physrev.00039.2011; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Petkov PM, 2004, GENOME RES, V14, P1806, DOI 10.1101/gr.2825804; Pinheiro JBD, 2020, R CORE TEAM NLME LIN; Ramos EM, 2014, EUR J HUM GENET, V22, P144, DOI 10.1038/ejhg.2013.96; Rasmussen AL, 2014, SCIENCE, V346, P987, DOI 10.1126/science.1259595; Rutledge H, 2014, GENETICS, V198, P735, DOI 10.1534/genetics.114.168138; Rysavy Noel M, 2014, Bioarchitecture, V4, P127, DOI 10.1080/19490992.2014.995516; Scoville DK, 2015, TOXICOL APPL PHARM, V289, P240, DOI 10.1016/j.taap.2015.09.019; Seiffert J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119726; Shannahan JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074001; Silva RM, 2016, TOXICOL PATHOL, V44, P673, DOI 10.1177/0192623316629804; Silva RM, 2015, TOXICOL SCI, V144, P151, DOI 10.1093/toxsci/kfu265; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Suzuki OT, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00272; The Jackson Laboratory, 2011, STEARNS1 LUNG GEN EX; The National Institute for Occupational Safety and Health, 1994, IMM DANG LIF HLTH; Threadgill DW, 2012, GENETICS, V190, P291, DOI 10.1534/genetics.111.138032; Toti F, 1996, BLOOD, V87, P1409, DOI 10.1182/blood.V87.4.1409.bloodjournal8741409; Turner S.D., 2014, QQMAN R PACKAGE VISU, V7, pe1002043, DOI [DOI 10.21105/JOSS.00731, 10.1101/005165, DOI 10.1101/005165]; Valdar W, 2006, GENETICS, V172, P1783, DOI 10.1534/genetics.104.039313; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Wallach D, 2014, NAT REV IMMUNOL, V14, P51, DOI 10.1038/nri3561; Wang X, 2014, SMALL, V10, P385, DOI 10.1002/smll.201301597; Weldon BA, 2016, NANOTOXICOLOGY, V10, P945, DOI 10.3109/17435390.2016.1148793; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yu K, 2015, ELIFE, V4, DOI 10.7554/eLife.06901	73	24	24	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4600	4611		10.1096/fj.201700187R	http://dx.doi.org/10.1096/fj.201700187R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28716969	Green Published			2022-12-28	WOS:000413397400035
J	Tarafder, S; Chen, E; Jun, YN; Kao, K; Sim, KH; Back, J; Lee, FY; Lee, CH				Tarafder, Solaiman; Chen, Esther; Jun, Yena; Kao, Kristy; Sim, Kun Hee; Back, Jungho; Lee, Francis Y.; Lee, Chang H.			Tendon stem/progenitor cells regulate inflammation in tendon healing via JNK and STAT3 signaling	FASEB JOURNAL			English	Article						CTGF; TSC; CD146	MESENCHYMAL STEM-CELLS; COLLAGEN SPONGE CONSTRUCTS; EXTRACELLULAR-MATRIX; SILK SCAFFOLD; ANIMAL-MODELS; IMMUNOREGULATORY CYTOKINES; BIOMECHANICAL PROPERTIES; ACHILLES-TENDON; IMMUNE CELLS; IN-VIVO	Tendon stem/progenitor cells (TSCs) have been found in different anatomic locations and showed a promising regenerative potential. We identified a role of TSCs in the regulation of inflammation during healing of acute tendon injuries. Delivery of connective tissue growth factor (CTGF) into full-transected rat patellar tendons significantly increased the number of CD146(+) TSCs, leading to enhanced healing. In parallel, CTGF delivery significantly reduced the number of iNOS(+) M1 macrophages and increased the expression of anti-inflammatory IL-10 at 2 d after surgery, with over 85% CD146(+) TSCs expressing IL-10. By 1 wk, the elevated IL-10 expression remained, and IL-6 expression was significantly attenuated in CTGF-delivered tendon healing. Matrix metalloproteinase (MMP)-3 expression in CTGF-delivered tendon was organized along with the reorienting collagen fibers by 1 wk after surgery, in comparison with the control group showing the abundant MMP-3 expression localized at healing junction. Tissue inhibitor of metalloprotease (TIMP)-3 was expressed in CD146(+) TSCs at 1 wk with CTGF, in contrast to control with no TIMP-3 expression. In vitro, IL-10 expression was detected only when tendon cells were stimulated with IL-1 beta, and CTGF and significantly higher in CD146(+) TSCs than CD146(-) tendon cells. Similarly, TIMP-3 expression was detected only when treated with CTGF or CTGF and IL-1b that is significantly higher in CD146(+) TSCs compared to CD146(-) tendon cells. Signaling study with specific inhibitors and Western blot analysis demonstrated that CTGF-induced expression of IL-10 and TIMP-3 in CD146(+) TSCs are regulated by JNK/signal transducer and activator of transcription 3 signaling. Taken together, these findings suggest anti-inflammatory roles of CTGF-stimulated TSCs that are likely associated with improved tendon healing.	[Tarafder, Solaiman; Chen, Esther; Jun, Yena; Kao, Kristy; Sim, Kun Hee; Lee, Chang H.] Columbia Univ, Regenerat Engn Lab, Irving Med Ctr, 630 W 168 St VC12-230, New York, NY 10032 USA; [Back, Jungho; Lee, Francis Y.] Yale Univ, Sch Med, Dept Orthopaed & Rehabil, New Haven, CT USA	Columbia University; NewYork-Presbyterian Hospital; Yale University	Lee, CH (corresponding author), Columbia Univ, Regenerat Engn Lab, Irving Med Ctr, 630 W 168 St VC12-230, New York, NY 10032 USA.	chl2109@cumc.columbia.edu		Tarafder, Solaiman/0000-0001-9659-690X	U.S. National Institutes of Health, National Institute of Dental and Craniofacial Research Grant [1R03 DE026794-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE026794] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Dental and Craniofacial Research Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study is partially supported by U.S. National Institutes of Health, National Institute of Dental and Craniofacial Research Grant 1R03 DE026794-01 (to C.H.L.). The authors thank A. Tsu (Columbia University College of Dental Medicine) for administrative assistance.	Al-Sadi O, 2012, MUSCLES LIGAMENTS TE, V1, P68; Bedi A, 2010, AM J SPORT MED, V38, P308, DOI 10.1177/0363546509347366; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Chen JM, 2009, EXPERT REV MED DEVIC, V6, P61, DOI 10.1586/17434440.6.1.61; Davis ME, 2013, J APPL PHYSIOL, V115, P884, DOI 10.1152/japplphysiol.00137.2013; Del Buono A, 2012, J SHOULDER ELB SURG, V21, P200, DOI 10.1016/j.jse.2011.10.020; Fan HB, 2008, BIOMATERIALS, V29, P3324, DOI 10.1016/j.biomaterials.2008.04.012; Fan HB, 2009, BIOMATERIALS, V30, P4967, DOI 10.1016/j.biomaterials.2009.05.048; Fleming BC, 2009, AM J SPORT MED, V37, P1554, DOI 10.1177/0363546509332257; Gulotta LV, 2011, ARTHROSCOPY, V27, P1351, DOI 10.1016/j.arthro.2011.03.076; Hutchins AP, 2013, BRIEF FUNCT GENOMICS, V12, P489, DOI 10.1093/bfgp/elt028; James R, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/2/025011; John T, 2010, J ORTHOP RES, V28, P1071, DOI 10.1002/jor.21079; Jones GC, 2006, ARTHRITIS RHEUM-US, V54, P832, DOI 10.1002/art.21672; Juncosa-Melvin N, 2005, TISSUE ENG, V11, P448, DOI 10.1089/ten.2005.11.448; Juncosa-Melvin N, 2006, TISSUE ENG, V12, P2291, DOI 10.1089/ten.2006.12.2291; Juncosa-Melvin N, 2006, TISSUE ENG, V12, P681, DOI 10.1089/ten.2006.12.681; Lake SP, 2008, DISABIL REHABIL, V30, P1530, DOI 10.1080/09638280701785460; Lee CH, 2015, J CLIN INVEST, V125, P2690, DOI [10.1172/JCI84508, 10.1172/JCI81589]; Lee CH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009696; Lee CH, 2010, J CLIN INVEST, V120, P3340, DOI 10.1172/JCI43230; Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X; Lee JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024381; Legemate K, 2016, J DENT RES, V95, P800, DOI 10.1177/0022034516642404; Legerlotz K, 2012, RHEUMATOLOGY, V51, P1161, DOI 10.1093/rheumatology/kes002; Liu J, 2012, TOXICOL SCI, V129, P363, DOI 10.1093/toxsci/kfs199; Lui PPY, 2011, SCAND J MED SCI SPOR, V21, P3, DOI 10.1111/j.1600-0838.2010.01164.x; Manning CN, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0059-4; Murray PJ, 2005, P NATL ACAD SCI USA, V102, P8686, DOI 10.1073/pnas.0500419102; Nirmalanandhan VS, 2008, TISSUE ENG PT A, V14, P1883, DOI 10.1089/ten.tea.2007.0125; Nourissat G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012248; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Ouyang HW, 2006, TRANSPLANTATION, V82, P170, DOI 10.1097/01.tp.0000226232.79106.72; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Sahin H, 2012, J ORTHOP RES, V30, P1952, DOI 10.1002/jor.22147; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schulze-Tanzil G, 2011, SCAND J MED SCI SPOR, V21, P337, DOI 10.1111/j.1600-0838.2010.01265.x; Shen H, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0406-0; Shen WL, 2012, CELL TRANSPLANT, V21, P943, DOI 10.3727/096368911X627453; Spindler KP, 2006, J ORTHOP RES, V24, P401, DOI 10.1002/jor.20074; Staples KJ, 2007, J IMMUNOL, V178, P4779, DOI 10.4049/jimmunol.178.8.4779; Thomopoulos S, 2003, J ORTHOP RES, V21, P413, DOI 10.1016/S0736-0266(03)00057-3; Tozer Samuel, 2005, Birth Defects Research, V75, P226, DOI 10.1002/bdrc.20049; Tsuzaki M, 2003, J CELL BIOCHEM, V89, P556, DOI 10.1002/jcb.10534; Voleti PB, 2012, ANNU REV BIOMED ENG, V14, P47, DOI 10.1146/annurev-bioeng-071811-150122; Voloshin I, 2005, ARTHROSCOPY, V21, P1076, DOI 10.1016/j.arthro.2005.05.017; Wang F, 2007, J ORTHOP RES, V25, P378, DOI 10.1002/jor.20294; Warden SJ, 2007, BRIT J SPORT MED, V41, P232, DOI 10.1136/bjsm.2006.032342; Xu K, 2017, J TISSUE ENG REGEN M, V11, P1173, DOI 10.1002/term.2020; Yanez R, 2006, STEM CELLS, V24, P2582, DOI 10.1634/stemcells.2006-0228; Yang G, 2013, BIOMATERIALS, V34, P9295, DOI 10.1016/j.biomaterials.2013.08.054; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995	52	42	42	2	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3991	3998		10.1096/fj.201700071R	http://dx.doi.org/10.1096/fj.201700071R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28533328	Green Published			2022-12-28	WOS:000408713300024
J	Lu, ZY; Casalino-Matsuda, SM; Nair, A; Buchbinder, A; Budinger, GRS; Sporn, PHS; Gates, KL				Lu, Ziyan; Casalino-Matsuda, S. Marina; Nair, Aisha; Buchbinder, Anja; Budinger, G. R. Scott; Sporn, Peter H. S.; Gates, Khalilah L.			A role for heat shock factor 1 in hypercapnia-induced inhibition of inflammatory cytokine expression	FASEB JOURNAL			English	Article						rodent; macrophage; bacterial infections; stress response; lung	NECROSIS-FACTOR-ALPHA; MECHANICALLY VENTILATED PATIENTS; OBSTRUCTIVE PULMONARY-DISEASE; TRANSCRIPTION FACTOR; LUNG INJURY; RESPIRATORY-FAILURE; ACUTE EXACERBATIONS; HOSPITAL MORTALITY; NUCLEAR-FACTOR; IN-VITRO	Hypercapnia, elevated levels of CO2 in the blood, is a known marker for poor clinical prognosis and is associated with increased mortality in patients hospitalized with both bacterial and viral pneumonias. Although studies have established a connection between elevated CO2 levels and poor pneumonia outcomes, a mechanistic basis of this association has not yet been established. We previously reported that hypercapnia inhibits expression of key NF-B-regulated, innate immune cytokines, TNF-, and IL-6, in LPS-stimulated macrophages in vitro and in mice during Pseudomonas pneumonia. The transcription factor heat shock factor 1 (HSF1) is important in maintaining proteostasis during stress and has been shown to negatively regulate NF-B activity. In this study, we tested the hypothesis that HSF1 activation in response to hypercapnia results in attenuated NF-B-regulated gene expression. We found that hypercapnia induced the protein expression and nuclear accumulation of HSF1 in primary murine alveolar macrophages and in an alveolar macrophage cell line (MH-S). In MH-S cells treated with short interfering RNA targeting Hsf1, LPS-induced IL-6 and TNF- release were elevated during exposure to hypercapnia. Pseudomonas-infected Hsf1(+/+) (wild-type) mice, maintained in a hypercapnic environment, showed lower levels of IL-6 and TNF- in bronchoalveolar lavage fluid and IL-1 in lung tissue than did infected mice maintained in room air. In contrast, infected Hsf1(+/-) mice exposed to either hypercapnia or room air had similarly elevated levels of those cytokines. These results suggest that hypercapnia-mediated inhibition of NF-B cytokine production is dependent on HSF1 expression and/or activation.Lu, Z., Casalino-Matsuda, S. M., Nair, A., Buchbinder, A., Budinger, G. R. S., Sporn, P. H. S., Gates, K. L. A role for heat shock factor 1 in hypercapnia-induced inhibition of inflammatory cytokine expression.	[Lu, Ziyan; Casalino-Matsuda, S. Marina; Nair, Aisha; Budinger, G. R. Scott; Sporn, Peter H. S.; Gates, Khalilah L.] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Nair, Aisha; Budinger, G. R. Scott; Sporn, Peter H. S.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL USA; [Buchbinder, Anja] Univ Giessen, Lung Ctr, Giessen, Germany; [Buchbinder, Anja] Univ Marburg, Lung Ctr, Giessen, Germany	Northwestern University; Feinberg School of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Justus Liebig University Giessen; Philipps University Marburg	Gates, KL (corresponding author), Northwestern Univ, Feinberg Sch Med, 240 E Huron,McGaw M-300, Chicago, IL 60611 USA.	k-gates@northwestern.edu		Sporn, Peter/0000-0002-1006-9437	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [K01 HL108860, R01 HL131745, P01 HL071643]; NIH National Institute on Aging [P01 AG049665]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131745, R56HL131745, P01HL071643, R01HL107629, K01HL108860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG049665] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. Karen Ridge and Dr. Navdeep Chandel (both from Northwestern University) for advice, reagents, and technical assistance. The authors acknowledge support from the U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (Grants K01 HL108860, R01 HL131745, and P01 HL071643), and NIH National Institute on Aging (Grant P01 AG049665). The authors declare no conflicts of interest.	Akerfelt M, 2010, J BIOL CHEM, V285, P34469, DOI 10.1074/jbc.M110.157552; Budinger GRS, 2011, AM J RESP CRIT CARE, V183, P1043, DOI 10.1164/rccm.201002-0181OC; Budweiser S, 2007, CHEST, V131, P1650, DOI 10.1378/chest.06-2124; Comolli JC, 1999, INFECT IMMUN, V67, P3625, DOI 10.1128/IAI.67.7.3625-3630.1999; Cummins EP, 2010, J IMMUNOL, V185, P4439, DOI 10.4049/jimmunol.1000701; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Gally F, 2012, J INNATE IMMUN, V4, P59, DOI 10.1159/000333089; Gates KL, 2013, AM J RESP CELL MOL, V49, P821, DOI 10.1165/rcmb.2012-0487OC; Gonsalves SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015934; Gupta A, 2013, J BIOL CHEM, V288, P2756, DOI 10.1074/jbc.M112.427336; Gupta R, 2011, NAT METHODS, V8, P879, DOI [10.1038/NMETH.1697, 10.1038/nmeth.1697]; Hagiwara S, 2007, INFLAMM RES, V56, P297, DOI 10.1007/s00011-007-6161-z; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Helenius IT, 2016, J IMMUNOL, V196, P655, DOI 10.4049/jimmunol.1501708; Helenius IT, 2009, P NATL ACAD SCI USA, V106, P18710, DOI 10.1073/pnas.0905925106; Hentze N, 2016, ELIFE, V5, DOI 10.7554/eLife.11576; Inouye S, 2007, J BIOL CHEM, V282, P33210, DOI 10.1074/jbc.M704471200; Kim HP, 2005, J IMMUNOL, V175, P2622, DOI 10.4049/jimmunol.175.4.2622; Macario AJL, 2005, NEW ENGL J MED, V353, P1489, DOI 10.1056/NEJMra050111; MacIntyre Neil, 2008, Proc Am Thorac Soc, V5, P530, DOI 10.1513/pats.200707-088ET; Mancebo J, 1998, Intensive Care Med, V24, P1339, DOI 10.1007/s001340050773; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Mohan Alladi, 2006, BMC Pulm Med, V6, P27, DOI 10.1186/1471-2466-6-27; MOSSER DD, 1990, P NATL ACAD SCI USA, V87, P3748, DOI 10.1073/pnas.87.10.3748; Murapa P, 2011, INFECT IMMUN, V79, P177, DOI 10.1128/IAI.00742-09; Murtagh P, 2009, PEDIATR PULM, V44, P450, DOI 10.1002/ppul.20984; Naidu SD, 2015, TRENDS PHARMACOL SCI, V36, P6, DOI 10.1016/j.tips.2014.10.011; Nichol AD, 2009, CRIT CARE MED, V37, P2953, DOI 10.1097/CCM.0b013e3181b028ce; Nin N, 2017, INTENS CARE MED, V43, P200, DOI 10.1007/s00134-016-4611-1; O'Croinin DF, 2008, CRIT CARE MED, V36, P2128, DOI 10.1097/CCM.0b013e31817d1b59; Sin DD, 2005, AM J MED, V118, P145, DOI 10.1016/j.amjmed.2004.10.014; Singh IS, 2002, J BIOL CHEM, V277, P4981, DOI 10.1074/jbc.M108154200; Singh IS, 2000, J BIOL CHEM, V275, P9841, DOI 10.1074/jbc.275.13.9841; Singh V, 2006, CELL CYCLE, V5, P2443, DOI 10.4161/cc.5.21.3434; Singh V, 2006, P NATL ACAD SCI USA, V103, P13092, DOI 10.1073/pnas.0604050103; Slenter RHJ, 2013, RESPIRATION, V85, P15, DOI 10.1159/000342036; Soberanes S, 2009, J BIOL CHEM, V284, P2176, DOI 10.1074/jbc.M808844200; Song MC, 2008, J CRIT CARE, V23, P406, DOI 10.1016/j.jcrc.2007.09.007; Sun DX, 2005, J SURG RES, V129, P114, DOI 10.1016/j.jss.2005.05.028; Takii R, 2010, J IMMUNOL, V184, P1041, DOI 10.4049/jimmunol.0902579; Tiruvoipati R, 2017, CRIT CARE MED, V45, pE649, DOI 10.1097/CCM.0000000000002332; Vihervaara A, 2014, J CELL SCI, V127, P261, DOI 10.1242/jcs.132605; Wang NZ, 2010, FASEB J, V24, P2178, DOI 10.1096/fj.09-136895; Wirth D, 2004, AM J PHYSIOL-LUNG C, V287, pL953, DOI 10.1152/ajplung.00184.2003; Xie Y, 2002, J BIOL CHEM, V277, P11802, DOI 10.1074/jbc.M109296200; Young PJ, 2014, CRIT CARE, V18, DOI 10.1186/cc13773	46	15	15	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3614	3622		10.1096/fj.201701164R	http://dx.doi.org/10.1096/fj.201701164R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29405096	Green Published			2022-12-28	WOS:000435104500011
J	Dial, AG; Rooprai, P; Lally, JS; Bujak, AL; Steinberg, GR; Ljubicic, V				Dial, Athan G.; Rooprai, Paul; Lally, James S.; Bujak, Adam L.; Steinberg, Gregory R.; Ljubicic, Vladimir			The role of AMP-activated protein kinase in the expression of the dystrophin-associated protein complex in skeletal muscle	FASEB JOURNAL			English	Article						utrophin; RNA-binding protein; fiber type; PGC-1 alpha; Duchenne muscular dystrophy	MDX MOUSE MUSCLE; GAMMA-SARCOGLYCAN GENE; NITRIC-OXIDE SYNTHASE; RNA-BINDING PROTEINS; MUSCULAR-DYSTROPHY; GLYCOPROTEIN COMPLEX; MITOCHONDRIAL BIOGENESIS; FIBER TYPES; NEUROMUSCULAR-JUNCTION; OXIDATIVE CAPACITY	Stimulation of AMPK induces the expression of dystrophin-associated protein complex (DAPC) components in skeletal muscle, whereas reductions in AMPK are associated with DAPC dysfunction. We sought to determine whether AMPK was necessary for the maintenance of DAPC expression in skeletal muscle. Fast, glycolytic extensor digitorum longus (EDL) and slow, oxidative soleus (Sol) muscles from wild-type mice and from littermates with skeletal muscle-specific knockout of the AMPK beta 1 and beta 2 subunits (AMPK beta 1 beta 2M-KO; MKO) were analyzed. DAPC mRNA and protein expression were similar between genotypes, with the exception of elevated neuronal nitric oxide synthase expression at the sarcolemma in MKO muscles. The content of transcriptional and post-transcriptional regulators of the DAPC was also not affected by the loss of AMPK. However, MyoD and myogenin expression was diminished in MKO muscles, consistent with previous reports of myopathy in these animals. Furthermore, we observed decrements in extrasynaptic utrophin expression selectively in MKO Sol muscles, likely due to the adaptive accumulation of peroxisome proliferator-activated receptor gamma coactivator-1 alpha at the sarcolemma of MKO EDL muscles. Collectively, the evidence indicates that AMPK is sufficient but not essential for the maintenance of DAPC expression in skeletal muscle, yet it is required for preserving extrasynaptic utrophin levels in slow oxidative muscles.	[Dial, Athan G.; Rooprai, Paul; Ljubicic, Vladimir] McMaster Univ, Dept Kinesiol, 1280 Main St W,e207 Ivor Wynne Ctr, Hamilton, ON L8S 4L8, Canada; [Lally, James S.; Bujak, Adam L.; Steinberg, Gregory R.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Steinberg, Gregory R.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Ljubicic, V (corresponding author), McMaster Univ, Dept Kinesiol, 1280 Main St W,e207 Ivor Wynne Ctr, Hamilton, ON L8S 4L8, Canada.	ljubicic@mcmaster.ca		Steinberg, Gregory/0000-0001-5425-8275	Canadian Institutes of Health Research; Canada Research Chairs Program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs)	The authors thank Dr. David A. Hood (Muscle Health Research Centre, York University, Toronto, ON, Canada) for the gift of PGC-1 alpha knockout tissue. This work was funded by the Canadian Institutes of Health Research and the Canada Research Chairs Program. G.R.S. is the Canada Research Chair in Metabolism and Obesity, and the J. Bruce Duncan Chair in Metabolic Diseases. V.L. is the Canada Research Chair (Tier 2) in Neuromuscular Plasticity in Health and Disease. The authors declare no conflicts of interest.	Al-Rewashdy H, 2015, HUM MOL GENET, V24, P1243, DOI 10.1093/hmg/ddu535; Angus LM, 2005, AM J PHYSIOL-CELL PH, V289, pC908, DOI 10.1152/ajpcell.00196.2005; Apponi LH, 2011, TRENDS PHARMACOL SCI, V32, P652, DOI 10.1016/j.tips.2011.06.004; Augusto V, 2004, BRAZ J MORPHOL SCIS, V21, P89; Baldelli S, 2014, J CELL SCI, V127, P4813, DOI 10.1242/jcs.154229; Benziane B, 2012, J BIOL CHEM, V287, P23451, DOI 10.1074/jbc.M111.331926; Benziane B, 2009, AM J PHYSIOL-CELL PH, V297, pC1554, DOI 10.1152/ajpcell.00010.2009; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Briata P, 2005, MOL CELL, V20, P891, DOI 10.1016/j.molcel.2005.10.021; Bueno CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045699; Bujak AL, 2014, J APPL PHYSIOL, V117, P171, DOI 10.1152/japplphysiol.01101.2013; Chakkalakal JV, 2008, NUCLEIC ACIDS RES, V36, P826, DOI 10.1093/nar/gkm1107; Chakkalakal JV, 2006, HUM MOL GENET, V15, P1423, DOI 10.1093/hmg/ddl065; Chakkalakal JV, 2004, HUM MOL GENET, V13, P379, DOI 10.1093/hmg/ddh037; Chakkalakal JV, 2003, P NATL ACAD SCI USA, V100, P7791, DOI 10.1073/pnas.0932671100; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Chopard A, 2005, FASEB J, V19, P1722, DOI 10.1096/fj.04-3336fje; Chopard A, 2000, ELECTROPHORESIS, V21, P517, DOI 10.1002/(SICI)1522-2683(20000201)21:3<517::AID-ELPS517>3.0.CO;2-9; Davies KE, 2006, NAT REV MOL CELL BIO, V7, P762, DOI 10.1038/nrm2024; Delgado-Olguin P, 2008, BBA-GENE REGUL MECH, V1779, P74, DOI 10.1016/j.bbagrm.2007.09.002; Delgado-Olguin P, 2006, BBA-GENE STRUCT EXPR, V1759, P240, DOI 10.1016/j.bbaexp.2006.04.007; Dinulovic I, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0111-9; Dumont NA, 2015, NAT MED, V21, P1455, DOI 10.1038/nm.3990; Dyck DJ, 1997, AM J PHYSIOL-ENDOC M, V272, pE340, DOI 10.1152/ajpendo.1997.272.3.E340; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; Fu X, 2016, DIABETES, V65, P188, DOI 10.2337/db15-0647; Fu X, 2015, J BIOL CHEM, V290, P26445, DOI 10.1074/jbc.M115.665232; Gan ZJ, 2011, GENE DEV, V25, P2619, DOI 10.1101/gad.178434.111; Garbincius JF, 2015, P NATL ACAD SCI USA, V112, P13663, DOI 10.1073/pnas.1512991112; Gramolini AO, 2001, AM J PHYSIOL-CELL PH, V281, pC1300, DOI 10.1152/ajpcell.2001.281.4.C1300; Guiraud S, 2015, HUM MOL GENET, V24, P4212, DOI 10.1093/hmg/ddv154; Hack AA, 2000, MICROSC RES TECHNIQ, V48, P167, DOI 10.1002/(SICI)1097-0029(20000201/15)48:3/4<167::AID-JEMT5>3.0.CO;2-T; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hord JM, 2016, EXP GERONTOL, V83, P148, DOI 10.1016/j.exger.2016.08.006; Hudlicka O, 2011, MLTJ-MUSCLE LIGAMENT, V1, P3; Hughes DC, 2017, J GERONTOL A-BIOL, V72, P640, DOI 10.1093/gerona/glw109; Jahnke VE, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-16; Kelly SM, 2009, TRAFFIC, V10, P1199, DOI 10.1111/j.1600-0854.2009.00944.x; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KOVANEN V, 1980, ACTA PHYSIOL SCAND, V108, P173, DOI 10.1111/j.1748-1716.1980.tb06515.x; Lantier L, 2014, FASEB J, V28, P3211, DOI 10.1096/fj.14-250449; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Little JP, 2011, AM J PHYSIOL-REG I, V300, pR1303, DOI 10.1152/ajpregu.00538.2010; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Ljubicic V, 2014, AM J PHYSIOL-CELL PH, V307, pC66, DOI 10.1152/ajpcell.00357.2013; Ljubicic V, 2014, FASEB J, V28, P548, DOI 10.1096/fj.13-238071; Ljubicic V, 2012, AM J PHYSIOL-CELL PH, V302, pC110, DOI 10.1152/ajpcell.00183.2011; Ljubicic V, 2011, HUM MOL GENET, V20, P3478, DOI 10.1093/hmg/ddr265; Masuda A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00209; MCDONAGH PF, 1982, AM J PHYSIOL, V243, pH491, DOI 10.1152/ajpheart.1982.243.3.H491; Miura P, 2006, TRENDS MOL MED, V12, P122, DOI 10.1016/j.molmed.2006.01.002; Miura P, 2009, HUM MOL GENET, V18, P4640, DOI 10.1093/hmg/ddp431; Miyagoe-Suzuki Y, 2001, MICROSC RES TECHNIQ, V55, P164, DOI 10.1002/jemt.1167; Mounier R, 2015, TRENDS ENDOCRIN MET, V26, P275, DOI 10.1016/j.tem.2015.02.009; Mounier R, 2013, CELL METAB, V18, P251, DOI 10.1016/j.cmet.2013.06.017; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Nguyen T M, 1992, FEBS Lett, V313, P19; Noguchi S, 2001, FEBS LETT, V495, P77, DOI 10.1016/S0014-5793(01)02368-7; O'Neill HM, 2011, P NATL ACAD SCI USA, V108, P16092, DOI 10.1073/pnas.1105062108; Pavlath GK, 2010, EXP CELL RES, V316, P3067, DOI 10.1016/j.yexcr.2010.05.025; Paz I, 2014, NUCLEIC ACIDS RES, V42, pW361, DOI 10.1093/nar/gku406; Peladeau C, 2016, HUM MOL GENET, V25, P24, DOI 10.1093/hmg/ddv444; Reznick RM, 2007, CELL METAB, V5, P151, DOI 10.1016/j.cmet.2007.01.008; Rice KM, 2006, J GERONTOL A-BIOL, V61, P1119, DOI 10.1093/gerona/61.11.1119; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Rybakova IN, 1997, J BIOL CHEM, V272, P28771, DOI 10.1074/jbc.272.45.28771; Safdar A, 2011, J BIOL CHEM, V286, P10605, DOI 10.1074/jbc.M110.211466; Salminen A, 2012, AGEING RES REV, V11, P230, DOI 10.1016/j.arr.2011.12.005; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SMITH D, 1989, AM J PHYSIOL, V256, pC50, DOI 10.1152/ajpcell.1989.256.1.C50; Theret M, 2017, EMBO J, V36, P1946, DOI 10.15252/embj.201695273; Thomas MM, 2014, FASEB J, V28, P2098, DOI 10.1096/fj.13-238972; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; Tinsley JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019189; Wakabayashi-Takai E, 2001, EUR J BIOCHEM, V268, P948, DOI 10.1046/j.1432-1327.2001.01954.x; Wang W, 2002, MOL CELL BIOL, V22, P3425, DOI 10.1128/MCB.22.10.3425-3436.2002; Wilusz CJ, 2010, CELL, V143, P863, DOI 10.1016/j.cell.2010.11.041; Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200	80	10	11	2	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					2950	2965		10.1096/fj.201700868RRR	http://dx.doi.org/10.1096/fj.201700868RRR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401588				2022-12-28	WOS:000432546000006
J	Griffiths, JS; Thompson, A; Stott, M; Benny, A; Lewis, NA; Taylor, PR; Forton, J; Herrick, S; Orr, SJ; McGreal, EP				Griffiths, James S.; Thompson, Aiysha; Stott, Matthew; Benny, Ankita; Lewis, Natalie A.; Taylor, Philip R.; Forton, Julian; Herrick, Sarah; Orr, Selinda J.; McGreal, Eamon P.			Differential susceptibility of Dectin-1 isoforms to functional inactivation by neutrophil and fungal proteases	FASEB JOURNAL			English	Article						elastase; C-type lectin-like receptor; cystic fibrosis; Aspergillus	C-TYPE LECTIN; IMMUNE RECOGNITION; INNATE IMMUNE; HOST-DEFENSE; ASPERGILLUS; RECEPTOR; EXPRESSION; RESPONSES; MINCLE; HYDROPHOBIN	Patients with cystic fibrosis (CF) experience chronic or recurrent bacterial and fungal lung infections. Many patients with CF cannot effectively clear Aspergillus from their lungs. This may result in IgE sensitization and the development of allergic bronchopulmonary aspergillosis, or invasive infections, such as Aspergillus bronchitis. Lung disease in patients with CF is associated with neutrophil-dominated inflammation and elevated levels of the serine protease, neutrophil elastase (NE). Various C-type lectin-like receptors (CLRs), including Dectin-1 and Dectin-2, are involved in the immune response to Aspergillus. Here, we show that purified NE cleaves Dectin-1 in an isoform-specific manner. Bronchoalveolar lavage fluid from patients with CF, which contains high NE activity, induces Dectin-1 cleavage. Similarly, filtrate from a protease-producing strain of Aspergillus fumigatus induces isoform-specific cleavage of Dectin-1. Dectin-1 knockout (KO) cells and NE-treated cells demonstrated reduced phagocytosis of zymosan, a fungal cell wall preparation. In addition, NE cleaves 2 other CLRs, Dectin-2 and Mincle, and fungal-induced cytokine production was reduced in Dectin-1 KO cells, Dectin-2 KO cells, and NE-treated cells. Thus, Dectin-1 and Dectin-2 cleavage by NE and/or A. fumigatus-derived proteases results in an aberrant antifungal immune response that likely contributes to disease pathology in patients with CF.	[Griffiths, James S.; Thompson, Aiysha; Stott, Matthew; Taylor, Philip R.; Orr, Selinda J.] Cardiff Univ, Sch Med, Div Infect & Immun, Tenovus Bldg Heath Pk, Cardiff CF14 4XN, S Glam, Wales; [Benny, Ankita; Lewis, Natalie A.] Cardiff Univ, Sch Med, Cardiff, S Glam, Wales; [McGreal, Eamon P.] Cardiff Univ, Ctr Med Educ, Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Forton, Julian] Childrens Hosp Wales, Cardiff, S Glam, Wales; [Herrick, Sarah] Univ Manchester, Fac Biol Med & Hlth, Manchester Acad Hlth Sci Ctr, Sch Biol Sci, Manchester, Lancs, England	Cardiff University; Cardiff University; Cardiff University; University of Manchester	Orr, SJ (corresponding author), Cardiff Univ, Sch Med, Div Infect & Immun, Tenovus Bldg Heath Pk, Cardiff CF14 4XN, S Glam, Wales.; McGreal, EP (corresponding author), Cardiff Univ, Ctr Med Educ, Sch Med, Cardiff CF14 4XN, S Glam, Wales.	orrs@cardiff.ac.uk	Herrick, Sarah/A-3121-2015	Herrick, Sarah/0000-0002-9085-5664; Forton, Julian/0000-0002-0580-0432; Orr, Selinda/0000-0001-8539-7825; Griffiths, James/0000-0002-7147-2465; Taylor, Philip/0000-0003-0163-1421	U.S. National Institutes of Health (NIH); National Institute of General Medical Sciences [GM62116]; Sir Henry Dale Fellowship - Wellcome Trust; Royal Society [099953/Z/12/Z]; National Institute for Social Care and Health Research Academic Health Science collaboration (Wales, United Kingdom); Wellcome Trust Investigator Award [WT107964MA]; Complement UK; Alexion Pharmaceuticals; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER; MRC [G0601617, UKDRI-3001] Funding Source: UKRI	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Sir Henry Dale Fellowship - Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); National Institute for Social Care and Health Research Academic Health Science collaboration (Wales, United Kingdom); Wellcome Trust Investigator Award(Wellcome Trust); Complement UK; Alexion Pharmaceuticals; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Gordon Brown and Janet Willment [Medical Research Council (MRC) Centre for Medical Mycology, University of Aberdeen, United Kingdom] for providing the NIH3T3 cell lines that expressed human and mouse wild-type Dectin-1. A. fumigatus (CEA10 and Af293) strains were a kind gift from Dr. Paul Bowyer (University of Manchester). The authors wish to acknowledge the U.S. National Institutes of Health (NIH)-sponsored Mutant Mouse Regional Resource Center (MMRRC) National System as the source of genetically altered mice (C57BL/6-Clec4e<SUP>tm1.1Cfg</SUP>/Mmucd 031936-UCD) for use in this study. The mice were produced and deposited to the MMRRC by the Consortium for Functional Glycomics, supported by the National Institute of General Medical Sciences (Grant GM62116). S.J.O. is funded by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (Grant 099953/Z/12/Z). J.F. is funded by a National Institute for Social Care and Health Research Academic Health Science collaboration (Wales, United Kingdom). P.R.T. is funded by a Wellcome Trust Investigator Award (WT107964MA). M.S. is funded by a Ph.D. Studentship awarded to E.P.M. by Complement UK. Funding for this Studentship was part of an unencumbered educational funding agreement between Complement UK and Alexion Pharmaceuticals. Alexion had no involvement at any stage of the project, including its design, implementation, and execution, nor were they involved in drafting or approving the manuscript.	Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Baxter CG, 2013, J ALLERGY CLIN IMMUN, V132, P560, DOI 10.1016/j.jaci.2013.04.007; Benabid R, 2012, J BIOL CHEM, V287, P34883, DOI 10.1074/jbc.M112.361352; Bochud PY, 2008, NEW ENGL J MED, V359, P1766, DOI 10.1056/NEJMoa0802629; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Carrion SD, 2013, J IMMUNOL, V191, P2581, DOI 10.4049/jimmunol.1300748; Cunha C, 2010, BLOOD, V116, P5394, DOI 10.1182/blood-2010-04-279307; de Blic J, 2000, EUR RESPIR J, V15, P217; ELDAHR JM, 1994, AM J RESP CRIT CARE, V150, P1513, DOI 10.1164/ajrccm.150.6.7952609; Fischer M, 2017, EUR J IMMUNOL, V47, P848, DOI 10.1002/eji.201646849; Gersuk GM, 2006, J IMMUNOL, V176, P3717, DOI 10.4049/jimmunol.176.6.3717; Hamon Y, 2013, INNATE IMMUN-LONDON, V19, P611, DOI 10.1177/1753425913476741; Heinsbroek SEM, 2006, J IMMUNOL, V176, P5513, DOI 10.4049/jimmunol.176.9.5513; King J, 2016, J INFECTION, V72, pS50, DOI 10.1016/j.jinf.2016.04.022; Kotecha S, 2013, BBA-MOL BASIS DIS, V1832, P2391, DOI 10.1016/j.bbadis.2013.10.002; Leal SM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000976; Loures FV, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004643; Mayer-Hamblett N, 2007, AM J RESP CRIT CARE, V175, P822, DOI 10.1164/rccm.200609-1354OC; McDonald JU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045781; McGreal EP, 2010, BBA-MOL BASIS DIS, V1802, P649, DOI 10.1016/j.bbadis.2010.04.005; McGreal EP, 2006, GLYCOBIOLOGY, V16, P422, DOI 10.1093/glycob/cwj077; Meier A, 2003, CELL MICROBIOL, V5, P561, DOI 10.1046/j.1462-5822.2003.00301.x; Patin EC, 2016, J IMMUNOL, V197, P208, DOI 10.4049/jimmunol.1501204; Plato A, 2015, SEMIN IMMUNOPATHOL, V37, P97, DOI 10.1007/s00281-014-0462-4; Rivera A, 2011, J EXP MED, V208, P369, DOI 10.1084/jem.20100906; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sainz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032273; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Sun H, 2014, IMMUNOBIOLOGY, V219, P25, DOI 10.1016/j.imbio.2013.06.013; Taylor PR, 2014, NAT IMMUNOL, V15, P143, DOI 10.1038/ni.2797; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Taylor PR, 2005, EUR J IMMUNOL, V35, P2163, DOI 10.1002/eji.200425785; Twigg MS, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/293053; van den Berg CW, 2014, J IMMUNOL, V192, P1787, DOI 10.4049/jimmunol.1301920; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250; Yamasaki S, 2009, P NATL ACAD SCI USA, V106, P1897, DOI 10.1073/pnas.0805177106; Yike I, 2011, MYCOPATHOLOGIA, V171, P299, DOI 10.1007/s11046-010-9386-2; Zhao GQ, 2017, J INFECT DEV COUNTR, V11, P89, DOI 10.3855/jidc.7570	41	22	22	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3385	3397		10.1096/fj.201701145R	http://dx.doi.org/10.1096/fj.201701145R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401615	Green Accepted, Green Published			2022-12-28	WOS:000432546000039
J	Neirijnck, Y; Calvel, P; Kilcoyne, KR; Kuhne, F; Stevant, I; Griffeth, RJ; Pitetti, JL; Andric, SA; Hu, MC; Pralong, F; Smith, LB; Nef, S				Neirijnck, Yasmine; Calvel, Pierre; Kilcoyne, Karen R.; Kuehne, Francoise; Stevant, Isabelle; Griffeth, Richard J.; Pitetti, Jean-Luc; Andric, Silvana A.; Hu, Meng-Chun; Pralong, Francois; Smith, Lee B.; Nef, Serge			Insulin and IGF1 receptors are essential for the development and steroidogenic function of adult Leydig cells	FASEB JOURNAL			English	Article						IGF; steroidogenesis; progenitor Leydig cells; testis development; adrenal gland	GROWTH-FACTOR-I; PROGENITOR CELLS; TRANSGENIC MICE; ADRENAL-GLAND; MOUSE; TESTIS; DIFFERENTIATION; PROLIFERATION; EXPRESSION; MATURATION	The insulin family of growth factors (insulin, IGF1, and IGF2) are critical in sex determination, adrenal differentiation, and testicular function. Notably, the IGF system has been reported to mediate the proliferation of steroidogenic cells. However, the precise role and contribution of the membrane receptors mediating those effects, namely, insulin receptor (INSR) and type-I insulin-like growth factor receptor (IGF1R), have not, to our knowledge, been investigated. We show here that specific deletion of both Insr and Igf1r in steroidogenic cells in mice leads to severe alterations of adrenocortical and testicular development. Double-mutant mice display drastic size reduction of both adrenocortex and testes, with impaired corticosterone, testosterone, and sperm production. Detailed developmental analysis of the testes revealed that fetal Leydig cell (LC) function is normal, but there is a failure of adult LC maturation and steroidogenic function associated with accumulation of progenitor LCs (PLCs). Cell-lineage tracing revealed PLC enrichment is secondary to Insr and Igf1r deletion in differentiated adult LCs, suggesting a feedback mechanism between cells at different steps of differentiation. Taken together, these data reveal the cell-autonomous and nonautonomous roles of the IGF system for proper development and maintenance of steroidogenic lineages.	[Neirijnck, Yasmine; Calvel, Pierre; Kuehne, Francoise; Stevant, Isabelle; Griffeth, Richard J.; Pitetti, Jean-Luc; Nef, Serge] Univ Geneva, Med Sch, Dept Genet Med & Dev, Geneva, Switzerland; [Kilcoyne, Karen R.; Smith, Lee B.] Univ Edinburgh, Med Res Council, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [Andric, Silvana A.] Univ Novi Sad, Fac Sci, Lab Reprod Endocrinol & Signaling, Novi Sad, Serbia; [Hu, Meng-Chun] Natl Taiwan Univ, Coll Med, Grad Inst Physiol, Taipei, Taiwan; [Pralong, Francois] Univ Hosp, Dept Internal Med, Lausanne, Switzerland; [Smith, Lee B.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW, Australia; [Calvel, Pierre] Univ Paris Saclay, AgroParisTech, INRA, GABI, Jouy En Josas, France	University of Geneva; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Edinburgh; University of Novi Sad; National Taiwan University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Newcastle; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Nef, S (corresponding author), Univ Geneva, Med Sch, CMU, Dept Genet Med & Dev, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	serge.nef@unige.ch	Nef, Serge/AAV-6445-2020	Nef, Serge/0000-0001-5462-0676; Neirijnck, Yasmine/0000-0001-7236-8451; Smith, Lee/0000-0002-4103-3074; Stevant, Isabelle/0000-0002-0193-2526; Andric, Silvana/0000-0002-2908-8136	Swiss National Science Foundation [31003A_152636]; Departement de l'Instruction Publique of the State of Geneva; United Kingdom Medical Research Council (UK MRC) Programme Grant Award [MR/N002970/1]; Medical Research Council [MR/N002970/1] Funding Source: researchfish; MRC [MR/N002970/1] Funding Source: UKRI	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Departement de l'Instruction Publique of the State of Geneva; United Kingdom Medical Research Council (UK MRC) Programme Grant Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Cecile Gameiro and Gregory Schneiter (Flow Cytometry Facility, University of Geneva), as well as the teams of the Bioimaging Core Facility and the Animal Facility (Faculty of Medicine, University of Geneva). This work was supported by the Swiss National Science Foundation (Grant 31003A_152636 to S.N.); the Departement de l'Instruction Publique of the State of Geneva (to S.N.); and a United Kingdom Medical Research Council (UK MRC) Programme Grant Award (MR/N002970/1 to L.B.S. and K.R.K.). The authors declare no conflicts of interest.	Baker J, 1996, MOL ENDOCRINOL, V10, P903, DOI 10.1210/me.10.7.903; Bandiera R, 2015, MOL CELL ENDOCRINOL, V408, P145, DOI 10.1016/j.mce.2015.01.009; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Buaas FW, 2012, DEVELOPMENT, V139, P4561, DOI 10.1242/dev.087247; Chai RJ, 2012, P NATL ACAD SCI USA, V109, P8167, DOI 10.1073/pnas.1202774109; Crawley J. N., 2007, WHATS WRONG MY MOUSE; Davidoff MS, 2004, J CELL BIOL, V167, P935, DOI 10.1083/jcb.200409107; Delacour A, 2004, MECH DEVELOP, V121, P3, DOI 10.1016/j.mod.2003.11.004; Dietrich P, 2000, MAMM GENOME, V11, P196, DOI 10.1007/s003350010037; Efstratiadis A, 1998, INT J DEV BIOL, V42, P955; Fottner C, 1998, J ENDOCRINOL, V158, P409, DOI 10.1677/joe.0.1580409; Freedman BD, 2013, DEV CELL, V26, P666, DOI 10.1016/j.devcel.2013.07.016; Fujieda K, 2005, PEDIATR RES, V57, p62R, DOI 10.1203/01.PDR.0000159568.31749.4D; Gaysinskaya V, 2014, CYTOM PART A, V85A, P556, DOI 10.1002/cyto.a.22463; Griffeth RJ, 2014, BASIC CLIN ANDROL, V24, DOI 10.1186/2051-4190-24-12; Hu GX, 2010, J ANDROL, V31, P379, DOI 10.2164/jandrol.109.008680; Inoue M, 2016, ENDOCRINOLOGY, V157, P1222, DOI 10.1210/en.2015-1773; Jiang MH, 2014, CELL RES, V24, P1466, DOI 10.1038/cr.2014.149; KERR JB, 1987, CELL TISSUE RES, V249, P367; Kilcoyne KR, 2014, P NATL ACAD SCI USA, V111, pE1924, DOI 10.1073/pnas.1320735111; Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009; Lecureuil C, 2002, GENESIS, V33, P114, DOI 10.1002/gene.10100; LIVNE I, 1992, BIOL REPROD, V47, P561, DOI 10.1095/biolreprod47.4.561; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Manna PR, 2006, MOL ENDOCRINOL, V20, P362, DOI 10.1210/me.2004-0526; MESIANO S, 1993, J CLIN ENDOCR METAB, V76, P968, DOI 10.1210/jc.76.4.968; Miyabayashi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068050; Nef S, 2003, NATURE, V426, P291, DOI 10.1038/nature02059; O'Hara L, 2015, FASEB J, V29, P894, DOI 10.1096/fj.14-255729; O'Shaughnessy PJ, 2002, J CELL SCI, V115, P3491; Pitetti JL, 2009, SEX DEV, V3, P264, DOI 10.1159/000252813; Pitetti JL, 2013, MOL ENDOCRINOL, V27, P814, DOI 10.1210/me.2012-1258; Pitetti JL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003160; Potter SJ, 2016, RESULTS PROBL CELL D, V58, P101, DOI 10.1007/978-3-319-31973-5_5; Sirianni R, 2007, CANCER RES, V67, P8368, DOI 10.1158/0008-5472.CAN-06-4064; Smith LB, 2014, SEMIN CELL DEV BIOL, V30, P2, DOI 10.1016/j.semcdb.2014.02.012; Svingen T, 2013, GENE DEV, V27, P2409, DOI 10.1101/gad.228080.113; van den Driesche S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037064; Wang GM, 2004, BIOL REPROD, V70, P632, DOI 10.1095/biolreprod.103.022590; Weber MM, 1999, ENDOCRINOLOGY, V140, P1537, DOI 10.1210/en.140.4.1537; Windley SP, 2015, SEX DEV, V9, P297, DOI 10.1159/000444065; Wu HS, 2007, GENESIS, V45, P59, DOI 10.1002/dvg.20266; Xuan SH, 2002, J CLIN INVEST, V110, P1011, DOI 10.1172/JCI200215276; Yates R, 2013, CURR TOP DEV BIOL, V106, P239, DOI 10.1016/B978-0-12-416021-7.00007-9	45	25	25	2	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3321	3335		10.1096/fj.201700769RR	http://dx.doi.org/10.1096/fj.201700769RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401624				2022-12-28	WOS:000432546000034
J	Schur, RM; Gao, SQ; Yu, GP; Chen, Y; Maeda, A; Palczewski, K; Lu, ZR				Schur, Rebecca M.; Gao, Songqi; Yu, Guanping; Chen, Yu; Maeda, Akiko; Palczewski, Krzysztof; Lu, Zheng-Rong			New GABA modulators protect photoreceptor cells from light-induced degeneration in mouse models	FASEB JOURNAL			English	Article						anticonvulsant; GABA aminotransferase; retinal degeneration	INDUCED RETINAL DEGENERATION; GAMMA-AMINOBUTYRIC-ACID; MICROTITER PLATE ASSAY; VISUAL CYCLE MODULATOR; MACULAR DEGENERATION; VALPROIC-ACID; ANTIEPILEPTIC DRUGS; INDUCED RETINOPATHY; MEDIATED NEUROPROTECTION; EMIXUSTAT HYDROCHLORIDE	No clinically approved therapies are currently available that prevent the onset of photoreceptor death in retinal degeneration. Signaling between retinal neurons is regulated by the release and uptake of neurotransmitters, wherein GABA is the main inhibitory neurotransmitter. In this work, novel 3-chloropropiophenone derivatives and the clinical anticonvulsants tiagabine and vigabatrin were tested to modulate GABA signaling and protect against light-induced retinal degeneration. Abca4(-/-) Rdh8(-/-) mice, an accelerated model of retinal degeneration, were exposed to intense light after prophylactic injections of one of these compounds. Imaging and functional assessments of the retina indicated that these compounds successfully protected photoreceptor cells from degeneration to maintain a full-visual-field response. Furthermore, these compounds demonstrated a strong safety profile in wildtype mice and did not compromise visual function or damage the retina, despite repeated administration. These results indicate that modulating inhibitory GABA signaling can offer prophylactic protection against light-induced retinal degeneration.	[Schur, Rebecca M.; Yu, Guanping; Lu, Zheng-Rong] Case Western Reserve Univ, Case Ctr Biomol Engn, Sch Engn, Dept Biomed Engn, Cleveland, OH 44106 USA; [Gao, Songqi; Chen, Yu; Palczewski, Krzysztof] Case Western Reserve Univ, Cleveland Ctr Membrane & Struct Biol, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Maeda, Akiko] Case Western Reserve Univ, Sch Med, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Lu, ZR (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Wickenden 427,Mail Stop 7207,10900 Euclid Ave, Cleveland, OH 44106 USA.	zxl125@case.edu	Schur, Rebecca/ABE-2442-2022	Lu, Zheng-Rong/0000-0001-8185-9519; Melo, Paulo A/0000-0003-1250-6933	U.S. National Institutes of Health (NIH) National Eye Institute [EY027283, EY024864]; NIH National Institute of Biomedical Imaging and Bioengineering Interdisciplinary Biomedical Training Program Grant [T32EB007509]; NATIONAL EYE INSTITUTE [R24EY024864, R24EY027283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB007509] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH National Institute of Biomedical Imaging and Bioengineering Interdisciplinary Biomedical Training Program Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors thank Dr. Timothy Kern (Department of Pharmacology, Case Western Reserve University) for valuable insights and critical discussions of this research work, Mr. Da Sun (Center for Biomolecular Engineering, Case Western Reserve University) for assistance in in vivo experiments and data analysis, and Dr. Amita Vaidya (Center for Biomolecular Engineering, Case Western Reserve University) for a critical reading of the manuscript. Z.-R.L. is the M. Frank and Margaret Domiter Rudy Professor of Biomedical Engineering, and K.P. is the John H. Hord Professor of Pharmacology. This work was supported, in part, by U.S. National Institutes of Health (NIH) National Eye Institute Grants EY027283 (to K.P.) and EY024864; and the NIH National Institute of Biomedical Imaging and Bioengineering Interdisciplinary Biomedical Training Program Grant T32EB007509 (to R.M.S.) administered by the Department of Biomedical Engineering, Case Western Reserve University. This report is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflicts of interest.	Age- Related Eye Disease Study 2 Research Group, 2013, JAMA-J AM MED ASSOC, V309, P208; Akula JD, 2015, DOC OPHTHALMOL, V131, P1, DOI 10.1007/s10633-015-9491-0; Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; Atlasz T, 2008, J MOL NEUROSCI, V36, P97, DOI 10.1007/s12031-008-9059-5; Bavik C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124940; Bhalla S, 2013, BRIT J OPHTHALMOL, V97, P895, DOI 10.1136/bjophthalmol-2013-303084; Biermann J, 2010, INVEST OPHTH VIS SCI, V51, P526, DOI 10.1167/iovs.09-3903; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Bui BV, 2004, INVEST OPHTH VIS SCI, V45, P584, DOI 10.1167/iovs.03-0695; Cayouette M, 1998, J NEUROSCI, V18, P9282; Chen Y, 2013, J CLIN INVEST, V123, P5119, DOI 10.1172/JCI69076; Chew EY, 2013, JAMA-J AM MED ASSOC, V309, P2005, DOI 10.1001/jama.2013.4997; Collier RJ, 2011, INVEST OPHTH VIS SCI, V52, P8108, DOI 10.1167/iovs.10-6418; Collier RJ, 2011, INVEST OPHTH VIS SCI, V52, P2118, DOI 10.1167/iovs.10-6304; Coyner AS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159776; Damico FM, 2012, ARQ BRAS OFTALMOL, V75, P71, DOI 10.1590/S0004-27492012000100016; Danciger M, 2004, MAMM GENOME, V15, P277, DOI 10.1007/s00335-003-2336-2; Duboc A, 2004, ANN NEUROL, V55, P695, DOI 10.1002/ana.20081; Dugel PU, 2015, RETINA-J RET VIT DIS, V35, P1173, DOI 10.1097/IAE.0000000000000606; EHINGER B, 1991, EXP EYE RES, V52, P17, DOI 10.1016/0014-4835(91)90124-W; Fariss RN, 2000, AM J OPHTHALMOL, V129, P215, DOI 10.1016/S0002-9394(99)00401-8; Fernandez-Sanchez L, 2015, MOLECULES, V20, P13875, DOI 10.3390/molecules200813875; Fernandez-Sanchez L, 2011, INVEST OPHTH VIS SCI, V52, P4998, DOI 10.1167/iovs.11-7496; Fletcher EL, 1997, J COMP NEUROL, V388, P1; Fletcher EL, 2000, MICROSC RES TECHNIQ, V50, P89, DOI 10.1002/1097-0029(20000715)50:2<89::AID-JEMT1>3.0.CO;2-9; Fritsche LG, 2014, ANNU REV GENOM HUM G, V15, P151, DOI 10.1146/annurev-genom-090413-025610; Froger N, 2014, PROG RETIN EYE RES, V41, P44, DOI 10.1016/j.preteyeres.2014.03.001; Hilton EJR, 2004, SEIZURE-EUR J EPILEP, V13, P113, DOI 10.1016/S1059-1311(03)00082-7; Ishikawa M, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/528940; Jaffe GJ, 2015, AM J OPHTHALMOL, V160, P1226, DOI 10.1016/j.ajo.2015.08.024; Jaiswal M, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002197; Kalloniatis M, 1999, PROG RETIN EYE RES, V18, P811, DOI 10.1016/S1350-9462(98)00036-6; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Kimura A, 2015, AM J PATHOL, V185, P756, DOI 10.1016/j.ajpath.2014.11.005; Kohno H, 2013, J BIOL CHEM, V288, P15326, DOI 10.1074/jbc.M112.448712; Kubota R, 2014, RETINA-J RET VIT DIS, V34, P603, DOI 10.1097/01.iae.0000434565.80060.f8; Kubota R, 2012, RETINA-J RET VIT DIS, V32, P183, DOI 10.1097/IAE.0b013e318217369e; Lenis TL, 2017, P NATL ACAD SCI USA, V114, P3987, DOI 10.1073/pnas.1620299114; Louzada PR, 2004, FASEB J, V18, P511, DOI 10.1096/fj.03-0739com; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2006, MOL PHARMACOL, V70, P1220, DOI 10.1124/mol.106.026823; Maeda A, 2012, NAT CHEM BIOL, V8, P170, DOI 10.1038/nchembio.759; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Maeda T, 2003, J NEUROCHEM, V85, P944, DOI 10.1046/j.1471-4159.2003.01741.x; Maguire MJ, 2010, EPILEPSIA, V51, P2423, DOI 10.1111/j.1528-1167.2010.02772.x; Malmgren K, 2001, EPILEPSIA, V42, P609, DOI 10.1046/j.1528-1157.2001.28600.x; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Mitton KP, 2014, MOL VIS, V20, P1527; Miya-Coreixas VS, 2013, EXP EYE RES, V115, P206, DOI 10.1016/j.exer.2013.07.026; O'Byrne CP, 2011, J MICROBIOL METH, V84, P137, DOI 10.1016/j.mimet.2010.10.017; Okada M, 2000, GRAEF ARCH CLIN EXP, V238, P998, DOI 10.1007/s004170000215; Pisani F, 2006, EXP BRAIN RES, V171, P511, DOI 10.1007/s00221-005-0298-1; Rogawski MA, 2004, NAT REV NEUROSCI, V5, P553, DOI 10.1038/nrn1430; SanGiovanni JP, 2014, CURR MOL MED, V14, P814, DOI 10.2174/1566524014666140811113606; Schur RM, 2015, INVEST OPHTH VIS SCI, V56, P4936, DOI 10.1167/iovs.15-16522; Sparrow JR, 2016, P NATL ACAD SCI USA, V113, P4564, DOI 10.1073/pnas.1600474113; Srivastava P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123896; Sun D, 2017, MOL THER-NUCL ACIDS, V7, P42, DOI 10.1016/j.omtn.2017.02.005; Tao YH, 2009, BIOORG MED CHEM LETT, V19, P731, DOI 10.1016/j.bmcl.2008.12.033; Tilz C, 2007, EUR J NEUROL, V14, P929, DOI 10.1111/j.1468-1331.2007.01524.x; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Tsukatani T, 2005, ANAL CHIM ACTA, V540, P293, DOI 10.1016/j.aca.2005.03.056; Tullis BE, 2015, INVEST OPHTH VIS SCI, V56, P4560, DOI 10.1167/iovs.15-16378; Varga B, 2011, J MOL NEUROSCI, V43, P44, DOI 10.1007/s12031-010-9406-1; Verrotti A, 2007, PEDIATR NEUROL, V36, P353, DOI 10.1016/j.pediatrneurol.2007.03.001; Wang QP, 2008, EUR J NEUROSCI, V27, P2177, DOI 10.1111/j.1460-9568.2008.06175.x; Wasowicz M, 2002, INVEST OPHTH VIS SCI, V43, P813; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Winkler BS, 1999, MOL VIS, V5; Yang XL, 2004, PROG NEUROBIOL, V73, P127, DOI 10.1016/j.pneurobio.2004.04.002; Yoneda S, 2003, BRAIN RES, V967, P257, DOI 10.1016/S0006-8993(03)02270-4; Yu DY, 2004, INVEST OPHTH VIS SCI, V45, P2013, DOI 10.1167/iovs.03-0845; Zhang JY, 2015, MOL PHARMACOL, V87, P477, DOI 10.1124/mol.114.096560	73	6	6	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3289	3300		10.1096/fj.201701250R	http://dx.doi.org/10.1096/fj.201701250R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401616	Green Published			2022-12-28	WOS:000432546000032
J	Delgado-Calle, J; Hancock, B; Likine, EF; Sato, AY; McAndrews, K; Sanudo, C; Bruzzaniti, A; Riancho, JA; Tonra, JR; Bellido, T				Delgado-Calle, Jesus; Hancock, Benjamin; Likine, Elive F.; Sato, Amy Y.; McAndrews, Kevin; Sanudo, Carolina; Bruzzaniti, Angela; Riancho, Jose A.; Tonra, James R.; Bellido, Teresita			MMP14 is a novel target of PTH signaling in osteocytes that controls resorption by regulating soluble RANKL production	FASEB JOURNAL			English	Article						osteoclasts; osteoblasts; antiresorptive; osteoporosis	TYPE-1 MATRIX-METALLOPROTEINASE; SELECTIVE-INHIBITION; RECEPTOR ACTIVATOR; DNA METHYLATION; BONE-RESORPTION; EXPRESSION; GENE; OSTEOCLASTOGENESIS; OSTEOPROTEGERIN; OSTEOPOROSIS	Parathyroid hormone (PTH) affects the skeleton by acting on osteocytes (Ots) in bone through yet unclear mechanisms. We report that matrix metalloproteinase 14 (MMP14) expression/activity are increased in bones from mice with genetic constitutive activation (ca) of the PTH receptor 1 (PTH1R) in Ots (caPTH1R(Ot)) and in bones from mice exposed to elevated PTH levels but not in mice lacking [conditional knockout (cKO)] the PTH1R in Ots (cKOPTH1R(Ot)). Furthermore, PTH upregulates MMP14 in human bone cultures and in Ot-enriched bones from floxed control mice but not from cKOPTH1R(Ot) mice. MMP14 activity increases soluble receptor activator of NF-kappa B ligand production, which in turn, stimulates osteoclast differentiation and resorption. Pharmacologic inhibition of MMP14 activity reduced the high bone remodeling exhibited by caPTH1R(Ot) mice or induced by chronic PTH elevation and decreased bone resorption but allowed full stimulation of bone formation induced by PTH injections, thereby potentiating bone gain. Thus, MMP14 is a new member of the intricate gene network activated in Ots by PTH1R signaling that can be targeted to adjust the skeletal responses to PTH in favor of bone preservation.	[Delgado-Calle, Jesus] Indiana Univ Sch Med, Dept Med, Div Hematol Oncol, Indianapolis, IN 46202 USA; [Bellido, Teresita] Indiana Univ Sch Med, Dept Med, Div Endocrinol, Indianapolis, IN 46202 USA; [Delgado-Calle, Jesus; Hancock, Benjamin; Likine, Elive F.; Sato, Amy Y.; McAndrews, Kevin; Bellido, Teresita] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Delgado-Calle, Jesus; Bruzzaniti, Angela; Bellido, Teresita] Indiana Ctr Musculoskeletal Hlth, Indianapolis, IN USA; [Delgado-Calle, Jesus; McAndrews, Kevin; Bellido, Teresita] Richard L Roudebush Vet Affairs Med Ctr, 1481 W 10th St, Indianapolis, IN 46202 USA; [Sanudo, Carolina; Riancho, Jose A.] Univ Cantabria, Marques de Valdecilla Univ Hosp, Inst Invest Marques de Valdecilla IDIVAL, Dept Internal Med, Santander, Spain; [Bruzzaniti, Angela] Indiana Univ, Sch Dent, Dept Biomed & Appl Sci, Indianapolis, IN USA; [Tonra, James R.] Kadmon Corp, New York, NY USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; Indiana University System; Indiana University-Purdue University Indianapolis	Bellido, T (corresponding author), Indiana Univ Sch Med, Dept Anat & Cell Biol, 635 Barnhill Dr,MS5045A, Indianapolis, IN 46202 USA.; Bellido, T (corresponding author), Indiana Univ Sch Med, Dept Internal Med, 635 Barnhill Dr,MS5045A, Indianapolis, IN 46202 USA.; Bellido, T (corresponding author), Indiana Univ Sch Med, Dept Endocrinol, 635 Barnhill Dr,MS5045A, Indianapolis, IN 46202 USA.	tbellido@iupui.edu	Delgado-Calle, Jesus/AAG-1417-2020; Bruzzaniti, Angela/AAP-2225-2020	Delgado-Calle, Jesus/0000-0002-2083-2774; Sato, Amy/0000-0001-5061-1369	U.S. Department of Veterans Affairs [1 I01 BX002104-01]; U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01-AR059357, R01-AR060332]; NIH National Heart, Lung, and Blood Institute [T35 HL1 10854-01]; American Society of Hematology; Instituto de Salud Carlos III [PI12/615]; European Union through Fonds Europeen de Developpement Economique et Regional (FEDER) funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL110854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060332, R01AR059357] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002104] Funding Source: NIH RePORTER	U.S. Department of Veterans Affairs(US Department of Veterans Affairs); U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Society of Hematology; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Union through Fonds Europeen de Developpement Economique et Regional (FEDER) funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank Drs. Keith Condon, Gretel Pellegrini, and Sumana Posritong and Meloney Cregor (all from Indiana University School of Medicine) for their assistance in tissue and data collection. The authors also thank Drs. David Burr and Munro Peacock (both from the Indiana University School of Medicine) for critical reading of the manuscript. This research was supported by the U.S. Department of Veterans Affairs (1 I01 BX002104-01 to T.B.); the U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (Grant R01-AR059357 to T.B.; R01-AR060332 to A.B.); NIH National Heart, Lung, and Blood Institute (Grant T35 HL1 10854-01); a Scholar Award from the American Society of Hematology (to J.D-C.); and a grant from Instituto de Salud Carlos III (PI12/615), cofunded by the European Union through Fonds Europeen de Developpement Economique et Regional (FEDER) funds (to J.A.R.). The KD014 neutralizing antibody was obtained under a Materials Transfer Agreement with Kadmon Corp., LLC. J.R.T. was an employee of Kadmon Corp., LCC. The remaining authors declare no conflicts of interest.	Ager EI, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv017; Allen MR, 2006, BONE, V39, P872, DOI 10.1016/j.bone.2006.04.028; Allen MR., 2007, BONEKEY OSTEOVISION, V4, P49; Aspenberg P, 2014, CURR OSTEOPOROS REP, V12, P189, DOI 10.1007/s11914-014-0200-9; Bellido T, 2013, BONE, V54, P250, DOI 10.1016/j.bone.2012.09.016; Ben-Awadh AN, 2014, ENDOCRINOLOGY, V155, P2797, DOI 10.1210/en.2014-1046; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Cappariello A, 2015, BIOMATERIALS, V46, P58, DOI 10.1016/j.biomaterials.2014.12.033; Cosman F, 2017, J BONE MINER RES, V32, P198, DOI 10.1002/jbmr.3051; Delgado-Calle J, 2017, LEUKEMIA, V31, P2686, DOI 10.1038/leu.2017.152; Delgado-Calle J, 2017, J BONE MINER RES, V32, P522, DOI 10.1002/jbmr.3011; Delgado-Calle Jesus, 2015, Curr Mol Biol Rep, V1, P157; Delgado-Calle J, 2016, CANCER RES, V76, P1089, DOI 10.1158/0008-5472.CAN-15-1703; Delgado-Calle J, 2012, J BONE MINER RES, V27, P926, DOI 10.1002/jbmr.1491; Delgado-Calle J, 2012, EPIGENETICS-US, V7, P83, DOI 10.4161/epi.7.1.18753; Devy L, 2009, CANCER RES, V69, P1517, DOI 10.1158/0008-5472.CAN-08-3255; Eriksen EF, 2016, BONE, V86, P139, DOI 10.1016/j.bone.2016.02.009; Galli C, 2008, ENDOCRINOLOGY, V149, P146, DOI 10.1210/en.2007-0734; Gutierrez-Fernandez A, 2015, EMBO J, V34, P1875, DOI 10.15252/embj.201490594; Hikita A, 2006, J BIOL CHEM, V281, P36846, DOI 10.1074/jbc.M606656200; Holmbeck K, 2005, J CELL SCI, V118, P147, DOI 10.1242/jcs.01581; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Huang S, 2014, BONE, V60, P235, DOI 10.1016/j.bone.2013.12.023; Jilka RL, 2007, BONE, V40, P1434, DOI 10.1016/j.bone.2007.03.017; Kaneko K, 2016, ARTHRITIS RHEUMATOL, V68, P521, DOI 10.1002/art.39414; Leder BZ, 2016, BONE, V89, P73, DOI 10.1016/j.bone.2016.04.026; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma YFL, 2001, ENDOCRINOLOGY, V142, P4047, DOI 10.1210/en.142.9.4047; Miller PD, 2016, JAMA-J AM MED ASSOC, V316, P722, DOI 10.1001/jama.2016.11136; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; O'Brien CA, 2013, BONE, V54, P258, DOI 10.1016/j.bone.2012.08.121; O'Brien CA, 2010, BONE, V46, P911, DOI 10.1016/j.bone.2009.08.050; O'Brien CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002942; Pacheco-Costa R, 2014, J BIOL CHEM, V289, P8508, DOI 10.1074/jbc.M113.529735; Pacifici R, 2016, ANN NY ACAD SCI, V1364, P11, DOI 10.1111/nyas.12969; Pacifici R, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00057; Rhee Y, 2011, J BONE MINER RES, V26, P1035, DOI 10.1002/jbmr.304; Rozanov DV, 2004, J BIOL CHEM, V279, P50321, DOI 10.1074/jbc.M409174200; Sabbota AL, 2010, CANCER RES, V70, P5558, DOI 10.1158/0008-5472.CAN-09-4416; Sato AY, 2016, J BONE MINER RES, V31, P1791, DOI 10.1002/jbmr.2869; Saunders MM, 2010, BIOMECH MODEL MECHAN, V9, P539, DOI 10.1007/s10237-010-0195-9; Shane E, 2014, J BONE MINER RES, V29, P1, DOI 10.1002/jbmr.1998; Silva BC, 2015, CURR OPIN PHARMACOL, V22, P41, DOI 10.1016/j.coph.2015.03.005; Strongin AY, 2010, BBA-MOL CELL RES, V1803, P133, DOI 10.1016/j.bbamcr.2009.04.009; Suvannasankha A, 2015, ONCOTARGET, V6, P19647, DOI 10.18632/oncotarget.3794; Tu XL, 2015, P NATL ACAD SCI USA, V112, pE478, DOI 10.1073/pnas.1409857112; Tu XL, 2012, BONE, V50, P209, DOI 10.1016/j.bone.2011.10.025; Xiong J., 2017, J BONE MINER RES; Xiong JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138189; Xiong JH, 2014, BONE, V66, P146, DOI 10.1016/j.bone.2014.06.006; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zucker S, 1998, J BIOL CHEM, V273, P1216, DOI 10.1074/jbc.273.2.1216	53	18	19	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2878	2890		10.1096/fj.201700919RRR	http://dx.doi.org/10.1096/fj.201700919RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29401593	Green Published			2022-12-28	WOS:000432528000045
J	Luo, JJ; Su, DS; Xie, SL; Liu, Y; Liu, P; Yang, XJ; Pei, DS				Luo, Juan-Juan; Su, Dong-Sheng; Xie, Shao-Lin; Liu, Yi; Liu, Pei; Yang, Xiao-Jun; Pei, De-Sheng			Hypersensitive assessment of aryl hydrocarbon receptor transcriptional activity using a novel truncated cyp1a promoter in zebrafish	FASEB JOURNAL			English	Article						T-cyp1a; TCDD; biomarker; tumorigenesis	POLYCYCLIC AROMATIC-HYDROCARBONS; BREAST-CANCER CELLS; PROMOTER/ENHANCER REGION; FUNCTIONAL-ANALYSIS; SIGNALING PATHWAYS; PROSTATE-CANCER; DIOXIN RECEPTOR; DANIO-RERIO; IN-VIVO; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN	2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is a persistent organic pollutant (POP), an unintentional byproduct of various industrial processes, and a human carcinogen. The expression of the cytochrome P450 1A (cyp1a) gene is upregulated in the presence of TCDD through activating the aryl hydrocarbon receptor pathway in a dose-dependent manner. Several essential response elements, including the 8 potential xenobiotic response elements in the cyp1a promoter region, have been identified to be the main functional parts for the response to TCDD. Thus, we aimed to develop a convenient and sensitive biomonitoring tool to examine the level of POPs in the environment and evaluate its potential human health risks by TCDD. Here, we established a transgenic zebrafish model with a red fluorescent reporter gene (mCherry) using the truncated cyp1a promoter. Under exposure to TCDD, the expression pattern of mCherry in the reporter zebrafish mirrored that of endogenous cyp1a mRNA, and the primary target tissues for TCDD were the brain vessels, liver, gut, cloaca, and skin. Our results indicated that exposure of the embryos to TCDD at concentrations as low as 0.005 nM for 48 h, which did not elicit morphologic abnormalities in the embryos, markedly increased mCherry expression. In addition, the reporter embryos responded to other POPs, and primary liver cell culture of zebrafish revealed that Cyp1a protein was mainly expressed in the cytoplasm of liver cells. Furthermore, our transgenic fish embryos demonstrated that TCDD exposure can regulate the expression levels of several tumor-related factors, including epidermal growth factor, TNF-alpha, C-myc, proliferating cell nuclear antigen, TGF-beta, serine/threonine kinase (Akt), and phosphorylated Akt, suggesting that our transgenic fish can be used as a sensitive model to evaluate the carcinogenicity induced by TCDD exposure.	[Luo, Juan-Juan; Su, Dong-Sheng; Liu, Pei; Yang, Xiao-Jun] Shantou Univ, Med Coll, Ctr Neurosci, Shantou, Peoples R China; [Luo, Juan-Juan; Su, Dong-Sheng; Xie, Shao-Lin; Liu, Yi; Pei, De-Sheng] Chinese Acad Sci, Chongqing Inst Green & Intelligent Technol, Chongqing 400714, Peoples R China; [Xie, Shao-Lin] South China Agr Univ, Coll Marine Sci, Guangzhou, Guangdong, Peoples R China	Shantou University; Chinese Academy of Sciences; Chongqing Institute of Green & Intelligent Technology, CAS; South China Agricultural University	Pei, DS (corresponding author), Chinese Acad Sci, Chongqing Inst Green & Intelligent Technol, Chongqing 400714, Peoples R China.; Yang, XJ (corresponding author), Shantou Univ, Med Coll, 22 Xinling Rd, Shantou 515041, Peoples R China.	yangx@stu.edu.cn; peids@cigit.ac.cn	Pei, De-Sheng/K-1466-2017	Pei, De-Sheng/0000-0001-6408-9575	Three Hundred Leading Talents in Scientific and Technological Innovation Program of Chongqing [CSTCCXLJRC201714]; Key Application and Development Program of Chongqing Science and Technology Commission [cstc2014yykfC20004, cstc2014yykfC20002]; Natural Science Foundation of Guangdong Province [2015A030313440]; Hundred Talents Program of Chinese Academy of Sciences; Li Ka Shing Foundation	Three Hundred Leading Talents in Scientific and Technological Innovation Program of Chongqing; Key Application and Development Program of Chongqing Science and Technology Commission; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Hundred Talents Program of Chinese Academy of Sciences(Chinese Academy of Sciences); Li Ka Shing Foundation	The authors are grateful for the support from the Three Hundred Leading Talents in Scientific and Technological Innovation Program of Chongqing (CSTCCXLJRC201714 to D.-S.P.), Li Ka Shing Foundation Grant for Joint Research Program between Shantou University and Technion-Israel Institute of Technology (to X.-J.Y.), Key Application and Development Program of Chongqing Science and Technology Commission (cstc2014yykfC20004 and cstc2014yykfC20002 to D.-S.P.), Natural Science Foundation of Guangdong Province (Grant 2015A030313440 to X.-J.Y.), and Hundred Talents Program of Chinese Academy of Sciences (to D.-S.P.). The authors declare no conflicts of interest.	Antkiewicz DS, 2006, TOXICOL SCI, V94, P175, DOI 10.1093/toxsci/kfl093; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Bekki K, 2015, PESTIC BIOCHEM PHYS, V120, P5, DOI 10.1016/j.pestbp.2014.12.021; Boffetta P, 2011, CRIT REV TOXICOL, V41, P622, DOI 10.3109/10408444.2011.560141; Carvan Michael J. III, 2000, Annals of the New York Academy of Sciences, V919, P133; Carver LA, 1997, J BIOL CHEM, V272, P11452; Chang ET, 2014, EUR J EPIDEMIOL, V29, P667, DOI 10.1007/s10654-014-9931-2; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Chen YJ, 2012, CANCER LETT, V319, P223, DOI 10.1016/j.canlet.2012.01.017; Chu J, 2009, HEPATOLOGY, V50, P1656, DOI 10.1002/hep.23157; Clark AR, 2014, BIOCHEM SOC T, V42, P1349, DOI 10.1042/BST20140160; Dahm R., 2002, ZEBRAFISH PRACTICAL, pxviii; DAVILA DR, 1995, J TOXICOL ENV HEALTH, V45, P101, DOI 10.1080/15287399509531985; DENBESTEN PJ, 1990, AQUAT TOXICOL, V18, P231, DOI 10.1016/0166-445X(90)90004-9; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Fabregat I, 2014, CURR PHARM DESIGN, V20, P2934, DOI 10.2174/13816128113199990591; Fisk A., 2013, US EPA RES MARKETS, V36, P726; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gammon MD, 2004, ARCH ENVIRON HEALTH, V59, P640, DOI 10.1080/00039890409602948; Go RE, 2015, J STEROID BIOCHEM, V147, P24, DOI 10.1016/j.jsbmb.2014.11.003; Goldstone HMH, 2006, DRUG METAB REV, V38, P261, DOI 10.1080/03602530600570099; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; Kazlauskas A, 1999, J BIOL CHEM, V274, P13519, DOI 10.1074/jbc.274.19.13519; Kennedy GD, 2014, TOXICOL SCI, V140, P135, DOI 10.1093/toxsci/kfu065; Kim KH, 2013, AQUAT TOXICOL, V134, P57, DOI 10.1016/j.aquatox.2013.03.010; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; King-Heiden TC, 2012, MOL CELL ENDOCRINOL, V354, P121, DOI 10.1016/j.mce.2011.09.027; Kozu S, 2006, DEV BIOL, V294, P497, DOI 10.1016/j.ydbio.2006.03.015; Lemiere S, 2005, MUTAT RES-GEN TOX EN, V581, P11, DOI 10.1016/j.mrgentox.2004.10.015; Lewis N, 2004, MAR ENVIRON RES, V58, P101, DOI 10.1016/j.marenvres.2004.03.002; Mao XY, 2016, ONCOTARGET, V7, P33461, DOI 10.18632/oncotarget.8075; Martini M, 2014, ANN MED, V46, P372, DOI 10.3109/07853890.2014.912836; National Reasearch Council, 2006, HLTH RISKS DIOX REL; Ng GHB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064334; Ng GHB, 2011, BIOCHIMIE, V93, P1858, DOI 10.1016/j.biochi.2011.07.006; Okona-Mensah KB, 2005, FOOD CHEM TOXICOL, V43, P1103, DOI 10.1016/j.fct.2005.03.001; Operana TN, 2007, TOXICOL SCI, V95, P98, DOI 10.1093/toxsci/kfl144; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; PERDEW GH, 1988, J BIOL CHEM, V263, P13802; POSTLIND H, 1993, TOXICOL APPL PHARM, V118, P255, DOI 10.1006/taap.1993.1031; Prasch AL, 2004, TOXICOL SCI, V78, P68, DOI 10.1093/toxsci/kfh053; Puga A, 2009, BIOCHEM PHARMACOL, V77, P713, DOI 10.1016/j.bcp.2008.08.031; Pyati UJ, 2006, DEVELOPMENT, V133, P2275, DOI 10.1242/dev.02388; Ritchie JM, 2005, ENVIRON RES, V98, P104, DOI 10.1016/j.envres.2004.05.013; Sengupta S, 2014, BREAST CANCER RES TR, V143, P113, DOI 10.1007/s10549-013-2789-2; Stevens EA, 2009, IMMUNOLOGY, V127, P299, DOI 10.1111/j.1365-2567.2009.03054.x; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tu ZC, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0031-x; Wang JW, 2015, BIOTECHNIQUES, V58, P161, DOI 10.2144/000114261; Weber R, 2008, ENVIRON SCI POLLUT R, V15, P363, DOI 10.1007/s11356-008-0024-1; Wiebel FJ, 1996, TOXICOL LETT, V88, P335, DOI 10.1016/0378-4274(96)03758-7; Wu R, 2007, J PHARMACOL EXP THER, V320, P448, DOI 10.1124/jpet.106.111773; Xu HY, 2015, MAR BIOTECHNOL, V17, P831, DOI 10.1007/s10126-015-9669-1; Yamazaki K, 2002, J VET MED SCI, V64, P829, DOI 10.1292/jvms.64.829; Yueh MF, 2005, TOXICOL IN VITRO, V19, P275, DOI 10.1016/j.tiv.2004.10.003; ZeRuth G, 2007, CHEM-BIOL INTERACT, V170, P100, DOI 10.1016/j.cbi.2007.07.003; Zeruth G, 2005, ZEBRAFISH, V2, P197, DOI 10.1089/zeb.2005.2.197; Zhang XL, 2016, TUMOR BIOL, V37, P2555, DOI 10.1007/s13277-015-4099-2; Zhang ZY, 2006, BIOCHEM BIOPH RES CO, V341, P399, DOI 10.1016/j.bbrc.2005.12.203; Zhao B, 2010, TOXICOL SCI, V117, P393, DOI 10.1093/toxsci/kfq217; Zhou HL, 2010, TOXICOL MECH METHOD, V20, P279, DOI 10.3109/15376516.2010.485227; Zhu GW, 2014, INT J MOL MED, V33, P1431, DOI 10.3892/ijmm.2014.1711	62	8	9	3	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2814	2826		10.1096/fj.201701171R	http://dx.doi.org/10.1096/fj.201701171R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29298861				2022-12-28	WOS:000432528000040
J	Haffner-Luntzer, M; Kovtun, A; Fischer, V; Prystaz, K; Hainzl, A; Kroeger, CM; Krikki, I; Brinker, TJ; Ignatius, A; Gatzka, M				Haffner-Luntzer, Melanie; Kovtun, Anna; Fischer, Verena; Prystaz, Katja; Hainzl, Adelheid; Kroeger, Carsten M.; Krikki, Ioanna; Brinker, Titus J.; Ignatius, Anita; Gatzka, Martina			Loss of p53 compensates osteopenia in murine Mysm1 deficiency	FASEB JOURNAL			English	Article						bone; epigenetics; mesenchymal stem cell; osteoblasts	NEGATIVE REGULATOR; BONE; DIFFERENTIATION; HEMATOPOIESIS; PROLIFERATION; CONTRIBUTES; EXPRESSION; OSTERIX	Histone modifications critically contribute to the epigenetic orchestration of bone homeostasis-in part, by modifying the access of transcription factors to specific genes involved in the osteogenic differentiation process of bone marrow mesenchymal stem cells (MSCs) and osteoblasts. Based on our previous finding that histone H2A deubiquitinase 2A-DUB/Mysm1 interacts with the p53 axis in hematopoiesis and tissue development, we analyzed the molecular basis of the skeletal phenotype of Mysm1-deficient mice and dissected the underlying p53-dependent and -independent mechanisms. Visible morphologic, skeletal deformations of young Mysm1-deficient mice-including a kinked and truncated tail and shortened long bones-were associated with osteopenia of long bones. On the cellular level, Mysm1-deficient primary osteoblasts displayed reduced potential to differentiate into mature osteoblasts, as indicated by decreased expression of osteogenic markers. Reduced osteogenic differentiation capacity of Mysm1-deficient osteoblasts was accompanied by an impaired induction of osteogenic transcription factor Runx2. Osteogenic differentiation of Mysm1(-/-) MSCs, however, was not compromised in vitro. In line with defective hematopoietic development of Mysm1-deficient mice, Mysm1(-/-) osteoclasts had reduced resorption activity and were more prone to apoptosis in TUNEL assays. Skeletal alterations and osteopenia of Mysm1-deficient mice were phenotypically completely rescued by simultaneous ablation of p53 in p53(-/-)Mysm1(-/-) double-deficient mice-although p53 deficiency did not restore Runx2 expression in Mysm1(-/-) osteoblasts on the molecular level but, instead, enhanced proliferation and osteogenic differentiation of MSCs. In summary, our results demonstrate novel roles for Mysm1 in osteoblast differentiation and osteoclast formation, resulting in osteopenia in Mysm1-deficient mice that could be abrogated by the loss of p53 from increased osteogenic differentiation of Mysm1(-/-)p53(-/-) MSCs.	[Haffner-Luntzer, Melanie; Kovtun, Anna; Fischer, Verena; Prystaz, Katja; Ignatius, Anita] Univ Ulm, Inst Orthopaed Res & Biomech, Ulm, Germany; [Haffner-Luntzer, Melanie; Kovtun, Anna; Fischer, Verena; Prystaz, Katja; Ignatius, Anita] Univ Ulm, Trauma Res Ctr, Ulm, Germany; [Hainzl, Adelheid; Kroeger, Carsten M.; Krikki, Ioanna; Gatzka, Martina] Univ Ulm, Dept Dermatol & Allerg Dis, James Franck Ring 11C,N27, D-89081 Ulm, Germany; [Brinker, Titus J.] Univ Hosp Heidelberg, Dept Dermatol, Heidelberg, Germany; [Brinker, Titus J.] Univ Hosp Heidelberg, Natl Ctr Tumor Dis, Heidelberg, Germany	Ulm University; Ulm University; Ulm University; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Gatzka, M (corresponding author), Univ Ulm, Dept Dermatol & Allerg Dis, James Franck Ring 11C,N27, D-89081 Ulm, Germany.	martina.gatzka@uni-ulm.de	Vikman, Anna/F-1115-2017; Fischer, Verena/GVU-3636-2022; Ignatius, Anita/M-6012-2013; Haffner-Luntzer, Melanie/L-3562-2019	Ignatius, Anita/0000-0002-4782-1979; Haffner-Luntzer, Melanie/0000-0002-3333-2613; Vikman, Anna/0000-0001-8531-9712; Fischer, Verena/0000-0001-7039-8008	German Research Foundation (DFG) [CRC1149]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was funded by grants from the German Research Foundation (DFG) to A.I. (CRC1149) and M.G. The authors declare no conflicts of interest.	Armesilla-Diaz A, 2009, EXP CELL RES, V315, P3598, DOI 10.1016/j.yexcr.2009.08.004; Bahrami E, 2017, J ALLERGY CLIN IMMUN, V140, P1112, DOI 10.1016/j.jaci.2016.10.053; Belle JI, 2016, CELL DEATH DIFFER, V23, P759, DOI 10.1038/cdd.2015.140; Belle JI, 2015, BLOOD, V125, P2344, DOI 10.1182/blood-2014-05-574111; Coudert AE, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/372156; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Florencio-Silva R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/421746; Franceschi RT, 2007, ANN NY ACAD SCI, V1116, P196, DOI 10.1196/annals.1402.081; Gatzka M, 2015, CELL DEATH DIFFER, V22, P1451, DOI 10.1038/cdd.2014.231; Hayase Y, 1997, EXP HEMATOL, V25, P19; He YL, 2015, STEM CELLS, V33, P1304, DOI 10.1002/stem.1925; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Kemmler J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131194; Le Guen T, 2015, J ALLERGY CLIN IMMUN, V136, P1619, DOI 10.1016/j.jaci.2015.06.008; Li P, 2016, SCI REP-UK, V6, DOI 10.1038/srep22211; Liedert A, 2006, BIOCHEM BIOPH RES CO, V342, P1070, DOI 10.1016/j.bbrc.2006.02.063; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Nijnik A, 2012, BLOOD, V119, P1370, DOI 10.1182/blood-2011-05-352666; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Petrov JC, 2017, EXP HEMATOL, V47, P76, DOI 10.1016/j.exphem.2016.10.013; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rapp AE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147465; Rauch DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015755; Rontgen V, 2010, J ORTHOP RES, V28, P1456, DOI 10.1002/jor.21148; Schmidt K, 2005, J CELL BIOL, V168, P899, DOI 10.1083/jcb.200408013; Tao WK, 1999, P NATL ACAD SCI USA, V96, P6937, DOI 10.1073/pnas.96.12.6937; Tautzenberger A, 2011, BIOMATERIALS, V32, P1706, DOI 10.1016/j.biomaterials.2010.10.053; Tu QS, 2006, BIOCHEM BIOPH RES CO, V341, P1257, DOI 10.1016/j.bbrc.2006.01.092; Velletri T, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.367; Wang T, 2013, BLOOD, V122, P2812, DOI 10.1182/blood-2013-03-489641; Wang XY, 2006, J CELL BIOL, V172, P115, DOI 10.1083/jcb.200507106; Wilms C, 2017, ONCOTARGET, V8, P67287, DOI 10.18632/oncotarget.18617; Xiao ZS, 2001, J CELL BIOCHEM, V82, P647, DOI 10.1002/jcb.1192; Zauli G, 2007, J BONE MINER RES, V22, P1621, DOI 10.1359/JBMR.070618; Zhu P, 2007, MOL CELL, V27, P609, DOI 10.1016/j.molcel.2007.07.024	38	13	14	1	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1957	1968		10.1096/fj.201700871R	http://dx.doi.org/10.1096/fj.201700871R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29203593				2022-12-28	WOS:000429051400018
J	Kjobsted, R; Hingst, JR; Fentz, J; Foretz, M; Sanz, MN; Pehmoller, C; Shum, M; Marette, A; Mounier, R; Treebak, JT; Wojtaszewski, JFP; Viollet, B; Lantier, L				Kjobsted, Rasmus; Hingst, Janne R.; Fentz, Joachim; Foretz, Marc; Sanz, Maria-Nieves; Pehmoller, Christian; Shum, Michael; Marette, Andre; Mounier, Remi; Treebak, Jonas T.; Wojtaszewski, Jorgen F. P.; Viollet, Benoit; Lantier, Louise			AMPK in skeletal muscle function and metabolism	FASEB JOURNAL			English	Review						exercise; mitochondria; glucose uptake; plasticity; diabetes		Skeletal muscle possesses a remarkable ability to adapt to various physiologic conditions. AMPK is a sensor of intracellular energy status that maintains energy stores by fine-tuning anabolic and catabolic pathways. AMPK's role as an energy sensor is particularly critical in tissues displaying highly changeable energy turnover. Due to the drastic changes in energy demand that occur between the resting and exercising state, skeletal muscle is one such tissue. Here, we review the complex regulation of AMPK in skeletal muscle and its consequences on metabolism (e.g., substrate uptake, oxidation, and storage as well as mitochondrial function of skeletal muscle fibers). We focus on the role of AMPK in skeletal muscle during exercise and in exercise recovery. We also address adaptations to exercise training, including skeletal muscle plasticity, highlighting novel concepts and future perspectives that need to be investigated. Furthermore, we discuss the possible role of AMPK as a therapeutic target as well as different AMPK activators and their potential for future drug development.	[Kjobsted, Rasmus; Hingst, Janne R.; Fentz, Joachim; Wojtaszewski, Jorgen F. P.] Univ Copenhagen, Fac Sci, Dept Nutr Exercise & Sports, Sect Mol Physiol, Univ Pk 13, DK-2100 Copenhagen, Denmark; [Treebak, Jonas T.] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Integrat Physiol, Copenhagen, Denmark; [Foretz, Marc; Viollet, Benoit] Inst Cochin, INSERM, Unite 1016, Paris, France; [Foretz, Marc; Viollet, Benoit] CNRS, Unite Mixte Rech UMR 8104, Paris, France; [Foretz, Marc; Viollet, Benoit] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Sanz, Maria-Nieves] Univ Bern, Bern Univ Hosp, Dept Cardiovasc Surg, Inselspital, Bern, Switzerland; [Sanz, Maria-Nieves] Univ Bern, Dept Biomed Res, Bern, Switzerland; [Pehmoller, Christian] Pfizer Global Res & Dev, Internal Med Res Unit, Cambridge, MA USA; [Shum, Michael; Marette, Andre] Laval Univ, Quebec Heart & Lung Res Inst, Axe Cardiol, Quebec City, PQ, Canada; [Shum, Michael; Marette, Andre] Laval Univ, Inst Nutr & Funct Foods, Quebec City, PQ, Canada; [Mounier, Remi] Univ Claude Bernard Lyon 1, CNRS UMR, Inst NeuroMyoGene, INSERM Unite 1217, Villeurbanne, France; [Lantier, Louise] Vanderbilt Univ, Dept Mol Physiol & Biophys, 823 Light Hall,2215 Garland Ave, Nashville, TN 37232 USA; [Lantier, Louise] Vanderbilt Univ, Mouse Metab Phenotyping Ctr, Nashville, TN 37232 USA	University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Bern; University Hospital of Bern; University of Bern; Pfizer; Laval University; Quebec Heart & Lung Institute; Laval University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Vanderbilt University	Kjobsted, R (corresponding author), Univ Copenhagen, Fac Sci, Dept Nutr Exercise & Sports, Sect Mol Physiol, Univ Pk 13, DK-2100 Copenhagen, Denmark.; Lantier, L (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, 823 Light Hall,2215 Garland Ave, Nashville, TN 37232 USA.	rasmus.kjobsted@nexs.ku.dk; louise.lantier@vanderbilt.edu	Viollet, Benoit/N-2397-2019; FORETZ, Marc/O-7334-2017; Kjøbsted, Rasmus/AAY-8228-2020; Viollet, Benoit/O-6927-2017; Treebak, Jonas Thue/B-4521-2017; Hingst, Janne Rasmus/C-8430-2015	Viollet, Benoit/0000-0002-0121-0224; FORETZ, Marc/0000-0001-7017-9032; Kjøbsted, Rasmus/0000-0002-0628-4994; Viollet, Benoit/0000-0002-0121-0224; Treebak, Jonas Thue/0000-0003-1488-7012; Hingst, Janne Rasmus/0000-0001-9302-6813; Pehmoller, Christian/0000-0001-7102-7727; Shum, Michael/0000-0001-8784-9928; Marette, Andre/0000-0003-3950-5973	INSERM, Centre National de la Recherche Scientifique (CNRS), Universite Paris Descartes, and Agence Nationale de la Recherche; Association Francaise contre les Myopathies, Ligue Nationale Contre le Cancer; Societe Francaise de Myologie; Canadian Institutes for Health Research (CIHR) [FDN-143247]; Danish Council for independent Research-Medical Sciences; Lundbeck Foundation; Novo Nordisk Foundation; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [DK054902, DK059637]; Novo Nordisk Foundation [NNF14OC0009315]; Danish Council for Independent Research [DFF - 4004-00235]; NNF Center for Basic Metabolic Research [Treebak Group] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0009315] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059637, R56DK054902, R01DK054902] Funding Source: NIH RePORTER	INSERM, Centre National de la Recherche Scientifique (CNRS), Universite Paris Descartes, and Agence Nationale de la Recherche(French National Research Agency (ANR)); Association Francaise contre les Myopathies, Ligue Nationale Contre le Cancer(Association Francaise contre les Myopathies); Societe Francaise de Myologie; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Danish Council for independent Research-Medical Sciences(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); NNF Center for Basic Metabolic Research(Novo Nordisk Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from INSERM, Centre National de la Recherche Scientifique (CNRS), Universite Paris Descartes, and Agence Nationale de la Recherche (to B.V. and M.F.); the Association Francaise contre les Myopathies, Ligue Nationale Contre le Cancer, and the Societe Francaise de Myologie (to R.M.); the Canadian Institutes for Health Research (CIHR; FDN-143247) (to A.M.); the Danish Council for independent Research-Medical Sciences, the Lundbeck Foundation, and Novo Nordisk Foundation (to J.F.P.W.); and U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grants DK054902 and DK059637 (to L.L.). J.T.T. was supported by the Novo Nordisk Foundation (Excellence Project Award NNF14OC0009315), and by the Danish Council for Independent Research (Research Project Grant DFF - 4004-00235). The authors declare no conflicts of interest.		0	193	195	14	73	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1741	1777		10.1096/fj.201700442R	http://dx.doi.org/10.1096/fj.201700442R			37	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29242278	Green Published, hybrid			2022-12-28	WOS:000429051400003
J	Ranieri, M; Zahedi, K; Tamma, G; Centrone, M; Di Mise, A; Soleimani, M; Valenti, G				Ranieri, Marianna; Zahedi, Kamyar; Tamma, Grazia; Centrone, Mariangela; Di Mise, Annarita; Soleimani, Manoocher; Valenti, Giovanna			CaSR signaling down-regulates AQP2 expression via a novel microRNA pathway in pendrin and NaCl cotransporter knockout mice	FASEB JOURNAL			English	Article						water channel; miRNA-137; p38-MAPK; hypercalciuria	CALCIUM-SENSING RECEPTOR; RENAL COLLECTING DUCT; CL-COTRANSPORTER; AQUAPORIN-2 EXPRESSION; PLASMA-MEMBRANE; VASOPRESSIN; KIDNEY; MOUSE; PHOSPHORYLATION; CHANNEL	High concentrations of urinary calcium counteract vasopressin action via the activation of the calcium-sensing receptor (CaSR) that is expressed in the luminal membrane of collecting duct cells, which impairs the trafficking of aquaporin-2 (AQP2). Pendrin/NaCl cotransporter double-knockout (dKO) mice display significant calcium wasting and develop severe volume depletion, despite increased circulating vasopressin levels. We hypothesized that the CaSR-mediated impairment of AQP2 expression/trafficking underlies vasopressin resistance in dKO mice. Compared with wild-type mice, in renal inner medulla, dKO mice had reduced total AQP2 sensitive to proteasome inhibitors, higher levels of AQP2-pS261, ubiquitinated AQP2, and p38-MAPK, an enzyme that is activated by CaSR signaling and known to phosphorylate AQP2 at Ser261. CaSR inhibition with the calcilytic NPS2143 reversed these effects, which indicates that CaSR mediates the up-regulation of AQP2-pS261, ubiquitination, and degradation. Of note, dKO mice demonstrated significantly higher AQP2-targeting miRNA-137 that was reduced upon CaSR inhibition, supporting a critical role for CaSR in the down-regulation of AQP2 expression. Our data indicate that CaSR signaling reduces AQP2 abundance both via AQP2-targeting miRNA-137 and the p38-MAPK/AQP2-pS261/ubiquitination/proteasomal axis. These effects may contribute to the reduced renal concentrating ability that has been observed in dKO mice and underscore a physiologic mechanism of the CaSR-dependent regulation of AQP2 abundance via a novel microRNA pathway.	[Ranieri, Marianna; Tamma, Grazia; Centrone, Mariangela; Di Mise, Annarita; Valenti, Giovanna] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Via Orabona 4,Amendola 165-A, I-70125 Bari, Italy; [Valenti, Giovanna] Univ Bari, Ctr Excellence Comparat Genom, Bari, Italy; [Zahedi, Kamyar; Soleimani, Manoocher] Vet Affairs Med Ctr, Res Serv, Cincinnati, OH 45267 USA; [Zahedi, Kamyar; Soleimani, Manoocher] Univ Cincinnati, Dept Med, Cincinnati, OH USA; [Zahedi, Kamyar; Soleimani, Manoocher] Univ Cincinnati, Ctr Genet Transport & Epithelial Biol, Cincinnati, OH USA; [Tamma, Grazia; Valenti, Giovanna] Ist Nazl Biostrutture & Biosistemi, Rome, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Cincinnati VA Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Valenti, G (corresponding author), Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Via Orabona 4,Amendola 165-A, I-70125 Bari, Italy.	giovanna.valenti@uniba.it	Zahedi, Kamyar/AAQ-3428-2021; Ranieri, Marianna/J-9421-2018; Di Mise, Annarita/AAP-4176-2020	Ranieri, Marianna/0000-0003-3118-5813; DI MISE, Annarita/0000-0002-8132-4917; Tamma, Grazia/0000-0002-8890-0278	"Intervento cofinanziato dal Fondo di Sviluppo e Coesione APQ Ricerca Regione Puglia Programma Regionale a Sostegno della Specializzazione Intelligente e della Sostenibilita Sociale ed Ambientale-FutureInResearch"; Telethon [GGP13227]; Italian Space Agency (ASI) [2013-091-R.0]; Progetti di Rilevante Interesse Nazionale (PRIN) [01373409]; Merit Review Award [2IO1BX001000, 12111o18]	"Intervento cofinanziato dal Fondo di Sviluppo e Coesione APQ Ricerca Regione Puglia Programma Regionale a Sostegno della Specializzazione Intelligente e della Sostenibilita Sociale ed Ambientale-FutureInResearch"(Regione Puglia); Telethon(Fondazione Telethon); Italian Space Agency (ASI)(Agenzia Spaziale Italiana (ASI)); Progetti di Rilevante Interesse Nazionale (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Merit Review Award(US Department of Veterans Affairs)	The authors thank Elena Ciani (University of Bari) for assistance with real-time PCR experiments. M.R. is a postdoctoral research fellow supported by "Intervento cofinanziato dal Fondo di Sviluppo e Coesione 2007-2013-APQ Ricerca Regione Puglia Programma Regionale a Sostegno della Specializzazione Intelligente e della Sostenibilita Sociale ed Ambientale-FutureInResearch." This study was supported, in part, by Telethon funding (GGP13227) and by Italian Space Agency (ASI; 2013-091-R.0 to G.V.), by Progetti di Rilevante Interesse Nazionale (PRIN; 01373409 to G.T.), and by Merit Review Award 2IO1BX001000 (Grant 12111o18 to M.S.). The authors declare no conflicts of interest.	Abdullah HI, 2008, AM J PHYSIOL-RENAL, V295, pF1082, DOI 10.1152/ajprenal.90316.2008; Amlal H, 2010, AM J PHYSIOL-CELL PH, V299, pC33, DOI 10.1152/ajpcell.00033.2010; Boone M, 2011, AM J PHYSIOL-RENAL, V300, pF761, DOI 10.1152/ajprenal.00247.2010; Bustamante M, 2008, J AM SOC NEPHROL, V19, P109, DOI 10.1681/ASN.2007010092; Campean V, 2001, AM J PHYSIOL-RENAL, V281, pF1028, DOI 10.1152/ajprenal.0148.2001; Delpire E, 2002, ANNU REV PHYSIOL, V64, P803, DOI 10.1146/annurev.physiol.64.081501.155847; Delpire E, 1996, NEPHROL DIAL TRANSPL, V11, P1967, DOI 10.1093/oxfordjournals.ndt.a027081; Di Mise A, 2015, AM J PHYSIOL-RENAL, V308, pF1200, DOI 10.1152/ajprenal.00352.2014; ELLISON DH, 1989, J CLIN INVEST, V83, P113, DOI 10.1172/JCI113847; Ellison DH, 2003, J AM SOC NEPHROL, V14, P538, DOI 10.1681/ASN.V142538; ELLISON DH, 1987, AM J PHYSIOL, V253, pF546, DOI 10.1152/ajprenal.1987.253.3.F546; Fenton RA, 2008, PROG BRAIN RES, V170, P571, DOI 10.1016/S0079-6123(08)00444-5; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Gianni M, 2006, EMBO J, V25, P739, DOI 10.1038/sj.emboj.7600981; Gkika D, 2006, J AM SOC NEPHROL, V17, P3020, DOI 10.1681/ASN.2006060676; Gong YF, 2012, EMBO J, V31, P1999, DOI 10.1038/emboj.2012.49; Graca JAZ, 2016, AM J PHYSIOL-RENAL, V310, pF518, DOI 10.1152/ajprenal.00208.2015; Hasler U, 2002, J BIOL CHEM, V277, P10379, DOI 10.1074/jbc.M111880200; Hasler U, 2009, AM J PHYSIOL-RENAL, V297, pF10, DOI 10.1152/ajprenal.00053.2009; Hoffert JD, 2007, AM J PHYSIOL-RENAL, V292, pF691, DOI 10.1152/ajprenal.00284.2006; Hoffert JD, 2008, J BIOL CHEM, V283, P24617, DOI 10.1074/jbc.M803074200; Hoffert JD, 2006, P NATL ACAD SCI USA, V103, P7159, DOI 10.1073/pnas.0600895103; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Isobe K, 2017, P NATL ACAD SCI USA, V114, pE8875, DOI 10.1073/pnas.1709123114; Khositseth S, 2017, KIDNEY INT, V91, P1070, DOI 10.1016/j.kint.2016.12.005; Kim JE, 2015, AM J PHYSIOL-RENAL, V308, pF749, DOI 10.1152/ajprenal.00334.2014; Kim YH, 2002, AM J PHYSIOL-RENAL, V283, pF744, DOI 10.1152/ajprenal.00037.2002; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Li W, 2008, CELL MOL LIFE SCI, V65, P2397, DOI 10.1007/s00018-008-8090-6; Loffing J, 2004, J AM SOC NEPHROL, V15, P2276, DOI 10.1097/01.ASN.0000138234.18569.63; Maiti A, 2008, J BIOL CHEM, V283, P175, DOI 10.1074/jbc.M707269200; Matsumura Y, 1997, J AM SOC NEPHROL, V8, P861; Moeller HB, 2011, AM J PHYSIOL-RENAL, V300, pF1062, DOI 10.1152/ajprenal.00721.2010; Murer L, 2004, J AM SOC NEPHROL, V15, P2705, DOI 10.1097/01.ASN.0000139689.94776.7A; Nedvetsky PI, 2010, J AM SOC NEPHROL, V21, P1645, DOI 10.1681/ASN.2009111190; Nemeth EF, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290015; Petrovic S, 2003, AM J PHYSIOL-RENAL, V284, pF103, DOI 10.1152/ajprenal.00205.2002; Procino G, 2008, SEMIN NEPHROL, V28, P297, DOI 10.1016/j.semnephrol.2008.03.007; Procino G, 2004, KIDNEY INT, V66, P2245, DOI 10.1111/j.1523-1755.2004.66036.x; Procino G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033145; Puliyanda DP, 2003, BIOCHEM BIOPH RES CO, V303, P52, DOI 10.1016/S0006-291X(03)00215-8; Ranieri M, 2015, J CELL SCI, V128, P2350, DOI 10.1242/jcs.168096; Ranieri M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079113; Riccardi D, 2016, NAT REV NEPHROL, V12, P414, DOI 10.1038/nrneph.2016.59; Riccardi D, 2010, AM J PHYSIOL-RENAL, V298, pF485, DOI 10.1152/ajprenal.00608.2009; Royaux IE, 2001, P NATL ACAD SCI USA, V98, P4221, DOI 10.1073/pnas.071516798; Sands JM, 1998, AM J PHYSIOL-RENAL, V274, pF978, DOI 10.1152/ajprenal.1998.274.5.F978; Sansoe G, 2010, J HEPATOL, V53, P856, DOI 10.1016/j.jhep.2010.05.021; Schultheis PJ, 1998, J BIOL CHEM, V273, P29150, DOI 10.1074/jbc.273.44.29150; Soleimani M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159804; Soleimani M, 2012, P NATL ACAD SCI USA, V109, P13368, DOI 10.1073/pnas.1202671109; Tamma G, 2003, J CELL SCI, V116, P3285, DOI 10.1242/jcs.00640; Tamma G, 2014, J BIOL CHEM, V289, P27807, DOI 10.1074/jbc.M114.586024; Tamma G, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-133; Tamma G, 2013, CELL PHYSIOL BIOCHEM, V32, P200, DOI 10.1159/000356639; Tamma G, 2011, CELL PHYSIOL BIOCHEM, V27, P739, DOI 10.1159/000330082; Tfelt-Hansen J, 2005, GROWTH FACTORS, V23, P117, DOI 10.1080/08977190500126272; Trepiccione F, 2014, KIDNEY INT, V86, P757, DOI 10.1038/ki.2014.107; Uchida S, 2009, CANCER RES, V69, P6438, DOI 10.1158/0008-5472.CAN-09-0869; Valenti G, 2010, CELL PHYSIOL BIOCHEM, V26, P901, DOI 10.1159/000323999; Verlander JW, 2003, HYPERTENSION, V42, P356, DOI 10.1161/01.HYP.0000088321.67254.B7; Wall SM, 2003, AM J PHYSIOL-RENAL, V284, pF229, DOI 10.1152/ajprenal.00147.2002; Wall SM, 2008, CURR OPIN NEPHROL HY, V17, P18, DOI 10.1097/MNH.0b013e3282f29086; Wall SM, 2013, AM J PHYSIOL-RENAL, V305, pF427, DOI 10.1152/ajprenal.00022.2013; Woelk T, 2006, NAT CELL BIOL, V8, P1246, DOI 10.1038/ncb1484; Yarova PL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0282	66	14	14	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2148	2159		10.1096/fj.201700412RR	http://dx.doi.org/10.1096/fj.201700412RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29212817				2022-12-28	WOS:000429051400034
J	Goundry, A; Romano, A; Lima, APCA; Mottram, JC; Myburgh, E				Goundry, Amy; Romano, Audrey; Lima, Ana Paula C. A.; Mottram, Jeremy C.; Myburgh, Elmarie			Inhibitor of serine peptidase 2 enhances Leishmania major survival in the skin through control of monocytes and monocyte-derived cells	FASEB JOURNAL			English	Article						inflammatory monocytes; parasite; dermis; leishmaniasis; in vivo	DENDRITIC CELLS; NEUTROPHIL ELASTASE; MACROPHAGES; INDUCTION; INFECTION; ACTIVATION; PROTEASES; SITE; RESPONSES; IMMUNITY	Leishmania major is the causative agent of the neglected tropical disease, cutaneous leishmaniasis. In the mouse, protective immunity to Leishmaniais associated with inflammatory responses. Here, we assess the dynamics of the inflammatory responses at the lesion site during experimental long-term, low-dose intradermal infection of the ear, employing noninvasive imaging and genetically modified L. major. Significant infiltrates of neutrophils and monocytes occurred at 1-4 d and 2-4 wk, whereas dermal macrophage and dendritic cell (DC) numbers were only slightly elevated in the first days. Quantitative whole-body bioluminescence imaging of myeloperoxidase activity and the quantification of parasite loads indicated that the Leishmania virulence factor, inhibitor of serine peptidase 2 (ISP2), is required to modulate phagocyte activation and is important for parasite survival at the infection site. ISP2 played a role in the control of monocyte, monocyte-derived macrophage, and monocyte-derived DC (moDC) influx, and was required to reduce iNOS expression in monocytes, monocyte-derived cells, and dermal DCs; the expression of CD80 in moDCs; and levels of IFN-gamma in situ. Our findings indicate that the increased survival of L. major in the dermis during acute infection is associated with the down-regulation of inflammatory monocytes and monocyte-derived cells via ISP2.-Goundry, A., Romano, A., Lima, A. P. C. A., Mottram, J. C., Myburgh, E. Inhibitor of serine peptidase 2 enhances Leishmania major survival in the skin through control of monocytes and monocyte-derived cells.	[Goundry, Amy; Mottram, Jeremy C.; Myburgh, Elmarie] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Wellcome Ctr Mol Parasitol, Glasgow, Lanark, Scotland; [Goundry, Amy; Romano, Audrey; Mottram, Jeremy C.; Myburgh, Elmarie] Univ York, Ctr Immunol & Infect, Dept Biol, Wentworth Way, York YO10 5DD, N Yorkshire, England; [Goundry, Amy; Lima, Ana Paula C. A.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil	University of Glasgow; University of York - UK; Universidade Federal do Rio de Janeiro	Mottram, JC; Myburgh, E (corresponding author), Univ York, Ctr Immunol & Infect, Dept Biol, Wentworth Way, York YO10 5DD, N Yorkshire, England.	jeremy.mottram@york.ac.uk; elmarie.myburgh@york.ac.uk	Lima, Ana Paula CA/G-4122-2012	Mottram, Jeremy/0000-0001-5574-3766; Myburgh, Elmarie/0000-0002-2007-5902; Goundry, Amy/0000-0003-3406-4689; LIMA, ANA PAULA C. A./0000-0003-4631-2694	Medical Research Council (MRC) [MR/K019384]; Newton Fund [MR/N017269/1]; Wellcome Trust [104111]; Fundacao de Amparoa Pesquisa do Estado do Rio de Janeiro (FAPERJ); MRC studentship; MRC [MR/K019384/1, MR/K019384/2, MR/N017269/1] Funding Source: UKRI; Medical Research Council [MR/K019384/1, MR/K019384/2, MR/N017269/1] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Newton Fund; Wellcome Trust(Wellcome TrustEuropean Commission); Fundacao de Amparoa Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); MRC studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank the staff at Biological Services (University of Glasgow) for care of the animals used in the study. This work was supported by the Medical Research Council (MRC; MR/K019384), the Newton Fund (MR/N017269/1), the Wellcome Trust (104111), and Fundacao de Amparoa Pesquisa do Estado do Rio de Janeiro (FAPERJ). A.G. was supported by an MRC studentship. A.P.C.A.L. is a fellow of the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The authors declare no conflicts of interest.	Adkison AM, 2002, J CLIN INVEST, V109, P363, DOI 10.1172/JCI13462; Alexander J, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00080; Belkaid Y, 2000, J IMMUNOL, V165, P969, DOI 10.4049/jimmunol.165.2.969; Bosschaerts T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001045; Carrera L, 1996, J EXP MED, V183, P515, DOI 10.1084/jem.183.2.515; Charmoy M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000755; CHUNG CH, 1983, J BIOL CHEM, V258, P1032; Contreras I, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003202; De Filippo K, 2008, J IMMUNOL, V180, P4308, DOI 10.4049/jimmunol.180.6.4308; De Trez C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000494; Eggers CT, 2004, BIOCHEM J, V379, P107, DOI 10.1042/BJ20031790; Eschenlauer SCP, 2009, CELL MICROBIOL, V11, P106, DOI 10.1111/j.1462-5822.2008.01243.x; Faria MS, 2014, FASEB J, V28, P3050, DOI 10.1096/fj.13-245126; Faria MS, 2011, J IMMUNOL, V186, P411, DOI 10.4049/jimmunol.1002175; Favila MA, 2014, J IMMUNOL, V192, P5863, DOI 10.4049/jimmunol.1203230; Gomez MA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000213; Goncalves R, 2011, J EXP MED, V208, P1253, DOI 10.1084/jem.20101751; Gonzalez-Lombana C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003243; Gross S, 2009, NAT MED, V15, P455, DOI 10.1038/nm.1886; Guyot N, 2014, AM J PATHOL, V184, P2197, DOI 10.1016/j.ajpath.2014.04.015; HART DT, 1981, PARASITOLOGY, V82, P345, DOI 10.1017/S0031182000066889; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Hurrell BP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004929; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kimblin N, 2008, P NATL ACAD SCI USA, V105, P10125, DOI 10.1073/pnas.0802331105; Krutzik SR, 2005, NAT MED, V11, P653, DOI 10.1038/nm1246; Laufs H, 2002, INFECT IMMUN, V70, P826, DOI 10.1128/IAI.70.2.826-835.2002; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Liu D, 2009, INFECT IMMUN, V77, P3272, DOI 10.1128/IAI.01447-08; LOCKSLEY RM, 1991, RES IMMUNOL, V142, P28, DOI 10.1016/0923-2494(91)90007-6; Morrison LS, 2012, CELL MICROBIOL, V14, P1271, DOI 10.1111/j.1462-5822.2012.01798.x; Owen Caroline A, 2008, Int J Chron Obstruct Pulmon Dis, V3, P253; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Petritus PM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001858; Pham CTN, 2008, INT J BIOCHEM CELL B, V40, P1317, DOI 10.1016/j.biocel.2007.11.008; Quinones MP, 2007, PARASITE IMMUNOL, V29, P211, DOI 10.1111/j.1365-3024.2006.00935.x; REINER SL, 1994, J EXP MED, V179, P447, DOI 10.1084/jem.179.2.447; Ribeiro-Gomes FL, 2014, INFECT IMMUN, V82, P2713, DOI 10.1128/IAI.01600-13; Ribeiro-Gomes FL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002536; Ritter U, 2008, MED MICROBIOL IMMUN, V197, P29, DOI 10.1007/s00430-007-0056-z; Rogers ME, 2010, MICROBES INFECT, V12, P875, DOI 10.1016/j.micinf.2010.05.014; SACKS DL, 1985, J IMMUNOL, V135, P564; Schuster S, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00067; Shapiro SD, 2002, BIOCHEM SOC T, V30, P98, DOI 10.1042/BST0300098; Shio MT, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/819512; Silva MT, 2010, J LEUKOCYTE BIOL, V87, P805, DOI 10.1189/jlb.1109767; STENGER S, 1994, J EXP MED, V180, P783, DOI 10.1084/jem.180.3.783; Svensjo E, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/143450; Thalhofer CJ, 2011, INFECT IMMUN, V79, P108, DOI 10.1128/IAI.00338-10; TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x; van Zandbergen G, 2004, J IMMUNOL, V173, P6521, DOI 10.4049/jimmunol.173.11.6521; van Zandbergen G, 2002, INFECT IMMUN, V70, P4177, DOI 10.1128/IAI.70.8.4177-4184.2002; VOULDOUKIS I, 1995, P NATL ACAD SCI USA, V92, P7804, DOI 10.1073/pnas.92.17.7804; Wiedow O, 2005, J INTERN MED, V257, P319, DOI 10.1111/j.1365-2796.2005.01476.x; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182	56	9	10	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1315	1327		10.1096/fj.201700797R	http://dx.doi.org/10.1096/fj.201700797R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29097502	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000427246000016
J	Ji, XR; Cheng, KC; Chen, YR; Lin, TY; Cheung, CHA; Wu, CL; Chiang, HC				Ji, Xuan-Ru; Cheng, Kuan-Chung; Chen, Yu-Ru; Lin, Tzu-Yu; Cheung, Chun Hei Antonio; Wu, Chia-Lin; Chiang, Hsueh-Cheng			Dysfunction of different cellular degradation pathways contributes to specific beta-amyloid42-induced pathologies	FASEB JOURNAL			English	Article						Alzheimer's disease; autophagy; proteasome; lysosome	AMYLOID PRECURSOR PROTEIN; ENDOPLASMIC-RETICULUM STRESS; SPORADIC ALZHEIMERS-DISEASE; UBIQUITIN-PROTEASOME SYSTEM; DROSOPHILA-MELANOGASTER; AUTOPHAGIC VACUOLES; SECRETORY PATHWAY; BETA-PROTEIN; ENDOCYTIC TRAFFICKING; PRESENILIN-MUTATIONS	The endosomal-lysosomal system (ELS), autophagy, and ubiquitin-proteasome system (UPS) are cellular degradation pathways that each play a critical role in the removal of misfolded proteins and the prevention of the accumulation of abnormal proteins. Recent studies on Alzheimer's disease (AD) pathogenesis have suggested that accumulation of aggregated beta-amyloid (A beta) peptides in the AD brain results from a dysfunction in these cellular clearance systems. However, the specific roles of these pathways in the removal of A beta peptides and the pathogenesis underlying AD are unclear. Our in vitro and in vivo genetic approaches revealed that ELS mainly removed monomeric beta-amyloid42 (A beta 42), while autophagy and UPS clear oligomeric A beta 42. Although overproduction of phosphatidylinositol 4-phosphate-5 increased A beta 42 clearance, it reduced the life span of A beta 42 transgenic flies. Our behavioral studies further demonstrated impaired autophagy and UPS-enhanced A beta 42-induced learning and memory deficits, but there was no effect on A beta 42-induced reduction in life span. Results from genetic fluorescence imaging showed that these pathways were damaged in the following order: UPS, autophagy, and finally ELS. The results of our study demonstrate that different degradation pathways play distinct roles in the removal of A beta 42 aggregates and in disease progression. These findings also suggest that pharmacologic treatments that are designed to stimulate cellular degradation pathways in patients with AD should be used with caution.	[Ji, Xuan-Ru; Cheng, Kuan-Chung; Chen, Yu-Ru; Lin, Tzu-Yu; Cheung, Chun Hei Antonio; Chiang, Hsueh-Cheng] Natl Cheng Kung Univ, Dept Pharmacol, Coll Med, Tainan, Taiwan; [Cheng, Kuan-Chung; Cheung, Chun Hei Antonio; Chiang, Hsueh-Cheng] Natl Cheng Kung Univ, Inst Basic Med Sci, Coll Med, Tainan, Taiwan; [Wu, Chia-Lin] Chang Gung Univ, Grad Inst Biomed Sci, Coll Med, Taoyuan, Taiwan	National Cheng Kung University; National Cheng Kung University; Chang Gung University	Chiang, HC (corresponding author), Natl Cheng Kung Univ, 1 Univ Rd, Tainan 701, Taiwan.	chianghc@mail.ncku.edu.tw		Cheung, Chun Hei Antonio/0000-0003-4181-1435; Lin, Tzu Yu/0000-0003-1678-7779; Wu, Chia-Lin/0000-0002-7906-2364	Ministry of Science and Technology, Taiwan [MOST 104-2320-B-006-037-MY3, MOST 103-2320-B-006-051]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	The authors thank Y. Zhong, G. C. Chen, C. C. Jang, U. B. Pandey, Y. W. Liu, P. Raghu, R. Regazzi, T. F. J. Martin, and S. H. Yang, as well as the Bloomington Drosophila Stock Center, Kyoto Stock Center, Vienna Drosophila RNAi Center (VDRC), and FlyORF for providing experimental materials, and L. Wang, Y.-C. Shuai, and K.-S. Hsu for constructive comments on early drafts of the article. The authors also thank the technical services from the Bio-image Core Facility of the National Core Facility Program for Biotechnology, Ministry of Science and Technology, Taiwan. This work was supported by the Ministry of Science and Technology, Taiwan (MOST 104-2320-B-006-037-MY3 to H.-C.C., MOST 103-2320-B-006-051 to H.-C.C.). The authors declare no conflicts of interest.	Abe N, 2008, J CELL SCI, V121, P1488, DOI 10.1242/jcs.020792; Akalal DBG, 2006, LEARN MEMORY, V13, P659, DOI 10.1101/lm.221206; Belote JM, 2002, GENESIS, V34, P80, DOI 10.1002/gene.10131; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Caccamo A, 2014, J NEUROSCI, V34, P7988, DOI 10.1523/JNEUROSCI.0777-14.2014; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Cataldo AM, 2004, J NEUROPATH EXP NEUR, V63, P821, DOI 10.1093/jnen/63.8.821; Cataldo AM, 1997, J NEUROSCI, V17, P6142; Cescato R, 2000, J NEUROCHEM, V74, P1131; Chakrabarti P, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004948; Chen GC, 2008, AUTOPHAGY, V4, P37, DOI 10.4161/auto.5141; Chin YH, 2015, HUM MOL GENET, V24, P5542, DOI 10.1093/hmg/ddv285; Ciechanover A, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.117; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021; DECAMILLI P, 1995, CURR OPIN NEUROBIOL, V5, P559, DOI 10.1016/0959-4388(95)80059-X; Dias BD, 2014, SCI REP-UK, V4, DOI 10.1038/srep05556; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Gadhave K, 2016, J CELL MOL MED, V20, P1392, DOI 10.1111/jcmm.12817; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Gong B, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00004; GREGORI L, 1995, J BIOL CHEM, V270, P19702, DOI 10.1074/jbc.270.34.19702; Guglielmotto M, 2014, AUTOPHAGY, V10, P1827, DOI 10.4161/auto.30001; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Hardy J, 1998, SCIENCE, V282, P1075, DOI 10.1126/science.282.5391.1075; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Iijima K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001703; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Jang SK, 2015, EUR J PHARMACOL, V758, P1, DOI 10.1016/j.ejphar.2015.03.071; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; Kleiger G, 2014, TRENDS CELL BIOL, V24, P352, DOI 10.1016/j.tcb.2013.12.003; Kumar P, 2007, HUM MOL GENET, V16, P848, DOI 10.1093/hmg/ddm030; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Leitman J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3753; Lilienbaum Alain, 2013, Int J Biochem Mol Biol, V4, P1; Ling DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004201; Maday S, 2016, J NEUROSCI, V36, P5933, DOI 10.1523/JNEUROSCI.4401-15.2016; Maiese K, 2016, BRIT J CLIN PHARMACO, V82, P1245, DOI 10.1111/bcp.12804; Mizushima N, 2005, J CELL BIOL, V171, P15, DOI 10.1083/jcb.200508097; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; PERRY G, 1989, J NEUROCHEM, V52, P1523, DOI 10.1111/j.1471-4159.1989.tb09203.x; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Saido T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006379; Salon ML, 2003, EXP NEUROL, V180, P131, DOI 10.1016/S0014-4886(02)00060-2; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; SEGLEN PO, 1992, EXPERIENTIA, V48, P158, DOI 10.1007/BF01923509; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Soejima N, 2013, CURR ALZHEIMER RES, V10, P11; Song MS, 2011, NEUROSCIENCE, V178, P181, DOI 10.1016/j.neuroscience.2010.12.055; Thal DR, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00025; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Tung YT, 2012, J BIOSCIENCES, V37, P157, DOI 10.1007/s12038-011-9176-0; Umeda T, 2011, J NEUROSCI RES, V89, P1031, DOI 10.1002/jnr.22640; Urushitani M, 2008, FASEB J, V22, P2476, DOI 10.1096/fj.07-092783; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Verhoef LGGC, 2002, HUM MOL GENET, V11, P2689, DOI 10.1093/hmg/11.22.2689; Viswanathan J, 2011, TRAFFIC, V12, P330, DOI 10.1111/j.1600-0854.2010.01149.x; WANG GP, 1991, BRAIN RES, V566, P146, DOI 10.1016/0006-8993(91)91692-T; Wang L, 2012, P NATL ACAD SCI USA, V109, P16743, DOI 10.1073/pnas.1208011109; Wang R, 2012, CURR ALZHEIMER RES, V9, P606, DOI 10.2174/156720512800618026; Wilson CA, 2002, NAT NEUROSCI, V5, P849, DOI 10.1038/nn898; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yu WH, 2004, INT J BIOCHEM CELL B, V36, P2531, DOI 10.1016/j.biocel.2004.05.010; Zhou FF, 2011, PROTEIN CELL, V2, P377, DOI 10.1007/s13238-011-1047-9	67	9	9	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1375	1387		10.1096/fj.201700199RR	http://dx.doi.org/10.1096/fj.201700199RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29127191				2022-12-28	WOS:000427246000021
J	Poli, A; Ratti, S; Finelli, C; Mongiorgi, S; Clissa, C; Lonetti, A; Cappellini, A; Catozzi, A; Barraco, M; Suh, PG; Manzoli, L; McCubrey, JA; Cocco, L; Follo, MY				Poli, Alessandro; Ratti, Stefano; Finelli, Carlo; Mongiorgi, Sara; Clissa, Cristina; Lonetti, Annalisa; Cappellini, Alessandra; Catozzi, Alessia; Barraco, Marilena; Suh, Pann-Ghill; Manzoli, Lucia; McCubrey, James A.; Cocco, Lucio; Follo, Matilde Y.			Nuclear translocation of PKC-alpha is associated with cell cycle arrest and erythroid differentiation in myelodysplastic syndromes (MDSs)	FASEB JOURNAL			English	Article						nucleus; erythropoiesis; lenalidomide; chromosome 5q deletion	ACUTE LYMPHOBLASTIC-LEUKEMIA; PHOSPHOLIPASE-C; RISK MDS; SIGNALING PATHWAYS; K562 CELLS; LENALIDOMIDE; PI-PLC-BETA-1; AZACITIDINE; INVOLVEMENT; ACTIVATION	PI-PLC beta 1 is involved in cell proliferation, differentiation, and myelodysplastic syndrome (MDS) pathogenesis. Moreover, the increased activity of PI-PLC beta 1 reduces the expression of PKC-alpha, which, in turn, delays the cell proliferation and is linked to erythropoiesis. Lenalidomide is currently used in low-risk patients with MDS and del(5q), where it can suppress the del(5q) clone and restore normal erythropoiesis. In this study, we analyzed the effect of lenalidomide on 16 patients with low-risk del(5q) MDS, as well as del(5q) and non-del(5q) hematopoietic cell lines, mainly focusing on erythropoiesis, cell cycle, and PI-PLC beta 1/PKC-alpha signaling. Overall, 11 patients were evaluated clinically, and 10 (90%) had favorable responses; the remaining case had a stable disease. At a molecular level, both responder patients and del(5q) cells showed a specific induction of erythropoiesis, with a reduced gamma/beta-globin ratio, an increase in glycophorin A, and a nuclear translocation of PKC-alpha. Moreover, lenalidomide could induce a selective G(0)/G(1) arrest of the cell cycle in del(5q) cells, slowing down the rate proliferation in those cells. Altogether, our results could not only better explain the role of PI-PLC beta 1/PKC-alpha signaling in erythropoiesis but also lead to a better comprehension of the lenalidomide effect on del(5q) MDS and pave the way to innovative, targeted therapies.	[Poli, Alessandro; Ratti, Stefano; Mongiorgi, Sara; Lonetti, Annalisa; Catozzi, Alessia; Manzoli, Lucia; Cocco, Lucio; Follo, Matilde Y.] Univ Bologna, Policlin St Orsola Malpighi Hosp, Dipartimento Sci Biomed & NeuroMotorie, Inst Human Anat,Cellular Signalling Lab, Bologna, Italy; [Finelli, Carlo; Clissa, Cristina; Barraco, Marilena] Univ Bologna, Policlin St Orsola Malpighi Hosp, L & E Seragnoli Inst Hematol, Bologna, Italy; [Lonetti, Annalisa] Univ Bologna, Policlin St Orsola Malpighi Hosp, Lalla Seragnoli Dept Pediat, Bologna, Italy; [Poli, Alessandro] Fdn Romeo & Enrica Invernizzi, Ist Nazl Genet Mol, Milan, Italy; [Clissa, Cristina] San Salvatore Hosp, Hematol & Stem Cell Transplant Ctr, Pesaro, Italy; [Cappellini, Alessandra] Univ Cassino, Dept Human Social Sci & Hlth, Cassino, Italy; [Suh, Pann-Ghill] Ulsan Natl Inst Sci & Technol, Sch Life Sci, Ulsan, South Korea; [McCubrey, James A.] East Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC USA	IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Cassino; Ulsan National Institute of Science & Technology (UNIST); University of North Carolina; East Carolina University	Cocco, L; Follo, MY (corresponding author), Univ Bologna, Cellular Signalling Lab, Inst Human Anat, Dipartimento Sci Biomed & NeuroMotorie, Via Irnerio 48, I-40126 Bologna, Italy.	lucio.cocco@unibo.it; matilde.follo@unibo.it	ratti, stefano/AAC-8714-2022; Cocco, Lucio/AAI-2206-2020; Lonetti, Annalisa/AAB-3647-2019; Suh, Pann-Ghill/F-3610-2010	Cocco, Lucio/0000-0002-9206-8277; Lonetti, Annalisa/0000-0002-3944-3090; RATTI, STEFANO/0000-0002-6258-5345; Catozzi, Alessia/0000-0002-7263-5203; Poli, Alessandro/0000-0001-5808-820X	Italian Ministero dell'Istruzione dell'Universita e della Ricerca-Progetti di Ricerca di Interesse Nazionale; Intesa S. Paolo	Italian Ministero dell'Istruzione dell'Universita e della Ricerca-Progetti di Ricerca di Interesse Nazionale; Intesa S. Paolo	This work was supported by grants from the Italian Ministero dell'Istruzione dell'Universita e della Ricerca-Progetti di Ricerca di Interesse Nazionale and Intesa S. Paolo. The authors declare no conflicts of interest.	Bae Yoe-Sik, 2017, Advances in Biological Regulation, V63, P92, DOI 10.1016/j.jbior.2016.09.006; Basiorka AA, 2016, CANCER RES, V76, P3531, DOI 10.1158/0008-5472.CAN-15-1756; Bavelloni A, 2014, ONCOTARGET, V5, P4222, DOI 10.18632/oncotarget.1972; Blalock WL, 2011, LEUKEMIA, V25, P236, DOI 10.1038/leu.2010.264; Buontempo F, 2012, CELL CYCLE, V11, P2467, DOI 10.4161/cc.20859; Cheson BD, 2006, BLOOD, V108, P419, DOI 10.1182/blood-2005-10-4149; Cocco Lucio, 2015, Advances in Biological Regulation, V60, P1, DOI 10.1016/j.jbior.2015.10.008; Cocco L, 2015, J LEUKOCYTE BIOL, V98, P769, DOI 10.1189/jlb.2MA1114-541R; Cocco L, 2015, J LIPID RES, V56, P1853, DOI 10.1194/jlr.R057984; Cocco L, 2010, ADV ENZYME REGUL, V50, P2, DOI 10.1016/j.advenzreg.2009.10.007; Faenza I, 2005, ANTICANCER RES, V25, P2039; Follo MY, 2012, LEUKEMIA, V26, P2474, DOI 10.1038/leu.2012.133; Follo MY, 2012, LEUKEMIA, V26, P943, DOI 10.1038/leu.2011.300; Follo MY, 2011, LEUKEMIA, V25, P271, DOI 10.1038/leu.2010.266; Follo Matilde Y, 2015, Adv Biol Regul, V57, P10, DOI 10.1016/j.jbior.2014.10.004; Follo Matilde Y., 2014, Advances in Biological Regulation, V54, P2, DOI 10.1016/j.jbior.2013.11.003; Follo Matilde Y., 2013, Advances in Biological Regulation, V53, P2, DOI 10.1016/j.jbior.2012.09.009; Follo MY, 2012, CURR PHARM DESIGN, V18, P1751; Follo MY, 2010, J CELL BIOCHEM, V109, P1065, DOI 10.1002/jcb.22483; Follo MY, 2009, P NATL ACAD SCI USA, V106, P16811, DOI 10.1073/pnas.0907109106; Gandhi AK, 2006, LEUKEMIA RES, V30, P849, DOI 10.1016/j.leukres.2006.01.010; Greenberg PL, 2012, BLOOD, V120, P2454, DOI 10.1182/blood-2012-03-420489; Lonetti A, 2014, LEUKEMIA, V28, P1196, DOI 10.1038/leu.2013.369; Manzoli L, 2014, MINI-REV MED CHEM, V14, P873, DOI 10.2174/1389557514666141013125936; Martelli AM, 2005, HISTOL HISTOPATHOL, V20, P1251, DOI 10.14670/HH-20.1251; Mongiorgi S, 2016, EXPERT OPIN THER TAR, V20, P677, DOI 10.1517/14728222.2016.1125885; Mongiorgi S, 2016, CURR PHARM DESIGN, V22, P2345, DOI 10.2174/1381612822666160226132338; Mongiorgi S, 2012, CURR TOP MICROBIOL, V362, P235, DOI 10.1007/978-94-007-5025-8_11; Myklebust JH, 2002, EXP HEMATOL, V30, P990, DOI 10.1016/S0301-472X(02)00868-8; Narla A, 2011, BLOOD, V118, P2296, DOI 10.1182/blood-2010-11-318543; Poli A, 2017, J CELL PHYSIOL, V232, P2550, DOI 10.1002/jcp.25642; Poli A, 2016, J CELL PHYSIOL, V231, P1645, DOI 10.1002/jcp.25273; Poli A, 2014, ONCOTARGET, V5, P11526, DOI 10.18632/oncotarget.2578; Poli A, 2014, BIOCHEM SOC T, V42, P1471, DOI 10.1042/BST20140128; Poli A, 2013, CELL CYCLE, V12, P1713, DOI 10.4161/cc.24806; Ramazzotti Giulia, 2017, Advances in Biological Regulation, V63, P1, DOI 10.1016/j.jbior.2016.10.005; Ramazzotti G, 2011, CRIT REV EUKAR GENE, V21, P291, DOI 10.1615/CritRevEukarGeneExpr.v21.i3.50; Ramazzotti G, 2011, J CELL PHYSIOL, V226, P14, DOI 10.1002/jcp.22334; Ratti S, 2017, J CELL BIOCHEM, V118, P1969, DOI 10.1002/jcb.25894; Stahl M, 2017, CANCER-AM CANCER SOC, V123, P1703, DOI 10.1002/cncr.30585; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262	41	16	20	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					681	692		10.1096/fj.201700690R	http://dx.doi.org/10.1096/fj.201700690R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	28970249	Green Submitted			2022-12-28	WOS:000425146900013
J	Yu, XL; Chen, H; Zuo, C; Jin, X; Yin, YB; Wang, H; Jin, M; Ozato, K; Xu, SX				Yu, Xiaoli; Chen, Hui; Zuo, Chen; Jin, Xi; Yin, Yibing; Wang, Hong; Jin, Mei; Ozato, Keiko; Xu, Songxiao			Chromatin remodeling: demethylating H3K4me3 of type I IFNs gene by Rbp2 through interacting with Piasy for transcriptional attenuation	FASEB JOURNAL			English	Article						histone modification; RNA expression regulation; protein-protein interaction	NF-KAPPA-B; PROTEIN INHIBITOR; GASTRIC-CANCER; HISTONE; ACTIVATION; RECEPTOR; REPRESSION; TRANSACTIVATION; METHYLATION; RECRUITMENT	Type I IFNs (IFNIs) are involved in the course of antiviral and antimicrobial activities; however, robust inductions of these can lead to host immunopathology. We have reported that the Pias (protein inhibitor of activated signal transducer and activator of transcription) family member, Piasy, possesses the ability to suppress IFNI transcriptions in mouse embryonic fibroblasts (MEFs), yet the specific molecular mechanism by which it acts remains elusive. Here, we identify that the H3K4me3 levels, one activation mark of genes, in MEFs that were stimulated by poly(I:C) were impaired by Piasy in the IFN-beta gene. Piasy bound to the promoter region of the IFN-beta gene in MEFs. Meanwhile, retinoblastoma binding protein 2 (Rbp2) was proven to be the only known and novel H3K4me3 demethylase that interacted with Piasy. Overexpression of Rbp2, but not its enzymatically inactive mutant Rbp2(H483G/E485Q), retarded the transcription activities of IFNI, whereas small interfering RNA-mediated or short hairpin RNA-mediated knockdown of Rbp2 enhanced IFNI promoter responses. Above all, coexpression of Piasy and Rbp2 led to statistically less IFNI induction than overexpression of either Piasy or Rbp2 alone. Mechanistically, Piasy bound to the Jmjc domain (451-503 aa) of Rbp2 via its PINIT domain (101-218 aa), which is consistent with the domain required for their attenuation of transcription and H3K4me3 levels of IFNI genes. Our study demonstrates that Piasy may prevent exaggerated transcription of IFNI by Rbp2-mediated demethylation of H3K4me3 of IFNI, avoiding excessive immune responses.	[Yu, Xiaoli; Chen, Hui; Jin, Xi; Jin, Mei; Xu, Songxiao] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Pathol, 3 East Qingchun Rd, Hangzhou 310016, Zhejiang, Peoples R China; [Zuo, Chen; Yin, Yibing; Wang, Hong] Chongqing Med Univ, Minist Educ, Key Lab Diagnost Med Designated, Dept Lab Med, Chongqing, Peoples R China; [Ozato, Keiko] NICHHD, NIH, Bethesda, MD 20892 USA	Zhejiang University; Chongqing Medical University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Xu, SX (corresponding author), Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Pathol, 3 East Qingchun Rd, Hangzhou 310016, Zhejiang, Peoples R China.	xusx1979@hotmail.com	Xu, Songxiao/L-5737-2019	Jin, Xi/0000-0002-2981-8581	National Natural Science Foundation of China [81273315]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001310, ZIAHD008815] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by Grant 81273315 from the National Natural Science Foundation of China. The authors thank Prof. Shuai Ke (University of California, Los Angeles, Los Angeles, CA, USA) for the generous gifts of Pias1<SUP>-/-</SUP>, Pias1<SUP>+/+</SUP>, Pias1<SUP>-/-</SUP>, and Pias1<SUP>+/+</SUP> MEFs. The authors also thank Shu Qiao (Dauntsey's School, West Lavington, United Kingdom) for assistance with English language editing. The authors declare no conflicts of interest.	Ballestar E, 2011, ADV EXP MED BIOL, V711, P1; Black JC, 2011, EPIGENETICS-US, V6, P13, DOI 10.4161/epi.6.1.13331; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Chang TH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000493; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Facompre ND, 2016, CANCER RES, V76, P5538, DOI 10.1158/0008-5472.CAN-15-3377; Fang MM, 2016, BBA-GENE REGUL MECH, V1859, P294, DOI 10.1016/j.bbagrm.2015.11.010; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Ge Z, 2010, FASEB J, V24, P579, DOI 10.1096/fj.09-140087; Gross M, 2004, ONCOGENE, V23, P3059, DOI 10.1038/sj.onc.1207443; Hublitz P, 2009, INT J DEV BIOL, V53, P335, DOI 10.1387/ijdb.082717ph; Huo HR, 2010, CANCER RES, V70, P8726, DOI 10.1158/0008-5472.CAN-10-0755; Kim H, 2009, J BIOL CHEM, V284, P19867, DOI 10.1074/jbc.M109.021485; Kimura H, 2013, J HUM GENET, V58, P439, DOI 10.1038/jhg.2013.66; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Kubota T, 2011, J BIOL CHEM, V286, P8165, DOI 10.1074/jbc.M110.195255; Kurihara I, 2005, J BIOL CHEM, V280, P6721, DOI 10.1074/jbc.M411820200; Kurt-Jones EA, 2004, J ENDOTOXIN RES, V10, P419, DOI 10.1179/096805104225006516; Lao MX, 2016, J IMMUNOL, V196, P596, DOI 10.4049/jimmunol.1403254; Lee JM, 2003, FEBS LETT, V555, P322, DOI 10.1016/S0014-5793(03)01268-7; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li PF, 2012, INFLAMMATION, V35, P1611, DOI 10.1007/s10753-012-9476-z; Liang XM, 2015, ONCOTARGET, V6, P17661, DOI 10.18632/oncotarget.3756; Liberatore RA, 2011, P NATL ACAD SCI USA, V108, P18097, DOI 10.1073/pnas.1113694108; Lloret-Llinares M, 2012, NUCLEIC ACIDS RES, V40, P9493, DOI 10.1093/nar/gks773; Mattei F, 2010, CYTOKINE GROWTH F R, V21, P227, DOI 10.1016/j.cytogfr.2010.05.002; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Naidu SR, 2012, CELL CYCLE, V11, P2717, DOI 10.4161/cc.21091; Nelson V, 2001, APOPTOSIS, V6, P221, DOI 10.1023/A:1011392811628; Nishibuchi G, 2014, J BIOL CHEM, V289, P28956, DOI 10.1074/jbc.M114.573725; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; Patsialou A, 2005, NUCLEIC ACIDS RES, V33, P66, DOI 10.1093/nar/gki145; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Sadakierska-Chudy A, 2015, NEUROTOX RES, V27, P172, DOI 10.1007/s12640-014-9508-6; Salifou K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10174; Seward DJ, 2007, NAT STRUCT MOL BIOL, V14, P240, DOI 10.1038/nsmb1200; Sharrocks AD, 2006, GENE DEV, V20, P754, DOI 10.1101/gad.1421006; Shuai K, 2006, CELL RES, V16, P196, DOI 10.1038/sj.cr.7310027; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Tahk S, 2007, P NATL ACAD SCI USA, V104, P11643, DOI 10.1073/pnas.0701877104; Torikoshi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041186; Tu SJ, 2008, NAT STRUCT MOL BIOL, V15, P419, DOI 10.1038/nsmb.1400; Xia M, 2013, IMMUNITY, V39, P470, DOI 10.1016/j.immuni.2013.08.016; Yoo YS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8910; Zeng JP, 2010, GASTROENTEROLOGY, V138, P981, DOI 10.1053/j.gastro.2009.10.004; Zhang J, 2004, FEBS LETT, V570, P97, DOI 10.1016/j.febslet.2004.05.081; Zhao DZ, 2016, CELL REP, V15, P288, DOI 10.1016/j.celrep.2016.03.035; Zhao D, 2016, ADVANCES IN ENERGY, ENVIRONMENT AND MATERIALS SCIENCE, P29; Zhou MR, 2015, ONCOTARGET, V6, P1249, DOI 10.18632/oncotarget.2859; Zhou S, 2008, J BIOL CHEM, V283, P20137, DOI 10.1074/jbc.M801307200	52	3	3	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					552	567		10.1096/fj.201700088RR	http://dx.doi.org/10.1096/fj.201700088RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	28970247	Bronze, Green Published			2022-12-28	WOS:000425146900003
J	Lachmann, PJ; Lay, E; Seilly, DJ				Lachmann, Peter J.; Lay, Elizabeth; Seilly, David J.			Experimental confirmation of the C3 tickover hypothesis by studies with an Ab (S77) that inhibits tickover in whole serum	FASEB JOURNAL			English	Article						complement; alternative pathway; C3 feedback loop	COMPLEMENT CONVERTASE FORMATION; INACTIVATOR KAF; C-3 CONVERTASE; PATHWAY; ACTIVATION	The complement component 3 (C3) tickover hypothesis was put forward in the early 1970s to account for the spontaneous activation of the alternative complement pathway that occurs after the genetic absence or in vitro depletion of Factor I, the enzyme that is essential for the breakdown of C3b. The hypothesis was widely accepted, but experimental demonstration of the tickover was elusive. A phage Ab against C3b that inhibited the alternative complement pathway, but not the classical pathway, was described in 2009. Studies using this Ab in a variety of assays have now demonstrated that it acts primarily by inhibiting tickover, thereby confirming that tickover really exists.	[Lachmann, Peter J.; Lay, Elizabeth; Seilly, David J.] Univ Cambridge, Dept Vet Med, Madingley Rd, Cambridge CB3 0ES, England	University of Cambridge	Lachmann, PJ (corresponding author), Univ Cambridge, Dept Vet Med, Madingley Rd, Cambridge CB3 0ES, England.	pjl1000@cam.ac.uk	Lachmann, P J/I-7968-2019	Lachmann, P J/0000-0003-2849-3524	Gyroscope Therapeutics (London, United Kingdom)	Gyroscope Therapeutics (London, United Kingdom)	Some financial contribution was made towards this work by Gyroscope Therapeutics (London, United Kingdom). The authors acknowledge the invaluable secretarial help of Barbara King (University of Cambridge) in the preparation of this paper, and Scott Stawicki, Kenneth Katschke, and Menno van Lookeren Campagne (all from Genentech, Inc., San Francisco, CA, USA) for generating S77. The authors declare no conflicts of interest.	ABRAMSON N, 1971, J IMMUNOL, V107, P19; ALPER CA, 1970, J CLIN INVEST, V49, P1975, DOI 10.1172/JCI106417; Bexborn F, 2008, MOL IMMUNOL, V45, P2370, DOI 10.1016/j.molimm.2007.11.003; FISHELSON Z, 1982, J IMMUNOL, V129, P2603; Forneris F, 2010, SCIENCE, V330, P1816, DOI 10.1126/science.1195821; Gordon J, 1926, BIOCHEM J, V20, P1028, DOI 10.1042/bj0201028; Janssen BJC, 2009, EMBO J, V28, P2469, DOI 10.1038/emboj.2009.184; Katschke KJ, 2009, J BIOL CHEM, V284, P10473, DOI 10.1074/jbc.M809106200; Lachmann PJ, 2016, CLIN EXP IMMUNOL, V183, P150, DOI 10.1111/cei.12714; Lachmann P. J., 1974, SCHER S IMM 1973 PER, V12, P262; Lachmann PJ, 2009, ADV IMMUNOL, V104, P115, DOI 10.1016/S0065-2776(08)04004-2; LACHMANN PJ, 1980, IMMUNOLOGY, V41, P503; LACHMANN PJ, 1975, CLIN EXP IMMUNOL, V21, P109; NICOL PAE, 1973, IMMUNOLOGY, V24, P259; Nilsson B, 2012, IMMUNOBIOLOGY, V217, P1106, DOI 10.1016/j.imbio.2012.07.008; PANGBURN MK, 1981, J EXP MED, V154, P856, DOI 10.1084/jem.154.3.856; Weir D.M., 1978, HDB EXPT IMMUNOLOGY	17	18	18	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					123	129		10.1096/fj.201700734	http://dx.doi.org/10.1096/fj.201700734			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28855277				2022-12-28	WOS:000419172700013
J	Zhang, J; Shi, KB; Li, ZG; Li, MS; Han, YJ; Wang, L; Zhang, ZC; Yu, CL; Zhang, F; Song, LJ; Dong, JF; La Cava, A; Sheth, KN; Shi, FD				Zhang, Jing; Shi, Kaibin; Li, Zhiguo; Li, Minshu; Han, Yujuan; Wang, Lei; Zhang, Zhecheng; Yu, Changlu; Zhang, Fang; Song, Lijuan; Dong, Jing-Fei; La Cava, Antonio; Sheth, Kevin N.; Shi, Fu-Dong			Organ- and cell-specific immune responses are associated with the outcomes of intracerebral hemorrhage	FASEB JOURNAL			English	Article						hemorrhagic brain injury; immunosuppression; spleen; infection	ISCHEMIC-STROKE; INJURY; INFECTION; BRAIN; COMPLICATIONS; FINGOLIMOD; MECHANISMS; SPLEEN; SIZE	Severe brain injury significantly influences immune responses; however, the levels at which this influence occurs and which neurogenic pathways are involved are not well defined. Here, we used MRI to measure spleen volume and tissue diffusion changes in patients with intracerebral hemorrhage (ICH). We observed increased capillary exchange and spleen shrinkage by d 3 post-ICH, with recovery by d 14. The extent of spleen shrinkage was associated with brain hematoma size, and a reduced progression of perihematomal edema was observed in the presence of severe spleen shrinkage. At the cellular level, lymphopenia was present in patients with ICH at admission and persisted up to 14 d. Lymphopenia did not parallel the observed spleen alteration. In addition, patients with ICH with infection had significant deficiencies of T and NK cells and poor functional outcomes. Finally, in mouse models of ICH, spleen shrinkage could be related to innervations from adrenergic input and the hypothalamus-pituitary-adrenal (HPA) axis. In sum, the profound impact of ICH on the immune system involves the coordinated actions of sympathetic innervation and the HPA axis, which modulate spleen shrinkage and cellular immunity.	[Zhang, Jing; Shi, Kaibin; Li, Minshu; Zhang, Fang; Shi, Fu-Dong] Tianjin Med Univ, Tianjin Neurol Inst, Dept Neurol, Gen Hosp, Tianjin, Peoples R China; [Zhang, Jing; Han, Yujuan; Wang, Lei; Zhang, Zhecheng; Yu, Changlu] Tianjin Third Cent Hosp, Dept Neurol, Tianjin, Peoples R China; [Zhang, Jing; Han, Yujuan; Wang, Lei; Zhang, Zhecheng; Yu, Changlu] Tianjin Third Cent Hosp, Dept Radiol, Tianjin, Peoples R China; [Shi, Kaibin; Li, Zhiguo; Li, Minshu; Shi, Fu-Dong] St Josephs Hosp, Barrow Neurol Inst, Dept Neurol, Phoenix, AZ USA; [Song, Lijuan] Shanxi Univ Tradit Chinese Med, Collaborat Innovat Ctr 2011, Neurobiol Res Ctr, Taiyuan, Shanxi, Peoples R China; [Dong, Jing-Fei] Univ Washington, Sch Med, Dept Med, Div Hematol,Bloodworks Res Inst, Seattle, WA 98195 USA; [La Cava, Antonio] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Sheth, Kevin N.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA	Tianjin Medical University; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Yale University	Shi, FD (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurol, Tianjin 300052, Peoples R China.	fshi66@gmail.com	/AAG-9576-2020	/0000-0002-8839-0933	National Basic Research Program of China [2013CB966900]; National Science Foundation of China [81230028, 81301044, 81471535]; Key Project of Tianjin Health Industry [14KG110]; American Heart Association [16SDG27250236]; U.S. National Institutes of Health National Institute of Neurological Disorders and Stroke [R01NS092713]; National Multiple Sclerosis Society [RG-1507-05318]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS092713] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Tianjin Health Industry; American Heart Association(American Heart Association); U.S. National Institutes of Health National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank the patients and healthy volunteers who participated in the study, P. Minick (PM Publications, La Jolla, CA, USA) for editorial assistance, and Dr. Q. Liu (Barrow Neurological Institute) for technical support. This work was supported, in part, by National Basic Research Program of China (Grant 2013CB966900), the National Science Foundation of China (Grants 81230028, 81301044, and 81471535), the Key Project of Tianjin Health Industry 14KG110, the American Heart Association (Grant 16SDG27250236), the U.S. National Institutes of Health National Institute of Neurological Disorders and Stroke (Grant R01NS092713), and the National Multiple Sclerosis Society (Grant RG-1507-05318). The authors declare no conflicts of interest.	Ali M, 2009, EUR J NEUROL, V16, P624, DOI 10.1111/j.1468-1331.2009.02559.x; Diedler J, 2009, CEREBROVASC DIS, V27, P272, DOI 10.1159/000199465; Dyvorne HA, 2013, RADIOLOGY, V266, P920, DOI 10.1148/radiol.12120686; Engel O, 2015, STROKE, V46, P3232, DOI 10.1161/STROKEAHA.115.008989; Fritzsche KH, 2012, METHOD INFORM MED, V51, P441, DOI 10.3414/ME11-02-0031; Fu Y, 2015, NAT REV NEUROL, V11, P524, DOI 10.1038/nrneurol.2015.144; Fu Y, 2014, JAMA NEUROL, V71, P1092, DOI 10.1001/jamaneurol.2014.1065; Giede-Jeppe A, 2016, STROKE, V47, P1239, DOI 10.1161/STROKEAHA.116.013003; Hammond MD, 2014, J NEUROSCI, V34, P3901, DOI 10.1523/JNEUROSCI.4070-13.2014; Illanes S, 2011, NEUROSCI LETT, V490, P170, DOI 10.1016/j.neulet.2010.11.065; Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Li M., 2016, J CEREB BLOOD FLOW M, V37, P2383; Li YJ, 2015, NEUROSCI BULL, V31, P755, DOI 10.1007/s12264-015-1532-2; Liesz A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074839; Liu Q, 2017, IMMUNITY, V46, P474, DOI 10.1016/j.immuni.2017.02.015; Liu Q, 2016, NAT NEUROSCI, V19, P243, DOI 10.1038/nn.4211; Lord AS, 2016, STROKE, V47, P1768, DOI 10.1161/STROKEAHA.116.013229; Lord AS, 2014, STROKE, V45, P3535, DOI 10.1161/STROKEAHA.114.006435; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Morotti A, 2017, NEUROCRIT CARE, V26, P160, DOI 10.1007/s12028-016-0367-2; Mracsko E, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00388; Mracsko E, 2014, STROKE, V45, P2107, DOI 10.1161/STROKEAHA.114.005801; Ohwaki K, 2008, NEUROCRIT CARE, V8, P271, DOI 10.1007/s12028-007-9007-1; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Sahota P, 2013, INT J STROKE, V8, P60, DOI 10.1111/ijs.12022; Sun N, 2016, STROKE, V47, P1899, DOI 10.1161/STROKEAHA.115.012236; Sykora M, 2011, STROKE, V42, P1218, DOI 10.1161/STROKEAHA.110.604637; Taylor RA, 2017, J CLIN INVEST, V127, P280, DOI 10.1172/JCI88647; Urday S, 2015, NAT REV NEUROL, V11, P111, DOI 10.1038/nrneurol.2014.264; Vahidy FS, 2016, J CEREBR BLOOD F MET, V36, P1012, DOI 10.1177/0271678X15607880; Walsh KB, 2015, STROKE, V46, P2302, DOI 10.1161/STROKEAHA.115.009880; Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110; Wurnig MC, 2015, MAGN RESON MED, V74, P1414, DOI 10.1002/mrm.25506; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Yu H, 2013, INT J STROKE, V8, pE57, DOI 10.1111/ijs.12175	38	38	40	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					220	229		10.1096/fj.201700324R	http://dx.doi.org/10.1096/fj.201700324R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28877956	Green Published			2022-12-28	WOS:000419172700021
J	Zhang, WW; Xu, J; Fang, HH; Tang, L; Chen, WW; Sun, Q; Zhang, Q; Yang, F; Sun, ZJ; Cao, LL; Wang, YC; Guan, XX				Zhang, Wenwen; Xu, Jing; Fang, Hehui; Tang, Lin; Chen, Weiwei; Sun, Qian; Zhang, Qun; Yang, Fang; Sun, Zijia; Cao, Lulu; Wang, Yucai; Guan, Xiaoxiang			Endothelial cells promote triple-negative breast cancer cell metastasis via PAI-1 and CCL5 signaling	FASEB JOURNAL			English	Article						tumor microenvironment; chemokine; migration; invasion; targeting therapy	PLASMINOGEN-ACTIVATOR INHIBITOR-1; GESTATIONAL DIABETES-MELLITUS; TUMOR ANGIOGENESIS; SECRETED FACTORS; PHENOTYPE; DISEASE; MICROENVIRONMENT; EXPRESSION; APOPTOSIS; PLASMA	Endothelial cells (ECs) in the tumor microenvironment have been reported to play a more active role in solid tumor growth and metastatic dissemination than simply providing the physical structure to form conduits for blood flow; however, the involvement of ECs in the process of triple-negative breast cancer (TNBC) metastasis has not been addressed. Here, we demonstrate that ECs-when mixed with TNBC cells-could increase TNBC cell metastatic potency. After treatment with TGF-beta to induce endothelial-mesenchymal transition (EMT), TNBC cells could produce plasminogen activator inhibitor-1 (PAI-1) and stimulate the expression and secretion of the chemokine, CCL5, from ECs, which then acts in a paracrine fashion on TNBCcells to enhance their migration, invasion, and metastasis. CCL5, in turn, accelerates TNBC cell secretion of PAI-1 and promotes TNBC cell metastasis, thus forming a positive feedback loop. Moreover, this enhanced metastatic ability is reversible and dependent on CCL5 signaling via the chemokine receptor, CCR5. Of importance, key features of this pathway are manifested in patients with TNBC and in The Cancer Genome Atlas database. Taken together, our results suggest that ECs enhance EMT-induced TNBC cell metastasis via PAI-1 and CCL5 signaling and illustrate the potential of developing new PAI-1-and CCL5-targeting therapy for patients with TNBC.	[Zhang, Wenwen] Nanjing Med Univ, Nanjing Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Xu, Jing; Guan, Xiaoxiang] Nanjing Med Univ, Jinling Hosp, Dept Med Oncol, 305 Zhongshan East Rd, Nanjing 210002, Jiangsu, Peoples R China; [Zhang, Wenwen; Fang, Hehui; Tang, Lin; Chen, Weiwei; Sun, Qian; Zhang, Qun; Yang, Fang; Sun, Zijia; Cao, Lulu; Guan, Xiaoxiang] Nanjing Univ, Jinling Hosp, Dept Med Oncol, Med Sch, Nanjing, Jiangsu, Peoples R China; [Wang, Yucai] Rutgers New Jersey Med Sch, Dept Med, Newark, NJ USA	Nanjing Medical University; Nanjing Medical University; Nanjing University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Guan, XX (corresponding author), Nanjing Med Univ, Jinling Hosp, Dept Med Oncol, 305 Zhongshan East Rd, Nanjing 210002, Jiangsu, Peoples R China.	xguan@nju.edu.cn	Zhang, Wenwen/ABF-4970-2021	Zhang, Wenwen/0000-0003-1285-3118; Guan, Xiaoxiang/0000-0001-6145-0046	National Natural Science Foundation of China [81470357]; Foundation for Clinical Medicine Science and Technology Special Project of the Jiangsu Province [BL2014071]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Clinical Medicine Science and Technology Special Project of the Jiangsu Province	This study was supported by National Natural Science Foundation of China (Grant 81470357) and the Foundation for Clinical Medicine Science and Technology Special Project of the Jiangsu Province (Grant BL2014071). The authors declare no conflicts of interest.	Bajou K, 2008, CANCER CELL, V14, P324, DOI 10.1016/j.ccr.2008.08.012; Barbie TU, 2014, J CLIN INVEST, V124, P5411, DOI 10.1172/JCI75661; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Catalano V, 2013, SEMIN CANCER BIOL, V23, P522, DOI 10.1016/j.semcancer.2013.08.007; D'Esposito V, 2016, ONCOTARGET, V7, P24495, DOI 10.18632/oncotarget.8336; Dano K, 2005, THROMB HAEMOSTASIS, V93, P676, DOI 10.1160/TH05-01-0054; Declerck PJ, 2013, SEMIN THROMB HEMOST, V39, P356, DOI 10.1055/s-0033-1334487; Fertig EJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep12133; Franciszkiewicz K, 2012, CANCER RES, V72, P6325, DOI 10.1158/0008-5472.CAN-12-2027; Galan-Moya EM, 2011, EMBO REP, V12, P470, DOI 10.1038/embor.2011.39; Ghiabi P, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0386-3; Irvin WJ, 2008, EUR J CANCER, V44, P2799, DOI 10.1016/j.ejca.2008.09.034; Isogai C, 2001, CANCER RES, V61, P5587; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Khalid A, 2015, MINI-REV MED CHEM, V15, P1063, DOI 10.2174/138955751513150923094709; Laubli H, 2009, BLOOD, V114, P4583, DOI 10.1182/blood-2008-10-186585; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Lee E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5715; Liu GT, 2015, CANCER LETT, V357, P476, DOI 10.1016/j.canlet.2014.11.015; Lu J, 2013, CANCER CELL, V23, P171, DOI 10.1016/j.ccr.2012.12.021; Maishi N, 2016, SCI REP-UK, V6, DOI 10.1038/srep28039; Miao ZJ, 2016, PROTEOM CLIN APPL, V10, P1122, DOI 10.1002/prca.201600046; Niwa Y, 2001, CLIN CANCER RES, V7, P285; Pepper MS, 2001, ARTERIOSCL THROM VAS, V21, P1104, DOI 10.1161/hq0701.093685; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Reymond N, 2013, NAT REV CANCER, V13, P858, DOI 10.1038/nrc3628; Suarez-Carmona M, 2015, J PATHOL, V236, P491, DOI 10.1002/path.4546; Sun LC, 2016, AM J CANCER RES, V6, P2277; Sun Y, 2015, MOL CELL PROTEOMICS, V14, P1265, DOI 10.1074/mcp.M114.046946; Szasz AM, 2016, ONCOTARGET, V7, P49322, DOI 10.18632/oncotarget.10337; Tan AR, 2008, CANCER J, V14, P343, DOI 10.1097/PPO.0b013e31818d839b; Tang S, 2016, CANCER LETT, V376, P137, DOI 10.1016/j.canlet.2016.03.034; Velasco-Velazquez M, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23660; Velasco-Velazquez M, 2012, CANCER RES, V72, P3839, DOI 10.1158/0008-5472.CAN-11-3917; Virally M, 2010, DIABETES METAB, V36, P549, DOI 10.1016/j.diabet.2010.11.008; Witzel Isabell, 2014, Onco Targets Ther, V7, P2205, DOI 10.2147/OTT.S65344; Yaal-Hahoshen N, 2006, CLIN CANCER RES, V12, P4474, DOI 10.1158/1078-0432.CCR-06-0074; Zemzoum I, 2003, J CLIN ONCOL, V21, P1022, DOI 10.1200/JCO.2003.04.170; Zhang W., 2016, SCI REP, V6, P1, DOI DOI 10.1038/S41598-016-0001-8; Zhang WW, 2016, CELL CYCLE, V15, P1344, DOI 10.1080/15384101.2016.1160986; Zhang WW, 2015, ONCOTARGET, V6, P7608, DOI 10.18632/oncotarget.3263	44	51	54	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					276	+		10.1096/fj.201700237RR	http://dx.doi.org/10.1096/fj.201700237RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28899878				2022-12-28	WOS:000419172700026
J	Cappellari, GG; Semolic, A; Ruozi, G; Vinci, P; Guarnieri, G; Bortolotti, F; Barbetta, D; Zanetti, M; Giacca, M; Barazzoni, R				Cappellari, Gianluca Gortan; Semolic, Annamaria; Ruozi, Giulia; Vinci, Pierandrea; Guarnieri, Gianfranco; Bortolotti, Francesca; Barbetta, Davide; Zanetti, Michela; Giacca, Mauro; Barazzoni, Rocco			Unacylated ghrelin normalizes skeletal muscle oxidative stress and prevents muscle catabolism by enhancing tissue mitophagy in experimental chronic kidney disease	FASEB JOURNAL			English	Article						autophagy; uremia; mitochondria	INSULIN-RESISTANCE; P38 MAPK; INFLAMMATION; METABOLISM; EXPRESSION; AUTOPHAGY; PATHWAY; LIVER; HYPERGLYCEMIA; TRANSDUCTION	Unacylated ghrelin (UnAG) may lower skeletal muscle oxidative stress, inflammation, and insulin resistance in lean and obese rodents. UnAG-induced autophagy activation may contribute to these effects, likely involving removal of dysfunctional mitochondria (mitophagy) and redox state maintenance. In chronic kidney disease (CKD) oxidative stress, inflammation and insulin resistance may negatively influence patient outcome by worsening nutritional state throughmusclemass loss. Herewe showin a 5/ 6 nephrectomy (Nx) CKDratmodel that 4ds. c. UnAG administration (200mg twice aday) normalizes CKD-induced loss of gastrocnemius muscle mass and a cluster of high tissue mitochondrial reactive oxygen species generation, high proinflammatory cytokines, and low insulin signaling activation. Consistent with these results, human uremic serum enhanced mitochondrial reactive oxygen species generation and lowered insulin signaling activation in C2C12 myotubes while concomitant UnAG incubation completely prevented these effects. Importantly, UnAG enhanced muscle mitophagy in vivo and silencing RNA-mediated autophagy protein 5 silencing blocked UnAG activities in myotubes. UnAG therefore normalizes CKD-induced skeletal muscle oxidative stress, inflammation, and low insulin signaling as well as muscle loss. UnAG effects are mediated by autophagy activation at the mitochondrial level. UnAG administration and mitophagy activation are novel potential therapeutic strategies for skeletal muscle metabolic abnormalities and their negative clinical impact in CKD.-Gortan Cappellari, G., Semolic, A., Ruozi, G., Vinci, P., Guarnieri, G., Bortolotti, F., Barbetta, D., Zanetti, M., Giacca, M., Barazzoni, R. Unacylated ghrelin normalizes skeletal muscle oxidative stress and prevents muscle catabolism by enhancing tissue mitophagy in experimental chronic kidney disease.	[Cappellari, Gianluca Gortan; Semolic, Annamaria; Vinci, Pierandrea; Guarnieri, Gianfranco; Zanetti, Michela; Barazzoni, Rocco] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Barbetta, Davide] Univ Trieste, Anim Facil, Trieste, Italy; [Ruozi, Giulia; Bortolotti, Francesca; Giacca, Mauro] Int Ctr Genet Engn & Biotechnol, Mol Med Lab, Trieste, Italy	University of Trieste; University of Trieste; International Center for Genetic Engineering & Biotechnology (ICGEB)	Barazzoni, R (corresponding author), Univ Trieste, Dept Med Surg & Hlth Sci, Osped Cattinara, Str Fiume 447, I-34149 Trieste, Italy.	barazzon@units.it	; GIACCA, MAURO/J-9287-2016	ZANETTI, MICHELA/0000-0002-2634-6363; GIACCA, MAURO/0000-0003-2927-7225; Gortan Cappellari, Gianluca/0000-0002-0438-5003	European Society for Clinical Nutrition and Metabolism (ESPEN)	European Society for Clinical Nutrition and Metabolism (ESPEN)	The authors thank M. Stebel and R. Munao (both from the University of Trieste), for excellent assistance in in vivo procedures; G. Spirito (University of Trieste) and A. Falcione (International Centre for Genetic Engineering and Biotechnology, Trieste, Italy) are acknowledged for their skillful technical assistance in ex vivo and in vitro experiments. This work was supported, in part, by the European Society for Clinical Nutrition and Metabolism (ESPEN) through a fellowship to G.G.C. Presented, in part, in abstract form at ESPEN congresses in 2015 and 2016. The authors declare no conflicts of interest.	Barazzoni R, 2005, AM J PHYSIOL-ENDOC M, V288, pE228, DOI 10.1152/ajpendo.00115.2004; Barazzoni R, 2004, CURR OPIN CLIN NUTR, V7, P97, DOI 10.1097/00075197-200401000-00015; Barazzoni R, 2012, DIABETOLOGIA, V55, P773, DOI 10.1007/s00125-011-2396-x; Barazzoni R, 2008, CLIN NUTR, V27, P142, DOI 10.1016/j.clnu.2007.06.013; Barazzoni R, 2007, OBESITY, V15, P2614, DOI 10.1038/oby.2007.313; Barazzoni R, 2006, AM J PHYSIOL-ENDOC M, V291, pE428, DOI 10.1152/ajpendo.00225.2006; Barazzoni R, 2012, J RENAL NUTR, V22, P171, DOI 10.1053/j.jrn.2011.10.017; Barazzoni R, 2010, KIDNEY INT, V77, P23, DOI 10.1038/ki.2009.411; Broglio F, 2001, J CLIN ENDOCR METAB, V86, P5083, DOI 10.1210/jc.86.10.5083; Byun JY, 2009, CARCINOGENESIS, V30, P1880, DOI 10.1093/carcin/bgp235; Cantarin MPM, 2014, NEPHROL DIAL TRANSPL, V29, P2268, DOI 10.1093/ndt/gfu249; Cappellari GG, 2016, DIABETES, V65, P874, DOI 10.2337/db15-1019; Chen CY, 2009, PHARMACOL REV, V61, P430, DOI 10.1124/pr.109.001958; Crowe AV, 2007, NEPHROL DIAL TRANSPL, V22, P1177, DOI 10.1093/ndt/gfl721; Enoki Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep32084; Filiopoulos V, 2009, INT J ARTIF ORGANS, V32, P872, DOI 10.1177/039139880903201206; FOLLI F, 1986, METABOLISM, V35, P989, DOI 10.1016/0026-0495(86)90034-X; FRIEDMAN JE, 1991, AM J PHYSIOL, V261, pE87, DOI 10.1152/ajpendo.1991.261.1.E87; Gao X, 2010, BRIT J NUTR, V103, P608, DOI 10.1017/S0007114509992108; Guarnieri G, 2009, J RENAL NUTR, V19, P20, DOI 10.1053/j.jrn.2008.11.014; Holecek M, 2012, INT J EXP PATHOL, V93, P157, DOI 10.1111/j.1365-2613.2012.00812.x; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; Keren A, 2006, MOL CELL ENDOCRINOL, V252, P224, DOI 10.1016/j.mce.2006.03.017; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Koppe L, 2014, NEPHROL DIAL TRANSPL, V29, P1666, DOI 10.1093/ndt/gft435; Kovesdy CP, 2009, SEMIN NEPHROL, V29, P3, DOI 10.1016/j.semnephrol.2008.10.002; Li YP, 2005, FASEB J, V19, P362, DOI 10.1096/fj.04-2364com; Lovric J, 2012, MOL THER, V20, P2087, DOI 10.1038/mt.2012.144; Meyer TW, 2007, NEW ENGL J MED, V357, P1316, DOI 10.1056/NEJMra071313; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Muller TD, 2015, MOL METAB, V4, P437, DOI 10.1016/j.molmet.2015.03.005; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Nishikawa M, 2015, NEPHROL DIAL TRANSPL, V30, P934, DOI 10.1093/ndt/gfv103; Ruozi G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8388; Ryter SW, 2014, CURR OPIN CLIN NUTR, V17, P329, DOI 10.1097/MCO.0000000000000068; Sandri M, 2013, INT J BIOCHEM CELL B, V45, P2121, DOI 10.1016/j.biocel.2013.04.023; Sarparanta J, 2017, CURR DIABETES REV, V13, P352, DOI 10.2174/1573399812666160217122530; SATO E, 2016, SCI REP, V6; Stenvinkel P, 1999, KIDNEY INT, V55, P1899, DOI 10.1046/j.1523-1755.1999.00422.x; Tong XX, 2012, PEPTIDES, V38, P217, DOI 10.1016/j.peptides.2012.06.020; Verzola D, 2017, J CACHEXIA SARCOPENI, V8, P131, DOI 10.1002/jcsm.12129; Wang DT, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/684965; Wang XNH, 2014, NAT REV NEPHROL, V10, P504, DOI 10.1038/nrneph.2014.112; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Workeneh BT, 2006, J AM SOC NEPHROL, V17, P3233, DOI 10.1681/ASN.2006020131; Workeneh BT, 2010, AM J CLIN NUTR, V91, p1128S, DOI 10.3945/ajcn.2010.28608B; Yamamoto N, 2010, ANAL BIOCHEM, V404, P238, DOI 10.1016/j.ab.2010.05.012; Yao ZY, 2016, AUTOPHAGY, V12, P1971, DOI 10.1080/15548627.2016.1235127; Yu M, 2003, J PHYSIOL-LONDON, V546, P327, DOI 10.1113/jphysiol.2002.034223; Zanetti M, 2008, J RENAL NUTR, V18, P70, DOI 10.1053/j.jrn.2007.10.015; Zhang Q, 2015, NAT IMMUNOL, V16, P458, DOI 10.1038/ni.3130	51	20	20	2	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5159	+		10.1096/fj.201700126R	http://dx.doi.org/10.1096/fj.201700126R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28778977	Green Submitted			2022-12-28	WOS:000416588300004
J	Mizugishi, K; Yamashita, K				Mizugishi, Kiyomi; Yamashita, Kouhei			Neutrophil extracellular traps are critical for pregnancy loss in sphingosine kinase-deficient mice on 129Sv/C57BL/6 background	FASEB JOURNAL			English	Article						DSC; histone citrullination; innate immunity; peptidylarginine deiminase; sphingolipid	SYSTEMIC-LUPUS-ERYTHEMATOSUS; FUNCTIONAL-CHARACTERIZATION; MOLECULAR-CLONING; THROMBOSIS; ACTIVATION; SPHINGOSINE-1-PHOSPHATE; PREECLAMPSIA; 1-PHOSPHATE; CERAMIDE; DISEASE	Exaggerated maternal immune responses must be strictly controlled to ensure a successful pregnancy. Neutrophil extracellular traps (NETs) have recently been implicated as a potential mechanism for promoting inflammation in pregnancy-related disorders. In this study, we demonstrated that NETs play a key role in the pathogenesis of sphingosine kinase (Sphk)-mediated pregnancy loss. Perturbing the sphingolipid pathway by disrupting Sphk genes during pregnancy led to excessive NET formation exclusively at the fetomaternal interface and early fetal death. Neutrophils that formed NETs were characterized by histone hypercitrullination and peptidylarginine deiminase 4 (PAD4) overexpression. In addition, thrombus formation was enhanced in the decidua, but not in the plasma, of Sphk-deficient mice. Blocking NET formation with a PAD4 inhibitor protected Sphk-deficient mice from pregnancy loss. The PAD4 inhibition significantly reduced the expression of hypercitrullinated histone inneutrophils and ameliorated vascular injury in the decidua of Sphk-deficient mice. Moreover, NET formation was induced in human neutrophils stimulated with Sphk-deficient human decidual cells. Together, these findings indicate that targeting NETs might be a novel therapeutic strategy to treat idiopathic pregnancy loss in humans.	[Mizugishi, Kiyomi; Yamashita, Kouhei] Kyoto Univ Hosp, Dept Hematol & Oncol, Kyoto, Japan	Kyoto University	Mizugishi, K (corresponding author), Kyoto Univ Hosp, Dept Hematol & Oncol, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	kiyomim@kuhp.kyoto-u.ac.jp			Japan Society for the Promotion of Science [15K09711, 15K09499]; Grants-in-Aid for Scientific Research [15K09711] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank H. Kohda and K. Furuta (Center for Anatomical Studies, Graduate School of Medicine, Kyoto University, Kyoto, Japan) for technical assistance. This work was supported, in part, by grants-in-aid for scientific research from the Japan Society for the Promotion of Science (15K09711 to K.M. and 15K09499 to K.Y.). The authors declare no conflicts of interest.	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Arai Y, 2013, BIOL BLOOD MARROW TR, V19, P1683, DOI 10.1016/j.bbmt.2013.09.005; Brill A, 2012, J THROMB HAEMOST, V10, P136, DOI 10.1111/j.1538-7836.2011.04544.x; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brunnert D, 2014, MOL HUM REPROD, V20, P1016, DOI 10.1093/molehr/gau051; Carmona-Rivera C, 2015, ANN RHEUM DIS, V74, P1417, DOI 10.1136/annrheumdis-2013-204837; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Dobierzewska A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175118; Dobierzewska A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157221; Edsall LC, 1998, BIOCHEMISTRY-US, V37, P12892, DOI 10.1021/bi980744d; El-Benna J, 2016, IMMUNOL REV, V273, P180, DOI 10.1111/imr.12447; Erpenbeck L, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.140293; Fuchs TA, 2012, ARTERIOSCL THROM VAS, V32, P1777, DOI 10.1161/ATVBAHA.111.242859; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Girardi G, 2004, J CLIN INVEST, V113, P646, DOI 10.1172/JCI200418817C1; Gupta AK, 2005, HUM IMMUNOL, V66, P1146, DOI 10.1016/j.humimm.2005.11.003; Gupta AK, 2010, FEBS LETT, V584, P3193, DOI 10.1016/j.febslet.2010.06.006; Hahn S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00362; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Kan R, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-19; Khandpur R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005580; Kim JW, 2005, BIOORGAN MED CHEM, V13, P3475, DOI 10.1016/j.bmc.2005.02.053; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Lewis HD, 2016, CURR OPIN CHEM BIOL, V33, P169, DOI 10.1016/j.cbpa.2016.06.020; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Melland-Smith M, 2015, AUTOPHAGY, V11, P653, DOI 10.1080/15548627.2015.1034414; Meng H, 2017, ARTHRITIS RHEUMATOL, V69, P655, DOI 10.1002/art.39938; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Mizugishi K, 2007, J CLIN INVEST, V117, P2993, DOI 10.1172/JCI30674; Mizugishi K, 2015, J BIOL CHEM, V290, P2053, DOI 10.1074/jbc.M114.628867; Neeli I, 2008, J IMMUNOL, V180, P1895, DOI 10.4049/jimmunol.180.3.1895; Proia RL, 2015, J CLIN INVEST, V125, P1379, DOI 10.1172/JCI76369; Pyne Nigel J., 2015, Advances in Biological Regulation, V60, P151, DOI 10.1016/j.jbior.2015.09.001; Redecha P, 2008, J CLIN INVEST, V118, P3453, DOI 10.1172/JCI36089; Redecha P, 2007, BLOOD, V110, P2423, DOI 10.1182/blood-2007-01-070631; Sokolove J, 2013, ARTHRITIS RHEUM-US, V65, P1719, DOI 10.1002/art.37961; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Warnatsch A, 2015, SCIENCE, V349, P316, DOI 10.1126/science.aaa8064; Yalavarthi S, 2015, ARTHRITIS RHEUMATOL, V67, P2990, DOI 10.1002/art.39247; Zemann B, 2006, BLOOD, V107, P1454, DOI 10.1182/blood-2005-07-2628	43	15	15	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5577	5591		10.1096/fj.201700399RR	http://dx.doi.org/10.1096/fj.201700399RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28842426				2022-12-28	WOS:000416588300038
J	Jing, H; Liao, L; Su, XX; Shuai, Y; Zhang, XJ; Deng, ZH; Jin, Y				Jing, Huan; Liao, Li; Su, Xiaoxia; Shuai, Yi; Zhang, Xinjing; Deng, Zhihong; Jin, Yan			Declining histone acetyltransferase GCN5 represses BMSC-mediated angiogenesis during osteoporosis	FASEB JOURNAL			English	Article						mesenchymal stem cell; Kat2a; vascular formation; bone mass loss	MESENCHYMAL STEM-CELLS; BONE-MARROW; OSTEOGENIC DIFFERENTIATION; VESSEL; REGENERATION; ACETYLATION; EXPRESSION; PROMOTER; MODEL; AGE	Angiogenesis is disrupted in age-related and postmenopausal osteoporosis. However, the mechanisms of the disorder remain elusive. We confirmed in this study that, in accordance with the decrease of H-type vessels, the proangiogenic potential of bone marrow-derived mesenchymal stem cells (BMSCs) declined during osteoporosis. Screening of the histone acetyltransferase family revealed that GCN5 decreased in BMSCs derived from osteoporotic femur. Further analysis identified that GCN5 plays important roles in regulating the proangiogenic potential of BMSCs. GCN5 promoted BMSC-mediated angiogenesis by enhancing H3K9ac levels on the promoter of Vegf. The decrease of GCN5 in osteoporotic BMSCs led to the decline of proangiogenic capacity. Accordingly, overexpression of GCN5 enhanced the proangiogenic potency of osteoporotic BMSCs. Furthermore, recovering GCN5 expression in vivo by lentiviral expression vector significantly attenuated the loss of angiogenesis in ovariectomized mouse femurs. Our study results revealed an epigenetic mechanism controlling BMSC-mediated angiogenesis and provided a novel therapeutic target for osteoporosis treatment.-Jing, H., Liao, L., Su, X., Shuai, Y. Zhang, X., Deng, Z., Jin, Y. Declining histone acetyltransferase GCN5 represses BMSC-mediated angiogenesis during osteoporosis.	[Jing, Huan; Liao, Li; Shuai, Yi; Jin, Yan] Fourth Mil Med Univ, State Key Lab Mil Stomatol, Xian, Shaanxi, Peoples R China; [Jing, Huan; Liao, Li; Shuai, Yi; Jin, Yan] Fourth Mil Med Univ, Natl Clin Res Ctr Oral Dis, Xian, Peoples R China; [Jing, Huan; Liao, Li; Shuai, Yi; Jin, Yan] Fourth Mil Med Univ, Sch Stomatol, Shaanxi Int Joint Res Ctr Oral Dis, Ctr Tissue Engn, Xian, Peoples R China; [Deng, Zhihong] Fourth Mil Med Univ, Dept Otolaryngol, Xijing Hosp, Xian, Shaanxi, Peoples R China; [Jing, Huan; Liao, Li; Shuai, Yi; Jin, Yan] Xian Inst Tissue Engn & Regenerat Med, Xian, Shaanxi, Peoples R China; [Su, Xiaoxia] Xi An Jiao Tong Univ, Coll Stomatol, Key Lab Shaanxi Prov Craniofacial Precis Med Res, Xian, Shaanxi, Peoples R China; [Zhang, Xinjing] Chongqing Med Univ, Dept Prothodont, Stomatol Hosp, Chongqing, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Xi'an Jiaotong University; Chongqing Medical University	Jin, Y (corresponding author), Fourth Mil Med Univ, State Key Lab Mil Stomatol, Xian, Shaanxi, Peoples R China.; Deng, ZH (corresponding author), Fourth Mil Med Univ, Dept Otolaryngol, Xijing Hosp, Xian, Shaanxi, Peoples R China.	dengzh@fmmu.edu.cn; yanjin@fmmu.edu.cn	Liao, Li/U-6866-2017	Liao, Li/0000-0003-0030-1009	Nature Science Foundation of China [81470710, 81670915, 81470679, 31601113, 31670995]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Nature Science Foundation of China Grants 81470710, 81670915, 81470679, 31601113, and 31670995. The authors declare no conflict of interest.	Bidwell JP, 2013, CURR OSTEOPOROS REP, V11, P117, DOI 10.1007/s11914-013-0139-2; Bischoff DS, 2008, J CELL BIOCHEM, V103, P812, DOI 10.1002/jcb.21450; Brandi ML, 2006, J BONE MINER RES, V21, P183, DOI 10.1359/JBMR.050917; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Clarkin CE, 2013, CELL BIOCHEM FUNCT, V31, P1, DOI 10.1002/cbf.2911; Ding WG, 2012, J BONE MINER METAB, V30, P400, DOI 10.1007/s00774-011-0328-y; Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919; FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009; Gennari L, 2016, EXPERT OPIN PHARMACO, V17, P1141, DOI 10.1080/14656566.2016.1176147; Graff J, 2013, NAT REV NEUROSCI, V14, P97, DOI 10.1038/nrn3427; Iordache F, 2012, INT J MOL SCI, V13, P15074, DOI 10.3390/ijms131115074; Jing H, 2016, MOL THER, V24, P217, DOI 10.1038/mt.2015.152; Kachgal S, 2011, ANGIOGENESIS, V14, P47, DOI 10.1007/s10456-010-9194-9; Karsenty G, 2003, NATURE, V423, P316, DOI 10.1038/nature01654; Kim KI, 2014, BIOMATERIALS, V35, P4792, DOI 10.1016/j.biomaterials.2014.02.048; Ko JY, 2015, BONE, V81, P80, DOI 10.1016/j.bone.2015.06.022; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Laroche M, 2002, JOINT BONE SPINE, V69, P262, DOI 10.1016/S1297-319X(02)00391-3; Li BX, 2016, BOUND VALUE PROBL, DOI 10.1186/s13661-015-0512-4; Li Y, 2015, MOL THER, V23, P1349, DOI 10.1038/mt.2015.101; Li Y, 2013, BIOMATERIALS, V34, P5048, DOI 10.1016/j.biomaterials.2013.03.052; Liao L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.130; Liao L, 2016, STEM CELLS, V34, P1054, DOI 10.1002/stem.2274; Liu K, 2015, INT J MOL SCI, V16, P21897, DOI 10.3390/ijms160921897; Liu WJ, 2015, AGING-US, V7, P205, DOI 10.18632/aging.100728; Lu CY, 2008, J ORTHOP RES, V26, P1384, DOI 10.1002/jor.20667; Majaz S, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0114-6; Ramasamy SK, 2014, NATURE, V507, P376, DOI 10.1038/nature13146; Schinkothe T, 2008, STEM CELLS DEV, V17, P199, DOI 10.1089/scd.2007.0175; Schipani E, 2009, J BONE MINER RES, V24, P1347, DOI [10.1359/JBMR.090602, 10.1359/jbmr.090602]; TRUETA J, 1963, J BONE JOINT SURG BR, V45, P572, DOI 10.1302/0301-620X.45B3.572; Xie H, 2014, NAT MED, V20, P1270, DOI 10.1038/nm.3668; Yang N, 2013, J BONE MINER RES, V28, P559, DOI 10.1002/jbmr.1798; Yang XJ, 2004, NUCLEIC ACIDS RES, V32, P959, DOI 10.1093/nar/gkh252; Yin YW, 2015, GENE EXPRESSION, V16, P187, DOI 10.3727/105221615X14399878166230; Zhang P, 2016, J BONE MINER RES, V31, P391, DOI 10.1002/jbmr.2704; Zhang YX, 2015, J BIOCHEM, V158, P445, DOI 10.1093/jb/mvv059; Zhao QH, 2013, FEBS J, V280, P5801, DOI 10.1111/febs.12500	38	31	35	1	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4422	4433		10.1096/fj.201700118R	http://dx.doi.org/10.1096/fj.201700118R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28642327				2022-12-28	WOS:000413397400020
J	Grechowa, I; Horke, S; Wallrath, A; Vahl, CF; Dorweiler, B				Grechowa, Irina; Horke, Sven; Wallrath, Anja; Vahl, Christian-Friedrich; Dorweiler, Bernhard			Human neutrophil elastase induces endothelial cell apoptosis by activating the PERK-CHOP branch of the unfolded protein response	FASEB JOURNAL			English	Article						atherosclerosis; human plaque; endoplasmic reticulum stress	ENDOPLASMIC-RETICULUM STRESS; ACUTE CORONARY SYNDROME; ACUTE MYOCARDIAL-INFARCTION; ATHEROSCLEROTIC PLAQUES; POLYMORPHONUCLEAR NEUTROPHILS; THERAPEUTIC TARGET; OXIDATIVE STRESS; ANGINA-PECTORIS; MECHANISMS; DISEASE	Human neutrophil elastase impacts on atherosclerotic plaque stability by inducing apoptosis in endothelial cells. Our aim was to investigate the proapoptotic mechanism of elastase on endothelial cells and to evaluate the presence of elastase in human plaque material. Human endothelial cells were treated with purified human neutrophil elastase. Apoptosis was assayed by capsase-3/7 activation, TUNEL, and sub-G(1) assay. Activation of unfolded protein response (UPR) effector molecules binding Ig protein, soluble X-binding protein-1, protein kinase RNA-like ER kinase (PERK), and C/EBP-homologous protein (CHOP) was analyzed by RT-PCR, immunocytochemistry, and Western blot. Genetic silencing of CHOP was achieved by small interfering RNA. Elastase induces autophagic-apoptotic forms of endothelial cell death in a time-and dose-dependent manner, in conjunction with a significant increase in phosphorylation/expression of the canonical UPR-activation markers PERK and CHOP. By using CHOP knockdown, we identified CHOP as a key mediator of elastase-induced endothelial cell death. Immunohistochemical analysis of human rupture-prone plaque specimens confirmed the presence of elastase and colocalization with apoptosis. We have demonstrated for the first time that the PERK-CHOP branch of the UPR is causally involved in elastase-induced apoptosis of endothelial cells. Ex vivo analysis of human rupture-prone plaques confirmed the presence of elastase and its colocalization with markers of apoptosis. This novel role of elastase underlines the potential of combined targeting of elastase and endoplasmic reticulum stress in the prevention of plaque progression and cardiovascular events.	[Grechowa, Irina; Wallrath, Anja; Vahl, Christian-Friedrich; Dorweiler, Bernhard] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Div Vasc Surg, Dept Cardiothorac & Vasc Surg, Langenbeckstr 1, D-55131 Mainz, Germany; [Grechowa, Irina; Horke, Sven] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Pharmacol, Mainz, Germany; [Horke, Sven] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Thrombosis & Hemostasis, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Dorweiler, B (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Div Vasc Surg, Dept Cardiothorac & Vasc Surg, Langenbeckstr 1, D-55131 Mainz, Germany.	bernhard.dorweiler@unimedizin-mainz.de			Deutsche Forschungsgemeinschaft (DFG) [DO1289/6-1]; German Federal Ministry for Education and Research [BMBF 01EO1003]; University Medical Center, University of Mainz	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); University Medical Center, University of Mainz	The authors thank Wolfram Ruf (Center of Thrombosis Research, University Medical Center Mainz) for providing the PAR-2 blocking antibody. This work contains parts of the doctoral thesis of I.G. This research was supported by Deutsche Forschungsgemeinschaft (DFG) Grant DO1289/6-1, German Federal Ministry for Education and Research Grant BMBF 01EO1003, and intramural funds from the University Medical Center, University of Mainz. The authors declare no conflicts of interest.	Ahamed J, 2006, P NATL ACAD SCI USA, V103, P13932, DOI 10.1073/pnas.0606411103; Alberelli MA, 2014, VASC PHARMACOL, V62, P72, DOI 10.1016/j.vph.2014.06.001; Baetta R, 2010, ATHEROSCLEROSIS, V210, P1, DOI 10.1016/j.atherosclerosis.2009.10.028; Barnes JA, 2004, MOL CELL BIOCHEM, V263, P227, DOI 10.1023/B:MCBI.0000041864.14092.5b; Bentzon JF, 2014, CIRC RES, V114, P1852, DOI 10.1161/CIRCRESAHA.114.302721; Carbone F, 2015, CURR DRUG TARGETS, V16, P321, DOI 10.2174/1389450115666141110093013; Carbone F, 2013, THROMB HAEMOSTASIS, V110, P501, DOI 10.1160/TH13-03-0211; De Meyer GRY, 2015, CIRC RES, V116, P468, DOI 10.1161/CIRCRESAHA.116.303804; Della Bona R, 2013, INFLAMM RES, V62, P537, DOI 10.1007/s00011-013-0617-0; Dickhout JG, 2007, CIRCULATION, V116, P1214, DOI 10.1161/CIRCULATIONAHA.107.728378; DINERMAN JL, 1990, J AM COLL CARDIOL, V15, P1559, DOI 10.1016/0735-1097(90)92826-N; Dollery CM, 2003, CIRCULATION, V107, P2829, DOI 10.1161/01.CIR.0000072792.65250.4A; Dollery CM, 2006, CARDIOVASC RES, V69, P625, DOI 10.1016/j.cardiores.2005.11.003; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Dorweiler B, 2006, THROMB HAEMOSTASIS, V95, P182, DOI 10.1160/TH05-05-0357; Dorweiler B, 2014, EUR J VASC ENDOVASC, V48, P248, DOI 10.1016/j.ejvs.2014.06.038; Dorweiler B, 2008, THROMB HAEMOSTASIS, V99, P373, DOI 10.1160/TH07-06-0387; Durand E, 2004, CIRCULATION, V109, P2503, DOI 10.1161/01.CIR.0000130172.62481.90; Engin F, 2010, DIABETES OBES METAB, V12, P108, DOI 10.1111/j.1463-1326.2010.01282.x; Garcia-Touchard A, 2005, ARTERIOSCL THROM VAS, V25, P1119, DOI 10.1161/01.ATV.0000164311.48592.da; Guasti L, 2011, THROMB HAEMOSTASIS, V106, P591, DOI 10.1160/TH11-02-0096; Henriksen PA, 2008, INT J BIOCHEM CELL B, V40, P1095, DOI 10.1016/j.biocel.2008.01.004; Horke S, 2007, CIRCULATION, V115, P2055, DOI 10.1161/CIRCULATIONAHA.106.681700; Hotamisligil GS, 2010, NAT MED, V16, P396, DOI 10.1038/nm0410-396; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Intermountain Heart Collaborative Study Group, 2005, J AM COLL CARDIOL, V45, P1638; Ionita MG, 2010, ARTERIOSCL THROM VAS, V30, P1842, DOI 10.1161/ATVBAHA.110.209296; Jacobi J, 2006, AM J PHYSIOL-HEART C, V290, pH2051, DOI 10.1152/ajpheart.01040.2005; Jerke U, 2015, KIDNEY INT, V88, P764, DOI 10.1038/ki.2015.159; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kolattukudy PE, 2012, CIRC RES, V110, P174, DOI 10.1161/CIRCRESAHA.111.243212; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Leger AJ, 2006, CIRCULATION, V114, P1070, DOI 10.1161/CIRCULATIONAHA.105.574830; Lindstedt KA, 2004, ARTERIOSCL THROM VAS, V24, P2205, DOI 10.1161/01.ATV.0000149753.74793.88; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Mangold A, 2015, CIRC RES, V116, P1182, DOI 10.1161/CIRCRESAHA.116.304944; Marino F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124565; Mattart L, 2012, CELL SIGNAL, V24, P199, DOI 10.1016/j.cellsig.2011.09.002; McAlpine CS, 2012, ARTERIOSCL THROM VAS, V32, P82, DOI 10.1161/ATVBAHA.111.237941; Mihara K, 2013, J BIOL CHEM, V288, P32979, DOI 10.1074/jbc.M113.483123; Minamino T, 2010, CIRC RES, V107, P1071, DOI 10.1161/CIRCRESAHA.110.227819; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Muller C, 2011, CELL DEATH DIFFER, V18, P817, DOI 10.1038/cdd.2010.149; Myoishi M, 2007, CIRCULATION, V116, P1226, DOI 10.1161/CIRCULATIONAHA.106.682054; Naruko T, 2002, CIRCULATION, V106, P2894, DOI 10.1161/01.CIR.0000042674.89762.20; Preston GA, 2002, J AM SOC NEPHROL, V13, P2840, DOI 10.1097/01.ASN.0000034911.03334.C3; Ramachandran R, 2008, BRIT J PHARMACOL, V153, pS263, DOI 10.1038/sj.bjp.0707507; Ramachandran R, 2011, J BIOL CHEM, V286, P24638, DOI 10.1074/jbc.M110.201988; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Rotzius P, 2010, AM J PATHOL, V177, P493, DOI 10.2353/ajpath.2010.090480; Roy A, 2012, CELL SIGNAL, V24, P2123, DOI 10.1016/j.cellsig.2012.07.014; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Scull CM, 2011, ARTERIOSCL THROM VAS, V31, P2792, DOI 10.1161/ATVBAHA.111.224881; Smith FB, 2000, EUR HEART J, V21, P1607, DOI 10.1053/euhj.2000.2127; Soehnlein O, 2012, CIRC RES, V110, P875, DOI 10.1161/CIRCRESAHA.111.257535; Suzuki T, 2005, AM J RESP CELL MOL, V33, P231, DOI 10.1165/rcmb.2005-0109OC; Suzuki T, 2009, AM J RESP CELL MOL, V41, P742, DOI 10.1165/rcmb.2008-0157OC; Tabas I, 2015, J CELL BIOL, V209, P13, DOI 10.1083/jcb.201412052; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Tsukano H, 2010, ARTERIOSCL THROM VAS, V30, P1925, DOI 10.1161/ATVBAHA.110.206094; Tull SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043916; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Witte I, 2011, METHOD ENZYMOL, V489, P127, DOI 10.1016/B978-0-12-385116-1.00008-X; Yang JJ, 1996, AM J PATHOL, V149, P1617; Yvan-Charvet L, 2008, CIRCULATION, V118, P1837, DOI 10.1161/CIRCULATIONAHA.108.793869; Zernecke A, 2008, CIRC RES, V102, P209, DOI 10.1161/CIRCRESAHA.107.160697	70	31	32	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3868	3881		10.1096/fj.201700012R	http://dx.doi.org/10.1096/fj.201700012R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28507169				2022-12-28	WOS:000408713300014
J	Lajczak, NK; Saint-Criq, V; O'Dwyer, AM; Perino, A; Adorini, L; Schoonjans, K; Keely, SJ				Lajczak, Natalia K.; Saint-Criq, Vinciane; O'Dwyer, Aoife M.; Perino, Alessia; Adorini, Luciano; Schoonjans, Kristina; Keely, Stephen J.			Bile acids deoxycholic acid and ursodeoxycholic acid differentially regulate human beta-defensin-1 and-2 secretion by colonic epithelial cells	FASEB JOURNAL			English	Article						HbD; UDCA; epithelium; innate immunity	NF-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; HUMAN BETA-DEFENSINS; INTESTINAL EPITHELIUM; EXPERIMENTAL COLITIS; ADAPTIVE IMMUNITY; GENE-EXPRESSION; GUT MICROBIOTA; CANCER CELLS; IN-VITRO	Bile acids and epithelial-derived human beta-defensins (H beta Ds) are known to be important factors in the regulation of colonic mucosal barrier function and inflammation. We hypothesized that bile acids regulate colonic H beta D expression and aimed to test this by investigating the effects of deoxycholic acid (DCA) and ursodeoxycholic acid on the expression and release of H beta D1 and H beta D2 from colonic epithelial cells and mucosal tissues. DCA (10-150 mu M) stimulated the release of both H beta D1 and H beta D2 from epithelial cell monolayers and human colonic mucosal tissue in vitro. In contrast, ursodeoxycholic acid (50-200 mu M) inhibited both basal and DCA-induced defensin release. Effects of DCA were mimicked by the Takeda GPCR 5 agonist, INT-777 (50 mu M), but not by the farnesoid X receptor agonist, GW4064 (10 mu M). INT-777 also stimulated colonic H beta D1 and H beta D2 release from wild-type, but not Takeda GPCR 5(-/-), mice. DCA stimulated phosphorylation of the p65 subunit of NF-kappa B, an effect that was attenuated by ursodeoxycholic acid, whereas an NF-kappa B inhibitor, BMS-345541 (25 mu M), inhibited DCA-induced H beta D2, but not H beta D1, release. We conclude that bile acids can differentially regulate colonic epithelial H beta D expression and secretion and discuss the implications of our findings for intestinal health and disease.	[Lajczak, Natalia K.; Saint-Criq, Vinciane; O'Dwyer, Aoife M.; Keely, Stephen J.] Beaumont Hosp, Educ & Res Ctr, Royal Coll Surg Ireland, Dept Mol Med, Dublin, Ireland; [Perino, Alessia; Schoonjans, Kristina] Ecole Polytech Fed Lausanne, Lausanne, Switzerland; [Adorini, Luciano] Intercept Pharmaceut, San Diego, CA USA	Royal College of Surgeons - Ireland; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Intercept Pharmaceuticals	Keely, SJ (corresponding author), Beaumont Hosp, Royal Coll Surg Ireland, Dept Mol Med, Smurfit Bldg, Dublin 9, Ireland.	skeely@rcsi.ie	Saint-Criq, Vinciane/A-6602-2010; Adorini, Luciano/AAE-5149-2020	Saint-Criq, Vinciane/0000-0003-0042-3735; Lajczak-Mc Ginley, Natalia/0000-0002-1277-0761; Schoonjans, Kristina/0000-0003-1247-4265	Science Foundation Ireland Principal Investigator Award [10/IN.1/B2983]; Crohn's and Colitis Foundation of America Senior Researcher Award [354322]	Science Foundation Ireland Principal Investigator Award(Science Foundation Ireland); Crohn's and Colitis Foundation of America Senior Researcher Award	This work was supported by a Science Foundation Ireland Principal Investigator Award (10/IN.1/B2983) and a Crohn's and Colitis Foundation of America Senior Researcher Award (354322; to S.J.K.).	Antoni Lena, 2013, J Crohns Colitis, V7, pe652, DOI 10.1016/j.crohns.2013.05.006; Bajaj JS, 2016, ALIMENT PHARM THER, V43, P11, DOI 10.1111/apt.13435; Barrasa JI, 2013, TOXICOL IN VITRO, V27, P964, DOI 10.1016/j.tiv.2012.12.020; Bevins CL, 2013, DIGEST DIS, V31, P299, DOI 10.1159/000354681; Boniotto M, 2006, ANTIMICROB AGENTS CH, V50, P1433, DOI 10.1128/AAC.50.4.1433-1441.2006; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Cobo ER, 2013, PATHOGENS, V2, P177, DOI 10.3390/pathogens2010177; Feng YB, 2009, J ETHNOBIOL ETHNOMED, V5, DOI 10.1186/1746-4269-5-2; Gersemann M, 2012, J INTERN MED, V271, P421, DOI 10.1111/j.1365-2796.2012.02515.x; Ghosh SK, 2011, INFECT IMMUN, V79, P4578, DOI 10.1128/IAI.05586-11; Guo CL, 2015, INT J ANAL CHEM, V2015, DOI 10.1155/2015/912631; Hamilton JP, 2007, AM J PHYSIOL-GASTR L, V293, pG256, DOI 10.1152/ajpgi.00027.2007; Harder Juergen, 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P75, DOI 10.2174/187153007780832091; Hazlett L, 2011, CELL TISSUE RES, V343, P175, DOI 10.1007/s00441-010-1022-4; Hofmann AF, 2009, FRONT BIOSCI-LANDMRK, V14, P2584, DOI 10.2741/3399; Joyce SA, 2016, ANNU REV FOOD SCI T, V7, P313, DOI 10.1146/annurev-food-041715-033159; Kanda N, 2011, J LEUKOCYTE BIOL, V89, P935, DOI 10.1189/jlb.0111004; Keating Niamh, 2009, Curr Gastroenterol Rep, V11, P375; Kelly CJ, 2013, MUCOSAL IMMUNOL, V6, P1110, DOI 10.1038/mi.2013.6; Kiilerich P, 2016, AM J PHYSIOL-ENDOC M, V310, pE886, DOI 10.1152/ajpendo.00363.2015; Kim YS, 2010, J ENDODONT, V36, P64, DOI 10.1016/j.joen.2009.09.022; Klag T, 2013, DIGEST DIS, V31, P310, DOI 10.1159/000354858; Kliewer SA, 2015, DIGEST DIS, V33, P327, DOI 10.1159/000371670; Laukens D, 2014, LAB INVEST, V94, P1419, DOI 10.1038/labinvest.2014.117; Lee HY, 2010, INT J ONCOL, V36, P941, DOI 10.3892/ijo_00000573; Lewis SB, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00068; Martinez-Moya P, 2013, INT IMMUNOPHARMACOL, V15, P372, DOI 10.1016/j.intimp.2012.11.017; Muhlbauer M, 2004, AM J PHYSIOL-GASTR L, V286, pG1000, DOI 10.1152/ajpgi.00338.2003; Nehra V, 2016, PHYSIOLOGY, V31, P327, DOI 10.1152/physiol.00005.2016; Niyonsaba F, 2016, CLIN EXP ALLERGY, V46, P1522, DOI 10.1111/cea.12843; O'Neil DA, 1999, J IMMUNOL, V163, P6718; Oliver KM, 2009, ANTIOXID REDOX SIGN, V11, P2057, DOI [10.1089/ars.2008.2400, 10.1089/ARS.2008.2400]; Otte JM, 2008, J CELL BIOCHEM, V104, P2286, DOI 10.1002/jcb.21787; Perino A, 2015, TRENDS PHARMACOL SCI, V36, P847, DOI 10.1016/j.tips.2015.08.002; Poupon R, 2012, CLIN RES HEPATOL GAS, V36, pS3, DOI 10.1016/S2210-7401(12)70015-3; Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057; Salzman NH, 2010, GUT MICROBES, V1, P401, DOI 10.4161/gmic.1.6.14076; Schroeder BO, 2012, Z GASTROENTEROL, V50, P1171, DOI 10.1055/s-0032-1312865; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Shant J, 2009, EXP CELL RES, V315, P432, DOI 10.1016/j.yexcr.2008.11.003; Stenman LK, 2013, AM J PHYSIOL-GASTR L, V304, pG227, DOI 10.1152/ajpgi.00267.2012; Subramanian H, 2013, J IMMUNOL, V191, P345, DOI 10.4049/jimmunol.1300023; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Vang Sheila, 2014, Glob Adv Health Med, V3, P58, DOI 10.7453/gahmj.2014.017; Vavassori P, 2009, J IMMUNOL, V183, P6251, DOI 10.4049/jimmunol.0803978; Vongsa RA, 2009, J BIOL CHEM, V284, P10034, DOI 10.1074/jbc.M805289200; Wang YD, 2011, HEPATOLOGY, V54, P1421, DOI 10.1002/hep.24525; Ward JBJ, 2017, AM J PHYSIOL-GASTR L, V312, pG550, DOI 10.1152/ajpgi.00256.2016; WEBER K, 1969, J BIOL CHEM, V244, P4406; Wehkamp J, 2002, EUR J GASTROEN HEPAT, V14, P745, DOI 10.1097/00042737-200207000-00006; Wehkamp J, 2009, GASTROEN CLIN BIOL, V33, pS137, DOI 10.1016/S0399-8320(09)73149-5; Weiss GA, 2017, CELL MOL LIFE SCI, V74, P2959, DOI 10.1007/s00018-017-2509-x; Wilson SS, 2013, J MOL BIOL, V425, P4965, DOI 10.1016/j.jmb.2013.09.038; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yang D, 2007, CURR PHARM DESIGN, V13, P3131, DOI 10.2174/138161207782110453; Yoneno K, 2013, IMMUNOLOGY, V139, P19, DOI 10.1111/imm.12045; Zhang KY, 2015, CELL MICROBIOL, V17, P1561, DOI 10.1111/cmi.12501; Zilbauer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015389	58	16	16	4	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3848	3857		10.1096/fj.201601365R	http://dx.doi.org/10.1096/fj.201601365R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28487283				2022-12-28	WOS:000408713300012
J	Schoepflin, ZR; Silagi, ES; Shapiro, IM; Risbud, MV				Schoepflin, Zachary R.; Silagi, Elizabeth S.; Shapiro, Irving M.; Risbud, Makarand V.			PHD3 is a transcriptional coactivator of HIF-1 alpha in nucleus pulposus cells independent of the PKM2-JMJD5 axis	FASEB JOURNAL			English	Article						intervertebral disc; hypoxia; skeletal tissue; transcription factor	PYRUVATE-KINASE M2; NF-KAPPA-B; FACTOR-I; GENE-EXPRESSION; HYPOXIA; CANCER; HYDROXYLATION; PROMOTES; PKM2; INHIBITION	The role of prolyl hydroxylase (PHD)-3 as a hypoxia inducible factor (HIF)-1 alpha cofactor is controversial and remains unknown in skeletal tissues. We investigated whether PHD3 controls HIF-1 transcriptional activity in nucleus pulposus (NP) cells through the pyruvate kinase muscle (PKM)-2-Jumonji domain-containing protein (JMJD5) axis. PHD3(-/-) mice (12.5 mo old) showed increased incidence of intervertebral disc degeneration with a concomitant decrease in expression of the HIF-1 alpha targets VEGF-A, glucose transporter-1, and lactate dehydrogenase A. PHD3 silencing decreased hypoxic activation of HIF-1 alpha C-terminal transactivation domain (C-TAD), but not HIF1 alpha-N-terminal-(N)-TAD or HIF-2 alpha-TAD. Moreover, PHD3 suppression in NP cells resulted in decreased HIF-1 alpha enrichment on target promoters and lower expression of select HIF-1 targets. Contrary to other cell types, manipulation of PKM2 and JMJD5 levels had no effect on HIF-1 activity in NP cells. Likewise, stabilization of tetrameric PKM2 by a chemical approach had no effect on PHD3-dependent HIF-1 activity. Coimmunoprecipitation assays showed lack of association between HIF-1 alpha and PKM2 in NP cells. Results support the role of the PHD3 as a cofactor for HIF-1, independent of PKM2-JMJD5.	[Schoepflin, Zachary R.; Silagi, Elizabeth S.; Shapiro, Irving M.; Risbud, Makarand V.] Thomas Jefferson Univ, Dept Orthopaed Surg, Coll Bldg,Suite 511,1025 Walnut St, Philadelphia, PA 19107 USA	Jefferson University	Risbud, MV (corresponding author), Thomas Jefferson Univ, Dept Orthopaed Surg, Coll Bldg,Suite 511,1025 Walnut St, Philadelphia, PA 19107 USA.	makarand.risbud@jefferson.edu			U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR05565, R01AR064733, F30AR066506, T32AR052273]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064733, R01AR055655, F30AR066506, T32AR052273] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases Grants R01AR05565, R01AR064733, F30AR066506 (to Z.R.S.), and T32AR052273 (to E.S.S.). The authors declare no conflicts of interest.	Agrawal A, 2007, AM J PHYSIOL-CELL PH, V293, pC621, DOI 10.1152/ajpcell.00538.2006; Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Azoitei N, 2016, MOL CANCER, V15, DOI 10.1186/s12943-015-0490-2; Bedore J, 2013, ARTHRITIS RHEUM-US, V65, P2634, DOI 10.1002/art.38075; Bishop T, 2008, MOL CELL BIOL, V28, P3386, DOI 10.1128/MCB.02041-07; Chen S, 2016, LAB INVEST, V96, P561, DOI 10.1038/labinvest.2016.32; Chen Y, 2015, J BIOL CHEM, V290, P20580, DOI 10.1074/jbc.M115.653584; Coimbra IB, 2004, OSTEOARTHR CARTILAGE, V12, P336, DOI 10.1016/j.joca.2003.12.005; Dayan F, 2006, CANCER RES, V66, P3688, DOI 10.1158/0008-5472.CAN-05-4564; de Wit RH, 2016, ONCOTARGET, V7, P67966, DOI 10.18632/oncotarget.11817; Fu J, 2013, MOL CELL BIOL, V33, P3050, DOI 10.1128/MCB.00273-13; Fujita N, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375964; Fujita N, 2012, J BIOL CHEM, V287, P16975, DOI 10.1074/jbc.M111.334466; Fujita N, 2012, J BONE MINER RES, V27, P401, DOI 10.1002/jbmr.538; Giannoni E, 2015, ONCOTARGET, V6, P24061, DOI 10.18632/oncotarget.4448; GOLDRING MB, 1994, J CLIN INVEST, V94, P2307, DOI 10.1172/JCI117595; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; Hassett G, 2003, ARTHRITIS RHEUM, V48, P3112, DOI 10.1002/art.11321; Henze AT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6582; Hirose Y, 2014, J BIOL CHEM, V289, P20594, DOI 10.1074/jbc.M114.565101; Hosios AM, 2015, MOL CELL, V59, P850, DOI 10.1016/j.molcel.2015.07.013; Iqbal MA, 2014, FEBS LETT, V588, P2685, DOI 10.1016/j.febslet.2014.04.011; Israelsen WJ, 2015, SEMIN CELL DEV BIOL, V43, P43, DOI 10.1016/j.semcdb.2015.08.004; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Johansen JL, 2010, J NEUROCHEM, V115, P209, DOI 10.1111/j.1471-4159.2010.06917.x; Kim DJ, 2015, MOL CELLS, V38, P373, DOI 10.14348/molcells.2015.2314; Li J, 2015, J BIOL CHEM, V290, P7195, DOI 10.1074/jbc.M114.611483; Lincet H, 2015, ONCOGENE, V34, P3751, DOI 10.1038/onc.2014.320; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Merceron C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110768; Moser SC, 2013, DEV CELL, V26, P381, DOI 10.1016/j.devcel.2013.06.014; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Nunez-O'Mara A, 2015, J CELL SCI, V128, P40, DOI 10.1242/jcs.151514; Palsson-McDermott EM, 2015, CELL METAB, V21, P65, DOI [10.1016/j.cmet.2014.12.005, 10.1016/j.cmet.2015.01.017]; Provot S, 2007, J CELL BIOL, V177, P451, DOI 10.1083/jcb.200612023; Rajpurohit R, 2002, CELL TISSUE RES, V308, P401, DOI 10.1007/s00441-002-0563-6; Risbud MV, 2015, J ORTHOP RES, V33, P283, DOI 10.1002/jor.22789; Risbud MV, 2010, AM J PATHOL, V176, P1577, DOI 10.2353/ajpath.2010.090734; Risbud MV, 2006, J CELL BIOCHEM, V98, P152, DOI 10.1002/jcb.20765; Rodriguez J, 2016, CELL REP, V14, P2745, DOI 10.1016/j.celrep.2016.02.043; Scaal M, 2016, SEMIN CELL DEV BIOL, V49, P83, DOI 10.1016/j.semcdb.2015.11.003; Schipani E, 2001, GENE DEV, V15, P2865; Schoepflin ZR, 2016, J BONE MINER RES, V31, P1287, DOI 10.1002/jbmr.2787; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Swain L, 2014, J LEUKOCYTE BIOL, V96, P365, DOI 10.1189/jlb.2HI1013-533R; THOMPSON JP, 1990, SPINE, V15, P411, DOI 10.1097/00007632-199005000-00012; Wang HJ, 2014, P NATL ACAD SCI USA, V111, P279, DOI 10.1073/pnas.1311249111; Xie L, 2015, J CLIN INVEST, V125, P2759, DOI 10.1172/JCI80369; Xie L, 2012, J CLIN INVEST, V122, P2827, DOI 10.1172/JCI62374; Yang LC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5436; Yu ZH, 2013, J BIOL CHEM, V288, P35406, DOI 10.1074/jbc.M113.508226; Zheng XN, 2014, GENE DEV, V28, P1429, DOI 10.1101/gad.242131.114	53	16	17	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3831	3847		10.1096/fj.201601291R	http://dx.doi.org/10.1096/fj.201601291R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28495754	Green Published			2022-12-28	WOS:000408713300011
J	Nathan, DG				Nathan, David G.			Cholesterol: the debate should be terminated	FASEB JOURNAL			English	Article						heart disease; coronary disease; statin	STATINS	Here, I offer personalperspectives on cholesterol homeostasis that reflectmy belief that certain aspects of the debate have been overstated.-Nathan, D.G. Cholesterol: the debate should be terminated.	[Nathan, David G.] Boston Childrens Hosp, Dana Farber Canc Inst, Pediat Blood & Canc Ctr, Boston, MA USA; [Nathan, David G.] Harvard Med Sch, Dept Pediat, Boston, MA USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Nathan, DG (corresponding author), Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02215 USA.	david_nathan@dfci.harvard.edu						Endo A, 2010, P JPN ACAD B-PHYS, V86, P484, DOI 10.2183/pjab.86.484; Fye W. B., 1996, ATHEROTHROMBOSIS COR; Goldstein JL, 2015, CELL, V161, P161, DOI 10.1016/j.cell.2015.01.036; Levine SA, 1929, J CLIN ENDOCRINOL, V8, P245; Levy D., 2005, A CHANGE OF HEART; Steinberg D., 2007, THE CHOLESTEROL WARS; Steinberg D, 2013, J LIPID RES, V54, P2946, DOI 10.1194/jlr.R043414	7	4	4	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					2722	2728		10.1096/fj.201700385R	http://dx.doi.org/10.1096/fj.201700385R			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28663517				2022-12-28	WOS:000405931000002
J	Deckmann, K; Rafiq, A; Erdmann, C; Illig, C; Durschnabel, M; Wess, J; Weidner, W; Bschleipfer, T; Kummer, W				Deckmann, Klaus; Rafiq, Amir; Erdmann, Christian; Illig, Christian; Durschnabel, Melanie; Wess, Juergen; Weidner, Wolfgang; Bschleipfer, Thomas; Kummer, Wolfgang			Muscarinic receptors 2 and 5 regulate bitter response of urethral brush cells via negative feedback	FASEB JOURNAL			English	Article						chemosensory cells; cholinergic; cystometry; overactive bladder syndrome	KNOCKOUT MICE; ACETYLCHOLINE-RECEPTOR; URINARY-BLADDER; OVERACTIVE BLADDER; SPINAL-CORD; GUINEA-PIG; RELEASE; SUBTYPES; RAT; LACKING	We have recently identified a cholinergic chemosensory cell in the urethral epithelium, urethral brush cell (UBC), that, upon stimulation with bitter or bacterial substances, initiates a reflex detrusor activation. Here, we elucidated cholinergic mechanisms that modulate UBC responsiveness. We analyzed muscarinic acetylcholine receptor (M1-5 mAChR) expression by using RT-PCR in UBCs, recorded [Ca2+](i) responses to a bitter stimulus in isolated UBCs of wild-type and mAChR-deficient mice, and performed cystometry in all involved strains. The bitter response of UBCs was enhanced by global cholinergic and selective M2 inhibition, diminished by positive allosteric modulation of M5, and unaffected by Ml, M3, and M4 mAChR inhibitors. This effect was not observed in M2 and M5 mAChR-deficient mice. In cystometry, M5 mAChR-deficient mice demonstrated signs of detrusor overactivity. In conclusion, M2 and M5 mAChRs attenuate the bitter response of UBC via a cholinergic negative autocrine feedback mechanism. Cystometry suggests that dysfunction, particularly of the M5 receptor, may lead to such symptoms as bladder overactivity.	[Deckmann, Klaus; Rafiq, Amir; Kummer, Wolfgang] Justus Liebig Univ Giessen, Inst Anat & Cell Biol, Aulweg 123, D-35385 Giessen, Germany; [Erdmann, Christian; Illig, Christian; Durschnabel, Melanie; Weidner, Wolfgang] Justus Liebig Univ Giessen, Dept Urol Pediat Urol & Androl, Giessen, Germany; [Wess, Juergen] NIDDK, Mol Signaling Sect, Lab Bioorgan Chem, Bethesda, MD USA; [Bschleipfer, Thomas] Nordoberpfalz AG, Weiden Hosp Clin, Clin Urol Androl & Pediat Urol, Weiden, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Deckmann, K (corresponding author), Justus Liebig Univ Giessen, Inst Anat & Cell Biol, Aulweg 123, D-35385 Giessen, Germany.	klaus.deckmann@anatomie.med.uni-giessen.de		Kummer, Wolfgang/0000-0002-3946-0683	Hessian State Offensive for the Development of Scientific and Economic Excellence (LOEWE) (Non-neuronal Cholinergic Systems, Project A5; University Hospital of Giessen and Marburg (UKGM)-Justus-Liebig-University (JLU)-Cooperation Grant [7/2016]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075020] Funding Source: NIH RePORTER	Hessian State Offensive for the Development of Scientific and Economic Excellence (LOEWE) (Non-neuronal Cholinergic Systems, Project A5; University Hospital of Giessen and Marburg (UKGM)-Justus-Liebig-University (JLU)-Cooperation Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank M. Bodenbenner and K. Michael (Institute for Anatomy and Cell Biology, Justus-Liebig-University Giessen) for skillful technical assistance. This work was supported by the Hessian State Offensive for the Development of Scientific and Economic Excellence (LOEWE) (Non-neuronal Cholinergic Systems, Project A5; to W.K. and T.B.) and a University Hospital of Giessen and Marburg (UKGM)-Justus-Liebig-University (JLU)-Cooperation Grant (7/2016 GI to K.D.). The authors declare no conflicts of interest.	Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4; Andersson KE, 2011, NEUROUROL URODYNAM, V30, P636, DOI 10.1002/nau.21108; BOGNAR IT, 1990, N-S ARCH PHARMACOL, V341, P279; Bschleipfer T, 2015, J UROLOGY, V193, P345, DOI 10.1016/j.juro.2014.08.098; Bschleipfer T, 2012, LIFE SCI, V91, P1082, DOI 10.1016/j.lfs.2012.04.007; Chen SR, 2014, J BIOL CHEM, V289, P14321, DOI 10.1074/jbc.M114.550384; Chen SR, 2010, J BIOL CHEM, V285, P40427, DOI 10.1074/jbc.M110.176966; Chess-Williams R., 2002, Autonomic & Autacoid Pharmacology, V22, P133, DOI 10.1046/j.1474-8673.2002.00258.x; Daly DM, 2010, EUR UROL, V58, P22, DOI 10.1016/j.eururo.2009.12.030; Dando R, 2012, J PHYSIOL-LONDON, V590, P3009, DOI 10.1113/jphysiol.2012.232009; Deckmann K, 2015, INT IMMUNOPHARMACOL, V29, P51, DOI 10.1016/j.intimp.2015.05.038; Deckmann K, 2014, P NATL ACAD SCI USA, V111, P8287, DOI 10.1073/pnas.1402436111; Ehlert FJ, 2005, J PHARMACOL EXP THER, V313, P368, DOI 10.1124/jpet.104.077909; Fisahn A, 2002, NEURON, V33, P615, DOI 10.1016/S0896-6273(02)00587-1; Foster DJ, 2014, J NEUROSCI, V34, P3253, DOI 10.1523/JNEUROSCI.4896-13.2014; FRYER AD, 1984, BRIT J PHARMACOL, V83, P973, DOI 10.1111/j.1476-5381.1984.tb16539.x; Gomeza J, 1999, P NATL ACAD SCI USA, V96, P1692, DOI 10.1073/pnas.96.4.1692; Gomeza J, 1999, P NATL ACAD SCI USA, V96, P10483, DOI 10.1073/pnas.96.18.10483; Groen J, 2016, EUR UROL, V69, P324, DOI 10.1016/j.eururo.2015.07.071; Igawa Y, 2004, J UROLOGY, V172, P2460, DOI 10.1097/01.ju.0000138054.77785.4a; Irwin DE, 2006, EUR UROL, V50, P1306, DOI 10.1016/j.eururo.2006.09.019; Ito Y, 2009, BRIT J PHARMACOL, V156, P1147, DOI 10.1111/j.1476-5381.2009.00113.x; KILBINGER H, 1991, BRIT J PHARMACOL, V103, P1757, DOI 10.1111/j.1476-5381.1991.tb09859.x; Kummer W, 2017, CURR OPIN UROL, V27, P85, DOI 10.1097/MOU.0000000000000361; Matsui M, 2002, J NEUROSCI, V22, P10627; Milsom I, 2001, BJU INT, V87, P760, DOI 10.1046/j.1464-410x.2001.02228.x; Mohr F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141136; Mori Y, 2016, PFLUG ARCH EUR J PHY, V468, P2053, DOI 10.1007/s00424-016-1879-5; Nandigama R, 2010, NEUROSCIENCE, V168, P842, DOI 10.1016/j.neuroscience.2010.04.012; Oliveira L, 2002, EUR J NEUROSCI, V15, P1728, DOI 10.1046/j.1460-9568.2002.02020.x; Sculptoreanu A, 2001, NEUROCHEM RES, V26, P933, DOI 10.1023/A:1012332500946; Struckmann N, 2003, MOL PHARMACOL, V64, P1444, DOI 10.1124/mol.64.6.1444; Takeuchi T, 2008, NEUROSCIENCE, V156, P381, DOI 10.1016/j.neuroscience.2008.07.056; Wess J, 1996, CRIT REV NEUROBIOL, V10, P69, DOI 10.1615/CritRevNeurobiol.v10.i1.40; WESSLER I, 1990, N-S ARCH PHARMACOL, V341, P510; Yamada M, 2001, NATURE, V410, P207, DOI 10.1038/35065604; Yamada M, 2001, P NATL ACAD SCI USA, V98, P14096, DOI 10.1073/pnas.251542998; Zhou H, 2002, N-S ARCH PHARMACOL, V365, P112, DOI 10.1007/s00210-001-0517-7	38	5	5	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					2903	2910		10.1096/fj.201700582R	http://dx.doi.org/10.1096/fj.201700582R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401598	Green Published			2022-12-28	WOS:000432546000002
J	Jackson, KC; Tarpey, MD; Valencia, AP; Inigo, MR; Pratt, SJ; Patteson, DJ; McClung, JM; Lovering, RM; Thomson, DM; Spangenburg, EE				Jackson, Kathryn C.; Tarpey, Michael D.; Valencia, Ana P.; Inigo, Melissa R.; Pratt, Stephen J.; Patteson, Daniel J.; McClung, Joseph M.; Lovering, Richard M.; Thomson, David M.; Spangenburg, Espen E.			Induced Cre-mediated knockdown of Brca1 in skeletal muscle reduces mitochondrial respiration and prevents glucose intolerance in adult mice on a high-fat diet	FASEB JOURNAL			English	Article						metabolism; disease; breast; cancer	CELLS	The breast cancer type 1 susceptibility protein (Brca1) is a regulator of DNA repair in mammary gland cells; however, recent cell culture evidence suggests that Brca1 influences other processes, including those in nonmammary cells. In this study, we sought to determine whether Brca1 is necessary for metabolic regulation of skeletal muscle using a . novel in vivo mouse model. We developed an inducible skeletal muscle-specific Brca1-knockout (BRCA1KO(smi)) model to test whether Brca1 expression is necessary for maintenance of metabolic function of skeletal muscle when exposed to a high-fat diet (HFD). Our data demonstrated that deletion of Brca1 prevented HFD-induced alterations in glucose and insulin tolerance. Irrespective of diet, BRCA1KO(smi) mice exhibited significantly lower ADP-stimulated complex I mitochondrial respiration rates compared to age-matched wild-type (WT) mice. The data show that Brca1 has the ability to localize to the mitochondria in skeletal muscle and that BRCA1KO(smi) mice exhibit higher whole-body CO2 production, respiratory exchange ratio, and energy expenditure, compared with the WT mice. Our results demonstrate that loss of Brca1 in skeletal muscle leads to dysregulated metabolic function, characterized by decreased mitochondrial respiration. Thus, any condition that results in loss of Brca1 function could induce metabolic imbalance in skeletal muscle.				spangenburge14@ecu.edu		Inigo, Melissa Mae/0000-0003-0298-6611; , Stephen/0000-0003-3627-7258	U.S. National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases [R21AR059913, RO1AR066660, R01AR059179, R21AR067872]; NIH National Heart, Lung, and Blood Institute [RO1HL125695]; NIH National Institute on Aging [T32 AG000268]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR067872, R01AR066660, R01AR059179, R21AR059913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000268] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Tom Greene (East Carolina University, Greenville, NC, USA) for technical assistance; BRCA1 plasmids were kind gift of Dr. B. Henderson (Westmead Institute for Cancer Research, Sydney, NSW Australia), and Dr. John McCarthy (University of Kentucky, Lexington, KY, USA) for numerous helpful discussions concerning animal breeding. This work was funded U.S. National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases Grants R21AR059913, RO1AR066660, R01AR059179, and R21AR067872 (to R.M.L.); NIH National Heart, Lung, and Blood Institute Grant RO1HL125695 (to J.M.M.); and NIH National Institute on Aging Grant T32 AG000268 (to K.C.J. and A.P.V.). The authors declare no conflicts of interest.	Coene ED, 2005, MOL BIOL CELL, V16, P997, DOI 10.1091/mbc.E04-10-0895; DiFranco Marino, 2009, J Vis Exp, DOI 10.3791/1520; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Garcia-Cazarin M. L., 2011, JOVE-J VIS EXP, V49; Gilliam LAA, 2012, J PHARMACOL EXP THER, V342, P631, DOI 10.1124/jpet.112.192146; Henderson BR, 2005, BIOESSAYS, V27, P884, DOI 10.1002/bies.20277; Jackson KC, 2014, J LIPID RES, V55, P668, DOI 10.1194/jlr.M043851; Lovren F, 2014, J THORAC CARDIOV SUR, V147, P1946, DOI 10.1016/j.jtcvs.2013.09.060; Maniccia AW, 2009, J CELL PHYSIOL, V219, P634, DOI 10.1002/jcp.21708; MARQUIS ST, 1995, NAT GENET, V11, P17, DOI 10.1038/ng0995-17; McCarthy JJ, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-8; Pao GM, 2014, P NATL ACAD SCI USA, V111, pE1240, DOI 10.1073/pnas.1400783111; Privat M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102438; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Singh KK, 2013, J THORAC CARDIOV SUR, V146, P702, DOI 10.1016/j.jtcvs.2012.12.046; Spangenburg EE, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/598358; StoneO MR, 2007, J CELL SCI, V120, P3999, DOI 10.1242/jcs.009241; Suberbielle E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9897; Thompson ME, 2010, FEBS J, V277, P3072, DOI 10.1111/j.1742-4658.2010.07733.x; Wall CE, 2015, P NATL ACAD SCI USA, V112, P8714, DOI 10.1073/pnas.1509930112; White AT, 2015, MOL METAB, V4, P569, DOI 10.1016/j.molmet.2015.05.001; Wohlers LM, 2011, J CELL BIOCHEM, V112, P3675, DOI 10.1002/jcb.23302; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743	23	13	13	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3070	3084		10.1096/fj.201700464R	http://dx.doi.org/10.1096/fj.201700464R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401626	Green Submitted, Green Published			2022-12-28	WOS:000432546000015
J	Leckey, JJ; Hoffman, NJ; Parr, EB; Devlin, BL; Trewin, AJ; Stepto, NK; Morton, JP; Burke, LM; Hawley, JA				Leckey, Jill J.; Hoffman, Nolan J.; Parr, Evelyn B.; Devlin, Brooke L.; Trewin, Adam J.; Stepto, Nigel K.; Morton, James P.; Burke, Louise M.; Hawley, John A.			High dietary fat intake increases fat oxidation and reduces skeletal muscle mitochondrial respiration in trained humans	FASEB JOURNAL			English	Article						carbohydrate; substrate utilization; adaptation; exercise; metabolism	CARBOHYDRATE RESTORATION; SHORT-TERM; EXERCISE; PERFORMANCE; ADAPTATION; GLYCOGEN; AVAILABILITY; METABOLISM; EXPRESSION; CYCLISTS	High-fat, low-carbohydrate (CHO) diets increase whole-body rates of fat oxidation and down-regulate CHO metabolism. We measured substrate utilization and skeletal muscle mitochondrial respiration to determine whether these adaptations are driven by high fat or low CHO availability. In a randomized crossover design, 8 male cyclists consumed 5 d of a high-CHO diet [>70% energy intake (EI)l, followed by 5 d of either an isoenergetic high-fat (HFAT; >65% EI) or high-protein diet (HPRO; >65% EI) with CHO intake clamped at <20% EL During the intervention, participants undertook daily exercise training. On d 6, participants consumed a high-CHO diet before performing 100 min of submaximal steady-state cycling plus an , similar to 30-min time trial. After 5 d of HFAT, skeletal muscle mitochondrial respiration supported by octanoylcamitine and pyruvate, as well as uncoupled respiration, was decreased at rest, and rates of whole-body fat oxidation were higher during exercise compared with HPRO. After 1 d of high-CHO diet intake, mitochondrial respiration returned to baseline values in HFAT, whereas rates of substrate oxidation returned toward baseline in both conditions. These findings demonstrate that high dietary fat intake, rather than low-CHO intake, contributes to reductions in mitochondrial respiration and increases in whole-body rates of fat oxidation after a consuming a high-fat, low-CHO diet.	[Leckey, Jill J.; Hoffman, Nolan J.; Parr, Evelyn B.; Devlin, Brooke L.; Burke, Louise M.; Hawley, John A.] Australian Catholic Univ, Mary MacKillop Inst Hlth Res, 215 Spring St,Level 5, Melbourne, Vic 3000, Australia; [Trewin, Adam J.; Stepto, Nigel K.] Victoria Univ, Coll Sport & Exercise Sci, Inst Sport Exercise & Act Living, Melbourne, Vic, Australia; [Morton, James P.; Hawley, John A.] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool, Merseyside, England; [Burke, Louise M.] Australian Inst Sport, Canberra, ACT, Australia; [Trewin, Adam J.] Univ Rochester, Med Ctr, Rochester, NY 14642 USA	Australian Catholic University; Victoria University; Liverpool John Moores University; Australian Institute of Sport; University of Rochester	Hawley, JA (corresponding author), Australian Catholic Univ, Mary MacKillop Inst Hlth Res, 215 Spring St,Level 5, Melbourne, Vic 3000, Australia.	john.hawley@acu.edu.au	Hawley, John A/U-3814-2018; Trewin, Adam/M-1584-2019; Burke, Louise/X-3127-2019; Parr, Evelyn/J-1576-2018; Burke, Louise/ABC-5691-2020; Devlin, Brooke/J-6251-2018	Hawley, John A/0000-0002-0886-9881; Trewin, Adam/0000-0001-7322-4054; Burke, Louise/0000-0001-8866-5637; Parr, Evelyn/0000-0003-1710-6381; Devlin, Brooke/0000-0001-9317-2351; Hoffman, Nolan/0000-0001-5168-7082	Australian Catholic University	Australian Catholic University	The authors thank all participants for their dedication to the study and the support team: Dr. Andrew Garnham (Australian Catholic University; skeletal muscle biopsy procedures), Sam Pinto, Bill Tachtsis, Marcus Callahan, Ida Heikura (Australian Catholic University; laboratory assistance), William Smiles, Dr. Donny Camera (Australian Catholic University; analysis assistance), and Andrew Howarth, and Prof. Rod Snow (Deakin University; analysis assistance). This work was supported by an Australian Catholic University Research Funding grant (to J.A.H.). The authors declare no conflicts of interest.	BERGSTROM J, 1967, ACTA PHYSIOL SCAND, V71, P140, DOI 10.1111/j.1748-1716.1967.tb03720.x; BORG GAV, 1973, MED SCI SPORT EXER, V5, P90; Burke LM, 2002, MED SCI SPORT EXER, V34, P83, DOI 10.1097/00005768-200201000-00014; Burke LM, 2000, J APPL PHYSIOL, V89, P2413, DOI 10.1152/jappl.2000.89.6.2413; Burke LM, 2017, J PHYSIOL-LONDON, V595, P2785, DOI 10.1113/JP273230; Cameron-Smith D, 2003, AM J CLIN NUTR, V77, P313, DOI 10.1093/ajcn/77.2.313; Carey AL, 2001, J APPL PHYSIOL, V91, P115, DOI 10.1152/jappl.2001.91.1.115; Churchley EG, 2007, J APPL PHYSIOL, V102, P1604, DOI 10.1152/japplphysiol.01260.2006; EVANS WJ, 1982, MED SCI SPORT EXER, V14, P101; Havemann L, 2006, J APPL PHYSIOL, V100, P194, DOI 10.1152/japplphysiol.00813.2005; HAWLEY JA, 1992, EUR J APPL PHYSIOL, V65, P79, DOI 10.1007/BF01466278; Helge JW, 2002, J APPL PHYSIOL, V93, P1797, DOI 10.1152/japplphysiol.00420.2002; Jorgensen W, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13207; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Lionetti L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092753; PASSONNEAU JV, 1974, ANAL BIOCHEM, V60, P405, DOI 10.1016/0003-2697(74)90248-6; PERONNET F, 1991, CAN J SPORT SCI, V16, P23; Peters SJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE980, DOI 10.1152/ajpendo.1998.275.6.E980; Skovbro M, 2011, J APPL PHYSIOL, V110, P1607, DOI 10.1152/japplphysiol.01341.2010; Steinberg GR, 2006, APPL PHYSIOL NUTR ME, V31, P302, DOI 10.1139/H06-003; Stellingwerff T, 2006, AM J PHYSIOL-ENDOC M, V290, pE380, DOI 10.1152/ajpendo.00268.2005; Stepto NK, 2001, MED SCI SPORT EXER, V33, P303; Westman EC, 2008, NUTR METAB, V5, DOI [10.1186/1743-7075-5-10, 10.1186/1743-7075-5-36]; WOLFE BM, 1977, ANN SURG, V186, P518, DOI 10.1097/00000658-197710000-00014; Yeo WK, 2008, J APPL PHYSIOL, V105, P1519, DOI 10.1152/japplphysiol.90540.2008; Zderic TW, 2004, AM J PHYSIOL-ENDOC M, V286, pE217, DOI 10.1152/ajpendo.00159.2003	26	37	37	1	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					2979	2991		10.1096/fj.201700993R	http://dx.doi.org/10.1096/fj.201700993R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401600	Green Accepted			2022-12-28	WOS:000432546000008
J	Witkowski, A; Chan, GKL; Boatz, JC; Li, NJ; Inoue, AP; Wong, JC; van der Wel, PCA; Cavigiolio, G				Witkowski, Andrzej; Chan, Gary K. L.; Boatz, Jennifer C.; Li, Nancy J.; Inoue, Ayuka P.; Wong, Jaclyn C.; van der Wel, Patrick C. A.; Cavigiolio, Giorgio			Methionine oxidized apolipoprotein A-I at the crossroads of HDL biogenesis and amyloid formation	FASEB JOURNAL			English	Article						self-association; protein structure; solid-state NMR; myeloperoxidase; cholesterol efflux	ABCA1-DEPENDENT CHOLESTEROL TRANSPORT; NLRP3 INFLAMMASOME ACTIVATION; HUMAN ATHEROSCLEROTIC LESIONS; HIGH-DENSITY-LIPOPROTEINS; SITE-SPECIFIC OXIDATION; ANGLE-SPINNING NMR; MASS-SPECTROMETRY; STERILE INFLAMMATION; SELF-ASSOCIATION; FIBRIL FORMATION	-Apolipoprotein A-I (apoA-I) shares with other exchangeable apolipoproteins a high level of structural plasticity. In the lipid-free state, the apolipoprotein amphipathic a-helices interact intra- and intermolecularly, providing structural stabilization by self-association. We have reported that lipid-free apoA-I becomes amyloidogenic upon physiologically relevant (myeloperoxidase-mediated) Met oxidation. In this study, we established that Met oxidation promotes amyloidogenesis by reducing the stability of apoA-I monomers and irreversibly disrupting selfassociation. The oxidized apoA-I monomers also exhibited increased cellular cholesterol release capacity and stronger association with macrophages, compared to nonoxidized apoA-I. Of physiologic relevance, preformed oxidized apoAI amyloid fibrils induced amyloid formation in nonoxidized apoA-I. This process was enhanced when self-association of nonoxidized apoA-I was disrupted by thermal treatment. Solid state NMR analysis revealed that aggregates formed by seeded nonoxidized apoA-I were structurally similar to those formed by the oxidized protein, featuring a beta-structure-rich amyloid fold alongside a-helices retained from the native state. In atherosclerotic lesions, the conditions that promote apoA-I amyloid formation are readily available: myeloperoxidase, active oxygen species, low pH, and high concentration of lipid-free apoA-I. Our results suggest that even partial Met oxidation of apoA-I can nucleate amyloidogenesis, thus sequestering and inactivating otherwise antiatherogenic and HDL-forming apoA-I.	[Witkowski, Andrzej; Chan, Gary K. L.; Li, Nancy J.; Inoue, Ayuka P.; Wong, Jaclyn C.; Cavigiolio, Giorgio] CHORI, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA; [Boatz, Jennifer C.; van der Wel, Patrick C. A.] Univ Pittsburgh, Dept Struct Biol, Pittsburgh, PA USA	Children's Hospital Oakland Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Cavigiolio, G (corresponding author), CHORI, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	gcavigiolio@chori.org	van der Wel, Patrick C.A./B-1428-2009	van der Wel, Patrick C.A./0000-0002-5390-3321; Boatz, Jennifer C/0000-0002-8240-5778; Witkowski, Andrzej/0000-0002-0442-4586; Li, Nancy Jingyi/0000-0001-8533-7304; Cavigiolio, Giorgio/0000-0002-1622-0628	U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute Grant [R01HL113059]; NIH National Institute of General Medical Sciences [R01GM112678, T32 GM088119]; Office of the Director of the NIH [1S10OD018070]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM088119, R01GM112678] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018070] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute Grant; NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of the Director of the NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Dr. Gordon L. Watson [Children's Hospital Oakland Research Institute (CHORI)] for contributing the wild-type mice for bone marrow extraction and Dorothy Tabron (CHORI) for taking care of the animals and extracting the bone marrow. The CD36-KO mice were generously provided by Prof. Andreas Stahl (University of California at Berkeley, Berkeley, CA, USA). The authors are also grateful to Prof. Shinji Yokoyama and Prof. Rui Lu (Nutritional Health Science Research Center, Chubu University, Kasugai, Japan) for assistance in troubleshooting the cellular cholesterol release protocol and to Dr. Trudy M. Forte (CHORI) and Dr. Shobini Jayaraman (Boston University School of Medicine. Boston, MA, USA) for useful discussions. This work was supported in whole or part by U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute Grant R01HL113059 (to G.C)., and NIH National Institute of General Medical Sciences Grants R01GM112678 (to P.C.A.V.D.W.) and T32 GM088119 (to J.C.B.). The Agilent 6490 triple quadrupole mass spectrometer was purchased through Grant 1S10OD018070, from the Office of the Director of the NIH. The article's content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflicts of interest.	Arosio P, 2015, PHYS CHEM CHEM PHYS, V17, P7606, DOI 10.1039/c4cp05563b; Audet A, 2012, HISTOPATHOLOGY, V61, P610, DOI 10.1111/j.1365-2559.2012.04265.x; Bergt C, 2004, P NATL ACAD SCI USA, V101, P13032, DOI 10.1073/pnas.0405292101; Berisha SZ, 2015, J LIPID RES, V56, P653, DOI 10.1194/jlr.M056754; Boatz JC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15137; Brouillette CG, 2005, BIOCHEMISTRY-US, V44, P16413, DOI 10.1021/bi051018v; Brubaker G, 2006, BBA-MOL CELL BIOL L, V1761, P64, DOI 10.1016/j.bbalip.2006.01.007; BURSTEIN EA, 1973, PHOTOCHEM PHOTOBIOL, V18, P263, DOI 10.1111/j.1751-1097.1973.tb06422.x; Cavigiolio G, 2008, BIOCHEMISTRY-US, V47, P4770, DOI 10.1021/bi7023354; Chan GKL, 2015, J BIOL CHEM, V290, P10958, DOI 10.1074/jbc.M114.630442; Chetty PS, 2009, P NATL ACAD SCI USA, V106, P19005, DOI 10.1073/pnas.0909708106; COHEN JS, 1979, J BIOCHEM BIOPH METH, V1, P145, DOI 10.1016/0165-022X(79)90033-2; CORNWELL GG, 1983, AM J MED, V75, P618, DOI 10.1016/0002-9343(83)90443-6; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; Davidson WS, 1999, BIOCHEMISTRY-US, V38, P14387, DOI 10.1021/bi991428h; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DiDonato JA, 2014, J BIOL CHEM, V289, P10276, DOI 10.1074/jbc.M114.556506; DiDonato JA, 2013, CIRCULATION, V128, P1644, DOI 10.1161/CIRCULATIONAHA.113.002624; Dunstan DE, 2009, PROTEIN ENG DES SEL, V22, P741, DOI 10.1093/protein/gzp059; Ekstrand M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130898; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Fritzsching KJ, 2016, J BIOMOL NMR, V64, P115, DOI 10.1007/s10858-016-0013-5; Harris RK, 2008, MAGN RESON CHEM, V46, P582, DOI 10.1002/mrc.2225; Helmus JJ, 2008, P NATL ACAD SCI USA, V105, P6284, DOI 10.1073/pnas.0711716105; Hewing B, 2014, ARTERIOSCL THROM VAS, V34, P779, DOI 10.1161/ATVBAHA.113.303044; Hoofnagle AN, 2012, CLIN CHEM, V58, P777, DOI 10.1373/clinchem.2011.173856; Hoop CL, 2014, BIOCHEMISTRY-US, V53, P6653, DOI 10.1021/bi501010q; HOROWITZ BS, 1993, J CLIN INVEST, V91, P1743, DOI 10.1172/JCI116384; Howlett GJ, 2006, CURR OPIN LIPIDOL, V17, P541, DOI 10.1097/01.mol.0000245260.63505.4f; Huang Y, 2014, NAT MED, V20, P193, DOI 10.1038/nm.3459; Huynh Kathy, 2015, Curr Protoc Protein Sci, V79, DOI 10.1002/0471140864.ps2809s79; Jahangiri A, 2005, J LIPID RES, V46, P896, DOI 10.1194/jlr.M400212-JLR200; Jayaraman S, 2011, J BIOL CHEM, V286, P35610, DOI 10.1074/jbc.M111.262485; Kee P, 2002, ARTERIOSCL THROM VAS, V22, P1912, DOI 10.1161/01.ATV.0000038485.94020.7F; Kerschen P, 2016, CURR TREAT OPTION NE, V18, DOI 10.1007/s11940-016-0436-z; King VL, 2011, CURR OPIN LIPIDOL, V22, P302, DOI 10.1097/MOL.0b013e3283488c39; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Kristen AV, 2010, CARDIOVASC PATHOL, V19, P228, DOI 10.1016/j.carpath.2009.04.005; Larsson A, 2011, AMYLOID, V18, P229, DOI 10.3109/13506129.2011.630761; Lau D, 2006, PHARMACOL THERAPEUT, V111, P16, DOI 10.1016/j.pharmthera.2005.06.023; Lee CC, 2007, BIOPHYS J, V92, P3448, DOI 10.1529/biophysj.106.098608; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Li J, 2011, J BIOL CHEM, V286, P28988, DOI 10.1074/jbc.M111.261750; Lin HK, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15462; Liu WW, 2014, INFLAMM RES, V63, P33, DOI 10.1007/s00011-013-0667-3; Loavenbruck AJ, 2012, MUSCLE NERVE, V46, P817, DOI 10.1002/mus.23415; MacLean B, 2010, ANAL CHEM, V82, P10116, DOI 10.1021/ac102179j; Mandal A, 2017, J BIOMOL NMR, V67, P165, DOI 10.1007/s10858-017-0089-6; Mandal A, 2015, BIOPHYS J, V109, P1873, DOI 10.1016/j.bpj.2015.09.016; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Medeiros LA, 2004, J BIOL CHEM, V279, P10643, DOI 10.1074/jbc.M311735200; Mei XH, 2011, J BIOL CHEM, V286, P38570, DOI 10.1074/jbc.M111.260422; Melchior JT, 2017, NAT STRUCT MOL BIOL, V24, P1093, DOI 10.1038/nsmb.3501; MUCCHIANO G, 1992, AM J PATHOL, V140, P871; Mucchiano GI, 2001, J PATHOL, V193, P270, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH753>3.0.CO;2-S; Mucchiano GI, 2001, AM J CLIN PATHOL, V115, P298; Murphy C, 2011, AMYLOID, V18, P219, DOI 10.3109/13506129.2011.574354082; Nagata KO, 2013, P NATL ACAD SCI USA, V110, P5034, DOI 10.1073/pnas.1220703110; Nanjee MN, 1996, ARTERIOSCL THROM VAS, V16, P1203, DOI 10.1161/01.ATV.16.9.1203; Nanjee MN, 2000, CLIN CHEM, V46, P207; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Oorni K, 2015, J LIPID RES, V56, P203, DOI 10.1194/jlr.R050252; Panzenbock U, 2000, J BIOL CHEM, V275, P19536, DOI 10.1074/jbc.M000458200; Peng DQ, 2008, ARTERIOSCL THROM VAS, V28, P2063, DOI 10.1161/ATVBAHA.108.173815; Peng DQ, 2005, J BIOL CHEM, V280, P33775, DOI 10.1074/jbc.M504092200; Pennathur S, 2004, J BIOL CHEM, V279, P42977, DOI 10.1074/jbc.M406762200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Podrez EA, 2000, FREE RADICAL BIO MED, V28, P1717, DOI 10.1016/S0891-5849(00)00229-X; Rios FJ, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/198193; Rios FJO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036632; Rocken C, 2006, ARTERIOSCL THROM VAS, V26, P676, DOI 10.1161/01.ATV.0000201930.10103.be; Rohatgi A, 2014, NEW ENGL J MED, V371, P2383, DOI 10.1056/NEJMoa1409065; Roijers RB, 2011, AM J PATHOL, V178, P2879, DOI 10.1016/j.ajpath.2011.02.004; Ruberg FL, 2012, CIRCULATION, V126, P1286, DOI 10.1161/CIRCULATIONAHA.111.078915; Rye KA, 2004, ARTERIOSCL THROM VAS, V24, P421, DOI 10.1161/01.ATV.0000104029.74961.f5; Saito H, 2003, J BIOL CHEM, V278, P23227, DOI 10.1074/jbc.M303365200; Sankaranarayanan S, 2011, J LIPID RES, V52, P2332, DOI 10.1194/jlr.D018051; Sasahara K, 2008, BIOCHEMISTRY-US, V47, P2650, DOI 10.1021/bi701968g; Shao BH, 2008, P NATL ACAD SCI USA, V105, P12224, DOI 10.1073/pnas.0802025105; Shao BH, 2008, METHOD ENZYMOL, V440, P33, DOI 10.1016/S0076-6879(07)00803-8; Shao BH, 2014, CIRC RES, V114, P1733, DOI 10.1161/CIRCRESAHA.114.303454; Shao BH, 2012, J BIOL CHEM, V287, P6375, DOI 10.1074/jbc.M111.337345; Shao BH, 2012, BBA-MOL CELL BIOL L, V1821, P490, DOI 10.1016/j.bbalip.2011.11.011; Shao BH, 2006, J BIOL CHEM, V281, P9001, DOI 10.1074/jbc.C600011200; Shao BH, 2005, J BIOL CHEM, V280, P5983, DOI 10.1074/jbc.M411484200; Sheedy FJ, 2013, NAT IMMUNOL, V14, P812, DOI 10.1038/ni.2639; Shen Y, 2010, J BIOMOL NMR, V48, P13, DOI 10.1007/s10858-010-9433-9; Silva RAGD, 2005, BIOCHEMISTRY-US, V44, P2759, DOI 10.1021/bi047717+; Skvortsov AN, 2003, RUSS J ORG CHEM+, V39, P170, DOI 10.1023/A:1025523832425; Solomon A, 2006, ARTHRITIS RHEUM, V54, P3545, DOI 10.1002/art.22201; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Townsend D, 2017, BIOCHEMISTRY-US, V56, P1632, DOI 10.1021/acs.biochem.6b01120; Tubb MR, 2009, J LIPID RES, V50, P1497, DOI 10.1194/jlr.D900003-JLR200; van der Wel PCA, 2017, SOLID STATE NUCL MAG, V88, P1, DOI 10.1016/j.ssnmr.2017.10.001; Varsano N, 2015, J AM CHEM SOC, V137, P1601, DOI 10.1021/ja511642t; VITELLO LB, 1976, J BIOL CHEM, V251, P1131; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Westermark GT, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a024323; WESTERMARK P, 1995, AM J PATHOL, V147, P1186; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wong YQ, 2010, P NATL ACAD SCI USA, V107, P1977, DOI 10.1073/pnas.0910136107; Wu Z, 2007, NAT STRUCT MOL BIOL, V14, P861, DOI 10.1038/nsmb1284; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; Zhang HY, 2003, J BIOMOL NMR, V25, P173, DOI 10.1023/A:1022836027055; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zhao L, 2013, BIOCHEMISTRY-US, V52, P1913, DOI 10.1021/bi301313b; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	112	17	17	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3149	3165		10.1096/fj.201701127R	http://dx.doi.org/10.1096/fj.201701127R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401604	Green Published			2022-12-28	WOS:000432546000021
J	Martinez-Sanchez, A; Nguyen-Tu, MS; Cebola, I; Yavari, A; Marchetti, P; Piemonti, L; de Koning, E; Shapiro, AMJ; Johnson, P; Sakamoto, K; Smith, DM; Leclerc, I; Ashrafian, H; Ferrer, J; Rutter, GA				Martinez-Sanchez, Aida; Nguyen-Tu, Marie-Sophie; Cebola, Ines; Yavari, Arash; Marchetti, Piero; Piemonti, Lorenzo; de Koning, Eelco; Shapiro, A. M. James; Johnson, Paul; Sakamoto, Kei; Smith, David M.; Leclerc, Isabelle; Ashrafian, Houman; Ferrer, Jorge; Rutter, Guy A.			MiR-184 expression is regulated by AMPK in pancreatic islets	FASEB JOURNAL			English	Article						miRNAs; glucose; beta cell; diabetes	STIMULATED INSULIN-SECRETION; BETA-CELL FUNCTION; GLUCOSE-METABOLISM; PROTEIN-KINASE; MICRORNAS; CANCER; MICE; IDENTITY; MIRNAS; MODELS	AMPK is a critical energy sensor and target for widely used antidiabetic drugs. In beta cells, elevated glucose concentrations lower AMPK activity, and the ablation of both catalytic subunits[beta-cell-specific AMPK double-knockout (beta AMPKdKO) mice] impairs insulin secretion in vivo and beta-cell identity. MicroRNAs (miRNAs) are small RNAs that silence gene expression that are essential for pancreatic beta-cell function and identity and altered in diabetes. Here, we have explored the miRNAs acting downstream of AMPK in mouse and human beta cells. We identified 14 down-regulated and 9 up-regulated miRNAs in beta AMPKdKOvs. control islets. Gene ontology analysis of targeted transcripts revealed enrichment in pathways important for beta-cell function and identity. The most downregulated miRNA was miR-184 (miR-184-3p), an important regulator of beta-cell function and compensatory expansion that is controlled by glucose and reduced in diabetes. We demonstrate that AMPK is a potent regulator and an important mediator of the negative effects of glucose on miR-184 expression. Additionally, we reveal sexual dimorphism in miR-184 expression in mouse and human islets. Collectively, these data demonstrate that glucose-mediated changes in AMPK activity are central for the regulation of miR-184 and other miRNAs in islets and provide a link between energy status and gene expression in beta cells.	[Martinez-Sanchez, Aida; Nguyen-Tu, Marie-Sophie; Leclerc, Isabelle; Rutter, Guy A.] Imperial Coll London, Sect Cell Biol & Funct Genom, London, England; [Cebola, Ines; Ferrer, Jorge] Imperial Coll London, Beta Cell Genome Regulat Lab, Div Diabet Endocrinol & Metab, Dept Med, London, England; [Yavari, Arash; Ashrafian, Houman] Univ Oxford, Radcliffe Dept Med, Oxford, England; [Johnson, Paul] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England; [Marchetti, Piero] Univ Pisa, Dept Endocrinol & Metab, Pisa, Italy; [Piemonti, Lorenzo] Ist Sci San Raffaele, IRCCS, SR DRI, Milan, Italy; [Piemonti, Lorenzo] Univ Vita Salute San Raffaele, Milan, Italy; [de Koning, Eelco] Hubrecht Inst, Utrecht, Netherlands; [de Koning, Eelco] Leiden Univ, Med Ctr, Dept Med, Leiden, Netherlands; [Shapiro, A. M. James] Univ Alberta, Clin Islet Lab, Edmonton, AB, Canada; [Shapiro, A. M. James] Univ Alberta, Clin Islet Transplant Program, Edmonton, AB, Canada; [Sakamoto, Kei] Nestle Inst Hlth Sci, Lausanne, Switzerland; [Smith, David M.] Discovery Sci, Innovat Med & Early Dev, AstraZeneca Res & Dev, Cambridge, England	Imperial College London; Imperial College London; University of Oxford; University of Oxford; University of Pisa; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Alberta; University of Alberta; Nestle SA; AstraZeneca	Martinez-Sanchez, A; Rutter, GA (corresponding author), Imperial Coll London, Du Cane Rd, London W12 0NN, England.	a.martinez-sanchez@imperial.ac.uk; g.rutter@imperial.ac.uk	de Koning, Eelco JP/H-6030-2011; Cebola, Inês/AAG-9652-2020; Ferrer, Jorge/A-3176-2012; Piemonti, Lorenzo/P-7605-2017; Sanchez, Aida Martinez/ABH-5957-2020; sakamoto, kei/C-8806-2019	de Koning, Eelco JP/0000-0002-1232-7022; Cebola, Inês/0000-0003-3528-4982; Ferrer, Jorge/0000-0002-5959-5729; Piemonti, Lorenzo/0000-0002-2172-2198; Sanchez, Aida Martinez/0000-0001-5142-2527; sakamoto, kei/0000-0001-8839-5980; Smith, David/0000-0001-6831-280X; Leclerc, Isabelle/0000-0003-0044-7921; Rutter, Guy/0000-0001-6360-0343	Wellcome Trust Senior Investigator Grant [WT098424AIA]; Medical Research Council (MRC) [MR/J0003042/1, MR/N00275X/1, MR/L020149/1]; Royal Society Wolfson Research Merit Awards; Diabetes UK Project [BDA11/0004210, BDA/15/0005275]; Society for Endocrinology; New Research Investigator Grant [MR/P023223/1]; Juvenile Diabetes Research Foundation [3-RSC-2016-160-I-X]; Academy of Medical Sciences (AMS) [SGL015\\1031] Funding Source: researchfish; Medical Research Council [MR/L02036X/1, MR/K019023/1, MR/K001981/1, MR/P023223/1] Funding Source: researchfish; National Institute for Health Research [CL-2013-13-004] Funding Source: researchfish; Alberta Innovates [201201154] Funding Source: researchfish; MRC [MR/L02036X/1, MR/N00275X/1, MR/P023223/1, MR/L020149/1, MR/K001981/1, MR/K019023/1] Funding Source: UKRI	Wellcome Trust Senior Investigator Grant; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society Wolfson Research Merit Awards(Royal Society of London); Diabetes UK Project(Diabetes UK); Society for Endocrinology; New Research Investigator Grant; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Alberta Innovates; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Delphine Rolando (Imperial College London) for helping with computational analysis, the Centre for Genomic Regulation (Barcelona, Spain) for the generation of the high-throughput sequencing data, Exiqon (Vedbaek, Denmark) for the miRNA detection using qPCR panels, and Patrick MacDonald (Alberta Diabetes Institute, University of Alberta) for providing human islets. G.A.R. was supported by Wellcome Trust Senior Investigator Grant WT098424AIA, Medical Research Council (MRC) Programme Grants MR/J0003042/1, MR/N00275X/1, and MR/L020149/1 (DIVA), and by Royal Society Wolfson Research Merit Awards and Diabetes UK Project Grants BDA11/0004210 and BDA/15/0005275. This work was also supported by an Early Career Research grant from the Society for Endocrinology, and by New Research Investigator Grant MR/P023223/1 to A.M.-S. Human islet preparations (Milan, Italy) were obtained from the European Consortium for Islet Transplantation; the Human Islet Distribution program is supported by Juvenile Diabetes Research Foundation Grant 3-RSC-2016-160-I-X. The authors declare no conflicts of interest.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Andersson SA, 2012, MOL CELL ENDOCRINOL, V364, P36, DOI 10.1016/j.mce.2012.08.009; Bolmeson C, 2011, BIOCHEM BIOPH RES CO, V404, P16, DOI 10.1016/j.bbrc.2010.11.024; Bouzakri K, 2008, DIABETES, V57, P1195, DOI 10.2337/db07-1469; Casimir M, 2009, J BIOL CHEM, V284, P25004, DOI 10.1074/jbc.M109.015495; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Cokorinos EC, 2017, CELL METAB, V25, P1147, DOI 10.1016/j.cmet.2017.04.010; Cunningham KA, 2012, CELL METAB, V16, P113, DOI 10.1016/j.cmet.2012.05.014; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Franconi F, 2008, PHARMACOL RES, V57, P6, DOI 10.1016/j.phrs.2007.11.007; Fu A, 2013, MOL CELL ENDOCRINOL, V366, P127, DOI 10.1016/j.mce.2012.06.020; Gendron CM, 2017, AGING CELL, V16, P1434, DOI 10.1111/acel.12673; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hall E, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0522-z; Hunter RW, 2014, CHEM BIOL, V21, P866, DOI 10.1016/j.chembiol.2014.05.014; Iguchi H, 2005, J BIOL CHEM, V280, P37669, DOI 10.1074/jbc.M505392200; Jonas JC, 1999, J BIOL CHEM, V274, P14112, DOI 10.1074/jbc.274.20.14112; Kameswaran V, 2014, CELL METAB, V19, P135, DOI 10.1016/j.cmet.2013.11.016; Kanji MS, 2013, DIABETES, V62, P1602, DOI 10.2337/db12-0841; Kaspi H, 2014, TRENDS ENDOCRIN MET, V25, P285, DOI 10.1016/j.tem.2014.01.003; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Kone M, 2014, FASEB J, V28, P4972, DOI 10.1096/fj.14-257667; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Leclerc I, 2004, AM J PHYSIOL-ENDOC M, V286, pE1023, DOI 10.1152/ajpendo.00532.2003; Li Z, 2017, BIOCH CELL BIOL; Locke JM, 2014, DIABETOLOGIA, V57, P122, DOI 10.1007/s00125-013-3089-4; Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175; Maj M, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/1964634; Marco A, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140024; Martinez-Sanchez A, 2017, FRONT GENET, V7, DOI 10.3389/fgene.2016.00226; Martinez-Sanchez A, 2015, MOL ENDOCRINOL, V29, P1067, DOI 10.1210/me.2015; Melkman-Zehavi T, 2011, EMBO J, V30, P835, DOI 10.1038/emboj.2010.361; Nesca V, 2013, DIABETOLOGIA, V56, P2203, DOI 10.1007/s00125-013-2993-y; Nomura T, 2008, HUM MOL GENET, V17, P1192, DOI 10.1093/hmg/ddn011; Pepin E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153017; Rajasethupathy P, 2009, NEURON, V63, P803, DOI 10.1016/j.neuron.2009.05.029; Rajman M, 2017, DEVELOPMENT, V144, P2310, DOI 10.1242/dev.144337; Ramalingam L, 2014, BIOCHEM J, V464, P251, DOI 10.1042/BJ20140845; Richards OC, 2010, ENDOCR REV, V31, P343, DOI 10.1210/er.2009-0035; Rutter GA, 2015, BIOCHEM J, V466, P203, DOI 10.1042/BJ20141384; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sorensen H, 2006, DIABETES, V55, P3463, DOI 10.2337/db06-0307; Sun G, 2010, DIABETOLOGIA, V53, P924, DOI 10.1007/s00125-010-1692-1; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tajima K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064633; Tang XQ, 2009, RNA, V15, P287, DOI 10.1261/rna.1211209; Tattikota SG, 2015, J BIOL CHEM, V290, P20284, DOI 10.1074/jbc.M115.658625; Tattikota SG, 2014, CELL METAB, V19, P122, DOI 10.1016/j.cmet.2013.11.015; Tiano JP, 2012, ENDOCRINOLOGY, V153, P2997, DOI 10.1210/en.2011-1980; Tohyama D, 2010, BIOCHEM BIOPH RES CO, V394, P112, DOI 10.1016/j.bbrc.2010.02.126; Varlamov O, 2015, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00241; Vazquez P, 2014, DIABETOLOGIA, V57, P2339, DOI 10.1007/s00125-014-3341-6; Wang FF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139241; Wang J, 2015, ONCOTARGET, V6, P19456, DOI 10.18632/oncotarget.3318; Wang M, 2014, INT J ONCOL, V45, P362, DOI 10.3892/ijo.2014.2413; Xiao B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4017; Xiao XS, 2016, SCI REP-UK, V6, DOI 10.1038/srep21735; Yang SY, 2016, BIOCHEM J, V473, P1791, DOI 10.1042/BCJ20160137; Yavari A, 2016, CELL METAB, V23, P821, DOI 10.1016/j.cmet.2016.04.003; Zhang J, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.11; Zhang L, 1999, NEUROSCIENCE, V94, P251, DOI 10.1016/S0306-4522(99)00234-1; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	64	23	25	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2587	2600		10.1096/fj.201701100R	http://dx.doi.org/10.1096/fj.201701100R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29269398	hybrid, Green Published			2022-12-28	WOS:000432528000023
J	Ganz, AB; Park, H; Malysheva, OV; Caudill, MA				Ganz, Ariel B.; Park, Heyjun; Malysheva, Olga V.; Caudill, Marie A.			Vitamin D binding protein rs7041 genotype alters vitamin D metabolism in pregnant women	FASEB JOURNAL			English	Article						25-hydroxyvitamin D; nutrigenetics; nutrition; placenta; reproductive health	TANDEM MASS-SPECTROMETRY; GENOME-WIDE ASSOCIATION; 25-HYDROXYVITAMIN D; FREE 1,25-DIHYDROXYVITAMIN-D; GENE POLYMORPHISMS; HUMAN SERUM; LACTATION; GC; BIOMARKERS; CALCIUM	Research has identified reduced circulating 25-hydroxyvitamin D [25(OH)D] in individuals with the rs7041 (c.1296T>G) T allele in the vitamin D binding protein gene (GC); however, the effects of the T allele on vitamin D biomarkers during pregnancy and lactation are unknown. Thus, we examined the metabolic effects of GC rs7041 on vitamin D biomarkers among third-trimester pregnant (n = 26), lactating (n = 28), and nonpregnant/nonlactating (n = 21) women consuming a single amount of vitamin D (511 IU/d) and related nutrients for 10-12 wk. T allele carriers had less circulating 25(OH)D, regardless of reproductive state [thymine-thymine (TT): 80% of guanine-guanine (GG), P = 0.05; guanine-thymine (GT): 85% of GG, P = 0.1]. Among pregnant women, the T allele attenuated the expected increase in vitamin D binding protein (DBP). Specifically, although GG pregnant women exhibited greater DBP (216%, P < 0.0001) than did GG nonpregnant women, that difference was lessened among GT women, and TT pregnant women did not exhibit greater DBP than TT nonpregnant women. Furthermore, TT pregnant women had greater placental 25(OH)D-3 to 24,25-dihydroxyvitamin D ratios (251% of GG, P = 0.07) and less osteocalcin, a bone formation marker, in the cord blood of their neonates (24% of GT, P = 0.02). Overall, the GC rs7041 genotype modified the effects of pregnancy on maternal and placental vitamin D metabolism, with possible functional consequences for fetal bone development and infant health.	[Ganz, Ariel B.; Park, Heyjun; Malysheva, Olga V.; Caudill, Marie A.] Cornell Univ, Div Nutr Sci, 228 Savage Hall, Ithaca, NY 14853 USA	Cornell University	Caudill, MA (corresponding author), Cornell Univ, Div Nutr Sci, 228 Savage Hall, Ithaca, NY 14853 USA.	mac379@cornell.edu			U.S. National Institutes of Health (NIH) [T32-DK007158, 1R03HD080824-01A1]; U.S. Department of Agriculture, National Institute of Food and Agriculture's Agriculture and Food Research Initiative-Education and Literacy Initiative Predoctoral Fellowship [2016-67011-25174]; Gerber Foundation [1843-3882]; American Egg Board/Egg Nutrition Center; Beef Checkoff, through the National Cattlemen's Beef Association; Nebraska Beef Council; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD080824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007158] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Agriculture, National Institute of Food and Agriculture's Agriculture and Food Research Initiative-Education and Literacy Initiative Predoctoral Fellowship; Gerber Foundation; American Egg Board/Egg Nutrition Center; Beef Checkoff, through the National Cattlemen's Beef Association; Nebraska Beef Council; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Lynn Johnson and Francois Vermeylen (Cornell Statistical Consulting Unit, Cornell University) for their guidance. Research reported in this publication was supported by the U.S. National Institutes of Health (NIH) Award T32-DK007158 (National Institute of Diabetes and Digestive and Kidney Disease; NIDDK) and 1R03HD080824-01A1 (Eunice Kennedy Shriver National Institute of Child Health and Human Development); a U.S. Department of Agriculture, National Institute of Food and Agriculture's Agriculture and Food Research Initiative-Education and Literacy Initiative Predoctoral Fellowship 2016-67011-25174; the Gerber Foundation Grant 1843-3882; the American Egg Board/Egg Nutrition Center; and the Beef Checkoff, through the National Cattlemen's Beef Association and the Nebraska Beef Council. The content of the article is solely the responsibility of the authors and does not necessarily represent the official views of the NIDDK. The NIH and other funding sources had no role in the study design, interpretation of the data, or publication of results. The authors declare no conflicts of interest.	Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; [Anonymous], 2014, R LANG ENV STAT COMP; ARNAUD J, 1993, HUM GENET, V92, P183; BIKLE DD, 1984, J CLIN INVEST, V74, P1966, DOI 10.1172/JCI111617; Brannon PM, 2011, ANNU REV NUTR, V31, P89, DOI 10.1146/annurev.nutr.012809.104807; Bu FX, 2010, HUM GENET, V128, P549, DOI 10.1007/s00439-010-0881-9; Christakos S, 2016, PHYSIOL REV, V96, P365, DOI 10.1152/physrev.00014.2015; Christensen EI, 2002, NAT REV MOL CELL BIO, V3, P258, DOI 10.1038/nrm778; Chun RF, 2014, J STEROID BIOCHEM, V144, P132, DOI 10.1016/j.jsbmb.2013.09.012; De-Regil L. M., 2016, COCHRANE DB SYST REV, V2016; Diaz L, 2000, J CLIN ENDOCR METAB, V85, P2543, DOI 10.1210/jc.85.7.2543; EMERSON DL, 1985, AM J REPROD IM MIC, V7, P15; Henderson CM, 2016, CLIN CHEM, V62, P179, DOI 10.1373/clinchem.2015.244541; Jolliffe DA, 2016, J STEROID BIOCHEM, V164, P18, DOI 10.1016/j.jsbmb.2015.12.007; KAMBOH MI, 1986, HUM GENET, V72, P281, DOI 10.1007/BF00290950; Kaufmann M, 2014, J CLIN ENDOCR METAB, V99, P2567, DOI 10.1210/jc.2013-4388; Lipkie TE, 2013, J CHROMATOGR B, V932, P6, DOI 10.1016/j.jchromb.2013.05.029; Lundgren S, 1997, J HISTOCHEM CYTOCHEM, V45, P383, DOI 10.1177/002215549704500306; Ma R, 2012, AM J PHYSIOL-ENDOC M, V303, pE928, DOI 10.1152/ajpendo.00279.2012; McGrath JJ, 2010, J STEROID BIOCHEM, V121, P471, DOI 10.1016/j.jsbmb.2010.03.073; Medlej-Hashim M, 2015, ANN HUM GENET, V79, P394, DOI 10.1111/ahg.12133; Nielson CM, 2016, J CLIN ENDOCR METAB, V101, P2226, DOI 10.1210/jc.2016-1104; Park H, 2017, AM J CLIN NUTR, V106, P1439, DOI 10.3945/ajcn.117.153429; Park H, 2017, BONE, V95, P183, DOI 10.1016/j.bone.2016.12.002; Park H, 2016, J NUTR, V146, P1537, DOI 10.3945/jn.116.229971; Powe CE, 2013, NEW ENGL J MED, V369, P1991, DOI 10.1056/NEJMoa1306357; Reis JP, 2015, AM J CLIN NUTR, V101, P1232, DOI 10.3945/ajcn.115.107334; Ritchie LD, 1998, AM J CLIN NUTR, V67, P693, DOI 10.1093/ajcn/67.4.693; Saraf R, 2016, MATERN CHILD NUTR, V12, P647, DOI 10.1111/mcn.12210; Schleicher RL, 2011, CLIN CHIM ACTA, V412, P1594, DOI 10.1016/j.cca.2011.05.010; Sorensen IM, 2016, DIABETES-METAB RES, V32, P883, DOI 10.1002/dmrr.2812; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; WILSON SG, 1990, CLIN ENDOCRINOL, V32, P613, DOI 10.1111/j.1365-2265.1990.tb00905.x; Yan J, 2012, AM J CLIN NUTR, V95, P1060, DOI 10.3945/ajcn.111.022772; Zehnder D, 2002, AM J PATHOL, V161, P105, DOI 10.1016/S0002-9440(10)64162-4	35	13	13	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2012	2020		10.1096/fj.201700992R	http://dx.doi.org/10.1096/fj.201700992R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29196501	Green Published			2022-12-28	WOS:000429051400023
J	Mettang, M; Reichel, SN; Lattke, M; Palmer, A; Abaei, A; Rasche, V; Huber-Lang, M; Baumann, B; Wirth, T				Mettang, Melanie; Reichel, Stephanie Nadine; Lattke, Michael; Palmer, Annette; Abaei, Alireza; Rasche, Volker; Huber-Lang, Markus; Baumann, Bernd; Wirth, Thomas			IKK2/NF-kappa B signaling protects neurons after traumatic brain injury	FASEB JOURNAL			English	Article						neuroinflammation; apoptosis neurological outcome; neurodegeneration; conditional mouse model	NF-KAPPA-B; CLOSED-HEAD INJURY; SPINAL-CORD-INJURY; NERVOUS-SYSTEM; REDUCES INFLAMMATION; FUNCTIONAL RECOVERY; ACTIVATION; EXPRESSION; EPIDEMIOLOGY; MICE	Traumatic brain injury (TBI) is the leading cause of death in young adults. After the initial injury, a poorly understood secondary phase, including a strong inflammatory response determines the final outcome of TBI. The inhibitor of NF-kappa B kinase (IKK)/NF-kappa B signaling system is the key regulator of inflammation and also critically involved in regulation of neuronal survival and synaptic plasticity. We addressed the neuron-specific function of IKK2/NF-kappa B signaling pathway in TBI using an experimental model of closed-head injury (CHI) in combination with mouse models allowing conditional regulation of IKK/NF-kappa B signaling in excitatory forebrain neurons. We found that repression of IKK2/NF-kappa B signaling in neurons increases the acute posttraumatic mortality rate, worsens the neurological outcome, and promotes neuronal cell death by apoptosis, thus resulting in enhanced proinflammatory gene expression. As a potential mechanism, we identified elevated levels of the proapoptotic mediators Bax and Bad and enhanced expression of stress response genes. This phenotype is also observed when neuronal IKK/NF-kappa B activity is inhibited just before CHI. In contrast, neuron-specific activation of IKK/NF-kappa B signaling does not alter the TBI outcome. Thus, this study demonstrates that physiological neuronal IKK/NF-kappa B signaling is necessary and sufficient to protect neurons from trauma consequences.	[Mettang, Melanie; Reichel, Stephanie Nadine; Lattke, Michael; Baumann, Bernd; Wirth, Thomas] Ulm Univ, Inst Physiol Chem, Albert Einstein Allee 11, D-89081 Ulm, Germany; [Abaei, Alireza; Rasche, Volker] Ulm Univ, Core Facil Small Anim Magnet Resonance Imaging, Ulm, Germany; [Lattke, Michael] Francis Crick Inst, Neural Stem Cell Biol Lab, London, England; [Palmer, Annette; Huber-Lang, Markus] Univ Hosp Ulm, Inst Clin & Expt Trauma Immunol, Ulm, Germany	Ulm University; Ulm University; Francis Crick Institute; Ulm University	Wirth, T (corresponding author), Ulm Univ, Inst Physiol Chem, Albert Einstein Allee 11, D-89081 Ulm, Germany.	thomas.wirth@uni-ulm.de	Wirth, Thomas/X-7172-2019; Huber-Lang, Markus/AAJ-2209-2020; Lattke, Michael/AAE-5079-2020; Rasche, Volker/P-6523-2016	Lattke, Michael/0000-0001-5533-8592; Rasche, Volker/0000-0001-8844-3583	German research foundation [CRC1149]	German research foundation(German Research Foundation (DFG))	The authors thank Petra Weihrich, Melanie Gerstenlauer, Annika Gnann, Ute Leschik (all from the Institute of Physiological Chemistry, Ulm University), and Sonja Braumuller (Institute of Clinical and Experimental Trauma-Immunology, University Hospital Ulm) for excellent technical assistance. This work was supported by the German research foundation (CRC1149/Project A03 to T.W. and CRC1149/Project Z03). Melanie Mettang and Stephanie N. Reichel are members of the International Graduate School in Molecular Medicine Ulm (IGradU). The authors declare no conflicts of interest.	Acarin L, 2000, J NEUROPATH EXP NEUR, V59, P151, DOI 10.1093/jnen/59.2.151; Acarin L, 1998, NEUROREPORT, V9, P2869, DOI 10.1097/00001756-199808240-00035; Bales KR, 1998, MOL BRAIN RES, V57, P63, DOI 10.1016/S0169-328X(98)00066-7; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Braunstein KE, 2010, HUM MOL GENET, V19, P4385, DOI 10.1093/hmg/ddq361; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Cucchiara B, 2001, J NEUROL SCI, V187, P81, DOI 10.1016/S0022-510X(01)00529-9; Duckworth EAM, 2006, BRAIN RES, V1088, P167, DOI 10.1016/j.brainres.2006.02.103; Engelmann C, 2014, NEURAL REGEN RES, V9, P707, DOI 10.4103/1673-5374.131572; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gabriel C, 1999, MOL BRAIN RES, V65, P61, DOI 10.1016/S0169-328X(98)00330-1; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hang CH, 2006, BRAIN RES, V1109, P14, DOI 10.1016/j.brainres.2006.06.045; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Herrmann O, 2005, NAT MED, V11, P1322, DOI 10.1038/nm1323; Jayakumar AR, 2014, J NEUROTRAUM, V31, P1249, DOI 10.1089/neu.2013.3169; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kaltschmidt B, 2005, BBA-MOL CELL RES, V1745, P287, DOI 10.1016/j.bbamcr.2005.05.009; Kaltschmidt B., 2015, BRAIN FRONT MOL NEUR, V8, P69, DOI DOI 10.3389/FNM0L.2015.00069; Kaltschmidt B, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001271; KALTSCHMIDT C, 1994, MOL CELL BIOL, V14, P3981, DOI 10.1128/MCB.14.6.3981; Khorooshi R, 2008, J IMMUNOL, V181, P7284, DOI 10.4049/jimmunol.181.10.7284; Kirkley KS, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0871-0; Lagraoui M, 2017, BRAIN BEHAV IMMUN, V61, P96, DOI 10.1016/j.bbi.2016.12.005; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lattke M, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0157-0; Lattke M, 2012, J NEUROSCI, V32, P11511, DOI 10.1523/JNEUROSCI.0182-12.2012; Ledoux AC, 2014, BIOCHEM SOC T, V42, P76, DOI 10.1042/BST20130156; Lian H, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-47; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lothian C, 1997, EUR J NEUROSCI, V9, P452, DOI 10.1111/j.1460-9568.1997.tb01622.x; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Maqbool A, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-40; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Mattson MP, 2001, J CLIN INVEST, V107, P247, DOI 10.1172/JCI11916; Mattson MP, 2005, NEUROCHEM RES, V30, P883, DOI 10.1007/s11064-005-6961-x; Mattson MP, 2000, J NEUROCHEM, V74, P443, DOI 10.1046/j.1471-4159.2000.740443.x; Memet S, 2006, BIOCHEM PHARMACOL, V72, P1180, DOI 10.1016/j.bcp.2006.09.003; Menon DK, 2017, HAND CLINIC, V140, P239, DOI 10.1016/B978-0-444-63600-3.00014-3; Mincheva-Tasheva S, 2013, NEUROSCIENTIST, V19, P175, DOI 10.1177/1073858412444007; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Pennypacker KR, 2001, EXP NEUROL, V172, P307, DOI 10.1006/exnr.2001.7817; Pennypacker KR, 2000, ACTA NEUROBIOL EXP, V60, P515; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pizzi M, 2006, EUR J PHARMACOL, V545, P22, DOI 10.1016/j.ejphar.2006.06.027; Qin ZH, 2007, ACTA PHARMACOL SIN, V28, P1859, DOI 10.1111/j.1745-7254.2007.00741.x; Quillinan Nidia, 2016, Anesthesiol Clin, V34, P453, DOI 10.1016/j.anclin.2016.04.011; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sanz O, 2002, J NEUROSCI RES, V67, P772, DOI 10.1002/jnr.10140; Schmeisser MJ, 2012, J NEUROSCI, V32, P5688, DOI 10.1523/JNEUROSCI.0111-12.2012; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Schmidt-Strassburger U, 2012, FASEB J, V26, P4990, DOI 10.1096/fj.12-208587; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Turner MD, 2014, BBA-MOL CELL RES, V1843, P2563, DOI 10.1016/j.bbamcr.2014.05.014; Villasana LE, 2014, EXP NEUROL, V261, P156, DOI 10.1016/j.expneurol.2014.05.016; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wang DB, 2014, BBA-MOL BASIS DIS, V1842, P1186, DOI 10.1016/j.bbadis.2013.12.015; Widera D, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.4.041804; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; YANG KY, 1995, NEUROSCI LETT, V197, P101, DOI 10.1016/0304-3940(95)11919-N; Yang Li, 2007, Neurosci Bull, V23, P307, DOI 10.1007/s12264-007-0046-6; Yuan YM, 2015, BRAIN BEHAV IMMUN, V48, P287, DOI 10.1016/j.bbi.2015.04.008	77	49	51	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1916	1932		10.1096/fj.201700826R	http://dx.doi.org/10.1096/fj.201700826R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29187362	Green Published			2022-12-28	WOS:000429051400015
J	Murray, J; Whitson, RH; Itakura, K				Murray, Jennifer; Whitson, Robert H.; Itakura, Keiichi			Reduced prostaglandin I-2 signaling in Arid5b(-/-) primary skeletal muscle cells attenuates myogenesis	FASEB JOURNAL			English	Article						myoblast; differentiation; prostacyclin; migration; cell fusion	MYOBLAST MIGRATION; SATELLITE CELLS; STEM-CELLS; IN-VITRO; FUSION; DIFFERENTIATION; PROLIFERATION; PROTEINS; PATHWAY; MICE	The AT-rich interaction domain (ARID) family of proteins regulates gene expression, development, and differentiation. Although Arid5b has important functions in adipogenesis and chondrogenesis, the role of Arid5b in skeletal muscle myogenesis has not been investigated. Therefore, we isolated primary skeletal muscle cells from Arid5b(+/+) and Arid5b(-/-) mice and characterized differentiation in these cells. We found that Arid5b(-/-) primary skeletal muscle cells showed differentiation defects and impaired sarcomeric assembly. Microarray analysis revealed down-regulation of the prostanoid biosynthesis pathway in Arid5b(-/-) myoblasts, including the genes encoding cyclooxygenase (COX)-1 (Ptgs1) and prostaglandin (PG) I synthase (Ptgis). Down-regulation of COX-1 and PGI synthase was confirmed by real-time PCR and Western blot analyses. Correspondingly, the production of PGI(2), as measured by ELISA, was reduced in Arid5b(-/-) cells relative to Arid5b(+/+) cells. Boyden chamber assays showed that migration was increased but chemotaxis was impaired in Arid5b(-/-) cells. Myoblast fusion was also inhibited in Arid5b(-/-) cells compared with Arid5b(+/+) cells. Treatment with the PGI(2) analog iloprost rescued the defects in myotube formation, migration, and fusion. These results demonstrate that Arid5b has a novel and essential role in skeletal muscle differentiation by regulating PGI(2) production.	[Murray, Jennifer; Whitson, Robert H.; Itakura, Keiichi] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol & Cellular Biol, 1500 E Duarte Rd, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Murray, J (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol & Cellular Biol, 1500 E Duarte Rd, Duarte, CA 91010 USA.	jmurray@coh.org			U.S. National Institutes of Health (NIH) National Cancer Institute [P30CA033572]; Genentech; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Genentech(Roche HoldingGenentech); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded, in part, by Genentech royalties to K.I. Research reported in this publication included work performed in the Analytical Cytometry Core and the Integrative Genomics Core, supported by the U.S. National Institutes of Health (NIH) National Cancer Institute (P30CA033572). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflicts of interest.	Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; Bondesen BA, 2007, FASEB J, V21, P3338, DOI 10.1096/fj.06-7070com; Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; Chen AE, 2005, NATURE, V433, P317, DOI 10.1038/nature03126; Chen FH, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2514; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Griffin CA, 2009, DEV CELL, V17, P649, DOI 10.1016/j.devcel.2009.09.004; Hata K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3850; Horsley V, 2003, J CELL BIOL, V161, P111, DOI 10.1083/jcb.200208085; Jansen KM, 2008, CELL DEATH DIFFER, V15, P1619, DOI 10.1038/cdd.2008.90; Kang YJ, 2007, PROG LIPID RES, V46, P108, DOI 10.1016/j.plipres.2007.01.001; Korotkova M, 2014, NAT REV RHEUMATOL, V10, P295, DOI 10.1038/nrrheum.2014.2; Kortschak RD, 2000, TRENDS BIOCHEM SCI, V25, P294, DOI 10.1016/S0968-0004(00)01597-8; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Mackey AL, 2013, J APPL PHYSIOL, V115, P900, DOI 10.1152/japplphysiol.00044.2013; Markworth JF, 2011, AM J PHYSIOL-CELL PH, V300, pC671, DOI 10.1152/ajpcell.00549.2009; MCLENNAN IS, 1991, J ANAT, V174, P115; Mendias CL, 2004, MUSCLE NERVE, V30, P497, DOI 10.1002/mus.20102; Murray J, 2011, AM J PHYSIOL-CELL PH, V301, pC630, DOI 10.1152/ajpcell.00033.2011; Mylona E, 2006, J CELL PHYSIOL, V209, P314, DOI 10.1002/jcp.20724; Otis JS, 2005, EXP CELL RES, V310, P417, DOI 10.1016/j.yexcr.2005.08.009; Patsialou A, 2005, NUCLEIC ACIDS RES, V33, P66, DOI 10.1093/nar/gki145; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Rochlin K, 2010, DEV BIOL, V341, P66, DOI 10.1016/j.ydbio.2009.10.024; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Schmahl J, 2007, NAT GENET, V39, P52, DOI 10.1038/ng1922; Schoenfeld BJ, 2012, SPORTS MED, V42, P1017, DOI 10.2165/11635190-000000000-00000; Shen W, 2006, J APPL PHYSIOL, V101, P1215, DOI 10.1152/japplphysiol.01331.2005; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; VANDENBURGH HH, 1990, AM J PHYSIOL, V259, pC232, DOI 10.1152/ajpcell.1990.259.2.C232; Whitson RH, 1999, BIOCHEM BIOPH RES CO, V258, P326, DOI 10.1006/bbrc.1999.0643; Whitson RH, 2003, BIOCHEM BIOPH RES CO, V312, P997, DOI 10.1016/j.bbrc.2003.11.026; Yamakawa T, 2008, MOL ENDOCRINOL, V22, P441, DOI 10.1210/me.2007-0271; ZALIN RJ, 1987, EXP CELL RES, V172, P265, DOI 10.1016/0014-4827(87)90386-7; ZALIN RJ, 1975, FEBS LETT, V53, P33, DOI 10.1016/0014-5793(75)80675-2	36	4	4	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1868	1879		10.1096/fj.201700453RR	http://dx.doi.org/10.1096/fj.201700453RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29196500	Green Published, hybrid			2022-12-28	WOS:000429051400011
J	Romey-Glusing, R; Li, Y; Hoffmann, J; von Frieling, J; Knop, M; Pfefferkorn, R; Bruchhaus, I; Fink, C; Roeder, T				Romey-Gluesing, Renja; Li, Yang; Hoffmann, Julia; von Frieling, Jakob; Knop, Mirjam; Pfefferkorn, Roxana; Bruchhaus, Iris; Fink, Christine; Roeder, Thomas			Nutritional regimens with periodically recurring phases of dietary restriction extend lifespan in Drosophila	FASEB JOURNAL			English	Article						lifespan extension; sex differences; insulin; metabolic rate; impl2	INSULIN-PRODUCING NEURONS; CALORIC RESTRICTION; METABOLIC-RATE; CAENORHABDITIS-ELEGANS; VOLUNTARY EXERCISE; FEMALE DROSOPHILA; GENE-EXPRESSION; BLOOD-PRESSURE; BODY-WEIGHT; PROTEIN	Nutritional interventions such as caloric and dietary restriction increase lifespan in various animal models. To identify alternative and less demanding nutritional interventions that extend lifespan, we subjected fruit flies (Drosophila melanogaster) to weekly nutritional regimens that involved alternating a conventional diet with dietary restriction. Short periods of dietary restriction (up to 2 d) followed by longer periods of a conventional diet yielded minimal increases in lifespan. We found that 3 or more days of contiguous dietary restriction (DR) was necessary to yield a lifespan extension similar to that observed with persistent DR. Female flies were more responsive to these interventions than males. Physiologic changes known to be associated with prolonged DR, such as reduced metabolic rates, showed the same time course as lifespan extension. Moreover, concurrent transcriptional changes indicative of reduced insulin signaling were identified with DR. These physiologic and transcriptional changes were sustained, as they were detectable several days after switching to conventional diets. Taken together, diets with longer periods of DR extended lifespan concurrently with physiologic and transcriptional changes that may underlie this increase in lifespan.	[Romey-Gluesing, Renja; Li, Yang; Hoffmann, Julia; von Frieling, Jakob; Knop, Mirjam; Pfefferkorn, Roxana; Fink, Christine; Roeder, Thomas] Univ Kiel, Inst Zool, Dept Mol Physiol, Botanischen Garten 1-9, D-24118 Kiel, Germany; [Bruchhaus, Iris] Bernhard Nocht Inst Trop Med, Hamburg, Germany; [Fink, Christine; Roeder, Thomas] ARCN, German Ctr Lung Res DZL, Grosshansdorf, Germany; [Romey-Gluesing, Renja] Univ Hamburg, Dept Biol, Hamburg, Germany; [Li, Yang] Ocean Univ China, Dept Marine Geosci, Qingdao, Peoples R China; [Hoffmann, Julia] Amedon GmbH, Lubeck, Germany	University of Kiel; Bernhard Nocht Institut fur Tropenmedizin; University of Hamburg; Ocean University of China	Roeder, T (corresponding author), Univ Kiel, Inst Zool, Dept Mol Physiol, Botanischen Garten 1-9, D-24118 Kiel, Germany.	troeder@zoologie.uni-kiel.de	Roeder, Thomas/B-9016-2011; Fink, Christine/ABF-7102-2021	Roeder, Thomas/0000-0002-3489-3834; Fink, Christine/0000-0003-0083-2168	Deutsche Forschungsgemeinschaft [CRC1182]; BMB+F (Vision Epifood)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMB+F (Vision Epifood)	The authors thank Britta Laubenstein and Christiane Sandberg (Kiel University) for excellent technical help; the Bloomington Drosophila Stock Center for fly stocks, and Sangbin Park and Seung Kim (Stanford University, CA, USA) for the dILP2-tagged flies and the reagents to perform the initial experiments. This work was supported by the Deutsche Forschungsgemeinschaft (CRC1182, Project C2) and the BMB+F (Vision Epifood). The authors declare no conflicts of interest.	Alic N, 2011, AGING CELL, V10, P137, DOI 10.1111/j.1474-9726.2010.00653.x; ANDERSSON B, 1988, ACTA MED SCAND, V223, P485; Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100; Brandhorst S, 2015, CELL METAB, V22, P86, DOI 10.1016/j.cmet.2015.05.012; Bruce KD, 2013, EXP GERONTOL, V48, P1129, DOI [10.1016/j.exger.2013.02.003, 10.1016/j.exge]; Brzek P, 2012, J EXP BIOL, V215, P3191, DOI 10.1242/jeb.065318; Colman RJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4557; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Deshpande SA, 2014, NAT METHODS, V11, P535, DOI [10.1038/NMETH.2899, 10.1038/nmeth.2899]; El-Kholy S, 2015, CELL TISSUE RES, V361, P669, DOI 10.1007/s00441-015-2137-4; Fink C, 2013, APPL ENVIRON MICROB, V79, P6984, DOI 10.1128/AEM.01903-13; Fontana L, 2004, P NATL ACAD SCI USA, V101, P6659, DOI 10.1073/pnas.0308291101; Franz O, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.11.e3; GARABEDIAN MJ, 1985, P NATL ACAD SCI USA, V82, P1396, DOI 10.1073/pnas.82.5.1396; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Gill S, 2015, SCIENCE, V347, P1265, DOI 10.1126/science.1256682; Good TP, 2001, J INSECT PHYSIOL, V47, P1467, DOI 10.1016/S0022-1910(01)00138-X; GOODRICK CL, 1983, EXP AGING RES, V9, P203, DOI 10.1080/03610738308258453; GOODRICK CL, 1983, J GERONTOL, V38, P36, DOI 10.1093/geronj/38.1.36; GOODRICK CL, 1990, MECH AGEING DEV, V55, P69, DOI 10.1016/0047-6374(90)90107-Q; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Haselton A, 2010, CELL CYCLE, V9, P3063, DOI 10.4161/cc.9.15.12458; Haselton Aaron T, 2011, J Vis Exp, DOI 10.3791/2722; Heck MJ, 2017, J GERONTOL A-BIOL, V72, P616, DOI 10.1093/gerona/glw094; Hildebrandt A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023796; Hoffmann J, 2013, AGING-US, V5, P315, DOI 10.18632/aging.100553; Holloszy JO, 2007, EXP GERONTOL, V42, P709, DOI 10.1016/j.exger.2007.03.009; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hulbert AJ, 2004, EXP GERONTOL, V39, P1137, DOI 10.1016/j.exger.2004.04.006; Ja WW, 2009, P NATL ACAD SCI USA, V106, P18633, DOI 10.1073/pnas.0908016106; Jiang JC, 2000, FASEB J, V14, P2135; KIRKWOOD TBL, 1991, PHILOS T R SOC B, V332, P15, DOI 10.1098/rstb.1991.0028; Lee C, 2016, F1000RES, V5, pF1000, DOI DOI 10.12688/F1000RESEARCH.7136.1; Lee D, 2015, AGING CELL, V14, P8, DOI 10.1111/acel.12277; Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105; Levine ME, 2014, CELL METAB, V19, P407, DOI 10.1016/j.cmet.2014.02.006; Li Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep35359; Longo VD, 2014, CELL METAB, V19, P181, DOI 10.1016/j.cmet.2013.12.008; Luo JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108185; Madeo F, 2014, NAT REV DRUG DISCOV, V13, P727, DOI 10.1038/nrd4391; Mager DE, 2006, FASEB J, V20, P631, DOI 10.1096/fj.05-5263com; Mair W, 2004, EXP GERONTOL, V39, P1011, DOI 10.1016/j.exger.2004.03.018; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; MCCARTER RJ, 1989, AM J PHYSIOL, V257, pE175, DOI 10.1152/ajpendo.1989.257.2.E175; Mirzaei H, 2016, CURR OPIN CLIN NUTR, V19, P74, DOI 10.1097/MCO.0000000000000239; Mirzaei H, 2014, TRENDS ENDOCRIN MET, V25, P558, DOI 10.1016/j.tem.2014.07.002; Nassel DR, 2015, GEN COMP ENDOCR, V221, P255, DOI 10.1016/j.ygcen.2014.11.021; Osborne TB, 1917, SCIENCE, V45, P294, DOI 10.1126/science.45.1160.294; Park S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004555; Partridge L, 2011, EXP GERONTOL, V46, P376, DOI 10.1016/j.exger.2010.09.003; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Rajan A, 2012, CELL, V151, P123, DOI 10.1016/j.cell.2012.08.019; Roeder T, 1999, PROG NEUROBIOL, V59, P533, DOI 10.1016/S0301-0082(99)00016-7; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sarraf-Zadeh L, 2013, DEV BIOL, V381, P97, DOI 10.1016/j.ydbio.2013.06.008; Schramm G, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e96; Sharma N, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-90; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Wagner C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-446; Wei M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai8700; Whitaker R, 2014, AGING-US, V6, P355, DOI 10.18632/aging.100662; Yatsenko A. S., 2014, JOVE-J VIS EXP, V88; Zheng SQ, 2017, J GERONTOL A-BIOL, V72, P464, DOI 10.1093/gerona/glw105	67	9	9	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1993	2003		10.1096/fj.201700934R	http://dx.doi.org/10.1096/fj.201700934R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29196499				2022-12-28	WOS:000429051400021
J	Wang, MA; Yao, LC; Cheng, MS; Cai, DY; Martinek, J; Pan, CX; Shi, W; Ma, AH; White, RWD; Airhart, S; Liu, ET; Banchereau, J; Brehm, MA; Greiner, DL; Shultz, LD; Palucka, K; Keck, JG				Wang, Minan; Yao, Li-Chin; Cheng, Mingshan; Cai, Danying; Martinek, Jan; Pan, Chong-Xian; Shi, Wei; Ma, Ai-Hong; White, Ralph W. De Vere; Airhart, Susan; Liu, Edison T.; Banchereau, Jacques; Brehm, Michael A.; Greiner, Dale L.; Shultz, Leonard D.; Palucka, Karolina; Keck, James G.			Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy	FASEB JOURNAL			English	Article						checkpoint inhibitor; mouse model; patient-derived xenograft; pembrolizumab	T-CELL RESPONSES; PD-1 BLOCKADE; IMMUNE CELLS; ANTI-PD-1 ANTIBODY; HUMAN-BLOOD; B7 FAMILY; RECEPTOR; MOUSE; SUBSETS; TUMORS	Establishment of an in vivo small animal model of human tumor and human immune system interaction would enable preclinical investigations into the mechanisms underlying cancer immunotherapy. To this end, nonobese diabetic (NOD). Cg-Prkdc(scid)IL2rg(tm1Wjl)/Sz (null; NSG) mice were transplanted with human (h) CD34(+) hematopoietic progenitor and stem cells, which leads to the development of human hematopoietic and immune systems [humanized NSG (HuNSG)]. HuNSG mice received human leukocyte antigen partially matched tumor implants from patient-derived xenografts [PDX; non-small cell lungcancer (NSCLC), sarcoma, bladder cancer, andtriple-negative breast cancer (TNBC)] or from a TNBC cell line-derived xenograft (CDX). Tumor growth curves were similar in HuNSG compared with nonhuman immune-engrafted NSG mice. Treatment with pembrolizumab, which targets programmed cell death protein 1, produced significant growth inhibition in both CDX and PDX tumors in HuNSG but not in NSG mice. Finally, inhibition of tumor growth was dependent on hCD8(+) T cells, as demonstrated by antibody-mediated depletion. Thus, tumor-bearing HuNSG mice may represent an important, new model for preclinical immunotherapy research.	[Wang, Minan; Yao, Li-Chin; Cheng, Mingshan; Cai, Danying; Keck, James G.] Jackson Lab, Dept In Vivo Pharmacol Serv, 1650 Santa Ana Ave, Sacramento, CA 95838 USA; [Martinek, Jan; Airhart, Susan; Liu, Edison T.; Banchereau, Jacques; Palucka, Karolina] Jackson Lab, Dept Immunol, Farmington, CT USA; [Pan, Chong-Xian; Shi, Wei; White, Ralph W. De Vere] Univ Calif Davis, Davis Comprehens Canc Ctr, Dept Urol, Davis, CA USA; [Ma, Ai-Hong] Univ Calif Davis, Davis Comprehens Canc Ctr, Dept Biochem & Mol Med, Davis, CA USA; [Brehm, Michael A.; Greiner, Dale L.] Univ Massachusetts, Med Sch, Dept Mol Med, Worcester, MA 01605 USA; [Brehm, Michael A.; Greiner, Dale L.] Univ Massachusetts, Med Sch, Diabet Ctr Excellence, Worcester, MA 01605 USA; [Shultz, Leonard D.] Jackson Lab, Dept Immunol, Bar Harbor, ME USA	Jackson Laboratory; Jackson Laboratory; University of California System; University of California Davis; University of California System; University of California Davis; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Jackson Laboratory	Wang, MA (corresponding author), Jackson Lab, Dept In Vivo Pharmacol Serv, 1650 Santa Ana Ave, Sacramento, CA 95838 USA.	minan.wang@jax.org		Brehm, Michael/0000-0001-6813-3262	Jackson Laboratory; NATIONAL CANCER INSTITUTE [P30CA093373, P30CA034196, R01CA176803] Funding Source: NIH RePORTER	Jackson Laboratory; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank the Flow Contract Site Laboratory (Bothell, WA, USA) for processing and staining samples for flow cytometry, and Pure Transplant Solutions (Oklahoma City, OK, USA) for HLA typing. This study was funded by The Jackson Laboratory. The authors declare no conflicts of interest.	Ahmadzadeh M, 2009, BLOOD, V114, P1537, DOI 10.1182/blood-2008-12-195792; Ashizawa T, 2017, CLIN CANCER RES, V23, P149, DOI 10.1158/1078-0432.CCR-16-0122; Brehm MA, 2010, DIABETES, V59, P2265, DOI 10.2337/db10-0323; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Chen QF, 2009, P NATL ACAD SCI USA, V106, P21783, DOI 10.1073/pnas.0912274106; Dong HD, 1999, NAT MED, V5, P1365; Felix NJ, 2007, NAT REV IMMUNOL, V7, P942, DOI 10.1038/nri2200; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011; Gibney GT, 2016, LANCET ONCOL, V17, pE542, DOI 10.1016/S1470-2045(16)30406-5; Hackam DG, 2006, JAMA-J AM MED ASSOC, V296, P1731, DOI 10.1001/jama.296.14.1731; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Khalil DN, 2016, NAT REV CLIN ONCOL, V13, P394, DOI 10.1038/nrclinonc.2016.65; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Lee J, 2017, J CLIN INVEST, V127, P2433, DOI 10.1172/JCI92030; Li Y, 2016, EUR J IMMUNOL, V46, P1291, DOI 10.1002/eji.201546132; McGee HS, 2010, AM J RESP CELL MOL, V43, P432, DOI 10.1165/rcmb.2009-0258OC; Merryman RW, 2017, BLOOD, V129, P1380, DOI 10.1182/blood-2016-09-738385; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Mullard A, 2013, NAT REV DRUG DISCOV, V12, P489, DOI 10.1038/nrd4066; Okazaki T, 2007, INT IMMUNOL, V19, P813, DOI 10.1093/intimm/dxm057; Palucka AK, 2003, BLOOD, V102, P3302, DOI 10.1182/blood-2003-02-0384; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Ribas A, 2016, CANCER IMMUNOL RES, V4, P194, DOI 10.1158/2326-6066.CIR-15-0210; Robert C, 2014, LANCET, V384, P1109, DOI 10.1016/S0140-6736(14)60958-2; Rongvaux A, 2014, NAT BIOTECHNOL, V32, P364, DOI 10.1038/nbt.2858; Rosenblatt J, 2011, J IMMUNOTHER, V34, P409, DOI 10.1097/CJI.0b013e31821ca6ce; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; Shultz LD, 2010, P NATL ACAD SCI USA, V107, P13022, DOI 10.1073/pnas.1000475107; Stronen E, 2016, SCIENCE, V352, P1337, DOI 10.1126/science.aaf2288; Strowig T, 2009, J EXP MED, V206, P1423, DOI 10.1084/jem.20081720; Tanaka S, 2012, J IMMUNOL, V188, P6145, DOI 10.4049/jimmunol.1103660; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Theocharides APA, 2016, HAEMATOLOGICA, V101, P5, DOI 10.3324/haematol.2014.115212; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Waldron-Lynch F, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003401; Walsh NC, 2017, ANNU REV PATHOL-MECH, V12, P187, DOI 10.1146/annurev-pathol-052016-100332; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741; Zilberberg J, 2015, BIOL BLOOD MARROW TR, V21, P1000, DOI 10.1016/j.bbmt.2014.11.001; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326	51	158	163	8	57	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1537	1549		10.1096/fj.201700740R	http://dx.doi.org/10.1096/fj.201700740R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29146734	Green Published, hybrid			2022-12-28	WOS:000427246000033
J	Berryman, CE; Young, AJ; Karl, JP; Kenefick, RW; Margolis, LM; Cole, RE; Carbone, JW; Lieberman, HR; Kim, IY; Ferrando, AA; Pasiakos, SM				Berryman, Claire E.; Young, Andrew J.; Karl, J. Philip; Kenefick, Robert W.; Margolis, Lee M.; Cole, Renee E.; Carbone, John W.; Lieberman, Harris R.; Kim, Il-Young; Ferrando, Arny A.; Pasiakos, Stefan M.			Severe negative energy balance during 21 d at high altitude decreases fat-free mass regardless of dietary protein intake: a randomized controlled trial	FASEB JOURNAL			English	Article						hypobaric hypoxia; weight loss; metabolic rate; muscle; substrate oxidation	WEIGHT-LOSS; NITROGEN-BALANCE; BODY-COMPOSITION; SKELETAL-MUSCLE; AMINO-ACIDS; EXERCISE; EXPENDITURE; MEN; METABOLISM; EXPOSURE	In this 2-phase randomized controlled study, we examined whether consuming a higher-protein (HP) diet would attenuate fat-free mass (FFM) loss during energy deficit (ED) at high altitude (HA) in 17 healthy males (mean +/- sd: 23 +/- 6 yr; 82 +/- 14 kg). During phase 1 at sea level (SL, 55 m), participants consumed a eucaloric diet providing standard protein (SP; 1.0 g protein/kg,) for 21 d. During phase 2, participants resided at HA (4300 m) for 22 d and were randomly assigned to either an SP or HP (2.0 g protein/kg) diet designed to elicit a 40% ED. Body composition, substrate oxidation, and postabsorptive whole-body protein kinetics were measured. Participants were weight stable during SL and lost 7.9 +/- 1.9 kg ( P < 0.01) during HA, regardless of dietary protein intake. Decrements in whole-body FFM (3.6 +/- 2.4 kg) and fat mass (3.6 +/- 1.3 kg) were not different between SP and HP. HP oxidized 0.95 +/- 0.32 g protein/kg per day more than SP and whole-body net protein balance was more negative for HP than for SP ( P < 0.01). Based on changes in body energy stores, the overall ED was 70% (-1849 +/- 511 kcal/d, no group differences). Consuming an HP diet did not protect FFM during severe ED at HA.	[Berryman, Claire E.; Young, Andrew J.; Karl, J. Philip; Margolis, Lee M.; Cole, Renee E.; Lieberman, Harris R.; Pasiakos, Stefan M.] USARIEM, Mil Nutr Div, Natick, MA 01760 USA; [Kenefick, Robert W.] USARIEM, Thermal Mt Med Div, Natick, MA 01760 USA; [Berryman, Claire E.; Young, Andrew J.; Margolis, Lee M.; Carbone, John W.] Oak Ridge Inst Sci & Educ, Belcamp, MD USA; [Carbone, John W.] Eastern Michigan Univ, Sch Hlth Sci, Ypsilanti, MI 48197 USA; [Kim, Il-Young; Ferrando, Arny A.] Univ Arkansas Med Sci, Donald W Reynolds Inst Aging, Ctr Translat Res Aging & Longev, Dept Geriatr, Little Rock, AR 72205 USA	Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; Eastern Michigan University; University of Arkansas System; University of Arkansas Medical Sciences	Pasiakos, SM (corresponding author), USARIEM, 10 Gen Greene Ave,Bldg 42, Natick, MA 01760 USA.	stefan.m.pasiakos.civ@mail.mil	Pasiakos, Stefan M/E-6295-2014	Pasiakos, Stefan M/0000-0002-5378-5820; Cole, Renee/0000-0002-7345-5650; Margolis, Lee/0000-0003-1697-825X; Karl, J. Philip/0000-0002-5871-2241	U.S. Army Medical Research and Materiel Command; U.S. Department of Energy	U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); U.S. Department of Energy(United States Department of Energy (DOE))	The authors thank the volunteers who participated in this research; the medical oversight team, and Dr. Stephen Muza for their support; and Allyson Derosier, Nancy Murphy, Katelyn Guerriere, Karleigh Bradbury, Adrienne Hatch, Ryanne Haskell, Laura Lutz, Alyssa Kelley, Marques Wilson, Christopher Carrigan, Adam Luippold, Bradley Anderson, Grant Holmes, Anthony Karis, Matthew Kominsky, Aaron Stein, Dr. Stephen R. Hennigar, Dr. Taylor Roth, Dr. James P. McClung, and Dr. Scott J. Montain (U.S. Army Research Institute of Environmental Medicine) for their contributions to the project. This work was supported, in part, by the U.S. Army Medical Research and Materiel Command and through fellowship appointments to the U.S. Army Research Institute of Environmental Medicine administered by the Oak Ridge Institute for Science and Education (to C.E.B., A.J.Y., L.M.M., and J.W.C.) through an interagency agreement between the U.S. Department of Energy and the U.S. Army Medical Research and Materiel Command. The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the U.S. Army or the U.S. Department of Defense. Any citations of commercial organizations and trade names in this report do not constitute an official U.S. Department of the Army endorsement or approval of the products or services of these organizations. The authors declare no conflicts of interest.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Barnholt KE, 2006, AM J PHYSIOL-ENDOC M, V290, pE1078, DOI 10.1152/ajpendo.00449.2005; Berryman CE, 2017, J APPL PHYSIOL, V122, P1485, DOI 10.1152/japplphysiol.01039.2016; Bhasin S, 2001, AM J PHYSIOL-ENDOC M, V281, pE1172, DOI 10.1152/ajpendo.2001.281.6.E1172; BIOLO G, 1995, AM J PHYSIOL-ENDOC M, V268, pE75, DOI 10.1152/ajpendo.1995.268.1.E75; Boos CJ, 2016, HIGH ALT MED BIOL, V17, P25, DOI 10.1089/ham.2015.0098; BUTTERFIELD GE, 1992, J APPL PHYSIOL, V72, P1741, DOI 10.1152/jappl.1992.72.5.1741; Butterfield GE, 1999, CLIN SPORT MED, V18, P607, DOI 10.1016/S0278-5919(05)70171-X; CALLOWAY DH, 1975, J NUTR, V105, P914, DOI 10.1093/jn/105.7.914; CAYOL M, 1995, CLIN SCI, V89, P389, DOI 10.1042/cs0890389; Chaston TB, 2007, INT J OBESITY, V31, P743, DOI 10.1038/sj.ijo.0803483; CYMERMAN A, 1981, J APPL PHYSIOL, V51, P14, DOI 10.1152/jappl.1981.51.1.14; Feinman RD, 2003, METAB SYNDR RELAT D, V1, P209, DOI 10.1089/154041903322716688; Fine Eugene J, 2004, Nutr Metab (Lond), V1, P15, DOI 10.1186/1743-7075-1-15; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; GROVER RF, 1963, J APPL PHYSIOL, V18, P909, DOI 10.1152/jappl.1963.18.5.909; HANNON JP, 1973, J APPL PHYSIOL, V34, P471, DOI 10.1152/jappl.1973.34.4.471; Henning PC, 2011, MIL MED, V176, P991, DOI 10.7205/MILMED-D-11-00053; HENRIKSSON J, 1977, J PHYSIOL-LONDON, V270, P661, DOI 10.1113/jphysiol.1977.sp011974; Heymsfield SB, 2014, OBES REV, V15, P310, DOI 10.1111/obr.12143; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P214, DOI 10.1093/ajcn/52.2.214; HOFFER LJ, 1990, AM J PHYSIOL, V258, pE832, DOI 10.1152/ajpendo.1990.258.5.E832; Horowitz JF, 2000, AM J CLIN NUTR, V72, p558S, DOI 10.1093/ajcn/72.2.558S; Hoyt RW, 2006, AM J CLIN NUTR, V83, P1068, DOI 10.1093/ajcn/83.5.1068; Institute of Medicine, 2005, DIET REF INT EN CARB; KELLOGG RH, 1957, J APPL PHYSIOL, V11, P65, DOI 10.1152/jappl.1957.11.1.65; KRZYWICKI HJ, 1971, J APPL PHYSIOL, V30, P806, DOI 10.1152/jappl.1971.30.6.806; Layman DK, 2009, J NUTR, V139, P514, DOI 10.3945/jn.108.099440; LEBLANC J, 1991, HORM METAB RES, V23, P336, DOI 10.1055/s-2007-1003691; LEBLANC J, 1993, CAN J PHYSIOL PHARM, V71, P879, DOI 10.1139/y93-133; Longland TM, 2016, AM J CLIN NUTR, V103, P738, DOI 10.3945/ajcn.115.119339; Ludlow LW, 2016, J APPL PHYSIOL, V120, P481, DOI 10.1152/japplphysiol.00864.2015; Macdonald JH, 2009, AM J CLIN NUTR, V90, P1193, DOI 10.3945/ajcn.2009.28075; Margolis LM, 2016, MED SCI SPORT EXER, V48, P1604, DOI 10.1249/MSS.0000000000000944; Margolis LM, 2014, APPL PHYSIOL NUTR ME, V39, P1395, DOI 10.1139/apnm-2014-0212; Margolis LM, 2012, NUTRIENTS, V4, P2035, DOI 10.3390/nu4122035; Marriott B.M., 1996, NUTR NEEDS COLD HIGH; Mawson JT, 2000, J APPL PHYSIOL, V88, P272, DOI 10.1152/jappl.2000.88.1.272; Mettler S, 2010, MED SCI SPORT EXER, V42, P326, DOI 10.1249/MSS.0b013e3181b2ef8e; Nindl BC, 2007, MED SCI SPORT EXER, V39, P1380, DOI 10.1249/mss.0b013e318067e2f7; Paddon-Jones D, 2004, AM J PHYSIOL-ENDOC M, V286, pE321, DOI 10.1152/ajpendo.00368.2003; PANDOLF KB, 1977, J APPL PHYSIOL, V43, P577, DOI 10.1152/jappl.1977.43.4.577; Pasiakos SM, 2014, INT J OBESITY, V38, P1015, DOI 10.1038/ijo.2013.197; Pasiakos SM, 2013, J NUTR, V143, P1811, DOI 10.3945/jn.113.176859; Pasiakos SM, 2013, FASEB J, V27, P3837, DOI 10.1096/fj.13-230227; Pikosky MA, 2008, MED SCI SPORT EXER, V40, P505, DOI [10.1249/mss.0b013e31815f6643, 10.1249/MSS.0b013e31815f6643]; PIMENTAL NA, 1979, ERGONOMICS, V22, P963, DOI 10.1080/00140137908924670; ROSE MS, 1988, J APPL PHYSIOL, V65, P2545, DOI 10.1152/jappl.1988.65.6.2545; ROZA AM, 1984, AM J CLIN NUTR, V40, P168, DOI 10.1093/ajcn/40.1.168; Santee W. R., 2003, TN0303 US ARM RES I; SIRI W E, 1956, Adv Biol Med Phys, V4, P239; SOULE RG, 1972, J APPL PHYSIOL, V32, P706, DOI 10.1152/jappl.1972.32.5.706; STEIN TP, 1991, METABOLISM, V40, P478, DOI 10.1016/0026-0495(91)90228-O; STOCK MJ, 1978, J APPL PHYSIOL, V45, P345, DOI 10.1152/jappl.1978.45.3.345; TODD KS, 1984, J NUTR, V114, P2107, DOI 10.1093/jn/114.11.2107; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Volpi E, 1999, AM J PHYSIOL-ENDOC M, V277, pE513, DOI 10.1152/ajpendo.1999.277.3.E513; Weinheimer EM, 2010, NUTR REV, V68, P375, DOI 10.1111/j.1753-4887.2010.00298.x; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Wing-Gaia SL, 2014, APPL PHYSIOL NUTR ME, V39, P318, DOI 10.1139/apnm-2013-0319; Wolfe R.R., 2005, ISOTOPE TRACERMETA, Vsecond; Wycherley TP, 2012, AM J CLIN NUTR, V96, P1281, DOI 10.3945/ajcn.112.044321; Zaccagni L, 2014, HIGH ALT MED BIOL, V15, P176, DOI 10.1089/ham.2013.1133	63	40	40	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					894	905		10.1096/fj.201700915R	http://dx.doi.org/10.1096/fj.201700915R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29066613	Bronze			2022-12-28	WOS:000425146900031
J	Gomez, NM; Lu, WN; Lim, JC; Kiselyov, K; Campagno, KE; Grishchuk, Y; Slaugenhaupt, SA; Pfeffer, BA; Fliesler, SJ; Mitchell, CH				Gomez, Nestor Mas; Lu, Wennan; Lim, Jason C.; Kiselyov, Kirill; Campagno, Keith E.; Grishchuk, Yulia; Slaugenhaupt, Susan A.; Pfeffer, Bruce A.; Fliesler, Steven J.; Mitchell, Claire H.			Robust lysosomal calcium signaling through channel TRPML1 is impaired by lysosomal lipid accumulation	FASEB JOURNAL			English	Article						cellular aging; calcium signaling; lysosomal storage disease; RPE; mucolipin	MUCOLIPIDOSIS TYPE-IV; ION CHANNELS; STEM-CELLS; DISEASE; LIPOFUSCIN; RPE; PH; ACTIVATION; AUTOPHAGY; GENE	The transient receptor potential cation channelmucolipin 1 (TRPML1) channel is a conduit for lysosomal calcium efflux, and channel activity may be affected by lysosomal contents. The lysosomes of retinal pigmented epithelial (RPE) cells are particularly susceptible to build-up of lysosomal waste products because they must degrade the outer segments phagocytosed daily from adjacent photoreceptors; incomplete degradation leads to accumulation of lipid waste in lysosomes. This study asks whether stimulation of TRPML1 can release lysosomal calcium in RPE cells and whether such release is affected by lysosomal accumulations. The TRPML agonist ML-SA1 raised cytoplasmic calcium levels in mouse RPE cells, hesRPE cells, and ARPE-19 cells; this increase was rapid, robust, reversible, and reproducible. The increase was not altered by extracellular calcium removal or by thapsigargin but was eliminated by lysosomal rupture with glycyl-L-phenylalanine-beta-naphthylamide. Treatment with desipramine to inhibit acid sphingomyelinase or YM201636 to inhibit PIKfyve also reduced the cytoplasmic calcium increase triggered by ML-SA1, whereas RPE cells from TRPML1(-/-) mice showed no response to ML-SA1. Cotreatment with chloroquine and U18666A induced formation of neutral, autofluorescent lipid in RPE lysosomes and decreased lysosomal Ca2+ release. Lysosomal Ca2+ release was also impaired in RPE cells from the ATP-binding cassette, subfamily A, member 4(-/-) mouse model of Stargardt's retinal dystrophy. Neither TRPML1 mRNA nor total lysosomal calcium levels were altered in these models, suggesting a more direct effect on the channel. In summary, stimulation of TRPML1 elevates cytoplasmic calcium levels in RPE cells, but this response is reduced by lysosomal accumulation.	[Gomez, Nestor Mas; Lu, Wennan; Lim, Jason C.; Campagno, Keith E.; Mitchell, Claire H.] Univ Penn, Dept Anat & Cell Biol, 440 Levy Bldg,240 S 40th St, Philadelphia, PA 19104 USA; [Mitchell, Claire H.] Univ Penn, Dept Ophthalmol, Philadelphia, PA 19104 USA; [Mitchell, Claire H.] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; [Kiselyov, Kirill] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Grishchuk, Yulia; Slaugenhaupt, Susan A.] Harvard Med Sch, Massachusetts Gen Hosp, Res Inst, Ctr Genom Med, Boston, MA USA; [Grishchuk, Yulia; Slaugenhaupt, Susan A.] Harvard Med Sch, Massachusetts Gen Hosp, Res Inst, Dept Neurol, Boston, MA USA; [Pfeffer, Bruce A.; Fliesler, Steven J.] State Univ New York SUNY Univ, Jacobs Sch Med & Biomed Sci, Ross Eye Inst, Dept Ophthalmol, Buffalo, NY USA; [Pfeffer, Bruce A.; Fliesler, Steven J.] State Univ New York SUNY Univ, Jacobs Sch Med & Biomed Sci, Dept Biochem, Buffalo, NY USA; [Pfeffer, Bruce A.; Fliesler, Steven J.] SUNY Eye Inst, Buffalo, NY USA; [Pfeffer, Bruce A.; Fliesler, Steven J.] Vet Affairs Western New York Healthcare Syst, Res Serv, Buffalo, NY USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Mitchell, CH (corresponding author), Univ Penn, Dept Anat & Cell Biol, 440 Levy Bldg,240 S 40th St, Philadelphia, PA 19104 USA.	chm@upenn.edu	Fliesler, Steven J./AAE-9243-2020	Kiselyov, Kirill/0000-0001-6683-2895; Campagno, Keith/0000-0003-1079-947X; Fliesler, Steven/0000-0002-2557-142X	U.S. National Institutes of Health (NIH) National Eye Institute [EY015537, EY013434, EY001583, EY007361]; NIH National Center for Advancing Translational Science Grant [U54 TR001358]; Jody Sack Fund; Research to Prevent Blindness to the Department of Ophthalmology, SUNY-University at Buffalo; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY015537, R01EY007361, P30EY001583, R01EY013434] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH National Center for Advancing Translational Science Grant; Jody Sack Fund; Research to Prevent Blindness to the Department of Ophthalmology, SUNY-University at Buffalo; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank Lincoln Johnson (Laboratory for Stem Cell Biology and Engineering, Neuroscience Research Institute, University of California, Santa Barbara, Santa Barbara, CA, USA) for the generous donation of hesRPE cells. This work was supported by U.S. National Institutes of Health (NIH) National Eye Institute Grants EY015537 and EY013434 and Core Grant EY001583 (to C.H.M.) and EY007361 (to S.J.F.), by NIH National Center for Advancing Translational Science Grant U54 TR001358 to SUNY-University at Buffalo (S.J.F.), by the Jody Sack Fund (to W.L.), and by an Unrestricted Grant from Research to Prevent Blindness to the Department of Ophthalmology, SUNY-University at Buffalo, from Research to Prevent Blindness (to S.J.F.). The opinions expressed herein do not necessarily reflect those of the Veterans Administration or the U.S. Government. The authors declare no conflicts of interest.	Al-Bari MAA, 2015, J ANTIMICROB CHEMOTH, V70, P1608, DOI 10.1093/jac/dkv018; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Bach G, 2001, MOL GENET METAB, V73, P197, DOI 10.1006/mgme.2001.3195; Bargal R, 2001, HUM MUTAT, V17, P397, DOI 10.1002/humu.1115; Cao Q, 2017, J BIOL CHEM, V292, P8424, DOI 10.1074/jbc.M116.772160; Cenedella RJ, 2009, LIPIDS, V44, P477, DOI 10.1007/s11745-009-3305-7; Chandra M, 2011, GASTROENTEROLOGY, V140, P857, DOI 10.1053/j.gastro.2010.11.040; Chen CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5681; Cheng XP, 2014, NAT MED, V20, P1187, DOI 10.1038/nm.3611; Christensen KA, 2002, J CELL SCI, V115, P599; Coen K, 2012, J CELL BIOL, V198, P23, DOI 10.1083/jcb.201201076; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Emanuel R, 2014, ARTERIOSCL THROM VAS, V34, P1942, DOI 10.1161/ATVBAHA.114.303342; Frost LS, 2014, EXP EYE RES, V124, P56, DOI 10.1016/j.exer.2014.04.010; Goldin E, 2008, INVEST OPHTH VIS SCI, V49, P3134, DOI 10.1167/iovs.07-1649; Gomez NM, 2013, PFLUG ARCH EUR J PHY, V465, P481, DOI 10.1007/s00424-012-1181-0; GOMEZ NM, 2016, INVEST OPHTHALMOL VI, V57; Grishchuk Y, 2016, AM J PATHOL, V186, P199, DOI 10.1016/j.ajpath.2015.09.017; Guha S, 2014, ADV EXP MED BIOL, V801, P105, DOI 10.1007/978-1-4614-3209-8_14; Guha S, 2013, FASEB J, V27, P4500, DOI 10.1096/fj.13-236166; Guha S, 2012, J NEUROCHEM, V122, P823, DOI 10.1111/j.1471-4159.2012.07804.x; JADOT M, 1984, BIOCHEM J, V219, P965, DOI 10.1042/bj2190965; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; Karmakar M, 2015, J IMMUNOL, V194, P1763, DOI 10.4049/jimmunol.1401624; Kawasaki T, 2013, CELL HOST MICROBE, V14, P148, DOI 10.1016/j.chom.2013.07.011; Kellner U, 2008, DOC OPHTHALMOL, V116, P119, DOI 10.1007/s10633-007-9105-6; Kim SR, 2004, P NATL ACAD SCI USA, V101, P11668, DOI 10.1073/pnas.0403499101; Kolzer M, 2004, FEBS LETT, V559, P96, DOI 10.1016/S0014-5793(04)00033-X; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; Li XR, 2016, NAT CELL BIOL, V18, P404, DOI 10.1038/ncb3324; Liu J, 2008, INVEST OPHTH VIS SCI, V49, P772, DOI 10.1167/iovs.07-0675; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Lloyd-Evans E, 2016, J CELL BIOL, V212, P755, DOI 10.1083/jcb.201603037; Lu WN, 2015, INVEST OPHTH VIS SCI, V56; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Ma XC, 2012, AUTOPHAGY, V8, P297, DOI 10.4161/auto.18658; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; Medina DL, 2011, DEV CELL, V21, P421, DOI 10.1016/j.devcel.2011.07.016; Melchionda M, 2016, J CELL BIOL, V212, P803, DOI 10.1083/jcb.201510019; Mitter SK, 2014, AUTOPHAGY, V10, P1989, DOI 10.4161/auto.36184; Pfeffer BA, 1991, PROG RETINAL RES, V10, P251; Reigada D, 2005, AM J PHYSIOL-CELL PH, V289, pC617, DOI 10.1152/ajpcell.00542.2004; Rowland TJ, 2013, J TISSUE ENG REGEN M, V7, P642, DOI 10.1002/term.1458; Samie M, 2013, DEV CELL, V26, P511, DOI 10.1016/j.devcel.2013.08.003; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Shen DB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1735; Soyombo AA, 2006, J BIOL CHEM, V281, P7294, DOI 10.1074/jbc.M508211200; Sparrow JR, 2013, INVEST OPHTH VIS SCI, V54, P8325, DOI 10.1167/iovs.13-13214; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Strauss O, 2016, ADV EXP MED BIOL, V854, P739, DOI 10.1007/978-3-319-17121-0_98; Sun M, 2000, HUM MOL GENET, V9, P2471, DOI 10.1093/hmg/9.17.2471; Toops KA, 2015, MOL BIOL CELL, V26, P1, DOI 10.1091/mbc.E14-05-1028; Venkatachalam K, 2006, J BIOL CHEM, V281, P17517, DOI 10.1074/jbc.M600807200; Venugopal B, 2007, AM J HUM GENET, V81, P1070, DOI 10.1086/521954; Virador VM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005136; Wang WY, 2015, P NATL ACAD SCI USA, V112, pE1373, DOI 10.1073/pnas.1419669112; Proft Juliane, 2012, Commun Integr Biol, V5, P301, DOI [10.4161/cib.20373, 10.4161/cib.21799]; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wimmers S, 2007, PROG RETIN EYE RES, V26, P263, DOI 10.1016/j.preteyeres.2006.12.002; Wu BX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133032; Xu HX, 2015, ANNU REV PHYSIOL, V77, P57, DOI 10.1146/annurev-physiol-021014-071649; Zeiger U, 2010, EXP EYE RES, V91, P613, DOI 10.1016/j.exer.2010.07.019; Zhang M, 2010, NEUROCHEM INT, V56, P35, DOI 10.1016/j.neuint.2009.08.011; Zhang XZ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10938; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	67	28	28	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					782	794		10.1096/fj.201700220RR	http://dx.doi.org/10.1096/fj.201700220RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29030399	Green Published			2022-12-28	WOS:000425146900021
J	Lee, IW; Jo, YJ; Jung, SM; Wang, HY; Kim, NH; Namgoong, S				Lee, In-Won; Jo, Yu-Jin; Jung, Seung-Min; Wang, Hai-Yang; Kim, Nam-Hyung; Namgoong, Suk			Distinct roles of Cep192 and Cep152 in acentriolar MTOCs and spindle formation during mouse oocyte maturation	FASEB JOURNAL			English	Article						PLK4; PCM; CDK1; meiosis	MICROTUBULE-ORGANIZING CENTERS; CHROMOSOME SEGREGATION; GAMMA-TUBULIN; PERICENTRIOLAR MATERIAL; CENTRIOLE BIOGENESIS; CENTROSOME FUNCTION; MAMMALIAN OOCYTES; PROMOTING FACTOR; MEIOSIS-I; PLK4	Mammalian oocytes lack a centriole that acts as a microtubule organization center (MTOC) in most somatic cells. During oocyte maturation, MTOCs undergo remodeling processes, including decondensation, fragmentation, and self-organization. However, the underlying mechanisms of MTOC remodeling in mouse oocytes are not well understood. We showed that two pericentriolar proteins, Cep192 and Cep152, play crucial roles during MTOC remodeling in mouse oocytes. Cep192 is present in MTOCs at all stages of oocyte maturation, and its depletion induces ablation of MTOCs, delay in spindle formation, and abnormal chromosomal alignment in spindles. In the case of Cep152, its localization on MTOCs is limited at the germinal vesicle stage and then disappears from the MTOCs after the germinal vesicle breakdown stage. Cep152 exclusion from MTOCs is involved in the fragmentation of MTOCs, and it is regulated by cyclin-dependent kinase 1 activity. Our results demonstrate the different roles of Cep192 and Cep152 in MTOC remodeling and a novel regulatory mechanism during meiotic spindle formation in mouse oocytes.	[Lee, In-Won; Jo, Yu-Jin; Jung, Seung-Min; Wang, Hai-Yang; Kim, Nam-Hyung; Namgoong, Suk] Chungbuk Natl Univ, Dept Anim Sci, Cheongju, South Korea	Chungbuk National University	Kim, NH; Namgoong, S (corresponding author), Chungbuk Natl Univ, Chungdae Ro 1, Cheongju 28644, Chungbuk, South Korea.	nhkim@chungbuk.ac.kr; suknamgoong@chungbuk.ac.kr		WANG, HAIYANG/0000-0002-6362-6022; Lee, In-won/0000-0003-4336-5897	Next Generation Biogreen 21 Program from South Korean Rural Developmental Administration [PJ011206, PJ011126]	Next Generation Biogreen 21 Program from South Korean Rural Developmental Administration	This study was supported by Next Generation Biogreen 21 Program Grants PJ011206 (to S.M.) and PJ011126 (to N.-H. K.) from South Korean Rural Developmental Administration. The authors declare no conflicts of interest.	Adhikari D, 2014, MOL CELL ENDOCRINOL, V382, P480, DOI 10.1016/j.mce.2013.07.027; Baumann C, 2017, J CELL SCI, V130, P1251, DOI 10.1242/jcs.196188; Bennabi I, 2016, J CELL BIOL, V215, P611, DOI 10.1083/jcb.201607062; CALARCOGILLAM PD, 1983, CELL, V35, P621, DOI 10.1016/0092-8674(83)90094-6; Carabatsos MJ, 2000, MICROSC RES TECHNIQ, V49, P435, DOI 10.1002/(SICI)1097-0029(20000601)49:5<435::AID-JEMT5>3.0.CO;2-H; CHOI T, 1991, DEVELOPMENT, V113, P789; Cizmecioglu O, 2010, J CELL BIOL, V191, P731, DOI 10.1083/jcb.201007107; Clift D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8217; Clift D, 2013, NAT REV MOL CELL BIO, V14, P549, DOI 10.1038/nrm3643; Coelho PA, 2013, DEV CELL, V27, P586, DOI 10.1016/j.devcel.2013.09.029; Conduit PT, 2015, NAT REV MOL CELL BIO, V16, P611, DOI 10.1038/nrm4062; Courtois A, 2012, J CELL BIOL, V198, P357, DOI 10.1083/jcb.201202135; Davydenko O, 2013, J CELL BIOL, V202, P221, DOI 10.1083/jcb.201303019; Delattre M, 2006, CURR BIOL, V16, P1844, DOI 10.1016/j.cub.2006.07.059; Dumont J, 2007, J CELL BIOL, V176, P295, DOI 10.1083/jcb.200605199; Dzhindzhev NS, 2010, NATURE, V467, P714, DOI 10.1038/nature09445; Firat-Karalar EN, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0460; Gomez-Ferreria MA, 2007, CURR BIOL, V17, P1960, DOI 10.1016/j.cub.2007.10.019; GUETHHALLONET C, 1993, J CELL SCI, V105, P157; HOLLOWAY SL, 1993, CELL, V73, P1393, DOI 10.1016/0092-8674(93)90364-V; Holubcova Z, 2015, SCIENCE, V348, P1143, DOI 10.1126/science.aaa9529; Joukov V, 2014, MOL CELL, V55, P578, DOI 10.1016/j.molcel.2014.06.016; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Kim TS, 2013, P NATL ACAD SCI USA, V110, pE4849, DOI 10.1073/pnas.1319656110; Kollman JM, 2011, NAT REV MOL CELL BIO, V12, P709, DOI 10.1038/nrm3209; Lawo S, 2012, NAT CELL BIOL, V14, P1148, DOI 10.1038/ncb2591; Lee J, 2000, BIOL REPROD, V62, P1184, DOI 10.1095/biolreprod62.5.1184; LEMAIRE P, 1995, CELL, V81, P85, DOI 10.1016/0092-8674(95)90373-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Ma W, 2010, DEV BIOL, V339, P439, DOI 10.1016/j.ydbio.2010.01.009; MARO B, 1985, J CELL BIOL, V101, P1665, DOI 10.1083/jcb.101.5.1665; Meng L, 2015, MOL CELL BIOL, V35, P2626, DOI 10.1128/MCB.00068-15; Park SY, 2014, NAT STRUCT MOL BIOL, V21, P696, DOI 10.1038/nsmb.2846; Sanchez-Huertas C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12187; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Sonnen KF, 2013, J CELL SCI, V126, P3223, DOI 10.1242/jcs.129502; SZOLLOSI D, 1972, J CELL SCI, V11, P521; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Wong YL, 2015, SCIENCE, V348, P1155, DOI 10.1126/science.aaa5111; Woodruff JB, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0459	42	9	9	5	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					625	638		10.1096/fj.201700559RR	http://dx.doi.org/10.1096/fj.201700559RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	28970258				2022-12-28	WOS:000425146900009
J	Wang, XJ; Zhang, X; Chu, ESH; Chen, XT; Kang, W; Wu, F; To, KF; Wong, VWS; Chan, HLY; Chan, MTV; Sung, JJY; Wu, WKK; Yu, J				Wang, Xiaojuan; Zhang, Xiang; Chu, Eagle S. H.; Chen, Xiaoting; Kang, Wei; Wu, Feng; To, Ka-Fai; Wong, Vincent W. S.; Chan, Henry L. Y.; Chan, Matthew T. V.; Sung, Joseph J. Y.; Wu, William K. K.; Yu, Jun			Defective lysosomal clearance of autophagosomes and its clinical implications in nonalcoholic steatohepatitis	FASEB JOURNAL			English	Article						NAFLD; autophagy; lysosome; asparagine synthetase	STRESS; HEPATOCYTES; ASPARAGINE; FLUX	Autophagic impairment is implicated in nonalcoholic fatty liver disease (NAFLD), but the molecular mechanism is unclear. We found that autophagic flux was significantly inhibited in 3 murine models of NAFLD. Interestingly, the number of acidic organelles and the level of mature cathepsin D were reduced, suggesting defective lysosome acidification. Asparagine synthetase (ASNS) was induced by endoplasmic reticulum stress, leading to the generation of asparagine, which inhibited lysosome acidification. Both steatotic-and asparaginetreated hepatocytes showed reduced lysosomal acidity and retention of lysosomal calcium. Knockdown ofASNS in steatotic hepatocytes restored autophagic flux. As a potential biomarker, increased serum p62/sequestosome 1 (SQSTM1) level was an independent risk factor for patients with steatosis and lobular inflammation. Impaired autophagy inNAFLDis elicited by defective lysosome acidification, which is caused byASNS-induced asparagine synthesis under endoplasmic reticulum stress and subsequent retention of lysosomal calcium. p62/SQSTM1 could be used as a noninvasive biomarker in the diagnosis ofNAFLDpatients.	[Wang, Xiaojuan; Zhang, Xiang; Chu, Eagle S. H.; Wu, Feng; Wong, Vincent W. S.; Chan, Henry L. Y.; Sung, Joseph J. Y.; Wu, William K. K.; Yu, Jun] Chinese Univ Hong Kong, CUHK Shenzhen Res Inst, Li Ka Shing Inst Hlth Sci, Inst Digest Dis,Dept Med & Therapeut,State Key La, Hong Kong, Hong Kong, Peoples R China; [Chen, Xiaoting; Chan, Matthew T. V.; Wu, William K. K.] Chinese Univ Hong Kong, Dept Anesthesia & Intens Care, Hong Kong, Hong Kong, Peoples R China; [Kang, Wei; Wu, Feng; To, Ka-Fai] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Wu, WKK (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anesthesia & Intens Care, 04C14 Main Clin Block & Trauma Ctr, Shatin, Hong Kong, Peoples R China.; Yu, J (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Inst Digest Dis, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.	wukakei@cuhk.edu.hk; junyu@cuhk.edu.hk	Sung, Joseph J. Y./R-3203-2018; Wong, Vincent WS/K-3864-2014; Wu, William K.K./A-3277-2009; wu, william/HII-5817-2022; ZHANG, Xiang/N-7918-2015; KANG, Wei/C-5451-2016; Yu, Jun/D-8569-2015; Chan, Henry Lik-Yuen/B-9636-2008; Chan, Matthew/J-2884-2013; Wong, Grace LH/L-8586-2014	Sung, Joseph J. Y./0000-0003-3125-5199; Wong, Vincent WS/0000-0003-2215-9410; Wu, William K.K./0000-0002-5662-5240; ZHANG, Xiang/0000-0002-3222-5824; KANG, Wei/0000-0002-4651-677X; Yu, Jun/0000-0001-5008-2153; Chan, Henry Lik-Yuen/0000-0002-7790-1611; Chan, Matthew/0000-0002-3574-7855; Wong, Grace LH/0000-0002-2863-9389; WANG, Echo/0000-0001-6229-5690	National Basic Research Program of China (973 Program) [2013CB531401]; Theme-Based Research Scheme of the Hong Kong Research Grants Council [T12-403-11]; Collaborative Research Fund [HKU3/CRF11R, CUHK3/CRF/12R]; Early Career Scheme of the Research Grant Council Hong Kong [24115815]; Shenzhen Science and Technology Programme of the Shenzhen Science and Technology Innovation Commission [JCYJ20150630165236956, JCYC20140905151710921]; Natural Science Foundation of Guangdong Province of the Department of Science and Technology [2015A030313886]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Theme-Based Research Scheme of the Hong Kong Research Grants Council; Collaborative Research Fund; Early Career Scheme of the Research Grant Council Hong Kong; Shenzhen Science and Technology Programme of the Shenzhen Science and Technology Innovation Commission; Natural Science Foundation of Guangdong Province of the Department of Science and Technology	The authors thank G.C. Farrell (Australian National University Medical School, Canberra, ACT, Australia) for providing the foz/foz mice. This work was supported by the National Basic Research Program of China (973 Program; 2013CB531401), Theme-Based Research Scheme of the Hong Kong Research Grants Council (T12-403-11), Collaborative Research Fund (HKU3/CRF11R, CUHK3/CRF/12R), Early Career Scheme (24115815) of the Research Grant Council Hong Kong, Shenzhen Science and Technology Programme of the Shenzhen Science and Technology Innovation Commission (JCYJ20150630165236956, JCYC20140905151710921), and the Natural Science Foundation of Guangdong Province of the Department of Science and Technology (2015A030313886). The authors declare no conflict of interest.	B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Balasubramanian MN, 2013, AM J PHYSIOL-ENDOC M, V304, pE789, DOI 10.1152/ajpendo.00015.2013; Bernales S, 2012, FRONT AGING NEUROSCI, V4, DOI 10.3389/fnagi.2012.00005; Coen K, 2012, J CELL BIOL, V198, P23, DOI 10.1083/jcb.201201076; FENGSRUD M, 1995, EXP CELL RES, V221, P504, DOI 10.1006/excr.1995.1402; Fukuo Y, 2014, HEPATOL RES, V44, P1026, DOI 10.1111/hepr.12282; Giatromanolaki A, 2010, J CLIN PATHOL, V63, P867, DOI 10.1136/jcp.2010.079525; Gonzalez-Rodriguez A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.162; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Lin CW, 2013, J HEPATOL, V58, P993, DOI 10.1016/j.jhep.2013.01.011; Liu HY, 2009, J BIOL CHEM, V284, P31484, DOI 10.1074/jbc.M109.033936; Ni HM, 2011, AUTOPHAGY, V7, P188, DOI 10.4161/auto.7.2.14181; Porter K, 2013, AUTOPHAGY, V9, P581, DOI 10.4161/auto.23568; Rikiishi Hidemi, 2012, Int J Cell Biol, V2012, P317645, DOI 10.1155/2012/317645; Shen JY, 2012, J HEPATOL, V56, P1363, DOI 10.1016/j.jhep.2011.12.025; Shi B, 2017, AUTOPHAGY, V13, P285, DOI 10.1080/15548627.2016.1261238; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Wang XJ, 2013, AUTOPHAGY, V9, P1500, DOI 10.4161/auto.25573; Wree A, 2013, NAT REV GASTRO HEPAT, V10, P627, DOI 10.1038/nrgastro.2013.149; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Yla-Anttila P, 2009, METHOD ENZYMOL, V452, P143, DOI 10.1016/S0076-6879(08)03610-0; Yu J, 2010, GASTROENTEROLOGY, V138, P694, DOI 10.1053/j.gastro.2009.09.058; Zhang XQ, 2014, WORLD J GASTROENTERO, V20, P1768, DOI 10.3748/wjg.v20.i7.1768; Zois CE, 2011, AUTOPHAGY, V7, P1371, DOI 10.4161/auto.7.11.16664	25	46	48	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					37	51		10.1096/fj.201601393R	http://dx.doi.org/10.1096/fj.201601393R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28842428				2022-12-28	WOS:000419172700006
J	Hormaechea-Agulla, D; Jimenez-Vacas, JM; Gomez-Gomez, E; Lopez, FL; Carrasco-Valiente, J; Valero-Rosa, J; Moreno, MM; Sanchez-Sanchez, R; Ortega-Salas, R; Gracia-Navarro, F; Culler, MD; Ibanez-Costa, A; Gahete, MD; Requena, MJ; Castano, JP; Luque, RM				Hormaechea-Agulla, Daniel; Jimenez-Vacas, Juan M.; Gomez-Gomez, Enrique; Lopez, Fernando L. -; Carrasco-Valiente, Julia; Valero-Rosa, Jose; Moreno, Maria M.; Sanchez-Sanchez, Rafael; Ortega-Salas, Rosa; Gracia-Navarro, Francisco; Culler, Michael D.; Ibanez-Costa, Alejandro; Gahete, Manuel D.; Requena, Maria J.; Castano, Justo P.; Luque, Raul M.			The oncogenic role of the spliced somatostatin receptor sst5TMD4 variant in prostate cancer	FASEB JOURNAL			English	Article						splicing; biomarker; aggressiveness; metastasis; xenograft models	GROWTH-FACTOR-I; ANALOG LANREOTIDE; SUBTYPE 5; CELL-GROWTH; PATHWAY; NEUROENDOCRINE; INCREASES; PROTEIN; AGGRESSIVENESS; IDENTIFICATION	sst5TMD4, a splice variant of the sst5 gene, is overexpressed and associated with aggressiveness in various endocrine-related tumors, but its presence, functional role, and mechanisms of actions in prostate cancer (PCa)the most common cancer type in malesis completely unexplored. In this study, formalin-fixed, paraffin-embedded prostate pieces from patients with localized PCa, which included tumoral and nontumoral adjacent regions (n = 45), fresh biopsies from patients with high-risk PCa (n = 52), and healthy fresh prostates from cystoprostatectomies (n = 14) were examined. In addition, PCa cell lines and xenograft models were used to determine the presence and functional role of sst5TMD4. Results demonstrated that sst5TMD4 is overexpressed (mRNA/protein) in PCa samples, and this is especially drastic in metastatic and/or high Gleason score tumor samples. Remarkably, sst5TMD4 expression was associated with an altered frequency of 2 single-nucleotide polymorphisms: rs197055 and rs12599155. In addition, PCa cell lines and xenograft models were used to demonstrate that sst5TMD4 overexpression increases cell proliferation and migration in PCa cells and induces larger tumors in nude mice, whereas its silencing decreased proliferation and migration. Remarkably, sst5TMD4 overexpression activated multiple intracellular pathways (ERK/JNK, MYC/MAX, WNT, retinoblastoma), altered oncogenes and tumor suppressor gene expression, and disrupted the normal response to somatostatin analogs in PCa cells. Altogether, we demonstrate that sst5TMD4 is overexpressed in PCa, especially in those patients with a worse prognosis, and plays an important pathophysiologic role in PCa, which suggesting its potential as a biomarker and/or therapeutic target.	[Hormaechea-Agulla, Daniel; Jimenez-Vacas, Juan M.; Gomez-Gomez, Enrique; Lopez, Fernando L. -; Carrasco-Valiente, Julia; Valero-Rosa, Jose; Moreno, Maria M.; Sanchez-Sanchez, Rafael; Ortega-Salas, Rosa; Gracia-Navarro, Francisco; Ibanez-Costa, Alejandro; Gahete, Manuel D.; Requena, Maria J.; Castano, Justo P.; Luque, Raul M.] Maimonides Inst Biomed Res Cordoba IMIBIC, Cordoba, Spain; [Hormaechea-Agulla, Daniel; Jimenez-Vacas, Juan M.; Gomez-Gomez, Enrique; Lopez, Fernando L. -; Gracia-Navarro, Francisco; Ibanez-Costa, Alejandro; Gahete, Manuel D.; Castano, Justo P.; Luque, Raul M.] Univ Cordoba, Dept Cell Biol Physiol & Immunol, Cordoba, Spain; [Hormaechea-Agulla, Daniel; Jimenez-Vacas, Juan M.; Gomez-Gomez, Enrique; Lopez, Fernando L. -; Carrasco-Valiente, Julia; Valero-Rosa, Jose; Moreno, Maria M.; Sanchez-Sanchez, Rafael; Ortega-Salas, Rosa; Gracia-Navarro, Francisco; Ibanez-Costa, Alejandro; Gahete, Manuel D.; Requena, Maria J.; Castano, Justo P.; Luque, Raul M.] Hosp Univ Reina Sofia, Cordoba, Spain; [Hormaechea-Agulla, Daniel; Jimenez-Vacas, Juan M.; Lopez, Fernando L. -; Gracia-Navarro, Francisco; Ibanez-Costa, Alejandro; Gahete, Manuel D.; Castano, Justo P.; Luque, Raul M.] Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Cordoba, Spain; [Hormaechea-Agulla, Daniel; Jimenez-Vacas, Juan M.; Lopez, Fernando L. -; Gracia-Navarro, Francisco; Ibanez-Costa, Alejandro; Gahete, Manuel D.; Castano, Justo P.; Luque, Raul M.] Campus Excelencia Int Agroalimentario CEIA3, Cordoba, Spain; [Gomez-Gomez, Enrique; Carrasco-Valiente, Julia; Valero-Rosa, Jose; Requena, Maria J.] Hosp Univ Reina Sofia, Urol Serv, IMIBIC, Cordoba, Spain; [Moreno, Maria M.; Sanchez-Sanchez, Rafael; Ortega-Salas, Rosa] Hosp Univ Reina Sofia, Serv Anat Pathol, Cordoba, Spain; [Culler, Michael D.] Ipsen Biosci, Cambridge, MA USA	Universidad de Cordoba; Hospital Universitario Reina Sofia - Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Castano, JP; Luque, RM (corresponding author), Hosp Univ Reina Sofia, Inst Maimonides Invest Biomed Cordoba, Edificio Maimonides Inst Biomed Res Cordoba, Cordoba 14004, Spain.	justo@uco.es; raul.luque@uco.es	Gahete, Manuel D./C-4969-2009; Raul, Luque Huertas/M-6948-2018; Ibáñez-Costa, Alejandro/L-5323-2013; Gomez, Enrique Gomez/ABI-6063-2020; Castaño, Justo P/A-7124-2010	Gahete, Manuel D./0000-0002-4578-2179; Ibáñez-Costa, Alejandro/0000-0003-4649-0095; Castaño, Justo P/0000-0002-3145-7287; Carrasco Valiente, Julia/0000-0002-3974-3990; Gracia Navarro, Francisco/0000-0003-2128-4228; Culler, Michael D./0000-0001-5168-8739; Jimenez-Vacas, Juan/0000-0003-4391-3726; Moreno, Maria M/0000-0001-6846-8601; Luque, Raul M./0000-0002-7585-1913; Lopez, Fernando/0000-0002-0534-2304; Sanchez-Sanchez, Rafael/0000-0002-9821-0211; Gomez Gomez, Enrique/0000-0002-8753-3306	Instituto de Salud Carlos III; European Union [ERDF/ESF] [PI13-00651, PI16/00264]; Rio Hortega Grant [CM16/00180]; Miguel Servet Grant [CP15/00156]; MINECO [BFU2016-80360-R]; Junta de Andalucia [BIO-0139, CTS-1406, PI-0541-2013]; CIBERobn. CIBER is an initiative of Instituto de Salud Carlos III; Ministerio de Sanidad, Servicios Sociales e Igualdad	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Union [ERDF/ESF]; Rio Hortega Grant; Miguel Servet Grant; MINECO(Spanish Government); Junta de Andalucia(Junta de Andalucia); CIBERobn. CIBER is an initiative of Instituto de Salud Carlos III; Ministerio de Sanidad, Servicios Sociales e Igualdad(Spanish Government)	This study was supported by Instituto de Salud Carlos III, cofunded by the European Union [ERDF/ESF, Investing in your future; PI13-00651 and PI16/00264 to R.M.L., Rio Hortega Grant (CM16/00180) to E.G.-G., Miguel Servet Grant (CP15/00156) to M.D.G.], MINECO (BFU2016-80360-R; to J.P.C.), Junta de Andalucia (BIO-0139, CTS-1406, PI-0541-2013; to R.M.L., J.P.C., and M.D.G.), and CIBERobn. CIBER is an initiative of Instituto de Salud Carlos III, Ministerio de Sanidad, Servicios Sociales e Igualdad. The authors declare no conflicts of interest.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Berruti A, 2001, PROSTATE, V47, P205, DOI 10.1002/pros.1064; Cakir M, 2010, J CELL MOL MED, V14, P2570, DOI 10.1111/j.1582-4934.2010.01125.x; Carascossa S, 2006, MOL ENDOCRINOL, V20, P1506, DOI 10.1210/me.2005-0286; D'Angelillo RM, 2014, TUMORI, V100, P249, DOI 10.1700/1578.17192; Duran-Prado M, 2012, ONCOGENE, V31, P2049, DOI 10.1038/onc.2011.389; Duran-Prado M, 2010, J CLIN ENDOCR METAB, V95, P2497, DOI 10.1210/jc.2009-2247; Duran-Prado M, 2009, J CLIN ENDOCR METAB, V94, P2634, DOI 10.1210/jc.2008-2564; Fotouhi O, 2016, J CLIN ENDOCR METAB, V101, P3616, DOI 10.1210/jc.2016-2028; Friedlander TW, 2012, UROL ONCOL-SEMIN ORI, V30, P408, DOI 10.1016/j.urolonc.2010.06.014; Hay E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008284; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Ibanez-Costa A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08714; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Knudsen ES, 2010, CLIN CANCER RES, V16, P1094, DOI 10.1158/1078-0432.CCR-09-0787; Ladomery Michael, 2013, Int J Cell Biol, V2013, P463786, DOI 10.1155/2013/463786; Lapierre M, 2014, J CLIN INVEST, V124, P1899, DOI 10.1172/JCI65178; Lo Nigro C, 2008, BJU INT, V102, P622, DOI 10.1111/j.1464-410X.2008.07706.x; Lopez-Bergami P, 2007, CANCER CELL, V11, P447, DOI 10.1016/j.ccr.2007.03.009; Luque RM, 2015, CANCER LETT, V359, P299, DOI 10.1016/j.canlet.2015.01.037; Martin-Rodriguez JF, 2015, SCI REP-UK, V5, DOI 10.1038/srep16298; MAULARD C, 1995, CANCER CHEMOTH PHARM, V36, P259; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Mole D, 2015, ENDOCRINE, V50, P442, DOI 10.1007/s12020-015-0594-x; Ogata A, 1997, J IMMUNOL, V159, P2212; Park KS, 2006, J CELL SCI, V119, P819, DOI 10.1242/jcs.02779; Puig-Domingo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085527; Rai U, 2015, PHARMACOL THERAPEUT, V152, P98, DOI 10.1016/j.pharmthera.2015.05.007; Rajan P, 2009, NAT REV UROL, V6, P454, DOI 10.1038/nrurol.2009.125; REUBI JC, 1995, J CLIN ENDOCR METAB, V80, P2806, DOI 10.1210/jc.80.9.2806; Ruscica M, 2014, MOL CELL ENDOCRINOL, V382, P860, DOI 10.1016/j.mce.2013.10.027; Sampedro-Nunez M, 2016, ONCOTARGET, V7, P6593, DOI 10.18632/oncotarget.6565; Sciarra A, 2008, EUR UROL, V53, P652, DOI 10.1016/j.eururo.2007.02.010; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sternberg Cora N, 2014, Am Soc Clin Oncol Educ Book, P117, DOI 10.14694/EdBook_AM.2014.34.117; Sun LC, 2016, CURR DRUG TARGETS, V17, P529, DOI 10.2174/1389450116666141205163548; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Theodoropoulou M, 2013, FRONT NEUROENDOCRIN, V34, P228, DOI 10.1016/j.yfrne.2013.07.005; Uphoff Cord C, 2013, Methods Mol Biol, V946, P1, DOI 10.1007/978-1-62703-128-8_1; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wu GJ, 2007, CANCER RES, V67, P4123, DOI 10.1158/0008-5472.CAN-07-0012; Wyatt AW, 2015, EMBO MOL MED, V7, P878, DOI 10.15252/emmm.201303701; Zhang JS, 2007, ONCOGENE, V26, P111, DOI 10.1038/sj.onc.1209769; Zhu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091817	45	31	31	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4682	4696		10.1096/fj.201601264RRR	http://dx.doi.org/10.1096/fj.201601264RRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28705809				2022-12-28	WOS:000413398500003
J	Kim, M; Furuzono, T; Yamakuni, K; Li, YJ; Kim, YI; Takahashi, H; Ohue-Kitano, R; Jheng, HF; Takahashi, N; Kano, Y; Yu, RN; Kishino, S; Ogawa, J; Uchida, K; Yamazaki, J; Tominaga, M; Kawada, T; Goto, T				Kim, Minji; Furuzono, Tomoya; Yamakuni, Kanae; Li, Yongjia; Kim, Young-Il; Takahashi, Haruya; Ohue-Kitano, Ryuji; Jheng, Huei-Fen; Takahashi, Nobuyuki; Kano, Yuriko; Yu, Rina; Kishino, Shigenobu; Ogawa, Jun; Uchida, Kunitoshi; Yamazaki, Jun; Tominaga, Makoto; Kawada, Teruo; Goto, Tsuyoshi			10-oxo-12(Z)-octadecenoic acid, a linoleic acid metabolite produced by gut lactic acid bacteria, enhances energy metabolism by activation of TRPV1	FASEB JOURNAL			English	Article						UCP1; beige cells; fatty acids; gut microbiota; obesity	BROWN ADIPOSE-TISSUE; DIET-INDUCED THERMOGENESIS; CAPSAICIN-RECEPTOR; WHITE FAT; MICROBIOTA; OBESITY; MICE; INFLAMMATION; ADIPOGENESIS; HOMEOSTASIS	Gutmicrobiota can regulate the host energymetabolism; however, the underlying mechanisms that could involve gut microbiota-derived compounds remain to be understood. Therefore, in this study, we investigated the effects ofKetoA [10-oxo-12(Z)-octadecenoic acid]-a linoleic acidmetaboliteproduced by gut lactic acid bacteria-on whole-body energy metabolism and found that dietary intake of KetoA could enhance energy expenditure in mice, thereby protecting mice from diet-induced obesity. By using Ca2+ imaging and whole-cell patch-clamp methods, KetoA was noted to potently activate transient receptor potential vanilloid 1 (TRPV1) and enhance noradrenalin turnover in adipose tissues. In addition, KetoA up-regulated genes that are related to brown adipocyte functions, including uncoupling protein 1 (UCP1) inwhite adipose tissue (WAT), whichwas later diminished in the presence of a b-adrenoreceptor blocker. By using obese and diabetic model KK-Ay mice, we further show that KetoA intake ameliorated obesity-associatedmetabolic disorders. In the absence of any observedKetoA-induced antiobesity effect or UCP1 up-regulation in TRPV1-deficient mice, we prove that the antiobesity effect of KetoAwas caused by TRPV1 activation-mediated browning inWAT. KetoA produced in the gut could therefore be involved in the regulation of host energy metabolism.-Kim, M., Furuzono, T., Yamakuni, K., Li, Y., Kim, Y.-I., Takahashi, H., Ohue-Kitano, R., Jheng, H.-F., Takahashi, N., Kano, Y., Yu, R., Kishino, S., Ogawa, J., Uchida, K., Yamazaki, J., Tominaga, M., Kawada, T., Goto, T. 10-oxo-12(Z)-octadecenoic acid, a linoleic acid metabolite produced by gut lactic acid bacteria, enhances energy metabolism by activation of TRPV1.	[Kim, Minji; Furuzono, Tomoya; Yamakuni, Kanae; Li, Yongjia; Kim, Young-Il; Takahashi, Haruya; Ohue-Kitano, Ryuji; Jheng, Huei-Fen; Takahashi, Nobuyuki; Kawada, Teruo; Goto, Tsuyoshi] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Lab Mol Funct Food, Kyoto, Japan; [Kishino, Shigenobu; Ogawa, Jun] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Lab Fermentat Physiol & Appl Microbiol, Kyoto, Japan; [Ohue-Kitano, Ryuji; Takahashi, Nobuyuki; Ogawa, Jun; Kawada, Teruo; Goto, Tsuyoshi] Kyoto Univ, Res Unit Physiol Chem, Ctr Promot Interdisciplinary Educ & Res, Kyoto, Japan; [Kano, Yuriko] Kobe Womens Univ, Fac Home Econ, Nutr Chem Lab, Kobe, Hyogo, Japan; [Yu, Rina] Univ Ulsan, Dept Food Sci & Nutr, Ulsan, South Korea; [Uchida, Kunitoshi; Tominaga, Makoto] Natl Inst Nat Sci, Natl Inst Physiol Sci, Okazaki Inst Integrat Biosci, Div Cell Signaling, Okazaki, Aichi, Japan; [Uchida, Kunitoshi; Tominaga, Makoto] Grad Univ Adv Studies, Dept Physiol Sci, Hayama, Japan; [Uchida, Kunitoshi; Yamazaki, Jun] Fukuoka Dent Coll, Dept Physiol Sci & Mol Biol, Fukuoka, Japan	Kyoto University; Kyoto University; Kyoto University; University of Ulsan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan; Fukuoka Dental College (FDC)	Goto, T (corresponding author), Kyoto Univ, Uji, Kyoto 6110011, Japan.	tgoto@kais.kyoto-u.ac.jp	Goto, Tsuyoshi/AAY-2344-2020; Takahashi, Nobuyuki/AAX-8671-2021	Goto, Tsuyoshi/0000-0003-1283-147X; Takahashi, Nobuyuki/0000-0002-9705-662X; Kim, Minji/0000-0003-2322-9900	Ministry of Education, Culture, Sports, Science and Technology of Japan [15H02441, 16H02551, 16K14927, 16K07734]; Bio-Oriented Technology Research Advancement Institution of Japan [26002A]; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry from the Ministry of Agriculture, Forestry and Fisheries of Japan [26002AB]; Advanced Low Carbon Technology Research and Development Program of Japan; NEDO Innovation Commercialization Venture Support Project [15101647]; program in the Science Research Center (Center for Food and Nutritional Genomics Research) of the National Research Foundation of Korea - Ministry of Education, Science, and Technology [2015R1A5A6001906]; Cooperative Study Program of the National Institute for Physiological Sciences; Grants-in-Aid for Scientific Research [16H02551] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Bio-Oriented Technology Research Advancement Institution of Japan; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry from the Ministry of Agriculture, Forestry and Fisheries of Japan; Advanced Low Carbon Technology Research and Development Program of Japan; NEDO Innovation Commercialization Venture Support Project; program in the Science Research Center (Center for Food and Nutritional Genomics Research) of the National Research Foundation of Korea - Ministry of Education, Science, and Technology; Cooperative Study Program of the National Institute for Physiological Sciences; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank M. Komori and N. Kitamura (Kyoto University) for their technical assistance. The authors thank S. Shinotoh (Kyoto University) for secretarial support. This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (15H02441, 16H02551, 16K14927, and 16K07734); the Bio-Oriented Technology Research Advancement Institution of Japan (26002A); the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry from the Ministry of Agriculture, Forestry and Fisheries of Japan (26002AB); the Advanced Low Carbon Technology Research and Development Program of Japan; and the NEDO Innovation Commercialization Venture Support Project (15101647). R.Y. was supported by a program in the Science Research Center (Center for Food and Nutritional Genomics Research, Grant 2015R1A5A6001906) of the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology. This work was supported by the Cooperative Study Program of the National Institute for Physiological Sciences. The authors declare no conflicts of interest.	Akiba Y, 2004, BIOCHEM BIOPH RES CO, V321, P219, DOI 10.1016/j.bbrc.2004.06.149; Aron-Wisnewsky J, 2016, NAT REV NEPHROL, V12, P169, DOI 10.1038/nrneph.2015.191; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Blad CC, 2012, NAT REV DRUG DISCOV, V11, P603, DOI 10.1038/nrd3777; Boulange CL, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0303-2; BRODIE BB, 1966, J PHARMACOL EXP THER, V154, P493; Burant CF, 2013, DIABETES CARE, V36, pS175, DOI 10.2337/dcS13-2037; Cannon B, 1979, Methods Enzymol, V55, P65; Cao E, 2013, NEURON, V77, P667, DOI 10.1016/j.neuron.2012.12.016; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Cheung SY, 2015, ENDOCRINOLOGY, V156, P2074, DOI 10.1210/en.2014-1831; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; COUSIN B, 1992, J CELL SCI, V103, P931; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; DiBaise JK, 2012, AM J GASTROENTEROL S, V1, P22, DOI [10.1038/ajgsup.2012.5, DOI 10.1038/AJGSUP.2012.5]; Dorfman SE, 2009, OBESITY, V17, P1200, DOI 10.1038/oby.2008.662; Edvell A, 1998, AM J PHYSIOL-ENDOC M, V274, pE1034, DOI 10.1152/ajpendo.1998.274.6.E1034; Enos RT, 2013, J LIPID RES, V54, P152, DOI 10.1194/jlr.M030700; Gao Y, 2016, NATURE, V534, P347, DOI 10.1038/nature17964; Goto T, 2017, J BIOL CHEM, V292, P9175, DOI 10.1074/jbc.M116.767590; Goto T, 2015, BIOCHEM BIOPH RES CO, V459, P597, DOI 10.1016/j.bbrc.2015.02.154; Jequier E, 2002, ANN NY ACAD SCI, V967, P379, DOI 10.1111/j.1749-6632.2002.tb04293.x; Julius D, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005991; Kajimura S, 2014, ANNU REV PHYSIOL, V76, P225, DOI 10.1146/annurev-physiol-021113-170252; Kawabata F, 2009, BIOSCI BIOTECH BIOCH, V73, P2690, DOI 10.1271/bbb.90555; Kim M, 2015, SCI REP-UK, V5, DOI 10.1038/srep18013; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Kishino S, 2013, P NATL ACAD SCI USA, V110, P17808, DOI 10.1073/pnas.1312937110; Kovatcheva-Datchary P, 2013, BEST PRACT RES CL GA, V27, P59, DOI 10.1016/j.bpg.2013.03.017; Labbe SM, 2016, AM J PHYSIOL-ENDOC M, V311, pE260, DOI 10.1152/ajpendo.00545.2015; Leonelli M, 2011, BRAZ J MED BIOL RES, V44, P1088, DOI [10.1590/S0100-879X2011007500124, 10.1590/S0100-879X2011001100003]; Miyamoto J, 2015, J BIOL CHEM, V290, P2902, DOI 10.1074/jbc.M114.610733; Morales-Lazaro SL, 2014, J BIOL CHEM, V289, P24079, DOI 10.1074/jbc.M114.572503; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; O'Neill S, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12229; Ohyama K, 2016, DIABETES, V65, P1410, DOI 10.2337/db15-0662; Oi-Kano Y, 2013, J NUTR BIOCHEM, V24, P887, DOI 10.1016/j.jnutbio.2012.06.003; Park JW, 2015, J NUCL MED, V56, P153, DOI 10.2967/jnumed.114.147603; Razavi R, 2006, CELL, V127, P1123, DOI 10.1016/j.cell.2006.10.038; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Rosenbaum M, 2015, TRENDS ENDOCRIN MET, V26, P493, DOI 10.1016/j.tem.2015.07.002; Rothwell NJ, 1997, OBES RES, V5, P650, DOI 10.1002/j.1550-8528.1997.tb00591.x; Sacks H, 2013, DIABETES, V62, P1783, DOI 10.2337/db12-1430; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Shintaku K, 2012, BRIT J PHARMACOL, V165, P1476, DOI 10.1111/j.1476-5381.2011.01634.x; Sun WP, 2016, EMBO REP, V17, P383, DOI 10.15252/embr.201540819; Suri A, 2008, TRENDS PHARMACOL SCI, V29, P29, DOI 10.1016/j.tips.2007.10.016; Tilg H, 2010, J CLIN GASTROENTEROL, V44, pS16, DOI 10.1097/MCG.0b013e3181dd8b64; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; VANDERTUIG JG, 1984, METABOLISM, V33, P26, DOI 10.1016/0026-0495(84)90158-6; Velagapudi VR, 2010, J LIPID RES, V51, P1101, DOI 10.1194/jlr.M002774; Wang YX, 2010, CELL RES, V20, P124, DOI 10.1038/cr.2010.13; World Health Organization, 2018, OB OV FACT SHEET 311; Woting A, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040202; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200; Xue BZ, 2005, MOL CELL BIOL, V25, P8311, DOI 10.1128/MCB.25.18.8311-8322.2005; Ye L, 2012, CELL, V151, P96, DOI 10.1016/j.cell.2012.08.034; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; Yoo S, 2014, MOLECULES, V19, P4708, DOI 10.3390/molecules19044708; YOUNG JB, 1982, J CLIN INVEST, V69, P1061, DOI 10.1172/JCI110541; Zhang LL, 2007, CIRC RES, V100, P1063, DOI 10.1161/01.RES.0000262653.84850.8b	64	44	46	1	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					5036	5048		10.1096/fj.201700151R	http://dx.doi.org/10.1096/fj.201700151R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28754711				2022-12-28	WOS:000413398500032
J	Kwon, D; Park, E; Kang, SJ				Kwon, Dohyeong; Park, Eunbyeol; Kang, Suk-Jo			Stimulator of IFN genes-mediated DNA-sensing pathway is suppressed by NLRP3 agonists and regulated by mitofusin 1 and TBC1D15, mitochondrial dynamics mediators	FASEB JOURNAL			English	Article						inflammasome; mitochondria fission; IFN-beta pathway	CYCLIC DI-GMP; CELLULAR ANTIVIRAL RESPONSE; INNATE IMMUNE-RESPONSE; INFLAMMASOME ACTIVATION; I INTERFERON; NALP3 INFLAMMASOME; 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID; INTERLEUKIN-1-BETA RELEASE; ADAPTIVE IMMUNITY; SIGNALING PROTEIN	The stimulator of IFN genes (STING)-mediated DNA-sensing pathway plays an important role in the innate immune response to pathogen infection, autoimmunity, and cancer; however, its regulatory mechanism has not been fully elucidated, and we do not yet know whether the STING pathway is counter-regulated by other innate immune pathways. Here, we show that the NLRP3-activating agonists, ATP and nigericin, prevent STING pathway activation in association with mitochondrial fragmentation; however, the suppression of the STING pathway and mitochondria fission were not dependent on NLRP3 or potassium efflux. Although nigericin-induced mitochondria fission was rescued by knockdown of either dynamin-related protein 1 or TBC1 domain family member 15 (TBC1D15), which are two distinct mitochondria fission regulators, only TBC1D15 restored the activity of the STING pathway, which indicates that inflammasome-activating signals curtail STING pathway activation via TBC1D15. Finally, we found that deficiency of mitofusin (MFN) 1, a mediator of mitochondrial fusion, inhibited STING pathway activation, which leads to a decrease in the induction of IFN-beta and its inducible gene, ISG56, in conjunction with diminished activation of the signaling molecules, TANK-binding kinase 1 and IFN regulatory factor 3, that are downstream of STING. These results highlight the crucial role of MFN1 in maintaining the competency of the STING pathway. Collectively, our findings reveal that mitochondrial dynamics regulators modulate the activation of the STING signaling pathway.	[Kwon, Dohyeong; Park, Eunbyeol; Kang, Suk-Jo] Korea Adv Inst Sci & Technol, Dept Biol Sci, 291 Daehak Ro, Daejeon 34141, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Kang, SJ (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, 291 Daehak Ro, Daejeon 34141, South Korea.	suk-jo.kang@kaist.ac.kr			National Research Foundation of Korea [NRF-2017R1A2B4007817]	National Research Foundation of Korea(National Research Foundation of Korea)	The authors thank their laboratory colleagues and are grateful to Dr. D. C. Chan (Caltech, Pasadena, CA, USA) for helpful input, Dr. S. Yanagi (Tokyo University of Pharmacy and Life Science, Tokyo, Japan), Dr. H. K. Lee (Korea Advanced Institute of Science and Technology), Dr. J. W. Yu (Yonsei University, Seoul, South Korea), Dr. G. M. Barton (University of California, Berkeley), and Dr. M. J. Song (Korea University) for providing valuable reagents and mice. This work was supported by the National Research Foundation of Korea (NRF-2017R1A2B4007817). The authors declare no conflicts of interest.	Allam R, 2014, EMBO REP, V15, P982, DOI 10.15252/embr.201438463; Arnoult D, 2011, EMBO REP, V12, P901, DOI 10.1038/embor.2011.157; Barber GN, 2014, TRENDS IMMUNOL, V35, P88, DOI 10.1016/j.it.2013.10.010; Cavlar T, 2013, EMBO J, V32, P1440, DOI 10.1038/emboj.2013.86; Chin KH, 2013, ACTA CRYSTALLOGR D, V69, P352, DOI 10.1107/S0907444912047269; Conlon J, 2013, J IMMUNOL, V190, P5216, DOI 10.4049/jimmunol.1300097; Desmet CJ, 2012, NAT REV IMMUNOL, V12, P479, DOI 10.1038/nri3247; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Filtz TM, 2014, TRENDS PHARMACOL SCI, V35, P76, DOI 10.1016/j.tips.2013.11.005; Galluzzi L, 2012, NAT REV MOL CELL BIO, V13, P780, DOI 10.1038/nrm3479; Gates LT, 2016, J IMMUNOL, V197, P923, DOI 10.4049/jimmunol.1502611; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hentze H, 2003, CELL DEATH DIFFER, V10, P956, DOI 10.1038/sj.cdd.4401264; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Huang YH, 2012, NAT STRUCT MOL BIOL, V19, P728, DOI 10.1038/nsmb.2333; Ichinohe T, 2013, P NATL ACAD SCI USA, V110, P17963, DOI 10.1073/pnas.1312571110; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kim H, 2011, NAT METHODS, V8, P941, DOI [10.1038/NMETH.1733, 10.1038/nmeth.1733]; Koshiba T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001147; Kubota T, 2008, J BIOL CHEM, V283, P25660, DOI 10.1074/jbc.M804479200; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Lei CQ, 2013, J BIOL CHEM, V288, P12596, DOI 10.1074/jbc.M112.444794; Liu YL, 2016, J VIROL, V90, P9406, DOI 10.1128/JVI.00748-16; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Onoue K, 2013, J CELL SCI, V126, P176, DOI 10.1242/jcs.111211; Ouyang SY, 2012, IMMUNITY, V36, P1073, DOI 10.1016/j.immuni.2012.03.019; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Park S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15489; Park S, 2013, J IMMUNOL, V191, P4358, DOI 10.4049/jimmunol.1301170; Pelegrin P, 2007, J BIOL CHEM, V282, P2386, DOI 10.1074/jbc.M610351200; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Prantner D, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.382986; Prinarakis E, 2008, EMBO J, V27, P865, DOI 10.1038/emboj.2008.28; Ran Y, 2011, J MOL CELL BIOL, V3, P283, DOI 10.1093/jmcb/mjr020; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shang GJ, 2012, NAT STRUCT MOL BIOL, V19, P725, DOI 10.1038/nsmb.2332; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Shu C, 2012, NAT STRUCT MOL BIOL, V19, P722, DOI 10.1038/nsmb.2331; Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054; Sugiura A, 2013, MOL CELL, V51, P20, DOI 10.1016/j.molcel.2013.04.023; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Taylor EB, 2011, BIOCHEM SOC T, V39, P1509, DOI 10.1042/BST0391509; Wang P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004726; Weinberg SE, 2015, IMMUNITY, V42, P406, DOI 10.1016/j.immuni.2015.02.002; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Yin Q, 2012, MOL CELL, V46, P735, DOI 10.1016/j.molcel.2012.05.029; Yu JJ, 2014, P NATL ACAD SCI USA, V111, P15514, DOI 10.1073/pnas.1414859111; Yu YX, 2010, IMMUNITY, V33, P863, DOI 10.1016/j.immuni.2010.11.027; Zevini A, 2017, TRENDS IMMUNOL, V38, P194, DOI 10.1016/j.it.2016.12.004; Zhang M, 2008, CELL RES, V18, P1096, DOI 10.1038/cr.2008.277; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhong B, 2010, J IMMUNOL, V184, P6249, DOI 10.4049/jimmunol.0903748; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	66	17	17	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4866	4878		10.1096/fj.201700328R	http://dx.doi.org/10.1096/fj.201700328R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28729291				2022-12-28	WOS:000413398500018
J	Nie, Y; Littleton, B; Kavanagh, T; Abbate, V; Bansal, SS; Richards, D; Hylands, P; Sturzenbaum, SR				Nie, Yu; Littleton, Brad; Kavanagh, Thomas; Abbate, Vincenzo; Bansal, Sukhvinder S.; Richards, David; Hylands, Peter; Sturzenbaum, Stephen R.			Proanthocyanidin trimer gallate modulates lipid deposition and fatty acid desaturation in Caenorhabditis elegans	FASEB JOURNAL			English	Article						procyanidin; CARS; worm; triglyceride; natural product	GRAPE SEED EXTRACT; RAMAN-SCATTERING; RATS	The incidence of obesity is rising at an alarming rate. Despite its recognition as an urgent healthcare concern, obesity remains largely an unsolved medical problem. A comprehensive screen for functional dietary phytochemicals identified proanthocyanidins as putative targets to ameliorate obesity. A full-scale purification of oligomeric proanthocyanidins (OPCs) derived from grape seed extract yielded pure OPC dimer, trimer, tetramer, and their gallates (pOPCs). Forward chemical screening conducted in Caenorhabditis elegans suggested that pOPCs reduced the activity of lipase in vitro and triglyceride storage capacity in vivo. Proanthocyanidin trimer gallate in particular modified lipid desaturation in C. elegans, revealed by hyperspectral coherent anti-Stokes Raman scattering microscopy. Exposure to trimer gallate resulted in the transcriptional down-regulation of nhr-49 (an ortholog of the human peroxisome proliferator-activated receptor-alpha), and a key regulator of fat metabolism, and 2 downstream genes: fat-5 and acs-2. A combination exposure of 2 or 3 pOPCs (dimer gallate, trimer and/or trimer gallate) suggested the absence of synergistic potential. By using the whole-organism C. elegans coupled with versatile biochemical, biophysical, and genetic tools, we provide an account of the composition and bioactivity of individual OPCs and more generally highlight the potential of traditional Chinese medicine-derived drug leads.	[Nie, Yu; Sturzenbaum, Stephen R.] Kings Coll London, Analyt & Environm Sci Div, 3rd Floor,Franklin Wilkins Bldg,150 Stamford St, London SE1 9NH, England; [Abbate, Vincenzo; Bansal, Sukhvinder S.; Hylands, Peter] Kings Coll London, Inst Pharmaceut Sci, Fac Life Sci & Med, London, England; [Littleton, Brad; Kavanagh, Thomas; Richards, David] Kings Coll London, Dept Phys, Fac Nat & Math Sci, London, England	University of London; King's College London; University of London; King's College London; University of London; King's College London	Sturzenbaum, SR (corresponding author), Kings Coll London, Analyt & Environm Sci Div, 3rd Floor,Franklin Wilkins Bldg,150 Stamford St, London SE1 9NH, England.	stephen.sturzenbaum@kcl.ac.uk	Abbate, Vincenzo/K-6204-2019; Littleton, Brad/AAG-6345-2020; Littleton, Brad N/I-1463-2015	Littleton, Brad/0000-0002-1561-9688; Littleton, Brad N/0000-0002-1561-9688; Richards, David/0000-0001-8038-6860; Nie, Yu/0000-0001-7670-6411; Abbate, Vincenzo/0000-0002-3300-0520	King's-Chinese Scholarship Council scheme; Engineering and Physical Sciences Research Council [1252848] Funding Source: researchfish	King's-Chinese Scholarship Council scheme; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors thank Derives Resiniques et Terpeniques (DRT; Dax, France) for their kind donation of Vitaflavan and OPC-enriched samples, Dr. Norman Smith (King's College London) for the provision of semipreparative chromatography columns, Dr. Eugene Schuster (University College London) for assistance in the microarray data analysis, Prof. Robert Hider (King's College London) for additional technical support, and Dr. David Barlow (King's College London) for granting access to the Chem-TCM database. The authors thank Ms. Clinda Puvirajasinghe (King's College London) for her help in generating the glo-4:daf-22 double mutant. This work was supported by the King's-Chinese Scholarship Council scheme. The authors declare no conflicts of interest.	Appeldoorn MM, 2009, FOOD CHEM, V117, P713, DOI 10.1016/j.foodchem.2009.04.047; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; BRENNER S, 1974, GENETICS, V77, P71; Brooks KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007545; Camp CH, 2015, NAT PHOTONICS, V9, P295, DOI 10.1038/NPHOTON.2015.60; Del Bas JM, 2008, MOL NUTR FOOD RES, V52, P1172, DOI 10.1002/mnfr.200800054; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Hogan S, 2011, J AGR FOOD CHEM, V59, P3035, DOI 10.1021/jf1042773; Ibars M, 2017, INT J OBESITY, V41, P129, DOI 10.1038/ijo.2016.169; Kee TW, 2004, OPT LETT, V29, P2701, DOI 10.1364/OL.29.002701; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Lemieux GA, 2011, NAT CHEM BIOL, V7, P206, DOI [10.1038/nchembio.534, 10.1038/NCHEMBIO.534]; Littleton B, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.103902; Lizarraga D, 2007, FEBS J, V274, P4802, DOI 10.1111/j.1742-4658.2007.06010.x; Del Bas JM, 2009, MOL NUTR FOOD RES, V53, P805, DOI 10.1002/mnfr.200800364; Montagut G, 2010, J NUTR BIOCHEM, V21, P476, DOI 10.1016/j.jnutbio.2009.02.003; Moreno DA, 2003, NUTRITION, V19, P876, DOI 10.1016/S0899-9007(03)00167-9; Nie Y., 2017, ANIMAL MODELS STUDY; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Onakpoya IJ, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0735-y; Oprea TI, 2009, NAT CHEM BIOL, V5, P441, DOI 10.1038/nchembio0709-441; Rasmussen SE, 2005, MOL NUTR FOOD RES, V49, P159, DOI 10.1002/mnfr.200400082; Rothman JH, 2012, METHOD CELL BIOL, V107, P1; Schmidt BM, 2007, NAT CHEM BIOL, V3, P360, DOI 10.1038/nchembio0707-360; TimTec Compound Libraries, CHEM TCM DAT; Tomaru M, 2007, NUTRITION, V23, P351, DOI 10.1016/j.nut.2007.01.007; Tu YY, 2011, NAT MED, V17, P1217, DOI 10.1038/nm.2471; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; Wang P, 2014, ANGEW CHEM INT EDIT, V53, P11787, DOI 10.1002/anie.201406029; Wren AF, 2002, J AGR FOOD CHEM, V50, P2180, DOI 10.1021/jf011066w; Yamakoshi J, 2002, FOOD CHEM TOXICOL, V40, P599, DOI 10.1016/S0278-6915(02)00006-6; Yen K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012810; Zhang SBO, 2010, P NATL ACAD SCI USA, V107, P4640, DOI 10.1073/pnas.0912308107; Zhongzen Z., 2004, ILLUSTRATED CHINESE; Zhongzen Z., 2009, ENCY MED PLANTS, V1	36	4	5	2	37	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4891	4902		10.1096/fj.201700438R	http://dx.doi.org/10.1096/fj.201700438R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28760744				2022-12-28	WOS:000413398500020
J	Mazzoni, E; D'Agostino, A; Manfrini, M; Maniero, S; Puozzo, A; Bassi, E; Marsico, S; Fortini, C; Trevisiol, L; Patergnani, S; Tognon, M				Mazzoni, Elisa; D'Agostino, Antonio; Manfrini, Marco; Maniero, Stefania; Puozzo, Andrea; Bassi, Elena; Marsico, Stefano; Fortini, Cinzia; Trevisiol, Lorenzo; Patergnani, Simone; Tognon, Mauro			Human adipose stem cells induced to osteogenic differentiation by an innovative collagen/hydroxylapatite hybrid scaffold	FASEB JOURNAL			English	Article						genes; matrix; adhesion; bone; biomaterial	MESENCHYMAL STROMAL CELLS; BONE; TETRANECTIN; EXPRESSION; MARKERS	Novel biomaterials are of paramount importance for bone regrowth. In this study, we investigated human adipose stem cells (hASCs) for osteogenic, osteoconductivity, and osteoinductivity effects of an innovative collagen/hydroxylapatite hybrid scaffold. In hASCs that were grown on this scaffold, osteogenic genes were analyzed for their expression profiles, together with adhesion and extracellular matrix genes. In hASC integrins, basement membrane constituents and collagens were up-regulated, together with cell proliferation. In addition, expression of osteopontin and activated focal adhesion kinase was studied at the protein level. Our in vitro data indicate that hASCs, together with hybrid biomaterial, is an important model of study to investigate in vitro bone induction.-Mazzoni, E., D'Agostino, A., Manfrini, M., Maniero, S., Puozzo, A., Bassi, E., Marsico, S., Fortini, C., Trevisiol, L., Patergnani, S., Tognon, M. Human adipose stem cells induced to osteogenic differentiation by an innovative collagen/hydroxylapatite hybrid scaffold.	[Mazzoni, Elisa; Manfrini, Marco; Maniero, Stefania; Puozzo, Andrea; Bassi, Elena; Marsico, Stefano; Patergnani, Simone; Tognon, Mauro] Univ Ferrara, Dept Morphol Surg & Expt Med, Ferrara, Italy; [Fortini, Cinzia] Univ Ferrara, Dept Med Sci, Ferrara, Italy; [Mazzoni, Elisa; D'Agostino, Antonio; Trevisiol, Lorenzo] Univ Verona, Dept Surg, Verona, Italy; [Manfrini, Marco] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy; [Bassi, Elena] Univ Parma, Sect Anat Pathol, Parma, Italy	University of Ferrara; University of Ferrara; University of Verona; University of Bologna; University of Parma	Tognon, M (corresponding author), Univ Ferrara, Sch Med, Dept Morphol Surg & Expt Med, Sect Pathol Oncol & Expt Biol, 64-B Fossato Mortara St, I-44121 Ferrara, Italy.	tgm@unife.it	Trevisiol, Lorenzo/ABD-6737-2020; Patergnani, Simone/AAC-3969-2021; Patergnani, Simone/AAK-2929-2021; Mazzoni, Elisa/K-6313-2016	Trevisiol, Lorenzo/0000-0002-2732-238X; Patergnani, Simone/0000-0001-7951-9267; Manfrini, Marco/0000-0003-3154-9269; Mazzoni, Elisa/0000-0001-6829-8569	Fondazione Cassa di Risparmio di Cento; University of Ferrara, Fondo di Ateneo per la Ricerca (FAR); University of Verona, Fondo Universitario per la Ricerca (FUR); Associazione Sammarinese per la Lotta contro le Leucemie e Emopatie Maligne (ASLEM) [CFR/2015/2016]	Fondazione Cassa di Risparmio di Cento; University of Ferrara, Fondo di Ateneo per la Ricerca (FAR); University of Verona, Fondo Universitario per la Ricerca (FUR); Associazione Sammarinese per la Lotta contro le Leucemie e Emopatie Maligne (ASLEM)	This work was supported, in part, by grants from Fondazione Cassa di Risparmio di Cento; University of Ferrara, Fondo di Ateneo per la Ricerca (FAR) Projects; University of Verona, Fondo Universitario per la Ricerca (FUR) Projects; Associazione Sammarinese per la Lotta contro le Leucemie e Emopatie Maligne (ASLEM), Grant CFR/2015/2016. E.M. is a Research Associate in the Department of Surgery, School of Medicine, University of Verona. The authors declare no conflicts of interest.	Bononi I, 2012, J CELL PHYSIOL, V227, P3787, DOI 10.1002/jcp.24088; Brodano GB, 2012, EUR SPINE J, V21, pS3, DOI 10.1007/s00586-012-2233-z; Capulli M, 2014, J BONE MINER RES, V29, P1833, DOI 10.1002/jbmr.2206; D'Agostino A., 2016, J ORAL MAXILLOFAC SU, V74, P1238, DOI DOI 10.1016/J.J0MS.2016.01.052; Docheva D, 2014, BIRTH DEFECTS RES C, V102, P13, DOI 10.1002/bdrc.21059; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fuchigami S, 2016, EUR J ORAL SCI, V124, P151, DOI 10.1111/eos.12249; Gothard D, 2014, J TISSUE ENG, V5, DOI 10.1177/2041731414551763; Haylock DN, 2006, BRIT J HAEMATOL, V134, P467, DOI 10.1111/j.1365-2141.2006.06218.x; Iba K, 2013, J BONE MINER METAB, V31, P399, DOI 10.1007/s00774-013-0436-y; Izu Y, 2016, CELL TISSUE RES, V364, P623, DOI 10.1007/s00441-015-2345-y; Jiang PL, 2015, ACS APPL MATER INTER, V7, P14384, DOI 10.1021/acsami.5b03172; Kim M, 2008, J MOL CELL CARDIOL, V45, P270, DOI 10.1016/j.yjmcc.2008.05.006; Kobayashi A, 2007, ARCH PATHOL LAB MED, V131, P563; Lane NE, 2005, J BONE MINER RES, V20, P58, DOI 10.1359/JBMR.041017; Lavrijsen ICM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087735; Mamehara Akira, 2010, Kobe J Med Sci, V56, pE98; Manfrini M, 2013, J CELL PHYSIOL, V228, P1229, DOI 10.1002/jcp.24276; Manfrini M, 2015, CELL BIOCHEM BIOPHYS, V71, P1509, DOI 10.1007/s12013-014-0374-x; Marques C, 2014, INT J NANOMED, V9, P2713, DOI 10.2147/IJN.S55943; Mazzoni E, 2012, EXP HEMATOL, V40, P466, DOI 10.1016/j.exphem.2012.02.008; Mendelson BC, 2010, AESTHET PLAST SURG, V34, P455, DOI 10.1007/s00266-010-9473-2; Moreira-Gonzalez A, 2003, PLAST RECONSTR SURG, V111, P1808, DOI 10.1097/01.PRS.0000055432.20074.93; Rakow A, 2016, BIOMATERIALS, V98, P31, DOI 10.1016/j.biomaterials.2016.04.023; Ram VS, 2015, J CLIN DIAGN RES, V9, pZE7, DOI 10.7860/JCDR/2015/11268.5438; Ripoll CB, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-3; Rosset EM, 2016, MATRIX BIOL, V52-54, P78, DOI 10.1016/j.matbio.2016.02.001; Srouji S, 2013, CLIN ORAL IMPLAN RES, V24, P1288, DOI 10.1111/j.1600-0501.2012.02571.x; Stockl S, 2013, CELL PHYSIOL BIOCHEM, V31, P703, DOI 10.1159/000350089; Sun Z, 2013, J ORTHOP RES, V31, P1804, DOI 10.1002/jor.22439; Thangavelu M, 2016, COLLOID SURFACE B, V143, P15, DOI 10.1016/j.colsurfb.2016.03.021; Venkatesan J, 2014, J BIOMED NANOTECHNOL, V10, P3124, DOI 10.1166/jbn.2014.1893; WEWER UM, 1994, J CELL BIOL, V127, P1767, DOI 10.1083/jcb.127.6.1767; Yang W, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0826-y	34	20	21	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4555	4565		10.1096/fj.201601384R	http://dx.doi.org/10.1096/fj.201601384R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28659417	Green Submitted			2022-12-28	WOS:000413397400031
J	Versteeg, RI; Schrantee, A; Adriaanse, SM; Unmehopa, UA; Booij, J; Reneman, L; Fliers, E; la Fleur, SE; Serlie, MJ				Versteeg, Ruth I.; Schrantee, Anouk; Adriaanse, Sofie M.; Unmehopa, Unga A.; Booij, Jan; Reneman, Liesbeth; Fliers, Eric; la Fleur, Susanne E.; Serlie, Mireille J.			Timing of caloric intake during weight loss differentially affects striatal dopamine transporter and thalamic serotonin transporter binding	FASEB JOURNAL			English	Article						obesity; neuroimaging; brain; striatum; thalamus	BODY-MASS INDEX; D-2/3 RECEPTOR AVAILABILITY; DIET-INDUCED OBESITY; NUCLEUS-ACCUMBENS; FOOD-INTAKE; I-123-FP-CIT SPECT; HEALTHY-VOLUNTEERS; HUMAN HYPOTHALAMUS; BARIATRIC SURGERY; CORTICAL SURFACE	Recent studies have shown that meal timing throughout the day contributes to maintaining or regaining weight after hypocaloric diets. Although brain serotonin and dopamine are well known to be involved in regulating feeding, it is unknown whether meal timing during energy restriction affects these neurotransmitter systems. We studied the effect of a 4 wk hypocaloric diet with either 50% of daily calories consumed at breakfast (BF group) or at dinner (D group) on hypothalamic and thalamic serotonin transporter (SERT) binding and on striatal dopamine transporter (DAT) binding. The BF and D groups lost a similar amount of weight. Striatal DAT and thalamic SERT binding increased in the BF group, while decreasing in the D group after the diet (Delta DAT 0.37 +/- 0.63 vs. -0.53 +/- 0.77, respectively; P = 0.005; Delta SERT 0.12 +/- 0.25 vs. -0.13 +/- 0.26 respectively, P = 0.032). Additional voxel-based analysis showed an increase in DAT binding in the ventral striatum in the BF group and a decrease in the dorsal striatum in the D group. During weight loss, striatal DAT and thalamic SERT binding increased weight independently when 50% of daily calories were consumed at breakfast, whereas it decreased when caloric intake was highest at dinner. These findings may contribute to the earlier reported favorable effect of meal timing on weight maintenance after hypocaloric diets.-Versteeg, R. I., Schrantee, A., Adriaanse, S. M., Unmehopa, U. A., Booij, J., Reneman, L., Fliers, E., la Fleur, S. E., Serlie, M. J. Timing of caloric intake during weight loss differentially affects striatal dopamine transporter and thalamic serotonin transporter binding.	[Versteeg, Ruth I.; Unmehopa, Unga A.; Fliers, Eric; la Fleur, Susanne E.; Serlie, Mireille J.] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, Meibergdreef 9,F5 167, NL-1105 AZ Amsterdam, Netherlands; [Schrantee, Anouk; Reneman, Liesbeth] Univ Amsterdam, Acad Med Ctr, Dept Radiol, Amsterdam, Netherlands; [Adriaanse, Sofie M.; Booij, Jan] Univ Amsterdam, Acad Med Ctr, Dept Nucl Med, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Serlie, MJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, Meibergdreef 9,F5 167, NL-1105 AZ Amsterdam, Netherlands.	m.j.serlie@amc.nl	Booij, Jan/AAD-7159-2019; Unmehopa, Unga A/E-3623-2012	Schrantee, Anouk/0000-0002-4035-4845	Dutch Technology Foundation (STW) [12189]; Netherlands Organisation for Health Research and Development (ZonMw; Investeringen Middelgroot) Grant [91112002]	Dutch Technology Foundation (STW)(Technologiestichting STW); Netherlands Organisation for Health Research and Development (ZonMw; Investeringen Middelgroot) Grant	The authors thank Roos van der Zwan (University of Amsterdam, Amsterdam, The Netherlands) for her help with the acquisition of the SPECT scans. This study was supported by The Dutch Technology Foundation (STW) OnTime Project 12189, and by a grant from the Netherlands Organisation for Health Research and Development (ZonMw; Investeringen Middelgroot) Grant 91112002. M.J.S. serves on the advisory board of Fresenius Kabi Netherlands (Zeist, The Netherlands). J.B. is a consultant at GE Healthcare. The remaining authors declare no conflicts of interest.	Anderson JW, 2001, AM J CLIN NUTR, V74, P579; Arble DM, 2009, OBESITY, V17, P2100, DOI 10.1038/oby.2009.264; Baron KG, 2011, OBESITY, V19, P1374, DOI 10.1038/oby.2011.100; Berridge KC, 2009, PHYSIOL BEHAV, V97, P537, DOI 10.1016/j.physbeh.2009.02.044; Booij J, 1998, J NUCL MED, V39, P1879; Booij J, 2007, J NUCL MED, V48, P359; Borgers AJ, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-34; Chen PS, 2008, NEUROIMAGE, V40, P275, DOI 10.1016/j.neuroimage.2007.11.007; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davis LM, 2009, NEUROENDOCRINOLOGY, V89, P152, DOI 10.1159/000170586; de Weijer BA, 2013, OBESITY, V21, P1143, DOI 10.1002/oby.20220; de Weijer BA, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-37; DeFronzo RA, 2011, DIABETES CARE, V34, P789, DOI 10.2337/dc11-0064; Elfers Clinton Thomas, 2011, Front Endocrinol (Lausanne), V2, P78, DOI 10.3389/fendo.2011.00078; Erritzoe D, 2010, NEUROIMAGE, V52, P284, DOI 10.1016/j.neuroimage.2010.03.086; Ferris MJ, 2014, P NATL ACAD SCI USA, V111, pE2751, DOI 10.1073/pnas.1407935111; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Garaulet M, 2013, INT J OBESITY, V37, P604, DOI 10.1038/ijo.2012.229; Garaulet M, 2014, PHYSIOL BEHAV, V134, P44, DOI 10.1016/j.physbeh.2014.01.001; Goldfield GS, 2007, AM J CLIN NUTR, V86, P308, DOI 10.1093/ajcn/86.2.308; Halford JCG, 2007, DRUGS, V67, P27, DOI 10.2165/00003495-200767010-00004; Hesse S, 2014, EUR NEUROPSYCHOPHARM, V24, P1240, DOI 10.1016/j.euroneuro.2014.05.005; Horstmann A, 2015, OBES REV, V16, P821, DOI 10.1111/obr.12303; Jakubowicz D, 2013, OBESITY, V21, P2504, DOI 10.1002/oby.20460; Jakubowicz D, 2012, STEROIDS, V77, P323, DOI 10.1016/j.steroids.2011.12.006; Kassirer JP, 1998, NEW ENGL J MED, V338, P52, DOI 10.1056/NEJM199801013380109; Kelley AE, 2005, J COMP NEUROL, V493, P72, DOI 10.1002/cne.20769; Koopman KE, 2012, J NUCL MED, V53, P1087, DOI 10.2967/jnumed.111.102277; Koopman KE, 2013, MOL METAB, V2, P417, DOI 10.1016/j.molmet.2013.07.006; Koskela AK, 2008, PHYSIOL BEHAV, V93, P724, DOI 10.1016/j.physbeh.2007.11.043; Lee JS, 2015, BRAIN RES, V1598, P97, DOI 10.1016/j.brainres.2014.12.029; Li YH, 2010, PSYCHOPHARMACOLOGY, V212, P251, DOI 10.1007/s00213-010-1948-y; MOORE RY, 1978, J COMP NEUROL, V180, P417, DOI 10.1002/cne.901800302; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Narayanaswami V, 2013, INT J OBESITY, V37, P1095, DOI 10.1038/ijo.2012.178; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Norgren R, 2006, PHYSIOL BEHAV, V89, P531, DOI 10.1016/j.physbeh.2006.05.024; Orosco M, 2000, BRAIN RES, V872, P64, DOI 10.1016/S0006-8993(00)02449-5; Parsons MP, 2007, J COMP NEUROL, V500, P1050, DOI 10.1002/cne.21224; Raeder MB, 2006, J CLIN PSYCHIAT, V67, P1974, DOI 10.4088/JCP.v67n1219; Shinohara M, 2004, J PSYCHIATR NEUROSCI, V29, P134; Sleipness EP, 2007, BRAIN RES, V1129, P34, DOI 10.1016/j.brainres.2006.10.063; Small DM, 2003, NEUROIMAGE, V19, P1709, DOI 10.1016/S1053-8119(03)00253-2; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; South T, 2008, NEUROCHEM RES, V33, P598, DOI 10.1007/s11064-007-9483-x; Speed N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025169; Stouffer MA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9543; Sumithran P, 2013, CLIN SCI, V124, P231, DOI 10.1042/CS20120223; Sumithran P, 2011, NEW ENGL J MED, V365, P1597, DOI 10.1056/NEJMoa1105816; SWAAB DF, 1993, ANAT EMBRYOL, V187, P317; ter Horst KW, 2015, INT J OBESITY, V39, P1703, DOI 10.1038/ijo.2015.125; Tomasi D, 2013, CRIT REV BIOCHEM MOL, V48, P1, DOI 10.3109/10409238.2012.735642; van de Giessen E, 2014, J PSYCHOPHARMACOL, V28, P866, DOI 10.1177/0269881114531664; van de Giessen E, 2013, NEUROIMAGE, V64, P61, DOI 10.1016/j.neuroimage.2012.09.011; van der Zwaal EM, 2016, EUR NEUROPSYCHOPHARM, V26, P1190, DOI 10.1016/j.euroneuro.2016.04.009; Versteeg R. I., 2016, NEUROENDOCRINOLOGY, V10, DOI [10.1016/j.molmet.2013.07.006, DOI 10.1016/J.MOLMET.2013.07.006]; Volkow ND, 2002, SYNAPSE, V44, P175, DOI 10.1002/syn.10075; Volkow ND, 2011, TRENDS COGN SCI, V15, P37, DOI 10.1016/j.tics.2010.11.001; Wickens JR, 2007, J NEUROSCI, V27, P8181, DOI 10.1523/JNEUROSCI.1671-07.2007	60	15	15	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4545	4554		10.1096/fj.201601234R	http://dx.doi.org/10.1096/fj.201601234R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28679529				2022-12-28	WOS:000413397400030
J	Zhang, JQ; Ma, RJ; Li, L; Wang, LN; Hou, XJ; Han, LS; Ge, J; Li, M; Wang, Q				Zhang, Jiaqi; Ma, Rujun; Li, Ling; Wang, Lina; Hou, Xiaojing; Han, Longsen; Ge, Juan; Li, Mo; Wang, Qiang			Intersectin 2 controls actin cap formation and meiotic division in mouse oocytes through the Cdc42 pathway	FASEB JOURNAL			English	Article						meiosis; spindle; chromosome; polarization; cytokinesis	POLARITY ESTABLISHMENT; RHO GTPASES; N-WASP; SPINDLE; PROTEIN; ACTIVATION; DYNAMIN; ENDOCYTOSIS; ORGANIZATION; PROTRUSION	Intersectins (ITSNs), an evolutionarily conserved adaptor protein family, have been implicated in multiple biologic processes; however, their functions in mammalian oocytes have not been addressed. Here, we report delayed meiotic resumption and defective cytokinesis upon specific depletion of ITSN2 in mouse oocytes. In particular, abnormal spindle, misaligned chromosomes, and loss of cortical actin cap are readily observed in ITSN2-depleted oocytes. Similarly, a small molecule that targets the Cdc42-ITSN interaction also disrupts oocyte maturation and actin polymerization. Moreover, we find that ITSN2 depletion reduces the activity of Cdc42 in oocytes and, of note, that forced expression of the dominant-positive mutant of Cdc42, in part, prevents the effects of ITSN2 knockdown on actin cap formation. In addition, the localization of WASP and Arp2, the downstream effector proteins of Cdc42, is altered in ITSN2-depleted oocytes accordingly. In summary, our data support a model in which ITSN2 depletion induces the inactivation of Cdc42, which, in turn, influences the distribution and function of Arp2/3 and WASP, consequently disrupting oocyte polarity establishment and meiotic division.-Zhang, J., Ma, R., Li, L., Wang, L., Hou, X., Han, L., Ge, J., Li, M., Wang, Q. Intersectin 2 controls actin cap formation and meiotic division in mouse oocytes through the Cdc42 pathway.	[Zhang, Jiaqi; Li, Ling; Hou, Xiaojing; Han, Longsen; Ge, Juan; Wang, Qiang] Nanjing Med Univ, State Key Lab Reprod Med, 140 Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China; [Ma, Rujun] Nanjing Univ, Jinling Hosp, Ctr Reprod Med, Sch Med, Nanjing, Jiangsu, Peoples R China; [Wang, Lina] Natl Hlth & Family Planning Commiss, Key Lab Birth Defects Prevent, Zhengzhou, Henan, Peoples R China; [Li, Mo] Peking Univ, Ctr Reprod Med, Hosp 3, Beijing, Peoples R China	Nanjing Medical University; Nanjing University; Peking University	Wang, Q (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, 140 Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China.	qwang2012@njmu.edu.cn			National Natural Science Foundation of China [31571543]; National Key Scientific Research Projects of China [2014CB943200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Scientific Research Projects of China	This work was supported by the National Natural Science Foundation of China (31571543) and National Key Scientific Research Projects of China (2014CB943200). The authors declare no conflicts of interest.	Benink HA, 2005, J CELL BIOL, V168, P429, DOI 10.1083/jcb.200411109; Brunet S, 2011, HUM REPROD UPDATE, V17, P68, DOI 10.1093/humupd/dmq044; Cannon JL, 2001, IMMUNITY, V15, P249, DOI 10.1016/S1074-7613(01)00178-9; Dehapiot B, 2013, DEV BIOL, V377, P202, DOI 10.1016/j.ydbio.2013.01.029; Deng MQ, 2007, DEV CELL, V12, P301, DOI 10.1016/j.devcel.2006.11.008; Friesland A, 2013, P NATL ACAD SCI USA, V110, P1261, DOI 10.1073/pnas.1116051110; Gryaznova T, 2015, CELL SIGNAL, V27, P1499, DOI 10.1016/j.cellsig.2015.03.006; Guipponi M, 1998, GENOMICS, V53, P369, DOI 10.1006/geno.1998.5521; Halet G, 2007, DEV CELL, V12, P309, DOI 10.1016/j.devcel.2006.12.010; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Kim SH, 2000, J BIOL CHEM, V275, P36999, DOI 10.1074/jbc.M003430200; Klein IK, 2009, J BIOL CHEM, V284, P25953, DOI 10.1074/jbc.M109.035071; Li L, 2016, ONCOTARGET, V7, P50927, DOI 10.18632/oncotarget.10815; Ma CQ, 2006, CURR BIOL, V16, P214, DOI 10.1016/j.cub.2005.11.067; McGavin MKH, 2001, J EXP MED, V194, P1777, DOI 10.1084/jem.194.12.1777; Mohney RP, 2003, J BIOL CHEM, V278, P47038, DOI 10.1074/jbc.M303895200; Na J, 2006, CURR BIOL, V16, P1249, DOI 10.1016/j.cub.2006.05.023; Novokhatska O, 2011, BIOCHEM BIOPH RES CO, V408, P663, DOI 10.1016/j.bbrc.2011.04.081; Okamoto M, 1999, J BIOL CHEM, V274, P18446, DOI 10.1074/jbc.274.26.18446; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Pucharcos C, 2001, BBA-GENE STRUCT EXPR, V1521, P1, DOI 10.1016/S0167-4781(01)00276-7; Ridley AJ, 2001, J CELL SCI, V114, P2713; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Roos J, 1998, J BIOL CHEM, V273, P19108, DOI 10.1074/jbc.273.30.19108; Sengar AS, 1999, EMBO J, V18, P1159, DOI 10.1093/emboj/18.5.1159; Shao XW, 2015, BIOL OPEN, V4, P1569, DOI 10.1242/bio.013649; Smith WJ, 2005, BIOCHEMISTRY-US, V44, P13282, DOI 10.1021/bi050591b; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Sun QY, 2009, CELL CYCLE, V8, P2741, DOI 10.4161/cc.8.17.9471; Sun SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018392; Tsyba L, 2011, GENE, V473, P67, DOI 10.1016/j.gene.2010.11.016; Wang Q, 2007, REPROD FERT DEVELOP, V19, P1, DOI 10.1071/RD06103; Wang QC, 2014, BIOL CELL, V106, P193, DOI 10.1111/boc.201400007; Wang ZB, 2013, MOL BIOL CELL, V24, P3832, DOI 10.1091/mbc.E13-03-0123; Yi KX, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0002; Yi K, 2011, NAT CELL BIOL, V13, P1252, DOI 10.1038/ncb2320; Zhang X, 2008, DEV CELL, V15, P386, DOI 10.1016/j.devcel.2008.07.005	38	12	12	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4277	4285		10.1096/fj.201700179R	http://dx.doi.org/10.1096/fj.201700179R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28626024				2022-12-28	WOS:000413397400008
J	Li, F; Xu, RJ; Low, BE; Lin, CL; Garcia-Barros, M; Schrandt, J; Mileva, I; Snider, A; Luo, CK; Jiang, XC; Li, MS; Hannun, YA; Obeid, LM; Wiles, MV; Mao, CG				Li, Fang; Xu, Ruijuan; Low, Benjamin E.; Lin, Chih-Li; Garcia-Barros, Monica; Schrandt, Jennifer; Mileva, Izolda; Snider, Ashley; Luo, Catherine K.; Jiang, Xian-Cheng; Li, Ming-Song; Hannun, Yusuf A.; Obeid, Lina M.; Wiles, Michael V.; Mao, Cungui			Alkaline ceramidase 2 is essential for the homeostasis of plasma sphingoid bases and their phosphates	FASEB JOURNAL			English	Article						sphingosine-1-phosphate; sphingolipid; plasma; hematopoietic cell; erythrocyte	VASCULAR DEVELOPMENT; DIHYDROSPHINGOSINE 1-PHOSPHATE; FUNCTIONAL-CHARACTERIZATION; LYMPHOCYTE EGRESS; MOLECULAR-CLONING; SPHINGOSINE-1-PHOSPHATE; RECEPTOR; MICE; KINASE; GENE	Sphingosine-1-phosphate (S1P) plays important roles in cardiovascular development and immunity. S1P is abundant in plasma because erythrocytes-the major source of S1P-lack any S1P-degrading activity; however, much remains unclear about the source of the plasma S1P precursor, sphingosine (SPH), derived mainly from the hydrolysis of ceramides by the action of ceramidases that are encoded by 5 distinct genes, acid ceramidase 1 (ASAH1)/Asah1, ASAH2/Asah2, alkaline ceramidase 1 (ACER1)/Acerl, ACER2/Acer2, and ACER3/Acer3, in humans/ mice. Previous studies have reported that knocking out Asahl or Asah2 failed to reduce plasma SPH and S1P levels in mice. In this study, we show that knocking out Acerl or Acer3 also failed to reduce the blood levels of SPH or S1P in mice. In contrast, knocking out Acer2 from either whole body or the hematopoietic lineage markedly decreased the blood levels of SPH and S1P in mice. Of interest, knocking out Acer2 from whole-body or the hematopoietic lineage also markedly decreased the levels of dihydrosphingosine (dhSPH) and dihydrosphingosine-1-phosphate (dhS1P) in blood. Taken together, these results suggest that ACER2 plays a key role in the maintenance of high plasma levels of sphingoid base-1-phosphates-S1P and dhS1P-by controlling the generation of sphingoid bases-SPH and dhSPH-in hematopoietic cells.				Michael.Wiles@jax.org; cungui.mao@stonybrook.edu	xu, rui/GRX-5734-2022	Luo, Catherine K/0000-0002-2646-9566; wiles, michael/0000-0002-3620-8386	U.S. National Institutes of Health, National Cancer Institute [R01-CA163825, P01-CA097132]; Sphingolipid Animal Cancer Pathobiology Shared Resource Core; NATIONAL CANCER INSTITUTE [P01CA097132, R01CA163825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM130878, R35GM118128] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Sphingolipid Animal Cancer Pathobiology Shared Resource Core; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Peter M. Kutny (Genetic Engineering Technologies, The Jackson Laboratory) for assistance with microinjections, Cindy Avery at the Jackson Laboratory for animal maintenance and genotyping, and Ping Ji (State University of New York at Stony Brook) for assistance with histological analysis. The authors also thank Dr. Ye Chen (Southern Medical University) for assistance with animal studies. This work was supported, in whole or in part, by U.S. National Institutes of Health, National Cancer Institute Grants R01-CA163825 (to C.M.) and P01-CA097132 (to Y.A.H. and C.M.). This work was also supported by the Sphingolipid Animal Cancer Pathobiology Shared Resource Core. The authors declare no conflicts of interest.	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Barth BM, 2013, ACS NANO, V7, P2132, DOI 10.1021/nn304862b; Bu S, 2008, J BIOL CHEM, V283, P19593, DOI 10.1074/jbc.M802417200; Callihan P, 2012, NEUROPHARMACOLOGY, V62, P988, DOI 10.1016/j.neuropharm.2011.10.005; Chun J, 2010, PHARMACOL REV, V62, P579, DOI 10.1124/pr.110.003111; Coant Nicolas, 2017, Advances in Biological Regulation, V63, P122, DOI 10.1016/j.jbior.2016.10.002; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cui YZ, 2002, BONE MARROW TRANSPL, V30, P843, DOI 10.1038/sj.bmt.1703766; Cutignano A, 2010, PROSTAG OTH LIPID M, V93, P25, DOI 10.1016/j.prostaglandins.2010.06.001; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Dworski S, 2017, BBA-MOL BASIS DIS, V1863, P386, DOI 10.1016/j.bbadis.2016.11.031; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gazit SL, 2016, CIRC RES, V119, pE110, DOI 10.1161/CIRCRESAHA.116.308929; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Lin CL, 2017, STEM CELL REP, V9, P1488, DOI 10.1016/j.stemcr.2017.09.015; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Low BE, 2016, METHODS MOL BIOL, V1438, P19, DOI 10.1007/978-1-4939-3661-8_2; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Mendelson K, 2014, DEVELOPMENT, V141, P5, DOI 10.1242/dev.094805; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Moritz E, 2017, CLIN CHIM ACTA, V468, P25, DOI 10.1016/j.cca.2017.01.029; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Onuma T, 2017, THROMB RES, V156, P91, DOI 10.1016/j.thromres.2017.06.001; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Proia RL, 2015, J CLIN INVEST, V125, P1379, DOI 10.1172/JCI76369; Pyne NJ, 2017, MOLECULES, V22, DOI 10.3390/molecules22030344; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Rosen H, 2003, IMMUNOL REV, V195, P160, DOI 10.1034/j.1600-065X.2003.00068.x; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Snider AJ, 2012, PROSTAG OTH LIPID M, V99, P124, DOI 10.1016/j.prostaglandins.2012.08.003; Strub GM, 2010, ADV EXP MED BIOL, V688, P141; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Veret J, 2013, BBA-MOL CELL BIOL L, V1831, P251, DOI 10.1016/j.bbalip.2012.10.003; Vogel P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004112; Wang K, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005591; Wang Yiming, 2012, Cardiovascular & Hematological Disorders - Drug Targets, V12, P126; Xiang YQ, 2014, J CLIN INVEST, V124, P4823, DOI 10.1172/JCI77685; Xu RJ, 2010, FASEB J, V24, P2507, DOI 10.1096/fj.09-153635; Zhou JH, 1998, BIOCHEM BIOPH RES CO, V242, P502, DOI 10.1006/bbrc.1997.7993	46	24	24	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3058	3069		10.1096/fj.201700445RR	http://dx.doi.org/10.1096/fj.201700445RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401619	Green Published			2022-12-28	WOS:000432546000014
J	Wijesekara, N; Goncalves, RA; Ahrens, R; De Felice, FG; Fraser, PE				Wijesekara, Nadeeja; Goncalves, Rafaella Araujo; Ahrens, Rosemary; De Felice, Fernanda G.; Fraser, Paul E.			Tau ablation in mice leads to pancreatic beta cell dysfunction and glucose intolerance	FASEB JOURNAL			English	Article						insulin; MAPT; islets; Alzheimer's disease	ALZHEIMERS-DISEASE; AMYLOID-BETA; INSULIN-SECRETION; TRANSGENIC MICE; PROTEIN-TAU; MICROTUBULES; NEURODEGENERATION; HYPERGLYCEMIA; EXPRESSION; ISOFORMS	The microtubule-associated protein tau is highly expressed in pancreatic islets. Abnormally phosphorylated tau aggregates assemble into neurofibrillary tangles linked to Alzheimer's disease pathology and has also been found in islets of patients with type 2 diabetes. However, the significance of tau in islet function remains relatively unexplored. Therefore, we investigated the role of tau on beta cell function and glucose homeostasis using tau knockout (tauKO) mice. TauKO mice were hyperglycemic and glucose intolerant at an early age. Islet insulin content was reduced and proinsulin levels were significantly elevated in tauKO mice, resulting in impaired glucose-stimulated insulin secretion. Loss of tau also resulted in increased epididymal fat mass and leptin levels, reduced glucose production, and insulin resistance at later ages, leading to complete onset of diabetes. Transgenic expression of human tau in islets was unable to rescue those defects in glucose regulation, indicating structural and/or functional differences between mouse and human tau. Cumulatively, these results suggest an important role for tau in the proper maintenance of pancreatic beta cell function and glucose homeostasis.	[Wijesekara, Nadeeja; Goncalves, Rafaella Araujo; Ahrens, Rosemary; Fraser, Paul E.] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Krembil Discovery Tower,60 Leonard Ave, Toronto, ON M5T 2S8, Canada; [Goncalves, Rafaella Araujo; De Felice, Fernanda G.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [De Felice, Fernanda G.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo Meis, Rio De Janeiro, Brazil; [De Felice, Fernanda G.] Queens Univ, Ctr Neurosci Studies, Dept Biomed & Mol Sci, Kingston, ON, Canada	Krembil Research Institute; University of Toronto; University of Toronto; Universidade Federal do Rio de Janeiro; Queens University - Canada	Wijesekara, N (corresponding author), Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Krembil Discovery Tower,60 Leonard Ave, Toronto, ON M5T 2S8, Canada.	nadeeja.wijesekara@utoronto.ca	Wijesekara, Nadeeja/AAW-7230-2021	Araujo Goncalves da Silva, Rafaella/0000-0001-5334-0816	Diabetes Canada; Brazilian funding agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); International Union of Biochemistry and Molecular Biology (IUBMB); International Society for Neurochemistry (ISN); Canadian Institutes of Health Research (CIHR) [MOP-115056]	Diabetes Canada; Brazilian funding agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); International Union of Biochemistry and Molecular Biology (IUBMB); International Society for Neurochemistry (ISN); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	N.W. was supported by a postdoctoral fellowship from Diabetes Canada. R.A.G. was supported by a predoctoral fellowship from the Brazilian funding agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and by research fellowships from the International Union of Biochemistry and Molecular Biology (IUBMB) and the International Society for Neurochemistry (ISN). This study was operationally funded by the Canadian Institutes of Health Research (CIHR) Grant MOP-115056 to P.E.F. The authors declare no conflicts of interest.	Allen B, 2002, J NEUROSCI, V22, P9340; Amitani M, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00051; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Bharadwaj P, 2017, J ALZHEIMERS DIS, V59, P421, DOI 10.3233/JAD-161192; BOYD AE, 1982, J CELL BIOL, V92, P425, DOI 10.1083/jcb.92.2.425; BRION JP, 1993, J NEUROCHEM, V61, P2071, DOI 10.1111/j.1471-4159.1993.tb07444.x; Chuang CC, 2007, ENDOCRINOLOGY, V148, P4267, DOI 10.1210/en.2007-0179; Dawson HN, 2001, J CELL SCI, V114, P1179; Easom RA, 1999, DIABETES, V48, P675, DOI 10.2337/diabetes.48.4.675; Fernandez-Sanchez A, 2011, INT J MOL SCI, V12, P3117, DOI 10.3390/ijms12053117; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Gu YJ, 1996, J NEUROCHEM, V67, P1235; Iqbal K, 2010, CURR ALZHEIMER RES, V7, P656, DOI 10.2174/156720510793611592; Iqbal K, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.225; Ke Yazi D, 2012, Int J Alzheimers Dis, V2012, P873270, DOI 10.1155/2012/873270; Lei P, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-29; Liu C., 2013, ABSTR APPL ANAL, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0084849; Maj M, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/1964634; Maj M, 2010, J ENDOCRINOL, V205, P25, DOI 10.1677/JOE-09-0341; MALAISSELAGAE F, 1979, J CLIN INVEST, V63, P1284, DOI 10.1172/JCI109423; Marciniak E, 2017, J EXP MED, V214, P2257, DOI 10.1084/jem.20161731; McMillan P, 2008, J COMP NEUROL, V511, P788, DOI 10.1002/cne.21867; Medina M, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6020021; Miklossy J, 2010, NEUROBIOL AGING, V31, P1503, DOI 10.1016/j.neurobiolaging.2008.08.019; Murakami T, 2006, AM J PATHOL, V169, P1365, DOI 10.2353/ajpath.2006.051250; Spires-Jones TL, 2014, NEURON, V82, P756, DOI 10.1016/j.neuron.2014.05.004; Stuart AAV, 2012, J CLIN ENDOCR METAB, V97, P463, DOI 10.1210/jc.2011-1858; Takei Y, 2000, J CELL BIOL, V150, P989, DOI 10.1083/jcb.150.5.989; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Wijesekara N, 2010, DIABETOLOGIA, V53, P1656, DOI 10.1007/s00125-010-1733-9; Wijesekara N, 2017, FASEB J, V31, P5409, DOI 10.1096/fj.201700431R; Yang Y, 2013, NEUROSCIENCE, V250, P140, DOI 10.1016/j.neuroscience.2013.07.009; Yuan A, 2008, J NEUROSCI, V28, P1682, DOI 10.1523/JNEUROSCI.5242-07.2008; Zhu XD, 2015, DEV CELL, V34, P656, DOI 10.1016/j.devcel.2015.08.020; Zierath JR, 2003, BEST PRACT RES CL EN, V17, P385, DOI 10.1016/S1521-690X(03)00040-X	36	28	29	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3166	3173		10.1096/fj.201701352	http://dx.doi.org/10.1096/fj.201701352			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401605				2022-12-28	WOS:000432546000022
J	Xie, X; Almuzzaini, B; Drou, N; Kremb, S; Yousif, A; Farrants, AKO; Gunsalus, K; Percipalle, P				Xie, Xin; Almuzzaini, Bader; Drou, Nizar; Kremb, Stephan; Yousif, Ayman; Farrants, Ann-Kristin Ostlund; Gunsalus, Kristin; Percipalle, Piergiorgio			beta-Actin-dependent global chromatin organization and gene expression programs control cellular identity	FASEB JOURNAL			English	Article						chromatin; epigenetics; genomic reprogramming; genome-wide analysis; nuclear actin	NUCLEAR ACTIN; HETEROCHROMATIN; ARCHITECTURE; DYNAMICS; GROWTH; BAF; INTERPHASE; ACTIVATION; MECHANISMS; COMPLEX	During differentiation and development, cell fate and identity are established by waves of genetic reprogramming. Although the mechanisms are largely unknown, during these events, dynamic chromatin reorganization is likely to ensure that multiple genes involved in the same cellular functions are coregulated, depending on the nuclear environment. In this study, using high-content screening of embryonic fibroblasts from a beta-actin knockout (KO) mouse, we found major chromatin rearrangements and changes in histone modifications, such as methylated histone (H)3-lysine-(K)9. Genome-wide H3K9 trimethylation-(Me)3 landscape changes correlate with gene up-and down-regulation in beta-actin KO cells. Mechanistically, we found loss of chromatin association by the Brahma-related gene (Brg)/Brahma-associated factor (BAF) chromatin remodeling complex subunit Brg1 in the absence of beta-actin. This actin-dependent chromatin reorganization was concomitant with the up-regulation of sets of genes involved in angiogenesis, cytoskeletal organization, andmyofibroblast features in beta-actin KO cells. Some of these genes and phenotypes were gained in a beta-actin dose-dependent manner. Moreover, reintroducing a nuclear localization signal-containing beta-actin in the knockout cells affected nuclear features and gene expression. Our results suggest that, by affecting the genome-wide organization of heterochromatin through the chromatin-binding activity of the BAF complex, beta-actin plays an essential role in the determination of gene expression programs and cellular identity.-Xie, X., Almuzzaini, B., Drou, N., Kremb, S., Yousif, A., Ostlund Farrants, A.-K., Gunsalus, K., Percipalle, P. beta-Actin-dependent global chromatin organization and gene expression programs control cellular identity.	[Xie, Xin; Gunsalus, Kristin; Percipalle, Piergiorgio] NYUAD, Biol Program, Abu Dhabi, U Arab Emirates; [Almuzzaini, Bader] King Saud bin Abdulaziz Univ Hlth Sci, MNGHA, King Abdullah Int Med Res Ctr, Med Genom Res Dept, Riyadh, Saudi Arabia; [Drou, Nizar; Kremb, Stephan; Yousif, Ayman; Gunsalus, Kristin] NYUAD Ctr Genom & Syst Biol, Abu Dhabi, U Arab Emirates; [Farrants, Ann-Kristin Ostlund; Percipalle, Piergiorgio] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Stockholm, Sweden; [Gunsalus, Kristin] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA	King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); Ministry of National Guard - Health Affairs; Stockholm University; New York University	Percipalle, P (corresponding author), New York Univ Abu Dhabi, Expt Res Bldg C1,Room 108,Saadiyat Campus, Abu Dhabi, U Arab Emirates.	pp69@nyu.edu		Xie, Xin/0000-0002-6784-4860; Almuzzaini, Bader/0000-0003-1176-9037	Swedish Research Council (Vetenskapsradet); Swedish Cancer Society (Cancerfonden)	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society)	The authors thank Christophe Ampe (University of Gent, Belgium) for kindly providing us with the beta-actin<SUP>+/+</SUP>, beta-actin<SUP>+/-</SUP>, and beta-actin<SUP>-/-</SUP> MEFs; Jillian Rowe, Marc Arnoux, and Mehar Sultana (NYUAD Center for Genomics and Systems Biology), for technical help; the NYUAD HPC team for providing the computation platform; and the Science for Life Laboratory, the National Genomics Infrastructure, NGI, and Uppmax for providing assistance in massive parallel sequencing and computational infrastructure. This work was partly supported by grants from the Swedish Research Council (Vetenskapsradet) and the Swedish Cancer Society (Cancerfonden) (to P.P). The authors declare no conflicts of interest.	Agarwal S, 2000, FASEB J, V14, pA924; Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Alexander JM, 2015, DEVELOPMENT, V142, P1418, DOI 10.1242/dev.109496; Almuzzaini B, 2016, FASEB J, V30, P2860, DOI 10.1096/fj.201600280R; Almuzzaini B, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0147-z; Baum J, 2011, J CARDIOVASC PHARM, V57, P376, DOI 10.1097/FJC.0b013e3182116e39; Bunnell TM, 2011, MOL BIOL CELL, V22, P4047, DOI 10.1091/mbc.E11-06-0582; Burke JP, 2010, BRIT J SURG, V97, P892, DOI 10.1002/bjs.6996; Chen TP, 2014, NAT REV GENET, V15, P93, DOI 10.1038/nrg3607; Darzynkiewicz Z, 2010, ADV EXP MED BIOL, V676, P137; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dundr M, 2007, J CELL BIOL, V179, P1095, DOI 10.1083/jcb.200710058; Fraser J, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156492; Gieni RS, 2009, BIOCHEM CELL BIOL, V87, P283, DOI 10.1139/O08-133; Gonzalez-Sandoval A, 2015, CELL, V163, P1333, DOI 10.1016/j.cell.2015.10.066; Herchenhan A, 2015, J BIOL CHEM, V290, P16440, DOI 10.1074/jbc.M115.641670; Hinz B, 2004, MOL BIOL CELL, V15, P4310, DOI 10.1091/mbc.E04-05-0386; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Le HQ, 2016, NAT CELL BIOL, V18, P864, DOI 10.1038/ncb3387; Kadoch C, 2017, NAT GENET, V49, P213, DOI 10.1038/ng.3734; Kapoor P, 2014, TRENDS CELL BIOL, V24, P238, DOI 10.1016/j.tcb.2013.10.007; Kind J, 2010, CURR OPIN CELL BIOL, V22, P320, DOI 10.1016/j.ceb.2010.04.002; Lavigne M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000769; Lennartsson A, 2009, BBA-GEN SUBJECTS, V1790, P863, DOI 10.1016/j.bbagen.2008.12.006; Li JT, 2008, J GASTROENTEROL, V43, P419, DOI 10.1007/s00535-008-2180-y; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Miyamoto K, 2013, CELL MOL LIFE SCI, V70, P3289, DOI 10.1007/s00018-012-1235-7; Miyamoto K, 2011, GENE DEV, V25, P946, DOI 10.1101/gad.615211; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Morris SA, 2014, NAT STRUCT MOL BIOL, V21, P73, DOI 10.1038/nsmb.2718; Olave IA, 2002, ANNU REV BIOCHEM, V71, P755, DOI 10.1146/annurev.biochem.71.110601.135507; Poleshko A, 2013, CELL REP, V5, P292, DOI 10.1016/j.celrep.2013.09.024; Pombo A, 2015, NAT REV MOL CELL BIO, V16, P245, DOI 10.1038/nrm3965; Roy M, 2005, NEOPLASIA, V7, P253, DOI 10.1593/neo.04493; Saksouk N, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/1756-8935-8-3; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066; Serebryannyy LA, 2016, SCI REP-UK, V6, DOI 10.1038/srep28460; Sharili AS, 2016, SCI REP-UK, V6, DOI 10.1038/srep33893; Shimi T, 2004, J STRUCT BIOL, V147, P31, DOI 10.1016/j.jsb.2003.11.013; Tondeleir D, 2012, MOL CELL PROTEOMICS, V11, P255, DOI 10.1074/mcp.M111.015099; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; Visa N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000620; Vukovic LD, 2016, INT REV CEL MOL BIO, V322, P1, DOI 10.1016/bs.ircmb.2015.11.001; YU J, 1985, J BIOL CHEM, V260, P3035; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	48	34	34	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1296	1314		10.1096/fj.201700753R	http://dx.doi.org/10.1096/fj.201700753R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29101221				2022-12-28	WOS:000427246000015
J	Luan, PP; Zhuang, JH; Zou, J; Li, HL; Shuai, P; Xu, XP; Zhao, YF; Kou, WX; Ji, SY; Peng, A; Xu, YW; Su, Q; Jian, WX; Peng, WH				Luan, Peipei; Zhuang, Jianhui; Zou, Jun; Li, Hailing; Shuai, Ping; Xu, Xiaopeng; Zhao, Yifan; Kou, Wenxin; Ji, Shuya; Peng, Ai; Xu, Yawei; Su, Qing; Jian, Weixia; Peng, Wenhui			NLRC5 deficiency ameliorates diabetic nephropathy through alleviating inflammation	FASEB JOURNAL			English	Article						albuminuria; innate immunity; macrophages; diabetes; kidney injury	NUCLEOTIDE-BINDING DOMAIN; NF-KAPPA-B; IMMUNE-RESPONSES; RECEPTOR NLRC5; RENAL INJURY; MACROPHAGE; PATHWAYS; MHC; FIBROSIS; PROGRESSION	NOD-like receptor family caspase recruitment domain family domain containing 5 (NLRC5) has important roles in inflammation and innate immunity. NLRC5 was highly expressed in kidney from streptozotocin-induced diabetic mice, db/db mice and patients with diabetes. Based on that evidence, the present study was designed to explore the roles of NLRC5 in the progression of diabetic nephropathy (DN). We examined kidney injury, including inflammation and fibrosis in Nlrc5 gene knockout ( Nlrc5(-/-)) and wild-type (WT) diabetic mice. We found that Nlrc5(-/-) mice developed less-severe diabetic kidney injury compared with WT mice, exhibiting lower albuminuria, less fibronectin and collagen IV expression, and reduced macrophage infiltration but greater levels of podocin and nephrin in the diabetic kidney. The underlying mechanisms were further investigated in vitro with peritoneal macrophages and mesangial cells treated with high glucose. Reduced proinflammatory effect was observed in peritoneal macrophages from Nlrc5(-/-) mice, associated with NF-kappa B pathway suppression. Knocking down of NLRC5 in mesangial cells in high-glucose conditions was also associated with reduced NF-kappa B and TGF-beta/Smad signaling. Taken together, NLRC5 promotes inflammation and fibrosis during DN progression partly through the effects on NF-kappa B and TGF-beta/Smad pathways. NLRC5 may, therefore, be a promising therapeutic target for DN treatment.	[Luan, Peipei; Su, Qing; Jian, Weixia] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Endocrinol, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China; [Zou, Jun] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Nephropathy, Shanghai, Peoples R China; [Zhuang, Jianhui; Li, Hailing; Xu, Xiaopeng; Zhao, Yifan; Kou, Wenxin; Ji, Shuya; Xu, Yawei; Peng, Wenhui] Tongji Univ, Sch Med, Dept Cardiol, Shanghai Peoples Hosp 10, 301 Middle Yanchang Rd, Shanghai 200072, Peoples R China; [Peng, Ai] Tongji Univ, Sch Med, Dept Nephropathy, Shanghai Peoples Hosp 10, Shanghai, Peoples R China; [Shuai, Ping] Gannan Med Univ, Dept Pathol, Affiliated Hosp 1, Ganzhou, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Tongji University; Tongji University; Gannan Medical University	Jian, WX (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Endocrinol, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China.; Peng, WH (corresponding author), Tongji Univ, Sch Med, Dept Cardiol, Shanghai Peoples Hosp 10, 301 Middle Yanchang Rd, Shanghai 200072, Peoples R China.	jianweixia@xinhuamed.com.cn; pwenhui@tongji.edu.cn		Zou, Jun/0000-0002-4781-2538	Chinese National Natural Science Foundation [81670746, 81370391, 81670230]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	The authors thank the patients who participated in this study. The authors also thank Dr. Wei Wang (Columbia Center for Translational Immunology, Columbia University Medical Center (New York, NY, USA) for her critical discussions and comments on the article. This study was supported by Grants 81670746,81370391 and 81670230 from the Chinese National Natural Science Foundation. The authors declare no conflicts of interest.	Abdel-Rahman EM, 2012, J GEN INTERN MED, V27, P458, DOI 10.1007/s11606-011-1912-5; Anders HJ, 2011, KIDNEY INT, V80, P915, DOI 10.1038/ki.2011.217; Bashir S, 2016, INFLAMM RES, V65, P1, DOI 10.1007/s00011-015-0874-1; Benko S, 2010, J IMMUNOL, V185, P1681, DOI 10.4049/jimmunol.0903900; Cha JJ, 2013, ENDOCRINOLOGY, V154, P2144, DOI 10.1210/en.2012-2080; Chang AS, 2016, AM J PHYSIOL-RENAL, V310, pF689, DOI 10.1152/ajprenal.00502.2015; Chow F, 2004, KIDNEY INT, V65, P116, DOI 10.1111/j.1523-1755.2004.00367.x; Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040; Davis BK, 2011, J IMMUNOL, V186, P1333, DOI 10.4049/jimmunol.1003111; Devaraj S, 2011, ARTERIOSCL THROM VAS, V31, P1796, DOI 10.1161/ATVBAHA.111.228924; Guiteras R, 2016, CLIN KIDNEY J, V9, P765, DOI 10.1093/ckj/sfw096; Hull RP, 2008, BMJ-BRIT MED J, V336, P1185, DOI 10.1136/bmj.39576.709711.80; Jian WX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094763; Kobayashi KS, 2012, NAT REV IMMUNOL, V12, P813, DOI 10.1038/nri3339; Kuenzel S, 2010, J IMMUNOL, V184, P1990, DOI 10.4049/jimmunol.0900557; Lamkanfi M, 2012, IMMUNOBIOLOGY, V217, P13, DOI 10.1016/j.imbio.2011.08.011; Li JH, 2004, FASEB J, V18, P176, DOI 10.1096/fj.02-1117fje; Lim AKH, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/146154; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; Mathieson PW, 2012, NAT REV NEPHROL, V8, P52, DOI 10.1038/nrneph.2011.171; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Neerincx A, 2010, J BIOL CHEM, V285, P26223, DOI 10.1074/jbc.M110.109736; Nguyen D, 2006, NEPHROLOGY, V11, P226, DOI 10.1111/j.1440-1797.2006.00576.x; Picken MM, 2009, KIDNEY INT, V75, P574, DOI 10.1038/ki.2008.651; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; Robbins GR, 2012, J BIOL CHEM, V287, P24294, DOI 10.1074/jbc.M112.364604; Saran R, 2017, AM J KIDNEY DIS, V69, DOI 10.1053/j.ajkd.2016.12.004; Schnaper HW, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341126; Staehli F, 2012, J IMMUNOL, V188, P3820, DOI 10.4049/jimmunol.1102671; Tervaert TWC, 2010, J AM SOC NEPHROL, V21, P556, DOI 10.1681/ASN.2010010010; Tesch GH, 2007, CLIN EXP PHARMACOL P, V34, P1016, DOI 10.1111/j.1440-1681.2007.04729.x; Tian SJ, 2015, AM J PHYSIOL-RENAL, V308, pF69, DOI 10.1152/ajprenal.00484.2014; Tong YZ, 2012, CELL RES, V22, P822, DOI 10.1038/cr.2012.53; Wada J, 2016, NAT REV NEPHROL, V12, P13, DOI 10.1038/nrneph.2015.175; Wolf G, 2004, EUR J CLIN INVEST, V34, P785, DOI 10.1111/j.1365-2362.2004.01429.x; Xu T, 2016, INT J BIOCHEM CELL B, V70, P92, DOI 10.1016/j.biocel.2015.11.010; Yao YK, 2013, PROTEIN CELL, V4, P168, DOI 10.1007/s13238-012-2109-3; Yao Y, 2012, CELL RES, V22, P836, DOI 10.1038/cr.2012.56; Yiu W.H., 2015, KIDNEY INT	39	32	34	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					1070	1084		10.1096/fj.201700511RR	http://dx.doi.org/10.1096/fj.201700511RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29070585	Bronze			2022-12-28	WOS:000425146900045
J	Wang, LJ; Iorio, C; Yan, K; Yang, H; Takeshita, S; Kang, SM; Neel, BG; Yang, WT				Wang, Lijun; Iorio, Caterina; Yan, Kevin; Yang, Howard; Takeshita, Sunao; Kang, Sumin; Neel, Benjamin G.; Yang, Wentian			A ERK/RSK-mediated negative feedback loop regulates M-CSF-evoked PI3K/AKT activation in macrophages	FASEB JOURNAL			English	Article						SHP2; MAPK; c-Fms; M-CSFR	TYROSINE-PHOSPHATASE SHP2; SIGNAL-TRANSDUCTION; MAP KINASE; ERK ACTIVATION; RECEPTOR; GROWTH; DIFFERENTIATION; PROLIFERATION; PHOSPHORYLATION; INHIBITORS	Activation of the RAS/ERK and its downstream signaling components is essential for growth factor-induced cell survival, proliferation, and differentiation. The Src homology-2 domain containing protein tyrosine phosphatase 2 (SHP2), encoded by protein tyrosine phosphatase, non-receptor type 11 (Ptpn11), is a positive mediator required for most, if not all, receptor tyrosine kinase-evoked RAS/ERK activation, but differentially regulates the PI3K/AKT signaling cascade in various cellular contexts. The precise mechanisms underlying the differential effects of SHP2 deficiency on the PI3K pathway remain unclear. We found that mice with myelomonocytic cell-specific [Tg(LysM-Cre); Ptpn11(fl/fl) mice] Ptpn11 deficiency exhibit mild osteopetrosis. SHP2-deficient bone marrow macrophages (BMMs) showed decreased proliferation in response to M-CSF and decreased osteoclast generation. M-CSF-evoked ERK1/2 activation was decreased, whereas AKT activation was enhanced in SHP2-deficient BMMs. ERK1/2, via its downstream target RSK2, mediates this negative feedback by negatively regulating phosphorylation of M-CSF receptor at Tyr721 and, consequently, its binding to p85 subunit of PI3K and PI3K activation. Pharmacologic inhibition of RSK or ERK phenotypically mimics the signaling defects observed in SHP2-deficient BMMs. Furthermore, this increase in PI3K/AKT activation enables BMM survival in the setting of SHP2 deficiency.	[Wang, Lijun; Yan, Kevin; Yang, Wentian] Brown Univ, Rhode Isl Hosp, Dept Orthopaed, Alpert Med Sch, Providence, RI 02903 USA; [Iorio, Caterina; Neel, Benjamin G.] Univ Toronto, Campbell Family Canc Res Inst, Univ Hlth Network, Dept Med Biophys,Ontario Canc Inst,Princess Marga, Toronto, ON, Canada; [Yang, Howard] Univ Rhode Isl, Coll Engn, Kingston, RI 02881 USA; [Takeshita, Sunao] Natl Ctr Geriatr & Gerontol, Dept Bone & Joint Dis, Obu, Aichi, Japan; [Kang, Sumin] Emory Univ, Sch Med, Winship Canc Inst, Dept Hematol & Oncol, Atlanta, GA USA; [Neel, Benjamin G.] NYU, Langone Med Ctr, Laura & Isaac Perlmutter Canc Ctr, New York, NY 10016 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Rhode Island; National Center for Geriatrics & Gerontology; Emory University; New York University; NYU Langone Medical Center	Neel, BG (corresponding author), NYU, Langone Med Ctr, Laura & Isaac Perlmutter Canc Ctr, New York, NY 10016 USA.; Yang, WT (corresponding author), Brown Univ, Alpert Med Sch, Dept Orthopaed Surg, Suite 402E,Coro W Bldg,1 Hoppin St, Providence, RI 02903 USA.	Benjamin.Neel@nyumc.org; wyang@lifespan.org			U.S. National Institutes of Health (NIH) National Cancer Institute [R01CA114945, R37 CA49152]; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases [R21AR57156, RO1AR066746]; NIH National Center for Research Resources Grant [P20RR025179]; Arthritis National Research Foundation; Ontario Ministry of Health and Long Term Care (OMOHLTC); Grants-in-Aid for Scientific Research [16K08681] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [R37CA049152, R01CA114945] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR025179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR057156, R01AR066746] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH National Center for Research Resources Grant; Arthritis National Research Foundation(National Research Foundation of Korea); Ontario Ministry of Health and Long Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Dr. Changqi Sun (Rhode Island Hospital) for technical assistance in constructing pMX(puro) expression constructs. This work was supported in part by U.S. National Institutes of Health (NIH) National Cancer Institute Grants R01CA114945 and R37 CA49152 (to B.G.N.), NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases Grants R21AR57156, RO1AR066746, and NIH National Center for Research Resources Grant P20RR025179 (to W.Y.). This study was also aided by a grant from the Arthritis National Research Foundation (to W.Y.). B.G.N. was a Canada Research Chair, Tier 1, and this research was also funded, in part, by the Ontario Ministry of Health and Long Term Care (OMOHLTC). The views expressed do not necessarily reflect those of the OMOHLTC. The authors declare no conflicts of interest.	Agazie YM, 2003, MOL CELL BIOL, V23, P7875, DOI 10.1128/MCB.23.21.7875-7886.2003; ALONSO G, 1995, J BIOL CHEM, V270, P9840, DOI 10.1074/jbc.270.17.9840; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Arrandale JM, 1996, J BIOL CHEM, V271, P21353, DOI 10.1074/jbc.271.35.21353; Caescu CI, 2015, BLOOD, V125, pE1, DOI 10.1182/blood-2014-10-608000; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; Dowling RJO, 2010, BBA-PROTEINS PROTEOM, V1804, P433, DOI 10.1016/j.bbapap.2009.12.001; Edouard T, 2010, MOL CELL BIOL, V30, P2498, DOI 10.1128/MCB.00646-09; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Feng X, 2002, ENDOCRINOLOGY, V143, P4868, DOI 10.1210/en.2002-220467; Fornaro M, 2006, J CELL BIOL, V175, P87, DOI 10.1083/jcb.200602029; Grossmann KS, 2010, ADV CANCER RES, V106, P53, DOI 10.1016/S0065-230X(10)06002-1; Gu HH, 2001, NATURE, V412, P186, DOI 10.1038/35084076; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Hamilton JA, 1997, J LEUKOCYTE BIOL, V62, P145, DOI 10.1002/jlb.62.2.145; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hersey P, 2009, ANN ONCOL, V20, P35, DOI 10.1093/annonc/mdp254; Hilpert K, 2007, NAT PROTOC, V2, P1333, DOI 10.1038/nprot.2007.160; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Kandel ES, 2002, MOL CELL BIOL, V22, P7831, DOI 10.1128/MCB.22.22.7831-7841.2002; Lawrence MC, 2008, CELL RES, V18, P436, DOI 10.1038/cr.2008.37; Lee AWM, 2006, CELL DEATH DIFFER, V13, P1900, DOI 10.1038/sj.cdd.4401884; Lee AWM, 2000, MOL CELL BIOL, V20, P6779, DOI 10.1128/MCB.20.18.6779-6798.2000; Lee PSW, 1999, EMBO J, V18, P3616, DOI 10.1093/emboj/18.13.3616; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Leung GC, 2009, METHODS MOL BIOL, V570, P187, DOI 10.1007/978-1-60327-394-7_7; Liu Y, 2002, FEBS LETT, V515, P1, DOI 10.1016/S0014-5793(02)02425-0; Liu Y, 2001, MOL CELL BIOL, V21, P3047, DOI 10.1128/MCB.21.9.3047-3056.2001; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mattoon DR, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-24; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Montagner A, 2005, J BIOL CHEM, V280, P5350, DOI 10.1074/jbc.M410012200; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Neel B. G., 2009, HDB CELL SIGNALING, P771; Novak U, 1998, GROWTH FACTORS, V15, P159, DOI 10.3109/08977199809002114; Novak U, 1996, ONCOGENE, V13, P2607; NOVAK U, 1995, BLOOD, V86, P2948, DOI 10.1182/blood.V86.8.2948.bloodjournal8682948; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Qu CK, 1998, ONCOGENE, V17, P433, DOI 10.1038/sj.onc.1201920; Qu CK, 2001, BLOOD, V97, P911, DOI 10.1182/blood.V97.4.911; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Ramjaun AR, 2007, CELL CYCLE, V6, P2902, DOI 10.4161/cc.6.23.4996; REEDIJK M, 1992, EMBO J, V11, P1365, DOI 10.1002/j.1460-2075.1992.tb05181.x; Rohde CM, 2004, J BIOL CHEM, V279, P43448, DOI 10.1074/jbc.M314170200; Sampaio NG, 2011, J CELL SCI, V124, P2021, DOI 10.1242/jcs.075309; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; Schaeper U, 2007, P NATL ACAD SCI USA, V104, P15376, DOI 10.1073/pnas.0702555104; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Sebolt-Leopold JS, 2004, CURR PHARM DESIGN, V10, P1907, DOI 10.2174/1381612043384439; Sefton B. M., 2001, CURR PROTOC PROTEIN; Simister PC, 2012, MOL BIOSYST, V8, P33, DOI 10.1039/c1mb05272a; Stanley ER, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a021857; Suzu S, 2007, J CELL PHYSIOL, V212, P519, DOI 10.1002/jcp.21045; Takeshita S, 2007, J BIOL CHEM, V282, P18980, DOI 10.1074/jbc.M610938200; Tanoue TJ, 2003, CELL SIGNAL, V15, P455, DOI 10.1016/S0898-6568(02)00112-2; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; VANDERGEER P, 1993, EMBO J, V12, P5161, DOI 10.1002/j.1460-2075.1993.tb06211.x; Wada T, 2005, NAT MED, V11, P394, DOI 10.1038/nm1203; Warner N, 2008, FEBS J, V275, P2561, DOI 10.1111/j.1742-4658.2008.06405.x; Wilson NJ, 2005, FEBS J, V272, P4141, DOI 10.1111/j.1742-4658.2005.04826.x; Wu CJ, 2001, ONCOGENE, V20, P6018, DOI 10.1038/sj.onc.1204699; Xiong Y, 2011, J BIOL CHEM, V286, P952, DOI 10.1074/jbc.M110.166702; Yang WT, 2013, NATURE, V499, P491, DOI 10.1038/nature12396; Yang WT, 2006, DEV CELL, V10, P317, DOI 10.1016/j.devcel.2006.01.002; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Yu WF, 2012, J BIOL CHEM, V287, P13694, DOI 10.1074/jbc.M112.355610; Zhang SQ, 2002, MOL CELL BIOL, V22, P4062, DOI 10.1128/MCB.22.12.4062-4072.2002	73	28	28	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					875	887		10.1096/fj.201700672RR	http://dx.doi.org/10.1096/fj.201700672RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29046360	Green Published, Bronze			2022-12-28	WOS:000425146900029
J	Okada, M; Shi, YB				Okada, Morihiro; Shi, Yun-Bo			EVI and MDS/EVI are required for adult intestinal stem cell formation during postembryonic vertebrate development	FASEB JOURNAL			English	Article						stem cells; intestine; amphibian metamorphosis; organogenesis; Xenopus tropicalis	INTEGRATION SITE 1; XENOPUS-TROPICALIS; THYROID-HORMONE; GENE-EXPRESSION; SELF-RENEWAL; METAMORPHOSIS; ACTIVATION; PROLIFERATION; EPITHELIUM; REGULATOR	The gene ectopic viral integration site 1 (EVI) and its variant myelodysplastic syndrome 1 (MDS)/EVI encode zinc-finger proteins that have been recognized as important oncogenes in various types of cancer. In contrast to the established role of EVI and MDS/EVI in cancer development, their potential function during vertebrate postembryonic development, especially in organ-specific adult stem cells, is unclear. Amphibian metamorphosis is strikingly similar to postembryonic development around birth in mammals, with both processes taking place when plasma thyroid hormone (T3) levels are high. Using the T3-dependent metamorphosis in Xenopus tropicalis as a model, we show here that high levels of EVI and MDS/EVI are expressed in the intestine at the climax of metamorphosis and are induced by T3. By using the transcription activator-like effector nuclease gene editing technology, we have knocked out both EVI and MDS/EVI and have shown that EVI and MDS/EVI are not essential for embryogenesis and premetamorphosis in X. tropicalis. On the other hand, knocking out EVI and MDS/EVI causes severe retardation in the growth and development of the tadpoles during metamorphosis and leads to tadpole lethality at the climax of metamorphosis. Furthermore, the homozygous-knockout animals have reduced adult intestinal epithelial stem cell proliferation at the end of metamorphosis (for the few that survive through metamorphosis) or during T3-induced metamorphosis. These findings reveal a novel role of EVI and/or MDS/EVI in regulating the formationand/orproliferation of adult intestinal adult stem cells during postembryonic development in vertebrates.	[Okada, Morihiro; Shi, Yun-Bo] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Morphogenesis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Shi, YB (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bldg 18T Room 106,18 Lib Dr MSC 5431, Bethesda, MD 20892 USA.	shi@helix.nih.gov		Okada, Morihiro/0000-0001-6384-6917; Shi, Yun-Bo/0000-0002-6330-0639	Japan Society for the Promotion of Science Research Fellowship at the U.S. National Institutes of Health (NIH); Intramural Research Program of the NIH National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008858] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science Research Fellowship at the U.S. National Institutes of Health (NIH); Intramural Research Program of the NIH National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	M.O. was supported, in part, by a Japan Society for the Promotion of Science Research Fellowship for Japanese Biomedical and Behavioral Researchers at the U.S. National Institutes of Health (NIH). This work was supported by the Intramural Research Program of the NIH National Institute of Child Health and Human Development. The authors declare no conflicts of interest.	Bard-Chapeau EA, 2012, P NATL ACAD SCI USA, V109, P2168, DOI 10.1073/pnas.1119229109; Gao JS, 2011, FEBS LETT, V585, P693, DOI 10.1016/j.febslet.2011.01.033; Goyama S, 2008, CELL STEM CELL, V3, P207, DOI 10.1016/j.stem.2008.06.002; Hasebe T, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-18; Ishizuya-Oka A, 2007, DEV DYNAM, V236, P3358, DOI 10.1002/dvdy.21291; Ishizuya-Oka A, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-37; Kashiwagi K, 2010, EXP ANIM TOKYO, V59, P395, DOI 10.1538/expanim.59.395; Kataoka K, 2012, CANCER SCI, V103, P1371, DOI 10.1111/j.1349-7006.2012.02303.x; Kataoka K, 2011, J EXP MED, V208, P2402, DOI 10.1084/jem.20110447; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kumano K, 2010, J CELL PHYSIOL, V222, P282, DOI 10.1002/jcp.21953; Lei Y, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-21; Luu N, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-43; MACDONALD WC, 1964, GASTROENTEROLOGY, V46, P405; MCAVOY JW, 1977, J EXP ZOOL, V202, P129, DOI 10.1002/jez.1402020115; Miller TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055585; MORISHITA K, 1992, P NATL ACAD SCI USA, V89, P3937, DOI 10.1073/pnas.89.9.3937; Nakajima K, 2013, ZOOL SCI, V30, P455, DOI 10.2108/zsj.30.455; Nanjundan M, 2007, CANCER RES, V67, P3074, DOI 10.1158/0008-5472.CAN-06-2366; Nieuwkoop P.D., 1965, NORMAL TABLE XENOPUS; Okada M, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0065-3; Okada M, 2015, ENDOCRINOLOGY, V156, P3381, DOI 10.1210/en.2015-1190; Okada M, 2013, ZOOL SCI, V30, P154, DOI 10.2108/zsj.30.154; Patel JB, 2011, ONCOGENE, V30, P1290, DOI 10.1038/onc.2010.510; Shi Y.-B., 1999, AMPHIBIAN METAMORPHO; Shi YB, 1996, CURR TOP DEV BIOL, V32, P205, DOI 10.1016/S0070-2153(08)60429-9; Shi YB, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-30; Sterling J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047407; Sun GH, 2014, ENDOCRINOLOGY, V155, P5024, DOI 10.1210/en.2014-1316; Sun GH, 2013, ENDOCRINOLOGY, V154, P4396, DOI 10.1210/en.2013-1432; Sun GH, 2012, INT J BIOL SCI, V8, P1217, DOI 10.7150/ijbs.5109; TATA JR, 1993, BIOESSAYS, V15, P239, DOI 10.1002/bies.950150404; Van Campenhout C, 2006, DEV BIOL, V294, P203, DOI 10.1016/j.ydbio.2006.02.040; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Wen L, 2015, FASEB J, V29, P385, DOI 10.1096/fj.14-252171; Wen L, 2015, ENDOCRINOLOGY, V156, P721, DOI 10.1210/en.2014-1439; Wieser R, 2007, GENE, V396, P346, DOI 10.1016/j.gene.2007.04.012; Zhang Y, 2011, BLOOD, V118, P3853, DOI 10.1182/blood-2011-02-334680	39	4	4	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					431	439		10.1096/fj.201700424R	http://dx.doi.org/10.1096/fj.201700424R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28928245	Green Published			2022-12-28	WOS:000419172700038
J	Cascella, R; Fani, G; Capitini, C; Rusmini, P; Poletti, A; Cecchi, C; Chiti, F				Cascella, Roberta; Fani, Giulia; Capitini, Claudia; Rusmini, Paola; Poletti, Angelo; Cecchi, Cristina; Chiti, Fabrizio			Quantitative assessment of the degradation of aggregated TDP-43 mediated by the ubiquitin proteasome system and macroautophagy	FASEB JOURNAL			English	Article						ALS; FTLD-U; UPS; protein aggregation; motor neuron disease	FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; PROTEIN B8 HSPB8; MOLECULAR CHAPERONES; SELECTIVE AUTOPHAGY; MUTATIONS; MECHANISMS; BINDING; BAG3; QUANTIFICATION	Amyotrophic lateral sclerosis and frontotemporal lobar degeneration with ubiquitin-positive inclusions are neurodegenerative disorders that share the cytosolic deposition of TDP-43 (TARDNA-binding protein 43) in the CNS. TDP-43 is well known as being actively degraded by both the proteasome and macroautophagy. The well-documented decrease in the efficiency of these clearance systems in aging and neurodegeneration, as well as the genetic evidence that many of the familial forms of TDP-43 proteinopathies involve genes that are associated with them, suggest that a failure of these protein degradation systems is a major factor that contributes to the onset of TDP-43-associated disorders. Here, we inserted preformed human TDP-43 aggregates in the cytosol of murine NSC34 and N2a cells in diffuse form and observed their degradation under conditions in which exogenous TDP-43 is not expressed and endogenous nuclear TDP-43 is not recruited, thereby allowing a time zero to be established in TDP-43 degradation and to observe its disposal kinetically and analytically. TDP-43 degradation was observed in the absence and presence of selective inhibitors and small interfering RNAs against the proteasome and autophagy. We found that cytosolic diffuse aggregates of TDP-43 can be distinguished in 3 different classes on the basis of their vulnerability to degradation, which contributed to the definition-with previous reports-of a total of 6 distinct classes of misfolded TDP-43 species that range from soluble monomer to undegradable macroaggregates. We also found that the proteasome and macroautophagy-degradable pools of TDP-43 are fully distinguishable, rather than in equilibrium between them on the time scale required for degradation, and that a significant crosstalk exists between the 2 degradation processes.	[Cascella, Roberta; Fani, Giulia; Capitini, Claudia; Cecchi, Cristina; Chiti, Fabrizio] Univ Florence, Dept Expt & Clin Biomed Sci, Vle GB Morgagni 50, I-50134 Florence, Italy; [Rusmini, Paola; Poletti, Angelo] Univ Milan, Ctr Eccellenza Malattie Neurodegenerat, Dipartimento Sci Farmacol & Biomol, Milan, Italy	University of Florence; University of Milan	Chiti, F (corresponding author), Univ Florence, Dept Expt & Clin Biomed Sci, Vle GB Morgagni 50, I-50134 Florence, Italy.	fabrizio.chiti@unifi.it	Poletti, Angelo/A-9016-2011	Poletti, Angelo/0000-0002-8883-0468; Capitini, Claudia/0000-0003-2834-1424; Cecchi, Cristina/0000-0001-8387-7737; RUSMINI, PAOLA/0000-0001-9989-0733	Accademia Nazionale dei Lincei (Rome, Italy) [47/2014/A]	Accademia Nazionale dei Lincei (Rome, Italy)	This work was supported by the Accademia Nazionale dei Lincei (Rome, Italy) (47/2014/A). The authors thank Neil Cashman (University of British Columbia, Vancouver, BC, Canada) for providing the NSC34 cell line. The authors declare no conflicts of interest.	Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Baloh RH, 2011, FEBS J, V278, P3539, DOI 10.1111/j.1742-4658.2011.08256.x; Bang Y, 2014, NEUROSCI LETT, V566, P263, DOI 10.1016/j.neulet.2014.02.056; Behl C, 2016, TRENDS PHARMACOL SCI, V37, P672, DOI 10.1016/j.tips.2016.04.007; Brandmeir NJ, 2008, ACTA NEUROPATHOL, V115, P123, DOI 10.1007/s00401-007-0315-5; Caccamo A, 2015, HUM MOL GENET, V24, P4625, DOI 10.1093/hmg/ddv193; Capitini C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086720; Cappelli S, 2016, BIOL CHEM, V397, P401, DOI 10.1515/hsz-2015-0250; Cascella R, 2016, J BIOL CHEM, V291, P19437, DOI 10.1074/jbc.M116.737726; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Chow CY, 2009, AM J HUM GENET, V84, P85, DOI 10.1016/j.ajhg.2008.12.010; Crippa V, 2016, HUM MOL GENET, V25, P3908, DOI 10.1093/hmg/ddw232; Crippa V, 2010, HUM MOL GENET, V19, P3440, DOI 10.1093/hmg/ddq257; Cristofani R, 2017, AUTOPHAGY, V13, P1280, DOI 10.1080/15548627.2017.1308985; Dantuma NP, 2014, FRONT MOL NEUROSCI, V7, DOI [10.3389/fnmo1.2014.00070, 10.3389/fnmol.2014.00070]; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Diehl-Schmid J, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0489-x; Evangelisti E, 2016, SCI REP-UK, V6, DOI 10.1038/srep32721; Fecto F, 2011, ARCH NEUROL-CHICAGO, V68, P1440, DOI 10.1001/archneurol.2011.250; Gamerdinger M, 2011, J MOL MED, V89, P1175, DOI 10.1007/s00109-011-0795-6; Gamerdinger M, 2011, EMBO REP, V12, P149, DOI 10.1038/embor.2010.203; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Halliday G, 2012, ACTA NEUROPATHOL, V124, P373, DOI 10.1007/s00401-012-1030-4; Huang CC, 2014, J CELL SCI, V127, P3024, DOI 10.1242/jcs.136150; Iguchi Y, 2009, J BIOL CHEM, V284, P22059, DOI 10.1074/jbc.M109.012195; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Kim SH, 2012, HUM MOL GENET, V21, P4845, DOI 10.1093/hmg/dds321; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Martinez-Lopez N, 2015, ADV EXP MED BIOL, V847, P73, DOI 10.1007/978-1-4939-2404-2_3; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; McKinnon C, 2014, ANTIOXID REDOX SIGN, V21, P2302, DOI 10.1089/ars.2013.5802; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Pandey UB, 2007, AUTOPHAGY, V3, P643, DOI 10.4161/auto.5050; Parkinson N, 2006, NEUROLOGY, V67, P1074, DOI 10.1212/01.wnl.0000231510.89311.8b; Romanov J, 2012, EMBO J, V31, P4304, DOI 10.1038/emboj.2012.278; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Ruegsegger C, 2016, BRAIN RES, V1648, P571, DOI 10.1016/j.brainres.2016.03.032; Rusmini P, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00176; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Scotter EL, 2014, J CELL SCI, V127, P1263, DOI 10.1242/jcs.140087; Sturner E, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00177; Tashiro Y, 2012, J BIOL CHEM, V287, P42984, DOI 10.1074/jbc.M112.417600; Urushitani M, 2010, J NEUROSCI RES, V88, P784, DOI 10.1002/jnr.22243; van Eersel J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022850; Vilchez D, 2012, NATURE, V489, P304, DOI 10.1038/nature11468; Wang XJ, 2013, AUTOPHAGY, V9, P1500, DOI 10.4161/auto.25573; Wang XJ, 2010, NEUROSCI LETT, V469, P112, DOI 10.1016/j.neulet.2009.11.055; Wijesekera LC, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-3; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; Zhang YJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-33	55	25	25	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5609	5624		10.1096/fj.201700292RR	http://dx.doi.org/10.1096/fj.201700292RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28842427				2022-12-28	WOS:000416588300040
J	Cheng, JH; Zhong, YH; Chen, S; Sun, Y; Huang, LT; Kang, YJ; Chen, BZ; Chen, G; Wang, FL; Tian, YP; Liu, WJ; Feng, GS; Lu, ZX				Cheng, Jianghong; Zhong, Yanhong; Chen, Shuai; Sun, Yan; Huang, Lantang; Kang, Yujia; Chen, Baozhen; Chen, Gang; Wang, Fengli; Tian, Yingpu; Liu, Wenjie; Feng, Gen-Sheng; Lu, Zhongxian			Gab2 mediates hepatocellular carcinogenesis by integrating multiple signaling pathways	FASEB JOURNAL			English	Article						HCC; knockout mouse; IL-6; Jak2/Stat3 signaling pathway; therapeutic target	MAMMARY EPITHELIAL-CELLS; GRB2-ASSOCIATED BINDER 2; OVARIAN-CANCER; SCAFFOLDING ADAPTER; LIVER-CANCER; FATTY LIVER; EXPRESSION; PROMOTES; GROWTH; OVEREXPRESSION	Ourprevious studies have found that Growth factor receptor-bound protein2-associated binding protein 2 (Gab2)-a docking protein-governs the development of fatty liver disease. Here, we further demonstrate that Gab2mediates hepatocarcinogenesis. Compared with a faint expression in para-carcinoma tissue, Gab2 was highly expressed in similar to 60-70% of human hepatocellular carcinoma (HCC) specimens. Deletion of Gab2 dramatically suppressed diethylnitrosamine-induced HCC in mice. The oncogenic effects of Gab2 in HepG2 cells were promoted by Gab2 overexpression but were rescued by Gab2 knockdown. Furthermore, Gab2 knockout in HepG2 cells restrained cell proliferation, migration and tumor growth in nude mice. Signaling pathway analysis with protein kinase inhibitors demonstrated that oncogenic regulation by Gab2 in hepatic cells involved multiple signaling molecules, including ERK, Akt, and Janus kinases (Jaks), especially those that mediate inflammatory signaling. IL-6 signaling was increased by Gab2 overexpression and impaired by Gab2 deletion via regulation of Jak2 and signal transducer and activator of transcription 3 phosphorylation and the expression of downstream genes, such as Bcl-2 (B-cell lymphoma 2), c-Myc, MMP7 (matrix metalloproteinase-7), and cyclin D1 in vitro and in vivo. These data indicate that Gab2 mediates the pathologic progression of HCC by integrating multiple signaling pathways and suggest that Gab2 might be a powerful therapeutic target for HCC.	[Cheng, Jianghong; Zhong, Yanhong; Chen, Shuai; Sun, Yan; Huang, Lantang; Kang, Yujia; Wang, Fengli; Tian, Yingpu; Liu, Wenjie; Lu, Zhongxian] Xiamen Univ, State Key Lab Cellular Stress Biol, Sch Pharmaceut Sci, Zhuangjin Hall,Room 319, Xiamen 361005, Peoples R China; [Chen, Baozhen; Chen, Gang] Fujian Prov Tumor Hosp, Dept Pathol, Fuzhou, Fujian, Peoples R China; [Feng, Gen-Sheng] Univ Calif San Diego, Dept Pathol, Div Biol Sci, La Jolla, CA 92093 USA	Xiamen University; University of California System; University of California San Diego	Lu, ZX (corresponding author), Xiamen Univ, State Key Lab Cellular Stress Biol, Sch Pharmaceut Sci, Zhuangjin Hall,Room 319, Xiamen 361005, Peoples R China.	zhongxian@xmu.edu.cn	Lu, ZX/G-4586-2010		National Natural Science Foundation of China [81470111, 30772546]; National Basic Research Program of China [2013CB945503, 2010CB945004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (Grants 81470111 and 30772546) and the National Basic Research Program of China (Grants 2013CB945503 and 2010CB945004). The authors declare no conflicts of interest.	Abreu MTH, 2011, MOL BIOL CELL, V22, P105, DOI 10.1091/mbc.E10-03-0185; Bentires-Alj M, 2006, NAT MED, V12, P114, DOI 10.1038/nm1341; Berasain C, 2014, J GASTROENTEROL, V49, P9, DOI 10.1007/s00535-013-0907-x; Bhala N, 2013, CURR PHARM DESIGN, V19, P5169, DOI 10.2174/13816128113199990336; Bocanegra M, 2010, ONCOGENE, V29, P774, DOI 10.1038/onc.2009.364; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Boudot C, 2002, CELL SIGNAL, V14, P869, DOI 10.1016/S0898-6568(02)00036-0; Breitkopf SB, 2016, SCI REP-UK, V6, DOI 10.1038/srep20471; Brown LA, 2008, GENE CHROMOSOME CANC, V47, P481, DOI 10.1002/gcc.20549; Brummer T, 2006, J BIOL CHEM, V281, P626, DOI 10.1074/jbc.M509567200; Chauhan Ranjit, 2016, Biomark Cancer, V8, P37, DOI 10.4137/BIC.S34413; Chen S, 2016, J MOL CELL BIOL, V8, P492, DOI 10.1093/jmcb/mjw028; Chen YM, 2016, TUMOR BIOL, V37, P10861, DOI 10.1007/s13277-016-4909-1; Chernoff KA, 2009, CLIN CANCER RES, V15, P4288, DOI 10.1158/1078-0432.CCR-09-0280; Daly RJ, 2002, ONCOGENE, V21, P5175, DOI 10.1038/sj.onc.1205522; Davis SJ, 2015, MOL CANCER THER, V14, P1495, DOI 10.1158/1535-7163.MCT-15-0039; Ding CB, 2015, MOL MED REP, V12, P4007, DOI 10.3892/mmr.2015.3951; Duckworth C, 2016, ONCOGENE, V35, P4036, DOI 10.1038/onc.2015.472; Enguita-German M, 2014, WORLD J HEPATOL, V6, P716, DOI 10.4254/wjh.v6.i10.716; Fleuren EDG, 2010, INT J CANCER, V127, P1486, DOI 10.1002/ijc.25172; Goyal L, 2013, CLIN CANCER RES, V19, P2310, DOI 10.1158/1078-0432.CCR-12-2791; Gu SQ, 2016, BLOOD, V127, P1803, DOI 10.1182/blood-2015-06-653006; Halbach S, 2016, LEUKEMIA, V30, P1942, DOI 10.1038/leu.2016.92; Halbach S, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-016-0129-y; Hu X, 2016, CLIN LAB, V62, P1087, DOI 10.7754/Clin.Lab.2015.151008; Joshi K, 2016, CLIN LIVER DIS, V20, P563, DOI 10.1016/j.cld.2016.02.012; Kristiansen OP, 2005, DIABETES, V54, pS114, DOI 10.2337/diabetes.54.suppl_2.S114; Lee SH, 2007, PATHOLOGY, V39, P326, DOI 10.1080/00313020701329773; Liu H, 2014, P NATL ACAD SCI USA, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0113875; Liu XM, 2016, ONCOL REP, V36, P1385, DOI 10.3892/or.2016.4971; Marengo A, 2016, ANNU REV MED, V67, P103, DOI 10.1146/annurev-med-090514-013832; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; Moriguchi M, 2016, CLIN J GASTROENTEROL, V9, P184, DOI 10.1007/s12328-016-0670-7; Nagao T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084746; Pan XL, 2010, NEUROSCI BULL, V26, P241, DOI 10.1007/s12264-010-1109-7; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Scaiewicz V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081065; Sha F, 2013, P NATL ACAD SCI USA, V110, P14924, DOI 10.1073/pnas.1303640110; Shi LH, 2013, ACTA ONCOL, V52, P1739, DOI 10.3109/0284186X.2012.750032; Smith PC, 2001, CYTOKINE GROWTH F R, V12, P33, DOI 10.1016/S1359-6101(00)00021-6; Strazzabosco M, 2012, GASTROENTEROLOGY, V143, P1430, DOI 10.1053/j.gastro.2012.10.025; Sun L, 2016, MOL CARCINOGEN, V55, P40, DOI 10.1002/mc.22256; Swardfager W, 2010, BIOL PSYCHIAT, V68, P930, DOI 10.1016/j.biopsych.2010.06.012; Teal HE, 2006, ONCOGENE, V25, P2433, DOI 10.1038/sj.onc.1209288; Thompson MD, 2007, HEPATOLOGY, V45, P1298, DOI 10.1002/hep.21651; Tian LQ, 2016, MOL MED REP, V13, P4279, DOI 10.3892/mmr.2016.5076; Vaughan TY, 2011, AM J BLOOD RES, V1, P130; Wang WJ, 2015, INT J CLIN EXP PATHO, V8, P10575; Wang Y, 2012, ONCOGENE, V31, P2512, DOI 10.1038/onc.2011.435; WRIGHT TL, 1993, LANCET, V342, P1340, DOI 10.1016/0140-6736(93)92250-W; Wu J, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0229-3; Xia CX, 2015, CELL PHYSIOL BIOCHEM, V37, P677, DOI 10.1159/000430386; Xie GZ, 2012, INT J ONCOL, V40, P1171, DOI 10.3892/ijo.2011.1275; Xu XL, 2011, INT J BIOL SCI, V7, P496, DOI 10.7150/ijbs.7.496; Yajima I, 2012, DERMAT RES PRACT, V2012, DOI 10.1155/2012/354191; Yang Y, 2013, ONCOGENE, V32, P3627, DOI 10.1038/onc.2012.367; Zhang XC, 2013, MOL CELL BIOL, V33, P1657, DOI 10.1128/MCB.01353-12; Zhang X, 2015, WORLD J HEPATOL, V7, P1282, DOI 10.4254/wjh.v7.i9.1282	58	17	18	0	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5530	+		10.1096/fj.201700120RR	http://dx.doi.org/10.1096/fj.201700120RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28842424	Green Published			2022-12-28	WOS:000416588300034
J	Hilton, BA; Liu, J; Cartwright, BM; Liu, YY; Breitman, M; Wang, YJ; Jones, R; Tang, H; Rusinol, A; Musich, PR; Zou, Y				Hilton, Benjamin A.; Liu, Ji; Cartwright, Brian M.; Liu, Yiyong; Breitman, Maya; Wang, Youjie; Jones, Rowdy; Tang, Hui; Rusinol, Antonio; Musich, Phillip R.; Zou, Yue			Progerin sequestration of PCNA promotes replication fork collapse and mislocalization of XPA in laminopathy-related progeroid syndromes	FASEB JOURNAL			English	Article						HGPS; lamin A; DNA DSBs; DNA repair; genome instability	NUCLEOTIDE EXCISION-REPAIR; DNA-POLYMERASE-DELTA; PIGMENTOSUM GROUP-A; DEFECTIVE MATURATION; GENOMIC INSTABILITY; DAMAGE RESPONSES; BREAK REPAIR; CELL-CYCLE; ATR; PRELAMIN	Hutchinson-Gilford progeria syndrome (HGPS) is a rare genetic disorder that is caused by a point mutation in the LMNA gene, resulting in production of a truncated farnesylated-prelamin A protein (progerin). We previously reported that XPA mislocalized to the progerin-induced DNA double-strand break (DSB) sites, blocking DSB repair, which led to DSB accumulation, DNA damage responses, and early replication arrest in HGPS. In this study, the XPA mislocalization to DSBs occurred at stalled or collapsed replication forks, concurrent with a significant loss of PCNA at the forks, whereas PCNA efficiently bound to progerin. This PCNA sequestration likely exposed ds-ssDNA junctions at replication forks for XPA binding. Depletion of XPA or progerin each significantly restored PCNA at replication forks. Our results suggest that although PCNA is much more competitive than XPA in binding replication forks, PCNA sequestration by progerin may shift the equilibrium to favor XPA binding. Furthermore, we demonstrated that progerin-induced apoptosis could be rescued by XPA, suggesting that XPA-replication fork binding may prevent apoptosis in HGPS cells. Our results propose a mechanism for progerin-induced genome instability and accelerated replicative senescence in HGPS.	[Hilton, Benjamin A.; Cartwright, Brian M.; Liu, Yiyong; Breitman, Maya; Jones, Rowdy; Tang, Hui; Rusinol, Antonio; Musich, Phillip R.; Zou, Yue] East Tennessee State Univ, JH Quillen Coll Med, Dept Biomed Sci, Johnson City, TN 37614 USA; [Liu, Ji] Sichuan Univ, Dept Biochem & Mol Biol, West China Ctr Med Sci, Chengdu, Sichuan, Peoples R China; [Wang, Youjie] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Minist Educ MOE,Key Lab Environm & Hlth, Wuhan, Hubei, Peoples R China	East Tennessee State University; Sichuan University; Huazhong University of Science & Technology	Zou, Y (corresponding author), East Tennessee State Univ, JH Quillen Coll Med, Box 70581, Johnson City, TN 37614 USA.	zouy@etsu.edu	Zou, Yue/ABA-8429-2020	Musich, Phillip/0000-0001-8816-4242	U.S. National Institutes of Health, National Institute on Aging [AG031503]; Progeria Research Foundation; East Tennessee State University Research Development Committee [E82083, E31231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM112168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG031503] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Progeria Research Foundation; East Tennessee State University Research Development Committee; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by U.S. National Institutes of Health, National Institute on Aging Grant AG031503 (to Y.Z.), a Progeria Research Foundation grant (to Y.Z.), and East Tennessee State University Research Development Committee Grants E82083 and E31231 (to P.R.M.).	Aliper AM, 2015, AGING-US, V7, P26, DOI 10.18632/aging.100717; Bailey R, 2015, NUCLEUS-PHILA, V6, P187, DOI 10.1080/19491034.2015.1035843; Buisson R, 2015, MOL CELL, V59, P1011, DOI 10.1016/j.molcel.2015.07.029; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Cao K, 2007, P NATL ACAD SCI USA, V104, P4949, DOI 10.1073/pnas.0611640104; Cao K, 2011, J CLIN INVEST, V121, P2833, DOI 10.1172/JCI43578; Chabes A, 2000, J BIOL CHEM, V275, P17747, DOI 10.1074/jbc.M000799200; Chibazakura T, 2011, MOL CELL BIOL, V31, P248, DOI 10.1128/MCB.00630-10; Cobb AM, 2016, NUCLEUS-PHILA, V7, P498, DOI 10.1080/19491034.2016.1239685; Constantinescu D, 2010, EXP CELL RES, V316, P2747, DOI 10.1016/j.yexcr.2010.05.015; Corrigan DP, 2005, BIOCHEM J, V387, P129, DOI 10.1042/BJ20041359; Cortez D, 2015, DNA REPAIR, V32, P149, DOI 10.1016/j.dnarep.2015.04.026; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Ding SL, 2008, CLIN INTERV AGING, V3, P431, DOI 10.2147/CIA.S1957; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Errico A, 2012, CRIT REV BIOCHEM MOL, V47, P222, DOI 10.3109/10409238.2012.655374; Essers J, 2005, MOL CELL BIOL, V25, P9350, DOI 10.1128/MCB.25.21.9350-9359.2005; Ewald B, 2008, ONCOGENE, V27, P6522, DOI 10.1038/onc.2008.316; Gilljam KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049199; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Gonzalo S, 2015, CURR OPIN CELL BIOL, V34, P75, DOI 10.1016/j.ceb.2015.05.007; Gordon LB, 2014, CELL, V156, P400, DOI 10.1016/j.cell.2013.12.028; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; Hicks WM, 2011, P NATL ACAD SCI USA, V108, P3108, DOI 10.1073/pnas.1019660108; Hilton B, 2014, BIOSCIENCE REP, V34, P831, DOI 10.1042/BSR20140158; Hutchison CJ, 2011, BIOCHEM SOC T, V39, P1715, DOI 10.1042/BST20110700; Li ZK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068297; Li ZK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028326; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Liu Y, 2008, FASEB J, V22, P603, DOI 10.1096/fj.07-8598com; Liu YY, 2006, J CELL SCI, V119, P4644, DOI 10.1242/jcs.03263; Lopez-Contreras AJ, 2015, GENE DEV, V29, P690, DOI 10.1101/gad.256958.114; Maloisel L, 2008, MOL CELL BIOL, V28, P1373, DOI 10.1128/MCB.01651-07; Manju K, 2006, J CELL SCI, V119, P2704, DOI 10.1242/jcs.03009; Mattout A, 2007, J CELL SCI, V120, P77, DOI 10.1242/jcs.03325; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Misteli T, 2005, NAT MED, V11, P718, DOI 10.1038/nm0705-718; Moir RD, 2000, J CELL BIOL, V149, P1179, DOI 10.1083/jcb.149.6.1179; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Morafraile EC, 2015, SCI REP-UK, V5, DOI 10.1038/srep07886; Musich PR, 2011, BIOCHEM SOC T, V39, P1764, DOI 10.1042/BST20110687; Musich PR, 2009, AGING-US, V1, P28, DOI 10.18632/aging.100012; Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P965, DOI 10.1007/s00018-009-8734-1; Olive M, 2010, ARTERIOSCL THROM VAS, V30, P2301, DOI 10.1161/ATVBAHA.110.209460; Pacheco LM, 2014, AGING-US, V6, P1049, DOI 10.18632/aging.100709; Ricke RM, 2005, BIOL PROCED ONLINE, V7, P60, DOI 10.1251/bpo106; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Schumacher B, 2008, TRENDS GENET, V24, P77, DOI 10.1016/j.tig.2007.11.004; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Shell SM, 2009, J BIOL CHEM, V284, P24213, DOI 10.1074/jbc.M109.000745; Shumaker DK, 2008, J CELL BIOL, V181, P269, DOI 10.1083/jcb.200708155; Smith CE, 2009, MOL CELL BIOL, V29, P1432, DOI 10.1128/MCB.01469-08; Spann TP, 1997, J CELL BIOL, V136, P1201, DOI 10.1083/jcb.136.6.1201; Sugasawa K, 2001, GENE DEV, V15, P507, DOI 10.1101/gad.866301; Sugitani N, 2014, J AM CHEM SOC, V136, P10830, DOI 10.1021/ja503020f; Tang H, 2012, AGING CELL, V11, P363, DOI 10.1111/j.1474-9726.2011.00779.x; Toth JI, 2005, P NATL ACAD SCI USA, V102, P12873, DOI 10.1073/pnas.0505767102; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Widrow RJ, 1998, P NATL ACAD SCI USA, V95, P11246, DOI 10.1073/pnas.95.19.11246; Wu X, 2007, ONCOGENE, V26, P757, DOI 10.1038/sj.onc.1209828; Wu XM, 2006, CANCER RES, V66, P2997, DOI 10.1158/0008-5472.CAN-05-3403; Yang ZG, 2006, BIOCHEMISTRY-US, V45, P15921, DOI 10.1021/bi061626q	63	26	27	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3882	3893		10.1096/fj.201700014R	http://dx.doi.org/10.1096/fj.201700014R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28515154	Green Published			2022-12-28	WOS:000408713300015
J	Singer, W; Kasini, K; Manthey, M; Eckert, P; Armbruster, P; Vogt, MA; Jaumann, M; Dotta, M; Yamahara, K; Harasztosi, C; Zimmermann, U; Knipper, M; Ruttiger, L				Singer, Wibke; Kasini, Kamyar; Manthey, Marie; Eckert, Philipp; Armbruster, Philipp; Vogt, Miriam Annika; Jaumann, Mirko; Dotta, Michela; Yamahara, Kohei; Harasztosi, Csaba; Zimmermann, Ulrike; Knipper, Marlies; Ruettiger, Lukas			The glucocorticoid antagonist mifepristone attenuates sound-induced long-term deficits in auditory nerve response and central auditory processing in female rats	FASEB JOURNAL			English	Article						glucocorticoid receptors; mineralocorticoid receptors; hidden hearing loss; synaptic ribbon; auditory trauma	SENSORINEURAL HEARING-LOSS; TRAUMATIC BRAIN-INJURY; OUTER HAIR-CELLS; RESTRAINT STRESS; ACOUSTIC TRAUMA; GUINEA-PIG; MINERALOCORTICOID RECEPTOR; COCHLEAR SYNAPTOPATHY; INTRATYMPANIC DEXAMETHASONE; INNER-EAR	Systemic corticosteroids have been the mainstay of treatment for various hearing disorders for more than 30 yr. Accordingly, numerous studies have described glucocorticoids (GCs) and stressors to be protective in the auditory organ against damage associated with a variety of health conditions, including noise exposure. Conversely, stressors are also predictive risk factors for hearing disorders. How both of these contrasting stress actions are linked has remained elusive. Here, we demonstrate that higher corticosterone levels during acoustic trauma in female rats is highly correlated with a decline of auditory fiber responses in high-frequency cochlear regions, and that hearing thresholds and the outer hair cell functions (distortion products of otoacoustic emissions) are left unaffected. Moreover, when GC receptor (GR) or mineralocorticoid receptor (MR) activation was antagonized by mifepristone or spironolactone, respectively, GR, but not MR, inhibition significantly and permanently attenuated trauma-induced effects on auditory fiber responses, including inner hair cell ribbon loss and related reductions of early and late auditory brainstem responses. These findings strongly imply that higher corticosterone stress levels profoundly impair auditory nerve processing, which may influence central auditory acuity. These changes are likely GR mediated as they are prevented by mifepristone.	[Singer, Wibke; Kasini, Kamyar; Manthey, Marie; Eckert, Philipp; Armbruster, Philipp; Vogt, Miriam Annika; Jaumann, Mirko; Dotta, Michela; Yamahara, Kohei; Zimmermann, Ulrike; Knipper, Marlies; Ruettiger, Lukas] Univ Tubingen, Tubingen Hearing Res Ctr, Dept Otolaryngol, Mol Physiol Hearing, Tubingen, Germany; [Harasztosi, Csaba] Univ Tubingen, Tubingen Hearing Res Ctr, Dept Otolaryngol, Sect Physiol Acoust & Commun, Tubingen, Germany; [Yamahara, Kohei] Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kyoto, Japan	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Kyoto University	Knipper, M (corresponding author), Univ Tubingen, Dept Otolaryngol, Tubingen Hearing Res Ctr, Elfriede Aulhorn Str 5, D-72076 Tubingen, Germany.	marlies.knipper@uni-tuebingen.de	åå, å·å/AAC-7392-2019	åå, å·å/0000-0002-3281-7547; Vogt, Miriam Annika/0000-0002-3400-5067	Deutsche Forschungsgemeinschaft [DFG-Kni-316-10-1, SPP 1608 RU 316/12-1, KN 316/12-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Grants DFG-Kni-316-10-1, SPP 1608 RU 316/12-1, and KN 316/12-1). The authors thank Michael Paolillo (Interfaculty Institute of Biochemistry, University of Tubingen) for reading the manuscript. The authors declare no conflicts of interest.	Adamec R, 2007, BEHAV BRAIN RES, V179, P192, DOI 10.1016/j.bbr.2007.02.001; Perez MA, 2013, NEUROSCIENCE, V246, P94, DOI 10.1016/j.neuroscience.2013.04.044; Ashmore J, 2008, PHYSIOL REV, V88, P173, DOI 10.1152/physrev.00044.2006; Bharadwaj HM, 2015, J NEUROSCI, V35, P2161, DOI 10.1523/JNEUROSCI.3915-14.2015; Boudaba C, 2006, AM J PHYSIOL-REG I, V291, pR102, DOI 10.1152/ajpregu.00795.2005; Buran BN, 2010, J NEUROSCI, V30, P7587, DOI 10.1523/JNEUROSCI.0389-10.2010; Burkard R., 2007, AUDITORY EVOKED POTE, P229; Canlon B, 2007, HEARING RES, V226, P61, DOI 10.1016/j.heares.2006.05.009; Chavez CM, 2009, NEUROBIOL LEARN MEM, V91, P382, DOI 10.1016/j.nlm.2008.10.010; Dagnino-Subiabre A, 2009, BEHAV BRAIN RES, V203, P88, DOI 10.1016/j.bbr.2009.04.024; DALLOS P, 1978, J NEUROPHYSIOL, V41, P365, DOI 10.1152/jn.1978.41.2.365; de Kloet ER, 2013, EUR J PHARMACOL, V719, P53, DOI 10.1016/j.ejphar.2013.04.053; de Kloet ER, 2014, ENDOCRINOLOGY, V155, P2754, DOI 10.1210/en.2014-1048; El Sabbagh NG, 2017, LARYNGOSCOPE, V127, P1897, DOI 10.1002/lary.26394; El-Badry MM, 2007, BRAIN RES, V1134, P122, DOI 10.1016/j.brainres.2006.11.078; Engel J, 2006, NEUROSCIENCE, V143, P837, DOI 10.1016/j.neuroscience.2006.08.060; Felmingham KL, 2012, BIOL PSYCHOL, V90, P224, DOI 10.1016/j.biopsycho.2012.03.011; Fetoni AR, 2016, FREE RADICAL BIO MED, V101, P211, DOI 10.1016/j.freeradbiomed.2016.10.014; Fox LC, 2016, BEHAV BRAIN RES, V312, P362, DOI 10.1016/j.bbr.2016.06.048; Furman AC, 2013, J NEUROPHYSIOL, V110, P577, DOI 10.1152/jn.00164.2013; Griesbach GS, 2012, NEUROSCIENCE, V210, P393, DOI 10.1016/j.neuroscience.2012.03.005; Groeneweg FL, 2011, J ENDOCRINOL, V209, P153, DOI 10.1530/JOE-10-0472; Hickox AE, 2017, HEARING RES, V349, P164, DOI 10.1016/j.heares.2016.12.010; Hobson CE, 2016, CURR OPIN OTOLARYNGO, V24, P407, DOI 10.1097/MOO.0000000000000288; Howland RH, 2013, J PSYCHOSOC NURS MEN, V51, P11, DOI 10.3928/02793695-20121219-01; Jaumann M, 2012, NAT MED, V18, P252, DOI 10.1038/nm.2634; Jia H, 2016, NEUROSCIENCE, V316, P261, DOI 10.1016/j.neuroscience.2015.12.031; Joels M, 2017, J ENDOCRINOL, V234, pT49, DOI 10.1530/JOE-16-0660; JOHNSON DH, 1976, BIOPHYS J, V16, P719, DOI 10.1016/S0006-3495(76)85724-4; Karst H, 2010, P NATL ACAD SCI USA, V107, P14449, DOI 10.1073/pnas.0914381107; Kil SH, 2013, HEARING RES, V299, P63, DOI 10.1016/j.heares.2013.01.020; Kobel M, 2017, HEARING RES, V349, P148, DOI 10.1016/j.heares.2016.12.008; KORTE SM, 1995, PSYCHONEUROENDOCRINO, V20, P385, DOI 10.1016/0306-4530(94)00069-7; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Kurabi A, 2017, HEARING RES, V349, P129, DOI 10.1016/j.heares.2016.11.013; Lee HY, 2017, EUR ARCH OTO-RHINO-L, V274, P143, DOI 10.1007/s00405-016-4276-y; Ma LL, 2017, STRESS, V20, P312, DOI 10.1080/10253890.2017.1323861; Marcon S, 2008, HEARING RES, V237, P76, DOI 10.1016/j.heares.2007.12.011; McLean WJ, 2009, JARO-J ASSOC RES OTO, V10, P37, DOI 10.1007/s10162-008-0152-9; Melcher JR, 1996, HEARING RES, V93, P52, DOI 10.1016/0378-5955(95)00200-6; Meltser I, 2011, HEARING RES, V281, P47, DOI 10.1016/j.heares.2011.06.003; Muller M, 2017, HNO, V65, pS59, DOI 10.1007/s00106-016-0266-z; MULLER M, 1991, HEARING RES, V57, P63, DOI 10.1016/0378-5955(91)90075-K; Niedermeier K, 2012, ACTA OTO-LARYNGOL, V132, P1252, DOI 10.3109/00016489.2012.701017; O'Byrne PM, 1998, J ALLERGY CLIN IMMUN, V102, P879, DOI 10.1016/S0091-6749(98)70322-7; O'Leary SJ, 2013, HEARING RES, V298, P27, DOI 10.1016/j.heares.2013.01.012; Oitzl MS, 2010, NEUROSCI BIOBEHAV R, V34, P853, DOI 10.1016/j.neubiorev.2009.07.006; Plontke SK, 2014, OTOL NEUROTOL, V35, P1168, DOI 10.1097/MAO.0000000000000434; RAREY KE, 1995, HEARING RES, V82, P135, DOI 10.1016/0378-5955(94)00171-L; Ruttiger L, 2017, ORL J OTO-RHINO-LARY, V79, P93, DOI 10.1159/000455705; Ruttiger L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057247; Safieddine S, 2012, ANNU REV NEUROSCI, V35, P509, DOI 10.1146/annurev-neuro-061010-113705; Schmiedt RA, 1996, J NEUROPHYSIOL, V76, P2799, DOI 10.1152/jn.1996.76.4.2799; Sergeyenko Y, 2013, J NEUROSCI, V33, P13686, DOI 10.1523/JNEUROSCI.1783-13.2013; Sha SH, 2017, EXPERT OPIN INV DRUG, V26, P85, DOI 10.1080/13543784.2017.1269171; Shera CA, 1999, J ACOUST SOC AM, V105, P782, DOI 10.1121/1.426948; Singer W, 2016, METHODS MOL BIOL, V1427, P263, DOI 10.1007/978-1-4939-3615-1_15; Singer W, 2013, MOL NEUROBIOL, V47, P261, DOI 10.1007/s12035-012-8372-8; Tahera Y, 2006, J NEUROSCI RES, V83, P1066, DOI 10.1002/jnr.20795; Tahera Y, 2007, NEUROBIOL DIS, V25, P189, DOI 10.1016/j.nbd.2006.09.004; Tahera Y, 2006, ENDOCRINOLOGY, V147, P4430, DOI 10.1210/en.2006-0260; Terakado M, 2011, HEARING RES, V280, P148, DOI 10.1016/j.heares.2011.05.006; Trune DR, 2012, ANAT REC, V295, P1928, DOI 10.1002/ar.22576; Trune DR, 2006, HEARING RES, V212, P22, DOI 10.1016/j.heares.2005.10.006; Tsigos C, 2000, ENDOTEXT; Wang Y, 2002, JARO, V3, P248, DOI 10.1007/s101620020028; Wang Y, 2002, HEARING RES, V165, P96, DOI 10.1016/S0378-5955(02)00289-7; Yao XF, 1996, ACTA OTO-LARYNGOL, V116, P493, DOI 10.3109/00016489609137879; Yoshida N, 2000, HEARING RES, V148, P213, DOI 10.1016/S0378-5955(00)00161-1; Yoshida N, 1999, HEARING RES, V131, P29, DOI 10.1016/S0378-5955(99)00008-8	70	21	21	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3005	3019		10.1096/fj.201701041RRR	http://dx.doi.org/10.1096/fj.201701041RRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401591				2022-12-28	WOS:000432546000010
J	Yun, JH; Jeong, HS; Kim, KJ; Han, MH; Lee, EH; Lee, K; Cho, CH				Yun, Jang-Hyuk; Jeong, Han-Seok; Kim, Kyung-Jin; Han, Man Hyup; Lee, Eun Hui; Lee, Kihwang; Cho, Chung-Hyun			beta-Adrenergic receptor agonists attenuate pericyte loss in diabetic retinas through Akt activation	FASEB JOURNAL			English	Article						diabetic retinopathy; pericyte apoptosis; vascular leakage; tight junction protein	CAPILLARY ENDOTHELIAL-CELLS; SMOOTH-MUSCLE-CELLS; TIGHT JUNCTION; BCL-2 EXPRESSION; GENE-EXPRESSION; RAT RETINA; IN-VITRO; KAPPA-B; RETINOPATHY; APOPTOSIS	Pericytes (PCs) are crucial in maintaining the quiescence of endothelial cells (ECs) and the integrity of EC tight junctions. Especially in diabetic retinopathy (DR), PC loss is one of the early pathologic changes in capillaries of diabetic retinas. Thus, preventing PC loss is beneficial for attenuating vision impairment in patients with DR. Although many studies have revealed the mechanism of PC loss in retinas, little is known about the mechanisms that increase PC survival. We focused on the effect of beta-adrenergic receptor agonists (beta-agonists) on PC loss in diabetic retinas. In this study, beta-agonists increased the cell viability of PCs by increasing PC survival and proliferation. Mechanistically, beta-agonist-induced protein kinase B activation in PCs reduced PC apoptosis in response to various stimuli. beta 2-agonists more potently increased PC survival than beta 1-agonists. beta 2-Agonist reduced vascular leakage and PC loss in retinas of mice with streptozotocin-induced diabetes. In cocultures of PCs and ECs, beta 2-agonists restored the altered permeability and ZO-1 expression in ECs induced by PC loss. We concluded that beta-agonists, especially beta 2-agonists, increase PC survival, thereby preventing diabetes-induced PC loss in retinas. These results provide a potential therapeutic benefit of beta-agonists for preventing PC loss in DR.	[Yun, Jang-Hyuk; Jeong, Han-Seok; Kim, Kyung-Jin; Han, Man Hyup; Cho, Chung-Hyun] Seoul Natl Univ, Coll Med, Dept Pharmacol, Vasc Microenvironm Lab, 103 Daehakro Dong, Seoul 110799, South Korea; [Cho, Chung-Hyun] Seoul Natl Univ, Coll Med, Ischem Hypox Dis Inst, Seoul, South Korea; [Cho, Chung-Hyun] Seoul Natl Univ, Coll Med, Canc Reseach Inst, Seoul, South Korea; [Lee, Eun Hui] Catholic Univ Korea, Coll Med, Dept Physiol, Seoul, South Korea; [Lee, Kihwang] Ajou Univ, Sch Med, Dept Ophthalmol, Suwon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Catholic University of Korea; Ajou University	Cho, CH (corresponding author), Seoul Natl Univ, Coll Med, Dept Pharmacol, Vasc Microenvironm Lab, 103 Daehakro Dong, Seoul 110799, South Korea.	iam-hyun@snu.ac.kr		Lee, Eun Hui/0000-0003-4555-1730	National Research Foundation of Korea - Korean government [2014R1A2A1A11050981, 2012R1A5A2A44671346]; Seoul National University Hospital Research Fund [0420160230]	National Research Foundation of Korea - Korean government(National Research Foundation of KoreaKorean Government); Seoul National University Hospital Research Fund	This work was supported by National Research Foundation of Korea Grants 2014R1A2A1A11050981 and 2012R1A5A2A44671346 (to C.-H.C.), funded by the Korean government), and by Grant 0420160230 from the Seoul National University Hospital Research Fund (to C.-H.C.). The authors declare no conflicts of interest.	Alikhani M, 2005, J BIOL CHEM, V280, P12096, DOI 10.1074/jbc.M412171200; Alikhani M, 2010, MOL VIS, V16, P408; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Ashcroft M, 1999, ONCOGENE, V18, P7637, DOI 10.1038/sj.onc.1203012; Aveleira CA, 2010, DIABETES, V59, P2872, DOI 10.2337/db09-1606; Barisione G, 2010, PHARMACEUTICALS-BASE, V3, P1016, DOI 10.3390/ph3041016; Cai J, 2008, INVEST OPHTH VIS SCI, V49, P2163, DOI 10.1167/iovs.07-1206; Chintalgattu V, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005066; Dohgu S, 2005, BRAIN RES, V1038, P208, DOI 10.1016/j.brainres.2005.01.027; Dohgu S, 2004, CELL MOL NEUROBIOL, V24, P491, DOI 10.1023/B:CEMN.0000022776.47302.ce; Du XL, 2003, J CLIN INVEST, V112, P1049, DOI 10.1172/JCI200318127; Feng YX, 2007, THROMB HAEMOSTASIS, V97, P99, DOI 10.1160/TH06-05-0277; Flusberg DA, 2001, MOL BIOL CELL, V12, P3087, DOI 10.1091/mbc.12.10.3087; Franco M, 2011, BLOOD, V118, P2906, DOI 10.1182/blood-2011-01-331694; Geraldes P, 2009, NAT MED, V15, P1298, DOI 10.1038/nm.2052; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj.onc.1205181; Hammes HP, 2011, DIABETES, V60, P9, DOI 10.2337/db10-0454; Hammes HP, 2004, DIABETES, V53, P1104, DOI 10.2337/diabetes.53.4.1104; Hammes HP, 2002, DIABETES, V51, P3107, DOI 10.2337/diabetes.51.10.3107; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Hori S, 2004, J NEUROCHEM, V89, P503, DOI 10.1111/j.1471-4159.2004.02343.x; Iaccarino G, 2005, CIRC RES, V97, P1182, DOI 10.1161/01.RES.0000191541.06788.bb; Ji Y, 2013, CELL DIV, V8, DOI 10.1186/1747-1028-8-1; Jiang YD, 2010, EXP EYE RES, V91, P171, DOI 10.1016/j.exer.2010.04.014; Jo DH, 2013, MOL CELLS, V36, P465, DOI 10.1007/s10059-013-0228-1; Kowluru RA, 2005, ANTIOXID REDOX SIGN, V7, P1581, DOI 10.1089/ars.2005.7.1581; Kowluru RA, 2004, BRIT J OPHTHALMOL, V88, P1343, DOI 10.1136/bjo.2003.038133; Machida K, 2005, AM J PHYSIOL-LUNG C, V288, pL860, DOI 10.1152/ajplung.00131.2004; McDonald DM, 2001, AM J RESP CRIT CARE, V164, pS39, DOI 10.1164/ajrccm.164.supplement_2.2106065; MINNEAR FL, 1989, AM J PHYSIOL, V257, pH1613, DOI 10.1152/ajpheart.1989.257.5.H1613; Naruse K, 2000, EXP EYE RES, V71, P309, DOI 10.1006/exer.2000.0882; Nishioku T, 2009, CELL MOL NEUROBIOL, V29, P309, DOI 10.1007/s10571-008-9322-x; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; ORLIDGE A, 1987, J CELL BIOL, V105, P1455, DOI 10.1083/jcb.105.3.1455; Park SW, 2014, DIABETES, V63, P3057, DOI 10.2337/db13-1942; Pfister F, 2008, DIABETES, V57, pA234, DOI 10.2337/db08-0325; Pfister F, 2010, ACTA DIABETOL, V47, P59, DOI 10.1007/s00592-009-0099-2; PHILLIPS PJ, 1980, BRIT J CLIN PHARMACO, V9, P483, DOI 10.1111/j.1365-2125.1980.tb05844.x; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Rangasamy S, 2011, INVEST OPHTH VIS SCI, V52, P3784, DOI 10.1167/iovs.10-6386; Romeo G, 2002, DIABETES, V51, P2241, DOI 10.2337/diabetes.51.7.2241; SATO Y, 1989, J CELL BIOL, V109, P309, DOI 10.1083/jcb.109.1.309; Schuller HM, 2010, ONCOTARGET, V1, P466; SHEPRO D, 1993, FASEB J, V7, P1031, DOI 10.1096/fasebj.7.11.8370472; Shin ES, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.517; Steinle JJ, 2009, EXP EYE RES, V88, P1014, DOI 10.1016/j.exer.2008.12.015; Takashima S, 2005, J SURG RES, V126, P114, DOI 10.1016/j.jss.2005.01.017; Walshe TE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005149; Wiley LA, 2005, INVEST OPHTH VIS SCI, V46, P744, DOI 10.1167/iovs.04-1023; Yuan AH, 2010, ONCOL REP, V23, P151, DOI 10.3892/or_00000616; Yun J., 2016, J OPEN INNOV-TECHNOL, V2, P7, DOI [10.1186/s40852-016-0033-0, DOI 10.1186/S40852-016-0033-0]; Yun JH, 2017, J CELL PHYSIOL, V232, P1123, DOI 10.1002/jcp.25575; Zeng H, 2016, SCI REP-UK, V6, DOI 10.1038/srep20931; Zhang XB, 2011, BBA-MOL CELL RES, V1813, P1978, DOI 10.1016/j.bbamcr.2011.03.010	55	23	23	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2324	2338		10.1096/fj.201700570RR	http://dx.doi.org/10.1096/fj.201700570RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29269397				2022-12-28	WOS:000432528000003
J	Arnold, C; Demirel, E; Feldner, A; Genove, G; Zhang, HJ; Sticht, C; Wieland, T; Hecker, M; Heximer, S; Korff, T				Arnold, Caroline; Demirel, Eda; Feldner, Anja; Genove, Guillem; Zhang, Hangjun; Sticht, Carsten; Wieland, Thomas; Hecker, Markus; Heximer, Scott; Korff, Thomas			Hypertension-evoked RhoA activity in vascular smooth muscle cells requires RGS5	FASEB JOURNAL			English	Article						vascular remodeling; G protein signaling; VSMC phenotype; blood pressure	PROTEIN-KINASE-C; GTPASE-ACTIVATING PROTEINS; N-TERMINAL KINASE; BLOOD-PRESSURE; CARDIOVASCULAR-SYSTEM; TENASCIN-C; IN-VIVO; PHOSPHORYLATION; DIFFERENTIATION; PHOSPHATASE	G protein-mediated signaling plays a decisive role in blood pressure regulation and the phenotype of vascular smooth muscle cells (VSMCs); however, the relevance of proteins that restrict G protein activity is not well characterized in this context. Here, we investigated the influence of regulator of G protein signaling 5 (RGS5), an inhibitor of G alpha(q/11) and G alpha(i/o) activity, on blood pressure and the VSMC phenotype during experimental hypertension. In mice, loss of RGS5 did not affect baseline blood pressure, but prevented hypertension-induced structural remodeling. RGS5-deficient arterial VSMCs did not acquire a synthetic phenotype as evidenced by their inability to decrease the abundance of contractile markers-alpha-smooth muscle actin and smooth muscle-myosin heavy chain-or to proliferate under these conditions. Mechanistically, hypertensive pressure levels or biomechanical stretch are sufficient to increase the expression of RGS5. Loss of RGS5 severely impairs the activation of RhoA and stress fiber formation. In stretch-exposed VSMCs, RhoA activity was amplified upon inhibition of PKC, which mimics the downstream effects evoked by RGS5-mediated inhibition of G alpha(q/11) signaling. Collectively, our findings underline that RhoA activation may depend on the restriction of G protein activity and identify RGS5 as a mechanosensitive regulatory protein that is required to promote the synthetic VSMC phenotype as a prerequisite for structural renovation of the arterial wall during hypertension.	[Arnold, Caroline; Demirel, Eda; Feldner, Anja; Hecker, Markus; Korff, Thomas] Heidelberg Univ, Dept Cardiovasc Physiol, Inst Physiol & Pathophysiol, Neuenheimer Feld 326, D-69120 Heidelberg, Germany; [Sticht, Carsten] Heidelberg Univ, Ctr Med Res, Heidelberg, Germany; [Wieland, Thomas] Heidelberg Univ, Inst Expt & Clin Pharmacol & Toxicol, Heidelberg, Germany; [Genove, Guillem] Karolinska Inst, Integrated Cardiometab Ctr, Huddinge, Sweden; [Zhang, Hangjun; Heximer, Scott] Univ Toronto, Dept Physiol, Heart & Stroke Richard Lewar Ctr Excellence Cardi, Toronto, ON, Canada	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Karolinska Institutet; University of Toronto	Korff, T (corresponding author), Heidelberg Univ, Dept Cardiovasc Physiol, Inst Physiol & Pathophysiol, Neuenheimer Feld 326, D-69120 Heidelberg, Germany.	korff@physiologie.uni-heidelberg.de	Wieland, Thomas/Q-1506-2019; Wieland, Thomas/G-1772-2012	Wieland, Thomas/0000-0001-8262-8261; Wieland, Thomas/0000-0001-8262-8261; Genove, Guillem/0000-0002-8558-3107	Deutsche Forschungsgemeinschaft [SFB TR23]; operating grants from the Canadian Institutes of Health Research [MOP-106670]; Heart and Stroke Foundation of Canada [T6799]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); operating grants from the Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (SFB TR23, Projects B6, C5, C6), operating grants from the Canadian Institutes of Health Research (MOP-106670; to S.H.), and the Grants-in-Aid Program of the Heart and Stroke Foundation of Canada (T6799; to S.H.). The authors acknowledge the excellent technical assistance of Maria Harlacher, Gudrun Scheib, and Yvonne Feuchter (Institute of Physiology and Pathophysiology). The authors declare no conflicts of interest.	Althoff TF, 2012, J EXP MED, V209, P2277, DOI 10.1084/jem.20120350; Arnold C, 2014, EMBO MOL MED, V6, P1075, DOI 10.15252/emmm.201403864; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Brandt D, 2002, J BIOL CHEM, V277, P20903, DOI 10.1074/jbc.M200946200; Brandt DT, 2003, J BIOL CHEM, V278, P34073, DOI 10.1074/jbc.M211650200; Bregeon J, 2009, AM J PHYSIOL-CELL PH, V297, pC1062, DOI 10.1152/ajpcell.00174.2009; Brinks HL, 2010, BBA-MOL BASIS DIS, V1802, P1268, DOI 10.1016/j.bbadis.2010.01.005; Chan CT, 2012, HYPERTENSION, V60, P1207, DOI 10.1161/HYPERTENSIONAHA.112.201251; Chen QW, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-52; CHEN YF, 1985, AM J PHYSIOL, V249, pH71; Cho H, 2008, MOL CELL BIOL, V28, P2590, DOI 10.1128/MCB.01889-07; Chrissobolis S, 2001, CIRC RES, V88, P774, DOI 10.1161/hh0801.090441; Davis-Dusenbery BN, 2011, ARTERIOSCL THROM VAS, V31, P2370, DOI 10.1161/ATVBAHA.111.226670; Fu Y, 2006, CIRC RES, V98, P659, DOI 10.1161/01.RES.0000207497.50477.60; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Grobe JL, 2011, HYPERTENSION, V57, P600, DOI 10.1161/HYPERTENSIONAHA.110.165829; Gu S, 2009, CLIN SCI, V116, P391, DOI 10.1042/CS20080272; Heximer SP, 2003, J CLIN INVEST, V111, P1259, DOI 10.1172/JCI200318099C; Hilzendeger AM, 2013, HYPERTENSION, V61, P716, DOI 10.1161/HYPERTENSIONAHA.111.00356; Holobotovskyy V, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5038; Holobotovskyy V, 2013, CIRC RES, V112, P781, DOI 10.1161/CIRCRESAHA.111.300142; Huang J, 2007, AM J PHYSIOL-CELL PH, V292, pC200, DOI 10.1152/ajpcell.00103.2006; Huveneers S, 2015, CIRC RES, V116, P895, DOI 10.1161/CIRCRESAHA.116.305720; Iyoda T, 2012, J BIOL CHEM, V287, P22635, DOI 10.1074/jbc.M111.335695; Jones PL, 1996, CIRC RES, V79, P1131, DOI 10.1161/01.RES.79.6.1131; Kubo T, 1996, Hypertens Res, V19, P213, DOI 10.1291/hypres.19.213; Lee DL, 2004, HYPERTENSION, V44, P796, DOI 10.1161/01.HYP.0000148303.98066.ab; Liao DF, 1997, J BIOL CHEM, V272, P6146, DOI 10.1074/jbc.272.10.6146; Liu WF, 2007, CIRC RES, V101, pE44, DOI 10.1161/CIRCRESAHA.107.158329; Madamanchi NR, 1998, ONCOGENE, V16, P417, DOI 10.1038/sj.onc.1201551; Schnitzler MMY, 2008, EMBO J, V27, P3092, DOI 10.1038/emboj.2008.233; MIRONNEAU J, 1995, CELL SIGNAL, V7, P471, DOI 10.1016/0898-6568(95)00014-G; Mori K, 2009, J BIOL CHEM, V284, P5067, DOI 10.1074/jbc.M806853200; Mukai Yasushi, 2001, FASEB Journal, V15, P1062; Nalli AD, 2014, CELL BIOCHEM BIOPHYS, V70, P867, DOI 10.1007/s12013-014-9992-6; Numaguchi K, 1999, CIRC RES, V85, P5; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pfisterer L, 2012, CARDIOVASC RES, V96, P120, DOI 10.1093/cvr/cvs247; RIDLEY AJ, 1993, EMBO J, V12, P5151, DOI 10.1002/j.1460-2075.1993.tb06210.x; Rolli-Derkinderen M, 2005, CIRC RES, V96, P1152, DOI 10.1161/01.RES.0000170084.88780.ea; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Satta J, 2002, J AM COLL CARDIOL, V39, P96, DOI 10.1016/S0735-1097(01)01705-3; Seko T, 2003, CIRC RES, V92, P411, DOI 10.1161/01.RES.0000059987.90200.44; Spyroglou A, 2012, J ENDOCRINOL, V215, P375, DOI 10.1530/JOE-12-0429; Walsh Michael P., 2007, V365, P209; WEN YS, 1992, ENDOCRINOLOGY, V131, P1377, DOI 10.1210/en.131.3.1377; Wieland T, 2003, PHARMACOL THERAPEUT, V97, P95, DOI 10.1016/S0163-7258(02)00326-1; Wieland T, 2007, CURR OPIN PHARMACOL, V7, P201, DOI 10.1016/j.coph.2006.11.007; Wirth A, 2010, BBA-MOL BASIS DIS, V1802, P1276, DOI 10.1016/j.bbadis.2010.05.002; Yang Z, 2011, J BIOL CHEM, V286, P11444, DOI [10.1074/jbc.M110.212480, 10.1074/jbc.M111.229344]; Zhang HJ, 2012, FASEB J, V26, P181, DOI 10.1096/fj.11-185454	51	15	16	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2021	2035		10.1096/fj.201700384RR	http://dx.doi.org/10.1096/fj.201700384RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29208700				2022-12-28	WOS:000429051400024
J	Kim, SH; Zhong, X; Kim, W; Kim, K; Suh, YG; Kim, C; Joe, Y; Chung, HT; Cha, YN; Surh, YJ				Kim, Seung Hyeon; Zhong, Xiancai; Kim, Wonki; Kim, Kyeojin; Suh, Young-Ger; Kim, Chaekyun; Joe, Yeonsoo; Chung, Hun Taeg; Cha, Young-Nam; Surh, Young-Joon			Taurine chloramine potentiates phagocytic activity of peritoneal macrophages through up-regulation of dectin-1 mediated by heme oxygenase-1-derived carbon monoxide	FASEB JOURNAL			English	Article						curdlan; fungal infection; phagocytosis; resolution	PPAR-GAMMA; MURINE MACROPHAGES; PATTERN-RECOGNITION; BACTERIAL CLEARANCE; FUNGAL-INFECTIONS; HOST-DEFENSE; BETA-GLUCAN; INFLAMMATION; ACTIVATION; RECEPTOR	Resolution of inflammation that occurs after microbial infection or tissue damage is an important physiologic process in maintaining or restoring host homeostasis. Taurine chloramine (TauCl) is formed by a reaction between taurine and hypochlorite in leukocytes, and it is especially abundant in activated neutrophils that encounter an oxidative burst. As neutrophils undergo apoptosis, TauCl is released to the extracellular matrix at the inflamed sites, thereby affecting coexisting macrophages in the inflammatory microenvironment. In this study, we investigated the role of TauCl in phagocytosis by macrophages during resolution of fungal infection-induced inflammation. We found that exogenous TauCl substantially increased the phagocytic efficiency of macrophages through up-regulation of dectin-1, a receptor for fungal beta-1,3-glucans, which is present on the membrane of macrophages. Our previous studies demonstrated the induction of heme oxygenase-1 (HO-1) expression in murine peritoneal macrophages treated with TauCl. In the present study, knocking out HO-1 or pharmacologic inhibition of HO-1 with zinc protoporphyrin IX attenuated the TauCl-induced expression of dectin-1 and subsequent phagocytosis. Furthermore, carbon monoxide (CO), a by-product of the HO-1-catalyzed reaction, induced expression of dectin-1 and potentiated phagocytic capability of the macrophages, which appeared to be mediated through up-regulation of peroxisome proliferator-activated receptor . Taken together, induction of HO-1 expression and subsequent CO production by TauCl are essential for phagocytosis of fungi by macrophages. Our results suggest that TauCl has important roles in host defense against fungal infection and has therapeutic potential in the management of inflammatory diseases.	[Kim, Seung Hyeon; Zhong, Xiancai; Kim, Wonki; Kim, Kyeojin; Suh, Young-Ger; Surh, Young-Joon] Seoul Natl Univ, Pharmaceut Sci Res Inst, Tumor Microenvironm Global Core Res Ctr, Seoul, South Korea; [Kim, Seung Hyeon; Surh, Young-Joon] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Canc Res Inst, Seoul, South Korea; [Surh, Young-Joon] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea; [Kim, Chaekyun; Cha, Young-Nam] Inha Univ, Dept Pharmacol & Toxicol, Coll Med, Incheon, South Korea; [Joe, Yeonsoo; Chung, Hun Taeg] Univ Ulsan, Dept Biol Sci, Ulsan, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Inha University; University of Ulsan	Surh, YJ (corresponding author), Seoul Natl Univ, Coll Pharm, Bldg 142,Room 507,1 Gwanak Ro, Seoul 08826, South Korea.	surh@snu.ac.kr	Zhong, Xiancai/AAM-3069-2020; Zhong, Xiancai/AAV-2761-2020	Zhong, Xiancai/0000-0001-8312-4057; Zhong, Xiancai/0000-0001-8312-4057; Kim, Seung Hyeon/0000-0001-9197-5978	Global Core Research Center (GCRC) from the Korean National Research Foundation (NRF) [2011-003-0001]	Global Core Research Center (GCRC) from the Korean National Research Foundation (NRF)	This work was supported by the Global Core Research Center (GCRC; Grant 2011-003-0001) from the Korean National Research Foundation (NRF). The authors declare no conflicts of interest.	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Bilban M, 2006, IMMUNITY, V24, P601, DOI 10.1016/j.immuni.2006.03.012; Billings EA, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aac6250; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Brown GD, 2012, SCIENCE, V336, P647, DOI 10.1126/science.1222236; Brown GD, 2011, ANNU REV IMMUNOL, V29, P1, DOI 10.1146/annurev-immunol-030409-101229; Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240; Chiang N, 2017, J IMMUNOL, V198, P842, DOI 10.4049/jimmunol.1601650; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Coste A, 2003, IMMUNITY, V19, P329, DOI 10.1016/S1074-7613(03)00229-2; Coste A, 2008, J IMMUNOL, V180, P4939, DOI 10.4049/jimmunol.180.7.4939; Dambuza IM, 2015, CURR OPIN IMMUNOL, V32, P21, DOI 10.1016/j.coi.2014.12.002; Drummond RA, 2011, CURR OPIN MICROBIOL, V14, P392, DOI 10.1016/j.mib.2011.07.001; Erwig LP, 2016, NAT REV MICROBIOL, V14, P163, DOI 10.1038/nrmicro.2015.21; Ferwerda G, 2008, CELL MICROBIOL, V10, P2058, DOI 10.1111/j.1462-5822.2008.01188.x; Fullerton JN, 2016, NAT REV DRUG DISCOV, V15, P551, DOI 10.1038/nrd.2016.39; Gales A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000714; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Gottardi W, 2005, J ANTIMICROB CHEMOTH, V55, P475, DOI 10.1093/jac/dki054; Gottardi W, 2002, ARCH PHARM, V335, P411, DOI 10.1002/1521-4184(200212)335:9<411::AID-ARDP411>3.0.CO;2-D; Gottardi W, 2013, ANTIMICROB AGENTS CH, V57, P1107, DOI 10.1128/AAC.02132-12; Greenblatt MB, 2010, J EXP MED, V207, P923, DOI 10.1084/jem.20092531; Hoetzel A, 2008, AM J RESP CRIT CARE, V177, P1223, DOI 10.1164/rccm.200708-1265OC; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kim C, 2014, AMINO ACIDS, V46, P89, DOI 10.1007/s00726-013-1545-6; Kim C, 2010, INT IMMUNOPHARMACOL, V10, P440, DOI 10.1016/j.intimp.2009.12.018; Kim HJ, 2017, FREE RADICAL BIO MED, V110, P81, DOI 10.1016/j.freeradbiomed.2017.05.026; Kim W, 2015, ANTIOXID REDOX SIGN, V23, P163, DOI 10.1089/ars.2013.5825; Kumar H, 2009, J IMMUNOL, V183, P8061, DOI 10.4049/jimmunol.0902477; Lackner M, 2015, ANTIMICROB AGENTS CH, V59, P6454, DOI 10.1128/AAC.00957-15; Lee S, 2014, ANTIOXID REDOX SIGN, V20, P432, DOI 10.1089/ars.2013.5368; Lefevre L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7801; Lefevre L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012828; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Liu M, 2015, J IMMUNOL, V195, P5055, DOI 10.4049/jimmunol.1501158; Marcinkiewicz J, 1995, J LEUKOCYTE BIOL, V58, P667, DOI 10.1002/jlb.58.6.667; Marcinkiewicz J, 2014, AMINO ACIDS, V46, P7, DOI 10.1007/s00726-012-1361-4; Maruyama Naho, 2005, J Inflamm (Lond), V2, P1, DOI 10.1186/1476-9255-2-1; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nembrini C, 2009, J ALLERGY CLIN IMMUN, V123, P986, DOI 10.1016/j.jaci.2009.03.033; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Onyiah JC, 2013, GASTROENTEROLOGY, V144, P789, DOI 10.1053/j.gastro.2012.12.025; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Ryter SW, 2016, TRANSL RES, V167, P7, DOI 10.1016/j.trsl.2015.06.011; Serhan CN, 2017, FASEB J, V31, P1273, DOI [10.1096/fj.201601222R, 10.1096/fj.201601222r]; Serhan CN, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016311; SMITH JA, 1994, J LEUKOCYTE BIOL, V56, P672, DOI 10.1002/jlb.56.6.672; STURMAN JA, 1993, PHYSIOL REV, V73, P119, DOI 10.1152/physrev.1993.73.1.119; Tam JM, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5020034; Trinath J, 2014, MOL CELL BIOL, V34, P4301, DOI 10.1128/MCB.00641-14; Tsoyi K, 2016, CRIT CARE MED, V44, pE1236, DOI 10.1097/CCM.0000000000001999; Underhill DM, 2012, NAT REV IMMUNOL, V12, P492, DOI 10.1038/nri3244; Vernon PJ, 2013, ANTIOXID REDOX SIGN, V18, P677, DOI 10.1089/ars.2012.4810; Wegiel B, 2014, J CLIN INVEST, V124, P4926, DOI 10.1172/JCI72853; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; WEISS SJ, 1982, J CLIN INVEST, V70, P598, DOI 10.1172/JCI110652; Winkler JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep18972; Yun N, 2014, FREE RADICAL BIO MED, V68, P168, DOI 10.1016/j.freeradbiomed.2013.12.014	59	8	9	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2246	2257		10.1096/fj.201700817R	http://dx.doi.org/10.1096/fj.201700817R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29247123				2022-12-28	WOS:000429051400042
J	Hashimoto, T; Tsukamoto, H; Takenaka, S; Olesen, ND; Petersen, LG; Sorensen, H; Nielsen, HB; Secher, NH; Ogoh, S				Hashimoto, Takeshi; Tsukamoto, Hayato; Takenaka, Saki; Olesen, Niels D.; Petersen, Lonnie G.; Sorensen, Henrik; Nielsen, Henning B.; Secher, Niels H.; Ogoh, Shigehiko			Maintained exercise-enhanced brain executive function related to cerebral lactate metabolism in men	FASEB JOURNAL			English	Article						brain-derived neurotrophic factor; brain energy uptake; cognitive function; glucose; high-intensity interval exercise	INTENSITY INTERVAL EXERCISE; COGNITIVE FUNCTION; BLOOD LACTATE; CATECHOLAMINES HYPOTHESIS; POSTEXERCISE RECOVERY; PROLONGED EXERCISE; DIABETES-MELLITUS; ARTERY DIAMETER; CARDIAC-OUTPUT; GLUCOSE-UPTAKE	High-intensity interval exercise (HIIE) improves cerebral executive function (EF), but the improvement in EF is attenuated after repeated HIIE, perhaps because of lower lactate availability for the brain. This investigation examined whether improved EF after exercise relates to brain lactate uptake. Fourteen healthy, male subjects performed 2 HIIE protocols separated by 60 min of rest. Blood samples were obtained from the right internal jugular venous bulb and from the brachial artery to determine arterial-venous differences across the brain for lactate (a-v diff(lactate)), glucose (a-v diff(glucose)), oxygen (a-v diff(oxygen)), and brain-derived neurotrophic factor (BDNF; a-v diff(BDNF)). EF was evaluated by the color-word Stroop task. The first HIIE improved EF for 40 min, whereas the second HIIE improved EF only immediately after exercise. The a-v diff(glucose) was unchanged, whereas the a-v diff(BDNF) increased similarly after both HIIEs, and the a-v diff(lactate) increased, but the increase was attenuated after the second HIIE, compared with the first HIIE (P < 0.05). The EF after HIIE correlated with the a-v diff(lactate) (r(2) = 0.62; P < 0.01). We propose that attenuated improvement in EF after repeated HIIE relates to reduced cerebral lactate metabolism and is, thereby, linked to systemic metabolism as an example of the lactate shuttle mechanism.	[Hashimoto, Takeshi; Tsukamoto, Hayato; Takenaka, Saki] Ritsumeikan Univ, Grad Sch Sport & Hlth Sci, 1-1-1 Nojihigashi, Kusatsu, Shiga 5258577, Japan; [Tsukamoto, Hayato] Japan Soc Promot Sci, Tokyo, Japan; [Olesen, Niels D.; Petersen, Lonnie G.] Panum Inst, Dept Biomed Sci, Copenhagen, Denmark; [Olesen, Niels D.; Sorensen, Henrik; Nielsen, Henning B.; Secher, Niels H.] Univ Copenhagen, Dept Anesthesia, Copenhagen Muscle Res Ctr, Rigshosp, Copenhagen, Denmark; [Ogoh, Shigehiko] Toyo Univ, Grad Sch Engn, Saitama, Japan	Ritsumeikan University; Japan Society for the Promotion of Science; Rigshospitalet; University of Copenhagen; Toyo University	Hashimoto, T (corresponding author), Ritsumeikan Univ, Grad Sch Sport & Hlth Sci, 1-1-1 Nojihigashi, Kusatsu, Shiga 5258577, Japan.	thashimo@fc.ritsumei.ac.jp	Tsukamoto, Hayato/AAE-9348-2019; Olesen, Niels D./AAM-8337-2020; Sorensen, Henrik/H-8404-2013	Tsukamoto, Hayato/0000-0001-5512-0497; Olesen, Niels D./0000-0003-1233-0413; Sorensen, Henrik/0000-0003-0819-106X; Petersen, Lonnie/0000-0002-5155-9651; Ogoh, Shigehiko/0000-0001-5297-6468	Japanese Ministry of Education, Culture, Sports, Science, and Technology [26702029, 15KK0358, 15K12676, 15J04023]; Novo Nordisk Fonden [NNF16OC0019196] Funding Source: researchfish	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Novo Nordisk Fonden(Novo Nordisk Foundation)	The authors thank all participants of this study. This study was supported by Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (Grants 26702029, 15KK0358, and 15K12676 to T.H and Grant 15J04023 to H.T.). The authors declare no conflicts of interest.	Allen TJ, 2000, AM J PHYSIOL-HEART C, V278, pH1993, DOI 10.1152/ajpheart.2000.278.6.H1993; Arvanitakis Z, 2004, ARCH NEUROL-CHICAGO, V61, P661, DOI 10.1001/archneur.61.5.661; Bogert LWJ, 2005, EXP PHYSIOL, V90, P437, DOI 10.1113/expphysiol.2005.030262; Brooks GA, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00408; Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350; CHMURA J, 1994, INT J SPORTS MED, V15, P172, DOI 10.1055/s-2007-1021042; COOPER CJ, 1973, ERGONOMICS, V16, P601, DOI 10.1080/00140137308924551; Dalsgaard MK, 2002, J PHYSIOL-LONDON, V540, P681, DOI 10.1113/jphysiol.2001.013062; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Deijen JB, 1999, BRAIN RES BULL, V48, P203, DOI 10.1016/S0361-9230(98)00163-4; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; DILL DB, 1974, J APPL PHYSIOL, V37, P247, DOI 10.1152/jappl.1974.37.2.247; Donnelly JE, 2003, ARCH INTERN MED, V163, P1343, DOI 10.1001/archinte.163.11.1343; Egner T, 2005, NEUROIMAGE, V24, P539, DOI 10.1016/j.neuroimage.2004.09.007; Endo K, 2013, J PHYSIOL SCI, V63, P287, DOI 10.1007/s12576-013-0267-6; Febbraio MA, 1999, J APPL PHYSIOL, V87, P2341, DOI 10.1152/jappl.1999.87.6.2341; Barros LF, 2013, TRENDS NEUROSCI, V36, P396, DOI 10.1016/j.tins.2013.04.002; Ferris LT, 2007, MED SCI SPORT EXER, V39, P728, DOI 10.1249/mss.0b013e31802f04c7; Glenn TC, 2015, J NEUROTRAUM, V32, P820, DOI 10.1089/neu.2014.3483; Glenn TC, 2015, J NEUROTRAUM, V32, P811, DOI 10.1089/neu.2014.3482; Grego F, 2004, NEUROSCI LETT, V364, P76, DOI 10.1016/j.neulet.2004.03.085; Hashimoto T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002915; Henderson GC, 2007, J PHYSIOL-LONDON, V584, P963, DOI 10.1113/jphysiol.2007.137331; Holloway R, 2007, ACTA NEUROCHIR, V149, P919, DOI 10.1007/s00701-007-1241-y; Hu YB, 1997, J NEUROCHEM, V69, P1484; Ide K, 2000, PROG NEUROBIOL, V61, P397, DOI 10.1016/S0301-0082(99)00057-X; Kemppainen J, 2005, J PHYSIOL-LONDON, V568, P323, DOI 10.1113/jphysiol.2005.091355; Krabbe KS, 2007, DIABETOLOGIA, V50, P431, DOI 10.1007/s00125-006-0537-4; Li BW, 2015, J NEUROCHEM, V135, P742, DOI 10.1111/jnc.13143; Lucas SJE, 2015, J CEREBR BLOOD F MET, V35, P902, DOI 10.1038/jcbfm.2015.49; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; MADSEN PL, 1995, J CEREBR BLOOD F MET, V15, P485, DOI 10.1038/jcbfm.1995.60; Matsui T, 2017, P NATL ACAD SCI USA, V114, P6358, DOI 10.1073/pnas.1702739114; Matsui T, 2012, J PHYSIOL-LONDON, V590, P607, DOI 10.1113/jphysiol.2011.217919; McMorris T, 2008, PHARMACOL BIOCHEM BE, V89, P106, DOI 10.1016/j.pbb.2007.11.007; McMorris T, 2016, PHYSIOL BEHAV, V165, P291, DOI 10.1016/j.physbeh.2016.08.011; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Nanda B, 2013, J CLIN DIAGN RES, V7, P1883, DOI 10.7860/JCDR/2013/5855.3341; Noakes TD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00082; Nybo L, 2004, PROG NEUROBIOL, V72, P223, DOI 10.1016/j.pneurobio.2004.03.005; Nybo L, 2003, J APPL PHYSIOL, V95, P1125, DOI 10.1152/japplphysiol.00241.2003; Ogoh S, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12163; Quistorff B, 2008, FASEB J, V22, P3443, DOI 10.1096/fj.08-106104; Rasmussen P, 2011, FASEB J, V25, P2865, DOI 10.1096/fj.11-183822; Richeson JA, 2003, NAT NEUROSCI, V6, P1323, DOI 10.1038/nn1156; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; SAPPEYMARINIER D, 1992, J CEREBR BLOOD F MET, V12, P584, DOI 10.1038/jcbfm.1992.82; Schiffer T, 2011, NEUROSCI LETT, V488, P234, DOI 10.1016/j.neulet.2010.11.035; SEGAL SS, 1979, J APPL PHYSIOL, V47, P514, DOI 10.1152/jappl.1979.47.3.514; Seifert T, 2011, PROG NEUROBIOL, V95, P406, DOI 10.1016/j.pneurobio.2011.09.008; Seifert T, 2010, AM J PHYSIOL-REG I, V298, pR372, DOI 10.1152/ajpregu.00525.2009; Seifert TS, 2009, J PHYSIOL-LONDON, V587, P285, DOI 10.1113/jphysiol.2008.162073; Serrador JM, 2000, STROKE, V31, P1672, DOI 10.1161/01.STR.31.7.1672; Skriver K, 2014, NEUROBIOL LEARN MEM, V116, P46, DOI 10.1016/j.nlm.2014.08.004; Smith D, 2003, J CEREBR BLOOD F MET, V23, P658, DOI 10.1097/01.WCB.0000063991.19746.11; Stewart R, 1999, DIABETIC MED, V16, P93, DOI 10.1046/j.1464-5491.1999.00027.x; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sugawara J, 2003, ACTA PHYSIOL SCAND, V179, P361, DOI 10.1046/j.0001-6772.2003.01211.x; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Tam E, 2004, CLIN SCI, V106, P371, DOI 10.1042/CS20030302; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Tsukamoto H, 2017, MED SCI SPORT EXER, V49, P774, DOI 10.1249/MSS.0000000000001155; Tsukamoto H, 2016, PHYSIOL BEHAV, V160, P26, DOI 10.1016/j.physbeh.2016.03.029; Tsukamoto H, 2016, PHYSIOL BEHAV, V155, P224, DOI 10.1016/j.physbeh.2015.12.021; van Hall G, 2009, J CEREBR BLOOD F MET, V29, P1121, DOI 10.1038/jcbfm.2009.35; Verbree J, 2014, J APPL PHYSIOL, V117, P1084, DOI 10.1152/japplphysiol.00651.2014; Wang CC, 2013, J SPORT EXERCISE PSY, V35, P358, DOI 10.1123/jsep.35.4.358; Williamson JW, 1999, J APPL PHYSIOL, V87, P1213	69	59	61	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1417	1427		10.1096/fj.201700381RR	http://dx.doi.org/10.1096/fj.201700381RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29127193				2022-12-28	WOS:000427246000024
J	Hatazawa, Y; Ono, Y; Hirose, Y; Kanai, S; Fujii, NL; Machida, S; Nishino, I; Shimizu, T; Okano, M; Kamei, Y; Ogawa, Y				Hatazawa, Yukino; Ono, Yusuke; Hirose, Yuma; Kanai, Sayaka; Fujii, Nobuharu L.; Machida, Shuichi; Nishino, Ichizo; Shimizu, Takahiko; Okano, Masaki; Kamei, Yasutomi; Ogawa, Yoshihiro			Reduced Dnmt3a increases Gdf5 expression with suppressed satellite cell differentiation and impaired skeletal muscle regeneration	FASEB JOURNAL			English	Article						DNA methylation; epigenetics; atrophy; knockout mouse	DNA METHYLATION; TRANSGENIC MICE; PROTEIN; ATROPHY; GENES; FAMILY; AGE	DNA methylation is an epigenetic mechanism regulating gene expression. In this study, we observed that DNA methyltransferase 3a (Dnmt3a) expression is decreased after muscle atrophy. We made skeletal muscle-specific Dnmt3a-knockout (Dnmt3a-KO) mice. The regeneration capacity after muscle injury was markedly decreased in Dnmt3a-KO mice. Diminished mRNA and protein expression of Dnmt3a were observed in skeletal muscles as well as in satellite cells, which are important for muscle regeneration, in Dnmt3a-KO mice. Dnmt3a-KO satellite cell showed smaller in size (length/area), suggesting suppressed myotube differentiation. Microarray analysis of satellite cells showed that expression of growth differentiation factor 5 (Gdf5) mRNA was markedly increased in Dnmt3a-KO mice. The DNA methylation level of the Gdf5 promoter was markedly decreased in Dnmt3a-KO satellite cells. In addition, DNA methylation inhibitor azacytidine treatment increased Gdf5 expression in wild-type satellite cells, suggesting Gdf5 expression is regulated by DNA methylation. Also, we observed increased inhibitor of differentiation (a target of Gdf5) mRNA expression in Dnmt3a-KO satellite cells. Thus, Dnmt3a appears to regulate satellite cell differentiation via DNA methylation. This mechanism may play a role in the decreased regeneration capacity during atrophy such as in aged sarcopenia.	[Hatazawa, Yukino; Kanai, Sayaka; Kamei, Yasutomi; Ogawa, Yoshihiro] TMDU, Grad Sch Med & Dent Sci, Dept Mol Endocrinol & Metab, Tokyo, Japan; [Hatazawa, Yukino; Hirose, Yuma; Kamei, Yasutomi] Kyoto Prefectural Univ, Grad Sch Environm & Life Sci, Lab Mol Nutr, Kyoto, Japan; [Hatazawa, Yukino] Japan Soc Promot Sci, Tokyo, Japan; [Ono, Yusuke] Nagasaki Univ, Musculoskeletal Mol Biol Res Grp, Grad Sch Biomed Sci, Nagasaki, Japan; [Ono, Yusuke] Japan Agcy Med Res & Dev AMED, Div Regenerat Med Res, Tokyo, Japan; [Fujii, Nobuharu L.] Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Hlth Promot Sci, Hachioji, Tokyo, Japan; [Machida, Shuichi] Juntendo Univ, Grad Sch Hlth & Sports Sci, Chiba, Japan; [Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Tokyo, Japan; [Shimizu, Takahiko] Chiba Univ, Dept Adv Aging Med, Grad Sch Med, Chiba, Japan; [Okano, Masaki] Kumamoto Univ, Inst Mol Embryol & Genet, Kumamoto, Japan; [Ogawa, Yoshihiro] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka, Japan; [Ogawa, Yoshihiro] Japan Agcy Med Res & Dev AMED, CREST, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Kyoto Prefectural University; Japan Society for the Promotion of Science; Nagasaki University; Tokyo Metropolitan University; Juntendo University; National Center for Neurology & Psychiatry - Japan; Chiba University; Kumamoto University; Kyushu University; Japan Science & Technology Agency (JST)	Kamei, Y (corresponding author), Kyoto Prefectural Univ, Sakyo Ku, 1-5 Hangi Cho, Kyoto 6068522, Japan.; Ogawa, Y (corresponding author), 3-1-1 Maidashi,Higashi Ku, Fukuoka 8128582, Japan.	kamei@kpu.ac.jp; yogawa@intmed3.med.kyushu-u.ac.jp	Nishino, Ichizo/G-2676-2010	Nishino, Ichizo/0000-0001-9452-112X; Ono, Yusuke/0000-0002-4802-7507; Ogawa, Yoshihiro/0000-0002-0834-2836	Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Council for Science, Technology, and Innovation (CSTI), Cross-Ministerial Strategic Innovation Promotion Program (SIP), and Technologies for Creating Next-Generation Agriculture, Forestry, and Fisheries (funding agency: Bio-oriented Technology Research Adv; program of the Joint Usage/Research Center for Developmental Medicine, Institute of Molecular Embryology and Genetics, Kumamoto University; Grants-in-Aid for Scientific Research [16H04926] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Council for Science, Technology, and Innovation (CSTI), Cross-Ministerial Strategic Innovation Promotion Program (SIP), and Technologies for Creating Next-Generation Agriculture, Forestry, and Fisheries (funding agency: Bio-oriented Technology Research Adv; program of the Joint Usage/Research Center for Developmental Medicine, Institute of Molecular Embryology and Genetics, Kumamoto University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Microarray data analysis was in part performed at the Medical Research Support Center, Graduate School of Medicine, Kyoto University. This study was supported by Grants-in-Aid for Scientific Research (KAKENHI) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT), and by the Council for Science, Technology, and Innovation (CSTI), Cross-Ministerial Strategic Innovation Promotion Program (SIP), and Technologies for Creating Next-Generation Agriculture, Forestry, and Fisheries (funding agency: Bio-oriented Technology Research Advancement Institution; NARO). This study was also supported in part by the program of the Joint Usage/Research Center for Developmental Medicine, Institute of Molecular Embryology and Genetics, Kumamoto University. The funders had no role in the study design, data collection and analysis, decision to publish, and preparation of the article. The authors declare no conflicts of interest.	BRENNAN KJ, 1993, J BIOL CHEM, V268, P719; D'Souza DM, 2016, DIABETES, V65, P3053, DOI 10.2337/db15-1577; Egerman MA, 2015, CELL METAB, V22, P164, DOI 10.1016/j.cmet.2015.05.010; Ehara T, 2015, DIABETES, V64, P775, DOI 10.2337/db14-0158; Ehrhardt J, 2005, CURR OPIN NEUROL, V18, P548, DOI 10.1097/01.wco.0000177382.62156.82; Grounds MD, 1998, ANN NY ACAD SCI, V854, P78, DOI 10.1111/j.1749-6632.1998.tb09894.x; Guasconi V, 2008, CURR OPIN CLIN NUTR, V11, P233, DOI 10.1097/MCO.0b013e3282fa1810; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Liu RJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep35355; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Miura S, 2006, AM J PATHOL, V169, P1129, DOI 10.2353/ajpath.2006.060034; Mozdziak PE, 1998, EUR J APPL PHYSIOL O, V78, P136, DOI 10.1007/s004210050398; Naito M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006167; Nishitoh H, 1996, J BIOL CHEM, V271, P21345, DOI 10.1074/jbc.271.35.21345; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Oliveira AMM, 2012, NAT NEUROSCI, V15, P1111, DOI 10.1038/nn.3151; Ono Y, 2011, CELL DEATH DIFFER, V18, P222, DOI 10.1038/cdd.2010.95; Ono Y, 2015, CELL REP, V10, P1135, DOI 10.1016/j.celrep.2015.01.045; Reynard LN, 2011, HUM MOL GENET, V20, P3450, DOI 10.1093/hmg/ddr253; Rider CC, 2010, BIOCHEM J, V429, P1, DOI 10.1042/BJ20100305; Rudolf R, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00099; Salanova M, 2013, IUBMB LIFE, V65, P769, DOI 10.1002/iub.1198; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Suchak A, 2009, EUR J ORTHODONT, V31, P196, DOI 10.1093/ejo/cjn095; Tajrishi MM, 2014, J BIOL CHEM, V289, P19985, DOI 10.1074/jbc.M114.568626; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Xie SP, 1999, GENE, V236, P87, DOI 10.1016/S0378-1119(99)00252-8; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908; Zhao P, 2006, J BIOL CHEM, V281, P429, DOI 10.1074/jbc.M507440200	32	21	21	3	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1452	1467		10.1096/fj.201700573R	http://dx.doi.org/10.1096/fj.201700573R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29146735	Bronze			2022-12-28	WOS:000427246000027
J	Zhang, CB; Zhou, YC; Xie, SS; Yin, QQ; Tang, CH; Ni, ZM; Fei, J; Zhang, YL				Zhang, Chaobao; Zhou, Yuchuan; Xie, Shengsong; Yin, Qianqian; Tang, Chunhua; Ni, Zimei; Fei, Jian; Zhang, Yonglian			CRISPR/Cas9-mediated genome editing reveals the synergistic effects of beta-defensin family members on sperm maturation in rat epididymis	FASEB JOURNAL			English	Article						male subfertility; acrosome reaction; sperm capacitation; sperm motility	GENE CLUSTERS; BETA-DEFENSIN-1; EXPRESSION	The epididymis is a male reproductive organ involved in posttesticular sperm maturation and storage, but the mechanism underlying sperm maturation remains unclear. beta-Defensins (Defbs) belong to a family of small, cysteine-rich, cationic peptides that are antimicrobial and modulate the immune response. A large number of Defb genes are expressed abundantly in the male reproductive tract, especially in the epididymis. We and other groups have shown the involvement of several Defb genes in regulation of sperm function. In this study, we found that Defb23, Defb26, and Defb42 were highly expressed in specific regions of the epididymis. Rats with CRISPR/Cas9-mediated single-gene disruption of Defb23, Defb26, or Defb42 had no obvious fertility phenotypes. Those with the deletion of Defb23/26 or Defb23/26/42 became subfertile, and sperm isolated from the epididymal cauda of multiple-mutant rats were demonstrated decreased motility. Meanwhile, the sperm showed precocious capacitation and increased spontaneous acrosome reaction. Consistent with premature capacitation and acrosome reaction, sperm from multiple-gene-knockout rats had significantly increased intracellular calcium. These results suggest that Defb family members affect sperm maturation by a synergistic pattern in the epididymis.-Zhang, C., Zhou, Y., Xie, S., Yin, Q., Tang, C., Ni, Z., Fei, J., Zhang, Y. CRISPR/Cas9-mediated genome editing reveals the synergistic effects of beta-defensin familymembers on sperm maturation in rat epididymis.	[Zhang, Chaobao; Fei, Jian] Tongji Univ, Sch Life Sci & Technol, Shanghai 20009, Peoples R China; [Zhang, Chaobao; Zhou, Yuchuan; Xie, Shengsong; Yin, Qianqian; Tang, Chunhua; Ni, Zimei; Zhang, Yonglian] Univ Chinese Acad Sci, Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, SIBCB,Shanghai Key Lab Mol Androl,State Key Lab M, Shanghai, Peoples R China	Tongji University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Fei, J (corresponding author), Tongji Univ, Sch Life Sci & Technol, Shanghai 20009, Peoples R China.; Zhang, YL (corresponding author), Chinese Acad Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	jfei@tongji.edu.cn; ylzhang@sibcb.ac.cn	zhou, yuchuan/AAF-6202-2019		National Natural Science Foundation of China [31471104, 31671203]; National Basic Research Program [2014CB943103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China)	The authors thank Lianfeng Zhang and Wei Dong (Chinese Academy of Medical Sciences) for the generation of Defb23<SUP>+/-</SUP>, Defb26<SUP>+/-</SUP>, Defb42<SUP>+/-</SUP>, and Defb23/26<SUP>+/-</SUP> rats using CRISPR/Cas9 technology; Xingxu Huang (Shanghai Tech University, Shanghai, China), Jingsong Li (SIBCB) and Xiangqi Li (SIBCB) for the helpful comments; Yanfei Ru (SIBCB) for the rat epididymal tissues collection (1-19 segments); and Winnie Wai Chi Shum (Shanghai Tech University) for polishing the language. This work was supported by National Natural Science Foundation of China Grants 31471104 and 31671203, and the National Basic Research Program Grant 2014CB943103. The authors declare no conflicts of interest.	Baker MA, 2004, J CELL SCI, V117, P211, DOI 10.1242/jcs.00842; Bendahmane M, 2002, ARCH BIOCHEM BIOPHYS, V404, P38, DOI 10.1016/S0003-9861(02)00278-3; Bjorkgren I, 2016, MOL CELL ENDOCRINOL, V427, P143, DOI 10.1016/j.mce.2016.03.013; Darszon A, 2011, PHYSIOL REV, V91, P1305, DOI 10.1152/physrev.00028.2010; Diao RY, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009071; Duan SW, 2015, J CELL MOL MED, V19, P1077, DOI 10.1111/jcmm.12502; Fraire-Zamora JJ, 2004, AM J PHYSIOL-CELL PH, V287, pC1688, DOI 10.1152/ajpcell.00141.2004; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Jelinsky SA, 2007, BIOL REPROD, V76, P561, DOI 10.1095/biolreprod.106.057323; Jrad-Lamine A, 2011, J BIOL CHEM, V286, P8030, DOI 10.1074/jbc.M110.172114; Li P, 2001, SCIENCE, V291, P1783, DOI 10.1126/science.1056545; Ma YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089413; Morrison G, 2002, INFECT IMMUN, V70, P3053, DOI 10.1128/IAI.70.6.3053-3060.2002; Moser C, 2002, INFECT IMMUN, V70, P3068, DOI 10.1128/IAI.70.6.3068-3072.2002; Narmadha G, 2016, J REPROD IMMUNOL, V118, P100, DOI 10.1016/j.jri.2016.11.001; Oberlander G, 1996, J REPROD FERTIL, V106, P231, DOI 10.1530/jrf.0.1060231; OBRIEN DA, 1993, METHODS TOXICOL, V3, P246; Patil AA, 2005, PHYSIOL GENOMICS, V23, P5, DOI 10.1152/physiolgenomics.00104.2005; Robaire B, 2015, KNOBIL NEILLS PHYSL; Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699; Skerget S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140650; Tollner TL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002289; Xie SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100448; Xin AJ, 2015, ACTA BIOCH BIOPH SIN, V47, P861, DOI 10.1093/abbs/gmv089; Zhang YL, 2011, J ANDROL, V32, P587, DOI 10.2164/jandrol.111.013060; Zhao Y, 2011, CELL MOL LIFE SCI, V68, P697, DOI 10.1007/s00018-010-0478-4; Zhou YS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003826	27	16	18	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1354	1363		10.1096/fj.201700936R	http://dx.doi.org/10.1096/fj.201700936R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29141997				2022-12-28	WOS:000427246000019
J	Csoka, B; Nemeth, ZH; Duerr, CU; Fritz, JH; Pacher, P; Hasko, G				Csoka, Balazs; Nemeth, Zoltan H.; Duerr, Claudia U.; Fritz, Jorg H.; Pacher, Pal; Hasko, Gyorgy			Adenosine receptors differentially regulate type 2 cytokine production by IL-33-activated bone marrow cells, ILC2s, and macrophages	FASEB JOURNAL			English	Article						A(2A)AR; A(2B)AR; ILC2s; helminth infection; allergic inflammation	INNATE LYMPHOID-CELLS; PULMONARY INFLAMMATION; TNF-ALPHA; T-CELLS; ACTIVATION; A(2A); EXPRESSION; IL-10; MICE	Group 2 innate lymphoid cells (ILC2s) represent a rapid source of type 2 cytokines, such as IL-5 and IL-13, and play an important role in orchestrating type 2 immune response. Adenosine is an endogenous purine nucleoside, a catabolite of ATP that binds and activates >= 1 of 4 transmembrane G protein-coupled cell-surface adenosine receptors (ARs)-A(1), A(2A), A(2B), and A(3). Here, we studied the role of ARs in the regulation of cytokine production by ILC2s. We found that A(2B)ARs suppress the production of both IL-5 and IL-13 by ILC2s, whereas A(2A)ARs augment IL-5 production and fail to affect IL-13 release. Combined stimulation of all ARs led to the suppression of both IL-5 and IL-13 production, which indicated that A(2B)ARs dominate A(2A)ARs. Both pre-and post-transcriptional processes may be involved in the AR modulation of ILC2 IL-5 and IL-13 production. Thus, we identify adenosine as a novel negative regulator of ILC2 activation.	[Csoka, Balazs; Nemeth, Zoltan H.; Hasko, Gyorgy] Rutgers New Jersey Med Sch, Dept Surg, Newark, NJ USA; [Csoka, Balazs; Nemeth, Zoltan H.; Hasko, Gyorgy] Rutgers New Jersey Med Sch, Ctr Immun & Inflammat, Newark, NJ USA; [Nemeth, Zoltan H.] Morristown Mem Med Ctr, Dept Surg, Morristown, NJ USA; [Duerr, Claudia U.; Fritz, Jorg H.] McGill Univ, Res Ctr Complex Traits, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Pacher, Pal] NIAAA, NIH, Bethesda, MD USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; McGill University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Hasko, G (corresponding author), UMDNJ Rutgers New Jersey Med Sch, Dept Surg, Ctr Immun & Inflammat, MSB, 185 South Orange Ave,G-586, Newark, NJ 07103 USA.	haskoge@njms.rutgers.edu	Pacher, Pal/B-6378-2008	Pacher, Pal/0000-0001-7036-8108	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences Grant [R01-GM066189]; NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant [R01-DK113790]; Intramural Research Program of the NIH National Institute on Alcohol Abuse and Alcoholism; Canadian Institutes of Health Research (CIHR); Leaders Opportunity Fund infrastructure grant from the Canadian Foundation of Innovation; CIHR New Investigator Award; Fonds de Recherche du Quebec-Sante (FRQS); CIHR; German National Academy of Sciences Leopoldina; American Association of Immunologists Careers in Immunology Fellowship Program; NIH [1S10-RR027022]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK113790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000375] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences Grant; NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant; Intramural Research Program of the NIH National Institute on Alcohol Abuse and Alcoholism; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Leaders Opportunity Fund infrastructure grant from the Canadian Foundation of Innovation; CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec-Sante (FRQS); CIHR(Canadian Institutes of Health Research (CIHR)); German National Academy of Sciences Leopoldina; American Association of Immunologists Careers in Immunology Fellowship Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The authors thank Dr. Joana Vindeirinho and Gabor Toro (both from Rutgers New Jersey Medical School) for technical assistance with the experiments. This work was supported by U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences Grant R01-GM066189 (to G.H.), NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant R01-DK113790 (to G.H.), and the Intramural Research Program of the NIH National Institute on Alcohol Abuse and Alcoholism (to P.P.). Work in the laboratory of J.H.F. is supported by a foundation grant from the Canadian Institutes of Health Research (CIHR), and a Leaders Opportunity Fund infrastructure grant from the Canadian Foundation of Innovation. J.H.F. is supported by a CIHR New Investigator Award, and by a Junior 1 and 2 Investigator Award by the Fonds de Recherche du Quebec-Sante (FRQS). C.U.D. is supported by a fellowship of CIHR and the German National Academy of Sciences Leopoldina. J.H.F. and C.U.D. are supported through the American Association of Immunologists Careers in Immunology Fellowship Program. Sorting was performed on the BDFACSAria II, which was obtained through NIH Shared Instrument Grant 1S10-RR027022. The authors declare no conflicts of interest.	Antonioli L, 2013, NAT REV CANCER, V13, P842, DOI 10.1038/nrc3613; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Belikoff BG, 2012, J IMMUNOL, V189, P3707, DOI 10.4049/jimmunol.1201207; Brickshawana A, 2011, J IMMUNOL, V187, P5795, DOI 10.4049/jimmunol.1102242; Csoka B, 2008, FASEB J, V22, P3491, DOI 10.1096/fj.08-107458; Csoka B, 2014, DIABETES, V63, P850, DOI 10.2337/db13-0573; Csoka B, 2012, FASEB J, V26, P376, DOI 10.1096/fj.11-190934; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Duerr CU, 2016, NAT IMMUNOL, V17, P65, DOI 10.1038/ni.3308; Ernst PB, 2010, J IMMUNOL, V185, P1993, DOI 10.4049/jimmunol.1000108; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Hasko G, 1996, J IMMUNOL, V157, P4634; Hasko G, 2000, FASEB J, V14, P2065, DOI 10.1096/fj.99-0508com; Hasko G, 2009, TRENDS IMMUNOL, V30, P263, DOI 10.1016/j.it.2009.04.001; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Huang S, 1997, BLOOD, V90, P1600, DOI 10.1182/blood.V90.4.1600.1600_1600_1610; Koscso B, 2013, J LEUKOCYTE BIOL, V94, P1309, DOI 10.1189/jlb.0113043; Koshiba M, 1997, J BIOL CHEM, V272, P25881, DOI 10.1074/jbc.272.41.25881; Krishnamoorthy N, 2015, J IMMUNOL, V194, P863, DOI 10.4049/jimmunol.1402534; Laffont S, 2017, J EXP MED, V214, P1581, DOI 10.1084/jem.20161807; Licona-Limon P, 2013, NAT IMMUNOL, V14, P536, DOI 10.1038/ni.2617; Maazi H, 2018, J ALLERGY CLIN IMMUN, V141, P893, DOI 10.1016/j.jaci.2017.04.043; Mchedlidze T, 2016, MUCOSAL IMMUNOL, V9, P1384, DOI 10.1038/mi.2016.20; Meylan F, 2014, MUCOSAL IMMUNOL, V7, P958, DOI 10.1038/mi.2013.114; Molofsky AB, 2015, IMMUNITY, V43, P161, DOI 10.1016/j.immuni.2015.05.019; Moro K, 2016, NAT IMMUNOL, V17, P76, DOI 10.1038/ni.3309; Nemeth ZH, 2005, J IMMUNOL, V175, P8260, DOI 10.4049/jimmunol.175.12.8260; Novitskiy SV, 2008, BLOOD, V112, P1822, DOI 10.1182/blood-2008-02-136325; Paclik D, 2015, EUR J IMMUNOL, V45, P2766, DOI 10.1002/eji.201545635; Panther E, 2003, BLOOD, V101, P3985, DOI 10.1182/blood-2002-07-2113; Patel N, 2014, CELL HOST MICROBE, V15, P339, DOI 10.1016/j.chom.2014.02.001; Raskovalova T, 2005, J IMMUNOL, V175, P4383, DOI 10.4049/jimmunol.175.7.4383; Ryzhov S, 2004, J IMMUNOL, V172, P7726, DOI 10.4049/jimmunol.172.12.7726; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Sitkovsky MV, 2009, TRENDS IMMUNOL, V30, P102, DOI 10.1016/j.it.2008.12.002; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Sun CX, 2006, J CLIN INVEST, V116, P2173, DOI 10.1172/JCI27303; Taylor S, 2017, J EXP MED, V214, P1663, DOI 10.1084/jem.20161653; von Moltke J, 2017, J EXP MED, V214, P27, DOI 10.1084/jem.20161274; Walford HH, 2014, CLIN IMMUNOL, V155, P126, DOI 10.1016/j.clim.2014.09.007; Wallace KL, 2010, BLOOD, V116, P5010, DOI 10.1182/blood-2010-06-290643; Wilson JM, 2011, J IMMUNOL, V186, P6746, DOI 10.4049/jimmunol.1100117; Wojno EDT, 2015, MUCOSAL IMMUNOL, V8, P1313, DOI 10.1038/mi.2015.21; Yang ZM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068433; Yu X, 2014, MUCOSAL IMMUNOL, V7, P730, DOI 10.1038/mi.2013.92; Zhou Y, 2009, J IMMUNOL, V182, P8037, DOI 10.4049/jimmunol.0900515	46	25	26	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					829	837		10.1096/fj.201700770R	http://dx.doi.org/10.1096/fj.201700770R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	28982732	Green Published, Bronze			2022-12-28	WOS:000425146900025
J	Dovmark, TH; Hulikova, A; Niederer, SA; Vaughan-Jones, RD; Swietach, P				Dovmark, Tobias H.; Hulikova, Alzbeta; Niederer, Steven A.; Vaughan-Jones, Richard D.; Swietach, Pawel			Normoxic cells remotely regulate the acid-base balance of cells at the hypoxic core of connexin-coupled tumor growths	FASEB JOURNAL			English	Article						homeostasis; gap junctions; bicarbonate transport; pancreatic cancer; metabolic altruism	PANCREATIC-CANCER PROGRESSION; ANABOLIC GLUCOSE-METABOLISM; INTRACELLULAR PH; ANHYDRASE-IX; EXPRESSION; METASTASIS; LINES; ADENOCARCINOMA; MECHANISMS; TRANSPORT	ATP fuels the removal of metabolic end-products, including H+ ions that profoundly modulate biological activities. Energetic resources in hypoxic tumor regions are constrained by low-yielding glycolysis, and any means of reducing the cost of acid extrusion, without compromising pH homeostasis, would therefore be advantageous for cancer cells. Some cancers express connexin channels that allow solute exchange between cells, and we propose that, via this route, normoxic cells supply hypoxic neighbors with acid-neutralizing HCO3- ions. This hypothesis was tested by imaging cytoplasmic pH in spheroidal tissue growths of connexin43-positive pancreatic cancer Colo357 cellsduring light-controlled H+ uncaging at thehypoxic core. Cytoplasmic acid retention at the core was halved in the presence of CO2/HCO3-, but this process requires a restorative HCO3- flux. The effect of CO2/HCO3- was ablated by connexin43 inhibition or knockdown. In connexin-decoupled spheroids, 4,49-diisothiocyano-2,29-stilbenedisulfonic acid (DIDS), an inhibitor of HCO3- uptake, had no effect on cytoplasmic [H+] in the H+-uncaging region, indicating that DIDS-sensitive transport is not an adequate pH-regulatory strategy therein. With intact connexin-coupling, acid retention at the core increased upon DIDS treatment, indicating that HCO3- ions are taken up actively by peripheral cells and then transmitted passively to cells at the hypoxic core. Thus, the energetic burden of pH regulation is of floaded from hypoxic cells onto metabolically altruistic normoxic neighbors.	[Dovmark, Tobias H.; Hulikova, Alzbeta; Vaughan-Jones, Richard D.; Swietach, Pawel] Univ Oxford, Dept Physiol Anat & Genet, Parks Rd, Oxford OX1 3PT, England; [Niederer, Steven A.] St Thomas Hosp, Div Imaging Sci & Biomed Engn, London, England	University of Oxford; Guy's & St Thomas' NHS Foundation Trust	Swietach, P (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Parks Rd, Oxford OX1 3PT, England.	pawel.swietach@dpag.ox.ac.uk	Swietach, Pawel/AAK-4169-2020	Swietach, Pawel/0000-0002-9945-9473; Niederer, Steven/0000-0002-4612-6982	European Commission through IonTraC Marie Curie Initial Training Network FP7-PEOPLE-ITN [289648]; Royal Society and Worldwide Cancer Research Grant [2012/0027]; EPSRC [EP/M012492/1] Funding Source: UKRI	European Commission through IonTraC Marie Curie Initial Training Network FP7-PEOPLE-ITN; Royal Society and Worldwide Cancer Research Grant; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the European Commission through IonTraC Marie Curie Initial Training Network FP7-PEOPLE-2011-ITN Grant 289648, and the Royal Society (to P. S.) and Worldwide Cancer Research Grant 2012/0027 (to P.S. and A.H.). The authors declare no conflicts of interest.	Cardone RA, 2015, NEOPLASIA, V17, P155, DOI 10.1016/j.neo.2014.12.003; Cheng G, 2014, BRIT J CANCER, V111, P85, DOI 10.1038/bjc.2014.272; Cruz-Monserrate Z, 2014, SCI REP-UK, V4, DOI 10.1038/srep04410; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Dovmark TH, 2017, ONCOGENE, V36, P4538, DOI 10.1038/onc.2017.71; ELSABBAN ME, 1991, J CELL BIOL, V115, P1375, DOI 10.1083/jcb.115.5.1375; Elzarrad MK, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-20; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gatenby RA, 2008, NAT REV CANCER, V8, P56, DOI 10.1038/nrc2255; Habrook CJ, 2017, CANCER CELL, V31, P5, DOI 10.1016/j.ccell.2016.12.006; Hulikova A, 2016, P NATL ACAD SCI USA, V113, pE5344, DOI 10.1073/pnas.1610954113; Hulikova A, 2014, J BIOL CHEM, V289, P25418, DOI 10.1074/jbc.M114.547844; Hulikova A, 2014, FASEB J, V28, P2762, DOI 10.1096/fj.13-241752; Hulikova A, 2013, J CELL PHYSIOL, V228, P743, DOI 10.1002/jcp.24221; Hulikova A, 2011, J BIOL CHEM, V286, P13815, DOI 10.1074/jbc.M111.219899; Ito A, 2000, J CLIN INVEST, V105, P1189, DOI 10.1172/JCI8257; Kaluz S, 2003, CANCER RES, V63, P917; Kaluz S, 2002, CANCER RES, V62, P4469; Komar G, 2009, CLIN CANCER RES, V15, P5511, DOI 10.1158/1078-0432.CCR-09-0414; Kong SC, 2014, BIOCHEM CELL BIOL, V92, P449, DOI 10.1139/bcb-2014-0078; Koong AC, 2000, INT J RADIAT ONCOL, V48, P919, DOI 10.1016/S0360-3016(00)00803-8; Lee AH, 1998, CANCER RES, V58, P1901; Lee MG, 2012, PHYSIOL REV, V92, P39, DOI 10.1152/physrev.00011.2011; Lin JHC, 2002, J NEUROSCI, V22, P4302, DOI 10.1523/JNEUROSCI.22-11-04302.2002; Liu MH, 2016, CANCER METAB, V4, DOI 10.1186/s40170-016-0160-x; McDonald OG, 2017, NAT GENET, V49, P367, DOI 10.1038/ng.3753; McIntyre A, 2016, CANCER RES, V76, P3744, DOI 10.1158/0008-5472.CAN-15-1862; Moll W, 2008, J APPL PHYSIOL, V105, P365, DOI 10.1152/japplphysiol.zdg-8016-pcpcomm.2008; MORGAN RT, 1980, INT J CANCER, V25, P591, DOI 10.1002/ijc.2910250507; Solan JL, 2012, J MEMBRANE BIOL, V245, P255, DOI 10.1007/s00232-012-9446-2; Swietach P, 2008, J BIOL CHEM, V283, P20473, DOI 10.1074/jbc.M801330200; Swietach P, 2007, CIRC RES, V100, P1045, DOI 10.1161/01.RES.0000264071.11619.47; Swietach P, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0099; Swietach P, 2009, J BIOL CHEM, V284, P20299, DOI 10.1074/jbc.M109.006478; Wykoff CC, 2000, CANCER RES, V60, P7075; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Zhang A, 2015, ONCOTARGET, V6, P11640, DOI 10.18632/oncotarget.3449; Zhang SJ, 2010, CANCER RES, V70, P4490, DOI 10.1158/0008-5472.CAN-09-3948	39	16	16	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					83	96		10.1096/fj.201700480R	http://dx.doi.org/10.1096/fj.201700480R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28883041				2022-12-28	WOS:000419172700010
J	Bohl, C; Pomorski, A; Seemann, S; Knospe, AM; Zheng, CN; Krezel, A; Rolfs, A; Lukas, J				Bohl, Cornelius; Pomorski, Adam; Seemann, Susanne; Knospe, Anne-Marie; Zheng, Chaonan; Krezel, Artur; Rolfs, Arndt; Lukas, Jan			Fluorescent probes for selective protein labeling in lysosomes: a case of alpha-galactosidase A	FASEB JOURNAL			English	Article						Anderson-Fabry disease; protein trafficking; live-cell imaging; biarsenical probes; tetracysteine tag	FABRY-DISEASE; TETRACYSTEINE MOTIF; LIVE CELLS; LOCALIZATION; TRAFFICKING; MICROSCOPY; MOLECULES; CHAPERONE; VARIANTS; AFFINITY	Fluorescence-based live-cell imaging (LCI) of lysosomal glycosidases is often hampered by unfavorable pH and redox conditions that reduce fluorescence output. Moreover, most lysosomal glycosidases are low-mass soluble proteins that do not allow for bulky fluorescent protein fusions. We selected a-galactosidase A (GALA) as a model lysosomal glycosidase involved in Anderson-Fabry disease (AFD) for the current LCI approach. Examination of the subcellular localization of AFD-causing mutants can reveal the mechanism underlying cellular trafficking deficits. To minimize genetic GALA modification, we employed a biarsenical labeling protocol with tetracysteine (TC-tag) detection. We tested the efficiency of halogen-substituted biarsenical probes to interact with C-terminally TC-tagged GALA peptide at pH 4.5 in vitro and identified F2FlAsH-EDT2 as a superior detection reagent for GALA. This probe provides improved signal/noise ratio in labeled COS-7 cells transiently expressing TC-tagged GALA. The investigated fluorescence-based LCI technology of TC-tagged lysosomal protein using an improved biarsenical probe can be used to identify novel compounds that promote proper trafficking of mutant GALA to lysosomal compartments and rescue the mutant phenotype.	[Bohl, Cornelius; Seemann, Susanne; Knospe, Anne-Marie; Zheng, Chaonan; Rolfs, Arndt; Lukas, Jan] Rostock Univ, Albrecht Kossel Inst Neuroregenerat, Med Ctr, Gehlsheimer Str 20, D-18147 Rostock, Mecklenburg Vor, Germany; [Pomorski, Adam; Krezel, Artur] Univ Wroclaw, Fac Biotechnol, Dept Chem Biol, Wroclaw, Poland	University of Rostock; University of Wroclaw	Lukas, J (corresponding author), Rostock Univ, Albrecht Kossel Inst Neuroregenerat, Med Ctr, Gehlsheimer Str 20, D-18147 Rostock, Mecklenburg Vor, Germany.	jan.lukas@med.uni-rostock.de	Pomorski, Adam/ABC-9677-2021; Krezel, Artur/E-7047-2011; Krezel, Artur/AAG-8729-2021	Krezel, Artur/0000-0001-9252-5784; Pomorski, Adam/0000-0002-0669-3421	University Rostock Medical Center; National Science Centre (NCN, Krakow, Poland) under OPUS Grant [2016/21/B/NZ1/02847]	University Rostock Medical Center; National Science Centre (NCN, Krakow, Poland) under OPUS Grant	The authors thank Flora Luo (Harvard Medical School, Boston, MA, USA) for language editing. This work was supported by grants from the University Rostock Medical Center (promotion of young researchers) and the National Science Centre (NCN, Krakow, Poland) under OPUS Grant 2016/21/B/NZ1/02847 (to A.K.). The authors declare no conflicts of interest.	Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Alexander SC, 2014, ORG LETT, V16, P3824, DOI 10.1021/ol501721j; Fernandez-Suarez M, 2008, NAT REV MOL CELL BIO, V9, P929, DOI 10.1038/nrm2531; Fessenden JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064686; Filoni C, 2010, BBA-MOL BASIS DIS, V1802, P247, DOI 10.1016/j.bbadis.2009.11.003; Gahlmann A, 2014, NAT REV MICROBIOL, V12, P9, DOI 10.1038/nrmicro3154; Gaietta GM, 2006, P NATL ACAD SCI USA, V103, P17777, DOI 10.1073/pnas.0608509103; Garman SC, 2007, ACTA PAEDIATR, V96, P6, DOI 10.1111/j.1651-2227.2007.00198.x; Giraldez T, 2005, J GEN PHYSIOL, V126, P429, DOI 10.1085/jgp.200509368; Golubev AM, 2004, J MOL BIOL, V339, P413, DOI 10.1016/j.jmb.2004.03.062; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Higuchi K, 2010, MOL MED, V16, P216, DOI 10.2119/molmed.2009.00163; Hoffmann C, 2010, NAT PROTOC, V5, P1666, DOI 10.1038/nprot.2010.129; Ilegems E, 2004, J BIOL CHEM, V279, P53346, DOI 10.1074/jbc.M407467200; Ishii S, 2007, BIOCHEM J, V406, P285, DOI 10.1042/BJ20070479; Landgraf D, 2012, NAT METHODS, V9, P480, DOI [10.1038/NMETH.1955, 10.1038/nmeth.1955]; Lukas J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003632; Madani F, 2009, J AM CHEM SOC, V131, P4613, DOI 10.1021/ja809315x; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; Matsuura F, 1998, GLYCOBIOLOGY, V8, P329, DOI 10.1093/glycob/8.4.329; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Moriarty-Craige SE, 2004, ANNU REV NUTR, V24, P481, DOI 10.1146/annurev.nutr.24.012003.132208; Nagerl UV, 2008, P NATL ACAD SCI USA, V105, P18982, DOI 10.1073/pnas.0810028105; Park JY, 2009, EXP MOL MED, V41, P1, DOI 10.3858/emm.2009.41.1.001; Pomorski A, 2015, ORG BIOMOL CHEM, V13, P1395, DOI 10.1039/c4ob02256d; Pomorski A, 2011, CHEMBIOCHEM, V12, P1152, DOI 10.1002/cbic.201100114; Pomorski A, 2010, CHEMBIOCHEM, V11, P1214, DOI 10.1002/cbic.200900768; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Shih W., 2011, JOVE-J VIS EXP, V58, P3589; Soon L, 2007, MICROSC RES TECHNIQ, V70, P252, DOI 10.1002/jemt.20411; Spagnuolo CC, 2006, J AM CHEM SOC, V128, P12040, DOI 10.1021/ja063212q; Stadler C, 2013, NAT METHODS, V10, P315, DOI [10.1038/NMETH.2377, 10.1038/nmeth.2377]; Subach OM, 2008, CHEM BIOL, V15, P1116, DOI 10.1016/j.chembiol.2008.08.006; Unzueta U, 2015, APPL MICROBIOL BIOT, V99, P5863, DOI 10.1007/s00253-014-6328-9; Wombacher R, 2010, NAT METHODS, V7, P717, DOI [10.1038/NMETH.1489, 10.1038/nmeth.1489]; Yam GHF, 2006, AM J PHYSIOL-CELL PH, V290, pC1076, DOI 10.1152/ajpcell.00426.2005	37	4	4	1	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5258	5267		10.1096/fj.201700058RRRR	http://dx.doi.org/10.1096/fj.201700058RRRR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28821638				2022-12-28	WOS:000416588300012
J	Macedo, JP; Currier, RB; Wirdnam, C; Horn, D; Alsford, S; Rentsch, D				Macedo, Juan P.; Currier, Rachel B.; Wirdnam, Corina; Horn, David; Alsford, Sam; Rentsch, Doris			Ornithine uptake and the modulation of drug sensitivity in Trypanosoma brucei	FASEB JOURNAL			English	Article						African trypanosomiasis; chemotherapy; eflornithine; suramin; histidine	SPERMIDINE SYNTHASE; DECARBOXYLASE; TRANSPORTER; LEISHMANIA; EXPRESSION; PERMEASE; TRYPANOTHIONE; METABOLISM; RNAI; DIFLUOROMETHYLORNITHINE	Trypanosoma brucei, protozoan parasites that cause human African trypanosomiasis (HAT), depend on ornithine uptake and metabolism by ornithine decarboxylase (ODC) for survival. Indeed, ODC is the target of the WHO "essential medicine" eflornithine, which is antagonistic to another anti-HAT drug, suramin. Thus, ornithine uptake has important consequences in T. brucei, but the transporters have not been identified. We describe these amino acid transporters (AATs). In a heterologous expression system, TbAAT10-1 is selective for ornithine, whereas TbAAT2-4 transports both ornithine and histidine. These AATs are also necessary to maintain intracellular ornithine and polyamine levels in T. brucei, thereby decreasing sensitivity to eflornithine and increasing sensitivity to suramin. Consistent with competition for histidine, high extracellular concentrations of this amino acid phenocopied a TbAAT2-4 genetic defect. Our findings established TbAAT10-1 and TbAAT2-4 as the parasite ornithine transporters, one of which can be modulated by histidine, but both of which affect sensitivity to important anti-HAT drugs.-Macedo, J. P., Currier, R. B., Wirdnam, C., Horn, D., Alsford, S., Rentsch, D. Ornithine uptake and the modulation of drug sensitivity in Trypanosoma brucei.	[Macedo, Juan P.; Wirdnam, Corina; Rentsch, Doris] Univ Bern, Inst Plant Sci, Altenbergrain 21, CH-3013 Bern, Switzerland; [Currier, Rachel B.; Alsford, Sam] London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England; [Horn, David] Univ Dundee, Sch Life Sci, Wellcome Trust Ctr Antiinfect Res, Dundee, Scotland	University of Bern; University of London; London School of Hygiene & Tropical Medicine; University of Dundee	Rentsch, D (corresponding author), Univ Bern, Inst Plant Sci, Altenbergrain 21, CH-3013 Bern, Switzerland.; Alsford, S (corresponding author), London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	sam.alsford@lshtm.ac.uk; doris.rentsch@ips.unibe.ch	Alsford, Sam/AGD-5139-2022; Macedo, Juan/B-4151-2017	Alsford, Sam/0000-0001-8621-4920; Currier, Rachel/0000-0002-0381-3029; Rentsch, Doris/0000-0003-4313-7683; Macedo, Juan/0000-0001-5759-1196; Horn, David/0000-0001-5173-9284	Swiss National Science Foundation [CRSII3127300, CRSII3141913]; University of Bern; Wellcome Trust (London School of Hygiene and Tropical Medicine Institutional Strategic Support Fund Fellowship); Medical Research Council (MRC) [MR/K011987/1]; UK MRC; UK Department for International Development (DFID) under the MRC/DFID; European Union; Wellcome Trust [100320/Z/12/Z]; MRC [MR/K011987/1] Funding Source: UKRI; Medical Research Council [MR/K011987/1] Funding Source: researchfish	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Bern; Wellcome Trust (London School of Hygiene and Tropical Medicine Institutional Strategic Support Fund Fellowship); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) under the MRC/DFID(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank P. Butikofer, E. Sigel (University of Bern, Switzerland), and P. Maser (Swiss Tropical and Public Health Institute, Basel, Switzerland) for their valuable input during the development of this work. The authors thank V. Yardley (LSHTM) and P. Maser for providing suramin and eflornithine. J.P.M. thanks M. Suter Grotemeyer and L. Cardoso Alves for technical assistance and helpful discussions. This work was supported by Swiss National Science Foundation Grants CRSII3127300 and CRSII3141913 (to D.R.) and the University of Bern (to D.R.). S.A. was supported by the Wellcome Trust (London School of Hygiene and Tropical Medicine Institutional Strategic Support Fund Fellowship) and Medical Research Council (MRC) Grant MR/K011987/1; jointly funded by the UK MRC and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement and is also part of the European and Developing Countries Clinical Trials Partnership (EDCTP) 2 Program, supported by the European Union. D.H. is a Wellcome Trust Investigator (100320/Z/12/Z). The remaining authors declare no conflicts of interest.	Alsford S, 2005, MOL BIOCHEM PARASIT, V144, P142, DOI 10.1016/j.molbiopara.2005.08.009; Alsford S, 2008, MOL BIOCHEM PARASIT, V161, P76, DOI 10.1016/j.molbiopara.2008.05.006; Alsford S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004130; Alsford S, 2012, NATURE, V482, P232, DOI 10.1038/nature10771; Ariyanayagam MR, 1997, MOL BIOCHEM PARASIT, V84, P111, DOI 10.1016/S0166-6851(96)02788-0; BACCHI CJ, 1980, SCIENCE, V210, P332, DOI 10.1126/science.6775372; BACCHI CJ, 1983, MOL BIOCHEM PARASIT, V7, P209, DOI 10.1016/0166-6851(83)90022-1; Baker N, 2011, MOL BIOCHEM PARASIT, V176, P55, DOI 10.1016/j.molbiopara.2010.11.010; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; BIDLINGMEYER BA, 1984, J CHROMATOGR, V336, P93, DOI 10.1016/S0378-4347(00)85133-6; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; Brenndorfer M, 2010, MOL BIOCHEM PARASIT, V172, P52, DOI 10.1016/j.molbiopara.2010.03.007; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; Burkard GS, 2011, MOL BIOCHEM PARASIT, V175, P91, DOI 10.1016/j.molbiopara.2010.09.002; Carrillo C, 1999, FEBS LETT, V454, P192, DOI 10.1016/S0014-5793(99)00804-2; Childs AC, 2003, CELL MOL LIFE SCI, V60, P1394, DOI 10.1007/s00018-003-2332-4; Creek DJ, 2013, ANTIMICROB AGENTS CH, V57, P2768, DOI 10.1128/AAC.00044-13; De Muylder G, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003731; DOHMEN RJ, 1991, YEAST, V7, P691, DOI 10.1002/yea.320070704; Duleu S, 2004, J IMMUNOL, V172, P6298, DOI 10.4049/jimmunol.172.10.6298; FAIRLAMB AH, 1987, MOL BIOCHEM PARASIT, V24, P185, DOI 10.1016/0166-6851(87)90105-8; FAIRLAMB AH, 1985, SCIENCE, V227, P1485, DOI 10.1126/science.3883489; Fischer WN, 2002, PLANT J, V29, P717, DOI 10.1046/j.1365-313X.2002.01248.x; Glover L, 2015, NAT PROTOC, V10, P106, DOI 10.1038/nprot.2015.005; Gobert AP, 2000, INFECT IMMUN, V68, P4653, DOI 10.1128/IAI.68.8.4653-4657.2000; Hai Y, 2015, BIOCHEMISTRY-US, V54, P458, DOI 10.1021/bi501366a; Hasne MP, 2010, MOL MICROBIOL, V76, P78, DOI 10.1111/j.1365-2958.2010.07081.x; Hasne MP, 2005, J BIOL CHEM, V280, P15188, DOI 10.1074/jbc.M411331200; Henriques C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0950-y; Holzmuller P, 2008, MICROBES INFECT, V10, P79, DOI 10.1016/j.micinf.2007.10.008; Iniesta V, 2005, INFECT IMMUN, V73, P6085, DOI 10.1128/IAI.73.9.6085-6090.2005; Iten M, 1997, ANTIMICROB AGENTS CH, V41, P1922, DOI 10.1128/AAC.41.9.1922; Jackson AP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-26; Keating J, 2015, ACTA TROP, V150, P4, DOI 10.1016/j.actatropica.2015.06.003; Kim DH, 2015, METABOLOMICS, V11, P1721, DOI 10.1007/s11306-015-0827-2; LeQuesne SA, 1996, BIOCHEM J, V316, P481; Li F, 1998, EXP PARASITOL, V88, P255, DOI 10.1006/expr.1998.4237; MARCHESINI G, 1992, J HEPATOL, V16, P159, DOI 10.1016/S0168-8278(05)80109-6; Mathieu C, 2014, BIOCHEM J, V463, P9, DOI 10.1042/BJ20140719; METCALF BW, 1978, J AM CHEM SOC, V100, P2551, DOI 10.1021/ja00476a050; Miller-Fleming L, 2015, J MOL BIOL, V427, P3389, DOI 10.1016/j.jmb.2015.06.020; Minguet EG, 2008, MOL BIOL EVOL, V25, P2119, DOI 10.1093/molbev/msn161; Mukhopadhyay R, 1996, P NATL ACAD SCI USA, V93, P10383, DOI 10.1073/pnas.93.19.10383; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; Pegg AE, 2011, METHODS MOL BIOL, V720, P3, DOI 10.1007/978-1-61779-034-8_1; Raz B, 1997, ACTA TROP, V68, P139, DOI 10.1016/S0001-706X(97)00079-X; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; RENTSCH D, 1995, FEBS LETT, V370, P264, DOI 10.1016/0014-5793(95)00853-2; Rentsch D, 1996, PLANT CELL, V8, P1437, DOI 10.1105/tpc.8.8.1437; Roberts SC, 2004, J BIOL CHEM, V279, P23668, DOI 10.1074/jbc.M402042200; Nguyen S, 2015, J BIOL CHEM, V290, P19987, DOI 10.1074/jbc.M115.656785; t'Kindt R, 2010, ANAL BIOANAL CHEM, V398, P2059, DOI 10.1007/s00216-010-4139-0; TANAKA J, 1985, GENE, V38, P205, DOI 10.1016/0378-1119(85)90219-7; Taylor MC, 2008, BIOCHEM J, V409, P563, DOI 10.1042/BJ20071185; Vincent IM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001618; Vincent IM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001204; Willert E, 2012, TRENDS PARASITOL, V28, P66, DOI 10.1016/j.pt.2011.11.001; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; World Health Organization, 2015, TRYP HUM AFR SLEEP S; Xiao YJ, 2009, EUKARYOT CELL, V8, P747, DOI 10.1128/EC.00047-09; Young GB, 1999, BBA-BIOMEMBRANES, V1415, P306, DOI 10.1016/S0005-2736(98)00196-5	62	8	8	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4649	4660		10.1096/fj.201700311R	http://dx.doi.org/10.1096/fj.201700311R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28679527	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000413397400039
J	Erickson, MA; Jude, J; Zhao, HJ; Rhea, EM; Salameh, TS; Jester, W; Pu, S; Harrowitz, J; Nguyen, N; Banks, WA; Panettieri, RA; Jordan-Sciutto, KL				Erickson, Michelle A.; Jude, Joseph; Zhao, Hengjiang; Rhea, Elizabeth M.; Salameh, Therese S.; Jester, William; Pu, Shelley; Harrowitz, Jenna; Ngan Nguyen; Banks, William A.; Panettieri, Reynold A., Jr.; Jordan-Sciutto, Kelly L.			Serum amyloid A: an ozone-induced circulating factor with potentially important functions in the lung-brain axis	FASEB JOURNAL			English	Article						air pollution; cytokines; acute-phase proteins; blood-brain barrier; microglia	HIGH-DENSITY-LIPOPROTEIN; CENTRAL-NERVOUS-SYSTEM; ACUTE-PHASE RESPONSE; PLASMA IL-12 LEVELS; AIR-POLLUTION; OXIDATIVE STRESS; ALZHEIMERS-DISEASE; PARTICULATE MATTER; INHALED OZONE; IN-VIVO	Accumulating evidence suggests that O-3 exposure may contribute to CNS dysfunction. Here, we posit that inflammatory and acute-phase proteins in the circulation increase after O-3 exposure and systemically convey signals of O-3 exposure to the CNS. To model acute O-3 exposure, female Balb/c mice were exposed to 3 ppm O-3 or forced air for 2 h and were studied after 6 or 24 h. Of 23 cytokines and chemokines, only KC/CXCL1 was increased in blood 6 h after O-3 exposure. The acute-phase protein serum amyloid A (A-SAA) was significantly increased by 24 h, whereas C-reactive protein was unchanged. A-SAA in blood correlated with total leukocytes, macrophages, and neutrophils in bronchoalveolar lavage from O-3-exposed mice. A-SAA mRNA and protein were increased in the liver. We found that both isoforms of A-SAA completely crossed the intact blood-brain barrier, although the rate of SAA2.1 influx was approximately 5 times faster than that of SAA1.1. Finally, A-SAA protein, but not mRNA, was increased in the CNS 24 h post-O-3 exposure. Our findings suggest that A-SAA is functionally linked to pulmonary inflammation in our O-3 exposure model and that A-SAA could be an important systemic signal ofO(3) exposure to the CNS.	[Erickson, Michelle A.; Pu, Shelley; Harrowitz, Jenna; Jordan-Sciutto, Kelly L.] Univ Penn, Sch Dent Med, Dept Pathol, Philadelphia, PA 19104 USA; [Jude, Joseph; Zhao, Hengjiang; Jester, William; Ngan Nguyen; Panettieri, Reynold A., Jr.] Univ Penn, Dept Med, Div Pulm Allergy & Crit Care, Philadelphia, PA 19104 USA; [Erickson, Michelle A.; Rhea, Elizabeth M.; Salameh, Therese S.; Banks, William A.; Panettieri, Reynold A., Jr.] Vet Affairs Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA USA; [Erickson, Michelle A.; Rhea, Elizabeth M.; Salameh, Therese S.; Banks, William A.; Panettieri, Reynold A., Jr.] Univ Washington, Sch Med, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA; [Jude, Joseph; Jester, William] Rutgers State Univ, Rutgers Inst Translat Med & Sci, Child Hlth Inst, New Brunswick, NJ USA	University of Pennsylvania; University of Pennsylvania; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; Rutgers State University New Brunswick; Rutgers State University Medical Center	Erickson, MA (corresponding author), 1660 South Columbian Way,Bldg 32,Room 229, Seattle, WA 98108 USA.	mericks999@gmail.com	Erickson, Michelle/U-7754-2019; Meredith, Elizabeth/AAM-4574-2021; Erickson, Michelle/AAR-8717-2021; panettieri, reynold/AAG-9485-2019; Banks, William A/K-1330-2017; Erickson, Michelle/G-4815-2014	Banks, William A/0000-0002-0496-3619; Erickson, Michelle/0000-0002-2575-1594; Jester Jr., William/0000-0002-2872-6095; Harowitz, Jenna/0000-0001-7459-7821	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences [T32ES019851, F32ES025076]; NIH National Institute of Neurological Disorders and Stroke [R21NS093368]; NIH National Institute on Aging [T32AG000057]; NIH National Institute of Mental Health [R01MH106967, P30ES013508]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508, T32ES019851, F32ES025076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH106967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS093368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000057] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences; NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences (Grants T32ES019851 to M.A.E. and J.J., and F32ES025076 to M.A.E.), NIH National Institute of Neurological Disorders and Stroke (Grant R21NS093368 to W.A.B. and T.S.S.), NIH National Institute on Aging (Grant T32AG000057 to E.M.R.); and NIH National Institute of Mental Health (Grants R01MH106967 to K.L.J.-S. and P30ES013508 to R.A.P.).	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Akhter H, 2015, TOXICOL SCI, V147, P222, DOI 10.1093/toxsci/kfv124; Anthony D, 2013, AM J RESP CRIT CARE, V188, P179, DOI 10.1164/rccm.201211-2139OC; Balazs Z, 2004, J NEUROCHEM, V89, P939, DOI 10.1111/j.1471-4159.2004.02373.x; Banks WA, 2015, BRAIN BEHAV IMMUN, V44, P1, DOI 10.1016/j.bbi.2014.08.007; BANKS WA, 1988, BRAIN RES BULL, V21, P881, DOI 10.1016/0361-9230(88)90021-4; Banks WA, 2011, METHODS MOL BIOL, V789, P337, DOI 10.1007/978-1-61779-310-3_22; Baranova IN, 2010, J BIOL CHEM, V285, P8492, DOI 10.1074/jbc.M109.007526; Bartolak-Suki E, 2000, AMYLOID, V7, P111, DOI 10.3109/13506120009146247; Bender SJ, 2010, J VIROL, V84, P11030, DOI 10.1128/JVI.02688-09; BENDITT EP, 1979, P NATL ACAD SCI USA, V76, P4092, DOI 10.1073/pnas.76.8.4092; Bhalla DK, 1999, J TOXICOL ENV HEAL B, V2, P31, DOI 10.1080/109374099281232; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; BLASBERG RG, 1983, J CEREBR BLOOD F MET, V3, P8, DOI 10.1038/jcbfm.1983.2; Block ML, 2009, TRENDS NEUROSCI, V32, P506, DOI 10.1016/j.tins.2009.05.009; BOZIC CR, 1994, J BIOL CHEM, V269, P29355; Bozinovski S, 2008, AM J RESP CRIT CARE, V177, P269, DOI 10.1164/rccm.200705-678OC; Bozinovski S, 2012, P NATL ACAD SCI USA, V109, P935, DOI 10.1073/pnas.1109382109; Cai L, 2005, J BIOL CHEM, V280, P2954, DOI 10.1074/jbc.M411555200; Calderon-Garciduenas L, 2008, TOXICOL PATHOL, V36, P289, DOI 10.1177/0192623307313011; Chen JC, 2009, NEUROTOXICOLOGY, V30, P231, DOI 10.1016/j.neuro.2008.12.011; Chiba T, 2011, ARTERIOSCL THROM VAS, V31, P1326, DOI 10.1161/ATVBAHA.111.226159; Chiba T, 2009, J LIPID RES, V50, P1353, DOI 10.1194/jlr.M900089-JLR200; Chung TF, 2000, AMYLOID, V7, P105, DOI 10.3109/13506120009146246; Cooper PR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010235; Cray C, 2009, COMPARATIVE MED, V59, P517; CUETO R, 1992, BIOCHEM BIOPH RES CO, V188, P129, DOI 10.1016/0006-291X(92)92359-6; De Buck M, 2016, CURR MED CHEM, V23, P1725, DOI 10.2174/0929867323666160418114600; De Buck M, 2015, J LEUKOCYTE BIOL, V98, P1049, DOI 10.1189/jlb.3A0315-085R; Devlin RB, 2012, CIRCULATION, V126, P104, DOI 10.1161/CIRCULATIONAHA.112.094359; Erickson MA, 2011, BRAIN BEHAV IMMUN, V25, P1637, DOI 10.1016/j.bbi.2011.06.006; Hernandez-Zimbron LF, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2125643; Gackiere F, 2011, J NEUROCHEM, V117, P961, DOI 10.1111/j.1471-4159.2011.07267.x; Gillmore JD, 2001, LANCET, V358, P24, DOI 10.1016/S0140-6736(00)05252-1; Gonzalez-Guevara E, 2014, INHAL TOXICOL, V26, P485, DOI 10.3109/08958378.2014.922648; Goodman JE, 2015, CRIT REV TOXICOL, V45, P412, DOI 10.3109/10408444.2015.1031371; Guo JT, 2002, J NEUROSCI, V22, P5900; HATCH GE, 1994, AM J RESP CRIT CARE, V150, P676, DOI 10.1164/ajrccm.150.3.8087337; Hernandez-Zimbron LF, 2015, NEUROSCIENCE, V304, P340, DOI 10.1016/j.neuroscience.2015.07.011; Iqbal K, 2010, CURR ALZHEIMER RES, V7, P656, DOI 10.2174/156720510793611592; Jang WY, 2017, BRAIN RES, V1654, P55, DOI 10.1016/j.brainres.2016.09.003; Jung CR, 2015, J ALZHEIMERS DIS, V44, P573, DOI 10.3233/JAD-140855; Kahle JJ, 2015, ENVIRON HEALTH PERSP, V123, P310, DOI 10.1289/ehp.1307986; Kasahara DI, 2014, AM J PHYSIOL-LUNG C, V306, pL508, DOI 10.1152/ajplung.00235.2013; Kastin AJ, 2001, PEPTIDES, V22, P2127, DOI 10.1016/S0196-9781(01)00569-1; Kierstein S, 2008, ALLERGY, V63, P438, DOI 10.1111/j.1398-9995.2007.01587.x; Kierstein S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-85; Kim MH, 2016, J LIPID RES, V57, P969, DOI 10.1194/jlr.M062174; Kim MH, 2013, CYTOKINE, V61, P506, DOI 10.1016/j.cyto.2012.10.019; LASKIN DL, 1994, ENVIRON HEALTH PERSP, V102, P61, DOI 10.2307/3432216; Lelieveld J, 2015, NATURE, V525, P367, DOI 10.1038/nature15371; Li F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080782; Liang JS, 1997, NEUROSCI LETT, V225, P73, DOI 10.1016/S0304-3940(97)00196-1; Liu J, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0493-y; Lopez-Campos JL, 2013, INT J MED SCI, V10, P938, DOI 10.7150/ijms.6152; Mahley RW, 2016, ARTERIOSCL THROM VAS, V36, P1305, DOI 10.1161/ATVBAHA.116.307023; Miida T, 2006, BBA-MOL CELL BIOL L, V1761, P424, DOI 10.1016/j.bbalip.2006.03.013; Miller DB, 2015, TOXICOL APPL PHARM, V286, P65, DOI 10.1016/j.taap.2015.03.025; Millers DB, 2016, AM J RESP CRIT CARE, V193, P1382, DOI 10.1164/rccm.201508-1599OC; Montresor-Lopez JA, 2016, J EXPO SCI ENV EPID, V26, P162, DOI 10.1038/jes.2015.48; Mumaw CL, 2016, FASEB J, V30, P1880, DOI 10.1096/fj.201500047; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Pirozzi C, 2015, INT J ENV RES PUB HE, V12, P5061, DOI 10.3390/ijerph120505061; PRYOR WA, 1992, FREE RADICAL BIO MED, V12, P83, DOI 10.1016/0891-5849(92)90060-T; PRYOR WA, 1995, FREE RADICAL BIO MED, V19, P935, DOI 10.1016/0891-5849(95)02033-7; Rivas-Arancibia S, 2015, FRONT AGING NEUROSCI, V7, DOI [10.3389/fnagi.2015.00065, 10.3389/fnagi.7015.00065]; Rivas-Arancibia S, 2010, TOXICOL SCI, V113, P187, DOI 10.1093/toxsci/kfp252; Schroder R, 1999, VIRCHOWS ARCH, V434, P551, DOI 10.1007/s004280050383; Shaashua L, 2012, BRAIN BEHAV IMMUN, V26, P996, DOI 10.1016/j.bbi.2012.05.012; Shaashua L, 2014, PSYCHONEUROENDOCRINO, V42, P11, DOI 10.1016/j.psyneuen.2013.12.001; Sipe J, 1999, AMYLOID, V6, P67, DOI 10.3109/13506129908993291; SLADE R, 1985, AM REV RESPIR DIS, V131, P742; Stukas S, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001156; Suissa L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004060; Thomson EM, 2007, ENVIRON RES, V105, P224, DOI 10.1016/j.envres.2007.06.005; Thomson EM, 2016, TOXICOL SCI, V152, P17, DOI 10.1093/toxsci/kfw061; Thomson EM, 2013, TOXICOL SCI, V135, P169, DOI 10.1093/toxsci/kft137; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Uhlson C, 2002, CHEM RES TOXICOL, V15, P896, DOI 10.1021/tx010183i; Vancza EM, 2009, TOXICOL SCI, V107, P535, DOI 10.1093/toxsci/kfn253; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Wu Yun-Chun, 2015, Alzheimers Dement (Amst), V1, P220, DOI 10.1016/j.dadm.2014.11.015; Wynendaele E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142071; Xu XH, 2013, NEUROEPIDEMIOLOGY, V41, P2, DOI 10.1159/000345138; Ying ZK, 2016, INHAL TOXICOL, V28, P155, DOI 10.3109/08958378.2016.1146808; Yu J, 2000, LAB INVEST, V80, P1797, DOI 10.1038/labinvest.3780191; Yu Y, 2014, J ALZHEIMERS DIS, V38, P133, DOI 10.3233/JAD-130818; Zhang N, 2005, J IMMUNOL, V174, P8125, DOI 10.4049/jimmunol.174.12.8125	88	22	22	2	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3950	3965		10.1096/fj.201600857RRR	http://dx.doi.org/10.1096/fj.201600857RRR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28533327	Green Published			2022-12-28	WOS:000408713300021
J	Yu, DY; Yang, SE; Miller, BR; Wisinski, JA; Sherman, DS; Brinkman, JA; Tomasiewicz, JL; Cummings, NE; Kimple, ME; Cryns, VL; Lamming, DW				Yu, Deyang; Yang, Shany E.; Miller, Blake R.; Wisinski, Jaclyn A.; Sherman, Dawn S.; Brinkman, Jacqueline A.; Tomasiewicz, Jay L.; Cummings, Nicole E.; Kimple, Michelle E.; Cryns, Vincent L.; Lamming, Dudley W.			Short-term methionine deprivation improves metabolic health via sexually dimorphic, mTORC1-independent mechanisms	FASEB JOURNAL			English	Article						Fgf21; amino acids; diabetes; obesity; dietary protein	GROWTH-FACTOR 21; FAT VEGAN DIET; ADIPOSE-TISSUE; LIFE-SPAN; LIPID-METABOLISM; CLINICAL-TRIAL; AMINO-ACIDS; INSULIN SENSITIVITY; PROTEIN RESTRICTION; STRESS RESISTANCE	Obesity and diabetes are major challenges to global health, and there is an urgent need for interventions that promote weight loss. Dietary restriction of methionine promotes leanness and improves metabolic health in mice and humans. However, poor long-term adherence to this diet limits its translational potential. In this study, we develop a short-term methionine deprivation (MD) regimen that preferentially reduces fat mass, restoring normal body weight and glycemic control to diet-induced obese mice of both sexes. The benefits of MD do not accrue from calorie restriction, but instead result from increased energy expenditure. MD promotes increased energy expenditure in a sex-specific manner, inducing the fibroblast growth factor (Fgf)-21-uncoupling protein (Ucp)-1 axis only in males. Methionine is an agonist of the protein kinase mechanistic target of rapamycin complex (mTORC)-1, which has been proposed to play a key role in the metabolic response to amino acid-restricted diets. In our study, we used a mouse model of constitutive hepatic mTORC1 activity and demonstrate that suppression of hepatic mTORC1 signaling is not required for the metabolic effects of MD. Our study sheds new light on the mechanisms by which dietary methionine regulates metabolic health and demonstrates the translational potential of MD for the treatment of obesity and type 2 diabetes.	[Yu, Deyang; Yang, Shany E.; Miller, Blake R.; Wisinski, Jaclyn A.; Sherman, Dawn S.; Brinkman, Jacqueline A.; Cummings, Nicole E.; Kimple, Michelle E.; Cryns, Vincent L.; Lamming, Dudley W.] Univ Wisconsin, Div Endocrinol Diabet & Metab, Dept Med, Madison, WI 53705 USA; [Yu, Deyang; Cryns, Vincent L.; Lamming, Dudley W.] Univ Wisconsin, Mol & Environm Toxicol Program, Madison, WI 53705 USA; [Cummings, Nicole E.; Kimple, Michelle E.; Lamming, Dudley W.] Univ Wisconsin, Endocrinol & Reprod Physiol Grad Training Program, Madison, WI 53705 USA; [Yu, Deyang; Yang, Shany E.; Miller, Blake R.; Wisinski, Jaclyn A.; Sherman, Dawn S.; Brinkman, Jacqueline A.; Tomasiewicz, Jay L.; Cummings, Nicole E.; Kimple, Michelle E.; Lamming, Dudley W.] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA; [Wisinski, Jaclyn A.] Univ Wisconsin, Dept Biol, La Crosse, WI 54601 USA; [Cryns, Vincent L.; Lamming, Dudley W.] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Wisconsin System; University of Wisconsin System; University of Wisconsin Madison	Lamming, DW (corresponding author), Univ Wisconsin, 2500 Overlook Terrace,VAH C3127 Res 151, Madison, WI 53705 USA.	dlamming@medicine.wisc.edu	Lamming, Dudley/O-7191-2015	Lamming, Dudley/0000-0002-0079-4467; Yang, Shany/0000-0003-3890-7671; Richardson, Nicole/0000-0002-2772-3060	U.S. National Institutes of Health (NIH) National Institute on Aging (NIA) [AG041765, AG050135, AG051974, AG056771]; NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant [DK102598]; New Investigator Program Award from the Wisconsin Partnership Program; Collaborative Health Sciences Program Award from the Wisconsin Partnership Program; V Foundation for Cancer Research; Glenn Foundation Award for Research in the Biological Mechanisms of Aging; startup funds from the UW-Madison School of Medicine and Public Health; UW-Madison Department of Medicine; American Federation for Aging Research (AFAR) grant; American Heart Association [17PRE33410983]; training grant from the NIH/NIDDK [DK007665]; training grant from the UW Institute on Aging [NIA T32 AG000213]; UWCCC Support Grant from the NIH National Cancer Institute [P30 CA014520]; William S. Middleton Memorial Veterans Hospital; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102598, P30DK020579, T32DK007665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG041765, R56AG056771, K99AG041765, T32AG000213, R21AG051974, R21AG050135, R01AG056771] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute on Aging (NIA); NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant; New Investigator Program Award from the Wisconsin Partnership Program; Collaborative Health Sciences Program Award from the Wisconsin Partnership Program; V Foundation for Cancer Research; Glenn Foundation Award for Research in the Biological Mechanisms of Aging; startup funds from the UW-Madison School of Medicine and Public Health; UW-Madison Department of Medicine; American Federation for Aging Research (AFAR) grant; American Heart Association(American Heart Association); training grant from the NIH/NIDDK; training grant from the UW Institute on Aging; UWCCC Support Grant from the NIH National Cancer Institute; William S. Middleton Memorial Veterans Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. Ildiko Kasza and Dr. Caroline Alexander (both from the McArdle Laboratory for Cancer Research, Madison, WI, USA) for assistance in establishing the lipid droplet quantification protocol and advice regarding the collection and analysis of adipose tissue; all members of the D.W.L., M.E.K., and V.L.C. laboratories, and Dr. Dawn Davis, Dr. Matthew Merrins and their laboratories for their assistance and insight [University of Wisconsin-Madison (UW-Madison)]; and Dr. Tina Herfel (Envigo, Madison, WI, USA) for assistance with the formulation of the amino acid-defined diets. This research was supported, in part, by the U.S. National Institutes of Health (NIH) National Institute on Aging (NIA) Grants AG041765, AG050135, AG051974, and AG056771 (to D.W.L.); NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant DK102598 (to M.E.K.); a New Investigator Program Award from the Wisconsin Partnership Program (to D.W.L.); a Collaborative Health Sciences Program Award from the Wisconsin Partnership Program (to V.L.C.), the V Foundation for Cancer Research (to V.L.C.); a Glenn Foundation Award for Research in the Biological Mechanisms of Aging (to D.W.L.); and startup funds from the UW-Madison School of Medicine and Public Health and the UW-Madison Department of Medicine (to V.L.C. and D.W.L.). This research was conducted while D.W.L. was an American Federation for Aging Research (AFAR) grant recipient. D.Y. was supported in part by a fellowship from the American Heart Association (17PRE33410983); J.A.W. was supported by a training grant from the NIH/NIDDK (DK007665); N.E.C. was supported by a training grant from the UW Institute on Aging (NIA T32 AG000213). The UW Carbone Cancer Center (UWCCC) Experimental Pathology Laboratory is supported by UWCCC Support Grant P30 CA014520 from the NIH National Cancer Institute. This work was supported using facilities and resources from the William S. Middleton Memorial Veterans Hospital. This work does not represent the views of the Department of Veterans Affairs or the United States Government. The authors declare no conflicts of interest.	Ables GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051357; Apelo SIA, 2016, AGING CELL, V15, P28, DOI 10.1111/acel.12405; Baar EL, 2016, AGING CELL, V15, P155, DOI 10.1111/acel.12425; Barnard ND, 2006, DIABETES CARE, V29, P1777, DOI 10.2337/dc06-0606; Barnard ND, 2009, J AM DIET ASSOC, V109, P263, DOI 10.1016/j.jada.2008.10.049; Barnard ND, 2009, AM J CLIN NUTR, V89, pS1588, DOI 10.3945/ajcn.2009.26736H; Brown-Borg HM, 2017, AGEING RES REV, V39, P87, DOI 10.1016/j.arr.2016.08.007; Caballero F, 2010, J BIOL CHEM, V285, P18528, DOI 10.1074/jbc.M109.099333; Centers for Disease Control, 2020, NATL DIABETES STAT R; Cornu M, 2014, P NATL ACAD SCI USA, V111, P11592, DOI 10.1073/pnas.1412047111; Cummings N. E., 2017, J PHYSL; Cummings NE, 2017, MOL CELL ENDOCRINOL, V455, P13, DOI 10.1016/j.mce.2016.11.014; Douris N, 2015, ENDOCRINOLOGY, V156, P2470, DOI 10.1210/en.2014-2001; Durando X, 2008, NUTR CANCER, V60, P23, DOI 10.1080/01635580701525877; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fontana L, 2016, CELL REP, V16, P520, DOI 10.1016/j.celrep.2016.05.092; Fothergill E, 2016, OBESITY, V24, P1612, DOI 10.1002/oby.21538; Goberdhan DCI, 2016, CELL METAB, V23, P580, DOI 10.1016/j.cmet.2016.03.013; Gong Q, 2016, HEPATOLOGY, V64, P425, DOI 10.1002/hep.28523; Gu X, 2017, SCIENCE, V358, P813, DOI 10.1126/science.aao3265; Harputlugil E, 2014, CELL REP, V8, P1160, DOI 10.1016/j.celrep.2014.07.018; Hasek BE, 2013, DIABETES, V62, P3362, DOI 10.2337/db13-0501; Hill CM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07498-w; Keipert S, 2017, CELL METAB, V26, P437, DOI 10.1016/j.cmet.2017.07.016; Kwon DH, 2012, J NUTR BIOCHEM, V23, P791, DOI 10.1016/j.jnutbio.2011.04.002; Lamming DW, 2014, AGING CELL, V13, P911, DOI 10.1111/acel.12256; Lee YM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155918; Lees EK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10381-3; Lees EK, 2014, AGING CELL, V13, P817, DOI 10.1111/acel.12238; Leib DE, 2015, CELL REP, V13, P1081, DOI 10.1016/j.celrep.2015.09.055; Malloy VL, 2013, METABOLISM, V62, P1651, DOI 10.1016/j.metabol.2013.06.012; McCarty MF, 2009, MED HYPOTHESES, V72, P125, DOI 10.1016/j.mehy.2008.07.044; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; Neuman JC, 2014, JOVE-J VIS EXP, DOI 10.3791/50374; ORENTREICH N, 1993, J NUTR, V123, P269; Orgeron ML, 2014, PROG MOL BIOL TRANSL, V121, P351, DOI 10.1016/B978-0-12-800101-1.00011-9; Owen BM, 2014, CELL METAB, V20, P670, DOI 10.1016/j.cmet.2014.07.012; Perrone CE, 2012, J NUTRIGENET NUTRIGE, V5, P132, DOI 10.1159/000339347; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Pettit AP, 2017, J NUTR, V147, P1031, DOI 10.3945/jn.116.246710; Plaisance EP, 2011, J CLIN ENDOCR METAB, V96, pE836, DOI 10.1210/jc.2010-2493; Plaisance EP, 2010, AM J PHYSIOL-REG I, V299, pR740, DOI 10.1152/ajpregu.00838.2009; Schmidt JA, 2016, EUR J CLIN NUTR, V70, P306, DOI 10.1038/ejcn.2015.144; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Stone KP, 2015, OBESITY, V23, P1836, DOI 10.1002/oby.21177; Stone KP, 2014, DIABETES, V63, P3721, DOI 10.2337/db14-0464; Thivat E, 2009, ANTICANCER RES, V29, P5235; Truchan NA, 2015, ISLETS, V7, DOI 10.1080/19382014.2015.1076607; Wanders D, 2017, DIABETES, V66, P858, DOI 10.2337/db16-1212; Wanders D, 2016, DIABETES, V65, P1499, DOI 10.2337/db15-1324; Wanders D, 2015, BIOFACTORS, V41, P391, DOI 10.1002/biof.1240; Wolfson RL, 2017, CELL METAB, V26, P301, DOI 10.1016/j.cmet.2017.07.001	52	41	41	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3471	3482		10.1096/fj.201701211R	http://dx.doi.org/10.1096/fj.201701211R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401631	Green Published			2022-12-28	WOS:000432546000046
J	Zhang, Y; Liu, YF; Wu, LH; Fan, C; Wang, ZW; Zhang, XL; Alachkar, A; Liang, XM; Civelli, O				Zhang, Yan; Liu, Yanfang; Wu, Lehao; Fan, Chao; Wang, Zhiwei; Zhang, Xiuli; Alachkar, Amal; Liang, Xinmiao; Civelli, Olivier			Receptor-specific crosstalk between prostanoid E receptor 3 and bombesin receptor subtype 3	FASEB JOURNAL			English	Article						BRS-3 receptor; EP3 receptor; PGE2; toad skin	HORMONE SECRETAGOGUE RECEPTOR; PROTEIN-COUPLED-RECEPTORS; HAMSTER OVARY CELLS; LUNG-CANCER CELLS; AGONIST; ADENOSINE; BRS-3; MICE; ACTIVATION; MECHANISM	Bombesin receptor subtype 3 (BRS-3) is a GPCR that is expressed in the CNS, peripheral tissues, and tumors. Our understanding of BRS-3's role in physiology and pathophysiology is limited because its natural ligand is unknown. In an attempt to identify this ligand, we screened toad skin (Bufo bufo gargarizans Cantor) extracts and identified prostaglandins as putative ligands. In BRS-3-transfected human embryonic kidney (HEK) cells, we found that prostaglandins, with prostaglandin E2 (PGE2) being the most potent, fulfill the pharmacologic criteria of affinity, selectivity, and specificity to be considered as agonists to the BRS-3 receptor. However, PGE2 is unable to activate BRS-3 in different cellular environments. We speculated that EP receptors might be the cause of this cellular selectivity, and we found that EP3 is the receptor primarily responsible for the differential PGE2 effect. Consequently, we reconstituted the HEK environment in Chinese hamster ovary (CHO) cells and found that BRS-3 and EP3 interact to potentiate PGE2 signaling. This potentiating effect is receptor specific, and it occurs only when BRS-3 is paired to EP3. Our study represents an example of functional crosstalk between two distantly related GPCRs and may be of clinical importance for BRS-3-targeted therapies.	[Zhang, Yan; Wu, Lehao; Fan, Chao] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai, Peoples R China; [Liu, Yanfang; Zhang, Xiuli; Liang, Xinmiao] Chinese Acad Sci, Dalian Inst Chem Phys, Key Lab Nat Med Liaoning Prov, Key Lab Separat Sci Analyt Chem, Dalian 116023, Peoples R China; [Wang, Zhiwei; Alachkar, Amal; Civelli, Olivier] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA	Shanghai Jiao Tong University; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; University of California System; University of California Irvine	Liang, XM (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, Key Lab Nat Med Liaoning Prov, Key Lab Separat Sci Analyt Chem, Dalian 116023, Peoples R China.; Civelli, O (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA.	liangxm@dicp.ac.cn; ocivelli@uci.edu	Civelli, Olivier/A-8392-2012	Wu, Lehao/0000-0003-0127-2609	U.S. National Institutes of Health (NIH) National Institute on Drug Abuse [DA024746]; Eric L. and Lila D. Nelson Chair in Neuropharmacology; National Natural Science Foundation of China Key Program [21135005, 81402806]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024746] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute on Drug Abuse; Eric L. and Lila D. Nelson Chair in Neuropharmacology; National Natural Science Foundation of China Key Program(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by U.S. National Institutes of Health (NIH) National Institute on Drug Abuse Grant DA024746, and the Eric L. and Lila D. Nelson Chair in Neuropharmacology (to O.C.). This work was also supported by the National Natural Science Foundation of China Key Program 21135005 (to X.L.), and Grant 81402806 (to Y.Z.). The authors declare no conflicts of interest.	ANASTASI A, 1971, EXPERIENTIA, V27, P166, DOI 10.1007/BF02145873; Ayoub MA, 2004, MOL PHARMACOL, V66, P312, DOI 10.1124/mol.104.000398; Carreira MC, 2006, J ENDOCRINOL, V191, P147, DOI 10.1677/joe.1.06714; Civelli O, 2001, TRENDS NEUROSCI, V24, P230, DOI 10.1016/S0166-2236(00)01763-X; FATHI Z, 1993, J BIOL CHEM, V268, P5979; Feng Y, 2011, ENDOCRINOLOGY, V152, P4106, DOI 10.1210/en.2011-1440; Gbahou F, 2010, J PHARMACOL EXP THER, V333, P51, DOI 10.1124/jpet.109.162131; Guan XM, 2011, J PHARMACOL EXP THER, V336, P356, DOI 10.1124/jpet.110.174763; Guan XM, 2010, CELL METAB, V11, P101, DOI 10.1016/j.cmet.2009.12.008; Hermansson NO, 2007, ACTA PHYSIOL, V190, P77, DOI 10.1111/j.1365-201X.2007.01691.x; Hou X, 2006, LUNG CANCER, V54, P143, DOI 10.1016/j.lungcan.2006.08.005; Insel PA, 2005, BIOCHEM SOC T, V33, P1131, DOI 10.1042/BST0331131; IRIE A, 1994, BIOCHEM BIOPH RES CO, V204, P303, DOI 10.1006/bbrc.1994.2460; Jensen RT, 2008, PHARMACOL REV, V60, P1, DOI 10.1124/pr.107.07108; Johansson S, 2005, BIOCHEM PHARMACOL, V70, P598, DOI 10.1016/j.bcp.2005.05.023; Jugus MJ, 2009, BRIT J PHARMACOL, V158, P372, DOI 10.1111/j.1476-5381.2009.00275.x; Kiriyama M, 1997, BRIT J PHARMACOL, V122, P217, DOI 10.1038/sj.bjp.0701367; Ladenheim EE, 2008, ENDOCRINOLOGY, V149, P971, DOI 10.1210/en.2007-1319; Lateef DM, 2016, AM J PHYSIOL-HEART C, V310, pH891, DOI 10.1152/ajpheart.00963.2015; Lateef DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142637; Mo CH, 2017, J MOL ENDOCRINOL, V59, P61, DOI [10.1530/JME-17-0020, 10.1530/jme-17-0020]; OhkiHamazaki H, 1997, NATURE, V390, P165, DOI 10.1038/36568; Olmo IG, 2016, MOL PHARMACOL, V90, P609, DOI 10.1124/mol.116.104372; Pera T, 2014, CURR OPIN PHARMACOL, V16, P72, DOI 10.1016/j.coph.2014.03.005; Porcher C, 2005, CELL TISSUE RES, V320, P21, DOI 10.1007/s00441-004-1032-1; Quitterer U, 1999, P NATL ACAD SCI USA, V96, P10626, DOI 10.1073/pnas.96.19.10626; Reitman ML, 2012, J CLIN PHARMACOL, V52, P1306, DOI 10.1177/0091270011419854; Rives ML, 2009, EMBO J, V28, P2195, DOI 10.1038/emboj.2009.177; Rozenfeld R, 2011, EMBO J, V30, P2350, DOI 10.1038/emboj.2011.139; Sabourin T, 2002, MOL PHARMACOL, V61, P546, DOI 10.1124/mol.61.3.546; Sano H, 2004, GENOMICS, V84, P139, DOI 10.1016/j.ygeno.2004.01.008; Smith RG, 2000, BIOCHEM BIOPH RES CO, V276, P1306, DOI 10.1006/bbrc.2000.3610; TAKANO S, 1978, PROSTAGLANDINS, V15, P485, DOI 10.1016/0090-6980(78)90132-6; Tan YR, 2006, PEPTIDES, V27, P1852, DOI 10.1016/j.peptides.2005.12.012; ToiScott M, 1996, LUNG CANCER-J IASLC, V15, P341, DOI 10.1016/0169-5002(95)00597-8; Tullin S, 2000, ENDOCRINOLOGY, V141, P3397, DOI 10.1210/en.141.9.3397; Xiao CY, 2016, TRENDS ENDOCRIN MET, V27, P603, DOI 10.1016/j.tem.2016.03.003; Yamada K, 2002, MOL PSYCHIATR, V7, P113, DOI 10.1038/sj/mp/4000974; Zhang L, 2009, BIOCHEM BIOPH RES CO, V387, P283, DOI 10.1016/j.bbrc.2009.07.006; Zhang Y, 2014, CURR BIOL, V24, P117, DOI 10.1016/j.cub.2013.11.039; Zhou B, 2015, EVID-BASED COMPL ALT, V2015	41	6	6	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3184	3192		10.1096/fj.201700337RR	http://dx.doi.org/10.1096/fj.201700337RR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401613	Green Published			2022-12-28	WOS:000432546000024
J	Caudill, MA; Strupp, BJ; Muscalu, L; Nevins, JEH; Canfield, RL				Caudill, Marie A.; Strupp, Barbara J.; Muscalu, Laura; Nevins, Julie E. H.; Canfield, Richard L.			Maternal choline supplementation during the third trimester of pregnancy improves infant information processing speed: a randomized, double-blind, controlled feeding study	FASEB JOURNAL			English	Article						saccade; reaction time; visuospatial memory; longitudinal	COGNITIVE FUNCTION; MEMORY; AVAILABILITY; ALTERS; EXPECTATIONS; PREDICTORS; LACTATION; EMOTION; ROLES; WOMEN	Rodent studies demonstrate that supplementing the maternal diet with choline during pregnancy produces life-long cognitive benefits for the offspring. In contrast, the two experimental studies examining cognitive effects of maternal choline supplementation in humans produced inconsistent results, perhaps because of poor participant adherence and/or uncontrolled variation in intake of choline or other nutrients. We examined the effects of maternal choline supplementation during pregnancy on infant cognition, with intake of choline and other nutrients tightly controlled. Women entering their third trimester were randomized to consume, until delivery, either 480 mg choline/d (n = 13) or 930 mg choline/d (n = 13). Infant information processing speed and visuospatial memory were tested at 4, 7, 10, and 13 mo of age (n = 24). Mean reaction time averaged across the four ages was significantly faster for infants born to mothers in the 930 (vs. 480) mg choline/d group. This result indicates that maternal consumption of approximately twice the recommended amount of choline during the last trimester improves infant information processing speed. Furthermore, for the 480-mg choline/d group, there was a significant linear effect of exposure duration (infants exposed longer showed faster reaction times), suggesting that even modest increases in maternal choline intake during pregnancy may produce cognitive benefits for offspring.	[Caudill, Marie A.; Strupp, Barbara J.; Muscalu, Laura; Nevins, Julie E. H.; Canfield, Richard L.] Cornell Univ, Div Nutr Sci, 302 Martha Van Renssalaer Hall, Ithaca, NY 14853 USA; [Strupp, Barbara J.] Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA; [Muscalu, Laura] Ithaca Coll, Dept Psychol, Ithaca, NY 14850 USA	Cornell University; Cornell University	Canfield, RL (corresponding author), Cornell Univ, Div Nutr Sci, 302 Martha Van Renssalaer Hall, Ithaca, NY 14853 USA.	rlc5@cornell.edu		Nevins, Julie/0000-0002-9414-320X	Egg Nutrition Center; Beef Checkoff; U.S. Department of Agriculture (USDA) Cooperative State Research, Education, and Extension Service [00444528]; Institute for the Social Sciences Small Grants Program; Bronfenbrenner Life Course Center Research Grant; U.S. National Institute of Food and Agriculture; USDA (Hatch Accession) [1007195]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD087137] Funding Source: NIH RePORTER	Egg Nutrition Center; Beef Checkoff; U.S. Department of Agriculture (USDA) Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)); Institute for the Social Sciences Small Grants Program; Bronfenbrenner Life Course Center Research Grant; U.S. National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); USDA (Hatch Accession); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors thank the women participants for their extraordinary cooperation and compliance with the controlled feeding trial and for making their infants available for this neurobehavioral follow-up study. This work was funded, in part, by the Egg Nutrition Center, The Beef Checkoff, the U.S. Department of Agriculture (USDA) Cooperative State Research, Education, and Extension Service (special research Grant 00444528), The Institute for the Social Sciences Small Grants Program, a Bronfenbrenner Life Course Center Research Grant, and the U.S. National Institute of Food and Agriculture, and the USDA (Hatch Accession No. 1007195). None of the funding sources had any role in trial design, participant recruitment, data collection, data analysis, data interpretation, manuscript preparation, or any aspect pertinent to the study. The authors declare no conflicts of interest.	Abreu-Villaca Y, 2011, BEHAV BRAIN RES, V221, P367, DOI 10.1016/j.bbr.2009.12.049; Albright CD, 1999, DEV BRAIN RES, V115, P123, DOI 10.1016/S0165-3806(99)00057-7; Altman DG, 1998, ENCY BIOSTATISTICS, P1000; BENSON JB, 1993, DEV PSYCHOL, V29, P434, DOI 10.1037/0012-1649.29.3.434; Blusztajn JK, 2013, CLIN CHEM LAB MED, V51, P591, DOI 10.1515/cclm-2012-0635; Blusztajn JK, 1998, SCIENCE, V281, P794, DOI 10.1126/science.281.5378.794; Boeke CE, 2013, AM J EPIDEMIOL, V177, P1338, DOI 10.1093/aje/kws395; CANFIELD RL, 1991, DEV PSYCHOL, V27, P198, DOI 10.1037/0012-1649.27.2.198; CANFIELD RL, 1995, INFANT BEHAV DEV, V18, P351, DOI 10.1016/0163-6383(95)90023-3; Canfield RL, 1997, MONOGR SOC RES CHILD, V62, P1; Caudill MA, 2010, J AM DIET ASSOC, V110, P1198, DOI 10.1016/j.jada.2010.05.009; Cermak JM, 1999, DEV NEUROSCI-BASEL, V21, P94, DOI 10.1159/000017371; Cheatham CL, 2012, AM J CLIN NUTR, V96, P1465, DOI 10.3945/ajcn.112.037184; Cheng RK, 2008, LEARN MEMORY, V15, P153, DOI 10.1101/lm.729408; Cheng RK, 2008, BRAIN RES, V1237, P167, DOI 10.1016/j.brainres.2008.08.062; Cheng WL, 1996, J NUTR BIOCHEM, V7, P457, DOI 10.1016/0955-2863(96)00079-4; Dougherty TM, 1997, DEV PSYCHOL, V33, P146, DOI 10.1037/0012-1649.33.1.146; Glenn MJ, 2008, BRAIN RES, V1237, P110, DOI 10.1016/j.brainres.2008.08.049; Institute of Medicine, 1998, DIET REF INT THIAM R; Jana A, 2010, NEUROMOL MED, V12, P351, DOI 10.1007/s12017-010-8128-4; Javitt DC, 2015, AM J PSYCHIAT, V172, P17, DOI 10.1176/appi.ajp.2014.13121691; Jiang XY, 2014, TRENDS ENDOCRIN MET, V25, P263, DOI 10.1016/j.tem.2014.02.001; Jiang XY, 2012, FASEB J, V26, P3563, DOI 10.1096/fj.12-207894; Kobayashi Y, 2002, NEURAL NETWORKS, V15, P731, DOI 10.1016/S0893-6080(02)00059-X; Koletzko B, 2008, J PERINAT MED, V36, P5, DOI 10.1515/JPM.2008.001; Kovacheva VP, 2009, FASEB J, V23, P1054, DOI 10.1096/fj.08-122168; Lauder JM, 1999, ENVIRON HEALTH PERSP, V107, P65, DOI 10.2307/3434473; Lavenex P, 2013, BEHAV BRAIN RES, V254, P8, DOI 10.1016/j.bbr.2013.02.007; Lewis ED, 2014, BRIT J NUTR, V112, P112, DOI 10.1017/S0007114514000555; LOY R, 1991, ADV EXP MED BIOL, V295, P373; McCann JC, 2006, NEUROSCI BIOBEHAV R, V30, P696, DOI 10.1016/j.neubiorev.2005.12.003; Meck WH, 2008, FRONT INTEGR NEUROSC, V1, DOI 10.3389/neuro.07.007.2007; MECK WH, 1988, DEV PSYCHOBIOL, V21, P339, DOI 10.1002/dev.420210405; Meck WH, 1999, DEV BRAIN RES, V118, P51, DOI 10.1016/S0165-3806(99)00105-4; Meck WH, 2003, NEUROSCI BIOBEHAV R, V27, P385, DOI 10.1016/S0149-7634(03)00069-1; Mellott TJ, 2004, FASEB J, V18, P545, DOI 10.1096/fj.03-0877fje; Moon J, 2010, BEHAV NEUROSCI, V124, P346, DOI 10.1037/a0019590; Niculescu MD, 2002, J NUTR, V132, p2333S, DOI 10.1093/jn/132.8.2333S; Reynolds RM, 2013, PSYCHONEUROENDOCRINO, V38, P1, DOI 10.1016/j.psyneuen.2012.08.012; Rose SA, 1997, CHILD DEV, V68, P630; Ross RG, 2013, AM J PSYCHIAT, V170, P290, DOI 10.1176/appi.ajp.2012.12070940; Strupp BJ, 2016, CURR ALZHEIMER RES, V13, P97, DOI 10.2174/1567205012666150921100311; Teubert M, 2015, INFANT CHILD DEV, V24, P522, DOI 10.1002/icd.1897; Thomas JD, 2004, NEUROTOXICOL TERATOL, V26, P35, DOI 10.1016/j.ntt.2003.10.002; Visentin CE, 2015, J NUTR, V145, P1491, DOI 10.3945/jn.115.211136; Williams CL, 1998, BRAIN RES, V794, P225, DOI 10.1016/S0006-8993(98)00229-7; Yan J, 2012, AM J CLIN NUTR, V95, P1060, DOI 10.3945/ajcn.111.022772; Yang YL, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-22-j0006.2000; ZEISEL SH, 1995, J NUTR, V125, P3049; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156; Zeisel SH, 2011, SEMIN CELL DEV BIOL, V22, P624, DOI 10.1016/j.semcdb.2011.06.002	52	77	79	2	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2172	2180		10.1096/fj.201700692RR	http://dx.doi.org/10.1096/fj.201700692RR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29217669	Green Published			2022-12-28	WOS:000429051400036
J	Lillo, MA; Gaete, PS; Puebla, M; Ardiles, NM; Poblete, I; Becerra, A; Simon, F; Figueroa, XF				Lillo, Mauricio A.; Gaete, Pablo S.; Puebla, Mariela; Ardiles, Nicolas M.; Poblete, Ines; Becerra, Alvaro; Simon, Felipe; Figueroa, Xavier F.			Critical contribution of Na+-Ca2+ exchanger to the Ca2+-mediated vasodilation activated in endothelial cells of resistance arteries	FASEB JOURNAL			English	Article						NO production; endothelium-dependent vasodilation; endothelium-derived hyperpolarization; Ca2+ signaling; endothelial NO synthase	MYOENDOTHELIAL GAP-JUNCTIONS; SODIUM-CALCIUM EXCHANGER; NA+/CA2+ EXCHANGE; NITRIC-OXIDE; CA2+ ENTRY; MOLECULAR DETERMINANTS; INTRACELLULAR CA2+; ION CHANNELS; NA+ ENTRY; RAT	Na+-Ca2+ exchanger (NCX) contributes to control the intracellular free Ca2+ concentration ([Ca2+](i)), but the functional activation of NCX reverse mode (NCXrm) in endothelial cells is controversial. We evaluated the participation of NCXrm-mediated Ca2+ uptake in the endothelium-dependent vasodilation of rat isolated mesenteric arterial beds. In phenylephrine-contracted mesenteries, the acetylcholine (ACh)-induced vasodilation was abolished by treatment with the NCXrm blockers SEA0400, KB-R7943, or SN-6. Consistent with that, the ACh-induced hyperpolarization observed in primary cultures of mesenteric endothelial cells and in smooth muscle of isolated mesenteric resistance arteries was attenuated by KB-R7943 and SEA0400, respectively. In addition, both blockers abolished the NO production activated by ACh in intact mesenteric arteries. In contrast, the inhibition of NCXrm did not affect the vasodilator responses induced by the Ca2+ ionophore, ionomycin, and the NO donor, S-nitroso-N-acetylpenicillamine. Furthermore, SEA0400, KB-R7943, and a small interference RNA directed against NCX1 blunted the increase in [Ca2+](i) induced by ACh or ATP in cultured endothelial cells. The analysis by proximity ligation assay showed that the NO-synthesizing enzyme, eNOS, and NCX1 were associated in endothelial cell caveolae of intact mesenteric resistance arteries. These results indicate that the activation of NCXrm has a central role in Ca2+-mediated vasodilation initiated by ACh in endothelial cells of resistance arteries.	[Lillo, Mauricio A.; Gaete, Pablo S.; Puebla, Mariela; Ardiles, Nicolas M.; Poblete, Ines; Figueroa, Xavier F.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Fisiol, Ave B OHiggins 340, Santiago 8331010, Chile; [Becerra, Alvaro; Simon, Felipe] Univ Andres Bello, Fac Ciencias Biol, Dept Ciencias Biol, Santiago, Chile; [Becerra, Alvaro; Simon, Felipe] Univ Andres Bello, Fac Med, Santiago, Chile; [Becerra, Alvaro; Simon, Felipe] Millennium Inst Immunol & Immunotherapy, Santiago, Chile; [Becerra, Alvaro] Univ Bernardo OHiggins, Fac Salud Deporte & Recreac, Dept Ciencias Quim & Biol, Santiago, Chile	Pontificia Universidad Catolica de Chile; Universidad Andres Bello; Universidad Andres Bello; Universidad  Bernardo O'Higgins	Figueroa, XF (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Fisiol, Ave B OHiggins 340, Santiago 8331010, Chile.	xfigueroa@bio.puc.cl		Simon, Felipe/0000-0002-2653-9798; Lillo, Mauricio/0000-0002-2823-6619; Figueroa, Xavier/0000-0001-9656-9100	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1100850, 1150530, 3160348, 1161288]; Millennium Institute on Immunology and Immunotherapy [P09-016-F]; UNAB [DI-741-15/N]; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) [21120178, 21120399]	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Millennium Institute on Immunology and Immunotherapy; UNAB; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by Grants 1100850, 1150530, 3160348, and 1161288 from Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT), Millennium Institute on Immunology and Immunotherapy P09-016-F, and UNAB DI-741-15/N. In addition, doctoral and thesis support Scholarships 21120178 and 21120399 from Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) also contributed to support this study. The authors declare no conflicts of interest.	Absi M, 2007, BRIT J PHARMACOL, V151, P332, DOI 10.1038/sj.bjp.0707222; Adapala RK, 2011, AM J PHYSIOL-HEART C, V301, pH757, DOI 10.1152/ajpheart.00142.2011; Andrikopoulos P, 2017, CELL SIGNAL, V37, P12, DOI 10.1016/j.cellsig.2017.05.013; Ashley RA, 2002, PEDIATR RES, V51, P472, DOI 10.1203/00006450-200204000-00012; Bakker ENTP, 1997, AM J PHYSIOL-HEART C, V273, pH1848, DOI 10.1152/ajpheart.1997.273.4.H1848; Birinyi P, 2005, N-S ARCH PHARMACOL, V372, P63, DOI 10.1007/s00210-005-1079-x; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Bondarenko A, 2004, BRIT J PHARMACOL, V143, P9, DOI 10.1038/sj.bjp.0705866; Bondarenko AI, 2017, VASC PHARMACOL, V89, P39, DOI 10.1016/j.vph.2017.01.002; Brahler S, 2009, CIRCULATION, V119, P2323, DOI 10.1161/CIRCULATIONAHA.108.846634; Buvinic S, 2002, BRIT J PHARMACOL, V136, P847, DOI 10.1038/sj.bjp.0704789; Daniel EE, 2006, J CELL MOL MED, V10, P529, DOI 10.1111/j.1582-4934.2006.tb00418.x; Domotor E, 1999, J PHYSIOL-LONDON, V515, P147, DOI 10.1111/j.1469-7793.1999.147ad.x; Dora KA, 2003, AM J PHYSIOL-HEART C, V285, pH119, DOI 10.1152/ajpheart.00643.2002; Figueroa XF, 2007, AM J PHYSIOL-HEART C, V293, pH1371, DOI 10.1152/ajpheart.01368.2006; Figueroa XF, 2013, NEUROPHARMACOLOGY, V75, P471, DOI 10.1016/j.neuropharm.2013.02.022; Figueroa XF, 2009, ANTIOXID REDOX SIGN, V11, P251, DOI 10.1089/ars.2008.2117; Fleming I, 2003, AM J PHYSIOL-REG I, V284, pR1, DOI 10.1152/ajpregu.00323.2002; Fujimoto S, 1997, EUR J PHARMACOL, V330, P177, DOI 10.1016/S0014-2999(97)00180-5; Gaete PS, 2012, FREE RADICAL BIO MED, V52, P860, DOI 10.1016/j.freeradbiomed.2011.11.036; Girardin NC, 2010, PFLUG ARCH EUR J PHY, V460, P109, DOI 10.1007/s00424-010-0825-1; Goedicke-Fritz S, 2015, EUR J CELL BIOL, V94, P391, DOI 10.1016/j.ejcb.2015.06.002; Gosling M, 1998, J BIOL CHEM, V273, P21084, DOI 10.1074/jbc.273.33.21084; Goto Y, 1996, EUR J PHARMACOL, V314, P185, DOI 10.1016/S0014-2999(96)00532-8; Graier WF, 1998, J PHYSIOL-LONDON, V506, P109, DOI 10.1111/j.1469-7793.1998.109bx.x; Harnett KM, 2003, AM J MED, V115, p24S, DOI 10.1016/S0002-9343(03)00232-8; Isshiki M, 2003, TRAFFIC, V4, P717, DOI 10.1034/j.1600-0854.2003.00130.x; Iwamoto T, 2004, NAT MED, V10, P1193, DOI 10.1038/nm1118; Iwamoto T, 2004, J BIOL CHEM, V279, P7544, DOI 10.1074/jbc.M310491200; Kraft R, 2007, BIOCHEM BIOPH RES CO, V361, P230, DOI 10.1016/j.bbrc.2007.07.019; Lemos VS, 2007, BIOCHEM BIOPH RES CO, V352, P130, DOI 10.1016/j.bbrc.2006.10.160; Moccia F, 2002, BIOCHEM J, V364, P235, DOI 10.1042/bj3640235; MULVANY MJ, 1990, PHYSIOL REV, V70, P921, DOI 10.1152/physrev.1990.70.4.921; Nilius B, 2005, PFLUG ARCH EUR J PHY, V451, P1, DOI 10.1007/s00424-005-1462-y; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; Niu CF, 2007, EUR J PHARMACOL, V573, P161, DOI 10.1016/j.ejphar.2007.06.033; Palygin OA, 2008, AM J PHYSIOL-HEART C, V294, pH1693, DOI 10.1152/ajpheart.01337.2007; Quednau BD, 1997, AM J PHYSIOL-CELL PH, V272, pC1250, DOI 10.1152/ajpcell.1997.272.4.C1250; Rosker C, 2004, J BIOL CHEM, V279, P13696, DOI 10.1074/jbc.M308108200; Sandow SL, 2002, CIRC RES, V90, P1108, DOI 10.1161/01.RES.0000019756.88731.83; Sandow SL, 2000, CIRC RES, V86, P341, DOI 10.1161/01.RES.86.3.341; Schneider JC, 2002, AM J PHYSIOL-HEART C, V283, pH837, DOI 10.1152/ajpheart.00789.2001; Sedova M, 1999, CELL CALCIUM, V25, P333, DOI 10.1054/ceca.1999.0036; Segal SS, 2005, MICROCIRCULATION, V12, P33, DOI 10.1080/10739680590895028; Sharma V, 2014, GENESIS, V52, P93, DOI 10.1002/dvg.22735; Shigekawa M, 2001, CIRC RES, V88, P864, DOI 10.1161/hh0901.090298; Sun L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025432; Tanaka H, 2002, BRIT J PHARMACOL, V135, P1096, DOI 10.1038/sj.bjp.0704574; Teubl M, 1999, J BIOL CHEM, V274, P29529, DOI 10.1074/jbc.274.41.29529; Traub O, 1999, J BIOL CHEM, V274, P20144, DOI 10.1074/jbc.274.29.20144; Tsoukias NM, 2011, WIRES SYST BIOL MED, V3, P93, DOI 10.1002/wsbm.97; Tykocki NR, 2012, PHARMACOL RES, V66, P544, DOI 10.1016/j.phrs.2012.08.004; Voets T, 2002, J BIOL CHEM, V277, P33704, DOI 10.1074/jbc.M204828200; Watanabe Y, 2006, J PHARMACOL SCI, V102, P7, DOI 10.1254/jphs.FMJ06002X2; Wier WG, 2004, REV PHYSIOL BIOCH P, V150, P91, DOI 10.1007/s10254-003-0019-8; Wilson C, 2016, J PHYSIOL-LONDON, V594, P7267, DOI 10.1113/JP272927; Yamamoto K, 2000, AM J PHYSIOL-HEART C, V279, pH285, DOI 10.1152/ajpheart.2000.279.1.H285; Yamamoto K, 2006, NAT MED, V12, P133, DOI 10.1038/nm1338; Yao XQ, 2005, CIRC RES, V97, P853, DOI 10.1161/01.RES.0000187473.85419.3e; Zhang DX, 2009, HYPERTENSION, V53, P532, DOI 10.1161/HYPERTENSIONAHA.108.127100; Zhao YZ, 2015, J PHARMACOL SCI, V129, P83, DOI 10.1016/j.jphs.2015.09.002; Zuccolo E, 2017, CELL CALCIUM, V66, P33, DOI 10.1016/j.ceca.2017.06.003	62	15	15	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2137	2147		10.1096/fj.201700365RR	http://dx.doi.org/10.1096/fj.201700365RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29217667				2022-12-28	WOS:000429051400033
J	Mohammadalipour, A; Burdick, MM; Tees, DFJ				Mohammadalipour, Amina; Burdick, Monica M.; Tees, David F. J.			Deformability of breast cancer cells in correlation with surface markers and cell rolling	FASEB JOURNAL			English	Article						cancer stem cell; cell rheology; mechanical biomarker	MAJOR E-SELECTIN; STEM-CELLS; ENDOTHELIAL-CELLS; SHEAR-FLOW; VISCOELASTIC PROPERTIES; ALDEHYDE DEHYDROGENASE; MECHANICAL-PROPERTIES; CORTICAL TENSION; CARCINOMA CELLS; ADHESION	Although the cancer stem cell (CSC) hypothesis has been around for many years, the reliability of cell-surface markers to classify CSCs has remained debatable. The finding that cancerous cells are significantly more deformable than healthy ones has provided motivation to consider mechanical properties as a possible biomarker for stemness. In this study, using the micropipette aspiration technique, mechanical properties of multiple breast cancer cell lines were investigated and correlated with breast cancer stem cell (BCSC) marker, CD44(+)/CD24(-)/ALDH1(+). The results indicated that Hs578T and MDA-MB-231 cell lines with CD44(+)/CD24(-)/ALDH1(+) phenotype were significantly more deformable than the MDA-MB-468 cell line, which did not express the BCSC marker. The BT-20 cell line with intermediate deformability did not express any CD44(+)/CD24(-) phenotype, but it expressed aldehyde dehydrogenase-1 activity. In addition, more-deformable cell lines were found to roll with shear-independent velocities on E-selectin-coated substrates in a parallel-plate flow chamber, which might be a mediating factor for firm adhesion of CSCs to endothelium during metastasis. Our results indicate that rheological properties can be considered as a biomechanical marker in addition to, or as a complement of, surface markers to find more-definitive evidence of CSC characteristics within tumors.	[Mohammadalipour, Amina; Tees, David F. J.] Ohio Univ, Dept Phys & Astron, Athens, OH 45701 USA; [Mohammadalipour, Amina; Burdick, Monica M.] Ohio Univ, Dept Chem & Biomol Engn, 171 Stocker Ctr, Athens, OH 45701 USA	University System of Ohio; Ohio University; University System of Ohio; Ohio University	Mohammadalipour, A (corresponding author), Ohio Univ, Dept Chem & Biomol Engn, 171 Stocker Ctr, Athens, OH 45701 USA.	am131709@ohio.edu	Mohammadalipour, Amina/AAB-2510-2020	Tees, David/0000-0002-7961-7745; Burdick, Monica/0000-0003-3168-0072	U.S. National Science Foundation [CBET-1106118]	U.S. National Science Foundation(National Science Foundation (NSF))	This work was supported by a grant from the U.S. National Science Foundation (CBET-1106118 to M.M.B. and D.F.J.T.). The authors declare no conflicts of interest.	Abraham BK, 2005, CLIN CANCER RES, V11, P1154; Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Barthel SR, 2007, EXPERT OPIN THER TAR, V11, P1473, DOI 10.1517/14728222.11.11.1473; Bose S, 2010, BIOPHYS J, V99, P3870, DOI 10.1016/j.bpj.2010.10.038; Buess M, 2009, NEOPLASIA, V11, P987, DOI 10.1593/neo.09670; BULL BS, 1973, BLOOD, V41, P833, DOI 10.1182/blood.V41.6.833.833; Burdick MM, 2003, AM J PHYSIOL-CELL PH, V284, pC977, DOI 10.1152/ajpcell.00423.2002; Burdick MM, 2006, J BIOL CHEM, V281, P13899, DOI 10.1074/jbc.M513617200; CANHAM PB, 1970, J THEOR BIOL, V26, P61, DOI 10.1016/S0022-5193(70)80032-7; Cho EH, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016001; Chu JE, 2011, STEM CELLS BIOL REG, P15, DOI 10.1007/978-1-61779-246-5_2; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Croker AK, 2008, J CELL MOL MED, V12, P374, DOI 10.1111/j.1582-4934.2007.00211.x; Croker AK, 2009, J CELL MOL MED, V13, P2236, DOI 10.1111/j.1582-4934.2008.00455.x; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; Debeb BG, 2010, INT J RADIAT ONCOL, V76, P889, DOI 10.1016/j.ijrobp.2009.09.052; Dimitroff CJ, 2001, J CELL BIOL, V153, P1277, DOI 10.1083/jcb.153.6.1277; Dong C, 1999, ANN BIOMED ENG, V27, P298, DOI 10.1114/1.143; Dong C, 2000, J BIOMECH, V33, P35, DOI 10.1016/S0021-9290(99)00174-8; EVANS E, 1989, BIOPHYS J, V56, P151, DOI 10.1016/S0006-3495(89)82660-8; EVANS E, 1984, BLOOD, V64, P1028; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gout S, 2008, CLIN EXP METASTAS, V25, P335, DOI 10.1007/s10585-007-9096-4; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Hill RP, 2007, JNCI-J NATL CANCER I, V99, P1435, DOI 10.1093/jnci/djm136; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; KOLODNEY MS, 1992, J CELL BIOL, V117, P73, DOI 10.1083/jcb.117.1.73; Krebs Matthew G, 2010, Ther Adv Med Oncol, V2, P351, DOI 10.1177/1758834010378414; Lei X, 1999, J BIOMECH ENG-T ASME, V121, P636, DOI 10.1115/1.2800866; Lekka M, 1999, EUR BIOPHYS J BIOPHY, V28, P312, DOI 10.1007/s002490050213; Li QS, 2008, BIOCHEM BIOPH RES CO, V374, P609, DOI 10.1016/j.bbrc.2008.07.078; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Lincoln B, 2004, CYTOM PART A, V59A, P203, DOI 10.1002/cyto.a.20050; Liu SL, 2014, STEM CELL REP, V2, P78, DOI 10.1016/j.stemcr.2013.11.009; Mohammadalipour A, 2017, CELL MOL BIOENG, V10, P235, DOI 10.1007/s12195-017-0485-8; Moss MA, 2000, ANTICANCER RES, V20, P1425; Mylona E, 2008, HUM PATHOL, V39, P1096, DOI 10.1016/j.humpath.2007.12.003; NEEDHAM D, 1990, J BIOMECH ENG-T ASME, V112, P269, DOI 10.1115/1.2891184; Park S, 2005, BIOPHYS J, V89, P4330, DOI 10.1529/biophysj.104.053462; Pelham RJ, 1999, MOL BIOL CELL, V10, P935, DOI 10.1091/mbc.10.4.935; Prabhune M, 2012, MICRON, V43, P1267, DOI 10.1016/j.micron.2012.03.023; Pravincumar P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043938; Ricardo S, 2011, J CLIN PATHOL, V64, P937, DOI 10.1136/jcp.2011.090456; Samanna V, 2007, J CELL PHYSIOL, V213, P710, DOI 10.1002/jcp.21137; Schweitzer KM, 1996, AM J PATHOL, V148, P165; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Sundd P, 2008, MICROCIRCULATION, V15, P109, DOI 10.1080/10739680701412971; Tanei T, 2009, CLIN CANCER RES, V15, P4234, DOI 10.1158/1078-0432.CCR-08-1479; Tees DFJ, 2001, BIOPHYS J, V80, P668, DOI 10.1016/S0006-3495(01)76047-X; THERET DP, 1988, J BIOMECH ENG-T ASME, V110, P190, DOI 10.1115/1.3108430; Wakatsuki T, 2001, J CELL SCI, V114, P1025; WARD KA, 1991, BIORHEOLOGY, V28, P301; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Wirtz D, 2009, ANNU REV BIOPHYS, V38, P301, DOI 10.1146/annurev.biophys.050708.133724; Wu ZZ, 2000, BIORHEOLOGY, V37, P279; YE CL, 1995, INT J CANCER, V61, P455, DOI 10.1002/ijc.2910610404; YU P, 2010, CHIN GERMAN J CLIN O, V9, P31, DOI DOI 10.1007/S10330-009-0178-4; Zen K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001826	60	13	13	2	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					1806	1817		10.1096/fj.201700762R	http://dx.doi.org/10.1096/fj.201700762R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29162703				2022-12-28	WOS:000429051400006
J	Rajkumar, P; Cha, BY; Yin, JY; Arend, LJ; Paunescu, TG; Hirabayashi, Y; Donowitz, M; Pluznick, JL				Rajkumar, Premraj; Cha, Boyoung; Yin, Jianyi; Arend, Lois J.; Paunescu, Teodor G.; Hirabayashi, Yoshio; Donowitz, Mark; Pluznick, Jennifer L.			Identifying the localization and exploring a functional role for Gprc5c in the kidney	FASEB JOURNAL			English	Article						pH regulation; proximal tubule; NHE3	PROTEIN-COUPLED RECEPTOR; BLOOD-PRESSURE REGULATION; TUMOR-SUPPRESSOR GENE; ACID-BASE-BALANCE; RETINOIC ACID; PROXIMAL TUBULE; MOLECULAR-CLONING; SERUM BICARBONATE; WNT/BETA-CATENIN; COLLECTING DUCT	The investigation of orphan GPCRs (GPRs) has the potential to uncover novel insights into whole animal physiology. In this study, our goal was to determine the renal localization of Gprc5c, a receptor that we previously reported to be highly expressed in murine whole kidney, and to examine physiologic parameters in Gprc5c knockout (KO) mice to gain insight into function. Gprc5c localized to the apical membrane of renal proximal tubules (PTs) in mice, rats, and humans. With the comparison of Gprc5c wild-type (WT) and KO mice, we found that Gprc5c KO mice have altered acid-base homeostasis. Specifically, Gprc5c KO mice have lower blood pH and higher urine pH compared with WT mice, with a reduced level of titratable acids in their urine. In an in vitro GPCR internalization assay, we observed that Gprc5c internalization (an index of activation) was triggered by alkaline extracellular pH. Furthermore, with the use of an in vitro BCECF assay, we observed that Gprc5c increases Na+/H+ exchanger 3 (NHE3) activity at alkaline pH. We also find that the NHE3 activity is reduced in Gprc5c KO mice by 2 photon imaging in seminaphthorhodafluors (SNARF)-4F-loaded kidney sections. NHE3 is a primary contributor to apical transport of H+ in the renal PT. Together, these data imply that Gprc5c modulates the renal contribution to systemic pH homeostasis, at least in part, by taking part in the regulation of NHE3.	[Rajkumar, Premraj; Donowitz, Mark; Pluznick, Jennifer L.] Johns Hopkins Univ, Sch Med, Dept Physiol, 725 N Wolfe St,205A WBSB, Baltimore, MD 21205 USA; [Cha, Boyoung; Yin, Jianyi] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Arend, Lois J.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Paunescu, Teodor G.] Harvard Med Sch, Massachusetts Gen Hosp, Div Nephrol, Boston, MA USA; [Hirabayashi, Yoshio] RIKEN, Brain Sci Inst, Lab Mol Membrane Neurosci, Saitama, Japan	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Harvard University; Harvard Medical School; Massachusetts General Hospital; RIKEN	Pluznick, JL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, 725 N Wolfe St,205A WBSB, Baltimore, MD 21205 USA.	jpluznick@jhmi.edu	Paunescu, Teodor/AAX-7533-2020; Arend, Lois/ABE-2002-2020	Arend, Lois/0000-0001-5434-7630; Hirabayashi, Yoshio/0000-0002-5774-7354; Paunescu, Teodor/0000-0003-0227-9028	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [R00-DK081610]; National Kidney Foundation of Maryland Mini-Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK081610, P30DK089502] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Kidney Foundation of Maryland Mini-Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Gregory Blass and Alexander Staruschenko (Medical College of Wisconsin, Milwaukee, WI, USA) and P. Richard Grimm and Paul Welling (University of Maryland, College Park, MD, USA) for sharing their protocols for urine ammonia measurement and blood collection from the abdominal aorta, respectively. The authors are grateful to Peter S. Aronson (Yale University, New Haven, CT, USA) for sharing the Megalin antibody. The authors are also grateful to the members of the J.L.P. and M.D. laboratories for their helpful discussions. This work was supported by U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant R00-DK081610 (to J.L.P.), and a National Kidney Foundation of Maryland Mini-Grant (to P.R.). The authors declare no conflicts of interest.	Amisten S, 2017, ENDOCR J, V64, P325, DOI 10.1507/endocrj.EJ16-0338; Brauner-Osborne H, 2000, GENOMICS, V65, P121, DOI 10.1006/geno.2000.6164; Brauner-Osborne H, 2001, BBA-GENE STRUCT EXPR, V1518, P237, DOI 10.1016/S0167-4781(01)00197-X; BROWN SES, 1991, AM J PHYSIOL, V261, pC954, DOI 10.1152/ajpcell.1991.261.6.C954; Busse D, 2014, J INVEST DERMATOL, V134, P2823, DOI 10.1038/jid.2014.273; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Cheng YJ, 1998, J BIOL CHEM, V273, P35008, DOI 10.1074/jbc.273.52.35008; Curthoys NP, 2014, CLIN J AM SOC NEPHRO, V9, P1627, DOI 10.2215/CJN.10391012; Dang YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095548; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Deng JO, 2010, CANCER PREV RES, V3, P424, DOI 10.1158/1940-6207.CAPR-10-0032; Donowitz M, 2009, J EXP BIOL, V212, P1638, DOI 10.1242/jeb.028605; Feldmesser E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-121; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Grimm PR, 2015, J CLIN INVEST, V125, P2136, DOI 10.1172/JCI78558; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Hofmeister MV, 2012, AM J PHYSIOL-RENAL, V302, pF358, DOI 10.1152/ajprenal.00343.2011; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Imanishi S, 2007, J REPROD DEVELOP, V53, P1131, DOI 10.1262/jrd.18102; Inoue S, 2004, J INVEST DERMATOL, V122, P565, DOI 10.1046/j.0022-202X.2004.12628.x; Iversen NK, 2012, RESP PHYSIOL NEUROBI, V180, P252, DOI 10.1016/j.resp.2011.11.015; Kang N, 2015, BIOCHEM BIOPH RES CO, V460, P616, DOI 10.1016/j.bbrc.2015.03.078; Kang N, 2012, BMB REP, V45, P612, DOI 10.5483/BMBRep.2012.45.11.232; Kim SH, 2015, BIOCHEM BIOPH RES CO, V460, P404, DOI 10.1016/j.bbrc.2015.03.046; KINSELLA JL, 1980, AM J PHYSIOL, V238, pF461, DOI 10.1152/ajprenal.1980.238.6.F461; Kleinz MJ, 2005, PHARMACOL THERAPEUT, V107, P198, DOI 10.1016/j.pharmthera.2005.04.001; Kovesdy CP, 2009, NEPHROL DIAL TRANSPL, V24, P1232, DOI 10.1093/ndt/gfn633; Kurabayashi N, 2013, DEVELOPMENT, V140, P4335, DOI 10.1242/dev.099754; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Lee HW, 2009, AM J PHYSIOL-RENAL, V296, pF1364, DOI 10.1152/ajprenal.90667.2008; LEVINE SA, 1995, J BIOL CHEM, V270, P13716, DOI 10.1074/jbc.270.23.13716; Li HC, 2013, J MOL MED, V91, P951, DOI 10.1007/s00109-013-1015-3; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Meyer RC, 2013, P NATL ACAD SCI USA, V110, P9529, DOI 10.1073/pnas.1219004110; Mitch WE, 2006, J NEPHROL, V19, pS70; Mohri Y, 2011, DEV DYNAM, V240, P1626, DOI 10.1002/dvdy.22651; Murtazina R, 2007, J BIOL CHEM, V282, P25141, DOI 10.1074/jbc.M701910200; Natarajan N, 2016, PHYSIOL GENOMICS, V48, P826, DOI 10.1152/physiolgenomics.00089.2016; Navaneethan SD, 2011, CLIN J AM SOC NEPHRO, V6, P2395, DOI 10.2215/CJN.03730411; Pluznick JL, 2013, AM J PHYSIOL-RENAL, V305, pF439, DOI 10.1152/ajprenal.00252.2013; Pluznick JL, 2013, P NATL ACAD SCI USA, V110, P4410, DOI 10.1073/pnas.1215927110; Pluznick JL, 2012, CURR OPIN NEPHROL HY, V21, P404, DOI 10.1097/MNH.0b013e328354a6bd; Pluznick JL, 2009, P NATL ACAD SCI USA, V106, P2059, DOI 10.1073/pnas.0812859106; Rajkumar P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111053; Raphael KL, 2016, CLIN J AM SOC NEPHRO, V11, P308, DOI 10.2215/CJN.06200615; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Robbins MJ, 2000, GENOMICS, V67, P8, DOI 10.1006/geno.2000.6226; Robbins MJ, 2002, MOL BRAIN RES, V106, P136, DOI 10.1016/S0169-328X(02)00420-5; Roberts EM, 2009, J ENDOCRINOL, V202, P453, DOI 10.1677/JOE-09-0134; Sano T, 2011, BIOCHEM BIOPH RES CO, V412, P460, DOI 10.1016/j.bbrc.2011.07.118; Scarselli M, 2009, J BIOL CHEM, V284, P3577, DOI 10.1074/jbc.M806819200; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Shepard BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068758; Skelton LA, 2010, J NEPHROL, V23, pS4; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Sun XM, 2015, AM J PHYSIOL-RENAL, V309, pF120, DOI 10.1152/ajprenal.00507.2014; Sun XM, 2010, J AM SOC NEPHROL, V21, P1745, DOI 10.1681/ASN.2009050477; Tao QG, 2007, JNCI-J NATL CANCER I, V99, P1668, DOI 10.1093/jnci/djm208; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Tokonami N, 2013, J CLIN INVEST, V123, P3166, DOI 10.1172/JCI67562; Toma I, 2008, J CLIN INVEST, V118, P2526, DOI 10.1172/JCI33293; Vargas SL, 2009, J AM SOC NEPHROL, V20, P1002, DOI 10.1681/ASN.2008070740; Walther C, 2010, J BIOL CHEM, V285, P41578, DOI 10.1074/jbc.M110.162156; Weiner ID, 2017, PHYSIOL REV, V97, P465, DOI 10.1152/physrev.00011.2016; Wu C, 2015, INT J BIOCHEM CELL B, V64, P75, DOI 10.1016/j.biocel.2015.03.008; Xu JS, 2005, AM J RESP CELL MOL, V32, P381, DOI 10.1165/rcmb.2004-0343OC	66	10	10	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2018	32	4					2046	2059		10.1096/fj.201700610RR	http://dx.doi.org/10.1096/fj.201700610RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GB4SP	29196502	Green Published			2022-12-28	WOS:000429051400026
J	Kugler, R; Mietens, A; Seidensticker, M; Tasch, S; Wagenlehner, FM; Kaschtanow, A; Tjahjono, Y; Tomczyk, CU; Beyer, D; Risbridger, GP; Exintaris, B; Ellem, SJ; Middendorff, R				Kuegler, Robert; Mietens, Andrea; Seidensticker, Mathias; Tasch, Sabine; Wagenlehner, Florian M.; Kaschtanow, Andre; Tjahjono, Yudy; Tomczyk, Claudia U.; Beyer, Daniela; Risbridger, Gail P.; Exintaris, Betty; Ellem, Stuart J.; Middendorff, Ralf			Novel imaging of the prostate reveals spontaneous gland contraction and excretory duct quiescence together with different drug effects	FASEB JOURNAL			English	Article						contractility; time-lapse imaging; 3D imaging; PDE5 inhibitors	URINARY-TRACT SYMPTOMS; PHOSPHODIESTERASE 5 INHIBITORS; REGIONAL-VARIATION; TISSUE; METAANALYSIS; ANTAGONISTS; SILODOSIN; SECONDARY; BLADDER; SYSTEM	Prostate carcinoma and benign prostate hyperplasia (BPH) with associated lower urinary tract symptoms (LUTS) are among the most prevalent and clinically relevant diseases in men. BPH is characterized by an enlargement of prostate tissue associated with increased tone of smooth muscle cells (SMCs) which surround the single glands composing the prostate. Secretions of the glands leave the prostate through local excretory ducts during the emission phase of ejaculation. Pharmacological treatment of BPH suggests different local drug targets based on reduction of prostate smooth muscle tone as the main effect and disturbed ejaculation as a common side effect. This highlights the need for detailed investigation of single prostate glands and ducts. We combined structural and functional imaging techniques-notably, clear lipid-exchanged, acrylamide-hybridized rigid imaging/immunostaining/in situ hybridization-compatible tissue-hydrogel (CLARITY) and time-lapse imaging- and defined glands and ducts as distinct SMC compartments in human and rat prostate tissue. The single glands of the prostate (comprising the secretory part) are characterized by spontaneous contractions mediated by the surrounding SMCs, whereas the ducts (excretory part) are quiescent. In both SMC compartments, phosphodiesterase (PDE)-5 is expressed. PDE5 inhibitors have recently emerged as alternative treatment options for BPH. We directly visualized that the PDE5 inhibitors sildenafil and tadalafil act by reducing spontaneous contractility of the glands, thereby reducing the muscle tone of the organ. In contrast, the ductal (excretory) system and thus the prostate's contribution to ejaculation is unaffected by PDE5 inhibitors. Our differentiated imaging approach reveals new details about prostate function and local drug actions and thus may support clinical management of BPH.	[Kuegler, Robert; Mietens, Andrea; Seidensticker, Mathias; Tasch, Sabine; Kaschtanow, Andre; Tjahjono, Yudy; Tomczyk, Claudia U.; Beyer, Daniela; Middendorff, Ralf] Justus Liebig Univ Giessen, Inst Anat & Cell Biol, Aulweg 123, D-35392 Giessen, Germany; [Wagenlehner, Florian M.] Justus Liebig Univ Giessen, Dept Urol Pediat Urol & Androl, Giessen, Germany; [Risbridger, Gail P.; Ellem, Stuart J.] Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic, Australia; [Exintaris, Betty] Monash Inst Pharmaceut Sci, Drug Discovery Biol, Melbourne, Vic, Australia	Justus Liebig University Giessen; Justus Liebig University Giessen; Monash University	Middendorff, R (corresponding author), Justus Liebig Univ Giessen, Inst Anat & Cell Biol, Aulweg 123, D-35392 Giessen, Germany.	ralf.middendorff@anatomie.med.uni-giessen.de	Risbridger, Gail P/B-8655-2008; Exintaris, Betty/ABB-8055-2021	Risbridger, Gail P/0000-0003-3089-4028; Tjahjono, Yudy/0000-0003-0187-0270; Exintaris, Betty/0000-0002-3260-2175	Deutsche Forschungsgemeinschaft [GRK 1871]; Monash University, Australia	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Monash University, Australia(Monash University)	The authors thank Dr. Laurinda Jaffe (University of Connecticut Health Center, Farmington, CT), for providing us with anti-PDE5 antibodies; Dr. Dieter Muller (Justus-Liebig-University Giessen, Germany), for helpful discussions; and Ingrid Schneider-Huther, Tania Bloch, and Kerstin Wilhelm (Justus-Liebig-University), for excellent technical assistance. Funding was provided by the Deutsche Forschungsgemeinschaft Grant GRK 1871 and funding from Monash University, Australia, to the International Research Training Group (IRTG), a collaboration between Justus-Liebig-University Giessen and Monash University. The authors declare no conflicts of interest.	Andersson KE, 2007, NAT CLIN PRACT UROL, V4, P368, DOI 10.1038/ncpuro0836; Angulo J, 2012, J SEX MED, V9, P2293, DOI 10.1111/j.1743-6109.2012.02821.x; AUA Practise Guidelines Committee, 2003, J UROLOGY, V170, P530, DOI 10.1097/01.ju.0000078083.38675.79; Bozkurt O, 2015, UROLOGY, V85, P1085, DOI 10.1016/j.urology.2015.01.011; Calmasini FB, 2016, UROLOGY, V94, P312, DOI 10.1016/j.urology.2016.04.023; Capogrosso P, 2015, ANDROLOGY-US, V3, P1076, DOI 10.1111/andr.12095; Chapple CR, 2004, BJU INT, V94, P738, DOI 10.1111/j.1464-410X.2004.05022.x; Chung K, 2013, NAT METHODS, V10, P508, DOI [10.1038/nmeth.2481, 10.1038/NMETH.2481]; Corbin JD, 1999, J BIOL CHEM, V274, P13729, DOI 10.1074/jbc.274.20.13729; Dey A, 2012, J UROLOGY, V187, P2254, DOI 10.1016/j.juro.2012.01.072; Donatucci CF, 2011, BJU INT, V107, P1110, DOI 10.1111/j.1464-410X.2010.09687.x; Gacci M, 2016, EUR UROL, V70, P124, DOI 10.1016/j.eururo.2015.12.048; Gacci M, 2012, EUR UROL, V61, P994, DOI 10.1016/j.eururo.2012.02.033; Hennenberg M, 2016, PROSTATE, V76, P1364, DOI 10.1002/pros.23208; ICHIHARA I, 1978, CELL TISSUE RES, V192, P381; Juilfs D M, 1999, Rev Physiol Biochem Pharmacol, V135, P67, DOI 10.1007/BFb0033670; Kaplan Steven A, 2009, Rev Urol, V11, pS14; LEE C, 1990, BIOL REPROD, V43, P1079, DOI 10.1095/biolreprod43.6.1079; McNeal J. E, 1983, PROSTATE GLAND MORPH; McVary KT, 2011, J UROLOGY, V185, P1793, DOI 10.1016/j.juro.2011.01.074; Mietens A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092603; Muller D, 2011, REPRODUCTION, V142, P333, DOI 10.1530/REP-10-0517; Nemeth JA, 1996, PROSTATE, V28, P124; Nguyen DTT, 2011, J UROLOGY, V185, P347, DOI 10.1016/j.juro.2010.09.036; Oelke M, 2013, EUR UROL, V64, P118, DOI 10.1016/j.eururo.2013.03.004; Plant TM, 2015, KNOBIL NEILLS PHYSL; Roehrborn CG, 2008, INT J IMPOT RES, V20, pS11, DOI 10.1038/ijir.2008.55; Rybalkin SD, 2002, J BIOL CHEM, V277, P3310, DOI 10.1074/jbc.M106562200; Saboor F, 2016, EUR RESPIR J, V47, P876, DOI 10.1183/13993003.00574-2015; Tatemichi S, 2012, UROLOGY, V80, DOI 10.1016/j.urology.2012.01.039; Uckert S, 2001, J UROLOGY, V166, P2484, DOI 10.1016/S0022-5347(05)65621-2; Uckert S, 2008, UROLOGY, V71, P526, DOI 10.1016/j.urology.2007.10.051; Wang L, 2015, UROLOGY, V85, DOI 10.1016/j.urology.2014.12.005; Wang X., 2014, J CHEM-NY, V2014, P9, DOI [DOI 10.1016/J.PLANTSCI.2014.10.009, 10.1155/2014/681364, DOI 10.1155/2014/681364]; Wang XH, 2015, ASIAN J ANDROL, V17, P1022, DOI 10.4103/1008-682X.154990; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017	36	5	5	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1130	1138		10.1096/fj.201700430R	http://dx.doi.org/10.1096/fj.201700430R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29089445				2022-12-28	WOS:000427246000003
J	Menou, A; Flajolet, P; Duitman, J; Justet, A; Moog, S; Jaillet, M; Tabeze, L; Solhonne, B; Garnier, M; Mal, H; Mordant, P; Castier, Y; Cazes, A; Sallenave, JM; Mailleux, AA; Crestani, B				Menou, Awen; Flajolet, Pauline; Duitman, JanWillem; Justet, Aurelien; Moog, Sophie; Jaillet, Madeleine; Tabeze, Laure; Solhonne, Brigitte; Garnier, Marc; Mal, Herve; Mordant, Pierre; Castier, Yves; Cazes, Aurelie; Sallenave, Jean-Michel; Mailleux, Arnaud A.; Crestani, Bruno			Human airway trypsin-like protease exerts potent, antifibrotic action in pulmonary fibrosis	FASEB JOURNAL			English	Article						TMPRSS11D; bleomycin; fibroblast; protease-activated receptor 2; HAT	HEPATOCYTE GROWTH-FACTOR; PROSTAGLANDIN-E-2 INHIBITS FIBROBLAST; LUNG FIBROBLASTS; EPITHELIAL-CELLS; E-PROSTANOID-2 RECEPTOR; ACTIVATED RECEPTOR-1; SERINE PROTEASES; IN-VITRO; EXPRESSION; DISEASES	Idiopathic pulmonary fibrosis (IPF) is characterized by the deposition of excessive extracellular matrix and the destruction of lung parenchyma, resulting from an aberrant wound-healing response. Although IPF is often associated with an imbalance in protease activity, the mechanisms underlying the sustained repair mechanisms are not fully understood. Here, we addressed the role of the recently identified, membrane-anchored serine protease human airway trypsin-like protease (HAT). In the present study, we show that both HAT expression and activity were up-regulated in human IPF specimens. Next, adenoviral overexpression of HAT before bleomycin challenge attenuated lung injury as well as extracellular matrix deposition in the bleomycin-induced pulmonary fibrosis model. In vitro, HAT prevented specific fibrosis-associated responses in primary human pulmonary fibroblasts and induced the expression of mediators associated with the prostaglandin E2 pathway. Altogether, our findings suggested that HAT could have a protective role in IPF and other fibrotic lung disorders.-Menou, A., Flajolet, P., Duitmen, J., Justet, A., Moog, S., Jaillet, M., Tabeze, L., Solhonne, B., Garnier, M., Mal, H., Mordant, P., Castier, Y., Cazes, A., Sallenave, J.-M., Mailleux, A. A., Crestani, B. Human airway trypsin-like protease exerts potent, anti-fibrotic action in pulmonary fibrosis.	[Menou, Awen; Flajolet, Pauline; Duitman, JanWillem; Justet, Aurelien; Moog, Sophie; Jaillet, Madeleine; Tabeze, Laure; Solhonne, Brigitte; Garnier, Marc; Mal, Herve; Mordant, Pierre; Castier, Yves; Cazes, Aurelie; Sallenave, Jean-Michel; Mailleux, Arnaud A.; Crestani, Bruno] INSERM, Unite 1552, Paris, France; [Menou, Awen; Flajolet, Pauline; Duitman, JanWillem; Justet, Aurelien; Moog, Sophie; Jaillet, Madeleine; Tabeze, Laure; Solhonne, Brigitte; Garnier, Marc; Mal, Herve; Mordant, Pierre; Castier, Yves; Cazes, Aurelie; Sallenave, Jean-Michel; Mailleux, Arnaud A.; Crestani, Bruno] Dept Hosp Univ Fibrosis Inflammat & Remodeling Re, Paris, France; [Menou, Awen; Flajolet, Pauline; Duitman, JanWillem; Justet, Aurelien; Moog, Sophie; Jaillet, Madeleine; Tabeze, Laure; Solhonne, Brigitte; Garnier, Marc; Mal, Herve; Mordant, Pierre; Castier, Yves; Cazes, Aurelie; Sallenave, Jean-Michel; Mailleux, Arnaud A.; Crestani, Bruno] Lab Excellence Inflamex, Paris, France; [Menou, Awen; Flajolet, Pauline; Duitman, JanWillem; Justet, Aurelien; Moog, Sophie; Jaillet, Madeleine; Tabeze, Laure; Solhonne, Brigitte; Garnier, Marc; Mal, Herve; Mordant, Pierre; Castier, Yves; Cazes, Aurelie; Sallenave, Jean-Michel; Mailleux, Arnaud A.; Crestani, Bruno] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Justet, Aurelien; Tabeze, Laure; Crestani, Bruno] Hop Bichat Claude Bernard, AP HP, Serv Pneumol A, Paris, France; [Mal, Herve] Hop Bichat Claude Bernard, AP HP, Serv Pneumol & Transplantat, Paris, France; [Mordant, Pierre; Castier, Yves] Hop Bichat Claude Bernard, AP HP, Serv Chirurg Thorac & Vasc, Paris, France; [Cazes, Aurelie] Hop Bichat Claude Bernard, AP HP, Dept Anat Pathol, Paris, France; [Garnier, Marc] Hop Tenon, AP HP, Dept Anesthesie & Reanimat, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite	Crestani, B (corresponding author), Hop Bichat Claude Bernard, Serv Pneumol A, 46 Rue Henri Huchard, F-75018 Paris, France.	bruno.crestani@aphp.fr	Mailleux, Arnaud A/J-3576-2017; Duitman, JanWillem/AFX-7298-2022; Mailleux, Arnaud/AAH-8799-2021; Garnier, Marc/J-6438-2017	Mailleux, Arnaud A/0000-0003-4191-1778; Duitman, JanWillem/0000-0003-4254-3380; Mailleux, Arnaud/0000-0003-4191-1778; 	Agence Nationale pour la Recherche [ANR-14-CE15-0010-01]; Fondation pour la Recherche Medicale [FRM-AJE201121, FDM41320, FDM20150633109]; Laboratoire d'Excellence Inflamex; Roche; Boehringer Ingelheim; Association CARDIF-L'Assistance Respiratoire; ERS/Marie Sklodowska-Curie RESPIRE2 postdoctoral research fellowship [RESPIR2-2015-9372]; Societe de Reanimation de Langue Francaise; Societe de Pneumologie de Langue Francaise; Societe Francaise d'Anesthesieet Reanimation	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Laboratoire d'Excellence Inflamex; Roche(Roche Holding); Boehringer Ingelheim(Boehringer Ingelheim); Association CARDIF-L'Assistance Respiratoire; ERS/Marie Sklodowska-Curie RESPIRE2 postdoctoral research fellowship; Societe de Reanimation de Langue Francaise; Societe de Pneumologie de Langue Francaise; Societe Francaise d'Anesthesieet Reanimation	The authors greatly acknowledge the scientific input of Keren Borensztajn (INSERM Unite de Mixte de Recherche 933, Paris, France) to this work. This work was supported by the Agence Nationale pour la Recherche (Grant ANR-14-CE15-0010-01) and the Fondation pour la Recherche Medicale (Grant FRM-AJE201121). A.M. was supported by research grants from the Laboratoire d'Excellence Inflamex, and was provided financial support from Roche and Boehringer Ingelheim. P.F. received funding from the Association CARDIF-L'Assistance Respiratoire. J.W.D. is the recipient of an ERS/Marie Sklodowska-Curie RESPIRE2 postdoctoral research fellowship (RESPIR2-2015-9372). A.J. was supported by the Fondation pour la Recherche Medicale (Grant FDM41320) and M.G. by the Fondation pour la Recherche Medicale (Grant FDM20150633109), the Societe de Reanimation de Langue Francaise, the Societe de Pneumologie de Langue Francaise (2014 Research Grant SRLF/SPLF), and the Societe Francaise d'Anesthesieet Reanimation (2016 Research Grant SFAR). The authors declare no conflicts of interest.	Antalis TM, 2011, PROG MOL BIOL TRANSL, V99, P1, DOI 10.1016/S1877-1173(11)99001-2; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Barbier D, 2012, AM J RESP CELL MOL, V47, P149, DOI 10.1165/rcmb.2011-0405OC; Bardou O, 2016, AM J RESP CRIT CARE, V193, P847, DOI 10.1164/rccm.201502-0299OC; Bauman KA, 2010, J CLIN INVEST, V120, P1950, DOI 10.1172/JCI38369; Beaufort N, 2007, AM J PHYSIOL-LUNG C, V292, pL1263, DOI 10.1152/ajplung.00191.2006; Bertram S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035876; Bottcher-Friebertshauser E, 2010, J VIROL, V84, P5605, DOI 10.1128/JVI.00140-10; Borensztajn K, 2010, AM J PATHOL, V177, P2753, DOI 10.2353/ajpath.2010.091107; BOROK Z, 1991, AM REV RESPIR DIS, V144, P1080, DOI 10.1164/ajrccm/144.5.1080; Chambers RC, 2008, BRIT J PHARMACOL, V153, pS367, DOI 10.1038/sj.bjp.0707603; Chaudhary NI, 2006, AM J RESP CRIT CARE, V173, P769, DOI 10.1164/rccm.200505-717OC; Chokki M, 2005, FEBS J, V272, P6387, DOI 10.1111/j.1742-4658.2005.05035.x; Chokki M, 2004, AM J RESP CELL MOL, V30, P470, DOI 10.1165/rcmb.2003-0199OC; Crestani Bruno, 2012, Proc Am Thorac Soc, V9, P158, DOI 10.1513/pats.201202-018AW; DOBBS LG, 1986, AM REV RESPIR DIS, V134, P141; Fabre A, 2008, EUR RESPIR J, V32, P426, DOI 10.1183/09031936.00126907; Fernandez IE, 2012, LANCET, V380, P680, DOI 10.1016/S0140-6736(12)61144-1; Fernandez Isis E, 2012, Proc Am Thorac Soc, V9, P111, DOI 10.1513/pats.201203-023AW; FULMER JD, 1979, J CLIN INVEST, V63, P665, DOI 10.1172/JCI109349; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; Hansen IA, 2004, ENDOCRINOLOGY, V145, P1898, DOI 10.1210/en.2003-0930; Haslam PL, 1999, EUR RESPIR J, V14, P245, DOI 10.1034/j.1399-3003.1999.14b01.x; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; Huang S, 2007, AM J PHYSIOL-LUNG C, V292, pL405, DOI 10.1152/ajplung.00232.2006; Huang SK, 2009, FASEB J, V23, P4317, DOI 10.1096/fj.08-128801; Imokawa S, 1997, AM J RESP CRIT CARE, V156, P631, DOI 10.1164/ajrccm.156.2.9608094; Kato M, 2012, J BIOCHEM, V151, P179, DOI 10.1093/jb/mvr131; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Kolodsick JE, 2003, AM J RESP CELL MOL, V29, P537, DOI 10.1165/rcmb.2002-0243OC; Lin C, 2014, THORAX, V69, P152, DOI 10.1136/thoraxjnl-2013-203877; Madala SK, 2012, AM J RESP CELL MOL, V46, P380, DOI 10.1165/rcmb.2011-0237OC; Marchand-Adam S, 2003, AM J RESP CRIT CARE, V168, P1156, DOI 10.1164/rccm.200212-1514OC; Marchand-Adam S, 2006, AM J RESP CRIT CARE, V174, P58, DOI 10.1164/rccm.200507-1074OC; Matsushima R, 2006, AM J PHYSIOL-LUNG C, V290, pL385, DOI 10.1152/ajplung.00098.2005; McMichael JW, 2005, INFECT IMMUN, V73, P3609, DOI 10.1128/IAI.73.6.3609-3617.2005; Melboucy-Belkhir S, 2014, AM J PHYSIOL-LUNG C, V307, pL838, DOI 10.1152/ajplung.00012.2014; Menou A, 2017, AM J PHYSIOL-LUNG C, V312, P1657, DOI 10.1152/ajplung.00509.2016; Miki Mari, 2003, Journal of Medical Investigation, V50, P95; Nagataki M, 2008, CELL BIOCHEM FUNCT, V26, P279, DOI 10.1002/cbf.1434; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Sakai N, 2013, BBA-MOL BASIS DIS, V1832, P911, DOI 10.1016/j.bbadis.2013.03.001; Sallenave JM, 1998, GENE THER, V5, P352, DOI 10.1038/sj.gt.3300610; Scotton CJ, 2009, J CLIN INVEST, V119, P2550, DOI 10.1172/JCI33288; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Selman M, 2001, RESP RES, V3, DOI 10.1186/rr175; Simon DI, 2000, J BIOL CHEM, V275, P10228, DOI 10.1074/jbc.275.14.10228; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Sokolova E, 2005, AM J PHYSIOL-LUNG C, V288, pL793, DOI 10.1152/ajplung.00343.2004; Sokolova E, 2007, PHARMACOL THERAPEUT, V115, P70, DOI 10.1016/j.pharmthera.2007.04.002; Spagnolo P, 2015, ANN MED, V47, P15, DOI 10.3109/07853890.2014.982165; SPITERI MA, 1992, EUR RESPIR J, V5, P717; Taggart C, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01200-2015; Takahashi M, 2001, HISTOCHEM CELL BIOL, V115, P181; White ES, 2005, AM J RESP CELL MOL, V32, P135, DOI 10.1165/rcmb.2004-0126OC; WILBORN J, 1995, J CLIN INVEST, V95, P1861, DOI 10.1172/JCI117866; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Wygrecka M, 2008, THROMB HAEMOSTASIS, V99, P494, DOI 10.1160/TH07-11-0666; Yamaoka K, 1998, J BIOL CHEM, V273, P11895, DOI 10.1074/jbc.273.19.11895; Yasuoka S, 1997, AM J RESP CELL MOL, V16, P300, DOI 10.1165/ajrcmb.16.3.9070615; Yoshinaga Sumiko, 1998, Journal of Medical Investigation, V45, P77	61	4	5	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1250	1264		10.1096/fj.201700583R	http://dx.doi.org/10.1096/fj.201700583R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29122847				2022-12-28	WOS:000427246000012
J	Kojima, M; Gimenes, JA; Chan, TW; Eliceiri, BP; Baird, A; Costantini, TW; Coimbra, R				Kojima, Mitsuaki; Gimenes-Junior, Joao A.; Chan, Theresa W.; Eliceiri, Brian P.; Baird, Andrew; Costantini, Todd W.; Coimbra, Raul			Exosomes in postshock mesenteric lymph are key mediators of acute lung injury triggering the macrophage activation via Toll-like receptor 4	FASEB JOURNAL			English	Article						extracellular vesicles; microvesicles; hemorrhagic shock; SIRS; trauma	HEMORRHAGIC-SHOCK; TRAUMA/HEMORRHAGIC SHOCK; INFLAMMATORY RESPONSE; ALVEOLAR MACROPHAGES; DUCT LIGATION; GUT INJURY; CELLS; TRAUMA; MECHANISM; ORGAN	Acute lunginjury (ALI) is a common cause of morbidity inpatients after severe injury due to dysregulated inflammation, which is believed to be driven by gut-derived inflammatory mediators carried via mesenteric lymph (ML). We have previously demonstrated that nano-sized extracellular vesicles, called exosomes, secreted into ML after trauma/hemorrhagic shock (T/HS) have the potential to activate immune cells in vitro. Here, we assess the function of ML exosomes in the development of T/HS-induced ALI and the role of TLR4 in the ML exosome-mediated inflammatory response. ML exosomes isolated from rats subjected to T/HS stimulated NF-kappa B activation and caused proinflammatory cytokine production in alveolar macrophages. In vivo experiments revealed that intravenous injection of exosomes harvested after T/HS, but not before shock, caused recruitment of inflammatory cells in the lung, increased vascular permeability, and induced histologic ALI in naive mice. The exosome-depleted supernatant of ML had no effect on in vitro and in vivo inflammatory responses. We also demonstrated that both pharmacologic inhibition and genetic knockout of TLR4 completely abolished ML exosome-induced cytokine production in macrophages. Thus, our findings define the critical role of exosomes secreted into ML as a critical mediator of T/HS-induced ALI through macrophage TLR4 activation.	[Kojima, Mitsuaki; Gimenes-Junior, Joao A.; Chan, Theresa W.; Eliceiri, Brian P.; Baird, Andrew; Costantini, Todd W.; Coimbra, Raul] Univ Calif San Diego Hlth Sci, Dept Surg, Div Trauma Surg Crit Care Burns & Acute Care Surg, San Diego, CA USA	University of California System; University of California San Diego	Coimbra, R (corresponding author), Univ Calif San Diego, Sch Med, 200 W Arbor Dr,8896, San Diego, CA 92103 USA.	rcoimbra@ucsd.edu	Gimenes-Junior, Joao A/F-4439-2014; Kojima, Mitsuaki/AFO-6200-2022; Coimbra, Raul/AAP-3019-2020	Gimenes-Junior, Joao A/0000-0002-2958-1174; Coimbra, Raul/0000-0002-3759-6851; Eliceiri, Brian/0000-0003-1811-1916				Adams CA, 2002, SHOCK, V18, P513, DOI 10.1097/00024382-200212000-00005; Aggarwal NR, 2014, AM J PHYSIOL-LUNG C, V306, pL709, DOI 10.1152/ajplung.00341.2013; Beck-Schimmer B, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-61; Bonjoch L, 2016, J PATHOL, V240, P235, DOI 10.1002/path.4771; Bretz NP, 2013, J BIOL CHEM, V288, P36691, DOI 10.1074/jbc.M113.512806; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Chow A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05750; D'Alessandro A, 2014, SHOCK, V42, P509, DOI 10.1097/SHK.0000000000000259; Danzer KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-42; Dayal SD, 2002, J TRAUMA, V52, P1048, DOI 10.1097/00005373-200206000-00005; Deitch EA, 2006, FRONT BIOSCI-LANDMRK, V11, P520, DOI 10.2741/1816; Deitch EA, 2001, SURGERY, V129, P39, DOI 10.1067/msy.2001.109119; Dewar D, 2009, INJURY, V40, P912, DOI 10.1016/j.injury.2009.05.024; Essandoh K, 2015, BBA-MOL BASIS DIS, V1852, P2362, DOI 10.1016/j.bbadis.2015.08.010; Fanous MYZ, 2007, J PANCREAS, V8, P374; Gambim MH, 2007, CRIT CARE, V11, DOI 10.1186/cc6133; Gonzalez RJ, 2001, SURGERY, V130, P198, DOI 10.1067/msy.2001.115824; Han SH, 2015, J IMMUNOL, V194, P855, DOI 10.4049/jimmunol.1402513; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Imai T, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.26238; Jiang H, 2014, SHOCK, V42, P271, DOI 10.1097/SHK.0000000000000212; Jordan JR, 2008, J APPL PHYSIOL, V104, P1161, DOI 10.1152/japplphysiol.00022.2007; Kao S, 2015, EXP LUNG RES, V41, P163, DOI 10.3109/01902148.2014.983282; Kim YS, 2015, J IMMUNOL, V194, P3361, DOI 10.4049/jimmunol.1402268; Kojima M, 2017, J TRAUMA ACUTE CARE, V82, P42, DOI 10.1097/TA.0000000000001296; Levy G, 2013, SHOCK, V39, P39, DOI 10.1097/SHK.0b013e31827b450d; Lowry DM, 2014, J SURG RES, V192, P12, DOI 10.1016/j.jss.2014.06.012; Mastronardi ML, 2011, CRIT CARE MED, V39, P1739, DOI 10.1097/CCM.0b013e3182190b4b; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; McGhan LJ, 2012, INJURY, V43, P129, DOI 10.1016/j.injury.2011.05.032; Mircescu MM, 2009, J INFECT DIS, V200, P647, DOI 10.1086/600380; Moon HG, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.282; Moore EE, 2010, AM J SURG, V200, P681, DOI 10.1016/j.amjsurg.2010.05.010; Morishita K, 2015, AM J PHYSIOL-GASTR L, V309, pG202, DOI 10.1152/ajpgi.00097.2015; Morishita K, 2015, J TRAUMA ACUTE CARE, V78, P52, DOI 10.1097/TA.0000000000000489; Morishita K, 2013, J TRAUMA ACUTE CARE, V75, P767, DOI 10.1097/TA.0b013e3182a924f2; Mulcahy LA, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24641; Nolan JP, 2013, CYTOM PART A, V83A, P301, DOI 10.1002/cyto.a.22255; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Reino DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014829; Reino DC, 2012, SHOCK, V38, P107, DOI 10.1097/SHK.0b013e318257123a; Rocha DM, 2016, ATHEROSCLEROSIS, V244, P211, DOI 10.1016/j.atherosclerosis.2015.11.015; Sakamoto W, 2017, MOL MED REP, V15, P1989, DOI 10.3892/mmr.2017.6259; SKLAR MD, 1985, J CELL PHYSIOL, V125, P403, DOI 10.1002/jcp.1041250307; Sodar BW, 2016, SCI REP-UK, V6, DOI 10.1038/srep24316; Subra C, 2010, J LIPID RES, V51, P2105, DOI 10.1194/jlr.M003657; Such J, 2002, HEPATOLOGY, V36, P135, DOI 10.1053/jhep.2002.33715; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Upperman JS, 1998, SHOCK, V10, P407, DOI 10.1097/00024382-199812000-00005; van der Vlist EJ, 2012, NAT PROTOC, V7, P1311, DOI 10.1038/nprot.2012.065; Welton JL, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27269; Wong SW, 2009, J BIOL CHEM, V284, P27384, DOI 10.1074/jbc.M109.044065; Xiang XY, 2009, INT J CANCER, V124, P2621, DOI 10.1002/ijc.24249; Yi J, 2015, SHOCK, V44, P336, DOI 10.1097/SHK.0000000000000431; Zhou WY, 2014, CANCER CELL, V25, P501, DOI 10.1016/j.ccr.2014.03.007; Zughaier S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009165; Zughaier SM, 2011, J LEUKOCYTE BIOL, V89, P469, DOI 10.1189/jlb.0610369	57	61	74	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					97	110		10.1096/fj.201700488R	http://dx.doi.org/10.1096/fj.201700488R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28855278				2022-12-28	WOS:000419172700011
J	Marqueti, RC; Durigan, JLQ; Oliveira, AJS; Mekaro, MS; Guzzoni, V; Aro, AA; Pimentel, ER; Selistre-de-Araujo, HS				Marqueti, Rita C.; Durigan, Joao L. Q.; Oliveira, Anderson Jose S.; Mekaro, Marcelo Shinyu; Guzzoni, Vinicius; Aro, Andrea A.; Pimentel, Edson Rosa; Selistre-de-Araujo, Heloisa S.			Effects of aging and resistance training in rat tendon remodeling	FASEB JOURNAL			English	Article						calcaneal tendon; proteoglycans; turnover; glycosaminoglycans; strength training	ANABOLIC-ANDROGENIC STEROIDS; LEUCINE-RICH PROTEOGLYCANS; GROWTH-FACTOR-I; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; STRUCTURAL-PROPERTIES; COLLAGEN-SYNTHESIS; CONNECTIVE-TISSUE; ACHILLES-TENDON; SKELETAL-MUSCLE	In elderly persons, weak tendons contribute to functional limitations, injuries, and disability, but resistance training can attenuate this age-related decline. We evaluated the effects of resistance training on the extracellular matrix (ECM) of the calcaneal tendon (CT) in young and old rats and its effect on tendon remodeling. Wistar rats aged 3 mo (young, n = 30) and 20 mo (old, n = 30) were divided into 4 groups: young sedentary, young trained, old sedentary (OS), and old trained (OT). The training sessions were conducted over a 12-wk period. Aging in sedentary rats showed down-regulation in key genes that regulated ECMremodeling. Moreover, the OS group showed a calcification focus in the distal region of the CT, with reduced blood vessel volume density. In contrast, resistance training was effective in up-regulating connective tissue growth factor, VEGF, and decorin gene expression in old rats. Resistance training also increased proteoglycan content in young and old rats in special small leucine-rich proteoglycans and blood vessels and prevented calcification in OT rats. These findings confirm that resistance training is a potentialmechanismin the prevention of aging-related loss in ECMand that it attenuates the detrimental effects of aging in tendons, such as ruptures and tendinopathies.	[Marqueti, Rita C.; Durigan, Joao L. Q.; Oliveira, Anderson Jose S.] Univ Brasilia UnB, Campus Univ,Ctr Metropolitano 1,Conjunto A, BR-72220900 Brasilia, DF, Brazil; [Mekaro, Marcelo Shinyu; Guzzoni, Vinicius; Selistre-de-Araujo, Heloisa S.] Fed Univ Sao Carlos UFSCar, Sao Carlos, SP, Brazil; [Aro, Andrea A.; Pimentel, Edson Rosa] Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Struct & Funct Biol, Campinas, SP, Brazil; [Pimentel, Edson Rosa] Heminio Ometto Univ Ctr UNIARARAS, Sao Paulo, Brazil	Universidade de Brasilia; Universidade Federal de Sao Carlos; Universidade de Sao Paulo; Universidade Estadual de Campinas	Marqueti, RC (corresponding author), Univ Brasilia UnB, Campus Univ,Ctr Metropolitano 1,Conjunto A, BR-72220900 Brasilia, DF, Brazil.	marqueti@gmail.com	Marqueti, Rita de Cassia/D-1622-2012; Durigan, João Luiz Quagliotti/D-1110-2012; Mekaro, Marcelo S/M-8639-2017; de Aro, Andrea Aparecida/E-3753-2012; Guzzoni, Vinicius/E-6860-2013	Marqueti, Rita de Cassia/0000-0001-9126-3882; Durigan, João Luiz Quagliotti/0000-0002-7511-5289; Mekaro, Marcelo S/0000-0002-1267-6759; de Aro, Andrea Aparecida/0000-0003-2895-0000; Guzzoni, Vinicius/0000-0003-1024-5952	Sao Paulo Research Foundation (FAPESP) [2010/19390-5, 2011/11229-3, 2013/00798-2]; Federal District Research Support Foundation (FAPDF) [193.000.653/2015]; Brazilian National Council for Scientific and Technological Development (CNPq) [445069/2014-7]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Federal District Research Support Foundation (FAPDF); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors thank Prof. Dr. Larry W. Fischer (U.S. National Institutes of Health and Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan) for providing the antibodies and Jose Campanholi Neto and Patty Karina dos Santos (both from Federal University of Sao Carlos) for technical assistance. This work was supported by Sao Paulo Research Foundation (FAPESP) Grants 2010/19390-5, 2011/11229-3, and 2013/00798-2; by Federal District Research Support Foundation (FAPDF) Grant 193.000.653/2015; and by the Brazilian National Council for Scientific and Technological Development (CNPq) Grant 445069/2014-7. The authors declare no conflicts of interest.	Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Aro AA, 2013, LIFE SCI, V92, P799, DOI 10.1016/j.lfs.2013.02.011; Banos Charles C., 2008, Birth Defects Research, V84, P228, DOI 10.1002/bdrc.20130; Benjamin M, 2008, J ANAT, V212, P211, DOI 10.1111/j.1469-7580.2008.00864.x; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Borst SE, 2001, MED SCI SPORT EXER, V33, P648; Chen SJ, 2013, FEBS J, V280, P2120, DOI 10.1111/febs.12136; CLEUTJENS JPM, 1995, J MOL CELL CARDIOL, V27, P1281, DOI 10.1016/S0022-2828(05)82390-9; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Docheva D, 2015, ADV DRUG DELIVER REV, V84, P222, DOI 10.1016/j.addr.2014.11.015; Dourte LM, 2013, J ORTHOP RES, V31, P1430, DOI 10.1002/jor.22372; Dunkman AA, 2014, MATRIX BIOL, V35, P232, DOI 10.1016/j.matbio.2013.10.008; Dyment Nathaniel A, 2015, Curr Mol Biol Rep, V1, P124; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Freedman BR, 2015, BBA-MOL CELL RES, V1853, P3153, DOI 10.1016/j.bbamcr.2015.04.015; Goh KL, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2898732; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; Gordon JA, 2015, J BIOMECH, V48, P2110, DOI 10.1016/j.jbiomech.2015.02.058; Hadler-Olsen E, 2011, FEBS J, V278, P28, DOI 10.1111/j.1742-4658.2010.07920.x; Heinemeier KM, 2007, J PHYSIOL-LONDON, V582, P1303, DOI 10.1113/jphysiol.2007.127639; Heinemeier KM, 2012, J APPL PHYSIOL, V113, P827, DOI 10.1152/japplphysiol.00401.2012; Herchenhan A, 2015, GROWTH HORM IGF RES, V25, P13, DOI 10.1016/j.ghir.2014.09.001; Hollmann W, 2007, EUR J CARDIOV PREV R, V14, P730, DOI 10.1097/HJR.0b013e32828622f9; Hornberger TA, 2004, CAN J APPL PHYSIOL, V29, P16, DOI 10.1139/h04-002; Jarvinen TAHJ, 2005, AM J SPORT MED, V33, P745, DOI 10.1177/0363546505274714; Kannus P, 2000, SCAND J MED SCI SPOR, V10, P312, DOI 10.1034/j.1600-0838.2000.010006312.x; Kilts T, 2009, SCAND J MED SCI SPOR, V19, P536, DOI 10.1111/j.1600-0838.2009.00909.x; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Kjaer M., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P41; Kjaer M, 2009, SCAND J MED SCI SPOR, V19, P500, DOI 10.1111/j.1600-0838.2009.00986.x; Koskinen SOA, 2004, J APPL PHYSIOL, V96, P861, DOI 10.1152/japplphysiol.00489.2003; Kostrominova TY, 2013, AGE, V35, P2203, DOI 10.1007/s11357-013-9514-2; Magnusson SP, 2003, SCAND J MED SCI SPOR, V13, P211, DOI 10.1034/j.1600-0838.2003.00308.x; Marqueti RC, 2014, SCAND J MED SCI SPOR, V24, pe39, DOI 10.1111/sms.12135; Marqueti RC, 2008, EUR J APPL PHYSIOL, V104, P1087, DOI 10.1007/s00421-008-0867-7; Marqueti RC, 2006, AM J SPORT MED, V34, P1274, DOI 10.1177/0363546506286867; Marqueti RD, 2017, J BIOMECH, V53, P29, DOI 10.1016/j.jbiomech.2016.12.029; Marqueti RD, 2012, EUR J APPL PHYSIOL, V112, P1505, DOI 10.1007/s00421-011-2114-x; Millar NL, 2010, AM J SPORT MED, V38, P2085, DOI 10.1177/0363546510372613; Nourissat G, 2015, NAT REV RHEUMATOL, V11, P223, DOI 10.1038/nrrheum.2015.26; Oliva F, 2012, MED SPORT SCI, V57, P53, DOI 10.1159/000328878; Rees JD, 2006, RHEUMATOLOGY, V45, P508, DOI 10.1093/rheumatology/kel046; Samiric T, 2004, MATRIX BIOL, V23, P127, DOI 10.1016/j.matbio.2004.03.004; Sarasa-Renedo A, 2005, SCAND J MED SCI SPOR, V15, P223, DOI 10.1111/j.1600-0838.2005.00461.x; Scott PG, 2006, J BIOL CHEM, V281, P13324, DOI 10.1074/jbc.M513470200; Screen HRC, 2015, J ORTHOP RES, V33, P793, DOI 10.1002/jor.22818; Semba RD, 2010, J GERONTOL A-BIOL, V65, P963, DOI 10.1093/gerona/glq074; Smith RKW, 2002, COMP BIOCHEM PHYS A, V133, P1039, DOI 10.1016/S1095-6433(02)00148-4; Svensson RB, 2016, J APPL PHYSIOL, V121, DOI 10.1152/japplphysiol.00328.2016; Vidal BD, 2010, ACTA HISTOCHEM, V112, P53, DOI 10.1016/j.acthis.2008.07.005; Weibel E R, 1969, Int Rev Cytol, V26, P235, DOI 10.1016/S0074-7696(08)61637-X; Wood LK, 2016, J ORTHOP RES, V34, P346, DOI 10.1002/jor.22824; Yu TY, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-2; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776; Zhang JY, 2016, ONCOTARGET, V7, P8498, DOI 10.18632/oncotarget.7381; Zhang JY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130454	56	31	31	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					353	368		10.1096/fj.201700543R	http://dx.doi.org/10.1096/fj.201700543R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28899880				2022-12-28	WOS:000419172700032
J	Reeves, PM; Sluder, AE; Paul, SR; Scholzen, A; Kashiwagi, S; Poznansky, MC				Reeves, Patrick M.; Sluder, Ann E.; Paul, Susan Raju; Scholzen, Anja; Kashiwagi, Satoshi; Poznansky, Mark C.			Application and utility of mass cytometry in vaccine development	FASEB JOURNAL			English	Review						CyTOF; flow cytometry; biomarker discovery	IFN-GAMMA PRODUCTION; CD8 T-CELLS; TRANSCRIPTION FACTOR; SYSTEMS BIOLOGY; IMMUNE-RESPONSE; MONKEYPOX VIRUS; B-CELLS; BET; IDENTIFICATION; VISUALIZATION	Mass cytometry enables highly multiplexed profiling of cellular immune responses in limited-volume samples, advancing prospects of a new era of systems immunology. The capabilities of mass cytometry offer expanded potential for deciphering immune responses to infectious diseases and to vaccines. Several studies have used mass cytometry to profile protective immune responses, both postinfection and postvaccination, although no vaccine-development program has yet systematically employed the technology from the outset to inform both candidate design and clinical evaluation. In this article, we review published mass cytometry studies relevant to vaccine development, briefly compare immune profiling by mass cytometry to other systems-level technologies, and discuss some general considerations for deploying mass cytometry in the context of vaccine development.	[Reeves, Patrick M.; Sluder, Ann E.; Paul, Susan Raju; Kashiwagi, Satoshi; Poznansky, Mark C.] Massachusetts Gen Hosp East, Vaccine & Immunotherapy Ctr, Bldg 149,13th St, Boston, MA 02129 USA; [Scholzen, Anja] InnatOss, Oss, Netherlands	Harvard University; Massachusetts General Hospital	Poznansky, MC (corresponding author), Massachusetts Gen Hosp East, Vaccine & Immunotherapy Ctr, Bldg 149,13th St, Boston, MA 02129 USA.	mpoznansky@partners.org	Sluder, Ann/AAS-3102-2020; Reeves, Patrick/I-1066-2018; Scholzen, Anja/D-1046-2013; Kashiwagi, Satoshi/T-2420-2019; Poznansky, Mark C/M-4996-2015	Reeves, Patrick/0000-0001-8202-0723; Scholzen, Anja/0000-0001-6481-6090; Poznansky, Mark C/0000-0003-1344-7103	U.S. Defense Threat Reduction Agency [HDTRA1-15-C-0020]	U.S. Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	Discussions with Nicole Paul, Dr. Katja Kleinsteuber (both from Dana-Farber Cancer Institute, Boston, MA, USA), and Dr. Narges Rashidi (OLink Proteomics, Uppsala, Sweden) have been critical in the authors' understanding of the strengths and limitations of mass cytometry. Timothy Brauns [Vaccine and Immunotherapy Center (VIC), Massachusetts General Hospital] and Dr. Pierre Leblanc (McLean Hospital, Belmont, MA, USA) were particularly instrumental in fostering the early adoption of mass cytometry at the Massachusetts General Hospital VIC. This work was supported by the U.S. Defense Threat Reduction Agency (HDTRA1-15-C-0020). The authors' perspective on the use of mass cytometry in vaccine development has been greatly informed by their experience during the development of a novel T-cell-based vaccine for Q fever under this contract. The authors also acknowledge the many helpful discussions with other members of the VaxCelerate consortium who are helping with the development of that vaccine. The authors declare no conflicts of interest.	Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Angelo M, 2014, NAT MED, V20, P436, DOI 10.1038/nm.3488; Atkuri KR, 2015, DRUG METAB DISPOS, V43, P227, DOI 10.1124/dmd.114.060798; Avraham R, 2016, NAT PROTOC, V11, P1477, DOI 10.1038/nprot.2016.090; Behbehani GK, 2015, CANCER DISCOV, V5, P988, DOI 10.1158/2159-8290.CD-15-0298; Bendall SC, 2014, CELL, V157, P714, DOI 10.1016/j.cell.2014.04.005; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bodenmiller B, 2012, NAT BIOTECHNOL, V30, P858, DOI 10.1038/nbt.2317; Bolinger B, 2015, CELL REP, V13, P1578, DOI 10.1016/j.celrep.2015.10.034; Brady RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124877; Brown SD, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0248-x; Bruggner RV, 2014, P NATL ACAD SCI USA, V111, pE2770, DOI 10.1073/pnas.1408792111; Buchman GW, 2010, VACCINE, V28, P6627, DOI 10.1016/j.vaccine.2010.07.030; Carlson CM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001136; Chattopadhyay PK, 2015, AM J TRANSPLANT, V15, P1155, DOI 10.1111/ajt.13193; Chevrier S, 2017, CELL, V169, P736, DOI 10.1016/j.cell.2017.04.016; Delmas A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163305; Fogg CN, 2007, VACCINE, V25, P2787, DOI 10.1016/j.vaccine.2006.12.037; Frei AP, 2016, NAT METHODS, V13, P269, DOI [10.1038/NMETH.3742, 10.1038/nmeth.3742]; Furman D, 2015, VACCINE, V33, P5271, DOI 10.1016/j.vaccine.2015.06.117; Gautreau G, 2017, BIOINFORMATICS, V33, P779, DOI 10.1093/bioinformatics/btw708; Giesen C, 2014, NAT METHODS, V11, P417, DOI [10.1038/NMETH.2869, 10.1038/nmeth.2869]; Haag AM, 2001, J MASS SPECTROM, V36, P15, DOI 10.1002/jms.76; Hatch GJ, 2013, J VIROL, V87, P7805, DOI 10.1128/JVI.03481-12; Heraud JM, 2006, J IMMUNOL, V177, P2552, DOI 10.4049/jimmunol.177.4.2552; Howard LM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0167488; Japp AS, 2017, CYTOM PART A, V91A, P85, DOI 10.1002/cyto.a.22906; Kashiwagi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082899; Kleinsteuber K, 2016, CYTOM PART A, V89A, P903, DOI 10.1002/cyto.a.22935; Leelatian N, 2017, CYTOM PART B-CLIN CY, V92, P68, DOI 10.1002/cyto.b.21481; Leon AJ, 2013, J VIROL, V87, P1957, DOI 10.1128/JVI.02476-12; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Li C, 2012, FISH SHELLFISH IMMUN, V32, P816, DOI 10.1016/j.fsi.2012.02.004; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Linderman MD, 2012, BIOINFORMATICS, V28, P2400, DOI 10.1093/bioinformatics/bts425; Lonnberg T, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal2192; Lutz C, 2015, CLIN EXP IMMUNOL, V181, P343, DOI 10.1111/cei.12635; Mayer KD, 2008, J IMMUNOL, V180, P693, DOI 10.4049/jimmunol.180.2.693; Mei HE, 2015, J IMMUNOL, V194, P2022, DOI 10.4049/jimmunol.1402661; Miner JJ, 2015, ARTHRITIS RHEUMATOL, V67, P1214, DOI 10.1002/art.39027; Mohr E, 2010, P NATL ACAD SCI USA, V107, P17292, DOI 10.1073/pnas.1004879107; Montgomery RR, 2016, CYTOM PART A, V89A, P886, DOI 10.1002/cyto.a.22992; Nair N, 2016, MUCOSAL IMMUNOL, V9, P68, DOI 10.1038/mi.2015.36; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Newell EW, 2014, NAT BIOTECHNOL, V32, P149, DOI 10.1038/nbt.2783; Newell EW, 2013, NAT BIOTECHNOL, V31, P623, DOI 10.1038/nbt.2593; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; O'Gorman WE, 2014, VACCINE, V32, P5989, DOI 10.1016/j.vaccine.2014.07.115; Ornatsky OI, 2008, ANAL CHEM, V80, P2539, DOI 10.1021/ac702128m; Pejoski D, 2016, J IMMUNOL, V196, P4814, DOI 10.4049/jimmunol.1502005; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Rubakhin SS, 2011, NAT METHODS, V8, pS20, DOI [10.1038/NMETH.1549, 10.1038/nmeth.1549]; Rubtsova K, 2013, P NATL ACAD SCI USA, V110, pE3216, DOI 10.1073/pnas.1312348110; Saeys Y, 2016, NAT REV IMMUNOL, V16, P449, DOI 10.1038/nri.2016.56; Sakhatskyy P, 2006, VIROLOGY, V355, P164, DOI 10.1016/j.virol.2006.07.017; Samusik N, 2016, NAT METHODS, V13, P493, DOI [10.1038/NMETH.3863, 10.1038/nmeth.3863]; Sen N, 2014, CELL REP, V8, P633, DOI 10.1016/j.celrep.2014.06.024; Setty M, 2016, NAT BIOTECHNOL, V34, P637, DOI 10.1038/nbt.3569; Shahi P, 2017, SCI REP-UK, V7, DOI 10.1038/srep44447; Spitzer MH, 2016, CELL, V165, P780, DOI 10.1016/j.cell.2016.04.019; Spitzer MH, 2015, SCIENCE, V349, DOI 10.1126/science.1259425; Sripadi P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012590; Stoeckius M, 2017, NAT METHODS, V14, P865, DOI [10.1038/nmeth.4380, 10.1038/NMETH.4380]; Strauss-Albee DM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5722; Swadling L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009185; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Van Gassen S, 2015, CYTOM PART A, V87A, P636, DOI 10.1002/cyto.a.22625; Wanke-Jellinek L, 2016, J LEUKOCYTE BIOL, V99, P483, DOI 10.1189/jlb.4A0315-115RR; Weber LM, 2016, CYTOM PART A, V89A, P1084, DOI 10.1002/cyto.a.23030; Xu GJ, 2015, SCIENCE, V348, DOI 10.1126/science.aaa0698; Yao Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172625	73	16	16	3	30	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					5	15		10.1096/fj.201700325R	http://dx.doi.org/10.1096/fj.201700325R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	29092906	Bronze			2022-12-28	WOS:000419172700002
J	Rumora, AE; Lentz, SI; Hinder, LM; Jackson, SW; Valesano, A; Levinson, GE; Feldman, EL				Rumora, Amy E.; Lentz, Stephen I.; Hinder, Lucy M.; Jackson, Samuel W.; Valesano, Andrew; Levinson, Gideon E.; Feldman, Eva L.			Dyslipidemia impairs mitochondrial trafficking and function in sensory neurons	FASEB JOURNAL			English	Article						diabetic neuropathy; DRG; hyperglycemia; palmitate; mitochondrial transport	INDUCED OXIDATIVE STRESS; AXONAL-TRANSPORT; FATTY-ACID; DAMAGED MITOCHONDRIA; ANIMAL-MODELS; SCHWANN-CELLS; CALCIUM; DYSFUNCTION; NEUROPATHY; PROTEINS	Mitochondrial trafficking plays a central role in dorsal root ganglion (DRG) neuronal cell survival and neurotransmission by transporting mitochondria from the neuronal cell body throughout the bundles of DRG axons. In type 2 diabetes (T2DM), dyslipidemia and hyperglycemia damage DRG neurons and induce mitochondrial dysfunction; however, the impact of free fatty acids and glucose on mitochondrial trafficking in DRG neurons remains unknown. To evaluate the impact of free fatty acids compared to hyperglycemia on mitochondrial transport, primary adult mouse DRG neuron cultures were treated with physiologic concentrations of palmitate and glucose and assessed for alterations in mitochondrial trafficking, mitochondrial membrane potential, and mitochondrial bioenergetics. Palmitate treatment significantly reduced the number of motile mitochondria in DRG axons, but physiologic concentrations of glucose did not impair mitochondrial trafficking dynamics. Palmitate-treated DRG neurons also exhibited a reduction in mitochondrial velocity, and impaired mitochondrial trafficking correlated with mitochondrial depolarization in palmitate-treated DRG neurons. Finally, we found differential bioenergetic effects of palmitate and glucose on resting and energetically challenged mitochondria in DRG neurons. Together, these results suggest that palmitate induces DRG neuron mitochondrial depolarization, inhibiting axonal mitochondrial trafficking and altering mitochondrial bioenergetic capacity.	[Rumora, Amy E.; Hinder, Lucy M.; Jackson, Samuel W.; Valesano, Andrew; Levinson, Gideon E.; Feldman, Eva L.] Univ Michigan, Dept Neurol, 5017 AAT BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA; [Lentz, Stephen I.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Feldman, EL (corresponding author), Univ Michigan, Dept Neurol, 5017 AAT BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	efeldman@umich.edu		Feldman, Eva/0000-0002-9162-2694; Valesano, Andrew/0000-0002-3649-8352; Lentz, Stephen/0000-0003-1686-7998; Hinder, Lucy/0000-0002-5206-8010	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R24 DK082841, R01 DK107956, T32 1T32DK101357-01]; Novo Nordisk Foundation [NNF14SA0006]; Juvenile Diabetes Research Foundation's Angelika Bierhaus Postdoctoral Fellowship in Diabetic Complications; American Diabetes Association, Program for Neurology Research and Discovery; A. Alfred Taubman Medical Research Institute; NIH, NIDDK [P60DK020572]; University of Michigan Core Services - NIH NIDDK [DK089503]; Novo Nordisk Fonden [NNF14OC0011633] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK082841, P30DK089503, R01DK107956, P30DK020572, P60DK020572, T32DK101357] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Juvenile Diabetes Research Foundation's Angelika Bierhaus Postdoctoral Fellowship in Diabetic Complications; American Diabetes Association, Program for Neurology Research and Discovery; A. Alfred Taubman Medical Research Institute; NIH, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Michigan Core Services - NIH NIDDK; Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Stacey Sakowski Jacoby for expert editorial advice; Carey Backus for lending expertise in mitoDNA quantitative PCR analyses; and John M. Hayes, Colin M. Mervak, and Nandini S. Abburi (all from the University of Michigan) for contributions to pilot trafficking and mitochondrial depolarization experiments. Funding was provided by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grants R24 DK082841 and R01 DK107956 (to E.L.F.) and T32 1T32DK101357-01 (to A.E.R.); Novo Nordisk Foundation Grant NNF14SA0006 (to E.L.F.); Juvenile Diabetes Research Foundation's Angelika Bierhaus Postdoctoral Fellowship in Diabetic Complications (to L.M.H.); American Diabetes Association, Program for Neurology Research and Discovery; and the A. Alfred Taubman Medical Research Institute. Confocal microscopy and image analysis were performed with equipment at the Michigan Diabetes Research Center's Microscopy and Image Analysis Core, supported by NIH, NIDDK Grant P60DK020572; and University of Michigan Core Services, supported by NIH NIDDK Grant DK089503 (Seahorse XF Analyzer). A.E.R. and S.I.L. share senior authorship. The authors declare no conflicts of interest.	Akude E, 2011, DIABETES, V60, P288, DOI 10.2337/db10-0818; Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4; Ashrafi G, 2014, J CELL BIOL, V206, P655, DOI 10.1083/jcb.201401070; Belosludtsev K N, 2012, Patol Fiziol Eksp Ter, P20; Boulton AJM, 2005, DIABETES CARE, V28, P956, DOI 10.2337/diacare.28.4.956; Breton MC, 2013, DIABETES CARE, V36, P740, DOI 10.2337/dc12-0354; Cai Q, 2012, CURR BIOL, V22, P545, DOI 10.1016/j.cub.2012.02.005; Cai Q, 2011, NEUROSCI RES, V70, P9, DOI 10.1016/j.neures.2011.02.005; Cai Q, 2009, NEURON, V61, P493, DOI 10.1016/j.neuron.2009.02.003; Callaghan BC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007543.pub2; Callaghan BC, 2012, CURR OPIN NEUROL, V25, P536, DOI 10.1097/WCO.0b013e328357a797; Callaghan BC, 2012, LANCET NEUROL, V11, P521, DOI 10.1016/S1474-4422(12)70065-0; Centers for Disease Control, 2020, NATL DIABETES STAT R; Chang DTW, 2006, PROG NEUROBIOL, V80, P241, DOI 10.1016/j.pneurobio.2006.09.003; De Vos KJ, 2003, MOL BIOL CELL, V14, P3636, DOI 10.1091/mbc.E02-10-0638; De Vos KJ, 2007, HUM MOL GENET, V16, P2720, DOI 10.1093/hmg/ddm226; De Vos KJ, 2007, METHOD CELL BIOL, V80, P627, DOI 10.1016/S0091-679X(06)80030-0; Edwards JL, 2008, PHARMACOL THERAPEUT, V120, P1, DOI 10.1016/j.pharmthera.2008.05.005; Eguchi K, 2012, CELL METAB, V15, P518, DOI 10.1016/j.cmet.2012.01.023; Fransson A, 2006, BIOCHEM BIOPH RES CO, V344, P500, DOI 10.1016/j.bbrc.2006.03.163; Fu MM, 2014, DEV CELL, V29, P577, DOI 10.1016/j.devcel.2014.04.015; Gao D, 2009, BRIT J NUTR, V102, P1557, DOI 10.1017/S0007114509990948; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Gumy LF, 2008, MOL CELL NEUROSCI, V37, P298, DOI 10.1016/j.mcn.2007.10.004; Hinder LM, 2014, ANTIOXID REDOX SIGN, V21, P588, DOI 10.1089/ars.2013.5248; Hinder LM, 2013, J ENDOCRINOL, V216, P1, DOI 10.1530/JOE-12-0356; Ho PWL, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-3; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; HUANG JMC, 1992, P NATL ACAD SCI USA, V89, P6452, DOI 10.1073/pnas.89.14.6452; International Diabetes Federation (IDF), 2015, IDF DIAB ATL; Iyer SPN, 2003, J BIOL CHEM, V278, P5399, DOI 10.1074/jbc.M209384200; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Karki P, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0003-8; Koshkin V, 2008, J BIOL CHEM, V283, P7936, DOI 10.1074/jbc.M705652200; Lee JM, 2006, DIABETES CARE, V29, P1192; Leinninger GM, 2006, NEUROBIOL DIS, V23, P11, DOI 10.1016/j.nbd.2006.01.017; Lovas JR, 2013, BBA-MOL CELL RES, V1833, P184, DOI 10.1016/j.bbamcr.2012.04.007; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; Magrane J, 2014, HUM MOL GENET, V23, P1413, DOI 10.1093/hmg/ddt528; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; Merrill GF, 1998, J APPL PHYSIOL, V85, P1909, DOI 10.1152/jappl.1998.85.5.1909; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Nguyen LH, 2014, CANCER CELL, V26, P248, DOI 10.1016/j.ccr.2014.06.018; Park SW, 2007, J PHARMACOL EXP THER, V320, P1002, DOI 10.1124/jpet.106.113472; Peeraer Eve, 2011, J Pain Res, V4, P55, DOI 10.2147/JPR.S15452; Pekkurnaz G, 2014, CELL, V158, P54, DOI 10.1016/j.cell.2014.06.007; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Remizov O, 2003, MOL CELL ENDOCRINOL, V212, P1, DOI 10.1016/j.mce.2003.09.026; Rintoul GL, 2010, BBA-MOL BASIS DIS, V1802, P143, DOI 10.1016/j.bbadis.2009.09.005; Ruddock MW, 2008, J BIOCHEM, V144, P599, DOI 10.1093/jb/mvn105; Russell JW, 2001, NEUROLOGY, V56, pA394; Russell JW, 2002, FASEB J, V16, P1738, DOI 10.1096/fj.01-1027com; Saotome M, 2008, P NATL ACAD SCI USA, V105, P20728, DOI 10.1073/pnas.0808953105; Sas KM, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86976; Saxton WM, 2012, J CELL SCI, V125, P2095, DOI 10.1242/jcs.053850; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Schnell S, 2007, MOL CELL ENDOCRINOL, V263, P173, DOI 10.1016/j.mce.2006.09.013; Schwarz TL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011304; Sharma K, 2015, DIABETES, V64, P663, DOI 10.2337/db14-0874; Sheng ZH, 2014, J CELL BIOL, V204, P1087, DOI 10.1083/jcb.201312123; STEWART MA, 1966, BIOCHEM BIOPH RES CO, V22, P488, DOI 10.1016/0006-291X(66)90300-7; STUMVOLL M, 1995, NEW ENGL J MED, V333, P550, DOI 10.1056/NEJM199508313330903; Takihara Y, 2015, P NATL ACAD SCI USA, V112, P10515, DOI 10.1073/pnas.1509879112; Tao K, 2014, DEV NEUROBIOL, V74, P557, DOI 10.1002/dneu.22149; Tian YR, 2008, AM J PHYSIOL-ENDOC M, V294, pE1178, DOI 10.1152/ajpendo.90237.2008; van Spronsen M, 2013, NEURON, V77, P485, DOI 10.1016/j.neuron.2012.11.027; Vincent AM, 2005, FASEB J, V19, P638, DOI 10.1096/fj.04-2513fje; Vincent AM, 2004, ENDOCR REV, V25, P612, DOI 10.1210/er.2003-0019; Vincent AM, 2004, DIABETES, V53, P726, DOI 10.2337/diabetes.53.3.726; Vincent AM, 2007, EXP NEUROL, V208, P216, DOI 10.1016/j.expneurol.2007.07.017; Vincent AM, 2010, ACTA NEUROPATHOL, V120, P477, DOI 10.1007/s00401-010-0697-7; Vincent AM, 2009, J PERIPHER NERV SYST, V14, P257, DOI 10.1111/j.1529-8027.2009.00237.x; Vincent AM, 2009, DIABETES, V58, P2376, DOI 10.2337/db09-0047; Vincent AM, 2009, ANTIOXID REDOX SIGN, V11, P425, DOI 10.1089/ars.2008.2235; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wang XN, 2009, METHOD ENZYMOL, V457, P319, DOI 10.1016/S0076-6879(09)05018-6; Wang ZX, 2015, MOL NEUROBIOL, V51, P1309, DOI 10.1007/s12035-014-8810-x; Webster WA, 2013, CAN J PHYSIOL PHARM, V91, P375, DOI 10.1139/cjpp-2012-0138; Wiggin TD, 2009, DIABETES, V58, P1634, DOI 10.2337/db08-1771; Xu S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.331; Yamamoto H, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1735841; YOUNG MJ, 1993, DIABETOLOGIA, V36, P150, DOI 10.1007/BF00400697; Zherebitskaya E, 2009, DIABETES, V58, P1356, DOI 10.2337/db09-0034	84	43	43	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					195	207		10.1096/fj.201700206R	http://dx.doi.org/10.1096/fj.201700206R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28904018	Green Published, Green Submitted			2022-12-28	WOS:000419172700019
J	Gao, XP; Zhao, L; Zhuang, JG; Zang, N; Xu, FD				Gao, Xiuping; Zhao, Lei; Zhuang, Jianguo; Zang, Na; Xu, Fadi			Prenatal nicotinic exposure prolongs superior laryngeal C-fiber-mediated apnea and bradycardia through enhancing neuronal TRPV1 expression and excitation (vol 31, pg 4325, 2017)	FASEB JOURNAL			English	Correction									[Gao, Xiuping; Zhao, Lei; Zhuang, Jianguo; Zang, Na; Xu, Fadi] Lovelace Resp Res Inst, 2425 Ridgecrest Dri SE, Albuquerque, NM 87108 USA	Lovelace Respiratory Research Institute	Xu, FD (corresponding author), Lovelace Resp Res Inst, 2425 Ridgecrest Dri SE, Albuquerque, NM 87108 USA.	fxu@lrri.org						Gao XP, 2017, FASEB J, V31, P4325, DOI 10.1096/fj.201700163R	1	0	0	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5625	5625		10.1096/fj.201700163RERR	http://dx.doi.org/10.1096/fj.201700163RERR			1	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	29191966	Green Published			2022-12-28	WOS:000416588300041
J	Wijesekara, N; Ahrens, R; Sabale, M; Wu, L; Ha, K; Verdile, G; Fraser, PE				Wijesekara, Nadeeja; Ahrens, Rosemary; Sabale, Miheer; Wu, Ling; Ha, Kathy; Verdile, Giuseppe; Fraser, Paul E.			Amyloid-beta and islet amyloid pathologies link Alzheimer's disease and type 2 diabetes in a transgenic model	FASEB JOURNAL			English	Article						insulin resistance; beta cells; tau; neurodegeneration; hyperglycemia	INSULIN-RESISTANCE; MOUSE MODEL; PLASMA; DYSFUNCTION; IMPAIRMENT; ONSET; INFLAMMATION; MECHANISMS; HYPOTHESIS; DEPOSITION	Alzheimer's disease (AD) and type 2 diabetes (T2D) present a significant risk to each other. AD and T2D are characterized by deposition of cerebral amyloid-beta (A beta) and pancreatic human islet amyloid polypeptide (hIAPP), respectively. We investigated the role of amyloidogenic proteins in the interplay between these diseases. A novel double transgenic mouse model combining T2D and AD was generated and characterized. AD-related amyloid transgenic mice coexpressing hIAPP displayed peripheral insulin resistance, hyperglycemia, and glucose intolerance. A beta and IAPP amyloidco-deposition increased tau phosphorylation, and a reduction in pancreatic beta-cell mass was detected inislets. Increased brain A beta deposition and tau phosphorylation and reduced insulin levels and signaling were accompanied by extensive synaptic loss and decreased neuronal counts. Ab immunization rescued the peripheral insulin resistance and hyperglycemia, suggesting a role for A beta in T2D pathogenesis for individuals predisposed to AD. These findings demonstrate that Ab and IAPP are key factors in the overlapping pathologies of AD and T2D.	[Wijesekara, Nadeeja; Ahrens, Rosemary; Wu, Ling; Ha, Kathy; Fraser, Paul E.] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Krembil Discovery Tower,60 Leonard Ave, Toronto, ON M5T 2S8, Canada; [Fraser, Paul E.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Sabale, Miheer; Verdile, Giuseppe] Curtin Univ, Curtin Hlth & Innovat Res Inst, Sch Biomed Sci, Bentley, WA, Australia	Krembil Research Institute; University of Toronto; University of Toronto; Curtin University	Wijesekara, N (corresponding author), Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Krembil Discovery Tower,60 Leonard Ave, Toronto, ON M5T 2S8, Canada.	nadeeja.wijesekara@utoronto.ca	Wijesekara, Nadeeja/AAW-7230-2021	Sabale, Miheer/0000-0002-0330-3993; Verdile, Giuseppe/0000-0003-2475-0124	Canadian Institute of Health Research (CIHR) [MOP-115056]; West Australian Department of Health Award; National Health and Medical Research Council [APP1105698]; CIHR; Diabetes Canada	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); West Australian Department of Health Award; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); CIHR(Canadian Institutes of Health Research (CIHR)); Diabetes Canada	This study was supported by Canadian Institute of Health Research (CIHR) operating Grant MOP-115056 (to P.F.), by a West Australian Department of Health Award (to G.V.), and by National Health and Medical Research Council Grant APP1105698 (to G.V. and P.F.). N.W. was supported by postdoctoral fellowships from the CIHR and Diabetes Canada. The authors declare no conflicts of interest.	Akter R, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2798269; Bharadwaj P, 2017, J ALZHEIMERS DIS, V59, P421, DOI 10.3233/JAD-161192; Cai ZY, 2016, CELL MOL NEUROBIOL, V36, P483, DOI 10.1007/s10571-015-0233-3; Cai ZY, 2015, METAB BRAIN DIS, V30, P839, DOI 10.1007/s11011-014-9631-3; Chen L, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/508409; Chen ZC, 2014, NEUROSCI BULL, V30, P271, DOI 10.1007/s12264-013-1423-y; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Clarke JR, 2015, EMBO MOL MED, V7, P190, DOI 10.15252/emmm.201404183; Combs CK, 2000, J NEUROSCI, V20, P558, DOI 10.1523/JNEUROSCI.20-02-00558.2000; Di Rosa M, 2006, EUR J NEUROSCI, V23, P2648, DOI 10.1111/j.1460-9568.2006.04780.x; FARSHORI PQ, 1994, J SUBMICR CYTOL PATH, V26, P137; Fletcher LM, 2000, BIOCHEM J, V352, P267, DOI 10.1042/0264-6021:3520267; Fu W, 2013, CURR PROTEIN PEPT SC, V14, P338, DOI 10.2174/13892037113149990051; Hasnain SZ, 2016, J MOL ENDOCRINOL, V56, pR33, DOI 10.1530/JME-15-0232; Hooper C, 2008, J NEUROCHEM, V104, P1433, DOI 10.1111/j.1471-4159.2007.05194.x; Hsu CC, 2011, J ALZHEIMERS DIS, V24, P485, DOI 10.3233/JAD-2011-101524; Hu RD, 2015, ACS CHEM NEUROSCI, V6, P1759, DOI 10.1021/acschemneuro.5b00192; Hull RL, 2003, DIABETES, V52, P372, DOI 10.2337/diabetes.52.2.372; Ito S, 2012, J ALZHEIMERS DIS, V31, P493, DOI 10.3233/JAD-2012-120046; Janson J, 1996, P NATL ACAD SCI USA, V93, P7283, DOI 10.1073/pnas.93.14.7283; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Jimenez-Palomares M, 2012, AM J PHYSIOL-ENDOC M, V302, pE1373, DOI 10.1152/ajpendo.00500.2011; Kalafatakis K, 2014, INT J NEUROSCI, V124, P944, DOI 10.3109/00207454.2014.890934; Kim DI, 2017, CELL MOL NEUROBIOL, V37, P955, DOI 10.1007/s10571-016-0434-4; Kulstad JJ, 2006, NEUROLOGY, V66, P1506, DOI 10.1212/01.wnl.0000216274.58185.09; MALAISSE WJ, 1974, EUR J CLIN INVEST, V4, P313, DOI 10.1111/j.1365-2362.1974.tb00409.x; McClean PL, 2011, J NEUROSCI, V31, P6587, DOI 10.1523/JNEUROSCI.0529-11.2011; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Miklossy J, 1999, J NEUROPATH EXP NEUR, V58, P803, DOI 10.1097/00005072-199908000-00003; Miklossy J, 2010, NEUROBIOL AGING, V31, P1503, DOI 10.1016/j.neurobiolaging.2008.08.019; Olson AL, 2001, J BIOL CHEM, V276, P10706, DOI 10.1074/jbc.M007610200; Oskarsson ME, 2015, AM J PATHOL, V185, P834, DOI 10.1016/j.ajpath.2014.11.016; Roher AE, 2009, ALZHEIMERS DEMENT, V5, P18, DOI 10.1016/j.jalz.2008.10.004; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Son S. M., 2011, TOPICS PREVENTION TR; Takeda S, 2012, DEMENT GERIATR COGN, V34, P25, DOI 10.1159/000338704; Takeda S, 2010, P NATL ACAD SCI USA, V107, P7036, DOI 10.1073/pnas.1000645107; Toledo JB, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt162; Unoki H, 2008, CURR PHARM DESIGN, V14, P987, DOI 10.2174/138161208784139747; Vandal M, 2015, FASEB J, V29, P4273, DOI 10.1096/fj.14-268482; Verdile G, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/105828; Wijesekara N, 2015, DIABETES OBES METAB, V17, DOI 10.1111/dom.12529; Willette AA, 2015, JAMA NEUROL, V72, P1013, DOI 10.1001/jamaneurol.2015.0613; Xie L, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0001.2002; Yang Y, 2013, NEUROSCIENCE, V250, P140, DOI 10.1016/j.neuroscience.2013.07.009; Zhang Y, 2012, DIABETES, V61, P1434, DOI 10.2337/db11-0499; Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com; Zhong Y, 2012, BIOMED ENVIRON SCI, V25, P8, DOI 10.3967/0895-3988.2012.01.002; Zhu XD, 2015, DEV CELL, V34, P656, DOI 10.1016/j.devcel.2015.08.020; Zhu XW, 2002, NEUROSIGNALS, V11, P270, DOI 10.1159/000067426; Zuliani G, 2007, J PSYCHIATR RES, V41, P686, DOI 10.1016/j.jpsychires.2006.02.008	51	65	67	1	24	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5409	5418		10.1096/fj.201700431R	http://dx.doi.org/10.1096/fj.201700431R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28808140				2022-12-28	WOS:000416588300024
J	Wang, Q; Pronin, AN; Levay, K; Almaca, J; Fornoni, A; Caicedo, A; Slepak, VZ				Wang, Qiang; Pronin, Alexey N.; Levay, Konstantin; Almaca, Joana; Fornoni, Alessia; Caicedo, Alejandro; Slepak, Vladlen Z.			Regulator of G-protein signaling G beta 5-R7 is a crucial activator of muscarinic M3 receptor-stimulated insulin secretion	FASEB JOURNAL			English	Article						islet of Langerhans; pupil sphincter; CRISPR-Cas9; UBO-QIC; fluorescent biosensor	PANCREATIC BETA-CELL; RGS PROTEINS; COUPLED RECEPTORS; SUBUNIT G-BETA-5; IN-VITRO; COMPLEX; DOMAIN; RELEASE; BINDING; PHOSPHORYLATION	In pancreatic beta cells, muscarinic cholinergic receptor M3 (M3R) stimulates glucose-induced secretion of insulin. Regulator of G-protein signaling (RGS) proteins are critical modulators of GPCR activity, yet their role in cells remains largely unknown. R7 subfamily RGS proteins are stabilized by the G-protein subunit G beta 5, such that the knockout of the Gnb5 gene results in degradation of all R7 subunits. We found that Gnb5 knockout in mice or in the insulin-secreting MIN6 cell line almost completely eliminates insulinotropic activity of M3R. Moreover, overexpression of G beta 5-RGS7 strongly promotes M3R-stimulated insulin secretion. Examination of this noncanonical mechanism in Gnb5(-/-) MIN6 cells showed that cAMP, diacylglycerol, or Ca2+ levels were not significantly affected. There was no reduction in the amplitude of free Ca2+ responses in islets from the Gnb5(-/-) mice, but the frequency of Ca2+ oscillations induced by cholinergic agonist was lowered by more than 30%. Ablation of Gnb5 impaired M3R-stimulated phosphorylation of ERK1/2. Stimulation of the ERK pathway in Gnb5(-/-) cells by epidermal growth factor restored M3R-stimulated insulin release to near normal levels. Identification of the novel role of G beta 5-R7 in insulin secretion may lead to a new therapeutic approach for improving pancreatic beta-cell function.	[Wang, Qiang; Pronin, Alexey N.; Levay, Konstantin; Slepak, Vladlen Z.] Univ Miami, Leonard M Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Almaca, Joana; Fornoni, Alessia; Caicedo, Alejandro] Univ Miami, Leonard M Miller Sch Med, Dept Med, Miami, FL 33136 USA	University of Miami; University of Miami	Slepak, VZ (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Rosenstiel Med Sci Bldg 6130, Miami, FL 33136 USA.	vslepak@med.miami.edu	Caicedo, Alejandro/AAC-8544-2020	fornoni, Alessia/0000-0002-1313-7773	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [R01DK105427, R01DK0090316, R01DK104753, R01DK111538]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK111538, R01DK090316, R01DK104753, R01DK105427, K01DK111757, R01DK113093, R56DK084321] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Jongmin Jeon and Junior Tayou (Leonard M. Miller School of Medicine, University of Miami) for sharing technical expertise. This work was supported by U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grants R01DK105427 (to V.Z.S.), R01DK0090316 and R01DK104753 (to A.F.), and R01DK111538 (to A.C.). The authors declare no conflicts of interest.	Abramow-Newerly M, 2006, CELL SIGNAL, V18, P579, DOI 10.1016/j.cellsig.2005.08.010; Ahren B, 2009, NAT REV DRUG DISCOV, V8, P369, DOI 10.1038/nrd2782; Alejandro EU, 2011, FASEB J, V25, P3884, DOI 10.1096/fj.10-180349; Anderson GR, 2009, CELL BIOCHEM BIOPHYS, V54, P33, DOI 10.1007/s12013-009-9052-9; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; de Azua IR, 2012, LIFE SCI, V91, P986, DOI 10.1016/j.lfs.2012.04.010; de Azua IR, 2012, FASEB J, V26, P4275, DOI 10.1096/fj.12-204644; de Azua IR, 2010, P NATL ACAD SCI USA, V107, P7999, DOI 10.1073/pnas.1003655107; Fridlyand LE, 2007, AM J PHYSIOL-CELL PH, V293, pC1924, DOI 10.1152/ajpcell.00555.2006; Gautam D, 2006, CELL METAB, V4, P363, DOI 10.1016/j.cmet.2006.09.008; Gerber KJ, 2016, MOL PHARMACOL, V89, P273, DOI 10.1124/mol.115.102210; Gylfe E, 2014, DIABETES OBES METAB, V16, P102, DOI 10.1111/dom.12345; Hooks SB, 2003, J BIOL CHEM, V278, P10087, DOI 10.1074/jbc.M211382200; Hooks SB, 2008, BIOCHEM PHARMACOL, V75, P76, DOI 10.1016/j.bcp.2007.07.045; Hunt RA, 2003, BIOCHEM BIOPH RES CO, V303, P594, DOI 10.1016/S0006-291X(03)00400-5; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Jain S, 2013, J CLIN INVEST, V123, P1750, DOI 10.1172/JCI66432; Karpinsky-Semper D, 2015, BIOCHEMISTRY-US, V54, P1077, DOI 10.1021/bi500980d; Karpinsky-Semper D, 2014, MOL PHARMACOL, V85, P758, DOI 10.1124/mol.114.091843; KATADA T, 1984, J BIOL CHEM, V259, P3568; Kimple ME, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.40; Kong Kok Choi, 2011, Commun Integr Biol, V4, P489, DOI 10.4161/cib.4.4.15716; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; Leitner MG, 2016, BRIT J PHARMACOL, V173, P2555, DOI 10.1111/bph.13538; Levay K, 1999, P NATL ACAD SCI USA, V96, P2503, DOI 10.1073/pnas.96.5.2503; Malmersjo S, 2016, EMBO J, V35, P1810, DOI 10.15252/embj.201694071; Moran BM, 2016, ACTA DIABETOL, V53, P177, DOI 10.1007/s00592-015-0826-9; Nishimura A, 2010, P NATL ACAD SCI USA, V107, P13666, DOI 10.1073/pnas.1003553107; Osei-Owusu P, 2015, PROG MOL BIOL TRANSL, V133, P77, DOI 10.1016/bs.pmbts.2015.02.001; Posokhova E, 2010, CIRC RES, V107, P1350, DOI 10.1161/CIRCRESAHA.110.224212; Pronin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096435; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sandiford SL, 2009, BIOCHEMISTRY-US, V48, P2282, DOI 10.1021/bi801989c; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; Selway J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033004; Selway JL, 2012, ACTA DIABETOL, V49, P277, DOI 10.1007/s00592-011-0314-9; Shu YL, 2008, J NEUROSCI, V28, P21, DOI 10.1523/JNEUROSCI.2352-07.2008; Slepak VZ, 2009, PROG MOL BIOL TRANSL, V86, P157, DOI 10.1016/S1877-1173(09)86006-7; Snow BE, 1998, P NATL ACAD SCI USA, V95, P13307, DOI 10.1073/pnas.95.22.13307; Tengholm A, 2009, MOL CELL ENDOCRINOL, V297, P58, DOI 10.1016/j.mce.2008.07.009; Tewson PH, 2016, J BIOMOL SCREEN, V21, P298, DOI 10.1177/1087057115618608; Villasenor A, 2010, DIS MODEL MECH, V3, P567, DOI 10.1242/dmm.003210; Wang Q, 2011, FASEB J, V25, P3949, DOI 10.1096/fj.11-190157; Witherow DS, 2000, J BIOL CHEM, V275, P24872, DOI 10.1074/jbc.M001535200; Xie KQ, 2012, PSYCHOPHARMACOLOGY, V219, P823, DOI 10.1007/s00213-011-2409-y; Xie ZH, 2016, AAPS J, V18, P294, DOI 10.1208/s12248-015-9847-0; Yang JQ, 2010, CIRC RES, V107, P1345, DOI 10.1161/CIRCRESAHA.110.224220; Zaima K, 2013, J NAT MED-TOKYO, V67, P196, DOI 10.1007/s11418-012-0644-0	48	12	12	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4734	4744		10.1096/fj.201700197RR	http://dx.doi.org/10.1096/fj.201700197RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28687610	Green Published			2022-12-28	WOS:000413398500007
J	Pederson, T				Pederson, Thoru			The Hemoglobinopathies: An Empowering Era of Human Genetics in the Clinic and the Laboratory	FASEB JOURNAL			English	Editorial Material							BETA-THALASSEMIA; DIAGNOSIS; CLONING; DISEASE; LOCI											FRITSCH EF, 1980, CELL, V19, P959, DOI 10.1016/0092-8674(80)90087-2; KAN YW, 1972, NEW ENGL J MED, V287, P1, DOI 10.1056/NEJM197207062870101; KAN YW, 1975, NEW ENGL J MED, V292, P1096, DOI 10.1056/NEJM197505222922104; Kazazian HH, 2017, FASEB J, V31, P3712, DOI 10.1096/fj.201700502RR; LIEBHABER SA, 1980, P NATL ACAD SCI-BIOL, V77, P7054, DOI 10.1073/pnas.77.12.7054; ORKIN SH, 1979, P NATL ACAD SCI USA, V76, P2400, DOI 10.1073/pnas.76.5.2400; ORKIN SH, 1979, CELL, V17, P33, DOI 10.1016/0092-8674(79)90292-7; SCHWARTZ E, 1967, LANCET, V2, P1422; Ye L, 2016, P NATL ACAD SCI USA, V113, P10661, DOI 10.1073/pnas.1612075113	9	1	1	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3711	3711		10.1096/fj.170901ufm	http://dx.doi.org/10.1096/fj.170901ufm			1	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28860306				2022-12-28	WOS:000408713300001
J	Mediero, A; Wilder, T; Shah, L; Cronstein, BN				Mediero, Aranzazu; Wilder, Tuere; Shah, Lopa; Cronstein, Bruce N.			Adenosine A(2A) receptor (A2AR) stimulation modulates expression of semaphorins 4D and 3A, regulators of bone homeostasis	FASEB JOURNAL			English	Article						Sema4D; Sema3A; cell communication; RhoA; beta-catenin	B NUCLEAR TRANSLOCATION; OSTEOCLAST FORMATION; A(2B) RECEPTORS; AXON GUIDANCE; DIFFERENTIATION; CELLS; ACTIVATION; MODEL; INNERVATION; SUPPRESSION	The axonal guidance proteins semaphorin (Sema)4D and Sema3A play important roles in communication between osteoclasts and osteoblasts. As stimulation of adenosine A(2A) receptors (A2AR) regulates both osteoclast and osteoblast function, we asked whether A2AR regulates both osteoclast and osteoblast expression of Semas. In vivo bone formation and Sema3A/PlexinA1/Neuropilin-1, Sema4D/PlexinB1 protein expression were studied in a murine model of wear particle-induced osteolysis. Osteoclast/osteoblast differentiation were studied in vitro as the number of tartrate-resistant acid phosphatase(+)/Alizarin Red(+) cells after challenge with CGS21680 (A2AR agonist, 1 mu M) or ZM241385 (A2AR antagonist, 1 mu M), with or without Sema4D or Sema3A (10 ng/ml). Sema3A/PlexinA1/Neuropilin-1, Sema4D/PlexinB1, and receptor activator of NF-kappa B ligand/osteoprotegerin (RANKL/OPG) expression was studied by RT-PCR and Western blot. beta-Catenin activation and cytoskeleton changes were studied by fluorescence microscopy and Western blot. In mice with wear particles implanted over the calvaria, CGS21680 treatment increased bone formation in vivo, reduced Sema4D, and increased Sema3A expression compared with mice with wear particle-induced osteolysis treated with vehicle alone. During osteoclast differentiation, CGS21680 abrogated RANKL-induced Sema4D mRNA expression (1.3 +/- 0.3- vs. 2.5 +/- 0.1-fold change, P < 0.001, n = 4). PlexinA1, but not Neuropilin-1, mRNA was enhanced by CGS21680 treatment. CGS21680 enhanced Sema3A mRNA expression during osteoblast differentiation (8.7 +/- 0.2-fold increase, P < 0.001, n = 4); PlexinB1 mRNA was increased 2-fold during osteoblast differentiation and was not altered by CGS21680. Similar changes were observed at the protein level. CGS21680 decreased RANKL, increased OPG, and increased total/nuclear beta-catenin expression in osteoblasts. Sema4D increased Ras homolog gene family, member A phosphorylation and focal adhesion kinase activation in osteoclast precursors, and CGS21680 abrogated these effects. In summary, A2AR activation diminishes secretion of Sema4D by osteoclasts, inhibits Sema4D-mediated osteoclast activation, and enhances secretion of Sema3A by osteoblasts, increasing osteoblast differentiation and diminishing inflammatory osteolysis.-Mediero, A., Wilder, T., Shah, L., Cronstein, B. N. Adenosine A(2A) receptor (A2AR) stimulation modulates expression of semaphorins 4D and 3A, regulators of bone homeostasis.	[Mediero, Aranzazu; Wilder, Tuere; Shah, Lopa; Cronstein, Bruce N.] NYU, Dept Med, Div Translat Med, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Mediero, Aranzazu] Univ Autonoma Madrid, Inst Invest Sanitaria, Fdn Jimenez Diaz, Bone & Joint Res Unit, Madrid, Spain	New York University; NYU Langone Medical Center; Autonomous University of Madrid; Fundacion Jimenez Diaz	Cronstein, BN (corresponding author), NYU, Sch Med, Dept Med, Div Translat Med, 550 First Ave,MSB251, New York, NY 10016 USA.	bruce.cronstein@nyumc.org	Mediero, Aranzazu/AAA-8362-2020; Cronstein, Bruce N/D-4678-2011	Cronstein, Bruce N/0000-0002-4295-7383; Mediero, Aranzazu/0000-0002-5368-574X	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR68593, AR56672]; New York University-Health and Hospitals Corporation Clinical and Translational Science Institute [U54TR001364]; New York University Caregiver Intervention Center Support Grant [9NIH/NCI 5 P30CA16087-310]; Instituto de Salud Carlos III [CP15/00053]; Fondo Europeo de Desarrollo Regional (FEDER); Spanish Instituto de Salud Carlos III [PI16/00991]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR068593, R01AR056672, R56AR056672] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); New York University-Health and Hospitals Corporation Clinical and Translational Science Institute; New York University Caregiver Intervention Center Support Grant; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Spanish Instituto de Salud Carlos III(Instituto de Salud Carlos III); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (Grants AR68593 and AR56672), the New York University-Health and Hospitals Corporation Clinical and Translational Science Institute (Grant U54TR001364), and a New York University Caregiver Intervention Center Support Grant (9NIH/NCI 5 P30CA16087-310). A.M. is funded by Instituto de Salud Carlos III through the Miguel Servet Program (CP15/00053), and cofunded by Fondo Europeo de Desarrollo Regional (FEDER) with a research grant from the Spanish Instituto de Salud Carlos III (PI16/00991). A.M. and B.N.C. have filed a patent on use of A2AR agonists to prevent prosthesis loosening (pending), and a separate patent on use of A2AR agonists and agents that increase adenosine levels to promote bone formation/regeneration. B.N.C. is a consultant for Bristol-Myers Squibb, AstraZeneca, Novartis, and CanFite Biopharmaceuticals and has stock in CanFite Biopharmaceuticals. The remaining authors declare no conflicts of interest.	BJURHOLM A, 1991, INT ORTHOP, V15, P325; Boyce BF, 2013, J DENT RES, V92, P860, DOI 10.1177/0022034513500306; Chitu V, 2005, MOL BIOL CELL, V16, P2947, DOI 10.1091/mbc.e04-10-0914; Dacquin R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026627; Edwards Claire M, 2008, Int J Med Sci, V5, P263; Fang KX, 2016, MOL MED REP, V14, P2449, DOI 10.3892/mmr.2016.5568; Fang KX, 2014, INT J NANOMED, V9, P4649, DOI 10.2147/IJN.S68895; Fukuda T, 2013, NATURE, V497, P490, DOI 10.1038/nature12115; Gharibi B, 2011, J BONE MINER RES, V26, P2112, DOI 10.1002/jbmr.424; Gomez C, 2005, DEV DYNAM, V234, P393, DOI 10.1002/dvdy.20512; Harmatys KM, 2013, MOL PHARMACEUT, V10, P4263, DOI 10.1021/mp400357v; Hayashi M, 2012, NATURE, V485, P69, DOI 10.1038/nature11000; He WJ, 2013, FASEB J, V27, P3446, DOI 10.1096/fj.13-231233; HOHMANN EL, 1986, SCIENCE, V232, P868, DOI 10.1126/science.3518059; Kang SJ, 2013, SEMIN CELL DEV BIOL, V24, P163, DOI 10.1016/j.semcdb.2012.09.008; Katebi M, 2009, J LEUKOCYTE BIOL, V85, P438, DOI 10.1189/jlb.0908520; Kikutani H, 2007, ADV IMMUNOL, V93, P121, DOI 10.1016/S0065-2776(06)93003-X; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Kular J, 2012, CLIN BIOCHEM, V45, P863, DOI 10.1016/j.clinbiochem.2012.03.021; Li YF, 2017, J BIOMED MATER RES B, V105, P2060, DOI 10.1002/jbm.b.33730; LIU X, 2016, STEM CELLS INT, V2016, DOI DOI 10.1155/2016/2545214; Love CA, 2003, NAT STRUCT BIOL, V10, P843, DOI 10.1038/nsb977; Mediero A, 2015, J BONE MINER RES, V30, P837, DOI 10.1002/jbmr.2421; Mediero A, 2015, FASEB J, V29, P1577, DOI 10.1096/fj.14-265066; Mediero A, 2014, FASEB J, V28, P4901, DOI 10.1096/fj.14-255703; Mediero A, 2013, BRIT J PHARMACOL, V169, P1372, DOI 10.1111/bph.12227; Mediero A, 2013, TRENDS ENDOCRIN MET, V24, P290, DOI 10.1016/j.tem.2013.02.001; Mediero A, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003393; Mediero A, 2012, AM J PATHOL, V180, P775, DOI 10.1016/j.ajpath.2011.10.017; Negishi-Koga Takako, 2012, Bonekey Rep, V1, P183, DOI 10.1038/bonekey.2012.183; Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489; Nogi T, 2010, NATURE, V467, P1123, DOI 10.1038/nature09473; Perez-Aso M, 2013, PURINERG SIGNAL, V9, P573, DOI 10.1007/s11302-013-9368-1; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Saad S, 2016, ACTA BIOMATER, V30, P311, DOI 10.1016/j.actbio.2015.11.025; Shaikh G, 2016, BRIT J PHARMACOL, V173, P3279, DOI 10.1111/bph.13615; Shaikh G, 2016, PURINERG SIGNAL, V12, P191, DOI 10.1007/s11302-016-9498-3; Sims Natalie A, 2014, Bonekey Rep, V3, P481, DOI 10.1038/bonekey.2013.215; Sims NA, 2012, CURR OSTEOPOROS REP, V10, P109, DOI 10.1007/s11914-012-0096-1; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Togari A, 2000, BRAIN RES, V878, P204, DOI 10.1016/S0006-8993(00)02700-1; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Xu R, 2014, CELL ADHES MIGR, V8, P5, DOI 10.4161/cam.27752; Yang YH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150151; Yasuda H, 1999, BONE, V25, P109, DOI 10.1016/S8756-3282(99)00121-0; Yoshida Y, 2015, ARTHRITIS RHEUMATOL, V67, P1481, DOI 10.1002/art.39086; Zhang Y, 2014, J DENT RES, V93, P1095, DOI 10.1177/0022034514552676; Zhang YY, 2015, INT J CLIN EXP MED, V8, P16352; Zhang YF, 2015, J BONE MINER RES, V30, P286, DOI 10.1002/jbmr.2322	50	21	22	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2018	32	7					3487	3501		10.1096/fj.201700217R	http://dx.doi.org/10.1096/fj.201700217R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GJ2MI	29394106	Green Published			2022-12-28	WOS:000435104500002
J	He, SR; Wang, CS; Du, XJ; Chen, YN; Zhao, JM; Tian, BL; Lu, HM; Zhang, Y; Liu, JP; Yang, G; Li, L; Li, HX; Cheng, JQ; Lu, YR				He, Sirong; Wang, Chengshi; Du, Xiaojiong; Chen, Younan; Zhao, Jiuming; Tian, Bole; Lu, Huimin; Zhang, Yi; Liu, Jingping; Yang, Guang; Li, Lan; Li, Hongxia; Cheng, Jingqiu; Lu, Yanrong			MSCs promote the development and improve the function of neonatal porcine islet grafts	FASEB JOURNAL			English	Article						neonatal porcine islets; MSCs; development; proliferation; islet xenotransplantation	MESENCHYMAL STEM-CELLS; PANCREATIC BETA-CELLS; INSULIN-PRODUCING CELLS; BONE-MARROW; IN-VITRO; ENDOCRINE PANCREAS; RHESUS-MONKEYS; TRANSPLANTATION; GROWTH; DIFFERENTIATION	Deficient insulin secretion caused by immaturity is the predominant disadvantage of neonatal porcine islets (NPIs) when they serve as a source for islet xenotransplantation. We hypothesize that the transplantation of NPIs with a combination of mesenchymal stem cells (MSCs) can accelerate NPI maturation and improve the engraftment and function of NPIs. After indirect coculturing with monkey MSCs over 21 d, insulin secretion and the expression of regulatory genes relevant to development were assessed in NPIs. NPIs alone or in combination with allogeneic MSCs were intraportally transplanted into diabetic monkeys. Glycemic control was monitored, and graft function was evaluated. Our results suggest that MSCs benefit both the development and proliferation of NPIs in the coexisting systems in vitro and in vivo. These effects are dependent on platelet-derived growth factor receptor-alpha and are relevant to the inhibition of downstream target Notch1 signaling and the activation of PI3K/protein kinase B signaling.	[He, Sirong; Wang, Chengshi; Chen, Younan; Zhao, Jiuming; Liu, Jingping; Yang, Guang; Li, Lan; Cheng, Jingqiu; Lu, Yanrong] Sichuan Univ, West China Hosp, Regenerat Med Res Ctr, Lab Transplant Engn & Immunol, 1 Keyuan 4th Rd,Gao Peng Ave, Chengdu 610041, Sichuan, Peoples R China; [Tian, Bole; Lu, Huimin; Zhang, Yi] Sichuan Univ, West China Hosp, Dept Pancreat Surg, Chengdu, Sichuan, Peoples R China; [He, Sirong] Chongqing Med Univ, Coll Basic Med, Dept Immunol, Chongqing, Peoples R China; [Li, Hongxia] Natl Ctr Safety Evaluat Tradit Chinese Med, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; Chongqing Medical University	Cheng, JQ; Lu, YR (corresponding author), Sichuan Univ, West China Hosp, Regenerat Med Res Ctr, Lab Transplant Engn & Immunol, 1 Keyuan 4th Rd,Gao Peng Ave, Chengdu 610041, Sichuan, Peoples R China.	jqcheng@scu.edu.cn; luyanrong@scu.edu.cn	Liu, Jingping/P-8908-2019; wang, chengshi/AAX-4864-2021	wang, chengshi/0000-0002-0650-4109	Key Program of the Natural Science Foundation of China [30930088]; Natural Science Foundation of China [30872382, 81500590]; National Program for High Technology Research and Development of China [2012AA020702]	Key Program of the Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program for High Technology Research and Development of China(National High Technology Research and Development Program of China)	This work was supported by the Key Program of the Natural Science Foundation of China (Grant 30930088), the Program of the Natural Science Foundation of China (30872382 and 81500590), and the National Program for High Technology Research and Development of China (2012AA020702). The authors declare no conflicts of interest.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Berman DM, 2010, DIABETES, V59, P2558, DOI 10.2337/db10-0136; Blyszczuk P, 2003, P NATL ACAD SCI USA, V100, P998, DOI 10.1073/pnas.0237371100; Burlacu A, 2013, STEM CELLS DEV, V22, P643, DOI 10.1089/scd.2012.0273; Chen HN, 2011, NATURE, V478, P349, DOI 10.1038/nature10502; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Deng YB, 2005, CHINESE MED J-PEKING, V118, P1533; Ding YC, 2009, DIABETES, V58, P1797, DOI 10.2337/db09-0317; Du AP, 2009, DIABETES, V58, P2059, DOI 10.2337/db08-0987; Duprez IR, 2011, UPSALA J MED SCI, V116, P8, DOI 10.3109/03009734.2010.524320; Fiaschi-Taesch NM, 2008, DIABETES, V57, P2745, DOI 10.2337/db08-1085; Figliuzzi Marina, 2014, World J Stem Cells, V6, P163, DOI 10.4252/wjsc.v6.i2.163; Gao K, 2008, TRANSPL P, V40, P634, DOI 10.1016/j.transproceed.2008.01.053; Habener JF, 2005, ENDOCRINOLOGY, V146, P1025, DOI 10.1210/en.2004-1576; Hanley SC, 2011, J ENDOCRINOL, V211, P231, DOI 10.1530/JOE-11-0213; He SR, 2013, EXP BIOL MED, V238, P385, DOI 10.1177/1535370213477974; Heinis M, 2010, HORM RES PAEDIAT, V74, P77, DOI 10.1159/000314894; Jin S, 2008, CIRC RES, V102, P1483, DOI 10.1161/CIRCRESAHA.107.167965; Kim SK, 2001, GENE DEV, V15, P111, DOI 10.1101/gad.859401; Korbutt GS, 2009, XENOTRANSPLANTATION, V16, P223, DOI 10.1111/j.1399-3089.2009.00542.x; Korbutt GS, 1996, J CLIN INVEST, V97, P2119, DOI 10.1172/JCI118649; Krishnamurthy M, 2011, ENDOCRINOLOGY, V152, P424, DOI 10.1210/en.2010-0877; Li HT, 2012, BIOCHEM BIOPH RES CO, V420, P793, DOI 10.1016/j.bbrc.2012.03.076; Lu YR, 2010, CELL BIOCHEM FUNCT, V28, P637, DOI 10.1002/cbf.1701; MacKenzie DA, 2003, TRANSPLANTATION, V76, P887, DOI 10.1097/01.TP.0000087114.18315.17; Moriscot C, 2005, STEM CELLS, V23, P594, DOI 10.1634/stemcells.2004-0123; Mundra V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077591; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Park KS, 2010, TRANSPLANTATION, V89, P509, DOI 10.1097/TP.0b013e3181c7dc99; Rutter W J, 1978, Symp Soc Dev Biol, P205; Servitja JM, 2004, DIABETOLOGIA, V47, P597, DOI 10.1007/s00125-004-1368-9; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Smith SB, 2010, NATURE, V463, P775, DOI 10.1038/nature08748; Thompson P, 2011, AM J TRANSPLANT, V11, P2593, DOI 10.1111/j.1600-6143.2011.03720.x; Tsaniras SC, 2010, J ENDOCRINOL, V206, P13, DOI 10.1677/JOE-10-0073; Wang ZW, 2007, CANCER RES, V67, P11377, DOI 10.1158/0008-5472.CAN-07-2803; Weir G C, 1997, Ann Transplant, V2, P63; Wu H, 2011, MOL PHARMACEUT, V8, P1458, DOI 10.1021/mp200135e; Yang KM, 2014, ROM J MORPHOL EMBRYO, V55, P305; Yang YG, 2007, NAT REV IMMUNOL, V7, P519, DOI 10.1038/nri2099; You H, 2009, ENDOCRINOLOGY, V150, P5455, DOI 10.1210/en.2009-0468; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984; Zhang S, 2012, J AM ASSOC LAB ANIM, V51, P842	45	11	12	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2018	32	6					3242	3253		10.1096/fj.201700991R	http://dx.doi.org/10.1096/fj.201700991R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2TP	29401607				2022-12-28	WOS:000432546000028
J	Wan, M; Tang, X; Rekha, RS; Muvva, SSVJR; Brighenti, S; Agerberth, B; Haeggstrom, JZ				Wan, Min; Tang, Xiao; Rekha, Rokeya Sultana; Muvva, S. S. V. Jagadeeswara Rao; Brighenti, Susanna; Agerberth, Birgitta; Haeggstrom, Jesper Z.			Prostaglandin E-2 suppresses hCAP18/LL-37 expression in human macrophages via EP2/EP4: implications for treatment of Mycobacterium tuberculosis infection	FASEB JOURNAL			English	Article						eicosanoids; cathelicidin; innate immunity; vitamin D-3; cAMP	VITAMIN-D-RECEPTOR; ANTIMICROBIAL PEPTIDES; CATHELICIDIN LL-37; INNATE IMMUNITY; CUTTING EDGE; I INTERFERON; CAMP; GENE; PROTEIN; AUTOREGULATION	Prostaglandin (PG)E-2 is an arachidonic acid-derived lipid mediator that plays an important role in inflammation and immunity. In this study, we demonstrate that PGE(2) suppresses basal and 1,25-dihydroxy vitamin D-3 (VD3)-induced expression of hCAP18/LL-37 via E prostanoid (EP)(2) and EP4 receptors. In humans, VD3 upregulates vitamin D receptor (VDR) expression and promotes transcription of the cathelicidin hCAP18/LL-37 gene, whereas PGE(2) counteracts this effect. We find that PGE(2) induces the cAMP/PKA-signaling pathway and enhances the expression of the inhibitory transcription factor cAMP-responsive modulator/inducible cAMP early repressor, which prevents VDR expression and induction of hCAP18/LL-37 in human macrophages. The negative regulation by PGE(2) was evident in M1- and M2-polarized human macrophages, although PGE(2) displayed more profound inhibitory effects in M2 cells. PGE(2) impaired VD3-induced expression of cathelicidin and concomitant activation of autophagy during Mycobacterium tuberculosis (Mtb) infection and facilitated intracellular Mtb growth in human macrophages. An EP4 agonist also significantly promoted Mtb survival in human macrophages. Our results indicate that PGE(2) inhibits hCAP18/LL-37 expression, especially VD3-induced cathelicidin and autophagy, which may reduce host defense against Mtb. Accordingly, antagonists of EP4 may constitute a novel adjunctive therapy in Mtb infection.	[Wan, Min; Tang, Xiao; Haeggstrom, Jesper Z.] Karolinska Inst, Dept Med Biochem & Biophys, Div Physiol Chem 2, Stockholm, Sweden; [Rekha, Rokeya Sultana; Agerberth, Birgitta] Karolinska Univ Hosp, Dept Lab Med, Stockholm, Sweden; [Muvva, S. S. V. Jagadeeswara Rao; Brighenti, Susanna] Karolinska Univ Hosp, Ctr Infect Med, Stockholm, Sweden; [Wan, Min] Karolinska Univ Hosp, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Wan, M (corresponding author), Karolinska Univ Hosp, Stockholm, Sweden.; Wan, M (corresponding author), Karolinska Inst, Alfred Nobels Alle 8, S-14186 Stockholm, Sweden.	min.wan@ki.se	Brighenti, Susanna/AAA-2255-2022	Brighenti, Susanna/0000-0001-8540-153X	Swedish Research Council [10350, 2016-01496]; Swedish Research Council (Linneus Grant CERIC); NovoNordisk Foundation [NNF15CC0018346, NNF15CC0018486]; Clas Groschinskys memorial foundation; Eva and Oscar Ahrens Foundation; Lars Hierta Memorial Foundation; China Scholarship Council	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council (Linneus Grant CERIC)(Swedish Research Council); NovoNordisk Foundation(Novo Nordisk Foundation); Clas Groschinskys memorial foundation; Eva and Oscar Ahrens Foundation; Lars Hierta Memorial Foundation; China Scholarship Council(China Scholarship Council)	The authors thank Devaraj Basavarajappa (Karolinska Insitutet) for generating and sharing mPGES knockdown cells; Gudmundur H. Gudmundsson (University of Iceland, Reykjavik, Iceland), Martin Rottenberg (Karolinska Institutet), Yu Gao (Karolinska Institutet), and Rubhana Raqib (International Center for Diarrheal Disease Research, Dhaka, Bangladesh) for scientific discussions; and Peter Bergman (Karolinska Institutet) for critically reading the manuscript and advice. This study was supported by the Swedish Research Council (Grants 10350 and 2016-01496, and Linneus Grant CERIC), the NovoNordisk Foundation (Grant NNF15CC0018346 and NNF15CC0018486), the Clas Groschinskys memorial foundation, the Eva and Oscar Ahrens Foundation, and the Lars Hierta Memorial Foundation. X.T. is supported by a Ph.D. stipend from the China Scholarship Council. M.W. and X.T. are co-first authors. The authors declare no conflicts of interest.	Agard M, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00045; Aronoff DM, 2005, J IMMUNOL, V174, P595, DOI 10.4049/jimmunol.174.2.595; Byrne ST, 2007, J ANTIMICROB CHEMOTH, V59, P313, DOI 10.1093/jac/dkl486; Chakraborty K, 2008, CELL MICROBIOL, V10, P2520, DOI 10.1111/j.1462-5822.2008.01227.x; Chakraborty K, 2009, J BIOL CHEM, V284, P21810, DOI 10.1074/jbc.M109.001180; Chen JJ, 2015, IEEE INT CONF COMM, P1, DOI 10.1109/ICCW.2015.7247066; Chen MJ, 2008, J EXP MED, V205, P2791, DOI 10.1084/jem.20080767; Coulombe F, 2014, IMMUNITY, V40, P554, DOI 10.1016/j.immuni.2014.02.013; Divangahi M, 2010, NAT IMMUNOL, V11, P751, DOI 10.1038/ni.1904; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; Gupta S, 2017, J PATHOL, V242, P52, DOI 10.1002/path.4878; Hirata T, 2012, ADV IMMUNOL, V116, P143, DOI 10.1016/B978-0-12-394300-2.00005-3; Kahlenberg JM, 2013, J IMMUNOL, V191, P4895, DOI 10.4049/jimmunol.1302005; Kai-Larsen Y, 2008, FRONT BIOSCI, V13, P3760, DOI 10.2741/2964; Katzenback Barbara A., 2015, Biology-Basel, V4, P607, DOI 10.3390/biology4040607; Kaul V, 2012, J INFECT DIS, V206, P1816, DOI 10.1093/infdis/jis609; Konya V, 2013, PHARMACOL THERAPEUT, V138, P485, DOI 10.1016/j.pharmthera.2013.03.006; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Martineau AR, 2007, J IMMUNOL, V178, P7190, DOI 10.4049/jimmunol.178.11.7190; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; MOLINA CA, 1993, CELL, V75, P875, DOI 10.1016/0092-8674(93)90532-U; Nakao K, 2007, J PHARMACOL EXP THER, V322, P686, DOI 10.1124/jpet.107.122010; O'Brien AJ, 2014, NAT MED, V20, P522, DOI 10.1038/nm.3516; Peres-Buzalaf C, 2011, PROSTAG LEUKOTR ESS, V85, P75, DOI 10.1016/j.plefa.2011.04.024; Pike JW, 2010, ENDOCRIN METAB CLIN, V39, P255, DOI 10.1016/j.ecl.2010.02.007; Rekha RS, 2015, AUTOPHAGY, V11, P1688, DOI 10.1080/15548627.2015.1075110; Sassone-Corsi P., 2012, COLD SPRING HARB PER, V4; SassoneCorsi P, 1995, ANNU REV CELL DEV BI, V11, P355, DOI 10.1146/annurev.cellbio.11.1.355; Schmidt M, 2013, PHARMACOL REV, V65, P670, DOI 10.1124/pr.110.003707; Silva JP, 2016, BIOTECHNOL ADV, V34, P924, DOI 10.1016/j.biotechadv.2016.05.007; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Valdez PA, 2012, IMMUNITY, V36, P668, DOI 10.1016/j.immuni.2012.02.013; Vilaplana C, 2013, J INFECT DIS, V208, P199, DOI 10.1093/infdis/jit152; Wan M, 2007, FASEB J, V21, P2897, DOI 10.1096/fj.06-7974com; Wan M, 2014, FASEB J, V28, P3456, DOI 10.1096/fj.14-251306; Wan M, 2011, FASEB J, V25, P1697, DOI 10.1096/fj.10-175687; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Woodward DF, 2011, PHARMACOL REV, V63, P471, DOI 10.1124/pr.110.003517; Yuk JM, 2009, CELL HOST MICROBE, V6, P231, DOI 10.1016/j.chom.2009.08.004; Zaslona Z, 2012, BLOOD, V119, P2358, DOI 10.1182/blood-2011-08-374207; Zella LA, 2007, J STEROID BIOCHEM, V103, P435, DOI 10.1016/j.jsbmb.2006.12.019; ZIEGLERHEITBROCK HWL, 1988, INT J CANCER, V41, P456, DOI 10.1002/ijc.2910410324; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	45	23	24	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2018	32	5					2827	2840		10.1096/fj.201701308	http://dx.doi.org/10.1096/fj.201701308			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GG2MW	29401596				2022-12-28	WOS:000432528000041
J	Kim, HR; Kim, YS; Yoon, JA; Yang, SC; Park, M; Seol, DW; Lyu, SW; Jun, JH; Lim, HJ; Lee, DR; Song, H				Kim, Hye-Ryun; Kim, Yeon Sun; Yoon, Jung Ah; Yang, Seung Chel; Park, Mira; Seol, Dong-Won; Lyu, Sang Woo; Jun, Jin Hyun; Lim, Hyunjung Jade; Lee, Dong Ryul; Song, Haengseok			Estrogen induces EGR1 to fine-tune its actions on uterine epithelium by controlling PR signaling for successful embryo implantation	FASEB JOURNAL			English	Article						P-4 signaling; transcription factor; uterine receptivity; epithelial cell differentiation	PROGESTERONE-RECEPTORS MEDIATE; ZINC-FINGER GENE; NGFI-A; CELL-PROLIFERATION; NERVOUS-SYSTEM; BISPHENOL-A; C/EBP-BETA; MICE; EXPRESSION; UTERUS	The harmonized actions of ovarian E-2 and progesterone (P-4) regulate the proliferation and differentiation of uterine cells in a spatiotemporal manner. Imbalances between these hormones often lead to infertility and gynecologic diseases. Whereas numerous factors that are involved in P-4 signaling have been identified, few local factors that mediate E-2 actions in the uterus have been revealed. Here, we demonstrate that estrogen induces the transcription factor, early growth response 1 (Egr1), to fine-tune its actions in uterine epithelial cells (ECs) that are responsible for uterine receptivity for embryo implantation. In the presence of exogenous gonadotrophins, ovulation, fertilization, and embryonic development normally occur in Egr1(-/-) mice, but these animals experience the complete failure of embryo implantation with reduced artificial decidualization. Although serum levels of E-2 and P-4 were comparable between Egr1(+/+) and Egr1(-/-) mice on d 4 of pregnancy, aberrantly reduced levels of progesterone receptor in Egr1(-/-) uterine ECs caused enhanced E-2 activity and impaired P-4 response. Ultrastructural analyses revealed that Egr1(-/-) ECs are not fully able to provide proper uterine receptivity. Uterine mRNA landscapes in Egr1(-/-) mice revealed that EGR1 controls the expression of a subset of E-2-regulated genes. In addition, P-4 signaling was unable to modulate estrogen actions, including those that are involved in cell-cycle progression, in ECs that were deficient in EGR1. Furthermore, primary coculture of Egr1(-/-) ECs with Egr1(+/+) stromal cells, and vice versa, supported the notion that Egr1 is required tomodulate E-2 actions on ECs to prepare the uterine environment for embryo implantation. In contrast to its role in ECs, loss of Egr1 in stroma significantly reduced stromal cell proliferation. Collectively, our results demonstrate that E-2 induces EGR1 to streamline its actions for the preparation of uterine receptivity for embryo implantation in mice.	[Kim, Hye-Ryun; Kim, Yeon Sun; Yang, Seung Chel; Park, Mira; Seol, Dong-Won; Lee, Dong Ryul; Song, Haengseok] CHA Univ, Dept Biomed Sci, Seongnam, South Korea; [Yoon, Jung Ah; Lyu, Sang Woo] CHA Univ, CHA Gangnam Med Ctr, Fertil Ctr, Seoul, South Korea; [Jun, Jin Hyun] Eulji Univ, Grad Sch Hlth Sci, Dept Biomed Lab Sci, Seongnam, South Korea; [Lim, Hyunjung Jade] Konkuk Univ, Dept Vet Med, Seoul, South Korea	Pochon Cha University; Pochon Cha University; Eulji University; Konkuk University; Konkuk University Medical Center	Song, H (corresponding author), CHA Univ, Dept Biomed Sci, CHA Biocomplex 612,335 Pangyo Ro, Seongnam Si 13488, Gyeonggi Do, South Korea.	hssong@cha.ac.kr	Lim, Hyunjung J/D-5343-2011	Lim, Hyunjung J/0000-0003-2191-666X; Song, Haengseok/0000-0002-5027-7310	National Research Foundation of Korea - South Korean government [NRF-2012R1A2A2A01011274, NRF-2015R1A2A2A01006714, NRF-2016R1C1B1015648]	National Research Foundation of Korea - South Korean government	This work was supported, in part, by grants from the National Research Foundation of Korea funded by the South Korean government [NRF-2012R1A2A2A01011274 and NRF-2015R1A2A2A01006714 (to H.S.), and NRF-2016R1C1B1015648 (to H.-R.K.)]. The authors declare no conflicts of interest.	Albert Y, 2005, J CELL BIOL, V169, P257, DOI 10.1083/jcb.200501156; Andrade J., 2015, END SOC 97 ANN M EXP; Bhattacharyya S, 2013, J PATHOL, V229, P286, DOI 10.1002/path.4131; Brown SB, 2015, STEROIDS, V99, P8, DOI 10.1016/j.steroids.2014.12.013; Chung D, 2011, ENDOCRINOLOGY, V152, P3246, DOI 10.1210/en.2011-0223; DeSouza MM, 1998, BIOL REPROD, V58, P1503, DOI 10.1095/biolreprod58.6.1503; Fang F, 2013, AM J PATHOL, V183, P1197, DOI 10.1016/j.ajpath.2013.06.016; Franco HL, 2012, FASEB J, V26, P1218, DOI 10.1096/fj.11-193334; Guo B, 2014, CELL CYCLE, V13, P2626, DOI 10.4161/15384101.2014.943581; Hewitt SC, 2003, MOL ENDOCRINOL, V17, P2070, DOI 10.1210/me.2003-0146; Huang N, 2015, PROSTAG OTH LIPID M, V121, P170, DOI 10.1016/j.prostaglandins.2015.08.002; HUETHUDSON YM, 1989, ENDOCRINOLOGY, V125, P1683, DOI 10.1210/endo-125-3-1683; Jeong JW, 2009, P NATL ACAD SCI USA, V106, P8677, DOI 10.1073/pnas.0903632106; Jones A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001551; Katzenellenbogen B S, 1979, Recent Prog Horm Res, V35, P259; Kawagoe J, 2012, DEV CELL, V23, P858, DOI 10.1016/j.devcel.2012.09.002; Kim HR, 2014, REPROD TOXICOL, V50, P60, DOI 10.1016/j.reprotox.2014.10.010; Kim Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep19548; Knobil E., 2006, KNOBIL NEILLS PHYSL, V2; Kommagani R, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005937; Kurihara I, 2007, PLOS GENET, V3, P1053, DOI 10.1371/journal.pgen.0030102; Kurita T, 1998, ENDOCRINOLOGY, V139, P4708, DOI 10.1210/en.139.11.4708; LEE SL, 1995, J BIOL CHEM, V270, P9971, DOI 10.1074/jbc.270.17.9971; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; Li QX, 2011, SCIENCE, V331, P912, DOI 10.1126/science.1197454; Liang XH, 2014, J BIOL CHEM, V289, P23534, DOI 10.1074/jbc.M114.588897; Lopez-Lopez D, 2017, EPILEPSY BEHAV, V71, P226, DOI 10.1016/j.yebeh.2015.12.020; Mantena SR, 2006, P NATL ACAD SCI USA, V103, P1870, DOI 10.1073/pnas.0507261103; Murphy CR, 2004, CELL RES, V14, P259, DOI 10.1038/sj.cr.7290227; Pagel JI, 2012, INT J MOL SCI, V13, P13104, DOI 10.3390/ijms131013104; Ramathal C, 2010, MOL CELL BIOL, V30, P1607, DOI 10.1128/MCB.00872-09; SCHNEIDERMAUNOURY S, 1993, CELL, V75, P1199, DOI 10.1016/0092-8674(93)90329-O; Seo Bong-Jong, 2014, Dev Reprod, V18, P1, DOI 10.12717/DR.2014.18.1.001; Simon L, 2009, ENDOCRINOLOGY, V150, P3871, DOI 10.1210/en.2008-1691; Sun XF, 2013, MOL ENDOCRINOL, V27, P1492, DOI 10.1210/me.2013-1086; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; SWIRNOFF AH, 1995, MOL CELL BIOL, V15, P2275; Topilko P, 1998, MOL ENDOCRINOL, V12, P107, DOI 10.1210/mend.12.1.0049; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Tourtellotte WG, 2000, MOL CELL BIOL, V20, P5261, DOI 10.1128/MCB.20.14.5261-5268.2000; Tourtellotte WG, 1999, DEVELOPMENT, V126, P5061; WILKINSON DG, 1989, NATURE, V337, P461, DOI 10.1038/337461a0; Xiao S, 2011, REPROD TOXICOL, V32, P434, DOI 10.1016/j.reprotox.2011.08.010; Yan SF, 1999, J BIOL CHEM, V274, P15030, DOI 10.1074/jbc.274.21.15030	44	19	20	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1184	1195		10.1096/fj.201700854RR	http://dx.doi.org/10.1096/fj.201700854RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29092905				2022-12-28	WOS:000427246000007
J	Lachowski, D; Cortes, E; Robinson, B; Rice, A; Rombouts, K; Hernandez, AED				Lachowski, Dariusz; Cortes, Ernesto; Robinson, Benjamin; Rice, Alistair; Rombouts, Krista; Hernandez, Armando E. Del Rio			FAK controls the mechanical activation of YAP, a transcriptional regulator required for durotaxis	FASEB JOURNAL			English	Article						mechanotransduction; focal adhesions; directed migration	FOCAL ADHESION KINASE; MATRIX STIFFNESS; PATHWAY; YAP/TAZ; CELLS; MECHANOTRANSDUCERS; HOMEOSTASIS; CARCINOMA; RIGIDITY; SIZE	Focal adhesion kinase (FAK) is a key molecule in focal adhesions and regulates fundamental processes in cells such as growth, survival, and migration. FAK is one of the first molecules recruited to focal adhesions in response to external mechanical stimuli and therefore is a pivotal mediator of cell mechanosignaling, and relays these stimuli to other mechanotransducers within the cytoplasm. Yes-associated protein (YAP) has been identified recently as one of these core mechanotransducers. YAP translocates to the nucleus following changes in cell mechanics to promote the expression of genes implicated in motility, apoptosis, proliferation, and organ growth. Here, we show that FAK controls the nuclear translocation and activation of YAP in response to mechanical activation and submit that the YAP-dependent process of durotaxis requires a cell with an asymmetric distribution of active and inactive FAK molecules.	[Lachowski, Dariusz; Cortes, Ernesto; Robinson, Benjamin; Rice, Alistair; Hernandez, Armando E. Del Rio] Imperial Coll London, Dept Bioengn, Cellular & Mol Biomech Lab, London SW7 2AZ, England; [Rombouts, Krista] UCL, Inst Liver & Digest Hlth, Royal Free Hosp, Regenerat Med & Fibrosis Grp, London NW3 2PF, England	Imperial College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Hernandez, AED (corresponding author), Imperial Coll London, Dept Bioengn, Cellular & Mol Biomech Lab, London SW7 2AZ, England.; Rombouts, K (corresponding author), UCL, Inst Liver & Digest Hlth, Royal Free Hosp, Regenerat Med & Fibrosis Grp, London NW3 2PF, England.	k.rombouts@ucl.ac.uk; a.del-rio-hernandez@imperial.ac.uk	Cortes Lopez, Ernesto/ABE-5343-2021; Rombouts, Krista/ABB-2602-2020; del rio hernandez, armando e/N-4262-2013; del Río Hernández, Armando E/D-3555-2012; Rombouts, Krista/AAE-8179-2020	Cortes Lopez, Ernesto/0000-0001-6106-1323; del rio hernandez, armando e/0000-0001-5062-8910; del Río Hernández, Armando E/0000-0001-5062-8910; Rombouts, Krista/0000-0001-9440-0571; Lachowski, Dariusz/0000-0003-1194-8019	European Research Council [282051]	European Research Council(European Research Council (ERC)European Commission)	The authors thank the Cellular and Molecular Biomechanics Laboratory members for help and advice throughout this work. This work was supported by the European Research Council (Grant Agreement 282051). The authors declare no conflicts of interest.	Attwood SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34334; Carloni V, 2014, LIVER INT, V34, P834, DOI 10.1111/liv.12465; Chakraborty S, 2017, CELL REP, V18, P2464, DOI 10.1016/j.celrep.2017.02.041; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Golubovskaya VM, 2008, J MED CHEM, V51, P7405, DOI 10.1021/jm800483v; Handorf AM, 2015, ORGANOGENESIS, V11, P1, DOI 10.1080/15476278.2015.1019687; Harris AR, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/34/345102; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Keshet R, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723556.2014.995006; Kim NG, 2015, J CELL BIOL, V210, P503, DOI 10.1083/jcb.201501025; Lachowski D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02689-x; Ladoux B, 2016, TRENDS CELL BIOL, V26, P420, DOI 10.1016/j.tcb.2016.02.002; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li YW, 2016, CELL CYCLE, V15, P2497, DOI 10.1080/15384101.2016.1207836; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Low BC, 2014, FEBS LETT, V588, P2663, DOI 10.1016/j.febslet.2014.04.012; Mann DA, 2010, J HEPATOL, V52, P949, DOI 10.1016/j.jhep.2010.02.005; Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Michael KE, 2009, MOL BIOL CELL, V20, P2508, DOI 10.1091/mbc.E08-01-0076; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mueller S, 2010, HEPATIC MED-EVID RES, V2, P49; Plotnikov SV, 2012, CELL, V151, P1513, DOI 10.1016/j.cell.2012.11.034; Raab M, 2012, J CELL BIOL, V199, P669, DOI 10.1083/jcb.201205056; Rice AJ, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.54; Rinschen MM, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aaf8165; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Sulzmaier FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/nrc3792; Sun M, 2016, BIOPHYS J, V110, P2540, DOI 10.1016/j.bpj.2016.04.040; Thomasy SM, 2013, EXP EYE RES, V113, P66, DOI 10.1016/j.exer.2013.05.014; Tse JR., 2010, CURR PROTOC CELL BIO, DOI [10.1002/0471143030.cb1016s47, DOI 10.1002/0471143030.CB1016S47]; Varelas X, 2014, DEVELOPMENT, V141, P1614, DOI 10.1242/dev.102376; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193; Wen JH, 2014, NAT MATER, V13, P979, DOI [10.1038/NMAT4051, 10.1038/nmat4051]; Yujiri T, 2003, J BIOL CHEM, V278, P3846, DOI 10.1074/jbc.M206087200; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216; Zhang XM, 2009, CANCER RES, V69, P6033, DOI 10.1158/0008-5472.CAN-08-4592; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408	41	78	78	2	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					1099	1107		10.1096/fj.201700721R	http://dx.doi.org/10.1096/fj.201700721R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29070586	Bronze			2022-12-28	WOS:000425146900047
J	Martin-Sanchez, P; Luengo, A; Griera, M; Orea, MJ; Lopez-Olaneta, M; Chiloeches, A; Lara-Pezzi, E; de Frutos, S; Rodriguez-Puyol, M; Calleros, L; Rodriguez-Puyol, D				Martin-Sanchez, Paloma; Luengo, Alicia; Griera, Mercedes; Jesus Orea, Maria; Lopez-Olaneta, Marina; Chiloeches, Antonio; Lara-Pezzi, Enrique; de Frutos, Sergio; Rodriguez-Puyol, Manuel; Calleros, Laura; Rodriguez-Puyol, Diego			H-ras deletion protects against angiotensin II-induced arterial hypertension and cardiac remodeling through protein kinase G-I beta pathway activation	FASEB JOURNAL			English	Article						PKG; CREB; H-ras(-/-); cardiac hypertrophy	TARGETED GENOMIC DISRUPTION; K-RAS; N-RAS; BINDING-PROTEINS; TGF-BETA; MOUSE; HYPERTROPHY; GROWTH; INACTIVATION; EXPRESSION	Ras proteins regulate cell survival, growth, differentiation, blood pressure, and fibrosis in some organs. We have demonstrated that H-ras gene deletion producesmice hypotension via a soluble guanylate cyclase-protein kinase G (PKG)-dependent mechanism. In this study, we analyzed the consequences of H-ras deletion on cardiac remodeling induced by continuous angiotensin II (AngII) infusion and the molecular mechanisms implied. Left ventricular posterior wall thickness and mass and cardiomyocyte cross-sectional area were similar between AngII-treated H-Ras knockout (H-ras(-/-)) and control wild-type (H-ras(+/+)) mice, as were extracellular matrix protein expression. Increased cardiac PKG-I beta protein expression in H-ras(-/-) mice suggests the involvement of this protein in heart protection. Ex vivo experiments on cardiac explants could support this mechanism, as PKG blockade blunted protection against AngII-induced cardiac hypertrophy and fibrosis markers in H-ras(-/-) mice. Genetic modulation studies in cardiomyocytes and cardiac and embryonic fibroblasts revealed that the lack of H-Ras down-regulates the B-RAF/MEK/ERK pathway, which induces the glycogen synthase kinase-3b-dependent activation of the transcription factor, cAMP response element-binding protein, which is responsible for PKG-I beta overexpression in H-ras(-/-) mouse embryonic fibroblasts. This study demonstrates that H-ras deletion protects against AngII-induced cardiac remodeling, possibly via a mechanism in which PKG-I beta overexpression could play a partial role, and points to H-Ras and/ordownstream proteins as potential therapeutic targets in cardiovascular disease.	[Martin-Sanchez, Paloma; Luengo, Alicia; Griera, Mercedes; Jesus Orea, Maria; Chiloeches, Antonio; de Frutos, Sergio; Rodriguez-Puyol, Manuel; Calleros, Laura] Univ Alcala, Dept Syst Biol, Madrid, Spain; [Rodriguez-Puyol, Diego] Univ Alcala, Dept Med, Madrid, Spain; [Martin-Sanchez, Paloma; Luengo, Alicia; Griera, Mercedes; de Frutos, Sergio; Rodriguez-Puyol, Manuel; Calleros, Laura; Rodriguez-Puyol, Diego] IRSIN, Madrid, Spain; [Martin-Sanchez, Paloma; Luengo, Alicia; Griera, Mercedes; de Frutos, Sergio; Rodriguez-Puyol, Manuel; Calleros, Laura; Rodriguez-Puyol, Diego] Inst Salud Carlos III, Red Invest Renal REDinREN, Madrid, Spain; [Lopez-Olaneta, Marina; Lara-Pezzi, Enrique] Ctr Nacl Invest Cardiovasc, Myocardial Pathophysiol Area, Madrid, Spain; [Rodriguez-Puyol, Diego] Hosp Univ Principe Asturias, Res Unit Fdn, Nephrol Sect, Madrid, Spain	Universidad de Alcala; Universidad de Alcala; Instituto de Salud Carlos III; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Prince of Asturias University Hospital	Calleros, L (corresponding author), Univ Alcala, Fac Med, Dept Syst Biol, Physiol Unit, Carretera Madrid Barcelona Km 33-600, Madrid 28871, Spain.	laura.calleros@uah.es	de Frutos, Sergio/AAE-7761-2021; Puyol, Diego Rodriguez/AAG-9752-2020; Chiloeches, Antonio/Z-5993-2019; Lara-Pezzi, Enrique/E-2350-2015; Puyol, Manuel Rodriguez/AAG-7049-2020; Calleros, Laura/L-3122-2015	de Frutos, Sergio/0000-0002-1225-5911; Puyol, Diego Rodriguez/0000-0002-9125-9311; Lara-Pezzi, Enrique/0000-0002-2743-1033; Puyol, Manuel Rodriguez/0000-0002-5230-6664; Calleros, Laura/0000-0001-7739-1319; Antonio, Chiloeches Galvez/0000-0001-7162-330X	Instituto de Salud Carlos III (ISCIII); European Fund for Economic and Regional Development (FEDER) [PI11/01630, PI14/01939, PI14/02075]; FEDER; ISCIII RETIC REDinREN [RD12/0021/0006, RD16/0009/0018]; University of Alcala [CCG2015/BIO-034, CCG2016/BIO-043]; Fundacion Senefro (Senefro); Instituto de Investigaciones Sanitarias Reina Sofia; Fundacion Renal Inigo Alvarez de Toledo	Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); European Fund for Economic and Regional Development (FEDER); FEDER(European Commission); ISCIII RETIC REDinREN; University of Alcala; Fundacion Senefro (Senefro); Instituto de Investigaciones Sanitarias Reina Sofia; Fundacion Renal Inigo Alvarez de Toledo	The authors thank Santiago Ropero (Universidad de Alcala) for intellectual contribution. This work was supported by the Instituto de Salud Carlos III (ISCIII) and the European Fund for Economic and Regional Development (FEDER) (Grants PI11/01630, PI14/01939, and PI14/02075), FEDER and ISCIII RETIC REDinREN (Grants RD12/0021/0006 and RD16/0009/0018), the University of Alcala (Grants CCG2015/BIO-034 and CCG2016/BIO-043), the Fundacion Senefro (Senefro-2016; to L.C.), the Instituto de Investigaciones Sanitarias Reina Sofia, and Fundacion Renal Inigo Alvarez de Toledo. The authors declare no conflicts of interest.	Alcock RA, 2002, ONCOGENE, V21, P7883, DOI 10.1038/sj.onc.1205948; BAKER KM, 1990, AM J PHYSIOL, V259, pH324, DOI 10.1152/ajpheart.1990.259.2.H324; Ballestar E, 2003, EMBO J, V22, P6335, DOI 10.1093/emboj/cdg604; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; Calleros L, 2009, CARCINOGENESIS, V30, P1670, DOI 10.1093/carcin/bgp188; Chamorro-Jorganes A, 2011, AM J PHYSIOL-CELL PH, V300, pC683, DOI 10.1152/ajpcell.00251.2010; Chamorro-Jorganes A, 2010, HYPERTENSION, V56, P484, DOI 10.1161/HYPERTENSIONAHA.110.152587; Dhanasekaran N, 1998, ONCOGENE, V17, P1447, DOI 10.1038/sj.onc.1202251; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Eguchi S, 1999, J BIOL CHEM, V274, P36843, DOI 10.1074/jbc.274.52.36843; Ehrhardt A, 2004, MOL CELL BIOL, V24, P6311, DOI 10.1128/MCB.24.14.6311-6323.2004; Esteban LM, 2001, MOL CELL BIOL, V21, P1444, DOI 10.1128/MCB.21.5.1444-1452.2001; Felkin LE, 2011, CIRCULATION, V123, P2838, DOI 10.1161/CIRCULATIONAHA.110.012211; Frantz S, 2013, EUR HEART J, V34, P1233, DOI 10.1093/eurheartj/ehr445; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Goto D, 1999, Angiogenesis, V3, P137, DOI 10.1023/A:1009050131966; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Kataoka C, 2002, HYPERTENSION, V39, P245, DOI 10.1161/hy0202.103271; KIM NN, 1995, AM J PHYSIOL-ENDOC M, V269, pE426, DOI 10.1152/ajpendo.1995.269.3.E426; Koera K, 1997, ONCOGENE, V15, P1151, DOI 10.1038/sj.onc.1201284; Leask A, 2007, CARDIOVASC RES, V74, P207, DOI 10.1016/j.cardiores.2006.07.012; Li L, 2011, CARDIOVASC RES, V91, P80, DOI 10.1093/cvr/cvr067; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; Lukowski R, 2010, P NATL ACAD SCI USA, V107, P5646, DOI 10.1073/pnas.1001360107; Macara IG, 1996, FASEB J, V10, P625, DOI 10.1096/fasebj.10.5.8621061; Martin P, 2014, AM J PHYSIOL-RENAL, V307, pF75, DOI 10.1152/ajprenal.00398.2013; Martinez-Salgado C, 2006, EXP CELL RES, V312, P2093, DOI 10.1016/j.yexcr.2006.03.008; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; MIYATA S, 1994, AM J PHYSIOL, V266, pH2443, DOI 10.1152/ajpheart.1994.266.6.H2443; Muthalif MM, 2000, HYPERTENSION, V36, P604, DOI 10.1161/01.HYP.36.4.604; Ohtsu H, 2006, HYPERTENSION, V48, P534, DOI 10.1161/01.HYP.0000237975.90870.eb; Panse KD, 2012, J CARDIOVASC TRANSL, V5, P814, DOI 10.1007/s12265-012-9400-9; Park BJ, 2000, CANCER RES, V60, P3031; Patrucco E, 2014, P NATL ACAD SCI USA, V111, P12925, DOI 10.1073/pnas.1414364111; Plowman SJ, 2003, MOL CELL BIOL, V23, P9245, DOI 10.1128/MCB.23.24.9245-9250.2003; Potenza N, 2005, EMBO REP, V6, P432, DOI 10.1038/sj.embor.7400397; Rodriguez-Pena AB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/124902; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; Ryves WJ, 2001, BIOCHEM BIOPH RES CO, V280, P720, DOI 10.1006/bbrc.2000.4169; SATOH S, 1993, FEBS LETT, V324, P211, DOI 10.1016/0014-5793(93)81395-G; Schieffer B, 1996, J BIOL CHEM, V271, P10329, DOI 10.1074/jbc.271.17.10329; Schuhmacher AJ, 2008, J CLIN INVEST, V118, P2169, DOI [10.1172/JCI3438S, 10.1172/JCI34385]; Straubinger J, 2015, J PHARMACOL EXP THER, V354, P406, DOI 10.1124/jpet.115.226092; Sugiura T, 2008, CIRC RES, V103, P53, DOI 10.1161/CIRCRESAHA.108.176321; Susic D, 1996, HYPERTENSION, V28, P265, DOI 10.1161/01.HYP.28.2.265; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Grande MT, 2010, KIDNEY INT, V77, P509, DOI 10.1038/ki.2009.498; Wang Z, 2010, CANCER CELL, V17, P597, DOI 10.1016/j.ccr.2010.04.024; Yamamoto K, 2006, HYPERTENSION, V47, P718, DOI 10.1161/01.HYP.0000205833.89478.5b	52	8	8	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					920	934		10.1096/fj.201700134RRRR	http://dx.doi.org/10.1096/fj.201700134RRRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29054855	Bronze			2022-12-28	WOS:000425146900033
J	Ang, ZW; Xiong, D; Wu, M; Ding, JL				Ang, Zhiwei; Xiong, Ding; Wu, Min; Ding, Jeak Ling			FFAR2-FFAR3 receptor heteromerization modulates short-chain fatty acid sensing	FASEB JOURNAL			English	Article						GPCR heteromer; FFA2/GPR43; FFA3/GPR41	RESONANCE ENERGY-TRANSFER; GUT MICROBIOTA; INFLAMMATORY RESPONSES; SIGNALING CASCADES; BETA-ARRESTIN; HUMAN COLON; GPR43; ACTIVATION; INTERNALIZATION; EXPRESSION	Free fatty acid receptors 2 and 3(FFAR2/FFA2/GPR43andFFAR3/FFA3/GPR41) are mammalian receptors for gut microbiota-derived short-chain fatty acids (SCFAs). These receptors are promising drug targets for obesity, colitis, colon cancer, asthma, and arthritis. Here, we demonstrate that FFAR2 and FFAR3 interact to form a heteromer in primary human monocytes and macrophages via proximity ligation assay, and during heterologous expression in HEK293 cells via bimolecular fluorescence complementation and fluorescence resonance energy transfer. The FFAR2-FFAR3 heteromer displayed enhanced cytosolic Ca2+ signaling (1.5-fold increase relative to homomeric FFAR2) and beta-arrestin-2 recruitment (30-fold increase relative to homomeric FFAR3). The enhanced heteromer signaling was attenuated by FFAR2 antagonism (CATPB), G(alpha q) inhibition(YM254890), or G(alpha i) inhibition(pertussis toxin). Unlike homomeric FFAR2/3, the heteromer lacked the ability to inhibit cAMP production but gained the ability to induce p38 phosphorylation in HEK293 and inflammatory monocytes via a CATPB- and YM254890-sensitive mechanism. Our data, taken together, reveal that FFAR2 and FFAR3 may interact to form a receptor heteromer with signaling that is distinct from the parent homomers-a novel pathway for drug targeting.	[Ang, Zhiwei; Xiong, Ding; Wu, Min; Ding, Jeak Ling] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore, Singapore; [Xiong, Ding; Wu, Min] Natl Univ Singapore, Ctr Bioimaging Sci, Singapore, Singapore; [Wu, Min] Natl Univ Singapore, Mechanobiol Inst, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Ding, JL (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	dbsdjl@nus.edu.sg	Ding, Jeak/H-8057-2012	Ang, Zhiwei/0000-0001-6583-4733; XIONG, Ding/0000-0002-2232-9013	National Medical Research Council [NMRC/CBRG/0055/2013]; Ministry of Education [MoE 2013-T2-2-007, MoE R-154-000A31-114, MoE 2015-T2-1-122]	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Education	The authors gratefully acknowledge the kind gifts of YM254890 from Taiho Pharmaceutical (Tokyo, Japan); CATPB from S. Kim (Korean Research Institute of Bioscience and Biotechnology, Daejeon, South Korea); expression plasmids, hFFA2-eYFP and hFFA3-eYFP in pcDNA5/FRT/TO from G. Milligan (University of Glasgow, Glasgow, United Kingdom); pBiFC-VN155(I152L) and pBiFC-VC155 plasmids from C.-D. Hu (27097 and 22011; Addgene; Purdue University, West Lafayette, IN, USA); FFA2-Tango, FFA3-Tango, and P2RY1-Tango plasmids (66281, 66282, 66468; Addgene) and HTLA cells from B. Roth (University of North Carolina at Chapel Hill, Chapel Hill, NC, USA). This work was supported by grants from the National Medical Research Council (NMRC/CBRG/0055/2013) and the Ministry of Education (MoE 2013-T2-2-007 and MoE R-154-000A31- 114 to J.L.D., and MoE 2015-T2-1-122 to M.W.). The authors declare no conflicts of interest.	Ang ZW, 2016, SCI REP-UK, V6, DOI 10.1038/srep34145; Ang ZW, 2015, SCI REP-UK, V5, DOI 10.1038/srep08134; Armando S, 2014, FASEB J, V28, P4509, DOI 10.1096/fj.13-242446; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Bjursell M, 2011, AM J PHYSIOL-ENDOC M, V300, pE211, DOI 10.1152/ajpendo.00229.2010; Brantis C. E., 2011, Int. Appl, Patent No. [WO2011092284, 2011092284]; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Choi RCY, 2008, J BIOL CHEM, V283, P11050, DOI 10.1074/jbc.M709266200; Ganguly S, 2011, BIOPHYS J, V100, P361, DOI 10.1016/j.bpj.2010.12.3692; Gao ZG, 2016, BIOCHEM PHARMACOL, V107, P59, DOI 10.1016/j.bcp.2016.03.003; Ge HF, 2008, ENDOCRINOLOGY, V149, P4519, DOI 10.1210/en.2008-0059; Gouell S., 2009, MONITORING ACTIVITY; Hansen AH, 2017, J MED CHEM, V60, P5638, DOI 10.1021/acs.jmedchem.7b00338; Herlaar E, 1999, MOL MED TODAY, V5, P439, DOI 10.1016/S1357-4310(99)01544-0; Hudson BD, 2012, FASEB J, V26, P4951, DOI 10.1096/fj.12-213314; Jacobsen SE, 2017, J BIOL CHEM, V292, P6910, DOI 10.1074/jbc.M116.762385; Joost P, 2002, GENOME BIOL, V3; Karaki SI, 2008, J MOL HISTOL, V39, P135, DOI 10.1007/s10735-007-9145-y; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kim MH, 2013, GASTROENTEROLOGY, V145, P396, DOI 10.1053/j.gastro.2013.04.056; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Kodama Y, 2010, BIOTECHNIQUES, V49, P793, DOI 10.2144/000113519; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Lee SU, 2013, BIOL PHARM BULL, V36, P1754; Leonard J. N., 2008, Patent, Patent No. [2008/0312277 Al, 20080312277, US20080312277A1]; Levoye A, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00167; Macia L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7734; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Masui R, 2013, INFLAMM BOWEL DIS, V19, P2848, DOI 10.1097/01.MIB.0000435444.14860.ea; McNelis JC, 2015, DIABETES, V64, P3203, DOI 10.2337/db14-1938; Natarajan N, 2016, PHYSIOL GENOMICS, V48, P826, DOI 10.1152/physiolgenomics.00089.2016; Navarro G, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0247-4; Ng J, 2010, NEUROSCIENCE, V165, P535, DOI 10.1016/j.neuroscience.2009.10.017; Park BO, 2016, EUR J PHARMACOL, V771, P1, DOI 10.1016/j.ejphar.2015.12.010; Pei L, 2010, NAT MED, V16, P1393, DOI 10.1038/nm.2263; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; Priyadarshini M, 2015, MOL ENDOCRINOL, V29, P1055, DOI 10.1210/me.2015-1007; Rico AJ, 2017, BRAIN STRUCT FUNCT, V222, P1767, DOI 10.1007/s00429-016-1306-x; Rodriuez-Ruiz M, 2017, MOL NEUROBIOL, V54, P4537, DOI 10.1007/s12035-016-9995-y; Rozenfeld R, 2007, FASEB J, V21, P2455, DOI 10.1096/fj.06-7793com; Sergeev E, 2016, J BIOL CHEM, V291, P303, DOI 10.1074/jbc.M115.687939; Sina C, 2009, J IMMUNOL, V183, P7514, DOI 10.4049/jimmunol.0900063; Sivaprakasam S, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.38; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Stoddart L. A., 2007, INVESTIGATION FUNCTI; Stoddart LA, 2008, J BIOL CHEM, V283, P32913, DOI 10.1074/jbc.M805601200; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Tang C, 2015, NAT MED, V21, P173, DOI 10.1038/nm.3779; Tazoe H, 2009, BIOMED RES-TOKYO, V30, P149, DOI 10.2220/biomedres.30.149; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Vieira AT, 2015, ARTHRITIS RHEUMATOL, V67, P1646, DOI 10.1002/art.39107; Vinolo MAR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021205; Wang YC, 2010, BIOORG MED CHEM LETT, V20, P493, DOI 10.1016/j.bmcl.2009.11.112	58	52	52	2	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					289	+		10.1096/fj.201700252RR	http://dx.doi.org/10.1096/fj.201700252RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28883043	Green Published			2022-12-28	WOS:000419172700027
J	Chandra, A; Wang, LQ; Young, T; Zhong, LL; Tseng, WJ; Levine, MA; Cengel, K; Liu, XS; Zhang, YJ; Pignolo, RJ; Qin, L				Chandra, Abhishek; Wang, Luqiang; Young, Tiffany; Zhong, Leilei; Tseng, Wei-Ju; Levine, Michael A.; Cengel, Keith; Liu, X. Sherry; Zhang, Yejia; Pignolo, Robert J.; Qin, Ling			Proteasome inhibitor bortezomib is a novel therapeutic agent for focal radiation-induced osteoporosis	FASEB JOURNAL			English	Article						osteoblast; DNA repair; bone; irradiation; apoptosis	DEPENDENT PROTEIN-KINASE; NF-KAPPA-B; MULTIPLE-MYELOMA; DNA-REPAIR; BONE; APOPTOSIS; IRRADIATION; PATHWAY; SYSTEM; TARGET	Bone atrophy and its related fragility fractures are frequent, late side effects of radiotherapy in cancer survivors and have a detrimental impact on their quality of life. In another study, we showed that parathyroid hormone 1-34 andanti-sclerostinantibodyattenuates radiation-induced bonedamagebyacceleratingDNArepair in osteoblasts. DNA damage responses are partially regulated by the ubiquitin proteasome pathway. In the current study, we examined whether proteasome inhibitors have similar bone-protective effects against radiation damage. MG132 treatment greatly reducedradiation-inducedapoptosis inculturedosteoblastic cells. This survival effectwas owing to acceleratedDNArepair as revealed by gamma H2AX foci and comet assays and to the up-regulation ofKu70 and DNA-dependent protein kinase, catalytic subunit, essential DNA repair proteins in the nonhomologous end-joining pathway. Administration of bortezomib (Bzb) reversed the loss of trabecular bone structure and strength in mice at 4 wk after focal radiation. Histomorphometry revealed that Bzb significantly increased the number of osteoblasts and activity in the irradiated area and suppressed the number and activity of osteoclasts, regardless of irradiation. Twoweeks of Bzb treatment acceleratedDNArepair in bone-lining osteoblasts and thus promotedtheir survival. Meanwhile, it also inhibited bone marrow adiposity. Taken together, we demonstrate a novel role of proteasome inhibitors in treating radiation-induced osteoporosis.	[Chandra, Abhishek; Wang, Luqiang; Young, Tiffany; Zhong, Leilei; Tseng, Wei-Ju; Liu, X. Sherry; Zhang, Yejia; Qin, Ling] Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, G14A Stemmler Hall,36th St & Hamilton Walk, Philadelphia, PA 19104 USA; [Levine, Michael A.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Cengel, Keith] Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA; [Zhang, Yejia] Univ Penn, Perelman Sch Med, Dept Phys Med & Rehabil, Philadelphia, PA 19104 USA; [Chandra, Abhishek] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN USA; [Chandra, Abhishek; Pignolo, Robert J.] Mayo Clin, Dept Med, Rochester, MN USA; [Levine, Michael A.] Childrens Hosp Philadelphia, Div Endocrinol & Diabet, Philadelphia, PA 19104 USA; [Levine, Michael A.] Childrens Hosp Philadelphia, Ctr Bone Hlth, Philadelphia, PA 19104 USA; [Zhang, Yejia] Corporal Michael J Crescenz Vet Affairs Med Ctr, TMRC, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Mayo Clinic; Mayo Clinic; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Qin, L (corresponding author), Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, G14A Stemmler Hall,36th St & Hamilton Walk, Philadelphia, PA 19104 USA.	qinling@mail.med.upenn.edu	Liu, Xiaowei Sherry/H-1664-2017; Chandra, Abhishek/AAG-8781-2020; Tseng, Wei-Ju/AAC-2819-2022	Liu, Xiaowei Sherry/0000-0001-7247-2232; Levine, Michael/0000-0003-0036-7809; Chandra, Abhishek/0000-0001-9423-9669	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR066098, P30AR050950, K01AR066743]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [R01DK095803]; NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant [1K08HD049598]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD049598] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA087971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR066098, P30AR050950, P30AR069619, K01AR066743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095803] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Martin F. Heyworth (Corporal Michael J. Crescenz Veterans Affairs Medical Center), for critically editing the manuscript. This study was supported by U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases Grants R01AR066098, P30AR050950 (Penn Center for Musculoskeletal Disorders), and K01AR066743 (to X.S.L.); NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant R01DK095803 (to L.Q.); and NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant 1K08HD049598 (to Y.Z.). The authors declare no conflicts of interest.	Baugh JM, 2009, J MOL BIOL, V386, P814, DOI 10.1016/j.jmb.2008.12.081; Cao X, 2011, P NATL ACAD SCI USA, V108, P1609, DOI 10.1073/pnas.1015350108; Capriani C, 2012, J BONE MINER RES, V27, P2419, DOI 10.1002/jbmr.1800; CasciolaRosen L, 1996, J EXP MED, V183, P1957, DOI 10.1084/jem.183.5.1957; Chanda A, 2014, AM ECON J-MACROECON, V6, P1, DOI 10.1257/mac.6.3.1; Chandra A, 2017, J BONE MINER RES, V32, P360, DOI 10.1002/jbmr.2996; Chandra A, 2015, J BIOL CHEM, V290, P157, DOI 10.1074/jbc.M114.608158; Chandra A, 2013, J BIOL CHEM, V288, P20488, DOI 10.1074/jbc.M112.447250; Chandra A, 2013, BONE, V55, P449, DOI 10.1016/j.bone.2013.02.023; Chargari C, 2016, CANCER METAST REV, V35, P277, DOI 10.1007/s10555-016-9616-2; Chitra S, 2012, INT J RHEUM DIS, V15, P249, DOI 10.1111/j.1756-185X.2012.01737.x; Chouinard L, 2016, REGUL TOXICOL PHARM, V81, P212, DOI 10.1016/j.yrtph.2016.08.010; Crockett JC, 2011, J CELL SCI, V124, P991, DOI 10.1242/jcs.063032; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Dou QP, 2014, CURR CANCER DRUG TAR, V14, P517, DOI 10.2174/1568009614666140804154511; Elliot P J, 1999, Curr Opin Drug Discov Devel, V2, P484; ERGUN H, 1980, CRC CR REV DIAGN IM, V12, P225; Gama V, 2006, EXP CELL RES, V312, P488, DOI 10.1016/j.yexcr.2005.11.016; Goodwin JF, 2014, CANCER DISCOV, V4, P1126, DOI 10.1158/2159-8290.CD-14-0358; Groll M, 2006, STRUCTURE, V14, P451, DOI 10.1016/j.str.2005.11.019; Grundy GJ, 2014, DNA REPAIR, V17, P30, DOI 10.1016/j.dnarep.2014.02.019; GUNGOR T, 1982, ACTA ORTHOP SCAND, V53, P333, DOI 10.3109/17453678208992225; Han ZY, 1996, J BIOL CHEM, V271, P25035, DOI 10.1074/jbc.271.40.25035; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Holt GE, 2005, J BONE JOINT SURG AM, V87A, P315, DOI 10.2106/JBJS.C.01714; Hoyt MA, 2004, CELL MOL LIFE SCI, V61, P1596, DOI 10.1007/s00018-004-4133-9; Hurchla MA, 2013, LEUKEMIA, V27, P430, DOI 10.1038/leu.2012.183; Jiang N, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.171; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; Konstantinova IM, 2008, INT REV CEL MOL BIO, V267, P59, DOI 10.1016/S1937-6448(08)00602-3; Mohammad Khalid S., 2008, V455, P37, DOI 10.1007/978-1-59745-104-8_3; Mukherjee S, 2008, J CLIN INVEST, V118, P491, DOI [10.1172/JCI33102, 10.1172/JC133102]; Oh D, 2014, RADIAT ONCOL J, V32, P213, DOI 10.3857/roj.2014.32.4.213; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Richardson PG, 2009, BRIT J HAEMATOL, V144, P895, DOI 10.1111/j.1365-2141.2008.07573.x; Ross GM, 1999, ENDOCR-RELAT CANCER, V6, P41, DOI 10.1677/erc.0.0060041; Sawajiri M, 2003, RADIAT ENVIRON BIOPH, V42, P219, DOI 10.1007/s00411-003-0204-9; SHALHOUB V, 1992, J CELL BIOCHEM, V50, P425, DOI 10.1002/jcb.240500411; Song QZ, 1996, EMBO J, V15, P3238, DOI 10.1002/j.1460-2075.1996.tb00688.x; Vahle JL, 2002, TOXICOL PATHOL, V30, P312, DOI 10.1080/01926230252929882; Vignard J, 2013, RADIOTHER ONCOL, V108, P362, DOI 10.1016/j.radonc.2013.06.013; von Metzler I, 2007, LEUKEMIA, V21, P2025, DOI 10.1038/sj.leu.2404806; Wang XR, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001232; Zangari M, 2016, BONE, V86, P131, DOI 10.1016/j.bone.2016.02.019; Zangari M, 2012, CANCER TREAT REV, V38, P968, DOI 10.1016/j.ctrv.2011.12.007	47	21	28	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					52	62		10.1096/fj.201700375R	http://dx.doi.org/10.1096/fj.201700375R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28860152	Green Published			2022-12-28	WOS:000419172700007
J	Jung, KB; Lee, H; Son, YS; Lee, JH; Cho, HS; Lee, MO; Oh, JH; Lee, J; Kim, S; Jung, CR; Kim, J; Son, MY				Jung, Kwang Bo; Lee, Hana; Son, Ye Seul; Lee, Ji Hye; Cho, Hyun-Soo; Lee, Mi-Ok; Oh, Jung-Hwa; Lee, Jaemin; Kim, Seokho; Jung, Cho-Rok; Kim, Janghwan; Son, Mi-Young			In vitro and in vivo imaging and tracking of intestinal organoids from human induced pluripotent stem cells	FASEB JOURNAL			English	Article						KLF5; ISX; fluorescence imaging; reporter system; human intestine	GENE-EXPRESSION; TISSUE; DIFFERENTIATION; MODEL; TRANSPLANTATION; DISEASE; CARDIOMYOCYTES; EPITHELIUM; GUT	Human intestinal organoids (hIOs) derived from human pluripotent stem cells (hPSCs) have immense potential as a source of intestines. Therefore, an efficient system is needed for visualizing the stage of intestinal differentiation and further identifying hIOs derived from hPSCs. Here, 2 fluorescent biosensors were developed based on human induced pluripotent stem cell (hiPSC) lines that stably expressed fluorescent reporters driven by intestine-specific gene promoters Kruppel-like factor 5 monomeric Cherry (KLF5(mCherry)) and intestine-specific homeobox enhanced green fluorescence protein (ISXeGFP). Then hIOs were efficiently induced from those transgenic hiPSC lines in which mCherry- or eGFP-expressing cells, which appeared during differentiation, could be identified in intact living cells in real time. Reporter gene expression had no adverse effects on differentiation into hIOs and proliferation. Using our reporter system to screen for hIO differentiation factors, we identified DMH1 as an efficient substitute for Noggin. Transplanted hIOs under the kidney capsule were tracked with fluorescence imaging(FLI) and confirmed histologically. After orthotopic transplantation, the localization of the hIOs in the small intestine could be accurately visualized using FLI. Our study establishes a selective system for monitoring the in vitro differentiation and for tracking the in vivo localization of hIOs and contributes to further improvement of cell-based therapies and preclinical screenings in the intestinal field.	[Jung, Kwang Bo; Lee, Hana; Son, Ye Seul; Lee, Ji Hye; Cho, Hyun-Soo; Jung, Cho-Rok; Kim, Janghwan; Son, Mi-Young] KRIBB, Stem Cell Res Ctr, Daejeon 34141, South Korea; [Lee, Mi-Ok] KRIBB, Immunotherapy Covergence Res Ctr, Daejeon, South Korea; [Lee, Jaemin; Kim, Seokho] KRIBB, Aging Res Inst, Daejeon, South Korea; [Jung, Kwang Bo; Lee, Hana; Son, Ye Seul; Cho, Hyun-Soo; Kim, Seokho; Jung, Cho-Rok; Kim, Janghwan; Son, Mi-Young] Korea Univ Sci & Technol, KRIBB Sch Biosci, Dept Funct Genom, Daejeon, South Korea; [Oh, Jung-Hwa] Korea Inst Toxicol, Daejeon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST); Korea Institute of Toxicology	Kim, J; Son, MY (corresponding author), KRIBB, Stem Cell Res Ctr, Daejeon 34141, South Korea.	janghwan.kim@kribb.re.kr; myson@kribb.re.kr		, cho-rok/0000-0002-4474-6563	National Research Foundation of Korea - Ministry of Science, Information and Communications Technologies (ICT), and Future Planning [2016R1A2B4013501]; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program	National Research Foundation of Korea - Ministry of Science, Information and Communications Technologies (ICT), and Future Planning; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program	This work was supported by the National Research Foundation of Korea, funded by the Ministry of Science, Information and Communications Technologies (ICT), and Future Planning (Grant 2016R1A2B4013501), and the Korea Research Institute of Bioscience and Biotechnology Research Initiative Program. The funders had no role in the study design, data collection or analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest.	Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Aurora M, 2016, DEV BIOL, V420, P230, DOI 10.1016/j.ydbio.2016.06.006; Bitar KN, 2012, NEUROGASTROENT MOTIL, V24, P7, DOI 10.1111/j.1365-2982.2011.01843.x; Bitar KN, 2014, GASTROENTEROLOGY, V146, P1614, DOI 10.1053/j.gastro.2014.03.044; Brugmann SA, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt362; Chen CH, 2006, INT J CANCER, V118, P1346, DOI 10.1002/ijc.21533; Chinen J, 2010, J ALLERGY CLIN IMMUN, V125, pS324, DOI 10.1016/j.jaci.2009.11.014; Choi YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086358; Den Hartogh SC, 2015, STEM CELLS, V33, P56, DOI 10.1002/stem.1842; Desai CS, 2012, INDIAN J GASTROENTER, V31, P217, DOI 10.1007/s12664-012-0243-8; Finkbeiner SR, 2015, STEM CELL REP, V4, P1140, DOI 10.1016/j.stemcr.2015.04.010; Fordham RP, 2013, CELL STEM CELL, V13, P734, DOI 10.1016/j.stem.2013.09.015; Forster R, 2014, STEM CELL REP, V2, P838, DOI 10.1016/j.stemcr.2014.05.001; Howell JC, 2011, REGEN MED, V6, P743, DOI [10.2217/RME.11.90, 10.2217/rme.11.90]; Huber I, 2007, FASEB J, V21, P2551, DOI 10.1096/fj.05-5711com; Jung KB, 2017, MOL BIOSYST, V13, P1565, DOI 10.1039/c7mb00174f; Kim DS, 2017, HEPATOLOGY, V66, P1662, DOI 10.1002/hep.29324; Kwak JE, 2015, BIOCHEM BIOPH RES CO, V457, P554, DOI 10.1016/j.bbrc.2015.01.023; Lavon N, 2004, DIFFERENTIATION, V72, P230, DOI 10.1111/j.1432-0436.2004.07205002.x; Lavon N, 2006, STEM CELLS, V24, P1923, DOI 10.1634/stemcells.2005-0397; McCracken KW, 2011, NAT PROTOC, V6, P1920, DOI 10.1038/nprot.2011.410; Noisa P, 2010, STEM CELL REV REP, V6, P438, DOI 10.1007/s12015-010-9159-9; Richmond CA, 2010, PROG MOL BIOL TRANSL, V96, P207, DOI 10.1016/S1877-1173(10)96009-2; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Shroyer NF, 2005, GENE DEV, V19, P2412, DOI 10.1101/gad.1353905; Sinagoga KL, 2015, EMBO J, V34, P1149, DOI 10.15252/embj.201490686; Son MY, 2017, NEUROPATH APPL NEURO, V43, P584, DOI 10.1111/nan.12396; Son MY, 2017, STEM CELLS DEV, V26, P133, DOI 10.1089/scd.2016.0181; Son MY, 2015, J PATHOL, V237, P98, DOI 10.1002/path.4551; Son MY, 2015, PROTEOMICS, V15, P2220, DOI 10.1002/pmic.201400510; Son MY, 2014, HUM MOL GENET, V23, P1802, DOI 10.1093/hmg/ddt571; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Watson CL, 2014, NAT MED, V20, P1310, DOI 10.1038/nm.3737; Wells JM, 2014, DEVELOPMENT, V141, P752, DOI 10.1242/dev.097386; Widjaja-Adhi MAK, 2015, HUM MOL GENET, V24, P3206, DOI 10.1093/hmg/ddv072; Woo DH, 2016, CELL STEM CELL, V19, P397, DOI 10.1016/j.stem.2016.05.024; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695; Zietek T, 2015, SCI REP-UK, V5, DOI 10.1038/srep16831	38	28	28	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					111	122		10.1096/fj.201700504R	http://dx.doi.org/10.1096/fj.201700504R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	28855280				2022-12-28	WOS:000419172700012
J	Kamandulis, S; Leite, FD; Hernandez, A; Katz, A; Brazaitis, M; Bruton, JD; Venckunas, T; Masiulis, N; Mickeviciene, D; Eimantas, N; Subocius, A; Rassier, DE; Skurvydas, A; Ivarsson, N; Westerblad, H				Kamandulis, Sigitas; Leite, Felipe de Souza; Hernandez, Andres; Katz, Abram; Brazaitis, Marius; Bruton, Joseph D.; Venckunas, Tomas; Masiulis, Nerijus; Mickeviciene, Dalia; Eimantas, Nerijus; Subocius, Andrejus; Rassier, Dilson E.; Skurvydas, Albertas; Ivarsson, Niklas; Westerblad, Hakan			Prolonged force depression after mechanically demanding contractions is largely independent of Ca2+ and reactive oxygen species	FASEB JOURNAL			English	Article						eccentric contractions; aging; muscle damage	SKELETAL-MUSCLE FIBERS; RECEPTOR-GAMMA COACTIVATOR-1-ALPHA; ECCENTRIC EXERCISE; RYANODINE RECEPTOR; MITOCHONDRIAL BIOGENESIS; INTRACELLULAR CALCIUM; OXIDATIVE STRESS; DAMAGE; STRETCH; MOUSE	Increased production of reactive oxygen/nitrogen species (ROS) and impaired cellular Ca2+ handling are implicated in the prolonged low-frequency force depression (PLFFD) observed in skeletal muscle after both metabolically and mechanically demanding exercise. Metabolically demanding high-intensity exercise can induce PLFFD accompanied by ROS-dependent fragmentation of the sarcoplasmic reticulum Ca2+ release channels, the ryanodine receptor 1s (RyR1s). We tested whether similar changes occur after mechanically demanding eccentric contractions. Human subjects performed 100 repeated drop jumps, which require eccentric knee extensor contractions upon landing. This exercise caused a major PLFFD, such that maximum voluntary and electrically evoked forces did not recover within 24 h. Drop jumps induced only minor signs of increased ROS, and RyR1 fragmentation was observed in only 3 of 7 elderly subjects. Also, isolated mouse muscle preparations exposed to drop-jump-mimicking eccentric contractions showed neither signs of increased ROS nor RyR1 fragmentation. Still, the free cytosolic [Ca2+] during tetanic contractions was decreased by similar to 15% 1 h after contractions, which can explain the exaggerated force decrease at low-stimulation frequencies but not the major frequency-independent force depression. In conclusion, PLFFD caused by mechanically demanding eccentric contractions does not involve any major increase in ROS or RyR1 fragmentation.	[Kamandulis, Sigitas; Brazaitis, Marius; Venckunas, Tomas; Masiulis, Nerijus; Mickeviciene, Dalia; Eimantas, Nerijus; Subocius, Andrejus; Skurvydas, Albertas; Westerblad, Hakan] Lithuanian Sports Univ, Inst Sport Sci & Innovat, Kaunas, Lithuania; [Leite, Felipe de Souza; Rassier, Dilson E.] McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ, Canada; [Hernandez, Andres; Katz, Abram; Bruton, Joseph D.; Ivarsson, Niklas; Westerblad, Hakan] Karolinska Inst, Dept Physiol & Pharmacol, SE-17177 Stockholm, Sweden; [Subocius, Andrejus] Kaunas Clin Hosp, Dept Surg, Kaunas, Lithuania; [Subocius, Andrejus] Republican Hosp Kaunas, Surg Clin, Kaunas, Lithuania; [Katz, Abram] Ariel Univ, Dept Phys Therapy, Sch Hlth Sci, Ariel, Israel	Lithuanian Sports University; McGill University; Karolinska Institutet; Republican Hospital of Kaunas; Ariel University	Westerblad, H (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, SE-17177 Stockholm, Sweden.	hakan.westerblad@ki.se	HERNANDEZ-GARCIA, ANDRES/B-9051-2014; Katz, Abram/AAL-2244-2020; de Souza Leite, Felipe/O-2657-2019	HERNANDEZ-GARCIA, ANDRES/0000-0002-5343-5513; de Souza Leite, Felipe/0000-0003-2493-8872; Bruton, Joseph/0000-0002-6985-099X; Westerblad, Hakan/0000-0002-8180-3029; Ivarsson, Niklas/0000-0002-3830-657X	Research Council of Lithuania [MIP-017/2014]; Swedish Research Council [K2014-52X-10842-21-5]; Swedish Research Council for Sport Science [FO2016-0033]	Research Council of Lithuania(Research Council of Lithuania (LMTLT)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Sport Science	This study was supported by grants from the Research Council of Lithuania (MIP-017/2014; to A.S.), the Swedish Research Council (K2014-52X-10842-21-5; to H.W.), and the Swedish Research Council for Sport Science (FO2016-0033; to H.W.). The authors declare no conflicts of interest.	Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; Andersson DC, 2011, CELL METAB, V14, P196, DOI 10.1016/j.cmet.2011.05.014; Andrade FH, 1998, J PHYSIOL-LONDON, V509, P565, DOI 10.1111/j.1469-7793.1998.565bn.x; ANIANSSON A, 1992, J APPL PHYSIOL, V73, P812, DOI 10.1152/jappl.1992.73.3.812; Aydin J, 2008, FASEB J, V22, P3919, DOI 10.1096/fj.08-113712; BALNAVE CD, 1995, J PHYSIOL-LONDON, V488, P25, DOI 10.1113/jphysiol.1995.sp020943; Bellinger AM, 2008, P NATL ACAD SCI USA, V105, P2198, DOI 10.1073/pnas.0711074105; Bellinger AM, 2008, J CLIN INVEST, V118, P445, DOI 10.1172/JCI34006; Brooks SV, 1996, J PHYSIOL-LONDON, V497, P573, DOI 10.1113/jphysiol.1996.sp021790; Bruton JD, 2010, J PHYSIOL-LONDON, V588, P4275, DOI 10.1113/jphysiol.2010.198598; Cheng AJ, 2015, J PHYSIOL-LONDON, V593, P457, DOI 10.1113/jphysiol.2014.279398; Clarkson PM, 2002, AM J PHYS MED REHAB, V81, pS52, DOI [10.1097/00002060-200211001-00007, 10.1097/01.PHM.0000029772.45258.43]; Coffey VG, 2017, J PHYSIOL-LONDON, V595, P2883, DOI 10.1113/JP272270; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Dargeviciute G, 2013, J APPL PHYSIOL, V115, P1191, DOI 10.1152/japplphysiol.00686.2013; DAVIES CTM, 1981, PFLUG ARCH EUR J PHY, V392, P168, DOI 10.1007/BF00581267; EDWARDS RHT, 1977, J PHYSIOL-LONDON, V272, P769, DOI 10.1113/jphysiol.1977.sp012072; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; FRIDEN J, 1983, INT J SPORTS MED, V4, P170, DOI 10.1055/s-2008-1026030; Fyfe JJ, 2014, SPORTS MED, V44, P743, DOI 10.1007/s40279-014-0162-1; Gehlert S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049326; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; He F, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00486; Ingalls CP, 1998, J APPL PHYSIOL, V85, P58, DOI 10.1152/jappl.1998.85.1.58; Jackson MJ, 2011, J PHYSIOL-LONDON, V589, P2139, DOI 10.1113/jphysiol.2011.206623; Kamandulis S, 2010, ACTA PHYSIOL, V198, P91, DOI 10.1111/j.1748-1716.2009.02041.x; Keeton RB, 2006, PHYS THER, V86, P1146, DOI 10.1093/ptj/86.8.1146; Kerksick CM, 2010, AMINO ACIDS, V39, P219, DOI 10.1007/s00726-009-0432-7; Kerr JP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9526; Khairallah RJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002829; Kon M, 2007, APPL PHYSIOL NUTR ME, V32, P273, DOI 10.1139/H06-115; Labuda A, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3527913; Lima LCR, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00300; Lovering RM, 2014, J APPL PHYSIOL, V116, P1439, DOI 10.1152/japplphysiol.00174.2013; Magistris MR, 1998, MUSCLE NERVE, V21, P194, DOI 10.1002/(SICI)1097-4598(199802)21:2<194::AID-MUS6>3.0.CO;2-6; MANFREDI TG, 1991, MED SCI SPORT EXER, V23, P1028; MCBRIDE TA, 1995, MECH AGEING DEV, V83, P185, DOI 10.1016/0047-6374(95)01629-E; McNeil CJ, 2007, J APPL PHYSIOL, V102, P1962, DOI 10.1152/japplphysiol.01166.2006; Morley JE, 2008, J NUTR HEALTH AGING, V12, P452, DOI 10.1007/BF02982705; NEWHAM DJ, 1987, J APPL PHYSIOL, V63, P1381, DOI 10.1152/jappl.1987.63.4.1381; Nikolaidis MG, 2008, SPORTS MED, V38, P579, DOI 10.2165/00007256-200838070-00005; Nosaka K, 2005, MED SCI SPORT EXER, V37, P746, DOI 10.1249/01.MSS.0000162691.66162.00; Palomero J, 2012, FREE RADICAL RES, V46, P30, DOI 10.3109/10715762.2011.637203; Patel T J, 1997, Exerc Sport Sci Rev, V25, P321; Place N, 2015, P NATL ACAD SCI USA, V112, P15492, DOI 10.1073/pnas.1507176112; Place N, 2010, EUR J APPL PHYSIOL, V110, P1, DOI 10.1007/s00421-010-1480-0; Ploutz-Snyder LL, 2001, J GERONTOL A-BIOL, V56, pB384, DOI 10.1093/gerona/56.9.B384; Proske U, 2001, J PHYSIOL-LONDON, V537, P333, DOI 10.1111/j.1469-7793.2001.00333.x; Rader EP, 2006, EXP PHYSIOL, V91, P781, DOI 10.1113/expphysiol.2005.033043; Rassier DE, 2008, P ROY SOC B-BIOL SCI, V275, P2577, DOI 10.1098/rspb.2008.0719; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Sjogaard G, 2014, J ELECTROMYOGR KINES, V24, P789, DOI 10.1016/j.jelekin.2014.08.005; Skurvydas A, 2016, EUR J APPL PHYSIOL, V116, P2215, DOI 10.1007/s00421-016-3473-0; Skurvydas A, 2011, APPL PHYSIOL NUTR ME, V36, P353, DOI [10.1139/h11-023, 10.1139/H11-023]; Vandervoort AA, 2002, MUSCLE NERVE, V25, P17, DOI 10.1002/mus.1215; Ward CW, 2014, ANTIOXID REDOX SIGN, V20, P929, DOI 10.1089/ars.2013.5517; Wright DC, 2007, J BIOL CHEM, V282, P18793, DOI 10.1074/jbc.M611252200; Yu JG, 2004, HISTOCHEM CELL BIOL, V121, P219, DOI 10.1007/s00418-004-0625-9	58	24	24	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4809	4820		10.1096/fj.201700019R	http://dx.doi.org/10.1096/fj.201700019R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28716970				2022-12-28	WOS:000413398500013
J	Liu, CH; Wang, ZX; Sun, Y; Chen, J				Liu, Chi-Hsiu; Wang, Zhongxiao; Sun, Ye; Chen, Jing			Animal models of ocular angiogenesis: from development to pathologies	FASEB JOURNAL			English	Review						choroidal neovascularization; corneal angiogenesis; macular degeneration; retinal vasculature; retinopathy	ENDOTHELIAL GROWTH-FACTOR; DENSITY-LIPOPROTEIN RECEPTOR; RETINAL VASCULAR DEVELOPMENT; OXYGEN-INDUCED RETINOPATHY; EXPERIMENTAL CHOROIDAL NEOVASCULARIZATION; TISSUE-SPECIFIC EXPRESSION; MOUSE MODEL; MACULAR DEGENERATION; DIABETIC-RETINOPATHY; SUBRETINAL NEOVASCULARIZATION	Pathological angiogenesis in the eye is an important feature in the pathophysiology of many vision-threatening diseases, including retinopathy of prematurity, diabetic retinopathy, and age-related macular degeneration, as well as corneal diseases with abnormal angiogenesis. Development of reproducible and reliable animal models of ocular angiogenesis has advanced our understanding of both the normal development and the pathobiology of ocular neovascularization. These models have also proven to be valuable experimental tools with which to easily evaluate potential antiangiogenic therapies beyond eye research. This review summarizes the current available animal models of ocular angiogenesis. Models of retinal and choroidal angiogenesis, including oxygen-induced retinopathy, laser-induced choroidal neovascularization, and transgenic mouse models with deficient or spontaneous retinal/choroidal neovascularization, as well as models with induced corneal angiogenesis, are widely used to investigate the molecular and cellular basis of angiogenic mechanisms. Theoretical concepts and experimental protocols of these models are outlined, as well as their advantages and potential limitations, which may help researchers choose the most suitable models for their investigative work.	[Liu, Chi-Hsiu; Wang, Zhongxiao; Sun, Ye; Chen, Jing] Harvard Med Sch, Boston Childrens Hosp, Dept Ophthalmol, 300 Longwood Ave, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Chen, J (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Dept Ophthalmol, 300 Longwood Ave, Boston, MA 02115 USA.	jing.chen@childrens.harvard.edu		Sun, Ye/0000-0002-7674-9056	U.S. National Institutes of Health (NIH), National Eye Institute [R01-EY024963]; Boston Children's Hospital Ophthalmology Foundation; Massachusetts Lions Eye Research Fund, Inc.; BrightFocus Foundation; Knights Templar Eye Foundation Pediatric Ophthalmology Career-Starter Research Grants; Boston Children's Hospital Faculty Career Development Grant OFD/BTREC/CTREC; NATIONAL EYE INSTITUTE [R01EY024963] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Boston Children's Hospital Ophthalmology Foundation; Massachusetts Lions Eye Research Fund, Inc.; BrightFocus Foundation(BrightFocus Foundation); Knights Templar Eye Foundation Pediatric Ophthalmology Career-Starter Research Grants; Boston Children's Hospital Faculty Career Development Grant OFD/BTREC/CTREC; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by U.S. National Institutes of Health (NIH), National Eye Institute Grant R01-EY024963, the Boston Children's Hospital Ophthalmology Foundation, Massachusetts Lions Eye Research Fund, Inc. and BrightFocus Foundation (to J.C.), Knights Templar Eye Foundation Pediatric Ophthalmology Career-Starter Research Grants (to C.-H.L.), and Boston Children's Hospital Faculty Career Development Grant OFD/BTREC/CTREC (to Y.S.). All animal work was approved by the Boston Children's Hospital Animal Care and Use Committee and adhered to the Association for Research in Vision and Ophthalmology Statement for the Use of Animals in Ophthalmic and Vision Research. The authors declare no conflicts of interest.	Afzal A, 2007, MICROVASC RES, V74, P131, DOI 10.1016/j.mvr.2007.04.011; Ahmad S, 2012, STEM CELL TRANSL MED, V1, P110, DOI 10.5966/sctm.2011-0037; AIELLO LP, 1995, P NATL ACAD SCI USA, V92, P10457, DOI 10.1073/pnas.92.23.10457; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Al-Latayfeh M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006411; Albuquerque RJC, 2009, NAT MED, V15, P1023, DOI 10.1038/nm.2018; Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; AMIN R, 1994, INVEST OPHTH VIS SCI, V35, P3178; Anai M, 2005, J BIOL CHEM, V280, P18525, DOI 10.1074/jbc.M500586200; Anand-Apte J. G. H. Bela, 2011, RETINA ITS DISORDERS; ANDERSEN SR, 1961, ARCH OPHTHALMOL-CHIC, V66, P614, DOI 10.1001/archopht.1961.00960010616003; ARCHER DB, 1981, AM J OPHTHALMOL, V91, P433, DOI 10.1016/0002-9394(81)90230-0; ASHTON N, 1954, BRIT J OPHTHALMOL, V38, P397, DOI 10.1136/bjo.38.7.397; Azar Dimitri T, 2006, Trans Am Ophthalmol Soc, V104, P264; Barber AJ, 2005, INVEST OPHTH VIS SCI, V46, P2210, DOI 10.1167/iovs.04-1340; BAUM JULES L., 1965, TRANS AMER OPHTHALMOL SOC, V63, P91; Bermig J, 2002, GRAEF ARCH CLIN EXP, V240, P169, DOI 10.1007/s00417-001-0378-2; Bock F, 2013, PROG RETIN EYE RES, V34, P89, DOI 10.1016/j.preteyeres.2013.01.001; Bottoni F, 2005, ARCH OPHTHALMOL-CHIC, V123, P1644, DOI 10.1001/archopht.123.12.1644; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Brown DM, 2013, OPHTHALMOLOGY, V120, P2013, DOI 10.1016/j.ophtha.2013.02.034; Campochiaro PA, 2015, PROG RETIN EYE RES, V49, P67, DOI 10.1016/j.preteyeres.2015.06.002; Cao JT, 2010, INVEST OPHTH VIS SCI, V51, P6009, DOI 10.1167/iovs.09-4956; Cao RH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002748; Cao ZQ, 2010, NAT PROTOC, V5, P1903, DOI 10.1038/nprot.2010.149; Carmeliet P, 1998, INT J BIOCHEM CELL B, V30, P661, DOI 10.1016/S1357-2725(97)00121-0; Chang JH, 2001, CURR OPIN OPHTHALMOL, V12, P242, DOI 10.1097/00055735-200108000-00002; Chen J, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-279; Chen J, 2008, J CLIN INVEST, V118, P526, DOI [10.1172/JC133813, 10.1172/JCI33813]; Chen Jing, 2007, Angiogenesis, V10, P133, DOI 10.1007/s10456-007-9066-0; Chen J, 2014, INVEST OPHTH VIS SCI, V55, P6535, DOI 10.1167/iovs.14-15615; Chen J, 2011, CURR OPIN PEDIATR, V23, P173, DOI 10.1097/MOP.0b013e3283423f35; Chen J, 2011, CIRCULATION, V124, P1871, DOI 10.1161/CIRCULATIONAHA.111.040337; Chen J, 2009, INVEST OPHTH VIS SCI, V50, P1329, DOI 10.1167/iovs.08-2521; Chen Y, 2009, MICROVASC RES, V78, P119, DOI 10.1016/j.mvr.2009.02.005; Chiang H.H., 2013, AM ACAD OPTHALMOL, V1, P35, DOI 10.1016/j.asoc.2020.106210; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Crawford TN, 2009, CURR DIABETES REV, V5, P8, DOI 10.2174/157339909787314149; Crawford Y, 2009, CELL TISSUE RES, V335, P261, DOI 10.1007/s00441-008-0675-8; CRISWICK VG, 1969, AM J OPHTHALMOL, V68, P578, DOI 10.1016/0002-9394(69)91237-9; CUNNINGHAM S, 1995, LANCET, V346, P1464, DOI 10.1016/S0140-6736(95)92475-2; Cursiefen C, 2005, AM J PATHOL, V166, P1367, DOI 10.1016/S0002-9440(10)62355-3; Cursiefen C, 2006, P NATL ACAD SCI USA, V103, P11405, DOI 10.1073/pnas.0506112103; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082; Davis J, 2011, INVEST OPHTH VIS SCI, V52, P4158, DOI 10.1167/iovs.10-6726; Dejana E, 2010, CIRC RES, V107, P943, DOI 10.1161/CIRCRESAHA.110.223750; DOBI ET, 1989, ARCH OPHTHALMOL-CHIC, V107, P264, DOI 10.1001/archopht.1989.01070010270035; Donati MC, 2006, OPHTHALMOLOGICA, V220, P31, DOI 10.1159/000089272; Dorrell MI, 2002, INVEST OPHTH VIS SCI, V43, P3500; Dorrell MI, 2009, J CLIN INVEST, V119, P611, DOI 10.1172/JCI35977; Doyle SL, 2015, INVEST OPHTH VIS SCI, V56, P5424, DOI 10.1167/iovs.15-17264; ELDIRINI AA, 1991, RETINA-J RET VIT DIS, V11, P244, DOI 10.1097/00006982-199111020-00010; Ellenberg D, 2010, PROG RETIN EYE RES, V29, P208, DOI 10.1016/j.preteyeres.2010.01.002; Elman MJ, 2010, OPHTHALMOLOGY, V117, P1064, DOI 10.1016/j.ophtha.2010.02.031; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Ferrari G, 2016, BRIT J OPHTHALMOL, V100, P1005, DOI 10.1136/bjophthalmol-2015-307901; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Foxton R, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.110; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; FRYKMAN PK, 1995, P NATL ACAD SCI USA, V92, P8453, DOI 10.1073/pnas.92.18.8453; Fulton AB, 2009, DOC OPHTHALMOL, V118, P55, DOI 10.1007/s10633-008-9127-8; Gal M, 2014, AM J MED GENET A, V164, P2996, DOI 10.1002/ajmg.a.36739; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Giacomini C, 2014, EXP EYE RES, V121, P1, DOI 10.1016/j.exer.2014.02.005; GIMBRONE MA, 1974, J NATL CANCER I, V52, P413, DOI 10.1093/jnci/52.2.413; Gong Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132643; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Grossniklaus HE, 2010, PROG RETIN EYE RES, V29, P500, DOI 10.1016/j.preteyeres.2010.05.003; Gu XL, 2002, INVEST OPHTH VIS SCI, V43, P496; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hahn N, 2012, INVEST OPHTH VIS SCI, V53, P3260, DOI 10.1167/iovs.12-9676; Haines JL, 2006, INVEST OPHTH VIS SCI, V47, P329, DOI 10.1167/iovs.05-0116; Han ZC, 2013, INVEST OPHTH VIS SCI, V54, P574, DOI 10.1167/iovs.12-10959; Hartnett M. E., 2013, PEDIAT RETINA; Hartnett ME, 2012, NEW ENGL J MED, V367, P2515, DOI 10.1056/NEJMra1208129; Hasegawa E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106507; Heckenlively JR, 2003, RETINA-J RET VIT DIS, V23, P518, DOI 10.1097/00006982-200308000-00012; Henkind P., 1979, OCULAR CIRCULATION, P98; Holz FG, 2004, AM J OPHTHALMOL, V137, P504, DOI 10.1016/j.ajo.2003.11.026; Hsu CC, 2015, J CHIN MED ASSOC, V78, P323, DOI 10.1016/j.jcma.2014.10.002; Hu WZ, 2008, INVEST OPHTH VIS SCI, V49, P407, DOI 10.1167/iovs.07-0870; Hua J, 2011, INVEST OPHTH VIS SCI, V52, P2809, DOI 10.1167/iovs.10-6496; Ishikawa K, 2016, EXP EYE RES, V142, P19, DOI 10.1016/j.exer.2015.03.009; Ito T, 2013, AM J PATHOL, V182, P586, DOI 10.1016/j.ajpath.2012.10.012; Joyal JS, 2016, NAT MED, V22, P439, DOI 10.1038/nm.4059; Junge HJ, 2009, CELL, V139, P299, DOI 10.1016/j.cell.2009.07.048; JUNOD A, 1969, J CLIN INVEST, V48, P2129, DOI 10.1172/JCI106180; Kather JN, 2014, INVEST OPHTH VIS SCI, V55, P7637, DOI 10.1167/iovs.14-15430; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Kenyon BM, 1996, INVEST OPHTH VIS SCI, V37, P1625; Kiel J.W., 2010, OCULAR CIRCULATION; Kinnunen K, 2012, ANN MED, V44, P1, DOI 10.3109/07853890.2010.532150; KINSEY VE, 1956, ARCH OPHTHALMOL-CHIC, V56, P481, DOI 10.1001/archopht.1956.00930040489001; Kitamura T, 2008, NAT CELL BIOL, V10, P329, DOI 10.1038/ncb1695; Krzystolik MG, 2002, ARCH OPHTHALMOL-CHIC, V120, P338; Ksander BR, 2014, NATURE, V511, P353, DOI 10.1038/nature13426; Kurihara T, 2012, J CLIN INVEST, V122, P4213, DOI 10.1172/JCI65157; Kvanta A, 1996, INVEST OPHTH VIS SCI, V37, P1929; Kwak N, 2000, INVEST OPHTH VIS SCI, V41, P3158; Kyosseva SV, 2013, EXP EYE RES, V116, P63, DOI 10.1016/j.exer.2013.08.003; Lafaut BA, 2000, BRIT J OPHTHALMOL, V84, P1269, DOI 10.1136/bjo.84.11.1269; Lai AKW, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/106594; Lambert V, 2013, NAT PROTOC, V8, P2197, DOI 10.1038/nprot.2013.135; Lange C, 2009, GRAEF ARCH CLIN EXP, V247, P1205, DOI 10.1007/s00417-009-1116-4; Lee H, 2014, INVEST OPHTH VIS SCI, V55, P2885, DOI 10.1167/iovs.14-14093; Li C, 2007, ARCH OPHTHALMOL-CHIC, V125, P795, DOI 10.1001/archopht.125.6.795; Li YW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017106; Liu CH, 2015, P NATL ACAD SCI USA, V112, P12163, DOI 10.1073/pnas.1508426112; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; Lopez PF, 1996, INVEST OPHTH VIS SCI, V37, P855; Luhmann UFO, 2005, INVEST OPHTH VIS SCI, V46, P3372, DOI 10.1167/iovs.05-0174; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Madan A, 2003, FRONT BIOSCI-LANDMRK, V8, pD1030, DOI 10.2741/1056; McLeod DS, 1998, INVEST OPHTH VIS SCI, V39, P1918; McLeod DS, 1996, INVEST OPHTH VIS SCI, V37, P1322; McLeod DS, 1996, INVEST OPHTH VIS SCI, V37, P300; MIDENA E, 1989, OPHTHALMIC RES, V21, P106, DOI 10.1159/000266787; MILLER H, 1986, INVEST OPHTH VIS SCI, V27, P1644; Mintz-Hittner HA, 2011, NEW ENGL J MED, V364, P603, DOI 10.1056/NEJMoa1007374; Montezuma SR, 2009, SEMIN OPHTHALMOL, V24, P52, DOI 10.1080/08820530902800017; Moore KL, 2009, CLIN ORIENTED ANATOM; Mwaikambo BR, 2008, CORNEA, V27, P1037, DOI 10.1097/ICO.0b013e31817780b6; Nagai N, 2015, AM J PATHOL, V185, P2534, DOI 10.1016/j.ajpath.2015.04.029; Nagai N, 2014, INVEST OPHTH VIS SCI, V55, P3709, DOI 10.1167/iovs.14-13989; Netter FH, 2006, ATLAS HUMAN ANATOMY; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; NIEDERKORN JY, 1990, INVEST OPHTH VIS SCI, V31, P948; Ning X, 2004, INT J MOL MED, V13, P87; Ohlmann A, 2005, J NEUROSCI, V25, P1701, DOI 10.1523/JNEUROSCI.4756-04.2005; OKA K, 1994, EUR J BIOCHEM, V224, P975, DOI 10.1111/j.1432-1033.1994.00975.x; Okamoto N, 1997, AM J PATHOL, V151, P281; ORMEROD LD, 1989, INVEST OPHTH VIS SCI, V30, P2148; Ouyang H, 2014, NATURE, V511, P358, DOI 10.1038/nature13465; Paneghetti L, 2016, VASC CELL, V8, DOI 10.1186/s13221-016-0036-4; Penn JS, 2008, PROG RETIN EYE RES, V27, P331, DOI 10.1016/j.preteyeres.2008.05.001; PENN JS, 1993, INVEST OPHTH VIS SCI, V34, P576; Penn JS, 2001, INVEST OPHTH VIS SCI, V42, P283; Pennesi ME, 2012, MOL ASPECTS MED, V33, P487, DOI 10.1016/j.mam.2012.06.003; PHELPS DL, 1984, PEDIATRICS, V73, P1; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; Poor SH, 2014, INVEST OPHTH VIS SCI, V55, P6525, DOI 10.1167/iovs.14-15067; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Rattner A, 2014, INVEST OPHTH VIS SCI, V55, P8614, DOI 10.1167/iovs.14-15693; RERUP C C, 1970, Pharmacological Reviews, V22, P485; Riordan-Eva E. T. C. Paul, 2011, VAUGHAN ASBURYS GEN; Robinson GS, 2001, FASEB J, V15, P1215, DOI 10.1096/fj.00-0598fje; Robinson R, 2012, DIS MODEL MECH, V5, P444, DOI 10.1242/dmm.009597; Rogers MS, 2007, NAT PROTOC, V2, P2545, DOI 10.1038/nprot.2007.368; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Ross M. H., 2005, HISTOLOGY TEXT ATLAS; Ryan S J, 1979, Trans Am Ophthalmol Soc, V77, P707; Sapieha P, 2010, J CLIN INVEST, V120, P3022, DOI 10.1172/JCI42142; Sene A, 2015, TRENDS MOL MED, V21, P43, DOI 10.1016/j.molmed.2014.10.005; Shaw SG, 2006, EXP BIOL MED, V231, P1101; Singh Parul, 2013, Oman J Ophthalmol, V6, P83, DOI 10.4103/0974-620X.116624; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Smith LEH, 1999, NAT MED, V5, P1390, DOI 10.1038/70963; Smith LEH, 2008, INVEST OPHTH VIS SCI, V49, P5177, DOI 10.1167/iovs.08-2584; Stahl A, 2009, ANGIOGENESIS, V12, P297, DOI 10.1007/s10456-009-9155-3; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Stalmans I, 2002, J CLIN INVEST, V109, P327, DOI 10.1172/jci0214362; Standring S, 2008, GRAYS ANATOMY; Steen B, 1998, INVEST OPHTH VIS SCI, V39, P2194; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; STONE J, 1995, J NEUROSCI, V15, P4738, DOI 10.1523/jneurosci.15-07-04738.1995; Sun Y, 2017, J EXP MED, V214, P1753, DOI 10.1084/jem.20161645; Sun Y, 2015, P NATL ACAD SCI USA, V112, P10401, DOI 10.1073/pnas.1504387112; Sun Y, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-8; Takahashi T, 2000, AM J OPHTHALMOL, V130, P774, DOI 10.1016/S0002-9394(00)00772-8; Tang ZS, 2011, JOVE-J VIS EXP, DOI 10.3791/3077; Tiebel O, 1999, ATHEROSCLEROSIS, V145, P239, DOI 10.1016/S0021-9150(99)00068-4; Tobe T, 1998, AM J PATHOL, V153, P1641, DOI 10.1016/S0002-9440(10)65753-7; Tobe T, 1998, INVEST OPHTH VIS SCI, V39, P180; TOIVONEN J, 1991, ACTA ANAESTH SCAND, V35, P496, DOI 10.1111/j.1399-6576.1991.tb03336.x; Toomes C, 2004, AM J HUM GENET, V74, P721, DOI 10.1086/383202; Vahatupa M, 2016, INVEST OPHTH VIS SCI, V57, P4898, DOI 10.1167/iovs.16-19212; Wacker A, 2011, CURR OPIN CELL BIOL, V23, P676, DOI 10.1016/j.ceb.2011.10.002; Wang ZX, 2016, AM J PATHOL, V186, P2588, DOI 10.1016/j.ajpath.2016.06.015; Wang ZX, 2015, ARTERIOSCL THROM VAS, V35, P855, DOI 10.1161/ATVBAHA.114.304627; Wang ZX, 2014, CORNEA, V33, P405, DOI 10.1097/ICO.0000000000000032; WARBURG M, 1975, ACTA OPHTHALMOL, V53, P217; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Westenskow PD, 2013, J CLIN INVEST, V123, P4900, DOI 10.1172/JCI70230; Won JY, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/391384; Wu YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126750; Wyne KL, 1996, ARTERIOSCL THROM VAS, V16, P407, DOI 10.1161/01.ATV.16.3.407; Xia CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011676; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Xu QW, 2001, INVEST OPHTH VIS SCI, V42, P789; Yanagi Y, 2002, INVEST OPHTH VIS SCI, V43, P3495; Ye X, 2010, TRENDS MOL MED, V16, P417, DOI 10.1016/j.molmed.2010.07.003; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047; York Jackie R, 2004, J Perinatol, V24, P82, DOI 10.1038/sj.jp.7211040; Yoshida J, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/137136; Zhou YL, 2014, J CLIN INVEST, V124, P3825, DOI 10.1172/JCI76431	197	78	83	1	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4665	4681		10.1096/fj.201700336R	http://dx.doi.org/10.1096/fj.201700336R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28739642	Green Published			2022-12-28	WOS:000413398500002
J	Mahmoud, AM; Wilkinson, FL; McCarthy, EM; Moreno-Martinez, D; Langford-Smith, A; Romero, M; Duarte, J; Alexander, MY				Mahmoud, Ayman M.; Wilkinson, Fiona L.; McCarthy, Eoghan M.; Moreno-Martinez, Daniel; Langford-Smith, Alexander; Romero, Miguel; Duarte, Juan; Alexander, M. Yvonne			Endothelial microparticles prevent lipid-induced endothelial damage via Akt/eNOS signaling and reduced oxidative stress	FASEB JOURNAL			English	Article						extracellular microvesicles; endothelial dysfunction; Nrf2	NITRIC-OXIDE SYNTHASE; CIRCULATING MICROPARTICLES; NADPH OXIDASE; HEME OXYGENASE-1; ACTIVATION; CELLS; NRF2; DYSFUNCTION; INDUCTION; RECEPTOR	Endothelial microparticles (EMPs) are endothelium-derived submicron vesicles that are released in response to diverse stimuli and are elevated in cardiovascular disease, which is correlated with risk factors. This study investigates the effect of EMPs on endothelial cell function and dysfunction in a model of free fatty acid (FFA) palmitate-induced oxidative stress. EMPs were generated from TNF-alpha-stimulated HUVECs and quantified by using flow cytometry. HUVECs were treated with and without palmitate in the presence or absence of EMPs. EMPs were found to carry functional eNOS and to protect against oxidative stress by positively regulating eNOS/Akt signaling, which restored NO production, increased superoxide dismutase and catalase, and suppressed NADPH oxidase and reactive oxygen species (ROS) production, with the involvement of NF-erythroid 2-related factor 2 and heme oxygenase-1. Conversely, under normal conditions, EMPs reduced NO release and increased ROS and redox-sensitive marker expression. In addition, functional assays using EMP-treated mouse aortic rings that were performed under homeostatic conditions demonstrated a decline in endothelium-dependent vasodilatation, but restored the functional response under lipid-induced oxidative stress. These data indicate that EMPs harbor functional eNOS and potentially play a role in the feedback loop of damage and repair during homeostasis, but are also effective in protecting against FFA-induced oxidative stress; thus, EMP function is reflected by the microenvironment.Mahmoud, A. M., Wilkinson, F. L., McCarthy, E. M., Moreno-Martinez, D., Langford-Smith, A., Romero, M., Duarte, J., Alexander, M. Y. Endothelial microparticles prevent lipid-induced endothelial damage via Akt/eNOS signaling and reduced oxidative stress.	[Mahmoud, Ayman M.; Wilkinson, Fiona L.; McCarthy, Eoghan M.; Moreno-Martinez, Daniel; Langford-Smith, Alexander; Alexander, M. Yvonne] Manchester Metropolitan Univ, Healthcare Sci Res Ctr, Fac Sci & Engn, Manchester, Lancs, England; [Mahmoud, Ayman M.; Wilkinson, Fiona L.; McCarthy, Eoghan M.; Moreno-Martinez, Daniel; Langford-Smith, Alexander; Alexander, M. Yvonne] Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Mahmoud, Ayman M.] Beni Suef Univ, Div Physiol, Dept Zool, Fac Sci, Bani Suwayf, Egypt; [McCarthy, Eoghan M.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Inst Inflammat & Repair, Ctr Musculoskeletal Res, Manchester, Lancs, England; [McCarthy, Eoghan M.] Cent Manchester Univ Hosp NHS Fdn Trust, Natl Inst Hlth Res Manchester, Musculoskeletal Biomed Res Unit, Manchester, Lancs, England; [Romero, Miguel] Univ Granada, Sch Pharm, Dept Pharmacol, Granada, Spain; [Duarte, Juan] Inst Invest Biosanitaria Granada, Granada, Spain	Manchester Metropolitan University; University of Manchester; Egyptian Knowledge Bank (EKB); Beni Suef University; University of Manchester; University of Manchester; University of Granada; Instituto de Investigacion Biosanitaria IBS Granada	Alexander, MY (corresponding author), Manchester Metropolitan Univ, Healthcare Sci Res Ctr, John Dalton Bldg,Chester St, Manchester M1 5GD, Lancs, England.	y.alexander@mmu.ac.uk	Mahmoud, Ayman M./S-2613-2016; Duarte, Juan/AAH-1574-2020; perez, miguel/GXF-5077-2022; Langford-Smith, Alex/K-7624-2017; Romero, Miguel/K-6053-2014; Duarte, Juan/K-6472-2014	Mahmoud, Ayman M./0000-0003-0279-6500; Duarte, Juan/0000-0002-9153-5857; Langford-Smith, Alex/0000-0001-7006-0592; Romero, Miguel/0000-0003-0578-1099; Duarte, Juan/0000-0002-9153-5857; Wilkinson, Fiona/0000-0002-0358-3489; Moreno Martinez, Daniel/0000-0001-5633-0998	Science and Technology Development Fund	Science and Technology Development Fund(Science and Technology Development Fund (STDF))	The authors thank the Science and Technology Development Fund and the International Atherosclerosis Society for supporting the travel of A.M.M. The authors declare no conflicts of interest.	Addabbo F, 2009, HYPERTENSION, V53, P885, DOI 10.1161/HYPERTENSIONAHA.109.130054; Aharon A, 2008, THROMB HAEMOSTASIS, V100, P878, DOI 10.1160/TH07-11-0691; Alexander MY, 2000, CARDIOVASC RES, V47, P609, DOI 10.1016/S0008-6363(00)00079-1; Amabile N, 2014, EUR HEART J, V35, P2972, DOI 10.1093/eurheartj/ehu153; Boulanger CM, 2001, CIRCULATION, V104, P2649, DOI 10.1161/hc4701.100516; Brodsky SV, 2004, AM J PHYSIOL-HEART C, V286, pH1910, DOI 10.1152/ajpheart.01172.2003; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Burger D, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.001842; Burger D, 2011, ARTERIOSCL THROM VAS, V31, P1898, DOI 10.1161/ATVBAHA.110.222703; Cade WT, 2008, PHYS THER, V88, P1322, DOI 10.2522/ptj.20080008; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; Cheng XH, 2011, ANTIOXID REDOX SIGN, V14, P469, DOI 10.1089/ars.2010.3283; Chien SJ, 2014, TRANSL RES, V163, P43, DOI 10.1016/j.trsl.2013.09.008; Cho HY, 2010, TOXICOL APPL PHARM, V244, P43, DOI 10.1016/j.taap.2009.07.024; Combes V, 1999, J CLIN INVEST, V104, P93, DOI 10.1172/JCI4985; Datla SR, 2007, HYPERTENSION, V50, P636, DOI 10.1161/HYPERTENSIONAHA.107.092296; Dignat-George F, 2011, ARTERIOSCL THROM VAS, V31, P27, DOI 10.1161/ATVBAHA.110.218123; Dimmeler S, 2000, FEBS LETT, V477, P258, DOI 10.1016/S0014-5793(00)01657-4; Endemann DH, 2004, J AM SOC NEPHROL, V15, P1983, DOI 10.1097/01.ASN.0000132474.50966.DA; Feletou M, 2006, AM J PHYSIOL-HEART C, V291, pH985, DOI 10.1152/ajpheart.00292.2006; Fledderus JO, 2008, ARTERIOSCL THROM VAS, V28, P1339, DOI 10.1161/ATVBAHA.108.165811; Guo WX, 2008, ARCH MED RES, V39, P434, DOI 10.1016/j.arcmed.2008.02.001; Gyorgy B, 2011, BLOOD, V117, pE39, DOI 10.1182/blood-2010-09-307595; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Heathfield SK, 2013, CLIN EXP RHEUMATOL, V31, P225; Heiss EH, 2009, J BIOL CHEM, V284, P31579, DOI 10.1074/jbc.M109.009175; Hill AF, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.22859; Hirose A, 2010, FEBS LETT, V584, P61, DOI 10.1016/j.febslet.2009.11.082; Horn P, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.003764; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; Italiano JE, 2010, CURR OPIN HEMATOL, V17, P578, DOI 10.1097/MOH.0b013e32833e77ee; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Jansen F, 2012, ARTERIOSCL THROM VAS, V32, P1925, DOI 10.1161/ATVBAHA.112.253229; Jiang F, 2006, HYPERTENSION, V48, P950, DOI 10.1161/01.HYP.0000242336.58387.1f; Jung KA, 2010, MOLECULES, V15, P7266, DOI 10.3390/molecules15107266; Kim YM, 2011, ANTIOXID REDOX SIGN, V14, P137, DOI 10.1089/ars.2010.3153; Lacroix R, 2012, J THROMB HAEMOST, V10, P437, DOI 10.1111/j.1538-7836.2011.04610.x; Laughlin MH, 2008, J APPL PHYSIOL, V104, P588, DOI 10.1152/japplphysiol.01096.2007; Lee CH, 2014, INT J MOL SCI, V15, P10334, DOI 10.3390/ijms150610334; Leroyer AS, 2009, CIRCULATION, V119, P2808, DOI 10.1161/CIRCULATIONAHA.108.816710; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; Li LR, 2014, CHEM-BIOL INTERACT, V209, P56, DOI 10.1016/j.cbi.2013.12.005; Liu TS, 2014, J ENDOCRINOL INVEST, V37, P645, DOI 10.1007/s40618-014-0086-5; LOTVALL J, 2014, J EXTRACELL VESICLES, V3; Luo ZM, 2015, HYPERTENSION, V65, P896, DOI 10.1161/HYPERTENSIONAHA.114.04760; Mahmoud AM, 2017, BBA-GEN SUBJECTS, V1861, P3311, DOI 10.1016/j.bbagen.2016.08.013; Mahmoud AM, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0491-1; Mann GE, 2007, CARDIOVASC RES, V75, P261, DOI 10.1016/j.cardiores.2007.04.004; Mause SF, 2010, CIRC RES, V107, P1047, DOI 10.1161/CIRCRESAHA.110.226456; McCarthy EM, 2016, VASC PHARMACOL, V86, P71, DOI 10.1016/j.vph.2016.05.016; Moreno-Martinez D, 2014, HEART, V100, DOI 10.1136/heartjnl-2014-306916.6; Mostefai HA, 2008, J IMMUNOL, V180, P5028, DOI 10.4049/jimmunol.180.7.5028; Mostefai HA, 2008, AM J RESP CRIT CARE, V178, P1148, DOI 10.1164/rccm.200712-1835OC; Parker B, 2014, ANN RHEUM DIS, V73, P1144, DOI 10.1136/annrheumdis-2012-203028; Perez-Casal M, 2009, HAEMATOL-HEMATOL J, V94, P387, DOI 10.3324/haematol.13547; Quintela AM, 2014, BRIT J PHARMACOL, V171, P3089, DOI 10.1111/bph.12646; Romero M, 2009, ATHEROSCLEROSIS, V202, P58, DOI 10.1016/j.atherosclerosis.2008.03.007; Schiro A, 2014, ATHEROSCLEROSIS, V234, P295, DOI 10.1016/j.atherosclerosis.2014.03.019; Schiro A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16658; Siow RCM, 1999, CARDIOVASC RES, V41, P385, DOI 10.1016/S0008-6363(98)00278-8; Toral M, 2015, CLIN SCI, V129, P823, DOI 10.1042/CS20150111; Wheatcroft SB, 2003, DIABETIC MED, V20, P255, DOI 10.1046/j.1464-5491.2003.00869.x; Xue MZ, 2008, DIABETES, V57, P2809, DOI 10.2337/db06-1003; Yuana Y, 2013, BLOOD REV, V27, P31, DOI 10.1016/j.blre.2012.12.002; Zhang HR, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0237-1	65	66	68	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4636	4648		10.1096/fj.201601244RR	http://dx.doi.org/10.1096/fj.201601244RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28687612	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000413397400038
J	Xue, JX; Jiang, W; Chen, YJ; Gong, FJ; Wang, MY; Zeng, P; Xia, C; Wang, Q; Huang, KH				Xue, Junxin; Jiang, Wei; Chen, Yongjun; Gong, Fengju; Wang, Minyan; Zeng, Peng; Xia, Can; Wang, Quan; Huang, Kehe			Thioredoxin reductase from Toxoplasma gondii: an essential virulence effector with antioxidant function	FASEB JOURNAL			English	Article						protein expression; enzyme activity; immune evasion; gene knockout	PROTOZOAN PARASITES; OXIDATIVE STRESS; REACTIVE OXYGEN; PLASMODIUM-FALCIPARUM; INNATE IMMUNITY; INFECTION; CATALASE; CELLS; MACROPHAGES; EXPRESSION	Thioredoxin reductase (TR) can help pathogens resist oxidative-burst injury from host immune cells by maintaining a thioredoxin-reduction state during NADPH consumption. TR is a necessary virulence factor that enables the persistent infection of some parasites. We performed bioinformatics analyses and biochemical assays to characterize the activity, subcellular localization, and genetic ablation of Toxoplasma gondii TR (TgTR), to shed light on its biologic function. We expressed the TgTR protein with an Escherichia coli expression system and analyzed its enzyme activity, reporting a K-m for the recombinant TgTR of 11.47-15.57 mu M, using NADPH as a substrate, and 130.48-151.09 mu M with dithio-bis-nitrobenzoic acid as a substrate. The TgTR sequence shared homology with that of TR, but lacked a selenocysteine residue in the C-terminal region and was thought to contain 2 flavin adenine dinucleotide (FAD) domains and 1 NADPH domain. In addition, immunoelectron microscopy results showed that TgTR was widely dispersed in the cytoplasm, and we observed that parasite antioxidant capacity, invasion efficiency, and proliferation were decreased in TR-knockout (TR-KO) strains in vitro, although this strain still stimulated the release of reactive oxygen species release in mouse macrophages while being more sensitive to H2O2 toxicity in vitro. Furthermore, our in vivo results revealed that the survival time of mice infected with the TR-KO strain was significantly prolonged relative to that of mice infected with the wild-type strain. These results suggest that TgTR plays an important role in resistance to oxidative damage and can be considered a virulence factor associated with T. gondii infection.-Xue, J., Jiang, W., Chen, Y., Gong, F., Wang, M., Zeng, P., Xia, C., Wang, Q., Huang, K. Thioredoxin reductase from Toxoplasma gondii: an essential virulence effector with antioxidant function.	[Xue, Junxin; Jiang, Wei; Chen, Yongjun; Wang, Minyan; Wang, Quan] Chinese Acad Agr Sci, Shanghai Vet Res Inst, 518 Ziyue Rd, Shanghai, Peoples R China; [Xue, Junxin; Gong, Fengju; Zeng, Peng; Xia, Can; Huang, Kehe] Nanjing Agr Univ, Coll Vet Med, 1 Weigang, Nanjing 210095, Jiangsu, Peoples R China; [Xue, Junxin] Shanghai Entry Exit Inspect & Quarantine Bur, Shanghai, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Nanjing Agricultural University	Wang, Q (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, 518 Ziyue Rd, Shanghai, Peoples R China.; Huang, KH (corresponding author), Nanjing Agr Univ, Coll Vet Med, 1 Weigang, Nanjing 210095, Jiangsu, Peoples R China.	wangquan@shvri.ac.cn; khhuang@njau.edu.cn			National Special Research Program for Nonprofit Trades (Agriculture) [201303045]; National Natural Science Foundation of China [31472253]; Shanghai Natural Science Foundation of China [17ZR1437300]; Basic Foundation for Scientific Research of State-level Public Welfare Institutes of China [2013JB10]	National Special Research Program for Nonprofit Trades (Agriculture); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Foundation for Scientific Research of State-level Public Welfare Institutes of China	This work was supported by National Special Research Program for Nonprofit Trades (Agriculture) Grant 201303045 (to Q.W.), National Natural Science Foundation of China Grant 31472253 (to K.H.), Shanghai Natural Science Foundation of China Grand 17ZR1437300 (to Q.W.), and Basic Foundation for Scientific Research of State-level Public Welfare Institutes of China Grant 2013JB10 (to W.J.). The authors declare no conflicts of interest.	AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Akerman SE, 2005, J BIOL CHEM, V280, P564, DOI 10.1074/jbc.M406367200; Berens RL, 1998, J INFECT DIS, V177, P1128, DOI 10.1086/517411; Brantley EC, 2010, TRANSL ONCOL, V3, P380, DOI 10.1593/tlo.10208; Brizuela M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092411; Butcher BA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002236; Charvat RA, 2016, SCI REP-UK, V6, DOI 10.1038/srep22997; Chen XX, 2012, FREE RADICAL BIO MED, V53, P395, DOI 10.1016/j.freeradbiomed.2012.04.035; Correa G, 2010, MICROBES INFECT, V12, P497, DOI 10.1016/j.micinf.2010.03.004; Debierre-Grockiego F, 2010, GLYCOBIOLOGY, V20, P801, DOI 10.1093/glycob/cwq038; Engin AB, 2012, PARASITOL RES, V111, P1725, DOI 10.1007/s00436-012-3015-6; Fereig RM, 2016, PARASITOL INT, V65, P741, DOI 10.1016/j.parint.2016.09.008; Fomenko DE, 2007, SCIENCE, V315, P387, DOI 10.1126/science.1133114; Gan F, 2015, FREE RADICAL BIO MED, V80, P33, DOI 10.1016/j.freeradbiomed.2014.12.016; Gay G, 2016, J EXP MED, V213, P1779, DOI 10.1084/jem.20160340; Guillermo LVC, 2004, POULTRY SCI, V83, P776, DOI 10.1093/ps/83.5.776; Hunter CA, 2012, NAT REV MICROBIOL, V10, P766, DOI 10.1038/nrmicro2858; Kaasch AJ, 2000, J BIOL CHEM, V275, P1112, DOI 10.1074/jbc.275.2.1112; Kuntz AN, 2007, PLOS MED, V4, P1071, DOI 10.1371/journal.pmed.0040206; Kwok LY, 2004, MOL MICROBIOL, V51, P47, DOI 10.1046/j.1365-2958.2003.03823.x; Laliberte J, 2008, CELL MOL LIFE SCI, V65, P1900, DOI 10.1007/s00018-008-7556-x; Li ZH, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003665; Lin HC, 2015, SCIENCE, V349, P91, DOI 10.1126/science.aab0515; Lingelbach K, 1998, J CELL SCI, V111, P1467; Lobanov AV, 2009, BBA-GEN SUBJECTS, V1790, P1424, DOI 10.1016/j.bbagen.2009.05.014; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Marshall ES, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-80; McCarty SE, 2015, MOLECULES, V20, P11459, DOI 10.3390/molecules200611459; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; Moncada D, 2016, EXP PARASITOL, V164, P36, DOI 10.1016/j.exppara.2016.02.005; Naderer T, 2011, ESSAYS BIOCHEM, V51, P81, DOI [10.1042/BSE0510081, 10.1042/bse0510081]; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nebl T, 2005, PARASITOLOGY, V130, pS45, DOI 10.1017/S0031182005008152; Nischik N, 2001, MICROBES INFECT, V3, P689, DOI 10.1016/S1286-4579(01)01425-3; Novoselov SV, 2007, P NATL ACAD SCI USA, V104, P7857, DOI 10.1073/pnas.0610683104; Oliveira MP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158429; Pino P, 2007, PLOS PATHOG, V3, P1092, DOI 10.1371/journal.ppat.0030115; Portes JA, 2015, ANTIMICROB AGENTS CH, V59, P7374, DOI 10.1128/AAC.00057-15; Rahlfs S, 2002, CELL MOL LIFE SCI, V59, P1024, DOI 10.1007/s00018-002-8484-9; Ramakrishnan S, 2013, PROG LIPID RES, V52, P488, DOI 10.1016/j.plipres.2013.06.003; Roma EH, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1472-y; Rosowski EE, 2011, J EXP MED, V208, P195, DOI 10.1084/jem.20100717; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Schofield L, 2002, NATURE, V418, P785, DOI 10.1038/nature00937; Seabra SJ, 2002, EXP PARASITOL, V100, P62, DOI 10.1006/expr.2001.4675; Shen B, 2014, MBIO, V5, DOI 10.1128/mBio.01114-14; SIBLEY LD, 1986, MOL BIOCHEM PARASIT, V19, P83, DOI 10.1016/0166-6851(86)90069-1; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Sun QA, 2001, P NATL ACAD SCI USA, V98, P3673, DOI 10.1073/pnas.051454398; Tawk L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001286; Tobin CM, 2012, INFECT IMMUN, V80, P55, DOI 10.1128/IAI.05543-11; Vonlaufen N, 2008, CELL MICROBIOL, V10, P2387, DOI 10.1111/j.1462-5822.2008.01210.x; Xue JX, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1643-x; Yan C, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1432-6; Yarovinsky F, 2014, NAT REV IMMUNOL, V14, P109, DOI 10.1038/nri3598; Zheng J, 2015, INT J PARASITOL, V45, P141, DOI 10.1016/j.ijpara.2014.09.003; Zhou DH, 2014, ELECTROPHORESIS, V35, P533, DOI 10.1002/elps.201300044	57	20	24	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4447	4457		10.1096/fj.201700008R	http://dx.doi.org/10.1096/fj.201700008R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28687608				2022-12-28	WOS:000413397400022
J	Erickson, MA; Jude, J; Zhao, HJ; Rhea, EM; Salameh, TS; Jester, W; Pu, S; Harowitz, J; Nguyen, N; Banks, WA; Panettieri, RA; Jordan-Sciutto, KL				Erickson, Michelle A.; Jude, Joseph; Zhao, Hengjiang; Rhea, Elizabeth M.; Salameh, Therese S.; Jester, William; Pu, Shelley; Harowitz, Jenna; Ngan Nguyen; Banks, William A.; Panettieri, Reynold A., Jr.; Jordan-Sciutto, Kelly L.			Serum amyloid A: an ozone-induced circulating factor with potentially important functions in the lung-brain axis (vol 31, pg 3950, 2017)	FASEB JOURNAL			English	Correction									[Erickson, Michelle A.; Pu, Shelley; Harowitz, Jenna] Univ Penn, Sch Dent Med, Dept Pathol, Philadelphia, PA 19104 USA; [Jude, Joseph; Zhao, Hengjiang; Jester, William; Harowitz, Jenna] Univ Penn, Sch Dent Med, Div Pulm Allergy & Crit Care, Dept Med, Philadelphia, PA 19104 USA; [Erickson, Michelle A.; Rhea, Elizabeth M.; Salameh, Therese S.; Banks, William A.; Panettieri, Reynold A., Jr.] Vet Affairs Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA USA; [Erickson, Michelle A.; Rhea, Elizabeth M.; Salameh, Therese S.; Banks, William A.] Univ Washington, Sch Med, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA; [Jude, Joseph; Jester, William] Rutgers State Univ, Rutgers Inst Translat Med & Sci, Child Hlth Inst, New Brunswick, NJ USA	University of Pennsylvania; University of Pennsylvania; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; Rutgers State University New Brunswick; Rutgers State University Medical Center	Erickson, MA (corresponding author), 1660 South Columbian Way,Bldg 32,Room 229, Seattle, WA 98108 USA.	mericks999@gmail.com	panettieri, reynold/AAG-9485-2019; Banks, William A/K-1330-2017; Meredith, Elizabeth/AAM-4574-2021; Erickson, Michelle/G-4815-2014	Banks, William A/0000-0002-0496-3619; Harowitz, Jenna/0000-0001-7459-7821; Erickson, Michelle/0000-0002-2575-1594	NIMH NIH HHS [R01 MH106967] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH106967] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Erickson MA, 2017, FASEB J, V31, P3950, DOI 10.1096/fj.201600857RRR	1	0	0	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2018	32	1					535	535		10.1096/fj.201600857RRRERR	http://dx.doi.org/10.1096/fj.201600857RRRERR			1	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FR6JU	32754671	Green Published			2022-12-28	WOS:000419172700047
J	Pederson, T				Pederson, Thoru			Molecular Biology of the Gene	FASEB JOURNAL			English	Book Review									[Pederson, Thoru] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Pederson, T (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	thoru.pederson@umassmed.edu						Haynes R., 1948, MOL BIOL LIFE INTRO; Oncley J. L., 1959, BIOPHYSICAL SCI STUD; Pederson T, 2005, FASEB J, V19, P1583, DOI 10.1096/fj.05-1002ufm; Pederson T., 2011, BIOGRAPHICAL MEMOIRS; Pederson T, 2012, MOL BIOL CELL, V23, P3281, DOI 10.1091/mbc.E12-06-0448; Pederson T, 2012, FASEB J, V26, P967, DOI 10.1096/fj.12-0301ufm; Pederson T, 2011, FASEB J, V25, P2512, DOI 10.1096/fj.11-0802; Portugal F. H., 1977, A CENTURY OF DNA; Ptashne M., 1986, A GENETIC SWITCH; Steitz J. A., 2003, INSPIRING SCI J WATS, P159; Stent G., 1963, MOL BIOL BACTERIAL V; Watson J. D., 1965, MOL BIOL GENE; Watson J.D., 1968, DOUBLE HELIX PERSONA; Weatherall DJ., 2011, FASEB J, V25, P2513; WEAVER W, 1938, ANN REPORT ROCKEFELL, P203	15	4	4	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4399	4401		10.1096/fj.15-1101ufm	http://dx.doi.org/10.1096/fj.15-1101ufm			3	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26527575				2022-12-28	WOS:000364514700001
